From f93bfa49ad13a8c72c1b79dd32ee15cbd6e86bab Mon Sep 17 00:00:00 2001 From: github-actions <41898282+github-actions[bot]@users.noreply.github.com> Date: Sat, 6 Apr 2024 01:03:52 +0000 Subject: [PATCH] [automated] update transfemscience --- ... (USPATH 2023, abstract no. SAT-B2-T4).pdf | Bin 0 -> 102446 bytes ... (USPATH 2023, abstract no. SUN-B1-T5).pdf | Bin 0 -> 95898 bytes .../USPATH 2023 Symposium Abstracts.pdf | Bin 0 -> 1298178 bytes ...USPATH 2023 Symposium Poster Abstracts.pdf | Bin 0 -> 789666 bytes .../USPATH 2023 Symposium Program.pdf | Bin 0 -> 5097727 bytes transfemscience.org/about/index.html | 2 +- .../articles-by-author/aly/index.html | 2 +- .../articles-by-author/lain/index.html | 2 +- .../articles-by-author/mitzi/index.html | 2 +- .../articles-by-author/sam/index.html | 2 +- .../articles-by-date/index.html | 2 +- .../articles/aqueous-suspensions/index.html | 2 +- .../articles/bica-adoption/index.html | 2 +- .../articles/bone-shape-changes/index.html | 2 +- .../articles/breast-cancer-suppl/index.html | 2 +- .../articles/breast-cancer/index.html | 2 +- .../articles/buserelin-inexpensive/index.html | 2 +- .../articles/cpa-dosage/index.html | 2 +- .../articles/cpa-meningioma/index.html | 2 +- .../articles/e2-equivalent-doses/index.html | 2 +- transfemscience.org/articles/ec508/index.html | 2 +- .../articles/endo-system-muscle/index.html | 2 +- .../articles/estrogens-blood-clots/index.html | 2 +- .../genital-e2-application/index.html | 2 +- .../high-dose-transdermal-e2/index.html | 2 +- .../hormone-levels-female-puberty/index.html | 2 +- .../hormones-fat-metabolism-suppl/index.html | 2 +- .../hormones-fat-metabolism/index.html | 2 +- transfemscience.org/articles/index.html | 2 +- .../injectable-e2-meta-analysis/index.html | 2 +- .../index.html | 2 +- .../articles/nandrolone/index.html | 2 +- .../nonbinary-transfem-overview/index.html | 2 +- .../articles/oral-e2-leinung-2018/index.html | 2 +- .../oral-p4-low-levels-literature/index.html | 2 +- .../articles/oral-p4-low-levels/index.html | 2 +- .../oral-vs-transdermal-e2-suppl/index.html | 2 +- .../oral-vs-transdermal-e2/index.html | 2 +- .../pep-cardiovascular-analysis/index.html | 2 +- .../progestogens-breast-cancer/index.html | 2 +- .../progestogens-breast-dev/index.html | 2 +- .../index.html | 2 +- .../progestogens-sexual-desire/index.html | 2 +- .../progestogens-transfem-excerpts/index.html | 2 +- .../articles/puberty-blockers/index.html | 2 +- .../articles/serms-transfem-suppl/index.html | 2 +- .../articles/serms-transfem/index.html | 2 +- .../shbg-unimportant-suppl/index.html | 2 +- .../articles/shbg-unimportant/index.html | 2 +- .../articles/spiro-testosterone/index.html | 2 +- .../articles/spiro-visceral-fat/index.html | 2 +- .../sublingual-e2-transfem/index.html | 2 +- .../articles/sublingual-ev/index.html | 2 +- .../transfem-hormone-guidelines/index.html | 2 +- .../articles/transfem-intro/index.html | 2 +- .../transfem-lactation-literature/index.html | 2 +- .../articles/vte-transfem-analysis/index.html | 2 +- ...-manautou-1970-cma-stunted-mammary-dev.png | Bin 0 -> 1452383 bytes ...ez-manautou-cma-mammary-dev-no-caption.png | Bin 946655 -> 0 bytes ...ns-mcginty-1941-p4-stunted-mammary-dev.png | Bin 0 -> 865556 bytes .../lyons-mcginty-p4-stunted-mammary-dev.png | Bin 1678616 -> 0 bytes transfemscience.org/feed-posts.xml | 2 +- transfemscience.org/feed.xml | 127 ++++++++++-------- transfemscience.org/index.html | 2 +- .../misc/hormone-conc-unit-conv/index.html | 2 +- transfemscience.org/misc/index.html | 2 +- .../injectable-dose-vol-conc-conv/index.html | 2 +- .../index.html | 2 +- ...l1=&i2=2&dl2=&i3=3&dl3=&s=0&h=0&xm=30.html | 2 +- ...l1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html | 2 +- ...=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html | 2 +- ...l1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html | 2 +- ...=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html | 2 +- ...&i2=28&dl2=&i3=42&dl3=&s=0&h=0&xm=360.html | 2 +- ...&i2=45&dl2=&i3=60&dl3=&s=0&h=0&xm=360.html | 2 +- ...3=5&dl3=&i4=5&dl4=&s=e&h=0&xm=56&cc=1.html | 2 +- .../misc/injectable-e2-simulator/index.html | 2 +- ...ml?e=all_e2&d=7&r=y&di=10&xm=60&lh=bp.html | 2 +- .../misc/wpath-symposia-materials/index.html | 2 +- 79 files changed, 143 insertions(+), 122 deletions(-) create mode 100644 files.transfemscience.org/pdfs/Vierregger et al. (2023) - Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile (USPATH 2023, abstract no. SAT-B2-T4).pdf create mode 100644 files.transfemscience.org/pdfs/Warus et al. (2023) - Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults_ A Retrospective Chart Review (USPATH 2023, abstract no. SUN-B1-T5).pdf create mode 100644 files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Abstracts.pdf create mode 100644 files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Poster Abstracts.pdf create mode 100644 files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Program.pdf create mode 100644 transfemscience.org/assets/images/beyer-cruz-martinez-manautou-1970-cma-stunted-mammary-dev.png delete mode 100644 transfemscience.org/assets/images/high-dose-e-breast-dev/beyer-cruz-martinez-manautou-cma-mammary-dev-no-caption.png create mode 100644 transfemscience.org/assets/images/lyons-mcginty-1941-p4-stunted-mammary-dev.png delete mode 100644 transfemscience.org/assets/images/lyons-mcginty-p4-stunted-mammary-dev.png diff --git a/files.transfemscience.org/pdfs/Vierregger et al. (2023) - Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile (USPATH 2023, abstract no. SAT-B2-T4).pdf b/files.transfemscience.org/pdfs/Vierregger et al. (2023) - Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile (USPATH 2023, abstract no. SAT-B2-T4).pdf new file mode 100644 index 0000000000000000000000000000000000000000..ba035769b08678d776b985fb352ded3a5cb94fe8 GIT binary patch literal 102446 zcma&N1yo#3vo4IgyF(zj%is{)-QC?~aCdiicXxLU?(VK3KnTIYC3(+#&Uf#xvsdq) zuC98jx@OhPUiGXYR}c}SXJ+6)gd;C#8d*hzViyaN*Ff0b#STcq!YFNN;;c==_ScYv`JY+$AB4Y{ z|7p+qpY~3shCoYuI}t;mDU}E}3lj?)6B`o?GbbAh3llY?@SkmaC#sK_EnRG>85NxD zO=U3Ai{GSjJFR4r9YBy~=#I=IryEuMCREYT<<)F!1NiOm+>n%px-Efp({ z&j(Jwejy{Y2Ar#~$+~1$esyrfmo+y#vSy<{l#%Vt@G~s5Ue3`>9(e4G_}%o{wT?u_ zM6#*gZM(L!CwS47F?qOgg_oQ&J#Cog{xyv%=yIBnyFl7Eq7*ZFy2z3+&FYSW6}l^J zzBwG8cNPigl)ly5Kx}5=;Jj+krzxlYHuFtKd?m$;O-ToTNz`1P*;@4_gq@>m2Px1v zSiZ_V17H!#k&cd&)FMQ=3IE^~s1I34`SAo4WOq_mb3pM`77} zE{1Y4(&G{X=k&6@FqQpZm@A%&W#kfvJQP#!$FJJL9d3iBTciXY)7caE5h;uJ>RUNq zsG>~Ofv5e-k(XBcm|9wzXDBuifx4Db$}Xs(6HmshAk zVPV)dhm??bkd3u$zDvU+^G5?%9^3%ro18xk_9BbuoAHzbL0X1t>1GO`6s}6>Nl(WsN@D|3kEhT!^(hV&E(_Gn1 zC5%B)=eDYuG~htB(z9V$XL&Hm`K&xJix&T@?pPaN8^`Zh(0zM*{z1+AA%L|9RrBW{ zg;Yl+$>;8{RMV+7sZxVzPW{&Fp0OXXEM9TB2{ZN0_&aNgzuAB!K@2L=ve%KU{1$Yw zeq)D`5@7F0X(|iNJsr+3^RWf$iHL;SWHIVyo@XnTG1nW*15;H&VtD3Vn@c*UrE1J} z3s>bF^e+W$VQQWa{YyWuTHyurj7Z+JnrzqD4Y{(}*=f0~V8ER4*`4kNT^!j(wN&GH z)N+KynG!y4B#~FAQhDN3yYhT%ckjfw4iVUE{>q8D97Bb;x>hk3xy&p4`e^~R~| zBQ0eu_cwATQYEQIU5Q#Z*aeB&xO?$M&~i^4K&vT6r@e2xXT)JI`(}t*gd&B891XKu z6v(KowW8prb(RSIa>DXj&s5~3S7Z?`qtejN%XTg0G%4(-YBW2WsmkNap64hWM=apM3u(y61@C``pP?rKoJZxWXr+(rS5?PLdd)9F1#60W0;yaq;u%!31TkFO}=| zP^nsj6nhMK_;p$VHR!_71G9^PMfr$#An4`cgq{53-SglR3dwRrRQjaO^l{XW#oAv% zwvAv0T-oPnAfvFV^6BuXw?GW3Z9~^ly)JVIhu|GyG#J9-(9cdr3lBc6|>GMt>85kP zJ7r=wu)DuV3BjCl!(FZvy}4q@MH&uO47J83h6rw29!8IK!ixmtHSqeL^P$<|!w`pc zJRYEe4h@P*4OO61>ez|cZ@Jg_8!>H=BZ5xekpgv2}!na%IExbCj{rc{o4y|pbj+M%OD$F1zZ z{&TmWq0KN?g&|sKx-42>jIu=e8}|j0Mn`CBAiLuwYJk9YhS`9ZO#;5Q%e2Z#g~WS8 zlOv*J@JOZe*U!FO9&RIB{JtI0%zLHe>cOU8YGbYv;7Vu8dLHMeUF8!(!GxVw_&r+Q zk6bd};sm}_IkE#e5)EaZyb(>ovkDlvzceExZFRilA{_5x93CsPn5XqScAUZ<_`eBO z9I6%r$c!Tx&0Zc(77UM<0+NJY_jhYDTv$=rg|vIHg%_io8on9v%#=9(Qm?HhCllLV zCf`(+q$qy8`m8M(w_8N~7}-75BF^XOKx!UZ!&P-C(gdP7m#NPvxAY&sb_*BFRfozr z+6>C3mA~M++=!@(s0ks?H7sOO?mPBP0h+OZI7WzYT!v*}-c|;Ib=Np`gogU^(91)t zj+RgWPPNm0arx4bsEHCD$QNJyl6VhFwaSdRCms#Uski3hxF@j3e(B|(VT-GZh8%te zvZtINhrc(SGVnnhZcg1_OO%Y?K86hzMy!08Q0)9Ay)O%!n;9U z$-_n(PEP0V>o`!cODhTF^@UHr(k=lVBG~BktG6~-3JYNtp}%kxc9eVjA`;snsIDMy zru?wV=DK)i?w%XAX1llKySIpG)xBan+G(uV&R53^FWJgh143wYpWeYq)gv;|&{D)` zcHMG?6Gh-(GEl3q~OuzYwozCCNs3`_P(OX(&L1Ex3-)A8O&WPy=C6Fz%t?k zd!0p4*`UNYktp0|@$<|s2LxVdaKi-c;XY_wyz_9G3Wbaqs5X*v6XX~mD+zukE_cQo z({#$?$Qz56K?(6U$r~H#Qk44si_XNG~)0a)FS#VgP z1N`^K^i(w<90bUQPUoU>>=G+ge;%@2uEpB>Vl0HN3lo<~Uc3F^oCN*D_S@ml)8i?O zp**HOFyK#ZeFy^VqqRB}Z~yj^YsL#gwofs-8%RFT`u&TWW3r5F1aFj1<^D&s#6iB9 z_|g~g>R%Guuh<`7%{VCwNpq+(Eyxb8A{OMDcp02iX4!Clpnor0r<);x1K4j(6Ky8- zhFJn*0Yo$ci}0Wu?I8fpk8ZIWLmGmzsTI`9esydIpQ#%=4Cl!Bzu|e8nR)RPr!_XJa~S4`CM{vdBm96tvBU zF23J$lX#yWxoVRlPaS5*w4sv051aKJR!Ys0~)%C2-O?D&_igVqD=?@PkNM z%-KBd>u#W>1@hOx%_c4A%Cx|lhy}w1mspW5HPK&K9Rflg1Fhdsr#5=DAh`ucCCsi{ z{01ze%?aZ~>3u;RC#S-ECeJUf5vL z%*GeTKS@J8C#?C>ezId%{Ka6wgXx4~Dp2&i|DLTbo3uHK+Vi45H4pTlMkDDkIcS$! z;Z8-CQu(QNEjR)Cxjs12!M_r*_^NLfq4dQ?9z3}^Tf{Kn>CE?yzj|2)j>);yzlAV- zces4%uHH~Q45CF9$Xy0}4O(ZBc?n?M13nI;RGDfTJx;8GXu7F|d%x2gez#BRz%P(0 zdhs35@2b4PZ6l0eBJOdmuFrRM=7w}cPws7Hd1`7y=p+_9?1KTD^^)4W1{ zaxiBKdsco`va-m4nIBk$ZKpOEg7>rD|8xjG+@yP`C?6juT%e#J-z|u$w{z7i1;gg5 zVhGyxwPF^@VYFP2+Xa@%V$&d{vg`^H?KMP)YWk;jX0eyo{tZ2f=_9Cyl_qoG{2C>d zZR>g9n2j0@(JAPf`gH^$lGGR8W0n&wG*~wgsdxrXM51$=ALCQ)XyW_UhED_|(c961 z-o9jdal*)ixsOfgLC$%E>*{Iwx+M=vqmHB*05K49=j!bt#VX-uPyWSOp`2Nih_Ps{ zp$(whP7#{gAxCb=EL@E_x*!YEmgAYMugy|H@5H+LdRXt}Q#AOaKp!9f+3NzrzOQC= z>qg#gF{O|LYb_w=#Jy1868a_*Q{Th~#Ss_Q-2;Xp*DSq8E9t@s71cFn!L}EyiB&Ba z;}ONrcX*xNgs55yrb}bR%rTT zawUDrcXU8EOVNUBdmM~PST7+yhZJCXX>E0@Y53FO7r{O`tKroQk~qInxQQ3)dL4iA zedSjGdY;gJZEY-+u2NU+do=ublgJiAer~iKRN;}q*53SAvYY6xaLXfckxYn*B_vmp z2+Z~tw}O^x58od#UW$BWK5fh%Pn@{UpUgD7U$a*e!Ac-Qi2}rOHtz5MKQV)(P+LlW z8E7oxQ2`7?cl_9{xh)+pc`@y)S9yL_bg22homryljlmv~?_i4xazF+(%QD{92{*k* zP1IY;Xv`1l8L&UqYd-!qy$cW^+en5%H2dsWwKr4m8e`(GC6qt`Rf7h3m{9O=HjJ|^ zY1nZT>2}Zy&Qap%N>RDtL?gh#%HTqV)SE+&^u$^}>@|avJUl*1JYX5n*>DCj7xna9 zZoZn1;hxOcp02bNj=L0*mYt5}+Fcl^e9&&EBy*>-gD>i*K_$Bzo>P50x|wYD1nJ%v zJ-0BElNU_x^!<7Jo5`BVD0_s#m*M30xG@RKTT^bNO>l~@pHJ{=`^vEQrJ2D1XtuIG z{v!RWy+){z?F09)XkHPKN^L4do#;>c>Zo*Nq;Fq{T>l-e2zRwrdmx~U5xd!YNWu@oKD`e|gXAtuRu`rhhp zjtX047cGy(I9y*E!@~CrF2}_o>XQ#bvu1CCXOcDhMz*I!fq;_-zpMT0G`)<#`SK`aO`GGcJR6mLX5lrQ_!DYbfJ z-F|CW-pGQQyW#o?d7K5Rn1z@!0Hi^A1ms3x_QbhDy-%Qbv%Z{GW1FT&tU{kz&BLLCbymq52=Tps zm}`N#^yXy4%JfIj+{_t3V9dObMqY{VH5&5Lwqo>;jyI`3wzJW!tp7d)e)gaP^F#LI zq>>zf)Q}Sts7HqgkQ*l8job`Qtz9)H5*3%lT}O1$NulJ2M%=RM zpyuFpIA}20(lK10;Q<+Mbp-Yuv(S<4iQcpwOf@a#z!`z6U=D3a{DKxi8qSuK6b6s}_PtcClsHB zYf%Ou6OW+HQIJw9q++>vxJ3e27yc+KrRl6a4iYG5SP`OMDW4HX^RRnF*PVaTYC54q zQW+sPARvl@MVm$ZB6l*TEv?irIRfEco~usD8|d%f5QiWjOr(D1Mvtn%U~CBb&33*n z`y|aQk)7ulH4(N@T;Dc!O+0Fx!>&{lIt(eE1WVHaLvWa6Y373H1X|#{PG{{x|JNDk z;cnzsU(8$$QybgjfZD4dj}k<=U9h(jv3dKLh*TiN?q?FRZ*AJOlZn{(@5SM0B=^D@8^NOxY*BYBO zsG=7S+MGpN#5J;PPP+8r{oUWj^X_p$i2=G;aX%NuS{~^)+2jc=sAtceFR~YUlQ+-a+vyrkj*g}LiBn_U=7miCA`lH__#8}QL zKF7U)F|PpERUo|t%0&2p_WZo#)_q7VD)^4e-jbY@k3zg~o=k6Y5^dKRIVwx|YV48? zd|+Wa@u6ZQ_Ws+!5@~n_*h(P+NQN*rn{2L&g*~_5L&V_Dl+|Q_qT_Q3K7`!CyF+#4WS%z zY&g$)LVL86U#2#%H7`Gp3*+EbmQ~JxI{Y(LWD3Uwz(6SLgI6SySRMvt-cKY zMEjC`a7=w(svgL0cOdSEH;dn@S5k9)R1lvfd_s33Y30uuTsaD+bY6|j;1p-zi48aK&k4o`**KsYcN#c$P zDg&`T0bwqFo3{|W27!T}0rHnJrb`{eM8zQ)xkz|m@yObbf!swksa8X?c4xm5g=1gM z;qNN`sB=ob=v-HZibo9X*Lx@;Ui;xfC;omU`)E;6+9&x@Lh6_-$tl0EF05qA2lfPq1B9WYJx$ZMS}L;S-@GX0P2_83=d{>E(NqTVVg>o3jw`dwcuc~n0he? zg0$AsV7)U1CB~X$1CaHnH^D8@%L6p%O-GJLmjTK*}>F~iQkZ}Cdzn3xmFAWwpc1C3vBj6v-L&eF(^e_3LVy|jv`KJX> z!u5~(U+Lc%)GbYb79W%c3kT=l!3qG7008WN2PY>N2|GIn2{RWn2`ek>KjTC8(ZK&l z_e1ut-M=>fU-N(Ke_;H<`8z)ReJ~Lpp8gCDmJeFvWBgq+Gm~(9MD}O>#}dHwkKP|I zoFCr*>VC-o+WnW_f7|^R1{WLKe`B+M;Qhg2`mg&R9H#$1?;rGk`Mduo%0G4=x__eki}?rlV|-Y%|GED;^PlMtN%am{+#}Q^!_>bKe9jff3p8? z{{QIxtN$_U{wJCA$M3%-Bj{}Whst99;M6{tJO>F=OLGe#2?sMfeMfQSyUmv@{m9Gq?GNKQpyeBjM!y zhcNqN{XfOasPSJ10Wfp@=gI$s@bAh0pJ_BUE~XDU?jKH#nS|@3O#U}k%{$dY2SXfd z%+KDl6DJh(SOEjK(>#C7T_mPcMAxW$Rkkp38K77sgaQd6N*+l8)o7&B{e4gyG)}Sm zJJ<*h4NaJiRV;2mOvEL(?-CAwri+1@wSQdK)6mlCyO&~XY(}}gcWF9 zx8?19S#LD^rhjZmzofDZ@Cak`#dy-aotub}EtJRG6H*51TkG+4e0p&4Q3G>XhesPR zla2T5RJp|V+ya5Zch8+ziEtUYANuFM5E$CC&|g_e(F=`tW*#6%ofmT) zcdJ$C82jqGm*rz+WR2=x7To`^THe?kTdkATes{eF=Z3fl`n+y{fTSoxxO=wLA-&4c z<#KbYHmle3j`8f8*ZcOH;HTWX8#Dp|oBQ~jp&#z=)yJK8gW++-ed6D?Khpc+-p&pk z4=KG_92btlCA{$f1*xhx3H{c6f>E8l;=$y_lc*Bzh0w4^h=9n&chdiT9=9nir+VMxSZc|5OvMI=2z zmdRn~a(R7w4T(x~c$!!)v|hExNJ~!LrmGV$Reh-0bn6{?{Gw6qW^GmQlW>%SJJ^01 zQTRJKmujO`_C-7jT{PMWEVWQ)z0f$;M98U?`~y`(7pGb_9Rup($npW;wm@SREMt*g z)LF<`?r>@ByzG+kGU{O_KRG`~uusDFa}S#e-Y1{WF-a5>=p`Wwu;-B~^qR$#N#>H)$Fk?Y-8x^?Hc@A_$uvcCbT^CdDIO*53s_)&K*c78H*tv)HLw0eapxo4VfYc z&~wp%K^+W%6v8WOms%rNfni+IyKuOrcg)72Wt}Lr3Qz0f?qYUyaTlT*uyw{ zQ2!B20#O2G3dxtWA=${L17}~rsVS9mS3-Io3sm={;7j}T;t-j0oa>~|RUKiJojpu# zHm*sJvDvCXV2ERz-cN1TU3fN4-O2&gq7cm_XIV(q7i#p2HWF7VHSs0Vh`H<+VcFUZ z=7@zdK^e{f^>bFtNy!QCeH1t!r|6o`wWk-coTI-_y-#{ir=ikN(`Y?KBqL!X**x=V z!bRa(_t@+WI)keJFS&b1;BaSiXP|Zt=(VkFORJQ21wAw#4W88R_dR|j$lUV0Xb>Cf zejh-ckL^yY8oPYf%!%RR#+I!eyBWG|pseYT@G6h+_5sDTv(l5!J4x#Kb0((~$6OhBBw+`B*VimjdYc5Az>-A>&ssW0GlZ#&|2A#8_t zC<>)8vvG?gcYq*UllL(O)pBw)GttJcDNFmRotzGao9ds%dcgv7B zwuYq{^@WZoglO0CO=qmBT<-erY^k%fyt8$h3`nNWp}sms-swwUGxtUB+>Ny-bJe2J zrOu-L1Kf**prH0xQi8#han1+lv*a0)RW_pCC#IViOfVsq=&eRb2XJgQl zLua~SY$^eErSIhL(!b!4Z(+))lh_j@A(WC}c_*T-iX9PKA@W2Fyd5$CbYX=CArChKx7Tp3Q z3<*!T!YY;E_dRmoVZKBO3UJ(WJl!&U6&Z3BDN|rlAayVXiz1h*0=cRpU|Z;uOEE_| zy345iuME2;U~6`b0qr_XYo=*Ez=mFXY^4d2F3Hv;YZ#?9!*)QgHO1C=a~-KQ$+W>H zb;z}0+Xi`aa_WNf0oWRMZQgMO!ZVK4FmweoX)M0Z?3$gUFjj@WCYd@5w?^%niP^|{ zMaMHX(*%D-+BMv3n6{4Tnu6J2eZ}215UB}EYifE$L2HhA0p(J(QQ#VhBB>G)SdJx{ z5Mfs+2E=YDgsw7CtB1Gjz zk%U~o^QvF{#CK6mqjIW}z+D%)45?bkP^si1nNl%%5!qQeu?%q0-B#dOrdKVn(=MxF zUD2$X<2J{14F1_%M+Pj8U6}6-uq!tPR@+r)opBP@p#zn-Whk9Ki#xL6Gwes{Or*6( zGu~tNP8@qrd+hN7D|5u)#wft_}>tiV#4eW)#k z*;V)-LOl|UE7CuddSn<^X@6`!6ZR<8EmS?=^{CY?Ub^(|jDDDaE$>eL?%zHhAdFJiZA)f_3$MaXmofSQk z`N;THf0@s_I3yTq*b2vYMvpyom)k4dibm&(Na6}n=89Pix(s?sN6!x0X2$k1kiWw8 zM!c`*_&LzKhWv5}LJ%J0z=SkVz=;rc2tyE2x5QD?H1A)o!4s9kDIT?!+U>xbqNc z%hE{}dFvRC<7`5p`!Q72a=W3j`hG?CGS_9-(?V4{t{U&MA;of8OTL=>vLXd@MGIsQ z2ni|}pDzFo7GT=~0tKxD699_r9qum?-l!$S##XPTxju(tM1qAUXlw!Ih=L4j_)voo zMLut3+Y<1(ivF`OT(J;dv9R;FzszFNrlS|b!M)B@TSwxJ1Ew#c<{X%o5bb#A${f^& z5RV1&tN`>YvM;!^0Yf*a{UEP9{K*iQ227LzGu?o_AvN95&3CU?P`}~4@8-M#eS4Cx znDYCUyg}v-D6@vBxnoA%{^ahc(zj@-`=;H2>J0>S`-t5UZS`RG#^gH#G~Jgcdwkt- z$lpJy9gU&B&CiltN;ZR<3yH-Ev08F5R52;0ZPo0B_wML zF{Db^q{>c`1v8S#lT6`S@>7>08!G@U1+7c58;h(<0o)5sOOmA%Y!@=RXBgyR4@$xq$G5pLgD$?C`zT1bnBX~3A(0j-+f}IQus`BugIXsKkcXDk)a(yJQZe> zmQAJ|Ro%HHP@Il?IQ8mKVNaGgd9*jHO)NXr=rD4O$2c`@(X>U$bSU@Ix=s4r#lK4U z;$dx{-qqa^-$gkj`B3^LQi{NPDCH)IHj1Q1tTgKEB&XcvR;RW!>cN&^(iVARR^UZu z(Ws47KrE{Olp|;~ODcgW1&u1wDfAmv?3Fne<=hpum01&t9bl@+%gPT*9+hnuMbDMK zm3?^mP?dsK^>~G$m4;UBcm-mWidM~dhmgw}{G)lVe#D0GSTpZG6%Ut00Ftt*i@(~z zW1X(*k4Uqj-q$?s zyq-;eH}holYU*C!$?H+w;r46%GM#tccQAWr{^I=B_FD3r#jm4p&~MXkO#i&@PW{FD zwdFUrUr*kR{dc&j*^}U>k!-fUOy!eiF5{U@A?F#4jQi3x9VYUVLTW&oOh$)IZF*Jd zmJaLcG@?C&zJu|WM%7xUL5c=;jnXCB@+RnJ;{cZHTxx4$OAPyZ>vXGem+LrttNDv- zFrlS*MuS=Q=45o+MD^rA*uceJk%8=Y$NH7mvTx z;UtOxA}Qt)2@$kSAPNn2Lm5u=TH2awWMQhM;!?CCI#f&W2DeE=b85zzR^Y}-My2I# z*ZuU=D|6C)_pFbT-(&BM$E?@PY3>b3k|9*4;E68lTCI_KOVv86YcZjzdYgWW^%~$> z%hi@=qtGL?$*xqr~f7%ZpY7(6W! zEi5e}k9B8ytz9V3oHtH3dN%$P0>d3tRLBgbmMro)m2IiFow#%d-+O49BfsA`x&`AY zH|92;oorjG_GXOhWxLC^r=1VSsO=s*(0H4HV$meyajVvjgX631(P&4^wma)E0$|-N z9oJ4QJ;5w_bJ+HR-5GsLg=1RQ&8xF#OQfx1b5qu}tBcw$ZZB$2`ow_h%Rg-{ue&?<)LbH1-ePy2Qsw_4TTQkJf|-s$MbnvFamBkOwdwF6ch+J_tS# zzQ%FI-8ztS|0*c=d4X$>0EomDmLqf;&Pgp7Q8%JLZ0RV55n-fADm9|%D3^_`J_2ym z-9q6Qp});(r~ektf^v$8LP1zrmsU+~J!zo{osC<~>VmbFROof45>F|Nyc8r*WcTq{ z5=1=q!_fx}fvYGA$n4Ih7PojPSUT?+J(GZFB8*FmAE1!rQkx6LJq=xS*IyoDu)>B* zi65jgY0_;&nl)j@B1kcDatDY%g?>|chk@gpLw+Eur-XS{q0vXbs<1=^_Y2h~J9@n1 z9|f;3<+E6vpIW^&3$Qc7x+pbEurtHD6lof!TZTOWZ<;y^vRi#X^g$nvglxm}*LLho zTAq>u8M_EFyd_b$u8MgGja_aq>(De*%Z!_%Y1*j%DC-up98G)n^xX{ksWP*obrbeU ztUH${!gZ>QKF@a5FN++nK0CZGJrpUSGS-){t8rV~zYR|uRckXp)! z6r!WJz7os7on>Z<(o@57J0ZwFzC266di$YUndk8y_k9j4%vXR`PI#Blzk3(EbvK5* zxWqeE-;%XAN;!9TB5XdzTi0*+GW?E9BqAJul~8Cxb0CBow%$}8O~$G2I!uTEmh+pL z_krdiELRuYb|sJ}%3^y~{%2G<%}RQ>rurfSlPR*1Q+%yMy6=JgU7o^cKq!LSJE{F+IK6t;X~@ogl@P+4$K-h?znkD=> zFPl~I2XtCGrY0~|&U>T7NioK{P%1XYW|n4JmA&138qOgqkpirifX5(%A%`8>1V_K( zdxFq4QAaYnNy%^-DC9$e+;EAR6F~RVZtu+=c=&>-FG8N~S+Y}JmViDGg}NS;RQf1? zXbKzhK>M}{A-|2OG14Y@7;Zh80^2ZC+hX~D}8@DygcLDP3*Fa zu&5;+I5awPhBBQn36R0m_Q*{ige=U>wP?Yr>EPj0WDb9TZ2)~UvCf#<=FAC=2!5Y3 zQ&r15ToCgSMP3HIs=;BEZyt27bhinaXP}sevnEQLR>|g-RX+kCmCK*iO`KT0D%d3O z#X~}?YHz0%9&2rUa(0Ki#lpQao?V|->UDB(>G7FUq^tUAIarEFP~-TC?0= zxenpOVP8SQ%NLE`Qu?8gpEjc1S)};_a^GHWVA1pa57sakCWf?>TLXb!jN##Xn{JCuPMm`3txWH8{@;HWe?xi;ofhx zGqLR(J6P7XiiHUdR5?@JFbBJx|Xy;|EbY$4*44EZwzwDjX)A|^!(Xy z?GvP0cgHuZY{~Q)YsEXZzDfi{Qh7_zdPtJg{8heeoH4L?w2)}Z0ttj@qaI*mzvtQK zHvg{`LY5)ZQ(7UCva8nxf}!`Ool__|2G^k|f*u8-A$N3iOYyW@_`o>#pt!9URZMyw zu}e5zYTed!oyLyXc2G}B&4ZWCuh>*FI|*&yu8yr5wI%dE5x8vg1p6>qUmss|x7enG zk4jY(9%2bT_`n?e;03i^u-!EJ#a{k-3;kQl%`OeSL!@&`JylNrX%;lGjzV&o{f$ADA6wimd66)G?gzKCHx*J3Z87Dp5M{ zjUWL(JM3dumI6pomH0+*j^7t2SoPNpO);$%2=j^#dT1!uJL>F>g+bY?kxSK8L2$zm zX9ldLUQMCG^wr)&_NoKsSxBl`te-dqCpW-Nh?s3CxU%odXU_R&xl*{xn70bzzY>!o zn3iUVLgC4Gb=Ec2=Nh{2z8lm%zn*(=^L1Gy1YRx~@$}3EKfMBj)Ppq4cM<^=P?DK+ z?eWQJ_=5xuTACz~@)DmPqyPi~)fgBukuolFFEur1&+lC2oiD+0XxmYS09MUWi_x*n z?-ci1y0{3TLoS|%^DZeAM8%nP4wWl{qeYO?lpdioLo+f1%G*B4Cv`Q<=t8NdVDWzZ z6`|~~R)Doo;@O#k0a6U^ReB{QAYq%zb`70!p^}^Ov&QpUkDkLt#D}4~yz$5j`>++E zc_5Q1n8m#KQ62LaAu98_jJ!uN&+1JB=i1+eIp zxeU#wn4NVdBvDZ1JVBDfNO(f$M>%HfxW(F`{}elJI?HvffYKSDP3*c(}1M=WQlU*WZ`8|=NL`9)o) z34E@VUwaB9wVRS|;J|@qD90e?hI}xJAX(CLG-(F6aIDa6c5V<(;yX6d_F=sSw`M~J z#&K3CM99)jpk+yr7i)}XVza0ntnSP_I?9bXJ@ zm=EGd*LAbLJH9+04Nk2@Ka)PeMk2xtY+V8BkZhA@ldA1rQ||s5!VRPy4UU>VZ(?4C ziEzA-ZTzdIBq`3JJZ8yp*t7huG#->jOEO;-zgnANr0oNI@??&x8-G@A8+#yVa6_hQ zQ!5`!^?8ZTY)hQjd-$<{+MpR7f25a|{VVTRSq^uRWkO?WTCmBO?XN;XhlG^! zcWx#)_@QR42Lc*`1MwJwz2F!2=#(Mg23_7V%{K(wc+W%QEA`z0=<>O|?@_yVDQ7!x zyav#Iacs@RyGMHIZb(1NUP>%THW+nn-plWcdgZyloO^8$4=Qm)LLD(+Ach{m^p2`v z*uqw2F5sypHTxd zs-=!BEm3HOcU7RvkRjjbM2l#(qh2PTlt3&yD4_YBl3`~ZHG)AN*=)j+ATZH)R=cuC zQA_K6qibziqeolgs@`Z~ZTjhJt4+_!N)XrvNTibYr<~W_Jd<>vD4P0D|$v zJS1uJ)^dSqh%$=xuh7@cotaIpc0T6xSwSJK#e)W3fP%fItB0LHZNMwh-17|Hce!!Yvty-k5Hobu-=SJQVsm{ z304&~j_5WN;)v$}Jy+t0Pz9NUkMsn78 zY_pa~){$(nOEuW=>!}ranLGR?XizT>vv20m`C$DSxkBgX*>G9SR%=@(`{OcN)kc-8 z7;rx`b9?yVkzR_rk}-3G1F}x2&^emqF#A$A(J^pS`PouHC2u=j|@xPWc0Vy%e9wKPe z%4kq1#x`|409y<$W?ZMM%~1|R+F9t1MHkgwD~UVy<|nwHY#=NI(ILkUS}k*kRZR35 z@v6yI7eb%oQA7lre}Vh@>DrR!f>Md@(wu3aJSf7)T~ z%24e6wrMNx#%_kh&%fpBG=zL*Y;)New7hF8z3tUxds$oN+GguxxG3EwPA6+mNaJVu zRg6z_{0kb_rmyWOjkR%6$M3KD?HjGy&icvDy{$#ob>0PIN%}(*->Zy?15~+oDI)~7VyvV#{%v}i@!(9y_ zpmDTNb(PJ7F~&qp%K`EDqTL2EYkQ-CPzY6Roe8q=P>`qW-n-|Z7CPk)=8l)5d8*Ke z-WA(Kcjts_0@F^)c!jfaqk9Tb;pee>yywr5YuYRMhxp-IjJ>Gjy z@SG24&nF|&d&LuRzb_en-&dp==3_&hRAHyp+A~=3Kh4Kf8Qbp;b8zdwDT<#){ElVh zvDn6bAAT$2SAn+Mzs#v4x=?{u`KiTm-#`J9;8J9TF$Ou3|5}>0`{@d$OL%)9d~kNi zPh=#h^8<%ex(bvM%J)cA|8r)2xrqJWo;MhX|&(8_AUN(dn+J5XUlI*>%tSSBXM(CRgXuC|6QOa43uTB?U0zr(zJkpS}q zBi4a9g{aloE0v9wVXUx`P>GsBmV#DW4!_|R*etqWWUFoTa?2%Ss^XfNojV}_&Tmop zwcesi9I+8b*y4=*>oKAM8^50G$XLal8 zuk^OkL53{>#Vr8=fLBKmr>6z z-I8AUM9Y%$l~uVq{7Tcn^7YqRL2jaE5I=!}URzMW505ky*4!hA>XGmfOmG{mDlc`d zA#w4n!g7v+dQ%Fzs$?SdP*xob6~vVF(@*pF;MsfftI0;dCyTx_%QyiuMyyp^%(7W5 z52GPdF|>+BJ7j7>6iZ1IMV+&pJXCmH?lYAxK!T(fs8MqcBePar@HD&)`-w$mTA9|u z&a)W*Y2bJD&Eq}00t>y6-uczz_;YN!cPIDN`|JA#ue_Oe=Oy%CGn!R(h6+-_5*-7f zRP$dRW`-yX?Fbs8T1?rQzmKpiSqskRBW82KnH(`13(j8^GsBRzW|JEv);a6ktW{R| z+RU+8cYo%b7g=fpP$~j4)Cis>IkiZYFAQ||j5pW6mtT!P!FR`hHQ3ku!B@FE_wxV9 z7pwDDsLkXLFmF40yD;w+daP%h*vS+zI)ll~TC}tt6FVS_)1o4(ShO0oT3Ta=S8!Gf zYc?A6wjwQ6j2T*^M~Ibd*mji$js7|a$^pfwc^xSht`<2Q&m5YS+4a-v|BD5=%mR>n zP{iTDmf2Qqq7ek?;<6SSjb;r66;lIBgN1(&jG5K2dWF%bUkp_;#!kd6a(Dtx`C*o* ziNQhHgk_+$4^kmOYXguaN@(a?9R4@kRRbHvafN4Q|893@eYJ!|*gt!HN6y!qbyzW1sSc;flFJGaf>uw~xTMfICE zRXr=7K2TrY|NT{mY92iBt-RX(O-uK`vZ(3c+z>?QDKaU}69<6hnwl@fo##o3WBRT43DlwTbClU!#IR(0Q%4vF_-P05luGQz-1QG;6T2)nD ziOtUg7RXW90mx8`(R4dKc#0lOw@=d7PU82;^m;t2Q|XWCb7YKYWHoxyuR-hhI|%bK zyUc0Fs74b+V*>mja=kKdDQO`a$WGD)Z|>5uMFY>KCd^4kfloRlX=YdwGf$DJO*~HK zRgQsE)sT1r4BU6>2F8{>RuzZRG1mT4*^K4nA`>a|2B};!38&i*!0jP6oFW_|o>py1ej_WVL;d|QVHh^L5B4aK zI%m}&!!0E;8#zP7E*R4#9?KMIr*eSny*bCTZV!(^%LpUM^gme~&@E&lcAf~+ANK^} z3^cYK3&al#lnK8Q&InA{OenNQP?cb;Cfp?KCS+@OKOti8wjioM&={G_!yYBIBUACA zAM6D!oS<*$Q3bSY$JvhhMg5^-J!ckEQL=B@5n$nw2 z1wg|NVF^$z!tn_y;2iE8pOH#P|1r3Y!H%6hpOgQ0r72iR#+7bBEpd$7c1YJ{T++lR z#N-_B_$;^Nf7i5sB+C2Petp09N}i-DdXO#jFV0^ST2QpyzcPPi=+UB9rBz?$Z_95D z{iJ9s`?3=~E=~?@8Vi1Gc zwv{aGQ0cAe< z=CD!>+7U+Fp~RCNN-{$SlB6?=O^A6HwhkQz+|f+6J7zW%G}TU0XW4?Y_Ocayax7#< zpk(*3nEw9sC!_!_A6#Cz>hVM2YHn^WI%foczx&z@Lkv4aE=n09N0^&FWat7PlxByw z{U)-pWdcJha#QPg*XEv0-&;3+?CRE6&v$R%-rfDo_C+Z+PDMKZ-Im_;^hfD*`cJ3d z9Heij4}W%tuBGd4Ke-n${&zyySAa2%<{`p*wcO5KLvy1=TtmymA{P|9Bq`X2Rnsc& zWCz(1kNB=gRU%7FP$kM49o3xZYIshBqWFf+)L}3%ZrPRt*N6kxJO{22Ejxr@bP?yE zFU%#|@YYDURvxY;(U@dQObY44G(n#ynNrc7IT7arKN3ssLAh!`nuz1ckd&*lq5EP~ zm2F8_%`Qd_9G8V56dIc2l9yWq323O`5|xS%kx_K>bz~f zZT=U07kt;l*Ng6i`3L%-pG7s(Bg>?|l%8-zFrwxVJKnq0qSg=%_M@K! z9qXlxYxkwQHY44&T)G=ct)p-p3N5BQ9bwOs7%^$R&8_|h*1|TholIoI>>JPs9z5qH zX$qUW3ar0Qb^@6~mzSEbT-o3X@(hb*Q`T0C%!oP5jGFTM(|3phiRyuG6)rbl>zhf6 zrk;YV#iKQf6vbdspys|d#sh|vy@71@qUeT@B2VX+l+^*CTxE^qnCZP3!ANU-bX^ueVOGICbIp z{>Q%!NK8)O5DNf_74+^5me4~%8_zcwArw=lg2NA5UaA>h?u}|%d44n^M$02oxlwBH zUl8gdlp|RHx z7g~>5n~Q`;3);+efz<^+Gqwiy8ZQQ3C^}(iIydq}g~IzN0>K97M`)0g!|B%cah@** zhuLuwVry*`ypzB^!*?Gpd^2$2n?VDfllk7B!&`z9$fCMh!}DIH}Fca%|5 zW|lG7_0%BFFYBBW9HR9-p>aA)>p=!wwDlY_bUrvlU(154V$y+Ew)js~q;ec^ZvxW@ z^buk$1GOBydZd^D*$FUe#&Sg45kw$S#Zqo~HNZ}Po7WpD7r`2AD>tCyi{v|qia3a> zs;ov(q5g}*S5~qj8#t&^>T;$FFhrPwcTzgLEZJ9lsCDO=cXm`S4*2wrp}p&#d^ylp za_hY1AUZuIvDE~fu| z189SUp#qxFqiMuo5k%ev!l%E?guO3m$XNoBTqcoSL(OrEYe+7)$gZL0*v2&!Pj;}! zH58YfJ)Yc{EH!ytLvjt-HB{Hg@|azh^sV4)`CGi3U*XbXVX^TGQSd>@B3u>}Nz(-d z*w8RW1u-B9qF@ll4QN|N*a!$mM!Rf{h$0LjqnbFx)(lFLX3r|F(OjC-GMdUUZad;i z8=`f#q1dxaYm{9jwMwU#VUFrXpoTD$#TW>En2dA4m>9r0tUqsvzU)BnQ`8>Fa#P3& z3G;^OkeoS{xSO!zh_`rr-`oljDx25q1=?G%66C7^^3@jyp15l3)p23=oVXy)nw7vM zngNI~#tv{>kMmv2;@mEa^Vt#jo)dT2vN_9|_kBo3(Et}!Sumh4sTxG-Lb&KsX+?E) zRfbEUL7~-Fb$+QOSd_hSZx4I>^~;z0(zUeZgfQ^+q7&(3P`MA?YlVVshu6Yp(6R@Vxjahq8Rizy( z>kwO+Jkbqh(waE?&#`Z~VN4o|?Q8qs^Pm5Iub&blMe$H)GU2gZUBsoiRXGyXHbWU^Atu^VGL?lVpRGcZ}tjy!)|WgO)O(%=Q-eB*%1(Dq9DPH%(JP3!xl`TY|j7t7(N( zRXK-eaW}^yyTCd7+htxi%qV>TUYu#)G|C%jnj7X^4s;EvStiKBMGZe!f6%^ju&;Z0 zcgd+2$c>4!b-NE=!sbl}@4q{Nw=4S(jGj2!UsvNHpS_m)##d5fzq@+4{}vp-7LcZb zZ_Yro@TUgn%$0F2ZowQ5lms;gb~qqT1%&)ymctsvD6G(+#bzxf=v63myv#SfY}WE- z2BXA#3FRFfLh+L>?1iCb*RoI>x6-uIywsY`{<0fS+)u z!tkSDq<~bx+3uaCnOo_Z4H`9nAgGfrsLOB=RP#Lhogl8#95vn+?|SbxFYi?{3!ocJ zR;5O-hyIk;Lu>Yqkivn;)aaDMa67t5>3<{T{M0bBj);Ux6_07aW7jXE$7f5gmN zz*ML(l@ZKa?2b;3BlNb^u~f?uzijTb{0-FsDq9Fw1260GHkj?Qr3`_WDEH$XvD*8| zCCV6`c@*d-O}mf~($N<97#OtJIlv0#8fILZQ$yKRk*A7?6HNt`F4w$PZm2tzTwE!i z<97aYAOG*Z?iW+8)aN4~_2Ikt>dS~jOMx}nz#1;(RYiv-Hl3Yig@}3~V!DvqgLKrCb(_uXPd|f;aV?*INVlc`Q)Sw( zvXeeIpS~IFg`=4Q^ao{qZG{KV^epl$D!OC;v`ny+;jL&Z?&3F@J8T>6n;l!c2he`p z&F?Yqu+3Pd_(Ed(kcVVVjjE|c?fJr0-D{Y^&}WKU!`nsp#>C0mw z$n3Y?oEc)OkoKMU#tzg0bJ+lNu9V3_ARxL*m@K#)VjhzP(I5*|G@;<4qKdhhVN8$8 z2tILV8Pvci4S4N__B$6Z-ECX9_h4%5#*Nh2;T3z@);zaw)#~S~7xgUN(c8Ck+et1k z^T^s`AAWpn)%R!49)148B*gqnhc4q~Yj*Eyd3x{e@yXhrx}R>}dAgV8>4prmf@l_L zX1q$H)|LzI9(IDak1<$MlV`pF7x%Ohic6o90n@3_H%^~(cEnZ^l%-s$PU0jf3)N%H zhCqkn6dN#&8sHQH>-K0QUd|M^oHZOUOG%_q|GN1Or4D(hhzD^=o5k{ylX3BX>^gm~ zhqj6uH`2ab?SImv6+GoxUa*R5_pI};F4*GV8tnET2p;vE@?Y@Z_1p=Kh1_5CyyEHe zaMd$cilii1C$-RAl|whd*Xz@6I7qk6T~KVmey#!gxjOdgHLgN7!#dmK*wi|kVVw=n z*PPSCR?lqewL{>wIt#)&3&J`J!kx}37C1F0arQ)}u>dSE!+;F_ry|z_3p|gCAzKwp z-WtdYiD|Gmp?C+5H!%a`ZBp6*q32VfiaB9_d)9v&U^-4cK`Q1JQ|E(M1i*JW6++V# zX7E-S?l<&#x>}cRt*^wD=hqF7W7CyG$!E8GcH*@U$+e$s`d0s`uC2%MQf156pWODr z2D`7Z4Vyps7%N9pe@^`)^_SGZ>leAXFAa~r+zs{z_&$da-oqDxhnUb3=71rX6-1MT zh%ugvVUf3z7{qQwLU0$4n~xvyF@2z3mQ<1qGfWZ!LjrF`8r+4bKT(rlCN@Xq;BhXI zNN`Pw#Q4cX0(Lx|`Xk=Oc9hVoY{zJ)ZI|u4wjbH<*#x+yMb>%NFIgL{&sc}7pIA*c zt7M{;m|~(RNWAR~WT1MjK#1|IxE%-yqAA8(=i91q5RduevR-KH{%sh7D=X&>!%6CwmseGC`guAI6xC+8J_Sug z8_*~Gz~K7XcOFZ3D31DcHo%_4#*avEXfmPZo+rbHDh8LJqp8@OxZ zDUOgGz4+)rYBY6ufZpwm_&8t9i|lT%VO16jBIZpN6y|W4Bc?FVi(v>nuae&oLM{r( zZ^7ASTGbNewsHqWYm;#AY5!uZq$&tAX)lLtH)pV26bXilH`{4lkvY)_)$zOvI&9|g z)#LNIcj<%sYVX8Ly^reIc5;Y^sS|T1fzX~|#6!;n4bz?p>7I#aLL3(pk>4B=u#oB5 zoj7zXR-2?vdvwn@1o$DqOig&WXBbz|KmPIY3J#A?a@WX?ROP;N877)8lf1euEr?1Bc{?($(Jp%TGf567fxTcbJI5e zsdxXruYLELIkVb3axW1+j|>9=TljuJlnXyca`Tl4gFvJ6+O3S-D#Y@rb$(RL<>Q`= zBssDza84k?${WrpH|;h6KND2-4d>iz`9-Yd7t!rSL2=|?^g98gIe{uTw@?%(;PZj( z%0EVaMYLCrWss`~d@$}E`MAdkZqUw;i6L&GUY7b&p6(|alZ++OQn}rDmfd9hmjAWz zrg6nkCB6k^aI>*gJ!D+fuIg7^GN*Am=VDbw<~dH&U6LS*8pM*IiHKp~Ht8bL)S0NL zdEqO}vSiIi*4QYgdEqSCJcx`(l@f#VtkeoVAs-1UC2!0P*#9@OmFyI;(*udNW0lu>jso$7=$h^PR?xd~rd$=N2 z68lH4FwDpe+cBlbp?_{`EHAC)`)@X)aTX`@`o!6}JMvBj}Yd7UgQ3w?`UDMRPtpH_tmzsv?JDouYxhDqSkD7;@P z_!bh|-aeR-41UGvqYVANE!IiW^o{Y&>)h{55XBRb_ z8isvp4n1z7M$9R|DHL{l*8o-g+Uo z1>N)1)LF9|f3PF>9$L|soY6Xc-j83%b@Tl#eUG&5tF1WRwd8PnH9ObsU)=Py$H#xN zOVp-5+Bo-#YDm-Kk-zcZhE5Ve6A8MGF2c(r&@x9Z^^jacZZ4(2NunrIqc4K~xF*uY ztcz@7w(|$ry?P(pqyI)f!wg2QM%*q>#2tySmBKi8WofkRt9r)!pf6Lhlz%kxUC;BL z?d&$!_R{@m58m&7+f~eXnULW%LLA7{2S>(DqoYT3+%%&I2ox?hH8yN=vXLyB#U!IJ zBZSHV`JxB%MGrVdS2BTQR6?N3^ia=86e&`Pxo81#3Q)H!Eg;kqf@?!`(6E~qe3e}V zrK&=!!)XO{jVm$?jSKg(H9Z}itQA9Wq(fuvT0yaE^NlPZaIx|@)Wj2q4i*rTq@Q7* z*F$VE*K^{Y+^;SS<<7o*5Y0I8XLMKnFKbV1dG)UgR$P4MXMe%C`lCIU4HI3>F+zBhqVIli=ZyH3-(0I&No4{EFLR zpng?VmGF5AWy6OVx!>{qzQ}zGbEgMh$>m;sxTd?V`rga?E?%!RiQC={z_|n!Q<))J zFQ34hk|c@@%aM{PvZ*qXNHFd-Jd?$F?5wB~)v*%NIT;svyi)+VAZGIaAZD`sIjW}B zKjg5$DM3?S*s@L62JcWZVxM`5sus^9M$V^_yF<0?bowl3+s(yq?O>~Jz0I!U`@3@u zujTY^lAHaIoAr``d0K>ofazi_Q;-o#RwUwMm>wU+^mu{kdL|B22;{J$ z9kU>*gETYL6q3w9@GeCPHH9v67reTw0#!uv$&Tcc9Vv)vBpFqZQV>oHYI>x5sam$4m zieiLZf(0^utV57J#l@}wm2?-C^qPsaHkQdlhfWb)zdPX`qwM~GI01vS3!(tx&Vjg3 zakKZ~6&rJBcAd-Z?D;ures3p2FD4IK3xDzW`V(udsT&a9{N$A{l+ zJE*f~N$-y)t?X*Lf8E!g-8qoE(e>~Y9BazTF6E4Z z6&_<%0#zIX1!)u%q&yUkW~8Vnf*bn>g#ZK}r&Vgm3~I=FN6x2x)RZA=%CcQL(y^My zfttsGYUAKoMzuLd;HkhveF5@G4*5p)0>2|gQ5{9~X1!fssdM!$!K&=4d}p}b8*Dg1 zKo3El8dB4;6KR7$V6|BVs+!h2Se8LxwX@w%Bwv%s;i8j z$31(`eeB)4cQ@G=37c%$0)Y}jAS_LXTX0Yej}*(2gzkXDFwRsu5>!U5m9#p5mC?3N z8PJN1Q*C^V1o9vTg*4N#*iLQ7=|DSH${$LVF${wlL_#)x=iI%^(&~tl-E+Qs?wyL;Y@<|@)ZwHCZN1Hkko#GK-G5%YfH`%is?sHH$qFdht+#<+i# z1CD$f9%ZISm=uiiqmy1f^a_^ndR*@wcZ|2 z%H5qCw42lH8Fq|8zk^=+4myhZkg@=|s2#nJt|I27;qVzm<>NB-C|=6h-~F6j@pE?F zwY?!u=Ilqxxy}l*UinDJi5{5L3Z31%TBph*5aeXJluqUOrysykCZQDlGhdtMeADunc`SMdQzk!d&d%wE!^IxOaZY73ad-Q_fRG19e27wvmVHww2THli6 z+Om7~#epUI$MsEgFFjAy-TJ%qU64)!^`+#S%?>C}v!5xKInx!qSUINk0E_QN$V?TXlIR6(CX|3ZSIxh!F)tYeC=Ylo%K(!(^EoYGn8*>tmzrB2(BWxi~W#Rh(9P)IOD} z!(?y&e?=&uCL{g-j(pc{i=$r1U`Y)~JvvqB9-n}(AeL4EKdr6e3)r%c-Pd3}VZQ=< zyg>m&<#sD?#ch4@Pqp=>9_s2NEBoB`E`V@l`kken#{*>L!}8*4zZn*xz3Rrm2-sG* zncJ4#tO-lEp{0@c3pyKaHx_iC8`kO}#`6+6MSSa1IcVw&L)Bnb=K>-HhLhv<(VXH& zb0Q^!v%sv%-EPf>PVr{ky{piGx}k$p@XA0yp^yrRp2{8Qxd^CwQK^S<9fpq@J~&3+ z!Rpju^3*h%x_%XabPhQ`^~+m_$fe6g#j8bSF4Q7JFUndpF#+ach^G}$Oys3Om6TDH z`pKhZO-Juq<6i&BY!UcRv&E%?CuxOzL)4eAUd#FHPz7H70Wj(xQlTC~C=db}OC>;yM{?W>hNYYWBn1P~a>bo3EYlIUS;(Xs!h~yvg}6p^BOo!z zE&ICE*Bc5)@ay?L2kVgK`F1k+?lEb?|@vX zTot)8xpGnM8DSBria~S<`6or7CZ|7LuB!M2BCK2lc&4zj44Y})X%5MSnZURf%rOv5 zT{te@CJp(LQzVZZWRtubEXnVHpDy`YgoQ5?3nt{q2QB3}Q>b7PuL)A_9z;SsN>W_e zZSFPCLMYAE=IRigqs$7 z_tKZtfI~u-)yN0{5#eSq*vL4T+}se_fL%-o=bCN+Nm`aI^0d|IafmZQdVxL`o?vM{ zj28}?ny#11R@Y@AyINjPyXGDP8zbPhg$;O?48s<}=s_L$=eA6^?s3$~JW7Xl+Snc@ z`IBk3mGv-SXwuss7CIDxi~2h;RWEh znPP4vM0O>Oo95{f!T;3@>WRE#_`;OO&1$ldO1}1t2{#iCuh_^46%wM_OK1CLb&r5Xr;z^(* zo`wYp?g3;GGZj?A0C!jAAcUhst8(0J^30~33T#9K10}$0@=S4>k)~^8a;g=DZ$w;A z3`M}K@yr@9tAu&uc$uDXMb~?UWKxc>`e9nid8mzrq{rbGUZrH@)mufVnkSV#P%%A| zJ&2%f(;u)uvA2hqlSy7~T@;ifxJKlbcfCiXA3)qLxyp*3hc%(3({hMN;K!&7pi%Hmzdy^z=me zrV6zv(yRJ{8;q-x%~YW#MP9*}knpIAgiBCXlRY)KCgf9Q$SJh@5f7C$E$umP#ik*W^ttVEUr2K zN1Xcd-=6(_@jQ7AKZbuWR{ZgM?-!2_p2c0Ki~lUXiJNh%9~<8-{sppk1T@4H^m-7* z@qM16-5&mIl(gAx(arYesA8D40OTkZuN9TSojVfZR3yZiz5#EM;@`>gQ;;5c1ww=C zA_d$ok>Z5wh&b_NI*H+vj0gRQ2mOc#%OWNCKSfHZS+EhX zC8cx-;Q~6$8+HpYI2^Z3P%tNVSQaE4$H6|aL$*f4^76D>*A%NIke9l;FxX2LH)rq7 zX6lZRInS-#@m%MX;_r(4@#DWfQdqO_8^v$35zE;=^w_E5)YLC1KCtJJuU7>TWT0dE z+w2PTPZgR?sLa6gTe3gQl0>|viWoDLnMx)#BRVsh3Cv~lV-4B+S!--rb`4t-Tb(Vi zjhT+@=h)-)E9?M0z@A6nqc5U=GhQ{YOOA`oLR&^A0D@>)6Rw$z@ z+J=CZO_>;FoeIR+|DFAe(Nt+peD}Zev+wS`-`D?5{vvl#yUtzrUDpF4lH?jmD-rVK z75$KL(GcQVqtUEojrscgP+Lt~-9n>NT<+?q>JD{Rch)S6EUR5ZR#&Yxo;MDJ4j6yd zKQ;V{j;g?mhJsm`*bBL)U{=t*dLx-d1k7voytUrYHNshWtUqzuolom*-O{g!$|8X!^pD$2O^CFjkqz&U=(FAik68R zHNYU0GG7(l>^@DtD*lECe0@OIMWxn+v32&i%a?V7n!B?QpEy^>dCqyRn4$7{ZWA@- z{!PJL72!CmsvAZuT(4;{73X-~8Z)_VmDI4wZMDShOgeC$hJU&Ni7mANam{Bn5*AAJ z>CNs~rbvA_+fw4ZiweLDBO&~I&!+58jvV{#`-QiEIf&ZMQ61PYapU#%Zvy=<7p|h< zr_c1P=sS{6?#VvC;xy{{Z|rQ)KT?w$7iY&v^?Tcy)KvPQf-nuh@$~bwzyqRyN&3Qr1=8=uFZ;;%VBeQ=9~PLU-a ziEWGx#Q0dP&Ty(Toa$w{)Bj(&vwUqfscU_`>^`R6Eh=_rMY;1|(~F2UgKSCllF11; z$fg0<2vEMqF(pZMI^Uy8n5=x!z>tTKl9R=pnpK^%T<%#kLZE&#!#W^|1pHYSWED5O z9l21}S?h&&4ZO?YqboQh`F%iyoU+dE=a34i1J#Jy#3UIGMW1u7P~`p%X7N?|kqoFK## z)A?-ZF@C=FiR!kRxv_bPrF@sQr+QiaUXP;=BC?r$VyuX>!eB*$6?G=Aii3+qoD~Ku zVDOi@d9samW)3+-->^sz*&MmRc@!kAB zWv_joy5G4g_Wk%P_CxBSs&Fy>=2B6^9W(-x(SQt&YY4c7X;TfZ52VMQ+8*2+#KE{` zPlXe46ek*?LT{rOC*hP74r{y_oss~NJXOr%E{|wWn;tLz1#_u*%wbnZG*lf9idKuj zV+)GMYT=xPgoCL-j&kT_$R6VwmqN5FFdGUdilBDXi#DQz$bv@EV9u5bM?9WKJLrW8 zrL>(M(OZEhSRjEu+$rmWRG|+N1ItLKWN;0rfyPdU19vpg=P@bV5SSLV{f}dbcB%v; zU|4QsxM}A@zvX5M;HE@ZO+Ec46$<~%!-faEmZBPhF|b^MGKp0NGsWx3v4l+ra^T^ z7-x#aOc=3*VN7psX~_VA!O+0CELC2gCiqM~Q+qRdPT8M2yYty!EN$;;Ev#Fz=IQU= z{_(M|c9Svn_#1;qvoq1<BG+zQ2fz`wiX*Q*h_m@eVCkXZyq3Q~^}Lv4%}~N# z!4sTl;jy`5ys59#X2V)VUD4^$s;CQl3f02CLXg;xAHVwrox7vZ&(*@*c~PtB{<5Ji z7nY0XL_woO(L7bn%|fdq0bGXxMV2W${ z&`{jYDfD5nlRi796bn#m!}*AYB3iqKd$o<)fW~WI+a-*2+Kq^eWO{cp+?{N?r_9__ zX55j>?kNlO5;Aj7x$K^DzN)pW(mj)T%A!S1=+P>>h4I;Dn~V4j}tYe)0XG z-<ckenTCo@+tHE;E zWMW5|2h!x<%dRJ~`b4MfwcFn*{q7BR62({PhzCVDMkr^;x%%u=7`=>tiZP~VToKYva1-ez2gzx2ix4u3UmR9?A#?eG ziv8C>KIvO`f)+!{3i!wM*^lfYQ<4y<_Ds>~4lNv1mM$FhF6kbG)y=hcFCXGm0O7xe zBsZcv(F;WQ=S=g}1*7X>bjy-%h*;d@>6u+!6np*9q;^&Cyi%}72q&78O3_GriYUq; zXdq_54$ql5`$x2MN=M+M5%$%*m^{-F^JZz{tfpw?2t8!uM?uLx-7hCD0adMs5r;3pU+)e3y76$WgZ zya1Oep8qf5)fyYcb%p2NJ2N|vJG1lfcxTqe>|(IJy95JXV-IZVA&~Hh3?^XnXtwYJ z3QpWs zxzF0`8ZS#P$Fb?U?nC`XXd|Z5VW6a!bMiu-ZWcDvN1Z*w9{P3XuyB|@={zGmL!Wcv zfuk$%>JzT(l;#Sf0_UdK zN-dME!2w5-Q=EWt3PB%6oGVCDljGJoj%!g_ZgMPeEtAIMDZ{KY4AYXSJD<@>|Et8&BN53BsX1kO1&iH*no&!u7(?jQ%5%T_>+)o`f)by7ytBFSf$P7ieEV|cgVtE0 zu5uN6dCyPJeZHJbmy?xS|2jQJF5G>DFa9WXWXpeEk2?A`K$cDRg-S!^448=v5c#qO z5tFLwd-FvfZCdl2QVm#R1A;gYo!VV(K~30hZBxEaVg%U%AebJiS8>M5*xjg$bW7cG zx3*sIw7P7?vQt(%Z!x38Odf?*i&i;WB{r*vz~R|{5oS)H6Dn@uGqE-`tG8I|`1R6y zmA!GRw1+QBkE;jtJ=RflgnvSMQXSNfSkLm`lbCEcVV$r~@~2{_lyiJZny`M$UzPsM zUz4WvKUp{Uo6=4Fy0uaS4jq`(1fE{ctST`J4fEfl%!x3oQqHL}T*VaoMMkl7<{2V~ zH5f4%;0Yzn>J`eO3eO@SQPRdkYQ-1W!oyG4Qnc)wxS}@z_zT|c8Zf> zM9TzgT8ff7N(qb?LNK;9jZ#i(caQ@}OVNO0=wk;bQp#E7ib9kUDvckECP^t!#IeBW zGd?tk0sj;zDbA~N-cPehlG`!E@K<#I?%gilE`k$6uy_v!hlP9K#epYc+IFD+~EA@^5C z8hwq;%B79I9W?p`E={jb6l|+L@t`DwM|kj5csN*P!8#0&jD;$>n$ zlGhV{1LW<-sFh%ty%Ff(@E#b#4BWal>V|N>7Hj~AZv$fiilwa5uJgyxG4Yr>E%FQ> zq7;)wQ5K1;P~g~dN>S?+MHPuC6KK^zJ=-NIjDTPvk*XpB$$``o_5xW^05ZVy^b&Rh znaYm^$_okxP>ctfs?rok9@~k}gy0wtWEgsNp*Ui%RYQS9BT@88B$KdvNz)_1gyfuQ zq1#5ex?E>kr~rP!tWK)oRk@r5>`P#P3B6$*W{&~p(RULtMH&~T$e2WB%KsYLFPWP` zAq`uz8bDJ7v;?vYFp=N_U`${1d{&-cS+vox89}O8B5MO>NCkngP_dTZo(l(#xlpwx z-cbJF7E1R${LnX0<0s__{4LU3dF1)$pFWG;nH??vglU5esM~j0ZKB;(j<$%;%QZHo zRGpClOJ`_}Yi52c+9GY0i6W_T#FYb`a=M1pCJN-FNrdiLF7%Wqqt2Lni--In#LEgV zDN4(dbiPeNcR*^T5D&D3SK8FZJYt4b&nT=st0J52!XrXcOvI|v1U*r?jK(2y9#Y%D z#a2rJ5bW)=M@4EV0iI0Y2j_z-YpQ2=jbNMs4g zt%YCKL^{#Bu5@SGL9w)x!C&-ko&5u!oV~iA{Bn%Eb$I*v^Ruy|=UE<3R|c^Qd5CdG zSssEMPjUzwf|%oC7Swu7yub@9pqGU83PT3>r{J--rJo;jb8tYY*m7Y8YP2waLeM%F zIS8tKY>3kl56;LC;#hQ{sy)KviAf$%+_&=T@ME(Y!6casYyu`RWi54nsgX`#=zaxDWzLcXpV~ooO^y zd3tIJy;K=IC$>TibAPK0@~0}FbA-!;F;LXQ;iSNM{HBd8v7Z7Y+k0<^Cj>^@&Pt!a zXI{#`Q5k&kMcCWVzllB)-iJ3F58t4Y?u3`eLEOwkEkeT z7!DZ-qhWALc=rf8NlN(8DE9c{ze4R?wWw~-fEp_o;h=2(6(eB20Eur;{+=DHnRK9! zethGf5QEEMZu{I#zLEbL*T!{`WnnZcWlhd{S~8o_vRPkS=X5o!&u+^WwPN-OZ7_Ri z^(pOS=4bVsw(!kG791`?-$;iZI`^uZIj-IZ67;-X_GeBqo&f_3@{oh z_FERS0%f+75v!fdTbfwv=2m9&KJTyG#&2CYAnnh6QyR>Dmk!gb^p18XXLjYGOpNyB z`NZ0EoqI6zoea)2w(C9m8T~bVP8VL&-_gI&iGH~@QYHp;%GxP(h0n%Vht*jS&}+qh z9Xc#nF&+oo63si^4X4@ofUY-^#DCc?*VrhoD~{hgv%6!@?7a3dv%4O9z^vCK3)pzq z#HLFP}+tRk~WkUCs zQY_M-#!kl zM=T53D*hHSvs$dPcECkma38$T86NdA<9r*Rh6WkMyQtgnGmKu|)O&v=48-bb*Md6xLCx)-O z!D+9bJep5U#_Nt;F)mx%*wx7GZKRDRd`%}l+$>=~-zm+TRk6yNlH#h=cr9v;E3=NC zuSuQ_Tnun_peeuwB1IJrM2a5>6rVFGA5d`l1I*0=G5m30l#+XdnpMF)2x$0A0+SoG zfe|AqwDrQV9}XIbA6_W*_Inp|gLu4ggEaLv^`x76;j~9bhZ*^B8=RxCQ#3@hGv-&I znQ78i)=BtuIv7+QIKfZsTnl?$E%J3N=B1cvS`nrLu+1oxH5m{C9Uk7OXW)sDK2?Fh zxXM(0cFL58*k66NIyJ5`AXI;w%hVZ$X+)zD!yK351A@Xqn5n~?_}sH6TMwO?{lc93 zHQlRdX6BA9KP*2STX$*ajsuIdQnT`mWj=jw{gZXiKezhVsq)vFXZ>#5f>#zq6giQs z64y96tXUt0!N(%C0YQb2ZXf0VQuU6L? z>k?h|$H8v1JN}RGm*$u8&&sdc!*+a(zecTz)cTuL$3IV97QG`%;Av~VfGbB_bl=#?1CkzpD1|NQkWO$Eo-eum2 z=lLp*>!NfQ-AfPCKI*e+6J1Do=)i_p(n4_8DaZ7pjBcvo18E59ri^ZE);ch)*sTUm znZ|IwG=kqs;}x?XVtPHA`u5y>4RB^-JpljU{Rx4@!%IiD-6E~69f0njqNYTF+GA@K z$rmVNh87Swbh4&&BicRIUf`zsluTU(7uCqP%4$AhBAfMDq?bcIo^D@UTV0pYy%o8wqZO zTbr4~eO|RMmK2w?)C*KE(7XV*=p-U>gkuF-R@tIb73Fgg*#OSy3t5s7vwRX&qCyF- zwZPU|2;y1`8m_g#vi`#5^SCs<+POjb!=A+4r0=0!EffE#b zfFR-n1m?=P!0dJ*SWF*ba#{8qmT;pm98u~*``o4D<}QBxv6E00bu}!5tL^=1JhJ@& zQ3mPM3O(>bUa_%VR%{!}91*I$5I9807h}XigBW7cD+z812A|E~8*3I5RhQ`55D;vb zLJFaE#g)$;DZllH?xFv*f3frT*X%>_EsyUwu>VJ`KcU;q&Wp61iU%q8%At44)~x;O zM_2#yDk$YFAoo*HN*$Ck%#`wFk@Lw_a#sG1?5~g1TaR+z6PHAmTC2Ec{VPkKiL_W< z_GSN-@F(#b;Tw@#=D*`Nm?9dsolc;P&P|}E3X`~`Jjs~K)yn{DK$O38xta2;$RpOH zVqRV)-w6E6xI_CDjYfGz(o|4NNze&MC3p@1Ft-yv1HdY`JQ{};Dp zUaiu!OFGqbM{m)$>Y%HbDz3WfA(StjRWPWtdH@qkXKD+hU%{=wgsvbHaDJ0Xtd3fS zXz8cD*@3XW81g6!d6b1*%8utlNkJ=)37RXa-^!mAE()It!-5a#TPW~C1xsO87zh<^ zYBM5PaV8`fk@1S`qER{tOa*UZ+x@wZOZ?6@pMkPGm8s-_`#pgcYk;ey?HKpa|LK+6o@n2zQrb1lxyY- z{z7T9w31)rUthXXDv4tC$CerbX9-5-79OiZAN%h_1`@u>p{eo7*7VT)#B^(M=*jpJ zYene!#0qP3U~_bU8;EJdpsH+|i;NaygTWh?x=Y)uahm2UvqXWM;tpW0dM?)Gu&vfW zb9RS8$4nrs?;cgAM-_{2du62Q$WW4Y;Eu`22+mK&A{%#1#)pQI1RMn*!-fw4nmRG!=$T_8*Ix_EF%#jT3}TqZEG)c$_cZm zt>6a!+G5Z}E)nP*eVT!c$!j&D)oNUr*F;~qC~smJlQ*#_Z=uGgmKSQ$dZwn(HcH|& zlBpwlL>Oxza&&Bpm6!bTQxk5U{9@=9ja<7z6?*q`@sHb{d1J7fTO4f2?|k`vnm6}# zP#bELARRyS_o4r4V-B5KO?PjfvHCse8c7&1-0J^`m~=VguOd=P)p$+3HtxhX#PJR9L4rsGi6rB3gjAv^kqN9-Vxq*# zwFvGkaho|7{F7CJ5Zvix-PpcZ{0u!s#*zUll2|%DFj^y^anSm6T8;@tZ@RZYnwoOC z-2dpV{@5n2JAUu(y?6KSY@g3Q`@)h>S1sJwzH#Aq)JNJMS-7RRw|K7ea{EX5e|1_;nx-b@@!Eoxq$-k5yiHmna?V~s zXc%?nAumo^T1~(Mvswh8H z6fWcl7jhad+ zsZiY2&dsT??zXZFuJtF^c-WtWK?%jVRso5*#8u`JUn^W!1|b+h8iFQGE0UCKAtK4c zjz>BGo!Ab$PE*MRLOYWFRO-ii&?rz4pq%5R9e>X31PPIS-*T3fEL+T~$&h(%`?axj z<*uPanHbtV_U`m|&%XHPo@0-`JNnxXjvgEO{wuHUdHR)2%^TdMTOaNodjVD6dkLY# zFYUec`1R9I|590WcIwpc-+JdQt|td2Nx2Le%0|EAJbhhCLw~27vI29N7vtOH;$_Mz z}XcRvK4|PvxTU(p-1k>Gm#LhB0;wCI;#%iJj7G93 zs)2$@AYp}l5=bB_WM4CMNmmFc*OJnb34~8oH|D15 zzp$vPJclGoDAuX!5($ssQ9OpH@I_3g@HCbs+=kD<5ym{5bE@G6)v%x%*7+-7VVXEF zO#rh(Ljm0KbWS_GPP?0MJHZvXJN8~Ji2TFq?rDkd)ZGA@w=gg6=@D#kJg?hA2jop6) zZ@xMD_S&r=chL9Bb*Q7EBt#W?@m3^7Gq8}BYaxtp&$EpeF5LpBL~^H9`Y=<> z=zqvHs;~&BIfc+r8{Ee!|D9Y3Ms;l+T<*YZlKH87_=_a+G4dG|V zQT7h~BmN7$M6am-qn~K0gsu}s!7`;PV;USVO>?7W5eI96IH{N8tv1deZ5D#SXFir zf~?&utp}xs_V?})b|m;I34TgKDWrrjrG&5|O;}M=B>H~)>TO|W3S!nHbb-%L*9rq` zuYO#(3N93fKM;+I<@6jRiwk%t{x+RV}Vua$6m>Sl^c2<4Fq3W$DjW%hA&>iq1>KOiS> zy@|$Vch78w8_goSEe6PIA6C0O)h6CQ^bfI7Ul&_tr5@BD2 zk8It`%VI4r^VcQ!_-ltNR?mgZXObKlAr}Z<4 z8QyhV(*5Gq%eKEpPTuINr(8N8=CQo;Jzkj=N2Fv(%)(<(B806FZVl~lO9*E}xH*LR z^+EAkLO2`3%^@6_n{D7|2**O$4B=#GT#JWrB806FPKE+{IIJf^*b3n&h%qmYHdzOt zvw!v08qu?4ZLn&*sF{FHRmH+ombFFM_yeJh*2$jVbH40CyU2=vzB}J@exA?s z{e8cnsw7l|B^WadK^4XfNWzlmL`9zc#Y7DnqOd?8rs!%4M4BNYUG*7} zCMJT?D#_u~{>oOkSMZYvVd5{Fx}B^UK)d@MHWkF#ts*&8u^l9V)s`yCO~iC;$BMpi zA$EaS@0C%k>4?}5({4z9U&=43VdQlOtbl=tEf#S092XIO ziA_4_YX~x|epjcr>4){x`k>D03_T~HS?p;Rjhf}VG@{V=`&HG{-_MV(!b8zjwMAF9 zqQ`>;FMgc6c!np0y(y^NZ?**oGtAy2ady%P{0Asv69I`fKl;Bst8uDJa0t90w7w2$qV4ie5DQuA1nJtbjLc1gcBP_3Ch4e4BHyyu)7^y257L=kt87=@)VS*cv z(;uuBu5>ucE0v>n`(ZIjLF_gZu&AUU-V;_-PS)gR@rdFTKE^ZrTX;+|&eC%Pa;X_tZT;hw0SaLRDLu+imgB=Hjv-|U27d{U7H-6TrAi; zB2;HYb%2@K-!6)55Es4eEJ4W(O3Hl95f$)rI3iI#KZ#64ke2p*`{MgZd*RM&!(*er z>g|5Dw{LHEFYQC=eY?i~R=#@Y8z_q0S1w=q^To@T@K5R+7{a%b2bDU!YhL-!|R+Iq*AaHZgXyxT9uCA*6?8L zn*XMLGjuI_+kZQHD>fd}5^SAP7nsX7D37u$mG#Qs#XD7Fim1wr7KuQk)grP;$;Kq0 z3>#3!1W=KpksK0`A{2xcVUNJZ2v#wI7>;2h1rgv9^vdT4RzCYD;fn+{z)FB!;(>(~ zx{z-UJ;!U&;Y^x ztjZc@<6OHeV#(nm1I+Y^E|$;N)r08xtRAKX{4~ZTl~x%WFx@>32fp&Hp|+jFFRXuk zhI)M0?l(_#?Km^m>Nx+M#~=Uh_#4N@K6&l2hVmy&&(#Z;Z(P3g7fj8Hu~z05rbeM6 z=(mKLc9E{5Gx`F$k$zs{@`1e3XzY(3jyiI_TsR+H>RTFK>suRs*7t03#hJ?IU9({3-20tlJ-oh`h}CBP>QGD9@oL z(L&j1p(bca7O5IV8S)^-Q}DES_ITK6LBxv`CA@gN&|Eyw--sl6I9N=NM$Qo<1qY8^r~RIByMiG-IID5myFo{oeu}1*EE4pRv*aoXC9x!x+-=S_SDVl# zwn=U7{#1Y3lTIbm$*J>_>xFgV=G5leu0&UIPxAZ1kE8>&ho&8z)g$~&I+pIK?Mq!u zX|-0Ei(5s)Dw0+~u7L%OTSdYul2%bQF#gwqH(I~mnXZupHWW(*SaC*GXn;Ohh#S*@ zlWHSxtTr|pr;K+D&SO*?&l$r8TW!2<(8hU;Q2-Nul0q0jKU}V$0-_Z(glGyWh{l>f z*yq=Bh!85PIfQ1Es@kjQsz`um;W6M#xELWULQ(Jmi)>_uSRF#4q*3tcxh#A=3-V;> z=6{e0Lj#96_GEzU3K^YhtZj%9R zgL`Kzk;BEuWF|9jS&QCR%!J6ZOi5>QE!n{=ozL#c(pd!|l%#Ys9g^)6GnWB(WhmeY zp*RN*8LP;nR*WS*q)~dv5Ann*n)?7EB(7v4wGxq8&Qwda=!p+g2y!V+8MDD?;l_#e z(2_>bMeH-`Mz=Q+Lr)HN)?vN0Maof}CE>#SXs5S+Ch50$Uzf=n-p%-hH+9hT`i1oL zXu{$DFWpre8^v*kXJ$WV_H*`*JNwSYhwZZuALS@_#<+3nMI?g61@l!G6I`LDF(Pq+ zlBz&s8cvz0uNAzf=wq_fn%a zkyub4=)VPFM#<&7v%Hh%d1o#!=)EHr=Ihp$)}^Gqu%aU*dq_2byNJfYZNwLnP%E}{ zpLU*qX81sR`qd9!?_IUB?Ul`k-rdGW&8K$_KN*YVl1G2{THme@4t?|qez5MTeNQ~} zU{g(c`6EZxuQ`}$$gX{6XU(SVn>w26>LaW^Zjr54 zrI0x{TS*^ARjgOVT2-u8#SFGjQ%ivg%r!%BxE3R9S`14l=F+UgKs8E+<2Is3Z2b@U z#zNRMf_yXaoTfiaAKszu)edVv(PRYn;SFt6yQp2#R86Qu!4_Jm4ujycqF@b85J^DG zA_!PI^rWFN5n>Y}wd7Ai1E!rPPof&UVr;OQLtv>v(A^3hr+ZzH^{wu%nJz)rJfC+z z1RGFx2gxxB^xX2|kYoVANy~jYgh6p|o6&%~nJOTVU%ot7G6LziSk#tw-UQ6u0W8zR zqXG}aO?<8ETSH5Z9vwe(CX&r8{N)Mvt53X19)A&QL$fcvIP>bdB?-YZKLVbamRq3P zXT{1*q6ADjT@WvjR3uh##87L!XdxTH&3Yte;z-N@n&vS7C?5kIR?=IrYOyL!7ON0O zU0*C+6Ze6p6TX<~cqS-4F~{+9b2oiMOmaNn=(r$dL&)cNR7`YSaJV66Hg1aPhU>e& zC8m5XjxWY>e0@SdBvx2a7){(xkiCgF5~GQ^gq$$TpfJmzFhk`q-e;z1ML1B5Xo_B< z(^RHq;Xo_Gfd-wTOmv8fR|k55643!lM7QYr+BF-h)*5n8VEIH2f@A&@iU_gr-Cd!0 z2+~YKc5TbCh^pzTuIQ5L%4QN-I!_`538Ag+2xvJ0iy}x13GCpq2|z|n4PekML>xe1 zQF{P^Rscbs!)_PZV1nhC#*HsOQ2cpu?RR?HpC&(@8Gq@^Yc_8F z@iEeQ?<$}Gpdj4<6fp9*K*0srrlrL!_7R~otdhL`w6ffKIffQMJ(U)Bs^>!zy*A}un}Tg2w3e8qc~$MhHIFVJ!N3VR#9$=*e0 zwK4V~`UAU)K4v%3KiEBVhb@8Ouo@I&8Pvi$STFJ!ReUd2Pyoh-F*O)Fh4F}?BVkE> zN8pH|fbYayh`PWcidhM2iK3VWASQP$3v&atMkR!moQcgw-S>TZm=bypC(roGVTC9V`7}j*+-Q9I7Xjy6iQ1Wg znSn&jt?L6q=nAdd-6goJ8`9Q@vNSt#=>3tUHR99{@)y|ay8~5l&!T~TT#l0yO1Rbm zW(8#}!ud!nzM>a<}tX{}Aq+6C0EeMNu3en?uQ`r10Z z$5`#G;g5QcIh(wvv~TM>y@ToxwD0MY>Un3v`;U5$W(=M|8LQRKIIUhTx)ODG`}ODa z2k-ptRLc9*fc|rIjSJ z9oa)%*YvdJq-`&akgZ7;Hq+L*xhsB$pfL-wLz@V&g`*Lb8N7vM`4)K-+s=phFn@tF z&Sc0HVmZQvnV;%`!1U&_ci<zXD~o98&Tjac-qYvCQ%UhA+W0h&+xEY-{K9`-CF>>T;JPkTAu!=L4Ziz~xb@D61! zBtHp~-^nxhZshJ@U@B_Y-5D6D0aE}!kpu^7{#nUugK}hDbwa%V1gIRb z-S;)y?GlHG#nCg`uz8fM9`!eD+gh|zW{O;xn+8KU4g3F65iN649zYeZEPeWWMhlhp zlaK)}jcLnpP`_w%&uD(*w(6VHV_GV_>A}r~)i>eaC%|&S3xR1aoz|9#*PKQx$@%d0 zl{Z!%k5@m==cdP5N=_khA2L5)y*>ET%M)HFS^@{;fU!s?47$H0i1rCK5N>P$5A@&f zcK+W-&_louk+`6UCaG1zJ+tqeKh-VgPfea^e{kZrv&DB#E&eOe#m}zuKat%t$NxM< z2Jc-Z!)LzuNT^x|^vu73Ib4zr^^7&2iQNi&(D_OUDys#`0tXwaOsGm!3$}t&6L`~H zHrNe39tac1!%kyurz(WWhT6_;|K+;cW1G6p_<3Ak-}kw`e#DM%z;;LoyR?qtJY-^; zTV4Yu2(-Mi&23SuP0%!1R?5a>3EfIj2c@ikbg*hF>^(FIK?s*gTlV>`ufKD?^WER?`+kSLCcGvcGQPvk`_7B!{l8%{b0gVW z8kEC&t=Wd>sn6s6s+6|Y3qAfGb%XJ3d{8;4o+btDiu#uEw)sANSN@&;NAs3qRavcS z$O^Ei4r*BBW!2yo6A{soq7Wb_@5lf_$S5D;?iWOn`XyP$qA2?W3dbY{8dJxN=_Z^h zK)0$?GZm2$rkIz}Wto@_NDd(+Q=(tivEHE3kfu>ZmMJBosRP%L(rsaDnLenc6t+>6 z2VDgu!)aGsCGHZbSRe~sBS8mAsvAmmp(3z;Ng0jge$2m=n{}4nHnxkI=}+hVTNBQANtexAGGH- z48K?Y7T$a9{dwiTktSRo|8(<$%*SP|^bTI$Q_geDCCjVn9l%^I`4z|9Fg&%%z8cah zM!0H3ss;mz@{6ekUuoG!^{!quw5k7V6`f*K4ZUjc15S0SDOhWtfOVY`VpOGej9H>8 z23?CKR98z>;2ldlwbyE+qqQ-U4;<@7uf@iPnT;9G`?GeoDYT9qQ>d%EfT2WFbF0a} z{F-b<^r$skovqE*+qHJR%{UZLo2;hb(nych6YL3ZvNi=bg|~@Y^=*Oeq3z+_`Zojn ztbM_kLI;(fsOQYHfuD!|uKYFhU%h0GhbHV9RxoN93)WVs5DBVwTwsgX3yiYZ)F!+r z;Q{6=1n6K)GoibH7LJ92!3IkS!3EQxeKe>_NL7`fWoeo!@(GY_+9YkiX%o9Zx<(je z#0?e58dvSIT#Gzzy=f7vfES!%IE5C+6@JUhnVZm>wQh~B(k3(l4`9J?nn8w0*U5Nd zC$thsVQF9tdPo#lU>2k1*v*)EGe1zQjhaQz0^}8^sUQIbV2nCOg$sK;;6tA*j;xaE$Qn>4M#9-ZDx9sr9||z2^9ug&)96n8c#IZk z##MS_j46tjO;4kDIlzYCY<`mL;O}X@4w3*)n?s?_xw)k^fkvNNe&)h8CpFXg^T~4W z!?T)qu4^rS@uz0ftoYNcPG~9}dhYq1TglTOUpcm*=TXj*CaBC;fh7jM6l|2D<#xbbaLjcu3YI>fQzomS&no{)h*9aNdKE1Z9-*Bvgjmr{h^!ip1x0b$p_R|MZcoM6x6VpW4WDfrWYE z!wLxb0&O1YLNiX2T2fT^X07uPl{)+gJNVeD_uB*RVQ2hVOOchjdzzwF<( z8UN!|Dv7UtrS#Yi`E@|ax$%^b;rOyJyi%d7og|7eh7a6NfISVx~j5j4bSccCZ< zk+>R)2ztWNI)TtQ0ZQhEYp5Xf&4heaLsvryS|A%-D8*VWL=vkR*yk;rGwmT0R?tbHu+%v^)cYr)F`qlc@I%{R;)m*#1xdTm1pzk3h-1g5U zjht85k6y-W@MhHHnjnGjZ`oZ&((C|~X;LWDlS>_p*%^{Va}emSe14z}W>`LPTd;i> zV1`ALGoXJ1h~ut7(w$wMq|-)A9fCX0kkq8xKpS6oRk@!Qg@?dviRbkJx`;xk<2bf? z7p@J3#I-Z+v`tJK|I41>W3xSEQyY5q!BadATdD@}WyhQGGZ4oNFOH>^IQ~J|AA(msoJ2^?4JVA9=a+-8X^5b0@>mWS+PBr2qc65t``+2$m9@&Jux` zF(K-dUuE4z5cO2&i9}1ZqGglg@Z#%Y-xVnSbug zIpN+YykPy6z@UgQ3WABD9p3s6%0!~5kBrkk29KW^~BREQk>1a|Vny8(|A)1Ua)=x~vj5zfRCnS@MIL$~kCE9jKlg?Dlh?y9r zI1O>?$GZL9ySs>(f7*rLocr#3@7#NT=XdWpk2OhiyGZ*J7=LS@yxezZ$(`FDAQ04x zY%_#96?ayeqh>$EVsNI%`jL@@u4}Qe{+KqFcm#yPe5m>9bKBQH%1H<1U!){=^&~uu zxdvimOw-U!q+=7bC3TkLPaWNP@o5qCcCvGw?4MtBsvm?Hy3J1OOOg6C8m(sFWMhdZ z8L5z4qJDIxj8S)u>sy?W@?1VlQVTL18ghZIH?Y&2HldH$X_J%}pYmdtUX&B%!{x6* zaC7eU5C;z?DF=vTh4urlM$WKO0^L+T=Iu&6n8J=|v6Jlx|pMS{&~CCz!mq21sPJ7+e(o&0vz z#-;^w+)Kr3(Ihm%+(jP0!*26CosK|4Qodt36Gf(XIpNX<}* zf3e~dd(Yq3Em@RgA_L1dY9z^GuqSHorL&*O`g$;{=)_*}xNUZ#0HZ;4%0t5=EFz!Ox|FwF?prA(B#}?CgL0k>jSKRG1MPJ6~uccABkOf+L5SHRQ^)`-d2-DIFZcen@u%tw#sq>joSg2&4yY%Syk+N_3!^GWf(4n)i2cAk#PAJ=UxHh&je{zFuxt`=n9x~h`vrBEL!?Hou;C9Ml z<5bj>EOG359LpJ%msXxWA#G;bfy_@buV$KDLmjX!kVXuzvP_@T6{mR}m=V`UWm|2! zVT$3yyy82vjqg2T)$MI8CE&8!N;qRF-W+eaSMyF8cAU?r6qZ7nunzL^`2lNImIG4J zVjLOXkNLASoFxa`@xBL3va)>7k1}+d-KU%4bG?mCIGSCxNV0R?9~M4rUr(?{@+50? z9IC-!UrjlZG;a3=!zV)cU`Pm~c>S2{-?%b)P4 z&Qd&ZV0lc7vxu?s zB#C1Mg#{0(c%a^w3dVPU60(Af~_gG*lzS`LwVNp)R#SrOM`Jiy{NeAY>F>Cw=`$GbJ_DRRnDAT^kV6V z6*9x3N}%0eoKAn*>HpF6nk0YC7c;V?{qnW$t2Yk@f8`=`Ixb`IynF)?Wp}31qb|C6 z@a9UF>KXWp+hU1y@#20Q;(w>7^ahFto)F3OYhxD8X6vb%@26KJv}6kC2j~SnyC2u% zU_X}c;`vJ8Jm3dr0ZEa*DZqT7LSEz9kL0`Xu}u0=wt=e66k2M`3I#FV7Ndin19qa_ ztY4%LEXA}0*YDxI<2q5Hd}*``L3S#70V#7OW5%uj(4yf}0THfF%w24n3YJfY=LBWx|;1*Y>(TB84g82EbExI~%+bSHT_2bAgy zXsRhcorhX1~M@=VO&k=6`GOSRQiB6j1F*!xhc(t*RWH?GrVW^M109{ z(kut4Hi9(iQ|=e3SD|wMxQ=DK=M67?nT65JNfz^mcM6|v(YNK5A+eP#qeE!n% z49=9@G)aGvCTW}K8T}ef(0nw;$VDI4gJ%!%D>TDwr#!^+NnF1>$ZnMoU2L(@j&-(x z&o0^lPV4n9{-EB)45KA<*&uexXyL0=`#w7utUY{BT8V-8{@4Eh2mDK;1!rbU=zF6p z6vBEo%RM2kuv{QDYSDiLXaus%Y_`>`Wo@F8To$4}V5uIU5+gu`dOPA1k8>V-0sWQ6 zH*{Rvh*)=pzGjX8<-Y8Lt17Mle%`(Jy%#_x2_%jQ0=7oM4^ZMjwNerzMhJ=`lF+~y ztdX_`DAnpT{juQA|wz^BlJ9gV>zb2K)ne>U*}9}V*ZdwrzUKKIG1$VH)jT6X$~ zWuKSWc4c!96Guype%)fP$?Rw|=Z+6F`mPG@Ap42lRo)c#e7QW!I&$0^?j!XuS@*=8 z1ury>3mOyMI`&y((PEk7en`HceQ%OX6E6y+4BhvcI%29yt&5h)E3uQ3?@hqh?vYA8 zD_w``qi3J?xb#fR#!noQA>Pkvlg)c!kE}9#P$=t+U1;Ab5#5XULlVbk$I?c}TW$Ij zO0Qr))|kC8{mDhthIKC(GnOs)nSA1;{46>_%D6+TnO@w_dJR8;RB7 zhc%z5lZD=Oa!0I67E`x4il1cOMbypZ{$9u3T|oc-f!`M9UO>I}Ezn#>a|FFF@j~ex zt2TLn7#%cEVSe|7taeMJ7CXKzt&V+|Cxhg?e*VU!jF4dZjc$hg5cw77CV7_`dho3= zbeH#xeA_FPe0KYW+dESL>a3 zDKC?9Z#eyHWrkNFkGZd7dw-Pf-c-(-e$nT!lRWyLV%&hpF)4RTxm)x3{){+CJ2S^t zf3)I_l0l|l3P#ruOJ`>ct1974(O19E&=*}>^$c}9i+*OEIxhXRjrWoaXP=J1RY{o` z=PZ^Du*&(9-0t2jPe#`J4Qz6;#i-P>H#G7T4EBb~4tR#|>yf{L*OFy&x1sVO%wz05 z$SwLVP@EzerjojqungV_|4T*ZIa_@y(LR2|8Rc!n8i<_s8x*@e`#g;KhIwD}8x(A@ zM2XFotoRd>|poLOW=+hZkgo;uX*y>~h*Z8KK19>e4QICwPffVKFc`;qTaNAyly13mf9r0$!@mqnVJ_m#dzyfTNn?LptPV7&3k{>^WTe0~~UOZIQBhe!DSClJq@|BU<%avAMEq2FBOZbd6FI`-Yf+h~nK85@(*B>q8SS30ro*ZAEg)lAKOVxyV&Kf#>fkZ zsrdmF79G`x+#E1kv14&p=`40%a4hd2MyJN<|F#^)`H*fSBwvXa`VESmm$u6TIw^OS z=XSMh=N(-xTX{)XwrTgjZF^xplPkHcSof~0=-a~E)|UH+I@tHP^}YpV_UMjO@B;&b z82SqQ3!l*!h*ACvl%G!fLh{o#Nj~LTATIg^P^teRheZ~PIG_40lz&7y!#iNwP7J8* z%${w#)%@J#hwPd0gU_q}as%87z2J429-g(nA({Ilhp4OXT(8`3@*2U)0XvmL<-4$n zaysR7d~sGR6Te+3>-e6J?2hb?e;)@^@#XhM_xdfd@0&Iy{8#LKPe$SAXLyGg^O*kz zK7G2Eko5Q^QbX*VLk#WD|4ZpxOF0{PS^NrF!#F$Xzer<1>=bdZjCj~hV+Zq=%1WrB z?LFQpdC~15BN->pJ0@9yyfNA=4{E%M4VDazdDLBl9BAY*a^uM|5(*e^xW*cH12*z8 zeThF#mh5)N%5HC?Jj!^RyVuLgZhK{ATBQ`H&6cIHdRgkOkU7+?h(9MQV%JHHjuFOH zjfvqm$y6lX*Tnqklyd`F6t3CM35l zJmjbLe7Z+Yz5n~9ly3zw{)yI@Un-N)vq1OM?CoS3=RVE5Ph+~yzZQ8|9`NQvu*bG8 z;au!XOGmj-n49oj2BY+x4a9D>D`QJZCPYt|^BS#Z7VXI$PS^AIcj^8ZX3^e}9Pb~1 z4XK_A_LT!=&Ihz#$sL`+UBL#uCFD%?GB<#>{#w&-n&~$(HXaJlYbyQf{o`%Oyf*yf z-UL}_V88VIoGgDA@=@m<=DJ1F&Hg=xPS48y-W2j7kzDps*L|5ckb1Sx`+@U^Cn@Kd zwFlDdRU!S-Wwco%Ih8wDg#XgqTQ$F8--5RB9a0=G#9n(yadeC1x!)mw*@LgUoU<$8 zT+?NadsO;)H_JnArc^4CV!ttR5=o}6IG<4e0rJO`Yoy$HPaa^us$m)|WZlh%{p1S3 zeVG~Xu;SE5zQq53fv*SOeUsnR-6Go!;TZL@HU--GN1@qyk-3Yc(%H!ztI&mc+zjrY z1%18|Fff?sPOpqRb|$ym&{yRRHq@)U$|k7KwV_^Rkqz}lXVIghb{*-_QT^36)L(rO z^yp~ZD{ZL1@*Mh&v7vrU7xd_8pYv>}&pU@6V{ND(YwLl3;vJiKi?``Uix2kWa1=G~msJ+Y*%ed6-u8cn~= zZTK$SNB{oF@oglwCGmfU`~@6=y@6i(-7nY=UGokdtIaRS=iYLB#uO1^bymDSDZL-a zUB>4gJR?@kH2(0ItT+D7$M+4F{8&%&ke8)M^9J?d(T7d@MbS!PlaQZ~E0}!YBZ+!% zN>21+sqkjVNOwDV@tycv=J4udl8&u@TXPO~f!q!E{)hFl0j{FD;`n)c_wK$IAV?rI z!IDs+;Un^qP;C`a3Hl5vh0qWRDV16x0zw&i>avUv$SXY|ed=Dgj#_wL#IanAp64ny4JT=-4I z-1@9-TEAR{Ha*-{`1?FHqh?zyCsPdlJ%0$UpG96@OFxni(SrC~YW7aS*A|+Ad{yX8 zqZ{PoR36l}-dsw^&d>$c#v5q5e=Y8Brata5`f{Qky6yl~V$QxEygSfZu1`I1pVw@s z-GAVGF&L|ThQH8Zu3HQ}2F;}N_4hC*wc4L?oIl-7`y0O)~IvPZfo6{ zS}*3fjg+Ug19DergE2N!gM5^hVNVQ6*ENBT3N?k)Yg`??Bm5p%&Y$7;TN}|Edfsur z!p)^(nTx#x-ONrymY53e;4KWcTgVdGvC*` zZZ79&`3baW6%}D^Mg!CoYBs?6Q&a32PhtK338vyO-f8avUUSt6_p5DRJXa5xIzzX? zGxe1HKiX1j+Hl_sZ`<}94=!5XHRw8|PgJLBJ!-UdTN~G!ZJPePoaHl&J<>hY z!-1Y`Z&$$146dQ`-o+Vx4t@IoFVNBH7HwBTqbxL5YeTl{t$msI8f(3D8|v!I*vskH zh>kVqEU-pb*QMDztt|@lbtW6??>1H`dz~HX^-OjWCA99e)_)rD5E?YF_I}rh_1e`> zQLER4gw?UE-zzZhOWZZkqE~?T9pgQYJG7!f04+~w)0(;BYbI>37o?*;L}27jMH>;Ef&IUpaIG@hfa$GPx| zKxHughnA%QN-@E_2lE)r3%>0bzI$fqbMSsU?&n>{&$}*P)OTOW_b51%M?qjcrbEB6 zKAO`8j!$UY-Qr?aWI({3L;joOs4*L)Tk56aHZGv@#` z(g_1i>1clZyUqUd`Oaw&$_|AmGZTInML&=U!25q=mn&` z1#o3Ok0=;sW@cu-;dF<&!wel}W@e@iGcz+YGczZhbeNg*(%=05%xu-$oqfA?udj3^ zS(aV0UAE7$Jp1+SFr$8F5LbmX`G5TE%$Wv}cX`BD6T+O3DqO+h+8%5esT|@3UJ`cC zd?13fedTNOVZ_CRylNll4BfMl&vigKzk++mxW%%^rT?i-CMQ2~y@H84!lcJEf{;L&h%|Dz4>b^+4t?{BG^MhJdlZTzIjNk58WY$PDjgd zyTRA`l#^;N>N6B}rBRHEVCl3RkH9g_RC^laHA z0)WCPgKcFldUGF3QqQm*nWBvW>o!meaXV{^%6X`t28-N;$Pa9Ta#r&B*r-k+H6}8r zTAv*5AcvgL(sV2u<&ZDN*Q@=X*WANZ#amdT%2g9(75W4W-Oq~NBmU^m8vX#tpZ?;2mRv@dla zMSp*eJS?kCD@dg`-e={fV?Sav7?_*>a`k&nYn*aCk1GC%oJYJoTI{_iEjc9+w)%>n z!=lTxUc#9FsQLM@{8Y4_dezRV?b5pi((4WTc=xAEpiqsJGFCOMbFvJ4xf^mES$CP4 zfjY>9r$R@QgnQR=I|j!Q?w*wyua;Q^JX9C_g5`|w$eWeGNz9UFZzYt|C(9vl(&rxQ z5${wXHsoo#7EWU}dfG{W>(L}LrUejeko|_E>`?J1rOW}Mfoj<-6wrvLnc>B@!DXW_ zS0N&V7a88-R$LN%P zvqwn7+V2S905<7?rWsUUF`H>zrN~U@XSY)r79249m~M=y%x=5E7Vf}Glwef1T1_$5 zg|?*7HhpDV<3C?tmP>3Wd^Ln$igvis!J(p5EUvjA!I`>cj5&5M#G6(R(3*SBxaItD z;?#$uEQFd_pysZ<(!^-#bD{Q*Fu)m^9pU9Z z^fG!c!T)ePSMvaC-kP&SgtOZvd^*54BiLWEaqyZM`{In>|0;cvf3Hh=Z0^~+Zq+@Ov=CSi(%=(0E0-HY6c*VGw6!C0p@`&gAit3bT30$F zBooBRif-Tu>Lq#Sp%IJfGF!hE68$s#Ks}qT7WD+q(;dQ@hZF57F8YBK<~5ezIYH(0 z$J#4aRsX*wAsTvYa3y6KWk_38SeD03QmdFO8KJ-cz1I4t*5(5NqIBA6~Zn) z->fnB{o>_8Z8qD-aaTQ3KT{F_c^WphJo-1m{5nQX;!i~K&Pw-6dtqJkZ@euK8{>Asp5UINTeu)YzTbbgbQ*g^@egOC z^Iv8s)^k$`t7k$-Lz*QNZ990B(a%~$6aLI#g>~-yxHQ2DF+dwGmL`gMX9?9kzT8n8 z`UYwkVn;uQ^CD~balg?{NJRLatYg?AJHtk=MENP>B#Zpp9eId8&*D393PP}7`FES~ zZ?6?2I>WubQ?%5no2d@I=40MMnoC=p@-R-38i^91#TK34K#Q6KWH-<~6lDVV5Hu;P zMRlI=@3eC|S+yb{Yaozw>}+DOJBu>sR61afz4| za0BJQgOjLXN<^q)gbU=pRh&ch=QK4Koq?|BN)M|PN}n!7Hz~@$dEA@x(nFsM|>9V8GHC7^AAqPF()qt zf$V{K#lBa4A`g=c6{07Urw|p@ctk)M!hJk zen(iZM(T<$p5r2YQ)zl6-^H9&8KDzW-F}`LjWnk$wh@RtUE^$ z$3ONQ@@?X|TgV5D6nu?GtKZ@dcPPTcBc5RR*u(9|uPjFmtwe(2&8tYfy;anLDG5{> z@C~77iBE-*3ju|xq7G@dgoR%obB?vkk7R|c{*h#`T3x9_Ru!)nW6%Yhf3_93tI=7l zaeEvd94whd^&3V=4LWhJ@K$qGXT&<<3&z{4X9wSEx;Vlge=YaIH1N|D&1BXK zdFGvmO|h0un%6B&c(J!MY}<60TP+0e6gTii#;9F*p}!m9l3wL>X?T;aSpXhe&KbUQ z9o7jI;btJ-V?-Ze|mY6!p7CE#J|DvO3)$3gZ;W~z$6-8V9-BF?aTpv4VG$J#iW9kQ{HQ0s9lj1#hU4Hg(8tN%aG^m1b80c0Vj;+ao zKlxTx=et7fE^f>AQ>ceAqNs)PUFPGMgVN9?ixa0!vA!5zD9btMmYsx$@mN*XxJNe# z{u;#u@)6FV&K1)h=WnmHrmj9OZo*5ogoa6NxSA z+q)fy={6 zfffuiRu_ZYk^){)*7{%XwR183s(uf&Xi2<0w3w1zLw-HPm}OiAAj2lv$}n;#-=Xf) z?ZI#c+|`3^Vsd%!9%7ny{zunJi z5KL=sDR*Bfe#}K}4TRmDk0|?;ydq6AR1=!e+~@8ypX^CMA7}5!i}}SY$1N^cEm0To zCVAer;WljVK4L=~UJE>9UPKj#YJsRB9!P8n`~dda0((h{W&I|gF|{T(oLOm{4P=cY z?7weC6jE(z&BIhe$duBFWgiXM1%l-bR-*z$>J5%2N2vU*&2N^+kGX+0_#~ zeE_pLC7)i;hoS+CM!C*DSo9l@RI#gjlt#G7o(pT_pN7Q z@b?-`0-qs0BoDXa#l9f~Aa9s{Z7Ji0WPTEXf8bC3kUBT6V810)Kg2O`w>$VQ(e~IA z+@Lpu(yl&M&(*sI-rgKVIMOi!=^noE%6i~(0ON8^OBCd4RcH}6Zl4^$fLV33vGNI=G5v1z>5nL&nWgK5&xr`x z!m(Wl>0%3M8~S?fA@mu8*TElh=)-|WFGqz2^A#BA{{wK}1%}|=7k|kbfLMeO~R|X{8g?3-$*7V zOCtSw4P5o{XGv*$8|G@!pA(#0SZ(cMo%0ildw12x+$l>jO1elfg;D?_55Gt^T-F?K{yBOSFd2dS&S6dDmoLozpJxGd@4&XGA|FY z984rFky-*4r=&G(^3PS)YE1!>>BL|qkR{DEbW8Kmi}SA}339YY5{dd5X93w58fwe> z?cPnKmS8jcOO?iDv8{OxiC&S9krER^;?bm@n;#3~tu=B}j`&i-Rk~Bcm&_FB!ke)g zb%`oT5c{qoWm!$h*Xt=0W=54c8C((1rS~bl{9&umqn9N1*2N>2R_gtttm|m3_zB%f z>-kFBQU}ASqzBc7Cg9c4LJ5>B5lG#U4j4t_X`{%6qPxjnC_F?|nrL3uarxz+HqJka z*}FQ7oHITcru7z#Yb;qTl>2=f{LUKSPg zo3o#_erj_qy7d;_5;faqiQfZSXJ-VMt7l+~=i;P5)esb6qm`ivxY<)#Gy}L)LGSCh zDgi>QR9KT{kxHP9N`And(SDjEu5_a)Djj2?NQp#Oc8zc{W`S5B?dJ4l;w%+0QCPW9 zrEFo-W9u;U(d)p##Kh#$-h#UwMRzNc>Gv=K0>SFitsA+7K3%}tNNw-C&^8vYvl{Nl zn#uH@&og!Pucy!WkM5fSm){p;Gkex*ds&CxxS}K%SIf+Er1lHh#cwVSj~A?;vD!mk zsHh5B-x+>E;_dO7d|h%$V^>Ep_pL>rs?xR7p>XkyhZT1~2gUA9xH1Ez zMqbiRc-hgSYm`DjL`82;OrOGo!|(hATYCw0QA=OyEQJ9jkY{5)ZjSr}cdiUi-!?V$bA@v$apjE0FsvOrTU}pc$9-kE3QBj0bp4pje>B zz7{LzPUx!$hPmGBPeqM^l0L!jqAqk;IaJZ@H!$85W-DovBJbT0DwzCiAA&5Vm*#HRA6W0{COgpigj~Qs zu)IErUHgtY->(8^+ue71(NJQtI-pfx_r zGpn%tvxL@IC1(NIsFSmV)F>-|3fI^qXMxxVXAWM9o|hz1Y1W3Us3(8B_!^!*!EHV% ze~NDYr=(D^JV;}5Va{~oYyb7I)G1CO?#AwV#xL7+_+rl>DrHu*;#u?znzd%xH;*nA z$xNoo)lJ-1v8%D4zIqi8e`t?2BD}r@zJ8xC2M%D0F>ZxCDs{%lmbt#tc8rMUl{TC_ zdl@f>twOLV?6?N9C2n8W;RmMNdn)m(6E2#&SG(lE;ZE5zoB_F!;^}-R`#Gc+B;Yl9 zhwU@}E7TgoCnyQyk1IgH;nQiXfA|P`=eO^QX$i6rfE(3=f;%`AOnh(28L&^4ns`El zv4LOdEAc|3ch~stj6Nvm$C@8uJBHOD^uPl&H?T~r$mQS)VsEEsQ7%gx18&*VX6RyKobvc?C_ozzb+ z!Fu1F)vwZ(mUGR@FC&{)Z`}>8@IoKKgzWlFL-J0UsYu8Ew9Lq7jL$-$<{vOuF#!j&+9;L&Wv?kVYklHZ4DPm|TqKn%A zQG8gqP4NyL)oV~#H`BQIEMlZ^D-&B)f~381`VVh;MNb`miOmFs`J34K9~^6o3La&F zpdZPY5{0pigb0*pG~WtThE<0}U}BQQ>A$b2N-k!aTU2D{F(xT^2bT9g$r5m7@yMPi zK*nD%hJfbA?&yC_%lx%3D6RE6H1T$D} zZ42+8E+Qv?0VQG?5t^8s9Qf(^8I$Z*eAQ(Tl7;|}TIX$&6 zB+*rMzpkYRkKNR|HfpX0KA^>jq{_UuEnv~e4!5;ub?^+N(+SU}LBtj+K+ zM%IQ7j`l`+R{x+j`sVO3TtrMn{~)})jG|_ijz;#3qLzA&M#4r0Hikxw(ni)Mj;2H$ zoXq_E|IR8NrnNY3z4i?aVy81(KWUT%#KF2Y@D~U(N`#Km8YI!fFA{VE?7E%v(`*4r z#-yI^KdHOv26nvaR#||}-8c%}5XJh*EzwCi>$SIsV+te-Cz#HkPG(BcQvcadBfMG$L^*Gs?QFd1GZKfkCleK_x?XGOjFOSzh4`t&79jA!pvl?_#fLT5Zf=< zF>jAu>E=B72qH*a&V3%oj}vZn9ww(Z)!o5-0r&nt28HT+DrxA( z|3`phX+zE-e|rb;0`L7lfi!sI{P`WnH9U^uNj-=E0hn0fH#%|S%l-q?@DF}kfi}Xw zfPUl%>>&O>fi%#A9M&Drffv?~;qsd#sS3r(lv-Kxi4;w0)(1^4)(K^%{*HZuCAN9BH%`U7_JE@Qssno9NN z>$_!}+?eQdelND;11qed4^I!u4IEaDo7{22>Zp%}Vml1}K^tHQAfOrh`~R)OGc)}+ zj~CQ)FcP(~c4QP$7ZFhwrTuPire{enXk%$8qr@m;{nZ7`tW6kI&8)v$JDC0Fe^E1g z2S*`OJ$oWn7RJBXg^e5x?9FT)ZS0AdnZML45HU*Y{Y!*}iJ4K+N#D`U)`(Hb-pNSm zAH+u4+U#!!BVuO#5BYz{|Cpj`X6R_@ph?66;3Q&YWhG(*uziXA{Qy{4h*((vgZh`l z%E?8<&dK(ll7DmjP3-I(|F6F*8(M%IpB#;|iR3hCL38=0AyIuZexIT-)?;a?U#D}dwgFmB@T zZx0m|v~krWqUT`Y{D(=z^0(T5HE93iz@mCqW|nSL|F}Q(e^AUUjaZ17S-#5s^5(ye zDXV8?^uO&Vf0>G3(~6^kDWj~7y_KHjKk};ovWtm{QNmHr(#+tywTYz>5fh`Lqmh-$ zm*aCV{-@LbR|jHL`&WI~nYsQiE%4Wp|9PTf z4Exx)w;AJ!?jv3QJj(JT$Y(ZRFj^!Z;<>O!t81f>^hW|i|1N(mjaFx_)Nv&^2+KHx zdJQtjLqbEKm6Zxz$81+0O~^i^yo_zE0P49iNm%r9tF!3gpL*k^ga}Wnh4OxJa5Bz70r@bB33~TBGcYzxxxE=qG7Tn1ncXyw<`J029g{q+&Ux zAQhUw*`nU>SJtFY zJjKvp-4(o$FDzmUemouzX`wPj1jsSu&BIOL%Kp>qauQc-X3t@F28*3!Sv#L~K$^?V zLa}u84`hSfTOlVDk_P>zmBi{i87~GUqVIo-(Uo;@8pq-n*pH6*Be3N? z6DYKpENum_-|Tn>X_mznl;wI)}J$JDc>>wW@*3SiwGcE8>C_X?4a2)wM%==l(STvL*Yih8}M z-<71Oc@hA)`Sm7N?85fq<0z%2Q`y`kPZrGPO(rt#2b1d$3krSiV_I(yd^&&b=0y%l zB{67bwd(&VTePTKs?yAkic06O8C`9&dX3I(P10_EJVSptpXT}Hb2YO|Dh3M^gU`rq zce8NJYBIg+c^woNk<5^+)9QZiuFge6Q*OP{;e_kb-MH3O-UZnx@TtF$&8Qskks@TB zSb>wf#ux~N+~-IvGlG-^r5VJs8`M_HEqF$TfGHLRI{;_b>MHL^#c%R`qEcd>U^Z*6 z4L&URI`}qNA%KUI-c{;qTEW-w7le2~VN4;iLc(1tnC+GW*mEe?)p$Z0x z>m@P8C~8qyVvYqRo7*@QJXLWDMxtYeNe!aww>~BKfm@I?a;<@!!-H}Tk_pxJqDSuB z?PTnjC`d^pK}f{HqlrlzEBGmqY{qrPXGt(V9X#%#t&eN(6WF`r4+?W7Do!Lg;7~Q0 z=5VfXE?^B(8*?b!{Xx@A^~a?eN)cU_PuTv(TopG*mYoZSL4uPgM-;-`2BrJVf*0dEtWKF3XsmGHKj(Lep(GR1LRCqumsm^~%oP zrqrSVzV3Y4`#KewJ+ap@M?A7VDRWG0gVDy`p>xrB{tS5KgmcaFX2Gf{21Z=qeQbVR zOJ7Z2yLV=6pV}Izs%33A#XO_oA#m@)Ha}QCcGD^nkgTA^oZd6LBpzDJ?P^!?z%@+t`uAZV$(wp=MqucW_o+)^$}{k7E(TqSdhk*~?cD>S5b5 zIwCqQE#A3@@=DbYu6O2MnK1KjGPp445X65MbJ2FWZ5u+QEMcg3!nX z+wbea5g345=b$KKMfmhbi->7 z4GEuB{<*7PazlW#0)x6K=6MlcL-NC{_gFq?!Vkz}B>W-TjRH6gX|W?JbU9-D{GxrC z;nL8wSj6WzLi4My0G9`j{;~={jXC6w;j;7C+){@}xG)7toW7psB9+Iy=!&>7B%t8) z;55BH*ErjI{9oY-W2GHq8D@=W3TYh^t7e^Ga^)08q>Yqh(Ul~W9YIAFlD6`k7YGD) z#M(w#R`i5ax$?2|@SY7#BcH7A#9=$eu$QH56BlcKbm{HzSqSB#s2zCyBC;;v6Q z*JRQqt1pC|Tw7wUPd?OiS`w~L->d*9O(WC^oiXv`$tqCR=U4cm*BP8~(&|&LNH~XQ z8k?-BJ4budsTu0*^zp3B6itqfWns!>>T6P-V|HNmp-TA0tlIifsWlj_hhC(9_0tOP` z_meIVsq+yB5(=rtU@rxF<<6WmJn(1`oC)6mcX}X|ES|Gz&pNVH5Q_MlBN9j;lK)1k zG=Go#txxU2V@Z9PTBaiTNe7KGrc!EK$=D*fle)G%`bk+^QB^taNl{y&wI*ey;*!~E zq|*}30o1vfuGo<{eqp{-WL5F$soJI-U@pojBYIiJQ8BY87H@FYvL%7h7F&1UzH1=) z8AkO=`Oxonrqr2$i+#$Vc**Ve0@sgB6YHKvt(ma4RN1*vZjs`X18$k(akA)LclR!x z9Ly6D_gbC2-PxnRo*|ks|99wKuthQKnMM9^}Z(^X}dRn$X(8Q-1B$p63#&06ML!o6vQ0G z+*7_NdL^7X&;fRWH$rh8@P-{wt;e70AlA+R;RuqN!r37as%($dsG(FW zso;t?)a784eP=27M#C1uCJt!bNLsgJ&fY`mnsj+$Q2o993z$BKyun}E6yAymc1@7S z6=7}f>(2ZXc!wPsSJ;C--V{XGpTukZ;I7ec9JoAO6GFs=R)b z*JxQotgaXl*LX=gZghjNYQdPbc#OM79scO9=+%4h9bwH^99zBZYGIEXmKA-kPe6qF z?EHN=o^a!OL3af)jZea&BjOeP#VnGd<5=p5+48=0AnLk9aXCa13I)(%BNP;39KYa= zNLST{MqTZxg@bulg*g(TSzK*!sa~dd4l-dZKCaTbf&1Hd%me%^mtX47Ug~ zvZ%aSw&0;TPMja8N6mLA@6i-}e9!^Vvu6 zBO%H)I7>YmRK9|0kRml%ggp=|Q0YHeE&VEM;G6mp(gqP*(+ICU-uQibcx18wTz4Wz z+qsNFxTV^`g#WFqc7QJHZTO z@;qrRjO77(J253e@{ItR7DU7yVx@l4)$ja_JU8F@2SQqtvTgAN{+P)2bO5nmVVUnj zFZ3$9Qh@ZK5CuZH0}~sSP5jC z_IUT0&j@3m%tPjz1OY1jzMY#S#<+qygT^?Fo6uIQa-GJ~n297+r5g61a&hG!8*;T} zwc)BVN{Wd&X{CmVWphfw=A|qmJd2`@%J@oRiy}_St2AOcCsp>!h>6ASWjbZeC;2aB z-eui5IS^&v&1-P-g3I*GTX1qk%j9+Bq7F#kMn4~sn||)T*$}de%E+NEqOm8&aPLqJ zBSPvi4!`N!wCzD`uEY-N~7i z@G2pwzJS^TNzHUwq{wx!i&;B!gefTW(ZuDXA6ZF~i8QncM{iym}{?7iP z(cQy%x9lczVB#?GrXQWII|=PDm%&mziS4k2mhMnAkO3$>@TX?Qlxb}>WJsqi>eFIh zo^Y~3$aXnxuT=?i+M;P>P%~N*aW{sv9EZ?c`L4M(w#2b!xX!U2eZEG#zLIsmj_h23 zZzP(|Y>mjeMAOUwP6$yR5aZ9@JKU?mIu!{(o$z^PxV_4%VvFv+RJZ=UwUM#iIE*5J zMAlT0fKZkKS&J%VMUKMSl=l^Av9$90f^2D_NTNa}oLMP*gS@h^IY6>Zf0}nlLG*d^ zdB`!#CzCe`d-v zRAsJOU%p=J4BuX)Js#~4&Eqx&O}YKt%XOS#FUw<+Q9s3X*wI349j^JiDPGDa-%39^ zaUA{#_9d?CKyXcV^)AXGv}hK1>>tmDmu)V0NV0$C%R2NNhnKdzKLL+fqS{+e3~MVPHbF)Z5*7AeBi`7 zS9!YRaM})St=gQPe&+1r(Gqq6YyG1+e|_})%o&;&p4R{Y475v(z@sld>!!iPjaa8d zwXdG9V5e25#iYac(2cxPLC35*Qgw;;F!7P314c)Lk^a~BS87ToS|%PQ%3o$tjYI0F z1H^~4Po)2o;JoR9;}ziXak@sPJ8@_(mrGTaP6$1-{&Q4W&ZsiTEv51?Py zx6r^0vfJSgm_hWB_21wBQZ`J8Ok&=VE|Z-P=*^mHi@1Qfftvw!f-zmtahbvIjj?g8 z;s*=HTO7W#yE2U=C?EEd&c8E#53V4#7}H=u2z1x{F&F>6c=e|e1Xd!napAbDI&Ogm z)#*rET~-Ans$rhzcMc#of}@ZZOu3_IhPh8550IQ6qrcgEv&1d1o>(_A$6`7&lcJ92~V#C@!-)IC$+F!}cxL{@NC`4VK2pi?nN$5%p|PU^Z%eDw+;pM| zy`$#DRDm$EIACthKHum_Uq3*{K0fhk+^Vj}&qO;(Q@>WhOqdokp;13o0U%6=ugmq6 z-%3U_#9dXP7lP-2~w2Cz;@-&Tz>)!#9c-Mwvz zCo0h?liXB)JR%_6S7Z37ys2)G{2u#k^=WVFCC&;m2+KQv3mls@;LHV+BoT?(;roQi zZc30;bkTsIRE`=`K$P@Pj@WTc8>fB0{*W;jjWEsZ4k&(3zkc>?nH&z?iPJY1&b)dj zu+0D%5#K)u*+eIk{mgk~d3s2g)IK7c=|2WPb! zzh%>2gJ&FDH@zwOP>CqOO(I`^V1Kd2ARyAbPSZT$MlljzTbYRju$B`q0q;X1hf*npy4W|eAfB+z09dP zVm)KT;4P|JEqDb?zAt`!rxD`WQGUDv&MZ0POFyZ;7bs>Li1!V5?BfnFy2Q(#e<3Tlt^H>nsku?5K@DH@4a!d!h2YuGyy8taQb%iCpT;if!7L5}H9?(^g?-+TbX7KT{5fpMw<(;kS;5UNeGC+!6 zR#dLL$cm3k2la8{azm)#R`w0wl%z1f=`um&^=b=g@`5$1 z9*HqN08xwHpiPBX5?oe@Qx#nbJM+_6TvGh%n6h`Ux3bsMCnP&&3wrpib^!-HGrVdA zXe?vk?C@BuO<_YIr5pNjce!Q^>nnJhEA65E*Hyqtcb)^G6u)ECoD!a3PuR|%xvW7; z6eluae~Z~^@+N2uePg!S$w(x38AH8EgDFu{RwXZ)DnsnBA`!)vGmYQMLp*7p(NAMv zYXi37B)vPT|9afg9}N#>0>)bGGB_`uA`ivF6#s=E*TWVJoi92R_6XQH7evefe&8LY z`QTwA*27MKU}ByVbU=5C)(zh$8txaUmRw{gCcSW-IC8))7mF>yJu!j&@i%Hd zz4LA0O)}F2kg*Ao?&$*kllzdVx!hqWB*VZ&u~kdtAhtRk71U#f_Xz6~?W2+;qT~A= zxkl0VGr-O1H$6FQEB}jNIb5nDB<(uP>ImKYfH|ugGUT!gK`*K(iU4=mcRHU$flZ%r zLXqvgRZ6Y&>?<+30a@PJ1O$VL;@b>p{HEu3-p_4x>3qDl!9T6sl!AyN?!4acfIZKy zAB6QNa_86$DEMCBo0g;jN@K;EccDVH0A!_f9HOnE(064VV)yaRg>c##Q`062&aInf z>7k!VW+huRM{bM_c9y3EiVn^CfG3pSX=ueL~ zx%f|R-}FN4=yEmQl+k7%fPxX3jFjGZKnK$cYIsF{d@b8A^U|3pSsdmP3}u;2QYq~} zyO3L}UBuo})qXVa%&pFLb<%fKvZHOZ897Mhv`Vb)W8&hToO?%heK8ffz}1VVp|FBMHW169%d zWxpV9jC|Klgf{yZ3V0WLV0Z_*60K>O6t~Vmm5wFVKw>yLG>a+_)gmpqVwsra36#=W z#@LUN_7K+6g6YfYreLKEtYm~T@e|ea@1)@5k=9BKxoMHs1EepeGa|KEX^ISqV2(_f z4Km`W&!E_e2leiR(L{IYO4`Mj?cGefyUJk`3oj)xG}MpC@&I%rNu|SJ*3*1%ZR7eY zI8&*#c`kBzZC!s7gbVasfIUaL{I&X#!h%>{Oc`&Nf5IGJYkr=2>`S44*g9Ax$P&{a#7cHrU}V_PLuiX4#Ni3oR0X}15xI%nz^wMdjb!%WNb~RR z9*I^MWb)5&z@P;|K9+a;s=QkDSJ-pPnUoev0Z(OB5CJDkmE0oI&?$;ND;6uUOEaS= z$8piHBpW%Nrho;G?5LpJH}7u#UQ8(#Zm3{)V@|~;5yu%9*wNjeD&$;zEX_Ejo5f;N z6{1UNhh#r*tiV3yOH|k)m%N>O)icu~OIMzK`hx5|ZL8ThdDD;;C9Mma0!VQy?0MTT zG-nr1go9s3!bLq7LP4kzE67hphl*GxulC>+ew3hzn{n2ps03|%Q#W?&{`6_0PMtW# zNlf}IZDz67Wz+m#I^>UgZo;vGJF|)g#p=zN*!x}EE-rH`h-#P>CIMt=v&zvNtO_^5=8D4Nh3>ggZBu1>L&2 zAqhs8?FUot$2yorMyc@2zWD$Pjz~w?EYnR2mkR0KA*U~$?U^&Fi=6A%68aJaV^2uR zZUM6G3T@zl<7;Qd6v7YqSTS~rFH!vtENlXg$p03sFS`eqFoN!=kf#7tU7{UtUww6c z#mod(y)QZ~ACG*b@48yOc5&}ULCTjEQd$~l9%%RC*Z7Dq!#GD?w|GY|^~2Q?3di)* zq0botgbRK2V93QbCdSydwqV(>3_?&>uWMpGGjF<ME-pM%y87 z8U9}E^PxCRo)EsZVc!Q%`Z<5UrSRy{OvST=d*s)VF`_k^W+BAYqPDM1BHA+~&b;0gUK&X+o>2^+shvaKKsFica%iZ}=_-(f58S-F z7eg0KgdE!C9mlOSTb6B2lg4_Sqx~%f#%+!KJ26e#Nf<{R%NnYOmDSZ(t{ZV=!TnaV zrXnI9YBw`-4O3F7zG^Yl9YgXAI7tI9+||W>D64VRL$QnwOn?zwSZUa)ns`pBC-hc- zM49y<(OswA@E$1g4Wjk+;&V^ZZ3v^QJ27pHd4seQ-a7ggdW-_`~ems+SGzee$`#Yvsl*>OfgpL|oq z1Oq@7;>Fv0_4afBZ1a}Ijk#Y5*2k8@&%+U0np(xJxarKaBLP09+hY7-=gYU=(qmPD zjdU-IowKuQ2BT`UhLD@xm4$IlA+Zwr2l7@66Ox5z^z-%gM8E3J8EnXtd{CyaZDy=R zTAu0J?D{|h#9sB36S}@LlJ96Ebec|0NN>b|1hq;We}zP|x@eMZ?P=Ke=ivrD7U)PM zIgP3f%Wm1QRsUF#Z^{SluBdd}a45YmyYz@w^Ca^_NTP=YdndK%vJ8E7es0LWK`M-R zgA0MepyWCc1kEkVv}6^Y{-mo8J$AFW>|RBO7Qp*Ne!jc7K9fCOm|t2<^SNraGkb}P z#Q~Ak`F(YYO+k&P{(YuTh_hb6S7?`d-yK!*qZFhwDu|->gOIZZ88Jnt1vO$=sYif+ z=|y3ztRPQ@aw9v1prS{7ZJQ9L_w~^IM{l-ifAf~x+p-OB55VpzMx%f4QD70Hk&-)( z`-I{Xgbe;jyY*R+eM_~w+ppkc9=>49*l4q&bIyEk(~{4LWV^MEh&x1zlW18jgK$xU zKh7e6Cg%C}K~ib`l#YISls@`I)};C}P>u34!d`*cM0WFmrl?N}$w90w|>NxVw!|BJ{y;qQ2GpF1lBEP({lJeT}Y3UP+1riTWYp!ZHHfMFA?69Ou&mpc)+Uk&tidQ5SW#qEe(j ze1gk-?p93pymSb44PSr% zyfKpFZ8r6`+5E06D*KVw<{7@Hs5w|l@n_dOaZ z*mRClm-QF8nNr4tVf^vz4SLD!HK5C!KOnmo>T_X(J=EnV!6lPR`s2iAgHHMc>l1oK z?@A(H-YS&idC1tzMVKyiv?`q=(l-*GFOZp`MPFNHzT7k#x9P%KL;< zP=bvPY{S_x0@xlBog6D1>s0*Ys0n2IkghB^;=)=s!{J=lfLGp-ji+-`Vx@{md8psA zSL^ob8^QPr3(zhEfOc8kAH|*bF;aoGjAk53;q)tsBSVndgagQivSWdUJt2N@{hTCK zgr#tAc3uf@cD`7@#vdD`Cg)`c%2DSr{ZQDm-hP}}s3dG1DyYKr(R@{H4} z*G{4nt2{_}jVeIy<~PnWnT=w&seVQ#3mTn4JrERfqBa3R;Tmk;aI};DnQ23td1c#? z=v`9cH{n_~T~5Bb%W+z``GF;rE?buT@5>QCUTmSvfpP}GA>VLM*Nc~&s|7Mswv(C zSfvT^2lwiLUR4a80Db7Mow(4cU5FmI_yS^w(8X0Kj|?OANpB37T~gBqPgV=FM+4w& z2?Wi!NKs{6-K4LlV_AX@D!1RyC8QHZ_M-6?1EnV zh4ElgQ~X*s`=<)E!ekme)PD{Jh(|`bQ|!OFAW&NgkH5D0Vwd}~=BE0S81Ge@nZErV zT}u5WrA8k`nfoaa&`0`Cxd6i*f+}la!kGZ0B1gmdJ*ZOyxmhPFzt?&{^gF${zx6~L zvOi=m;iN-GMt99FFHGMH8(8+$$ngCC0!=`&zo$=c#I4|cSdAuJ;C5q4&KD$NV=-@I zZ9FS|Riqrb{pa|1RyH=Q63kCEEWCZ~%Xzh>=G}Q-%$W~jA2K(q{xLsP7sIhY+&koJ!$U}$JT9ipn4ExtYDIB! ztRQql4_k+6w?M7Xf|Q~PpaOg-=`OIeWueEHd&gm%MM^=5kgZu>**So#9m(h;qe6~ zI*8y?y@+Mu2GoZePH`O&;j|Dgg+I){!83foSxI)m0#0+B#gF1@OV#OCXn<-#+f>+< zu&~J{XHp2EvTH5rtY_-hoxHSuhNGShek;Y@WvtH%5bS#nwzg;6_cIW z-;<|r_x751%wxFdF7xtN%l~a&BYF4>GY1&A3>a6&rN9>yW0K&ANae1%t{Uxm`9;S; z*L8>JQr)hon(x}{0z1O89Z+zoY9Bdbcpb9G;gDT+5A7EX%q+m2V0ho4*J+DgK^YpW zrG~7-vV_L|1hfEJJQ)#Bxy(Ixt0C=q2LDpIy&3i*G9<$^WME;^Uk%NU%Yu8xVQumpA1~|p?q}Sn6V~jlh7_4)VjDX z;Z;Ys`;4PkJ@4*UFT3SjE}_m*wt0KV`^tcaKZh>E?JVZ~E+rTN)1naO0Yt%+Q`V!! zQ4*zqMN^d`HpBsOL}bK1TzB#q#+ZUNL1&AhEQVE+Tn^;imN!%&-)MERRY|^b%yu7-M8A+>R4&5!}1}?MwXC3mO)?} zoM^-3VC-N6Cb)KEYyt*CQ?9`_F;JWUc4#udOv2Sk2Qwuk7^pcyupJr_hC8Lx3=FtO z2HHuWWa5Fg)Jaoo-T$p@#!Xvk_K>vNeeZkU_y6BFXJ$uoo%ZnhpR@<48f`&uqJGPFx=2>wZLkN8zql4g)1^nCv&Av=_Bc?^gGGuhiu3i z7_XEs;e06}RY>+^%C>?XQOZ3*0_Le%+{*YRXv@!)yKtoU9zW z!?|F+-OLy!hRi2pLY6n4*FE&D`VyR6v|UtglA8vuQEp1xB(r%;*fg1$YI>S^*0hXU zAb=}!GzZ&*yUe@Y`^^X42R#R}-whrZcQDrDIhE~dR@#)dwDusk3)XQL%^T6(a265i zd4P@5sVAZpQ5@~XTcMSGtjbPzd_`t!Cho{YnVGyjL|G)lWwDSN!l7=wRW;kqiJXcY zoJ0SeL%;Fx#M>t}NBSzP$m*Gp-p4iv`kd(n|J@CAdsUlA)<$H#4@CNFBRXt!)44O; z37D0&kqFAmn-rfs+&*dD=W=s`^ebf)h1gN&X!?&Ae0lA&yG!d^HfYJ4mp1>rsi&@D zW_?}xta?v#b=9iX)r%WgS9D+f{u?*;FWMU}IKB2$?ZtI{%@@(EIrHk~RMgccA6xzE z`liL}w^Dcd1guWluo{1>{$Q%D%+?^a2wQ}M1yK@xib- zJ5u5t)sZt&`ZT-yD(uMa38Zvt8l}&NkDToP(dP)j!xgL$>J^?82We7)=H}!f9ZQFf zYb}zEbDpYdu`S(uXrmGhf@e_KmHZTLHz(U|#;r(C9mgF(g7#|k{7`tTpq*N}0hxN+?dNzaS=?LlRj6QZ$Li;53_>q*B8ir;X z&T0!Q=~$LR6>1}wnGA?j8`Ur`Ta-AFWqW*zdrG=Wo^ven95V2tQ(@F}Z=41%%+zET zWm>!Oo5$s!K@(i9<|ruBn2Ed$0#71~e%a}BVyDM%^~*An(|zxZWLUb!u(ucI_tOXq zrXcz73pshGHexT$v1Cm^!<$Wxemjcggo^4{R%~(d;_(n1L5LLwaFFjp&IU#xT^UiiO2- zJ_I|1UNl0J;=Bqw_|&J)^atTL*o|ev(BDGFd{YrqND`){%u?LIE+R{W#m2v|)>0m9 zm55lQC~^i7As=IamD}paAfEb(+T*0^Um@f+jyPzA;&?QQ7;NKgnKNeM^Go$s<717q{_Gm{` z@I_L**LtgGq zT>8sH?KR8m+P2s3Ybw>g)XXS!_DJ~Is3oD%iF{)Xau9-B7S*+?42HX;}lgUhA3Tw`&V4G=?!>><0v%j|iHBv1u--`O&Q zZZi)+JQQ-9JFXv%z?W`Rqq^MVIl-b@>~Tw3ofXkmsyf_pYc~q1Iri~J)_UJEm$}dA zxAMfGJv)LO24ppO4KYX!uzDvlep30!+m_3Z}dex?{wC}X9zTQbI;akAa`M^*aYTO2OVhH5^jH`ibFp;pU*frf*?Ofs{ z#jeR2?HPN>PKkJJl$MG;V3mdRU>CJrDNfQ^sY#u1rY!XRPZmC+ zAf4q(L}}!5I_=b!(|2x)M2}<28(`5}IO|mXE8X?u3m47U_`?3=H5B@MUE%b)l9HDy zA3sTYGxN@BcYkwoW5G60==>Odwz#1H9c! zP>ggzOCuu71u()!F(5I5fiGk6bRz>6)Z;V9%qm1ePV_;Ei&09zj7+0vq%RAmV?*Fg21f$Fn?;c91% zTQqJ3+se24cJk+aJHyZC3nOgg2gAYq((KYmX{>Y{Utm5)my6ZrM*4laEwVXwGH}xR zo&Rm?l6AuhkOIS2)#en&W)~{$ixJ8zC^tk<6R!AaM)fKfIexT}9@YbipDX(8-st<~9I9qj(R9Ur0 zcwPab%A#zj!0{6SjKP^-nPJn>8qBqVN|#lV8r)Lv9zOArd*s!Dz90SxWuqBW+z$$0 zX?^qh(CPZu=i&U%(!HxY&Z2eiUPo&mUwHkUncv-h^Iz^A_s+s(Kg6ke#bghkKX-}+ z)g{3~7SrHSFf>FnbRAO3I0tm<+%_(FhUW!myyLI)H~2}TztxWwRJ;5Ge(J|&CfNhf zgfej5@?ZgOy6IhxwM-aP&ON*m53eNC2GsOFcpZbpy}zHLQam4(x|h?Z_5So5_@Udi zct={fz1;wh-#|=6d&aASocE_s zXdII(NYjpKgBlr7e5``H2zOL_nob`}=BCk5YO0l`OKpPPs{QRorF#GETG+>gksIU> zu#cd&+L^e4|I&|_i*Jh!{tecK>}^(u#pD8WM^-tg7$}dRjj%e}U}FeXgiy%*XQ4zg znv>o#Cg>JhsnpG}-vlw20SPL~2Ic~VKB=TQFYGxT{0mfKm;JTx%Et(Wb-QBC6H7rJ zG@M-1`m=xk&2C99Np-{S_Cx01Qkh44oftPzFes%?Frm;&g%n)sf(r>g_moq{j1Xf6 zQ4&jn#FA2gq>@AsZo+C%RB&vXX>!JCFJ9ZNFW@jaLFUmIzK4r35_{qcR76!lL^5sY z9w?%K3h4de*&2L7OhwA*cI%vX!PNz~s`)vh#_Ei!Iw5S+p9Ivr)6GjjT`75`&0Fb2 zCmAJT5A8I%=rKA#+4IJ)=n%cBgBlze?3uYVDHI$g!bPz$S8gV4WIx$24#*>|i#=J< z%p3@3W?13Pu*jQ7*L4SSYP5{VL*5ADW`^f35d5?3{ebfo=tt?xxYpg_J_XGry#>FJ z{_Wiz_}G8khar=PfTds7U(53_Qv$S`w7@pSX!JOg|Js$ zxrgBQ2KCqOEc{HdEKn_&)PBu}BaUg3Nqmw?C~yNb6h{=yNlJT8Rnj}n(b;*aU@AO? z!2k?h6MvVWIi<|O1=JFSasr-0Z81%*!|UmjVxw%r&GaR4M4k}+@}{^g^A6KJ;;?*M zoR^pIW%|CjB5&X!dR=@h{Y|1-K8JVH=frNg2eXytlXxRtC)UfY_I{Yg^| zUX%eq7Iy+ANmC8*=%8b%3zHM1QD8@@afRKQYK7QLBI^;juJ?x3gZ$o+DyJNN#im?{ z1fd~9C^n@`5Db?XUPF8oV;>ZiV7xGZ0=>xJ18SD`<5?bkJyxHgt?;ttNj@uih-?9Q^RFtR`oxu>R8lDr_!nFSi}OO z0uQVYQ?Pl`lGJ-2kMGJfs0e@!AT@*7?7ir9BoRZW z-C_5td(Hg|Fi(UG-L9oSxYMG(fT>Pko(W1-pg%eRK@1)xVNQd6+Dr_}7 zlOZCKU>qoj6OJ(>0?rH0icl3XRT0yKaRFSKBG9N~)|m|^X*63+++_}!IHN?k7=5W% z^MPf{k|Oayx03gDD==};uf`e{+<82&{0MN;?Ag1fs^H;-GB{G*YtRvZ3T|gGGH^;L z)Oc2}%%h`u-m2D?fM=tOWII+nz zo+MR#3I8!U%)7`@evG`qO{IVxF{3hx9T=FZJpZ&r65DEEp-OnN&k;palXy7{-s;+M zHr&C$F=G)-!fXmIVO4krdjvb|n|K8iA)L<^P+_6qwwzJiDF4fZ)UOK>UsI%{U_ z>{V>2Ubm@i?4ylAVU^|~L2(Gm?nE|TiE`Xa>Ei%^a`Nu&T5|gCe5L(Yfo{72x-Cn~ z*IsnKu}|N}JAIu2$`K3jEEXw=G>fJnYszlUZKEB$!`Bwr8SDtP=eCF2BW*Ds3jz{i zxxrW{7RimVoN~X2mNSx9a#SKsTGGy_F2}BjJMo5iW4txq6*uhoCvhCNO1diJ9<$NYYF@&aK1K;x#^k)=U+Hz#gzDG8mKl|d*t@FOMpt4Kv z&nvombXV_&?A-Jv`lj13b;2Np>r=)!$ZM`v3dVGMTYOj10qsEOVBW#7(QIuG zH`#5nEzoYYhdT1P5f{a={7^hp6fOQvc$>yIYiJewFV|%r9K~^k@$Q+PqvzN|d(JL0 zvon%btNk>)Cl@KIiVq^ypE}P3vfI!4qL5XcJkqcvlK*-<- zTm^xDOdKqOZ2}}15~naJhr%SVtGwA=K+deDdwOcC)Z6cS@BO|7AhD)U(-Tel24TH> zeQ1roL)a;|xc3W3{HOgre)rJuZ1+N8q4Ydz0vy2;(bMS1h!psZXtcmDAeLu}`T?3p zJDG_cMU#y|l(A3D>5em zyY`lqn3J6LtFB3d|Kv4=7e?V<;stm<-k5Go?|5(1Ppr}Jy^y~DAO%A64Ug;}Vk^yN zd|+gVOa$GtUQ9TvoU?>Q@*?H;bf2TuJmR=WC0^vEfasSh9Ah10or371Zm+}Z^tvh> z70z+aWsWA-pCx%YU9SBse;r+?t;y%9-%AyzW13@`<0Z#d$7>GGp{t5lRTZb=Qv?1& zkIReeysciw>qUCR7BWcMheT*_$E_$*U4Vuc!qHa#Am7cO=Lx^I!Nj^*W-?~P*H_O* zUt-K;>8(4-N5J^lIA-cI)aIlEC=t6eVaQN2!~mo|B%^e}?+|n+;-R{SFH(Qt` z|NN-=)XBOPi`vt_=~+7cnRz2V{bR$S-{iU`pL_9*kNZ`wX-oeVk7}!pq;|8D z3TA(I!cz)obJB#~8{{ic|3G}+8hOm!nSZ4C^gtqb1Yf`t@C8fix%%Q~`Q_@f#g~*G zQ>m3^IA$2N<^pA2-u%eI;`sxg%U_e<5>fI@o28!UAGc?#UJJ#i8dJ@a#z~Vj8ja>^ zW3_qBxMuPtQcNu{3e1EWH>;&;b&N6ET%^{UP3rT;dUb=bSK6n(X?OtSRo>uDP101q zAsD8l5*(Nrv@|`wB#4&;_XL?>7gLYI&>xggqJJ2N2YFdE9@`D0Dx}BDu!X1KI=l(D z;)A#wi}*`og%U1;$)Few-tGzjU(?;g({I^4%gaO9` z6Rgf2%ClGJEoWXr)$ zeOb45)$RS*ivvRXqG!d5)m5bfEAhb(mc81G{*eA6-GeXp+q|x6YP>3(H+cBWrUMP{ z&-?0}+W3QVBM~nwowxYJD=RzKkcFwM*+hA^6#dMg)|sk7f?9eXgVakA0u>cX?S=6tKHOp@%B6u6|(SEX_%o>uG~#kF zrcq?aZ3`}zJsW?%vN?o{%T`}J@ZqJE-h9B58z(B~ES}$TfGv5DPT%{arFQPF87uF? zsrU9m<(v+`kH?O7#9|Tr0H`fv3#NyL#k<8G+{0WVmpIP0Aj`RJxP{q4wsU(#kwr3J zD%v)uPJ9jv8uIf4P!V5+#__WtiY&wE7-g?CQx4udHk6E_6-Ib--4glEcU~`fggw3=v1TGaNBUyLK$f-N{JNT#2 zfQF_1&2`;>pN#zPSX-|GLc%MyZ^XS;UI|;m>+-i{0tYEuaBw`FU^~ogpZSnh4rG4Q zqM`h_q`{y(Tp@eK+4Zp2pC2bW3<6j=UI`%|9e@g{@DJ&x@-_XB^tHmB;m%5DluytF zaE?977wB_J+sJENoAieAE@|i9l{%C^5;~X|T&bihyT}%9m-K5z%>MYpB6g^}%>|A~ z)_hQS0OJ?2x4gSO>j`&TKHDMw&|b+ri?9GTkY-#UsPM51%(SEM;Zri<^v>S0b{8qD-PFa_eF^7#gXJ8MFwp2VI6;DPoxIXtH1Q$0A6eQ!})^FV;EKMbIB+|z1724?Q@~8NMz`rbS z$6MK*+%{n+-73F{UuS6u`-Ea#B-G-W!prOiZUd!pJX~NjNhhV!7&1|MN_vUBDs3iv zq*ii){6$iSl1ga{*(IGJXQlH*kQmC#0xR+|VMPu>WI04dmem<>N3h^!Sx1}~b_ZdD zAc~aA2_`OdCU^@T?`EG+ zX%=c=_-1xG;mV4%13FwZPHaxd&gYI&cU-D~;i1{g^sUDKF8B&K>;fD)O@s4}$tcm(#@0rKlnYrKn&Ue03EK<8` zQ8`l`@c&~kLYq+{#aZ1Z7W`6Hnum4VXbK;Xk#=_|Aa<c0U`Q(n zJ%U9<5~gGIDw6Q=2YmGwYG*sq4%El?qy6jw#N$MAw#ivA4|=IH1HO8ZOs`iAa~+rG zp27ugH{Qn`;Rf+#&K<)FHxDPc7QBF4hb?X^?&N-s4+yV_llUGdLjiGwfs8qn&tzd+ zz*wMUP@{2a6H`0&1^omP>7mIxQxy+jN9Hi+(6`{KX=(+jOF;M_5#WDVo_Naa1nEQy z=-M#KSpufeZR#0?NFLrkhz;hQ_Z>Vy=q8}#jpvI%1=xWKpuxB2?QhUxcy&CCcXTl?qo8eC) z9+ve6HP+Co*y>=;*no<%!rRM8%ZY2eI#BOe{7RWho1;mN#`%(u(?8l2$~4K@XeBVf>RphVyuZxrBgl z&xvr`i7;a>%&@G07_Uw9)$ZBe++&`T9{d)0tbJemK0Ej#S!TiwZ}#pU$7Y()H%+AFt``TfGteu;J@eWB0N( z%d?7z|26;k(cH^J_V6!XToY|H__nrzmo^_+9j#16*Dqge-%{)Js^-OAb?L^`PJsL{ zu;D0ZfJ{ZHw?-&+deW*Dn;Ii4B3SKWyM!*SOV33gaBMxZ*t^(YA6d?<_OA9Xj~wNW zxdo2|bfm(t2?H)JK=#5fiZUgHl6<&7j^au+rql8;sp0Zri1iE$1!OT=`u7XD{s9dB}CCbnmGBmHnN4&;Hw%+zCAA-H!f~?_WIi7V&JG zVC^lC2?q5~YkjwzQ*+wWazQO<`}F6GH}D&t8_Es+bLBIAj2+|0{A0mM*1yodFt|!x zrM2lfPr<`2QX92Ko!;ZxBOi7hl3zB?sb{qj^`hpM9EL_r$uX+|Q_6bD6(epsQTCbM zONgNaz)batlm$~M3+7STSAnOOAlDhVl?ZW&Tt!K$#!C*o$qr~C!VxYRFv8tsDA$ta zGQV~_Gclfl?s6hO3XCmHWHJ!TwGl9Ny0x|_dWVex*MF^=mbY#~d7l>t}01-2j*)G}Mxd@h-+pIM-qtqb{*=>Mt0 zY_}gSJ->O#erR7GIEajrTC?o=?JvEsYscXeTXLuhfhR`BQLIe$zqjU@cTW$UItlAt z3hS)`t^}wkdS`@EAWz!Frep5o-rp$aTxW&L?#tfcFwX~2J6^%I2_5ls-iz$T@J-

HpE+;D1{*6BbG;&)J|!ege6@ib!)d3(5=~l7Tt==Fn|Q>M5`VD)l!1{L_4ls zfEgjo$VU%^NciA_TUg?pE={&Lb~-mo6g2O=Ua|ls ziM&)Iua_(UtL*=3nn9d*XEI>nv&8=tK`juWc%mv@PdHA|NsSP|PjY}`L-@Z)Zy5W7 zefPxz3jBE-scgxj4{m>Aa}~X}Yin~eLK|w1pBjAa3*bV=zG+|C_ltJ)%Y*=xog15UGzg=5d7OJlO4-=KVr|u&Dv|6oxdXmCnonq2O>n#Ihfv z1wtUFs;Ma3p=`VO*RAUiy70SJ#DBN>*PX_H{yDzAZo{5k4ePg;>GNDOLhk&`HHS`| z?Yx34$p4G|~L>%ULR-$>}Omh}PSuxfpOy%`3j}mh|8LX0wQX+9v z)IoxV;~nHPhLMjwhgf6${$e(K|5J*dJZh{!$IJ*_R7YZ|n-B9Dp1J%v0k?V(m{iK; zR8(0NzZnth;%Zf-?h$Rs8KzZ?u)mY&VB}E>RMV*B~g&DBr+Up!7K;0qAV7Hml#R1u!HpX6Mmd06bE_4uUBYG7`0L; z2m$-#lGmoJ1F4Qr9c%FdQm9Z7Dm9_-2iw0>*s6Xc#HUe$nfzox48^Euk_>GPu+=7T z3Pjz4Q-gnAYezm*j;f9Q=uP9##_jF+{P-Ap)%elG8g#YYI027-IHi?C6owi_$c*9& zOt<1w_#(cHZ(8FLKy``CQ29p=56zd|bk>1F=+;RSxe3m;a zpNd?Ld>*kxHS&`*cP1DoT)5E$1 zD`iu|b}dm|Sf`;^U_l1yvV_f_77nDty;ssvT{=pKduOu4VVx++0gBR1aV3_Jb7C&U zt;0w4!~!_taAfH*J@K62cOulTe%OhJ7##R2g# z&@n)@V=Xo0G!03r2}>m-0Qx58Lp?V|3EiToBjh5!&ttkjkK2SO{Q*QhM5}Fx>9|;b zU{2Z57d9Ww0n7^ME9N)MHil=E%w5nh%NSAziB`6L(b5p$uFYoX;s)YuD9b^%7ODz>jZC|LEGa*~!tqLbwEFi&Y z6n0Z4WK(Doe&qi_wqyy*R#IO@kslzpj7ABDJcit6rM?B;sl}L9@1e(_+AIq&74Auhm^?4^3G!3UzgULMyFXr)MK_QWnNQeWSZ5*MztQiNTZiUgwj!s zBW8!R0GGkIW`(mK;qPa6PxO3+V#Xi7+-Ka`jWP~2HSOQu)O3J;;w{AOHa@=jmGNQQ zWdD)={=T06ev)s8@iN;5`KsW%x)ZbKITkr+dyFYoiXE}EQl?xfca)~xOB1WOst0~- zjK7yA!2bA6rysuiB(3zVetY*{)IheoQ` zr_)WzpJ~n|I;Nhhf7E}0zJyMaoWWueIv^J8Vb&dpEBIjJ5TcFop;evBp~db!_3Pf) z@x2YZptTh*8lM>x#+dQ9vXv8GFhi%`KYaT5QR2Z?L+PB3E>0JkgD4=lJh3EBO3y1*j-)5)uL>NKj-}rf$CNuxS);6JqzJ6VMT+3C@HUn6 zg3+8|k03;aHO*$K!A>Abe=sHg#vaN4);H3RwoDbE5jRTpjz&+TuRZ_;KpJO?H;srl zH&JiM%-m&GfhjL~xAyGj-H5rk@lYHw#^{?b*0;BHC&Jo_qZgSFYtN}^2;%5u)M=@&Yn!G?(`H>mn?Xo4TBfNgQ-(^zw6PA*(lKBRt!*}e+CPvgI;5pZ zwkBgpWmI%yLJU}?wkje*8K8=afI>(`3;OoH; zf;3o8k|25+AP6Vm90(8%6lS2RBrk^lqo5Z#Gw=ikIs@xFzrK_V!=!uMdZ>Fm_u#_^ zFS7L;F%#lmRevlsMJ5V#!!^@DkvKj0`%ZGEy$&&6|2E|IHMWF`gFc*LmJ z9mh#1wT|2P1%1T)Qs|2f$I>T5UrWClI+dPsrV_>pc+vVsYT&d>au)x z*I@T2&;l;>0v&=AFb^WZyzhk}px&JoVZ0N-?I9Ef={yy<31Jss9d5N;e6Qu=OD#9o zmbKi>S{&*caKQJLSvA(6^|(c?KHJ6qRc1r4y+1!&LDf zfx&~1x5TQF@RR<73xBz>49%H+eW|MESjY@?Z~5daUw`{sFRa`0KutJN9jf|VSNC(@ z`SmzfQO(MqgqNi6VORWx+Ylo$NU(;oc7K<@zf6gSNJI>Wh!w0b!3qi{L_}3#iXP$a zE+f`CYupltaJp=X)-=$G5b&lkNkX#1anrABYBOslq!|VgCGZY66%mtGurE|F&zi5B z;*fd5{I>alId4kDEH`6ji%HF>J#y|oo$4NML!8)zI59)amCGCZH}~8_CbclIxqKnY zp#>2ZF&A&0^Q1-@9vovJln9ufPc81WB)T+^$hGF`0>YD*wfd_1uE--#?S3+^sn0$O zHcieJ_kSf*Re3Yr`rwXrr{I^fzxjUgdGyaW5oI2tNn}Xhb*%$|M+2uNQI(_eW?^%n zTj&n_QBXWh8=zX4u#jmoRjx3Tp%CE!=?{B6DGV!E^Z$n@slJa1k`Ly6;QQaww$x<) ziysZdbDo|;BjY8rxu%K-#69gle(cDF-4LzWSLl2q4biiGk9_9BY2jQkGJAN_-eYrc z8O0*nsUZ`5812-c(hW%|yE&`yLFR*x4=Ay&PvY#!)R^6#eU*YNYCa#+wGf1aplGW$ zb4ZhRRnxJy=iTs{Se6k-)2;g;z+0x^UT5u*AP%&jO-u1uuo&H#3*f#{wchqwR1+j|V1)AL{+@Dse!&S1mh zb&5wE;uY40whe6+D8Vij_e1@=?Uw8>|2f2q=)L9Nzp*3S)Ff1we5#@%+K4{Y;kWKO z^eiK?z!XWXBw?YN1|(ZC)oK>d^IwzU8qqiQB`A9 zuOv1NOQsrSAze?96s?z<)D)}N*O4}9i`qeU3Ol7vWtV!KjL_rKh&sZK>!ai(9hFY1 zC)ucegWRCkq-*L8c1^!cZqqqwPQA_M^tFLYDyXjF<#uk=jHOvQP(yIv%E44)EpA^_DziD`=J zlYNRJNtE&c>kK1JShK(27yKAi-&Pg;B!*5qN;EuOB7%P^22tb64A>>IVMlwG?a1=7 z9bJx;qDV^dE3C?_^3C1{;Vc?I)!O|{`02r z+HxP}hK}_%o`PcvOF~B30PRW# zbSY!nlDwp-bu_7@S(di5ZFCR&DfR7U`)NNrM31r&c$&RTPb+V+YxEYo#|)7wips(? zM$@d77FY*WLo~|T*&cR;ou`-Rdu)-a3R*iEjPNSIK8XyO@+KbA16iO?zEgYSY zTUDG~&3AaOan_hML__44g;tGU4$h;ykjchK3!&ujzw37x>viEyw5NPv(OZ$`5+>p> zDy_|AhBKp2Um0B+SzQ57P{M~&cE7=5n8@6~37mPU{~=HulRp)UhP3qURV6w@3}0y`+e*dVTliX zA-c9eSp_17ZRk|f4EO{=LnMr~QPU_OPSsSMPNs>C#8))(-Sp=oCn z8>TiHY{zz{HfoF-CXOMPVPwDl&fQ&t)IZuT{JwMV{l5D+=l;$)_xhp>w1wE!fC#tw zvvm<*)zdvz*fq*)g-w1K{Ln|CO<|83he)a$hUQK78MZpcV(fc5wn> z(DLT^vMDn)H?=lZy@PNoPe@r|mJ$ExvEfwsi&msY(u3ixydh#rBuSAqMJQbJiz14Q zo*8B<;?DMsKgKg`sBAEZCr86U=|HenLz&%o4Y$>roR}9O5~i@_VqRqW>|(Z5EF#uC zdD2FLeiRA%lxEXe2fO9mc}KNHA%4~JIHWtDMtt6sl7Jlu;^9v((V1qbusnr&Y^>^- z6PZ30ccLkr#0q>O6#Ys}jBYQTT)JfI`~~H~$7j?%9fU*ql)LwpGc|RyC#3wt+gQ!k zpMYD>C0O4UWo`a0P2hCsMDpyEuv_3^3YS~CC%$qk1<7;Vb39d|N?9dVDO>%ne`*&! zpKDhM&zGy3P=novBSC#be+{?v759c3IPML8c@58AmZCn!@-x_uixFQ^dRSQG&V_WF zF5b%!qdI;aL)fmDTcsdxyOWEOZ4cm;aju&3XNZ{vhN;gOpDN6m`QuY3h*#@!^5#dk ztItPQ?`#?^PXAqWt;0Q>>TVwY!mFuBtD8%&Y__>%B?bVKfSv?>O zbrG3`B8ZZSQ_y3PNruj0t}r>-G&POfN|v~5X6bj6voc)~m*NU~x{t?vr);o)u)jB+ zaO~bRTyAlR9r`oIij4ckBFGRyTxR3Ij@%cm+FIoW%sKwIe6_*ZSoujLiIfbTf_tCC z@Yn25C622UYLB#oy)M~X}KP&av5^=}% zFoYp>FmELnlI0hEu7v`((h8AfJ;U@U9Ii)UrYG0)xySKno_1x{>GWT1V4Z6Id!=w4 zGt4PaX5#R&QYC^hMZ`e_QIwe^_fl3L&MRGR6@Tdpx`=;o zUM(KO^3sdf9~l_9KWLMyL7q>A>;agMMa!wwrh$QhO}1z8YKI4XF3!+|xiUN?bm;Nq~gjYRVUXr%9|`EvhQXD={I z>88hFmniF{Uw7^?z`MUeuMR-hR#2XcoK~!}L~o-O)V~cBOEi+u4%1q-4|~u?n~eQ* z6z!zs0sS;t`HV7*$y5OQRbl)kzz;CyA0!`E@EV-YAjfIfaWiV9T3|Ki?n>B+ZG-w; z>}wUiz0dvtyS@mlf(=@L23{ZL&taQm-|vaa=x^}t70mM_19Og(fbOw(nB&6i@ z8p-?ftS6Mc18`+c^uRfpOl(YSXMz{op4hf++qP}nb~3STJ1@33|8IAzc5Am5_gAM* z->&MecW?E%@7%uK=Qx#1hO()u*{@#7;JP-J~SzL2W~y zBRohccOj=7+?T}jvp$sv9IdIbP#UnKyz~5#YGy!i85@N*=d`g!gi_6I$To=AEPm|! zS$D(%0jBB2zY29JcQa4DkgNT49)so+O$waw8uv3uX3Ka+{!7G;AFU1wVdm;>7%H5Xq9i4w1N>S4DuUBh;{(|C_icg-VU3@FGKCB9a@Oe$iHtxKWK z4gQt^r3k7O!Y6Xv0$}RoNv36}epzG%UHz%V`MJdz`PIJmC1pKONXuZ9S7;KtO5w2si8DUZyhPo{6;3~+|Uq8&2dkhfzJ z2VSoPfzK6@1DlOZm&*!%ngkFA@3eTL91G4R2t2Q4H*xcN$!xf1U?l@=JMU|n`AyBL(hgRguFD0k;|xfIHKoNKiw|z^|%ej>tEVW2HyI z2fBCo$3a)##pqdwwc$n>iSHrkJS2}2_h8=Kq4 z6GP)9_0lfEM(mwtt%u|e<+PsG4*htZbo7=@VnWl1filhpc$wZyBwcXv1S8nJ-N#AWGmf>2ISep_as^d3G{^#aql3{q0aD3DL zz1m+@w$G=+kcRP)XG?{H^Zm~nyb0`VTN%E|ElQNa%O}25kLzLl=^-Ppl_EsK7d_yq zhWYUi;v^b+hQc%W)`X^Tcv}0?p=y1H)Xm<=*t3Yx_O(g*wvkc1oQz;m5d9`JF$G0Y{M3Zq>R0(57in9u4z$QJ;-Z^E z_>|$>`dF#&@(Y*i9TC(K4&%q`f_fBCM;}gNK0(&P5bybe^t)gV;Sf*gRs`twZ zq$~1+b&Pu`WD9-y_T8Y)OCFW;RA-mVCCN~&K9XDF6#bq2EJDib;A@x4&HT>Ps}bj; zCMpTjMdVK&exPexd=1;x9A3WB9)I^@) z$&;7Lh0^Kp=V_j)2H3i@a_ximKMtBKR1dE0p^V3XMAQyx<&L$(wdH%(FY^1lldn7* z2a_JAmTh7a+Stlc$<2mYFYGFq>3EB#FkqAiHrCx2)Z-K(+mD{FoT-4E;a@sIM*`AM zCbvCA@gwIa&KaJ?jVOyhjMpxCluGKU@nBTg-Jf-sB-CBo(!AeT}VsE zwXsfu8cRVp*Ls`DWZll{(a*Ij=v8SY?RuX@eTv-=3e@XQ&I9uU(zUB%9YT8$Cz!Y{ z${4WsyjPh-2oSrTcHVc~nTB+xVvdl{B0813IExKIn;OfVPrCwST>KE5)Jznw0+&$i zw+ONUKPX^NK|d4sB-Em1PhH(tq<3l5j~Zfz+ndzDdBQ2`uM69r zU=E=tyG?JHu}c>t3|Iss%M8b3oKui-zmD>4%)hYrIZMyUrO6wEw4+6m?+-eDZ+Uc> zZ|{*S(?XSBrdWy{q4mc&^j72$s4Pd*ay^Uh8wVjP6DOZIUwiony+2w}#&*KmeI{|^ z+ho>+w7ZViu3l0w&gBK$bOqx*ws5+xqavZbCIj+4M^$3k7|n#pW3L=Dg-HOJ_#LsTlvWjl0(ZZm+c&UlRF&^?mPyQDG8I`!rYxsr5fQx<0g*Ine<+(AC){h!;8D|nI(%UVw;^SSa z>@N5NS+H)>b;*ZsNnU$Z)p~%1HjMuJeS0deT=x)Lm+Lf3 zGfk35CZ2IOGnq03R}4Z8@h9u83j7D0}6)q`%xsdB7VUJwmP^I7#RSA zy5L#IfPk@El_9H$VQcO3s>VWas?hrYhnc5C@j-E+N4J<;ELd%QrNBl);(`CTwQ>)i z23plO$69WkBdLDlq!rXV0{@KxPa~@f+M@#gtFj@W4Ha1Q`YVxbKhmce%Cn)$K~02X zJ#u&=rv-yfI)5SP-J0lxP;wz+rfl$&LJ$ z!DWb_yt-mRw%xL8@mgw8@+rpy~Wm_lU`lDggMZtw)N1!(u)$};W|Iay& zgNwc=Oc#&jnIY@23h~VG?hov>yiZsY zJh&zcv6$eq4&l7+b*q_zJUdR&yzV=vdu+_0*ErTZQ9&<6Fjf zuYR}pw9YS>m%{_iwU)=GgNK>u)Y5q3Y-T0?D(XBE8e>qcdqUqU-(|jjigB?QJ&`c~Fc6utVD#heK zz%Yy)MRW{d3^h<9m|f&E-uc64$u;)Loh^0;4;Za29+jFLpXNpY-h}_mk~>eN@-{&* zcRESB&W}i1>ZwQvycFv9d1GM>&cA&jZa=M@9enWk=h_Wyf~tK^wPkR%V;sXuxHSA`wv2-YsHL-DFTSTt*>XdSE{Q=SKL3PD(>J$Di7Oh;U?3 znvwcY2Hnuw?nv>}pM()3>)o;gWd8_?KJ$o!3e|}J{QUW6wfR>Blsd_fY9jFn2AVhp zmO2HZ<;fqh?s^MSB9B+DV;Ar7!+K!TDCb?;clqgk%57@hp<9LxCyPft*rY?k>^&5< zf+wP+fmNx-PE@qWUb?@sx#}>y=@N&Yta+>{4(}MZqX6e-3t@m{4(JK3s zD{hf-g2RVi6oK6R)|C^DlZ3{BN9V8X_tqhCC&%t0>#jxTrF56f&3zzD`?BKs;X01i zW-)i1H+Q+gCcA`He#I4!--mm74a}b@@1G+a|0&nA{K3mI`f%@_V2H^IT z{~kjx4?8^CbllU5Eo(HXv`|wb{M~-C@Pl^3Sm+hx&`Ws-dtb6jnLgl*Z`$=t%8)e+ zE6Vgd+$#wCWFEM}d|K~zC^0l}&j67f;7m%^=vmISR%ijU2K#Vlixm4Skt69 z$JHrU@m>GQESsH49(>&+CZ#!r2XKiHXXM z2T<>QWe|xdBR+E{xk)C-Wqf}8x=Mi;JGu$nZ9?RV_y>s-MD?0t}6Txl0O zc;47NG(vf&NA3-nbINS#UBAPd+~hknD*yRFOGB+9YvB${y)R!anOV+?rip$-xiHBN z;w8Pa-2VE5?vtBH!KD+wkx;yKYPDF$O4~aVt^p~g!V)}nN{LvBik1F~V z$UpJlKq<#J0!6HLUhKXdL(G*7J+x`Bx|Uu;*NLtkrLlh6#^1M<_r+T%VNI@3TRO<^ z@~=BxPh1a|iFaLOTT%W*6fUM&aHd=zHmOxAN4U8$^zsK!w$lSIHt2@JmL4EXZC`U7 z1JO%iHVJXUP7HHzq|V8aumIL`Muzqrc(t{ib7%&Z6AJ)~FaS)jn1gqnpzG}LJ)xn-f2ywDurzyp{ zqwlHMDE9Jjni!C!wA+sMw|~yd7?^GB;G#B&?#1rKg=9Z`7(3R2Pj=`wM$!Pk;W~L{ zIA@=-n^+q%vQI;1l9ee-y!(hcxfbtsE3jqfP?}Qe#HL(slH(D69acNF>8YaCeB6rN z3g?Yu&vx}p`vfSd4{PND0SP?f?c3^4_hCcZrrC0ERd!65Wz)u-T<3R{wJC647y5vQ z;w{{*kj&N14TO*)736`ikSJh>(skXYj|=%l-t;ulQC>-zL%|kOxgT?LzE(*E?Za}0 z6xOjKl{$Cm=e!NgiKjl0Eh9zi4~k_aY4P4T*=PN< zdkG3}XG>9JLoHk1kuk#ArlCPeO5=H#3@?|(rT(;4Q{o9`;nrc$ef)e%+0aI!4s9V! zSp#Xx`_~7nT7dZJlounUl*6x{_VQ$#$qr*N{H}(AJIikUeRzx20;S{gtdgg~>V)cL zF7~L@x&7A8-V|&{s{wb)#f}I!clgg_gA$Sz5A|cap6?gFm*9&4jN?ZwL#L=Cmvl}p zbM1-Ik2%fiigk?-3=Nv6oekTpNT;U{@HJ~YuFBHwT{N{~_6+r{i=r)p<7MX+$aUS} zIvlsDL%RfxyF91T%1s>ynu{-7l}aha(B4R{5b2AJU!;$|l^YWOd-rOMgPWENVN0%6s=Q;EqVz z#b)HUZ4GG8mS-ZGIrm$@DvXQhIH}!i`l{kJKv!{*AZq zg7C-l6$ysa2iOWUu;=AU`F2(Rtc&<5uP8hpYB1xsX`YT)@}s-3#;oOeDJLH-v?%>& zkf(#}6f9?6$6`pcY|ar|4$hXV17yzSKsPvC8Q?{g*IthIb{!nI1edk@;HhZE4dd*L z0pFJJ!#bd4hoD<>jvd+shf}6a6<^^%)#qZP=mh5||1M49GZlwpxoxGcnC_{H&RPqC z^Xs(T1=LG=sVfE7pl#tK6{u=WA2QF3KpRKDWHXd&fu9%)QLb~3vPEd%*foG%sxZ*1 znPH8vX);{?VBTmouj@7c)pFPMdd>C4XndjawcHj75sI(#H|u4gEr~-(9>??S-3uY( z^^4;zqdA|{w8fmMIK$#?@`}{p;|h4h{h+n1<5eueH11u$AD;Z9b#e`%6ZP-$}6VDH8VbCU2lkSXtN#9suc6yclR_nV=DC<&K0kfRXyGp zN*7_dibq;m5gU;MeT>%|4M+X^_TEgiWiOQ&0j*j2dFV2jAEp z&x*A@|8Q{fQ>zIC9eIvDKpWwEFZ!FBSj1P&esPbFnp9mf`(lS{l;bWJ0IH|=bKCOi zz)5)CNQf>WRfVR+mi9-$1Q54%{muHLgcjmG8uJEAtBm(QaH9{GJPjK+1+2hTH zP@{sIah#i=6IFMlvew|Hr|`RhTg$%eo$2H6xM-CTVPFGNn);*AnDz}r#msnxVIfUT z{N>iK7r@)$Pn^YXm-B1O4h#lrJV$v$j9F@3I`a@4S=br?B)ZoDZl)i-CHSfL<~e_DDM|vCh0h1M-J|)#S28 zU6JZ@rtg7X9&w*xyCJl;Ew|B606GDn2S4SoZK(J9(;i)L&wivsDxp|VNKZv@&-}p# zTd&9IOdA79B|s>dq)B=ykFS?KQK~$_{@QCyDKUk@hwp5(UXP>Xai_0PazpBp5P^-0 z0rnN&GsK>jQhf8O41cL-+}nKr|lP_{cd^0C1)S=2Kfc%=YmGzC(H6bvU`}#2H2RfR_){m?t72sg6#?6jyJ@4)Z9!5 zpNa_=c+QEk36HSdhRhC#I=R;~!IgKgvk6RB$sw2wv2EcTjfB%E@mH?t24|wH@Tf$Y z+#rW;jh$B`{gNZ`ch!d3;@@QOm^pn!)0)*~4Vt_xAC-q14_q&ZG(!!In|_;}Z)0q6 zB2)v`-&yB!3{?vYCZEBtwgr69GcYa}$B-eS?!rI}u-?*cUR@<)jkx^juF#2MC~B4! z_+Ib^d_*IQEY-e=$I$@#CjhWi*op`WJRP5yD>WVsuJHx z%|mKHRZyBO0E84`>;BMwl#fFhz?d~8YR8W_lWGU+neCcE>{y!tko~H`&$u^~l=(O0 zlnF{4^aQpmb{Wp6Bd|^#Nh6O8F`B0`x76Mask|4qW;^()MIHX6*&X23z@x_v%e=tK z2}jtEVH4tWM6s^(30AkI&%~z*8qWd9@|SAj%h|t!9Riv2r=o4>@cCpP7QW=6>5Z(E z60-Y9Hi3Z8hQcrF<_n%NxkR!**t~xw_+p}7B)tEBeR0TIHzCwA73*_e##cDI-%32ES0vzC4V@m=Tdma%sTGEYzjG(G6+dbtVfeC>nlex_9}3tfPsT6F9zrmr+>PZhPe`kV~mC4a>pJDoQ0 zce-UV$8&m4ZvUw?xzQYJ_Xgm28*g4p9;A1v*naRZx%$6Howp#ix@Wt8KS2y(Z%EqO z(OTsNlw|=XSkiSBGGx=8ea;`ypPAjiBc5eG1z7j?P7mF8MI6_hstvlwbu;(eALF$& zuO{}?{<@Ev5nSMWN4WHmCZj8d8(H~j=nWZ}EsepOylck`+KI;QN$m1SiYc>=(*4u$ z12J_4LGl&34OX)HM?Gdr7s3c7SaGeALO1NjWX5ZwL9gSI!_cyy8dsHx4TSyIj{__4 z+q9k?4ZhjGxq%Nk|C0)?01AJuJ zM=InqWZ^Xn+>mq!@p`Qcjg!&U2ASOhvv6k+IGcr^kp&*Ig*`)ww8U9F4G%pW?J)C` zcG1;@^O`3o92es_o4H%3Cu9%Y(U<%cFI?IFLHelqkauOwxu7gYG(?aIZ0<9pG!dBL z^5{DF7yM~NIrK@8H#T|M&CW+L#AJdjMUxBXFK{D?nC~i#3*r?~aE+DmTLaXrN>kA8 zS9w>~uXQJ^0y+H8Wp8CJ^tA3(IOpmYFmeJ`uT3+a2V)%1CwUQOG|A@%?ENA5=b4S; zm}j|4gU$`nbrx30ABc$;kel^9R`mdCYW>zE`u?*7ZaV|)1aBf~2^uwVR)dfFE}{jI zZR}LmKQxT3$I^BlZaYfmR z1Sjmtadl}=tdR=&;a@#ZqZkpZcOv2)0o6 z@9u0dmkns)wE*vN{L{0raIR!q9aViPbbaq?r7IXGC)LI7THZY!(eqm|(UtN`_(7q+ zaJYS`zp>6rXpo!Gz%&H;djN*)qzqDlLF#p4E( zFKj1h8}ys4RO$G>MZObI$LW*PqTMfcB~I#?5w(uki@)Kp~oUnel#|aN~N^sM7vS!gW484V*mK zT4gx<%5}Bl*vhZr@w*&JW=D@#A(oN@5O@;f9o&rr6?SO2SGk+zBRvND`;rIZPSk@F z(ddi>hh|0NlMuVa>)_rR;n%Qe=#OhV84WuDy50ZVjf#tdo+ME zP*+4!CIlP{)FZ$B-xA?P)RYoq{zQ~9MWhAXTYH&fVH3)HOdGqV6(g*pEu-UuhC$%h z2y^3r=CbqX{o|M$Cwb)UKtxReHuT7g!Lo?`Ak4r-%@U|ZW2x3y`g+c?{v&{lkz+Xr{Iv3$YUVh2)<*VwK#wQ|+`*oea?HoCN|BLizF z=ps&CvMp*(K3WP^?;I2Wag_8xv^-{06!s{4_%&a)?+=9;5d&{gM^bBgk3LBs#75c|CYV)&3YPp60g z8v<@y1Xe>y)$xs`2%k3Dr&O$MBQxu$&BK&desx6Vuu`jjkCbHtlk*43U}z_}y468r zoJT|vP^s+4lW9q<#!iLVO+aMo({ps0hoF@xW2gHdf`*$$83^CnX)eZpsr!-xC=-x74Vk*(@6o_ zm}^>Md?VJCQcLv7Fn8yu;?o|)MB?+Yzl<3vc1ecH)vEeoll5xr=q;emgW5Z@d`!q% zJIcM`s&*EA;;EM4=p#4-+kgy_u&3X_^PsCU)Ez`xcH}qs6MrWo;{GPGYmMhloMG{s zdC$JKRX@~89MBEM8hj^5B+G+&b}>uN3YZeC5vVyOFPOn_L~HqrCiFijqo^VNhm@hy zl|d{K1Hpf!kNEzFsX!DfC{aNeYUuxvNG4D4AL(L#-jl*EucUtqfhA%ynI$3% zqy~x{;(tg9@&5-i64*D3fnfbV_55m?zJ*VffLiKX5R=Iy5y>D?0?VLK0-^eU>6!O0 zyfK1P=KuVU{4nUy{~?_055YG;%j^^s{GXJd-&hpF{zqjTLo7qAz13NPJ3U79BpVZm zlt4I*-+!1j7sf1O6skf5g7$;#ntqF~EgxI@w-De+9q|1JQyl1j%nM25Z_tY&>3qq0 zUsUO#o2~_1sk8j$Y?6tESQ{Q~e_R&ReycF#e{-{!dt*ml_D=rQM4a;|N5rKV-pV=~ zPPIdKPvnS|9$1fiLik%)eS<;Z+Io@wk({8M2MHWWefW%ndu=MAwC09HIB> zo=SGMGQUt{!x1rv2`)YVc%)mS8nV|X3$QLu<3wnN!hA2Lm`f^mTGP6Qki}E?r4_KF z02j{vL2}STIsXq3b;@5>g^&*&=)xU8AhlF8meK^OwYdz31g^xgvUYc=PROQ6H zf!ZgdlR&YBSx%C|t?&~o;0DceKI+r#yY-?s=|2WwF)DX0y5Y&+6?)89RT8X|2BB6| z4#m5I)RtRfd9ILJlfsigr%_p1;gDImA5~dQQkMgu%;qvp2gCPm@e`k4fYssid}!a=cuaU#K=_U!!)B&%pC*W>yTgA{ZRzS&Xl;i z@o$-361UM{{HXSD5Ayvu_pELTQ^QcXT|IyAcjtG+?&T{Pwg74L<%Ry49(1!2chf{i z5bp*3$db1jS2|fUaNr#sVoep*=VPoQ>d%puE~`y0=t$Nt502AF#_ z={~o-eNrf4{~Is(G4)w(IJ?5OH`oy$9mkP8rNF@$SpwgoS!hV1Rfv5yTf|cGLdg^_ zp|YL~Srntw&cP+=SyglY@|y0E0gr?A98RP_)q(f%+^uQl;+@Hr?(DtF0~}N|D)3@E z)nqg0&e7J_UZP{G9mGn4D@oB*JHqA4&+e!P9f0hp8L&;qMiLPiLp(YqPlg`wnycxr z6%(ykAWSr?(mrL@!aXLRGF6Pr$fE$_4Vc5(T5b9AnEuH zmkVX@+lt?Bh7Of7>Do(7F0~efo!xaqJ^{1K);vfN7WS3ay=+x#x7ohjUE`&5*CcV5 zDSN&?gkOD3ld>rTwKS~DVs9n_ZAnl`nBu1iZg193)*7t9^~CzK#Ku-E`f!*G@YSBY{bn z?8DOhK8{pLk^@mb+6%Jnwl{7ZWTQm^yWPzLQdkQaMvU8BD#Xv<1*xXOvwzs>39bN! zw}f>Og3#KRlPiFik_J`<6DK^;uK;$3j@Qf)7v%WcN;YA=7tvYok2-0+yKvBufLdup zb%|^F@}%FB6Vy}!sdf>+MH*>ly%40SJ;Y$J5#hFk?FQl?9t(vNMM9wV*S}=s*_Qr# zwm&GlZuNw5Isf=|$%&j<(~gD`ew~E>m5VKH`FKaY)Tdau)9?lPk!5v80|#wnZRp@= zZ=`4SU(rV291fbEk${fizY-T0K*Y?_(a0VkVyWk7BxGb@V`v1BG_p2vG$mkWr{m%I z-`k3XX)bJ<@5!Qq?YwdQYqJE1FEsd|3Yi+fXip&QPk@@*1Ah%+=yzUU99LG(`5{$G z?6JQY@Vls8G49?0{M`RAUjlTqtE zULzIPe$;a;aagxs_UVNY{_vAGd-7Iv%HfFp*5A#~av~Tw5#4F1O;nSrGBQ0eJpz~j zjQn;8>NMIS>S5?1>Y+Dz=a@s&i)a*HA+kbh#z-Tsr-P|ypknwy`V{jC7 zUTyfloucWXxc|b-6Wu}je^Gil{yafm(66YEl;3}JXsJnFe_j<|e|s0{?5g}fDAperV7xa5PR?Z1u?pG@ZNYY7epeg;CucL}udX>i;Cucb)EDv-^)qj4xI*?o z53=#I$`I_pSejm`t547y)m9E~Ee=ofk0qfk<6Q@c#TLDha}#y9`K`VovyS_=-)|E5 zx0Ia`JwIW8P%|>!|KATwrvJmR6tuB+G_rPdAfRXdu9YVM2-@4&3fQ=6e4o(~u+TFQ zu(C5~0i=u!&Gi1S)v|i_-;KZht^bG7QIdrl|wz|Ag&sEqn3_n7K9oLd-g zEYKc}NjA;&tfMo=ReE#YM^h)ktlil;$4{i33QRn{O&dBt$4|sW%?CYV()vgpF)ZTa zO}NlshddB-*X$;7dNf{52;^y^w=@o`%25qO_w@BbSm~BU&)S`f4wE;kbyfD1Z(81C z(?skp?Ns?>&q~3q=eEquYQRtQx=)_Yu!@^NdpR1XB&F!F1p8C`~*yY=ciy^gebnmgUNCKFb_=k3Hg!Cqy6^a za7T9C&RU-nLDy7wc%8Az$VR(`9WR?;LpyY)s)rj+Ex|5xe~$6+tTiVgX0|v15%z38 zg`0(JrvGRPath_XCYUF0)s0_+1N8Fr*|e^1X1L==OKFT>G(w-Wb=$j=S zlrx50E^rTC$y+UkDd9`;&aec+1JDe4x8Kk(r(jaguqv`)iTp55_qO_sKZMBfa`kTw zK8!ZPJj5BvR$^6gwcf3HpSlA=>Y)oqV48f}v94FFa@V0#{C@HcEeLNGF^wLKCpgVi zVR_GttnB8SVAj}1lGE%XZU4R2n&FQ48%eO930)6UKJ)$wiY@jV20Vg-$2r2{-8d3& zvP6ri&5ikhg#%XhYDRzOm&UG2?j0@|*GRetCRYZkoc8Se*L?lm)Bh+l{1 zY+^MMToGvg4)@<*wp6{Fms^u zo*C!VHA)yya3`^x44d*N=7|8gpT0yL=JU=BShXtq-Z7r33~N;>+K&=G`+w=8euX4n z3*ibc{Lp1`NF=+@HY72rMRw-g2Wc-4eW=jqE}!IX6xZ~M)(hi@WXTcWQ?HgrSnOmy z1!)rmEk{%L&|wL%QdIBYCm;}X;Go7E_Da}8BIc0Uu=ce0T1J+UUFlfu!7-cFQ$-F&aad9w759jfP3RB?EP*^IZM)Co%H7J@59z!uXtUAIn ziq82gdO{CSq-bKu$w%>ibKSV7@)UU%5w#=Fu}a@N7uwqd$W5?+fT`y@GscjM`52_Q zh435Otr7KejuA^3D-^CXJ$wdgtsKY-; zwgaRtjH~a0rQua7Q=y0z?$d|;uyI|Bq<0`cx{L+!8KrHBgAEHZFu1836fSFDc0=@} zKrrhnm$?1-7jB5l1sSf%_Y0{16hm5DaTt?1nGuM*6V}P-l>I=N=s)mF;^EHm%vzJQ zPZX-xoWH`RxHXU6vs$k!6rY}Xtb^_4s>O$U>}pDqMvFM@W25Eu;tlyr_2z0RN6k;< zWSg1(5)u39)K!*bOKzCO#iP9O7KvfB8Zt(ng!T6`ZkSnLrTlbj`SL5&jk+1=#m1BE z{YOpkQEBmi(&HzbNhic{f3#HIcdu%n?k}HxX^IX26=rn0o3X#Dr}h(FE1Hd7(_t(= z!XvXX>u~*G2GgROnsRwGzak#Hr6Thh5?l`I*f`rFAN}7)t})+6D7vXn)XY5vSz9g_&l zg=YOO!xFjEJ6B9xG#*J@l^gU^YM&67PSxpW@zZb~6sSQ#Vf&maWcGDWze-bRQdhRT z>`G>W9=~vnRgfb0M5jExc|$0NX0iS2%9Phn#YHKN_MKp2Sbf4Uqt4?%IjLaE9wjM= zHR~Uq>p#s!<~RQpI(KasJ-^*at(RE~|I;}cs# z4eYOI&n_edTaPI1lHQ7M`>tp+Ij5k6t%8>BI+(=G7ecZoI7;Vp8E3MT-%`r|y zR~gKj{8ZShaL*v}?2n7Ea-rV2^2%a`#B<=IxzGA5UxZ`BZ|()Ph*dTz))gQ4j@C+l z-84YeP@}o^+Uu0D<=POVmcH=k%=MBJ zj#p8YwpE8{Z-#c^9ys2I-mD=t(Ogr*{>T@;#>;U(+n7omL6P)gB{cCSoVq9PAd8fo ze=}+HGQ@BI|7vnmHvNk`I~68%;vqWa?2RR|RkteeIlSzSk-sP@8)*!I=iwxz@+C_+ zNLik{IYmi;KFyLY4t)iO_)F2TU&#d0GsG`unI8W&4AoHp0|{vjhw!eP_o8A6ckqYK zO51X%?3h@V@FaK-R2m2+;fo<2Qa3Ikd~LE~XMLbZMFlaS1K7(l^mE3UT!ID|j;+Lt zJs$DxBf-MK4SS5!@^aHjGYl!)%asg|%hpJa)fEcWr<;S)uCRb8oWulp`{y9C@@vBz z#MC<45rG|aIHg37?DC4B({{(t1=`d;4rz_7N?*vGNfJ$PzGN342RfSV1|p2`=XUbN z9moy>pSgmqK$&ubi^uNyC7i$=kh*`Sw;O#tAu{-ADg@*@E`F7V^#!&FQ#y-AvINbU zyAI*bf}D9#A$HSL-_$i^V_zE<*Pi3hM&sZb!&7OXY;ft;wYj`*tzhj$FpnRe!Keen zcnK^8w_nPJvY9>3u(JSG(~()+~l;t=wqRZEOU#+wIOSx>WZwKC+ZX zZ6|iMyr(>vuSczm_S)iZdu1A!1hm#H<>XAU+O>M>vH{ZbL!1&r!noKsyj=`GlettE;32^Q2X-(!y*H# z@bsVMlKI*TIJ@08%X}1O-}=G;2pNynr|$aDpKv6pc!OVr%@=-hT({@GtkY7Yw zj!7A|xY(U>GDv=27Lc??hRpysz=C&-hpIkPrcD6X{9@As~cqb=KgY98MLAd74)q*u8g}sA9tHY|Z!`OL+jfcKg zJe}~R?#N177-pjX1RwEQRG?75j1yTRN-hmpnW6rf*FDQ=0cns1h`Ltt(;vRZou$TQ z%+5fjvX~;B2!igS21tTOb%t{137a(QrxJ(ih^Vs`b{Zw@n><_%Z^CiWsEGsjq{y$sqiZU*|`oO6uY38H%X&asN*!ztC%};G`VY7{VtNr zM-jW0sBlG~EWzufWf9I+0Fl=IhBm#Y4?O3E- zjtNfw!U18P)>ff`t>3!V^c8*5Vy-q9QbhuO>fgXYc03?LHPZeLSg<#dj<9m%RQ60d z9P%VR_lM1q`P|~J{=vN_yhO65~Hx5Ff zrRHlI(Co?S==+Qq9X9Z*j@$H0W7KsJkeV%@BkVZgAW()iy)9_VTW8evm7Q4~iM=k4 zzv<(O+>2uF8jQe6uH53R7|*%HbYxcV)X&;8(^orlfAGEI4_oSRCn~^)P5}h+!bJWy zbhDW;aZ*s>`mhbz9~=&aS010z`5(-PZ$ie^4u;Eg+;JYp0&5`1%OoSM!cAZne+43# zh6k#8MnvmKI+j>=y+(9PMzD`Rv5{zo1!$k*7B|t5I0{;*zruQvr2WL?ZxHK@pPFW9 zBSdNhU;6#WlI)29@C#6j*35=w=|0<2i_LMIOeco;xz|85Y5&a?>5Sl&-vn65q*57va> zJ9%?Z$z=>D7`jA_J(nqzC2`OA5ggYv(DcgPtX4N=;ldP!T1o2sbRy`No#XgNtSZ*v zXcK`w*f_rqO}1^R@>5kOOI`aCf{1&&R)&AGJu{E>Y!VCUWuPY1Xq6@=;D@?e7rbY0 zR@1#l4MisP0%6^4jiio|#q7Aqly<&ifXF`U?9$R8;{ryF2VeFce~v%nF(RaxZ1-n) z)ARLHtH&S#@S*kR5(1b=z$kVdM_^{hZQqZ=8D=r4E~||%{nMmbqi7&93{PFS9b9qI z5w;+|fVSq?#XjN5BoYfsdPf1rR@qd}P`9bIinj;NGe39wr+8!d3igfe<_#1^DjUK( z2)MxDbkZ%W8_#ecuUooyaI(V4eKX?CvI&*BN{ z+gtfRCswKLwlR`Fy2s@v{{r@;AO0EJjweNz3j100ZILf7QEayP@uTWk%9DF@o@~)R z+HmoDmUd2TuIshdoj+HvGpaMS-}GW?mab&3&5l=Xx4x(au|NO)uH{@5j zzPYNteaSi1U(7F4)}^qU`D9t1{@g2h<;qIY;_nN5O4gaon3qxSKW+NOq_1tCcJx*5 zSzJH0=)>y&@0xk@Q(X0anHrYLoR(vGb6K{v>+fvdd37rLJUpV~+?LMNtGisiyxmqa zY4%&6=c^-k)?IsHuxdecHG9b08OaN>($1>rFBLTjpV@iMHmPvp+IyZxZ>JygyS}bs zx#IJyhm=-+tKPWy<+Wx>XeN;>&5j{<6(x3;T%)$CqT^>5Nz#Y_CF9>3XU8fIzr z`r2d1UYAo?U$pOtXFOsm->$KV^Y4KzZ!7)>hHbXDn|*%T=Q*AE zMw=hKoEf{2%Q-zeJMH?GA9ZVQ+_XtV5O$n7W_y5h;1JnC#wD}Q+@3A|Up#?f@)lEetP=qhMX71LT)+W(Gav~E3TCFJ#-<7&87MF` zR{*mV@(^NXz>$0qKoT=F1`hP2i5X$hYhnPLfIwAeW^8DIE@p0MjA5_2u?4!AshO!c zy1l06#zw%oHxxTeEes6N-E3-MWRC6@OH)G=bhlWVS{NFlnP+JRG#(*VQk0mPlUl^f zWn;t31)ST+FHr#MPzVBYJoD1>6+lygAWm>*RVpyR^*vppZ46DEE!<3uT?{RZOe~#@ zoXlN~jSNj)oy{E$%`GfUE$s-ahy~4!6qh6xl|UlX(7@2r%!HRqRn^tsjh71mU3>!4 literal 0 HcmV?d00001 diff --git a/files.transfemscience.org/pdfs/Warus et al. (2023) - Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults_ A Retrospective Chart Review (USPATH 2023, abstract no. SUN-B1-T5).pdf b/files.transfemscience.org/pdfs/Warus et al. (2023) - Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults_ A Retrospective Chart Review (USPATH 2023, abstract no. SUN-B1-T5).pdf new file mode 100644 index 0000000000000000000000000000000000000000..1d6a30e49d126b0dbcb7a28e6e9c5847ffdd44eb GIT binary patch literal 95898 zcmbrl1CS-%);3tS*=5_dZChQo?JnE4ZM&+=wr$(4n(p`B`+YZJ=8u_(iF5Mo%!OyK zwPR&Q=CksU$P0_oFwnBWLXqS(3@*b$G2qkV+ZtHFLUD7`$?KaMJK{6`ktpKRDZASl z(+TN2>08;F^76t$8QU2BWA|769|s{@XB#Jc20AHoBS$TK=6@V@{^j`()_?mk{kNZk zvA&bJt&On0lQFq4CnG&0Gd(jsBLh1#6Fn0JozP#ktpoX=Sk0ZSDd^-KY>k`^jsHjR z->`ot{oinGoQ!Rp9PwHHiR2HCt(~B)o7SHrdVE#}Mtn97MjbjCVYNFf?}jvn-;vHco#AW#vC0{{mK4X256o3#y3E%lkJxLnUJ;ExJGP(kUCe zIqCcnD%v{zNe-W$PRYr^+0f}<=#Kadj7)UO`UZ}4O8>h||DDd?$p4d$sJWGsu>+l` z)gK^XV?$dbV>)SL8&fAUd=_Rl7G7RQr$6gt4GSe6mZ-Msur7||wXF8Aj)X-jjNOT? zD<)sqwNy#MWoChmobCM!B6L9$guR%&=Hqc*OyvnsoXH1~AUB4yzP^4+m8=AButKc_ z{r*1aN9c0RG@7HmL%SxdFrg|N*{1;aj{}1yw1*oV>HSl2TAb7nd&;3veB4pFjs&_c zIW+~on38-~j8E6c@lpP3<&HUa4Cw_!_qlViitnt_d!)xUIl1jaR1MZ*7Sk}@z)y+H z=;5sQL!s7pDO=RXd3N+J{lp=|Sx=0|26kkgTMEqb<%X7r&!`W*?v(KaZrt!K+oO)q zcwzTj0r!M(Tsm~q&J!e=^T%W!fOm zOl`ZiSgHpyk2;jKH=p$3058HfiAy2G z-^T!+cidquZ0O}TG#JEif4_y=juin3VOOT3xnQ;Fo<0=rq!i`$0OX{O1P4q z(cl4uEwM5rG5gZIshVziQI58_(W2VG=fZ$D zO4%(wJh4E`4(x=*w1YXc_}zD)TSO*foC$bK>4`(9d-b$Jc1~J!WM$&Pl!*8E;(~t| z=m@Zhd%plET8By+lA7GU5yQ&Fw1mmPWG6N?OLe?X#nmwt+^7v zPoQh>qbAd;iq{)3YC14IXL;R-{y3&+5x{f`>^vob^W{#`4>}yPL^Nj#T<=0$9Mf7_u^xGh6~5Sr$EztfPxw+~`Z&+#gm{8p!%^f@6$3}(frn#@faxeSBY_?R zd9a}0fXu8Oh8E(b8{oAoK%=2h;iI|SZnks1TJWE7_{qyopK-HBJaFx_70I_|udfl) z`@u+;QF0I>FWQy(K(Jhk87rP_gp?s_gz6~;ZCW7ML=reF#S;*NNjPz=VG^Xe4qWU3{Z|q7zS#3?t*=D{z!;et-g=}`Vk_k*VIv*g?Gla@WRa<8)ApLNs2 zR^oryyF{GtU~4%}3<;w8UpR2Ul9ruw7&Oyel%pkqOzKhL1?NNw%XdOF6zN;t)sl90 z+l;MSurQ{%1nwbj0IM?e2g)J^MKU>#BV}B4Hj@B#{)mW<(6n^y-7u0bAc5Srkj)rMrg6ta=)Fzf|Km|UNTw-c zd#1Jx{31YGtB{$NR!PYG^tXQF8wE3p?%Cqp^{zZ2Fkj|JWRIMivGI2n9e13L6L<-E zBOiQZ$e06QY|uUMH13Bv=}(KEWF=lrKGwZ8MLN!FwI2#xwJo1l5W4IBZPL_+6F#c> z3}Py@eM}(_wTt8lM%Z#D5&3X;zNsXH?`19M4qDag#^(q>shfN$B!epC0|)_ha`G82b`_nj)@=8Q{RW?}Q>*`sF@wRgP=Dt9}rGS%6jks)y*X zi15U${$Ynu!hfNVIY<3!0RI>Q4`bNE(PZYK#DSEdiQ~Jz-QwVZ6G(AE$ggZU2jI<% z*xAAiNE;epBJkB9ktrj}C-e$xfkGIf#Wvks#+2d$D<&E_S}|NkH{?dcjJFZM%YeCZ z|ASHNB5p6hq7d#&i>7c-5?s@txff6^(fI+#n=>F4GG3+wjzjJRv}y|gj6P_QSU0gW zzT}8Fm#Gkl3t!MEGj8POSi9OUS9m@eX^|(*(C#=G1azlSMFVO$0B?OxT*>-argTG8 zvw$yVq+9p!Sv;Dj-5a&sf&5u)d&MwHU?Eu(yyC5JzqWjml1{*UJ(@uC#Kt@~%UYSA zqY`AS4LFyWTRu(05Iq{e0PjWt_)tdQoLs6I60e3z4qcw_X(h%0I8i~vJ&14>;cXMl z4V^V4oWNMCJuiHbkBe)U6=9UwFwmT-#&zlf3Vbun>dXOJgD^>p@xg@fvljJTKG;z^ z@)=Ce=l!-^hB+5*-44dfa*Qsgv?D@-l6F&t{K%12@>Xqcupl4vu(ernkVFm-$eptM z4P49MSAB(*wxVf)NluSqTWzbt6kx)nx*5X3S;45#giArueCV51Kyc@*TwV>s83+v1;hx;2m5Q z@>O*rWXXVoNpqO>+RBRuXMIC5B+w$1!~T^a4}y(?=~i&evbE&?#=JHZ1nYzc)U$-z zw7h~!gKlX0T0DY8Tb$U762FF^vbAu59E#xP{Y_=f86!Hv;*mG7aljZGGCsT{n!ly0 z;)f+94iU-I+|5g+YvT2SUG`Q5hm?hR)`LT9ic`Ua72XGN#?T@gh!z{(A0BkfFl+Md zxfLd@3gMLbF!RFDZqEgMlE#ca#WCwPUmM(*aqH1wCDkCS|IBzRgrxznkccm~&OK@4 zY^dUkF>?qg05Z|&Tz0v!;QmP(aOWilN3UhK553h!btY!936RtU)fFp2*OWN( z3y!KM0*Nw_D?7e{GP{k$@qCaFe$dn%gfSKzAZv{Fv*%H>rB+ZQGot|;!W4p_G6V)3?z^^b_XC7To z{Y9vF9=y(fw$WTpq`Q?PS-J=uS{R82K1%_JjuUD6f(D`Scg-B-9U)wCuzseryBUIo znVTa6`hVYQhyT6RKHIclL5P>M;XHTNSltsI1z z@GE0c%h0v3Je&+`TV3OsL+5aD{lOACKblBkYcj!6BG?V!|4rPrk-p9vPyTVG=QnIO zK7fR-yTc~(G$b)NmRzZ9fkyy{)`SKq%Ba}%e(p-US>kEJFFD#BiUI*+^5!tLJjm6a z*!8?8Q+AVd7dY8owe>WYQVhN0@CoQ`2Or6Adl9fFMH-1fd6CNIKvLEvZd(SoOd{2v zMnCTzJatZL&8nHXJ1)zT6$Yr}iDFnYl&iE`N1IQoQlpaLrNrW=y4f9WM$Ol+pyUIkEo5lQFJ8119ud*K&}XuR5%9) zJUbt%@0Y{0NsA<<_#yAEEDHC@*UC86$VIz4Xp6f}GF|ED+;$Y{>8NV%yR*^wJD&X#1}_3%wpu<1!JK)5aJV?k9=%%=5~0{n zPx3VJ`0M%B31}9OiH^@BXB#*5|GhsH&>pE~Dm zu?(l>6>Aa}T~Dv6X#_=+lBd_d4Uo^0%@ar(FYTTJ*6bE+{JzP$8Z5_ptOk^tKgGD`I=S27fbJw{O(>dq zUT4BWJ;N>c%SDLeQwzcy!szd4mWmRCmO!|E2}uiC8Ebdv1ApEd3|*pRZ40 z!r}C7$<$f=Sd|io1j9s9Dsp^B8zXd%t0m(@lM`ZsI7^1g)iMI1kUd7ec!ltv59)N$ zIIHAgann8)j;TW%^QK6}($TjX1^qOrT!Wltc`aYfBx=8u5?1rbzlS!@?;u^h${{19 zKVm0sWFl5QoO~+^qXb}J4TF4xN(}KRY!KrFK*A}wcz8h%{~5wt{i@i8xOple zdgP}VC6PCDKgIaCPlWl&UM{gL;t>d897w8)@$#jBZHVAUpn{c`toIo=Av)XW_@1$h zW(^6hjkL|bWQ+-27Yh_Gtse$4f-)rLg3}}fS5o>rpA(@5h4Vfj_5y;7K81AhUnsT5%%?gw&Wr!BYoMAb2)qhE6p zee4JOh5!`)kg4hPK=?16vqE^S^`Y9GW%jZCpz9^4hQCi+)k^~TP_Q-hb-`n+A4su= zs3l#gU_?3u)g{nhH?LvRym zLV+3jQKN0|JtFJoR4A0jvoR`3P}(HqXtdS4;-46)z9rFtG$m9GUWlg0Q2) z=+_OkFZ&qKIYbf%5<}PyQom?;Hrp?s+lR|tDbHt`_bpwG!^yGMlvk~}?UHvktpHFg zsAhco?g`=;EHo<_8x|H0;s8v+mAZN`!7|w$Y+heY8<*`n`ZPPua9)NvZJYY^<`a@4lMsP#&OfXKPxY8{Pzxm*}3aKWgo6 z93QuMPrg}t^xnVgBYbBfHcX?sbmsNrt90M`Q%z5!eb;zwZ?my9kAZc%9q^ZC;Gcw3 z(3hR)Jh&sFw_g!Mh8nVK&o)r9j;O+eytjm}P1k@zj+nYG#qK%DrqnQUp3+++p0#h8 zY(G_{17@G-d{hC~+T1W$)W@}|Ys}u!?ddRt=v*8pANT;l07fv}P5+_4|HHTbhY9~n z2LFev71Vb${>u~7iD-z3sEAStIGF2O(FodF8ObQqiP-!hZ_RB?>D0_^1Z*75|L0iL z+`-XF$V}e>pNa7wnpxP`(a^!%?hpBm&-O2>Sz7DfB1Q2 zTNNAgzsxW`$G^<~k^U2inz@ma*&kM(k&PXniHQlHne8uC{`bSi$cWF#^e^dO4HG*D zJ_|eZ|5*O@_`9*Nu>ODA{=xWz^DlH(hQBR^zjOTe#>&d}hk<9nXZwTu&;0+!|GWQJ z&i=>$ANxP@zqbFe`yao*c7Nm?%*_9c|B?S|&VT*>jrT9se~*7-`z!mq{dZn}_u2pC z{U6Ns|e^LMc?ESMs ztZaXJ5&zq}`CC)}saOF=!@vCw26`6OKW!d6abt5+GbemD23ESiMfg`m!^Fn=xBFn~ z_@D9={HJX~!^+71j}o8pZ`OYibpEMcQGIK3D|hmLYMm~e|GB%u#LC9b^6ys5pNeH+Vq*O7W{X#{yEcj# z+OV&!N4p8O=mEm*&y#FF+yVxR1>;4MA+9SMl=^m3Nq+d)-A(XJ_w@GnD`UW)V&hVNsaN z1(Kf@PQ1@6tpfuj!^P4Ru@(b?Hk#!ZyglE*_&CA}UfLjQ~0Yzk9k1Tse4oUry#|%lduXlgVf=S>C~86OitD zw@@M-Er&?hch`yo`0@qrZztr8MA&H1ypmLtFXK(Cj4yClf~um6*)*20z;bfJ8-bzV zl}M^hZ)L}a@nO$3NVzPwpfVo;_XyUuX~S=g7Qx*>@XHdF`-2^ODki0r1w9yyY+8j< zE@PWim!edpc$Rh6{WQaa?f&-h-WGR;u-3R@$=V;LH{OalD3J1~*|y2@+a<)6)8*{L zCZ&4w3*l+_ipS%N;-gFV`uS?UMeiFBnD58KanHwNf3FZBA>Z5jjJ_}4*DV>5sHpdw z#zSeUx)&}RC$Ij*ihbCALOhwYbQ-g}^6hL@-Xrawq%`-=L^)Q%W1Ay-CFo~E_#if-^GzHftt96FVNuT&wM zq)N=ZHM&3u#6BkinGu9!2(2K--Jtd|PQeReICQZv=m8k}Ha7(?a$Zw`i7JVC+}Z58 zcG$4s+u-|P#Q-jL8aJt%X~kbgv0&l>MKMK)iira)IhY~^Jq$BujOkH0Q9_aZk+VbYLo7o&q)B0E>1iL* zfW=FsqYG0H&E~NbODK5xP`8i_l=8~qy0;4HR5VHWB+93`PD*`A#3VXtCDh8viT- za)~AouTBn6_D`=Aqy|w9+FlaqByRIF)W;bV#}{0f7pjj@Z0(|WvMNThkvW7j zWE$iS8fln~wsdZ+rzr*YZ|mDR9iw=1y>WnXmS@gRnKtb@qv&-QsfAmnQ*8>(dgtV9 zlW9`|-gdq1pI{!(o;m1Rz@ONhl{+Q1L+N1bP`m2Beh0j>!?@-9F#f150fb-Rer|bR z%UI1=dvu}enA#esu4C#jL%*Qp!u9CJusB*ib=NNDldPmd=RE`Dek&v`Fk!W$yWN^d zCwy;u$FWFWUEW-GrmNtr@X&fR$mLv~f7AW>SZIOEP{F14Tz#d9V}WIc^%J_~u{LP6 zeT{Q{ZB@FNwfTs(p0|0eiciD0(dYWqn5HhfF1s1+ZVvQZ_8jmWz*5f=&$4vUh($BN zSABYz3ougZFrN7;>t!uhjJw!(1pZuf5=^Gq#QW3Z^XRT(S8Lnl*H>OmG;#of8v5be z9mLVzM0~4lYOBn~@I6r6Hb&&I`_t)nsJZvq1B`XIO?|cY^Ph)2(V95ioaGxZjj(MQ zT@hW^R-e3M1?8G2w+9RF&C)ltN16wrtp&C1O`^AKSk;y5>4%K$tw+a&q(@t~hUG`Y zGjNvXgO*g@idoL}#^38$H`ShU*U8T9&O$}ME>lBZ1)1w_0Q3wo&|wtJfhgsJ z9S-zia1B9ia*#fkr0SF#RS64<5EyhG zl(N_N7IS-_SAsYpPTDDscGj4(h{`Fcde#{#PhN3E+E`f@RarvC30Pzyc`M�hez_ ztbLSm#h^Km#&~?iA$e4_HpvQAYjUZUx;eQDS!mTGIZC_P&)O(s#iTjtu(rwyYkkV4 zHj6q%Vym`giCmq ziRp@lOSE_YRD*$wUs7$v1yaX^uKHz9xzYsfBRW zits|1Zl%9UJ*7*+ra{Xpj?1%J`gucJ`FVK%3y`5xdK^Qn>47xj1oq~Ao5(Uj2m*d51fW0!|BWr48lkSxO{los=r*%4zMTV~Zrt8afK7XXWk1)fHH0#qC8lT4Ys9OXla1 z&P$X>5SQk9VkhD_MFq~0)g|ZW>YMUxb5YKj(aSPUN?E_-um@+YS`+E)F!T-_x(8BT zq10|vj{WXu%3N?cSf&h1mfZIiIOMWSZGJat&xEz7$(ijE>-OU7sXz>eb9uJYsgKqMrzM$)bbGf=NEU{Wk9suwBUL#AjY>g`^Ef8Phd4h^uQhwIH_hY8t-zz!?0V~*~vV}~2w5B!P9cFZh$3}e$v(}rq# z$I?B;_CmV7x3m%5K#!-kYoQ%rSqA`ZkAt@BvGEJb9@%DyrghPYg)ZG{9=2uICBd+L zA5N`RKn-lKldXztNvC3t({!_;yz+fXsAA2-Xi+_;%Bf<>!(dTEt}3#22?(K>3If6( z1QZhi!m0w4o_$9U0>*7e2t-&gaSV93JQSdga_zHSBpQ;^6E#vTDrb$hH<9jS6j z73&Y7lZ!ztz*xvn$sEEg&epb(yl&5svyaq0>H0#ewznJ$NRvy_=r3&sYmE=RCdlOm zx3=$lgOv*FxFh2RebmRD3J?90fZBhs7NjSrs1~ND|N0jE1JSoH=k~{!|M0CEw;$Op zO7;+w8(PFIcJhup^&qr*FnS#}-L7$`KdKvQ%|2{rSj!FTR&R%T*z<-}W#9V?0GGDdFxx#7+NF+*7 zMT(A+1x{nJlSW8QxycLRjAblMdDIqCmnR$+ayTdMXXFXSP|o>N4_Ie{bnkAdg}MtFZ}NI)VxQ&!u!RE5slhYyn4Z6%dOd` z)^DlZ#W|<8V6B@Q*ex9ymSE`uCbbv_!Rh)Ytr+^E=?Ys~TiUkSY};BpG!JO*5$42E z`LoQyLv!qya>yqw4@jTUq;tgS(mf><%t_bt%x}OlB^VEkU4p)aYNsse5;gNVC$J+S zDz%tPzctB!395sO)Mn%T23vv1_{n7DS5*t!+z*#N2;Y{DckB7V>-(EaCYz1pLF8mR zk4{K0sQU=Bb+p4B-FL*(jqZB?(~I9E4J5%V{m%sirlnKjmY-@U?w6- zzO**l@&Jv!n6em1jgkPu~|l@t0FG2+ot2#X;k+{bgOc3P%R7Oh;+lFDF;RzGTqdA z3AUjq99mOJ_lJUQ>aP|W1 zJ!8HjbbT^USsxO($TSD`?viNZiW;<<<52EGTX8D&noDD*lH^tD7>5<&Dsmh0b>(&8 zYBI`7NxA7|MoHy!%E1<8j3Qi%qD?9|%3_Nm&MK>vV!3D44l3|TB_8FvyGI^%}OhcLaF!rVGNI8`<&8HsZ%}cqJ z5!(^lQOjXef^Y*Z1f7Q%`@{=iF_vFQ*DjulQ@xL3Ust?Lc-ef}z8Uq>Y$u*M^iyWCcPJ9?dXXs5rI?iP>mP}$eE}>*N77t{y6&?9gFrmw|wHeW7P!;!Svn)?I z+rs6zo_Ex#hBmGc8fJ(1PNDRRqNNv-A%4YBEhlvLR3SzS7>`WLGms_grh(>}_piZZ{1hNgxn6 z7be1$r-IiZOIed3F*WBKTB4R!2`tE#6^SG%X2F=3u{0{E2wSj8mK#iS4=IYiZoUpV zWt)DbZQXB>z0y2qK6_8Ue|}7{4Z<*%xnOiu>P*qvimjktgu9S*)Z>_|)fHTraSc^l zs5Mlq*SWxU6zhyfJ4SQ4PeGDxzxHyRW;)1nnPxUjaU6HH64-=m?KLMz`4(6kL??~I zo4Kiv*glyEWIJy9!~J)CvVn&g#Pd@) zJ8;Yqz)Zl`U~@o@UCME%+PSF8!rG8n-(_CY)e(UOHP(;5~PzbtiBHGZI_#HHknx0OD^ZBd>I5Lr5Gl`8Hh*DOmkJ| zOOEFqkTz;985tKYuAZ%7SI{Pyh=&9(r=*eQuqnd^^kOv5k zsb0!9r*KVc8m3pT57@y6TJ~yRWU&#qBMSCX*=g?vAmiwK5Xc5e>@`qAa|Tdv8(Jx$ z23hQJ2F$_wi2ENOV^xe2Ba<0+q|0UJ1A4Qk+9R%@?qFtsouSMYbX{j~dSh&zs(C?z zu@{FQ>~G8>aVv)XqzfL*K7%U>EXOn%;Q~Fh+a=gZ)T?G$|T))4(d!BtIW% zug|WeLpI9y5?}>z$2|#oLzh2^rk(o+@C3@08{K2+%@()(@xru$Nnks!)q4Glg@!*v z)ug%F@aUwSRB4&X(b@YxTbB8L!Yk`1T56C9;)!am@0=QcrRI(*tR0nZOY@l)8MM6*ZO#;`Br?wff2HKex@PmT49Fkgfi2lG#k@|^nLXxeZvE7`NPMSc#<-; z3gKPN*E1a4V-1?G>WA6};ojJHn{P*RFF|&YVOaj*R3gPP~DIaMsNyu3aXZ zF~Q>#U#|QZen`4J8?6)tyL(PvNT@yoO`bRRsBff-l+bKMDMeE*+85wA#o(-V6MqiX zEokPcP4kDcFS&>!%p~IN7sfZ^prWm&Tn<68+mwPe1*VNNDa|p2JH$6lQOqt=zp(GB zUX`b-`kv;(~noQ z80jm$C$`EnJ+--^`<4WO+C8e$^<51x}H7>V{u$8$ltrpl5!Xh)as!oRakp_EzF-T`wYX`Jt zCwe$(Xf;joN5Mv#fU*(04$e;?%}25{!+GPy^0Wg%<%tf3J^^&e0}^wD9r#3QIeOZN z^R(x~otS3_9?+Yja>wzFhKU8%mX8cYrxC6fM-15IV6?-X99jYO$woXDMkJ&otMFHY zly}ElRf`seGdx7$08Y{&XB+2sSJX{mGeUH!$_!WDUl48*v{qiF#9Q#dF~phD;^5Td zTa=^GSE;4cc>G-_vy_BDbubu9d(%-Ocoh zVT2pwEgnpHrR0b)&>e{G8@)0X3ZYW|B5{tI6m&d%XJawamS_VxDqQ}n`Bp?Bw;OHp zgc<$-qDdioK}?w08ZZhil*fRrrO;|t`2nSZ*q*>PU-02QqcJe#{>NIM$Om}#L==0L zY*;;GnyI{!ZB_S*s2v`5Ock*D)K4qXN1j}&Pi!9{^{e6e3R(s z1>4;@zrH+%wf|MHJQjH|f=)epO@!WKz?^k0F=F|Zpf`CGX@CdxC$(=9-=^<4p2+t8 zDw%dh&W)J-fGqcHBAnqw$$cgyPV?(0_xCocbOCnz;9(mlnIOD~2e%I_+rC$~99{#G z{3S*s5{@_MrWH|u@>q%1L#R+48=`UsCjQn?=%)%Mfya2)LO9ionOQR_`_^5H^w7^_ z^U^KK6L-2sd-Ti`vG)^fXxflS#X2AIBl8$e_}?vjy>PO}mu_UR3(*DZBV3tS5q0X< zs1uDa3u6M(=--pBi$kpTTeruDS5`S$FPZ2)M~4$6a6iFAh-I;tiCbQbPX&MY@n1%Y zvxX7;=9Mq+l~jv@5Be>zENf8FZibXJw%!bH>dy)uMVrBFuGj&u({`KtZdG*Tkef-Sr12-wulme?wu!0`%#>ai`_<)`M3%7m7MmrGW zh2qRFi$!8Pz=KU6@Nr+}#o8<-097;WOacC#O_q1!Mg!~{_2v0459h_5 zUq8g2I#2UM1!eXLAQ+zBSownscrc@|mRm&b&tv;_eg-`mqvKqnku1Gw8kxg)H)30j ztJp`Hx?CgI-0Ez17fojs3(7{jv7=OOo5b1yIu_R1xtDIt`e9{NS+xVi(->4nQcJ1~ z_PD&i0y#;MV?O3cnKVD<53@yU3i#*`PBB^3-lVNRZ?A9=$!w%j2p#2pk0p+$-D#4d z4X}r|1P>$8bHRtnezLxP#B9i_s)dCd^!u&0Bl}|fEkSOq@k!}A}d+E9Tdio zk?h)wQ02rTfp)V5hIgVWQ<;@Zaq13K>spZyB!#0wGO7WPFH(^xm5WK9K`5_fj>(mF zgfNvAPG3(q2PVCdUV5a>0MVP-j7Z&&bS2s(5GQ){Mj3JB zS73~!qXrMWX#9r^Wu21ijvo5mU6rtjg}2feN{VMh1vXS;N#)~Urt<MIp^8$o>4+~a z-5Tx=FL-yQe8%{=4~rbRv7-d%LCnGncl#lti0r7iC3ywAL};zb#v1bG@JC5~8WS_o z_G;KGjSA`|M2Tr20%dz`5Mm6-A(TZCg7Cy!^1@!Sh`c0DKqd#_CSr$hg!xYo&m?O! zVue>2K;Xh4U#o`$HE!*O8;m)XEHX>wfS2-Wuz<6rDozn;$W*1@E0!y9OEaTLr}5Fy zgd4eDW^448w4f$hTnzF87&8(t8xupSMU}LDD_y|$MV#Veck}y;qBzl>@P6$Y#5F01| zdCp7PFWWc^OisSmekePY()ckz91W-ec}6Gs@?obibo?A`VgedCa8Hz`1(G0K&8KDM zuWo`iMOD8`(yr!u7F>#Dh5$Tmi`Wo%osopdX()`*ufMWS5($&zz8Es=7MAEO*jDgs zHV%et@)k)cdZc0%=4HZoJI&$gD9MUR7=*_Gyf-^K^5<)TEoNBUga_vjOX_tCBSN%p zyD$2@uXPa1%rfD(1B(GhOp(s8S^B$F4ppLuWA=(e> zZ%_uFSpP69W?+7Rr%G{CJV_c4AYl{O`2P1GeL26e@FJ*Bint1aH6%K)4>VTiSIkYZ zH2R{`3$RH>`fh79>K6C!6s3MKflEsR%meIR#g2~%(~h&|_lS1}Q#{=)A+b)s9Q$6t zfw|H|4~ATAqoa*&>j;*|X5s<6dEXM~oBL3=cEOe;oDvuRia!JDr>M5xp|cy}l;Q2g zxEzYt;tJte8~*jgPBZ84w-g>dnx%A+_=xyEGG<3@N>dAZF7Z^DBt$)!nZ%Z%{)3^3 zHhmH$O~eoW-kbYS>V+h&#Gv4IOUORV%Xi3yB~Q)PO5fZHG8PgVP7U5g`SIZdeTVDT zizVvC(maHqM%3=TSwv@s(1qKl(pxk6%`1xbJFRQT2f#LST^ z8IM(`qVu$ka?7f{dD29meYC%|(4@VIcPFMb+#%&{>IJn<>)=Wgi zQ~hp6zHv$_?U#BCMdy$LEoSn-8)r>PAJS@k%}^YjBR$&)7PK_jX6OQa(Oz3myn9A2Lv9Eku| z)wuoXNE7zR+HYMWryE&qboynDUbaJutEWNl(>t=D2;@ItqK#Wx@))?6te_h0GKrf( z2(xrH0d-s&`_n?0R9u}q*ryJh_O7bMP5IXb7MEJd!T(&vw-zUL-)G0^jC>2s;1dnm zs^PCbK5MpL`)6CWEblD*N`HK9DgHbjv7@Y0+KQjfN6*a+KPv#H58Gz=u}H-= zU6<1kXb9h{k$OhmcR?tCGD5B8+>G!+z?P_9h3T)DWL_UlxUDk{{rNiFsLu!)i6F08 zyqKZGE9T)2N$hbl|kSMTSJxCc~e%pF_= z5C$RN1t(}>S*|Us_;Q$`HuT)X=(>9o9a;$M8~Od|>h?*=3jPI z6elalm8sIiLMo`_nNZg*gzj@Y^!U}AW7glY<^Hj3%l(_p{v}4UfB%_p5v_@gGoJH| z^c#p6_C%-cRgh&%t*6JY@N6EoaLdGav$AW>Vt><$$C+@utsS2;M2a1MSv?bPQIj{` zGJrDX_5MjxdHtN4W_pw+`b^fe<~mTF>^tQA4Blp~egB$ABKbhP*@&z85HC(96U43s zL=c;i91%LQkQufT0f`+sIVwoc8WN^2251uy+7(BNwfRp|D(~T}a}HCOe?TQa?>!H^=Jr0aP4`F{T$D9_wEuNVPx(qW4kdnvDA zQ~{-cD4C$oFtU znh~e93dVA5Gm@{MsEl=iAxgfSEa56&m_xp^w6=8PoQj(2@#bO0bl+PSPtWLm@8_do zd#<%Ec4l42pfBOc>(!jtc=p?3vijBiB|OuY3^d*-@`_#cr(4>sgVdy!KQF~b!RtC1 zsH#unpV#su!B#z2enKe8rc){4xE0J;H9W@^1o!P8an1=uBLthx zvFkC#f|@I5P8cPe&fcMx&fcnLSY`9;L_HPz)^N8N;21LJOAe&PFN#gG_Qyf34BbZ;+r;L|It3VYm;RRVLE(hegokXszfIPDKhf zKC%mEK?`7hN^*9pbgEbNlc&Iy?L)Y+WQ`AN-3*6uTLWDAKs1@oO^uT(CgP&_$XTu5 zZ)gJHDJn#{;se-a@^}_^IY3JT)Ha@RB7!lfB8Ut@XcrD39?FRW81@2_;PLcdecZNnw5K3zfCN#hHo_~$PHw*FBqW#P*XM}g%iXz^ugEly6&I-kEg;n(Ltw{9BS=Vo!1 zzt@#a658^gIUw#(eCnRte5Z6D0wHUlhb~0Ub5jrctV+if$ju3U;^%t^X-hRHm;$Oc z!^?554(M0MQ1j7*#_q(2PVIvIhDj(Sa132sh49QY)|m7`bKNB}YxH8WG=DY(%#nc8 zijNdk!O}|(O-f-5I;z_Kyp)iZoU`&d-iTW%%26;$Bpi^W51_ARPWSle@?+|CU3L8c z{sOed$5#fe5LDUqxCDJ-`?6t0MY8gPNH?Q`S8h=GqO79CANXLPLHpSmlsn=5CDbdF zC$xJd@2YN>SBn%KSQ5w<@*K$3j~5t3Ulp;Oz(pgCGKx_QLYn9YHUrVk3CSYpeNdDD zA~nUUZF_L8SSL)Z$whH^G(a#i%9-lG?+Qm@Ej<3-{tKhRpD8cRpU`B#%G~T@Z*(aw zR!W^FiY)J&FQAX;lWYNsGXz=I(v&?BN>!ecT_C7S6R|}%s-V~AAXI=x+}~!R9nl}W z7jM!rGqb05mm8|@jTt28W@LE2M9y}gYR6kWid1{Y#ZY1jo!G#T!Pd~4o61|I5WDU3 z_{CL~m9-LSLXL&H)BAGVy{YJE(_MEW4c;ee5X-k*yWZ_}jAdOYr~AET*~hKk-Ni(J zph}U(j08d@J+K->Y2A_TF#a;nRET)6bIjS@BdtNZ=D7V^Nan`l#^>4xFKo?tz#wNG zYtdN5--pgb+?kQ}04{BWF?cEThwP@#1*r{G4HxPGzTTN9$`0xc{O>fVl2zq6FYU7s zOmSUfvy`noyrq~^+mp;M20mr<{yP2*t^><{A@K}u+Tw}S%wK*MBK8iI_)bFbS|R2w z{8cmliTO~uKwjjhw6%@KdBZ85!}^&bk^*6|Rk|y=ACPsLl_OYawC3wKp95ar{mH@U zXL!e{t2@ZH)?J+i#&*X7_juPmhFim)1r^yF4L+0eZER_aQn=stA#H zD7X}@NezvA?!?(seAQAIQlxoWGZ%ssA}RrWGeodAW>=<}o>60fnvk`+ols)?{FLrG zVc2>?dw-`k{%x&GjPIP z5HBgJQ3rAI~RHk%>DwvT%IefFumzy$S6FJ29~JuE!Ck+*7_ax!mgH3bw=I@_X{oN zesS-NEmZRWOxxY;1d$%4p0F9_y=bxtcD?!Q=XtmjSzFTQN8aJ&F?~mSzn3k@Zq;sa z2`A_J`m*RK@cmYo!TnTIwqB<@PHQU&LJo}fL!Ot@R%#uoX~GOG_Ck9r?XHSg%X?&j z8qf8W8ePYsHf`RNLbJQ)$otr@5WW!F{!8kkPg;^6fb;nXM}We;iAqZag9=DRzeJRh z2w4XJ?S+j7c(q;cehj7hvj~_*&-)MERRY|^b%yu7-M8A+>R4&5!}1}?MwXC3mO)?} zoM^-3VC-N6Cb)KEYyt*CQ?9`_F;JWUc4#udOv2Sk2Qwuk7^pcyupJr_hC8Lx3=FtO z2HHuWWa5Fg)Jaoo-T$p@#!Xvk_K>vNeeZkU_y6BFXJ$uoo%ZnhpR@<48f`&uqJGPFx=2>wZLkN8zql4g)1^nCv&Av=_Bc?^gGGuhiu3i z7_XEs;e06}RY>+^%C>?XQOZ3*0_Le%+{*YRXv@!)yKtoU9zW z!?|F+-OLy!hRi2pLY6n4*FE&D`VyR6v|UtglA8vuQEp1xB(r%;*fg1$YI>S^*0hXU zAb=}!GzZ&*yUe@Y`^^X42R#R}-whrZcQDrDIhE~dR@#)dwDusk3)XQL%^T6(a265i zd4P@5sVAZpQ5@~XTcMSGtjbPzd_`t!Cho{YnVGyjL|G)lWwDSN!l7=wRW;kqiJXcY zoJ0SeL%;Fx#M>t}NBSzP$m*Gp-p4iv`kd(n|J@CAdsUlA)<$H#4@CNFBRXt!)44O; z37D0&kqFAmn-rfs+&*dD=W=s`^ebf)h1gN&X!?&Ae0lA&yG!d^HfYJ4mp1>rsi&@D zW_?}xta?v#b=9iX)r%WgS9D+f{u?*;FWMU}IKB2$?ZtI{%@@(EIrHk~RMgccA6xzE z`liL}w^Dcd1guWluo{1>{$Q%D%+?^a2wQ}M1yK@xib- zJ5u5t)sZt&`ZT-yD(uMa38Zvt8l}&NkDToP(dP)j!xgL$>J^?82We7)=H}!f9ZQFf zYb}zEbDpYdu`S(uXrmGhf@e_KmHZTLHz(U|#;r(C9mgF(g7#|k{7`tTpq*N}0hxN+?dNzaS=?LlRj6QZ$Li;53_>q*B8ir;X z&T0!Q=~$LR6>1}wnGA?j8`Ur`Ta-AFWqW*zdrG=Wo^ven95V2tQ(@F}Z=41%%+zET zWm>!Oo5$s!K@(i9<|ruBn2Ed$0#71~e%a}BVyDM%^~*An(|zxZWLUb!u(ucI_tOXq zrXcz73pshGHexT$v1Cm^!<$Wxemjcggo^4{R%~(d;_(n1L5LLwaFFjp&IU#xT^UiiO2- zJ_I|1UNl0J;=Bqw_|&J)^atTL*o|ev(BDGFd{YrqND`){%u?LIE+R{W#m2v|)>0m9 zm55lQC~^i7As=IamD}paAfEb(+T*0^Um@f+jyPzA;&?QQ7;NKgnKNeM^Go$s<717q{_Gm{` z@I_L**LtgGq zT>8sH?KR8m+P2s3Ybw>g)XXS!_DJ~Is3oD%iF{)Xau9-B7S*+?42HX;}lgUhA3Tw`&V4G=?!>><0v%j|iHBv1u--`O&Q zZZi)+JQQ-9JFXv%z?W`Rqq^MVIl-b@>~Tw3ofXkmsyf_pYc~q1Iri~J)_UJEm$}dA zxAMfGJv)LO24ppO4KYX!uzDvlep30!+m_3Z}dex?{wC}X9zTQbI;akAa`M^*aYTO2OVhH5^jH`ibFp;pU*frf*?Ofs{ z#jeR2?HPN>PKkJJl$MG;V3mdRU>CJrDNfQ^sY#u1rY!XRPZmC+ zAf4q(L}}!5I_=b!(|2x)M2}<28(`5}IO|mXE8X?u3m47U_`?3=H5B@MUE%b)l9HDy zA3sTYGxN@BcYkwoW5G60==>Odwz#1H9c! zP>ggzOCuu71u()!F(5I5fiGk6bRz>6)Z;V9%qm1ePV_;Ei&09zj7+0vq%RAmV?*Fg21f$Fn?;c91% zTQqJ3+se24cJk+aJHyZC3nOgg2gAYq((KYmX{>Y{Utm5)my6ZrM*4laEwVXwGH}xR zo&Rm?l6AuhkOIS2)#en&W)~{$ixJ8zC^tk<6R!AaM)fKfIexT}9@YbipDX(8-st<~9I9qj(R9Ur0 zcwPab%A#zj!0{6SjKP^-nPJn>8qBqVN|#lV8r)Lv9zOArd*s!Dz90SxWuqBW+z$$0 zX?^qh(CPZu=i&U%(!HxY&Z2eiUPo&mUwHkUncv-h^Iz^A_s+s(Kg6ke#bghkKX-}+ z)g{3~7SrHSFf>FnbRAO3I0tm<+%_(FhUW!myyLI)H~2}TztxWwRJ;5Ge(J|&CfNhf zgfej5@?ZgOy6IhxwM-aP&ON*m53eNC2GsOFcpZbpy}zHLQam4(x|h?Z_5So5_@Udi zct={fz1;wh-#|=6d&aASocE_s zXdII(NYjpKgBlr7e5``H2zOL_nob`}=BCk5YO0l`OKpPPs{QRorF#GETG+>gksIU> zu#cd&+L^e4|I&|_i*Jh!{tecK>}^(u#pD8WM^-tg7$}dRjj%e}U}FeXgiy%*XQ4zg znv>o#Cg>JhsnpG}-vlw20SPL~2Ic~VKB=TQFYGxT{0mfKm;JTx%Et(Wb-QBC6H7rJ zG@M-1`m=xk&2C99Np-{S_Cx01Qkh44oftPzFes%?Frm;&g%n)sf(r>g_moq{j1Xf6 zQ4&jn#FA2gq>@AsZo+C%RB&vXX>!JCFJ9ZNFW@jaLFUmIzK4r35_{qcR76!lL^5sY z9w?%K3h4de*&2L7OhwA*cI%vX!PNz~s`)vh#_Ei!Iw5S+p9Ivr)6GjjT`75`&0Fb2 zCmAJT5A8I%=rKA#+4IJ)=n%cBgBlze?3uYVDHI$g!bPz$S8gV4WIx$24#*>|i#=J< z%p3@3W?13Pu*jQ7*L4SSYP5{VL*5ADW`^f35d5?3{ebfo=tt?xxYpg_J_XGry#>FJ z{_Wiz_}G8khar=PfTds7U(53_Qv$S`w7@pSX!JOg|Js$ zxrgBQ2KCqOEc{HdEKn_&)PBu}BaUg3Nqmw?C~yNb6h{=yNlJT8Rnj}n(b;*aU@AO? z!2k?h6MvVWIi<|O1=JFSasr-0Z81%*!|UmjVxw%r&GaR4M4k}+@}{^g^A6KJ;;?*M zoR^pIW%|CjB5&X!dR=@h{Y|1-K8JVH=frNg2eXytlXxRtC)UfY_I{Yg^| zUX%eq7Iy+ANmC8*=%8b%3zHM1QD8@@afRKQYK7QLBI^;juJ?x3gZ$o+DyJNN#im?{ z1fd~9C^n@`5Db?XUPF8oV;>ZiV7xGZ0=>xJ18SD`<5?bkJyxHgt?;ttNj@uih-?9Q^RFtR`oxu>R8lDr_!nFSi}OO z0uQVYQ?Pl`lGJ-2kMGJfs0e@!AT@*7?7ir9BoRZW z-C_5td(Hg|Fi(UG-L9oSxYMG(fT>Pko(W1-pg%eRK@1)xVNQd6+Dr_}7 zlOZCKU>qoj6OJ(>0?rH0icl3XRT0yKaRFSKBG9N~)|m|^X*63+++_}!IHN?k7=5W% z^MPf{k|Oayx03gDD==};uf`e{+<82&{0MN;?Ag1fs^H;-GB{G*YtRvZ3T|gGGH^;L z)Oc2}%%h`u-m2D?fM=tOWII+nz zo+MR#3I8!U%)7`@evG`qO{IVxF{3hx9T=FZJpZ&r65DEEp-OnN&k;palXy7{-s;+M zHr&C$F=G)-!fXmIVO4krdjvb|n|K8iA)L<^P+_6qwwzJiDF4fZ)UOK>UsI%{U_ z>{V>2Ubm@i?4ylAVU^|~L2(Gm?nE|TiE`Xa>Ei%^a`Nu&T5|gCe5L(Yfo{72x-Cn~ z*IsnKu}|N}JAIu2$`K3jEEXw=G>fJnYszlUZKEB$!`Bwr8SDtP=eCF2BW*Ds3jz{i zxxrW{7RimVoN~X2mNSx9a#SKsTGGy_F2}BjJMo5iW4txq6*uhoCvhCNO1diJ9<$NYYF@&aK1K;x#^k)=U+Hz#gzDG8mKl|d*t@FOMpt4Kv z&nvombXV_&?A-Jv`lj13b;2Np>r=)!$ZM`v3dVGMTYOj10qsEOVBW#7(QIuG zH`#5nEzoYYhdT1P5f{a={7^hp6fOQvc$>yIYiJewFV|%r9K~^k@$Q+PqvzN|d(JL0 zvon%btNk>)Cl@KIiVq^ypE}P3vfI!4qL5XcJkqcvlK*-<- zTm^xDOdKqOZ2}}15~naJhr%SVtGwA=K+deDdwOcC)Z6cS@BO|7AhD)U(-Tel24TH> zeQ1roL)a;|xc3W3{HOgre)rJuZ1+N8q4Ydz0vy2;(bMS1h!psZXtcmDAeLu}`T?3p zJDG_cMU#y|l(A3D>5em zyY`lqn3J6LtFB3d|Kv4=7e?V<;stm<-k5Go?|5(1Ppr}Jy^y~DAO%A64Ug;}Vk^yN zd|+gVOa$GtUQ9TvoU?>Q@*?H;bf2TuJmR=WC0^vEfasSh9Ah10or371Zm+}Z^tvh> z70z+aWsWA-pCx%YU9SBse;r+?t;y%9-%AyzW13@`<0Z#d$7>GGp{t5lRTZb=Qv?1& zkIReeysciw>qUCR7BWcMheT*_$E_$*U4Vuc!qHa#Am7cO=Lx^I!Nj^*W-?~P*H_O* zUt-K;>8(4-N5J^lIA-cI)aIlEC=t6eVaQN2!~mo|B%^e}?+|n+;-R{SFH(Qt` z|NN-=)XBOPi`vt_=~+7cnRz2V{bR$S-{iU`pL_9*kNZ`wX-oeVk7}!pq;|8D z3TA(I!cz)obJB#~8{{ic|3G}+8hOm!nSZ4C^gtqb1Yf`t@C8fix%%Q~`Q_@f#g~*G zQ>m3^IA$2N<^pA2-u%eI;`sxg%U_e<5>fI@o28!UAGc?#UJJ#i8dJ@a#z~Vj8ja>^ zW3_qBxMuPtQcNu{3e1EWH>;&;b&N6ET%^{UP3rT;dUb=bSK6n(X?OtSRo>uDP101q zAsD8l5*(Nrv@|`wB#4&;_XL?>7gLYI&>xggqJJ2N2YFdE9@`D0Dx}BDu!X1KI=l(D z;)A#wi}*`og%U1;$)Few-tGzjU(?;g({I^4%gaO9` z6Rgf2%ClGJEoWXr)$ zeOb45)$RS*ivvRXqG!d5)m5bfEAhb(mc81G{*eA6-GeXp+q|x6YP>3(H+cBWrUMP{ z&-?0}+W3QVBM~nwowxYJD=RzKkcFwM*+hA^6#dMg)|sk7f?9eXgVakA0u>cX?S=6tKHOp@%B6u6|(SEX_%o>uG~#kF zrcq?aZ3`}zJsW?%vN?o{%T`}J@ZqJE-h9B58z(B~ES}$TfGv5DPT%{arFQPF87uF? zsrU9m<(v+`kH?O7#9|Tr0H`fv3#NyL#k<8G+{0WVmpIP0Aj`RJxP{q4wsU(#kwr3J zD%v)uPJ9jv8uIf4P!V5+#__WtiY&wE7-g?CQx4udHk6E_6-Ib--4glEcU~`fggw3=v1TGaNBUyLK$f-N{JNT#2 zfQF_1&2`;>pN#zPSX-|GLc%MyZ^XS;UI|;m>+-i{0tYEuaBw`FU^~ogpZSnh4rG4Q zqM`h_q`{y(Tp@eK+4Zp2pC2bW3<6j=UI`%|9e@g{@DJ&x@-_XB^tHmB;m%5DluytF zaE?977wB_J+sJENoAieAE@|i9l{%C^5;~X|T&bihyT}%9m-K5z%>MYpB6g^}%>|A~ z)_hQS0OJ?2x4gSO>j`&TKHDMw&|b+ri?9GTkY-#UsPM51%(SEM;Zri<^v>S0b{8qD-PFa_eF^7#gXJ8MFwp2VI6;DPoxIXtH1Q$0A6eQ!})^FV;EKMbIB+|z1724?Q@~8NMz`rbS z$6MK*+%{n+-73F{UuS6u`-Ea#B-G-W!prOiZUd!pJX~NjNhhV!7&1|MN_vUBDs3iv zq*ii){6$iSl1ga{*(IGJXQlH*kQmC#0xR+|VMPu>WI04dmem<>N3h^!Sx1}~b_ZdD zAc~aA2_`OdCU^@T?`EG+ zX%=c=_-1xG;mV4%13FwZPHaxd&gYI&cU-D~;i1{g^sUDKF8B&K>;fD)O@s4}$tcm(#@0rKlnYrKn&Ue03EK<8` zQ8`l`@c&~kLYq+{#aZ1Z7W`6Hnum4VXbK;Xk#=_|Aa<c0U`Q(n zJ%U9<5~gGIDw6Q=2YmGwYG*sq4%El?qy6jw#N$MAw#ivA4|=IH1HO8ZOs`iAa~+rG zp27ugH{Qn`;Rf+#&K<)FHxDPc7QBF4hb?X^?&N-s4+yV_llUGdLjiGwfs8qn&tzd+ zz*wMUP@{2a6H`0&1^omP>7mIxQxy+jN9Hi+(6`{KX=(+jOF;M_5#WDVo_Naa1nEQy z=-M#KSpufeZR#0?NFLrkhz;hQ_Z>Vy=q8}#jpvI%1=xWKpuxB2?QhUxcy&CCcXTl?qo8eC) z9+ve6HP+Co*y>=;*no<%!rRM8%ZY2eI#BOe{7RWho1;mN#`%(u(?8l2$~4K@XeBVf>RphVyuZxrBgl z&xvr`i7;a>%&@G07_Uw9)$ZBe++&`T9{d)0tbJemK0Ej#S!TiwZ}#pU$7Y()H%+AFt``TfGteu;J@eWB0N( z%d?7z|26;k(cH^J_V6!XToY|H__nrzmo^_+9j#16*Dqge-%{)Js^-OAb?L^`PJsL{ zu;D0ZfJ{ZHw?-&+deW*Dn;Ii4B3SKWyM!*SOV33gaBMxZ*t^(YA6d?<_OA9Xj~wNW zxdo2|bfm(t2?H)JK=#5fiZUgHl6<&7j^au+rql8;sp0Zri1iE$1!OT=`u7XD{s9dB}CCbnmGBmHnN4&;Hw%+zCAA-H!f~?_WIi7V&JG zVC^lC2?q5~YkjwzQ*+wWazQO<`}F6GH}D&t8_Es+bLBIAj2+|0{A0mM*1yodFt|!x zrM2lfPr<`2QX92Ko!;ZxBOi7hl3zB?sb{qj^`hpM9EL_r$uX+|Q_6bD6(epsQTCbM zONgNaz)batlm$~M3+7STSAnOOAlDhVl?ZW&Tt!K$#!C*o$qr~C!VxYRFv8tsDA$ta zGQV~_Gclfl?s6hO3XCmHWHJ!TwGl9Ny0x|_dWVex*MF^=mbY#~d7l>t}01-2j*)G}Mxd@h-+pIM-qtqb{*=>Mt0 zY_}gSJ->O#erR7GIEajrTC?o=?JvEsYscXeTXLuhfhR`BQLIe$zqjU@cTW$UItlAt z3hS)`t^}wkdS`@EAWz!Frep5o-rp$aTxW&L?#tfcFwX~2J6^%I2_5ls-iz$T@J-

HpE+;D1{*6BbG;&)J|!ege6@ib!)d3(5=~l7Tt==Fn|Q>M5`VD)l!1{L_4ls zfEgjo$VU%^NciA_TUg?pE={&Lb~-mo6g2O=Ua|ls ziM&)Iua_(UtL*=3nn9d*XEI>nv&8=tK`juWc%mv@PdHA|NsSP|PjY}`L-@Z)Zy5W7 zefPxz3jBE-scgxj4{m>Aa}~X}Yin~eLK|w1pBjAa3*bV=zG+|C_ltJ)%Y*=xog15UGzg=5d7OJlO4-=KVr|u&Dv|6oxdXmCnonq2O>n#Ihfv z1wtUFs;Ma3p=`VO*RAUiy70SJ#DBN>*PX_H{yDzAZo{5k4ePg;>GNDOLhk&`HHS`| z?Yx34$p4G|~L>%ULR-$>}Omh}PSuxfpOy%`3j}mh|8LX0wQX+9v z)IoxV;~nHPhLMjwhgf6${$e(K|5J*dJZh{!$IJ*_R7YZ|n-B9Dp1J%v0k?V(m{iK; zR8(0NzZnth;%Zf-?h$Rs8KzZ?u)mY&VB}E>RMV*B~g&DBr+Up!7K;0qAV7Hml#R1u!HpX6Mmd06bE_4uUBYG7`0L; z2m$-#lGmoJ1F4Qr9c%FdQm9Z7Dm9_-2iw0>*s6Xc#HUe$nfzox48^Euk_>GPu+=7T z3Pjz4Q-gnAYezm*j;f9Q=uP9##_jF+{P-Ap)%elG8g#YYI027-IHi?C6owi_$c*9& zOt<1w_#(cHZ(8FLKy``CQ29p=56zd|bk>1F=+;RSxe3m;a zpNd?Ld>*kxHS&`*cP1DoT)5E$1 zD`iu|b}dm|Sf`;^U_l1yvV_f_77nDty;ssvT{=pKduOu4VVx++0gBR1aV3_Jb7C&U zt;0w4!~!_taAfH*J@K62cOulTe%OhJ7##R2g# z&@n)@V=Xo0G!03r2}>m-0Qx58Lp?V|3EiToBjh5!&ttkjkK2SO{Q*QhM5}Fx>9|;b zU{2Z57d9Ww0n7^ME9N)MHil=E%w5nh%NSAziB`6L(b5p$uFYoX;s)YuD9b^%7ODz>jZC|LEGa*~!tqLbwEFi&Y z6n0Z4WK(Doe&qi_wqyy*R#IO@kslzpj7ABDJcit6rM?B;sl}L9@1e(_+AIq&74Auhm^?4^3G!3UzgULMyFXr)MK_QWnNQeWSZ5*MztQiNTZiUgwj!s zBW8!R0GGkIW`(mK;qPa6PxO3+V#Xi7+-Ka`jWP~2HSOQu)O3J;;w{AOHa@=jmGNQQ zWdD)={=T06ev)s8@iN;5`KsW%x)ZbKITkr+dyFYoiXE}EQl?xfca)~xOB1WOst0~- zjK7yA!2bA6rysuiB(3zVetY*{)IheoQ` zr_)WzpJ~n|I;Nhhf7E}0zJyMaoWWueIv^J8Vb&dpEBIjJ5TcFop;evBp~db!_3Pf) z@x2YZptTh*8lM>x#+dQ9vXv8GFhi%`KYaT5QR2Z?L+PB3E>0JkgD4=lJh3EBO3y1*j-)5)uL>NKj-}rf$CNuxS);6JqzJ6VMT+3C@HUn6 zg3+8|k03;aHO*$K!A>Abe=sHg#vaN4);H3RwoDbE5jRTpjz&+TuRZ_;KpJO?H;srl zH&JiM%-m&GfhjL~xAyGj-H5rk@lYHw#^{?b*0;BHC&Jo_qZgSFYtN}^2;%5u)M=@&Yn!G?(`H>mn?Xo4TBfNgQ-(^zw6PA*(lKBRt!*}e+CPvgI;5pZ zwkBgpWmI%yLJU}?wkje*8K8=afI>(`3;OoH; zf;3o8k|25+AP6Vm90(8%6lS2RBrk^lqo5Z#Gw=ikIs@xFzrK_V!=!uMdZ>Fm_u#_^ zFS7L;F%#lmRevlsMJ5V#!!^@DkvKj0`%ZGEy$&&6|2E|IHMWF`gFc*LmJ z9mh#1wT|2P1%1T)Qs|2f$I>T5UrWClI+dPsrV_>pc+vVsYT&d>au)x z*I@T2&;l;>0v&=AFb^WZyzhk}px&JoVZ0N-?I9Ef={yy<31Jss9d5N;e6Qu=OD#9o zmbKi>S{&*caKQJLSvA(6^|(c?KHJ6qRc1r4y+1!&LDf zfx&~1x5TQF@RR<73xBz>49%H+eW|MESjY@?Z~5daUw`{sFRa`0KutJN9jf|VSNC(@ z`SmzfQO(MqgqNi6VORWx+Ylo$NU(;oc7K<@zf6gSNJI>Wh!w0b!3qi{L_}3#iXP$a zE+f`CYupltaJp=X)-=$G5b&lkNkX#1anrABYBOslq!|VgCGZY66%mtGurE|F&zi5B z;*fd5{I>alId4kDEH`6ji%HF>J#y|oo$4NML!8)zI59)amCGCZH}~8_CbclIxqKnY zp#>2ZF&A&0^Q1-@9vovJln9ufPc81WB)T+^$hGF`0>YD*wfd_1uE--#?S3+^sn0$O zHcieJ_kSf*Re3Yr`rwXrr{I^fzxjUgdGyaW5oI2tNn}Xhb*%$|M+2uNQI(_eW?^%n zTj&n_QBXWh8=zX4u#jmoRjx3Tp%CE!=?{B6DGV!E^Z$n@slJa1k`Ly6;QQaww$x<) ziysZdbDo|;BjY8rxu%K-#69gle(cDF-4LzWSLl2q4biiGk9_9BY2jQkGJAN_-eYrc z8O0*nsUZ`5812-c(hW%|yE&`yLFR*x4=Ay&PvY#!)R^6#eU*YNYCa#+wGf1aplGW$ zb4ZhRRnxJy=iTs{Se6k-)2;g;z+0x^UT5u*AP%&jO-u1uuo&H#3*f#{wchqwR1+j|V1)AL{+@Dse!&S1mh zb&5wE;uY40whe6+D8Vij_e1@=?Uw8>|2f2q=)L9Nzp*3S)Ff1we5#@%+K4{Y;kWKO z^eiK?z!XWXBw?YN1|(ZC)oK>d^IwzU8qqiQB`A9 zuOv1NOQsrSAze?96s?z<)D)}N*O4}9i`qeU3Ol7vWtV!KjL_rKh&sZK>!ai(9hFY1 zC)ucegWRCkq-*L8c1^!cZqqqwPQA_M^tFLYDyXjF<#uk=jHOvQP(yIv%E44)EpA^_DziD`=J zlYNRJNtE&c>kK1JShK(27yKAi-&Pg;B!*5qN;EuOB7%P^22tb64A>>IVMlwG?a1=7 z9bJx;qDV^dE3C?_^3C1{;Vc?I)!O|{`02r z+HxP}hK}_%o`PcvOF~B30PRW# zbSY!nlDwp-bu_7@S(di5ZFCR&DfR7U`)NNrM31r&c$&RTPb+V+YxEYo#|)7wips(? zM$@d77FY*WLo~|T*&cR;ou`-Rdu)-a3R*iEjPNSIK8XyO@+KbA16iO?zEgYSY zTUDG~&3AaOan_hML__44g;tGU4$h;ykjchK3!&ujzw37x>viEyw5NPv(OZ$`5+>p> zDy_|AhBKp2Um0B+SzQ57P{M~&cE7=5n8@6~37mPU{~=HulRp)UhP3qURV6w@3}0y`+e*dVTliX zA-c9eSp_17ZRk|f4EO{=LnMr~QPU_OPSsSMPNs>C#8))(-Sp=oCn z8>TiHY{zz{HfoF-CXOMPVPwDl&fQ&t)IZuT{JwMV{l5D+=l;$)_xhp>w1wE!fC#tw zvvm<*)zdvz*fq*)g-w1K{Ln|CO<|83he)a$hUQK78MZpcV(fc5wn> z(DLT^vMDn)H?=lZy@PNoPe@r|mJ$ExvEfwsi&msY(u3ixydh#rBuSAqMJQbJiz14Q zo*8B<;?DMsKgKg`sBAEZCr86U=|HenLz&%o4Y$>roR}9O5~i@_VqRqW>|(Z5EF#uC zdD2FLeiRA%lxEXe2fO9mc}KNHA%4~JIHWtDMtt6sl7Jlu;^9v((V1qbusnr&Y^>^- z6PZ30ccLkr#0q>O6#Ys}jBYQTT)JfI`~~H~$7j?%9fU*ql)LwpGc|RyC#3wt+gQ!k zpMYD>C0O4UWo`a0P2hCsMDpyEuv_3^3YS~CC%$qk1<7;Vb39d|N?9dVDO>%ne`*&! zpKDhM&zGy3P=novBSC#be+{?v759c3IPML8c@58AmZCn!@-x_uixFQ^dRSQG&V_WF zF5b%!qdI;aL)fmDTcsdxyOWEOZ4cm;aju&3XNZ{vhN;gOpDN6m`QuY3h*#@!^5#dk ztItPQ?`#?^PXAqWt;0Q>>TVwY!mFuBtD8%&Y__>%B?bVKfSv?>O zbrG3`B8ZZSQ_y3PNruj0t}r>-G&POfN|v~5X6bj6voc)~m*NU~x{t?vr);o)u)jB+ zaO~bRTyAlR9r`oIij4ckBFGRyTxR3Ij@%cm+FIoW%sKwIe6_*ZSoujLiIfbTf_tCC z@Yn25C622UYLB#oy)M~X}KP&av5^=}% zFoYp>FmELnlI0hEu7v`((h8AfJ;U@U9Ii)UrYG0)xySKno_1x{>GWT1V4Z6Id!=w4 zGt4PaX5#R&QYC^hMZ`e_QIwe^_fl3L&MRGR6@Tdpx`=;o zUM(KO^3sdf9~l_9KWLMyL7q>A>;agMMa!wwrh$QhO}1z8YKI4XF3!+|xiUN?bm;Nq~gjYRVUXr%9|`EvhQXD={I z>88hFmniF{Uw7^?z`MUeuMR-hR#2XcoK~!}L~o-O)V~cBOEi+u4%1q-4|~u?n~eQ* z6z!zs0sS;t`HV7*$y5OQRbl)kzz;CyA0!`E@EV-YAjfIfaWiV9T3|Ki?n>B+ZG-w; z>}wUiz0dvtyS@mlf(=@L23{ZL&taQm-|vaa=x^}t70mM_19Og(fbOw(nB&6i@ z8p-?ftS577n0!s|qy@YNIWM@CknDFDcOy$RRj%ov+9P#uVZJ3K+l9Ht{>VNNm-C0| zIz8?q)6svdy22XEOxptY#)eop#-w3$}`kg@=^wD|{!$LIA z)k#yam-Eo~zzEsGFnh#m%(YWH4qNol5oy;RWrEftbp5z@_)#Y5S_7i zEE&V!{jcr+50p##aaxJ;ExpHapwAxm3G=qd1u_#7?Wcfkz%*A#w7AxYcC&(PgQyQ! zt3~KhJwgRqCzWWa6oH*4qrJkIBjfHajDJqtre^Hd&&*VssNO_u#9YcHE;pqG)MAsq~zSf@m=N?_$lUUPUz3^kz*XkNRD%y`x4)el*9V(L+tpg zjKkfuH15|^fm|R5WBe{2M>^DYrw=~*sqvB1VU{=@>IJ96IN`#eY%68(sn8>4g7OjlOvxD+m%rEn3rHlh)Y=r-zdhgws#6ljqwufKD@_rm83 zA%OIszM0>gckjE)x#yjG&$+rjZ-BIp+pJI9fcA-RkdA>p))-rq8yh`ud>C8knC@|t zZ%F(t+P@_86X~)paTn*)CCTzQOUztlGAWU7?CzL&eV+YMiH}W?;&@B{W8?ojec!&q z9;#%2DKWlfNSk=2l(3hIjeU}GneHFEQZm#>SYLt3Co1vr%`(T`AE$y&ZBz%7|1mH3uQm26DdsF0 zoT!wS-Hy^rZs_rMCS{BS(?7}>^O1e6N97<|SiHw{FE~GD@0G}4d#j{7)5sq_kcC!` zEVf7Ecjt(dy#;U`y|OME+p!%pGseuz%*@Qp%*^aKW@ct)X2#f#nVFfH@j2Q1-{;(0 z_nrG*ebv(%sk;R=EorS8Nf?cz3$=07YiADh)18*v6Wgw>w@hd12!k6*HPYYTMvO{t z6jIDz+D&?I9tq#JJ$8K`33t_m!jW|Mrbwj*T1Q+b^r~jYN9~qAO1C+QTMBg`g%{xG z+!R8`4PWjbuE6J17(S4_lor^zKya!Gveb$qC3t4`tLV`=IzY7IYMs*?_?^3jPrkaj zwonCETs`RTA|Q0esyn0hhw4$Wjsuem-3xkuL8->Q?+KE|Q|n*c8&bK`&Q`5*aQ^<( ziQx@%5x5~gi2wIh^EWg4ZaI`HL&W(Yzd%t+(HfiOy<-O&FTb2*f+nd9W z92*CdF2<$}LKB+k@?y!gx+yQL3aE)#i-wTX2oEgGn-7Tl@$al(x<0bT{jvtX>ICfb zOFx)gN389Z0vsmTsVD`_LxoDc3FWy09D*H6-O-$oTrUDS;ZkPDco8E?rLVcuYzDW! zSvoEcx8qk?3b?t}+KeUYwpadsU%r4`l2+2L^_kNr+j=8IzI^A{HQyy(z9`iBZV%)H z71Kc;1^SxvEE5k7WY^Wo^NKTBm&#bk9`s&7t8x=#u_|CwWx4romxqXh7i5#1j^vf+ z5{#9&^u@4Z^nZop|ruVU0tY>?sQmT+=@)o!A?Ot-$2k)Lt#l z!QvfVG|omP*^}PbewbHZX72M0#qrcGf`v4Xb-G(OdEuM|!8{do7Wr{yN)6lqWuSBq z`gmrW+zB2wk5mL5K#T@=Q8GNGe0)ET`c-=%l7C80@Gk(mD_uH zF5YkLjH%#^%GOj99ZU9%7oy}zCLZ0GKFe`!V<-VAB= z8N-Qfky#eh?l@S!cuGP)kr!yu6^Qj%$L_e0vlec_FtO8Ul3X4fDe!;zHRNc>e((bQ zNMdsD{|MAI;5Aq87Hk7L4uLVo#zSpALUj<{702+lCg$XK@YMtXIp6G!SIz|-l4fLmWhdrvaslENhGyrNXQvP6u8VI%YGtd`--t4yl; zS(T+tFKK302SX)yAGMJ;E9$)j%&Okz&@+oZ7yG6&ZH|=k6XR1FU#f2l*kcgk-frn- zZ?94%H-T@60ySf<^FF-u^4d$P)_tsAIi#BYbyH7_%qwTFgkt0yQ2MX8t;sxcodc{L zt`p3S)CnHxxW=7KB+5v2J5uOHAyaFMtfdmHXwD^OWN45MNa)tD`{7iIczLT>>R?Ww zBmi`(yhj}ae1=X{`iuhl_2u)6Dhq+}eD7UsChj)HJH^>9-9j$WK(&>{JR1p#JHCVF z@@+h7NYx)%)^aQC3AL+-%^==kcrWz08W|ms9%Zl}<#m27$fpI*U*lPK!hIScJnJeP z)P&hr!Y5XLKhK0$Qu0}`VBw8HxyIgvbD@YEl!>2qDh?zw#VRauTxy&eB*p4v#DMoT zhP)JXYy9l${CPoTxQ;O0qXmUVJaZ=C-5l=(S9HNo-Z(B%iRdxUW5w2<7pxz)%Wk-z z&V~4r#%YL`xU^_N?TMvamkAZx$YA9%9RH&Y#loW;X+y{F@~!T-i-HT;CVzJ#vgtwA zPl^+42N!)$s19z)V?&lf6~f7btuI*1Iq%RWh>g!g0(p}vM$*W~O3o38vnE10+I!Jt zvv4hexG)VCqEUgzZ9+MnD^`8m>a9_=UH9fWeub&EvQU-Vx^TY#Cc-yfPg=cKxZBRO ziuA@j$?&M{d8Zlew~AEcfLmx$F0HCLAMHM$%HR@MFBzh=L3gl);l?+?fo7Es5aUR~ zj-;DrvYBL9T_t6E81uRY?2_(62GaD$?8M8^4G6zhlOOCeOluw3j>lEeHV$Zwv7PSF zOVhOow}j03G2!OJ#q&4uuxrIr4cMIEBCcQfG^;{#^!Zi+iO8$A{@5fcN)bW{K^G zQaNit7@O@x9Vh!lO|_K7eO?N+J3P_Q1}C3$AueC7tW7+y*vINsEc}Wc4z&d^wF7L! za+qnl%F)5qe@3?BDausft?(_p2(HdFc`fF7w%#W zoL|wW?2g92q*L;FqsQb(YX?}`Qij7Jr@UH3BfH5UX}J9U=F$cI1~@UoGjviKxH@>( z284wof>00D2Gi>XS9gYsCj);E8(QgWUuzL;Wx)k%4hiDb=+-y#i3J%6+44lJiNLAN=IFiw}HE~bNrFY%x#P9D{wyQT|U8fqiMnPb~S(G?$&)Y ze{Yrf&KWbuFv{*jCjv+6e(lPE%0Wc!z^x-D`?+*T+{v-Cz`A43c|O%8eQoCys&zr} zWN!sqYpswg#+$3uV2w?}D!1%{+xN}AvrE~#m$=rZZx`0`mtj2tDw)OL^ ztlWv?)6^^Z290nL6Dv;Hb4R+H&QJ>03U2E~eDM;a&{#_%I>fv3`5|+#c(DorVild# zRcfBH!>{|`^Sw5Y79IDLLdz;mN-gB1u%B+g%zPm2P!@W5S#(m~f!^mVQl@vzR&arTQN&cd7C#ru^zaWCl?m$Ub-6VWuN<(>W${nUgBi`BCyTx(`PAFkIv)tR#! z#5^OV8#kcV`@$d`UPgTKMskfrgyH5H^;OFtekbY@xxK<;!~~A)b|*XQ)ob$9)`%-i zynf;|SR{?h9rl%UOeEC2q;a3LbD(_`cNJ+tUuQe*#4<8}*@DHSL3F2WTVLk_7GUp# z0Od+E*T((A>Y)+LGcj~)z?4;DOXvEzy~$OsL%lM^8)^!21xXWENb+szQqkl>MkICQ z3(}cMW&jWIjpfD%1)5KGJQ=4>>}p)$`jORK4GVGosmwaw9c4rZka)7D3i?Wu>V>p& z7gbLa@ifR-9q--G4nlS@H(CYM9C8`Cw;cDL%m55~?pE8}JeC`I3@Tw3X7PZ%FL%mm zeWB(AZPF3+-`N#NzIymRn(q+UO@DwhUY)g>j#H$J_+%)(m|~TJE1^9_j1toQ(&38? zv%go-FGB>zdjTOIS@jpT+I+J6oETy(rs<(hc-1s@8@i5mbSVw@($u3|m){nyBZV}$ zLagf`zREvuc06$2oyXsFkgP}iBp`D!&44lGe6vZeP}#@Hj-r#_eXyPAd$K_@6teUH zVr==CX77uf53z}h5ptrRej#>F42K4=oG^gr6BWlRsLjOrCRk2+ir(NzM{d=p+Eu4t z2d&T8S8Px8gB#_kT>wB#`glfuZRwML?tyt)ty)Qh*35a_&-Kc5B=X7zPOU}E)}{TxX=FFRQ(`DFDS+{Q9ZCrY~Mt(~DJKE~^asJpP^$i}EMag(X z7dg~U&}1y!Z$q>&MT;XX`_%OlPMvZO(o;a6X~@c;uEwN;@Pq(p4d28?!#T7L)@WRi zlMNenG3E_jSJ`Tzmxt46pDelEM&wWX$DFjjsroifDuc*wtZtldYaQ+(OTTYDYF* z6*QXn>(T3>JTYvUuAV9H044Q7t?W}k9JhGuhWf*8$iRkarW{O#9pib)gfR!_$xV56 z63oY$KH#o!9cMi#eQ9kKE~r2Su`eVj;MjsZyll3m#HyV ztEi0TZXrzy^FWbOoh$f##)kUPQ~#7TElG<4$+DcdaC?MgE;qGk30=`JgmK&ydf1ap z2p`j=-7mgNqQwO<>2@jYx0!1Hjq5u=W;=cW-v@F-a%+uLY_yh6!5}SDU^~GFLsRN0 z3syh+fduun2#Ke?sUW_NcV7ra)*~Mwx~@)5L=N+*?$dY8yu+JyAJkUCsq zT#GitgMrkM5~dUHFW2STy-W0nmt1uLbRhPJi?e^a+BQMM7V2K)oZYaVFic`STzmQ{ zzBG+QZ#qBGD}qZb9W;%&&YPLje)Y<^+m}#kmLCZ6A?{iwZ@?K(R6hki|M^`ngUZgJ z{MLQ=bW=FxY%P55+Lcj0Z?q@^Gr9Ecj;9SS`E%dU5-8@I4Zc(C!--eegw*P~*(jekRo*N0iF)Bm(bHt{4IjM;Amp#=4}SDE%4%_!Ao^+k=DN( zICk`56)W^LYo=Mlt(gp#-kH~1&FFf~d^Fv3JYRBtFc_byd@Qttg9qd3h-Ey@wj{7C z$zyvSzk0!?J%6yjq&4Oen>Lv<7N%Lej9m~Lyj`5`bKPkz=y(;4*|ywp?Z4p}Vm>Kp z-BR4KI+^Xs3XF;x2BpOa&B1dFWLSN<(fyKsGCaRr_o6n%@UFIG zw!=#U1(`$FZC6w0=diB!vuw0|wKf8Sh2dS*_{HmP37cXza-cwYZ4y>nrtW)$+LKo` zDezD%h?9AQQA@jc``pd;xWl;mqSH4Y8jvNxop`U9~6)Vhvbgr(E9(tf}uLLE~xvQ=wu zJ9-r%;Ei{9n|smPo^LQP@uArSoR&1p9-s~PxfcCJO*HJIYNxQvM@_0Gk!`NcHNtU= z69CcG{k~!Ouj&juh=MC_7{eU zx|}cn{0Ex{8voZLR^_wNrHqZY&YKK}&KvIp`EgABGUr_?k-}3wazHnU3tPCImS}s< zo&o9IuS!zcf{t+YY13DKFOQh_kgXsZ+otQt2LLVqsRtkVplz`C%ELBoVAoE#L-Kdg zfS|6jz^<9yRn~5gqsbO}qH=&>B2k0%d=76nTf9_hoc*QOuu^;ynGf&r?^-?fqWjIB ze92X*^Y3u1ob=Goc%DJ_H00uI7bSS}T_fJ+J8u`9jjeA(NX+yaDxUe)m03naTUgYGvALoQi67*~i-P{6Yq`R~jNzesMO*6N_6hMTn$@3?L~8uKeqbN+FyoQV}vRDtUphk%Q95W&l`ILyV&6OK}$nFpBqL5kGKf|GQfOExq5b$j5gx@ zNqd1t5JgtCpuqct+vg(^)*0q4lzcM#_>Fqsjj$($HP8oyN;xhN17=0Ly22*cbins6KkU#?D(7xU&7Sp z=|$hY#})Go|KcHg$d^GA!V`GWj+0RqxB2(@hf!+JzHg;Zm4xS0V*PFW=`%+nEoiX0 zBySc!NP|=BS;!@1cMxp+0q=GBAJ&a$+{1G5Y9$W_6qb?w-W@46DZ8CV_sHK@I>5AL z*e`@RWO=sb7>go=xgO^2B;)kn6CJEEcV1j|xW!sCnzqy!)7(@A*2+GDxsCJWr{hJd z(_>1S^6dPrG)A1FZ&{f4l59G(-?UCAvxG9bgX_kA4$6{mChw&vnNB|F!wot!+^szu zS~85dZ7??P*U3qLq})33Y^1*kre9&dwIA4mJ%qBPJ<;B`9N0^$k-vl+&^s|-= zHy#=B=pdL#Z6lwYeUH%hWSu7*9mDnzw^O$3Xha88>q!50Qp|#^gVo-V+@^nv&|OD} z*Y*D1K{YXQzdy&`a7tMICivxJ>nkd+gOK z1a4J<6`a(7VP^Suj$&M>v5chyC-thR{{@#t84FCg2D+(@K~2R@WEYoBVM3_o9>Lfh z_wzfnQ$L1$I5^Sq>;r3nQ_2?v&p?nZ+BWA>7aO(53z}Sg z4hL`(KcWwuj_UZ@-O`z2IXuTUD9TN)G>2Qg0odNgYv+=?sU0e|Z`_QoKVKtGn&6w= zGu=OX5JTuIqLxd#*R=cAR$@SnyTj ztT3?wxBvLEYXx?l(zU6NV5Xk407*q<8jB!5o8QujRjo=XuEHcMZhT z5N2@K-F30ILd}fXMOJ>F(L6k4KO4bb%U(Y^B)Q{?Jm)KW;>`RRppTsU?WTk&8-&@2 zn&4X;tNSD|br?pdJem&P8D9!P7G1)(E1R6mM(6z~LJ|Syg0b0?Czzplj8_$gS@E(6 znELYA^*$;VrEy62i<}GV=bA$n{w%)7l9v(}IvV#1>=X4fC^>$s=Y~no-C_2}!<;ZP z>ckTRw%#DTll1x#jN@#je&@Q#8Vf7LH~9FoZ)>&ORB*Uw$#Rok|#xYIi;Nk*=eqO$N@69XLZx^z@}? z^Ti!K>T^axSb~`-otdI8tB^v=e%>Q^N5>(doQbwNs`^rB`regF7f?=4s&k#yJli@V zC)c7Pi>2qV{eogJI6cWIn8!ubhz+Qq8UlP>07EundMW<^^%_x^SsR7=Uo4NgjdM7# zi*l4S%W^Zi72lrEY)5J8^c$^~GAf+$b-~MJr_Di6lX);t5n>s4KR2UL{4%{StwD@z|KX0*74B#wN{OfkuYz6LF!kTkzSop<67j1 z;@+U|a#suc zdi3_UMR$bl$h(Ikk!f)bjf%#HL3Z(%f!$R?&mobJZd zhFE?#{T}Hz3;?@?n;ro)mYhWH97J6?$s=y~!)x-hqJ^LJmxS#EVED&t7D3DzOEpI; zkDDriL@1gesuGZ6)r;x!{}jwWDwRGdr6vi6j%aA%#+_CBX`7@}%Is9bEG0oIbqC^s ziQ<)f&up~eaGJnJH)^k%oy$x^0umAnvdVZp+J)@<`C(XVdoQ)(byuNUhi{C7G39 zFye5w(2ZY_ACBMwHuzk&a4d$Bsw1oOVLmOg56PGtMrPI#YkNt}eCqH_A;ng`9!U!Z zCMS22fsjrxHB0@*-2P^;dTL(>L~DkN9CH;ALlC7rqc89)OkZ$qNHw;C9;MH^HWw~U zNFFC3dvJ2=M>l3?qZH*GH#E4^I|2d+RLSKAJ*JK?F)X{o&pjLASMdl#@GtP?g7qRu zWz!~uydfLNPnVIM%^^9M0{Eo1ZV|jesa4?XlClWZyc0+H9g52g8kF?;k{pd>L@Yyi z#=TV09WW%st{gpbD&-El^!Pu-m*EsBlWoYl~aV3yKb~1w+ z5=WkBbyl=8ebJapT;1cShBwz+ev)ocVukRXIL3$KU%F6JqegsTcnMp!ZVa3l{*b+i zvUndXwTV}4c^2t;&u@=i?0NS!1k`rLvCX1u7?(Z9BA(im7Yp}r>q+Fpbw*AAdXhFb zetZa@KZ_!()qLq&+=zjxFt4>#az3k263kX!npZAkY#KlWy4Sb|TJlBq3Apg}=@vI+ zdBt4?2h_-2BfK(OSNL7(EWEl{3gOt@bGHfH_d(Ul!Suug)(Rad-)9od$&_^H2XqWt z$DDohQUPn)IU3`)jk=^E#4}=9EVe`&3vqXjC_L(dk0(4C7Gp?DvP&>ju2j_z8LL%W zL2CkW?$_R&;$=kC+EnfiRkgF|5l^-RLmR^G+W@2qhdiJJ&VVdUQne9i*^yr1jf#zh z#fZhTX^mu$9%J&Ec~3pJRNmD{?9%o}8+;y)NRk8f=wg zi>aT4ZwcQ>VhPXuO#?{|{x75i`Tl|l0rV4d{-C|UdcM_+pTw(*PbKw9@QEan@Fd@m z{7WE^{2_Y3>Y4Y>zA%81=K}vlZU|)XAB2)n;D6%OGBXJY511U}6BhZj#>xmJ#UD!T`xj=7`B4k#`KsXlAiY3arl0h~mX|g4lkl;nc6tATF$Ux> zW(1}2R_R0$bUtLg&nooLOqcyG)S1ON8f2oumj{2h-YwC2+({^_!KL<{Fx8U^-MV^*gI`X=@+QGZEH z=7OGSpzS~_4AXmdPbN8DoS7}KVGrxa0F$1%-`A~D4chLJ1y~oRaKJS}V7wNRO(&E( zEo)tZ%i^m4py9V80~5;rLUdb4yFGJ%u0D)H_Vw&1)f}jq)vpl)hqys)eHh1_OFfVh zg*SipZt4+PWaaprzUl{~Lx0iPDGs9i_0U7B(^cxnT;zwTSL-=%;$QTqg~(jhXoiPk zi*y*zszjKFb%M>v?20#e$xYXU@|;1{Ci#c{PQPVkg@UH!zEor|N}czCFqz9Vkai)1 z>$MfIX6JGdPOQytCyQ*9tQ6J-&^%?>>(JQJkLiF|#uN>S}^rLUJkSKPw z^6Yc$+g$tAP^dZ(V%h!s*LfCfvQmb3%XZPU)9R}hIty%u=Lo;RjYX?d#^nf9nYzJS zMt5e9V=mmNm7Qx^xT|_(77Ayyo*FB=wBc16rB=r^!%{)tSlVN~$A{Ua-Z(0^`Ye)+ zX|Y&NJ+=?-W5D#YN#}{>^@BnYn^>&C+xUB>;nX7Qc7I!JWDI-axB@#vcoA%yX1*br zRzBA8Q~`6*6FFn7gvv_dw}L30R(4KF&x)$sr{`3UG+1oR$4~+V$~N4$$4*Tv7w>e= zRA=uc?$drnqdYIxBTZIwt}JbR?Ri?(>VC`wn4%<2wS64U+|0IGkiKtiReiRpSO~)W z!|?k@q=}GyUei^*)gp7v__qCL@`26IV2HDJJ(47EX z7oex3SA#t1%8EQurz*=ao;BTevpW%dhet$U_uuZ2CPh?q*+2C{Ml23EeIYQ+IuDx> zq07abnZD{uPK51ue9Ph?eAB9*or4zNE&nPCM1Y;BE{yMmb*)$EV8d`9&5%9%hdB+dG3l zY_}J>z?_>*rA@vPbV84oSt?OX;wJvcML3lX?#8mKqURg8*91B$kjigc_8(}^nu@O8 zQAAV?m-XANG<{JL7~d0pm>XY55XyH#x&KiW4bhxkGvAg)2Hkw&{MBL!5TC8{K^8PMfYKg?+ZhEhwLkqj zfUe(ud3I1UQ75h1d!$M#rggvTKw__Er{vuWJ@gKkCv)stWZYq&?fR#iujOdq>1brT zp*BHPvdYlJ=)@3U6flJ15YTS4PS8c)MbJfO^2$Dqsuxx-v`Aou(1@NwSW634OHWDv zhVU-x9;;9h*v{R1A!_|Hr42j`qJjmi&4SM#47MjsOuEen}O6NY#y7 z&%*kb7?_ywnV6XW5-TekJ~J~5J{=n!J_7^8zvwfLiIwqRvY&DP=>4Pff8+m=|FrSP z&R_b>kM?g)e{y4?r~gZT!pxr)Wce)FpSVAoOtk-!`;!anXYPMxKjZ)E{afxodY?Lf z!fcF;|FQkY-XA-(|GxgQL;Iil{;~c~`Tyqj?{=X7llv$AN&mzDtB!%U2S z`p5qhSQ-A;68)FVpBDVDyZ`fg0@e_W28&?f{ zYG!7pzlr$tf13G^1+BksB&=s;X6Z)u*Z;`>6=P;;M2}BL|5>O{pZen-(t1`#fd9== z|HLbNjysM9rT}Rhdn-N5zoIJtDiR|tEkMjs&(h3*&)US&2%i?9;Amu}jL*sn_>a^5 zmjeS-|6LO%I=26%?tjYgPu>6D2Qo%BS~jMCk7{)IY@eP&_umIL&qOy(WD(Rs9~<{p z^gy6JS!9e>lk7oP!H8BtE&cWdsodB(Cb>L*c+jsx#Gxc$wfc(fm%SQ5QF85%IS5U`9gj5Zj0^n4g{7X1xx;=XN|m{l0xSnYL^7Ll zt1Y^t!9Da~yw1$QbCGZ*Ng6)v%wKjL*?}6wICs=xteTa3ens_dy*3L0X`-vAw=0)u z8hGot7GSEE>uZrd^n$huzx-FBU;jhhLw}V**KhSkyv19bGo=v zp3v_2Kz?@4>U?|0zL)-R0f)wBbRC-1^TBvucv%0??H`ic!h5&6P40?%JKV9`A@!uU zo8Ao;^~7W%c0aC9UTi+Pf?zNv8BgURJ*sQDi9G;3zJ>+p6y|&1MG2XOb!pc+s(l{T zM5$6Su3G23_6(DP#bUMo(`v=#baZ%pslj7H`=;})1>D~+2o~=*hx_ScNZb=>ku+K+ zo5%TUKv`0Nb6E>SC@4n{@H?_NX^aU`Nh1p(6#N1=+;YWbw{9lOyQzlE2G z9-=))-ge)w;oV}>$tIE%cJHo1pGx=`A2DBHg#CU`j?qrj4$%INHeS?SG*QGzsY#d` zTpU2xjStTV*9z~8h#5H4RkA(N^#c|vIE!Z*!GIrE*+hm21zB0l`tEql!BTSJL+v+t7@?OnV)+@(}&>^nP;VAvJ2` zl}1@?J#?$&ZgS)H+`}>QMi#IJ*>GBEvs|*SK>bI`Pz>?J*q2a!x}ry%qQwi8U#1G! zMd&@`&uJ0+1^b*gVIW+rLW^E!?jCs3c0atTy^=dx_2m2N2C7Ly0XVgUQ*;Y4$GL~? zgA*4>G)g}nrElyU`&;WU7KP=jMqV2ZzgY;wbbW)^3Kf3YO*_F}5? zvRZFcW|m1C-`AU2UbV7jHb%1gDP`0ru)ra(woNkTV7}HaVkhO?lh@gu7j-gyf(qPV z*Kl(JX=U`#I$u$1Rl25Jc z>aTD0DT6y~RLmg~o~LP35x!Bb(jPzY=B=zX)*73wtk(c6FTZSd{nLTMl}k3R~nm z^oLc$%3MJy>k}p-UcEd*IOC&rZDSnA`1v(Q5@7ch1@nUyW}{Cv2VymcAjaoHfAlIU z=3=9;hMT#DGc^ZLC=!Bw1j3BK2dPSm0B_TQs3nJ}iS}EL_LzwFYL51S5E%gN?>JEP zqml74%U=?INIXKqU41Jek7JGv{VE^#jRVsZ$*PdL9wovSo{(j_TWrOY<19NPUTA4o zTKyUyXK#{*a}a7-%EJ_pVup8Cq{+?;eguzGNEk07a)gdEXwxipRG%(ADK=aL%r2C< zD^yextuAMAO@cSOm9;D3?HD*Nk7X`Fd5E1+1mze*GsUtib7uS1Z8j75kX|bX7FpCC zGPg|8|6`NbyPqpolmrCh2ve&FOHq39Mc;Acc*-oVkD;l zna33CI>*NJ3SG)2ipEro+jluak7^*lc!?b?*#uTd_?ZyNvgOw%N#yF!I%fvqC znl($fm66e7);q_>s56t6(=QxDur+IPASjKDPDv#Wz@|JU)L*c~~Lw**c3dMw2 z=L$QbHROVq87h^ht{J;5HhmPdaHo~ER2!-eW29yi&Jr$mx%!MQl zu6q4dr~HZQxST@qKrx2BDs&E1DVL^H-bpN>WaK!swRCun$w_NXmSv7wDaTr)sDfc$ zt!$Fr1jWw(zP^gkF+Xy8s@2!J*ub&ex;*WW6{iZxQDIGz)SgJhjuDGyD@=1ZsW}{Q zgVH&?=Q-xK$>~^{AtD`dvsmJk$?7z&P_z!yoCw7(MtXvrQ99$;YF)|TSSYy#wkkWZ z0CmgXAqtq6xRvja1T0YAt~}#($X895-C=epSIwL_b*^Va0T+P~yBlnlujjLzP;X^5 zQopV^A7;2Gd8>34Z7kp&uKD(MxA4ks@^4CJt6ofb+y%L3tyjSv`aMT;mq#7uJrjCK z`jqobWgYKe_tmThV>uv2?zl>C7OsXPv4zC31t_pZ%=n%7JtZTh`>oNTdFaZVqIkmG zRI}XobS}cZ?0mrv_Oqph?a5(<4%+#K9g=6u7}-<93Ol&-)f0#m462#U#FoUw4$As> z1#4Q>4NT|nrskg-4p`P!JFu%} z_EK=Gdyp)L!@TVefl6j;HKpY@^I9jFP8;r~N*Yn+m?t#}W^?K?U38!z@rr0Zr z%$6CapGgh;gdRfXpnm%gVpjx-E5yVtqxPRFHP}^KFzq2t)xb6e#Opm2?I-)2TF5)`f{MiwNQnwE)3MdY zSW=}8v0?y_h6>;@t_>BIBuR#euE{@NafarW05RpGhZYFWCa20`|55;EDlm>06|2le z7B65FFWQgiONl3rGlFc$PMi&`En#ZNX`GE*o?)2vWuLB_6)PNOJeJftWSLFK%(K4b z+>><~F2J3QySU~$7ILd}o+4gwUUDjCxy$LCje4H>f+^}}N(+;d!x$bo^9@rhPjdmL zW#CRyXJ+D-1!R<$Vd(69zm;n>)3_Q#KQL9#xEVuFI91NL9%HBDXzXVFdfx-8Jz$-{ zhAyIzjxljy$~Bc2Fe&&<-67hQC&rjkIC)`4A+__unDNfbU`o;<2$;b;LUB(pp0c2G^2`cjfWQ?eqDOQYH)W ztSN8ZMJZq?+9GK&0UH*$4?APdnQL+%2n=>Y7WY@tV1LpWP{-f zP;>gSyF%U(;8Owd2WO+f%NLGNEvY%jXc;wKdPR;Va2aKu5`qtX-%7+JMBM%Ql$%aa zG?KJicI^~Haxmm(->FH4Hd0{k)?BYVJZE2_31AtDu&-OCXbO{TQRt*}8S%P~eiik` zL|r?$uDZs%4zrE(BK3(S6@+q=&x{eO6-*47uhm?SPq@x3Pi&~whA2Rx%=1Jk!3<5K zQ2tf&bxx51ry$E2UERPnf~FuGa&_Z`d)!L*KbMTc%|I=r-r(S!YqeVu*En~JCP z*Tb<(V|Rc@UHj5{R)^9$yH738Sk_V3_QbWxi^E&fYr#9cPfJ&?&x+5W&QaC1%8SKo z!#lfAN7jYSCFJPDzW>v&bjGe!h5dRqgYi^;hjHYTo5Dp+TH^g&a;7B7lord%21XZ*O`4hys6`+;c9#rSa#Kzi&2GdX6{qbfqrss^?#mj_Khpjz+g1*)HsTR@2fRT;^g0scZa$ z@#UCs#pwz}KM!Pcgr^{{DMAllOj=Y5%}q3un+=yk0&DPJW;d*ydF%dEu=Ol7^7;%=l7STaBI)I(DJ=9Ff#gKMw z(<$N0u;UWLYsaO)R!|>9A5>qIzsb_~6_?;l`;@-O&BRE@crrzWqaS|zgAlBIgHV*P zln|6K92Tv~mDYhAlb-15NaQZn=WLAZq)*=!uTpxi+cHBNgNTz@T zc9bRH9P5aG?iaW zc3P|OEWfC)GMcH+gX!T9VBkq`N~@B}i7iG<)xgs+${Czc7vpk04i%$G1>k1=c=N13 zrzL)PgSU2Gz|d@YVUBdJjLK0nJA8#x?&0GxFopsclvuv9aZZ()!0cn-dDq>=0lM>y z7^GN!iX(>YmIP_T#`Jt7!~54v(FfpfiXYz~xhCQ62&+lIJu6b^Af1+&!GQP#Y7p)| zTyqbAR2OoY&P!ThQ8pl{0qn-%X^;6A3?1R*e?)q6T+`)Ju^@oBsVgAst zYmJ*575_4L?5B5yuVPUaaTgdlS7Y3wrl*`5HA+#pT>k0S4aOO2Hq6NzDKeu)#(7JI z%p<7RPET-8ey3C$iCTs#OJipSB&lNbD$;aJQdUJnf@x;PttooOscOcJDF*wgoD4D- zMWW$k9RUPN(0qK)M(8dhRXLU))=w9EDt36G_7^_jQ_9aECIVQvg?X?3!%majigV

|dvJNBUQB>~WF8d0Yk~{DAk+)FA*$?*$N|Bcrd@o}$2Uqjh_9d_l zMYyuzVQjzgWZn)_Q-!F>A=vGqWgcFhC0;#!kjzc8IQP1Uf^xHE!4+aYM0Kt|gs)r; zK#xx_4^&pAZ1fY3TYIyoTFmMG0d{JX^4Jo$y5rUTLio*$6Rh;{&u--D> z={WBw?t(J4K&<9}a)g<#O~~Ab6;sS72dk;f(9jye>DxzF+9rE%+gxYK5-}ChEXn|( zIOITgq$8LI1)B+yC#r8HO*sZj%ab#1BG9P^9SM5s_?+lu56AO%Y@VUEy9H(Cya;}f z%M?p{gF}jFCMJlaMGC|T=O9UMtsmNmgxy_xmHt3M(oKnvaINY+RhhE5;KS1*U@1L2 zZc!q1T!R}7>7N{|kBsC!66Q^b+)I(wY!VcS@g3hU)U0eQaq#6^y!(PF7G}o5wIlut zCB3I}BRjswNo&q@YeBw&awa50hrKo;n?eXz3R~^Sq&&v2L|uO#_#7A+Fdmrs6!NYq zF2p_hF3jcf|mJ~F`^)CS)NKixjtb;=k! zpZpu_z(pZDLhBK+U`a5z9qi0t(eZtz_NR@`i%pQ=X(4auEUm+M`>Zrx9Y=WbY9IoM z-R!AzVQ#sclYg_q7dfr>9Th$J5TqA=^f5 zn^}lyB|*=Q{;mU<(XgSfB#MSxW^ylRZf2%w18PMJ2bUaO@Et@A(3_z}%IF$vMqr5l z$EdNAa@NkYu$K_r9MEY6I)hAouWPBRWxx~-$rPjoZqk@yI;WJ%E)#6A%wg5=zWJ-H zWeis|D7ccwT2k(w`to-NSI9F|8-%3^N~-?{M?kp0LLPVL&%uSBoXG!_K1tCXS=3VA zqFFRtT*6m$0?nh3I8zOwCDfdAsf<2DRmAF1plTKVT4bvQ;uS6+p|)Xnt+*abU72Qc zf4RnbEH2Y{Dp59FmA{AgC1Qt6R!?*q4@Ct`p}Caf&!9=VuR6y=(EjzN`szC9mMarg zG_KP?m40B_9#r>!aG7YMNiwhEk3$e?W0cpp%#m&Epr-+2Anx2|4U ze{F4bdC9tX;rzm@=e};{#=n*w%bZM~I6ivp=*aMq!$X6{p;r!mWgzu3J)o2QFZK6n zy*EG*QJE8H7&k9dQR z-1}7(Ejvc*3SB8(wwPS9xsJF2dM8=p``gJEC`{gwx9;raYO-5MULhQH-8+PRFl+7Q z>b$jWm;=U2siNZ+LG^tI;`BTLZPIPqV)!Mam=!J<0LY1A%F_IX{%ox8QsW0Ia`&d{Kz#{Iy0ZS6InHMSR6 zZSVvn#5puQ*N80U7SSn42u8{TEU_r~l;+K98oA{(h{4asFp90fidWNd`eRxk} z#rrnIY8_{W1}W#b?uv)x6sR#Z4-4Q#{+`WVHEhb34XRUX6@2kBs8wHZ@&HL_!lU@^ ztY_l8^NZG|iV(TGU_Fqqly@d~M2--SplJ-Dc_2lEytZi~R1w^O zAPBr%#YoU1bs9$Hs^rsDU(tY2WWu$wTn+dfvo0L~TEwSSeCdNV=?HLC&UuL7#6g1T z|2#kzEK@mQX3Q~jT*^rh5l(sll!qWYhSA12&SA}iIp+kqiYwljscnjx=4z4^kmR&V zg9es!u{{%kKHu^4FFZKEXl;xmm|wIYF~NVl(t;6t_mC(|JkKv0R;%Pr&qD@srjpi_ zJ#4}UGECVw>GyQ*9lJnp=|H56K(z)T51s0>U6;V0LR88ZEWhO}JlF>_*{rf$m(}_p zCtjefFjVB#Mjx*s4Q)TDYkLc{aloysW99#-4XkJQ5^u#L%=f;EsIMPRXliGrHbDi~NNAyVQ#yRf%2e1m7i;8Xl{;Mh6ED&-QG2bKI@GJydBP<9#S%d2nE%CZBRRm#}et?Arrg#U>b%T~x`OR*P zU+h->D+ib>qQhs?3RJg2L`sQRLf~MdE%T=A@_XZwV?ZS0Zih=wy0GDwpjHJ2$`>4{ zYeXeQB9^+O0R};s;+PE+`GV0D7liTR8DOs)-cmUAf+C(b4PQ7SW)+tRHd7Y~iwA%k z29pwLU~=d2+@d%aV4-;Mf~hG8uL)VD@zJo07HY?aKYof2)#?l84+Dx_KL8-#y%fGX zv$qmnW*yUWmoy0MkSKB}2!AA_Fq-&K!rP&6ReIm-M8UwejFfO-8>5~`D7Y=jzkyG} zD1ILwMoB~cdv+&#PW@Z<>`oTt09KztGcv5l^>_*z3`O=Cksm!XgXo`#1Rg;NL=3)M zeiVEN>Z0gfcH6MLkf@*%3Rb0Gnk|uRNQq_w*-!@KBilRMD7W)jPV@Q%cL2B&3Mnn0 z%F#?P9mt|I$jMnrA{gUO6{Y2e`cL0W8U|Rkls&6HR<~h_ZS@P3%bitsKAWDmHi7|! zv6@x0wmmYe!ADit3`Hb_lDS;(*3l!wBX*}8KNgqe>TS5waOa(9s216}hL?aPd zmQXm7RobJKs1$_*+U$=#W-LC6ds=V&JjqQrctq75V<{^F%Z=U1LWAQS zCr|QsWEdNUX13x$SV6&%6hXcN>TeS#g#%!_d`z_O9NilF!^qaKynz!>o;?4H-}05{ z-u*ma2Y-(=v>)H(UYK_d_NV)$Xdv1zU2OlT^P|2`IzQ=q+8@GFH;M-2E))%h;t0OR zR1|FqtD4dpR+F*zu$pM=2*nd^opM*AZJ*SgXzP)>ld)c@TT}YvE=}o|yOOb&Lh)p5 ze<-dgil(JdvKaI~!9fm$aRbJk1ZnM%DUT+pn>0-SkTeZ5?yuIg({a)~D!FH618p<_=*~tg(w7QzJc5Z!VEt`Xdwxq&fdo`ipv+VWWkX>!e|Fb~=GMVkp zQK5u$Q6x)+6@5F*UT1Zi^;%l(GwoWf&JJIw!w?xcEn8FJpe)B?mirC_O60tCGUuuD za5ANyGVi54yod5~9*XmDo~N45+**lU0Ht zAqiCxj~?-c1mrv76P`%q9YexqFeD-dPohYS(OL4^rBxcNnZm9y@)~lI^TVS1b})Voqxs zG|y=cYl<|E)U6i_*_NrFn%+L85(fKl&;4fypaQ^|o;C$p2ulDp=Li10D)ya0ci=N=6mE9tRPs zi~$BOw^tf9G>sV*kGghj$-#0-)&3Xd$VopuBUdlZGBZ44e`(1^ zJz2;<5;@y`ZRaX$W23qL$zQnIwp(*wlykneqie5xsk=m1um>|6_V{vw@h2Tm?hLEN zYv;^6^bl~F9*Mwb0VLyO0q4vS$B`1UrMSfD%#ss|+3v8}?GC$>H#r+kN)c}{`0AqVW1ZV=BpQ%u5T`CKKap&t7C89#5X!${ZU8fiT;i+J80b( z|HS>LK2!&8;p?5R9_myFRQ6go^RXrXk#(bL6vqX{p!}wr-y!S}yF=aK1H#Y4e?-ND zr9TtM3*minvd^{OLq-I=QQYJq0dh&o$#M<5-pj#AQ9vcpNb&~AbBiTj-74F85e z_LcQXq>tI>BJWB!17t#Y%SpycZraG!_?SSpimftf4dX_6L!2y=o86>dSnMQ`l9ZeH zo%1AuYHG@ALJWhPf>6p!f*?s_OpT3UYW$TfuB|MaPwAZpO1&)`xo5c392Mpij&L89 z9=2n9mNY9a$D*WqXU)#`J>r~1x%s3=CoxHCX%et06@y+F%yk1uk^OkL53{>#Vr8=fLBKmr>6z-I8AUM9Y%$l~uVq z{7Tcn^7YqRL2jaE5I=!}URzMW505ky*4!hA>XGmfOmG{mDlc`dA#w4n!g7v+dQ%Fz zs$?SdP*xob6~vVF(@*pF;MsfftI0;dCyTx_%QyiuMyyp^%(7W552GPdF|>+BJ7j7> z6iZ1IMV+&pJXCmH?lYAxK!T(fs8MqcBePar@HD&)`-w$mTA9|u&a)W*Y2bJD&Eq}0 z0t>y6-uczz_;YN!cPIDN`|JA#ue_Oe=Oy%CGn!R(h6+-_5*-7fRP$dRW`-yX?Fbs8 zT1?rQzmKpiSqskRBW82KnH(`13(j8^GsBRzW|JEv);a6ktW{R|+RU+8cYo%b7g=fp zP$~j4)Cis>IkiZYFAQ||j5pW6mtT!P!FR`hHQ3ku!B@FE_wxV97pwDDsLkXLFmF40 zyD;w+daP%h*vS+zI)ll~TC}tt6FVS_)1o4(ShO0oT3Ta=S8!GfYc?A6wjwQ6j2T*^ zM~Ibd*mji$js7|a$^pfwc^xSht`<2Q&m5YS+4a-v|BD5=%mR>nP{iTDmf2Qqq7ek? z;<6SSjb;r66;lIBgN1(&jG5K2dWF%bUkp_;#!kd6a(Dtx`C*o*iNQhHgk_+$4^kmO zYXguaN@(a?9R4@kRRbHvafN4Q|893@eYJ!|*gt!HN6y!qbyzW1sSc;flFJGaf>uw~xTMfICERXr=7K2TrY|NT{m zY92iBt-RX(O-uK`vZ(3c+z>?QDKaU}69<6hnwl@fo z##o3WBRT43DlwTbClU!#IR(0Q%4vF_-P05luGQz-1QG;6T2)nDiOtUg7RXW90mx8` z(R4dKc#0lOw@=d7PU82;^m;t2Q|XWCb7YKYWHoxyuR-hhI|%bKyUc0Fs74b+V*>mj za=kKdDQO`a$WGD)Z|>5uMFY>KCd^4kfloRlX=YdwGf$DJO*~HKRgQsE)sT1r4BU6> z2F8{>RuzZRG1mT4*^K4n zA`>a|2B};!38&i*!0jP6oFW_|o>py1ej_WVL;d|QVHh^L5B4aKI%m}&!!0E;8#zP7 zE*R4#9?KMIr*eSny*bCTZV!(^%LpUM^gme~&@E&lcAf~+ANK^}3^cYK3&al#lnK8Q z&InA{OenNQP?cb;Cfp?KCS+@OKOti8wjioM&={G_!yYBIBUACAAM6D!oS<*$Q3bSY$JvhhMg5^-J!ckEQL=B@5n$nw21wg|NVF^$z!tn_y z;2iE8pOH#P|1r3Y!H%6hpOgQ0r72iR#+7bBEpd$7c1YJ{T++lR#N-_B_$;^Nf7i5s zB+C2Petp09N}i-DdXO#jFV0^ST2QpyzcPPi=+UB9rBz?$Z_95D{iJ9s`?3=~E=~?@8Vi1Gcwv{aGQ0cAe<=CD!>+7U+Fp~RCN zN-{$SlB6?=O^A6HwhkQz+|f+6J7zW%G}TU0XW4?Y_Ocayax7#hVM2YHn^WI%foczx&z@Lkv4aE=n09N0^&FWat7PlxByw{U)-pWdcJha#QPg z*XEv0-&;3+?CRE6&v$R%-rfDo_C+Z+PDMKZ-Im_;^hfD*`cJ3d9Heij4}W%tuBGd4 zKe-n${&zyySAa2%<{`p*wcO5KLvy1=TtmymA{P|9Bq`X2Rnsc&WCz(1kNB=gRU%7F zP$kM49o3xZYIshBqWFf+)L}3%ZrPRt*N6kxJO{22Ejxr@bP?yEFU%#|@YYDURvxY; z(U@dQObY44G(n#ynNrc7IT7arKN3ssLAh!`nuz1ckd&*lq5EP~m2F8_%`Qd_9G8V56dIc2l9yWq323O`5|xS%kx_K>bz~fZT=U07kt;l*Ng6i z`3L%-pG7s(Bg>?|l%8-zFrwxVJKnq0qSg=%_M@K!9qXlxYxkwQHY44& zT)G=ct)p-p3N5BQ9bwOs7%^$R&8_|h*1|TholIoI>>JPs9z5qHX$qUW3ar0Qb^@6~ zmzSEbT-o3X@(hb*Q`T0C%!oP5jGFTM(|3phiRyuG6)rbl>zhf6rk;YV#iKQf6vbds zpys|d#sh|vy@71@qUeT@B2VX+l+^*CTxE^qnCZP3!ANU-bX^ueVOGICbIp{>Q%!NK8)O5DNf_ z74+^5me4~%8_zcwArw=lg2NA5UaA>h?u}|%d44n^M$02oxlwBHUl8gdlp|RHx7g~>5n~Q`;3);+e zfz<^+Gqwiy8ZQQ3C^}(iIydq}g~IzN0>K97M`)0g!|B%cah@**huLuwVry*`ypzB^ z!*?Gpd^2$2n?VDfllk7B!&`z9$fCMh!}DIH}Fca%|5W|lG7_0%BFFYBBW z9HR9-p>aA)>p=!wwDlY_bUrvlU(154V$y+Ew)js~q;ec^ZvxW@^buk$1GOBydZd^D z*$FUe#&Sg45kw$S#Zqo~HNZ}Po7WpD7r`2AD>tCyi{v|qia3a>s;ov(q5g}*S5~qj z8#t&^>T;$FFhrPwcTzgLEZJ9lsCDO=cXm`S4*2wrp}p&#d^ylpa_hY1AUZuIvDE~fu|189SUp#qxFqiMuo z5k%ev!l%E?guO3m$XNoBTqcoSL(OrEYe+7)$gZL0*v2&!Pj;}!H58YfJ)Yc{EH!yt zLvjt-HB{Hg@|azh^sV4)`CGi3U*XbXVX^TGQSd>@B3u>}Nz(-d*w8RW1u-B9qF@ll z4QN|N*a!$mM!Rf{h$0LjqnbFx)(lFLX3r|F(OjC-GMdUUZad;i8=`f#q1dxaYm{9j zwMwU#VUFrXpoTD$#TW>En2dA4m>9r0tUqsvzU)BnQ`8>Fa#P3&3G;^OkeoS{xSO!z zh_`rr-`oljDx25q1=?G%66C7^^3@jyp15l3)p23=oVXy)nw7vMngNI~#tv{>kMmv2 z;@mEa^Vt#jo)dT2vN_9|_kBo3(Et}!Sumh4sTxG-Lb&KsX+?E)RfbEUL7~-Fb$+QO zSd_hSZx4I>^~;z0(zUeZgfQ^+q7&(3P`MA?YlVVshu6Yp(6R@Vxjahq8Rizy(>kwO+Jkbqh(waE? z&#`Z~VN4o|?Q8qs^Pm5Iub&blMe$H)G zU2gZUBsoiRXGyXHbWU^Atu^VGL?lVpRGcZ}tjy!)|WgO)O(%=Q-eB*%1(Dq9DPH%(JP3!xl`TY|j7t7(N(RXK-eaW}^yyTCd7 z+htxi%qV>TUYu#)G|C%jnj7X^4s;EvStiKBMGZe!f6%^ju&;Z0cgd+2$c>4!b-NE= z!sbl}@4q{Nw=4S(jGj2!UsvNHpS_m)##d5fzq@+4{}vp-7LcZbZ_Yro@TUgn%$0F2 zZowQ5lms;gb~qqT1%&)ymctsvD6G(+#bzxf=v63myv#SfY}WE-2BXA#3FRFfLh+L>?1iCb*RoI>x6-uIywsY`{<0fS+)u!tkSDq<~bx+3uaC znOo_Z4H`9nAgGfrsLOB=RP#Lhogl8#95vn+?|SbxFYi?{3!ocJR;5O-hyIk;Lu>Yq zkivn;)aaDMa67t5>3<{T{M0bBj);Ux6_07aW7jXE$7f5gmNz*ML(l@ZKa?2b;3 zBlNb^u~f?uzijTb{0-FsDq9Fw1260GHkj?Qr3`_WDEH$XvD*8|CCV6`c@*d-O}mf~ z($N<97#OtJIlv0#8fILZQ$yKRk*A7?6HNt`F4w$PZm2tzTwE!i<97aYAOG*Z?iW+8 z)aN4~_2Ikt>dS~jOMx}nz#1;( zRYiv-Hl3Yig@}3~V!DvqgLKrCb(_uXPd|f;aV?*INVlc`Q)Sw(vXeeIpS~IFg`=4Q z^ao{qZG{KV^epl$D!OC;v`ny+;jL&Z?&3F@J8T>6n;l!c2he`p&F?Yqu+3Pd_(Ed(kc zVVVjjE|c z?fJr0-D{Y^&}WKU!`nsp#>C0mw$n3Y?oEc)OkoKMU z#tzg0bJ+lNu9V3_ARxL*m@K#)VjhzP(I5*|G@;<4qKdhhVN8$82tILV8Pvci4S4N_ z_B$6Z-ECX9_h4%5#*Nh2;T3z@);zaw)#~S~7xgUN(c8Ck+et1k^T^s`AAWpn)%R!4 z9)148B*gqnhc4q~Yj*Eyd3x{e@yXhrx}R>}dAgV8>4prmf@l_LX1q$H)|LzI9(IDa zk1<$MlV`pF7x%Ohic6o90n@3_H%^~(cEnZ^l%-s$PU0jf3)N%HhCqkn6dN#&8sHQH z>-K0QUd|M^oHZOUOG%_q|GN1Or4D(hhzD^=o5k{ylX3BX>^gm~hqj6uH`2ab?SImv z6+GoxUa*R5_pI};F4*GV8tnET2p;vE@?Y@Z_1p=Kh1_5CyyEHeaMd$cilii1C$-RA zl|whd*Xz@6I7qk6T~KVmey#!gxjOdgHLgN7!#dmK*wi|kVVw=n*PPSCR?lqewL{>w zIt#)&3&J`J!kx}37C1F0arQ)}u>dSE!+;F_ry|z_3p|gCAzKwp-WtdYiD|Gmp?C+5 zH!%a`ZBp6*q32VfiaB9_d)9v&U^-4cK`Q1JQ|E(M1i*JW6++V#X7E-S?l<&#x>}cR zt*^wD=hqF7W7CyG$!E8GcH*@U$+e$s`d0s`uC2%MQf156pWODr2D`7Z4Vyps7%N9p ze@^`)^_SGZ>leAXFAa~r+zs{z_&$da-oqDxhnUb3=71rX6-1MTh%ugvVUf3z7{qQw zLU0$4n~xvyF@2z3mQ<1qGfWZ!LjrF`8r+4bKT(rlCN@Xq;BhXINN`Pw#Q4cX0(Lx| z`Xk=Oc9hVoY{zJ)ZI|u4wjbH<*#x+yMb>%NFIgL{&sc}7pIA*ct7M{;m|~(RNWAR~ zWT1MjK#1|IxE%-yqAA8(=i91q5RduevR-KH{%sh7D=X&>!%6CwmseGC`guAI6xC+8J_Sug8_*~Gz~K7XcOFZ3D31DcHo%_4#*avEXfmPZo+rbHDh8LJqp8@OxZDUOgGz4+)rYBY6u zfZpwm_&8t9i|lT%VO16jBIZpN6y|W4Bc?FVi(v>nuae&oLM{r(Z^7ASTGbNewsHqW zYm;#AY5!uZq$&tAX)lLtH)pV26bXilH`{4lkvY)_)$zOvI&9|g)#LNIcj<%sYVX8L zy^reIc5;Y^sS|T1fzX~|#6!;n4bz?p>7I#aLL3(pk>4B=u#oB5oj7zXR-2?vdvwn@ z1o$DqOig&WXBbz|KmPIY3J#A?a@WX?ROP;N877)8lf1euEr?1Bc{?($(Jp%TGf567fxTcbJI5esdxXruYLELIkVb3 zaxW1+j|>9=TljuJlnXyca`Tl4gFvJ6+O3S-D#Y@rb$(RL<>Q`=BssDza84k?${Wrp zH|;h6KND2-4d>iz`9-Yd7t!rSL2=|?^g98gIe{uTw@?%(;PZj(%0EVaMYLCrWss`~ zd@$}E`MAdkZqUw;i6L&GUY7b&p6(|alZ++OQn}rDmfd9hmjAWzrg6nkCB6k^aI>*g zJ!D+fuIg7^GN*Am=VDbw<~dH&U6LS*8pM*IiHKp~Ht8bL)S0NLdEqO}vSiIi*4QYg zdEqSCJcx`(l@f#VtkeoVAs-1UC2!0P*#9@OmFyI;(*udNW0lu>jso$7=$h^PR?xd~rd$=N268lH4FwDpe+cBlbp?_{`EHAC)`)@X)aTX`@`o!6}JMvBj}Yd7UgQ3w?`UDMRPtpH_tmzsv?JDouYxhDqSkD7;@P_!bh|-aeR-41UGvqYVANE!IiW^o{Y&>)h{55XBRb_8isvp4n1z7M$9R< z?ZQ&SDY8L*K^9ZQ6oZ3;awCteig3B`5!q7-{pV|DHL{l*8o-g+Uo1>N)1)LF9|f3PF> z9$L|soY6Xc-j83%b@Tl#eUG&5tF1WRwd8PnH9ObsU)=Py$H#xNOVp-5+Bo-#YDm-K zk-zcZhE5Ve6A8MGF2c(r&@x9Z^^jacZZ4(2NunrIqc4K~xF*uYtcz@7w(|$ry?P(p zqyI)f!wg2QM%*q>#2tySmBKi8WofkRt9r)!pf6Lhlz%kxUC;BL?d&$!_R{@m58m&7 z+f~eXnULW%LLA7{2S>(DqoYT3+%%&I2ox?hH8yN=vXLyB#U!IJBZSHV`JxB%MGrVd zS2BTQR6?N3^ia=86e&`Pxo81#3Q)H!Eg;kqf@?!`(6E~qe3e}VrK&=!!)XO{jVm$? zjSKg(H9Z}itQA9Wq(fuvT0yaE^NlPZaIx|@)Wj2q4i*rTq@Q7**F$VE*K^{Y+^;SS z<<7o*5Y0I8XLMKnFKbV1dG)UgR$P4MXMe%C`lCI zU4HI3>F+zBhqVIli=ZyH3-(0I&No4{EFLRpng?VmGF5AWy6OV z zx!>{qzQ}zGbEgMh$>m;sxTd?V`rga?E?%!RiQC={z_|n!Q<))JFQ34hk|c@@%aM{P zvZ*qXNHFd-Jd?$F?5wB~)v*%NIT;svyi)+VAZGIaAZD`sIjW}BKjg5$DM3?S*s@L6 z2JcWZVxM`5sus^9M$V^_yF<0?bowl3+s(yq?O>~Jz0I!U`@3@uujTY^lAHaIoAr``d0K>ofazi_Q;-o#RwUwMm>wU+^mu{kdL|B22;{J$9kU>*gETYL6q3w9 z@GeCPHH9v67reTw0#!uv$&Tcc9Vv)vBpFqZQV>oHYI>x5sam$4mieiLZf(0^utV57J z#l@}wm2?-C^qPsaHkQdlhfWb)zdPX`qwM~GI01vS3!(tx&Vjg3akKZ~6&rJBcAd-Z z?D;ures3p2FD4IK3xDzW`V(udsT&a9{N$A{l+JE*f~N$-y)t?X*L zf8E!g-8qoE(e>~Y9BazTF6E4Z6&_<%0#zIX1!)u% zq&yUkW~8Vnf*bn>g#ZK}r&Vgm3~I=FN6x2x)RZA=%CcQL(y^MyfttsGYUAKoMzuLd z;HkhveF5@G4*5p)0>2|gQ5{9~X1!fssdM!$!K&=4d}p}b8*Dg1Ko3El8dB4;6KR7$ zV6|BVs+!h2Se8LxwX@w%Bwv%s;i8j$31(`eeB)4cQ@G= z37c%$0)Y}jAS_LXTX0Yej}*(2gzkXDFwRsu5>!U5m9#p5mC?3N8PJN1Q*C^V1o9vT zg*4N#*iLQ7=|DSH${$LVF${wlL_#)x=iI%^(&~tl-E+Qs?wyL;Y@<|@)ZwHCZN1Hkko#GK-G5%YfH`%is?sHH$qFdht+#<+i#1CD$f9%ZISm=uii zqmy1f^a_^ndR*@wcZ|2%H5qCw42lH8Fq|8 zzk^=+4myhZkg@=|s2#nJt|I27;qVzm<>NB-C|=6h-~F6j@pE?FwY?!u=Ilqxxy}l* zUinDJi5{5L3Z31%TBph*5aeXJluqUOrysykCZQDlGhdtMeADunc z`SMdQzk!d&d%wE!^IxOaZY73ad-Q_fRG19e27wvmVHww2THli6+Om7~#epUI$MsEg zFFjAy-TJ%qU64)!^`+#S%?>C}v!5xKInx!qSUINk0E_QN$V z?TXlIR6(CX|3ZSIx zh!F)tYeC=Ylo%K(!(^EoYGn8*>tmzrB2(BWxi~W#Rh(9P)IOD}!(?y&e?=&uCL{g- zj(pc{i=$r1U`Y)~JvvqB9-n}(AeL4EKdr6e3)r%c-Pd3}VZQ=m&<#sD?#ch4@ zPqp=>9_s2NEBoB`E`V@l`kken#{*>L!}8*4zZn*xz3Rrm2-sG*ncJ4#tO-lEp{0@c z3pyKaHx_iC8`kO}#`6+6MSSa1IcVw&L)Bnb=K>-HhLhv<(VXH&b0Q^!v%sv%-EPf> zPVr{ky{piGx}k$p@XA0yp^yrRp2{8Qxd^CwQK^S<9fpq@J~&3+!Rpju^3*h%x_%Xa zbPhQ`^~+m_$fe6g#j8bSF4Q7JFUndpF#+ach^G}$Oys3Om6TDH`pKhZO-Juq<6i&B zY!UcRv&E%?CuxOzL)4eAUd#FHPz7H70Wj(xQlTC~C=db} zOC>;yM{?W>hNYYWBn1P~a>bo3EYlIUS;(Xs!h~yvg}6p^BOo!zE&ICE*B zc5)@ay?L2kVgK`F1k+?lEb?|@vXTot)8xpGnM8DSBr zia~S<`6or7CZ|7LuB!M2BCK2lc&4zj44Y})X%5MSnZURf%rOv5T{te@CJp(LQzVZZ zWRtubEXnVHpDy`YgoQ5?3nt{q2QB3}Q>b7PuL)A_9z;SsN>W_eZSFPCLMYAE=IRig zqs$7_tKZtfI~u-)yN0{ z5#eSq*vL4T+}se_fL%-o=bCN+Nm`aI^0d|IafmZQdVxL`o?vM{j28}?ny#11R@Y@A zyINjPyXGDP8zbPhg$;O?48s<}=s_L$=eA6^?s3$~JW7Xl+Snc@`IBk3mGv-SXwuss z7CIDxi~2h;RWEhnPP4vM0O>Oo95{f z!T;3@>WRE#_`;OO&1$ldO1}1t2{#iCuh_^46%wM_OK1CLb&r5Xr;z^(*o`wYp?g3;GGZj?A z0C!jAAcUhst8(0J^30~33T#9K10}$0@=S4>k)~^8a;g=DZ$w;A3`M}K@yr@9tAu&u zc$uDXMb~?UWKxc>`e9nid8mzrq{rbGUZrH@)mufVnkSV#P%%A|J&2%f(;u)uvA2hqlSy7~T@; zifxJKlbcfCiXA3)qLxyp*3hc%(3({hMN;K!&7pi%Hmzdy^z=merV6zv(yRJ{8;q-x z%~YW#MP9*}knpIAgiBCXlRY)KCgf9Q$SJh@5f7C$E$umP#ik*W^ttVEUr2KN1Xcd-=6(_@jQ7A zKZbuWR{ZgM?-!2_p2c0Ki~lUXiJNh%9~<8-{sppk1T@4H^m-7*@qM16-5&mIl(gAx z(arYesA8D40OTkZuN9TSojVfZR3yZiz5#EM;@`>gQ;;5c1ww=CA_d$ok>Z5wh&b_N zI*H+vj0gRQ2mOc#%OWNCKSfHZS+EhXC8cx-;Q~6$8+HpY zI2^Z3P%tNVSQaE4$H6|aL$*f4^76D>*A%NIke9l;FxX2LH)rq7X6lZRInS-#@m%MX z;_r(4@#DWfQdqO_8^v$35zE;=^w_E5)YLC1KCtJJuU7>TWT0dE+w2PTPZgR?sLa6g zTe3gQl0>|viWoDLnMx)#BRVsh3Cv~lV-4B+S!--rb`4t-Tb(VijhT+@=h)-)E9?M0 zz@A6nqc5U=GhQ{YOOA`oLR&^A0D@>)6Rw$z@+J=CZO_>;FoeIR+ z|DFAe(Nt+peD}Zev+wS`-`D?5{vvl#yUtzrUDpF4lH?jmD-rVK75$KL(GcQVqtUEo zjrscgP+Lt~-9n>NT<+?q>JD{Rch)S6EUR5ZR#&Yxo;MDJ4j6ydKQ;V{j;g?mhJsm` z*bBL)U{=t*dLx-d1k7voytUrYHNshWtUqzuolom*-O{g!$|8X!^pD$2O^CFjkqz&U=(FAik68RHNYU0GG7(l>^@Dt zD*lECe0@OIMWxn+v32&i%a?V7n!B?QpEy^>dCqyRn4$7{ZWA@-{!PJL72!CmsvAZu zT(4;{73X-~8Z)_VmDI4wZMDShOgeC$hJU&Ni7mANam{Bn5*AAJ>CNs~rbvA_+fw4Z ziweLDBO&~I&!+58jvV{#`-QiEIf&ZMQ61PYapU#%Zvy=<7p|hZ|rQ)KT?w z$7iY&v^?Tcy)KvPQf-nuh@$~bwzyqRyN&3Qr1=8=uFZ;;%VBeQ=9~PLU-aiEWGx#Q0dP&Ty(T zoa$w{)Bj(&vwUqfscU_`>^`R6Eh=_rMY;1|(~F2UgKSCllF11;$fg0<2vEMqF(pZM zI^Uy8n5=x!z>tTKl9R=pnpK^%T<%#kLZE&#!#W^|1pHYSWED5O9l21}S?h&&4ZO?Y zqboQh`F%iyoU+dE=a34i1J#Jy#3UIGMW1u7P~`p%X7N?|kqoFK##)A?-ZF@C=FiR!kR zxv_bPrF@sQr+QiaUXP;=BC?r$VyuX>!eB*$6?G=Aii3+qoD~KuVDOi@d9samW)3+-->^sz*&MmRc@!kABWv_joy5G4g_Wk%P z_CxBSs&Fy>=2B6^9W(-x(SQt&YY4c7X;TfZ52VMQ+8*2+#KE{`PlXe46ek*?LT{rO zC*hP74r{y_oss~NJXOr%E{|wWn;tLz1#_u*%wbnZG*lf9idKujV+)GMYT=xPgoCL- zj&kT_$R6VwmqN5FFdGUdilBDXi#DQz$bv@EV9u5bM?9WKJLrW8rL>(M(OZEhSRjEu z+$rmWRG|+N1ItLKWN;0rfyPdU19vpg=P@bV5SSLV{f}dbcB%v;U|4QsxM}A@zvX5M z;HE@ZO+Ec46$<~%!-faEmZBPhF| zb^MGKp0NGsWx3v4l+ra^T^7-x#aOc=3*VN7ps zX~_VA!O+0CELC2gCiqM~Q+qRdPT8M2yYty!EN$;;Ev#Fz=IQU={_(M|c9Svn_#1;q zvoq1<BG+zQ2fz`wiX*Q*h_m@eVCkXZyq3Q~^}Lv4%}~N#!4sTl;jy`5ys59# zX2V)VUD4^$s;CQl3f02CLXg;xAHVwrox7vZ&(*@*c~PtB{<5Ji7nY0XL_woO(L7bn z%|fdq0bGXxMV2W${&`{jYDfD5nlRi79 z6bn#m!}*AYB3iqKd$o<)fW~WI+a-*2+Kq^eWO{cp+?{N?r_9__X55j>?kNlO5;Aj7 zx$K^DzN)pW(mj)T%A!S1=+P>>h4I;Dn~V4j}tYe)0XG-<2$S@c^Uf>hU6~A^nMQ%BO~G6&O;96O&&TDot;yDF+biys4%$xJZrPNGt=)zN ztcbYiFQ+7AQy@}c_&QDNS@^arNfD8FMUikoK1{qA6A3PLGa_@M)F+}oEK>L=_1Sh2 z4TuLtI7TRE$GQ6KQy9IBe~K}tXIv4|PH+?HB?rlAa*Gf$ieDU7dLeW9fr|atKtAbP zcY+o}$_n_$_1TZ?AybkNsP;_J=?*O%RF*Cr^e*Whgw@TpcP}5}Q~=?>h9ozlJJAb7 z_~%UX)di#LVRXxqZiraiziF3~wsKA)wY$!W%DF0IvvW=7u~g;Cd`oIp8N4Ce;djsuc!oo4f#*DW3l? z;nf-&#dU?}-a9ipk2|yT@OWp|#_VFSy}JYhUSkhz>LHNuhzurR^Jup40}4*uR^(Bn zCY7Q{#T7JyszQw#HTe;#Y95f_2i_JbLaEgXMQxN+YVnV{YLo&>KxtJgD%88~xwEsj zDUm9B&ON^48J#=leCK?hQ1gS1fehDTW~>(1=hnfjTIX)#wwT+jE$%*Uues0K>l!ah zFUPUzy6!{$Mrb3Z(qW*amviz$o^BR4(?^{>!XEl{=df^?KIuFoJVT#z;(|j7hb$nm zaU6d0o}RF56Co*K)z?ILLBL`Rs!xITBWrp*PU~#Ta_SSV>y+jSqXOrq*h(#vt-%3D zl2e?3aSA~nMw}~1Qj_D>IgV>lS#EMHa4nO@<0-?eGYr#`spL9B+%%vWLr4N~jd)y^ zp$s4<*Ro8Llah%<(%2}YU0e#j*e=e2E8qmQ>ryI(5c0edI(@M!9*Rk?x14m#<)l}3 zcRYM#^YwYfU_?JmEWr89+U5Jhy{mG=-w&(&z6Hv1ST`mo!4xKI-eLn~9)~hF7lFc3 zTCH3aUV(=0*zYG3m|0(I}*c52SZ8? zD|QttwgrpbftpcEs~AJ*)yi|f`|I*#w}KL%eY~@|@qz2VseJo#<%8B(qONikdU?-J z&waj}OqY|DTmL#eMlRfagfIRmb!5wbUXMEZHb9n5_JvAAU;A= zA8lImn^Fx}V*`RX51rawZ9z@gZf#S(Phtew0U($js#kHw%Glkgi*!rfa<{f#@3gvX z#j;aYI&U$f!%QB9Rf|?RS|v8Chrr?4e-UO*pc5)?;WM!|HLJH+>-hE3dX>F#tF(tN zN{_1t^gY&5bcBCGdQu(Kk66$0-;J%U_lL%wLnH^gmfQ z_?yyA{kpYM1P&dT)C8Vh&#Wpj3k~z%qs)mgt5VLXGhD?K`$a~vbmkc%hcy^67~lyd z%<2`&q6*I=9kJ)iu(~x0kre)hIqz!8-p|+wT(ZIH>*mjDOVMNOWYg&qu zI!XzQ7eX+$HH}hEYIl$WNK4UxV(4QBCsN8;<%&X-5-N=!j3!AbP{gso=rcYvhyni; zC@IdXbKXz0Ns`+!!|+#h|L)x`-Y$X@La=xb28V@v;Ks4j_T7cW(WP3{lJ z0~;P(aUK(!9tSX~bJKz9`DmHv>u!S&Dr0)2!MCdm51;W;gD)*>@FDkCMjCyM&B~>X zz8y6B1TIalPZVscKJlO=gGYGqRCqX8Wx+cwU!_aZ4@g36 zcP~m8!*)M9{=dScVM2qZE5p|e#~dTI9cW?B)le(rt_r<@l-) z=`~K}ES|;hRetzvPv2hjgL3ce9jrdk+1FG-fL1Z$Ulbn-`Ijn0^oD}7NCaq$L_kD| zR52P~RGgoN=pI&fw>B?%Afg-Xh@Z_a;%9dkDai${7LVYr*2D|_KjLL#K$6!Jegov~ z#;BEGn7t9`;P4(8!VKKHHtL3Oz7}i%hi?O80g9!p(ysHz&@u6tIxX@HAEFeKMNt-s ztWe3u zTBrbi!K_ZI;Z?bu1nf&-fC;@}9cGUK=FxW(Fhv>{rpTB?Wy=2=+Ao=#K_LxWvl>8C z1hfRQ3^0-40$@yE^n6yHUs<%#uo*$BSR!i!Wk>~quu!p<-<}Hxj=4~^Cf-o~;1){v zJ^au&P~#`%3H&Y6TY2R9=bt`{-kBXO|Ac9S45-_8S#6@-RgSiZ&&xG7rBt1f0ZV6S zjcaCpE7~G$m5Cy$a>SJbopQQ{)Fuk#q)CMCST6LGC!@}ody9wsA;ilHFDXjPl61aJ zL3coEr4SFagjd?s#ynz%RnI7_JgXv`?ZP8MQ%uCF(gZzGxs1jkavoCKz{OTe0TAr% zv`0m1Qb(L1?&3U+=~|#3y))391IyeOs+xQT0WKjTbWJqKQ$*qN7)%;8rQ~kk!4{tD`id2dRj7@(Xv@zTjz8&tj})C7PVsb32iWYX!R-WWaek} zuO#2loHiJlW2!3lw=xRiG4B`Nn{Ai8%Wae1hixA_e`%98*Q2J=+zc=pD)w6zvjSzd zlM$<(%v+jR>gHBv^FHsd+{SNRIUw!NeN!6DeU}c?tMra`Cuer$p-hbS<@vj#{B_Eq0iVru(c1J7=*(&}P zGP7E&vv}!&71|0ieRPpahHsB@!MmNdf~K3M~4~ta2uSXuv0Wdv@_;cpqXjXR@O=Q zbUGMR9yq~I>|6_bT`lr;Eas({X<8Ac1F+2~lr86ZsY}Pt3t=O#wPMOAVzBGd0 zO5+u?A7Xkvn)>$Kd<}4BV?6->;Qa}K#KTKRw%sDFtsQ{wprWQkf!bqh70DMUV}=$G zICQe6bR*h5)?VPI`jkvv1sB!GxXNliVj`RMS)`Xv{7pyuk*5!}IYVFl>C74~+x*i_ z2jAVe>7f7A;MZ?1eDi}BhHedA{Uv?tZ1d|E{&wm71@N#%!=LlL;2Q~Ug6{S_tA= z3mUGqz_R|r<@2~Sz1q1#9lpVMo!O;9YFjhHGt8yorDjXG#oWW~;eRgg*Y+oZC30MB z<(}hP{TqWDVCUbc(COV_=AJ<}k?SFtid3tw*e=C*DyH?PyWF$L6ESivqQUCV>+ae1IV00|e&E zxWMdoAy`ZwVRBja9F}mSFdR|pLi^mM z9Vx%{hwh>Ow12Vl_t)%0@hy+ql4r@+v6h zEFkw&P)Z$?GR&0nWs&pARdQDTj_j|G)LV~o-xHTamRhU0XZt-yv1HdY`JQ{};DpUaiu!OFGqbM{m)$ z>Y%HbDz3WfA(StjRWPWtdH@qkXKD+hU%{=wgsvbHaDJ0Xtd3fSXz8cD*@3XW81g6! zd6b1*%8utlNkJ=)37RXa-^!mAE()It!-5a#TPW~C1xsO87zh<^YBM5PaV8`fk@1S` zqER{tOa*UZ+x@w zZOZ?6@pMkPGm8s-_`#pgcYk;ey?HKpa|LK+6o@n2zQrb1lxyY-{z7T9w31)rUthXX zDv4tC$CerbX9-5-79OiZAN%h_1`@u>p{eo7*7VT)#B^(M=*jpJYene!#0qP3U~_bU z8;EJdpsH+|i;NaygTWh?x=Y)uahm2UvqXWM;tpW0dM?)Gu&vfWb9RS8$4nrs?;cgA zM-_{2du62Q$WW4Y;Eu`22+mK&A{%#1#)pQI1RMn*!-fw4nmRG!=$T_8*Ix_EF%#jT3}TqZEG)c$_cZmt>6a!+G5Z}E)nP* zeVT!c$!j&D)oNUr*F;~qC~smJlQ*#_Z=uGgmKSQ$dZwn(HcH|&lBpwlL>Oxza&&Bp zm6!bTQxk5U{9@=9ja<7z6?*q`@sHb{d1J7fTO4f2?|k`vnm6}#P#bELARRyS_o4r4 zV-B5KO?PjfvHCse8c7&1-0J^`m~=VguOd=P)p$+3HtxhX#PJR9L4rsGi6rB3gjAv^kqN9-Vxq*#wFvGkaho|7{F7CJ z5Zvix-PpcZ{0u!s#*zUll2|%DFj^y^anSm6T8;@tZ@RZYnwoOC-2dpV{@5n2JAUu( zy?6KSY@g3Q`@)h>S1sJwzH#Aq z)JNJMS-7RRw|K7ea{EX5e|1_;nx-b@@!Eoxq$-k5yiHmna?V~sXc%?nAumo^T1~(Mvswh8H6fWcl7jhad+sZiY2&dsT??zXZF zuJtF^c-WtWK?%jVRso5*#8u`JUn^W!1|b+h8iFQGE0UCKAtK4cjz>BGo!Ab$PE*MR zLOYWFRO-ii&?rz4pq%5R9e>X31PPIS-*T3fEL+T~$&h(%`?axj<*uPanHbtV_U`m| z&%XHPo@0-`JNnxXjvgEO{wuHUdHR)2%^TdMTOaNodjVD6dkLY#FYUec`1R9I|590W zcIwpc-+JdQt|td2Nx2Le%0|EAJbhhCLw~27vI29N7vtOH;$_Mz}XcR zvK4|PvxTU(p-1k>Gm#LhB0;wCI;#%iJj7G93s)2$@AYp}l5=bB_ zWM4CMNmmFc*OJnb34~8oH|D15zp$vPJclGoDAuX! z5($ssQ9OpH@I_3g@HCbs+=kD<5ym{5bE@G6)v%x%*7+-7VVXEFO#rh(Ljm0KbWS_G zPP?0MJHZvXJN8~Ji2TFq?r zDkd)ZGA@w=gg6=@D#kJg?hA2jop6)Z@xMD_S&r=chL9B zb*Q7EBt#W?@m3^7Gq8}BYaxtp&$EpeF5LpBL~^H9`Y=<>=zqvHs;~&BIfc+r z8{Ee!|D9Y3Ms;l+T<*YZlKH87_=_a+G4dG|VQT7h~BmN7$M6am- zqn~K0gsu}s!7`;PV;USVO>?7W5eI96IH{N8tv1deZ5D#SXFirf~?&utp}xs_V?}) zb|m;I34TgKDWrrjrG&5|O;}M=B>H~)>TO|W3S!nHbb-%L*9rq`uYO#(3N93fKM;+I z<@6jRiwk%t{x+RV}Vua$6m>Sl^c2<4Fq3W$DjW%hA&>iq1>KOiS>y@|$Vch78w8_goSEe6PIA6C0O)h6CQ^bfI7Ul&_tr5@BD2k8It`%VI4r^VcQ! z_-ltNR?mgZXObKlAr}Z<48QyhV(*5Gq%eKEp zPTuINr(8N8=CQo;Jzkj=N2Fv(%)(<(B806FZVl~lO9*E}xH*LR^+EAkLO2`3%^@6_ zn{D7|2**O$4B=#GT#JWrB806FPKE+{IIJf^*b3n&h%qmYHdzOtvw!v08qu?4 zZLn&*sF{FHRmH+ombFFM_yeJh*2$jVbH40CyU2=vzB}J@exA?s{e8cnsw7l|B^Wad zK^4XfNWzlmL`9zc#Y7DnqOd?8rs!%4M4BNYUG*7}CMJT?D#_u~{>oOk zSMZYvVd5{Fx}B^UK)d@MHWkF#ts*&8u^l9V)s`yCO~iC;$BMpiA$EaS@0C%k>4?}5 z({4z9U&=43VdQlOtbl=tEf#S092XIOiA_4_YX~x|epjcr z>4){x`k>D03_T~HS?p;Rjhf}VG@{V=`&HG{-_MV(!b8zjwMAF9qQ`>;FMgc6c!np0 zy(y^NZ?**oGtAy2ady%P{0Asv69I`fKl;Bst8uDJa0t90w7w2$qV4ie5 zDQuA1nJtbjLc1gcBP_3Ch4e4BHyyu)7^y257L=kt87=@)VS*cv(;uuBu5>ucE0v>n z`(ZIjLF_gZu&AUU-V;_-PS)gR@rdFTKE^ZrTX;+|&eC%Pa;X_tZT;hw0SaLRDLu+imgB=Hjv-|U27d{U7H-6TrAi;B2;HYb%2@K-!6)5 z5Es4eEJ4W(O3Hl95f$)rI3iI#KZ#64ke2p*`{MgZd*RM&!(*er>g|5Dw{LHEFYQC= zeY?i~R=#@Y8z_q0S1w=q^To@T@K5R+7{a%b2bDU!YhL-!|R+Iq*AaHZgXyxT9uCA*6?8Ln*XMLGjuI_+kZQH zD>fd}5^SAP7nsX7D37u$mG#Qs#XD7Fim1wr7KuQk)grP;$;Kq03>#3!1W=KpksK0` zA{2xcVUNJZ2v#wI7>;2h1rgv9^vdT4RzCYD;fn+{z)FB!;(>(~x{z-UJ;!U&;Y^xtjZc@<6OHeV#(nm z1I+Y^E|$;N)r08xtRAKX{4~ZTl~x%WFx@>32fp&Hp|+jFFRXukhI)M0?l(_#?Km^m z>Nx+M#~=Uh_#4N@K6&l2hVmy&&(#Z;Z(P3g7fj8Hu~z05rbeM6=(mKLc9E{5Gx`F$ zk$zs{@`1e3XzY(3jyiI_TsR+H>RTFK>suRs*7t03#hJ?IU9({3-20tlJ-oh`h}CBP>QGD9@oL(L&j1p(bca7O5IV z8S)^-Q}DES_ITK6LBxv`CA@gN&|Eyw--sl6I9N=NM$Qo<1qY8^ zr~RIByMiG-IID5myFo{oeu}1*EE4pRv*aoXC9x!x+-=S_SDVl#wn=U7{#1Y3lTIbm z$*J>_>xFgV=G5leu0&UIPxAZ1kE8>&ho&8z)g$~&I+pIK?Mq!uX|-0Ei(5s)Dw0+~ zu7L%OTSdYul2%bQF#gwqH(I~mnXZupHWW(*SaC*GXn;Ohh#S*@lWHSxtTr|pr;K+D z&SO*?&l$r8TW!2<(8hU;Q2-Nul0q0jKU}V$0-_Z(glGyWh{l>f*yq=Bh!85PIfQ1E zs@kjQsz`um;W6M#xELWULQ(Jmi)>_uSRF#4q*3tcxh#A=3-V;>=6{e0Lj#96_GEzU3K^YhtZj%9RgL`Kzk;BEuWF|9j zS&QCR%!J6ZOi5>QE!n{=ozL#c(pd!|l%#Ys9g^)6GnWB(WhmeYp*RN*8LP;nR*WS* zq)~dv5Ann*n)?7EB(7v4wGxq8&Qwda=!p+g2y!V+8MDD?;l_#e(2_>bMeH-`Mz=Q+ zLr)HN)?vN0Maof}CE>#SXs5S+Ch50$Uzf=n-p%-hH+9hT`i1oLXu{$DFWpre8^v*k zXJ$WV_H*`*JNwSYhwZZuALS@_#<+3nMI?g61@l!G6I`LDF(Pq+lBz&s8cvz0uNAzf=wq_fn%akyub4=)VPFM#<&7 zv%Hh%d1o#!=)EHr=Ihp$)}^Gqu%aU*dq_2byNJfYZNwLnP%E}{pLU*qX81sR`qd9! z?_IUB?Ul`k-rdGW&8K$_KN*YVl1G2{THme@4t?|qez5MTeNQ~}U{g(c`6EZxuQ`}$ z$gX{6XU(SVn>w26>LaW^Zjr54rI0x{TS*^ARjgOV zT2-u8#SFGjQ%ivg%r!%BxE3R9S`14l=F+UgKs8E+<2Is3Z2b@U#zNRMf_yXaoTfia zAKszu)edVv(PRYn;SFt6yQp2#R86Qu!4_Jm4ujycqF@b85J^DGA_!PI^rWFN5n>Y} zwd7Ai1E!rPPof&UVr;OQLtv>v(A^3hr+ZzH^{wu%nJz)rJfC+z1RGFx2gxxB^xX2| zkYoVANy~jYgh6p|o6&%~nJOTVU%ot7G6LziSk#tw-UQ6u0W8zRqXG}aO?<8ETSH5Z z9vwe(CX&r8{N)Mvt53X19)A&QL$fcvIP>bdB?-YZKLVbamRq3PXT{1*q6ADjT@Wvj zR3uh##87L!XdxTH&3Yte;z-N@n&vS7C?5kIR?=IrYOyL!7ON0OU0*C+6Ze6p6TX<~ zcqS-4F~{+9b2oiMOmaNn=(r$dL&)cNR7`YSaJV66Hg1aPhU>e&C8m5XjxWY>e0@Sd zBvx2a7){(xkiCgF5~GQ^gq$$TpfJmzFhk`q-e;z1ML1B5Xo_B<(^RHq;Xo_Gfd-wT zOmv8fR|k55643!lM7QYr+BF-h)*5n8VEIH2f@A&@iU_gr-Cd!02+~YKc5TbCh^pzT zuIQ5L%4QN-I!_`538Ag+2xvJ0iy}x13GCpq2|z|n4PekML>xe1QF{P^Rscbs!)_PZ zV1nhC#*HsOQ2cpu?RR?HpC&(@8Gq@^Yc_8F@iEeQ?<$}Gpdj4< z6fp9*K*0srrlrL!_7R~otdhL`w6ffKIffQMJ(U)Bs^>!zy*A}un}Tg2w3e8qc~$MhHIFVJ!N3VR#9$=*e0wK4V~`UAU)K4v%3 zKiEBVhb@8Ouo@I&8Pvi$STFJ!ReUd2Pyoh-F*O)Fh4F}?BVkE>N8pH|fbYayh`PWc zidhM2iK3VWASQP$3v&at zMkR!moQcgw-S>TZm=bypC(roGVTC9V`7}j*+-Q9I7Xjy6iQ1WgnSn&jt?L6q=nAdd z-6goJ8`9Q@vNSt#=>3tUHR99{@)y|ay8~5l&!T~TT#l0yO1RbmW(8#}!ud!nzM>a<}tX{}Aq+6C0EeMNu3en?uQ`r10Z$5`#G;g5QcIh(wv zv~TM>y@ToxwD0MY>Un3v`;U5$W(=M|8LQRKIIUhTx)ODG`}ODa2k-ptRLc9*fc|rIjSJ9oa)%*YvdJq-`&a zkgZ7;Hq+L*xhsB$pfL-wLz@V&g`*Lb8N7vM`4)K-+s=phFn@tF&Sc0HVmZQvnV;%` z!1U&_ci<zXD~o98&Tjac-q zYvCQ%UhA+W0h&+xEY-{K9`-CF>>T;JPkTAu!=L4Ziz~xb@D61!BtHp~-^nxhZshJ@ zU@B_Y-5D6D0aE}!kpu^7{#nUugK}hDbwa%V1gIRb-S;)y?GlHG#nCg` zuz8fM9`!eD+gh|zW{O;xn+8KU4g3F65iN649zYeZEPeWWMhlhplaK)}jcLnpP`_w% z&uD(*w(6VHV_GV_>A}r~)i>eaC%|&S3xR1aoz|9#*PKQx$@%d0l{Z!%k5@m==cdP5 zN=_khA2L5)y*>ET%M)HFS^@{;fU!s?47$H0i1rCK5N>P$5A@&fcK+W-&_louk+`6U zCaG1zJ+tqeKh-VgPfea^e{kZrv&DB#E&eOe#m}zuKat%t$NxM<2Jc-Z!)LzuNT^x| z^vu73Ib4zr^^7&2iQNi&(D_OUDys#`0tXwaOsGm!3$}t&6L`~HHrNe39tac1!%kyu zrz(WWhT6_;|K+;cW1G6p_<3Ak-}kw`e#DM%z;;LoyR?qtJY-^;TV4Yu2(-Mi&23Su zP0%!1R?5a>3EfIj2c@ikbg*hF>^(FIK?s*gTlV>`ufKD?^WER?`+kSLCcGvcGQPvk`_7B!{l8%{b0gVW8kEC&t=Wd>sn6s6 zs+6|Y3qAfGb%XJ3d{8;4o+btDiu#uEw)sANSN@&;NAs3qRavcS$O^Ei4r*BBW!2yo z6A{soq7Wb_@5lf_$S5D;?iWOn`XyP$qA2?W3dbY{8dJxN=_Z^hK)0$?GZm2$rkIz} zWto@_NDd(+Q=(tivEHE3kfu>ZmMJBosRP%L(rsaDnLenc6t+>62VDgu!)aGsCGHZb zSRe~sBS8mAsvAmmp(3z;Ng0jge$2m=n{}4nHnxkI=}+hVTNBQANtexAGGH-48K?Y7T$a9{dwiT zktSRo|8(<$%*SP|^bTI$Q_geDCCjVn9l%^I`4z|9Fg&%%z8cahM!0H3ss;mz@{6ek zUuoG!^{!quw5k7V6`f*K4ZUjc15S0SDOhWtfOVY`VpOGej9H>823?CKR98z>;2ldl zwbyE+qqQ-U4;<@7uf@iPnT;9G`?GeoDYT9qQ>d%EfT2WFbF0a}{F-b<^r$skovqE* z+qHJR%{UZLo2;hb(nych6YL3ZvNi=bg|~@Y^=*Oeq3z+_`ZojntbM_kLI;(fsOQYH zfuD!|uKYFhU%h0GhbHV9RxoN93)WVs5DBVwTwsgX3yiYZ)F!+r;Q{6=1n6K)GoibH z7LJ92!3IkS!3EQxeKe>_NL7`fWoeo!@(GY_+9YkiX%o9Zx<(je#0?e58dvSIT#Gzz zy=f7vfES!%IE5C+6@JUhnVZm>wQh~B(k3(l4`9J?nn8w0*U5NdC$thsVQF9tdPo#l zU>2k1*v*)EGe1zQjhaQz0^}8^sUQIbV2nCOg$sK;;6tA*j;xaE$Qn>4M#9-ZDx9sr9||z2^9ug&)96n8c#IZk##MS_j46tjO;4kD zIlzYCY<`mL;O}X@4w3*)n?s?_xw)k^fkvNNe&)h8CpFXg^T~4W!?T)qu4^rS@uz0f ztoYNcPG~9}dhYq1TglTOUpcm*=TXj*CaBC;fh7jM6l|2 zD<#xbbaLjcu3YI>fQzomS&no{)h*9 zaNdKE1Z9-*Bvgjmr{h^!ip1x0b$p_R|MZcoM6x6VpW4WDfrWYE!wLxb0&O1YLNiX2T2fT^X07uPl{)+gJNVeD_uB*RVQ2hVOOchjdzzwF<(8UN!|Dv7UtrS#Yi z`E@|ax$%^b;rOyJyi%d7og|7eh7a6NfISVx~j5j4bSccCZR)2ztWNI)TtQ z0ZQhEYp5Xf&4heaLsvryS|A%-D8*VWL=vkR*yk;rGwmT0R?tbHu+%v^)cYr)F`qlc@I%{R;)m*#1xdTm1pzk3h-1g5Ujht85k6y-W@MhHH znjnGjZ`oZ&((C|~X;LWDlS>_p*%^{Va}emSe14z}W>`LPTd;i>V1`ALGoXJ1h~ut7 z(w$wMq|-)A9fCX0kkq8xKpS6oRk@!Qg@?dviRbkJx`;xk<2bf?7p@J3#I-Z+v`tJK z|I41>W3xSEQyY5q!BadATdD@}WyhQGGZ4oNFOH>^IQ~J|AA(msoJ2^?4JVA9=a+-8X^5b0@>mWS+PBr2qc65t``+2$m9@&Jux`F(K-dUuE4z5cO2&i9}1ZqGglg@Z#%Y-xVnSbugIpN+YykPy6z@UgQ z3WABD9p3s6%0!~5kBrkk29KW^~BREQk z>1a|Vny8(|A)1Ua)=x~vj5zfRCnS@MIL$~kCE9jKlg?Dlh?y9rI1O>?$GZL9ySs>( zf7*rLocr#3@7#NT=XdWpk2OhiyGZ*J7=LS@yxezZ$(`FDAQ04xY%_#96?ayeqh>$E zVsNI%`jL@@u4}Qe{+KqFcm#yPe5m>9bKBQH%1H<1U!){=^&~uuxdvimOw-U!q+=7b zC3TkLPaWNP@o5qCcCvGw?4MtBsvm?Hy3J1OOOg6C8m(sFWMhdZ8L5z4qJDIxj8S)u z>sy?W@?1VlQVTL18ghZIH?Y&2HldH$X_J%}pYmdtUX&B%!{x6*aC7eU5C;z?DF=vT zh4urlM$WKO0^L+T=Iu&6n8J=|v6Jlx|pMS{&~CCz!mq21sPJ7+e(o&0vz#-;^w+)Kr3(Ihm% z+(jP0!*26CosK|4Qodt36Gf(XIpNX<}*f3e~dd(Yq3Em@Rg zA_L1dY9z^GuqSHorL&*O`g$;{=)_*}xNUZ#0HZ;4%0t5=EFz!Ox|FwF?prA z(B#}?CgL0k>jSKRG1MPJ6~uccABkOf+L5SHRQ^)`-d2-DIFZcen@u%tw#sq> zjoSg2&4yY%Syk+N_3!^GWf(4n)i2cAk#PAJ=UxHh&je{zFuxt`=n9x~h`vrBEL!?Hou;C9Ml<5bj>EOG359LpJ% zmsXxWA#G;bfy_@buV$KDLmjX!kVXuzvP_@T6{mR}m=V`UWm|2!VT$3yyy82vjqg2T z)$MI8CE&8!N;qRF-W+eaSMyF8cAU?r6qZ7nunzL^`2lNImIG4JVjLOXkNLASoFxa` z@xBL3va)>7k1}+d-KU%4bG?mCIGSCxNV0R?9~M4rUr(?{@+50?9IC-!UrjlZG;a3= z!zV)cU`Pm~c>S2{-?%b)P4&Qd&ZV0lc7vxu?sB#C1Mg#{0(c%a^w z3dVPU60(Af~_gG z*lzS`LwVNp)R#SrOM`Jiy{NeAY>F>Cw=`$GbJ_DRRnDAT^kV6V6*9x3N}%0eoKAn* z>HpF6nk0YC7c;V?{qnW$t2Yk@f8`=`Ixb`IynF)?Wp}31qb|C6@a9UF>KXWp+hU1y z@#20Q;(w>7^ahFto)F3OYhxD8X6vb%@26KJv}6kC2j~SnyC2u%U_X}c;`vJ8Jm3dr z0ZEa*DZqT7LSEz9kL0`Xu}u0=wt=e66k2M`3I#FV7Ndin19qa_tY4%LEXA}0*YDxI z<2q5Hd}*``L3S#70V#7Os&ikcOO||xC*^Mhq<#Zui5t$+OlP2 z2or1eUL(%?01SL#3}3^(N9T6Lt7=$5c95sGakd0`+yI^mH)5QrR#4kd!(&+jojt+! z*oa`8CVlGh<(SjCgz>O)0DilG3kJxdYYENlh*l(j>obEL`zmV5g_3Ro@*C-m7pz4p z8rx1G5K9<#Y7V+$e@?TcP_UGhj1>>(U_ZO|3XJw^ZnkRpt9%w)7@I%utrSwgf z(UY09*|mNC(202%GL=*;#nKWARx-E%iF?5odP%Iq6IRPcKj_4Qy097*;}S;_<0KD~;1pmY{DitXiR0 zoI9_ACv{%5xWD#&je-@29fiVy@>dc`<+%bH4>!m}UvZBpBYr{s&L0$o`!(z*%SZ^U zR_zb4-SS$>XTWKa4ZRHXjdxG&n50~1c@N>nbL4^yF^QTgIxo;%2)F?mP z8P^8ygWhLW1l2Yh;y3Y|8Jt1tyhhb}XW!4Pp7FYBS;opzm402i;2G+GnJ^ith7OQT zq5kEf^d+^=)8sk!XwovToL@Ynb>=SFBe~+Z4{vY3G|gPNvY25~`)+*HR#e_*KMSYZY!vhdcuqPz? zgM1;XrG@;icOfg`FE7xLC|z}}J}sZkgx?FR7e9vWnr14^?F$n0i3`Mx%c=8TGe`t` z{Z++{1^*r5`NpIncvt<*7Y;>0NhBCC-o#)$Z<6W8Q(2d2 zRDI1L^D=@yVZ4j9GQJ6od1l|(_H9b+i&uRS`GoP`0wnry#|`bv#l&mNpZZA=HQcKnU8UneRMFjxU|vv}ALtB)2Im6c4Jn!t zLkv{(OXov$-R{E7b5rNstmO&xPEXcE&8tz@?qzGZLrf>Lu?8t*SCMXbaVisX9BhrOTzkjNVOc`LU zOH4RX?1CM~e-dRi2;DEV%)M^8R2b@2rc9uNk69;sl@_4H-A4C~gt-Qluj=Yh4 z-DlA^DbuHCe@FPK##nqd4a)U6AUz%8%1H`LVMnC+T{FQSS z*jsVQ`q^MN)pp%ATVdUIWI%3};uCnZ3ucbFTYSHvNO2_nZ*>I%E*nBjn^DzVjO_ z;cv_(|D0~v>`=6y{fW#2;{mUT@**d}@} z5_KEmX>>tBXjdl{K9W*-Ly)kAo7X|}Sn1q=hp^7v{JD;717?q+cG9ujYp1pLo{Ge! z=Ag@}ZW6rKN2q@gwrUI|`4Y5FG){f!ydXxF-vi(5hinC!kv+&dpqljR9`?q*a#TEOGFVqvk*>}~H5Ny0?Xwut&<1bM@gxcafm!nH=o zUPtRtA~JM`ASV(cw#(mRo3t1Qh%=IokxdEWxf)$S%vNJT2Id#E-OWDAnmvhkFVEw7 zuT>$h^zpkj=>Vp({gRmd40!Rm3JHSr>^BLV4*rcd`Sp9eu|v73Z9A^>z$jEWxd} z8M3w<6}R;RGyrS3BV(+&VSJ@ZfinMy5uf|)15x<~tfxRG7h{+2&n{61xfy0;%Ito-)xv>vLN&?QPP-8wTTtvxn3qpxfyv@)f=d&nlr-rG0_hBrpxBzHIw z*{MxK03jCllpVK5yB#V64n0pf?IvqPr@gm{SR(7sDs4n{#qQ#-#o3hmP@y?Q%hg{= zhwI%K^-};Kkn|4o0V{WcB<%AOR#L9g{fF}@ket|-E-l9$s!BPMF7)pbodUUc>`8u7 zg1?207nHEe4u^B>+h!h?HbW27&jQCPo}2+on9x<%H0qqj4!ZPvhS0K#6aAVc$8+-T zK@{O+$*s29aA%<{7au20HiAwA=7XD@*u$8^7(W_xwX-dR4C0Qx?j#fR_Cf0qqAatv zW9bn}dXa`i6N9v-#$DdLRh2xz$qQ0=>O5fT{1y=2>-=aYaY*P?8|5*l zXoh}~GWe;i;7AnC;yH0d$3Vt3Cd{Z4(9XTUhG)|rfs=wA?Ky1_NNKgn?YuF-^BR-X zv89*X9RND#hJ=eNr5w8T4LUd$iVS*Ww!wx59lXuWb&Cm0M^cLGyma=f;{>Ox!o-f%2YXeHItWPlu}N+Ag{6{J{q7>f?Xio_nt^C zCgAauCp7*z< z4g3Cf(8C7&g^rbR=jB5dn;*&f=N+o;R_V!+C(#h4vB5_;;W=Hr{`F@VB%MFbt8wf; z;3AZXWhcE6eezI)?s3w*L5D#wSy(#=Ik}|A*J--)t?7(Pm6Ef^(EFp4OXTLy6*|B9 zz?!zKde$}lDf1X_^*c}gAxVc4^>^{6o!ri^7K=LaY& z#)CbVu#a<5AszT!TxmN>HBrKDjLnPVT3a}v>5BG2#8l2MDn?A*GKqlk z$#hj+`fP=vXMdW)Qs!6+c+}{gSMi`yCB-fxex6q_6B)YDCH{ZIX)(EepJEB{>o zYw}N#1fC7O_oORp?@Ni*R!+0WQA~kEw+NN+%2IlrXufwL4!(F7BJn?-N6x_ym6?oY z%fRCfw#(_doZBtYNu`YdXDzEhZjf4_Pg07BGPWFyFCgZx4#TvqK2v&|e5^k_U($@T&!L8uO21pU8brSoziNQu@x1Wb4LV zh57)v0&8{P*s;3BXs{w8GO?EdOcUCGx^C6f4#|{F9-lBu*16!;Cn$#CnZEj==AS^96Lv?u2Jmj{0sOWG6*i@{u$@^#2&G|)`vniUQJucrh_U-I)dC5>O!%< zKQuSA2Mdeg+hMDf(SjAv3s@>ny2ByUtD`9g8jEb@qGht_!qXHVUF5LRn$I|ZbAhoQhQHWTf;6n_1f1A%} z=uf`_GJC$<@4q?*cIpE}SSC6$+jA2}jb?_NQA~faT#?+qYq22Ank3+6_%UZ}d%H+Vf`usL^B8gtlqN@&V`u1cD%^Q3E*&RWpElDygUpz-Dxbml=zp7URWmd{7`%C~JA14I~`e|DaG;G81b3XX>(JA&L@dc?f1-r4q8WphfKynDY>t1Kq%O{=eu#L-k`XLc2< zV*{REXp_wdEtV5!v=DEkyRo;%b{8(p;N5PVvHk z)d+PKTSo~f5oM65C+^}^CU+L-IKRP3A<4tTHKU=-&)n>5_yqp|X#ccX$IhEeFV0^) zYPO;w$Zq3j$KVsbs#vnr-mlVh5{RpZUy?C#o7FCSdc&!ZR$ahp&C;AY+5saIICD>B9 z(om0HXw7aVmfQvV3dl`a$1RN-W`ugob11s&3#4|HwR^WQ7bf7B0}dMTyCOwU9;n8L z-i*~@>rTXsxvB~xEVE-<_(RNcAILSpm0M}w!DtQ4FzYb>MoPUb2=9`hqp3=zv?OJu z6n{?)&y99T)zb;~5ANcq*P~y3hA;znzhCdACE1&%&_*H9V=VhS84a(9p$ZSqxEZ9I z?SUW^%Px#}e{|-o#~bGvvopo`oK*Wh^jJTQHAYtDww{wowUZ{xaq8I5r&$WJ$8-YqCvUSZ1eEt(f01iQ z5@Z)?dl{@YsSwpvwI@3ZxSQl$`v>9+kK|qOj+wE#=n$VDYd_-l2t?&ZLcDtK2Cn49 zuJ~8TgIL0PJq)_es4cIBk>0~E_d^Qlv zw@I5qIIRWnfe+A>0;hhw`EfDV!^ms&quX?`W&~X+dp?>wNlxRhQGnBCU4Dz0G)^7C zG_9&OQv<%RlOJae620lg*pBW!@$rbXPYdP|ykzTGA;Mej6?pseQa0d6`M9KFumF(A z%m)DZbm^@dPvAaLzYrQ@oV%@)%T`CQkL}}y<|Zsac#{xw&476yFXon{d7!*-Pnr|S zEW&w=w0a5eeEon=8Kle~=q1>Ck`hWiUsT zNi&kKmHh2d_~MU_0*Ke)YIY#CS>Qza)rC((9|b1#jcBt>Hw!p8`TO) zu=@$lFk_7O7Fy+1;K-k1#00PE!LMyBzBUUTrb2Z zrIU>jgKnKvvI6%0&OTuqLt~r;#Bzf^omi5Gni2MuD$vG0@`M@fovdp2N&vouI{*H zl$9lYIUVe8Gw3U+Hwzc|jOiMsn=A(?wS`ImN}2y45d9^?hXSqcdL2_tuRY zcZ3)ShlAz(3Ip-;0|;b1zZNnHheFKT&$_9KPoXnIeaDShn8cgM+Z z2Qqq+s+b-*0ErD}F7~F}*))5n_=e+)m$>6*B(ikF!rL!Z?9W&Ncj|2L^Nkmf_{VA_ zejj~rF;P-Q8uhlYKP3<^aOD0p>WoLoC%d0_%%tU@qH;t#md%I*&C=o`TU1h9>W1fn z*?j^T;aoFWO8gOduSp4W*nsUR#o}g${j^G{YlH{!%QnmkB zTy?ahUBNSHI?j92r4EL8Qw;nT^#)77BfZzY^4@k3qex(DMQx>q2oh+Y^h1+G-~LJk)l8A`r&-XkMCmaiEk81jE=30b)gYK)!6#uqNrw z_YP0IKxE`GyUYE{{PJ9ta<4;f^zzcw;!n%w3tV>K^(y!6GRTe}csqi3ic>h`37Z?N ze`_ZijtfRPF!*xI)yxi0?G?Rr%_!%mE7EHaBn3x>au0kNwuJwBBHlo~D>4}~Egh*J z@thT={4KhZ#c-#Rl$mW+YBZmJQb4mTH?KghQVf+H@G%R}lgZ{b3B47W!b)>cN|`b$ zPr7rq`_j4$o}4e{7cOlOjf&Mih7diPQ!t$7b?EvsEZFiRT8=p03-0`oETPE4yCRO+ z0mPhziQKOs#KQG}?Ju#SV4u^Sh>sFri9Z~vJ0s1k&{X|KD=)#Tp3gF&p=Wu27r9P* z$7QtkRUEArYx9qaZdcwuJJylh>jg7jjM&@> zB=_@;yt#u$v8?p*g1P&CzBFsJUl(abcrQRWO@T4Z^Yt{5%p_{?)QAJCwtg;;(M(c) z46!i?v%qFT{G~mxR4DhxLe)3gneIEVR|QwL@r3K7mtUOS+K;0T6y%at)bR`A`?>-W+G3gd^~A*_8lwZt7anc-#VBNa7W+tvlEnNjG71%SC53wpJI1k5 zXAJC_an#}(^?Vvky&dK{4l>OXe6H*?BGf`sUAq#)oOm$R?^Gkv(Oss|uF*^1!S{Bl zua7w}$sq&MZwbNcOYU>Lu+qAe`?%J(J;0AC(u@&v#0Eo(?EH*w+L26ka^x-{^UFKo zoVBKywM;7mmYSeI_Ehb$Ag3mmlC3Q;_%A?Zy-IuJ;n>-5a*NK&TKi6B7ynsmJHz^@ zc_A@mvyEK#CjzoxbIx&J0Up@Axr`3lm^{#Kju8!6w@Vra<6j{flK1LEp6< z5*xs)&Bu(B+pudJD+J+eI`M4Xqs+0r2{!%*AeZ{KX-^wkW9J~uRYt>= z1|@ZlLGO4@>ieQr^BIFLDxnIEhD2+?gm3_N12E*O*YMLhYLiY6Npo5uyNMrTC4g~K zlVve$7=PtGWYE*thJnkTO=VO}{Q#I67j7)Eo9Lpq#s-FqXxwO$0Y*LKg2M-`q#&S6`OYvqjIj z8v6;?=oi~23^}I;a*$M?FU=uQvc?|Gk>Bvd^>U0{sRZ!QTR?+KJn16+V{y)HL4FyePO*DchD+JH*vX7*Wn9BhK5ANoTiv~Q*ylj{3 zshNhnH7Bblp;MFx}kRDhH{lxL2v9GFObvk;}YYK-EGRmzB4*lFXNE z?UP?%85oor9_=$;d1)c?N9|;p*rH_dBR+qsB95+Qv80Q5DVK-C&a=Z&Vmke&Cij+3 zr!emA6#jN+F!?s$>HUj!9&@#YN@!B&dmUgTQbS>e8`jISJ)APjV8=f*s-Wvwc%->d zXT|?1lkP!YT)kdRIC)|ujQp@qWKaw?5&^A4!zvncio-L*g zTbozqWeG;!mS3fHi-pf)44lwAJCydH*z5e30WJ~(sggQV77Nu4pkCzK*h%>F@RpRXP(Nc_(H~ z_1vY+*eBA&@grm~tM=AvH3)316nd)2g&q1*7P>#MvQ`XMN6rsb&a=A}Y5D-CR*3Bt zwb!g9nT=5k*zLK`qTddaBx|F7NQ$Yqd00!4sTicekOC+USH*y2D!o=$`l1AvQ z*&a>HnrV8LaZqC3{7zYk9yP=_f}MO0$oKOcqMHs>$E(sw6boaw)xcGtA=OnLqb< zaXOEI63UlKqBDu7OVsI&lon`4VyEfEGtLk0h7Z&6lBG0?HNQ_Ud&76K5s+;&OG`_H zv#n6uYa@6z*Loi=F7^EEh38v2Q?|f`{<`i*$rVx&H*Jci14Q5MaSTMp8}vd52vqgobHt%jZirg`UF7ne z(+|c;i564lDi0{Qc;<}v^xL_WVa*1thM9Fhq$?>oW}=HJndnpCRPV^Q*Q4ku(vY*6 zh!7HIDP0^l(iZIDXXZsl7<9*>qBz=J=Ei6(xE`leuM%`{NYQ%zJ>x%77`S}F@ zpma^$kUmkf8F;Spf-tI{7&@E4kw-&{+WRbaI=r9jD|s4v$^~G1W_XQTnG0nX>nkGiMemwhto6Mn<~U&2rfI`CVQdS}e}sqIM<{*j z3rnJet2)~p$SdVB>Kb=~9cp?aCY?&_3QCe0CzWPd6qSa|w0&JiQv%z&o|0hLzAPOn zP&vD2G#RzN5`fkKlvU={0CxZ!#}s7@CG{Ca*So+g0C^?={>&k+(I3MF@UHDRFY|fZ z_AUl>jY+3@=bOf~vz1ySIp07i<1OrvB*6$hvv|us zKgq_79U8dLgh2v*9Q6`V=pQ;#%V;T%mlto%Q~H{j>O6llH;zQzlzP3Sg9uB7KxXCP zg-9B=y@F+l?^-A`W?`-$bq?2Eb0?NE>0_qlDn=oVAc`_61WD)dYZv->8Z^=7wc1TM z7wfms{;jVSSB?GHjEP(RKQ=isVHPFlHif7oStVOmi^BrzO1rID!p3S9Tl7Z5yxCWc zN}ms~8=F*Y@fxvhP|Jx5QskN^! zf88l}O;AlZcRCvn$hGP_-Y|I~zJ98WjspI~KE9y+Gzy&<~mVZkkJqC#K{H+N)qItuj(mZdJ8Fc43t& zO%kh_o>C1zWJ5$!-_X1#=v|Y;wSKs4_TpUY9v&qmqc3&hBvFM-lX_XoW#Kveqw|mU zfEOCw2Xb*x>=>bLgR*V#rG`%g2Yw^t&CzP^ZD{xN!28ryUS#24sWn_AfSyzNls|Ci z<{V@l`>(G|8b4@g#OjvtB$vr!{qdaY@>BgWy+IPxnN({&i2$1X z>C~;e`kcI`H~91|!D25PBcrM2m|+i^@z|Wb_PlBiZYxfxq#_*0xR(^%00L!@S7K6PpbHWqpd_=a*Mx7dtFs)T&snNVg3rDVDaeVdG)q1M{Vf&mF10#{Tdc^AiRn z=tc3Hk2LWK2JUa;6E>Hq1_b95Kb+Wnt1hwe{jA1^7kySkEs60v@3!f%qhne{fbW$O z4hrBJ$b>sRKWnH+v64!JF`{`H0KLb3Nlp2qel5QU%9%CYyLd+(cTBL?^wl}*ve=7f z1G23$X$@RdUF-e=TA7E6xfvPl9A7qe+@nOhM)uA|b_ki_ee9EJRl6i2fc%j%%C;yy zjO;IlXOn5k(YG~@ZHZJ=cKx6#a~x*0d5~S)B6qN@6xI+AR!$|6D~@lZ!DTvpCsCx? zr`0Eo8JqHv{r#NQrwCptkUql*12*Genmc>}yEvPh*#9%>XljFl z$ql6CqWxz|M1)hu+Rnw?nN!Bj#Km07+|2QdIj4fTgQbfVEl7Y{OzeM^{TQx4Gvu%! zL5Q{r%{5IKpnnc_s0)gF&iy*lP<;WN_BxK9$c*gA>d`^2_$SVkuFkFWwM;W75gq#+ z{^hjS20rB=E7Hhcd8oM zF1*eAQ_*{_VdL@l)*aXAEpYw5am?DSjU(Jz$zBZ6#)#K;%tvyu=fO7VBT5}f?|$Tm z7}`s^FuWcaTUHsiBo)n$DdkQbetRC}8NxRFt#UZRZaCy{IEHdK;GzE^OrKk;UwK%$ zUw-@Td4y;1!|+3tJ`mP#yX_PT&No^mxkL5+Z$q(;iDm|o#eWMxvr8)A!j)D2I~?Et z3Nmmk3a3_G7AQfbBPQVg0xa#R8eN5`l>UhsRNKb(fJU4CdH?SJ(`Z3_d_X?h ze;oM_&N@o`2LmS;{pBab@1}>asO-m1bO+n{*UvyIGb48nLFcPiiqG~a;iEy zy3lg}Z6{R!X5<_!9BKd2X#69iX6}|y1WHMX{ns7_Vq!R$U>6f-m;d>Y1o?RR_;E1bzLi#%!NL3=sUAJM literal 0 HcmV?d00001 diff --git a/files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Abstracts.pdf b/files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Abstracts.pdf new file mode 100644 index 0000000000000000000000000000000000000000..2228c97f8e8f9e0c529f160b01487f08fe7a9954 GIT binary patch literal 1298178 zcmb5V19)Z4vOk=OZQIt4ZQIrkCbn(c)=ZL_iH(V!iEZ1-#Lky_&$-_{=Xu_H&;9Rb zuT|Z>8&$Qc>sQ^qHieRy1OtGP1A$_DXJQ5cmIc7cOw3GdZ)}CY$HydRX=es>vh*@D zB?d6b5d&Dbxd5D8Op3%G)mWIsi2>Xk9BiCS3d8_*RwlJSzjFeZnVF=Bb&1(o0K@7NdX|N8tHgB$SQV~ClV*qfRu0iA4}KSmU_w{f+#b0%hIQgSjgwKQ?D zclzj7K!8cY(#FNiiAll+=wkMdCQQ;|x_kh3b}?oa5r8lofK5V_jafuQgzbYx4lZ#K zW^oR7fB+v0Hw!Z}7pEvQK!TH9j7^k_O`MCBo0XfJ{o}^U$tj@EByDGE=ArwS=&Wpi zvY+igB;?@!U{Zxi&dko-#ex{X{1;1Z{}d9yq+)OH@<$JUL{VW<{ZJAy3kx$FlbWZ4 z8IzWZ*=HtAT>vpFG2lZ3&Mr=7KwAV@i*;jTQzK*}BV!|@GRVXj=Ppx>2-7pDM7bFu z@@q-v9}tvu-Q-jmZD1O#7^81+l;(lb2G!hE!sMc85jl4lQY;D}N5*{ANNN1=ss==`6f{!{zTExc*hjQ+0beU3GN9 z`{|B*ql~we8%q?66Rq5F^mmRa278o5rco=;CkbL;bP~jpMG2xvX-7GqkIW}PGX1Cp zdm#3KRBWxy%;*6rQI56>TK&LbfEX6beW9akH`BQH#fdfCl>O7#LPzpO%f0*fMUHdw zGYClXJKN%?9I(x>=^aQs?S{aD-pA_l?l zxcVwcTqij_t~ZG{^s_iVR61(+2W^VZxa%f;EZH-uOa=KdCMb>(&uDPRvJTF9+2VrV z?WH;tLp7KPRw^8UbTjCg_YNuEN3!%jW;Eq>%N zPUqxGz{^$q*mSHKbRL+=Z=!uKi(ku4dN+!VxOD-j@Dj4G$Dr9S~5IW5c+xnnnr zBb}K`nb?P!Jhaau_Xq>0u4R;5R8~h=^XH+0uUfvN9A`h*b7M4hCq5uO^tHNf)Q?kh zz9i{%|K%#G@Ngw|Vq+Zo#nUe$!8iSx?UXmVPtA_+Cm^GaG^?>`Uqv1X`)xUM4mxs8 zZSBdY;)ES)&Vy^YJ7l!l^jX(cg@t9Z?MzzoC%KrXqs<&C;V)D%SX{o2)l{4J>dI&_ zHrsS(%P%O4TBG<(vmztZis}|8_us~Sg()I+92ZW%)==G%av-3Qrf_WRp-nKjS7Zm0 z;UfK%_%fv+P$$uZJ&^Tgq+Zw>BS$UPOJ5Nqav*}R7dsS5r%@W(PrI@n8hSd;hvRl& zvwdtasPTJeixts&dw({Hfou067b3RdKp1Yr$1toEqQjTGjdx0+G6)Y_?+B{srFHoKWyY}71RL}xWlus;6ppCZH zK)5gc2$&$#g`_r)bTTTV)IY_GwjlDN8Nf$8B5?K2qi7#)Ybi!jih*G(=5Frs>X`E9 zuqW1NI$;uF6=81xR?1!=hA`)u0r@X37BVl^lc%4gBe=$dh?PVfi#Mb{~-I4B0&N(T?-U$EaHf3ER!b zV_(>z_r^|eY>@LNzm30fQ2+F${{=ljJ9Fx{cMx$91rP=hbr4k=CV8Nf^&j8-0TX|c zAE4yoo0Gt1T;631A5xKx-co)nf(J(nEn(xe|T(GmVbEc zkH#i0YEEWme|d6N_J1_}%YBP}bY^33{@>8`2k-vHJKEd1nAy2F|A7pSKb`%-0nYzQ z{MFB&lE3idBf<3tQUBE8`U@-mB>uSCze?EtB=ng?o$MV%>^*du89(ZNTpR$Fk2@## z$6cRE(#hV{;Sad{gK_x}Tm=4)l|O*=gSC$_SpVvpNyW_B-qp#(><_q#d$>rdx_kiW zM_N*q`J)o|UtRuz*AJ0CN<~==|0@1V7$!BfzcT;8K{YkNA0GY^;iG|)lf8+mnTsyd zM*zX3X6E6-ByIblU{QT0Ek$E1Gm}5PN!$L_{x9(bK0Y6q`Db+E56JjS`TyY6`6I6e zG07E=J+cl0sN!84{lUlZ2uLV+B8<| zR=AK~F$6fMYugOL(IHQ{6cE_tQHoC(!TG;)WJ8}wg%#0fbzZ<*jyQ3om*~=)M$PJR z^=@$&K`4R)#V*B?`i!ceH4&k*q%4@3$rFXmq`&lZp^V3LDT_3lZZd5`K*CDm8$uce z1+b7@tWW*squ7XYJvrLV@hi_>F_u>x2zl>5?EhA=zdggf#YT`^*>cUs&$QgxU4M0R z?6-4tbbn5N7BxO&hVpVOe}flm^cMYjFT3`qAFJVGDP8L`nb%R(NTc=nMvUgIroY%s z>)7WrdtrI4OPnUzmrXf<7fXIgM=%CA!d`O`RsViFQ-_JmQXTz7RxB)qG zT}G_fI^aH%tzV;5AAv(NaM(sSzvrZIk}PU<@zxqKQ4VM7!Ze<)D(x^L)J>%x&| zW~fn&V`RyMIdMwoPT$Qj ze?ylW1t=1y#!OG@p++><^>skqE7q^^Il2|u#Q6u(A*9#=#&saX|$9QF*6`8^venfG|;(Mg1rou z52CwnQm$zV=YA>~BSf4)OA>EAV}F(n>GNE?BOpWi!8%$;Wa45G40k_8wx7t`bfCVQ z#vBM#c%^4|FTAH(^e>=V-Bq;MeDez{s)|9i;^ET_bB%K~_w8&Nd`Ar=rJ`|o%Xd0r znxJHZz{XNdji_aODhul^IH{>B~s(+RP2Gyk{Ck&4utU9;L& zLWkIV=Id{mel`(y*FI}( ztt1eA^lhGfW(!kYVHf>rU?-Z}188s32N;HwR1C)3&ul#T97eMct#4GB@Lc?yDb}hI zeIyfXi|gg*@uDBL7flXp^hQGJEPXYhzHjPyPagk)*Gq51Q7HY*XDVIv{nkOD zFei@xEbFC>;6m|nwA1jV?Vg6dk%0EPKnrJKjM)HB|zp|J>G%s+% zLdi{(|3HBGK?0$^uutfBG>57dm>H?Qv`=bJ7=FcuTbln1;T&flW&e*?gC(Ok>&@rW zvB~TjPEq@Tb@+CikAnTvv8n8ti%Z^D#LoYPyrbUJKL|EQspj=|qJDnR9Dwf~&IEq< z@DF{aThAA)#usP=nHO9CyyXlv*906oG1u{&S??aOY`tm0c$Ou)qG^ln{IE)TR<@hJ zw@UW^i&b)P0shS@=SJ+7h0q~4+w+anevyJY+tq|5fC5mX4b+yQi0=|eF-&l3H_uM; z1!b7hx;pnVx3Wzf`Lu2GIM=q4C=J6^>&DXS1zpY(CcZTl{yL)QB>ed$r}%DCZ@tQH zW6W^@E7|et&Z}d0r(`8R>XA>rBbIX_eJkrcZ+S+xgNf2Gi~}kBoPF(8%l2Z%^m+ci z^9tae&L$r%ZguUacQ{k|-p0Gn)*|n{SikeyyZ6LA{>Zxh+%RG3*2)-ZsbDK`-%5$p zdd`k@edIwu?ZZzPP3nH;e?M}Ra&2%oHnFBOYL3mH8}|*6K1y*F;~7Rj8dN?S^$+{R z9}RpNdWp~jXbvfkDh|o+Q(Q%PhQ5rx#OSdu3|a3xhC3G;Zel$_`29bVVr`&C7RKlQ zC&Dqms^t82W0Ug>JsFH6T2J zy%h*b93v9oDb?%#RTy-p?MuB29Lzjm2PM4c?RGqoEZI>{8aVP0k z+xR7_5o5lb`!iqR*LL^Hho<}3q@uJlFfFq0%rIS|LI=?S? zO}u+*y9(169rxQkuRrGqr=RBcY;C=nda!^(NJ<7zAt$|7sumQsD%7VAZ$tUq^6GMF z<2qCZoij=cy9g%z4k4ak%d%uqC7}$L8>yu&(Cq+YhF4P2%#h#rj8oLa)7l`cDO-YOp24Y!~F(UgRw6t=BTM>gd@1O35nK{<7!{ zEDm#NK+hzDxd*K)CzL{#(Vt$~wnQp%NiccCzB6~F5=j&wgzJN#hVDP%XCB^tC`ITu zMHlVQQYtTG8`_}`EaCHom8F6IEeT;??C6~nIqf0n7T&+7vk$R2Ev0!nI)Y7ArEPCl zg{6syE$4G>9V&lY8A8R;sRrJF`8v4O+f+(=)zjmZs^<@_7mTG^?p=n_cQnPv-(sHz zgNv|9u6tsNA@TVfY8No;9^Ald#Xc&Qrt04FD6)B^$R`4aTlh-M?X^uNwU(RC$+PlLvm#=O!PSQOXVi}u$`wrH=^~^Al4CocJur&1%oC?0df;!+uJ;YtjNqW$V{~HAa!cgXFsFse=G6^ZJ!y3 zHo9H)d5FkM*j9~;2M=am63llbs+m?DBPJTM7cf(Hm+qr#r}(TyDU;5g+wV*{ah`5cbc-s zr(?5jHh=`G4w_ieAqwqNfP;QP1ywVH{y=*uxEcwVI(b2oKu8CE`e{xwKKaO3vGGn% z;*NX05h15~O8z=skHLl{%tbHX0DrS$XRtR?b;oZx-Y;d;sd!fx0Rmw9+ZX!#@f3G` z9s;5yQn!#uieeYd)oK^w$w98~pM3gNr~2{WWl(*)f2UTDIr5fHirqLKP6~%oKCLeu zpzkZpxD{ODVTGZuyAp&9Ym}|Z{#et=5YS`K?(~nFZZep8eqS@1_dd-AyYXIA#630n zvhmpuZhdL0@=6@ed^Y4~9rW4axXg4DHpZ?4y&*81m5Z6l)r8J``E=|l>=e}kry%dM zvn#(sn@SZfhGvU@{O|zGwI12+3N_%O%=g+M^+-fglj{Z!FNgkjO}Ii*CQK%wnC3mK7!kk6hTK2oiVurhWGI8aaIyjDpZq)v055)K&Epqrm0zj#+9F zIef8?sC!-^El@;nA$Ow0OPph(^k-=wicoV!l-y}!&~k+)>nCVO8v>1N<(n62M5z=X zqDi<4md>{fLL>7;ClLsycGN>H_V_ZMTi4Fxrf%MWvDG#djZ1~%>Bu&x(r2aJK~V)u zylzQ7SQ$KEtDB@02U*s3hQ5~G@724E4l@eAc&V_gGR`}+OD--(bjIu6?hb=m?W*}@ z@$jy4N>rH~&OOaml-;u|*xInrZveB86$4O6_e!xINA>VDrMY?*0S>guyrvfe? zAgfMrw(bdyE0AjV$uaZgk*qEIYh1IgBMR(Nnr8+=l~6qRO(FC2!|(HIH1cDmw4ga% z;V`c0Dp8Xa)%@wubUV~e!3$APGU6e(TiO^d>4Z((QCSsCZ7bhnDDSFw67rCE1#${e z@LG2nt=)>D+5Gl4$nLOIhnj~*sN?B8Ka+IX885^_1%JYpWh@LnI+u{l{$LWA6>p?me%88h z1tbMxl3XL!Y*Y8;swy*CmdW!Q(8V;0_HR^E9X7D-n(8w`g{kZ8lWy4;nKcBvp_OV7 zOB7Y9VKzDIFXMH~BKzyt+c>p^=iCNCHbyIiCAwVC7;aE&Kgg zLz}%9bnjDj+1Bu$WB&C_*{I884}(yq;_Gj#=*6@nv^Gyju~1&$+@ASyfmh+1C3kPs zt|NXEn+k8d;OV>k<@`E$cr*CH4dIq{prB`j3mLZ%3j(?;l2I>Hrsv%in2lZ|=U>sp z>43L*KsUm+b;z4OtD(Vg|82T%)dr)?zzUqR5E1VpT!=mZTdg*-=Cu{ltHlH1w=+}( zBZZhaMG9#yS(V1*i6-?emmiI{9PqN<}3k6hV3Xuk`BUfynbWzfl7?< zG4x8*^~FGD2QC&~r1D@D_E>|%E?9C<-|S?v!i!ZAavnNdkg)YuOG?P&s{Zz_6*QBC z#*D>f-+8SKuDK8cmr>)Jcr7}gvfP2E zAz5_+tK^X`qp+w{i}NC!3g6$`mR}|^9@3JP(K4OtSbnWW<4XNJUOeo+wtYl`W!B`b z&I_JlLkv}FvN1$5^jaOwZi*rf>LeGiTKD=)FC`(!TU??q((MgU8%@1`<7TWLL4EIt zyOjK}?d9O|wZFCPzc#o3qiwTuasRuMmygf>h{Lbx_MuZRjfr8@%2Jo*kt*s{ik+hG zx*+SM8;r6T@NPHUUjQ5l7IOw&gcE$7o~%2^x(Py~IEJ zPzv=On_up25e8*nICy(sJG{F_6FRuxdzQthr-Fo+A{fWWs2~KvRR$PGqm#w6YdW-E zN~YA}KZ^g3sz`WxvskKEZquN$s(L)%QVmHg2GGc2^|!!2eTUhZTh%-JQKg-huDY+O zMM1x26EneBP9F~z$-1!mB2``UXfoPxuYu||pZ!9P?M>!I8??Zu>R7Rcx(;(6I&3hD zDce|=r>C^)xQ6GGU{4MTE$8-$wZ7^!21l}id4)bAC@xRx z4jO~)Gt5G^M2=sT_QXwNM(wwp!ZKeN_)$L%)Fo{g*B-|x(tT@A`7zThmx7X|nbj9u zh{TX(%LR~J_g)q#s<+g{G6GBti3e16GJ||d#*J@SS^6t|Op#*B67HQl$?R>5|6TP>D_J9Mnhv&4CpypJ-RG>EGG zpr-WO^rmNpl>^eS_T`Q*nhEl_IcDuFW=m2Rb+qv_6_$9mKntO)$-x*jq+dKFZiGL=s37p z|J5jC)JHxd59GFIx;tu&R4e`~2Z2JN$!I%Eq!=+t8hVw8v&P5gtD3s{UGzioqP{%` zH@9ZmdCU^}NSnW2$%G6+9hv8&i&&+Gy>my~mp@Xu*`*#l_=M+jnNbh%PGOLMd>`X(` zitR3_C4L$4yBI!8^zYKYVBAD<)xL{N3(&n4x^IC|^q5|5DG9R=lPaJCt9}DKgO`N0YIZhl%WL`Ng;jwZ%?}Oo8q8WFM|! zyR^FTg@W9kbi=ummJ;i9xR^l}RdeBP*Bwkt%XH3*uS=XvW3x#Bdbi{RR2 zL+yq?#VFP(0qXvYKR{t)whr&h@>fQNIi`z8&8c-H6+N0flQr+J(BNYg{1-caV}Y-J z-|GaXW2h3X22FAuR(-tYp+z-L_V>pBFDI4%v+=WYv;C{_>!plEZ404G+90j7FBc_%<=j!h7?*ZKpm!)?%20H}8r1h37 zaeCYRV_cCB9BfS_`)`cx*yfe$?OVlZ~NlrZ`;n?99-t@ zZ46Mx*t%obcMk8g4#md5I|IqsqHL?2#h@5fiL>IT`~o zoGmeuZ6So3h^z%tYGhFet(35Lgjbf=v=C}-LYB0!SDBV`x#f^3BxwU>gPsUtkMIt$ z<0O|9J{uw`RBSM90YOOOfK=jg(JbsV1qM1|*lg77$7LF38fCiQ5dRkqGp$LCY((Zp z_;|DE<63KQ(M+D1)|Y3IWs!$sAec3+F`b&Nn`Kq2R%6aN;+k6wBNb(M4#rNYl;{>Vgr&$IwboN0HO#*#Fo|3UDB;r^gma71wWcYOWL=nQLg z;^2_+E}$0MGlpJ*knC@=HC3e1gN57D@uK}SdEVbIuZt=j?sIAff!tLz;s<*ybIGV* z&rU1%u}BgFr!#BixGC1w&V6)t7}DnSNID8F^H-?^+vR)#&n`$#nnj;(ve>SvqtH}+ z##^2MagKe(HCdlm_~w=weH7LUiNsdf{pHNKA{_iKb|2#V3Wd65U!9`8> z&rU?gf##(JQXSP}A`~+Ap~_A53}QE;TWmTIkJlIj(U6V&9KVG&4RjcHZAnN$uEB-@Vk&^0lDm&gST!)IE5Iniz0@ z`^t*KuugH;vK#=d_uGY+;-1nlTBAhhi+1({xOsFCd)z0QjlizXXb!l07ua<7t`pZ$ z<{O38Q|a`3?l8{9gN6uIDgbdrQ)JF=lMPTKMK2ANqxJNp+BupVy7shgFX=vdF5lzzjF~{$WopBqGb+8J6$ZI^Fy538o@Sw ze@x`R?l}E&liT*v&8#mu4TFJ35Y$OTu(rq4JuHF}1h0};^vN@?az*}7JA-ZUJe)a3 z`kBq+dg1Lt!3S`QQWTNukFXA5{cP?y(vczgjw)cgz~tI3P^>wvycn&Ry&VoJc)b(T zxQTIDSe05zTWodak0tY?Hqy!4Uzz=TMbq)L|1l+ccZfV1kJxpkaF6xvqg&v;tjqDT zKl1m8-&=fCm&g^zc=q$3fZPKHaodo^p#3d^amS@zOJc$cHNjR+gh8Pa@BXoJ8hQoC zkKxAR^b*w3lnPPPCDYP!@Hm()Ck-adc2-%!M$`nqwB@ES!E1of16lR@6<$Z8soMl+ z;n%|Wm>zru*@4VEWnH9{mTP=nf*-ph?)>#De?J-iPv?jLj(>|$=;OvEp{U%K`7|`jj)&Elu@Z%*3bCdS>fGdS_clh0@- z9y9s4(t3wRAqm^e#`I}qqiF;=vgU?jDlTM4pH0;ic^EhFVg86(7eL+r_oDuv4yV}v zZQ5s5*S#II9Jk24zIVO@mAJlkb#?W0brE+5Kvf4wBNA&EA%i$_U;Ze8XPzEE41|mU z`QQN44W|9?Iru-F7O--${{OF$0EoF*xY_=VB|UXGwUj}OxAW1LR_JI&bS<{G6WUl% zfr0@nadb>u^we-zT1QP`O!QAgFcPy5LZbtkd|_h7a^--I(l@Pos|LWp;th76g_ZGg zR92CI4%r!Ztn}=wHgUFBt)|?^3vG(ESUMRe~>u2;jsN$QTq`U=4W5eF_ zgoo!>-ymPwsu_>9HC>h}37Z|^*fvRxPQYk1r@Snnr>z>m?^uqv=mq=Xrv#+X zNH8ft^M3}d@589ceXgkRAm-&4mt=9d?r`hQ7lxT9=ShHPkw;USS|$RWpHk+Hk|K1o zg(6jFBL%tUiN_0EGBjO>&Vl;u7`=z|&K8inC@a1geeal*^*HZ`FU&6>!KG4zle!pT zrNtcSZXiLKJn)Q1GhHr8WV7eK7zLS@8_~}drGO4x??YAl1?N)+TX+}-#12;}FPz%< zkrPhViTi{dyF~ppeH7ohqNUphYsFE_&qiP~y}^V>HTbdOF7%PJ?|1A%HH>_H;heC9 z5ozZO$|L4}fyO=!3)~pd5*U<$5fS?Iln|8|yfssoYgB5@_i>6Rv_vf4!`_T6jQuI2kKD9J04CNB>Eh*nZE9aqYd}FmN^qQ44T$I~JE_ z%Sz0Y=~q+0h}nfLEk0xDxcF)kGkxF^?u&?#tLt;l@D#meOh4oNMJOfu);Rb(7FK`! zG_9y9-jecN5}9cpeZuuFs5TkGW8_O~8)awmeWn~n`Oi{2TAlvyC|0FeRgK?Ij(>89 z^M3U;foV+9($GQFeY5o)$TB4`AFJNiUeHF;7KC$hcJqq}e&8p3K8(_%)xRR1j{?V_ z8IP*VnNUq+nt?DcU6d~CBQ3>RYk(a=280Y0Xp6JXf9qe_<^_nA%uo-D)EwR`WmCwV z?b9gxMywoT54xqXYiillYpvESIs_0y){MoQ8e))5Y|1W)X*6K?t9PR-H1#8L$JK2% z%S=0MCS=zrrp=Jzqcaje7))A??*QtvpG7$OXYQv%&`r3aA&07}@mc$^n#Ww*V5?L+ zX!~@?l_)BA_$#CGmThF2WF?>Ks8s}}0*^^%8RP7bU8#PA0wMN(>5LFK!dy>%4|3Fg zOKZ1Be>VMTHP7;E1fv?7PT7vJACy5d_nU}RRsi9u1?Lx)0XnD&+2%62tvt7gvS;f1 zKp;!5J1Lj5gtI}+0iyEA4dgvcKaN@-yFg;=qV}wAZ9fp*sv@!#@qUN(O-_zwqnEM{ zxo!+0V#iO(R-<+x_W|;xI=S=(PC4vbvlHWt1%o`BmF4H0%Sc&L*;&5FjuNJs9$b!3Z8!`83Bi`5|Wa41F4G z182;EEB`&WGRS!Lu#LrnYy1ll^awfUJo-y40OARDsHudtz8MyR+p+O9Cr67&{Ep1`8Qj zk@Atu{rOmnrou0|WRe3A^9o4z9)v3ncs%yS{4^$q=a_(3>0hR4Ilujrej!mL6G^M+ z@}opL*8Cj#frs!z;gwl_cnIhxU&^Y#jN z%jiy9Rt5*7;8=nVKG^?-kt<{gc|XR%T$>=2N*RuQ6?}sv?q@7;5FwIQv3_Mpjo~^NtSi-dNKy?xJJSMA`GBIx3mxcbk%L;*2 z%$Zd{qmOxqxl9}hf6FJlGvh_OQk1vt1r$LhZO`YFoZ~^ouSF9W%0*CV0)`ECZOMt( z4?oB*v$IEd9x4wL_wR~pj^^OEztiVdM3%1N2bV4u5k`m~c6a)dHY!P@ zVz<%iU6yWH%C46vpcK{uw|Z?OyPZ|bvh@6HeDpcve!cB}e+*yS^oE$khQFdWsX36n zL5X#_r`!c@@sgbD^HMl+BGV#7E{&`$8Q)mb8gOp1;u#*tXtkvspEak~qvzOHLUcH} zSPhI{u<@(1_Zp83ianJvEMAke$932(Rb3BrTqzGvbNp?0Q*UG=WV0ap7m)msEF16u z{&^yIquf{vv{9P~N}EK|;aI+6;{<9G&*ABtlt8(Tfx{qu;4`VLeT|Oxylc_ee(HNL z-|?jPJ#PE!ujX~LVyBKX0xd}Hn=}d?JJWR60Sx(F2@zFt3~5h?$jktbF1OI%UZyHU z!(P5aGLc(eO%){q2lX)i)HnVL!;EjipMRbIuFuJI({IB!L|}I!V~%F@u0wIlSP7oQ(?34bhWwz zFLb>2Cqny*jCSu*e+`PLCW5t08`*kIoLli#WU_vaz_+Ef1GLLIl=VhnyD<6)PYO^5 z+e(h1ch5-npe5v0jt#g-rc7qqCs~swhX)q|sgjEg)5vdfS@(*QoWGVGqqwD*;^#&z zK+=3DXRBzM2g)E&%=%fToS2>jW)jAz9ltUYS>RWdd}d6nbg3*UdCs^KrDF$QT%C&s z7uTFJdSaBE9^H&~x+vg!m2uMt(Qb6hAbaO7@C&M0)>a=d>5vZx1k7=!v)_ibDQiV6 zJU|kf{nIF$N0SprORT#C16ZavInT%-i>|z_jLdTK4n7#w)Hx7}Os7jSB-)Vw6{gtaq4N1vFc`#R(ikxT)h) z-+>><31Jmqb%JSn-Db(@Wd|n$G^d}p6=cafIv|r!?-r%opq z8mkT(d?A)CjP~Z1j^0ZV=2u=o8m?0J&9gGM4hLz@s2dP&%E?tbw1&VmLkH zSl+aCx?O?#{f(5e8;_>lwPI~biD!T%8P6((OzyI9r{C9)p2LBD{^)8VBFwny=z8c4-sdPH%j667PHud#o24XpNp|Pnur;6?V{85 zjASVw(a^GnJ&ubOWV1yKKRFSLzg&t%s#_gZU~;@5Tcy$^t*49VTSrWX>0qLR9$o5A#js0n|aIV6LOm?3|W`TFoKdw-L_j}rHSN)q>vzT38Sc1>H4x zrimtYFBv^;HqY$c2Yl=09&7X_b_+Q@F9r+v=EC`d{8TA8FBJ5fRo7k`80tjz6HONy z7Y!F#_T~iGW$}}2>|rt@6hJn7@w>#zRS(mjOQI#Mb_rQnSpGXW?(c~hwW)F@t`D3G z#+~@$%I(N)N(^xirR)rJjG6uF-B+chMyVRg_~mv{Y2y)&hXiJy0Ct$PbKM0!4W*@* zIz0=ZhD-xgJ)!KZ+o;jT{PNq=yIEz~{NS1(jA28d1d@H4oM(zjd!p{=Ysy3gKmzyu zi|=Pv-cSMS{X0f)e z^Kl{7(+NPNt0*l+!h-Y^+A1$4o1a37X8-Pt_nU)*Vwi({kYhVOX;2Go%bE{kFSRCi zESpmtop9$x)q=^O!$SZ4$lYN4a(-OQ>Dl}@jdjQUA=q2fNL7#nWC(|d8%0v(ZnnSQ z1=dXG8-@QxAKnJP-}W@!prF7x&BJ}?16}&NScu_ocf~fxH*l0o_Y{g$X@i42iI^2L zF}e)ht@G9(ns2UtfpBka2a8Aq8@)%n%1d@sy2nx6sSI@n{ggBK zFP5g$S>H|!c=(f7Z(BqC-ZbC3M`y+99>c@0FE;ca4uaxO-==!x-)uQXUQUsheAnXT z-%S+L?lVy;>*2az+j1X6K?6K>+H5DP4;JB0bx&cpy^1fPs=6D!Mep}#c^4U>zpk>C z)>%_$86bVbLl>_DVrmQ^k2=LSRknDJD1Lsvv$wI;_-r1Z8+{6kNEE<6!+Zo^uDpnO z)K4osyh4y_&$@tdsplwNffQ!CF7#_RDJm!EXlY4X2T%7!sh*TFs;-fygnm7T+8$%6 zKfAF06s$IY#%#V+=YCOj9iT zUk@`~@G79_Db*lAEi>W(4k51jfX#_7nf+0FS*&@AGC!fD36pNzO_T6f*@Htv2~mHb zhW!WxX$a9pebg#xc@~V(w6#GW#L3HCYj0m$X?bnt-B|GQZ9E|x$B^@NJ5yctvJ|qU zVW958(sOj8qnF{5jmVl5k}60M60u;GC;5~JOU+gs#0D_;F-n>o2sMULPef5kA`-_a zK*tcF!xERbxzBB1NoLrSoLFwZZ)4?Uz2LjJ=Iix#OT_YF`mXsBME*o-s%#`};dnFk zaMd+DIefVDyDj6s0`?~KYKmxpGcn(bcrwsSVAeG3gOJAbw~*!*5Pwx7{a%dCEL9dpw< z%*cla&GdMEi%0hvc^ z@L=CIkRd785-nFNNU}{@FjzD$4+WM20OWjwsc-J#(QrJ`5?AwMsUe zg*+d-k!^gOLB6+vA9<{*Geq+8^6mal4ZxSD*|PlgLF>z9Z^d))n0JJ6lzgxO(^GS3 zUNTLMbI96khFwS}8m!c!#Rl#15--`j4Vk;7V1qaGc#2&VXet;j5)V1ITDm%4k&IuT z9iPH_4Ut!CT%jsUz%)C-G>6g%%#2)64hon`pgGia!S5Iaz0(8Gf*6oVj(OvGFRzVA zI;z$}a;a?*pS$9dvJc_StMh=o!A_MT1GX92yEPEPJyCs5YnG;2#+rd%#5)bQKL^Pg zL8pp-9fU&cj2OOp&p^Iq+S~o`ysoJs)DneKYl6E2g1TtyLJN4K`w|$S{MXNFQ1;Nt=X{k&KT>WyO}8Aci1Ue1w~=G^0M-2a;n;Kf#i=13W}z+4(lY zi3}XLtk0v?0|7McfaI@f8svi$^m8=^eTgI-ihY!BkZ9t0>gQK6PU&=e3UyBY9{3Sy zseFVaf}$`*TW-2j;XKkv+LDc^c{x;upWvGAZNEu5kERu4zw^w&_@TaNpO@G%^L5## z`x^`+x#&%2JN;T#(PM3}8k^?3P}qBRL>b3ELJVx!cdQEY-Zl87}a;)@|NM zG;jc#@5}tQxnlovv?z0Oa|A(9#wft)W$pTw+S>}||9UxogwfgQ@DfVoi;$3!+cBp3 z303u>8$R_?oQz{-BO;QSE;9vG(7~i#PF=jgv;|s_v>B=$z|Iy57% z*^E#)6G+Aw92TRSd-8b-Dbk)}>Kgf+Iq96KKi^YDp5??o>K_y^*?37$UfyE4SNb|BRx5cQjC~utD)VkalJj+X zjh}fqNDOXWU+&nmxLnvhGS{@-s38NmJPro8^M@a3U$pr+9t$=Jb11=MD}jYGlF7)0 zwZTbczS+~9h0@=qK!`b{_U%Bbi0iHjIW+YDN!hLn-K61puL-%#EuB=<)5s<-Ab@jT zHV5uPni15k)DFO!#X3oG|Ikwop;$$IqRV3qs7=`35);02B>hfOY=Td;%a!*vf;t7O z1%(B4AaRqdF~);1s{oM6lr+~HM7%P`&QMF|?DR{OyPJPd@0a-MXVt07GJBM!xyC3k zS|I!J*KSNPwj^SFV6HY1v|XN=?@&T##68#KGu1Vr+#Y2HrHe%qyX0QM7iI9s zfjnV`yt;ZqyQF52Z?TbKEc{^~`%3z_gR3(uzM=kFx4{&GPzZ;cQjIT;*-CAUF%_#! zF3g5AYn+ao=6EWr05yhS*=17r*Pb(4`!Q0wm$?@786sSG;x@ILE(O|m@@wPwL0K{$r3UtilT!A3+O&Pk!IAV37 z?K=ur{G&Q=$jA(~h9}=R7joa^{8Gpbp>1xX`bydF<@YflN_a1+L)0WG`L>gmDKSv5 zt3s;(xzOyn!2fWhx%@Ln`j~MYK5zUde{SxfPcyp#FZSnG`9rjsoooPF7*C>vLX$*IkLEk(oHUG>w{zd2DQ}#TIjFGV; z-*}rvB25Xe^k_XC0{du>VlVs)+h~`fXy^W>WUmxhX;8x&(dRr}ya%GSIndQUSMd$= zd&>nKX*%GqTJY$Y>R5&aHye2DRgcW0Nnk{c?x4)+JOw#Ji4ksaZ;@z$PjCLV+&8vR zwothh?C*F&VHp$P7W&hOW{2h_2$nRKBT5Bd5n*CRkaf>}?Hg)|BPH_7zBOI&ukjz` zIgb=bj7ed09KpB3<0-K#M!Ul6S^qq~#@yx4Z{koKo|!=-#`{wKbI0>jhnhh^KDT{< zoI)QZM`Af%`J^TgqK$>*A9A0T7 z+69cXP}8tIfSkIvMNixp<0*Ckl%^z6li`%~P?_R^PNZ{PwS=Go_{ctE?1Y_X+Ni+H zl;G9&1?MZ7>#O97-JL!`=K90hBc0#XfNU9}^w|0T2TVY-za^Com5=}TZ_hoG`rjY7 zC%=Q|;nn!y`QBd+Uu{3sI`I0dZ@mR~X(8xkKz*J&z9A zf?dG_Tk(3-PaIB&A^&`U`-y1qDpdMj5qxn3LE8I#-P6;E#>9D0)xp@44=#3 zf=^mhAkGQS5jExkoQbOIu^SQ|h#x&c%75g#N$puQLpeIxukq=Av7%p4&Yz}S*4rhU zd9h?|EpL`YclNe82(u5utb<(d=dGs4mf7_Fd<=qNa}poq+wv>@qW1g6KOOsj_GYjb zu1FuiesR_})C6!zU~XV;(GBfZrL0!sHE0c9Exn*DcdpP@x>n`wK-=+7X|uB4xk=mX z+LiY^?}c$b4H-eC!A|?jaaJ-P;kUUAL&4`tl6=w*|DrD5bO4s z5vT$lj6AxBcn0t*{Z&Dm`azreLCY|mhzGlmP)r9%M`E%)X|g?OvNb6YpWN-|U~qG} z@tc0)?|JN9TWf^C@OO^etgq=zwu@A97n4;6CXIe@YmP22bfXtPPvJeh4-xN_6d@fcX$^y$O3$@&#;G&|Msp)3Sw#o=b#^q*J zgY43PmvnXBID78)(q&tArG~CtNe#X7?B=D5U*5K;W9!VhJzPro`R8_@$4@Tav~j_6TQ&`kHuN<9Y~6-Kz1&Z?q?u))Qqm@PWuewN z5!AiV3)(&;V97;Z=mG?H%qbj~L9YO&SLa{6L2p^iImPg}C%PNm)a}kiO&E(N(4~7> z3+7e>ltLES9*nhDiHch#5)PQTUBIl zWPWjG=!t+C{Yv1e=pxz~SQhGtt_rO&c7}EsdjkhUXF|6FHzGrkai0&o9_S0unI&Im zWQx(~Uci0Tc)kh#QDP}uFwu)u42iMJ>A5DP#8(+o)CKV!MZB=9sU25%J|{UA{g zVHVh1QTuY--YNu8a=I-6gq&wgl~BTCow=VBK+8@&PHLtWbLE3i1i<%sb;8{g7V!29 z+;{Z_RxfN`(=-iFJH710Fm_znoqTE4hj0A+eRA=qFMRvh!PRRH;AVZ*x1L!0UY8b( zFU87x*RZ}f^{>=Nseh*uzc@>$?mIE~+D?!^xG!DkpVBPpSBRn2LjSbgbe&A7%&0=- z)1(c4prq{>G1)2H1btPL=|_k0;fO>+id2Uqu*6EoQ*9!7bzJFCenqGu36Ee1ylE0Z zl?Md_wTDfo1WY3`W7H%lSP{BZRdESYaH&=Z9`QsO9-BvuGA{bO>O5OP*VAr-r5;(U5Fk zo~(oO)QKb2f&^O%1dgP-zmqY7AvoH}&lRh#i1F%EP{UiK0%_*(4Eh`XqF?JB+1LAN zIa^0|OVBG}XiN#u8AcN1Og1sknQY~Z9ga|1$52R#$XHJ2>_$6etga!+llJL3qlht? z0G>?w(VSsi!=KWu;TnpEN9jefKD97`>v3HowFvSyI)aegDxZR^xyg2Z(%BQB_qv~9 zRnF*eCRVe?<*Zn;P{_dONB!yGzNpEBTa{MfGK6E0#e0Qb zsdp%g)o1jrv`7D~e1VQntuTi} zgIHmj10w|6m>ynkQN*F;!cT-!KIZ3RG$LuaaFuGvvSKjG21u8wB1OAp5=_V`>;zUg zO`jG)-*C_`H%XVJYZC2|urz?N>1@)@Ij(86N5dNbu6rDp9b~Ozor5^O=lSzrfO#r->wtK8ZjsAlF=!9Bln2G9sPjO8E&AY~dvI`zY<+?sop;39 zJnx9{r8cX^wLRT0d8pzzHF^h{)ccl}ui#DOXFtM66*fR0Gqp}dL0D4Yk78g|eRX|3 z?;$v|qPQAIX#pKqK#Pi*gOch$kf*O69@%%`3jXkib0&?imQOvHgU_VCK-%!0lP~Vt z0nFb6KK&M8*(*B3zjHL7h-us+vw_hYW+4}3=Hp__7zYAV_(_?79?RvhWKR}8wC=rMW z5c*aOCO=B;V-zqbvpDn+^cwN;dWzD$9Pj13m;Q`rBGv!clvx7 z8KUeW1y8U#AChJL03p@hf~r8q_PI$E7gSB3#$8@f6pC`ybS{)U-b0FdFLp2LczO5# zDX$vXrmib|?|tw3-S_Kf=f_Em!*dclA%W!=5`!79O+^PRYKoX4fN3@~I<2r0IX3kTLqMkzb*yARjGqJ&pc6E!v`JMZ)NVl6jiC+LRxK1!#2CTO&b`kzLEE%W ziSIqnezM;^=lj0%o#p*+ZOgub=Re!Ac*(-&Udw)nH>`B*iGUtaS@ zYwer;k00r6mX-!e*L5v=a>m4fVst#QaOu;{kfwE$f1#V{`zV4NIl7LmC0~s|TM(m= z$jx8f$9UwR7IQ81fUigT(esfVXfOS#^ds|xG;IFLJc}+zK8XaZU?dQUNcFzDK>ajl z`om_bczH>x{44Z{$hU&u4epipSbL`p;{9YW@LQ`06{8Bf*shR4rY;_>O9)fw)Fo^` z5GY(!X-MHpS+(Q-#VGE8d#jip$`?J9FM23fbS)K%I}C#^i%T=b1X5Ue<=WL^B86g# z0zxezxH&E?U_g`!K1%mNsT%O6u&aTt$$r~5$RQ=p?FuO=4sydH50A~y{_@Ir_WY}daOc?X@yvOrTgP7c@t;?3 zxVq(se4kOQPa6DE;B?6>>P!O-~-o&OMk}2T!^I z5P1R+8N&y}*(<`u;S$nYi`TFs9F%HmP&61KF;qzeWJ>tcV(bf5S`rMVD#r2JSj~M3 zQ!_34t#kG-qvLpFqM+z{E z#2pQ51sG~#2-3>qYggR|!!A30E0;-Iq>?v@+`!q`0O^ElE+p^@0!BNZb{~?f!_z9J zl~0p=M%<2-#HYtuOpaH_%FIXo0az;4XcW~*ups`M z0C+oTCkw5s{#mY6;StHLsfk)JvT(J+*y8hP%gB148Z0WZLV^UAAVEuGtEXA~p)20y zOqd-D+{cB|kn$MTJ&yxDj|1Jq!AMH?ILG0s!9#rt^06HG{*fo&ZMW1T zpW&F;F}uxPbE7HG>nUqU_vIT@p+)831cA7O*0dm*NH-=qA2FB{NrS4o=6Xp&7z_%d zL=bYpJ$KR?08+xM8rJ<|Fs3|Vt4CJyUn3H=phPx2Zi5`2GC(7HzF5xqd%hShz1>aa|e>d?V|Lk zELXF?=WBK?U$a}T?b%*Yv)AQwJySeG=js(l`@!3$d-^sdGX>KKHCZ5GL1^I>`<+kQn&)<_`v-8G!0QAV}JnQOOuEW)8HtX z>-w809-xQm8G4DzbTQ-a=}iiDz|0?3BxRIr8TzkG0twZf|JTgj$hR$H-XI?oa)sf# zn@RVL!^AMo1u)5Jl1%a!aDYz>7M~U5_(lY|Cy_d8F9@J>)$>Ps2R`07~3|S_L_tS)P#jt16rT@LfD! z3Snu&$4j6G6RfH@A-ly1UXo)m2ul)Erj8!|&A4w(Q+ApvOQw=CA zMaTvGlxAP~z>z$m>3h#;qbm7by`|Q~> z0hk&Zau7jb4`1$dMTm?~tddw|u~M-zj`nIE5#ipz9B`W=%!(>TE={Zoe*&IX#uGf9 zM{$Y`M+>(3#X`Z~VoOI1lBw~7^KTP@_>xm3g@VW?Dc8)|L|?vK;%gD+XSvyUQ;bDG zDeo}pDT?QjAnZPah@TacFq1bMTZ~^rDvd?PBEK|4j+ry971Ansv-wSHtI2diS;CxS zJwld94=FC|G9R?G-DHonOWDN+r2~pDNc@)7L@oX^A#g00O@rrUABq&)i zh@jU%S2F*iyy}CTD9`x&?(UmxE}Q*IHoKb(x#W`DyGy`B zE_?);Ug$vS0f#Vp$7e=n3e+nf_V8nh{Gl^d&kE{j2ek?~4sE9jXyH!00@I~_~u82=ukvefj{$JB{`7@@;ZsaeYz?P{)HL1pIK;1gkgc_CMM`Vea zCt0TE$@+ZrG{a1R&Ezr}4dPidi%z?f&FtqoAMM-n=;{yMGw%I(=gIw*rPto$ev2HJ z^^M22o^U585Ak^SUF*JSL=aS9RrMkAA$bECsDtBK1@_$JJne9{HQV6ANuh-rj#x`9 z8_1JsX2H3R%roaYOUY8R*Qt>H>?-FLvXj4)?B;iqJ?KgPyXYW)7M+csL+8wMRw79X zC{L~UJ>Wq=7~}I~W}ZTl8sR#+_li^DFB-Q|P(EWgz4GJh@VX$HktWi<(*T zoS<1kTDN*eJyYY=N(F7FjXJcwxoi-Gf{Nuhxl~6yo>RCo&j)j0+D5koLrRLdH-)*k zoIgY1|Cy~+v|q4lAG&_sjG0CYQSykiepVV z^4Bsn}lT zt8L)BzD8$iziZVH&4!!DdZ5SQq|^n##(?r+`I-U&I3b2WV~ zom6;;%{3XMa>6cYpr&lftl?JH7#_be zm0T!!6dR8lu|P0x#?5G!zlH;b%`beqjQ!#!~Nmv{c+H+>!bOREzv_itM{Ewkj$ z_?dejTlV+?cRD$K{m*yo{q2;t+_KxSvxh`EKPrt$c0bHONAc7^6rG@En_TJgdYEDlRfwW@g67Xk65tB0S(WlgQ!2mp`V8 z9_S)?2W1NGUv%$IBE|0(5cRNq-VVss%k>^os+09Q_^a;lw^ON3_}eK2>ORH`IKN{A z$@e;b0N*FgZ}A>CQPUpmaql<86ZJ%->KpJiwaP3sR zUVV|Z3a!*u=_@Vu3GoSq(=5ySV!z6coyZq-%67uQ9|>8WE05V-&*}Sws|5h7~gmOP4~Sl%YeYYm%a*RV}8fnjVrw z%OHxTN{EA$2ydy15(cC1g|)jPGgL1dkpV7 zQX`s5!tR>{89kY>C#_`*H!e6|XBS^YQ(}SNr}^(vX}GUZQeV9Q7Kdf^^l3QEJMBk} z2hi9GXl(6@#y+YyS-_Gt{oMxF@{Rf%RZq=X?TL2z%7qcBOv>;tt1+{C+bh6txbR;u z5Z;n55?V6M8DdR%_fY9gdjoeznegt8>aaw+L43pP4r09D-TBJfxx}0%Y`*{c_1WaK z^FMXBop4`m51KLe3_1R3&*OXkn&ba8nQ%Y&c-JWZJgD-@?)1h*pB#YB+T{*%7G)*$ zRW^YO0$;$KN&*EG)On5z2A&s48>Z%uvO*}t^;4oaB<{PJc08~)H21_j*5?q_TD|!Q zB4d2l=oYY20tCRfs3t_fePL3eOZpq=KhT6hk>MqWld8e%zw`8lRtrF2~Dx&|J$A z2NZ^|ia9(C!5DYLQG6di#;qUWY+>j}xC=4t_FbH~h7#&n6(8=9SIo+nw_wDC8j@c(VPTRlkc-{D8hqxe)Q&in* zl+bmiafw8aGpVGwo<=QZi&dDKFP4PT)L!AsQwPM=g-zmM;SOn7IwM_*Tq zD_1mUWMbA$owsyyoyjh_M}Am-TCU3EY54{DZ!#~R@TvEu0a>EcMINiZKT3ygfbau06ey2ALqyV9<`t9|LUlDzgBBg-TL{E$pARq7>_M{3NoR+=UvCJBWY0*C}k zCz*jHg@Gp1(9V!QO52b^(uUFk^Png-7)#kDv!#)S89UR5pLJj(4k7#q*T8B@%7NqVFs zwmocFNJiFq7fCrNL3o6M?x~?HCA{SJ_Qr;mCM2 z=|kG!bssD!D{irsh2k>0B~w_t8nRjwm-boi26 zobbHkU_RA|?>kD>*la^fPYbuRg|?XRZ@Tf~W*PhXPI=y}jn&kbl~$$Rv!i;~sT?C; zpFAa;6F6IF6*wVW@-HD=`hZZn&cwW+vH%%i=`qHVV*tOIz$RNkWhqj}Zz42K9vNrR z*^8LyZo!jYD5mj^!Zk1brP;Kb?(fGDrZ3%k4PN%Kcy;f?MVvf9l_?rgV*_DLK#TB) z6f3$3pH2q?>H|ml3EeATuj?efiPgLuGfgYZx)`<@<3fD~TG_zt#>N>OW&{{yQq9>( zlOAF}%~{BAHG)|8O)dk;&WuJP;ix$_#S5a!L78d7lla`T$GY~NocY46=Hy|z9^m4Q2q-8#RdexIn&p)^9*Qv_aI%fQC)0|i4gjFSxtd&+yc=+*R ztoVAHv-sN+*Wdhl)5DYLC*v%ATzmbj&L`$R`~#eFHbWoVpldp*$N*HOD_&o9F+&zqj%$-yJ=mM^vA{kqQfpLW)?b z9D{DSJrYx5qhdn1Cd@Olhrn>CNo$^N6XFCXr%z9Riu^PvO(#&;}^#U8dunC~J z!kPe&VE;h%A~m=YgoX>@k-U*1!4jdw$KG^8P%&Niv0RxM30%C(yc5s!wH((&={CBP z?x#1Y&!(+(F6AkPQEXZ$?mCs&UX;;Ib-W-ABHfhH4QJdwgl)x6jp8lS7~U@pl4YjW*6;LMKo0sMpaHv|$7zXr06R8#l_0DXu`x*7p$53f*VpHRW68WjlVlZtuHm z*X{KmAN=agxo>{(!qAPOOTVOVo$7e~?BC9xISU>(Z}@Zm8u&(nTkK|KbNHs0gr&05 zl9qdg<`ueE;1(T2Bo1&aZf4aD8r4uf=aJRmjJ}{Hi!sY5Q#B%%;aZDqt;GPYwW#A- zi>&L8Xu=1$vNN+hKy7PUXqve&w9xDfb(%Z49sJLg-TLlCpiGHNUEFhg zmw#lW>;+Z<7 zRil$!6|ROuj5CKpHjAN^U}!yRMLhA2cxXpT;yorGNuCp_Ew+lBsNw}g2`?ZrSH=Z) zr@cU_eZGx)&FVxsC2BO3&Qqo$ZbXkBsTa|bGK{GoT~ zKWo0&`uofFzW9dkZP~N?M_oUmo6PQWw314DDfi00cPf^z`0GcP{_-j)>^gcn*%xo7=L%AW~$T0Qm!|HaTJ@%~VM_=frK zct2CbsBNbcD5Gr&)KqaImsBQ3r*O?m8#i5<5q{KqOv)=um44x0(L3~(s?!Ls%DM(h zDT@XHsRYjfAVy2&ZLf)98A?ug7=e7%8rprTs{LQwl6kFG*UuYNHyoqW*l2*RVyn37 zY6MZf43=O}XAJ=x%V25?N56zqfeAxJCgAmTCb0%;8KPyJ@a_(T^~In^S6oayqWX>eDe;{6sW>e9kiNMhFIKS@X2C$La$B1b$-?)-!YOYeYW`Zp&wvTB> ziwBQ)X#?G);d@%iPhN6*!^O2-7hdaptN!3%_1?AX-u>-M>)+Y@t2e&h^)}^yJbx;u z-kHG#Km6d&XL>(8jo#b_-dqJ*83E#=?$luuE5dc~1%IKuLter!_pd5nB9}!l{jsHn z!dZY-rG?LR!H@lS!UG9kV{l5m(V7};PfWGu2cL{DuoefOPb{|93+p2T+(1kxQK~7X zIWO87T^;44mbOjbsdKvStFR=I9Ow36uX--lmJPRSE!P(ahj=3W$|w}#!j2s(Gy-EK9Y}SM*Kim zOFpfac|NTtMJM@S*5k#)tRz!TIxkj_LdaqWxuRwK>z~1J|Dhacwjo=3UhEmZ(&J&pYe0mfaQ i zZ_v3AuS>pAN#3LiCT~(n-hwSpEh^NfjZA%^I7;Gll4&AFSR4~Y5rS9d1J7bn;)2*-}>_VG;i)YL~Y0@0XlBz??eC9tM?sWMz?RC zw(LEa8c7H+-01&^m~;{2uPR(lwRnBJA@0Oi$9DvNp}en@C6sZ>{&-K^7spMs6Lz+; zOyL8XCD90%4u^caK%}?BG&~$~H>*1za(t$@ai%8-rn^%x@0hhd!gD_ZS3?jQC$sU^ zNn3Vy8=-LrB`EGFAVDOIM3QlMgw&uYk@0L)Vxq+2S{QehxWgPP{>hRc6nDDWG`1@i zKS__1F=T*BB$iGOjMfMk9Q0c`J;#LNTKZanw6^AQxj|5h7UO?(SAT31*B!ri_ujjE zcec-GpM6f8;3VD=z#gL5Nyuh3$0$Kvfs~DUNk=raQq;9*BZ$(Ljt)cxNTpN6KP%Iw zq|=0|P2EE9N=mB{sa2&(n}BJXCaMC}*aThaqOD_;AIZM&ozEP!CBpA>=R4o&eLvsN z=ktXEuXqMVLyIz%YB1HrSt2W0)Xbs+DlFQw2NggFJ~*!?aM_qEOwOQkFtN zkzde~$XO*T-&N`=_jH4HfKhRuN|jQ1YjSKX*}Qkh>J8atOTTvCsZ+|24~{%h?*B&O zr+WX!Zy&t5nd`(?X4fenfKJSl7Rd`moi-W}&KEoH&EMO(x^uKRUR1l=yBGEq`;Gqgl?&ImuV45b^^x{R7H%x= zE}reY)c#TaU!9hdrl~3UXl+4DQWZ%j-X<*(IcK*ZG>p3PE-y}6T1~?Swswh8H6fWcl7jhadW!up&dzoD)nPM zXcQ<2P|k7Ejz4F1f`rJvZ#i8h%NDb0GGtzxe{C#Xv3=KpObqRqcz5QzXI^}B=aEO> z9slhIhmY*~{wuHUeEOBa=5_AUO%L}>ynrh2y@b%gmv-NL{MxCff2k}wGkx;+Z@u#t z*OUE{q+EgwWuxD5p1v-np}$j3S%JCCi}7u8ahI}EIT6L;RLW^8JDL@-Y=t1nY$2*` z=#e|}OeDmrNRVy3&T7PEUa7l0$IvuGX%S}99w!i6AU~4!sL{@%M9z@|uT&@>k$%q2-UEC-$=)XX0_HU3r-t}EGfe=w9}Az!i>N7trSJ(vk+ z?2$r+bEgsq^zognD)^>V@rS}*l<;*dMq{cQqme9%YM@{eNLXQy1QLh}+1CtR(iH;A zwWPL%s3;f`ed!VtVmh6&@|K_rO=a%3ZU_$w?fm^ZA?NK2N-@7*Q=`pfCfMX5PH*qrcwx#5XJ%adaA6O*Li@AvT-)S zrrCKm!&Hgo*jBcijnz+GU~^2*F&Ow%EGvvEZ_G{Ce_>Hoc@9aGP^?qcB@!OP<9Gs3 z;|rKh;~6YVxDB6%BaC@A=TyTDs$oGjtn*jE!ZdMUngC{nh61?h>6~_Wt#&uzwt*{h zckH`T5c!Ay=SsD0r0{wFvd6JbsN@MgHUB}-DcMy@DL|CBc^j+UN5n=qM!skpM&k5DVH*4uBGXNC2XZYl5a#0uTv6v>q?rDkd)ZGA@yQ zgg6=@D#kJ0uI72ZenD($$KnMCoeNcZ& zc~U>C{EezdD9Y3Ms;l+VWvnkc5FNrpbWj~)yYMsQFnfpo5&wl=q?gtI(NDBgLf46+ zV3|^tF%1rwrnxG$Rh23jyF|AM(RFBZtRd)MLRAgiK+^FPGCf8xrv&NH_))42CLURh ziy@|Y6b30H=mI04vEgsl@v7lUjrM8KzTP8VtSY+*LDue*20*Ey{k?mH9SMF)f}fI5 z3MnB>DIuIRp|iN4>yYIB&Gf|&IPUEuT6)xz+aD<2oGfD6Up4@9G4IlcSI;sV|k ze;d|JAqGGNrfL;Md>*CpiuHqD^Z|x)?0H3InW$9;dm0%6ky)`}(9>D5wU=qFtre*D zxyjaESpGEGCYGb^z2ZfNhNY2VG$IuWaL4NsotvI)?*#@-Pp0{DZZh6W{Y4x_#B$W| zZ!Qc$fAAZ<#CsTNb{d{$+ZFKvcU_&#@S8t8n)NS7!$Z<=9n~ceo}2Yd9aI}jSOZJN z)VI>UJ}cq$*3A@^5XvJJ6cGL5^6ca2@XsEu zhiK2I-E(>L^S$yePi$QJ84h@t(}jNZQ@(b*N`!q8KC<;JD~q+<<*!Tb@z)Mltey** z&m=iAM$QvF03S0%$&syOH<=?CwnUc|KP2&A5@9I?)6tlOrllDmWGFFRyPcR?Ly5^J zr$75?^})~gFaUF6GLRZ(CauMHni+R9$WFq~MA+W;8QyhF(*5Gq%eJ>hPF(M=r(8N8 z=CQo;JzkmRhoodk%)(<(B806FZVl~lO9*E}xH*LR^+EAkLO2`3%^@6_n{D7|2**O$ z4B=#GT#JWrB806FPKE+{IIJf^*b3n&h%qmYHdP0pvw!v07}2teFXD^redq6O@4 zo9t+9d6vnxF-6JGYoRGVVX27bo15bLX%~&U42<8 zfX@@O0|uxNkp%zOA{Ip`hLKbPP6{F;a-mz|1%`_wIMmHq!8TvWVF|VBFt`|pkq|yu zfdnU#S<&QV{#4hV<27Hq_Wd)%$?~#Y-yV5#`=f_i+4QmYE!&>_+1U$|8TxzOTUw6| zP9CR+_U?V`JFiZDXs6dZsIE0|2iJAc?_xMV{X;kk|HS;oe~)?K=UD6y5{S3YLGU^p z*FVyyb=GtTlz`?#=@oFANAxJNGAqI=j>=bNB5bszq;!&4b&_5sl3OK`Tcw%YDiOVt z666ZJu_U)jB)6jP|FkG3k=!cbTuWNDR7BZxS_0@Jwd+`4!#Kn0_jG!fenLN|kLj$= z(2YUO=ALG=QL}xQMilzNh^kup`{~hDd?>oAj_Ar(^?0o4L({p3R(M9(+e7d{#St8= zFngcG*;zlJKTJhrB5BpL=BOP zarp?PTo$Dqbi&a#G>c0EZ$5i->&eHUIFjADdiQBIef;doUF-4(CU?^>Jk!&5^v2}R zQIlFR{V|(CZ1GSAn8tj$5Y+Jt`;qVvP4Qv{+JTWle(>?4A+O?AyGz_A_tRXb+ua0P zeXZIeeI;D$TdS?q%dWDp0akn!ZG+z9>JhfX9$$~PUH>Ww3Y^QcnR&wXgt%GmW_GxC zh~2Unin6?l6f)4}Y&rp(Vgy%dScIiODpJIhiV(W-DE;BxLP*DFd00JrZv<~90mN=& zfH#!@;yv+>DyiD01w5d5$eTRFzk|jk<6J253vVH%#MemiWYYqK6`N!;VNJ2vR%}Bx zK*@?18%?5WG9guzkV+w>vc!vsH>D9;717XG6=_PYK9{nei}i36Pl8$)ZfdT!{K_mQ z!QNa2+0)8weo=*q!UVDcy~sdf2PkZGZ4|b-wh1h@c|@qrOX?`oFw!kaYzTp&ZkABV z3QDjU@rVirI24g6e}F_LB1kI+U%c{rpzXW+(ygh9pAHSYFf@F4V2JjE%*%VG{y6#W z-LHc<@Z7k5}R#EUmp><9ivy3uE|#b-;Bui6)llCPGc z#!zwrC%`#y53n_$0M-KrV5>)(BOuKYkmd*oqk)Wv16av0hsdQG9vH}YP}HjszkpG* zs#ympx;)euA=ah)x5>ZiS&J@+FIbGQ7Eu-KAgSKS2&JfshPZLDTal3DaM4j_{!AAu z6ml(Cbo_P?(}DpS(IuTx83$no23wDQ`5WV1&)(YC@k+gVYR}%cPxtRWKh^2F^v%Z~ z|JL;DZ%uvj(xa`DpD=^(UcUap^=rRFx_X$R=&Oh|D&Prc9%=9c$bux>#D13D$bO0K zXE{N23vR*VR|OBnxPe5rn-Yb(BW~bMn10}=6RN%Bs=W!SU0SMT*o*LCDR+4Ee-u?m zYv4!~&vGSX;VI6MCfj|hE<3F`(*7lu8L8awyN%WvuW}3eV58AO!Cwt12QK3^?*o;{ zMQj_8TaZSX#SXXNbP6FJFDj2z{qUR1It!bhTDE-oBToh5Z2DyH>ekblRfVm6lfS{; zzcBqVa~`eX0ya+aR%pfq+Q2}dt(lZTouec&4xD!2S_e)!aMFPj4m`(!%^91pzr-d2 ziB@5aup(7T>`3evUKXBDo$|ju@0W~62!-{~g0=I08*)YHFVHm115q!#%R*T!OJ%w2 z>2h}oU1FEiC3ks7(jysfCY{Qp<}OZkh?}JC>Fss>$^O*A)NA5*<)d}S=N(%xDE>%( zD>GO(oW7FQ>TJ87utCxWDI1V$@P;OAkhDR{2C>oUKNNlOmJWBORu1`+%ni2;}wH8E+HBP5yQ`*WI9$1;L9N>0vdvG zKvMt$8sI1y(3${YsG>FjP+yL9$LLrz$g_AF_$CDI5H4a+^kXiv(R!&S48kd+=+~R_ z`1U-OEkn1CSWOHK)7dcbora0;G9Z2{LnFN%{n{p2+DLDvcw0AzOMEJep7)bz%Xk)K z@zD4&S?mt*vkAbDLEx`sCA06?n?791hRIy!WU@_L^J96skUyBG^AG@#qIApulkzdG zZ9uw<0iGcS7x5&`YLC@QX39&X&`Vy#YvSv@*sKNcM7#=~g;yq)g|n1aEqN2SD1eg( zO&JSuD@D>+>0Ni<(KAse$xZaN6U#&B zZU^Qam~&tel}|F=Bw)^^5IAT63dkN2Fq8&`oL5A?fRVf~K_!6aQyR2r(I$Z!v<#+s z_ex>qR(=`2WydwXty=Wq4+GcXns?bM`KG_BmlX_|_tE>&9uNNxC1p-8lq5ZKMdj?++CB2@jrBA_%t zP>?0k5><&5kjamxj(Oj?4_}0^Z)e}#ox7cn=Y5~&8MCMDlQy@J|B)^18vpCy-&JG{ z8;L|KQ4A2NcFlFvq$kP=h%~M3@<_1vR4a^T9 zU8~;S=q(U>4gJ?KZUAF%sO~ac;5TDKB6d;f`znw^legpuf!+-pdg@ZIki|`1*{81W z>s9^0GS{m#;(aE1MPKRSB4;&6XPb^Ps~u$)Ib1u+tcS~;MMvr5k}qWG zbe3js%OONEXeM))a_qs}Pjh3rg`Ao58ldnRpzvzS;qVTxAezEKP$Kf;q?i?^Xb1<< z6b?cUN=O`#z*lR%Aheql42LCdYu~i3Wv`+3Xi@(^wy`E6aN`FDYT`kcnVcB~e&{o9 zJKV7xu#TqJL3~Gb5HyZ!);tbs4q;IRX<>liUq1oJ$Z!pVK~!-7fzCb+fmHy4UIp2X z)!+tky~}u?(N&3y}A11>MdUx>iZh|-u&TbKDKH59p8D9m9Lxu6aW;A z^MC@$?n4wDhcvBkW_1Tcol)CjvhYE3yPZZ1J%DM5R`iO$YITApDxM8yc~ z2Nt`KJ0OQg)*K-#zADlWt(~*RTBS|#h;acE5 zZ31vr^j&6Io(qWSIa`Fafn%mPQzSiugBnF0Nx!rmryyin2uTdaKpCegg@H(r(~iR! z<+cZSBoS9iUBuCTnVcwy@5Zgb`Q!Ta~z`3?4@MkOc2ngmqF)`jDMtR^A@K;-KhVxERu z4TPRoOZmvG=f2elIBVk5Soo-kV6uqdh}V4uhoIh7EPU96a?psYJHo{taZ3+pu?Mn3 zV|dqOQEhm<9&odnR{}=WD4hXJss5eNYxam6clE29J?zCE67Du;W;S9lN?k2I&NqL< zY{bwb-!NBQFtecE_3zD@nTv5Pd#7+TiPGfAwffU7!1+|w^R=)&pST#QyjOcLT@51r zU^?l+NG1AODuWUa{1D|Kpw;&{R$Na}W=c~@yig4uRv_7CW}?$G(W&ALRtHP~lxw6_ zKV`x+U1P46>{fNRdR7@YIgTTk)eLPm0)@mTmUot-rOQ^K(zujNE?-eHxhGP*L$t@1 zNlfkvH*n&Jq>Qw^)ah`S1uICwUgH#l66v#Va&8VjX>8(&z17*`ZVWf6TjRUK+v6|W zUvTb^AK~A$zwS)&W8p;nAAUu2yQ-UX`>TTPa8=xszLE6Ddz~koL&o#oOY~*-vil3~ z2$|r=f;Y|6{IBA?c|QDSJjXv2OI?m5_H-NRHsCdRjBQ*mD;+Wj&6p_1b_#Y_2;u@E zfo=HIEBHqjPAC0HV?I=eH5gEzrc+$HYNafyJI&kWJ!+TQr=C($NfT-XZbxln7MHrB zO>a+e4nBAtox}f{bcRnyk~S<0xXiYMl#c6pGExc@#FoPriNOeLPDW%Hi;lxTCa*qx1(EI3*xmWK;>u9elW6Mx1WwujxF z!SnQxJmgNYqu!hD+rjUnGse5(kN)4H_hj72YS$yN3fp{8!yLpfPmkdA0#r{NsWSC6&HhzE`{3zR)1bJgW>l%Wk z->mkXKn+outEmVO5ddyLk-yP<(cH!NE7v3viik=*O)8H@CkPHd3`ZTE9<>%um@@;; zKpkq;plw;%#r1ZVmA$TP*?&GY;5}mC%;Q zq!}nBN!xVNX38T|CnaeVn2F1Thvc5SmTZzgmF2x>cXjUG`|WqWb58NV2Z!&D&8{7K zulQ5?+=ch&6+easTD-BOX+iU?qEdK^F6${~IOnR153tXWa}oFh=iCs!waL6{DkURW zHY&=7h9%1HrxJWAWvk`8zOtcA{az{6DQem9l?~qDl&6}awel5O&yY=xd08y11>9b@ zVF$Fh*H+>sdWVyV$c0Ggd?c*%fpb0Yq}b??7NZ)+{mEFm!Ca{g%FOoJ$f0;cQ%dIt zQSk&Se4#+Sw_d6DwJNQ?7WIJN+Yo3lmR9rxdW@dny1+VPU2uzgvu}%ktGPA!wC^YW z-GSZ4v*yp_UweP6ANRj*ej@+d{I9Q|-!La)cLj`)sxEl26bcoFHx_kii?knWObbtK z!dWH0z)UFs+B8kkF}q+b95xN3HXxgLqA8d@YQ3`Q^~y#dpeSB9pMb>l7$jpSVi3zg z`-p~!*k%q^*xvSl9e~w=69EY1=z>=@T0_1bmH90PGdr#{DV+-IQYI9@7qDO`sUbqp zJ{*m2$5et47P8}*LqZq@dOoC&kA?NIOg0}0>3PRO=H;hDLBbHgF_chCv9QY_KIRD( zH8?b_!N;+v#L{iz3K#gEL|KB(iHoncrRAEow2Cq@5={GRg6R_dQGl^JFY*758a)v` z8fH1xY|DLNO_OB@O{Ye0Phd0{^}Lg8!bJ6!?LmXyi)|gAowk>u(FhHmq@Jc}`F^?>7EAYg zI`xO?3Rofadb;#J`Y1dqt@muB8>MZY=jhYYvz{At9HL>Vjy6gOPg;6GdXI`+HAeMd z3NU$L75J__Gmxe*&m)5*%e54+{s4-Fi5u1k3EaE927{FMXdb7WN~kjAs5Xq%h~PdB zs|XmLFpi&our>k5Jp1$G6`$?#%eB~ ziRI&%JFN~quNSy6me9vJR|=#(pRn`~+pWTfeqMBydNEyngHyrDvrdvlQj9dxItgeQ zJ&9w9XQxLwiX2Mkhcw$mGY*9$lu?a?P#Ug`M$;atB6<(6j*nIHOJCS>MH)=}k5o(x zEY1@hlChA_v8Ite-s=fDmOR$y=4?tJndZ#l;@U#pGpk#wgH&v7t`0W9FQ5EYv6HPW zoa*1Qp8jValid4$Sorof&%ucavTWjtD<+(VIbvZkUerYEdn-^U#L#J>W>A0E4=4)6Gp5cp!(k2+6rVfn(x)Ux@ z*3SmW0Au~6pF$_?0>IeT8L(Z{MRV}TF?fdMpnHUbUH^E|sjfQ;P56k2lHJW0 zcRkaQxANl_2`3|kP$VCY=%pc#@_jv0!1$xQ?U`&kGf~@vk0);G@<=G6qkV3{<8j%7 zvzO*%Af521ljre^`=Ydke;Lx>6}sKR=I14+K4ST34uMG;{o;VQS7ahJ=9-r3 zQ!H$&?8-<=-9*K?k_D7ljO_&q;ZSz+U1m_75R<}~ejOFbu}FKyDp+|GEv{8K(#g({ z=x6n_h}jRa*(}YLJ`@pD!0S~jO@m6dh$Lu_oNqs$MDQHUf-_rEn0qSSZn63fo0_NM zUt2Z1Eyd{mvgLZ?&o4Y=(~#0>^KCOu|Cx71z2Qd7K)m`4nbp5jAL zRfLmDM?`+1i6X>6EJ{_)QV`L4U*)}6!*M`;n*f+a5Y&1Sr}m<6|5}4(6Ed z*r@d!#X`P3ei_awB(qsW)`3$JMbl7xgxHjP1x}--IcSP*vA(snt@#f7p;J|fRkK@L z*x$>B>kEW%{sWCmDpq$-TReBaiHEJ2yBXQWu^a)^C|Sr&jM+M`ABDrfYVpBw1RgIA z>pDD$#;3zR%`vVGD~e;>9QJx06U3g*2TPWC(O`s6PhipjLXsq_)=w=7ujzai)s8C4YF;9|K9)-^0s~;xRwR2J!oIZoLHM5zlnLhsgKYeiW ze`Hr_a8uV6KKH(N-+PiQTdE~22#)H`Xjh34Ku|l(-_i{Sn7A5WFV=n@147z zyPfsQpM<9)dW(4;`l5Lce9;x^g#{lHwsOkO(^JN9mVKJP7dP6{;ew}7Y|H(x@hsR^+l_P?JC+f zOy`O`?WwVIvv=4A zY;*$HILoiWwOEqvhaJ_v!s2nhQQa&noDq23=P$1F1%^%|g>iLSgTps8-|8#NX4&1m zB%G!u7uy#Km(St;7>x6UPfc%lwlVIB`udyu9QUARk-q*uY1ZKZ&?wampBq7$tlmSd zrhlLxb}NFB1O1U3P``j20}|;=4+dc4Ws@1Y`~8UBrDvn&jBtq%y4^dXzCIKRmz3w} z9({r*({4{r&hrpWD8I&-+l9o$Bh4NpI#7YIyTasEVJf-fVmW?hO;!UCn>2>Bv|0w` zqbj|6bveHIQim&Yq0K|wF3p?EibhpdRg@1IY{*Bw+7+KtatPG8xKs**D5_7~EJg=3$HYKoTtHBN%Oy_AlfYfS@wv%n=FRQPJ zx7BXZqkbqpQ@&JEG}RErYKf>;M+@ymLmF5Z8N?_5?n)Hyg=?gh(F{XaRn_1MBSRRf z$W^#YQMdsHYHnPJg_=zU<8W$kL9TzLC1g0z*_TbGM5U@rb+`A$fBo<0PpF6A&L8SW`Z_nPhqKriFQ|s94iE zulO^c_0>rw5Pfe_UPh%jbARF+%DA&XYkeLDbx-tZ^>Jvfi-xlr^TuY6cGbC_N?DTf zO!_lfi;C9T)}^n@+G*RJ{<7U(lEmtKvkPB0I_;|6VNI@l$NonTre2Vl3ZHL7K;U*WPeHA9nw6VbuBEu3)FsWdLmFhoXd6@T~feNB;_Ic052HtcWu<(8p42Cj*1ubTjI3s67LZ`#)q~~jQ=QKT5P&4#hzx%wFgDDO%qH*>}gR+w~=mD z;EnMy$ihh14U3b{&~0`nQjkK8xipO_szs)7U9ty-yWtYqYbmrUE~`~h6@@Xwj+Uz_+CjV3<^(^oI;^=?#X31D-SLlzU&8N! z&%NO^t(R#{@gM(6rSZ$Gb%$v*Q6M=c1%L8YS2h!n@wT39O;$8A-M;DgQ(^w_^U7b@ zMOMH{KZvel2QNq8kN)8jdsQtO=;Bibh7Y9iMFYR!*X6CZ;!|TrEE~h&Y2tZtM4S*8 z#8q)e=p=H)3b9EXPBit3n6TyuCW9KKP~@61iYd@!O~fm=!!~((a+&c8;+L)@yIJ@= zoaAtzgxIGSiv=PHS?+`E$}=^ulu=7-JZg!>Vkcl^d@@s0e`RKRS6dTa+oCZJuWdZy zwGpj6{2NJTT_^hD{`p<=QflrR8HU-@e!X~@q<`Id*Li{@rK; zjdRfbH}9`=&^P%KIS*)wCLVl%6Z{kUk-Cc9z+^p(R*RW5i|wE}yn~*VP_ihjc2YCO zcA!26^o*Q~@iTy{Kn*Yx7@BCC3d{$l%R0uMmUF>lh2&$>RW!%Qq2*#`Yyj&W5IwXQ zXhXSOy-vrqAT2}v80MWPJzYi+N>5>8( z+I`@&J8|A($SH=F0v&;t1CxGo(<9nbJfqINd1sx0QU_I2zdSdP92c;IQzeBbI z;}f(Fe72##7V`>FZ$Wt|_Mw5M0C_+O@1!8y&RNg^&i_>W+&~XC$}>MW6ZW6j)BhvB z$NEQsHO~QF9*o@twLG%7Z=>Z~n5$ z)rHhxNKp>bbkRizWgVDmVpVKFJw!*8ej1Iwb=m=(VG$~&(LPRXIy8F zCV0tp^0ZEBN+3`2l=>oN7JE54$Xn`^l$k+l%6F3~_n*siN||~dQ4%9Y2o^<2LL*~P zQ`!>ot%Ds4u_y^3j)G7Wq~IXX1V=2Oz%VuK_$XR&>NKd;c3QAMkWL>I?AS<7zqRi< z;j%-x1nr;RnQzwF>+XH_I(x6Z*4p>WME5DV&HIN;aEHinem4b1jO#U*n_3IE|4S=QPel{cV{xezDVtA8Q}+t_*^BX|O52J=pB_3O2_JdHxXmU=wRGw>_s$58A?fIwZ=aDZTWF z@~A&r=7jNVgNZjsdE;jRy7Z_Kj zwlFT=@H&bfG}XqrrD1H1uxxfF^HpW+Dfa5~N%mrEyPc7Zr?Ag_r@ohQ+Q(Zh<5;Ip z;KGz_o9Zl;CRpeEUaoe(Ef2*u2fJD1Qj3Y{ZEsBMVHoa>kyqgno-aZE0$xhBsoloN z$M6{MZboj?dx7GV$XJ!=*1{@yC;BfPo##~gbo_q7?vvU($Tbi<8thi={;cy@<{RsM zE7+~zi)BiDzT_qzlw5ZZ`tulPwf%maryWw@O7QPYHl2>t)vJ9Si_^a`+7IM6&VWzS zad`No7_6HvzD`NX4$9(`F1lq%C_m0*x+9&kOjo#Wn zrzB|8HMjM4+uqkqZD*TQrxW=>yFVoK11 zMcG(XyU*$FIFV#O+tTsMgX7ec=V%?R zwXD|9rhW{ixxbk@mU%^TBZ)oTw0_mvS?gD%zP~>18+*#JYo@U)%p2*kHFi|iLN@dZ zWi5Taa0UhYh&@^O_c8898x-33m{g<)-XnKqk?UR~?jA$FOS?bvSd`PE*xDh+X2@w@ zce|@O@+@*{VMw(_XZncCLMAD8F77Isa`##1@=kJedY=BO?I_PjbQ>>)N}@Q}t=M&G zhdLlbJ5!z8)wW%Cbh&NSB~ja^!~eGLMfFU+l3vb7X+CQ?vKF96nEo`$! z*Q7%n7#!x%=iy((jQ&853YO8Hm;6!+lP^jk?FJw(21QV#{~^c5mWnu^2ghmun0B`J zuIW2Hq$ZO;+kUI{xv39XGZP1&RQqKFTnWA4WtbD~wca6_`%ey8SMRxARdCGP2UZQ3 zQI3&&;6>V5w6loCx$zw0cCl>Yc_FepvODp8D$F95-{8L$9FPCd^eN-NQty75NSwdZ zYvG*-gV%}abG$amN}MD04A#378 zrC#3=OLFD-Rf7ymr|7bhs=IW(mnHga)z^X|ASq+K8CsU zccicPcfg0#P6hw!3zg1C^k2&vy_2(o4|>a~nHuHM5c&oi&A2$Pa++Y{-UgsU=x?Hl%`rU_3kIOV~CiRd=KI^F8-Nze@Uj1_# zu>bH7?E>@dp)_k%%(yI>WWJG_${jAke@XXBt*=(x!ui?8YNa5?28>nQmHG>XXrmdK1I7;s+@(br%{XYakh2K@!6v2U^s`pI3eqqB7`ut8sN8at-gpr2yfL44vK+x8}R(=Esk z!+d`Tc^wk(YkQq%?iazVu>E1!?9h3>UH{T+v~Q(6_a-NFf2wbZy^XZ}$T~B=<)+^q z+V|EqZRK09)?-xlcC-=L$tC^|zW}AMNYp7&&PClK**TK4i>qN?UDl0q31{ zj2ZU;%+lpJ86#h@ZKOurO^Nn!MBWwHY&+ukyWV zxXFDSCE?xHn}?|T4eA18)9NtY{|?{Rqpx!US4V59>yDtDbN0Qk?@((wK6>%Jtl3_( z|H#DxQl@;SztmxlQ$RgN&7|`6k2oha%AY$Ve>&UX*h>KSQ|9jR801H(y@p|VGzS~J z&p8f{I<)}(5`9t!*!39T--klC76aT$u2BJX^S?RIlaL--#`Y$EI()Y}xIpc;(V3<6 zVwTf@9HkwYyAn2RqaJnc60G8$7@DeULLHUR6s}t1%CL{bcxWYmCdO}UlHO4B&iAEG zHVWKq?j7om4%YbOXJaeNt_=08--J@%rrm;>-jk?sZ|A)9M1{W(S^hZWh(7aurR(NN zj&{GG7OlVluFV+2J4G;u@cac+%o&e!{r*9w@-W_Q-Vs^zpc~&;n!5ZR{8ZmFR2hB? zerf)XG1TZXQuoparo6<1R>Macbr0#AtW%X9)!MqfP3U^He_~zQ6#aQQD`%K{q-R18 zhkCN3T|+x7e5TI(h-dU!*6mBYP)Da)mR(DYvRGTC4aIIY_7&M{qV-a3LRVkLUQWLz z=~#WvLaTN4vJ`u_u>(SV-IYz~?{+o_%yajIUhm3QA*ytzvHnwxht!~cG zlx)?Sz&1Ko^m{4ieTB1uTJ#FYz7xF1xd+-)CD^O+Zv;C62+rzMf-?%ayLE#168j}-Lp1&&jne;DfO7z!nKUg+Sx<7| z6`{%y{7(%lLxMmE=RKUqa9%jJ6CC%fgwJ9Brroc)j$d_MzOHd!$@gSvqw{32+30Q2u?sYi-{~dF?iRmqb)Io>HE|8w)8(2~9gT;Y$RAZ-HFh!EV>ydAC7X)E&Nlx&eqY9VO%!fyFLFw^rM`t_ zqHSgTM-WS&iJ1Ka?J(+y(LrP66O44K(SvK6L2lq$A2#;~xi`H-I9tKXe16+{1JeZi z6O<~}1&#JVVyycbX1k*>#Jxm)aE$xlV~lh^$BXW*803{RkG+ZoNcuVP;3D^3h1DD! zj%=kbNqCcy9o>&{TtlQuS!1mRLK~@6`3T(8i14-HdD4lBMrZt(>hu&O-%bLptkBG-r4s_tQq%TSg0t#(dTKtK4hp zOP`?8Do38FdzZeK28+paq?GNh=RM|TA#yfYD< z-P(H3;ugWVmF0wL47S%vUA@*_J$n-{P_X*5k3O9|KgxUE!@L_x-Mp@!t)1v6sQosu z<1@$f10gZ)uAVcvw@A3(5_|e`p&O$kF`Th6jy%S%JZBa69(BKN4?P*1iX}EO&R>)qVe(%s+r1#V)Xri2msm!v zXxf*1Qi;?TozJ*8USgm7T~tb}m6)n>2DPZ%(-?1RB(_+GFx6=%)AC>LF6RD}DQA%JVsuw}$!N=l6uT$1UFkwor@_?e zSiTw+&SCD84O~0P$p>+rI~m;)_by<#%)fg=-B(KZT{K9W&X=4gc~Y$t*Qk=3=oBKU z_X4LG6|%POZOD?`#d$hFjwab@8kMJI9$To((wTS5R3D6SY(Ja(^sMny?kBn2rz;b8 zzwj;>-Zg*`&db13Ig#C_=3kT!R_$2eaH5KSvXuGgsbioFC2BDJU%=-Ued-|t9Jk6eb{ z7#TqdNfjAuEMqRlt2iI$e8(}>&Z0gj=RS#H6rT(Ef0XkGwfaE5k5fzk9Fu4(?Oe`7 zoVhWs^mUQEa~8AQFs^T$>%RzlY1I< zMXi<2`&t}#Fh6vs_E{#rD1TU9zNvHjAamLZ)H(b3t%Y_zNn;)x#^=+hi=0HA9p^f+ zjJ=od5AyqeXbbs$p0V%q-8{yJt61&>tafH0&6~oQGaqTrT+$u+9`96)GgH~d_gSY< z_0z(fxDU@LA38&Pns0nEL{0{0>C@A+yU2T?FR3U$k`X^r+fJs%_>Z3dopU=bKBM-0p~#0 zM6HF{1NQ6eTmH+qrOavVqwE2-N2+0k>(4z|ru;sk{H=4ojXBCU_T$DF3%K^23n_DF zqD{S@o>ujw9KWeG6yIc?x8pkH!$GyTN~K@v%@Xyg_U$kL7$^hY z!T;GW7vQL>Gmigv?_)QFq~Q_e8E%1w$6(Au8nHYih7ckz(_jP~nIyYOws~yKCO}|h zBpAY=P+DeaAjP7TM^eg^F%(KW!cav^TWTNB4s{$VXj4nEqt;5*-2TtmyGd9oX=z8> zdXo9=_nmXk{m$c_^PTUDB0aiJzr{Y#yDa<%nePrz?vc8uFFV3V3IEg=yvO!M{8w}z z!j}mc1H^axwchMPVXyUlAW@bjPJh4tm`zUMm{06;Xj6170eU0n7nDl43P0$?!ci0yU*cbF|cBg*H?({s! znD9K(J@J%-FeUbg$Wpo{aZNs;Qb9sOMvt?vSo~j|H~agGj46H^&bhR9BpW9fiyUy` zj}VqHFU_W0!}3VaK@2n#F~ppYCyi&(>}f-cc^;#jSY^HU3B-8@VMt6o@7XhqLqsgI zh;ldMuORm-V`_nnzenS^c02dxG5VD{#!`!Uue73{%nwCA_%dUdEx4Dl_G|1vTf|PT z9Q%xjTiM@(A}*q>fH@WIvG?02y?OS)*#1c8KFhu)XFUhEYd_=Q{X8?W4#V8{F%R31 z3BBra9XY{~k@{*W-@%h4fea5z`>Hzyo2XZ~wlh~a&bauvj72`f7UBE=T26(Ro^*XXFUao*;5gDv%@K9!d(wmqK>^ zo^k=@Rm#I8pUjTZ#a`bVmi8DjmJ~XCHHzEW_SckmkhDmAPyK+F#=LC+&)Lth%@~XE zqK-^-Z^F08E`mnt=j(#u|gI%kTLL1A?2assI!Tt9Watt}#>p45Kl-n9W$Hih2bCx<#8qu+Vq}cbd%k%%L1_8otYzw9>WIZgB0e zpK_1FDA#$rLmz=Gvki@mE1UJ*jHBBqt4JAgwKpkQZxlMus52*QHowhsA#kFjfUgSmhi60;66S= z>7#VY977V@yEv~zzMDw9VoXAcI5tt$1Q`^QEd?e$LcJ8%{c!+Hli+hpdIUchbx9Yp>H$8XoPW&Z(M998s z6ri8HS3}5hzeW8Nec7MwcTLVu-%L0!y_ju_`3)~(E5A`bDUk4+3v@sC;%{Y~-lUso z(%QHN29mTN^BZpG{rQ6ZH0_A}GgORAj!oo(8T_W5_PhECa+Y}o>|6A+1YMn+zlifw zv;pwZzb3ifr@egIeGVH;3me#fIrp}(xk%(WaxJ(v(P#dn%331NTVhXKcwM~I*PS?- zu^s7&hq?~&?9%<%)2WXj8>y$043ZG$!^eOR){}MA{cMv)c_e)2b(Lwa;CJ3S#PL7; zS9xRHISx+)8gDu6au50{hZpIac*A;l!+Bo^Vrzi7P9TA!9JrsGZwPq>7X`2{?DUBDOn0gLVelM`SGz4g*dz%tIE=ncTf z@sutPQ^t2I%YkanqlPzs?X$qj_kh)0&ozu19zA*!T=~bWWpuLE*9(q!?Un0kO!*IT z;>N7&_+;P}iS_gU3wX7M=9C-o9fjgk$c6u1HY9v9Y;5`WdHnRp!={Zl&zGT4C=?2X zLZSH7(4zQQIi*l26bgkxp-?Ck3WY+UP$(1%g+ifFDE?{ADHIBYLZMJ76bgkxp-?Ck z3WY-Pe}@Yg@HO{gOvPz<;6?)O#(KcG)wm3UWgs30`KuAQhlyXQd*EZqCChNdxz{+l zhIs99N7t!ucXX5bK1cT;O*_n%EdceHT7)elPhPjKJq>0 za7tPa*S)cCD?g0(fl+M>EZ zusX$>Sy^f22g=IpLRP*%8DTK@`bL5;tS zu%@9_ykiOTsTo$X5Sf##{G!U5ax1r}x+GXq!P>lFd9{^W?+b~Z3d#c^tFpJ9(%|3O zuiDtAt}}ejxoPYq4R$<8LgV<{#EB`nK&XKl2u-eyP0Bo!KvHIB8ToWaAZ<{b5NXoj zRvOY!S5kEn+nBVV{+Oy(6*t#a<|IgA%GRw}H_+BGiGHQseyl&bl>S)9FYh_$I(%rf znkH@1r1|=JpZC1)bI*D2x#xb3s*$1o;h}-PVKqM@G$R;PO^=L^4x~U&j!pE9rquDL z2UDZ!m^hC8o$6PH22xL_Q%!0*l~Pkr^`{00Q-kWT9aRTY>4DLq6XF2n7=x*?zMIgEv=f*DjSq)tBLDb#h>x43%bIa6%`NMMrl>p5#SQA z02GiO#fP{X_B3Dsmw*M}8c>MmyiaCTU<8-~mPJOXR=k$V-Qf+&dhEL%4|11MK~{hq zprFnQj9Nk3fF58Hm;wr=PDDn4)4&4oiOlFqh4sQV)LvmdD=BkqI4GNacC-8IvYGj6 z(&hsPZI14@WxH+JBirrpmWa(8Hrec{4;q4tOM_R!CL^ATO~Wa`n>&a5d5PKCeB zJ|vfb1wdgRV*7x7Ku)t|G3T%?z!b0mTm@EuLbi+vv9sClK9G?Q>yTXBmS3f{XNYInpE9b(FNU|Ww}=VgMH1Exs6ac= z3!DH7;a!J!ofyFLz(v3Wu*zWFfXbGDH-YP9E1(1IfRkObFie(RwE__yE@!`Gza$ly z@!zmtNq&>PF8SB&7n0uq`@l==b<4*|xCD8EecWI-xDojW*v~R`9-a%Au?5T>hiwE} zfHt59m;?&h0;{zKxd)xhlO-pC(jp&8{t0=}N%Uh}5A4MPRD}ubehePWlsXk)df@yI z(G(_d?gedZa2@@DR22YqkR}Va40&Sh}V6yDTKdsxqLv6>Y z8g{V>%+dsAX#%q}K?>M}*vPE{QQMEKh6c>o1zp?Nz>PU-T&Bh$YP?8|6g5s!;~8q~ zp~ewvXw>jh!$%FB8uN4~roy25YxgvF>6O%2qQ~1Dpm{fI?Z$3c$!n zzQjwiFi~`4zVJ4nfGuLH#a6>=^lG=)t+^jpCcV_@CJI5x)t(!fc=Sk}pZr$_;R$!io*U|42UjbGg-9-Yl9=wyJWqSwlIt6bh zUiJz&Xn7A~HWOL365<&U$z9SC^#p86+-P{FI;>{w;4SKkk)@l$|(|MoV|`LxC>-IQolv`?;P* zpEJD0dxY#cuS2bQ9Yn%@{i=9qqp|ilroW!{{n_Jd3d~=eug>FIkWP~k{zMBavzFNht zk2)FNmCP?GaTf20(71VJfW-S%^KTvgEG<6RWj^4KP}379@y>|3Q;TOExkF}1i<^%2 zuO+4_J(on(WZ%hB(wWH8oCuw%GCg|}vxL&JGtX5Ce)!CD$t0;PKiN{*;%P41wJ&-f z)0?;2onPfWes#n=AMZ$5J6?XdI+8Sl($D4K$Ib6`sNIQK`YHV+7M-Ox1tk-+N;Ca5 zc1XmP=4dh*&(gzEM^t(fIxL-=Qs=}|TIh)C^x3)#wyqxgLsusVx}qXdFLm`rMN(Hl zg>E`s7mH5U)k#eSUfiT6U7_BsS*nMozFum|4YDLPOXY^pn9Wk+^+MwFN(p_4c%{Tk zACi*8cO;E@$=TbIvvMSb-qCn%P3iKgrgRw^?O*++BAP}sP04}oSjr#k^~X{`ulelB zqm`!7ud34nNs&-ZCD7YHa8z(#%1ruGQFFi_Ri~S}@00Ep=_Y@4nsmoH6Vu&#Drz<9 zO)-C8G?{5_-yXVWth2Yr+TMPj&e}z1+r?O|q5GsmBHb#+3W>2oVysrZRgOjEQg2U8 zJ4qzDx7+3nD=EgZ?X9XwM#|kMn&ld9s;N9xHHTN1mq>}0G#~Uw%u+z4HitKdMGBXe zNUcHGl}}ZkYO1N4qc7!CZiLJH5u%Nar^iWUY$$5~)A%7YHZCUIwp#l0e#pg4y)T*` zBP4D%bi~b;gI$SfhXc`GaY*Lw)mTYMEStMx2e%-&TLcy5wot_Oh*(ikUii=Fe>~57 z#Z_Ri`3%*46rX@e#q`BH8SV(3T{zb6uEZQ(ti-b-ox}mAsYcVQedNp5G-9`jIObK1 zjpx1mT#V(}-V?i|SEuCmPfV6}d&b6Ow{kkQ?nHQv@~F~?PYbSW1#bp#1_!}GrBU|; zxWYob$Qj}##Zm4kjPli9liEK77yzEjcQXwNWo~41baG{3Z4G5^WN%_>4Kgt}Hy|(| zZ(?c4?5axX?~VRU6gWn*t-WiL!+ZfA68ATu^MI5jU!Wo~D5XfYr+H8V3Z zK0b4Fa%Ev{4GKt!e3p4!6h{`ve{XuaW*kQ35bo`D{tF>2Ih)g{I|?rs#ax+Y43 z5Cj!LQSnR^vT9Vk@Iu84FUAw`0>wKbDjr;(nF+EnakGveHO5uf8D>%geAvw&ruy?< z)q8byeY@&ag8(!|Is`;U4DHk%NEwq{)Ydl_2yz0f*O;W42|l-Lvw@JFK-8dR| zZja@5=-A}c88|mBk=sjvfg_V9#>KMm4MTtn54atZ96KYWRVIr9=?C)m@`Tvr`1{wE zIk}y{=f9jXaZ0MYJ#K@Vcks{v z<);-@UK+K^lhifn=st@XQGAppTrg~KKNvmtl=CSED1MW)d<(Rt~cdN=d&_498Y&?2y9tJZCT48f9Y zG=+pJ=C*IOYyWnKcRF_J{BD=7-Tn~v$L>9P{we&uUhntr)3;y$0Rul6^yk0)^~1qK zA|gNf+t6WuAO7(tBSuDj`dRd-m{@!sH#$CH%-C^>K^X7lOVBw;S#Y>hhTb{XM<*LyZ7uB z_U+F*kbm&d;Uh;23XdHxI&t#U=`&}~;e7Fhl8cuvmtMJg?Rr@`Dk`gP+`M%gcfYmT zzN@|mwLkx2)SoX^gZ`L9Zk4PWq1rEm2ob_`Ax+2-mIzygGU0`~sX9XJBn}rxi3`LG zak+R=d?-F=LCmd5(;m^D(z*?ahVh2;hEjt&I4yWf@Xu0!WRM0(gQbt95mJ=&nKWBE zA{9$jl2v*lJ(pZ^Gub4Y<<4?9xu@Jq?k`8nDe_D?Oa=;P?`IOlLX-dE`@FW+72-;DrMaAL zr)S^s9hakm%BUKt$`e9`NMV*Rk5gPGY!}Lfmuhcyr1-8lLW~s`iA%*5V!8N~fdy+K zwK>`X?F|Ds#Uw+q!4-_)^x&M}XHrW^mIg_Y4HQR7=~97IBHfa{lb%U0_~!TH6x+*P z1Z){=x(Zzx;4F7u`Tv9a zI1G5Aeli%arvVStJomTz+MC&%+VyrXyUyOkuCX(_Xcz1%J05zz8EWR&>3LkHKT51C z7e49%Jo=<2qh>a6FY(^Ynj-tP`yFbQ+1K6MbuX(rt9o1YVxT(L)B0Xu^`vSZF{?XQ z_pa_*9cmkB8(<5!^{|E6y4pJ1+SyFDHn!$AvOc!jtv^|Rw0`gDWi7Fuv7WXT^3nzC zPU`{d0Bc`sA8V-9WHnlYe^}4QI{}PK<&re+o%q_IM?9u~$PepA%?3@jW_|s7{pRwk z;alH!fc~McjuV3rR~O~_@(AYQ%#yfon7B>c$MXV_-x-X@dG_i5h-rQ5^bBpjZnCai z_sWaMMz4_`pV#mPS&83GUPWGaxPGDMQB<$?c=T$0-KhE&^)2*6-qcs$-6Q&*4OZCi z&-9y~-t}|TmGy6Uv)A=w>IXHp3gn2j${h^#kq`NjA8PPV@~7r>f=*HZwV)+*icZrRI!ov1 z8w#YBIDmX=MXl*P6;m4uA_E1}1uDUR@fzRbK1n2#kxX=vF41Kwr7LumuF-W0p-@uD zOl4F~6;w%8bOS}ymfoUv)E+@Yi` zPEsecqpW}xvSaKxD`F?uNp^~zW@p%0c8-0+&a+~6ft9d}>=L`oO4${5m0e@kSs5!= zJJq#nm)b2tBvB;_qFNM1CTc{j*hJKcUaW#uvMP3y-D0=d9d`Fun(MQT z>Z-b?uB#jBrn;qWTPLkk)@kdEb=E582<>TKN9af$rK5F>uBYqkSlv)J(v5YTj@M0e zQ=Pz(9L3RWxRft&8DHdbzQmXL3Rmz|=YjLksdgSYHO^zF)_LO8IZvHuZosu%(22U4 zPSVLbMW^cKI!&j`B#z;FdcIzu7wScNv0kE=>ScPlUZLOC@932}U$4@u^%}ia7wAI0 zP8S7E21@n%z-hffZ`7N@KW$6+w{6qg^$z{6eow!zKhQe^X98yf#ewr-L6+!Udbj>i z@6mhpKD}Qb&$2{zby|6d-!M@lJ`{Mu{h=Xu24#A-~42R*Zs zI1b0-gkTXj=QK{|3~s?KxfN&fHNMU__$J@t*4&1(FdtXpYFvYBu>cEk9Twqw+<+T# z6K=*WxYcwuFPd!A4Y%QTlViH$4p+EAR|ev|H?2F?U8~YMXWg@^toznOtJ->G)mV?M zbgR~SV%1qst&FhN0uZJv2nd1%1sV_tY^wz@IN(AE40zx}1VloV)e@p1#%g6{LOrMt zvCse-LL+DlaS$I?-^#F960Fu%8%VUWpcy1VGNeE%G>0@uH@V!F+i@|U;}X8jcla(> z;@6M?EubZ|f=p-)Z6FKULOXa4+T(xl8<-7q;7xc7=E6Lf4+~%+EP}r`uL`KL+tiz`=N=C~VSr4C4fGh%8 zU&fN4AW2fB35m!iCPy}q4P_(QSjNeCaw$ZHJlRAxl?gJDe2Sn*ilS(Wp?XxGVyOW& zq(;=3;wYY)P*X~vL|0J~B~uEeQgce9bjpy;WD>QYmeh(esWr8sENV;b=s9Xn9q4)L zD3fIhb)wGn8|p$YP*-}9vZ)*8PLV zq(L;8hR{$NM#E`@>$)M=xSr{4`k20^pXqM~xZT_wx4WBb2AV-;uo+^8nqg+R8DU16 zQQlkLTyLH?-&^1<^cH!GX(WxJ(KLp}(l{DV6X>_}68(-Q(j=Npzo#iQmG9Fu`U6d; z8T2x}LVu)J={1^3uhXCC4akR8uo~9DS}1@*SO-P0o*%#l*a(|oGi-sauno4u4w}Ue zxtbsGd;C6sz&lNzH#zi0=-;6)Ltlly<{G%kyLlIX$a{D%@8kV^KxUZ)lW3ZmB$Euc zyh;2RZkrUiBNm87Vu@HLR)~DDS`>;Ru}N$Tm&-1(SL_!D#bI$o92I{Ne-r-{Uy5(U z4<_BTGFhg*=>&JhF>yki5hbEbTo%{FEpbOwLM7aTD!301;2~7QBiTVdFFW!f5aKEC50$5Ss$QzM>ZAIqeyYD3pa!ZzYOorjhN@v|xEi5Gs!?80jpif#$^Z8ewqW7> zZyz;AO;8in6g8EPI^ZbB4ofb=iE$b@aZZAh?4&wrPKJ}|v<eX!Uzu;s_vS}$x;Mjn#hdBP^8W1Qdu#nk{#1X4|EfRJpXJZ-=lM(hW&U!1 zh5xqyj=$2+_gDF={WbntzrZi_*Lg+eXLHQ_Vvd_%%?WeToHD1)8FSVYn{%eboHwQB zf+;f>O}V*bE}JW+!dx}i%yn-LpLgrKu~vz7-YT^&SY_5ldS(Y~%LZH6L0j6&);8K? z+cw*d?b;#R*q-g%5q6{*UTS#ILq+??OF#}Y{pB(|iK4yu?3u@g&eB@#2XqGM|nsjWfOPN}6ul~SDyX{j}| zQB_20H%h8v&pgIbM)}?O#&n)%{+ZtM+$Z@h_nh~A&-?xS&NsyjGO2bMyR2Q#E^kNJ z73_+3CA+d6X;-nM>}Wg2u4-4atJ|@54ZEgY%Z_u7J9*9tC*S$OIq95oPCI9uv(7o^ zytpB5id*8glS_Z2ZDNj<%MIuY`jWopLfTH*^o?_frqKb)key^_*$qy&t8?fM;?2^lb-UlXL%uBs8_BD@M-MK3Lo zLHj8uFe@-SFei{{jkU&E6T~6sEBLA1&K_s4v(MS@6i=*P0I4<(U z36U>;5GTbYaak0IpTrgMv$!e>#Wisq#Ayb?B*XRfkX2-qjFvIrOsY=PgTbE8x{K}# z@(j=ebqZ+IUU$$P!H;iru08~Y9M#A4aqwu29;?TJOr!K@{f4X|Ysy+O4upDJPtub? zr`cds1{jqIW~Iw`SsSEUDC@|&vYxCj6J(-%K{fz+9_WYq7f|SqF4F%1djgKG^ zo=9sL_%qxZA#clDxbJ{9EkK)AX11iqHy@h~vY~uY-j@$#8`)MS$#$~6+snLZ-jb8#WD{wkoMR^1q?>olR5Q&? zH#5vk^RCG-v-B>i^!(mPl~gQMBJ!{P_YMyAuNHq+{8!u};>!QIf4jE9A)bX}iK6ZN zgv!xlIH3eeB1MnjJ^u=ywv&gmkKr@JM1R>z@5f3>)Du2-0?nb#bc9QC7ky6O_22fdlSQSdCSn>& zH@P8q6dP2S|FVC9`qEc)82J{D9MxBC)O~}^{nh?KDnmQqRrl}#ov7zMo9eIiKc_In zlYokJ!a9R!I@t6b{gdvAbU&TiQZiP~g}aP`XROI*Z~~qprpS|27uohlwBzVQ%EFH9 zqTRF?wfQ@|YayI#MQ+D~K$d$rQ>TeMxl(4!Q;OB6sCQMWjv9>xgTADrbd2&?WB&Tw zg@^GdexFx!fyfef#3L1|rmJ7oGaVZ&2>$AK@*h%psz4oRBBi6Y>z@<#IGv_@bf13V z05|3#yq2@@`)~(m`WVq!j26qp2C)^iT__KzhN`6+u8ye-&|qdrN=WeOC&9(Rt-*YM zho6t$3CH}g)EX6?imuoI%ACaP=jlhfQrth7zX|u@*RaYMp2bUeE9Y`P-$Iu3e8h+* z;*VH$l=utkH0}90ZUd-O%$*D3M{!#`lv>6>F>m0Ul_ht|6Y`o0s9053C8*A-54>$6 zMjKFQlis2a>buZlnl;+G0dF`X^yss=XP1H$91_e5Zb$EiqLU_~5^HE3`aTMdfU(PFe9e<7tkON#$jEEO4M6yT`gW)+c za30OZ*ad!`5$8k^A}=Saf>#Mpc^}zVjzkV)lKxS=g0DH zYRI{iZVAams(`lfMNy!>7R~5159A27QI6C{L^N#yjTVSKVmG&>Y|&Ko6ssh0A#b8W z^!uB%gopDO+QLQr2cFE0IGs+3vND-xP*Z=MP+WqO_%0y=nyS+1HTvC)U!se2Gq^^% zY7+Rgla^seKcmb1DLrBB-vQkuXp{oV%tgP?q+;szhtATW#|RK)gq26xY!QVtvR+mb z=`Q_?Zt7j=sFon<_25voM*ZwJ^6NlhP#JB4?uJksD5elyvKOz5U-g61ZLlN}s_sI4 zD2*nAdJFw5f0aMof6E_5-{aXQT$`WpM^MC0JkgX6W6Y=XoCzJa`Tacq-xW-w9Jeb_+{xr7=b|Tj7T<#A;3ORs=-QEjSq#uLDx=VtGZ|smCD<;4`+fl2aPV9 zG-*=14_&oQnvQxRnt&d<&~99W8Tcvcft@u;--CKLVFC5yP55nSmxC2riRw`g`!`HbNZYj> zB}eF8_>Wlz{}uT6@}V90c|c)@aV()){8bdu_5g+tFlAKyI|Id=q_8|iPibFA@1mP9 zCo*%=lw?jYXPGB*|Gp8quXjiMnOIM>JJQ+FzP&BHtu++fx@B`qpt(ufg#-7 zkK5&}t*NeZ2=>Yfo0YeiO&rTmf>9_XrE{Vh$f-;~8W?ERZ7C0q{5nTY6~UF>n4^k0 zBTd|xDMRL=|H_ohnetjD7Q{G;w}!-&B&xqnN@59*4rf4rH7R99b-~bw4E=ROuK?Ze zhX!KGJ((0$oD)-O`sAdN$|d1(MJu0>5(U0Bgo?ZsR4ZtzOFCY}u3l^?#FdH_2{Kmz zDAg+^Q>sTw>IhWYoXStAyN5HWq|fiqwuV%k7?%#JNa|PZK_dkvjBZpep_+_t#3TA> z&_%Hrno};71avSLv`t78`2!i1=CgVqjv(}#R9&at~DGwY*%U1qcJ3}{Q5(>Wy#U0;GC4(=79H*z+cQSn*mQq)JHkE%Srf|Sxdxuc?L zk@}@ciGS*tA85lPPiAyjc(1SA;=#uU{>A&QjoD5SwBi=mY| z0W)$$wIp(i5Yzp7dzEb#BvJVc0RyCke{A&RS3F#^@EOuoohNHlgZQeh27~I>tvW?a z37AvB*lXC4*3iik>5`5MBHW;SXgAb0pN)l~{C>Ya!52$1ItYe(W;j!}MRd@23(4VN zRwX$-GPfG3-KR&+tVY(F=OkeAZ3O>Os8%%x)_!)uS)H1Uso42{!i92taIZ8tJemmX_~a^r`7fSs275jsaN->Mu(8{BTjm=l70g zW(9=A^COvC1d~LrKU-{qSY{T^E3)Awx>tAVhNv585ChL|5wnr+o0SndV?-IlVc6p( zj0~T7)rZk|iIjapxuby5kqjrz@e)&x$g9~5_{?SBnR52#m25La1U+&G!JdwcVELnO z8i|q2dO8?uEZb^iA{M@I{xG5b+XQQzsYLqZYQ!=cMZAg8F!Go=RwMN1IDjm0>~H@a4csnum$T$ z_N0|VEXACaH=9@(F|{t5%@mnMfe-V2JmpLHC7GvUqw(HDafy6?#&$KKS8r@#X>19Q z2@4Ka4|Y`b^ynAhJMnxqjreP6has;A5Q2Y`V71W??wV!?>hoy0t#wkG5Tw7U;a!T36?- zudncU+>#`Q!)?)MMMZm9^3YJU&P$nqSdS^Z#!)UBmc;rxucyKi*^;lukuP&FH^>_c zObgDilQ>KG6}f^BP1}V=;dSAPzz8MWAluug?R+EO24(Q{41LQT1h$L~EiH{L2ypEZ z=22hY&_bU+ei%8F0Pe0H!hl3?)?3)-}%GQx87^=YJsR2{@zkx=g4p>u~XiX&z+j+KRqz> zrya+3@BG23=~qA8n|*8G?Ch^DWv>*phw|ar)XQ5#N2o3KCAn*7BGma6?c3Xxfv>&L z83*d412Bo-F&Nb=JI}G7vxH+0!C9ETCUt|zfOtSf{{f)Rpz^R6D&Fm62bc6Ee~zeBGbkYM(3pC>ai70 zF2b^bc@g3QtYtigr2vTtP`wU9YHO-oPEz>gn^(s7zcP2>@Q#S24S$UP{daizB=_!W z?`zLJcw4(MeMm==03@=3LR$F4L&jJBn{|Yx%omh-dDfBfu!ow4W!;?W!tnHEG^H;Esp9=XRq&sSSSC7>*^0~+PdTKJxP}2 zNVa4OE$K$u3Vw? z>a5wWFd!j7SwqXUqrDwj1HAy(wbwJFTS<>UTvnh~_I*m4t+Qh(k|n+8&-e4=`vRe9 zb)lvZ3C(ieG#u8Uqsc)Wv(SbJrq|}ewRo0&mQ%!)VuwgXO+PxOgI29J?a#ymS~io6 z2mD!$?y_)3OCx{f%uF&JxUCFp%H51Vqot`f)G>`vswb1~qC`1Ryr{6K-0LeWEA{a7 z*k|K?ULRj%`{H2rW4fSiUL2gUyTyMZ==tu_N6Vi2)s|T9^X(5a{!I%X$rIRcuKjqK z@p4PeTY^3*+@ty1Ck0l1v<@&^j0V|y_6qo3wV?@&NVw(_#$X6jPMRxG9eAVAY_s=~ zqlUua<~q_rju3`u(l}o;kOgT}oXljC>Cy5PsL}B^zG^;$pTP+K)Z8_QcVHgxFn62x z%-ytJo6Ix#6|BM7l|7=6W3%(rOoFyUczTZAz5y5VF(=Yd1eHL-Xj04Ou_4phVJebL z7ONFVr8;p(LHahnD3K`7|2ftsZ(3TuxSH(4+NEv#*GGO5YFCBM3@qWW#({-H5P+3_LX&XtaP$gflw(PPQnoIYc`UJxZR2jc-jHj{1Il) zpqPPt&fx~Y43nfGbBNX12z#7mS9RpGgi|l8i=G8()@)m6tMw=B?lT?MX~Z(rkX`+>zL&pHXI%BE(8CgD|c% zntJ@bfiuB(*?0T{{sCQX=wc7$<~>WOIR(9C!zm8gTf>IC)5f$hZ9a~XE>A!R!}N9L500q5w~8AqrqO4w=X@hSrD}PTgJXCT zz?llC*;J8yT^U-zBuSS0@M{M2rXB{YnMkb6$b_{c-jMs{0XR5^ zC&D_2;8VSbW#IrcEJKpbDYJG;%ZCP=~iffYC+pn z*p;xb$tGt~2%+Ud){a^%3m)rqI=`mwx1@)qTIsLShZ2WINel4CA>zt#sal$wuVNLG zo!Q@$r*HT6ns>}&xacnP@>k3MZC)dJ_zN=!7`F@uBe*t+Uo*4!m=GuaH(n^IbwJnvd7_&U3L%c7Y)oTz@1=t-=NoNi(Nq( z8mpy-ti!T|*eMb1DGw!Ij>kJK;wkYM9>&v$|6q7jRac4?Qmj-ebqb@m5d4p&0yfK@kNkj5ey8E2|G3e_(!j z`S0c@c=G36H?lA7T=>|k^@|p+XCKe|58YJ)+{AT;_r2Y>+STelrh!{lJ>U;`$&c4KS;20~M=!8S2aoB(!cGQdp2)kz04B_tTAIYO`<8WM&(rPB-y zxJL%sNuXrnfwt61Q)}J-t!&0kTWR)?wAy{|d*Ao}-#2GwM{=F^@cN&$2dEltL2sgk z9}eEzvZLkoZJRd$ORGS?ZeXdzwDmCD&~3HAYKt2sk2HlVGEOIRrB3N1>8kWQ$>@h{ z$Ql^0lrQ0YDIrxztVCxl^-`0C4xhppaR$L8fHY6!8<3$J*Q*v>!6MdUM&Rg%Q7ECE z2K1QJ+pOHLQwNRAJp#_l!DH<5+wFx_>?h3wuORKOhW-oOK16=qsFiBUSro%-{t29{ z9J<4~V7=YU7$%0yCu2gEH=fr$^sV|5oLsbBRBn=+2Ch+VO4}r}c}&@$kgkCpJg=Dy+!rnULPcHV68g=>`AY4Rm`|n@HA1WW5hW`fDRPY;@DP zGu#Q7m9>!w%FCM+pFG??Y2D{?bAt3MWfXsvNx$(xrp|GcTE zu3~0=UHPnfPjhwEs@2tt8(3F#U;X|YH})^u8!kA#_EYV}b$!hj(X2W1>gH6`)h8cY z{p$Lr#p}0HclrdZPTH^=;~&q#L)8O?y{s z)Rt*)pJFp#+qw3Qt(#i`#mit`{>EBbamvR}Z-( zP=2Au$t43olth0j!+@o-U8X4nrL$&w9Q=DKlVGM3^4Rb7J6oAD)o3;uEfT%GL}OW| z@oiFMHQKsZ%PN-SG13?x7Xui(Wcs93E`x{l%L95ggXif8>FJCS3BbS*Bh*TTZFfUt_IFV(0e2RNYx=NmNEb<&O@S;;;)O2s01~1Ii zWEW*xyYZXH<)1+lT&?CPDASmUybJ2qSI$8Yt^GLqAM?~G(vy2h}#7w7lW z2n(hl`S1%ld8amFFV-zTs3(_7<$F$))14^K!u;_4AvAly9oV@1N82+rO+p!W{)Vz& zJX{?~Lg;HLG_C8n_i7JpE3MJ&I`o)<7dbHHkJ#N$uf+s6(3}BY!IZ(@K)xsMv;W)$y zCYQ?tDPq1VdEp*lKw2SpcH=Rs=oL{+Y!$KCi^nh=Tp{`(W2H;;77QbsOb5k)J#Z(> zpK5sW4itF6H&HU9AGnbZi6WxM+4lA4+M{lIFvuk(?dQ&=T-WfN2SWL zquH}+Aa<}r+Hrw1_6})))Zj6mD=HdJ45_@~_p|UueuZVp8SSIi`tN^#)d8>&ARRiiVb_0bj4*68+V zM^x}dW6&Pba(s+Wi9t~4#;>0kUr;#`HIopxYF7?KQdS?pN|w+~FYbEaatyT|&nkA% zz~!Nb)?*6ISk-XRsCtyb$_iK=Gx`7*8U*|kvhhga2OaXn4>4{+;bh9^U|udzc=$tJ z?oM3#%R}uo%j?><*Y0a7)xOlsD0KEn_}Qwm(s7@4B6~+nCtDbrCIguoLv^AoswtU+2VVbt)58Wm6$Th~p+)&Hg#4TxCoO_ww z{6+CPdtLemD+a`nDP$g-HrCll8pSpu7!-rcrMO&UahMGdLx}7lyTr@vd5I)Y1$f`t zGJ|e24?sK=a+^D@AC175Zd9YX+~YaHqFU^6OIe*2(N?ND+;M9+3aL5v@kZ8q-!hlE z&*-=E#GpMpf*l5AHFym%NDZ)hCo+Cg`N-Rr%eAyX=r-*kxRWm;^hi%?X?Z|2suG^d z_0gj5_qm*|lwGsQwCr;UyUz z-Aho6bU{laBFhCZ!bUM5F@k|FWASt&0~XZdGsny-L_$vVL5Yh|O2CXvqi3WqAb89Y zJ)C@BRs{5vRZKunAS?18vSJBTq=MK)@Sy(TZ3mYayoYZmee6Wi`>pojH`>Z?VD!6S z^qXMxBC|?O!034rF!+R+a7MT#aQVV^0Sf|?nt}-9|2Ny!0vpA3Mdy8H-e-2#v zusCL$6(%+x+`s&?{nuA}8aZ7ZRGa^@{p};e=_SWhI^__w0vw`7i zXN_AlZUx)QxB7PS=Y2cF&*uvxY~%;S!Ti$f(nx8nbR1t`K1P>|)#gU}eY!2OId(E| z()ykMZR?VC!wQfB!&cSi6vk#3D(#CA$}1>0L{Jr6aM6++l%uLGM^)S8yz(rfLEnfz z4v$NMD{!H069{>H1*qO=NtZ-fvQSn?B30EDwH$t+>QwO7r^6|)Uu3Eeif=eub&ph8 zwMTef0iw#HY^cET69J6DnO~V<)6p8twSr2QRgxOqQtuu<@sWGv)q%br{t0EH8B^R3 z3SVh`^ZL-~`q$^-{Lj+8t2@r3b?;tBYad^D{hgWL-G1|5?j85e!el?hsd~j^51&7G ziUrjr!9o_(;88F%L^E_9Qpq?6bn4tTE_jCL1!uhDuk$zfNu$5jj}=tA`~!aK$7Uwk z1JHyraNY7?0dBhKU5>R(7*x(Zyb=$uB+~}e^gnnVgT%eRpQ2JcACgY?^6u#%V8J+pRC)FgZcy(HOpmi!l;=;tNznRY62D zZRj2-qJRqM{o&afd_hb_%IJ3MoOi+11-GjCIikkujH)^zY}20v)V$NpOF&&Id8N%; z=|m?PC1MZlG`i?9IzZX;#;@oQy{Us592xAHxil#h945j=u`yR}CT(Ot*)I;rBcz|4 zC-N-0NbX89SALb?O`yb3S*m`OhgM@`s3&OF7`-DyPEM9tLo57wF!(|>)HZ`Pu#<~D zS<%cK2xn$k;mxqfn@87m2Xbn(jL1XY2;ydj=PnTZv+VtV^A+ev>C3p*-Qhk3%_O}A zzmWdz-5vPYf82*5lZSw%U)EpKbZxE^t78ho6!eA0sUBmP+<*4Q^uGHE*i~3soF0X+ zS6#V>;P(dg*X}I*OtCCbEtu4P&4(k7X_85Nl1V6V12hyz6wFCVdrno-JI&GAd8uG3 zJcYpk3|$j{m!LVN%)tfJ5`}UCo62okY{Jd-C2>Ta5dHF|xGnPz(>>y_ zd|RBCm+)o!zPKW9;30Zld@TJ7 zT!;jrAwnoNrA!bEml$3{d=z6J6qR7SFn|KR$ln8MmiFUW9(_GlpP{YrvgJuV!5sE1 zNBqpQkcBg*ZTf&VW;sFND+d;84lL3Vg-W)=Yy66Vtxr?KWo1_NKdkCl)Jmt)sp?q7 z0;2*CtPfMLdCRN3OtIbPTt;0=&N4te9~nGu+RBpDdmoSQ$~345fDIrugV^l7=yfC! zL#N$g_o{o%{R=QpgbdxTr9ZgSqP~EsPGFu1N>!jgIsrip9wlK;gTT6Qx|*sh#s4a7 zH9M0bB9dSnD2Nk|F(U%b3(ksA6){y2(}ZyWT$&=#sAJZd4JK(cTTR?$4wyKjM7S7z zsaNxXWy_Kx@j$nd_jM~UanP^E8W!AnJg@u+aMJAAyQZq(;e;|cQr&CN5r7JAXD~8w zN+{HLRZ#65uz~;uLCiyZLbdpCB#38hn>;zHO#k={3#5hMT@DDh# z$uyoMReTBmF*(e;$WeZbyunSSfE_WTGKn1+n5sPgv_ulyYG9#Cc(TtCMN^Y_ISk(F z+Hp4A!N4(N5lq5t3NB$)cm{g}JM5cy1rs5h&lcl{*#Y(n`#rvbhwu&dIW|jhDf>EW zX6@`%Y^Ywhsch_{jX`0R<{?3G2+Hn6HeQKx+)L@>0DyAx?(JG~`tE$C{a1l*y8*f_ zOUu_@biT1q-^V+BodL=b3-Bx!DTy?TrXXv|Zq99^9lXQW7T6i=2({<7hub4w6B28M-&ZsWOu82GFhInJVHQp6B?D!{f9JflkG?WFV zqr%Ji?w*2{x9&+Z&mq)%4q>=vSP^1<3S4FqJfzZI85^Xbkdj_t4nT&jnwR+Xx{e++ zAMJEo+%s;U+k&Qlbo}_WtEWy4;`atS8@tQqxKFzW+(Yg&V20Lz?v9L%+`V;2or7`) zx1b8tIW#%NhTa$Ii;%DBXr2DPj)U37{y;#>x0JTd(s9Bw}J@2M{is%T9nm#92X!Z7`7wV}wA+ z;0Rm=fqzUKEQ4(VBp4E>Fe!(^B(STz*cLSdowJZb_Q!4uKb=*Nf@_>E|^z%L+{XNvj( znnydCi5*3gjX{*LPt56#Go5&v-tbeps!A_;WQl_wqt(F1*uNFAh>nY%NH0sW+5?3k>y2)~jT`1s;8-d~BP6C+; zaHvts+HxG-^mh6{dNppwRd_63Szes(N+hm! zbX>dkmX(;3oc61(NrV67HH8;O;a}nfcs|~kZcOiZZ_`h#(eJ&GzW*QvLh}ue>>pw) z&1QUHWQa@z-LqayIIEnqghlcq<@a=-qt!g(xJV^l=%Q|~!|U|A zDjXHgan5CqCfA=Oc{yFK{VabSU8k+d=c(UI6{lmGW0~V6$5zK{4$h&gidR(?r{Yrs z{z8w-i|f3tUdHQ1dc+noNZN-)XmH1^C{kU3h8M!oR{kL0&7bE9zqY}|x>;s2X2jQ5 z&qiNj%w*}UJIP1D_}DmR>NC{lqys1syE9?PP%^{-q&_60biwZrcp~gz#x&jT$9gwg zm?i)GsQJ{%x)qDs)4%CiI{le>BR>6T(TK_83l87px+b4{@r{rBRjz4E{}qpFtBs^~ zvy%#De|N%D3TJcDgx(wED^UMHeBK&)%-xxPr1a)d{ zlpa&5m1a0*7`5gCWnSL=$im|J1E0%Zliw0i@=Tkhp6DO9XRBTd#itrm&6CDSlQbHQ z=4xZLdCj)irD}DIG1^?D)|*Z0^Tv90gRxiIr@m=;0OVEP;7v`^ zRKFn@rlb-am>IM*J-#G}mjw3&nP3-FkHXL&lu)977>5UWSu`Ho4WlZg$IGyVr{Frg z3Af^dxEqW3OJao*E`rIR7!BU;4d8&~3B&`{LbNC}7;?sS(8ai_@ojfDfZCuBbJeJN z+U$3bRaskOM{knrF3crMA&g*p?<7mEXXm9Q*CBzjO(lcc2AoGY|4GwE=Is2pL!N{I z#{(0r&K}CMSLZEfUP9IL5>n=N+VB2uITU!OCZwQ!dlDsmui6|0`i4ov)N-R7&ap}z zZHzVdO8X57C2Mm<(o^X7XG?xG^C^#4Ksz7-t_X5h;C{vzFjFZbKLu4!t#Dx5cX_{^pQ z4e!tU>YUp6gK{GgFD#w6_{1wKKl>5Jw!Q{Jw>SnlETE;9SxU=D88?MC&}O=c3OweR zLc%fv5@{e1BCBi?!hG7!Za|=%qE5~nwWYk7nP~A-(essBWfVO zQX^paUj3Nsxo$BcV+^3Bmq&a6cvsRj^y%D(5Vo-*SL0d5})u`=q6I?yeat z@4~6~_Cn>H4!@7bj&{Ui5&QtCEn^F&hla(w#U9+lTq2h^&bA=Sxox)7da)n$agmhxrl2)=pJZ*fGe}4)_Kbf-Wp0hM8;8GK{e%Jd>-N zH7N};EO{rHED7Fv#QV3tN&Amkw!7VxrPvMt*y&(%k{N`}v@!%P6(u8Ccgo1AJNP^J zr_g|grT)!z-G85q{O?#>uL45CE4FXMy;fccTf*z|w`BqcDO+%GJe*)V%xs_ekX8<4 ze$%3%{J5mSpgde5d&SxHu-2a+CpruQSUFw^As-!p3aRi9>8A2E{g3pu!kyvHN@tW$ z&;@XgJ<1p8b4uIDYh0W3hVm|H=iZe%ls^(Wm>68Cq$|6~7H*gHYemfd_`@Q0sJzVu zj!4#gPj-m-Qc zOkij45bJ3cDS96TNIb_4ktMGzOOzJ`U8G)7q(oMfoLz)}!YYWtL}58e7O2RJg23fO zk};0ZR3YeG6a--}6&=a|X0WC{)I&(CNhL$UR4SyUlEF!k@HZZ* z!j=1Eb`O8<%!u5!Ijrfcmv2s4my;`TFrExr5U^Gc5rP3HOQF=;xiM%Rp zCVQk-a)JCsQiqaCX$#pUogrtX^F)vs%F6;P@-ksX4nbr&L`9a>8E{9i;AL4yoELTn zVS^xwl*$O|?eU|$PRP#Zj#77As(|64+068<#{V&0t+7#DS9tE7*_qjy z-I>|h-PxIaWf!m4m<5czV;h5mhZu}`+E8%3z}BFE$*NWCC9NQl5Qrv_w553zHH8on z6apw|)nH_7LkI{pkUv!`eW~z$K9E^-~G;azEdnx zyK7N7QyuXCV=qFRQ5q%CllDS5d(*ybU&1AP#jZx5mll>J^w1`5X1WBc>jvz3>f;d* zppUF2V*ND%F*M_%ImX4%uJUmLBftbXR}w5o+6csOG|-blG^X7QPpv<2nR2DGVk8yD#Hr4RA4so$550pm2N zu~%T#Zqz$Mantt(;c5%L~^#tSuhWJsWSt^acL7%JM{(q1QO|?$vaaO4`4^;Fz3*>;HqhA1*uCw_#hGBe^{P)%IpN` zL<;EIFv?j1rqFHb8HGq5-ad#8=AHK)JV59spyZ9`i$Dd~feN6(x99C|&|-LY29R4h z{cmPIvxKUk>QK>onhWz$S4<19inK>pR{mZ2(&uh4+KeaDy~eKeq4evr5)dcqwhGPeP?zakbPTb=9) zp)W(IBh(Y>3(+AXTUa{NBiJffc!A9;V5W;Ohu`;MksZ9(yA4k8Y3$rSnXoFgf6X1&qW__Y(2BsyVzeJSH=_QEfUG9`qPe7HZ3;z~89)ABH?wmhhxIzaL^)>6j1 z*t~YU)O=^1QiQ&UIEiuMX+g@1d6aMMw!~hxSLoGx^+ME@&ru|Kl0JY=^(hnpRu%Mv z=`FV@0NG(=92~fA+oh2$=PlJ-`CR^IFYMZR$aSf7@2LHi{hfW!{@a$^2|VZBj{cMH zUp(~|@obx5?JbZA2K7&CeYc!bbK28#K`m(e^yiE>@Ee{R$_@Q<xj_V|BAxndm0av^QwjdPLGF#YuE}5*KS)iJ& z3;B}h|Ea=kw;wJ&zj?@hXkQ;Vh>Vh2v+VipFTJp9$KexOa;OS{Cq~9mtW5R4x8|95 zPY<0s3F}=7>#YK=1gI!_XM|E9Puj$$WA5YL-zeu?XNAk|%iiHI&j(ODUct5r9r1JC zi|oblP2m&IXTo1RliUNZH!4Si7AQo}l6Y@=bQC6kMoLIti;;ia&%*-oCJ?cbD204A3_(=smyGK<4<_nCd>ICkT$WcjD z6D*UcCf*b8i=T`$aXHCbUfBe|XVfr55YH1*ImM)PYqu59t=WMV-HOXFfCTGAs~!K< zQiA(LJFZ=T87lc0n551~HHia{rcTV5W#YjZO~8)}Z98hq^w;6lc}Xqi0E?s|LCq3peW8ezTfVC`?}q`-Fx4`d0c>7 zj#H805UH1PMnXhK#Sn>yLC{77lM--hoKC7?B2kf4q8Y^^3bm<{iH#N?1>26!ByG~M zGquyPGfivEw01BvVI-}hMp*j)_P|Fn9oX5uy~qBazlSm0!-gw%v{hz(q!zDOa&`Py zOu4!H#tOF1R1kS+Sz_Imz|H_|mzC!H9ZG9Hn}IUvOlA%$pbMA;T1YQsR@;)!WOh}g z3R?A&?XGs$VV|!Qxaa2-%v_?Bx|igX&K#8|JklQEY>TW|a%Dxgx;?I0itKT--Yl{K zXUz>T2i>ZfLvq?8r_MRKsRhW)PMz~(sYMW7X(sX4Vgfipn@&zvX%;EC#l?GlTyDe? z_InBFh(4d+-=2Dvis&dK%ZMv_@j=f6W6E7YU0+Wl<}M9f65HbeE0w~ z#~fc%0aHW*lY^-ADT-?`am&`|Y|P#esgE}1afIbO*zK9-{X&4SsR8yBhBT*@&ddOz z;BY>~vLB)aLLjHAsVLi_Y`gf^t?LlF@Vi#Tf4BM9oyLFuIljGa!=7CY>$jKb^IS7R z?)=O(hfbXByn-yq|BLkasvWyMuAk$VQ49V0clIoGuBBg+&SrVj?3ec2Y!> zAnKva&=U6(S+TdheO|iRJL;uxdXblMhTSd`w&1gUE;Q;wE}y3)Rrr=o(fHB{BJSa8 zZ0ePX|HLznKutZSyb|K3?WsXTAk3g$Fv>BL?l^LZ-rx1xwLQxN#&E`pC(D`&jA4)k z|L$GXysL9!FP(q9y0El;$HbSAG|cupu!tw%lA(BN%Mc|(WF?wZk`OCIx>Y%`Z^KDdDyj;Fv60*fW6%hc!a%^J`|9OigdqIuvH^YE`7}5pBpBrd5ovzmw=-kCCsiYjf_}dHK#vTeQfY zO6KkR_b(k^W3!F2I6L+RbDN-QJ4{|Jmsd@-pIS$ zasHTmmOCq-id>F-9Ik>yoQ z)6>$^!@2}3WmCg;Em2)qr=eG1K?dovgw3B84y41qSJF{kI!cFoXR^a#ohZoxiqcJS zC6JvT)O-J+-?vC=NYyQ@sf<@9;RPg$98gWD#^rEfq>_U#OTfAzS0E z3MX4EAi-%Ac2g!~Q)m)?2>ARuq^2APNA8JN{DBy*x;=>lWLWt%ANFf(FeJMLYF)!UZMYv{~=zHhw(6XLs5?l zm*_uo9}2&h@n)f&YZDmFoI;C-l*q~Q&SKtQm)4v{r&&YPW40@0UQ=ddn$^WdwH~}k zqnAa5(ou~gW{0!@m%+GZg|i>w?`L;U^n8V4#vi`iXWZG1G7dB~?cd+jbbx;1EyV3M zKEC;t@nPF!|B?RwzMlSml5dCcGTR0Ds^Gi26SL@&FTpW{$}u6TEuF#g;muwV3ua86`te^l%(=( zSvnGjMyl7R(@n{rY0f1&rk<;R)PI4#giey2!D13RAQtRl)*Xl|_+aA@qK)yPRh`SB z#qK@z>)zP$y$!pdwG}TKpBWRznDMu=l@nhuL#N+AeERrN;=xu!?&~0TjS5hQ6Giqo z9aCb?c=}?xR4H{XP8XVkC?L2zu_R7P&ns1qq$laG3LKM;rQa3DlsisYqpWG92&~0L zir}#DHkI>&(VStAAVh^V&1R~>P9REuFeU%S9?AdKH`0%`OckIJH%j%6Mo*)!J^%$k z8fS_(jfgilQE$l1++|jQDKC1r_Uz`}h`G4&P#iJF=$kLrx3{fbyU%!;c0W_Os~4#V zIHr2_;jhb>Ge7G+dg|n%4+ux@q$sAy?0$bDrwb#|iYjqE-i(<%`zmXLwb{-}qD>CU zbf-Ki(bIwX{oPko2E(AW?e&@K}a-Orl~4ZhDyVZ8m}0 zKaeUqq@_u=CSyotRCHrP3|OVMDk4G|po)rsLP$m9@P6lXAS5{Xz8~ki)4ji*_j!WC zVDOpX>%k9#G+0iOAbJ@f2q)ki2oMbvW}vDhFNXi4pcgqa@B{`r1M54#zLX5Zq_p%(26TW&YU?s+aW9FIqQ)yK(J4_+?BV)#YHU3dz$yjvc2BXh7Y@E{0 z1kXD&y0SIl)^1Ne>Ksar21m{3oUhiZZOI*Sht_56E$fIs;3!UQeX>o@#dA(Bk*if? zCI!@Z#HiOD$4Mx)j@$SJeZ>4y=!*@<(kDY-OTQXAm7a2@62=L5(fUT@mGlqNwa4(CRSeAx^Bs1gJETM=+?)&`Ll~0IhImJOKlEFN z;4y0v7+3 zi??^`vV3;eVD~4`0xt9d9fA`u4W<#&NVhgLr4`&tzO5J=e!?z2W z)&4%0DLJF`XTL{>$S@uQ1KU20)U9^qJy+F&g|ZY5=!ZYQY2IcIJGJNWs}9&M{LL%WJU{M46k zesuH0RPi5y!Gn*t#Hy0;lm3GXf4Q*?&6$0DsjB8!$P9FE`Q$5KfBRc6tlRQHO*l~< zs`^}4_jBL*^*B~h&B~vIm!$7uSNw(B5F;^2u!gdBf0w_%Oo@g_L=15tCN1 zFH|tkny;JUka@!Vw)ufMZ%V{0H)CdtNzJG|a_&Bz>K<=HoY;goF+Oq(&JY9AhAq2$-HvE$*}=x-^i;wdU#q!jqS^`l|Y_$Rkhf zeloAA&prz_P0kkgepB#Uk3NArpKU?bM*s4M{1xIjitN=7Wz9D6y_j;_S)PnBAUzm4Ym4J|EMy z5QK!FXsb4JNRxI|)3LVa-SC=NmJvxaNmQ#NX)R0IwNav$AZdz$p?mMrR4Yq?s2~$Y z3I(nhGn^RbE8U<*7}c1n3IfQuR`UjbB2tygYDSIGVz>r1EXyuu1-2Ju*tF2%YE;N; zv_SV#k-jCgAVodlmgzYHF@z8iqWTrgttd~fOr+<|0CuW@=$;*ixBtQ0dkme^^I#tE z6TH&SV8h~dibovc71oBf4Q&-D!7df|L;bt$mh3P8ImC-JEcx#mwKFx(BsmGI>L_Y zqvRwVl}@TB*{FVl+@RN_Yw8VlO}|ZU(>ZBQz0KzIyW}oil$Ml5^)6e~n^t4w10?+% zVo`^R{Ch&U&|JRLWJF;FQ$XcW)Jc6}Yns7Heq4C}9edzYEpR*aB6&3skaZ!Z+;y47ZUV^fV??b5gTJdj}rZ6)) zg=v2N^QQ3Hav$b~j`cR=)!Uf+LP~j;3S-I)+=6S$ydn7%n?~f6+(tI~I-wt)f@2Cx zLPpsD?Mer9DP!7_yriggG^wOnmbSBPbPxL}_3dW+X+JwekFpVXn!QX}!8T00qx@G8GPi42+YCLYoQS)fdz zJaRbsi0Tu$C*Evm%C3mOmu^|OHY+9t)f5C(k~MAh?|BXQ(zWn!ElDJk5J{FKWSBlx z)rd4L9G#F`Rh(SScX+RH)|fR!L*$o*R*hc{&ZE1K$;LvtIIb>U95r+i@1 zTao4xCgLzEt<7YHGow#m8C@G$T>(!}!iQ3JzrkXd$lSmQoQancJgx)7!%qMoTEUAe z@TltWOz|Z+@b=H3t2hSF7tde6DI^53cnfNa>hiB(SMd_B_iB#gCD(+$$HOgy+O@0{s&_|(7VUHSzNU9r#=1uk)wn70z3n&^`glkx! z76-s~aROn`^5*!mDKj-UwKi3~gK#TPNLgW)5&!71;Z*pGR-{JKgW;{bA!14-Ns%>0 zC|vW4B8rTj8D=Zu&i0Kz#xrcFY%qu?N5etsK(JOrnca5{x7C`Qm=_@urm*E=US#_0 zVzyK)BGx>4(nf-Q6bbs2X46>*yXD+@N3}&Ee%10gq&uHReBP9jfE@_p;ZHBonP#Z4 zJcW8}tm>E(nLZVFqA8rj3Vb3I{Yp%XZZDl&x@7D81?9oVXVg6%ghTn1yZ4ndHFdKm zr2NC%Sk2a-fLqTcSlDz;B@Fj^6ZqbTi{^|ms`0fzH%!C$#dLuJXNAfStV8} zTm7zoY8O49Ygas)J4ZWeb|~w~MQ*Ver))$hk>fckQ@mx{hfdgh{*0;bM5o$|v z=i65NfX*^9nNR4JZDm@yR>azB8CC{t--&yZ;x}FSw9T`NuUeo*62>q+X;)P-pdf9I({8P*shmbr66y+lZ%pV58#z?uA1^^h?xb3sm~anD$JSr<5MSy zSL<@}=0~@y&qr79Y#J?2|6O#g%Ta}L^IUZLA@d$N4(&sPyJHq9S(J^w^($~OHYQmHf&5Sjke zu*k$^W4cpS&RHUDnrIWA`$Z>!E2V#PsU;xtJC0 z)sBH#Js=Eq5t)S|h?0p@&|{HFhR$KGFge*YHI3X#mbhzX>35T}GF=gu;tG1YkH>tc zY_NZ@zc-$6?A|n7ZgGhn`ZLCgjQhnR$PhtXX5+w)+!w9dTIB`IIsUhNwZYj~`AH;+ zlnkAMd!NJb*X&Oy2j`Q#Toq>5v_{eT;fEXuMXQTs&#_FR3GsfZqq+1V0nb6Fzr^LU5t$+`7I1yn0(9R+C;-o2APw{-JpnM z5?S=NH!#UFs=?;Bv}Gvb{AR->HS)oU7ymH)cwA>@ z;vjCA`45zjL~n%FFD+R7gz~cJLAj|~mepswHZ`xyTt9lnqUepT%{yX6f*z~XYPDWJ zEA`kCamV#Agdue>ZzUI!z085p=fXp^f!o==7B0ho_P%c<0+fq{Wdwrm;xOWAM4o0OtB zTB%+A6Rp!4$q#(b97EOmIa(@i&{KG~1}Ig>&}i)~s=)V6s5e6HRf?QJd|wH?3FHH1 zKo+nJSQ5t~;5+Ek1+-#}9Ty4`$%0`$L(B(eYT)|H?R8;;^-iMDqh^r0=Tv za{pLoFEC5#rpIBIDC?zPckVI3yT3uN4nWsdP@apNR;;r`Z=)8}zYP>iG?LH`(^|C; zd(cLkjQw;J?WE)Z{WMwmj53VLQ~>)`Vf-b)4>0B*Bp+7r8l2A{$7$DbGisz-U^V9M zO4x~QgZf4O)N(ULWSqVVh&$?}^IjZ}9CE%=07zbB>dM?y-HP zCiJhzSVGPd+lQD0@P0LH`Zn+$@OxfE0+MHO$gx^URa%`dAOk=K&<*Tnz5%sB5r2dE z-T2-u`3lZ3H<=&I4gH+t>LOlyOb6);uf%=kN9ex{2m;y0Tl7>M+4z?2Q^%ZTe@TqZ z++xloq~!D($@}xHCv$3;d`<791-u41FSwPE>~|PqyC*;kXN_Lk8h@XMqmjavc8xJ_aA>0&_SwaD0~e0WlhA zj`MZf5I?)I-ZmAkmM8hJ?#wqoBJ{k&Z@cs`1#&@-+NyoWw8W8C|g+s8w{op1PX?=3k+Ms z618Ef2qNRaU`x>%XiH@Xn9Q_y7w6L@$?`Z$%v@zMDUomN?wELep8ZjYk4=!`cuW6d zgl-d8$1{3_ZGXAIG~sUK(Z6OB{({vUO}c;%AmeS`o+Jm$6PE{mW&l^HZ5> z`@Cnu^Y|nE;(O$Q_#@<5MT`?*<wJp&!DrJq@+j!Qq&=C3jsJG}#4ld^W4wL*5lM(YH5c)2Wy zt?~C__pNezV-&4`izw;GGoNQ6>AUr^e?`qu;H-|7`)i zjQuytJ;sOL7uWLqW3hcw6g%l(;XHShWLdI|Jxl2q{3q&*O?~A5;VXG+^Jsmv9R072 zl^J(NDxn{Qc)60VIPcOPqGjSizT&EnW!Ep)&D#(K(i=OCa0<}nbp5j1Tyhj^Hs!T^ zKPz`Bb>#x-p=etL+jds4^K0% zzcjbsBWEs zjosv`FLTd2EGtB6ibbk^BT_wubBJ@QdKYyQc<+Wh51G`>KoX6rPVzpRZ^z*XY;@Yn zydbY^LwR_zZ_SoqyspXq+V2Y4PE}sAf7N0r;r%ES@cujGYUCx_@1|cNashP*PDCZG4y#-Mxob4qgNO=QqEQ@TONg00i1g>ls0do z&p$bPnh{?wky}2em=G&cl*B(w>}tlD`$lY^e+hYnayw#KS{T#9v$ftC+el2i-Q}B& zk+%?2#{|rX5Y|r%h^&zHBNupav0}B(gsPc;^m`ve*L^O zng=viZYW`RNGX>o*ZFSB(Yz!qN2&L{zV9XTnJo5ONMzsLEbP-E&Mg1!aKDB+ zME7ysehbR(cV!q14`pndbmtuD0n35As^1w&4D_GY_?D=a+{7-)rA++wUxE9fFd6&& zjM&datp8{lRJ(|>=NvI@CkGTZ=Fd^T)%@J#huF;M{v7|}qU68;xD(3YiMoHy9g?|E z+C*Nx=i2Z2ml*3(L%Co>l6&49z3)+OM!6Yhaa*@c+Q-YKg!jeBbYwc``waLdXZD2n z0l&t5)wFqtZw1Z?8O=FAEpE#!=ZwFTGyUOsrdZw_`Ju*6@aX#@eV6dw7TL`ENY*gU zF8V*KF~G|t4qlK6?qF$8-7<~CFqO8CVA}_*Q_`Muz60Mf1KHDkoOy^>ZVwYFm_Jdz#yGur&o;I# zm3y2XX1+BhRui-1O&F(%(cRcMs!KQ*cByG77YcI|7;gOLj4V_iqud)>26Y7{FBmMN z_+MinGrm|doux9~+V1bKYeUYYe&ifAKD$))RMfvl|}; zVtfm|K1}LlH^)~a(C6U*8``1%3}+Iy`Xoc6&{t(n6zWxWjS|#nMWJ5hkSNp-xrQDM zwQER^hU&XTp}yN~(4(PoJ4d0u^L6wa8HM_hH=##EcJ2~|`YzYeV{{biM@RMGd?J?D zzQG;!=Rw?`hb%)5M9zYr@Xo#0pB9u42JIfZiavgafMGC&HpFB9AFv+AT}9{eGm?G6 zdHk8Y{|ou$P9 z-mOW!Yg;3~70f5eHJW}~ui~@)e9rM2UE9~MqPo}a=KV)O&a@}6<)-AkHQW>ZHqbNp zUVQajkb~S4r*j^rYphOKT-K0!)|xYShO|tHRo^k^;Td^B&pQ`woG(c`mmH2U(lu|; zGu+%KIrq(d@-O5km8NlZV~5c@-BOa_Za2r!p?8@2XQXpHOFHX(ULTo&&H9FOhq)GKY_s6MtM9BxQvC%O zWpqYgWD8_l6N@!>Qk(oiiqR)q<0p1&;l$)KZfo{cwRHE=$S-~&#c7tj=uM&B0U6-D zB)#kAB)76FCBuDFvg1FH3}frfGRHlEU7z3|29o%&+#4XR<2zZ`23hAEWULL+F`gl9 zOzu!&#!kv`jP2wzl~RIFWJU9uFpsLsZ;s&;MkQ8}O6I*x52zS2>{V(ffA7ph^#_{L=UN4J^5(6#B zvWPNZh_JqlN|*v6i^$u)P{St0Af^7HBZZ_{BPs#{D%rLKiwRmJ##odi$QTw%C>mNQ z5NzlwNWQXbB_ezJJm+_Q%jL4{waGj4ndf(Y_x#Rz&f9aoPdFT%K3axnyGv>Oh!m?n zi>I?URj+YJN2PL3xKudfW;n33&2{itk}nu`jhVsvy#_TLx~ttg5Y)Tr$oneyE&rSE z!8BKg|IB>%JlruYsiWT>+2iW}nl?Ug9Dzgb%zmuTIrCg=HU06{>3Vs<>DKmbp8h>S3daADr*;f610^6$B3)yO8G)|>9UMR6@(A2s(cG6MnbotTz zDc>$er!_botNOj1d0)tx8`~bb@06(7G)2w1mKX{CR_^FFh)SqeA`-7LP4SweR&&Mn zi0s{C`FVPQbAv=eD=J3rY^z(_e%}P4& z={%tdRf&uiT6`5taIFT);v<}B@Yc?s4uD|tRI zvVQMlj1W&s(DO{)CPy>#`WF0MW0d2M@D#kQd&_4JDD>l?pZtB$>~Lj0i%PW5?1)F3 zJ$erOC(TESYN@v7C%(qK%pTkm*J5Ado9k?jq}ppYXSGPp&qI0xXD*YCj6s;z=J&Bm~s@bQ|*PV_nj{6hsXP$*W zCG%|G|0)-Mpp+;)Uy|IDrrzmo)v-4vwCqpbAN4DZy#Y#?Tvr&|w^;8^R=+I4wH1X}bXwE8`%YU6!`)C`g2UQpOjm#r4#a}^=i*oi?VyhAY zANvC-%iM%UZQ%KFDB=AX*qdP%&wa7Cz+`yLy}wn;!Y;HG@~rfx-V=$ncnRKL68uv7 z;Jx=e_3o7Oy(Zp`f+8q)Xq^pcJpFH&tykt9ppP+926jN7^S@-ZuCv~1z-FrK-6`xX$&hWy>ZHx^E%P5eYpKqSzbOmjhtQG_ z$z&IcRBP#7a+==jJYTGPC+si7Xo=g$U|Z00M$bb9u|d!8weAdG8_bi3b#FN>s2cMz zzpLD)eS3Ax!%!)4-;RQE_@SG_(X_ifEMtzq8^9e1Ipy`r=Uon#bG~K~TL$qw==d`0 zInHs++QwyanG!TmPpOpi{f+4GO1^oca5*|v&Q-h{Dc7}8K1KS+S?O=Ttu9>l-jLpk zKan|}czl`uFI8H{U7+kQlRiqi-&*(diN@b(o>2|0aWw9!&t^M3>+`Izmks~zVlVZk z-W}eDoY~#n4~L~!62pmyjqJNs@Uh*0cPH(k&(9*}p{J>Hquvp!fi_a+wn zrxQQCx224;usFfyW)JG!WMik7wClZ3KRj#hV$W^0l;|0x-sOe#lGB%|#@v)&E~E>o zvn7}O|NS>vgG%YneKQD6a|FM-s+MofyJkoqy|bh9Y`$XS4r|$?Rp;xSr}w0;ldji1 zIgOaob&ckCnmasd zUd+k;(p;{q+gtq@TP^qC+;E+Yb@%-S+HP??tf=4N7Fnh_n_AxOrQRUt*LK(l+hE7B z9C^;=ag$r~p>@KI+_E(4!TX&OWhe8#K_a^+PM508eyLILZ;8VDCv)%_@<_N41_QGv zBb+7X+Owi@{!771sqw!rUkT>QsGx#)aJLK&reN=(?ejS6Gte9N@_d6-`?t%G;CA^k zR0m7h=eNsv)@f=m1bw0P=1Wz$QpSgWCBNJ$wH?luTI>Suf+1m@EOBG3^m@wd;6|D4 z-Hg@pcr;R@%%_bSn5y;lKf4c@t>AsB3pVrLLF^pp&-@ORny|Cf@ok;IP5K8P@qU2R zMg92iBp6No1=tGgzxnT0^4VhQy(9ObrHY~n#G4gpp+Xfw{9XGz@_odi*80zXW zA8;Z4ZiBbrAihk}ISO|iJ5RY-A5-L5f9>3*=p5#v^O;Njm>fFSx!AF$F!!x6Ze0gE z|LMAS1AR``y_X$hxzy;G>{xCwhto9=E|D?TZ^oc&AC!;>s$cXI-XUXjy~7)*Q^UAi zn{E%?XUD4bYP4b04qi{QA&pu2eXu72$dUtfYK>*N zyh^;)^Wx5P&RW=Y2!AdE*)R1uVd?=;ogX+TzBeh146Y2bXVmukTLdYKJoD_Ze8*nQa9VL$mP zcSTXF_AXFHZ$`O9Kavsf)zlX9s|`)wUr~*0b@El_h2RmhHMkUQy288|uOl!0K+57i z*luz`$A*^oxMv42C!caJUJoS1qS!`$}naK#HST@{{O#xhFm(L3F?zwsmL9qU>%djUSNW4x!Y>73dV& zVjs;7ACzUPX;f1y!7lXoI$02OM;mwHKHeo2oacVwMZ{js4>!|p52+7-hKBBG_VMjR zv{QLzk$FRPE53|YUBumdMf_uVx8qRrX!aG6j#tPTJ}WBUhy)k(95f2q%E(K z?%o9XFZ<;J9Mx6E@&Dd?_ih3t<*_XUB)QP?&O0EG#G3F32_+EIBqc$to86mahs|!f zy8*&D48u4DB`6fy+7vJ|&Y&ewrl9s=r>(VGXLQ7Ar>(=NWuQ>S8E0BifkM{*IeQmE z1nD?d?abMo-~GPxopZkPew9+r8e*$<|rS{z$SM&jB#B^yrJb|C-udyCs3um zj9SuY{Dggbk^YI{hc0lp@{ac}FhcBmK`F;@h<@Am;xLB4&wB z4Ei5@hjK0{O5N|NAJ)Iiern_W?>x4;{m2tGGF#h;0n%^u@Ep7yqJNlPpTT{w5MI|N z$}J;QD1^r{+rhShLZl6($ZDpTQ!}T&}6JTt7DbtmRwvJoykU#8-X zhpz)y6SiwFAt*@Of(n5t_Qsp+kJ=F|bp4TMu5)hC-><|QkZ;2QGl*M+r0)}Pde{LJ5WF3Q8cHG zMm_h|aZHn8{+4rY8sqzTUp`5?owwmxG@E%?L*1+Yh(2bcQqq)2u$+;px1(`{ZClHA zkn}e;<(F^0Uj1F{(4R$}z=*TWg2zxP;F#r^RcO%nVh_i5Gxgp2WNb6bdEYd+=Ce^w z|C#i4Ki{1DM4a&){k-RJ2KS0LoB1&Ix#x0DI%(Vi&hv-3F2p#jMz-l?KVK1NP2v>m z?IDd~d^px4%*`BoN^w?ky|x%HuwPEebyS}UvkqS4OyV;AjbPpplwf`#y)4hm_U6z& z$^1UDc?Rb4JZm=d*9aw+ zd7L$pJABRGDy(PmT*|tBFC2bm-R?}}n!Q(W{XR5!g8Yr^w-C5`o_Z(s#bgZeB)Pg4 zxKct^P%md1PO+;`CeOUVcKr(eoW2!{_)q>qH{#;y<$B>pblP>UW4_B^oZ@=+l3iTy z%;H%|ddX=Z?HrKa!Fx_7Fscp6*aBpJ2#lUi7(bTbaX$mR7CC$)clIS2Pu~;10%ZLV znAi_Y`VzSeOs)X38JE2e$SDP;uvJsO4BX9|`m|%fbk=jm*MV6)t!Hlsa{mD2Z3gn0 zzu;Ry(Mh0$^`FaLnfLpf^I7)Ef;wO!)0EOj*+$@VUj^LZv$%%eL`GRC=?2XLZMJ76bgkxp-?Ck3WY+UP$(1%g+ifFC=?2XLZMJ76bgkx zp-?Ck3WY+UP$(1%g+ifFC_YuVfH9A2Z=f7|VM4=b6rc(4+^4+?H^V?Cp5|94&?btn z)IA6=F6f)J&x`{tNA>hf`wufq6qV;HJ}4FWi28IlQ??NB`u2?ic%L}AMHVz zBA+pp2=Q;Bp0;-8k0T~SHl@wf>-i1Hlo|Y2Gt^3}jSaM{lHS8CH&xCGdhem{Zu+t4 zH$tC5_^JD;cQGz{tsLuG?F&&tZThv)eB{bH_~@aFX)TuPV>!ZyAM2d7%NgpRRm66) zj+KNn zan>TpoH6!7rA(P@QK}U_Stl_A0w^~HmcaK2R;3R(5R_KtYWs<&fybiEzOw=y!S?bfKh!CKX2hZ{tm6~3NGciaj^ z+Jk<}AL;6eiaeHZUsz&I7h-;{RqqRRby(HDus`BoN9*!PN7$=F%>Wd!WFFBppDFKu4Bw6SVVWi;puVY0<{ev&m?tG zHJ=ra`T};RFS^c(wB5Q}|I3ShghVa;Ps_qzie|DDji|z$A=^M6TO6SbuvQIntlL@V zkgWg5%k!U1HFSIWL^h}70S+W);2qrLS2+p|`cd)M=3z2&^r!VBycFc-g19%W6G!GnW z6y|~B6-$bxEGbLMf+8u8r6r?1-r}6fiOg0&G~D56tH?LWx5>-IWQ7Ls57NsowyEom z8eiasx2mn42`w9J|5Irf^e5rsy218Hcd+>P4xqN8Wnw*_BLhTbL^Eq^rc#&@A)3z z^ZWeH-yGk33T;4~-{kZ1kU)kTNaRhl@Edrquu-l-8xY6nZ(uGr$ivzb7e;lxP`6oi ze_c~;{5mKvN)wud7NIq06FH4?4%&b?YV&BDCydYYYtj^Eq8{%&6A_$CUo3@H_&%Y0gr6dQZ0R_BC;TK_ZS@KM5-v40 zPP^bWW0UBw58-`$E9pdYg16#65`2JfCv7@xOg2{g8Iv917-sww_vsKXZy-Hz4>x2? zSj*hji+{OL_m~>rWod4W-Q}0KL0S+siKuPDdzaT^XY2J$h6;5JvDw6CK7?rwVOa#m zNU_SNbfQxdi4skGknbR^X!{;-CtKl%_)hJ=;MeeHCiu?^!5yNs%-_`1k5p20-&;Le zy@iIxSSeA*d(rCf8En9e?tHco+#e%}Anzbih+&N z^bvjqEmsh;m!Bh9ek`3+kRVI9h1<4m+wPwBv~AnAZQHhO+qP}nxbvU5@#Tuhe5iV> zjEbGP*GicZbS$ehY*sc9NOdxn{c9EeXU1C%!x2+b{NBkkzeYZKiafLRj6ql5(Xi^4 z?oXhj4;ZKQzaEE^$ZVYxecohps2(;@Bhr{l?VjomRshZAl&xd#Is^;-jdz)LWe!OH z*$V<_!S!2pby}oP=Fi9to0gE-iC?+LSj(T$3fm;L_K&~)KSf;$YyCg|M)VE6iJVIq znkJQR2}oDARb`_6eEO0_@I5iJ^!=%OyMDi-Hy>gs>h%DFYrFBV)fNp_$}ZQ{%EEan z>nkdiEUhC*fG?Uafb0G!zQMQtzI_r#>|c0W;PmzK4~SoEHr0W5x~pHVRwB6eFMORs zFN4qx^058!Aq^tuDla)C%d+L&2EpB600ZvH<8m3c{hn{zn8E z6~RBQta4J3@qs9T|6y4K^B-05OmR$c4%Qci9*h_<(;O^-(t;7R{{La#QWU$2QKSYQ z1Uvw^Z}v}qcKjR}|3rWzeZ>DCEb+kqu_!Eqzr`qqsQWADb6u^EZnhD4tHCDD-7Fgi zzA-x9@vXQP}Oq}~7PsF1X(Z)U>LA}TDMC62(5x69|z&keA z%zCD17I@w0+SxUtZ#bjIa)X(P79G*wbu)Ow`C9Oq0Jf>{j!&{9lDFRV#w}o!V9z5%+QTq5~=^;kw$j0wzyPm%N03<2`01n za-vtO7JASxM{iS-&JEuJiTPDRv5;KhyrF#uE{CV#M<-}c0Va|MK=RbcaIpAtqcMR> z0dgHcvkYo(Jv?dXm^i9q0PB>0rw?4N_#MR6M>{EpqLP$9Sodmt79_Sb&rMRa6LDsJ zwMF|@fbu&3WwY!s*7`uKz!O?$T67lV zJT50E5;`vrP@T;peKQEmY9ZT9-irdR-&xF&SHMeB#Fo<`E(~vrT$F{*kQXY+a$WFZ zc))yL;s)@QtEPq%D_d0n-GWB3aC+rYkMzzNfGkLMq0G~R|G?^+w2KDqPkn%URN&8j zV0~Yd7LLN}=7oCLQ_vZAP@rtodPQrXAUte#)WbpCLmLxGd=LzfBYEGYCO=3r$TDrS zjYvuIg=T^ncW}-x4}Tx`=3gfwhEu1q^pWtr+;u+|p#g|g`SJs@!j3~x!Te*@C6;+r zci+xviNpL69T>8^W_`u75sfC>IQqom!RC3vix<0j_`m>v--NQyMhlBMNL8M6CiTC~1qh;;tlf{$a;(PXqSPFC@MICaB@zb0yXHpP&-ifce#zgZs=Mer0oL?Y019- z0}S`HfQqiy1{Us!R&o>sLVcC-67ZoIBMYMr_+3x#?>lXViag78>r)?>GZ7&I5+Ya7 zLAMM!l9KDml{X4fS@6{-kx}kVzjE_f0l>(3N^iGDxQ+-|krLsrA-qEcR|m#wiaQie(H*EY`}iBH)hn7oam(Z$={ za8vU7=JTG#Km$}Ax8w3d|Iku$^NA&)X})VZ=%5>nmBb`W@nviInnbK3$px<%?*rU* zKbSNLw$-M9+3n#2EUJSDC&q0l6BZEYhEP}KJ3Q|40#gLVTfw>xg>UQ6%@f2+O$V)p zju)94Py~HM$7|t=4|YPemP_31LvYcj(jaZ{5D6X;R4w03Ql5Cft>@+d>$^W211UNDR{X9Zo@-ZyjjhphDhvZy=1%9Tw0dCvss= zKN(2`Ig1dNk1K2a{zADipjdj;^aBLQw!WZ+g)+7=a&&Sq*0+ZJH?uXcfMsIj;2>Zi z_}`R=hhEg&%E{P)Uerq8$ynIf(ALP9Udq_U)X9v1g_D7k_5T-)1f1;b9E^N?|Nkl| zv2d>xcP*5^XrsQi9vv7VfX8wum>s5hqi({{9m3iMU8~Xs3CpbVg@Op6AR?p@WMB;j zN?msYnt-wLU3Wmk+*DMdS{5;w{?Xx=Ts}(}d>PJqCYFA&o$rH7r;j?_9?H)Zmz&zP zSRj4K

CT7EZ4@KDW|Rhj`SfVP!#ML!8F`qyWKyK8W&;iAO@{7OH^OEr3=dOGD<6 z-Y-qpKp+-?v0di(kEK0PY@2>D!F}S2Qcg!Go1cc0Zf#t6^eiFVULK%QU^gwt*Kuh< zMMw3FrS0ym_zYHFUsGjb+j9#za(5m(F=Am-GEchaJ|HNXv*6>*M92k(J2TIq!|#AL zmdK_v;tnpNWM(Tms=fzTXG2$p@OTd{hFPuVcl}hCQ(^r~VEis@VaqY_<*Ay!Tx>6s(im-&xR7Rwu(qpP*jn!hgBz+4~~fh6mCFmUox zxVvXd?UJkPozA!SDziG>zbGFrxjo-MI4?54uHY~@EN)|S`o5SytFJr1dP8IK`}jZB zPieie-)D#RhvZ&N_6tX0VqRFRq#hSdX=`og_mIpcWHTAOSK2y|pa;Rj{&>=1kFCVbp z=c~;Er7zNoI0`z-94?KXmtN9eMn2EvCFNxc^om)Nbh9X75qgtECz6RF7Y8puo<}Ir zsuz(fbRWfOj*G67yvBJ>ejoijAh;)FQOu?)9z8#RzLyKIykUL8iUy9)O*1Soj4+JH znXKupnJQtX*C)@9u8m;mB}HXNX-5r4$B&%pDcfD@1pu2R|4O)+ytamJ3|@U-178bWrC!a1l!bhZxMJtBuCTLl1>lOup!^MN?0??A zr>BzyO%`C)aaMys90&###42r*SR++}pkLCtu)C+V&%&UjLspHj9D=&11cr8iUNtg* zU~PTcLpgj_eTpFfDF!nJmnCOVICQuQF?O(p!ai^x9CanR+g z3OC5g8lp5AQ>R7QY>~s!$FNT8qcrI%IGd(yVFzoLi(-&5FQDiRF?genz?4Wy_>3@M zEPcZ*UAsjcHdDkY#ptK}$c#QIKH+(c1m@)sS@XX3@Whv~_w%mvPV4T_R~T#@sUwS^ z$88{S*c+(98zBwzh6=k{{=+G2ys=*u-7$ef^=(GNpLTq2FOgp|83!g*Syb zB|k+V#Xkiha^9d0sv%1*Scz=zGggSvuDlPW+Oke%fM#2Kq?7-8YAp zRRa!Iqdr%nmPL+3k#%sg_s}W^#3@MkpKp*Z1n9j7m>2PZfo(BFI0L0&f?y?i81ro* z*lpoRNd+*!14>E-IH(*^=5A4}ZNXGZ#9+T6u#*U(YEplJ4j6&e)56uohODOgO~nSZ zrUrpY3;|CL9chNpDfrnG?nr+n-=N^{AxbF|*%Bf^6cQo0vCNRIOK6)=qwNrg*%$i6 zH_f=O^Rkmf){kT~9td!c=jeDwp*N&G&FIt3@vlp@xcI@(5pYY0lm7la$G{!6ZIeE4 z%95EApC|?563ICdDJ_rFkhgpw!(ZCZJ(Bcs3Yk&BwvePg!^tj%c8aH)XFrm?wgYir z$^klK($0rN5%Yj5s8kC2-6QoG;!O}E1I9eZ(k{hTk|I@-Fm_4|pbSD`lIK*GBUP4X z-4-NtE@Cf3b{>&^OSfrsYRRhBqh6CwW8G=U1@}+NwhY~971SGx9-eHf_HG;2wjkAH0H?H2k~H=#rH!H(H6jCY~}2 zwMOZZf!e@)MZ-Nh(+GV<)H&3npSq6fl8jn!dBxS)AE6FOZESo+Ms13E0p?t|k?#_L zAg&Z1P=+QFA8u11>V)200A6XNT$QnH;=0!QTiniLxt$Jo8*MCf4;DD`inWVR<8CyBXk!#0dS5QG3M zfF#U75TtM=ON6i6`O>X==e?++QaV+N=co zBaW{s_N?%O*jviC>d$=c#UajM{Z<&ZBXZ24o6KIxRunR4cp_)8B4_ks;AP-@8gf?P zHY2*Hp6nH>7wlsl`%8b%8vN%W08Ut-9Rpl{J_k(bAp}l%p&d(1e?14>=pl#~AUPOx z8>guqnW;Ur&3H9OX6++v&vJTvrT_>8*FQ) z&53)WVaFldmbrs8{MIoP``HA4*K3Hf`F4Fp)#HlxWsdW%hnccwY!%jJeX{wohHMqr zWqC5{iUz=d6DXiSTpm9#kiT^^02sIygg+p>SD2qzSc8Tj3rn4b`uZG#0RbA8fT0nqf=7W*qx)j+2$phuT%5X$MIUs8hMntjbQd))_&afg7 zYq3d^n0QSAibOGsMCnPAKzb5sqA^r+UdmELLpf`6e#=tK#v=2QKi5Lzl6c7k%Y~Ho z8T(RlPNB^c&#|2AL^0k{;_UEBTLH2yjuo8{haUzZMRr&p*Tx=$=t0umGt2!OZE>xvl&^pF#RI_ zIjTpp$-Lzgxd*OFzl9pGr9N&|sMi_*Xk9#hAK4m=rXICb;B_6a%K%-*G<!96EfZNr}K@V;aJdM5Gr0=>jqSi}EqA(<$NP^ddbJ}|A) zSV|F~2Jvb{DdDIF$!f$8BK~VcE<8e9<{IfO zC4uKKu0xRa5-1S{@>Dfpmj!}K5maRXop$j5N-J&<%XeZfNwX6&UTLv+@-@fgTBEY< zJCJFod0==#v^@S?Zcxue1T=txVR`5X3MG>?>*_A?+QzMS-Z4|jyv8|K#NcCu`zct& zNJk*=1zAL;lc`6Q56t&vjgiape> zlim+;Ut&I3Xxpa`wGa3Yk#>pRTOd71i?f(VFpi>}hgsn> zB&HS2+v$i@kjcRlLhM4Q`4w~BbAfWwWix7`80JlchgiG9ncX`|j(s?c_?fd)rzf{3 zx+m0+)$coBXVZ5k9`v4#UF$o!-O4*$z72n-bI*GZW*t zuyK-JVSeBFI6d{nnE2Q=>+RtC+H>nZ>p63pa|@8D50)WtqRqTkW1!kxxsK>kglnwY zs@rV2_OA)f#hQDg#&EUya{c)lqtkzTE~Xiqb66%^@gmE4hVwKVdWLxVmzS}XYCr{hJ-#JUSaJwnA=V0@RoGQ<71~NnZFNLg2DkT%F1p9Kk*r+=ry}gVB z^kVw$m`+3M74heU(>n84_npvw=pgeT^k8g|={n)2Ygmp$`e4jnN{mwyg_7dAU*O3o zB!|E#G&LMGBsDCzWk*_#O$hg#7e*Fx7WNbj-2+%;@C>SkH2gV*b%~eFU&(gf-;h*$ zKHo89Gx}35)NL#q>DCm@&1jd)Hs@^*8*laz>peCn!)-dUMWgiBtr{D4_HpZ@k@o0q zH|8N2)^(FKOdHX(c$1{fA?ph^N8~Lf_GxKX&yMab;nw!eO=*|TPD-2Dy~sVu6FrJE z&!c*Bo^wiB&lL1KDmPT#%|SGtRp{3!^e3L$gx3hw^~!^Pr3rULog(yO53F&g;NMEW5Kz2x@Xy3`s)! zz9E{#N3RcjBfxbfyk?8@Q>*tT{x$|^7bPa~HYRA7!i_^T%aA9)jZ;T~HmlFD-pE4{ zpsiSbn)V%u%Tp2nqZfht_XMhzmC?^3G0XKP?dtj}8L?ATjT=?}KI>+aY;{|fe&L0*U8#^t6!V<+hbLG{0N6zU+{UA4`5RvY`l`fub>I% zIXG;$8 z6�hxaLwkxu{6aaeUeDvy2Q8T1rSR2N>Dc&kxBjFJEK}(_Eh8UXsv)JUMX1_+K&I zhhNcqH$%{iORQ7XEoobWy2em#2l(F zLp0dm**}at&s5K$IoiP1D*@b*X4|u}FOg+bD`{css*7|C#_$FXaW!^nJ_oiBxpE|| zC3I`DfT)i7Fx^>*7NKG0!jvf*`>FFzVKNGoEPIHI8lmUHUb?=Qx_J{x{M~!kXkG51 zx%r>Mzm&3NGCtr?f3;GQ|7OMrC5q-F%k1x*+5U}ue(z?3||3P=ftWqEvQV}bQAIs5)(WV zlJg$^qa`82H|6(AZN}@;5-X7xPPfR~F`j`77rK06b~Bu)uPCr5>rQQZ2vnso!Tye? zG^FSQ*UT>mxjf13t)_k7lje70MXRPDlL&r5t}eYIfZG~peN=m7=9WzU$M5=I(0CG+ zzlL;B^%C}+r`77;XJl#`hDIP|jz@#TNm2UR5DFIhCZ;B8rM=xeDvm)4;e51a|JOjh zLAxF5czfTXN1Tu~5qn~rN%1f#F!)29oG`JO6V|Tx-JaV$;IIV|ADCS2vm}SyOnzM_ z1j;%$49n~0A3QhSIkq|CIIJ`H;tq1V{DHm)Tf81G-;&?= z!^<UM5kdB(73$a=tUBg^!u zZI0}a@Sxu*6J?d$!v#@q5%^`mt7;5p*`@)v3OB3Zc{;LrC`-K5X{9V4Y1JcExH8$Z z+KCg3FFC7t-Z)TjWzFr>f@6&hLPs~KYcyNL^;v2fK|I&f+5X_1tg+uDKJj^6^(BR! z0(BNGtpQahpy|R`4n^2}(xoiN@+dwb<)I7tJPXtx4WmlX15`SK{1$!J>NY${?Q|1I z-}Vs?8oEU{DtR{TkI~;Kl}{nFq+HqiJ%OCuNX*s+YYhoacNsIL==_Ybtjeq+?r@~-@mO@|A>(*D zm7m{tqK#+HfSW;=z1)@$NsT-@1+L~t^!HtYPV9iX%5&`tiCz8F*t&tuhPaH-j!611 z83&jb&uE2jS|8dL^Rhny3TFV;aAsI2VS|{rM~-W^MiWTpKOE_(6QVdNL{PRw8i)P4 z?^J)M75;oj-W!BlAGXb0J#-=!7xR%7Cm*QGmT~Efr&zU@P^xT25Lv6&73N-RuUn)R z6phs+u9@$zTnF=Fu&uyh<%z^?DLl#LrOs#w2(|NK2>9aw<%i~caza2tE&0PsTjr%K zvp15^qFKv3xSo9f%Zc6TN*8(6pY4TyJ^@~1@Ab+y5GIoy?NT<>2$UIvcx-9~254$ybH*F(!Cs;>}C^rhk4l z@8%sJ>ba?ziD}!|L9?`$FNn9Jz=$J_0)uWkLtxvh>jU8R_6R#{0ts5c3mAlmiFUjcf%7PmltQR_1W{fhB31i0ja zAqYPDAkkkV1Xby3zd_3qPn)rne_-jYfPp2FH3zH%B}mCz<;}tv1&Tuojv~(&gNZWe zc53MJI3sEG8!s0$51yXV2o{%Kz0Us^Bw^e!g^;ax9fBa>o*xqYKtr<>N4qtU=s~W2@VPmTP9e1u-+FU(Y|)@8rbCG1yv-ft&0u+b ze9_fxod!H2QC@I}Ch+VHaqz?gXuV*)Y4FBYMzV!`lYF~NMQaz~m|RDZop*Vo44zW5 zYHW6s@{`xPy0!Jqd_jxg+F!smX}&}!{o<}YmfhJrZ>f2->5{I?qH<#bo);AuzcCY=p;XMaG%+ST=LcH_MsKRm!-P zA2*Iq1Y=y1DFTKi+u2duSeK*kw)?AB`|)+|&c)kl79ViAWWe1$7xez+6sQ`gX1bHW zS`H?jLDLqOl!`roQ?H>;04gg+@+`rM<6nh>A{8O!Ec01iefIIoS=R9x6pOSSsn5!+ zK4La9nsG<=sG*Gs6Ef)Rp+E1OOomsKQEOMRA}~@2DoO4hGBY?M)vvhiope%L&4?_R zatajZ%U2%425G^%7J@%JliyE-!nI1Ppx}htsFv`=mn~2aOlrlzEc<4RhpPXqOR;!5=*a}5URIhucGG$%62LN%ifx@?& zD$|3`$HIywBv&%4TjM?TOb|jvIZ~Np;TVLNJad?QcLI^1t`>75CB!X1 z0*EfHVX-+PXDrdUi&q)-Cxkoggg8U5)%&Qp-~2_V)JtH zOX`1AwHkrvTKF`l08+ZhY5EWBs0Oq3qHjqDB5{($Jw_5|FbhTtTxaJ7pv3Ob;kFO! z)VS2^+fj})L&$%8Q3pJO-UNuqT$k&)LM+pIy|rI7m^*g(Bfo;VB`)f8$@I@i(e-jBOEN_L zZ7&J$)@PB1WCauo4+wALu3{3x$>fj|x}yQnB&LDjRS&#GroHcAJp5z^9>(uT;D$Fu z)Mbkf&d;e%R-vS?i8}4X_qH(vs1kZa6Uw+$7$an0R0h#c^YIG?D{%v#bq-8Xd7rk4 z*1b~srUp-=E*Lajgi>l15S9p66Wr4)q8RUJ%~Jsdn?T1Y zvlJ#3Axh~e0t6FCJ4k~?eh-*OK@Yk=z|^b7-cjIq4j{^5ht=gEGC@s+U{gegj0E?? z21`UT*K;_%-zwlh*UNXi3n-_AsD)H7zMrp)M6(zT`QsA-zkC6G0uLOa{ReYQ1kRjtuZeTOtPT6DkO1QtTB`V2I54$i&jG~Qpyw_iL zfWikKUsPP^+tY>IQ|4Rqh5|m1@ZU$|tE z?!>$l1MXM>%h%ja}sYQpGvEKg!MCY(qy)>D_>?#D_a0y zP<@7SV+$`+RsUb*H5d_+poDg<+m(6ZL1LFuoIhx($A_aGfBxK;&gXu^=_VGo-F>aj z{@j0&YijNdvLC^ocMgQ2JsI8%k_mRovcnaL1}<-xp7{H#ifRf%c}amXK!FL->IxGh zs;9_tBq(nbCYPZE18-c#G{=hmh8^>(44BaHMR;o1e({V;v%3i|;~G*@15HM6j|&DK z;*!fgxEf(#hnTb+@T&>*$Ds)H0AJW5lLrIqb$UrP-QsLxeGHDR)OGnI%jWR>M(#c& zpY43}=z;sjvNYlE9_ggH!o8G!7Ml@l&}&=$mOU2s$a4KT_uRlAP+*S$JEB8@4LN}5 z8Bs#9hOEq3z*0%9f2qqbyM!1IMj?%8GGdD7pXfcS zS=l42q4v7fwluERp{{mOZ7{MlCLC|E>Rwq11lmBz1HHf!tM3?` z13?bO608>z>vzg<0)smDvzCiyW}u8EE6-$+`i*0OWxlChXj;Gt?aH3qh3-X3i~ zz0tnj=|1J&eIMGiLUV~1ms~_q54swSI$$iEEmBi}Eg?i^baqcOl-Xuj-igz;p89PR0ANbL zo{`TFa+D{L3`X_lp3*UO&V1I;xMsfAsGfn-EgM9@`q@ra8~bfBuVeIWEQg-e zP4C_BGX=kE0rcYgP4j>|0tb7DezWR{FS=)AElr(WLa~1$E`t)0PZ)xVf4Qa{6p6oZ zUm~Eap4AqXj-iEH-W45P!X0N~6l4 zVig7IB_pSs4;t>XurmoYC&)kZ^zmcD8^!uLb4rvsA33K3j7HV3{6r9z!TKRY5*6V0(-y*etjdb95zKM{mU2;0JD9+AZ^X@qvSu9_A6zV{vG z&UE>nn@ww3S2hzkKE5p%he7x&L#xY&u!_msV?U{YA;vzckXexKzI8 z9d(l&ds+%DYrV=lg;ndonXzBq90Kmiab<5{ zDu*pkr?{UG?9%bV`%D2z4vhd$rw~Wuks6BIhR&xFkR#S_>ejE}IuqHsB?<&CIWPk( zRw7`G#O4)A;lP9aZM;w~oY}SDb=C(1 z#!`dTRx}Mn8{#o6`^RC6bm>X0?TrM0!Bn<(#7jeifu6E??VbagX_eWT+Fy#~Ducs% zm2cxcoa3(XPdg}L70k+v?8!y`wbqJ(M3A*@$4{*UOg6OOp`!Meik_S$=g z=6F8)I2o4QE1HP?xupAfEKk+XLkBylL{F`;rL*9BpO3CIwA~$I=hFR_|9cw#6GP8! zwvGNf^j*rQ1a7l`nO%!_p#-kxdAj7Q#A=OVi~q0d7rIq7W z9ey%ii=k%<3pL$nK?AM=C7m=GwWbVq{k>C@$bx~jrorbur94ib*+u0b1mV<8^hNeLLCcgbWXT;@@HAymn?!3qoDYcfZTR;;p76KxGDFoTFF9v8N*cftQjmiWNI);E& zKMX`e4>-=Hp%3_u+ne2&Np?1RpWCCoh7#x7n%mRKjugK8>Ep~U9j)A6 zrzg+vKU&^DUnkR}uU!szgQG4_^gF+oRlL-&W z%I#cV5{rEg&#M{&HU%aKfBXYV_8sEwur+n;_ncp?69k;=$)$x?eG8HhlmOA zP=xBJFd}-EQ^AEn9ZGs$lzn{NTlajZ92e~)kL+QdE)! zHnI>vkrYP}$!^TzQF7D1VNRyw4=6$}lXrw8ZdB2}W9fqZ3>PuhNM9M4X~g(7-*bJQ zKIH8Lg6@vnd0#$!bF}JkC4XK1y!-^K?Min&C4JIm&QNv^fl}y4!UfJ(dep@;388?w zhQKP&kXldgjjf|mhn_hlHgW7v$6>^Rp3y~R9*k=?NyH{u;k?|cQdW82n5tKI^*zZ# zSGNF`qXJ@Dg2*A|Y!*wVhjDt1Vqfh|)s6ns?>g$sy0-e&uiDQ2`tUo3Uiqj}Hhl!o zV9V{%$#9G6QDvI7Hjcu`6*xYn(bR;8%uNuvSU^;v)`ZoppL_HjuI3I5J8BzKXwU7g2Eb!f|2GBd%ji~b7+YA;}ulIMI{PY${|E3 z$V%-LzFD6;JJ-u)yq2#!)utx9UGF=eJ+BoAZU^t}+^y5Qb;dgjBF~xZ%DmJ$d~&)w zzu(HC7I-{&)mp6XqUy+lweDHOr?PAV?qr8p_Jr;nTCgXk+qg zfMarz^G@8nZV`A=t+ETNG6%2YPaZs#is!NCjz&>tMywtSwE~xK+z^jUom1wcWunN! zhCp8g4&6+)l;(ukV=@b%wl@p)BEYjHWK-gQ{bjjG%uUpgm}TS3rFmpdlwJgOb?cs?Y zUxTx&sfUQz$I~Q$lc)6Dwfcfc8C0Vg7B9!>TEMYf?SQ;IlrU@|LdHU-3@HB~oIa!+ z?Z7=G0M2BpR0=%)mc~D-JR|4sTUDSHW?AF-|dv0r>DQ?P9L(RyEsL*rSQHk zp*6*qHhjccHs*gCC?#8qD^RL3 zuE5FwgMz{m=_pu?Hz+_KS7vxGuX6N!-Tk3r50~|I^}P3tjcVz`LyFsm5~iEzIX^NX zD^!|f3GnINGSU-NPchtTQCOQD+}fzz#9G)C3e5dr5ME(4PAqHD?&vZiI9%0 zS7WSbsXUWA#wZu|Q)b!wRzNLbnCy=G^qO+dulArl={ZH#e0^6}WbvD|yT(()f)1%^ zED=$s_d@qt z9bApP33><1;M>6jS|63&VTf%_9izcUAr^anCCy~|4HWq4W=RoRV@4=*7K$S}Wt6#-o%Ry{K^ z=r8ofl(YXb=pW`5uooPYR%Zu+zV0aY=*!oYU-c=)pqQ?U4*D ztx>xY`*;Uk@#(yn?e;STfO}$6)q2MlL3_m3;wDtZ?eio4mftUK#LGhhz7L4%{W~i zMQH%*kPH?h4#Jy=!UXce3N~)6eKNk8tJsw2{a9Ai?0JWgN8Di%9AOm|RibkFKaqo~ zDh))~9Ayd@4kgeG!f64n3S6Bu>#AO5&Zp_FE=u%pZ%;A#-IqCDoO7xUm)*35)s`x^ zH&VM@FQMiiT6beTjh(Id&|eAG>-83|IlT2h@VRH|+YU}PPp{x~CBNRlW`RNZKpAs| z=0kdj!aJY?rM*)@-Sp;T>Ok>YWbxWU)Ao^;Vsx!zHTfrNBdjR0E_I`cJY1*kz)q9rjnq8T?`wIs8_4m;7cLL)?T4*TZi=d!ua}1)Oj06w` zdI%%1W}2dF5D*BT`) zle9^jB}!BEV=hGVLKqTpwYqujZb2bZWv*U=ZfMpa9aRE8ETeAoWHf=32hF zzchK*?4Pa^Kl|JN{E1S9wo+Whd!EaYuwgt}B^~R`--sF2<$4M9@szM1*Ywf%HBj0Cb|5>E& zGh?l+ZSz`7!YS!sD&7F>B;&YP&3c|DOd`Ibltp=1HFbEY1l$k9N=`erUQnglLK%vp z^WMukHOevtt{8Mc%%?r*#Y?yfs^xF=MO2lwOApH{G3iih`7diCa*-1LDe{>BP68SH zzPEc-3kwlIWy~xsFoh|9>ILnMWYj5|N)tSaU0P89Iv*!gGoY)#(mYsEnKRVXo_&v%c(Saf)! zb0@s+z=<^YZ7;WfEA=OQR1U|6uIeFSZgLAwFB(oST3kth?F@h8T`Ab< zRI)vtO+OA?5(q1}3kQJ=Xwa8l${^MdMb%v1un8^cnKFe_*A#oV)yjhjSmBT-q65)*Ge-}(|8x>Dd%HO*6Z}GdsYcTcj&M= zBmy>+SsL_QCC>{eZRL(YUL8P>Oye1ZvsAa3R5vtiaOpm|RiEsdU#?y0z+ItUk)Klk z`b~Cmy5@O0EEcOTL0KYQ*`ytU(j(7jHbKn-4(krut;a1J{jD++bRM>pO0j5d=ugtB zkmXBE+<^bs(pl1r1o2LS`Jqt=By1+oDkoMSSfmhWeitIH_7ixSD;sDC16oxKQV3-z zaa{5&L-H{M#1s?o0I*bY>3op1$gq_KlJpX;Hj5AH5pgL~tOw}~lV0?vS0B5lyyjs* z2&z$k@NyvX?$`CrpJJO|yItK+8=0v}PyO)`{9HGeNpqj_rk1LftMK06{qx%5pXbl- z@!P%OHt5`rtb+FFeUhgi0Fg|xXf6hL-=QhZKBY2-WW*`W zs~DLW;-{9SdZkIkUaOm?FW6;3DoqGgVEW5@wzTVpVi^Baiq}Kj`i;+V(g}=gca$?S z>CQNWg?Y3$42-5V&OWGPEEBCvMWJ=&_|k|lWNFZ3y45Zfn=%{NLN2 z8+65*rBh=3=l#yNi^(t{Nq^S$J}i1Fe&eGF;2oF^c>*;FYnT)41v!n23Frtx@wsCN zg+X#yG=dq1<1kVp;F+|Gi4T53`nA-C*g{=}-J>VvEtKOn!DX4$$}4nbQBGDN&Ot>% zQymg@Wsy))w(M-<;4lwDgO0e(K&Pc7=gjFV**}4i_O!V^Vy(r$ipCqY4T*dlxjmRy z!G-BSPvFMh*1_PjPc#oSR2_!DO;UA9`_*RDHwWzL+*a7vnYfx=;B!7()3=Pbb=NJo z_Bc;J8}7r`4TX8|>-wdJ#cOj@=3Q`DZn#VCyjvJoU1t3$pmYsbA~2Q2A;Rjh9uNX@qh33`yFy+y#EbdE(Tck4=&#keVd>vJc=cB)Qd={#YiwLXl`XFu<(uO zigMxW_W|W?%e4ME(+JJMO)2ujs$`a73?l;H2NhqLF?gamd?=CgNkhW1tJa+?OoNKJ zm+ZF@xFtZxbpWTDq;Ww4f)0r^nl>B*yhPA>0%&EH{JnyLi1u`Ssn`h!K6_Klr9KK+ zx9gA>Zgl!>Yt7bIJ&UW6=%uxNRL_kSo>trCi_=Qb9Tg55|pJ}sZQb~DGSwO%!WXR z;uIS&jT+z-0_*l@Bwo%Gx12Q`FiT0KQ2)C54y6uxsE7w~Nt?y;l9O@qf9yJauZOmZ z8aL9uTa|1QwK@yJIt#)&3&NewDHb?2Cvo;frm+AlFvEZh{-+|>0}DKliXmGSOx_yE z3yEp4H=%e3jyEv_!3Mjp zu??F)_!uikQ-4nVBlVZm!0Q*exi1ZmzT6G=2lzgR5Z=QVfrpsT66Sy*m=#2mg@`ep zi(!$sk{HBpL_%;EkDHGl@iBd%UY1mn3^Pm;0z(3CMjG6Os6SDYU?w(4<=}BHkw|b& ziNyHHL;`j^o%$o*#deg?t8B+;r)`(*yS5+M?%4#mrA5|x)-PEbt+Tj$%Vg(zRclMs*j||;L>tg2 z{Nw!FNJL%iRQ5yMc7bq$$eD?7o;1T39BJ++n)nv3hY7V_Q_&fGCd3oJnU7)G-p!`v z%?ySyni)`b)L)x~e?EVvUN7_+#RHm+2hAdaC~_KM<(5Yi0H#D0D;cX8s~fm$<0+1i z9liMIKx#B~d4S&SjrcfU&5P`AuVGad3nJ!C78K@im?Nez&x>IQJg<`95JD~r$Zx^f zW?Iz}<+gGMMQf9A?`i*HtfVRkGifh}Y&U1HT@(q1i#OY8U6DD_2-Wet3Oa1&@zvw= zxp(P<`)cpROTCZk*>-Y>hp7{DCV|kNVZ=kv1P#-k3F)4RXF?no6OrE>60nfz*_}9a zELNMOO?!0DI0X11z)VeexMvtw&_Dk1@d^%)Pjc7Dj#TRauEDW^)GFGyW=M&4;X1fL zK6*WkSx~?L>GF34$O`{60n%n~l}NLF*?&l{7T~DLD}4X|zF(WWn|)1G0E|a{vEiH&j3wb*-uF)=f_v9&cQ;4+KqZ%>T96_`T ziv-)~95VgY@zrj3ha- zEpSdC!pa-YDL3sl06!B{^$q9TYxza2pIJZy~C*bpe?8-kz zenqrbj%ARm2z)T^9r?J&32xBNkBK2}p{M~gC#i0s^E?lkuy$8G|p z>_sT8HfwK+A8PC-4Qb@qC=ySL`1@j)h{Y{M@0_)jv;;Qz3j(h~CC1PYAT1RdY8a$A z9ooQ8sH*y&F|c7mkp8Eg0mNa0F)-j77}&tu{{g48Q!-KcRnaYb-CV<@;|oqT{)lxD{>fTl>T3K^3~|| z_Yr`l$E&LF0LL}PGO@+6PI;XyEDL>$UnxW9;-6N93ct(-D=JNYM21P=(kQ%ND)<%> z+ulByk>z5KSy?%LJX0Dmp+IG(>1L!LoSQ408yw}0g5ZBNdajZQCIyWQVnXl8#dLz$ zKEXpQpCAw*2oiZxfkIF45?BiJ5@W8L7seL)se#1w;rf^s8|t%`8D@DbTl3H|42hsT2$leQ#ALJc7lsQLjv=dNN*$Rck}+slHMV9#ycH++pX^+`Wc|hmyWV;sw*}qv z)YMtC8-K7P_a0i&mYmT#ecq2>$aVAmEq#x)?W?Ug-nHa#do?@P?O)vVwa3SQvP;ya zKH50SK@$nOjxNH>BhWHOF7=RHLvAjmze%DfQ=>0}{5 z*Y?u=Xb;}+e%n>dc$tvlH9{Q7)CWh#O{1enblfzf2nZA|HZ?YEa{b{V!`zY@pog^r?~9-=whQ(|%g_wTW~bXQix?>|hDCusvCJynV&%_=P)~l zN!62PJdv(r!=fZeyu?YIP!bFUv7joT0SYVl{9b>tpB2Jvz(O7u?1ECMh5U-!VxWFi zRh9603T4BG8RN65=CCZ_5BNPkF9wb!teQHTWEH@y9q8W&TAyrL(>domn@_FJ9Y)hO z@2$SK>7|Z2-MQcK{l3V33v;IjUdiQNeYmE(uKM1~`z~IuG>O~Z4Zyhs6;qiZS}&i# zo024o49k&{DYB_Dl1MP_H9V8WdF-sH64kL1(m5Fydc0Erxgcip{~%_v{5h(o)j#C0 zz$rmfUf8lt*9PxUGGd>3iK-UQBSy}rlDk8->~#7pXWPxiZ|z{KZoSQ}@GnUAze6QVitmAfMwO8tV*&Bh?i zWOgF5V={4!X5v#R@O(N0``PzzUBHKio5|Zx?;c(ZPr3s1wGZ?)fnK5S9twNIKHOe` z+N5ISVdHVe@&s^#F)(J|W0)Qv#q@ZA>3Sv(QwZd+q8+m! zse?2#)D)7;K=3X_3N?i;au>Y1s{&O-^2v_mlN~9DY9tv|kWvs;#UQ6CCCNn(jS|QtQOxd!SI14+5+!II-b4jXT#0dRix;nZ(q zT!IBMeyl@~J;lYY0F`tXmGqj4wKkT?Lx)ZgUB5fw9;593fH(nzv;bheC)$A;ZHK1=68y!!$sB9S$}Z)Mf)yTP zRRUEU0|jXm6r?;9j%K8&D1saN2ZaCxAE#An$P8-8dPmNuebkg8YRa-*I?}P4$AOy1 zfokL6SVpxuN8qWzLwy1ANe=l&^#Z>mMNu6^^=7?YU#WBTEy1ens(fd--5YE;K|l{d zo*GiqvJ+{8Kw!051*)3XJ6M)MV7Db6Q$jY}_S&^>ASG-u*zY;~hrl`#y18AL)he&^i1%hKwIlihQ^d+wc^{a(M{ z?;|(I#-;*nWa=lR>*gxbKeZOTIRn7-B*dKJb`kS_;`>j1gQ%rIP%s`0md3b$l>?4^ z8y;n*N0=0h@}rYpKIEe%dnhlkjxdO2|I!DV<-Vxd+vhiW`|LU1o|)zCHMQOzPs-h$ z8?>9#>=|~9LBE4u`3^dY`jD~!xu_kzkFFx-q~Y)xMCIc$^(bD-+28$~UGZ~v-L<_T zPUh@K%DK)8vR?T}$B7=8)C!&5yIQBpBM{_dxs*=j`KKSiQ6`}j{WD`?nt?dCOn*Q> zEhZS8koaeBC!Yy?fqXHrKe#^}&?M>&7y|T$adJSZ4QbjPC9YMJxOTh5wXCk+MKAQ{ zdDa-7zC0k@mxl1#@Mu9Ap3W5~ZnY>@qmYi^bi|FcN47?k2+j%#>~rj8znh!BY9U2(DflR3)lgEBk(O#98J8@Ez(oUrOnvtL zW9rUrs~?>`*7@>NFTa70#(TfI^7CJ#*KQ?-Uwia|;8d6l*#?0b5KSP0=F~OQv{*on z_nSFKoc6;tFYSuhYvexK?^KKP3+~DU{Lfjl9^hIc@qjWn9$x`tpQ`B^*BMomG}EJu z!4)7xdBrLu*0b>XaB5DZ^x$8){_uDC=XR>>^XxC%HH?8daQDd(=Las>5V& z|9?d&pe7^z|BiguZi}N{$Y4ngNIg1L=pLVduOOCI0Y9y+;tSZakKNZ`Jz>8Bd%Qsb zL*;fWZ^dnW@lUn&r5@_)BP;vd_AY>MW%`|^oyP-Y<-_vgYQGs4p}p$HzzEn@xS89Q z-K+^qx1ptx_X|23ZZ{TmpBvWdA;$9(IYoTyQ#okr3q#dlR_6jD1%{L3_0gQ-Msp%1 zgR{V_%H3|whEDNj+`X&NfV!cBQ}D__K%tNdiJr`(<>{Q)rQA5x(nLMRXd4{YkO0iSDl zfKI^pmB5ta#7iYWi$`+Y3WlYe0we_k(sIR}EiBU!w^_)f8p4EYhK0CBbR!@!$SwiU z%^?XuHaK%>pyc@t-}76Z=L^7_H{=3%J34B=_10+Ei9v3?5%gUA{KB!qN|s!}OqfkoVG; z)PO@mmet4z01@G4FxbdAnB3eD+JIe522ZiNLVAHd7M@^fK8zO* znwqYc%2wB9A-h^$PrK$G0~;gYwuKFNmJGud!stOA_~*7vxbAV($vjGjcG}n;Ci#vnzorIDO-|rHh*YH{$Z`p}L$k zuPzrH2D2q+HMK}{a6X*QF9A#EuI>V$3FrcWE-5!C@SIuPcnEa1+!Dd{IOyO8=1WJ>?hj4PjB5^rMy15Sh+YU5a9*jxS3*Z zBt&*4jhp7_62bq~3+joyWB9_9$IWW8kxIVyj0rar4zJkAO}P@#ODYE%;zXsCYYHKn z$`uMSVzMkFXoZZR{`nwaR3N~7`NYbSnt8nrO4m)whAX5EoHp8xt;SBH$6yApoMB5- zZQ9e)LHNmcH_Iv?mDA-}wnD8n6dGD(y%f49KCGXe9L!(2+&)DXi_c4R`r=8TBc6r@ z3GM-85i=E3!T@(yOV$PYgxC ztnthmFsp=l<9L~#a7EX9g=A8Wu=-(I%6X`bg`~&f7ha`g^DwawqimgPAn2}O`8XK~HYtdLNo+9ZQH@rTwKISGn zSckUB-Wc8z>56TM=aZXK--;b3cA}P2r`FJ_?$DZ56-83zYt5m2RW_|+_4M>a`KAiB zDAKF?f*XvhlFd}1CPiMsn2_+OiiAs0R+Bw7xF+ONX2>t0P>C}2d?+g_hnLQg>77UN zC{TgBi5c5~9M^f;rm$8>n|1zdZic=LON~ZoE(qf}UO(@(cOU@>7r=c?Cj)>mmi* zE|KDd>xeklTFD0dP z2;l-c%o}zKFgP5yOi(Zvu|u{-!}9X9Th|n;C6Jf8x-i&F7B^?_&1UM3 zkU7t--SJ%KmE!M;`|;zyK2lh-@EgT%vJuPKKJ?hB;?&eHC_b>~k*`+;5oDla`rGUZ z^iLITirsVQ(W%qsOk=NS9jJdi!7^MLsnO?fZqde>sTS&QTrMFmdDc^=|_GFBh(&;HS^@ ztmr$EPwvS+zv49N`Q$QMHTG`dXP=xb{AGVSe;8$lko=>98_dgDb zpmVkOdnO*EZpDGzEurq3)#CaZL2{a5)!bUmZ46AxTqrwTA6nR0p|HX|I(c>29cYIA zt>M~4vx^>ACz_q5y;|DC=YJZmHj1CacxP!(KhMpFBJNlaS`b;P^n})jHc8tY+tpq2 zi|VWPH`Gz}bH`_@6SO?yQoSyh>QZfzJBXtJO}4mQPP>ihlBD?p{;=Ib~@jqN|>yC(ZG<0kdl+doSIdgvs~_3G(w<$Gs8L{i3I#v7i1MTydAkv z)>-R?cMZJD;iD@!B>8PHf>bGqyke%x;+Jp2^RIe~^#3CVmdZ`WzRRU_J)RY*f^7R>OKZ zODpJSMF5I9HRd=wWMl>tTScu@)S-$x$m$cFyj}tXW(6u1x%$qP{7PXn|C}Ji6Vv%@ z=rMl2^@-}Xnz^xgiKTp(wWoSn{a%lw4kEIdd}6GKv%+9Sf)#Zpu8M<;MVu7|D`4=K zxp}mzw;M4W;}h`~wYhF?ye-`w>8$IBuT#EbU+Y-y?bEj_JM25uoz5+>&GFs*K4q_c zpSs_19^ zaTF&Sp+aw?7$@PB6b@^=8J&^doAcHcYle&LJP&?V=F{mUNRJh$!XI^VaFGmiB=`|heWAH3lB z;ei)cEY4)s*0-MAy5$d>pS#Jyv@}7g9Rm-uBA?m8TA1WoSz)o3X50$JoFc=~>hn8y4Z-T=BHV!aH1Zfm+9*zh|7)9umC4z98M?BOgk*V=u z89Bw&d9ft&w@ssj;wn@7`%K*nX6oVSFN!0tJ&3dUM_}op;k=f=LG`?tW6e;)UcnQb zXyLKBV!WxZ(`Lh3MP1S9(WHe~zE*F-I z=R`rHMA1A|&CNoqI8Rt0ZdHFyK3A_aVddRuIC=40E{CYha3N`p{6^ z&MEX^v6DVKrW6ZMYs2}7h9X+KhI_S*+JMGuU)v>&blQ!GjAVLuGTfbPx~I(CQ)b+e z%kC))^b#_2Pr2-#a=xmytI|D_dCHer@2wDW2j5W^+(o>^76cj3dr-Hm4+Kfd$h5i)lFtt*B5#||L-O@8tHq2HYR z_8H`*s~|xNn+K~P2$S@c^Uf>hU6~A^nMQ%BO~G6&O;96O&&TDot;yDF+biys4%$xJZrPNG zt=)zNtcbYiFQ+7AQy@}c_&QDNS@^arNfD8FMUikoK1{qA6A3PLGa_@M)F+}oEK>L= z_1Sh24TuLtI7TRE$GQ6KQy9IBe~K}tXIv4|PH+?HB?rlAa*Gf$ieDU7dLeW9fr|at zKtAbPcY+o}$_n_$_1TZ?AybkNsP;_J=?*O%RF*Cr^e*Whgw@TpcP}5}Q~=?>h9ozl zJJAb7_~%UX)di#LVRXxqZiraiziF3~wsKA)wY$!W%DF0IvvW=7u~g;Cd`oIp8N4Ce;djsuc!oo4f#* zDW3l?;nf-&#dU?}-a9ipk2|yT@OWp|#_VFSy}JYhUSkhz>LHNuhzurR^Jup40}4*u zR^(BnCY7Q{#T7JyszQw#HTe;#Y95f_2i_JbLaEgXMQxN+YVnV{YLo&>KxtJgD%88~ zxwEsjDUm9B&ON^48J#=leCK?hQ1gS1fehDTW~>(1=hnfjTIX)#wwT+jE$%*Uues0K z>l!ahFUPUzy6!{$Mrb3Z(qW*amviz$o^BR4(?^{>!XEl{=df^?KIuFoJVT#z;(|j7 zhb$nmaU6d0o}RF56Co*K)z?ILLBL`Rs!xITBWrp*PU~#Ta_SSV>y+jSqXOrq*h(#v zt-%3Dl2e?3aSA~nMw}~1Qj_D>IgV>lS#EMHa4nO@<0-?eGYr#`spL9B+%%vWLr4N~ zjd)y^p$s4<*Ro8Llah%<(%2}YU0e#j*e=e2E8qmQ>ryI(5c0edI(@M!9*Rk?x14m# z<)l}3cRYM#^YwYfU_?JmEWr89+U5Jhy{mG=-w&(&z6Hv1ST`mo!4xKI-eLn~9)~hF z7lFc3TCH3aUV(=0*zYG3m|0(I}*c5 z2SZ8?D|QttwgrpbftpcEs~AJ*)yi|f`|I*#w}KL%eY~@|@qz2VseJo#<%8B(qONik zdU?-J&waj}OqY|DTmL#eMlRfagfIRmb!5wbUXMEZHb9n5_JvAAU;A=A8lImn^Fx}V*`RX51rawZ9z@gZf#S(Phtew0U($js#kHw%Glkgi*!rfa<{f# z@3gvX#j;aYI&U$f!%QB9Rf|?RS|v8Chrr?4e-UO*pc5)?;WM!|HLJH+>-hE3dX>F# ztF(tNN{_1t^gY&5bcBCGdQu(Kk66$0-;J%U_lL%wLnH z^gmfQ_?yyA{kpYM1P&dT)C8Vh&#Wpj3k~z%qs)mgt5VLXGhD?K`$a~vbmkc%hcy^6 z7~lyd%<2`&q6*I=9kJ)iu(~x0kre)hIqz!8-p|+wT(ZIH>*mjDOVMNOW zYg&quI!XzQ7eX+$HH}hEYIl$WNK4UxV(4QBCsN8;<%&X-5-N=!j3!AbP{gso=rcYv zhyni;C@IdXbKXz0Ns`+!!|+#h|L)x`-Y$X@La=xb28V@v;Ks4j_T7cW(W zP3{lJ0~;P(aUK(!9tSX~bJKz9`DmHv>u!S&Dr0)2!MCdm51;W;gD)*>@FDkCMjCyM z&B~>Xz8y6B1TIalPZVscKJlO=gGYGqRCqX8Wx+cwU!_aZ4@g36cP~m8!*)M9{=dScVM2qZE5p|e#~dTI9cW?B)le(rt_r<@l-)=`~K}ES|;hRetzvPv2hjgL3ce9jrdk+1FG-fL1Z$Ulbn-`Ijn0^oD}7NCaq$ zL_kD|R52P~RGgoN=pI&fw>B?%Afg-Xh@Z_a;%9dkDai${7LVYr*2D|_KjLL#K$6!J zegov~#;BEGn7t9`;P4(8!VKKHHtL3Oz7}i%hi?O80g9!p(ysHz&@u6tIxX@HAEFeK zMNt-stWe3uTBrbi!K_ZI;Z?bu1nf&-fC;@}9cGUK=FxW(Fhv>{rpTB?Wy=2=+Ao=#K_LxW zvl>8C1hfRQ3^0-40$@yE^n6yHUs<%#uo*$BSR!i!Wk>~quu!p<-<}Hxj=4~^Cf-o~ z;1){vJ^au&P~#`%3H&Y6TY2R9=bt`{-kBXO|Ac9S45-_8S#6@-RgSiZ&&xG7rBt1f z0ZV6SjcaCpE7~G$m5Cy$a>SJbopQQ{)Fuk#q)CMCST6LGC!@}ody9wsA;ilHFDXjP zl61aJL3coEr4SFagjd?s#ynz%RnI7_JgXv`?ZP8MQ%uCF(gZzGxs1jkavoCKz{OTe z0TAr%v`0m1Qb(L1?&3U+=~|#3y))391IyeOs+xQT0WKjTbWJqKQ$*qN7 z)%;8rQ~kk!4{tD`id2dRj7@(Xv@zTjz8&tj})C7PVsb32iWYX!R-W zWaek}uO#2loHiJlW2!3lw=xRiG4B`Nn{Ai8%Wae1hixA_e`%98*Q2J=+zc=pD)w6z zvjSzdlM$<(%v+jR>gHBv^FHsd+{SNRIUw!NeN!6DeU}c?tMra`Cuer$p-hbS<@vj#{B_Eq0iVru(c1J7= z*(&}PGP7E&vv}!&71|0ieRPpahHsB@!MmNdf~K3M~4~ta2uSXuv0Wdv@_;cpqXjX zR@O=QbUGMR9yq~I>|6_bT`lr;Eas({X<8Ac1F+2~lr86ZsY}Pt3t=O#wPMOAV zzBGd0O5+u?A7Xkvn)>$Kd<}4BV?6->;Qa}K#KTKRw%sDFtsQ{wprWQkf!bqh70DMU zV}=$GICQe6bR*h5)?VPI`jkvv1sB!GxXNliVj`RMS)`Xv{7pyuk*5!}IYVFl>C74~ z+x*i_2jAVe>7f7A;MZ?1eDi}BhHedA{Uv?tZ1d|E{&wm71@N#%!=LlL;2Q~Ug6{ zS_tA=3mUGqz_R|r<@2~Sz1q1#9lpVMo!O;9YFjhHGt8yorDjXG#oWW~;eRgg*Y+oZ zC30MB<(}hP{TqWDVCUbc(COV_=AJ<}k?SFtid3tw*e=C*DyH?PyWF$L6ESivqQUCV>+ae1IV0 z0|e&ExWMdoAy`ZwVRBja9F}mSFdR|pLi^mM9Vx%{hwh>Ow12Vl_t)%0@hy+ql4r z@+v6hEFkw&P)Z$?GR&0nWs&pARdQDTj_j|G)LV~o-xHTamRhU0XZt-yv1HdY`JQ{};DpUaiu!OFGqb zM{m)$>Y%HbDz3WfA(StjRWPWtdH@qkXKD+hU%{=wgsvbHaDJ0Xtd3fSXz8cD*@3XW z81g6!d6b1*%8utlNkJ=)37RXa-^!mAE()It!-5a#TPW~C1xsO87zh<^YBM5PaV8`f zk@1S`qER{tOa*U zZ+x@wZOZ?6@pMkPGm8s-_`#pgcYk;ey?HKpa|LK+6o@n2zQrb1lxyY-{z7T9w31)r zUthXXDv4tC$CerbX9-5-79OiZAN%h_1`@u>p{eo7*7VT)#B^(M=*jpJYene!#0qP3 zU~_bU8;EJdpsH+|i;NaygTWh?x=Y)uahm2UvqXWM;tpW0dM?)Gu&vfWb9RS8$4nrs z?;cgAM-_{2du62Q$WW4Y;Eu`22+mK&A{%#1#)pQI1RMn*!-fw4nmRG!=$T_8*Ix_EF%#jT3}TqZEG)c$_cZmt>6a!+G5Z} zE)nP*eVT!c$!j&D)oNUr*F;~qC~smJlQ*#_Z=uGgmKSQ$dZwn(HcH|&lBpwlL>Oxz za&&Bpm6!bTQxk5U{9@=9ja<7z6?*q`@sHb{d1J7fTO4f2?|k`vnm6}#P#bELARRyS z_o4r4V-B5KO?PjfvHCse8c7&1-0J^`m~=VguOd=P)p$+3HtxhX#PJR9L4rsGi6rB3gjAv^kqN9-Vxq*#wFvGkaho|7 z{F7CJ5Zvix-PpcZ{0u!s#*zUll2|%DFj^y^anSm6T8;@tZ@RZYnwoOC-2dpV{@5n2 zJAUu(y?6KSY@g3Q`@)h>S1sJw zzH#Aq)JNJMS-7RRw|K7ea{EX5e|1_;nx-b@@!Eoxq$-k5yiHmna?V~sXc%?nAumo^ zT1~(Mvswh8H6fWcl7jhad z+sZiY2&dsT? z?zXZFuJtF^c-WtWK?%jVRso5*#8u`JUn^W!1|b+h8iFQGE0UCKAtK4cjz>BGo!Ab$ zPE*MRLOYWFRO-ii&?rz4pq%5R9e>X31PPIS-*T3fEL+T~$&h(%`?axj<*uPanHbtV z_U`m|&%XHPo@0-`JNnxXjvgEO{wuHUdHR)2%^TdMTOaNodjVD6dkLY#FYUec`1R9I z|590WcIwpc-+JdQt|td2Nx2Le%0|EAJbhhCLw~27vI29N7vtOH;$_Mz}XcRvK4|PvxTU(p-1k>Gm#LhB0;wCI;#%iJj7G93s)2$@AYp}l z5=bB_WM4CMNmmFc*OJnb34~8oH|D15zp$vPJclGo zDAuX!5($ssQ9OpH@I_3g@HCbs+=kD<5ym{5bE@G6)v%x%*7+-7VVXEFO#rh(Ljm0K zbWS_GPP?0MJHZvXJN8~Ji2TFq?rDkd)ZGA@w=gg6=@D#kJg?hA2jop6)Z@xMD_S&r= zchL9Bb*Q7EBt#W?@m3^7Gq8}BYaxtp&$EpeF5LpBL~^H9`Y=<>=zqvHs;~&B zIfc+r8{Ee!|D9Y3Ms;l+T<*YZlKH87_=_a+G4dG|VQT7h~BmN7$ zM6am-qn~K0gsu}s!7`;PV;USVO>?7W5eI96IH{N8tv1deZ5D#SXFirf~?&utp}xs z_V?})b|m;I34TgKDWrrjrG&5|O;}M=B>H~)>TO|W3S!nHbb-%L*9rq`uYO#(3N93f zKM;+I<@6jRiwk%t{x+RV}Vua$6m>Sl^c2<4Fq3W$DjW%hA&>iq1>KOiS>y@|$Vch78< zb9-jL34OF5{Ii?uA=>w8_goSEe6PIA6C0O)h6CQ^bfI7Ul&_tr5@BD2k8It`%VI4r z^VcQ!_-ltNR?mgZXObKlAr}Z<48QyhV(*5Gq z%eKEpPTuINr(8N8=CQo;Jzkj=N2Fv(%)(<(B806FZVl~lO9*E}xH*LR^+EAkLO2`3 z%^@6_n{D7|2**O$4B=#GT#JWrB806FPKE+{IIJf^*b3n&h%qmYHdzOtvw!v08qu?4ZLn&*sF{FHRmH+ombFFM_yeJh*2$jVbH40CyU2=vzB}J@exA?s{e8cnsw7l| zB^WadK^4XfNWzlmL`9zc#Y7DnqOd?8rs!%4M4BNYUG*7}CMJT?D#_u~ z{>oOkSMZYvVd5{Fx}B^UK)d@MHWkF#ts*&8u^l9V)s`yCO~iC;$BMpiA$EaS@0C%k z>4?}5({4z9U&=43VdQlOtbl=tEf#S092XIOiA_4_YX~x| zepjcr>4){x`k>D03_T~HS?p;Rjhf}VG@{V=`&HG{-_MV(!b8zjwMAF9qQ`>;FMgc6 zc!np0y(y^NZ?**oGtAy2ady%P{0Asv69I`fKl;Bst8uDJa0t90w7w2$q zV4ie5DQuA1nJtbjLc1gcBP_3Ch4e4BHyyu)7^y257L=kt87=@)VS*cv(;uuBu5>uc zE0v>n`(ZIjLF_gZu&AUU-V;_-PS)gR@rdFTKE^ZrTX;+|&eC%Pa;X_tZT;hw0SaLRDLu+imgB=Hjv-|U27d{U7H-6TrAi;B2;HYb%2@K z-!6)55Es4eEJ4W(O3Hl95f$)rI3iI#KZ#64ke2p*`{MgZd*RM&!(*er>g|5Dw{LHE zFYQC=eY?i~R=#@Y8z_q0S1w=q^To@T@K5R+7{a%b2bDU!YhL-!|R+Iq*AaHZgXyxT9uCA*6?8Ln*XMLGjuI_ z+kZQH0ER$$zbiH#(-Lf*QWu!ZHYks>E0y)i-^DvsV~VKCj24MNqtzm^NXf<|pbQ&O z#spB2qLCaDkRlX>7GaOT#t2q1f*6irBLxxQ67mhM5H+)LNtl&s1c zX5(DDEMm#wA_L6yi7uAU*VTjQ_^ckL1^hI|C6!hg8!+8H4F|sRt)aG^!!N9VeTI5` z*X}n@bnQ4Z*6KL_oyQ;l?)V$W#y)xNv4-*|OwZK|mv3CY^cPIcim_Ja7N$m_BIvh- zns$+{qci#fx{-cf;_`vK(P-?C9*#P4zFasTUFusJUh7*Me%AMFxFxzLdY!xB9pOHb zKGv0~bX=+n)YEgNFVc@n>*-edJ?VY@1MMSYB>XAuL9E*!iio_-`6DbwB`D9KCecFK zXrU%(NfxOZMH%uS#Z&OKc=mYMXhFn_6eYZPywF@c(BFt8c{o^1k4DZBBLxfU(O?BZ zR*4Rg%LSseU8)6*YDs}wk(gjnP5zF5hacw0dA6F*^Q*C3S;E0r$f_;!Ng{tC7>AD& zK_qI!hlmIoRne{~xiynR?@9= zP9zdBpafU#ekXFqV?N}g!5-YOGgxR^)#iKKZ{t~pIj+Yqu%Y#o@~3Y3r3*0Q+fj4)9GFV%CB*?|p3O_z zePob_S>drcal3*cJvggz+PgtVn0|_;l`InUlC$J02_>;4mE3L4HdmX_Cbmg! z?*3GN+LKNt)5)pxlIw+a;^x%m+O9-ba!>O6!jGf_wTGr1oYf=zOgfhCsqIT$Olh@N zn2TFQ!YYzhL9T%Xjax;+Dw0-FH8B3yf;U>f-kGkE1U3{)1z2%LRcL@dS%@3cfRkz? zZ>%;p8mEkR49;Uz8_yZT23u{sZqUYgj8Om+ev(2MKtEirpaP;5G=yjhDTv0JKiKEj za)=Nrt2u;bl&adR=&DG7XW=p6OSl*zEJ9K60gG&8hFBd!p`=mp>A5U?Jqz+==;nWr z2}1*%jTn5>h{3lE1%8#G5$A``E_Runlion_mQMCz!O7tJ{W4NNltCF78g7#TZG(Gf zERn;-$7CimZ&{1pSImUSvrI{6axK}xES=Bp$PELW5kpT7cGh9Nv_;BMoF(DH{Aj1QekSR+cwd*v8{WO~}i#0B$J7ZY5erZFOMfs(2~ zV;WFVOrj)hnjax*E7DXdL5f-%9|jYWA~lVgR#s3&XoEy$si;K}NHn7S2(jIFcJI!I z)ZX3BzB@a6J0H)y&+{y4;jZUKTuE)TQb|NJS`sT?f?{D5E*IHNNz~Y6nfhXu#F zdif(q)~`93X~?d9W@pW&?VCE9>gpq`IlpRn`?eF`cpI`+^W0~oO?e%~@otf=R;7?R zH(N;`Mpdj=#adOYR>cgqPg6^Q3d}V_aJUvDY+4LUDCW|v!$37khT}G(Mr{2L`Nl%n zG=h9H@tmeVOdsB%?bQxzKhb0a_Tdd}RJ*8M(o{{TL%|kWs1AeRv!Y-PO%O>y%OVI^ zI`pKWF%e=DBDLgCLIb9qCr_dpykcyynnPfzLD1a_9jAL;koB$Zu9+@D);yngKLi_4 zb_dBZ3H03Z;*ewjze&q|I)p)SaGTM9yO}B=kYBz$S26sv!hjvgI9b0(6_Ed1pO_p495NgjU@YeTayy*Tsgx+Mw0Gd}{JnU-6i+h@hf zO`-%$I$aPikW?gAaKun+y=WmD!OeOkX5vW90Gj47|0o{=9ahp?uxha?O%|&VMqOVl zT@&|#rW3xH>3Ak6Ju%1eb8|O+Lrii!;OMv@Wkbm4cvMVuTyVG{W;Sk$>4xjOz9pu7 zE{-q8aeRG3KqOXJQ5a3!PLREcHxi?XxrCfB%b+mJpfE$_Fy3dTX+=0tjA)8pqSI8S zW#K?8!hr^zqD*v%idP4EffCUHN<_El`r0)cs@58EPhj~(4uWI;6N(72@ZDXZcnH!= zLUwJ-v52bas;=mg>dIykSvpT51PP(7?FeW&0gEC?3kmGtvI#&&ObuYrEkqnZU{QMj zfmQ%Pp2Kbz*$?M0aL=NFeq4@|6H2(&0cHhd zEyDRoEWV;6lE?TrvqSG)PdC(LZ%)qcmRn|y?%cEG`{Y=FN);jHETGa;Ze9RnRS;!cmUrdS-dDEA0Oljq}b_fCr5_&gv-HBf&+32?q#G_63`-tY|( z@st_fxLCB^;KoHiCnD|#*NjUTnc#=8>Hu0TQxzH4pi!L)H2z=0tIuyqJ+k`D6TLE{VaZq6gCfL(AoW3u2=UiwbUCeXCF!xBasX z%>`LCX+%xZT2GOYtQyp?bK^d#n&N!`JF1iwRc>DF|^yAWN z=1Ke(dCT~;ejgYNL7BgSm(55M=i_Nx#MJ+9)-t|Qpse9V9k?thnuz)bk73~pzE3@ zQk&;EwvAZyu4~~P)?VwdB>|dG`YhGU@E-OoBkUacx=(vK-ou~ego`V~RqzgFFC;$+ zlHbWQ_-^FxU|=e0*WDQyr~y*|Kam6nYW`Wtd~WFrL&v48$b)iZU3Egd{{*NUvEBDI z+wBsEh{e$}+OT<)tRD3@Y};D2Qf7)=n41PeISu>&QV}h4QXW7RuPlA~dqxYD_LGnS zE{$o+a8SQ!bI)jgmHyy?Nsh1ECV-zUIw!3%+DE}hnviPxM)E6Mrr^_4eP z9*P7^s8MBS-?_09R$KP@uCKpyzVqGR@B4m-y(YXS9WuVd&il@b=l#E7GIJx@S{jtY zdac=p=c&)*{i>9<)(buU9(9B9ZG2EUsGcST?TY%A@wWLseOLaS{zvncVpUnKYRC$( zs19may$@ z65`=Awny^lG5HMx=S)t@RiJj#h}LCQo^Q1-tEFnP6h8d=L^5mg=AwkNIF-!GuAQx- zsV6^x91te}KTnOgnwLHXnuIHzmXbDswr4&pMZ6p5@J-Pc8pn~Dh6GP zB~({SRNx&;JGIwpqocJklMfv0MX$xihnbBT&-=4>wkfoZ9aE^QyMUoYQ**1yzxcJz zmqG`XpQz`|vw@$7{;vEr^k2PXj)x}f8CEcA7z@@`s1OONc3fbK*b9uZ*wiMxDB%I- zD+K6ZOf#XofEJF0g24t$3Bd)^pnWu`N=Q|epk-;AD)I@CZQ3MlziAV@K)Oa4WW)^> z$QoDevRsQiZoO#{tAH1rVmO5s#}$6d%bAP(T1z?OiMuiJ|Jm5p0FrWrUr)%(8 z5S1X^CT{Zr-{VwEaA@NCsgA6Y>c|>UCPu>9Kq{QAz#j@QsPhW`@6+f`{CJEOXvS4~ zV~i<^mrYNjcR9d@;B0=9?BMTdy$+H9PMbra&bhgzHGxK-T7KrjH77OG`SZzg@58g2 zcdlzKfAObg)2#T@tWIbu9eVEhome3N2{=vU|*ij zbd7aZf&5w`7H+X>TA@+Bd-0RxNoljZ18$J4ez+Oo zH~lI7uz```8c!IzjJt-<;C{3CEn^E(1~EQ{a5w5l6NsWH{~5)Yxh2WVr?YYldS`Bh zSu{)BxapW<94jT%RdjOZt*%_@R)CAH%2~`bE^#P$eb#HT0E&@0xKSdwnmvi<60R8hX3@Dt39E z`2uYo>E&lVUxB7i^okr!4uGkpg%{U0EY>I6l40y`&m_Z5x-4*7LJ$+_}s+~fN_BxWH;$r(iPpc{ol?GZxWpvNeoTM<9H~~uLhHI!G^v#5PRYO-p30fcuL(z2YXf{0xPYu2@=}{h8TYIJ@QWNo*7UtAyY^+a- z>o@-__rmtYi|ZfW+wOkjk=!%IZg+q@F#6T{);eot=ha-hy}1KTOrY-}B;5ATC5@a{ z*pFVuYw%{&4Q5zAaa*u`7hr}( zlQW=y1Bm0ULDHRFout!7OC5qc&ydul+dvy%cU8Hc7KMkvYl-Le0lJ7nsN*=cc^9q? zg~YWp?X*oy8~@9m;A68rWK$b@^}$m-4qK`Q@ny%G@iP#|3@?tQl{o%WiQ`7{ZjvMw zFOK9?9QpgaE>3yvM<0S$J)A^H%2ide_E-w1l&8Rzl7?wtr_J-O2cOryHQxnGL<`?S zUhaHuO{~@DrW#rkKI|ifi642n^W8Ur!*eIY(PW;t`lSEj#~vG2l*XV&0TH1Z<>AE@*9o)>d*J7Q z4`%4~-T(YRIEtg?+lZj~!adUGy9g2a(PJJP>k%dX9GoPP==TYPV&u;WZ_wQ1P%2+R z2hd^ULj^KxSo+e-lgwXHx>u^6&A7%a!l?`@zzC>cm;`D-CX>#1WXpsz@R@(^%sJuS zD7;|(mB65gFbaZ+p&j1(56VQMsE>@(J_e7U8RMGn(-lqX6P0lv)^T4KIY16Wde@q~ z27uJP2`iU!W3YOf8)lwY1NhCWLr6Dxla+gQ$>&r2l)%;TUMTr#C)3iBhVqz(;BWwH zBh;y6I2piT;%nsr{L0b)abER7QC(O3-22|!`(QtD7ZFwh#0V^?(13hpfz_C3YBee% zijvesQzJM^i0NojC7P(6#vz)FG1gB^#*8@i3nwI#j5y6mH6_}1NR!S~&4`&8r8o_7 z>c_hM-MhPpn19-Z-<2urHKgvl5r0XPG#agD;ACToCmE@b zTcUn+rHoN`jq6*Sk@8$VOi~Ln92#L}3*lClL7oYNCmtK?;<-_H#L2z^K z^$-USCMgGqWQFzvuSU+WQUcvnKIZL8JebIPMX#Hm7w6slj5y=w$Hj3sKPV2m`7W`` z&6`A%o39e9-29e#%fsu;IuEZlt3BLi+C1FjHbsKXX(i2h!=c^a4m)Qyzn%Pc*2bm< za@!yxVmhnOwD~ zyauZ2L9$n|aP`Pi7XRcrVzZmC5o_FhnONrL3(bWdUSU>5 zxOCdA8hKjWl0BOpq&h$+Gh2l0$Yr3IlbI63h1P3OV6dLlb#a&%t{c`y= zteYe$ekmon?&zwqVDB+*?U&7cieck^N*frnPP@!Xl_Gwt){y=;aZ&KY;*Wy=+hlK< zdraP7t}%I~xzOa?WG3Pq3F`x_e=*b_Llwk(CLf7ic-oPuQB?j?|K3)UL^zfFxwv>x zY+m`PFks#%5rCEW-q6CQ`!S9@9c#3Ox&tox&1>xC+DHUF6{1IHtINeJ(YV@bcdEv< zR+~*VZnnyD0*%`Nm(7M+Jy})kd-d=CDrFchh2=K>HXC20;gdg>St1o^9!~a?t$O;c ze@H#l-kHmXV`s&OGhVAT##R#3#*ZCyY=08B+jw=r$yuze#QMJFr6E%o-;UUq9UWS= zLLJdK5l)R=_@WAoF~ zzsg^iRypg@%aI3R+a-&(PA7K z-jDgSG@K;|-0{8#OR}$8?BBRPJ8a>P&YXQLJtZqH#Yf@i=E!P>YU;fokf?uTWypXBP1!C-kzi?fKa@+664 z1%(9THTHJGV4vymQ&}FICQ*T=Zh;h!rx! zqDr9MUz|>V+Uft%^qM4p%@;GWr2X=>?yENs27l!ub2=_#@VtBj5M_6!(xWcAdGO{+ zm+Be#i`!y}bn)VT9O8ecr}PGj2c8hg^lM`l&1UPVn(wDqB(!7-=m+QpJi8y)<6u9Q z@8bDN;5^_5W&uf&zA3So&$EG-K<}v z4=lyB1lRB3z2iDjp?n7KY_aU8t?1v5`_H0pC+uuo??HPW-ph@&W5h;Eloqg{-v>Xx zi>x<8J3$3{L+BfA*zv%6)Iaq&Hc-=q;Es|^QUlZmZnbZ9U&vEiV zV9ZZ}5xh8b2{vZH+y-OqAUvVvQ6p?E;031hPFkY>f*AOE*SJKQ1av2PItP^M3uvk- zKb?xH!f2&!@*0?;&=3mh+iADfM@6`|(y|5XSOC6%23)5cew9XBM$&5NYXbbg3hac> z@01=E&`gX!1~yN>q%^b+cmregMtPFl;QCd>bq2<|E%yW7uK*?@E{#B)oDas&k(|r8 zvsrhF@oYDqnJ0n%1O=>JYEr%<--oY}5gj()wbYDfHiFj+usRSg=MaU`Sp>Lu5`Gc^ z3y=(q0WJZ}KrK)LOa?MBHep;%=@puh+En_0HjEB%h`A}vhS#uD#WTET_C$QiandXY zs5XK$=~M0(saeeBaMZWlQ&KZgtMpx~bpJ28PN}JWi@m2`p^0)1Y7atNQ7iWy<}CNa z79`aT${wJ#QnPY?Q7d_oT2q{0PeiPLz*=+F9)Z<}Mntr}Hfp0>^xH-B9(?}N@(j+D z-84ymktS)I=o$SQP0)Na#>hn<)`Mpc@hddLY^OZL@=093JIHR85M6As(T;VtfX^=4 z0Z!}nF8-k2#SEh*blD(w%4p%MRQofPg;qA_x{)Z{|Ed_qXlPXOXz!}D-^=|6olzd3jJ?Z?^Ov*()js#htH?#6eOh+ySDKdO&YAE|y${Y=>2mMQ%gI`!DG`r!jo9^C6M2b7@W(ctdm zhdJ*u-;Wjh>tb8|^=>bJeJr2v_aW-9V=rd4#?*;^B8aEggt0VPFFnFI8of!T2mWl0 z@i(XBMH5F$jegx?ugUCaGv|&EH2SUz?jZY#-c{Zd_I$ZK%Q|x08txZ50$_PF#+%f?R}k|EyDX_L)+VUMgbdr&Crj9qBoDiPg__(KxMX2;S-$6Ias6iTmP zKh~JNF#X9z)P{907&DeF_nCa+r2H&8LCUy8tK-$Onn#6jFV-{0tMn^TUFer<;&q)& z;(pcQn`-enV(h=%Z+17Zo>};HaI4v)4RTqunmw#CYai()eQb^1AGcnvRvU@c;fFP! zsFQ`>b#h0nN)}VMIEtTS-bK{S<^EpB-CaQc{(;{X=3YR(_ASs{MsozcFY!X@9ji8Z zfEXP#Pho!dgsgT;q!v5AEv=4ym?wkeyng=1q>PYY`i*Xe{1EvS=O%fV8G7)oF?5&r zjC|WGm3(&ycQ;c8d4J%pekL!u=~ChCmzTVq@~oD<-ZIeL%=)*ITWbA5xmW9*cPTHE za&I{OYh{L4A&POwm`r&(IfLTlEZeJd1v2ojNZ4w2k+Y3}>H?z*R|^80RdO z4Y11jlicp!El)<)`weVzvBjv=vNtsH6b$x;$_{vj@9UAjg4dE|a<`%KAN5z8K#oDm9Pxn3I9t)=Q&$_D$zcE!x`mm#2Sd4_8SztJ^MV2`G$F4^BWXwu|$c@ zmaO;_lI0Gdz90RpaaFv0iu{D`xm|CU z?Q`v{>}-*WR6;vwwTBmEgyI#@9_(`3J{h6J-sHbG+n2p{olq{rkmYx?(;I~BdVinEpX8npgDRPIpP_Em=IzPihk|A*%jo{N1x z=r_b`l-rO4kY7cPN0x*#_0HP&)~*YE$=TXicVkFLWBxzE-PsR&;jRDmToJ)mAp>GZ z$U_RqBM*_EOp-YwE%=fzZh*D;q5F~VQAhMnTmwD%&ZO>}$d^T$oA`c|`a?;4$Lk}j zg1j<^y6r*Vv|zmP$^Ol6i+p|>UQ70Gu7^kX{wEO6oBxdb4RRUnKcU}T^H=D%kVrq zk@j07JpayQGHoGI#`%zLBP3sm7y1o~otL)D13D>pmgjc0 zZ08+aE?ap?Shi{RzioSAK9eiCtyuT2tLWRp+t!x*hdS8zxb?mTW%lTfRPX}>gBbb> z{0pDa7l={*3zVNu`$F>5Hc39^S|Bd^1yHH~A%{g4i#VV9EtG#mIm0_(+D;6p?985R zyVd;M!Ay&0K>R{G7<_HZ@9)9cLO%^F@1?Y zPL}L;$I5PRqddxZo4eP`%5HmQWm=^ar_Gk7v3gnRu8=v@t%yG-D`MA4jgAq6CK=Sro3>&IyculjSbr@++zHhW*ltiKVAlKXa?Do#i&f_=Ql(Iy~g3 z_I$cWPQCy8q?B(3G5(3xm|rTB(X&AJ)a>nK8RtIDyH8`f&c7CUSRU}^L$JrTF5z74 zOG`(&P?($WT?V7{oDIZowJT#wNhU;3nDZK~XBO?r9ZuKt_jl?37-rGlksR+IfDNgh z3ig!)WzGk*U&$Sv!Ck=yy(Q#K^)ferw*FevZ<^^hGBzFx&}%CF>iy$w$h{TKC(q*(+BRQ2jScL!5+*>ujV&8(c@f}heFT`GZNO5$F8z5%lP2 z+$(LUzw#XVjj^GAOc(U%XrJ?JsLwlx9%F5&A8YG@f8rgRc#F5`M&$cJygz}w3yJk5 z-r$?}g+DbYzaO;w2`q!3!f7Z9z~}iDw5dV<4c5ZAHWK@gmy7v@^Y}~PS}0A zOwMfx=1go!_HWsQeA_Bt3V%(`XXaMl+km_hmIv#r4d&gP)IG7Jt$pJ1S1Z>B!(G5T_%9=h%TRbtM*9=toyTCPt$aG%#~r`>07E|BwozMYdGZp#wP>HOkB3X?!Du!-;5A!^cvI2|P-t12&U)HE|&~9tpnOZOA zxQ&#jwF7cjXoE2}Q-gezmSIl}N!K-jjtVt})N5QFyd(S`Sk9l}_gfp$8+zVxzrxL> zVwsD*1KrWiTA%z}+K9GG13l|EQ-v>JH_#04Nve|H!n|~+Dt{N{_;*kq>oecix^6D# zX!!}WXcZM#cp6_Zn-xbQ|jG%h=25*NBca z=Pa;BSJ$Q4JFP7W^mQg1>hCsIDSMqA>h(-^5+$_mwAOzb@emp`u=ak}i1pglPf@Ga zgoM?xtlujz?@Qb@(4tp>_Z{Osjy=$pNsL%dKj;V#nS}A@w8iTD%i{eM{Xo1h9d(+4 z&yN|@D$7aBFBlOcV%+8FsM8v*-8#T~5$^@@!3KYyLF@l3fH@!^nKYiGt;f0Wia=#B z{)d*O0ZK8!ya)3b%nQEl7`}UE=yULXJMQOQ$IrViU(|PB$@eHYlSe^dJ*Gpyu|As9 z298f?+uh<}US9!?;8n{C24|%g&h1CyZtN!z?bB`_JdN6vvDbVS84t?N&ok!$HPQ(K zP3dTU{JYKm^ZT25lIQ3ytG$lmJGyXuXKd{2m#Cz*Iu=Z#LXIuSyL`@vxqqS=Z8e{& z!oJDpvw=J*(Y~9!pOVgB)yr}LV!|o)7x@UZ0KmHzS@v1h811LF!rrLo`3BknyD184 z+X9B$m^`W0TfNOXcD~_atGR#4uORk{v-pm4l+U`sy_NE{ewjt}AYYusbLa(p!(wq4 zjpCdku7|dQ{$RbJ&jL|*_Z?V67tBkg*cdtA#k9z+#ykPmM0%a}AO~>!J-UA{8y5%g zyTrYS<8M)+a}w?F4E+}K7;+meU|l3oQONPw7ZcESf_hyvz?NIif*-=)Ni@q@M1#c) zDs>J(@8shCePAB`=fQRbQ^0EQAeHF*=de#cMSCDzT>lMLQY|QTKCvt_@bg$1)jHd$ z7Mi#g5V`ihhv#+Z*9_r?@nR>8W*0Xq~rVw7r%9jBYz8tR5M?EVWzolu6I8GIs z7gUqz53H5HqFHhz4VD+64-R7=9HE=!$Fxe`LIb=?Ro3-_x zqnjD`7PMn(Xpne;` zbPV+~F&wcmMFogo1@1EJJ?MTj9(6}-D&yFQIDejVgw22T8223OQjv%F&#??z(T>k` zQaSf$osYOThGU=n8dY?}n?5yhQpZBXY5vc(i>;r!@)<`{SL%9jGv2rddB+6^+`VV>C&+F3u?Kb z)*u?;zC`Q9J9mD%f?xXcwv$4g!zoT8b$s0O{>;?zG>)-?MCOAxV z;a^zO$viJ%J@j+pF?Yzrn6EvQh>xXwugT~Y@hHuY)l&@v-=1f1|2H9(Q!V7`A*SPkpq2DiG7l!k+?3w|B>#)(CYnhKLsuQW10wCE%GrBDdfhK z*4L$c&s~UiL$SUotp7t)EqBvw`45^d&(elO1#N&`EgTvlN6|Wbn419V9b~`u}_>zwHBMSSGK6aE=>rdMI7@mtLJTLD5Xb9fF z68sSygikkvdO5o7d_`ejLq2Njx1PfQp38K2ZUeIIJa+)kdldcMb1tnz29^Hv(Deb}q_Rt3M8pYwcrXQ->U9c>Qb9X-)zI`!4>=CPkN{^`E6 z5W_H*HxbVZk*kj49@Eo2)BfA<3VrAGXWucV>|%U}mTbTo9qSFiSOsYR6X;6bBh_FJ zCB3bBt#U+PYCt@=2HeYW0el5~$=(|R#(+U!xV>h3jXuYp6+Z8um9sh~L|L5)jt6O! zrr&dWsx8rLjvrv0GYfXT{_kfRhhr4Sr%WJ^{W6GO>F?lJ#y|sPhjA^+8v0IT{`K6u zA0Qw7mtJJNPS7+hR44yUbxslDdJ)DgqH93`m=1=4t3hweK>Mu7UdO?J&MPUI-I;TM zYRY~?Th`tr^femHgc^98IwDCOaaXGM-S^b{{#0nfLsaVjpZ#(Vj;gxj_;>d{HUSbL zA&3;htuWy+G$sTLNQ4q&3=sq}0R&ogvwM?lv)K*18z3-J8-!2=hL$M`s6{A`M5Ita ztnCQHptiJS>;v1OOvhHGOzYH+wp37a`#opx2C|ki?bPW%Cz;Rwe&=z2=Y7uamra?A z$$gKBD5ZNG=j3B5O(ZU4dOvUEi~pzNW_y2^KE=%XkfE+UqgU$Q!jPWu$e4WTN&tbUhtE|mfk1Ss<24`mTojpT8MEElED0k8SigK^g zrxr;6`&Jy+ZsXp3iT6r^zSKg#E8EdW#)l#vJWn5H6Yiz2{SMo&5WbVA(m5miR<`#g z;TO?X$Sgxw-}%nTjA|#RZ$FIZKC9>zv%UeZXCM9GeLOQV4@10j8Heq|m}~N?Tsg*- zsr-nPf5S7RKlxlzI+wkL*g(C>vz4*Jar(u_r7v<5edt_)KFaxrK+O5SLw^J#1=>4Y z!)x>##*2GB&9Qgj3f(OzL~~ttov)q38XmX-&5bO6*F!dz;pI%CjYGJ&6u; z0qb34`7pOF-j~Kb^mUr4HzA~3v^f}ajE6DFWXxyY!u}TH1^T36&tj*|v(0(dI~>D3 z=bR(@P?VdUXs2J$GHe&wQb@&y7zn9eJ^4&ju9^kFnG?J7&i$%&wVI3 zEcViBvnTj8K(i5@8yOJ?& z968)SrpZ@^cPM-&{h`}Y(dW+y_?||EtRKe!^H~fuwsSt0^G;qtQnBG1xZn7Qdu9(t zYgP1}_sVlr#_uw9IB%z7M?Hu#?E~I%Nqc6>uAa+#zXBcFCd?7&8s}c{FylDleVVqu z!hL=ct9^&KXP0pAbYYDNz6*Zdjb~(EhS1gw?M@sQW%`SZ1qI)hG2sl3Z?##^b9tKW zxOI#I)N>x@h;`65VxTz!PjSsUxEHRl-;OAg>(j__uRy-Rs8zgG#v;BoCEUlyD1(%4 zntjM;eGkW#$8Ym!SM*6p;m795Hwrwr36AY7*Z(}{xsA5xLzi)HF{T-Rpzkl%X&csO zn5Z+SVF7*VQf&);@L}{ry13Wg!UL?cP`r!m&+*KaxLM!fyyu(1H}RLeBjV0wqZWPS zyBbHi_kHTG@-F+UbIIiR^o@k$((72aj%)Z9HgkII zFp#hPglo8!@8@gIPTCRs=N8c~**6gjmT*lkI+yel^ST?f-{JQe31sm<`4{eu zr-)nvSP$k&-ak(PeclB6mXR|+KU&V(N5`G5W}g6V8bpHRZ6JrQY;HR+s2?zxy%=(i z2fhLregv>q03&_{6i^>kK)Qj^JApB@GluoXUP|%>wpqj%x0s_XVSgs9118c|DchXP z5#K?5%6VXFBQR|&P|iM7`~|4w>srOvvHE3T7WKL8M-BB_wm<)ez#{hZ%cp>c9s>Lq zfx4K>r6hq#gyjwEfe^ji@C!hculABII=gd#)+@kr9`Y5p11s70uhO%4g!A&~i*zh6 z0AJ_)JWhKXHUS$s&dqH9Tg-c+9N79BU`GzHlXJJ5ecStsB>Re7uJop}EREQ8V1GNW zT%~K0%W{{4E*Gxy+}QsCoX`Db|AG%cTb^Ha9XJmMxHjLV2X}A>aESZydqe+^9K1e< z=YKXFEl?;F3WY+UP$(1%g+ifFC=?2XLZMJ76bgkxp-?Ck3WY+UP$(1%g+ifFC=?2X zLZMJ76bgkxp-?D#;Q(sZpx=DSntNT!_9c4|Ao=Kbe+67nlV5q6Px)<4|j6 zsr8t_K8e{0$?qa^Zl}oaZCS%cGusq19hAS8+oM!nOXkO!Bj&HAX9cg0LzE}jix9tz za~7t{n#mERM&Xxz5<4I$TNHh6lB28tZ+1_oHNL30)T(W?ty$4XG||>#TX#icEzy`i z5sF3%t?A*gRTFAxOvJ4kJ8s98+QC9AE33+`i`mPp*)4XYR(vzl-xh66Sm9_xC}0Jm zEp0LJjU~(%l~@Hrl#a7%{Na{HtI8hZlrYwgrWV^(>n zE*uK@!qOb86_2*Y0yaf`Vwpc?Tdk3x9kUW*95ZUInW2CkiQ7}GxNTc@bDbRw z+CeLv%(a4cJP-@Dhyltrf_B0m3jdS+s*R1}IKwlu&fVIMx$_ll6Q6I^K6?pX;K%_v zz{K7=?&_phWCIS|xh}Q=w|rGboB^p)VUdbdlmQjS9@*COc_m3=EQ8v}vBCXA-xxf0SR4M@XV2q*`6;iE`2Umszw)Ga;_f8S<8D~v zp67lWMk4O;*D=x~a@3!v{C9Kr?lb?9UB-PA6H;73E|3Qt<2`5NmC7n{vL@0%xMC=+ zc)fF_)$ug&g7RoyujALRC@aZ4z?7Aa(ZDB_6-tBC#?68f&Igu7eeu zxD3nyWu#vTA?}Ag4OqZsUz%l35KH2F8GSkx?3yprdhre1)>yy>(Pv&9^Pu zxRc;6!QI^woW`9XO>lSDU;%;4sNE9+P~x&E}=QQ_oCP-=)kWY;&-|&>g{KoYvkBSn{y$5QAaxVa)uk+o9JD zFZtHGzO#6z+|3J8LAwAR+ws|8m;m}W=;hh1%p!gHIPVeK=a;^`zrkfWWPVH5jC4xV z9QOHfHOw|#QMT`6BJrxKlhvV|Vh)Xt!B=Oys_yVf$D-=o!X%nW#aVg<#UbOj?_Ece zgId~uCeES0r*BJc1=;|}(!RWZ0|NPDoSg>5(}%2-lsKVXGEvD?a<7rx&Jr9;lk_9M+=yKnf4qJ;mLZoZC`N5&7Ogzx+7 zl}G1Z>*LvniDs|$4($0Dzr~ioJ_x!R^NBGnyWAgtKmtK}MW<%@$YW_mYeuu9T+4Es zZ?o9-mCDu#_4+xpFY6Um4pHmD%GNLHQLW%gaB`D@6_yYTHA9ulnTPQ7VF9ZVl|vk> zZ^Z>_Wx+Zl(~}m%Pv>8EOI+hs<1ZY~#{;r0`cAftqdrYYm4BByLgM@~=by`z`qEON z(!*26L9MO6i@9onn51`$Ga|gU5v_JxI0u#20(Zy)H)=Q+ip&OK{DmGIu0O?k00aq! zENK>j2ui^J{W{kdfXB82EDYuUH)6IiRd*4>!?OWYT2$dfXFs}{k#WXZxbP73=isevxJg3_I zRBNWU@IHJ^{9-zJ%W2s2Rj2w|C22!<@MmDW*?uNc8o26&a=$h0u_1E`AMa{zLIUKR%*KRRQ1Ju+7c3q$~xNG1($%6c!Asr-EqVH<#+)cd&|$1X@pL$ zcpwnUf%qH~BILqplERhw+c#A$sbD*yxeVE8US2r`W|5qRy*G z#gV#lzJrh2+NPEHxL+!wLBZT`(xOi<%<3x;t)<`~jc8s4v_7CCk`mX{ZhX#fWzCrG zUAiZYJ;B-sJ2+)r6?k!M`R*uBT5>L_ZgiONtSz*PxV?L~dvaCZ_5c;-8qqr&(I#O0 zLZ(jwqIQLY<=Z3iF4L^&D5Ae$HIqOKNYPwB_D!g)yuF5`*nXJC>WB2wH$pq>azTyP z!AdE3z=F7XGIZJ_hBx_|eOi5z$T7(>%%byJvNM@h*5%o`tjVhHKa_RdDU$MM2`V0_ zA|#x!hQfS~+cN3|Jx#-V_=d$aJ!oJV@s(w>tNG%|{OZ#=TrUigmnkOp`jHx%g~&Z+ zb`EHP>5|GSCy0_Z5g(IMQa=3h`4yAmQRacn#FJTM_HmQdNV8gepEQKza}nO$;#_)a zXK0d#)^<%}J2AI~U3Jvt7qp;8Q;JGY49cg8BQ05^WRGSgl9o3Um-)L*2;9wVBzPE$ zruK%qQ|MwCF@9XH59*v*omn|x6KhbIz1c;MICtXiWn_$BJ_KI$Xx8?=hQ$XUedKIF zLpHTDadvSsHMB*0s@WS^p>eSD@sqQWKUal>Sj8+|oRv+T#O-Yz?CnhLT*&!Y#qDkE zozxr*jZIl4Ox-MvO{JX-J)f$^_9mvvhEBH5|4lPza`xx;uC{j00rtVv^6w0 zWmSK!zEv`^GBtK#)v`2s+V(fIe{>01ChVw#9SQ&dbmsglF^Bidd8+>Zqpb5n!2?+0 z0{8xvLVmXY8HK9SVt+CrA+G*k^1#E!&Byl_6AFgT*5rT4MfHD3%&+-hCjfNOC&ifp zOr9Bm`n3e;0l>pPm#24lM0j|3L}Ww+1Vm(1<-(J4N!9vBtekufn#Kgpe zWPcSX1bBD^cm!lbL}au-8ay?5iHe4Sj{Xw+<;&+6HYUzz``RyLm@t`eEHN81_~Ay1_cfSTlZ--6f_I~76T3*^A$S+mZ%Cg zg&`siE+vPiV?bQu1fH1c=Sh4jYECXbDRm7eXP5Ydr0QBEWCB7OS~_|LZXRBKaU-|D zn!0lV2}x-gpsbqKTWuX<6H_yD3rj0kcMngmpbxJ-vPX1A|l3GqZE^3yT|@Tif4ucK7xV&Mq#mu5WJdzTaa2o)JUCA;Teh z|JENU05k>+>=R&76*w%_fH-Ul4lzT=&m9wIYVp+@=kN%KlvJGRPDsc&xOn&kgw(%b z<$40k$1fl*Au06?R73L_snMTMon2hrp3w&W2{$1z=|2(I)YknD`Y+6re}euC^IwpE zEdo%V$brIu#sItqXiVsiz43Mv$Mxsu0*g)%F zL59qyc{xtH>NP*}xJ%n1og>_GU0?PvsuY;KChfL5EKmY++djj|+mJ?H^@3R%(eAi~r8nC_f$LI2yJk!v_+X7k{%XXaD zkSEUag6)N&j(01f-aXx6g8jE;dfO{+jMh)Cs*vM>bw=sVXq=X-=Y9Q#UFC1f1q~A` z4YlZ{TA(H&IEy=#&W0@io6FhWs#AUuym25q}m@rSX4{{v(HHgdo9=4s?kmKH)a7%P{vpzBba=ji|A9d7Knlxvp1f?T_?NG7%EXLpYiFxkK?=YF$qL2U21@Z@{ ze@pM*1@aGX_)8$wM1PU>|H=6No6r2_-A_K_Zu?)4T)O9>`ELaO7bEwZ8~>+k9ZCJ= zGbB$A_*d{y*~7AX{9OhG4J!X|z`ZB3{*r9Wv!?#oCFGxEN!klTAOGP@I7)Ate^Xw5 zHXJh~#fbM$XSSrPSjz$Z8HHlrH2+2XKWzb@B17{P%AZk9We@L9U{!Aabb0D0`2X1I zh25jg!EiEBimC@m=Ua(7Fb^nUcSzy=SBWm$K;=*52`@>29 z>B|3b(&$#nD=S~$*CIHOzv`RC`K|4=!-3np| z?-}pM-0E7y-kbNf;zb?%s0TiNJBi+;%IE=L7)hIU0!br=at_BHV^t&hVd;RFXrNthdF@aMf2})zu+xqxCuN?c~@Ogj7bN$5<)mHwjXU5tPMy?$A5SG83)=+EVvk zpSJ+Mkm0szrmHJWNP8BkDqB&xLV_KOihWo`eb`vv$EMyX*+`z2O7K2rr( zBf7-A7%v(LG5K}gD~ACF^X<4V?e2s_ag$t@#2f0EO0kaIC25HDONiWp6t*Xw_KTxh zePItO)gwSSkSCcrd<}UkVRYC=b0H^pGv}+FD2O=yMId5+{0w>=n9pDGu7lv7MR9G^ z>MOQw?0uWaQo@dbN+bJl8I5^|dOnrb{V--YIbv>6jM`Gu; zQ~AQN#?8BdRY~!0geMu@jZ5BIIowHQJCbz!Q4_(FuJWr>ybojc%3FsdZpwSK8oiSL z?k)xv4pR2mnE|V5CzKeYeJf9|%(;sgtq=^Jo9;1Pq{4B2Z-rmxyD zSz?8sId$XM0qt>P^WMN_1PED`anO&^Dl7m_(Jd;c_|bl~!?!ERAOwVPaW7Yb7x`9HG8fVaP=Egaqp975#p)#S&K zI)fLTAozma{pfd+tEpL( z#+h2alkEqZs;?|F@Y!9C-rAbjxb^hZ^Q7Q$tPa>1Bue3^=<+KsoVR9ZeQ8l!3uo!~ zeMe?HaLJwRUI*chPPH#v(X-P5*S&NT*uK_Y=_@(iP}SK@{dDJ&p)?utFg^E~dORnP zgQ0%swQ^hgL+Q0XRrsF)@4u@sq_=CuFMI=1p9Xub;wVgdo>eH8)ZODo#re4t_P=JP zUrRVlU7hSXj{wOmdjg)Z*%QYi8Bt;DmpQl3O#IEZLhfL3R0 zX2K{ARU5Qwb>!d1#y4EAcwQX z{XQbdrrgzmM%<;7sj2zhn}FZ>mfF-C1Mn=)onhZrW8rD9G5;5sK^;CDcv4?Cj63 zeB0vM_B5HQmu~W(?CWXhLyufV`x{B$BNQzb>Dn4@r%6lD{Ji0xXkkDpaw#et37$SS z1q)YxN)pk;_fBG*s?Vg=Qh4M!p#KrR%66l^5ejBtmc_BWP@qiD3zjj}aplK@Sv+Ho zL1yg5_q13moU>lRQCPRCiyiQ)Y_LwAH7nZOOh-B(gdZc2p7KC(9{ZDYs1-@~t} zpeR;ubVYAU$=uY+yx8sAL~v>$fn&y5B(`l{{aUnJ`n>E|ec;S9&qA=#(|zdc z3z@b?VHy}>3+oJ#bYvpU!3_6$OCYR#61y=Au1t;xg)Aa7aLZYJ1QrGOim8y^bThw^ zzfT~^cr%N>^k6tdBNY=7Bi7$35|6dnMYNlxX52NMId`JGeucj~x#3LO5#_xhMF`-# zl!LXgOg1O_e0l|^^1OH7aGLWSC|U{2+M&-EUa1$D5YW$7RF6=v%wu(0RJ<|D7aizY z*#ae}nDR5p(oZk_WUKt-<5v>*UjVa|Q|@xoe_dQy$LdmYEheD-!(qucL#buEr1c*k zs-UmM-H0r0+|2F|b{?tY%)?Y981e&&gxpg-j0*j5qB8HRJa0b!0`xJEd`agovZa1p z0q4!yi6cX+!Z0W?lUCdlr-F_LtrNQn*t z8$!QKZu_qAh){d8J`g^5KSt3nz`9GZ516fxb`Awx1e3>sUXT^PGw_}9s$#znzCl>g zDn0l5Z}aGf%@({{ORCo79*`%Bsx+1iP(#| zk3;XBUeqdsbaiK3o7}Gn7BxmSUv2h&1*vo`@pD%#a|fn%0eZIi}w z*-{c{@J1`P`j&3F>>;)EL^Uz_wbs+}O#y*6t^zvb4tbR(ZFm6zh-xB}?;tNDc`x0; zzU;N}$U=2`9z~UE2pAlOMXI(xkl2Y3UYA?zvV=UzXWxGR_Wm$?0EzYCKm;;NvP=&U4C} zshKRvMXwGOr@CZ*VV3&zJbt01D}%>&LsG!XD4|9fgfXwkKagWH2d7*98 zY`KxI>IE~+9jcP0)6yq9ZD~r^=`0B{vxWz)Y9c|f=019ZeJhpd2R!!p1j*Jh*HFV_ zwODUSrqdszPAT?+_4yv@@gSXVp}Q(WgxPiD8)6fto?LI76@$j7D>cAchBxoWfX!65 z<5lubwwBKFyDv!s!UAE5qn%%W-B&Ykxzo3-Z`Nub>_fS(;f>RPGP2I*nX_i$*|OM~ zmB*AMc)Q-v(0dg~#XM7j5^Lh-Btx?9rhc(Byj#L}?^bJz8P6Mu8`T=UZ05lE^!VMS z@jcZ-W_*^gr1;uePgdp0E@?_!ps{4t9o($@!sL<9o6c^8yExDxmpe1 z(rQa42o6w1GZBab%IqfU`=xi*cijA*?z91qi$ZWG8!^gCm z(yGy$y0A2{EsJe*LeBWL%S>{w8MwO#_M*IW;5UciHkW7S zN%bqnVQ4sI?xch!DqDWLMMX+pBSnPJ*7|)!_^>=}rM>BmILh0p(uRJ1xWw9)52WPm zE5|D%wq`LEAu_d5*QR4`Qk+04|M9P+5c7p}`&LW{dJZlKduairyIfhonC?mGfGWca z0i#8RY-FhaY^8@)k;K^qBJE@?kroaq&Fk`>pT2$fZv7$<{wk4=A1)s%#Pb99=gZeu zpwG6xAtiOXprW2)ZPy{oqAtEwg}V^*M1yF4gP_+GR?c93^C92*MeCKqX`bi{q$*@6 zRJWU>IBCL@KEf1D8+6(Qnor&&H8(^AwVFiSMVM#v-B=X{FoWC4@lq=rEyHqT^tpCm z)jUI6LUi5%xNhi4t_+91SECBc)VI-cqUWf4F|*+8o1nAVuljp&{81O~`!> z^+kpX74l|E)wQSS5ozpJbyPUiS2H`cB<(NTH#Q-UY9Ff#TX|t1*L9$n0M!rg z-w!W~RBRLHKZ5lSyz`sAgM_RJG$rNjz&B1vBeIs*aeC*xllvmWysNzs(v-0Y?%H9q z%Tbk7l&w<5xwXF1o3imZwYx{L2bhzx85J!6`ay+9JY8-$kRqHe|DTmWM z;=ob9G4~yX?OQ7tN2)nz?vd#zrb?&LKB`}Uie)(2&nB!}+5R*6*VtCGvBN}Rb2&`M z?pE9&mrtpX2)(lgF$d`#+mV=rBujTj%CgcE72NvrmlIH;j?Tjg)W&uiUbWhSsYj)V zhh+m|eaofSuCbJ**B(`@)F?zxDNI{8HLt9|lkV-()Bo}~60N5X-cM_uK4cE^((B9O zzSgwL)MunE8zD-pqJ}fJQ<<4n{6>`YZTs_I_2Z{H;@-g_ty6U6(+Vd2%BaDC6KNlQ=nBw~sgBUD0i}CtbKij=N^S9w#`D1}=)_>&+|OjV zqhYOX`y%(UBFvdsUdNNZSBaIcojfpO3unTL6}VdyFPCV3RQDbeu4nFOP@$sJ#uyZ5 z_f+NDjZ{2u>+@v(dMV#~pRuzqE^b|h4;m?GSXZvX>zpQ8*Wv>>Vl%Il-{^RTfd_#L zbr?Td?*Z*a=|LRBU@u$DjESp+oom35NeWEJ9aID_3aA z%n~*#-AXf75tWdq+hMGUIfYSY57snVlRZQsSLW3?R=D>EXjbg)ML0#xZ#MVL#hHoIi|Qa^XPnWq7GJE-rkMXlIFd* z#SE~&MX_20mr`J{Npu90=ujXF;%W1x^g=0%3SYZe&3%2{j>0I48sCXSM4+Tf6z$|e z>~`Z&!TU6<_P-5l%wIe3c6>-^Z;1uh9O(Q&7uRKkL!3wH4kIo`)mTDnzt8w?5vnmm zooe)vYT~4}Ziqk`k$`>UlOqBku5Tc1=4nW&e;ZP|JFttw;WJFt#>atmS+PawinUM2 z`LPx2g}?`e7=C6-mG`s}Cf z`np?++$)9r4UsWsISV$QxzrjG|8fpDKM#B)|M9yKMl_;Gk;h3A?U$`gll`>e2BHZo z2J%!&v3*Ea9~5NSoFB%W66f<1FuC7=`EdOu0D8Um+h^3T^oX>|lcchymw4Zv&eXAt zQN4hS2P-e@!UY9vnV7IJl+{71wQ;4xg-5F)KXav{GJPc>Ck?p5P3O(*Y4ztedkJ%P z38(pY7I*bmf9!*MRycI7y=6_?;h6g_rjtbt)85NByz5o+GW7Z@2iaP706J(Z*rQ<% z9Jht3WLL)J7~Qs1;vk=E5`(<7ZCBH1I9mOa*%$NvS>4%aWVmf%!q1Xd3P~jG+M{l3 z9jX^t`GO^h{O(QckfW1fi1PV~)UcuCc|?CjWVDHiu~!4<0b$yykVy|cv9>oN*TErn^@bK-Q;BKgoFu3NM*yX2}zFEcJ7*3md4pvXn zf7t)ur7u*dDGUaD?cp8YOfb(}8)FNvVLXuJQV!-$h5}u>c8u0hw zLbjI_`#W6z;QZ*-#Gts0a-o2dp z;>)04ZCL>45b0ilCu4!}wTr83+zi&dRW9y{$T!BJr7}#-aKtq0khgh}rl}v15j<&Q z%ki%tp|vI04>T(%dDc}J;&qev2sV9^i1+O+6@v?O_g^-KY-uJGqxX}juzA#Eb+$u$ z^G~KNS)W`jP*TbV3J#f(W^|#}d=_B`jiVz8!AVu=7jVGw=wl(ge5FvMO*d;DC7Z4d z1Lcys4kDS^Z0V1rjP2#<00J)hi8+raaUkaVa6V?)O6`wfymyZ_F21?bUJ{Tq1+Sk6 zilw}X^V*;5>Q^+838kf2zBSZB&=D*O^yh~JQTl1PP$z4TT;(L+w72ZpLU|G=L{9$#C@dcGr!u>~&YFYMVtOB8))y6s1QTOwS>e*i zoQpdy@kOi=nhHv52`233kV1il-k5zby=$;&J%`fF7OhxsS(jgsZ&j1_h&k>mNCwRX ziaFytmBFMm`tx*PQ5>;oURg10!+rF?!t#MzeDmU>)TM&WmN!F?XCPMpRxEd*fF(y2 z$kf(c2ui)$(lkV7h}f<_G8BPtD~;7`K~`hIBNUO%flBf0O@$zaPOzMR{UjApN27hG z*%OB@wfbqJ_~|HOTAy^m0~^_RbR3QgTA}h2JlON1$*Q7wL80i&#eG8Iei0Uj!im>d zA_TKh{YS?Kg|F4UV;Ze8LF5%Y!(y7ck7{aXjq_YXsH11KFqt!UGvvlx`wM8rQ*J}j zAT6a;Db0fu+vOlCOn;83Xaw>=#C2&5kV;*6Pv>De0usUH(@!)R@wk0ivpz)?mruS# zUUdCUV4Kn9Q+ijO$6gZTHFC5Tz z^7$boYS6BNXXd4Q_(}STeE-_JU(-rFsdl?G++%an9r`}|;P0>xvOjRLCG}W%Rk1wE zUkKQ?iHb~qg(G!Y@(J`Uc#k}mo78)tzsd+RnrUsxgT|i?R-SJx+GZl?o-yzdmmN1jwL^9SDq9l z!3IajxQhY;wS!DD0D!Hk1^txkC~r0J!uxnQaO>v-XX^4*EPFx)6nS@54Ub#pVjE~) zQNXFaLvdi<@<@GMfQii3-38~TW}?YV$hcj~RwduKt64&p%hLObqDAQr(a8#RJl8h} zn6kwHPeleLumH9oXMGxYY;j}*_lB1UJavk|ijq4(dWjlB&a*Efn`WaJT$@f`%{mF5 zo3AWkx`kgdcPaUZF~U);!WjaKk!ZF`ev+FE!*zL}W=wd7QU!v*n>4@V&!isGd78t; zDOG5@q+#K^-R5C=-9!4PkNxqhquL214->sZG0ZxbHPg+~ji0ypT2JR!wyvaaoH8^gv5-ag6WJPvio-RqeLGulJ> zmoUD$9MUpl{Mj+0~jOrGdU4FVD)!M>C!RFaX2n4p!MgoDbO zRM-JPuLDgm8ln>u=p_GGoDm@(vJs!O9yO4of#YuE3! z4vxqME#t-)^R5bN8P++{n*v~=UyKoTb(7J-=RW|aqE{@_CCe<6jb(9f+;26~cP%dUQQe7(~J0>%Dna9NCEbqdWZBIAH|wHWhYugk)vZLDL)Gc84zo?0ELCB3nn zz4208{h%W05}nTGu#H)@+VU@~^1nRj0w$EIC$&p3^04AVqv+le`3$dZFQDI5p{!=@0G=5t_wOp^P?|yB~*Im#k%00 zdSBcUJopQsS3jqwXgYP3=Lr=!Eao-x9oyc_(%t{yG9Wxabmzl9y0^zpZ?r)FO!cne zMhj<5f!~6fZSk$}5w=9l(QShZl~Y7+JAnF*xN&ubQRo2ND@!8+5kbzi1Uu1L%<`!9 z2dj!4G7Hk za9~(=<_Iz+5TmZ!(V18?A|H8_4Jo30Di zk+XozWv(Jm_OYK?i{vWo=?NJAppZumh>PZKxfG^yatY<=FCE&Y$#H1Mh+|GhNB17_ zy0vx5RJm%0Ao=fqB3yTiXkQvbvo3V$RP~&)y$5GolEJCe4N0g`MGzKmz6}O=Q-u$M zw`|cBg_${&=A?kHnWo;EakXad9U3t~fQ!2L*C2CkADf?<4#G6pD@-)8FWcEQSVn>% zY-N4f8WD8SQs*>;@FrIw_(>ydyBX_HR0YJkf{u=O?`(@e3b>rJJ?30-TVFjX7-N{< zf;c83;MA!V578!)gohFPMa1Rzz1;Q{n4tWuuLg~^>YR1TkPeMfJRUZ8Uf6aA!=Dr4Z_pG2Z`-=m^zzs=1AoA zjn={QP&j0|otm%Tjv< zj*$2kO@u$wR?MF%&V1r2Nm2ioIZyWd?e9r2-v>uYz&5O1g7z?Py?oO$bbMFx!uDsw z#$p;q&i>>JwEov31u%>jty>>CvQF{pzpR+6=62q$Bj~YwBEAJ+2Ms@tR}>a73HsK7 zi*1Yz?lo$2pf?h?L41^v29ez_N=05XFFGC5KD(7BA?fj~vM6i01~U3IBF zdO`thSlvFqQRM~!1Y~ct*&g*Y9@?(dGa*(>TwnoMlB4|)u+C^jJ%)~_sLAYgsKOX* zJThH*FJUlY>$=WJU2wpb%ww2rDOV!YvEsl-s=hSOh$5cjrB2_xp_Z+TfVrL3v6L2Y zD9DYTP%dX!qTAEl6Vv2031ixyU{c2h|k%|syq9< zPV6x_jayj?rmK5i8i|4QEhnc9QrPmtrZLbl*0&B;)vpfCl2u|yxN7A#w*Yi0ue|RxS}_N= zbPrYKf}=g$#R)!Cnv4P3bNRQ~fF)?F0iShRREDhGQxoGNy4!Eu{g2ljweR1LELt`= zjv1pJjJm4_ame@!(g_Z-=@KpA99D=W@p7kZ+kNQBpyh6_MXtxc#TD&}a=;o5CQC4- z?aW56yXr_9NOkTK;(XyM!-L%Wbk)-}sX1Ow`}l;y#Rd3QE+_;we4?1@B^2yMMPX5) z4u>d9k|QT%09&yFeGl;%@{Tf$f#Xg2boJD+{c&(b*AT51Yxo3yhg#E?y?Y>_N1{$g z|6U25YNOx-$)hYNdbCR?Qi6Yx0j8tE?!>;Xxg@GP(8WxdkK<(9VU)KqOZx^+d1W5# z%d^G51K2n+JOoyVT2rYI0>MvUM`4>(+94kA%EO8;f@C4T+V6pJ{Pq z$CJ1GRx=*WvsJ-T+rFiPC}=EKXXwnvK4N}MT4J?CTQbiIVv1iF!EB}hvgDft^9w!D zE07Kz4kSWTuxEIvi-#uSVb3JfZHFaGVbH6kkY`RrGY52UHENb__IB9yskvj1gYF_X z>3I!SKs(H>@uD!4I4m8Oz5;d-1S)=2=baC{rZ#mwW~c>~La_wKamtjn0{5hBv@hmI zzTO?HAI(nqs*j!eAUt>#;py0>9bi!Ci85(1De2CL9K8aVqbdSN;n_8OIeMykTHJA~ z(0Wa@J9)N^cwqA|Ie=8gB-erw`uv(Z2;}Eqm&}6CIZ=%qErrru6bY`JlwXSr+@GJ} z_QlI6t;kqA*0MG<)4snC2{zfgl%5`rmr9VN2!WGh82pg51rgmyP^GI&x48aPo}V_W zZfXhn@v^yi`DL}L`-P*9LdiH~3;VvT?YwJU?)QNTDbMRrPJuhti2JyDgGaFhT8`HCP451)y~w zsPGHuNmJ&blp@lpXs(t}6E$IVoeXIgr!%5pWCTA_{0%KNQ#qLCQk|Ea@dl}Hwt}*R z*gOcm!-eI2;sxY_%t)c5N0v%P))aK*tgk>>nGQM7$NLlO)tyn3-3jfxIFVl7i>8n4 zb(aq-Y(K}X2%9-{!w-^SUqr7YLT!(c3NeJ5I}#*X-P^7A>b`%&<`K=;$KaU^F>suL z5?GI(V0*xk=1ZO+w;C%RfirV#$lLl!;nwI+dpm)D! zG$tf*oWw9Bu~mUM8lIG{$u#UhBF4N*-nfaNyvS`+8CbIt?T6RsNsd+f;QLDf%LGsl z&LQQe1;aQ9*q{r}T@Id!A7F_E$b6IarIq00>?ijJ+leY5TZiK$;X4Z=QEVV=T5nc} zu63~dNp0a#ID5Q1$VV@8wvX^jE9&AgHmBUg&Wxp?>`Sb5JIU4o{qY`@q6B#Mqwtuk zg6hz`zXc3|C5Sn4M^6pC+Nv+I+Lp{Os2?Xngpjvxnkx+?iSwI9Ic_RJ$C z4OS5eEAI82e@?+?JtSjIU^lm^!aEb?jEWvXpEeMA>B>Y zjgxjoQ!Eu}gPW65(cWgFM3NNe3>qFV-NexdpQwnZSPP_hnqelg5?-LFXy_j9Wj@JpN3PdshGE)&w^aa_Ua6(UE%4~ia-OuZ?yvN78y`z%Z&j6=AqJ?}}l zx-$S}xl_wtXVuS#DQ`*zFsDY2=H4oOhwF9n5(#cGz#9=ElZsW`V8(zmgm|7KaYiNH z2Xyq)Xt-#RPTV`mVhlPSwHP@b9~V$Uj7Yv7_yQV@{ho2Yl~TE3+HKd)Ht9x5wk|0~ zznroqvl>#pg}MO{(ju>gBOsqntB1qIgLwLz0sGM{<*N%$0=^E*&Fn56Uw-%TT{O9h z_)Z65c%Y@-BT`-2#*(8NKwc`ZqAW-0G14+K{YX0QAB->{A06jMjVJleWcv}u%C5nW z?oO~RcKet`tcc%A0RKl?GwY3${W!{Cye-ebmAJ^{!R6XjFm>iIBzS3A7X^P_oKbN{ z=E9Kbq?(d8Q|g}ZsRjFU3!=f8K^IOd%9annzO)p8lVi6Wvn^9fk(CTXp`-$6$S>;nd+TgYMUNeOVE^%7OL zP{rc;*E3Aa`#sDmJh#l3oXHk@K(H?n`4M0-7C9Ki=^>xCGIl-KVCtZ_ZuKJpyEMBB zi?cU14y*UtLZ+3w5QTf4}!0;>*&YVfq1p1Yy~tHWFQrkdcG^N za{wYV`OF0z|9+^ofFENBTVdsET;|*TWQ{!8w-wix0-TEvB-vjf<8Db35A1bF>yQ>j zADNowxE0hhq84273qJcOZsZ`nMQp1ta%mmpW;;^MyZgk;TqQ5ar=3aS_?(efB(E0j z{dfZI2@`9I%odM)SG!zDN-gk|=JLJeU}xv}5vm%}cIYV+C_`?D(7wUPyBvod7cW*? z##*bBUm{v4qAC;za|sZ_+I5_x2zhY^uvAeF@S70H$BUItZ#JYz4h8s19slj zF96BSR|DzqdzB@g^mX0|SMf=TkDR_Xb=iHh2@hfO?}H`Pvbhkp=VsalEq?*Bl$330 z&#&`;Zn}|uR#D#_f%?vUZC{h-x0^6md7(OHaNtWH#`_ih%%H&+UB{Alh43oWymB>D zQ1R1J#mu_mmo9?(7|&Y==jbENj3axo1^#^w`JWr-evuj{F~0y*4YGa)efLNt%%E(a zbD=T&+aTvr#QQe9F_@eUt;XU~6ZzkbnbV_l{uXOjd)y=>Us zy*~}uW3eQf3GnA1kYn$Cx|C(I^sOh{;d{=f9={qLA7i)GH8Ha=Z{F17@eHS@6P>a$ z#@gk^A&MweQ24j-F)rB_#8VO0OqKTvdtK&kT{4j?R^FUgmXMkJH+3bXoA!|0Z_&t9 z{^-=`Qr2Zav?|HnIP_wqag-&Py5Mh2maTbwaC8TGej+qCe(dIIC!f`#&ozA*rc3PF zm?wr$EBTy{3$>)1iSop2b;e{K{0wUMcxIc^OzYNzyj}WwJQ7cmVNdeSx5D@~dNV7O zRcv=*J^@e%XaK}BUHJM2_60LIl4t?5cBfm+%?IM7On8?s74d|VbdDYVzJ=>EU+GK} ziLqw9c(Af|i~|hSLt^-~?TwNdw?geAqj1{9ogRptnVsM*xtPGhyjw7=fm<~+37t2`-!Wv~ z{U!QkOag7A=FbaHdpp9Ncj|rqCnWyf*zijhn`sR?-m_gTpsK3E!YQ-qF(p#}w~`!A zPQXoIo>SF{hC6-wP1A&Ys+&}P#u<-xT7MF3 ztc~4m#-Up-{soW;yA!j{kBos%3H3uh?}HfyO%Z#0Zq+Mi#k^Ww*vg{qEZp(qsL)){ zmROQB?SmEL^)SEK!sI*aeY2~(8m%QL@P0($*0o|urel%uRdc-2rr-~^r%RrM#k0J& zNs8&CS}454y=Zu@y$U+QYKn(hW95`2Ug$E;v2y4np)i@A(_G*67E?QSJ6}SV7V*Qz z$_RzQWO`G;Fu~*47s%q{0CrvO@?uDFjw_Dy4q#v1t-KN(L_p;YXY+W#A>Z(e+BOoL z-pKk%!u9E}H-?P2YqxcM*fcLXI|k3cLC));8a%T7RfCt zJ%0k<>vP2y7~5R3$#)+li5`jlzX3*_9KYQ#9K}8PWE0f*X*VK$^X7HL7P^p9e3PS) z$H$MC%$>A8z4vDXrj#D(b49JgE*(2i-d?!2*KKuSNNrz2pf((W*`-QadZMvUst25*mRpPyhf##68&`PbiN<3)6JlNFaWjjTpU<_U(k6V>C zD6MEqY&atlT-c2*&nr!)kzDEA-j3%$1R&p3QL3S9Ic!vEclolLxO-bTE;KDS%YPg0 z^VFWsZ916i$ko;r&Lc;4E`8g<8iWoJDY#hBz=w$u^0Yc>AgK-~ZOxCg&%jpg;}bex z(7*Z+`8EJHa=&Gs2~p_ojGLg_kE#$yGb6&jP;FRsR>QAlV;q{dQ97r{gK;S1KJfYmjx&BL--nDlSsh@XQH!4Hm>h^2OKUmpat|hvz+m@iWBcJQ{lg3N`~>) zp=u!G$e#CEHMgmsgQuRs9x52bF+^of`UcCM9+}?Ze&#K@p?SJ<0E|bWe+8OvZ&)?z z@@Qm^Z|)}D(&aD#nYemE64tkgLOi9RIPMjdVzPuvSH_K9dQN+WTpiI{L8BgD!{T`x z-3dk42{;E1iv@&D-6r_ZyJqC~rwts|^U_@NlN)$VH6VHWRsr*|$jP=_fli_TEd9D> zj@XqRn(qp`Z(u_ObIzX@yN8ld+Z+ot?m#&70P-1Rz9Huaa|ptX7c~cEh+gQ9R$t;ob@^IJY3Pb)Ez&llri?&+ZJ-!*;OX2=nN9+!5<-$3_1y z(*7!{%`NWwhJ(9H@gkwPyLICbw765;gG+$YBE?Ct;_mLQMM7|Q0x3>$DbPaOy82C|eL?d$c_Uli}Sp*@AU0 zA8`;JNhtlXk%;W}?X*a;kghau_;?xmxB#yvPvCQvB-6rBP3Mt{w4lNXFMyB)D={`G z$<0AO(ZgV}RrEQeYAFG&jj+$NTFmNM-Sn>&qqW<=M_59e21mrbEzi9YJZ!!-JsSGG zEhBn;hxL(PJoUdcHvPBuzi#oAq%@?e3cCvXB&{#`7L9xRsM$`SN& z_c~Qap=tmodE*Z%fH!gdC*g7Y>F(2USG!14ad*(7xc3Zx|8qb~@J;Yldm=g46}!bo z^~dPeQ0;akDz-guR#|z>A#ID<-k1TuJxx~ckO>oe;*#pxYGbEi69Px7m7z`-TJYQE z>9RE`!YfV7GthwH7-WSrD+Y>)_gM9VT08lnZwfJgg}JvSxkuOLnt8s-JPu|ua|+Bf zvr6piV`vi**CdCex&Pz*m~6Rer7ad#*q1hSiGB5Ko3So+cBp#mpcou=NhRx!zqWMs zd@Q3$!`{>VB_&0H9>kMEKw2H%!i=s?b?oBQnXAsPx0m^b`&J_fmLyfj0~n5V5d+3_ zQ>Wl2wUNzfMXIvZSIQPhon<*Ut%_SX3p7ET?p%N-9ES-HzPIxXUUW&9pVUK5I{zA) zA1y)Hd$3U>Yi~=}grx+NgEzB%3E>CLd}>ryJ9=nNPDVz6G_yFPci13c3V>lAzweWM zSj7yuL(}!5(vaA$H-0yTWsask!W1Ja(lyhp{=SgF6m79mYB}@na@9>zL6S$Tdo{4h zY^|MU;P zZqp=QfMIH3IwZP(S%r8%oB;FF{72`%WuPtJ7nm5Q?l19rUKg?(XMp*Rx*d#xJc9A2 z;TkD;CsC$Nr=dH}iQT5+KZ%ygV{l~Sm?McK^r75y2V3i;Y@~S6%WiU!Xv4y91^%-9 zJMqmY_D_!H`8g7*@$ZR2@AmmMN7_DkY+I*QsUKOFxnp@p+YosXv(}5FO<>|^gUeH8 z_449?%gTz&7RTDs)Xo^H8Mo~gVqM}$p48qYZX$@l36)L7#F$cVbQPZ0`dKeZ5d$Dz zp&m&QfgZxw|}QeX?g zq%L)9fkC~|D}mBs{p%(o&b5&!iA*(wNN+WPje|oWMtcGTyQLWbAojLQvv%0m_;x18 z3f5_8S^G^;W2y2s!($;kXy4u!t1lL+wc|Qf10Zbl87ka@8dh2-N`oT5jW}#VwN$Zn z*djKFm-P6}{uXl!0ew~2l(<_#^i=)<4*s^YW|ll$w3sn~bxJ5FYpN?bs8<1g>}@4$ zIP&MPi=L;G4u#l8?YL;850<#@1~Gn6wXs75-pXh4GV~mbZ!|FI)e8ZIp1-`SyWkvZ zQUf^Lyu>rYhmJuP0G~JI(zT#bYOV?%g zIX(|~ntb+Fug&V-Q>M*RQmme~*tOC>l1E~b6N@io?Ax2DfL*{nsFfZIdC zYv+f7tQHrnnEu+Xy?p@|0-7XG$y7yefDe)RM`yW*z^kRJk)w<2-OR0hUObyZi3G!m z36vWCbSm6wfG_&DX=i2Ta-QTNX~#nR3;`P{wfGnQT{}}i`SAc+85u*6GMqTvnp}%; z&$IzC1$OFa329ktr;hN<-Lla4WEJ5s5>cI#P)_xk(Tpl`Yk&BNLOkEe#5eF&70Q@C zpJ&Bzq}nE3hd9(HD7)_$(Kbsmo#_zysRuHjNCB739h|78In~#MCgt@m&>}1fvbJW6 zH+FRAt@8WbrKUcA@r-B9L7M>C19`$h%r~|hqa4zG5Ptqf^0hTCjzXuM1e(P{H4lp3 z+Ts>T%y90b$D&Ua^SikP4P#$^mptcXmq%)^O&IT_8g+p%F+jsjnZ1Nbs=g`g-JeH1 z^E>d8Kks-{&gzB@O7?mp#K3pOY>7420|2ya5`gzh}voC z%g0H171$!2czsfEF%uSyEv0qp{OtLwz_vkRU(jCYz!p1?xlP{jreE|_-sb(E1e~7AyL^4nyIcoBG`hXV+D=t>ZI^(bmUFP?+S=LcPZPCW>smg=3AfQbuVqh#MGU})izR`fA`@PGy zzCEv|RI`Wp@5+T@e3LW%oN6exU|EYi6@~*C8_H9EScHK3l-E#)1QkFIWsG{(n?g=i z%AMg!NBvDZm&RpOAF4mmxV&95!;PR++Ek?D_eMkJ9 zr-cOl>aQEQz`x2qK+ZGPM*D+b?Md%GTFw3pXhIUW0=G1UNasyFO>b}jprj`?x@~{= z*L(kPkSuL~-83qwjAJZ~6Wm=RhnaCKr|;E5Yi`}^cIS+d)URYI{{pKYjtVBl#|+h} z{exJ=ENvLlWA_sW~Q7gV2{sZyh;KK z0KkD9a*N*CE0%8QmX{^Is8Q#|^TvK}u&+X@zjV<;q2V+Ld z<^c|2(1d%MJY+kZAHcgHxSs!B+9TBfEB;h!E_)$Eojbp#xj zZN?+N$IGTJp{iW^&wMNcK)Va|vjcEJ4h#kaZkZ0u)AiLflF(5v1MROLL=Q(F z|B!ko;GJ##+-iXL+FX6_^=pPd$;7h3-t~QGF(EFJf$wNPy`rkASOrr)uZc7>iie6G6g;<=`Y7SuGwux~N={Q6r$owgr z6Uh;6Y(Ld!qDvK?$^UG1w9*UEO!Oui=ss6S52YUpd?ef-u-FXP`mnxEM+!UUFjNn! znC6YvEHv9SWTMJ&qw6HB)B!gz`1F>s8u`OesALsw-&bd@TlDWjk2S)%iWhRt(y^HTgkQX;1SX!{*p5-dI9Q2j?QXF1dWJ z^0AMZ*h@j(E@rex96m;IZw2ScwLO&8{nZ@TCYdPThS|NR2)`c;{qrH8d*{UHyYH*q z-=mc8C8|Q4Ctgz|Lq`jOAyAHVX*VLq4=d+{-4KrIkf(0{FFNeD?2|W&hEv^^-QyK7 zHQE=pfcp&nDe#+Y&JXVk*+BX-g7oP)xrdI-ZMlXn6YrrA=Ol?gwnyVkOy(R38!9+f zetlmlJUidV&joe+jc2C2jcxz<#P`nqd^AkEdO<}ChfOo1)EDa9F{;0|<)z$2VIlM_ z*WfG%;&n)(4+)Gi?W_u<)7_pW^EUVS&d z5b8fW;Et-jZ8nWm*cBQtU2+|^P#q|p@KT1Y-lYupspx*UFH(vi0<;#{VwOxjJ(-ipAxXTBxq1?>gQ>%*Yub1aQ26oj! zIZJcBXRd_%cIz+z+k`Ael2&r^s!s6R#7>d;0kMFaqu74)MTFeX%ZUhPU_iiy1+H#w(GeNL_Ls z&Bb-~pU=e2xt^=vcHHPis)3!)6%_}XA$9Z!jfsREj~*17Mw8&?IDTJ+e?Px}s1=Uq zy(VANa)Z1@@D-!+ohSwXPoq^`4M5Y%bf-(vwk&R6f=W4|GoIG0xybDD=?8bS|u@4WWQeE&-SFpz>8DGad?c=CUgO}{N(`VZhHR-o(BC}tI8 zme)8iXjYNamSI`ui71$e!Y>Y$oz)4kTis8#j4k`iO5s{^5jpPc>XoKBXKS1mXa}sF3svQiZCRtxN8U zB3*N)I;p3Vx5z-yG*J@g;7!0?jp74o&oa0KtwWCoBi z94KdlGbjzU@h;O6&33h^Cawp3!o~@cvg+Dl6SS4+#ejWtYKJmO0dD@b<(@q$Aa0iH zZMQ#1%wY32MQt7TtiOLSU*CkP-Lr;#^jI6fZaRi`F1IgX=M=kk<*KA{(PwwUm^xzq z5wZK4zeMu?Uwj28p_ICs-A_L-%#ufuzUr`dccH~#z?)sx*|_`|(Jrl$8QWle`gmP} zoLaP)pd!rsT`|E8IfxLW-6YNmQD|PjApdRLvwG3kczNmR(S+#-Ox@OG(C!Vwh(Wu< zmAuBT{L5RI_~&^kjCQnX;Aj3CGFHoh^g(7D!y)SHK>iaqm1Fx~ii?i>5XAHas;TBo ze1>Tb?0HGO#idr0UaJcLejF%{K_kY1sGOH}~lt!n?6k!`DfDm$!>IrLpSY zR_ywlqpNo0(g_rDRc(N0)1PzpV$iT3rZ35d;BC0eZ=QEXeEbq2liy}GJ-x&=tS z)1fj_tbS1`vS*IR;p88T0$87R-1%gye6*1fqm%h7kt0^B8A=dr@>96fED^f15U|jb zyc-jHuqz!th#DpmH0a>)L1hGIigG4ZC`lT#KsniNoKI4cp75#{inf}#jmn^ zi&jl~YfE^fNcCwIU;p7OU3d^n5y`kWWbK(U-`2 zYp6;Wi~+NC#k5iHNAr@5N;^(ZEb!04WVl^uw<7)CYdx@}3avP20d{=L-Gy&(iDphT zQ93YTk_X*BCAXO(-Mi==n=bjw1GF`s7aN*5x)MgV_T61B%Mw)87u4vh$cxEm)BJW4 z5>7*)b1>1rid%;pI~II>!`_VckYn|A%vXDbHc|OWk+?tu@sAmS@7*LU%AtvEtBr75 z;)<$Xq?JTQ#+I;bxccg)u~bIqbk-QMC;T`Em22j=3A{(Mm3KM9P@w5EiPE zN^JBXC-miRs^h2!2PbZVd3UMYRnm|btNV7A^>Uf6r$t(yWp8ExM{mw&t^BX}zuFCD z&wrb~iw1Nq{hL?W^3=8!cI|9lnD^<;+T!1j>-TihNY_u=%cg%eFW>%btDH{@6^JtX zEuZoBKfpiRbE~|+xsn%64%wDI9k&(*R4*O0X8)!7s3^zruRGUIbEusA^=Lm`(b85= z+2m`iAeXWM+JChM(*KSf{GM{Nz5l@=1FC}7cM|N$NYq(=m#!2_C7en2JhV@FBT~5U z8njq-IK8R6ZT(MwW#yY3AFsOmvZYsQboE8DfvxV=P9;IXUBR6bG7r;|`6hoBzy~y=hJc$H< zu~WNAOhPYwJvYrtHmcB<(Bbxi^~+yMk7c*MPSFx8yWnYmsMzA8TA){2)?&DM04@=2iyTyW`)!R?fn93{2a@ZI{m z0H;sR@hJv`T)$#Kuhz(7m99buU-tXIds6Ypn`f%LB|(YG0Yn(3-3z<38+`2Jw`pQ*l70x4K9Q zK|X9Rx*=9|OYr-2srt158$peg@>cZLu47}P{C4sbrDrkYNEV)qXanz4nws6*=Kc&k za}MGIT!{I(>{?@z;Y>4^bG}wd&Lvd8UiiG}id3opUaj)wuLEFLiCLJVx%k)grD5hY z_~BKOcCa%5^h(H6ebYWELkg4YjxHJ*6%at0a`oB!FdX9PGZ)OX%fs_-3;aqI7BpBW zx@%^KGaf8x$}fe!vFmDXrbRI4LJG{!YA0~Wk|7K);I^kmVds!*vbMB&W|2oKTn+2N zgXnfP!NjT6pj8V?0gLO62AB(&fkyD91?%XUwUe$9n#Jp89 z^&hQF^pIi2E6nO48)epYHQu#U8_vuvs0ZbcQn^|xedLRr7)lbHxOto$I>5o350euw zD&HyCM5^>87=CrmxxDpa6&~ZRBV}jKe5Y}Bh=J$`m0RYIZg3;=@}b`t<%;J^LRKx~ z+Wo$W&QLW3=z0+^syoBxc18V!%i0*I+;=(ybas)i26hukhseKJVab zq63(3Ile;WWmx#bcclGfSHGt?F4A?iSUCl7ngDAM!9PkKGz}#u-ww@BA88KcZAo2; zf1H`Qo%bPX|47Co#VlP-BT37V!ZFzD4{lxxSa)gQXLB`3WbOQ5wOaPZx$6!rEy(Jcb5>4w5R&#`zlGvCdB5KWxq^YLPz^V7#Z^5Ea`8~p8;yQtwjU`-8eVni%DR8>$L^+Sbh(L0MP40k29dnV1YxH_d*_rZYNf zj^tI&dC}^{LL)x!>tby4U}GkJAWix_qJU-UMa%#xeAD*m$!TJy)2ONsesimyf-Wfg zi9SXpv|_`Bj&b?4@~rSdf^jX^ie-xr24#HS`S7$<+QCG`0ZZ*IxSF^F?S|H=NL$BW z%5tbBjETJAP~TLSiG@#-3kDxdS`^^%5#5rydHL?6R2*2}3BmXdT4<@N+(RMP_3)7L zuIQxCiqo8y0nUiqjU?FA>7T@>t^BghzQ0<}q1g>?c6yXyT3jMtcQ)$(qsVJrBlXAMJd`lliIIniGy?w3QjDIg{U2 zyaR^o_#uSxfCrPNV}jYdCNTuJQ~x@SCKG?)c{A)$IB#&);mU5{);DA9rSZBhu^)c; z#M37!VKwhLn2G;pQj#v|L`MIX&|tjMEox4EP4Q|)HqAbt2=C@+is5ixi{xXmGZIWXovNNX4TF#5 z%P)n~w+yfN2BMG&skFZY7p`)YB53?zN9LvsFCM%T)<*snh&cO>4@~$^76}J_OMvHl zd6r|YkXeMO1>eNjT`gTs^VXgz5IpyXb4rw{fsbr*H_x?bL~L)I9><* zl%aa#y^7&)#vCwV`7!sGzV-$geMbhgmvITJ#NU2Mp}WG|9Z|*%gXp?u|f(aXewm`wjVVM5{d-cpPP^t%z=1(_U>) zJ%0bCmR)O;GM)66r1o`?xlF^ywUH&xD@9E|PABg1u=sgcH^&&_X5LZB^Wja;AQKU; z2Wzn+Vd}oHtX&lB$qo-A+Q;b2CRX>4S0CQ}-VXFG=%ejg--FIo$!1ykN3Nkz8(z`x z%CNG-4bcTP10PqO!FG0#^hik<#?}M_xOCe5ox2Y zDIW8#4+FQw+vU?Vt&xBCEsTtLPH)>a2YP9^4{h=pat&(?m?Kys|_#dE* z)5Ls9%sXwMqf9w{ONY($P&Gj{4ol9I-LJpif;noG#I{#pt3blVBQV_^tTXS@t1@DZ zvUVdMBVz^3)zFo`>m~s) zBITM@0WX26f}@+h98U@LLqm-#w7Y~P&Na%%l6O{##hIE{M+Lh;BBA~QBv(459aR9~ ztK2&8{H@n%e!OH}$2V94ap)ox+|g%MP8!YTr3l3tgvS08jhHRkw4VR*!`xhM@q*#C z3yf{6>IzL~cgU(&Y7tEWg6a>L%DnG*5_zn8ZO(R2y;c$uyF^gb%>L)L_Gxk-#L=Io z+o=P3{NCg$;qFdfu&`L`83&r{zq@j?e<~rD>b#T8|J77{I;AcvFAxe3RueL?60ll2 z-spRq?`1}BvEVP$z+@^Ov_yx_1n{z<5sQHXD2=B=hX@A z-HM6nXpKRo)r9;T5f7!jnJ>rR#-$dEBy`&0Ki&q!FAe58hds#>=m}4Je5-0|uJ%?R zo@;rDQ@7UNMHl;B`QaSs%S#f{VsI5nM8#g;XS$LXa0kgx20XXU|qk80e9X- z?z10u-YZh2W$Wn5m(~EU7hlpN3eV40Hj;9s;Y;I1ix3V16CG_%cxwBHMsCSFjr3U> z;nWnP*f;uu3XGpkGF-p)D)b(wDa6mC<1XP^xBPSMe%W5Od5Cf zG$G719rG;JGWrQz={auOMbCxrp>my_>qwpIEyo#=&7J;gT9%v0=r=YBL;9bE7^0k0 z#ERM(@xg73y1K^^sJQIxI{ z1>PbO%hOF8)m%cUZ{1zFW((bSZ>|s)V<6-zy5uVYXINs*7D{~y-jr0-kxgXubrGuZ z)6VgbyE^sejd&jC9{UQdTY`W~_I)A7PUC6)>-FX4)+f@Izp`J+6HTCTm@TD3QUKwE zKOlz4%H_h$z~uACuf>aNL8>NO#%*n(DvN@0C4o@;j_+rjlQd%^?o@X(pylJ za9q~Zad>uUHqcjueKK7p_N)(B>+2eR&?OAK?8ZGB6ruem$51niRpA;lQZ73}7%?~EUsvd?pxf_R6L6WnjRz#Lp@_KDgZuKz4B4SQ$}_*%)0TO& zICF#I*=Hr<5Ofw85yb*l=08TuxJC;JA8Q-Vp!x~i`mU6EYTO_JK7C^7qw^x{n@cZ7 z<2{i#f8$daM?1WcIFtbMy=Pg2u9xuOTs(irWm7?znn|Svxs(lF74ws3vE)_t+7wb7 z=c|_dNj?tdRA7{sESAh^kU2yfmgs>jb~>}cvHO+UD3@R4mi3Y>K_lr~V<^N3Lhj8^ zoAb48A*t(dpO0TgI>r%vP$Wxr(uwEr2cibbTk99noP*T-T& z+8jF352(ya+Wa}uv}c$__fO%IbCj{Ma)>MDc_}TiI;eq8+f4!W9M9TkFKy2|;fJVj z{b+^Bd2%A20G^r$nZ6xG3oUIaCkW^pUO44dCUZ)~2TKEK?XnJo-E`WEl#v9l)X%Ns zEOFEUFQsI72S`mu{Uf?nCdN^2>i84+ph~nvJeo9JCSa(n8{bz)F68#2${Zhn9GCA^ z%bw0ki(zYun{vLgB!ff?{W%?K&&I9+$EbH|YCPeF7A3g{zoj}l8c1^q;9}Jt0T9Zw zB;)jh$^!bq7d8iR$3jRmeUutwbLQ6OPMTm{YTTAq=g-7h zH8ObM!ky2w?5l=+d({qCo1QPUg!F^iG;k7VU+O?#dV11fx*3I)1uL$CqmbZ8tur7K zg|Z$AJvXs$ls#K`&zpee?G%fNU z(1!Pep&s!99x}4v2VsM+VDg80T|%`W505^A7XqnrT=H?FeLQX$FH_)lujn@`j%>*2SnlCW)TR$iKZ*KJUYpX z0PZ(HefqZi(R26E9!D&MrqtbE&V74|p-F!NlRNwbaR@J@(Hmv>&C|J1zJ}mn(8`fH zz&z4U>sbA83kCSH6cdJs%tbFE#oFl^8{Dwh6#$J z9W!>gOj2Dz(^wSBoL<<>uJdHIdWl};NcVZ`A?UH55X_bIU*Au&9Z1T$5 zGg$hO&~!!pv!mDk`9!~NU+g(C98h=mQ(Y(CjI=2UZwqGZA-O|Fl(l&@>eM*bBk9I` z828;a3pA(z#M3+DH)9(?mB^b3CLiym>~aE(L*xop`Mz8bVGQU(jt8&hIaeRuR;)d# zC30ywN~JX{0+vz-6BNon#}}&>n)tiQ@j)bHi5-kzFwaON<)ZoVol!FS8bOXe-n*v|JH)Yv|L7uSCly1`@lb4R}r&qg9qrY0>iA44p-M=Hh>emF$IxcIHVR zjt0;s?N}6y6D!bnOYQktt zo1wa_wuZl7ygssQXHd3c?$`Q_b>BKk0RjzQNkvw_V)Un#4YWBs-mNm|NLSU2*(4*2 z^{&VYW53u}dR1V~cQGjSja(zHgaqA}rW5p*OO|_v5qL_#@CHo2Tc^p|$2YQP$KE@z zpqr$Fee>2*f9acE%m#!vm?b`XRNNGigEw<4d8`uBzWQz!Gqi7n{g(31nX5N3A1y`L z+jZQ4+_Q^N9X|5{x{OQP%Vf*XIbE`zZqD95m9V44Z}F53-X4ec6A)vb&|Eb6-9uaT zmDZkCt5f7@Twh_@a|_l(@ZWEukeVNGjLU5-#5H#9`(%ZK8H}xKQ+Q2biVcy37U392 z`nU)wG;0-3B3_npR$@{Ul1;ixYzDk_I>T-7TyzbH(m2q>I}&&CC2J9N4xp+PCN>S>} zB-IjGZg}9`cJ_T;k5=cSn+D?;NUsP%{)!NU4x?oio&U*BG8pnM>=Jgyy`tIv~QA&e^I+PHwvT0VSf8$Pg9N>qu)877W* zCwI4B(Ewp*j(u!y6yy2!L}pQ=kr%Bw?sS-FBC}H*`CtEA{9j_7Qcne#`ah|}|BoM3 zir(BEM^M(ZE;cM$zi`R)Z5-*Bl9A;7pao3nFST|(VQ;k+R=Z#04!%*g9!+sDLht#w ztdnlO!YAtTW1!k{*hy#xqE$o2HieOHC3hUY!n*XRroOphN5pt}q4Ca-%#0XK6DGfDvQPll*zwoFwXKJg%}JdK!OCS|S}TiuuL#=1N#7>6%Q-$S+sP;>FJ; zC8r%R)Sa4{KKm{#NV`bmt5Csshp$R4*=drVylr10J`O;|{eh>tWN8aQvzn3jk;~U8 zT_A_74PJwRPr{vjX`Srz>2J)s z5A5wkLoaeFb)fy-!@KeixVsvJ(ETBYq%^z+#)8XoaVX|+solR)iE)_xc<)oCs9Ivq zIG|;b$BOi0`ZO6hOu{}7mc;4|BKoy0OE&VOstgYk;r-c%ysZ|__4IS5_JD|R;mrwv z&pg;F1Dp#=Xa1G9ZNZnGL?tVXHXF+4<`FX3j7RXGNG;`ob~fi-g~Ni8t z)JvAB`=y`2&dFe{kpo9r656lQ_$q|Nn*f}&ka2bsp1qw=yBn!CIu=EXN&YD#a zkgA?L3hniK=^J1)-!iVOhRRCch)DR6r5y8*$y>n4SgB}~&^u;}VS83N>|N7>9^w*1 zG;@Ic{@NuKPa07TBZu250pg~^prCHF{BRz8E-$`g*WM*$T`aG+g!%#8#yQ4st`YAl zQ~oZX@XPP&*3|tNODbmXVOlA%%efaf=h4*$Kh&TmB&&|4+?Ceho%#s&uqC9M0dmsX zU~Y+;f|+S-HU4{FqUs0ZrteB-5>s;zZ`1S|!1u}r$m!YltC8vwD>i2tI7Wj(0?_?) znAt&+_g#AKWj&CAqddI%S^+cy76|q zH^u>$qQsX@S-VilWuv&tr8T?nOTOcvu@L4yrtnjq^*dJ|UD3=EW7qu`s3;D%A&>CE znAAR6y_A^Z;w(){Jmu9({v0D*Gw`s}4cbn<)}_BQy;g*$Wy!r;`BQ9Pet2S{f&K5_ z@*jMMX7S~~ZcOO$1X08gK$E1e`o4w%BVxkN2W2IzFx1eox{yxahQ3(iM5sz1;4{?Z z3N!}(uxK*q_MJWZP@dGxffILG4+dZW=!)ahBPVZnFISiXoq zS@H-V3Klj;84Mb1G1y<8EAsi$EfpgwK@vtj8Lt_)6mYT+MT`rstam+?=vflO;&u&_ zt^hr|zTQOcl2&-{^LqBpA_(PCw^@g=X>Ip?8y9@0xBgC;)J!$&2@%L42mJe1%p{HP zvf`M$t|-(NQx(D~Q?_P*W0Yt+TwYRY-<_PkuLhh;4|&d?7{Y)b67!peE65H}b>_Nb zcuD0gTidl#V=^wusna|PyUAvi&)E_VXll^Y-sZz-^x%(4$9X0EWgu+u@*ntt}_`nv4D9*|}^ zfmtXW{t723Tna@Mm)-%bwICf)?{00zO!G^Fd)wj3s(9Fb&6T3+SE6K@S#xPTyLRMcbl(h{{`6LJd30Y(C%uqAza(dl6f#{)m&&lB^2R&p zi{bd{?@fD6)!Ny;&hJwbpv_Ang7r@IX6F{PV?Q1zOXOLSuGWS=KV*n_AH4R?R|C2o z4oSfgGP!&RC6%RP+}IB<*f3H|i{i__ohSD}T1t1O>I6TxANHgBvD;gn2_a4E%VeJ3 zLHl|qUP)ov%iaN~5?!lBN~ z7gRW;&wI_hD`Zi?uT(KcUF42!Y{xjk-1w7?1A3-#MU_}N#B}9yY@^coJbec|SY^7B zRe!6|Q>Dp%A9~LEi&vKMmyLa<`XT7(YQ2N7^AwINc?8o8C!Abr)Wq!{^nFssGU1tx z8{!q(+$M4q?F{rCxF2pIg8>zP86)Ir#*=h0qKr2PWH17PSb-%<@Y%UY2TC?o5z$QLPJSsIl~^E<&lYS@?fk3IPvp6 ze+Q8eroM!kDEu1Fkk~nq9LLMMajcM7PzM@D87~wo_vyc-|KFX)FcMpR&+vu%Tzu#) z`u~2diMm<@0rgZU|8IGWo{Awl1OU1tTmtF;UtDxu)OOeui2MJpFj8!x#aF)uq=MKr zIBP!#J^=EA&_AA~X?)Q$dS?+Cshi?_RRgS1!6fyDFdZ1-o9?3PdefGtRY2SxhnmoF z<=}P=68JYwhRY>AR^y4})dV8k!4dQ?xa{b;{U9}KnfEk}=qg6xb}90fQgxh=X^XQ|bbr<+isb z7E7TvDF`~NliMHzm;!UlBwMVbiBeuX5H|-k>wWqLa6ao~`cPl??m_5~-;hKL7?K9J zXC_SHaj85XCcp8__QgJBjAc;=_=vSF`v0&4Alt_LbIOgRui)=+WLd2KV;BoRQns ze}F~-LS@{MX!dw4m?U9P1R~eninT5{Hk%kU=>lFJ$)I;^%L<`Djt59~3&(mZRwEdQ z*0^=lahTVdv?+AtbGq~wYyp<`41yo3q-I3}^Az)3SR(hoeKcd?Ztyr}t)u6nDB^0k(!%Gkm~(UZAi#dOi*u{2BKE-h8A$LDHi5wADUWe9z_#pn+++UG64$F zFf!$Az6x0E6$jUc>M=X`RUSzS)1_F;A zW)u{o+n2w3isxRfa87GV>qkI%ou4MZE9nRHt)DoKIoo<(z_ttN`|N20dY#C5=fy=k z9uTr%E_vZ61FvE-2LW8ZKb~VB`-bF|djzxyOI|t1>WGX+0O&^A+ifK*IFj<4btH27 ze2@tnx+}OI`}t)=rx66h5$w1JTg1eErs*@YG0d3fRNjT0jDr&sS5@ZfFgM42kVtW0 zf^O@nvn$xQi_jcp+q-tPnIuR{*sm~oC|^hSaMV!myKM$<+P!A%6BZFLS+gITL?IMt zs4ADP?J_*s5fN?KYyvp|)+*#e} zaj7#`6e|;a7{nhlJkS1>DWRGH!hbO%0l3DD#rZyR$4##~1m&H5-$V*8^8a%5eV-6* zn=)D`*^l?(;$1K2ND2 zZA7xqqLq?n9MC_LLAd%QSvF%!?vQm5HAC`>>3dU!&Cum+}K54lCWPnp;S9lHJbm#|e-{4V=gpGq%&n3;S$S>#*7eUfUh7e7!rhzC&u z=I-^g%$y)BfgPhU-_VSsujb(IB+8e@`yWVLyO3R1BR ze~dE86M7E~k9qi)-Y5u|SJ(BM(Sm3uc5x34cT=<>7xc6#ii&uWOtxSCG5>u{hcF6P zGhq7nhGPs6ksg6GB~M0^>Ij=*JmSoEV2KqvWVY*k#B`G{7ZTdRkx2qr`s{D+k_cc>GS4kE_Z*$#ZdL5=2`pi$nDpA49Y(pIzGOcYmz2eu@NEg(XYw_#c~ znC=B?waBAr&j&?)6eJkOSF@SJYxok%RqOVc`k+t$Ax8Uz=9`V0$tW!wPJBaWRoSR( zg*J8$5Gs~)KaxN*$^9!Yxe(~ghMpr<(;gEG%2$m@7Gjf13BD;!u|D$wfq_KHIAHh? z$`SYjAB`7pS4H}=eWGk3&AmaxA(L6T*4$A0kGBn~o*x%8VkASFsj190YEJuQHt&^VWef5PDMO>A2-O@3MLvVyn1oxUmA@6u3{z`C`3)Ly za-}_FY^N%w{xcD(n~Y25Y$D7ID~^^8NVj@MHtJ|E6tmm){xqHwjrd&BSar^~EH;U| z>p5TIvChYZGMr6><-K0yhQ8@zemIt$whuV0*pBZT;X7M0EM7tZW{=DZHil?P1a-^_ zIT~K)POLkES|#eCH)O^U5^L7i+pk#-$ebsI-0p2!Oa`zL>TS*!R@{siYI;xV6*71O zs;4%UDkq7uyQf;OwJe*k4};JSL(%GPcPgT9Ov}$dCoss6g1E!f0p5%&MOv~G_sQhJFlGafvUjL{drmrR zu2;CE=v$Y?X)<~NUL0mjdh*t|;m%Tw#V-_P-#HVP96Ng|IPCQYhswJfnW0dnH?5z$ zBw94GY_flvww|n{NTH!XIIJ!8tZ4|%;C#XJ75O;@K+CY+Xw0qTo`FldaKUIi1p~^? zBryr9p;u<@>SqB_YVPby43t@67Jqyi%HkN?;YelLvELr^sy#>FS_QfraW4zLrzF*A zF~~n)_OAVfU0CaoLfpyDZD&U*-8_wbDT^)NkQvKLPr5JCE5aIylT;OR!31oMyqv|Jg(kT-qV=%xX1ViIN1>nbidf0Hz{;4mWr1) z9d{p^GE|((ZGEWH{ecnWL&{aT}dZDY4m&dC9Y%$knW8t#-lCtWQ{A0!y z(l&-Zti{2$k}1b&1kNF<&*^3na}s{80GJb&+OzAzJ+$zY`ab|@p}x4eP1Axy)7=H` zQ>V^P&}_7ew?jKry^}e0`L@dbq_Cj$Ou`s4|9RMz2cb5}g-;m%NHdD>b@_H?6C9gs z=^~x)&X=-$+0eD7KF5hz8(13@lpmLyR+p~5h`P`J&8@d9vX6}TIukEIBI6tKR13F;ll*-Wh zdC48A*(jqM!6i7rJHn899x^6W-JTH;`RaAfcg^m9=*4D6x(fn|>z)fh!dS0)ZiiXX z;~St$z&RBVqyi#>qLA}X0`9(CsBQ%I;4}%#Y{U$A4h|5<&x9oIaJL7|$AQ%3Hc!^fYp6M$JRM;+GbcS)SAPTWlHYQB zyqMXmvhuKsTaU*t+l290hO#O&nQ1P@$$}*u^ubzHY5L)Wl_!L=u$-?RY&ioVUqUXl zaEw{sLOeL%*MifR(yMuJ5*yd`b~s?{a~D>wv2E)bZ^JH)u76!K9mvq69)Ju9GeGz@ zVqgll%>~`gFEy2&9W=k&W&BIq6_v#)#o+F(mFr2-p`Vg9*;p-YjpwCTZV1bZ;3TNr z;m8bz`!_cJnyC{jH&a zjtl8(O5`54X>j7AH|GMCQ^_KN3O(xH*c?kru3~0obM25KKu&1jdeukOeP@zMRo4z{ zr?!Ik5jab8*yxJplHNJQ?*q%N_HEm*hP1x2N!qOhNznTRT7yV)HMAsO4!O_pg?{!B zf388lS`@QFgNpj#eyG+2Ocs?3>r72MeOG>p3UKLIm12`8o;yutcZVHxr5;)Ij=2yN z`q8ND9SzmnvS0LeXsBUi^}+s%}n5f4Dg}3V6#~^ z#Bh*-Gz}jsv)iAPm`Iy-YWu2?{kimRQPKgaYlYddo6pHH&<<4W*-junEHHb?D##F! z!-Kq#VlXpnsEBuq;q8rQp}p{|eMm6gc$1!A-MfzvWfVNR6lY^ z_JsuOV6lZyqcV|fLZt?Oj$BuanP~{3dPgaikJl9TamZ~D=$vXnFfWGL(FLxH4oS9b zH9dTX8uj~&D4nrUBc&!lJ-AI+538nP^3M5kr$9IQ^LA^gSrOuV^EGi2+}4*zNz2y# z5+}^DIhT9JaAF?yjvE=ZJv>NI+>o;eqCdow)QA@j>GOGN_NnUnN;>u^*N z?tSlgREaEp3;xQAeg6WZSsV784Pw2y;Dee+VcrLH>`ucU=YQM0*vv`GH@PzuyAk*S zka*etxm@$WD~4q?rP1$YXVl_JRY(IeZ7?)AWn&UgwhE=Z1}k2udhSw}bxOj+lNE0G zp*`rAS#G3brJ&{JEBHb1c6>Hs%0TOf=T-RTZ}}VZNFL1=(}?;#f`Q&XAHIy0F@hF9 zSx`aYMKQ@kT6=-obzeQkk}Ero#>S>UbigU`fFQ5#QJ~*X&ZI8eV=M!t1u_8pb!)f^{6DM^e_`o4z-9W zbxz*$-uWLurO!Ijt4*kN`SPD$0WYW8G5LJ7?zVbcuUvq2C^PJlCpPeav>nU8%Hz|$ zI4QXkq)Ky;mx+jblJ`@3bULE7!ZX+3{j5tXWQC>TgqH-XY?FD)>}`Qul_-%>k^B{0zpp z98E%8D<#Z(R5*Ie@+_Mn`J=DDFNbRQc~>=8pl0S?gl$()5AJkl#|5;4dKoRZ_+U~- zc3NuRK+*N;N2|qN=xMLEZXsre<;F|u42InQePG|R6&x35k$t3U^tQ#I$C1$D3GMnB zrSNAb8{fm^GUUu*P7zA&ByyM}4bnWGKy+8y!(0bFsoqe|^%mwF__*)JCq_N+@m zw}Ww!toG6&ovX6}Hb{YLuN&>D9rxi3j6N9uWd93T!O}dYGUjr{G3Aum1|G-S1xQ3qpPCHObT~yNF$dHSy!$ z3ERCeRo69sv)Mf8e)c4*KgXmT>-wB?BszSvzaJO1AOsU=-dj*I_tzIIn8w)5*%lBkl1KTAiNDih=3sDFO|3FEfs!Pu`XJ%j6^%*YmSG*L=+zO{6MbipP+q zy*rq;{8f*+TX*s{`9Bm~gSm>bGOZ~^`^`V~qeey2wfWUwzoa>?69EpQApL9kdF^@S zyyu@Yh61~(nri{ge+s#JTtiGc)9GDPmCaz6hau5}KnhdxpVFGej_Mqm9z{5*N1>K6 zn;qZ%gLVZ}7xSVIXhEp^P|(4vw~5y>maAJ-vrZ2Eqco#{fQUBuYO}dE{9%2+9zA|4 z^OFyJ655pyF7mH&NR~YTs=8ohG6RIJ8+@pGcIBLD$d&AsF2sZKM)21vOVicyfH^)N z{mC0>=j!ljCa1sC*~p2d_)=%~mM5^ZN;Q^$GK_C{xMQ81{OvuM@P>ImEJ|wvpb_c1 zna{q}2sf_tKOlU^9CgXj@546U-ss)nTaj#W39%$R_w~UoWk<91D@5@9Q-w(=$LPyW z5{eFmkQEJ1QAg$NO$p2ozq1P-sX-E(;vemqy1Mee9hLc!RrGyM^C3|!yMqCBM^!zV z#5N+{BpWl))j?sKHHTWEkuA`$SbGyU6}f25WO%?1z8ib<)T}YkCBYiOm;eqXgdcul zj&e$e17F|?7M-h|(ia8FL=s|k#=$kH6x*Wk?}iuk393}ou_HiD{z2OPjLgx1J(D#U z*J=kBsxz58ql=CtNlo>Y1agpev<83{`iyJol!wE9>pWuL`#urul*a=}bI}UwX(-^J zL)~>NT4+`#-wm2g)G74~RQE4^z=2X3D;R)}iAYWLed|ttBti)agm(TZr<9CH9m;C4 z9n@UFvxYOUx?6d<`|yb8q*^gmycYn#z@-1I)o;VP-=?pmLf3xv}Yb)X$NMkEw{*Cad%@Nsy_AYYev&oFPlZ|q|HM%l*L5M*z&vn5d*bOs;G zYcX{%j5*}bfr0|TtKodjB6^ay;cGjNV587aOw6DjzoDi$+l0+9lI+VJ=W!AbZaZdB z#85(GgHrOGQfP$|}mVBHg3E`wWaTH~GjY{5gSwtmN|g zuqQX*2PJ10s0C|=9m0af6+6Mb)-EgfQ@qe?Ra1SOFIr}=ba*G}4p{LjcdS1~{3CRf z$ad$`Qc8`4vz^?14Ab)*yV1bNkLxT^)F8EUaH0*~yBJtQfl&k@SIDY;;)+|js0meq zD|s1}{%{U1Zy`%g>$3NjoB3}j=^o#ckWcQnbT905OvYQxJDCw#-I)=*>T z=3;`5`zwRmj%0x(D$y9zem`ZvA)4ztxBAT7);@76M8hN{?q?}b)O5!H=YAd0rIIH* ztKN9a*ig3a4tdY}*QC3#ug%WeRxOHi{?5U74EAIBrtO0%DgOw_y~kDI>YOhmQ+v>E z`^=#Xt+~8Yf#O)ogg1D2Nd^oqsWV#%@&M&_XGfx@6fgc5#soNKaH}Z`Q(gaTx};F_ z_8&Y{lm4M}Edq{m1Rq2#;Qy=w190zu1!tjB%iL?8X2OJBdj=i4L$&K#3G@K~LX=f- zPJH?CIr>{u2@Rn>W6*wm{87;fy|4bj7o-?-vX|2Fpy_K)dp+?H1pIEYUVc2OX(RQC zlcyVp$h>zq^@a{9lbo5ZDY@By=l2C?0W>wQcYoN~AQm9Dwq|WT5a3JT%P!WPzu&*9 zPiMC)yPG@+GvXl^F-cjjQv5xMQ zicC^%vWqdlvN7-Z{55CfFZGn^9$Gb$8R`u!*^{G&%HF;n6w;R{@~#NXIw&nVS|U3L zMtZFc4D8R4Z)TLH_^{?se;7tufbb4@Aqc+Pp8zJRaQRH(3RnC2U#VK<`Yv9+QkWUi z9p7t!fA{7PP-2uFpW03`f+WYiq0xLI3;7O6=kzstf;vW5DPx$GF8lFEe=fJ8 zwhN|t@5_OxCiU>B8YjTMRGJgicGr1oUie7*$!tH9sMk)Q2>9V~$(aMfOep8MVnsS2;5p&sFe23g?24dN)+sJCZEV+;~(cn)<2PS7kz+WuLz0q@*o_C zvCQ~F)EMKy3e#O;_M#IGU@CPudicOCxTPHrUljMfflE>g?%^kGM{U{?y6YX?{mU+( zGn;Wju}58ly-x-r`+uvZYlT>8^FLjVpQp|r=>rK#X+*^fvF>tv1#F4u&RQ}-eNkHt ztVAK}B_tD&`GyC!&fdVczdXfqrMFUyNvxy8(Gs*2iQp+euwD|nXiIOyPI4SH z8F#j&+tjh~KY*kGCe%r&BE&4GD?w3HZD4o~EgrAfd;& zUS6?t`Cq+)-4Of-l!@Ue1wmTYlA+=_6C*KsP|RD7;LQ!8GclYpA;86Q@)3J?y=PT!R(*Y&C_PEVR61SaWE=DM3xCuHA)m8RB9(O}U*{088%| z1u?6X{I|0{A@9X)TU=(>p7Y)WHHZD;Rq^0BKde1bt+&3s#7kepdILu38IrT7s8Ier zj9K_+s7X9hMotcPxl)u?-R5&|hX8@w`>n9_< zn%Mep=O0I*&~AhlCxyQF3~O1dQe}N_7Fh|uv7ZNdA3;~N_arq$IQ%Z#p6b%SNYr>f zs{!@5a+=O2OvJPo{W5odJocRoba!`MOd7OK(6vn_{-ZEjJ6$vMXo~u-s!g{QQQaXf zm@Mgz!#|V|ekSYeHz#1qAVoc1S0~3GRi^;Q8T3D}b4q4XzvRuRmE)k}UHFU0Hz$+V zHduy{#^R48=G@T|R||rfbGw0r&~TEE3{uD0^k1 zuE`hJ-+oVuU)-QreKv}OJtcq*Lg0Ud|+E$Z9qJC$$ECq3c4UG5YRhzyy~PLA-> zu6<3G*PD1yqL|W_Ef@!4-xr|OU4B=(leXT;7Jk3IyAlK>R=(_ndwvaOJF^Y&GcP(aD~O0>)2wb0u5 zLlOn0xbwsOVT*EJ>#hMMjt}d;P*#eRlYEki)^)zF-wbb-=JV^x1>7H)d#@ywMp5;l z-YKCt?zW(q<{mJ6Wj}1&@gqf=FG?8w!~K`dx?A!zv87PZ44dOW*TPLqu}qZf9P>Ch z$_GVAK*a&)7d&1V8rXB`FqQQkKjdYQu!_ar@g>Tl>{{&RfbTdJZuXS!bg3E3yO><7 z7k|XHc;E*;+W8@&uQ=ezHZge zhHppV+wZ;VteT0qmvl5-xlugKN)MII;%dM_l5#D89L}mVC42#LRB4w>XA~^=agZb_ z5qy+Tc_nk@Ltz)Ro`YSUw4%FhN%MGK1s7+pV_Dh4AIaS1D~@8y zAK~s%SQA$>*5~RqT>r_{k1oIH(5OInA?Y+xaHS1f$isPkM{>|m1mqf140{y(wtes`;QL}r84c|q!jl61@@ z4?}`prE`urJKM?rYk_!I04N%vSck5zweym%JZ`ONiRgPy682$Mr<;N}Un9owNK2n^ zY{d{&w~G;ICIFMGG{Q}Cu6pZ&jNHp_!+K2U;cik{OSexI zlG;948zz%@wKE~O!dUStEnIW!w~=}OdWS_v_o0JR)lZ!PRe!z*RFFYEG!CFG9jaeD zAs&n5tzvEG)a;pOdjtHjdy;B(OaAA1ZTXTBBg-8d}PT_Pg?%>Y}8feP8P93`K z4D?g9IzpwjPi;xP_VdM$(B8<0i|{Un3m1qS7R7omkS|OAC|LTVpzvx!ql-= z<6z{VNktR@vDEYyyeRU5$5nQ1JAVHwe7l}#A||0?CJ#*$`ZpLx9q`j{We2*;JfzUH4$8Cbta}MxVQv3eqpIgBM3du^{5yAg(>X6 zE&Z56X$UYmuXEm?D|&EXBUd#VqF%Y!vUFM5)(5)PpXtr`_8)S;%7-b)PC!Vt6Evd4SSV^`Bcj+%rbC1PliCO60VONIRH_KZXB25q~xjH(xF?e`MZ zyy)>n05HH#zBEXZ7_U&Es(%KaX5X2l@EDes8{gUT-*iu(e$RO`O{8pZYxc3)JLaTN zK{@-w%o$YgpR=f8-B`5aLhafyen{$tm+N!+aL>9+(3KV{nW41{X^~@Q`>zXRCm@L< zWXC22;91!YCG8~PB)FUf#^meJpaJ<9jZfd96IPm6*0F@0zEr8RAAInFlO~~Sc}@5< z8bUo6+BKvyF+DT1DSlUg+xqX6IynOQqm}+&USF392ax%{5(7tDUDPL@X!!^^VtE9J zox%JyllF6W6X|27Ok1P7;PKb2OJnli31BI`6<&LP(K<8=XMIXaZM9xH4&c~oS$&gWjD0$V*qn8t_2d<-L}`o@h6NuUC>2qV+%$Zm zL@dQk;qyT#2o3@$?gn|r3A*u$%s%LM-FB-j`))l(oBE9@U#aat68tF0Vc>W>?wAk{ z`cMAW;MVB`@@)V#ithz}NkdT-+;m1{Qso!>*-fKUzAEyeP+>95$NuZO|!`HPi+0v8nDP5hMOFFS+R5+#3EDR zM7!Zj|92IdH6!V`L&Nc+!?*cxw>C}}Ge|vf*U7)|R|Pm0V zQk5f}s2R`?0Kl2WoB7Jw*7)c}7&e>!$Xf)uq3xS!DWcL>Om4-OcMiY~k@wBu8w^iR zQ`~YDwITKVWL_`?;n70nOD;*5c3~{f6UB)*S;LH>iuV+nlK%tHGTsZxOHN4p>uy8+ z7eHsL4q6mjY96%KTXl6&QMf(6AcQj8(nuO<-|55f3@B%BtEs^IR7>*sYVbVbCdpzmxpwP{dK zw6#9w%lDa`dkfj)tM!u|`Z?;oZKgK-dDwTGGLFtTai-yGX;JP%JGwXanT8qxNzfeg+VYliBQ&|o45AYMmsO!6jdiNX ztn6mkb)~m#Y3$<|?C4ED)0+hfx(sfMXDJ9t{T8xvb@#WwXuOzZeV5zl&gro1U z$=1CJzWEJDdl#c*WOBPW)D}Rp3%c=n$}9>ouP?4xbs#>c7M)0teI@?hWokY^SAE9^ zyMz?zNRppWsAa;#|2Z?7jw8EgCdJ-5s|0(p;v)n4q=?E1jpRchMDZfP`(-(h8!$-N z)+pLT-0y_MC{0biC^MKk5p8s&@iB(d{OjNy6C~d2M#}nz`~n|&4_xwNo<0COMX>Fc z-&Qo%2$sNgWR&eX-y%39FctO)dgN~#nxu*xb^F3HBkU`=c#s_4^uWF>L|DVHWJyEH zJ(^=eqPnadG2o@NJS1qyj9W{P$zO=%O^r}yW-{=Sp0O&?&M!L;O%hZV*q{XY?TTvP z7;Kb_1aq_KXyyqGAdGw+5VDA+qsHtG>rA}$?V1-+U@lNkLxkhV_SG1cF~6YW}HFvzwMo0*wTA4U@)cicha5pr)U*d{rB zCGh7*hzO0?L>lOO8JnbaH&z_jWv$}xo>AZRQTQh|z{GFxPHRwh zUe|d%11?CYRWaRyFW5jxd@Kt0zoMUMcr7s=_V3YNC$5SgB4Fd9O(-?76F%$DC`&#l zO$@1_U&zyP5Um{H_kYVx4X*azXR4X=;8jx~JK&jou&`mKwA#A-{u+cfU$;gs< z0A~Va8T|QX9VqV_syi_??_Oq0yq2%qzTXtDz3W+1D(+Pa7?V?>A2HR zDl%cw%?Uz&5fe$+d4G3#VingVLS#zXL#RG<0gCN^;W{HgHP#|{NQ-OJ4PaecJAb1S)z;M!hGrj>vNYwu#!OqFW6IdMR=J z{4{{8IhTRLCvgYk-;MP;3|Qzs`(6_ie$xe;rrLf?C!Vfrow~*Y7c7KHX>mm4Cu@Jr z{uo+F(fpEsgs@R3f8(H8s2}l$fvSD>y<_O7z|gO3)$uNqPl7Ve6wYcpHj}$P*G>t< z6YNWNeNJa7MQ%gpgiC50R1zo6{~z#>&TPT$Dg4>v5wG&>2ZJ;+vEZ*R!*1zCpL+i6 zZ>0Z;Vev_`x?WqmvDMjqscgr^nmZ$$>SR-km5e@|i)s!{f?9Q74X~)Q-%?5rUv*&b zglI~G%$|)mihZ?OzOJ6+jPGyhtvW29? zpV#cYKKfK{{;Rr;HRm!RVm$zxbC#2D_#IST%ME6dm93Ku?v;?eQS*KjDq52)me5#h z4lk*;?TnZqUdpdJrz*?McpKI8(#B(+^HPwQ4UNqh`9wYP0TvDdL7ABzfb5BORO*h@ zYUV*Ffd{R{*zM4lJ$!e=#S78n>vD5vpLW2LywmI4Kwq4-&XKr8f^lo;ZpL&5*exOT zJ5rezIar30VIe<4Eu1}TLt9v3Z_kgHndsB((!9{V9kJ=gYsJfo+08?fO#1=KSKz>x zJ0wGsDnMTI8zHGGbwMTlu?Ds3Ju1}D5+S#zuBY_b8dkYEVC?JzMxk|xhP`QxVyr_w zAQ5g0DNJ?95q43w{ecXyhXkHh%CkunRFlkH%@( z1Uuh?WJ~bUgn2%&Pj7nvw}8Fk{`{)gO_1S!YjYv|D&XyB#JA8$y0kQfksy}4d2;+r zfNMH_9+{<@k@N+JRuqRV{m)%{@dVbLSmvQ->uTAdsiUKX(8%z9ld?J-9~<~}5tUyA zLhcWahOGfgvzFzD9nb6S%A6+TK-|{gV?7D(YZG7<2>@?C1FTwfzgvQQl5Ak%?^Y!8 z3eUj!FW}`r)$H&j;y>H|TPs4(TN+bM6kUeYo-s}0e>P1L$Q7~b)tD^@!}2i1e`%Pc zrk#YCl|O4WNZ`(5zoh%RgaR~#}U7@unLv%&`iq=-E3Vvr7{0@%D5SOMxrJs(>OL*d_db?pUPx739F0C`kk zLoi4)Km!Pn&Ac}IHNH<)E#0a`_SO(0dJ|(2<);Es)Sy>-Xrz2^4-M?uiNrtRS3OuX zTmH`^$)PK{l6B}!Z~EIiauIel4G_!7N=Ssk*VW2Z4$GUAI%?aD*MctX@$+O?v1!got} zp5+~OzHKpq)SriSk6sFs9UcVSuTjQ&&w8TCJS#Jb_?7VKgfJG0V^n+T!aXFDrkD~= zmTMO1j7N%7zYtMv!JDgF%&z7t)bkbO403ME!QXW)%aue=;AevM}UT$Lwc4(WB6S{s=YC#|T|* z^)H1wUsEa;KY>o77iwQRS_m*2KS>Z(F$wqEE0H@;V^%43jyGvEvhPj_56>!LE6dg~ z<{A&x4C4Ag2-43gqQJ1ayI$<~d2DJ}gc3UvD^;ZYpiPdgkipxqy~g78{}14%14}+d zTW`UGb*ocHb>0j)Y8j2RR$c+VlU)BWF4UDyaix90{78RO>0o&-pHLaf)szAJp;S28 zZ~#65Mrz)>c4@U2It8`nq7V!^KKYeu;FOe~egA%-)**{9ZI83wQf(P6Cr$ip0+0iU z^7oCIPwY~94E`b9E$DCrH_6Zj+C-=kDJXPK>v*^5{*kD6c>ry22yIb57@_~XcG;=R zE&SEEwS;(bXxf)o@!paQ%zUUT#TXXlyssGdNAH}A8b?<8AiaHPG&9jAC^f*N<#;i( z*3)0hZJon(cnUp{F>|mkw|8kqf^NhZOAaLgM|ttm#|i&#uOeIz@})n^G}!EBU@c`X zSn_L~4J%%n`lAm-3FH5l(xAYnO4dI?EPb2UX|NvXOr?U)^24iC3=EX4vf;NQj|o=I z&Sqbv%WMRL+ChPMim%R541GG^b-@LKkMGU#qoW44yI24Et~=0TAWRE_J3YLvts038 zgQL)QiZ9Icinrpk6EQWHQ}^p#y#00~C5#kKm}dk&sQfK*rta-+$GB)Wv46>S%%;*P zkaW|dvH9Goak(SE%1G2!g`{MdMR#oQ-k8$0SGHsMVQp0^&bn`;r@wkUf!nZ%KjVNZ zthMnansSnDV^{3(vMK?6tF~ArA6wh)zoA~yR_GdXe>OxlM0hvO5NkZ zkU)=T=p6L!Y5idftW(UZs-I5$?FOcl81#GcJT%sj<05`FPPxOPhl?+%AqThQ_Em`I z3}%gNT;T|;JNscE%ye^2WY7=yRkzhpJVc||KCg16LMUVci}x^MDG_+ZK{3|a;$0?{ z-S)d~pCZ*duRnGSlxKBTyu$fABdI(EKd{7zcQ+6#yH2x6ffL}ddPFkD3+s$1XSMdd zk-){7pdM-8Xe`OWG*`(2ouW;Pikd0@T}^v)I{q|ai4@Y~WandMW>#TlD}AcPr}D%u z>p^0U$H(5PPMfa5oy#dN$29hneImyJIzwW}yg5Vz# z7bcFpSWMUxx^H1>H>KH50bZgUcyeVrAncWDrWq7sUZQLZE5qX|&MRJ9NT)rlGMftW zt#ZGhe`-sLtf6=%IxCuaS5qBJJ=yw?sa&c%Y+aJ+nAfLj|Mn@5kWxkXs-v-D4f-m? za(i0zK>Q0e8GW=7)iO0{tv?^?OkCw#swefMWcbZ01o-$C)VY2SJKoL75>}`+h0@n%Y;T z;vLrA&iIU%6Ate}I#C4;g>icy`S!&Ygf4#=|LujM)WGDWd{!&IHSP&!iP8eaC5y7@ z`@nw~*>*$>Kuinu2Go=HNnXpJK=Qz`7-Dd&F$Kg>Q|P{ycFIT!@*P{x4^Q-(`-ld^8Icu!g0zw= z3G|h?sGNCf)u1!})cc;l|35Tg7*e*3-1b@FCR8{r*@nLVU^gv_bof$y+JZ)02EJb!`orG3dnWg!0JLK`Z+hrXexiS_%2CN zFXZ7v*@Jbc7>(8*jrV^w?~?c&z&-CvwkKQ<(ws~O+Sjgo4K{^*u9t>-7oV!@R|b#0 zgY`>ZSem`pkd4Mrjo(m=x6jnYFUebNsjFF}t$R})(9dQLwtL@BGgzvqr>wXDvwu)S zS=kLIMZ`+*h@G+t+qH;&&a^n{z8TezrKe8 z&z?Tn`}#Zym}1ByoQ0%i3>GoWIWVzOD!WYvGWiZeEs?769%r5|wz%XE-v4b`kNn-? zcO@w!V`YYxOs)B-MK4^Mw*bA<$CD$r1m+EmE3<7?W9#cK35&}YsxLcO651of6lq>n zHjU8;br^hkegovCJJzAgXi+rs(*raUkX}YukwkY6;fyNdKFP$Y=I7%Vvv9z&wn;{G z5G(2xW2@5d-gfjP3l*Qf9Ft>o5$=nq>T1PMmL5V8ovhrT+(rsGPUg`9>7ut;PwCkX zGwhRfyR=oDRpd^J_)jN!-5O|DQw!XJ`X}-=6A<`w@Rq)*bzL6Px_+=_D=zeT@y4k@ zplb19Wbxn5Nu0_?Kvur)< zVlh0opYB(RqR_h=T%cst`k@(Urz|-I?P(I-wVh!WlTDFXue`#ivLc~i8MnCI#O?~FRj z30eR3xot#E{8Y_Q5U!-26)xhPRU_han7vl^%l8cHDlBZE)uOPTe(k)%IIk7*KY&xO zq`tYLd`h2C4bAq|fxiUp;HNT}HT#^1ltSK3u=evtH1#&tb{p)25B)(i9sR)pXOOe% zH%m~aQ_C;zfoiPvl;RIP5y>1i0>^<{C-2$Aj9%g)Ec4Z#zLlD8gM40Y$K*GHeo)X2 z_gPPBMD(G~1H+b&R38E<{m!eRg<*9eNRv;6JSmRJeTPLr%k`(yf9D*WV=IyL)xSPVlIiF$vEWg;psTR4Q1vSf$Pnc`0br zU&2Zz&U>kn;m#{oltf=Tpn{W2YJ#y1DK6<<646Br^xb`%Fk!T{VOt+g*_GYo6i7W% z9j$qSwqW`#t$txALzBP*puLRoW0Xf%x0tbT&F8jdc*>(bM+)j-ntJFog&;{?1qyHj zKJ4Gd5PKK>SFcg%@DtVai;!nG7mB`iOq>YtyE{fTWX1#9;)BeX#l0Rqdhg=cGqo%3 zHDTP?iO`o(?!6WFcKGXdl!ipsDM5Sj7%#5~I=M7J=G!KZUho)Ty{dT-a*HJV6zPK3 z_^g@v4cax2x`4~KnQ7t?3@)Tl_*+dLZQA0Mr{-gf+c2)xjh;U+6?|O3+O5mf6dQnb zrTK696ZaQt+15N4D#$;r9c?K@HlenpibLGcD6&zJ9 zxmycWZ8Ut8PHO)z*e0Jb*y=qm_B9EYY@qBDzb%iJ66*CaK_Nc%sY0K&vR6WqY;^f4J z+)<^2x+KVV+g9Lw0QliNYKUGrxnBm8r*Aak(r4LRZZjHUC3vaZ^(Kw$y^(_ia`OVN z(lf3lY)PGK9sUiLr!1TFcL4PUeIF06vZTYojO}9JseGpqJHy|7QqFt{eJIngR zQHR2ek+Ymcf=YNCq$Kqf^PBW|MP>DqyZoOk4}VosKSYMQ#Tji?B>zJaFgf%qfeAQU z9 zB~EonUeJ+Pt=P>kg)f^sZcyr-rQ(UcSP9y;`7o^J8q%+HHn^yH! zujDYS52!(@L>*!rX7mB!~`IoYska?vY-|MCN? zG1lPQ2zPInq!;L(0;v#Q&yDT4`nl=-ET_v^7?srxBFnA|mJ4r=A5X_ci2e5aVaJ;E7%)jN^w@K3Ev`_kh8_kZUk z&bQBeRFW?0?8~MK6(xv&^Q3!X`__L@tj5_O6nnVyqz_pB+2OGTv_)Etr9ExAsBII z*qbtwQ4|4PZ7!?bGFTM}zF3SGnpUA2$DK4`7(5!JB2?@sg&+51^smNjUZMaZG_3GBYvv$V*oZ&05H_r2CQ z)@a96Cal_}mSe21UNc8`iThZ~9xie6SKauKU?H2exU+;Fb!#)$F^{!Z4DEGuLfGmE ze|b6=i>^&`!3ti}l)4n!5~)Ah2EMLbBhN7&r5T#w325!PM#gQ#&$WLJsWV{AJVZ&L zFbbt@1+TGL_mfd*i_ITdeCHt{9#a&-;c3uwS-$z9hqOA|^H%ph4bg7vY5`c#pkNXY zO)bX@-uaOA0}ITz!@=MJy1M{FZE-yZ|BAi>0BV(fN42?+w31GJ3EUtIyz;AJv#dO-iD%Js0bhkx{?JtLlXm1< zdAQmPmRpH@1E0coPKUaHw4hY=TN5ot$g_|%cLuNLi@uM@(stkJ^KQ1uc!LOl$@qzK zp@&ZsD%oh>m&@%n$?!PgwK&S7(x?GAJRsTq79X_DYlBgR4XumpiK5{!+*{*E|() zTbLKO4PdjM#2(FkkT1FHr&fcJ&pNS%H+=PccUeEbGAJBWpEx)J5v+ea-GWCh(c>v;0#ne;&BQ26NZwmSLZ5IW~tOdZhT2Tz?ZS0oaW4mgup7%vl&&VcS*r~2AZ?e zmO}fEulsoSwW(gmjzsfh%a&v25Mq)7wQph{Z}Kapuv6sa7?|hJ;)lL2Y+Q+jP6hnl z9+yB#Z&NQXFbQ90*F;+_x$^bm5+N~Cu4px9wJG>YzoBPM_`2zxV(4LpNdyVAD&ACb zD~zJr_2Y|dd8`LY2Y1a-2)m8^7E;La-*7NPE+y$F#NNad!fwZ_0mWeXWJeZ5X+>|5 zkuIw3_F&5E9ZxeQDuyd}PK%OW2|vvoM-m^q8)0Kn^;WAlK9X$JN@2Kv67_Xs_2Dl@t|s#{sV&)I%oUTAM{6aBh*-fkatD{*v~bj(G@E@VBPmtB;MMszC8)bX$@ zPAk5ddc}YvIq~SDBYYUFX-6j|a1PF}DGT1vpB&0l)xx^Q?l6pA9BV|2r&T~==KLid zPR=@uEOC39EXj_9LNdA4|YfyuZ2P|t4RatMxxtibghVYZBSU=g5ROh_Gh!`k>N7O3lFj<)*dRw&kiTz2H-sRV?w4qs#ld4-S zRKAY_MVdpbQLLZvb(Zf6t&hVaL80CpYk0j6fV(*zAv3|yjrM}KehX;r2>DobQD8Mp zT9hTt`Q!QvgKph7@2BN6RF>C}`Grk%7&uwbQ9H;Z5oRAn{Y$b%Z8P3XsmP8Xy2%DK zt9&y|Mk?66Qva)IBsRTSSJrR@>iMe%=1noONt!r;JY*E1t%^dCUB{B!c=4Ru398;8 zPSUr8g70Hp_n=VHQ`Agyy($JP3 zBP%H~C!ABoo5cNK)uzWr0al%Yc0=Y=Y?z$Km|tskxZ_0BY9B8iooaPwMclIk zi>0#XCo%gFnb4g+^zo_k94SUqibHyU=l=oL{Xb~ls(CzZgp;%EsMo zt)BVD!drAYqvBtD>2m&%yV=4L7DMj#z>KM*)KRg1?F(9uO53CP3lyz0j*ZmQIlZ0& z$EM8#(@SSEH!(F65OOhFQ2M-$krkkWCD2jC?UUwJ9t$J`VM$MWJTM6y%54WcQYGy7 zNJ8Zxb|g3KXduZb>>xc4CNOGC-_~#W9O!tVT^d`yp*b^F<;LGc=9eL)cSC+SPKs}+ zJ+l!TxXPg-Hs3NWvvWe#LMzO_Y5*EaXJJ0DIW`@S9h2A{tZ%neQh1k+3dJLoA#<3Y z!6m$}ltpXh+t{g4a^7HrTbk%^VZyAKu7PNeDUQL7Vue+`oMKQ%iI z8n$eG&~>A%kky#EIuY>z1K{uQjuMmsY#Nk8q#S2haV}&I8-r7h>c8NS&(2X)g-KF{ zQPgDr+9}_voC>NVP_r8m_tYrR4Em!-^1i7Vel`ia->I}?S1cXyYBKCPo8>%!?@$!W zXm#DHMdxr`0`G;*IJcRccQq5fQEQwjyeA=P=SI;_bj~|9veq{BfUBG-Fk+tZ} zWe{%#7dsMc+r+gZs6=%83TKux=AuEZ%@x1ME8%s2-~;o~F(J;{(V!^A=QMV7nx59O zIh?}{Y5Ie;0K%U83pqH1ysnJoW+o)hInFiq;8b8wl&M&m1e-JTj4?>?zye6@>1tS? zvS{LqH5;}KMl>B8ejnz&Pyq*7tg;<#euCb(`eT zmN*)C*oSh2aR4*bgpJB!4v^p-1@Y6cQ^zao=f0%3^jW7h zeXRC3BT&97-1j~{wE6V!6mv%51GR;B=WWu5V5H**Kh*Y|*0U1MwAnm0y<61a3RD?D zAW+79&~FfsnH5xu56Ac8MA?JqJtVy`NBbCyQ?{(>0`VisNyt1mgC}>t!xXh9lS6Sj zbDP{$p{|UqDnxdSiVMdifd$4r$kVD+*y(C(ny|{xk|p7v zm>Ww|W>Pe{;b|(5Sjb)P<0ZIkpdaK|24q%@p3TFt&%Y!)AO>3*=7ZbWfjzuIZgag1 zn>|Is>6~$T^m)!}Pk??+o=uKVYM;FCXG=z%xiX1DlCNSux4q8^m^r4lH_OL8%|{za zOoZ)_NU9?E9pkk!7O0zJVDT%J*T~$psX{^VmBFt-H;?yqr0oYbW#)7CB?(<(t?U`# z-O&u;?LlYj_cW?D1MyS)0Q`)Eu2goyo}F3C#)Tm0eb~@>N!$92T2_n^n)Zb0`t z8!xcmxhBEnS;rLy)d`hp&8Wr%CtfbcdIGWU|%YIVA)24 z5a%IWgepzkeN=1noLwJ69<~Wi;a0TQi?3;4j?_kS_!Dh^l|gSG(9WcD4Q1ToCV%=<5G>|-!vkBg3fklqJ4}l=SR{G4f%RLl^qk=0G2Z0A+K_cGX zRT)m4>Hg7o=!jFm(9%*+5Tx)W^k96RMc)%2i61;m6VZQE3361_^^&YZO|cc4eAL@G zY;=L;xJkykHIXRM=s9zRA+*h37AnlqS=_clY}VwJCb0|k6pzBEloaKaci^d-VMh!O zN-PfgoWqvEcdXaFdXTOdZc&r%RfO+54oC@(n0xa~l59|ltIu9X2Y|wzZkj~RZ_Es; zph}HMo5n`70@BDEHIs*uJhLX^p1jU!EV3AU7nKYcf4qBP=Z`Fuc`WgHJrwbbOh}er zC`WSEJFer0Hoa=rP_LtFHKY@3GVo;_euwCYeCBQggzC>sF9_T;)Z|fD#k*^$cLDFF`6(=G zMqn8?V-BI3^>8w>d?F4{%rY!~BFu(|+B>+9YR0Rj5toQeq87`HXg~x&qk`pFbd+7` z{M1gBPTpB8w$~22I;K&j|Bg&*ZEG}5J2T>H(U4$+7SUYJS#VI&nvL!BAol9MG-ye0 z)Eeu$Mxr@K8mguULLkJg%4*K>s2Fb0&dH-3LKI|@8b9j6a!@*1W99vlUjb`brZyg= z6gFz5KLBk{9xhv1N=s4%n(S0B;7B=Eu_O zidJ4aSuwXNTfz^tpG7yMsUyk<0U`7l=~&S*O#C9KNq!377Kd%P`a`@IXPsmsM~XId z1WKrka$REhamH7Iuh*U@@@?Bh^$!=%phRfTgwXG|Ew?C2PsyPL3<6|wOfcBaRpimE zTJbff;&CzfyI5#N>o@d9LaTHq0oXcu)$Z^&Z@y7EHcnobRXW=DTTHpPmcjDdM7J2Y zcP@@ASpNed_`grgOwYZGvk2Y0XS%HMre_oa51|C{AeyBVxl=D3WDK_;DZqmp(VL_|4?LZ`5aoMpbA03Ir5Sb zdUC~csg5A^ZRytoI;!k@)G?MndCsS zVypz?`1&ND1nU(|H-ZFNgfj6MWr$m%P-L^57u~UX^4j03g%;-NQ$=m5jxL{Q)WOA# zt-b;RgUg*bf(V1LyYs%Sd`m33(hREXiRYJQ5y;nl2pidfk;bBlJju}MooheuAMVUgksce8BXR#5GYE@`W~ zWneIQ%vSatFY!WV^LTYCP%~EZPy&kq4WRaW&nqE+(k@OMwm|%+$Ll-*qWO62MwXRYc*-Y1>nSi87huN)i=gFlUoYg>g z-7YR-!}Dv}7fbFQyv!FGRfRc7NH6?TZJEppS9UYaszyAeq%AIc*;&W<_3y z?kriqyZ71Jr`Vrj@lu*_E$$^$bmT7G-d4D3!4-=IY(e9O>s=Gf8>~?z`&V6HsiPb^ zFC5%x8DSr=)Q)5yXu zdnX?>l*o@=nE!$7!-kSdSb(y~-aOamsrSH3V5aoPsB!f?@+^kbr}W%bV0SgHEt`NL zTBd1~CVQCV8}-&YPV>@)2Pdmt;0BKarE{c7W&gqe|EEZJl=Oe^)U@cboAqa`B(DWmYXuu%l&rF4SKoP^Lwq> zQF^x|x3oTLaO<*mg)cFOh@L~#==g4X)jb&;x>rA?ac?pz)pum$k$@jyuim;yL;LBo#qhl=83?SU=nB^-=$#e3wy^oZvM7JRg3mm=f|Txi&*thc1~+k zwG#|KL2SgEUF$}&6bx7bUT*(Y%6NEnHivU_R+T?d?&`cB?HoaG9yM1#o!6!IUO`OT z@e80q-_m?SJ+Cy-&$GfXFO9u9Q~=s}ixl^^*wuIm&=D-Jc}GXQE^Cv`3EC62ZECuZ zicBD*h5(u^yAE)denB_co&=6j%Y)oz`i!OyL?+5!Suet9Kb^={xFbZmEvGT~QvxQF zpqv$8wxj$+yk-_5Y2CBthWF&CFjvxOOtanl`Jh4aUgR3wi5jeP8*_i zgolrh9Qid+$I|YKty}%i%8dbR8jihmoJLBz4EY401YV86`T{x;J6Zl`n2;Rr zn+hRxF7{DjQ$T0xt#H2B8Ke-vRdmH_Mqaz6hjGLEwD367O{GL}&b+6~lRevODSyGyxu1M67DF1$E zwgVk;b=WyN{=H*lpUW~tCU1H<|lJWrJo#6Sp z8a5>>6^opX$s8nnT;|JtU5Lq}tDb*a9;mXZhV$lCO<%PPmEGi_;WOwd-jSz~3{$ji zq;K9c-7e&r`e!1&o9voLw_=t9dZ%BLWY=*Z1dlJASSbEV-1YR4&YT3nzQzGBGR zz{gdMQ?gx8!wd4JW+T%kkO3t<@imu|{t`8irVIe9)$I#fDg)#g7jNU)zIQcVa*}!( z+fBNSBHUjb9d3{LxROM>PcW3SGVEa+R|BJB3slv)p%Q1g`gFQ;)|nz&HwJE{9F^DJ zQ*Ia^UpRdc~Xk&=!TzDxI3gyCOtFrYXO+Bie19 zPOLF%UAujlqWIyajZ|p7-A3bn9S)J?&L54l)nzTJWwO}bWJwU`WR#ejS67P@Xgj#iYgzC*Mh1yOri z7yO4{o_o0%70Raj!MY7UUIn}&LHm^At!p0AV2_gmtcy&JS`RXJKyKyo01`~X`&UX(S1vP51-)kHF`)BsqIUByRdmy?jC_!LUiCwI5Hyf=KgVwluv7b+^ic|Gr*=}ls$oZ%&p5|rQl<*s2p*D_)rjb06ec;50 z_g_p^=N5 zpqustG);DZxF&q20l%543#x$ZQC7B8e}+%su=VxJP=Xb4@aWP4SWF^xPg}{< z*64;bl)kRSbo@nHX+_9^M|JYS!~7#9GNGXUf9K`jj%}Weky;DiI`|%1-W#Ad=YMRw zp3VfGg`#|SMT=>bklUZG##of!eohmP~W9XFMzf7u5Q|p!^1a_iNE=&Ko zB8drVYWO?N{oW?zfi5JhrtNJz^RrLK)cy_Sk7S#+EZP7KqdWR9le5Q()r%oQ2k}R@ z#h?FX5T6S^kFSw~+151e`_xcgS4D{~5A{gH3~g+5PLJ|BP6sM3JSxEV6Gm z*7S;U?#0>oyYE?&lvxx%;uR|?m4L?pSAx*5_tS5hJG7q03CBrn>U#+P-}1cO%-cJ}k4C3^BJKqX=R>(7BhKVDgJ_0(jd*atl| zXD$o=)Rx8#{TRmDy~R3ricN(D%0!J>E(glTjUCQsPE;vXC_@-4bmnUUPJ2#?texaS zJMPC92dKpsIi6SPj&^}k$ZpM7Gy7xp2q^x5qdTakY94}(Nu3Xu=4d;!{7pUw|C;PE zK7<<5L797&$raQKru=fEpX4q|(-;IaT+Mn|M#D)?89`*nVSHB_wq3XkAkx`u3Yyxn zq{i%e1wBhe>*IE{Pum>s5-SW8I=rN4fWB+eDx+;F-l#I@HjJ4=a}FpU`J`t0)J+|j zysRJ~nNbGZ(5!)QXU9NVsTY!7(u?Ilr#xUp9^G-3<)wCgn=6>E4s9TxJR{ zZWYov<6!&SOfT_e!PI6nuuq^&d8s0svUVjtFe=$d)fem7t0v1)rH*u99O&x^@GMNp z!I7O+0q{OJb}!-E<)9$j*F%PozNo&5v8{OpWHta1y zV=#v{pCadUH9O9MF;Y`WSWbCF@QA;UzRkOO0bOi7Iynh4cDyyUf0@3NicJb>l5{bE zN{gZ$7{l#A@NIrPOod zt-aAnPv6h0+aZ1%J6U!&DT>~t-R$%NFYja#8VBRzHjf}ao+Rn6vMgV1V*@(y=`G9w zgeVXt5x|+hB}#`NTv_lN3Gbf`+L$jhJoQu#BZN5dKQHcz0o6}zZ^T~lwV*_UQ`ER_ zk8^akgEl7d{btQ$<3o0L^RvdZWzvzihFmgD(uYKXp*?{&w+_s?yOKUk9eG36a%ENo zk+pkEb{cb!2JE@@Av&aM0i)pfd&fbyh(BE#E4*E&i5*^iwAO!_)u+nE zrd6>eHumA`jhS8OX+=J39VY9lw)7-Vim!^r6d`XeVnv>rB}zAIzRZxyzmz~WpY^=T zu77@ITm7PAR2~#dv-uXyJ9dk?s~Een-V!xm7MQoczq^wu zrY!J4

Ty%Tv>9THAIg-jmuKV>Z-ko)sdxeDp8^)%tQd|V5*ES##_pt`YXRZ2EnmZ#FE-3f|Do= z7>G!OzLA8V=-5J>1E)1_e!_ni{NOl`-=IIFf6*5FyG@EW?IZQ4(b{L9u74tJ9DUs$ zzy6p;m;Cga?sG5WnBay&zr=ra%9XLOm*wXQe*6~X=o@OhxSyF|H7{Y?xA+HghW|8F zK5)1He`%1~$<812;zcAKt;rpW-(m6r=_UD2>7VWDeLJh0Dtit$c?EU)BUUtTkg0Hq zIC=wi_&ZWI+U6IMMk9J#Zgze9rJq59fAi0va&3d<*8gy@``?2i+M@rje$xMsern;0 zzS;dFG6O$7g9s?8`l=8XhouIQY|*05-hf3@^^%c=T1dNLd;U&UDqhX{=D=B%Vr?W7 zu^fM=%XIBal%u>lQ`!RYqI5W``Qase7FT?y#*U@z)%wlxV*U1mNje!m0;jI7i5o7i zTCvWi&c(VLwoh>nM!Ms)opS*ROU>fk;7lBXX*Vnhe3B=HLOWb59X8U%Rjnjmb65-d zO17cA;s(!o7HJyR4WV*}EQ_K#9`|vMkzp;{=O?hea^nhLu>Hu9dwf$vltCPoJXh3C z01W{f@OwW>)=j5q#f)QO$+D!j%U~SutAw1Zprp2`J05=7CQ7)C5%1k>sqA5czU6X~OJufNc>E58{VwU~nz4T{}MN-wUnpD3Dyi=LrIK z|6)UcP;`!eV<^f7N=B4K64S~++MDXW!2rrT41ZEq8lt0gaUHoAGbJxQ#@8K{Y6bKa zx_EH>TGV`@coo(JoEs-=9LJuBU+4(D2Ee6KEZSMlmPx)$sC4QSINLO3W%4dLD4)&? zto*5yd|6OB`)MPnQS@O(J6&GV+9KcL<=rh{ar5o%uDrI_W%;aW4Dp;wh>y$EgwIo* zj%TO$N7%-@m}NFzpG4KzX~yA{x_l9#fuZ4Xj*sTcFt2oI`=!!l7vFvbX|*d}^pCAk zT5(dtUxCrL1rr_j*hKfG@)LHjD-jJ#CrS9?j<5o0$$L(w<3!BY2F{IP@%9rEEQ5i3 ze?gk;+3Pyj$ub;L4|9$HD91{PbFHyoK{VMisW3eNCiQ$u;Sr{PHr zH|~<+J>0#EHD7#!QO`j^L@kriP|GWJy|VefAnMR5+5pTW=r3hhc*3=5+iv^|O3-w*+ zEsqSx(={&R(lj4Nc;pe&opEq~-t~thB=8-%uhlqU>y#pireHAUI5WI$0korQSr?`@ z))#SOX)6$7`nXX$bE$YADxd{MKYc5MbnP(LGrgDcKyyH|-Np&}FpC%*-|lug}9KS&Mv6eSW&d%n9w=r7b@qYuPw ztKI>4Jsqn?R@NRP`6mKJTRx<14rc1N0yoaox*J2_CiN5Q(nGRrP2b3kUM;Pv;$W{E z!Ug8PFTkKhi3NOMxbQzi`z1Kc&THEm{xPE^>`>BdvU6YDz6-AeLIb%T1|Q4lWo?{f z?M$4n(Jwv}n-=Y+r=P0OP13wt6E(g_j^%bM6;5@#u&v+K=S@XXPDis_Q(oQG8+q}n z#=9u~SmcS`&kV=6Yxg+#y%s&JdOzW@fQZd6Csld!QCXF2+_vaC&r)zK+$fa z7Z=w=`_B&ATq+#bqjA&uRK@&+s6S;$HP?b<>D+iB6 zQPp8Z^syQKgIOIY0r}-MHv0eJK(()OUYdL_P@P=Shn76ddMP^VxZfLYwa3`;Vk!hB zTr^x6hBzhedoh&C4y4lDsWrB>ALHWMMu)Uo+v_v4^UATJbJH|I@7Wg=)h32}( zl~W6PTMw4YHXRT|(q8QSbuINxX8WdL(oj&MwjM;BI+UwcPKSFM}Vs~VW(wm#?C?l5hIfrgrz7u<_M7^F#fGDlu)rv+! z>MzY?D~@TLd(~E>{e&Oceev$ik%i)Tz$;PigPV5n_;KoC>F5f8^^QpF&=IvBq&E#_ z4%|Rge-<*hm$b_0<}9Ie?VxEz__r_s3ltL2>!T%&Z0xE|&jRi#bk7whm9V>!(fKHD z2fKg7r)i>*{%J{w1(q^{=nJDmn5xx8@zn0f;)N`r(WGIl9E`(N8ViL+qX_I`ULR8mD>_8Y-Cs2!RC&utsuu>DWb`b1Pp&2V&3G>bz-95Lt@0Nc zO`D=;>!;W9^bx?i^RTBoboe;x{f7c`I%vdR`+>ksBT-8jk*8^%MNdqCvy<8`#`RKN zRa8_NN%wPry1=iiqH6q>T%DQ+pXj2y$BhRzsz7o)pH{utNG$IpqqLg@fnLch5Bg|^h^ zFDlo(IEJ$b%KrzP`~Ua@HozS0@y>j{}h*q*p8`E@ny+egae zVyvFaiQ7iib=%p}hD}keFU^4*)y$OEX%u?Q$c+O2T`hXf{fLkC=Yl8uP(66}GPB}V zWdDdY?}^y&K=$}8=fhiU8tFl9^un%k@b7jeY}Y5%|L z2ykZhrY^3|W=3`hUwaP5)(Ff*Oho_q&+2?+c%9$!3{VvS9Eym1uYRgEWE5L6~f-|XxHKLWm07Z-U2hLlJ_VXWKB%WmAKOVck04;t=nZg2LFFKJFd{oO75wc%s;$xOpd zBrIBeM~3y6z|e3(EuCfz9jB%Z{^g|QAgomL&B5XAgVtjiOnRLsg|g#HIvL=vF5O6x z`r*~%N*Z(>zHa?L4WH|I#J_R2GFwa4=F`41NEk3}+dnnjyXtK`iL+Pg+I4gp%?j3o zd=V^SUWC`nZXOptElxt|ir=1ytBr8=$4C6x8RPM9ez)ne-#~$D`m#7o^$6};|3&0H zclwa@U%N9*bNnz>;H1oPcU14qrZXq~!51jL(yno0#e`LF)c9I!3!+P9jR$I#vp^oQ z_jZ1$3}bU#p{X9~_LNTE>W4U)>Td5XifyJBp&m+AHzT1{fg88>6Ux!%ly7<5w*%B+ z+_wCx^G|lPR?NQ3iI`5g_TLD!gr0i{hI&%Z<$h`lms44L(!V$txK&;y8-+>iO;wW{ z_-@18y;_|i8Inqwy&J!`GghsytFu-+j=JbpXV5;Hv_6p6EbIi-Y+P#JlvdgxckdBy zNHHfze#16(Qd8p#*VIYTOte`Z*-rmON5DF~dbl%4>ZmzQ{<^ZQhUvCYvLabnBg}$_o z7?NdLUAxh-1<|3oq7N2i^kkl3cIR@SMjm^{@js^W=zz>OwfqzPS zix4CSjws;rxRTx)=y|pNF}x6NOicTW!BBKMk3Y)oOPg1YukDS{Qf&oNQA%q*cc;hT z6Hc9Q-M}t`?!<+Oc%P%Ba))s+u?@Vd<38v0hF*6`Z(u&$b{i0oF++uNZA!a)2JfAv@hjgCt zZ_>gL-j=q9PzualWvN>_DR=hbD4^R{w~b0BMJ}U~h6YL$D9=?e$P_c4w7zvDV6d=f z-IC-slA_Ykg#K-V33-T}PGQ-)i-5e}TZ#V?B-tJ;)H}=XqV%qx_(3DTGejWgUNA>E z(9z%{R)bnR9ibO_)fuj_zb2r0|7-~(2nCT#v6#oVB?#I8xTWaM)8ctC8mtO|J`lvc|cEghjB1x%P}EQx}JaxD%{v$ zBD!<~ZxDPI{MXYWP4^z94x8py6#en$XWi|Z2Xdnj)hyX3fYo7r3M*1C_=3>(34E|; zQCsi!gF!y_I{;S$;s-_51~Bc}KTQrf=*Tg6T~R85U)dVJPIS2m1J=R55j*E$IE z!dpLhBN%QNYXZ>!@ezJG{|Cv8MIbSaXu7y>7WHbC8R-Ahfo$0@oQ+Jk?b0mb5Rh~7 zjDC55+&)gW?@~ToKGq7mrSa`*OHACar~f`oAI#!wxdu&+`hoW;)NEL#t8Qkl9a-k7BU&Wqy=Z24 z$v#f!bJ&QR`x=ShX{~gLmD_P|NW6Lc= znn)-APP{JSxTbZ*EU|ctVOMiD+r`42V#w*~zzxZ)6&1W_$f>eSZ!6psDz?gUEM;Mb zAW)Tkk7?w`fO2tF*>dA>m|q`UYy-igG*t-)RUkni7N6;8*x%Y93LgcuOfQ63 z4`&!CEg^Qb#KXuQ8d1^iLeLF*$>IZzNR+c?28fdjI{Lj@EMN)BP-TOLlF%YUd8npf zXPK;XhIdkFR5uj|asy=+Tg;N(uKq%&2Z+#cUjcNJ(jG0kLGz{Op$$iXrqb9Zm~8ZL zi41v=(|{FI#5DA}BZ`}bs&WUOVa8L#WUlg3r)Wcbqdsm)Yzl_23tDmqay-#qNnNrF z4CgeI(5xXqx~3}nQu>p~^@|;+Y;mMJXM909B!M^$XR>@?XXc(l^sR2OXruTn;%~d) zqdw(_v=ZpDl3Y^Kk=sBqP8KNyrHN7iPsRusgzGDatuWIm?q8TQZW5UoBPlpu;LqITn2Dl*fTjw0N z*&hMp*=JygDeFE?g6uWRsA(*(-0M;>CA%KQ3J ze_~>SP(P*Q4+=jzPPg@67>nUOE?6S36xkUJQ0jCgFrnal^sy`)+&M z5Xrxg0Paxhhy>KeM{LQpTV&0ij|S+*g{0c%t?Pv(=S{KHxHxs4)O_vv=q|9Np{fio zahAG=DHEWXT7<-$D_UrZdCxejAZsZqRqJ8JiBehbcp0{;V2A-(>u(WF$;M0-)nZhi zD16#qQ0LbAnN&>`?DR5f17d9bx)NF(B|f*!?WMy{Vr#_9if=$XU0^;j8s* zZ7An?*WN;_0K*Z|2jkI~wP%Y{_HeR97SaZykXT9?yEFpQhrV>iGTX*MM$nx~*bcb> zOP+lM7-IZ6#sxtDdQsyoWyh%$e_21z6ZlU1BZR&Dvjxc=@$p~*a}F8`g)+(sHmx|V zRhC>cda<8(s}WXuZ(~)}q(^pZYbpE6Wwy?TeJA;0E|5aKSgDIR8Bn4_IEf&{(fXS| z!@opLuO!v>XZi-zyVW7q2N&{T35m9*ijG9 z6hFEXcXE}sgdLISx&|A-5Jjk237BmnGBRI&VJ?|nvD}THp4sCL+JedGsH1oV<95uF zaz2@MI3+;HGM`z+JUT_6te1=X{N6J;^;k+V3r$et2uR~;Wa|9C*G9tfsZJ1n| zYY$SFz*n<7Y9(MzLP8m%hEIlM&Kzn|kmy5Htrm=4nJ@x0o*CWj(FjNkl1lNzFW<@{ zwMtREa&HUkhzaBrx*geaN%PFGAiP zZh69_`~BL*y$%#g9V$Tc5;{c4FDm1jV-0Z4`5}Z-faN>0T}a=Y!syhRAe)_-E29mA%!DY~SN=l-IhplWbvRa5`-&%|;{Vi#APqe7NcZ7#yiG z2Fl(@80SpgF3$JYRaS%u^#?Mz(fqpGvrE}O&pWpI?OD&j7mV&t@1!@aAO0Bf1^#t! z$S%iBH$OLjoY`FJGfax3i*Q|+G*RAsx$*tcZ~w~RwACN+HFg)zqQ_#@++`f8yCj`! z3dt24b?^Hp!q5E?@pO8TxX)BsL&of1+h?{Ie=??@&3Yr-Ql@72wfTtj$p2M8us*+8QlsL48sC5eV6R z^8((v`hzms?S)fWGktLpM=bC!C4|7;PalHvy)--*X}bWi0ky5%nF398CB(NwXDZC- z+an^qjP#uE0pV-a)|P&FqBxs-EkrpVi&`neG`VF0C>U;9C+BxD1HGodsubEj8>aLw z)hpNEDn#f{d*tm|Ve3AfUxGfC2H?l-Jt0RG%X&y&Ft17DNT+kCF7%awBYmCzVY&WV*wQ|$o)W|ZPR&F_eVodX*!rw-ihL zLS+}_rgZSDC4(!O;Wf#;Elt!4`HkmU-idWulli|Ll6RW;0%q*&9zt>WB;9Q8R zbSfpdznxU64DeZ)#*I69ZdTp@z-RHq+8Dyf7oU?b@8Z~0Ot%0WW{$v-!Ub1s3G*TQE`WU zZ;3_hgRoK3sn0ZC)m-?!OI`Mm?+=8z+DlC;%c?EwWf;~RIMDz-Oydw$(0_>d?<&i3oA>7rU7(`ETj zZt&q(^Y`3m3LOPj%JyTPmnHAa@okB7LgTtu6{{mdl{y^GRt90c@{3-=*Qn}8Z+S8o~s7}f&N;;&* ze+aV?T<17A$e&O+)?gRKAIA9rZx3jEV@r4U2DNrN-yY0~*eY!i@|ZSwakVu>`Xke= zK}DizigZZ#o^K@#rwC=wZr*fG=HjZT9)iq`5WS6Vm`5Mi3GVkD`{kI8?M(_1^tV^1 zYiQQtep|LrQzZr1aR~)5;soxWNO@`BB@T;8FtzaLRZ2oG*CK4FBWz#_eUBWX0)}Ij zhB}3l($;2is~SLsmaUY4l6z-21F@T5IK0ph)^W_OnSz5sp?rtLISw>M971^90d|y3 z!-I6;zpa{QBcyS0D__)m>)axRz(yQ+$qxE|)_6Z<+f8P&p>x8tFt15z^NBY<(=*5u zoBinPO`t#P{94yDD!ckD+APhC7iFlu^yxRXh!M4Ji5T)6vZVXOxurY%<41x^?C+i@ zkVUZ@bOV#0ostpgSReMs$szI%Znu>u@uq9lFVP9cyL1Jsq~8b1Asw=*(-*})5H$n9 zhmO=ctR_$i-#H;nQOLtVc>J89&GXwMS_GLxSV8_iM3SOAbQ!kt)l@KE>Db54!Dv*8 ze^A|k_x?Dt)ZU5ASQ%1r{E;y?Pp??sz;jw)NI(?=Ed$og6_#U2Xt)wsH>}0kvQ`L` zxO~f+so2o+t?M_+ff&_I)bWy8#oH%oQbXHTZJ3lTzC3{q$eMo zQKGe0^hic$_s#`L?#+HmhFN`B<|S5&Mm&7s-p9`|*p)kY7FT)Nk4RA4)oT-h=5Ws5 zIE}1L7~>>0oi>7VPC+7pTX7xh59n+|X4@mZ2%|#w<6YU{U#Sm zL|+3zOL>bIl|dYYBBPu4_h!~hC zdv~ol%{agv_Yy6R+4D)9|5u7(XJ;$YSt-#{*I`QHx2goZ_IrBX^Lz)R#r`DftH>xn z56m0tG@dQmSt)y?rf|J!=kuS#{9hy+&Mg#fSth1c;7}^G$lSph{SZ=-#z$aO+*)H3 znGv?zWvhm~D7&4R@G%Cqd;K&~dn9PWdZFpN2m&G@kC!<7{lKsuIq2U!Ms(u>81Avd zu8E9>JieE4YC{P&QW_j7wYipVz$AJ@)p@8u(N+d4+;F4844jQ={O&gd! z4OPw9pX9KmKXrAh7<>pno62;)#`EK#a$4xyZ(i+E=BgN1{A@v-Uf^eJSdNZOAHV0y zI>8^W>L)|QibxzMO4KY2TrnhWpe?sv?P-qQNO&FmAO_zYZaML-(~a<}rn)?u850RF z%YiuAfX*ac(G2!vS2P@qS-}sJpdftDMf1Ua!aR8`qU zm2KOuzsyyuY}>YN+qP}nwr$&XuiZ20?wRcDPA2JOPTqs>=s9`w<$15%*WKqtH;zfR zpC>RL5-^xkp1)O-qs4S=?OfkKBc0Zv!!aYBa%^QGDn{+h@vqegl=HpMn!Pi;*h zFQ^ax)vRfo6M00h0u0rt_HKAL$z$9__8ZQ}2biE5+WjnN*twV1QX;cCkJLsMUCUdyASQ+va|k=4$xHr8)&Z zp2ZSqcB>jyO09;+9v=FU$oW?4HY(z}Pr<=Ef6d|2M5AZCk-bx|6w}Kd!+l=!$N07h zBSPgcMB@qLL#rF+XI?-=IMXJ$jB>i|?8l_@(heb5kD>hqg#+l%Z%8^{&U%9ASSWCU zB&utf`Nf&(nO?l1y05pR1}-*vbxd+=#v=nTHa-!5XXx82V|)-N_P{1 z18nbvMOKR-48>mlGNf%BDh$RShltVchD~6Vt2VLvaLqM!QefWuvIKn*xSr06j;6$J zW;`oS()}V=FPF;J18{n|{sWy@yjg*J3}oc=ow2FLF5A_h9Kq(CBEK%bWO(1x3U8pP zBrm>omaKJ`Y!I$Fe0$M!o-}#v`R>aH$lXuFpH=RC+{AxCQ=RvaGiD_Md-&rPSrV>i-jtV)`#|)PD^9zsFH5OdS6!j>=Tou-{-u@_JF( zHL57A3MK2!U`Y~Bq9xCm91fpYmZVBrgIG5#w4{+|#^XqMdk33E*QB7F<_#nA6V{Q= z;bqs!&eRS&nUSGCv7!4*rQONilNyn*aKwZvPs5ibIZq;$q`D31`ATIxR*90JSko+% zgp?$iz=S?AH8wK$IIroiPu%*gWQdr&a&TPX~w;2XJX?26jUmbCd% zb>V&HU~KW94nG3|m){&OJI)WHVYqrK@~G!g=gZl`%J5MD3)^tJ!6^BgwSU&=Ip&Up zP3+CeQv2xrAez-l>I0(tvwY_$Pvdgv8lI(j|7d47RU;a1+6sF#cze+WxO3^dM#D~o z@p%iE=Ez}`a~L#d3*1wxV)ub(nBG#)$yaQTe$xC{vveCYnulYw&p40@aG&*t^Cxs;VInUb50F)z|Bb35D1MT8UQgRd1DK~L_85+AL}=5nwlCWg3&ak`v)GI z4ojUPilSIRqSZg4$O^aRqp#nE7Ta3ASXl0X_)f~Q&Ll!Q%~vYhszRWKXim#*fTaOg{#vh`{|eW4Y!_kF>12G?MVdv(P2r=lQI)wpmOc4rk#y&oapPsf zPrdZzAdZ;tZ}2J1+^TP?f4m{yX6@0kLo^nX$;z zej-Rix)g_@Fq55vFv~S0`T&@C>3`iL)xDbNX%ECPTiI(CxROXiX8MxPmLHJFOV|*0 z-b*Z$Cd_;}^zUlSx%C`&)$ zJ5cdd1mv9zgAM)_=YVk9-~{(n`D`C*k?Iozje!ZaNCFXw#$dZ{}XMG85=JCyo_Hb%VntL)=y8rK z-rl9~w{9uBso`VC#_1sItOiuIV_YJ}ruU>1daup3ZREqcFL_z}mUykQ1(!9juwSVc?nQ_s zHETBI@hcBIP#k)Ry6Y91ri+=bJi4uvX`cqC3$mm;rhQJ0K&Rb^#me1V-a!ZW)@BTs zqrHeuMzW1Kwv4fFPN-gIPJH%n`f^+MF1@J&MEW8(*IU1Dwr~bwuelH`?sxy|elh~e zBZ*><3}mL71#G6$F?i}|a>i3@>Q*U@QRSIh%fJPVD&HE~2Vw4Pld#DM(Qio;J|Z9O zJ=$0}NN#8?s<|Cz<;zUVaI_6Ll);@Zm z)BvLcbB>{#fG0syJ!)SjIeS6yaF#g$8FT4-5l)zWZjs6ws=1ETCbc{Elx?tsMi@M5 z=&Q?qeO`*n@9TGVEtTejly8Z0E_$=)1eZLDVT3de0$lopG>r-z7I|Ha_EK*u3g*Q^I#FOiuOoLDpLKIyk`ULu*vQ66 z@tvfhh#gzT*UYA|cxEz2I!^l*$!F>!v!@$#qbb5Ciku@7c<`OtKzm_%%`;5qW)kV^ z2#fajx`f0|zDN%S_A!5lB_o^vrnEZykWC#2rq(A^#h3&q=!|Q~H7#h+7ac3A^=`rT zI+u_hO~~%3qP%g#049DkD$^A(RKjRouJ3WXR6UiP86v_qY2p=(6irnIhoRI@4uswL zE#1`DAD>sCogt5eQpy~u2_5M2VZh!lDG1PbGtf)Z6t!yrpLX%?Z}GjSHR{IhLef)! zpzlO~Nj9x5tQsL38oH)|fEWgjS92>60wW%J=2mGmgoVh^7dt08+e|gz?%DuS(8F&B zd*NLXXdKX?2!Zx%gOHlt2o>;;A7I+4ETe-k?SgTCoNoZt+FF0nDaaE&jerB2obq^K z=0AI&&M{-oV=BEO6EZERv5~dB0xGj@v^9YR+wT5FS%xgP8|Pi}5^Uu5dQz{l^u~P4 zlp>c^j-fKig65$@)|5OA+q)sha)kt=yRo;^<+ysP8N6POSG=3`ixTrDn>*{G8HHm) zJ`LrG%>^zs+R0;^S;u$=3-uSu`_x!CuxxSO0FWXIe=|K$5mU#FDp2;$58ePErRgv` z(uX(OTq#+7>D#qjNomzfM#3pBVS+D2Jn5#YG=bA@Y;LjT&dCAjksy&KMwU5V6h8h; zKwS1&fX1B(f7)H3E)it4ll9&kynUYa_3Mjm;lAC%hQY-`5Dv;cuQvVI6~-++sMinU znSd^wP^N<93(tO^31g}BlI6l?$l}tfdg_>~I+?8gXJBC-rsklRaO%L#(@JdC@FO{h z8d@=CzD)bLZYQr* zHSyc}4S1u;6IK)?rPB#@exV!6^@lYb>8i_EQL7UAuR3;} zZ|+@x3N(`}7a2QNIn|?;z+2w&@Lp<%xLH{LP?L+~F$-CNAe9$CBlAgMsmh3b*_pga zJ%wGygz`jRwYtmRdwAMupxk2nDDLqsBK_Y@5C(U?h`_`Nn#gR4~w# z^PUwG_lx}+Bib!|4>Nfuh`rqHJt{YLs-QKg=*PI=&=wjn*Hdn`DN@QO zOAoVJm_^Oq@|czGjwvSG0DwV(#B)b@H}dZ+*%Yrrz_)$i-x&;x`ik;U$>bEhmg+*n z@IqiAY)<3A7*bc;Q@4>mP(j&pXgz)uJ0JrNz7nybW?kJ_1<{7W8oQhpvE^ebM8L_~QE)LXN zXDxb2mt+6D{ouz*0N2F8oPI^n5al4vkJS-oxQ1o;YunAW8j8nQZl$GreOhFZ>qCS~7a%rr6xyuD9gV*05OEc1)<6FW0*hB0 ztW&M>AdH!N8&1c;dg$kzG9EOQYWsZEKqM@gNT;jC-)sN{p8y)H zNSYFv&*STCKCgF2y4$0PSno|!ykp?D1BZ;#Bp58#?IkC}{t?#Vn&>SwA#UDaiZT+o zo!N|EXY7G*hzTj2K)-H@C!yv6?PI6X*5;jNwnuSKe=B$@Q&(UvuBqVI8$28`57LCD zv6bL&t(UBD^og^{pE!3RX`jP<*v%?SV{%~tKCXuXR!Cu}OhY=VvXs^~Z>X+M*Mm8N zMe$s1mf}Y+8!}rWoH4tL`|N>6`)_9_E#_7^~`e@`WRKCO1ORm^e)A8*lVEPgZlr{wOHyG%!E#} z)i0=uVemQ`Sz~BlEg?knyg)n`Qh?d`G%h`70QLHX>&iLUu*Z_-C;#@(-yQ`8b%lR4 z%t9ar8DT_#2~PeSjWfy*BGkPd$85lM9|8%*DIUr-s>hBKXdG~cssq9nWu0oHDTQ1I zA2QEPVbhP3CX5hMrT?6Ji3}vBS1GBTd?4s&5iEh7W2EQ5+oJFU%`xS(@^)VI@@MeKiu|*m&c8l`y z>K*GYf$dai=NBujLa5 z##gLRaJ&xXM#_~dmpV5TGms!djF|Tn`{$e{=PZQ zjlY2i>|)@Mu}Qu}v3zGtQc>fQtWjViy#J(Y;q`7u{Btr+5Z64dg?~F7`-;h4Bj1Hn zP)!zz%9%LTMbi*F?e2xXiA^$}g07H@!aqtggtdN*(b!v4iG~>|Yb$3+46bv>s5Zuu zCfkX+%v4pCj10^~Y-S%5yG#b6rJESyot=&1BFb5***}_;Kl*87#;f2@KhVDf{lJ1A z&f9rNdAyQ$9c1efg~i8nIMz+R%?aC83Y#l$#t=eYj%1Pe`}=63y(%zy_KSq;nTKC) zAK1e)J?rBOEOC8qVP8%QSt}H8emh?Myyl0KO)xfJ^U_HsHs`cJD_EijE2~*S%WI7< zEiq|Sm4{*&oc6Pl`qupQIt&@em1bUf-*2e%4C#;xmb@dhW1>!GRUSqTi&R)(_(CuQ zl2fq$7}NUhG7Kye7A5j`rgHVFDXLlc7NH=*fSOc4kc90lyK-XJk)ds#Y!l=xM53B#6-L6jD@%q9`4D!-Aa2S zc)cgwVl(Z-oPm>PaX=zayc-0BfZ)-kxj?QvrL3zap(=Tg4W*Z8R^H|xE<-Nt@uiW% zlQaElreiIFK2|WEDtBG?V1KdE8_T^CtZXEyyxw4;I62wrqtWUOS1|a^x6jm6(ud;waEOo@uAr^cHSN-Ifef;$W$9bz@2^d z$1j+w+Ru8R@yvM;w+*Tv{yV$n-O<0cIE9c9c}1Z2^hMtP<#7r2>jOSKVKUlh;ig7@ z$I72*;E7YolBxPt{OizRd;)Ank+Ef}PO4fn{in5OynTH9&rt@a1~wV4&r5#oq=YpE z9@VNo>|o)2LWqI^N6|5PIEvOd_jVUmD?#{Qd^e)&V3n`=5Q#sQ7p6H!8Rq+q75*7Y z-`;wbpb<*lQAdq2gi^y|kF&ba*|~9Y8JiPk1=bj-8#Zp~_rOONc+Z(j2dtU;ZiQ0F z!J*PMnmpyRKI5M9DaHHkG;g#jIh+*F_zH><<@M}%yHFz)jn06gOZD_%#LB&`3^A4Y zU;Q#tvIl3s1waP^*jJN&G*&Ns_LPG;@g-p>rnTz3FlBZa%GI)4pmH%6dn9$ImWj+X z;DcOz7yt(s^Q;VfL$!NuPc?-Bn14QBYEex6BU89+Tci+X*hHR2PQ-)Vy2@0U^3Oes z%JY8;-jM?wIQn*&;JG1Opo6_|HvcsSF-&!R^eK)~l(|D05*%pKmLApXL@L0022PA?z~=Mky(v;s4W z)~lAY6o=rk2y`yZPcQeD^&B^CrpllZ*>w7nXjdWGqW)vEUxf2f{iUAgkan z&MN?sia_DN7Fa20jQ#1TT)Ow_%hoI6KPBsGkc&_$Ia_$`^vfav1a;1D6`f@04iZR| z4u3KUH2B*t{T!78Rf+uLbE!D^+vLp8lBQC$exPgS>|gEO3)G#>AVNxh(Gk}zD=oG> zU6~I*?cIAzAtIkFgEJA5Fr~X)Xc?8*1Tt{(QFBYE?{RQ-d%amS+__t_- zd*jQJKAxH`Z)wG7YnF?%O^e`Fg=g5jj24^gZ@&eg9{T4(+lK=nt~Kn%lCL}T_)w{q zT$FtYJglj;#PN{x&+sehfJDu7;z6{lTP1?!d;JoM)U=fySKN*1$-sh1UL<;lZ4=bN z30+C66JRoTnz=R*?iZlyY|JR(u-AEWm!h-UWW3f#4%dJL?Yo%O-w7%R$ewe*Sf%l= zygF}$N?f%~XG{Mi0z*stEz_e~rs7Qr*o$L&o9)M2$;ih11&A8Ugq^S1i^O&Bo>vyL zHfkGyu6~Nt5+UeW;`OT%r|r;%U$3 zmNXGdEFCL;X?zaY9G}rZ_Y6&V1ET$UcH)Dr zCvwt5dCMeRM+=J5J2TSh@$YubIjQsguYmgerb?IXd)|4oiV!!|u5QiWV|=(8Ln15w z6ksJs9jtE`qvAk*4LU!|u7-dfIRV#IMTf2zOTP^iD!Q!AD*6-U{~^N)R_KRl;R z&^@1TE{Vx2Reok!k8i1r&r)lmBV-h;WUQ-V1I(-=r6$+x9TD*s{chAWjJATY3FD+H zc2+6mP&)i%D%s$-o7!hd<6vJihov!GtO=cHa}ZKGI%XlNOQRNhpHqzrV@O`0K7co` zoVBr%9N~7_wm3PATsGD(dc#p60Hn>0*7*;>$h6xpxP0OQE8ZitWe1UAQ~1a7o$9^* z>OenV*TXeRdd;8Af`U!y7HSHDm?_6kB$P1&swwis4y+D})bed5hCNfzA>BP9ADQ6X z2;+m$ML-f78z+Lf9Ma?8!tfS1Ase66Le`+dPQHdsgEd!&(_TQmO+#dxb+tnLHGIof zwhLOjh(gV%q8%fm-1a2azlX8w)SU7apNMHJ)i3y){uO`!abwJ)Eoe*E?95{;KsvW} zOzq4*dF8=U_(Y~GG1^$0U*6N9M&CguhaH$+S#a><=G%+VU`D_$VduXcIM$QN(={(wcOUs7HOIuJM#e!ZF*CwVIIfTiI6u~f2f|F>&)x*_NYHPnXRqWhMSFOd(7LF#fjdOKE~0Ve=N^!gJ*oex?|O&4m#CVXN9P?qX3n!((z2~OaypOP{})&C zB4nU$DyS|tj$~&FN$C?*qQ#Cx1hNX)7;QWu^h(OKB;}4Tnj_&Vx_Ulf5n6a1fKP8F zKz4&EDhMiVKPZqw!0yl~k|wol96GHc62{8KPtq@9@I!?Fg-|+(=JN50hdSLVl2+!7 z5qQi}W#7cknt0D0<809=a_j-Ysn>}IW9>a*VK?l*L#XFsf799 zz4N8v^XAOGSx!HA6iHx;bFCC*ne*~z>}l}C642f76RDXao*E;ULDQzM?fej;etyW; zgsqNB)I3O^4!oi6ykqeu9WPPI+KbnlLg0M!(+}b#>k6(_Iv|KX>f0Bwe4|wVV{V)$ zY$p1B9}HKs_ipFI@fZk*4UQ-i2`THKr4|o6>}lrBFE*dn#1sDKfx#Z&06hB6GijGh(3DOVT+LkhtTzedUQ#GS z!^G~ZCk-n$RlA}ObfQl_~(yv9Bln zLrE`*LobPQ?;!c!zk39kjV>X1%OR~*+@JKWl!E@Z3JX-FMG0FKR20SuX#oBq(eR%k zt2EztoN~$BgGCHf1ZgJFsFCI_*G;@0SiE5r-SgVDlb-~XUntID;dV7;j~uz^!u$zX z3khlMF4np$(RCy2M7o@M*69T6Gc7IYO!X(^v`|=SS1O(CcvIn;UHg=b>2+yyA+oUU z9zwbVd3>DtlVAo#w^pZ-~My#ac=nP4v?nzNDC1J#$Isuev5;R(NlWggCv~ ze^r@9?@tSGMn%c?pJGi)d3O$`U5fy3o0h{(+CJRcHI!K*qiZl4I9MC!BONts73cdets6 zax5)5N(j7}ypRO$+O4B?5NP@o>!c@lDw4_o^)u5A`H};rg?o`4_5qNJjS^#e2$)CB zPCx;dowgSNNOdWXw10K58iInF{1qM@RcKVg-6OwmKUKgzl!Ekh<2Tk3odg88Qu?$h zOeqE^4YoETKf@%f?;z4Tw3@U<%o3FFW&v$HV;uT7-A3S4Mwk&)5UUI~(Jtw{jKLkT z7)!@YT^dD5!l~{2s^-_=D0OSt3&BEUbVtB7E@v-gp42ZFOaldl3d-nb?8YCCjhmQ^ z$@~-=)9ppd7Z}`;1{$ga@(?$UZJ5AVX21$>K9Q8J!~NY9N`)=fMY-E6lxUt*TKb&Q z!NxD2EnsnhO?=*iI5@uM*E`J4K%mZE;Br~T9N(0lgPx{6fnwGz32+&Bt+&myvRFe=WuyzR7*@C^-Hh#dF`fz6tW=DOvSrr#Au7xi8g5ksM1*y+SwZEOeLQSBuyz2e-(}VI7phI%IVH(1x~rUkKi+1e3)={cVaL(BQbEc;(dqiuG7JpIBW|B95{=j^EKi zKfggctq*}hzU^!OCxzpW6;@DvyNrvrFX}}-Fm2O7Z*mof^LOf=TacUf7wFq#z3DkO zOsWa~nT1UlX8xh9L>F~h&~s80Mn$rpF^}CN?Ar zrjLoTazrIS_4tXmaAh>VQ|@$d0yorOPE%kSD~QEz^9L=#jk<0s zjO*0z*?BD;Cf~{TQu}$d)k+le_4bFOCi%EEirDj|CRL(*5(Qnm)47duND1n!{FI*q zmHL^m-50pEf(lqQZGH8=W(KDC<02cp6~zlF2<&+7>*<97M2bvZ<4RKwiM|AkBN;F$ zoHX9Y04K?mbybaPVUIVJ9C5(jZrYNW|S;3t@srk$^ z>H#`%5#Mu!*Bz~w1nF|D1OZX819e3~{l1x+-xj4@lTb4SN3S8sf86Bs973#0iugHJ zCC170Ijw>TaiJXq0LHP_CLxoTIvTu%J|M@VU@T$3^IsYxZ>hkGfuVn|Y2}Mow**hO zcOM3*!d?GL+D&=cztOaz__X}v9)~Y>#U?BD@m7E>acP{)PCo#DL`U7cE8So-0@vBw zD?w67pCHPv?zmSRf2oYZP{u(#Q+^l}NM=-=7)F?0nWzIhQ92D2N3#(yP+|2kNC~#= zjDQht)GpX6bBa*zlhPa`mgwQ zA-cm@A(W5ohFag2yjv@#E4X>D={0%3M)=f_Z(yGAh(qc=Y~lBDUdZ0%K@Mt6lMi@( z7&CMHWC6nd^$A`qFzPWTKR(0SzVF}i^}>zMxWd11axVW8TR>6gg{SgJ-03(=Ny<9* zis}8w1(*3eG~t#Flxg68vrE&I2^j4>zN(#hRf1|u>JwoTQ}X;fKn0N^yqMKfWVsea zxx}5F`=VzzZdH4+C|=lFsts%bp`t~kYvcA91OOdBu7srU@SUvOD$%4y zA2$me93a*w&Qld~^d3h6Tc3=nUVUzPfh;>Io$%{*?|I$pVXJ4eLS<)5yQj@g8-t-Y!jP4ty{wGFoE}ZU%s7qT(y3gUVr)`Z;XR!*me#PzF zPVvKg)ry@3M_Z3x(*lIfJerlJcc-cqc_1*v83X@-dOEPA?oN~Xr2(`E%#vIh;pZDtv^h}!SPe?1W$8F5z|xgm=s6z({Zmg&QO>Vh$uHWs2pLp*CRT= zbPt|B+=hzmaL329fCFE%O(r8;OyUOy2gc+qS=4OB!2hh%FlO>EH)H@cE=GBUJgI{M zLYP_mH4lIPl9<+hAaI2MHuOlN9$=HBTEf8|9|Sb43(nk5`%gy%kf|RPz2N#Xbkc_t z?X8B*lG_&?V@c{VsN%l zf&ykntJU+-Kg2L&V6!avj=22cV^OK^{SUryY6=Q7i(&7xi{q)aAMIe$z|T}AgNBDy z%A{$*PIATbv5@3nWad~835HrYC8$0NiSrG7MaM{ktf~k5eHW^Dvez1@6tmLECwE?j zVW}21rPXe3WJ(>=xT=_SBO|$-200ZSlY)Dx=Bnm|sQYVU&L6API8%D>uF(L>_fac& zo`^^)Yd3<9CHZID7SD$06^>b%0=K6-vzDZh=dNCBH<6Z!=1XB}QlDPTd%_+susvvm>ZEF>B&sZd_oBCWr>ABk* zT=1`D5GS&+V9F*g z{K1la&#bCAV_l<1nyxqqgPWxAv+d!?kE0rhYul6AHIHKmcZgBH1%6(&+5me!wY$MY zWSzl>>~}xk(Jc1U1#~P`PYlN7@*C-LttTXx_+=x=7xCq9mh+`}@Di*~0z23_c{5_cR4+bPV{U=4d|TH2=dXv` zUAR{-O_u8I?2LJ}lXj1P>vTdB#g`nL)4t}<)T$eI+=5}xds^^og5nH1>rrxDVR?J`!6pKu7gp{^Ew-Taw@w3_Z3GF*;Tw)AK8&xB^{O(UZ& zX9P9IgQKq{HRi6!NUgMYQL#)S%;cM{w;Ym4H1<7B_^Q@)ySxf3m9m=LB@)@5{tR6n z+>Ah7s=xkdtxg;=v3GNVGj9TN1mOF`VgJMCY@JPWmu>U(1$_}T(>jkpfsn|LW!_Z@ zmE0wIr!XbknbVg=3%=bH()1;`xi_bZ9@X$}n&MbxrSjG@2VK6=RrFS^KUb5L--k*E zboB~$>j8F)J~`%B(LN}OTka6wU4TMKCyO5Ce4GksUW~7;4<>3rxusSbMqz?Tt*r;+ zfy}#!3F#k?BL#94U^zh$(+)I;xKoihb&YxmGm2f(1zXuWXjRn#Nrb}_@P@V#4j~Jn zr0kl0#EIw_W7q0M;Ibr&H(@BiN8y4=B{2m#V=L8tqi|4NtR>xKICg$w&yeYC7`y31 z95>X^VEQ=D-E3J|;@O};Ias*LXiM=va%pwIy@>Gr4USHbi1!dcW+#vHX-7eD3pR9HHd`Pp?P&y_(cRfkcX?bVk z=RWY@{*{_>o&9uKNnQxTgwr@}yuBu?)LSMBRBpLbfz!Su!6^3Gpm! zNh<~WoWRT*KSDnwMkif$aDN(`#=-Vd(wdJ2p+w1VQ+P5lr-8an(Sf-QkchEEvPlF7 ze2=lMWm~%S6x=a zB{l8j6DH;E?2t-Ze=3@~{GLv`FzBGjrZHmwnzqUdOXOfj+~eZ`Azb0ZJ$0?UU3QTCf2Vse&_vY_RVZ26b{$?PH1l=!do|K&!#Vw&iUCktk zTvHw#zAn7_bO(+s{K7kc#(#MfX7}OQ`r$oQcs&E@*_7-VN)a#rdK@SHx;T_Idr&!2 zY96Z?6cBm$4YH3bFfC=*G>f9m&&iPPuM+*z?6)AOT*N_p7#hSg{+o4;PG9@$OWzj$ z@^uUEc7LI1v`Pl2693G=a}P@Zgs(8AiY~H?%Zt_I#Ol=C=QM(P++UEviDcR`+Ovz8 z6}nxcvLxpCooc%Vf|34s6xe~wWYn~Egb$yR=eazKWZd-(-a!hvq;@wkC|JmugRYg! zjm&N|uMNXPxW9H+UOd`rj*?;KDQmP~aduWA4FjqoH6Ey!_|ks%bPm^~_<0*o&w&+7zWU%Cm{Vl3EljMk?sF& zgk%5zD@bAaFF?wF4E?_aDF7C>|AzxEQ$@pJK^4jSL?v^?6&iYrW^Hj%5fcdmBVG)w zVUey0-riB)ge`fJ1Uy)$=VbmXE5Zo*c&y%0TBqmw`+aDCtU=;#f_`RNr<(({?Dc5{ zy@Y-!!6ZV6im9&EjY&FzWol?&{S@NqydssfK|E5yX`Oqit+auqOuTND`^|CQvFeo* z%LLiZo{K78GLyU1=iQ~s`+)?Ve1F>8^jp!USd3CyS)NDvUCgnILpe0T`Y~r{gS>36 z>M1)?B;p4SlSQgnscNQC{3m%y0Ir9?p<3jiY<{5uFx%P1rgK;g2RIm`+S<@M8 zAf|-f(Y}xJ9tj@|a;IpDZfiOxEkmI;EN#mhfUhG@oZP0;f6;4(Q?#y03u$7Q!`&z} zQ%hJkhGUQ0Po(SF)9~jLzu0Lv@S#A=S*yw_lx1NjN|x_M9J9eTscjDeZI*4aRweU< z%c~5;=sPBQGaLGfDVW`X8Fb~AIHwq0vW=uHtF&r3D(OJ<8y3_<4rp*e+_j8d&^PE# zgmcE-S|i{tB>G$JemAENYKLN>LN4FR%_gu2HBPhC_$@CzxUZ-}^RZ(C`8Rfpb2FZ! z0x#_`)+lhm5t(&Cm$PojPW5f*l)y)WQu$MFq|X$ajyN|{VWB|lZ?9S&iiehio4Mx7 zR_u<=3ld3OZt3xv2gFm=pq9ou7OeL5sh?7n;-ph<1m{>WX3KEX#9A zt}qD@uO?*)C~}fK4-QwimtL-Yewbbh0FN+z(x?HXvDdokMigfFGty1mB@$|BGNMTZka?Lbl;fCLZaG0ON{EI{J~^X9 zO}gEB*XX&J&|9)f)nw(^<;LHhEOe5&(odsIO+HSn>8X0=(bAo8?gBczrRZtH!%O%D zc4arWb8N&9-#dkd*V`2r$F*q0uj|yDH*$&;o6#YRPs|hm~`lcck&12%RR@d zTu72FgBDKROw&_pKEXYRp>)5^u_{c<4G?l*YELe`Mq&KX%Q>HRmVw##X`E$GJ-1$LSj$glL<0J zBI9l76Is{2;nE9hdB=5yIFCL2*C+a2_81u;{o)x4L-$}NuhKmfpq0Bzhd^28AV5;CGf)5G*a;+_@S z2BNMCsuofa93{dmhbZC{dKHYG(#d78g!o(hJdH8p1#Q}TY4@AR%l~waGg_nJmqik8 zxBl@$Se9aInx>3p$uY!m3Mk_k9FVTu&*G@4Ji*Y9tw~(ac!*-BUT!9@hZp_Z+GEQ#UmtpE zL3^(St+72r;@7G)XSRuf-rpUaCyU0u{r$RhFVSF-3iH(!)0}RnMnUVbi_(2~J~_&p zAiLfxM71n-t}lBmgc?vh@vN_sw!JSeM@-I(p!%WvlX=Q*Qne;ND<@wwPfg#&o&9j+ z|KpKct~#{{won?ZUcSb(v2&i;V_#WfsC^&29n2^1nLM@L zVvX0|1=cX$bb-QHs6Q+_uH6-*r*{4q)QkM&xYucv2{RPY(zPqtk#tx_n**ogNF-cg z8NZE3(cyxbLxS27oY}Vr(_SX`E$`O64Z6=H<$XOx4=?qNs|af#Y5Q}gw1+>m7IS_b zBoWly#Ia!^ZDi|!RqAp?x_lX(fJa^NWIib*Ihg>*n4grQSPkfN_)K{lvhAW-ix3nT z87{#M>VwAzSPBP{^b=zfFi4P$7sQzTYoXQU>%$fAfJh2cJt04O1xtC^lqSTR>aY0l zjjBSlktQt!whpyr$Mr*Mo~*zQM_h7VXsTWS%Uv16vbKywf$$yTON_9P1+Dv=Y)Gzo zP|s;~tHu-{)ock?-;!J0Y5eO~63UAJk_&B9+%1AXBt96r8pu9H$f`o@30%}9i zwMBf~)$v?wGGB#6UzWQ|(Y~uug|UpLrVY!Dt571Sh@R^(&)J5xQ$Z>`)8c?0eNTpx z(caie{Y}K)qo^yW?Lwwc6qL zqZxrm$i2sn=7Rh^!nltLK#uu+z#?`L%g}BfTEXAgU4gfEXX1u{lzv2N-1czqaoKSU z=Y_744lJlH9iycF)hbRb@J-}Y-K4TuGnMWzfw}UyB8^EPe&yPXr2bU_dBDN>1mf0K zEaT<)_-!j-%=*YD7nee%=&lrD7r?tFL~I}8*?5|&YX0suY57_QS+OC}VDy1qiO9^@bLRPXY*3*jm#V>{ht_eG>B z6ssZDzHd?Z&<`8>P^|%L>nrxU6&EnmRp*E&dUZR9)e$@nr_Pso=aw!BrfRT3w=L!) z0i-pc-*HtbDX#fqgj}q=sbLi8{HnU`Fm`)+h~{DtZExdFNkF46%_exoKE1oLgbX<+@iHRy;=oK11M|1;R(fux(63 znbMx)fy`iFwI04Adh}{IRj}F~k8M?pytM04{trga7Fy<^sdw8{(ya`i=mZ$+kIR&1;evLyR1df+YRLdbNxpjL` zYob1Y-64sagB`yg*+(p>(Nc*mMbWWt-^-vVu7bB1s zKHOzPKl_Qu?K_WV?LNc+rh)E%;gcFos)=tgU-2LMWONwMghiwccOqWTo6MoM?qA#H zNvxE|QUX~KvhLS|6A$F?x+oncE-rCy3{k@$cFnnaUT3<57rqg}F(YSLA@ zxuw&5*|Vl<;*U##D>eIt{m)?-WOoSw&iywA{Y5>66&i%X-xy4Z=7|ZTUuTMTH&&uj zsOpU=11mc0SokW5hc*xZOv+lw^lcdKuMH{%*Nvg2j5usEDvUw=;+2X zvaXhKu%waYJdjvj*?U=!PZ`)f?88Z`Qn)Jcnw?-jVNsGh+_; z%F<%7iF5*R;4q;I{3C9Fz^*{nizD!WBg#U7&`GNA@d_~#WeRZsT6i-v@-TZNIs5xF zbQ%IPTQ{^=59osAdW%gb6v45Dj@`=fp#kDp`Ox1sX#~FWTmJ|itRqQ+t-xW$Xk>`JuB*|- z0xU{O#c3E(3hhm(k{J=0V>g*1mu!R_wHA;9DS~=ROL_h>4yNlwN66;zoQ}GzsqQ&1 z-MCuTTe)RN0*3+X7(=Zej!#_LrB1zkAfI9-R-i)iet;mN>2qTqN2ARKUKYN(lgw)_SrR)(`V>6z6-Fn<(mo1N;cId25^Mr!i%4 zY)1d1?qC6F76SGO=JPN7?|yD1YU5hKd^Yn1L6Yor{)hawhLyxvEmkO6?!|$F}yX5v3n^ zL#A#SB@X0)oh&WNCE+r$>cf*G!YdxF09-}I5e_zkl4s8=JV&;noGnWaJu<3MS9xkP zenjsSt%`xDs1W1;Mr|xYb#69TDTy;tJYILCZz*7+z1R`THc~DpFKdvM)>6Gd)VVfT z{bN5-HPH-DBM0d7!a$SE*afa(c|IQ^0>NVZ#WtK-Y z8^hSjJ6NfkA0vd@?sV%ob)gaw&A|02<<4Vo1!)8BzK{y>i%i0P`8jLPrfDG3`?5FS zTZI>$)%e?gpzVm+6O5z+l0iuyZ}tWdTlbc9I2eVc#Qw}swGdmyrWpsIQe+E{WzYRz zDo&o3#>Y{gg*2+K4rIcFH}1IQK`2-ZR12!2{wm{8gSR1nUePOM*R#p$Qy?}u8Wn4QH&7PS>i>mOC7qt3Q<(VjdV zVBN_C;S0LWFbv3%65@T~wi@@Gab`|njBynz6+5NqnJRq3SkDRXkFW4mX@*eCyrT@88WnR{FOTH1v)edzt9Ou=(7RW2*s@Im;z#LI}FdvwpCOdWY zcP0Z{=A6Q9xnDXH!s=c}`J=Po7`9|JxkqTvlXnwUmo-Y9Rh?Jzofwe*%9^F#Ag371 zgO)U?)HF{t$>z0c;W)-bxQ2u#{|aH%EZG}(X$V``CML@?Q5Qw+ozcP9WEl{|5A#!b z!$~!N;h6Lbld#y|St8FxtijW#iQPd*&GMVA0r34Co=NfwC`nG=Vt#C!`1e9>u9}j% zI=Ut@xjmD)JieY@Z>JQSMl?EIotQaW+lOhVois9G&%7q61TD_-wT`>4Vdng_Z}k^P zkT2&7zqVnuzrvYOGJn(m6-KBCKa)9#6! z!hz&oPb(jiisskv=mbmny08POvUnyU$d}!7GRmQWQy>GBH6F!%x`%B>KtBzYt;-=S ztwsHv#3(e|gbub27BtX1dy(a?m7=D5*ilMax*!DHP;9Ls-+&uJ1~*5U7eZjoP@m+H z#=^#Dx-38g4WTgF&Q{lbt{pOSDLRh=+x|6Bn)lbk#)$e`NUq9_Cc1E>6~JA4+AoLv z>Cbgr$6X)+bN?F>*GZ}WIaSW-UpmwF$@idN@=dVk1xbLI@=6%nD%!@R} z@KE|N7Ig{c~v z=XRGx3t>%5#xHe6(^vj0lrt)S;-ZQc(0Q-f8KfQy2Uyk^x9OBfF2`O^+xf;=@lb8{uQxe9?n1MhXKPlGUzatf=xv8B{6LlK-e=Aw zgREx@+3WTk4U41VABpf#==^k86YI`~{ftki?4LSI-UD1S{Y=3#;Oq+p#^(gc;-mvs z*521hYkyd@^$r3*b!kv+bJ3&r} zWQJ%xHP^ZXvibHh+|J=6-VZ?cSz9jjgS^wkTCD98D^<2&Xi&DuEv{7bF;)?30n(Br zWyaXXQK(iv(Ni&Nzg52zW$vs-&+SbCE3c}9-wM3C9wzaZAM^Az(*43hSFF4I4V=Hw z-hQ-V=-jzYRNM@oSkh6Xl&hNXO`8nV<`fuGb+Xd5x`XJ?E~Ij6CA~JAl-t9h_hpp$ zb|$Cxn;@Zf+uQ{xx?#fciCqj7AlsUlRIz$U5~_|t!l^MIi2&?)@s_nZ`*m&q_U&u) zNGfUZ^sIa+o#*)yTW~X7a4YLsft}t+%f&9@v1Ji4V(PKy;;qnmi<7%_D4r*pm`FiHv5 z^nf%NkC4#dD2VZLLe+q5DJBnTdjaR_K1tjP9a(i96J|eTVT2@L;*k%_DE+x0`%>;) z0)~Bg&zSIzpI0+~>_)mxpqbz!Myw+xfcypoufztqlVg`(si1@|wmKZd<5?ASCXky;-Q?(odXnsj^~sv>P%iZ(XDjG(hsc_)HK<| zE1I4msa#__F&G)|kAgCwsw|@=t^I*mlzbGE$w4u7<`v*lxpK1VZ^&lZt&?Gnj>70Q z{^iuD==)-3KXe3UlM&z!?J%Bd8aLS^g*%rh5I?Of=qLj0x;{4mH0mceMYjY=Q_^JY zxwG}$Lfc;vA(+|XqNb+vp|xUG$tl@ts83fbzn!x`Qep20tG4IYW3#^ArFxcadhrnS zQU+lQ<|liL`n|z#?`hUSPIr^1qyV;8n{xi5;pg)z8H7N^tZS}O0z^yCnQQ1X_eGJ} zYu=bMeeh@HR)!Sv7&Q?O^*gRoxm>H;Uf7bh-E5{``0>>=?jR`OxMP-yaxk52{0%1g zF2%E~Sd`OM}^Ivk@qO(@w@ zy7o7xwA*kJ z9%I|HA4UOI?99+6%@aj_A`vs}C1vuoSui#?7EBVfr7o<=#2{lswb1~>N$@Q=YaQl$ zY=}+}Qc&hLAQA3^P3M6~gG|!tPGLa?7x91X1_?qLhDSOv!6q5MB$EIH(^gm$23a4b zP@>nIQ!wy`XuD4+(~l5e0>VV4OO)zf*xY{GXO5GaXQle)uCUz;f}83++jOQa%#nff zrGP2#mZghK@*vp_QlqDupOo(!cMx7@t`B6v|4iXER$A=(4Dj__(s;>>$nrQ*VAlASm|cj}dS&#}3I~sj1B6j@97krylV} zIjOk=3{vPXH!`R2zpoePKiH{x#uVzu-YOKUxyz^bN687rzi20eSQA0l{LVZYm8sOS z_p}*xm5dRX&0do(4pg(V;8UIIED=R!7#En)flaxfebzAtT$PSit|^|uiY>>I*7I_T zV)YRav;E`6W;h8nNvkm=-=e0bDvI>WM-NHGLY;C=I8WPgNvE!q#VXpR$6N4YfOvLT zE3V&<>7|`_KRPQg5iH7Tk$`qw6h=#i0%AZ}eGqtk*|xmoV+*QC5amhfIIteoo;yk* z=qN@!_vT_bWhtdnqG7Tru25)w+Ig~&e4Yzx$p1K6oFfcZa0qm?hymZzQ{qQBl=NU+ zv0~U<(;YFoIh{PLG=@f<9JCZgEY>n6)nE^O7Y4bbzZ^?Hi4J&B05S3;a@jtB3T5 zz3XpaXHmic5j4mV5D)xma&GFZ#z7gcrspraizLJxE1nHA=Hb*WFV`)q_i)@c_%- z6*>vG?kPrON;ATVQ4aXNE#CU22Q`4RJkWQ|oEpqull-eybYxiWl_5tFtGI|75q`Xm zu0*kl+%7$GUe~h`wd7``?suRtR=HF5V|I+;1_vD5gWQOt&l?Tl2yr=tf`z#*h>T^C zRzTr`yYF)uK7Z4Rk={Sh2{Mjw4edE&0>f|gGOmVLOEo9u5D2Uty!i6ME!)5OWMY`K zHj>ZDKMw*_PU13B0PS#>wK1QO>RfEm$aiF5wkwye{>7gVF|lBW6t?tGp}@rzyljWf zJqbhVzFhh2h_G!nQxVbdRkR*Ei6%rUa-w9HT^LJ#EF}qG_3@drf}-)UYiMV zdw3V3B%l;X+NfQ}k!ceDJeULqQVg&NkkI(7Utb{>QFmRg<=FD$CWj29#t#Y-BCH~< znfyM4lxF7b75)s3Cu5)vlif(r*))4!;A*&8=fphnY)r4i6U4BysAEZ>$c(LW(Rq%8 z8lvV~10sxKU&GXDniQ&U(bZi>L5|(@P4KGemxS1ch6W1I!P*68i_*XJa*gw5s)h8n zGpk}nVJPeC{ZdVn+!KYXfilP%K~RSf6@4;!<(~@o?gBgXN)@Rdk>5<>9!AC4NQNYfPl>N%)TUQD^W)wyS!S)4^$eo{VUwV-x&4$ zUz>4#?-4+EIkosBue#itJG2iN9lRJGUqsfR{R-P^$(Ed2=jsZP$<_uc@dFnsq2UPD zCg}&y@?YN|UR8wl7K=iRu)U0I6*DtP?$ZDA_G^q{F*Z>)acJL%99A()r9r`nWzbaU z#(?VEPUjxrq_odnk;{&Mm3S2R=r4}+qGBRQ^R7)yCx#WoZ#IPC8l-#2MwvBFIz;z> zh(D$|4-uegWQN?ypv?ztD+Xv~!D}-@;SYBth0nhfJA}h793JE;z|+9OKY#G!#?ns^ z{<^kl;Ed$7yJcpDYNQHKVJ&oyi{x)XE%7klyTC<@bHAB{XKL;$S2EcQ@2ua%9771U%}bgWni14>xR3kJuoZY}UE! z8vw|&Zp}(mXS1wsTT%1HeL;X1n!$C$i`cFgHjUuOP^Rb?W6quaOk8A0=x~!&oF?;G zzf$Ag2w~Z~#?U-FD63te3hq^zhH%c<(nz{^SR+ORo$s_Bkk3C*Rioe?gDcD9s%wSn z&l#C$<9z}{&Jmlr-6tQGO=j=yJabQg0q1Kp`_;nGP~pxnUyu+-BqWbkP?NWZ5?n7! z5_V{b?Gx-8l0k5?6$m7@s$&;Q&=Sh~OUKg6aR;&#ys>;rzY9_n1vIA0i1$SHr1736 zX04xE8+!_{!&|e_tUzczSmQG#yayx(u4KqM*nl!XcV+JZqvHaqh}Na2Jg7AYsqo`D z@kM$H8KEy$@CJJsB#Au{Uo4T1t(t*kiR~k%iLPJQw!@xzLF5RsmeNH&%PUF(7r)L%{3BC-eaxEsokc|}rc|{RMA5Lny!WMZVEvTs{7s4ob!wsik zJ(WI##mEK=tVH7jVRUUQ78?A%h#+@y7Yhm^O5xM8B^qVEC%p62KDyIC$01At1#f>WxJF-RApNtIpS z?f6UoL5Pbt(Wewrvr!O4`qZiOa}+Y=POZG9}RKsbZH9rdd^-Hzq+4Z8zc}QAj$eB*rusH^){* zI^8}syS-jstsLAcO&V0Ov6r2{CY91SyWRDm8tX`uBnxVpXpX*}J-Fm~AkClAncW=pRR!YRc}G66l=(o$ZqF)3&- ze)N|Pbc3h@CIKn~ERvTRoK7mj)O~SV9WyS4ys+jwV#R*~82sB)-Di2UV(3|&$s|y$ z_gQnNnw6Do<*;Nhs&94rqw+bUAe>1#Ln9O)_kB^CI3=t~E*TfVWZdXWc_PF-7SS!l3;@TVFS=JicZDOEOIy#DP-sVAO`*3wcppY}b4aZrcc^BkM|IK@bD zfm}6_y(TieM5q!m7^LY|5~m^&V!I$TF71JsqEeCEHsPl8{mCq*eAhyXubM3=hFz=B zZGGtbBvzi+sR#G*@x{8C%gfW^=a*j{o zbB}wfquez6HjIEbTbz4rpLCi_yLI~9lcM_e@{bJ zTHFA+naXqp&nhB( zJUB|c87|t!AiX=a^zgNA(r5MapYdHI^S*cMz5|I>G4AK;O#SDy3`#x4qjrvNxHXsq z)d^42Uc`~QEqd=%Y`y`yx59nm4y@}s%%;`_Hcn%)S#r#`6C@>XcxV#z1K5ak%xH!Cqey1uI z$*t2AVT9LuAi6LZiblxpnOfgvZW?J_nMAn~AagLU0W|gJh}J;c+93Js<9W(B_9z^S zkL~1pdKWlv=6dsd1d_C$gV+|1b;ddi)r)92TT2xhG3E?psM#w463nNrdg3B$~G#h$%L!*f}d5b{oI}#XDiet6DPP_>BC{dm5 zrQzx?jE;&!a?sE+?vyXq}FL|L!ns zcF}`P?U~G$;2@|CChH=_IjKxGjdvnG)++_xWJ$fh0_}jrD5;ddx}6R?7x`&eT~dY= zjPgC^?#=!=rsc;0l=b<65jdV+R@&$Sk$pix$(sC+Uw@xg8J^^2ez!4Nc92@H1H)a+ zqL@+LINK~k1P6-hppO4?Dbd3oqr`lczB(chYH{tyH;HXH;I=nZ$P^&cI|NbIQ15W4g(6InsOR@oMdc=@~jNuM)F>)`H z;KPP)4#K&nVp^$5EW9<(lh8%#$YSz;iP5y7kE^BXT2hPrt zp6uOFWOP~KZAU?^@!@|njx#+$yXX)A$vNUH-d~o2E^mJ$3w<0&)~Cpu8vLOcCq^Dg zAj+e9Z^6^~CDx_J&ZmDho4|V~j;WAalUTmXZ8{eGP z@BX2FOR0Dv{NmxN8ZpB))!Diq)y`rN8rU^4{j(wOwO5WG#WJoy0b+yQ`W%fGqG^~6 zmS33QNZtbs6ELEuLeGhQr1cl6_&(jgfw2nH&@(XP%|mRoMoU*b5EYsL3`hM+ES@wH zzwysywoy>LOV_izQG~=yxM@9d}&s0x1|B2@-|+tgiY$m z)qqhR*<}8Mx88IS(%qnq7Y$r@#Go*R(pLF^hoqq{Ry|PGE+v92@4=1PI7n7#)udcg zFuco%_nxbEaxP~-=iP|V;=8@cF@xS@TTRcjd6GCq`oMH4{c0Ck8r=_7Kfsm3Ldk!S zVi^7t5}x6IkO}|)sKxw$!fvqsck0Xk9tNI)f#rYgQc70SvD*?y{1>W5-`A}c8Wu0+ zt+s~8k8lgX*2fnQ?g}%;6FpI%)Dd=6D`?u)^UKb-xp>dVJ|!urIFOceb5VKDx*mCa zz4$wI%4WBxQHe#(>d0o>8H&k_NsbsBc$%&=fRpwH$ z`l!*MS$=(gxb$~SLW6qQge`+Ms-%;-O^&BK7iGoJ2=6jVie=-+jk;Gup?1x8rfiC4WC2zzS)_ti z#YQ&ie8s-|^HmN@#YD)S;d;CAz^-U}>Fxpx)Q!IKXr(#iKn6>jqzK8q@=$jh&g@khY#`SZ0~>}{aFJLS>4`n&$|Ytpu-tso^EU`A{y z^x{l+9Uk+lhfPd4yo>j!ic&+PimukRmRgE-YB9A$6Qv5#1*6wqz`LQVW;-dy_?%Fo zQA~UD-0;m@g95AH@!HMO3wB(0{4cgzK4-;CY*N6bqGq{tdw=etetm4?%Gt9;!)snSImxk<`LDSFYQOBUWkuM2vhLV`jJL|{J!ku-mchWZ}#U*PJs}QJmBwTQYpF93F8}uCnW2KyojhVa`*url$fn$dyMF2VYbyG-{%fO zTy$BQMEIn*AfR3_O{GTgx4v*-r>f(E=W982?8VpQ{$LFKjsKgI_2m3bWVcT=E29(;z& z#9x3H?t_<9SSwr3(P`x%D>TlmR(Tj(d+72&X!jJ?`qb8wmTX(h6VGtj76A16j2)-w zWq^z-O}?Id(VH0v>XC&y(Pry?Z~z3J33N?DW3;**z+|1l?1LRB57hTx)BZv2U+Kj8 zysN#J1i?Zq9Osy0JS2cZ5V7H5eQeM{4S*J%hi`FLjjJB^KN-g&V*xbmk`ks`pqfj$ z<=kfmxr$VSfwDh^kiyD^q?U=Z5rd#OM4yviC~tksqAR5*V}Y-4F+9g>=&$^wY8zU0 zrgMRIm=Q#4bNnIxZAN&p^gMbJLSebQ zB>22wIBg-{9b$BMbzZ18d9m`%ZrSVt2~Uf%pFY2*KO$xbbwGst<9Z#jrP)?S1?wT7 zcmgut@aC5|DLrMMqB*LetvDm+7|MjbU!)X7_-ln5?ZSUzXpOP;G0&I;%VaJ4ambyB zczEtNJk{*6u?PZwMhQQJG%B%^#OJ%?c2I^+ z%w;{FYc%Pq&|iYlc+RtW=o-na*LhJhNWelc<0mR1Hj(ZRJ00E;sB7N>7yI@W$Jp}P z3%X-|avKn5=j}W5g7UL$5$9A0Hm;%dPz5=(;98W811To=TV?egCtIaYP89AEav}hO8Yxt;7PLO3T!DOyg_Jc|Y+iVcgWw}wRx=j5cKuPoYE^Ajm?0YFtU|Oc&590w!(O@qP1A3JOD$A`ta8lZdYhi5)WAVqk5OGe<&*ExKS+5AYKdxq9snjfg zY*M9Syk8R*C>cGUvJuctJFG%v_E~$rV-f35!3Z29FUgKW9y%jm1@u_58bYw;jCT1? zgC`j4N^}y!m_MiZ&r}9YzlY0AX29bNq0{b+KZpl(Gf}L>3l^3`J_&g95AD6Y!KW(5 zrWE>(VQYZOPEqm>`=CfQIhe(*YAEm9f*8O+ zlJ*~cd1(U1czdg6t=@w;eDp~soC?ciJey);hMN`pqKfp(FyW-UYYx2PF_FHdG&RMS_w5C1ohbMbRu3}8Vneun=^%2aTzLa z_t|&SRp z=Hcs+dFP1~Bn&uiv~n|S;4MF};KT*4B^9U=0zO@S!EACGMW26_i*yU{^gUiD!HbSS zeKlh22ecvsiS5h7XJ+sS?!;N^{L=8CY0S4aUk3W{3i_H8BT_qll|6xHW*YFEDFfE9 ze>_s~ILOy!ypy$Wqc2VLck7Kj#PXz?JO&ME+hM=Jb}aXZSj1Pevwo2Cicr3=&X%(c z<=M<0$3PLemng)p2eGLSp=CYn=z9i(+QdMq5v&`}gXH+whALILfY7(O6IWNzxhQ6^FNl~g8+OF;+0Dk7{t4*i6>BoIsh=wAld}u_GzO14#v-t zvP`L&Mz^mcMnqZkjqudF+jX<^n{DnY3P`|qz5&gn*9lz9Y?uu3#d!?rILPQSI3IuP$*nr4H0%YlVwR8}nanN1D%iRk#10tHvlO)+!pWlcPf79A66IJm@pv@Cg!e~4+wOb1eKia@ zd5I&Vgv2U$&zH?gGU2qysCiucLgt^Q|Eb2BBas{V}q1v^iC~tXIhwjW({wo6F{;vE>$Y z@IWb}Ga)|CU^@js4wK_^U~{r5XrFDQH%w%?F$1TNY?%+Q6KQ92#7EDq$2mf3<7;6iijMJl?#0o-vv2kzQe^Nja1DHabJ2XPp-Zf z5sitdEiu>9rnoKwZtMNoNlPM4&Q&Tm)z@wke%Rx zy>HQ_umANqwU)3Z5`Wy(mA8fbA*!lN#6dzbFftqqFbHQk@VQfhVnKxR(TFmg_Wo8@ z*{y8U8tjtGzp1V6&gS+|e2&rqI(pJ*NSlQkU;KHPYy6@yaXd3X0s%=ozD#sj6&GV_ zE8m48mENAs=V!_aF~Oji=ha>;Rb|F)Uf~p z5mb{%bD-)aol@vBKH_OR9jHM?N^>kF_GFt!I-qgTKAr^Av3cvYM=aK)*n;wX;{!HJ ztrDI{NBj{eBJbk2VnU{}{)^aiRw^sf)P`vT2AL7>AE(kE~E{2?!;UR$a&K5wRt02 z$FSV|5ujZ-yvT3LpnGh|vXgnQs@U3+Rz6lW%COkAIun@+l}WLv;ASl3qzxvm53lbDRA#^$y(ANQ(=GJR?qD7!F4h=?1bytzV@R1GU%%bV(W;-q zWCDzOzlH9=5^C?>!F}%Z>O<$gL7W@LR|H*#Qf~h^0O@@$8G8_Cff}zmcCq*8(c`-B zdHOOhZH%1sxoXjyDt9#OFF(@s+TG_1s*Nw7Zu`=V!{IB3`{%eJSW($Hy}mN9yDO5) zpdp8wEe}=n<~6YnHLO811brq5I*CuRF>X;ukIl_mwn!|~E4Jy)&Xf0f$P4QUwlW-( zvCP-Z7XrdYDqpwK{d%a5=J+PwPhYXLOlNaO+b(NeEaFWxv7(!ujnM$bubyJ3Wa(7$ zY!B{~AjB4!&ha9m>Lg0Qsv>5z`a-s${Z^$?P;<@ThQZu+SoE7a`+Bpu*%Ws)+joci zQeiVl6WP9?gE;)%`+daNhZ~vVcQX5g{qtkrEsp%RX=*z@E)E#Zkni)srfs_uAu=&c z&-OqDq>KlWF5O{J7}i@qNeBP5F<$^kmmq(1cJ_2gIb*`cWZ4uwQWB4XqFlMuRfcoI z9P|33(1f0QH4P&B^L2Q${4<`gV2c^>PUR|n-_lJ-RGYYqY!ydtudoW9GE*xSzkwLs z%>n_hgw%9vC)9D|nq4&se+CmOg5l>tc3Km84uxz|=8))x@7>@&Gn@9GXpP=vPs}m z9c^>&+}QSIxZeACBG4!&5-CH2UNJI5E`Tks$9y zNR=GsH;XC#d?FgYL7G`4x7i?dKJO>%M$f>t$#>^45IbIPO$0I6dW^!Zcav_spoDfL z7-B{{VM|0gDNea~dijFSaO(0^T8W))+Ej}o1A-V2_$WQnC0hGZ_Z(V`*T^h zH9{SATd*dy-KsvbuuDMf{{gje7WaVxp>!o^|NSPH7Lu8=BqFRc4J^mfn(PF;)8q6A z965XW1i8gW)OzHO=WIP)w1y5v_uRMD=Ki}_I|tI-yEgODN29xPT^3|JifH>qtc-Tt zke3@4^P{`%a|0Vbplo0y#fFyhSh$IXZW9`_WS0vtEW9((*Gn;4DWYK?Y~&wFAa{X} z1w8pT*;Xu;dm(eb=uurrs{uPILZ&O^CtGo&9F?p#D0`aN>x$|(TB0u7;(h7kL zyjiYo*T%#XkOfJab)wWn3v`W0=gsP@B7-|f76PI!a%1ij9LD|qo%@=^Q2L~bdrshd z(PX0tO+Gn3LEoQJh!A(b#z%wq$4~Ys`MY}{*}5Xx!s<8?y0jiwdfBd9bSA1jol;WW z8mgtQbPZ7jLlh25`)S#pr)FHtNX=CU%4S{f$8OLA%?Z+L71R-xz{pnw5fgzunTaN^ znwY))hk;XLec#1TAYxTp1$neI<$}D$!MV{bh9)W)dDI6w7r|ZYntwXvs<-yOrk0}$ zviWXL05d(F0%WL2dSUrrPhv$ngd%C^sB&Qp#3uJW!wkz_JHi_w@g_@eqn2Re5(*KX zFn3Ep_r`BbwF#(7(H$eqBtm6#*rdShc}0W{Z1GFAv?HZKur`_zJ=~7p1fnX5`mN|t zma{m{91{w25*Sf3;jlG}%Xl?~1Q88{d#57cxXM%DQPZ#7J>Ok@wFnkr>oKJK?QU1D!#3_1h;U@a521bjA%UcQ=^1B@ z^5DoG3>!xby()GW|Cm{T>7vp5V(7WpCQ(H?!fzZagY6#$qGUKu&O@UCt10ejFgtx| zP)l|alo>6ZSvuEEJjt-|RZV;}%BGe43o#%$;dE=RFIPzrRyTyv^d}f1@tQOr>KmsJ zv(JFVex;&NWZ^o-MP&qvV$4qgBB0VB=~zzs`O_nsSX}!!DDtm8Rg|vF|bZpM)Xi#jM|p2@-^g%}<)A%AfLw__8>n z&neY~2~qVQsk2SAz;pjSTlY`xZ$NQq?uMLuQF3?dsZK&-gmtD3iwQ z2=IQ~>~QnvwPZhw#JN+`na?DY_l6YG z2jVo?2wgtZL*s8XWV+<<7fBv*@SE`jIE8}M-KEPHRo-x<1-&J=0liQxKa)Ar7d8cI zx!M_7-q$FOvg_I>p}wUlm3GTrcPX-liJr@(*n~)#T+*qLKst%M-V2(iq9b6oK)LmY z5iJG3LhJs60rYCSX;%WjlM3z41+UA{2#vizJt{hw1{w9kmtD0htbe5n>flcwjZ;$u zuggzP2#vdSAAKc-XZk3%2ZhsmZ#YbW6s|Dc&200NMqs7G#QU~d*W1OSUugI=p^ho_ z?3Nm$x>|=U2H|2}QfZFcWByeVY0|icYt6M@Dq(+O#3gCfT zh^sd@RNf~@0{84j_}rqVJixe#vrAZC(Tuc}@V0Dx->YtcX|b`gm_slEQ=PO?5VwS( zb?TUV!hd_oL>xGO$^Bw=&nl=L7oAyN<0_oJBav7Zj(1lngm+CW?%Goo5iJy#0zg|! zHG=_^ORl%c7JKA~K2vK@JArXO#49+*5e{5qUaIh=pfIyRLfbIP8_RMOYCp=#F&Kz% zon^Xi#nN8FM{Kg1UG?qk0;%Gel z60E?lif+7B6lK66{wz&5IY~sL%qd;u70E~>#A~M~DOQkQV097mEK&GHLDsW3*Wxvk z%KOkizc$!N&M5!&xAnvsaf)LK!MiFbuzv-{j7bD#Hr+Tr9GdNkol_RKTgv)+!CIBt zUp@bDWETQPT-KN;QWo{v!W3@fWx%W|+s2Cy(kl0Nm5Jpz9=^7I`jg_FnjBJRZy8qf zfwS_RvZ#qk(-B3W+wN7<2`~ymQD%**t{7L z*bm}Q33=4lsyU}1JRQ^}&liwwm2IxH5w5TJ$7FspDn}DdaGz15cn=UhiUfGrE}=jW z7OS#|U>k>262)X&x@s|cq&30>=Q!LVd2T19+u*Y5rn&-$Zj+ibqYI zk-{l*NPe<|G~8sI^u29en5w8foos5kJ_6g*Wtl+Q4qVXhB%TY^E=(g|JXPg~h`62* z>xSMS3{3EyN)3`IoWGGOtW#wYyF@-(6Px6kbT{qZUAxOkEaK1{$Ogy*+-96U4(vD= zRcGpNztt!IxQBWcIK)7DD_|XfvBFyp&p7{2x@q^nV<0W5ENl6zgs9CzW}g@(PUWX^ z#uxoW95SZ0pKXw(G>AjIohc><@x+4O65hRSDDoDy+zf53KsZv3$8PNKd$1OCA6;9Q zWd#{cnEh+%RF%)#g>C|JS+$A{+42Y8narABKEJBAPGM;P#FpbBcuu4fP@T3F*9`yW z5k~5h02}bT;bHoLIFzqtA3P)!MB#gq{#NDD3uoB7CIiy;cB1%Y(?hFibNdMcc3V1% z(X^&c8{~p2theG)r2W&3UwNYK<3qFdXO9R1yO4LHm&5J3b-2v+xlOqQ`~#oXSP3Zg zKWO7tWIKqL9ICS0Nwzh#^Z3>An)}m?nU_udgg(@l1-1$+w4>`gUPHiKSf7H@*yT)^ znfU{!9iCwv9Wi&~oDNZ_hQ)yqH`HVHY-;Kc{>ZA!%-dZ}>QeUk{~xT~Q><-ayDjKx zn`_#(ZQHhO+qP}nwr#9w+cs+LQ#YrQKf6vkvk-XV zj~4fvp}-PH8Lr^Sq7QhjLy#v|Syk)=dWU?3j2W+kMcIi~FT1?*W+~`!&%hhls-w)} zUt6QHNoT%YGvvWj_osJvl9-=^-A!uY=-Qr5>qgN)?9~6BT*d8Avu@LiJK-c-Fs)48 z4Nk3z4br`a?*2jZPz5Y=BG*2a$+05K+b{~bEh3}CDu_=VD~)i_$abx_da z0w=+)p3Hdf!t7#83`@C&%o3aZLPhUp`Cgvik~7;n!1&i7(IlpVUV?;aj4)F8aW!y8y#x#K9L(%?r7CN8`8!9PD{v3H?I*ddZ@{`mt2$`2CWs)-(DHh z#J)%Vk{ar7^-Mx~YtWKRRPQxB$luj)ux*$HX^KGcO zj}b}y*mJP&8Z?A{b5|^480nSM-mWWqscQhJkOGxLFX1p~!AT#= zVROh}mxu~W#+^fnv2MsazHo#9=|&4LfTbWND(=RZCGR15`fdatuNBDPbV3&6q|Vz} zO+EanbC62T*N1|Q5>g)Gk@!=~bRpPYLz1giEo-*Z>=X@NA%n&Lui8uWb7=wD7##tV zaH%t>KxHzlHVoo3QsDua9L{9mzOms18o9JcC4#Mk6tk)_C|p&Y0ZXrio|Hz~9oD`!To;-)Jj1SK!mC9cYlskesy) zTcIYDDO9t(NMRHx`f%_Sv2{O(d?{A++|C{=rB3HeoI}?1bRWs78|mqgZ(ba!-As^h z5y<_p_3d4_2N~&}Yfrq0MD9?b)(gSSR_5vMV&?7U@2eck2f?C#|g+Ez+t{?yq5;Jib?aGQd z>HVvp1~=y9+r%W-x((or&GwcQ{p2O?=2?E#*&AidFxfpGl@gmwfe{ADLU##2FD^Y> zrBzfh;l1z+=E8gS(|2701D8E@8TH7SG}R?tnI_wZE??8lw!qf_3K$^Jtt}AVeR#-a zx+Y?6-ZrP~-XnHkFc_(O3amPlQ2(ovIQwW6!jlKXubS@2y1DJ?i+mmmlN^=-Hn%bQNq^S+i52Tv4}DK}$d)uenKPsf+(hZQ51 z0##;Zd^byw6z2><{S}omixz>NkM=8D7=8@9o- z+KKLjJLkrusQI|^EBCKGiCy-;+LH?D#Ic%<4(i;&0FmnbRSiJ`c?NX3jpQ1y)@&Gz zT}SH1w*QqURdHclZy}AH*T$*U?F5BkuTL1ODsDp}1)1i8Lwtd=eIkh&!}}|c-+>gh z98Dsa?Q#}L(_t+bnD%$8Dn}XC$E>kd}C2;7Ze^eVLS(6{6^1rR0@HF)C@YM)5 z-B_NG#iFCaTJ*-{Tuh_iETA}Mfdk+kOx`eDs7hC&uUkRPkmz9t(Yh-fnb`f9%0J%A zWoQu%TG5Mn_wI+jZsE2Oe}DZoSy1-;DPzdO;`$?9zBVY}59pXBE+>Kjd;(AO0F^lCQ~c-jz0X8cTnC3&! z4L1x2j0^K*TR7@|QR$tr?(89;Ze($!6oZm#oa!IJq=XyG9a+0F*eM=bLq*%Rtu%N> zi7r~!Y{x!!UZ{g%|1Oq(KVsv*IVg2fBd^OJU3p%>w+t=@Z+6t_(Ve*@pF85C5Ra?xGOg*d|rYY za)&b}qyZhdj?^yNR{fQdv7uO~j7lL55zrg0-Y^4*AMcv*bDJ`QPr;f*I@$`v^*7kp zN-Q$%3?$k=JTudGDYYeB?6E8|`VHZrN$6F#^M^pWM*PE`t+_~Gh~~7`j+uFz#QAtB z_YbBPlhM&mRg=3{==f$9EKD*ibG;_#Er0f7-4W{vitRCb4tmp1fj|rA)bnW&3B#iZ=sIJx-5(_;xVD4~eOJ zTfUK0B#cqyGMnsxUmn8#>eG1EU`IEKT}g^=98->1`w3A|n{0CqI5SNWwA0mn;t_D1 ztco73f1jZndhJkFWm@Kg?WX2=!;~s<N}G$6T&J+IQ_ z9UadE^_{>UjRRT>il~U?i?cyeJNh0Z3!)8cwF5%rQIh79_z#oHPcZ0egl+E7c3cL^-x6wV^5lA76Jsenv zXbdLK4Qv1D`BJP_C6kp<;wZ$#K}RIKXUXrQJnOlxm$A_S7sIYsy&+zki$EYFQXIl? zjQ7M-?onlt8RJBo@8ADdhhy?bGS8}0Sl6^v)|CNF0oc%pJTqb0MA5=z#RbyDd1-d& zH@~NrYT76p4F(FNE8`^wY4!6RON`MrSVT~bbRU{ zo9;Z|#29Wb`R$d?`1nRR#jW*t8ncbLiWrD`pK-G;ac4EPe_#BD_mBGz@W=JEzKpuQ zpNEgIzje|YnRb2OKPg^sCo`+nf>*Q)rYT&fgxJk5jXNoT34KgUyx0}?ugL>_-SE8+ z3)SFh`}z@8w6z--9HsGH5Ci`L`-#MWQjU@=@q(jTB~7(-!?{C8NCQ*G=@~ zbmf4#wK%b+9&@A=uhLK9?W}Tn5FUg<>TBVC6Mt0RVdP z*sUU-&JhcAU*`ZMd@E)jK`(~@^dIl~@L?xUd{pyY;1KloMSR9A2*gi<7IB*em1igJ zMZ`4Bg<9!mSN>33^)v=V7yM??pdk3_>Ey27pg;*^t_3H0jbGgyQHfcGOHQXF!HE_i zhy=hN;@T0BrbVkZC94OuvNul8%(zyLaz3XT-gv|_TlsZLB0U4?7JesG{9Hx^tkam1D>mUK5zXNfEf(*`kyZPUeRjZ8*z8cVbSnZ*1M;0vtM_{?$N-S$w z|CZyUkd}KvygvpT>WK!Hqw#>n9`dXO{fQPE91M-KWy2XU#N)v0?EJhR*MEUv06Lwm zIsa1({+|?OhW|lE`M;0B{}ZG9&s1i_XJY;@l|b>oBbC|zyGZ>1%v5G(Vf)`B@#KFL zz-Bv~?_AxUk#ngk@r9`iXU;@T*Sf`q?4c~)#$*3*^|mebyYSmd2WG(eWD_YddLfK)MH7oj97hj`B*53p7lJoPhZ~UuWNo=bodOCx1AJvTA z+x2SZzJHfCe}_?dVSsRrX}<+!N?C2A{`B>yO;S5p8O-FpOsTmA{!nF2bhG{Lo4?_x z8d|9ZB8r#_Jsxkl^Rj==jgx3LtTt=x;h?;`ONo)YniTb#Fu5}&Zc3{Ao$M=YV38?l zT3di)Y?FHi38?J&Lk;QE!u0{aV}#X?Qop@=i`-RPPY3+!e7S;T&`~A5cTQHd1`pGv z##_8FLxktU!cj798St{@Y_^VCSC3b?90cp1-dueq{LrzC7*l8)a_s#1#VL|($4?$` zWiaOrgheEFHiY!MTDd~@>}j~PF6G5DLLv@mAtB0nquyl9a$$uQkrn+|917t6&Mv@! z`$6~aC;D|&`5f0M^|1Kyqc6vdkutJR+m1vQ z3zJiGv8a7T8VJRWr@n#am8pf`_o-OTAl$~^?9YCELv&lS2nhj3;HZG@VuZ9PR-uyV z!UU2fl(P8Qf@+BX$-qD{@?ykDMKaQqF$;%j+jB@GD&0&fCqK|oiFx{|BQ;dflJsH9 zd{JfxF#eUcH&!3#9%px9E&Eiv2$W{~8AEpnnwnLG)sBXG%tOULN)#0DPyCIX1ShSH=0Nid zIx>`?-}gMG5Fa3FEp*!nk%4Lo`*#?ei`RfY|E`txMC$mQETXEGJ9?dKU;lm}3na!l z3rC-`+L?sK=Q0Rm28NGVC8(*0Auw$8Ht?D;tq#Q4NW5nDM$`fOhV-YE=)s_;l03+s zS9&t%NwbsXKI>qiZQ|acbzH463I8!;T7(qcwCM;N+y4=ukUB2cWbl1t&d{dhj8A0; zq)|dw6>d6{r2ab-RZrsC9!5iwYak6oDgzCeLn&p+Y-w*?y&eZrl;|?b`+ck_oHNxJ z1;Cy&kbB*v*{G6H$!Vd20~RL+{i`5Q5pdaG-syU5>2?5kA2`$*UBvsDo24 z)QsV^AYjOo^G7XLIB`<%(wxwsf`Ga3b4S;!%}g9WDx&?zUzw3Q!{&ep7;%n6{T(p| zOrpoG+8w`4P%YgBe6@|6%`$dBRtpT*Us3?}lURrt8bgGO)S@BoCxg2uGB25us|(T* z!@lithN~+Q6+eXruM$$s3XbaL4UY=3r!Fad&zJK=z(oDC?umcpa^L`ZeIO_+MKZYK z&tbYmBdhIr77wz21s7pIV+oIS2UnSV6@+E) zo!j{jC;lcw4!&9fXN7kv{3Q;#fA-EWaf758(!7L$uIUT889&)fou!W%^oQfdcVI6! zWTn&5t1!5bUs3C(5rLz^?y{>=cqS1m+`s0)A-!;UXe%IQ5)D^ZIRR?w4cKpf2M@?}4v&84SbLgvl3V1;WpL(HWH^1d z02G9)aP_!X66SH`H=^1MRk98?lUykFNbx~)Av$fIRV?=a;hAfL?_LfJ;PIw1VFvS| zH^#ESA_!~qC^DGp{KKAVQLFKC8iDF(=0r9avLy{egPlusrGvb|k9TLe|J#pLbvBQS zQmG4*qhIR*jXA4_pj$qrS2_z&gP(`bzn`m}2y{Bx+PON~U=%vNT%B~cD3SBfO$<2l zfnr7>A<>8CmX??MhrzW+vjG|tCWBSZ9QO;{zgx@qKZ{U%Vy|k*rlArAOz|`^NI?j^ zYz#Ho%)nA(Y-t%8A$tsn1Yq zYf|F3pXZ-e=EFHfXl^Lpk=6~5~9N1h!_5rn{ z(A@$Ae3dQjqk@O$BUBQ{g#8HmEda;7;QanhFBR1n-Buz>%m^_fU~mB5K;qVOl+(w> zEz3eA9X9_?soG>ZZN}z=D`hiFNwae{<6j2d(504iXQt!>qvA4>q$g03=1BBAJQp7= z^G+MDW^RCa`WRByFo2HV<-C0IL40<%9g9Lkv5N@qyD0H1oNn3LWlqO3B(dwDf(FUH zZM7ag*~U(neV)`F8cLIF0_$fRu{&koJlF3240dI(!*S^ z*Jp)^{3IuOF1Q0X3SYh(VoI=&8d=YmVi5j0iFV-vA*v03U0eWbO`R}c5pZ(W{p z9?y6(N}kF8xQxVntPy%~>RgZE8j~`?!;o1}6{hA2+@Z;yrN-@A_$09NBi=Zlo-87S zjj=VQIW5W1n3=cm>6^qhZX6U3x%D&7xrWO?rIUJfJ^k4phz9cb_*t>R*d813;SNYc z2x1DOI8M#PxqEPXZE7r1HbO$cZH&6wOPI3(`8s+qmeda5KMU+&nt4uS^e-o4l?Ab! zPZc}CX^6=Zsn79jM*9k8)Kx?e4Qt`g9SAKRzJ>GDcB<{6XR&SVCAcJLHv29B!l@_* z)sy23?rz0w$9u0d)rP{oSUe-|lyOXsC_ad7MT~u?e<)}zvgwv;B4Mm)>YiKD9nB(*#$ogOWV5W3cpq%3~1Q5XF||QRX4Smlkwdm%{l$8R-1C&8b#dxr1G4& zhuj~q!sSSvYZ#$!l&?l+B7>%ajyIpBN20G6K6`#X7h9>h0i!2Awq{0|KdY_nbh)h| zT{WjoI;L&fCtIXy2RzGFrQeKfMH0Tx3KCrp%x;gS-fCM($bYaPKZ5NCckS7CBhnLe zNuMQWV8cAi7oKnUr!-4!QxbB8n2B8**njs_aOr3o&2!z|i*3ookNb;iGz*eA?@dJ) zo`fp^vv%)Wx%u|aM!L*=_vzmb`o@fv{ou1nZlb~t<%xMv7ID8{ARfR$5if2*6-U;) zAbSC;qZF&@QxgKC# z&Vb?#xN{k60~7m9T3CqX6iO810NPO}YXPzjj(xy;2gn~UEt$2|$ju47%4CK_RQ6~n z95b#WvF;N6RW6+g198#=aS(w(Ki8#S5|&2_R5`N$1F9BaI;?nTcmeU-LC<_qsW{^w z6RCmBemeqFo{*;f;Yz~o1cHskavMxHa?mnZ`*pur{~)s)SodU>NY}gLGcMxVwmA%d zCTe$y!@++|8d+US#R>n{dQFqMFX?YsLSeLM~ z#Z&>h82HJp;h`M?eJV9yMY#(!V(=)%#A{q)OAt!%AysQJzKo zb!Thr+NMb%=|&asugt!KhKfc@9U=42lx6cYOExmfyxt-6Y;X>{Mh19?G@ycpY`xb^ z=g`_(44c91jO&3C5?!=_t2B(&mk7X4+kGdPxaIotNaj;~q)E#4~_d$V%szyVEhQlIo zLw3$b28Nus!Y_&S2gLBnvpW_K*k8+l7&SC@ipM-TW8I9fDFAF>4ZEBdAUpvchSDiP z*k=|9?`tFx*|PTeo`;Jrm936HS0`%|V<{vMlvZN!xZ9J3=XQ0vmAAg`HNIc>VQO^0 zz9p>}WqH0GjdQhiPA2m%Y*S3l2@?7p6FxqEkCkTa-LsaPps$PQM@HmpTF*=lNOb4a z4H9m}@1yIT_;>5A)UD=HW@Qijct~gd{F;KQhdz323vl<`I+gSkaKJY3 zIq+Z6VHTDUwhZBjW*BxkP&YYK(h8=Rmf!&pIZpLbN6i@NL|pC{YzT*d`!Tn}7NTvD z#DlQZjy+3k?SC#8**4R0*QS-3wg5JuOefA9rL`GBN=Qu;+LPl=rlPXex{?FlMdK$# z=Unnn#-Cf+Px+Apf)GtoS-mq(SvMlUwO>|#f+FU`HUw80tlXH2gG?dZsD>I`<%bZl z8ZC@ozydu;r{1~$3Im?#=5v8IzO}MjR8c;u6TW!XiRw-I3c$%5a zqgW|SF5vS=ZHiGL(F6zyNXdLX!4ey46(yqby|$W%nqv8`veh?Fd1~J!%Dv%Xgc-8< zY>C57ZK)|UIH3z>x#JJ(^^otiUyvad>ew5LUo9tm>juQtQgyu^cHxb?cInn{xT)Ok z^kUM(lNW+3ct7L~KSuy}r6nSxS(pz2?(#mAk7lA|8hFSay2>KD@5?W{!-aoRdLqQ0 zKUHi=K64*!wYIg00xacB^IQ5>p?eI4$~^LjdN@g>_^7=Cw$RTpO#2(dgV4;Q6~^Hg zJ%DCNV7H$Z%f8+tqWhKI?}}BBM+p(^8SW!)$o$2;<^>ep3o!eoU688o$n`YZAa|P@^lvUR#!2&oH|&mw)9q3 zhqcQKSzjxcU0%0EoWh5orU(0g_J2Y5H_z94VvEY&t@qBd05u@SU~)2VJ2 zv&jn?qnkIyct>7K-<pIfu*#7zsVQT43 z&1R!oHr-%sr#dVX1zaX22^-}cmQ2nRfpZM!n9W4<%#2TZTKW#Uds?l5G#zC0Y;|@U zyF$}u{_Zqn?&h$q|IB<-*5SzFnM;WFU3j)MR5~v=FKXA%vcCBK{MLLfPvz|j(R2h$ zMN%3knHB;TWCRiU>;&(}Rn5Wwp+6v_MX0nMNctO?quwWJR?xj|#ezTf5`zh#1o+K2 zuW%ClB*iaAeg+9P87kmz@#cukUy*G5J(IrvWFsg?0ZHIp!wgdMa1qAIFFbG_ymir5tNLY5Q-ZQC@+Fo6n+(zewCC(yKa`0o=tT38Yt^* zJ|`M`W&eju#Rd54{v1L@x*8LtLXJA{92FYhl$FioU69oP96gs<`@#@)=2V5b`*5wO zga~;btB$&9+Y`$LH)+H8@Yte0J;DisAH!k7x%(SolRg``5-5*W+`cyT$V@jdkBC>a zw#rb~r~4iQfsTummvSi6>LAz%z=ldj#oYQM$#Ck3&f`pt0b_S0e{Z2?zcTU$a)@>C z+olor245jzbBR)7j-*7u-|?O+hKZYSBH7Z?-V}g}l&L1;^6TDXzYPA7Y>v@dBkJOQ zy_yjjea?Rf*|h&(h=&m$w|V?)K%q3%yIqRC0XeWVmmW^IHrf(yqjc|mbdp7_ciTI| zmXSzp#<9zA-Pb7Al=xA3k}syp~H3d0-NLg+S27*^G<|thRN)7-M4EW{x5qs<&yAyLK^$y!Hgsi zlo;|F*eBbWH)1!Du=$RgsB+HRETaNSLk=UO2hSTHM+4IvLy?e9?tq+bmU4PsrH(5Y z@B1jWnQvv!_q*s@yX@(d^$$$sh23yGPu&s3#Yi>=$VeO2Ff8V*V^R@!x=ZW3r=^Wq zy{Cn`QIc9hn~#Lju%*rE$j;ZYs`tgT3|MV|=4Fws`1gt zm{?@RBMlXs+$6-D$e>=G2$8%A=x$HsiR7^eOK<-+K%3xPv;&C@qA*c1e5p>k8bYyG zlJTsfnn80J)J^rgZvqUH_8p@#SvUE&Ve3yhj;h2s@%FC)RjQt67*JMj|WP(?zDuAYy_A zVh#d28AeHZT!dvaaqo`O%+q6gAL`ZcJPHp#O5S9pv0n<32M2|NL}QZ;c$VDc1&h(g z6>;R63nd(E&VKcHVnEg#FX*ZRTjl?R%l2RobsXvQgT2IHaED~{ElSo1hDF=gAH&+M zkgDvT#EmuPj_HVwrU-yJ5P^%02j1ZbkZTrj3t#CB$%vkhX@V|zq$#_KOJvSkwG@vX z1B^YS)nwas1Af4mxmxHRayq;g)~5RLDq*cRf60lKdX|FSnOf0WW)B78@{|D>;pMLF zHN-SH#25Io>G(oVYY2%}Ojmr~>0-e(Z%dT0x-m z`vU^J;>tk$r?Jw1GNl>*2T|$&?_;I^Zj{9F-;I*~&s1r4CZ_*=l$5QuZo4Ut=JTqy zTm%^m!)7B;1n!vaj5M6luj)xJJ_k&rO6;apjFja{rpMQ^kyabCc9O4&~sPRQza7AZwR2`NRC{Ti$k~)rJ_PscVY5djDc4!MReG z#nn{AHYMr6>3q%fY`q#OdRF(*@IFXaLNB$VM1^-&)vJB2vm{4xIup z*~XC1aVu5&D#MmSh0h9}Z^cAcqN zFG^wGmn$8-vqpi{lw?GN5OE5^@=O}qEBn476(iHTay9j6FuI5d)y%8q{;3fM_zoY0 z5>!d`B$fxS#)Z3IOcGY#k32SS&IOZleBFw>D|{~U3YVoF-dQM|D|90dLk~QC-)%ZB zCh%TWx>(u8yMx)ahQFDz=%chPw=tR)vH$8&>E1^kvS~GY%US~69xc+0HxpmAb=BDx zRPe3?*`!>d!5%T118>z6N2~9AsNvo zIF=;(FP!|;Yz`}Fzr>a!Q$EzWS0azqlP)In3c*cFQLi~DDKy%hh z@K$3ynb=aZgu$NdG%IE=AkX>?>_0gDdHvdRMDVebM->FuKJKN5FANzgdcat;iG4`G z&bC-Pl_E2A7hquQ8`L+M6EMJQi3xMfOnCRZ=8%%0UaB0B8gGZe6)A#57W$_3fDA_> z#J+M(mMk5%ZqJ{_x7i9dz`yzHdsiJQW5kIo-*MOJXCf;x^>`xsSE9bhglp0}r^Og7>M>G#bitBh9{* zxh=Zlc<_b{$s{Hwd+8NFH#+YFYrM_=zBLJxNA8`4h?W}K7DV7rJeI1uXz(7-7+2fo zODa0cN`hD9TlxsPSRJg9bimzxvxSs(imc34F9h#}a{bFIcwCN6b5_v=5jj6g(AET@{q zImDQ)G_a2CtvHV_w+s`tG1?8#w+k>5c=0gwIy`3n1ziQp#F|&eItSR63A&3gVf-z7 zR9`ZxhaQ8r32`##o~!4JRkk)~wf%RQbr>VD1}ZNpyI{XOZB>PJZm7UO%%IHymt31I zxmcDE$?|6Z@*ASnkvX)5;Nboe;k|h8YJW{1i-3q1PKF---Ko6fr3S?sl0T6q!b%=M zAJKUo-y)qpfMuT2mI(b?_scS!^0BP3@e7E|S5H*9dTv)QdNu74h@bMPn6%mY%#|ArR|Al~o*^WG$? zT6PKWwVl4On%uLEI|B%0Sa&p}epUF4cr9G$I%CKeK7{y&`+Ssys<*T8Num0SLN_Ke zB5}B{%fD=JT7o|(4X;+wk_|Ab6RoP2gY&D#&f=j_;t_EmN?@c=ST7>gYiMhiPjO@l zToai7kB4`DbNiNEM&o#E&mKbY#TDKW8s_ump8RTHx8aY2P}FxSd@yk*3oliU<}$!k z-X1|!PGPN$x5|Rk{vu}B>m;k3`$qr(Aamd~Fqn<>_PSRDV8HobV7}JaZ0$={fngR` zYb;yTBnQV`IS-;+Lh?09d&B&6VPI*?fFxi_Tb$t74!FESQ$*}m+~e+8s*0|tOFI$w zP8UgiDYXECwgZDL(P_)SY~|p)L*gEH>-2fsI0MG}^?i_Q({+}mxG)C#=wv)@f-y?a zG+S`_rfdD5hm{lBMj927>Jljg=Zs>aSAv)M$gL3o(Evicf6Emg+C?E*B!a50+#aoJi1Q#5OajsOZ5yTQO18z47vnwV3@U6e?`#)^93#J&( z&4DK!tFfFN)sOawu9lm3f=?+aY!yth4z^%_9_Zs)IAR-d=`lSAQ+O3pd_JDXyf_x3 zQ^+!hfzu-%P2j3n6D$Wt=sLVE2X1)uV z=B7N3C@GyfbGzVbEk!AzTYSGW zPyM8kFk_ZgX9?5*;sIa~sh?eidqkV8I{peS$9_C78z*DE7Io_SE@G@O|nF` z-|X5=B+Q~eO?B08iH{LK>zD%RDw&UfwjbaT@spDJFhAdRD5bT&{)SiXX+~@&8FR{( zar@gjY6{hu51(vdEA#-ZzpG#$bq~L562=@!#01-(O$Bt^RAg=eE$*DgAv^}8e{vGw zW}1=(SiI3cXL3Fb1}<@rx=gAA{m*=&;m_9W8^5T8)6B~@Hzb*k#j*xhzWIP19W{kV z0E4;ELer=)<~_cq6~=Fl6OrCC7o&K}b}$Enq)*fYHyfE$8{$S@R{@TGEfp#8dh^%~ zOG-q(DTg8Z4&1->hl7cs0tO6;pyFyl&m)KB zksR@EFD1R7)AK+3=>&{#><-Ij29n5Mh`YTfD2LuZs$&ZV>vQkw1TFQ;H;GS*#^2`3 zZHF>hkzaZulxIgz|e^Pr+m~k3MdpLm94SjOhX$8=r(CnwKrP^PZ)M z1A+fbSn^3p36d&K{<}nT^$kSAEm2i~+@UE`$j~rL6Vv=C+Cu=hPk>kr!9njAwuONt zsCz`Ng}&KnT;H^XT;2k58nr|eG7q)9oXt=oVdPluzwca(d$FIZ2WHG~=GZ4?9l*jh zy&s{{`k?tlo`Z$A*5usFD3=1jZr@-7FpTrsnWBq_-xO@!JFhH62Xu7@LA?YmSQ^r; zNp9SdM~uW32f8I^E#ysCRSgEC7{+USUqOH7;f;nPDZ{`25%$bE%$;{cQB6zO6-FyX=c&fch*G9IVx#Y^+FCqfeO!~SuM#mp&R`YQ)Rgs zugFN30GnN3L;jzl`)ZWtd*|SY=s%Q}bbg3wC`YGE8!9e; zUTMRSYgLPTT2bxcwjX|OHoD!v7rH$jKW;u=Mz5wf+iq>YHumMg+BlXH)tVEs47(_V zQrDJSPNCO3=}@3QH_5!KXsxxOJhiUPY zTk_jO6T&Lh>IsNGYIrvd=>Ne@-f0XE)zXAKqStj%Q28|P7B9msFDzE_D-j1}^fU~h zH>?YHjZaU#fo*#DBiH?TPis8`bRc`iq5v5O@zM5{MBJ`Mhb(PTj3v!jW^G3R$nJFS z^#0>2scsT=jp+#m1@9BvYLRLe1Tt>31#sFSn)L;2f)?HksYYp(1P9l?b!nv1VsQ&G zE>~{`88pmgVm@_2LoDXD#ISBIk&1HADoraU|9k47d&C`LEF+ zbDEwONp|&|MXfILk*RIiA&`U7;Y%@yhvij$$1Pyv!j{?q&fh zO)nxoa>6JrQ7j`~j0C4!8czv$Y?3pe6ZsEA;Gs3sK+NGZI8(hwKl;_q{_!yC3uVdl^Uo@QzuU%z3sw6|$1fq?cH&DAji;)HWjX$p;5M|ayV_0O zx!U#eQ!T5C4tiD&hclgTBlN1X-WA*a(7%JJ13v2WAvr$K^yY~*`_msXNp#Fpka)Rk znt_;_sOwo#cP6FeKdQ<$ltiHi#*Kv#h=vjGXxj;?63U^q(kx2>tfXm`#y}cHkL?A0 zN@bQdKDktvFFVxB70pa8m8-G)Utv@qcS-$%_*_!Pr$g&1NwA(T@b{ghnVlfq?o>>YDnL(q_q-TYR0{cTSvW@;9t>GoAjLJ zI3SFLl4b0z#=t|%d7eMd9J|(>7;2L=`Zkw%4gPcbFTZJ^-N*0*P{H#YtD>gCSx0)! zDHH^^?(Q!g8Ij7H%=#q4S>?7O2Yn;{a=$;4VPyNtl-N7@8>ra@E{yUCp44tYQQ5g- zDY+aev$}N7>+>-U;=jVG%1dr15)v6yGhSio*xR6bj&4&4PUhwo7a6$4HknS$`a{u9 zjZG)w#JNDD5(hbrUgd~kq3A4fPNJ|iDiSg~E|dJ2(8jGum~!JV=8#E$RyYz0JlHO` zC8dQ)WU{D=yZxlHvf$Ll9WSZg&-UoD3{-7^g#raAw?88uA1K6-T`puyV9ZeEb13uW ztpFyXF93(yD%&AT8Vi?^;@!ln5H-3BnFM@%ZhReu=Dfpw)(9jR0g2crmty!Yr!DHIFgdM}X2{P(4HC2R(9di>9so1YJFN7%+($S)%%IsNV0aMbw{oHJHyMN4gx;=c{e7uZa zPOdlI*nF?;$zu)&=8y?ieWR#8p81?ausUqpvKYlntYS@7ti5-uzx27gwb7N5mXSAt zN1W8Z+|;oL34QL;C=A`+BH_fYq7K}Ys#{T`^h^y_u4Wi=Y+*=J?9V_K0WQS`N#nK# zt#z7)|1GlEzsE!)*jp`&H3?tkNNkz`L^;U?%>&i5%S*5cafSwj16~kOAUYXqB6cfm z5H-&caYmAez#NkKqk%Hb?ZkA>71s$BsC&FyE_`l701(O_A_wOhGxZAC^^*zFHQ{st zPUF^MF|B}>ukzZk5B1%bLIT9prvDVKRF+dY6K^8|6_RlPcj7ug)8-+$70b+7XwGs# z$S{aQ=aZ-D+OwljY#EMM>v-~+B8eC21ul&Mjlze@m}?^ zIKC&8<0BYQEA8yRiRzp-9{3!J;sf~uaJex9bf6Eza`k)>i~ ztIMMQi?wqI5(Q|x^UNLFwr$(CZQHhO^NwxXwr$&HZe^3C>dRlL%D?PYue!VXob#S% zefHGs@%UD(oFm^YiWn*6XB}r6)ze}$#v<_;=Bj;s@R1v#Yr~H>=n>=U-K8a)uA)f4 z(YgmdLccNXQ6$IMdZgwQ%4P8io2~5kvB;p&Zx&5vVEsz8`ce40jdN75^d+1lp>aLy zop6!MkJHSuf6MnzTGz6l)$1<^_XA$ng(%KR2(RPdRMf?)Ra=_QehuDUn;VSX6AxM) zN}TRKP}`#^M(>zzf8u9gR`vUa*{5UqfFq>US<%L%)Gmtl8(n$8gd4|?u^N#}`+r9T3NW}m-9ue0vOfyL4`!G}g1g9MG9`gcw zKmeGk$lZ}f{({yD_H4JlGyE1sBzFH}VZ*R`fwW=?Po`gU4rNE{UA@WfC8T_>=#$Oa z+`cRORj@qEFc4pGzgMCoC2r3oT)w@0#9%BxaI%<51a6L1Um2oityWX2&X&+vn5?h& zfUb@C`DPZ+;*Mth3{rrc2Wvf=(WasX^wnwme&)+ckKq}QSF%~Lr`^H)qW#$8Qs{w(g+pH( zs8qji3PeJMa+A47X`3VfKp%+o;z|k3zLVctqhMLAnjCl37P+$Av-g^W;U5WVPl3X+ zg>i5VVQfe(6Y(O+Yl?#Qmna7qDHmbXyrI}NGQ9Z9DZGfkUJ^OZT|w^kQjZdiW?}Ww z;|D6#~0a8O596GLWH^vL0NCI(zM@ssY(S5z`rE!ToB{* z0-A0g^ylI>nh5N3XJBQupgyNUu^U*(@qSfx0RLn5=Jzd-2R@*Ta3KpjY>+PzN=%-b z)RrSX%WF`ED04mdae8qdYr?0AzZHTTy#9^aU41~bgX8O$4*_V$^b z_!pYQ-}@9}Y8&krJgmpjec^;?h+#5e%>lID!;qd2c>i&_zGh?PBCD@bT$ay^-W?am zU|fK0(E(3T)-V`K?ien5phQ$^@jc>4A?9LLdr$)_+)t35v;Liw&SUR`Q;(q0{`ygF7I=TulH_FS8IlJnis{JTx5 zP$~ad=K|o$`;u>_wyNN9ptq)o<<5R3*4zc^>Pky ztX4rG1URa`mBczsC$6{`knATPE@1h}?0lemYAP;0 zny9WEo7@2`!zV-_S)Z>ZrihyymSVgT>=1)!EX4R#Yqm&V3_Q6Y5m(pYaEQv*@s`P! zEfntG{{lKOFEq!{frgF%x>Z~|3Dv@_)V@=-akd7;9rSm6ofTD1o|LK&%S-NF`4Hj+ z1@->QU21$Gsz@B1`btht`SV@7UWNGU1I0yVYR;5xB|o$T1*?OTK9S2fo#n6PX%1bR zqg>NL0Ez@dG?tT))@@e;eiJw5gSo_NFI9#MmR(@D*D6EB%*xAqzg%l*i!2-PAK|p8 zizMV$I%daN7~nl!`r!Il4FhcYLez&G{5bYy2`S=Sgd5wpco%vda z8(ab3$|LgBob3kCi_P6@W!ne-^{YBbi06ud9x=;V3unsi*IuK9tH5rd$C_valLqws zO<4Mi)wsLx^?Tg;`OnchfIWjiOq32_%~D$$AnV;)J0J7 zoD&i3cVsIZeyU zquvvR>I))0wJDYsdH(HC8Dkt)j_rE~h(ih0vDgI)icoQtsoNsq*d-l(Ei?qSrRpzi zH>suzCv?DK;+ulKB*dWDm1}v1duH_bV#O`Ux=f&LRv^3PQfv6-KCA95Qckir{95Fk z^lxPi7O>L72ah8)5*H1SEw^&30p1S>+oEqCRw$Ws)xQYZ&iz=n7kwtK5yh1ExhT{z z^DCp@$m2H5y@5muSqR9Q)W*sfK9?>$kX4Ite}Mw_GtY$CW5cUq;8$@+hAGK5N}LY> zU&Fn$gA}xEPwH{1XfBxNGJBqcB)Bq+30Kg|h7_hAiDw`DOIUf!rI*?{B`DqLU95~2 ztV30g!!iP2n+ps#-U7*qIzf{}L?a$DC zWE~3oK9ycJp&jFwlXIJq!fT$Yf_kS7yr8eDBpFq9z~XgyLaYtqVbCnhshSNGJz>xj z;lHse@V}%RO4_dIBKK zY3+74mQ)!ixSzPxGh$bhsS8AjZA#m}=FsPn6P^Jo+e~U04j+`zT4TW>n_!xBbKgF4Cv%t{dbMu79k9TTpj;}! zm(LdxPt)+Ppr#h{E1L{VMj(!V`Ak_Us2izQiJS|Uct(%H+B3P(}_8!pAshE=M< zz-mmaV188J6p04Uvds~m5s@x}Z%FOZvO_p`WqVdotkX)wGC#nVa9prJ6{U-K7TK7Eh2u6o-=j5!nP)fsvJsg5cAq$L@9%+G`FsNr5@+6d{c)k(zK&HJ@iV zVGcqO4zOv8R60z$gm4iR=TM7fL;jSo!7d>Q^9}+#E z4&?j!G(VaGHt|>&3nU_I9H1hcdW10?wMYHNU^=ndqsb!ASDY&DbW2KEhXbnNNs{3D(>&NM3cAL&J_W^9x8Xss z*X~~o+ID0&ooE|*rt=3I0U#`-E4_VXBZ<__=~lR)9<|V$4GwY#7Sr+)bH@RA$lAQ+ z%v`Qj;CbK49gzcjEW>|6f$Lh=utr3*>M#r!yLlovLAfZyA-Vt&DsG-iDJPX$YN1Lv zbX}=YmSfKV(Z_)!ejbZ0cqH>ZL)_szofD@5s&3;HOo3>v&{LgZQzaWU76~FJL$FP> zE|_|oUB%)Q!S2l;uvlVZK#hm%1Xb#a!iMvai$Fcp1UX^dlyhC)n2^;KGlZy@Lxk|R zVG1L#Z)t2m|JSv`__{O!($)w98@i>^W{U7|kC{pL+2As}X~GH87EWR4WhhfFAQlj|ux^2`!<^VTlJ~!I<-#?{v9gi!~AW z_9v1z6ALk#On{S=G;qaeg`uFR?kH#N4g%3&!3binCN(pi1DhAwvt>E@2Xmb=!o1M0e;8P%-&-PdnX$K7zl0hF@2~bc} zq1{_93%!Sg~n2kUX^A$vXOCZ13b5aagz^k!uu0ccYXo zk?mD{ShJro^7Aex+7JQ(w=VE6awQqK|TC4ON}c*ZAb|r)d9m0rfqD1D*mQ z-5+(*Bau@V7HP2BqXJ%$W!>ez%aEzsa}O*~t;SY=P=dSGS#8)?46$#FAUo0# zpI0>Iqpt#yq0$DV3i!25#ru#`yw#=U4N#(ZIw&}0#J+Awc^eT3A*~4s%W5Sg-hF(2 zI}{Df49C40Kd^IdSm=O|o>~?-9G@pjLsU=aKpWiZ~*MQB3bvn>>c9)x^`5e*kAO?JaWOg`$ezc!&)6*i1XJOWAjIMe0^{pxKbeV zPzAf%_iFxDiULZYP$)Il4C=R9nd*rh3?)W39u|Awq;@jeAy5XowpYU8}umwmW79pqy1W^ICy}G3?8W)6uMPFAZ1FC$u-$M zPPIiKby4sTabWFHu+!D4%J=+x`}JiRo_=f}=6Yip-eod5D1!%@u4h5cB|x8$He ztdc<`V?4}Us3d3XC>~?z{2^zOS;@HYKwmG}R2U}rbce-rbxuI%ZU?jyX6D`2`NeCP zMQV{Vxox07*sk)=iFcWTh4ukqFB&eTMj)1u2bmi{wMD)S?E?PU0*=|2)6_~RR>%_` zaYwVr*u{F`=fD{AeM)|B{Lz>XR`w*uyIl5s)MT9~9k-6fgztP(kh(f5h>L9l{Qb>r zbD`GAWHeyQZFNls8uHs8YD(wdGZIP^j1H|nSwuXHjc{JB`Qi$*sX=rm(#oV@(D?=-z$m1b3Wa;xL18DpgO>g5b!5YyYFN&hdD%Q)$N=Z&0qV zOCZX5Odk6D0|1rgBW#>aahf+&t zSsJ0LDV4bWdVw}_2_o?vc;RUg^E*9s@aSpS&DxWv#+lZfc>N=xN2yC|ckDOpyB7(k z#&`<0}~1;NLg7DX+)mHGk%@yKY)u5)xCKWI|E>X7kRpoH98 zva}ZCY97Gr@f4EN3E;vGma; zc343+iW(wzQoBRdsx|HMcaigxYSKwF?Y^T`3~1BxVvN6&6pS_5Cj3c}xaYhl$@EL$ zB&O|!Yf{&}@{G|#lelp`PLFhzY||x-R>=VTd+3IQnGU@$xL@spZTm4ootrE@YSVMsM0wwC2QCh7iEJpLD3>#}Ivo~s| zxpqj0A?sJKnDV4CP3pL&A+M5K{Q>3jzLFw}H;*#&um7G84ft`JbfGsnq_e=@)3r`TS;Eg6T#k-IwEQvmW=+ zJzv~QX+Lj=Ll{tvw*$Cf#`K+l0O%6{wv%jo_-YuSqATHfa@feL-Hj-lvl^tFVC7tAAVmBX4a*jA%@nAC#tmy%n z;PzVxUK({%lD#+YbvN(g+fq4=b$0-Kv~8Bdwg_mx9#9I5(&}T$iiVODg)%q~a4}N#pV-Mr&|o`;JP<2NQ)dEpOcEk1Ayr z9q|`mr~2kwTnQI*Ex9cVbH`hZ$Xy1BlBeb3ou3)$+I`8fz*&b3tvB?zrax??bQI3G z

>J$=z#V99#P!Kpc%m6Ob~KQ(T${UYfD$aw*^{|B9&@jp?S8UGup%>T_gJHvma zv;RL~nOQiPSpWA7{XZ;o+~x{`&ueWP9f+#P5DFi$WVKb^OG!i!COsmckN8KQjze*^ z8u4Xw_Q&q4?^Je%mxKkIT*25Uhto_3lU-|V4PWMJZ7pAym!A>p$#hmL+wD~4<+ZDU zV`H~p^B8K>g!S!IcCIg5mUUx;-?jO#GFr(D+WLeqSI@`u#dp;N>q$ixO+#_}$AgEe zSxWoG^=?Z0Mo4Sv-K}lQlqJ^*f%N&{D6Mx_3*G9;#dXybq|J6uwY0LL4m0$NjZxdYmXZ*h%dm4gVUv&AVPFzy6 zD#g6;KNp?l8ryjW^=IXci@V@zd)HQPZrOfkxr5{OvneLhUti=ucRT!HvxcK0G)xP5Y`)ogoxCgqp|*)HF^ z?+N}Yp>L0x;24fueI}#;Kd#-ey8Zk{%nILMYW7rPV77*jjtKdK_YlA%-|U(_4$wIA zm$~nz{!{8~jNsv89S7~~g@i5XV{|C>yzX-1BXjnVu-P}N*Ns$1)0lY$2wKzUACQS! zufei$O7p*RauI{u)1lfXRZ{6z00+$idd4CGL@|dcWXxHcygHHU*aky55H;QMMx=h@O|CTVU1W!m4A8)u%A7O-Lhp~=QS@l7pADRx$d z__3>`Ns8FFkfR(>AL355n{pG9)VMS?X`)({s=%^Wpj=UKBu6>SP$7c^)*f?7J&Z=} zwip@G5e7tKf?{&SZ}zQnf`Hxspfztlk%w#_Y)A--gL^D_N;@4`bJXHcphPW7VYHJQ zyU(1E+RVjYKB&6qU`YWQVAdp=3Q*gSQ3a(VXML}3SMbMZG`Ui{_|1Dig8A?-#27pv zr?u6>5dYRfIQCRP@e8Vo9=M6?m{6&zNPWMj=COUY5Y-=#gTY8LA&ER7`|!_4a0yEE zmfpQHQhC<9Ljp#K(+K8*dH+P|yPf`<=3NFkXw^}Sx*rQaaN>=hbyDW50L3~xuX?HNVxMobucElEBMIaXhYg3pCIyLrr!%JcZY5T7u7iXO5Eq1yz3*esIO4 zXp!Xs1Gx>pvDH5)qVjbNABA50cx{3i!l_hT{Y|rBJkoH`B`~(H5*H!12TQ^uy{tIf z6fbP3E$o$Oa>vc=01?<@VvWLnUWSD&^xR$ja$|-6mNBY<4?4ZEl;_ zgiYZ{fh?sVRYv5MGHs7^On86$*A+L-TioEBlf2aN1t)UexjbNS4GXn&Ze-Pb3(dYi zF(JNIqoL?pnfoDe0o!!%rr-#MiYh+h)=R%{KtLdN7!rkHNa&LgAbsom$XGFUogQr@ z@2FbGx(jrSK?)(|I;OFPWCFo;Li*MPcF=2xZjtOQ@FS_sgs?j803GCP<|wsNlCK9~sV!%_I8=Cf42 zy$a9^uJTK^!L0}PH!XV`Z{Q-P=JDp2F{0_q>C+5WEL@5wbb&ZE_rDvk)(XJ{O|+aX zye-r5lA~5kdQPV)E$5CJ0f8QmYAj_vd*udE;kj4|baulSNMTMk71>k6{xd4vCFtj{ zaP5$Om*LfPmlPqV62M>ryeh5~aFF#BCOu#USD>AlnnWr}2i0gI2WfoLopszecp7JC>63SNIH>t%qc(f~|ye#O;w; @@ -467,13 +467,13 @@ Using the term desistence in this way does not imply anything about the identity
  • Abbott Laboratories. (2009). Estradiol. Architect System. Abbott Park, Illinois/Wiesbaden, Germany: Abbott Laboratories. [PDF]
  • Behre, H. M., Abshagen, K., Oettel, M., Hubler, D., & Nieschlag, E. (1999). Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. European Journal of Endocrinology, 140(5), 414–419. [DOI:10.1530/eje.0.1400414]
    • -
]]>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations2021-07-16T12:00:00-07:002024-03-18T00:00:00-07:00https://transfemscience.org/articles/injectable-e2-meta-analysisAn Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations
2%)dy@TS>HOucShmE18&hPQgWESmMbW45DvHmSku6zdx4hmtrSY2?& z+D|N`TP*O8@ATI|KKvRylQf%4wT)R86~hNSt_q7F`-6LVs7&rac{KoS9^MBkI4H}q zj(uEh!lDeKj2S2z<$bJ@v%ch(K$jto#zyV{lxN~k)X$Q-H=7JtOF_>5w9|DOj)$cj z|3bz`c_?=hy3!AknWk_X7{wZqrLfOWH&^NOr&v6Nn7N=bLIaAfNs2l3=-eA>3I0z4 z(-|x+!$R52*EG(0N}^{0H8Z@K!7k2zk4#n{ixI}@otQUXv`-`^EgGnPMKteV*8&M| z6R=Q`EX)b(JzJ4qt|DUEx{IZn{Lo?wr`kbOGgE&}A181QTQT4`nG-)i^*LJ-EX{i= zX)A!NU+&MJVb(>G6*br9&JfFS8VW2cW<8ETM@Ryj7jt{m-4S^$lcpxTp}IY!Ta330 zY>Ou%4Ut%=Ce$UZ`W(2l)F&rHP?jvXNWpNRMbM5GhF8A@Rp-w3**}Gcn@EP+V^Pbo zHxG)l=^m;mAw}8zRSWA1+;KpvQB@)|+Y>m3eDh5~f>V!(bR>5dh1mA*Jv1!mrxqS4 zrX_?c8S_&hiK@WAlrWQ>qW>x>uU&M^MP~#9VQ(VXj`YAHNO)11Byh&d9oi;xU`h`I zryJYzMJQd-(83NlLF{Fgr=+(#E=+lhS#pt$p%&uPp5!8e8e0jg{mbLfZHHMVEN77r zb?6J9p12bm1v4+oS3_bRRvHue9~h zQd%@{wWkE;BtIE1b^Q5S7b7;@Jp#bTGa7`=U(lJ)*T*p(dnZ5St3LqaT)0)vn5FLir*=U1Zd6IfJ zd80s!uV+U%cRRLxCFJ1KgDx)9w{WVfqQ!bw>2Jcu>sZ(7PHgR3Y?>sXCi?)dO^I@? zYm}K_^OD$rT2c{Hmk6XqCSlW4Te8Q_PnN9%7OO;)KXs*AN|57^Qanzyb9eQ*fTX$1 zBYISdMIPHkR5)K=q+>vaVw=4Za13ibXeQLpM8CeQ+zJo3j%avLg3#EUD<@N;w^ng{ zzG9v~Xf?JF;fZYV_*yyDG)0vrjzR%#Kfi$L%nAf--H_(Eb)GNe3k5XC!|X5>EZ+e$V1no>v#t6h6O5H{F+y+lsWNZuBrsRPyb2m* z>A%3F%jV}>GXQ|}jv|9|#o>*)i&t|^dtBm{&fRu>N(!#SU(Hhl!XG)$6q;5WZ zr3am6X$N6=xjNZB97>75hjDZ>PixcDisV3V^KHY)+lCdd9Q`rM5X2TBE`E|SM~Y$I z@^~4vz0{P?IZ8gGG|;}G{b1K4Q28CmT)PsxN1kOPU6ZN&_N zn0AY;V=}=74zN5C$D_b;tn`8R6p_$f$FCn*uw(#H91%Gb&48T<*yd7btolfx2dhbI zWeX8ha@OqfLaPsr?W34p26z)9qUR^sTV8fAMI8Be7dRLA;nYs*OV$KSI#=y5TAMa? zxUd_7+UY&mk%>;o%a1F4BJB0MFQ(dJo;V%ju{K4Oh9~T;c2;e|tll?fVfoBOo(G2mc@z)WVX^WiSjh=p znqxJRH1kt;hAjuBWl6_a0CjySSO?Ga!4TN*hQt6OL z(-#GSKv0U$DT#I%r+x%xrKeFXOM?B2#4#XPvk?O_vK%q*;{^OVT0gX~%u$ZOayv^X zoWn;+ci(eh|4;ABhBiq9+fojct?B;xvJAJg*ET{Mv9?+FV7B#x>+lg}z5last z#(hx_V{D+_TA(eKUB>@x&^Bo|-pnf~gV~NGEK=QBdlI9u>NT_;)!W|t71pH=e2EUC zYyuvUx;BtlZYsv0#_AGS?QuNu6F|W9wLoO&A8*r+;d1rM9}Mz1j3xkHVM0u2(L@Et zOe#kixboO<<-@sb;84ATXY`M(jQG-4(m2$pb?BbOBr^@K{@udJZnY)l$o6BEk7Rtp zIby6hNbJfij+^GBP96mS`kZQwST%cDT5RXI_-; zo-l0O{Cs5U{=0}GERnshKz3#J?UOokHkf_6q(_%infWZfvBoge#%sXmT}Y*3LZ{TA zVm=G^XCR?h6(;cG^W_3%Vkj$Q$$(dIST${bxyH^QxLxtc@! zev%?ao4jMyYR2Ha88o^h#XZ7ozKe?Y32{dAet)$tIc=}}ccfbNV5PG(QG{jeZn@NQY3E?}HA?dDx2XZ~XIhBI z1J(V7w?SYb*wU^UXqBh*u2tlESA`({+6qG!fI-OfBVs1smpf3*K8o^YNQXjyP;cKJ zm0_V&4310jDt%8Nr56;|{wPVU@M6-p~Z=*l08OY|oh1uC_#Qjr> zBMxZeZj2wK?$eZY9N)_>fZII4_!G)k*~mqeI~~#yERuK_gg1~&;*mlw877p7s=$|C zp>b>;OzeZp0og;jkQq-#xuwWn@kCii;ydZ`hy|r_v5?tX%JuCP}8>s9VhCgcx4gwH08A zOo4CfGRFZW`Agol~KZ z(-e<0vcY8^l|lD|-EBoAXda{d7?YeP>@ix;0;g~~glvFD+YlBG7NIN%$8`$6VnFt&#)C8TsvK;pT%acn~jY@7i239t)$+0O`NEIma2R9yIDt&rK^VLCf_u7zlPF$nQkG; z9Ee8l6{hgia=*#DY=PXBXGnU%o{Z6>vYx23X^XMs%;X`)k~%!}xX)UkR9GLwefdDg zw;<^>(02sf9egpmRIL}u0|w9CQtv`HLGF&!1W3@-+s&IA(jH*h0+U;UN5q-?GR(n; zYks)~FUCv8cv4yZ*a)zh#gxEW#4H209yNwMyFB9{&;v5sOQEx&ArL%Jo84<7J-~?p zhW&fe8c_iZP}txE2=u8jQIGvgu-hCWJhCoGph-osz$PF;$mBWokp;Xsnfw3n78#l1 z^9}Vq)TI(F;S(D6l-w^Xe>}Yg3!@9rbUtPtMPg;?DhQAp}F^(Dk8yUy{R|`RiQI8&!waB_u5<@mu6%5&6sJ%j6^!=16JU zStLke6We-wyfP+l5*@D&xQPp18M)HzOnW$Xv$J&~R%>Th&~E8OC{-&TC!ri1Th@yR zk+L?EJTi;Qk+ZM>@%V-qHBt?8FBV@a6ALC5ij)l(bG$jXTYQ+Z%oxXqEk0ddW~alF zmUP+F9*L7qDmgfEW?6q@i_A{MGmkuuXS_M9?V8JokxJjZ*e0iE)xJ*&6%Lw$LUwp5 zhR;>4?;DFn*q>m6p}{)v^lG1FEtLJTr_m0Sx!3*z)!1r%7TfayMjYTZwo9j~GIVYq zXmM$m-$!`85{HjCxlfT7!EK+(=p6&?lz?ry1b~8j#%I%ArRjELu7|WXdKlD1`Va@> zga``LoI&4QE7;4B`al&vY)c@qy`&+R-^MUVHDKp9-XJ5h(SLEF&u~IS<$L6o84^r+ zi5&MKh@fCQ;-BN+L%r9au-rTsefmpn6LHg6dUhhrlxRYwm9IOu;PfE}LY+P6xowQi z@a(~m*UA+Hk5v?@3yOj#A@o+ud^kv&>Png_QCK9I-W-`jpIDxEJt~0dte2rknF|PO4wHZ+cv~WqVtg=K~Y)$bP0kIs-t~)L-cmb zu&_8&mG6Y^>`WtK%df}!#t*7Pd4Z$^rKeoy7hZAr1Zr08%6 zhCG#eYad@mp^vl+k+JXzC2;!+^ADUIGocc%gQxxXT#Mk|os#K+mV&?LS#e|R%b2rV zdY!$a{|5qxpqu}2p8%g zIH5t(SX91b&z~RJtxphf?Qo;*%^OlvtNCf-;}N=&(8Ej40;<5l44JAzr2r$`pve%} z0AaPMP=x37YJxy2TZ^Wm4~Vw{)@RYt01Sm$@~-hRc!gC-bUR0^zYSt>!8dt;Z{Ooi zNX!QZA_YVTiGW<%y@zQ&E24ST;E|}fMMv0#yDWAd_1db}oK z-RR(R5Lk;fvjoloEthGUM8oA@0hjt`w~2;-vDqHD#dimhS= zX^qfd-q06ANa)#sQepQEXueQ+*AHaD-FUX;w@^QO&6todf{@Z9^GZl#3L964{)ymh zKUkGfI=&@nT9@y4)66a#k$d=LWRMyD(eRWSSC0FNGA}!={ctK2-CT%#sFv<)=$Zt% zrxyc9@#Hn^G9`nsfk>F8#ccx8Atwly$&H+?4Bs0_E`=BxX9oS|`*@|rqRvuLRi<&j zz}xx5R^|L^@rzU&qMCe``NjgFk-0-Lv8%!;FDj{`#rpujm8o>vQ7*aSFw z*1@>5azY9d7i10%UcngyyeE%yhK+50Q{Sju1qlTjUBmhO zLd*>M3-tN@?5HB43m?ud$*&0xQ$T}#kF`ska|_#uFR0*AtTQ5hWH*`(k9bY?%bH1 zURyKIrsnb^U$5&^>Sop5*`^Fsg%34Z!U^*4K+Plg6cp)jW*fjmVv%kmS@E?zVUiaS z;FyyLn@`GI&F9~A2FaoFSB;4U^Xh7l$gug-z5x%1ov5lLEbb9))5H zU>1!92klqkL%H_EEMgbCY!CUh70OFlSM9C>-L1%KrJyqM<_nFgE{8P5R+W8rjFS1M_oghx?{(d-BYAhR56 zGaaiLg0O&MC9k&vAD!@5m5}WShg)jldWrH zhoD9@dpJ?F>CJesZ$s7-G|8U6_F1k=ATWeEEQ0B3>3)Pwt^3Q{SO}}PZqURSo!Y!T zY>~OS@Thbzs38?05}M75(n^gNW(M@unyV2V7E)eg?GctJkugC;^vBZ_s(dsXx#k@N zAT&ZpW)R2)$5t_WTFxvIPjw1KQEXM7PfYj13GKIHZf0hJoonuXWmEK3n$zwyx3v}k zbIDrJY*M5_y~~@Ch|VVHML4`0qO_UT6&ne-P}bxT1GkJr#|i8MY@$d3PKbS=)4uqT zD-jK+0Bc$ge72?TsF);#S9oBEE$$tKgLIQ7fftgZyc4Uf=4pvq3!1~3Cl$X7)yOqB z2@m7$Q=2C4C~PJQ&OqLEX`2E{_!B8>tS1H>Tn-b!fR@^eoAc|*i!32efdDFr+MbCb zS1$+9(@ot_V!yF?>JIlcr8Xd@m0ei(88C+6D9ukgE;!aw8 z1XuXs#&89kBj z0etn=wWPoUiPkc>&o43WepQQG%vi}riSx~hKf)`(y%D7?8}oSRVHEU`m@%Oe!>Uj( z+!yg3`-aQw8P}%IcmzHk1mmJhBAJ5TQ^uiacg3);oQu3pn7v!Z2+sr-m3eksM`6}m zQVWogna021dMcIpQb84(T19|hcDk~vU8NoK#pm^1_V%m=huf-P-d+t^oQ@Gc2rkFJ zAX)psdX4)pGWh3|iclf2yo61D-(&xCg$3%QOd3TeL$JlSywJ1ihN(4CE`$Ny_O3t9 zHuGuR_okny;1jnNADy?9h9~PoVe>EXmoDDLVf1md>GB-|d~9ScR~F9ptmv651P!?j z!tT=hD19^g*YFxEWq4<29d=VNcP=*%vcByvAi4e~d(ONMP{pan`NEsWA_c*f-JZ@u z+Bh(b;;TWjfVok1DkB9lOMNOQ0^C$;>8M z#tc_5o3Jaa=+FFpF)UWjYmhZKo;yeuc_|x8D>)oO1B?53>lyz&&g-Tbn*Vs2yLT#H zzITE7Wvuwv!0_c8PP|wM%w24~h~;1_c5ED1gLKL$P}Fan(_sGzUeR zV}LNaG6}G{0eS7~>aDkP?>hkhsMlBoqW}4M+-j}fs27rH1e)5H4R)>?`j4}H=1oQd zt|i;-FyJdcyiru1#`%NV=u#e-Fv>HMF!+c<7cQ@p)9N3h#h9uxrr4eXAWk0h^Z+ha zLjcI)t$abxyaWN&_KQMpRS|Awv54D^fT?f2Cm-nhb%EUgyiOnJhYeci0UzxCBB8%5 z%Cke_?{b9H)Wu!vheSk=w;CbFg;t2W-lB7+;j}w3$tSuKPL&GtdNCzyFqq+@&08f=_m3Dkv#8v1H&4!r(Cn*=vKJ&$ z9_MOjt5!5W$S<_#X>tIom&;m(xXWD4h9;;Ni_9{p7evK0k~Sxze56B3eXIlZ1Ce*K*I zEB)@tu0pL&xjOcEx(#Z1@!fmQ#EPb9DI=0i=r31p&#okWGE+Y`m$|ThBAK2ee|ELa z$%;=UvXzSBd5WYnhZMAX>yoHqb8>WcGZj+3)EaTH;*0zrbXAM054LKj>Du`Htaqzd zy+1q464PkaAH8Ju;BVirPGCZQQ+2ypQC8pIKu!1Gv3Pc$Ct|&NwqG>m`YV%AU}IOzb<48XTECLMS--x?gD<0t-MYWd*^R3VM&ba zZr3(Knw9$t9zFcu=2%9lVTT%01w*V4_11SibDtBD<83EXyMcei;0U z+XEN0jVt0#q#RoP?ipE#Go}=i=~!-(B{*8aru8fcl0tadPlM3@U}J(ZN=3eBb0G8H z7!~iCcDGfFGMk&QbwrxUySxc{E4F7mA7=ged&d|lhZ^#O5nH>LBtpl#tjZ+Q)odF- zHMOt+?6LF)SPi0)=$eTlGNY}^z}V% z3FBIALnR;|g8E<*`+--PQ9;6p$cYM)JUe0B@Dn7 zoX}CJ30_ij+_vY}bageOMxqAu{me2xNvJVK$C7oGa*R6h!d!N42^T|9QtFX9)daV* z=QACwC9>w*H0S&Ahj3A&0)a!zazx;Xp>`^gSS9}g?{gVHgf?BUkV`q$xV#}*>>MTu zdApq)Iovp7o?+GZxy4YyFWPW2nl@tCNZLEs-I!egP*Wb82fj6$eD$Eo?V&?qKGGip zluwHuc!jO1L+uNJ6$W@XZ@Y75SaQzCI7w3u9m=}Hi1P-sGwFaR-Qs7*(rVh!gSl+9?eP0D;q6iU3zE|{g&(Ap2)?T}beko}l*PYQ zZg;`|DnTwv4z1!{c|qi(>XjI&RW;W%k9Q7VUl`WAu;INlJY}zFGRi?urkN+FJS$0b zXD(&HH3E^{+H#93{!v<0;P9+3dhuesqIznYIgJf$+2u3Fn4}?ZrR5kY^VLvK1*v&> zvNZpVMvUkGIw4t0c4n&@mv_HR4^g9B8<(sf)bf#;W}K0lR@hxHCVk&3jN2|#`0=b0 z<@l^`r0vQ~c|Hamk52ej$d!flZvGuPa~qWSAt~*H)p_q8_g6ZlMWY)Pu9?{JCe49l zPFagNU%P>S4kddE^@P;c?({J3SyQ_7ZMLD`!$lgPx6uXuwYgn^A%6(fis^&5mDjj7+^lO=cN2M+trH~{iLtz zl-<^4D=~^oM29G?c|jL83L3tvfxP8Y`ChvX>FNx23)^f(NxYs@ixca1Uw0Ud^duaF z(h?&q7!qu!GmPU83r`nMon5u^=6Ac$SE}AcaJixtTf9$5K%wvhjyjhgBT>dMIsr>e z)S_EWH$V)MkjEZ41%%GuB?t`-*+qP}Hy3l3Ywr%TI zwr$(i^z1}z>_mL?-`S0cIJh_$c`h^GH}iR@ZnSZQH~THtsFNX2qvF;am}enyI*lW*tVuYA5S4fYSVX^+W~iEIDfaOY&78?aDQTBi ze@@7kS0kx|9y@RfQCsfM-*6lKBEl{L>aYGBu(0-l66%(5K3N=2Bw0MYA8>X82MrCb zns2gFXS4lI!ND1LzBW)v+j$=f$|XGz;5U+R6qy3oZ{PhH4x1jpr9Ma7r6cIa*5nt0 z$bH4q^{&^>Wq&dEw@&91;ehL|X7J>fvT4ZXi-ARfAjn!2_m%^+Ak|pbE)KKFdxpaV zsbkqHHZU36tmZ>!6z7bZYm!i|SS(At&+tlucec9Lq}FXb0}@0NPMqy{C!)9wnz`?< z{<+&?Hl}4GP@}o?jDV?MM&n1++EgBX?@l~g^vCz`{TBY}qd_Q}YzR;xKlbc{n0_>8 zJFu5u+=iIHlNgU;^dmB5ux}nY&0})-BYR=2apxwHz>|nz!7}Uyz6?gb=0}_-$jF%U zyRuccmN+s7ImRdD-9iF_P0rn}(69(x8twx_#{j8W$euq;6oFvJnm)9Ad(x>e>2NQqYWR%0Nsg}62r(%+!wrpR;unQO2p3$3y z#EG{f(%ic$qjv7^o>=dg0$#kTZN?xA!WtL`nkV3ej>Zc9n-(ye^+r`n}|S z+rRC~Z>RFYQX2vK{saEbp!B-kHtDF&b>ycIO=}A(m!1$x*$HsDk>3Gtsza4BXx3|K zzRJ12g_aOFS%$#fRYAl(^xiM3T`z9c2Qd2baH>J-0{mZUt2bN#gJ%Y9J=RD7@R7mB z-g~+y3}{+W>`#CmA5dXd3%XEp0>Tf`xqikX>uP`5sRB9*9i6i30)!XIx&+7D{*Qrs?=1)NAQ# zw*R!D7XOQEu8z1J-Rjqp3Xn558a*|WivQ*QhIo(j_(r-_sYZI|ThHam1=Zt5YhhF0 zmk)2H=`_C``KFE|jR>cgrdHOvsHhx$xijgfupc_vVA%JkZ0I7JwV9|t*18z+yR*LB zAKab8$8`&uPBI%)MYpP^jQ!l`%rbXkw`yrjHad87XDaELxzueQDXSUzBd&ef^v|$Y zd(XMAJnGmJ_q#s08h;@3)r;EK0N#tVTWI=}ogxlVvDHxknRM$YukgyX}9@@Y$nT!z>ud??x!rUHG9Fm_xb&PlJ22r?8wWWdLS02xa ztfq=9Zn3_YY6k;C;VIfs8eJEz0{PZ1{cw)*5^oSv{o4*@{(uMY2ed!;@Kj>tWY{iV z<;LoRl`75pQmy~^mRl%|yi^h9OnNXPt~!*yvx%5cS{O8{5zGG4b6j4FcofriMBNgm z$?!D3V_Su-N($S;;T;rCpamD3Yz!|`U|@eLa^huBp3o?ayc@RJ)`6~2#T!Pk4v zbrsgP@j@L%!)p8HQ6rSdocI>G0lEW)qS zqeXaD@%nIY8#IsecP*l@CKQ-A>V`a+wZHLuWebLOxo#)6B9m%@_Y2AZgbYIUi!l7Q zNghJaIp;_#usR-M0-j$+-WZ2;Wvan3Y1VPNFKMTV9Gik8v&fSi`6sOn$vBlzi1Uru z($w;4;$X9^yOciIEHl7H_^+))$+aSz=m0ZrExkzyg$ zJx$QC-hNx?7Y)!(URo%tvR>Eq@gFRSJhxh*QGG7DpJfA&f2I>BS(nf-8!?~`5Sy7T z*EOH%tPHi~VR@$oKpriG68-Ue>LeJRL7zYZjL*nZlic%`!WfF zB&CJm*-?9mo0;$~w6H2QVC#IhKSfWh?wLVMgX_Q$SoVGt;5m6B9Ctrbfqa+Kc%2}sV_4&y6=UT=)Q+6b1A52^Z z1^-CbEQj~Hk&l+b<}w!Hd<>unem=WTflwe%{!I;|4xy?!&_^lyDS>*%QOsZDrffM? zJJR_&1h0&pnEYqc+?aC8`?#g{c0V`6x}oi~rb5r5L_wf$ul9M+|8{+p=vpihx%Ku1CF9CH#k;Yz3 znO-+={+`Z9D*sIRjA@|x+J0Ml<>>lhIs3wesb@wZQWJ6@yX4A8I{=wWMOjdrStx~f z`Zxdy%NCNsciE2o!fglqt}2hgzt(NT-4*j#>&UM7?<98iC?53rBTDVTegbg%@O>Nn z5Dosm)A-cSEVT@;1$pmTJTnqn{32Q%o=jp}pt0?i^~x2p$meEP26{&UcR}V5a~3f) zfk#v(i=KkTXlSRv+nUM8G9rAFY93H1M@40!;-3SPa{C)6*Z!{dirMl5F+1xF5LBzp zmw3kR_8KN***NlvZ&{8&C|J<+4&Z1c!jXWx2;^^hanOSa8JzT?*QnN*gl_T#emeTm z^MtH7e3|;pp zjYncT^lv(_5_wP`eBL%*S?nSWc+O{ZXlSM*9L&%vm#h&?{X(K37q(q&MnWD1iEh>W z()5g&Qq+rNvQrQ-wQDGbnh1A}$ceB*{ytzZ$}C9`hXDYq^&{}y$p%~iGGidd*ExcL zZiELFxOFx7hKE=)H9v1bhHPp8W@Kjur_u`wYTC@scB@i=_IdQNSMDEG!z8S|bG96N zsvW^nhp%+Pkr(71x%HwJqjm6nXYz+1M<>#`p+o6mMGq8%A?{r#`o-M2*4<@ZB2m6L z)$fG8<{^+kZbF*Yh_kxR@ac(DyvsgAv9UQ96jE*r(H?kXzv?eg3c|Az`EUXVBpYJU zYNn%TR8VFLe0!RUwTLP+WQX;mNs)CRxH@IWobDx(4ED6Ed#*%T!Xqx4CW9nssj59> z>juY@0}CaU4U`Hde8gNV_(~rRk##^?@H}ThF_96FPl3QJyH_p|YFT7Ie6`6h2d7Qucd#} zqC3SdFIUH>>%ro(p^FuJ`l)p@<@u@!=p5ofXY&z~7ENyY9Y@=gq4}U`=;pad{5#)nRsmq0h93NdDl7z<)=eyQS-zas4)Ab)c6zG_2c#if7ANIJm*rr(Q>aInbubkBe-I z8W5S`YSs7SL03tu8#|w4yojbwD3%%g7n~a$g+?9+qV~}ler04CpaBNxBy${HN5w#L z+)0nOT+9gR-V$rv1wxQiRNmznK_aY|EIQ z;gPbGH!3u$8i!Gphc>UFfydtEQ=Nrs^HkLo3E>Q){{HZ8MZDOD8aR-~;}W=^}0C;-@qxzAh6zCmm z=_+q**TJs2FBTp=&!N~g+D?6~!ux3*(eu#8fbX4sDzn|VR=>o^F|AYP8bH>u%HA%%4CmbHOG$Ih>L$# zhkXJC=HF24LO}0@Qu$t^jBXZ-Cu@*bO_?;oroocY2>I!ld3PX$dNn!p*4*6>LA67G zQ1SGTGP96nY!$7K-+`;!WC;;}1i|jy%n0uj2w(6=z;ZX8L{{)Q5W}r@qB) z=mPV67h#o~`q}9|?H0t{f#snj45G}&xblCwf?&YICBdG{yAZ`FwzD;3$&dkE89!x_ z**eL3nVhF_bCX?94FCSP`YOiN{FD@>#aQc#ho={t|IWR)(*CFND!6%z@YJ@ZE*Qd= zXjdvPIFeSe9-@+bUS56&Co-77L*5MuS)N|Gnf$j*$N??`$P)yl=j8NcIcF?yPS1bg z-44Ta@+S{JYxX4Zdw*qLXSaKv{WCT6h^9xdb!m3D@nD4ttJx3Cdp^cJ zdzhQ;b!FCJYOC+rZ#ts=wnE=v^?d^;+crV3IdkyrCJJnAnu^T2qq%%n-}W>wTywhD zxR{c?h?c#821=;lHWlWhi{zXM{L4U@7EIMfh5g&BkD90yN*uM5c!(ITZ)2z|O)Bzx z74+!MhfI~kzX_!c)m+M*)MF){Ufci5o`~`M@^f2rVr~uDTo*u)i=DQaJaCxLOJwj( zo7BT!oq(OFP~jIUCDtGPR?(>G_*g+yA^uQ+$ghU_B39mHtAP=c1ZG=$zN-=BZH`uG z3as)0iAxA99i~YP>k1wdk6*pn^O?d~Hyg(1r7L?Ep-l6zq~1Z*slf;6Ek-U=-?T(P ztvA893=q;X2zxVsIE?}ia`$NuIk+dFEV01t3uAJYCHT^+e^ij4!l;gnemT5?NYz(hPuJ5iBx(z@yNp@@G({#7{1#DMcWL~O_p zI^U&G)Sm|cl`b6g2s9A%v({N%c#+iQ3pjxm?MM`muQjnb(>z z-WozwAM8q)6{T1&&6(K5p=5jVg5P?CU`A z$fS7JXYDf(OOsFB1OJ_3VEOE?FE6_LEh~5|Rvr0*b^Z2D_Rgh83xH4S>8^MBC3yo1Ls$Ae?nm=f(%qY)C>*F_{ zV-`BmxV6l1UgT&r+VC?u9YEgm>-JA!~`nJ%JTBSOV?5E^jS7WG<8Yaa^8-&Nz21dC08M7qrg6O?iQWt8ndF!W-c)uxUCoof?k~1=dmMUkcnci0zO7 z3JD(2+To%JMM=Ia+2R*$mn6&oqElhC$WDLuG&q*+cDJh%oR=ig@8g`e+r|cF4j65a zgbAQ!o=Jq{%-UKrCxUCq?y1nYUK~D=PY4k@!k@;dvFkAUqyKSHQ^7kbp?eEnhD1b? ziRNLpGPN$9Rw3ep-bt^1#@w7aGrg^tPqRcv7EmCS$}>3FWJQbVPEBQ9l5l|DJ)j!B zYqBGcFlu<-Cb3W0b^n~Rd=F(%qEZ|3{s$dbFWqKRZ$VHx-)$TpGr>muoBZLyR=U|p zwZcjQExtfmS9@4_RlLtkr*u^(+mX8{VGISOsMId^wAX}pD8@?!&@$~|0az@{UJ_2 zE_y$T8MG3}EO!bwS6c~(Oh55+z=g$+ov&=+NcSqXjggEmQg87bffN}d$&#qciA!kw zt)RFP)~+L2t_JP^x6Kp9d^#k9du{bv_D)#+p~+AJzHuW}; z-I?p>`%To<*~wj~=_)Z)M~L5P$ymbG$r~QN=Df0eA%6)Fk69sae^{^PIBzh)AW7MI zqM`KsSeFlszXJ3ZDLqiDBZQ#o67^F z>sc1JzQDEQ#GN)E7Z#X}qIV3Bb8G1O(SB|hiPJ~ZRnaHA|OhabZBps_d1c22>cEtaDmr&h>Y zK`;c`nNEW(++hlMWv^lHS4CUFW^$d{SFmu?k-TloqXQ1`2x|U~f1foyk{Haw=3m@> zN&`YU+s4sATO6{lDD(xLk}9_4Wk~(v>a$-*x9HEUI?AV+Y#XFgsVoPZY=!#?wqlhy zFC|!(MH3zMCIoEGLoHPaoUzYKI21MdEYt_dGXNVdX`o7eUt2HL8)OyYqW8!)vI5bE zpm6b0TDOk#!XC_54i!iwYyP%+Mr|@-ZwH^Pd;@TrES(=(fsohB(a{0K9L( zuOxKSf(`p#tR&gRlKPSJqHigDx7h^V8CQpM!e@Y7aTm^+L@0>1#Ow?=Ard#$vXHA+ zfIkVgNlDdZym2D$wR}xb2a+@`a7>DTvb#|=ct%p1l*7@-j))Z8uK-9%ZlocCAr>@( za>anr9I3@huIwxsW2C-RuCf8l#3F@@f#*c>WRwi?;{C@IwP8Qw3jy72xT6aqC^&kqL znD!>iC2PN8`izE{6={crTql2#(@;gKgEpQ6!Cd}7Iv%xF9Giq~rgHnbc_P-9+|I_CB|4Mkv$nswW>;HSkTTUj<|2bIy zzp41jQe{krI?(gUQpq%9^~&*8$)~dIN*_Q-#!4+v1O*1QFBk4+?@So}F84%2&R1uA zf8HN2mc}Nq?;d98Yo~W~!$dysCoUqL9q*l*r9`OIa^=hCJ8`<{eqor(PND|7!;x1G8_WqkX^9LY0tG||dW`M!-D7^Tr|KXz)+8SC>& zsJwrcS>6O7n^}yWkKQW_m-cJ(OKwIeLjQPXg)3`hdO~Kr)eb|{Ny)-MgR)}rE&4=f z)uGCJMwmGp`~Rccm=Hf7%Q#5cE~D?GLKu5ZiT-QG?@#$FcjS-{Y_3ihG@IUe&;od( zou7))S;r3!b0Kh&xaB`lKk2cb)#Y!t-5%N8jzjQNU$pB~(r)EvMi>vzVIIw7q<97e-jFKNRQ=aC$BY{+^|4yuOe7W@hJ!8ApF)RpoBhZvk z|44oJD-fth`_B{WV7Siud?8jgYZvgh)JJU2rX#ur%Yrs#+@)qeQu~igoYsLLT^cix z^JRL(^A!gzTY|&MAPxNiizZNpN*n4ST`dcwhMokjoQI{YX!EKy%QUb&6b zqT%8lc5cz13&X%%Gtl)-4cL5umw;0%lIk#0nm7 zZw)q5j3R^Ti)n$$i^c~Ur9gI{xCZ^$&uk+vtIu7}oOu2TAH7-cy4*k6oNb?Z>LJE- zgjcTA((>m;)5$u3sthR6kT(@~jl*!BZzj@1bBfZNtADd4*+u5!O>qN5V;@zrBlIG7 zx6&OwPXT_{jD4LwuIm8DX07VX>ioW1S!kGJrGi*mLjW_P*%bW74}Xe^*SYkbxrQVD zI!>z%it&nlf2R#~WmYb7lpsW<4@Xet!RXn(bI;R|IS~d)n3CXuN6rcMOz{$viSvce!f zsq_sR7!~hG5ZF~Qq$1Y(TosU`xXVdX*-k61<8N^9ToBux1zG6RgA;7=joho$K!yQj z{p%wb!ixKdCew!v`f6*?Y*1QwQt=B~^@XrJKO@U1UUA(a#|V11qVUuP;-qcNXN_N2WbK;c6%Obnm9nV8Locj$Pzm1=uBWgR&&C!E z>jV#RD}z^>h=7%twn|NBR#)<14%s4%hKdzj*>k6)pd+UKle@lnidE_zthQU-+9}SC3F=fi9=EL{Vg; zE%qH5L`Qd(XwaVf}F96SBp=cU{eq4 zY}(*j`;X(pE`=$y(U-xo_z$O3Dy;3D0MH#j#h=w#?lx36YqXKYqQ?FJ+Zf-ao)LIq zCT4lfyA4?WSe8=DGsbm-GOutSU&!)5M#f!a8jk534qW`*=~#4w#u)nql?t&wtgczp zP~qQTHLaf4+ZlKbV%vO>030F1GBDx3rYu$ZX=63TIFmG0-0j>+y)eW{MVFebqfJ#PDg>fP~3qJ>X!kzT@E%*!Ajq zrRL0fF68bhH_8Qhmd=s8QnqeN{a2Ra4!Ukg!f)Ly)^^9~HX*Re! z9BIS{LZ0pO(ob6Y>FB+RRQM+)6B9knNJdHgWpy743sa5_`$L8wIhMSP{Hp>cxhQ#A zx^a^r#NQDmo$K!T(p|^GH+j{gbhA9pg>HJMve~)&`PcNU_9BvbEA_%oGDAMkA82#k zhqktb@PZZ}7CQL}56yeEXYTaF)Z>gnygEqkBNrTR+%n8!q z;|(~f>A*XD3>u1`LdD7NBR<8NH8m88L~0<;&D@-_oPNr+0<@~{gM1IkRNlSZ z!ANVa5~L(Ho%l*0+rnj76UQr)>)SyxW$7PDwgrBKfB1Ptr1QoO>@~{7h@A1`^Jys) zCAi+gg1LP6(Gt04J%>~=q}by;nqPSpxT}0K?3AEoT#}`VNGP|0;LFDdL7Nk1rFsAQ zogaLUrC4Ug27Vg{mI^ zW={?!I5D<~Tv4WQ8Tdk&j40+Zi;sUJlvazpuCCGf)OS%X?&fXeoEy1Oa zvTek5sU+qn%b^RYu_*dgZ&+dc~iN`9*b~2o*;VSTLg`uO%UZJyTuLX`0wJC%e zbd48aNM{bL2d%6qaz8|G1JT{3iO&g4^smhDC9BX^)AfYKdw%7}`gQ>GyArdbxTIzM z-Z3plLL`&oxeM3~+U9R$!?sf>W~u#EWj}fc=}9KLFG?5@oB)8C8042LmPuDAi(Ud@ zU$;rvoLxe-b3$kpA?)Z1Ie{0Rs@@)EQ{@LF4r*333*uE|2_JzV%5D+rfK&Y;I zS&f*7p=(Pr?Zbt9?*Kz6ieq?%0rk^XfP=NV1xzl-EEJd*>-s7xnyhvj$h8lcd8GS2`u}0Nsb9vkkKIU)<&8I6~vStvFEk-YmCjIzi7S zo0Rlx6{|d2BKk3m*Aqe{m^F-_J|N;fuCUt7k<}=`4tGhvc$RsHuRqaM0cwcSoRP0k zrFlGvO0zL=@&8$-0N@!&LnhM7^r!@$A0TS3(<~c_3-rp9`{{@E8{0Q_{T(gmsN5lf~}0IOm*u2{6dVrO>geq4LkSTM2ZF z|0(vG)IioRWm-Of*L^G#!l$a!c!K?R%8#RWNUX(VE|#u>UvaI_*Z~rEm_f1UF)wzEWpm#*z@dd_N z7f4O3_E|$Lz>EDb799xDWkR7izSu1bi7c4H5j!rSFLKX^dz?4!z}T)Ji0~!zZJ7&d z&0S*JC8xy3mSr<-*lrD7YK;3{bYl}HcJ__PV%wD7kn?vj@#B-j!zkOeZG8p;L8-1f z`)hOj$61fH+YwvxF-Lzc6}(EoDCE!wLJ(-=o)8i^QWw};L!V=CSt9(+FxFD@`-!l# zQcu<0`QI`vI>W@>b*b`24?08Z{WbBOtf*cBPCfw#!v^0~NOY~TI9H7tb~sM)};34RMm;u->Ep(Fh07Bz
W z;BrmxH-gMN#ygk{;et?pRqN*u(&FqCco;Al#I2`jhRi6=()&#_`@?$JCxLq{*gPz0 ze@!@gO!45MKATV(!A>%iiA{bIJ{y)EPO6jm75~mrXQVmbGtE zIBA#Xw3a24)~mgMYcKJB9tI)!W7?q)f-?=io4J*10<>2eS#<2#Lk?Cukbh>$#-G3d z4r`Jgrcs*AUS$iKxweuP|39;VHK8Bgrl5eq@Y%)##_%UBq(T1livS!L#L%$vJ)PIp zVXmS>Z3Hy+93;v&D)0zALZfxw)N7~7mtV>j>#bWr*9BrS&ZsYYl27xh?b9tA<`OC2 zptjmttwumI4mh6rre=KoEU&t0s320a?+PS>2u#EVVFiEr@9K6XzrwO@m>v}>6ad8h zgr?ml9c70c%=m~q!Vk%08*waawqk>)92_Dpzr30myQ3O7lFzZc*1BW#EDFQ*mfPvS zrcB&?s`>N}Q8alNI!d1JU&QoE4>^8Ul=h|EB+etrURlZ$GtSc2KWG>^cKb||mQR3uoDmu%y!tkU zr!CAKDLOr-HKJzw>8i{tdP=dpX4L-0jjK$<;a?y_R@bW6>YqkMuxbEN`04Kw45zyv zaHHj#^MyS2CNZLpLXF>y?x8$p^Bc=o#BE^nLXeSQ%0S9sTma=vqC9?M{ zF$HhI{=P><%SGkuH>E1(m^v|0aJsCFd>)-tX9+K6MW2toP}2*C2sa7}>gxwqz5QY2 zIYobjeTN9#)AkFlMr$cb99&qTcq`;>Vf&Y&44)6#67Sq_)#`Ol;;_$M0voy>_LkVX z=T9j1D@$BbJwd}FFR`U*i#FO1KqJt=ux_s*2w6U07>>0W$pLoJcQ|g>vYySMZ-ANk z$v}SQ)2vUvkm_#XA$l45>K@y06qTWouEGb<+^!sE&yX4X5hWqQ(Y|^uPPb+LeD(}m z_)!{N&77A?4ZI`;;}GEuaGYbJj?fhl6{TY>H9Di1U+SGb6FQ5nNdsfEVZ=vc6z+@kI2D2n2v z)wfAs5jpQ5{GG=Yr6rEt!aCfdMq{j<*(_KCqqoiY+h^7k`B7=k5R;`iXX*&G$xiQM zYRCm@4%y;JU8qtY(0&-)bOp5z*7rx6BT@=_M4{_1?JKxTXTj@wU;&pD63O>~{SgS# z=|gJ-RmvtvaSkEhT_)%jeSidiz@+_`(+?B)hc-pf`*3sVuX~G7$U$T2Z!A&NW-6YIFdbad$UP|#bCkX^tS}r>L z!7XyJtY)#Wgb13S&$OKRjDQH_?6M(>v0vSE!(tX`>9Qr6c(zjEV6*~9<{rTPRP#CF zm&Ei6`LM^iIC-#eryx8Iyy#suIb|AE7@rN!jt3Cjb-Fu4#>ediNfFn3Z%|4;coD(W z6p&ZmxRQ{+DvF3v8vyBhnZDLST8(Yv6T=I!r z_HE7UqG_xGq|RFy=5Fg~8lF;cUNaFy>vN*siL|RzPO`n@IbM`HNPvcyoRY8Zn+NBe zj&{1u!t)IH#Woj(D}rwnOEA8|@3mN2fP%YP_gh~|88mYtK5amS=8d4SM31p)MCXQ& z6}gi%~qH&y6UgtaF~xen5!qKJfyk=HJNEJO^-|X|XKZ=ZxF?o;-#{9lg20^a@lZ>b38aku0B6M0v)TfMPF=qp~Er=0e%+r3r?BrVR2Tfxzag9;^NnZzIP2eKBl9I%lAg*&;ijSvjY6@)r@*#Lm_{)ZMn5`@xp)ae z*}jnaM;2y;S+q^MV+gV{_d5XTs~8M01Fw|dzSRy*auLfrN5JzmlNl0Q1GNHnr)+j$ zxFCV(*f4b~C*_FLOIqS3!@`?epEkjoki(ZAPP2^h2XP9vsMV`}O6x*BGQb9?jwQIx zPxkyFj4Ji6(xIWx_Pv_j(C|hN&>BZcZ5x*4KJs7KZzd7=zc&6Qneyy6zP)UocD`Rv ztrwPe&ur|(ep{SG+H%}FbG7mFn|#DA6Gzi1>)djKMB4IVhK#}9Z5pysZ+8R07Ppb) zy|23%+`SU`pO*u;v3j#}P(IT=oNl`2k+S_nkNWpY1j}Vp)vxrJ=VoDg5x9SD+P9}~ z3iw`DOH&i572IH4&Hr#f8udDP!g zJSpH~Fk^fX#(A465qH7SLBSym**cfUee>r!aHbT*%nI@dF0xAJ4`Wx18;*d^#`?Ns ze<6I!MnP3cCzWZ0cu}UOlD3m2eNjLabGP+sf;f(jbm6+seAkA_C2WL?rw2nXNq|-Y zgWk)?gDpXJt0j9yjdWfRNMay_g3#muw>-lZ(cS|mFjsyXNHa4$svm!s+H9b2?7N*`6MLAA|ZJus})|QeOY5JNQpV zUFQFTM&18G;rU+~b^kwi2dw`^ckqAx_W$dqd^RQ)mj7pW@Xx3l^WTlSFY1qlO<@+S zwFyXIx3p_ucQy5eqKF(HeOOLKn%X2+NF&^D?^n`GXE2m&cZn1YogE$Li{;AnZt^)j zXghvCk5d!5`r*y5d!ZP$dJ*LE?w!qXM(!Ub&2q~ZDwlRaz6!N`k+u!ALsr#lnWa={ z$vWhwbZ#T$H|SSCDV5P0St-=%67{c5I?0lB=vQ}k>1P=4fu4CkSKV5*_{i&oi}n@x z+jI*g#4uR2D*Ri~U(FXv^{4iw-0B-e$dRcNsu?yz`{P>3klRYy+JC!wIIM;3d1amy z>l>Rji)H?3WT5?xyQ;$m@xnkVbng_fCH$#i~s^;f{5TQ;t%d(vD{$JmEs(Z0B|V< zL-}9v__LGaaJcz@jEe}pFlR;S`H1B%?KTnizk^HE7(Gm&o|IL&!~62kJedjiuhYV5J9_v^fv8YhvCgqLaq0b<%R*ji9=UY^W?No@ozDhTsMu^ zp`FZ~18`h;5o0)>_J2>(>QJ)SDj3@&(L1};nF~pL>8lGb-Krdoc;?JYCowmDT9)A4~+})6`&G{MxFqDskw&q*aoMN@W70gNhEgW zI1ECX$hu;kir}bs@6pSqa+Q+u|NT1h+1u1fgSEshLd$4)-ndW?3B=(i)zp#!!B|&} zO18J0QpLMgeQ>uH4&!ci z+uFWX8m)pQxZ3dkAeQ3-R-#AzDGEby8$7eKWEpUzq#exk^P>tdh%O@zdM*R(U|T;J z=)3vUti8;AV{e5-pG_aPHriu%LcAD-S}cTLzPMq%p>2i66b=r>2B7@nY5(??M|yX{ zk4qnG0x21XE#4blyYAY2rd-+FE9tlxjnba;qQS3%5=wcGUuB+T@i)bz z5-}5)@==j~%Rt<|7tThkojkyH{P~R0$tkhO)Uo`1p*CYt&5EwFXc4#~qPly=I`iq6 zc}k2`%a{0j=*GwoRe;UykXc^oX|)RV$SZSHCH4;tG+<1+u|Q@@zManVz#ZjFIf-=S z`z9yWK$`m26ELWAAWN0{XGewVFz13YKtL*_I?MG><-}vbiGtlWns4h~i5cRl%ogmN zEZ9`p?3=g`7eI=;Ls5$o(YA*W+p>A-gMMd>N!+3I9}&mG!(!-W`E5>?GF5ll$@EQI zXZoIovUk@>(SLv2q3dF9j78p>^XLu*gRC}EY$bAKO!X)72AMOb(y>YE&xrX2*Fi^& zoPu_wZ82?7Kgj)jx&ft5l9jgH#x|{<(*8OG*9Bik`d`zIr!z-%SUi3`MZ)_uD5zPO zdKFvE>~NJPI7r^#uLKEuB@54pX=XtTM*6{ych>e7QnQvM3-*6|+)Q;2=AmX%j-`8xuNSAz(OohM$Z{WJ8Z`Yk~Gc4-NEY5r1{wgp{pJ8Imbo z9!k;g5M#{7He=ZsUsoJ4D{jJg=bSYoN4EPz;3>Jc9Y@#gj9li=YRDQ|FAM>gF0dZ7_h4)u!XwRZ|8{P#(Kq zVv8Kad*=RenrjrqY6p4Vr79@qM|XMQoxxUVA_@N1aI(?aorBaWh@fGHdMe)+Fp}13 zrBg6MNcB!tJDfo1PN7#wUKItO#0O)8i2!Qa>U+7w_kr6J4SQ>ECOYVo1e@^1$!03& z_H}tZ6K6A|edNg6M9q?BctvGBgSArO*g9kk{Ot+N`n*C2AQ?~W3VZH5!MCF8L}0t+ z-Ek$TTQOY4FCQWSHkImEm1&J-p4>qAn{S&O6%tzlg3sqF{<=6|dO#;McHTKl9CPD= z($xc+El|IhWc$6y2dENMf=)mGAd@PBFPoJas2zzpLir6tns8us_~!XmWOnr%t#3z_RfHoW}?H&tsNEg!1>DBFQ8FM zx>f8Ex*OZh5(GM8*5KLmV_PK?9Viru2GsuUJa7T}!|8)4s(T|>i@Wnxah4(_8s}@p z`2|>81MR4ny*|)ih=afh*)4f!@SiNo!CX3nyAsKBQ(!9G$6y*r{%i%=jfG+rO?i8ioiB%YiyF0RJ(t-oK!91^O^c2t1?G@ak?p=3gDJ% zLdXe$Ne@u|^5iW6<`J1|AVFQ{sb-V#h<7rF$Za6@8s>obDbnqZi2_zK< zOiP2m8bH5SrAQj1+YJ?g!37F!1&x!YQA3=YMjv;k9`a;e7WF-93qg9eNQkYhI|-ik z*F@TXrDZj`tPafOoMPE)AAmQY3yCN->t9SB1Benk`rTMT zsJf&pfZ5W#@-9=9rPZDdA+(s2*We(K&Lx~Pp=@Hh9mWmdT$Yep$w5Q+e4p+qXaFtk zj?jO9fMc_{3Xm_q2|;43*^9}_F=2A8X}q6rQMUz*Z&^HkTxaGG2T|Z=xl)W2|QX;-|fypuP zeGtFsjhF=8Fi|czp>Gr19bg7vJzegD!N-=y7+*+@-%*ejigSFfkr1R<_J${0mhrr# zHefx+t=~ic57dtGEUf_IOR9QU9E?ky-;HMAWFoL*q^-{^vI%L=#0XNSZ9uuoG_L@xw# z-!0C*Jkb-ZkYyu#g@k))B~2WSAV%{nMe{7M)tiZC8GHT`oANdJ_Cl4wO)z0-z;vg| zXP#vRA)#lggr8QDJgkMz-4vI*_AfPAYP#xp+41Cixe^tGnj4>x!Sx`FwggI+)+;ZR zE^?%rd-jQZurZ(sX<O%Ym860)w>XI8r-}dp8s;5f|-!%J< z+n;h1nBJW@6u^Cab?DjVm3>KFVvDrRSfs18#W^_Sg;?#&NWR8X^%VQsemafs!8rO3 z`~4Z*zurt_8fdL4TTIVZsCbRAxZfhFISQmvg3l2L*~4YZq*X zGaM@wHIm@SB$O|11fn`14cC@f0AW(n94?f*Tvp9%qUTChIG=n3vJ3Vr3%M1dfU0N} zXUlWHiAR}Cj)EheH5=*0htf5U+n-S2cWnKG-*TlbyB%?O&j3Vw5^wg60*6wcl66nrdlB1*croHu(fjLnmG7G$$+GE#Wc;YBY`a zD7D?IeEy!FjD@-6q&F}N4=XnD37*ehy&xy_p)%T%+i!Y}aPRZ0qT9352kg*~C(`VD zgM`D_t9-kk*2szIpUD2>6CqzYey>2v!UNFu>mattb7PyEE`vevk)@a7Bvy zV`Rr~&P}gSlmuM_Vwm^W{CgOA?;i?-?6s5yvxQXK->Zs;N0$`iOxmg&>5vs%I+GjF z&yk%BwYGp+Qx#OLOod>G5>vVJYW*dFF(Ke$L>;U|w+8AUj}A2#m-r^>`;Y*|G}6~n zwN*5kS7KQICg&q4dHyF7{z?FFo}m~(k|5S?j|;I#BDZwjNn!6 z9aFnbw&r|OX4Xm1SvAZrozL)y92!Z@_Hq7JVp|M1lHkW(lR-{jYpoMtH-6_Xd2%gX z52Ssx6Xr^p^sDoI&df>HEjJLO$1n^=LH99Yr8+ty#HmF@*AUd!I>S_>ktS6U zu6d&-Dc_{h7VW>NFtY3X(;&>b424FOX2X5G4V^k?DB!NfUT#1wRhoGrp!tZLH2-?> zFB^t}TnNxHvShj>#?^Ex>WFM7W(z!52$w&ImL`%vdnt(I87*xg9)&UeV(vPMMVd}l zOg_6Q=s8i&{#b(jogw@H9hixSqON;Ib)*S;ab1bU(NA55)+ZhM-{GY7bivR6jkR}( z6)kGCtdDKm#yz&Jdu-dbZQHhO+qP}ns#|~lMpg3iB&nrH*_QO|~~kHFv4ybs+}BF;zEJRGl(F)uY+$h~mh;p+86h;}BSt1Cv<4FTW&X0s8BOOAUX(A#zYCQ8cxZnV}yE zj|h|~yx=apzILsEiP($oKXy$QhhGj#i{bf-A}vj+6t?mR2kqV&`?@?2(pWbzAI=c# zG{H&UBxmBR?TtuVH-SGCm{m`Xx_FI)@XHDSae(z|F^VzCVkxj|$454#B##7~B|<~O>pfwjwEJ2~P@c8i}f z^D{Wg^%_a#R6SzYll2ui;GDqIscyY3!zTeUR7^;KTFCipHVaxlBkj z6hs)#CS(u#x}*WR`wg)^$o<+Kg$&YUEkQO{%giI)rddWo^<1Ucs$s_3vRDss(zXX0 zohTQrXzcyb%ZKk?wQ=k}@JN%wG_bVOX(uLH+)P89RD z)Fk**7CgvQG+k^J4FzH)=Aq~asS#Z^XBY^apwW;$KnXBp7Q4*mmw&mio5~g_5R!!% z(w#qR_Esc6q#XC(E(8QyL?(%}GBm;%>?>;oTJSrWY#V_07RHQ0Fc#B@)Ce*Zd_VZQ zsXvV34t#BdM3gr86*i^Z$Jidgx}rojE_Gi zU-C_{@I_T(c{}U(bF0S&L<9%hGZ~~2-B@H9vbq%KLOvWMJyL6l2ku_ubPK*%GqWB8 zFR@s*P_ym!&Zro{b%p%F;>mqj5ujuMGhPvxvyor4@dyv&LVfg)sqJYfq5yYHv*JFv zh9mLF+CW#=-*Nk3h*zmL82XVnxaD1$`B7Yk#`h5oLm}?g+Lr`&rsL^8NV6cGo=mut z74@jE>JcKL1#$H$f?ek{j788MC{6rTjwOR+0bB=)tCS>vzUyto9paaQzeRb?3FbNP zipDaiKAhx^w1pM?b=a^R@l(;OrmbL!HQL=Bk9EAh6F*NfYj?G}dtA6)uUmI@KTTU( z+cQV*^m9g`KBZ7i*l?KhOR8M*@m2q>R$5&{_dHlR`O2F%idA_q^SoIjvy|CwCkz|u0Ul|m+(!=V@BXovT(O7kWDFdW;S>=^DAi_ z@XWq(Z9*5vxz>ExeNXS9b%^%Zr!f3$FQ6Xkk!KuDj{wI*x+E#+RHrHFw#6@nr~-cN zYwLxGMS}z1yDgyuZ6x99Lywk=8Ze1bZbV_nG*vq98-=aKJq^#KVC{}SUg1$`#|YPQ z7MSn%a1}h#T%d)^$%5qgCac4-bp1r z?bb2v=P}h+{&DF9tMNC^xBj|3b_#eC@Z%$Zt_)=C?cdL$m5}x+9TRt**dULf_Rbpis*BWYGhEm2+AA|z* zFkjrTh;qXKAwpC1Gi#NmlUSCE%vlYEAhnc>{i>9$=e0J7gsaox$N`~@RnpdtodUd= zmDXKYRSgD>;rKLy=(kTyS^f*_Y@mLSYkTKI2=-JdVL;3(QW})u@_Z&N@#*T=3teofoSQi83YQAI?8SQ{(mkC$z3~IGqOtppkCFe)% zds^@n-LXz)wSJIdZy1|rJJ<1KSxxm327K+}W~cV!i+=uBm#{<0jO>s(Sc!#p13Dr4 ztjWmRr(7jB0z>33x&0^KGAB^kM-zGD)^4L2!1WC5$&T@~gK95=Bj;njUJAuKVj+c& ze2R8kMq5jgG7jsCUPyXkvC|f&pbce>(=|Ut!C&_W4uvb2t~)o)byQSm-A+_yMijPc z?xlmPT*Yul%isaP%}vtcj&}Sqn*$qWvu8JR)cKUcR#7E&^-aq1pwc3X&|$p5!62&& z?6$xe@=@voMDR{)5~vPmiD0rPq^f9VC)3HE_Ku$iz5i;L^q+f*|Dtwb`mY4bO#g#| z<^No}FmU|u+DGA^9D(8glp`<_FfspsFaF2*2J3&SVE%iuWmeYzi;GmG`ft85hUmSj zIz=o`Du@9Cfb=J|(oBAwv-zQd=7uwz4L%P5Q6myS3dzW`m)G(9rX3(Ddm33l?~gaf zzx~GM^!Pfe=l93e!`F5O>D52i@};B8KOX`~RO9sZICpp=iD4!-7`(0;W-4eVxkIy$ zMv+y2Vq4tq3wdKK`lZ?9s6>Hl*|Is!f)>vTd1Lzrv%LXQWK|H$YI<+(D5Y-O=kg!8 zO^z$Hx`Rb42Nj0e*cQ*iKkc zFv_XP1uxPp568f)KhbeM<=5LtJX!00$V-4ZPKk7i0;bzz3S;J)*WWL}EuTDL;DZhV z8E)7f;dL5%CtHIXt_PvIw?NJl`e>NM(G|}-+LZ2E;!fd?+JWCu04oSt*-phP(J|G! zRoEncb?xYcE2#!l!w+Amg0O41c$~GP$&P2imf7+D(vTw3f$Yv z4+U?G*&kA3qo>oCO+^C9w|j)0NTJr*E{p_CQyoiJKn)d*L;Hh0m#&+(2TyNYsMkm* z`6|CQsG28~U7DJ9Esp_fZn959_LK)H)>(%BKc`g^SW@w9@+$t6!P^6ZD zXSad}t3n>p#mPE`6Wb)l@L*4WZuJ9qSziKF znj(8!)DOr|+{&*}%b;e|l4c{AxmyKjt-0gE(391~l=`jiql;a3V5+k zJ8204a2$;%bXeZAzFCmJDe0$`gtf`!S$~sUt_k>i&3Pe)fG5a+Scz^Ne7$%(~n;WwYG*u(0K2j57iuq?IvKR~Vr*-Lm^Msj6S+ zwAfp&cMG}vdPjNX`(WL#Yc;j57O9}d&{x5b8CWD;us71_8V_fQPD&Ll3qLQ& zu|C-wOhfVLLjP-1ln@8#+rgyi@mSAA9Vp{4P0T$sozLyQG z+Ot4d$2bUP$V%iTp6&2QBL1WHuRyEtx17+J={MmXl$j5NZ=xJnc;JY5o+*Ga&_C5z zX-Q@H6y8Xv59-hW1i6Lnk>mDG3&XfEnL&d#j zu=gXH;{0Y?4C4&FTT_XD^i}{CEDyaHFlK2J87^ffFVw`q0!~2o)Q};?)l#0u%O}it zV96sB)a))Xd#HeO*|ho$t0g#s+b1AE=v|!-Ko8UCkq1B#mzrpY2@0u}H80F-j{|H6 zUc2Zq?2z30LT${GqBvD>nwvlW^RO+v6Xswem{$AqdillJAeWIApKX-QC6^$gr|_br zSfwIfHrG{uC(m$}4Sw(_NH7Iz%Rk8*8YGm0C=6nUY&}^gtbzgY1d6GHP_i%?6c?)a zNU1n%-UjF69P3@M^(|2jwpaSDWUV}aKPh~PqeP+5Gu_d(40Mjsjg!EXH{S%`d7O-36pp-+tA#o^<=LvQ=n#Bme^#X=X7h(El zA$k74DdiM%hhOGHU%kW5O|*ggXqZo7NJM5~hb|PkaMI|0sIcY)MAjnH5UrmByR&aD z1oMRI@ux?pW$YfE3lh!1@K7I(^*d{UxJG#cL(VdmFv5DW(=DN_j8wvBM1*{aJrK`R zW$wJPvyykNm!Zp?=GD7MDHauBf8fB@?SyHMqDp=}QM}IJ6xJ&swJ#j;phgeW4DLet!;xF+Y#_`E!079e@1W;r5TL;3GIaB+dYgG!Gj*hKWEe_ z3gHv(!(X3#B1}o=APhy;DTp-=f4YbBy1ar=T?N#@ouFlqqbf^cg+X~~#p@0Ub7sEa zCZ3xHpk8M@#j^xRs0>tnH$ZBH8SLc)p^X4jqcAZ=a&B&|eD&OHjnDE3Gz1CT6@~2K zYEfW1A4ng=Sk~uC5OMn@%%b=Xd6gCuCu5pSO{0!zUEDP1f@0C{WJ|}ux~KJ9Aeuq9 zo3!#lVG)#DTvxFE3!@*(igNTSaPo!p2t9S&XtVT#E72^x&4f;b2EE^3c8TeZA3&Ga zkwX~$@-KGKEt?N)ICjsspp$)QQ@bdbRDKIsI1)iRwNQ?z^eJPmjW)rLiQ!NRD}314 zkA$kn8QAu(rR%$Am0Urfs;Pl&W(Zf~I~t%Q^{Q{BO?}5_YPHG8+x=%a<9)`JW+w*p zYlBM1oyD=C!CRyZR)Tj52Swm8+EW|xI#1ki+I5J=JZICrEsD8wUT(GxKtfAHK7i^P zF2$@XE0I&yT2wek6RDE~{AUR4j5VD{-CcHG5n+a>1dg0Ul8_ERMTCPIn;EVrOV??>-|lQ?qut zYMOd_yFz1XyVIpz>6$4$P_)~s$juQNcmzTKWpl1zRx&1Cz3acOmpdum&Dx@h?4$vO#mf8_Df}-AeG-^~LwS!au*$1! zAuS#Gxc)ZQ9ZK0+Mnw6BLhtP$VF`4+>2%;j4P1-znmUt`_zprMp3sHgb4B0QwUsuK zp61>m(VvB2RhE7fBbfmGdi`nDZ($RqY%y3Fwz|JsOs*?1orzLnxGeO&>XC-i89`YY z!E0st1p}m&F%ou+)$m(vgXEYvEuTHmmF%>K#yP!8!^5%43^+v2&1_RML~Jr9N}fe9Z;$8V zh-RI<wH?cs6>?LIEa_ui7B-a<{;}Ay0#o`<(`M!fEF+wlrlY{Ab`sul-}8FmJNwLl zzxQUGw-iEeQ+sCg?@z&4DRm(E9B{YzWjw1+Gyhz0W}xG1HI@M^;-mWr?ZlAG0-kMW z^aqT3x7ewIu^B89V?l$zjJhm54%lK(H@fq!Zh>JKtQk=-tZndTB0<1YhsSl4@gDZ9cw*OXA)Lr zMep+nw;$cIXOOx0ho-j2kE2g3(B+R-B5fu4C3Nvy66alUV|FmXx`hq3^1L4mZfWC= zL*BS5a7K&1r3%v4K-3*wmmg7|7Cg{U`LRYX7L#kr{WIiSo&o=EuZ<3Ffdsz@a>YdZ z7N+W>VU#KL`krETGc$V>T$>;{X|BTf7#kG$sq?|J51Z0#ZAs3O3P&DQ6`H63O+Wnx zhSdbXF)yRvi8=BU7{X$AfL|hX^YpSFlwjd2L(j-pUh6SovENU)s^&_NWHKtxv);xj zqxlGR3{~lU3L`((Ee@xo>9%HGYXy#Xxg__zL&@7{bEJxX~{OFou+kSW}^ux)rQgi_N#pkPo-h|89ZgY+HYceuTSQL z?9-us^#e&0iiX1-Iy;pIu}IJv9WFj^x~+}|?2PM)j2MsRpsH9gRM3?BN*mX-dUFkz zs)=dfM+193*}$l?gm&h=GWM3y7Ub6RKM#$akfPsi)2$1@(Vob~=eWHd;88>5LwcZa z#lAP&X0W=H_?Ge`rj9DaWSAe``*MLV_0-y}1mo8sjt?;}u#w4XhXPl<^+Nk3y3~^U zUhdO8GrSl>6R~sH-843}t@PuZrjRA)+sR>_=)&=QsP;}Tiw$%GQHW*C9HpV04 z|3(V_ww{HEI@W}BtLe~pW_iDzyYpc%D#OMrH!Q!5e~s47FXo+vPHw{&JJBHc=b z5k{K~lFEUa<#Z@%IN`d$9Y%V^T@1J+^gRq05PAA~ zo^Yqiw|jtqF%ns*QQ%Mlr8}W_T7qGkbJO(3}@|A|tXSs4GSRSw zHEXz9!`Iri5Q*dCsMC_Ck4cqma^B-s!f^3)>pBd#({j3$2_T24RKyNo z0fjAgP_-TZW1PXnQWWg(Ul?RkuP!x#rLrwCvBzpIVd^~ES&w=HD8TguE(*Ik+CKpP zUFg+{P7>j{bg`$K2Nx_K+Rmn308Lr0N601CiX;gM9a7nPP&hkb;2F-&2eUvLaLhS=+ccVzd=-J1YwrpiGFJf$L-@YLAJ&U>2XI6U4c$oyf6VeKv z?bGU|nkhNzK34WVws(l{>G9?8U0n-_Mx{+3K%pNnTcl*!%G9gF4F!y?f>ir9 z?>7tBsX?BkDamX8IZ<)gy$8!cr47-}yzlk8GFU^@4xP8s5ypQS#Md#Mv}q|>f3Yip zGtFq}J8SDg@Ks$o(W7=bODvcUisFl>oTPqlXm=2^hvqoUT%;|q5I*|ZZ4yo&;IgHFzQtfrX^NVp#ei_mLdgYr z9rd)F8tm%RllKb!#Vev|FC5vt)Gld#(8jhvKI8QHd{aD?HK>NVhF2Y>WmzhZ-K=0K zEIQT~K9{Q*JsrD?p$&#yom??P;4VIWfQ2_oD0JV>&6v2 zhxT!rK;(*-FEPOrj=2Z&aU5>n$p$);#(*mAa1CVj&sak~?|KUk5?~rNbj*;LSOXPk zPl!i%Y$YIbwo=i)e-rtBe#YJcWy1s+(hCU2^1tC)JipVD;&Na83EQ! z)&N5#9W?s65EXsG4Lw8{7~Bo1M=Q=PQiloR*9G~ZU;kvd{EqwWOKA9+Ri*ijR@CgV zjtm6JoJhekc&RLGXpk6&;w;YfZ>#bC0?BCiQlT{=Cp^r7uHP9j&C#aX9QaAou3GaB zWU?8*U#Kps7(t@?!tF!CZlf7IB4ur^kf#>~PXoZ3ZMpb`^u(9^iCQ;4+x#D_XYP&H zU_w=jDMqTh-l%gCT;?CRAr@Q?(q`IoFHEE@PYa2{X<*ZKBd(r9&mB_B#IM&zC-)y3 zS9FGIZ+atH*N*|0%iK+2O(SJxs~BE7v^px6*#pd* zj?8VRCDT`xy;RfZ`Cr7G9>ex_7@nfhe$deoD@13%I%DNtV#9}D;tQUZfJuwBY|@NO zn0`*fTu#Hwe-ywWSPGRrvuhE{YRFF*dTeguzL>Aj@9zdoQpEH$hHTdQMcyEKuwP)Q zz}(E{H78ilo{5)bBu~{nA*X%`5%EKh)RW6J-eif~H!9q$cXXZuXD${2*O*lC)W=#J zy6&M#!GmMQ*r-)`{0^nm;asur>(1M4wpRS!_uPNHqp=r+#Q!Qh|F6`-O#g#w;s5vW z{67ZfZ2u`R|L+NeSy`C=&&|S+>ZHx)7}EA9wFjk+8cb)VEHOmf8X#Gq8`57C7_e~~ zv&fRHaPi@kgz@i>&De?yaMI|6Y3+C`*34&i=ZmGt;q}DUtMf(j)zsP=wUHbiPkZO_ znH(B4%tI@CSJv4Dn#uKpl>TY9l_Kf!lk^Si8>)V)oZ@1SR^H6-`v)p@FV4v+bdOf? zVv48h2P@Xq+Lx@fVn$oNSuRYUS;cQ`@D|jr45q zodD|`^x$Z#V(Smf`%3U6ZYgX~m`Ie8_=g7#q4oYu&$|=6F3^DZOUD!Ucn8Y#h9WAg z$a3ApcA0bft;#y8&zq#|lM>IlJ-K}2*+ln3Ydnu;G>sD0r53#@+*IQY2o+Z2iC{`B z8Rvdr#RAF0iD5xsiu*xFQC&275me)FRQu#9Xn=+$x%5Xt;@2J~SBrC|L1`|p^}(A@ z$7oxd2TR+fUP^vH^bM$DoJsY}x9cY06jzH%6R z{5-u*|8A+Nh3fI$ia_d{EsHk$#NopjW_K!wT|{?{5n;t*XCDH?Jt_I4vw_X%Xal$-legMSNYv9fE0JiZ zeXEx(Jh92!YsRnRcF4lXI?f^*_Pu$sdwQ*giJ`S%{vf+_C4LjRgZCfNQdRZm$d;M6 zKh4Ou(X$)wpdi6<6Ap&f8FKm8I~ES;B`eC$5|ee!$7hnhq2$U; zUw9U?2_l0JCC8 z!5~(KHj4sPoh5x_Tl}|dFeb0CF-E={4mk0*KX8e!*jJxSR3_|py3(Et4N5xUh7kfp z{nv|-ckQ*ve%bSDH;7JyX#R_|>(SA}pczmbK=W)caG^ykc@pY!ivMWdutWAu!F%CG z>m$K}zn@mWf?Td|1)UJxPVb)9P^@}!!hm=BU8=;!G5!0<`f?V7NL%CID zb%R}0AN%h1G_~(ebL&hhQ~LzQWi;*6cb!G7%+QQp(2V#XE#x1~Ud9Akw@%d(iWVv_ zFEZMl`-d~gNBLKD(q7di{+Ge`>yYZF-+0X+D1UH*ebZ>21}U;^=Hyty>(h$OUhjU; zc3L5dW?A3rb^|=RG2o=OdIk*N|S}w56-9RcxQGw7PD)?AI zgVqhu;+BIX$ass1WAQ=}RxzyjoKU5&vNjTqbg8pOHJB}Ql`%}LX^DPN%L!t=pv=C+Pwsyj%2=xz_T)_b3pW+cR&@hN9^<|pVlYq@1=17E$pWoIAr6zB* z0u;fPPbYB$Jv|x10EMBhOG1(nE{br6ro@h^=}|S$vJ`5Z{V`Lr?<1wRF8d)U zvTXZdLjkke+Fxx|+db?c<|I9ezh^z%>(o)~o&wRs?N=7HbH2kp^w@<~g;ms%gUR|J z*3c84Pm_v!YBI(NxH^&X!?0b(RI7`r=)BWtS)~cFXK%hQ61=1C#X+8eu7? zkbl8#V3H~>Vm0`!&lk)-i;snjn3pp+LoM(_s|V$CV=T`7knaCp8+7{6|HQac?U9}~E!)0%8plN!G zCBv76K%(wr1)?Z7wkQ~tV2B}V?jt<%zJUc&st)zn!%q+Ob7^h#bYJzQqvj%Lg!uZc)Tn zWqY#>bCLQI9=bTV)*nDS$ng=dHVBwio9LU70cT~SJtp9KKLF0+a347~*09U4x78>Z zChZi`!C}}_ger8xPS-JWmL^l5rc&lZl%A6neCOf)__-0UyQZ~3=OPye-skfOmidyf zd%n!J-e_a;e270lPt>m#iyn>U?~2G9 z!__HtllOhpyw#z^W8JIMmUHauM}BgnANLq@&bHbfPQ#MuQE+0DM|%kiwabyqa61Mh z0hlvaAc>|DM=d=N3wNPf@&UmYo5%*&^tow#Y8p|kaEa~{qQMU7T;Tc{ zytaE}Ofx<#hQ_eyGBoE(gTtI9ot11E#R^qTnlY}?bBMB;dI@Y>cpTd#m66uik=@oH zp*7Fizk-b%S?=*)!HY}J77l7W4xRb-hpGfG+wN;~{>nMwAUV%%&`+VkK3v$WGym2` z5EgHO5%Vw5WeS|FXT)Piq4ES1ChmgpCYM?0(XGT~ppm4FQ;MiDfqmzl>RTa!8ZM}P zw}4yAd=_WD6lolUZ)_d(R8ASi#{#0S(gMRZc(pgqSk!r*y9?G0 zUv~Y_=*`|G9_WB_-cO7<`mSXV2bs$2@AiTOg@LT^nv=r*N-9(Q5Q&VTe~yy~WC!() zV|#^#Pt|ntB5NrJ@hUmS0ws-Snxj)HHHS<46mxr#I1BaWq>#dTNb0(eY0)3<=L>}l z6Vs$3S+ffNid>W);oV&*(3Syiv)}_eXeG3}2QkjQXW=uBI=m~7grKWlCmzntl1rds zZF-4|oPA$OS~k&I?Ch>wBZppttz~@bJ&&ObzWo3qF#|shxohG#R_CH zkZ&ntcefVd{JDntAxh_AhaQ2@j=~WsCY3*_7vjCsxz?iNLn55ra+JN2O(#`ac&#O55((&Hm*c+zF0Y z;~dRTCwO8$Zln$PV))35%l7fy^I|&l{mt*Sr0XryOD%{DGG5rncCx;|VlUy)|K#HC zu2)nnc)E0sCnADuna*3%uL}Js)|G*n!d+$G;Zu{%U_wB50G6IJP>GB zSN*y>^<<&S*CDP7blj?T|9ne6wNYv-*P?UjZgj`?IOuYZrOUjLeqkRrh1bM`v*bJx z|JZ!h0eqxx-aRs9ro@x+IdfOMHnLrrkIjwr_P*)+_e*JPp^s7ZyaUj>i>n*&-_2_z zt9p(aP~NwJ_TCSwwrXCjpai|47|2zjS2~CFN51lPK|*J&i5(YpC*>}prp{l_r?pl( z^~`$J*FTyNzWPJP`jqQS5bi0M6f2SD$^*yeQ zLlE9yEAOA0x$YiIk!0jWeRiqe>ab7;iwkL>k#iR*5LBl{uQaIN>2PRG3}-|B)~H@h z@5bl1%Ki*BZIlBfsGVJn)%f#GD&@JvXqA>-sr8XidEI`Js3_^spv^5hnO(ccjd9$p zXVqotaO^U;$n1YO6x*_q23PInxI0=|>rG`5jN1~z$^ix7`L;NqIGsr&Nh#2yAmK9PdZs?Q}k)9)pZc@$WC}OPelL%7vcP3h%vxA z)jFZ^=nQtwT6mT*q!SkK+ckQH=5KMBj=s_3c255U<{;O73xRQ65<+=btQjxd?3C`! zAhgaai%^6tL8Xryr8a0Ya3D1aQRnl8s13O{eDJaZU|j5@Gu+nXcIswfUZ=oj9%1EG zWWZF;@^voUmjD^06Oa&2B0K=(=g&$j|qj99DDbE?%d6j*$fI9I`TPm27{2wK((W> zQyL2Kinv0&EPc$L)t+h3#JsKN*@;A@wfw6mh)@~ZDD1YA!n$(3pju*L5Bq5PK%`uI zfE&MTA-t#%*x_VxJqPm1bG^7#6nF1cDp(UMQ^Xtg?iCUD-DsXSKiDo83>E{v6#TRX zfhe%=9CvkM!Rd2hPNX_d#&-fD01GQ#U;`oEYOEzVfD|DTEewk{0!oqfFh3kvmscb; z0_VNGS&CBn)wNuL&~15B-n9bX1LKn!RV+yEHejfnUVR!Y0A_+jPVs1Z;^QTW-GTUN zEXaXC9P75+x!XAC=YDBs=zYC$6gyv1*?w1l%k;@}?bOof7$Y^be?{WqjbP@AUoNw< zY)C4Q5_~q!8~_ltFR_{dn3av>AlL{ddGIpUwt=_+R6|DpGcwk&d=Ve>1y8phy~9e6 zQ-|YIoW(UF<9s(ZUf~@qN1BPe1t{-b5xR1oU0Me7ALW?61p*BEV;d2S3lP|*8Zt^y zA9IXEjY^>z8{C-f0P1D0<1qnt_-Kiox*mGG1tNF~zI2}#G}7jTW1IRK7uA2)Cz_-( zEFs-VH_5t57q}VBU0#1x$U91|?u>7?scZgV9zb{Y>@2=1t&WeI$~0>wWkzEdwAIoa z!>4-bR>}yL`0z_xG za^y3Bg5aPA>ou3R7q_JgX{ta_z~F%sz5LT8+iuZXLAf9sZ(gIqV7$WOSy;3IlDoUs z0(M=>kjX<(B1#D-ciCqJI_cW?FkAkb*!MlQYTlGxrY8~X*tIPx{|Y(wTwx1tal`IQ?-%6DZ)%eWpi-i-{5Jvuos}A z^#`rLvlmS0td<-YAX>)V)F;ONxvlunQcjW+@pJ~dZN;(`$x2)BpFEE6E2#f6PiJdX(VD;axMLsBImllDfe$l zHNY2~zW31>{`+DYtasbgIcWb6d|b!fbea3}$}dZL^;9z-$uV8XV0N`>ctjSL-w#ay z4O|HI9f_kue$Pg@HRv`sLzHTo^o9-%6{&TUf_|_RMsI62X~ojGwZeV*-22wY*{X83 zo$VtDUTZ;yiDmCB-Hp|HDrBazggUT=p7s{})!NxR?w+5IepYbZYL54WZG_w0N0C5z zLkpQ?ymGLe0ki2wM8DI8{4jkH?0D36Ds%P`j{AKRG$aU3{-1L4|DJG{gYEyy$^Wr^5;jK=y?1NV zN|zXo1^WO9_>(6oC8(3H7s#k0WALlE{h(>uQy>U56dJys)6;vVo&dC}AA}Loq;zF+ zdB43J?~kHCem==p>3ljA%0Ko)PgUubh7+gBl+!o1{&jdH(#;!N6rXxJ-YSADb5Wlso!_{^~}A4H<9jze|iU# zFGjv`H6C@zH>|Y3OdlUbF8(y5>r@P%#BxYokZ7K|NL&87*?Q5^ZgGv=%8^Rhn%vxC ze4Kmg5{R$f24CBVqjUnpdmqPLru?K{+3!K_%#-2anN2%{ad!=G{b^9Mz|Ql{ydz2O z_*$-_xq`0y+6G!J-%rWP8+^h2WJ*8=9%{6dJ&{(?gy)K}A6;GSnRVkLuL`tVvpy$CS3LXZ5;qVXrU#ATVL@b)!QfB#eGA=>Z zkYsg>lF96$ct++Ubm9ocEiB`vjD)IY!*4(}fr^B(IcYfwl!MvehuOekGWU{2if0rT zhi)lO>)+YQHY`t8T#b5n83wk?=X~Ne0|_IwQVe&ULFmss|C}MdcP+>TVVJM*7b74E zPO`((R$`(wO7D&oN+J79IlP5tb|c{wbzN}Y#xz0}O&c#M1GmKh73C&m$p-d>f_FO;37hZvR*o5xBQMf7RCs*B4GCq#24_a;ykfj(+||?i0X|vMbZNw))F=U!$ZD_wP^i0bW+b zN@Ev1^opSXF(5&3MEvv1ZRw8aA85}OW3WL8Hws8FSa1Q_4P)D+!gDl^qI>*+g5-`vZe z0+^q$^DbZ+Uyau8n8j?1ZlGY61@j-2=c)->^&2hD^2&bB)X?w+GMyjge^I63izVFR zlg;sbNLr#r%8Gn5Im*qnJ1HpF_R?b6t>=mfs3`6xfVET6c(5tBS6`p z9QacaM6L}59;o0(@yrtRhQ=tvZx5GfPtMb~QI*&|!#owj3?P)J5olxJ^!1(GvR--< zY(!kEk;9K({YSam@6lW+LMy@1J z9imzCsyhG3#ZJ#od4mqadC=e)xsOg+zBKLX=&V0}X^$}T;N~82lw)J-Pj4#Ruz@Bh z@B6G@PL97d{~O*4LHkzd4EkOjuMKfw+rUQmI24M%DdWC2P2mnmxOdw5S?#gZ*a*mS zEBB_?Vwtfv;@hpuZ?oFLT0|2=MZ`uz4S|*5MYGc|dX7VkKB&;YmC0ph4PkQW+Y+d$ z#8hr0mU-U2X_^nsM>rd?nSuuMU+Zaxsz{dJ55yw&JrGgiiEA)OV1-<~pxL&npz2Yd z)R_3rsb2NM1Q_?oEO?Ph-sY?AOQ$7*Z42R+iPjqvR6|Id5#(V2yL*h1+|GQ9X?d9Y zovtrX2P{YhE+i&6go9(+QWHC7x2_F^q50=w1!q5We|FmP4)fH-{$pC%YY@-(@Qwt+DM7!*6vQ#r< zUDA6Q9F#e$`U`UfME-P`HCF;!9U;bbFWVsRWV?A$MXyN5A+)ycQZ=4Y%PyxH5ByGy zt5&*u03b_VwL-B1o@FW^QU$~_gp`|sA>I7R)ZOH{w%YY)dU_YGt*b_Q+#7obtfgMn zRt~Rz?ZOovTLZ;oWNxgYfFiLOZaRbZGhu?aV-N~nB++)zDzPPPXWCxx*X6h z%)?;yQCM^!&Uo8K)LYbngPa2`@|eYcT?!v1X*WE6_*oGn$m1F6l$o)waWQ(SYzSUW z-HW6Vcw+?Lrx@OLe~@XH4JV^X<|1kdoZy6;QBku+fcNR}A$~JmBr-}%Ke~?b2f2wL zIBoid0ksUZSTY6*n&ljt+w;y{vqqi3g)7GxRh3Oz+XTqGu%a8%_TqeOhJ0~&u`Q*z z`K-s5p!2g+{OmDoFcH`XGu`>F#UucuLLQ`P%wgQmL$rc>QryWX34JjEFZr^nLMgr4 zYKLT-H|@NtB_pq?T1u$E7jZnSVq~NGcb2BGRsfo0f(+(9QWH`1(avTDMSW(FMpvvX z4duc=lzZn9Ds%i&0&Cp*f^?RsfW^$fnSC~u`e2g7J}DDS!AKCNJN^IylQONmL&ch~ zLDtYxNIzNV3zrkshkik_^bfeMs_Ns8(xSVi4CAK6WQ=4c_2Im%feA-}k!bSnz$Wt7 zAmmz9os9;nPKw-&61X#a5J+)8XP}R$pZp=D&K0quXN&ecsV5oF zGoU--HL$Ygoyms3D~Dr#&8>Erbo7#C%mx8eTjBJyphA@a5I%(lcpE{ym(7r8{U4L} zFDZUK$E*E%*=Y@V?zPvJ&T#7DYqxjtc5n`cIo;;#fxLCrprG;4H~z;se%mFkYR3R^ zS>>v}c*?Dg{>;e;m%7-wv`|HoNR3??F_XIyw%k@bTbz#Djod+-8{oBgckCiI6#4v zVL_uffki-iHv|}V1G45U)GAG|3w}ryJk~RlC9iTU^Yl%%&7=sw09u6fmdk#;fGj$e zzuT5wM?6J0OkwHb_a8b}gd2`gZf_Zr&O+@)yLI8GfX~c1OxpX;L_wg+p>QNn@&w=b zF8Z;-Jz;S}YyXS2cWM$PfYL3?<|*5@ZS$0E+qP}nwr%^AZQJHl_jF9mjp*sQ5BDGB zQ|8Y7?QgAk#I6H+8DuyFfnhtyyeq_O^3`rU%QW-geL{Hf-~`X2fjtn1wZGI)4*p>( zlq@sUu|z`ux~455;j_s&!J=&irT6Z#sUJO@%t;S&r1vQQmR*Nc!>8U;pqM2z6hj3) z+)HEq?Kbg5a8SQmm*tj!)p=`fD9&bhdK)i6{KM|ps?PtCWdsF}hO)$Ug)e$4n0KZ} z;GD<}pzAp*_`BpNX({bvw8w5G7(;@B1UnQTW&)_g$0 zTu_E*PH$Y4m?9{Sj*mXsrEpu^P<+0JuGgK-?x7uJ3x*kG*74iNqj)stQC9&q!G^5DRaEWCJcsfvXT_GhgJoqaD$*!B+Ec)oMQeEgSUz5nsVmUUKheWvdH z>gQR%d}vov+SyT&kx-c*FR#UCnTn{Fol-+%pO)nF;T5^s&nuocD`B(T=LoT1-Jn*^%aJ7Qfw#G z>}$NztzqbjV9m;TlWe?T-H+OaJjPSYqk_!wFLD$ilLmY`&jcoDm!#(f7jtiydaSEfneSkL_Uv_L~{ZAhOk3n3cL+pe{jb^UiFXzK56cdm(l>pdmf{u z`>f^Ip}R8b#TDxrPzUwP0j`P>@3tTulf;-8Dx4r6QNk3PMCm`H@nK?<^J$Jz!1O{^ z6K_+TtEoK4);Ohy>0AHvN1WF5ixJ#*UQ97weeAxiFqZ55>4L}PZCymp$O`@tgA$xs3NhgJ(07srv{%Zx5Rm?*Geuvwu92sc}(N|%l#-qXpBsqq}+ z#pq^SFerIvym*K1H?2tTF%)dqzZ@MIlQX;*OA(CrJ*uIBi}>EiegUL%?Jyp*SA&At zXr6NFJ?KqFI6dGO_1e?Tf8WEbm=RpccM)QJ>+D2XBv8VSqF)t1h6g*ag1uw!Lfp01 zB!CIP^gN>wrGZ?x5`TrSDrXmE1Q$mP)4%783_Y&n;LJKaqq3^46xU`Bp#>JEJPO3>2hvzxuCY9BGvsFa5|VeD?zb>_5&?x#03)hqGt}~i zNU260xdu@_B<>QYLodu^le2c}XY$Fp#;%$1L^#;nZ3eljs>Y*@=knHI39Hky?@v^J z8q*af{M_KvY1+iFD36L?10r|Vn<&N7ZMggLv4|7nRb;5a_seiGp+%g%1cNYCjj!*# zZ8y~`rnR#ew`dRtdIx&BzWMEVo_E&Lsuw7$7b;$ln_V>GDb5Sb7urd?$3eDmZ;dTf z8rG~D=3qv$`@}<=B1{F>6c>k)Ut#Dl&X-JLIS`<614G>UrwrE+TLPQ^$~9S~B~jT8 zdxJ)%@A*(&6mz%*O&Q}uBDjoE;ZCC1fuo8a0%5Sb>?U@h&VSdd`Uj-qf_~WnaJq^Q z#~ZGZ5ky#)j{0WbZbApO(fygOiBeU5#L3T=GvXD#Oe*zH^`5FqEo}(aiQOu@ExsE$ zhaMcy-CFqh=}A`AlnDBamFkx&gKUsrfs{ul7yx`D&uCbj(%p@TSsjkh!?BSOp7b(D06 zJOUSB!v`Q@=Rs0HrwZFa-B^I!U%9#Ti;_8y%J5^R3-d*n@*3Q9?9N5tQb~i*GNnoy ztUtI-c1JNg%VbR6(8Y`ACb2P4dZ;>pMTGiwVS}^}LO=Om@fn&E&sU2JwNX5-g3WN| zaw%*+;NG}qS@Kb{_GSi$W|+fb=K6J)DQH8t39bflVpOS70LHiX4&9X%89<=RaAG!t z;<;!}YR6MiJ&*%_%g_kynx#Ca8Lf8&%*cYg%Q&E5PQ5cOf>67wsA(T^l|IL(4WH*8 z15S68a~5$T3i9fZ3wnCrmO-wpjcH(Bc~r^6Y(#q6RTamGh`K0Cq-Yg$tPg0!v~dt& zf3`%s@{h~lpO0_zd)j%)iZ+>SU;1AB$9h?d@O8+XXUx>Cb4NXO+qxpH$u zB6?wmUoa>QpCx5m`HYYl*W`NI=`sRTX+0u@s+c;cRW_Ps&nqveUM}~mJ-^CgeFy_qy)`W7hRRcCu*Pn6p&@-r~(qksHvNJ{5MHjU!``GF9<3CYl;zKPSi&=$YEjp3YdthxAO=^Nw9t_#fm$dfjrCN15P$$WaI>!rH``QjgmT6N7pBpl2-^<5=`j=e6QFa9Ebt8=%zobXmVw$pj@?+ zFwlaiV4BwTw3#59Ery}8gn9cn*p4H)B}LZqD(V80A5ibprRKkIo!W@W4litk=@h{J z?2z{t>1U|QB9yF#z<&%s%dVQd0g=s7U9>dF>o8DfNe8}06`+EFA@pmU0g}zD$V*0> z<$5Q;y#CeCsp6G#))5|_Z!FQlZtULJz<&eTeMA0%-LGfZ<^ab!)!9UNB<@?G^Ob@D zX){e|i*4XtyUgJF>wyuwJ!Wz%*Ltz2TBktV?KGeB+C7gqofcK~PhClvz^S?zz>O32 z3qOVR>COL>ML|UAdI5Pifir|?IQ`ow%}pG-ry`ZWO`}r-2nyNHKJcpR;*En@?OIuS z?4hk>Jq^BOSHixZWE~&iYt)+n=L}OnSx{3T&1%i9&*v0S|2n5VggLcIOnVR!imT^` z@=f;Bs!Ru`aGVghF;EW4q6%$kC77>&sBuJ4M11|kh{Y_4Ffpz3cdIkL}O!C*q9O+}}u?7h744V0~gPVX-TDY+7InU>Zd{N`1oh#hnhTVJP{5J?c8FYR!oBpyji0#Fk_vO$LAq*@; z`9-$dBG`$0llhpH^eSuL( zG$(Ct>Tj-YJ}F`yFos%8U(w$Q7n1Lpn7OL0Fs3>pA|;kI8#(kJvM=*Q8R&~(r@pHK zqGTB>r4b%{*4sD`xVP{dUO{VUs>52UEWOC3DbkLjS8n=p>%`#<&K;WUh?9U5-5f+0sAC`{m{_0=BL6`J4D->&yGG)Oc`(*LK zGQLDCmDuq+a#zNJUzn6%iyi!ydIB{cd`sX|w#>4QB=kiih*iOJpKLYc(tM%2WpS7r z$~R}n{Ra_dsEmF8X z(gzW&o=2a0k43>=>qLEQZ&pF4yPKtDcgegt^%`5wZ%p#t1qY<&ou18y7HR_{pF&%B z*+y%IhpqIX7nZBrCo{yZ=dMpl=&y92zqJQ9>MXh5S3Xs7el2y}Foema_ZwBCQi#m$ zLe+?~#SNn+6IErT7CsfV_@TG$m9n@Ec$mM(iuv`ZjbO8NadnX)X<^-+c$mkZEs6h% zd;D=t9fl6YSS2DHOnOpl;YJGIdS6K7GmwXamd$J@3-z&fsO49~Tsu&rHktR$p_(8s z2m#c4^I_(QggAx#EWG3HvS6dXGHTj-NF-7ih1^|d49ITXzK`3z z77>gD;7oK9`535=xWHbzbN%w?$*A+Jox+4Wqx3Y=Uv4qu91DZdM_TJRb+gDg8ke!@ zDOn?lo&`d)qwGcy^2rkZYNJJR-{8qG9v#q2qY<)-{`glO4MekB%**;fcgqnqmLh}~ z!YjwYYE{^f@so7P=1@;EN$o*V=h`?jM2_xP@E3F+3r@h4InDjGqo2fygWu@*Vty16 zDius*HwtRwrE#17*4iVVG4vI~SWwh$S~;?cJF666G|a;kSp9A+NYt zQyEjlFeKBHxGO$s?R*iV+&na_gH`_a+%6C7_WWLcy}p-BRiWR+vFno|t7AAGMsf7Ck+xD<)m=!UVy0b5szBLnQs z4N>H0w(neCFMAT3_S|`iZC^VNYD>E6pjIMoex{I~wtryJeo~Dxfextg(2j2MxRumD%tN)1b0U zhvAw_OzL38?H$0B??<1=UZ%0jfW1Vr287P}u)=vrkE6+gn#$&uq_&!U{x7sxsF#Os z-xFUa)E-wc&zrWPJ4l$y3jbaJcyCbl$*!;o0cOz!x~#w*urb0Rff9kTj8Q@E=*0;u z{&1Fd(pT+l{!`tqHQf_Hqg;Rs0AchhY-N|#CVtl)ze6r*5e$ogbypZ07#2yAFiZBi%9W*J@K1 zVaS+H6HrV-Agj=hN<`?7E`qi#`0}6KH9{!am)lO8uQ;^|!Pg%AF>#)_<#l*L(j~No zFIK2OoGRbmv6LIGathv4UX}iWwTT{_?y~tOA1EGR!LrDTCF4b9QG&TkB%sDN+qF1% z-|uI6DS+V?Sf&Y`s_E*7=JUk=NCUe@z767592NDNX2zp1+T-61GpEm2XOE{OF=bZY z4=%-fYA#8Ux+*O(m?lXl7DvjT&6drsJTb_KrzSJDP09pq%i&U9Di<_7qb6)wbHKZ#OxaJ9R3VaaX^ z*>1fJNYak9F37qM!v1l`Td&}~^7{M({rL%mXU_u+wd?rF;-r zCrPvrrR6ZW5?kvHX;Zz)f5~QN8)3=8uh-*nvz8IG2~%=c!d&s2`B%8e-M&OSAL{+( z!Ii;qhE8)Ino~`K)1Z}YPmr^E9mslhsv9bjkKV6pnls?VKBEH#r>iSEuFJ!B!P zis7IS8e#NM?fCh?g&1KV$vf6-cko%m(Pt73?vz$$czM2%wgt@1FvL7H$8_$X+!J<) zTPHzz0>jXi6>&U-{9+T$5^VV(Tir6cGVl~|i4Z1`^q+#Spp$J?vW53G>HduWY(BpPnM=cjmt0M6pK>e z305at;lAp=jaH4;!6e4(EV;Ci|r!>M2$cu+mgTj>Yt46R%E)v69TP3y*N)nQ)yEGCQ#c_5d0eEZZmLG(Io@C&%rf6{Ub01yq5;zb&Q=W zQ|L=B3@M9x%wiuW6?$#k?wqu*k+C1BPK{=B#&Ze z?QLcYN97?gSLYy!CFZlQmjaz(7e-57E2RgtZsIpZYO?MzZFo>|w9WEhA5~MY*#Y`! zj4eJB{=4Q8EtcT*&vLTvmlNVkh_E%ZuU}&o7v4>5elN}<8~1CdICu+CQirG*Xy7G3 zAuWqG^s;D^leG-OlC#m9VRwG`vDcxQwAU1Ks;%uKRW^vg zJYe{jbV(U{KLDMQoW`XN9p`6?Z0;v z`ug3tkqUZE&v9#`LGIv38>apMnsbe7yl+$TB^t(^WLMg3=$xRn6BM>sjkaz0Nky>GQzbAJ?i;h(P2RlH?i z!NpLdF|k+__+M&CuU{@Z(Lx1Nk_1PXj8W=MH_XjBMe?*LXZtGo6V2& zrVKSR?>Ru8TL-Zh&$gHYwyX2i%5__@&XW~me^yqzoCMKCoYjKu2B(*~9ME87Zrw}8 zL7&~Lc>ZhWT`~o0mz=^bwZa-ok*qXJ~QUFIgaaZyG@b9R^2Y5 zA3NC3g>ERTmgpx;VC`wvsBdFMnO1pqJBWdE&GLFivT-9mdw^Y4?}TgH8j#6;;dXSf>5g?+#m@UdyaQ@&-3C z3}O`s;|bD#C{@VqDVZE{6w)9HLgBD7MN#_jVHnI3BjP9J`PC6~l~K`;=Ge&oB09i9 zgoCcjz%U^Yfl?eGo-BU)7=eJ7z33xxTsB#mXeSmCc=QTWsAmZhMLUzp$dD6^hFSgD zNa=KNBEymP#Fl-i0hz@Hvu+)L+hjal!B>MA(sLKz0iBt$|q#$fHb`&uF0#yW=#%uVy~vr>3( zN!qPp%Q)}-YT_IQ%Tk}{xRqq?;}latJ!hr@`Pv`sbFDhCB1ViLHf8`YJoC(W|qd@;Q z=3H%KsvS*qN$KAjfsj6n=Td{+Ma%&fI;?M@E8G91II*x36H7De*^+~`g2d3VZiYOLl;LawNkF3>y>O!}7Ef0Zvyvt>X zRO5g+jp;>aS_ zGq&<$2_mU?EtmeuPVP#O@*7bEK?TG|^#|?I^Ik^rxqlaBm!40eMurzQbdNb_ zoMg!!{`jhmd#jyoE9rg%tV%8Nn0fu`=u(}|i_vC-kY*R{K&dJ~96%t6F?k4-3zTGq zLM=y8jW_m3i-mmY?xzXP8(dPmv{fN7{F9t#sTsDR#kxp(+5#w9SwCeP0F_Gz{|}87EsD$wxQO|+8r51h#xDQ%zijy&20>f=$7JOu5S>)-n8+6~jdJ?ViWkLs zA$jAYcoY1v25`Cx--E}17q~3?Wn_pVlNXEjH7ar3cq96RD=J3s&&Cp!vbh>JMA*gI znq)31*xgr(xTDP-+`t9%6fAk&1m#DB8~@J&v}wP?aADTa$5EH z0W|<}1S|=$UnCCp%TmsA@s(7+H?Nj28o|43{fWiscL$dakp=iMUg3 zCa~)!V<9H~xaUHGTe1&)MC@A>UeZE!LaU!*fD#=Kg3~f!!4z`4s{>|Mt52=AYE1`6 z_$np6K~yqwpR)}4#Ih5a$obNP30*$V^cS^=x`YUQqo0P{@@*7f`+vn7m)u~>ltQ|N zyxpzV1Nk6jo33>MWFb$DUrlCokucqKN7LIW*=AM70w-YFjB{$}yQSZrgkf0f_E+ir zc*Ii;Vu0tKRye~bIJkb5qLP`yF!6I*&vzlBWB9eR0JwCR0g$Wd7|cMxOte^{n9OtT zG~iw*17yaTlV%HHoFTPOlQ4w%X z706TIazn^Vm&>BNaFk>}zjhzC6qCiti1YVJl7Gg32PUh!1UWMz##5kJu*=9v7typ1 zg(KZ7jmEkf7Uq;TPJ8e$p7U*Wy-E220^Gp;P5tkd`v096nEC&p82JCr2mZgr!2cbg z{(oBJGt&PLi~Rq5?EhaeFbg{i$Nw9$^B;@+4e|dJ15X0&4-~9Tdm@0?8JLoG*0a^2 zzyO)zk;kX77{+I;V*Y);Xr)tLLX&K0d!7z+i>99TfAJm`q?EpGOq1f_ESgNBh=9cx3{XhyjoCFApr z{pI-_TPR#Dv)C}soblyR)H?ns^>8~RoVA?XU>-}lqJ^<0!j0M$WXrW&Izbw~fNb@6 zXPng-E@uP5>W(5)$!?7FOq*e1KTY}*QQ|zccF349kxjOOS72W8otyr1qN?Xg`Ga;2 z=qfB^3T*8*y-gK4Z7VUo0nyH9?e$=)c=t35DZ)J~G-pl!yuQdpLZyVh~@_^5l4 zc1J3PX`*scMV#-FZw8mLdkxYKw>W*>c;RO)%yqOj+N=7Iy76vxZd+XQw3<9xeUy%% z*Fe5t7UhuZ6X;*}tg>JVT5gjdJ(zIdfQN#x z3C?;!Ig}*o&BtDz@V*FflCJ*;A;rPKlaJ{*ND4JOe}bUAvHh8ml^BH(>G)DON~keg zVlGOO(Oye;MS3|ZSj9vIA6&_~l8pFR1Cw~lO^BwleLBiB1iY)+lDbos^zrOr=Lpo* zoq9H@?xS1)A9AhTXfC)L;7*`*6SRk~3#5db~8bK-z;+5k+n@T`$Y}}_&Q+z zO(|uS+z4_#E=C9lorO*dWK6f%lJ4v*v#S6$2wEj^`>fsdsSgN>SIXfdP<#7y_kTspa z@1&MkZxSdv`Cy(y-)-dV;W#|Wc9F?0!_;7M9y zpviyg;N~avE^;V&Fv|%7SO-Tai0uGt2BKh;AX#t1&OD!y6Zim94D#PGeo%!cG9uh* zM&&|42R`{>RJfb%)jru@(#gU_)Oi=&Vy35sCoFZiU`0Iq!NO699%HO$hi8&n2rMqq zPlEU0B3-NOyj1$YS(H%?-RaO@ZMLvyhOWc9i`jR&IJwK>p-FyVR8HJF{ z>w}g>$*R><1z}OshVOgK^b3ZlNUP4>Ogw-7#wLl7rl%+~xaw1bW{egWQig$DAQNaO zpvAqQ1Zmzs+3vxH(Kzfa)}B%!fY8P+U0qfnd$Nc0(rT>Wd;oc+P^(J_}xrE1}q5iDeYb5WY|7eCL@G56kN8xT3s4Ha z!(qu-<^79EYEH*{d;RUipp2A>qety*_zZx+4<*@Nja`MJuijE$u&?}GAg%*}_k}SJ zz0zK{P>Z2Hf7@^);|4nbJBJ%y7;=XF&{(x+3Hov45X1pGtcs(F@MMT$%K{0WUJ2(7 z873D-D*H3!N*5l9;rxigal^Ar?(>zDoJ>pUK!Cb|USzluV9PAJv=IF|o=5>?^CZG{ zWxmq}cVXw`#G)jN~0S6-=fU#J!iaLt^sl*=b5?N3zu^H3HVUFsmmOCS}u=<3t zs>X(<^$Zo^kG7C1I20CsTk5GF zz%rI3j*NX9kw)(AYD^jeft~3Q7yxEbU9{DytMp&KMD?`s#py#?g++7Z@OMu;w`iPj;q~@>y0GkQi%w~||awFvDLRxBFanJ{XuS#zD5f|gI025YAwUVcxu)dooaJ;boXM;W?hb9xeQt8i(^nughmz^xp?;|sRaYlR*RGxc? z-7f&P+!+<2jqn<%uzPu8#DsBc@Np)@ubjIhNAfx(w7&7!LQ+q2@b)NvO8TE8V?8;KsPu_pjuc=HziKA5}2@DgA@<0vy12_-W(a#iQgb-IR;3u21Tw@ zDz|Ks-S(bcNxaJt={uxU=OJ7uPh0s(|b*E-o36Fw-Pt8>|3{f)YY8I&BoNPvJgEkto!ty_}1)kmT(wWqcwUPa3{27~O2o7}D#JA*U)-08^t1sqeF^ME0iHMvKpPA(~>%M~~kbWSbUBkS> z&S6SbKpx*{7MX0|BE_jM;r>Z|u-LFRK2 z(mMV5+GKWqOwr@IReZR$BR0I!eq;K_MNuO99H}KQq3wWBo=*+BjbV}aJZx79+$;dX zHcAXI?ot{ndS`GCNgr=mE_*HL#!z(`y8Yjjs=iCWaOD{^MRHPpJe;2t%vzH27^|%& zYdn;EYH&JR(i@<3#|lOY-6+fItySqv!>Ht<{MnD{F{lJm?J#W~PhELTBE@G_dCu~c z;lVB;9yksyR_ie6kEv%Yo5MlgQ$4S?D)I__I%gKnWoY%kFC!JVg%j^Fad^DbJyj3( zSs|aj&mp%K?J+*P&N2Qb!@0mUh@&)<$i6|38viC(-9C8@a3sN=hzb4%I&i0g3B#D? zF(A*Le3xG>Y(&oBIhQ$-1w0Az?HTZ2oXRlUE5#9(ki-wfSspWF`%o}L!ZQ8Il35$b z2VtC)4eoVVvn>Zn3JIJO;YuK17d)gf9fx>bl$(2#TZ@WMa)xu)-K&mh_|1u_hF}@g zKhV?E6T6#$mUnK_ml{a35W=|g+oQ;Gmd|xYwO)YBgN42Y8jw6ru8_*$i9kp3-wtqr z7q5dda)vxKHvZNIem4nne@;z4WwAx9Wg4#Uaezq1LVb-+ zE%F$TFg*bl0b)DBha}3HqkwfJnh7eziEhH`Z9EP@MqG1r$qpp`%QcUmFj(d;mkvu0 zKSWr_7~&h@orF^dR0}YA^9`zL^LJ~?Mq79$PKYnkArZy(=O3jR=~oQN+aQg0;fI}) zzdrSX7}s9h`v)qc5L5Kp2|=@`wST$JSfSttUfx#p7>{ur#vr3hnq@3H{>W^B3w$Eg z@^IOX(_|;qJi8c3fuffGDoHyyRu2Dy3K;%)YyTwx)Sty)y8XR``x!z5`6w0bKUe<% zFg{~8R+F9b!v+spzEoKh;)vBmL^HmamS7C98ERx!5X?o?)u4zyIf<42Xd&x_0)bmm zv9{RYqQUF{%KvYRzJ#9+x#z!g&(Kl62)c2dxLA4}f2fDoTu z%f&cvW2vD8JP|DV{-tzXRJ0;wl`DT4ok5{RysEI25mA0q%1N_{n5Y@L@@6OK6pKa8K1z zcU?QPc++vmTk2TWUPL}K>>~Wijdyi7qPM0%ZbT*l2&eB|X%$^m`9cbHfcz2G_!NsV z&UOi*;H3}QoRP;QV2B5-05ri9gb7Am8n0g8Y-Ej@2zt!NSGY_&gU5tcCXVo|Zq5P5 z{%`Rfvw8nwjH8mI!=_jMaILe2;6rZ%I?b`m@Lv;N8rxEQ1sBLHzOOFTZqUw?78>V^ zb2x~_eP5=zKYewv?0S@|x1Zr0^ui|8*aCpKx5`z3{4C;&ZVtSsA_xq=BKssVvsZ9f z+aiyOqn}I#M@l<~qv)u-(Dfhns31ax96+LLWlXlm`AAM*vmHBhuf1cCyq@U);uEo? z|ENojh7-$(H&SE$8yB`%KE1;aUq)RQkvt8PbE1}8|@uUYPqx}Z$ya{yS63Q1;YtU5R2%*an-R)ip2>l53t#XXaSv<$nnL@9Wv z@(#vZkCI?9I3ib|ZxLA&W&ZN;HumwfH}v`W8h$_DnxLM>^X<}T|JC9u8rr`cv4P-M?J3aGic}w3}&d+q|BzSU+U+>P$Y5&^3ko z5W&+4>|z|OQ-@}(tby`%>msn&cREaSLz z3*OO9YleGVffUc#!S=d+G4#;vNctQh9NB!Tv3947(55s}Vw$LQWgjXGKFVjZNht8m z3LHnE`A8!)ke57A(ze{^b7+3`$+UIh=i<>`b$k1@5H8OvlYc)&5bnM5rDd}7DTHJB z1-cxraGBoZRVhao6au=IwQ~Ry{(giB#X< z9pO4+#?MIzI|%~QnH7D0eY27n_03WmicWL#I31YtGO9$8j_H)QJz;pdbiY=c%Seq0r;m>loT=Kd^>&ex5Yk$y>0)lV8_WKUjbcdiP7pYQBkn(T!EJXehiC`-ts38 zQcM8#yAR6!x}NXfW>hj3WZFpbCchXcF{B7N3pEW)(5~H#uKy8I0}azPSLo?TKyxsb+?T3^#k) zySBoVZCrp6QtQuk!JPzn!#zl62)AudS_$}tI!vd>sp&3CDaW{mDd)^F;eSt`;{Mu@ z1Hq&rm+g+E4@b8b8udm+nA5e2Hpu0PWh8o4VD3`d%7iWs7lusVFG!4*5b_UAbFCRI z!|pt871^ir#DRQ%{GzdIyS~;rxz2NA9_?+HCSloh&yxLf?lb95_ozxZH70Dm3S+BN z1>hfU?m z+%oq7Rtk) zo{`Phyn=-rsVAP=r32x*$@8-@`X>g(DP*nv9B{ze0PEIW`$DS%ti|{AW3o*S`9p`P zZ#HAr<{GUFe7k4z&(PJ>6*Wa$?uwQ&P_DdClXX`kZQldS5nnbXl*Wn$N}a)DaPnV( z*~Bq932zd<=?#n>y7=r20Njvh%ND<|J)Ej<+wxO;{lm3U2xQ9oYgVQ?6qfjEY)iFC zum~vd!*#la93roI!-AqjnyONr*Xx?Il!G-COsEHH>FHp~CJ}MPXp|tdz;Wm}Yi)f$ zYJZVIX?eA{|IOB)`M>khGXEd+(*Dm||Njmd^q;r<|BsiJPR_yBP|?^)lTJ=plupUm z%}JY=mrlXfN#DsBpPo+9$-&vsNlxG4KRXDF4F6Lo@V~37{a-?X|5VkA{zoVhW(;cMzQMVn62pF#s34nyrkW{E{%CTGKI*zY! z2dyEMza_kK1wovIFafKd!ym-Q5F3x>1@0vKOR`pRplmAfunA&UV8vt+&B^;gxYvFC z2V?^*=rHcCrX-UU3h*HVZU<@WQxddgd%gyyh&La>8KDupJzC;0-C#vYs=1R@otxgJ z<7!YEh2R)jB2=le4ovP!i`P4mBx|z`80QJ55$y31`5{s;qC0RgY}u|WUMGKFfbnJ2 zRQybgj$WeVTHD|W7I=+Z1C2arqhtw^QE;s@ZE>)Jw7LT8p->GZ4hKI&rrJiHZWg#F zcPA~sIe}VXs(_w!9GC)?aF;Xe`7x_XK%_iGC{9q4Ia1e80@5qg&;u6=cx5=zuOJ09 zr9cce9L3x=xrYJo1na{&)?gU+ov8?T(gLXYM8mU)Py_C-bz}86NGs?3TE0Ns`;VbE#;yyvpbG zEL5QY6p}^{_9`qw-UayMoTLYUjpQ#hoHCHP2}n1WMK_iWHOFq~)__l==?Vqg4~uqf zi;c8=UQ`p`wkUS;W#-Uw+>M!D6B~@>psW}M3h84xnNTlfJWQ76r zr(8QcOZD!7Rm?p+Q^^-g@UpNXv~)D2VsOY<#jH4d8BZH9-KtDStf7%w z?Eb`_jatUDytNR-%-CFaluBD4Z!^Q@4Cs@8L-(%pya#Q|nu+^d;e171B1!=Fhw`iU zqiHz^jZ7QS526SU3k~Tr{WX-a9w_n)mJ{JKnI1#t{GB7zDr&mOu6xL!hFe7O${vdv zt!Oc;wV&@`6^{J@((N34y@=&uGP8J!*O)8TZ(#zf7Ee^s#%kP{Bx|99{;0UfOYEvH z&>U03XSTFd6lRmJ_|_?bGYk zjF8g~Ifsr!f}g6;{^r*Q6XSL?d&e7$>%vEzO; zA%#;M!2>bNy>7P{E+0ak7;U)m`Ct>txVOE|6Y(XBC!&#O%R1*=z-QeFO^?|Gp|n8u zl6GpI7fUYt+7{HQi<$AK+RrkZwvAvs7++|PfYhkb$Qe&2**&W+dcgbvk_MMJEu7OZ z9^RQBUTUCpf>B{QSmTO8)w2ilg=(Mn)9a@17%gpBhYHYHui z54{CUs3_)g*zn;pSyLSyuv<)%}tJ(~En zt9!o>8uvEM9!srE&9~-Rsq7|g5RA}aXVar;W<`-hZUv`N&}7~gw55vZ0Hu^{xuSL#H#+w~ zi1!A+H!@PMIoV52Vl`Y$VmJY^kr+Nsw=7K=+HNU`c~IjBuXd#nlN8$radh~5Bm#_$ zAHR{ZPEj!Mm)|9odgX;fY|~?}1a>gxIIfB&miQwmGI0(tT#(+__;o+!_bCtM_a9DN zHP0%Jp-AyK4O%=zdG&f8R@H8wtJQ2;-SA0pW|;6xPOsPdC#$IpuvKx?ME#Y+Rd zGObrDr4|9Jp)h_|{-UgQ&6N|KbqVCHUbvvb=(xufX?j)aeQN51ApXw6V7$lMwG^(A zwK7pJFkS>zNhtRq%l{w=oP-Rn1(ok0SZ&lpG_ztL!{B!-v9+OXOH{#`#f-( z{1f!C=`B~JT}c38rWc{x(xsdBXro+)2{;cnk)j4JTgL_1X;StsP1ZDeX*rawI=MTG zHbz*NUIv>pWEpNo1#(O2ddrT8>aZ!QcftJoJ(PrD7yXeR zJgGZBz~K}|`K)nNBnDomCsJ+quu!F`QoDw*F;ko_U)?+eqJ26y0R+HFQS1M7#IT`~yL z@S+$!hJvTyf*cR{!LQ;7XHu}=x&H-n3kNIkxHyeF8Yyp{&+ImL`DCGuSWZ4nlDW7C zV!~1b-;YqxSTR^EPN$4{BCZ1gWd{Ck6vTkO+`FKl*lGEu+c6S`aSU*AL*sTe)Tyo{ z#RPAKe6Jj$&qDK|p{ywokRNqO?OB{f4EL7|&BRiSM7mA95pkp}+9i$BK?KQ+cm8<} zBv)FY#2d{fTKqj|U>k^29O+U1!)I1fTQ(WcQfft%=9!m%pcR|LyCa%Qh+;*JBtLn% z<7dT*7)|o`Vp;PBr;w8Y{=ZKZw(r(;uWKljv&X72CPHqpjZ?CcGDG3hT;dah7;BW zNi&2(IhO)S~iG+-xddgRA0QpxLTXQ#H~Y`UQ0@9FgO~tBYNaqx7MB zPx}Nmb(pr6+=&*8csgv1l`&EzYbevZXaQ3AVWFs{=*48&cGRCl9kSt&A`jP;7yBNWYD4Ic!e~Y+5 z8>x_UBr2VPNcd;SonRBXg#g5~^`86qKJnQ<#d!0DM3goLA5QNjLW)G0`8YCb!2!#Z ztTPqA7Sw}f`knv8A*GTQl&eI8&BWAWpeQ;D+u%)q$Iew+L2MGncU6d4(pSd4h2$esSG*S2hrL=%79 z)SjgRn9>tPqA4s`!Sfq&VGz}?)*b7(orX7fEuN{Ci>h-ED|JVA+1?Wfwt)a7{ zgZ4B_^L)QqfHbAK9r**?6TRqz{3QGbs5lN@sP|xrn$<59L`v!3Q`Uy zs6%GzZgxf{CtW(1s%Z#qd#3g3Ssn{GjI*>y*dsHr&gONWc)3ZW@)cXR*AyE}6_MHV zQ8m(J(b9}lfl8-xE**C8+lwX>QExooM$;XI7}*y-cfh~m4y?iiZNeYja{i(a%{1pk ze@_ABSUF+T)>KENzB-H8{cin&gwO=_K7q9|WG(fA+J#D2G5{S|XMbA}O3 zKP}zQ)n*D2r*U_Oig&wqXRSl!4vK1D?I{5aPK4aUF ziNpYds+WpBW@XBi*Xk1!B#}YLkCu2FRo(58a@)+GER~o5j?1ryCG2eNOgta{f&1!^7Bj}JHQRZkpe0|cZg<1d^~)(A8&tRwi3ymE z{wc9X&F9_cMJOqzO5O&Bswhpq0M8Aj(qzfuo!Gang!V}@s-}yFf7k3VfcrAB5Pr%w0c?LlnU;o2%!bt$q` zZUgZ@`iK@NFDHy*f;BXpU&B+@d3c$&p#zto2Pa^~k$5jOraa0JK019YOk97wIj{Fv zOOJgsW>167FWqB0oIPEhM{jFk)`+SYFnkN?%8$F4^xzhv^;c6jaa%?ZW9n_FLcx*FcsGtM z*7yU-x@HVgvth)Q>@8Jq9e2?4G(dp}rq2u;X^uV#WM>aMVi)^Y*0*CQ0Oq~(6IDPz z2R5RI`!iBQMnK12aev!fQer!GaY2rPh?RjG5>>i8z;vT z3KBY8l>F^Hh|V?hpYrY#T!Zr^pU;WxQlJ-G55PyBrE3-v*bFLjRUYZ?2r16M|JMZk zJ5>5>YSvaCIC=7FVWUGBA|UuwKX1=FZaOnEC?#7^WB}ph&GLmRvrEhgizsbA2HK5p zi0F+E`Q@`|2%N8;hA8wAL(S~e>R@Eb$FQ;?ZB~VEUB<_Yq$CfmD!dbG*W>28%goot zv~)#G-H47su^8=$rWFXdf*je`%&jlUMzZgjjuUW(w|Aed^#N)iRd)WTJ6UGAQWIb!m zZ{MU~V&J-fZp?&+Z(B4w?llhAhB?_Tir{k2w$C@*L>W3HNaKFtYmxCGQ!4o8pYW!bD> zlk}R3@eEpqaKo;8km_8H6Q8^OVfm5na0L@y)Z_eLiEMGj*Am2;v?2k=El028p^dN$ z3onHD@GvN+CS7?T%WbvgsP4cf3ZYVagb&Kc2q@WY5{m@NMKsrjOy@P~7}zHXjV{#e z^S|@^*FO1rn`dWpBS;d34eh!a!QD^b_YOA`N(~pvx5eVV=Sbct&!MiBKxqwL*Q)qn z+GMxMoWb3B%^>sB&^>!1ifh_%^M~7xf_aMryNJPfJl9vf;C)7Cf!m4O3md7?-tGzT zsNPM*itEK~z_>p3dQ?C{3rar(I{KlpUv~1!xLMQ~$xu<{^X~fuX^FyjRM)hD0wg)C z#+wC?qr`Vz3cxfn5@ne#UxO_juug5_CCSpID8}^5N7IVa&uRtd-iOk2TnF^2rJ4HV z#2ok2X(k}vx%QFy5;~yEYYalFF)KwV%auriOn@scG*5cB0RTQQ+;xqx6Yd! zTUOw9IOv@_3ljAxSuaATL%T1IPfi#3&a2X1z!O>OHJ7y__(1n@JL|)u*Wh$Hd(Q-Ey&1l}eJXFt-HgeFRzHEhsm8ZrpCZ`(QAV|nO^T~> zTAsDRkYrp`Xp6s^gD>f+7z(*{_<26Lu8q7{&XjKvv9;≊aZbtJ{?Y|gr`&DAnD zXg4iKfgV?OcRY*2Ye5vqxoK1%ovroop;|agc0$ZZTt8dRF@}oV^T8kkwKWL6$n%3w zq$LSrIJn`UguXX!YkN#r2^w&OLBNPkFy2a>J-*NX{xjrokD<%|C#?RTinYxD2aC1; zJy!ouWBUIuSe@~|!|MN=L0i`UMbuxUHtDcAfv|l^WtvF&kOB$F37Q@40|tu{3&F5Lw* zr8kissGLQ2>m(04Hl`h{Z~Wc3JKv_cjby`R&kMD4MT7qKdmY*3GSH)6uIx=Wa^iXa zFw8^0%WzJ!+cE;?+Nih;F0KlC?=H&=sRJ{d<#@?5IyHJvj=2b~-#N&1N;O#JlV|;` z)=j3FZt&b)x5n2q2)?8{Uz)a+lrIadr2Xu6mC zmrnY_12KSp;c3G!;;gDG2A@-&rM;`ROkaa?$~1s=6CA0dG%q*rJsCk@#ah}nVgBC7vXp@s6yshm)eaN!hafek*QLv)CI z4*sVQV88f@RuMGlh3rBXy7H5@i+TIFE`0)2UYsgwu0o+wqBb;#@QE6p7+15&?v!$r z)WeA3_<>=b8naMD7UKhA-jRj9e?aBeG-e5KnO$Xvt;saU2=xi`px7Ab%O>U{uB5kuH(Y#7Vbro(>A#z!DBZ zp6LdktYXRpQNByMf)ZMuTjhtSRprN|cWNAm`(h9pEEt{LI{po#!4j*Y=PdhFUm=qk zo|2GalL#o{c}Gc5k>Hc}P3> z?%$Q5MELfvGFGNG4G{%d>n0=UB5${y$V~=jc?Q&9(S%biHHW+87HBxm8gq?f)QE0QS;jjqlr{R7S@`k{+oS{0c5FM=TZD$ zsF(VdwIj>f;mwh=L(#)x?fMr!Bi+gM+j=%DYHA+&hJr{2gs_d#WW0{cc*s|?u(2jH z+>ogC$C5m2yyc(XkDT)82i82qnww<*p0LF2CM!^g;uoszFrvTR=`eFnb}IY&Wp4+l z>ms9vmb}TOz4@7s5&|2S)Yt6LQkUvZ0meSA9eHOOSF>6-5q7N0wom94VN)6PC^W7% z@D?X_`(hQcq7@clpMu7-iD(IK$;wh9!iA&&I0Zt8oY?CQNi-8%Ky1%ky)l@kXiY80 zr{o8Rx@)U$Vt)j3?4SO&;b4Vm{wyq=t*U`Odbks^)F0ZUYmz{UP{@!_z>;%@bvb4 z9ZHJd-~4NnKU#Iml8w+bZM$2XGW`Kdt}WQVKLvE&3w^B3^X?tx-5Nf2yCDBt(xai~ zbbCc2YB*rkDqZh~VZIQkrnlQKVf&h`ADC4==i&1j38YJ#1tXV!3M4CVW(69_sV-v! zi<4-J7+sGEA*?5q=h3MEZDPT}=ps-HmK|}*(A6++;= zcJ_=l6>Vj|PQ%BA(I85F?sCk*JK;u5*{lK^Cib8qeP|EcGj*3`@{-!#^Os_z(D1S? z_rY6xI;ik|#DF5YKm`b7v$f;J?-092a&?5oJMtWPJ@AI@PZ^F)M49DRf#H zyLZmJu-*8|8bcx|sN zX&R)#O{NTwU~$w_@yRtRg5KfcN(sPC==fimHJi5S8ax@|KR?1v zUDxtgYxf{%)m$fxRcA=|gE{HE`U7Y&_*v$whf(u4C|&BL8ts_(2la>P>-{HXX2UyP zjJ4I#k<+Ecgez`A%_%1e14Jqvj{qmrbW?{qMJaA3kJNN~J2FiunG|H&IM_Aeo`vT;%0Wx7Ds#imP5 z!UXgL;eWVWa$A-1K_Mx|uccKba`g@7-rZ4gU+ojnvh#M}24}J!q8#=$Nc3A3c(L{~ z6ND}e7z~?M@dhNTqw+}Jqt-XWzGsNGA$~Pt|%}sA=wYc*p7Yo2!x`< z$6rI3R^0R%I$plzpQaIR+p{}%JVtJWWrE&#>gVLFU{~P~PI$;AlO-GTeYP=$tl(-4 z#A86zFpn{05XdC|+K`q^dFvX;MGG{HEf#5_2xR`@C5nE7FmKN?H2GalNmztfGvQnx z{D(%g(B==kV$FgOC*W?6<8u+psns*Y?XX8EGNP>Po*C!_kR~fSuPIP`4msW0U zZm3a|<63K{1!YZDr#5!3cYeXQS~|$IvdpwSMbYz(_mz|nVZ1^*ymWHz_rBV`zz-=8 z-sL7pGBzryZy>QqCS*Db>8caUG(igM?>IMtYsTD)Q|ZeeGgJ6T#AvIVsB94XG)NGj zha*LyR}Q^Qa2(=Fa_VG2$99k+i5u5l*wyz1T47c>#D6kq1Z-m?iG0Oz2Y1={82K4m z>-u~m(8VUVV4QqGAo-j8_UhxQYLTcN!99)Cj@gBWZFX>CNr9x0cTzI*u?l*^UA4}%lzKQL$cLSXZ<<*9?&uKaXO%EVu1N% z2&*50&?hMLi-UWzpzdXHO1rZ_3D5<|#WTz?`77qJ%+hL2-2eI&;mxdsDg%_qeSINZ2XLl!--jG(4(PlN^?Em{abP_sIz!8oqW}3Hg`KA$u}_7S>>2;4?ybI-a&?*)6-b$ zq3TM{{mAq!sjaqAY@4Dmd#|%6MuxwSDgvU}OrT0Udp@Av=Q9VJR;#J(0j}sJpM$tEA%VQae+(N%TJtXvbcSl!!9- zDX?y?rQ!F?`?DRNY9W7Wvt~x$SmU_S#6MniGG3;6WVc3l^K0xv-9B-`!cRlyw8fL) z99^%3bW@ze)|o1zultuDCHdbLjwc+ND?q${^X>_!*z_GfJs#O{!EjK|36Qjy`godG z=tF+9?$zOd&fn6NO-GSvo^WC#h>9}VD9$CuR?o!o%oWBYY|n~N7h2*gTW@0IEF4NS zEhaWemiUw*a_WkGSn*EUXkCkgO z&I{$?@jCu}0`!^fh}Qi>^_7cvW`yO=bphZx#<2d6V9}QFL(WHSK$3MuKI`rZei=rV*e+*#FmjiJFGxu;{eA$+N=b_(ru%I< z9bHRSr1*t8vx!Y8IL4q;kwJ&8|Y!Xc2l+^W80(hnQ?IAdxEiES3wFh4eN%Lxm5{Zm=^uwR8#tRMr>&YMwiA}d4r#h62CQ#FgV>xSWDCR|Xq|bZ zAsX1hQ5J&%kFzM4p18jQq8f|TGYn0A-w(8ImINEtKjB&+jD3l)bdA&6@AVXvYn{c8 z4-SA-4(Wzvpcm5q+hc?QK#rspRJp7aTTLXQcfQ zfw!ey*z0KHY+YJmOZ^pn^p*(zW`i6vh;41YWMJGm!Xuf21;M2{dHVQRAUpJcE7`>4 zsmKHIEyfiSVVnbV*SyHvFPi-sGJ_#NT!1ZUC>TZ7@X(n2vPQd`A$>=@4~bDhPpNGDZDU&@M4{?x;AbpP;`i{Deavk7K5; zv&n3GyrR!|IllAM^pZTk3y#c<(e!d4>g(A4v4fkKqF!qewzbJ`@_-=Y2}?EGE50~c zJMSdGEW@Rd(F3_J5B$xm6{5v0;r3_A4y7d=t7d>#09lP-?sVN!S4-x?w^pbrvQFWW zkK4Kvi^Ff{r>$@ln8)UPm5GLD`kpL&JMyifDrnt=QgXbQJ#e|JehZk|)Nr&u+}lxh zVLsuZ`24>S4H$>HPB?y;3&)_ru8NGsjJD2*R!$_xh7Rt(yzb8eAUJG>A*!W3*`xkh zc@?~Ap#b|+AvLA*;Rex!03v_!594H*GYsZ|HY>UhQu$2v_mgd0cbTD0;^dt$Ds{2q zfo(yc)e0%N7z=?YfC2CRJP{?NmH|fWC#YlBuI+5p;sAqf5DkxVrni*NPl*T~2-v@!T zXyWt}!31%abdavi$qtI~_n4Pp4O*dgW8p|y>9vy6lJ4ey%o zNlV?D(T#tIboWc`pPi-x(l_}(0rmfswq^dWMyw*;|Bz%3IQaJWPPQ^7q+R85toe-_P5{kvg|${q_hU!sez~C40o7 zvXw0ej~7y=xl)7*wcKSXC5j57mkNMwrMaJ&l@(a@g>4#6bZ?IRqX!)0ul$r2M?MlE+Z;CCY$>qF5b2w$a8_BMelF0Vsx+wA&IyA4# zevX>UmgVzqS~YlM2HG4%O`u%d>%=>vbS1LC?5tJM6hFa=)td ziPqohM6~00-1xO~xexl@gG&})!b=a;4c9uOt>q%ZgRqF#NtI$;cyStb6Pv2maD9?S+?~G=7REp8uXFYR=FUohIN`)Pg;$_D* z9-ZV0g|Z-Nhl?FoQ520?D9m`}FX@kCCB^!Ks9NkNrX{#~U~olzD54JuGt{y>i~d)H zFE9-h_P?6yYJ$39*Wpz`NR0Z1fJwsY^E@g`OC);gD63APNt=o%n-E2GYAAJaZ3YM1 ze`@PG1Fo$5m_vy%lFJ`+FX z0319*LPiXuSg$K1<^OE*y!WN6@4gU3G^1**gZ8iasox^ZrBndW=OxSnIvG|8!CYqs zAoQnnhX=k#R^+#0Q`dOen~ui1Bb>k(Qfx&T1V-;SKlhg)yhde#vt{YT&VCQcdFn%E zC!m(rvsK|@&&vC9LsVHRf7YPbs3s$R_eOw&jrFzHi7sc!v?>xfLoAdH%_Q1dlc4?N zGQ)L?Jg@k(a5cX(-86s_@e^F(!M+9=3afOHIxO70XFB6Uxc=qvd$~#!X4Sv$!ghI9 z!?PaRF7>h<3X3#%~S6 zP3k;PJ+v=i$D7##XMs+33AI}kPQLjX}S(#+3x17rZ0(ClpfhCHK& zrWy9FMAzVQ0||4J-|8&EwPXygL62=U*}{@hgXY4D2`PJcu{~~_fZ=Gg-*Uq5f{!{D zvsf^O4T$c$X9_`ja5OTywg$zfJo1PdCN&s7bPINe!`SGrkQM1)hE+&>;aAQO@}Lg> z2r0(pj}WneEs9^AYb_NE5qHggUhPg4rsx+(bfD!4D*FI~^T01Uddn+L{y5E%M|jLX zTW+M~0z{>TgR1qH0*KML+aQwP7+VvR`6L$mont-7MUpv5Yu6u@oc2uEv4@?q` zYR`VgttvE-*}jp~s0Pt_41-@G1bcB%>+yRj zh$Mm}O!APAre@99KqgTzK~blJvtaW>-iF4lR@#XgNy^>1kg0a|{?+j#_u5OY=DP^A zcx8vp$-wj$r4rSuT?wq5BG6o^$XqKq1X{!G;bA@*dz5wCNbY1cHH^%3; zT36~ZrsawMc9+UX*)$G{L}BOm&0nM^pQu!HIW%|LKXrmH`OWA!tjlevVpd|foZ~G9 zv`*rym#`y&Z6eY3oII+H`L|KB&9wrve&AIsd%twmi9d@RsGt;FWacY(10sIcwwki~ z6U0p>-?a7(yPJ38!#|WpAoWB=^@_+rjGYVuik_(Ge%5gWV2QV(3PP ztDtb@4d0{YNougPX^VRWr9(}GP;*={=M^n~mfwbjT2F_M2AL9yMoEq-8Y9< z9GLFL^j2$Spa!IhGHsi*r4W*18aeG2+IUp!tOaAc;FKvk&;=!Y%VwN5vO+SkO*J+- zB&7A{_eEH*RB;q%$$hAP2Bd+zCtC z+>79Ya^1O96v~sLlLZh?^>#M{<#vmqW{GF1wmq`)9Q)5(*QSebx9=pZV*}VUqqoem zc>Ho&Dx|}Obw%(Ry%DJ4p0AdrFN3(>31Q}wYhxdqBR9otPqP}B6Pj%=1Kpkj;>$v( z!^ZdXrz|SvFKv>`+iGM>jR0sRI3COoERJPpbh@7sTnDpZ^pSK50J2?> z9!hR{v}Ti7iqze3*z8a+CSF^J8I1~HP)y!ka7StIaWTzF@mQcG}WPVz3?H87C0IRFao zcnS2sla;DitRutlV>aB(6WaRNAK;-c#en6=JtPw*46uG2qrY{66qx}OD?U|t;kSK& zsBxWzgdlw}e);<$0c`650Y$j6JQ95g^bSVN+H+9F^Z+h?<@(AD-TF$FsZ$-zD}^mH zXMi^#YqVtI30z7w7J+$yNZD1V!Q&s!p0$lKKlYOvS3)CS_81?6IeEul92ZzqPMYV} zZlt?l>Am^Z@QOlaf@LrquD8V76yGiGGhW$jNczcrUH!82&C>=Vx z;GRQs%?9SKe%ex*z;Eb4#&`pa00+*oL^*O<*c-y>^q4>!Pr^CC2?T+SGfcMfUZEqx zOdAR%%SzPk8I4CmO}k_E5{&k)>vO?`rPtHhB-G4py^t#5~5U&skS|O zC@5(IS~EL+L3Pfl@--l}R^RqRNnm1z7@E52Lba_bHkxL?bF`-}}BvY7&l{rik62 zYJ29zgdqTJ;^oQ}h+O3vf!sBarC#WI_`rlr41gZYbv*CSk2Kr0Xnsi!4KP5v3*R3! z@>EvL_Ff}qE?uU#FFXb$FY&W4gZT)PC~dPHZ;nb!`w=YNlVWbmyqH=E6P` zOjGT5-zd`D%1u0SJ~>qn5~bZaD3@>6WkX<1wA5!DRoYb(Qphfk+)&U_jolK+sA(kD z?r5`#lkd5ejED=j+&lut5Gm-X=1Pdm&G)bM{<;`jm9eMkHPj?`+_4vH zvt!0axHS2Ga&NApa2EA_pMjS&{V598qtGsyV+e@QpvyTm3Oz(p`UAeurhrZ)kK(v0 zi;}ge$qggIO4U-H@AjUwC-s7UJz!9#`Dm3Jg6fS?TX53ji~f?Fogd0A9WyWZc0(f~k$XjNgNH*0m`b>2n;Q)7f#%t- zn41{&NRFc_WY~w4Jf!)K-U88l(c9W?M&k0FaYA4fsAEeZB{e$u%3Xh^wXKrpO%TrE zQ@sB2jk05o1}pHg_xUV6R}uo@uz;nkTZM7YNQ^lstm4Ps2YED1=g9!fjBNS=g5-#i zbym0~WQufGyIa^y&Jk%w^=J>2pd-{R;p*8pW1%wz@&tpHS9ebpnvhyj=@lmaLIJ(9 zR;5f}l+|T~7if|Q@|HTM8d@+A_AvByH&8x{$hnaf6|zt8*}My(^2y!X-Qa3IK!WkP6Pb`GhHb-5>v6ykd{@2 zV;6WDEyorvP#WNn>rk(x0l`?gQo90|mS&9UgHX_r+=+t_0Efphd9_u^M=^cPda^S) zk;>+t@xYGG>qgfyQdk)$Pd8tdAip}kZ3p)Jl?#G@!%tJ522ZVt6P=XH>J+2~KcjW? zD}59M`f#Z)_iy(^6Z#N^0nU8QVnp5anAXd8?cx%6C9)I^*~9pQGFh~+rPratsfQt2 z9u#ui96N}Y?mz(8WQHUN-M0}oe-(O=2d((A1@W8SZAsu5wnA^iKmVF-B%mDIF4La4 zj?q&elR!prIpt8_BU7hYoqH-atRfT?iol-Mx6SCUOk%}NrMsi|p7$C4i)V#8jrk3P zDZtR)!5@NMSsEKBFYIp+@~RyYg4RGHO!VX9+$|G1(Hgatex9f(=!FnF)M93%Otfjn z%9}q-{;Ye2x5>TxotLB!+;$G*zs;6^P9{A|#8EZk+{EsGT%Qny-Q0@QNXdfGl6miY zDjArp(wp79hX<4y4zwqpMuhDdhjpIYWUM(Sam(A^5wb_Ib51>Gq!Wm@24>9|Md;&d zs;HsE;N5*Zem82(peDq$M>y*Uvpl!9xZjl3HH{rL;7i&W{wa71u1u7)$3)O-59q`# zsU&YFC_%M~-nGCNZ|a0zXkZ`)pn$~gmv2|8p~w4gR2S(%Y7Pjh4^}JZB#fEy+a9+k z`@tlP3e@h(mp9MJQ#=4HG7=HOw*z11 zGeP1j@>}dVxZ|oZo78c4iOw?OfBd=LFD_VRW227Oo3%2X*YYzL zttnNG54)(Y{hk;pxMoK3Bw(~ReV&rb6v6zqvZ4fT|0m|EbldOv0dL78?ilccU~WE3 za7vk7a4&fVQHXsfq6L161R;ON0>J=&B0LkfDucgm9KQ-1f`}EwJ^*7xdt+q)5?Lkv zZ0)Hph7q{=o7VOjoaQRB+KZzC-A-HwJa=vU8+8S|F5eo1#)F&60XlmU<*C zSK63QJsiU~8absE&IC|r;+xkP#Pg09*o(I=KJ!q9J%R;PemK6p#(w*)H8 zhL175m-_~sqs-^?kdR@D>W5#=92Qyk1)=)0Q0~<@Js?6+K#3-DdIabAoz4lm1N^xL zabj3=(r0B+rW`J$3zI#BY>Jx^sMvqmn1MF$6lC5gy9hW6v{sb-AB8!C)Xc}xAu5Xr z5Dc$F1Q;ZE1)0q2DmUs4){g$=ru;T+7Jq+}4puJeBbW_pj^lkH5psmVcYYpt1IiFdbX%y*v?qm3LH&yDPh;C-Y+}XmX^qI0RoVLe?dJ@kTPFWSINs?oY{6O#4GIh02|ATI!u3A`-#cZ?kN*0Yq;^qEn~|{?@NVNvA}?vf=Q0h&6Q`JaDb8Mw?PV=mBh@eLrR5t;=xS&X z2d$ODTemd}CP+~Mx!VX?5tR*5$K$C7^&#_TZGU$fQY(i`da~7D^jzqE==uO24=D`) z6a4;9y;bJ_n^^z<1i$~+HTi#IWMTgAK=^+>!vCYDot24|{eK4GRchl7|1|C0msA(x zvSIKQb@8yFWLD*5nm8*_hEq3@Jm6u}@s^PQLdYhcx1ALZ<)FyZF=>&)0L@1a566>m zkByO9_b=DO)5p)rW5b=Ucr~=c>%(3-&=e=HX6`AcC!>PWcdKj+lcvq?%$3`_2>w9dixvianl%1rr5kRYJmycD5g{ImjN(>%EywRl^1fsKt;ZCMJ(O93~2HK`f z3?H01OD~Nf#|13ESdY8aDTYqaou2GY;FV3=MMG!UGj^F%mowBA!{(5Gd&{~oGe3XO z<)A!?bbg%q+G0!Gr){VSXB zP!Ff^7Glksn|Z<8AiTa|3gKrlA&H(9kv9~i7!opRu;|}VGNvZZVxbsllcN7}FUZ9a z&hHd@-t-o@)d3B(V}%ijsz`43I2s=`MgFOrGpk3>niV z>ZXnJ)(~ZCsI>G|`2%JBDSjq}VdD{EW2udm@F9Ge5rH|SP`PvBAT24k(v!L-DPLs_ zH!BB7=xb7gin5QjB$arQAHdt@-~zZSaG=28sH2zhAA!8{q24-?x#=7$H1S^Z8(6$} zgtsv%Lm}n}zAsrk-u}?no^Osfa$w2-!P+|nixM?jn#Z&b!W0V`w ztqMhea{;{k=Fg?VtAmOfA>56dT5t0%L59 z$+fqmqjv)Ie{^xf&)9n*^gWsk>+dkjhMC|o?x$+bkLanj;R)G_AoHJ}JZC3>S zRBxn(;Q55ErM_@U&Y82nP~eihq+-)G3z?|s6Vwh zqUt>Jhoqn9I6V)s&g*mTm4Cq>NP}&<4JQnPOJz6Z)q^O)Iklr{lZBy|45a7<)wMsd z{-I|SegPR8TZm#vCw#OqfNBv^hfjs5dMG+N$1$nf7+D5t>yJtQd6td1>w0Ck2rKQ@ z7f8j76MEuB&@@)V zH{|?5gliHm{9+mcj>LD^QF@(D;?<>Uvo5m}eyumf`t`*;Y6~!2>f2SLj)v2(l|CSzqA2lJvw_<9B&M^fVrvM9p%%JyD?zdjEfbNgkuk%{8_Pb9NafizN=XN z>^0{P90~;no6{%$a;&ot#=G(ks>g&v+Y_N~#C9lBqn`FUZ|x?!p(4bM#MtWtd-tpb z4vHx5iX-$_;J)oi-ep(Bd*SXKu^lm^tZ0H~Dhb~0ft4R>)qD1=X%ZV5{)e;##2K!UPm>o?9v?@Te{uRK;7_Zp;jFFR={qj%@dv=JxtJ4sDym9dnPsq7fRcOUklQR8MC&v z`eia;HX^HrPTp-W{A=tG-jFS1hZCVJi!P!WRnDbWUkh51s@pO%zJnn&q z<4z^R;;z_(tA=+4+-;4=xspsfWe7$De0w=i~Y59kUMs?($5XW|Qrpb&Rr|C2*O>v4*X#>&xw> z?ZfrutJC!2;ZE}l54kr*Fp7m^aU&m&I||b8l1%1R?+dm{$rX{CR^!AmU(hz zz{K&4q5%$acCHI%-kXlHeZFnI>Qv|wX>B#c1GY-h2WNWA-RnEI+ivf}8q}g2)IR$) z>YMP|9ZA0W`h)19N1{g>>F@>J0_4tgWZ+!5fMLw^mJ^NG%V;?-I5wv1^^;VeQ6(qr zz}L&&q=}+yj<~x%&#|}Lti`?o0{G@xIvn7oD;1GQGRl8Zyl*Wgp}mB~|?vIO?1-1<}5=^pl>^4o48 zFRa>$RzOmt3LO<2I;2sK^-wfsuAT%apy^7C?OtV$h`{=yR{3Sl3`gaS9^1FO6=n^_ zWv!to6=m3>MLCU7f3r1YbE)2Nqp_1U|^G`+_rPG^}3L+4czXSd!Jq1^#J52Xf)ZB zLkGm)3GJE38y1{H$}xh-?Pco=M@zldL4 zXo(nL$4P4ln9w5xwpHC6zPwkZ9JM-t)n2FoiI;00jc;dR^hj(hSH&>=tZ_9D#?Lne z&~_>cHUS^+?-z`Mpc54yb<3&klG&P#!l`IM9T!+Rhx#SDBQOPY#%WJ5o!00GId_fJ zAybB6x>Rtby&)fl)Qq!^)dgtu{$Sl4Uf|?V|_DOG`-3p(%2l< zKS3o$e#_NbrCa^t2lmBgZR#}ogJ3TFcBe7;6j&b!J_bPgg+%l&Kq|mp_c+a%k72VD z2;Xc8PwJVb{|x+Fn2`Sa@!Jw0vS;x+B(#i=JOC|qu7c1I_@4Nh zB6ZNJl}MdZ3b?mRcm-nteiB@2B_cK+`>qrP7Nj*#XuH{rEo%ecNHNv*W8Hy}KBC?Xq`CKtZD<}v;m^-G8*ErVIGAp@rYn5~EixTp~Zr{Z4kWN(fq z-f$~C4m3rn7(+zijTy2v5fod6uBtrPDrRKakYH`pMs3r)Yr26qFHV@mRYA#!vv~uY z`m5`bJk%y>7+Y-ukfr`GsD<`?$IeZ?cG5~xsb?)^RZ>|<@-d>c<^st^SrpM^c}=Jj z^kCJcfhP2lSo%nwQVjM_X^Hz{3D6}dW+*aZy^>-RinMHCO=Tw_2;f++b9Y zjzuQgr=c+=$2@ljzJ9KR$XUcy>6{JG1-!f3WxN#7*2&=quX-jf;8j2}B`n265eI;X zTvBtirG$b~$Eyl|I_jcWYrqE3%G5cDgJUrdrDRh!6v452J|hBQ37NAEWrfguAocw2EE4RnM98)qn7IwW znZYL>>Y9zgLKl1Bsa@iU3ipYedwL*CqM?)JW?MT7s)ktrmuBKb(JtM@*<5)3*=RDU zkV5KRGnP9Y$3_!|a=I_)WQ0nT!_v_aUjY%-_NJFt;aW4IJ=dxRZS6dq3CMJvB8gr2 z6Lr>`jp-JlVflq$L=%CEGzW2h&MxFfiJ~iX5l~ok2H~RwLqNQcO@3^f{OjPv)XoNr zU(t+u!sdkObF3G8tvfZ^Fud7F>(1NPu|^ea%VdxZa z%zf!H!322Gb;3%jeLzV~KaKsmlv2q9K5t*UpZmL9&#$+GzmMwjGmBpjQ_1Bw8z(0* zAA7DU7i}H`{W%b2u{NX8o?_4ZXNNLoH)^@x%AJ9=Wzy_rdM`H@2eiCBW&dU%$Dr{^ z2hdpG2}Jqw=FvJIUoIDwQ6nP;S;-Hu+AjYt_dG8a0BKj;XLmf-Cm(mmKSU+-=WNyx zoYO-g_y)Bp(AVYysJ`nK8-)o;nV~Ha0mm=rANN64Odi(mHQ-F-F7W|91~kMgh7kqW z&AXDXkbU%_m;{FzHF1a%ina~u-L+5VNkBIA^x=FF z)WZEJ*X)&yuq$~Dh*@m!ZR5V}RjXaFfV1XkZH#Nzw*jvc39Xe3hyQenXM0<9>Gk5b z;-B?d_ml0$eF@oiJ0}qt1-ONUWzTbEbLW;i`J#GA~_TZ9}K$ z$HDVb8q;fTp53sL1pmnQx}kuSb-F=xT=0hS9uQ38V|M0q@U{_Ust*6Vjr1a&T`+xe zoN4OH?rMIkdw*4aORi_u?;6=w$?b32|D@nY=H1sMseg%XAM@oki=RPWPg(Q1SUA>6 z-FKy+sDOP0TA%!k?o_dN(fiMKg<^0Y2S>H{z<45K-)nk22ZbJJ=Ny>fleYI3x~<*D z|BAhZ@8bgZYTfg(ZJVC@Kr#)4Kd#W{l#ULRI>as-LFr^KH=JG0QOoH)3z!c+(H2Or z*F1CZyVtXSgvEE8c}yn>Gscn5GVW>GzsCtbm;8#}XW=)NJ{Pn~;rW-!p&T7a#OdvH zz>tnFhx|m~Luo==X6kC)#H`tX1zx)kyd`m_54n%;^Ow*BnI>Ka7-6voEXy}c$>z5# z%IFPkDJpcc_Y*i*TeVb%IJCypeMs#wk0V31Dt7luRjYw$n&CLJe@+7D{K6A(!GR4D z0V_ITfZ3t|JS^eTKejj#(J4IJ+RSglwYmRje zY;6y0uk7KG-wF$LwQ`d0Y#f?bFiZ`naeQOl$*B7e6GAa1|Mo$*jbaD1xc6MyY8e&I zH#|<0F_y_7O)r~E180hK{YrB;N@ZH>9Q%CLLx^@wpX5mM`wAkD40;YOqnRKI*P9VotJC zeX(iojuV%(^v2+5RxCoG&f+=mu%HH2wW*VZZqy^KB9Q2Gm#IZON_VXyiubg7GQQd! zlhcRq=V(>VQsiF0SuC%va(;Z;eJ+1@S!pk?&4qIKYvIp_NDlH}%KEqHpPKI)HM&y6 z1m70;aGzu4f;()B9AN@eZi|0F!GU0C{gOIM@Y4dh)VeMJsv)-LQtPxLY`ft43l^R%T5jXXme9_Eh~aMcCN^t8t<2P;mAp^Rl?e@?VUXEG$S2;z!*-RG4$Ikn)#T zkhY`?TUq6RPegR#Q3ykeXTAY}<6?NmfpetO2`Qrq!ZKg7)vi~|uy?!b!T=gG`o|St zaU6Uwrt$MzdT4s2s>0L4uN5m^S+!pvrT|)?9O8uwB!b-QxH`bIaaM$J?BPeWKmenO zACB%QuqcCR$?VcF%c@R)>*BN#6Kxb@a{kpzJ$PgXVa9n*DFRlsM}0>2>yo1h22!4t zmD=!KnBmbCN~iUhE;ObdRO&uc`$UDUgP*TNV>96eX7Zq3e*CJ4^^vV4>II z$ApxEpMb?GL1V+YL+zFDNCG(^cJjyt&X@;Eh>2kIZC^y7+ZHmoQ}w}kcCLA{LjkP& zjHg}N<$$<`Y^TW-WCB%YKzfj{D7rg}_SLUNKtJ-84ObCa-ZIlqG%<|aZgqq@0Dxcs z5EG8-|Ed1@Pi9`$|2Z@7|10_ZA2ai^{x_A+|MS}a$I6G5orUdxuYCTQc_&f-3&JlA zSQ&w#M@l6D{D$<@5xd2*DhPf26v!s7CP%D9o^)8Ezt?%ydnz>P7~Mz0#JT<2yP6ff zvN82~`207WJ$+4`2-SX9M@KiRIlWqyim6d6e`b+H*153@{UhA#i6U*niO#H&%hr$9 zsd0SKL@#RPMYx2QKG)GL$0Qau6=1&gfgVYsg$L547j2C8VK z@I?0ZET^0}(|Mu6%uFRx#ex$s53zLZ_q9ReEO$PKMOGsWj<>iYE+KNYKl*FeVbKH| zvtj>Mq6^=a3DY(!zu+k<)Gz3$f|cGr*5a4;OB+JszOoDb?eUDBwb`Gib%S6>yzbfF zi}s0rv;2!Rs11wIuRQXG;o=B%Blcs1OpgMO(P|+W6~N`pwIgJIGDZoJwJ!hAUawmJ zIP4)l;N!XwBWzMcyI0|x$?*(08?-(*bYlSDA{Xc)Sy;nIg+FF_V-B#d7|Pl>L-k?L zULfE(Sfo1iq+g1I{xLk?zZqypIcR!#Oi&6=a7i?!zM;^M`yPUV3TnfNfrcVAnChJr z8322`)*25WiZw7~;%=n$%tZlJE4A%=1o+|i05i4}FRe)S(E}}RN~OgwlBe_sx>&d} zvViG-illk%C<2ea#rPP855J1Dg&{AvQ!eIp1lcr@+Qi6lHZ7^k2Ri!_-_OBzAQQ&Q zIm@g)28VO>C+RVk;Je$*16v`|RC|wSY}I=x$l2<2g*bL#I@h^@9)X#E4Jz{V3p+d;$&B7Vj;oLm$E;87KN3m{Y68-7i!?;|^J{-=072m+F z8EXryQd)p1ky7O|zQjqMvd7EzK%j4DvOtXzk|(^Mcc)A1CI;D=!0{2NxSzmFZapG{ zDGylo;jB9qz6H#5O<Zweg3sN9=g#;{CWJ0gVy}^6<1DNAR!+9v#MPT5TkeNaoVc z3Z$am;@p0LB6h2RNan$Y#~$C+CsRpcIiOST&#ppL#r~a2+3nq5x{rD<>#ay#S{D|? zdn(R)WQaSxs<^}50VJ^Tr7&%S+U&vWnDD9A#2uL{uLr*{$JsVwq1f^USG^usmLSlH zUMj=XW^Xzg93s2T8gz@NoQI(t9P(&->;p&QvMk9oYV~I$Y6~b5zpb99x&3$<9 zq?O*TfgGRA`UyaT0A#hm)q-%ap>X_f{~B@BW;KOeHE-ZBXpI}%7k8DtYP}q!bTI2N z%m@X}H)X;{^<*pk80xFxyal|Ykz@x`RJj9iGK>we7)h3qAI!*h4qaVAq@bu-Q8WP8 zcFQN2qbBX2JB#))0Y0>@?gPYBWi&T+Mjf`T4l`7ajPiCfAyU^lS}vLy$x}Z5m&3`p zrA}`I`9Mf~9A_KD?$L^W967F)Z3;}aLO(!OD0~D#G0~@YTMNvZ<_aax!H){)MaPK= zv2S0h&~P+KO#zr<`~9wJ-}lyIkd~< zO7?lBT=`d(tB;Bi#um$=1^)Hrfc&$e9sVL%oy_QjhxjaF=a03~_>Az_;04hc<7c;6 z@@B+I!1M9>wV0p@hirb1!f_(BozdFDA2j)0yJGE2GY97)z{I`j-vyy`xkRDU_PG;X zbY1w=Fi)LNK(LVa<$zFjEIdPljBaL$gc7@$ewi7^2A_(F-8Is&aBxg3ta|^Mac0ch zqw_zKF1$XGxW^xVZ2MiE&~*wP3jJIX;A5GtEE%d(FwT4!T4|$7 z6r9*#8KY$RJZR0fVy$1?*vIXOU0<{g6KTufwj`a{!=isgM-D&LWGngK<-#S&@rzf^ z`@+zdeItS!`<#Vt63?mXKE({O!G`}1MbJS-tWlB2OM(XkH2JaVth#Sgu&;~f^{5f- z;(=P+4Bv+dZU%#)cXdD*c$ek8VYwxtFwEFg;TskORylBT=MJxt%h1%;;zz2toyI`} zaKvTUC5Uh%yq-%=TTPj0@{L-aaFmyjXCGrK-(G>Fmi8Gb-B8O$zEiKN@+V?^i=cWIAY*^~UqG_V$el_` zlaFwJEG$KfCwU(R+3f0!CBL~@ecWFQ+&l+i+x-*Kr)_3zbI0G%%DfyW!`g6UIIEd_ z^5%D*!<66>RpvEmVJEX1cJshctuM!&Yn=-9$~rg8Fro>avIFp|G{HuD1r z6A@Om8Qzy5)b^B;(sDF0H1o(Wp6IOkE7IE9-DVLVBkYTAFS07PDX1IV<|TUltumiC zd@!QmvgNey&+^a1%5kWwbvQ;!mM5>X;LU;ydCDB42Bt72>!;Ezi?JncWUx|sm3EvY{ksWbeQAf$|dg>I0zd_OGlpS#Al6dlCM4*PC7{KK*Ki8ACfnMv?5Ch6%DwyLdX%r&Q z8B3netI@2KD9{Oma02YGcjVqb0AezWKjz+IetY4BOjo%1d!kIuafXVc&GYC8;msy7 zj!YU!=Q&h!Otl@7A}1eG!zF(zil8dd9E$4^5Ptci$laF3C~a#^wS|2OqKsVn05xWh zB^m$p$7lTVenK9V)Lc5&<(DCz#s8-UZ{~N{JN2o}(d3}pUsM+i0XW=@-X=o1a0XQ6%mQ@RQpIs(Gi> zGWD-+qc2VEqiHYcv}PE{uwb1hDd`&>g8@Fq9ke4hqa|`*?vQ^Rw|lw7W9avy*)Nre zLb!OOEq@rl+?m-;>RS>eS9qPzg*1UkiP;MZ*_Kh!yTvvlv=qW<5A#6HJiMz6USTE~ z5gPFIv|J&!Z;sknUjE~Z3*G^W_JD-;r~cJ(43D}n2R!itM7|JLtcI~Iz&Cm>1fBC# zGUdy>i>v(m2urT==HLP8D$Rbm=_iQmn;XuvC(`2CgCgSjYG(Y<x6gQgbFQ8JbyM1)|eLuD~d}D z%sPitEtt7BZYAD~Fap{a^a)t98HkqHguB=;xQflWaB{t0gDtLgY4!kqBJYKEjO=i_ zkq(@&R`mw4CF>gl2zNvEw?zGJ;iaFYx#=Y~@uvt0Z0xJ&5NOzPM)bA-dYBiSi`82^ z!mdMfSX}C|gr%o1`bw!~=5=w;JDw6>v>97i!_eU|9>VI1B&JBGp~tUiSySp)0k~!G zg+lKT>+RjOlt}8P{ISg5(Vg(Ja6RES>Fs^hkgTF5K<3@=z=@MH8Xz&_rzsSKejk>vj-eS0Ym^n;xsRU;Ml>y zT%?gL+xZymMz9?wh&dh2W9eHBXZ1qJ;bC2alFWO%;zZ(@s|JQM&zPYvQ8YIv+)(%# za1|NUPyr&<3~M2PJU#n5%8k~y%}74RzxVkM*LJom)_q&`&eTTT=H~B_$F&gEL(xCV zdYZf!dNt>xujXsiVq$jTx;r9P^{?7&2;~Z!U86vH77~RhHagKC>>g6F6Ba_@EU^65}Lg(tkZGfBihzMfSHGF&4O-CCj7PCTBg%+~;NcUm1sE)&4JIJfGFPK`_(s)pMGRgbANT;OmtRWudK*kSnFn9W*;1frXx}=p0 z{lAdLI}VTYs3;kJ7TBfyfAu!iv+)YH;>FXJ94mk;C{kCVwsvIYc&Pb9b$Lb~s@TU^ z;{!Zpi9?eE?0mT*rcTA*q2u5M8NGb)%{<)f&g(>>#E_ z?eq)l+o*ZQ-7tYV3V6)yAm(a9(Bho9F{ahxtoZw@3vLRF*sdLJfhksVYjgL<1T`&{ zA?@H3gx4UUvmE)ti(sgBRkbhr?In7bARVsP&mwjF2;a2Q?2^TUxRrPjNts%IDQ8?r z@!`v=9?$N*r(8=>;szpL%02Le0`Cu{XEqQGOEru#&`Y()qF8I@>qRvECgbhi?l>!g%BZEw9BAFh$hv(Fp12TA&B*y;15 zm)pI5yQF0!1(=k7pc2JR_xcLnbPro#K zeWEqU_(Ir~#_HHLxu?12{(Z_3aK=MiA-m6>?}^=CsgBIY%0NI>u5Njv5DMg8ugXj% z#g-wzhRU&h+H<@cORVX0(z(vGt_2YeqrGV4t?*C0V}VNGRa!*PjEz-A`APUj(j!<6 zW<5+tHoswr^UTVk@G60;5FTe;l!hEeBx1UB=sj@SV}M~6B|Yi7@=V-C6C7X#$wbnc zU0WoDcmSIrmYpAhGvdC?B`ReduE$IZbmQ_yUireU2h<)|`=0h4xWHT^x)h6aCN!71 zEyI<;O;(1aS7ZM5e%qa6e(`9<^N$kbLS%Q8I(WdBGq8R*3HU3LY9*Tjq--EIUocYk zc*Seu!k60b&5zFGf!>?^%Lm7&OEaxg)u<%xRqF@Aclt`52 z0Tzrhlio&yAxzw@s*gKZUTVQmVP?I~%0Ze{Y;Wh;N%ko+55D)do+_)=D4?vBs)vBy zi;);pp8$g++l82==s#{>Qf0H;-mYj>8XweeJ?+$=R;D>5yIxfO5b$B>KAJioD_Z?F zYvYg0JzU9) zj)DW-HspdX|pFjCG8lQ&w(97@u^(y^O3_nW>LSz{ z_buQFmdoK(8$E3*v_x)?o^h<1IO#HXW1F+3 z7FIPD#ducrJdeIU0M3D79VD!EE1fijabo%O`}1h!<@76?o0qEJAE8w%9v?SGb#im) z(nA-m-VaQ4jztZZA9{!4_m)ZWS*&!{mwu{Qt5!sJRjfMs-W{J9vDrN<#lFjJwksFv z{BM7MvSMB9R?hjTck<`_8vO(G^}p(QKF=QL$wU38dX>*yw>sytlM^S?`15mSXZlOD zvX-rO?iq93=ay@`pN=wBJGkg;*g4^wHI5YSNwrS~>8C$G&rtie&06c+OFz^nrv2p>2Bo`(i_)X43j{1`h!GRb+>y^?KPFotaATz2(;H zzD&HN@OtJ6F7nk+d;U+#?Bnto>y;F}GLZ;8dIUGYEE;Q;12+12cn5 zB3=D}$6Sz8R+TRf9+)QiegX|_yX4f71V{Xz*2&;grR$8>C zg_}?uMyG0O&>8-{C}SYVw<~=4RmXe~HzB1DQL>oAd1R2J-zea%6C{_j)x{VZc{0l7 zCuSCpYbgoS{Yh|7h3l9GRS%w*O$$sK%={SS|6M$2xiZ=PNRmKy5aQf~1Vy{@rLw6l zy=-*u0k?V(xUNRlCCGX@cQu1&OT*mOirP;wZ@CvCa4T?IgZ+rp7zu~T5$q4Ns$s*d zm@XkM!o1{rWaZo(aFo}ek`_}N(D=Xx#nwh@E{n&7iprPPckUL`*$dEl);_IvSY{Sg z!aV-8_=MXdGv!OBaxnsJ%esS!R=lb6@NkxAsJ+mSd& ztUv<}Cq}U-v5|{YaS`FhV8jW5g1O_DEWF#;*P1j)cseG4_>?J9f!O@&cbaU-65-qVwxTG%b68%_OHdIe zFs!bwfgqU{`DPKCFB^GX8R^ zsh^y(GWyF&j}4nO1NhaJc}s`=S?-pgtNmgbxNx#^j)=xTc*sj*XNXAelaA|>z_njM zMz3|F0+9$;EIXKcl%|bh^a8%X{lX1ROh$aW=9M9A6hHiTWzNGzI{amGOYQ|and+XJ z70=7LTM@rk-R98UODK(L{&hJXr|A<2uTbmKAm6xxOx&ikJ8@zS;yrqL4r{mB&R-n- zMh(8=05}xSy~4i!FzqGuiDwbt#!NI)6lKE+8bo^x)H@*QFV}%ic;dD8rx-8~ zpP41i%3xN05S@oqWLSov3XWZze6}-^{$L98fEFO&s12b#a^?>67o>5V!K%=SRu%~s zM143$=M7?Ojls2vffOPg!k>|g1I<=LHC_fLQDONzf0?`9W)qN`oy z0|md^YF&4h3rKg@#@!{3BN1AQ_0htjeW;#0R12z0Pcy^0b#$vY%nd@2xkChy{OC-v zGQXsy#rDOAcLhAM3p#g@zYi1q8uw(Y42#qyZ+P)sIQN*#IGD_%rGSTz-4vkZ^wKvD z4ltEO+uR{RV1LWD&8ar0YJrqFMR3E=5-i_ zF1J-fdJV!1n)^h=&OR~32O8qs?y&SO(AY9S6d2l=e}l}`2FSjRSh!v3&U?Lp>m)K~ z#D0nEYsWb)u=7XNt}D{SQjUYcw#&I(4cqHjEHO^oD;zcpu(rqR=V?BGGl#I<1lsG%=N(Qfp(Exb)t z$jHl=j&eHYxm8=xpq$;d6;qjJ&E5Bs4c8+$Y?&|}kmo$_@=B3KiX zf{75BbO+RXh|vz;bfIbCq+)IzjnPc;OaiN4v06+Z##sk*bO?0IkqOcu#3F~=T;r-9 zN{j-w{)D?Rgx0X6MSUP}8=)TuKO13MyEo)f5DD$qWA~eiYFQ!hwG4SAS)lPJZ&{Ny z{xbMJ^ax%t;`rqcI16C+q6(p)&m^~iv{!tF;E8+R7(`0c1<^ZBg~X}qPA*R0(%D(L z`qMf36veZ%X6W`d9jhFig5n27otK2&q(e}_8dV|UH)ww9rL zJTHKZ>*=;{wHifOyIaU>Ys}}EubD1RLeupk1!Pv9Nh6xuuXxPr^_QIM6>q4&q8Cr4 zeZWio=-YD7Id}X|`D=#OY7lupu|yU=u+1~kU(ndz2>RaL6L>+vbpor$sXjiyZ`MY1c-Z%MmW}CA#i5=-)0%N zS|)NEc1=>gLT%p_IGvE7?|eD@C;rtf1u$bAo~L<6d$QU5z$i)uT7VK@xy|GnDr&Ur z^<~T6@&Xe389r!IJ^eYzTi)#$a_2F;$w<_7I4%vF#kID=HZpIV{JGQbI#*fIGQGC` zo1ADSvAlr6F+mQy{h+_uw^>nTd9jQCdM2(5gtjUxyzq`k9xJ%pQEDffqu)E}1Cx=u z6!8b={D8X6mF;w#eX|&(I`XqaL-=2viD(Z2VW)sk0z+frYSrP^XJts zG>K{4flv^>MBRS1IBYf4CpptJ&rHLlYh3+_Dg(?Te;zmPD{z}(_yYG>1#g>CEfOcB8OstCT%kJ>EsrZsy zQ9j~oT{CIi)1vJZ8ukfNY=6Pd2{yJ&1#f*zwiStAQ^|Z^j|crrDRlc{n4N@=SS;pf zP$+8r)p_0*&Qn<`-21-*rJ&glk?r>Z_Zf=M|DGfKc=)ZtkXNi>x(sDa~ z*hi>#4zd`96a})ecY-O4z_kcecTG(dcg?S<@>)Zs^26&}^QArV1dyqag6yVMD?XXy z7Q6-OlTaT%a2_qdyXS@(O2p=^7p&U*=wn-*Dm)!3j-@TPNW-z<9@b)PGnu@+)xgxd zu!O%pJ~zlPI#54yF=RaP>;*`9l5Sl0obKJX}bF zaf;XZu%!xowQbVgEYjeYP4hvzAz!kqs6%74VYSP(jb=PjKVsEdyppy;pd~ z9J*Z=j(fT9A28bTwx>kqnr&J|n)~|-jmb%B3|sa5KF9bmxbQDfL@anXTqBIKn&q5l z=vPznQBxdyz@Lts-wdk@jRBYcg?a42q4X2Tt$|^E5An&}m?0|)3I3b24zqz#Hc&xA zn9_H&bnXyxilAjI5j4+iJ`&IBlC+k+wE$WG0IotnxywWz1boEcnQ}oqAY>)wWZgHQ zvkXaiH$l_2W@&gKg=#Lre1!fhyDlzecYxA&dVW`NZQRH}6X!cc-r5Vnim$oXh>OHw z`Su5YYEq}~1y`KY0*RuyuoFC$`NSx5-+ms6AP(5X=II>V5QKN%18&kWW(QCB7XUEl zJ%P@N>gZIowP1Ht*(RFa0GF=Rw6hht`)ANB zk6%Pt`!UG|P>QvUp@$csE+*+O2p;970L2VkYg~kl3ONu_?>M7D z*b{9}*&XhF;CvF>0X!Wea!bH!L1AwoqOkp@#aj)Vk7a+6rWj#yt<|dMd@g5!G7m4^ z1?Rk&_`|x8F8pSj_Tc5)nZseboW(p4(Nij0Wtorz*tl+9uKJOtxZxT%2F}_lKuwYY zr6kh7AYLx&-$yOEPk~;7$^O87Zguc0g}NUP<&L?TmS9x>@cX^*$NyMyv@N-A3DhfT zBPh{wkDfEwG325@@XQ2r0%@&nw(5`%z9-XrpH!J2w-}efp2S#t?D_O47Ga3Xg9~dg z{#0mjPI71cXG^NW!ZWEoKHG%LBFB{9 zNE!OY_y8Epk3ZXO27A_UIkzC1C=z$ZM>xgq1xDyKmCCh5{o{CLt6Q88KEuP|lzp9k z5Al~eV(-Wn6(eAB7v^x$V4oqi`4o%LJPFUam1PEEK!eXX^{gsLc5{bk>olH#M{>9B z&7>Mmte{nf_(5t?`j673fLXq=Dc>T(KLZk&RfK)2zkK;fD@9L}&ophUFnH42 zBBhH4_VfT<H(BJWPfw-P`K5S_sQ>FgfIHjbrL{L4Jd$dMwY&!SN&3* z*NRSUW%XHe-Kprgm103PXP4FNm%x=r`6c!PmWJ9cNFKxk{%tUYTmw@L$j~LUn{?iq zM$y}{LSG?b^5CFh0?`p(eT(QoDASOT=wBP{KLSa70w_hc3uRP{t%!$`)_axYQ`t2b zYM`cdcf^0lt%P501cw#MTx^pmTQOJU7Ucj`$$D0Y~)Xtl%obZGsohF-C-*l zKe4ZCueIlz{dUm-j-wv-T4aQTtGC}cIb$tAOnHddhZUl*R5!IXcAr6cGvqj<)oflgZC{fkC>Mkq66j2EwF;p}{d1>{*%eKC`bLHf`(#fB{lSOgQw02Dtp0HAP^rmX&h`z0 zmiy?z!76)(xQkG)LJez-yf80D|d47GIel2aRm|N&~ zdc1o1xOt}I7>u76w!3Lt6r1>T4{;;Ru`so61T2rvpw4LYFJ3lKq5i(2&a4RL+fY-N zXd1t8D@3 zPi}EJjD*%Dn4Jp>Cav<6j~y-!E~FMh*!m7UF#p-SAe@SX)QnQwWPq4Ex$ZR~L&V0$ zO~TU7^aoJ2#L7U}0DBq8)-d+6F_IA|ONfdT<7UNZqIF|*UTO4`Wc?K~hS2~(s{U_u z$+Y>$a-f$3^z@p1y84;C)=>PkZ4JOVa914923VtO*M}U6js)t+#)sY#4g1F8fz46x z%At|4Ll`d-hr>ht_O_K#cYyce(KG)dtVYiQjh;?plcOmxf`@Ld2>Ix@kZXbhcnXhS zaEr(v+6>h}xs0aKo?j54Q}wzVuI3fQ^VmR%0)b+YpTLqO5?=OwHO~~CnkAwlw8HmU zFMWfO$23+82B9?RnYTT5-&Ebr3F*qr=$=U1Mlnb4vNYEIE2qU&orZR=%9X^BwOWbf z!v-4O)^568WXY1uA+B4ttuB2qv4fs)$0?T1K*L8ne8_2sz(BLrh(yo;p@Xk4TdyPH zR@OrkDH@wtem#V7Eh_pk2fSA~i}g2-$YzBVF!)pN#1A(H$b!2{47H^l(v~F185`Q;zE1apwBLYDo5XoZdBQ{ zBW_geLu6ib^wU!p_6LHz)i#F;!N^Kj2?rj^1xA4&3=8`pTOlj&>8J4v;)qkNwI$S{ zNIB?*9H{~y20xOC3l<*Y|J3pPCu=j?|2}K;|GMM(|JUkp{CBO+|47UHv#rJae+4ZX zHMAUlBolrsH7BXy=0I?A?AL@)hElO{k`YKTC}22&AnY-F=djL}WKmh1ii zY!&ntqCnY3pM64n&7oH2{9lv1rs;3sI5E}uotryU1uwZMWA0pX8*8TTzVg)K$m9GJ%`g{L!IR-q)&Sv{v2l^s=tnnJ zxRZ=D%zxp{mBrPR9T3a|`zo!W&8H)ZdFlbO3jd8!gGWr#&D+D&#s;~Ka9 zw->ek<+c}?ddy9_2`vht7jsJ`>s(tTBg{<_vPvy}fdWwvq>a-iVhO2?aKz3xelXN= zBdq{cU}^r6EuI{AYWU73UWR*?6@fJjBo@an3ywHFT8LjwiRZ;`M)nTO={ zRtUtr!d^ecyp%U~Qx1#O651HIYMtOs1auQzu@k^PXW~YUSTS{1hbd@2MQK0BfKqQ| z=u@CayCgsQ9JJ(f`4YnTlCU|(#8uPbj)6CSE`&h)e_7ab5`#Go$=&CY~AHM@#5~) zd`XG0*sD|koAjQ|CTYQLXi*R8Tm1dEw(I&-^j4H&KVx++;>F)Z1~q^+%1Z(!1L&Wm zvn0GZs*_%Jh{?RTlXOCYLjc_J%;-jV=BUp?DyNuzhx3IT)2tjJKkemSTnf2l9HG^n0$>`wWDYRuG5#&57Z%7-~E3+Y* z1-O$q3jBANLdKR&`>|KV6XTZNSU6rnl{58snzhR%zjB*R~R zF7`Rn1{Q~6DDqgGX^wwQv-U?(aDBZ-LYFfPwJzVLo0JMykKIw;L!#Ud8yk72?uuCer8z4PC&8ACH`+ws>g*FL8_P43 z#(25SnrQIM8BaAB>bP%;HSd@-*c7%0e)6pZ^ZYqu`>@IZGb=So#2n4vJG05MaEo_# z7gKmSk{_V?wMl{&S@qlgXIKvXG-!asFnQcXTO1(Nd7j3}_?~v8*{wHGH}v9;8jIf6 zpLufT{x8x&XrRWnrG(UZW2aS=aoCjtlR%eFw>m{?Gd&vK6d|w?u97A#>UTPW)6(n< z^tuxZNMFX!fLTPO(Sg`Pg=uw|H#DWgdu&GSUbGcRBadVF={itf1kNb_j2Lw8z%$cS z)+>Yf;zA2OwJX6vqHypU5GFIg)89!np>Pz|=OVNk_S}f<jeInGnmUa3N7cCUC>T4VV08t#1E_X3idjK~v&e$@bAtM|Pa$bk_a_S-i zt#*qN-xejJNhMpcPiuW0ZBcpLpcT5_6s<~)r?yB(y?tkhxfJTT(h z$$63ys{QBmr4{FPdSr+5v8t^MzspOh$Mp(QGVz;`@tYb^wbPuFi0PS4UX>GgbU)6v z4#C=X17eQZ9CM57u9eHh+)#iBiFhcUO3b%qRkAr!rJsQ-Ovho%#Mx_=5-@x{z!Ruc znf1dldUknULS7;8^)sh2xK$c6m_9qoGejBK2u_Bet~>xxkA=<+g$rN*#CrCK`LAY< zU;dF*=T0>uyGh4lZrumK=95Ym6adp(&;%J?Vw+fAY z?x5YT`5)?^s%m!C**_Bo`xFb2XIj_S8ex{ceE-EeR>4SI-74VOhG=rTmu*Y?oWNAqb$s*-O@T<9(3kTc_ z`}I3n04E8@JwyZdgcjifhy`)tO3FzL$L;<#XnJM9Hfira-S~*rgxCs1#v3++Hf00I z5gfwrsV%6fzdXr=26I-+BiS>YD%1#r)NuJN0P`h!`E04b&+pDflIme1HGnu z)2FlEq%E;PzX7R;D^jcEc9?e11QdcJ7(Jh`4%GGW;{NH|XGqQ+7tY9)ZPTl(+a!{> zrwj-=Y(TiQ=4o8urcS(Iw6!4gGJYvrC@p1eU0|XZqcQ?2EPNVjoe{Pi0BCv2nq-QQ zW&~=P_P(ZPitalON$v>?=I`dh(WwQ`;e6~Bm*9ly>pDs`y?H&-+E}yViz$(Z6!9hV zd*}VJ>bl}6$1&DRqo`pQ$cq^f@?6Ms_<-)Kc~6Tu$6eP{`UmNxn+ImD zE>+aj+I8(9XQc#+YQ1>`iy;Y^FWdItpGO)>zmkK^x6z}f8fFZ95FE6&kgWUYkHVKw zTDk@9uR+dvC{-$w)i6a^V3y%y&-*sjCL-QLr#o9KoWa?iifzC62THHXqI!9N3E+x; zJC0!D=bdnBWCHL-UqG*NG*vo#kc5y^EPyJdfKCBTj%$9__HqN6a|r^oqm$WxFbu;U05OgRaZ(!wvwlQ&rJFR zv&Cq|yP~~c7u>7bLF5h!u0Hm0scL1G`XE{aDp@^q=zfW>$hEQ%f^7IDgZIGR#pysf zx)bm0lUlMxJ33`CVMg5B5huavoMAO1n*(D4rI~Jia(&*0WN@!}`)`He{@YQXYyv}M69&sa^#-x98)7S0~2F4f)_n>LLwzz^*I_{I69Acl??FbC5 zrj^dH)$A%J%#oT8&H0qkv61AfaH#5lJtPgJVvJUJr*@c_kh@N*XP5m5 zD^%ANPKJ|VadUuyn}wnHW9Mdnz@~l0UG>o>bS{j>+(=$v#9|nck=UZ%&6fR=a6SrW&!{#` zzm)_wP^mQ};g96FFj+E z7A@hgk#+I8d`lxb?n4EmeM~IcD%h?GcBfx?XBF8=`3nG-uI}PX-GT*G%DZp}G4~=> zmG@BFlP5LbWaAPf&6ZysX6Ac4>{%yIaT8GV>f@ePtHDj6^4JO=PxSa42$^X7zz+Dv ze)vVs0eK9#LUb`#B3KHIG!yKXZT^1FnN0O@OvF?IpS?fN(7uN|GPUKuab~7qOaqCX zuXA&(o==At9_3@WOio@9mzJ8M4yqu1AiT#+7FN>Iu-&6gsAJxy_(<+a(h`3p(g>1Q ziX{DRRzAJ`2MNypLDuG-+X2=H1?_ir%}=y^0oL{bAlpuyv1@y{PFT&0yq7haSu8iO zKj7{0tth!mQvl57qs~UHi}Y1U*VssjO2-2_{*S@{D@hri zD5mLfyPI)#4&Hz4L?a`^M^d?mb+eLXcFv~DwGr37j7{%c;j z=vM!B8a6t_t37kF^<&IWOYXBW!o1ei^_(Bn=F6`?>o#W1JWJP6|HgU$J8xo;v_aM~ zKc5PX_4H0b8b=<9XTqJ`7c39bchZAvk1cm^H1>%ASA2TS?;Iz_AdaVScjRJ-7ITiR&r9L*LY_ z0en(0`aBkxZ-D&0_YQg2@Cvzyr-<-{rsOr}gc zZ7YmvGEh@jeI-t#Cgp63YCeke0{97$mDjnjofF+unDyv??|KMeH= zx=K$>cj?J}zw|trH3P)B+P<hbE3h2N zg}*-KKMnT9h+s_dJAH@Mq+QWW0bw+N+ACkj*7jgDbE@mR1ND3P=SzL=O96G3ipov9 zX`CQpCWv`EsMT^?og}1HOTvm2IhHU>i2}Z0Vt0Z_Ir(KDWRG=FH5W)G9QBd6S{x^L zU*?Mf3S2WB8yEI-aMeaM95|RwYtj<<@K=b5GPlPdrdA6u2cagDSf<*u024M%S|HDW zO}2-F$06pM1&GmrNJ}?N2Zk7tP?jMo@q}piB%^kWVInJg5&}w{YcC>>i@5n{Ig!*M zlIcUa0Hs1E;r8b9pV z^(~z~3=|?@>D>;gA6KjA`T}HZuZdt z^M#L(y!aI*?Z{^zkxx7yeKUFTJMRal@pjO$rh)L5V8U^u!~^SYq&7+=NZ9oocj7J% z$Scs5?@q-XWoG07NVa{?iOB54UQ_xLqSjy7z0 zeIk?kqk7875*TJ7<>5!f{+zbwv^z%-O3Q?z#+Nm_;HDJf!7`hThAk5K&cC=fDmRB$ zjnJ?aq>a2?bf$EQMC7eo?$!EsfZfr4E1K&bqW#rOLaTU{=DQXd3C(=4Ka>rHq_|=) ztwo$PLbZ}lVn$=sD9}Ba-GjkI%cn_4j%zxiC8fI)kUo7!nj-_v%C>{JxQMMk<>QRn z%&Mn%X0tf&S7T1`?z{2?gQ7S3V}q#qht$Z$;1qN)I>lMedvJ5DAQu-nM!G?TQ9Q+@ z*UAU-whq9fLwZN}9;)EZd>I%!vN4xJBWO9!I5G+~>^g@;w=Nj|{t{+JoP|a6qtw`c zgGBSRbhHm!>~(jAcjZ8Dj5AW9)6sOkd{~YLRh@^v#IorG>We zn|Ia+0^}jO#|*awpB|8scsAqV^C>=d7nU@BoKl+w))6NpZpdoQJD0>1Mwt#1mB83m zy0XUL&l&+fsO3lfle6^UR6B)|84LmrrM~+5+#_5k8<#_S(CR@B0M%h;BSiQndoQb2 zH$yVptoYgzz8-XHBon>2SvGTU-CR?bYQ45;c9hs(Y^}S51u`RxZivr&`R62Q0cST# z?)l1(+NQk1=mV64`9_1K5yi2B2_aL(983|+%b@KYDMAc~mZ)*Wm779C9#IPk@DObJ zthSjo)!&u=Xyag2!Ow9=tP;-6Ngc5W{r0&`MsoU~*8P8QaapW!BuN#OdNJgQ17pdV zTt)NZdUIPRo{l$Sf~jb|!ma@QP5!sGByq;lNX;RH7cgs2{X)P%A@Dwva&e zk35?f;NATgw+^woQ1PQde+PS$LGC|l|Xy3Fgz=$qLNAg;6YMCJJG-q+9jXdQ6I$LgA@JZ3jpQ3gywX7 zoc(2Y_f9`LHkjeOigJXmLrL*$Qn>+=0+52tX%!Bhm##*ZgEO9v;uWav};+Qr&A8MnEu?sV&&b@Rj$jeWM)iw@d@HBYh02@3UgeA+U`7LLt;$SZ{u9 z8}7IgqBiVX+H(pIiYhqpM4BITLN6<^atl?TSwhjRz5b?fQDUtWGqk|IrK?$}B9+Z@oKMc_{D9r?lF?Z6AtMPxvk(U3E z0U2SJJYJ3%npVi5qhe2AVT&Y#B_h{8mF|g#T+*K)$h2lI`tGCWv^>lr5&pA;9ecI=M0JY11Yi%9=ln)eha%?yiXBaUPlgrZxg-OMC^ zz!T~bq3;%za~~u;xwIaW^pwvvN(|ctlQ55cZXxr_>H=B*#mZYT2{iI!fq}2Ob9?zo z7G$priguLi*m%;x+N7*}u`p0KDCKFP$iDLj+#UG~7@t~o=^}%kA1c?WbvxEht@e6L z-3gMwkh#j@dX!(7PlkGgPWEJYB$8OrEG{f1(Z2ZsY}pxoCB$I5$C!$6W~0DB5%54LUGVFB z$s768>)7*#27{eE2x(=Y_(khldW4xmOh75x_ZqN`2F=!Aap@&yL6>J|yPGs!cPW^5coO-Y24zGIsmDi#wVPUuDq@pCIW%t3n=S3vyzG#ao-9qfhnwX30<3?~)N%o+V(b{WjYytf zK~{z1IT4QaQTTOz9{v6WFb?h#+95jk^wcP=5*u$*MutxV?Gv!C85L;G#KCorGWq4+diis$1Wy*bt?XvX35~boQ>0O7EQ$&ViQO25 z%Hf0z&MD%_%t3}UIa%mXf5x3Gb}Egfj`5y>LR~f0Yyoabhrh4!mk|@8o~OT$W4U1B zv`btWP^p*icw88ilXveF-F>@F*%h%6$M0K5J5z3oRe&mR-mciC11Q+6&CK$Z(#Sak zg2kaV)VN7qGsh{^>MP|y$jS74aIxoDU1hlTihh~NvZT!`_N9G;{ToT}`jxH@VVG?j zC#(Eb+~1$+%BF+vK~nGiMV>V%@CUD z84QCIDYvEu6AG0K^ywtpb%>l|@);BlbeJ}UVAUrU2M0P8(OF-mY+uHTo8+trygVZ3 z;jTaTfB-fGJcV%6t1cb&z;vD=4rk>3F~!SiP#HWyIv>}|A&f~o9&#lLde|s*o$@vf ziqxzZyi$htAne_h8R%{QN0F2GJY|A-My{_eA%3RF72xuBbhyGi*`z1xI31K>I7`u* z=T@nEiGR|Zo%z+4Td<_6t|}#pg$#`%H3onr(_(3>tqGhz9v+x%0gat01H>s$K<|si z#mf;-DI_2jYN+H|l)rW@(B$n6=u$%Fe zX**!ZbXts?DUGKYC$4MNO6>v9&3p!gDFv=Wi*+9*i-3Zd0oNL^q}XY@A%XdVYmT!) zziC*G(nXMLIL2Z@WiUQ2AK5#S?#;(gouacfZz{;&M|e z<+${lkmHj4g|O?2fj=B!AUwi6h%|8kcFVHFt}utEN=$B;d&Y{NJH_q@5AD8L!^f2f z6kC1nTB^t}`4UF|HmSgIu|^|%$>!xGa^a6R5IRkV!5M~54ZAq3ySe>WY^xQaA$-n! zVi*wENGd4{o1F(Lg#rn82Qu4h^;bM|LoCc5HgLhQswr4W0yxE$&=ONm1H?Lp#pGIz z5x$_ET2iZ5=VjSdgxODh{kH;fjG&li6GuZ z{v~7?;-mYdd9F4adE%;x9t^aeli}S3yd>plTbGwD+$}OH;lramM@wkO^C<4lmThWS z67T5kXupTA_-C!`ll{ZMQ!+m)S?h_EyOML3un|_*MX^~l84yC8jGCPT?O5uE8gNl; z+i<)%fRG^Kl&l|1HyR>f8dVR6ilam1J`;Ac zEHv=$)>{LX*Iamy2>~qC05grZCM82+65{6t6c-4pGFoa@>3kKx$p^hnXDjX?G)dEU z#-7f?#VfMSqtlFY!&50c5R=P(WM!DgqV|H$auE>tc=)4;oYd*#hJ=ZbgWu%#2>UB8 zpG^M-AuJyO7EKvIJOvsof>()9FK%adppsJcK-#9eB&hS(`K-Wm8Y5aY*=28K1D9}r zK9GbyeFh`ktDZIs^!x4y6Q9@pdkTMCEGS5%`yrsb5_5?;yGMAufCd_o^=DP-KH;Bn zY*jc&K+-n4m`#(RJApY4DfQBn-~eh#73P(LaQa4wrK98l?>!`>S2Wffp)#_;id1~& zb7CH^{t?!YOrpOic}h1fF=?Dsv&nUS0oeFmAtF?|xF+f0-G!wr)~nw^YF-8!*Qgt% zm8O`myRr-Mr|>Z4LTlw$O>~{m$Bz++s!#R>XATdDXdsw&1}16q6G5|0afZx1ijki2yfJVk_Ddciv{ndQpm}LN6{79It5=yc+B~* zP3B!|bo2=VjLx5Zx*`k~?OXgcYm`G2(U57+t*uLYdC;#`K{lyJjkGX_gjnBb${Inn zD0b3;8Y7$=npMZQ8kcs0IA~cdZqcCEh9mE9lP+to1M%3Ct)6@aF3MUrt@wt>wGN6&ZIN}Gy?&)4bTv^l`_+&*cpm?7lIo4@b5S-WDodaB?6*v?J1d><=lsC)#%V<9a#Ha;!( zI@ADg3d#Zk=PgMSZ_Ag&h=(|>BLrhGIN}z2K0WS>Rvi39E=3AjTr8VEU2V(00CK$9#q5P5AmL&k(3mAD2kx9f}-r3%a&Y^Y16YQnf>2OAkTM3yB>n5v(T@*_R zthNz`JP$~I*MROliPIPkqr*G~s#>O{l|`e~8$&kCnY$f-&p66gaVlt@5Xy7ySZoCU z8ACS?(R7CC<$f#QgNbpP?ZJtZA(|08BEo!%HYO?I66y@s&Qao$%%nOW4LJSNEllr4 zF&j_eb^?5cbg;7@Ns^R<;MjE6F291%4t)y6nx;e<#|woXFaTzlH`L@J+CZmgXNFlh z(J)}>YlS(PVieDw5!ROvn7SdMIDC{Gz=`wcCC$d#zbm9_m|)R`yE5z(cgTZDQ=8=@ z;V2n#o+2ZTIQXr5c_P;iOA z&bCw%8z+=_W1dFq@z(k@O5HKmvSi|e;Zt7|EtTJnCMtT$=D1}aY@D<y;ULx% z%?{yQV`z`3am~>p=WK|GO)PXyF2@;|WAB0qs7lq2B_m8}_N2;s?U~jid3T}uqZ1m{ z5Jub=k#cLDM_IB>dtlPBoQ1%h+gKs6w_y`wUj3S-bx@mm?Na2ML)vD-BHe%1qOKcB zX<*u6cj3Yylt@GfzXHgoA;p&kKwc@Er7{e#kL|6JuTFawrg_<)gpi&|@_C>s&H!i; zoKv8#WN?oW%6*UxoavDo$9-GNS3i8E^k%ZN}^D+T(g>I0PH;J z49zsBrlD~xc#i{@!K04l*mL71sBv|;yYW#!yDQp4gCga>R^CUtuw#EqLQO1tA3OK$ z9W);f53l_PHhI(Llo7cM+rR(Zj}i_dP?VA^?oX1&UUs;6M9BpoD_@y1vG~k>F9~dd zl^U*2z?$&3;TZUAws_SNmFH=AuweGTVXA?Mkt^JS)~!mtXk(%-U5|5H)<~}nYL{pn z!W2f%S9Mp47OCXwa9<9QcV-?aI?;?6U>HwsNsV5}vx(}IEop?jpS!RajjpWV z>ywG4RAu5hi;P?SQIoQKNNmrWvQ0S#ttz9r6RsoYiv!i#6zI?^9zwDnGNwkyXl~h+ zz!?~nW<+FrD3y>UxyD|`MIq7#ZP+(HX|X-A$c3v#T^_~xN8vc-x4+_oIfr5ka`lV( z5aD4~{Osb2;;u6QO!^_2ppwH^u;HcQ8~0R`k^VgcZ>KkxL%Y!add@@epH1u?UMlK+ zF0Ah_>&)I!fVRhq2Mx>pNSLqRkEnj~We*V|mLwX+`f-6_VZOSyY+9@WQJ(!>A}Jm$#7) z5Ap>I!qdJ8(X>lrrg)df@I_HRd=%HYKvp|U-2fcy3p)(7*~=Dds;9EZ1>Um<_fbI|bd)+QR5q~LJ!r{;Rifsq zwzozsf0*#mgGBn)sU4{=bV9ZP5gJ+0%HCHTt80t&uO6%4@PSek8xLYhqO9mu!O2c_ zm&WE)rZD9pWs0tUc@xnBE=3p>>SX1YBV7ed6U1P(Ze|8viiDOeIp<>X==zlbd-BuV zEtU~S2;3xuFWm2-76tRcvW{=8$v z`~Kh7&gA>^HU6~#U)r$Gi{mq+fVY=)jH{l(_T*DVT1#uu_oubJ6^Tx(PX|E#C>vD9 z;@z|M_xS7fk?wkqL&~y1dsxlYp2F4M3I06fZ*Ah{FozRItWWv2e!E0<%uh@VNRrOo zM-6{iV6I2s-HfOskPWA?rDfjCFVW28bB{$c--Cu zHbf&&$eoy;jU?2O)WFu)W*UK$Eu>>0}pLVDCCsCcZY5oAr5B&ry3SIex8G~1Ge(0`FP=x z)|_?>Tf2x{ldFXJ9w=v&=)atY!QLdUdN~8Hvw1cpT>m8Xlo@Q%tIQ13qAIKT-ADIw zQ*(4lD75sGJGS!rgxZ{PSP;wx_u;{j2R$yvncB(bj_@mBjQ_|6lp0ss6tolt8gk=HBtz8qdbb^zm z3!Oo2mPGAS9t^ERo$B-|bTnqaeipSz!;8H|UpIdAN5qfZxXm1);>?^NdGSWdvnJ}C z_IqwwE?vj0ySh|{1Ifng*23R!C`O>Ph6Jzw6!-rphdSH; zK8O1MI`01u`(6K^!+);-F8u$WS=3pX{vYAL)qjQmKl@!wIm)8r!AvZzC$44EsVk|O zF`^~xMRG-iNXW@){`JVd7c~kqvhFiN(#GX?edxfGbDwXI=T`%-+Y<(Z=PL{faoc!N z!WY*B_yiGMsrQ~lg=q%YXr4;FaWqUr20MeaIZHRcDlY%aqmJ(R<59Q1HfEkFre+vA zyga@jxPSHzS<^|g`(wray^_sW+{myM=OBFKwVc5g)iu_}{$Cn(njejNhd{GLI-6KE zTXkDnra864;Gr7((l9iDu)a*S4f#(&oaLH9y_J=IrbV(R?^touniF{-cs)DKg)|j8 z!60xO8NAi|?T%4TD900sW{3tsng#zSE=E^SONiFvX&U{h#B!boLuPt%Fqd8^qHun2h%!-zz;* z7yb%VJHEi7A}y27%Bkuh4=Kn(eXqbp+4yxI|J^B8yr0>ba!~D-^rV05@9+FJPK=fA zqN}1rLJDeCzykyBOiEa`6+?$1uQ0*0Po-ddY8>`EDmPLwH)>>99|<39jKck!IIF!k z^0?+td_pYq{SKk8p^(q$w_&!{e0X7BR{AIPV>D>U1)DLL?SU}aM&i43I0IYbINNX< zCo0#p=<$FU&mRY1Ev}k+odlj|r=)Qzr}`PUhSFd;sqtfTc(U0e?ha@MfvLJ%cOuQ< z7J?7awz1}$Q6E=S+3i;QQ6^4UNr7samVS#-QpQ%ks@1N-dy>EcGA#u3Ftz2@+0QRX zUkc3q#9bv^e=WA0DXq*%2??=la!XMuPQ$9WC^?c93MzYJY2(@=>XrYcaD}AhpYy)& z_7sR=&96n37q(<2xlzBCOXIurJJ^DkrQsTi`F2O+Wqv|)0o*k%aP`|$(@?xq@9NsI?3WJ@1R%@TuIc}skAa#kC4+~!NM-Ox(g ztQM%rYp4q65-mt5KGekk;vW13qx)|6ZIOmEK>1H^-)diVjR*(BDkvb0@GmrP07>Bt(J8<-OjRmE>9j#I9sx<+P-;~&c7s6>QP5GZ(>-qk}@v?(F0sm$K_LO&MJ+NSLD5XI^%{5}wq z>8LC0aemtOoq@=B&fdOG#|iBP5>LyrmBh~eXzwZ{q-bt#5`x3fitmzi7Mp_?N2Dpv zmO7^@+FlAGP@}@sIp0@7;^pD!O3AJ}t7K8&rOXF>Nz1TU-5ECLfNr$G%iLl6Fx!+x z1!7Be$h!$ByF`{9JuMR4-W47AoX#i}r}@q`-*_$m+X?aBKj|s^z@?w0y%p)$rPE;( zBtCleyBJ}8k=O<^I_u_(Ynw&G41BA7n+e#(>X>mUO@LhbG8PL+Fg;r{x%IZ+UASQ2 zc<1T2>cawnuh!5NM=y@EAbgutGp-T}-2rWMY)3K+k8nRJYJm7hgt{BY9tovD1c*_@ zY)=%{XrFCUvJG3clcOYnTl&|Yr)ZZY!8%2vBg`CP)exUjDHmb-Iiw{s{1hA3HPUSm zE`#w$!}QRbLkwAZqK_jJ4<)(n(!|22?Uy3wqYTJHs_(C!D)=k^Z3RZ!#739S!%~WP zx#BoPRjGvyLxNi(7&ri-;?iE}JJ*qkFn3E{R67Tr;6u#6R#EGgXhDZs$bZ2ExU{z5 z>12N5cZwH|@VZ4y^*Xkw>W7x|Fe)1|T>+QO#qcGHyP9%g;LbP!FVmx1*ZYb<@9TF| zcPXOV|Ml@9lwMhmO*BVYv625dR)eaG8cui{#Cct`%wBG1J9;W)wUs+ch-eJu(|HA3 zG%+*Hz>h1^`zoHJ=M%y}t@+)83V0zpWnVT=&GP5SUD9G?kcH;nXxJ|5{wlLH- zikN6Fxek6zRSgG&dp<6PuaTJE1e$aFyw^ZPSl1KSCYu7}s37+owZFnW)+*RZB_agqrfBmGKgsG2iW!_q)ab2QpeGei zTL8rXzH3wf{-QIU>aOOCC))n1|cVJx!c%-XdlH0uT-6<7MGr|*rt+Xt5c zeA>@wwB-v`y;N9+px+p54u!e%Yz~glY)_=M`Zsk#hwS}G;JEY?ts-apYgV1mIBnAy z)YZ_e*n4og;wgc86x%E-ZCR&n!F$SpvG|ua35|!w3v;Q^578ANlf&u!iDf9XGBJ7b z9szb7H8bp`Lb}-aDiH4B%iH@Cqj$ozgBCzeJ*<2-vImumQi&j6hy!dHhWaMV%r|VF z-h%>|F;VqcyFJOVy56FrOLxS-<(PZxWaBoNStp#?`Z~!lus@=VQL2@RZXbp-xdX}} zY|;9475zf(7qy^jqax?bG&^CiL-R`2GTIL#Nmkw*q&V_o>V+JKdl}OY=?V_&mCYAv z0$Y(Q%kWU3Y|5Pp?>nc1;e07ECkegBj zUQbWmF5~){htOCHBS(92=X`j3v37m4;!@bT`b43&L!^iyJCR61m|U%`v$jvK(C zASZ-SjFNLKfk%&BGUjO2Z%Mi~#zu^Gv405l?O-SS0!k) zbj_SW#k^;rbWi#5&E`7XL|=~v`xSOAF(eV)?=){#M&L+t@KSniK|t!67uezK5c#~G z2B8`7Ruq|7T*bJTD-H(b@@g6gWDbag3iyM=!d?2Pmj_6AYNj`j%rg_qpU9Y-mSkp5t3bAkt%3-aMJ=USjIIu90b$P-%`)koE)k zZ^OVD<9ScG{c*=I;k=Z*bslMel1@VcOKS*n_^^r4kdKIpKb%-r_Q5IJ?h7{F6{>kp zlIl0J14Z%4&YlEb&UPd|_(r_}jT(qSsT{cUk#xfdA``1q;;l$8`l1<^Poo7=Tk05o z?Vj#v(f$kuO)plcNINhg&0G<=3ckH!^XyN~byLguZjdX7@iXaXeY%M5)v9vuvs9T* zA7ebB9mE8elAGGB!8kw3Q>O(?hZ+=p45BDdVb|F8l#hkUqR!;=&i%tRyUl3HKadF{ zK6WvePg#`Sn9;=BrLCtF-f@iMDm8zR*&F2kQ?zvv3kG8F-_pR)2z*n$zmj%Eovdi? z09boFNK39p2-=JIuxz8C_BtF=4!T~xJ8}X``rAIv)n<>l?gpjGA8b<9_wfCJJGIBe z&aTz{0f&GgSwf#fBSzAzJ}=xX@gg~ZMQr~0AzR*nVTRG8SafRQ2WG25@?g7N-k!NZ z7_0p8(jU$4!6NZZDV2Mh&Itrl_gyIw>W6S-tHBFI{!5R3sxT8qNE&>?w%7>HntH^J z;mY|0!__{oKRZ#0xN)xNTkYh<>)}`0_Zlk<4-3!W^zEDv1UWs9B@ed>?@c*1`+wCM za_FZwr@pmjE3FV(;q)nc()_AUFdIC5>hdsm1SBATWrJZ9E>;{}e&#>En9$C~UW+xR z!+?AejFXXb`sjVnfl-yAHciVDbVsoT!2FrH%id&?mI76#;ceS^pWcr za8rz=@sEmzWD>x#>?gjFg_6vSrtcS$#S-{+76KQ+0hc&OBdq3%*@XWY>3(4;vd*5b$>mUGv^x=aO?2H{8%b2tJs61FQ(b9KpPFf%{|C$m>%#!(<-=rc)v@#i za?3Xu2j6#e{Gsl_RMe(a_&M;CX$G}{{^k9LLI-OUydk(|RHZVz0l1gEIE4&nPOv`` zJ%K}w1W4>N?|6g)hc?Ay`>!Jg*c;R&P?*8PXA8LU1YY7sPDUm7FJsD8bcr6`-&?L8 ziYKbtYA0j~Tk5PL9wYLo6al8h4c?V&P+gT0>vYZ&f3-2*_GvZ*$jMK?w)z&!e~Hz1 zrYI0IY1IA&#-5`gLkpF7cP1+o*f!EbO3r?u{%Pa77GyNHu#mYDJZU)o{A?w*+t)cy zZR>f9fEsk1I5825lq*^K=Cz>gs`ofoz&2PWhfUDZ>r zGAo3Jw0S%{Zcb=77Nml|cRPBkCBNNH5_&BMxhGmjXoF{^GTG^dF@I~Zj^8`Im1hW6 z)WCPUV)vuC8}$NC%|1R?5q+e!9g&=Dd0IPL4F1@D+dKqovxsI7BhIyN)FLg6q=j<@ zC#DjCVEd7nFyps;g&A=PeqMLQX%J+Ox==JigRtefkr{CgS{-}}bm4xq&|~FgV5$V` zXNIgs-zA-&qRHW&W6zZKeC3Z#&)khXQ zBADcYd&(wVsE*~rE~?(;~CI*r;*jU-naF+Y8rud~oEHmzZVQsI=t zUL<+0X&uWt$>q#Zpjfna4h>TXr34Xc4(z7dOq0CLx;*I71Kvhe(bJDb$NEgTz}r!k zR5NP?Ch(~kN{V+9g7o-LIP8YTb67;3(aloniDPO0J`Y%MA;dzNHWW--pco7PBLV|9 zhWur8Q1{}@nok{o^RMoj=JrIFxxU)-1eIzEwTYn?ow41JsX>by^^{gr#CZIX zuNlNzENG-t|rG!AB3coz>m>>MllsfPPs6UnZBRvrXPC!_Z`SL0KbnwxAR#nFIYjVl{X}gu}n6qcJAPFsebaNX|8F{|1{# z!okLnj_jIJF2)&Le#_Lcoy%aO_pY`CGR~dR@F@^ zl!Dy=jzV1pUhdfO=rUC)2W3QuZpCVGveR60s!tsW4ozK9WFW0hK6eYMOc)Rp#E|nX z8XQ$}w8#seu>t(nfj?@W82q(CjF7^($rdv*_HsDk)F)wDHKlWDPr>K!zHpW!Tkod& z|71hH8&$l)fiiwodD}J0H`Fo9_A|0J6$1WNCOUX|C@>XPRAkyRtv1qo269vYARZh# z{t>%jzx>m72&S~qjP-1aW%HbK_&~YiskP+}p|k0(+ui+}GgG6~$W9q_;^PMMZa)%{AdBgl2Udr_{+S=& zyfT=nt_p*(L;v(OB9L2vpR_*hn>I|aN^y2iFtK@$;me`Q1%AP+)b?y^xvTBlgUr?KfdONX2cdI?Fb*Zg zbs2iqnIpyfpAW?W81JxW9&Z-%;Fv0G%nzBbbE-2_WVnP(GLNhHEqlAPE$eYQa$Wdo z>O;#K!%6UGEZFlb`t5a0f2B^Vyf=&^VxzQUfJZL1lY_~aOif`}P1=)cw4J6jusMVW z88eKf{}s;pI-l+(V3%*#CL%{_y_8JQcVrC=N@9;)*;H#3mX&yXz8{?2Sz?O_`~Nna z`Y-rj9|#HRA4_kCloW7}YwToKj?R}1?3`o@{5b8LgudEmGWv6I&$tNF9?CED=)A8Z zst(D0|M2@$Rtb5(N*au4V1u6R90WQ6urN}YtQ`LKj78AM!g3*fXGKGyz{f%iAS;1# zvu>R~Ua|$Opbbfz;e64fS*KrlyeFptdE!e_5ER;B@J=Ins8L^8xUEevN*8 zI~hrx(dWlZe?3YqnfV*uFmmBa;at}(kZEC+B2~8y^^j}ei(Ua}LVA#`X;x@LbImD= zRIWs{xUq0RNl!6;rcP&^ta;CxOnoouk~#ML*XCPJqkM2ooYXL0ZpvR^G}R7UWA{Uj zZY@6I4FAe|*lq1N6udB)VX?tTQ)MXf+{~Fe9((UmF}JW%TC6?(vfXI}oTU)_+SwFq zNmx_%-&)PYHTnIOB+fynl78^U>NFVQ*)7{3BB9WswPZLhnCNMTfQR-bzE?*f>584X zZ6l(s?3>Si#&e(bXA)!dc;InfUwekstOexxApAj%^B7;qLamzNV7jZ=lQTyCKtb|G z5Ufd@)cq~kWAbNL*~i;{?GR?WYHy3M0A(uWh&pKk5_uPIdQN?D31-p{r%r$3aUSZS zs&>aYlCN@D2XrvmY;;!Iw;$zoN#H0LEwWw`Q%1BFX9Vp16OHynEScf4JL;Jq$4OZ& zS(R)ijvvCAh(d%2TlnIVc3;&Rki?A{<^gH=4v+FRWi@lC9J3kWtEp~9?@LJ0r-AgEk2|?6l6pll{&QAs zyTGW?8jZZ}(=d(v%43h2q-~GV0;X~r^ypOr#_zUS!+1pt>T_L8aXTNI|FuE${vGz* zT^I>zU6lm2^6pVbj4LDf1L6KU!26|`{@zkEV>gZ0UKq~T1P?SD9t5JQH+nQ6!k_`9 z#&{}mF4j@VwQCI~v@$^5i;r&zqWC7e;21^a#d~BLuSAB(ctwY>sKO?H(K@+?wjm(lzqgb$YiYSwzNr5Iw+n5sI-=URWQYUNwd!9;2 zgr_i?iQM4Q>uYWRbeLBfkU$OR8MCPFy53=}Z8vm--!fE0-mXu?b{jO4!_q+}C@D9-9AVI6mj5VJKkw&h$5?A-^%# z*ZzWRAK;3sgm@!1+7Pn4Zzh1Oo1+d1Y4u|)WS~G~-re4=>dmu=+f&Ri*R%LVFPSSV zPb=XXC5EIWzvP6!rwjf_b7esVH2^|hX6zmlOfsYMSF6veI5v6hl@_)iFcQoYrZVRS zAPlwU4LVQ40bzJrZPwxmm|4%AUKmdZ$mmh{x4!brDF<99-VCT;q4(UBJ~(U*^t;lA zgT1KyV3LoSD}+HC6E>319q4)Xb6COCv=Q8Sj?$}|Wahlz~3)sG{ z{F83ENH7K9@jbXsCCHMZvKWsIx7}D{RcboaTQYs2mJh5^u8$c#@+M&+$Yn%M4C9=R z#vFUq>tP@_lcNwP@(n6+Dpsn^7!eQB8L26W-qr#k{Q;jzkBg2O0RirwUuw)d&N@56 zn@Qeu;xcV=L>X%vh;;!)!2=ZUOvbX^$wq~1G#Cp?uxCVhv)nxqFAW2djPt%$WWq32 znh%L6rpzfssB&I0kl4`mqkohX17Ci{W#XzzQAD+ik7VQ4P zo6IM-OnvLBB2A;?YgQ#)R`0bYmk`}bkV3u`N)&xQF1Y;TGc%vRds#;k7|6@_D$|RT zk-JGWA@&DIuegaWAZ5hj+re=j;166e#)PDnfigFo|0J2GUfOq;#*h!txsiv*x zW!^C#*Id82;`a<5MNw!)0sKOkminkl_Wb&fG!uZ4=gQQ%-4`@7-W&37Su7wmRMWbOvHy6&h$4SU@So>#GN=#49OgZp&gZGq4E z8h0M6c5i&@ewGza`(Ls{gE#4l&?Hz(9$)xa#KoRk?b;c|Z|_EIv5;?x$3l zfEF(-QxruuUB$}|MZ}KwK-0wG(3+2s@?p#%A@LwF*|v1rdu!*EC^1(}RdNh;qWHOihs&tT#1pWb65yn}0f?$8Cg0bJc zb7YY@Dr$bj#UgQLT(1!YoUF77*EJ8cWl)Pfb|G9w@T*G*=i=JVWNsZ&gJ5E-E&dJ( z=#3UM;b4y0-!mAnu5BZ%dx8A`P)rugAGE#K`VI*s=0B_&Mpm3&B9+{#mpaUQxLyGo z&h#X)sbxtOzlTfkS@bedJ7PQH9A14g7D~6$@e20apr3qXanbgwhb(tt_EF>l(V}a%hrGc0B($C2!&ZJ09d=mcNJ}WI zs=WothasCgjx_54^M<7ShDwUwfyEoUX(|WUcWuE%@~+Nhco@BL>}c}rMpH`B+oXkY z6wNSbiln3v$d;@j73Wy=Lh?2K6?Hmm@q2e|?)OJy3##|t5A=oXiC<*(*^YMm#d0NZ zRQt_rC_(^VB&0G>%7Qh}7NsoLqN=_(nyR76#r*C}Rk*g_0mw5SF@fky8wzbivG)CG zZ8<#a;uO?)m7?$pn50m&-omrmXqSxXRVF zE*!xiOlEePsO=dQ`w~f8tbmHhT_%EvQGCScc~L^qjzDmD$S`1eCZ!SBHWC?Hol&j! zNe$ETzT1BBO-a3qF$dR1En_wNob+2SeT*}aWng>m#o)w*AxZ6EtJQI=mY9fFdIil4w44zF!8F4JC`|49*0|S|3DtbK#YH z*vMf>&7nAkLd*g|+9I);h_<6?sIg}ZDNUE~9S2MBg|+wNgPuL%6Ku~rsNxV5;#lx@ zifvP^lx(lz8(AL0X3UN|jzNP7eyTIZB&nPDqyg&wYdbkrK(y%dwfl9VY?4BUe0Ha& zgB0UQ3nW{!EZ#1}RD`78jd{Z=$jq)66cpRrBcLcIkwd6r>YslftT*g7pz?3tB77So z!jK*EP0@faSM8z~!}nUL;~s;XEvcKt%Hxj)zuvE}C$qZZSk?uk$lNX5?N748Bchee zaUaTCr6D51^cRedHiGuFgr)mU=x5?EtM<3NN_u!~UReWxzjZq5!2^2JGE=_So%)%v zPOTq@QNik0!gM<{apk13aI}dgOXAZdi}k_Xe_HNO%d;dGb1rq^LSbAv6&<($b{mfjKc0<*ilZcOr!BN{yV=dC1$b!^w8=sSEz>AOW^ap~g%@Nplu? zYF&y%v1(EIRGoRiEC398;uSaKI}`-XE%xhG`6|#x&P=<@dnx6@{HFF?v|8-32%I{- zfP9-EXJCDYTLc0wRG|@sH~lfyGDo##SAdkkz#V|Z-d#IWj5UT+>WN7CDFwX&z(ZWw_Bak1RzN>l&+YtYWbEH>XF5QD3i=(BH@P`}p$L)Y8Su z2<7qCl3ID=W|yxKz`;m1>g}(3udQT9qJm2Nk1R6k07TU{^%VZZ;ItD)y!)fG3}esi zM2!A@h^V)T?`sgE`@G){5{n##8pRSt!ScG=5X&Idl>9$FXGa2Zg|J=e_9lN^X)zL(H`cl(w9U2#pwcpJ4b|H3}S}8oXDGEf;Y|K zvMNMcBj~-47?Xx2Iv1DD--)iq%vYx}ly^ljgp~fdJ{}CTLHs&!gRnrRp_Z+a4?fVR zy@fN^@(Bcp=GzEWd%>~Nsppu^qr6}Z5>cJo45v}HlRF}YZwj%V7hxne6w;i`Q~YZz z@%ip#UU6`-Maja^^ZaSp=Qfq19GFc2(YED`eb8c|bq1w>U@6$pPp_Wid_8J8oegAW z%0rT^1uCi$_oiUxc{@^${6hg}VD2DKzMTCYKH8oTJ<(onB29A*g6l%roaw_$ zR42XU?J?9YiI_i9?csjSPrl19r`0bO98+bfxXFGuX@z%1Mnhe zumIvdPS4U5^fqTZzV%U6{Sp4w58K?tQBdI5LhAC;d2KE>(-dC1MR=gjys);6_-vqE zq&;6M3yY_xb%6;5$-7){rCW2R7@WVS~P!#*X=#j{VFtto<~ z=(2?j$yHoV`rHHS`rKe|uA+iHJu#`v;Y^*GGRF6yi^C8oJ5IzSvf#;)PQIXpCJy8( zfHYjb$Q~yrz5T4Ua=pr-WVbJzAP1#~8Uc;yRIbL+maKv;gOu|E$b2$b@S4eaAHrj6 z@DLA^hqN`#tL7EAz2*{7TuFcXRKAp4$ld^NA6HOV4QAE9A2u%Yb9$uRfyfld(pD`+ z`~0?aH`}gOaWyWN_=#`Alt{h58&{MwQfP_te2=+WMJ&QAa&Yn?+b|oO3GsSNZMm5u z^gYzk%9|eAP~qN9xW3JK(H$jllFCYUiQS%qKwm0ifMylua$H(%k4-39(8W0o+Bo=> z1?=$pxeP~}0(C3yUdzOHOMrc9$ePrD^1C#$vzkEPoIIpG|5;xzy5`&xgowJ)tT9T| zG*}{IyOEkV0kgv_^a7@Z!~FPYVpGkTt{}^955W&p-W(``Sdev~^EfyOG+?%*YmUMK zBdt0E#uZI@P^_G51>)2U>c29- zG7sf;22Y*9`>rJ(5r()1?)Ew=iVLdX!DY2}pf}w!y$(o#{w>rOdO#AIu`~WC4I^L% zeuH_{odPsjKV67pjj3#9Pd6x8@y)dx>&(fWZ1>5$4viI?9@NmM6B12v1svw|dojPFfPiJe(z95d1fYUwnhNu0=?q zeYC#eeY(tyw!0rXP(W-Ij`NSyW~(|Uicz$@qq}0CYt?I2q0^DT)4!SAbB6ba0tw|K zN(hYyHDU&C5-6J_Al|p_+-cqX32l-4q&+gCO-KBf&`apIstl)sm#=U(fd#&wZ;QCS z@n?fmj0yC%YD}dmJeu>t`=0jitVzy%oz&rFTL^`!$a_*tAt?{>P-NmgtJ}7} zF(x}9!WJWNQb#{CX(CLui~IMUOlG%`ygJ8ABJlMBD#nal3YM97*y1~Ruyo9FWam{6 zm91yySejARo@RsZeG?{O2-Gcqc7+m8l3z)dmW7ZclZj%eFdfp)Re=IpSM!v1uV@ofK8p4^`dzOQ|AJ{p_9Kq}BADj*uPo#o|BDv#|2~-hpWZF7 zGXHnM^#7H2oSl=E`9BBKl^Pq)|LzuiUo<93)3rsgfI8cBtMjREs$0~xQ)Mk^>mGoh zNu|S~Yw47le*|341YCfrCf4|n!OXqho!=kRH8L$I9fl$?DJ?EIOGq#o4Z3;sA}uI0 z9=Sf%sF#Z%@-c-dN_KpDGOalT23+>EVQ)f zr%WDf$%Zri5#LfRh60v-u)fN+s2g!b2$j-UpZ|^_x^m{wJt}xBl$c1-*P8F#nK-Dq zPdU6UV1DVOd+<1!*{uMAK9K!FoAS2WbHS+mjMOvGZSNOa8?Sj`O;1wqOzj2ApO<~R zTd0>1o3sddtjd)l<~Td*?6}fmW;UqroJ{poma)qcXO_$22uB(vHhDJa_m`Fr`+drF zPS!A-8l&H3&4cNS{c@6Jj5y>^s@V*vUhPkslZQEaI`=fPx!|zA_I>0cElB3MXSo}t z*de_yqbPu)qJT_x(-@)DUb3~0+>h4slOFAy(VWbsVDGGtGgAtbKR<-lt{%PtFP7X7Fx)_*A?0Ig1#Q!CmTCTfZoVp($F4k_2r*x zt|V|@((e{sr%vkF?0j&0=fylBQ!i4W@|k-e^ewU&hTQB=RZ{7?c&8EP_bxiXm?hel z!MLu~i2s&kcRS0GNxS)Z;c0P|IReNh5)_=}O3!Dkl10< zYvURI&R$?3CQs7rN*+@l0<{xkLN%hZ%Zas656%X<4tm=#Az2L8TdXtU-wHSFbuPl~ zMCI9y_TQhu%jBBIae-YvkM6~+rzDE4^~KY-c~8y9d?&(KGxr;Zu|or`@qr!yAp$ju zZ+hSu`>;tuWaAQ|l8~N?S)v1GF&QPUAOya|8!f2|VXnmAy3Dpo6!M;4fgL4QyhZAM zJsKSbE23I3%>#+eve>2cHe{H!VI0LG_Ci;|IIUy`4$X0EIwIuEb)CRZuh##3~TP~d`3DYLt;+qFygddCK7bo}K zSYqB;SOTeYN8CK!D1_Das4ICWYtH)Z(1>ajN3%6jP<$EK;VOUXxo;`Ut2}oNw?jm%#QN%sCv) zj+u6#4ElYWbjUEc#wf#WTLL{1n-4-h>E27W>_<^fH1BA$TVcH_%WUFYqH!+K0lTOR zEeK8ZXsr_JWYfvc9#c*GE9abaN3rpHIvhd+r~4Cg zF`Y)7rl7yetYiN_-gm2fIiEe>_%OJ($Ls@Tjiu&2RcklqHoC_6wIozT)$mwS=d`Ux z1P>R&5m}AP{W+~`<^c=ZKa|rDhA?ZxFq4vFztE{D^;BnI+Tao_%>A=-t z)4iEJdkxX>As9+D>-TA5fT)tSs}&G@zt%K#a%u5K=#S005a5)bwE^8d zu$x0&1|Jx3;4iaWeI|gY%)nGE;%V<<1h5XZG_P)zIG<8y1+@;}Q^YMUE@yFhiF!zI zj_7U)&|hL!Xw5e&@hi`J5o>$jvgor<8NBE_N0-LxvG$%|&3T`(KQ*%ZkgbOlqqGB2~ z_uOgz#HXE){3$a$Q7jtTLi0(h?^u~DwBI_96XIG>bW(zs9!KBxwgjQaa%#=XC@iCS zte(NqKu$Eyb^l1k-F>uh5v@SMrw%+U(Lk5WF(TTr^49P$5F$mJ{jI_5hzs`#h%lC1 zyd`P#2GMC$V;k2Bm9j@gNyzLGwm`ybnN|2YZgihWatb*@L7|Q?Omgf<0@*>F_1_D@(z8akS z#gB~0#LEf(;+T&Xd+S(^D@m%Rr9?-Z3@N1qvx6rmYxl3^tG`zI3O&Y8UY+_r zk5cp84fL8K_$C^{02H=+n;#|}NOfIYNO!ArTbEZ~zUE8wtA7V$k-WE;3v9^BdqK+F zv&qAjC;98lbXe3(R`zsEmePVMOWvj%`emSXy z5Pk%5b*_wk;+{KfVrJAMAWjt)N5IZ3ER*QyiP&q0(5+WhY(CPbG(5T55+v!c|O5 zM8grYe3kH2U-SS=+ra8nON8!ZO?NyD*`_%qOjy=03t5(eGga4ZmUbg2gmMTg)<70O zB=d$Wk$464g6kxu-aF{MS~FJ*0GnBWf-_?RAP8hxri_4K<00!B5143D9lUB1a}tA+ zI6fcMDwJj*Zwft*9Ha1XOrK&gmw9|(N9+vRi?a^g!U80F3pW+wvbuES9p*iPMgD9q zBKFBrXI<#05I+G@G+M9{gGy<2JyE*v3i9koUXy`8_fOM961-K)W5-5>Hr{#VHWq9; zDQ4|Bk_jOa0*5*>V7#F5sh;tf3fIx5;#Fzla$;uq@T$Nl@`wVAwYjNfB6>3 z#vJaKf`vUIhu+enmYOSDmBfP>a~+l9=m<}N41rn81LDiyA}dzq%6F&_)jg?EiD*W_ z>;~#Xp@<+AD6CJbf%jJIV-x*k*NY}ooQEr~&JY&Qx#5cd!uww_^-MzQMD|18P6MDp zPM#$1?g+t;H)gmy6cAcnT+8ZvD*>;hG4rUBJ!{vSRT!n(tQmMtNY`_asax*pe`|t- zqR+Qp2=>tyh%YH1`~SA|$0$Bfqs<|}fzrG~T#k_R1!g%z27Sc_qd?SWl&;3!nKIt}W9F6P=jM#K$2hKn7^n z9F`g?6f)Mo=?WCjRTxDxdCkYhGP)X{h+im3XYR7T_?sz{h@a5XXVE4uuM``;gZj4kKW*)A zuFs`{-`U&Nw0-^)RQ- zJ94R*HD_TciNgo9nZ2)j{cv`;lpNRhyuGOmYcaXhlNh8$C6Ah@Wtnl%C-)lkj!w7rSy5lRscOyHc$2K*d#T4!uyA3+H%W%-(LkC;Yk3Vs%@L55X zIW*i+4^0J6@AZ0I&c)hnCvvbb{HmcukNMPCmlVyoDfp?M z#6DbXTFziJUSo!qswY$CZRzn1qzc1IM?mNpy z<`=w6)8X&uWd$4GEc>*CSi=-7e3x2bHGIKulPeI`x^uco#J(XhD^W2FHd~{*O|l02 zQRSAN3?Z7KCIPz{NE2syT70f?k7@x?iI+=I-e#$lBB6^*BtC_e!0Hc_&aLI3Bp`|& zndW7palGbqWdZ3J#eFp9q+OI^TVusS9&e<^^?dB zOEs(iYFHXnn&efSr5gs7TwMCrSr+?F1SfG1v)(b86RQhBYgOQLx3LT^{opJ-r(1|m z3N@1twC@lVnF~!aPJ7oTHy`<(dF|FDs>B^=Z1UER!KtcH5&}(l%ItItDAk^c_I zhZH==9nV;>ieZtf6%fp03!L`<|RpUIhJm^yP>VSLU>B&o)SX zHz5NBJVzndS!P>0A9UXDlRZvbliWY02|Ku`7FCR|$R+qCYCai?h2Xm=0#T6em*^6c zvdZae>Vv>=T^!J5Euqv<%+3+!(dT8f9DItl??iOw6NQV?bBVcenE4+6#pZT~Tx)5{;$&XoY5+zN&t*CX`n~%v z5#l!UXXTM@qe9O;vkD#)Dw$81%tatgH`yH0&%%iFif1e&^Nm@X`Gk~TmcWk}S;_C! zDN$jR>j0vY^vFcN^busGhE4B8pi%+egVcu}fHO+ymasE|z?L;IJJ0M9G25-4 z*x6kdgr`Bv6tS-5myX%`Yd*Q*_T?MWpY%+7fDz3Uy$cjoaY_kZ{LK2Z{CwN7c(4~Y z%o%RO)yU7(J;CFID)udI3dP9Xl= zP~p|L>w<`)u99#`waDAh=A&`|PZe313c4@YH9Z@+^a#t1mS~z@{c_X4+Mt>(Gi$JF zy3qlofnNPu+I+*^;Vpx(-y$n(JMPcm)3CiN`&zUI^aq4WUsd9QgMplX5cPQo!bf<| z%*=PH?zn2b#sl0>E}~M-FTTW$rx53BxUaE{zo+v-m5cpM0|yvUu;-V=65NTi`Ve%f zQ&U$M*3mri-Tzj2+XD;bf3OXEU&2TDfMoc;*RfZM?d6`+bf@@_xUd$=1yE2;-Wp@k za6F_vP*&We{Z0FHL#Hd^0)DAc6``r;y@f^Qod=dK=m&Z!IEpmoiYs5QAvL)Q-oxH5 zacMeA8i5jR!we#YzEX_!Z3Zy)_M{a`&b6zk*pEvIN+Y^KTL2Q++j81s*@%M27vo#9 zm9@(YG#Dv~p;MYP8|pW+o(kna-4P%x6R8tVK>U_UXyyC8%d^OEtk90z%qZRg^m<*1 z53vd{bgzFLk{8p)lr69`(9#P+Ya7$xzA@6gE-aWEOoOdk?!q_j9m@fms&GngF#(onR(UHNusl84i7^zitW)%|*a3OLhfSFO+fw&o*005bHaX1bXzG#s-1rN?*Nm(BB&$sF+aiPW zs7Opy2Ieyz4Q)p9&mE#gJAYknIkjZ!#C~t4TcF!;(rmphoiBOg3;WV+RmTSjm(z%o zJ;QILLlxN_jzGQRLYQnW831?BP&4-mAZqIv)CruTP}Q^H%dGN zsq3@Z*^U9gO%7uUOx9`i3saytd;X*@oGYZJQ>dr%2zfjD#OLI5G|AIgN4ZB8_J&ic zgUva)#?)!(&?Sk;?Q}cKMcy&GDp#RcXx&S-ZL__Ndr?1BJnL2^T-=`#eZri&Mz>Yr z(VJ1QV?S6ZUz_7{x<6XKn&HO@-+38}5JH*eH(if*K+0p7*{1fyvNc7F8QKU6V`(P) zHuzu78gs_qP2|>+PgCj)wmU|4m#48B#R>l;Kh%-zOU{GNPm%XieU1V|l>lgYI2xcM zpAeYc*%^$@ZS$FYoGY1UHNW&dWy0c31toh6`B9b)#(T~VG4!I!8nrWJo%EOt=p-W+ zvIq^+@4?r6OoVKbka9w^!>Le*Z^~XE$H#G+|0;F=ue{J4|BGJe|2}p9AJ@TI{=3xu z|IQ1|#KQWYQ}?X@H+5gpn3O3WO@aaq#65G?ElO^zLzPiacWiF%^!)wrk8KzXYoW3J z?fr2Q@S+Qp;G6>m!s>goP~u-ct-l$rQKP@9+uemy=kfJkQX%8?oL_DnA9j9ciy`4e zC-y{iyC+4LFGg(6oVBb_gl2{!Ax2R?wN^5A07&^2p7v-^+~C=Wl*qWC`s1JR-SEDl zRVhZz%rgEU%gXcMm#Qk7Z4>`snJ!DGTe5LWq8q31`7PXI?Cn)1V zhB}Gs5m&c5d(`~_5&J&vRU#V{>e3#Ew%;-aP%jPS-qQTE;+e=7k@d^mrxeEQ*&Ff| z9iPiekq@gmM_666Ukj+A8pZ-iT^Hx;^?V&Px2N`zCc^U+@?t*0LSnAMSNHFMuY>H{A6FgmTK^X);~p?F=aE5%p*H0lG-Z1UTsyA zDYnzjgf(h-egLG<9_(^bFAX@C$HGPci&MkqC&lSW7^B4}yew#y5opp)^`6=F-de`xrQIVB2doB&Eo|_;)dps@lB@k%oa^YJve|8+8*($`OZAo@k&D8X1Jnu! zpK41_x=*gWBYqj?1qQ!;wGVgZjjz`!Z9pJG59K4#+0Rm4DdD=hu9GNERYl}pXBdTO zDfXN=7dkxgOT;8L8~NPQ8Y9UKk{;!j={`I5^`#2mt`TrMMgi{)=Ua5;kGLJc&gSEn z=C`^&4pS4<{N}yzS&4gCq}6UzG2Z+OQlk>rsmW;}QMXhXD8zfYF*biR&)o?&mcG6l{u)bfJ^ZBjyoF5)94GWm=$z4l8x zfVPXU-yQDpZkYVAcw@}#G_@@hhYJr)cyXR#6vDHn|-LdX(xlzOFjFRCH6R60b8xKxi2DI1VgQ&a*)RO|yqF&PFKJ0kvm6 zA4uV;;t>Wp$AS`;0g%7u2Ovd=%3#tXJ0wFdNHIM%Axi#860D;~fd-oO^%3ieyq7qx zLmhWViID30+qz@zCZP0>{>M1Rd)V|ZB_Fjo8=$Ijm0=j8zjTnGJnVyJ9d<|`)dsm( zV9{%SxzturTJ-wJw%x*NBZO|XCTbY@-mOLr zV7E8kj*)^TarM8!gaBndFz`pK4Am*(jnI{sW#et=Fg?CbC}h;dQYNHZ3$xg*XLh~; zVUajO(~=9XM9^VjC%c+$=a?+T3%*h*1B}y0UHUS~y(_jBealm}%I0FZnai<)d@G_a z4Hq|EDIvT|y4Rg4rKLwwyH!g;!^hH7x}hnA^woW4hEF;!a(0@oisDO*n(cbWAgv5d zQ_{0-LN?h&4%%0c4$Wq3b0gexZb6CbKIKBqCQ=nN%EDuUs4d-CtZ=68Uk+t^Je?0s z9c|FYhpp83w=3V2)BN#YD%eJ3B{vFDP%t(>6!KdjVdgtXfDu$TX$<_Uo2*E1#xM>* zO;6>0xNq=W%S`pyD{96BjFe{5a~@+T@y+OdShPO&Q)`=89LLE7gdwe--JY(%)SK}l za|O`SWv~n1TFXf=*LawS)vV}lo8(FvbHMZ@H8>h~#|e8(5UKewMm!Sk|i zxy{{EQSmn=@n&K{Vn#hwIcm0Y3Zq&qhlp3x6&-ARZ=Sa3o(3j-#~inCwbFY)v_}8J zDv;hBg{Qyhecn60(}a>M`QeD1F&O(LcaN>(0gfW5VA19^+oSkBVa3#)28KA2+M~YO zbiUL1E7uIp-EUEBViM!Q{*^#Y0tL#;GQI#e#&ciP3^hq2iQJcG58U2T|>p@jp5-P`>_xO}(zX0yx_)0{0;s zm!J{&cwj$PmiL|b-o66QU#J!()0}1Bz46_fh1&Tg4ndJqRvekEIP|fApv3_t12A6l z8bAMIdQ{-w{C$d%_@vx|HoZN)h;dRHw=peIoXohq=XUWxJ13%ug%sOSy;*t^(;QL_!Rh@=rsR#| z%de_Z9CeP=7XklnUo#32`qyBF!p(2~R#_|o=Z=SRX%KaLHM1|pN|EudJly!4)NzTJ zJORD<2rVW4#Z3~l{gt|-%h)fK$^%+DmoM1;G^KW_B#W+a*!yO>=Wm5=rq!E7Oj?BE zn`>siZpEObEF);Y7XA+Pr?cv_%MCD+Q%!y8(Jh5bgx&D5*EIt~dq63z`VDt-(Torh z9X%BXTC9@P}sTD%ojkz_7)4MrwCN6j-eU4KWS&{nL3+W%pse&ZcHjq`ag$|QYMBsy!1v=hY)g4u2$ow zW&X=$OhZ7InO7=peDqBzEuA3nF=4Cp5}-$AEwVF@D);I)!W+F zWI6y;#V14C;cU4dMX$Ehufl~81q==NkLMfsLh$EbH?qX!szmOg{VO2zXj5OEN*dN% zhEd)ePvvy==|W5546cBXmYo`5wY@T|ZJK$B9qE&akNAlQByO$i^$D4d1(COimcV2%YJ`>v(UlVd z!Uzi(#FpzKx4p8+G(_)SQke1t*4Af#_~?qgoO{}prod63V!`Wx&Y%L(g~obX{KUI5 ziJfeZr}>D;FTbq=k^`U;k8H&n;)U_-Uq9@`{{7%_KAVq&I>G^Zm(aLAAMMtZlzGKr zRgr~%jnBE2#bTSold13H5CFhPGF|AQ?dkvLp0GPvUzbNs9m#G!&=#G>^PljRR+|Sk zxWzcxZdf=;hZ)E5G?N_WeX}h(CxIL@3B?CYiZr-zg z4Fh(kKGFvbEFt=LDpYaNvL9{TzG_sp$M>e_VoOUzF*Q48`G)Ma=wiu(<8{S)-Trfa zkFqcTS5#SlE#p$YX|)sRcHpnJzph44W)ybywXHTt z<@Ge(_4H02xNzv&>)r8ISs~?6ug=>G%8#4TcT>&FppLr<6o2ggsM?E^*QZ`b&Ch%m zf-Qdte_OWFF&TLSoXz`&9!ICO&vQu6x@5}>bs~-^U3w&8C-`7`!S8`e(aMc%VRvtd zFZL9;YD{jWnkeFxhkp5^Gxf%`2Nd|mD@u8iM>-q)@54x0GTEdt8(fzSe%Q0&WY@(& z@NW-@#MY}bod2gNQUeOoB65v=yG~j*c5=|G0sx>?xNQEk=p%Eo^hxA(9OS2u(O{K zvOf`Zya6DlQ2&}+df0KB*yqh)=ai5~DS1X+fl4Ae#2}{dnaDMXUFjIrNia z-*q&Dpg=5);RPR=BU_L_%kGhloChjKq%-ols;VFO_a8bt@HHR23~-F`kQxr{?!3+DCef=jOw05&HyUczAfEU8>2A2BU zB)_3`wk7;EP-V<^;>s+9qxS$@(UD#u2{?(vm!)Ya^l2z^`*WjzF!WRp_lLheD_9}L zEGyO0$8~=&|5^}waVx}E8TI2n>$zMDojY=?=JW5TR#<~2(8J%UMZGsK9=NamA%aQ) z^>y+}!8OWgTs2#Zox+W>#Hz{uiL8&b{Vda7ip)oYk*F@w^OZHDvEEKbfVR{rSxPr} zGIv6mB0a`GM9+acQ_M>`@?3fq53Ld|o3-_nd4@65kLp2a2QidCoWO zVzLB*OoFRAxZmoxTY6!6@ZSCV0aVRpd1TLL4mmoJ{`u&0Q6}{@QdTP`LmrAAkA@}% zR92C&^u`WFIP*qGI!EG8i(b(j9ZWTDPnrirZde#a9l_3otN}E&`%^L*k7*{5guA^_O1NR@MsD~OzQmG) zJX2{BVVJ-)kRf=IHVs{2iNE#&Zz@~H{O1(Khu}B;D!5CU-w;;DNbs1Xhvfj8woQgw zB_uuJAHhQvUEY>C@1n`XEy<{V6}eg`Amf(@t3f)S+Q2MrNugAyMY3rVhXlqN+N`Jm zv&l(Wo@4I3tI3#=a;hRxi8)FEMp*su;f41r`3cyc^l5U#Rb;B7XUH#D$eScsV&;EeeZM{q=y*6*0= zX!zvqvuo9|K$o-KG2Z#Ai4FP?TX<@(th};d15U9QL>0xB69Y@a29u%E(Tv4kVt2N( zBd1ZMrldmM7=~9=#yN`aY9qHb;(I0!2I_D!0@`sav3#vR!05r1DYYdc6-JHv`eG;< z(qv#r$wedD{h^Htm2pqew56-tdl#>FpgJkcC>79+r4i^b1uSN@^?{)#e%6FXsJ_AY zd7^`P_e29!8RhjIS>=HDVhQHxI#(828xuWkG zuV_98Tzo}5DsM@qy9aJfdkn~Ao$ zXpzKHekFTMI#@?$G8Zf-YJMqv|M3kU!X=;U6nd>+mRa+}K z&G1Nl;wyF`3bUD{=vj$6--uBO$B|4_f&7}hNtb+u4Y<#-|Cyw#tDbT%K)5ydK^S8 z*;Ke)I-;@>5gToF#P5hadKm9}rj7jdJDqn$ekSpF`^ZClY#liEei{egZ%eZl8=6vf z-#UobSgZ91RPAPC#dlkyT+N_5g?M(NFiRxQkoF^+SNi9{eHX8TN*5{TN6s*YVbKy) z*r6&!uk`n7FTBvSxUex4%U`6ljVeWqZ=Kd%)ct^I?JHT%wQLBryoW`jtwL8(UEOsj zWKbLF;0-f#?7V7Y8BS5R*I3EjU+C!wXI;MAx>c&DVo}5Mb-(8Qe7SdOmcRGo?&Z5= zJyXy3{dvL1%|!*{@1>YaJky@fW!S<%zGaks?(dy5zFe|0pOPAWxy|V64~y$DPjxno zN2|@mZP+5mVRq=t)-YiwT5{2;`&cJC5%soSP>6tF#H}tgaJ=c-5$4~0VPqJHic11w zv*ux#2}JvXAbMj3{p^+3ADn=4XCg=>3idLoj(FHkO5tb zQ+@pKLwHziU6eBpTpV2}GQmF_>BeCL9G%;@Wpyk}jlsq@0d` zkYVOfff}B!=mxf_1KW|pbwKTEo^VRsQQ6IN=my6Jr5d)AVsI(dT0!I#M%vU2@eBmLWFxj9AI{Anl~kS7sIHU##L42CchHo}>MO*R~Qd_NUkKA4C%*2oj5dzOxuDwOEe zW^?uaZ=kWq%ZE0}!6?37ZeE1htXh?Dv7yVWb?%TvV#Km$Ilbd~RQX{i(xdRr$}U=l zda;Bys$q-Qi$QDTiHUaPdMk3@>>8f^n*F#dH@I5oIoru@WpQ^1wnYmwys?L*yRIo0%s8RNNt<6|BXp;=D zNca%h{xYo{32v^nwtctIK|E3Kh!YL%M-j)6Eos9}hMHk~W-j$dtK;56j{-&7nX@me zjUT}<7AHILw~G%DO2zVc_Tow9@)Adb#u(=Jhq!P<_k&|rB?sI4?Kp#*k$Ao9Az42a z2_O0OavSTtXWCyQz?OY#lXh7QilY>7P7`EDaz4^LJ}ms%EQfy{0anyFocr)W?6(Wu zK3pE|bgaIeDsgb2+H1fb2iiLmCd)sFYWGZX6_KY!RI*M=!yY|*RKCL$pJG{ycSW=X zHtfyf=*M6dZ6bf_$I%@$m$BGIBxv@NJx}~OX`X4EmM1xd$}Co#XCnYva|fv#qCD2V7>-m6~{D zNeq}P44a0#-=w8YzJMpj@_u6P`=^4!k&cbwj;~5Q&J~?tk@IDWw8xRs6czYklB_;Z zeig!?+Yl~5`N8}_RMcdYaS6i;_n2nDYx#Whg>er8SWMN@CiyKKh9p1x)Nvy=XtjF7 zFWfa!ch7>In#NmR)s*_C`NBIwy4tURI5gfcl<_bw@}A{nfz2$r$4cYTuuy4nF+G3M z?spDU(}bNilT|EmJ)OF+8>9!@p`e4Qf_~9B2rqvfCcGUJ_cuWTJO)lHBn9zD)$qTZ zEl%t~be*6q;9YSI^4#3;BILgy39_%9GHjGEsj9HFAEZ)&6jV)uo6VLJd-8Ndhv9au zBaRfV$&gJpm=~g)w@R=Pthnc+IH7eg4DV=;t(M}jk0O$g8c#A2@0_Wd&|(aaF{&Qo z%^XsU38djgI@CBn?7925WUo;VKk5z|T_=AJ6eH}Y$CSk4%S7X;bt#rWoj%AgiRuoU zXF`hqc1gxGm>sz!Q_x)J@m<`q{_$)Z85 z+s%6yObLvcli6SPOFr9`dkGU~((9+fz=ZeD+N(a{0w63M`flV6%4R zZ_{E%WBS8=-E-f$u&8}i6H&_LVqNq`Fy+-+%V-Qwq}sLy?BzexK<;rA9F~J;RCn^0 zOSaDolIlMJ4?-Rd#)yLn;<@hS7ofv^V%yZaIo=#+icxyp&rCL>>g29WwtHk4gneL@ zBO~r7zkF%7!OdA3FkAlABxx5Vm{%DkfV#Q|+;Gymqji}&np&Gtj^VQAzZHauGImg) zJdNl+w4eT%Y{n)oR$hyv!O8y(=*kBt1PAVp;!;dLqc#FTvpZaH5hyF*K)|ixumtF0 zGKc45AdfSKM5Vk0gzK>RA{+R$y}pR}JBE)jm6wF@RAEZAoodPfPizWII#7%J`W2eL^io)Egnz|VCatj(0dvAnjFKn9T_W#&uM*Dc)v@&U}SA!9BP z(Dl&JD@be?)XU~iup7AdT7%I7ARi1m6dWqw$)VGTppq`2b)?2O#?0b?XM=F=MbDSezFp>CJw`9u;C;4mB|BQd)}%Q{DmYhtWm zSDkb3dH%{Azh%Hv`ux*IJzm))9M;=hu;6ETbts#))#3J{tt7=x_Qs=X(+!8>es}9y z`c3rNdN^}uB~0b`nUbPX=uo%r=8p=Cfr|V2;n*!Ud82Z94K5~@K^Vvp2}PG-HSuSR zz}fzOU8Bn|beYKYp#JMYqtoHuG>q+TDdVz&!EONm$A4li#DinK<^hfrv(ZXzvv z$V~=EGS{`U?M8)_aOn$)LoU60^6{w@r^h%zS9oy*R4+Q!gya5o)nc0&Rk5KfqQ$un zT(NEyYRCH(J1f(;dT*If^P{G%G%A)a`{xkqx8F4Qo69%1ldY$aU$~R+VP=fH!b4Hw zW%-fjVUkvvqgzRCPsg0-n3&yAN*C`Ui&K-LlUW6R?Xs6z*QH>0lRWUbww#h@5zA2v zRJ0@FD`fWZuX})B-Xd;!m0PoY&?*eq={k|DrQU2kAb$d&bpz8}hYFXI%YAClj@fn(ljo>REljn%SG=D`$gR)hTL&>+~Auh5=q^HC)auYIA>A$Pjp}QQz>{P)< zTx`U?f_$ubsrp$!Zz#)lkDu0AX%-yvE^_?Xm_&J^ac@-_DN2DDZz_Ey0{cWQle2A` zzdtFZ#pj@eWEz$~Ipr`vLoz*v(=zMNS9M~|@zxn`yXvq-u3wy0FNPWicWo|O8gfqb z228iL11WgW)-gXmlhF_K&bBk5>>-m5UXVpULr%65S`p`QBV!NjL3EQu4wS6NddNik z$u+Rq>S}qsG_j83`1cDfDKhuYJP`3I%bl(vhlcU!7JXcY-01d37gGx)tlULw*xs4u zAIC3|Gw@Z`zfCR|nXhXfp}r57+!&C8ewF8Zy7?g&XxZgxwUMe-v#SX+Quw43$#VF_ zGHXF!8k8laYVapUw0|=u*1I{G(p9+Lw`h8d6^h#yB6_DrMVnkIfX?_F>tEN%^~}R) zy?jSmNPtyIF;~HkD=&d1Mie`nlu8iG<}7!#8TYyvHZx@iY`oM;sf$YDD)AF>#oOWC zk#4joJR3?r8T75MIasmOxT?JHuLY90k+x_a&4I%2c}^!TuCNbhuK@wjceF==2;! z1NWkF^E|$inJo^11TKAhHggKDN-!8bzWRTF5yQ>*M#2$5v!d1wf_`DbMIH4b_e@-( zU(t+m)2#tch=$QX8TVo;DtQ^z+Iq;nZp+N`wHe(m8Gh*obqgF3L7txhywbQE&xq<`~U2 z%ic1~_ei`iwY>3P;AWDGEkXB&y==LCPoZBAYlSMp=ktQr7%1Vu>v2FQK*X2h*PCX7EJZ<`G-T<6|*?OTj3X7@HOOoWn8#8 z%B``)!|0M7Mm%i3P$Hc@Q*!x2CN#8?7~lMOW4SLWMf!n1Nn%=%+Y1mC44|^bi0E6# zQ<1T6q?MRdi?P?cOzSH)K)>m&CLgl$#FzXvDOSRq+=VmA$y6zaW%%b5T-iwNdf9q( zFF^kKa%C}rEO&mgB_mzIIz&L^EpbRd|1Ije$UJ0=-TUhciZ`t6%tvFdM>ndHFjTBe z$3>Hs!Xr+f4}f1e1spFQpYinp@RymF`EPsCoA5cn)u^+aTw6jJAnvFQ%sHA%dD9W$ zjZH15l^l92Po%(dAp`?;e^@)|;VT8hEYDe!g8}LM`wSOhnl-M-==6nrk8!z*W?&1k zP)>fUSjVoPKK2(mxov4AK0*dKrc%Sd9FM5fy?*z`F(>{jCU1!ZRxk?)R&6Gx=p%rD zRsw=*L;qJDnOcJm?u(aPt)oy0FpH*1$G=o4E+kRr_Mu{sfRh+1?pKOx*E$K|yDSUI zQ+NvEukPa!JA{w88_23<39b+-wGWq1NJ|f>mbfolq{qsWi<4vYdKNerC@xe8mx^Nf z7`z3rtH-henPCvatci^PeWAfMrs@u1UXD#bB_21PmG`exPI zZoXFXsY~LlFr>lk!#_dCA$9u z1L#TZ3i8%Y&6^7AUGLliRi2=-A8h$zcMTuaVt@4Sn0Z zDiU*X$@#(8uck<+C)qiQucQbapUMlY(^LYg>n5y|O#yzou%XB4D{It7t`w(yhJx!- z9NZg!fCzj7|0s%ijGa@&s@et42f|mfGPx%7(jOXXniPQjd~U##@?HG#K_EQ$JwDfH zpd~>gaiDM$4!c@ zz-G{CWRpW|&5%bgidE#56LMvfyUy_$4U)1U@%&SlyI2|iXQUJ9Vi@e{%?F@vS_67U zXr%V+=02&o?D_g0u+UQcvNQ?km`OU2XiBWbD6{Ds>`$q1*iBLt%VY|YmmhVh%`ql0r!q11|Jc7?U)DYG7To}jk1AC$s+f26 z4KLK}q}4GlY=>RRzFqi-wMwmmnmBv;X|B)(&K_8?kt$d3)*CvRPVQ( zDHp=29MDT#56Hu)Tr?4zn(@Oa7ve=cRdZ7m?iXd-MG2{IGJGdgoUG)!%A0!*42=3^ z9U&b^;v8>K5{sN&)}Qy6 zI6koC^r58(YTf1o$fs(yf>bIX+o*j`pO6}^!zV`1-Fd?&CQ(8TkzKCkr^rNw8Tri4 z{SpJk>i{#^>AtnnMXKyupVX97=W~t#S}3hY?OKzZ2`Un*wgI;3l_UF=_O53H_qi!4 zAw=mNceG6tc;z(2#erL(Vm`=@i67+;+m7#$ofe%&VQJO#lq=O1DrM49btTK_=tnRE z%HK4<)vDRHd5Ol9xxIjsEy!m)YO@_!7)oLXhLm2IgPR88c+IFfkyiFZ)X>_l8 zlm@RNaYlk`$I%lP-N80n!2uvk^5@#I&{9S&SYMPTvt&ELvsvh?#G$@7^ z4&7zdCUo-0)BdL7JVDIgIn)zc9B$43t9~~-(vpCCmPZuO9fzAVIgIg%*4^Wg*8OqA z_PHN+YrEs)o`>7`uchnL_viYCZno6$8_lJm?mDY}21KJ_T1bo0fBI1Tb zJ2|Z9PcS@$)a(!UL(W>Z+)kgUV|LB3tNX8}=P%T?KTP3iERv!Y){ng-;^Cox#3vz{ zvlyy;S6WqyOlebm!GAg&xJ98@r z9{8_0{llUgSXo$LEK0~YRpoykCFa7yYm}WE2^mv!l~H_q@WKp)y!ixC*(PyvHj6} zt!tUN2!vW5hbBO*0F*Cmq3U!*sn*^V;5c~(e!45CuWa1D_kC9Rtj=m)Uk)Onrhl-D z=j=`e?L>Za7W`CHOMYg`d+Bb1@|>hBC(KDfQ(v?#vH3O3UYiZDTkhE==JpLLIl{`f zlo0bYURmF}iOgO@j2$3zahy1MNmLiBv~Ds@8j$dED#`VL!OnvR*Np@;;60!yimlX#Cd(cyIroxrW1l2Pty9izr`oa`j8OwCbg)Oji8Ty?I zgyuYC_urM0y}%9pr#XqQwWfxdSZ}_r%HqfB;nhBt@IU1nP)j!A>JmCW>XfBr%WVsf zb3yK&vzicFC=e9aD7NZC7z#ak!`(#+92*Lmysfpit#3&3HBo9+!yI$)JQCcny+#Wct> z+|umc@>+>aL*CTn<5baAJiMOl@wsC{CZB zvew(`|0`YLzoI3x{U4+y|L^Mx|E-q5^51C*|G)UitZWSb6CXMGKZys9|7Zz&^IMS^ z_f(XuDO6gnOu1OxbXqe@s*UjVkWxG9#fjHR-2ZXeW*&Sp)=P9*)!bJRc=!|(Gf?z%`mPo*}g~$SYqPoCSEL#+qAYk6}ldGz|zVS_b}Zsd-h*(O)loa7(MX%?EqQ_=!GQO(*oaevcIEHqZm zFgv(qsw%fGZB+BynlQbjdMMT-tMi3U-Lb5H=*Ub`SE4|HN3D7J`9WvfwHL-jU<;{U zyE%E;r%u-B9@prATbadDM+QLhp7!;{eo>BrW^{qxI*lzKRxk13eIr%w30L%3=l*ZDg^n7R*bna4m)b_;?$G8&1-9Y%;X21k|_e_8cD^4FD| zHifUf2U%KD_zl;l7rH(`Z=9`zS@$rS_ZQCJ^7EM(L^s0E^REkb&Trl$&HH--#}|m| zel+^a^98)mA7cnd|6Jv}ax3cMWM4K@q6ZFJC}{bAaOjXGP0V3zL)xI~=|p6lZ0pM% zr{Y+(!k!DWH1EvmPG#>NP##A%ddS5e<=!v{%BXkWt8kJtJm{(NB}=gkk%Nf^@h`A~F+pYnc0_rW-zZ0Yi%;bh-T1SP z&<(k~M|XPbni3n2ZSWk}nD(~hpKUbs=ZAv_5ym+(4L0N(D8r((!N6IrW>4Fm?utT$ z-~k^DgBbOE)FVDx847U44wo4rFAHiMt^iVOl%I0{0-r&uldUSC)C#*Q*E7+$6ke)_ zqc*W*&EzQ=zPBSysz(3{%*BrfXRsxN(DeBAuIsgt_P2m&sMCyPTrNzgj&@n(g32&0 z1uX;IP{%v6j&-RWurw%bW4nKkfOBlrlPVQIXWL|7OmhX6z>3`di!(}CJiLYKYG+LS zYdCUj;*nxX`i*L9SFFC8t6cqwjT(Zz>R?ObJ?s|R{18#iVo&o7amAHc4I z8qyeuqBrnLJdvf|sFdA7?fFdp?%?cjpjZdLpy?;E-wht+&QSZo-uY)7mL_$Esry%| zZkBWOhK*8Aib2W^>og)&#~@H!{v(Rj0~Wtryw)}q$JTik9jInkyPH&4eus1W?SN~{ zRo;N%fH5TRY|D>_r5QkX%DQkm;p2?>tGjRavJK4eBpv!PAOP2wtGkdru)1q-I8EAV zmAyG!RzK)v7{}j8$=9=HbVS@`c_*D|LNR1ik)tW*ED#cFfiqo&g8`3}ld(3XrrX_W zfZ<`SLT{#&G>R#QRvfqoV{EmO3fD({laiIe!MJcmq(4bx)F%-ON$6Bt@kN{d+D-#t z)KP!m;nX}*QgYth&{^7qg6KE-0ApJv?r{5(cPQ+zRNau6C6P4GGNkCB07SEMqzTqw z*ImIejy%dX+2nlSFrN||`d^>o_R&VeX%migoL>O^i|C0yTm>eATpsbfN{NdOPuj^v z2g{)=zF%6r5EM>Gy(OoMrrwSwJ)gd+?r?!S0vkZ7@eQye!}MJ=E1nGR&bQ7kEg+x1 zIC)PwbND4qgNJp&HlL4#>By+;Z_Tv2(eBHg6FBY1Ibf^vU28}QJ+c)1C;$PZl*1_b zn}(Kb%|B1Q&_^E}-upypUqf)2PI5F^JiOrX^!D-FK_1s5WH4%p5^ zWh%6H&Dl6CXtX=KGzCSTjMNI>Ya}^YYWvUAF;(eP>X_<982@DFpv~@>!O=$Y0J$CcdJJT>F9i7#VC8;)Dj4uK zmJCRCiNG=*(9YaI0(G&~z#C2^*4NIDv>tIN5F(Mi*CR7vl4^2>8Sh>ZBbIJTymX9v z>Cgsz+`3~dqf;%^Se`73wzG;O61HwBr@fMO>3HVxm(HXJ?$zLCeZF{wh<1yZreRsD z*H>A=ABk$FzrO*|>&Fs6yzv-lwwU1jA{;JR>=c$43lgo!fh3 zGUbM%Q3N=vnvU<(a`aigPUkAbxbJ!Ky9 zJ9uUJIjm{O9AvM`)c6KaWvII`U8nTGwa%jLQ7`ePw0^#^e#N6&Hl$ffpY@dcKjEEF zcDVujg+cbg*6~5Oj-TQmtua`{E;^Z3kjUh64#mQ*VvHXD5|}EP zVxNsUca0jh;_iLV7j!qo%lR~ixR_lQyBOGDs3c9q5VX#4iQ`#|SkIe=nvhf08wlgVq_lk;&t#;~cY1pqN(Em^rQ*%W!YzFEzk zs-xRiJw+Mb$k=m2lXtbPkb(|e2j;4}qmGM2nLWxrM-idPooKcE@g?$yK2eEqlv=Mq zq)3pYT9HTDm2Dh|keC4M-WMb(4%U`LGL^OoL7nM_3sL~49c`&zgEIoSVh$=83^E=6 z&H$iSH>V&YpJ}<}Qp==9e5rEKl&_-ULa_sGUCe>NGu?7OG%C2$7Yvssj!0RxV4Ka& zaxfdjbTfv^&L?C(OogVXyadT)i3Pj3=?6qC8t`=>kG&hQh$wx3cn@f91^0;6s-t?S zWU?x?;LAdM?^!IR-OtFXvEFy>10S?^W{M&*w6QD-%I-AmHUZ#ZiE*~>q0Qw*MReXe zK9KlFSyA|Po6-5>1hiLn`MwV8QBA*m26M@{6D|#x<+LO?X{LF0nj0fh@L@wd)ZCrr z!BvHJs2w9K{1oOIO<}go(zsB!nO>8fe&p(i%#ir7^(4x^5WNF&N}a2RIYJ?!fSpE! zmbuwZ&-5f(a1_B;*1WvR0bI?IvRXZ`Stg1kO+oz7aAz_annfyyP*82ft1>;)jwjmC zj>0}qu7**|?6}M#D1p|SE-*A6%NsRH(xB9!f0K!x%#B!;-r)TC%yRaAy#Z+o8AU_OT-f*rdjxwBx)}06i3Na*^LnHQkZNi7>@XH^?`T?} z&ei=8`EHipo_8t%FgIfjh+4fAN3#)Cn(_0JI(LS`276}`bolDN%Nxjv zX=WeL&XM;H_HJtF(Qjh1gx!`pV&L-~bqgjQjHqzjS6mZp23Ugwk_@cTp3Pb(Qo5Qf zLxCdh@v_XrZnn4+e%Y|<>lGkiN<0*(J9p+ae~#N=<0qbhcE&5`G)I*Al}CiTX3V4GkRh;R2Ur<&RV z?}(UBhqcoRPnCuY%!4x(XFop#AUNkJ*($2h5Npz=CCcBV{_i*$Y-d#1_ zuBS0pZ?u@OA>3qd)Y(qq^|yrM`8j#f=lP?Heyw6D598({wqcLJyN^dz&780Tg1e@f z#HKb#GSFC5%4&Lp8_M&n?w|5(fDz$@(mM3nsy3)xI>SROtYMT)ARRzdZ#-`0W&a#e z$N9n_cYVdA^j_dqsrJ{u-4@omLDTVQH<}GN$rXuhb$EXyxzS>OfwuA5?Ul-GAwbfh?ad=5T9;S;*LGnJD7hJk?k1PEzeb$2J(h{#Y?`S z8gsgR)so9R!_xoLZs-iEAWS)L#e_afB&>y(ZqMiU#yrr+F~xisn*niU<_M@!RDID- z?Sf%us1dF6;jh@)oLA{Nt%pmNN0fTY{tDoi?P^H(44lQAPDLs-sML&5_sFt4p^Iu! z18IOXAw^22$ylq@#>C>Z`csCuB#dVF^w%y-p~6D==NrKKR$tJB@NxjoA(DO@t7~{N z0IkQu%xWgUYN{map-3JEG8w~VJhO($C63P2kSg8Ce|>;{Lj`2zvFNNYEHbk}@VSNr zY@)cL&z`KpZenA@?p_V+MyKzE45LT#_Hxw|YrvX8olv1gYXr%+6CX)~PKncT#W#@Q zy$5fF9Q>W0w&^0ckh)-AX9Z1If*|Z-JfT6ile^pGP^Y{$7qF4fVFEKIE}tUr#)vT5 z980i}>e$D0`I6vXrE<(M`4B|te6h}&k)+kJ!O9rwU$!*^ckCRZPke)!*_R--dh8nJ zk#Op)L@q+wx2{3bt=ky@5N6P3s_C&CaL*r(BWWrQms?{!VGM_Du?!UGCURU!dh2SU zEmRc-L-TiKQ0t@;b@SA%Ia!hA^lsFSAQx_Z*Ow)w%}vXlC-Zul%*od~A8O!Fesy!J zQ~3GbRq(~7^z);+JnWbM@oP`cGaH~Z^(uW)JM&iC!N2eWI=$kEl}Mwaw+wdG3~2b* zmBoUrh~TGewL|yz%B<;fiKCzq!31U7$CONYUJ@hLj4-AOwws$s8G$A)%QZ=tf!9=v z#h-%^H_mWZ%v%O_7;n97k2LF-y7{N9LQ)Y03QiY(<4^a{y1w4Zb2lbzv06=vEUDRh zapK9_)U%sC7XR)0flk~IWSk5Hv=6@gb?CmN%|Tj6L8nggPFpH7=L&*Jex{!=QgRgi zEiaT?e3>6IO!j#6+=+6?yajAKM9CbTTu;+kKlSPoGhC|30DzJYX{#ZbxStuj~ZYa9e1KO zAuBxrpFccT*Ub>QXjPVjr2$+FT#~6^HvOrwFt7>Gvp^zzrZl~o!Z>YlQmZ1kN1kQ| zr6HjM=CY^v{vzAN=1e%~uR|&Dw~6WKbBdY{XpL;B%G() z@%47>+QSKz){U#a6bAq}?yAc0&F1M4|IB7n3EgU4zKtsR@&gXriuBxU=YYl%3F@9E zSfZ3?f97>?rJNOyRa=5YrFrPp1h7|fZx*tAOvpt^wYK7g<6l1)q>9#e3c&~Qm84+D zChpYb`<-YayEWgoV+Y7B*NVfi>4Gk;0qoN?PF`Y*IDe|gRs|- zu!e0zMYR*(xIhb%RquJUfgzCQ(iR@fIKl*g%`6e0RfEbZJixskAsZ|96DE5}59CL$ zr9FE;26m=tseJMvLZc}iFqB532ywXYrv-bquvya)R#W?B9M-@8F!v6q0}VMv?^7Fu zD}?$M;I(@OmP`+T3tzS(Zthf{r0c8D{wJR+f(-RX;TYQC9qFtxav8*bF zq6!K_NPc%|%s!SLHDtPj6SycJT&=Ko64b4zntlvM*2iQjs&G`Bah2}`eRif7%oB}> zsF?a#S5o(!6i^V!7J%aP`mycNRC!{nNva~pEzP-}?0?722c9Bo1|y%Sh`SLZf;{e4 zJ-=V|V3_l+woJ>#p1lj20Rugny*7x1TjNPWg_Rk>RG9uncF^lk=3E^@)8O8!tY-ZI z-TSL@gik3;GovZSFtYYzX=G9o34!!dfEVAk7}&?xA1aWUkC6(2JYmZ9k`a5A{*t4~ z+N_-}wxKmUo2w;MR$ zJFH2+)m;bnsWMeQ?xI{3XXSHcm_rECkkYo*0D$w1*kbvprTPf!H8#Rh@nvi&wB<6d zN7WexOpR@msT(`!=&;pS32o1kwbDrh~{c*a>(e9 ztDpx9Ja^3SHJvBzO_4YE6L51xwkG`r3qjNlcP+gqhK1rkEq|QU5=8$F23ly#-3)`3 zE;2g&rBw1t+3P^@b+X<2L*EBb#FIq)Uk$zgE9xuz|3T{O|I^d|ze9cfA7=XhZ0w(z zo?hP3&Pd6`S&Lp?Sd?Db#NAov-%CY1X9H&w0tR{|XGa$!=l{pM??k}N`rpjN|L;@% zul@CGO#c%UwpeY`c2oR+`0Ec0hr-bn6d5r38ko6fhVTYeO%X{x1+E{V2_*6_*D3$3>#pUW$=K1-$`Z~H+ie9AY>1OAa7nwc2i5=XlOa=aItO&{7XMbZm3m632O~oc^v_ zp<5D`v0(GG+?YrOSSZtS-@didBlUx^DQUYt_^pel_B0Lh-|H?n|7;9&tkV4(fWKE2 zB`{HsBD3-@d)OT*zT4Qo3-7ww+^YQv;>c%nIdZHTBMk=XL)7Z@ViR4iq0uZa!J)ii zZLto{gSxNHF>p>DEJNDl=1kyQx1aRY=&~IU`B0evWKuDrBBP(aJuuHteAg4BpOp#e zsGRJooGia+U$I?AP+?yRgL!mjo0*ol1$#6$2mIX3I&18o(>7#JRctG1A)+-^Vms<& ziP|E&)?(YYbM-U-W4jXl54XsA^C6K~hRo`o3j>Y4lf<8BU}0$QQWBJq(cU9HaPd}ykEkQp%;am;&yYlPg6g;yN97{DV2>H(1%^`Iq^P3p-_FH#S z%E*_86D5Ie7}QB}I23HPWygN8s$p`|QT%!ZrTysL@ca9Z2R-k8uZgqIe$`jefd7}S zdb<=QmR@#$BgLhYDQu&r>n*cxub0jh4U7vKj8HLyOzCPNi#j3}I&J)fwL4zmE~5`vu(tO9V(pxoL<^(D+O}=mw)?hi+qP}nwsG6GZQHip zxs#fQq-tuCROJ_(m-Dc{ReP_c8%q5bLA&LS31&wEp4`t-fTUv-eKeeY7hB|%i|)^M zgD7|uqhB$oDJUv2Zt)=x<}As~%EopKiM>kIE^;AOoUlw#zH-5k{9$HOX-nfqn6zGD zrUS1oYeB!)U4bX< zR$CMhrUnd!e4_}f#tAo+$o5-zK6 z3IM1oBAamOJFV^^rZt={9L!;zJ6+K*aMv`A8S`;rS2Qnc8YfB{XzLcX6>}YAykA|G zi4mMmohpw*3twR*jnmyF@b%5`!L8ZSxd>WeRb!qy%o_eb-QLO&_#tjtK=cnRRX9Y% z8hmW16_~+k+0T7qbm#x*MMdL~Zu3&GHGk9lq2gu!nEC@%7s7hkOvzei2=dMQ82Tb? zY#5l*X}l)4IqfVIQ1aQJ0K-YHdG{PVS6+-ffULWeue0JKzEL|hG`%~yUEeEv%ls5V z!XX6l`;c)G7WCj9pb(|=xqJI0zPPkEGuJV|v zvL_moN{TP$8A3bsege^&so9b&3H7M-kL+k-Mj;u+SUp3QcUfeu>yb_;f2-5vc4S{T zBoCMfn!rDpAW(bmQX>Q$OSpy%_mu#UMx?nz91O~AS-g-C@5Oa7nqqp3>HR|YBs6D% zGSJ=hS$92d8&Hvho?BvH)8Ly*isEQ}yi4^gfA!>TR+^Ts z(ldz~`K7qg)p_31t^%FjCQjKvWaGUWZS|BCPU6dA|3!cU=o$g<5qxdBmiMSllmv%% zvsz!bFW=PS0cM7OZlI%dX1&aju-kB!@u0l*5T_6=*YqYIn-5G6jk@dSBWjf1UT3 zo1Ycs3rA6nYc#TMFr^wV>pk#;+iah^{^Tg6 zn&+p6LDw}L?PLC=4`nyvRzZYm^FPNtA&et^fEtrD3DD-NKiVp{Kgh8&9CW}X&~B#b zLOY!S5Mk5_0QdD_IClbqZuu?l6^+4(kzu{#@y@Tn_5}jXUuJZf=z6=;=}2{0?w*>gsE1`qxwry8FMFN{t`(*u1^Y zJ31yRq{A$CotqTTlJn_#jcd3-ja3g1h+b=>B;=8*Pu7c#HOR&cwA?UE26Fi@c8C4t zD{}2Vc*j6)2I=mJv4oP3y)ZpKVT7FOIH6#+x^2<5bVB!8$57G|UE>n4Nh(vo#y?Wp zY-emea3C#0GPqc=34FZLbevpj+(R70R_V3pQTwWhO0~r|?du7OQ^*f@A=NN9tTj?y zV`)Xy0|n`8B9YfJh!sQ<4i|K#E3Bp5GZUvOi@5>nOKu^~mxKDl(~)INn#*pRjLZj> z5@-%W#iN{L)iOm?uxW1yuf*)8zeY-<$Oa)~qM+G9J(?U9qbJcG(0RE`7$4O{;Y%_7 zi;ju_*(Q6c8TzODBv6~hD!?J12vwIoN?!NFXOP~7(cUi!1-JRqg?sIVZ}u^M3bTj_ z_qat-Ln&m9iU%u@iM>>QR*&rrJT?HZ*`+bO5N9eG!lTHNhdvo2;%E7iW{D)KX<{P( zUwzDQeknju4d%2NhkSxPO@)|t!BAtD5RvD&@SMiYKvJ16G3bE?7DMYVUqU2May@+T zqsjr*x58Il=C-V}|2T26eEOZ394r0qKz0UrtH`5XMbIm7%O&XX%U3kKPu^Wv zUa=5JQR<=hvz5f|u^3EB-@@-qOa{)m7uLdnJ9`u_vp8cGpRE022ErC)X-MEHWCpdm z)aw&LmUoc$>%`dN$Q^KC^(9~?lya7?j4aa zEF`X9l(%+yPITnlvErpaL|C}o*?74H7bW~e`MD8Oq!$71(PTNbgH5N=I`M(T(K6t> zQgNfh4{>?Bw6+Eq5^w4W*tyZaDW|K-bAKsY^Vv}i1g4MlLNv~NK)}eB7XZEcYn3+k z#6jlB)=vNN=^y`@jwt61_fN}sUSMUzQ&p?|El}`$v|_MC+!R|>*Uz!@r!8fgo}?)! z?X{9FO6+eUON!HO80z01apU*We}F9I*^Dw#TT0rlUU)$zfIbbKaKRdzP$z1mXwAve z4Gso1TbH)+Z*NO^Vu%8(2NrShSK%3ZPaIXx=XN~i09oP0gL$V%SIzYFK9NPE?{Bt& zneAM|zSv2YUztIeEW?7R`lyo61fpDpMorvoNGaoHbL##2b2acW_C>e18n)SXmy61y z%Z}(Ojh?W_=#B>42O)tgCu5bSvf09Fbn%xyqNVs$VUzBgDo7?uJ)S#eZ(i=S_zSEq z!Z|k@!AmUcJ4jfbFt)wRI+Mf+g|8zaTIwn%a9(KmLvH|+)7qZc>5}Hhim!Q*qvf&sI#7s``4^6S)9=Z3ggovI6wu=r70L zj-8ei;*VUt{?<%%G%32Y;&k>=nL_}Xn~<7=LUCP;h}3BHLVYcp9KGF)?TmGJ#ReUa z@U!pS3}&;L;G8nNFvq1O9rcfOE|%(U@K@!|@lHGXoq<2d4Ky>&;s{|M(fm5|Pb5kt z7L(NzkWgaxiDoA24BB9;K|P>oa364Jr}aUj%^8VM$LV$Y4bM_Zf02qn9$Ys6gfZfv zvKpeJ+h63QJHk`bCk08#FG#AOiIEBtVfqbe4l9rcnb%GN{Mnv4jx}q_o~waR_(oRA z_00d#j$BCS&`WeeRqI+nz8t5rFBdONVGteKM8VfU9}dA9l*gq~tNEmJZ@GTe#%{

Agy>4S4f?0GQitfp0FAl0> zU#f}uD)G6D$Fk`N%KLXqZvvLML9hVFx6#kd&9Nr9Vc+G$v%$Qgu|pyI1+9NoE%@Q& z&!I7>cT%m!Dkg9-MNNb*%osXshY#9c?OQ@6UzmqqmOBc;Z@;si$b?gKQG z&)S@0Ar4kh=1oo7>dP?s0A(^G*$vxF}Y&ZyA>3MGy=8D`vK{VviwfGzRhaZ)P)UEt?@}cmL zBWuAZlc=aDO9omXcfL^E%WikBr3F1SQ7QmZj2`Gd?6p~sYOKpfTPe4-cUPn4G zKH7Ma%`cOs*G!Do?jnRg2cw&nV9^|#45O_ENMzqRGJecZy#w)yyN4TfzR_kY(034l z;zk&sIczhvqS#P{iG8&Aa6v^hQ2yFmHQb5QOWh;1mN4EiG_OtuNqC8bD*Lh)$xq8C zCcW+6Cyt&6Oqau;a!gRHb^ZYrB@SqS z!JfXYTtOoqZ>lto*_v=?^V_M)@WcXaud#m8XNvHg5eg^lKux-nI)h!YaQL!GLfr9j z^nldILLFQ&6vQ;n&pLfPe5GY0+Fo4<_m3>)JHStYx~k~kECu_#g#6i4SFZYr2WnZh z^h@a|Q&a}~pk97+H@QRjgcSKEl|yQ?S6hil9;Fylv1DfiePCM|Ww=-WSrtwo--^lv zlHWG>*VU-7vd&H0_hj$BgpSa~McQLzCJp0YwTg4)WRM#s+mr8@Ii8FkR2Ddd0CwaS@C=VoW z4b;E=x0HD+;(5YBEmVy;v#l^c53W(VJ6=?_slSIK5@eF)8QpG*Yl&{Xaj{tSr7B!_e-5 zzdgmkbU%V@WFu=6HEpuB{2NMFnUS?(Y@gYM4*?>2=qw^q{QZAoLXJNS1;H0Z^!Vr7 zA>pH2H@xbF21|Zew%*wl$kp)2(LB)gTvD`k`-+I!LNi&_h=<+@=5={zx<3dE<*@6^ zQ0;GVhINZ1uD&CVZEQ^(Oi)&kvpix-npiytDtlr<465HPg=Oz%y-|jFCilxK>yCh7 zW+NSPa{O%z0Fv9}?t7fn^4H@FTgED>DCg3iqz8}o z$9-mzUT>PZsYdfXPb$?isvfAgO=-uED^p9)$yndcL^m9hyayt+Fgj!Euv_>mFuC3@ zN<~Lv@?z*xS?Ef0x7YM@JX`O=%=*w1<}YPQtRMO_Ni&sAU3Cw`M!tD0q%{O%7Kn`o z($ZWE+E%;0xzea+O77r{RbhctMB-J+4Y!p2JAgu1CF-Q6ocb>6kflCN2zG+lWH+=5 z;P~{NPFZv7^jR-VT>S*2J7Whx^-)_Q7gF!m>7cxQW&s^**2Q7bLLYl`bTVScj*Mb) zUj5G_%(mh7`zC%oVqdZNbo8NAIUeM&+UqBN2f*@tU^>9gCm#w#b`|uKVXKENR_`q^CNY6lQyeV&vkFgy)^?jFaLfKRHW%fmix^V_Un*|#H zbTmn)h|%kD%$abVMT)A+IjMnmQA=v5xfW~KTuLl$dVUd2T0{(by$tQ1spWOZCiruw zx4e8W@+wT&L<#$sj{~<|WlA@;alQ1($@E4Li?q)ZvAu#~hD=ZOinm01!@X{@qM#?2rs?MlEn* zcNT7u-~@l$8?EO}O__UdW9DVgI39a5c=~Ga_(Lpu-e76oYn3I!3gB4E5i7MC7drte z&wQtLbp2iN2ON{yhFS=3_VHxGNKx2{j5tXkDbaMBnuQ~g1?Hs!S$3VB=Q3Mif9oN8 zq}rIS5_yA6!n3oY7DvSFhG+^9NFTAFZ=x$q8iLPpI=7irqWKSJrO z>rBxfR6PpA?vVYFeswJ?cnfe)`#FQbq=7+Hu2rl0OzmGarj{j04fCED3F2po^y zexDf>gJRDzj(~`G0d+=OzYY=;mYF4~joV{`YxtY%JdBiQyCvyuKk$_!Z%!mUh>LRj zMb-z1Yv#}YFDNtUD)^lclSSvC&w&cvvA4@Wv7uOro(M=7no4t(5 z#2%-4slJPfzGt0X`RJ#MFYvs< ztl))SYhS6f)%&T2;impfw24njQOhd4X|Z}k&G4>6foEWIRU8MwUWZd**(}E$qwI*f!@&-l^^!~+#dhupUDXHM7 zl()j67F=l~2iLq1XzWmNrlsm1yc>igz(Qki=aV%X-ZI!{(!a>j>V1aZ3Ed5>0mvvl zVJM6_7u!B`ABcf2RDV-*>RGU_6PDe?LP@Iv_1+8pCl?1VhbI`2KLgjFTLA#*2dNu| z{%QH3Ee^h$ii>-(fXVTndm#fFsm1`P*9?1bbtA+L)(G}x(BSBT$3lz|^pbbSMDQ-R zNkaj);O1Eb5SxnyguC_`Kp*?W1+}XRdt$-?$N!PpCPgXj0fpL9JR$K+SCsY)izFuh zfzATBN4%>o(sZRgi);|rvLEtMGMgHm2TrabBFS^nJKN6F_ONhiGyF^8A`X)yp7tf! zsbvq1wa@!aT)g~3ftKfOId7l(@D#{8;B+_Fx$=~Zqp?c9jyphupeC;VlrRB!0Fbr_ zJ`mY$O^urM?WF5Q9Sxld>yt|z_IMkOV-E4H)lcBfbkU@ zJGF@6t^c9{J{jmiLVY7>=$dD9X8SeoYd0q2i?+qjuT0a2E|O>grZ(++BI4Y|R5db1 zw$C{Eo$%D4l@GPNCGK;OeM+!y$iuvoBPuxtZ6x0$0VZDLfz}Nh@0n4yZyA&a$DU{k zqQ2Ul-=n29Om~VZfaIKTKsHj|T2%euvLZ8f+%Q|P++_toQsOO(jc-eS_xsFS75eNDbbkfqRPf%4gJ1wzim7sZ)~kh_Pv zLckY8CxmQYhA|cB8q~ODWtvq=lr}@f3V7tg$bP+( z!o}MMvsVC^LO2Npc1S+_>AC(FcV6(AywV5T#n9XXvYn9vlY$2Ccga3}M$gaXSd%oj z&iTAUy@CEgJvAb7Cj#7&UJ)4cY5@rUz2R$s6OrO-w1%^z5G#xx0U8Mln{$r7o>$Qs z($4#D8g~&2CP{jmXW{nSSyBme;xkY*tESw&;GV^%Y9x~4jhRQSH;aW z3mnTZgEu5@q~}T{z=SAYqs+Yqq@EUyfb}(g zx+GBf%qjXME3pzcLF+eROB7^G2CwX3NyYaT1A3c~94AXOWuY$F4;hiAxk#p)rlX{9 z*b|v{iS)0(>MMJ3oeZtL4>iHEH_muWmuR|s+&W3ce9;2EpNp)-i4n}ua^#&Mc2Eer z#LZh&5>bf&Z9$7?ha`0LwFe&Hh6wJS?NIc74jI2qV@&4v96gWN(3rCuWh?qX%s@0T z42RxdwXgHCxnmrMG3L&jPI+G@eZ#vg=k=J{y(1Nc{SsdqK}v~wW=Ybr_E-Y|M%UkJ zu$L)XnMqSEjYa;Y1*@5bjb4hC$0(ZuPfyIf7Oa*R3N3iu>4cj-$S*yjwa0#*ZwM*d ztbL_f<)`zckc^aAe>IcfX7ZDQ8wgvGC^fh7bSL@X1cq6pW13J$N28oT`u+XN=&6r+ z!||NAi?M*mx7GfuW}{~4D0#*@UYg(f;a~OD!b60ca5mQS4g|!Q&Yr5CI?iB&L99=V zdt{iG+2RPyYly`Y)fh*>yV!TY8ijg;=yWP9zCWKIf865G{>s*5Vtv(kV9V3)zEd;N z<|>D)8U*c!SmP4yUL(5Hi~-OqIo)YL=Q^TUMk3)`A?dT5(gOwlQO_o~7|{KUL~s&DE51HrUmP@QUd67`IAWVIWE-%ItCfGr zR+{CBG&HPiI`S-+|b6_fSGMc72W_CAqmYP%v^|^!)dvVhRNjsaNK`WTh zIT%d8ib?=#g4Lc%mtR7B5D8-1A|-ujiENQaavd~yN;shjDp{lQ15ZOChyOF-fsSXr z2hm8m_@|W6I3i3byId4Ku(Z;ghxnklC>)I+DD5ib=t?F~Y1)(Uxo)R98($_A+*wR? zCya{Zufm}s74Y@Aak2+GyIQlDQBVuZ^1n+(6ZeD>0YrZbIEB%$4amwD0lf_yThV6^ z8%|~xPy1Vv0%-5t78*<}MY(Rx87Z@=y$Wz{v6Gmc2qh=_5wSr)vd(jBUOi}S$Qp2E zK&&mu!xq-~MCq12r6i>4+^|&iAg%D&=!TW^>k#F7jgpM9yiJ$27SbAitfhN(69^Dv zOe1GSJtvi=>f&kPJTKq`mJIeJ14(50GzP~uKQkK~w*qp;K5iYJgV|h$6YIoWq~KpU zpt_h7;COVicV&|WKva2(vKlby+T>j1)L^f@{SdMQ!WqL&!CVoB4_O!z2|HrCB>C*l zD#0%C$)}_E@%E{(d1=YHeUrV!aC*++IJu6-Df=uwtFDbBz55iC+IZcY_ccE3!MPC0 zK=h#A;blYSXeiwTL@@7Oc%F6{u65`ni~HVoYzj_S(dPScc&IfEK-GhZaqJAJlAk=N z4x|l5HXt6MYjcZvVIC$E`SJU&!1@B^3^wi(5b~dQk5l3jlx5kyPg=yN65_9G4}_@k zD@a=PsY%Ddzy*`!;WX&QrL}wryfYI#$wW|i8ogp72Mh`GxJZIVCRouH2LX_W*~_?$ z2Pc3Kc?pZ7l^}nRKAa4syV{ttRHg?0ty2l&fFiMQ#O%+R(+GOWWk7}`^SQxac zNhmT{Z51+wp7T{cq?RcP%9Du`N-Gr9u){-M0aghNBP6+GkqFeBDKr0Q6Vb5rDU!&N zMd2}P<7#cmpV)`+uo1p0Y$7IL67~+*#~;7Q@F;&|u6 z5;kQdwUk<)IZe$nBXnk1YTNLm_-L{VVb+D%C*i-QYW;oP3*m}ooyJJ0NeMPocqtDQ zx}HNv*R(!lxkLw8E+>sf;)*;w)21_`4$dZhEoYp*lf!oHQPN!W37DiJ+$0DheI(Hu zlW*S6;u}Q=iQ=hLJ?8Fe4l&jT4NXr@vM+PJf1Zk1+p0Zkw?Pu*L#T2y6wRi?N>P=R z0BsWEN!rW6^%Mbnf5;Xm?oI@eTD~6b{m@T{f-&DK z4eM80ah_F%!Fn!~^lcc>zzH}oFNo5O9f*vqtJGa$%v)3rMc*Lc01klbf9UU37B<-u zLvDXic`{?tWzg6i=zuw2qyy_&EyQl}6SOI!TB2jcn{8mpetmV9wJZsbDbm3{45cc+ zX?G7A(n$qL_W9lI=_zK z5WDO^)7OFB$w=arn2*OR=*zZ@=WdX|IYas`tIP!MM(G)MgMmBiKZYh~A!`2-K&Ef-l$piGb1X%0cbcjjPpu;MQq?9`i4X$8;}^U9`y$`TPus ztN0reb{BtE&ZC>iU6>bV*y*Ot@)WvOPLu2YVB7>V$G~huqBAk9r9K5~_hlhMClFFV zE0Q1siDB5EE>{&vjHHNVHaLCFxgX~DkR9Y4m)>O>r%LvnJ1daKo*?-S2vHL#G>%w# z#_2z2K@euZI1vsGBos5TJ?-br!YzsCuxJdcrOKLqlfeE=D&&8=9 zlKSGHI+AH4Zs_@|12jggy>;s<QDjQ9^}WRl*O@} z!`jy?DK_mLr3?1KUJ2zn&?$!Pqe%VY)<+%Xv##TYqc;Zf*VX;a_&? zJ6pG_WbMW^YAx;NUa)wqtm<-dxu5Iy(RIW}FI|VNz@I0V#`RfpZcuGGW*GWh9?{N{ z6PLm%8ogDAbiL$e8)Q5N+P;~%iJOu=rQMk}{L*p1*MWrK!YT&(<2sn>QkbC$&i=k;#@4I&M7dhf0;v4<@VEuMKGcz0aHj(Q zm9?f9<-eX=I-LW{LP0mUW-$wGAaf*LdGu^O>JQ{4cDKK#us^R5q~&ySE92!rw-_}< zDb=#@f|E36s&2W{K-xzD;t(D9c$S;(Qy{tGBse7;XMePd!#dVwFWwlfn^Kv8Y zggRM*Y5W7wj`&LuEgm*!A)Ym$*J@-k;n|~y!k0;1>qNotstXF4?sA8)T%OY3pG1En zb}npYpYfgAI6=i)98Ax2@YncmpSheY#elnihH)YvJ9VrlR?cn`)oc&5eQ~BtdJjeu zZ69F$$K|wY6S;o<7Qxuc_PY8BN^PjDQnFZp+$B>2K1AtP#+mR5bTn9jv%=3m!fI{H zSF>IVSY;}srDo&DhGr}hPg$oqXT47V7pgA@FIDPxIGCK0VCH&OP=QCJgT6=GNGfW? zZ_qok_6E!}DnFl?*scU0K{$Mu%jFMmL)O82vtkHroObSgvd=f5W(xFnv9!#?jy3c4 zxN&}BM@>4z`M0LfZw>|+H21gM9r_Q`+TLTdf7r9{?KJHty?VTYRud!e?T^1kY(r+X z?~r0Aw{Xg;ynP+KL(2Ja7I5C!z*||NLt9jaDx#^6h6p>bT;4 z55Onb--Gu+4rjUL(0}jx4S(KW5_QnecBIJvh|V6*(UK^)CdOLP)JyRn&clv~T|mZl zI1|AX+3kuz+u_CNt!abn0}LXY@3GiV!@`7T5go`SBs#m zXpDOHD+)( z;#u-2fYMEu>yk%}(QrM2<{v42_;VYS<}TMDD8){3!vj8lbqq$w z_igxl(XJ@*++Ed(_3rIyLf;+XFVdj-y1&;cO7N@pmkT)6!A=v$Z82k{u!tTD3rAtA zxMXAO%;W++hnGmW+q=*5wa8xoK?6yO&`W`#4pmx;O&SeK6AO>tCt zx#{AOQVoS_7Iq2a^;6870TyO~k7iVarf~@@Lv(qqzOvg$ZFs+Vp&J#_o0j{!hOVWR z!^)X|KGX-BL>lJ|NUIRp%Xl5h2RSQkm$Jxipa_HBJRo|Pi9_+v3E+ny%cH3%K;W`# zUFqb&bOsldnTH0rL}y9Xiy#A8HdBpv|Gw1>6PFMimYQ<9s8442 z!s=o=E9_b+OdU!m8$VSX)wD~anTk+$zuR_ODEdv;$tz@J1HR8_#lS6htU|oeY_;iM zlg%l@Aj*Dicwakni!kk`Q_i60hQFb@Smiu8?kSk)PJgzbRV;Rmfc0=t--yIkSz>us zuXA_XbwCMiY(8K4cT7mqeVSns8d2-w7F4n;!uO&N{9Ba0x!it^&>-rBaAfmq#Id-@- z4Iuo|Rx1~InrYI4W+c}sV2~n^1VxQendWk-4yq+4+oFyDwy7)^acI-Y{YUOLJq!Z% zzasqqRqmGk|6}gMgR6_LM?vYu@uV91>BW(CcW$M0jh$@ixwB^Fv#8A3d8cMc zRr|Y@>#JOpHf@6i7yIoCIldfy5|d8FB3VW$v&+XFt447Nm(BEUJ6Fy2MgR9ENu#sD z%T|Y+=4*ok{p{3%Vor}_B#T;E%BE#6LsZ`OEL(xRr^sXcI=V*g%yi2Rm{mto|9Zijx^LRmp#c0rbQ?Gv6a;e_Iv@;{y z+%N35{PsGy(LbME?cZfsJG*zL=FuWmZ+EZhU7T#f7c4ItSM%0dYF+!4Yi0Zg$dGwo z7OggQRhgO(rRnPrt=`QIYq%N%gG1T*$XnsA<(Iy=FH|@st?5|^mzv&}RPl+L-S-KT z7iUM3@5LqxwCwMT(CR(Cj`g-|+L~D}P4l;pnvH%cV}GA@&Qk=&97lO#DK(3Fim^E( zj-1kWpwQf`pbyIqrhq}!JVOblCF?%)3T7Tt}BRLIw5u zpIxLgAjJc?sT7pG-q7giO7kK8195vbl{NB;F*t!Ku3ZawEnjU)yX{cTg{9xI$5Yc!_d+a%PY1vwVO5R&yZq$HRgSLI}#7 z5d@7J=C)&frCF8X0;<{BhUkww3=D{Vhk{+UV7#Tsy*ei?I6hN1je~*=RcH-7ZBq;Z z|KI?`S6uDvlHTooPo=}Y<$n-vL&aE&NH3vUB9pG(gkda0;V}4*E8Y3~(CQuL*f_=0 zFTNx7FQpPTfIw1^gvlq&JED=qcgS^VkJD_<^1WFA^U4l$$9EdP+1^P{T&#n3$*W$fz3($N#6z;JBEP}x4Y|@ z?2D>c>ER%IZ`JO;8Sqi5)do0v?*5pdQB%Y?)%BK~m5qjn*;|6Fc`z&vU9TfAyX6P2 zc*X1W8z9?MK&PIFTG&t{soYf&al=jYO{8)+MuB{PZG~IqMZaae=S^Isg(6{MI65+f z*mi9MKFTPqyC4btc1i09L<%mj>`wrkAE=FnNkx>ty2BX^w7n^~^NRAdP|yL-)j2U^ ze$@jF*cya?rr}&kqEFS(jD9lI%Q0OIvStr#*jxaA~`g(S+A z!95~Aj?a^B94#?yi5U;$G5VmgIuHx>{s$|JN{s|0BP4e#KnAQi#BePh2Jszntazs| zKpqIh;%=PyUKAAm%9~R;fdQb7nt!ByRY|~K4^Hzz&)v5L#PRQyNw)mj^xzcTkksrK z(opzvUy}`bcZ5Z74F-iWsvA7*7+yx|9Li5VgnwB~cuWa32u$zZRQ~xcn6|EHz^q}& z32Naerl$ae@&RCfq&5b%VXP1~Zh-0F^=5)WW6Y4?{NoXT_ADpY+)t^XClrriAdOCP zR1wz%#BM;WVW(Z9KQIST{hbI;i)GkPd)i!jwpsT8FrAzEs>*10#&MhY7Li=pq8o8d~S)Q&SxCdgn-8QZBXnXuGz z0X9byIt{=n>Ldh&ATD(@prwPpUbJg))TAW)pKKz}#&rRnE3h=QK`DvYk!fjuBVu*= zqGbM8y}fR|s2QAG5H}lbm%C_|zZQOr>ku7W{DQ}Qj8kdhwltONBo;s_KH<@rEHcr+ zu(+RRh~5_1UGzHBgT2V$njN|mHGI}YSj$Kx=Yf&pqc-?07|z5$K!Ufvx+LPQM`t{t zkiij!orOd^6B;7(?{O99|PWm;h7zGV`Xi1rVIjMGZ)%_JY3`Co<@a-Q(h$o?4x znqCjv&`x(D5891SNHEm8jB0c%+Fe7RHpJ`%)lEf?##}e}Y<`d2F+X_l4FUTh{0%YE z;(Bm3(#)@CZsMTHQ51AoNzp_nI-e~sL9*So5R-P81RE>tESVHmeDgv2L;vu3Z+@a% zhexVDj`1NJUh^lLi$e0BOS|S{lYxG zr_J1xr?gM>k(gYjf*#Exj~=MaeCUBYobd!?=vG4IBdRlG+S|8LaJ2P%*$@WvBQ}6e z>`)LJLq}h4fjBeftfU&Bck~(@9bjr8o*6xOS^@f`IabS3kTaLIzpbjY59u|{#$P~vi-d( z5MD?r3E^QQc%00;z+ER_B`_Oh$y((lpPE!}s|g;_fWS$pq}efixr0#W*MR@lDfe7A z29?ce74qaGl{Wy#kJ_eEtsp4u{q9 z4!8_i!yLBvcJw{vtWyK@M}%OY#bG$lv2mod@+#51Ymnk=32}1$@HsGOFo`gp1tT6j zk>OLb-dK2nElc9;q#Ob`e74kGv=Rh}U;O57x!+>iCU6HpHhC9X_Iidi3K4oY#VhzV z<2_#}l#)3{O+4^T&E2S$4*%(x67|ft?<4bLgapad7g4(H*GOuk{!8h(l(fPf)*U5M%tL(T?xi4t`(8jGp2h0IVW;pAmx^|mka>$#EkjkkKBP*V#~A2# zietieHGrML@L*9L4KSx$o}Jy-~*yt)fh z9yqQb#Xl8yEG$Mp>-r8zoo1D*N^#hdYG7rzf}Cg*ZKB9Rqy&Lb#3Y1a`4hf!QO=9_ zM&>EWh*)Knpx3t;3EtSjM$TD<5bk^;OSX)%ZvM#bzrGh%wP2Yc&6-;}8Lvctcx5rO z_dY$`5s*G!K-JYgyW;+*sxiJlL+k(|f)J%kYF?vBUae$$f=ybQmlc@PN1a{~8{r#5InbV<4~N<5Xu{bHgzA`Nt>y*US|pU=sH&q)JxykrTL97sUM`6Z_h zm!?_aF?7S&LC(SnurCYL(XSthya_|GV2=^&a)Y|$iaz$hR9oHI0Nq|#*&Gf_Vf|AE z^Oyn5%MD(p!X-$kXs2JK_}pp{Zts0U6n;w7_@C!L{l=|@U{Gjkjj}cHvBRvmJ?tvU zG4QDrQ`~lr?N6>e1P@J$DyHA%x34;3-y@{MX2dJ}xL(ICLh@~`20~3C%BR!xqUgO} zd$h380(zF@zXWuA`5VFHJMi)ZyU-VIn6a>LY1&g$Vf45}kmiOY5Q4zU^9=J38f}&M zC({srNe`QG4poAN3!C@QYG6XBqnyC1*Jts(xIXoJ67tg`N|ZPiCzC^X}N?FY7T20jGVLc?(f9=r7YR zaeUwQd>JU6#rksVx{m@4(P)U|`_mWw5x%wWLhoo{J?fnCG@ixShv#P&R zzx8JrpG&;Ncsw#+Oy1Z{Sxb&I^Wp)C;ENPM*k(<{W~;=yj}@F<TAcS zj0hj{AsG;Vm!AIdull5S#-(wQQy>#G0B@gL7a9!YG+MZaq1^z2OXSuW!#V7{d14Yg z@v$tA`QX_$i&ICB8zM6gMaF09bmuZm6&e$~W`t-;Yop@8%1nZL|8ZxYjs1@EvA}vt z+&vBDLNz6vB|jnU{HBsG@f?j4PJ*0JeNk z1=gf$0`B&VzE_lh$lTlXuS&-hPVP|v!YNy#MsCSC+d!h6IEDtmhIT%it{QnYpAkBA zguvaFpT6~$*au{3%qgapU89@$qMqV{nGl4p5Hsw^n3#ZUYa@0;-R-&8Wc27fyP!6j zlzk`VCGVvn*UU^e#zJo&LUlcaZ}8L=V#Z^^0|0jqk__29uhZD6X5H;L|2%Suz%JZa zhYrE15A*F~@w`&*l5g4>#w0?p0s4KJUa&iqNeY`XYgR)aili!z6~Lhh57UW~Dt2b% z?eLgff=?hBEXHEb`UAv7bI7Z?^ZF&cAAqc|-xuZJ&J&0L!G%Pli?f^SC0y&XF^DYiFM)ZE zEASUT26F+p)7M=>8wA|7(Xi?Re@2PU*V<3o=BVYA3k(IaX# zA8S(qTUOM$jBsl$8bbOjTjDOepM#oWLE2lCi|RSQ zJx2mj6Xn0&Zd%52w`d!aMUo$?a(=C+jO(`TFKber?MQ^g*6;Z^Z)U@SJBBCjtLt}@ zZG00}^SbUPdRq^V_`Hq1E0VMFh@=IcI*rz^FAGDPq@7GY`sePGuUgojdK0mrl*uuT zym-6;BTfVcOy7{77Yz`^7u)kye)C>%+e(#aqw7t)8^+5zMhac^4FnfW-iN@Dx3%Tk ztdtiVM#&r+vJdxX-f3H4Hu)u_1 z!bk>70Pwm!LL(xsQxN!=5s6(_rTjMKyZsdHI)UPfbIfni_h2{%=xSf7db)xz0MQi@ z9SMHDo!AMW*vnq6`~I)rg9#5ueE#d@PHVbXai^^NBycBu7db(GGqibeZ&Xv|q|rxb z_R22M$7U>tr?{5t#yG&~-wpWVqYD{h<>C~IuME!neD+c~T}Y>~&b-y<{m*|}Zo7%( z?LyWyq~94V=d5^@BfZ7DyWJU(IrUB-ldpVd&Q(#6K7KhA<>3>F{uv0XP|O2grM>cY zf8VUX2A^p$UD!~T(>B6AC^fY6fSK6IoFswKIMJXQ-jaN7aQS=NirtcWXJ?>%JVemw z#=O*Z?X{izw8vc3b7ys}f9^+SBVE$7pvUW#Gbf#Em)hk@yq%icdNS^fX|1uwN1c9} zppYD<1$BB2nWIp{W@5en=?sf*<2P2zIdoLDZnX70tn73PNz4Y$u8)Z#F;B+rn&1+1 zs2 z)bRE!PFcyISDF?8c6y2`wbGolwzE{Z^M$$>{b;3FLw}@koj?4BMt7Y>ly`o@x0EW& zs6;(Gj5m)VHgC-?f^*5`$m~Sr-Yp)S+X|(Z<1#ud_#jCqRe~ZlQ@SK=TQ3+3@T+Jr zXPdL$DS7Fqi!7O|ub@wo%7Z1_$}K(jj#whp{2OT27Nx2buT)QE{EbB#8m|572Y>Yx zKoSnyr(!vB&v&Rxx2B`6+8Q(B*?MzVpDq}v&fU*r@RiF-{_J!JEe z8SqmnA2dywYT({ta%skHBUgLjKmVQI-%lZgp${Hg+a`}3N++9A_2xkeD_=`v2+1@5 zn#UL~7gr|4EmOSys>!J;u_nbxH>SO=@tbK5q*AQ9vQetAp!pRJ+-&~1uSXV&UvB-? zzHgX74GHx7G2Hzvbue&o!avWE*R}jHsevLrN{v07Po5B6`9k+muMALS9WCUfMp;C6 zVt$BR0CQRPVUkP+s{e>*)ywK4t6_V4Sf*hU3qoiY$_5fyFK$NvBQ3WOs+sC-nRsVK z_B9q>>rwEsGoX!1+>kz{sAE}I8C$>V%jaRzT1>d*QLpwio~Q_*B3Co<;1YxM>bD|X z)F0}9wEk2jLYZTvREW z75zV0d#CQq!fw$vwry6Nys>SkV%xS=v2EM7?WAJcwvAnD-<);voqhIcZT*9JImgq- z=>2S>WvyR#43{}byZ9cIacCirDp07Kt^2m6o?TR>8qo!VZ%!G34yP57D4yk6DAKMnt4oyr>_<8xsp!L^pg?59O59SaQao z62ioYJQQ=jx8M|1pQK;83s7f06<3C@kJ~J*6@O1N`UbP(HCB{hH|o%Qb1vSo3?q9P zl=LfTS^xIArDYG5^OaaLda+HZq4t{gm8(!!Ri38OX~&r2548CDT);#X8>#HEvqGc) zRg;4Lh+bk&&ipg?Uv4c6FJeO)8kBnF;9=Z-&VJFq-6BqR*9DD`R+y|HUMR^7zf0P9 zUQAO-`P6V!%?Bvmy3tfURtMFZSZU=f$YwogpavrZV*Fp*xnSogWy>gaty=Au3F#W; zr;;uhY34tJjiSOKzr4GSG2|5Hb~Yw#`fBkHY}+URO}HTTe7C?AIxl_4+#5K+VDy(C zR=&Q!yQXa8{?_D;=a#i!RoSGWEN)e60=;fI-Io;V7lz=te(tthtSwW$FN4Mb8kL*X zHsGf;Axjn5b?+?i4ex8`W%8dz;quo6(-i`Kx5~0^bCifxp!2U~)qHv12fB)QxJvT+ zI`z}}$nwUNK*}P#S0zV~Fw+f)*0VCUC2vpBJjfywOW1Hzut%z2P;NBeHp|gM;9>-# zf(*D*7K_>GOxyTuhj8ngeQczxx&AU9%)Yv}Ytt05$;;)YP3Y1nVEn-vRghS=Hlvgq zAEpwA-SX0GAjp*gZ!((8r0#t4PRfYfsQo7G15yAoR{T$F=0630+5ZQFzyHH*hU5Rl zX8x}tzibSg9RHoo{F4y<*Qv$7aclCgYCIJx382eHyC$MqdB2+DA|gFBDH~D(FFpbu zZUyCPX~zt(RcZ#2XH4hO_Nw!GEp$B7LdkluD0ezCIAilqdQF6w zY}A)qIeF*pBieUo4j>|#*9n)8anFQMS9dkkiq(U)I#Nn@-G0%>fY2A_&+~$YM#t}Y zX}NIxj{B3d-qzl>HmQie!z^xlGKz<1{vSt?rO}3}oT#B6RZW(%&%lwVK@7d>Xt!K5bC)My(&bsrZ)j#uMcluN7H-m&u z9j%a?{ekZs#2c3rJEe^iWYmMD@~3Nd~)LnmTS1xpRCI=f1ei#=-0@8roD>S zu!lp(wzzMWC?d4`+gsG|pmNSQ79*HWtlt$UDZ8(44bdIFuc|53)()>%8{A!jY<^`` z=G&h7k`}M}6sO*uSzhN--Y+EY{##`z%6H^sFXgGSVlv^HQsX;Ga!ja|XFdG=H@eIj z>LpL}aa1nYEI0cong#j`o_KP;c^lEi5iaP;uXTyyP&mZ(@F2tG`}UaWi}+TNDhU2!YdUF*(B8G>;;Ve;ut-- zEQNlN;3{6r?MlG^a#o0Upj6I87;#g{Z(FaVG1==rL{3CKG6D-^ws+yARMim&M4o&w z`TBtfEXsLE!Xg2RI$Qu@6dCM?_c&}L?CrdxtP&h`)9a(S`$z30Epj%vO}z0k6U>gVm)!D4wFg>tkMMC8N_>Vg zBu#X-ttTbBbq9_qFvD1%(L7sTG}*QAdiH8_aI>W(az+&(%Y$LdODn))oIVpwg0B?k zR4LD*JjUidFAE5(icsa49)W-?L!~I9E({fmS<~05)@mK4Z2tg%rP$0rwk_~IYr~Vd5|XrYEH;5$sgH**QGX-k>Z-9WxG2 z-XpNU;K2ESc>3+4;lq;S5HJ*~1dIxYT22W4!1>x5nIfb6_T(`owr9RyTxLNhSy426 zl=mTCN6uHClUqq0>f!)`_1b&}YlwZQ2#J$7|AP6~iqT@DsnPjgUh_0G8Gn~ZD>OP{ zdhnWb`UFZ0g|iLIVp|P>L)$>McCJo zBKyt?hGFRn^)kPr;oY*Mf7OxARRK*F-wqxo=<5r8%Wahrgzo;y=%47*H_8Z+2KxnV zhme}s!aPtL!;T?>Yl7-NxFgtfhX+HxtSauumnw=zYlh{M^}LUr^E;20axU>%|TPpKthzrz_j_AHSeY z`|GA(o^E+OCg&IYzF-XCjI-|mCADyV5Y$sE zdXJM{3t96{xW)t8r92kwFHp%Rr?C@7*IMnThC=LGHiz<>Vimh1XXeMdG3Z*el*!6o z4@;j$sqq1*Yc){uQ-qV0HPW%KGN8R}6cY+g2Ovb|rd;4$5k|-Y8n&bR$(zoQXR0I( zR&&)@%2>=2j!@L~nwfx=$8}jezD>>U)utm=G#tMt(D(DMZnSHbSt;D#62I!5aUe+k z9XbdgicmH*)3)KW@yD0+{p}UYzz+PPger#ESGfp?`ho9Gqw4u~oC{WEw4BnZ`OD*T^u3+L;t#mk{97 zoSr+Hj$7vRPtx%M{2DO#M-lkL{Nj$kDGuxm-WrM|EG@EbxQEo?t{eUQjn|1jxDVc_ zgLF`;bg4?4Rn$Qqn?y8>&R^#ZXZJp?&UHIf3iU4`!P;I7xiI2D+%S7yXIg4=?!ox; zuwHQH*c0jiOvX4y)4~v4n7>()!Gk{upUen_V=xlU?~i&%S`AlK;X4(;{SpzT-jmXP z<^6sn-0=Pd;iAL)wMg_#LZs*#X+b%FE%N+FTZ1c6D4__5T$F+dXV8e!Ip|S`b|rim zihGyHWq4$I3ic{3PdoSyL)nk_i_S!yEz}*YsoiYC^pbX;BivWq93qZizhA+tsB&j~ zq3wcZ*`kK#Lxd6TmzK~mUk2NprmTWWW)O?l0;wKnw!c=GByk#s^l|<=VugwGgMO7p zJ`6GuH82P2bdo^{0_O#&%RXqXdObZn;?%D6!JKsHEiWvQQ-Wn#>B8g=^VQl2_Xb#4 zL9w7_B+$=*A$j^i6Te@YCKul+D1&3}oKMMSJedwd>oupWBGC%U2LCE~8_pAXEij*m zvJIh6yu6k4P97bM={RstuC^k_iAL00ffW~Wbz#H|i7tnYSIR<)$zYaheiCPvlrQL+ zTKJDJGnZp_(ygL?HumN_nx(tg&A#qiDY<#q_ZX`hg!J#n8p=(&E#JAAQ4x?=ex zBI7tmv|cSr^zWe^7a(K8EA%Q+F5wB{_1axH)Q~ty*qI#idI-MjX6xov{d`ro`)7wB z|79x4FmjhRhka-PMYT9t=+^h98{(XB2Av5;WGpx)z`Y5(3(}DfA!^Qc*wpZaP#VVGciYV1 zE2{B*y3wrV?EK)_zS*#Tqjae@FWV7Mf13!PEe|&JpPnJb3GHzi=Qiasy0|K8kS~oj zvS4#DoM?Y!dA{qk$qD|d!mfdCHdS`@I;M3@xP-Ey`x5WLg9N!?$Rq?dN$!eknp#0i z41Xz(s|={?LjZ@rgyhw?rJu_3;JZ=m1!?}JJ)Cz$s>(34Oj=I~aG4U(n3ZA)p5dp$A^(mu_Q$0W8hrl=hG4*n5@gY`-kRf04Q#IH#=x>x1xUkz?q;?HncE! z;5;Wo<5D?!s_K*z3swjcT4S_>Jfde(Sch~m7!iFmru^7u+I%|kR1o#zXWGjO7l*4$f8tRyTlC+xX0Lzsqbm@r9W4Ev$I-r=4*94cckQ zyhT28`G(Rhd9E32oDe0K`;}QYl^U^Pp$xV?F#32P75VjbiE$8}5QM?FM<1AK zgfOON4KjrpxYH0;TkvU>8kt$a8NZ%QHlwnqHetyKHz#nH5|M8xIlk#c!$64W2+XR= zuZW0^mvH2X>Fy8L47$%y;^{!~tl^p(3{$Lv=hNpTM}r_WX0d0^O^2CPM};>U=Mv^& z8}|e~jU;DT-#dD6y<3K9z8 zFUHNf)hJlx!nPBKmWW|W1wFTs-Tf}O2l&fNb!n67W9r?m2rBUM`l`-OcB6)B!R}kv zTwu1)ch?FUq=F$F!Qdj3ZWBai-uY)KK|0W3x2lfhEbH2d>eWsnNl_o7lE4c4xczw* zAqxfe6~=ta#8GxSk{XaVH4V~{dqsIQ4ovoL&v+a-DMv}mS?InBO?tmeLtieed)3Id z6XwYc&x5A(jO{H`>w7tghrD@Z?l9o!58PfCesJ>1UbP1q})dem)#$&ESE#8 zZf$x!w$CMXdrAW+d%kQP9{3tIdpt(1X2u#sQyKytTH^73lS_`awG|5U&68PY6uhvb zga|S^+UkW4(dzTqD4=Ns9U;)znvdg;?HQ@#jxP6nrFWT;z7{?Ft;5sbwWqgTSgo7u zx)Ybm*!RxTxz+iGG6US~F;oUmQEasDwmSEjJhnQ=-lop<`J515U#~(j5yXpp9N$Y~ zWdXSKBp6;NSf-Ls-+bB9M63mjgkov&lxc}d4?KW|HFmuc9V?tJ*5?WcL}7@bVulKf z@mVXPaC#VjQe;9g1*ia|5nNFV?^3le) zGgD8*$e;8Bt-~aoGN(@}ihZGJs)>C;Q zt{bNoDj}?B!Wb0y`K6Rhp!KvczUZ((!;33NAucnThh;|1+?}*1z9@4Gsg#G7Z@xJr zj+goSgDA~|kpO*=>8>F4tz^=BjV$HFnbQr}St}Cs+ssXF6oa}WYqmvCTWJL=G9quE zD^Z%ozD~v&BuNmK_`KaBpwCg_4I9DB59e5VIWq>Q7e0O8_!osmmh)}UKsJ)QBXStn z4u73QiGr&`nKtd{lz0^eXb*zZwDUD#0^(PL_o)Ua-c&*q!!?{KcDm~##Yu9emM|Dw z5_ZxiP9bavQZU*m>akOKj3S2OmgGz+61Sb`ymEVJ4P#b|tl0}Vw)1t4cUQ?~6uMil zs93PAYD2xJf{?a@xn7V3sJo!Us?|WtkCTJ8lh|q96S;4GA%e!ncy$qSD_LIUelb}dFNO4CC1y&W^S%W`#0Phcg1uds_f))|;E)dy z9P1p~1QoR&#QB3CSN;p+w(N&$8DK$j@+rU&6IJH7d?B$Txn*ANo!R884@_&;n;?5i zTdRc@bHBwx5RS8QgCb)88GHLzJg!BQvHmJ?s+u#RnzDfzIPIg55`~yZ;6nXU%fHjJf*<`z}W~OqHgG=IU!x=#7Y*-a6F)xnk zdNXizt)Ju51@uu4agMDrMQ_gieD>bgRgA;b`39vajZ`xuw9mMYpx@#-$q`V%DBz?`S~4+UxT++uJVymh;Ei(Ys; z;R8-N;qzr0*db#~Q)0Ikdgf^clVybUcEB!~p(SL@!DfGU)f{D19jlz`-oiAkQGr(! z{W8LM4lm~v+QJ`)hPdx2o{MG$b>Fp>E)-+X5d`rF zo>=bs1kkUGuZTV2UuA4hgjrmVaIxVZ{2EAUe<1WIN%}yRYkr-kCu+!Xq;U&|0YPtz z3V05)Rmy%uYle)2iIp0#lUzgzfmp^sL=@RTy|t95Fi-OLAFJN^Xy^_3?>B+T3Za9@ zc%g2(p!^+%>B?xLbf#5y=mbO1HtSKyRl^g|@3@q__WO*1^)>MWd(Ph)mslwpvAQc! z5u$WS^j-@8eBehQQYmAr?yk-+SPg}Fp#Fh6E_#dtGPFYKYr!_<)r<{QVfCmH$1DVu z(nHhOHd-?OH#2m(k+_TH zTQo;uMjW;hef7Dccmm?tA`i!R^D6L@DOr&0rQbq=f`Dj*q-zQ+2PgA-F6X>xRZq_1 z6o%kM0yd7$aupf zI4$dGFP!82TtPCEB-h9z$j|t1PyMed^fG8+3V>tpz+9v=zKyVY z`es<$XpE{n&`k5-ia<$HO6m_puWG*5&$NXkElR0L4KdD+1MVWTB;*AX2eZrllp z5=mS1$ZH??>}Cj4v)TT5{A~RJ!vfNO_IdkHkmEnqhuQxJ>%;%Ukc0F81Ude%>ceb| z9Bls`a%BBK^M2#WPQ)Z=>GZTBwg#q)uXpfSOuszZ zjfYBOk8Q_2JwI=o;>(8!9A^eN3Xq$1bK zCsh2X$P^3KSWMIFmegMTZOWb9IP%-4&iTXi{bty1L>0P)d|Ae*U~vV_>0uL3cF6f| zl#f4wBl{qOJ`tRtM|IyCN99giW<8pfY=QlUGkU(Q0pKrd$Q>ij``6WtU zNAslX68JA$bbZ0{;6~k1Jjbpz!|mDF!R$qYD%5FW6|1Y&n%$Uaewa6DjduJ_MTThb zAhxt~IjF|dp#|M=$c-m+H+~>BZSJ4J62~&Lil6-iD%+yq$It5{-1)BcD3oBi5ea`J(K=on-4Q*a3W7I1!L)u2cq=uUchy)beepG z&rZwk<cc>aD&w=OmaMr&-Hp$0sZ4(vEJ`0+|G zGjnCh$H2bsYiY<^H{!d?Izd5D>=S2YpTT4>+yor}9s^E3)L(hgUYXYh*1Z%a{w7+V z786he9Qh?0QTc^#Y5Ie0C4P{AOkgNB)}2b65zrhLx!jIYZb*BY1u)uhEx;vi4S1pE z(fQnVMs-`ENJ#V515`Ur`XI?8v=^j z0;^8ganMrbi*WuH5!a%d|ESKOf|0b=Fy(&5nIMLMe)XN8eSN2s_XN)&qr$1}^%7m? z96&{WK1(xi$vSDL>dcx}=@JgeVTwaBt2$+eF`$kjOjg#T7m>cy`#v(n#_Y)%^7|Q= zpVJhzlA&#V0^C=${0!ICbgfWS+ut1-vwsf1wk!lrip*|NW#boMCDT}p0p?Z8tiA)C zlt>=A&&eC8?USMSqMK|^sq8bTp7hw($1?_LZ=xHAjFQr6tt`+n|G^55#hn~{6KZ*0 zO^Er5WMUZDzc{CTem>WF8Zg;+9K!Loh-8MY83buz6#d*n+*9!0w6(_~0=mIle{vU3 z6In^(3Y~t1E`qD z3EuD^VtGCuY_c*}%eonAMw(zU0|<2TRnGnd!8D!S*sN?Upk1;Zxd0OvgDObJG1aU* zMS36)#GTHsbag5Z3Go6cj$`V;BjfIuzP8R4KAKg-0o$yc^|G%2^ckDH!5}9MwR!jp z!e9IFf6JO0OcB~uUEjrGUy%^(tz%gdDDGvgywN8^6Y6ZYTZM0dDnzObE25A~7kSaJ+WkHj8v2kS79wrPeXTRsh;B0 zev!iNi`~hPeGl3t2gaH;Rf6pGMU*<4a#BqRycqZ&Iv}+|*NF3S4_yVp4KvRIL z572sk)^wIt`wj)7U2{Hxj&eo6w5zmZeSZG3WMsxt$g5!fgKa$26Q!cZSrlt@ zuJkaIA$ZC}&weL|;p{I1753A(Ci=>^0S<4? zFK%^THOXhCMjogKfnfVR&pq?X4%~S1+#B5_ZjnvdD?+LE{<^zSrkv zsOhRx)l2i#VF(_agINKQt*Q|5G&bwDW00jl@$&_kC2zU5(a9rGAbn-ix01cok-J~X zGPN!kz+Pkf$(h&r%bEMpZxC5wNzk!~#kn+mbWUjj4zjEmFchw5@oPlY(ADe?8~Ffm`1s6gjb#PQOvOCT^vcSNbLCkQnl_t z2a&AWWi(t}aXx;rgZ%u!^!jN4w@oiyL}R$1Q{g6Ug( zHkiIUICYaMXS`dCZW&jJwcC!}m)< z6}gm33-((YCXIMCn3MUSNn!HOmmji^6$cgh;|s6vkKYH?Z7y*h(%C?DFG^Yg?3U_@ z*ai@Fjd?#sn_HYjult{%8!+aslf~6ipH`?A*wZd0p0hOCBjP6<1z~coBw$0n19aoN z;yitAe7$uvRd3w(Xob!p%Ds5CRU;i_f7-SrIl0){>5$Fe2TU^vOO>0IYGr#br&CbV zb81sgA~QEczw*tMme2_8-#^%tHLqem90U-)6jS>}e(HZSEyx{_tnhnEs5gnDjt9kq zCQ|Eg8Wj2@Xq3w?;wr7bTJreq(&Az^V*9_W61hwhEM{|vN-A}xcP?r49bCsrzB z&IV#&ipqt2Lm=BoW>OBqaC6UP%H1(2yM@}wnQ8ER&=|;>IgQQm6~eBk8>K-mm*!Dk zLp{1_qTxEZAht7itQz(-BettJ=c(Mi5VY5qB(wUqabK3(S~;Y|@UZIdW{|&lWE@Fq z7t=#7qW7ObN;zP~PAhl;=_#KmK7G}JdKkjHdsN&TL*(!y>WKs`D>*g44&QQ`U{7Uy zQTZL2nACsGmz^X_p6}%)>fQz*9LoPuro0}sR2@6iq{n4U--95UkQ@wMCf-TwyC?+y+gsfo7#jKs!D%7XzdjD{V5O()3q{~5 zv`+4r`^tT;uyEWED|q>Y!Q<6xA&H-tn6N?Vq}H;sbH%6NT*ZumlCDwz_19=U{qr5^ z^m+x}kCa=hxpXd!WR|dY$4f^?rmv40YLBf>nG|N$&)@?!C7u3mi6x3#>+<{}LZ^CV zv8Y$gIz%b-E0Tsf5`qoUO_(~&<@&UjVfrZo3{dSk%}ayA9K=hrg&Ti;8PSK~ujZzq zRw=EsWjoLXc==qv5bw25( zk~!=+BVpL4gH$Tdwor8r-0=5~vHeYFo(`L82SZwRMZ_@H+Yd(b>+Xm|rCpXkc9s9NwCUU19 zRd9pOwZHf1AJh_u@;)yL_m9<`WJP~cjUMzKYtjrIEcxpr8fao{-Er=)xp{I2meU@| z(w(j28l>f9VcEKSatQdNwKS@<+?wGoKkf#XQm!KnSLRzuzueL=qRN{Hcjjn#c`r}* zTGfE9VtYzQSRWT|M*xSYKX`@38$lUs(j$j>J@=hybpTwCb7onXgZiqdJnK_HfZM`W z{X0IddE3+dDmM3l-&RlOR2hD)P-)uaHqZXg!SF>}@i6+y4v*sws_~BYcy!>)%=L?`MoiTLFMQ8)1uXzbAL||z@-PE z;}K3Pys^a6yTuTE#Fy)|#>QY`9@)wxL0v32ibj&;Zuo}ZCYY zlDJ(TCU(>dhY`v-!!kX@MxcH0FdG=mMZlMi8gB(*crmU;OXHF?#U327C-;$Kq zwk&-lz4u~0_ta&s`#eXKK2b32j=^oCdoYgT?4wt}&A2S~qu>^8b~tzQ)<^y<`ekmo5fP@lV-fF5SU?XB*02AE{iI(0J#=u;v3 zu-%`24}SBYYA?77V$`C-hY3%!5<#_jUawJFyF)i8cskD@Pt$odojFArhHk<2dI061Wth#^zS3m$`u!_q2uXu`lH9KE*^Fk> z2~nut>2L5zU$;0yR1|DhH#6l2#%ra^9J{k1b2}*$Ky*wwE zz4<^TwpO+~buL@mQcSuN1z$v-FWS%>=7{UiY|gkFL6mQsfN|(XwibX`8yup~_7ftY zLx6~!baDJ*jF0KiHFTaS*{}fFf(fCP&FVK5B7~2w@?FYAMsfA(w{2)6gNnA^Kw)Hh zawlCpXmnaK6mgOi$pZ=fR2PyX0BDIWTa}fgGeNVFFm1rT2MJtHM zw+BTha8DK@sQf!SAiGS(mpI3?;#?w`!%x?C$N@UjaZoVCZ%JoJ2lr9snOGTJOC6~t z4e3?E>t~N87|3OI7SPT+SKv>Mw`7%QH4ICorr?Tn%=;sRNDh(UA(3 zLpc$S$LqQn$gr4^NIgPJ@v?tw+FvGZ9)7|Gq=YRo7;g?wVd=NrKO#O`c2%pKABpmn zv-WF7pP@0wrM*CxIJaAzsP?G>EPrXRljQU`g`FNgG*B#{Rpv~hc3p&aRk1&Q7n2Qj zXZ38OiF|S6e}RUs2NL#yx2v)L`-eRIt9Os=sBF&H59%-NJC$xddLh2caQNuO*CvcC z$$ejio(Ydo7)yfUH=9#UPE z8DNzIPR-%%UNt~BvT9@-c}O^m|3c<2Miwo`hjAH?Sf`lot<8Nt-$ z4%tSVbguSHWJ~PGQ{A|8L#l8{m2#xX>A8UuM4(mLR)GOC09)6OGDb*_fi>N?_?YN% z45Ux!5EY9DLTp5qS&;sS*u-|vrCnyo~P zCEJ-9=fCQaG@6Mt6;^Epxx&<$=ANXoiwZ49%-4-!B}c}cG}F`gshnOZj9dNIOabia zLQ!>!O8nX;N~12pE=RWERBDHPzHP=Ed3!-uEC5|;)CiW-NtK}6;Df7q!?H)FwV#aEF ziYRm#2OLZ2EmwBTjLb(qf{L%IMzBEEvAR@AGMaI0+s6x$s56R50p&F9qhOR#S@E$G z@oKm`&%*x7Q$@}ng-;e2mA%IHHh;RNA zJo!%*YmWcHiuHfl!4&EL-zwJsf9+i?4F3ms^1na(|1-wH#=yk#-{DD@nwHZ>8@lg5 zdzX^ zdaTOBs6*nUm?idaVYmcFulVSRscgzbM+hq+d2ND)jr9#5?tzrdkQq<0k3FHg)& z^;W)G(;>9&Qx@WOS|En{i(VaDYT7}f$U4m2fXmsD#E77XAJd-ScjGet1-si_d~&;0C*e{wjGW?raG|5hG)= zkHG02ieYprwc-m1|GbfNGxnG<(l~bNf+mJSLlNGveq*O=BGsVwm*%R-)OTp?%a^_2#g|LoTlLm(OCx#C%nD7sggRV%=uao;p8i}26n(#5CsSiv=yuC-zeZECu zzg$`N0(VI^ZN|e~91hEiapF^+cLI>IQlmE(k5@g=FxLwHKqjoKvHwIDl|X#`Se&7= z!?+<#$?W$TFhfM~1mnCb(J8LH0lUzhirt&+8lujV!AslmTq7kY26ol$g}TNEjkM`SajIQ_2simq8^{Mn^hW zOd|8tPzuXeEj%Yu|N^f8& z#TN9bg7jCIuMYss8>+s6cm_Q+`>8r%%o6o8Fwgu;G+>jL)dtnZfiANu|A2y|Gu4y9 zoEP?g>Xd(CIR>WhN$n5a3zp-_q2P$I4HA;~II~$^g)Gq8v8>ev3L<hd#$2RCMJb!$#uiSXFEk#zuJTJDHZn?X;*vA>C zEK|+n^nSGqju(eSH!N|pMNIcBw5tEzw?l=cT`)*5pIYPW+6^u}ap;>^KKbqL?I<%+ z^H1~tDHB(!Hfm=+B^`Fb!R30RkYQ)$9iJCgu3am0$W>LDTB4NX)^I0@6VSNVBQ{#2 zYfy3fa0crd-vc%Mzw1?nv*Q4DG1bzjF|ca zjW@Z;$#lqn>m{gxb~`WFs)sy;v~ZToJO&kSwksDbXX0`sK<_hCyX{wh zp`BCJ`Odk9H~uQxCZWeJ7&fPE@$YK8s&qc zT-q`5ns7HEAv5%6HCj2yg{EcEUAAh-1N}~A=CReB>FiKKNiYeX+?IBAlO#~Lq;74XCQGqQP zPDFSpTVr$PK^mqV4+<0ypat=QV=2J6ADqquw%lHjI2sPpW8%^a-b;S0MpQ-+a;Oi- z2;(uLRvoUNTTPZ85viAA(R>zZ%=|dDRv!O6_h?*^nmj!7 zn<4wnH08;q5G$${T8Ey!bI4G8B?4s7!0u>R38Z=-;yxLXZExGU72&;z#1>nRJ0Fxj zo2k_T9qlE4*Z6*p#}wT9JzPsWIaZ66Zr0REaBsY;qv{Rc&PZ=u*B}jH8l)0!T)7d#RIf~^?VRuib8}5Zh zcERR$n=mg&rJ7|sGJY>aU0Ceh&A4jcQKyhV3%(HeaMjxizY-1?;CKyTxL^owH_S~A z_@RAM#A^^>#fLPAPqxQE?RKMV$&aHQVzuyZCk8O4kf40XYZ;~ijWwG#;!#8-ykygy z{w4|`d+#v>y8$q8NSPB-PP;WMwIoIwd9c@V1H;={p%G7q!Sb{94a&-($j%e`gLyG+SX-R*L`-Fsw4s_PwOYZ1^dkt$u3|WbpNz2THy?A_^#Z2; zxQj}Th=G6mzn!bpzxxg49`8TLPZ2Au?ZPv(K170f_^r9nNy>%=S!b zd_{mP$$(%1j+m^p;$*viLsrmKXuecl z)q)+_7k*$k>f2C`#*IO z-x~1GaY*!UGftIBO!C7q zz}(J|g0w-?(huD8y2WLGrc%o+((VTU(~UPSwpA`L2m3?3A@pL6>c$s)s2{s&ooj<+ z&lXq)Rwzl$o)p!i+oX&i9z++EjN$Gh`d zFrJUwJIB8Pu|HHpQ+A!GggMIS!|OE>zi7|G>5?z8Q{~9+`#&dy+plP%C15*2c#ytd z5;;K3jGj+CPu!en9}@=+H0^Y&)F_Y}NL+TC z>9cNTvfCs+ZHae6AYhtdOLk!>+f*_EBjGF|x-mgSz%cf4B- zn%*4$32&=c%T`0mKGUz?QGE^tm6e%px7yGSwvs0LkXgRur^dPZfuV?sFd@$`9d%07)xuWvS$hF! zaY^B&w4S}xnPn8x$N$Wlc$63W@@_wJGIVvx_1TuIpikO*eq7i6%gm>BxK&(5ZQjjL zXCgXA`tnqBA0)Vx><=S$?OSZ+A4ZvuIKf7oM?4E_*5L6+(f9!wJV{$FAFn{?`eU$| zA2jjj;qYusS=H@vwi}vU+x)YVe=p3aF^!W7Gx-yPav!S9E=K6axr|8sJ<(Z5PyFb} z*@xeDK;ZA?4z!JXs>F`2U%eq*F&W}h}>ccO&(RF>@%$W)2^!?AU+d8_A7@WRA zeDHG-cBw8wv!$u#jLk=~&MR4-l*v=%`z_zIz0~XKo0Wb(p@TTNj}_!kb4AETeuqnq z3%?-m3dGR5F9QjGO2}yAL|@LZQ$2Fb7>$kA9)F(C8?`mQwG&G3rYEnaFhdUl0g-b# zZJ(}5AT_jNyI#$>ceES z1ut9q&B0Zowt!%Z;dkdM26Gop?qfe-o_7~E6yI?23St)8!tWOjRX92`8Eof-YaN$y zR<9x&KL7@0&(H#Fr#57F2h;WmZ8>G9y(mIN5_ z%&qj%vbl*1hQ|BWby1kw_15e&4TblA&+;HGX+fdrs5kvwJ}d^^rW<|q?@V@#UZA*< zhe&gm(MD7NnM%aEAK7!$+4nNcQQA1UGuh@7g2z&x99FWo08-B|4G_9~>%BFjd`elE zPx=*+6f}v7mnU`kVPN|l(%lp4IoS6NoZ*1sz~J!Al0l;|)wWJlT?4p5zf;4Y33n}} zg(d(}eQi>l!u%WK*-x5am&&1{!(-KV3J2cYv;UpTbgB-Tp6z2x2P?JMum0q*Sn&A! z>V@TnH~ISKF*=-3P``+(hKru{RrBanS@YkEu!cr*xiMgCa3jH#W5C=AaA1FCXdZk> z8V>mS;`ae1b8$L zD7NYQs^{VQahz1%GK^WQ(=OrfCq!?!k`0m|7(IIZ!kSQ6djtd?oK6@@1G5*?}s zklgZa0XGpEKh5`4F-7uj_ z*_C{r%wpQD52#l{*P`Rui(T)A=NUAzZ(~J@AXM;EU+Yk~z8uhZxpc#(DnfE28tLyB zFEW+PvcM`Rl7dqkt(>g3C>6)6JBX~2rp*^A)Q6t%VTU#5tv5*=n*F;rPqD?3<*UCa z5?+x2buYjo#y-{mrdK5R>6@NdK}9noc_PI9S4A~0{Gbd#C$ViMMGsbm|0^F)WHkG` z6|DOl@+B>gmy3ul7CSpG7;RISb)!yONfM8uRup*H8fS=PYMS~G>8UOY9AAln8o8Jw zC4H2hOBdZ3T-$S@T{XU>zK4tPni2uqa9nrD2zjhI^nS4$YnyEhu*a(`y>05%&p z>aw%dd1+8%zU#>4WMWFEIFy^$O&{Se*B!?SBpWsH(OSF^V~IVpd8SpJ+)QXig*o?= zjj*vtg`4;c1Q~*rhE~HqVT+bGL~l@mKJSG=at8{(6gTgNO=U`{1$0=vA1<6wvvrHh z%2xq4Dq|>SUN4rP>J(ihIwAo?p*S~&E~=+dNtOnyI(<3l3jkubmH=D%{-IybjvY76Srxs`(~ihg8XGoht{)=OpGe?) z?H>ew>Yjs`mgYkA>8H0_lndKkyHl-%97Js1C$lFzev5@jcZ*uGrdi3s_u_xzWxuf2wt|8|9=rpu>Du+aJK(Ej3MY? zYbRjqrb$QhFRJ)=vCuR8TUpuvt=hEG#zyA)|I4Rx`VRjju3%o6K-H zrHO^fLXd-bsAn}hEwgy}^# z)JFa-;YZ^xq(+}Y+@UL;i9@NW5fSRKr^GK#8q{X@pkGJxV_dD7JE+A6)8Vp5=2qquz6kSNy`RwgO^Ts#;`2m z5o8sZ{PNxjcPT1F4Uf^N^(~6>Iy>*$l{ZC2>R)Cin>P;SC<>c$lgDA!OrG6rQcdP5 z4Y>nYq#gpi2;-8f?+^SOV^3qIh$@7ND(oR@!w2&i#K`6j{ejP*jEz9WKLTx|7mAQ~ z!XdpE;A{?q4Mf?fLDbNuexrfJJD^KglImIOA7GNxS2 z{c%XM(k(f~iSm`~fJLUkcxWWv0Y&Y3ro>0%p()C8K&UESHYV!Af*gIw&<;6m%K)e` z9Pzi<#XRFS=!7Rq(Vi|0%f{VFIo7v+xo7K(yEgngLC zZKmc5e1sf-q`HT2c~*F|1Qb2|8}mAz_{-8Ze=oAlG!Z{o{ji{gdP$zn>~oKh+BIMd zMqplq{}FPW&uedIV29b?{zggwt?9^ZTeEnodgp|L%vH3x0ZTNunuIrh1TaPp8YC3k zH15o5KuGd6_Q-y4d#aFARCj5`&#%*^ikZI3>QhGJwL8I9Z6}JQ7@#Tc#u&L`f+{-o z+@gR&w*v6_V&AT{nibr>dY9;)LcXf#$K>rbzq>5yhEh14EQd-+9?MH4J@5 z*bVJ7$Gsqkb8*koyuhflO~e>eO{>YSU=z~N0NknI$DhaheKUqk_oLsPx)kN(88YbMXsChw6{YDH%2r9t6aTnnLE#b zstyP`w}&k%Mm);CE3C?XnDg0Ke)KCQZ4!~cj);g+fifXm8$m))b?A9e$##zcjs@Cf zB6QB@+=^(MvYO-AN3IoBwDS&u8|Y4Cyyg9ltKLHn5M=*upENiZAosd(`H!=>wmQLX zYRK*&`HVEN=;7P*1S&e{fvQBd`j$)G2mV(gyaA_M8}jeMu(rLD=Qywwy8LjntnTm=S6&vEgcsDtsH>0GJY+`RL}8>0}qP)9CVYeQ^K_ zHk$I5Zl)o9+=ai4LrP>sNg3QGzjANu(O4ee}Jy|c@nQ$@Ya6xryC@BbXPhh~x z=oA`XqqW1b%;yMMU;|^HF~;kEfAGF08kDn4Prn_u^4Y_clbu49w_}v1gCp+DUuq}Z z;@jbjWF7ETyScs-fQe&CSHtiq=drSgefU<5@=R}{FLswtr)Mh_P-j;)d!_m=YlD^} z>EI2?T0Fyj<`qCNVkuN^d9$9Y)To>v;o^@!<&)H}lt<-B)DV#0SkFvy&^6-U+ooqg zY8cFB6}O&!UT7GMRUY}uHNcBHO2hT`Y|FI4Q?7c?@u~T9FxfsAE%TSFvX#VvE;$`b zP0XuVyZgC>1Ty4Rb~oRLi}DwdrZKF9Hjt9NZ_KX!X)cCA0NBW3NJD6FV_mp95RzB8 zIh|0~#i?8cQa0@)T5FdB%?W>lq`&;(K4GPY$h7%gk0QoWWA1>Ka)a^&Rx6zN6SyIX zgw?Sc{(W!w>nEg8J~-bC7{iKHFrmB<^s6h%LelLOnIN@IH(Y?R1yVh6%P*a1#uf2sO(0|GPLoVO~Cs7nTgJwt-RD(x2)!IPz3GZ z!N3F@a}OD`Bq6ZTApjfK;XX~ebghAa2h%Bdga%0lE);|$L}H=FgQOatYU396Z44K6aC=F|6c)dE~h|6?MD#R73pJ+48bZk79`|SEkI>^KM(OPG8UAAnw`!El)wcs z1eL(=6$naY{PIiNoSfk~wUPMj84$>j)*^$bXDXjCWzZMI9%)!K4$*Rg956z*xT+$Z z=^~op1r*3CQTk74G)Vi41rw=O!E{?jVvy0Z~t@G){{y zuL-bCOepP#FsS^IedPu*`PndEZ+9SOh-}wXU#@ zY-?@fN$qq?3~GY9$h_9>+-Y|EssP{|-7|VLbDyTE$vfNht+!3JO$j|)O_6PMG%yLM z!Fju50|DO8{-!^|?(m#mYRZObxhiVJmoXeYUOZTW!?vdZY@uWwK|Ahj2Uz&De~7Is zT>i#P_3|A$J&)#rmD#O{_VCH0Bnq!RfoOC7^%?83Pq18g(|?P7u;F=*d~tM{HR_8; z?1%|(w{5J#M^VIXoyNLOXK=mY8*X)PQac>T*ReYVFUoB4I5h!@@X;lMbSrF_X^LRI zb&2uWC(3nFe|u$^HGzw*Z@}N&USzlc!TJ@gwJ!o92fwo6pFp&LEsRy57GUKVx8&ki z0ttXPibI7QXzBdmq3dC67|5cpli7Cy?fA;#Pbucnr}zQ_$Y^g=WK9aSi-Hexp( zXH|aT{Bzl}f2Rj4xf$~rSD?f+mIB|K2|!>Mu$2FOhR*D$nYhKtb`uq&@?bqJWMC>{ zkc)B%3Qi9#oqxNQ1U$pVu54u7B_?6PYPv*1I6*zNG|yf|;6YH|ylK$vF**;gn`~vI zL+L6m^Cj%n{xl|SE$=o{%Vr=XDK77#?5qkvj~@;Kc_IO!) z-T1l@YsiX;PcJcQoIC1M^?Ypv=mbywHmP2pz)u{+x{#4NmPTLb2QAD28M$9dvoI>H z-ZM9N`S>Ix(~=R1>6%998RO^#83HJYnx9#6_=5hEugsXAvk&tkbGr|HgWyvbonB6> z$0Q-x(8aP{y$+|MlQgPVg>6EfarGu8vpu%PN-Tx52cF_DelnewF#x*fU1x~aW|X&x z0hUBB8_2_Mb0Y(NVf7sLyUR7m&?58=1)L%N{Kp%JnjYbLTp-mQ3Y4oUL8^9QUUW8y zGdeFFX)l>M%}NfeTgjcmE%59aKW(-cfzFXHIwM1zXWgxU@MrSQ_a&to zgvXn)@02LsMMX*auCsL){`w-c}VdT5RHyzZX%T5tll2XO1W=5(;>3p5J*aJ_52jZg@qpcJ1PEQkYoLRX-`W4eggyFpo3P zjK7?t(u(sAOX)j??40ZX0)61-Wy6#`j62@wmiH-m8-Vq>JaDoNY)v&%at`?~lFdx< zURqg<&7I17dxU`e%DA{mY<6urc?M@Ulk1R&A z;JAyUm;7BNDN5fm3}NCD^%<`^5jafyzO9^^x7{s19dIdxqpHxy0C6DVzQ|dS@c4LJ zqkvYOFM+Mf4K&0R|LKK=a2W|M^$6>0iYP6V-O0GX%-f0zR?HW1FF?7n3Mthv?~f0m zwA_@q*oMgUM_JrZ5FS3W_&67;NxZvW?Bz=If_}yjJEU_cYrA$wH06{7)zqe@;Ox^G z;oW)xD&^uoVd0&N%qOF9#o+AWGplQi%c-jzR;|gOv%VKon>2@HaSOn;^YH$eIG zWQ&E0>Aq>S51Ur%=Q%G^)6#$jHh_CQ2qt1UHkMjA;~{R&=M%<$)neo7Neb#vZpDfB zYLQWnD&!|RTCcQhA~kuK)&PyIJ);*jMf*Etf)XfY>%M{D7naGvMkx)){z($!xuK+- zNNTpB+Z+_lLxt52Aa)A;^~nmqq0K#hIj#yB0^3Fug~p@@pMe3?&tX) z$KEk#&`h`lgm~eY#~xh&jKdW|Y4B@=uZfkA$vA=@<88f@NhSXsE(fcU4b3RZ#=B!m zoym@NloV1Dl|bltEHGlJ?E%|2XZ}dNK%Lo)A@?a&OO55ji^cRvCC`%kR;b1nu(w9F z1kS3^pjwoQ&OP$%8gEtlHyX3Ft0(=F$oy?75EkRvAz3E9aR$5fj}waT2kjSR@XJ}1 z6YI-ze4lku=M=*vh->FI&Y*U403yxya)5P7_j*`vtS4SXp?_|EW;1J15Tv4J{Ci zm)*CdFTXOPuCZbaersj^DiL$ht;T~M1Dj%GCxM?YToZ6Xu4y;gmVGg-GBM^MCNppE z6b*(I(?0#+rbO)m2IA~D=O1Bsn{<#V#&P`M%RA`H32gP)i9KO&ZpaCJ8abBX<;qeH zAQ!FYr{Iv>g-EV2!>Q4ID+-Su7_V1~TPJmS>Dpu;t@a5IrkZmtU7Ti#=<7)gQ+E9Y zH6Ulh1;t!D+_3qkec5G18J$L=T$phT-@Lo{$>`N_pq!rJo3C1N%mdCQ{8<#2P|xLvD#2=xL;&p0`nC%qvb7vqww|T zp38h_Fox0YKO7&lEwvmq{BhLF%<8C{92+JdO`S=qv@dk~8P)0pK4SjmjJ9$#*73}HiY;cid<@G?yLL&>PK zj(0hzDu4=NWOy+~HpCZ5hgeHvg|rnWxW!P}0dx>e4E=(i~CtZ zrPN9dH79GhjKpH+2DSZe6^Rx6&kO@bAwD^tZ$9K>irg=MtoRW(?rWa}j+PjsA8*UB zMCvv|Wt=Rt4r{?KuA33TH45r{%WYCGont+!@sohg^jw$+ z>&|AYwMr;9OLbyGj+OE=Rd!~@MuLJ8uwXK3<%ljZi+viYT@t6&TM||55(UrPlP-a3 ziArjOb5b#)`cM$k)DrbGY-nT35V03-Irz_9b zGg*Z(w%=cg2Yq;G8F3w4HHn}<{EHZ4<|#{fIXvuSO|QrZV7cM1L`gmFz*nJ7Pp>^O zkxzATg_t5}PduYTw@L&jU?Z8I?zyF*aipS=5t4MM>FaVHi;Dlk zcUasVHu$qgmGO``Gd-T~3t)@FhmDDxPO zVVr!|Ghs9!5fByvKW_nSK&%mRsZkE+03X3EA~i+h&UDxzWFT}u}8O4m7hm>?ra>;F8 z%0EeY5~ zqYLRGkm|J{p8+IwhpDop^(>8WBZN@wQDhkEw{pC3yJ1J%(<0-kUiqtVv9#7e4%wpa zxseN*Ya(6y+vMA2=uctH-CsD{E~B0>c4jfG=lHSS}{gp*`Hy0RapLHEX3+;*2!OUkNU;12rL|Mmrk@DLu90*RHo(8m&M@#$)ox( z#9(5!9cjw6Fcagj3=^cN&D+)uoc6QHV+&8uq^M~c=~y$7i`!Q*%5s9H0FYhTE%Mo^ zsBvheCgC@2XI*_woUDa%*tUc({H01*vM#s`9srNTyr(xQyO~IW*tTm=U=-m;@MFqM zmrw&~uW*6nrQml)DA#MgWAuN^WVJWD-w*gR*J=MqGM03RlkrvhC zEr+2c07=67*1@uYN;V9Z^fyqvOcYuK8?G$78H*5i`qEsF15)IkYRUkpkge#UgrS1m zQX#E^$+%^CGVVb8^DL!Yx?*j9ydhraVpvse3^NFV_lz=dB#|;B*sD0g<&vVAu74D} zLYW_n<$J)Cs2+cknToo`jupS>EUf)bp>T`&x=K43-&xzSF%pM$Alo!0+{oJV#+Icq z90>Z+LtQpgQ4Tz_#rpURBML9u;O)eZ_c=PxeDE$7T&$+(o)m9OF6<>|@MTYhU!p;g zdvh9U|3YJJqA{PTUC@f|xt9O$fz%8^Vsb_Zlnx#$n#EZ}bY(@BBWz!02rluBPmwlH z0)HhCnZ9E<{>}P+VgT1^HSl(;p~;*bOqPqp0Qqz}_)W$7xyb>^1Bny*(QjE5ajR@xkCOjw+Zcq4121 zEt+zo3fFhG9ZqxwRo0XV%V39@%!yl;aL1C?l^BM@uHe8@)m}}#^+}X`gR3fwjSYel zW2vOKT6g2Hk^)C>8iK+AMXD5{#QRgEI$X*at4eKT9r0tdRp!5~w-&1!84=W1F_&9) zX3IWcM6K5(Fmt`Ap<_1;i}#ym?o1g(?a|d4u>xmM7c&0|NGW#f{&WT(?vv7C*ueD61Bab`@!N}Ocqz&f0Et3SwqbAzi|!ijp16B1Gv2-j;o0{lrTLOi za-*N(aU7!8sG(0~6Q$feDN!(ms3lM3$sEOLmK+GZVVk4$l2ICaO{8gvloqPavpo2B zQhJ6?VF|4$es=#A47zDw#6m2x5V(JZSbT|aYVyZU(O&f63dhMLnhy3tl~k%oJnK6g zF#Qa$y!CX(?@w`lN1K|zJe#!Ps|}mlsknUHjOnO_!Qt|;W9 za`w90{5Is|Htr`?8q#{G^QnsY1W*JZMQF)~E|J{~v&3lUR)dFyLdz}m1oyxSnN%q< zI&>|%>cN$VyNgdfuhq@uGQUcbLSaU<(Y90!iKibN>PoCnETy zXof9v?lEp$3&GE6ox-T-fK|Zp2>fEUF`)yNyIuvBTa5R-B4n)ZKI1&F6YuU9+Ix>Z zE;(m)<1pe*E$JWE`N+{!HVCEu=63qz z+|O9flv0Q1TSKEd?xj=!K5>A2kc258Q!kALJzwIt=I*a?2FFlH^L|%IAQO2F=_2LH zkjdV^My%``amiz9`<;Yid|UK5%H|(vwj2!(SCe!x77N~b7YY+uEnjQlv``EO>&%M| zVGrFadb*#&atTRX(4HXUzUd`ngOj5eoo(@k;hp539Sv(bfnKln&v-BrUpB*d&5$PU zh_%bvkoofLlr8SfQP*_IlLKAn5#^kZL7PfeDFEkFNhwTs_<#fR`SEQJE_)C2SE zIE8!;RL$j6J)}b(&w5`_xi+iKkzJWlEFA;u*s_Uke2KHAD-?da{Zk*W)b*oHG2Hif zh+jQQ`i@+2!?u&WlQOSaZUUJ`V9GS}Hl?*k!ZV4u+3d#?{>he!I5o&ooB}80hAzFY zQf=x5;V2_s%#Kh8aXg0I#`6qH+}}giVZq*d6;i)kjL(M-Q?nDJz@```c6-sm&di(U7#4wiQJWH)U!)HrD6#;UGOMTdm?aH=5`3DLORO0XnH` za$3dNpu#QfN8K`Nv1v$o;rS?UB9#LKt;&i{Mn{J?)@LAtp8Z^RUaFjAOvZCHmzo8D z)MK(Lkp|xjGmj`GpwT45T-)$LPE9zMINRCQOal5=Z(%l<3UNoGq!0W8q>6pGN7=JQ z)3aDx5|7Ja70pvLjRSGtK-i;(ACk|RJ@jKO`30%+t7$rxHQci!a>LTUd&sWK1;=|k zo|pP1(d-uIY0e68tIQ1BFpA84x7$@Z4`;Ihy)tdT;TT(KZ7}`MY=si*NEY*Hb$OMA zOlPxX6((({iwbc444K(NXDhpyG+sqawmThX8`v?P##jwr{?ZP2W->gljmdJGeEKz3 z;`}aWX374il>-yskbfi1l+)2W_4W3GjsZ45Nwa24rZZrSLw{?Rqv19SIu;7E944oT z9PK@e@OQn$Fm8y2^rU;VPYi(L8Fcm)K zqa-D{9mrbeOn)eqUD#`m0sbD1IeC~c!&)Nz&ujX=lj zEre0m5yr`k>36cMRI=N2dRc>Uz0RZFutWtPk$ZKzO40Ub)`ZttLCD6v7VqPL zkJa!ru{YUKA3~-Y6hXoaLZwro){?tULb0`^f_S@RN8LY7|%OHdwi9Q z$eLYx;!3nojgY=T_c!M1FxC%^(kv$yk+E5Dm^jRle6)^23@AA)wf(_n_)6?8g|QG> zGCXyyG1^c>i{nP%J}Fxfy*Ll!p+xl{YVa*;&`hr4xdSB!1%ojSmK;H4Orr^I^s{ch^rYn$ zqH{pWyijlH<<}J4=k;F+#uXUg)DqG6p+o*Dq(kDyH9e)7wpLLrHh2UlH^9MdwghG7 z1>f{GIDlBu+VMM$43h|=6G!c2RFm|$sdxYT_V(7LMm32H^cbUs+bO?NGwK4YE6?K( zx8X*b!mN6;Z$wP5z0Er5>kUjSztaO&(jr4V-m9{)Zmp9Ftq}0IYoXNWVgbVZmu4~! z2U~=ob>P-{MMLqu4YE3y#4WOr!w7Q9c_a|evYt77FFp@~SGjHU#H&#Kp0m};`ck<*RE%0BTYJ6aHx9Vm187CUr?yXK3?3c5oWjkDV5*YG7a0YV!>poBKW&131aHo z)f-cbTvyzh$!1S?N#DY1{9X%+eJD`mhGDtCjq;O$X2nEB;?vE^6_OOjo}Y7?{#da| zJF3hlDW=8KDa$2dNh-`)E9H_XFmIoH=2?S-ZF{kbdSzxU(Fu9BdA3QJB3S{S;b^}# z4Qk{ldBx(vVl$er_r$_U*knCj9KgK=8Y!8UBfA%e0W(0fjoFGD3_omaoYXhQA^IxnG_5*16kV#w(g)^ZgB{Q;lqyvyJ7!_jiWMV@)p{{43?9+R5E2Rz8?b zaosGRCVH6bksvw{K~}p~!xN%+M0g7%6^hYSH#L^_5@odc&-uw-uXm?lt22qC8_DhX;L2pW{r^Y zH08^_2_&$Y%J}j76|dmbl+d#&y&146LuJ5uW$7mh1hR*e#-*x|Gm|&JM|t9@BCbg?qPb)P>}%=AVFDK%n2{D8(4V0 zcKfr6%4I&d`Jw{(I4gc-y!W5}EJ7F{wPxa*|qsbyC`$3;x+m5 zY0lqUxgbPc;Mku1SHsW$UV2>kg)tHpovzR z_NL*((q2a;2ro_66EWaj#VQ8Oh6l^JeisQT@YUZGqbS(urv!Edp$Bipwq4V;pzh}G zouO<=F^VCvT0H<50^gSgwPyJB4tvBi1_~4xh5a&*|EL=+6KyXX^?k!pOYt`*b|G(1c)t}HIssMk^s z#+BaP-fly${khiZ^>KE6{8@powQ2SA#Kzs(MV>Df#wEX{usQmrtbKIjkj=baBv)Ho zHdA$2m}3L*>ZR)w)jD?QlsL!$RB54Fu^d_E&IZhu^ON<=QyR8+pW#(y7&Bwc?C6Dx zk?GpCH6OJ12Fn^54r&NPkYJzPtmIxH(`E`eS&~bIJAXE2LGXO#9_-m`7Ph;}Cq>BL zY&8h4OLpViSZZTS&;&ASri!o*80AmTuatvt+DmjMh3)Xv?2z@6Hseh%HELKOkhMy~ zCJ{99@ED-_ed2Agmu3_%v&`w{&U1bl66mDbZ6W7u+>FZVx_wJ60jUpeW7s`*6oL(b z9+4Rm^}Tp$gVCjgJ!j*CV1L`)LL%5*dj9U>nK!Wa1i6cbmkfAGC2z6>cV z$|UAVvfo<@NqWzWw0n36ZgB#GcC?b(eaUG=Y2MFIk<+K-=aUvA&j7;&cQp-MfDIFS z|5a4oN&i=|drY$77$I4AP9G=rIw-!{aCSEUQL5Y>OmBu9DMRbXeeE6lxx1;RKKd}F z^r_A4&j{SMnZV;9nztR3^TpGyPi7&GrGn6%>JbWi);JZmWS+I{!l<-6Llh~epPg*Bq0D#}aIx>areMs&z$nrh9{`~V2bZo(pcnTGL(Kl+(;cA@EtzP=vBos;Z3T2XYLBE6z<4Rh7Ec&vj-#gZWG8uZFGvJ*S zV5hm*yTYVUC1Ug{jjhH+||MQXr_~44pVupn4CcoUdX^Y zIUPw0URj%Hj(L2Nw`*-nx|q&RcR9`^UO4q~-zlIIez6wbhBBr}|M(pLrYCGIOs+rG}%q zuP41_BWk1@j`!~7j;jNBhw1d&yWefbuQ|hXA(GBK@t^F09-66s$u)_P%-%hdCyoPG zMtY(j_W}PnSrhhjv^Rrkc|TX?&U~914MMQ`>F^CH7p;5yXX0Au)aUH__*{oGdv|&H zuXBi)bgd06c141Ede<)r`gsNfmxgF*-?%sCnLQ1hu3Ra_NO(8{n?gYSTCFb2_JTs; zhEi0=sF2dcV#?4WEugG(O8Oqw;8ZXe2`fsFNK)m60fM(`ZtqASF zONCCFXznr=&hEz$6*FcHgefk&J2dg?1tjhIi#_w3ia^>Vtny9-ELNv2;C=Elm=Qtf`^Du3b@4b7Jc^U-if+9+H zb6R&$yyp3hZ9{qX%)zCJ9F=ZIe6#a|>Qn;k#1$ux0`nom@whLJOO(U}W}daX{_KW{ z-&#Yr@{9DGq}kY@(luYaa$K!Ho0NVU

ik(kZ!DA=3AT$?bajQ-k>JB~MaS>%$&d zHy6Y>8fF`nQyP`l)?R*kHNL2hKu2jhS$h%70WK%pE8ARD?%mPT`5w1f&|dpz@8zj? zGM<@&r#`KR+8Y4@ScN1f3-zl}?N z=0r7s@ElGSJH!vIffl>w#}v42T_CWRI;(an-+xuvB4>#}vw62M=AM_!tm^#}9@ntK zuQfCS|H`*mG*jjgOaIA&zNX9|kFeGdR#t(axB1xYO9Q|<$6x|;Q?^NXzV3A;OkdCm z?A567Db#-b>lrl|*FI0$*Vt@*WOb0 z$cKGFQ@4lRL5Z`f9ezPW>0IK400wJ{<@C)7L!jpMLeRxTk(hOxb&yR6J|dr@+;u`$ zAKCS7uFT!T3;UvZZA>km??sv9usDS@Js&C_ApSG9i|#@Y#^m!$ID>)Et4JuDOVIX` zSjCk@OX~DOFM{PW%P(<&x_i%|?qXtex_*F?C@H!BaO)nNW#{1}g*P)5fR=-suE>0j z(`_gzi*EY#E88R*{}ukDD+b}#t@C#!Ymx`rNTwvzP`sp@*O}lGA9kEhP(0v z@Pr<|ID=-fI+PbU@T>exC8qRsyu%0iFjTZ)fbaAf{9AjpY(?E>h~D<{<9a~{q2~Lh zPt3UJM{eJoTTHF`+YkIqVH%MfdvKCtFvXo%H3q%)+<5^v=P|+Z#e{4)p{foWAh!^i zsY5dsK4YxB28aR#4yIP#nZo&lsbaRkOZ_q`34pgL8|eYHsL{Fx0;-d)>q&n&9-LVv zjRdhu2GV)p~MCSsj3iH&xhhy)I3(NYx5ey$tsI4zPYmk zK^MV?SUfIDo=MEpA=ya$Q*y7Y=`^nPHC$n46jO#ViI1)-BXu-=j_ximlSa;5bA|m` z7qX^6_JC4U)@mFF3mc=pIEdBg%*?b68s`AH?W)7vs^vggBO5d97Fp%Ou=AJVK4Bvp zbI>$eco3+A0=1{xVgo$KqV+Y;xnoSkGF9dfIRLH(p8|zLtsiT@W6qEdHSfQy|{-^@w|c7k}6* zkgzF^&P@PyEy#=f88$4mM@S>chdYfjLpd50onzu9S=5GCjY2hBa(k?%*oolYxod_q zbMvQZga&f}_1s>qA>qe;Uf=J-11Iy6_U~ELx;cjr$O~xQC z=w;Ylb@>}lAV4VFu{=5pe`)le0_=9R7gKV0T%PVxyFglZ5EU#nA~^SsX`dP!43+)s zpJ>-%XZ9&|HAAT0rbs%wG+-iln^3G9U%Nh>ef z9A{SI>atD_c;bq^4ULRj6{AuMp-!8~ax((%Mr{6xp)S>6ooJ5nX~z>l%A+*gnaW`8 zjNDY=X4YJNBC;1uf<>;k4A5(dKya38lxVrL?;LTRIpEjya=Zp^T*Vsf|bTacmy=`f$MLZN7-}z_?cd<}A}uJLd-%Wm1WZQHhO+qP}nw(Y&Fy=>dIy|UA(RHduloOD;tPk6rF&z#pB z16`N>1qD59Ith$ei6%|0?}vr;Y?GA7ayIce z+j+>aEmW*v6yv~E4L)Rje@Rh>SQC%bgOLF7mb?EU#Eps(Rql<-c3eWYJemDXw6d(>gCa`pyajoohX!>C@W+mEn@nxdir6hH&>*yFU>_#izD#|(X zwX;C0WUqxQgH0Ya6cVySDtj_Tfi>x^SY?|fcOM$6=|ZV;sdMNig4wsik+LVp>F0og z_9v=DgNi7$vZxju)VW_pjLz>?nB-NMaB9##w3tJ`jB7M4J}$ z@(Ry|$U9TbmkO1?!fT2sd25PJZo1)$wkpL2r3fE|{PSFICq9L1ZK^wVqSZOE(sjHP zOF5uvK~<~tB$nur+Wi%)ps3cEI_H*#sr>!&m8Z`L__#tK0=FQKf~sMuAT?fv zZyj&@%YKrwUQXJJLY-R8G&pJe-d$N;9J@-kOmE6v7y`$yReDkg9~IOy@_lf2#;XpC zC#}Ot$0hpZHRq)CT>|tL|9%lwg@!gs2&vk?`E2(}CAIAq*e+ttAr|HWvI@BA+?ys! zcaBZg&%43>k#d$04gFdlo0>;AYYSg9G32MM;Ir#xUoBdqT?tv%}& z9kkVWQ6y*(?p%R#j&9X9yJ+cYY)FMcs=+K@9i?{WD$i&RlQs{yD&F8RE6Bi=IOZH$ zl3xp>KnixgqZyQQfP(pQ?A{gqQ{=hg(C`DuFL>HbX0CC()3&qGRX0e(f|q;dHO+Y% zn_XsYm3yUH10})h%giME;}0|XFB`bVP*U!aI5EnBkm(nCogp)H?mAMJ(wWatKZttp zpQ1(26bAer9@37C6*z%?xA@M#Pm%k_-52Ppd4ZdcatfjTh)5sI5K}X5Bb>lC2M!T; zd{OepJv#Kte)qkkfEItt+RVdpR}sN>-w~)sdBC3(MIWupJS(0+QnL=(xzy{r*1tt0 zH$g$qe3@O-;qp?fvZt8z|C_XB$zxR_66*x=1j0L-U8N9-K{}iQFL(+7?j(kXY;O)a zj@s$Yvp*a2m^LWKG9B-Dnmz(!O9bq|JMMw-gX9X>8AzpL`E+JSCeNBgF!7c9vg;8a zdWOehewh`3IVb}g<3jTiU6(I|M0^7FP4V-!vIUNK?1dmR^im8~i}DI?-YtgvRIQ_a z*Zr}sz`Vh>Dq@fQJj*;0AKgl4j)mkI|B^D?VT@iHncIkNsJuY6q3X3#&WhctTFklp$4h??Q?9H}!jFstF? zDV-z}DUoa%M~*1GbL&iert7)IM5<_+R#(7!3qXX#I^1I|N}h<-RrE5l zviJF?96h3$>LuYRPK6k0HiL^&SpAXxxvXqtdUt+W_Mn4v8&P46_;wb`n6zEhIN~hl z(^E6JB@pot3DUe zw|6XTmZ#V*`OTa3BR=)dDvpWt&(f@)*{XT_s=nT}^gPzD==ABIq@fm9#myJLe6nI~ z(1Ra?KQERXgTJQOK&gX4tA2W3IL#-Yl&3)Fdgc~82W^AHPn5O=QGauEgA1Nz2j5Nk$`5h z8GHgD_GG{t`8i@hn1ER@4qW*pg)?R&?K1*++xC@b;|PfEd>o`gUMr@e)=v2x7-zyM zEXUOlwlYoiK8o~GNNCmY)q^Zhv}XZgZ;b}ln`REnyaR~u2<{<;wqGnEvZlXYsJ zt}o6vc*5KgAn?pBHiK_Rmb4S0pPC{e@6H?P96>idZwq^kpNlzeaUf6H`GBO@p$?t{5XBR4p zg~d1)6$;FD?tfmHS#30U-5vMaGu|hhnFh~5s3>wQ%uoySLKV|d^IOuC_qR@tjb71+ zs6SGuBy-eBQmNv}MHCM~0tDupeR&oDq`Drf6Ymug^wW+yCwgNU zMZ7@LPCx4HZKc5<`7xhme6G_NMW3^oG)ZBa)9wmF>z6ED_V6@0W5uiabcYSRMBJdUx{7@<6$t*rT z*^!In1jCRs>q7uDqP6CvZ|puY_a)yOCf~9B(4-ZMg zMKiIIO2D1X6@%5QRxy-pyG+_VIrKHOSfwS?o)8h^rG*eUhW!KbDI7CPQb%0E)0}T6 z3{(vC@z!~Odzb(p^o&HXniN6uU^N8o9TlQF?2-U3CO*zE6f$a*uTcF=H7}^#dm6Qg z%ITWW6l-@hvTmv-ny`~^r@;QXM>!N+Em+e!zDT@CR&pIO5M)tS$up;vC8=yh0*M;F zX22sXxSD!}Qk2Qi2Ca3hS&>?XGfLt}QH^jufKKa9;H#Evrkd*js|XRRSIs$*Lk@-p zm*e?NqPPRDN;*N4T@a_=9}H*Ca4&We_^CHmGjAbQ9O&-20HYO}SYn}+ZoY^~ymzpT zA1s`S$-egv4O~S<$Y^FZ!3-oD$!;UAEIc+qVJV9{UyD2-$aYvu+P@3h=7W#`2IkIs zqDBTjoX_AL{2YicbK;jmKAjUryCF!Ol~f-txfSh!)WxF(i`eDeg6(q4-eBtChSY(l z#w7MrqW5GG%@OA;VX;h=!T~>Ur>U)?$3uC=Ed~cf{528Q10l}hq*GF}3}RA-S=+&Q zWh3L3ZJfkMaFPGX9Q=-LZp#Nl9BCrX_KW3&&w z|HG&|ULJ>%nbnS$r3z)0^1{A%rWjUEYzpGQA636c69v*0!r@cdMfTjxB#D=>t$b2* z=zp$LTIQht45x4!VF-kgZVf;8AO<7xi264)|17RfkDFgkysKxo#)^;0uyBq%d5K^~ zCt^r11^g1UuRXos+YZ(iyRfGkE9?ca(*^!HO-;V7&mn2%&}wH4gCK1oi6I=-TyLNS z7*^=i0iX&jtdW?YLY zFVgRzIs?*u;uK#_?CTf8$dFP_W6r4(J$pi0Ex`nyH~-zE3j1T$yT#mZPuXPB2iH2y zO97R_I8a}V_otHvw!3%;OCk=lzVGO|aAo!jMx--S0dCQbC0kM^c5txNrLa78 z*@-A|L!ETXhxvR%aS98~XNF^7nN(Sbrj`K{>phkJg~F;~_(Kw(S8BHm4yQaiv3QKt(G25 zyEMeLj$?{MY0&H{d|=Scp+W-pS7mJf;LJe>)_1TDk<5FU5jdGkOuhXU7!27QT@IJg zxGV01LS|100X};`FQ+Z@)h4E=I@^+G;>(ed0%0Z(m4cfh>nhdl5FWHio3coeOVRdO zG-9gYFb>{fc8WC9j+9{1a+E|yXR0wqc2X$7OQygpv?f)O2xeu}e`8HhiPXz=;qDR_ zp14Rmsy5mVQ>&WxrS^(uDmz-bQBm*=x)TWK++!+3g?Aey*A_Ns@@Phe9zKbKProO} zPyP`{X+bgHjW20!@e$Jn!h+FHe{L6`DWhhP1q;&uoqck|J}g?5&lrBeO4}Ni$*+yGYG|xhO|S7F8K;&Daw4 z+=>`S)7u%E)b`*Ul-|1I`f&cKW)m*L+z1ibQ<}w{I zWwAYwlGzBiplao9pKn=NeFE-5y!c1l&iz=iIBen=!96)oiU_3nozS(;GOa9!u$2*i1hd#N(Q*{^~hkq_Mzq4n`{!`jwVC!~t z$M+29#{$;+6;y|Jo-~cyZF$Sv-Wy1aOFNXTD?AmwvzAaiTc>!qF)Xw4aVc>chd|Mb zXaBb&b4s2t+sju`Q0jaN&%J(?`(CNdpMD5uD8*;MoVG|4ksM9kUG|GUJ+L>yn)7R)dDa>@HztrU)6TGLSj%lhLCpuZ8 zGe0d=gWqWs(FVWECUC=Pfag7Es=BB{nBz_`y4zmAC>hn`JwB|FW5k2em`qXvR5{uDnM zg7;`UaV|-kUZ>X$a!vwJaV$vrR3$}YyeGoZjHo@~8Q`cskA0%r_q;$5+O%1Ym!v?y z-?h>rA95>(z~(!j1q+Gi&WIIUCoACmh`WPXletBk+NYJur)%%8E+3S5B}OW!u)}9G zOs;XbQ%E^)qzjYSKO!xq9vkg)wDp238RVJO2Nj~3l~22|)S4z>$K}eo3TfjCHvDsKg~YH2!X_AKkUr9O98+YF4NWm4x6M`2Jlyn1J;QEm=}z~ zL2liG?+i&2`#)apYvVN&2R!b%GV#t#)m0je?~QVKg?KlBDm80!tSVkr+Gs}{6j>~d zu>Q|TqYpxgLFtWG9Oe&243$4SNsKROU1=lsBwkviKJZ$aB%y#V0oDB_M3u(y!rt#x z#Jx~A3Ja|=mSj#2*?3VxsuY8?rpGZ#0aO{9IF-4aO4)?uCm67JN?;Tm)!vE~o=M;O z3fVBGRN$>^dSdwgVI%sDA?(-v7@e&prft>-vb9jMwDpb5)%b&oSL$25bztsTa~mMg zHjj`g+|vvlSMXmmCBeJ89p-6Y_O+xS{@;I$XE77(q&Ij})~w_FZf{k?XD!P1==~A= zefq6If$V_ZXfs$iCmSpdYbFo`5!~S@@3p*7=~{~?vNq?LBa>!HtL7}3wB;@T zg|PS%$lEHFIb{5F`kH_>#?EQD>CH72hfOa{Vxhek>*2}(R^S76o_D|}YQV&_Pn@A< zeA1K&x_+*a_ak?0;3tAh^_5xN7gLM%7=LR=5CZ`pW*mQGuXYw-slA5O_&!KwA_Rax z13nGeHjzzRE2*w+zyMoKukRqbH|qN8`=?J9`?E%ej{<(CEAy{ZdnRtDMA{}8o6-?9 zq0HgW3;hUXPwENB>V+SHN2aW%Rc9;-a$d*GT;b(AKXa*Y6!QZrUd88ewt|C~ay2Oj zdZ6v)y!soBo=(PSzqI>NTKq-4L5Zg^1n(` zudJDP_eM^@!``=s@#Ui7%wav5n1l@0?X1Aza&yNJrW9!S+Mr1MOBWQL>IjY76@%vi zp&g#S!VYVo7H}4x;cR{3Z}JB~J{ghPKEYDU#QM4`c;Pl%=)YGPE;mdeE zV2a&L5G5d}nKose@nmCqMCD-6Bjmb8qmYeaA294&^TM$dK9FrJ#!_gp$p>w8%)BIL z{A!!F9@exu0*INaZr~KPI;F3?7(&iCYQhfv87Nz%x2q-Qa4$NAc8tQ2kxt1QhgVLB za=%&c`CCCEcNsQu?vF?UusGJgPN&W`vZWw4|J?Qmfo=t6W`~Z{Gs%l~7)OW`ND(oL zZPRzeRUXm{$l>L?zq|+pqe3ZTP0OAtvFszLjh)y~Vv4dO2}L~6m$>>b>^Ka(u`LH& zOt67ai=Y!ZW>~(Ks#&Z!<5W{%8Rq=6_DUfpfXXF}Op#MU3a)n;2XtWWNGuIJ;2$oy zwTVEmfZ98=m<-GEK=NJ@B+yjVoBlL3WMDLba(~w8hGX8`=0SPmhNmCTFKNuEnr~1A z)xr;D4_|zUj$g4wDQ#JT&XCobGVbh?mo8F|*D$3*;F3rZhVs8w%B|f}oUN8gWC9}} zX2U>eDQ{CYV?gg|DGbS1cAsSFyM_L@`zkfCjr)K^XH-+ahOgdDJf;PcAG$+GLR`i? zNR@m23E3f?sR2!H;TUdNH^{g%JFkP4vd*%7IGy;PwiV79Am`CD_@d)DEyPVAh;YaN ze@!_zSPX!PRMz-D)BeI5?>SArJPSFkE;~9YnYsqA`837?ousl^oD;(b~6-P6~Ka!ObU3u_)oKQVYpLw%2J@>3a;E3Z<67q6EfQQj+4|}Hh%VWE1z>uPZ z+H4Vzz3i8`1y%MBwjLJ^+qMJB1-wUK0#a5ErCz?!7w2>e*?gBT)cd>3XoM>#Y~Q+` z!*sbE5}Mh^_x=qa#+X&q&{&R@8hjWbD;N-8stCL@oft6vF_-58X<5I8x(X$}wPo$s z#)9;@ukWmj)?}S+dqPzYPX*R%5!`hMi6$UqdeC@{G3UB6z=AID8<+2W8+wWvq8pU> zatDAVo~I>#jUNUKG}aEk@?>&-duaIB!Y$C4LUiFpg@QcnG+k3nL(d6H6WqiFUoqdP z8?j+1rhrXT3vbc+PD%r2i~{d8x^aJa@{67lLb?Hb^b!c6jMXgJEgtv@77F>4mMR=G z8M!uZRyO(sjr{o@ux4902kY4*d78Qm0b|cK+&pcw{OT*RjTBs@(ntA}9NCh6v zy4X^Onu8V`>+B&aw%ZWKDk00`vtN ziWng`e?wjgfE08SficOoP;U}@J|F-&FGLvAswC-=AC&`<;wHXE%x>DlQ}u!wXSC?+ z0-3IFx6boBv*Br)f&_tWch!2()347=-(>lxBmu#A1l<`ZN@SRIbYE`r+vEHDk0{^j zuW@4%!?R(ER)hkK$2wsZcq%l??a7%CE0Ucz+R#Y4${P+kTm5_5t(8_RmUiaXTa%A9IimMwihl<_HVw(JsTkl)IR89cCBOv-c`m@gjaU&E07a38MY!cH##MG? z6*Uqj_1NALt6HEsN)DrElmlWjO<~TjEhlYM>8|U4hAecVzLmB<-@|KXAk75l^kOzm z0fun$2SlZdWZ>%fHRE**mM|IxClU|VQebVnp=i=H&<%aFCbf4B=O()Fhkj6 z_w@{A0HqP1&@@72CX($=M{8u9B)Fn^ zcSMG>2Id|hHi z!rU}Q{HZ0GMAlHAQZqJZR^tpwOGvbDCaY0QsO2ffzU{|$lUveBT!`~awGgscGERWjQsT|z)LMW>CHsvkKypqIDg+*@<#49 z$z(E&*{M;W7#o`+^VSDC3grQ}=4_9hLO{-l*Uxr)Xr+QXQ+gQIBmvn!7^e}() z!P6H0$QY}PZe>f?grYyiwif9ReBF*d4`%-c^L3-x$l<4s{}ahSYrBc+%(n-6e%5-( znbE&1xA_meZjp%6Ow?%3RudpMz*HIFFqPHCj7R-s@ocSmHVB@a+@$-@rO(PfQqNt7 zwozx*)EOtaRig*AeSDmBHr^U(VK=keC;vP1uP)Eh2b-4XHZ~;9;TGPA?AmBRh7y^h zHxy6QHauw7yawOPS_x`&|1c;PUjALvZ%WWygiuY*#BA74XO=7`PDHWXUbnE{68w}# zOXaMm8VApZ!0TdN(EQ`1ddZqT$<2Fej99c{u51^1OpxR_$Dk@;R0t45gEaTqW~y;P3MqIf@7f z5A(YFI$3@qT73Q`rq>tRVR@jqB+f01%taBsNPgG`iW{77#U!@OJ(#o|V{rw0)DQBh zdhUe1?)iyARiW|i%npKw$Nsu=?X6JBeK)R?Qa9W5JjekdnljI8jjQ7Zz0y5*3sT4s z+rgE=^czA72D*T-0d@P$%(uGEwOIz)nnepa#88~SC1mnHls%)TLf7ikKb@2^zd&1h zDqejUSOWWF@SZk`8~)p1HY zo}kbpp=-)g;1cSIV56_uSu-DMPe932+dUeR1yK!T%s_P+?3raQ?fU2l@m{hM?`$;~ zNj1%%u|Z1#W)3?MC7?s{Niyf?-K;hf71ofI+eS=IzZWK0k7UY~m7dA5eG7H&f zZoc_&=AtCTdBOLl5;6w{3}j7E)ceK#i*Faf!a8~Cr65AP$SmsMBBq0rRYvw(U5f7r zv`cQs(|@wbrS*vpNszhuTCQZ#fq+@pjAUPML5p>^fNl=0SWs6-rZpx7l1^n3i&N*_ z*$to4>_v;wR+pO|oz%F&ldxK!_wFVs2d(wc-Oh6H*IhMf3f*XW{C_B^9-QsT-;40r zOh@ja+RvpN3mDH9e>XKzHL}0^q<_cYbl&s3<^Jq_~w{oeozMso*uacOs_(s560@WA?HWTBN^#z%X~9dxFU+49kupS~5@c^W)-$;~|Eh6`l@eR@@QsY?gB5Dus^Q(Z&q zJ|nN;kZYcd+7RGWidIAePlvwj2KZn4Y1vlsAaHi`=aFx+usz zO7wi7(S<~S!tg%*^@x^q0K)zlD;eG75>-o~oGEd;%{z7T5#PlhUhPoY3I*!i6n+4;6I0t|{ko;^M&GRm=bwsu&@wL(erV71HTM37!M-6hCuEe!5JOm^!K=PwAFZN39OI+JH2;&PQaqRS(u>TOPXGHM z{$Kii1mlnSpVIIDWLW0>Z!|3bUtFmF9mDcJuoDvjGt2+rI{nMR|F=+1tp7zg{y)Cz z|5Ite#>B+>KZoO+Nn34*|C9!Mq^jJMu%banIx2D1Hug$xRVt36*q?$k!0zB#i7moR zSg|F`tKk4$^1uY0Snrmd7&;$LA5Z7__IW&?s=lw=|BTn)PPI>|7zyHK@e>%ri z3+?pyHBU72tX-YUul_bXN!m7FTdie%#!vm1*Wx(k_kGDxu6GPlfkb;C*3#^~)D7~PNm=qJOon6zx% zg1P*e1#f!k_P(3U4-1|6n4ja@nXlw-cd*!jr^fy?b4K4b+>uscdx@gIF)u#bM=N{F z9fGwDX5Cn7y;5}MuYr-HdTFzNBlVXEM^9{>vHl|}X9(Zd4?jjvOwE^c48F5@zhe9s zyl%3^Th{;fwpap_&zptTpDW)5!D5_l>XMSv{MK}c`=vvn6aC7O zZzRS!C(+6L7G*1gpR((q_X{RX+gvmEOo(e1T+{4L+|wqY_jh`!wQP~Ma- zMG4z0`CL{7$KT&jT65x0M@4tK%e+E%+nSD>-kOVd`Yt_`wt_u|{EC$MHsqV7R#jK- zKVYH~{g(U-$F6fhewWFmW$zm_d^*4KH~R8@<|4uU%YC`cJgG_%_YN%uiw4pdH;iRG z;p;$pR&E#B&k(0q#p#d@JH~}YNOqU*=q_;bhx>bh9{FB}*37VUx~8fc4uhAxMmR0E zSbv?u4ZI3t8i?yy;K>-JeG-Gxk&8&m&K3>56!<{X1Y30mK@^v|H*nP^tU!!zO|#FL zC?2l!&WWZb5U#AkYECxOQ82Og&W-sc7UD&Q{BK7Qf-UuOc;<41+(fQ>kaW02w^4sL z?eAMkX4w(L3KTe3SqvR%9>(JjzfLJMfz2$YZDdT>FlZO20FySF{?Fean*+TzX4?yP za)JuTr%GTSuEP=GsN_JVCD=Wr? z>6Jz#SGC>_Luj4?J>6}i=+{jX9My(+$@ye7c<}r`z41KDlbQtZN{YXSBh8V_(k{q{ zqi*kP3`TQAsxfq}$x44O@`mQ0z$Lu`))2{p?;cNu7Y%an#-`XY7!>~Bn`)z2(TrB8>ajGZ?`ZVqKQ^Q$i zWUb2p6VzExqY8}}zuY882409z* zeB*uz!VDLs4=a_W?|6sMH`o)^bFJdw;Tl}%M;~WFvqlEZTpt3iPwQLpBSMc8Wx$SD zpzzJVEefrVM+>o4a&Z`zJuE=jn9kwFR@jdEiU*7W^AOtgIc{ z4-Xx>7rt;;L(jHXRH9HxNuj_uNI&7E;2=@lOGhHa(gS}NZZU>@w|BGjsHS_9nipd& z@tA#HyIbfm97Uor3bUi>#t_1G#ZzS}eA_%i$KR>wIUUyU_C0LPbF+n0NQwZIPq2vV ztpKkYV_z;wxJX)2a3YJ9(gwYD z5i%ImL7ZL?ujqFH*!HAkxmgOFOIi^{?7-!DUAGrlieZeDM9#mKLx`{F$U~41#|E=W zVqjM0Bmy}Y#wnYF?(s)N;}wl%v6k;LRq}OS{O+1l;I*La1m=`wv}MhkDebvI45g^X zMl=GtY@e}U)`TIz-q#Wo9_$(tZxlp}2na7`RI4UX&M97?3J?{$I<``3`0vh_j+f5CxzBO7`TKlzIr~yNL z_@4|zuNFt8YJ=a!L%&Y?^C9c z;pZ}9qd}zgjV~b~@!2x$_X8JfYlX9*WXzDdy15XFajo-M6XzL*vG>NqiAi=)b48Jy zV#z8wK?y>r59gFR^-N0 zf~D3S_^2+u&*yZIF;!>UM>bv>-OJzU6wYmUS>hU?MVtfkWH77Txm-(Igiy4Cvvwq- zw2)Z=XqD#K0;G*_(Ezkv@t|MVf%e?#=|FT%m)R;pieVi0;0P+?&$P>#(e`eSA6!5~ zN~Qo2ozyTgk^)<>6ty@K#M-A_Lpqcf6AriG@0swdwLt)sDpSLvb8-7NuZuy#X)u$Y z0AtOXDncC#p@TSp>A{l^R@kM55sk7%e|%%eg$$o^D{|@BdM``e*(F8JIeA=UE52ew z$mb%JuDq}iZgS%+G~&S&gHg^G8q2Z9j8x~=ip?B)N_6)X7Qn+c&1EO$ZR<$4Yb%2G}XNl?&FO z(~l*CCq^OV0V^+y-%BBFqve5=>-DfMH42V z&EF9r-i``T6@s-RywMgNQ;Z{Yp)+2^5hsb2AV7>V$q`USrc#e(Xkxtm>IGAsA}{Gz zt_egDYDEYr*b=fJ{yft{NBO~_DsDF&%b1GOVVsDYlv4aGQBg)Fu6b#}HG($$!g)<$ zj8yicQzJVLIIfCe>0(V{c7b{bVF{HifRkSh!Nn84NgUN^dWY7*xcBASxfs891A_pZ zYzCU`^mxpHx4a{V`ovFx++QR%FN&1DK@@|+lMxh7R< zjZcy}mkdLWHB3(6v6|R;5N&i4L>+%(JnGY(s(gg|Xmm6lO@<3 zF=hR0CxjD~30#?3j!+JJKy%Ku`2I^--*!w^NBS|NekD#8dbIAGs#B?giA^Eb0MGa! zskm=y6H7}jaR?+L)cfOd+j})BF^Hn-!O~2>UHwPBzD{`h>)>mNhttd2@8|vO>*+a@ za+5`*@by z)tOT5zE%)e1=tI@8LCP=RYDS;q6J#HV$e&Mvb2Ub%EtqP=Neb!?!&KEo@*o%Q7Q|1 zTexU^RC=0efGtgShz!)Jc{>@Nj_#1ILkUge(-m)K?J$VftzqJ#m5-DU{XhcoOyz$4 zlB01!x`d=F*t|Y>=+c5~(G3T>q=IdQ`()WyiL(YU6|!0n*7s=a9%172cI0?ZM(HX; zG6+)YdYd(Ocw;GSLxr>=s71chk-oX~vhuwpcU8y}App)ns~WKo=^-jXij(r%U)Yn3wbtHr3C$0fR|0bBcG)I?Qdo0ybb9>rd@BgmJ$-6cL1J=R(vW>^W8+FRrc_NXe) z7Id!^O|dF76qB@7ZAi_{xg*_=;4HSRph>_Tw+?@@DpjxNiOYcDn=GUn#*?LB``#A& z*m`zP(SwyS$&$%JyBEhUDDBji;)~Z*BD=RUP7CYvhcS`_#>kcu$wXg;9MvUC6ZLq( zb=G(zcb-eF8s7y#R?2S+kE09gW`4NhP%&Mp2fPOPd`gdL#I4KSGNnD0{mTI%hO^G_ z6YDBTWplAje6TJH&DL9DP1V?t-LM<-ZKLwY3JQuo-2Vw=yKAa(1Kk>8;15h&OT}Tt zdnQr(SNo(H93(kF{s7jT;Rz8nu7ll(`p??o1nZAL(*8OnF;IQ3UPUunpP+cZa1&;p z>fMbF-UJA!KpkZ?A{0HEe4HGgZ)e}NU2n$eTiHNmm4((@pOtyR_Z5!a_Y!~ScVrun ze#n|8^`544H~`uofPbg<-Gl(!$N(BGXm$<&X@4_CcnY(+35ab+zwt(W*d^D@Uty`mweZ)TfF2CkD&`rh>?u!Fa~YQGde&d{32!^dZcC zE9)2t-EO$Qdc#ERA3;FNN6})AY2_$H*lwNyRxK2I)GTrx-47I?Xw+Z+(kb)Yfs53Vnk+P9W ze4`sc;cM*|szZMP{LSlPcevtIhpzWYA33;nJ$af7^^7)wd(9t%tk)&f-u7(Vl&ZjQA!m_lTn7@El6V)}%}qSMMK{K7mPrN&qqB=S>{a zuOhcQJ?4bia|>rYfZ%p>J*NkkG5CAz-SvdAHqq%Pq=qf_$XkC1jE05dHT?=UHn^kQ z^P;r!9WO_`2krX&8p9P{!;eToHxm?R}7 zpQEaCQr$G& zlJV`)LN)1uGeNKI)Y2VnP@$a2@H39#MnA!}@}v-TLq3~2!^uA+=!xf4J<7&Omwnr% zx|y}dp}__!tH0b5HWkw)dIDkJoML$*tf_r}3E)2rsu^}pD{iIZtsdP!In+KhrKqhg z&yW$Y;m-roR_9pO_}F;`O;ABx6n$|gY)LDRli!iJwQJz+SSWI-4dpa_SRDOezUuGb zqV3F&^OY3LqP!%hNp?e;qcp`37f8?jIU(~QO^2{Gj5-nWg-Cx2eT?_8aXK`mbmkR7)NiI4teT7-iXr4kY1d=yz>(M-7 zR_| zN0LMxR@>oU-b!ljbJz+66s!*65!zRO+oS=;gS@H`!_CJlDsSe4Q$$3+rdv{Enl6)r z3JH(Iv^D%Pe~Xi)nqfAA*CuH}70y*XDDuhcJo?1glx2ZUoDAUjP(oGiiJ80_e?nD< zIq)4Pk?p#|2AJXgxN6c^HcsF)Wl|ywe(wKputf`6{82hPNCe-6WWh8gvExn_$w^gF zL9;;hd9oAcdMp>|u%W4*<&{WodNxtWge?fhH?l0s2cNy|W^Z4#>Zo&QM1`*^v(NF~ zuK5L``DnIA!|H&oi;048F81v-apGONa1Llm>Raw*W3BtwYQu7qr05DkTD#yJ>s7V; zHom;C@n$(@8ReWEKdNY~M4MA!Dz)Qz+o;j85kw%S{)*N3T}qY$LM^U2Bg}`@!pZR@ zqd@9y(z8AYQYMik$*d@UM241n{I|Ge|k9CbT1gh73UaH{=*<`&hg>BFwmYZ z)-${&MfH3MsCgQw$ENV0P&L~=OM z>`t79C{?OjFLiYRQ5f-Pnn1NUg>ad3to1~`#Lvgs_NgR1yribM3r+*;=;g&xfcp^pA+tcum}1{rC&O6U1R zZTPm~+4hgJBoA5@V~zn+=at@e$o(VTV{~iIZ-LNUIIl(Lg6i{xU9pQ*k()i&p?70a zyyDH-YL&W*1I4A+#tSZEX}qszER5E&5WduwG<{AF#h`?Juu9%k>om$m1kKYlJ=6f) zF}XI2m6?L4+&P0GwQ#NEDl9wWfv?w_N&zRKkvTP~LXExJtdh*)c+sK4j_3ZVZi*<9 z@-Jm3KgjMe8x~Gb%8N&qO0;FDz1Rjpjk7G5Z01ciJgn9$YhESaXi*&Ez3uDGj;NP2 zdYX0tlu$-W@lsz)k`z31@14!EJD&9}XsH$ty=PFzipAeWDa@5owcc;qplW1+bQ{>A z#oxmpBUxeUY9u;!Xf-T1WU^o=_T;!4cdD{wTwD@ZE!B9J9VtMp-7KOyR&Jny%P15# zKI2a7sKP~~5l&QR^fi!y9n~qlE$t^3=j~4fXQA2F11ry8CYYxhZxN35YP}-%T zXO%hlNuF{SI+$=EQMQa6x;oB~ix~W+q9|-iE3p-W<9R!Y@{>)eEAx`ayI^Kuo>ewS z;lYRw^J@@kejXEj`c4}?2ZsA0;(B-j{3b|IC6!h^icFlQpGNmbzd$emcb@dL|Dl56 z{7)un&i_V}^nYE!{3ndp|DOtm?Z2vE{+F!M|Ks)Mt1g|QkM$DiB`YPbG%J!HLNv9KY)c4*@Y z`RxX(rR=?f^$Lw{YhU-V#C3md;Qxgn`-1ZijlK8&a>lodJdI^HNW0p^PK7?@~83tmtALv;=4%&Xju)> zsq~G93u&H$^DnpiKUjN*Xi=g-J@eSMZQHhO+cxj9ZQHhSk8RtwjojB6bkghf>rPe% zwI?;GRfDR*ug}F3`R*FuMfvzzsAbYr&noO*^F}8sN`PIqxBQss814J3e;H|2o${iJ zM^m4#Wm;%GTlJYqXhm&i1AK z89ZdDA}L}Km(&jQbe=>Y5Rvig-cy{@42ez*LxD`xygI=qlQH32$4N zs*b(>nMa@Va96=oMRy;X+DGYbO~X<>MSN+o?h`5paOxhRL9$ddP7kn7q_)RY)hu)M zfqtXs>9)r&r?AdpC*td1gG-;gR8t(bXHRKOte6Yo%|=m8@!WMn%}x1+ZfJxAmAC$i^8C$8Kl2 zmNt5UTYj)m@U?I(BoMGYz@j}NW@~inKh(*ezT+ZN^3eO%UEUFmkyZHizJ&4ajUb08)&ygstb}WY4DcPs;eO= zEB-yjLf1JT3ftHsfMwF5Bq57WBrVyq$cJ`m^n959s*WY4uHy2#LjjcvjlQD3dO!bN zVq8hlhgTILg75U=T_iF%?teszKi_miN%oM7PtJX~FlzK7qY3`SH*{9a6_Lekkr-aZ2Mf;U9IklQDJ@-~m-*(yehZBpj(li*Fr{kiS%QHbHNJsn0v zi~1@Z`2EhuB>t98Z+YCYUBJczB3lhbdv4%f_$a0*$rW=+@XLb-5S9gPFeU$ji#z|Q zz1)-l57COvvbHJUCDWy;#AO2VDBypQx8Yvf>@B9#^zhTBP4tQT3DFx4`6mEVF?NY; zZSocP$J2#GFhH~_?1RnI>@n5=q%I}z2h0$PwF8NU*hH2pS^zqv6T+{O%mJx^$9}Y6 z%uDpblauk+?I^hU!q|dEec^V3UY`Qz`XT-i&Z>Veui{Fj56gc5Pa31Aa;BmyB7%XE?^uUm3yu!IfLpsK$eL(Pw zru>Mdmxf8mQ}9x@`0XdLj62Ck zh7*ZTQS`CJxX)o{3%Hlb`(O)0DGL4y#TD>zm{(T>)CgQE%Am;C`i!-sV!CpM3ZB)8 zmx2=b;92GJBSW6;GwiGWO9|qtgazqnj$jm1Z8xDH8F2t$WvlV57fS-NI||FZN#Hvj zNN#0c(&@7y2{HRUo2zV#uk`zv^gWmb2ghC>4fI8gg}pM$;+d{sBQz++$dZLpwQHCB zL`Dl!Fi0ca3&I0IZ+xd<$MynZY{MXkYwA(-!?KGE4{ zfi~>C-Z?&L8q&J%ztYg$h)IF2Dn4z>U-4AI6Y93A3<+O3AQ~kqt!v4TXci8{jG$2O zDP}a&CGR#-(m6|%;z;0|1}E>Ltwtxo;K6~m6d?K*FD}>s|2yGw!~Z zp^@}7H)>HJKTWPCZ(Yc^{EtLTA&#~j*4TG&k0cP)*Q*Y^lN{-`x!5ikrl7*Gg#p8i zX#s}lA|L0WCKNxL1C;(`z$fG_ll-#jl}7ctcHkm3@T?t*Ertth7#w`4NawTpN)ucj z1GydHJB35^+Y;Z0m{zB^)_u4w4ntoVm@am$5@o!m{b_ilHCX#!Jdr=Nf-9Xk%*H4+sl-Y>^PXFsDF2u@IDv@ zOpXAH9FB1S6M>8wfj08A&l1h`}@=Q3rgG<0xL2#JjH53LZ1}(k&NyL%`ze#l8>9 zHFk#OniFTMctLgkp>aUDs}J`X@diKxV^8MhbtnVjS3yZ9YbmXDEw4Z=!aV?DT2YL! zOxY&jnU;PnVrqZ2M+T-X_WWyTgHR;Pz!YUWR0kKrBw^^T>U9Xq`@_o>8#zKGqI67A zt_nx9#O^0?`m!6HvQ zyYX?=Hnt$zu7dhP!6})7yh!9cVTN;9k1o?zW_GA#7bmSHf~KD^cB5U2OiMgYywiU~ zi=ski4pj!OEOuLz-IP%gSnggIf3)o{ea#wIFfnx!TdXTf{b?{Lv83*#V{H0)$D+vc zk!{P6qmf9II#EQ#R+N*ll{HC*RU(mT{PB1RT8CX$8Cka%*M3LT>dXL6ZZ%KcwS*b| zaquhFzG8dy&DGzL6yYTLY~);Ixcy^a4^M2p*nLtP4qlMl?5~aPGZ(J+oQsKaas__{ zEJ7Fd@FNi_<5WRk@oYbpS6=)j5uNNTb{p4~!KX`G+ zGMRtFT4=IP;s`(=TvxA4a3*c1>q3yMgu_X(8s(8|jpUwFNyRWZ?6$bnr>m|+wAIo-Dx^I7)-07nzMK!#rQm>V9=4CjI;Fcjs z6gh>}z}E($Khbk-^ezV$UWIB}H7Z(+m!Jx4>e&0Vu_0%PTOSJUKjuSsxu0)XAwggt3&{iDKVDpY9b67x%ldui>vgc( zTGy!M@D{1Mw$*Q$jm}C{)ty|O{Nrg`kpgR|Ve~82=%Tn{i4w7UL*_*T<=P-r)y|+J z3?0X5p6gU$hxvpNfII9eEjFL%suD@hH2o^-nNHebYd&r3&&w;HBu^2lCH_$+A#*$p-LCeD3wHfJp$jUZbBi*U~H^YGUr6yS(#q_miOm<`RHRp5W^?Zr; z&yzM~9+?g1w);(1mwZ}+?{($aCdWg<2XkceiFuP#&3NL^uk&wot9fSkqt0dz1LAy- z=83r!YM_B&2^STV5|wJLvUag2=P8yiw|3?W8v#G{o8ywXL@JGv2TyWdP$4! zivb?%Va9NsS%jt2$EBg!{$;*s@czJL#*fSEDGe#D;c-YnOHv~_&Qz9GPyh7m3zU|T zeQjoW`l3lMo>g&z(LZNo=_p*dn<3_s2^Gxac$8g4aWl&L{I{j~uNpj1z8ad32QKhx zw~UipU&LHI0@@>u_Cuzu5!(Cbq6udYf7DAB%-{Oz=foCnii;C9e$vnceqGFpI^`#+ zzw>_fwIN|__AuRNx^=7+8M5llLcT|@bsncD!2CKBD_QbR-HJe|J3H9HQZ&=+Efa^l z>o$J70pNa&+AgLxJNISQY>4Jx!gx;$OGsc6z~pW^6#c6w<`asl%C#9+F5IVPVN5P|QFT)R>__ zlIa>D=$YzTGK;@g!ilD>*l5sZ-=`{;kD`H8@?w=d8)IqypTVIWjE??Z!UASl9T7#@$iD10511~p zt$mOBggN!I+%p$7x@Dg3c~c8oAxsN0hKG3yFZKj6(8 zhQ$D1#z`%e!9G3AOyL{`cbv{eS*_N=3XZ-QFN)d1_UwY9`yGiY^q1NK70N|g%QJJ6 z-t6MpD8B9kHiBrCxY%W81i2?EEfuCWjw#XhBqg%^_onA_ia*PGHR^!BI|?^LBOgO| zM%^uTtK2Q5Y5I{FNTU08_b&RA=%swp2c<$I9NBt(ujyikO(Pb`Krtz>aGxpE?E~z2 zbKyt9d4DB#a|VW-;Ktm=sfe22oI@ssV>!n@1A-1Y=qJhV@v2$-K5ecgZ|^H5czxNp zq)}V>-bjk79$Vt8LW0AjLA*a`z^7h!D zh3W4+-sbQP)w?*X1&ncbi3UA+69S+g8>NbZxY@g^6Qr5wX;yjE7^3lZ*hFM zD^^2eXLv|OEElkssHmtqQ4@cRlk&IFhPrX*GsoY>%Bbe$IVbHv>}tx!zm<(YqJ zdZx8+G+wuh<`rf3g1LGCSQWy(g5&fFTF%|m0-BR<{?)kNVaw%L)i`)T?Wl90Z2o(3 z)ZhxR6kMjh^=g6nzC|@dMznghU)D9%)9HSy1>!%k?MRA>W;b1EBzbOQ8pm~jvliwJ z+LPp$#{k53#1A!&$%v(>D7MMqv_%aOSYX=NP(S!|@GOeX|U_eS{FfRZK@r+f-F zIODSu^C7bmi_@*_u+0RtAe6<4xa#(5aujBZN&Xv;627SOUtSYZ+*SL{7cj)O^ zCrZ>BrvYrq3K0;AP|aBM9~vqyhz#oQ@2!;*&NDN#aL~Jjgw@bmR&S8JFsk>$(LQdu zpI2xZo-Dj{ZkqR~=M9fKdpYs2KoY%PTT2rIgw<2S+Nl}t1U6YNf1`Q*jXPNUkBBeIW25>*M?i{$aj0y+ znl&_oM$M&*0E|KOUTj?~h^g2!$?serv1xp1W_V>U9tK9MO zI9#8@D<`TeABgxX-Vb^M`qYSKg)Pu!LdQ z%r->siiiSX^-VG6D`wv)0q%%+aSEy6^=xN7E?r`uIdWJ$!x;!e<`+%PsfiPuZ1n#7 zQ-?G^owCrHVQfe+4Gucfw@82D{4cI!^`8O@3t3 z1>;~8xkFs0FgzCnO#r3{wr3}uBP}!NsVlG&$nQRA9iebMM*lXm)w4~H;%JBm80A~B zZ%{BUI%&{Lq0Tm_RAo^xxNa!(hMzGBzO$~*Xr({|ZCGb(NwTN`N@T!!nF$8$^D2?w zCM*2aB5!`}Oz_sdGAiCINYLiIhj6(J63T|k6$q)~5xlfPvF)*Xd1y~&(c1UNXz@T% z>WQya=T}_NpMeLZ3E-9=qZD>FxMT+aWCxb4Oc{dtoGJRj#kgOF+zM8A*jJ-R4*Y)skzZo+qsO`eU3#|0<=_^OT6Be^q4Mj>b8rr z4@PtAYG=0OY>&zc80-xyuM0ly-G~)8Md{CK@s7%33*)&;49D@%A8&g9lWAgIR)Kp7 z7U5YIzU=f&28Y5=a)!y|FlC(Bcpy#lFg%6w$;j0x-OErNcY=V3a76TJx=@hVc#whz zxxLG*V*C+`uEM_kSnqrWkMlMJby1gC!7P4SR|wZt=}i^9UaUn0)We<}+EXtw z6Px*@!Sd8Z!-*$$`eVnERKvl;bwT+|VQoM>00a~~@lnc$i3DSgR14!tlHhc!&6h@a z*+r4TNT-iLsA6ZTuoQl;Jma`^33ZXq{Ob3jt6&Z0757+F6Sv1oYXGX^p}SaB|F3Ie z7)O4aR4vd3V!P*~D`6Wiq&$VKTpn;QIi}!MdhJRkv7PXJ&xLmJQG(;75Zi|yPw$dk zTRy(ezyDe(AcAaY|CuH7ADc=4PsBLqfA=wjo$MWi>^-y@=>D}-{#|U0O#e=H&VQ#a zy{xH;rQ!eU-TzMf{znjJ`Cqq0{#TnQ?EjSw@*j`?|7@bLvN5szk4=;-_08CS$U)z{ zy0fxjhI$LPq@`g9pfTp8p$6WUjR&kK1AK}I;uvP4j0Tq2*UPr5%Z2IEBiENeg8*Md z%0^AyH03fme%)-|KQ+DIFZYvC=4n*QyS}ea4?;P-dNfQW%LgYm$t9X*OGYJEF*C~t zNtq>04Z4~8(?jJEGYgIdXkATtv+Cm(l{1^$H}TQUk}+KNc1bw3-k*KjbH5)&+L;@p z6>6s!u0{(&IqET=3~kUiSAi~}_-m-`f8;Ok^Q4+XN%ImD`b&sEy~DV-_T8aU2c}y) z<;9H6H+<1GHdnf-Jx|rp{s2c)Ka>|x_g1fg*w$U_ZavnT8RKx$Co9YgY{yj?+i!wH z`SAW7(bwmm&-_72Oe6jr+XW#f5k_W85~ZKQRS?q=pL_hcIGd4o}a!U zs-Mk?-tW$3wKq?P0v}$7d8&=?qVeYdcCz?WDc9#`mk*bS&I1>gr|o1;mTT>(yTUX^ zvUA`CYe(yGk-K4NPUj&jUA2-0Vb_W*SEpzfb>M)e2s_os`V+HmJA8wpbC2!Plrw9- z+%rr(FrY*=CU8PAy%ir|bn3Z&fg`bTZn5pZj0AaNShifW=={Z@>=)zn&f{=yX`C*P z0wB9W@9K_q6Z4z90{pFyf+L2*5{;NMuqT~WiKTi#%3GNjDJ(;PG3`M^>Vs|D!4b#hyde~RA|wI27G4-DYT*J-mMjjCyv9h#Czz8RJzPC zRR-rfO<3%XL8(-O5v1}|7_z0c%(vYXQ*zT#1TlR1)J0f|-{cPDL}LL0El6V=d@0Fp zmf7<|H=@jk_#=O48tXIevNl=?87`${n|1*iUs)svyM(#Y7t5vR6>f|XkF=^yfx6Ah zfI{u`ON=~ESIgk52zgU{X^qn8Uy&H!-^BJ5U8a`~ zycUKy@CR=NZ=}b~;m8G|i@De+5D@|~9X-l^=ITw;=L{Mple8j3#$bKJs3t{H57(&n z<$9nzt$C%ZWDZE1K%V2rmfG>Is1ox@gCT-4VXF#t^LeVvnv~e6OABfd7i>j7Uu%SD zmYx})T|wT@-{<=c;m-r6n`Qa~^5q=;esQxEDFGfb3@?_T&VA*Hd%~)CddBKKpBVLutXinxPZL^a zvDLDWba;&S`fiGqW)+|}o;S%wVUhxzIBBSeb2urLBW&e&4>89{jRG!_(mQN|P0x+2 z1uj4@JQ%hW8!d%mQBuT&v!u#$-h~M}M;pYcecr#_8P)B0BGzWuaJqFT3MSn^g4IIa@9^sMZ!i3!i_Qi8eat&o z?|2kTRt)YwN)vyu!<1i;!`FMCi5}up9E2VY^n!@6gfYx06a0Qmw3OEah2DD0JbP|Y zUsZr!V1~4LM!5M}#2~=jmOK#Y#rB;Dy4nGO)V%bY2E_xE(o;h22Zr2tU-HYd(?@c70K%_Hh^aA`wyvgoJY^!pOD@<8;23AGsI0)<}lueHAf|Qpxy7p(N>d za>%#|4|x__jSIfo<*m3cQk7JztVyA9rBWzCOZ1{xYeZDRn!b$M9Fi}oqCst&cXDHj zOD=;>helLOt~Bt)W(G``b~eNJ|KR|Odf9!_na1VF($IoImYFU zb1;T>!551RXBwbPgJ`E0sZ5aEIgbGrl9wtvaO-Ps;|V;Y69nhDXouwF*RRSGzkui= z3-fRqivnXYkyTX6fm}f3rd((uxXKd~l@W<=|Y>D$a|1!Ms=6*!bQ=<`g06 zZQ;$IS75uXfv5eacwV%l#J+Rmh5}p0VWPdf5}OB+uG+vm-?=e+mgmHf!XKOoJv3B2+Q=!Gg>a&VDET*G$x7X#UFaO7g# zobF0(S^aM)nL7_RH8x%AAKovNxC*q{Mn+WaTG_n0ySMiCmCJg(A>;Dp98mNmz(=k+6f6q}$Pudk;pVz0^EiTWAOweel$d$7+&MjgWW7uFL#`c&RR?3oG zcvPcu4l&qM#nLs~%iG*KxyYJ_Hvz!_@#GD1Iwb&l?hy3*3+~wfodQ?iB08OR*|VUY z;<=9#DUbXY`q>I^Br|7!wx^C$IXRtQOgWu1xKrC5)7d3gBs|PgJGsm}fHA41>o1sI zc#DU?-cB@eM7UN&IsSaG=);W6zK-R18HmT3H{jkDV6HW=2D5nqSwV!-cys*i^%0ed zNL>SpRRHMq28_D8f!6xEnN~e;smas_o?Ct|(VEM|ANyzX+<_@NCG5Me&LVLL{0kBD ze^6%tH=(Jm&V;jax3PP{xIc|#OdQ{`dXwBUi1*58e|z=e*}}@{=`#HUjdS zbzawaby{^_GZBTN{qp7=DOT&!n)lhLFH$Avdu;yu-gt=&-IjZa#S{LOo!s{lkSD&+ zZ2I=p<_{qVfNlQ+QAuP(U6ANt#H8`t7RqixRjd>FQ%r7(T)#IMFS{}0X$|U6?W;I7uJ>K+dl_b{tzwS|YBJExB>_qXZtVd~3DZf-x)q z!1boschG00r5!eB;p;c5b8{kV8i1tYgq^MGm*RNoN(%jP;uR=~Sg|o+evyLS`>Hu# zr@s5FznqhlDqSmtftgpQ{@+)u;NyHaak+1g@{2&YL(?5!o-7K!xot`3N|mdxTs%cw z_4W~nT33hyb~_+Or2*67jNGH!*t3@$l~iSzTC^o4Abgf^EzwIMa$y+_=cJw`IBi0D z-s^-6YeNd#!GM+!Nv9We`uMg;pVugVAh}fF1XmoeL7=KPz}iT1afqzLWikkU;AzP7 zQt3jeM0}uB$3Waw|37{+CbR@I_GO5UenuVKST+UKH)FV@%YudND&Ze^f zVmo!2wjE{>cY)FZhO%fIIPBOMEQwUKz=q!6Kd`R2vjS1=&TyTp?u{Bk;V^LqbK6|= zqQLwYOXr0_-z4gLJ5z@S9rt3;@y-oU0(%T?@{c{BHQ0l*+K$u$+ORtl8*|%{fSi23 z1&IYz*`Wlg=_07nAJ43G5liV>2F7tVCV_Maco!Br*b%5QSzdthx5sn16x9c%xPWnf zGDv{%rLM>Yv4~8T)Hz#K8G$Y3W(5HjiePhmmJj!W2ny<079E{+(^tAb&p~;OI)7o` z-`GLk@@fgj84wpM+6(fCy)m+gJ(PJLmz+!++ZoH`O|qk|hIx3jE~oIvS`g1?GeF91 znEob%=EmC{cgB|xi7@h2;$4^lpkS>l|8Tdp2&L&uZ+JA4y}2w&>gWQKn;Op{P}Fzp~`XHRNASWks zR1C}4IyN(IK#>Q}q!dHuS4gRO#;ZM0%kX)fsNV85O65K#CApM$CZOR7Z$+%$Ck!s} zwU_eKpS%=EQZq#G$>?gM@jw+9vo+>dEcRm>O~@unx8X99yNAHbK|-Ea^{kKKS$it^ zPh9WVyGeF7HD%OvEiuo;*I#gKLv;e@i<2BTQ*qHEqq&OOL}i;_6{%}?H;YxEQIRK7 zQITt-mw{+bK+l$5zNPxL10`C7p$pPR$xsR+waAM7$Vh=pm3>m%3PHm))a9#9YXjAY zk~7y z?2>5{Xr+=Z4iDBwIfwOkmY+B1IMV)*IM#D(1M1SF-^kjmE~M96k=isX(XDB%ZvLJ5 zMmEqW(GNwg-K;VEW40JX$B7cTvl1$WK#N&HF7ujJz2i5t!I~F`>lYh(>qQ89~|p1%8H6ghWh)g`Tzi06EU`Zl>aXnm(BM1WGENZhGH5upgJ zyPlJD%Xiz3D_Taa`k>bm8gvR2ASj!iYGpJ0Att0yD`8la=bJV$Fca%1WlPWv)4@8s zOGLV7nTH*k_*F&Iq#e5=6|hkpFUuVIWfsn*%cIuAL)Ac|58vY5ul2*#cTa<~>jN&) z>{id{-BGA3{IkhsBK5Va`cwYS`axNrydQ5D{I^L;{&$xa$u`f2_gDVfOpgQR5gt># zL_mo(z=FUB8A1V9fLFMUsQrb4BdJi}B8R#h=z}9ya{{$+$qCw06k-^9kYX`I+hdjF z@Tj`GlBVW4dlM67=W9oxPaGIXH_(SImFK4*$CBo@hiVkz z0xitCwfUgo%7o{gWZ?#;BiWJOj0|G^3Wo8p{Y2j%n?g)@InpeRWnUwsu{b86+cgkX zC2{Uops2*oD2((U1y4qp+oZTYuzagCFbfH?q@HmB1kfRUf$MPOTS;crDp`X%&>k25 zxlYDBe~K=a+Tx;@qp4{EPAIiQa~|!Obbw6NOuT4U9%{ozR@I`@) zDA|4}(TnvwxuZR=XawNWriyGyc%^f_`iP&m!t`268EoRxl;E3O)ojCA+%mJo@s&7N zE`v(HgxCLy+$5SUFn!7j6=jYNJs91Q@hKkPg+|A+VYud6?fM$WbJ-=;;72_{TnJ(ms z}G1*Jz2f5&p-cp^`*M;0j9 z^TylaZxXakRZu56@&VjV8wGX@htjtQ?!_*=hCEP~1B!wf{gpGYY2qKZLE1oqfEub* zDyG(oGI>1Ys9OTk1fIgrI~O5w!t5cAqra^>LkfphNTfBL&I`{@9Xe7s*s9@czF)Sj zUzgea9R4YX(_O3l-Hx({y}v)pS#NhYwT=a=x2GGwraKg0ZCbl#U*8y~IkGBaXMfnw zThIHw)s(Qp;hwg>bEk%4@xFSR(?9)`lsuxy0UaN!Tv`y0nZzm6Y*M4#I_BH5k6+!O z|Cl$3%l2C@ zHlUjp{s<@Wt`Uli1XVf%@<-ZppoW`PID?NDp0Nc-gSh|7x-y#Tc>cu>U66S^WO(40vDoGcqu6!$l2k0B7=& zvUsf#jsR%ghy_I-8%)Hur-$^_FN}^NT_&qhSV+Cm5IGmRl6j9Sxo+;@8<^rtZ(GR; zR3COq;3*0-h#ASdt7~)#-~J2O!|6ejh7t+>kESqyRPYLYTw#!&d40XD{)=P)5C$k8 z_n)cb{}~0G^Zy_P{J&Pm89D#2X{LW20Y(C*|GPc#zrESS@n0$B|G%){tn4iRQ(>U^ zKMDi?l=6Rt0pbKC!Y#p0o!UfFa%*v?X11J~>L&Pjh=hko0OAO_ZvDU8i)olJl9D^L z>Y773US6H@d3=vvZVoPndc8bc{GQ%cNRJoGmy5{G4lG%uWUNh>L5@h|l4fS=V19jb zd1hGh)Eb#{aa_!rD6MNJkuBPEzE)4ItAak1cbg^pNdU%Kh@fuqy(^X(%M z(s*wJ(AsZV!yTBqydsBCe&G>yH4V;p%zlX9)-Q11vg5l$oso8d%9=_Cx9|O9B2DyN zH$c`GnJYecJ*J<|oEbV}eU=V{qTo*1e@|R@3-3Yb=Efet@z~oK5ak&mUfm+(j>Kqw zFk_f?7UB`L%xkamw7Ej%FHNBR7O{Tjnz&o%=ALjvVG6f)KTl5Esf%U{C^2-RR=>6_ zQFu}S8dQrVu?1x{} z#@1cxAep~gc)@U!d|16oJn8?cUA=(W@w>jTc}00&7J*k0(IriUEoV7bW2lS%BN8VU zeIZFwfIDS4f}k2VOD47Jl+K9Nz; zP~1a6%&VtY-!IlOnm0?BVQ2P4Sy364J81i}3J%ul&QYj2L=L7seT&XCpsj_0^Y{vt z$!#&dHe2|i-qviP9H_{V0GW@mAG!oGUJ3!wN0)v+L?xdr=QCmQ>t7pCKN}WH*?XX? zpU~pw5C3a{bWS2=>onG+#!#M21raz^9Cv7rJuR?k8A2T{AIF54u3F6B9Y2XhyIj(x zEwa!p2(nJElajWYonBkc8Phv57w6kKQrt)^OOI(S{)iH58A{P$tqMD?RY{znFmz-{ zw{ON)bNA|3$@ku7Jm(D1d#}c53ljU9e|c-9B6J}U9$=S(u%Mj8P5Tpstn=jQ z#EyyKC`js!s(!14VLeju=lzXK&zVRuIeHBbE6+2FG$m}TyCVK9tw#y}WH_J(>yCig zs!Lu5ta^DkKHkSbte%Gg9Zms$WmIgWPG7Umxi33Nk_{iV$@TLPL$Z}z{3pOuE?Y#LFPQk zy4&F)p?@jUr)EA+ZaSGi?)xm^x=sj@M}?{+RD}_gEmW zoz{e(OE;tpPpqxvLVkR6`(uEL`hU8%I(SXE%zp)=9~c#)rN&0VY^mmcj_ZD(@8{}ut`M~zO4Ll;r&sA%(&k$? z{9U&+)uY7Om*cqH8MTMosylTel^0ZYjgS4agEWy->Di&`Tmj^Ln3*Q;Wud33sTU3y z^Wh^0A17v1xM8L-eK5A+x0*;sc)bA!a&Lft1(i#)@khkp@Kg4BvFd%K0P@KUPd>L= zLhA_^_5GKMIzy?9H`qts9)75GpFLJ;mXJC9eFkhOC@A&Z{o4&%2I^Q$+p!5xB?_L3 zGz3?P(w#Rb7Yhi9YxBGfw{Yk(x%J;TaQ&mDPAaJ2!DG3)L`Hs{mSqtN>Qfk__C4bu zX_NYgjUY4KVp)MDx-U4(@5~&IQxJMR-IFnr`S_mb%gNUePIm?_4(=}RmJYi*{0VEU z3aU#M6RojF2+A`_Zn_IpLx(kdtzSNGo#AYV=ljFi*U@!_B=Ud!hm|qprw{fl*d}4N z&NFK>;A$ZSa}R(i_Vr!Cz-14+nVL{_IA!%kC|loAwDEcYYof!g%My;6M6=0LNZfH^ zoHZK{mq=>KN~&dEO%{THzh3#cB+i1IRFl~~Xga6JaJqwm-)z0EWoMf^nuejOb=t3H$GBr$c|@*< z{WAaj+BqtaJ3`K9$s7~|)FB^vJr#R^bXEwk6P}TQ=myILKnSpuU<#%=M&;9%QodO; zdgCo?IHzVv{e*yIrq7T5i_B6r*3}{*s$Xu2n&8Kgx+#72wqe&@*`Kvo3~7O}(x}yK zQC=&8#QG-;QKgqR(_-4}ouOWh{#9dnBqsQ$z=)XqJO+5 zb?GFv{=r$O9xR1&vmN6pJ}dr<7=>hs*_=3`g!$FPzrZud4;qi=pUb5V5=H%aAijs6Nsq7N%|0hfHHm^}$Aziv7s0rdFwrMwK1t0EQ<|2p@8KPqA7Q*5h>M zlzNmZBb=9jnu6ES$+NpFu8h6I2ZSSYH3(mh+wVO>T$2+h;2I^4J6jn+igxM|a0;%s zVzKD#MD9ZsFnb4Lg5iOloN7c6*Y&K~Cq+ueB=50mUXBZtUg-f$s%Ru>anl)4NZvQE zP)Bn|oxvGvBgMG+bYh7L9dM>osluO-7V3T2puDT$ybG_VQKO-Q8<~r)jDP-S*0wMb zuQCzcVk!?IRXG03IB|Bs_7^slr&p&C>k*EZrlo9K|Cz-JL-pm}MM(B4{W%xL4=BT$ z+fpcDo%mh=*SxR+v(OtMMg1-JSt*y7`nY2_V)6~toJT^YPLW6KrmBr;Z3CytyDze!l9{=k*d7A@%mz- z`y$ctkQa5D{|;tqjg~yVXlp$zy^1B~Ipc~qiD;Xu@^2XVMI=Uw9n}OFGU`21J8q6)or(AP(NB({6&)pvDZx0Z0tK&y& zEk_{judm_lRj|WaN!Z>VxD8K+*+Pk5(bfwzq_J@N>za0+N}f31uVfGrMYUabV8xuY{cY zGkD4L{*KMGLupx8XC;=ynVwDMAhGY@xU8Q=S@Wr{3dN4=f&}RPb;9=@!HNzI(i_^+ z%$QM9{}W7~5N>A!4y36QRl#jNaK^ zxp_66z^HYzKc&xeyo`c zWkDEh0X`esZ@+e;FAhA{spXGJ7Mg{@%xcw~)rDK;%{I(h4+!_)!^d_rZcwQup%)ev zIg%u8`lok~h0NPRM1h1oluN11kh=*RQt3f{SA^kM_@J`lRCon_D+Nl+t_vF#wb@s8 z3N?A@^hg@yLj<7aVF2s>nFAvgKdBpdwli>yPYw+y*8Il^tBU-L`F#=fcC9I5;m|VPDfpU)#>ADF=!J-BbcC%30L7WNMx?6)t}d=RXvKSZD_KsI z?mpA}%-WT3VnK&F0O%`llmI{$EB$5joa1q!7jFZ=>>Zh9?FRAV$_JP+j;^byEA2D) zv^9@>kQ7xAY7Q<8z?8=M#s?E9<4MLH+O~Ce4`Z(vPMo4M#`|8XsoZ$bsJ`WCu<2(y zw+irM(8W^ALJqbzhm2X)P}f8L++l7VJ$lz{*vxv4_70x-9qoIyAUXoRTA0R_=9g$D z6GmcEA`3ovtplv2J5)0L`+L-Xej*~4wDd*wC*R{4L%f0dqBHNVfYgdHU(6P0Vp;G~ znn6c$!PwVtQ+IVN}&kJr~T5sigo zARTE?Hd1ae#}NBIbqn@UdB96tV!wFc0u^eq1wwnT#jL^*qmYA6b|dM2CObpK2QF(s zeu#h$lsRbt2@dTzrJd3YTMV0saM5;@m~P5@be1R^gVXI;?wcGv`-|HUxOn&4_I=Np zD8Sq{^m*6Q)v(UU1b_qA*(O4O0$?&9x3NX}Bxd?I;%X|4HM5|Bf%xw~C=fGB`SJp7 z2KkpoY|Nocy;4GRj>JY;>)9WwCt(I6aPnI~X?xx6j1v^xw}?lzM2Fx3kd4oyG!oJm z<}|G-WXmK$0}O}8nm)0!2OPv!%0|vpP|Zvfp!pdREM>n{Z$};7P%C?Bv>#r@?Kb#{tI35`ekUo zuTHLP!;=(S2w-s@afYc!IV)$|GA9F|0dq-cwV96rT@YS^l~3#%KgLPhLm`#(7<*lf zwwGgaG+vNYHTM?b=;Enjo(+XQpk4vQb!x+dWtM(%0cQ;Fgm=E|E;szcntjWc~-d& z73T=sk|f;d4)Y=zsG z8=bY8E-^Quj08Y1N-dBhDOJzQkLTY}8q{}3#i-J&)yNifp@IbLY&0Mj<;hX#4-jSzaMC+}s%yB1&+ zc1}rPalT|k-0cX!I1tLs?z$0M)Lb!`7ffdAmt^O@jSlC}qN>nPbDmTn?4FdxIt!OR z?B&|hWoR@ASY$r2?j`UW&CNa|9OHHtZ)`>J`C3QO%6(BEQm?7b@^k+}G>Cu)%F?M` z*nr@V56Os&yq@bQw)I|2{QP2;i+GBos|3cv`Rk-;0*C^Rq3>)pl6*fq{P7cLq?=(L zW9<`KXdcgSo6y1FFMb$wsV4eP;Zfq1Laxas$oi0mnXk~XaxxQdWk|zmRLf}MTI$(7 z4|hxX8gzhV?-0VGF*~O;k>78T=L8eY%>X$iW%{<$g3PhR8H@I~IG<@i{j+ktD6`BG z2uH3VzUs5NJe}G-ST)J)+pd>#9J}d&pXb|iA3Qv?ZUsiOVmwbF-Q)aHe;>|$MVNKS z5Hcbmc<(i3g+DZ2=&&1!HfMZU=@EgW)}}zeo@GsS%Bj_}rB}0JUkh7hvFW14Lgkq#hi#rkY7Gys z7w`!48%xcvZ}Ple^hf&SC?%+CpG1?XVD*mJU)UuN^)iqhQP2)m@P{cTuqy&n(c4gr z-p7Ol4dlPE_Kr=WgwdL1*|vSkt~zDgwr$(CZQHhO+qP}=xp60AdM57lbVuC$0U2*Z ze%P7MUiqxP&4*Aw;#cW8A$dkcBbP%KF>W+&iQ%LE58(>G3w%r}0!2TZsj~1Al=FM7XIcQuWK;Gl}ZUHQ2p(y?SW(N0}I-8Pqv>(pK)jPmFmLfFpJZ$S}r-8MA zcpSmRTmGDtrMogmFk80aSGnv}f?W8k07N04%yQ%x3x@#Wy+O^tFwsWjm7$LN=b<35 zVIIo1VGiAx@*kS}UoCsfqgdS@?6~8)rkG0mH1H{xJ1O($v>-Mov0_ z_WQm5IzO$FizT<#;OyJ1RAyFET|@Nxyehw4J>n0b>w5j%RQm3Qu5uzIXj;G?Dz25!D3y8+rBK&Rl1oszu*ccVv z070hjlr8q)))Dpb_9Bjms047+d^k*;)q_-G3R`b& zu!B8LyJQraymV4D21gw?%Zgs*TV|A7x=qqb(|BudfXYn}!G)cX1bDL$^C2EAIHcc! z-|H5eLY0jT+S=#GO(QQT2EgAZDT4nhp#QIw!tDQzO5y+Wfd2m!UuXYch4TMBTJo7S3G6Z>(kjm zyKTkjQrEbKo@v2SSy?HQ&Eed`!Qo!3)6LP|-qxcO?(zNc^&o(oU8NE(v3zl3mNF!s zP`+Fp0N(i2sWCFyzMiosm|RXNec+z2(pfk=YFnU=nR=nN8Y>S4PeZdM+Q=+(?wTLN z+ElY6+z6#pWxmh4Q8xWcJ+pj&&66>`?=S7OJki4xyKeqeyS&@Ci}Ed9Rk>GUPbn$k zW)l;m-1K36L2Dwbyq_~Wx?YQzWt4^dnL1A$nL3hQYSuzulh#}JMUHp8;#_U<;vy?k z0lo&EyCVCP+%>%f5zIQWVvl1#kh5Ftv6|=;%t@LT5kIy+=|G$ zOsuWknEMxdKHBP__#an>y**($tuOZ%AEjf4)8!>oU}ZCUKy&#ZRJuq~S7%5$-MRQlS5`VE{mW z-xHL##zX>eH#W<+uX~rxnYIVEQ;ho0y0ce4b^(~q*^O82w?eh%R!6*T`9UN9aO;&$ zA&Ua2;?~?;b&p16pdFA@5OA63icR+onZYC z$hMHN7QcRK{k?5(G*a2?%vUDx$rWAm?b&`5lZor%$!A&J&!Tkifn-D3&K~I}OCa;+ zBVHj?co;Ro_S`IN4jgq75%eFifB4;BDW0oyC-&q)YhRz-@E+a0$u_a}9@QaVEfAo; zQe-KMHMbb_vOes1E`5UL6wq595E~K~yg>m=wcoF{0dS9&f-?|r7FBuQO6u<3>wFB_ zeDkeRj03#DUWN>YIA0nzPcpO{A<{Y%%J40@tZ>En2=6XJMp9!Xut2?ogC}yK+>Mrper8aLpvlavY=8z)ZfOZvZQG+` zwWCLp?Q z{GJxYaM3U+GV{$DZ2VG7HL+n(DC_%vBGLJ1OBU}^_pS+-8C~Zaoa?mPa&d?&qzg$1 zfTT$e=0_SmX{AwBu^@ddx@2kj=oR*ceT=+0<6TRBr{NgQT(a`)5QDwZR>+-Mu^j~n}AkvzUj|B7SVvLLmq|>?6}-e>ELug z;dSr|5B7|42!SSwq2pG#$?yH#FwP=m0Rl$ytm<$J+M<0#53R@lsN0ljb8`P_vwE+1 zFSFF#EM^nEAEtn<^>f*qP1k|%M2S2;zC)V7pOe%~dpN6|+0R&>E|c3`sRwq6(2G!2 z6^KHk!;5c@s~ka{rDy{(?}f-VEU}fsGemu*NTNXyL3Dwiwjx5q)K~I3-fIqmH`{+1 z8k{-v6|@#{;@DoyryI#Uu1kA%AMVbK*qbc;w?|@iPK^8y>4`Yy>Ictg4uloH>*NNu zdu-GD9!5-I!VHPGT=Zl&?G|t$GKl0nipYJKcg>Mhj}vYgDRt+Kf%$`gLhnp7&j_Wo z@T25|z?E93rp-YMrENEA*)!tSZ z@q_;@V6asQDXitms_=t&EQh6ZCHdfF`&A3onW85zh8^;?6CJ3$S>}C9d5IObx}9u#?_1F!)uhhObSU2w}$K&ktdQjL7#>qhdbN6pKtd&Ayhqq-bcE$17LQ9R zGy`*u5nB8$pOHZ#f_TaKljHu@;#_u>Bmh<9QF z@r)N+?P+d1_qPW`K7CZ3kre!28(7SQ(k#6x%|reW$Ee;Cb#m7UWdEDcP0MRw%xO># zD~}!a@wx%qb6O~N#}aMY^pYqRpYXOboy_~0}dXDI05bGw!w!CbS)dHW+~08 z5Wn@z^rfU@?d8}=eKgWu$hVHii)kBQsUUrrc{SnoePanq>KY75uYkZ zoEaeBb&ByV70DYHJohCd37%~W!2Q9aDkx!-gQ;0Ado#Q!yn%Nj)@+K$WhGrH$S_JqH^#32Wt_d1IBRHGHlhZCU9MVBPrR3 zkC>$xY%@#O)pLSY5a%BfAq)lp$?IiV(#Y5GRdiyrg>JC4V&JFu5Vu0HUh?sIe^*7tSlgoCJD0_-NaOe>Hua4NyCgcF3ln zTUwZ*E&IiJr)@u^oEXvA=UmUeVsx2!<zi-XEVw=^bCa#3MsX`bu9Xgt zdk~6My_3kZ3j$VA^82X_Et(6;{N!0p$V2?mYW855s*;Xrok0~miPW!8W0|V4lRxT3 zeLrFT3i)|<4z>RC*=k@GX+&%b9A6pC{u++lQE*f+3mKpt1g$gJt0r8>Y|?A2b9{U) z%!5A6e?uL~x%ii{m`Q?C#91zo@FsB+=ZIk?Anw; zT_n29pA>K)F|fF_WH*0yf;H#O^HMuU+t)F?zqS}H2{GDaVz}$?Qg(VW(W6hx0}%y& zITO{lH#FV9)O?dY2X);WVb;Uq%$hXC`Iu6qwctdvN@A)mPmt1Hd2nR7i!4N*U7^F8 z+PmN+@;awFa5J=ly%t%z4{hUeR7P-f6*W5;0kl-uBB&GFVWyA{X^78JH>QZ#DlcXF zPo+gjy*-j*qe84;Iqd)9xD(*{QY+orRA&*?PL^VMCX{dyG=_>jYUeauyniuHEu3+* zQ;mXtil4W{%&xdZv!g2vX}ZtR2+9P8bBSRK}I{z!avC&!Q?oh%UZ?0KEw5fU(>uKxuDvrH+PGw%14<6&Gm4@$YTuNRj| zF8azY2dlwu>Eow=meJv{M=*u3m7##yY^Xa|f1+~NEgloimb{(3HMSEuRBh*|t%RX) zKM*v0@W?e<2!o`CWrk}P)mbOeDDQRGD#iw}8E@Kmv4ge`78GnfB;q_DQ8w-hX&gji zIG&Mi9w0l%AS0LOuP67LPO=ATXv8rv@84!t5W>&qn!>~VVFuzBDCaG6t^RW+#Ku|Y>9f*B7Y7+*;ov=0**9*fJ3Hh71@wI zALGx{lx?9UPD%!-(`JE;?ITCT_N}8IwM%6ObvOuo%p1e@M^%mL zF{x;Pd7;xEd>?HsFI&FL_`l>i4Sek$s1!egU&_n$z(!y0Q^r*qd6G2li;% z!e70{*x;iNq}zjK3eO=xkrm4_R!qMq`JW+kSIy5@trmz!t6N(+{H#_1wEi{XmB}rwC zs#~36X0tkUM;?QcBbyqssx-8%B)sd^{foJJ_2j#yf99#5m^G_hA!7KY4n31YxQx{g zspcC;NJHSj9#|p^kYR6D-$cGDGz!JpvPx7R&H5*EGMl=gokb!^l5*|q@~)Bk*HefY zhu#M^(+jRi!%8EpPKg+Z@Oe0|-GrMjtbAJZLq4x?SIx+|CP*t=NFD z9Xhn5-C0&vLe65hJMcdsY7ka?4wPC5dsMhe{6&m-uguBZ&~C_ zq*S}Fx0ylQ1e0t=Uc=T@Jqa9g1i}cf(%UXU<9|rDxWuQdo4G;D&X}uOU*B5@C*$`X zElCcX_i*fUlgY?x_~ynjh@aSWeDQyYUU=c|P_?XI_tSoQRa&hd5jPX)HxZF7>RdWE zPC= z+5a0u{>LQ$Uw|^tzl%=6)=A&Vn1G&6(aFKt(CI%LKpYAF(*G~=&Hp_2|8GCXKU3`g zgF4Pq)pXos!Sa5s?VFql<3yv`DV8E-a-rRH%8+W2&&}fLBN8f(r*JX;bKk2AunUT= zAhSs(PXOVy>Nw-t*wgkwki*;S@%nI0RgXZYv(@E6L0hwO89X-R;mM#|6e&!*g026r z6pyuDLbW-K?#bqJ>8M~F&0IU;`Fr^Ks?;c_l#1aq3&ot&WYnk!rIG(-oNICsXvL9X z^UV42N1`@!SGQ<8Z;etv=7zHsPJpddLcXSEA!M zvN_D&5XKr_`A;97qDY(95;rC)=~^8mLJ6cPQ}}ns)fvR2&k}b z?~8}sRbE}{Aa~Wj2Hz5^p;wyssEYyiTnD?z=>)HD`4pUr4#pZZ7LRK>XL2>aX_S+~ z8FZ?3r!Ff7TvPf1RZ3=PrZAI2%}oSjvAEUb{7T-U@D@e9w7vvM{;qdf8J{$P5*a*k|~sDxMFG>Frg0 z>RKHyc@d134YUyEQV0#j?Z-d1rIk+|X_*QN!qB)~RZaHWhqT|F1vDS6$~AJlk7$=+ z7VkS~#K7(0dS+pozjKHCMwj}TLVV^_evh{^3jBo84oF$^6sihZqKY)Ng(KfiVYEj( zh)^6=L0)Uz*{kVVkJ*;3=0hVjBjh{*?|^HmOAPJe?*!i=v|*ladS8R-sobb=&Bkdd zz|^AbcGG}_9mY^xS!X_!*r6M=7sz8EtZ@vbFNjn;Lo)?Zsm_OirJ+f987g5V>d|H! z%t0ld_wzd&YvgkIC?inULMD{9mg(bM`w>I1o{y_4&%|AAQCF1<$3!f(<~}elGhMYl z83g2|d01Am3PjAm1eC@wk|he$;@w3g3KBDn*raCIJtp*4<>{Yr(EAJ|+^CpqF)>cg z4Dv!!qD#3Ti&3`xu(v{8JJ$(yx?_7bqg#Lt;@lz0Tz2`y%55I6fPvP@gy`uxi6}4! zwK*^JD23^+M#teU|Kf-_Nc_=&+a-v;ffNG=jbF`EZ9z=pXhHAc0HZoHd@X|9VVKO~ zd#HqDhh}=9J>byl=kEkBuzV}LJnB?dR7s`Krg(;Brv81h&?Lj<25%ULRBB@fmpig0 zfBsVjY$u&Y$a76Ksr0k-lc8aM^X=ur#v(sB5wA4%TuHd&%b}dUh$!Sc5++&D?d!F6ltufsit4vT)pc47yf!;q zk)&Km-IjMu<*R8;jf>fN%1xw8mJpp3`560iWsngRNIS#0?$YmvU_8ACF3~q|1Ub(J zt_->g=2Z}gEGFJTcE_z_WD&Qj4K@+D4)M6?*M>-cO^!3jqi#`w2q*`(wrLEhS^%OK zN?&GFAZhoi@Nmd`oLhThunlRMTsMK?Mh(}>2qVcGkrcDFa9Ck!(JSr*YZQC9?Ix^m zh7UPtPa*j705rIXT#p&_c9Q}IjKlYRAWDLrg&I+Y6AxN(_yKyWy3VcVHQ|T0Pf0R3LHus!-yAv$b^ZehWy?T8p zsXPy6|NTQa&pTNi`{cd};w;yalWnpQoEk4*qOVXxIO0DfYei>$ZxHYFeu`K}>4%G~ z44JvW#hO;EdGxx6$9$+@;N^oKH)_yl{M8mh(YetW?(OnaRV>%ZbJrp}AmG6$gVM)8xih zxHCNra7J`b274k&rqwYMmCqZf`7XCa;&c^~Gr0P#4i=EY=@O9E^0SD@#Kr?m-SW0Yt-mJx;J;8Wi)1Wu5kKzI==G(_C%lTa$AOjEDtWT%`UEI?T@%Q9;!(1QJX>=8HDt^M1w9l9IG9{_= zyxu6m%n?gv6%f%9V9Jp2@8EFTVFe}1aEh;;>d5pRHAM)7Wg{sn8d0j#{)BOmDRE?) z5+sUgS~9o{EgIZKOA%*LFo!Wigm0)sGu7^PqoAwe4?Ui$-s<#t|6#m87@nqTY|%0O z*!AH2vv}h6&k$Om#ZT8;#G{QNclIo6j3kE%vQE~b`>#wnXn3~H%}@AiFTGh!x2JCs zcP5gFO}8|XluXYnaf-@OhKsp{@Dyxmq6*pZg2F1FNDeXub_3kKbwQf1-u3?M6be`mc^7omlaC{7nD!OtL=Ak zV7}Hz^AqmT)r>7Th+e&c40*4e(2h(Q3w8wlOCYC4s?(c#Tmfy8{>8ji|iA zbtY&#P1U@e(t9Ph?8ff}_+IrxCeYlJ#EYCq>2wu9k+9u4$L*ZSU+(9jSiUYC1G5qozl@lh4z`fyfVUKd$8Ez${tz2nI4);(Zg zz4A4Mia6-`yaVi`Eq1-W@IDAMZcSk;n?#K`t$UPhhwtqG?}dLxvFa^ld5%I)ZN_s7 z(LH6Qa#;~4Ue*!hQhC9X1N?cyZm5D5GrJnRwKFCP&O?Wc<$YJ*-4FQ{ z@bX+KHH3CM965_TPO*3t>KMRuTs*KO z5b{l-NLd^F?!dTmKafJpOv>v=DT?iT6*3}Xq~QY5CH$A3eBF79W(1%X)z-?+!Y4X& znB$E~TcxUMfxqq!hSff+|Mpe!;|k7aU`mep9*r{D5(UL=50b^ur^ypBY6-7hdO&Qy zAEKgrydDv5f!~rcDWjJNFCZ?V`zG>zqK!HfRsbJrkIn|G*-W8yJ>u!Mm>{nVlN<{m zqJk2Vyk@$ove0fTU7?OTBcIetN)1n1i_!5N5-kQ^9QK;6H4HyQII`e4QJ#W=Qn7w6 z7`3rrKPVuq$Zi2Zm{i^lUk+HZxo{RmC^c3rH`PCh;onG?c_V_F=cZ@XZJu}eA2;QZJu8C42pL$)T^~sQEJQ&|E&WO@h;k(*%OsqsQd<8T> zpR{2uq2x9@x3YA+A;_5}Cqe!LF|n+q*K;QXVA({+aC&UMtt9)d_}i=x1J5|9mhEq9 zt1WnW#uKE5%yI`dXAt1=G)dLn#yl{H1_1=^Fogbg4lzmwNCT4ZOTUeIiq?K9f-%Uk zlA~n5OHWu&x{!#De(d&O5R4Y1Rh&t;UkLEn86dKQ!%FqbkgnPF5#*jemsSX_TK7Hwify2*#@fPkbwTg zK;1iIAJN}N7i!>4783H)4d;#ba=8V&HC|}<5%s&luQ@Dj-`GY3p|8Fh+Au%5o-q#m zGZ<-;Nx((yhEnOESJ%aLx%|Q=2F3lcXdY($U$@_B)&==$Xb@*dc<$a-yKpd3!2-NZ z)E%b*iKBfAn9FcQ z0BNDk3jhFwPWie)qZ>$by$cN-ut^jdFY~DPdX-?P2#*=xt0L*Vi;$Ze!5m;# zY*Vp-=9VMP7`?%;1oeFR_uqHpv*QfB)61`vG*U*%I<6Aby1nk*FhJ@@w+Lneo5Yar5%9Be*H z%ouKIf}*Ss!H2YA*C+nS`p9^pHK=I=m^P+?bBZn;_v38tg>;d%k(ZOWAPJ#4(+(qSDu{U8Aodk{%MA_90hd z`JySZ5dn5`IK`h0P=B=WaYqv1eq!D60{MnUb=(n7kVnUcnd%(Fk53pib$+=BL64%9 z1lOa7G^vV4XwlspwS%Z9)q*rivbCL9(z%<#EG#_V>V}5Rc#y@R!OoL9W(24DpMk&& zQwbfwo`H<%>qM;(>$%}RQ!z-C$Z-7}9oI$Cs)9frM~MJ?Ji`vAtza7;^)_la4@(?X zdLz*(7NOZ)!l5f>Itc8oXzf1z0R1{^h(!sDW^@Th+1SI;A@9lmRU>*{6}x&J+_ABN z01_F1S8U!~by$8nBe1k7$-P)&QB}EP`fGW-^Y6d4x9$rGkSfvork)=x3om`7F$bk2 zjhdX;9c;A`_`-<36=F4m9TlQHftXO>Z(AH2c;LeY=!`=ZZj<^i(SzQ@NJAF83J}h( zu_Zrnm#+#pt3M`uvU_9LW3zyW_A8s>A8dwwfx#?`ORX$ST%xl_@IjB3R#coD`1#MC z4Aj*}qNg?oQCkSa_P|zq;NXR`Ovf{ywnn- z!RG>XVDY$yX~`-|H&Ukld>=Sex`qPI*f3{zuTF6OvIB(8Tzl-b?_P2M;aT&%s5n|O zPPEpKDa_~HwfTRsNR0gf!A-ny6#KzajS3N(5LaFt-sO@?X*N25!=rT{Aq=!Lh z&Kbv@XR~%hjYu4_TZvZc1}*08Ajb ziFmd^1{7J}P=ccBCTO9k3hmKLW`OSL@|nUV*_;dzv_lRg@r@4jnENBi%A3MYY8Q!8 z_3&;G|L@<(Vfwd!!+8!9EM()v=mc^wnTT=IaNM%cxi*3=*<9zwTpv2-#K+v!cs+v? z(XdG!H8bK4ed}_wa`hzhb|>?;_xI-Fxs%nz(&ue|l=Y?)9$$jV@Z}LHite01lwvvu zgY?Oxh@qv`mB{D_p$x4xhP09(Wj{WhAM15N693lgnNq77x3*IZw1-V=8EtS_(jTD? z5Wt;HM$NgGd~!b|D#GVLoA@sc>EUbVSmzcQM0N+=>3*m%EO%&r@k_?9RGzQ^<}(Jp zt{T;IfQg3`avKpY;>&4U#Vvw7vu4)zQVG)>AxxBbMvf&YB2Y17nFa{Y#?)EFImC0$ zW?FhlUeSSb&}=$Gl91sSIRq6POPBGdCMMqgXv2JZH*S{sNcS}CM)QgRHA?xyWSK#FGf=wSR4&frgYNj~ zYE3hZDdBx1cEUYy&V+A|aA7rz5FJFoPTw4;HwBcf={ARb8BUq!r-zZPwOJ)M6m7Vf zha=#ktx-3&$5(;_eZwZNTa{ormJ-f**}*vNuMgiHosNbx0dnf z^$wClptSy|BWm}BTvM;-F!noohj>npIIBfl&xD&xCGumbz1U{@xa>-86qR4>ywU|c zQfWLoW|Ph)nCtzCo&?Sy(zsgH04ieG`iiV4;8n?Lano%xT7m9L=tj zOr`LK2wNIloS_zaYT)JoFxDlA?p+EVJvtPwT&ws$9EKu%oY54jDnyw6k|qah+>;?Cdy*BeHbl{taJF{hWv+d5gG`(g=H5^FWz!GdOqk4h7dyQAt%?;IwC2a6Tw* z$5so)uVELt{#NY}>y*J&ya%n&8WQ`FS1?AaX&yT48Gln(Oho7$aFYi-$)@14id|Ad zZ>D&VKiQRnFv+sX0a)ymwb3t2BHAq24v)BJi;SnF*N_u))2iW$`vRXPPlMEpOa>sG zN**&Fe{b0eUiW`U zVAPPjd2(2)1zTvF-ygEH!g8Y7Lr7?Hi5vq!7C=xQqoOaE1fAnC=jqMyug9?92?tOGpzF*wqoX?az9SXRV|@jEpZ9^Zk|!+oy0(@b3qb zS?mW=xE{}v^Tgx+!o?@b|4?+rKm?ZzDcXmh(o8`LTV%tJ{M^8YDu&`0i1yod+YX9K zL`=@>Q;6?m0>%^sU@K;-n!Dvoc$?|#Yp0Rj{*LVx`iI~E4||4J0gK>y!p ziv4e1vM~HFmn{FAE?8EU|Cu8HpQ>FZZN`!yfCI75rHdm{a74?+T*Q@Jx@UO!fTSo9 z0ac7P;(L8OOXwU4%hx*TkRYatKmS7pONS;pyHj@Cvf9 zXqPluRFwffheXt?Q?IycVugB&lCeq7X5qY1*PFF2PpP=hl-+cv{3FH8u8h>#9OxI- z$q`VXWC4LbQ>p+}1iU_=&Fl*{Ea^}2y!*6>tMA4mOV;0QTsgTdhIwP)A5J3 zHuD6T$iNok_ZVw6!9fpVaikLF;dQ1N1pade=skeAv$P!lXK2DhAy$S9d*f3$dN?VE zHDzNKhDanDPW*poPbLK>Z?PhQEhy-AmNEuBXj>8|tg$75EjlWX(nKcAZqW1sXLnp| z9-`i0oJ8s|RczE-voXkll)WJ;X`)Xzus%D{ZJtSwbFY5r4%G}GvBo%`0TF4Ldl#Hq ztMN1EZ7fp*Lqp-28sX4%Qar3Gs*44{96DmNBBs-XY5>h`9~J6*d@=EBdhmedO-QFw zy$!hgh^KfUGy@65r#k=z;b-s^>W?2`vU2SZU*rwhq80lK6Ed3Kt3I&?)lXNfxB8NQ zhYceLOP5#{W-UIBmIAA)T_q!CX4NMWYin!8RsJ z3s>%2Y!O+SpymdZWM=?gX&?unqhzpVgkx_37no~Bj<+v!BPjbLM%6IPSMp$hT9OGj zi9NITLJN`8TtxW;L4sJfM1MJbaaSBCz)L^qnP(oX)s)2-TmMz;ukhCfWON4)6W5zi z2lhN4jVb51?39&u4~L3{*FK}2*m=PSVV|iRb4aLo5^6oWeTOeCYc0ec1QaB+Vu8&E5Lqd;`3WSQcUr?$3+Lem6 z5LyFllPR)elqBWEzkmyZBOGVNs%WhhkFH*VVU)Vq1M>*iNtu|aP?5R-2X_Ji{mk+3 zccJ`#*i9h=NvA!(=9U8-gp+tw!uN3P1z47O8qlPW10uPKw7`RrjvbK`=JP-k;`ZOi zy@ue_p)|jN5cMJGUlD&@F`8j!B%zUu?XXx79KhiHuDrBvjLjE3`n2{=+)&il_$|_% ztr4BMVb}iJ?T;{a0Ia;MB}4j0KmR!1O*a0w*N6UbiAMd-B&`bp@8g8-aC_xw4%2MM zV7DxxAOPj6%MVM9JIOgE@oEuAE4BKa7Hx2u>IR}T{JArl#d8Vf7DY6qN@O6%IPui` zopL9*e>akC4Dbkt`yAA2x zK6Cuzs{?Hw0mM++>2HFqdRezl!@$5xT@z3`pw#xWH0;jU=M)FSO4fq3zwSrJ4@rRIT0mbFn|RE2`SY z%NqW*OIkGTsqI-_Ytzuxm=w-?$l@ikPm$ts&*t8%f$LD^<@OL2+x>%g+S(QnaaCS+ z=C5Mq+4Zesr4#fAy<%HFUzWrH`zOD)yQzQjNIunN#=W4~{RK@gC+nP_qwU++YDiME z>nSS3ea%AV5#Nk6CPXWH^60yz?$P^tp7$)B4(1>eok;2a*n1+ z9+8psg;NlxcWJpgkFYS)%1LJL)af$02a#Kcktpv5@Zd5~chr^A7?%zq_V42jijAbS zmnc1J9OB4Q=+a!c0PBHytVSlejIiy>Wk}R4QB6Ep#zUy-MxrLs>42vDBA-de>IoUq zsJ2`x;N@LalrvNdRz&1!A*qOitrtP1WBIq*1)7xxWF`or*X;LjU4F~S*}MvgLK`^< z?|F+juiVFiB2{uJpr3X-Lnn&_<1}f*(-nk&?%&VJ0TjuYx{*Oo>+~=^>8F1dfZ@Gt z;-j6o>!vW)ST1&p8d_M1n1$x^(5Dw=j{Z9R{tkzC(I$RG4(@dkKD*jBLo5%P=A_sd zQGf9PnHT?XfJDC((FsGwsB-oQg`lHiusp-=YF>e&dpd>RtINWg5UPDp)B#Y{ zNv1YkXG5GXXP41X6NKyhMw=fuD-KicmCU~eIfgAGR&S-@RAV7Z`*N^!Fm-5rsjIa50 z$vU{;B!KJsHeX|M1)bLpOB7xZG!dHP67b`l>|a1n`=ccoTGCnl1L z2q6PU*zgXzbmQlVd?p7Wx6{QcVz(ZdPP#mRN{&MOF9%wqWOTW>XEPWTfsJVUyV6jxGCmk2mq3?-AdH-U+WY{p2G>`-0@X zNo%(sDX`3U-Ei+Y^GV2WchRa^ZqVoFJ>d?r-cOvTG82+NNOB7)T@o*rJQYVcBKa43 z8udWW3l}B&jQ%)gjvB9X&5{mF*xPopGSfeN^Xew0Mo8sPeOXTUyXR~>pS30O`P;qEF$qDg_>VJ$bhN4n+HYx{6_3R=WtByOt zg+YlTGJrc>{*bi0wROE|kwLRQM9_tiz(370eqy;CaSn%79}cY5`e`IN&hPHFYc-&K zCL@~3)!rHy445dW%{?@5PzZl-d}V%o3k67uRi||a%_s@xLQPx#nlPK5cgRz2mysjF zl*j4b8SHz>9@(#PLds@2e%Q_2yJnkMElWAXs#Y?2*iGnU#3hW|w6<@SkFlWfgx^UD zZ4;ADYpA8JD<1Vs{vFNyE$-fM*%V1Q`}7j-^`KW7iljDorSCg>h|_jMAOQ>DS|Ft{ zb`?fCG^79d{IjlHN-Mp=VDdWNAmrkzoXdfpPte|&h!6bJ>sWO<1kb7(*xgi4zr9e9 zc1`5?;Jt-ebNGW3&|i4(m6mPjdMQ*Z@Sfb(&DS{m^x)#7Avafc$>4+dFn46b@;Kjn zB#PtErs?$tZp`Q)kAX$2AA|LFx>%-N3P0*cfqjYnp;5(T5-595M*3yWXn6XInZJ~$ zr5%FClrN|fZ%K+$s~Y!(DKoQru5}k{M8~g`9kfWlew@Het6E$)d+dmBf4Ws}NJeaZ zr3S=>g_+XCbyBhRZ_0lINy9sI&Hk!VU(*K6vX0IM@0)TBn%pe`|Jfc_^BSDa6q}yE z_jORgSEcX+Hit0gkcU8RH@luSgIU^ z8svFMW6zYdLVgOPBcA=}(oCa^GDg{hh_2rDK0>DH6598|&75CJa0{b+B)Ep*b(v8ZzuYA9Hsf|O$*5`F!Wo!4i{9>! zpS^2J1d7*G4Vj!dS-(6$mDh7~b!BE4pq4G91Rf_WXQWzbl{$S)k+qo_Ny77^uNB8) z*2ch8naGI_&&X;$ScqS+hKa8+AfwJY8j*ut5{P$yy)dDi$0yGq`^))5&@+iEo&Zia zV;4&zpuNO`7B%WQ2Mfoq+(FbRq^)O<&{@A%V*+rB;86Av?n3 z24}~W4G45=rq%;=_37;O2}=WZ!kZ2vnEea=;{De4*(o}x;4-!t!qVhkqf@(d0_uXF zJGT0z!-9-O%DnZ(rp22I+YeHZXF6g`dW_i;W;=0zL{qT{C zl&TUit@X$y3o2U2nMD(Dp~^_3dw?1r>lJ=^XuAQ-L1e^W8a1bNjz*bLf2O#Z>^Rw8 zT6kVYcLh==2mu2&xurpmgMkyc9o%H;rVJ3Kzp}%_s^9AdvteD5a(B zv$1(EEIU#`5zPGbX<~DbW&+fIbdGvR;@7$2m`n3c^6xFmfbe}Zcf2TdXkv3Y7|z~D zPj0!Rk8$@7HTZa}VW}%oGXZOgn#`YyL5*9H$f#HN(F+!hO(2Iwyj zM^jN8W?RpRCS%(Iv|sKo7qjK_Js^38r0evnWJ{hRMSqYk?eqK}UyW$%*)yuDHQY|7 z9Ba9&tEfsU@l2;k z1GDH|K(-gqkHk4>MbfH8Ri0NVJ0GU~(X=ICp`p@JE4d^|?C#VJOy2WMZ^Mvq?njxg zo-uIiF`6I#2XXJzD_Yd3X)fEgZQHi@vTfV8ZQHhOb1&Prd!N)zSMudlRi~2v2V-80 zF_Y(2dc(0HlM4ar!dF;e!Wr_j5Cl1kfIz=}u`tIu=t>@dacK7k&9i!AeB?z|;; zvXGBvN+C1L;Dy@p$--;iHMtVET{;}I`%XXeYlSK~JAA45H&h74n`sJf%ARLvecL-4sucos&+^a-i1lsS#Qt%hx=A04;gQW1uvjP)$Oy21k>y^V^n}E&Ci}IsC^02Y z*GU@$-bl48Y~@i5IdwMs5x!Mb1a`(vb3SH-vMGq!rns1Cg`u$^bGgWTBCYGDsx*Q# z)h&!vSeX$Xnw*Fp&K$Q7uoV5(AJzz^Ls*2GZ4k+?Qn8jh-wVB4HPiw7Q|l- zISzx?8vB@d|3J@0T(t2=v+_$OzTr{#2VUmk6bK#?q7jN+tLtvqSr3AhF1LR&ja&$3 zUO%pVFLJw4**v#5of)eJGh>NJDi|ZdQgT)7vZo@Y5{}@iz1nO*Blv zpi&}TW;A@SVe{e2_JF^4m&ttoveYNaw{&@l51D_+{qG1)`W6~;EJ1z=)LFg52apzj zDSO{ZMjE?gcKgNeb;Y^mu)KD{WNsbGsL=``8Smj(^(%MEm`9M>L~aG>(6=P?n{8Ag z@j;b2wt?*_^+-b6Q%OT|<^cw!!%CERt>9uO!*0nR{6R*N27K2sRvEjN= zs0AU+PsJ1uFTo6s{N0pr0ZFx}16KzeIgh^cH{1+r8wbaE*l{sMsO4wPItI=`#TGWx zUp|){D#oWU<^e}sWr%}iB$46HQKJ(@8wJ7XuHT)r$*C-L_@m5C6#j;UH4mF7>1;OC zs4SPs=Xja@ar7@82^TnaFuf`_D1#L7TXHoDCH49Z#U7z#K?Cm~Scd{5uT zJ9v3A1}M)39vNgw1?-3@{I}2G@7;n;*W}BH^t9>jU9Mzti_%OlxVTK?pHx%otesJH z?2j9RCmpegG$MZ>0IHw3DvquXK0lp7%^kJ{>Spk0I`mgkCfYqW*DK~76|*o0staeq zf$GOxT>pqN{$`ca9yX-E5mDh`or>iYN-D)W&XzNlIjBkgC&$i9PERgJUZehPUyfJn z{YzoSg(nS&a`R1c9u=)GmSG2q2Wq@GpwoDzPvfpl;K%_w_ec@)BM^+Mv0fy+%?T^X zA~D80p3Py1Zsbe-hgR$5(Pl~nx0(f`_m`w*xt$e;eSfXpBCy%al4WH09~C9hG%%#pA<+61REmx%L+z5JTGm#orffo<&p;q(7SQI zZaLAf(d+sm@qgVtT+Dp784~(_-9KDo-ya-%_8=%#+v(CQjuawX)}$XU1*w-*N&T+; zQ%rIqH0c(l{J6W{c)XI1Do~mT7wU$q*Z51)ZIYODA~*Ob7gN$@?;arN?e>oW=pBZt zj`%PAu$W0Q4P?~QH_eDNet!lvlQz;m1T*3Pbk3KavBtC-=1faF$*tifb@UdaPH3C{ zi@LCX3}CodT~AN@ocPe0&eZ6d!<@S{qqIieYcbVLC+_d`wu8cByOH&t7yY_u;RYyhT&TEan9}Fi0~DSbB}3#_$REr zu_MkrHft+7Xvbs2cyRf`w=pthVQg?0usvBbn%^D)a}Lm=BO3OCI#p|Z(B9Uso@1qU zRP1xETlAumVpM&IU1_S7{x#?dfh=%#;m_h9fQ@3AvvTw+TDNCv+;4BqhJ~W|loJ$^ zLWF|@DS2@V1gwc!96!Geaiog~#dE;i0B4M1n$9OSrzVThI?x>ym^2Uz{^f4K=bGd( z2}AcDKJWv7me}fNou_>2#WyT}$dtW&AT|F6#+zQQFZ&Czl%Zy!GxeJ==TQ)&GwDyr zKx-WHS7C)yih*>av!3~@1BII(v0MBrvb7Aw+?X1Qz9@rv0B{tUjZtvNJ;dL8pLs-* zbyw72v05W}>NbG)K~TPztGEpiU4t1Fom2EEUk=bo90;RXgBNN8RMI!|_J zy(RGS4>~MxOUXr%geS})I`GpK8wt*m^Ti*`J#p5^&kSJ2U{y7W;pnZDjELI^@(*VGYkg=lW>b*w$%E^g+Y!r}?% z?qLjSs@8aTg0b5aLAvIVXivtNKWu0B|FUFR$_un#o-phMCwEK^ zl~5ONW(VwdW$;A7?1h{Mv;?P!IRo5c>YD>{-SgIz9F|AD?l~B?GR5HexkQ~q1l9ZK z@(QyS&Q&j1%}_#ts#daorsaS8=WGC|MB!$kA72sU{A8h6`f*5~G5$EKmNaVeiW6su z6LS=TeuE$5;1we)S!tLpJz@p(D|(6#Lur%i3Y+D`;$?gytD2XS&67qKzDS;AyjP%A zshFDLd2Kx+0JWC{i#934W;#>vu-hHbNtg^JJ%#Vjl(H={mz)|&kMz2`#=YA z7x*CCga6X>)xNk3i^UO*p=$bJRUedcCV-ybdz|DeWbv~PwBp~O_%~3@;{%H#5wUnB zciM@@3SeSMvdS1Mn6+qD+rg}MwxEG(iRTgcv#OK;gAn>oP1EXDOExUEqS&CExTjB= zN=uQ5X$PwUUgsXeYTe#~E8u=JR9oX@#=rBq09~ePjcc+)uw}au+z}CfkG}Ui@S&YZnR$f%Xgro5uN@zStT8*W3P}fsTLN?QYs{-RZfvIZ7#t|kb$55{b;Ir(o(tt z)Rl(>H}zOt{v5c2%@CNw8+FbS57#T7oACI3(w#Ac7)^lleRt%&1M z%Fnmz`{5`t0eqcbcp@mr`ZN2+6LRqai3;5Xt}>tguBj*&SC^hxCb5@+govPvR{w$y}%Zt!ZHAbIcid>~H9Ytla}un(owKQ~#q7z}3^O_|q3sXD~E?ZGVLm z5iyrnnI%~x+D1SxFo2TODgWIYz(g~fTs%D+&h6FyA@O^3D5ym17m7ZnHLf;|P4AXO zl}(xp50$zYIZe2n!M+W~oDIEP@uI-ZU8R^kUOkqM)vboKXr>{|aL}k-SIpbW%~&Lt zX9})DyBcUMm}8;YNW?pW!!$a_>%MmHU+CHiVD5;4j6$&@aVF&RIk*v15UqDnG72O8 z3j<>w23i;uv!NTthvX`yQ=q8$M)SYJd&;pB>jorIgn1~^K7)C|II3Vq!4hl|q8o$# zUxN7}A4evLH7yGr#^HHe(}3(qZtTNtk@g`a0h>HO#|lhq28s^xI)fO@+MBesC);%H z>LIH}y>D<%GB`ns&gDE4K3Mmqcr6#2A0K83rY_fg98<;Jqpb6S^9q9+Bn9)|}wAJB>7AzCqL$BlN2N z%6UWKKDanKn}9%o&Y$B%TTc}jds8LCVJxMyN-CvVv}%JU`pca$e32x|7Xw+DhN!eV z%-Sbma5nq0$LoePN!lljvb`XJ{V+NoQ+_#IVWW>jxWCZ*fo%;8Yz*=Y%jBS1D5}iK zR<4|@xY?SH1ev!oJM@NjIEj$iwY9~zGbpGpXfgW|UG^hw7e<|eGvam_KJ&5;;)WCy zXL`wJWy%7CIX-~y)epsha2k%bX>#hmal`es<%n8v4kOs8NB{>L zOh96zUOUxpCrj2pVDF%&BkQ7&4CHov>8yfNC`pG zz0|o83Nj~F4kUV^3*NsgCV!Pvrf!o#cy*G*yW)UMDB?o#V=rT9^Ugh9lvM?xS8IO! zqp6kbfbH&Exkx_#7pI_!%@YP96~Eny2$K@wH_Tl-UT(l8fdQ4U#%a*L+kOk{nQ~1$ zv}`0y!TUD=9L0L&vJVpxjI+=(!#qZraG6NPwQwLpTgi7VN0^xFPkFEEo>g|ftIn7W z+mGIOpJmMMHcC-|n>JCFw7(Hqmz+d=YSQ@Q4y{Nb8r`~kC4w>s(^qWAY2 z1RgvSNS((T+DXa;4#=SvQ4D*VwxZWy``X^ZG1z8SyOceg)h&Yx~ zu|_3u)zBvdXwy4#z(QsIBvs_JfuU5kiu1ma1mrpfz(Kn)*9S(4U}#vv>N(n~6i?Rx z1jk&Hv*LH!y`_cime}Cy7nF96rjE-vc zG|;x58*nl!`4kBt%f~%0%!kt${X5O2g1XxXMeo7D4frLzANmhpNg*QbeI<4GK9oHF zOGE!3OFxwAN4#Ee6lWqvw9b?8(t%tUHz3{hs5qm3EG|6aJR80mn$`CkphoZe*hDuV zhF;yv`@tKv%J^AnQq$mL-%fkcf}tHQ;45?N5zjt7V)sBomoO0IDBqDWL}M%b{;>j-l~*2uYxM#6LoIcDa4%)ilX+Rhazvb z-f+nq+N7TRE*E|3RG7%6AKZx0_U`9AY|z{4bk2vnW%yb&r&1JAmG&B+otzF>ln(~m zCtlU51@h6o*!^ec&oe zzEqP6JH`A}s`2?Opgh>u%kYzfE+*2(h8pG|OxH@G^Rw;lM>-U*eDX&e zYvDt_k-YmVDiO)uFGlGR*>O+A%L%)m%#?G+WZGWIkXMI4wQY9iH$$}BI$)wGuM3Tz z>{K$3j)WQ0hFQmN*p41eT((o2mhbk)avyY#R&lX23c!ib6dU={1w<*+C3F`6w8E2{ zocvZi2wO67yhh`M!h2=2&;;iqmG`e#uu+>k^EYKNGysItN(md{5j_L2e**2lZR6Xs z$xpJdnyFy!Ej;5UT#-IyRQ@@x(v%wDYXaeO%sAT$0=WwdY&qsd(0?E0nmGJiB`qL! zfm@^4^}8f|z|6~EG_X6=WYOP}f$IKTG-ZnAkZ03O6{cc=NGzD+e9f9X$CY4V69(6# ztB*Lk;K`2h_Vq^~7(>bwZByP&8EHxv44P5`Q<*o#G8dV=u(nVjt4ccspqRQDk#y?f zx?p2*O;LW3>0&r$!+S3XYmqlR>Xi?G1sG-uwnS?a9Yi1ECXP{=)0z!C=hPRTWXpWL z6=G@LrM3mu(Yo6hCdkNt5zjJ%jvr8ow}({by`3sJ!8-JD`B;H*qzT?j#aES#gr6s( zlnIdiILD+V$E901AYI;Y@Jr7KZ%=xNYzV znVI-;|C{{DFzUCTv$Ig%9iBO8&ugVky+Ww9i6uybI7p9%${iG}6H_4X5Y2Qi`5~)`o3*ZTl93`4W|rMHSe~Se zlVG*9%*{O#L0a0X^BL;w$t|EdTllzKaTY3p*Nu7071bx zfiT$$E|H?8C7*X+rIdBFYICPl=!=BI8EZT`Xn? zkpwU}7CwfB2a{I2bf~(`Ve^qDK;X?Em)q>+X*?)4y_9US&6_8bCx3S|ilRB-=kwb& zZ9lWG*a+yToa^-&p{YLr0dt9j2C z(hf8=K+8U39YvA(zHC~KHG(N#G|=XpR$d%T#9>Y0(Zuc{4s}Xpu**#Gn2>H}tj2$l!6HioaQE3$405!m z+=?}y>7LP}x9j6dttk}Y%FoI_ik2&Fx+$OEu$bk&kRNsHO#n1Xfa;9^$r;<)Y5s6* z>^=SV17y**2(2n#C;SN3{?IfJTrK8V*;>^sPS8&B%&|?L`QAWqh*z_XHRCxZ-86sD z`N|k44w9u*3>0;9orQ$BF;z<>5I52lOQbhZ0*N&jEko5{%J;Mmm8s6>DqICO-3P5`FqLGz zY=+rZE))PvA*+J%WQ{C07wF1)mOglR<<;gbgJSa$SpL#vXD;f?s>P1Aq~AG6Qbe`Y zEIAh23g_c(vj?iyX&`^RLiL?a7HKQs319-F0hNzy4mS@#M31giJ4i?o5eqxUtLKM| z)-8_0PbM_&z-eR9UZ`8$*#poQ;28&_J>g61{oWpXai1xcX-d}?dAQMiWY7n4&=E7| zBntE01d6*D-JxcfY)pg7qRP)1V$g%N1uuKfXlz8`6fsv7GG_8lVDD8!>ctsPj%Qt4 zwy|Y@9frN$M7i~K+Vy(8?tjnmw-dx=C-CMV5-b#ly zfjhF;0QC&w*>P-BN2=k_2*=HloI_I%{(Rfb^xaCPUQg-=#gdH zi*6lUTzrC=qLCKtj-v!Cx4_W$oC8Bud(6ayZ^rsyCQm)e@;HzquokZ7J6sWn zD(qF(rX6Om%2&A_WuJNC_^T*b%led_}N2DqJk8T^kx|3A&&GBW%R z3jhBb(5F{$v@=pRan_<&5D}wSF>!a+`ETl{nEzYG|6iZ-zh?YwEbRX?wp|S~rk!le4^{gyyx(cL_dSa*?qUrc= zV)1z5xHz%(#zQ@PQvC~j|EK7ErsI`L|$^#=3zs(x1&$m7?tz#YQ0$+4G zlH$l?lC7&Ku4y;WV_KQ5iwpjz>HV7`SzOqI>cAs;GVgi88qfMCvy<~kQmOx6e95M9 zc1+aa&HF0nmt)hPR0H8La7GvWF__$XlusM{QM)!9G~;Xb2jYY>4l`qx&S2>C_zy!I zk#6ILre33V#SCIrPtfl%>A@HsySonlBd{5Fxp^~^prw?mxL!&# zx02p%kcj6OZTuaQ9zwO=(??OGn;gM}M=}75X{__p%;OUuND8 zx1rlR&6uy+E9;rRuez8bHzIXy1qf~V={y09aM$+%Z9CVUh*aJ&o{fs_isUi+|*>IHzd<(AReKv-##?%B~A&HNva$MW7DF{7MBNm_TP zr`j4N#f{ot0Tz6pG{dSg`OaiH=*VPuj+NQ-C=q}pp2gW5a4JC^gh`=~7gmbmoSrvj z=LXF>xQ{w5K~AE*-J9nGUB9cRF{1_w9{z>?nkQ8cAsXM+-maHCi1kcQk$Vpb;>henN;NhHJXdRUNNC)J6aBA~Y#CntMnh}%4R!mh| zN4U+yHec}RpuF<_O~nX9L@fuLd=_ah~;=y1l0rYH@}kyhu7UFLBp zQ{bss-#Cv7#QtHDqa-H)#~xCuftTRZu9t{tRh=2{(@gwzqzd%HJHk)uPTUf*lXsOP zPUv5<7CE|qa(6==h00z~10p>begsd86KwG(w|>k)6xkB7JwV;#Y{Gldx~iA#Ar3If zrfz6w$54)y;K>=d{kR%y2iD#w2 zlUV<(em}S_QM+eIOh^X9QBUB7%HN)H?iX@>QNus<8iM$qssXRL_%V4OlhA&mlgZZP zA5|LL{O+faP%4|kUC;bX(+2XW^<~!HDnGaZ(Tbve3wwjn${SeJaH+JtQRP5=d!v-4`EVf~uS0C4Y`DrL*RUh! zvmtxN-Rt#Z&>yiv`GR$_~D}O6KcdI{tfL zj|VbBt6iVh6vNyAFd?<9O_UjOLns(;7GQKzKJ-6Bh_`(gk7WQirP{K#PTS4FAwjUB zMaxHu_c9a_HRY=EyeHihL|UKn61(wZQHje&ry?3;Gip-E)})+sVJl@EvAD0AM6Ga} zX=(G@xg77S&;Uh+gY#DjkC1sN{kaJbG0*y%cMNV%hc}Xd91FYc=zpV69qup3(TbhRQ z1A-kG&l^^;NQiC>P4t?xvBu{G44kzyc`F2Ms4AVsQzi{Mipy?8ThR)sUeL(G@fsLy zBa|&gR!Ms3Df6nt-h@A=WKP1qw(PFVn-MR;BYhAaSmGE}s$={Sre=XxznIZ=)V_H2 zwf`>v5~;xyO@zzkeg0eDdi;I2r+apZq#YK!{tZgQ;q1$C8i`GtBPOKd1hKP>6(LSS zc6T1i3Yqe>X3Yi1*l3Z6kfqvM+k#|mf2!tuX%XvgXbM~@0d)Yy8DH+JI1mdS&dCJ_ z4eaT02#>tvxeR)b8fC5PO(6K+?*;3iUqoA@LFi*-@cF9dX+ z`V5@OWLSyI=3;b6FS4^LT!H%Uhi(ZE?P|n2$v5GkFS$k+o{oJw`vN!28iJS-XL$TSndLJRO5{AXua8^hq0j(XRK$oCGRLfJ* zlI2SLxWAzUFXHS|vzf(q3Eruyp*WS#8gL%1#kE73Ye>eH>QL3LqTV68?$d`D+=86VTprS{7T z0CA_l71q%QyL*@e6|%@{(d_&fMHx^b-28WI^!jpnez+(aFG(CFxYg3oCQm(5V)_26 zT^r=wOU>ECXr8G16%iPNH>lo=heK+ZdVcYn036=c2d+})3M}8%N-jh((c0=%BXUYY zDcj(+cg%?I=(qhhl(Bch7UJ#*BN$1!IVe|V5%Z+=U-P=woz@tduYb$9af;Z?NAZQ_ z`4sxxwl?{az~ZzBM-fbvl-SZJ+RUOq-?r(gWJg;Df``MQW0#Nd$j$`o z7yV-51-vzck&epn z<#HrpQ_|>)>`D0FfxccnK7Mq#pkW<&gH|GuPYY2uHBf$|ubYev!akJ02OLUD{Fh z?f*GV0bY1^0sKQON_Iunq3|IzAY2%+6|omOtOEEo)kQOq!dkFd(AR*ClB%re{J7l{ zNwt`=!UWoj88*GJn8=VNA(xH`S*Vk$C*^>dMcg3X&73H+d0j?eGUbW`$IX}@)Ond7 zOW6fb&Vq*E(o-&wYi0;K9|+Ju4Gb>vhoIix-%UrOzBoQfbMEU_? z9o2o*SGA_>^{dXAGJ-~UkKp|Mk9omFtl_q9IDd%0E<>pqw1xwTL=o|L>oNO{*rZFF zlI|G&knkJGWy)&H)j|Q@{}~5zEaguuH=L}Xpsu(iry?Cz3X0?EM(l%4(U|2j2n-Ar z9b6Nki~wHc22bZZFan2eF@%lH zpq;yLY}*d+v9_4TwFSK6{Gbw9=+^u`1V;#s69^2zB5t`MrA&v5)?9TL%w5PpW8f24 zMeI!MO(jlSa`%wy{Ot4x=u`Uoe%U`_#kIX7w!7A`TZj2}LNHiQod~}d%adECW?G(D zV2Ux4K@-D3C3-5Dwk`%m!1r?NQTkQW=BnEJY#5~qFL0sa7H&)tL{hB(xE@>L>NEQgA1(A>b%{q*YYptvG$#aMpD`w?e@Gxjck(naBIg1n?j7M zv#d=io-C}{V|46;^xWMRBqTDq!*uLd@NRa-F}n4Ipm1e=S#lP4f}ZRq#e{uXYWI#K zYN+?FbQz1mp$9Kj!W9;I61!vj0s5u+a1PFu>Oj}Wck*YZW-Z<|dCn-T3r5STU~6-j zQDf3jjhlP0+b09K@yxn&iDAW#P{peYh4tTn%ZQkj>Pa6@tP*ivWKZpQtwiH6S^{F> z2@Js|3|j66q(xsuDW-8oU1>XC=)3M?8)C39E_!q$W-OT%P#5AQHm^qHh-T2v#hy!xLy0p68e17g=1n*5bxD$SMyoBI{NgLvIwC51;ASk+`{`}L!A z1;htTX52orJlPrFmiHd3B5E@FR=#|WOg8zryC>YiQ392fVdKXxhi|-1ek);bMwVn$ zf~`<*H~vZta8L5S{``>M1j9`$xpm>PUFpOCgMRjUvR|+6DHpCvAUnkJ|HbmmJ<8Mq z_8p$Zu!&x_gQ?ian7-P&VyiLWPd|}pDyFLE^kt3+G;QyR&?Sgk?; zA++mb*jo4HWr%=|ECyNPWX6MniZ3!=4aKdiBU9z7!cLd2GAc-kmj3kr=iB53uWG9Y zG_|n2y2K3J_>|tU!VeUBu&T0pM4;J{xk_rgKD*2h;;QG9(yyX3)*yF0Rgu0qCEO$|FNwdQTvQ?^^Vqp7XTThz2WWCVX{R( zl?Q%?5inx4Gl7Oc;GhoQ<$EUU-Fo4lg<$G`4NQ)SoqnAd|Hv3y)k~PIC1We1ar+zJou0wf7_bYhC9EVVLW$yHik7~vipZEGjkv!r zo`H%|dV0W+^kUrv?zR_{$8e=qe72%DTAc29sFf=YxymJZdb|L0nrPs;uHwqo#?6PL zQei^rP7jr^?o3{Y{56im{7S~g`_%ibw)~n*;SxLLU7ViR?rd7uSBf!fiW4gNCuhyRorsnnK3O)p;;rA7&#r5S7#@`z% z>i!IEor;Ce%1x!L`)OwrU~Z|q-d7AiTR^?Lj?%v2Ji%d3#@E+bnoK@X-S)Jh67d?=09C zg>s@>Od!=13#{txT;?0Lkt{9jV2<4R1}WtmtK3qk!!w4GzSUS`G_ieMT*QBX$%}v6 zOzrmg%J{2~3da8zb~-r{F`|SqZxO6?z^(fVYFM8_t@p(Lh>cpS!QczfZuscc7$&T2 z?3F#>#B_K5$?>aaml6{FIh0Q#h4bX@UG8HIvs_jdS4iQg^+h=CLO&9y@3Du9f9?c) zf2-fN{jBK)r%nCwFx$IX2#pK?jn6r zgseU?5uqE;--S!d(;uOwu`*Xd;d^PRra*=!N2@~`64#PJEXAP4N0$>QZkE7&+PEDj*vwKg+cz!KP!#>wK`M5Vu}lQ6l>92 zMo4R|F58HaDV8dpLD!#k|G2r@BJ$OLDjV{{!@AVy;40M zRj9PdZGt~tWoMaWmuhOUkFWX<35xb+SJ}8d?|;NqPo7?Uq|cze3+Y^Tg;}eflyvsa znM!|-{OE0>yIsh#RXxP`nd~}mSlhCHCw`lK!h3}+?iSdOZ5E|@@b0dUy?;gqgyNFeflfUbtuikC@bXhek&+d-=lfO7EexG}4MvULL z{A_V2GQM7u0q9<|b=@$LQH8S~$b?c;;_H>xN%Tg}Gk)HXLx=Z`B+d&c9)s zca65NZZ^D=sNQzeU(|AAv0tpGk&PJG`Z6yd}7$+r}c_=G2CyZGgWAwDcVR$i8~XME$q zo^y>3*PWUq-gV)4;3i2WfTgd`b6_f`*v5<6`;+dc)pA&p8N`$xZTJfz@>tdG z>|zg&Ud`gI_)YCrTP4oKeBf?(2I@8DGMMZvK$k&7HK+#Z4Qd{BR)BvMo6mrxzpO+| z5KAYZ5+wfZaWodnyKE2vz86T%ckZFM8XKV4$My+0+1Ti;Fs$LVtd2BIUf5`G1kcwE zTzA_X0h*&pV*_koqi-_DeqC-)J9#gjR`ZYoJ-)>$+UKUnJQhywvS>Q;mrD&P!X3hC zN#kh5Q%=^*wc&i3HB&ASqegKCVjYj-V#3JSTj(1+M~Oy=3UZI>O3PP8HqR9vq?Z(j zm(->VH;ZHizp644Av~#H#+mX5Jr+de+#?K;gUoFBnT?Pp*m7za{tH0LmWO!hH$182p@a~s$ZXpUJ8f`m1l!$`XJbi> z$koLxo1z=pS4Upf|F_R;fV_i1w&4@-X;oTZTVRwe00XEw??iuK7wV=RHNgP_9m<8M zRtnypo(_P;j}o?#Bmh!TnB6_}z%izv#H2jvhH%1^cWz47r{nTZlJlr++#LRG;Tln^ zh*y4$S7a9YyCEWRGBNbu(@2@mG*dAMh=EFr@&fQ1j^-WE!3z<-K(lhF5`BcxhV9I- zloF956MH|DwrOq*w_<)5SOAo83T{hC@2}TyLduSBL8;g;J5fk-9W)@k!5mH?o8}?e ze;P7G#JKLvOEvyaT9rNwy%jKoM8qs;?55MwzPxula!NVB2s1rOa@SIVIB+i3d-V`N%W$2@(|D!2|5-%j z(p|2e7KpFRyrifz}e%GYcL+`o$tg`bdNmq-zlYD&=AeDqfur2NQDzqN+B= z7**#nEVHrQ|`Gi#8MV#$Y&Yqc0|8PO_gd9O|#g6aXTcJ-2mg5n_Em$<8pigqn zXX4Bdci|bkLwb91^&hZrXuOhS;$iEk!_j#THTwdlO@!oitdZd!1zk%?ON%fe%T9E% zDJwM?wD$Hv6m27<8M`P(fO=dZ5lM#WCMYDh-@CQ2QxmIpIO~QfE}{>al$0(`gpena zx4bgy%~?%1_Rha5EXQOue&jWr0yj)n84jEn%LEd~2cUCAJJX+PS0>jP zYnTU-{o;_=s$%P{A{^fU`9M+QN^I#AVz8XO+hNK|FoL>^`bcF!1!^z5ma!De%N%$o z5Z(!V#RU6(A)T= z8-p?M*7p|(^@)k!tNLknkn%(o7wuS-?@u%dIU(n??$eLxF%|iu39kKcU+Pd`K+}8S#?5h8}mp*akI!bJg|mZY0G`}B$7ORHipQG|Pma^*e9u>IKu0a2-@;cVR`-!# zy-~+o6*QlVWlYij40A%qu|c$k=p=4$`;*NSF%7px9b}BE_RLg%@k$vxQ(AJg#|TY{ z6gIqQaCdZxEyB{nDI4wxo zjny2~nsARu0_U?jQ9Ta=qeR#l!Lb5CId+XQ7r^o>_{L6v=Zv&9=6^P@piMs+0+fw2 z6~;TIeP$T4?kA2~Aw1L|F(D){03koiO~OrIzMQ9)H07;WTV|O^J5uQg_XqQth=u#7 zS^im8IHmArv82a&{IDNVJ}lU~gJ{HSA&#i-67@5o(VQq*r5X^^zQ@^cSsS07M}ZDF z&jf2sh@)l6CXqUxqbXMu%WV4{}{RUGk&D8ONYWSuL6poHB3RF>SZaHHV#7?O{=$wbiD${N%A$J48* zR`;h?x5v}N>+vV2a^-T(Zg<0N)20AM_qLA4{&aOXI=8n16O#$IP&btim3_IoX^^UJ z=Zl8skj8P130Gh2_u)v7?=3CJPZHbLft@WZ&AFWg!KEPpr7H3=!eCVo@267eT`D0V zp-(Z=_&_wB9GC*R@+@KU9FY(0<0-qm@d)w0GrYnaD%#U}*{9`${MifuA@OOqwDjQ* zgNFCRs%>DbZb);2zi|qEqzOb~6Nze#fZEMELT?DOXuub zl&H$J!PH^ED0@#u=kXnT_nUI2);NQ2kh>rsd!ii{n`g(VErzI~?50?M2Le^P=svrP zonMXqM?Emb)}=`GziD3n#j09PTWrYQOSQf0Zcd9HlGmj)sT7)bI@hbH+iD)|6uolN zmgE{zc1;_{|A)1AY7#AKv@FxMZQHhO+qP|Ip0sV-#!1_@ZM)9b(J$3;<96MM`U!hK ztk`>vIp>(Eg9l4L2NbBKQP+DC3<5AKE$b53*$NOTz>5g!%9jz(&hdF%f~ zTM0~(@0v$usGM3)lgxmF$@L4#@zuz$wnM6_LiRp203(q{^5pDMj7Btro_);*iu;$k zPTUcF8K8Uj&{+qMAO=v)$gOhTuKNkT&maOV)R4iHv~?#D5Tg=Ng36O@D|r0|qR$;+ z+E;ahod#J2JSqTeb1&D4c#hVeV3;G7}DV)4A5u=1pjNW7NvB+cD@*;K>dtdllP2<$DT1&RE`*r zuZR+CL%#>YDp!tNKqB6bt@GgI@&f~l`F%T=f$;+2xc$eA{!1QekH6)BL{bRFw!fG; zv_+8buY08-2i-)v#uJBX>5fKev=5Kwk=~yklRhtZLpeR&93K8Y|MnirRrnK9-i#Ra zq>h3-&fo6cY#Oq|^{u1H<@T}ZrJpvPOdBq}scBzdr^lS#%aZNOp7)>6(_1<{{Y)F9 ze?$4lq}LW~wbUr*%j z*AZ;KH$U%=Lu}OM=ME}2{G@F{)LD013*SA?+CBwX=3Ju^kq;TP32!BFo_y}F=959y z1N!SkGN#X*+hvW#EfK&P%EhdC=8Bm39N6fSeNhn66CDJ9d!GU@{tnWF2*&`T&qVQ& zp|tZufIGKU0RQEuTx7%i_00*1|8t6IzQ2w+%uxSmqJxsXYL4EajpCC>k9Pj5?87hJ zOD-`}F0Y?1oqOK??%yZ5TpA@$4W;%BUNd9;B`#lG<=S{gG`^+mo!^nx54R;Th#+C7{3N?8=& zZxONEbBujo=Kb@;CMA3scjEnR%%Nn|V#71osEz+VIA3%14BK~vKxmEr6D5m+HagJ2 z=107f`Z#_IvzjcADGh`J6xulhwF&-ck<9Trsy4sku9WRC$-3I~^6R8>2_ZFlVcukt z_hWz54TSG>NAGzamIn4Z&+3yGP7H~Wd9R}kj?0@C+j^7>dW07jh&(ZE)XJou#>Q^n z?Zavc%}YN$OXKEVu&6Yfs&`V&?{M;D#F$G#{Bty2)LEc*J(^~mY?U*z;28f&tgSVj zo!Om^w8(`wA!be|SoXB3MuW~^vX^ZWFx{wn;y&R~W?oi`50ZpB5EwI+tnuj0RfD1ZNgv;$Wl}u_64CE8t;vpie zN=U|Awk|}5+d7$!^fd~cXQagaQ86^CpB;6~+PBtcX0of}oJ)>cHc@LGt}cc)6so|BZ@wZ4yMgf->Sum~rHFunwi?@lhscSb;neZWHkT|}8j z)aBMAZ?d%1{S&HX30s=j{uff4&)o-$Y7=zx`cc_Fw;~&@2!BC{=u>$z{5=UO(-c}< zE|vISYEPPRntUl!+p1+(HuXz)Dl;Q#l-t7XM0VFn3qo*N!n(i2BCe8KHu{s9o0YvV zk)fzm<0G)Fqp^i8Ve^Hp*v_h(&IY}Y>@4j}0UqWyX@X?;g9GK<-v`$T1e$Xd#Cst zo>1`RT^)*^o>j&ULz)v4k(5T4ztkhzbIl@_rnk}*e$_nHoig%m8CYpT)8C8B3AAZA zy^PrraC;!rWDkSWwLJD}F+Pk|FZK{6az>jNcB`6Y+Fb(-2e_7)mqbWGvRHIF6W8F1 zKpd(n+X7WO(-bC_mI|w`uH$nU$`zl}T_BuEBTk1VT7G9lPkaLdV>h4|ICAk6Hb%nD z(0}nuyyP1FPDKMXRyAq%G~3WVZHu8rZo_k`SwvlDHw1`oqN>GFbDv)6+V5|ByNI-0 z8@^bNo_l;3Dm5q8m59F!J4T3*K%qdN^8{9MbVR!;1V|y&Wp6ROr@w6BdN?WRBx$<( z7=z^fJ8wUit=#WA*$=>}}&=KIXhu z{og8rjy@iOc>5CYuM>EFRSh=9EC3*CD6V|_^^f+j+CZtylkx{)M_vz>6$S6QF#?Oj>r;PifVOZy3fL|fkkcsc)8msB+`4Js z4e?g7 zC&ny7eyN9dkp#nHjhYGBe#(%Hc*a!S+Kf{-g1a1IJAK;`3_OS=jEFV_N52>nR&s~M&7hWVArJ9w~_4j@d|Knz#{p<212W}zedQX-L?&!okkZ=!CWx# z9#<=qUM1j}3$CLhye0s4eEFEyJDu@3(_SXLFx3+Tf{&TywwKPi>yIexh^n@MkG<5W z$pVP?c@s~nTUc|F0IZM`^l@2?9dDXAY)cOMLdIHjj+(ZX!F*vZrQK3MED#zhlb?Er zRhW<|fs}P9>c+E2cmNA3g%#;`wWiJ0Y{2q`6DL+>8bHUbLzn>Psu#ENvWMlE6Tw+#fj^3?ip?WaVps^*Wo3tAVTjPqg9Z{=Lq-p+Lw8lf zpE3z50wA7FbTdiqZO!#rdV2bARSvze?86C3F-JR$J^hk-4n)>l*Jc+z2xQPB>I;$x9c)en5c(aYX zOxn?*S?jnEp=vXjW%i*Pr3$+Me`(>?D1p|@%GwV9LTO1fcbd$oh4=0Gj#KjVpnlig zI-yuJ1NFdx-1||Za&$LQie9owA#zZL_YCx&RT5pZhJ6*b>tj%}*tMtbd z+EL=6xJ>Kgug6{q(+rAEmg zmVc$udOf6Dej$TTrFr%#lC^&G=|Yupmdv3jF!T=SLH`BXdh)96XJY1qMB8WGE6@e- z88=~@7@QNL%%XK9qH)(9hbm>+zm^a8NJu+t#mKeNDV9SzHb^Ai)qs4XO|N==JGbWA z9p3N+Z@ude3hnKK9mAdffo^7@vw0F&+CG%HW%SUZ?;*Vdtl{ic0<(yS*N$eDKq(`o zM+fl6+AjH}ZFtwhw*twwgo2HSV@c}trzNahLj6b{G)eaU_E5t4`I#)rM~(oNB`9C$ zuo?5Ipb1k8LP0&t)!@eR0F`7}MrDsQ-vLQOT6X~r0mJ5XF773T`4#wTV!v5zgoCM_ zax)=;T4w3nwj2w?HW-6TIfTIo!u=Nmyb8CE*X%pOwBK}UE0UNln2ZnCiy!S<0I$#q zc}a5sGo$I4Bbh_eHXQoD*=2-RhE`!SAdOT5&d`j|w7z&sF%ClvfL^LB3kaJCRDv$i z`ys=Gpik&J0Jpzd!mY>deR1V(CYNvnnuqazqazq4D=IOxPnGg3;P;xeG;duChJRI= zK*ikUw>jY#O`dJ5OH!fU7M1L+RIh$AHDU)^xYwPE#j%AJ_lFy3@t(4F$mBj~ts(dw z3GYScEW;u5?MkW&rh1?RkBe7uQS$ z+~ZFiy5Rikf&jQ8K^j)N$wv2L5(Pa>N557S`#LfK=)@lr>ko|J5m6-G3y>I8Z}t|X zDRZIiCa(kBmn+ou`i6=`L8LW^=Fry)oMigET{2dbUm`G4L~0DEqKY?1ffh#ei6|vi zeq!78n|_oXZ`3KG2%#2Xu^UMAI&8HK3fLqIb7Pl-lS1PLTy;FPAnN9xWb!*!foH|$ zW8j!wghWVC9V53EAHdTdih3RA1~Etg){Q{1VrtChvFigI(Q*BRald zNPR-D>cCpQC*M6^G34PkoHJ80)U?XdavD;{TZVQ_=)DT9h~m4%=lTf3{H;ID>_(iL z>v$eR;m?LOBdEe`W+(y^emF)A19L^ZT1(i4B=D4t1%IysgObSCKZtZE{Jn^8#BDMf ze96be57gusxqol5rVPZ$N=T0*{t;l(GO?H<_pSve@6k~pN(6_ELuv=kO!zvD$Z)3u z0HV~ayKJ;!oYyU;=NW~5Py+=tqjZ+~i4N3ddk_hhaVgTQ8(t_*6UH>diZMlFn8R#$ z_&2}0>74Iwb9FV{^Sv0C4rrg%;18VOg@1j4v|!x;giRtdo@Y1Uwp3e~7_64dmOa$-6gzLi4k={ZUco%cDR;tjxjS+T|lb~yz zJNmzK^hvba)7hnghZ{B2<3EA)x*E06kCsl{q>_r3B8`?z)K=x3q>aSNUa0T6`Mk6Pwj0KpnDRc-a8OrFb)Ca| z3xD>+TKr(;NY1{nHMjF=Wb`wzQx3Q&J|H3ft+Yzrf@}P5Ro-lxP1(#08i$Mpe zNuZy7(|T0i?q_%e@lW}yfpPd=DfiIhp81DVR0obwgUQ|CLVDF{yUxzQ4Xz&6r$f}BwKQbX~(ZA}Ry9iHJ zJRhmvsq;@%Y{ZWInB12c^nDOF%sN*Ml^;JVhM!t=C^pIAH$sqU@y<7!D3GupCR0_=KRi` z#@J^FyZC0^n|$?+J;8q{ZzKG%o8J}FsB7~1sq{;SX{fztoJUil$XMFA_xvHsFlzy; ze1C11bo#Ta_nl=4#M(DxEDt{l6K-inLDHsbDAGE#W}+wcDWAP5`_^TMb4PHHqR30NR!J5i4V*l*= zZ-xxPT8g;3fqJ zb#-(pm|9s)FMz0Aa-;$Nqfr@huws6?K+e-+v0x+sv*$17EVM+(W*B$uq6NT&`@x3- zS&isnXV6~hg26(>ja)robvz1d#Le6>fs)-9bCw_&?%UfQ-c}#KK;#tim|lYD zjZ?%>6%-on)G7F?P$a&CItR`@L_w3uA1iwmG#6r(v*0qE^?_bzQ9y|9@Yco}9=qj` z33Dcxw=NE_VXnUpn}T_9?J0qA5U?g(n;UQ-@-Tka3c`t7$HC+)xj-?(Jm0ik@dAZZ zEvkTYBON|vJIA$vRz^uM;yVDEt*CRXu*@4_r3mpDV-o~06?jq|_C6)`sL!=?=ide! zgxf{0^2sKgssNV9$azD{8@B?~H&GIKlM)KRCBy=8^N5)_AgjCxEy1n=);kPFwAbC# zAA_sP8sI_Dna0*Aji!a)Y^hLmS1Ql1@oIS2Yr*dTCUwr8E%yY7m-h5_im5FL3?<07 z-b&}z=WD1ppX-ahy5_TNHGXv`a&FWyg_tV3@Mu{iM>VV{oXPQ^17443p%qiEO^(SI zbf^>QO2BG|Mx~&1IRoB|-tDccp@wiBYzpE|#U$?%(S~sn8qdLStw=)?L-~7UtQl*p zwHNu_SY#q<*!%qo74F9d1|Dr(99+Hr-CeeJc*Bu;<4vM`$RGBS{ z&WwtEC(Z?OHRcC;cw0XvwmH>b@4~oZz!G#TI|zx160Ja8OhDS7DVP4P6>u3=T~#$f zQHh^w)@fk&%8NPFv|)c4HLfO-uP#AgbN!gEp{BB z{&YJT@SESVOvlE5#Zs%zlD~~KH)7a9D8?xUEM81?_u%W*j;0iqF1hZ8$ zur6f~cCD`}pmlRZW6{^E_Yj$u-7y-n%~e$wa~BtE9(w67KaOuF&p!3x)sG|#TZv#ZX_Gisvj<8PdAvVKb=r8wpJqD#CC`98|klZl@IKS9&dM$@Fd`8Pa3%?jmH)or3< z7DuG@TIDF9)9}xJppI5n?i1mMN{_jno~yQrF(Al1N*n{iS15y+76m1vxv0(dIowLC zDe&o#j2}4|PyOeroUaQT-UQKe#;;R!-@f!jT}thZ()!4teHp)J+pT2$dRanTvx{4P zJZt$fE_erRfb4z^doMCK*=o^VW^Z=twm~5hd?%79g1XxAPjj7XW3t&vNo6AmvxbPXg2u?gxAusVv@?wDPL?BK z7vn>rZOk>-TlNmc&oqr2tRzoYcmcmB75LKHl{%8$X>&@L^^0U;nCP~eJK-&FPImJh zT9@36rajV+gfek59$03t?`bB_x15K;S@C3;`#ltoLhfJLb{4#pRxVqWo@{NlB$V;S z++<1$7fY7Yo0R7_0)+GOCU(bDY?uA%48;RExS_g?)HP(qa!Fgu^!7fA`fwk2RSl!^brt7~IQ<$B)UXNc@3Bi>>sG^$OVkIfv|Z&R%V5&j?{5 zUK$E9H&~J+QQ<<(*{dbuTqj9gOgZu?&;jNB{b_JTR&w2$a{Ytrnjdh6-t9n^Bpoo8^KzZ<1y zXD?EREjoY}q(E*iu|0`=!)&d{D+{G+C5znibFyfvO+oSE{RSYInC-OhNlAm~=Wq`w zQrPrUKe-nB_Z4WaBYBtm=kItieVS$>BQ<5ic0RI@YLK&RK5}wnC1&c*X{IR!%HS)SL?$Uq~R228{>mg4`OFcGJj- z1?t5ftn>kO(XAC;_oH}h}^ggdUYhP+c3jaj=1ME=|9o;X%2+V@i?6|eqv zye+S`4C|_oQbxSJdsOd{1dFm&z4o1Ie z)W8*V4o`FeM}Tg7h1`{!+IGsXYquZdcSD)6(6Pn=xFJL(Jy8w6flVji+U32_?_b*J z@ZkKn%tIb!Dke;?)D7E+jMJ9o$tbYw2d8Ks9h-_t$<{mZwwwZ`Zf#FVF0k@)O;*IZ z!tlj2QUcesoRo1XBC@fv?0KQmLz5=Zcb*|3c5i31IonUUN_sGgtQ0l*2^2IMOdy6a zxri_y$vpj;bZ4giWqOr^pII&XUB%B*2vTo%yJRB&^at|-N&=Z;3U$ZiBI`K)VpCdu z<7Hti4)WMPtpv8K%SEp`%-;LW-d9tj`nNTh7?;Opf4}8@VQHV#r6nkD0~xwX{APCK zT-h-C@LziTWxQoV-%%?IUe*KzJbPz*J!@s>g4@w&=9Hx-;<8vQrx5mQ-r6+){BE8xMfPj@p zv86k@m&-#r?9KXI&O||qmme%e2LPyTe5aZ3U{$bG{F`NBwI6?0<&t*8>u`!lM*LjT+d6GltQSPp z-toSz>tX?hL-}zv4_#ap-yDjo^TOj3H_t@~T>2s0pBC>ismW7fu<*$w4~II zF;Lv1tk}vE6g$&EiHXRjUhgKYsM(ha%(VPk)~7OhJ;v2L7-C@PO4bu_oi&eF{yGwn z3;tqJZGHm1hMhW=(`?rk^&wx$olh;->X0?QCz(A)<}=;*$cuRv z((}+>*k;3{Y>VQ?gxP1L+YrjgEj$K?>)POGw@)Nj90dQBQ7%>(rn{hDAmN|ETxj_d zg3pXt9U5w9AM-{47G-^3v)B4D)Q62zJ7*3vM-JlqoQZKsU{I%m^xN*XMGmKBbY=l> zq!bDrJ2tT2d&YE=<|-C1}S z%+Lb<=}@jP{ha6d&rsH;`o;Ql-*Vfo-fpkgr&dYD$4ysS-F2F~dj*q`D}SlJx+&kf=P@=;c{@);8rz?xcex^lf?B|yDX2FS0U{AF!cN? zmqAjK$=Io^6qowvYKh{^IX94Cu3{HWhYOE0qXxtLtXXGX_^-j%NbA8PehrUe?b?Oq z9s>lc{(mn$vK8FhtY+?GLgs<)d0jvA0z$tzbBtXk3sw30uB`wO4Q-o^5a6F4b*uqr zPd9wea~Cf;baU@;P|JaL`Wn8bjAi>*UTTZV@GMYG>zcD~iRJs{B) zV;rZ*To{Yw zNkXKsO-&P}?p?O-NJq_2L&Ce7SB#Ld77wtQkmw5mFFZIN0BoR}8~S~Z^Z3lb3Jpq}kw6U0 zyxVoV-o6dIoW9gEGjet8>S;vCr>E#?*p5z}+h#=Qo100Vsb(1{o7jeaXX5%pT)Onb zJd669`Y9-?xh0cIHm~HjW~N;rRKwMNbA1asQ*c7R@h^&5 zQ|Ko}BVWtWLoL3hsfT>-ca_n6yxmeiUEgVutnLkFY%<73wQ-s%C+^Nn$m1_GV^E;9U=Ud22205?g=6w#g|#Ye$oAlHcT+(oPhi**{{mjgLIg#6qp}t_s?X!_6Zp z>YOu5OzBQ)3rlme6bo_bnwk?q$*|}aclwvN)@`kmRN6gsq<$*!lTS*bnnc@%PH#(+ zZ&D`H+e0R+@T?V$D;@6jTH;(-*TU&Pn|=xib=g&zgSO$2j$;4vTIqO2>!uv&X`jJE zsYB|73N9x@Ou>)zAk!)1=Hpk5QWQ<2+_a9W-MA_)2LaU$S`%9dpyuT1N=o?}A1&ylLFJGGU%26{W?Pl!3r0y z?;3|Vu6E+?$pI7Ra1DUO#%+%#Yl!-Woo^xvP%PU`>wcY&20l1J5W7HwO|j>UXzuLm z0S`%{l1)TkLWaxS4S&$S-El&@zc}4Cmd9hyAt-a!sx_m?fYUOoOnAgH#zW z?`EY!2?)A5*8>KMyxbvU3V1EXNSkcds{ZWKN{ER%$R1GxrBgdZ2k*NM{~)e6Z4Ly82XTyn4ZtN6dQng$0}ZGA;a@ zef}Wm<#-OvWDnt5k<{dexKcs_fpT3yMiPa;Pn&P1bh8O$0FcnW0%C|1%&_0Qs2q3dw`SYL9YK zEs^FK$!W}Kr1AOEM?x$>1Q*Ey>7pCe8`T+WqQ|?ay!i5Tn6FU`6(i=QD>d3Ek21D* zgFND&Z(1#V#g(a8GOxBMB8(&l6n(nD`B@>xy+@(WF^Plt&XnTminINI>5`NZ_uXrr zzU`>-;90Tkhza#aT`W>HSx=j->y55Ji%JSJ6XB7x5t?g9Ki~0gQ-Me4ULwe$SLEd_ zPnu9Wo8I6)sC9wzFlIQzu6-42>J|G9I^pd(!iyFwf!5Dl)hU!bj+*C$Wr@r%> z*C_#SXxx|cF?9YGm35{+gX_&K#rP;S$EEH{uw#>kRiOPxU{M5no5<0zXAGSv$v0nQ z|3}4yN{l+D{#Z?-6jnL6OtXW_Dn0(jR1|jLbs?5gX&7?1S)*G-n#d6p`9eOKC+lfU z_U?DrSneJy#9BScA35^cIx(*3t>5QkBn#f4Y`Oaajb^p8qC(Xm(K zv^rp@O!}k)cP1Sp^1tJOPZe4C_LD0S)2Ks@W!^9O*8vh?QCY>?`P=3>@nE&!5n3cV zN2EWy;Aei8CCW61?s))jY*)vAX#8B;(ap`Pr=t_4gM+`Xon^LlQ|7m=CkH94Be_-k z>3x{VU9c!z4V;&kE~dykpqodi6RysN#p`tI`s#Jmi%@^TN1J2taPw5`&-(_Kd7Uf< z@YNt_V69!q&@T0psvbF|QLotWBW5q)Ic6Lgtz2FdK4ipv7MH15fHfEtjRRItb9*eV zxxj$OaISr!qsV)PQr*w{yOWeJ)$SUvv;j>AEH`L)HB%cgS=&2J+DX4Tu*0EEZt5}8 z>}tYYdfB+|b%()p@Hb+iUTFr+FI6F#gwA3%8hl`3oiREni5qgHt$z5MA%ctt7Rfem zBnrIjPIUzLi@O2_-Yb~TYdi=tXb03?XNXKqP{R(zTr@WLNmpte7;z1-!JnNC7?hVc z(R=ouQ6^m`jq2*7H|2}h5>H&&X4TG#N&yn1h8T&gPuOiH3;|j+ND*OImc|Z-!WHmu zH4iih?3v{lS}L#~n`@~{amu*w@+weIKNkt*pm*ZVz33snd6NwFFk1hhQ}z0j7H|4K z=1>MzaODXDOd#6f4W%fGPm{l3P$_KZMBMw8HUy9G7-)}CY?XHpsA_8|1p>Ru3lK_s z5K3>v5C~9)dx@FNo7A;jV|pAr<)+ z+!y!o2`zS!mqtF4H9FxRKX7ZjE47X~crfmmN&2|8~+6WfI?A;i%{m&Q)>rG19vbnsOvwg@;45 z)EnZL5E`8;#g{xwZqWH&?^vhCPIo8!(>Wp(oq}l^Svp-7CFfg-yQO7&*zkADjQ8S-@veB=BiRNAXW=-g3& z+brGj@+hD1$Q2xpMFY4&kP=X0@KOvCTqdAmr7;|(Eu5m$EC7GgX5TUI#-Cq#yr%;a zXGVX<3OLwkG);23#HhTFnSdO^dbqf;(m=2rn>OZ0uW{Fvf@JD2vWf%awc$}34f=rs zMN~I~D|o-kDFjAjC(sHlaveKrg_a+nUi~YoO2%DPSxT{5X*8y5ipivoT6`y6nBs^-#F82K4an} z<6=&Qt2+p%D`9@O)NX3gM&hj-k%)6Fbwv8!G^Nh|eLrwKW3pnkf6fTKpJk;DL`PN_|gRh+U=4S|*)wFKw6_VM2{u1BYYR3$JQOfD>m6$gPfD2;#%Br}y_R*Pc3 z#6<&ok?+YZ*rqkHz6Ot7gSO5oksGNNMnNx#YWGotE@Ydrz^BN@LdBB)%sUu%ghfc@ z+?EPTR{?a3+7jWvHeJT3chc-^qeBu6zazikMD!>Q_6$uA=2Bh#SoAa|!I1*?dosa# zZD8UtFNE&oX{lPqzN_r|y<_seP2Gnny&+&u8MUd+m`uDKs&XWdu8F5)>f&QH=6~GQ zykk~Ec{voC{)#~Av#Lz;PE?C$y-!TEmo@El2Y+9N0rz$P6a03s&uG$G;4tUE;O@uI z{|k}QkBR5Q2ku!0&Zg`Hnh@%`hp@YU8F!C9Jw+@7n~k$#R6fWvPyXB9%k5Px;Ms}M zD1~?m**oNV_hj7%oOz+C81K#m`Bjz^(cCcNgQq zr^?&RQQJ@Apj8enEGHm8;5>5)h{&-}(&&b- z&^u(CpNTtMPOl{UbY(Zp=#@yn!4x0&;!TM`j~*R--D(k|uPphzSRidp z3xiWX&^0;|5W4*}bSdfXl#Ua<9;UI8_eIU3)d}FYgOlZ=mEIn@e<8%hRtTG2IC1WG zCS4B`z9;~7l!F}7agP6GBJh{lWXDt0b))iYzumND34poU;+p^2boAmKxOZd{ba#uz$hdID`F)n6YMCtGh^o8qa zgI^Z&s&2k?7NaK$Z~j>vn@)}Arun)uu3kohY4v8oS48Y1M5qTFJ>C+h>>;uo zuq-&w;YhAxWQ%(arOOYQtl6Tn!b=L7Lo{lL>^h1_ zzXlQ4J!sb={6oBIX3n~NY_VutcF3}BN9yvp0%Wvh4}2L(0(2XJ45Jy=gtVXjYk)ul zguI^!vqvJkWwFPeR9#7f7r^1m0}HRMPiC`88Jmo7=aRDCY_ABMk`J~axhv1ckac*{ z9JFm)t>vCL?b5|u-RR=0mDu*KdUuwQQhV4$9Vo>E^Tu}No&i=QZZJcEGioh6?%D=_FuxAN|O<9qlo zKl=^u^Ez*&38ntawG8}zPx#jCf6&+x_Q^ge;B4RjmI$24b2XAtnbWCHyUs00)AMU9 z?#HyG8eBypObNNF_9hSdiKtcrs=M|ZVvB<@@bloB)kCLQ))%>eFwE790viRpL~IKB^lz)V1w-yet+{|J zA(vw=HjeG0Pbs_SJ;F=ur3yjZ++oV?U7E^Jkq7TNHkpa4qKPXUFD#867pSdd`aKX$ zG0wz@TbckC`^LkVX|{M;5=$_0a=9((^!PpIQe8wigRY z9Ul%^9*;ad$28yMafC0AnL-*FO8ml9<$dT~hghFI17e^_vSXf%388P0OVqBMBf1O5 zU*h^Y1{|FUS%9ryT>HZ2~{W)4(2jzN2XVUS}9IL>7qt+3c zb)6}QA95!vX8jYOYmwFrazg7aI}0Q1&f-3k!#W(BbEw4IcFFgEGBTdN@te`Xacey_P;<7*2hJxwYcj;z}7x@$v=wEX=DaM~% zADPqL#UO^ZX&J}(s^ODg-mQs-nFj#s-c7X>9Tav>n0vOV&|_gH%JdLzu;=-pH!`UZ z&{*q?QZIZ3QKH8bYZ^N9T~+nYF-)WIB-tNEiyL)CkZ>8zWl3t0uWUPoHI2;HEKX}= zI{vDE5=MM@dr?kzE?buAAW;CW{lb#z256g8vHkfUN`C zJiy}UOv3bn)to6mX#Kqf+XSH%y`L7@O1kkU?#ykxa`;suOQ1Zy$GhZ)2||&5;3D9F z8;%yy1%Yy?&eNyk<$j`@G9>!WMrrcLRy9pl3C=SZaY{bVY?v1;2#b!Le#{# z6kAPb-t$m3t&mK7qhkhb=n63@aj8a`=`O&nirjNC5S-$TzBV?E5bhi7c9<;EiFSj< zKK5tx*K~nNEv3XOl$Q_M7T`6+TqhLu&`C~7QFts))oiBC)@+I;DUC>m>_W!n!Hnog zs8_T#7=Pd+@hm|J+wLJz4I9z-!v=XWykH(rsb{b$9_oQu+UVe|(Pk+WX+zv#)1%9B zFUwibsiM-8!6etje4DnkOj7iI;H@s>SERi5NHg;779srS73XRJqu=(2f_-iHFsx1! zjtM|3of3e2xebwhG~h9Q?q^6v(CLa?Mza(+xJ^X?md5*A!iQ1P6t5!88Tv;qpt>)L6Z1@ebuVHK9bu?6H=0Pwk` zDLJVxRMP|1Ps=X44&5(4Z{ud=ce5*eYX8%3%=o_l@Uq+U`Zl!cBGxslB4W?eR6O=u zl~(%N9?T6n?`emk2i9vpOdsorqXDOG^eX5pVNoatD7Y7aS)qmKdqob3f#aw-QmrCA zdb+82g4csDqbd#bTB-&s6@kIkB)ow7;@Pv)6|ra_CW=MVKG5HWbi1!^qA*LS`iqI3 zQwE(_GMr_mwW^5Um*+|JST{)U;G!Kpbg{fX<+-B#7XoU4UqJoot1f>13n+g#swLBbBl6$FpBox-yi%&{%$GG(?4R!$|z-` z|K~lTa0^){T6zd?laQ8W5XIhxG1{B;4&u(#{p;@HqwDuyHzLh_JN3WB8vmtYn(_al zV*0Dk_WwO#d(A_-_@{?Efv+_&-xjv$6btu!gqs<_4vo#!V(OG6m+yekMw;vUN?WgMD;L*$ zwO$|JyT{Lu(D21{R#UXIt4pKSFqL9eSCJ;paD!Tv_J2mS$Xot3z%z%+GP z$Cj+TpIjeUa?ULZ$g(~yu}H0)xN~wcf0I4)j;xe^nQ~ASt?-ssy5|+m@Urx$jj=3Q zDe=GPj(ao0Wpz8nA7S~{TW+9x)p7Ycnx+GgKL2N93O!U^^%Z3@V zEAOgJ@Cpu&Zgnr&GF~^Y@$j=gdpl--Zeabu`;>0e(EK_SOxeP& z=@o-mo2>|a6zTEokeaeS(I{)a5TgV3JSPD znkudG|8rlkqG;oRFtPaAJc`}D{LC!4w3=Q~1NXN{4)@^hbsY5`O%24J44mwo4eB}!I5*cD_Jt$k>3qw!JMp(^&F@GT+v z8WQ-Tt&w~o{{weU2sJ2V&J?Z>^6am+-|j7k0PLH6Rc(vhK1F>r%ymR9<(o@}(G&}6 z0*31nRMj=2lB~2FKx(bY&6BisAtM(UU_p5Y!M0D5NrkT}_gjXY7RliqbSKLzrk64} zdXm2GxC-J6+x#*~$#{!3$1P&bNkj_!Qs0XU5gYUZZ%?&((B>*@3Y9fJ=^9QSSWXns z1)!lq{JvSD%x0&J3Ti$S_6Tme1--0XPctx)2Wly!7@d^-eY5d-B{PUO%kw_bIW(*E z8imK%5Ck1+1{PzfqCbX&bn5o`+Rh&x7S5YEXJJq z?c-FbYI44gXJu;p*C&Y{7K$Yl(s3A@WYygz>rO&|Ut%^I#p@ICh_GHaNDU2X%YzU; zHnteI$wbR&55b3pLI$>?BtRDO%0a}RAku331jdgFhe;Vu3lD0oK31f|3C|)#KuE$A zF0aWGB1Q)quc3Gd6xa};dtn)4buTZR5v+HD{dF5hnG|-VR@@r{r?D{NxHESiJsz-y zE~DfZ7RiYl#dG^lPKl9ZDs}Q&+QF^+-UPTo-rkaeB)}M+H42lo}?0K zlJJq3NybU`Y76@JIuJGG<&m1X@i!Ix`$gzCZ`xxjm1!R+JYGwyF!J=1BDwk0&>fse znRwSGQW_KLmfLl#NrO00*&QL|NJ! zZXq>Vzb?X1mEi_DR*uy24&PPZeVA8}wxg!&{e{vD>*1e)lGf{>2vM=u=_Zj+a~Vye zD7%)Yg^z5u71oZ}++W)>+K~e*CRe`59K)nA(SniVg~HR_Ji`p7RdB6mC2lmCjYoWD z&eF$JWKTF)?kHGX>Wsa!@R3{;O8Xnvz$J7?`O(ILTzp+7`=%7Wk7XxQCMs5_xG5;p zBKoqG3`dzI3+Pu*PnL&uX-1%l1n^ES-_+d9atXHNWD#tk3`d<6hi8kWPW{eG(}$)# zN{_$597sJldk#|D!Y_$wzuk)ZBH%I}!_>GdGv{n)*E{^&rT_=Kc?3?%vE5-**f4&r zzZS&e8A2?Q->@hXMytFb7eYwuDCEn8*F8n){5RexH`0t$3O&6`(XgEA8t^{vx7xUw zUaHl)*f|Nu5-^Zhf`!(R-DVtuWpb+^#}6$#|ssT z4@lzo4}xEWSggQ1A3BPkvFDj#sUYO2Y#R_twpQ~(wS(n#jDe@}S_PGng>MSo{zL9l zhQ(6ROh#W3_cBKbeO@PAnD|$~hk|`Rs)P8EiqMuY*^5f8y%FRcX{;WNDa=t2smBk} z`-&4rcvkEC$09GsKywV-$z8Lj_1BfQ&<TqQ}dtbrmj6mVIG zey(7U4>nf_TV0hQ<*o1e%hd*)%Oa!T`})FamjL);r4CXVvD^2j`Kgf>GAnw^dqN=iQli340#V z=)nlPLl(v>8TuM6^82Hgk6SlhWF&PB3F`q%vxPwtS51buJD-fz)SsRJn3wOn;!~RQ z(#69`dBoafHR?|fGLjfB|wJE`^< z*LZBHL%JP$E9wllfAkB;^?N>!w&#Ks{Ku*{pC~Inr8_q;wgbtIn!sW=k}2AG9TXmc ztCwicXUlCSb=pbK_ z4FNv~85Ao;c1J13vO_BBVj@m$GxTVRRM1dP7oj$py#i!5_pp0U_sUY0x~`%5QAC0z z^p)N)vrl2HV@1%Byw1RvKbnpP=Lx}XEwUv)%I4bAbn+VD(rxfH9}0!Tn2&tf5WEZ- zZxFH5g=?rLskx-+kqRk%%(t6C(lu=mLapG1c(L1vc-cQ^ZgFp~Lzhjdqv)Y#rp&d} zC4r((k>-0VJ40dzXlZZt+maF@$z1Wu>C)E_rj98h^#Nf{3+V5>;xppxb>s#zi zc@CENPYHT!QZ4o?cwEg9`WEFM(_0AM440o=85a}7DBpJz>@{;VnezbKFVjm4R<&Nz z_btxFZyt)Y`g!+ofEPp@$fmF#8G#US@oE96%+(IRqR50u7t;<;%hmR~ot>aR;bXwU zLZTqrs*U}*i`*beC~HfwvLbIy2rjWRm7PrZxd$+$b1rkYZ|2mI%P2SG4(G>TIR)U` znj@@#txciM(efndkYogm97e#1M_=^PhUuUFvG7Vl!#w((VHAa1uZjvRou!>?^Bn-Fhj4$2-DJBZhrWDLBlkVzl z17LAe#Pb;bKx$w)EcCv0FKJ5Io<{NjZl6{Phw%*IcADhb2EYow(!*udmvI<|L@6He z-xXF{35wQO$fFKa92u*6>a%}|p?4BBkhy%5c5Zm=ivlPx+bSI-GS+w)J)SN7=lR7R>tctpB zj4a9N%!Ot-#6$c!P28nS`^5MJ%pdT8n9uSX(c-@Z#VNe5m?~;LrFn{raX>%#C$~`9u*~#z@xy*hA{!AN)moH4eQWl>z$R< zyynHx8T{ECI9Pv3q4=2Ne-nF`8#c<$MSqNN^^qF0-s(yVhVnd*T_H@ z1=M7Dc`UVgJ-+iE2P8_R+K6!c5vzctG03Qq zD8YK19@l=;QOCLRawU1twm;mn_r^$GW@jjCVkNvaLDdf6AV~IuglC6N!ua2YW}#xQ zPt4Mto#%q#QzU*Q#$mU=vdi#D{ZL$}uq_D{aY^+e-V!J!X(e|c+-XAvbaH@xg$V6d zq=7v=-@0ZzYo!hFRI&CJbZ&PnvRbtry-~NcHgmnJIQ`J zS$BQ;LDYEtPi7PK&}Nv_R5BxJKMgW^os22BE}ZpY@!oXyohF5_A+{G9Kc`J7FM0NC z9=$qy5u2)$Ng3P^8u^u8XnQx`!ByRnja^0ho-{V#$cL)%*^at&uL2*GbKX`H-3chrb|awu@gaQq!F+GR1tECjevaO@7-_G0emvbgmhjVT7=QhAf*2-SXql?oLjTsY zAf=o{B#C>iM*lLS;kf9H-O_{_iHDL%5GEAj7p{dYUedcngczhezEPFJ2`FLFF1Wnmfb>oy#xxJpZjfM`^1gI8)AD9ur>r}3I@6Q z$K@uYx7U~VY*;-cb^m9i9Kt?8%@kYVY=yed!Zi(j9*=9en{)jtr7$GsNS zXM8?L9tfSRpx9P8mZ#vWx~}5niuKbH(=M3#2}|J|awXoqfIYH&@xojTx=%sz#caMD zM8SsD^o4ZTYm09)&xthb$)VBR>;u1{S&ypUOX<3P*QpmXSKGt6A3XB%?hU^YN;Y-a zB=VMJd3^68YyfRCLuI=N`A!|EJUQ@2hPq?YwddF`cOSz#s3fL)YFubh+7PvPT1WQ? zL7UMR2{lmFSGE^hHfFV<{y33qiXqZ>B3gUK?>FK;YuOF;`y!OoY|IoMI1YEP@xeqt zt&d~c10kod=0U?k@`AoYdE6Xu3dZ1>=3&b(R#{HT04o&jN7*1j2AZyt5z>94-*&|) zHaSv2i6|Gx|h|#msw6dPN7$4 z1XqPmHxj4yhOlTo6y|_M;rnJkjuaaexXUc+Op%6vV77sICoJstbvDcb=1V~DJREz# zp1IpGi(DT2vh20ZU;|oOm`J3x1(Ob&0J{27ktVw#9+xrD_jH5@!=O#YEZsQ2xBPx{WWJp;R&Mmz(gQ1}EfmIdYOATMBpZ;YjSR4ML4%rs zypMWo7Jx<*rc@`Eoa`OH0gtE!7_{;`kK&s`#X>8c)Uu+`kco10yQ&7_euv7=$+PF~DFM-0W*8+`jd&Yto z6J;H$z_W)wGL7bdfa|3cIXIvQ=@_K3*5!A}ttKuO3#WjR*WkwNhxEEROY9E-AYCQ9 zWn^O997in}G1)*F_tZ=ycDtW&j$}&B%*P`Oljrc8JD@_@nir8$!dT=oKE@;y2JSEL zLTJdCNH5fZzr5%CcY7#?K%9iO2p(W1V-UpUoDe9K*goxq?A61yF9^^-24Nj4uTxs{ zxV2_vczNH(x}#3M!-^?j-tL-K5*NSs25#uW9)j_LaT#4JA0h*f#oEI0o=3)Zdi<%J z=V;~>EPKa`Kn|4a0xwYo8?gCtQAG)f@0O=smZPvx-LrMAmWuhh?a97W;3V$;{0q(a zpi4VfFGJ?aWEE0V2MrvNxN^+|`L{fkTVne>v9EHOz-@M{ukEN7xz3X+`R}o4aMi@# zG-fuwnpDs}j-ckV3uZ_F~M){TKw^8K-Z-|bG#I5Dbwotz-0sM~S$EhT%5YGf0O zc#fnJAp~5$%OF*2ze7I1zCm!Zs|Gji@c)va4I0;xTC23@QB^i6vRy*JwJFBtU*6ag z>V782lVSby3nn`js`GVk;0>&gvr{$U02z9*kFFovwIaNeq%RQiGpZ}|^BUnE0>eTZ zgB=grRd3XZF-KOK8^7ND%>L~lN6>3;y$xtQbQJ47tKGfyDoC9@YoIH8%h7nd`l9P_ zd%oG@1BU%2gFVXrAJ^mmQP|A*zbI_}@7Lr1->rX+|8_n8Ke98kF){rYPEdy0y2DRf z=f^TJLEK8(*RwOGOr^qfSdrO?nml2&e7Fgr?k7G>(j%OQbG>ZpQPh46d{g&M#J{8c z=J57#nmitXem(HK-QA+m(fYggWj7>w8OHwBpfys2C69eanqpN{Pa-*RV9rIIr!0-vo&II|in0-# z!foKqgOe$GuiaZqyRqn@ffWM%HCGpty4gzP{sI!zd3M(z&HE3?XR#Hcje+Ia+9H=7K$_kjDFBwzh zadEj>VfncwXZEzNyn9`3d6VH2R^l@cSrBQQSuSs`PJw|1ti;n=6K9Ql`;fRiM4RC= z=sj3nui|!G-7E9WWK3=AI`%ZmoVB%?kAT>onsTVEu2lxXFVK|cF-?M5O-rHp<6d55 z+ede`nNtSt{q?;*t)ordoQG}_8zdW@L_+2(KTdNA@0K$qr2!2p^@f2xByF|UpRXRN z@F;IKMdTRjDf>H{dztj7DRMxHoLQoF?9Z8Px?oSuqW(xh^LsFlUbwIGZJ z3SA`Xrm9Dx2uYkG17KkP6YXY_@z-H#CQ?`e-F!!CtG6#;r-Lp7N-nkR$s+JGF<6R0!ql(@ z!?8u4JB%O%_uc+Y?px>6c}cH<81xc3u)*r`2TWjfHLk(Qo^#KNl~ zzo>;2PC-n608nlX*oN-NVN^)MO3Jr1wfa20@FQQw&EqlcCh z0xK-jhI>8(H>yhP8kK(wK)}pk=x?qzV2g%6Og1=Z5RasWv9KKzu%if8_28S#hqmCH zFSPpeCoMXAa(K&Y04{{|R$x>^*nX5%hSw{~U+)9f(t!2keqCy*Pue)?fVbxX7dT|9 zP(=DJBd-ant?DvL@E!od2>gTC(5$IC!7d^w>xT%)zr?q+k$EKZ8%q0`wDsr={r#S8 zfGg*GZ($a5i*gRj@cAx5SoX~)l9RX9lGb#gNb3_L^UN0R|LD3O+MEq~ zO5hL6w|_dZ_(bd$1KyjUDhUn>>OZ_hLIg-nIi4zY2_EUrr;u3v68r7Xfxd;O&D3&O zOdLz}P`hQW5j34n!NfL~fF8IYErdYP8imSvr4Wm%CnpzZs5`IYFMkLG2jrx5YlI9a zNd%!0R-sA2Sqd%4VWt4$H*(I$4XY{Jbf5(z&+6T9sQi^Hx2^1=mZ)b|I%Pwcc+>eC zp@WsTo#JJ2myoj8J>y0#V^Y+){9-6AJWFINms47aA-Cv8XJTV#Aa9W)alSKEpWx*y z(bPR~2r0Y(x@h^j7Bbch@1&-Fsj+MWCz)aV)VF_9?T?wc2F`-`1F8SSHALJynTtEl zrlZE6sBi+-sDyMkSJ0Jp&u3(NN*Lxqn97q~*^v;3#|>U)6@V(XN$9`X9tlj2j7@;< z&bX?H)%@(V56c>NkZGM1>0SXuK3e8Z>ew>rLLXR}rXdce^P3O}A$l&*+QQjyUYQg4 zQ+*^7@dgxhI=M2l^g?{tY1nxlr_^0l?xXMup4@Le#9H(iP^pn%3?{L${eyZGKqvN$ z=~i_~0Q=n2Et;!>XAkTd>70wCGS|E-5d_pk3h+S+X}KQFCC7f&(}e9&-IL(eHDn5g zIRd*NmKdmj3ycc3nnOFN~vKE$Fr6P&z5r0_^@?}MOho|v6o(^BgXj09% zQYw0VKzbpUlx-1|(W8rfF>rydu1uq9XMkVWsOLRCt&&x&d)rs$tM@HDaxVOD+ughj z*AEbY5_;$0`*ukbqm|buGoHw_W$i%agUHUV>kujnEUjirw5!|nxSEk4+bmsorwgvs zZbNMyURZX^hA6)k!jogd;T{RD7y^zg1VTKiSJc+qK|`Qn96ag~wXr$}Iks7aR$a_N ztJx_w*?|2JRH0a^_I?VGG`}5}W<1D0nRlJO|D!`Y>T?##Iu4d5I34Z?jbDh#*`Jat5_7_J z*?Cs_A-^7>Ni9u6)k`h@gC4$kkglgj``mMTfKf$W#t?B;6p&&hWYKQoZ|BHt$Of!u znV|7hT&}t|6?0;Eli7)jRAC}RTId!(bC-j=FDO2iQ@0&<>Im^&xejNJC&U(}r{Ik8 z>Ssv}WsEzJ5(CJC+soo}vB4+C$e`SLGA)~2B;JDuDyuL`aw}Ct<}uWjAdYl@toVD!CIF59qAqL-}E1 zW$HmD5>veNq|bAXg|{-@1+h;c_2acU2QOi95=G=s6hl5l)E}c^*9<%f(+(DDCaEC5 z&41^?C=;vRky9Tx+?r8#nnG%<5pRhqdqY9g?Yktm0&Mi$%nF$hQu;JG%NCdvEqX~w zIZEb|!D3^FiSl6s50YD=l!d#mr0G!#t~?Z-x%auy@aTRxHO>vNzP@bsd7yl4o|JCt zM-BI#Kv1f-)95Hl&j`XGeJ&;7uK*83^RO!8r6NbfAlQ|t)zO21C2I{wJL;W$n<|Or zJ96k>`p08a+*oN2HWI&PU4!DCRIQi}-AAR-9Q<-Ko#MtUKx`>fSTZ*B((Av<#U*)P z7j`wRaC`zTX7i2!24!RrePo-6=SUNzV8K(ABYJT=VKD*}Bvn;!^CzwY#-FG~-_Wg# z7OWFoz`@Lt3q@*eZlou=@Eae=oSwg0<9FmA;Av?t$9#}^a>fE z;c2fcNqJv!sU3R=ML074MCq_ZRj3we8R!m>+Ny#dAO3r=29r!1Pxg1p_d*|K=LKI%xf||Cn#TI>)M8A-8cRXIldvg0uiP|u@?L}& z>TcJwIMQE&JMU19iX?CN=bI|yh)jB*d9)M$AZ)Kl3XTo- z6Wx=NZAm`;&|3uFq;i}l9%})nOfLk3?;K23hWgvr#nN~1CE~I8Fk+1}+wKE~!084; z%lnara7ZF9YQfPaSy-1zl zTA;Z>Jxl}wn?&U37X3&{Hfo&n2fNBjVTbPBlxOA^#pEyH+Ex(%#V~B|cfbPW4XV}> z9~8I7^q_Bd4uJaxVka&9ufX*cC>WvbnybN39n;P}dwj{uwoeA3P>#Ig``It!?=1^0 zEh(haK43^0`uoL1mfH2Bue`Pjcg8jCVdTNG6m4~#-w(SDU&2W#rE87Kh%n}_@x?lk zjv0MmmPPJ_l6`U4>vV6&FmaJ&;Us+QY$ujaVr_fvN2!loZ#HQR+jA+GiFB=DmPr<{ z_p@ep^pMVZ0?TvGi4P}bm1L=nwpuoVBIDLwmE}gLK1X1`96p1+upwkudaPr$koA2E zC-1@Z;okyGUagCdME@Xo!+N0L(^NIWRX4)mcF?N2YgiQxuuamDJ+b{xs3&NO8bEb# z8h=ut%U+%P8eutVHAlyxA&>S(-#Cxp>)b!(oV05z@S@3OC4cyAcP*bdzTJgdIai%k z;~3V}TufM%V@EP&FNcap=-#v{0)_ZKUJF6V2HaM+r<-7vghb!Q6Mn4><99zJG{+~B zHNjQO>ROT8{{G^8p@}$+e~4q`45{+^4ZRajNr9O_bkxls))jD$hIXp9)$wP$K&rvgq@vuc7*`Z0#no^7p_PbZ+-;kOmij3&5_XSOCcnl!nQR zjPL1-JAja0q=Sbk!;RP5SBT!EpuxK-#Bjn4Wj`mA5UTCMiUD74FJu7C6Nn)`usV`H zmJFiF1vB{Qr0;f671!BRvv9S3M3;Dxt;)}oXGR7$gd{567Kvt$c4hWQ#nuGHn*K`<+HJdq95ivWc^~@_%Q_nWUzX;LCUlENn|!;rTNDEsAn?NXfOut z@R4fiCu92=W9imJp~vjMfk3j#Cni)Xv8F3&@VQNI)Lwl=VaQG6=|YFy#QBCo9;%9S zJ!s{f2oE)z99O+Y!6CpTEe*Mu6Gx{0Tabb=-i?5;-6#{6e$;f&4JHV8ElVvn5T>N% z#)Z}D#{i5p--o{I$Q6M_Dxx8;u1l{SjbI3De%~q6btI@9?aTAQ;x|EasNZ$*FSLdF zAc%-C2-^s7kmjl7L#|Zzv4lNA`ApQ0X}jlD(l~XBy;OH6<<0sJ(7+cBN)Gw5`7!Ze zp=)AW&lFUx;JDOfPHw834N~geKDv1mH%x{D2Os2f#4g4wlV2*#hf|~uVTetbOI$&_ z?tu7|QJ;ct5f5tmS*^i`A><@v?Sgf6mCY||IPIsBRI4N5W7?0W*+e5x-04Bb2gy4R z4sv{MM1bA=zguM|M-OK3Egw&&jJbp`;(+TpwYAASe?J z^|r0`s}c*TZC+xsac<+JGm)qwlV>-V6SLBxR2Khmr4xw8>O-|VF0jtWqgmL-6Le4C z$V_l3dyT7(h4@{;kH#wc8jQiZwUJrt+%enfhx8UyG6}x^dOEQ9lMT%|KLs4I*9t0H zT{sZ*`V_t6pg=;uT#v9ovfbgry9o)w zb4zJV<$DOxVMB7jekxUg!DgI~UP+wT-Bl(IJW;}MSp~F=EVObqldzs({)rwFfsRKJ zBx2h7Tol?xr&A6Hg8?akT%EKc8dCUa9Hy94^nYtQZk+0u3yV=LO7Gf1!4ThbrdR}k zR>l9|%5xG-n=s;13L{jLd;1?89!ptu4D$;pn zqEl|>Nk=WC$`LS&i5@p;Q`*H-+SLzbbR2RJu1pfeZvNf6xk+9Ck9Aj;ca$Qh?eb$V z2Od{MG#9ri9HrOojWb3V{h^8y`m&C8Xjqde^DnfA$q_=Rzwep5(L+b8u8@%dcBPzA z`KyB15+vz-UDUf@T7lLY>X~O!oD0%lf#rFgt93G>^k`EuF^lm|44$}cMi?Hrlc54S zz(cj8yV_}xd>ziJ1{O6dI}5>!dumDp_?vz=x`4Um5QLbrm{3dZfS_Js5z$kRSCd%; z76?bha9iMfpgaolvKCVL`7Yg5PI^A!+#+7ZDc0|fx4#q!CpQ|SOU;k!0iNKJTvld2 z{kgp(n4DIVCZP=3icX$%+09^N(zoeKxsD!tIa;S2jtQ}Vgjt{5R5)-JFmManLD4V# zl99D6^K?}x_RDShBz=*!3gc{`d$1#Zo4nvPx#&M-ssYHraIH5o$LGq@XazkZWm zZs>I)nDiovu=nTxAWcu*jK%P&sZ!p9EzbPFWc|dCD4Qt`z*9Si>;^Q^{ASq2C+E7T zY{EHrx}G0Q47=~!8CE3;ybiACoD$$W)aF%YYN;D_(VPeRJ!Q5K3|n4;I;_D0Qr8xh z2p{#awi-s6hn7PgA?Oz6U0ryc7(TAe-j|x{R;QYh;;CzYZ7C%lZ^wyJmxXa8`*D|S z&?s2m`X^y15;zQdg(a+Vp-iAle#qlekc0!99A<**lf9#W&9EiY%~rLMjIR(ch5o!6fOso>&`s~z3M z;;cwzk23ZkO9!AXrZ0}iOOfqVEGkQGM{GC9`DB;QcaIJ14DQCmYq) zYl2CYK*Y%qTeD2N8S^b^B%~|yekJWc9?6-09RT2WJzy0GrapD;oaqMNtZ1P`)c z>%1oPE2qj`nbDDuMN6$%aoOJI%DU(xrz<1OVl}I_)-`YRSC4;_a7-KwAo*9T)E*C% z4oqrLmc#ouevdKKzpd}T93QqY(-xi}7=_iYgGAzOu{o;Xl+SFFj5LN!Gs4*4kW`&* z`N2^iGBt8EQKyU(;@Ex-fEw87 zt}246LNYGkrRWv_Eq`5Oev|9h<10#@R%vc_!kJF7O0@1C;>w_n361q2dMMwcqmr3Z2BKJsby?+a_W(4sop|T! zGgI#`hEQ8%^BrJEjv09hP$drVKQPz|skQm~-X`b-SZbcO?V`g?u-=m6O)y{` zAt-t2e`)98!DG?NHi4N{H-oEmZH65p9UtpRYN$Fr@|i_opqojVumctzu#Q1h)mKFJ zQxedJ2Xu9r!x~c7uaI$7q{U{X$a$10kEO)rLi*M3I24BknjrgG!_|??6e9oG;H3bw zznUzQ$OpAB_R=6mq?+7BP;M+SsfCdd-X&B}6QJPZXc_BXq4KpT*V)ezn9dphu73{a zq-Mo(s@jws=dw-Hq%Yv>@QLMp-QA4;hGO_NI6NBtA9I%f8-x5mgMpB(jgzsBlOq8m zuB_NmgGmL#QDV^3rh z9qxZGqVA-26UAQ~?HW3BL2oR!7sf?S|o*FSU=FZ5hSBB{BI0aBLKH%pe00-y(D z9;nT&G+$`di>O;8fG^L`$!a(J0xQO0G6 z&hA<}XzHL2%T?haf>(WRe^EhfCoP?JiK|4LU!Vyew89O`HW{kWghXsy;sQ)zWhtDH z0ZYsUfj70;?W!wv>ukCd#cox&+BX`KQ1EumZrE3RdCT5mPGv@=S8%`t_xDua~Vv{DsNTC6*wT{*u_} z-82M-;Y^*k!Bk7zB*C6@+%`De*a^0*xO(YE`m?Hq1=XUI)o&8EeFm#IjxRe0f9kc0kCw> z9Ob5kz(X4Y%KvbxKMDzY-qAd!!UkL7HK+DxQ0ar>S0Zbx1cgP&{cu9A)*ZOCMSY$J z{6pQQ^5J#ZHcHGFLabVa^%!3v){J_EkSVF6f2*LOCNi?s&O8*2doL#NHmAX-$;$ol zJlmVfUPNe_l`3YkEN=ObAeG5uk;wg{XW`zS^7F&s50G5}r5$F|m z$PH^1vvTg{l~j=i3k%Y|i{ZOV`G{C;_S*sM3gap~e(OowvbqaTM}Yml@I_u zASchbNrZ)Fn-v#zBbZwaEu`@5N!UiTLjbeUUT%x-UiB(&#PgiwU7lfX0Eil7^SI0oUsB8b2YJ5;MR$4uGx%?XWFFT z-R~{X3oD>VWb)`e;+c0VD>kSPv49EvpswAT0coMno)v0qPM9qWEzyhLo>mc?A@80j zR!kBtqYNf0$=~#J)*G)-E4Yd(elmH`19>}>7l;RtYW+I$u;b&ht{43luH*0N?U1Xn zaR4@TG3mMUtyCI)&1M`7`R$%0y|~We@{Gp_JeI`xt@)c} zn|8?UH_);?&6>s4@-U{J8(UHJc$kw`7R4Uvlr*v`)Ei)~pceu`o&dW*e}j06W16|R zPdY~7AI&J;JW{N=^5TTPvg>c;zq@c}Q;h(a=_b0aAr3G*VzTziVlKNO>pfJAZg-S*&dpiDb9vML)A)op{8oXd&PEFcT;>#MHM!jKbPbY|^ET%m z2q!-Rp|EXuj)7YS<67+TwJSfE^SmPzqJJZ-G>)3T-_U39LjIg2{PdV}n+2MzXYZr> z4`9j8`M*E8Fet?0L4;ECUa3l$lTIlDCzISp6T7)GIP9| zs3SVIT!6|n?WfnQbZ%$J`@E4i??uVd%K)`^Mr!2TC6ahxip7dq-0$k_)ZA|utH2Kl z&PFgX@6CQeKd_=pGvQmo`kWYA_^MDunv7!0q3*^>cJO<^HU?bSx8fi*8sfPVcD-S4W2~a7Pv53BM z`HwI91-~>(K=RsdxNR#zCo`8F*fH3@WSTBiROIj;>^M^FZ+#v1Yx<)XKgwa>pG`7L zA$9eRA5g?oREMbw02&NM4Z>R>#LDBOzZE%*@aQiIham;#K|Dai(o`wVP9R^HZr~V6 z^J|L_3FFya8eZ_u3d|!PQ#3G$Z}J=0C61!9+%Ss78A}2<$_PP2dIzttZNl=`bRUbR z5$S0~60NgVCN{}?4l!GnQnR49Qu6Sa?0rIkhVpNs@&zY_&_hvksi89`{h|T&Va+t` zvl2S~DIQV{i-R$&Ls5F+5g+#~h3{4pA8Wg5voPz6Gz|Ic?}=VGM_2S9Zad*ICMu@k z*jOV^WcnU|az$2~#pYSfYHKJa1xC6%^OBfk(b#z8 zly<56y=YjH*buN}F27GN1-bIAlRGt56N@bY+)0%0W4VUKNQpl<%`AsV@ij{1x~25v z!sd9Opt^wx47zT4&2(M!)HNXCenQp?-+x(>`Fu-@_aL%lwR!TS>Ioz#9I5d}Y$IE! zjGvHEpSQab%?=nZuqaM#*yp{r{z8(zeSt)?`d=V;s55U*9t<=Y-9o#~y=(V6wy|TH zl3Q)N;oZBXFQ>w%rnS9r?Kcy1$(TErZt!>goG&()cQABebK%kZinCBSrH?ML%J9Ps zdhF>atcgXZe_D9+HA*Uv2{ycdAGLLAte@ekaSecIoCHMrpVmd~^Vr3$+AhT2c=(t! zL{uL4eYAnzmbml!(^;AK!Cmkk8;Hf47B=N(eDRX`eTrjDiIF%G%17xR8CqPQM$Mj} zU}xai)Vvk3W)Ju&fHRG&U?=W?2djQ=Z(=tCrJ!VAPrD&ivGQV`wq}jy=E>Te;rk%} z6~Zrf^o*Q^Lr8pV_zc2mO2Yco^k~)IKx`;(=N^9S#$N>ji&xFuS7-C7xVj4}k?|kj zi2vNi7TE1mXQS(CU>rFRPfW2P{!2P;`u!JiN7G$^Zr#};Q8$?N%N(g*D#;o82Uy%z6fAkY#p=m9no_s7diCUtcZQ)>2PaCS=3%}&j{ zI*Z;Uwmt|O-ds)1x;iVf7*di+#E=8!|st zu$K@ZX?hpmgb$-A=+%XO&J?amB#kVuqbdjIg)Z$;Z}?X+rU>h}BbfiO31{G>cxun; z=%w9GXXks)v~ePIgM5GR$(@Jh5QeW8jd`rIZ&Fu3-(*Q8RbzA+EtWV0UGZos{o&2I zZ74coZazW;{%^ynXMm_*^9>61-E(2V zwYlU+YR(Z7{4_?Pba<+jp%KAH$l#doFX%JdP@`UfVvyf~q;d_nc-ysWKu+&7u|!FY zViiU?9=%3dCu@qP7x}jd+OyJbAYvczzKzN&jU&rR)C-J7*k; z@sCSqEtg%S!WirZ(hq?{zMl{?6A7LaQV{squ<0_TS$UKD;qA6YCX zxg$#&PC*j@uMHWmg$=sqh6(u|sko{3R4f>RI%#-&oi32+9|&?6@~SuKh`a>hHVr(v zcxiNzYRR-EIvMv}`?|&r@OGd!Mi*IJUuqL2xl%N(NSw{5a9;qZkA4U16R!qNShxm7 zBY^YflWry6vXPC#bhLJcp~+UiRtNzLdYY_qfkmSN4)!n!wvg)HTN+@Kp1)y|@9NuL zGIDAIU8!Q&iH}^S_OEZ~IGXSq0}4AZ;n8U@AimTR4s9VL0rd%9B!EVq7*{5HQ8Pgv z$6WV7WUg>P-Wa`v8@9hzo74qF(N@vvo({a1hh8U9)OgOBO6-Yl}cSId&(S zZ-BI)&uaw4D%>Oc?_YoO#mcp>*>>uF&lqJJJ5g2%d7D|?q0W3X!6H-uc6lqpideLt zIEuE8E~XaL1NAnK#N$ke+>YI!@JuIv1`#j zSXlT+D2KqC{__3Zd_}Yu28x<(G8_hB@Hr%{;zeVULb<|Em!Q##9{;JNsKx(@VD^fn zd>RBzBsE3K;`$c2t^J+TeIfM6t)E1R#f+z_pnlE5Js07OH5Q6$(wA=crx z5Qb7?F&rS}Dna=9If<}aZo3t1+x>YoiNMzdzkajny4^iBz16Mz4|T7&wM4g~d0b{O zXaM>As0{SG>Sd1@bIr|>x|OV4uD}W9ul^jB6ui;mU%+lrez`*fXcs1eqW|w!O z4SQo@K0?Hr$57HIf^E^<(5`D>$x8ypCdlz@&PkqIMDeDLvJ4dmqY8+iVnlwpFFg z2pM-7cTMc^v0S{Nb*3G!?X!Xv0&SHOo&DV%J#VxsKDyQA1$q2J(-0dqBO>+(=wqhw zpQZ^A-Ey~6v&@CzwyLOOY>%F_J=H+yWzvAYT^SxCa(MLm%o6utq@;CuLGQ0 zu9ZiKHbt1guqX0=KUMwo&683F3Kw>!`QZs>^bxT1;94Z5*EDBlHUme6v;MeJ54QorDtn8pl6hej-NX!mMWpjB@{tv3d6l5g zve$)0XdTqbP7+J|(Jq6Jsd=tsI zzIQcoKuoCQrz_lRj7F7h_aqJoZC*3{p(kCb`Uz8~MP7<0A(hMuB=0zGc?Y^LF6^p} z9_%WxcDouZW#u0ikrpxkv@9JtZtYJVO3R}KMw&k_Rwh~s>~CQa2DYGJwk2^^37^`2 z8~^Rgr?YDp%UF;~tOh!d7YIXjssso9=SsGDN3vM^;~5?CznpXmoMnUOnRXaZE=LmJ{(oA}cxZplklyrXgi zF1jsfU}F@<7tDpSfZ5Y{6qXxkRMW=D>`hAY)|BUk#ByE2cf&PNJ10tvTkH>A^w20r z!MvBinvKxm7CU4wG-!1-OZazrH*{(?0ERu#?nQA86Q!u6d9wT|eRlc-N%G*4z2CHe z7qRpv`Z>pmlr@uMckR-s{qJsU^YxB-B%;vYxeY&w(qq=CjK`&MOI6NZif2Fd67^y& zLDAtaU8eJarwzRudPkBStJrEIO?HarH0uoM$v|a|+uIv-)oMvvtXX@9_lSW=b3Owg``WY9W?{Y-ZxF0#npRY`3kJN42rXbY$ZXA@VwKV9A)3uM9U=Li+o1av5z1+YG|0rG}m^gIyD&Rp=o;Q2Dk`cbD}F5@*GXRt}v* zy=H0&p3NpFn z1B+nn-kP2nNbMQ|Z2&+}fMUNkiT{!y{g)x%jQ<~oeE&}v^?wTa{(tM#VWt1?2-5#E z@BeF}H!C|E%l}G{ivH87vze$x7>xl9K$s$lLi3I(m0+?_PP59(|3{dT>d%y9)9U-j zRPjHjPGq3vKZN9TK6$=asz)2At6i7p=j-75aFbkom8Pegn_E|iHfb`!uC;?by+AAj zqNU5^{x(xlM7c(-QaP`>NMA`z6WRo@43>;?uhbH?goia-{%w5-+WleU6f)r9Qtr;cC0n3^Q11dtLD_ zs>;QRuVS?18}zlwU9NZdk^T6sV;n3XRrfz)%gW7aK`urTz5kF2;<;bV|Amc-bRX`IpCtRCgyLV z{)2DUjO6#-v?wZ&U}^t{k#?M$Q$Op82F(qYcW2PCa}G;iaKVt<)uOX12}zc=^tGRT zpHxlz1(zymV3=$O&eKkQg@m+i3dL2`=rK$REdD5dpFSuggzjSO%pXHjr~KK}b{X)U zCA*-rLBJO?v)yWqn4T}>U^z4=F^0nQ&1tw3QxW-sF$55nDpnRik{(06owBqP-s@tR zA_6p*Ik6lioWK{qlQEl1a*%^Lf=Yg2(D!eDIJ-T1pD<%#eLO%mYZwRqO9F29LpT5c zkrsi60hHw7n*c|#3{Z7fcUsWoD-qO-!A~&UO80y*7GgBRD>V**n;AJ?#c`SR7pw3eB5gTwM zAly-ahbaX^ibc^#CY!R^)?qCY+dAso{&w*xn-5WJTA>jvf_JBbuT7w{Fhx zA4SG~t*Mm1DXk$Yye7P19S`bX;z>0` z9Sye=>D=bhI60rH35`O2am0Q zDTHJ68-2m^SGaCAMovc&P(&0}-<^OrV)96I(y&Csb%nS!@!`jlJQP5I8_u(EFkR4) zqYLw9hE2AO%qet|`(8$Ix5R~OX9Zt-#KVzOQ$(klCCzkzd519*`M|st25irC_44!q z%>*igHiVV-flE^evk6wEBZ5Kyq_S6);OW1%th*nR)U$G9ls3NON{8=Fta{75c|eOxy%& zDaq1HSh_Aa$TmZ_<(@?J=OX-YeLn2;bT!j?eIl}Q^Gfk(=7}Vx{t@I) z7hn6|F?=QKK2dvSJdjG!B~~q?0%STaIHw=Fv7l&G_M@M*4_{rfY!kO8)yiHvPRC=e zhUS+`AX#KpG0JYQthXyGhRghNr7l82L4|toB~5Zw%yy3%7=AX9J1wAKr^%S<<{Ya+ zl+Cn2Cg5(pRGfkbr>VZInoA#;s9^UwXIS z_V!5={={}s=`N08bc!X;>!}8Z6@Fnz7TXJ=*|W){GhOnRIADVjedTNCjc5r{Rucp< zO2?zga&i{U2G%fvF!~<2bzc9J-U}p;)dq>f9w*YWi98$IRd!w2p6z^IGzgtr*V~4#pNYFWCx55Kqvl(BlX^u!&3V=1Z}Iv_ib0%S)=peX zA8hrj$bqqpYdjITpS{#Jv=8Q=Jp>be&{eer37WBiW-JB?&O}y|Gd4?cZGjy-Pf@%#XVG4p@&%gXMMuVV~GUC zUQb|XFA~LM5ucVqBhPvQK5ilavflJw7ewwp#U|NvlZI70d8bHMwRP zf#Q*t1Bzg$k1H)~r4T1lda~DP&^SLYUQxadB0Tdr&%cB(EtIJ4PLQy}1?W%9gXkbw z?Dl7d!Mcgv%zFOm%ONhptng_BFWXv1wj3fved~9tVJt5xtlOH%@@b&B@4u4g&)q*e z%fEqp$?|Y}lh8g8JC>^WhQIClNcGvk;EUCx2<5BVkb~SK=exJKq()lNVI9q~=Fn|*lga{bZ zQCL~`=E%T7vtiA0plRO=R#BS#`?}f9&X_W!0eSVP2k8ltXK1i>ybwJUQ@PFM@C>fa zG%MjUxPZM9=)?T-FBnJ}`%p9QFzVeuYSSr{G14C3xlC}m942MGKxZ+qi@L}kCp;Zg z-Iyc40JEokRW5|JG%H;ZGYiK2YTiV?8RWFfazK()Qjwinwy$zzJ&-bKmhtKk^q*3d?!K zOTmqj7G3H;!OOno2ojOzfPE(;TV9T|4&qKP79sYCt&7KwN849Z>bX(T1J%a#2_g)up`jn zL7lE3g%MP|s54`%Or*A_!8^@N9x!#+EMX}`;H#1{yuM(UoI4B)Iw+^f2e;l)k12xfNqbL`XJVe0HUm5c1U;6efc(haT_3eGB#Y zwrvWXINQj&)+gkUhO7_^gQpft4D7h20Kbu1BGH5lJ!lgr9{Kyef)i8B)p?d_+CE6D z(*Ev1J1y3stRlhbH$Z~z%$-*EQGOvXG)|q60o?}dZN=8+8WnVjXKu`6sq@m-FU6G4)3)4lh6@1n{xO#_;PDi)w>}MG{M>A zW+o*m0g?krbKSF!rY<2vFW})ie5DEwh3b4(xlmx4l?kEfBs^s)V)BQ6CJtTOCJYkr z`i4QkhAnZlp4C+CWDuf;8z z7-_q=4#hLtYR#+;=kty5AYGb5Gldk07vLlyH0P3IkVG?Ds_7`D9Dr_lE!un{<~U^e zmWB)PlR~hy42I^lbE1W#v;%zzw6;njudP!s=e$L+iul8<%`~+reEQjz}d8{2Whf;2Ij-82`9wUzNZG z{-jr;_{7E4v6&2GZRh04U79T!@2)b`+Z2(Rvs8E)3>@74ito8Tkk>Nh?-Ogd& z3A_oWemto6#Rl-!Cw;Xf7BOZ_xiy&6NE7d|sL7o|$a(LW+is_G10gUPuE411=xS{& zaIQ`Y)oUZxkbmLl$4S&-Bp7|l{d(Z(L)U3a6bLI#nO-RZ8jRt!0re*V5kQ9+X9H3} zuy9;ibbO0Y+yEeZiLNp$5M5N#rS&Y`P6rsO)T`wSE5gfQdwxAer+c~~ipu^=Uqwc! z=qw&P_wv?`vP}87^*D`^8xJEa*6tk#jC2N!^t59#`}FHjnj_zX+#r^Uk$hCIGt4Q! zMB58vGN=xgt9{)ju$Iz#dAZ!PrZ0=J2F%ZM?qNjD* z1iO(lR6o4`dSunkh8I^d;YRXYXOj{y9g(M=VO_j%Jc43hfMWH@moAg~$Clp8qUm|Q zUN%DL6f~rp7|xGyHYs>`H`aRV7;T(4z!3eANw{RWdwJoxJB}BKbk9H0RsD}Sf|m>* z^lH7E5`wEq0hAs`jtYjt*Pf+ zo4v)xL%`!fOADtZ=IXQ(b?NP5deYN%Fb1%JK{$h^9!u>0!H;wSVG{d@#X)E;_4(5T z%QWP?UpSH5aU~~oT1anA!M@-OskZA$a!N3V^HV*;KLI!>p zVV!%yM*tnf(r%{Tg3|DA8YLJHwAika1S<^z#aB}e(aWWP&-+Qp`}sZB4X;G_(z^|aZf5VO}I zr%I?@+`+ud2rU&npLU4W=zXn@M~Alu4w4yrifsq1AM3A^lZbph$K=y7syugqD+5SQ z=)dd;TSBAM&eKMUcUFQM%lpdZ@}akWYJbu`{gyO*N9mEisySVek z*<~8gJ0KmQlfGGVDo5N)pf*f^uMVxDG2@&jJrp$Ik!x;L2z{c$#@D!f747Y+3Gxqw?#y+Vj4Z0UZpLXmNIC;coi$y=j-{B;=LB)W;J1pBhZ+AXZPsAaLhV4*UUMoXX+u0JIAwKx3cz zLQ(c;i4wb%<#%{3CukEc(DCd#VY$vrr3hDndQ!WB>mu5&WAvi=wUH9YuxR@dg8o#R zI6tDYJ`%Dq!?abhYJLc>R|M8xkXBt`Tg`ErZ)x5*&Jj)rTmz9E6C(B24%n{_1@IVJ zf*mE}w$9o~%}(Wcv5e}`V#J&BejpSG?>MMQ2qg%P#vKGi{X|w_4 zU|t0VArfrS>b`O37Yqw9<}~BjBkv0@>A8%-s$tUq!}?n5_Ey zs!S;j-rd3g@{LV$G5TF%4DjmfisxtX6S=X%e1&9QslsRPxUJzHjSKECi-krC<+qvD zG(|^WWxj_FGu9~q!PyW-NL30FNCiOHs~fYC5UE&&IwS#tQKhYNe7%M z%zQEG&^77?!7YP&@*`ckqthmR0z^Y(7v&mVn^G<^ZzhnA} zDEZ;BKc$2+&^Z5u(xJa|6ca->!&pPoySGD-0D4;>neb9<1(f zQ)X-jYo$h%JZ$$3k2yZ(i$cc<5MPBHAHY4~%$;LwTM>_6Q%SQ2JUgPK{8LUK zQ|*ZxDvk;?r6%>^$(M&Q-R=6r1SgEOa9>I9YaMu0a=`_6T;>R&W#m5fOF4ILnf=OD zl!4>y>AF202ELwOGu%EOZ_`n$X{H9bJYK%%J)Iqy7*LyGO5(b~r|J#LG6)l;U5%yE z3wpcYJ;Z9ljaFG19tu!tYZ5ivGIHL{FViCKPD{Ea(q*5?&0B>irn7JpL?d?3;3XG?x_ zkVUA2U}rv2_<}FujtZ1#LkpZM?u5Rge^f`USy<8SwOrG~O*fKdhJ2@xQCtfjb$`ZU z(j99+qAb1-73I%;q?`KCKuQIikC5^`GMMYy*LniofY->(TP;_%x%$w1!t5`OW-=={dEag8~#91cCNhnZ%mN`v#K zf(d33?ok~T)D}H(!X$O;-17^*kr;O)8RjXHRQF!ThAhqo5HDOItR+8LhxbV#>eg^z z7^^ly@a2dCTO3tp)>9;LFzzVSLS@?Mtvg^_d8!c=A>;K#7u^17&WJ(Hkus8*litw7<_Y6WYcVyu?81n~wN!Zcbql zZ__D%r_y31Nx_}cG=T^IAmL8LHv=_BY-)tKBK{f|{f+zn`%I9b^VwkfBczEW1@$I| zoGNiJ@jak5H_&PL5UK$YRE~>LosXm388guF>X=3~l2oJ19QsHp+8iUJ-Ov0$@&p+| za!sweQ$ebwSp@3a*K&QQ0UU7HMS0hEdS$Sho*YA6$r(VbV^#8K`0gjU(cZa()K>US zVr&fl!7$2#qO40L`PBY8+8CF~qHRZ6-R!8dhM1N-L7XWwPsas#oJHW3NDcEu8!Cj_ zWHZ~PE~6%b{dY&H7OVq??HMQcjIpDlJ;mzn7#!EyrO(E^KjNh}IDfxA&cXKk+nmQ#zzaoc1L@dzrpa`n;Yv~`2ap#y!7EUmkN*Lw-HsmKOOalG771a`<|cG zg_VyXi`impS!z?|gx|QXqd7fj{z^+`LNeitlUEKG+-segVm}hA7_i^dssKD?*JPGL zP{AY;-i`^n@1Aof7eLyqjgo`o7aeessm#=H+jf`(DnW@nxl5{>kYh_Dg6brZ+Yd#& z(E&FMiIFif2&9;o0qg!kB}BkJGQ`bBY;LXuBR2#ee)7C40whq-DvJtDY+($5Bv7zo z2oS}IYC4xy+fiy>ubK|RB=Y>9d_GSkl}eqDn9`Y6gLUN;{YnQVa8#_IQym8QM^{e) zl1=8f)35r8V>(G%U_;FlXr*4*SQq{>jWXvn<&x_{+(+J{McNcc=D@9mVfGvo13W>h zmP?S&Z3_YJWQ`aG$8i2S4DD=K72b&L$34M4- z0QkzV=L1GX2m=QXfe*6*6Q%mTPSz_$s${0JsboECrMiw5+XF0GcQH($ksXL=^*Jb* za=$(cJ@S%74Htq7(3iJ*Nt}w%QwO*VWj2wn>G~?#+;FHql1hz&p0);hxV`g7zn2rY2?|x$?$Larot9~g_fr%`%L|VX zQRx*?M53?tYcaXdja86$F}YFt%7Qv)oxC!@Q}H4|dJE4_@>Pf@i{T;s{v=}W*O(wquQaPAk_hwE`#8#z3u8$wX<$oA3mPT1Aabi zH$n|-s;i}+Wafa9rg`UmmRfS8dobbES`1H~(%8#bm;>Xy+@~3 z)clhOb=uNQb44vV>sos|xH1O@@#;!_W}&&6@tfJ*hmtY!fSY1;ai8TNwNw-^v>}{&S!G3!`EF?}6Wcom@jF?`UVFWa6wvCoe2Yr)=Wx zti#Jor)cMF;B10VPp9PU=wjsjKR@C0Z&v>;1N@Jr{NEWMD;xd)#sJw7eO}e}=C>lv z|8z+xl`9Xsy0RrXs#uEIaeeYfC09jAP^KnFpI)NDIJ40vce!3ii6pf-v&rT;*>`uf zeNgW7_I7l>ds8vq?+-p-$F#L+(lQYYJNht8E>KeqJCf|>!%yZJCeTvyFgL<1UZq?R)xfA^LEPQnh5Mrd#pHX7e zDhg>UDu43*B+4kq&gJ|fd})G<$>*^8%JUtbJ>r|xv$2d+Op4FU<;%OAO0AYHUi4C{ zb0gc3rQ=15-^MPiklu=b*w?+S(l4z+IZ=2h6*x05f=M=g_RMZD^uJYXL}WG=3i~Cp59hT~#g$ zW&EobEht8I3h&(;VvN>-h-JWJ-c~bzW9GJ0NMd8YxZ&bTvo@Vu#|&psel>ePk1_(y z>3ELIz-j=PK)2wn3n5-qb?xdJQNQbQgAKN^DSLCq-oDZq3TDKQlj6-TEJ3%U>CoxH zX3v=%1FEO3KM&6shJ**b>Ut9Zw0VV*&1}obkb9T>gA9olAlhNYA z`db3{^t=}r5!iMneYZ3eyYesUhafmpDDY=A26sRdeml=yIv7V*5-m0lj}uJ45kpW& zNxP+Pj$G0Uo~z>MZ7}Zd^_H?4QCZIo?YIX5-&{I;yI1TSyvCgIL?IL=1LW$`H+%3R znX~{NXMLkj#V!L1!SeNYw&(~*E3|L@pyy-vohCp4qwtj)|NHs)3=SA?!)O`X19c7> z2WuGnCU!+^X3*gEr%|-|RbU(P($rxe#T{j5tPpnFI+3T1yEqkQ6bAHjY5K8e^n>}a zU5 z#p(kB8nT@SgVaeI5l_B}GM4EdRQ)KT#p)13p0*wGy_*G+EQky^&e)wios5a<>95Ru zsIBJ1xd+7Cmc`$EqrI@B_yM_<0P1&`)DQ?U3TI^2O#u_rM9uA^PMKC7$CQ`4TJ&5j zAG0-Rc+m_IczbsGEfVL31iYJJ1I322-3BPiS~)>#coVda)H1y=`&ugQg-!c)F18Mo z;eXv|V(Q3Ocxtc&uELp*Hey-Eu?MT>HZmuZbX!l2aNxC?E{0Y)?_;Sa8+WO5)IY~4 zxC75;HR%2h;;{WnM5$!c3&PO~-}HgbKEFy4{_G+(m_yf^2L&klcEc}QsH8E}`S2fx zlv(XMgkvvsLq#Y#IJIeyP7C4J#o{QSi^>_LOjGVr==u=X*BgAY?*WwPqN^D|T(7Zo zNZ}ZSQH3ApJ+7e-;%WXwS}Vg*2Fu5QnM$6=^>WTT(C?5PQL(sCOaLk zMFWyimHw$2*8us7++P<6#)OBeNoh>co>raHc;GV3Jv2@=Q*Gm{rhcqXexHt;VG=2#Nca{E7Hs^)bOwjT`?j*&H@wboNhj*!{>UY_k9BeO{ zUf_ddp^xaLHn|T8Kh2h5ZIh7I+J%8B6g!LwB+&#_S{pgD@i=k{7tl-axJc02 z%mUr%_akB)%>-S|+v@%KTC}`^!R4?7`ZL~6L)lU7 z&`0@RR8Pn?d(kQST$QZ=ng_cSEF76?QEY#hi#Y5pCXtU7N0 z0%TI!$;?~YNyfeKDb9VV{F4nKR~xs1bF+f?@gIS0wX}vmqfnT#PlS<1dGxEa1;bZ;{UCn&MU>wz5t7fMFIki-=5J%ZE>9oUSql$6_BQo2zJrh;NGl(gU9(6i=N*qIm@$e)ui4=Z zu2(efR^a*>zo`w5O&CEWS3|$O8nbuJa`XM%g8w5{16rjYf;I|Mgu@;t7SXFKN5 zf{nTKJs}C`6L%;`Mc^h8-z=u0y3(VpRE=lUzxxWctKiT8s(>shxOMP8Sf4;)rc1^3 z_Wcw($dW0v7iiU1`xTz@{3CzU7-Xb1Pw*dZ$0z#wFKF&W_ zHgrLnpnq4!GOz;a;TTuZ(Lz!aLmIFNk}}RC-R>&A#4@jAPtTvsbJiC7@Uje!4_plWHD)}q6!<1Zhix;w8mRx z%0#fQfS4xYgq&$rawvw;Rmmr+ zS3L7|Va9js`p+VVs^0$nz~=ndU_D2g@f%p8-i8KmA{2UHl4*YFVhSb*+;WOi5=)4- zaE^AEoYdK#`Sval>GF@rG=Xk<-*orO3tOy?!M_vO)yX07aFIoJS`sP^DUJsdH>6?D zCgl7@Y6FFYgSw}yX7r2S)6Q_>Ql;6#2t(W*y+61LBEqSfPoYT2;bWFR97NF6%{4-S zdy0ewFLvW!hpT=CDH-QIz+>z_4+$4Y94RWi8;*?!6F{VOmNHbOuhGFyKgs^hbH%t_hDlE;qI0@sw)f|(?s`v z=f8y%ShW`JFZs!HQe0tNVt3b{K)|1){N-;_IhkV_2d#R0`ZGe&MU?J|W+VnIHt76l zdQQ>fnS2x<&B|5x>-SBAUs8^wTgl67oA>~ro-`ATyaw#r`0jCjwR#QD#67x+e82IW z#cd)#>UvMAZqk2LE&a6EL>jlf_>LWu!cOE`6>ecXS?wHlt( zCT04^d$yxadLv>D_94u@dN;ALlw+G@J{mmLv8Ins8*k<0|)+@@KwuMoj> zLBVSP9y$ApG8b9GO;MNHnkNvw)pO`2J>9(W zv#wh~L+ftB+rR+AeKpRAYC?fy$~HkkAc#J(^@hb23u3~swkpzKrDk&`=Ai>Y*U3{Y z3LR?h$wqEJoafHKEEPzLUh2fRYgrCH^dzC}M%6N-nmGhELijz)--9Yod}0xRr)LJB z_oyh*UI{dB$&NiTeIvbK2S83ya28cXgj`_N#KL&R{1amJH2)15|0CSwQ#6CjX)Dtp z8rsV%7R2O`XAy&YeF6qtV82|Xj_FbeOJHY92d#ANDBFH$aB*GeYT&#TXLt778-D?q zTtV~DkrU85!s2lQ=?Ra*0uU9OyisDQl!9kxUU(o%u@?6;(&E#LDU~ZybArIYNg%7Je6}qB1UuNsM3u!zE-{qI#lbDm?6p3Uy!z zEBY6@sZ(s5Ferb{2TTwJ?I5;b7-*UhBjNOEVsPk?vClb?4Y8Gl&tkre?KXuIg$s#_}Y{}ZS?%d~h zfYOZmqiGnnotXfz@eK1O^_G*I$S2!tf@C zB{_vYO)*%?zN;u7B_#+tipi2PtLV7njfe#CXdd;5nB|E2L=40!7;X0^=~uOMQX9Ry zKs5L22@e|ZBq0$cNCQn3Lu~%ZD1@CM?2KIi+|7y`fjbPO1-k`Lv8G0pAHt#b8Gegc z?u91r38@tH9(!LPW|(S6VC}6k!|M4wHz*mIIu?5KedyHIYiLl(cZ}g0{-Y=j)pl*w zD3A)h7oaVDbrqeKE5R5{NJII}bs=-;|1v@_@yjlQkrPzHM1EyMADxIrsaT@ci zG3|UXbGNtw^2%A&4SbXv;!}GckQ90Yz4&TOJWS%R z0U+FV^7B>rM$@RIJs0O5k(|qXhsXpHl4GB{+5GB~Waj_e0j%w12gY{9Vf`IPP6Fmb zovNALA!eTNI5Ux5h02*Dihu{K%oHL0!Gf;}kx4g5#Rv3Va&)(g8gfj6SD2F@(0qGy0kO^ofPwR3ks!;%5oHSf^8(jlb0^Uv}Lz7Y`sm ztsGS!yTHzsFRjK7I^OQ4K@m>dqpx2JZ!vY7!(QYw_K8kvP<2JZV7XA4kOf3CGBR#6 zwJhm|<+@Fi`wECdwD+~I2FOMljt6V|2dA``1o31 zNi*(^Ec3TiQb#c&>Q0fgZ}|K2B7(rsdYN>(o-U`*tYKU|T(`C!NXly*)&d&7T&I|1 z#3=EQIV7xL#fcVTo%2vaG%kx?IOiL7Iv>nrIx}AWv>;J@& zr2T)MgQ;@l(gDlOoTT9=MhLWYC(&~b*k=j9Uz-ANqmhVK5F?=HQR5RZ3)ZLo zuxHJ6WcS!i+N+RQSXpo_1~8gDXxv1WlWQ5qC`O63{F{pM6MaYRG?|zrg%keNhbN!@1hxvtur2mCb0CJ_2sMc$aN=n9M+s%c5Yq-aY&?=B`wb= zaA#6+686p6TgQ@pN@EDfK{66ykZxRUV9!T`0NGsb9D%yW!PEC?nM_&6z3&BWDHTou zY+g>j7Ksq0rTuRA`P=5_Blbiv1tQ>H30|=*avSEcX5{KIDdeBV_zD5uEEUf|(86j1 zw>-q%8S58=*(*OBWxJ^CeWxXeVFPbzjuja3UT|a+nez!Gdp?XoH_CE`V=zS3cP5^rLB>?Gr zBlS+sT-3}`;sHgm(>A}|pJ}hvQ`+;}24~ML(A#SSj4=O9Fs%wo#>|Sv0Em~#VZ^$8 z;`mpb&FajaQg-o>C^=4oCLR=p`po0D#>ql@Ol)SP z4%QeZU3{QaTtRZ%_Pr1ZMfZ+XDqq9ZRw$wp(_aaxMlnwxZU1Ya1BZ~LsV$-<^@`Io zAIlX=k_`$0FfI!UdW`bMsu~?L3xj^8Aha&v)4L8afnhp1AE6eA9|;z9QeC= zDn&f3_rY^Fq1=$3KwpS+!LETER*@>!|L<@BQHfIs{fecl9IB+N*rn!y2C#hFp=vVC zM`zSE=XfxtB8WjR*ryHW(OEQir2OS;@tFaC zxF;Xt&f+gInxj5N@JeRYQxts#GIyv*|75g#_*FlKQNRd8gs^Wb?#I&#@XEErNw9SJ z&%jEzI}v_Lp|Lle(qMA5f~?|10>BW!2vndkh<2`)mrUbgcv%bh##o9vaB4hmZ)T41b@aFjfbiNGd_HAvrStS8ii1ZAe7CPNgDq z?K$Tb7Bq;21VM-MFBn8{$i_(DC*V9VuMt2`I@}#_7VaYK2o~A)vpicR_3AMib(LDv z20j#glCw2p@>{0}->0MB+V?Oioyo%M8+2f+^I=pJwx-MIj0te0~CrK-MW|OOs}O6)w$ik^LAt-K^_nXRCFb#W1Fov zs`Q_o78#lU|AfsL|66SKA4~baVlx(2R;K?In=Pqn*=&!8J)p$r37#wqzfDecW8lOzDzy$j%29&@DLDI(?sHsXcZNGTk2x?~fl{ zD+?bSPpU0OtZ`+}5+OvrKktx37Lp@8QUL;SJj+B6IuNvqddia)L>JbL4S6@eI{eb2 zs~Gxi>z4n1>LZ8Mul2%+ilj$=PfId8QbHir`ymz86~R4Oijlr#rHU4mXVSNiIftq*nS9Wq|8n1SdlLujg3fE`DuQoFCQa2G)hOUjsh*^6m; zZXEEu3-PtzSR8r^71jnQR<$TAi+##^Z=^Y)bUkYQwN_kwHl|(Z4_{eG8u8S74k4h$ zX2&|JmPn4LpDzWVE7&$fj7D@XFrBxuIlZP_D6YgLed7Af?A?q4ww{z?$eZwQx9ok{ZFr z(%KUZlS;j`FXtc!{=h~lsUUQuC+7s#D|MVNL6U{IwNQ)VJ&o>n0 zSS4l&Zb(~WHX6oi zCq9T{$z{g!t$u&-ZZMPR4vHh?@>#RcVpPMzvSS>1L?1CnI`9`(OTPGP#zb>6SC+Nl zTh`yV_;JE$3}=#N>#LmWgfp6SI;XfB24LjbYNjN0>94vygiQfBP5a~!;Gof_d%lwh zhe7}2SH{!U-v&2OFC#4@8nN9F-?{E#h*ZH|6E1w#tqTV*e^$674@S`KA@+XKB|01Q zpCScm6YsS@1*};3P^2v&-?o)F!X@LxN$g)IhVoqIvw)!8tGFbrKQ`h@yBAbRXt*^- zhMBOT2nwZH9cX51R=x|R2aJh2k_|{-%5%(I=-iAxmFwzo5^H}ed?XWxL>vt&AO-gw z0Th|%v%co{`OA%#M`)V2E#f^JS3Y9=B_Z{o^YS*I!4kl zKuS045Z?ut1L+0RA-9~qvFKTpqR(|iiAIB9Uo}57E(J9#GnG_ennqk1)<%%x;pwzo z?|D=J9bu@H^=zB~c_atcc8;~4Pa&-^f&W6VfnK&4IUE0wTN*SBlDPZ48lRrhQqdPL zH>rL#m95f7{BcUipth9nOrR@W>0v4-cGsSo?c&qciujmt>@gEGSeTr}?&V7Yq@S^# zVCKpQ|6ex9q5s$*mD00jjow*$cTBq!RQq@sjTWq{s@<`pAL!HMCPt0Wo!K3N2FmRy z7XO?Mf9fj_43NlryXqt1AMD^qX?oCWAn~bXN>C8d6ffsX%%C0j4nUO-*=9sJK+Q3B zF|3-iWGH=(?Okq^rwl5W>7;SEw?0_lfa^o*Zu1mZZZ2%_E@V})uVd+w^z19BoJ~%_ z#7x1m6)iANF%_J3HrOPa7$h6hKFx7G#cjY~>fmjn%BEKi+(s$~D?FPglgULn`oIZ$ zApFV|aK9@Re8mc?WX%f|Os?!fjIa4MQ^ku#F;OXoira<%ss9|VMM>C>s|H;P&uE-c zo^P6&cI#l$mmR;e%`B&T@ufOIhp+pUkhWM*F^@+UN#G@*IH3MzN+kS*OCtqqPMTeSPGQ!PDw|a`A{$K96geQDqc6T1LSHd3aJQ&_ouK1-K|Jx{T9jC@I@cdK`E)G%h>w9B544 zqk6}3GgasckYYqpY$|MgfmH_P;mL(3F47@Zy_YE|N!Soflt})~%%efu9{+>7cl;G4 ziW4o5jeBg{wr$(CZQf(swr$(CZQFRa-+XvIlb(K=WHQP81ywt#)K0D1zqRZ$Y+#@b zYgx59rAN!+xyA>Yq;dYNthz6oHQy6gY=3~KRI_bGjD-S*a9V2x=cc%+ZdkW84EH=@ z6QP^}v;g?B?s9Q=boaK`)ZPqJrG*bT5Iaf!kiL0!u2GS2qY_G0%Ci!se^pQtSea{t zZMxomr1xAdZ`GhRm>Tql4Go-%G7O7W82@D@5A0<`&_E4+uukys>eIF)wN@h3yz!!vn*~I2yCxFEOu6~x(8f7_pZgaH$XUJE$^}}$O^E$+5txP*XzLWYS)NZ z8tio}53t}KI}6fgRwGaR>3!a~CM?(cu=-{7=nTCG{51!7Jg{9O?`%Gp7i5_u(0kyP z!_v!{^BxXD(-VFOR`9r)hk)qd3xpjVn|A~SY_V{$oIhPwuTcD^J}D-kF3~9kI=OgI zj2Pv5IM^>?%gHSVmji{l;1pr62=Z~FzqNNybm`NX6WBk6F$)^=TZb;Y-wbd=XAh|7 zgY7HJqA&t-u5LgP{FgWD0I-3kQid*HYiNrJQzKDYmVy6L6zH3dwrNc4s0rg!OKgg7 zZc?n&c)xrIhz(?|mUtSgKf(teg%laDtgsf+Losay->J{>N1D?BDm5xuKygVd0%$e+ zZ~}DJ-lNMMekJa2xLd}_thqgmH3u8k$z6839fYsPGs2Ej)TE(n#S$-`02^aV>3!b(a6qwwT>G52_w zAI4GLlQvUc#Ym(QL*=Podf7;v7a}=jD8XfXS$v=c#gr$(LUZgWWiDrcUy^`4=q?AS zWFDFkcgtV>zUBvRB4lpg((xm%BTycLX~fJqK%qP1su6=^4Z)kzuZ+q}vSaq(kH@k! zbA7R$Ua$;krh6?!c&klW*I-6VDAGdd!5q_D;@Z7iHP{?vlQ$$8YEan=JabFZ{XX## zdoIw4itmTA`NbkfAfbq7?Ou-BmYtSr;;$V&haF6mdj0qg zb|0w)AkYXyH1R;gdY}AZBMNh2D3>GF&&yYB)1LM?*DYR-{4uBW_mj?{VOqSKpC2Pf zQ4&e#a|y8N*+}8WcC6=LTnenC)ur&J_)cL#e%_>tmk!|#Y(O?97hOFr{aLtcSorE~ zo7CQ}8To0w8e9pynE`7@JvOcn%4gaSVYVOTH;O^{Yv(;K!Jb`}D_;gtY_Q*;y@A`_ z;;`X!5D8-61%{d;R`0J`>4wSy|KmeUQ^pD2IV90dD>f9EP%-{hYrB-{a>K_eO4jmz ziA-mlcSD?Dp{=)7k@vrKMnZ^&yKz418U%#f_jd42#_cwM#nZx1Tx@kWdk@EGLw$-1 zty@NvUPUZv9*UAjGC9^l@B6@XDf4r(opJ1bt%vm<9Yh$5mq%JFF>bvv=g%oUl&JaG zaY*F5#BhokAua@~J-l$g*#hVSQ*W# zh1<+Bp}v@< z2ZU^GJVte9{Gt^Z^LsR=GM@?sRf`NUQ}!jCJMSw@!&~4oX#N!(6Y=Xv<+K zTnh3J@bBb>e8sDn^m^9v9#(%(=XPuUZBJ3}e{3jLE;^J8O|X=$PviW^Ua0FZCg_R* zsSXmq42oWV#=g~!cs#>XzZG+Pihe`b%B^Jpuee@j+y_cf>C~vQ7BO&r%D_IitxCHp zw;Q^B7dCqg)3XGuG@aVFTSn%8I$dMU7!aM{?+ohUTa(#(U&qRA-CcxS+qiXs{U=c5 zAPM}cu`Mm5-V_yDav=q_gCf*9iP{Q1hqjl9CLH~()##Qy95d{XZ(q)y%l>uw$P4;; zXu_FFKQ~XBDIjlLg-fp<+pH&jD4={?G3Lq9@scjk9}G>P@5s+!IA=5}uHSy5C~%W3*oR@zhjtDg#CIk@d3fDfYwo z_SvE*Trguj(rxX+a6e(AQUG{yKl--d)CWUjZf;yOvKlh+n^S}N8dY%%u7c4#X5}@~ zBXZrguPnh2^i{waG9qV>k4aKf-tv zRnTnPIoUU<$UJb#YuP*~n8TQB2)T-j59XBAI!%W8@!d6@tdC=>FO$*L$=bgYuwXG_TA*!R z|D$jQS=k87X*u-)$~*Du1*ze{RA+Knqd^1yI>n~g$$5ZSQNgoc=H7F`PSUFp@^p)I z7Fw<~#;*0LLOoXs4BFSh*g~(trD@nIzVYy`QSPh{Cg{0dq*B;cSu$;- zaG@CQYYL*$0r+xVpnxN(nV|;kcQxq73V-lE;q-UT8bcxpmt8=$Kh`8<)SIYr)P{%Z zJ^x*a#ym|bYDnpWWxm?fQTHbJ?yde%|t zFI7_&?N3-zLbf*%CrP8t39*>eS*c}c}1PzVj&u+x zzrYo`fZ39HhL7k1y9GllCGuxp$w$BJ8QH0Xu_Eykald*sijlNF6@N?(Mr=ttg%*!# z8-R_JjK^bprvz(x|oYuLRuZ{nnZ+WZHj8+h?y&?v0ZXoW#HiCc;Mb_l+5KC#ZQaAPFMCES;!}G*W@YEFnEKS28<~h$7p%oNri6J{vb@fDorRM#L!3^%8f@`BkD3p|& zVdL{WQ|X^lmS$12SeO~v2DsFbz4m5s^O{P;a+w_b`*fMSU}rJ!>!3|U`E&nN;_FGv z3-lZTEhYNJY;);Lh(%n(GWOrFkrgo2pLeFJ+SJYMkm3D50mZs7ggs@50=eelb@R4{ zI1E#X)(mhpzB6ZH9by6shr0cQ6GxJcYqcP1GaW`@X{K>yoAQ->@M@; z9J~aaj5mV{)r55?!Y%8Pjcopp~`8TO%ggj=g_eqHb=T`Wc*4#KnjLM%T)PR+>(p z%zI3qzA@ahNEAM1F?9Ppu979PxTQldX$?tGur$FJ{c9GZ1cHLLHplykFBmkcHl$I9 zVW;GML2H4ohvVw_Wy0iZCN_rAIJmYYP~B88Jw_vgc{Lj`xkxDoZN@PuS(Q1Yp4`#` z$^C!+J$G<5^ypNQAqP?Fau3%B6*@cQuY#$J7vYqTDx*>Cql9u7>SQ2zcLuv&s+nmI z@A@txpo^ORh2JJV#PhUz{lp!vo`d1UV5p^F2SFQ~`DthbU$|mliCXv~YRCIuBM{s= zcZDVUq8(GXp(0prf0xhpL5FAg);Mwe30Gmf9UwxMMcZL5bI~( zIv0%wJzU2k&oG(Yf`X<)7q1-`S3JC!F?5pMa+1Ya26JYJ4)aou9R)M(nqg-iJ?Rrw zCOrWZpyU8u%dF36X1WFuOnLDqwEF;e2$^HdidRaGD^jP20(Yo(@?H=3QXh@ZR?a*{ zkHrZiK@0p;(Bnl%IEwov(7|a3vgFsJWbma%3n(Gf0>&)Ws4OwjT&M7|lr4zhPVZO% zYrxr|71p3GF6R=OKG{|I5QO~;@$egr=NxbDrf>$U%`w=mE}%j67Qaf5mz`h|(7NCF zQV?}gM5%%tkzzj@t{S;JqXDh%G~R0?@rR|ksjLZE#z&BJ@v?~i_%X~Tg``{(W5e8Y z8MqFxW^c8ZEFH^|o2YeXS`O^WVEf6jsF=yPYrWr%%*((pI4L_7bD1hHQVn``TB~wZ z!}9$+uzEipe%k%e^#Raq1lRtT9G&HVVdnqD(OLh$;^_aCZ;nn`nGv6f`9Dl}ivOlg z{vVB^F#Weo{XdrVzh~;q9RDY#KBV?9Xe5gGA3-BALaTu`feyv;f*4`R@fah97ojfr zI0&2;2>Jx_e>I~`CZ8$5Fjd!9*GUypW-+;3J-_bWEw6V~pWpAvRdBLUN(H{JIzRWk z7hT%aaLMHdN4oIDBKb*ZmSw$SO<#pacisMZ5WWlPWeY?#d-Lws&m(5Z14WsQvM4jl zg}qrF<;!8XSK9)@oJl>kJEijQ50Z=$hZ54$w^uUmCDBF7ndKuOkY&pUd!%ot_s5)h zl10sau?(x?3-=t$>XgdvaihuwwfTocRw5FnDFYw+$j0?7I7*)}q?Do$X+$%ZXfxkj zY|+K3GDmnki7ZQ#k`Z#{Yto751CL7FCdfMv*xvLV%Vinn;L1yxziw|qjAVTqKM872 zVzw#jcOCmm{}k+wxU_c$YublcI!@4?nhJ_%bWUv^`t8nLw@agtRntvjGI-hpXqwA) zklRo$G9r;Ftu>e{mpe=`&zm2tcDHXT*W>BBAL#Mr74x@gbAq%ejnd~_CeaA^+ng^d zbO|dPXYIEbScumcM%rX2aU(~Oz2fkWij-_#47==+ihtl=uXXAObA0;ypKu6k9|fhr zdoq64u^Ku@w$Th4>hPiptwrTZe~yN+X*i-w ziUHS7XeAMp9ri<*nf%Z&)f{wyt!w}yPMhXV6>NIqy;X16ZI_TFin!F9l1FLHS4Xf<^^qbRdWJquSfk}^p1)kWE^z|T58 zv{5nmsFR21gadBD_Q+l2(#hU8Ae_O+5eI4#2~68>+j!33V}?9<;T$&ITEJ7%U7`3|9wKvS2n&;g^2y2u5L@ZeMDFd^GPH0=iol=X zu$J9WXE{;b@c2dH)FK?wjE!gi!XOqA6iWWm#l`>PjG-Gi79K@9g zH9a0qV>E1ps8y+5V%0-FEDFTa9VO(* zd8ee5Jbp{o124tAOkRe8>5f9KuR4`M)f3xnSmHQFBH$enFbuO7m-uSNih8g+@4MRN z=kCQfp*w_+^;^NFerz;sjvzv56@Ou>TAe^_w9W9BuL|aWR@S~~zy?~ycSDh9nT7Uc z2~~+7$}*5kdDP2xBgUDrDL}FRm^#lO1eB%Oh+4ayZWjeZs5dVZ+eb5B`tdLv=bTT-;+IwTTTC~*&U!qV;n_OfKB6YKvL z^VOa;>y2^z$9u_lR2&}%_w0ET!7vL0Z^c0+^-Adc?3Js-RXeGXER&TLuGZpLyea?Q zk$uk|+oIo4Vl#OZ-X*0iiKbO&ECA0;pQY$F@(v7~#5se~;@8sY`sF6C<6d*og5HgB zrv5@ohb%Jb`H9IfQGKeX$ zE~NW)8H0tfw5a#3N?JX5wwWo{>NLeFS4vBOi8s*#4j8FU{e8%6q-ILzAW^fc0piK} z0#7)h#J|l%WL?O(nge`Ko65z$e7FljXf)EBbogq)Hg$@+dIzAx?V>&8%^7L$%Q0a(p0*t zQmvJL%p;Vt_*v!5UOr{c^pYbiZ-B(YRHZ}%L!&_OxDg^l9ciptIdiiGbMn0Dk;)(D z#75BW_zRd&tzuuvPd6U-eCi6bHY&iveiMqcgyIck9)*3s4U^rCN_S`-o7af~kmixw z>y5%!#B4Y}tIC3GGGvU-W~0d-mHCDlLI`nt2WvOt@d<~(RH%NY_#7wCX^PH>jxaM& z)797xX@a?1*@20$$|Pu`3L+jtj_}8t2OOrH0|Jl$m&VdrCAr z`&yz6Zsv+3agIoL_dT3%AHxgAMl3vW5#L)eRrCCqb!n|wG5_rk;)l)^hx$Vk0byW zaoC;AL$%J@qN4V5sCGvX;W(T&TPDFSeGJn0&PUVvoW2j}c#2=1_-|^iXxC2SXS0QU z@aC=e?BMY{y|Ze5#Zw&NO@2T5Vu1s|$AJRvbD#zpd!IztiR})XTt0X^x^uOv>t%ar zRN~d(WmfqxDVXPuGNWXB(0I%Bm@#eQx~&FQ}Lx6S@K~JR`hC&WXt7C%qs}w=g<-!g;C_`GS?Z0w8M)-BxzK0&q zWiKBjUtz7Z^OK)w#;L^NRukq4E84@n-#0)tB%G%ucC14$FA&2-;!Ok}cErGFQPKG= z0L|L4XTbiJpEkWq4~_s*C;v@H#%N9;Ml`&FV8&Y|eDHtkWa5|i%&+sZi$XG1?}czN z!UCYqs#ge~U~I=`cM7jW>LGLVz&uRAwZ2PhfheOpJx%lgn(lElO6Q?U;fU*K$CFXD ziInZQGh=`7kUNa7s(dYAcb#A5zH6d_4;7NYeo`I54hTZy##5LaKM7emS2DT&cSwPn zfSuAJVg}xta@=!bqb)#O3ep=L%-ovexndho!s@JiPaQxyEHYNA6DVP&ui?2n=|;js zqDI0NQjrx$H8e9G_Lc2WRSAdeYSwnRyXHJ209^L0Fws^>f<}zX!+7zL;DKZKV@J*l z^&KqxQ*ZJ^!+?K_v)x^HMQC=6X?FZGAW|3 zDQxg)R+UyAjIDJ@79uM(B1M|#uW0m-+nf1IY)@kGZSscdg;)U+#R-HKdJLE+x?I=7Lg zX#0DN;rN+z*s+JO3C_NEu*C9xF7!mQe#G82yr)(yR(Am^AKTE1WfX79=cSl2$ zI{uBY;lO^rZrx11>D$l6`4t;zIgT8;uSTZ6dWpDJM_)N&HJc1lF5HULKsdCm{k0zb z`E0DNQqLZUMT$!Rm@@cG29OtlrYs$bR+7F}y4a6mq!9Eq(_xJ#yDeS45(^>bN+HTZ z)R30D_YQBAz3WSPd9a*xC|q+AHPMNDe-rANARTWM(0@I@d~#&%z; z!BOxUnYrKjO?YN_`Bv&tVKtj|&(iV6^$%8dDo)$4!`%6qpJHAht(@5^H%Ndtm0ET~ ztSi)jMV=bnCbITb}*NrvqOX}08To^53FT8!yi?CiL)C4jGK}FjkT>reT%oVu^5bT5Yn`q;o z>1}RAo{udxDRcGJqVA?4rr2G61Y8=u8E*QJ*f)U?^f|QufQWx3@#y>7Qco}q zC~h9<;F--3x>QP}9dgdGY9Tiw6%McBAeQVgmG74mR}@U2u32mCo~dz)`mka|gQk*^ zpnZ(%R%q2%FQnPIGa!>AM_tF61{B)~3j%f7qYXjwISbPhv3n#bh_}1qervZ`T}`Vvi>0 z=ICWQ=~WwAu7V;2_xJG0W{r;_Nv<)XpXkI_3FSUD`5N$85jQ5)jU25TzQG~OSMZNm z^ef;OVE!5mc1ks)T)IIcA{tD%01oNLFSd}COVb{A?HU{*9AiZf2_y5!{YvdI@kd3u zCZ(mW6@N}SKWX@uG~tR2At0Wb8`-*(VS8;O6N1nx@(D>o4)b z2F4^#3d1-_JZTm8FaR<*5Au@n$9TP0Z0ep^0?rco75t-c1}nSFRQ)+0(|xL94*d*Xyd5P#IVTpHqVsEoDbAH-8PW}5kT zyGdst;|es0h|%Q|lkt({vv^n>^$?An63bNrf_vB6dG1<<&<4ffi7>tek-;{pW!Q~a zDJKre2Ojf4Ht9Rj(Rg18sXgn~q~7AmH2WEJRQlyEPoo#J(jY5NBlm$Gd{q>^19e#R zux$z3&f~*iy$MrQ@i5{z?jEhC=Q;|VWQRChtX%5Kpo4gg-)BQh!U9qdz!AcPBUcrNFPv7M@t{$+G)| z!@VQ-g|)7-Z|ZRsHwSE~kK1n+^+aeHb&un!xu?6Mk<9&MTS=#ofEz#T7G#8xPN4ar z$G#s^ZgM4xo%9<}Ph(G*+@aW8ILK^P4-=w7I#_@#BWwfAu2PfIcYnbZ8 z886`R)|huLgrI_zI&+QcmfOtj7jbIb(VAp z=10ygRr~mKS+j0l9eO;lHkyf7-TC=Obce%Z-EWP( zMj{S*ipQ}$V#DS74JRH&Fgn;(M3;ogP`t^ zDc`$_V(O7ej1+;xG_fe+Hh0o)69$#SYe4mmUWfz1sH=i?zW6KfTM$K?z5#%c^-N5< z0_ecqV8Nj4YI#caV}Dt#2gYv{EVqkf{AuB*g!Qwo#si=GE1_b?2=p|s0H|l*3^JiQ zA4$-C?uT099l~uvu{7s(Mz$X|?-I~+q2EFijK{xyAQI!A=@yT1us-^1@nQIWq| z#(N_01)#0huq#W#IP06?}rL1P`yMl-sL#;pSkb2hMfO@A2yGeoFZR0!+}% zI{cTUn(cqV+y6wW{|~#-|4&3o%>ON&{*R^n@98uf>;E;DV!J7h=(DQEOi#B^C6Xv3 znbaTvu?xP@tvpZgS2SOsVb%PDKDvDYQac5 zWVqdVqvrBWj~?)?Z%_E~@k@;4b8n0PeEF_Vo>+d?ivuI|{j;o}7QJ+8S%_;) zDAN0{e3e`2)vZJGTd;F>Ox2%zb2eG>Ze_P~{Gn6BcRt*%lXxj(EXnwGd+@4j*)^YI zd}y2`^W;=5y$Wu{HC;g9vzQtq+0E~x{)Mqm@Jvyzp&T`2SR+e7=Qi_q_C+;Bjx>?* zlnVWeV9e%_D)Jq9L_BCOHCmq(1bxKoQ|W4I_@eAu zt(kuL*4$(pVBhlZ;S-~i+91|D==#E4@LG3waom2Kl+`y%wYSW!il}k0uY+l?Uy@=7 zTto)EO%EnM=8IXUR;Cpf<;32>tETzn2Lo9l!l2gH#V5B{#B?*%8K+slZ$#B}#cMTrGKn+6MS79DhIhAP*957~SO{ z>?Baw0kGwB9sOqZs9jYtScDl5+pPoHFn(V=lmao^&kY01(dwX-_ccv7AA4HSCYt` zb8{(R3gx-*0W2w*YAFmlNa_?$v^67ItuFv+^#WfJQ@Tn!tS|HKg<|Naqk zDxSGI^*bkmrgKg@f)x`yOiU+P4k-|Psv)9Sv+Xma>4sLEgtm>@V76@pmcCHH)nOFt z2x3W=rp`L%+*$Qe6ZV3uWHFiquP(O<6G(X{se_z85vMqSQ9_qc8{-=s0MVDgpJF0Id2zpc&(`+&|@0v~V>br$B^brReV(`&sO>bg!^ zV0)!Ft;_zTQ6^W7ihKGai#~VCNP7Ip6M|}xRkyLhU_WLm>R&SFIz-zr$_pWD zPxl;{(?8i4UtNwC&bOi>b~VoYKp41mMluJ)RBw{XX`(G_y~wJ%CUO&0PV!Z?yldW~ z%sxIWFUKlUAk%~Qvt?s&6gO*zPU`2IxdV%(s_}?{UaM<3gPm$|oC#y4xy2b2zJf_+ z5(-foiH#mIkL#$wlYu_+Mcs;fYwt+7mlR_q- zjw5tW$_2D8+KX?6oUqk9mly5J)AOx8--wckY%}%Bh>&@z1ChAoZK87Anr6rTRgNMP43_I54TsJ%z_Eod zx}8KF2!rH=k-C^@*lH*+R*}(2&pb>y>TBSQV;4i?RN@(%z=7xBT#gD}lxuM{DAd{@ zDth1l6$g@L*qc=*KuNQMxM8;x9hDu4%`MMxJzjl_y;2i$E4c&kAyli%Mw?~d# zqv>{nCC78Xa^|AV&%8rBt@37NP`1ERwgGZnbU~6>j(NigO%-2`~)$s1#}_*B~Hu;17iL!4&By7K2l z>fNjl6nrj~Fg`NR%WZtQLP0C#At^wMn{vdWd4*WAuv==JWoX#$u-)QDF2=0^gjC5( z&aHHM(T}7+iw5iqXao)z-q7Gls4&XsT(s;pCTv*Lh_;MCfCPXg_CjFaUN5qu=D!Sd z^p-oRTc#PW6~*=SDpTS@{GA9V+bWv77{`U|WA3$HF6NjBj`+|*5H0mT5(`v%Lly%_Nc`gPETo3o@QmMmq)LD`Iix5=P zoFJ@j6E7lI($)E=4z)qv{_sE`IG7qvPvwt7ZXXJ4LxLCdMUR7E0Pi;3fTwjGD#e&; zRUok&hHyEsN%+egVuY;Qmwi>hK;a37YHbQX&bEEyGfK~Dl8*K&sZ5v7Cgz`l4$UW0 zEsMSvpW7;_>nlD=_R%oK%1fEiK_)|E6aeZUfeFTa%8Z=-_WPgqQz3_X^QK_S36*$g|~h z8pWLf6(8syT-XzU`B2`Lpb^>5T)AE5+A7<49u)?b9SMM}iZ7GfIY+boF)z|}s?Fs` zs|gGUnFY>|t2sOB=s@^U1|faJM$Fl667)Nd!Fi38!SS($4hoakNg(`*+K+e`U@#|^ zQwnSGkaLi1HCOVqQ?BFoF=U>;GT#_>y2GG2i-70EveDNOY5PHHKyT|O-1a`DUSswH z4-~TJrWs}F6vJE*L{|1G^2jrvosko{wVvn7;qh+othVh5L;5CF;nb>D`jz_lHCU%= z#zhs$SLq^OsvQ?DBc>ZY$Uooyv7F^pFw==RosFH9)0-Vu?s9ivTm_FXxpl7}3j+FR z8J*ZPv^(jN)+zca=POorJNj4~)*Rli&VZ9nmP}kGTBKacGy{f>GprPBto?52V#-Cv z=v8*iU9Fwg{XF-T$GpHjA4}u2{Nlhd?s_rMzjq7u!HIf{W;v*btzh{1?Pty4!W*h`=hTn*ATh;B#Pnu=dgiQP9?E1Hm^;;Z0Jg`nm+gBz}a<}&pg|N8?-P- zV>`%m8f>1?+RMz3i*Kj%5VFIaMvJjCO-q`F5W_3kMMRipg>VbNV>ql~R_z5FZdv4L zkxNtd{*O1gp5yVf{R_Wn>ikJE$N(0n{)v|=`YiQ}pKx$|Y~nq;ol2`(90yuaLF-as zYh5$UIX+5SLtbB93O|y6%?^aBo{Dj-CL6=C4KAb18B)BQ=(zF)qT2INH4XF)yahpG z#ojaT_-Bl8C7G#5C0UNsVZ_n)%gzrf_1_j*p=tsVR#u_S5fNFLNMai9(wa}lJlE)G zWN{bXqm!aJvh)+zO(b5A8f^oZfVZ(~Pe0)Fd10_n*9pU-%%#}tCG|k)#u)oC1p~PY zMxP;h6y%uuG#~cm17}NQ5821U{Jc)F#GRv+wX;On>iPLPZwG-+EZ@iL(}P4Qi^S3Q zY%yOng_V$-6OSyP>|hmpgW%Q5l$2BvMd5SWT=7@OqNvG9>U`F>9K+uHy~V3BlQ;1L zwo!T#k1ZthbNoR$3+jO|DM5$LgoEc5EBcbCHeb~*-_GH^2|N4wU-sIT?Urc#kDY&0 zqLpD7_k`n65kR)uO@Nm8{Mt|XKKU}5aG3FuIHdQxZgfm$rfw9==aDk^4P0DKCs|D9 zJw1n^;ac#AzU+?w1t?oZBegVxB0$WHF_k^hs*I)HG1LJb3;re&8wH8 zK`JdXmo`O{t3I57(@XUWF2?<53|j)6Z{FyjpMZ^k;Ms!X-OD7>GmA6$osQV4fQ?9Y z=lsV1_7QpI_|^&iqrK;txU~MV76=d0DC)*)YVazm(`1~Oi_`tFgsf-GXG^JF$T)UO z)a@Rby1w!u5X+spY(T-)TXqIUl$Y#w2kK5jO8?+kW;?Un;urD)vej2y_hb8uaj+ov2n*eZnv zlKfBtQ+OR3lS6Q*!sBN5>%JH<=fVuoIqgw!I&yvsLTDo)$H5Y?i`$uEt|%SSk$lRO zOQjR9VO)b5$Isa8eO((5#0ve!>=>}1r@uF=n{j{DC_Z)Kr&?j?st%?-&*GP=xsY1A z*j@aaGjJ#9dGL)+6BsqeLgd+;)7TK4O2LS#q|0`!2_U1)NKakOq&Iv9tKlAOux2NWKq=6HpDRIb>z;;16C0M z=IJ+l!E$n3`G3$UXR#(57OresUQU=HM~m8vx9rE{zrA+MT|h5}Bs!IfR0lzb8s#h7 zZj(gfJ~OBG2W)Z^OJooFT%qWUOM6lEi`ek;W%Vh>fQcq4J-E3a9}1twA&&?_tBAH^ z>k6#dxPGJwi~+{{HsZ>6l<{rj?BO%i)5s3-BnnW%rqV>GVFQ;r9ebo;!DK1J9E^BW zI+G150GkpiCioB8GvD#BW4K1?IXoZwMxdV6D8iLLjzZ>Bd8<0@a3rKL3i;5SP|iPcAjyLv{aFT8v3P^fMhdf-B;*+A zP1kby0SG5$=l zm>e|RN0k~N7Z)OnPztkv97 zMPrCGOX%DdfF32UNQr~|jawgM3Yg~&KQ{ycKh;BM17Cphjos^P&&bPestW6qJnjYe zeWN>UMq_x|ZOoC3LQ)u5I#1@#=Yb_*!bC86r2EWsmofyx;Gu?#RO`y6vjL4Q$89&YmdUx(wXt*xYy%Zsn9=d1;R72SmkhAB@20XSyUN9QZ@1kVUEP+zvmvA*;h ziq$aI>pT@+?Y1XIOUjtdPDVAHH)%z2E?+7EHtt(fxvYFW+LTDm5TCa@o{Sq_|CJ4+ zC^4pVVmPz&Ld~ac&^0odP?lty!MTm*qQ1Q18(f9K$83bZ$S|41%6C@E_8~>J1Xm#W z`Rh6H8D!aLLe`PH=O3^1v7*sHnS+iEeim&LEhh*GQVhgPr?cQ?wde(c+#OT7{xT@a}&h+-8%S82WBw`p)xsiIa1#pUJO75}i-lZ5SuF!N_c)OlzW#G1>ldC~zE0>j)h%%_yNcSJOm}m}3en zj3Jl22EZG)BPJBZ_O43t+d$4zlX~iq718+2ppJ~3PH~#=_=-7jIat0pC@7CDZJAJ% z(m#9#8CIF2>FxS+rDEHoiM-ZST3A1HE=n?~*M4-(0#&}2=e))OrDgb(* zn9saY+A9o@u+*;K$~HxzWQElkaA2~YP}45RUIWPrm#WED(!|DF-I_Cd% z*5JQs7_j_zX#RiR_x~QvvobUMXBkV?f9jY=P#}!p7#~QYxYSow6}w1CD^i%@@dFVz zqXKRqCaLuJnw8Kw0gjE8`ydeLn|73bKK(11KNhm#4R5yE)y&q+h>-h!-9LRvV|S;| z3L%8QUzlTq8K6hLE0%%3U%)fKmb9aXIyU=K8Y&1I#FZNM@O(IbxiHWC6~7;rTr$UrJR(i-^F_MZRd~}lv-%xmZO)ns!{3=lmN2w`IYj(a-_0Ajh@}VlIAW;T@?i50`D@W=KPc~6IjzQ(EX53= z2Mq7xfLOGMtU!i*L0hA8p6(d+FV7S*!Jv8?b&s#1EWsJ9zN;9{Gtp)&P*MN}$G6{% z*SmU?Cdd{;($5@e(+gJFKcFtGKw0;7v@I1;i&kEojoa9fZ-QE*D1->b6zC|K31Uo8 z(np2Nl6BJnsN}MTc05e33a&^}!zT9=k15SOT z85mF6ss>k6F3ud z1Yi_EAj$HHU8YFk8Vk5>|IjiJEISXsz-k(BJO#t3+?GBnnuGDANroWM2A?@S36J(8x>lqgQ1X^6atMG1_G*q|e!usXWoMl9MUb?;lW ztpvG=({@lOyyC)UQoQ-Nrdl-AIE!cqpp^m*ke)pfgu&mPGd#}DY-RCQgFd}SuwJ@k z$UvL2%1MTxt3+8|8?&c@|Hb^iJ-(7^_jD}bPc5O7>Aa4W6_xx=a-ojBj>QJLNpP)J z=QEiv--s5Oa8P=l0?2&wLh3=#m1g#W9xO60nn1iUT=3>M>E0SymbTvmKwFRUw^K?*l;4Y&6PFS`}N_zeqb9Ehha%QBT8D<0d z4K16+pgO>a`^>Nr`G0vg1@8DwGZtqSNr(Jzw5bF(9Rj(8SU`-NgGn-p4y?_hZ-~@9y(N4yL}+b` z!7ds-2V>0)a_O@)#nFokd%geqvz*D(9kEK_= z?hgYSft0G*u!l(x>(9wWX%dWRbatn;eGSou(N;Qm{s(LC*qmwn zZ(k-I+wR!5)v;~cwr$(&*tT)Uwr$%rOtLH_+j=oXXouWu&WC2*(y8mcq6f-g7eAG%-?xmf+Qr!*xAy3h z7`^F=KJd(!zpDj5ZErhJP}(_9vGnMDiZ)UOT5lgbkJtcUIwb4>_)*|9j`HCTGglys_=*!HXkEh%+T?ti@ybHQfg& za=~Z<*`&&Wmc6uOJel3#uHDM5F|>wyQnt=hr~=7|25;y`Ldk!g%rqoR`~>=Ms6k6> zZ6qC}B%^Ll^%4qOb{z52x%Ki5I>{x1`~uO{8QgGE9H143vCzmG--}BZqA0kM-=dlL z)9s*YB@P$UtWvrxIAQl;i4UZHb*K+z=D&qipcigzAIS1#v1X8~f0}v-%A{@MJ2SSh zX)7t^0PnsA(UehuHLT#9`U-^jsmQl^O{XRr9&3j<};k4$9fsb$9IqR`tnaDu5z*IhBEIfgK-Ha39(tT z!olQ7Q>v+(|Djq332ROTk&t)^t*bz3Vo;%RxRV)Wzz<=DxBSN#x=5BOBSCB?13_1{0YFD$Nkvr6mRfsXkWG$YLxRp-!4rs06unTC8Z#+^Jsv5(63uNqY%R|r0NGz z?HlG(sJm_SsRp_1b^a#BIOthGs#W}m;99MX)9{IB9N$La`4u&?6r;0kmeJw}-OVFt(S`TT3dIT4yBQ8s_XA)w@6v z`L&vrw4CQ}TQv0R;~Fy72AT)lRKC4m6SM&|_PEu)(9E^~!c<2#ULXD@L< z>$5qNfdusLCf<~H)DE7LVYd^aR$)D61>7O%UR^4g;}J8(bu0oA0wmuixhkp-(Ub7D%C&2u#recPJ6hgoK@#43 z`Gn>h{v#drb5j-w6mx~{0g2t@OPPs5Wmv?5PT5zS^}OPi#_eQkD)AQBHJ03*oio9? zGkeuPjz9CuMn)JREZcRFEz>qa)2Tk-FlZEF8^8{^HN?U?I?xs(9p(qT*wV(DC&0xt zKEj`$EQs@nCzOBrX7*D5T)2Q4F>ch`=31$(*@>~0hh=vpJ(211=XDhX#jwf)!#qiR zyMan)`LZwX-usMHKS5RH?YGQp1kv{MyAKltVLG}%57FeGRBS>57H*t0=?h$I;u8-% zjEyUj4c_%&orZ7IA*j>1>XkqLG&6%M=6y>oe=`awJ7d+%bYOvv(1e104V>f_8)T?P z6%)qeN~!!Ujy&zy%8pi(z6qKrE^Du=Vj_jaZX>uV&l^xnzugOvrC%)#p-1E zyWJ|aCUvGEFEdV>D01yo)v9fWm~^0;tn6|ThdA!o;92dAw&Y^pibKIq8C*aD*bO&S zU4laOPH@N7=VjbeG&j!FVAgqJes%#X4~0E_j#huZi*5Xi_zl1*4|cnwzeRz7L>j(kI*|+gXcL<;efB`%}$#AoJHmc z9Qn|4enZJ0mTd&|+NodVKpbOp%GE2)GUAO>+rmw|8GtSqX|dbv26R(Q18-<7HorAt zvMfs^D*~jxTe_pR2$1)Z1}+M;=%rM*b47!0%vJ@P!9%Yp*^W-j`n9L!GNlyywAre!F{HYF04rdZ(%4!$2PMFoj+`q-bpL)TAG_fIn@;QYD^G2aeeSLwvYQ`ne`pV08W3q;<8urMJ7z;1~}%%fDU%dOt8>1gDicj&{j}NE}=S3;9USx3+2}- zgyB1PlX}mfL4!lMZFkuQgI(&%Gp}aSC2NpQ)dDxoiGh7ZRztSRp>RqugJl*EtX2V! zZ^vEp0}QBJ8!mfvmR7&V9PNJ<66pwla0v*YP?9Q$lNjv3k8qes*G<jqrQ?@8lUSlkb=jEps88${yspo2)8*-W)BwlO54&R5FiPNJE$kWcwU4h5Lhl zZ8h>y5Ba1`73u5p+CT@x0PO(5n6XcE{Svh5?tCX}fr9nF%8j9@q{D***t zwt8Yr@1IX7Ymbh)XAn_`89mug(r}5~<#ro1#eNM)#`ZvN1eTa%5GGa5JaV`=%5UIJCOKLJM%Aahh2c->;2!#LY zaP&&=@kU5mcpMQ3F}td0Ps|dA3P`g@0(JEIwtX;Tl)E_q|1Q$3`@WH{;Y#f#s84O1 z*L=kwj&|hY9zyMt=3%L|L9xiBdA`B%Ymdpp;f~Sc;dp=W=%W(wb$YeoruJ`dN+y*f z=Z%R<<1CJ&R8DqbK!7e~hzTaf6RT!3k9NKo!8$>;2aW0`r`4wRN_4~IAp9YgSCke_ z;3<=Bj1NejF+0i;$90x_lW4@yPjj=(vo`m)K?Orru6!wSt} zN|prtpq7mHGu^?hBjTEH3t%BUy?r2#mvxtn2K9=v48M{y@pOhdX@4~MLGHAS#L5Z( zdB?U5U0&@qTo}!2;$7Jp8z)vPK4Bv8*LVEk=+#D3<;a3&oLoJ)grQ}`o2}=yYjVLv z7iWbRdfPR@gt>jfp&n6Ks>~8sphRgyru@B&a1fM7K@YCg6D`B76I7Li&1KzVd=;?h z|BD1cNuyvdMTMXxi>5kPV}Nqa71E3Stk^46VWVet1w|~)w`t{`e&^8Jb9%AO6wkIo@5LC<1&|hY#CW!H8P>C!H z!dT{2soE5pb=ytJrg3MKvPk}F>g+kQr_;x3Oa6{9rf-MX_>)u)x;*>r*gTlN;*!+% zMjX|VC>q~VWsq@CHOTWuQ&Ds>HyQh_1JFx$Kyzg()IUYiCTRqV^1xW8f8acCg*Mv606E07zz$ zj`2XMJ!{Q1Pt9#aCQYtkVm2O8xM76fuaQYOkvvS#Pg7CfV3|+7GKdz4fQ%ixP?~2psw~HoQ@yMIR_C zfVk>|8DTWG5stc?`U4}#$#BYmp&Sv|z*rzUairUMn|9N!o~GN5%=7JNdq0}8VnpHp z{ycx8-@i0$&WsSOvYjbu^kz#kY({#iVcKc3K(HZyJhup=BQNI!BRRsCqZ81rGX z0UQ!$p?eULxoKG7Z*()!8|%XNc>jcHlRMs&WLwX_`C(eOKNr3;WG=dx>`-l*VgvfU#eTOK}X3oY!|@Qt-7&Wo|yb(MEitn)0cHoeGHnCi z)gBV1XFD4}l<9w9iv}YH{NWHA`H(SRRZ3f_1S1h>_5;3jtfm`1qx<%v=|Sw=yiKhP z#ocTyxT{xSMP+J1^ZN(YYzi9w{#kEmBsDYAF{|XCmQ*sI8tAc}nWTC!E&5~DuDzRi z5g`gOR)NIxBG%$@(tBPTffUuHOV{h?(pXgKWgm&`MskDIS>3nliVA@v=5^7;!kH^2 zsyH#(;O3Fmq6-AUSB6)S1u%1ztS{7jY*pS5n6ZX13$@fNVWq{&NM+lXM|0t$&ty!Pk+}6x z=@9An4UO5+yZh(S@a@?!Zu+JzJ#L+wW!{T;(=g2VsiV3Eu%0?uC!wLPYKK;J$k8#4 zP3`Hk!nq#6E19|p2^k&u$7Iq_7sXn2zB>T-Igs`;)<0g$+S*ztqD{!8?2Pp%-1AT`R*wK!SctgKHSiQ~&W&$;I~HwtW5QL&Av2Y#ifIgLXCt;CS`5`lgZzC!QYZ zOKBof4CW6=LDtCa#M!KLLt|H32~!9TPtB~Em~xkTeV16EGozI0fm)Q_e1;7q34^c_ z+YP4Nj^0&6b9KjWIJf<^Dk~J=N^kaN01V-?WKQ^e-);8{vKB)z0FW=PUpsF^_2 z8qXqAq@(5llmywh+1soaI08#xQC*W4Nk=6YwVAut!3|xH@G`*m_B3kQgt)=vYfz2&Yi`$v5&P2+h z#I`cytUTy*1nhSOj$0Z8A$EkBE`W~|@g?{cLvRpfNNS9pJb*Q?(f$BGp^YEPxn*nwIRB{p~4oFc636S@+L`mxtS;NHEr;oA(NuccvqVznL6Q5#VEJEI?O~w zLNLy#Gx-Cz;{KXbW%e|G-Gom4{p+@KFsbygXm$2!C{FcUVsRFdjxN(8WIUNV{!lWb z@(XeyCUxQ)8dZT$te>!*Fr|i&QJ%-Zj?jWBqCpDU5ctA*25Gyto!Nffd-S)AYAhLT zjyKQWW_T)CV|~V>LviXk*v=mF@TP8^UAE-`E(IY1ml|>{bykArN@3RF&A~|}`1I0I zGZWmuQa;cYy%>`)ylnV92@JI3T5V;0Ufk z5ZRa^#cj+`kwGWF$6W4f3LV5%wg9PGgiYi@)un~^E>{e& z(71cD8RnIwK%()X?@Ti3+5z5bB1BBC%n9ca%VW?HkH9O%(5?fO{;-K11FgjH3mnheA}agXxL~U{{ubkd7!BA#K+0js&ij|IL7Id84q3jv@j%$HPO{bYkdEhh zxE=eqZFB%@C{mL1K>0C@U|%6ow#*8gC^z;#6q0?JGafe#o~xTb8dXJ7+eMzPkjRLU zh)F*Q12w5KDP%br3@vktK)i#$aUgLSmvrMoM?P&!C)7!{fgu z7Di?r$`k$q89w7_JQ>{WgTuB6`vI3Z=n%yDAl^$n0SNLUf0)8Kiz4m=ZA3O#Dp$4; z=zXMCBNh9N-Tjk_`>h12cv|U-7CbD#Agu?lqduFKjT8 zzb6TmzU&80V;bG{Tc1gW_%Z@SKQlG{TF(}?SZJFq(is)9kI<@Y>VbyLQ1_avcWRFFF?=GW3aNWn`cIR^;@aUM8Ii- z?QXKVa`1wr9aprdZY(sQIgu8C7mPomXqLS`_{m?)!%SoZL;LJ>0^;1lJjn88L{p4b zC4U~nS^2@(ci|h7B{v>OXnR1JyYT^5f47_qx5?U`Kk-Q{Y4&cey5W>tG^PuIv0jn4 z5kT)X>m^sxZBaPcS?mL1WuaBn+qGor<--2v^D1ze?B-dZ9y!4b!=^kL%AzUFBEbMl zEPoqxYo;Es)tu_;1*A+!XY5LYr0;Q1(F!xwV@Q@8dL}rsVHS)TNPrL|5Q_YJ2RiLJ z;ln15G^rLg@b}&Hy7pKs322yixE_Q?29~5-pfS3UWLNRL0}6P(mpPmH!JqK-^tga= z6fCmG02r=9dr8d^+Z8ubuT;eQB64yJG8J}BxZifit%^wPZI_Y1aRI_*YGO>kG zUqzBY4Mc~RG@Fhy(N)Qq`=X|0D4AOlT-G&nYrxdLrpjb|K�JCT53l?&+Icn(V?d zIXV9jE^5GkyCuxl>@Vh%JoOo{>xRh2qvu5A_v_dSN*qiQ>S-9E__hv6!6k(9-4Tn) z(?cEhyD0}zcrk>6dt5eMFEunMd5OD6nf>cs2HdGzyIGj<0S98$%d8YM1hG&id06BV z{mb>24n6iuEEN*JQ$)&;r5U&m25bA8NT$k5$d*;9!!t(LfA5V<4_cSnjl7QVaD9wE z(TFDpwmhLAoHsqNw!p$V@^;bS8!5LkhtgHV!=?+VwHSFfj)t8ol!z9QVXE1jD~~A{ z#bnh#*Q^be$(Tr}T^_2+>D;W|MK5q^59c;tD!n4Y4mPbY9%~4+%*E*RK4^(lK5Yn# zrGt)JL!tQ;>?-qX-tPCOmS$GgOrFn|E-ud2uCBOnsJ-n7 zE{_XFLWZf)vRo+M`NzWjFo}L|k34+Ks-BI!aU6_S)-{N?J!?lf9kirpB~7a<1~luJ zwrB)m0Q3;pY+MryMOnZ43&avk`bEH$&+3F8m$BL&(G@d~I8PUHt zG#aVIlD@p3sPKe0(`Ye#DxNabNV7Sq{|AhofbAfrKw+3Ul(+4_QbeF|TKCqvu7BN$ z8C7l-qIAv3foRm6MT%2tS_%n}i1EKP0#_b}nKF;`$Vq&!pvCLP7G@dr;9|B#utH96 zbx|0^NL}7p@;K42ef5PXonfQ7WrpQ{)Z(S;e%$k%5^S<2+RSYZ@(7y(_0!%~l(pq; ziNLYeEc4ej^45zq#?0qBJin}Q;rju!jzt19U=vi`2H2qn`oP(0t2nTX^Z%~0m1?p& z$NGj5&BXF6>R~Oti4;&P;=F-(1)r}UEyNx$eB=xrt)?1Ed8i)k&C8KNNZKIGR@?3q z5aXZt+PO=@DZ@NfgZ`G)QEiG3Wc*=5nw~qz>P8};sC|fj8S_8}=Mg>k$)5U|fl&pL zC*>VB$~HLm%MJ*{%^mT=K#n-v3so%7H*_qdvLeP^J(D zdm$lciW)R)aeVeIblFstL11apLrVoV(gTA8K&-|dU;lxR`Coh3d73YlweVhR4u-c? zxKOnzYdH~@f{eVwk!kej5(^q27$Rm|@2?az3P4>a#fgt!2hUQ+nNS`npSq~{YM`@} z1goFzucRqa#%3;-?r65KdASDYCjh?xx+V&d|9#A1&CAt!q&Is&n3L%ralT2(NeAu7 z_8hA-(-v+Us+8;!`QmTbF+XVY;_4|TBXn1$<#|P&`XKCyTJ#V%(h&FYwr>dgfak_z znsHx<6<&2@REx()6#xVF0pIxpSF6x{D@lJ$@2+ft(Rkd5CwvLBJimC$m{Mw(NIpm# zvX{!5ExaFj@IL+$FMbYS#hwvdWq92rGLO$iPE*U8ax#{&P=tzxl&cIj=aDWa#&$>7 zA#4F9$bxaye}t3-dWBzBTJ0$Q6k1k8{vNPjzJ1KWyYiREzX4v0_)svA9k&=U;P zahMt?6q708QGN&u41jSU7J3eB<%uFui5EE!C=a=@*ky!!sXzr~!n;Bh-$WFY**7{;j8%w&Talx4|BF))qcCys;%)f8@&E@pzD38Zbv=4=L zusLuT+Ums3dr-};@;gt%&URbdgr08OlwMD_tNs0rYr~{gx4S1dcWb+*v0m}zVKsFD z`Q)y)e6q5OYD@Xruo0fMi|9+|DC>;m00#wGR5VYP(`f|}&leH_e{hhFCmR2gBhP)) z8;#vh6QBLf@}ew>{jcAs9SydV7{;-G<{9(Ca@;%#A0hP<6F*m06AORC7u*##L4!|g zvS&8OB1P_M19-=3nE0>P6aX>R6YNajod%r;a4_qt$`x>lLr$5cw@4qyr4Way(A+2p z7TFM0c(dR0Sp0|M5l($s(sA|OqlB^%Q&&khvN*w_1 z9G&xL+#y~>dv_-n7CkdFehi6f`)|?#VQ|4|J-zCiiHgqw1BEm)?xXr(?X1fVI0;at zTnjjel-<0Jn29T+tU0@bZuHF+y3RqM^Z9u4Brf@z2qoCtso?u5KVhBikS*@Pl8=C{ z%%~*5B|kL)SDCcfuJ7$7A7PYUDcH_C5y4!_ARu*9aq)*fP{Nl0LzP3G6OOb@@uItG zO&(sEgo;j*#R;37bc{)|Rj}EgHeR$e+QXHM9}QGh=srn*X_gNo_X4HK1O_ij{!lb= z-7KiiQnsSfL)$aergUL>F9c`~yz`tT9ds=S;T~Hz&NRAPhh0z3gXRvIdZxiBgNv)0T8l}zM2<>wH&C}N0dG8qhI zsp(Jr7S?5Kw&GmHL#_Wk(Cqu6n@zHwtl72)ezpFf8VybPRi>wv1Sru{uhmR$*Rn&Y z^>q5!|NaFFgxJuN_8+6~|7h-H{$DhA{`b-MehWC>$d}k%8Oako*9&{>Rkm zFVOH`rcPb4qT!ZAhaTUKPTMV7NrznFA7sl!xl*a_6oPJc<&LkHgXiP3dd%WYZ!Z_0 zA_V>MLxSYu=dnI&oap)^z z-M?#n@N$A>+L-74}OGWa|yg+hjMWG zLIZR&%lw`q3v{><%Udy)$pdA$ZBYpxl_0sfRhkh$vuCS5<6L#2r@`Jw(MIQzSiXE( zGw(|)hF$B}&ZW!AY*74fKqLJf#!U}u;gyA*c`f63%^xj`9Zu`rjWeG*>4Y+NqHOfO|T*u$wGt%}`2B&Ayun!=& zp)FIf0N74{UO2gT_q#C;ZUI=-4K>|-5YVi(p*!?MAo1A75rJKLRDjS(d^f*moUFI7 z7Kd@(sbA!2zxbhXs{V&`A>>8Ey+hT5fY=P(sA!Y)$(Ym=qm|}nwT-2W%!O@UL(EgPZf5Gm{5k#>?B4B`XU4{x%Ute1+zUvJ8b~K71d<=g zMJR)bA{MS1HPW-uLJyTfiR($fd}SJtTVnJ#cIA;i&?bFJ>+;Ikje9kUh-(HtYa5Gd z+hY0@V)_##X5+}Hrcw|lPBi%`59W-+p2z^5lX=*_u+`+_p&#*`BL~@4etI_7PxUAV z0t?`yn3r6F3#NkP*{X7L_J-QF*Fj$aW)=pgskjTib7#JPevQl*Y+j^Z#8eMY8ut^G z6o0!E%feKor*@ENyXS0tTuIE0p{SpTbrs`n_2 zz0(qV=2!nnYeG$;AOpiYl)y3@nu!t;L~Kheeg5rGoW`VB5WVY3YZyty$oN<&_A1%H zcf`E>jCKHJ`@zE@xRZvORvX{*!-mU^8R&(xNJhldibFy?j<}K_^M5pn(VtUJUJZkm zQ`(C0HQ`(jb(NSEsM}={Ro?Ozaay)kH;H8XH%3^Vbsm~~JHfTNhsT+%X@R2Qd-8(M z$dh*K+Y;q5UvFZm?`z!YGm4L4dq00dI`fDBZb9t1S)kpwQQnp!0>RdVufR#}nbc&# zbQI1`sNYg+75;)z#a>|PeNDoTbja2fc{=u$U@f8S1U0YzDyf|8mF4Ae{q1sg7cD6b z=gY}L%T(el31G}s@z&#-qj2>$X`{p!yj3C=SL)854-nmQ1`gL+5ah+wtzAM3z9anz zz55favr&tCbed4`4j)^v)WK6SFg2w^A>7nMUGl**@o`d;y}=BP#33F;Lyc^IZ<7qN zFDk0YyM0lTjl*h~Q5)Kd^V+`5B%$@?4x`28zA-S5ksvcoJrJT3$$h{pta^3R4JBGWTif>0qK*W+1&`e33Jnn*a!b9>y9yCS=`;oXj~Z0KN$gRA znyZ2U8B4HK)9{Tw9fr=ODn#=1p_5|Jc(@vCK$(#XeoPw{l#bp z8q%eMDrm}#inOUTqN~>9BZ$W?Pou8s1cEN<--r}+o;_$%fm6`!*J0$`=#MEeI!p@` z&7@eEwn}iG zX)(fGD%-`BUlPlRODH7TAC0shDej*bHfzBVuA00l{`OCw{9FqYWSfInPyuLR*6xPy z>!3|o;nBl37Pe8xLTfm(C?`IYjO~W-Hkxg84&H+9!C8xua+9NLq%{%TUdvKvO( z1=u|z{CA26A9j;nI_hQ^=|~?+!+Vd1wv^sQ{}bXlOX<1)->za4C7^6dSp_ z#@=WY3dgQ#n}My+7D_A#NW%;zV&_FNPe8T=8t;39b7|lvNJumO&dFDHG+Ce|(P z39r7CtqdHwoMvW$vr3}9mpoU4;kp5W7mU+iDI(ytow^d!yE9JRu#eUk`|ie6A|tMc_KM&t&)MP{HJLb5$ciEZ=x z?G?A^G@dRpv~H({wAX!fYT|G(Pn&vwEP7z{FsW){!2ahnD6%M#IqzEPGRTS>8=gvg z3kR6R)0i!rIrKQI1~0PrteEsWFPruGGQ;(LV`7#N@KJZ*bYxIkQ2{> zKpp`VTlwCN1l@}>ZaaGwV-8!v#Ot^(sNGBg8I~tGu?713ocq%DDv%v&ojWQ4u6a3s3(|lN^U?(|@EEwlAgcR$ z2HRLrF9~?#EB3dg_ttFbnQ>kbeJ=Ug9f8_>9(I|K$&OeA;k{O1PXvp75Hl;`#tO%; zGNqD4F=wv`sSf?KLEEFeKf`_k?-yr=*lD4fUy4T&P<3-+MbQ^a)p14SXY{T*3^Vgy zd?Ple1E@Nco1T-ubNn&V6I4fv1yPqqr*zX`!nBy4EQu3`GBi^+_t{}=4bOiMv(hQu z1JVB@#!k)uXiMU;kwGRnPvn?+hiTLd*zJcV=pkggh)?`9yztzzjO;l)=CBb!2Dl zLviA3R0EtGV!vHs^*f=_J?NJzuRYkCiXxz2zX(Fv*_l#Oe#FSG!}u1z|{u&DX?K8K4XgD+`w}0%qUn~aQk3@ zQB2^A5s0@n)Yrcu$uMGvqu{<$*+`!yl4W6jl)wV@-~g6kk2ao)ka`rQgy z223kB1KfmOhC0hI#7h~tGL*jZ72d&%JZ7O9P3-jO3D%0rf0ioe&vn3}Jst3%m%)mH zcf)loMbXmngU21uMv&_gm!e$Bu83R6x*HOk2_QENvRY@Hv53}iUC<~?1KOm+DZtNi zS(aNs2m<0s6E|C_4gDgNO^S-379n!f8R3W>;hx0Xz=6$zchob{4I*B>{kyCcfu(2_ z8aKN^^ubc3Bg8|F;G(@}Z6f*@^2it3jVZ%fa*l;bm}P{kZjsmyaaTXmomQhe1Yf~J zz>7QrpKDL4Fd6ZJy&PRdoi7~HajkPlb%J}f2(#=29OOaZ{gWws(V8mXEP}HZ z>$n+q|b_%fV;vuzHZ0C1xLIT zlM)$=-^{yOyV7u@EzRd9129m;FqaUlCrdmeZAIQ*g)I~E*DS~Y6_XDvzCDx{z3a>d zZz$KRnobHVNX9m=V<5yLw*8gKPeTAl15EG{T-4$~NStH-Y^;hJ=?Xf&Sfsp<#*JO# zNcGx-QS8b%jY_#@hN0)dwE5DU=~coVlb_zPq<$o;Fwz2w=94vw@@XL>GdmB=d*BxK zgntP1F3DfXq-d(iEWfRI68iBNs%yyEjk5%ZE*k zmh%wADcOa<=>qXqd=A6(CsrwfFHmAt#$2mJ1CXS&($Zs*|S zXN7tA_Z6n}a{0{0uFA=W#|fp;Nn3JzX2%>7V+~O0hMm780dPv+TOU`XaX3_+-P=6s4UNnTb8i5IK`KU)gpSh%&2Qqi?2Dc)A@t97cCpL)WOk6aqQjOoep>l!|%b zf-@!<9F9vK9r~1Nyq<}>EI(k3(xn7uTDgm=i&94UQ07ZZAESb&GE2l5!@h(KTC>_) zEn@@|!UlQ~^BMtJohdev5{g(W2X)!f?`o-fNEDRE%NzF!q7&}QlTvXRjDLS$vYQ4& zjCUjRrl(E0jP>F`r?lIE`aQ%&2n(BRcNGM^UB^X%O{3Q~oLzhv>F>|!rx=0UZub-s z?OFSU8Y6JM|IwLbf(g+D*Lu{sz+V*Z7s#_mbCF9qNATeQ6~}p5uX^o0@dDvy*nTBV zo#O;kTu(~hyFgrI#Jjk}27eE0J-4FKqEM=lzMoXPqM%xb@nz^jz0^Wko751wJ;jqi zA|cUeF&yw*wTU<)F?bnj4qY5B$5n4_ga9q?(r{-(nyN zpl^D+0r}578Av=*83+^h3jTLl)-REIy;;i3sv!g1Wz2 zd?M$NcLv{oK-41bXK`j95jH^gB%~A73y%ji<%72(Aq3&rMa-{LB25G&&mt9Q_Fd0= z0NNHAzb00Nu&LaunDde?0h-X}Wm!OQc#QF>@JfQ|X*Lx-C{q<#db zcZkS+l#pl|8p;X$g%ESijBQ z&@gGSuOTBd%0oEfP`9)3od2$RY@e40SRU7Q=lXRq>+EyRJ8j_FqGNIAc?{4*+61p1 z65tuLa7O5LqezbgHCA}!b`<$VZqS@!$bV z^Q2P(53^h{(>5Mek?oz_-M(w%Y8W>bq(X8u=;f-Q0nJt-r1(ixk=yS-u~yqHzSGy* zlDDJePZf<>LvLp;$R{?AHH{x1FX1PJNG+`am@j$*y_Y!zgyZVbdJ(>w^sk$xeo+h7<~YGosR}`J0Wo})^PcHLp%p{ z$&U*+rb6Anu=qB0LP){2K>XUkgAZJ(Y$Pj)1Uuspe`kAnc!CFLTNyFUEAwHvuu+#& z$`VfV16($FbqsaZv*c~Q;~KthZgc1W7EB{)rQk}pl-7>uNAK&|`W3OYd*sq{?O#I^ z!m;4ju7z}FONWMc^Ihoen5#svm+1hCtg5kYK>AAjo)yMFMT?(&s6OS5;ciqEXiC@o zR4fWn3Pvy3qs6?4(^~r-xlJ=6+w!A~Jy^V6fY#dOO81{qJ4(7ph3X@ymQxRwK#qE+23*26hyDdhr?IeuQMv z6iOGkC>xC)#Fx62y1Uadj1~mr#e;5neflz?s?P-tOtb!-VyvejOMX zf_FYaU`61ssrOWlwLPRutaW~H-yuyDL#AnTy!T<;?)D&ezbk9#ZRDeVf%7+=_M=yr zhFHPV*}qwV)tI&vPk@lBx+pih((aIx!s|YnvDQFZ&X2>pL#sUh3izwVD4WvG61HWf z?Ab?s#MFpMK1O1rgWSf=l~h!78zG^kU0_zMM}RxqGZL|Dd44YfMDJiOHtU3)%Drft zx<{q9_dA5Qk7_dO2?1c*lf9r{0Z4gb+@%KX1*H~s(9HT-`wnsWTN^~3+jXv)UG@_#Jvv;Uv^ z;jyqO-28|CI1Ua>=IWXN91Tb2sX_AbCnLHDKommJF!Do;H+9LWuvN@8*0qkjl+uyS z;d(N4ad_MA@^ta=`nn#Lp1N4Ev#psLI?f-Ot0DV$zttny2KY zVQLgF9ozI>*Yp0}je{{ZADwx}l94g@Vs{{-n66;uH$7EW&`SR9!k$YC(`hQErTM-( zJ0kUQKOVgu{XoK8n3&pu`+TJK-ijqRzi0zR&k1(&O05_B-TJ=u^Vqj$ODUa9jYg~K z(Q(~0T$A$hWX2Wx#gRYHca)#oZMm)`PbZr6IL|B%na}eRxI~pm9^J?p-&Y(B|N{{R^E&c6;LWGc=NPGkJkJ&h%{(k-nNe znCbWqiTV3{7^{>{6uzrE1_^R$o2rwo+cAMbWvu^}(x)JOy@&?Ht^4d5MPHqqPWAbN z>`uU|pOM`v#ui*VqfEqKAml^`$fs=y49ehoibpuWfick~O98q_t}!d6UwSmjaOsD@hqmX!63 zfG_xMN|XftBbkxAZ!b4sfoCGEDF44$d&eeCqX11aU1{6qo3?G+wr#7@wkvJhR;6v* zwzg(=V`Fxsqj!3v|G{KY=)qjK*fh5kG{_(C6r?gE# zs9|pl=}0o`eh!ijyNC7ToS5Of^=SuYv93PilE!j*3bj+cut?M75jOn^_ zDHz{a;=;5b&XYF}w=67rN%#)qJU_ropj?F*TGz}G0yM>8qJ#SYj^{AtVYhu&a0M!LjZGgqp=-l58 z;F=my*hL}&5m(SzjmT7`Z=rP-0IIW)b!!x3t`PB!slt`(6(w`a!le0j|G4I_2VD3X z=^8k5iZ&vMZ1;0I!WvLB7NEs6BCT1*MJ`i~v<>{VdW{N3xAe%p0;xC4JxaT5hy zp1YY4LR>7h&R=kNb0Py0j;v{6SQki+--l=}_`}7q1qsHps~zZ`KbpW{#Bx9{=8_L* z;y7)!FY)J!Ci`~mckq@Hmxg-~IgnqY!4ujqpk#f|2x^8XN33=(&DUDf;{t}rJb49T z9t0JMsV9O93kJm0v(rYP|5(X5{_pwNSMk^ajfH^LDU24#eo$S@sT??XO&+4#o2dZ1 z0MuQYm(%mo-9NdIXa9)3mc&xv|J>w);>f?6OafQ@d)$izAGlN~J}1$+&*VX}_KSn4 zNNBQ@LSIlZC%&@(?Ig3-az2btE=0PlTnZcbj*#>}=aGFbSSgDcT zJ8$*RBA9-+q_3ZF=<3i!T;g?fo;xVN_andzswdMU#S7M03iW>s~L; zlzo?LnR*6+U?5^8CZRJ$czr^o6fy;IHdEr0nbJ#1uxKBn?!7QV*H>DIpI=m)s2>MV zomKCJpCa2ewJIzRi?Ax}4*G6q3`5Kn%`6Ycj)CMkxu8GYLX$?|j!XOoIKY4v;htpsn-LGqLjenqHV`S>A8BeH6wNAlM4sANZ*X zQ_iE9V0efxhXl$LiTTYz$ic$H0=Ne{fJAWDJ+0DkIO;awb*$wA3zotNgNRS=vppxz z)+yQurDa~AeaHa2U!~He_~@ik@x`|RZCSq&>WEAxSAsMv$H^${5fxQFoWJ`WNq&JQ z`=nF7LVj6_;_X+Dxf}buHt_7JP>`3moFIh=SKdT2Zw3-Clmb7QIj}=K71FA}V@la+ zRN_oRa8hX{`~)=w#-uMzo+qE-`o%KT7Ola%?v}b0)38Rzuc}mL!}i!3n*(XJq>_xx zyP{S^38YEyXC!&-eSm-2sSo3sNewUJtP z=iT#@qd%Ma74h6UEX(E`6Qf|)1rdKY%XO`kf#^m?AkPn;bCHcu4rhiy-dvfs5!!4y zM}*@93J}FHo}>7*8d)E67%x)Cs9Ev=&oeB;{5dlqERu*oG0&}l5yS8f3ZC->LocYR zZiZ+0$L4Wp!rq_{~bB*4ye67d5&v3H{r6N3jI?ZCtjP^S2U2^DQopi#q~~39}bgqIrVJ z8k54PeFVn$;|Ok>rU1I5jsxCUkf~pZ9k}tP6GrU8`gy@$5pt{Rre8jozmB$XzD0lr z>8N52CL>Eze>cl+6}DRAw*-vv2CRv6eWAvJ{@e*F!eZ5n5B9H*!7}~{7RJHteoPoo z%UMm&rRY_Bt@x!lA3rP)N{lPxgOg0rIh!i+b1Xwm3^Z8azZMp1oZwVTlwgG0|5$vo zFg+;aiFw>qq1)p7W7e+stWA9dg7+GQkPzWR56UfMG1VO2^@T+925F2_zbm?k<3wY5 z@_-LB!vmvjDh%*xHbHMO-1~I@!P_-2nw($My*IRpt3&>o^>x6z&N4PV35Xi&iYnaE zxj*)PslL6FhY}J!*~IbJp?Nv73)45>7T<|`^gA({+w0{vd)d`vy}1#ySp336W8!K=2^&?UK&bzFwho4 z|FduGG7b5uuzyKsW#{|{PAno*^px^Gj=LwL!2K#Y+E3b355p6Rh}S* zXZCjrfTsq&cEr8%dCgZl)$L~SBfvPu z#+q8T^xsIpl%rI?9Z7fe2^s>RrU|i<6@Ht|Z`mY0TcDCdmNn-URq@Cp{b(pCY?S+p zdU+FPZo*r1h6bK&O96YpKDR(g&=*Gl+Y_k9t4S#sbf80LK-9B%hc*Sw0f*0x2(mBS z#Uz%*iFO|BGN>;gx7m0=L4U9G-+xhsd?Pi<=I~b?DIEcV_`GHEWjZ=Lpy!1j_F#)>3b;>?)k02E43hqsg_R3m(3EnU?O==h?KAM^uc|KXiUZXM}jY zpsfqVhg01P6$DO>NK#9aQ$!*VuQ*ZgTdE)k#8(dJuvmUmA$y>X)e*N=oE!2HPqD;V zJX*(2&--dt4t=}WN)YiF*dQM<5Y<(=@R=|~thvllda>Shw^?TPcI1u)diRk-=@o)u z>31*VMOV8>1CsM*c&&(B^+G7z-B5)nP{N%=4yS%ICEFjx8!@(qJpn3|r`o5h-(q`i zT6-eBOyiW3o^2}? zME^F4Ue9wQ--9q?XjO9f0pPp{ObA@H_%1e{b&>}X#T8y7fqc@Uvj&wjclUjZM5K1i z4nkL8aO0>BcfLt+yEV1v|MszL4s=*fE!-_hwfR*_(A#hRTY{I1}RU?3N8tnxM!zC0)_RU0^5s)0FTx@|yvK>mME* zR-9`v!fbU^FkkwfhoPyV8A1PQkl@+SnqVG=g51c}Ln@40oye^%a*hE@nhh->>RSRi zB+qTDTMfr)kYL#%HKww{#ATe19dUQSx!dSoGq}i2PRs`l0&l(gdoV4RR((S=K4+S3 zVY-FpkIe|i$Dvyq!09$UX7D}32m}M$>>{MPE z&w%D|&LND14PeEZv@GJ;69HJMK{L&dTdbf_Wa{EC-Ujr_c%@QfC0+$0TwUax{RY?) zfV)gM5Uj0xVr06Ro9!6G*A4gr&#_vwb_M5A5C$ql?sa6OL*Jr2Yp6vQZ7C1K(}{p+ z0!2|gU%J#*7cY>lZT;~demSS1fxkIf=i?5)vRZxRB)&?2@GaH;27o0#TtU1nx9#Y? ztCjx2VX?nJvR*nzI&GER=c3B&s|!T6QSYt?kV$V=eezss&b)Pz@O|S zX{>FxQh|v9%Kb}|Yo1_V46d=nCN%%o0!kK2x10~oDwkzD4k|?Ph_2OUIL*WMgn^Nk z#QlIetv&hxIKdKI@!O3jgIZ^921ex-iEY(SkE4#--98V6LiG>-jPVgE$IQ8S)^QIY z?h`=LJUTmD?x$(K;-mN`JF47WE_th-Bk053 zGjX@--z&b={i0efkGa~&ku&JR^0a{UoA^qNa4KXsVGh=7j zzt#LcUNy&W=`uxUzB6?%6xHkLR(ODI+=|l~@haLcr2c~pEwn*@?XmE7nfg+Ywk7>J zh5Dy%dyuCsm-gBwAar{^m-bY}FO~$|<&^AaV6GwyfVjrqu^r7kSlOG9rI4!llxt63 zL#a+KM+Jl$8xGP@k2AV*aC;dTI%PBcb$-n`9x=9{yLZxmFrHrtPl5**JKwPg1K zU7Q4#=Fggs(wgM#M_nG?^}q(N3$@5Jmiqa}!k$=2Q3lIgwaji2T^ zqdpgPO)8?=U#Pd?%v#``r8vqC6Y-mR%|%BNl01<*EStpE+p9vye>awpCMzo4dbhvq zXJC6Jzuns9`ko(WF!3qBomD=dYG}=-l>C!+au|J|d9k+KJLz69=;T2mkBdyHngCZ& zd@Hi|z#y7(QFCKU@`{6)fellS)xL!)!?n;QHE`S;v5gVe%(7vk3UNYV=)?T9znS`U z>5XO583#z3bjOi(yX!2Ea-HH}au_&ETCWj$8O?qQ=*hT`ply7ul>37-{?UCmA^qA% zc00Yv9R;8sbm_Dk#S%d>UHnI_-Jh#)Hk?fSJK7W;1dO5^N_3-wa!?tieiv@a=X|Q1 zA5yXp-zUDnxPq2e>9t_CK2wasa(AhH4w7R+QCzNp&1syOap50cKLVq~5xs}yt6$Dz zUB#R7z5d1DbSmE|W0ILPRlYOyNK0~%eSwoo)7G}wt{ZlaCXJF`k{;w)Qo>JMAElHR ze=hcBc#3Qg7(1v0Xp`=)1X8J5f9R&6u6^lBSxWb#8c0_;!_E7_FI-AZ{&Jvn9kjNR zbJKu3TW*=V))sjY*zHpVP?jK37J-X8X#GMr(+q*Rd`4<28iZa$VwF&0j^Zq~L<2?x zo9$1QM>liU`tBZQX@5=hE4`J4KTvnR ztacwD=uhN3S3pnfCRFNlG+7ADt#)zcK@gQ`@gsr?Dx}5H=To?0{_;A~O`&s_J)xnI zbQq%Er@kCD0dhFog*au4bYJ$=H*lVlFVYWl3~w%axxoV@TZ>>XQjFv_!~2qI1p7s(Kre zU7Dpjj4vi9K+wWUEkF$UgqB|y%miDt<`91hst<_+`()(hUoKW^{kL^={8aeAJ>K@F zK3c76{NB$_TJ0BykIb0WVVc);Cy&>Bax14|8W4_`3bo8HXc}Fv3DnxPXph%a%h{%e zPsT?rb5pGDZ_Y0Ney^0CU9Nvx-;_3rCeThASGV+brqxc;e28WIc&1j4?|kZA`C(W& zvD02!f6M?LvKF-;T+7M7Vm>_k_Lu#C0%I~=JzLb0Dvr=vw_}eF#^`cDgwKUfWG&qz zf^3d2%hv9_&eeMINp8Py9t#dgdQc~VE-U>#Ml0>7J>2DE-Dv5_e<}{yKWiOYdu7aN zS{J#_@ssaN71tXP1Yak`ACCL+Bu<`XhuZ_&R~FW|w225?w+#sl`0`a3{O$bO30ZhD zFE^$pQr5dzHGdA7-K}BEC7mB7+1Z`7aXl_`iM3~>KQ#2y(`|e7x;_l*$zQd>UbQ_w z*FdGM`+*%TrzX4bP|gc7C4Vf*!O2XCFJ=5nipY6q zVQo=cw#Vq`_TPE;e{>T6v5!tjnUb@(_>EX__Cw=tT#nz~*?TL&nxUgx>r9X`lQiYh z(iF!0Sn(_ZwR+KVJPDE^HLF|My*M!TH*@}7;Q2NbVfK6?M6Vtrnz^Q!Ub)3>vG4V6 z+Ekb3>u}z0Xsv4?yGetg;Zm}CG*xYM^d5Fd< z9BcQzy1A$A%tVlK$lKkL;EJUE2k+Rj4DAZ4=Lma~f5aT#v1VwVdoe3G^*+ukz2K=1yq#jf%=uT3G|u={>=JVr zTwH1h0^O>IwLO(XL3)l;YD-X`;b8gKV|ntyCk9!*jn+g>|J>dNvpRF1=9kCW$QxI$ z@kOZ>;)yOQ&5Rz3(|TPIwLdY}$`4dsW*DW*;#~wVu`xTb^_z}%DV4{G6`ZA3J#M0~ zVX@JG>e=*Nx|})1hT@b;YL^DcE)yrqfGV(jgdv~+bL~od9TD3X2|nc3MM_{@+oW&W zn9hD6G*TUtTWxyphFsBI|$Pm#f`W&g3Io`nwbmM z-Op50po9s=VuEq{Hc-ldy&7LExY55=Vmg`dIh5N`Eh8SRR`JrIGhUl9sX1$#|yk0O2-Xp|vYMryj_A=w#u`kw{k6 zcXp!i;$g>CF$*AZu~&H^{A<#z0K$b+T@cjc#{M3Aw9ZCKO^yIj*egwZ_uMw3Jiw8 z$C#Oskj1Oh5S?L^QJ=bvN-YLu;1w*@8qP=aGptJ)~@I^1R|nSbef1AV_2jk%7%!Y!5t?F0|p`*aE-#l%t;hN zt}xyPUi+s-S+Oo(#gKI~fG34*%x!16(qtEXR z(DNVtRo>)MZ`^-@4+*HKvLd)ZO4i(#O!g1fU(d97xxaM?*rab>;{8MCn-YmV zA`!u1uU#wq^OhX8l?C9|m-S#q98mUI^Q!AM^*1FdK0Nw`CpS()bXTu5GKTkLHP;l- z%a&ie-@F(L)$?~wR@V#XElXYw9V+iRJ2Or|BOYAh} z#8mo3S<7ey*SYQMt_v+yF?)qCTAAkCLk`(2`OPCMCb zahbjrWs&0mJ858=dy79ON~mlohbM8w&pQam9N-uU&~iBvnLq7fatvv{O@<$VyKaWH zSF9mj_ZH-YLp$PkB2TrI`8oC4BkpTa(1xVC%mT#_*hke}>K=@yKA1>pIK&8ub?{Qd zG%rl(<(zilN4aFhdzKw=2q*5J%LOQTgaWo4!Vbj9sWJ%G#8BN=@Ip|u91&x3J#EK| z7+s9Ca53P5%jNe2ER6y8OmKfl!U;o-Frhk+VnBz=t5a2)xl?%^}@b7cRjoHYFsVO94#DKH8GHzbK>ao!0 z>hAH%DrdI{cYalQG6ENsBuh--2a#TJfZ#4!WH4}{jv9m%#Xt>*vbBfvD3?|9EnLJ2 z$N_1Vw`Vy3xmvP!{pp#Lou%gfgj;A6I}Y+%>Esk*Y<8_xojmf=@ZZt=eeH z9N({7_FbilqU}|dlh#&5X@TV2yHZd^HQa7iuknccg6kGv3p2>jKVC`M7e_wlP9SlN zX@EwbDY@@>m6jAJ?~PlCRVj|~*wuI1MyAjdSrFMo5>SEK`^)5Xg<&De`8bNvi!CcX zjLHz#kvy4pmWMpOJIQyUkN19$n;lixS+oEgDs34wd2aUuRn#ej89I`|Ms<=jg^B%s z5b(z2N463Z`bU}ksqghVNkKfA)Oej9c!R)2sdMK5b{SK>DtJOrnHLN(?NP;?2M0L! zT>g>{pn3h=YM)`j1#gZr3-G@b$9}_!H80X6-VsIrm0MasO8GZgS_3sZ$jK!QV_4@c zC*=h8{Bem5DprkK2M-y+CnFv?6b7U!Cgj{=6wDx}iH1xyO2iFz0;#cTu&|pv2jS=x z)J;M1=6rz-nE@uR9Q|_7m98NUj$-BRBtZL%N+}X(I8U<2&E1j6bpQ*stsA@S@9$(T zqrXQO63!MW#))DHpt+&~@zL>h`1w@xXYpGw$dh)+H|p9W0|C~nYSBjRCvBOcF}16` zDK1MEpW~rO!AvUd4x^HXk3A1oazj-QL-J10_M&FH?vg~^F{^v(&=gqO9;mTxVfyNta9{7*En7Nk-A z@+1uk4;J~2shAxTcQApf30+2pZDmo}CO*muuHF1VW#UwX#p&^@2zOxAncsU58YD;h z%+c=b*Mo)3E+?8rtaMhRv;Ue>va8%*FBNqP2hJ!YVI49Ckl*{A(z!(r@~Kxr63T5n zs(~6d@*y{&q*5X>+qh%i(`;S(7G zYU%J@bVL%?{B(Lw^$|b;hIvahPyxS^V-7QE$S&V=`QYWyInB9Tc*Y8g9uS zeaezJ4aORC@-DOOP))Ng2`nJ@;VegXDV>`QWlXw2$}UCD*}@6ooJRQlCALh5k=Yp# zhHQE$0h@nC-CSe#%Rw^~sr1eQISY%4AkHPwPy~lF5tg^T#cf+@?muV5jdsWa$u;lcA9~%-hn6hKhkH_~$+oaoHM8;H^>G z?svK7F`got{YMv#J+&(y-<61PnCKPfskdEl;t;(|Q+!s#eys}0%#@r~INF2(4C_JnA-}Piy8<+Yo@s;z} z*VFS)rwS!kCnq*m>qgCjrZsopT-XLcZjo^@?Rex6=OfZ(W%Ih+Bms?vM?k=uxvduH z#kn#IHqm{V-S&7k1IvpO_f79P79KUCHZ0A7Z$?!mD+q_- zgC9`_&eg^uBGO9S@u!^hYDXJ;K0CqFRO3T;8_lURaUFZuk$lMU9EKbuOuSTf3Y3an zx~p6M{53NGasx@28y!@zp)IIDCJ2czgv^&219v7@E7LF06Q1bbih8w^6&m1;Xm zG{kjQ+L)V?C2`2tHPqluO6CKBPzHyzDX?Wh5&4>ekij|)$0pphtS)wf(?m30PqVAI z_4hSz?^6s((*|kY7K;nKur`FjMQBcn)6rqj(RH2xS`H|VvaYH14|cR!Vq96nD#V2X zw#RhZ3xuZK?~2tAE7uPk{;k8PwZ)vHHd%L)#@1-=RSogd-)gvvicp?IiEXk_I=AQt zv(xXrJ+V_Mag?J@e(R704&<#EnKi%Vbs9uvvu|_%*`ZR^g z5-1ylr$*~UL$V!57O99+PziW`g_9&?(O{EFW%d+#kPI0FSMY>pDS!1%fSVADPylM` zKgqDh9o|YE6sQb3ae^JpK2Yz8eP(0i!;m$SL=s>}yDRT*-pLV-@M^&yTEjOt42G-Wj& zlRqQNNw8eKNK7G(muw}qEL9umTMWzG2w{a0ftJ{YV@Y7+q;|ybyzU-)Pp3KHBy(Bu zu_k7N8c-{$t|vu%$C|-<`^0j=Rgc_B`#`W_Yf}#woao?o1L53TozM&90j+IO*2K-6 zM^{MHDNj~^gmjzfB}{(Q0wJISAE-xKRsX1dUN0GFL#;zO(R+yq^$aFsF%^UFhWrvF z7Owyrb$aD(pW2kzD@Y;S_)WNl`M`!;JrioKdvlopj9)FzO%>!cge!e&)9R;JHQ6^d ziDkAKxY&@Q16zA-9rF4Pj~R~`{pSXg)_u&*q9`7RQ{h;a7l3$1`#~w}5>qF~Tq_*v zIU%^9&@(xEP6kk65zHdl1mS+w-dU=gHQOu~OJ)P&OVxLZmv(tMjB z9!fhl7~mA@1UJlaojixOPOe2phau-`0A>-r0v(!chae={w=E0k^}6LdxxnIexWk4M z90SjznB}l_qx90>lx4R=Z(o*RNIEJnOweS(%s4`TB+cZqdY5*)$K)BpQk>y6)$7ol zor=OxKRMqua&vHb@A7P`v|~S?tb#oluTwbwLH+i(gO}oMLZ_CT;E-0W$r~{)W>!T% zZ|7_CKA7fOFxRa-I4G=qm?+1tOiF4j=Tu-dvywHiiZPUseY|_m`=(M(F?p9@)jntO z@ru=nNSEn}a#46(E#7*6Y;{w`)011PSJaW~D-66F%g)Kd0Bt+UdM2FMOsx%*Og^p1 z#uY7(s3XI4{v>8fSV?FySh%rUGEGjWBUmGHHUXO_rd`fB^w5hwYije3)QM3Mir=eTcUX&lXK0Fd_bfj+EuVNXquztA<-`fOQy~fJjC-qe zPEbdS{Otqcn%{hzv3h?!Olz5To$sas4p)>x$>g0|x2^MyE&UmQ=a7UzH}eBR(rB5c z?rwaoe&Ug>PF`0e7(h230q0R4jZCv*sM>ayQ8r=s+nyjtPz_ci>e_`9xN-GHFGzqE zjIV(h|EN4~7g*In!2~kMq@aUgY^p|(FZ!YDPp13cj96XIuingJ3E)9qriY9Kts zG3iNjD5>bQa>oDP*1X{}H~4=jAO8<^_y2;I3ftSc{LfVzMwb6R6f5ihdDMRm#rj{8 zkJ%aiGx_*`UgiIr&dSdA{|Lb+tLr*%w4wRV)b>rt4abT`}3|8PUkSU%>480Ta@i>)S*E-8tU0pJaQtd%AuLetkZ?J!QG8Tjl$`9o?VD zc)9kh0aQxZ+-r}cTBc^|7i;Ma&L9oV%RaR+N#n!vbU~nSbIB1h>6WX8Ucyt zn2UDkpdI^Xs!DS#-Hh|JmY&@h-qcs9R0)zf6g zEjDvI0y9s+L>GF_4L}EfEJvR*>xi^t9Z#`>7u{&fvh%|#$~YKmT)|=_v3^Ia>>@eW zRyEn%5yoIB5E)X!P(BM4>l($%qm$OfN0=+_FKv_2CHpqi zIrx4i07BPwR_x%;v3QoCdER-BR)=V4Hh2Y1geN+pXvJnVajc*FSMfFitmg8HJ)w5XUWbW zZ@J`U{AO;Htqj?G-T=Sy`tn-Yp@&%gba z>+Z+Khy8T~Lysd1_O$kyaj9n6@;BVRk#$%BiDnMm;z1GY=#pqyqe{ut$9>p9laRO0ki}Y^GHp zVegF+HRl;>^2kDzbH7pEeC)W`%uRDWut3T>iA5@*+_5oTQswL)4rbiObB7|MvN25l z+>pBum%FLSPH4PF<*rSQIxhBEPt*w zId3LDCYAr_u*DsB1~K?G3n2iin6#V-qO!n=_`HMnezbz%&~r3fGrk;RpR!zmfV-Y?Dd4%E-1P@^ z@vQjHv^d~G)Nlh(SW`p=;O!u-)}oziu>*$MABLL!+x7sk?40aQSl?#4xl5EC(zM?f zYtppy1sZZX=U}Ri>WG|SXHE8q!77>>2A4p*CB8s><)mznS_@HA1$-oOZ+#6WXux`b!5$n$$VCy+;h zr%WPXmkM-n5-NLWK(=tO%!&q#C7<7p1q8c&42ygTg@>FWBi+~TS6JFoSM|`fK1H?U zTKs?ouIdL_2gs zUf_EPQQYRc8Z6sOj^>&-H8=oRcxmCW2)D|Z87$zQQ8ZZ(n~l&etp&)&)&_P-sw5F< z>7s$epogX`7P8QYAqoq@oAcvuMZkg$2ZJS+IGagUPS8wEbRSffk{SUAnQUUQBd@5@ zfrC)Oq6|?vt&o-|l?;}YVhnXVb~rq^tXY?d8c-=W4ipUh`_9I8jj96CuToOyo&zSo zT#uMbglGj*9{efeFwT_dwus-_(~0Qn@RdHcE;_1iy<+<4+`!x0f;8;JKhG8}ku6%H zOOK{y9MVT2DsL|xNecPA4~Y&shBGcOYrQtr8gdj@Z7oz1HX9#p?uEgWR+8cnEspjj z45K13421~m-h7Sb;I2eXDuxm*$mCSLA%EqHJ`7idXcqK^B+t9~*W;SBj)L~U-F?x2 z5-^GprBV|d1xSDQ5z~hox5~1yP%n8X=7SxRAh{8tP{7i}Nh2{t9tc1oc_LwNMd?1s z==Iahym%a5IX$|$AzxTZ+Z*vw!Z7|@9;Gz&Q8-vbM_1-{p@g8OsFYMN;18 z3{rn|XT)3;r&M%O>rt#|BYh7@90+qd)_zET2C`gXPUB9|L=M?q7%PM`mK`DAl6yHNRY7E)MdeU! zs+;WR44OK<6T$QzpK4Jq8UMZwsO#VCj_2R)*cA!|$J*pVCv(oUN$G~POBYRD48qx< zqqRl1x}Xi_A$AC2&a1|8%ZBp}pPF8NXpw3Es_#7FZeULipT%Az74tN<_$C?`>5%Y)>4fc#o%MU5p>{WB?* zC!F%1JQAY>)OOw}&vQT%$P}Z5P%`1V)_GtiF~$a0ViNWCoHJ5vz@@JGb57^?I(#|_ zn)M8e(6JqI*?86j0@U)8@V*GWv$*u~a*Z#eyWYB!gJta7Og6Lkc!QR&wyG*(B8-6i z%oTp>j(c1)!}`n|p&<$)3C}qn7Z~S5Q)deN!s$G^*K$6$MgF{bHvJVvDoZA%i%PUd zdM5E5u`eKfXAgidKIRsf?Pj#$c5b~|z*mV6n?f>-`ujuoGN6~Skb?YOuN9J9$m5)3n#m)PpNk5=`&B0pA<+F z4O>KPEvPazUF%OiSHGxh6h^;KFq~$ z9)ii=YEZ^s>X*A-gM4#~w$Uf}OXa&-uaGyqZIe-RaX-v`>@gZys>Yu|W@EL;KO=zwz(;P@B%NP%g7@^y|vXcXmVW3EJOo(ZKWBsZv zKbIt_%7EadlUI*~!gkVE@_Cqtp$g9LTW=Aw#oTfyqGHy)AJ?jNCk)s<6trN4>NGyy zqtdMyPOf?j`|e|ge{A1PUzZ>A?sKmVw$#&3|Ka@}osWXVH!3AjgTBu)(bJb0$r-0Gowg_TGzWmuhK)H09kCiOi9ax64`1g<8E z*9*1bAS+OE@J%paK*Cx*gl($xa?m&zdy?z^8hZ9F&%R@fS62V%y+L#~Yk}q?{Sll^ z5Ig=V#3nj|ohPEuJw!jmLV%NS#<^*q)DB<8sD`hzp080WqM$v+Xg*VYBUm=S>$F`N zc|>tR&3tqIq!4~*kN54%;|I0E$#3wd%&OtYqS90{*^$F<@$h9A_kUOW@t25ecfDxlF41Z!P0 zoMa38W7tFmOFPo!sq319Le@BZE{-|;{WL{4+v^TWW{Pq=jbF_OCha#b%s>YYI8xmR zN@RQ$K@|b!@i6oI3DIgaR49DVUljOtm-J(hLmlc>b)hjUm&a11OK2BG+&Wi17>^Gl zm2_TpReoZ=`ci$DIc zmi!(4No5jJ_rQYg^*ml4BMuQuFmZ0;#Iia#o3*yJFQwgJxzCfy!Pc=!Lq}r zxlbD%inQg+=#9zEMfOJOx;^O;AUO#+cP4E~teIK#?VOujYoK1^yj%kq2wS>?2Iqo%s?~VMoSoCYNP@d_!Yz;(yLjr#h+2wID}`^ zsRWHBCNCzXsX%Q}>E5_^m8riZ6+ZxNVQPtvYVsLsWmTd=*msj~vbvJ3ldus)!WO}X z`@k)+N~?XhYO`l^+*hbg_DMum8nd$!-6R_O<<1A6(or#tRaP*_t;Qt;boTK zH}j@hS1WabOa^9)jUN_T$Y7(0-a@>55JbesKBH+zTG+(YXlvSI1MYE3)O`Xd-!;wI~@#b?U{dXVzL; z(o9A%mOX*AWyKLN?DOc}< zt*%NP$|t3-dv5I#c!LN)v(3`hly8Bh`oOr{(QbD@x!#s#ggI5_=jro;uUd zLm6O|EMW*w+6LO~<{$OCp*&bZR6+Z^aa}<6osGocQgW9@?8Ym{6W@41{4{*IZ&ebD z{vuv_lK1oay2$gLPdAxl!Xw+n`o&-PllQM(J02$$Wt1(ilJCFN{LPw+dhYD~_())W zA+*t`#3bFc_WF`GyJF0cPcnvTAtp?}T( z&cL5%A~wQBc)D>T&!Sk_N`aEpoy5Y}U%yrX`za-T9(%9ceLNF)d}M6R@6+-FM_6_5 zwnGllr@!TGEy5ggg{pW+esJ#(uUms8l(29^&gSs3&-OGZ_9WQfkix_oCEIox1Eo=M z5fAblOywUlv@s!gPhlx2j_G-Lp)J?cR(qP|X~%!RY_96+;fr4VdA_8@s4$LcpALU%CG03udBHp0K!C@F5|o*?>tfB$KB2Tu90_DU2pcu#3z51QB(c! zzLvd{0hBJJy{fFj_MEC@*TkGbHuCb1t0mi8c;wvjA|2iDq=WJHC)Q_L0`oJI9(fc) zuu)>`Z7h+`KvixFShJuCXQdIx^#BZyT?;?bt&+{i933H{vx9Z9W%g25i~OKU;b{@I zuBQ0_Rf+(@ zxndJFCF}Z*a{|^+?=b@z$;B3ZUU#Jo#vRe6(XUacH{_w1N@D%5mXJbtF%!tUTnEd>jt3#i+YI7x8CI{8}#(jiXIu zZs}NfcxsnkYKJlH{34C)lBO+{%kgUE=Kdkx?&1CU{9gE#5RvzP(Dn{NnuXz-ZQ7{h zpQ^O2N>|#pZQHhO+qP}nwrywExp4>G5vNagbaW5)H`$XNd-lE0yVm35{j%4^#<_FF z7#FcMwZ#@eynz_TBL@qGmj~RD5itj*9)YnN=lN|8aGBU~-l1!2Y5+T{W?OAdgp9Tw!V@3G;w0~5QFng1QSjxGrFbS>)z+jz`eE0IH?t&R z^uc){YLRmO`}`>DYwr5kUBY#Yfi0x^b1blzWEOk?0$Pk^ij^`hp!k#O*!#6rbY8J;A-{a`qt@iIY|(FoJHZeJ=fKB9#MVWlhSdh1h@^Vm~joV$96le~k<^~pDUKr;Ch}t|R!;xc+ z)m+%w^JkUM0PBWAaU6}$q5OfZq$8bkBdu}%fZsEY|2XJZ-HWuHQuT7grJC_rhNA|N zSBSD3F%zQyf%apqLJDNfS^^Oq`u=FW%F}uUwXJPJ*Op_S726tp>Xr{Xci?mo6QH83R>AYI&I($q*(> z$4_hqGrQc8g!KSOE2Zu~*Lv(U#UO#=K6EATLt-*|>zGb{PB`(kD=M%`TFBQoRb?bpT6{0tf=Y;`AwtAgMSKUuFfF zfH2SLxt{KCKjsg-pvh1JK}H!IPQ>9JyaNpbi=L6cDn^_e@=7#RT0E!a_Fiu73{9b+ z^^O{c5npIGbOm34iVqE`!lp6TdKPI4GKqu30PC#ludcJgsN(I}b3&SQlgMd6%Clb1 zsTQ4}FGU2-%Ii2KO^P+Q3sFl%Mk#M8|JBS3{aBU0S#>W8b(`-ZkhE2qyd3U87))c) zim;Nsf7EZKnOuospP5a2Ud}L6Pnrnkh4O`h%IDqofQ|rPz-; zvY0tHnI|2bwfQu8PGyT#n_#oh4S*<0!R~lD4Z$YwsCat*(J&zwQY>Gfr!1J&+#fueG&vvA6yxankVg>309Qe9RA1^SF(qhq zH7-`~v7=Wfe~1;wSRU`M^jHLWCv7ue_lwoItU9?KbRUN(7BVy?ZXPNMm5Jj&4a3ow zKnaif$FX){II*PV9@?B*U&B~m9E6PHuPgLf`t}6^gS1GrMEU$lvEba`8kJ8aqJ4g* zVP)1Fy4QZIUTy7CP)1ee4aXSkpe8oSv3v~;1nthU*`9ui5L=URspvir(ChBy3PJhi zTBRuEgc#%Q*LwG3xXKWJB{$5!G2+rx!S6Bd6%$xAVt;01M5)Votw%)jMn0+&p86Rq zOXURAXu8Ubh{YrcfD_810V43*&!#;6p}y)DwjVn=h<51A)UFf|&X7gd@!&d{+Iy48 zwJ{HogyCcaXwRh-l~%DSRl52OY%Ey`4h!CSJtp+HRVP>b6(S=;@*g@|BDE165)$5d z`3Me)BCN9P2y7J2So`O)=eK4IN)wDU%})-BTAvt73w+#4KFg~W&=76LV;apOCkwB) zK%Ezrn3PweRCkypPolmUrwgbwUaskL4jGRsvhO~~g!Z$#A&ryd+#wsu4R}vJ{ZP#N z&{H67xS}3CT;7Rt5B^gsop4#u+Qu4mDv5EN2KQ`sMiri?@7K?{c&o-?F8p$Q%eHCK zhqbJF>-tykx(Ory?4@wU=+UkxPau!X+)nR%ECqaO=ti=yAg?y=A2Z1!M~^ z)y|L8^oMVxR_5WC341g1`9Nh&o6I1^dxW%;p3t&%o8ke{3YdL-jlNJjf&)(!hc93qF&Q&Ei?l~q+Smw^G7irLLdwzBc z$$f|P<$3DUd05gTL718@l&|+;b#E)nd zd^r)0NiODRhVc(+Ul8cuG6tYiGgCxW6LK9QEOM&Asg58S5Sx5#O2mzV4aB6{VlI&~}l=@Zjd|)Kd87HIR_}d^voPGfIfO z>`SOI>ek+r1etIAy_f(Vr@cHU!j)SU!Dup@r=}v2yJbC;Ob9?vfwXu#h}0V`+;R!q zZYCZpU34}48%{gzeEm8Ei1<_1gCWD1XPse)c{&Jl#v5eOl-sWxH6lTaISkp(pZv2C zIW|hw&tAa*_}unL0otMkc$D+NzrF7S$Xe1kM3#iOV5*s{ zX4|O1&B^u9sI3^cq0eu#ZU~9RIy$IKB^sIA!BX7@+)@?Vd+t+U?5(Eg*=~)`p(b{1 z`5)<|#8gjl7QPmWhAbR`xfXVH;!Z9M`K8feZVAim0=M$x?_#L#k~+0By0h=_l37C< zR|b8u^fpTrDbOk$xlrrpT#L6IlR_ThX4i4VxI^x`j#rQ&n0U(brIaXWW&Jv=vzK(b z#;KdXmYt>9bs&$HJI01gVPjA`gs2oDQ;sU!^*jcQMmk0AbafD^C0A8UW$b`*^6&lC z7)yJ#?}ppi

)jz(Mg8P4d*J^C)Ea76=H1^C^#ot#u*<8yg7)8vN__Yk-lnCg*Pn zdEfu~_sCJ*hvN*c)E6IKD;L#QgTU}lq6b*`iba{g62V!}5RuROPlB1B%)V#qGFSzr7_Jsk= zFi=4b9styKZR`R976#eZ`@o;kco-!HV`o?ic(~ixQgV9d7gxR~&Mg`E2t`zA|z?>Z?F8oIxQ*Ip+}|8u(}D&^<~`XM7@4H5Hp6o{z0iJH)5mC;7@7 z#~g;qm)K!yphRbuI6<0tccsb55V=Osn9Dk+Z2Qe#h{*9yr zr6a;{-W;Od4>G!97`Gb3Z`vN^q<7N~t{ z7Z`s_{kS!Z9ad zPZYl|)`Y56dRc8mU=UbH$&-ENfPY!VeTg;(sIKvw^Qo-FCW;L-o;T{8791r|2A@u_ zEVDx_<0Sz-e$NUml-6TrGr_FLuLf_-G_%k2GcgqthKqKY_v^45(0Pq7272@|k*Lcv zK^)bhTOIucBTG+lN6hg7tUtByn2(Spmu49iX&`Ul`4rA@nDUd#-bb&9Jz}d6BTrUQ z{!S5rJaC{`;?E)oU#%~GkvsFloKS*bD5%IG11b?8%e}_-YalT7E*B=5(vrhOne1%* z>7o7GOak!BD3d(Rq+Jm?09)LOO>a-ExJ>~=bPKp@*?qn+K2%~fp%I~YB`JSKeYh1w67QCs4PaaY+(B0b#(K1dPP*i zARgDQw);DJNIslQB=TTI2=|UEjV0&;3i$Fh8wvz32BqrS`XN+f9?!dhE?7>K7UKtk z9b59yM3QX$cr)yXix5`!XH5Oyiebgjm)y;ib~j}Cg68(B+z^&PdT);6F@U?&POFSx zdejRc%aW7zrxPX<2y3!|Hk~e1%K!IEpKF6_?EN5Mvz@#-3&r$63kqE$^yK8EZT_v> z8)VMz&XGrVFjppjPUC$cGJ0fk&r6|&F0F#2Y`!RV1%a|VqDqEM-obDh@5MJ?)Np;% zBu(o;sP%bCcG~Z^&{IX_mS3A70lgV6AG}AZFF5nKU-iewNOy%|XujQC+Rn*E1quV_n2>Xk?T=BMjc2SG`O_$}4($-VP zb$LthOOnsE(&dEUCSN|Fmfd9D%TCy<_O~Biv84aiS$1N~Qw&)lc)@+Sk`QT|p7)52 zY!KA#r3SsJvBY2b6qVC|Nw%nwmbfI|T<8&}{zS`?L%P(42@B4_l*r`c8w*hyZ-fPM zqI-jT%DmZPb$2HDQYH~=89^vLl`n{>>lH!XpQOCFZwxAi5#yJtgM~>MYC-kYy~bgN zc}DGz3MxBw+BtIA@7ueon3q*6FSag&5AE%Uq6UXBtK{c*;^DuA0Y8nupGio{H+;W_ z9h`r{;o`68Vp@b1kLLLL&xR&zpMh=)Gnt8vNu(($8&`HsYwXx^j;)L6db#L}<6QM2 zk+-Iql-Xjt&ve|WY7NZ5+p(ljIOQn{VNPAS;hkT8ub{Xzh%Q(TlO2XOCwLrH{y~S= zneZA~MT?_0%!^aa<{K8vIv=(^HK!OEJs@pxHPyGBMGDJjb<>vgoY1_f-=#3ZumEM{ zQB0^vB|R1JuJ}3x#BcvDcL0qY?QL<+pfBOMHYSA64a`~k(RW2gC!o%f6)J4Hf1E}t z#r~H!zu3`?)_9>ZkRjwC^JqOV{A1#LYd&df_aYG6$oxJ z*qDTmX$`gsm6>P4W)ZDgMjn>)1#7(M-b5=jO`atZ@=M<`T7tetHF8#(dc1|-+%L48!vXV6 zHN-rZVUkD|4`VMv#@^R{>5vKp9q;Ps5`K|b(g{Ub{r_g(*wgkC&y@#PvI5-KkTyoz zDS?vx=feB3S?!!oQ>IvM3OE&o>*#IHY7=p%0Rx#QSOyc6|D?QyDhY*MgsoaSJJgmr zUOJ1;;`33jd$podKG^Sf)ouBe>uhdE!QTf-Dz!pMa%?S+ieAHtYU{jU=UstC0L9A}lYQ)=noNGWxkKGqwy(t?;6CDpZxmY7~o9s~qXF z)DvT}RpyD)8`PO09>X7ctfC>+mCxvMdnz55aG@J0NhW9DqL5(xL%J68b3!{0_*5`| z|1{{Sq$kJle^*i`9J#}x8@IEmINqc(8(teANjN;RS zk7mwO3`zFbGU|jXpw?9`$Ls$d^{RX|J<7L1Yt{4_l}+e&Ga^bAl2JP5a>t~CgjQ9l zQGF*Fm7(J6o`y=RhJv!yE%UY+CAV#lXv zRP)wNo(AKA_)kAwJB3e(cQIRiQzk4)6 zcxv&$vrfKY>B+OZ)Qpc&$55yimhPe_yNDFr@k^6TUupj4 zS~92YTPCp}6TL{RTk}3WrUBpi54H=Z1Lf6U$GPhfXJ)mUc=NXS-!|`6VB7ZkHz(jh zJmUW*$?qsVvah)|JabprDVtU1Bm{`YOouF`F{3j~_IfOf ztduZowhM^$1}i>c&9hVv*jpeOO7&_&66i)r)DuPdy5%G{WeqB`UrwPULF7I+PNncg zDU_;naW4U%>ypvhNkbBh17h5w;H+Jr@7CI%^lLrSIisE|Yj|N~m517IesJuvTb?=E z#pT{VwMs-GO#$sIZSl{OhA!ptc#yqL7Xz+z65MvB&kX9ASvVtY;^CKJg)#~Lr|RtX zC9{IMiOOEwyOw5n*onQb+uYZjO)J=jRO@>@CUORTqiJ9Hl zGI#T0u}A5@7sP2do9vA?Rqv$ZbA-~&wCSV-6487}z;8X0ZCYW?1-x=oiN_1I_Z34J zmK?;_O9vr;t*?;h9pv^J0}X4>(>F(ER<$>90CDrp`#x&7U5c?Aup#^{`6MWAPm(xz zz)DwDst77jT1ypMnx%kD7Bo>3(_*GGYw?+xGIBQ}8J64k%KAutPj!?COGIu~M&I{ji;bs>|t%ztT@OQ?3qOgi3laW87tdZFwEmO<71CAnnU+vu0MEP!5j)1vEAfal zFTkVy-i>dvxD?4zv&6#O$7bys{O0Wsy}=2&Hra6xT@#nEax3Kkyr9XpfHM_*hfuBr zB0N#Q3!o~p@1nW)kH>nv-`8S}F^(IsBT~IyAv`V#{U}o-#^kHZWDSS>>y5`GQ>{Xm zW0?KvHmP8mOfl~3Rt+^^S>8R#Wd80U6TtQg8M5BTC?MhkZKQIH=0*Eqc~!xn{%)I| z%Ls7<>k2gTKCYCH-Mv<_!B8GX7p)m6t>GQr`^?*v05 z+91KoEWBD~%613a$B+i@{W8%aSlv1;GfuqT`grrtPze<;h{@&bPATg9w9UzTZ#vp` zrD9_hH$LkTzV@;rQH0_hu%1>iG6?f8Zk;0OB|@ zBGUF|;llbFCirM+f>D^Hl}F+wvN&dIukX;->96u25PN)kfOCgjKi8%8A$bSnJ0?^l zl^dbcIgB>Dr7oP3?s_VF6*}R(-NTl4w#f2)!EiNNNi^w=zVUJL znVa6uUUE!cops;h7Xq014cJO=?{50<97ue-nD4`*8T>^@C;;IlNqG#+LA!m788ZgI zoAxS%)<$qWjxF1ydoihYc4ez4)^b2klR8N%pE1WG@g(k9{AEeI02d6rXb@2wxAMb# zQ9@Ja+;|pmYm64^GQSN`O#N)%kb-YW4>H z3*Y?k0B+QZUIF$7Xa~2VLpnOA;veQtKa9br@Y$NK%|V#(iQ~6`Gj0+>D2cDtj<5`GL0ToNvX}{x0KVH!T4f3Jvu42F`EhWBhc30Fw=R0pY2Fc;X)Ro<)pS;DfCpul( ztvtDNr@z{|7IL0;NU$YmF0Ad+F1Tg__UeAv>sbme$b;Gvw z*l@{y69xR)oZ^yg3p*?{o*l?yl^-XQWH095sCzgOu2*-?K)9-paoPs^MFs0(WqWmBmt2!v-tgHNv zpsJ6oWAf);1xZ&NwpWEuo$30@BHkc)$$A0Q`asfhd>Q%B_88js@4ao{!^RFfL7pUP z>*r49hMb)%ZI3qVh$GlM&tW@f=xs-o-u#HU0lfgQ@0hC{K5ph1`;@3{o0CXIb!FLR z3E^qqUo5hP0ag#h{=D6i$x=qpYDhTV?d`HACwPk$Dkmy{8(O72?H+Frv6H_|_8Z5puY~h@M zL=+J-RyO)xy;qba4Ikz4j(^+LV{qxPV4!jKY0jgl!DsHw8qC_g>`()~Q>0(#`3WS* zMh)`$-bO@p3Qm6;-X<4#CIKWy@9wx6zYVM=3RW0WHltO;J?`SaPGc{jA=PE_Cmf&= z>Z&XU&b+A_a(6T*+lX_S`&N*->ij0CsL$s*IV#TLBCI%e0CWNxl67;0Vqe7Wveuh<;?|HeJO<$5)BT zB2xwFx8^ARW0x$wdzo12WSNUE+PuVpd5~UM9pP&LAqhd=v#857TGQdiON5Sq!hq<8 ziELd#kReHb0FQ$L%Y`7Wt{aITq`b;raIrhfV;_t3jcA4A$QwnRhs49#Yn|zJS9<<3 z74>QHz}U34FW>SD4TamzX!S*C^<}den@PYpcw$(D?O}4|?~c$N8{=!Cg0dtBjZgH< zx>U?QYQ0Et^#e!2@EsZQYa#^OxfdjlTrT+(##QEXhZ{dP$KXStLK^lbHv@G#C)3}@ zdN9JP@vs9PJj>5hMA;i4(;qy^P#eMltmb=M_k3&q*BGBIH zHep3bgNnL(rF<>tbHv6vRs*kGKQbgbIiM?4r1V_k{iE!KS=b>OsJ%8IJ5&-Dbm!G} z%Jo78?r~TXj~I*<3N1M<4W5KXahAzPE^spHdnG*+FA`67 zjJ_sJnoy=yIqBqukZjin=^S;GetT-^U|Qhp0HR=*$*LGx63i;dathEM<*!3Y|U-BtNP}=t^2GF!>c+sQ{}{)R;@TDIT)E`)V$W zk-HN-pbAvNX1zDZmzFH5$c6tdHnUlbRC5C&dSMdNzk-w#GdZd6PdPqv%@A3Z9Qn4K zN=PU~dRFa9nF5HBt`$i2VU5P5xo%o&}Tq^XAk!@;7 zhnvSh4LBR}kS9$5MHz+5fQX^Jry)UGn>W%Vz4#y_H-lE1f=+h3Keori@GshFuk5i} z>A*~T!sw(X%P)s4{s5L$?<p5yL7VA{tVbRBWXL0?N*9s<$GZ87or@WXOs~^{@a7Mw9V5i zBkGF^$2Q97yiz&x^gkGZ`Q?%o?q(4VdXHO2*Ez%>h;Tl~b=$#xX<0j{7wi06u+Jl> z@y7*g>`XtcI&Ny%R9T5dG{qZNF2ht|_=kN(%4g+yPS+~hvLjw89-=$= z6se)g_QGly#P1eNj*s9=`H~l6g9jJ1=+(P+TWb00P;x>dtASW5>(m8MXd{G%Nao3Z zIxoK(a@bixQ=rv^JGpMD^B*otdeLuRY3C-&0#2Urz-w<;q1-;Wu2Hs;(orL6U(4%@ zbz)|WMhu3#e)Ww&TfZ)OZ7ulV zMfx%3ecgv8M>4a`?nay1q}_P(Fmu`$vT!tqFo|7zXG1tYwTuBN0Qcm2;d@&wwS&b%QMbp@+7$COBy z#x&n9n6zoMt}TKm;Q`N7{L3|D_Tz;Nuu$r3wHqUv9&}T*QoGOhi2;@Y@=K^^Qg}5< zxmKlCfdZFBNl9;v4Aw9qf71Dxqe1&A4t)(c3(X|I@t1%9t(tr1PCIi9h|qX{>D(dV zeCx{FoscdsaQY&vdQ4{BMx6uNiSl?OtqFjzHW;^HNBXSB?T#i4x~op55f?pA0p43!CxEx(tngT*xp5B&ly#6C0jV0Iq& zfBEMDOj-D0uo8bTE^4w=PLBXDeB%xs!gVC^LNqW19mMafKArMYS^{Em79pU_#=zy( zQztTk3ZqlRSt5)7mBes#tqA=wgc}1*g9RzH7}e-#{3$&RJdL(EeCFhe8NK<|{_NTH zw2BeJJT5)ws=!RQ;Ks6a#=g+U8KxdFQh(ZfX|uLFK<3>m!j-W#0=Zz>dvdIay<}(h z=R|2Iu!4%+DwOc7ZfG{%*By@A_k=vI6pvJ|XUG|Xhv*d&xp+Jj08_8Z1)4i%v^mId zsX&+ue#im>;SkF7vwd{{?ceH&ZYP`?*hn~mtdV4HUcEACg4!p-1q^5~g9sn8q&aBy zHE=@>_+W8_LIOohA0sPQo%8_9ldo5;g$}s_1{0G0ISTv)=pt<+zo$0}N_PhuNTOM$ zUuKj<^Ht~O9ntom+?IJ5X10K6hhT;ZJ!%&}u`1NvZb$BdFm*gKc+9#?**Y zcg`Yuu2kx>#S^51GB;TbzCd$Xsg{_kWHhZ#WC_B{Ksq=M+_gV=Kigrj{)&%~etwA9 zVr$llqFpPhKTM8g;!V3(y|8?D=;f|{bXT|--OwID&LH7l;geVES6)}HHW7*xEaCIa zHr%8u2(o4lbX@VUGJ&*q$sB(jlJBp3yG-qIT2S&swMIQf_Aw2DKMXq0GcX6k+di?5 z9~?^W>U>Wk9OZrkZa>XHra9GsS=+^}%9K#egS~mis&IUee_;*l*Mu*&fWmr>EM{xM zZo03T3d#C-lLmEh!1Kq-{vQ&|3hp%sNe_i-z`UTEV!M8Jopl>L`KeS zsq=H1AxhZhV zVui1wD+LQXdL8>YwoD69OvklMqP6Tm3EN8TZFw+5gmXPMZpYq>A}LxnA~V@4lm4=(eT8agMk{3WDmbi%7*F zhu#il=%>RfBBuo6i!8dj09$l`VhY8>d$19`rd?na!4QoC1antY_cK6xKyE`dZ}I zUp$^w^nrUqOL182gmW+UHD*1W_ZQtly_&3F*a9^Rba6-_i(hetl0>yXLb=uNE<3`2 z?m`RD8Vq5>%nIOUoRo>L!>>&?Cgv&OA_4e~N3?Xcevi<)?HRNQc&fNg0pjNI)jaZ% zF01hswc-(!IeL16{Db}$33Qy-Mg|Z%d~es zhzeFNafs@b%B|O9AQL-@Nl7IUkuarYu~CSut*M*fnI^<_)`<=^$4_~G zft+50{)(p?i;zMBn@w3Lk?B#z{p(TkPbsyQ@pcg;zEsoGtvb0h*KowBl&0>@fmI}y zZr;?X_}tg|UTi#OSt(rhw*FVDG2PINk#^DE!I9f^UFi>w5y#k)?$YQ&vDwX}L$;xL zZa2ILM_O6m((Ko8zk1ctM{zrDbn!D$$2mIP6zrc;>&Y84`Ba(3kv?1I=9r1S(#D?( z*ai#Zl=>Kf4r6KYOK&S{Cy|VRZTKyC*3RuwA*89$!YT)y z?iyb<`bCxM7njcyRHIB60ri@4kK7~I`1DCL$l$B{@t#e;T5gxs7=O!LI(RW-z^DAM zD}tKEpL|Ze@lu!nf@1H|Dq~ws@}&8RAu%+kN_9j+m?^_n>v!wDDjD@wh*(JbM*4_T zL(st?a^JvtupnuR%5}%?_eU!Ce0zkU0%iLnN)m z*!rE1b*hIFs!rkU5CK9D!3yUwAfkqZBwwRl0JFSYmm+X7c{6EbVq8Sr%&?P#fh9gU z=k!~T1HozqWc{-D5BLjb$=XP;TRuN<@6(nP+#aD=#90jQZga}3@dq1v)C~-d_(sd` zaa8grA#w|GT$ZlPSM9lW>`-i9w99f_ieubFN&NdW3})lMNyiFy_rO&A4lQfGD(Z$c zWq8102z(&p&t>`DgKbycNUF~;dNI`LG-_{}oBQ3$fxb}eHCKZ?6cfeTZXV3*`TPmn z`9V&m0L!(X)=&o@s$F$hTFOMW2e20-567huC7k@svA~aP>40hw=F#k4hm4J*9ZANB z-db)KH@jbsz`K7gb2wTDh~DG7HpZ}b3&AH?xzizwM6Wj#e|`4X3kt3!6lRKc{Sy|` z?Wm$1C#j*6H$*0;(H!>UGVGVwK%6+n^6_#{L)|zmLkJMfQ4jL7qGUFWA!ynq;{4;Ey4Jk%TB_}l^F4QVy5gZg@ z1F!+?%)`tSigU}I*X1E!?!sTU?I4X5k67wtHOTlv2`p0d^;YokTXXuOe&a+!+>Qic z{C)Ys1D2Jgdowb_jx#BCG!ZDLhxh0<1%ICxIS-3lc_!WR)bc5(K- zJ;H62$z{VW%*=Q`ECbzsg^hc(|3c50;ko2XZU3a_ zy`rQCUL@$?j>P9>Uf6U0r3;6{>SOr1FVj2S2X>n$#X(Ye6VxaAV0-<+N`4F2_(;$> zH0yYX+yTt3T>99d?dR|Jj>E3aXD@mdEj7JvFJ`Fk%FozI*MZa9`kYHzWJ#!{Bh$u5 zGN@DeF~5(k`7AA|28)6VAH_6mY~~n@h9H%0KBx{E;)k zOuSi~gu3K{J1g;Etuoiq56i$Sn_AN^J5Db3T zVRt@gq%qv5t&EVbF^PvY?n=wJ{J%yapJNk*X{RAyd;F}?Q6u{pq}5pEI>7==QS3e4 z!5o87k|Hf1z|mY3j)`dxez@sY24wN_9wyRtu8S>%Eu=q@|8Up+FL@D zP(K0a4cjlCYtyu3!z>qO&P(!m+&2|0(!3}>QjILr6f6~w)r-W|J{g&3J1Yv~^IB=v!=j3>E7D<0a^IDzXnB&|qz+kvcO?ImF+Pf!y|$q`In0DEovdAkMHiZSYx_GAaK|hiGar6u6`3qoV2? z2$inX7+Tu2at#MqP^lHlfW*3!7w{pn0-H~|#%y*lj;HSGQZ_D+7xR*M zq*g8}jYS1R$>=$0DZ?RvNVWIHYkE4Kg`OmA1Dwi!3Fj_{*YOit5N~xT<8&`}-Z_>! z>r-(TmYv`3D7h0i%gml}f%ooec7jVHRS((1 z7p}@?vt6&Q>MT2eTw+lCT6q9#f`bae5N=EuvB%gs@N48? zU3?{zh3EEyBm$hJbSOj)#M|@Uq=#pf^IWBZ$F}iue7u<-6mvxRaEBGz$PVQ3@(a?5 zZHcYLM5G(QVA2FvZqK=qwbD5k6|T82s+zu{3wgWsV3P_5S#nSQl|~Y=qd?Lul`6^hsbgUuNk!eH6g7``z_<%bTu4> zGw0$X)I+TgjO5~)1{*a5qAdZ7;pYOVOW;~{%M~;qt_#7b;i^xnk!k2SS9JM95fz)# z6`Af;#^FRez{d)uxjsA0crRiMykDd@Ljr!0dm85)-HD4G91kbJYx52)fHxzG_HWxz z|2vsYMp6cY`iBja;ywEcTQiELTA_L;bPy$7W=0r{A;FI1*PQYVOFvo)%g*r5Si0Pw2>W1P7M0W*Q1!Kb{Oh2n z4p+r=s-b8(!}#$Qio!RiA;Oxs7>okN(9bH3VVY)K#o5RkfLRFAA(&u@iuR1pS}nj& zwYG-*&u+MHNiYQlPP(r4IkdJEWe^fU_PRySyPDVzsRrtjLME~L-(D2FNqAPTS%-!Z zlv#QmG9YHTm|h&_N4UD0EP@MBmI!qMO{5qDOjV-Zw3y>^Xs;k|6hP^zY4HIlMdYaz!RUuAQ8i5BPfoivp1%ZL$5=Xrx7(8goOCFzCrwsqliaKB zc<}7CaH5%}a%A>h(RQg5Y38 z*93wJ>>}5Xb8|4sleqXW27U28jxgM1fovTCGF4!md;}Hb4N_WMLI3_Q&)P+Cwep+; z#`ms6C|__L_e2@{U*>jZysfIM#TB%Eg+i_CIr%^S#OAD!Q~dd}loKjWI6=DZq(Nyf z`ohvsoluLQzUyRvx9uQ$E8;q9@4BXK?(6(nFjOJj5$}gk?Pa#(2fAQ0=_2bwJ%81g zYUsR%7?@P^ntPSxm4yr2l!f)v>7>-ykQZpq%Xs)gAAs2<$W&6@3Liagm@9;5P?mg&5 zU9V5`K8@CI`4xbWRVzf<3wCVVpT1f5^}@>$?g|AzDMT-T^Lso*bjHVZBD*7+7Xk)6 zfFxj!5@;w+|8{vO$!g4~Vz|D`1yQ^GztMJ2L862~o1ojaZQHhO+qT`OZQJ%~+qP}n zw&u(~bFmZq?;v9KvZAi4A}Zpm%zX3dGkf{U+dfm3EZBm_zs_;e$9)Z(J^XXZ$*KFg zn0IJ>y}7WRE4N%_T1nxrKT2T)4n4@q>x{mmPV&g$#w?Q#o|KySYzxGZwjAIzS4@a5tC<3DB}5_}|G7vj+3QSP(9 z0u|h9&KR@8<&^d0XY2 z9lC^0Y>jH z5cqw;TWtF5xmJg80aR}EA77#dSsu;+NO5^nWXw}vfOd; z5?c%{#wZ3x1jxXMKlEe9Yk<9ktv+ro1)J^(wGv8d_!6l1K{z=ZrZB(~RC1OxJ)xz% zPXjU<6DgdiZn0GuxM|iKRm^FIz>YgcPFcK)3D0wGX9ss<)LCjs(m)NQeTa zv#A+9h9s2O(AkHXU5Y#|n?)Tm&;i!4ysFDe>qF!0!5PC3&v<9b5xVN@NSL!iftGKn8*! z_ixyE@d%kBsBHrX8B1O&9GM4mb4HqA*$+-=GO-*ZE9S|*N z%!z!U`Jz3mW$9TrClJ?PI(sAEcBz1jt~Bf8KAj$w;Q-lFo{MUQU`nX z0jt9_*W@7u5}+d0j6iTfevBI_qfMz`JP!QzW}KW^L$(VyBPQHk8#`t335oUurh3tK zKJ4V(G#Q4^AGLEj5zMVupnR!mRMq7V=?2cX2a1UsuVnTy#|^y^`a4kUVT}DjpC)FZ znWz_U{T9|`qFCEt)Eph2)n*T#l;5>eQ&46BtSJ>|23y=GQ>pz2h`+IbBO^t_D~Tz{w$n5HE87-O_u9 zhXSehZx8Vnwz5x4t~H&Rw=oHB@=Syurz_6{<2KkzZlGkd;*J= z;jVI}gun*YIDf()UFzC6lZ;v`@O-QDID@y5@5{{1a=DfFgAz5Gz4K1Pf0QTz+Om~I zyUL5%B~E6bny(8wNJeBrF~&0=KwTVF1G_ytb;E|M*7_Jev-_!^qC_oyx6Td%(0qXf zjA{OLBCn8LSu?yToleGkl)aZ9l5ZsMmd6-E7<16jq6JnuCd^q=rpKKV%m^c<%)M2x z)OJu2o*R46PXV3^^3?cHJ7_a32G9~=usr4Zk{?S`qK#lg=_lUNXe{=>H!OKb_lTl= zA9m`pW;TfF`Z&1mnNofA@yf&dyzt%P0%zTnSZjF=z2h|qPwRpG86hPB&EALi7eCU7 zH)xedo1t`fGwB_(>o&0V)&66D5R*4R9Ycs1WFA4+?~HKN*`f8?Ueh7+?vsa592##5U+<8I`}gMZU$) zTh{l{Hfq9<9C(Bj$3&i92xJ^2&9p^}XA8yr^?D6Ru1oX1Z*8PZWxYcyEYt139&6m* zZ`OZ7FaW614P^h*Cdz+GKC}GaBcJ~lO%z7X|3*Tqs4x;R{dfPFkMIA?>|pty_ErA3 z$mf6Uq5okSSho7Q61F6o?M(l#WLmx z4!}X~3?9%y#4rb;=;Qt;x6!Cb)eLARClA62Q@aD+eZ{;xPlU=e3t` ze9v60cjPxV?@-T}a4o4qS3PI7mRc8=sJKy$oKq_+A8ZWT59{z7BA2Ln!Y6dY^j;Qb zWVz_}ACQx`SecE=@{=NfRjw}|Wcz}e9jBTX^HczFP z;+?2$o5*AN>sqYwVjKo8>g&%qj2!9A+%UM&TgoJi=7#{_A#x`;t+9_HJ#a?T{mL%i z#DEHCp>2Z!{D?#d=v~0*^H?LKrb*prAxQ8D^#uMSat(XfIYR4L=N$9jrmr=f9JVMx z$X4od?<}^ZpvlukB`GEEE@CAmp{a-BX})6mm{~b*k$p-VD?G+D8rCq8>k18xL8w1m zw$GK1(4$f4Mr3)6786h~I&L)soKS%a^KOH@DM)zd;>+5cXCew6D4K$fH^D}0^WxHf zuI$I88&YdkRvDKeY7X`Zhd9^y;9R_C=P}04lI76s9Zeicn`t=@jaSVF1FQq1%$5m% z3d0-Wu|?nAuB4*8yz45k%;>~`N>|=DV~>brT5(_u&v>O`Q;xdt_qBI$J9bRfDv zh)0ZYfavhlS**#7cQxttqVkI)E}ZBo_5`KKXObjMvDTsB3D}OE{2}CQxXD6uZT9yp z!oSiw)50_%23Sdjg^{L6jG(A5GQUrVu8FB#{0Vx~D>;cwU;`VWmC2J=)!qZ$8rM4d zik*LwW{A+BIq_Iys)TutyiDjEWZ8`Bc?Y z3q1>!2(jV7`AauAJ%t!shpAmf!3@UTP|PQVM7Fz55Yu8k6_(&ulH{hd80(YzRPtd9 z>DahwBae8$@W&8{L!-|jOT#Yx48=5)xUD){9rs#?89;{32jFi?P{Dj6-Sv`Lb`L-m zJ~D=4t82AMmoY15xmff5baW44jm%vlsK_hl!ij}gXN2g#yld{)u_d|+Qy`4GaD3RG zTBlx_Jn7t!pTw_XC$G`vmzonbF&LxIKl+i$7{3B`?Az=#46CvLfELm40o4Faj?O0E zvmh4);{Z>UhO%aV2WT2Bu-R+K%iD;RJj3==RHX!iC3@RAP{Bvj4vr@eqZV7uKLS24 zmM@u^+49Wawn9*7hJuqA1Ds_f)j8jO8z~)pf5TeuQ!HtvyA~ccV;>uuD6n*#)z(CJ ze!48bzTLDX_b3X#d+}#rA1#`dv7=ll^wKHN34*SMb`v8^>)Cl81V`)HgvmLc@qYc6 zSW>lPy^X_MBxavB#D0JNNDp!133*=^a3N(X+HUL&hE@qlIRfqC^Us&=o}EBP;}5<+ z0PDR~m7*B;Q)X1Fk1b^n;0KQW_)6;AN&`=0xR1PH*T;kkZfI^f%fsvy5`(InHcMS@iOV4U#s|=-VstKJycRIdQqKx_ZOH9 zP4>-ca#dZkeG*a&Z>SPmZqB2{sHsYVI`!KGrF#4B{7f_7of;oRKv0v4uhw=+vB{Y7AlD_I)M$t_4KSt9xlsWI&_=C4R zi>w})55knjOYA%KYIW>1?cSJ`+Q0F`^A5@Yv|1=In11n)IqjBO_qrjBHZRSaa zDUKLbeeHsol);j>%Az+`x#w{kqw1zClJ#!%23jYTa;~jVUim?Jet{%gRKddd?5e}2 zs+uIfas>?Ix@gk^3*LYgjKhaJAn8XSwoCJ}qK`T*y&i!ZicZlUaay^t;R9vOy93*{ ztdzoX&$x(5V{IKZQKnCri#@6cVzT(bP)tB?83 z!jSEylgYpOGh-iuNngM$;WI0tZN-&~+Qjy&(W9bmoe#(#cQ?k2{GP%67!cj&Ons-+ zc^g1?_^!;ePm++q88FgJQ6DJ~muiL<5@KRVNZa6oZ!NVD3s5AU#Jfx;^X+mJ$0I@n zFjc&cM+P#H$>@2hryV>>&>FlQ>IBX=dmXBVX4hhT1-1~C1>gjO;%gbAkz1yT7%7xkh%diY6EF3Y z`=NQBD@)6nlHoZLEQ8hHJync`r#ipKCw_3{R;3dv>@|;<=5$GlTuALPZcyr?1(U6k ztSL9m>8{$B>}k3N$3tUW5;i+P46oM!wO|zHA7t3|OX4?weD2bsZj(0T-bvDuU1F*U zj`fK|M+8%pl7oz(OI=gIrWYS`OXNDb$Es8bL<&kQJlY{V46BAe8^3-ob=-~3FbYAg(SMd^Z?^X4STbm#d(IQRnOQi#lsXW z1$O&5jv#!d1K$BN^Kc|a2uL8T;6O+W#?)Pe=qmptV~=>^MH1O_7~`=BRH^tErG=AA zrs-=v4!GoXXIno^{X**09+thM&0Mhir~%Ha@NoFnK|+~^L>fLZYR-=gPY?sw z`?WCIyK8r}z&0~^#(x3wl6$S}w!`dBkV`4>11H0J7@Eu3Huqe+RZn>^R54DoWK-Pn z`T*Y9gomBHhGU*;ql{zgB6HH`-{vb=4M$JtmL!B`$KjO-g6Y4UFoh5hlXP_B1Gg47 zSmZfoHIY(c5q}90OEsOaa>Q$t)@WXD2A&wn+nUy?2cQ8cuAp{;ITcXW3^)+H2boSX zMt4%hcG138B8*U@pfi5MTNIM(uwxw%8HD6l9=s(D61Z)4JQG`<+Q~~@g6_-jt*jrc z^iQi>xo_$0rY2d^Vr;vcVO$omsw%X%xb&@6RQ?==%u5yfUMKFjWOe&CwD9iy`$sQ- z3>BVM#f9V$f-z5#_|X1?3BboL7IJ^xjVEoJ#*JBGC9AOOpr@-^gGZ?{C+UIoywQJ| z{)EP%uAOZ%k$7p-&3cQ)*ceGP+jlv8c3X;m6S4rM=HP9e@7D$N@Qu31jsOKDJz+?B z79k0%X)MMM@)g>pio=}_jA|u;>1fJwPLp>-9ev^%0(knC_%v_?{P#0aB6)1DBNPwh zaK>0>$TsRiUPl4=@+=!wE@pnAb97Q%Xv#0&kM5pxu)h11V$vAvtKH2g56$V`CnPLp zRgaPrH%ABf?E3~t-^k5w7avol@{CWg)Ex#E0 zT3=@^h811=lIRgyS|~K<C)#o7$ z4C)y|)-OJypiE5$+BFS%g7n9e%*DQ<9pD58ay0}c2DwmyL zfwGxZWmMrsqT^L_z6zc?ecSGOyvbY+9QG@DJtM3*Q#nVsk{P{Zmn~<0FyJ#cwLT!t z1`Xf8SCm-uJzC%;x150eLA7fCgcKN<_g+_W5Weg z%r(DYtC25|p7C(PxvA~*3KklOyx$DG_apbq+r$Z!_+eWDLNP52ZDL$MZQCfPDQpZ6 z?SFZ$A~oU<+8J>9D=Kk8boVG%6EAX>vA=ZfE>$cuEvDW>O`(-QM)uy}g zn^h6jUnfIe!v2o5Eu2Y|I{hs(wA@1}fuAy6g!nc<{1lY%6e4hBtk$lLqx&aL1@OS0 zgZ-lVL^;`?luBwrX|{%A(hO;ML1fXG2rZ3vuIYQsG3=1KXO$NKjS>TrH0J78%)JcJuz@%U^; z@`^KCjQ}?IF()V!;R1$MuP9Q=uuB3ufxzwK3sYSbEVI!aGSbxk@St{f>b9ax99zoF zzIi-BX01>Q_deN?q>V_>YNm)Z_}c4)6Qj4?M<{Qx#=&Nt+}0T)nl&Q!&D{fM5Ws>2 zp4kG*)FCw>6&C{ml4fAUc80O82oN7M1Rk!rSSRm`-aOGt!4pv1#A_w&QKNTcc*)I_iahMb-uJ)cn9D+CTd_n3k>cU#hO?4hm!2zFFnDOA$|9ur_ zhCH+%Mq;<^`Da6W4HxTZ3=8lYdkLFUNj_3`%9>z#-Q0?`J71;$vRBicNm0tGRrvlq ze9f~pwaTUz9<8-sBW(%$MtWwk8O~Ns@Z8BA-u9J*ZDIZcu2VA^o1EqE5vi{m)*>#$ zDbIMzshSmh$Z8hG&FSqzR-hngx}jx=q2KRzkGypq^ZiP{jtKEF9OyZ7$m8l{%8^z& zzB~i2OR|~6zAjA@UlJ3-069pm=lQL#IQ$jgSOgWkZUK)Fa|pyl?S>oEliPTc7uzF2 z6p4-r7QC=q9Ge_aAtW)Mg*Zsfo4*EWTWwsIV4;KXgnWcFf;(fz7Fi?a8n)}_H?{s< z=$BH9^L{R>%vM$^oD(OJuk2=lqaZ!5d!xA%V9eo?%gme#N~@0R2n)8YiE9(%ar$-n zdB}`|h_UiTEz6?kA5$lFDbXh5CZ6PvEst|e1^lR2N1x3(t;c^cwop?&B5F;njH!FA zZ-muCY|HNOmIqJm=A5~;nE652YTSt3xSUU+|^DcR0pnIenapulYCUcZf;&OVnoqe}L%ME3Q zH13ErFN_TopYPYDMP<^0A}MHCR;GWmQ$G;VDm|AH0W6l%kmQ=^4b zpRQRl??Z*k2DP+WPxLE8CfHxe%|w zp}0jc{xI2ruqWCbfn;z8i{+_T1tT<;qmzQuME7+rt-`{)P`Hq^5;Wv>_~#LR zO7a9#FZ6G}sS(2_XMv!Vy~I0}twE(*zEk8G?9480w;(bDYJdkPRe68;S>ouXxh1aZ zsZm%k=%k(MHlXtRgTSvfC6G^-R~H_-He2Rykp zV_1<*;;IG{@^bsWn7*1kEbBaZQN-OOw`7u)HvL_GyG>iJnvl?~XsDFB5c-G3x>n27 znHKak)!zKcd2RneZ;vV(oP7flp`4Kw!ZUs#z` zG+-XDkO%$z17v+nNV-D6^{=XSezZ3H-H4-ZuZeG;mtAToWw^}LSMv#M?M~g2OD@i8 zb9Akg4CKE&lT+vjG3P29ICJI#wbzH-O;yX^w`M5TFS7TUG7GSbM|Ylak4b=t3D^n*%?vSk_s_oeS4A?f4Tf zUDd{)_lI4YcF6R}Q)F*B!X`NU_?ejV0KcA$lGlB@L%f*Fe;I)|)f=;{ySm?5s0BAH z5pT@+n|ZCx`2NV!$uHBNsKU;S@^(1w&gpqjQ2iE>WAtm}u9p zaxCG+!Zyg2fx$He&cTzgcjX&If;BOYc&LH-(h zVyOo$fn}FcS6sJ%`FUvmwk}+$6VwRO)ax{*q~rFgt`ln$X_!hGE2i;{z*w6~ohC1G z{ImI9-ekTVXK=-6FAIb1VJ+%{x~+?`KoD+eYx+|`@W3m0*5ou$w+6or#;SRLI82_&&RU zrS7{Yc`qUp4Z6goq3=IHAc6o z(3`=XEerSis(5j!D?9i?caoWE;ZAMCqQ~kp)6OHL!j?-EP&qn=HJB?#rfswC6jm;N zm3b>%e~TgeW|*dOeJfmD)C@@V03ao@i)k)G<`UhsgQ9_8o;hvJgU5P_TS~4I#vp1` zRWt}qJ}^6-cJzACL_Q%%D~mu0Iod|J7hAOPb9)2q0LE<}#w~Opp4$*ZSne8A4$nVC z%vhn@D`xl4FCE|=hGl3O(#*T%P-6t5)+4!W5)jO?;t$bSqol3vcGG| zDdK8rDND$afohOuTvCVvnIbP~p>@?u9Lk^;L{5sOfdc5Jwslei>Xu}oT_O_6p_uumBkv2@@t z-YqQ%VEcW&tvzUgPQ1czm;tdzTk@rzk}jEtOGrAWxsA_6x!(TX-ouy`+t*MsZ6b?b zSpVQFMnK%Kh5^kpV4G|u_pXnBOHuFPEh48WytIPx2Z)6Ktp2VLJzR2C{c&LWwiGz4d6mR?&S%QjV|v611&%rccnwu5X!f9iAo34M(r9dROsh(1gu=)udbfJrR{I1Klh9y^kl!NvBmM9~G2T zTqqVp_|5gu1_kN*oKnJsd^2^;q}}1UJI8z`F7G_EkAE1yt;}kkZsZp`=;@l-PZn+T z%&hS*;xqmkv%&CQ9>RIt?qeJJ@_ENfJr9!Q=Z|IkGl3HAzHRp?Ymrw@$_xiJ6<1*! zU*qPtC=exgJ$|wR7{)^{6xV=Jn@xdW8iNs*6*K=<=RPI|>ekNVb@_%b9j`0#obVYG z?vQI7IZQ%OAPwJjrO0I-drEu*>>u8R)slCQ>|El4Hm{J%Rla%hX1kovf5rrSV>DQ4 z9g&g{ZmswKZ5vaoT9^X134`8D!klbe4vgeT=u$WrRZF#=!Hul5ZJ(o5Y=ZTQp@T|X zCx9OzOlvBaosNTJ6*ryRYy7V12~}gsJV= ze}f8v{aFMd?hmW`h#4oqm62@unK--6hVfdGBNC4I(PaP$5sCuUz=83qkm=dYH=^X` z1<&yUI~b_#Yo8Vne5-W%IpGT5B(+53SFDf0Ngaa4RscjY9T`#^v0y=-3>~qEHf3eK zDuqQ=f7y)!G37|C0O>HxmcW_&R*v0Ne+)OBAk;kw`uj9jV@;2gXY4U zQ2kRE^G$;Gc6f6WidV^D-Bo zgXaUEI|}e>KBM-N;xH)@QK489Z=p3dO=&82otgt`?eBi1x+t%>%?m=WI@d@(7;Nv4 z^=vEn&Xq5Y7A!At-pa?BkO!H;sQtzy-8`=tVy0Nlnhi3Q&0M!UvHt|`$+&RuSU15+ zzfn^4#Plz5Ft7v88OUiuXrqijUm14Lw_n!us^9SDo-qGxx>qMwXg)NTGWME!sIQl& zkqP>*S$8C-XP6Rmh>lZ5f8GexzBAV7R$nH>j|c|ZpIVu;1#95!veG)xGJI=JL6d*G zfs_Mk%MAAjG=qB*Dw)enD+=^Yu+3*GVt=Rzx*`f^E!*X2EG zN$z;Rn`2lJmF2euqc$pcWf>2QY0T0Otpt)ltVu8&QXoei^!c?Hpj<*s507!!)@B&hXOIc>P59v(~K!4KeP9|V)UJaLq~4ihOgA`|hdk`x zn}aP}BbWP-g@Wi%Hf?DNJRJ%KxraOHbK2|U5LV7L(T&>x96AV+Fg;DUlEl5k;zmhJbRmb zM}8(f5@rYknQt!$!p)kS!AtV@c8=rrn;9J#|2wh&?sje)oNzU*DVP7OvJ3sF*(C zC+sSgT9U~sBOSd|hI$5wNKCD1J(w) zeD4AF=H`*q&HXW{Y~slgiRNF&OLq|im};zb6J`L4E{>4(^Lkk`WkdLAo&iugv3c+?bK~|R%+)J1&Dc~>7osC`Sqdu|x@nHxTQWgP;WA1dAk{u%oOC)(L^*4n8jv&<7?&@*G_@Ac6pjvEfC08nle z>B004gu%p%r1{7zs$XPHj~KA3ijesTpL`}Y4Lm^weD@CZ!R~Yw3A7pGIHJ3F2XET(DtSY|EpRrw6NRi+kMk$xGCTko0Ode^wnHB0Nj`cn%RUI;YhtTnN1eG>=?-L~ilQq{XLF zm6m=yXJLLBr6|qeD`bNWO_YcNvQFHH7fnr+9q@yFQ5I`y_2pI+(ye-C9%L~YLCSE| zq8Xm^k0%4!HWJVv#t<>g^zQjagP#-OM5sWMIvPPQIw5dFV~X4S2%-oRQsvn#iq06o zJ|%PUESuuo|VVV?^u% z$M6!J484t|mX_np`W5kj`c$1aJj$(y-UoUuEPjv*yAG||G|g)SF;njpcurXT2?_Hi$AC~YiKMD;;x6y@rqLti(m|Jq+qNwrqm_YB@dhEV70Ksbdb zab3tb3!39Zq>fqA+X7?PWm&%u&|3tg6 z#qzk$lvj3o4$)_5;ot{KRDw-RBEZz)f0&yHfuW(2AVQMb)g8CVpM{-QE=@;{J zLY-ML_yVqmnOZC?YHy~|QNkYV=Q9W1S=2xOBXR$*?}~o=T)f0zwg3R(&ckGNTQVEw zMXZXb_sFQXm@SkAuf^tz33uk`JgVRY#eU%cNT(M_5MQAb(aUJq5d-~TR8XJUfd!i; z@Sy17btJ7V3h4(Jj7$-mCHY>2=wGJhV=}Gyw?(i?c~HG3jQ(d3D(3pVg|oECBs=>h zCiUU$B99)t?rg!^B-}8HXIHp*;9t);ETUCPa~cg)U{5v16`s+r7aXk~0_03#Cm=3? z404*$RIE)(=}tK3f?Wb+ou`Q-Y^8YkFJkN)Sfj7e;h&n6r8{DsoYR#AlNAkWoAk<} zLGN}V;4?0x4bmCQ6gS~1ftYn--)@t477g+x3KV*skF{n-9*48};&Eo~CYGzwS4-LD zn&hfQLkDR4tBYhTVUV~8#2f>VA1M`LW84UUKb2EX1%s6X(h7{3<4EeHWZHzpOs;ia z2@xk{HfP3-+ z`Kg)_L85`ArI}^ml>zCv5|6lzfcT@e%`VHojQX~+w#JfgyuCtkht+!$r(-QL|FZ8v zlA%xxm;|hiDV~TLYj}a#gz>sBtM=}BH+<;hp(gld)TlPnrwgsOm$lGKy)|h9H4WhU zzKW#5XdtK?fN^?F|9}^}WAdeH-eBc=nC&G(Rub`N3Ou*s7M%O2)IrEX3WX~Ys{^W- zxC7!U)e%Xd&fvZ>3rPq2=P(b%1qRP0xe20bYgtb3oXYT%D!cg*DG^gtJ=ErF3J5A7 zAhGtX;&x*VF$e}gji%Ji>Fa+GF&4k9C8H=!)?8HT5*^-4Nin3}`}l1ED#q{goCApuLy*&SsjRA<_GIj+z&Pl(Dyjccx2D;LC&3-L$}Cbk7uDh3 zn~E(9dqD@J1XKR%Gu2o4MIvQsdPKD`aT9=g?zh81tNL z1?GRpx0F?rv@8#+rftPBV(HGO+&uSbyrgKF>!AS4rOnW;atXB5r&v?`Mz+u-0T)bFT{I zYwDMDmI`K|=wFYGOc`Q25dxS(+)6w}x?UA3*1O0?uib`84SPbbmbm0p0t)XKhpO{L z-C1eY>vhUT7F0sYO;VGJ(bnwdK)neHHp%$8lQi3GCB=2%nzYoy!t)jf3uuUn6T)nc zjCQDm-5PNg$OIdXIctw5!jSTp(Y^}1hmINvls8w84x`|NHwFS<+z#eFnC`@mhD%}G z9IirMA(3}*0cS=!O3}4C51j=Je1-U=y?MNfVQoG@DIww|&*dz*DurwhNvEm|0!E_E zFh#!*+piEeIRi6iD#4>612fGmDMJNo&dl;TDepY~=6(;NS-_fI~R=om`At-HMa(^aDQOdz8>l-@%Xz?`)b_D&1!I`l6PM=oLdK_vDz?s&N0*sxE+xsC8CWV)7@4Wc*E)gCyD(Sn28#qXYw>T%AQIYk5K5st(+v1{pm)>VC2xFX zxq*C>C93I%OgFg?^TvZ^yH4`LTYHL#exjyuwinIfc_grm$?KcQO6kt+j2zRQV7X>M z(^B0B^ETVg<{(pjCiRCa0O0Sfd|Sm6W7_T+N3Sf_Uil5`nS1)P& z5u@Z`MWS(0IBvKuf6`JFQTZEsIXfONULiu-X45~(J1?j@7F&Mx6@VuiqeI_R=wY=% zlYdSIXzF5VKBnkEYD4JLbG}u&5F~`&kn#3KO}55ynxbk(*JfD_%<@pEd>MvLuQz>j zv%31c?E8Y1cQj}TM}+u;_2b>@!x$iiX+8|{^|t}ZPgND{z=3JzCKG-2*TKBI2cke3 zB`}9ayELaaexptW+X4A2C@vyEdc@;qn6_Z-9820K9Dhw;il_&1nrf+q|Msxss;#u_ z7YhJEuVeYv^7#b$Tk9~2TI=xTv9Ldxj4^puS;;4?=@JiKx7~WXhWv?v#PbB;w zPJ>5HHtrmAabPbGDtmY{b8x>Bwqz!{j(dmXOBR=r^}Ks>4B$FocKFjT6MV-=w@8gH zfxG_5JkNeZH?fxkbaDQdgW1eEJXx-mq zcr*owV_<{mv=N!-(gp^8fl{%GL-C=m*F;T3WynP#M*vC$)*pJ(w$=1C!XDOKZzBl&GK%Ug!{Ohw-+pisNt+7>~RghwXqUk8p34fSqbh!}oytV?7!r7T&X?YhBL zU>0-#sn)l0i_{n<)9&edF`>imBzy8Tk>HeZ%~PS$s?SwgU!B{QowVzr_D$QV%P$9t zIr?rk{DhgoYc=)=BM2|0gv0{Ub#@?Ie0R40U&S~O~mzXLiWJc-kO$Fe^GY-+>h6j4(~H^ z4*;_PsvebWJ|V8BX;>c)KS+m4mforavhQ<;)%e35$l@P`+)Yfqx=&!I8;T^gFWHpz zQ^9{R&pymqDClH3Gt zf{l7d$TY?WIPk;Lxz16Y<&VFeU{##USwNHizL>gL6x1lYCp|VzuFIt%58@vp^d8Q! zRcFt4h#_y6EYB}GZrOSn(4QB9d#x$KAwGm%x8lCadF;ll5vA6=Z@r9|=F6S0s0~&& z`3}zegJJ*xjJk;aXZ3H^|5OHN{l6%K|9{rMg_-mj{%v03{0{;Ap9cOP7ys{sz<+nb z|KrC0Xfi}=0 zfcsjYLvLhD*cBBhq)B%5`k8aQ=C(5zKLB1OQ8@A4jJBWVdb@sJz0+R|N1fKz>Tj1T z>FVii>r|P~+S^O3R&2V@P88B$yL#8A{#cgS@mJc`cRNT=-qo#G>81>aXuEj4Y_4Yw zms%{X?_L|J+HBQA_J)Zb>o4+mI$&>!FL#EeaCw*Q(4@N7tC_<`m9AAb>U!7@!gu?K z_rBgBv^L4kbm-I2M{evQ`1NXkeZG+2ii`Sr;7i&6WN2;u+}pT_$I)*KAM>kptl2c{ zFL8?7p--mt`q(dR{1^(oJBE3m@y}romQhy29j=0{JUIR& z&xe(KE^6aAvG9Jn`|$g*ToC>Zv7~zZVoZMl$KB=&=RRxv<#nIjZYXN3*{GAuY<*?> z%3Un5lG#pN*x#*QAtbN9M%i3zg#A2wy46~J@{w16{Yp5r75egI*WTJpl_xvgHiW%a zy#2Duo2lb;PU;d|pp+nMQ?1h$Pyr)`BKmH;fzk~Pjwyr1t&PL5ijzS7T=h3v%r*>j z3zX%$j)>E6Y?IbgOud-Bhbiv-9UB9edeeb3w_Y#DoodpRfxIGdSq9WKew$)p*%{vJ zhGd`+2VjZyuoF>yxIb`nr`AWXx8Ij4`)Svx3G%dAjLzWixbt*^?B^MIq#VT`c?H|w zE8e%Om$Ml>Etq~lRE8o_7&inY=r~g8On)8C#RonqB;>`(6&C>IYKM|}juiZq{x|*| zm#FP3o1vZ*|LCX>@mP3QtJ!dp zZ6W1LK!>r)h(1Ehy++yA|UNCB8FROq6& zTb0`QPRADE(9%W&9DniAqz(v45ECBba0n2~d!W3K3c^}IBbo3N2Hdjwca~p~9J+Zz zsrf^e|CnRSCGu!RhH^0sAyp zE#=eQ@!aOI7W>u6l{57N`rR+7=XG)=tqAvUbN$aGl{5qng41FTQ3NJy0X zn53k%aGRY&Ru|>=SjHTq6<_1=<%)vE0QZrue@Z^cG3Lvp4bKkTGJA9--Rxd{+FySVs}_O zxld_T21pz&S%_Q!x3>f5QYRsHK3&@^*|$vjfs9*hAV^F4*fl0(pyYF@hP}E-3Eh$E za0bF((YVd%=1giTH^?~2m=#Ic*jww3w7G19BGdw9@-Qb$+axbE5rSI1Q<hDQ z*$H1%E7Fp%WH{FiaxzgztS)J&o@}uKUckR94~TFFZ)VP*BZYsO|IBeHyg`*2FC89- zsTouTeH;+$VTV&p2I&w9k76d-g)(sorM@VNsyS(R$*|($%d)1eNOp}=dGxYVt#~Sx z=%wQ90Yu-J(+kHGkf5e@AnSz7+yxe^WJjVTYrwe9u`AGxpJm8$RvLn9l_}-A@eJ=pR zJbESK30s~gW6O*#QJ!*qpg+gplE$qbhG~+hufa}yO=ctYFE-oBpEvWb4dPuWM5Bs? zM;&h5Z_Vey@zC^QXA$9i zY2Dy|rOd-^BizRfOvg@))7GRMVQI}+Xg}TPu-AgAQQOmYME2-ui%IDY7#(K-B(nI> zgByHO$8fQU_;C+_E_uAFNcjyr>~tZ9ldFfey4evj03oVa`W3~E>_w@{vXtWBK7gq? z>wWoPTBEH(_CMcXo3d^sFz2-yLlE2MX+8@;uiYtgFH5mPqq*E9w&^L$F;m8U)o9J! zyB*{PQ%_FHe{)3W`02x-yGJZgp5do>i2yVo+tL@%3)5Kx^3W$;QPu^YvCwYhXzkgA z+I~;Wh`{ujx{i*o@bn&qbXaLg=tPz-ZnZ8&HuCc0oWt2}<_J!$v18KL5Dm_O_E7CbcU(U5zW0M_GY9P&BaPV``8)>>;z{_FwdK+MBMODUR zR!**nTHQDFh|?A~S8Q)MJ<~RycYw*J?hhI7G;-qUXPT5XVzXFgvCh$H;KDp!OmE3k zE0e7bGdVAjdNeLy1y9Zm3ppc8=&tl1%PK!!5H2u!Z4|r$(WyWo-Y2QR;&hsJQ@S+E zg`0AS!HOuJ0mOBsn;k7+E5Xo2f+6sEAqio+>oa%5;OM&iiQv-nDz!N|WbRO{j*NPa z1QyZ2dHawdZ1J27M)IBdFRZ;&tSAAyWxH(eW!tv*vTfV8ZQHhO+qP}nyt{91(tVS^ zPfjQOSnrieWzKJo;T5fMK{Gftb6}aZ!w&a#?wEl<-e?A2&-L%$%M9QY*a6%t-h4tN zC#Pi)bAx&$fpC;)ciit24srTq+V-+<4{U~MF8|!e*1yLsrXMNbDhW^NACUfI2rGqx zzmX4^>$$>d#b z*I++O&Fx4^-dW)<J>&2P%9a=`p%YQjUu$X zCuKx4+*^X5Qe+P$rQvyk21MTvPQYY6oW~TEHW3{ay~T?!WGvtUmY?KQ9&k{{Oha$s z>GW+3*ssw-1|&C^k(7z4p3j`2+%{;td==9_}L*e;(!Ywv{9nH4}8M1=9E zVX-5fZAE0KUk>NpzY%6`v|Vcs%zc>_whqs*kB0ylM&85|FH2H!fgL4wQSDdCRQYra z5%y35-eh6cW6pWo(rqwzrIO6L3gU6#n(#0ZJ6(w^>HeBc^JVEP?9>fpCwUWlJQ!szIs-Ve=jPn*&GhT zdM>Hnkkk6%hChu7VDPI~!~tw=RQ5*w7VJ!q+{WseiG+SWl$^Cc1Y){AkI*BR`3@@aIfY%#<}UsoaoQ7!zQccM#n9ommbP44K}XW=%NHqP(CcK6w2?KD3L-bsx|s zRQ3B&ze|fEvUZl@!3@6p=|JIq)GtplZB!6^!vb-wnarp^M*-Fz@2Ff@1AVx!w{@1Q zzJjUBa_Pm>&Y8?a)LU_w0VTK)VSibA!MTQdut(yWBh+A5zK#mYpX4SG-V{imYm>Y+ z1B(W+X?m727bM~-HnA_HuoN;F-M=HP3CV6rL0L$9sHsg*DEa8|M4kc)?d5oImAKz4 zL!_O4ErtWqVUz{6Y|dqDw&(zMEd+uE@F;u5AN?FxJKdB?lDCDRS}A+=wGi-M6aPri zL8^P384hy{Cwg4G(o3V+CAMhKEVcwaP-_bGh7;0C+A0wT0=3`MLKLUAG$vriGQDdU zkBo6xm?n;`z;@D6rRm1fRt$mwO(pkP0v8-Dk_UGfp-aoSEaX;5Z~NMIvXx>uGA*+x zH$^Xj_cRMH@pv4nT&T+DgGrF7)a)cneo;}6>p(~Mu{MYj%lb&-EQKxS^tIJ2Vx?lfzVW5 zW0eOxS~C|(cbvL9PhOn5yj==e(J|Key(*an2d7QNd+;qqbo+P&{lwj@;vCnko$ioW zqzvROIsS$1TD7DH23Buj#nLTiYn{gQUf(}G@Q4QQE0#BMOs(;^pBzs!T=fvi zg@L&UnpyL59$N|0fM<7itIsS}H)^))O8DH-eM!Zh7KEg}dV0o2J-w&2T@6ujbxk); z7B>=3MZOzKzhdqf#`BfU;OOpf$|<&*GcCVwbuQ@+aL)o%Akb>IAx}qk=Tjhy(TT!I zDh9EbG}TJ1p%9()bV+dmQDEJ9C!4Y!yKjQ?$kOXzXo@=8q%awTMPt}|*qyTUde~4h zRyb%590S#2?@T2SHFhW+;?3nlbyYX|O1(Zj2?S`@D0?I=&sd>Z!u#tTMoasPtF5i= z^KqA|saB`6yLHgo$pv;HK%-kvAVwsdjfmKDSOQcm7XnY@>t>`AMSb4##q*)rWns6M z^Y;s#wFX{v^EEvljViJ6^}b!x1fON$!tyALStv1M6{?ogtjVe;S0>*n5*0amW6fh) z!sLS=GXPhu7*5vYVP>qc)Z5_lQ+i9G@GjaUIKU zrWa<$2z*}4r57^eaTh-08_c3m4C7?%KzcOq+AgUR+j#}4d;KQ+AHngoaKPgZOIg&y z(zY{vFAisr3(X0w7t0Mz7y5RWTpjKA_s+yh;wj{wTug8232>qAnJI4GU$uGfx#)z? zMpC0|JAupbTp=!%{wHr3-t`gtp{f?@ls0JEtT0&4! z+>8>qra`8m;ei|wmw^^2BegB^i+A9eOK2IFwHii6#C_u-BM!K(j(q2UkK+^ow?+t> z>NIU6X3}5QKA9O}4{GU_ZB#o8Q>kATb|8;Zeb6g}=(eVFfgtDnnfq|2fjV%_O!rYx z>J1T}Vk>Zpgb!87oO3Cew|L5Endwl-xd?uJ1iBYb7FC+;T)~1p8>x z=;qKtL2|rkG!eKrF|hYe+i1ijt%wo*)ScSTi_W!m^Cy%RjBFkY#u5IRQFm=}Sh$?m zfV*KLM@UiQ2|i>AFU|^}&9cI1o|qLrRQ#rjr*gwsHuyenp}J>BJd2}yp!C`%$3l?v zbk0I$S<|a#W~pgPk}FTx|A6AFu#_~mfl`)|?+MrI*BizXa|9*lLFmVGV8cH+SI09; zC3DK!XSd&!*mLV(R=0T0j>aoI+{EMp*KEsIj>uc*Tb|Kc6!fGA&B<7nYD~%r-U#h6=;PC0+g@jD5)x>Hy#>kel zX|M6jAul}_=^bX-vuW-?*eIsX*CNCTD8%4p=*QM^Mg3v13<0JwD8>$`()XObh?azQ zj3!4vjVFbTN7_$y60yk-=&qyz>wZOyt$ctcVe<7ec#jL!5DQ#_-;Ml=A$qzR55ut6 zfUy35UL;*swaGLd$&>50u7_#a2z=9Rt1xm*H;!|KthHi}U+)baX1VH%GNwsM zH*?J*Q|+8lGct5($im1dI*39TIU!S3Vr%iUFXYUpwt^#LeDEte*m5c&mNMGzQFm@; ze#m6u?(~;G)m_m{h2~UKdP+ZKT;tpYTE72w!jqW2oV6ShES>qGDDx0GCh)3t! z#qN(MRaxR`8ilbZNq=*3uSZwi329E50_lh=s0BPRh(toe#!a(Jdq(t|6^eN zA8pGl{}*k`|J%U&e;ZN%mnHzV|1yLAZyA|{^`8kq1j&0mT)uW{I6ezAT$*VbEI3X zl#=rGZf(K$-`JT^%JQMJX}1KDcJ%P|b+>{9fv7Xpsr&uVdm)Ls*Y7ql#_#~ zh4eur5Bq0vI{(EfXcCd#evEcsbew`#%0}ZCeJhz>_LWQ{$XlNU%OulH@Na@(HZ(_W zc-i?^X$iZ-?(Wy1p2Kvbk>Mz5l*UL!djVQ+-a%NS-P1~pZX{BkjUe;VOTRWfVDotfPC~XtPPT7N=d8)&bTS560rGUR0nVFsU zMPQ1<@Cdfwb%kzh+l&WcYYXKdI`%0sj6HH-{E^bx7f6%vnHdvP3nKDIMvY+NfDHfm z73k($&D*ePwSrp>-{a+aUw%LjE>6%&aKFWYi-j)Kb01s78+$<_gI@_JMh-ARlK)-KA9xLpMp?M=&FWl+0q2l+p+- zxd;Y01QQ-wd7~I!0bli}@F%g}&4{IGb1PP>m91IxqTf(aSk;>|yqDVsj?kbGvZ;sT z$WX?v(yF_gSa*b;pn@gFW4o8pFK%ir9>U-Xg8-?FE)+zmUBsNWkQsKR4KwYXY+g^0 z|MuykkDs$bgt>F+>O)u=WEJNAQ6}-Ncuda8OYNx&&kac?9Yc>>vXq(2`MRx_|8;szP@8A;NQF-A*dAtE2^fHw z`tup_8}n3`wy1vpurSzt`ohh!Sm#z6q!~8-KDe5HH&HSljzql&)uIG0K_@bh-mm7% zSrYoiurg|N2d|#?AwK+CAvpcq9`!}MbsAEVz>3tfm6E+M9v&GNr}L;u?6_aa`#i@F z@-g{*bW}KljO7n``F!*jY}!}yAQRA9 zILYx_4ALE$R}8m;zpA6Oiq?y=hl47LkY{tF zEi?*{Dqxm*iI}I(RlwY2aRmzcI>AsBxYf2GhSg8*U$HgW=XqhM85qug!z~ay4d#`X zhL`5Rfb7X%7cmc+gl5`AR=hkZZuYBy#R??r+z4)KiRleDAIXh8n$r@>$$T%XJ493^ zY<q7*5xku3rmmlvGj-}w4pGnxJO7l*@F=SS~-zq-bFm*#a&{kE{&iJ3mAuz z1-Te?BEVYHQpLB`Y{_yV9>sn_T+Ch+-wsh_97TG<)YU)#elcx4oHsZ&S6;fZ?{3`g zjhc(%XqktOY%+|@p@Yz?@U6Jf9chc!A59dEba_CLT}o}U)?=}9X(0~&US|hu^{(X4 z=%>YRrW6;{_gAI)ctEM$OWTtm28?;^=*M5k_5wHsHxG<5^q%4xQpIBAhO*srv*SYD zy1`l*IV0HIr3T6D>WAG3+3wDi_%gSQl$`J@{5VhS5t9IKmHo&gnYD}(jX!7z#bEe^^ z_COPM9d?L{?e^!Gt1r=&g_@i~M)hpn8CJ|i+cx)=vB&X8(YEWvO1K(nHtmk)B$^>e z{PW=VqU~ty+#OOs6!gTa1&(HDbnMXSuC8GU;H)fVH-rxfVIIrca4S;xjB7^m31#+l>d$)yf0k0E+ zlYp|LxUj^nXpe$I=B;tIz<%gn!-ymYk<&kEftC7$UDHOy0#!E0#np;@#e3o!WjJCI z1$|VsZ2I!cmNPL0%d8L5lDq~n3ZF(Re5BMd6(t800*;1Si6Vj*jL4D4-(K(O@T_UG zKaP;TZLp)m;o=S6*BGnBTJK#zNDh*e?~GjqJR&_0#BEkp1nM)uCHhz* zgBFTCjt3Or)k;HA6_r5`kA**DA6r2?s_E1-hNJgq#=xMPx;^miKL5*DpXg!&!4?Oz zqsbcz?h%^T2|m3PXH-${2rG^V%(0K=fYYn|#v<9zP9K?x;x%oGsxb za9`6BP2gA@gXRWP5aZxMkeSRMHb_s0YyWSy67WO&Ui1S3#-%Ksxy?*~I>1!`V&Dl_ zWxB6~K0?M6a)`kCn+bFhcS~6GDaoqXx51wYeL9v~&paNeE-m zPs>i|W*j!~W}I6s5X=$G7HEyaO0S?am#&#cK9@CbDoiOg9p|XyHe;HCvjR?QLVc`J z{j$gR`~8s-J)MT{Ce|hUG~b;u*!!3ZrZh+mg*7dY8WItx%+9XN-6_OY0*h<+0_U#X zYr!pM@!|`D8vLPS!LUrsp=dIUuZvFNEtqHdG%0f=X7T5IDkgTZ&5Dv8eixzbs}`L{ z=u@(XKk{{&b$dEcO6kbb)c(7K`ZOe7+?EIT$jJiazU^bA=@JnYJ5)iYFE^p|uraqo zFat{Gw79d%Z2QEk3`Vrp{lUpzSpFzXl7t5YFtUFxKe=8>%boHfi|MnCAWGM6MUlNYO|H!x z`!MYN;f^Mf63Mit*ArKI=hZSqOc8oYJU>WUx&xV;{e1jm|Ma2I<^B2bbu?H`KGf+t zT6$;0D;r!hy_uiG-XGZ1t4?9vp0oc1DW7sTw;##%R5J+Z5Pmx>nx$BKKU`acg6=adzOj}|faXFS93E(BgO_BmOFASslg0?#;nV&! zu~0PjLPhtSnw)y+za<3?ysSm4&I`*qxeb(2-XKP0Cq-E6a7fINSjLv}*)QD`!yVSx(Z+(r{+*2qhZr2M z(wUTeUfy8HB`EG}Bnox?d-8n#b57yV6xF%+vKcOsp4Su=m{2P(CPhI0&O5sPC2pwI z8?`$8yNo@^6cGTAvwA7sQFwYBZS9liA-sgrSD&E?xK(L}S+ zNs*z>stOP;V+KmXTuL($)ikQ!1;(0i0DvIIMvt{5xN&Lg zW;_GzR7F81)WUS_+UO3In~9vewDP)M?l8z$y8>45msX`_eEMnh{6OFSL~m8rcZO^l zwznac=i9L#^hI`YuoXJj1dH-cuuWWdY9}c4OIy~ncLy)hc@Nl|ATP(~X7C~gW|A+Y zu@6*Z)Hm(rE?#A{0^8(sST^c(=C%UKgzQCtYG@<>fQr2AEtcei8uxF`&m* zV47K{>1X6=#Epz=UZXV<&L0hvt8#+cETe3wBr{f^a2SO7-tTsAC0`|fhAr#A|>wl^eKL4G8wOr>8x>LAlA)Husts;SzsUvRBZx7vfVr#LxHSXm99xsWSU_ zec$~@4##GTgJ;7aJvR2II)lgC6c8o2F!4Hr->=oM`09l)9tRePhbs7w1R~VxX{BumE2AoYel85x z$)7d@a-zRW$yhimF-xhEh7aKjgy@nhhY7@{&e%LZU22~x;~w)Mpaf@z_W>ZV&P6!Y zQ+!@DElF2?*+Z>%6Wq~)r<>J~jZWfTCuO~#Ejsq}selOF6FYto>#s`@xH2(89iA)O zhUIY1N6sRHs^?~4Z5o@rU|2p~w|s3}y0r!r${wMkgr6M{w3EFhBj{2TaL5}*$KV`+&ModLO5VP^Bx3?K2y3rIm^5j2 z_fz@?O8w-K06GOHtUH`&Nk76b?x zA;J);xJsY?N6IIXQdX}T+oi7USk$x(^9_f6aGz(5TGrI>nIAz!Y`B;m^N7m%8mJ}<5dyM*Fmad zPMv1xIGFP|Gr3Dip2;EupY(O)6~SbiS!`+QnBMZRmDTxo^79}YHKKF!!SXH2Qyfl- z4iMy1P3kDPBIdi6BJ97`Z_IB}u=5y%_1B%g)H0J=GgI9S;;MddKir5zuhHyW9=yPo z;;mK!ZhW@BtkwrspCY8~Bc$G?Yv|6%aj6!_W(VWc1ERa;Qju`k=pKCWXbSpoR#Va$W8p1qQcWI z1BCxtnniL2y&$S+Ax&TcKMZtcbfdF+)VQl$d&%a|lRzcwzlWv?;BGpZ_4zmJ+;Rm} zqM(EWBxr+hpsKs<1*6Yag~Qfi#SVs;SapDVa{QW+VgIGiyqjgH;Jf_j$jLji8xRwzqGRj`;e=8I=BtFu6UsrEWgSQ_!n zItrtGW&6+(ugIqCdAKcDu^F#HB8YCK_S{XzkQU!Q1ydk{oR_W(8&PWmQ?#W*CsxsI zeF}1G|3qnq!)8oX?8*4ax~}eBD=Mncmku2z$c+0L59zo3%z_9F%b!l~GD1tF$p_*z z=4d8DUrgp-&Hxv%?LsJBptxj-U#gWS*$K%L4KS%XX=+178^$}hE7e_-=-FfTb)(xx ztT16_H^&Ba3JB|1@tIQZ$LuXJc2qqyN()Ev@{DYCRkdJ`kU!cP3p2$*jI&99Y9ADEhlP^bmS?Lpg(98OHXdq2bbR!0Zhj?{JrFoMsaWE4T-4&0i99J@ z5DRYaPYQJKDbTJ`)*Fn!oiSC*`-#^yQ1p&)aW2Ls6kH1lY*-8yYE7`(>(y4dB9q;w z>kygIGf1nv#?2uTXnAR(d3i5GXW8BnxpIQWS=nSk}|d!KEoFJ;Z~ z0?|?H`N9UYQ*75SvMQ7ung$*Cc!(ZVa)2BrSN;xt&z&Nh26)uF>)Xv9u&UaVOe1(H zJA~0zvmBt)Vc^JyQrzD{%;J?x8f%Y78t>oSp^9G+m2Xe`4i~zvf=zK(NkHGTLvN3a1AQ)N|7IvUz(Ko(9| zO>TGvB-Kl>M9ia+kNEZRETMA*q~L0%LxPwp{&adhUnFA_9ZkJB&5fOv)y*vz`hJ)k zUoYq6>}eNQs<7e3iB4n}XLN3q`vBD8sZi&p(l-x)S1zew4xbd*wu;$_-4RyLDwnUs zEwtAdVq(z{b_3(IJ9laWxVv2Tiy1xHCRbR^y=+2~lAB0!!tgOW-5Y~s*um<_9Aop-Ih%{@lETzo1_(aYY^UdG3bXN&?bGLZ zulyShGY@vW!Fb2A*t6X5&Osw@_0_WKC)K3>G~zLVu;=c9rc;zZ(PU}J-boO6WCWOR zd6dF(Q%BYuKzJ~TzK{$Llwx5<=NWnF>PFF9#L}%*y@I?V^UU?4L+}9cREYVf@8d)~ znA~=q_Mzf>twFbLmJ6cG5op{LPbg%CJK*KoGP&> zF2~&BL9yB??VuvN4gYB0yk~X((~yYBggpwQA&e;kl3PJom4m_-;QQUt$}nJ zX0-3GUt85fTNdHq7jF8&{C)d!EL{Nw^B@klks5YY|-+Gy~O<#HZh&nyg{>@i~$VX%>f1ze%mF5untf zcfZ6*!sSrRp_X+nMj~UDVf^8P@yCdjtRj>6=f5)*7k59@YrnX(;0Zwy zviX8aoK|vL9SFQe>bTK>pR4f{d<2cI@#O>WEI+DjC53$hs&s>Fs*W38{JAx4S<6|s z%BOvWAN#T!)6MRXz0lqx6m-RdGS5&f9-c9%f;N2DDi7(Zi^;$Ep?$dnZ-(4UXul=< zp^+!4PJJvpWou@}F^oQY$+i2r`^V5a1Eyu~!|7@=V_n9kSVsOY)}#%NtmKOtFu8pNIu81Dm;x*TwYmFbW;Izr%y zj%E(k5?*TL%nc(%ts>3|bRO!TZ;$6Q_FbPFOf6heynl7DJw#Q)9 z36-dRIIHqOlbZlP*j@1a5|FT#1mdSG8->(!lh8C+*lwfFJHXHDOgHs=w_?967I;ih zPVNZSpdZ?>Rnuztf!+8hg<_hSh#z&s>01aa{g7Bo28q!%+2N!M`|HqWJkq?=!X|R= z0#mWy^tj%DI`pyW>UEcw12Pp=sk@jdOlqsRXw3~c_UQK18N>W=8yQ#uhUVweKjB8q z%`-o#+wi$A?jgxS-dcLN)F=wi7xOQpZT|^^3unzTfUgWx#-)v_Zd>(FE(sdvKhC)X@|S7J{T{u z%e>7w>^`}aoWhTPf0k(owzaA1Nj--~EmrKl=x^@ue)5v<>Oz|+sn}UiTAbvl)_@t! zj*)OBNCe-IPoxZ?%>+$63PnucE%&|nXX-6}4-MO)WbO0VgNs(AKr)~LaOZsdB>p6C zJU3O<72I1x);VK<;jSWYVx;5|+R+>S>zP}Y6qR)W@0OOX*F0b%@hWEsI7*X6!rB}Z zn@T>7z%g4DY-nT(Z{qud1DQP`Wa7?0V}u?2^0tEV$DmR`B;nKkR)SQ;L7S8;J+(u` z17mabZ(0erBbZKez&$`W+8uS2)xFDE&#KGWXiEw~lD2~*Njx=2Aay>EG}oG-{Lj%$ zc)6<0mII#=x;-FL0V88DQbfDDcta?Qwj_NU56!#uCJWNWDFKqCrHvtfQWQ|bE5{lB zEguzCLsWQZhbtMc_Q;W<$``EC%Q0oZZ2 z%_1ol7hsscV|p_PNM!8C+O3cff+qqLt*016lTlkz`X52!k_-xxA+dtzL8}w+jbtt= zTK;BZNhciRa7EDRe1{{PYcy8#)rjUR_&G@41u0|M=rNg~g zW8Qp5+1I4^fWvuPR_a*SIV|8j;A0KR9A-hN6qUNr?7<-;sC7u)7MoM3f2FXa@YMaV z=(O0~FMo)D)RFt7DU=_lC1PTC>&C#{uyiMQgp1*=)B9GCD_@mXVnQV&z?D1~p5`%q zDhfZWd5uQT3oVJ^2CGuK=90icfG4p!kq`yR)QY`6j8;{k9|VyENz+1oOt($zCR_yt z0{sxVHMUbEcXXoq`;w3xELni}A3B^P84%_etMZhM;SEx?@FB4>nk6j_a9aNY%AAzj z;`T8Hui7P-5w)80R{vYTUCfrRG*{NAx#D^$azpEHyF{=Esr{TqNY}iRbWK=YTUo+*SE-3!Y`R+JH1v zdkv5DQd^4S9tZSAoT>8U9`fa1+!c8XFR!!xZ{*!n%xAuF9Emi-nZzV`G#z`05EvNl%1bqviHl{3W+ zH;{8E-WP$zuA!e!5y|%C;R|1Og>XelV>DP)#pzBXOqTsn6t0G#`-y2=8%v_3b&M{y zbjT|T`sT>?>e6cm3}qe#rNeLmw+$IX~*q4lvBc0Tf)3Z9j$6Pffp9Ut@ug&LY) zG8covnMQ2JXKM7S_{5G5PYRXm7eL0&b6%Y-$fQRfw zBMk!flNcNXX{OV)wlbVetM{c(lC0pdY&8J2T)bJ^#MH05Ue;)?{Yp{CpF3)jyV?yYeDi~qwhID12|!rqUc@WU7?zgI!M;tXlao&Gs}kC8Qlj5oe01P%ft_ht8f=PnCvQYtjV9@tDa~f%C^#*>bEqs>Ayb)ar+-- z811IEEn>80OHQ5p+t8aa`xI!t*U>>e)Zbt9B?4=r-S9NeGR=k}vW2Cg+hH)t@|Lni zg!Z7kHZTdq_)1zZnVXvqhuiAlaksrrQ>+ZLY`?(GzTurJuWqqAfb9NT>E#&c2-Ek7 z#myX77`;=f49n1(9#gym;SdavAnK_b+}0P+`)V_M;JZxf=&~UTOP&I$};)r#yitM5Noy7oXryACWWnyzNZx#kX+#_EU0<6)d2^n{&}Rz3tE z@^m8<2VUwK=)KfI98wkog?JFZAe68+8$0o-f%xO3f+?{VCFWqh`d$3lw`8W7*##D- zxa2=@XS+7oTG$dRv$67c%TFJd%V^qEv?L(jMV{S^tzK6eq5p9M&ic0;c)^>0wc%~2K8K0r1DWSv!VBO z?B!}9m(Yjf=HR`<2ltB_bC0!an>3xs^W-BHu6g%Y-5>&hdLw5@@qPz1qd5owPDuyV z`)a19>iGyWL+ndnF){_tgC6{RuxWgzwcj5kpBeBI9+tP)CZ6%9{?o{YKJDFTvX6!^LWF_XwR6Zezr_<9+mpgTn?~%vy9AmPi4)4)&vyY1j)5cZ zUNU85_e2t}5pIc~k;LsQgVkfpu!MtS#vleLa|@(r{mr3a#l{^t z6$UM$U#v6TWiwmgk{O`Pe&$(VISe4(vd*e&Ew}Rg2zFe>wI23(JJmaGlHEVtLT=72 z-7-y)C5+Tw#-^@gdz#mpt1(GJi^#!Fq7fWAQ5;@BymKNy*sP3N7;&GH0M)OsMvM%% zy^SG4Bplf3@BY$=Jy7=?g*Y4yX9rJ0OY9-Zk40;Jz`Z5{_h#3Zgox^Qf-$GOInCB~ z0N<|}M<5z=C2?R^xPhe1vTl=Yp~ks|tI2vNPn#r3)g_3{GVocxn-QT1V5$MZ5O7>I zHH3oTkVCvmWJ&`8L189KQw5MhcjbYlB>7qvK5nOOuw`*(FE=#FpQO=;S&%Y&nl=|7&g;Y?S9TU>LT->-;AOgsR zeQzX}7Vo}oN%>8TzHqg*)`u8MDih%_aDN6zeQnu!%{J#_B<7>8J%%sD@K9~&Szjtn z5LEQw&}lZwlhC(uC>Sv(A2)gR7{QNh0D~gGSkSLUFM|a)G})xzSY&>-%iU2C6S}+;*;x1(5%SN2)S0r7DXYWbNM`oxVBSBcTQ*S9 zQa_A#(R5Q_(!fce!E~WoWD${$5$>*y&VaWzfcy7w45cYcwF=-UZendDU>tXxccpk9 z1+Z}i=VE%8iOSRZ*cKAv7mzDnx$W;<7WA&5V$~X*#Tp>-tXVHkuyM2kmp8V>nVE`_?`R` z`qpf8Pe*|QnNl%cxj9psEpsoah))!DoZGlcFKgYHf)-bpA8+o$ktt?7^;g|UBnO9$ zgJ-6RH?eSkaCwtk-hfrzb;AV?oT%h(k@P0lGRN%dNT)8SF=*O`{Xz#KxFfcobl)Tl z^R7b&^cj>axZaR}#qKjyA~m}a9OCWtzI4`Jn8g8ng!Yxv#7n5@AdF&6^|2qFpm)nh}0mE0#X3er6xN)LVnYDhQs*uvVkDl{ktb@tr{$O+oNIk`c|b8S7l5b8q`Z)UY=FBTi#S_S0q3 zDYvZl)PK8s8F#zC*1zrsCtp=pZKdKf@qE3$M`(7okeyI6+cSV&a;q-Tq*c~6*CJG( zX@|Ur58_R+(4vctR%0yD76&Ib3mnzFU?TAb571H1gHDsyOHmwJ(E)uIn&R9c@^IKQl34@L-(Vhlo`0GfvmenL#yQp8J#g>- z6p0N_8-__cME7>T1B-!jq-)X*!H-*~|4|3`Z`X zmDOU|d2W5H@bZIWVQ@Mv#Iz)GL<=vGYVC4>L7@2ai&KEl{g6oHSuWMts=Y<6+hl7w zMa@PfN|yrtvGlN*>{lh2ifQ0cRjhdRzF8qA_XlYVu+{I_k9vKek3=kZu4bzz-byL{ z8@6&*!z;9T-_HfoHY)JOmbZ*B<67(izr{m7s)6xus!z!a>3UNgOIFyZCKmkHWk|F>*&bTRUmCs5rFEja*^! zkUAe~vydX~&enyqV2*(jEjybwmQy0nq@q4lQp=%NA1(x#| z6r|{~SM4r6bo$JEiW3n2Eb13%zMagb#>=_+Bjz z6_o52kLsMqR{-xzZq;9Iy7(}h=1uPH3L4zH!Fl-9tL}8k3eUiEk<043ffOK6gB#bE zG=n|&F~X5I)!eiBnwF&hHCrX=o<=j7Be8EiFVbsd4;icK212?Gs-XV`)gdoSTqwuw zS$B!Tw!GzS|F8Zmd{Uj{wEd=4CfgsQAE(Fd-+wrrYh@z%Bj@}lGa?QFAw zP1g>{U*euL3~OIkOaE5r_{I^9hh_=EW^OMl-*$UETX@<(>vXxpnZP>R$fc{ zb!F-lB(r&Wk@U)29hbUb+rIj{sY~a8RU591N3n|axTU2PvHsGFW@|I`{goZLHxu01 z*zRE5lD4?$%1|2ph-|5}v#a21BzfC=h%DJ*@O69n(^V^A>8vXfv^s_mOx-L=M z?wI>@V|=QkbB_0HtaCmo?ugd8+?quFBZ;tlifZXNPh^M+2$2d!+&m1s1)3{=H2}s&x2jHoHgKgwvz4Dj z5FEwkN*mgyL6ycyj(|3mJyY906ma;8fz?;>`DOzZ4CfNxzI~Dt@OSA8E?v|=neUow zLKqwQZFjj7fdtj{1-!A$(#>?<@yV+z06**xqP9Q+0Cht|H;y__ZdrD3E61bM|ymx#r;=QBdCD3zYz%eP@;jmr9RQKEcaG7}-EkJ!b?=2qB({dC z>iK)#3h1+J00;0V=AlI(N(Y+K5s;EyyqyN_+cPK7k9Kl7$DLzvOz#tZ{2;81FzU@} zz<*1QV9lhjgnKV6kOOp{$6#yuW4JZeZR=132h#WZ;3A%uio*C%4f1kbYd4x{s773` zKnXhu@m22Pw2>oP35>4@0kl*Oxgr67)?HhCXRp9-qtVULej^tdG?lHVcNbO(@40%` z_g`R>0crjii!CcYnay;meKUAh`a%0EJJsb=hqM8unM*w!|mS@REELJW5mM1{lFJo`kx`=kM$_kpvBha%x#^BS#bz%EJ$#-;U={a4fDSeKb;eVs zXqfn-5KLR)Co!V7p;BI{(o<>hn)q*`QNq|G%te@hhLFX0ZXj`Mkb_@?imx0`qY90x z+QPd<2;OVE76|0lHY=zMIl;Xj0~2Xc&J=zC;HUz0L--nVl-n_Z;-)FPd>W<=7Qad}Wqk}Nm zoy!$I7O9ugcSP}r`7l@_GokXN9!zz;(Lc<}cEXCt(AV(-Q|)g*^t zsJeeP7t2MaB*Pyl$O8{9|D~jE1~TD`dSp*z-f~|w@*Hv=x7fQdYBS5vP+2Rk2yx)J z`0KB#Y5N4R;JDqZVwXIAA`!=<4xL00P-XWz#x0m7OAeTiTwze0hwTx*07EE(yWT}T zKmYv5AUr3p6iBFa$8s^x?kq;oui!6B+W$k`I|b(!1nRbNvSMq+w(UQ*ZQES2ZQHhO z+qSvlWW_ky`|PS)r)uAQUT)QW?WgXVHLGX$H@`75ry^;_eUYLZWFxlezu>P=c@isC znrsWmJ4N>Y`4V$h^oqctWA4Icn!GBWx@q>xfN&i>1T`gXRC zK#l^)z5(bQJBaq8=93r~M+yPPG(Dtzjn~+~u@t{BKlFYN1m6m zB8^zC6+nIuD(E$L2c7R>G4VjD8ncfaC&$uOOY+L8v9!PI+y2b4_b5V9-{J##-O4-N zcHHkZ&mT5sU4RN{8W@4&BJ}nCn;I{-Ny{R`$dkW1*hY3MbE=->=ZTj1`z>glv@6`~(u-D+)Wz;g@M7!)>>I z8gVLIY`w*>6J;$xDo~*M9hF3B3p>{$> zGH4JF!S9)Q$eQTKoWw0?@R!8Vl6n+R2*z^Y8w26z+Hmri=5-TNPG)OmBT=ZK7&a^>e1CXQ7S);qTonPKzVZp>?}gSx{JuQ z5Qg%xu5o&!CY&;pk@2-c%sKC>n^ecXgL4odJJ%541s5f-gs6U(@P)~eCln;$8J_C^ z0kpr^VZn)xrDe{GpRyv-;UP+<`JQKBJfb*{JU-^{jVs+WS_YH|&!7}7h9huC|0%Db zGTJFz;NAXPm&x^3yBL&-U7Yd6P` ztRO0?Gzr~EuuFaOc*`Z;gwqRhu6-^odfr=*-F@S7T)i4kkiQE6*<3~I0l}_zcUrod zok$G&8e84oPISdCuh)x>kCtt8K`~cu&Ox+F>-Lq$MXU-ox)a|SYb&fVukz1rSY}!m zCCL@t55c?x(hf$IlfqLrZExr6m?wYwD?lufc`z!vHvil|{JSVW(NQRbDNP>JkeuoW zUM+;t2KKBvDDH-d00c3Fp_R;Hv1;~ZwQ{)_yQx*xm#{3ZCRC;*PDbyKeg^%=-_yoH zp5W4;QsGy|7l6^&v{^-o9t8`zi`@ouS(z*x7=!S4tq2>(9*<$T7UtZfnYH$;F#mId zfW=7Y@iluK-p8bDyc)iQ>>|v=9QQ%jiI{w=AqKkG0|UDtM*iV&!Gb{uKP+-Hfl%jw zWl#PS75G8nB9)%3lOzGI*?+XX0hX8dm@6CujPlkGFA9=azg`c$r&~=XU;=fsdYA?o zq?-@++b0;39`=+1ebhWb@Au3h*#JxVl!@0$bd6r5_(+wU)zC_m^*5fOMRU3j+u2(8 z7?nD4h5P<$e@VGd*nm_$CyDa3yDDOI4E$E&ei{a%8)OiSz7sL{-Lf%HN9w#fUUyr& zeCcKvE8N9xY5mz+`s`S{47n}`DMHU#wkpOa2luM&R~|KWDAC#-bjm4bf~;n+DSTMQ zF~Dg?dSTWFUG(j#VrpcS#+Y`mwbp?jCU2Jzx;J1{W34S6VzR9+*KYuWzM6?{70|6*%!t%ba}vm*MzdnzZkOk2CPF))<5}w z(2W%@{(__Gjv>&wq}K`c>9AyB`(8rqTV%SFMTpMR$^gN)VVcJ8Q;$n*(NQ(iJN*m7 zeyESQ=rs;U;aQ$(l`~2^?z=MYE{=UZL|yL(=7oN6 zDoa7j)ANY;Iuv&PG?fhTL5M|Qt@aF{fYDV2_dkDcvebLf<=)96@G-S)EuSp--f@i0^QM4v4ih|iXlr9K|V#FqQASk4*n`GH42B+*8ckYYv(Q^uy#<5G;8AP zEv2~l_zg~e2~c2-xwW&#QeW)FBL^h7qn=n^T(c?WQiE$WnXXL9SINeF^~0mnr~&xW zygtAik%N>5@C1T9VqfV<{)`sQF^R)r&q7aV&v)>of3yd5nWhuB<09-#X@>Fx_I~DR@LAopvLs z{TU`1ZScdq8^c}8^e&%MZxEdMTl7H4%%tv^g{$T7quj3dD z^y+Qz*Jg9$eG_s_Kf*_N5x%m&SNlc_Qyf}JVe z8CUqQ+5_R8P3u(Y9R)`VGzEE@#T@9?Cy9LfMIm%to-Xe_vi9`#&V_8eY+C1q#-8F>Hu0^7Pi^tzo4 z3j1Obp~s+Ks0Ck+K__s(Q5@re9L{XvFkh_qS0p6^$5xoOwOtQ#n*(3VLW4QgNGB3d zXR1=SEhr6IpC(?KA>pumH>3GlRXaQBBTZMdMS4D_zO*(yRw4sa$vXvdIxnz(yIJ~p z0L;umxDo|r3vRHQrao5ZS-ybd&62zRO_l&CJ@?R~bk<2N6v0SJviM{S0ySQ5Vj`A=q`m zQ+X%OxeE@@R04OvwDcjGwwqk7VpF$?^Nu`YmhR~QwXB6HrdCj0t1nb^KnVTiq>kM4 z?J=&`D^}0tp41it?Q^2FQptm)H~uE#3RE?&6x{nVuTq&ijok^D>*f%e!dpH!_}sf4g&XL;qU+QbF z8)}o8b=7!5J;aLv{bTF|2}(5*p63FrMViv%dLh zG>K*lf@77o7fq|1gPFZWooY}R8$hzb>{P_j-IS{H@1Gyyr?Z3>zwqH^bKCq06jBk5 zbtao7IEdDg>Q;j1$>j*Mn30y(r>P&F%_N-ADa;97kL2ZR5pC&3 zD4cYoh^sirWVi!c>4HDliABjaODBy}+qDkIv*KCEYRx%~q6!rNTJ=v}A zzo{pw3(IEBY@6FHt24QoHc!4zm*=E-jjz*uJ4HUxn{ww{M@haNeV98vBbDZEUhFsG zGy8ZObp^Qm`xs4*4-h+<+KNHf7{^sfFrQbPJ3jE=i#NZykc-8*d0xW?;a-lIJupWm z2yM=eqs+F-X6Bonv66;AZO!Uw@GP6|C3uEPW=gemd2@hqp0bb?o9A z1ynf>jY<8EnlsaC4E&C?$cE#mL#7{aA0x8Lq?gXk{Igvu{rfPBT*LNWhb*=AWaHBK zJW?~merrOOK7v3+5>PZ$QImo0Ln6>92 zw~vbh^w8hZKPh=ty7BYiUu?$?NU4P1YC1`~z{T2FmR?mfB+dIyeYsD806>T+Mx$(` zHDJ@H#L{*1tv8m(BE8sz?@z)sou{Amqr@bUiV`jVpM+h!5G`svv@uu@X`Q(f5bHSE zQ9;hX^#4ucf=F!DA3JMLCf7qI(sM(Ir-+x z{z${%0y)TsSZMIOJ6LL7x@BrPm2A=9m z=eGT+^IA8&>q^^!+uj9PJC2;euEY^tAlbjQ zXnuRk)V13JG;wBMIi&eYy0}JF1=?!hsyG)US;!-tBzec`n91e}pf=r>@fXHHs2{@( zpmja*P>3TrErAxT%;MWZ%eh~19Lf%ATt+4m>1v$*j~0w4!A(SFK)`uB0i0PH)5em| z*+%V39=1>O2USn8JQ8pvrKr5Srs}Z6af8i%4csx2@#lO^8od$?%7p;&xx-yg;DreK zC)dKWzzyKkpk@EGrETGc_3Al84fKpvc0Du3(w$Z}e8tuG0ZzBHt+Xo=+oTIXQclI( zt{hsDPddLKPCPaBBvP}DY8*nChAD_Uyv0_nZ=I>#Z{?duq1T}x<6ejYkhFhMliOv@ z)p-aiOyn8&9EnZ+e#!lj%D&@Jw$TT>i3MJjOi=WY!&V5v8w5UwplR3|$X`B;dGjB+?>-p?BKt zdcNDbIC@mi%*fW#@#$75XXo~IcFB{MR;pAmHFt3T5Q?%Zma8-7eEFA|G-jsd8a-ZW zr&Q95$G5sRbG-1papV$Vrm&;iBPc4-@OS|7)xN}I0HJonvEVd^{ zx_MX;Ff1Q!wMp8sRcy;Y2Y9^feOC@8Qr6`Lgx>V=x$duCax3{aJWZVGJxiB#&5A}U zeY0U#CqqN8b91RC6Wd>BX)30>zZi0oBuYd(%KtqZF!zeYql%oP$B=b)nz+hbta{<8 zxRE{X8$RK8UUj#dnc6X>lLuqlOdoFTobPP+Y9Js?{cc|Vu#>^xjvvlWb}4j^woURjb=$mcd^-J;u*t)2OZ{*iUSLztIUM?jo3G@PF)N=_ z*YnrAJ8Ic$wS7TN&jvxtS6(!>BJcQ#gl@_NUsf_*sLgDoE#*DBf_VplS?h5bs_$TU z4R#}o99)`nV3#G0Sd~omZI6xZ(Z6Y1xQ6#j_%Eh{-O4*-)9(R`sVuN3D_~#W1M|E?+?^8KVXdJ(Toc+s%X4>m9_*mI#}qD z;l4b8E_)IZ6%cELH+y#Za&h@4JkDR;8{jn*w=q#-v7|Ilknxnh&|*#0a!5>DFFs9( zAV&p;t+pryjcua0eI*IE$ov_D<$l|fz~&B&I=mfHoY8m2<4xMRsN+&Xr&k`08391l zx~p%Nb7{)K-|`TS#)BhA78@ZBR?myD1^D|lCdzv(F%mhPJd&9vU*0M9EZ7sgXR||b zQ%XlUT)j)z5A3vll@KE1$b4vEGmrr6al0}@a24s2f{_B&Iagjh*UmhkTAgAFuT2Lf zVB9@?9$d4{2e$r~bVC7rH#AF;&V$4g$_hDK!wHPqc^r&CrMzVlJ`vyG5`%UHxZ2r# zf4LaQ)Zn%D7F3i9?{(Aipf(N*N&{BP;^GQ{ncLeZywLR_@|(0h1wyr|57=`;T(z_a zB%2TxPQg!r_B~0<-_?&^77$sq>nz;xRK(S&oec?%1@%R*5hh+o*NV}@!3DYJ;?xu` z4{So^MO?t_jEDE)rTNW{`3}~K;g-FlIZ}6n0&JrbA^-xAxW7OyE?^qCRot{GA%I;CWsY1YHaTOSDMB;bP`lcnTq%xjBp)9dpR8ny}U>Xs82XsWQGtBzz z7@mV>f85Hb{g=(1Jr>>VwV?xIC4q%tETNYcnac zID^j$|0NVl8Ydz}V@+puzWcfm%+AuSY;0VtjEqgCQaU}op}T5aref_?b$iD&Ie7Zn z`AeiA59DfMxvBA8Q@XmJn;6|HM7td;eQroeh9a7YeztkkLx z$y4419GZ|c;V0L)(5VQG+^NK`Nk1d1k7G#Pm`*yZdVSCWeXbyLzkJV9S1Bcf+3V!7 zicX=jC*aSP=HHBEb5HY+xpa$S7(G-gU9HEEH2=Y{^=F~P0$2&=?Vp+|uzTw-kJLt=5vQ}b{a-6EuY&oG2n;K4_%Jli>2zNS$fPsUN0n~B4#i>s|;?v z4*!DaD#2;yQA)KZkn6AA(R8#>&z>*6;LMXuTpfeD$O4D)s5k}LA_d-sPFF34DR~3xydq z+4{ZNd&0;X*-~Gb(hK0C`~>-}iiA6mMv{_A7p5g`o`-2k^LkR3CRirw-H<$4%SIY$ zIwF^JJ-M9rUAatE=ge4kwiiUFI(=d)^Y7)CIB=kI^r&lFms8Fq-77mw*&XNoKl0=W z?w~sJKL^pMU2|dy@%R}48EqEIgih(x0qtRa)zl*(IXF`8A{jKNi=bH;OS-NgditL9 zqXS}je%c`PfhTU-=}(ZyqszrH62N%)alvZ#bNOwgdS^Ch$sv=rpZr`b)UngkJQ7l4 zfUWlpP;glKHidsa5b+ zq{9iM99q9=b6=GkvxW!D#}wW9fSbvfyoVIdKN_gjR_i}br=73phQfx=DTgzVm|`!&C(YC$pb=2FIzng>G<<3^K4l3dd*>*koU+FKKdkFu^W`%D%%b%MMn z|1Q(RLbRzb7pQrXdTmrMpRhCk&@7=)VvvdTKZGD>35WtWrsdmRAq6{|Kka1N(eB=T zkVA4YoQZ2W6C1mX&>a)*BGoWAE&hV#0YjO@DvF|tuHKHHkGa*0%ge`$gTrE~rPtR^ zsdwvU$>j1w9c4|7;LTA62}Yd`g0GRT`!y|4uHQj^q_gdftwIc@hf_9}gH#E}G~dl@ zw0k(_QyUIJ21X+zhp}VV(2WH9;^Sa3OGH0Scqp;v?p0|s(8kp?j>=&frzSOk z_Iak6)11$Z>0YfwT z7xt*0mE?24+N{NpF<^T?;QrNaBt*s3+UwGM2_D}|v}Fl9)$Vc*?) z*0d7_dX9f^K4D6E^SyH9FfBCHV7_k0&hKB)kR0oS?PmrGnn?jn_!AeC28}h<^LT^6 zFw`1ALnF^<4D*s7L5Y{}K1~;MYCU4aVo_SRGVT2&_F=8y4oTxx+F&pJ+68O{$O6Au zTWW<`_S}ScPb?p~=>{hzR!~8sZy2JT{R`xU?Irj6OFQv!Ru)8->bcA%uy)L^Ipi|% zj$V}Z3*ppEy5kFT8=vbr(F&Ir?qdWyuFJ%C#)0NXr3~uhgw7ol!&HIjG=m5f#8Kk7 z0Rw)Qec=Bln={ENn!icAH&Qm)63#k%4e_RFVNPHnFgg_16RxZebSD2s9Nz~%gF_Q4 zhX1Ogp^W+VIbHBR0f{T1k|P036?e{_J8?y&eqOVw#M9ST%k>+Y>2$5a(L0)y6Q~{X z7IJf#T~ic5U%@^(t4D^}=FiG*86sTBqJoKl0=H>cx7%FXukJ~gK6#k>IO^5mM`~&d zPG0E{k)B7HDv6(Ieaqf<$~80GGd{S(8|G6xyl#LMrQ2LNy(!9sk7efk@S)+jU<2{T zO$BodaTj&zQYYKe-#G&LZbr39%ue_jVD52AijDNxvZc9Z$?1p)*#_EkX$w7^y2u~Y znnjdUAzvn|!BTh3qy;$uOLHkg-JPsdIdU@BA~e^Yd}l+lRpzOSMS+fa8<@?gWySLd>+14d#0Op4^7HaOP&{bxE<-M5NpYL73{My75&+d_ zFW#(YEx|Tn@i(ATDeP6Qv^L!`(5{3OH9o4gsF+_dA6qmDJ^~rJ6H%bEMjV*zC#nq| z@17$n6Q11ASN(zF*1>s)D!4_~N>12%t^d2D2CcS1_#Y?FnLTTT%i4B5p+`4XZ){!9?fYh|N z@mCa%o+64U9|yE+#T?MSE_ozG>25n9!KSQW>4My6mvI?SNNNt90c9}DHF#!cbF6cy z#FQKV+Kvb=S(g{KKQ2b-#i%z^CSH+3?3Z9KJl0&pFW6}4?xpFRT1$GwO_g{ zWwh+?Q72rxE)>bpSj_+Q7-41&isUFswG;Z80c(M_WpmyjsvBrvl$13asA;~J%uO5p$hgIVqux<3 z!ar;U*7X_7HG;opPA30|mZL0&74ht_2r@kZ5^R}#`SjYCq(XWF*AMy2@P%9vaWuc% z?b_4Sy;5UE(VthQ<`O8`b+f6ihs=P!3|C1fc2KVxB(OiQ6T&Oqyp(e_k!u&cM0fJY z7cml`MrtUNig4S=A50kHrlsp3yw8+Txi!Yo57}r>J@q1@eh6OyNp!|=@d&PlTi~D# zFl3cxbT=icDJTGFw5&gf=ZoW++yyoZtHLu?AgZB3+o5QypF~sfD;e%9citZ@C2>j>7@9OF|!tU`6p$! zki>?U-Fi^|EPwh3loyTSUNvZw!t$6`|nJ-k$S1 zdn`A}jp3^6x}n+LC@UrgSV$p|j%jg4k!_pKs$Ka;PR6Zf(1l+(MEm*2+WjL);C@!D@KNH=V3@&^rnWo9P|AQ6-4V3P%IQfyE4JC^XOQXP zk3?E7Ak%&7=Y7uI4!po{t9t8j)NIcqI@s`QP5pjsk}5$!{EGgTK^fJVwZm%7yJfSf zzoVb$4#c;;q=dr@F#9&3=pbc*@-B>#+g!+K_BA`)J^%CxNYReWy?k6y4^!g!viy7W z?~Ex0%{^Lj6#_s0EHzChETPHH%ixY$T-VdOvvO|O4d#41?I?>iC;ggzyXPVHrsPoX z3c)68C13cY{3SgNEjfQ;@oqVw85%v$VFRVIzrFYUAM2GZBWjJ5etK`}OPzT(l@miy zFDl+Obn_Jv9;S{Wg)HIVZGWDowgRH@Dhi7zPTTtos=Lu0k%Hje1Z2;@8>c*eCtu%Q z`=}}eGi=Cf>&oY(|v1~A;^j>6SWK*N2_i7flU_A8t zM1LX7aXmet*61IZtWr|T9XRk3nUwY$qKy>$Rn0NP2N;RS zxY{SrWc!$Uw&BK#DbuB1`w$k~H-$+y7F6JemDO+-v>rmZ;aVG62cW_JYd?5%PM7e< z@FK`q2}_A7oF^ef)}%Kpw1|e!jcP|sahOdeegR5lfe*-y@f_K{v-&#$<)9dJ(L{7M z!IB9X!625r%IS5$x7T|+9bHDP6<-r7frL}OBz(84&~ z<&i3bnL>E;T`jovNSH#-S2W%G+W6y7;39g3qsgLy-A2~h4waFa+T;P_KMxrDV9rtV z&hP?*-0tFfgGhq=de?hbtXW^oBiVKzx`#s^g&)a>gs@ ze$u3+W;9AzuXeV2G~yy8{vx`J<=OBs2QE6UTw7>j)6|jM!XQ;6yuTOQ6sME!LHZ}l zKifv(Bc$r4%> zkOcG$%KhQM{)wDNcq&~p_MO|2Zp_+s!iY$`Mk}VIh6|(k@oH9ne0Sd*gKy{BLAI@t z%5?MH&uvk@2w<8ML+6B(jL9?!oZy#u#ZfU`7ok+NtyvLf6UITIZsmCV`+jTgIlI^x zxl-E@voTdiXN%Yn9>3t(`@NlmU!#MYZC}b-R@orCSuIJ&Ib zsO7EM)@7|>vtp%h!U1H#>Hiq?AcH##(a0;+ObsD46od&(Wd^1TW5SwvNTuvDmNE)U z8Ot2x>iFUO>ut~Fw{%-?p>NB97r-*ONjw+Cu1@C4~)XwZ69?icgJ%Gi& zf@#Itg-CPKB%k&yWo4$=^vxV}xwwVeczbR@f1cpQ_f_~I>&Z1|~5)#aeNV@<(b3nJnlZC;8L4J_(N@ zn#g0CNMg>I{X<)1_Ua_J-&@A$6i(A-vd_d*Z650u1r`am@6<*vM}I}mnLML+`{K;p zA$;?jDVa=4beQcm&@{6tbQdWHk6aB~JW3dz;Hov*w0gb=E(M`4@80nl20g0lo|@yg9D zVddu7p32F}T@RpxF%BCp?uMbuiFFNpW7L-Hu&0^kXKbYcZl57aE>n7h+)C@TFA-2xreo>C2^bzUn7HO!Jn>8#=Tr1~6qcGF0*4 zG7zl%vgKqRQi}_Mf7Gf#yGp+ro~mM+PlYyo8c^$24nGNJxo3pJ|Hy!(*bkY)if}ma zrIklgij`L^P8f`;6kE*M;4@cKX;9e9Wg8bMBc>XkD9ukjk3%d&s4|`@amf(SsmF6o zc@z7-Cr&3pezSWhO)1he=;;;G-72Z&KOrA!GuV9hZ}DG|fwwujgQgJA-d zlg^y{cPSLxf2($8``-nU|DRH*|B^ZX7m@3S$)#xLY~XA{z(B9$?C4_TEN|fWpJ5pX z1K3#IGNtev~qH2 z-=2}NZ9%|zu;$ZCyXsCK@1-|Qv`KlIzrOyihHjiVU010Zr z%`K_4HXzIP*3OW)+Rgb~{CuR+TIY@ZN}Qo@@wr>*(as#-v`9xYReY_!hIzja{9czc zbHC;br{@$q9ZTky{%-s%eW1qZ&60CEof(pD{q8>7rhZHPd7shmiL^GY&OSZH^g|11-B9ax6q zCUjr|__9J-OrX>X*TVac8eEkp@v7g);BZ1bm+N<1=7?`Kir1ZT-KtyTD6aDLsrl%2 zhG#ulXlkaOMhfz6W5B#&SPpnhS$p!f`9p0dm0i0xf}8ni9K8OqzD4+p6;1u3{6U6S z{dTexjDY4WC+$|3e)dTOr5%_sxh}uf;L9=_wgl%g9?ImB)?*Y`m~dJ9j0-qd_m-8c zJTyfg<1c9}xIxpq{H+BR?Uu{OTyG5KNLCq5rt&uNd)r^lK|2yUkg)Swn!2Aj(^|up z2=A3h6)$5giiu+bEa)nh8yIFt8IxFVeH5(smlvP7R@>7&=Pk)35w#pqHyUqf(7vEJ zd@@*)F*P~FW#O2kvCVf(OSF@f1*V<-1+Dg3mpM=9ebQtn44n6 zDsmX}iUtrs=)sft9Emj$j~8q-dm3!p5;RWDQ*o;D}V_|s_f^8_g5+c z1O}_MyWfg8B@!quH3F@`q}8`Eo!=!;5w@w)89nY<>}Fdnskv2q19F<6I9(`%r@CuD zr{t{+_WCgA!g0`{P~z>^37jIQH3`mK7retsz+NY1fQmG}2u)5O16ArV*dC2#CgQHb zu9qIFh;uu1keKKTsR1N2w-8Mt5|#q)gZdM%)Z@7=^8RSnB>S#ZU}TlHwWxaBFYG!3 zsiUN)s>oZJ?JfJpfO> zX`5jI8KCz8sjzq)nuJBY z<*Tlu!opHi3@4M7#`*m1NE2|;uJoJ5#e?WkphQ?_$qK@wh`TlZxqjl8V#zi_Zb?8V zp4EW_d3*%TLIjOMO!}m|e4}RYA*zxW`LOj{AkHw2Q*0Xd=vj{|pNtdat5_3rDW}(E zK$n!x(t_MHF5>cDRv?Yb_)6(%I>j^M7a3al5Z=`bwb=ppY&wO00Q4RxCTG;Sy*;*t ztr@IA%vpfrxvYcLEXGEPwnb;mzbm{Pv&dm&zThB%WC(X%KI+-P{9-rj(F;TeTQg}~ z7yxWlmB3f)(TsSsClWKY>Usr*QHR36bIKd;YTD(Ez9#Rfu!6fOn5+{w9O?;`7@FPf zf7ED0akO{l`UIpo^wyY9tT{e3U=PWIdjP}vv|WcGcSJnjU*MSS3E{}8X?ElBYjcVJ z{47CmM8e&U-C;!$b&1>_+@?gFQ3)t{{Ig%_!C=XCRvt@Ii z9d@A2?|E>Lr)zEDwca)I-Goo+_5*zh`jR(J=uaF@%=S@TTOyt!Sbbl8Sfq&+{N9CS zBz<}bWT$S-cRZ6x4iU&=#S!5Ybsp>I%PeCmTO=Fy?%pue4arI4Wnps8eHIBB5LcA} zW{#uhS&!P1g4cZ6ZuyiM+TX+eI0eY`e!3jFOkQZGV%hLQ>%&C}P&ptkqD#(-pN*=8 zY4R<2Y{RK6M?~^a7BCfjA-a(J2389=QAO(trK!=j77ivY>}*n+u+HCVc5gbY z#eu3&4RHj3SPA{4A!-~Gu$_)w+fD???Fb-+1ldevS{CzNKW$PM<~TzWieYP+Q(IX< z{XmU93^6Eb+Eht!df2~X(s|SoGZx5xB>~y zJHMiK*U!~sO-}1E9Ubf~juI2Z#rYO7Mm!dAoL_nDFMYH-FMBYeLC+325m(to`Sov< zHJ2x7fnRpk11T@4!?V~a!$z7nv|kMSpbl=<8*$}CEi3c$v8Kl=DYL7}mg7whJP?F9 zAiVQD8cA`%WNu`wLCBHWSXDSW!9dG@Jhkz52^{K{0e|awzM?MHu!$to}jZ4v{9CD`k*2Nl$ut#p%su4@$>Ybqmglf@qYP~@P9GG zNhm+~#FN*v-pWuD&704+#VpPm_Qd5Hjp%*6=aTN}3#0h=uv>sV9kYuPK9fmlcO{>u za3-xYO%Q?tuEm2Esc|w7M-C>sfbQfspLc`*LDdTiDhKDl76lWm?LTWV73ph%T$wHW zRBF&&U$ilp>ap4LzMS1`=;(ISS8M5SYV7Q!Eq1!xJr8$mTAhqQ|HVz!1#_E`L25Yt zZ0j0Qm3uU;zDpUX?Z35{U;8!m=_fu#Oj_C_q9W~{G$tdKp|fyC3qSac)1zWIMhm$y zgOnS9Z_N6Gk=T?RD<1#)917I1Nkl(PX1Ki)-xlk8V}#wxlLlpvYY@5SHm&8aX;dv8 z$k>}wG=&u8;hoz?%)KncEZ;KcsS)VjwWYME>Y`!i!22+z&Iojr4wS z(oCvVLJN^uHoV<_VH%+>%>g#zw>$mI*{atiYozNwM;aTr0KzXOm!jX3aw6?5{Ez`j zVJiF6zVcw_9B(*kn8@}U-)n6SET=ey)fD0Sb93LL?#ryL(K!8X-_Tto^;BfBoj_3c z7Z(-g;XM?LE-@sN*+LtOH9$YSrjToA2&o(sW9c~r3AEXxzy{Y(Qh*)H_a9Kxd8z_=~^bphBF#&|0C z@5Kfiggi}Ki-Vd`$Fb#YH6yQH=;vx4B#NW_>kR?eGdNz;Y;fRwpw#HCuYS|FPC@dAQI7X(Po90tU-QdUjW=o`GLN(-@ z?;Oe}$aLpZcCXiX9_x@J^kjj92o3=`jyUoYy)rmQlo-5zMkr-2Go?UaLVzZ;b7nco z=ED6mUS)$C*B5?OOAK$>N7Le4p;=ZYj0YJS$9%`pd?GL_GAe=S+(&E+(GSXafOhkA za9?1kz^P1!{(WL>6lLyRCKT}0R{8|RY5^Sc$v*hZSTe+xxG!6`PW&%P6e`)-lGPs$ z6pwGXcov;8G=J3K<@+qomc!39?#~E z?p$ibI!j#fEO$iq_=4HH>7f7qk|1l9PU^Vu)6D%AG#tRLm&BiGO4aq*q9f>+tnB+5 zS&xmRsewLQ3y1Z^Zoz7n2h%<6jBtdEIQ3d}e6c?!0gCiLvw!Zn1WQXi8%_p=0iLMQ zAPLJP5^ZLxge`JNv?&9HvJ!;$rn@YRC^M#R_d5H7wlo9e;$+d%FQT0oXKhxch5}Fd zGm(r2sxN0Ysw&yj2TyeFcHA?J`@|Jx?7RmS5KRssh4!!) z$l=3x9viW6f9&8X`TvnM7R6-YVdSX%{B3w}uaBAhJe+2Jz0C*TV1^~3gZEc-YNu3K zI3u-GMVJN@mT3j8jJ+C>;TH3swsmhE6mhYdd7*vQ zLlW?kFbVjS%7@Eggqwz3pEm;+ANP2)^;!Pjp1N6EJ96P^GS1*_L*d;I=QIi%zR_3Z zSL^I|%#OzJZbK_RNp84_`ox!+K-`Z(^6%S3-?i7!$AMU}(}DR6nbAZ^r)f+QIGiX< z9;D>}S!WJmj!PMHtEDZ304PVc$R@pzMrfs`A`xz{U`+t zjA29#OU`9Bv1j3%0X4ghUHW^U;q4>iEUM5;VcG~CsYA~HV9Ro*%N<0;#))SEc&vKC z{31keTQ@}82K0R(*fMYz%wbB&_||PVIV{alUIaPpYw=thJP_rwL*%{An9A15b|_!U za)kl4zjylWGG7WqMKf%!+87=y(|E(RZ_XoTvVFhr*<%EOiLV6{H zw%hy$qDhjk%CLwdVUD?RUHb={PzPULQ$T*Mz0@Wb?dsi^ZBH7Yv-UvND3m~;tcl-6 zvPM>C7{ww8J0L@Q?-eGwVtXsL*{5F;eirWZMmyDj<>HAi$Jrb(N-!+YOWk9v3u70@P2Q6ln?GZ{ zPNRc+Pa|XUD5fEZ2*XDDA^q`DEww2(hMnbtq%^jdt@dPkVU8*683rsgt5XU|Kn0=$ z(wneIo7qQr&xH!Xp$9%~0bc4LybHmOMdWQZZz5k%n-EN&>+;kiiG~nm{wEn=+BkLp z;yRt-842yjc>i=8P}=W76{me1EhEwB-a9E*m!y=s?s+0ZH*%3=A%SBC6wdSnZD|zt zL(LRe?jv>@OQ27t*aKaA$|JFc3P#QW?IZ6DTAXvC>ECR?7UaBKgq&H8F_phkPAWgq zE<)u<(4g2DuiIQyX$y>E7mJQ^@G2;EubE%va&+Az*z z2`{Sx{e4U)5qUXrB)g^Z7i1BXKvC4G7I9Pg;9DI&#EIOLtM$?PG{d)WXhJ){~aG zRSVF$)<3;jGqo}B^>D3eTak^|t_5;^Q`F>xk5gat{%DyKYu5gjGLTI_E7|!kxl-1` z>BdLTY5mepX&i={t1NC+YSS3agR6Grl}7c+uB@nL>||gSOYPgk!R0WvZkzev@snEH zo_B2{xV{r0^pV=f&dq*VLswyf-b+(H>oTB+z{#x}L{h@PxAVCA?zHr6K8PQZ)~t5%pS=!HJme(HMt|T|d)D45x#EmgVz_qiS%jD(=laDdj@{> z{+6OdhOi0+aZL|-g`fggPrW>K57yroo9()Vm(WyzJrQJm`Cj>pq6G`{Ri|HJJNtgx zYKg3qjCDlQCKa4%O$?;ceK;vNar0Z}F?(S7>{QvyeR<2_7?t%KY#G~0w1UAkPp%lM zTvgMt_EoF7z{uTOI;FxBA6Ziuj+zGtsr$=jlU%$2Suyq%`wZ(9$J98QlcOWyL(GD! z{jmOGX`gDck!KCI5}2KDz0#)fSF;#w=DP2~VedwlM)c5i3xM4_hL#rD%45vi(T6aQ zeQNt3-OANQ^d8lt(1%1s3T(u)5gr%~KXMVdB4+kZK>tj3RehJAMnXMVNWFeNJ+7$k zvaSE-uDdg9SF5*9yVvrODTy5eFUvT=OY3@otR5s@qB!}jFY@nuivG7_olU7r$cflp zU=hRBh>gDHKGX?S_#y9bwgym9kto!$@6|^Z>!Z@=3sY<s9c=}MiRT<_DnTYN zM!(J#+KNfEo!^Rbn22Zwrc4(HCuZvJ4Zb>lV`#G~9H-G8o!*l>(&I7DcDgzPO>{s_ zPSR|pM9ygsbD6{sHz;F+FL$`rL;u0<2YvcL^O1liJpC3P6s)6>om?DQkh0OgB?xn*qmbZ9k)y^{0GbQ#gm^RqpqD6!@r?E|H|E2Qa@Qg0q5#wKM zX41IDd2FD!pshCZO4Dp%--sjOpdyT68^kVTjL|?o=?Rr|_$>bZC?Fzh2(p6alvcVQ zx;}u*u3EhR5{CSj*>KkX7qj92+ewZPqaOW#BuV}gdi(<*|33VmVA3<>`#e)`|4Lqv-B`8OD{W=|DC(c)-Mo3;-J_ z)h4}Or*mE>K=Q@%t~F%(v;QoL>($KC?nIc)($>)JYKJRx`~5szC}!zYt(K1seGIO1 z%Pc5IJd2j$Y0$2`7D!eEr~icU39E5O;|PIZ=EMEerdm^!5^A9VGU;$?dhA(i*Mvu9TJ^36Ctrshdm zKJvEGB?X_TVld;qH2T&0aY{w+Zk$$$7gasoo?K~9t^9I$xl|uI*PH2HrAO<8>Y5|{ zn@rQ47>mEB(lOdxf4^sH7-Y*NDrW8aYJYd6S&eXg3Sl1jOptoSZ$re^zi z0ZCp(YVL4Z?cnvzN}YLtnUM_ch^ zroPasNG2b3EH*EB?6j0gFFsfWSUN|qJ>0ff-64_PpRKH1R}O<4h2RtUa+QLOAU*%` znLZZt&ho$8h=L8(qQX~;rU!&IBv(U=a$3n=S-M0^H}3=9Bm(7vvQxOeY4{PdZzBl0 z85&tHV@ps;C!8j+`&5wIymYkKoSE|bsWp-q(2lPqx#~ROO>vyx6f$2XxqRdFqO_tC zY>SQ-&LVt)rCxxd$p>Y#a< z)|wLwt@TvZ=0YwoKYhygXm1dar*2RT6-SEEf1KtzRO#NK98S%cLHkH_#7P%HTdNc*V~Y29I56?w^WthE8}{JVY80Ik$4yPW)$!H^g+cOG94&8;uu}5+Cv;EKwV-? zx$rF&+8UE1GE5Xhhu%amr8k_K$y89FglgB+O+aHHoR{kLogDKcQ~!qE;|g(L1P;V# zo1>w71S<-2r*&mSKoc4aV?OkBR#<@8J1zpS;r~{!?K5?m}MZV2t+8ECwRK} zP|W<#6BB|WhtJQWIJbH=UB2kqKrtzS0Hnt|e%*d|8d@Hf7;ST!#^X6a(PI*SEes7< zi?={u^(;0A({FjXynDl=CPGuW=MYJ^I9!_+gCwq+93#%H@2YYA8@|L2X(liO_cqY= zev}R1yrzK_RFvoisSKKZ5U$S?hOMGZK)d>|x)czk>@i)7YCEhs07lllIX+dC0Hz-H z5Dq9ntJx8Wc z(8tF|QTxP@*W(zX{1C7q2V?_J7PTMNqjKPZBpYYu3R+&Sj#7HU7X6899NRPLUv(&M z5Mwts5I?=Y`L>`$5w6`ZYPWSw2OG|78Jt@_EzmVt)Ff&l!&mp&%C|u&YRT>t5B_Qa z_(kq(jA^c=RtzHSk;4d8!jQ(Eb`WW*OSb1p9XT9H7W@07>xHJM1W{k?!x5T_}!tQz&HmM^D=K9p!=K zVByU(EWRFR?Ek?I_oN zft<3+e3lsu`1O1Nd4M*!o*Ih9BJ@w__B@*oI(w1apb=iGg;~E1Yk-DYXUo3$=Rm7< z8xP&q>R1YT{7!}nLR8_j*4F26(Bev>4^}yDbXU6t0iMq8?fLr?n4{}LRu4#)RWaeE zn*|xsX7^1pt1f>8+P0-tcgOwhgZ-yl?!OaX{2hXz8$nMJ^vV+g|4^9!bYk3#bgd$8 z4t(pGrJ3<^93xmoHPsqIQ^j-|alS%mA+wBi?o$$c1rBPD383QWjsOxe)?+#F{LLtu zH0ew6PM*!khZj9zhqFfZ0aZCRUfM~#D7~D1hKs!+h8=cfCdJ+XSs`7?)VXCWdLg%qo^F=*V`CD%_Cf;%nu*877oSeE>g}g~X!SFnZ8o)S%{=F@zut z2Qj=)WB(_MgPqQz_ezCs+NXop0J7jv4XVPxn|E&CG>}bn=3Br)A|_I*5mn8Kz-KX` zGG4}rdrxd*Bjy`dZ98!;qTHhUwTnck1lSa#iuJoYJ|wu?tM|x@TE7j*5#P&sv*cI{)Co9|1)4B#ZCjsB9SQPxpdJ1SZ`7~ zQlhT)+HftPkyC2?yY%&hlxoli@FJE+qgmE}+Ah6diD1nSALuyl zYcj0o90er@Aq#zStDn_X)|2SS&I;EndY=x*^61sL3Gud8XvEzkiCS(P8zUoI>YkP? zkM6y&;^sg$YMGhc7%PBXOQ@$J^B7U*$ej4^Xc`^kn!sn_Z1K+!&h>xUPqNJ~>DDna z{HMD9m-(Pj(EJ>jW**FSjHgze^ykw!aTuU2>>aI?I9)o`qJjurv4iI7 z7@|uV1ESd-#B?;!^JXSyXWkhI2v=^PO2{qRVolk5ytP6Kw$wNgEB}6ytq)*auB5H! zTASIFUD6Xz0Rw;Z#j?}#|EKL+Y|>-jNVP?TM#qjq`Vn`_xHjp?cpcrO7oG9NdWNqB z^-OJKZ=iT`Xu8cruQ6R(hY6tF5OQm*UAiCjvS!u|&w>9b&4 z*(mCh;k)$M59gPjLGe;a2cIYhrzReY20*kqr9^jHt%=_M`<>hk-;|9oALe*0%S zd2b=X--k!641XSudbDQJWw1n4t`Bq6JsoiwWZZM00+HKkJCK zMfP)5XmghTmhH@s4v5k0Osn@3ifTfS3HrQ$XEG;!m!cEOH5FGc~{5 z&RQ^hdv7tPF?I@g`y20B(ztr=^Qx&2Hs~ABCYPZ}qrqUiREvKO*g2a;*xzg&H_}K7 z=0vS&blpY3wf~fLvM(=w z0+bQE&#a`;_bv9sE{$MZsv2=YT15SO{MhS0S6w+7aQvj}rttQP|GbM9)Yi($W)2x^ zd^HUSZvXsF$Melb4x#VyK8VI!AW!UXe4s#~y%&x9fP??uauAFfZCzgMTFxKf%&hb~ z#@K$C*U=syPVQ81PB=sJsCj-bZ~u$?_>hH7J5^{qBat3Qa^fM&W%Y60^Y+{kfp)HD ziXbA-%EDfoG5NEX@OAut9)E93z=Cf9RZ@r~r2B+|*T450{ z7q^1~*d%NZSCcTPcLal)LeSv_G{3V6=$EKGs=*1Hxr9|ti#tn}+}}gz^EMa0B_YI&8{3NX^Mfh3D7D`N%*)R6QG5qx(!Ay(=Ujm{p3HAWgVJO$NF)z>*y`D@jGe zU!BmHWp%BaBedJLfZQ_7fg&Pnglz0xcxH35yT^6A*gJE2d!{O`zP^r&J>1;XuFOmc zfjkS$lRQtR(mQkLWgQEHK|ho*5Y#XNocZcC@A|vHu5^7J>BL?W*uFd(=!R#u$WKJZ z9ZMAuk<&?4eO!$amJPx0Cme^q$e0qa1exIoD6s{rd^y@B2iP-DOumr?*iL~6@)K1l z|8TOZ1{Z={nnCC2337Y~kO8piw|V@@=nWlQ7s8D4YV;1d^hHCc_m4Q+T3s>It^fGM(RcIUPX_U^V= z)2hM&um%8*W$eeM&Ppl@8qx}h&Q#Vg{6~^T+Q}c(yvraw>O(`gC&sF+XT-ThT>5&! zKf1wjPXHFZjT!w6G)%?swFA#yniMvs&F2u?-XS?st&m##-P{$c75rYxs;BH{3>Yn? zbA!??+>d)a#j8Y1ud?*%myVXD9`zN$9q!IF^T@U4%s1XsT~0+MWZR%LwIU$(hZ7l? zuot7)62LHxOwThC5DF=cYm87Y=fIuJ{~6?fypX!YW?MMPAZ=V&P8N!hrqtU+F{WZ} zNfXox_a+f?dy>oWN>diAg|uAG;o()jhOAWtJ2CEcLGi>9gs&gGpWCeiEQ^9TI03TF zG|BpfR5UmR6al^W;hR7!$Q5XL+beXjZV;Jbxqr`CWymIQtxMQrsL&>0UUd>(bK~Y_ z=IDcx!LMS^Fb~;YeLQ16|MEr-n9KsAY>q(UaI~)$yt{{psG^rc@eG|ihlhZ z4u^EN$Trfywg)Yo!1qbduz#R4u( zH=CV?mI}7U;vx^6S+EHQJwp76_dvY2R{zQLGt`2$o+y7aIjvUi+p#M311L3?BA;fUxNk~EaB%MJt8ip zh9DprpV-4jnfaW%h=dpuRJ%~%AJAs5natEer0^Jte;|%T{9luXnbH}0i~@oU1THM} zCK2{1*?x*-Mw=N^H^smH_N45A9T5OnElJ^H?rnwAE9?9{Wnx%2G7zuBR}iw(Ahxjx z9XN_AQ6i`KYN>#Y&VPPE_l)3Jip}?q3-_zmY1&zU794Mvs!`5&KNLI&XGO6iql4-k z%e*9+t@*Z;`r1y%R+_Tff$>4jb^>RA8X$%$hw!WP*9r(G8d;d(h9-*(p-e@a)AY+ysadB_}n({Rj+T&u@ zl|%k`wPV7U26Z+}#gO^ket)93HMMPHt>PLU_84!+Zf(16gNXR!fs$q*>oJ_`r;ldW zcuNfJJs%Bxff&EJ$zpU>>ABJJr%lSKe`>#|fxVrPqOK$jO1eu2`?<+BV3F-j9Cc=@ zhYfk&(9~LX6pv?G%csmZGtc-j&-ie~MN@ULgHoC>(=x=dK4=3*mkBP$becLnhOWF0 z-_xob@!!uF<%FZ=@({z2s*7u@ud5<{kcjbQl=`4elbp!9G|F`?<@%dvX>=)a0&0>R8=f-YlLfBbg?yeO&75j zd8BXR06h}HSKT{ZgKHYGvOxj1`#iP;qGToxST{KOO-i&McxbS0Ns!kl#5xL77&=`9 zwxQQM`gtm}$=xFKrek4+Ggya zcOJ*~oGx+iQ0gUsBj~eFgf#~f$-anefWLzM8^jfK$=c!UIi`7*a9dTPT#hsWDR%wL z^8w3a$dLHlVSNQ+Ub!CKS*OW(p95+h+SJgUeazuZ-XeFfdaQ&p6xjCBx?N+o(lGZ+ z@rCS~F{Ty&3Y}4g1cMh`%&srtOC3W>fix=9B0LeBgwQR0N0O~DEgOOOCd(XIOr4xg zap7JIQHgo6?!L(-C4R_DX;8kv=a~dqsD)T;T1uS*P*BYAD@tDDIj{@KouOS^XR#cR zENIn!r;9zzlc|0PRjX7y0Uq*P4b3#l7^`iPk-S*mi%eh=G*+qm#IFCz<_VD@oqb7N zy}d&CQ&SCs!4NP^#Qw#xm=4r@%sdQ~diTsOJxJy$?LrbH62A1|pzxA>%AT!+OPddg zBW`ud4}b5KZKJ&jYaCQf4_4(Qpr1QXMhpoo@2CCV(yb2Rq#FOZ7=A)n^n;V1=)BqQ z4ijFUu3=%s zmg5Y!-GXMMhOljf!F4{?EuA7U%S9$l0b_VA>Q~Gg6Lm~SVUjgh>BVhCy3A=7dS8Gj zJe8Z{UkHw!9)Ps%mahmMPh97N{f>95FKePE-rfQTVN0a!oG-xavrST0C2V*4PNImp z2(x3%z1u{DHB3x;&aJX_rFN743h__cW-#k>qb0V(EPfR~d#Hy;z4M$1;+CFXwaOqQ zkl+;I+lLICX8_3w31JI*!@H}B=C(`w13?cky4*qZUs6bx|2bUxU&Mf{|7r94|6r2! zUvbBOq*30{&Pd6`S&L3ySd>oL#NAovzrl}8|1Ey}k4yPKFS8h#+5UIyJRU zw}c~rtuAHx#rn+ z>c{Kw`c<}uv8_r*H0sl3XOFq=s_CKXZfR~QX-H@7;VbCVzy5rTGf)f*6S(0ab1K$+umoJ|;6G;7P0pfNBiexR*Z`%fy zZ|Jk0Yy-o~B3{!4(=h!V*RaAl*!o1Ucac!5`dTXv>RltKyydd0twj%Xzfy^WhHA}D z<1l+@`=GD_020lu=<5+RKKP$*M=}Q-RFjktvkT4*OBeyMrh>4N8iZ3?yxdZaS)2L$>*3Z}dfg@WR{nT!1W0XarLQ!s;u0F_&c+o?1xN^k0 zzip+yimSABx`1ym0HCJm$o_N9$mldraw*>cdpwvCf+Z$>kk_nFv`4w^Pu>={B{!D1 z_a0ym-Lf}&A7%UAchT}x5dH?qp>>QRg)fH0+UCT0A2Dgy2qo?aczR0CPY8EA0jtVF zxvb!}bkx_!Yb&XVWgjy-al*f0o1W(O3vzE0J|%qrv?kmJ_8Uo`G-r?>8_)PQ9Yz3l z^SsI)9tgSl1m4&C^-(4i@}m6B96?2W7&jP(3YJ)a??EFDb!tLuKOm_dkBK!mfZT!_ zwsP^4e|UrS&r*<0t|shpV27`}l*Yb(>X_8WltMavU%)1Dt|@_o%7#^)t4B%N>buNj zmBE@wo<-&o0ZH0O1A6QZ`9Y1J`p6bcfvkmrr9NKaoK%#GZlLTO5WSgm=yYjnTDPj((0^eP_pYQF1ah^5qTJdNAgII|{R_|NU*))QkcJ}$YLZan5# z*Y747aDi|eP&5r5QSAJ(GGXoOA}06%lGp@!EDlcm$|K_ zy=UFA&HeNvU#$!iLaJIy=}lv6i1se^O8dg!YmghZT5;vf#UOS*Pcr8v^*MiEtj@+(H zSfCrPnM!6DMw=~k-xwo%mrCp>DQ1_VG<7)@MiZ{*wYApOd|XXBL?r!; zp=>Ht6M8zoH=r5A2JeEBWsM;N#e;TQSs+`2+#M>{icva4ftiLlnj?NK(lrkD$UipG zh}2EnhJ_}Kk}(WB1o}h`sqndpza*Bcyc1`wZv9Cv=8K}PIj%&A^eh1eux&#!zn}BE zfx%qTApnRaS=$63Q(ftMi~gpVh2rFs7eEwPk=iSIjOavrn$mWBw)h9eRF9%1G-mL3S)MfEs2kkX=;C2r%YVpn->S1F(w; zf!%e1(+#WAD`kkVJQte<p6)3K>C0q#yU>eT~;3nUu28%?)HWgC+Kd6 zr5qxG!r*_k2%^+Qgo{CCmJnDYh^z4|rn2e)@hayl_!3|ij8(qouAKRI{M^KQGdrT- z!|Bp~%3NHq7!%CequLn+1~!vK6l*K}tI9TG6ppnu__3$vgF@#_m#CX{)z6)=4cr9jHyqX$8r2v*JxUNZ1*kwm+^Xsm@2u)xU}gi^j0h)G zX91uBuMe--%ouyK_K=1+Ch*})7N#2M`TU6HNoWr`uQ<=bUP?XY61M%Y9foA4o07>g zq&L zGLp7fe8A1e(hbc}4q&U(%Wow7g}*&WfUtS)N!gWAA@_Sw_~u&4`Q`-nTr`NDIY0)8 zWRquNShoI>NhK~bdpi2hHx|9GB@hx<=*%{AMca+2nj7Czh{D5m{Epeaz^`A$1r>hZ zgl`LRr&=hMRN1L=?CAC=n4RJ+O{Siv+U@9+DgLV{ehhGLS~C_a+<8cnqL~&-9}-cd zqz?}B<>QeN7HCC0#w6H#8x+oCmD(EZGS*gZ!C58HJYp_n+`C*Nqa0j(tW<=Z2C!cP z3I~k~nnh{W&66+%$@LGApX zeF4O_7oAX9p(*YrX=WW$AX3h(>5OlSZymR}c<;c#=;?;fPrVt8lNQ0&stbmb?^rd{ z)6&9)GT=1hI^Se?Sc3k$r+0bE7s3W?_6W;o$(%;^48j0JllmZ`&ftk0Y%vT5by2#6 z?(=Fd2yb6>&HA`cx0k{aEI@7^v7hhfrdB5#NL=}GQmLRJ+iCQV(c+9a-^0g=ay$he znrlP{RZ-!z+FQp9i3(W9DowtFn6#2UwmP6mTYe1`vv6M`5U}IyNKuz!Uxv_2@*oFw znJ?h$GQi8H(3N*p350-}G8iz8dxeXiTYE3$R!hczEO}XK8~*(Jmm|PxNa+py6TBU{ zRONw8ibTL^Rf+J2`$uxTQ2;Yzsxj99?fK-ZGYfVR-vYkXV6O39V%1L&?N4jK#=rHc zWeq9!Jn)Fr?SWP~8IjCD{ChAaW*!(0oG}Bx5!tR})z{3iG=&6;SbTvoMpMeWDT^d_ zT3Bct;GPF!<}4Aox%(8%mW@`{6LtkU2lIUfHU|?Dz+P(rz?7>%3-CUH9o3El35;@N zR&3%KW4ssbeoDMaV2@d-;Da@j0m|f|1ih$Gb&TL1QH+&bIke_Xu1D=#us+-AH6Y{` zjTQss$TuFMd|ul3ov;yklw&9VFyw9^^c1vCWCAa-Vfzx16#bpLp4LU3Q`(fLcdR*Y z!L1LQW14dc=}L%Q5ER2HgGXjiA*9Z_YwF4c=XLp=4?yfy&lu*qk_Jp5Rc;jSG}&BtJ|+ceh`yS8 zl-@hDrc%v+mO4}PG)HGvbiWUKmHRTOEbaYb4f2%aa8BQ*quwqxExS!sMBmq1b~ul) zh_HPfV|iqGYBKXqS?I}i*LX6`f?|A>a#7Wm_gAjdsbg(%ikm;3bf_{pliEG+Cz+1%zn#t^Qk+91XqV))ecSdbulCayU|^3M!>UM&ZZ- z9jvjmH-GPgpwqzSMJ{mC5P&9~=+u&x*iPz_e^I&a?L8_Umi^fZd(Xr|8s(u+Z^t&O=NS4Hby6n#Z6^~ zaI={4uX&4L)*HhT)9!vI&V;jqw$~+GL3!_;@~#bRq=WD$oNGptoJT^9O=?IN*rh%;4D7GXAnq~6uXK@6yjj_D*o9}c^79zb zNxP?tKc(R;^c!_OQ?Brwh#+PU)kDUKD4;gQOM^0Lh+n&`W>o4UT3tE@&)!upg zsCMhKN-hvm*EsNd4xODBtz=Rb(0e*4tD$(*HvOxbr(PT!M}PdY0j{R<(dlQsotLgc zec#;BD!@mFLj8G_lmR(e?20<*P?q1)NY~GzmDrLoaDK|u2w^bZF$0{HEdG8Z{}Tvx(3?fi zN_fp#o$>ue+-RPXYk?m%qfK67u>L@Qj~;QG=sWqqFPYova&bG3;k2G^O9T8zM;ZQkkPXSzV;DZkp zjD&Oh^n*UIMyub$VLd{`efoOK#4~4}dxH}Z)eB=$9k$c>=y-y9orRwLxP6%0L2b5x ztC$~p1LLk|>kY_Ibs(j|2yI_X;aKa62b&9d9^b~FyEaXT{J2IixMM|lFIV%oA&O3y7CeW<($jtIGJ_Nt!ovM37TxLT>bVo_y zDaRTxZ2Lo6;oeG1VCY4L>F+Pbf5kQWb!%5ozp{52+h_A<$wE=4FKxMC_y<2(==s^* zbO-3FuC9e)&c(&T_X6J>;*1XyK2xa@SnPG*_=HaDpKIV>Ll@SV!=^e5C0fHk(> zLYY>+!3lM;H^rB(VuCwJI-gd3Dq9r3?|*IIHzEDggrDNgoyCCLB@#}~UJ@_l>N;4O z`#~_@ezmQ=@e^|P{S+K|?>8*pfD5X~3&Q82)djx&1fl+WCG0+}On`=vl!rg7)ykd2 zZiAUc%qQ)k^TT%Ug+s}9`TARwUiX6Ig~E18?b-*7;vh{-v3}k^8HZfG-)ivpAf`J5 zF}&2gXJG(dsT<$=0RD#4i%vkA$I#~WgJ(Zc^wW9gDx^G~d3^flzku3p6GxX=4X(RRq zAHZlnehY0QHUUDq1qo5ul)%!xdC2F+;)UGx#?43rj)H$PhOX7zIykuJ+aY=1-lc#} z8yHS2Fk7=7X70}y_`6+Ch!*;J#w#vy9a87H6EF$9Vcj&+g-@?%0vjH9#_}LmY(04g zL=nn~mXA1qVQN;~;;@PoHLy1Br=(GWnYLZydYo*JN!wln}&NK|Ayd3k?P(u*L%PWEOgq}i+KXKE0pTC;J|muR>J zq5Xu~^b&+U_orh!u;xNtzwJB|0;=_>0`N5kuR;<7v0cO6rsr8bz5(^WAAX-{<4H^ zdtDfEeppZw8;5G~eUQ34CxMwqQTl=#LABRTtRo@lyeUlQf}XW46jq}B8@Sh>2dpO* zo{rfVzyfn|;Ub2~jT~KI>9D?o2T%j;Tr6Q#(6{8BtNO-ft7@}pgtybhoLj8vp#;w_ibNj?qtKQp0%XrsE%UsjsTq*hcjTkq+dDp}NxxU7RSq*awXA0hq`z#T?Hi1--@c-ra}m_RiZyncSCE(OVKV?Gb{?RMDet6q&X~TZN(wP0C1hRZeYqbu#|0%6v;{n zL&1CuFtxW&KBohQL*x*mfnj;yHOpJ_R@tl;(QH+1sHhFyokqsxi54b{c39Xgi6)w8 zdD#h&JX=b(z*yYXrWkIxU;x1i){5AxD3TS`OBA*3{6a|8g?*F-G%5!1TGMJ}kM!$z zkihRfaaz3?wOK3c^p`C@dTB{g;H(hiRiU^o{^GuRf~mEQCG#{Hi_g0@mhyNmeaGuH zP+_wiVKY&~_-}F=IquT_=FQSrnwSG&aN{k9bS^l-Xm;Kt1aVuhEeBDXz0vZ4=EJH~ z(<`=iuIH-iJG11)iIu+aBuhmR7DGpID|;{pvXPoNxZixcS1rm0DnIT^b{fwaNXuG= zEzM-n>2pQ0RFTbEw^6gz!(R>i$)PNu(l91uhD)+$xCt>jgnARp=he{!1hI-2t;qd^%EauldWL^@bD%3Q>JZ8NQy5&bQcqp(X*K;J+P z{|k>{|Nj$@Vg7G<%zs?U|B=VAu(JK%+D$`h8cv&{h`y`;OnCz+g6P=X4YX?G32ukh zNo^}niT}tNjEZ2I@W7KeYqn~I&&F%peHCW*@C%tT5?YOs(Y5hN_%p7a%_t<6$g$(m4Ba$wg_ z25_iKo5Ce0tLvD5n@QxPXpWFFR2nWM5>)HfX+6_YOvTheeHi&=N~ancra1ZR`?DG7 z)m~MD`!wz*)NR~glnd(V7JYb<{p6#io|If*inysyb`I&j4SpEO{Y8EQ``P(xz(a8} zgDU!vo@c?DY5ZAU+74rhihwpp&fp3}|IRaBD#tb!1uX!(xQz zCB+hW=XQv%8Emm#HGt|4cNRhs6N-0_VaMFcmr8>50;K$z$aD96z?I_xS$sAsKfjF7b zZ(n$vl%37cBX{jz-Ouq^h<+7IMT2KaupHv}qYkKvk#%v{cY>Ou9PhE7qdO(~7Tq@i z+071sc}%|SB+7Y*JWeoI0P{t%I4RX~ZE^lSs+K*#tjgUKGu;es{XTR%*c~kErn{iZ zLcpB3;Iu^Ie6;T$coULAl8`T|5Y=#eXkJubDr`E}Nk*E-tgV4DF%8vE@FCL*(C3=y zUBjeVhW==f#R6$F&0;GWwX--Pla-ZmP4|L3vTQ|S&SGvZDRzoIP$8suafGllt9IrQ z3!|YUq`xC#eeeSkNv)D4$r?Z5c_7dZ5Ut@#0Zb_uSyBNR0anCb4WYX(w!e&;st3XRup}a#;&hiou^p>6E*Ao1gB>EafBx<>~3c##H zNn}!$>rpX=ab>!z%4H6l8I~ZE@6_VVzRhJ_aDc38lR(TMl7XZ6`PA0)3RV01CHxMspKXrh zjS@4cQsw|=HgTT{2Hbpza3Nw}h4`{*Y=J5?O_{Vlk-L%(yk|HBD_2!W=+& z*ksyn)eFfPVsKw-OYs&&z-=TLv`YSYcEkQkY`#I>7fhJ>3z6_|QrW;}t-cD- zzisQzo@jG%+Qqgfnhlpp_M`A5gMTK8h2aqmjk#9WsGzmGCVZYsMfU?@d`~ zs1m;`GFT5$Yp+JY32UQDvb@GOM>5w&;3Eq)Yh=)+6s_dL9aA$gHN#4|CJr$h_Ln(y znKBz=w?=QuN8gYxT!Rv?>P(n#5yRgipOyYlUjtSG>9fi;V zjxNYv)|5!nSqN)B3&Nqj`_o)*Sqf1uSb z$Ov0y1RE+?6J&k(Iq$BxsR5eVU_kTXMeBR(EWNpVfU zZ&XP=a!*G9^zP{7L?$l69XwwyPCmY(2}ZEl?dYa8FH2tNRZgo9$ow1mpk;trM4BRg zy+b+TFr|q<&hHPE#i2=I0ql9y>$7@@h zRypZEZH=m6ig8IrdfaO_J*J9uj#2ad@QHH$>WOA{f{(`KZv?qjr2@DkL_Ak_=jpZH z;#eH3`d8hVaPaFvWBO5oiH~v|L`i|d9bqKB14a$V{>9xPpWI~sMd?*@nX*?gGMhjw zfiX3he*-0#c*_Q~bO(TaDsoGMpd(Hlq)VvO+$SywuTt7qQJulQhhI#da%3G#D>ZMd z$^Od}0<-tB8qq<7gej1`d+Bhw*|haSh_lS^E$~o1ew~-HNSHXA?08?T*rHjg=oV&a zA=R$k)0Py-s$Rr2?sVwxk*dDauBIiwb6nT;tb6b5VfEAY#Weg4K}8U<{wIL~-(P1C zb?Yf>O1`8$uZF*w#J}W@dNCZUMpx3m`>Y(NPBRqK8(V2vFWhV_Ec;nOf|ubnFI*Vm z>|=7Qwuj$aBpgO!B=O=L^CaVm=2!UU3)~$Q0YizEMa3iQ%85&wC-Lf-eqDw&iF;6m zbzLB4w}m!wf}Xhem#NJ$(U{c3>w9xyK$jUTU$h}=rdNT8zPb(X+D zC+}$0a|VX|Gz>sFj|;)MTZa{>BzLhp)eX%hz(MTR-Psmg;E78t#Q7<6bRB(^zcKsh zYdQTqVaa}xxjYM`r~P%ux2-m#YKTj*9=g{}7riG(L?0(JXuR(Ln(h8(Su}57XF3Zm zxZxn}xJ}n7Z15lS4%ZowH|WCMTXUAqVu8(ah_OFr1S236G*9t&8PHKMnx97|d@16< ze9l1M(I*jBsw4d|Eb`C#A}}s4}eu&Mzoe79MiBrSOFooRe^J3Mo~?~ zml>iVq7sLCE(F-gthOP%n* z=;zWg0j<+YgkyX54w=|*tgAEGbfDdr+ZRVqS2y;Z<*Q)#D^!czLK<(-&XbT9g#C;2eR4Lx&c+KRJ|yY65aoUwRZ>-EsC~m)3$Bjv~AnAZQHhO z+qP}nwli&9&>!km!47w%YkGx!I-6{Ym;CvtIHtX^Q(J1?m}-BZ0pL z-V|q|~F*o?xSkhz`k z8<^(V2~tkHYoO1_=no&m0&LiZG3^G^G(iNj+6cc>o-NdE4kQCzy@hdyV1Nd?7}0i( zB`qxmo~URx_^WAT3?LXJU@!^lSwEjOm!8fpa|pwt?;!g0-{sYn)79f=E`tC~mb)w! z9=|X(*sF$n2R~i?zEknt{1K0XP7qj>2VAr+__+jb&tJ7&!&+eT40@*M8@~PMmOnb9 zds)>s_Os`gMne2nq5dPo!&0Iqqu2t|?C+uJ9`%1Kfi2oMa5w1QLVi>}h-yqA5k&4e z_y%OF_~8zu6jI(5Tt~cBhy}W7mi^HqhD(bTm8U*{R%=unZ@rJVvrZH@bLuJ?&%trM z7-BWhsd$&R&JfOW(kF}zk^%7UvmuMPDWj353cX3As>QzP-htyJZIBO2|74`0UW zwpqs~PA69^)NH%zzt&SaiW9qjr&aysV{Ydkw*Tg@^|sOa($U#2D{te+R9R{+Ga#$^ zC~B`Tn(tOrylbS-B#mtT>s|6ybizA)XNoZj&ql6I+U=#iS^0fxHINlDMs^{+U z)CtgI?}_9k$!KpQmXm-i@V!@46HBP&QkT~%-b#wE?K(9n#@1MmraBjEH$*m#8O!H! zw#sxTi}t`&uc<}AvcB$2AnP=>{Y+6OTs?e&+i5f7=T!OH8*)Nf>Z|=dtaBS13g~W;!j=td zo4nlxRWrZkrDXV%kp2u2?FlKPAj{x&iiAz^f_@H68!A|hVSDDAOs@Odb%gA>32f4f zP(;DjUvsi7)eP8z2Ua)Er&o`p)hsrl4qc<`jB3S+J{83b*QTeDK81)ax5U2S7s{SN zQgk5jIh;FVE-M|nVrEO$mga%_pbu267G|YOIU2e(bA*SQk$dl8>q>#;Q+)-^DtPfJ z*tYtTxa{Xt>bsA90o`{Ge9-xZ`9}y$b?UVkW|<(|0<6*jY!VXd--!F`E+S^N+6%=g zxZKSmX4;b9XoCbVrHx&D^wkiZTe>WJTlXS1Ll3Fr1ldH!k5+65BuJ|8WE{g7z2+91s1!`bq4H5|s#jw{jK?e_1&SR4?r{Sep-vyY z*P5laeoxUSpm^}klSZ4vAa9v#PU0Y@IX;3ucJ<1NMYC1i46){vr1=txtb4Q2#oQQZ-$2O(6vkd#%{PUOFDkjh-< zg8S|FAgDM~U>hsk4*Pg;bZMPob7**g+-wyc*SbIcUi)q#9&QH_!zCua1+|{>qU+F> z1(#!QHvartVBsKRj5Ss!)T}V|QN@zFD&kh=tct|SGaQ2XO>5H%t3h`8aK>4M@3z^QdSOe5NxQ5amv!I@{sXaOh>z4M0uQuAiVTXzTOXL z){$rkp_7#*-+>kCzq9lBdp8t6fkIsK^f$v@Ri_~P?gFI&(vwGpwlXv4pM2kWXLF~% z_e%M|)lrGBT-4D+BF{hvLY_0Go^3-|s#~@0Emm(=xJGk|VN$@>XPV+N2b1RAb;9|F z2R;}dssCOjLw08NWYE~E#^w}R6U(E7MQuXJme?~yJA{k(kVE2o(1*UvDlH-Glf8nJ zyPAFt^Ml6)n)WFo&UN#{&*T+w1OE~9D+(UBMrN{BTUR))T|6ot%}k(HF6N6YJ5sfQK-?d z2nUg6#-fOaBGEw=E8U!omh5f8uNKa95V5l!-L1i)nykKf46}_0@{n5!fvl%g7k~Nw zUX=?MY8^P*mat^rD!p+JgAR?~rZku{eRvRQND6)vM`A8@lFCx^v_hl``LHp;Av885 zR5BOOhAhlwRD8C2!l5@+>W?9>#fd=1eQqIA-An!kZuaZVE|UEY0$^O7L^2unxkTjO zAnnlKO-g-C65iIfC6OMoKy6ulnHgWnog`Od!9)WB_0|~oR|PU#6adnUG3Pz84YL&0(;NiULyrsjevnlbv1nlL_yIXv-fIk=-i^%aqTXWrDp84 z(ddF^)pWR>J3}a9Bg(Y0C;rfwRUzx?@TT4`ePtbd%lHdb4qFZX1Yrb9e3eyuu$QJe zVsT}-0L+ZT4QLg0)u$E7NO|~p0n%0Wd&*>;g#*IsE+T44LC$WNSX`mxp)LzBd%t_K zj<)qq9pmBR_(Uwxl<+&;ci5g6ULzW&*^t44bDJIW4wB@STjDB)uVif_7^h|B`}Q6V{r3v6YnMI{~1{_S{)6W0xc3$~2#fKc?Lc zH88NdQz%U;yy2WpQL#;PwF&67M~Sk8DK(fg$~g7sG1(H12U)5kLd~-Z{A>v-uA|Dy zhd78GAZmZ$mW0b#Dq-5(MmI#jwaDO7uLP@X(JzD=)^L&2=6Vi3`II!18&zi(hMwbt zDgX}(Z9>U%T6kC?Z%3rA3TN^)4!y?^O_SD>K{{-NZLvvG>3#YqKwqb6OgkXM!o&c5)}^)u zMnv)Ta?JvD=c+o14~fG*9uB$QPLEEqe*Y~vu;YD){-;2lPkG`u{Yx zDVjLhxi}h`IB|2+iQ3sZ|9kz1SdD?>e_TNE-v`70Ygyy{_xykM%&`1d^!z{W{r^wT z*_l}X_icvke=;@fF+`s;wP~&JY^qXaMkSB9sR7?9;o(Y&r}&Ar*2EKWwG5B-I@LNe3UU2!iZ9T{mY!FD6nC_t?O!6 zZp_%B&sL81?KxD|L#ix2UZY4U_}W1RXmaw~UDz6sGN&vU$DO3Sr>{6B zJ1>pam$iQOE>qFktx@D_3amSC;q5YZ3d_xH+_$P3s&r_-7W<$_IFtSb8kBTd2qZnK z&!Q=A@FDXMfMnE%_-22}fJ_D6V6n%VdS7>IyN!%4@H+Y(Z-mWT2s3fwy-$gM3XxRZ z5t5V6-E1z5d^kSC?e35)0#M*i2$KvIr=Ifq3?ok1IWIkW{94xUP#Jquu-?SU;|P!t z1H&#eK~~%C*`O}V(0~gP)lJlFp)iLOUS30%Xv$E51sQGvQ^!8sRQZ7p6j9VoVwWnd z>>Lp}!1VB!NT0cm2Arl2iDwqhCv~pBRFUpb__lnv}Y9nCNa!Wz(qb$PYTVrD0Y#_G>IPnaRU)7A|ti$h_*#EsJw=Y1B%Z#gc>G5s@VmDxx} zkDOIxkUa`I+xF)WQ8KogeK-t0dn*o5)lXp>Lkh~kLFz((Mm$gUumF@~)`sH^IEYLk zSV98qM^1R?Cw75=+Z$!-Md}p=yDaPQE{bq}<5rh+r|qxPeMyR-0D?X)aFuTnFgP4` zvUZg$BxONL4wiOko+uP$%ZwoEu+Or~c>UU8d6q$Nj;is)$@%+GEFTL5zHXx)F4ht+ z8f~VnaY#=@2^_E{NDsEF!V`|WOWrEZzoEYHSaYS(i(=E$7L^>6$XNRqk#V7#wBe-!MQnLi@Mad& zgG7&s%}9vE4S%oqojbq!dWO}KDMOj%+=e;~+}C{ypy4=bMGhxh)hP!J?-WNIpo6UO z{(VZ)fcO-xUI_2algD_X!1~BfwNWA{ZCOBBFtf~|tpvE3RWG%b`WLSia0><|NhydH zkWz!A1BTk3(W+N2&TM&HU1TL?5-)E6Mn3Wh9)_h=<2Le%JXhzGzrK;;+8m}#z7d%A z#O`RT@#Z-?_f95-HYz*D2$*Z!IN~)NN&rf-#VV?R=cy73 zwve`cWyq?bx(~LOMar{01v@934Lr(V0iVd4Wf(zYqp7J(lEzk3?PM8Q(xp|B#0hzl zsY-R~h4CO<#*uhW=2?OqwZN<#ic5or>YM>K+M3|p$GDnYL>l+Mo~IWsnU#%Jj$8Gih;5>kTnUde{PNE-D)zN>k)pIXsClei}~}7 zd5bf`-~B0t=sal*S!znVi$D5)k_Dd>A}{Zd3C-gu_vY9QY6@yFJ7B}Oza6TV6>i18 zMfU*rL@iyyfXY@bs&5JGs)lcJB7iq46yhMwz!||3@8JMqk59;?%#;h6MduBUS%Y`6 zf8jWA{rRW)feL4vix)@qTX2a(S}p&opbqgct1u~{I@M0C^Qeg1#XOUF(#Y8RM7GFE zYaE-p(J$oWQj)r36^)Z~vQ5d%!$kNcIIENFau(SBI&zEU@>ow7fR7DX&&3ho0@GrmFQau>)GA}cp1TEq=o z1$q^~f^@Cw9kk_*n}A4k)w@#(m#p>LZU*ij?w3FU_A~B0u12d^8>tM$*s#PR-_jn& znqdozdJBe{Msbe6p6oGr;x%gOTkdRZKjZ@EeHZHAsW|L8+>9YE6WS3{HN6C2;GO5< zhtB{JcCn5Of=V3GkZcW*u>CkSrZhvkpu#tPMo7P4CK~f!_P|E+4IT zhlzSKaDa$<9{31&yjE_cLc5Ag5F$RrWZ5FId_6{SaL-LWAqqA=389_kg*0VhLqKJV ze!jG3RWUwgz3Sn&&E}U~r2be42$MJB?=F3{bf+&r)~Dwt>uJl86%dFFa~{w9^$B*E zxBju`m=isvox5+e_EAEb$T`*Vnf*WS|@qwI*{q$%qk1k#DGUU|6fzCMsPlBhNAkg*09d z5DANet@WtM!T{M*c=<7qadaXY^9bMy0h~FGoyn#qmZ!9_81>OUrQ+Wr=TqQusbqPR z11FQhrJT9vvWs$F1zD2DQi61hY27RGD9;8&*(oMyObRrin@&qXt-CA=O=M>%8E1;7 z#S&aWT&$@|%qMO>iRW_3SuGXrD%PCANup?T6>^cLY#KKt#D=Wswuyw-{sCFMZ*iHr z-d$DYDa7sbz>f`u3w@TH+2u^~-)7I4L)&nWq{Apn-uuvI&zQOKeEUw^=r&g0Opt&{XOi(KtMdh!qdn3+tWdBDBe5z=S|R zsKdb7l40Q-BASCFQ0chmVNge03U()CDA{2H*yf?~8QK;eBi|;hby0teZNn6VoD3OT zGf_xfvZe9A{c6fMS3I>-NM!;Y%T-=GA2Vf{c{!(sh%!WPixM0?rt+CB^K5o*`aE8> zC3C-XVDSmFKnJ39y=1RtwygNASP*H=W=%tCSE-X=M+|S>)gCZ!;KUg|I z0Mn|vH5I+Amkyy7nH4T7ej9X2XKaYo{wWg{#28ov!$Uwg*d&v2Nzu$Cr8*Rop#N=7 zPm=XxV&yvc`gnTWdF{Z)FDRc3gT~yh*?pwiuRE?rFjmh$z*hK99s_a|dQiISW;?=M zrKbd1AB8qzU`n5Ab*u@5!-Z_`GK7ZgOifFR3y7 zfri!v6R;z9-3VQK0(;*4j~zW zJOHiESD00~Vmh;&M-~NYOtLcE>)5v`uY5NHnE|;8+NJT-=H=4UdDgX%V|@*MH+yL@ zWYOt2m$n~P^|A!j(dBSf!BsR3^;H^KTpq4l`Hm^+(DR7gbdMZF-dd+EpG>VQoKX;0 z25W*)@Es-CH3+wilpWbZHvt=7v$v^n`+e2tMDg`OczIP)vw+E*?qMG9Y2Ht=|GZeT zB^IVJn_7E(7p;^7S*CJxHc!GDDa?oiTD0c2CW^tZKg^wBdh9^wE6+fPnI*X-Rtdn{ zT(dkX@z7s(!;R&(?-?DNOFCu!kcynqPq5G2`g9sO=n=|kUT9=)_v8g9Pq~vaq_Y8`68QywLF1=ZiB#i*}hVmF$h&QI~9L z;DVgoI)yv+z1e>wGyGQER?63uy{AycnPFV}i+a5epB7nk4L?v!HYRBwu z+qN65V0c2C;AF85(Big)l2JgHLFUu~F+AoEdP@6<&&r^QKc}MC%90s+FQSH1QUtKe znU$Nyarb53u|U@l;pqVhUFun>&+HN}(ercZlLnUd!_n{~Lu? zc7B?pg$luthRJ=lF%3eWW=s$)Js}iX*V>58MohIZhlm4;o+I* zEc!>sW!hP#T-{#;xp&+P9X>&$t?<7uQ^`DGm5 zoV>0*!*c5aQVkU>sY}*Q=OsfsPcDZg){M;czMoQtrRdh5iV>rmpPQXJ^qDEo_uk%4 zHO{ws7x>@O-{rJ!!#4A@Og3t&jkuZ>AXcFtLZ5ng+>aue0Qx4gHPL&L66%>UOd(LU zqC&hAlB!9<=csnHSL#UeHsqi~jrh*9R=xwTm0CbLZ$vBexV?_2{(=}!*fC5Ug$eDY z*T2Aa(BPoa1Lp%aDm0}kEwEuY+RaEDhIcZXt0!|}0_e_de9nxAhga;=w@P1gwE|CG z5%qHZFf(;Lem<~k=jDwT;ZD@uND;4xAhrz*qy$e0stbrTd=){91OBi6hj!)q{e_57*#1Ee7dX<;6H@`rqv&82=$x8(=qlh;fsP|F7pLkbNpX1BI-Y;JoS@=e(3lN@g!n`#3GZEN ztU?HR5tc|JNnx|esgW$AN(q42d?BQUA!#D`(ko8Fj@EMk!s1b$iqa~UE$9q zwQggcHrkoXDYt8KQFeUFey|pA4ep^_5fH_=Sc5(c=&4-2Y01P!SppU$6NFl2tD53%|Y>U<5mNzso zS$SkV&dj=90JknjxN^m*DndxhtJ@rb6bEQmZ4`Pqh0U;!O2apj6HsSw30)AiXRXxl zR$JZ;x-|e8R(ieMgRHcS0SzcIsu{+?YYWAZ`ris6lKIZ0osnRI<_(dNVVBlQL5%sI zeLGFuw2>wQ+UCvF19WJ1SryUCPRxX3Ye)L|#WX^S69EPK4NOY}7}aMedr{7i}w_iN#3l3CgCB8%K!JMjAuy=k%xbA;xPdS3>z4)_F z1)VRhsYY>qTmU!Qi2@JELAVrfP7w>9ODA<^l?J{^0W0Em#zNCV!mr=+Athfj^2MoA z%VB`bS^EZ_2fiY69*nQjEGd?U^OA zzqGf^U}Bk|oPiSb%E9PqLJTPx;3BEirSeMp%)6zfpF)U>o_W_A2Jix5e`AolRCs0G zk30)$Q1m=1JLF70X2jrb(4KrtV7j`9wpGas-&rm!$eX@k-o-dk22o~<7n`z7U$SMX_)NYA`q~ILm6^Pkr-d9hT`af}t zLGGH0#B`dU-8Co5YK4A+lhCjgMCh;O_ zu@c|3&fn8(Kxh{BnH|Q`>HVpi^KI|v(je~PWMZK135Kw5188gNy0qQgY+#hB1RvnI zaoo{H7^{GKIKOkzCLB{inRHeNF5JU`!TXH}g%$tiqb{^fpU6iZD7x#ANDWnH?(N+X zf^Lo%c*l|3Bv6|+{q9hIXdo01@yg!!Gu+UQ$0GXqQv?2nNsPwMy&yJ*#^k93j(r_J z^^NKEYCkVu&J3?5hbvA6fMd~$*SaxJ!er)bRjRI`NOD7T*KbI!=Ri1bNstvV%~~5g zQ0kCfFv4d_9ZAWaUrXog8k>Fyrg5;OS%2W`7XFKfaKOKwFPi2PcqKD^%-V#;+9K=r zXKnV~;Ppw>Z-ZqDJJ(McgN>Vmtcysh1c>~FZv)3dMcyvLch&yMs{n$3pT=NX7HP$x z7ycLa%;f7&X~_TShl|KCjbS^rDI|9{ma&%(z1f8^tf z|F^mnDq%yxcBJB|6Dl26E!U9WR8sLPZ=cgepHm=3SxY?4EXUI{bMFC?drztg9$n$eoNjC0F6(s@XpL^LBezNe1&uG&6hw|5gV zj$Rf_IxC^S*K?+Y8-K8L@~(I^G^y2G=gu}X6pK^RBfvY2=HW|xE$@(?^vXksXqKz6 zH;El}CnX*7rqf25pDdZ}l4EkNJ!J0a^I*R);SOoEexxHA&(5^PeXskHu7V;*B*luC z&&Fffy7!T5IR3WYeXP{%MD1ZOJQCv$#qMIPwUiO>k^9C!G@g*Uf~#dNIr>oA8MN8H zsG8iiFkG(cHrai!Y+r%gT^GfhlY{O-RN-xu2)PHCMf9utJZzj?cQ$%J){X9(Xn3deuYW-mmNQ(?p!kcV)x z=~-&GeTzQI8USjuCld?{1ZwJ%X%BBCzgivd?Zn-TzSpRcOp|m~j(jSTZhbc5hI;K)`;k3~^6BI(PV`-ZzU+~;qSt&c;{9wm ziHl;INpa+c9iC4{<38|LIT`d>L%<`Ae83%G7)6j24y zW%;!fj6Wlr4E_0@WjI8|5nxyX3>Ty8oj$+y9B`-Iuo!(w3w{-zruJ(K1>2vmgLHni z;}Wgo5QfoE+xL=qEyrikQef<)GLoBlRSq-HBBo>mh?YqMuCm{c#;`o^P(N>Py$hBB zBVt{|%LoQ_u=3RC<4CqaKgu@J#*d>ZjF^f8MR4Yo;5UArZ6L-7=bz?L$UlHBG6P^k zkYx#!w3TzDNC4X2jad^=L59G$!9l#PiQeI-8NnS2TN7WtB;=67yla^d?GSGQjVhMd zUvOygUc_k#O46&S4lCyudVTUtu-Sa&?XwtbMsqcnOH;^xQ`l=iWAzD%QRPN-B&D_o z*<&P(q!UqKRIFX^IPmXZsC`x5)&l?FvKu*=B_a*uijUFJ40U5b_WY%qU%MgbVC0kq7nJAV4;P4)3;m2oAzZ5@N5h!5Qh z8cmJowTD4tmn0Bjc-G~LyO*mWx}3-XH-jt{l>K0a&yV%dhI*v&8^&pgDV$tLv<<(ipbDR-Z%rA$ z18@@_mN_q_>XRjvAwwuT_aaGwF&uB#6(;=ZQf&H=wBu;op8kB)>;4JlUD>W#{jHR{ z4-wF56e%E&mj8pcF5Wx=czFPzf*o5n-lV>EV5ZHv@CyzOtHv_91_QuF)+v))3&4{^h z8Mnv_KBZy~PVE@|j@m6X@$%AAnoh2;d_h!4y;I(`swd~`;r8zrxfi8YC%dQ9-GS2K z{{8u-Sog0m<+G)iV`7oI>KW0=(-X;wQ~ab;`?%GUHXVQo_eb};ie+l$LXj!;Vzx-9 zyDh5C)uH|$6_he+=;SV&GU#eqTbEB4d5OP5m#k(1RXQghIr+S&Q6oewGN!!s4Cxh* zA^t#m=E_h=fa5JWi3j%5UaBSAc5lpchAdCtUE7O=>$FA7QeDR+X9cT4 z1iPM(%?{6Db$Y+@hWK()V-F-%Rq13}EuC{2LvO(5+7MAgD)%5E+Ek^``1V`WjvB&J z009gP(t5y9gb@P2j_5sQ2fehEoA$x3I5h_uL=@wc#Ro~e5XUAUx9bz< zshyL$5~;cUB|bI2*l3;p%3-^vy$BMXz!N=;aUTi-;8s5gvI~C%;=e?KI~NN;Ejp%v zOvz#Kdmw%96v)Htpcs3oTkoI=gK%!huo(5uM5a*3VZaX9)UQOR{AJ+I&v78VMU^b9 z!5Yx-rs;8}D6;y&1cQ=NhE`pYjO96HCJ(X&T$pY1#@{*&&fec*SXRz31+qZ|zc8Z7 z3`khPDY}f+?%MZ#;B&)q@YGyG>$KczQa^@gv!f`N6DOI;CyFgH6(nW;d+c{S%|FaF z3RLOrOi5rvRGjWWa~xkUbFEd!P-B==$H9G^z-XiT;-uJ-E_uSy+?X`^inB9}o)U5} z#gY`l-JB1nyIrHQc7V#*aq#Q6O#AN*^_&}y-9VwSb3Lrm?pf@x|}#beO+VU z2d(_^R@_kU2IXV)3%G%weOpKPfM3j$T-@uPzjo+jSjx$%228Ye6*nM0zcKS%)fW2D z(}#p~4(2J9C%$ZT6s?>!S3YicF74STRRC(y+r&kC)6VexKrzq2 zb;6-$;k#}G;+uk|f!n#8$id~*Y0%>o6(j)93D)1$8mHebo)%@Mpw0jVZ)j(6cqpfn zmk6}$HH3227n3EEjTf^Jz@zwO8Z-)Zw1B+-Z*y!HLd{e0Jq<)>eW_$As$lWA6i*sf z$rQ{>o}8A#joJmX6@gokpPj!k+^wJyO4EuW?8Nx`+uW%Qzt^L3f_crp%JaQ=Gqp66 z=?ZrDchrKMZSGKXwRon{oA%?SX`(If@9+~Zq%+wZXOEOQd9AgyUSo=#QO$i)<4HVh z0$Ui5y0n+WI@}*5kdO?xXae`6&8S;-bBSfS=N6I9YROtYOPjSN(}T>T3LS280rR#+ z^u6o8m_4!W5F>k8Gju(yKiWp&L-quEf0D=;HC`r1kBjc)rTulWr!1&=TNv16JkeuG zN=peSeQGo=C-qT9MLtYK`!>J=X#jtu22bsKBtK~86AY;e$K(eT29j)k8vus5Q6dgz z1UPWv_^<+yB+((RxpOSD(!x7(;6N=cvRC@hs04VOJ~g+GAWEZCyOFy6W0wpGnp&F* z7V%~0k?{wM!Ip-SN;=YI+X_+RcY8HiNiUus^CZ|8E$lT5VB)Nk@};)3cypaJHhhLFg5`Yw1HB@Dh7-#!vwrGh`~sA+Qnd+6yiAODHh-` zHtfu)AVU#9y8Hyv88!koTUK>IM~XE0g%n&K$6R0uYj}i=?~Rt@M@&KV?Qon4Js*QpBytKgTa>9Y+FNVqZY?0HwSz_9v4zrm{v`o}LTfNY+j~*x z<%vC_zMW@xLlPqWv-hUTN5COC>=Ta(mrPn8Ed8H|b;!uMg^zBsiB6m*i_k5_K!(H( z($QX4q2mg_Ks4ClYRMsh%!DFvERdp57!v{}*7kgrb1H93Nx1k~C(?=jD!5#7Zw7xD zZFze8dKc(*Bss^sLKToVa|PCqJAoJC`LR2NaDOb?hzZRlyIzv^?$Wb8qXV$hxfKj;)XhLuHM<2gy6EiGgiP1!JN z)#}>K5)4IiX6K+`!&*m%PAykf6Qqv}v1*3l9lg+ZX}!ZH>JtTP_~(Pm2)M$EVzKMD zA%K3_{h)z%j$W4ApI?Bpv5{lcST85bO8jPtT>B9@!=4D_Ftl$lrqj^QX8?Dz${9#7 z>q7?dnpFC;%~uA>1&g_ExJ$fU6e(aY*kda52e?BUqpmuUXdB>^xJ2U4^0P)4mE{4B z0mvN2CA{@F8!9sTrBKPNNJw@z5&$g({Q5B{8T6bayuYly5;HLWG^$I#5E87ZvC>!_`9;~QDf(r-JK_h z8+!ZlwN~~Qa9SIkAMqRyMw^tYLD@Jm7WID)p?(s;(hzCYwy3UR@?nKnFuPwaC z(S~)IKvaANo)j$a@OD?WcM|mDpTk4o|FsREZhJaOl%N0_%?D>CwGj~;c9K-2j}^0t z3etlS8o>`rEwDYQ22NpzL8Mxy+@7K`nLhF6JE&3$UwH!*U*ob@qdTi|$-!WV0_)D8 z)IGk+N6<>07XAY#*zTd7GI+AEBo8vM`8+Z`kU!xqj}=OM$Q zr$gD{;@M+io07e|NLr`x=++#R4oal}=ie)h-U5ZlCV{s$(k8ei{mPQyGf&S#n!rw1 z*{c8i)Uj1oEAgnRw$_9b2e3ud(Zn3B#^N6lJJ!AIZ(WHawa2#h?*8rJEe-7<=*o>L zf4|zKij%`nS8+7g+!MTZE8QQcacmC6_kfPYTaB(rQmG1fli4+NbNl0BwT33}9!3_e)q?)|!) z_~B}i9#Sz@e{(>(KD77}t=Rigd z_?uxGxP)S?m_bG8}J5V#^-&rCCM~Rfe8+`f07KwD4A5{(U<}R3IM{C3C`sd z-F$#)7zh!LoG02LVTn3tTu?=y|6>W~_+cG?XvK!bZZ$On<_7%u$m% z#;kifO_sM2dB#qKaH1q8(FN}I+QmUdI?O3^g-TOKA_H@#xx+`$3Y>N()t1SE4t3JWMSo5mIzXy_MwKIZ86bV=eG^>M{iL)upCK| zCDrXjWo~$V1MnPTYJ9v89VxjvgLn@4s5Dhvg^b)DYLiag+1J7+A1@oVN_U1oh&FSR z{h!YDi0iCGlll`nrmEu7eU2$TR8SKUtfk8C_?!=`3n2Xuj;Y>T0cfs=qanz$JP| z$4GY%`97!WRs|j1?zQ@gW}TOTlUmgTM@?%I0Qxa zqP%G4IY~($H>lss_j0dom^x_vL!2;_NTBwD0sFJodfY)FbA3tsIZX z@$?PaOPLWVoF{HK@kJx|Us7baTQTLsrbp#HNlKTISzLcxkZ&H6RRnQPWii+OAj35oo2l(%I zdk_lJ!7-0mkMm@b&h zenNK-0!Nl$wyi1={dKZkHEavZwz) z7<{stmeQ6alJCEi{gmp4O2fR4D^&`WQIgIqU>GBrmKn!ig82H0fy6h2u;abE>1Pw# z#DH#pYMHm^ldHNeIaRT-w8NpWqo|Dy?cl?sv7`@a9Naq9g7D$XA9EBi1B|GZ9C`T1 zm8Nu%B<*NH4^2MQ28u%ZaixY$yd4<4Pzi(x0Vg(`n2~)%-S3h_$kNC)e&eF2H&mk@pBztY&=+R574Q}(Do7OJ|oRNYO zbzM$4GX0F^!k#on#eG@aBO%h9LugjgjU8n{zDgrl_oQ)PtucGXrtez6!nn&UIB;Fv zOCw0_qP=`#n(V#Ry=QPfYHL&-r6TpGU^aQ?i@@)kw*x?GfG10aue-}OV(FJA@gss{ z3)qp$M9h=(w)B})!G_kx{Ae>8EOKJyBHC#vJ@iRd7L8HO3p5`=o`xn*Z0etbng(!XeFp zgE4XCbkCeCX5^}lX_uu$z`&ip619>Vfrk(Y+Yyw2J?Zs@nb2UV;mG@kU4^@ff0GV> zYi(Gu44_cljnz7GSxBAXjnBPZfCSkh7Yx6}Nss(ruvQmR*W!+lU<`Kqo8@rA$gq(X z1_v9%cGiaMBjM{{P}TNra{rJ{(IT|vm%C(2?vimtJe7g zbwe&}L9|)t?*isc>Cw}FfhkzP)dee8s8Srzj1AyOsCRUIcsP6HYc`s%#x2(no2^Xb zE0v?~B^K$a5=F9)5$Ert!?~5om>=~@Aqb$EqZLv2dAhv=)8OwLL((Yjb+xQbL5;Z9 zx0tw&U5ys^rHzF75 z^t+puv<$IfO_LoaX$*{y6#4|-`v+5R9H(g9GT{a??7WDg#nRL=fadN4YS1w-Z$UYa zin^E99#(H+p)<0N0xi}N=^83tOz+k(-xfRBK6rN4Z}e5|%xgXd=HdooJN?agZYKgk zSzETO6)jnLtV2KF-!=(}O8q{+&SlGMY`c*KheL6;AXNjM@L56LwLGb9x6h907u=|< z|NKzu$t-gj5B$lu9t~ePk61Y~C(mqX+H8H@6Sf`-jk>FCz^L4u^D}cbU~Z$fQiXyE z3*u4QE7eYcPcUwd?htp?^;)wJV-rM*EBC?0+38R1Hf^8uN853Cv}*Jp`OazepXDF8 z?2xs@-&I_yIapFe$fO6;QXH7CRi8EA*==OlX#kY~I5KMj2s>IJ#loN1wQu!mOzY9P zK{@iVD|z$|6N;M({dsOXF;^L6#wcJyuA1(zzZ3dqGQHiMO_5CrV7MrkF<8rS4T*%W zZSYavx2<3fLOyE%)rHs*R0^V(W8sEjtQP(rvdy@SJpx!(h%nLBDxyNhncLH1E;pm2 zfSt9m-}HC{^RtS-Dg1_Q0s!8QS`+|kbET){Fe8u7&Z)NxN0?qgy6lG?suV_KrOujAdua57QI>7o&C8Nv{-jzOa+L+q< zGh)A!cByl9@d{mbld(=oVft$rBw0KB>u04`iq%$fn`Sr@GF(_(X(-Kc#NPI` zf3G5wAI7#*-n_5ND04s5{|Wmkz@KE96t^VY>3BSIGt9&ckYNQO%#|a30GsmClz(L( zzUarcrOu|_Gux#7QDG^hP10ulnI=mUI<}3=>A6+!6=izo$SddoZno#E319Ur~J4B)YP>x1&)8d|!2)BUt~lr2pY?_6W2Lg8D(SRh-JzGaF_RWDAK&h+s7 zUD5m9-kX6dD@xt_%bii}PPIy0*wDp~87hcgx&_MJ9gTRth(D){zDHN$GNq*Jk#-o> zfL<|;@tLx#IfDc=H$&_bVQSK%fdX!7EcYv>+q)Q=A_bK;tN-r-#R4i3CV@)B zhf#XP9yDg9c*+swSFVrho(aO7!Vgof+H^t{yqS=XFIic-G_Ja=#EA4>Mh0;i)z70N zCnsrD;6%I*I{+&eaD7PRZOWuwcsZQHhO zv#XvmyKI|Xwr$(CZCkt7`Ls{O8*85xu_Mk;$PY6!=eYB_Mw?R7o{`turO2D$UK8#mbaV zAS8%fQZJ7PQKnwGVplbaYAOytl>N1!pp;`-_iG5^Cg?^v<-`;(#%faz8(;W0_Xi?E zXJ);YSBTg1@SSEttBK1k?9?X1c619ZC78ldKOs2PDtjf>kC*Q z{twEuGIdcng*uA7VT|sNcY_(G5xb&-{h#ux`r;z`FpgZ zw3*hYll?rUkF#+~dndqr(H}f~?Y2@g+>d5l@#)@l>b{9jX1wkUEzZmcKWe1sS`yui z&}}wVDdRk8^>HPZZT*RL6!5!Imu+ccG{TtcRFY-5KJ~CCpi&Y&wZ11UZa32Giw7uT zSUj{EuG~HM;9P@7niP-PuUq-T2tBBoz@f?|Jnoi_1Fo4Ufxb2#(+;I;_Ny>(C->(`ej^}hL=Nm5tyU;1f zbPSuZ&M|$C>gB$5i)|Fn#4wCK8@{%^2&?Z#?><%5c?FilYe>b~MCsvNI+#@oY!#C{_Qk7%5W)TvrP%Q=97PFtRU4H!J|EhLG4<=KR}XDZBeM(?4s zkV2w@=CRSW?>tjuQ!8y1mc2Qf%0Rfox*U~xjAd6a*OY!aQuLb2Bn&o^ix{s$lTRBi z!Z}#n>t^7@Vs#Bo)_&fh+m^3t&HW465D0A)loUnohnlF&-036@N72TI@XpH(fj?!6 zHjE$Jot9$B8?VeIy#-f2*9>8F#q|dUkiTZ%oq11AWG}=K?jlSAZEOQe(q%94Bs%jb!hNwX9TF zu8aLA?5;4T@t$48@T_t7-v0{q#uYG5MQkfsw7Q&RXPl>o&9%WzM<}~8>|6Ej{7BWL zkhesWc)!%7$&}}pr-^|O*6|)1j!2V19>sBnCIR}8NfhIu|JLufFZb}Xq+Qo|c?wpm z@?X)Tr%AlLSnp0|zH-1bSYFnj0LRD`ed+wEi9&s5XN_{lPd!L9PWFCNB+pY=!dm1{=oUGnOk&Z3FU(f3U zG_#TkLgL^OkD!%r4e%mS3}z`Mk6N^u4{_-!3kN;J`ptQU16x85mL;GW9B z!`uc!cZji%E;f?V_qytI%V72-E(#R?doPj5_!s z&S@n%wlbu+ON7igKKj?7z*;u5C##t*NvX1awd>stlbA%NFvQN7^E?P|+*bweNMUE+9AYMH( z6tk8TAwhs%`nyK^_hMz7tB1qZPvb%om#f$^wWQ%7b^5O(x_S!r--LdlloZ`W?&Hc@ zazkrnwv(r!+dM+rJ*4wV$MTXOY>)()=&*-I&ZX;7hzUt?M{lGg5~PWCBx|k`Z1lvi zX20>9^dkQWj;$t|1K5GHHU{|CdA-T(=7lrZZ;Zj`n}56-qHJ?pW$K)%TqLsy!u9!r z6<-kgUxKxN7yHQ_FO_Uut{0`0!Va?#FwQrFclm}%*pTqo81>td_^0&bCPr84cE=n` z8YJG^Y?I->MW;c-hOlQe47DTzL!R zyaT_2RNb%T&yF!*E@3OpqEE&K+C@)o5)gI0 z)2KmC)v?4S6D`Y4LNPL};`Dkna@brvpdO&iHFHfD%(tlqV5eeQ%2v--Y{tL)6;IPh zoZ%Hk;`Z4`oOQ&WOuy7z;F<_a8Gij+L7o58!O4$IzMzSO$%rnyw2u^Gfiul}vDP3) z=#Q!RfpB%`zthZK#|i5?;+orZT@ariykC=Y#l9w~^##g=a*I@anpkMa85x8jw%6b{ z2yjB7;ckxdB$(=E=GuI97At;kDSO?fOM}&m#4^v%(Bg(MqSPP91Swf;`uTv2ZCWtd z__{>R^cN#Ws`aP_l;V<&-^JSdq&>syBI#*rD~i9DIm;F=_j7;>4gtqvKGV$de-mLl z8bc%rYFIP078IQ^rr?_TGnt@kX?%e1au(qt^B`(3`OtG9USR|>W`^{Z-@C+0Nc7MY zg@#JUvE1jCb7c>)(6-y;XqMlE)?#vuhgwG1D`+O6Wv-*{J6c7zx?cJY3 zx-V+&KYg{eu8{O#5q_+ixOoU!y@R3+etkKjFum%gsiqW5_9{2`jj#6gv|1HGs~nz2 zE<{C>w^|)P1DQ9OVY8@t#4*$RG!a@e>Hd%U@5-jD$}88-qf6+87=W?-PDyTBd+=29gNTU@t?o+k;+~?B&TD=0B0_GcP&j^X}=Op z=D#5Eg9~M<&?AIL0fqE++b2|fi2^CICdTmTnn>dmm7SD3UgRb*Lda%uQljEBqpqz5{dHo$GpC1Be4iGR4!d#L~ zha}ri;~m6nyU+X5`js82CVFe%;TU)P%S|yf+)Wj*bokDUl&*fR0i?P)%F4a@zA-EXOJ2ICbc2D5a}4lY4AF<5YlQjLmFP0uNS zaZ0g4*MW-a?=Dz?AvqEsH*{fedmjW)Lt`}x9lu+O|HXm+Cv=g02IJZ#LT2E7hUwu1 zW(>xKR}GOcZS!Q2NHvme)^`i> zGc&bPj~s)c;23HK>Dh^X>>XZCQ(1#Hdfo|{X&X9(Rc{>s&6d2J35AU?$Pu#fLQCmA z8QkE0tLutJ>jls!s|IEHV)=fA2O*tUN|s*<=uWyz+K)~S@wc;ptISxSIFc5Xn-yCS z357xWfe%J_VV^QDgm;WcfN)g*cR}E#B?-@2i$Y%;GncY%VFNR3vjPg8YHl+DQZoX= zFsSq`kn4L&nOc>=?t;5m)W8yN*lLus$9!mu@`BF#eAUS=5dNhGqQV(^+wArW0R&Rs zrx*sVpZOD!3K+QdwCB~WMy9gx2TfX?3aQ{DOO4aoyO{alL5vu~T8@xj1#1FM_%Fx> z{>%L+_fWdG1H}~iW=r)`;oI|;!KRyo-}m(o2po{AA@lKnQ&f{}xMGeRf$-;h(=9mqP2E|(}Gu0u| zx%{bBYB3h9&8gWLAD7Y7-u-=vlHX46!R2v(xVFE0DxIB$tCwRisah_tFk^mlzH3=0 zsaA~60eQwKC)1=^2K?ozp15af`pwpHRr9-gSc@As-61nj0AVK4IIV1eo=N7smd%ga zrB%9oua3J@VSG>YU&s0#Fvg8z-GCVPE&JQdzJZ~*xVb+xRi|%h!q5t+jhsEkR4g2S zR7e@q(4|!r8bM+o=A^qc#K^72Pdc3VfH2*5+EIjB{UL+v;XdUG8Lm3jKU%s_W+7y}>g<)$R^%0PxQ`-L1<&?2!4^ zfh$ucgP%MES8LHyv{parr8fU&X$}utO{p`d=Oy3LGW-vzi4FhKexP|ciFe9sbkBT` z!R-!LdI9G(Hs0p_kRFZ0X^NcDP4d(?5DQFhIa6`dv87E@|Ld66H*v9YZ@=RU=)4q^ zo9)HCm~a~gnPXCUyWQbwikpjqZw$_Nb#ip<8=D+0=csopACGt_Z(#37C+_iD+Fhq4 z1ll5asK@Z#mNfni)T$BZR0?4_NE4^M>Amtl@zY_>L3DZalE?Wpz#XlNHP#u-1z#g+)WjnD!kt~DY1BWuqX>cQ|5+nL%wrj^2ze<*rrDc&p zu1!%w2woe$ugzj!!aoiV3*e2f!L3EEEvtd|f`>%_nhYs%x~*QS9gG&>$Fu_iT;@bR?5V?|d ze5f)8AzHQ-wj&Ikw+0v#x%hP`?^Wt^S^6&WXtTD+^i% z6TIQ9r0}74SD`~WdcvjazP{`!GO>pMpztx$12O!eMBgFFhL{YLo-piVZBIFnPA&GN zvl*4izksg$jA*}w0NH>>%-mCxJ%qfO9F%YB9{}!4HH;pN#d=EaZQl6jqbny!f4uSb zZL#C^j=x||g4z)d7i1#gNpWL;Tl{1@5A7GS*jF+@;Si;Q;NC*XRNlSM%X4#~kxX)E zSzp2qZc|eya>o-z6`mvtkO&o_fDvP;;D*zm#-x0HimZ*LG;(~(w~tRd<%Ve$y&}j* z1_F&VkX>GhdG;FbrU+*vDuWLI56%OlvQa=;8~8M7@dm0gF))lg4AwUug1RD^(n?%g zmJ%|0m$Ouiizhuacty^QXYTYFz{jK~X>;d|zbi@R3=g`;q|5O5e7@rTifp8L`pmiT zz;Mv&D8@bWqZ13bsUqX=YOUJ`ZTTF(NzMe&AayfLe9B7y)5ZM>d1@O~*IuD6+1~;> zfoALqT{U@*I_pBahS>lExR$86skSp%OV!M78lo*5Td*-T7w+cErZqEUfn~Jkaf~H| zHG5__NCw!|fskg%+YdU3c~0S`Gz`A0Wrc?!d`wqOi@8b}_@ z=!+%ZJea83s5X=f@6uQKbA8{1XZElMG?q~W6UA_kmZb}8VzSU++T z_ga>p7@#s&mry_T5Gld|H}}GUCG-~jbg_rKsAGjqX^QT>TpgJcwALemdf4kciXH7x zyoSN*o4y|C6Ur$(I+NWEK9mTRFc;P;Hcv5a&Er4fG;}>aSlYXo!7lcVzYX5UI}5zj zP9d_JHub$+%>63W=$6(7rCB#BMDu)GYz1EiopD%V;YbSawi;z%C0$XabETJENX!gE zO-SM7EF)w&*_&ehj(U5U=A!YKx0YQk|hW>gI5l?a`hp6SZm zRmW$zBR!L=5GBvrPQOA;;32CNS$P!a@QeyT@E`Du)AB^=uiWp%XSZ=(Ywlp{@P-#>b3@t09ixm#~@sCU|N za8u->@3zrYI*wmD);1Va_d3pNpE`_lCd8r41i`V(n8Y0|U;RB?{+W>?79Pu(@TU^w z<~><>JI<(j_OKg2$nfwiXycIWO;R|_ifh)jc4iXAWZFa#7^%g&2E}wQX|?7cT_Th# zU}77IJu{59EsA$kuT}}nyMInT1Daj?8Ld` zD5{40ik#K)-s+;AXmxb^=E_djJWC=N9RL+``PWmuvz{DSD=5<7q&mKg&LN0U-Em}l z)k>XQ>dFrpvZ3E7YN+aczLJdf+h6~)DgbG}v*|?F{kYGPP?wi3BWtE_0JQEH_`eg) zHu(b4fX)dpdL_-g3hne9Lh5f>=p~wHcT+HG3m^z=Vu>+Wq@$*;iceLvq~UCJrJ4*}NCGLSThHla4+?Fv2F z3`J(&esfbJ1OIeA5*mxDztjl4eC8aQbR0;8}J-gK*9g z)YVdKURy=fqdqy*Vb2*cxDU*^IIt@h>a&A-pcYo6xrWQt=J#5;IY>V;?pHcD=&pcC zPWt@Oxmf~c2oMB@ikM$Qsn*m~g^NTEXBEg{q`sCFu6x3Adx#1`unC+u2XfNa`W`W8 zBU|s+c7-gCHnhUjGF4T;PrJXq*TuutD@#l)n0Sax$1Yn~XuztZLoZ_v>so`{7qYsn zf-z$iXBwZiJm1%eQ%6($z#BRVxpf|K*Dot8McJ$eu9?hhS=N03gedR~z>7|VJG5dj zGL*)rhuB9-DMG+9&&c8;3f+{YN=XU?{n~7LMvb9q#;-bCz6+w*O69|C>ys$Axo{Ln zdo10yg0g_tSoIl=m`0i7^*!3xr>3ClRa8&nPi>%n&jiyb1n&C-F{W}^ajq7u$QcZz zcBdRFD~L_e?izg3*4f+Z}E^6=mUcM-9#tJ0g)tiKxQEN(HvrID|N>+pZzLNj=BPm)JB`VVAKlK4kg6 z-`$!#3Q{HhY%QL#MiqqAGjfm0M1VTycM6*zAJo4@sEX$7Td^XjpcJx5arpv4vN$J4 z<;4_O@oOqYiuTD{c1CyqR4nZ9R|6W!3NZ$_OWAfbaC$YSZYO1KNn4Ph1x-&VHPE_U zkRRYLbTWj?BkVqU*GH{^I&haQfEo4VC<2>g*4Yf>>^DWAPmNS?=W|U>aVgp44r1I2 zOT6*EVG+@htBkf7&IVvSVMgqL{)?om7y{Hi=^5u$HJA+1ZOljYBFq{bq#- z&gIz;-`{3cYe3LHzv+IrXaawwY-@l zru9J+jsv~pT0Uj<-8L<4yjWOL{%$vD`1Hyrcm9{ol|0@MDU@w6Pt#D%=gXK*F-05% z_$ZD3%8vG4`15WYGEq?}w3^)OO!;(zf6&|yqa}Px!EviGvv;k05GJ8ndOR)rb?8?*n6H>CJUu)Gd6qnF$F?Xff>?X9On{RZ5jQcJsEdbohCnMi%k^=mXC#o|XQfo8Zu z8iZrQzRto4VM$2@p^a?P!9({0;mQR813LD*RGjvJu+oM{6RFE=J8Jn^of$G`c@B~g zxJt-b)=W4Si-vgX<47sVi4$g6(bVK)EFZmURy{O?@;NhC0 zv#`Dm^llXznuAy!WtO>J**T%odCsS#i}I|xrWFG$;)I*~9^4(HfWLIk^|iLDFJaB% zDlwQ6P9A|4pqLs8aX1`_q_A|*_zj_s%o?k2j>n|w^vm^sIOAkAhQSwmH6cIz<&j!* zn_OAV)UKGZZ?z-hh?*EF?NBvrCcWkb@F}E#?SR#wpRfllF+un<`U0_e4R0ZAFS~D* zTH&+_C(k5>aJBJBw<1ROCrMT1+V+{gKV2Q9X6~L0;!-I*pv_uYfSuiVfaOc?(J|oq9yz+NmRX`~wPw#yA zwMi^S3cP)3s1US!w~2u1T9SpAyI#w87>y3*6KK5%C$wXMk+0;+TTf7&90D7hTOV|P zjJCar>~@b70+|r*di__xN}kF$*=?Ptjh@>pFQ&liPvd@Xm2t78la0hTMdQhkKAe+NK0hxtNoVgAjxxcZE)JH;H2efs{7V?vuM{J znNrF-srX_;qdHL3oTw|;QVvwfT7^)Q;;j#mcDv&k+T_f9u9xp*C*^@)pg(+X-`5Bz zxD)c-3GD&#UU82H*=#0QYb(LV7U9*Pev1^X9*9BrQi9o?R&HbCe^_Fbt&yqghhZ4# zTv^^qQx{#_)%)g27rDVPs zl2?2|_tDWOC0gf6bj|&t1foN_!&%7krzjrwXDrd*NZ@mn_MuGL%QGao zX{wf@V>8P#|A>V$Hb&j2Oh(s5xvifJBUHAcO^q^i+_z8rOfkgnxy!`J!{41dJ$`6J za$kEo2r4FTyyIXxYAGl(Lgfo7Q&cDNGzYA8pN@)v+q6`omLwMRlHTj6Sn%LmVd<~i z^?;XS;O6!U!D5pBiw)Y*T$eJoXl~AX@E!{o=jta{QJryqE}QPQdL}U zBji#2JVLdkz)-9krof?@NCq~I;LK^*)>iYMu54w@v1_T^a7^Ke=(BTWEu}kNB+O#) z*V_KYb-4fjiS68!oh9|KCX~>!=yGp#K1q|WRuT=Mn7VYw9i{Ow1&{@{YmFI>$)LOw~6&EK=KYP=9NpJsp`rBqzK*4!jQ-tC*h z04OpnJH^d24Ob$^W}nJK@08Zd46$6jOFlb=j<_A?q0Q>PMt!xp`?KghFUt_}hgTb~iywcPo>xL#%`ux29amJ@lRn#~p z^_!=~=qHpbUQY1}_=G(fjms{(vBGRpFMun2^n#6{<)wc_opMR|sYK2BQ7VG-6OU)Sj;(e>nHaCtuw{OZ;%%0r$ndw`dqOdj$z%7!&40A`l@fqT$v2E&JIs~t? z)vZUy18C*Ml~c*mRmle8Q0C3ImiNz>TMGgIHfqOyD1mQh_zb^KJAMD!^^PKAD-Aj_ zQopW&LpkA)S(kpXir=oNGoHjZ=C{@mdgZuMT&8=wisx$*K7VnjkEbL7sSiRXgVjUo zl_59G(lv>m!LOA9yf&^~+?2yJyn;GKFgPe0ntnjW8~-Y-Sm*5)WNPB?OtzT6~&!xIo$HVr{1s^OlH?B<9aT~s7<|89mSU1*Dy!>`wo=t zoIU*fMZGp1HLN1;A^$3c?>K6a=Y`T6Rom~ohb3c_+)sD5oP&iWW3-V|gS+3aUo~~g zCQ5UXb}_09s(^OGjz+z5AUxr$lY>4C6k>QE3EBvpapmG?8G!t)^>1-k_Z6++y)jAB zgtg3ZN1iWH(RYZOop19TJ)dcm#*eUEcs6l(F9_p^me0WeG;mRwrx|2V(+kJ?<0 z|8mVLGyMOSKVVRFaxhUb1L!a)ii$I+nz;k?{+mbw*MB?G_^+k>pCbuuY)t?ANTX6? z!+t{&*=I)Mv7o6I^Nv^<1_G4Rl{wQe3$q#Il5iDL+m!T1lbEA9;ciF4pj=*qgKS9a zGSRGFOD|QWM7~SE)7_)U_wDHD=&b{mO{wSm{e54z%e_rgR<#`6KtGCN%rv2FNI9M0 zea?+d;kbyO`?o;3tlAkV6>QUL=c~7qz<8o+_U4&DI`!||l6)lMT~fgi(mPueQal#iM+TJqbP<%e})EVY+$tWBb+c8Yi7N4^7N zikgGN%#zfXWbAd6iL*0R&prp@a`?h%C~^;rCu7x-|K9k*8FL})|lVpulJ9Y!rX?J25fm$4nt?H;D ztE2kp$NXtV9}LkMvp+j8{AyGm4x7D2@!1aabkS};8;;#Zt+|2w3ZNLw?T% z6q!?4e3=O0s&ttast-G^45Xt%uZJoFvCY_Cmwb9j8<+D9A+$u*fvYT7RdXi2))EAj ziIhldq+=6=NDlPyXYRz(;7COQVKCEbMwd|!li18nS?2U+92Nz?jifum7>YiIkNKrv zl%vJ=AF?!$4~d&Xy^j(q%Mtu?#diFbQ*CkqYvW2Os^^DGmRTFrolIqOh~I1(87mg# z7Uzfa*`6HI(FX*tHxA^;hMGUEa|TB+!)LezEb7vBDp(cI@M~X^kez)tZZ|k5;ORak z1oD#?u+R4cZv@vt93Ds0`fVpY7b9ZK!89ip1n8fqA^cs$Cb`uPuPYr&!`qlJyaKRa z9tYR0$2@BZ&a>XqaB&;;G9bH9V}p=EPF2&}8I4vW+aYHi-HUMK-!Hy>2Cj$N87l_5 zKS*w^-7fq*5SN!)D6X<00Lvx7wQvXdxOCc@ebf%xyCZA_$Xk`d+ojh=m@IiXfgbu` zyAJGrR^kE?Q_-7YV>kX9>bA~(%^2vlm!6Xh7@fK7L=Ap^Cej_N)XAF=#-QL5St;#> z%L{A2O_U=t-g$uX6Y5s6M;>hsQc2HM7VRCTx09)x2(Y+F9`KfZqe@*ERfz-@gN5nk zfC#&sxd*o37YP{%it&=&l0XwE_CB3tj=8`uq7yV<6;2ss_{yltaz~UGlp`W}HaRQ< zeIlOMX$oXjupycNI&y^Ef;F86jSYw$$I6uy-D44tlp`svz<-w*{j!s?2kfchL-Ci znJ>lAw{h+$6o+C)#Eg@a}OP64VPniA~RQ6omrl>{=q9J%ub{A0% zo#oYtvZPALmT-CT*=XaGRq9=LyaiF$UVkkde^cKh;7$IZpuM-QytWz?-D&EHkRev( z?<$SSdFY;uMV)_g&RjkC6~U(9hIXML>Jaz018!ZDc}2OAqd#-@7y4`4>?$%eC1s$T zYv6;e@?Y&8(NL|!MHkpdkBH$aJeJ>TK}&(Ji}RidMhGDr2GQ^Ay?-DNxiy<+S+f36 zY=2=23hHbqDq`}+u|rAfP7%*?QA-p^20I&HwV-IpMz0o8D(rp8%{D|BzjRh{+v~Ja z__H1cH%iwNfBoDC%m@T4lLV=V`iopcSq12!Jp8H2bD-cAHV|^V+To0k?A~4zhMugXJYt~O~MWy9qTHVyzjbRMt zFA#3XW^-@RqMM<88$04ow^&aS)>;zPP#FHkeZ%QS44)wfpM?TT6o*fxjIXX5if`AC z?x7s!8opR4fg8516$t6VKxpqg@*$r?u|RAxocE}*8CWJ66V-^C>9u{E6ejvRndvRs z^e>Y~7HJcp+E+B;z&PV@-DhnZSObRiDp|2?ma@W79EWZ9UtjC0B-9JFp!PK6ecl;x zoo7luy{YniL0Dw#*@f9GvL%p#U#udL{j)4hbKAPR-0qP7y-8gvvLX;6HShF|@beaY zqITq;q-k1BU_>+m3!&^Av_-LuBrUey!6YUoJcQ}F)#4%2%0hx*xlxS*9%uyD{Y|@n zk}-bZw#(q`5Fae-=(LZdUj!R52O?B?JK91+zJj+=DCJYK=a5`2a|^Dl;qx9#YosHE zBim%Pxb%NMm<2;7ku_%nybjPya^g1WZ@fuTs`tY1Q_d%2CA~~d#+?8rG(+?*mL8d; zTEX)L1^MKpV4+`iHj*(B=*9H7m)?H^@wZwY0`s0<#d_+2b{V?-Yw@?3~WAz!MOV^3V$bXuz3JT6i_!b4PLHz0};w9QgDAk#xSz#-(Tk=mE+Tv5P z>=GC^8#TUD&V;>%OoU((By9YP-aHn3E!Q&%sew?6kP$BDYF+9GAvzpv%XbkRh9cG{ zcsX}EqRHk5QBhy4^=6E4#+pmnFdDJB$7PsEv;2X(=Xf1)@jY=9rAF}yDjl&m_Ej$0_txO^vj-8>%2>Kglk zsBhgrZq`7Wi(7Pe?!hV_0vDZHRxw=kdv@s4B?%j%>%jOzRoMngm?*=}^0!KA=_rYs zom@@(>FIz`vjQHkZ@_iUByY_iSW0A&Kj>E^_0`1-U>tc_-pP>g*x_2H#tY|ZyQ;mz zuHv?pMFD=WtXwuJsKqwnU*G&>IvW(avJE&4vHoQWauOR$-TL1PoR)%ft+^`;ZCk3C zCYS9*{?8d91lm`pF%$< zV{);Ihi2dwTxp>G$weMKmpmXZj^$l`#&R=DtA-3?I%Wm`B^ zI)U0vgP^FQCS#eH;A}PMz@!Vsl_ZFS8AAz)KX^N)r&e_diKkh5Z{|M6_JbL_4(Q%) zm_^FN7;5qCtM^E39vvJ@16$HeysfuZklokyg>#z^A~5R(M`~dx{_zM2O-*874dv}|omm`IY1 zbJ;l6P7*2RAg2n{LbBPbUid5RgLeLTD*(|jwn#Lw!R+{GBsgwDD*=X7%2b}FtlEIx zI1KsGnri(%vb_v-M;q=nboIGU8aP;fFelImV=~V6&cIAci11~0DpeFQ^IqNfP98Z4W-W)ml zjK-^MLka*vZl7M*nN7pDm+9H$$_IU~Nt+(Yd3;ZD=W&Mi8vqy0ur`C*!aZ%gKaDYp z5_qH@4wRrN({ku9D$hBCnHWO#Lk=r=PlJC;c1;Q#5%YI(7ozpzd(a=KRc8ifD><=v zr!FIeEF>EDIn`dOsyd=M78UV2lWrTb0F+~Em1(UzRWc%sc_nd|T5{V3XpFK+<9x+4 z%$HMbXFaC8%X)efqen@TxQe9TFma{=*-yk1?NM$a2#tqQs>avXug*(Lrmw==HgY7I z`+^~7@e#h?`yggC)&sQ5(8Z;L1-~J7FIZ}mo2n}?8Of`R|Gfc$Eez+O_F7i;i7(!&Jap1UKB49z#m&R~lXe6hG^QdORi7GCUp0(Zm^}(M&iOe`3Z2>o+U_BweH=5&Z^Q?E6_;!+dC7r8PFCk^@eb)aG9IG9Zbk3Ka3Y z_Ekj57Xtv=Vk@}e{(JMY-*@qvmnbHF+}F7Ix-F?|T=b+z!j{7Pft3<*HY+PVm+=&mn=9x0hhi*v|e0q-k4F(JdXanHfF>;|4Kf)ah>p!2p0AjQ2XCM-}n67ysqf0`CC_N zYV2!vc3Qi<9*(c%++E#T0KUoufkc{>{phKW6Nn6Uhcnb16TjVSthmi1KoBDen+AWDi81Fi9Zwa~>_mac(wEXv^o(C#43(qILMIREKLZLAuUSYP zf#ADA0Hu#SEC_#3f5);K7Y;Lsq{pa7wsFFg1vg+$bdmoG*+YGRM88<8Pw^!0zTdKAW;#MB$nezi%cb)9e#SH zPZqgiIwA@0HNzWO%N~zC38A$?w*E1F?r5e7!T!ko&n52 zSmVHvFVaD1G^}9;)*~KFvyCMZZkF`c!Rcy{sieNgO+$kv$hzIO)VrWlWDDiqqE{oy zdo|C+B2h3CUPhD3w}!nu(&ui;$}(u2pJRfMjV>5z2$O^`9X>;hc`|2l#@QgntC=u0 z>PP2`wA^N8OOSS>?Qw}3Q9lee{x$V)3~eN|N=G0z|KLCPyFHpHO$#TF+d>dk1@4lE zrJ_W1wpSt79FOE@fF>>)f9Dsb0FfYtq)nKIBAYRf1niJn){VZYm07^;CK@5)R}G$R zas!kKR)1aQjTg5u(-Lr3nCeoFxm!ml(W7m^j0CIg9Mc=<>AHAk`9%^`*A27kKd&w~ zy&hO)QJng^;*J9};9%6#)m;;Ye3d6kv1AUzvR{T9*_Q_Us~qLe4gi9g`I+fOr99E8 z41T0WNbn7kgLMG}k#E(%I$7DuCbocvk&|+mv!E;T^pp~j`Gsl~mmGB^Nd@JKs8?=6 zVA?nnp;aN5QqIn>KkOI;xtom}J-um~Ffri8p>={pf@XJ%CqsPQ))v?rkgoM8#I^2$W;>EVUK z4j757=;$bVus^y3`8LDyo+AESL$`0c^=j`JUO96`KQ4i{e@y(~EO)=>E;yq)a5?^9 z^TIbMa{;gdqxr`6xu1Pl(wv{S0zUcD#-~ z*kUz9FVVdfP$U`{B-*_(EL?b54V*pQEPteJ|1RnI*KO~7oNN3ax%Pjw*K+<}wAcRE z!+&Ll|Czn^f5f%982>x2{r@cG|H!r3nf~8gyHjK0AJ<0T`k=9it$+N%HI)=n${}mt}3*-?br=upOF3j7ub$6$) z%TC@Tr(HhXxN^`fXz946v;sP`{mjj_87rpZ_XiriAFtZ=J=JDyZZ_|;*R=LK3pP9} z461%QdVck^mq50BFBMYxptjHt63%mdZ?vME32^tUK%yS!@o1Ei;zi(+y)S%~bE<#* z-erM!;rFyl1J_uGBS+%>TvxFywvq?#q@f zm8r(yn=8HW=Q)z9@GYOldZ9VqA>r>MN%TUu7X{Hc8Vu@5W)-VwU+0CLq(K3)~U65`#%X2h3 za5Y>&XDZw7a5!%&h?*vzrL*BZn=}UPhz+{yPi5qcUxXaFUf0r|#)aJ~^W`b%>ZO)% zB8HXc>n{BoN!s#+YkzPX5hh_|4$F@|9rThpKk#6V>M2vxi)9*E4O-*BleL_8?y$;V zI>H`2kk!Gqe)&?AAKA>C77b6KcpKc~=9W%QULi<*XIFr~&h1G(y);KdFlKA|HAG@q zA*&N^Lamd1ZQLM$(K)(Vgm5WFK-q#}3Bpv`r9$$98RGsg*3PL(u&~XtY1_7Kv(mP0 z+qP}nwr$%sD{bdg&)m$#7ah|P^C!-E;@x|%wU(gyK5FBA&DPoG?V4e4N|_+p)0fMy zGGS@GFRNaHiCZkCuo^;r`B_m?;Dz+%mH5(A`ULeyj%{Bzeozlvl3HeNLdKf-q-^AG zzdMbhRKq=JQyw~-8T}XE=Y+TyEtEyTYIV zJecDcXJhzW5~N#{>rB`7pJBVud-jD!G~)rm$ILQ;;-T`L7Wn4kVOHSZ@p=*{d!hU; zkpO>II03Ij3t=KA-f(1{wsP^hu$gz_m0!j!}>_>P>;M7|Tn-84c=KL7&oW?QV@?e8#-?D(p<(lB}O7 z>>sVVjQjRe4J9<58gr}^czX-b(dLtYPS~n*sn*BIUj$9)z&mz4T!FLL9ZgG4qRFu< z7of>TqXxtamLm6b4Yhl!kStizQESX-)h$5%h*%|5@ePppo@W7PjfGw`1*2#N=6<++ zD6Gv9YXbz1C&}p3n|{D%o-E5-m0P~S>FMWf8WpECcVPfsbNFOT)1I@!CtycJE6{Fy zBQ4^p2N}EDzE)4_@luBVv?EZG`R4~R0CB|{?>bNuD zf#?x=l)l*)3lq4iA8Bym!R?s*WDc(e8aNjARh1utcz|oAVAuu39m@I(0!~ zV>-r5P8ITOBwrCeg`vCodvg%T!Z>b$2U`Txf27%xqB{BkSeAci5%9<3y|RpEB(2B6 zBDY@$r$v5P>DpryM(Iw92EmgmC?34vF02jh<2tyLvUmn$z)||^7Myn$Gu4OnbWhI+ zEU@Km0UrRi%2e!H!DvqP-56RG8!8bO&4O7xYKb}`Hs8j}Pc(?6jVbrOY_~HP>XQ;$ zeB!!rEQ4ZBLsQk=2amr{c~%)`I@Z6Ixzp%tekI2mFIFx33e(Y!3r4`rU$;U19ZH~; z_~U7!N}py;B@I>Z61_3Ui`R(1XImk@eZ$uXvi~=i7>;BN0Ri3L_onbeY#pTC<0c(U zp{q+7HY82^PJ-HSfm@VbLIjwK4?%u(HNg!=6Kwq!wWMNG?3SUMz703IfH4y-1d_3P z(tVv%QtR`>qMP#L>^vmPvhQT5e3}8v7C1+64n#H6rqZT0r~GB#0;M{!oiEOu^y^!6 z>=mKZhGPsG|6VF^bmFQZ%Q9ibWr6{8A%0-R^5mlVMAxWO(IuF6ZBU0sMn9gmp|9b4 zd~DVdjFZaUV~G_&tc&kfe1V#>bSA9rknK z5^Ta}7#j>~L<Pu)aSVO+iA#Ok`J>FLi{OX%q5$lzF2p2(}P8B9E6K zw)b(FI~zd{uU9vtP=)PyD;Ss~?O4$awV_c>#MjY!11JurhpV|@$I-{Oi*6!-s0(^! zmBgUP;txL1%w4CDHJUv5YkU&%Gp|2un7?`sB!sQqzJF2LJ@U#E4AB5Vb!czZb(3;% zuTkftG#wg@TpA{pw=`}n^*S@1tGM|6Or5x`FOxA7o|t8SwUwwh{ab}&C_ zC#Mp{rH+ieRUhvRI%%YypBlD%O_|G`B&{~{n5YQf>s0=Zu;d9nESTx0kXnpuAN#XX zU8{_fM$c?_QbaqUP*X+i^f2dG(39|_hiZ+xJV3}xW2&JrDukrJ3 z2D+Y*MAfl~n*rzDk~XV40%ABQi0!69vSp)r0`H7AOsZ5bsMx$uw4Jc@s**Cs_&RpR z012o{q1DFk>|Al=2>--O!{XKeWyyM%1Tz(4;?7blus(Nk&E61*PB@z(ntA*etc53u zG0<6qV&@jQ4PdZQ?sULeH{Q1>JM`wkCGh6oW1HqzZ>SOIXkt9%yz?!_7A848tRPY0 ze~TU<^Y1DvMvV^C$c>D+8 zbg~mOEHL1?A}exm3;w6Q!$t=-oR8Y)SSaF}UWbcutfGZK-`8}o=^rvzYu}jeDrMhJ z(q)QzBqtAM>h|rY4IKY&kw7{*Y?@F3<0WgvffPb1Fzfn9GUIbZ$tzD7^YB;E&T^GX zZ$ze{7x8y+?75Qy)%*VlN;#ZUHWt^(S+*JdM@eDSYNI@^}e#h%lYuXb?I$za}EwN@CERsEwE4!%~ zT)S-S;p1+Oj#BD{2N+2i(+jiu@}i@~_=)93!oBu zPY;)+G=&xr=d64~yJJi7bhaDltKx@wr|%)igvs}kt^VdnbHR!Kqj*+efrOZ=Z>>ac zZ#^&)x)(?H-PC}7^X#Sg-uh4ytZo|&7Cw0FQp>Z^gA!BaJE51bZfU)5fQs1s*GFO-4e{klabcLO#q6}b5D`dxGYr40${cfC^+JA&d1OTw}@kGiPOG| zaeOn)_yFzgntfuXMuZ{4rgEFl6Eks)My>3xuP4C=LQvVs^?dAdjGU@B4$$sh zEVJqvt-si8XFYP&q^&6Rbogr6kqP|{ooavOv6%4*AS^(XI8ub#^E^lWtNc=Aou*C{ zlwDK^gBM7*xH{5XhL~(a@s=iZ+48{Y+LOZ+_nJ9MKeIzuixAo>#eUZ76|_ELsT?^xQUq@Yef{L?C^oaN!&q&M zRIy9aRSj+eOpEMjEMDQ{!t$A+xga=T00?T0L9_93gQkLFq!`zbENv zSE}%+yV*)dSF#{@H1IWKO#*xt{fVJE=RZXI=fPOzR8|X$Bta||feD3O1(n#1n!7Z_ zR?BuIS`6vIca=j}dniFiLNp;R>ek)OPweFhd_H<;$T}6Irb!>cFFQRnM*Tz1u?h>1ey&wMMcaU ze0V|INIW(X>Pf`x2hg!D5e8&V|7XU4rb+J7Hy@umHbF-wst!4-A(qFhKh9XeXHevY z+8=kWOUhE&&=~L;jkosRIo<%vL_L%$dbT0-0`AqhGka2TjqfJakozP}x3t7G8jq}F ztVOZGQh)H_?hN8jx{iB6QHJ7^##%iM-1589P6Gr0tITwJDE%3Pf*O6z!ge^0LLR3c zyAmF17_5B#Zip}!bt+|wo<;#@2lKNlRU=!afZV?J8?YobV(JD3RHAwG>Pi{mKzZtP zWOkH=8b)I?1qn>8!2_&Nu31}aEh%~~zYxE~+_V=gseFiNi9s_>v+r;$ibV&_?<9)@ zrjB}PYYY<7CX{)0e8-d0wD`$7yw8xSVZ7{9{h)QUnv#B5}ExRF-MyL zBM|@G#)-kQd&WWyC)`ps%@S7m!e6w6&RBA?3@2_@Fg7|H?z9_m7r;Vpqs8h@6)WGC zo>sd}+dsHSeBC(iSZglAkOy7Ei#_kI$f^-Zpo;c?bbyxClf$yXULCyIPYV?aVuy*^ z_~ZB;ID&K;B?6J(I_>|k&K;kTonH}00)3p)|2dNVgl)U|h_r%#B~))SKy=?k*T;g9 z{tfOm-TnE;UF+P1+LGYt+`AXApw>ad^$u|fPt z3$+pROahbJGkb_jy z1?UDur4XCn5KrohAwA{7BX_*tNJ8Nz_cvcX>LpC=K5fLz=E9#q0#{IjbR47WjX)cx z4qMx}DTFzBeq~^8K1(PWOaV}!h~Mr!rt6G>hsa{!g$&WT_rFAx9`8~Bm3by!!?l)b z7{05kX{Jnrunllmr`einu0$u^@O6K=#INf5{5y5J)w3DKuF*Mt3iWgP^lJNE$yVrQ z`=o9&+(|W)q@WbqdREf;S6Al;*XBC!UCE!$17>{L^Nhk@2Z_rV?DtapgiC6suPFu> z!qR?PvOChZVrkg@vt0sU`R)alMv**1;UdS!0Xz@vZDlaerf_D@?$z+`K(Mm~c4tFm zAw0N}Rfm*w>C4adpz4x`BQ*dE2D{v8q}S>^s`n`DUiHH4?p@XnkD{1Iit0yS3~w@S z$gX$R*0>xP-y<-8lKWB||1y%RQ2#YNvXu_@vHZB4+QhWz5zWhhT7?19RDz^Wm{MY_ ziecs1)Q)Rq0&XV6-ulGM@qW-m^1utXH&^sD`h|8{g9ol5EyFJ)$8h|H+1&=o{TuI> z{|6s~N(muMRg#bs_&GFq-o+84a``6r$SXcl*9~oN@d$YpGm}hS*=r^IDPt3PmEL_y zTLNFggwba~U{9#D6^hEu%jgTaCW6;<7o+^ROzcL}>r;kk@xPD1%DlesP|(~49WQp1 zCmi;L$4KZK0ACuXv9Hsb?n}QqRXJ(T#*jaun>>T!i|%!-vhR9z3sHa-r!E8P$w6k zzL=P|PI1PpSn&aR=jk8ztI7l&@)BT8rize?z)L695>!|{f&oueT^gyqAnm77=1bWu zc~n*o$eH5#>CKQ6v`-;5E?SsAWzPE46ZD*E>+8T=&B29^76iw{Tr&%eOti*gAFn#G z!SYH;x+7r4a{~Ow=`3MeZv{>LiFKZcXa_*^Fmjy# zj|r#qG=Z(cRWV33{a^R;zepBw~m1|!@FwIoZ^ zTO@vV?(RwNg};y#x?n2A<@V$oz0aieF^`A>4!Tn-48L zxMYu zT9MeR8Oyjc?A<>oM*dMCy+a7J@P*UwuT4x(-9o9GZ>hUcXNOc6-elz`L_$C*)y4s1pP%a_ml$-(n z1`A6cq>$4wK>nu*Tg?JMQ|Ju}x+-k<@7XUM@`_dG#hrd~SADY!fM7w;<>(xdzbL*? z==8?LV#>ebb>H<$ij2fKuD)!Bhpc-*z}a%(ZxdJ^wJfKjSA%iZtg+U73Ro?0gC8_A zV~oL$ngHGU(M`*hDTzedzy!>9cX0Z#4z(sD-^7G>E%gt+hGzkQwBPx+uR%3y zIC13$LkT`c2O8=>4dt{HmC)!af*G9oY=G{F1!g5D2=i1XBrLg5_O`}o;kr5te8+es zE};+!Hfv&dR{tBP>Ku1LPx!iM2STcE}2Q<8NqyLVwy1 zkjqLr#h7GiT^n0Y5GK@7W0gjRIaE?Fx)+J1adLY;+5mt7U~wWY|5IMV@gH5l9RD9( z!2k2SgkD*hiGZ2qzmgoqfA#5!0(q`(@2A}JTX4|$x5wt?h8lShYB% zorlDv6D=(U*X|k~c6aesmA0^SbwG2=xK$duC+OQJ<;(2R%_lZ`wqTB7?LaTm`0;%Z zhnzj=l5mN>kw>S-iPxeG?twBx#iDdIt*}eRG{YB-{8|3ItOup-OM8#JDaDs#fu#a` zTW`U8MX=(?&5}gU$>H6LY3f-4E<&S#^@!?H)Ox0Dr{S!iHsx#mA+p;5CBs)<%j6X7 za#eJpea`KRgp;5ljdje~%;+HGB~VX3-j#FVuDIr?EDJ||RB(kZMkGBCkpVPEVdli-k3$m^wl|BC9Iw7v&-FZfvwQ<<;ep2S1q(hK1 z?voa(^wxY$)eiUWxB4Sbj$oQNc8VXPsV8p9iq7pU$t|Y9jG9FY6-GG(oYpmByG#y@ zqPc8rH;(l*#Ne!Sk-Vx!u8Ql>M7gPmiEX#`dizgC`X`T)DjvnqPS6IRgcX9{+Gm8Z zA*b*^C?AI-8>-A5&Z%IYEKb79OF~^{0!09?B-pvQ*0(`xq#m15IMhQX>;si0*LOgH z;hgT?UD7ZuP&Q#ORNSVVl0uxZtW{@`63`fGu?hM4Y(~r4B^>yENzRxOIO*d;j8;X? zPdJ+7`tGpa@;ISwWf~#d6Q>gHpPL+|BN=k?P*)$r$wfF^+&}vw?8R_CFgp7>p5`4Y zmL1&OBX@CybFC$H?~Ze_0U@A+8Tq!q2a{f=0CgB?7>9wA73-vgnnnenM4>Lj%4AgN zJh-L;`~zPfvvAI~B-0V( zeCk(t$#`Tdcuc8F+h?UY8%e#JOxCGbC{^X7<(SiByd3#=Gf5nLy)kgl3n4?5vBhx} zpNqMI#}%0%xvG1up6Tuzhi}@U%xAd`K-I>LU&X{#3Q*2S{(>jzuNoFyNQju2Rn=$mj zchNqFpU<}UV{Z$A{tk5GjERkL7}tk%tWlX7*J7$esqM$%S>0A&m%vSU z5-m}oRyi~3H7Y4lC12FHCUhyfR8RN*tzETHQ4J_FebkLkck|lEVu!;GZ4}N!+GF6^ zEHu}LMq4U(t;qAXJ>D0i&8ho<#=SO1?Tzs8N>*TvXTt*5Ddm#shJSp(uxuQoqKA_6 zWF+akckr59he=uicKYU=1qA>%3OvC*;882hX>m32Stg!H=egw2u&|02cqaNw33_Pm z=17oJt1V&q40T3dlPWV$0LsC-=knb@A>}pzPF5Ea8`zqkQBkE~HYLE6 z?c;Mt{WhEI_s@+5RGbKOnmKdia%J`wvP7`&WydAo^@Z-YC+`)H+(+H;7!WXP-Nq!g zTCvU<4<((5a|LmsU^vom6j5;{EV5<=c!0f0b~plo-Z;1%%#?#(4mpkp(|=#0fbZH> zqvt7Y@4)fmta?IG;EnEcHCBX^ulkC6#AVn9wCnhd>pC}Sl35ja25b{qQN=H)Oi)3cg<`(>e?>U=jNdYX`Smh1=EZ9j4RXqzWHCrh+%QcXn^&q@3E8BochU&^Z z=#X5Rs>KxzK53+L31ALX6m9jp3SeCfXm?w$){v)xqYQGZ=k{^&shV4u7aq?-=aUQ8 zh!!UQX~^f}nA_puCHnox^U9dpZJh|&e^oka#@MntKH55PS7f_l3(Xs*uLAhY(Yxo} z-!qLr3Q7WiyPz5;U}K`>B6LNycjx=fN&)oxUqI5g*x_pl$8|H3Dkzw-OUjC!ivB9) zMAVpB%7Rk*jM;*L^}MQIc{dZVa8d9U`EEv6v?|$LrOf4X4D!TYFc$`P-H-xcYfw`5 zqtIyu+`J3B^!hYjT@;?VX2NC_WmCn_8#pAm?wA$3Ras0ZpN>80*K?e=IgUD{+&q~p!lfd@^{4QN#s&+y1cLb8M-QhL(vAmyp7uRvYbC?VG z9Z*DS2ME0diD8-uNdl_}xboGaRz(vIa#;ex=|7Q~00EW3S=HcT_{7u@6iepjg4ICP z&FeTx3IheXNAlN7_PpPPBBzK5%VN417-Hi^xD9iqk0vLrsw`a@E<^amgL+-z?}r)s zL&g)MMsZ57!lTnBxzkLn>^H^x_J-f#^1_gu^%44qt@#5XWyJ~$hDSYp$u}bY6^XCb z)uky5r(rsOzWjdwat#|0AC%Xyk!#mysHq)#)vZ9eGD)#S5WPZLb;U{W3#& z7$PCGkT^6Wx53_XI&h;0O#?tXbUw}goAEp^=V3jA$8KiWC0?~*zAI~rP3?ny{PJk7 zhbeHZ=yQ>)NKl30L-CqIPIOHivFyS0pa3^KmC?;$V(rqk*Dzc}_^kbLAiCFHd|60Z zO)sWswa^<`felgF*mK zPFL_)>5Qvvb{ooPe(dsWkVc8YK$q%TJ1ik$CW5HNO>|%Uo_BmGrK#41aJz_ifdJY~ zKkar5eNLzNfX}#1{mg(J4RpKai%ZChOYM($-S0lf72a`rm#dpS05y-`t!A7m+JbK2 z1&F^@+w%orX;cJP(f!|~X7|iuA}ZW0bo8|EVrmTZp6F@ou>w1>0o;FRY@4T8F`EBq}2ucR5l8L|v{Q}|<2v8eIsBXz_k;-eCs;F+^v!XQ7 z>BTA+J9>QHnSS<@?%nk(&)Vp=KhZEGoAC+qjQG1O$2=EAs_K356gd*{` zb7ElXPN?i7VXX0>BDB}3r)R2;o@RUG=_dz%^vl0NM?c&c9BL6Db>=RLFND=^l7FDH zAq*(xP-~Qq+YTC}mCp*x{6{EQKNG8I1kl?FaF_6V=aeu0yB1b*_*7v+OKT|;`Unk_ zNIShV_O(oP!&Xuq#?kAFxKyO8)@-%_fI@pSZiPwf-&I*m9r>FeIT<|vBB}8rt>2u*5q|>sX*;Ee9yzco_xfsMZGpsK|?sB z`%oIJaUM~l7|8c#ZlD%a z`m{N*TNy4lGZu!yq`9`Pgw1kM!b_T~YSF@8uGd>&=e6f)q{25t5K&`zU)2Pl(?}r% zZO<1M0g0lUG-$kX0(ai*6^yIOY_Q@&@{ znPu^7pO?vIRD1Az&T%TODs)z-im9#2y|idJHFb~;k)!*+3L9PB^1r*#BuGZA zal1pl5&A?JopOK+cyRI75w+bBb)EPE3(jF1IkWhMJc!WdXh}n{f5aIuZ;B(#X#y%^ zr6F_LFz<-6Dn&zPfvfH<&%*ltXzhq#33N;)G|u%kJ6hR2I;Pg@HYr(RwDTq#`C?RW zcM@jsuhw%UQ+$=rFZ%{r)`h9A`@vk|T3D`M@!2#JdKlA+fV1JQ%{zF*2d}}xVtWRFrN{WtvQct7tvK?z4-Ewa-`CFq z0s@+`;s8@ye~rr`rd|SA2M2jc00;Ml1Hv8<10(rBmCH2;!Z;8up!;kVZ^7yu(^3k*8UI7YC%BmgX8aakt;S_hSswYLaMOZAs3p zj~yo@LL7MZvOW$Hf#u*p-iIBa0$o6O(lGUyKsqCWNhlC_dDj#a=j+YFnl^%ah|cg0*;Fvk>Jk`GIigP<@i6`*=@+=`+Vbx~8|F zpcST_+hJNp7TS-p-462Wq(#dKdX>(N%4ixDsUf zpSmZD>uO<0!~>l?0GtAM$UHK-rKO{B+O|bw~qfq9V#fIA`uldpTjQ ztlBg%s+D{W^w%$A;#a=1WRgd5`jmrB3q*-Vq3dN#Kk20PV#h@w$om0NQ;jHTD$O2a z32s*M#UFQh7@!3Y0ocjMP^UtzD(<*psn%cE7w23$kz$S!w*B93cfQvA6qEvTVfxB;s z{pcE&xOQrCWK9g9h1pp@TeHoP!QaaOP|4zm0Y8s^>E?7iaq#`Wqx@wqPj>-)w+9H) zoA#dsJjG3?L$?qpvmO#vE_(ySMFQkEf}xch#cN;sz0z2?T#V8yi#h>qWYVSMpwj zNe{lLZxV3Dq$a{S#)&JuAvbeKf|N`7efy5CyAncEcYNC90AI#Eyc=bEA%Q65FfGAE z8DQ}S;5|CzjuSw{90)*$YwE)>j)>PCXOY^i<#T1ePc8lci$Na6eI6ni(x*LPBSjU$ z=?Tq?K)X^2vlq3>nK@ByiPsmaz_A!f(LJ=rMH)j8O3SrGsTf4ipMisHIvUu_j7cI0 z9ke9+RR|>gwa6~1PB2GK+;#wcuayhruAI|7?Tn{~h7&^ABt&K!phcJTs1F(R8v+i? zioBw1HAmRATw*CQ8njgq^NAPH8H@EbP0i+>oF)R^*1PmW%8cjY4y9^ukEQb3a!H(h zzXBqv(I_RNos@Ox{<}(S2xZ7k13f~&k-p>*?+D%%xY^?I?NTJ7!3(z0soJCb3Hic6 zfOjBQsLyt&tY6_bDXZ5QN*ymz2mzKYjZ0l!%$a49>-@JoLyXCFiXG;Cy%OgPoEh}M zJ6A`NjX=$&3xt!GNcIEMJ-Ry$3H2Qj!!YYiU$zXW(#W*I zf!A&Up&r>gb&Lju=pRJSq1-v>X%ZbC!m%%?B&bqiFH{-UmJ z^jlTr@F{43q)w)}6bM+GXNZ!xr9lRC_f*VjAe+uNI+fLzu#J(Pe@byB)vJG|7*-NI*D0)8F2JQ?yWWuWN zemGv7#LrunsWc(Xn^xbWDtYwDO5~Kh@X6WOO%NSXDbZh+k~AuctES!RR-mV~(f`o* z186u~E&j)};XhiBIsT98;QtGC=)X@J{{$=J8LqTY$LXrP*USZ~67o<^)2 zXBO#ng7K>cs~<#KtEXS=?=NQhOhr`F+4IawJ|Cy7b3gIDmeRRD%KCC<)=p>c7k(Li z%=F&sqP6l)Ts@-1uIqeP=6~k+G|g1jw`vCxXKl{%(tqe|^}nP(i#S8MkKgFBCCNv^ z4n$9zwk(X=wnxt7nmig1{0?u=x;TYoAkz75i98k=-LS@HD@~*eR>6k0p~iEtR4dRxiP4dwF%T%425D?X=r}3!J?q zyLDTY^NWyo;-kK>H5=|Zzcwp$w}z+J+7Hiw7n`Bztln*-pFg{E(j*gljT z0$O$~IB-|?8m4PSd63=A z3JvZFP0=VpRd^@DTA+|}sdA?4I1ZMV*w2GxhKWm6(2ezY)`L+=2^N;okl2T$DjF=J zeTB+`4bA{|Y=kUwM=yhkp zLrF?51_wdiW^8Q*WASP5*`HTPye(fpE-s1vt5bto);l6qBInns zpfs;rObU#EnFY#Eu95tE8yGHRPb8EWRLNd2H7+n|rL-6p5x&2~J3@wpoJ~6p{dh>KFQSFe3MI!(+1h7+7f94tIadgU z-)Tr}^oG%#!`Y9TzD=8|P(kQnAmqp8k?38GdIY&~l-gTxHL|)n|K?sGNCOgy{=~-( z2Sfl0wxYU1jXj@R>6A@Xq&}(a{fr#VeQ{*fZ6Ccd(+{ZK2ldTni*KC$!gapMol&e6 zqIyXTcsr8nOay;TJ_M(dIy5TRkDWHJ0g^V@%mSkhd5IfmyS}jnC&58<9-nA1#c8pM zHx~G$&|7a{8`&5AU8+4^9@z#93mSdmhq62!41#9mwm@OvE0N{XZn;I^m5V&Tc!5Bm z@J&qSJjkxtH~|rF!*_8-ca(W)gn41QjNcBp+1NN;OSD%6kKB|~Re-QfL=aVlK*JNi zLfS4tBV~&$HNL%g>y@>!^1k2K(1r@L3KyMr{E@L^aYLn_m2+f@Lctp<;~a`Q$gw2n zG{mFi4Ld#g0^6x=^z0~p0y=O8IZCPS9toU^E*w)t*i-J*ad~oK)6iJ1a{yq6mGAd{ zO=qij%5LKjPDwbmrhZAotw>%9pm9M=4Bs(uM$PJFx)^2 zDQpSAmv4XgjO`NG1*>syI2cJ@ev_e2-knQKMQD=AE_G+>fM*BBq9W3|xlE5>RuQ2@ zY>n3zPYbkw2&_qgX7cxqVyF-e{1R*y7zONsIl(K3Mge%1288jNe>6$?glC2)QR-Nv zUNU>f4G<4`jj#D)Ig^DU%NZ?fC_Ou#G}1pT66GTv`f6qfB)Y-cqtMd1lWb2eySEs& z`xTo^B0x;ksv`tFqL@HCyfBzaUlJfw0&s++7AKy}LL6jRT^1|osdrSR@@xLIf{^0D zTE$NH2m-5Sb0oY64uqidsfUmvMH21_M-nq|$t>*lJ*E2IWV26ZaMLCdU9+EgvV&{} zPWev^X%-ysLc?z5^y;$|n3b-^V_F?5V8~8v_1zQoX3m>0hG_KkabkXTNvyf3f3`km z)iXdBueMmq+BRTcfmCqGU^3SNsr8!DAON-S4`zrrrWgtFgqGziV~CWP&W2D>C`&+J ztnw4p^O<9_VKk*5OR1~{iJj+1G5tbZP`d=DJ)7XJhu#Y@*VI;dhsw>k;B4dqd8|V z0C&+<^3_1T=Jnz{;%G&!T-B>T#q!vOsUVg*$3Oi-;Wv%KDnk4oBagXCoh}ei@$MMp z#M=8zu;8)*F3Dp+?K~=SDT+?$4$!L1jRV)euaMRi==y?42xC;Zpbl^NGMmXhWg){g zh(*XE>FWq<7QF62yvrmq$T|X6#f*kZGK>~DPc$AfP=Mi|x5^S;jLz6b;fY)1kES3u z`QxH!j^M2uv!^bqNfFLjd}Y>!=Elb)Dr2u;o(q=xOE11!ZNIfWDbV9z@(pts^xfg8 zS=AJ5#fBI}nRzFtf12R3gOvRMH^+IvE_eY*7`hp~{;Z1efpGlNk46R0CQ%wmx_W~q2+xcweK239Cw(YUh(y&PeQy*Q%ZE8< z*9eEf5;VR%cUOg>?{xBvK)}4_i24(iIk>oA6`Txkw0BB*ZMcPk$7zMc4Cn7y_CbDN zzt4^p6EbY}8goNiaB~WJx|i6Y9%kdEU%U&=;|om5#wCr<8em)`;%FyPT8udLd;Gkr z#wLZB+uqQ{auu2eV9{Bctz7gYca zRVpese^44aXQHnBdd(Fh z75AWh+D%zW6C6h!%q)bZZg|gJU_3t1%Q_!vFzs(%63bLhEy3_T# zcC+D{we{QTrZk>27Gu4XvO=c(g}*@8+RE$rS`-D(H&*`jOQ`?5{l9-lQCV;M<}@@3^;c!xsN1A<;?*9e%5u=WC3JY(o@%70$^jTd9g zJA0HTXJ1K(z-|)r_#@fvc>?6%&ZeT5 zG%j%53rot4fUUZ4{Jl2SoL4i*3e?S9dVgl<1Q|%A16iUyyNR)3s9h(Sqn~ndly$*w zn($LL1xX7t$O|j74Yn$_(_!7uAA}zofk!dv-4hH8NDuy!6^r{!LqaP;aBwnjFK}=RUQjFp zq_bE^V&Wm^=AMW$B4ax-eU<`#WPnld;dq!MR)Ou4CK#@_-X>C!tmA_N$|71uB+APe zz%1m=CEc}MbkBvO$6eALux>4h#* zsbkc0Fz@K-sFca(6#jEzgw%XlE1SeXi>Gu@XvdM&@_D@}ba<;?+{CDrCIB zw>X7ZCyHAq$}=&cv%cRI@i)uI!G_^2Qc-KKFsHSD_{PqBR*aJJr{TC!-2?~05^|Ls zVGDStQeEf1u&;2pIl?mpD+)$iW7d(Z_` zEh=b>Gk%c#>v3Xa5}M*Ymh*0+_-_1udG>z&J+t<5xr@`mo@C8d5%anC@Z0uR4c5Pj zZ3JXdGYcuVR4FMFly|zR0HbSH9n|-a&=FU+c>SrKtG%$rIh<^$e z1fnwN0|d4^#Yo}x^m-g=%m|wcw*rUg&|$d!+P+7lQzf?P{@#^kprX!;R6M4Qcn^{B!x2Y4E8Z)yd!!OED2bk)yu!iWf8HQ*22RU7cCIu|Hl!kpj? z3*E^PP}fG+5+@Vt_O17itZEL&+fbv^`-^X|-_KF6+DH4_N=GU(o&C`TU3pZh`UL#71?Fjdn*ou<;Nm{(()-Z`4d)fKvVA_yYe64Bt_7HgBQ}zWbTi zaHmTf5x++PV&C#;ho~9h>A|6VH7X{hOI>b9ybwt^%nJ|!+Em8-AqPV-TvP#by7P7! zXP>*Gs_Uq(5Bo;q#?5Oz5mk9)gxwA~c$g~(eCempS!njyu zl!o|es^R7||DEMTaE6s5-BU4u^wn+!4Od$JKRTG%z_{(Ea##4z?AEV1blv#mMm%p| zpdFA43n#bA|gNr)kNqZAp!D;TwNv6+72lYcXISX^2|u=WaT=MQLTS6FPhBnAu<(c=l|ME})<+Y&UCPOd;km zS@L&fLEE+Hb9>rv1wkaRKJ>cfuP=bL0w)+A2*DG@-6uMxd`Jw3#npITvC^)C<7dF+ zLWhu;e^-FklEm*ctA!s71&| z45OC}eO8rI|J29YxpiRk&4J2x(~_v{a8v>O+D|@AqZlH|!jttp^4^u0X?X?_Fe0C= zi+e8nOlDpSd~wqr&=X-6m#k?ZEzre= z9UB*2xFe8q=~K;)VOPwsw}ESI67~A7y7ZfE_bFVWFWDe=g)v3GSJ{u z`o8&{GCFbF-lc-1gufo!cPZn&@`0m{#O`o{q5*y=(&@jD^kAm`l_*Lj`c&ty@?|df z+I@MDlsNr!>1|;;KW$dI955(5BU+u@JR zP7L)PtV2#kvkXSKhNI31+Ow>LsqPr7*XDLz52}#mD3b% zC(+J-E1QbY_Uc%nw|wQSEGSRcd*ZMdJBLhK3MFrXSQbs&KBlbNaLT}fW51aWzfU_; z3<;&uCWUua&)MI%psi34@4Xxuum=d;leBuBNX~j4|lpqxAum~=9fGvDp5nj{H$2}!j*R+q6c@mm*Z@w`9F z=&O3LK5mMRRE-nCA*Iq59q^+jZR26i#juV@qmBqF>E6>Hb8fV+>k64sm)B}^dzca1 zFOV3qUK{m*1x%iUE?r9oo@&$yOT?U7T|$~yaX)>~SL6T0c(g`E#Y)Nw-9D=#?pMAl z%IP~Xo5$l-c@Qi2SL8CXluHzhtA^fClCn~I*BJ$ z1KJu%SnN=bw%0l9AfIRsHa&>U+bO9BioK&qi6?YmrPkx1uILOPP49@%HWLoMXp=(G z(09B5gC(yo0&2?Vh4+*Yd4mOIUxakEkGm)IX;1Ie22mt?)q#QD>MgA}bY$=>fQFSy zA726yY0H=dH<29{2A=#c*53I?v#{aTtS;Mjmu=g&ZQHhOv&**8W!tv(l+Ecgb0+zI zc+WRyl9TK|VDIEk_MKd7t*asy5(1<8)8&QN#JEX0+_%5L&Q$t3$W-*i>DP$~(KDG@ z8C7OO1?am{{sm1w+5s|DU2QCaDnBbfc|jQbxcw^Da>vw-$^f3#G?hYD@m%x9*peUM z@|h4kaNJ4r^nxGb8Er zEO&ZJnF%NFT=);Y6hn8{L(57s5r>4jDV;%iX*PK0*^5_f^Mt(<2s_sCD;F}L*Ov&$F%r;5 zeSK^52iL7^)l+d+$ulwwSi^B@>SEVQS#@Y-=IhjYdrZgKmp3ydCE8J@KfP*!DD2xh zBk10H8L0n8LXSoR^&S%xZElDKQR^4~oZA3vhN1g`qPJSp-E&n%YpTro5~}$qk60xz z@D)V*i>NCbvGy0Ah^+uyD$ay;Cbg2FD-p)K5&bWNu?&O?Eg$+TrL*2tx_=?h-<8U;E%m?*Fo z=2y8LbRg%6d4xMsu)MT&jfR{I?0g=y6FEIxsMJ858|q|MP|H>uY*!T0ksKijo*EaF z>d~+!t{~HcBijObB0J8J@~}yP`mCHv6TaZp?0K*IS3n3j+QI*iNZ>z;lsWznij@C* zB=Da^%Kx)~@IMp@{|X5IYXbo%^MA_%{`aKH%$&^sl?D9227(v$$4OvhGm!^5>M`&L zfI-r*2g4fVc(6HvMRH#vwk4kQjV(ZI&l7`8@uEE6;XBnNk`Dt%-I{mDD z?T&7=O1GD*r!VRM7-~{6F?u?;NhGt(ieCP!;6En5JItiHVw5 zw7D+(!Jxk+Non@A>Y1iu^z7L)7Da;556uiRipwxSYVAvATws9N-WJ!59n^M1O-yFg-ZF%7sn)EQlj{&+hO z$|o(N7_vEwI~fNV-g(HDYxZjJYVY^$QJU-4IfHQW{E@YP@YGw=J%ZRhjposua6Kgd z4&pzq(He4^(}vVrzu{1CzU=F|w+E%x>c0F0iHZbqt9cvT`fOKi(~$#ost>abtI|7@ z^Md3Hd0%MJnix(LqQWQ>^VnK+2Db8c4wa``6;@C5o&T@jYl$O z;7T93Dk_r{xgvTi=~eS@Nhg~3JQn^C*qQrJK?&>l$7;`rtRm>W9ogkS-q4I#lHUup z-%jL;xIFIR=)yqYDw0h=1`6serjW{>T`%h&5x6RWP`Wri{R1?BL-h6A=T`gW(YB`P zvCz{JHnhg$#)W?8=1iNb>8%@*UIpT|(rV+piwGMV0+~qld-tNVi)kJE2@Fx>rV+7) zhp@jK_(3G_)=OEf6RzJ(u^=S3LS*$zZy@f!i`hZ9Vi`5!QbO>A%>00Uq3 z=+tKR(A7@B)QFh=cFrwCQtYhq{V=PIA$sMasFflv?4ckcUCtXROy|X@vcX;!WNrvo z!vQKmFk%6EpG^8J7wgu_scl0?dUP%nlmz{hlwT=F)$AS0%sRHkJO%&;J`W8gEIbvK zb)~<4wzsFD%8my*gnlaJw{E5Q8vt5ct(A;@;EMy}o1O2u+U=`4`vufNjZ1p!;!7dOO#{b5I2 z<6Sg086gWxi=oxp=ML#JZXfM&Hq(BG5XMXpG0xDNT>{l-Lm@%o9Vwq`?K}6=v5iwJ zV&?MeXF9e`3?E~3v=>v5Te}tJAA^aVX?PDH$$OTw+9Z=y{Fa_gK{PkROpV>WiehOtI zhwJAsP?LXcy1Kz1`S z_AX!#^2k(LMtJn*H%3Aqo-V|_VYqhdUhjRCwHMH{NT%mGx0e7$$OmvPh);*t+$~dj}ud3OL56kG0 zh%sG}jA!XmI4*zv4B4j6IHN*q(ltMppbrU%Dn2V0*f zExMfZZoN+Cd>aYZ=?l*Wa2PL^^5k#qlVt+K6`nyGz6yVzz?&6VrTxJ}k)o@t`d9{J zLz^tv1nV2uD$92(KD?>vjJlnFDKIU*xanB$i;oyim+^&|D{Y>T(2}{+iOB&?ze~?L zX?w5#Q>P_2D6ci(PY=tedHp$`0^QtsTA^1`;6}vf+^EsJ5GnMv8EaTA9b#`Vicy5= zEztss!xXwQ7;WwqPUnuPUeFn%RYI(go{?(>CKbQ8csNA7lj(DV|2!Kx4De3)nD||8 zA}4D?2PCJ8t-%khVxU$*xi>8Q=bg+i{hHy|D@f>quRumy*F(1qe&`cO%hUSrjZl82dxbi zbFeEF-=cSN3A?jp0D)8!_f~xc%P9~#Eh$`Sibr#dXLH0Ja+dLzg2s0WikK;R3?{6T zuh(5~aA1+a3qm`7+ag~)xNZ*xdG3p#xUu;ycxm?zeLnG=Lmhy`sQXCu;G#{)~FQ(bPZPqX|1aGdgl43F@iAKS=Z`K|=9 z%IObVx%XPii}WmBRwQRrT^xJG^9SEK)bW@DpdJ!;l(VJ=!WIo^E!)Nop~nU`^{cgT zaRhy9x%F7Cc!vViiZ=8Plf`3}BHA5Wy?F}^@O)qKIRN`oT5&!^^-kiK$KZfC62T}h zI|OQtTk=3Ch7A+hpkp>^KEi4{j8awyL5NwN+e|={*Q7vf(peB7{jE@uS`X(>*tH7m z3OIP_$Jjmqbg+w@x~b)tHxLZP>c11>_zHbiH<(kllF#3r zxW%hgtHjNRW*Hvl{jy5~b+XuwM9l=%)oh^0D5ONPW-qf+YI~NN6~*SXQ%n5e)&Sp+ z4MF@NfzJb}`ILF6LT&+E86b`g$FAd{X6POO)c33?RzdfP=GpX(l;FoeXlm0)2d1{z znQ#}8_qz;w8B;j_3LDHi;@Doto_Cy{_H|4OMFKW^#68lb8pE3VZ^3#!nsxy%(XMcK zTY-J48CG~c$N?jmi|1%k86@t0f2xEE!qM75u0r8A7!fpRJ^6@G8Q1sBCq1uEcqKp! z8`ux3+v$Y5}YPDr`UZLjfnRz}xv zHv$Vm$UP5mXBvvTs*cLZ`q`&HL()9(x|4<3h494wET8NwHuVLA$6C$t~; zKu>Cds$)(uRSQ|`VV*(tE=M(385Yqk(=+|Cb+<%?wqgWW)eyzm7Ax>+b>d`h1$TBx z{4=2t0w4Ac+AP1g5Je+sMEiKs*i-(t4qyJTq-zaAz#rc2dFf14NCV*dc?{@Wni>`YX?fkj-LCL=6(tjeNA3aHS`cgg&bwwKHnOVGb-cpJ_(S~E zZ*lCxHjMxdoVGi-E{s%-H`tzf#ob`p+mV!}Z5Hs~?Qr8r zPFiCZg9%@>#ZH(Q5~y~VtW!kcFZDWM)F>vcb=R~876YI59#BvD~ z;O|o1!daR>8E4PBP_DRMf?c_;VHPSF_x7X?{Xm-&qD9uNx3y!{-iNklJ6l-?V=etr zfJWar-`F>4vUM0KQ`fydjDXY(3cd5?e~IEEc~dH(W z6!wIqEfsmZ%bq5FWlcDMue8o(%Nh8#nCA9$0hChCe#N ze+$-tWviQF30g@c4Qk}lg8Kc~Yr;;Xk|#3TsEFIBh}n=p(NX6cY}0LYI$`N8=j`Vb z@#3&H!Ljz}eMw{y=V`iF;GYe2;rjw_Q+HB7jn=lZ1wM!WsL|PSTB+7-gtm5U``uN$ z@aY8t2hPnjQs6!APNe?b#j`ouD;XFk`)!1CT#BBcp=uz!F~2qM@!QQ&ly`cJ-~B@U zCgGo};zmufJFNso$9#J}70l%z&M%9*(+Yi?(w!rD8d>Vg>nKN%O1ZVVAcZGUYL1TP zAugUn0qqe9w>+D;_vTnGKV;W9pAM1qa<~z6} zBV`iLGqAwzZ|M_KVRc#lFBsjSVM$Psm8}F-qc+2&YFvikUY``KJjWnOe)bj!E;|Qk zXlp+DwH!Ub{_=aw(#u(oDm{Abxh*Zd)<^kYoUAqLV(KF&-{mk)Om6DAP|Qp5xrcj$ z!>1UwZdPzXXg+J}3{3lzms_?;zIWZQ{v$Ob9-Zyb0|^ekBt1kX2$|g#?l0A0IBzu! z7XN28hMDS=@M`-xiZws})|t zN91a9_TT2c?E2d-8ipV}=+UFK6hjTQ!?pdJ|TgnGoWK_0Kv5$WQi$`Pwr2f1K#(3SZCA6`5ILNq54 z7|dSZhfKYqpr^!hbx`k6x3mjgsBe_lPqf|z(K(|U30Io z#rF^-BL-c+9qJwbGC@qn-2io*H-`I#6E)RSlGNX4HvfBneIJQqQ`kln z335@MD!H^mIWw;%wA@y<>a4iWy^9d!5+JC_E=;(KFrydK0gkLpx<24oL*Wm`8o@PZ z4~lZt7_(+x}lfT-Y+$Z%lmM852B)H`KEO=eUsQaEBL_|j67jC zHtSX?_zrVc}I&$!BE+)mpc(ibF65fwLB5Rv?u1)=Ue5H1(;7GEwI)b^cHx2{mEgx zw5;SMww_MMcCTvX>Mc}eKtDlo_ts0)J)Z0`M^V-=iHOJSVurYFHVbLxNA(4=hv=?0 zR}Y>r;Zd5|K9psdtgHMGjC3A!upO7}s$vc~u$pnzf2Kv|#=D4gcX$tL>NxJ-w?i4+ z5Ujx)Pi*(7H6<-=V*D=3zhc>{JtVmVJS4m-JqcH@jVLSmAdLvsm%_JVYNn7fdw;S4 z=+-UZgl=<@JUd_}+M*k5)90COIaA%3X#B;NsT@Ff%F#fI9vyHOn^Q~BPTl4-N&$d= ze+Sj>;-uul%#qyCw!iIF$PvHurQjZ31U7jXo@3#mM#3cMg$;`bL(L~9( zff3#PZnd^;i0W`vx80*=aH~j~xLPm`RM3Y`WIIrEZ;J9_M_JKT z-MkX1r0C?hSK_*d*)N$O>CGar-aFj3-9Aby&QzE#1V}!*5geC(RV9x|U~Xv9lWnt*yj|6?n5e$aj81cb1gi~||O0p2^LDU^ttN;& zaLrHhH%WG}o9=GWp{bfVY_+4{J{$SrG#i?PCl>#;mK4_9`q zr$O`r6vbf0VIAJn6&QPxD?p-GI~?&E5lRD_FkM`yWL0rSxDpZV4)MD>UQ-9$V|Ecv z35se=CtCJL%brVvUrh{LOi=N znx`Q|CtWc}>UTmKOuFyR$Yko%>6OkVZ%zEA-NIO%ZqQiC2MoXKjubZDSa~ZD9lMvu z90Jc^N9S%jXx%Jg`fih@A*vJ=@8}9+8D42Lzh;(=SbO^~3|J;h z%in43Vnkum*b_8jMi~tSAC`s`%|V%oRO%CD;*}nbaJ~4(4IY)ANI{zhHR$ z^wuAjRjE`Le-(*rec*V4Enve2`ty}Q=N@`=KltPz^_VcQ$n!)xrNKH>@qkZY4Y;%_ z>v!0?icD^k_AU!bq_C7ME7#Nj__OQi;8l;a2bUSeBH2ZT|F2t z72wD%xx%`tG76-a^&d_z@3d7j(NB%$k}a&wLUP^YtwdF2nYutOZ+Fb!0~J`z%OtTO znc$fohcg>eALkXwa1lC-q?S^d!T|s5RJ6_jec!24VUY=yDtz5uWQTgpIUm!76rq=| zVO*}jKz>)Eqkw*1vGwr_q)dDDh+=kcPXe*cb`1Y=qZH)P1gnrdP|-xSBmwzK0IjT^ zngg8HC&blm8P{^27lTj-)NJ18*w4udzxpv38bYIA{fH(92!75$_J^U$epTtRZZ z6m++qPWA#9U0#!vY-XoKfqsx6ksA@DmvB)S zLKfCRLW)H6w-7W4hto?q=XR%Ltyr^QPDlm$ZXI05Oa*`SEVfAv#C6YGk^OG|RX=(d z(bi9G0$~(gll@|7Q8P{%w0KsgmYb%jg=W;s^C7TBHlCR0A(U_HFJq8mXy^iRZSH( zD|MC#r9!4uhE&fI2r}pz`l(CW*h2W-NYDrMQ3AL%{Kyzv*b1d@rX|zA-57#!i?i`C zDR?NZR`iB8i!l4=^xD`MVNAdZW#C5?iZTfPO%sH;up(oF-n@`gXnaj|!+Y#ZT)y(U z=eFB{g+~*#B#BOR8iw=vJyRnyMCyx#D%8K%~vbLZnvo_D@gVh)V9KKsrduj{j( zf+wCNeTHSc-_2U(tS(AMFG^X8k$@2-_+X-g6dTPi7{t{t zS(N8Rvp9AiW_9K1S$9UXKbG(fZof}c8GSP|XkPn{HMq`fF&>kuZnS)`670cz@st@U zPq3{mrFXOk-7NBpV@rA!)x1tAQ;XJ|rcIk;r0J9Ok(r9tImpicVLSsMc0V)L0~a$+ zo|+~Z@&4K+k7W%!*yQtka!)S0)DomW@*YTkv`)NC(<(d7D(~dBI*CFBtlk5T6j&YT z*rQj#IMt85@2Hp{Tg`{h{?Miw0&DBZK;vl5#V(jMZ7r(kSaI~xiRX|^DIy)0@AGQ3 zEt&`#r$wbI%HRkl)V^{b26x+0L|SckO)E>AW>QfMKIxllYaHpvq3 zOd!=rBQ21EEei}iBHdp?=_`m)*_EJfM%|*BiGX8q#-ssH&*At>hqZLX0Mlk9tizK- z3E>xj0h9KVq0^=TaI|ikLBszVV*M6lDlx~%Nq{a{#ZAl6!zopJ1r|*bVC>+n^rqZo za%n943A&=o#_$Mn0T&uS)jtL+&76nAs||6x?p)4mg@@w|Vz&tIe%|->ECMS>DOvdU zL@C971f|6L0mlYH2*%t?Z27U*t~C+I?uu_vy!Ds z$0YP2y9!5=f^4?j=?1|kR#T0OweBo`tt@jJm2SUU+_$5xUE%S>KRpbk?V_P`q&siz z5ftgqYk<vd>NN3}(0VjPML&Uo^iGFZWSP^k%W##RO(jH9f$M6O$Uo97hk;wO(w|tWCX41gBjF44|N0Q(7)d zSaEVZw>);f$;og!W3Xs%KOK*?`Z5I*UAm%-D2Y1{pX40?ri=}raLuKGMksjTDJjr; z@FI*x_w76QG@IsiYi~twyyTe0*Pd9&ze6r@KU4QXI8s}{FBTAhwFhrk?c1-hWcKyN zva7~ca8#rZ07?&TzdF^`L|oz#C7oG^q>K!tgEIz`>GJj#!HFFw<%gPh-5!C56pZE3 zb=c@u?J9E`vm>ho;5R z&qogNC(k340KV|LqL$j;?XT~!NUy)Wbeo*%ofgDp%&M_A-Y5^}Na3k6 zQW?4y6OT25ROqOv(tnT4lKa@KaJx)H)n_VC#G?4avoT(CeBwh@7<1)V@5>_C#ya?( z1#TVd0merHFl3DC0e)DBy-Fo?XZ^$Jwah-L*@-F~m1cRJ-${G1G9_!)X>w1*+)A__ z2kCmE*n~MYPQh@vU_~TM=$~?utTR=dsj$Ii3L?m0*98e-THMhbcHkP-E@KntH?I5<-PQ#0+L9B-BMZn>;0tzdH5+#rO9iy|K%R-tbMR z`E@_@!(Ihs-on5lK4@m;B%|>l%e-Bz6Tp5!mqm!JDJ{}6m}!riPD?Zmm=ySv`PDej zgj3F%G>S`_m7rQ4TuGbXq_5G^*Z{U`o@X2y5gMl|i!Bd&M-x0Jxx`cxae-b&8!Nli zoZ(w`6#Z%`Mk5Q^Q(U#lD=oa8g15Wx2SvQJI3|w$C2&+PQ#vi0ZRsa#%j9oF1x|9 zG1kL+m7^gF@Nzl%M)9w0Ld;J`AgcS#K(K}R5jsrTlznI1B<4hKlC}K13nat}Fk>f8 zx{eEl8NqUEqnMSC!36q2>h98!{<|@ew{oE9xr62*ZxR%Rgy}imq~z7YI!W}tm3M(% zbCQ@RdK=Re!so0Z=V4#nSld>m1ArUXZiA!6tGS~sHq?sDKI9pmhMO&=DuhuHH%^-F zJr$%{x?Fhry|bgHU>^-T7h6*9>JNnz?FB^%gj(N0;jn35Q)( z$+fa`Jn^_Jam>u!b-BV>?l%YZB6b;Zc83QkZ|V6sVABZbBUK`hyaU6NCI5U_Jm26( zj`>f=x}j#`c%-jG76o1i29ECcz2|XVZtUGa70_*F)%sn`M>$zHm74f;YbW2npU*yD z+FkhtW^yWQwN2*bn^}XLM(RVbX9{%8zN>hGhd7c8rO<;jgaA9OsO3!YMDdV|DVL%P zOz_dmE7dB`%yR=N0A~>m#xD$2*0PHeDVY|FpMy$g`u3jq z&h(liRMs5sYY}U+MDMo)-HpT95QO^|uTmcQ60h3Cdo-Tr>Mu3<6hfa@sv>>!jn>O$ zW#gfwiszx*dQH0I{e9snx(7_fQb2&zxG490io0xR}A||i?!4Hi)2a8Z;{%=p#JXeI>;4zE%lsZC_4Ezx1&nYUJ>Zkv{N zs?wk!0;PJ3VHlqfIy%2labjfm@$pH8(m zcAVJE8-Cu5nNzuVOx&KmM%QNV8_)yn;c-X*Fep$SIr+fF#H!ivj8#5wgWF5#UddWs zIsb8@FLs`GZ*9eKR+(%Q`P+Me5Z01qvsYnBJPg)?KppgFpC=8HWN6@ClJNKQ3#fJU<|nySfZ)O}ln_r@ zJ0>}9(xItSN;GIm=QVGO!~-OKsEYYEV`TPr?u07xzs(~`VAriV6_sU~6NlJXp)_~n zkYFrcv)P1LIyRe;HYR+XS@x|Z&+{m3PK@-c_0oeOq(I1C@X8zy&9T2tSBKOpwE!hR zyzHgN!MDr!N79ul;f}G5D^D>Z@u;NuuR6?5f%4LHlDnjDwP<(?7#7R99mjLS=D399 zx>DD9$5G2{j-ifA=U(u&!d0ihi_~|xktaM=4KVgio>nSa@!};F1q|0kBuJkbuaJkP}9k89z5~ZDX#tgu~$Fi$gIBKrL z@-Da!$Q;NP;m@X^t{jDm_)jW`5T%e`%RZ{LhQ7YX@4rSohUih;6oz~UietCeB=TtU zi4LB~xhAkHERr!Pd%-;U8T&ZaH`3-@76u`^;*WF%Scp7`p7A>5t8;Fr6PM%uLkU3fW5jVtECn8(2=%dLaT_1RiXwx1<70IT&&bj?XTWEbIcM8Px zH6~Rtl=a)bSKa4HS9kdoi~;AW`LuueW&1>Fb`cnE={Jr%i8wQEGzA$2>w`EW8;Otb zHf}fu63DR3M~W&6w?gvgf_-yfi|e5Mj`zZL3U7KsI)I6FQz0eAk2I+kIZP*w=o^(q zz8CJsZKT`~;G0x)+aVk!N4KOHV-xYdOF_dYjS<#mlDSE3u z`T}m>W_Zt#o+ZmhfAo%G@|;XO!0rKx-=+P* zJ)YSBjj2^u>&+16KQ)!m+GsEZl`CeqCQyN-(zMb>hcE^4MpHOOFKb&BNVCO|VV`%w zzgQ$5U@$mxprbeC=GKPb4zk4IqTI$#G48ray+vtxy`4kmjSVDMMQEu{Cx@vrA&l0% z9W2v}nKQ+e$}AjO%)-NY_o=`C;P5Gr#k@acBpd`8)5Esb%aU9f(F&j6a2AvwJGO0q zV>A8O^{7IHY*qUpd96N`ro-bhkjatTszq?(sO&b6q%5*}rX{i1+69T2(e0)vai z^#t?EdufveTpBBTh4w+S0^_xi?_XP8U}Am-WJo#eZk#s;#*%MDIJ|$uGHkENYgomT z3SQX~S*GV%(#8?l4k|5FYmPbh$GwB806>P;87_y$UXJcjg4?9>~m~74BBlv6wF=wuQuIAiu~UJUJPWUsNl%5E+iBNG=ed15|o6LM}+Wb`sJ+*UCBo*Y1KhLIWs@hNu>4zS5k7bB@I zPhN7s`D%P`g8%T7kz4oGq&^=_wrE?Q$dE#fq!Ea8F|k4j30B&#K%=kAe`twsVHVw? z?f+qLNTC1a$@i!|aPXYwUdBN%HK-mH`+Rl~ufLah85>VgLIY8I5Kbl|=Pjm& zcIm{$`x~OX5UT_Uya%Px_XeY5dzbO&N^EKn?hg0~IDZ&JJi8MFc>OQ~SGr-QuY*9q zD)bN8rrCy-BLr(RZ5T14$90gsJV0P&z7fM7bF15wiE)A7$TFI0&ld=t@|x6|?=^SmaL8ZGF6AN7r`T0zFpRY$z7|u%`Wu5C zBDeJf4K7P}Mw6JEceYW1OQbgKs?A62+wX1U6L1XiuqaPYzuWC?-FkAGuiyJL%jZiK zGdTxH@ySWQ`6dcEbkiHkO?}9)PcMnHZp@sVPNRO> zjPX*6D2Y zblL{8(7f27jcVFe+g|04AG3jf4>rxWQY$AA~Co75(lPua|S_>4w);2Xjx)SwcX>Un<~hvTTzz&K?^h@^F!s z?RndA2yA08U8IK6<}RW8zn5 zTFCl2^v7>%fsv`&SLX3>4BbxsU6A2g<10%uF-;C~Aj=|L=n9@} z`s2{+VkmZ!`-OQ0lXRK}fGNH- z-5<{%904k%ma5c8%g8VGEIMRVD$~>Es@D1 z)h4CE2+S7Un>?~cEEOw`&-+iu`HAtYSODzneb0*5Qd62shQcZP#}81TVTWCl5ESuv2oUrw!9R#?vW+FQ@Ui3Z(ra zOVMJci!AZdt?t>GA-dA%nG zM9t+HtyMol+1RUg;Dd}q;ebHic&U=i8YiX^~)p-*70!S9$Ez_IKwhbx(DsWNg#(6^F5mVTBnJB$Ye8Vw}ET) zQX{_a5I04q0tk~XuTcJif@IkoRD$P5FxIlUm4-p!i(zGYa%UyoXY~8VZWFru*y+EhU6Xh4!&uvzHoC<%v_YN`RHEIv8>xpKV@+ zu`sS}Dbcf*ZfFUd=FDLzp%0Eew^hxe0&!6*JsW~@mIs!c&&~(7XbHILjr@{Z3-oT+cd*;!Nk zW^o}5rc;rY1w=9PSk1J45g2U4$j#W4FI$N=f1#B$$ zPgMnrVVietF6o?>sxjIvT$QuaeiX2Tt9d>3Ej?eg!U*OY5q@bk*{-n}a^|qHQFB^B z0z2WbIo%JqIUy#20^+dttJ+nxb~v`?Y&T z9`>+phN?v>l4;0MF}g6n zI2lyw)a?+bk%|Uw9A7wsCsqYVU?a(Dr^mo&)`OG^g%04?U?Aj|Y=gn=UTFup#Po%H zxKp_h@+lgjbqb71@odcSvVp6oe!X_j;luQL5UWa2*m`qDOh%{I@+h4o(}6o0*Nm{P z)Dy%f%x8q)mbHFVuG@pBX$_F=(P87%X$97x2t)MGE(R6-fx8DnDUZPGwWJqZnwvOa|nTt0F;|Qri7aost zb}~}1nAo^zs)NcY*>xUVsho0tDw*Zr+7VJH5Y@d0KI5mDedd-2BD))R&$+i$w%FO9 zU2e+2yA#*VB0ozrop<9E)BY>NX)5Z>`}fb?r{KvZh50)<@1PQ-r8qb9(J!AYbOGTpClAJ zQ(XaPm`jFKN;xKWd{`peN>ukg3~tJgv3jdX?9|l-g193_;pZ@+c{~D(|6Ot2ef3SL z9OZgzTV9MqM}>}i*?~Ptx1gcT5a&OKWLSnQa&N4%MEMuj1-wQ_SXvO9<0Vp{z;>ot zzqd^yj<)Nx%1MR9PhyiJoMgywrSmw6AE&4L@D`t6M-1a$DXDshDSvJ3RU&lhOxfR; z`Dr)##4uoCrxiZWmY*ZntgmN=DVpd|~NP4r6r;`Q4+hf|W^Nv>9z8UMzuVLA2HTpa%f z{L&}A{2acxs%XgWe;|9x0d)Ai=_Ge(w-*EWV|{8~#!yB^u>0@p!2DWrTuUvEGY@JA z97jK6&rL?u7#M@PYdq{cq9)SsW>>CZ`U!wBsMWpWI@+nMSk70+3NKm8R|7+- zbl-kJh}0vqkdafxsCep`obNdrBJI&JIgk&-zNBDK{a- zpF_B6rMJv`7np{9p#a&ql?_Vt6G_5t7SCsPxj-;N0~;pDPY=Ok;+==f6o|wGE^5Q6 zH^Gj9vXUTY;&Nv^u}!Dkjy!S5ndG1!_V*z=sIe_b@aURGS}R3-rW+}qd&7PxuAteNXL*ktK1JhyrJH5E#aPQvLO&r`8O3I6@gteWK#M!2}ma-LSm$UTOvrCf524 zc_sEpC~eel{_Y!n5o-Dv4x869O?=l~mxrIn%qO@1orZ?{2B#AImsuRR$+ni6f23X* z3i9!ZcKyW zDeUS?9Q6W{ioE&M#rr)siB0mtS(_Xw&(kl%OfZf&XwpfO2f>~qtth++*Kv<^td!C` z&G#GH0QSMjS3c5B2(5VM%c!KvF|W@6P~;&=9xLfWU`!;(Y+?L;-tmrG`+w2)jxnM{ zkDF%qZQC|)+qP}nwr$(CZQHhO`?ihg+1+F_+28(mb~F2-sy7?!){KjJEiIGVi{-Cjg1-f)ecfDqxDPdS{_aKAdHNlB%+V^!?w? ze7<<9mZc!+983I~al&?o%9ify^hHB~o0Xk7N}WCf*BPWf{2BM0UWVW+jnxfaCRPE| zT~)%oeyH_tZ4=wE@+AsCeEM}eEB;}$;)K)Tb-Ps6<+<4P^%>4jbu%p(BXG@Fq_(pk z`ze$N@$pre_sPTazH)^2u#l?l^~Oa^)pzE+0od4|bh=?A;LqX*9*CLm-XaPyPkGmu zoi7u0Rj9Rs79TFzfz4p2+FyxxX+FS)4!S_Z6r&Ov0}I{BY8_6=a^wQyp4yeQ9pX_( zTm(H?B122E@Gw7rcg~65T2iPj{+I>?DAggNeNL~Odv2O>IKcYd9)>L}G4-xRW1>Rh zI)uNcWQj&ue2DuUD%^+XI2h{19BMx7nOQ;od()2!{*H3Yq<@OcNhvFS7{_bO@P&n8{nY|IbeuPb4eY2!0FL_7 zMep1*s>Z!bro>Tvf)Lo5(uKY&ekxd)rGwA+FG94D>kUHrTJ94Z0u424AIi(d#R}%j z$;o!{Bk1g0^+!^wGRL<)4w#aUNP&C@P^QW&u(OlKAWAaShP9+a;X zZ1Uh)oE6BPg%2N%VjtXaa@{FJR5@hL37&X)9DU+eplc5HFXFeK;SFz(0paEjPLpGjR;`hE z;edeP61`yE^QVzfB?$Qi-q&Yno!SVuN&>u7ZN=z*DtaEEi`UX<*qI?=(_&$SHEuV= z(@nuXYM#Lc%H+;BJa!8f^Yqf%>Q>_r!67eyuZ+de zYC3+b?+E0?2YH>AAIZMrCo@v6z1wc{5a9S zsLn9+BT=CY;E5$z7yNLPwr1D-<|=oe$7oM^?o#hodiOUr3`YVJ^{&sX)r3FAAR)N^ zBH0`Fn9R>8ff5MKC9isFiMtuTzG@YJj{RF|%T0L6ng8wII*r5!9`Uo|r6 z-LUMcyOGT#lQ$5z-l(~Sne5yk5{KLO?Hi*tqY;*HJ>H?Dw%AcI^E+b>*i9hPapDuq zn%+{heM$O1%!t;~-hM)Tt33t?AZ`5*5Qv`PhQk$m|02y9AhZfgTeH!gTB=OYAsLnxP^8p|WPSSA>KFw-*HFi!1L};C)eow8e!H@z2NxOcf)k!bJ_BhQ3_C`m|+KGq2U??SrX<7bO-?NXMNZ# z%GRWX!`y@-y~W~$O*SALpfg2`E4U=X8T^dp9URrF@!Nq!y!I)z<_@>0M>ma+7zKzK zO~b%~v{s4gaj-leO*Q^F_he^5NcDwN{F~DQMxOZ~jJOiwZqVnVY(efD8EaI2X=9>T zS^qwCB6g?x;|u4@Mkd}5!kTVpnJLVHlP3pBP@f$bphE@2EHi}76|otVQnPA^D=aFF zu@2*`mHd|n3}(xsot%}+?x5aiOG|%!h7(|{#onp+Aa`2rdvmVOM?FN*3#2~(H0^AE z2zY~sk>wo%K0Se9#J2OVx7v*Ua}8Y#%mF`hxJP%I$g4O{fl!jm0*-Y|M3v+nU6_*9 zy9NfY+jNQ=Asm{R2;M>YkqQxfRg#*;TAq*ZP<&ngu0{V7(jrGetEENg=~5( z#nbK)Raf3gi}8dOenq%UKc6r>DrF|#hs?>SrldmsTCKGU-Pbd=!`+Cj-srh%x>lyeew9ytP6gmHn;X z&atdL~YjnP@XN@~%-%~{w*3Wf8tp-h-l% z6B{snZhsG<0y(pKudpq4s1SCg=Ir=vz@0%z1;m?Kjb1VV^)GBEJe3c}Jlq^iuAz~sWG-n*9)&r#^L3-5T*dm_18e4r@)-#O3Y7UtnGg2+wKLGb@!8ot@A-1|2Kq zOYVdU+|1{#ijrbG`*Q^6xB%DSsweNglWFG`GF_lR(AcR2R-R`y;UNug z2BoH!Z&)SjH2wiTASb0l2Xs}i!5_froBh-~inUNcQ_)kX5jDS>0^v1-MvVZ+K0)PF zDmw2xuHiCD*fBz&!PCXY$-!#%5`a>}*7Mba<1MAT)Y4CoAC!`bfO0AtUVH4%SyYi| z(Kl&x^evV<_E8_YRq{iaQ}97zztWdKqG`L{gBSAL4-+`?^Tppsj0Dv@$%_aYU-=-FTqNVTuD&F+{Hp0(=(=-1}hwVzgjZz0{<6GNE$Lr>qX$RH#_+ z@9C@o`Xh~^6AjHzX({=qXC}YcP@SkBr0(=zP;=CBKLt|bk^Rx7UJ5^Q=2t*V0Y3^G zpXxMtpCYNW#MRgMwl5l{Hmeqr(!vPI7Q#_Hc>9COkxL<|di2NJcjgZS9RP>A5Y&H) z`Pu)YSe^ZUp;-ODj`{x+*X+M!nX&wrG5`OZIh~E2?*9_=iy(Txs7@`?)RPSK?Fq~$ zOC;0CTqPANk3W{QTzLb4geejJi6U9M+x@52F{{NlzV404oR)sWzU}?~cz!WFNqP7C ze9+G9xrMulZG*1Z8sI=0asAm`}RM`Z5=cn{U76dnEBq~2ZCTd{5Rh(#T_zp_{Dn=>yBvzgaAH?Ijh)#pl?c!BCI&=rmS zg_v>uHgS`fw4fvDcROzRq#At5M87{Y2?n~xqjpFlg?~z6VJsif4wC}`rTGuna0@-e z+tqODJ_MdgpVwx6GbH-KWqywY``q><%zFw)hm>(dg;)3XjasxCNju2FROiVa^*!`4 zKwDtR25A$vng4~$A+6<)-IiJCA0|zKAC{KJLg?lFYrnUWz%P~Jl;@>nS^1*Tw}c7P zZ=*M4kcm?L#xZh%815Z=>f1{eWXz%>X)YNLfx~!5ce>5#S{%lq9zfhAeqnP3(M|=G zl}7ZJl2$(Ewh->ZfE&3mY|)8gv-I0&hekVd>i0JKo$8%;S+JyKTXLC#Z8BY%nmj7W_qY#g*^()$Ki3K9<~eF=&E)K2@Z<#~|% zHqU%(>Dh6uKz8dki6+2tOZ`%VuCVhER9isX{z{KIoY{{zQ8RfP&MUDkW7e^My;B?! zCOeGBZU1ez_J(tPyd;P|$g4_juLaW4HFG~Cmi^`)CwgLjP$)@Psut(2ovD7Zgyegn zQ>dxyazB#!YT_ebFed4(m5sSu(M7so$m0U_3KVE08IMb(<)=v$?sTa(Q@cC!5eo;j+`l=4Jz&j!)w~BB5U#NdPYkY1 zWO<$Y2gp)7ZvvA7F}+)6+))2ct@)%H1ek6{W4b4)+7p$0X9n93x`WIz$)FL%@!Tu%}7`?uu#d zCJ8O?82xa5aF$#FK8+d~xaBU^bHH{%pbAtCPhFNkYbA|NetdjEM-D37QSZb91R@UE zEo&6CqsfDI7s}FWm6uLL>mH`-6q<$W7A=jenKp-prjqEj-Szk`IgkI)M*ilDkHK#K_W)(Axf z6$}J}8m6x(e|zt@0FAVfpd$|Y{ZHK(wG0i$g6YTPZb#vI zVjUyLq+yFM+f^F+);*N8^`go*fPJ7(h)g)-HNpi4mcO-O`KfboY|~Q?dH9~i#);R| z%U9zl#3YV%ne!=KC-HK;Bzugqj(Xo3EQ)IA`F+P^cxWBNV@TAFO}#vgu=Z_M*^~K| zxOQhL!*te(9J>0!A-D=b7N7lnb&?_Bm4HsXC3OOP%Ak;U{_a` zGG4~+m>92UkZ3GeX|PaFJ!yIQOS+vEAQ^d>K~-%ulh8=am&k&!UvLNXaw^%MErBOR6BnCN;`&&Jsv z^&Idyc8l>z^uvAX)6h-I($RD7naG zP&w~HMm464GV48$RFVs49FUTOS+j?6-G;T6nLh&7=sa{>_5Js!5%)ViHAwgd zlQfGMDsv{=A{c4xSZJkkP=qy-_3=&+U?A${6-evdYwr}27npqpA%o6$sYoJUo^A7} z@TCZddEj}z^vCaS(VWJUrDyY)QMdG&9L6e9O%d&WDS*uG2wtizJa#T~hBAa_$Bk{P zVD_c&Dx%KzsX=ebYKAz|qTINJBJIuIua$Zta%;JYFOKiLq@YY6JRW{NCh@#4VZ%-I z1++8ThDDJ{-32q(i94jA9X#Vqtvo(5sH9RCyBe2pjT{@itP#@A>|5(Zf!f81wATmZ ztN!Z}e|=hgSwd1MqjPPIoL<-xYoUQ-yt)w-?L4D(O8Y8*pYO_c(@QdP=xRur?xSg( z0wDw&{F4lxI4eOV`La5F^G}WQ(>2Jk@N{>uJuYveTYgekhf8N=w;JA)_)Q{QX z3dPvA{1)C2%b4ZUV%-TrpQvs0x6Om36nmX~J_ijtb9$v$bu~rui_sc9<^UGH3cthI zN`>m)=b&58mS;}~_0nfjIr8lXV<7B|=9 zVrwR83`xqHmB7@8VCL~}Cux+_;)iLIw-LG{=ufk|ikUdh{7ks?nWyNCiw~yAPW`&T z_voqzdcm@kT$BkIuBWq*>W>`35P3!3_6#{b+AK?k1mr&$cwi-`0cBHguTcNkReHSl zaAYR|bOeMAY=Vah-s{R0oFM?+wf5C8xe2js;c3ubh;%@5f;S^vgdQ9M*t!&@u7)6y z%1R>I&Z|C_kw0@TekINx$gPJ^7x_k-ZZ`188>;*aEpu3ou9tbv&FLP{nc`6Zn}9T9r|WONvRy}&d0 zYAFWhIW7NGg!c!v3X{8tMzI7hSh$Vg%mZF{Q^NO9*WA@N=3w0#mDF8g)5Kuon7~qM zB5iT$)wjF8@2p|&MKVtwUqESGh4bQD3GTj?kK{0WUMN8GA7)I=R3+nHIuAtiKG!aX zYp>mD(QR!7b=dFEFT2(ZFg~-CMeincw|=HRS!_mciWU6(j_^^}Ls2W-H@4BK1{7te zgUG9br<9$6B55&=G7{ssADZ|1Rc`#pvl%5 z88C+!rd7N})~-Q^KC%}C?x@#AvY&nQmlnBOEl;vEdco9!l{F89o~O0oL|AO$aiITf zD^I7G=EP#o_Po9u;_^{K%R%Eur1=q=|J%btECdl)7a@&kMBin1(r)OUQzxQDjV!^~ z(%j*zA7F!>2`X7icZUDEpC@aOrP|AJ0*&BkUrK8*-`(Qz#LV|baIZVtlWLGE6Z@j4 zmwn{r(g8Xg;r}q?x>lzEK)1}qEIJ>yTCv!817)}0Wm$~I=-*r#1SI9L{?^+Zp@=|` zPA~)}Xu0;6=eoc2W1W>Ixi9?`A9ZaeeqsO?r5@MgUkP_l)>l4ZChyKjm3U3dww8bk zmbX7z1)oEZSM|3lQ#wFt=064@4KI5+89I(%>}h++6Xc}_l^K(k^|z)mn}-}~%h`-) zB!4^@rM=aK%*GQU7$uL^W`Kt>eCJ~sQSf@TPEU>>C))1q?y#esso8#eTVEcAOSQSy z>HYq0__;YTxe>_0D?#2*f`#NGpO7|cb+y0XWRUv4DI{)-3ZJ{$0twkOCged(p#DhJ zfw>E*Y;cOT_@Rt>0&ONR~nMB57ZG%;%Kf7sO?`n0?JEg|}`20(f4&BR!1b54u zrwwgJ0{sAiT8~+8kG}T~od9{ObUx)r)tQ~VG|EK(4Lat%tVpJD6ECttm{JzFHb?a* zzh|D)65KGIHu_fC-(d6>XPyd&F((s|(sG7mDj2exidG6Vx+{!3U)Z$8AhlFYk1E9b zE%-WlT_sSoS)e)-^HJ5)TTAK9dm`Is;ve7HK0A-J!5n@aVCe#lDmoU&u?^tU4AgN* zYxx8CnM|N1ZTt}9F4E2hux${fp-NO*b2K>92nxCEHO2C(w>_bP>jY_}JLf0OO3_ay zqDfC0%J2pKz!q0D-FaRPU8;IkL}kwseHyP!Lrx`+!+9Vcp)*jJM>ZaK_07*Sl6~;o zhm`R;#A&+dzt{&0RQX$IgKpxRXA%3>=m@1NIsEr&t77b(Ktk=qEggC`#brfYIHW2z)YP(*0McUmv*t1HUxk$W|!pk@l!<& zQRdgDT;yw*c&pwg)GzeW!ZFw%k3XWNsLi0)<~dpVY|Wn>R#Ui!Fj1@yIk89B!mZ>X zwrPOtily!P@cxz3s5pA>0iZBQyb5^aF2hh`euh>S%uErI%#cDM;g zB#=FMO0g%=f?fkzwq-SDn7)Zof3%!B`fzOG z>mN;CAq*~7EIFd#5sFwE=w1vx4sCozTM>x$chNn`K5FnOO|AsMEJ2H}(U}#)m?-#b2-7vB;X<3@A5h-~m)^v3f}ly(I&hgmSP}J3p1^R;UYY&#Ft5`~ zUAi_yqEeQ=Jf8{%ws)HRic`ZJ8gIsT0GZ_1rOvS{Q+cWGVyW*~ffMoQ(9R5KabV`L znNMaRxe3yO7_ZjCpasxS?}qj2%Wi)3tR>5$S|X^wua(j@ww#|7nb9dw3KThHonKiQ zVq8M6_2kPr;LivjPVq5;%@k&k>Z>dEXCEG{-Ck z(QUo;V{o24Zya-l2*pz$VGmPMe1av&FQB6}aeYW|HjTi7l+jtpu~R;iJJMrjqw3>H z{mRds@h#C5v4(Z0w|xhJp2i0E2?%PqfG_-4bFS{uT5m98N=)$(Um#fz1$R$RLu@A? zZFgci|C#V}yiAygjX2a4xPvXOm%jkqOqV=0+68EV-Y3XS1Z zBUM(1s9u)|Nvv3PhAsF)B`uD!SrqxP>ALV&rP{o~kEhGe4|%}IdlnUnfhu^WmYfG7^tQ zo5i(O*VlL5*WHoPHUAI~5&r0lztl+qyiU!e{*2eL?IqO51{J8=Na=;(`$JWbYyXHU zr;0Gs8uiUF?r&=_+=IRcX(ty0-f)-DI$R!@!K#N6z z(a}!UQ4{5`-~6ftrIog|@Jev|TV)M{4>NDWS+WH+hBa5)Maae@sRG#P$4$_R;+Xlh zPr=e4<$8s0XweMGJJ7jNjS(1&lm+|bLo~+HQaOs_OP-Wd4O3cb${I$bDOk zdsm@vvcqlV&rKkVt&uRzJ2SmA_9QOw)gn%C#8)Ovjt_BNsllWKbS3b%oMeD#hv!*%M2%xaBWDZ%OT z0AcyFXMN%MN+3UwFzGuXm95r+oR?s8DDe|{WSPfzLN&nxT*cv43$qG4$K}c)|0s|_ zw_|yQ%ama32`^Pm;-S_VhB{Th<~py;z!A-0EdnH01$&O#J<`v?f%7So23Pi6tGkJ( z`@^UBDq`yil?Rh_Ak;YquYHl}28k%-NKOtZ-X~#)I>8^>TH!a&i)(o9tvn zA}kbte+WJ%z|AN`ERiH-3}$dar7{sozU^jg|3FE?%{pr}*>>?*>u{CgXHUHlW1l9< z=MwakluMRj;)vyP^^9dGA7}akbhQG1izI|J)3r055;)I;IFmZ@NL)4;pDH=NDY?|R z^0_v-emN}k@!4=LFm5fdLcHU*$1*N7kRx{GFSYd@b?cHR5q0RMbn+xzpfau(?*8g&<;D1hm&cyaVGy;nL&qlx|q9!RcG!1cbb#;QV>XkP6 zaYQ>@covu#di+EL08xZPQtj;2qcIHtx%-RoAF#CZoW<=@*o@zrdrQ^LRz38+Kj{|OT7>7vlR6pJZ z+3_y&yhkU(*(Mt(U(%M{X%cMC8Iw(Or#r-om;O&Sy^Xy$kGdbqraqZyrSF~(x@+F= z{;&#g<4rP>^zH-M&)95D{fZ#pQC9aVfGYaSG#9Z+7q@jYH;D!fh#U36fMZ@{nETgc z{Vm@Y2-?xw{*?LE2(2Vumd|ANk)e;Mw$a8q=v1|9-1(Rse{A2Nb($lv<@7c_n|}Em zJxE{FgXyOulq^!Cy!!#CX<+#K5;OdHrSRsC4$Ogehdlsx-Ml0ZlSUfpO&UaMVOKFY zt>XM9nr#QF%@GTQ zj{A)OKq5!O88-PtJ%y%S&%Vz$BqWeM8$!7Y_SjIo+eNx+NyS+`)Vc_R^UO5P^?PRz!qIWY@M(2c!IATA^uP^$}42#i)sLsr* z(#1=>Cyw!{=T)e17e~*cY!}*d*CtEX4D}pqcSUzpsV%$bz8P*88i$ObHm>PYQ_L`0 z;=!^9k_KiDiDy{0NSjlSq6dZrANdvuT#WV&z&woOYV)why4-2jvaS%fBvse=chS7< zz&~MaZofr4?UcC!f%b!$DiH3@>QW>5&E3|u+y>A|&clGS zQ;apvM57<8H24s;ffEW5Qdu;kBJyCj%(@ZY3)x+4EC+dx8W_A3Pm{~Jweb?ONbGRe z;4CRp9Tkh4SwcT{pqm-bxD~gUi@$2apKRw|lGp-SH4h%BclR?qFYYR-E*{~wgiO*~ zJRb>_l@or@s-#t9A|husg7`x=K!>ZLKW^n)jkPf+b9V2YeO4cuy!!9z!9S-LW2=bY z%f=J6x|F0RqrcCXA+t{xdWG*QG?9(tdpM%C(0%yz$p2^)eaF0PG!mW>h5Dz7ZU`Gw zLdJd@C^QB@$zBiRN#Ul12$ac-s6xh*IoFnd33V-`vo&MijeM@UD~RL-rzH*lfz^`} zF)t+E0H4mZNj0yClZP22l223K=;WBRUtK<8L_W-T5Eyp&>5aobt-m?02VPp|qj2RV zRz!06_301~l?SbKX9|l*-@_6|`5wFuU-q7ZO&;jpjy00mxM$Ox5Q7lx!lIfcV@PrF zk+8U~fWE0&s|a_*0T!TnGL~$ZDDcA#6EDKkT%`$6zMS+bw>0q!s;$HK4Zw|Wd9^N< zQJMMSkf&9Siy~#Q%L-}Qeg;sClF>WqGZ}N)RK2ruiDT$KrsmpR26GFB+-~j-pE*MI z0C=k#^V|$qBDOE}g{FVPN&V@dG)?9E*|W*&^_I03ePo)$9~$POW@=)>*FY)VAQQL! z+#iAwho+yWMFWHF4FMta)G(y zAu*+eM`|2iKnWgMB)?|d#Vh!QEkOc!{bH|`J?3l26c*)?$pEDmP8?--htKfh)j&+~ z#HqFpi#!LD7}(H_;Z_y!J$0yEnPQh6PA+i_L@FxUxw$xGe{FxU#Uj_!^cYk0R$CqN z{0T?qq>}nk%k1xQYHWD+3SL7HP@%FpdsQJG$ZTiZ7NDy+o&9#lA`+|<+xJUmq0J#P z4XzKHZPLEcF5$`??ee83DK=ye6U5Ykgc$q7Qz#24NGu2{i}EtHN~Z(TwZel4Hp3Il z0r9jbOFt{wXLppupQ{i)QaYc@amhYUfD7-I0-@ZY;T?Z*br|nhs!rQZ)F{y+QfKHZ(fLSshzid-8u!FD|6uEDLwyByT6fx|D1yc$<#R3QeZ29X{>9!x4tEe}Z^JTMv%U59UhB0#aN8 zS6+#4h$*n0FUwMRW&ei|GNAb;ls~V=h0-bMmT=t>BN~|_yHlB!-=dxyne^n2?@M9* z=J2DcSAzVj%eVy`hrB&zOSrDF9?OS5&cHe+ddYQ;NX4i})a`kby8B`r_mF7_R6Cy* zguZ!v*w)~!FouM^FB?m7KjUjukYnbHY2t;!#IBPLpWYRhyLQ8d%Nr?X{Yg+es?s30sfkl#%wn8j zo4M9LdMnd1{Ny3%vwn z^(0A{q9s=11F*Hma*cC1O%wwr^Ud)`o7L}kUM9lZwUxO#q#N~)D@~&6Dr+Q;~qobd*%e9zm16G4$_h@E8$mmGO z+>bQNaAO$=Akru3k_>|Hh;(p>0ElOmgH%@=; zv+TBtIv-_+ij*e3q)i-Yvg1P{nwd5P4psnNf_?=#mW3-$c(S3pB)IDSkDR?lU><3O zWhB+3k@YeAJrLfeYi}atL>8C|Q7c$SVOg3lU)cIZ>Lld-QRPaK%V-BhrE_BLeG`_& zqZmn?Fx2v0)ct|`CWfk3@P=Bf7cl zLAZz$aytD?RMJLL(*0bu4XVaT9n#GW@U!vlpMKonsX?dvFaK^ee^I3H$>Pu8eBmj+ z$(Z{+e3>+!Mn#LL@njA$;J6HAk_@1J=uF^)Cl&;2L^ zlqalk`pQmy8H74%6X$y9p4==It{5R8dvKJBB==4x!z7T)$|A`G1c`?K(RQ7=_ux&B zq|Iv*#$NeSg10Dk0VeD~q{e1<4>oR)R3w1qv%}#oxq#kKn>O#QcX&5D{*>2P!hm9x zaqOrY>CKyXXN?qdhzJMG8XSLT&wi(jA56fIWSB+fEv|#=ZwyDX^Qkmmv$-ikbFHj5 z)$75&5#utNCt*GoBO!yd!?!)DBAio#BIe>T5PCF#PkJ_EqGxn$;QeE#r+WZ}>u}U* z!Ybr~Wsm_;L>xXa3GoN{Wa#QT3SND9*qvubX~E!BYR{`OyR@fUN$HD{G>_;xuRLGUn8v$Vs zeJZ!3Q{#u$^e@em?*&B8PTC`{I#SSqUE&jdTKNnYudy%e3NU3w*u6pU)qz_GdG?bu zpcen_AfLF&tMA8)nsVYxt#Kl@b6);9(F(ky-}Rf;N4{8)O)T_cOn@V_Ap4Ey6I?z- zNw!vvyhNIMl%!h%ODjN-d6W7mojw!H(*nk<(%UqxU?jvhXXM!JJ03(V`i%y|(4)(~U z4MUtX$&k|M5k>+>t1)K<0IxJDm(oo6i$vAZUd7;r4Y>@Y?laRR4EFb&RP)HZoXGR$@tzzVl|WE7VGM{_)sN5ZH&`=I(j}s@kR(l9Cfs z*$3}UnA0mG)4VaG7P_79b(I-`A9pMmJ(gZ)O4+avf)BAD5Y>12)Vxh1OzD(ed^gCU zM?9F!Hi694gqagHCZE$~5-ALx>Yz=(-G=9A(8F~R7Fv2^o{~pmm9Ll^$>N{c+}wdm zY2XLT7yS)=tlUpcFGG)~&2y;5T%^rkr9@BcZ@*TepPAOEJW)h z!NWaf#Wv^(D{^?nd>|bYzgwXjF)l448=Zj=mFy2$it65@DfLc0>Z#b##Y3nk zy6jILoSp%g@1QB3GLcx};3le0aQ9l7hXewscRHVsl&a?34qgI?ww@yUFFs_83kH;P z+x5UiF{%i3o?F-jPYEn(C3icT7bn125C1}8EskG_wcffG4&2R7gf-0+grvO_15QM#kjDap>rCT#w9! zi3fpMy{x*t#`aWSKWD^9JYkEKtw}Og!eQ+q6}KKn=0*!G4rHFwTWjjzi5$pPtNnF~ z{7omcg@XCB!VIRxH?^fzj+>-+r3Dsuv?7!8vegDdYt2GSM*hQ8z_!=4B(t|{=r$>* z>BQ02f4U25@LOa*t)>-_)W&(qaCN079`GbhI_6V z{o1D$&!sxyFi=pcA0sFTknq%cH8{zJUCv7L_?hDf%??D$M;-nsDq$c{D6wXVu)oBq z;@iqm0u(m4_CcXIO?D|zlUj%>ZGwcldK3~BJ0sTC7HOvUsT6Z)*!;m8N^L)Kv`PqCmoZwB z-&#k0G>C3kcV(+(V0c%H(F+*#sbj(g^U=>F+4|~T&hkUKhO_wfP7^7|{K&`YnY3>z zCR!ltDOq231AUguPvlhw@^|wOV|`{~0e0obG(A$%{)Qp07=IytKznUpu`^X@#SUw_ zzBr}sKUFbG9KJ<_EPEuHaPbsl!y`~T1S3xTXC<5D^*FmaWC@f3w}^d!_hiV!C=5{I z+L3RvyYS5;bO-B@Nvb*65QNS?&5M-E^;$)X=NjhE7sa?c5}IDubnwFp{LiiVDnc8Obh2$Kerb6lVyE zYkIXp!hQxY?B>N7qvyi|95;U~4shs}Giy(<<1Go&X0YZNcQQjE{K%q*YK_m8LBf)- z9R%k1m;{|*p&ZH;tslwgms|E5n|HtbNP*G4j$7;iZUGPM`|lea8t+`M?R$+xh79hrRA}0#~&z+$^n_F(BtFgX{Qa zbR;~m=sj1KYoI?Y?)!iNCsmL#rJH$oEakm^wl!a-Kk$0r{=0#Dyp5doKPJ-u-GcCc zAY24(ZJdm4oE-7#+5h(#SLQ_FpE_|NZ{|&x{&I#{XgQ`jqOV!=?!8_9dkUtI$Ny9r2hFg|f%+ zol;Sekq1kKIv=qR0|H=-(8OVH?oCha4XD_rx=}+scpl!1{Z0F+&eZJAcZtvI{`K_n z2W4^@o^MxMhmxu7>4Q+Q#kU)a%mMNEl2`r|+}A~7#&Bb}PDWoWg`#rCP@=$etLaOj zZh<{Us>RaMth|L!)2jhe^dj5vsX(;KtIii@H08rSpzdc36xJ7Sq$9J&RpH&xXC9Fb zmT~WS?)l4n@97WIbBUgbIfa@duSe`D?YRjZ!J>#I zl7bLfMcG1|WdJnr+)3)6(BpJD$6$fnzGPIozz|6@o8xG zEZh*oSC@He$o9&`s1d_gKYxZlZ2^SGiG_R2xscO=($G3o#p@gQlHrB0l5YUhr>{+C zuJOHHqIw2xL_0YH7!|P_sX0TrLW5#l9^*76qi>h9GOYhP@wU(%A2;P{stf83|8X-b z$XiI`$QSG1G<@U{ZR-+z)e=pI=zfptKZE6t?dCc0{rwAO3QQ;)19dU)yyFJQU56n= z?^!E^ycvnU)UHLL7z2IjPU)1%!0I#c(3VFuh__`MceroSM=k^uqfSDDe9r*}V%)Qw z!wC)qH|t(05!98DMUdF}i>w$J%s!A}Yz{#(dl+6L*V?)*WUQ4=mRf)3ghN7lnf=X5 z&)+O-vAZAZc)wgTGMotxF!sG3>sIg%g34UQe|33U_UCy33Bc&JEnpMIxtLEIf(~uR zP?itt*^P4-af6* z+2D$=TEnB3dIR;Fj0p-$Pl`^xF>Eb4v{1IiDGVeF1FS3+JKMq==5YCWk#|GQsgAJi z8nud{wqL&tW~kO!+ZM#oGGd`<%YhjK-Qn#si&33`W--L?!IFD1hxZ?A?2|z)%@h{( zI}(iO7wcf}Y-OVak!Qh#1)?mJ^4VW*G_%bo{Ew|HZXYmH?J4g1*{HNKWwJ(v3P0>M z<;~<|L)!=ieeLG!Zy7Sv$`}2gJ0d5;#lYx4W zAe)PmPEO$rmbNj^Q&9n6=(B0R4<$F%f}(U!a`+2dD_@uYsbe4ma|gGtY1DKS({Hit z>rd~d=-1Cmj$!A@b#liiit6sgb@|<$pi%Js#~6=xfBEX|{Y_R>-)sqr^p(q2$?agZ zhiIR;gea_4ZPNq*@qH&tcEl`laWLm?g;%g%_Hs~oO4L(($qEd3R?7HRf9 zqxw&CI#_=mMG?yJgJ`)h>A86->YiS0b+5oD&12>DI388mN@bpzD`?-pVNo$DauD|qWaiYb$%I$ym^_Ax zxid*TxYLSEVp9T3P?}D=gspYG!mHv=&~n$vg$odoQNQZy1jcuZ%1Sv9yT15@>ft8r zEv3p;GN#pNhCZZ4N)YQSiu55h*2&+-2x5)`Mqp~1oJ?rj#Z>9kFZs}osrgETjgyd5 zknhBv;mN>D(4&;V2;r(DxBgjuIv&v&h9u&uWWV3eO{Oqdh+Uek9wjEDKzK@oZIXLk zTv<|vVw2S=WZVzOdd!UHve2Er`7W3JE;Xexdgi^O-~TlUpGT-d*kA-bRVj9w0chgE zb7c>`QySj>2kK-aLYJkWuT+r1F-@;-4<$(QU&vc zN%Cg8NIeMY8Zc)HT74WkT+s#!Z+Bo43P1uz(*EKT=)2lVI)!V-#i1iBQ1v@p{!vHQ zW`F2G;5w07hMKv!JlHgykon|EQ>JkJZ|O31R*OZOq<#IZRezz?D3TZv7-*q?#qnZ4 zy5bvWD+9qC!!q?}dw`W`t~;@1n~TSPW9^-qL;<3#%d&0Twr$(CZQHhO-?DAovTfV0 znmf@iJrg}WUq|#m$fwN6ea>EMx|zG?te;hy5Ex7yfD_r+Y;1*czH&PvKX-jSsR#VKFX=pYO-1q`?4<>t8Es4Z^4-V=PYY9;t_4k}OIC3$d*mp!4 zkJ9rYV{_1{y3cMM%Jw)@=(JIS!s{tW1Lj85Or*{}1t{cpmhcHdsiFjN$`p03bZ>xe zm3u-5$5Ea2UXOY+-XaAfqK{)1k7@DVZrpZR2tQ5+7piK%Vaq}Ax0dg{V@us@USVYb zfjI)oj5@t>9I@XZ)Bt5}ixOK+|Hfuq;0lOo3g=sa0hQbW;!?5tcC|21hwYzw_^yy5 z^B9@}I_FMq-R2RO*}g?hJe4e!_9&ov#{rt$FdO+xH=2>kdCeJ57{Q0RAs1Q7=kXP@ z!Qyosi9Y)z^xNQ!Q-!k-k z;oC3;fDnLFfmS&&c_30;u&7#DIlMvb7*!#Ptr)qYkOvGF`WpgS?%@F>oP0y2W7qQo zXk9M+vxWMczeXf%wc*s-liV9ijt?DyZt{ZcW_IRU&w-h**a@?|qwhuGA`>U`X|k&Y zqWRtv5Lq|LxypaR2Y&?O$#aQ*O+_mf znmehXwYcK{YN&R`PAG!m5RBS9iaabNTF5~=b$R*m6cx7vl@-Ef^WmyrYK!3WS%{M9B}qXkV+1ev@(zxPBv-p zTm`PAh1%wn20k)tK-?D`ghgmlI4%0TLeflZL!vl|mfjRLI-C$J2nIsHqJ*o)1K8fJ#x6 zPN1@inzqVB3V(AF*OuibJ84FTgnK7q$`@Xw3?DD3A-^Yi45zhIkq}ux=D?Q@;sO&3 z3qwz#p@3xf8@5V+Ennl)nV$ob9R87Ra9OXhw5F3`0sf4U(9goD=$j-7gjUPJOH71m zFr=MZ1aR%bK`7R*Bsp6rZy+LQ*a65Qj_tswfEYCKeTx8iTj1GDMxOJWn6Euk0EO9r zgCQ+4Zr|z1X6>2L9ah!LD;a&dtU#1!TH=rdTw*U16*BnOTc(SIW=3daIF;4WTtrH11&kInBiIG=I^lP#R=4HROPo;{G-6E?625po+lr%spI}!O1*AomK&{ z0$S9RU~X$QI0jDUClM@xihe#aQe2bdIH+3$Y&%Qe!qy%Zl2`eVX(%$6@v~j7iE0VK zVGK%@iS7DggYAhAX>gT_CQ$o5_4dNNMr=+6Pfp7OiM*Nw0rI#a@QU=ju%vyZ|`2TWp1)IYO8kKu+CWI+xDKyaPR=pe%xVL!+P zCBZ5I+|_~^GLsR$ISm<5nec@tYDVCZ1x4c%Yvy)1j@W(1P(*nIwq@{recpBPhN5r)A_?)N&ZUUv7335uaWf18M`CVg2lAK&A3u zo8}2NtH@+g046QGeRN}~XP3%uU1sO)rdhB8olu4`}%x&ds|c`HbGj3d07U} zSjZj&Cqg7H5!LNK)t>>lEkQBsqK8M2oz+LO9#&}oBJv<%1hz3fL}{9g?Qd13I! zqa*67eGWsHKz(I!9RJ#Bz64G_cH81!n3QSqpT&Qp(){dTN=#v^-{g`*+6#XF zl(Pc!uyspm{B&xkc;zX;VijJ};2fl3#ShPM*`@Ucqf+crIYP+)=^0HZ^w7Y(_{i;# zorTFQzNC640B#MyA$G~Yw+23ySxufip{wLW70n6Sk?m%?v{3b(E*(RR`<@{3&rJnX zQ4b>{xfyKy;ql{;cNM?wWDTpEyD&JLU$a$%rmgzu^NB%y$wkQu4&K^E8R0xD*-v&_ zQ>B(QAWG2z$vU{ZFF{+9Wk8F*nEfGORbq z1JoQLPJyefYj6UT`z(gJDSCYIHr@!LCkyuL?v={IYt)S}lrvhzy1~1V(mayKIa*<+ ze0+bQaN`n_X&AEVm?*Xy?k5O3^AS7OgS~w>0}*KofIvogFrE7L=(O_Jpu149Who2S zBHDMhRTLuxt6=X)nF(@Ogyl}09w3yyzoLz5nSqn9?3yU0*h+;cBxVd#umm;8kolmJ zpyj!z0Wo^!n~?fzo1z<3b5BspNNKy&%pKu&JMQ`T;LgPxE@Krr-g?uq>CkMP;HNwc z#aqtHF{ohp#w%Lh-Z+7w%VY##b#R|yR`vAv42CxoJY|9rfy5b#N6_88w-G(87>fl? znM`}F{Ud7n8dHTcUuyu7mFkx{Ri})jR9n&1=#mAVgft4h=ut+bGQ*LiKDUcJe?nhW zq61D`)4?Y=auaQqu}v+O&?3*j@?Lca72RdOoJ9X1qr#7tT9qm_NPNZN6qC&c8@dN< z3F!!=P2Ed+k5=T1I+@U~@ifyBeW@2sPYG?j)%Hs+`=34UEDD=*qq5pH7|d52uYA5OWT#he@j4jrNVA5EmvOB62%W`}Yf$EIjlC9SG#4hkMPccU3C9`+=m0oyN4kb9xs;KKYUbQ{zx^*9KN3cXU5Q_b z)13BvDG~MV8uA#9+A4>@WXiq6jmfy&H&}!+O|ygaN3@gp&UtDt$FQceR~QtRq{ z?9HRfL`L_@N}-3^+(akdMs%(bltWJd@_lml#oX# z)zklG6ZHkD7JMgQ2l`*(zzGW)UdcokKd6r&ca$p3!te-LDj*?mEmVfi?#EK`ZeIak zGW0SOi$6`j2{TNry9CGa+d1QGdj~9-2#Bs;hjxO%FZyaZzq{cL&E)hZ%{cSV$*vL_ zp|o^=(rdNdv#FteF5C6^)2Po=@p9k*7h24yB*%lW1p*SN-A|{er4)`N9qF0Kh~qXz z(gd^(bjZatK29Q=PMe#(Sut4BbVd*DJgnC9xkf0&SHD>Q_|Z0gk*gFs1|CTx#Yjni z<^D5-c6CBe3nL(cLxywO7IO_PeU>Si9#En#PC1Vn+(QOhKeWqIqxO$3eN^Z(sm_x% z#~K90rrAQ-kdTBs9o z)gty~M)2;iFc^HY@C~nAn>kFE%8XcpZIdq$AsYEDHDzO&S}1kxGaMJnl%;`JUt_O7 z27UK%f}^RXtsu+S)mZs-Bc1PqQ8$}Yq!&Md!K-mwXWkI7rR1z@tRESf>s&Dp zBRZ5j9=th&ySA1KWX1rmdU0J22%hYg_34;K7Pyed2%>Ah{|srr9(?oD|NL7zi-#yJAt0f>{;W~iudU*Nt}@ewMXkv`1+?3vw52;GR7-5`A{`cB=JR= zY4zJ5td{9#4<)fkEMIK-GQ}#fZC;v+`D>05)lZ~Ya>(Aw=z9}1RI6s2CFB~@d6`(M zE^*#HvTHgkDjiA3%1TroE1wW!EcyNKyAJ_&`fD(cs%+|ZLdtt6r6Rk(;u;#PwEPc} zs`pabUFNQ~DHm@&=Cw7Au@`o4K4bYuce$w2ZGmaD&|RYDfiLP`a~n|J9Y{|Hw9B~dD^X#(voArtwZ}Nt6L4Dxk@xI1l}{uXMD<*-G8e24ZeOz0+gNZsOcy7y=u4Ny;suqbOUc@Ea!cKyzE( z1%|Qeynz;`4Rh<#-qrLtRU2WhXCCy%S|GKwWMn1y#K5UFJPJv8)h+pe8&m)OttVZG zBQ*^!_j(b0h=7Qe5R?#aWRcRBxB};2{*iLE%PqMX_E>4Ox;F8^6~|}JrF<{ zX3W;3fvP>&z~zKz2NdGh591>J2rBmIx7P=?x>x_84Q~c4Zafz*Z69{~%a$m>=}N<= zhmvuxHv7G)vd=CNMsCZyyoiN9kR8IcUOPVM0%>t8PqUbgyZ{SX0|J6})M(E*5?X&s z!BmFfq*QKIj+w=%7Bc5T`l+4a5jY~wwumFqucY-VTuGJef^z^@VGC2t=3TOoQpmCk z=i4dc7FZ-k#SmyjE=bEz2NQEmA|q?_XF!Mq+e42%ySqp+loGa++>?!~6Nb1FuTs_6`~^p#1~%%8 zRa}Qoc0AlYI|$?op4|wUKtd1lQx^*y)nKN~!_IujxJ{BlY}5g5t*B`CkHzxz_q%1j zxJpb1AUc*D$#tg(2d&7rqiY@^2MC!HGb|4Yu>h00)5YVw}d5IZJAQ7<2UbE(%6v^pMs2|f*X4?jua=~zm zQu(GR2*s%*b;GtM71yTcveD{#Q`ZKkbGX5;g44R$9h7Q^m-HdsIb1-;c&7=ZNn)`I z{$m=m=!5Wd#cIQHUhqh{&Kz-(sLE)P0-X8S4Z3GysPyfy!YgpQk^VE<2T@ingobet zTQ;^>nNkb3nVX{Tug{gXdJ-jnI}y04Q%C*VE$Ivlu6+$l>V&J}Y4ccsvw3<-tq_uI zvJs-qb!Y30Mi?$~qka9}_BMvks!q1ZBFEW77$1hpM!|Q%{OZAc$|wU&=PSe;o@)~6 zd|8>jCh&;ogI!0TK!*xz7Qlw3R5-R#=dWV_oR4HFsl%6zmN18WDQ?oy4%hX;k%t*S z4V1ZNr%jPt+9DHNWa3&fOI~DO5WRnRpDr_x(*%v1GsZ<-+mTaB1{ga8apmR)Xv-qk z;@}aQMSVMl*f{z-l^@^ze5H^(*WzCgyZ6#0UuaxQKKLTDm1eit+~4W?l=W1W**B}mG`O$^xLJ6xE+LUUGv9;xj?!h>xH71&3A%Cs-Ap`{ObqQkQC3?$2 z_%T_oocCEG+nAX@O* z8D-^q#W$_+jwifn5r5uSO^8>)Q|+OHHnJ)4ji*a3<3>cyQ2X;6wQRcJ%u;?|wraXn z$yP7RnH$xO&y1_;N~IkoK3sT~PZ6l+6)BrKlfkgW%U6fRkgiBmQ!1n9f;btD;lPdz zL`eEseporZl2X+E-!=O_MtQP!qgmub#k1b>ZM~E(zGx$SpKuyLuvq!$c*Tt1(2M{f zh!t7_^azHx*xj=XU}SGCC605Gp0=WIuKF(kd8&u$JSTXivYVJP@(OMHAfoDiccQn3 zwJFlE*IORA)QYIVSgDvU5koo8$w2xav9&uB%UX%+&eWL~hlWoKl9DiENcW)Oae6UU zF`{RmI(-2@4D+kxXSF}<@&|s^`F|VqfkR9cb!_C+hcw{1R-CaFEc0(-$LcUGv;f9i#JfFSZxo64C`OlZvEq?oemcZ*UhkD;IY+!tSLRgw|7F=IyEJMFG-IJ zSaR41kC9+BLF6fEsuV@a@*Dyi~g7>8_*@NVOw*qjT z>TwxJV8_xtNsk0F;GlRi76k=#g_GBivrNfS>}(!Ru-T+mIB>3eo88{sY{ZtuYx*J~ z%QwvJgM0cUFqVg&y>r?B*jbp2ezb{=EegQ?P+M77$dePhrVXPbR2pMzcgFIWXM{ zWWb{htxs1mq3y?>8U&IO)|X7lCh&CG2^3Xxm!@lScPDn&kIB348l*BuEYfk^Ce4|v z&(LEgm!;^bfX2xfS2d#Urq=rHQ0X)QD4bvBAkk zpCv~UxE=ThVm?S7+Gpv3BT!Ocm361m>!{mOjpY68u~{5=$EZ& zr&{&$oqTq~a*hv@KBaQW70Uo|H9@Q?i%b-YzvMj^UWXiUd)|H{-5?CW7QUap*c@Oe zl7UwmaRv-`!MWk2_7mJ1?%u6FDd+n6nddhbdF#ZoWb!;WGc!*v>guZU@(vgc{+GRH zQZZetV&hBTs}UfPiDc8##b`Ch#)Ds2F_5{&mIp(0IxH{ybT&9W2R8^h_{%k9b%)@} zIyz&Glfmr==>?xL+3kBnH?I{uBH)hKsy^s1zXZ! z%n3b;35KQx(#?PUVMI`52A<_8Gwufsdfn(-NDq^IA-)u+uMPys?ntT{$v`W-DEdjq z7=e$`Q%WTPpkeZwdC4da-6q#`Lg1!HX32@GeTHl68lJz?&SJbRv*wf|@*(G}k{r6^Kr$S3WCZexO9@3loqu~y4`>9JI~eBivQmv_4>z`=Om$p>8^|GhO? zT_ae(11G8_?ab1qS6n;hnS4zp0s=2iX2WG2x)4eQmD5O1_vQO)ctHA9)ALcYw#=(m zth?cM3%2c8S7h?clU7x49x@hc@yk+J_9MXt`x{MI?@owjb*WExz|t1X{Xy_H4}+&6 z!FE-@&0W|p`Lg~{&8huyZ^%mxsR$35m5_+od`nNIM4$$2Z7J~?LTY!5-nqY#`vTeBwwa;^8CFDpW4xc$0u%YD%34aDP#uXK}m|tZRG)ID-sc0);^M8XvsYrYz1NNSbSLcBu>|R=&5N8 zQ5)4*M;wxscH=G@v9K&k@uW%8thB0K3Tyxz4vM<<+ z3k~^dilOX+=z{Pf-peHM?$eR^ zbhIB`uopyqd0fj`f0fm5R!DqyJsh(dBP=0-3kLkks=4k_ji0h7zb6t`yd<_?rBa<* zgEzBgex6PszdZT7t#5fuI>@!z3bmQmSzBK)XuRO2kgcPY&0`zoGkaT!JAh{Q5nBg4 zk;;M%NtUCS%il58_qF>h<9IoL6!-{}7mB#YJfGXX0#@d{Ll2bH%**hAOR}T##mdZ; zFZ5JkNO5JzX+&6REO$0&=7e9}2)60gCVEF-wCXy}j}zD*Ux`?UwiQNRqcHj>rY)QR zZ+X&zdVv|Qz~UxCEJ(HA3Y*{VBEQR|D|+L4gfMzNyY?Xs?5OQ8q~@1Jmp``j+I;V`)MkQ(-@?5KKp zen#?9`-HFbZr+Q!g@OYlS;H-d>8{TdzY7L&flZ9(7G-?7(!7f3YTJU#T*UUU6as5e zWB|p~*i!&|BWRn;XxL+ltQxj(Y1Qcpa;SPf$=vkw_? z4K4oye&XAoK>n^@3Tz*r;dq4tH2=J=qWHU7mSi9-C~hewGj3N+s@1Hc<3SXTAGx0B z8?ct+T^@~DqH2+KbXVqjrA~!Z_FKIUe&3%R-}{l%TRq?B4cMD0`rjWeo~~}1+`ezw zw1kR1dJp2=pnZ9n2!+uj=%e%c*t~9&f~3T6YnZXy?xNh-N1CwKM#o&$yQ=V@-{4t= zPtuf2DvwIkOv(%I$L^Fb*m{`)WD7QOBqA1EC%1M%S;)6uPA|@)%YeSaqG081LFG+F z*BM;j5P){6Q*a#T>aIM;muexbYfCsw5W}64@zCKwDwlQyd38*A@#tpa8ez}j;wipN zS06?1LR+rI$b8inWUt6oifFHG&FRPz4_jUdHhQ&I-b0tP$h$r|y(hzE+;iw7Cq5bT z${QJ{RZ(sUh5q?8dG+r!8KHYhtK9Y-&wOf_(Jcfq^(R&^L;_CdIjc#7hhnT4vntZ=-Mm1A#W_{BkgpiQehW6c z7nS$BiRu-E1Ot{S*Qd!O*KMDDHni1+j0P8O#=P#{6<_BxkAyw(1h|sP(%rd~yR7?e z5B@4kNBSX-HDds$_Ux-XYzBul+Fh8rvGU|D7&%55D)kPEP9&u)IK!VYX`@Ht4Q!o< z>|_0Qxe>F23CCG;jZiDyCso^NA(BX$fFk-p`9gio#Asc5ddmROp$gAn%h$r8*qKD+rZLyfN3#5!9Ptd_k%?| z;i{8da-gmaH(pazxd~99&m?M&=%$z#sS8rWS4WLM<}x7)T7bUNqj^S<_-wSu@wc}g zD=mJh^F_Fj9V&a9v5Ao&d8#-iHNr0B3{?tK6zlEslE`|WT(l)B8W$q@*YV?%c^6~? zWwXXwvd+j^RTx@i`NH#0zr|io{DDO&PNWwl$eI&nAu7IPSwDvS4Fqn@I)ne9&ns!a zf=1NLh=Z@PmM89*k2orzUrW?5bNTTcI0hPI`D{I1TD8ioU&9i4@>M$WrY{>&Z<_AH z=rXWwr3GFUOv{t{f3A|w=N=SL1a@Pk7^ShasKJ*LgWniD8(G+pnF4&pavVbWQXIiw zvzu0wY>zR`imy31B{?wWD6^~m6KM@qQekgv4E%@rF~bu-BS9OF@g%(#+FfriV^WH6(+&4N%K{3EiArr*CHhN8}E7P6ZN3WX=t`9xv zH~QEgqeK`^80Fh2x8|1CG|xUawkqMe=x5Zd$>m#Rl*M;IuIX-U7{liG$1Ei;Do-tn zbb!$Q1pBUiAN3h}+7Q>dZ@wkV6fuZ>btR(9(G#SIjSC1>Qt?pTI(LwZ+C|)ES=!)8MeDX`?I#~rkhY+iV|Bjsm z{*_RF63)gr8gBSQ%d<3Ie}5*$z>#uFtN+TK;S2{SwIoqybtIMq5g-4jw=Y6ES+Ipg zc&!Aa9Ed73j|Jb;QOV#Pf2=Rm77O{bDv6-pBcN^&E7AfgW()qolWa-G2r4j;Hy&ZB6xm+2)K^1QlHY>^! zM_rdsjeC7(X8}gYe@|}yp^QgmmMlXwJIk&$U+l*CdSDs3!NE9IhjsYHzA{18Wm>;I z;#}D~v^CVAY)b2vAOXq-nG^={A@XhZ+Fe6(!lFYNt$dy8+o|vxV-xI>BFAB~#D=cz zgqX0PS2+0)KW+L$N__N6_rY~5%4vcYkgoX7zGD)4Pk+XNzL5a8?GJ*YH+)g1QI_H& zFcp}4xG1PUSJ+AJ^22tTMd6`OH;iTVkgsf@Xp8AKvO20JUu74aJtESdt)cqr10IoPb82+2l-+vtZ|G(nF!NU2UM}PkbIz*g^ zWOyLg+1e_F=DXQ~lPY7Lyyh7Yf>@~m(w;_<{{4KO+56W(K;96Y6E9N3G4XKY`bhc=C@hwp*8D zBr}as-xYtZwZUx~XOG+AHaGrJ>DgwwwWG*HyOQ4?!?ARY*(vC#wbWXYy3W2y$E-?g zk`G<5%$q8iPNSh>%j@gdzo2qQoqAw^Vyl^KAj1U$gn#?SYLn^{_0R_4g@Cq$f<BTrlT~y#QXS`W zCUXRK{PAS=y5NuJ$Z-q3JG8%nG-J&f{G;Gp6=4*rdP*uk{cMbc^B^rIR9gcDJEEO& z=Qu)EqBYnkzFbkmvVL@Z%r{h7Cn+k1+MPw-hU|>N><;efA|Nmg%!H5w)3}W3(k@5S z^l@n`lTHbo=7rx4R!!T8N+b19tlR60Y)Wy1zg?_fT#p zCv+PQ1M-aik1<$PQFK2Qmgq6EDLkMeXsqV`mJS$(1EWGAWq z1%Xe7KZq;We~^vAMo7f1V;!#u!jD2;_5Xs;bNLS81Lvb3RFw)!{&3JDO5zbN4B^wi zY4t`o9p2oCS4NmidO~bhhTjYeyAPbv)yR6lXQ-euvz#wIEoLr{VnY7OTrPKC(XUam zzKq?k8C)Q^e%47_F?CKKv*bEl>PdbOXRG!Oe89p}*g^>>`=p*Qc$rY;%p6JJ;pQNn zUyG9&JE0GuY*7atQcF7Zs4HUC5^1agfc*R89CRTEhLZk&71U`BqMxlg63HZNM&@ z)1#1YP=S43{w(Di@nLnr{fu%2+3887(MS{jYG%+!u9?T125=fNH5^Ha)ZVn+XaLCX zU|C?RCP)b$cB)`fYW_xn3j6^Fo_5-bk`MKOj^Vk2xb=3amYd|}K1813w{|eOb&pPy zCx;iw;?7II(5I}?0uiOQ6qq5ylS1y8C}S$XIHs>S5rD^ewuq8LsmfS=a8d4)B}mV9 z>cn^IsrnQmI$OQkYM5x%qI<+tqCc%~x12+OqAH+@vPe^A6&9iD25?~lFvnEy zwhJ*_%S4O+u)W}NCty?bzLZP<4E#NTB9h`_dLkmANnVvp-V>Lp7MFAG;Bd754-24% zFCM7zODqIL@^dFHK88mbk2E@_c9Vf^zrRHJL3N2w2_+*+4(MJMkPspQa^ONw*GScd znciILZNYf7Sk(x+kHk)1+>A}iiH`HrBI9XSaW528b(xb>gtN4>B`PS-dB)(&!qOgr zF;#&6*Nm6ZZ6Iwv11rYK<~Xe!$3N|{kd%{js~s_wH|-rZkPMPLIk3F2iHUQ?M+9_y z_S<`%L>YhrOiNG@+u&kA3`FIb1<}$BM!M`|M%eW}%hMvjU*2S*G^F$%nJz1ON|Hi+!J(*O%)UXk0gg-?+_*xSTxfaGWYXR z;dC4BVQr?s^vDvv@pNtU8|&=2aEw<0%*VM{s9u_V8}K7XU^m<+C;`16S@DE#?-h`@ zWI|@<0UGYM)zn){G{x|9L{Dm_Da3N<;nSHrqW6WGmIB%(1<(e&nwDf6>N!gNU=|t( z4@a0fNT8ORl1BX7{E<-qP}}5Pa;{o1n~&-Fc+1h9;V~obb7;p?AIwUIugglJ%&@m- z7=_Q=Sd`pJVL~-L|1Yr-LfWlWTr>X*=dGK!iih(R$f-t>g1Xh!a0-xdBNE^2Ky@3U zl0FNg((RA63g&6&_~b8`dfVHss!B%p_U>LH9DnQEy{3s7#N6Z=kR25AbUF(E(Ds=ETraCHc&(J5%;YO0#j#O8A;`?evO+gW1i;#6$E`nu%2 zS**C2RC{iZ?i;2FL?tGd`#9dZ_wjPNZ)&+Vql(9E z-E4-;HIW>aA@jxL!siHFcad?AP)F)-+t-P0-;_PL%#;ZQYK&L{JNCW}RP4_DpchNF z)aBWfLv30eK3i5igx2$<=OWh}|+NagR$6RgSr|IGQpH*Dt(>g#9e?6&WXgwt5pp1PwChaaQ6wk_W^q$jR zFKU>2JhQT!W0L&=(#!ee0zK{}kjSgx9@lv-kEEE20qs?PA?V)ePyAb<<0WzaJ)Url}OJUPqS!T3O9%y(-HLJ?AvD8B+Y4Nor{EoaA|P^bdDiOr%Nxg z08}YMwQuvCJkerjtx6npky^GPEJ6opgNrgZ4|w8pm9UTqDmnx=FKIeA#UG8UT)q=@ zuHn1F%QsN;$AioV73w;EHN(55-3WT;V#<=Aa6~e=$KbL=&MjN$LMNJG_euWk^W#F) zxI)(O(9Xh%b$ELfu^%YUz?J>Ut`rw|JSz!A#+nqmp15QYLO;QJyM*ZRnC4Yzt?OrA z1WY`gg>GqH1YI!CX(0XCR{0GeNh_qhQb;?T5>H&BV95$pumN}jb{W|bPxm>)rm8qu z!;|}4jlkcBH1Xt3N@eJePvAKdY$Pww%dnoVvz!vxgwKRFAlX{E_<@G${yBB_iSveN4y5}5nHcJntX8B(De9u(FZtDQKmx8{pN+TuLV9AmH3<5rYX!aXR z49|14^{$6njdf zbSaK0S383QZ1bOy@eOLA&Kx|5j`Tkl1C0^kHdPtq5#T+S<_U4Z#oLw~#}dS*nyoH1No1l$(*;3MRV&W#xnfbQf9>>PCa1Bifyot`n zp$-$Fd%ZfnxNq2Y>gMYXyvXcJT;a>@>xU7V9vCSYs0o$N;EbHXDIGv?Sha7Cg=q$S zc+l_sg%KGWm=K_Fot6)n!~hp+Yrpm#W=rNEB~F&H=IrL(|MFF_*Cxe^iA>=M@6I?{ z`+g4UI>!y$+4-sLfQ}8U>Wq1(f67Ed6&%aBs@&qKOlco>LELY-VxzOb)bcQ@6RII zKOMSlW&ef_c!-|o7%Ge)Nh9Ouz46MHm1L2U_M)pzgw^~|Yfn03wCWSq2?Er32v9=a z%!e%Lj2K07wXb%~&hs!<1E2PxkTYgAl8W~^KDepKD@cFvqpcdO$FmgyIYxS;0uFN; zng=`%6;*13OYiA~`8#Lvh$%;YEZx#yt==zS{9EN9z*4ND&RYWhR5OJZ!aeYHN6P@7 zjgp(&=&eukIgWsNs)@;GhW&5 zg|-ac5L+F_etbuu8HBIL|JW=|HX%-&qf1s)_qJ@B52XLd{%ed)79!`4!iP+7fX+M2 zU34Gjs)ArY>>NPFD(uuTdG4F0{84F%1y$S~xy1;FYri_@x2-#)+)cwx!G16fm!jI( zKenWk$rwDz=~z6iQ}d*+^pE8@j_un|@(@Is9U-f0eNoL`c-|zVWuIy;8<+JazjLdZ zWXc~SxjyHvtl}4fUJ$%(?)pNe_GSzRW0NT2&To2+*RkRwcrudnj&oz)>z2M`Teh2n zUH_w~6pYBwT_&`m*{lO&*CHRBrkmqIVm$JeqvpdIbF3v#dMhSNjxpmSGnP1;f6S3E z_rPH^vem{h5e@8DrX-fEQT_cSjJJ}4S5%m}=mhy@-i_PQR++QWJsk;iLIhPV+wDcz zyQp*5n}XWQhOW@ifIe>G>?p>0>xq1)sG(S@Y|b$+DPAynaukI%nCEoq8?UUv*0o%> zBmUOo(E%`TWqO@PxDg2u89-===bWpe+sL(@2~YRxzFG}YHs$Mh<=vFeRfnCQre0+Y z`q{MG{!Ell_C&XARWd|L~#MmA~P535zrhF$x+T9~Ea*rfYzzwO&y zN&NL54sG7x(eKlHdGP0VXK9gSbSEw1i}8VXhV8xq1`0bOy%|3i%FQ|^a&RE8bMdJO zmcOZeh`u8`rO(Uq$opmx{KN`ziPLC3ihr~AZJR0o?97S*CQhqVfNQfV6N&BTUYE8u zO7;HDrV3_(U>0VUGHYm=4qRs?<@F1@1ro5)PSp%`(RfB!j{a>SVYW<0#Y}QSbJ5=i zNAXnxuK_IwS4i-rdtOV+^!<}3{j$i|pmWn4^Y-)=q+wz>8*;W^O}5> z^8iFf92aQz?PnAEB$7SL$7AdI(Pu;BC$8jY(r1m@G};1R_&XR9$eq1|q>MAMjzw$XbRt;5Fu2ATF*?v# zFNC(SS;|V1`ZMcho%!F3;2CcgjwsDCGkr#c*b%O zN|uwEH;e17^@>ggTc?Brwu1;h*0pBmU?r>rYqBKN=JTs4$ERE9f&8&e@Bs8~iEgzY z6t)UyaER6!0yZy?=ilnuM*jUnnAB??WQuYmN$TA3cQXFyeNXv3PFKU*@AR>HKYl#B z+YhyDZccg-b>;uHfM));I!|!fE1%6Zvx?0|p}IDB_FDr?`bU_TZ(F9sB@&%~EE?ZF zqOvUdX>fHh?t9GoqkWBbXr_JCjI3z8rpk6m|9fUT@90VR1uAdY!tf}gh&(_~iN)j9 z>mV0fg3%cb;(`8x0?1@mP|M7N!J6P->XFVyv5`Kf3;e5I}^Hilm+Ao6Gg>l)giH80kb?)4>_Q0}D!!q1{Z za?lAn^Wx)~&&&i? zmOJ)g>TR3>tB1qsBAznsBZ=~LdVs7^@L zRjrDUzAUwD%yP=60^sdJEPrKn$@#u>v>T9lKftru{GKh05(*9Nsrn`(r81%YD9Y2X zbnbSy{hs~*<^B2&?}7hC-v1v(oBucDiHYHVQAhkg&->|BRG0{uS^n=1lG1;tCT3({ z{BN`W|06ds8xt%0f6o4M)YqLhN0EG2)&ELYjZ+~4nbjxsc2p*jj<`)Wy3%g+QgXv5 zKuF7x1SE=dJ-nW0>X{K%j=-}K8l>sT<@0^}^ftK{`Tcm_zU?g+PA=2;@$mB~aC<*` z)C6wgvrd_{WF6IS@Um*LismifU3;A_p1Jt*P&Q>^O^^Bi_1~P> zR_l`8%paMtV9NXLFovhTDu?9t4S$Taw3se*i#D-OJTHTM9W%=``6X}nSujb(Ni`&x$%U{DRFJP4kf_mBqsls|NUCga;42Y27~F;4w< zlYUp|mflk@9*8QAA{~b#LM--g7WIFzc8^V>h1+(3+jj4^ZQHhO+qQPwwr$(CZQHi9 z@24bHr*0*cRIMNJt~ur$k4)(%LD?#P({JUl>^WgRgHJHe$98@9;@Ga8?iyD=*mKrS zR|)K=zMTT6+DPJtzin=Bd8;eh+tbZnF|2P)Ud2^ExRd6PRm|wd%?}PAU*kM|6kOXI zQBSMFd>d4isy77Atz)E~>>4KT?_XM8?^v-eu7cz=sk{C&N=Z@=&xp^YZzs#^p?_+< zm4kz9{FYy0f?y&FlaPi2E0x%2iZ3?_3gCZz78TzE%ReBqfY6x<)L*cay3rjycFPn& z@Kfzra@yH$w6=E#mRAVg*FRv78(2?jaRgh+X2*XhW_eJ+d?i)bTzieW4PiR}0=r(* z1*vu>B9%~2K(!vX*)&xeW=u9#P*Pyt2AvqH?Yk>6h=w-ajF2`y?UchCo&KvFbB`-< zLIeNd+#-e)=U#lLhQ`Lis3(LIKS&4LRBUD4p#AY_2+FVaw}~Zny>OdajBwa~fk%fn z9f)mhaW86?NjzTkf~~p8xaJ;q*JZTa=s6wD2e$@1BG_NWwu^Z>{%*;vaPQbJp#(IR zgMEUY%+N<9Dn54az3KRjrgqZT_;%)!+RK#O#nZRjtzW_;^F5YkK^=;DUDtmpI=+4L zS8ax8XJT1z`T{g7nTy5^<7|!XqXHA%q(i6GX+07%Tv6mQKxU-sufFC$kDOfojzNhd z0iLfB2$t?Pqj=|+f@&@)SVqu8Xc~h>jCjd})PaMeC|7{If2muAHY>R8wy# zL^r^4GtGB{4vK-A|B`@Xok)6U4(LnQT{8H%Ua=2Uo5K0mZM9SSq87YK!}a#iHoqY9 zCIX^tFu7s5q6&&FssHlzEn}}G*O?diTBlK4a#LATy<{qbGbnT?p|z<2Mwk<9%qv1q zZu~PO`L=)H88;|tf!^M?2PDUeN~%EnPs47F6Fe~9E>n1Gm7xHc%=F1ek}`I}v~j~& zWTZd}LP}f>E%-T}aa=_ZE&_n*MYc?7jQMKSa6Y-jnaT6k`xw^U-XoYh{ z#UFG{v-Wa4a2OsdWmt}pd4%R5o-)+sZEH)%b`{0ua^oUzc*h2Nbvg#P;K|Qc+pV>y zov7_T$I08<5nI+baD@FHzy98S3kMOhiyFo$QX25cf@#QmbcwTKm0EMi+BZ?i0jCdH zXHJ1o1^mAze_#T{U8u=5i7if*NKDF2T|CtTqcTSxS1Yk51I=>_Cy@d(Hql+)8ZYAv z5HM`V)?DJ~LBh**nr<;VA^Ym;v(atIum*Vhw^f_en40cEh=$^cDK9^`z&u*z&D3va z*Zhz^uxoo#9o7EaaluvE8&kdqawv56KjWrO=o5}R5Z2Qs16?d|h=BvLq&bcVB~sB~ zIqL6pX4YewhSq0dqrSNY`(*oP{k7EXNXT1@D0TnAp8r_M0VnmtO&nJ| zkEFG6$bstuY5$|g^Vn2`%jqb4aDYa2?$LMG5mk1`3I%$W&6-~$;4EI6f<3#>T{AUI z$xs!xbg#P=Q!U~6hr|fw5@0+lftrGNS9J)pQt-!1owTHNhvRTLXejGN>C3$Sdshc- z7SB5PRo&;*7ZYTMWLykjA!0P_=khE=R>C(qC_G5tYu-j47D6Chj5s_rZYYvAO?c&> zKO%Cc$IP5(MN3&Ni~Cw@VPCzL}s+= z?W_gBu~ehA*Z6a_{-M9XQ!*PM`2f0dh7G%i1%ISGZaP|Y_)aY0v8Xlr$b0l17oMMR zg%%~(nSumQXvI{IyaD!va}egb5hZkUF?f$6-3x77CQpFtafz>Lfl;R=ex6gg`ao^%!TBZvmVrVfMjSchlik%8s#B4>X24=; zgFWjTvMgMZgZUV%xI)RSp>!9Yy?|9TtRH9vV#?4oSJBuK9r!shNIyc+p|04yjLE`G zhwl7^Fub2^yLse%-ot){hS+N%$)hxAgNi%?i9^~R5PeD9(Ii+@Y01KcSS7G7JRJI& zjjtxi>41q?&PFf~8v-Z5Q*4*Ecllj1w77Gu_CYt=kDl?1|uScg`x*S6c6$Xou8 z5T`*!7q)UL2);%Arc}9O+2#iS#IvNQ)n;%@R{T>z6~nSmqir+qr7gMEn1Zb(+rP8VOp+gZ8!5XCH|?%kj69#dYWUp)#z4F}<6&i?(|G0*>YNobx8_3gkW|;4=_HZVUZO zRU`r(EC!LsWOijC+>PO%6$XE=MD7d|muF&+)F;UEUqi26dBry1WYcsr6^3ZZ#8F^O z=mLi2NEJmNUCyvy-QkHa49O4;{!bn=0T4yWo1Ee)A?9P#%tqSjKTI;G5|TEHMIBQQ z8sGMFtx{w1Z`Pf~8_Y&E=emBQ;8@}?9f@IUFyVeWs6<5DW0l)${XSOEJf+MK6glai z=5@Z=2z^)l2z$EMoqs-KiH9}&?HON+>Qv{!UPYB-GnXE$N&bmxn4)ZN>% zsh|a40zKA6B`-FE=7KB}h<_NO^R->E;>UT?Lc}R>d1+NUSvjc@6%D57QwU7_mylZw z=w!pQP?6>f#=r6JAl_xD&o`Z?8dXc5p%FP5JKQ<9c3NPSy-j?}>?&dH#m16JCtWb^ z)xDA%gv6A}U7mVbMfE-VV~(Hw3Pb_0EWZ?H3=<6EGIZN!vGxT zlp9O!zrc$!VSSfKxCm|2&O6>0UP74%U(S zGTuo#NSvvBBLRrO$VVwUOn!Z({(3sQUWW&H3GdAObl76y)) z%*a1ZBqnP%u4$wB!T-T`{UtK5)pTVb6z6-$23Jxc*Ox-TV-VfC|{Cs1-4&aII3c(DMc(yS#jiz>tv)1G7Yu`5jt*~Rl3~i!b}sjm}%VtB=I9m zttEYs#9&HI{jQCeNGxlW8IH8NukdGH`KBfuvjJoRvuDV01C)CdU7BOwD(=)HRc=y8OJ|#!Q9P^?i_9F%daKwda8V6DxJh7>#snC=R?J=B1QeD28 zGOIOEm+8)$URy6~jMs!_-@RlH*!($D#9+kG2vo?N&eWQ}0`E$DV-X258zRyAIt(Mg z!}YwLwRpiiQrg6wYmUmZQ^^zy7patBm!`%w)c_Ao7B7BOE^&zY996G(j zA2#~io;n6rb$Zr>WYV|(3rrFzU|n%PYn(`aJ}b;6Pqyt3x`~?DKL15ELj)%%eIMnA zCWd1%tx1xA(zs^)mpm~hol`nNLX%&ICZ@$@*t2SPkH$+q2YV1vPK;3L7rd~x*PSUYLH#P!8KNblhPY>oo~A7Q(I=hC z_E=V|qcjqfDI zM1@#qqm1}c5FdIbiq4>n9}mLbI%m3YARs^>cM}UlE37XbGKqR6}lhX zU&|(3eG;%l2^@cKf3vQR$F?jGd0gyz4V#O7U8WAE)|@I4&*$1mu<4Je3F91Qn7i7-XROz_!aG zcO7|?#AMyX)%#e6`p#FsC4Hh`@pn-@5urW^1Lu)JRq$}NBTe`s-npLhXn}p6E)&)5 zDq^x;JJ?pFGvu{Zadz}4Ym*n4h znfE)2UdvkoYZq)HU486@18+Jib!g|fgQ$J%10Y8W71Z3Jc?3&ic~n_&Jz)#NSqE;G z|E%^$@ADr|&5~M+M*WMyhwmAmrmA#2&~xYlfxIO=rQZLEc& z0ZzdSV^tz5%0`3z3x%L3*x9m~&lE9;axsq+JU9Rb*V!o?SK5csv^)?*1*xaY9pQ@p zkdr@JGBRy(4vWW*II_oA9T!^C&y>2zebBZYz1|*A_2qR^_BMt4hrp%GM2_ZV8yPzAst#Wme*fY1(=$EBfu-?V?J% zA;v||ifPfXe3S#a#1vu)FCn>Zy&dv~7C*jwp%zF}zHZ{R@nWLW4Mu%SbVhl=5{(_q z^d-@v9d2CbmaEQ;lLt1MJeO9_ePq`5;m>q%k}vFSThTV6b2}agj%3=kIbNl21z{Y| z3_W8FO`V{M5eFNCLtFdn1?-J9itOdBj2UHBx*RZTuVyQ_YbvW`w8Ia#VhF~czcfF7 zqLp&f!9297E~#J1hfc5hG{NuueB)TU5B=U-p>lfcVZ^i`@{d-ddhJw?G(CHalirejFE0ch!?h@N0^m z^i{0AH7C3^bX)Z|qE4Y3e|Vv{@8?wpcixin`hPcfjn3vPoi_US+S7q`+TwONI~=Oq zV8a{va<g&Y~vM+Vop zlQ{AMWygA94>RZmNIGGx+&%yHW+Dqf_6PiZJ5P|klSEy+gV=f`XCW4Hj_^o6%JrwB zY0?j2g7cukakUs;H}i!$^>;)P8)l6NFTouZ#vOgaXp%+_Z6eGx7&~==wjbmEEyf%U znuWrDsl2E+w@ml2{Piy-r?81B+%j5q`E7h;?hL;s*zd!~>qvs}6VaX6qJfE<+18aj z!Kx+cstSU^@a5j+7#3P^Yx^!htGMNrhHI?(=0%aM$E>stY^#iWZy zsHcG^Sro_Qt5k{vy-P@WC6vrv5IL;p7t}UG6xoXCI=se9d#fFqtEj-@1V5v=%RJ4U zh;(OWxVV$~OXJP~uOUvPvP0L<4S z%L>4+sUn@9b-_gsV6_){%8J#WO!yO?J=f9hqZ{+k^z|o9JXv)4l{Pb-bArPpl|s!- z{HmgOL69WLhIb*qDJ(owaNm#Z-`uqf-u;buM31>^$obL%{jlyRr4%C|UdZgR&ipOL z*#ss;ujPS3c8#H=uRHYl1o_)uD8m_>Iml#$d>8glOb^m#wFD={1Hb5DwP|r0kR2JK zO^|PJ9p*%-&8qvwdfANiMEiFP@mj+uqxQOLkg6oKmm!}>fRGMsWr8i~K1dcaKg_!S zlVUf*5;dhovplHoghj&aS5QeO2{T0&!|UU?f^P|q%ljs5WP8+cC&IL}21W!L8`WH~5;AQGv2;|`)E zGZKIWI2G3t$M9KK;RcnVEt{+bQTTB{4xYk(cbq(qRkS9Aa|aacYSJ7$OeX@;s*5X> zhQbC$ns+iT@uvO`T|Vr?o|1U{aI3bXS4Y%cjhQxm#$>i!bWWqLKU$T_Gp?1S%<(IX zek#Zw#aXXwui;^+plBUAwOUf9JM$>Af+cO+uN6n)67F7yg+#E8un~BP2X3){Aj3yD zgwG}B`k#p3rMSuHuT~6Qt$;nahpt}=MOX)8bzSoL9|fzwG}TUU=YLqcE<9+~m{$LM ziL%xZi)|6p=tWK{gSI}_IJ5da{?`pgGkn9;f6Qe569vsk|NoJK{(sG6{;ybQ271Q- zHm3PMa-msSng2J1qw0UU(EnnZB*=Ziy9S4LOP}$SR!Nl9Y3_B8zaVk?u8{aC7PUXT zPUpNlOaR5?qoeIY0O}%1? z4BF)zS(>x+&<)bfUOnsRW>FTuwc3ynxBBdo&O#zAlh*T6 zrN#PSyN`Zq6~l(P&}R0kk8RL7Z}l`fEi8z3-+D>a^#$%#wZ`FK`63C0s%^Gh9p)zr z*z}q;NVhUyB`VjBXB;NzC-@&1@SUZtPJWGF)QxJJbSk4Z?M|odPbTTg2-l_QJf8_x zQd{HUZ=R094_N|io$4{T+{yT!$JV9f@#xR<;CKH;zlKiO6Ly2>i&xf>ozrOSDXBjQ zKDMO+$jxdV6%5-Db(k^Cfu(mVe}_K)6@s6m@ZFy}Qrm$*ZT_el8u*kadFv_(!k|im ziC732G&U~H+PSzkt-johdMPE7X04$bQb?_25{@9@cyn%)xuNVu{Amz^)RFdC0&GM% zcnF73u~z!KaDanA1S!lf`cK1RS%8S_60E!6D2G!96MgYlV1wb=9F@h((mqUX3_QsF z>*CfoQ-g??i8&csl6YL}uy2>R+|i}|_Fi^Z$>RZ&mq_Mah`e^YCm&cum%@3y$yjFQ zHYf>IR^1bL`FBS51_m=RvA1)Jiua8fpJAp8)^R3YDFaHB!n!CUla_dC08#aZq}(Pz z4cAtaxb~Dk*re@gGVXfY$?GiiY>bp(cUkXwaKo8FU(D8js1g{rGu%2=qQ{eX(s zvxk2g-pAZh`iqXe{%DXP2te8iDjqv8YYnQ-jowBBP@L^f7JT)04qBC==?Uky<{kea z_YtHhTV_k25B?l(pSv7t9!viXaAr{h57u? zZ7^(nQD@!yGC2p3D$;6qkAW!5b<#~IR^hG4qnXh(p8za0V^O1W6{A{u?g^?vpu%`Y zRz_#x6F6!;9Jt$s*#w56#Vo-9efI8Ph;qxN&R%FqB6%z^pFi|xs zCIq3)BO?I|d+k=CPEVT3Omo>AljdIot3W=vWxyRB9N=;6#ZAX`civnw0dx_;p_Zpr zRHWdEAw0P(%&Zc@;E#(7tAFOLT+Ga~b$l%_D_?$(7ayLequ5NyxBUjZkNncR)5Vv- zIOn!$BkeMaVWM}0jIgR>T9NFaWG95;^qNJFanixYUmZWNV*3E_CU9OGM@ftdT3f`p zQR@pH8fQt-K7>`Ft;{|veuFI#d&o1XCKS?#5!OnRhTvAjnWQO>tFBIMX5_7lai|Ui zVVuGg0I~X${-KM|oM}0Wu`L%eu|~3_ITIZ8S2Pcj@8AwbfN)8^x}W>AerX@)a3;$% z?ZN<-(-m#ECCg3R`o1O7paD5;s6AS7;+G*j&I~5Ynro5vctXK)7dfrtPl;TiLc(fw zf;Hf6-3+230M1gW+nZU=T(e5sY#M%Pq?7)v`>!BQlro*O{1dSAlX~2YUo)O0n0KD1 zk)@Q%p4!K$rdp!GMgFbjmWOy_FKwG2tdTbV86&QLC~l$LEnVxz6yg(;=k@MMWU~l$ zgQi+xLO$o2TvWs;u~}32{OaQ#m*jZMR4!8&66(QDU(ibM{eZ$n0|H}-pyik>%53zFKCf%hrKq8>PkKBV2p$~v;xb)QckCA1 z&NSMladf7)Bf~o*S%9Rxy*OaA-V7i(xXOlDpf(~~UL7@1HP|(X$Vf15dG-k{z~87q zf?-+?cGE2eqO|Ty1Q(tb*il6J=gP-UE7HBJ(ypXaiKr+x=fpE|cJ6!~YIf=H6zxhW zrOKAm+v%n=?nZ$h%NoNCJt62470fLRkd&7`txw~Xsm`g3IXmN%{u*?@SR4#`!6}hL z>YSje{BiGYgOxZ7DawchA+--#NuI17Vb_mBHDKM2CCg@kwAIYtNv{Er9bEVdNs{j@r|0kaxdKJh3Hm zjEd1jg!P@sXzpi{zi`-1bx?2ZcTW4<0+^h3IT0ZfQZ&-=oX4oun4@amD}nG~Cib(w z(((|TVWCDN1oxWwh4XZ#o#)I2{<%2SP%mRwz~P*DP7s?pAF2F+a7=gs5)A%(5L1BY z5H49?rc9V_hYV^9S1zbC?s9N*x&*qnoA%xmS*)ed_;_VGl&Tm4k4I-P%V#0Vk4KO! z>pmcP+)}LPjZX-IA7yZuf>+e*yQKPja&rnY?d5jm#IQU*5o|d}(WT=Ij^oq=6MNhq zs=|Ni4Oq&+JclzNk;(eST3Lm-d3`BE1|WWi(m|a}%fdagB}WnBG5gTgm;_{qqzyjm z=A2()Q~(!56+qaSq2w4uLLvt2@dLmbBi6GP9p@*w$U}9h!~R-}yTtG_C%kHd z!U1%7>x*Z(A5*YnR7xmgO>%44wEnDp-kd~t{4b9l%BBB$^kg(|)2ei+z9<o=Oa7p4dtDs>=NokPA7p6G3b}ai~;p#aGo;cP4Lej!l)$tMTy_hW&%pJ z#jPY;J^NwG(@xj!fzicbiR|Iz@y$uN9TNha+FOYtnx^$rod6JxtrN0^qMp8ueN+}E zfdGg9En<@70(k0~z|w3b#6urb7ThdJrS3JKz!cbe8CXI!LSY&r8Y@RHXb)MiHu<6t zgA2R%vASiZ4MwUY6lb2=7t=Qess_2rUX_`(D>r%D37+)MlsPUDGX%I+uT=%CgNE&S ziIy_nq-Sm`oNg?pzw#ae^=!u<=YlU$e68INO;gV(;>o*{C?C&&E!gb?`wb)%^$&BA zSdy6{*CGoC=Fo*kI0So<0n_0Y*R#>B(Pu=ziO^!xtS0-%{3{YyfD<>T*`RcORR}Yz zLUz0pyjJ03Pa_1NVJbl|sAJbOj+9ZG&(?r&hao*ofoWLQ0TD;Y9#Z*Gu9hvBoAWOW zqOuT2H#V!vr> z`eG#8opW0ItU+6_k^KhTuE5M&E#x+s@DXf6PHv-^Q9~=^-M{?oQ$%5_PIJoPmtC_U zH76t67$@Agw~5#jKkK>Z_N7-=kU-2WEF|ha%9AIkm{Mt-Zvm_F5sWO)2bWLzTR)Sr zH)%R8iffMZckizZk<6zsP;hrxq+E0a6T!jrS>kb#b(B>&*xJ8|Q4r*1+tq6#s~FTD z1o%5E>Tt{~!vYGn!I13Y@rtRO#kx_Lli@Q#)HAHUJfWBQzZs+%MhqBlI)Lhbjh~jb z{1$QOlhJ{zGl$^>gO(v59;t@|<4<;*)HZE5#gTkw)t)vrp`{RO6QcS7S`xP*5zGRj zUkS##=1jF1k>UerND|*a&TlF>eF%=()vqEg;(f{|%auyIuraQ82v`X@ngau{novv7 z6H`@sym5!WU|@xb5u7HF6Smzjmy){-v7XS{nflcjv>3v3rDF#w$pLDK2C{>!FEiU= zK;y`cvSY+4>AfRk=ywPo>pGl?7{on|e2dsloHi}H9ujQId1o3m;?)e=yL&p6>2!P4 zdcPhXE*_?-R4VlRy4_87b@XQ212g!OU&1JUUu9$>Embq=F@^seM-aMEh?q)lq|9zv zR&GkLIBhgLFC^>oE=+oPt}jaM*pps!No~F=c$S$xiqO7$4d%GvUYi4_DQBuH5mwUR zpKit{p$~Mc01T0y7ef{8gG3I}0xv?70ZI0P62cL#zHa^LEydTJR(+Pse;c{<+=j!1 zAzbi98#Gx0&^P*cA<2{P#saaD9szFSK_dsE zwTmG~LpX=~LV8_B6a;g8`s>Edt4>7&HZ>u#UDSVS^>>);4S@FiDN!tMgVnph+?bAS zSb;;X;|CR1<^?9vDYmPIZ`OdX0R`DEMi9{>w z&n}NeRC#s{bfqV_ECEH);(ZJ*R&4}CZZ*W^=@|CS@den`>7+!cZmRyJX&!)pJ#Xoz z|46EQ0E_i9eb`7~NX}6*+(Zk`%PYSHWGj1UUh&ZZsY2_yxB#A=Pn^**rWbP`-sMnpVM1?|vW_|a zz6m;4RyMIZW^{A;vYyC@Ci`or{9Gu8r63KS^8?NYp0q$2S9BU=cOfqC<2$6)4{thc z7g{lX1wREIyS#))#1OorN8vKTv<8Ie;|txqWVNKj0+n=H8nml;KKiorf)+70>>3(& zlHz!OBu)`2ZRAL;e2ye;py=4oR+zU=T!~g?NKG#+*O8GR(=38f`?vf_qlt>dDnuGG=WIL|9rQR4j0^@NE>=ac>q2>P zR`R;OsfW+^!SVax&rePJb|v)ZNL1CM=6Wy3uaA1KdRlpbYRPO`zgY6gs$+SBV@ug` zps&NL9OvZ$C$@isv}sXYyrnOr5KlYj#JLaS^k)@)0umKdsAsgm=8PKkA}NmDbXeW&`>Fu z)9m==7A+JI{bZv^8y~Jor9VUmV`6#uXS%0QBL#f1mkjb{hA*!)>dXAx!M9J-N=>b+HFnYHSCVbf4_ert=k1KCyYA`2z2!|viD&iPs+@dFIneXW*(FlTrw<L|`(|bJj!b=pk8TZ=I(u?`4%ivEpTU|@94Sm&9@oFJr!@|6ePZ9F$Qm?rS zc5sUCeKR&Wjz&-Hw_zZPo-a7bok4@MWh|_|Q;c!Mav7j6#y!ez@mmToO>c2)>l`>X z=f^ni&b?vyZ}C*#BLHwz7(T=@0+iszDWhG7Q*VOAD=&;x7VUciGVRxPvy}h~g+giz zYjMr9P|l~qCPQ)D(Q43yMa9T5`4TecTnH=DKRsR=%bGl2~<$nflOszDNyy(tO6 z!Ul5SdNvQ0>4ygkyAuroZ}hfj|E+;4V1_RLr2BJb>w$|0(a=X!iyC&ZI;NLe@<EX}(Y)0d5*wq?T< zF%3+Uv|@T`@8D(V6079?d!nI4^QZ}YvRpck)zZXY$0sgY-kc6YwR9(JXD4NPN@Y`C zp^Fpxr5d$o^cs008+hE)2&DAb^O9Q=(mpJ0=VRS<)3u3F^Qt{O-wmGRY#{q7qMeq- zK3Fcjv9ZusBq}Qh11x#%eh(h48sRL&iJ1ICdd}H|I5|CEkfgzengfs?$Pr@XZm_2E zfW8cPpQJxj4P+-TC}PPw+79f{MPK6VCU%WtqVD!oSr;d%*8X<}t6QBvA%7J?CB91X ziY#pN{+(T1-^49e~6u5Y1q~iT2tQdfF*k zJB2g899zLp7+MOz(59h&h?NlZ+wZ~xc?>U@-t|8M+Vkle(7Xr2fbu&PMN++?z@Xm4=s;5$`RBxl*I0_%@ob7$LRb813gx8b1xgCb3$g z)-R{UupFtVOtCH!u`uPLfCepULBye&(BlWW5mxp>=6e4zpS+o+om->e;+3^GjBo0s zZ|gTUJ^{?1RM>7n+Gb>h*Wgj3EAT(_sru(SR@u^#o~v%hy|GKh-$fLIOR3O7I4eHr z;m=rfP$uII&2fPXt!OR9^kC%8#d1!PonZgLqck_(sow=ZEoB;&O|k8wm+OWVg;%Fd zc}FA$8gOdj3l+)&QVJ!~zQHg6kfU{VE?;T9fIo7v5U;7p3DEkt`P<#qlS2jE*lCPj z9(Hv`d?=t`_D^=y(RU|bxAL@&POIZD(%T-AhBzri?77M1S~Lj*xFw5uUU|w{y`SXr z-N_I_MfbYO*mx#8Q1s2=D2;x{$b^5D6CG)dszj)GTpVvk6nJq2X-ibDa#cW!GqUh+MDyc3~~3t+4rituY(iUTV2Y$&~E*1W%oL=M)>cWhRBmNbpgHJ~@w z57-zu64-XLdM8#I6p+mA*i9lb<4ZvamU}4}fSYSTsPD-f0pQ8VcT`QHl8C$7F~{#+ zp29v~0-4<;^te{3bWSPn&fh>*6M@We?zjm|@9lDIS2O5yDiG z1$U?uR0@N}{#!jSo#0`8sa0$1D9%^1EsEVG^w=g-gp+y6l4FA2b!)TQYS|cG3*wM{&$_yiyDPP=rJQ&-`4E z$JJ{Kh5Zta`|2zSa$p#?aeyU?InfU6>bgP{)y$`=?iD>JkYM!eB2E)KKYWCAx*DyK zvnaqMFvejzQ8C$ly84ff?mA-Dw0-KlcYc; zmxXi=>D$ubGm|146G+Nj5*^{%*9?yGgu%A6!t;eXGX+B%qOkccHXI~D(fp2w1$C#- ztju!bDMhqBgPy-+Qq1Y>$%q#JXdPXXHB(VR$VOrzov5}2A{l9@yb~$&^=jPm*l2>ni;=uBO0-GLyO^UNS(oGr1(y0RD&QcfJ~)L{Hz zRcJ`4*s|o(aaw?8oA01W1IG3SI`~zt<$Pd!LPwef`?bJU^wXK@D|np(`|tsYB(x{9 zUw77gdE`knKc-~=iKl0z|NqF-|Mw}` ze>RH#FOxB*|27%>KlAC?*;xPA1E!&Wzo%GYNIw5C%EC7K(JU-FQ3U)J*G5R|A$xRc z)O%hS7Mca!X_(c8v6o#ty$V^E*SLfipd%5?nc~ilizSXyU7Or)_tKuvo8iq>KAno- zkDpJq)Y|1nw9RY5V@t1Z>z*;xNI{$0q;C4wo-&yhjSMxkA48Qgm7cMbQ8<=~9zM?$J4ky;kLmWvr})AkPZFC(YrrfV~&?iOhC z-|}xOymHyiS1B(abWKgSHrLlF$BPVAtD3FC*cUG3ndvE?hxy+@Bv`wdTiEW7!)7@5 zh%slo6dF|8t@)w0rckRFZ}jSzo04!Z^KF?&_ow(VS=&=DHzlfH`@Pi88J%>{k(}Fk zw4Z4uL?`Db!`s~=qS#i}gYlk07tfXx(y?Tj<14()++3O@pK9Im>*8|TQp8=^M+F~5 zM%`N;g1?ld@940-w}V`H%7Z8?^E!2at7>AfH&W*)X~ z$v0tfIE46puKjDYKt<-m0&hRrpX67A6)*YD9p{6C8h`F@dF;3!a5m!VH^JKw`W^PIba>n9gv^2b{|XzVeYdW*76s`8CfktkEjQKGPQ8@jJA7*U8MG* zNrC~SA6*NSm@FwKOW@#KTFM~cO((BQm7KXsTif7mx?37OvX@VUlPu;A>k(sQCZB^d zDEeVryDj-OXiBvo2S6r>_y7#v3y5zO&XZyom&wQh_RGj!OcnAD{>CU)_n2KQ56MFu ztnKqy6Vl)**ICtxHIA}nkLb_`kcmI;7H=fIj;?!~;AtzO(y$#rW8^1NHub!>_%W&= zJG7BGIBGR(Za>V&d{BCW=oE5(hK`}}7Giw{4&|OO$FB>P-FO#Dcu|nzNOt$for(q> zQ)URxoRk@I$p`d`Fmx?^*@!+^+)!UHYm_B0Iz%?x44@|Y!9m!|*k8%9?-0B46KBIC zpfJX3&{v<#x}*6hJ_J95yaUCYklz7_mLqM+amgvxJIWI8K%js-f+$6px5d>S&W&mP zJ1{qs1hR=J^8}TUmUmdN0?DCLhn0fZb*i$sA2AL_o`%~PF(ka^p>2m7U=jqc&X+w~ z-7deHgD-lbki8;E5FgH~XmCsqHM~1*U5SX~nFaRB$!$J$(j0S+`#ya-fISbszTeV) zay}%=&L>ORT=aQ{p5KnK^)_SzJm@WaxI=oy9G%tcXdM4TP|92=SYJk#p!SGJ`I+Eh z)@+#hG*jK-ct;)H%BoyEL9)3-*7|E>VX21c+1UCkrus=o0zCb07nZ$9o4$5-22n z4=Kbge&>J-9a!P{jZhXz7SJ(O!S`oz*e~iFd@e!0`*|Wsfq`UV)ut^Rj7?sxJSGj} zW+Cv2f=yuVjh%}>L}*`)%ra#!W{f2WPrxL0d9;xHG@O98Up&2fgtjd#Y*jAbO{_3t*0DYRBg|Cd&V@w?uIZC)f^ z+RVjNLT>M;!wI|eBFF8w(DiRQ+YgEF#@lAD8C5KqW`ALb?~O&P9=Q?M?RIlA-+(6rsw2r9Dha`@$uok1#IR&Y<9Ffr>5Kvqk< z9t=^vsbVFMdV&QtX5&|wTR?{3Vkq$KxmN0G`)u-ek?woY_?ZBa7_&cl{u+<#u9e#u z<_#xD0eq?bUt}OVQFply=@qcmxKsqN6+I;@xp;wLmSUg>d&?r}>FS8GfnS{cF^+A3 zLG&mg_NqDkO62APbVQ}lW&)MBj`SJLZ3b-$X%)6$N8pnP*j|#Ue*d;G(%NnOXG38= z%Z!0>f15-xNho$oTBT>|(i;e>|jroJdthZDOFj|XTQW+yC3OM0Pcr<0g_ml$0P_i6D z>@JMIz1iOEER;2bq5y4)a}U*ejR_bF4`~HXq{5;v-?dF$O&*^Zsso@OET~_+kTy7> zrtl!^tJ`p&;~qwulI<{22G{02F;9Rxkc7?O*Bnfh6(&RJz4PPj{@@ZzG6P|Gy}4_D z^R*EDu;LYlbSW#S(P=JI?EAS_SCm-yn(|DGzb3zB_(&e6#;NYI>v?rrj#>*P^*_Xm}yy7V1Kh8t4((7m!4rBg402&;{qFc@d70FJ^qL5=W2bEo1)f z;pS_N#mS7V=adKkHLQS*Dy&N<%1iiYeYw88qo3Di%0WH$%TMmAQC7=VOp8Nko7p-` zt7GQLCk;JZ!?%hD5fc@fk)Aezyv`$x0Q&>pzS}asWSe6SKYtuxwz!w5YRgu^@)}X}OkNn1l1ibn*+n0- zMh8O7Ap!?f^wTEtLM_}>C4`qjD?*qDQ9QiS5Sti)0T0HVMV#rK?E{UBGs9oKrF|nn z%U-5&pPUU-6zSD14fmUf0SiPzZ{;fhS@*}46aj2M!hPzhvJs6w9Kay$8j7&>>9H#w z9+x)HV~o~GL?dwo;cbiGMC;@7p&No5Y0n_4A2O(FGFEU%XK0aFuvL>(BzQUQylKWm z;%%1dmS2e!mr3OjfgKGSL%1a{(*6aiBba}|buZ}2@5F!=*YXEl@RB>A zGJ1#44^$0LRr@B_K%(4Tj~?^eU+TKgkXeWeHz=5(_b$U_N3FwA^XskTcae0SZcCAx zW>7PajgXG?poq)713-9c_)oqW%|Jb8TPPNs(!t_Ron<4K*{~&bO8^R52Dw3>%3Fo9 zNNA}4ZSt%ecE5V?TJf#Xc1fP@}f{>F^l;lH_3k-KP>+@o=SJq`G^f$t6 z^0HQ$SgJ#(df)nFVZlE8pU(L%;P-im3*Q)vuHi}HHq4S4>YS*1=!r%fKT3BuK)@6n zQcj%dNW3K;zupTl&|L>o z{!8+Om|w3DyRspNxjRd;7m)~{;5b>H_Gp;#F4tHBCAB32|BRk=!gRwivCUiOHJ-uL zLo$}#zm)suXA=V_N%ZBLwA~ncqkIC6qCbgWq?f)xYe*hJKi`z*$OQ9K0jU7ir=maV{%C6trPnDY*efQT2?nKYDPiCman*jEoL4VuoNhi6| z#W1`z6nh5|Lai1lrB7a3x9jqhI6a|4*LgI5=mpoLLEs?&=@M9tX6MC`TqEQa&8AW9 zx^EihXlu~EH|72-e=N<{Yo_O%a;NAYtb+!REM-MtEtR&Y*Ig(ng?q5>e{r)!}scUI85y0$fXQ;7&ew^Xp4@~SZBopXinM&dZrlz$b+9z7n zJCg*KJ&CO51_9i10ufm2gpGLSk*n3x&dQ4?k%U7L{XQav>6?oRrPD0Q^UlTvvI_;G z4e%nAyzs}$)O6ZMzQv+wZGt>z&ci5g#36K#@u;vWP_*a9sIQ0+Q#G|e8s#p;XW^)V zvRaAAhzCa8f0qotg|aJF^V#aUgES|uH+B^=hG-2|o4cY?i*^C$X0g>V`AaeV`}SzC zYmwLuHeE8M73+peu*qzRZG9ZM(H;mjBidOJx*HQ|I^n7${Z*+O&c7IEo*-vHNaYBE z0v@L1qSa_9nC zEe%*aAej^f#UzH2I5b-0$jA6I`;cje7*-P?eIWyW8J0(dS3!BT-J}9o@Qdg2GMzI^ zK-tEgM{&g0E%z<>Wc< zTmvy3h=Pd&I+kwhe95lUq`@5Fs?=`Gc8coIN}`1e-(0m|>aY03dJL#R=f zLp6k`UDyetD67ifI>~J*Pv$6w;A#;xD}byonBg5PV>_FzS6n1YJnlA2h^R+;@}(?; zddlQP=R^t2mjNaO7DrUJvl(#AZstE*%D4zE6OrFpSSxK)zH^9&HR86s%r*`-3_TJy zKOtpK1Xi-labb)#RXJeC8a;F)7=1(^kA5r#3PGO6Q|_mV=~fs`v0%3`5uZNbQ57_-pGv?!&LVLMsOMEZAX z+0e7uUBI)O(bHR*@9XjY`s%}#YIgZIRO4>ys=U2CxlE-7Hh>*^yddffeEIK$M)CIIYAu&K{OP`;Z2;rX6ztr; z{r}KRHpi!qzn_LaoqpK!WgBg;$={YfYq#LEK8jTE?e0f#1*EpdojFO*xhqY6Y-6Gc zml6yg4yznEcvBDD)Aq4RQuw@7k}2CKt3LD`D^1rMine^1nEz$iCF>A5joLR)AiI99 zjxTK>W?$;han^oMF}uDPdGvnG9cFLZKHrmiU>=) ziuq7Z2U%^9gkIj@*OiN{Pub{(NVXCuc?(>^!2$DB%W%xg5aMQ_@!sBq65%3&K%LVT`!X zDOfN0YH(80o4^sMr7v2AO_U9nn0;J|X665bV!hBw(N2|X)`4V>1K-0QbOdh)Y%sWT z=wAF8ND>~~spjYkCF1SP)H-8Ap|?eIkk<8ju4nh8hrfC??*CBno&(IMm)3Vlid=QI z1^rCSYn6g}GFUuVQlb+x9H69zw`*i-=^XlvxXTMS&QYf0HbG^cJfa{!+E+E9zUmDE1^;l8E3I{@2jb2k2p6`C2Fq>Yk6WDU-z$YSwziPsac zP^=H_*f^4~VFU2jkCa5VptOK{+qDTWxqG%xW7ht3r1ULmZ)?syI6ObXX zhXLI@Mie~ki8)dEEL5qb0O*uzG7_ky@;S?i_Dt1PT$TY^b5e#8>b)A+{(ZHDvOO)Y z%C$QR(J;R|BRd<~MEDOGyR|Sa^+|hJI@d#=gNI)C_4wH>8!H(2@J6RUrXGCX!R*EB ze#lRQ@TyO3d*E7Dck;)_g!a1So$Jxgk(0)mG8G8V6G8K7kQ&rJ>Rr%dl|r`Z;2&yi zum|LuP~9UxRsDb@ilVXs9cGb@?Ho`-F$&g=+ULsv;nuWJh0M@>%$!6l4M%rveDmgJK1+a zfLCjol<)A^_v3nFdJ`Q5Z&O^&a^WWoiSx7Imm$cX-&$zAryC?t=ev!qdh_?#%%09= zozM(mZ*wLF-x%BUfj%l*YIx&bqYnx*h98oMcBuSd?a1`cLdyOw%h5~D4Tu6d=#eFv zVrhwG&V+cU{|w5v(={&G$@)GG>RWcUOjNXM9rGS36~?=$&{fhkKQC2P7By-yi^#K! zt<1nswh`9VZU~gFO3YJE@@l~{na6jd7+p|u)DZcx0+c_ubXN9ZH3LEDG$P*rySZ;X zj~Tatje@``P${H;Uy+5Y!7wA}_%7pC@wPAD!_8%9-vtC{@jPGv`omCxh2GQ?>eoiF z!&aU3}h4evviu7 z?0SB9?$_%CkYJ8#ula63^_9?y8@dKx75_WEHRkzgCODFc6FVIHbs;b^tz1+1Q4z z^uYRxT`1Z4+g(Y_rK#yi#tiNC zNzfhtAWu}W;1*hnpZxB(8HO!mr>5qcx(^`w{eJR4oeum5J?#I>HT$oUzL0~houI9o z76aXHugUL^m67Rp%f|7$)uxv*HZs@$AMTaccQCebB4A=<`QM)o{5P)Ie>AN8a?SoX zCk4#^(@DX9oXr2a=7f#ozst~UsmVBQjv;nms7)zI(^4J?6{P)=LsPQW%FR}f>zU=uf4IHVR3Zhl zT?Vamk|HIuSzR07iaEb5e(-fEzUwVtL3Et2C8}keXJ_qB=Qn7t(sB9b&Zs}aJ3UIb zpg)8k;B9B{y!++{vPo^9cHYECuKZ8NdFCb_y&^3%zs>PXADVwGn(O$yf)1KmpWA6B z*I)H3ulya(Y<_P&F{kG4J>AUSY#Qy5(aW3}(@fox1sxqaIy$w({FRe-%bqnY_7FzV zXPe3{J{e7*j`(h`XGXp@_2*A`mDx|$OkF$stgn$!Q(s!7*elYDjSuIFtOw`%HVQS1 zu76&r+_Qn29YRm-8-F+RSR3Eo4z^O_3^tU)COXB8H$vyrc2YOLKTR4h|5)~Fdj3TT zz^S?F%TFiAXoywNuEwJ5;5sB2(B%nkwd_G&nf3;AV)OzaIQ!6j`>g|9hT%Kw$~9yQ z3+9c;7Kp&QV)k7m*f5>RAL?%IjgWG!Qkv0!VeyQScb-&L4kRl+aI_w6_!5`sBdqZ| zv-XML^z-~JKc#+$n&%OIvOwhRz3~2sTXj-H)DaB>^L2W2xh8t|Xl`IFJG_QBj? zOzTYm&A0iD@#D+pxK#Ab`D}~Wu}pMvp0PdO2OAvN0jDh}CE}M8`;FA{j|z3QQEN@t zf0gSs9{^)8^!Nczt*CnVQQ%c7i#q#HFum=>Fkf^zg?6W6w{Mty!&@RKxNDf6Ql;m~ zZpmcC4Q=rdH`2X${ze0(_`AYy*XRO;Gy>xe+}hx8muT6bUoPG>DJ(8=qtV`>^mra! zV9_zKd}w{DqVtLExY~wDEaPCg79gNUE3wC5CEEN&)Dp^||2)55AGs4U=U+OS)Xzp5 zH1{`wGmij-w|A2~eG;5tb2NUp4&{A-Nb)))rW1Tf$AAyGgoPWN(G>p3iX;0hCf(7h zzrt1AB&7eE4y#;0!9$dU7?s}FIb-30pbVq;0dSWe{dUo0^Te=&IrzOz;Ie#cesDR= z2p~2zw(7kD;rcP#1;rN(4XzhdK^FiL;u%cWCOW;Fxz&e79jgrX#nKV9WKe>y7Gm0{B zFI>vVL70&c`cOopJe>5EBNX{MFHFoLXNUdyy;kFWk*)RNgB}?4YPX`K%Hg+RP+IBH zkx2&y74>HuY$uQk=Pro?&hw_xSZRH>Y@GvIi%8y69QE5J*`D2XxkP7M8zCL~i?FA} z{*y?M8VLGWV+*?dgdM*UeHcIVPNP3wVVa;R{V7zJ`Pl;1_=C)h)7xTpnA*#VG}|Y8 zC#kk(^$;at^r5{k(58O$3>bgT(@R<){*Lj*ysZWniG(bk?x1yTl_lxk+K?k5DkaP& zgdLa@8&EIR=Fi(I%n16Iznwhi_Pe`iXIVnDG*gw`xAKbPAFzqzU~Alm<3S zvlV+*4iM@4*HoytOzI~s9Vb6kEL6l*xs`K zlmn(OfQ;b-%0d)<)O()G zd|6n3-6GIDSv9Qg2Lho#I$Q3yT@du4t_Th?85Dp%&sU;%y$gp>=VrFJ(KKxts57!m zyLg{LZcgqhNpaU{o*0eH9XEKArC)E{kd=cy0!{GHf&L8;&Rn>35A5H)jVY%20QH3(I5lL%gIA4nBeF6LZa!HfM|V{(Qf`|5ArnY zwQolX;DzEbve|ZDOyg?HQ)0ieH$gWH_VW-#rkW^cAntzcrrVT;TUAU?y|n?@nbL3< z!6v4w3cuY{^;3XnP1ZjMbVD!;Bvb?hwsAxSCKvHUX=wX}wUW#VU3(^Tq9Oq7!T}u9 zrpA7v)QRUJCM^m7AbDj|Q;4l_SdH*mj`2m}rRFM_liU z0R1bm&EY6z@*MlOITbrtDyz;ggW(K;Vn7pfSND=>evR53S$s!lv za?^D}m2v(~b=Bp6_Lj!qg*(3a%l=r^{;gU%>(rC;CbZa3Cb0MnZP>*b_@*u-)w?Re zv4Y?{({F+RE$k4JGmYj~dW;7T#iu~9G@Bx`3v@voM{~3*i^Ta0)&MP;@;KSV(-78= z{pzvF?v9@q)981pf!OTOU0T=2pIY>%YZqv5S20}_kK{lnrJ!e6Ja{#|3$dbrW)Y47 z(g(B{n7QOauZ$7yqffxYw!!)=<-Iw{Ino+0A?Fq=cQ+tipDNYA9Zg42TW9kCT$9=q zT?gnDw50XBm2K@fDpQ8c#jA8t&3#a;dvutq?nBU}dO)sP!ISBE#c6MOdzdjIs=_pN}OpmgoG9t-#-?Uzd|mA6e0hC(In+|6Y_)b*Cw7)KbKtwRJy&pIYqMUxj1DUI zvv;v?!9^17Fg6E|TR!R97keTlCy>_mte?J0ii6Kp7gE~lKw?4tb6v!w`>zLm;ML+a z<>bSUNosxr@U5Gj6Adut%I-H)Z_D?;WuZ7_43CYX{mj#vE0-JD#Ip zTBC)+Wdm*eP}}r=HcK~Fb1?`O@7f#4@*v%hHq54z^806{Zh7&D$ki|+MJkzx*;54;eHkRk zEplkAXa-7G;lhf61i4}S6qQ`EE`(zDx_<>Z%m?`cmxlgTj;H4?aOdXD;R!8Qm8^3v z;2Em)6GWvK0-C`fvp0d>WeoNqp#ypFKfix!?Eo3>lwAxrbhw4HSKJW8F)<^Fb$<(m z6~6zF!lhq+JF!K5*eC>zlC5-l$;bmC-d6(_jJ^E0S+zpJ=nG>q1Vt9<YHZNriv8z|r?(TOYqu z&o=epT!(YbeNze)R^1m?d$MNrZ_By)f-~uPBW1-yDLNN-q?cHH)QvuC(~xu~yYK_? z9nQH27!S2>a5HiYJrwMI)P9CZnqrMR1DCDrkp%T_NBeHPMClfMRPr}jjwy{Mv( zwAJi~=LPK#c*txLfeNKx`zy?hb>e&izX)D)uaXYwq_vim(@kw#Cq_+JEC!?nc`wD_ zKL)tlGEb@NB`jNl>i_u>NctAEv+xuf5BRhtcJEMUg75t9lk1Q;f`>jrNU z9O?(cQlVi62{j57VQ*Ckwby)4m~Ugb#>;TM?NksBjuW9W9x$>M09Ahc1U1?By^_Yd z{z^y)K@bkq$XE&$bK4PGQ0YH z2SW_>dN_gRQk;{2DyRwzjBU&dJ5sboGs&C>Ir?L|@@I=D8xKEYd%SCyTm@7)w|bAH znNpPnfeXdPB&S0S-qvhpGrE?=oXj9GgJ;3=q*=k7Ki{s2#l=wSyLm#7SX|heRjd!7 ziM=IWla8@a)jrNkK31B>Ka!I+ILfwf5(JMXI;^w8*{a{O$SO>7DN0B6Nx%we{!z+qjtjpQS(UAk?x5Q(DBPxnz}8loUMJ_+aEv#*XMpEgXB_SN$PrV zeiP7MB1?Z_$(0p~feI4g6gIPCI*EQEuS`3trh>M^8;OX>K|b~a%g#AK-Nm46?WRWZ zt@Uw!14L3kS4mx|od zs{`uS?1+@_>2}%UCv6*Wj@5rK*_pMbn$uXgEhDW6yBQwT7aqOysr#$2T>q3tw?31q z;_PzH-m2Y9zGror*uCDxAx_7wZ^nZ%LEZmB&w65pgpT(e*RhP-MOw>E%bqPWi z?t>;UQ;akYYS-#qm`=LT8e`i4MkLi#p9YgAYD@H0 z1gRH4MVNYfe5F8nhS}wPWxUZBULddlFR(UkxIXjgLs|5rtN~_>TgEEv7A+rTkdmb4 zf({eLPsx=48-I6lWgzzW;p4v%;3Hu1=efo+j;2^pW)YWoe}bl`7spmg&8QQspIHiIM#C|ZxmbLjTGo;z26SJ##fogx=a~BU%+)!Q2)@ny8B2{aX-7(vOzz%DEV~-){aD`P#gH|_YVgG^&_CAuR*gt-WSfx2R|iBS+Fnj z7LcyrZ!0YHZp@aQyVXqBOqT{|E1B%GP$xVz@43s{;TXG53;Q{ma&n^c=EUyg@7;En z7E%zMX==-*4Qn--Ncr_f$6k1eb*o#Ve3M1ls#GcOIu+bzz=U5y`0ExDM^KuQSoWDV z6AObHfuzn)VGbR)#7SY*<8PC)oG85`V0h3EzUbqiI#T$vrph?6b86A}p{vl>{{7jX z%;EVaT@FlrQkjLsx|II6zSGjwH@+HKPz9U!r&f^@2+QXZdI+r1nU{>R9eYXNe_c}yAz=3c#;KIAZ1&gT|hpO%-0 z^c+hpl}+NpNtJWXPoFw@5zrkBfNs+logPS8XDV_`a2~- z8mEgrO`ZkFDW5j0eChwVeiV1vpWhwhD#ugSm$m;h%`W)`GabW7pK7qbl!;lIgc}LK zK0ySHnM-+&ooi+BN;5*cB|N%R5Cf{7cxog(VnJR|62iJe&G=aD5LmO=B$Na_eLhpD zimu1jXxpt)VutFA8877^EiU;;Y z5sKdfRx}5u>3^E~lRY2Q-~l@du8=E`vbbh*e44GW%SJ8bl5+3iq^3ED zQ7vvsc_s0RC$z`$gomviIqKwX#8|J;)bMon1c@f z!m=3;g*c-Z;V2Mim+nNnO6i(O&?WHw+CI(WZQG?+ga^sREiMm|e@kb5fs7FeYGx`A zS;jBON+;seSJWAgdmAv=kYh8#TKBvOq>N@eB5<;))MSFWV2DU?M%EiPjVDUE5w)sZ zfeRgh9EwbxP3t^r#l1+#${Hwy$Gu%%g)nTb<ppi1)^R8$K#-Jz;Mtiwy+DW6}Tkp=6;uXEN}l&&RPU&7ax2pyRPxLS+2}nULQtx zc6PS+{Wz1AS$=w&-md2CRIe_nkgp7F9B0mzm1^Fg@YJ{Ys!4fsu+hnWj}$3K8)nX3 zwP@!1xbjMrp<8x;;K`hN(9E`cij#@xlK;oEt2pa4x?MIkxefm^zp_RDu;8`S+;)_@ zlwZHA@_b^bx_-mbyVMT-fF$;OS2tI)Pd&Wfv|YN12EOis^1OR(D8u;4_Z9l#dK8>N z{_%#Swf|bXUX;}ljP>4gmh@59*ZBb~cIM9Z>Hdd3oWtcE>EJ0#^Qp7F?8?Oj;%kWG zef9jtR7s6btMfsk<(*S?$s&Fh{m+M@Wks84*7I^Ma6HRQ%;QN{tO{%TI?|!B=h4FI zV0YZNOK0ZX2J4vBKHFTL+ZQ2>iH%jlK>?ZgT#Tip?yDjJ0XcKTs$Cj+ugHY1hX);X z-m0O>k+fyfylP2PJCG_R-Iow;W(%nCCsGzMEL~Z1U~2oT>4}ZkIN79E{tRDQ?uk(9 zS32hpb~PnGVEDVh3bR@JARhJvAVe#6ok!ok7?8+6DGPfRL%(U7J|8aMCi8TT8so%? zD>0pzd3I;LvguG)FqpWQYJ{M;qw$D^2fFu|#g`rKdgh~>4%PAcCL9VvbHx);XDm$1 z?2>kfgmoUeX4Le9h2U+x#17(MsC65TTl+-35~Sb;Ewz5*Dk(${XroaPD*pqpGHVft zW2szD8rzvSVtJm2^>^y-LN>(0PfK?qmS#vTo*MSYVrMXh5{=6~3P_gqh5-zkeGcSYQH=i+<^Vk5L zCe%JL+&Pl3K|MmciVe^SYy|A7gOu~!UO6q;N%e(m7eay8dyE^=N}k4sWQK3B1yuUe z1CFw)o%9BLuRJw_Cb{{TmW3k8q1tp5e+``wYl~++`xkU-!N@$!d}{!hX(b08aeFrQ zW56m~0~Zhu=(}~H39GlLzzk4#TV=%wnJ|)_lt=HSd15hP9%(@mOv%`DSyZj&x@-R& zalC@dRek)vVblUuC7#jI%(Dr%@sn7;v8k*qxY;+MpN zWb5jz$a%b0OR*4M9;b_D*jl}#GgL*^%QyhRTV!YufU=5H>VZeX<%rkzAOwLefuhA4 zkZyckS@a?nYjB3a)kL+^!&^YQO(yR|io{r(U;xIjZUk2I|MV7f&;`K&(RYb){+22A zQ|S4toy(L9EiWPGZy#1|4{Zy~Yaw{adR?w#?9nq~D`X$>S{E0y6h_JS67mslQ(6(C zl?Ac2*i7{tvG?8iC4T>nN+?{PBq6(zIROtCk}fRCBh5Xh2uSPL_BA40>luBlrF(E! zXtZ4;8@b=&I z0IHo6#i%wE#zAJKUMEy97^XFlwThF$v%MNerWo_@XfiEk#kP~|)>S!b?0c7iD*GJ$ z&~kRU6VcYz-rDu)Pzvto>1l6#QLP;K)Z~eJ>kEfBBdM%Nv_+TL3{4cu=z#d=a2Ii3cZrkGohpOwq0dv%YM-v*Oj=YnvA6PTp2w$)bB;z z?uD2W^pA%uOjyA1Es(m^gXx9b2bI}95Y<&-sY_p*Np5sY3s1Kufz}Zf7K%b{l0->^ z5FxfBitU>+*2#z}L4{#L)5jtxYC1r3O$pP4azYS|K%(NGgP|&|zc)k`1;C{67JZ9q zs)5f9bx&$U`6n-lOFUpTXfpu=7Y6khTpTskt(S&l!v@qKQ(GvW8U@7~8Zk+lG8x3= z26=GI{`*CmWlxc+Du07<*aJra53*XcGlejHBW>}JY_?CCve0_)a!3qR06~%l!ZWgW z)a4Y;XpbcI=@<@1xlLh}2cET?3ssfV;W;l``E?M>VNS0}r!k;d^uq*a!j^VBM1ji4 zJL{r2t|8DeB#qKNNg=0J`)8 zac$mdNE1RkIQb(m$_!~zvcQp5^lww4Fg%@H=G+K*@|822a_5<`8T-R6=XlA1^ z9)Vx*ps02JzD)|<5v zW957Ifi6>1_331HD@Nfu)#Li?0C+P~!^a$v>FICvHi1Z&=N)|WPpQun{oUfo?spC? z_cmn!Im_49f<-Q+n&r<2b?qV19A1vObJcn3+rDqkNhkhUkbI?UX=aYQ$=P+@tQ`>& zC~LEXbx@%rZrgyvlA*Tm1k8DVNHH33xNUamu4x4X~^(!9Ej}AN5+B#baulZoU-}u&% z#f-VY09ZvUvh6)k>tTnWauhrKj?>`=Z&Un&#hBB4=v*F%!<92d(_ee#Tdm&=4jPS6 z-NC0>Ef!9Un#e(nxN9PuV(Cco!mXW#-ET=B@($Q@rx?C%`Gub5ocJ2xOGe6#f)RTI zj{_m;x$?Wm8l+s@m@Aem%&z%4=Csb^O!>8lLhb`no|~n4CzrKTo7iZTbv9 zkYUAUjgyCC#i0>+Rvnv9;`zB;Wo#g5_} zaT#TqP5oUwPyhsrP%|33X28p6i-nHT&$XKVNsG#0=nR2)ID!V|cXBCIEDZkM3vl|U zY|z$HbsVmL>nBG>$iE+gN(Rnx^7%~|)QKh#oU-IlH^31(;BclxZdV^|tG8`XQjMd= zY@9V4sIRcMzR+MU0)Tx@^MXnJQ=E@~4-3l|Z;W>S2y09YxZ4I1FLwR?%~ansraIU0j90Wbx$alE{6#t`YymrKRl(*F2fjz$}kP6)n153+^U@i=U7#`mCQS z%6Ms+`b;(o@ieW7DZ<<`oHrsVjo-)A%rZMV-0g^`B(A zOXI66wyH$Z#jFu(g@fF$w`GPa`0nc+wdv($%mY>I0dC1K>t(%Q?GkgKZ$zja27|?- zo0%fw;55dJSALA}pnPA>ZWhh&t&)A8%+KgLrWZR2D;u2n92k@L5}*pnt1?l4@hchD zdV)lhKwf({hdd`#;Fq5l2*HtLv#YM3rU1_L2Z8?t1JF|@oU0PntOuJJ!3&>Z8p5

$#UAmedM7?yTCa9W`4)1)5%1OuG9eo|V1 z(x`m{7U|m)NjFJCo*kVDn4uJMUJ;SDsK3d-4X#zkwCoAncMhVVp}Ol3E~?PXdM?R z)EJq)<<{N=67o%iBnX2CMl9dhV>nb4H-EetW}93!yp2S|DpjT6|;KMIN5 zJx88%fb8X*C-UHpy|CBxJT-z$smo9)luG|`{auGOF?!s-&8S8^Eg(y-?p$*OrfA>t zC+%GH;vyRyz1|u!16%Q-@#1vfGlm9e#d&%LgR`1(#>z|wO>ikdX}C^VE3Qkj$wdY- z>ds~&9Vi%Uof9sKzuYHG)_n()p&MtNFJ2GkVg1TvaS%3a|I4k7)M5-}UEeq8w zeX$n|JIvGzXK#mZ+)b{mPlRdE;7qNN%RS}&tbaM)C(MRTN!sD9u+pFr}Q&`EI)UP-+U4gGKQCp zzCVQg0s2YVo-TGwiGT-0(>`l#@GtpMK>nNzM&2fO><9LSAPP%B{K(^F`vXnlzZ(aW zW!*(;Dw>sedCH|DZ@;qkh7kcv)_iKn*}J|QxbG9VQ0?=;(|*Z`vQ@qTEo!J5t(Lrf z43dE!Iil_i!&&#FR~*!dSYEIqqZ4y(i8s48Btx-CuCa_X}Mz?-ma{F`3QOejM89?QnJY>Cbjx5=| zg{687n-R9X@cj%>HXWyBX~`gugTGY<$(`NlRI%B;F@-Kk6O>z-xnoH~Hf!>ePn%0P z8+e&{$Y?B=`I~ppZ7XI|&BDb$c^cyFOlldC=ZLE;+@onGSHgAT{j8;V8Ndk^4<;6& zQ_yerMMbrx3E2-tgSNz*Y#xoppjA~*7(;Mi98?n#WEYS5EQ&00QblR4zCy6J7l z9ObV@R?`_!@d18G@q*DIhKuqcm31&kQbV*Imrf3X%8KX`Z)vwTM=5Sj*MVWX9tMie zQr@53ReV@zvw_VpcLo|n2-|mhc}tt!63S2+UFa?~Kvm2I))@9IJ}il5Aard)AL%5^ zMd&$NSb*hHHRgzgEES)tYZo z3@BSRqD;=cBq>OcdX6&Qd5DWp#8H_~!c~!u*Ws4ip=5gKo6t9q!QS#X;idOwH9%QD z=&E$GD7Zq<0nIAVB4@Anu8BsnKM}?Yr?kn{r!UDk_AR&gFllPvg6Tn(O(b*jinL2S z?(j=`nDVLGU#_Cbpr!HA#t0?yI@DTo3-3;I3Ru zMPVIJ_>pi@Ss5Z-K}{|I^#t=Mep<_J5P#W%yyu=4N-R6 zRrE6Id?Cc6o7Gr3ugTnqZU=0|yJ4~~=L`m~p#ALW8V2b_DiT3Sdv{DlcY#~BjEg)fucK8P; zTNF4}$J5V5tk094%XfAr-^(4@5+f7S1`UAF%!v7C?@o?`z%Z`@9`bqmU3nU@2j)W4 z`l+O^82slK+XvE*m5De`?@pF#M!cBr3v`Fz1I3bPpMd)(o5HulHUpV`A0Kp;Rx?DK z))+JDj>XO?*6qg1-FabDwKP_n>EE-_=44+C$*WvD7N0M&n~6bm#+Q{2;Hh(%)$-@6 zyUQUl%4b1$dCdVmhLhsJV%0}%bENDSrQ&v2lg+4S5o($9_vmqx$D)f$CD$C$8e=o- zv%fO-M&AFCj-c|4?uP27DfEWP{Ombs5&|!h7qG>T3qp+fCO5`mIpY|Vt5Q{EnYpXY zZfQl=Xw%{~;H<2swFT>~?;PP&mz7_cV`ElGhnbc4r7)b_@Gu6Wf^2kfHxSYZ=%41Y zWF_)teGr|t19(_~itW+)hIJ@({2h25%)0XDPyy0y17|^}1xM)w_~QVv4`vIH*a-(U zb_rRdx@O8FU)M)#!5xD3L3ri7@B!yK1F8!AQNyJ^g}^pdw44%IyX%iGV$l)yOYqR1 z$cD2Nmub>*E#1z_F8%`(lTFg?PSE43vuYH}KddKwBCWpCND$*3Xq(6>sD_d^(`LoP z7~X|k%8=S2`gJB#s`mapXFg~mZ<=M|WrLzl{;ezN-yZ+kzC0rry4+P^zZtEh?O(n; zn%uMOrg}8C#upIh<9*C{C+WG0@%K+hOJo3(LU7jFHtk<^s+&Z=rj5l=e zJr3O+o$de(CCqB)wfR1UA-tzKTaZJl&C(33g&OI<*#64Xnds$>Qp&~PSic?wJ1WY# z5`pKAxHThRnolyX%Ly2u6VgX<&Lymt5|@YZ3h*aY?24udOC;*+V!t_{Pf*N$a;ykB$PesIz`*7( zEO664*qBA&GR}E~IbA*;VwB?d{`cWs|Bj!0A8=lW_3az1w*<1B6UgTu0Js~q+9v}y z34*N)%~N5(6>YYfB1|6j>^swD;E5T@eQOfj(n!4?l#PN`E?AVv{uVtMP19o0hfA=P zGl_hBMV|xsoTWX&LIeEqt@}bqWfDn5X*MV9h>pithb|BgMd6TIFk@oQ*YsdUJY)O3 zX++zy%K}5uMA+ImG3hiwcZNM$#t|b?vm`uqh#;<6WxTG2Y3U5Vu-46-8=(Io>v1yeqTvEmDR&)$2Yk1*LeSw{hY!psMr zzCnpep$tyGI9887D|(22GC8c?nprQ!j7=cWn1_HWITPWQ3blH!a~Pg$&CKINC^%5y&>C)#0yyek zNPrS%^Wg+5+ms@x4rP%$Gf!Mlnn<0VS_H*I(W+3j&^ls?7z|tI;CFC3U|5eHaBS#= z#3c<=h=TQtBQe@($HtUdTqE@kOp~ral5(mOT}?L&+6sf){{-M`d(k&Nzd_PK9h9{W zhg@@51Zt4JXFeI}oBtl+S$4|Mb|y!@Q2*`Mlf@`7?UTi(-=~33vk*a|DF!asvJK#X z=YEmixvt0xAwpV4DyERn8d?1hgX4&?bEl))E7!r(U8u`F*HXCX^=!}Q3g|=B5s0Ka zJdwRv6ed?oAaI)JB)7)|$~swP*b}Z9yrQe}{Uk4O)yIPG8Jq6S;O71yhFyCAoq$|{ z9FO7~u9bZ5-M zpcAPgJC1AhxdIaYKhupA>5SdQ>tl4I~z@FS2~Y=!qGUcqIk ze3GxwzBA$U)Ud|DG}=ls&eN;UGf+p7hOJBzx9#HUVi0F>uvb(v^H-E=>0LwM{dz^Y zZ0BnPs|5G8Q%xUe5M|)S?Q;GOp%d#kI?*DHo~KUXupFmil>M;ktBf+dk(7UR-hN

&+lZh@U`xCDtmC*H49R|Vbpf0@C5@*%6N6wuG8ov4A?uknxL&IB)m_hEYx zP}NXl!_oVjioQ=-J2DAB9fvSlDP*qA_~IzEy$XaL>mem_YbG>YNI9dD(LYMj(Bvr? zF1%me5Grg;qBWkA{>!z#Q=*2hTSw$a$&aTs^;G2moR1TKQ0GK; z_rDrlZQl7=I+ga*$o4xRW3n1vkT?YieDH4HjST<5&Xbt81`zKZQsI7!(4Dh8Mb|*A zVhDnH|l#qSgf##?z!>m|YLYf=%}k$s#C z=bf5Rc72(l_K@`ONo^m#!1B8%tDpL`30FFKwOf-WJV}ic z8RcNVF4o7)lU8EaeUi*T39l65A*$&9h0*WQUdB!ZfVx@-bws1%+9=KBnwo~>CNJe` zA?!uylE#p*a*^S1$*69vB#GDB&{R^_oSzz%wI1mHGD0}!3}EFQsF(?pLAfH@Dnb)P zKb#1$KmkYKRltf6X}j`4lqT#Tj3h{O3Ehm#puEvY{#v{X)H!iy(1F4i*$YgqAGsEz zU`r{)Ryr}P$U!Lvo(=RyeYc0F6Ss z`cTSHGiMD45ZV&A%}h#WS9vh9A$VCx{P99i3dF}}Y(BW&$@sHVN*1ZC)GBVIX;+}WSg7lPPgVO@oAwj9v9I>mtphI%#w%- zJt-?w;hBh1%|)Q1=XK%IU}lDE*)6`@B_03)iPD`s3pc`1ZTY)D;>(jEH3)MJ+FOKLnoHk>Q{=o8%>>dgA;D-gzQZ8ufW=d#)>+i_Iej(^|N}MYC%Q4sZ@@ zJ9hnvMl(%1UshjV_g^pgzwJT!f47IM)@QDzzSZ_NJ1Oqr`((8SpM*GDMf2roIt`QA zr4lx`val+<6IG+qh|)M-+TEo?aV;E+M1BuD+ST-OA5I(o@dwu=I>vB4hhD`}SY&6o zc`slnbKK>fXPWD&NK58?B#asa9y$UU&Z6KPhY~Fi-$kctRxHwMN5P@3MC}ugY04t# zg>4qizq7lN&b)mN#C1Hf*!inY2_ltXHCoG(xv5B2Y*(Ar+>4ZE{-l&uGbjeKIVCOzC=b#MN1h(;vo)ywecRTi7 zdsQ3sjaJ;l%90il!6Q$Ch{zUkb%SsC<}JGz6W)1lS?=~=R0 z-R1u(s=81uEB|D?^xR~(ZgLvtMgQ%bY#+S*4OmJsU%bbVANO2L;Mvm9?`&Mj&69nO z2D*XqY6Td3y1G4uHRaB^5z)Fyudgn>!nOG z){l8U(-A7oOnB+{yN$x#DqxK@CBj<^9LxErtXjwLQ6Tosm!b5(VW*b4G}e1}IBVtu z&xr?}C)q`Ob{?vQg5M?H&474et)uK~l}vr;W?_wS+I>3TvX|=b`i(#0i>t4J(3`K*E-u#!TD`m{)Dnkwv{9&XJ>aRufqCyISlGU(p>>h~;t zRJv8wV_%a{Ndj5ymkOo2Mt(s}q!Uwvjmqjn?m`#Ds`eV?ZSVIFNX*Hrk)n0%s6CcR z5z>T*XJFU*ndxNF1VfPY#nkDkjZ|}Q&9BYB5}}X;rW!3j7n=95^{;at4og-OLdXSR zA((Hw4dELOb=>K2#oI5`W0<%8e?#3}UZ}}yhg>eB1H|O64KEf4xuAnm@b|wF@AF96 zy8bd0YTNb%o`7Ro6!>7!MNF#|-cQ6N4QybGY&VF>^D~+euoyVZ&ZrL%njY-(izZ2G zh^Fi@eS%an+mkpO(7k2V`K)g!rOqPTZiP$Rj2piCv$v~+ALdUWI2?6qEG;rPZK znuAMXh&3g&u4upuHHgs3ek#U~?K*%o8QWWl?G~Bn?}9LAjeig#+<1Sux*T$ng8IqL zTUk(F-pN1FXXtN}e(vM+K6JXSPu#3ON6MT_tXR_FW;idmB6);a{vF8}oTaCrwF=I7 zy{_n^O(vT8f^=5m_eM5zo@(C_LlSRjMy6$~k|Z$ODtzOSYAp&X1R+r87J6Ny}Y^Xjdb)+Nv~1Ph&kCFgiG{mgqjdL0A6 z(94)`32BaPTCnfmZ$fJ9m7YIz=v^n!`HQd$4^hx{G8&X*nVJoW`X}4&DhgV9(d*rR zv)V*Fia28TJ*r3JfxyC@_K)Uaz?}vkgGNxI4?}uRWfmPwYepg1LA^U2BE3_koj{ZP z(o$|J>QwZr-nu4c)=_90;ED%2!KkoWh zN{F(y`80ndd=$>OEK@tJ?BO^%KLSu;)`tXS_al^qexCLCOG?2$+d*xW42nZy`y{T1 zbXmjNM7N?0z6gnC8%Y=XRU52+N#Sb#_qZG4wHwPd*}MyG-~mP!f$i&6#pt~2@_@k; za+pFis-x<6IKeogwCq%Cd11k@Kt9r1v^>rx6{S1k#c+|*ty8Jq1D;Fb%B3x$ZCY|E zmh$M!OD@Iq>LaM?sTwc1@jG!D{j;az4wvyAu0UrQhe^}2_1?a;+u*KUpNjn%vceQ> z0b_1|xc~j`#AbhdMLYi@^Hsm#AuUG~{)N(Ao<4G%u#vXtu6<3L}LZJRabre3$|sG z_yuNG4P-WzA_rd)w60R%^3wowrRUKRtFF|Wj*2KbAo`>@-NJ)bZG~6c^x_A1k>@|~aQu?+^s9ZA&8BpwE*iwx$5;SVlvJi3-_X*&xy$N}H3}f<7 zMS|$<+z*bn)}t`t3Cshm7(*{S4f7kzhvRGzPB=VVgN&8XlOF-h(z5EG{Q)z$__Be% zLrFA~^WYYjTETVYQ3PG??c`^ZMsn#`YGyb=Wsd4f*zigbHTW7r6oGPP@sO!|BPb9= zzcy%)a*eQRQBq2#(6}E_C3^;fs}-I^$fRA?eQrDPDj0af*euLDN!4^s_?E@d>%$|y zCAA~rz`nQVLAxaEPH@ISJ`EQgel`bzV+iyqIrpO?@$kRCK1{$;eHKF| zjhM`uVdXsWkG?<;NdkTW%0bmXBS#)}(>hy4H3Cu_P+FTS`&S_z&CIhtK1p(^fzMD| zrucsnyJX5S)UJq)0Jn3+mKA+XDaHZ=SEFr#kZ?~X?<@@ z)^hm5^rT+680Gxgo~ORPvT3k8=d=RuOGS6x65+6-WUxtE^?yt*oi1L>z7rU^8 z`vejweTl~QoR(-|sY&>`NXroJwAHuY_t41FrYCg$_+gX=(ty^RB$sM~}^9Ltk^t%OMOK!)Ol((toyu5|sgYTeO#4C-U8!W_&A`ZdlJ@d19kL4;f<- zz(AnbU^F8_5+ZJ2{1|3_N1UL*5xkX`L`sSxQiORxR`TwW0IbrD#|7G8&W1Q8W2Um_ zDi&nCk43p?|1QhWH)h#87WBnh$fGcPRugF4e!O|%*l;$h%J*x9ZjW}H`kD~q+dL+7 zGKzbo*UA_GW{=Fh zX5IiJcZhboKqLu(3`F0rOW~6ET2CGb%j|&)z@fzoo?gn_q5G4dJ~1mBl6hOky#_WjSd z=wg#m0P-QoLU)3s0s|^>MrqBSB7m&0$%D_f7my%owdDf#b@$hqHFi#LE#46#U>-*0 zQB&Hq+;VQixPZZJsF>z&t08*{s!&`m(#^hFgA{%3sODP)p#?yyLKSUpva1X0>!JIl zgsFidgA`>K^IUu>u5q_Zw;LHlY87@Orfz!`VX z2p*hp9GGIbjK36?2Jsj}FkeLAy7`Nw#EQ}ghz|Fp_qg>CIv1I?U9=;0B7*<{mut_) zOJsyCV71qlhl$1iF4r*{7M6|EMRPQq-_OgH z&EI_z>E&^byxiIC$*NHT!#sMc*b<36(jXeU4DYB~Ty4yCpe$0SHeYH$DsNbH6z#Hj zE_ush(s-6^$d{$|FiZBPSmoC*rcCJj<_HL}+-9-qlDsoa7USj}O*WdtIQcr*@0ZtO zrvm+>ftv$4{$e9NQi}v%6zOl(Mg0Oxv@_c~(g0-5x%MCN@l&;2BK&1jE6-qkwroKB zgCab7q2yKEy0iOK)r(>a7Fp z9P>0cTH@eUV7s1R7#QB6 z>k|rT*)YB_AzDFYt{T1o`>k!H%zda<*lR$ZN3a-8Mer!HLF4e5rNfkcH;6EbR|Oe@ z3j(_TLN*dwoo~MAz9fwm1~aFUTOp|{4PiM3DtFWcAVpAGCA999{WKuR-%=N1t~^3` zg0#~c@WCWf7^0x7g7=4hB&d@c+%Bc&Dm}D>AbT2Ta93SJ!sA*U(CxNt87FZ_+nPd) z8<~?O%c`QsHAQxpkoIRT2D*0F6CCltrKZxxBaK`l9F&+cWDLsE(+H(z-Go)iJTh|- zl1_h|jpN85W7#ul4(X3;I+H%c1h$4(yMuz$3{KWCpoQ7FK;LTFUj?X(-`a5*oVhAk2XbsWhf8%fi4R(M_lThuEa9w=snVSHnTY6SNBIM_*8RxJY5T6O3R7pI7IQTdSTSZrN~g zEknFngh4rv9aB@rEvb?5fJEGJjNlOciy>5VO^cdsA?>B5L8<|fp=5LJ61mYt7)?FV(BG3r z9BTH$K;olwx^2&%Gm%==&YZ;0oQPdi{U?_Zl|8&nlsP2QOtl=4XF0tRD^|Cs{5z}e zc~+ka26|cP@u#P_ADtNJ4Ttz!M$}BTw_e+3h~!EZ!6HI;@Qi_FBPe3;M6Mqw5du1v z&W*NjjX=N;+R9VY9~1`J)Xs5|$EAZ=WXrsDjy>EUqYBN!xnRx$5jQIfauyw{2G!ys_n1qIBY-D$ z50#H9)o;}1JR)^A#8z4Z*<+E>kyYwlJ$$OgZ&5ir#cxN5_k$zpr{WL9W5zJsrR?xO2Hw|5t)_lX=P=W|A1&6k|C|Kd9LH- z-aC^hjzp7Kap<|KP?6zKlZo>`)fC!csc{xn7DWoJ?KBV;I^PnI;u0=a*-4+fskA~$ z*vf9iN_*kF?pPlpQZp88>NXmSW-~>)eLXk9Kn!haX%Gs|25f-L8ch=4f>pw zJpQ5e-3SGT5wlUmrFUrOJ$ia4I_8Yrz21Zz$ zFZbJtU&FubU@l;%TgLgc>uj9Yx~c$)Ij?W#Ny>DP0ySZC?QHEZtltQ?VhqkWSyO

uO-oHOkWl7Px<5kUNkf&}T7QzQL!EhfQgpG1&O);)HW z^4DHw_9PC%|Cruqd4<(18#`Xcr9I zo1NxN#~=jO)fqXigW|Nkch5{vG&4U1abW=pHjCrSr=>9Av#I@+V0{CsB@-D`3t3p9 zEDW4|LkH^bS$u`W#thOnn6dBX1rOMQcKj?aSXY7sy2n8;gF`2SLr=Go7C=&mQuTeZ?Y=? z*6Z?sdO6J$UJ*NF`-WHFV@w@ej`J)r%|6AINd9F8q}HbopOO;39YO+#bC1HUZ7Ik=!#L_%*O6npTNT)C4alkWY-l1yHS$|>8>?NPNJ zb^0etNwxtZHlfU6yOE6x2Npc&S=5kySg&kFcL+tms)~#lNz;8n3)bx ztq}1`_EDr*>O7gsu2<3-4|N)tp`ubTa`0#dDp?^>yL;_avQJS@Kn?U#A9vA_5NoPZv!Su07pIH8ew z7$ls46EH>%uqBnS+l-4`bG;CIGt_1V1LPaW?gN~A{9Nf2s@pqrAm4A$2!-{ z&G^`Z$Hdy-b_g6K3}A-~e`m-rQ$kq93!O4%Lz2Uw93)>uVi%lTFnJr95as)b-f7tu*XC4et$Y9S#m~M~30Zun*h2mr3&e z19Aj|$C8!#VGIxn3hY3d>l%vL6|>(>SH_4haju@Ouoli#R#hmYvhuEU54xg|(s2EF z1Y2MQP-HLLz+1ZS@rNm&ckW@Q)#Rbx_(TnvedP#sP~iD#U{x7ggyYKwU!1cTX)pOH zj?J4G+}(|4%Mdpufg%Uan}E|YZB+AwjACmkN!T+X)5%FGq@&%+R)kfiQm*r;R&vas zsl{=76_P-y6B>-+B(aDg@=5JVqLdRUuBj|!Xt#|tE4URfOeQ1LCBs|~`)A(felrYd z$-M;;Bxy?Zaz5C5PNx_lAe`2^y9CM;+^ZTkKheDHCM#@ z9qVH*@beDsOVSKW@E5VkO|e5W;=sa2r?cofHGjM0bUh6v1bYLV>- zOMl}ADpO7N$ci(njuWW99a|`L;!cj>2tDCn#=Ubc7@dt<5Z~!r`V&ZtrHJY9dc)S( zMf4vXF`1`)xAXd)5h9@T17-XjpC+0_&uloh^ZhB8Q|r+oBD9=;d&8g2SL!t)Hb>Oo zwMl6wc;4SCe|i(P(rJbCM`b-v(yWgIA7SG$9+`4NX8k~ zOMR+w8PZ|XwiCN_wxy`B%sevW_@fH5-GM6=Sgwv^YD7wO!X>$er;tui=GYG>{2t;% zI|{z2YHUMo1DJlt6@x~I0+4PF;hxEU#@L2eM}%9n7zjrhR>KlbN3*dW0_GD9#swl$ zNW5%)AUq}4uD^)IAtCb)Gz>K&I-A|gjPdydU>8>*CoTm_$0@>8?lR&Y7TUlK#uRp%$!g@&%R(L02 ztOUF3pF5u9?^Z}SdDiWP9g^sUg%)6fP|}V9`%b6$(@Z7T%q^n#6pKM^&x6ap$>t^a z@1Olbm^{v^SpKGjHL#1F5Y|T|3=OB%9OcWP29cqe`|CZWZ-3;>6*VMy1K(rE71hV5 zzT*gsg3oicpJKHnqyoQPNNf+H9&2|IT010a$8Er_2!j$_6e=+4lc?kzS{Z6u4$42- zHH;{tUn33OHz*71ji;Pg3usXGX}eGTx!?2rBOnM)R*UB_m4G4=2I%kbM-(q%QAHwh zw(6j<*^h?i1eF8FiS1RR1K$&e6sfMqkZL)qv0ox%WXtS=* zn|5jt+!PZ+XXJ7JLhu>ga9TCuETUJDM#0K1bG^zKoKS46^nekPQ;(pQra z!#*bN$*eZ7{>XNddmj%$o>zruUQ)c}q&m0*icxk%E!cJspUPJ|#O$Sh%?#@9?dBORn}lp)$8 zx()nZR?p3b!JGVs%ux3#R?NF94{_E8HoD3fc?~0s7 zKU+6sfF1p!lSUm939vMK&iuA+ucJBr*R}8GutkKxnt1QZkDb* z`Ml-o7UGxUkT=~$5yGO4M#(tBBu)gu?=@1XN01l-pj#kchW=cFVvgtMOcmeW!z(K< zZG1>)rru?rSW%Yz*lNVXyol?dU64KmD8{c3M6?Xq-vP)F!3~D8i)K~niyo)LMh_KQ z`0wWRI<*jC{NY5WOjT|3gi9uBc~2J28nwpLX;fOGJ)sf-nAyK1bORLN+d&}>{tUY# zQ}lD>LW>Vm24s_S>75Osl4hI~DR1zH^PT|(+-TN)J|A)Y54n3vmkS+wCuU@hU;XWB z_~RTeKLlLJb)JD=^Vle5m3gj~(&@tui_p5T*F6GXy!oT_(;_=lv6jSJ1%YZxnS9Yg zY5bRl&dA{}bu0OU@zpAH@Dh=XMdQZ=ivA*{?8h+%jj2GQ@z^*D`ihIfYglis_)81c zje5+JJMi{wov}(SzGu4C+C=MUJ&(zJ^udb2qFxJtoiPNR;4S2zW^C-mIS=ah{@ga% z8sbsB2t`TZJWyg@g*#;y>Rw3!cPG&)^RAsJ{TZC?jAC!GqOJPX?Y1q%Ek5iTZekfH z3@1LG7+|O^LyuQURV{8r(*$1O9b>C(x%0@3Z{ngbh&CG{oT%)_61LOTNNB-d-XwhO zE3Z*W0QsT&?F#sLyRCA zQEq^kQBC12%!}a~7{t3k#Elm<5m%J3(KEt?&d%i7oI(nLnCB&^vPu8*Pwg;Ct^4|}eU5tB|WleizQATH6z z=c0&|Z^)Rh&^4UMKZJVqmBlw%;Y0ig+ji#?)^WS}Y(JtwGyD!eG=Q-5`ZL9Nc}_B$ z45}H5jE37&#v{taW)@tK7Lfhvuj_-VA@^)<>zSnK?P{hTCER&mzbC2ZS zj{KS0mHoeIzF5WtT4U~kM}!$N3JKF8v&;Dw$59hLY;$7xFUNP0X7**4OXe-3-?`80 zB|lNmFC-2a9_h;Xw`4k9rGH`iXLW~$dFeEgWoQQ*Uv-|ISYln>?HT5SrYnxKu2SW^ zJlRZD8I5|*=*UCste(Z>+?GlwSIY@-d$+v6<+)pUfh}EYxPAuGM4|jeEZcX9o+H(B zdjF(X)?(q}&pp#mK1Bz3X12J>^Kl7wrs#g_dEV1D?Gp(6;8fUeV^LC-I)nbY-6-MU zHHVwRN)#1bkk~TQ=0((ysbK0pXhxe^U7WDE7HyLdyw9>Og}JAv02hYgQSTf%*#9fY z^-)E*3YpZ)dSt(+MRU&zMxKQ3q~u;F`D24x6s}^$g4>O1g%m4CCDUNS;qR7muo z23HWEGT+e&-HBe%@?Xi3#0qId^rk^85cUy0^ksrXT`4@X9qk7rDEA1eaPX+sLln4! zjM6$uK4tvMlu`hF;6|E4%)bU@5cs)~tY zmbyK2+<;P3?4q{AtHpVE!$=bSsIGZNR56RZ5y2jc%oWh~Cn7MAc?oV48#kdU3fTs)y5dHoaYwr{! zN)T@8wr$(CZQHhO+qP}nyKURpZQFMD-RI6c%tV}f?o7mqsLGdmsI16($o$v8))z)> z6SiexVL0pVuJ2U876{70j!37E3$|I=6jdp=?v}BR_%P6ba|DP|14Z6BRA6+fk(g9@ zu@;xt;GisXp=)j+(_44j)at5jl*jGm5I=BvBsys0Uavp6=DiPahZ%b941`*YA}tVc z8ww4@r}5>sYzn|Au8)?Kc?Emj)Udk~)V{n{!FU>yJ=Ps%iOb5H8t7T4BZoG^g{XDV?Y?Hewca(e{tJo$fEm6X_@62& z|0(g8<-d{m`(G<6{~7W3f9Ape$ISla!T(EySF(38bTK7hpjUQray52QFmy7tb8#kM zWMcX+)s_D<)Gq@weUEnD-JQ^+V`YzwEsO#g_>vemT`~AGHj7+RoW>x9?aq{sh((Bc# zDW_Jgd`C~PWXduB=~R9@jMgHX%FL3Pv3s@7tMufOH4D{ZrMDAPKa@cIStvR83GoEYTY&%5B;Y=e4C(^k7H50}L@bu)F-4$Z&4*I41n0JZ);_(73TIymPTdt$Z?RrkAmS~U2WlSU1>(N+k0bYNGO%9jtUV{`E4N|*d$D0(9dR-2 z>jU7w=h@_-o%r6e_y;F@cHJhfigtT#H;A?472D>4esfqZ ziexHnk}lO*LV0B?N!VgS|HeR+aK4sx#&14qXWrT^B#0pRGvq}O=jtcwCD}FB?%W*Z zKo=oGt9dg^Nz~spqDJ@Zj{J4EwK%)ss&+M0FiL2g zk=h7jDLe#3VzJEy-8DwI{b+K>wzEk<#`MbB0SGLcDr?ukJ9*IdW|z|hsEbM0 z@e=B_5}(pEI5^Uz`M#i#{b{9mLDQkt9(&(GIj|1I?=@B}6G`jUGLUSLl_rep?^v&)f)=$}D7N8Z22qe1oFe{%`fmh6z=NH8K^aJT7sOwYY$ zIQQCd4m@XTYQt|0J|R4xb|dhCvy^w7(MbuFq(8rWs- z*3el4y{EC?X+l}@6xOkQEpk}=rLZHAj7~Hv!bfmv`1*~&qdoQ-^tRNyuP}jJf0T30B{S)WTJ3yw*ZwLgC1P7a#v8_EeCB~DF-v;)`nvjyB9R1yh*tbY z&N1jOxu!0KG`$t=XjZdM4cEPH%O`-c*QHzo?8+GG%FN4)~`1#Kd~tI zCi5C3rVxTQP{dM+&~5GUxyqNZiZ&X{ok=d(WbpewVU2`cRhk6BjzD@V zcb2m=qO11)jy^d4HPr|)UJe3h{xm>6p(oV`W;_}=Mg+KVh{6|s{;Nz=Z4qq$?(r_b z34gZ%mKbeW!H{LmAix8Y*Q$Vn^d>ui$)P1+ zI82COZldmR+4kVE5*_k$)_mbTdttKdZ%8vk2~XRWSxFgfV=})?iWyr2`rUD^;qc%- zIcv1K`Qh@0zpdJg+m4SX?B+85svz>S{`Gel%L-#{PFBy&Ro{M%cU3?-44bnD6rC&h zoz!QMBr>LtS)HRXNN%r+czQWhtuMUU!9udL`rByCng!lQPth~=mxJVJ&w%!M$L=zt zoo1mpK1~kVi`1jL-7nX{9?Nl=QG2{DST3LdBP|->(7dv`c)G<7b_@Woqo-6~-SPtE z$SDqNk^S0B{kc7P{eGHs=NlG#yMW?(ZiEcljpR59=n)E0Qd*ud} zHa(T_TYlU-M<)H$X}>ap$BQ7DHi;&h+mm$wjH@O+riYfHeCjcBH2~w(-|oYOGr}v? z-7kS8$kKbb?wI40HNFT_CA2Lp&B6SHxPjcSeO_OI-MAu*vPY9N-p!@S)1Zhk+wDx2 zPJ-UxaF37;NKIhfKD9Q4hBG z@^EGh5C0lS0>!$0sRk>&eW2CcnJ(In5Rhm6%Ol@l;UT6WQ;j&8dgnHsnG|q=~E4kwId#hH~_bC_UbkCy2Xx0&x|-w z?Q((DjHpS;S+ms+YVG`JI1Oe5ZjK~NTB`|}k*h5O9#j0Di&Z62X^XjTEIx?GPD6Ao zy_ObnA7nnmVgAt=9~^_I{59>led}o8i*u|o@y3}blC}7wbTZgc=vdM+7v$LvT346g zh#HAUvY|5dEGeL;CHsv^&VLDNtNk;1gpAl!yW;AH@fMn9+Hn8ya|{bww{FWFO%7q> z-Dt%pw5sV;^5PUV!i^Ev3Z-W@^l0qEP#UF9JC`WeW-fSwI)fVz#dqezKPZ|F3zBts z!n4YL-#Im-14|DF*m%Oo$SzeGML51t;D$^`6&-G(fPy?e@^2Yzpm((u-i%Hxt0c6{ zzwJ9IB&WP1&?Qg1gz&&>5XdR5FcCA7Hw-|{FFjvP?St&Z*mZmfr7Cl@4PJGiq^1y& z%gdTmrPW~I*Kn2!KOgWSiI;C*euP{#R)&~!z*@%HkN`tN{ID#yC2Kl6|dDlbP4+w6sMwy_Y z1?pZ-qEubBS*J##5fYCN7P|!@zAXtPuiI*Y)ETJa7 zUnX(HokgQ1kMh0mZr&ESppfrC2S#P(CgYvE)60AVPz5%KaG2M91Cjv8rQ%0?zKPS0 z4`f1K_6>oKXF1l`sjkd828YG#5|nL4df*(*U|_6Ef)8BT;>&>Nmb2ABEy5a>hQneD zA6bUSWk1k79_sC5_ht-tjb)$c!nC7~)`uypb0J_KB|FW_qm>AKSK|%Sxk{*t zu_y6FxPD()a1Mm2t^SS+O;UMgTt`p42JfUjolku^;-2=WYfSAAC0lwvv^0Of#N6R> z?>9k0K-D(0bu`%OIM7AVUVZ-jCMskdI8RDb_+;)5*S4o5|NiK+}h%rU92|as{PhTmpYRG9CbdQ=Z1&8+PWYx|4mN861 z2f@!Rl^;J}W2yDi=iJ$Y&~&x;%`BLE^VJwMCS<@Mk$jZHc(q-l@X|yr#C4LSmJ-SJ zFgafw!+N=fl)sQ^rd*56iO`WkWL$xVQ@|rZ_b88k&gsgE zFR$A%nYkMv@kqHm4-mAjW@g@P-mooPGP_=;5pyM!*PayN*C30ZNQ+)lBdMYW_K*rP zVz~jxY_TkM55YZ{!uVu~l!eT8MIU#K0``|o>*UqMOv667>-z?NOIkAU$1$q?PvjY~ zs+Ww{-`&c5^IVPPW9LquWvxWUs%t``X2;^*a+v3_9{KzLsBe@HBkY!r!Kwp>;o|Vs z$ar9dr5!%G<|Fp3nt9t{5_=vjd`L##g5h~iC-zUNZxIv6Jpc&!d<_4?;dubUnb8Oj z7u5i&z3pJBx1)dgjCl`ONig)ArPuSuFQ4e8CkUUiz+0J-i8s3j=B;KDp)#rsYm{hH ziNVyRs0dEL;j`I&ni$2 zRXjDZM4RND?b#&3mb715h5q66+h*0>QFkMp86Fm?fFr$p$0XDNKan2 zH<73Y{CNpP2nPV82#64+5qe6>FnHOa(hd30<@9jt89hd**5>j85G2|&8I0ClbDqQL zs=2jU7%uIg%^>`HUXh6J6Yk(cPpm(z8fCw>`WI>Z;}p;xLU>4qTVfkJNH<_Fjv!mU z%WaHnv$1gKwYw64pNO`_M)HaWDE%>k4Y~q@JG!N#F-5D3vKqa}qloK#JOOb=+KmGz zzZ`|5FZ#RT#<}40^!{EYnWFc;qW!$CPHRqy^nk@fbV_`AnM8{r$e13#`q4!Y>JqLW zT@qd<8dyfM55I&x5>@`a_y@KWy!ht{fld7+Sqe(&uCBOBi`kdZ&j(N7u5NB#zV|Om zwaeA&r|B>2GqQCu*xk}x#SXcG*qMXru`jvz#E%0*fe8NaoUfIhZ=<2cZmWK$4Y=yA z_c&E359qIC<5`Bt{Ysm8=5Rj_7@Q+ZzA&YNRrS&=Ajzl*qB^)3_pUI}R1B^WCg9rB zF<8}I@1L}~NJ3HG*TY%}03cOW=@Kyz_x5PZN}e__y!r&Zd9st;%KpJndxs_kL%9-d zyu9IuVI{WAIg4ZV=eN6ZdaW-|{7k=;y5?JC*XdS5+2^Vg0*ofnutvx?N}y&as*BXA zT1fgv>#$UKx@ZWMVgeVn?4AkWE(xNZ6e;b48cCYfhTbbky`f;8W7r zrCQZ2bgE0As(yT`T+csR$Fq@W_>7{{CDhD0>IBQi3BJv8f@>Xrj> zu=^Zhs5XEgG@7m*i1TFH0+r)Yo1g@n5RC$3Ui$|iU?IX|1}UlQ2VM)C5}>_ELSc3Sk?F49vH+bytv82hfD?@@@Zo{?Wdaj(27T^3cLm(MeY z*I1s63YKw2awEA%c!J|ZabiB?dx<`hs~9Qf_5HK$@Qb-7=g}xIh@x!}^ft|jr!%B* z;#4>=R3`(peT%%GVkPuH2Dmk#F&%;{M}2Kti|#3KbavQ`w#@x#U#8 z_R^E>H-;2Vc6J9gJ0<(pwC0LB=RhO(zC*=#z7Yqf`OdnmA-jp?sm}n!W#rCv^;E5| z*Wu3ct+QQ}E(iE|%twx*Rbv9cOI_oko?^>uA9p5BPYHF1`Ku{>Yp&LZRjhgC*ErUm zh$;Tp210Cv=rX8NQ>N1-Ls~@@nGuvl9a3bKiWF3Ije|(0f-Wo1J3y?%+mIXo1*EHG zohpuyYX%aQ!WDi7kHisYT4dihj%%n+ospUA5&-1kxn3|V2cShrD@CQ?yxW%kCK7fJ z#jSnU7t9k|8m3>$+;oixJb+WZ_@ILO*?PgkDM@PRCsTJk`64srEi<4lls1}Zg9@Fz zvM-Lo0Pp%&=sT?bk?G;O_pt7O1VvhsL3&g5JBP#~!`s9VufunDu#mE&sc#HD>yk|S z+$`;@DRTC3wEwd+73C^bS{2ijMZO93S=}N{Px+?~M6}x`Ph!cTnm=W%OuMSvbK#h3 zaFTh^4C8~s%(&oP_8V{XRn2tObpa+6HVe!8Px-fIp6zMwOv3~u>#m@OnN!2$L*2*j zN&x-&Zc(R0Xd~_2Y-9OXT(S|k!Sy7Vgv1li3m`L4bgdHNXFxw?YM`>xzM>t_Cp`Vm zf!q@u&e#>*S&pSms%tgTbk&Th@ov{s>toH1EP3rpr+>Z$^!LE;D}#9)Q}w3#1Uo?C zCB~hPJA(M@n8R-qOK)4`iiW~pz8S2Us38Cgp@%&z0x`?-4#8jQi9`cq*vrW>r+8zH zkucaICpfwsvoOT*rzmzhg!D6y22vj`?}D-UBO?Kfcr9YRMnQN*%`_WV13(`T7b>hN zdHnGybQyfZJCnfM4h6di#KDFj0ec%`cU& z-X+FXX*p0gif0?}&#p+*mBq@gEOWy)6L?-QOz5w`J)K|9XJlQ{EaYloMrim2)q7Ev zdK%Ymmoko23dgmXo>&n2QtkGzEuu4~(7I*j_2^IiIj)VrQSm&i^SN0$r&CoLG*Nnl zj$HY!M}C!X6vCWcUM!34uwh*ll$G2*JK+`N1{O^zWw5+;e~+oAa_sBqm!p^Pm)F%f2S2Kaq$@#TI9eeYtS*Kz939SXf%mk*9?2L>P9tz=@fSvVCs`4Wb+e%5NUrxQGR zfXHn=<5Ru_c^UN_BHe*A!-ryo+}>D)rXbakxq-}>Bz*XdE;lV@UBWYCXM^I+Cg~f; zzqszK<8k@+Df;Y9!a#^00;8wTz_IlM=P5>qh!0WQb|m;#83g3z15srI7ZcmM$NDLA zfSx1kBmO48Ac`vQc64Dt9AQ})EzJ@63D1uM&9{SVKT+D16%h|N0RlYv&&@0GroDu0 z$hTDXO$(r>3kA>xIQ6a2@mgybpVJaf*tcE^yV9L?NN1|xp%Eq6H6QfxQIQM<2Qpz` z)vuA;<+I8_+7gTykRy{49L(hzCaK)fJqUev{5!9LHgEMjJ}tF#BF!1%uF`}+qJyo+ zWaTxqVaI_Y{yXoQSS1kbBzy4rq3HEN*c^XDPAdZ7OyFmo8EXism?)g*4oQxL5}@OB zRAMGtW-ZfpW<*ApL>M|+8UW6*iZ%d&i}o&?F(k5%>|#juTEuv zw(3hydDRux&aalVcQ!_8t7rR^zNIq-oPn$^CWFk1-IC|m=B|WP(q}&!(ILLXv0T2<(S|A){6!l-vOX8|8 zfD+7ph=c|4Tun_)vufn!_#@To<>-%(p%@Ws^>b*>j!vCgup&fi?Bw5qJQzntf6$)p zbY%|DCH~pE!yTzcCkXH+`Qyur+%do1pQk1SZdJM#IWT3GjXf7H#jAgF zD;|-aJLKhek5M(*%2>@K^+LWSbK=HwKaYjmKc($apO-k$dkj-XjTgKzpPM<5dG9H) zs@9s@p1xzh^n25%l6ml=cI;2OB9cTr?*%=Rqwwg_%}*1581j46>yP57d#&6IZ@ALU zVVBE5ap}zR-}aNx^TGEe%kC+%`Ec`7c&5v*_OF~8O&))0{g4l1dA^XyrbnWteO}2f z;!`}Q*2SM$n0l$Ij}BC>$=2vXy>oONIufX#$h{g-Ha`5a#)5r_J|uHs#!OJfFKD-= z!|4!loWb=8Pnh|9CiV|%@hxT+H7K?RHbDKoZ%-2!xz(|4I1+R}XdW8^)=)tC?xN}& z$Y#;hePG3tk)SkY9JUsTq;3^BrNkyZI=_gI17ou5zXZN7{L!3SPq%F*q-EbwX~+P^ zMSwv%G{$vkiW?`4ifG@Td9sF)-+xa5ydQWX+t|^o?r1Sd;Qr$((Q(GK!#Q<1q*v6} zn_nLBErCJop*63o7&#s1@m0o?@{R)!CTdHNC5=Cn;mgqSD2#Qs$BPrw0Y>MzQroF1 zQdv&zRWjS7n@oWO%`PzDRfC_Y`zVA(m43IaV7p9x&YC{GBdh2W*<3M%(WFsk$!t(H zSM;w^k{CmCu^R}JL}G%D;%@p7q_5zx`trsGu{d%N5!VUh)E4mEgKiU@iFYOBt6(6B zm>ba74&OU#)0LA=0#hbA;7<(0Fw#F9tnz`8n>N`bknT!MXL{fQ+Me_2&8$vJK-^*i z7_U|W7T(tX6-GV(%Taato?8ao(Ymkhom#aFqQ{To0yFu+yBdXQTEEjj#@*b*)aWC4 z4$bDR&70z8liM8IEI~gMPW{tQkQExs7Ed00?|eU#7fo-guF9K}h2hUKajZnFT)iPe zt;mVC7XNW9&BiQHUo##en$Dz(n zK$L4fyC`=`&wi`ihBOS*Knm51%!B@ilb&yz_$4}#wvX3P9d<9EtR)hsK(RKvTx^8Vc%cY z#ZhOdZ7>|`Ib^$^cNk% z*2eu4dz-0ok_I0u*F~0&6)a2tS^p*fU#Gybrm7RoSCJL4_+OUv1F-r1^sYOksy%!Z zXF3b(A+$u{XZCSTROf(FmK875DQat8BupTUguRXHhLW;z1iQHIQX$u9fFIlmrjC|% zFEVN2*+m6uWD5>ZjM~Fnti?BL(S0uUi__KvuK^$=(O5ADXV7|c_SSjqYE%ZV)3->Ys!{U@Gadx4OA=V;00rIM) z^0EczTW7%Q7A{#}CZ2VU$BSMD*cyT_N4Mz9JsfT4=}{rnperX%ShC7XPNP=(t17fq zkQsey{IL935ruAu=2AnOhX%6lUc1RnD^{jVw~zzGEnqdqp%6Kw&=_XtDWvSH?p9Ku zZj9)-1YXt&{uP^;D{BeKyULN#PSV4mkA9hsbuCH9Zg?m{{Lvxvqd%*szRlxBf|AG` z%Xv%@3I@$UBJsJTKM5(!Y7>o6G9(>=kUHP$qcOe(vpGJJI0g({mA=z&}=j10|ptH z)Gq68jJ@3IBC>3a&IQ&PHsccKLN#z5Xi8nIe|Cx2%g~_Al*C_@f)F5GibuIWEGo&i z_9=iFP_gG*mesC9r`1vyNH8y2Dl9n`EC&8LdQDre1d2M4VoCp5p=%f)t-N0V6!sfR zi)}o}_GN@zAiWXOIosA*Y?>?c9iOqmN$CsOUY>(I4-*cOnFf;$%n>)ljc{Q-_acz2 z0}GzGYo@e6)xHS9tiWmlnjpHYqP?-|FdPud1+Elx7HQs%;Ge_cVT{{2|5$h_b0TGH z;regxwmEs>hEQG+38+{v0{HSFcDJzr(nSQD3H~%o=E#ci3%`R}p%8^@v(L3wGN-%2 zii^ceRF75Ck9yFu;BN)tTH(z!b~p_K z0o`j+)r1-g#@}3&P_{jlt=JOND&~(L@6|hgm5Af*^hK?5qIebG{c9X6xSXa1Uj0#W z*ibb?MK5T%8AqsfW@lNDYpWu_SpzcJ0bD@BqmZd-j2;JIgny?9d@O5dNg>?|iC<4G zkFLP~@;BZHI7Ly@Gn8l@;bR-j1D!2AiqKTMvoLCfpPPH14Pk=CIK+~<-hK883Vb`# z=E4bDlPFc2>B)@fy8-o6A4Lv z>R$a|q__y{xV=?rgj60M$djt-16zQ0)@HyJ^uaeVcru2N9mf~68TI%)#hoFD`6 zNy`sip^JoJvliJhK^+|&yovQM{&lc1Wtt?t1uGn{!+*F3M)d^}3@l00T|(E_coQyL0&fgjXt9(R?QQ2wlPLv<7D1wg&s7AX=R%sh zqD5%wuV18kAc89kGt80kv_P=3@Ni~C|6jM-QU9^kzSy>6MM#pe<2r?Mj;raS$;XoM zi(+|tS>CF8rqy&69_TR5s2PEo4yHFOsi3`!Y2eo`-283#-#M;^U|Ge zyWHDMKx(2l0tEub?89kxZG^isrRViPw(>6ZA!MercIRa=y$pKK=^N130X{~+{wnxD znk)u^>MDcXiL|mu!oCu2jZ}IllVQm>Z1$4OmQ5>Xe@c!uHxf|U8^ySOv_N^kk*)gyIzHl58^^9i+rPgj$vPkhH!Og;qu zJoO?@!bQtukthk60|t*jNJQcW-V~Vu?3m?R8ZG`494^UuN;dkgM~Q;5y{)k&P_~?e z2+*hr5f>qM37zTGd~S`( z3eipZ{p6qhBUY-!-S~J{QoW9V6zxB38u2jJ^hr!Ni@^1f($(e1c0i@4W3k3wow;5cUfb@45*5W=jpKf5rpX#uN zI>B*?vn#oD^K`-iJxJ1-QMU5F&qqdhM_C_MiIOB`6h}2jGCa_(mZpTRf^Y{2%Lv<; z>hu-?e?JNejC+nKrXPpSFPs| zcV0`2sCyMXLR%Jfk*(k4lM^wVaFDeylc*ife3V8~0Wh*fLViG{gnN}Vi*o@W;TB&# zy`e`Lg!9$CD|H}lpUrovK=bxZsY~F;6EV^4!)ESIb5u52in8Jfca*!r0AZ$Et7JZ{ zBPvQZ$~^H6G)eEF68DWqLj&#`@-{l3Ww@3V|>UAydPA`%%O( zMhGNS#V$n<7$liB%;kM1bQ0}_!KpeKJ!aDlU1BbDRstBp5|px0)R};qiLuIo>2EhhCNCn8n~(KC)zR$FMh*5*&)%=w8ZKs=M%(?&!$iT=E0~?GPl894?7wLBu3B3 zMa3-KlQk21PJ8LoV;G=Kq+<=Iel1v81t2xrNc~Wr)!*v2V#>DO-myGTzCF9wt7^Ba z=Q^_r_0~(Q;#Vba=b3Vfe^X?8`{4R$er8AC1d*H3^2L=_k>#VV4k#mnF~qz(T=r`I z4hjVF00)j+5la`oSw$+j8mgAnR`^Gq}ql-w^-5vqu= zuVS%ktZ{Hq9m(+GK=viHjWn&u0{yJnaqtNWx}Ql##B~h|ODSlcZZ!yv94iM2HUz2Ey<@mhP`a=WY>VrHjc1B* zb&hG-u7P-1VR8BR2xrrDntjF*AukXgd34@C+^aSFZgmt2AX&2rM|Ex+(t=>hB3Au4 zS#jJ^2?~KH7*xAEsn>6u;)Z2Xt59}@r`{!^Yh1W^!8I*MEXczW{|Kg7Cq4=6BkGRD z==0adOC(Y}nF?37s<}Awq$KWrOZ~?&9&{0r)QQv>wu>w<4xZiq$M62>dSBZ6mG*N- zPxE+YvOWD>dvUk?lU+L)6dU<7R`Ich?f2R(Q!(b6%==>3=RI5h@)LW8L39A2dGZEz zoQ6`GPd9b0a(!*m4YNoNKND4BcPXe^=P=V{Q85ZG2LJqn$ymcuBpLo5=Ml}eD7YF z&e;;WU9BV*7$fR8aHH%?eVGxvtF~RVI5j^V6uTiGV6Ag@?FBMwe0n>ZJllt#KMp8Q z(Dw`V?XS%rf@!PtueVu#>%mkiCaC1Kq#k^uL>pk?G&a&iQZDrI$4|u{8Yu zeEL6H+zFT%+5YQd^nV8^m5JrQEJpvw1pW_-(Mcfr^B21rDx*Z|c?BoO(3&z62ZO#>*ksD6qdWJv4F<@0?%e62^vUwq!` ze|=q)uUS?8b1ENSs$Z-}KR%XHEx#W(k1*-eS-bWsz7#5*x?APeV>i2;zP8^)_(D7v#eh2$LUqHjc%lJJ{(aw_iktWu14FhAE@NwX#d!|p_O}@uF=X} z&&F!s9V?+Vfml9+Dij-*cf z<^Gs|NRM6xXr5o4+5S;nni>ToZs=|T8#YUmO|2(p&P}!VYegkdRdrAuVb=gpr{g0m zvyD_-yvQ`FmVL^8&T{kRdtVV)INDGBeNW-s>X}JnD~$5Os=2UbXsPAH z4#@PfcqpRbY@dT%LHqf`9arpQyKg&(eT8KnaB#sng=P&+fAy2f=Tii4?$jYXXjy07 znT+^_P~l>l10z(9PjLyN{J|2H)7Vmh!_ljhsidi&Gy%-L!9AX$F;De6II`JuI%ton z{Z-Wbuj$Q;ELd9{ESJ06Ns{xK9KGpwr^iR?2=Oj0mIr6-GV@xsUpiNR?{U=f(Jaq1 zez4^o{>Unet!MJ`;7QVx*~5OdObH3kgT@^1rkuL({BgpDKnG(7H^ue6?-SCOPb z{Nc_b@m%-r>o5eCrXkInS3~;x1l%%VN7e zjc<=?-SeV%+k)4OtNGwTaS%NlUY(#Xm$bz;3sp;$r{C)I9J7ax%2c<->STzoYAp}3 z-;;)P)9N$(bkMe%?ifLl z*sY5Fn=h-bO-kC+d(v;auLWC|p)g|6*l%w4ZVQjd33FtKdf0Bz7bDvN-DT>?r5usb zqP5Xs=gH4rW$px9=>jkj@S74SYq78ZBbawCP8@JEN%%KJl`05Y0Ni3rh3T%bb)^^^ zOVkanTO#L<;gSG=N@6xc41sjjp>cY{a6PLZy$a*S60Rp?^PI9y0=$Bq{>>F!VPE*t zdCJy?AtwKS;hqE55#gT!GrPH5ztt0H;KufJGVP4^Sxhwv>-!S*YB4j|H@g2|qFaru z-k?LR#q>90IyT;M<7k#d8{9Yv!4;oYqtKjuLB?^(Kd^lF(t+gTykXQN02NQ{X4|la zadR>us+Th(y$##d!kfvpn-Z{hnMde65ULfaZn{pG+8y?if>aWGt^=mc#hr8yuE$iZ zRlWyj%fSgvZMdO>YY(hZ%7DZ1Z)x+qoqtP2UKt#<5`Zo*$C3Q_Z`_cw7WFT0&)w_j zrX)(Lar@Wo6`7s3Nr_*P)Y1)2@q?D?jU)ZAFWO}PLO8!bg=EA)g@C5T;9{*g2QkBl z*cMOL8|5(ZEu+QZh5c{|QsnOzDRq^coI-6oikk9J3<t@|R))1Bk*8=yvXR4~-cD)1r&q&1=zS+5X?x?~uBm;6#d zGFCtaI-wM&Bkv_1+V+t)z-3#E-%U7O^pXT?L^+tU50qj=DxC7`SrYvkv2gpQXZDQl#6uh2?pNCSk zCGpkKpvx>k@+akFEVpu~8j`eW|4Z%2`sb%&FQd@rL4wOYYT&ay)^}2f<|#)aK_d(F zGYVmqEb+8wFE6ig4N#Fn<{US2+n!DI{8YgAe$0ApO!GG8B^lhO=fAiV?D=42J zC8xM^)>T0LLo`9+2RvGV41I76I3CWBt^87ERipeuY?*S^O0#> z!~>HqYTsJ{-2=@vEahRAjY>TiiL%#iTo)mffC7o%b*tH^3yyfiusF~7@Wh*0!j^yf z?8)*dZmX>mlMP+Y!kdsBjn*-oWXLWUve{S*@Xk|mtb6;Ln~2`e(Z-;Q%n8T5MU zoFP>zD8Gf6aGQmqC`dp|NrKA=8daPvhjOUltUp1~iNBmBoH2E-9mdQV=~XJjNNuJ6 zxI)_ixn7##job(zp`UlSZCh;*HO5NO5a~8OP!XZCVu4sA-ngHPI7-*3D>KC-nZ=c4 z4Y@ezNMs~l`~bV;E5jm2gGHQ5r!GY;gr|49LZw20lS%)}muDdeag+~<5bHh-<#Ayf zUlFUz54%7dAe5)E=Wjoq(Vzr0C+e13aJ{)`%9Og6byXLvXxkZ6!t$9t3$rK%M#NEd zcO&SCGtDr|b65gqr{s5coQioQ102DtzmqT;+vrlLju_V-B}#uhBr1-5-hlV=PzXnU%t`H{yOpEaT6KJMTdo`~J?Iu{catXQO2Z_;{USx_NDL~N z8a?WZUdb2`n!Hnp;%cX)qwoD^Tk}gTS_U2 zODRC;E2tx#1O4c?`gAQKAxH%<9?m-v`>fY{-_kGfAYF094>9C_a~I};FIDT;FMiwvyyuPALc5Hal*}iD5zkn*FofL zl|Ub;WHI=iG`fb7mCnudu>eL))xs$V5gK6Z$roA$tl1OiT{|lL1|kf`A%WF1D+aHQ zJlbmv1=N0S7kgkWKFnH(mzPh@GIX)>znk>)ZZR8_(YotgktQ^)TrsEP6N|2v!);E$|36?EwjL?cX z;YLERnDQpCmb&kNnKDQk%ak0;C-OQ`lNed=gp4512p_N&w&4JsGqs%(=3((+*d__k4$n}wO<<(IgRU&5vw5&vs=<&G zxf&rUs9lq^;x@QCS1sWdVA#U;ZUK}8G%0#HP%tsefv<5U)J2I+4z7W+HCcc%(STZJ z4reo<14$7Oh7|a07ckgh>0gu*%GLNvf1|pLJ%AXz{XzXkX_U~r#qkz}fQ%s)1&Sn* z(@RR%l=oiipS6idC-C$AsQ9SrG`9g3JQ&$AZjGt&NP*p!GNE?12NrwDg)#C)0~|mIF0wgx^U2O=&fao2^rcuGM;ICg zm?uK&)H@#*Z6WEE+AR$I9RAvKBMPG+wa+aokx)EHWS$hxUqAke)M17SRbRfoT6Gl;%uza-c9i334!}a`o||09pKiI7y{8J%uSUs`ruHQBPE?L*LzcoKf19UrzV?~)@L%;Q}RUW45!uImt2N^wcz z?nEKAH07tEJI2(>zQO@-h=d1q0#!NeZ2k+!B0;|1uie$QoZj z-2qt{2GVH-o82)N0H$kIGEoE&3z;;I95N!#`4+}1$3hZGW^Pq0UKb2SCA9HLzbX(i zts3l}!c8^_L!^W+BsdW+d@>)Sr$JEGw`qj)0y)4%jx0zeGjdiSt_5?f19JDhd#7(;l;AGBve1MQXJOq zElHfnmfY8Oc^ZJltt__bEuCX*v^xuCm#lC)Zto1$8MEhu;ETo|+TLO`zt5PUom&5r z_W5-WnkIxTQ*>K|=+}@a1~~G!C!sckB#p~(5jVPtIB-i_uu-OG{l}fz?jI>^L2Aa{ z%X18sO=KnslK``3{^!?Ou4Wo|zXu3hx6b+8v1cY(U8>S^exDI>TGS{%dGs;DZfNd| z&Lx%vyOW}-Y9HGt{ETAj-w8K!3BBa8!2lt$Y*2xk!tL_WPkYZ9HRYv^KK5nF^T&&o zW-m+&9I3^9vyQDo7?rfWv00GW9U+JJGzXHcL(}%?>-)w7+4>n49WK1e9&e z1o9_y-&H%se<(XCzfZJVLAW?UB7BdEQ#*UQ4hQaw5Y8p)t!}7)VmJuH3A1?t$#S4f zCjRmncM+QWrAFDRfkIVj9l#=1i*dCGJHeMzcW&x)y!TC}X)Lt2*j#-#>HlHv9fC9o z*fs64t+#C3wryKo=(1g1wr$(CyKLLG&FM4$=KK-goS4N#}bVr5CM!s;?nIYf2wN;mVFbxoxu8ovF z&_R@sfe#$;;O{gN-<;3xxNH@3fYUO$4}j$29rGn(Xo7anh?ib^&Gl`(sY z(5EI|6<^uocrRak8=|}m(21>1uh_4z$5cg`r-)N6a_bng_flL(YIv!FTHR33XZ+~X zokmX4ur)i!yX}KL@wQO?i1$#tZ5*FikXYGjaS<)g7wrKR*n5b7%&;+^{quKB-q-H1 zLCCN#xZ_Z0g`18in&Oe^wx6hH&dc2h=%GF#gZZ*&X`Ige4QE_-+!M7PFidpUv zHj%@--=q6!sVzK@{zd-tg8CwXa6<-2f{-dRlKUFhdiRJ<&=oKad7%SaRD4z7x2>ZD z+eIr{B2xi@7D%yST+l~t(|s#9Q+@o!rCWBGANyJ3=adTwPz7b7A{)mS1sG<&0 z#eK-{d`!HXc{1IY+;oWfIkOIth-6D0x;F~B6?0WCWBZ&6th|eofNaH zfqEGcuTVq)jq%vQBoiWfmAB?C_xs4mIBFdQa2LD zzdQQRr~u}ILsnfyT*bmZ7YfG2k5=cKv!3JCrrU!{nV#<1f62;hme&mbQC9wsR93eC zhg8=8?^FLLD(in*W%-|%SlIqY4f+3y%F52d%K6^|%|-teXcout`4?zjfMfbKAP5R3 zs6nmPlAK{J&1W}Q>@?PZ2AId#It?=$a)CKhcq?bI3e za#CJp^{01>e5}d+=g2yF5^yFwc@G%tl7?kM9pg|FBt?G%Uth`7ACJ%C?tw_V#ecnpm0)PA`C%E92@y~_pnaF!E#GiR=yLOIf^wqxht zlAxk}EcZY@sXN4_7w2+MM?1c}xX2vDcFSEnj_4%i0PIfij}f*!OLQqI5}gPp4%8)U;398MoSFA*_N*MK8Vs&72D$g^wns+Uuc}@uilyFl=tDtB<1GshO0tPEf4{2`>oR(ftK! z8E;931q{&D-2!wTLlDk&z=a%(`Hodd!JfUjl;dS?B=NKKHm6B>sUD^*Vzzw9w}X4k z+p3|j$&me~-rTR-ir|PNZ1T3*@~he$pmE{mXwd%-9vl_Vz@y;1y}tt;fMl-kW;)g4 zR%O~BY~N%5I)uB<0y^WR2L};vN+=kt%orD{3bHTE5SQ-p4Q*&Hi5Z^HceO!0 z(I@&`&4?i$L)$=HO|ug(#h*B6K1T-O>k>aamRg!%z~F47?vi5M-1E2S>GVmWfF*1w zM@q=Ji1frO&ro;7=WVz_zV{hx2sWE*r01_fot@2?WIq%_GP5hk$tQ9;VsVU8MNLX8loDc%y|O%;qwHM~8{fKHQx z!qMV&@%0I?Kwup>m=5ffg~rZ2$=H0*>_%dw?C(DEd}4}jq|Pl zU#7v#3)L{6nZ^b2lynrMyaJ@qwh_Lz^Kw^Qf0IJ;%rP(6x)1+yyliU@^O4NU*^3NFezJB<78h{Qga{ozZ;d6F{Y_y zp_u>&^D6XAA-fFAE4V3hJghgHcu03mj5JD~gUl*2@419V+CM5t!a8H#-k_F$%#^AM-Xk&xT;c zuH`3nCKlS};W|~^@_&0;W;kaxGcyJgD5<&Wkc^KPg~4&W-mM7v9jPKy*1#@VL+DE| ze6))KbGiHEX$v?HOk&O}H|f8pj;3>Fwkg<6Ga(lg!mWqLbeb^gvO<2nhfLj`6L8memSIE6W2eGgAzTQc zk#xAMP>LN(a66=6h{;8_6&LAB@cAiwk0iJ5IYOVsNJK;MN$-aj&d^ zqw4QCy2Q0xfP+3ooIqc0D_^{bAxl2{^SIWoQA|G1;a*r(kclDrkXyCk4GK0RIEj_D zNf$bg6hI0)*>6$Xj#&)j0Teer=3Ja=S1<_d3mnq+5B7oQQh(w%OKIEB#M}2_NT{uN zEV7UuBJ0y~Gjt+o^~Mz^3)y%`L7RIVnnOhcj;n`c@D~lk2B1eQ{jyV@CKd=c`qkK=_%;se9`c)T2>XKyIwGWbMMxE1D8qD9_3#L;l9hU8^?9 z(alvoe#kldC?22?pEb*UdxwFim+s5L{eXT}8~bu|!=Ed)8b#~~d#%caxwJt}eFgAN zJ&d=&hp!u!M(>@klhKK17}2qXNdoW8qhWR=GR#+Tuj@S+FY2{}xzc`T_j}lev@Tpx zkMZ3x*OBC$9vwf8F+sdwD+uyTi8HEK2^-m=jw*#QNGqDLtrfYTK2slQV4UuZke< zKq0O8{jZ43Vv6IEH7?tU=;9t!y>?GsjS#2L5^tkdkX!rQ!xDmRMQu1Ue+J%5qlL>j zqapAMGH&z8+z^YiZ}*#NBEy_N!-wPEt@?|F$6xbl>Y1F_l{8K|Hq`FDf4W4gQfQHp zSudcbp+56ZQm|Eu0)oI_8NSLVar$_(GzFp+qNJH#k3k!n zsP0Rnssy~Uff*?kwOF!Ib=Mpa4#+x$zP}@S1rCsV_uQ^=ixQ}mHl6Hu*UGkq{BU-3 zvaFVv$drm3w0!w~lWCl~<<;>+h+r1Z09MqsM<#Vu#XDX#52GrPlEG-imsqQ+275)n zN&|}=>URBMql;-i^FTg2=VsKVGXMRx^=}QsFVxw>xGJ$Lo;JiqJdsTBDH~2ZyG(72 z0Yc*#iACG%{Sfcy`o-EEnUsMi#5E;6dy2vg=_7=@JQ&^CyK!!MXrFgzY#7mgY#D%Q zmxg%062v~mX5U?6V3Exc5Y?cLA?k2jk@dN9l9@;-cvrp}`@4@b(Cv)1b=; z@Cn&`#J7}LZVEi4O;^9tp1vi#mY!OoN&8F*A*I3Fa-F$A+8V!0iUa!CoeKD?gn4$k|2VgKe}at8US}<@y+Un-h!vd7p2Tnpm3w7 zp7VBniIv{G$+FiUc?cknAwNOP zq-%)JP@a&{m9b}?63ff6(%p#H;uZa&r605>0w7#7>a$rZ&N@9v{`b!$gZrYkGi=s# z1lpwx*aWK4uqS6o+{+V^Q&GC}B~wz@ie~~M66=z?pTWYgyz(nw{-ZaM%GTeeDyirU%mKf!sZ=nL z6^MucdyYH^yLMp>N>n;Yyq(UlB4q0l}o884`5bVvsD-c=KjH# z`!GX>MCe=NYV`uVsxSG$Fjt=pQ6g4h%)n-=!T8e1i?i+QrM8-4j5l$S(Jr{p{=}LP zssxU&qy}XSCUQudA3$T|VQk9G2){M_3h3#cuADRru4YDet4GlgTb+SH?3`b22+O+} z9N+oA%%$i5P&A!91uytOD$9<%5olf-V~)v4J)EU5s;70bf{7{Lx0~o)3-wfw<&}v0 zse{YOzo<7+A{6G|u~mD|w!pH3+O!^cR}|+!IA$~6Zk1vv^AaTTPFy=YdWe8^@E2+h z=eoec^PxK+{v>?7*g#OGHJ%6h>CDvRMPWN`CWwjAXavW;ohe*xLk>-VM3__9FC6vp ztQZZ@9l>XM(Q9`@5|bTh6?gKg@!{1Kge+mqedx*q-4TCTEG;5`;9zESUXY63{VQu4 z&tiI|?I(yBu2piAP`OUwWlh{Up(>2vz}6W7g{y0xnUGN5-|9|~MZ(BIe&|h4?~xI| zv=uk!Uoj;ANsWhMgU~Q!5;BPVWE-j~cB^8wFLdA5)LNB-in>vV#}kF&lB!d1woa4> z&<)P%!TzNd9{g$xg^AX=KM=sX{E@RDVq6wX<{w|kS!l9UOvuFS9rt|Fbz@y`o z@yu)aJRdAwq{h+6H~q9Y3xWVZ`ZeHVwdhVvT7pH9>hF?^rxyO$oNXwUMq|qQ%t)SB zArh%FcU8Uts5tF8et;7TI>)Id5H zMB}5!Q^Hw7A%m`Dx1*0B5xF*h#NkxgdAmbrxe|mibB~g9T3{sFNexm8iCL}O^Daa( z4=j8zrgE2LUM>h9;+_{;6#)vQA(h|Wd9ohlA^U5nZC{_!NiVwO>m0`xU?PJ|4>=qh zBoA{v%WguG=auPNchv}7+5CEMHjh#&?MrtUiUHefP+XHziXpt3>DT##q@p~>b}?Q? z1T7!B#(vDrIOl!}FB%d#e67v|dQKpY0Ry#*hM7kW2YP4d`9Nr$ZRva-Y5`=$3Rk{Y z>Z5&Zo_QeJFlZvmH@VI-O?#pB4-r;^EOR#;Q9T&_MEhNKUtZ08WP>S(Xkv31o#y!M zndP+oJ3y^?BoEiiQ&u#D0r*k$VQ;mA&Sk+!31nZiTW{m-^C(hFuPUtyV%Cde%U>}( z(C4t05UNOhe>%*RG!-30{QKTB2_TDVxv-$;yfN~rCCfH_STUVO`sW<9Q>t+T0>lXt?=_#JuIL{X`U_y$)x{U z7&4($QFcs;W7$otsGY;82K_yai;wp$tm!Vo3%gcTFq<$`E;S=H$R_;|LG1d{q(KGI zSo&Rs>)BF7y(k7wV^$X+4b@i&l4f4C{wWu<1rGyF@+~RN0^spm!xmDVv|h0u5?ghV zfGrwZsMy~};_%{#B2!K7suCU};P`rj=jX$N_y0G?{!2BP{E5m!gs$~F zO=inq?y}NxHsoiJE$Fl+Xhp6L{H4Qt5ZQY}3UQ%}OE=#Xz==g0Ijds2;I|llrqolw z79g4)HYgLwvMeyX%y8A?@Xz$4vn6fo8F__q4MHJ*w}|6`kd1NMv?f(7GD+x*mMFFLN|(=elQZgJrP$JHfDbgrq+oaKdlw)e9GT_Q zUwe3^{HMYwDX}P|XCLn38=FlXtiBtcE%UbQS3!M`j=K&jSD7%jCilsP?V!wrEr<4>5f~Xa(9G)tdM$XoaGYyOg zmy@IszlFZsP}C($E*)Oi|8nH{)A}f-8%FsVrJpwR|h-++aAgODGx*F_X~{^o@Q1Hk*#fEcP|0>Y#X0UmSAoI zjJMlb#oyTLFaop`6(E^;w@)4$kBL8J4oR%5vDSazb1m(-Z<(!^ik~RWB7Z-n1(Das znJUFxpVAcr(Ym41i`VNqtiKfT=w8f!HM6yQ*~+Kqf6;6Beu0!nH!A!(w*ZVM=L40) zI1JZttus2)`#7E9cREodxBVhGW6@9#R`O~va6fM^q+DoL?G#809`KR|*F*ApV;w`{ z3CN`3@rkM=OBt>ZOA#oU1sIWluVPE6@cRyq6;~ws5Seank;ktVq^$W=B~GDVnMSx8 z3piz+u)ykN@`oA{++Xx9>ir}`0T$bgL_ov66cC^uF;^Y8Y{c(UQXEd634W5)TI`$0 zXu&m~_;z?bGL+a^ZZ(fVb+xqNV82w4S4$(&t=aQ)4c;1g($i9?6=Qqfht-rkvJDUT2l<=86 z|LlfT{!Ur?laD<#u78EJYcB%4**Utydd%iB9up1jHvaMf$^d;Ei_ldCi!%d^Db-ag z9QcT7f%D)$k_itu65eEsMtK?5M|YiZfW^JOuPEcgzqz>=H2ft829a-cF(Fd%mOd-4 z6grt{aLZ0u#-|!Vi&(^#JA-Ck45qd^n_||SXIC=DW#T9wQ`f3TZ~mm*lH2C!xIb_o zrKR3>Pq+FG=bVpjrAvx0_fib#euLGXo6voHUS5HaFu9t zdP@R7gre7#om|IK?@2_k|B~Pn!40hzK>hDd+_)V#TLjn*B&4*i65jC9RCV>A zYmma#{{7u0uvf&vN4>^=R%hDSR3WkaH1(GF1I-A8X}h!dA1$8$h%#pTe~2>vKUzE@ z%m$4Ass&vCdtm?H*#5tl|J)<^pQiWO|3|~;{|ao(#?H?5|2KR#Y&XWyeg2gObjWtY z$j#l674$$y9A-QGBJ(6pBUR9nq-5mjlsUt*+6;EuFDE7ym5UDh8Hcc@FDKTmYJD2p z+CB+uYUpovwzeWvbq#hldr$$Xkz&;Ua%dfC#Znp4_3mizL@LI2YKu~O5n2^)8>P|_ z)G~?8fXJz#zlVQS$=lOD{~71Ue_lMeGcW#prJm8MNR<%iFikax_UiVmH5)udXd!W2 zFUbF-grg*WC+aKwX0l|Txm|>H>e08lBp(Cttv4=jnZ4f(?Jy`?)z`C6G{?7l*fNkC zcf2~^eQ&#u>YL}Rq(7{4W@nO^-9D;K?&hWU^h{1#A|`fP+D2!TND+}6e5a`oCkXw} z4i&lBxm~XuG)Yo-pRD;Xw+(I6>7S>rzh;&*@=reHVyOKXPwc5ZI7S(3Kx`X<5P+goY4^cE1; z^R2JD`xA9V5lmMe^mjt+wq}4Z*O3WyYq|5-*fAb0>|A{6+cVD#)*cUueid7B3v zRbz+B2iP6E7R*F)(GpBg-Lr4j?DC*b6r{;1RBJrOx5sLFB_|UbCGgt|##Ne!-67Cw z=W@JJ?=rBt9uJ|d8X}em;n_CN8M$tje!-A7F45khTUL1L=KdYMq~C|xwSo**{3^~n zed|8pyR=DZq=Dv+DShky01|#(mq#rbEx;q*p3`cz{mwd>r@9JTrgi47h;?AY6&Oho zI&zSk`>_nvpJPd(*A^vv7dXO#{XsgJiZ}T#;ZcZ9G;MU`9aGmb@UtHAP4T%u{W(y_ z3(a&(*)kUpG`^8KqdD-qS@v>dY>%<}ZsX8ugCwiaE2=!E=}^Bj=iwkO>dy0QbGmKG zx;a~LUzC>ODd3f8aSOEo{W4(IOpu%oM2`*uRVeIzad_U`_-$w@dbm!sX)zx?oa2^* ze}ZHj??bgXf!?;6InnKv$<&m*!knH~go5oWnIq5#5UlKpED=($ag;IOpG`|M2*{BM zaFBHi-<9;e`jfxddY;iV>lUr~wimtI@fi(dnUPIJ=78>Q_Zls?>yn#KiT0nU{F2&T z-Y`-I((aN-vevuuSdAUrn~e#!^Uz567!p0`V$VFdmLI$t1OfxS`F=Wa1X~mzw+>i7 zVC1k-zA1eJclR;$n%^Ams<&n?{(>;zKzG3vN;p4mW4%t1Wi28)Ku4Z02U3bG0lM%U z3G)1L`W4iY@e_-xBzW(>D%Rnn+o{*psba%^?CMkgMV~ zuboV#$_U?RauFCSIu--P*-L!(1vSNCJKKOHO(3L{^yvga0XVj(p#sFDqT2``J;z(s zhEPwT7X^K?Xs)}77_f=}86QC-K3B*~nj%rEoF~Q#dgGWgPE@l;d!Jmf_zY@vAKXcte`iZx$JW^@Z6w%s#N zp+u+rXG&E_Cj{;Tu$5<}jDQ;83btc*Gq+_^8izRkIFWd9)4a#(zmztGzS`su4cyBL zOO{`%mVpDVo_4~@AXKKqm*!1kh=GE(K`1H)%dN|w98m2eyUqrL*;bm^1=YETZd;T6 zPf;x&sAyBN&xo(53}#|FWz0kOlf@bL;~B`x!={y;Br2Jh@29@CcYo7D``q}t0yD6n zJY>PaRPZ&kfu28p(p`vcvQ@`;acKNV5_L&M)ofs=C^Dv{a%=z&pbEtPY55rDP8Ox8 z*w}48(U=x_n4h=qC=Br>JxMuS=MVD@z2N`j{s{%4M? zafFWO&HE2l$xZ!Zba)xyI|b+MY9ei^llELvQ6)C6(yzxIH=(ksO4Z+*rHA;d;jJo- zpDYFYY*oDkXdPM!%SX^xd1Mg>6;H>M%a^ODEkUtm6ohHm`BQf~r2`}T*)T%;d|M{?+!xXGpL<6Y9n*g^wHYJ2Y zLw;fl7Zg~Jn4IDs&Y*WOdvA5QNx52Jhc2;xs>BZJ86pHX-G}{3_MwVuvOULG86{MJ zl9x`$PV8R0KZ2X+8VKTE!Uu6eJWdVxc}(44M&@|@?h7=!>}u(q%zVk?5zQ%~brLh4 z4|_%Yimt zThV5mCozbOX`URJc;FQCPzFJ#1ZFS}pCD59R@VBzswJFR z;zsCU`WtpF*7NhUFunPPiOZC$?f|d%m9E@ zR4a#^qzZnchQc|C-E|h2D<^ZF3L09rdd7J|w`TBAYZ5uxpatj*q!h5(GLDGlnYdtp zTTHy?&iyAQ8GD8lmLENU3FKG2s*}sMMJiIfmk{O@{_bi{%#|S$iQ@%HEat3W9rd|k zf{yDcenAfXm8XMvE?r_%!YRNdiNLZ+(k(5w#QZiL?J$(fFbA!f;Ag_^Uf@iqyFw+N zF?ugJ$7EBtnh+;r%x4Y#xb_aEQ3fk^BH+ z;lva57laJrF4E0KCwlUxZw)yaqcJ854PQ+cxVcK_knFsyKTlX4WD$Aoavm4havYK# zwEND7In{~{34*wGSZ3WaB=d}~?2(HsVr5Lfxb(D)EYOfvwrXg78DIP_2Mlaz42xxRyGS!p32Kkxum>_8_2$cSQdr<}AtQJOFk=}DmvLuPocg+`&bZGggjl;OUdH`j| z8Mslb9PuSGM+2Qw;5I^)c_)6ala+7mI5kUe0T8R4VNT^2{MQgFH~;+$O3Rth;;Ua= zF`d_nIX6Ucn0bjWp+i*s6WMY9rn5h{NGB1n_>FIw~z_uh3V?<{$%~{F{U@oDI&{CeqLfluZhPiP^xf&V&TLl_!=lulq~(;cFCna=l4pZE z92;M%;3HNpcNhv&pf`66j1o$F6l@vuf||hKRocdI-I8e6m++hr*HYU!P=hmvy*w~f zvS<5lV|A>49qs{gm&Z^5dByhgh|Il0*A=(fF9nF&*bCZp=za(sQ z5Q0G{XG8UK5N8XGoZ&r+lz1|W`4V-xjkJZ)&G>fp1&EZRrQa~A_V|#ushJ~kq3O(n z&n+U=`T9Abd+Tz1_sM-rXz{5ESf>i?9`h#Ei~JoBCVi5~)CxJuheZ69;YF}cVrL*~ zwtZ3OU96HR+xp>Z-AJWdu%m!*L^xVbAI2rAjF(9-cH=R1$2(_))_K*C4&{8b379{b z7!>L|XztypRbO_^rh>sCmJWZ4%CsL*8hG_X`N3)1<6HkynGTs5X&2XaJ3);#{RXWZ zTi-gO8HBW$THv*9Z!;ZzX?#oqPn1;HlV`la)_P}t@B{hlcCi0f-Vs>)i|6N-JM=@c zkE*qXLd*|;5;z$RVzNJb4$e6xb+d0gAr|8;a1#< z%?%uV|7&DzXEo@PhM!fcHPl|63AsTi++>*=cL-xoMJ*tvhAV`4%cX1`~9YNil4Ji zJ^n%Dd-o$ahRFcpZ861j`*q9O@I`Y*=ibqMLb7dj_8C@?7FOFYO24v8O0hp(%p3lJ zhdYkO(kVMX$uXBF89uPAMxzuH8n~Z5+n(YC#HLeFtSB>nbxrl^GxmH58#=;q z$!@7gq$l&By(p4|hBr>nbxmOX<1_ock@rPLK-z6LZ{sM5hj;@!JyIE+c{HGd`GGlW z7tSW+3&_1v9V=v(ddLd&wl#)VO9?(aBWN<(VIk0A#4k^EBC{3tIG)kDv{|_(oYJ$@S@o)b&qOF9iC)n*igrljglk!d3Q<_wJF&Lm&@+T4%P-rV^!rQs&! z5_{7#1Al%T98)QIe?SyvwZ!3PClEjCDv=h;+XV=?zWjm}@aRRZm*xV6`qp}5;xfU| zXIo;Se-!O1<=O6e?ehr%e-=B}4p8vH+FI+OUHB_9#93i{YQ0%BLdtiHaB-yM52|U7 zjM}!gzB$jPKez(*K^pr`YQQc{AC0m(5|MWmxGUW{K~*CaTEcl_`oK-HqbH{jaWhF0 zh@Fl4 zcX8lsYeX}-Sfsb$9K6}v)j$IAIvEx12E|M9&VgrymZ;X@gw?Os@rE3kz+`&g*&mb)4>uhxnl*NJkW z_`w3vf}benT`AOK!iP-0eHKoWQNx81o?1sH-KvWMF131zZYWVK*U@3Dki-o6j)z2! z2ohQN6vYXyA~aXh9$@9^zoaZf%Cy(xVs>boV+~r=_+7wwN9Ky&>-1#Dzw!KAlQ-^`L zd~9x4r^ik+XrjgMuXnpjby+e(`2;^n6bXT+Ovk=8siQ2z6Dyr*DNaqxF8BeDWIOP>n$GV&C&dN|;Kh6mLTP&7 zYbWGF*Clg(aZNA}F#!IMmFAH!>65?l|B1jhh_SLfGK=b9-p%M+t&wpgCc&BJmqS++ zSAgT+g3YGG3ZitEh0`T6@$`YYu!lzWn3x5MF(%3YZ$`qb)?k_)(3N;+kD|E6^o-*4 ztFBadUrd!+pmMf%YYsQATv$;N9qS2SK8d!>4+*hk)sFOi&8+^t!s<^(Ol`qXA0pMl z6LQSJ)@b$79eb{Z)Rxg2iVkH7%ul#D|+oc zb``if|HcV7e+QUO>wFMPYBxzmmR923Jx4Z0JqDq`ysX!U!K%WHWDBN;rR_r&@#A!2 zROhGjX31FYL8#=R-645=VM~i#IVrPj7?BN9kOyi#*!RahV&X$ihD+6GzEQ~| zf^A6!G0MP%@*bY-Z1=GDem?J|{=hN>)4MdZoHoQ!d{=7IO6iDx z4YUba7b}y=G-OwiRg!kJpqLX7qVTd0AS*rI-MD#{be;f7>2xOhAm{fRmek%{)EZ35 z>u-k<{PFg1`F;ov8&nYJ?%)JaFqk(=4jQ-cri&V(kr}fCZV6NQBdM!k+S%q2e-V#! z!bHkWt|!Kpx(T6}?K?w}d!$7!nDs!DJ77jG{9>fqh5yVQ7|_iEPb95+M5$`(Ck>4K z#{aZ>hFwLn!Xb9y)71;IRPR67KU4*4{By&?0F&6T=*6EiJsYF1A0HIXiJluUrkb^k zcrUS&J#b&(OWcVq~onW)@t@wBY!+pFewh2Q^# zCjb3~R(KmkUwfw6rAF`52WlzPjbXQYImld~!|F__<5fuV6UM>%eqTaj^~!r?IneWh zw*$YHsB?lwf)}>~`cv~!`#W?N=fib3E?x`g%SM7hU6@R*hc-dkkIbW7rAVZf)`aJ` z598asmBFJyyIb0N0H)sFs#e9=$U`V~F!t@Xn2CmUQATElm&@ z%&kAnGP-6t%@0!;@B_{`qMsgCJKOAa945vsYBi)i^H zhI4PIG_iV!p`3zfxBH{{H3*d#<)0Pr1(4eNx^atACmfSV;HH{B#t0QPPG%vk46e_> zQUM#|Fs^!RShOOra1$`-rd z^zekWE=B!$z%AhmsaBdiEcK*UsE%^vy31JCAdY(UUk}fTT%Kt#o*{AvCO1)GoJ!(b zSsF~4>q$DJBpuXNm&`TiQX#iX)z&_+`yBGe$~SU*pC%bUkEBW5D9EOn%3rXZlboIt z1dB}=x+t5)U_L{pvrr}a3-NW^ocw%SzcoGV0D?Fi)L_|VL(AZ3?Ht3rserX34VDb& z8AEeO%3|X|jWl5y_bb?Nc+a;VK3I;zV$RIUxVZ7=kY)ujd!k6gzOq?8Zte?!ycA}W zo3+7Cv_;xGkx80@ksB3|?6BUJht1k44G;_9{)L2te!wyX#gQ+k>t##`N$Dx7w7c8j zqS&*xwhomgZXGMH(!&41NK;z_kUic|fkkF`ifB`e$8De9E*}R&kb#`yyrm;WN>+OY zVsc8kV0PxcfoB0lPO5tald#Y&%2>z!6;xI5f!J+_5s*vg0V?}pT8yG4Wq~`= zzU1U2HUD5T_d;RoC%TD!-(OyW3#pE(!@sb|ZJza(9hj$iQuS3C+`*V&h4(FrGM9A= zJjyAF+CB_L*>EzPS_}yy?8=AWWoyjFbCI!>E!z8q%kygyr)H@C_u}9S4Tr_6ve7zI za;>N=>>R9tfrJseTn>qVkd+xy=945h+wxKxuk5GAtuXT1a!V@DmX#EqR`%>Et7ZL6 z>oQ&nlRGGEK}s>YKw8PSHh)sys+T;1mJpybV?K0u`UI+WABUFd1_{H9l$+?Dkh`#M zlBSegy+-pXLLe&fXCdn}KapGH;GD{PApEX24K2MK!gq|lY)za4w9_v0EzhiIrGWj2 zM;RA%1+*|V`%z+v6~2+0hrNP)2V2eMeu22^eh^E|PKxYbPDFd&?>&f|0EkV=Vn*wNZ03T$mQ5eYA3tedfrnZ7!1?w}Gk0bxqq5OF2T} z@6S?ay>h8S9ZaU|y%RQY_vR4YJl~gvei3Z?S;1dxrPV4LP8uwqQ$1KpJ1e$@rlZ(M zUUW*>xT$~iWSl>EPD0Z{hin8cc^RX0RwcKb8sDQ9J6ypYGx&F3nyU%=_;P?Hhhi}; zO(8rRD4KLp%Q`WqCEi@>9s2EjtT7y7F{V2RpC(!V4mYzmT$3w43Qt9oGtFU-FP2_b zrAt~JGftFlA1=lGmCwf_S}h=)v8SK46>$o|QA0a~C?1$5(w(n)ov~g2cnX{f^o}dn@qGh z?T1p*3KEF|g?Yq*{(}NYYg|38rK5u0{=?i7+#?nsgkR5+aZ}pBVUS7(FM(| zt5>V5cd{r^cr4viGo(vRUkOisb$^6{SPSV}Vq4%4n{lbN>WW0!rS^zT8Nkb38P0Lz zQ&+qh$GYiY)Q{^~v6hz?@cjJ#W4~UXN|%r-AEK8@;>#>{&Ze|GI1Poc*Lob2$?;+` zj$ts+(Fx2pBT}pT7RaS@H#YM+tJTdE{#pahAzYifa_L|<70VCpEc^rB{7Xl!$h#C{5snuFmUmiWR}aiYbL zj%ejOYPe3kea8C3fF=Ig=})`IuBhT78e9QNaGhnMDMXM(P(`_wzKFa z6v+d5A1)pbkLTAWt>p)bI~aB1@Oa_A9k3t%8hPn8S=jg^$Kxqc@}EQ%qpaXxMEIGB zM~LrL8Z4c6BUmoql2r(*`!SMQoY6?yt8lF!S*9c@A8>6|?_8vu-O z<*xSZVtJiHdRMfyhJ0xU+R8qij5+3}xinC0$%+uk(UyeNlxvP|Nn~Wq9+c0y`wqY# z)yZ70LB!rpJcZ=MP&n@6-2AlKQ>QsQztsLr`UwC5F_LaJrDO=dGl$jPN!{fpXzt(+NuzNkXKIRsN(2MN7 zW7QZ-Xw+G?`UImJs#7Mtec^DlxPgb>v=7bkX(KamnBZzlNF$6iI7C-5*$myViWsl; zRZ23_IvP0+9LPXaEWEMWa*uoLoOBRu6VEXluO0%Y&+mE@M$wX{S)p(LQ;}DIZycT2 zG!7hyLf_D4$sUHsqZ>99ei?SFC%n_mC<1;~&^DW#3jkO976=H({*67)h$!79*@=U~ z-&Ab27o=k`a^MhKg8r$APquTS1Ri?h7RHQHda5|heUr@sy4aAUnr}~FMJ4v7REfGf zaQWsT>1b*9{K=bT6bBhrp0b1lnCMtz%dASENL-}t=@a($6vpY_87b{kVclO`C z%QLY#t8Pzm^)lpU$`niDPg2ZNRysLKS+M0biQwi^^e2q zDKp-$B}<`N)^0`GuPblDd!V!6>HA+b8|2rN`GvG*l zI71;K0bA1XXikLR3f8MUs4mC|5~B2SfvxPLbuJM856}{{(CUFQ6}VD$*8;2pzaIg{ zs!`%% zytfGL7c$w6F#5g~S=nQrkWnhi26yrYr>$bm2-RtOeKSBk0bSg3uP43gHc;K)xh12NO8Tv z{VVN)^g{o2(^T9v)2H`T*&Hy|onrhv+AJkztL)I&kmX+V@ky}Tb@JoYEopiY*36Fa zZ|0f)$InXPYO0v$qp-X=-)yD4q8a~4ha0c*Wq{Fq&SR1*w1zt$dIqb3k~|tb=dYsG zb%$Shrjbuc2;5^s|xFUS(8aJvm~1GmSTU2$xm1n71Fla;cHg2QB(!G)eADl z7NOB`LsRS`@-iT^{vEr#c?CHN)g2Dh)8Jud18y_)EwRMTU6{nC8-%KOW5@)U9vA)DONof#M*07dh?=0zrCG} z`(y@C8VfwcUv#nJFYK&;lh%(>#GLHNu7)eWXkHM@5%M%T)iVuY6u5Q3PeE0N|&(;gi>IuW#z4RlA$ z&X?uuV#yKFWvZ0HLT8mAX0W5JB4Y%L(OMw2d1z45ck4dKv-c*KBej9JF4@d^zq0U) z51nK1WZ}&{+9*poox2Q4`h`2ErM=0E^8#HFtQt1kRrIXEpno0MT8m*Ywj53iMdh00 ziIH=@ZHpEAJXA8A%$k8x5*6&LiVjjcv3lPWnmryqB1a}dD~p#w38owmL03shG$f$+ z)QS8VCDvi5xNnl4m_A7ymRwbdV?Jf_Am26Caq!UgX-V=1*>2mvy>c;(GQFwnRac;) zm3SNZ5KO%Uy}8L2X;k=j#m`~zig3<0xm*x9p~E&uAA6-Q+`U^C%>-^_(eTk+KUg8Q z3QOC0S0s%ji0Sinh2^drl%#t!iY}96%+%Al64j@X^JG5MD=LH`oWMUL;=0dfHB7`~ z!M!Xh6KND0$9lK8C2nK=6e>N@oYg>QtpTIk2=?YcmrnybC72UO#RHb6K14qB*U=KB z5eZ}G>&PzY28TlAb5B(vLO&}}9+$G(1wFX}X6zGK1^aD=xu44q_uaLC80`1VxBsIP z+N%LRqE!hL3R$M8rA=uL3V*d4E-&Dayz`oDX898#Ye$B?AjxvHpil7hTMpMvAg z+~P(Su?O3~O#C0KJr+tv$U+D>+X!3a)dhGT8?B$PIqk2lsKfy8vd_N>X%fS?1nw1F zZg115g4Xg@Wi;Y?NR&|c((HVg)8=?}G|%{<2|yu;WfLD2Zkn2KC@{J^*k*k@Uj=?> zQ1DUOC_hbJxb9&y^Ze*zyd|4$%gl*pqfC45t?090&RmlIN(yD-1?;ms?Y`-}%U_f2^BzWU!*N>@@Ys{v0rH96MWzZ-=0pHvES` zdh>3Wf;!5c<-45*F!3mzo>rBkZoN1h^xeu_ZBo1R)hFOvNOyH^ zc@e4Cpb(>8_{CpC6Np(WNOUks`q#ED8Kq?fjDBa7VTyU{;d)IixV~FwWR;|(NsU%{ z{5_dCkg~j)&8O-o7RIK*i;OLxKDj$&sA}QN7^z%9MX7WK zV`o~EbP{G8KS1YQc{9c~He|g<$pI>GUf3OFqKi4X^?Wd`@E^hKj@Xu#|5Q%?Px+$k z{}=h9|FxX_KS!}y+5Y2al>cS4S^gui{XaffiCEeGdwBc*m^;e(U&+k>{fz(Xsdp|W zmj791uF}wU+FU{YCo^*@&?hh(ZUK9;q|XmWWY^uygiT78j6Bxp*Sg?QO%}sP%Eo^njc-aWScz*$!OlR*eTO2y~QrIdd8Yo@xD&E zO&m_o*p}e(J!_d4sP*NQZi4ITjlL9%sFi6`=(k-fddz_~Ju&0h(Oo$i+b!^@CU+5s zOp(2ZNZGAyIejU%da_2yoi1lIk$gd#u51HBX9w*)h^)wNXUz){i3#2zb90swFqzac2OJ$^fC4J}6-RnR8O8R_ik1wOySk0Q*}q zi?2oMp$0s%+5G4cg8Gu{`h0)^3RZj zjy#piLd$bU;jotrfT|O4ftBALDzY_G##AZogWH=JSt{;YmeMX_2A)(vPC6F>i&*p> zS=B%`yX5-5c`q9(sPd5Oj-YwPD~9%)k8*31!%pA#1rr&l(qcy{h(?8eRu^^-z@k#j^v~VTs4IA z8!Cp8RCaOw96V6K>Jx|m=tL>+`|-`Di15ZwaFC@32-4 zq2oSDjYP_vP8eVRVL|&f1?y>Q-KnsLy9AS--qfeg`n)in9dp!s*Q)`(r3hV59Avjp z^lNd;C;!`!{l0kBdllEkre#4c2UREE4&)|e4q=m++~zbZ+u({KktX7j?sN@b1w}XK zdX{9HTCf?9ZzK@DXHAtMhX{8LUU8hx_8zXeDxdCg+gz6U-RlTrtx!P3PN{KrE{638 z?{rXOke>hqpEf4>wp3r)zfL+?E>;bS9OP{bK@yQEr>T#OJ~KG3ThTE#iIMg^{gl2j zl%I&-Uo?a5)6n^NdDbjh0e&)w-2|FlZ8Y>slig%*I|w8GgHL5A;UJW#`GRc0rM{Cm z@}=_oJ3WwP3tzp9;jqf#*KBSnm+Qm{^h+xEnb@m;Pj;6Z){AcMMGej+~z3 z#z*=FZibvWHyUHfyBzAaLnoE|iHs6JDD*Ev_kk=i{M7X^JpC7zfbXMo+m9wt3G%@N zMi4CvO>-<0LL%?NpcZYCDpgqSkgZ`^GM&Y37)J({y=bbKDiI?|DhdV_KV~LidRYOx zrbBo4M8lKNlWOaUh#c3?8A%IKyX{4~!Jz~2uRyCgX6!f~FgZ5%00tQ@k(IjQtn?l3 zvAz}4jj#lVF1wU51C7C=A+pUKk||V^F8Q#I+{xKHgW zz}E=>EREbY9po#gaiV*>02{MHumYG_K4ox&be*KnKdw+J8Vp8%ebxDvgo*bC{6XGR z-2>}J=*jgC;~p8kSOc3C6!#(a z{o8W(`*Q9oN8K>?o#BTIBntH^5y~A9BOwmgemVgtGeh)&NiIt9UAH4mV$f>$8y!1F z(W0_B?eHBqq27&mpbkc$hd;=mQ7)5z@#v?YWL1z1zWoXkN}{kJwi|wf`FtCkn=*~< zX=6puW8C2{{ zIZazkYt+!8#aSt#dEg5+tU@{22CpdornA2G0|XZv4Y2ITcpz-ItqkhwDwZf|V6w5@ zU3#8hZ!7z-3_sBPF)$B~uhxh^cegU6oQF#x_f+8w&F`{u7;D?WMqp*dljfSX`6-C1 z3$9p7dt;}8b0iDzi$heZZioA)AO+vdnc_uSQ>;D`Dje0>mG79*$M1 zNpeGdx}PeKrF-lsEg*zo~!4j1Cyu%!~A?Ha|=DCW<~(3GVZ4 zwl}D1Tsfd|K#z=hLPX3x%e1>LYfe}phWMrzO=Q2DiWAn)Ts=9L|)?dcc9b*rDk$KAM3MJ8o} z3~gTHd|aaJaWp?LfZoOUVO%!5)cs@IiJSIUO8=JAmvgtgy0lre6qY!p64ZF1`DBSf z(1E;_hrETQpRqf5d0K%b`9)efdJMRbjNs(>xzErJnCE0ZO0 zA=8kw5y1qs#i}O-9KM^(7i*FFe)dXayS_;s3Mzq@(j^3CVWAqmXO3@S#kth>&4;PN z5e8^dQl^qAIFS6B-zK}ra+*1|pjo^Li1^QCgymkgZRPKU>ZRSl08Bnf-N7v>qLG7g zFDzDiji-c%1*n6iuFD}lp3PlNHA~WOFthCaDSc8;va=>g=+sDe6{uyyBqDO865^#| z&I>FL9eTJ+HZtPAI9#J>FH2LD({@?e_JDWcgF|PbDf~7JSWpgsL^iU4?`B+!g&bIqO->MUN@ncQJpe5 z;I-&=T#nd>1!{+yO&dm~A|jv{Phn%}7C-X(+h;rpEnF}8`&SIr=||>|3%7oxG5|uH$hc)MD{rELy3}(! zrrPwt432)Eoei@(Nw@lt%`0!UGkb6|#ERh4_mNCwmguoB`K2<+mSiLQUda`-+ke^$)0lN zcTPgT$0>!ow=v$l4JMXj0nmU!N*HhnZu$AX9-UfW*HunfY*I)`)w#Z!N@qRgS9%@OQH073BLE!M~ z>i7*!I!UWTxWJQ5tPJ;_+eTd?Wbj>d-#~yYdC>GDUFoT}Q5NxU+*OzAn+*)1zbN1S zl*vu_E-{TH7Z zoioTDSP>_J{9GDAX@}HtR;C}zemoib!FJ2MiG%=vfYP1BxrB@v#~Yozh_mNfHEC0< z2AabNF|*iI$y3B*Riy<%kFd-RuMAN~PqQ69w*2)h+qRIG^`rGGuf@#z;twEwBs|CD zkP61;Y9zkHx8KOx^nxx!ZmyVtz6e-UxKo6rCDvwcs!Mno2M?dZOLRFT3q-A7CBpZKWIks=^1eLKT1!)(Wyk)BPtW&%q z?BL7V#-@|PYmQ;j18&uW*2jv_*B^+=1|0X2F{jSDBQ^Q!j08fSEhUzMUB9}QqJD}? z3>++8nNrwt1_lIpape0?oZ6 z%*ffP3*)lndxfZ$3yiFo<_9|d2Maw2R1?F2SuY;9Xi3=aFEJl67js1O{&GQ^SW0Jb z@v%E&nD>~#Nn7HdC_v|4JA&2ze$-SF<6?!T&t-+_UWw7U!(t&%nT}5s2F-~!lujMh z!}o%7VbTS;H(NGwxR5x3Qt&bbNh_|8Bjz>iWl#~xaha8hS7utZgqH5Bqk z#d@eJwqf1yZQFZe^AGe_tgq#qQ%gLUo_7rr67bOLlmf|KzTfi~UT0r`3j^c!7p|sK zsP4}Vv@|g7?fsUtUE5e{?0)N3uK% zf)#f@3s$AlL6yC+AsjEoU;{%tu(!&__C6~a8GF1`e0BLP=ECH#gWN?aI2m!fzO}__ zkhx`y3%Vv;*F|lnN#4q+%DkIP%-Bw~+H#0!fos;dsQf99I%l{gPv;iY5S@3Z8y76S zY^|8yGzFWEe;yLw&Bpip#uKu(yC4meix7WqiuM!cI#2#M)t-Ag2^CGRgEOG=85RUB6a3585mp0 z6C%yq@*rtv2v|@GaP>^@99W0|0d)2YTEd(q^mr3uW-j#u78FYA%MB7uZ>It9W^7d2 z8)8g_&j?G#wy8UtOSZrH5)Y1l{zWq0 za8#O`(>oW{+RDY#eB7|K`+JV@82C(vCQ2-O{a#;jH;2CY8ha^M8dANuL`E(H!S$}6 z!M7=@P`3#F$B3~VuKTD;rfSg?!1`-Dho0suo8I!C9~iX|7cqBBu<*K}xPYJk4|}(Q znlkVElakEr_(`_*N$H(4@{t~Ju_k()k{7tv2YvS55ZRF<8O`EyLqh3XYq{q>wL;BD zx}s_vJCy0o_!LNcMxS0Ey7HO?s&qFInK(s{JW3%^gc29^M>od=hDY{_=J_2G2L~;J zIu4Q{69!)fyx{^hAoOSi!`&n&H-&(?oA=eWo`-~!DXIei4r%8wFc=%o(<9`SaSi1i zL{O4nJAAta8nLrB(-I?xqqPciBNbxr)Vo!;}=+8vDJKq1-}xHO!yk zg@LXdl}D#zfftc*iV2=QiH`7vBoWTlBhvvzpVGoT)$seZRRjvvcNihOTR##Dy*4|zEzv6rV}W^jZ*4?&tU&6a<39X+zlYEIigQYK!0XAbaMamGb|yI^Dy2*s zuovbv>A=k87Y?)dV`zsw#3yed)TE@CK(fO78Klqa9E_~6G)?2h@8krHMrL%XsO*} zm)FI``SHze*p9ud;D%=K6VP(6rcPNGo*33v-7;wB6liZbbflLTWs#k z>pj)zFjL20^}LZ0%e5MOg8w3{(oZX-`4VgV!6(@4<#=umCeSCx+hBagdzZa$L~xM% zP!+4yyY08CqeH9DY(Dy2-Moc(2Xkqa;d`vA;`q_;RbpJiK@zY&(eSICWwhZ=%;P0g zRsMS(feT;OoE|EcT$7ox=vC8eVIK9BKQkeh+v8QvvXzEw7z!Sum2_dQA)4i{==an^k`9M2Cb{Zv9CS&NQ>-0@K;}`lV z;nFVY+ZgtczV99VRom$0}?HRI9o6lAWm1692r>xEY%2nR?%;Ssc z+~qyw01vIRD28;C_IBl)Go?a8QyHh_U2;G%cl*EApR7RJyx(GSPwuDn7mrPLdbNUH zg~^v4V~SV@l?J!JOSPM~%%tA1*V3akjJ4 z%Gl0XU{en=_q5^b<~cL}@^6hNkEya^n=vseiu&#bd?d zmtw3`PO+2E>>qUos**;N#7t0EM`d{-`g*o6{Y0q*1}aE)9>23&vy*LUkX6FVUJ?EA zak7M)?^?fV`^59+4~N9A$X?5gqH=fo^^S3-N(sH}(jtGkpPP|d5{ z&jAVicCM{Ws(Ftb2K8f=^ch4mZd$6v$M&72zFD*P#6I%}t2#MoOV6T$a)bd?r(h*SXR&Iu#hBNcvP_Y5rt1Rt-+Oedwo>hhYFE9dDw!sH4+Tx~9>9#(Py) z{ERvCVWY34+0aZm@%&e-iQxdj<8FH>#y0->E(NvR_l?~dAb{Zc@m6(rDZ*Xis_IPb zA*AOm*;mVFYRVhMmIdPSHl_9tOqNNzNtWopj%DxKa*2Pw?2Tyzn1U17jh)*0BW0-o(Asn}`iAF>gQ>r#-+X zaI!VS7x%le$KnFe<0G45#`ygzQ=oIw<)VswXOTVwd(A`%Af?JE5vxZ+npWZ8hEscV zUMdJ)xKI_gfjna#*x1KdMpNDZ0?^R-*2cEtY?LSe$mxryqG{j`@2H(kX*K5=fc9dc zci7ZH&z;%R|!}4pN-G6q11)Y%jvb1d@qB z9Ar6xXU_HKEnJJd)u^le7Vt?h?Ii=GbLILO+*9cWt;*i8{Z4hav(c|fzT{J7lSHHu znU@-F^Y6%qEkX05^a$D^Wbg6L6XxG%MdavC^npy;U75a&`Yj5y&cp&k$ad52Lu$Ef zV?xJ$+_f%yVS~GZR?NRz{OxEYUxfMNY{>)N)dyVE20`@UCq+gwJE6pam$z?kJrbz$ z&H9^Kf{MIOZ-hp&FWsONc9kRC`>1 zagS4n(aS2ezTE&z<_(xl=Lygp3=E0cMn32fh%o6MkI+1ll&na+=1+xTfXLWQI6);k zB6_5%=5Au4tNdddh~Q0-9|jyKeXvN&l`#1Fc;KLIG>W2)ylrR%V7z1E5nT^xOnHm%{pl8CpR?FEU^CgO5LO~nJ?n) zfZ(Cv4By~qb}|`KC-bB9q3^zyC>C2=-4ESD7u|QX0#M6yWEJw++?j#Yo#7HN%5e;l zLbhWf>RwgAlt1N+tu#2dLgtY3T-7^vj@V6ZG8Klse{%+5j}n3LC!gqiv;|zfjPnjo zNtfx2&r>;ultxm`A^!ATv{$5UXJsFwYU1St7Z^}~v$|dD#CZ1DV09k%b86+EZ*%*g zyi3R*N%SvXf<`%IpLu9oi&G`eO6O$8A4aT?_9=wshz-(2r|247(J2PuyD?I;OtM0p ziA(r)m0(~tD=r#rpWo97GQHu*;`Xr{!oC>4I*=a0^8O^Jth4yXmr0jJ$_<-3SVSCC zW(mkm#5RroM3V3Q2_SPeo5JH6+gHDbx>){%#zCq@Hvy|3K_Jay4CrU2m}SNDQcr{Q zFqGhj!19b?{cE)TGOSOSLAhq7;BaQ4Jt()#?l0a=dHnueK;?syhINW1i|IvH1`xAC zOe#)G z#$q|=<^C|3r3~hAD;Flki-W@ue9J<-thB-EXwC7xEke98o)kRtr;A-F%tqi*XPR}& zj@NDi%F>B0@$_mPL0qL3ONRigbeFCX+(qW;MRe1j?n>41e1tVX!mLEvJRGq+cE~>c zXpY{vM~l-=P%k}yc?UpMWU0SE!IrWCbtG!LbTveNM||0huz2ZWYC#j5z3Zjmoi`VvF+ZLQ)1ZTWg|sji<$#DDX;bHPc7E1gCi~$;d4u)7;vO>z z^MNZGazcmpRW5mQ+Oox+T0#+7dpYMlzWb@u*}_nf@2<;G=H`pl36~;Z;slXxyn^y%= z#`%{!;V{9h3jqw}#Z{F{&v5_KS>aZtv8>_5kbbfHreT~?%{>EN@;LuGTH220z(%^+ zu^apev7jE`&_H;XsF0naRmJRe{GF>{%A*UCShJUO)PR)H$z9z(1jtJ6r7(AY!%f{< zz#$LkLs*~Ege>$9Z}1*2?O7<5vfcLNqj_EHtcOe8cK?B8`wTB+Jbuu>O=XT|EGsGy zicpFSdGyH)tZRH_u<97t8Z8sMEiTdhlYk3+zSn?-H!$*ww;~5PF#9}dMzx?-T^PR}1Fm@{ z!Nqn?t(Yt}7$$jm`VX;!Ddcto)jywzm|R)zf^cwJAk?x-_`;=c_vxL+|BUv$3x1fn z>hY~}fhr_*Qq9pI%32o>qc{w=%6aZj743&oFyr)5u%V2E&nzk{6e|#QcoP&@;uFqc zmi$wTzS9FvV@@~IGIo-N`fA%H%3y_boc<;MU+0m!J>BqLu#1mN``n}(PKGFq8fmhYMB(Cm@AgcSv<|*xj(lLMw=h^Jz;q}U`}LOXU|?Z2sRsk z<<}dHw5)LkB6Clzf5drn3l{_-Mw3RbEl0b^75aRZxWj~|IsHYgC~60iX=%qXLo6gs9C5`q_X;{$kIy%3B0hqWDwj$J z3@AiVM2q*o4Mum|FrWY{bHCBWJk|}dHejp5zD(mdG+zDq4q+y)a>ftnbxsp`K~r=< zK2)kpp22p*U*#f?R2R*6?0M3}7dU8hEX1d)={m@8T;q#^8nNO4(k~3wYG-3s^zz#o z!=O7UV$doyd&tv-7`Tc8m@qAH6j!l;c z8&JL0!W<83_Zy1!rv7|o)l7j~tA>5_ES2Yg{bY+?dXX@Joi#L>DkjtZh;#CsaU^t> z&rCh7Wy||T)Cpmer&P&tuf`DO`gZ|o1s63uuE+kHsv(n-8QQ-^XT`f5IMza0F`k<( zFYmxLT@2HX48CKAQvs(`^*hR@*c*l)Vrg%V218T@>Y4{=jaPx0N}G0@qwt;&+7o(Z zqy9FO;J=Q^bTrl))h1%8s^mME;lbn8x*(4yzx5sY{(O&UmlnBx@V%>D|SF^u8aHT|Z04Q)PE3v9n#Qk(4n ziEsu!cKLx{ns!|O0>p`?+J$HT))p7%G-=?^ph05{A`T))(O;h7Q&_NJY9^7g-J2wv z&Ftf`{a}ZhUNipox_w3JfjsCJYjYS$u?pEUI#;bXqu+sAa1YaYKw;_F?uw8ZTS=83XNUyi?L*}jii0#3 zdbzs|NC2Z!<$k6~t0xGX%h#oiclaV`QC8Cv$|x!q`G>!)HeCn#+hCm6kLBOmb0}yO zSAcFsM`_!$H0xcXi}!f*Qe)MX_8ruAW_Lo@IQEAdEsz?R-7*ND0c<<-uv;2_Tp0}) z{g=Tn4w1kRdlGsVPKm|16shRko2@E4)Yt7O)3@1cNhi!a+EY&vu>K~6YMv)%Y*G$L!C)_ zatb}B!5BG}nfonz7R6I)p@qx(&dtgdK5izZg@bOLt~f@T-P>`R?uo@o{$GpXy63mA zp-CDE^?CLoV`8>`4uRLJ8{Zl}|9`ZBK(({6u{kYtQtPF_#1P$&>Q^jfJfw0li<}Ne zCj(um2LE^{ldZS(burT><5~_q1u{Cn$2S5^Yd*`znZr=g&+Y+W7WmglL((2){)HdW z&){06MiEtlKOrU{_XdlQ=>7^@;<5@gUXY>(9NH{PGMcoQfpAq2_|u$RI}CkOSpkzREK@^`VH5<@;x0&XuL(NFyMA;y-*=|!>pcSljGw$%A+njQ=w1!=I6PWvWwzx_o2tVg7- zf!bgj8CYIYM$=R|Sku;s(3=)&@3}tb)O2)qnSbCyz7ol#yOBq$r4F@Fq^l?QqG##< zyYgylmNr{!8D{urRI7Koy#!cyw|C5>X%{hRm5RCcgZZ)R8&1#iX(vX8T}MRHDNqls zln)h8M>mMlPc*kTIv5GJQhPfXAz#S5Z#PCNZ{*LfMHViDof3;&W{7x6N!Ho{Ff1Ok zR3J{vtb-ulnQFLW7e8B520cqKWJ730TAYAw!B=&GWVP|45$FDz*NrTXx|hH}zVPa^ zonO%W`5&yo-#t165xh)w+DV*`yKKfREL#c3GQPj`z6VMSAe%(;<;-+f^7l_Byb_^* z-Np3D5U3gP7bGz%iBL$fQs**%TPmad3bzXov%iL;{7V$unT>5!U)TOb^N)dKgFNlv zeXMC(w_{<*>^!f!i{6TenA=)kakV?i{u}XxA02uMRsLuxT_ZK;gUg_2#kO;8eP`I?enHi_Ln~M&IeD(dA=R*b z3H0!Nj3PdNOX>e(<{Z_Ts9(~0-K`ZivU;6AhH?>94LyLE=FIa9<<5(>-D0ln;`cJ? z|C@I(6r}K%?kNW{9&x5lC(yKSastv?Y$ypH#MdpYr)xwI$R&RK{&RGc|RFa32Oe|Km1t;5f zwn5tbCUOSD8hnl9pE_~(cf^SBKc0xy%GN?&CSMX8{D|f#Y*pVi0!t&9wxeCeeMyLV z{Z9Ol8IAWEn7h)dQv5b_$`cc&n_+1Z<`7e6vv}(MCC?b`@!wNuEZVKTdFOyOZW{yn1?=i{y^PtqmQj#kE2 z79p(Rmh~ppm?OH+&DQ>q-Zn$!4hWlmkYPwEkS3o$ybY&&-d#v{`+Qs+Tph~FEqA)z zn4ffRZpxnb_&F$2VZ#&ylu8TQ#e!olPp;RzD`Odqm82S+FRWpJt!m_5Ehpwbw)n}S zWD-}OzF!^^D7G_ptcK7w@|Q2pp6;X!c_!-GxoW0*1=8JJ>Sy=~%qgxHbI-d|ukCpK zMijn9dl}E+y%I18-yd?Xx11I~v|_osvw&Ss-;wbrLZYH)kNwZ_K3r^JJQ70^u)7=o zC3wttv?+H0pL{t-q_ql+b~<^Vj5FtsBe^wFz@9eLU$^OO5W`F3$u`I`c(ZF?yNoXun0j^ha*JH}{r-V(lPh3j;U#e#dU{nFXu$xUri+GLdf-Q3jxzNvhl|#v1!I0)p{CL^d^7O zV4BELGI3>%5`pGBRDO?hNOr{8qd5zZw0Ewf-82yuipBGnQ^ATgF|x`>x}}~qSEeK% zH_i}mW$Qj4Kg|1$KSE)sX@UT=EFjSk6Y81ZYSaS_%t2H;K1fvR3E|yW&~&t7hHVoC z8Z{z%A$dBc3ka!47I^nbKHc&;q*booT*cTmeDOMq-n z0NPs!mUjB`$TRJ#_a<`S$A>_}~dLWOXVQ<3YA}a||)slp87)UGiArE$dwP!ilrA?LS^$6SabpNCcn;QdAYUa1>l8GOC zbrpC-ORvk8e1_!XqJ1%Ug6!7cMoQ;IS##mHetqa5Xg!o6-K?=-{W^TSC5%0d<*ktt z?e)4~!)RM_)?>RW#(PAVsz^tu^>`!D7Qk61Nr%`5bwO-MQ*!ur{(gx@)pD3Ghk=bZ z{lPRIEUB9+8P+<1&=M~&YE6)ghH*LO?hai13$h|&;eNN&eQTGf!G(k#i&rym#>dsu zY#8R{#NE(#E~HWo9W`QI3QGj5rV-N_mN?inhcQ2R;s)z-bNia{z(i1iai|C}5>R=9 z8=n0w^gv}XDRcb!Jp2QW1r+&;Zuy_O2mdJvnEn5e{Qs}G2mi4{ugv&=LIVEpb%g(~ zf$(3f+ORVHmrlZe9O8dnH{kgHkHk-DtlMr%V*GOwmSjLtD2&Dqc5vgJ&F+98I!fWE zL_7&B8tFWY5-!%J?q5_k`I;4z{z{p7popzFUaqvCW_`ThUmee0ecb5leL8=K7GI4L z>i51yWOsLU$!h*f$IUE|$-%mMOtU|qlUf5>68(-XzEqvm%`KJ3?LHb?D<51En*RK% zS}ZcD412lcre3p3@}q6JnBE-!?9@w@q95JLpe}slOp9YYo(!$lt9=M=R5K5)z`j4` zd1%zNYmk+L=1328xk}ls`EhvDaH*Nfk;$f38`Z3TIu@9HyleBNCS-XcK9nNY9~bK8 zU9J43;Z>Ktl~fsTYig1XH_$b#hHpdbi6P++e)asgT{RS6eI4XWoYs>TBiDkXy+U!QAxy;Nb-VqlbTY6v zNf6}X^;LH5w`Syxl=8U(Zw4NXB*J(`>bL?giMV;uw^OrK{ls7@lz7~V=$y}XK)~_2 zDUD#e#GZO7SMK}MwX<}wiR+cJyMi`q4!D+*U`*Zat{bg;DJYyXUu@ro24j(x99+hW z$1(NHCW5dvwzyic8p0}21UIaqT256-y1I{gY2E^VOhjxxpjDHubp~w=98H>-CIPmpX0#TCU)d5K750tD}tx10m zfzf@FHc3mst>Ecy$Ngs9j<&9BF+)j}*so>>Vr!zk8tOUQsAO@XGV{be7WyzHJ;5wx z%D{`exn_l{ulSZ@xx^Lqf#{j9JK^z8z~>)^H;E#9W6Z?T$;zp@hgxwYM0Uu7_Z4wZ zV+R)*H@9iM^{%aqR|}twb5dFWoHT8OEbU8!iHz1kwO<7(aVd1IwN@en4Tc@9G;x4j zcRQckc?rl%V3~$4Hfrv`MxzC&4VP`~g<4z(gR@OxhVgD~>s#j3wEne_67Z zQdjdQtUiy(P>mo1$umlU@-c8_eOZ#*hE)kBcZi;a!RHix4ToqdRY_{=7^hyMyo>27Jaf;ZGjGJb(pq@oJ}FEhipJk@fA{o1v&83DZ>Q}XIBr7S=f%`oY?pA z%sni5#1gjLwJ%m%ZgL!QA8g`=x~!i~-wgpu5GzNG0ru_u_G3^s`5OigbQW;#DL9VF*`QzRN ztz@}}U7&oN56ql_H+#N_V`rsx$f9Ut=?144QobL<1ru*8aTaJqS`aF2$Fy0y-J7G= znqU|ap~&~aQ4u4DqEYZQc}~ok!(O?>EubrC{)C{XT*=LOqwt&Rq-CtV3C^z9{S?zD z$-lMU0)h(3H+Y`)5;gFD@SgPEjCW)>tZ+NyZ@Rz5rR@bYmx)K81byw-S&yZ(??=aL zEwfDz3>>a2Nu^_kr3D`cecm0oqUIkwe0xt2tqhcO5d$V(-!UsHf=*FYe+^WhufUN< zsw55;FP2Z#R&&K9;N+rE0Sxi)B?f2#bT;3{k!!-p$R(F$p|mjRQy3HfB2rT1c8dqr zquEM=-UO}G$7Iuvi(hE>36OzBvUfLtTV2C7{MTSayYk>$a_q7FY<|w3=-{D%Vbw%( zwe)qB3Ep%##f-!*i(XepP9jK9!I(v2GyI%&@+RMw>h+-42N5Sn&9wl$9p;>vXN4%Xj5a*&gWbtfl(1ca zuw-sn#Qs~3A=?3m+ewS8%f439?%;!h$OY}#u@(DWb(^*T9XH#p7@b~fJ!V%4#X@?_ z5bb2FhU#$){GpIxjd=zTkXZtgEk=u8p$TE9MOKWHyij)9UrO|PpM)^~t+1DgVb2(^ z&|%o8$OM%xN0%o~!hO9RAApUGooi6m<^noVx<(|ynyH>c;sf#BY9Tf)#UYlG)xU3HiW&QhrUe><9fTsL2 za-chw@{9YZjZjj9i6|~mlI8^{ffZpjsWnXAO_+?JIKTs3TVH$8uOI3 zh$zf1ZkKJoB2PN9W=?S`ii}0ftu^t0#mlA`V%z*FP&9u|t!c-C!q_oN-Of;7=fg>j z-n$Q$HNTJ%wAGX6aJwM?jCug7RXYaKX0nDm+oZVol0YLrf(zId zWU{ZIL}j^2OoX8_IPGQp^)7k2P_inX5i}OiPhEdJCewi>1;zo9uCSGK-FQu^FS)rc z2<=#|BxPswZ~z*_We_FlwFV7$DlAag@rchVkCh@xc6^dTw~qv_Tn}xNF|AZxkk|_e z_saRiHh7uhppZWiM>p^;Kf3Vh0~9g$!`w>8q^ecpx_F07LLb;s@@pEEl-XY>^ZqQu zn<1>oC6-jA2KJlxjX}C|K7By;@XIe`$T_@exm-4JA3rwaeZF;4#_FmJyOalIZ({bY zO+uNHD@^!`Z&wS>%-kN)kW8ch&Fk|!W~?JZk$#f?Q0bR|&x`d6Ab0anv%~5qejJ61 zPp(k_Q&%-AxdFPI&n*0=`&b<#R>pOwP?=cB#PGOOg+TaDb62U~bO!)3qVJu~$q%?d+wt01~ zc#|aOP`b!0khvgpsYS8LXqlunGw**9NNC35d1f|-F{ecUWd>8e?G%yQEv)=bw7 z*qtv6W2|3A&w2$=g$H>aM1H2iG_wQqGZ+oBo@t^wc@AoL;*))-p!@yD)^Lz^#!93E znHwa1r2JD3+RB!iStMOTgkrqJt5Z|Uey^XtCc9eLMShix0bN&GC<}{yQu^qKElL`? z*IQ*)=+nfllUppOkue4RfcS+S1~=fKQVIlnBRxB}<9LHC76XCUGD+}DyzqDbfTom! z8mbiTsq}{u`;uzDO0Ok$OO_^VLj3v~sbCxOMFmPD|DK`EEArzFU7L076eV}emi&0h zqt4g0zVa$dvAW#(CxvafpzDf%;=@U~d5^S5XWb`TMES%f(yix>|69IU<%hiG$90}% z{>6T`mu;8#ciiXq`|-7Qx0^BgeLq~?eycGS|1=AU-gao)Fs@OdIslQ?m%2u!U~Yl&AJCjo~2#L}~=L1FyhQiiL8)TK@U>ufSl8 zP9|st=SGc^mDG=|K(YU#M{9yu3T*yj^FDqj50f*rbufvJrG0S*53H-A5Eb-<+ptKB z`0&euB4Wdl7M40}mMz=iRj2U}%`vQwX(sc4oL04ZDEtkzNbUBjWuG{_P^Y!t0$y5opO(>g?n*rI-F6CLy0to3`x9KqKpJf)>u{oG?Tx0_bt6S%~ zz(r>8e2}3KBd1A5p;#C@;78UB880KU-Tsj5`Amya_>~ki=});d7WN~L!Dtd#m3xD| z5gMW3?gOrzJq{ly|J^x_<6OHc$XuMAKC?o2i$+PvKS$TGZKZ2`jSVVAH2LzMAb|2Q zX++@CmMXY}2W$7sbjNSV4eUdUXrBg6mIEN$WZ51IvLw%70T(GL*45$$QWGHt}3!6;qbf)J^MkQdWIjGe0k| zF|6;Go8lMiM3FO&2WK0xZy$fs@wAd2lgWe%_?a#!5&67T-(%}~k{Ay*|14QoH@8jy zU0UvT*L=9eJ5Rp04O-$i+d+r-co@sEmbadgXO4}XZCrqN>AHMToI6ps3r+GP=XWK~ zq^mO@9La;tY>A;d{{6Z++fg( zR+e9xF1CJUR3&@LBkms2$n=XZGP+;+(}v(3Vd1c%xCG|W_!T<|h+&>weVt+e;Yiv6 zeh>JQXetUHNJ5`%on}?9vbM`^+^3+Km>X*(l}m%Z5pvZdo{VfjcF;*d z(vi&JP|0Jh%!?G=CbC0QzjKd^-0JQr8iCc;*g+{Aqi;jOkKXb zj^(=NHp$`qpY?E>sQ|YU@cVKpI3sBYcITg}rZw|fmowpqD$rT@{7^K)sxu_=#% zxBQDhuj}?!#+p9bf`_Y_fmEjJP%%7%u@~G^G_>b2aX&72GPjQPK9?;?l_MP8dipA; z*uhywvJan!3y>}e4o8^PN7z7q8Dn`D@?%a#sj*Gm%vA@7?v;-M2^_NIMlTM71a7^! z5*eZbOyZ*4*Jvc8BeJ0u3COS!|M)G4JtSp0X;On62srb$%cB_`TPQMdP7GnLK-SbD z*&8qX&u>I~1sTToi-9j2`N#3G=lX=?5ML234>lAT7TZ1$(tQa7{(HdykJP1Ke!_iA zDY2Zekxk8lw2Tn}Jtk_(fke1Noh#4ZZ9NQxVL2|0T_OrFw>S2%8k9=z1D?9UlEex* zt^2})9b%AWj|mD26VgCEfcb(P96olFA~2bdc2LEzdLwXMiqYqNj?~#@ ze@C)4iUw5_S&vy0HD{btIXPwCqnpNy3bw~xL5d%|_5JdeoFTC3U+kp%bna2|eqkGYzbt>_S@iEmUX<@R= zoI{Rq5p4?LzKG?)b$X*07SDMLMiwH$2E;v=N#$f-eD)ofM1V_8$QDF=wfU(S`YO&R zgy#s2C8gRB>w)jiY*$KW2P*yuf0IJZGz85?5sSo>^I$b=p?X|}BSw^=uAa_ogwzHc z&W}Yp<+7d7k$B}h&e$|cRV-V(wwe1#xI(Djh$X-Rk9(u|T#XRML{{Fqv<%B2w)F$E zklH;UD83y!TP+HYm~Y`Y%qtRUxt~lCSKzR1sn&ul|1sLrQMH<^wjJCW9t-MKJot|7AV zUFJ7UT*I(#x!Ad&PU-o#b;6SEbO_uj-=Upw#n=BV%Ah@Ar-oYSDeOE*5SY!>rAzI0 zfsQ_0p=0iMe?5BpL)`}e^YyawU-s(%OQkE@|Dw|M|Ic1Mt)m@L0ELuu+e*%akRzw7yM?0u@yJ}9iZB7SZ`WdmO zL`z2uSep_K9Q~}aMuktv1~hyk=^L%9@X4c)e65e!pbGI_w<(}5{9p@8YRe(2-^~Wf+d?`O zB0tLh;EZizse*fERQ^GNPUI6LFR^Y(2;ug!;yut)Rh=y^#zKTONz)qPy5`vKWXllOS^{2(!Vo)aY*x&`_YIsI7dr z_(9wQIr3&n+zYqBKmYYk0Zrg(oj^PnEDX5BuSEZ(WI?p(uzd_2ti(nCU`cy5 zTgT9NNCv<&IGI9@R!Q0t-ii%U}YZNh1hpKv7 z`rS@1huDo+GSN;UD3`b>gE@v61IWN_93gBJyj21o_stzPQdT>FKoN>bycUJR&;>jB zKmsp@0Ky_W7mlVlBv1zN+SN$8v}T=%NWJmX)n_lM`ab=WWSJ|0_0{HscSV?E>=qm# zQ4Gof$$N_YAe>m9HW+-fCmQV1!g#nt|D%$CL6KuD1Y?te578Qr1hBe(L1hM)EI}B! zAN0rq(cp58vuF6w1N8SrkCusNN>~x+45hq9%Max;og1}Tmj`Ae`?G)P{y+< zKd7$}@sPb#@mZM(GwkE<4HnYiLME^nc=UkOdCe8JRJ@SzDZMcYngD60HlposlQ$)O}lW9Mcqfvt_Q} zaWrZh9HF0~@(f@MN?>FM)TGbAJs&rUJ@&2DUBuqopa;TJx!5J`Wa5rO*6DmhO$FsYv5z z)+2CEbo?3x!Uq^s8B@Md9p;yEQhIJeoxC$dI1N(Ao$Wk7X}Uue_6tR{uL zu+>80b>M)RWR)sJ=U8Q%;O2^rNX;o#MNw@eMoPSc=1x5U^o7m?q9^;+cUW^(&>_Om z2MZ*U;Fz~H1{uXAY|)n+$k`$l-v~EtH*l^a)UQzy^7ihj5>Hb)U3vz> zE0?V&93KmS|OM%jX{GShZM7! z09s+&={P_cxU3jiq&H`j_Xb(Kk{<5M%Xr9!ia=4=u#$l6l1fUR8s}_ zaHeFkW?^-$SL@pu+U=InDcbn}y_)g2hg__GZpBRFx)9Suf!rACoz=oV@8A8nMr!{! zg4ychr;5b$@V?QyS>q$&=_bW^Sjb+=k}#7u8xMiQzHh;M05;WZwJo;mF8L^-&&JGS zX5fu$CEU5?)+#UFG_DfwEUMVX_X4BZ22fmS5RQCCc5lys%cx>LKJF12^P-seT9Y=Y z%K6az$0_eVr>79$Q7Xg+yRqJ9jsuyF2tgW){+h}d7lY|Pg5nyTpLd8t{tYxzf@fP+ zNgxIdM`G=oa{c?Aef>G@q&fia5HDNtIQQ|jua@5M8zd#_wI%i}d)Pg&*VPsb3yuRh zvB-}QlwE^t3?u9z+n;_jAwL{2mP`g%d4 z?h~y}=d(J00B}X+r{RQbRR9PD$C)poK48nLB5fln@>gL>KkBLj7@=$1we!Sq?sPB> z7CcYu0j3?BT)}sw5eMKM_-<91!NB-5Tpvlt@Dn$SZUEMeN24(_k;b3W7OH_&Yxqbu zylD&!9eXLZR4`JbXD)MTGBao)GE@-x4jgt)HKDtFfm-6TdTuZ)4vyFzt2rT&v`y5e zPvq;DjmFeU^D1+y(U>yPr3ckg9~U%zpXH1LIl3frl2YhEc8GHk-(|bq-;_3l^^Rre z(134+vyJw?oAYV4;wSc+SiaQ7ciYsAlbT2!-5Arg=vtV9Lw|l#exQ3Q(I471IrDLQ z9G@rZSTM6VIv4cY3D4BcU#ty}Hx@lU)Dyg4!uYO)$$shHXS5fNC*J9u5}IPNOh-p; zj*`i~K0dgeCktx6t)EiGzWAeo$PVS-FAvlkRToki_jHJ#x3=e}T<~-_L)h}5S4Ixk%fT%Bp@KNzELoZI!$(1K^tFws7r zWWL2t*5{zzB!9joz4_;iuP5Hru6-NJt)3aygtK-M5pC`&U;2nc?{%TTX9%{DJ95K< z!HctRKOjEhjh+6@8+aZ>bQddn1db(!BiqcxRP9wk#~1pu6)&# zB`e96kr^07^~IYzvqnXJsO`^cCJlsnc$?%hGk?9XH16F7cCoxl36pk6nf&sNo~LQBlc z`qu^Lx-0zNUB07g*gqCRR5mdz?u#p2&?aSR#@sY|I02asvibm>iE0j-mC?bu^iK=Z zh@C*nmn!)mYA|r5HdBcsWR2jn^GDz?TKBnDIQf$gzn{$9f}rr2@8Gh=RhS(LyKQ&i zZ09pvDDiWZMsR^~9Sw`ri%-Hwe8_e?`3kI>QmJ6L@}iWpIJkX>D);vgDSV~}Zv(1o zWeEz-%H(v!^IVk{oK%#V7UT+Y$E)}k8F1j9H&6$%^?{kFXfDISD2dB=qxKJL%F{rt zU3Rk3x?A>y;is1vrU1zV{i}GA+Kuh3C_@pPfELn zwAxz3<+`I3$?DX@egvJ{L$^_W!AxC40wKtWn-oQ@VZ~2oR z&{l{&r`hqtyvi6_jkmOAd3#2R6&&7pqSwRKcbawtXA6L9N7N{-zs!EbO%vni;oN*# z;~cja7!EqYD};Nmo*ZY)hg>be%U=9?Eu8Fi3cMKbB=rbdltZxY#P}V@c1=)&Frz{l z8(GTcGuWo$Ubki^ir2eWW!(h%BdAwiQs52-Um$sl%veb}FlD6C7*^&C(tfC^)c4`& z!ESWp`B$_V6Uug^dnEb$bIuoUn=>aXu<1x7HWUunT$nJrCOLtqnIQcJ5JjLHdrv{2iSeA7eS2KjOpzwDw5V%!<%0`xz#acp8Z+-5_a3p9w;;*r}%Yy`ILn)QeaSv zZB>9%?H$9E>g%MJxq93!t=<~k6MPOCmdLDu({%<@JxFMWIf*YjZeZpm>H^gxlys-p zPJ#(<^%W`PD)Ge#7xuO=&fVw1`E8Sm(hq;Q&FE5~oCTKPjG@FJio&Nwh5U=BGgLOI zK)2l|Bq?6|xANO~wO}TrVm)KnmASgGA{_p$NTO6E9dc2dyat2_ zYnfu4IlVZ(>x6efRW2vX zc?240Axv5Zm8m(#bcPTNiBkp|&@tU(hT9ohz+zap6}3-(&x61gy;DCcF>@M_l&M^L zF3Sj;ZuuM6a@_DA@!a-GaOT}^WiMOd$MMFNW|-GEFH8ekacvp-7ey+$3ry!Pibu9J z@~OW_6Hbk;wbfu?i}sDg-tM66cKPW0ylzjr+xz)xS4H0T{_fj)xH&uPdQ@%6_n$_x zJ&f0EG8O-%9&y4O9znS{zY2JEq~6njdaHMVHI|a*NM_v4S7OxicgToKAMr&@Yk~7Y zURX7oDfE60_!`Ti3M&=Snfm2UioNTOM?;+aC43UJ_WHhzyf0voUX zH4r>bI*eKg%}T}Blh-PIAFGgES5xus`|c=43Z5z>-;{_9V*|u!Wx~N#KO=wiy1M)( zvNl^{M`o_haobp@BIb`0`~vv*(h&mP4PYvUbaU=k8B>3$Yx3>NF7Dphfn(+)LCXg+ zZ2>ne$;;Oi4piM<8%MkCGhH>>7JfPD^N{plEx{&F%-%QpMmBn@hvI!PdBHiR+*W{_ z{b!VkWsUAO2ul}X_VW%XEa+(yM(>I>+E_G4Y%c!T(c`0Og0T|^bHR$rCTlHMIP_H@3^KOumHaR?W zaQ<-J2@`jtvCy5(!f?1sBlsA!j@Py>!I#IhF2Vceb@!op$Solw_3_v% zUeT}gE>9wgnlK)vYSZEvjV_WJyZeY`@x-w}|lj zFy05OGkI2}h}o|&rxtygRCxW8g&1izMnk4iy?A|c_V2%o=y5L}`J&%gY3gxL%?tmz zlGQpTwL4cG(`zZNjH9Cmkk#&79$>M_x4!ShYp))F?jTAYl$V1shKq{F(u6r1i7V&6 zNBBXLi4uJ}ptU%*-{F1So>Tng6I4|W;Izc@D4wbEzMx*&WuBnLbpdQiz`#@$Pipjo zuTI?~1<*uL0{=7PO4(Ps6~I}o*wJza-8CP-(LLrW0#^ALR8G?*ht=3c3=dFjBSHzh zH(HvbP^-n$>5w(96iV}Kw%~Q>Ps3!7iznZC3F#Vky9JF_`dB<4#?d{?^yjJ*c{`2x zaUCUB-a!W}SjlCp@=i0!&=hp8+z8TStLP~`=!{!h)F2tw?_3W-Xo?B32&6W~(>BC% z2W_c92bHx|;7fu}jkqi9!fXfuZRd-&DqE$b5wy;hzaa$ijF<_fwXTy3}<|1AH7nyp%`)c7$6(?QXkE zZaY9yb+s=M#MIMM7N2j&r;G2yNATOr<|?}R?aZ*wzanz}p3dRftv4%5wc<|R=*g5T zUEhQHA=v#vlQQl^Xy)9!!IP|%bk3uBWYo>wp2H(+ZkZ4%NpDx$IKkuUexYlI=bt%) zCP_!e9q4+YPL`hbC-Y~#D$%F`)%~gcc(&8q){c@47w?L_S%;@WeE_fer{x5txs(-c z_z3>NWOpO9z^qc2cx|kv1%Lf|@ZXP_pOw$G3!LtKw8Y0|W|YjOj+-sN^+1OA$VRKX zE|a-Z&~wQq$B+w$RO93%rJ#UWnu&jWdCyp@R~7bmvC7?e$OD7KhZP6v^c^?Zw=b^T!_*5iHx3m zc`^=DG~rnK?}TE))U@TVe!|+WF-$)sDU2i0Y87V&N1k|T8_QyW+9S5uu%hKGy1noXN|OdMLLF21fj80n@`$J^(Y>pR z3tE7rjU~Scl1!LVq2W4EYAumm1{w5lB03|v+!^9Y9DA$Un8$lCY(D4*g{6+t`n53@ z?)?h1JHiR$3+~~Lc?~30Z9cjF3WWOu1QpGLWr<-HWnHQ#j>BCd;#&|*=sk5}1qFrA zfyJ9i^U)pWGuAk3XiOdDUQsh;?^W0@a21(?S_!3?EzGE5u8gqupFK`bv4lp8sX_}b9-W$z{q3}Gee_lf_^0PS8H!TdJcwe+siuw%IBrn=vUb3u|0^m6TNaKLmj!mwHOhOnnyjprj2OB~YO~{nOR)N&Qmh zs1kSV`J$7pftbA1s&n}@MT6Pjr5ryq!HZHWy2YieOPP*rG|A$2lP|8d)YzBfZr}CI z)TaGt$JObe9TEqbOZ4%sq$t4ByA+~rD3^L#=L3PPQwDygagtMzGYqz+>m#V9uv664c%5>s@AyFIDf zW(%j9Ec5<6V|R9+c@G$C>{U6@#G@5-S?t?sH;tqGfHn3x5KWTFgW~E-iFD8VIpnR= z*nkQUh3K;loeSWDAjUF*+5TZ-*l`7Pav(DTQF7bKpth;O6K5m-*RzX)nZL=ks~ z5r&Lvr%O8H2z|D<_yvtKw?H-@xLSc({0l!~g*y^&47KYzJuA<-`p??|1&-JX#H4UI zhVoF|1_ii+ijN!XOW3Fwfy{RL4v6ZvG_-xea9B=B;Bx{J5Yp64>#Jzq0@{z_NFuA} znRH8FYvxn;ghw1NW*Coxr=^)1=zDNy1!Q4{ucnX%t|qZ&q*IvVoXk0xdf`)(p8mXP zd@-fLf7pNJ2Pq!`U!!WOc=4vvDRlkLUrwWhO^AqSO_{=9bl9r|J(ajydx|8h2N9rG zk%8>z_uZs+Zri~BoSk|`4VjSq2^I)@taQdTJW@OrSwqS|ZF)y@^>${Pa)}s_=>RAz8`P}yx-B+(3(CfGLoMzR; z13tJ?I?cmcepSxGXKBMFfA<$<=Kv{UcEmp~`ylFCU$=twM5JLP6SVd%hp?_%C|Tt% zlLaaSbfX@pqZoVLnx%x=?R%87WB!<(FH7bOCRsR3xXEzlTHvj42p!~DvhW%qIjhr& zPPzQC@ft`bh!V^(CBBpjqCcVaQElhAcIP3J+#(Al+TYU$md6K|n`25ZOUuV4EG2=| z;ewF!$ge2`RAiSm1>Q(Nb{^-{{oEP^4emmr1!W?)RwY4VIF77 z>nfF$a{d#_Y3k$Zu~f~5vLP>bCP_+s`9>C-2`n6+#t77_F@6` zL1>UnXtm$>cWV>pW*&&p`Qx#38OR7F_t{&;nv<#JvpA*5E~a>31!Ba%Gc?emJzY8r zEtlh{&2YG)m&zKmx`!j#ts;Wgnxt*h3j;_^C`%>}I_>41>K0b%CKLwWXtk|RTSFo#ts`bL~LpwBGm@Iim zSGqOVc$^fxud(y8yR!87xeoeK>267J#Kn?I*+>uXntyA>QiY3GN2|8iXMH2Ser0NM zOtYbzZR!PXat-W>xpAahzT-1ICy3kG7&{n{dIoO?o^ffAC!=`$cjt`}YFjuL(zAt$ zvoMWm;hhClvpbKU18pJA0m@L&bjh=`px5IJnsC^g=0ucbDCFPq2LoM^32^0v8 zb}8@>P+vtD=JLa;1vfM!H8|I>BpHVhjsdRx7(C74J98MatD56vKm7XLOEh%y-4Lm5 z4i(@l10WWd#rX`f-6`4`tzoMrNLNV(UUn`+pbkN{3f|0=sswjTNeozL==ElpZ?{R zDT_c6_Jp`>oj(43(6i;W(-wc*?hT>`Js_z36JF%DTm*>2Ee7QRSh&u!PQQgp+a56{ zyUMip^^vpbSY}WHmmo{ucZqGb85!dsW(#&T~LN86sS%`@KPGCvW zc;5|Amk0grJ^Hv^BzOF|8@hLzKq?*kX4i76n|mwL`JLqf^eaAnA>O%UFWY)D=eL_! zx|rRi;>m6OZdlTI`g43&*jXW4Vjx)b)I(0RDzv3F2%I=uB<|oFXT4k!68(vta}GKTa&6X zU|OLXVLVZu`GpY8NH<%_M1;Lk_?S?##%llk?|h{Q9(3l88};f+Y}JRT-vy4D)UV17 ziw$Jd;y}tIHRNdG%W{ci+@6MFOWq&pG+_8=HnONF(}OAraLCBeUaW_cAn`LY9)Cpr z2SQCEh3z2(Oybwl(~;g#;qUOUysNSnv&=UA0iPr9U93)KBdRiIvdH;Cv=S?_H$=OY zCbm{B%nsf(%e8uHV*wQne3M3PGS1;42}ezm?^1I~oZ9nLb4?w8nO*;IFhzd)@(fw! z7R6#&(kmCg9tK$IA5X4Le~Vs1MJ;_d1Pe2r3nZ=vZ48|i6AFtGd+|(p`~l*)5T|4No)-wjM%1lV{Lo*bFXQN#6s&M5 zdqoH8)~D%(rFEov7kxAOCz|Hnwqs|4v zg^XWj`|mr433USDpBxg)btU#n+f%+##os|1=99-9me2tVkfws0-bCmh?SWmN5m(AX zGIMdHva~#YObmlXUg(c92@>31E`+aFjaNbPfC;S}DWb8!VGN~H4H+`nVPhX(16>A8 zhpDpgtS5m^hn|Nw2V{a?O|c$E>+6a3Y9zf25v9qm4P-VZ&M8O#ur-HQ;u6ZT>PmGH z%WM6w(rGK=LUDdCutI5>Hy3MglL(r|m&vR`7|TL=t)wN6#E(T0N8>_if|#2GD`M%T zx639&K@UA(u~1C2dFXqWXi`xLyIb=2rD_q2wA@5;CuCWI3A;#77=jXO~ua% zz@MDD4PpaQPP7>0tNynT6H5XucET&~KncSrEB+M7O^|X}yFV8<7BO@)iiJo5WG)>6 zGXofwE^KJo8_GJQ9xV?Io$`Z))c0#Pw0N~oyhHRDmfIx1xaL%vd*%-bCRB}=bi%ve zL65KUyeFTll_h}qBQLBOwd*LGreNNAMXqy4KRG*I55l z;!;}teL_GW?f}vOshg)Yho}X+m9#^cA;^wQJ$)YML)Y@5_*(2v-==98m(%qRtkr57 zUr_m|NPsVfZe z4^5M?D^t6?OwwS&HD41yBji5|f|i&()!CYMXeN;)2@-I3BViwt1J9LsJ!V#1)*TV* zBEcxzxy+1E7I>YEg^4WV&%}rJ$u1B2=C0r%af6n0)ry!Ju#uj}P}jxaQwGPAmo8HA z=dS|^osJ0Y2dOxn1u|y9)#txO$0W>zw32o~#+Un^T2cxIDYKpdDipLpMP4<5!@$?J z0&iI;AM;eb4LA-xI;a4!cMb8iOxb7PpR!J5OaY4hxv znxBRMj%G{vrs%{HWtw9jG6cfGI$_$ctTi5(?kGUM*EygKx32kKS@{cm#ID$8)^bFvpw;m;@C z&nGE;(|`AB>rH+iT>ah;30)ht^tp_3PA4kDaW|Ch<)fsFztDc=`O<0P?=vjr`Ka^8^=THvZKhgQ_6U0#PpKA*L)h>MabZSOx&S^)XDUPn zbi}fs_7TeiPG@Z2xRh^for0<8T-oAE#5W|-GgG!anu9#XGGvKmATr*Mjt!j0#ktO0JE{OUvQL@o!` z4wE2`K#Lrv`cfppbQ2?-I!Dczvd9=R|1nNDY^I+C4f1wY%i^f%~*_%vZD=U}E%Zi@!j*$!BTU-!W;N$iJ5Ub$B22aq)u zYCu{vEES6bNtq}c3W7Fy_i_uhEmBB&A=(PPQbc=Kv$zESs?*Ku}|6Qc;f1Tz3 z6%fS6#KiEQmkx^5H~#^Gkp2S@v>6%v2az%%A*dgqM>ZjQ&3bJDD0qr*&Pe;AM$*cd zI^x%_va_;+J_!f-vjBQMwIhqm^}@vS=>^K~`}unKe3Ut@&%QT1D|=vm^VkUpljb&N zB+-Rw+^`+!8yMd=T(qOi;e6;P?U-Sb%u=9wS0VsDZb4!UcBsYL3zu3im zHSM&$84llvx%OPX@lcl)Q?|3!LXd5hY;L(C@t*w17=tG|~ z_!yJSRoJcieIdGY!+Ay%gC0hYViH&1GQMEv&T}`> zu}0kn10jhPol8(m-hC2#eRHyqmb+*TczGCHP*%YLG&*usK$^ZfyA%8n98@$*!P{wX zryU0-#@_A7A2{LK8$SodK9fhgVRwIWY=r-HHw~-homMJymxDdZClwjlu*Rsqg1Atr z#XCJ}vWaBs66vCd0K=mCFSX%8giMhEZ^(O6MR~fi4&J4lA63h>_80}uLN2IW+Bty% zXqi)|Za>}%H&Z{F-ib5vsj`G&E1K1%yD*j~gfQS{2JwV7e)mTt9kSJ$`b1YGZNtB^ za%U~+dFm08(gd`IaCoCdhb*T-uiY|G9dsuKlZw(e!9I?MhMcp06--5H?pnG4G3$KD z@?#g{u>Y_teu}=fK2yJs>+jpqTd6MZP>?ILFbwjE>38zL~+j=IH5UblkF(uk|Fs*^vBC9P}LexCaly4^@c{-LwTOP`Sb zvZ){@*}F$32%oz-Gz6d9v-o$9tDM2>q+k8JVzn3RyIz{25PnLsZp%k*gbXXS9^R5IJrUmc8aSSubYa1QE1PLV z&bd+Ig}8LuEd2F!-Y@%$C;R*;e?>-IvaxUy|kID9||Y0biw) zF2%7=|L0DC4T=9mg8|5H$riO$JV*iN=f4q75u;Xmt?bh{AW3nh7p+u+M{PRnk0od@beHs}x2q&GK%oHZE43eM%JB!H8AeV z@$t2skY3_@4*N%9>)`V74KQ(D%PJiC*e{0dTdIof;K=_EZ|B&fTL5O+vTfV8ZQHhP z*|u%lwr$(CZP%^2o%u48bUHoB%>0Fuyyv`m_TFm=yq&ED`!UKt@m<&RyTn76qzb|FPE^9eV6S9+Y-N|=-qo3c6j4%`?M%}f*h zFlQ}JX2I*h88GIRa74NT(&(>fM1nG{^FZuFnl`!lEcv$pw=S6(=@=Bq36s)3KJ#5m z$0%d^Ej3!48kA;*!cywClj3xS%7(SKBPqTpn%{AU%|sowLn^4=g4eJo9iSw^f-Be6 zq;0Rh^*hOIwU~)t*akY9(jvaLs!xMwtzo7uA*?7;hwx5T?bs7YxL|&A}DrH+;YO za2AxrH(OxP7AM8!prTXQRu*T^7ZWrM4Nr^LQz!$7v>XpL34RUKg5_r5n7WT>-0hZ{8Wj z#^U^Y(V3jB6$pU*7RFu5L$_B>9aN;A+p}} zLer0^u;-Y45RRf==NaOH%m(deavFp!OHWHj?Dd-p^uFaALJfA?IFn`4U^-%!5TzaH z_U_#kUt88soOL3Bsh($jG`Oc4qJ9v*+V9o;cfPM; z#qGD^;b5q>7H4rYtcgP`qLEm83|<=}*KB!aGSL;Th?a{!ZCq#|f|u?z1)d6G>rN=| zpu1tS>%=JNXQR4DEHV1D$*lncZSLU!nyU{gjNJaIkx5$N0D}6s-K(3_HEDQcsqK5Y zG9_Hxm7MIh*TyTuLem~l8{CmsHOW`!KyOUnt3Y5KL2O3Z^F^nD6l50Q`w!Ly509y! z!>7xU2`RNLT^J)XLPj%GJVI=L)sRZ##dscY*nWLVC_`ikSbaJSjR=8_j>N`AHZndr z@*oM$nE^}Fr&gEkDb7&Fp^P1&v318_DG%}D?2ne@{K#csXQ@6)AY?(UQUo8|C#sGz zEz;%&I1Aw`%!+J1g{BBh2X2FF?h60*X)TD&pZX1hYU!>xH>vUUFMs?aKM(RkZnG; z-X%Vx1yeq&n)OJjxu#eSPx31`M1mf2kX+=sjQ}V4v5cKK3LaK`p%Pl08DvlH580jg zm-RSamL6v56Al0N>V?fJK#K-y=Eb)Eev}c?t>mWf)2RIPLr`xQP?tb<4V z`V|4qVeY#V*Mt#m4G1!Wh|q|1_u@427g674$_7XLc}Jhoj<9lgWf$GPLq{|rnKr8! zCo-9uw1*~`v|nLeHv$0n^olv{mN`vVz~qpG9tmQ)r0gqusm$f=#TUSDcmbv`dtFoCE?BXjG&~N?;_`@A;j6-1FZ+;Jhe$wI-mz-lE>d z-Q4c}vniGV2@`7q?jVHjC=CJYkD`hih+3EW_}0 zz7;P~#QF4fp%Do{n>X`K20Km1-GnZ}TB;Ym=Rh&K?GC*=sFe!~g)SiN=$e*?E^^ znOS>vReMN=uHI@^7Xao)^4#6RiN>(sDx8yEGmvK+iC{Ts zN>F&P{Kg4meQ&5nt47borU{p##<-HJiSFFh23?>`oA0yd-MtXJgRb6$+eSl4OmdRO z>2}$NZkZ>;mqU@vIcg%w*T39pu)t8ek_sIR5@PGOJn^M!jFFyqT4El*ob!=QV}>k$ z3!luXO)h#hpCgZNY$%AHqCYh^)~fUGN>hnNu7dw>_4;0RtUY1BoEhTd zuy%Tz6?lAxl}RQLf^r5it8qHqF!olc2LlVYB8Q-=qRs;dsq^a-$7EDR5ay?EF;%XO zsdQ84OHE6CWASsx(~X~vHdIrKCQvW}*ezgQ`E;S*CU>CoWG&}Z9|XRT8z#%;E}5Ce;dGv)rv`UZ1;T*t5i?#T+u{fZ ze9zUr3cRrKDgHV})<8>msb=F^l|SjS=_VNfD`{>Q!fF!BgP`==g276m$qYa077mVr54hEt>GxOflym7~EE6?5*A-SPne!R686GrMe z4XO=R zGQ<%@Ec9HISO@l+{vBz&_I#;nZMx9$;ESdi;%DiBP8S$Mf%DQmhFx#7!e!iPV(r5I z-6juJz0#)>RtM*g(Bvj#ji?-D%JjW{=LV-%U+b$lOP$z~dMaz)nBzqF3YlG&pHz5` z=_ZOg9!kJi+LUfN7>CD0DOH^+xC?!^@U{kH(%wM7>kUwFve7>Ug!HBIha&|{R*#+D zW_YjsW@4Y_Oh9ivwz~M2JV}6wWJx$OW9#@IC)cg^(If_ZglbtS%sl+y>z2igSc>lQBHxUl}GI09xU-f7+7( zw+c9&yM`;K>M{`m;o;&y;5bopIsg6FU$o2OttH3F(rIT9({`{^_p3UG5`QO5@@^OH z7?VNXe#dzPT60mfw#;ht{8vQWuV%O1yekXO^tPKUe+S7-^(j&CIA8+ z>gCbcVOQI%09~{1nIEv1IG!SA#{Qwpt35(-)#H|t5=Cpb2Zjr`fM`eSM^oTPEdY1_ zTt#o!Feaj({%$N^K(=NA@+5e~b$IZ6GH^!OtM%-!2tpQ(afw3A3fW|FzaMv)4c7p! zi~m~-=SfG3IMM=ZXsF+t)^4>HzVnnWyY=^CT0laB*jjxxsx22>8V5-sl%3}>{1pEb zA{v}mTueLTdYMEWA(j81mxzTTM8Tq-(j0x!e}#aNi!a7*F`2K?yyBs#tT~3*K7BP8 z4*e6j{2*#b_Hdv;hwT}&x)cSakBvsRs~bNjQE4Of(b|q$-W6j%drPHOn=_{viV(I1 z?aXa$(FB6i1H?^C@>(`!`Dz?9erbxy6@$D&&!nc%CBXP=$)N9*3rqfjM72jR(#tFp z>g3+J(B|DM#pvT}0kfu$?=Z)%I3P{ayJ|(|wp~GwKpoPzM$LlSkx=f!Kk4cyA*W;4 z0*)T%#E0H)u3q7@Uc@gy-@S;#vrI0H?KnqsF0E(iH^gagL>?vY{RK$z*Vfe$#Cd2! z{+ru}FfWjz{9%)mJnnGuq96RRAl6QC1XHpbN-8k!x0{diB?!+fDNPSg*Pi0}mSGc` z-q>-VGav*8!Z*&yh@Sn~A;g0UYu9UGw-BTF-^CM0YF5Pdl+rH+tEp}4~ zcz)#!Hy~mH$<&L`*0}Tv;c53dlT7gs7FE`&$c&1qKTN+Q=dI{1c@kUhH2eB|W}<PB|bq(@f$wkWlR&4GGHez zlyquNBAAqH*7eJOsYkqU)ltY5B1G~?W~3_Q7x5D{jpQOPii6OFmFdPPXz4{YAAw`Z zI`eJLXRsV(j^KkB5XXey=7T);6;oPV_!80YnS#j__Aj=cSbMH8Iz`{H#)imGAFlyB4~=)fVMfNF}f z<#_i|0PUrG1Q5=e8MbmG5}n%3G+sBK{IzQ4tX`Skjul_YxarF>f!Q`zk`i;&sm$fQ zgJeHH`k_|>5r)KyAV>ShdLGa(XaJ^EMh?KWDQKVTd1}KjuL}IcN%1R5)~#h->-+l} z6Isy~OXh3gD`~Ocwu_?EV^?7{Vz>f#6_kv%8X5`VKQ~^Sq;&9opy44IjY&;i7%?cf z`Y6!dnEP4o-!^A%-vWAT+C$WD3vm^YyFjf283(Z<eXLhQP{3-gU)f#fJH@z!Z5Q&~MLPW}G-pZz>BHd{LJG*mzmFHeHJIaMwB5ps!{{T;XsqlXPw!-@5 zE~>g_1};IikFxOsS(NQe8aD!0b=~|SDQebIA?l@1wB6U7de)nD#9a~CYfdz-*d-%M zDp9+r?AgZ-0E;xx(E%^PvsZOO$!@(|!8vl7TLq;7iRnS>qViSU6XCt`SPAe_jr{S6 zgx!0^B7UMqqI!C{AkJcDHs(YH_T~Aq%kST61Dmt%YqvXZHV) zA}i7VfABHzBvzh!e~V`XLjUn7=e^$Eu#F{GX=>PrbZ7Q%ce>@8eeM%s=W zR}I&&nF!AEGXO+{iUtq{5k<$jHF?z&C1?TKPKaTpl$4Lhp0qqQ@-qFAF!(ZbbNyLS zDn8$DXJ0ZoIrS59Kgb1XjUdxNdj9>E?=;4%% zcC))-@0Y!#ZI<__iI(Pl89=TXei@s)zhCe_*7M@imQElu38%Q0$aP&s7;;i z!{1lmUJ6-v-CtQLPW1?srXCNA*(YWn_H=Ed)~*0_yz7V;Q77)Oq%GyksDsQ#le=?u z-|Q)pHM_;atB+mC<0<++J6H(P@&LGP>#Zckpm#W@Yo?XlW|wjZ`J`4RkgA#n5a zc7nI|<;~r_NP6c=yxn37d#6v2{UtY$2t*cd6v4t=hJWZY(~!2%5lFQUNg8L&5*?_g z`tsq*5XV6+Uf`OTgOPK0M03vo9(2`8X#(2WOZ7t<>ZIy_MCS;6z1dmHl`e*fNz>z6 zVgvh>5YQM$$p!ejK_q8qK~`acT11umRtryC_6OwBw=SP$H-(b`e}3!zfi8f$&%?s5 zBGym{U)T`2@?Z4awlaE#YH^q-Mz{x2flMd?zi)Cjn3l@fBvBA_g^~%TnHd)^CT$!_ zwajvF$UB``-+(4N#P#(HK6}3+*UuEY96-7;0;hy!$(#c+=BP$|dKhSKv)S+raw45$ z52fM~L0458!udLT*Gi@q>t6wY3oQpw4=;HK-&J%~C3{sc?BkQ@jF<@wf_Xre;(hks z3ZgBTWWVafFCHFdlkIFG_BS;57ZT^cmnFr?ewk~pB<#yoPlFUgKG?M6NsYC+(gn}M zw7?Eo>)WOIi$1hAJ2nvdr=0%GtQ#KfdFo_^g1A&}VA(2O6{zC<)zHeN*_(cIHaV?|1LaNJ z4XiO)E2W-pz;9;cu*Fun~jEaXb;(2)5o5%fM#t_wC>g=2 z9USkRDMzNRwJ`u3Oz;9j7#l1Nmp|~G{TpN|TEU?P)$Hjoh;8>~*rH`?8jm&?AAski zUkj~AsRO3B>%K4zKNbo&8qlMos4+m~k%DuuF$1EQckDWI1#!|_O(TZ4;ZMQy_cUxP zbD^jnh~pRfhT<$<@amsn8MC)++d=xyv(&@tw}Xpgon}Mau|8DDgs=1SOp&uLpKc9< zOLt=!!W0+76C42NJQf@D(b@T?0DX1z!*Jt!3m8HD4|dfT;vwYHjw#ATVV?zJp9e1) z5mFv9#dD;}zarq(0_RSc&a@?cM~2o@lf$n_eYf0NwMbN1S+01WSA?I4kK2r-Mppvu|>$szhGusHiX8tzAb+Yk|UKDO47i zqafxuFP%rjQDO>=5%)LZ9~3z}nUSr~V&HmJQ9Z$oBGXkI3tYZ%oqZ>#R}t6eGhGk+ zr^+`3qqP3g478$Fl`*clxH+m!Ax)8op6_shmV(z{tE0fgV`>MBCN`WAT(|!oDFkq2 zCRHM-KP|n1HVZO$nIEzqq1hlhHj&Zbs;bCGBoL*DR5*jsyH-NZ~NwQ9sYwC?oqk2ikR^_fw=Z+3fbt_^HRIZM3lS zGgE>nKtDeH?C`{e`oqD{#mGjQQ^D|9T;A+V&k7YX7y6p=g=RSwC9|x{Vr#_AVjjUQ z_wuK$PtbrK_Z9exZj>Jp?>x0ugX7bJ7k1q)S4fTS@yQbq58WozkwFrCqLB^w$r2@+ za>JZ@ZoptcDh}P|RJ>-_D{l>ut5RKdK!8d<8Ulj4I*vPpeK{oi>;8g{sPRlw;l4X> z?g!cD-R0=1?rJPGT^u~zKF1CiULa=yY}@bFAeya#(aVOboSvx`h#8%0D()DQAh+=% z<7sjPD#PK(Tna`hJzLTB_qxzM zCOfX*u%=lOx~waXc=Z>K2R3~7HmWX*dQ4}?sG=TW9JV!#)h8NVeAbQUM) z=22R^g!^LTkPA1SV3|TaEF3P_a6G}GL1#qjl3Ei6kvI?b!H#&73L=m% z-hEFN(+(((q|^e}P7fcOv{J?55y2zKPdUw(6gm8AMGPKiMKfg=^i_MyKH9t1R=&aM z|HvM^MqNjeMN2{S;Uli$O;gQ$&kJunp{^9&WDOQj#C}WMUEuUM=jfBWFwb^Z$-hUFrSBWr${!wx2H%8+}agA2g#99z}k067=gapA| zk8ieia;Z@_rM$jF<&lgL8?mlpaEW;OSf1NfqvK7T?!9B&*rrq@b=4M<8Q9p6XNdWV zK>KAli}e+s>`y}8FwKwd(&<=sj!(4DiG&!)42Qfp9Z_T@fEQyWW8Zml*B`z6Tg(*{ zGBZpxbytS##W=SZoxs;~8CYf&#K*VUY-yb01%!$XZe6P%s~NvlgGBPrdW>%nt~lJGUk$iK^NNeAb951QG_YjM`$$+3<=&?+J*7W_iHbABnyL~@mF`m0 zHZ2lFlbE;UIKAfLL#a+>ZJ}i&-4Ld2?itb45ubHt? z%bI9{Jw^BY8W1EO*!=u1blWYq_@$?n+Q&S!w<=24lih#p{{HJ+M;8^_bX@i?#Z!j;FNu`cZdyYmx zLVlOaVj_=AiJxcpu>M`=>~kEp^*6A3o><;!iMZ~PaPNGwiG>M{{ii%4;2vK@1reaf z(c;Lcb4wi#6|RP?E%VZ&nHDd%6}-B^>2o|9tr&Mq)jxY1IEogn$>BNrm8@$$X-y#h zyshh>Qq$B%i^klRFmF=Tn$Y7mwZxUKBx&&o5D9lS0-}-L9`?)2&A4SoS3tSpDF=aL zVD{nk`D{+k8&XaA!y9*67bEguKv?_es>Vk)ycA$yP8~#s5R`CQjCo&6Kya9`i#?lw)7}S==eWP*!ThIaHS{*!RkUf`$Dxh_h$-+fT(Te9XAMQs1#^@n7;^w~ zq`o@EDH30%sG_7KD{lT6c;e*fix=5;Lyl@n{@?x4Yx{2Qt*AU=#ukW_NeJ#XG~_zk zl2MwPcT)P|x?WJ`0j5_k{M^+yl%xDD!%}og&i@8Moqe9CpgmKLQGNRI_!FzEYXCk~ zS{@M(wks?hK(8&KW&%R_(>7>!R5@!w!CNV2*~3{MZ{v`!NF6M|kF9~NUzyXm0p*X+ zm;l%@)c}%&eOk4S+wb9=*ty`Xf#F#j_?`fIV;}Hnn2Z_&*ZQ{pkHm!D1Gjg#5zWry zH7EpAngfo7;6+-Xrs@ynB-9RL6Jv90YaqD=WcQ>mH<#@UpUH|mD~)&1Bmk$#ld0wD z)Vvhz=nCM`W&4shH!({={omRKL<$A}6=^*s)JD+!7AXS_S)%hUSPqs9KJ=a;nH*PK z-?&6q5rgmQVZ*APxQ(ND?A>(dg$VrV_e!WJO7X?N$<89mGdu|Ql}Ik-gCBo3zF1;5 zV&s?kTj(~-2Oyw0Gw#lpr~uMO)~<>Wx_QfhW%g0W@Q@(O{gwos2;@;2GRWJ}SV~G? z(q5wpTw$0b@vDl4nwrCbA~a!J4mpt^LwqmSEM5FxiuOv6P4ub*>-ib!Z$bETN{pwk zAf7DPRKB`3BK@Nj^*=rq4}Gx{v<0eon}=q>4%hKM(2}3|937}5!k_mKM31$2TG}-U z7ammgRGNN;$Kov0Ch@M6JeCAn`8J}Q35rf73PR=H$^4TCr?~(+L`cf1!mEs+0*mXM zHjCJ*h9(1|ZEXC9)J~#EERh)n)3tNxa7QJ*5~0zhd4Pn7iQJaLR^V&6VigJRiZ|k^ zCjH}6Aq1Tv6n;l3PPyvu85?dQ3?p>tfEr=SN+yzzP8y)2>~YN`qqMa*jSnN{i^?cY zw_EynJf2twI4a;*>}Pnu-iX#{t<0D`AyKOSr1D@y>52Bl;FR z7a4@JCc5bt>J*49KDp02-?~Z8Z(r(mV<6D?kJlXnS^=4Yn>4_|B^8ZQl{{L($=<1Y z?036q!DVpuiN@(Z7cf1nBBIMc94|}{ZXv$90y4S6!2f$^wo~OwX`ieMZd|nNMN>uw zBEpDBi%ARnf)+DPEk&B-^J)AO6~ z|2#i_KksO+n(+UAPi1I!bt+;0BgrvG^D{v#d>_pc@}#Y7XZT#!;>JNCj|Ti*84c&k z%OGm1-|igoYI~ocjkQf+?{0iu+yUMDan`nbEL;gxo&`$hJy0a%pKI175>?D)UbO zknaXVcgahlJ}++kP7VDG8x|f6C3>4~7SlJjPrynKUU+ic?!!Y_US_O=j+R1R*B*HpzMpZlj*h;js0f>%w>U#leoyJHFuuM{iC|H!YSmay zx?F+d;l&p5(#Qp+mmN)245a!a$>`(QD%0c>=zF%lPPVS`QWx=zJ{CUH2hdu!iR0xM za8#HTJ)fDMQ}5D5veu^vkZS-!BUuGGaM8LCEn9A+k9YXC<3;U^ z9NnydOWN&j5_=*{E9}GvI9pD){OT|*+@NVDTjhD@F8He^z$+1em(r&dS!wa=oJ5XPm0|*~6BSq60v~0~ zqzv-rOSMEIO(7uHyjLwPTVe=58&{rF0W?|oe7jwWP3))GF_mY6Ju zrPa50T1oQ+L33hArfw>|z`cA3kL1!2N&IbBM!*~|u-RU)lXo8|!0Y$#kmH@^m>YD>!6Sh$I?je%G+varuJ+&jBy5pegD1q*>bsDOXA4yVBf{ z8WVP}A;OxYa$gDDS0cnxV-QJdnc2TBOx;c)`|g&d9VK9y%>r@F$Bwqyd*AQ#wAyT` zjb4(}dkV~)>dRI*P;2w?OK_KaSTf3%v|P0uqIS|WACx2ONGHqGF?4LTnw~tOxb#)H zniyGXLu$u7ZMH!1iJHwL1BT3hs>duBmOrFX3eD=u;0tN(F`sBmr(5LO=oupElx#I8 z)K zk_Wj-JSp7&QiKAGLcM|m2DlP0tJ1C##$}o9b(PAHIyb|Y!we8DU>B43HDfYmS=e6GtRm0^IAeSi>Q zj1S4Aq0m?2G$qE7uZO!5#}Ac^6<$9!n#ud$(KhsbqsDfpP8*9IQW-vPJ9VK4XL~BG zSwiA71U39?`8pl5z~UEEv=)anIL*4q>3ve24a64@Hngr{+$p1Qoi*gOC=mAHm5rcz z7d5S4AHr=)VJ7q;UUKdcC zG=#=_Y3F++JaN_tQn1wIci=gU=@liuh6`a>OKt4yICJh63()U%0&0GsVPm|PscnJ~ zdW|jCa@1yuOX+CGNMu|{{+keD04#b5zL8AZfJ4iK?BRegim|_Nv>A1yDTNlP)FEP- z185eQN;bM@B_ad&7L9~RngQN_y_61WpZxRA>?@uwhJzd~&^w&N z-0hHcU@+Y-H0(oW(rt(IOokzekQ0Cs08J>awHASI{NcJ39;s(z@=3PvZX1$XpRRw) z%YTAdWB(k=_%fc-gU*-1Nfr6REn*ug;|2)Q5MPasxOcSJOm|!;q)o8k8*wsv#N_X| z1~zGNx+@)T%Llb^Dgn7l!}dSRE26MOZD4hW>C6v}P`=AZ z%n+a7b%i)`94`4$q25E^uGUX(6~p=LfWkd5hZw?pHFMUDfpoLB~UF_dS zA#~JX0YfnhEqG5idK%=)^G|E9Ud#RG0lyBkYfh|_TBU;!84Yga0&vDjavflUp%KWC z*Bz_=d6I7nlO&n*dfvR9IUV)j>;S<4NYMEq{?okbKlO*R|6lZn|4+Ti{~Lce>wlSD z{WtyL%q;(Vb|vey-HzCErM{m?B|9nn@7ucFuG7-Wrn(!cG<&;Ujl)62Qlvqmfw!a| z_WcSV^7aRy80W(%PNIInqTBcGgQ*~ zJAoE0WOI-5ZHVu)&~?MM<`lZi^Sy;~nM~j0s$`QL{f_=O8+GHK?y>2EO1nbZ=Zzuj zOtY5m&itvx>*z1tP7wFYm9?G;_wP8brP))-*Lm7T-&`yg4 z-HP>ZUd1<>X2Zri>mB`Da#({lie>@b%8>PX&k4ATAA6RaO=)Bv&nD_?pVfO;a|GNS zzhWZlzbip#S_|8=_torDrBsLNS5K!gcvW{%W^`PXl}!9e@#=YE*M&>*$@9 zAJ*hK-cxNHAO6Tkj(dYz%HGQFpKlKeACuRJJJB_$JgnIoMq2u6cVhgr;4_K~#jhMa z1v0C4d29<^>twIy&G)T`sY)-cGR_yfA*Ypx+tb{nqH0Re8EzwT$wIa9_Oo{UfPn(% zazcGlzFG+2%lPpfum6>~?KqV{uZ$$5yV?J)D(#tRDERdv_MKj?UkPp#}8rpf_ z^Iz8^F4azUKee}6%J>_eHK`%iZ4Q|)W#8bLs;@K`Lf}t-Iy?2Hvk3G&eKI@_(ESku{qhokMA6!#W;gE8GOa53bK$JNw zRGWz0`|+Xr72PU(<=cyO_(fPy6$p|Ssdq4W%aLi=_#Xpm@u1PH0%nJ3E1-*;b zUd0k{K#*YuH9#gmB@#u%QOsFXixGNCMSW32XoFzkbpUl8xE(<(;88l@9Har|7Qt0I zMO^+||AxrKY)!PKLy2U^t~)mjf-zKT5eT>d*y#*qlQ_61+6z+RiFdZ2RLQ%Hy(!u6 z2}1&15j^TuNkMV<-kn2joX8+TqL2G$1%A#)1bOC%0Z~aw`7l);sm2x5IOr~cF}##c z6Z8)#`}Iz#ag#k+hP$(^IL`RD;SFTkiOJyG(p#A6*Xi}`^Tl*e1xE}aDuY*we{G|Q zBI=2_@7E&+Bh7=Y!|M)@5uxRMS%n``L;`HrK ze?7W>5Z~UEYrR49j+0eVfzlpV71X#_Vs$*wKs#6Hg)PQ}3J+&$KCcUwTvpg4rD$0n zPO+@T3;BDU63b2i_!Ia*?K(ux-OIDFU&@(Zy|M(R15rYO?d;tK!Gr`Ltlu3Ts|2(9Z^g2pc>MhQ*(I+(%7$qXD~Mz&vWp~Y zyoV)W!G(J;nh;_jGh}fxTf?=NdA3`tN!>BI`kL%Y)2QafZH@A^d%~rid^P``X#A8g z-nBrLw&8g4^?L^=!B%jkzf^EyuH(ESDV;v2(@CshHwn$*2fk$$+Y=wlnZH5pl?PWl zAd2HY7)_`nlXwwLCmSkLjmT@kf*Ay*gBCy{R4`=UX)O~+6#(HC#s`U-8*rnLDzr-Z z#l+-z->$PhHgBIQ6j5=B$~R2_Hew%CfB`WoXgrJ)H^f@5XCj9qUF{Zðc1r>4vK zcwZ_74il6WiZC&zb)Am~>$zp!wf>DFHdH`PzzWcY>9tOHA|ODK%zvZ7RJzT79hV~e7sCfziugx12efWqgJ?Kx&OcLh ztsVw&lH)O;El_gwK&H^NA?tz=xI&bOvcdWsc(hOi`;GXHxa|T=^)Wi?CedL5quFVM zDJfgbFV-b??uHpFDf;xzs4M7}Nb8_)2|0_nF96l{TW$RSU}%t9Y*n3gBKv7zt*!#; z0@(hOMG-E41QZy%Hjt2Q-N>2DDmuYt$dT5-0l ziF2$M3QdH=4FK>%8=f^;&l_iKN{MyHq$~SHle6>l<}{|W-Lp)ux4YBh>2>q+rb@l8 zZl~$Tw}8fHhdf#h2I=450FOE+{SSVQv!)q~lo~MaQo%&v zZZgZ}b$_w9W^s-kfYM*LP6yE0v;xhsHgF4btQmKBTz3XX0|U*BnEA;DMHLJUN>-ye zc$@$`PL|b!^7Q6%nI5>H^Tmh+!JRMyn6DZ|%PFxUsSNiAjqE9n9BDG|IsH4cA-E#i zA;U=L(W+>>D^oR;F33^v-YTvGltTMxRKOM*4}pA0@kX_(V(wg&`)w+BJ*MZ?dHJB- zChkrR(^iW9a~|jA73Wr60g5hx0+W9-(N%t|F)2kEEk4Fn4+MWIknokYc=CsKI}ok* zuRwg-Ty4&)X4jEaYNJ2EFwa8q<;vw5qDr-WC9ch^AZd$-rah6PkQkPDi75HjrO}7W z2J!NUEi5=E5DQ>uvGqB#Ex4|K!11&|(JMxl{}edr#!bJ+AX*BfzV;i$dy@x+SjRR+ zF&}Sw<1`<*RynjlI z{{hZk8f#$1hcs!A6!On%yA1&`>5PCztEy6FRX*?~?VS%-UY>etAs95MFrP9!eGT@6 zm>GJ)q)odT;LKw~Mg-CGT4Y0m!30xoRyb)~9z#PL%W7x|Yz|aF#{;laEe^LTUkMo} zOeankN){YRUxW_UwCDzZal|4L1T)Oqg26EU4Fqr~Ur&TdVe-!90au3%t^+WBIH+Bp zd!8>-dSOzmt#NEj6qqt}kxt9uwRGfq2|2=RQ3}-G5kxO^g~Q-kO88js#<40q9wy#U z!V1TTWq>SrD39ad%nB+p; z`7)!7H!i$F4Y5$#aIDm1vY>E$bXhOFM`>81=q2GXC+MG_NS-B-poEO*w;%qU>H!m( zGx@Gej>X%N99Zt0fl3HBa?4+vN{)X=)}5-0ybW@9U;s~vAJ^fz;c{TAGOvY%V%q-FgB(kIz6oDRNb122yWy%8kj^DH{LOi>k9 zd~O7&d$_bDbMp6Ueb1nosGgN0)spgH`Q!uW-7jXnng{?oyh!a||38MkKT6q-Y<0MH zDpSpRNJ2Y;wy%6KR8IhbRsAkq%90@e$^{eJ0&la>j-$$J_ks>7)#`Y8tCD{#9%>cl zP>rtX#uGVW%bd!G!8v$l2amL&?qVj(Y4Hykt9QyfkW`GG_uJ$2)Pg&`#Z$FE29)S!k6SAq%pM$7&@og7h$G>P^{$u9>8OevBoq5Zc4x4*>_I70soMd>TZlZ7{gKDIN91=|LJ&|aN$G8ebjiVS(;TsCS%SY0Rk;jtS z;6zeK6{uW0GHGN4ks$_jm6HH*l7b{FaWXFMXQ+#@tOwg+NPokb6*rtH0xALUIt}~x z?;TqCh-7H*{vo7V+}&}+_s5Yfr-;wHP~Zw@EB>-GvN>tDk22-XV8`nHYiRnx{qLq( z8@5&N7ZVTQTyd||MPQjJ3)Xl{rX&j-n#9<%^iV1TicXmw&6=H?x$4N&IQE8s_%5r$|TZ&>P-+;r$4*gWdYo)WdM?C=Pt$WCD39LYQ7vYA(Z zhuydkwNt!;dt>JW6=ZQaXTB!cGrB_rzYgTK!w$}}Fvbebf@g0JbIb-+*wBP1)6-6A zRTl@Kjv=j@qer)TrCeFdq2l5+&ZX$G8_Vma`cB~cZNuiqbhCGn5M|u~rwV=&sA5#f zHA~m59sE-YS4p))Pu0YuK&!4tfTqXO3u@<`?Qx#@mcsQl<=5&le*H*>lz&k=YUfEr zDK+?bwVZd;DulHt^>7??#J^ZzGpEWjw~Nm3D0*Yj50<3!vDlIh8KC0lifX- z+VksCPiMCNAmQ@N3i$6H)>11E*aYLB0orfkIpv6s#$*DdjEa(uZ&oW-(3Wn`_2MA5 zB5mD(O32ze0Sk+W*-t;ie>*{8a}>8)Y5;@gRyWHOXa;6so{>j_gfalF|6UXLbs2U7sxlJ8)o5E52Gq&LG?zjgVhqXgm1;OflFo)+PhL6 zy2p2v+-$dzX1z>bhY4r?y!3h}sRSeHUHt9@&4SK5uKbcIo$Jq<%Swq;4@8^C*oL(e z7r;lQ*77GdP`r96`T3G5)^VaeNDqVFQNsqOS@liLSdWY!`JFCCe03kFu4qQr@UO0W zPt!xS2uSPpUm35*q<;ZR=*e`gB&+(Nh-I>4MIWGI$?6#5Np?E+<3j0Qp-+DDXLg!Q z3yvboCvq!R;3q+7GQ%=XPWd?oeOsXH8nhI&GQB~s48SHf+Qio$8pgDJ_72<#WeE9I zze{x)iEP@!PxDDx^C{psJprWAv@@PZS>_)@>qS5!_wa2$=r zt=cp)rU4uBtn0{s-r~>=<4cbpZa-T7Wjo@&spwsmoyoL=)h7t#w8tBe_q`LGOeceS2iE`+ojB4WDL*0 zqaW)}_=!^YX!<(mt7_3+nV$oy!O7)07t=}q;8HMgZ^13Dynq+W^wQ?NdYl0Skf2BL zi~ZC0mZ!d4zj#YHWUaf9b=gNzdW`fO^UN}xh7#yfSeZytoX&-&W)allyRk_ z=qNN~n2U76bog}@GB$zUlZP;pNLFs&kRIBMk7P`YZ(TK|thF5YeDASSF5(5Zo{+9p zwY;9Yr3u-KLy91%UJKR@790q}r`au(#mIa$z!SaCiM+YG(DWNUgvg8Co(Gmu; zu`X=PjWq?ROEfS)U@|1UaCOn!1Wes0C~-fsFbsnu{xWQmvQ>sM6;oLlt}2311XscF z%nAHL30Ck-a-cyA^rizTjQpFYPu+(G-Vx>*uyGa^=Uxb<@sYX@DYXFMNCrwr$&Xvf`EGtbgBq zs_v=Ub?(a@Z}Vx4m)TqEU-jPlvA;-8pD`wE&y_n|E%G-PkoDTZlDp+axbFdbeGHuN zk`Z{HGH!g3mGr}d;!;l=1dAR6_;?Iz8phep;Bg#V0hR7H;pCE4j1>)3izNNRC8`9Q z8ic_hVgF`i_o(%-h*)t$e#5J3E)J+Smihdd+W`9Bl1PL7V2zR|nIs(``U9ofnqoj$ zM&$X;#N=0J-qggI2;tij8k^eSo@b*hXY}pXAO0DQA4c^Co)t$f`;>8)E_7mSE6JO^T=obW-=q~fF2hPHd0MBEE%Ln zB6v1al_^DaxTpSjcgRwp_*Sv+F3zt?LCK!uR_i6gJ8Cla4e;O8P~_Z7{Dr93Rr;XuaF0i;f|2LNfa(F2p|mk$Es z0;yRJP>=R{N#CBos+k*y;KpyCB*DUk%KFL4Y44tncHav9?)L7U&JJ~!e?oE1(bT4%pk2zhpTXie?bGzCBXf=WMuP+0;pN-G&isG*B znSxu3xu(iIul@QD_bdE|)>rqOmW^IDHi=F4Xb%seh_Q#gjfJh}jhVOR5u_i!EP7i@ zx2xCnr!&_njkr^>%TH77_PRGw32k$N@Fa*W!WI9V$y!@VTLWy{xiOZqx3$wd3>Gty zT!xj?&D13Qq8sUeKf$k&liCnm<-(3T@;f4_IAZ7P5nY>ej`KSgFekO?96J#NJ9DwZ zEuH{P);V)8qlO%qr;VA47>+jdzTgYqepi3=C6&$bqePJhGR3qb9Y6O6Bfj&MftpvNL*pD~c%J1AbI6{;6m+R}HvG$Fp2(`3ttN@(xIJp!dmMSJ|b8jy`!^LcEZi%dMNrxCN5zoH&EyavsY+-xvr) zsekTi#yVZBCf9CVSppg>rD7Tz?z7)LnM5MKWkb^aDcZ&zj!SGIcYSjK1}No1U`8m+ z=dXl?>Ak~UViQ#1p<-NHWQ1)NwWnZl7g(0l&CR;bx943FyY0Ir(9ypagUpME)N#xC zPzyF$h5^h$s7N3EiV|FaL8bxOGDa0F#>D9L6RPm&i%Lm-%ta)I7^|w&-y&g%P<@RU z;c$_d6o+u`DVf(?Zs(M_IH|vw&gG?C-DH!GWHqpZsWAi&e`%woQ#P=OU%`0@mTUoV z+!xk@qClg||HK;{v_NrrYC|UNxahz9Nu%omEr3}ODuqu3n*C@Jp}Jf~bj)^wUXCVQ zhREh~s~uQg`A0)aM(aN6Kha-FF&|)2ps%a4M%?DHxO9k$!t9G-SoQiPimzq<>e=}- zm6i4=aMIoco|ZG5gYiJfLNGkh8e|B7BpRR|oZSWtDCDw^_5$Pr!vjSJj_~##QPs&B zhCM0gg-yhquN19anFV!1j+%6&3szHWje=T>=v*%xiaB5)L@HyDl4A%TG4W*OnfQlk zVq}K-0v@$Zk%h%`Fch>@A^k3w#rG*>PZ6Rt#$>m=$a5@e-v3ffssGJ2d-@EGzgaaO zSctkv-2Q0r5wEh7K!6&Mm6@$?`l0)^!@SOV=Ta!4*Zk+8yJ^brj(5jm^qQ_{H9$7n zlhm3u3Gu9jCny11jY1YhFb0z%R8-M^^mt<+>|hk;GgP&z&F76?d{7@(0HyOA-OYdP zvk>w-VLKBO{W%xz!JT=6t<;LsR)sm(ulJd3iX07G0#-8Bt!DfU7Qg#wj13NI z=u!>eox1a2ZwLCdm*zEu61A~K^oKsmwcv~Fla zLG+i9Eu(1`P%9^c<5fA$2^qSEVL|^ZMPT3 z?(g_GOE+niPZAZjBB&JY`LVt+d#I918O~~IYtgkyM*KzKIfH3(!K?z~5}_%%3X89# zY|#)BF!0U@)i-vq+w}DFv}zUUjo7-Y;UgXc?eAx2V8L}-(1QieBCmE}0M7G7072}( zaXes`y*;u7<6kK66~Q=-rA1TKVMHfeG8Oa z4k3Whvt8il^IDCoVC1&L?~wCl!9y>a#O4NzT_1%i1KmGq{17&)NgfNe1zo)mu`aA* z2t{Uq)fJ&EHJ!0}2nPgtYa$q}9D#9?QpHQ;r7-F-GZR-pONnJvg^+3^l$LKE*OrgATjZW3M3CbxI0TGfb=~G_CX{byC{gA#;=zd-fhMcF1G@g1yCU@GQwn56rE1^t0bh+QqPw+AD z<{QD+pjajcG|GQX^ya=wNQg|f%QV3VL&4@+C>~*0h>Z-tlhyVFUoJ64@CVKmjDJ}b zdJR!p`ZUIa7`QOMLzL1QB~!A#2YS&NbY!a-7S^>FL`cgC>{DElt^;fIJPID_gEFJw z2w%XBq3nQU;o^(Iu#{~H*}ZpFK0aO)C)G)t#|9)Pv$Gm*9Inp|FBH zqfws-c9@ZnKZ>3SHNKCi;{7SD;s;6fL_~2~a-voq;to7!lgsWAg?NNURXg2f?^ef4 zl^BZdFcc?lk_QP2{d?q6qu0YLNVi3lwMb%pdV>QR`5UsP4z&m^r0y!UJ#S`6H`8uIfytaOCD9T6YG zOh_@B48)3hH@A5(8jYaVnO(!DG2i+xiPX3}e9ZHHIDCA$Jk?ISJegWsd)YNlp#SdcP56pMoXiv zROp1tx@#(yCb2$)5&c&HqAEzGEh;ukFOjeg&IL6^RCUckNd$y=_8FLtQ* zIu#FL0fYDEwF@vtv+t+rZ0d5%UGxfZ>%^10QsiGr)~r_~C#R&$YfjXB4E~KRbmkBQ zn5Ei8?$xq*zrHbLIAng01OJ*W2u_VA!j{qY9?x5<#?um&`tJYbbc|^LfHo(0P8?gl z-&*{bM{qM{;Nj01E>!?Il-b-K>Y|uB3jUj)Uh^g6q_b#R@1wR*~wZO~YzSz_s7o|<%?@a`u6gP$0fe<%p8wgn}6 z_s39o+nHoOhOcr4S=JaOIkb`oBJT~v8x+-(n8pykjn;%_erV{50hICKGmaa+2}4ei z9nlH@qQvNdSYd|IC?E2QLt%34BU>28Mg4rLL@4z}UA1mdZE8`e#Pf<}#W6SC8vaSt z8g^LZHIq{uTY&X18Ee#z^&g70VEXtROb1}{7uFOG`r=HF^pp=GuS*x`%Fh|SLj^b(Bt;r^Q zchC2p75jH!KHxb{5?~Qx{e|hUStxgyDAm8yB3PoGZuTx7mXR?IzwP zOXD8Jyy9k#Ez$YeMQo?Wzmx6!&)}w$A_s-UT_vuzKCYhzlQnh|cEpjrPiRlVNGe@} zo$tvU7CjxRNGR-Gp{kw>qbNDWv{1MrVGS1MouAWU%|R8<(%CW|1^j2Oo3)@l5I#3< zHOJnZEm0tmYD%3Dx`RSNjNMx?J0T?Pjj!`wQO!S$9r+RjHTVw{oAh}?92YpKy1ghh zSD}@&)x3k#^#?wbA2FHoaM~$ahRck}HAh{D1!F2EzZ^YbXvqHZ%}GEyFIPrMrCXqjk*vIG1?*%9{@)&v z0l$KR2AfXv?|ePUtc(QKy=Z=6V?Lmc`?_E@9aL&0K!>B^p;kgoi|pl6$zSW}&YLW& z^>2FfV5POmuBRkl1p1}D&`y`$QOQOpWuSPFz<^^4_3l{29Wob>c}POv1-&8oDSOjh zBkw0pl1(JUWtk-EVTj(mCuLgbDmX8s5HF{+lgx$`U0KSj9D*mO&dv!0wPjEb9#R@<2=rXI&_zldC~;YRn3=v-K`{rXui8qykG$ z7Os8eu3JxIh?@jIB^0gUMiLHNCZDbDLuGXJHqE8y2l*|M4NxBU2T8=GfiJ~tki)0W zXsUWt!Fz{IGU$&bC?`_>DI*x$yyB`sJ~wm={ze zQAm#|u+<+_KC0kTt-Onu6)XaOjGp{JM@p7QJ4u~0#}JSH>}`(lvbA6H^nvHqPdM*U^|H24iow*^gbWVsQ2SGv2w z2t3>TsvD#Ld z-IWsR%h2L!7db?qcDL&BI57t}`}73u_8$lsvQE$wYW|%>0dIhgLGw(~=c7sXoTjJ# z`tVe62n$*a%l7^egm-aY)|#p#|<2gDgyDz;?qnuGTS&Tfp0;lzm9Mc)@PSq+3NcMJ=jVjj6t~CgNlyIBknRW3hQEHMwAzb??$)8Q-C2v=H0zle z0W5*ix*czI^vyjy!0<;^vI(sgQ=Au-r^=C||E?7Vawqbt-a zYo?JmzH2?_lr@{v6;qL`a_T9yT)S&tf#wF$J(a`zCQU{-5;SG3x(1s?F!m{JeGOMr z^sfRy*@1}@^b^v(nhS9{ra#NCzKQMKI}INP9u=#npTS3cdjf)!_p_+akC+jCv3VD9 ziT8HoEXH_qEsP|Mq-76a?x!#rTcD|Z8ssq7>&=TKctmurGB{Bmpu{egKvq9>+Bpzq zOB#?;P=!E=m{C_xX~nEonUp^@5*1x1%r(-C-$fY-BHgD{`ZZ1U2~J(6+ouCCArajW z6t&7vj5DY2BSjWOrd;7+&C}*?x3nTXrIx$%c_-!B!pTB2={`01QFr;pZJc2^_PsFf zBo z7-i3{+8O6XcSQPl7ys~M=U8w*JT(AHOETzs{?78UGVz;)h!t$2ogO&+u{aA)-z?|m zJx0A5lHhlvx_@CfPj=xma^}cE4_;_-EmBvNq`{AdCZZ#vYi^A57VhJ$iENqX{9r!B9rKo zHI)hW`bD+HQsZoYBSL~iKal#n{$I?6Q^@Y&Fboen0Cru2f|m1q&g!2eYJ+guHDtEV zw@Rwl49w|B3z2{J63GK^49QtyLB4 z4>P>o?SvbUi#>5BgDRJ-V0>>A2R(-E9SXm14TJ_|#QW8<-_sfy=uG1O6ig&uTrYgJ zK_HkLDtBLs>#LZgYiSABhTa;Kx`UTDyr-~Kp+(b7+!&_$0&mu3u-f12OW@zDEao)l z47O6tx=v0A2{%D061l0JeOQ;~LG0*pP9+uUMkv<@p>Kqr9RFL*Y0x1ok$9aNlZ$L= z6ap6wB#W#*s;?Lf>!q^u9_KM=iLjK0Ip91|>U$2mIk0_LY-VDrxQlS4e~?^=6C{8V zuW697;Y#rvUWC^%Odf_Oql=I!X+Rl#LK<9OLQh2M

J0IXlB#LUe~{TGRp(Jst6} z=5k8uo@ME82|HnbakTP0papkV`qklxF;(=YMD@0b+8vSd$#PBEAS|3~==rA%eI-X8&9(Lo4t5og z4wmKmcDjm1cP4a;HAM95_@@-46PBH9=_y&|-wrR9HX-JB{*p2Mr7_Bie1E%&3N6Gu ziDSyVcc_>UNUNeXJZ5T^5AEC&`a4_VRZ0-h4h=f}Ly1dM--j#3ijFr7>G89i=!sQ7 z?v-#}!=3z-pp;B0N%9Y{R`w?MFHh)pY<>Bpb5Kh3)DJT9BfD-jYuA&28Bh#iQ#TFJ zy<=S!Vjxc63gQkND6~QX?zSKco^yB856B|8uSBvz!3uoBHInTkG{^|%RlDj9}DYU`Gthkh_S$Ivv5@iZ*D>UwQ5PFEj5LRTR z=7uiz41D$5_aiEH_5@M_zWeM=$jrRXuFb|YaV_4UH0Pkc#<|~ec%5o{_FGw5QPcbK z=&AQs1j=MW0XZ;23W`Ht?QLGrd|%zK%xt%mc%G)P11>{Tq+umz62cJP0kTvHioR%y zPjV6iUxa>>=~rfSwpFfO`?IZEIHG2v(4|CD9Pz_+Fp5SvY&&ejKB?K5594ijegn6| zPEBtlolx@o3)YV`@olc@$fVeaCjfGtV|spXR7}C??N>A=<#z~NfS<1GcI5M(CD%OAzUXo1i!6{#>NG`SqvIJg9WbJgE?&9dQ{ zshJ&8*<1X8%0v%W&sQtfDJU@YHl~unaJog-39-3&qw>+r!MNf`6CpO~ffp zT+JGpw{6&%kD*9X@FD4@teP`vm4}U+RBc(nvp;gev(PiqbJRUstGvWiTC%kz>MGa; zaVp_f!>w5W!Z*3@5?vKN^ZHg~-gZ0XpBF;jD14#_D?AsVe~i3i`GpMXD=x%7kiJU& z4FW0!Rtr8t-$g&BpX<(imR^JCc3&ppyK;J(cZ@B%00EY58&_L7>lParn;IK3U&eop zug=|+FH=`(;2aSu5e?xh^##g;JQ6+J=W;K(_#L+QJTovo=w*U7+Ks|9sZX)rGGg$` z!^?xpEtiOwm_Y@s(=C;kTIjXkeEtprvNnNlg55PfPlb(3U?(DR&_4$VE-n0 z18(P0{;2Ya2$T{mIbgj7EEl}>Qw&w7 ziwk_hyZ4>@@#ZAS3&{%!3~>8VsHI(di&4&1>MrwCdGJ2-JJUO}J0r7*W|_Ef+{h>E zv43S=V*8Zhr3c2}<2a0Uxp?q98UiY4W9v%qA>WTo)*MhT0#+;%3zIBV4j!1G7b&|) zqsuSK*W=ajDo-o8%DQ;(uZdZ6Y%pyI)9=vt>5=bHr!!-3K#qARrMsnX_0$xm^`l*) zW1)MR^3Yz4qlT(ljK;I(FGR1-_|A=TR({oROP#CcuIBfcxKx8Vl7 zk2EJ1c17e#(_L7`HnzJswY#n4RmG=C*d`>8_Dmuqj}k56E{`NV3X@auSM248$nwb? zO0y{D+K!8U76exvHc*5jz-%!Kr|6EQQ42x?3y-e84;N)qm4Ne&%wAPoSl<)}iz1ii zKQ*L3HR4A%Btkc0N;jlRH{wz!M5Aefu4#g>X@b9M0>){A%1JV}J1N)Hi3x}JC=jDq zPy?X%h?4vpTG2wH9ZYLGg*<73RHBa_I-MofDy94!v1-FUt)Jv$68WRP8%3K$=Zs2W zEyQv;`m4n#LIAsv2)l?W`_Kd+#^c&gD_ThKVFJWIAn1YtJAxT2hC6CPZGL27E5zMO z47!yVg?nto@M0tY?X-9={9 zzF7&O3o&r#4YH#$fe%uYKlq+2y9jc|35d=Saey$l_7P_9&*?&RXn%u{)_x9oVtN@u;}j z4)IxppFGx29WhFkB4u|jw)(v2_Vy_I?2PT)WL24wu2=l>3U zc@m`F7g8M$sfvs+B+cJv;k*DsC=0=ritxn5JEi0vTyRYlC^Nwo8S~=I+edOuHn~7e zC|%->7C2hqJq?-UO+Pw^%{y^&jh}t;be{*$7sR+g)+?vsO{#b1)jN`M%|p3>P)L_K zR_>79sV$#4xkP8vt5;+(t?rboPpvt&?hxOhUz>EZF4tw?7>{#K$u2t`pShIJB5xaa zb<5bMW?9~G&e^WNP2w>vpHALjmbgvrTGs8*xm9{Ht)EtTGV9%@d7S`pYv@$iX+Wt@Yk~wX^C55SNr4;as4zZTjNv>hbs3RzU(5qL19>6Ahmsry#vLXiJz$LA zr;OhSa!ySlL;zbCcLn zdtLT>7UWY+ST=bUzr@aJgEn-)N=T<1s8tn_csG}NJtpZmq)l$j6Qq-xMaH#@nEg4tI#8y&yD#2OpE1c@z?R|Vr%a=RSjt;}#K=XZhUov~Z;T1D_&fp9MJk;z}IUF200`eJ9ZoFJm7iXihk#R)3Z5D$`N6!)&kBmaDT{x3BI>(~)ME83*XH zOWiRkxzWcl8M3S0u{g2~-MLeD;?wB5hS;wDcdQ#M8l)=dTF{7)BN1H^!Bmm+rep^Y z^D?g=T__n{tQlSMg(|Y}pOTVrx&)#v8Dq&rS5)?g(=xLxGylxsWZ=WDF6!zNo4@fj`O zGR-lX+m!X0HQ#t*-_md7dMTbM1N{>Tzi8q!ak??ZzNg;={*q1COx3zxzIpW$8rK%} zQYhCvb}i*INh%4ILOF?xm@!B>hnt#wnwZKgrM!uo&U_k~$|g~k%SC=N<5XoRFDd4t zOr52oypfwueH!aYt_9$tv7MFb&&{Yl4aRg)8rDV5oHCw4gJRPd;aHQ629vAqHd`#s zmddy!7qQNit+Hw^O~pwcOs2kXmkdpGWDR$MK)Xc-+(P z4t<_Se7^w^9Fq9PDlh^S7!yJmF@_sbh8uB;8N_IH3~snr@Qn*N*n30xj`=zGd4t$HvqQo$i;N z9<-ev(48LgrR^7{9WpaN25x+R%0?9iSzhvwJ%DXtfl;XoI^XvgRZ%)Py_@@}=T|;lU@4{HWyy3~&FGS-!r(1dNQ0;@gVb#Mku6N4j znNPps?#cTrkmEd}TS?$h?t{r;RlzgHe^Td}Ww*TG$^9$X<2<8VrSDMhgDv8MqdP~$ z6M?5YBWkDv?9OBa>Drkzg;!%AtbRO-NJTh5+!yVU z_V_9hLpKV+(Tsmw?G4cZ6ywbw=LxWgpG6U)~vFpUrbz-Zf+&&U0wqSz_PH zb9&l-WM9v7aN3b#-^+7?-o9jC#B)O|U8!&_(3D_IF#L_5vi0t9+OBY82k7?zAiuPVDV*js4siVSTrhPswmyKqFiv`o8_Y;u)ZP2EjRO-@Y- zPECcbZcW^7-u%Qe<+3X1vL$FO|7MZ@W?BDc)t_z6DQ{IOZv`rEfhtc0$4!x^ zr>6C?^2J->Ygr>oS}~ouMY{%|rsFCa;U;v(ra8o>O2Q^e!YW$=##hGcExx=Iz4|-5 zIxD+=BfDHHyNHXrT$#FvnYw^WLrePKR%{%~HoZb`dt-nni; zx~HnMx@5EHq{yrYjk}z{Rq+=TB4WySqbx+=kp1EUK)m+*T4b3UJ(C>vst1 z`yvYB3F->+`JS)zReCQe{tDXVMSXC88|uy)7&gon7$i9UmzeAo(mk+?=upWqjdL4! zFYaB^y|9}p7|gMXb2j32)Z^(8%&{PIkK9Abup#rH+{4PSb9WeU=keV2zC&_Cj7E$` zl17|HqDHJnvhp|Sn=$|(FiLQh@O1R|!M|Hzpx`a{$@&AzzqsI-;*-k1y5O|p6YF5w z(U+4f7i|_&As!Vz9j+JKm+sB`KF+Yi(5oA_7O@ty7PS_)7P%I?7QGhV3fC%FLlJf4 z@3f=}ssvQ3Xw^9lWgN5DWwGrawQg*`A)Sb|`_467heF)R65&5{m66g(Z6tT1*<#r~ zYQ%K^DsA^nWwdo=Ja#3PAAC!9btRr3(+BdU=$@!vca*m$%<}>e90?ss-8^L60+`$b z`>qfRs{{-{lm;M<0}$(yv=N}WtCGy=27k&I^>G!H=#F`vhst~4=kJergCsaY@r|Cl z=j!dxc!M@L!tsr{n+M-3q3JB*@h+tBF5>toWcVl&fH3@@iZK!V5mEwFW+WIXG1P>l z5cOhWJglrRc{3xH3M1MQBOVJQ%5O#-7e$o8bO+RQhupUN<^D$Mw8s_Pv-l4*yutMyA#4xm z{f+9o=eRu}*d7Dr9VX!&?eiSeg=LJ!cR?Y2`WHf%s_o`;MP0f zOgjf%J1$*2O7(@3><%40ivYCDi_JF;p! z)M`8Sa@`;An{n5K!t>zS=0F*N^gfmlwGj)hFmxMF9gfrWOGyMp2>>>6HOx_d(C2QEUoH5Nx)&hcpDMc%H znkskFDt8tucS0+7hAVfGmwa7RrcqR;*;J-URpz(rRHIb7l@|L(`MPS3`BFy+k6ri- zK#P6rbX_-R%x>HM$u5WvAeL?yV;4o&V%EB?zAmj}R$~`e*W%W?>ueih2as#sXkAy| zGT*X`xB=+3ZoRDQZ&`fa1mXci+}GpRl|BdJH=KBkC~i{oT3OszXE(gM3^8t!^;&7% zSL!$1x{Nq(B)ZJnZYVxC{F@AJI6im28+qKwZ3l2scT5tpPVuvh|sQ zvZ}EdDLfENu@fjLcuxdWE5NHONyD!XYaZ67{!jM}#B)u+!NsGyBfB`onvFqdN=nhu z;AkWDkv+j^I4|Mga>mY4WK1vUKCIYsye{4uF&3mS5u>^9&U+c3J$E;=v+`S68#6X1 zzjuE>>eQoaHLf?)a?}K#unMpwY69rgKi|o?5-ex^4XJ&;Za{VRRlfktaqQ>Pj-T#_CQrp=yiNW?tI*>1}G8 zk4?UH%<5WGbJS-a$*{!Kg17ESTT?HsGF$wu4SJ*WHlG_O*N^Vt39KALokT~b-La`k z$TTHpv9W2riwZ9tXsKV$f{Q1GwuyGh#5QKXZ8O-Csk_V?Y*Xu+rB^4&H;8J?dajfC zoF(C9!vEDh<-){wQS>R-EOHjJ^yzf2WJ(t@sZ*(3*~BPhhAGpI+QhVG(ez11EP4?# z;qpmBsEh$-QDUg+6tynL zZ>j*f6$)NT=21p+t6*G8?@(rTsvulS^;B|%DN;Tc^)4rTECFFl8nH$WS~0>E6`=|Z zS#pXgql&4(#uX;9MjKnP#uYWO#vfYp$`$^jHYt|OWb>%m(o2@yGlf~KG3HCS(xn}# zqED9mbcJDnNc1J-e-Or!tFACDRh9}6t-geU+zyC@mLx7s`OvhToG+W5sys~rA6_d znZS77Px!D547Us&wG1w|3_rCDO1BJKwG3&sjCg?*`~_A_!c7F3w*aoU05|ZzEjeOn zF~Udjf503BF>DB8`~YTfQDi?OtORK>VjN~{zhta1t+)y7s4?y#BR&cv(nDtGgk(Re z>g?er)vsWE*rBf?V?5KI$fOcR()6YNwI2u)HfYVDx)BPl`cfc8_-d)+(a z)%2L_j9%j1FV_JF^4;GaIUd4`U?!S5YGeTP@P0SAn+ z@Qw-GEBuWNIH2h6?|VQNI6`CAY8s%w-q+2|k^6=@JLt|$*gN`rJvnS>9<$R9#M42D zaX5HAE4ChDM?X0@($1N&pR60rw-M9R!TQW0-gv(?YC zwUe(MZt6x{IrF`oeQXEfIFr~<%e7N+9Gz|l>p0Wc&)BuowH>|S_TzCT@;Fn#AI@%v zbvbjupWbeV_&77%&Jf{F`n5B>9)0r${&L1dICR9H7V)H%xM#$lO~M^nz#Ss-BuzNf z#Gf(oq)j;D#Gga)Bp!Pr&7X$i4XfBp+m^L3I>V~y`W?A6 z_lldQP_-=-omMa@UO$*U8$@y>;Ci|=eO&v%_M^7n09f5E)5UvEwMj?I2+mT_v!|KW z{c0WVa@_X+w=_RnKx4BYIdTH|$BzYJE}!QoiOuaA!6Sg6Vg<@gQ*O4LWf{MPEuv5D zMnwfM0*jW@b6dVy1Jsd z;4rjoM|=EbnAa~}2EMThvo5=Nukrc-z^G+wmuc5jc|X(8nLKHysKsJeC@;%B>ylMdS|Pu#0dt+1k59BWKa4^{rnx&Dh)TC=hF;_%SKUHOz=eU($mf?jvk zEG0p3zgHdJkfiV`*AC4t*`wI=Gbia!FyzKCd>Nlp`Xzdi;-LoW>Jc~ZlKCys9aYwO z&`^F=-M}(g%+ep(@9*y@E+sP}>2sLR3g&b>W%R;?C>+h2M=2$Kdw&=C%KxRoAVrtcI?y(ZH_BN!RRcTEE-I zCoi5siakql*0I@sQ|=mIWpq_OvEM^_MOMXtlj#I9y?JGR6P^f!tf&p}ql_PgC{hO@ z^{k|(M@Bxhg|65*eNLy;n*ict$g+V=iTUyrg^O`<5^-Eq0h2Jrm6 zH<;x9@P4+MTN=Hv`-Ie44{g$W-rB!VkIosjOzZ~j4LKH(W}pgsc~+0;d$ZC~bGcnZSHIHGveqZY{sa8Z8?XJa`?UKM;49n|(1Z46Qi<6^QeF4O z_BfDiHH7^Ty-nvwPn+6cF|8dE>A!Ra3ICdw#p}RHIOs(KG5l=Rc!w z?9jAF*c>qNjk`;;^Cx?}NpkhVE&anJ9q)$BEuQ7r7N zU?sSTk{l$CzF13TO>e$~caU67hK@t!O$|TbjD?e3vB)k=A;9u{f>2}0$*dYAgC4nu zXkkgXmvW@wW*nsYFM&NVg`Am@h81AesGj6YZJ~bL#j@`LCv0c6$Soxnq56vz-s9BV zS1*qNbHEWOr`m3pFX;NPfD%q+!k~3sw&)%eVhX%JaOU)c*S8yQnG;>WrVADR7 zo9aYei$f4#{W{5KMO|o8UR-ZnhOn2eGqBc45ITvIK-{{@+FB&s2-L7~ zp%05XjmCASCP(9Cn z2fwA8sj8u`sUgz$@+XoA!9@DH25Yal@s&Gvz>ADAL6WySWs~b5k&DgGpg^Nhv%IT; z9j5!DqKE}R_%$z5*I>}l5bTTAB)fnp3Np&shB~>#n|%2Hs){W`FA)j$A!SNW2DRGp zMQTs;^N~q$=eMZbno?Z#fAd~!k9V``hFeW8d5Y?CDP}#85UOMAFcSz8v6~BF zE!0qMAdjp0{z%nB1YdiC4#wbJt6^QcWC^|+v>`>_?dYCT`>+W#&}TL^+DPiuSrSi; zki@N6r;$xJ{TY^WRts9A_CMgHosKnnX|)>NgTgz;EhgX+K?TY0~$++mCc(w2yDH5?{I~^ zEsB5hg~}&%m77%{Cuv3>s3!5-!Yx|%9p&WbHl}v*(xKCNiZJmDO(ix}h(Z5M~qJ_an zL&(zbdcw_;;3iBf8%L@s%CAFu2|hHXXwsDA7T6_lgu56Q8UZjWOD|-3O#Vf-2C!B| zwLF)s?w}S1hp}4F*u<2;Rzp@I$>dE@G~P$aBbs_fB+!K~zvbenG`qo<)@@mihg^RO zh1?QHg!@H(V^@mffzV%#+zPxE1o3`}Q%swMD{z!2elHoC8rINQkJQQ2AYDQYB!hKA zj+@Q9TVIETu9jfIjpwTFm#aItYLAkUSuq#Zh9nz4v%_YiY;X&4&h@=T>2Po|+4UtF zCN`KW#x927=hhMh+6JXoN!x7u4_0~Aixf?^zF)+262dcKAx9KCNeH_~btrAni9`8k z?nn4}{u(ebMjZhy3sWijqZ@P>^W&Cvq`|b4@5zci z6Jh^G=XJPv$dxP>V?VbbniR%g^djmceIh0lId-bvKxlDk8Y!kiGlgnRp^lgLE?}fA zbQaSQv`EwLa}g8Qr_c|N!foBppts_VTcL^mHaId+6Nuh^x>L^_;78I;d0!TQL=Ydt zu8R-Ep8iAr%V+7{iMi4SL7Dwn)e7-0rbIxv5)VX7TAA$L*B>{ggh+IgxcLWwx6S2E zT+vQo3PfiBCY0G@wTNo4G#^@v2kGJ}(!yCW^6dpei@SE?)6Uhz5>8voORHcAe^W&8 z-Pm}cHEX#p<1yB-bxf#lXn?#cldznXC=)@^!JyrZsE{xrJXPG~@9lh{Hxa^4?SUa8 z-&SNyW=^SmIS0fj*#$&-MA5aRXQx~4?JtC*6MWSbx3Gu1+~0E@*ad}wr_jdqgpiM& zfy9t+AW2}pD<2>|)aX#fnZKAz)pN2bqoUYVL;w@A+FRzf6d|MQ>+*H%(P&Ye{~0RCsxI*^mWM&3lh5VbP}qOt~Q&^suI-M_R_%#>_dC zsMMSDDoIV9(V0yr&!aZ9ZJxc1OYH4CThZ-{1_k+{m>KRXN3zzaysC8}-#wr2WiR*d z^Lwv)el75@u!`<6Rn51(U^T>1&Awd54a`sxm z+idK&xn58r^E`SX!`3kmm#7)RTR{7b(P6dT^oJ*+>W|BdE-49I*0_+El(DL~yt6d+ zqVcC$*;(ncjKW<;dWrK>VsiFH94@ozexuQa7J4+#Z#$ zq}_qMjgUFt%rvXxQ`D@Z=-Tc7#oAdu#qmT7`xgih2m}l6!6CujEfCz@A-DxyV382q z-7UC7aJN8km&I9pgD$qa_`a$8ez^a@t?8Ps>d$9py3d^RJb4VW^r)(t%z~V=xm0%Y zI5yTliHL{@56AgG$bWuwB*g5mBBPQ5oGUH9n+n?v%p`Wr*XruAAO0EkyXCHwMgPEO zU#;Ex{vu9LA~8XYGF8;yH$o7s%?-4d@!16IFIe}Mu_}HhR31%GqR1Ef?GSJ?U2x;L za-M!-yTVyXyYCz7zVwlgWJpGO^l0gxF}d6_8-sK=o@G*_E#v^RiZr9KwESV0y~;5A zA|(?0MoMgAoOb0N!N z)l?0{?ZBh}KQM5WU*OS$?3!AET`OiO3w0I`}xC9Ee7qs^r%L@ilV+< zF2p-G`e6?Xl&du7gjQnyqwX&{iOmhT5khNGtur4YU`3!rZe`FhP6CzGKNVH?Zb2Mw z*mWd*R}$sP{=CTHBXCR+q>#b_>VI>q-5y@tj06|+!t&_-jb&S3?vMPjf2qI)G0yRZ zx8rzRQXA}&cY3~14cpS$cRy+t7EgRUkT{bsUR@T8HgVZ7qiw@gfYVa;(n#x29dZ^s zOMI=|SXGq4AGxHKXsv#`c$3md6+JwKv zhV1=Ka)Vis>IB!)nk?C-Sn7OKo7zp!xJd6n^jq5N&BP2h$?}*uT)6|>$gWCuqe7Fq zR9sn=Lga@@$`qMei{Si+BGB5K(ug1jP}kh6ANk8b2lD z2;FwsVr9!w5??}LG*90@z9%)?^j4N#f>f98U>_Z+Dov`Tnaq!+Y49F5#99ZIAH^mN zo?!(sH@^_-bbc^!wFc`S;J_t^;WcON8a8gjC>tXv&2fNV*z_S6u?N_voJrnNvsx+R zUDg@*{Rh1Atrw`4=hh1&j7YcDmzn{e?g4H^h6vcr0U>CsRPr>Ku0InoZu2bBg}7d0 z2=VS8umgM{Iqm-dy;^e*xppQt;QSg)GWp3lvneRnCbkh{$iBj(DHFDw@LT`L*nTc; z|BWzzD{&k>UvY+CrI52ttK~5RlnWvm56td`*p}%H>Ruhypx$y9Jz1d(qc6GRHU z_Q0TWW1I<^Sf!czl#A@*rBYWi+f|Wn>y7BUll*p8$YZzq z#-RJZXb4=mjhQPl=?c}L?WTZ#*X5x|kAE&WlOL!*%@MY|9bYX&px_O zM3SeYvjQtw3F4amBJ#|R72)#1S^}}y8h04Lw`RP??5l`Ma2tef(gUvn&F~zv_n_I4w^KgUOeT0I^sY9H5f(M6{9X;4D zZGTeuMW8z0&Jdhn*~GN3pD&Ja5Bi7mY5YhUD+^JF;7gO`LHyL-c?PIjh)-y^K^i%( zdqRZ@#(AX+dyNAG_AgH1qIYd~Tn|lFBP^sOzlM~C-|4?^!_r(nJs1bao?3Ru*xO z(Vcz=+2j#*=IM4Cy=K(F%#@{?`mtUa$TJnTHshb_O@e(VvTc*F|0A)5C8PfH>iw$l zc~>)uO?CL6oX|HF zvLf$8C30F?{`mO}Mse`UX=zeTw@Xr+>;?O8Jkw)N-;MWizh1DGB^f07X7qk7FRSK; z`PN1pqPmb7z!!Z}65VveN+FrYIk_~ySsDO|G%T5%qtJh7Z%ia?T|g#uJ@oP|Z^)P# zjUbq-N+eav;`$f*e{`1BWS&C!k5L*DATx=g^P?n=Mdn2^ZsJbA;vZ}RN-z!yS3~R% zlcx?Tc0wmjpEz=kU@HQoJBjl+?-pxMQx21Ya^AfCiEHvMbAUDr6OD`X#cuywUuKCc z2l}nw6Xi+zT+$r)iei`iFRnw&pT_Lf*%pQuti!=H^H?FQ(SI*A987U)$ES?p)xv&M zT)ED{o8&$)^&y(tBOuWLd!sa1B691^%1sb=#v@BXi0R3#_~DOAUn?9f+q$AxWAAE-Qlr!Ve>IYQ<>*Y($v2!hpB3=%-M# z>Z6CZe3{K(Ij-(YM{B2Zs}pcE3wpyOaO}@@?fXe#H+<_H`Vb2VBj`VzY3E<00xa+` zuljfQi-*^QmX}#hb*Sf@QQ-pAyJhM5mUV?lpx>rYu;(z8YgTG#eXx4Rb$Yaau&p6x znxoFvthaN66OQcb0cLEi$;S~~vwdX2T~{W6PO9uPJ> zPRc%^C()c7%xlUT&3ZPJJ=a0jD>Vzw3o5c?+h2?}$c!r}LUYFj-9VpweqdRL!Zs|j z94%EmsDr#Gq~HNhBqz&7H2j17In+i9(HD0=!VO~BHk_^Au`VTE_0}Dvjn2uf3eXdJ zcjF=vtdhkN8S+TJ^SIvdK=xhFzrm4V{fZQnAiYZLZCOIG8iKRXnFvY-X0deJPYL-A zF47r6nE&#H&WzBmd%^G<)mmXEqEiBV+!e0UX-C~+!hR=?UF2m)27czG^H1{IA<{j& z^z$O!VF2pkGM$YPl}Y*nnyRL~diDJ7Z5FcrV-iNl1LM1VTlKsmnhvPYj1X}W@M#oM zXAM&sFztM!FW!fa^wU}>!Z#Y_BNF&2M@7$XXtZc z?eXX~Dr7B$c4YOKi%%1G!&QALy2`2}_qi?{y<>3xNb8gPaQ&MNr)RnxyUh;K-;_R9 zq@Jg`7R+oE=;$QeOg}YUZ#-a8$IAV!d1Z*jZGlpBn)XPpg4j_mroz48%QQW7h-3TE zHVW8Qbq{krD2w)zfMMf2WD$O-;#9cVP=a5`tp?=xZ}q2Joec{3jeJFFT@dZmoIM-N zH4{AVuCx}2y79%B9+?^zXpFPX?)W3t=v?}GER@Zqdqt;ZtA<{>T0$iJmUcPLGo#O1 zoo*4xc!+Q35}#@3bQ>FnGdbR-B3M42amI1(-6C1c_^nEKL>vRo_!66K-^1wm1JwC? zIwyCy-s%}V&pY@fpj(UAIeVtr@4$Pbb?)WeBi~ZZ=F4~g)QR4b%Qp1YZuax$MZ2ZtgqypQa zE2TA)eWk+!i(6{B?_`?oi%O?vNz^p!+2s41nqU3E_B^0h3^Jws{#(LtIY zJg&#A4^O;#Udq^qv(5CFZemV0=7k>N0USk7fWm|uQjrt0;Gu>&6Yc&l1n zeWaQ99);nH2GJwb5+coAYoV&0e&|6DmG*kFJgb1Fdf`*MC>NbI#N_EJbiir~KCxoS<6 zSmTPg7aI_}8poz}b^Vh$(*-)H8oS*U4$5x6f>FH)a%>mSk@SSNed^Ih!_}5lHl4%z zW9vD23b#u$FEgp)31$ZS#q}X}WceQ~(&}+-e{qZlvVYeCO`lVop24Tiqc;TG?an?| zfW(dKoDm<-Qa8I%w!I(QG*PGCsCoe9w>9EM`jdpl5KdWO)E2}p(BW*5=@8gmiEH^T zoK4wJv-zoDNqc$PJVsoZs`uGmzuircHI>p@?1ud|Xaa~^E&9ChY&&9FGQ$*$T>kce zbGVke>Md5IrA}B9fFA^&enc_{tRzPIRg|9&yg~{9#2-4zpp7p{&Hidy=0q z)cF0ypghMw^}@wSA-{MCRA--kgc!qW(YSGAW30J$Rx6Erc%1T+54H70snr~JHvjz5 z>~(hE$^CbAgavluo9kU9H3>u{=nYNcTM>D$Z`|OYvXkO{(rUGy#TPf()zTNXPk0*3Ku3LG(RfRKj$+NhP>R&OMWJt2Jdi18!cnDY~+P2 z$~S0_+4!%TkF^J`1v5S8;XZrr3=fsY;pEVBpLZy)K#|!dHl}&huL}RA;!e>aiJWV zK}rYvD`0~3R|j#P0)8pgq8(805=!7S5%8_bU^sE|n~5Q*BRPh4y$W)=+pQY&2~Le2 zBge_Do(cMA86r#;tX*FN)ipYzm;N&*S9`wDdYjR0ts_6Joq(I6y~xpGSG`GHq#>Bo zxyXiyFHV5Uf*<;n@`We9Z4bk3Sr#PY)*I8B$?Irx5*vqv7#BR>3(H=u;p%)Tpmqa! zCJ2*TZZVRW<81z^mp3qX3Uf;=@Wg`U-N(R&I!c52YpOB%2?cZLs(+|L7_xsHksb`(3K=wJA8?jb7EV~y%apgcQnUCjgwp<0JMIefp zrjw{~bM~3_TKo$ltF27h_#AH{A64x3ObzCqnZRE47a^M4Wmi{5&vPt(r{rw%81wL4 zRL2hyAB&(4dkMK6HB6o{-Cs0Q(~s%C{c*N@iOboUJNWpTb#uDq(E}Bl;Pm6TOz5I9 zd7XP9v&L+x{hhb%dv~VE7eNV)O7zFi4|y^c4)ur2Gy?nz)#NfL{-O+cLei=y;(|L0 zINLpBgeKsfK-sM=i^OH$Q#=zbT{jwyv<)KBjUui`shuX%K|i>D#|^z#mI}>1n+M(- z{Sw}=D-nL9R%(>G1WO6I_)P_R0q|J2)lDXF;p&DX#_R@i$-2zpSo#I*_Yft2M;S3| z?^S?ZNWbnX$by@#Fg4yR8+{y`4K6z#mytYW5gRkfN4IvbAI1 z$}i#b|H-$fg87i}cETSNNk9)|L(lzKLReK@h-&RMZ^a9i;~V zJLPjsZ{JrvS@W#Q7UX$A3pdqs1aYAO@IjB-J^Jnnuk~wuRC$r!o#sO1CFe$j`rBF6r+s3lY{B5K zfr5Q*HqXqphUkS3mut9%e=hGSB@XCrSixGS5`WEm3%qGtGgkh!Kl%5vQ%>~0ET5Vl z+tG{q>jyYU|8nacczUJ=^;8X8AVp$?f@NZRwwJ{#Usn+2Qh%8OW=XW@c28Fi;M^o& zUFNRksTUCvbT}nAM#DO{`SmXcmt*(=EntQ!!dCOXmHw1b(ITYCBZK>ufTzTWcZi-~ z1mrk`;(|^5bY|a=GtW3WGXF3~^`MR6$ft7nIRiEt-9M^}OZ;7z7Oe+|I3)e&e^Upp z?B`&%SHLJ{K-rF{^|bO7VDz1W<42RDE3xoAJxnuHPbqv~^t0FOQruZ+9vwqU-~LMr zb=;Yzdd+^32>Bj<@EdnP`WM<6dgl&{FRt@{tv_=*$nE|lb?dP$vgu_eNwSE3E$jk( zaf$~S>ZADS(bTdZs1u8Qy>N8;P|v6FZGUrFvPk1l-z?fry{u zHXl&C<*GKv8APKEGG)(#mHW{#r1)2{3SI#R*ex(B`93d&Rlv+J&QQ)@1?KxZPY&7o z4}Gqt3#tXYBm~IuAJKYLfx2<4(7S6JB^IUZ*l!}MfQ1^Z8;Z*_h9H1lKC}L%E7@#l zC1K85v)uD@^udS$3}7|(nVAp#-cucHkA2k>)1mdJBPP%;o9AIrK-}$F{tw9GUlSaO zK}mGqhrOD_NAW>_tC5ZM%nnBY7nP+pnQM1)j^J62rhmg(CkC6nS#J&fu>c$yYYsKBG4# zF?n?+fLJrz`rmy6o2Lhx`s3OFKkE9=7vv*259#@o1dhyvr}agGmxs;F04J1HKH8VZ z{LTq3k`~atICl~5uK}*!z4eKo=99lT3Ct6JF{zXFaqSt|!8e88!clGa-wI6yS@pK#cISS zT`>sx?3%8n8|r=Ak2@M<@b)B{(8Nj1KJpB)juS>M&6@pz|8*r%mLm3CLJ?^#D|y*> zRmCbI8cmbKA|{lDuqm?K zH(3*%9m!CY3S@2o;8&1hf^VdDh$+-T`T*z1qhN3Iu>ksO^@>L@2_A2q z#Y@=?---WU9=GiJ-L0;rwDa&Bu&ere__1A|_)~x5pQ+{5{f+CQYZ>D_VI!CIsNU0f z)t;OExKD9VNV>bguOZ{w)6Mjpqn^^%;W`?3eGU%~T|02GLalaOm6oJkQ^DRNjc{s~ zad14}vk?1`ANVv-^c~ym_zLyj_44o@tVh`|FE;36G7Xnraw)$+d82!H(`}!S!jF?i zCoRxuxJx&gK4|E;4yNZaVo{@)`umY;deQpjWxJkA0;%&3Qk}MWrRfo;1>rV85B?06 z$DV$0Cwc5_rv>X(wHNkSle|CCWKK@Qa1d3?)Bdyduf}ahvRtl^ex*0>Zm<17wRJPq z!RQ=&&xQ4~9uKs2>}F}jaK^}_qD(Ks>{o);%p#A~h3ULmUU+CTW~_eML_R;KRG*>oc7qZ_>^_RK9c0-`yy^x{WS|!Y}A1%;(%tTy)29J7_j^{??ZS zM7OyoC`1BiO#~;0yC)f;(pKTkED91h-@X!wgx1y_sQeRO94}EMaV3>t7LGuNPcL(B z4e5X`54At?%eP*#?%c7SjdWLLJZlFH#BC;gf{9vI`f<%mrF(&B+{;6o&;C|3LK1cv zSj9IwNu6?NdXlQ)S{KT!ox>^@B8zZkX(A-1{0-tk zb_Y6<(JQ&F=)I)>b7ei1go_oSNp4sr7CkA9v|N_o{@^Aj7Oo`^^`pmOHXX0T;%EBULL%28L=Qz}-`?ne0P35nxco3fyF`7eouD&bPLcX%wLYFdJ3V+(CR*7_EqOulQ>}`G z*caTl*3yAr3`kO5a3G}_5AS_OKFLs@Ck+?9QV_LX4}@Po@4tc<{|9ofAIvWy(@6b_ z?ha&Kx&)!~IhtXm(`~~7_M`sUy9#;dcQPSg<8BX~&m@Yeq^Kb8v~Hu(+taV=)}@6P zla|`s+i&`ZTL`rdv$+Db9(2oxDE>BxH<3#=ZLWsYwy^v4vnOM!a((4kPF<@vQ_Gy+ zebArHT_&d@{{l(M=^;}z)7P|Zi;*D%Dyz=u9g-p~0%RRKAvImXPAPkV^81lKC${^| zah&(T8C(3T@5~XRGq1Kslhk$9)C|8+E)7VeNqOFW(3O&{{eI&iar&+??8J(w`X=Zn z<0Y+*F~G6j#R{68H~DgVp6DzikSuts*{oakDLJ*r{m)&9m97E1@1q`V?DBt@?71Fo z1TVSP+gV=s!q5#!K+Ph>7RdJSlH<_cwKNRyY_uLsI`yv$b#KyR4OhG`nMfx>j} zK@XY6J1GkI{4PK=ZQI@D3v9u9!`d`9y|y~ z{!&>nQ_HBQAFXIke%~LZS_7Qw7ldSLDTFT8IhjK?DPW ztRohO$p?#@JGp2Qkyyn&A-0CZ+DjpD3q6SoKDMRyz9=(2#U5O@IrA)-{A*_=Xz*6l zLV1oj+Q$g;+(paqB!8d>x+Z;eoADkHR}9F%6Qaf6!C58`ZO#{(`CfQguZygQm*hmbjgd`Nte1ANu5_Xre{H%ijG^4rYlTc@xc3*lcr4$7X;H` zbpxv?oS9(GrhaR9D*r@%QL-(nH&Du3Jff{#w|snY<`BCjF?wq(c+(fOucmw^@QEkD zu%CJe^@&%vplrq#v(-YW-%`jpCm1g@0J$H<`$9 z>V5q!PhFRQLO_xm)tP}gfE|(SQ}II#&D{Q1!_u-3?{k6X?}93rq8|B&NUz`{@$LC3 zV5vq9vaJB3=Azm9Dp<#*0aE9t=XXnV9?^g286b0drfmdC<1YW$#Gke;u&pgihs12m zTt0hNn9knMo&==XQ4Mf{|4@dIvh4O5Iz+Q9NlEmRw3VXf53YkMy5@S|T(HZ2^wX=7)f z$*UrMjxxb`clJ1sRQBt{u+uep^>nb^i+HrJ6;oF76Jm{s#6$bdE|vQ_`Mtf=n^)M0 zc(2DtYlczABiDIY=7>*dd6KSmws98dbd(%KuSblOHPCI1G%B!4^zf_EWI_($?TF-n z`!_Rpqi!=>Titeuye)B{Pxurch?eNGFc8Zx1zyJUx!rwcGk9rZNi|tviS)SiopQ>S zEY^~AqYw?+@C=H+8^7P|XFt_4yo&Zo?IU4Uft7vmYqA=(F_ithGp+tZ6)|?)D%B=E zSjtDwW)-_x^|roQ({|;FDeVJw-2=AKufIfQDBv5ln!%8~txQo*bTCm%e#UsMXNJ*- zaUaeTpKm0=fBZ~FJ4rdS^*oPEKCqtPA-6I{{?#c_r3jCRj#&=`7bSgN{|!(-D~)%5 z=jZ@SF9Nmyx=~cr3r_Wc2b{dH$Dfbdl#5G87*t`Zetag*qK#jkObIpB)&;O65qL}S z_${jPmw!kcP(17T9h{gfnwYw_%A4MY?;Y9|IW}6Dl-)yEUJ3Zx^2{Z&?cLPKYvpzz z`6oCuS&;{n6PNGTVs2yV`L(k8{o8*kxyd5;L*!s-)&r<-Dm=b#>2PQc%^xU|zcGdp z@SJOjaWKez$FDPBXn<+Gn}(d_xx@4SP3k)jtw3(PRj@!ikOhp)-%P^$Y}&~`kx5hM zteS1l@txD%=ZwT3=&}#ZZYh0jH2Or?>M~-otxQzAFQ;wZ-yBCXVln5%W#|_lTz;@8@2^*4f?A z!jL(0>q^{!-0`QvkNsSaw2v0S>gp#Rzl}eP;Nxohg(Zx$V+Q{`{||OA;j|+phP|5e z4aLuhVN>PuN88GTRCBgT zn9fatO6W(Y0_U)go_MfO23;z~49fJ;zd%JqV&)OqQ$WPEvX%`abDY8oqrQ1hPe{*T zuyLuv!y!r_skQLWhhHtrLJ4Yi&mYqX_nug9UduiQ1iPf3I(dzs<)`zkT& z&=_{`G_%%wh3?g+WR6bqbZN?(67$~c4TMEGwtJ^1?(a>`SA_XFZgMH_|IBl@IluR> zgk&pF?ORVC1mgS-OsZ?dBA0JX%V?dlj1v@6cd%4K{aQyH zek2>De#8XUV&~jEqZ*t;yIBtYtLV<@H8w@*x5GW{?ItdthnxDQKtY!h;H@N*9sL){ zjmlGK5e)SHn*f`bqmhOJ$Z!#J{i>HHigFnl_UTgLB-h`Ce{v`2q@G@s*6jmf(%WRe zz8B=cr;b%i}roTni;#10ND?IX^GwYE=@CQ?fM5E8!Y< z!q6OZff2;tI5~BO@;t6H2w>?gd>Ip7GymA!$#SyRhAS2M9)Tlghqp9x;4K1vH;;DJ zWY=2rYBO1nLY9Nnc0O(4&F(~{#s_=^jF+cQGdnG!;Y(GZLGdQ<{M;yymYx%!R!_5*InMml^Vsn(0SJhuTuy0VCMktiM;%{mEty} z>PeALkGq!hbKJH4$>ddZ+Ypq71gNx`RkU$gMb4DpiaTX|V3b+P-nCvC?E4(&m+}?I zXY|Bm148hCdYglty5LJ56|FfE-6b*SSzDr^e8xk&2unDl0l<(Ob-~fDeE^!xn@v36fWfT(FeE?50Q?5T+S@7k1N^I zFp6?>Ci|bGg+1xw^E@+}6|FN<011rp@FaZsDh7gB3|Z$jJl34ExRg;Ewsp#pBqe~%v3QA||ejejW;ow8x7og~Mu(%!aT}-$6 zhX*w--m=Wr5O?bI_cJbX)~=b(p7kmoj{@mxx93h%X>$9J+M%x(wTfRJ$osvv`6V-F zj$R+Tt$Jip?)~DHzu*;7>ZD$T^(J;sA%ZDGOu645-_^MXe*bi3f%L=OrVuO8W_8Jrgz;6eSCdG$1!}ds;LZ+Gwa7d6G)utDkK(4>SSJ z6(QaKS;xqC)}R;T>WtIAVBxwWOVQ5$jf!5+(b}W{&$pdNc05Dtquq^E&?GUC?;DtY z7DU&1ojJ6&(KWC@>F9izJj;B{^GMiE^iiOgxG7?rYFn=na-Pp)LS^?c(2b_#+5DDj z*k6AED!T^|fzkvbXPC_zb`lDhKTW?qt4p-`AUA!=!y%?@%XcE>{P16(ax~*R=r8eM zgKNwYhl?Y$mo4+e)gJm$aeaL83fjcE{~x6B@52S$M+*N4Y{y&)$7=pf<1H}Ejh*^w zwx3u5!>5n!*oe^)ytP(vK|b883{OkjFG}#^?yv_~)F)eR8dA+K%h>>*<6a1~PPZD@ zPbB0Cg&p2y3dR#H%zsHcuYa++ee7`3;o!a4yXdKj^3^+dkelsH7&NjvWnRrWdYFv# z0}VYitGxa8Or+e?>+tu>%`;JGXM7-0WH*hKgS|`hxcK1qh~a$+I@zru5Vvga3dV77w3?xy<_!uFyU zisrJa&u#T3Nn^qmTe<2V>mF0_J8H<-2ec1(w3u1%qgrpX^w{4-))9wTu+`zcV(0s$ z>@?_TTsd*k82KmTcacG{w5BxeE}R!(N^6O)_BJ?RdsEcS_QEZQ_a+w#CBm=B;|5*D zDFJ*I3q^pRJ{|=MoM+4dUb*;mFskuD4=?6vVKaUwN7}^?@zh<08#@j2F~)Kq+Pb?x zY!8<=Y^LA^(kFB((5nQB0!X+GYjLIkII{{{1mY2h{0q&=CBfng-GKfi;PGd_vBmU% zqKyyMi95MxITmmGB0sci!rz^K&9(E9`i2cVyA{&(`-cRaeo_RJf5^ga3l$8*Q^1SZ4!hW`5T z9H0Jb+I$PZN@pnhR;c8G81yfw&CUn{@$YvyMFqpjWoA>XnD1zV?C|?ZqQm;6`;DW!fzjQO z(c;5Et8)%34MqFxFI16PUr!dvAbM6C#=~ut>kyt1(N&!hq1hXWT=(trfYq(C6q|QX z=w=Zg($6x6DlQw5Ph_wRWWZF#CKP}>YsV5?C89`n)%yh}!yWE?v3b4_^3*b>lp^HR z{~nFxCv($Ra)2Iw8_6235(WhS*xF;|CysKJ@$W#Fi_5x&(MdlXg|f!xOdlhWbtMra zj`No@YW^%J+GtAQyAs#x;ZeVvBL1KsQdBd%K{b~Ye9({kH6``)7FYJpVS;KE!jsL* zRQr)|n`W@#dEg+tCW~g3;%Wu^fyfdeG7+D|;tn^Mu>*Q2U9*Q;Yv%+k+7By@^F7CX zk_Y>>xxya~NlpJc47E3=KArKzRgqZR5djvJ5V-#Bh2SE|eE5O7B-7|B!?>EMN4Lrd z*0&klBtcT~2cfq7OOICI^!>`?7`;d;r;B`HcF%!L!?~PO_@)yw%8#Id@&@U-#Ldj< z#%0v4Xdt`4&!on_U7;*`UF2im9ql7nWzFS2z81A@tO$nPA-~h0I-DM&WLkNp(S*h~ z4BlSdbZHjUF*`y&KcK)qm7d#>CiR+zHt< zeXSHbxYwFTWF@nB=GRr6NjlFW`@syM!ptSpIji$`)P>|*7Y_Grmtk^^ZdwM9Axk(1 z)YK&-orRUQ3*$NJCRvk!%wkC4_s=|_=sjS1ii_K5p9I1A6)nS6Z$e5@w-TRIQeDM_ zwPR(s(X@yDsheWU$uV&?>!m2dv*N8CD+66TNbUw_f!VUvOP{$T16P^KMftr^!+$t} znIJ%?~yb_n_W9ixU4B z#XO5KX%S~IJ%7v~mUKFQcBf?a#v>C0Z{fs$xjpkH62h`p;Y5G&({=@s6OvW^{s9CA zi^9Nu-sIukOI#dQ-Vef-!2Ac|Gj8nyIH?*(N}Zij2KC6J7AfmF?C~rWpP)=lk=zU9 za66tkSnDL1PgkN-rVwGoT6JQV@^eNBI$(VE=V&-iwid|NQZa3QEPKq2=dz+D^7kcg zx0@k-HNTc(0=3%c0u*W!a`AE6yCv?I(L6M7$)*PzMmTaz;|l2fhkb`{2+i(vk6-8! z(kxLTBxj@%?5DbSMcw+4u5^(t@yeBCnt;F5p#IT9^Ix-A(Fz!4b)I@wx{Z9gHDx%6 z-==z1VPpI=#@4H+wmqyo0~bSG0O^_*J7{KOA8(X36DVadN4$;-QDJt*AnymvB>kJ; zo?Ux`N#?khLK2%fZl4N1!QnBP_F=CbkK-=vO=k*RHacp;MS2x~Og9U`I;L4=P0lMz zw!H{RE#UM=+fEM&nJsIK@shL_Cqywm5Ixb4>s99wGoOLYNTZ*oIzCMY(Ntwj&JB=V zXzn9Wj;JRA1P2>k*$jJ&M~=Crr_w3)YQLHMvfR`bSXa|OprZ628sC{eORd)kt`X8% z%@V-LobZJ>-jX?4?r^4{j+^;mKT3Tr-l8u{NM}~Re@~90uG|=tT0gf4RI?8LGcTZa ztz#E8Acz=O85;p>@?)y>`AYZBZs85Kw}0W}<%A^<<7J-w^@T&1bxc2tL8_E;q-5=1 ztBUVkDW)5&;6b~(CVCA*9V?6bCfFOk4bqDR$s#HEJCmteT`)K1&&b6@OAq;%+PdX| zZcp+njfbaa9afXAK1-LQIOiP+TibW44c3#>XKywL%!k_fpQ+3;*@DIEYiDs*u9~Ry zH?$_-!I9{R9>>4QNE=Xx*$Q+y?4a)-iROxXr?;2iig#5LXoeVS{bZUnVd>L3u^M@^ zs4dQ_I6TIXK4f4V1?w$a-TAXT@y+BG&fT~~;3bBKE2oLhbB|A=dodC*85@dX4;%1# zkyIYf9-5)_&g-sJDgQRIvRbuJ*bKt;pd%ddb!S&EK6yR=;xgAt*P>FOzk=TN8T)8v zRu+0_X;d|TppT*ValkJN(Z-)M_5+&>T0^@!hY#M2w=s?Rp5`_cJXRK&F>OUP2tP#e5mXhR ztG~)t@aBH`i{YU0X0gaE>%G>x&KSG7qHa97+UtFt!{NLVB+>2&IO6zFwQf)7U69-S~yA#{zw|j!0YL*aGx<@ zKJA{-dt{UO(V(s_fD+jUXz#%zW|YgvlE_$9OXknE)ya5GIzgU6yp~4VBq5X0m-%a4 z4^M^_??OX7tvBZUlwAtUiu!+YhtF}}Iza{$T&@M=w(41;s zWMUt7H=DhB{Jy{7705q(kguCJusYy}=DxXt-aZnHMPl^ry~4#eEOFy+@3+P&%pCtC ziEArmKUUn!eU)HiypVp&aK#np3x3bpDk0su7TY+ym}T7;&wIq0*SI~rAf*7lT~+n1 z7;+MVOG$!tf;f-$a=ItFPV{mKUu{72cxNixfE~*qm-3BGakw-f@#ZZ+T}2R}o=bm0 z&5mzwgn1$I$5y3zLKqPFnRSPJk7p)Z-lq{aSU%h|<{@jhGVzm4Z)&&)gi+^p+fNBs zmPwH!F&_@LJx5J29TDuv{o@Y8q#o)X6dOYfQz-r*5Xaxu=S>szmGLLdDFEyJZp-q8 z+KboGjJi|$3QAlLb?@zvq}Hwx~jr=Ik-kNK_EUd{Za-qmxb>Zg8020odczHc{- z%K*$j*!Xd&;A@Zn;O_%Lsr#AJ?wfynxqfp$V-&Tk98|dp&j&^WH__|q&BWeBw(L)w zfZw!m+?-@@5_P%`oFx#c1iOis?JXAipZ0Vbyl0)zCFem#@d012>`{ny zUp^g7$>Db65}eOx%|5%8E~1~G_4y9?{{Y@Kj{$g+ED#EIL8CXF64M@LHqSZ?B2ag* z>2L2TxgWt{xY^`e3CMaD zj(MCW6||a`4Oxzk8(h?TCvQOYH~72Q4gbf>iF4Q#$+ckK0LqBf+cS=j!HMSxyQi#h zn&u16x{w~IW>D^^h6VMAk`v2bE!@Bb$L{6d`OQDh#yGW3+&R`p&-gVNdp%#n^#hn} z<<_D*P}8c;Tk;TU?iv^(4QEmjV74gkOj}u@3+?y*nH~SDG4%Lj5IE7A6zrFE`ovYh zY`030r7oR)k3CD!<0_Fra3j1eh(SThtY-Cb8I*@TNg6@J^D=drxnl{7tABEFGD!5E z3Q*Cq*?wNsoba>^nV8+*7Rc&%BZf>{lae;mq*|#Zhkm7D`crOkkWcE0A#yL^F1i*Y zQ@{wgsm=Zy{2p^apYtX_IMHs=PQ1f5o{PjPIXyx6Ye;@1&pwk~lGO_irVHCYMiFG#=6zk=^_Rrr$E@v`qr*=@v7Q4%{{#?n`E4CDh=lTfd(IutwitXcP=Xca77B!F3fuC6jrDd9vV@7y>5Z)CQ zUh7?CPRJFb>xIls{m$OiI9i=rcmlFUuUoJXOkrn4@HTs5@eZL4?rmB)1gSNTLc(Jw zm3sDS_kO2L6>F%KA^_Ldi`@A8Tx5iQ{oBZ68mp%RKx38^HqNsYVZhG)jq00TmH59E zm;hmD=Op;?&4X({h3}jo+Z_h@lgmrVw5p4%y{Bm|x=X$N4W|o-lc!>Cu%mXvG-Tam z?x;rq(jr`=nlHfIdS4^J+#*~*&Fzxl=qZ=W<^pnP*2`U9uU#lN$xUBZS+UI#&~D8x zo}O(bYnUc=k$2)%$}O~C)X$Yzzg;-uc0pMeS~sYw_gG1LF+SEU`?nEb>8-s@S%_7V z)c2P@_A9eXFVK8wTv$|6XA`f!jao=dqt^5PavZ57snKQb5Wf(pge<+KD(g&Y>luef+v?KRrQ1M9x7} zeWSuA+rc;NmM(N$C`CGEoS-SenMrh9!XvNcbA)^Hoahc(N7V#z}7@B=}oS6Uj=7|t-^%=E0z~Y`Ocz8pm!ZT*u z40HtiKkD8wNR%K<*KFH9&C|AR+qP}nwr$(CZCj^p+qY*YHs)@`?A)IlTM?BNQI(NZ zsj94ezWmnkJm&8WtwyDb(ZS4^*%Cht5o#V_lXo|KPNb2hS0;&>RNGiW=drId;rL$rqnLI@O zuWVy|i^YJ&Ir2hVL>@-=28c63cKM?D2YBkR%-?9_4DqP?v?WnSi;Xa4%~4VM^ro{C z#^zneZZ>gC(|6HQbenVZj*1k;!&vUh&{nJ?Iz2TO`4($P(elo)jxQa} zuJstf^#KN{T|pweqyWrYGB>25c*)-7+mqnb|S+7fqB*mQqhv>lqGju&1Zl z{MTy@lwI{egXMFln~G)XS(DJ!=%>S~SC)t)N_i?zk1E&o#dy<(#*9VQnJLUxK%=+G zb)E%KjB$Q-0?VpM96j*x$Sadkz7DT+iS=RMVgql_xxrUTd z+WlyvS6z9z)zKc%ONN)~kCMI1b(=-r_PXxH=eHm0j6~3%FkfFKvl2}-1ui&bR#=;U zVGb)$$p@Nw4tSYV+kI&1U%Q5rcL66>+)5j(>Kj&P4wJMn#3f%jHTsbScU}#=K`g|Z z#^WhVRRVmO zbc+n93R90LPQ>$S$ZAk2ej0RmQwAA-n$xXdkcQK3ntLN!xSn8Gz~nOzUixIlv6Dst z4VO=2MSG!=OEXR0Vgr44I41~? zQ!3PnA%Xl=)ZQBaBCuhfSJrAmqRhmjyyZ3Op{( z*9%Vw6(6NFl>|RMBE>F;hZGOpzz=2@08%g?{D^gL#i|E!nO?J@fk2o+bN zsYu8>ngS(1>^SxXcFbZ|PbbHADJ_%JVrsnI_R&K$+OV-&qmpsD;w(mJ38UECqYRjt z!n*7YS)b^&Z!(pnd<`Ky1eeiOo$%hmCZ|I8#bes~+gu>Oqb!%?)co<~V%xWiczcI!?ZD=9 zPgg2?21DkKxdK#1!dBYn%zXP>@OkZrc|ne#?vCtRljnnd$|2Uaq~?O>EO~qSV{TWdP(a|H2IN58Jc~C za98b~nrdyHeQ}!_H**lD85!N=BVGoZ{CTC|pY`)hRx+8ZFdZiJ6-rx_Uu`EFxi4zl znvGSa}GwDtoLf+kEQyfzK9*BhEgSs(YX`YVKez4k5YGrO0Jwx?s7%$Yl+y(fdjIap=9?Y1$g%{7l_J{jK==<%V90SvhD5Fxel@6xiY=)5|F{h6GePpeO>FWXbAW9j; zH_OQK&NPl~e%2k7Wup`%6(1QMr&0EBMf;9Q@#aE)bEhg*xP-tMnitT0%siR%g~)B4 zjLf7zx!H%}<6;uc(b5#r)!{fX&Z9fAUnFR%$cu*D^n@(fjfpO4HTsO>ENhVI@HV$<9k+unBtFePV@k z!GMJc;2+5Wpdz5~m@#s{las~SuyvSKu(D3s`j!`_aZBm3tSc{zRO>i*aR0zaMeNLt zT!By80R=(OS45LnR<`&8<@Hx|y%3#|m?$h@YiaxNoS1)K`4*0A412R(9;B$#ED@%@ zlVs`LPH1?|8R*s{&a=Ci&bqyJ`ZFIFTy{^iF5>wn(LqN>`sR?Ky@#)U%tb%GX6cM9 zzV0x8xa*FPzHdf8H**FHeMCy+15v&!1!6f;f1IZo5L2pC>(ZUOrO@ojFtIMaq-TU<8K5I)v5U=DsxGhog>mpKSraM(QDC4U4r z5RiT@InW6{@-!d`Kj0zY&K?CX3LZqfNKONxEwt7lSbJ$LRMjElyZAP;naIZdBn%|d z;m-XaHkutI+X()<5H^x`q1sbK(VD+uVVZgTjbRx?#LXe-0_CQ#YJ*5OiKU3R z*9?d-qq{!NV_zTUPv4Zc(qAdWD+fWh|5gf-?JwP5TLTMNE-u>tK?;%a{~>*-71wVu zNCy*g;{%1WDQLgn2pN^a52rcV!0l&9nXX?Sy^nqWoVdNv57L78^AoO zwgJc}#ltqhY-5BdlI4w14Rm7dUy$ICyvZqYWB}dcER}+KW3c{lm%Y7IHv^wcq`H_gBAvhalTMUHo`Rh?Pd0r6U7Dn6z%xL|` zQSImJd`Z(SH}p`thKYzSb8lbXo-(eqydU*Rv&ES(ueqNY-YkK<+U}sthwmG+LnUSM z`i4V1IUNqAK>*!;l=>dl{UWCj_06*m#53X8^4D?|ES9c|8vps=|Hn?k%+5gnUzIBs-lV!|vn7J${i6Cf36v2Wio0Xlzz?t)(WuVn7ccb> z+!K$ip1Dw{Yly+vve)NB!TDVv#u#uslA9oNd%095o8!si=W<*H_pb;0 zWYTiB#7gH3;`aCXovM{hBhs1oLB}V#UX){Fl9`a$O6OwL@V!J2lO8UKhdMcU_{yK_ zpF$RIInJ`1`lIAG&pFXE>DRZtksNE?$eqZ&87_&}&o2vYl46cX;CSpXl&0`6fwgWD zpXvPZoZe3%&z+i;^B5L|`LO!*rP6hgta+cV7!{aRdNe02TX$Tcm0LInuoq9KxkZm~HjU*k6<8`M;SxDTn8Xw*-rvMCG6mJ-Teg_!hnD6fOIG8<|tH!Tkf2iLc zLTY$N`h`I`)<4ET*xgEncj1Esf=1+nA{no8l?`5bt2?S*GbC zJD^K_0MxBboRMkUGgCVSiVy?Xh)1deVMx1g@!&_7SBX9TEcbZW{z+=*wU$6F5io1fIVL-$vQwysRcbIP$| zf)jH8Ciq+;CO}Al;xzpc{6Tn-5_ebr`pP?@KQ-5vi=C4xxOEXvSs0Hnrs%+)~9!(d*5v!O> ztkxf#`Zro={ zO%*TMC?svq>B*52`-=w9ab@5S&j_SoAQi{>R4oTZujnFPPuWw_v))>6D^Jp%z*XHN zfiewC<0PbF!BeA9UCf$=#I36iG+2GgKu58ipoxx-!R?ky*o|3G>{=?!(R}CwbbF)1 zG*eK17t{~`Pu#Yk2M#Wx3dFuwoJ$Vv&xICkJ#eLXRsKtUqzi@pgyz7C{?MhJ7?@)H zj{fA%h(Jh&=s2gZP5;r?-6S-}ZB<_JVK~KoDuuQ%ZiFqVAqcoA=3&|0j6E!4mbsT? zc4vuEf_GfaQ$-#D`*dQ5OzvTxfUx~YIPkT}fe0g`JT#5hd=N+U0q5r*g}<<68KTQ9LrTSPd*+11~1o{``IAnq09vrsnHGA^k3Zo@B z;>uw-Bz=y6GhvO3Y^DIG%q?>1oC=j(5NQA%m2+^DhlCQ9A9^E$H3S{*77^i)H=|D5 zV?S(RH7Cxc_FcsFdi5cb*W2N%uV>rk`H(vePf{IsOS{qY1ZDYdLkUx#=uVlT>RFN9K5{C6+K32EDGt(#GuT*ITr#EEi4Wu@OecpsEB&oT>aLkZ3673 z*pF%ZF3lJ{7<7!|Vd~Wut%RAyKLAG4We}iKEQ)4ukE5twRwW|)0N3%F_j9pyUKRxt zlcJ*N&-iRbCUqJ^M^EAjj)Ldg z7FOZT*-AbZVJZbbjd(hgaeAYl^ESfUooz9!mZ;TbLCmE{CC~Zu>ioBkq)0^HP|cZc z-Fz1|E`eXG=JzvRhhrHK7=6+s|C#zxS7Hp(CQy@1RNWke58u-hzlWpu`{mNyaB;>3 z5&b@dLGzqiIUJLbUNVIODZ!1qNe1B=3Bmw^@EWw0Sb(9cR>t4COpf_AqJwbmG@2*{ z2T*%H&?o9k0`>~T8-WW*(T!=h$~nMV4ORdB95X*C!-?A*A&8<2j*;AOqTaQT?K)4~ zxgGb}^b4zf2@H>0B!g(0a8jQI23qrm>~kZVyW&K)Duv2b_k60cGd7G z5hhw`>I-(g8Mda&rL~K z#PPoGJ?mI7FhoZfbDR^2SUeax_Ffq?iRrR_IcX!uH`pZvMQm_9w-wOZ2qV9!dg<^D zY(H#|KW(+Q4F~GT2VT{>1t#{zQ{Vj6@M!XlhU^FzA6(3 zh#ka7fQQvl?&roC-9GgY04=wQ)@L*|1pC`-z(ZqGW*2@S=z;QQ0uH_^nI0+xCCC;* z2Jp6mheD|)+mks{aQws<3;p9_+Ek>~&rU`ww4pVEwbm1-zH_t}M4bwQBYL5-{=U&4 z9X??rv(fL!qo;R0PIsbDHJmkiIV)llS_wc<>18XiQxOk1RJ+-9V1;)4n(TbP<_*1L zjiy;ET-o_ta?AhJaKn6+njtDTJZRJ-?S$UQXV|J-ER=a0$sbY263i22kZfun#}@2t znJ;VWRxaSBWv;leOj}Hqyf`RZ!av$4pZ{EwJe96+UP-Z(SPPq?jgwG*5~BZoEO3(@ zG&`TNnSV0|ublgm%I_srM zMrN@l?Jg=Sf&)b@aNH0sVUoTlsSs31a#l6^w{MT6;TxzNDpP(9_={h;VZC%sW`qZN z)>TmK)Vt3G(RVRDet>1Qn+CP`aCD6%P^6VdD{%VbJC|dgPWi>h*1Q{XFC+cQccRjo z)rK&<=Y#TH9$4)$E~^p|B#v3Yz^Vu%;RwV|hb%rr-bFY@b&q3a)mFDcMirgi@IxFk z!MnUdv2<^1F(@{KNu-ejW+NZaVtN z4b>s`ZsRRGA8HsIs=M(3>RjokJhFJqq1NCk5Jy3oJkgQ^KGtGBth907@cYsiGk`{_ zL?BtmRH@E+fWc`((i8xZj9_{K{hc$L*;AWxh|#eV=?U-fBts^3uW4IPF{c)$tjV~u z9ES4q@a>u~3oZEQ%gZ{W_OZeAlOgTI^2oeq-{Tto}#RvlDq_q$qPsy^35Aj^Fkrz`subXN#$uvpwqPOA#7 zb?Lx4o&g;gQix^pTulcYhg z3Lpk{iZ1RHX6LJNle?{WjH4?@4mcXKjibwrQ6b0F3%DGhvW29i@XnCb& zQm-K&fP1!B#eRI)BC2J_Qf<6zL-*j!!Hd0*u~v;bda1N`z&b{W*Uv@ ziQ);jl)V$@Xh(y1^2$f!#)|)G{D?a0@Zb=3KlYR|PDWjT$g=9UI@YAs<; zawc=;w}J1_p_!=h6Vti&Sy1)%t4l{3;?g}M!A2a>hs#sxZS4f297gSC02){=4KIa~ zf_6n+L9zlBo3+pA-K2>I>B}9m7RD%Xbf@7WpI;C`=V{_Y8z(@KFNqE}SB2K;1Tllf zEXJ4b*LXHDpJSt1S{rFV3C|rc@XC85ykkDPEFK{S%foag$&!R)V-n6DM}i(+bZ243 zv!9EZCRYWO_Qe|@H8xHsLVP8MHK^h}sC!E*cLhd!NC7Gr%4)lx>g=qJBdJ{Fu@`kB zx0#`EiW_4}LiO=pz4dB8QE{H*9cfa{43afc=hof_d9t}T4>+G2;vZ4AmGmgT{RBPR zz@%$xA;fc2v{;PCAV5{Jpt+&HI}_idu|s;0P;CLie1s??#N}4e48i0zzDzvxKkZXE zCmyPbV{6TBf9L$MT(y7S;~6;7*iCshwwKzS34M1FlFAM7#@?HP&Y)~1Dz9CNXDK_A zaG_$xKQrc5m1PP35fgJ*zB_x@AMJHbZu+CS_A4J6@zx}DITW3|`ur3uS>^rX`ReZZ z3|&1KdNYuD!T8b_Bh_24Ol?cr4*i(rng=_*z6_@9<>=ylH8s6t?WE6J$J*A?`z4{% z2Ywgr>rC#%*9i#?r+a6*b576&WqWL2nJdkkpqC_PnnIH2ZK6^30{;Z7E8t*LmD))K zmCqjvR;J-2X&lf;Q%6TIq&=`J&VSZ$!su$Ar?N3+-C+cU9!XCJECzuvSJ-8l!JdU* zt6qn`*U1jX^_=bS@>U1m*{vY$CQ-^Oy#{q& zh4STjiQuCIgfSQj<+&!g8I|T8&<3~aj>TJB-y#hm_gGHFJl0tShem3kO}E)R0}xkrg})ye(2y4~SdDvf zJTByRBA-8^dJS`<(!lrUp%pXanA5k>x%#KI=cdmC&Ic4@ z$FDZ#;wQMaV9%m-M8!Vf) z_Bo#T04w^(b+0tI?QN{OWS-rJ3-YzKeGGU`JCPpGRSQ6nqOMmq56%SeDJDfpE=aF3 zfwL^E7)hZ51$JbthJY{)d>b5i#-6-k!8luRTg2a-X^+rk_q*L63D-+~v z(ME+VHa9a@lsoN3bp&)AGVlucZ;pe%gInn`V_80@X^+bG^1`#fiwG8wzQ0L8hW@^YktpoB#S ziD#A+`%ZF0tooU7`_vlvQ*Vv|v+0tb3$M(?lUoW?l=CLo+k-?C3hc=Fvm=Ptl>)A% z{EH;n1;f;-TlVyy;I5eYF#wfo_lJ)Ffhg`RG%7H>XBY;KV`nQ@g`KY}j4A70(a3ZX zmi7arFpbA=e2m2?dKIQl^YQWGjK0~^56S^y9qs`Un?QYG)~Rkv#`3QA0r?V$?KrBh zkt`9Kr!Kp&=J)sNDrk-cAA;doCdQB*wf`tlKVN~&XxX6id_uQW1@1vC!mw$I`TwCA zgr)>~D-{+fmoFq3|DB+i&gQ~Ta9K4obJN8Ji8M~9TlR-wBI3$CE|xqJ)!M65v~c<{ zpFDSYY&h8eiu{45131rIDf(}@0mFaG4H*Bw-!!)E;rcvj#GO4|*q-_6 z$)PEfo|!bg=+qL0#JZmRMa$Y=_yZsN6`P#NCDlmgoLKU0!Xer4o&2%%b?yt(dDs=1 zxwZJv@satwd4p?~7~;CeI%qR!LVdIUIccN3DfLtT{h-dZRoS~}#G?K4ux6Y{FrhN( zBfq?To#J}3DA99rfslIu{OVnd=hV*yKY5DR#dX_qROowPd!bX(*wm{v&041YLa7eN zdlSO^dCceO1I4g(rQMEiUY=AWe6Mu|e7#~D*IIHO1KpT7GN0gJ#~^Q?WDI&z-i0TT zE-_5T6{F9John&i*YofqU|`7#!Z?{SPcW|CyV-SH`kI`?z>!A}`C_Rx?ru*ECs4r_ znu}05sx(ep*0#B_YFsOy=b&@Hj*^hItVC1BrSkr_15XoW>Po&0_I8%mmDN1sJ;`3T zee&9PXY@m#LsK|7Q%fpTu<*J);E>oKvb-$b(FsC1P}9jN-&7e(J;rj!L2?y>CaA8K z)LMh(^>*I&Q9}2N1zS<|y6+=zn)UVbzzIMu+RV$|?|K9{G;RYBWv%_ZZg72#2cwEq zzGtEr?BaXPR~%llF@?`CSmfhh@^xS@s@=RPLo}#iR$SQKC$hEO zX`3O56_k|Ez6=aTnG5Rvu)@&mdI6|bvV-HNi2ZVoZ3rv1Z;T3Z(hXVNkW0nSA`2nG zVB(k()nwrjMR7uVkI}B~3nocN3YoTK%-IG&oO(-G1e4?TcB9u(o@FXQ zclrV))5t#|kLw^aYcW?Ah+J; zZ|~4hB9S8m6;E5q&_9Sp7l}or!n~yCf&4xkG+mlNP$ayvry{-;V{B2qp7-ImFq==wFc zz*~5Z^N+_O?eA<%p@3)5^nx)8`p)*DW52xN5abCfUS-xa+Ed0M?dCavDK7K#@1+c?# zR?*sb&?YNaHyGl0N;rb>&#c*eqdmqZJOE@Imq+0Elt8W?u+$+X0q7i^OW5wCB(kriYzaf1PoUsQ~ zp1mAEf+iI!y*Gg|5wh|vC=H@*7D#|a2{-RQ_qI8Pnv`yf(nK|m%SRO@f-fR+zXfkL ztgjU~kQ$P2C$n}ApDseFiPnf8hsL#oU9yNJLReAH=-<@Frs08cu^v_XO^Nc2bLVg! zRy^h9W6tl#<86jPE+ZBj#vDLMu8tceyzoj}x9s0nS<5HN0>AoY z`+PRg9za=JtDVZ9sVGF`pK6eeI3AKi4})7yn+(qw=S*G^(E||WNqSw*vIU_)s<$xS z=ois_f23HGV@8NDjqVI*oL2u`xC$Z<%#0Pn7PExavS-}`kkK?eUs0@luu#r$zf8V_ zyt&(M3qkUYj5i%}91b8>X&2=QrhTg9g^BkiQ6&7g+ys_-lzA0R9#XY0bBU*BTr4?w zm?L3LGtHZ4F~ggRfn=vR&0pSI?;0EC+V-Fp;WWwS?kxE83Yprm6{Q&C}9cy#e7Rv!1i#)OdrKC+6+@NjRN?zHM9((6GcjB0B! z4m2zCy301vK#)bevE2i<8vT051cj3Jg=IN^_N*XX{Uh$DW==r|2s(;K>7r%kKqQNyS~4Yt&ehND6zzG!Z#tYM1y>|L`>ihl=Yj> zrarF0y6Ym*8Lj!c_#b%t<)>@3v%TbEk#D$P;*S$;+nhCfrZR}~@%2>9$@z1-)6Lo2 z^SL)seEsziS^2&0k=+It_7WI4`9W>+criTPK$KxxQ`ktQ`*xvwABXbNwD#+6>}&XV zo{kDe=I9?D&s!+`xBdm*0{AW*psVSq6N|vh9`0G9FbX<3`kv`I*YZ8CXiTMp*-(FC zt1&chnA0`sU@Zpeqh!l_1Y@qe7Cf*5W^r&;k=+1RUjsXVSPE3`pbH`L0o6uD{0p(m z-19o`y{2DdtytxmgXfX_m-5z1P}4d`{2#g$8#RVLVB%LO3lTEgZrm>C&pd~lK_kds zeM|!zhqUB4%kyHK4B1N|U_3yL3Zl1esyW|fz)o(9YzHCnzh-BeyC+%hDrM1+4#vXr zFm!k!lecSs(G)LHDyTgAWm{?u0hLRdcENP8%&J|hg?q*N#@KJF51A%NZwozlVwGK# zS|!{UHljkqq+;uvveQbLh7i4KRzb96#5$5Rg1DDkYtjY#S&HMN#Bg@vyX>#Kpoib} zaNtBItEb%*e&4ss{Dhbv8HhU?ynkTKJBA9$r=?6?t}76X7Qa&;Db#JS#0y+~g||m8 z>*hfEnr$1Z{*_(w!%1(h2;VbAv_Nf&ZzpT0%D<4l*0EsmZq9X!Xj2|6Mrn2!g ze59perIESVm3*h$Q>8b=gp&kG9%c;~DVO4-3yqnOn39_X-0RQFC#_qle239&Vc!6j z-By4%6WMpy)9h&>7egsT`n%@J$wOcVi^+8+(=EqyxqXgFlS6|wVna`gZwU~+^$Xl0 z6B!bfH}Rfyt5L+lffrbEx^L~a?+JJO^(48}8?rPyGvOhdLp&<8^@k z`&ll@+G7tRDMI*s+bYD1rtc5av(yA#09Z9#tzi8mW@tG>6fPD%XskxsBKBrrR<#Wf zL2}YO!8zyGQIET$M~Fw`)lvfLhH!X1#w$!rSSrpJr`0vFS#nfiw@8~SG9~R3FeSiU z<0`=P(*f-r&7$}&gDEhXUj#%_`?;yvmV8++lVbm?I0zyfg~JpN$bm-0ia?X_7iWN@ z=^Nzd>ud<`y|;i&jp*+-|4UK8d3iV#j$0un1HPX$&L3E`xtOGLKN^Lyfny#>XEkp9 z#MD6S&s5+8e~OhIHPsH&F@$i7PIN;>FU!T8U zruB3#2AQ){sqe$nwBKc`s(XB$N&YTYEukSBU4JJXG6+T=4NK!4Oa>e1RA11oLpSK=5IKPLpbsS-FvCt{>`SpUUr1Go_HMuV|z`MhLIoVb}eNa#5?GZ zeWq)ZYmRAj{=3wODfL9(5oz_idbPb(*M3FMwbYq}RlU4Yc3=#Rc6Z;epgc5gIruf~ z3v%>2aL3j`_cf599|O0MfZi5IxAiFvC@gfF{G(%+wnNO5O%Rv+2^55hH^VG_9hjY* z@;I65({@h$aVa3sN24R*V05Lq6Sd-f3`1^L!JbICBw7FV{_ZVNypm_!TNNmgB|)sQ zkL9`l+f8L&|7I4y1vNTxIOuqiPZrSadovY|coob|0T*{$xN6+F!V}Z(U{A?!DFIIfR>gE}UJ85i&Y})T zcFp}-*bGT=b05`o1ivK#T;`%YIii=E22l(YYjBxGm+#hnz+S<|Qno#)Kk&>O?0U5; z1#tkTTT5^C;*ZvUp^@+IbnBolW8zK&!B1n`QO@o5Mldt=`m`4(-52X}2JUB4v%5NX zKdU7%IBPvM1>)sJbK8+2w(36u`kDX0fNBhu!qM1J4Ts+zj_{F|96)Qg=VjeAQs4*PEFH+StpD(h!wOQ_t&V^unI z;-u4bZ!ddn^Ih2uE&N?K?4^M^#09;NuO35udqmx@qk<7ft5U|Bdc<&1PNq~10Igrw z-inmme{)P=GxV%6^wMswk3euXRh)c!5D1(mo!*rw<;*)Zaw<5Fq+aR{%E|yw+iLQ& z?c4+%Qn1d?ccQ#T-NGgXj@9wfOe_=l&;-c&VV*O+= zZr+faK@ABqU)q5EQ!ekan~BQT(^$so$7|u{yP-3cgE-m~&H1&ZF@x0BS-i;a?|-;y zg|CT;fZ^UiHQn|r@qzUPjid_ySVl4R)|;cL*EwqES`m-`!;>DJ(4$Sz8>YP$6547o zTRXG1-_vkr2-K*z7B0kig3W^!1|_>fZT@xa_fcbc$^{2R>51x+Pmjp1B4`s`2*jS4gltzKnQ2#WY0f*J)MoyIb=8Gu=tK6IFnB|^U{ zE}*kAIh$wk1>@y|I39^&u9D`0gtF2g8Nc(Nks{QYpPxTqh5op7NWtAk4CTAw4AE4= zjXVK#wv<{ih%L8nuB|YAFp%p8$!%TXU4)i{Aa7`DfVnSvDAI8SM8t}5cq`}|YKMVE z&8pJJJ@=NY^}ctnE?ku7NrD5*v@9>=ow!pG?c4wtC8fSPIoNXm4^|0*;ysY4LIcP# zghhXVJjN4{9DyDj|CB98BU<~ZHuskSQl&X#q=yaxcG%(@ZsD7bsH@KmXIe*}f;Ahh zCvnoO5S-FTFJD<%TsM08+dN-HfKz;0`yHjiTX_0}9XG6=>;_i(P<->l(&S zddrKcNHhe$s&>?5hPu@@l*K5-1VnIQZLS3y7%%e_7vf?WvE+*-0j;xI{ws!&E8>dc ze4#+mqN%9c7LnT-%N%qKR(;wITx-G%YF=T*=UZ~Cu*!X^btNs9i#tlaOZQwhDOyx07oJh5 zOu5H`MTi)cAw5w9UV@aWvuS+ZG)`m%c`OQ!9^MW|!!B#_)3M8&NJvMYedl3nG`!`-Emk$(Wi;; zh^&TT3f`W`G?r4ABQoLbOxBbEyc3DSgNc)+PR@OlZ{18F)ifbn#<}ll= znWV`uEbphecR*@xG+tb>Mj_Rdbd_%T)5Rv;3#VJ{kWz)nd$V{5V2vYNL(IWO&^>QY zE-C+De^}5GnJia87P#<|Yyt-n(xWxz>5%WHLKE}~>tP|#QC8viZRto&Zf>Kz3kDFO zBoBo254+iUI#0L|dC^6rcv5v9BO+7-$T?LCvt_{K2wobqTP0JjP)2b$jo=pfoy5!| z39)>QqAXvp0xD9l#WpA+(VcXdW9VF`6)c+(pRQ_sf{T78vbN*(^sw&^8&(xl;mvMp3I-XvK;+BnfOO zT!*znG~k+H!KPr}N?z(3{d*I)h8BmBGXJaEoKK^6quq{kk`Usrz2vfZ(!qFI1m#MNrR3h;@R;tF%9UHZ0 zN~2ZkbibT$U+>>1dVIa#AAIQ6EGu-oKU}|eceHI?rBEn$&Z0*eH)xssu1}we{hnuS zmTtN5Ia~NzGqOmeNp#M4c^aO+WSUJ>n$8$~+n1Q0==_##P;PW=&!t_U8eh7csh+ES z2XA-Jn;7YtT&_|uZi-?x>zzhVf3vq`RmuHuKKA}_?orE>{cVeS=6K7^+eN3b)?_)F z=y16Ye7cL9De%@yIjLqkgW#53=1E`cy%(>KDY_k=i#^H5FC-QZAod4?n3?HD*4x9@ zDzBL_g^R6^L4t)^O(JAEG}q4O7BmoN^v)WSW`!ZNaJKJeNP0 z-#+z9$6pqOF00;mZ)1feAbD(`>cN~@Tg*4)y2r=Xg$M?fGh`7(cYWqI%iO6SQK@Rr zMy$=hQ?Wv7V(;lM?AXLjiMdFr@rL8*ym=6iCm|Ql<~FSy9f~*J09y{|hyCavZjNOZ zw%rdiIJdlz^KF7;rs?9Gx^*BX0g}RP<&(6}p(1cI*}5wRM-%TDTl-No8;+C@Clw>J z9(a1Yc}cv$8uI8q$RLrcYmHU9Z@I_v(((m`OE3EORMq=n@&C?rJ`4CSJgbibxPb8p zg^-uWZV0K&Kxma7w#JS8X@v7mAbK@|!3z6`>#56inb{sr38qKV)dUo8)v z$y6t1r_*)lIyq+9m^b86bR{YQ)lXIq#yaWj?3hoqYTT<3Utwc5%|fy$aR+z*SVCu7 zcPkJ7K(t1GD(q9e2KDLyIgJzLt9`DC>{@-Y#^oD%ipCbu8Z;>|S|lp2@bi$>zdGt< z$XlPHm^^c}19=MNRx?N2Gl@j($-Vi=1dQbUYt)=Kz zdQs7(02ISrlaGwTg+?LF+RPw$G};#sL%a4?pMA`^Aj0`Sd_C zDLp_q2Ql1=Arl6hJ#+@RRx+TZ@DqJX%4!!VXA0?>`z6z_Z$-nT-dAoFt%Ho0RXDW#V^Cb5f9bm!e>XX?U@ zB=DfHCC{Ed_7okKV5te92nFmM4xriQDQZJBg6H{5ejN5TkB>vXqG4$WE?CnwbeM<| zzWCy4jH2{Bl~ElRKKLq)c!P?)Fvg_jd_y$*dwJB?X*;enIetXQG@M^+zg(1V2#+=3 zKMM+XTw(GS7~tAyEJ_qE zX>QxLakg#aY}>YN+qP}nwr$(CIj4I%Vs1y=xf6Gye?V2#`mk!P$jtZ2D@0NlT^v%? zr4L;EDdB-I1TUYAP9Rw8RS*-P$MkTERs=GdKM}a9o?sRt04QqQqM~%^wt~4Y0g&Xe zWLXS}y)oQ99I)aCP8}9EJ{OT{sjxcucKaK}bXj2RhP!54%dWz?3YAhY;uf9YM?-vG zoB(D?;XnrYxCqd_VSyCDJJGR!Cr8BYPC^pu!v*tG!%HN`-^Z{BKoMJnc%TNZG=2|q zB(rdA466B}q$~dH>S$>M-AY=ddm9Byu#ZX5qD|}cz!61Hj}?V>>+pLq_-3Adp*Hp0 z!&cO1Qr+(8Uah819f|sSL}`xI3vbtmRr1{vG==o$1Ie(=dDpc#41ijAy7>tW0Dz6DB zK`qz2DU`e?_!Ud}x;*C1cwZj<*%`KX! z{#`|00Pa)VF-0ApPHb) znNyD^8t@RR>kqagSqj(YLg{a42 zM-+tG z&no@LRi9Nt3z@#==q_z;8Kx3bWOAXXZDNah zW4E)kJD0CV6+Ja~>2fs{fA`m+TH*O*y3_K}s#Wsy*CqFwKr@X7?ddX8V@||7;lcSL zBn$qrSRfs(0(QNrciZDKriZ~*VmcWsP})*#>l%CD!at|dcM2U_!RT|Zl_3432L6uu zX1b8x>O&P<$~T!*8#H~5Y|`tR+<@f3IKi3~=N>!@;&Rm4d=D~=uShunjW9u8hYCUm zf*)%Pq3ry&Mv`+QFDo>PcJXS=ZK?ms`I<-C&1)zPXxvTVJZ??|dqa)qR!tZwbVLg* z0}I<(b_E+AES<6BU-C({4lnwAAwM2#EvYimp3TaC-JoE@yrF%feZv|Zw#xmCm+3TA zYZwe{?~idb0RraweD}T;69&*Jc5z96-qG+-aR3&QL0(asUOf;NyMe)=EjCLGI87tY z5={O>5hC}U|9<#ma+svENb2@GyT0YHjF)gMgGmx^)6D%4DJ3;#(HxCG2m4#xMr#&k z6WOT3uUK3(PAIz;`R4Qo$GN-g z93?U=po>65D&RVq6$bIuOrN^iXnX(SdP~2W_}|YB&zUzAI!&F@o3=Vh4t#5}0q7*I z_}-;qZIxKa4eh*6JD|qAij!%6esBwp-gwS(J9wbjTtfPaQv`o25i25d0Kr%wO8F%S zN$LKzfjq_hna~~4ZHgzXGx#h;Q2RMWTnmzhQS6pjd4KT@2Rtsu1Wo+cO8p65C27SP z`%pHoVK-InS1ywO88TyIFw^xc4hzFFe{Q^#KhxDAH~3Vf2_H^;LhJZG?sx>wvrc&8 zFtOD?H{h`0^$O;=H=t{eOhH2_mnt0j&Z%y*N=U<+43!wDnHb3s&jPR@Ft~XZ0-T~4 zK6FzR4mZh^us2Bc@*`K60tg8sWT}Tlr9MMUXH>S}-#Im`b7Dl7J5LzI#CaI7M?cLh zA)HD$c|UmUW50J_nh8ht4Jm;lNmFy}SO>o-`db(_5bv(~wkD0NXQfPVyn*YK)Un&LNg*@gfs4GfcrG_LrChPH7@3N5)JBSdd+wZl8Pxvv zCtIZo8yY?FH+bzZ4%%~I3nfQySOl0=T=aROTKH3Ni9AQVT1^_!j+0>Tb*c2|yJ=xp z`_O-v^8$cI;atjL$x+mAn`z@+Z#^s#4Z9XB)85xB-23EK4ls4xxnZa3O~n-V)1cn! zHBhMlBx}OBLEW0i+fAMFR|Mg(#&R~hLWb8n4z>%w0oSATzA7vdg8~sMgvB_Q5diL9 zWcEB>5M8_j&VP|lgJ$)xmFBJGeXr&Bs(G66QTHPydQ4bi-+p|yGjg(37hfiK@;5=J zxm%i8;Ek)-fR8mSWUbz?R8Wj2mo zZ*j_rVRRY@S??0&XHWjvZXD=1$C_G9oqmVhA_U%%bDewvxUa51k3f~P&-=tE;o7d| zwC!%iLW6GDwp9fWjn&1c<6^e;EC?lCJ+G0mu6bDb} zSKk4b_yS+%GA|_Dr%`;;0=5OOyH=%6c}14gagh;L0togl;0J#CF6Ib=&J5sDBaE{5 ztBXM{xo_T$Qulx%ubzOA(#-B1!zW000@H&(tsky$kBCt~<#c6i*SYYD(K($@go236 z1dGT~Z^#IgM;6ZH{A}#1Iz}zd9UHo>mq)Cd6qesJ!D$?DN&F`a6{<~GX;&TLkW$%0 z+1ylMMjhK;nmif@5EW}$-DU?NJQPjkJmJE5(tTzd8=tU;U~0Lw$3|*ZUrpj_qq#nl z6P@JzAIU~eD$~7I2{<0fkqw7>xd2A6z`{io1GNNL_PeI7X;pjVTOV`&9A&k(9ME@L z^*Etkos(bvpt#Lixf()W!o-!pCxw?5_t0m#_ISN#%i~Ln4zX=~^NuM$w9ky2salN( zsxF{=Q~APjN<12^KSb0ndMc32Y`RHa7neI6D5=H$%S&L4jplB<3%A&1R(Zp%58pNo z{Hfe&xF9Pc1$XMH329WA1ify&Q@BhQNu%SEg-oYZkh2~03wmH!Qrs#8jthD&pM>xw zB9!WWH577iX^6F-ZrK=@3F}{gHXIZ^WpoZ~hSwKY`n+ZrVfj0v&J~ zrlg$Nfk@AN9-NgAy8ibH5ys>obpGy$Ai(*hE&S-=m{|hVj&_}l=thJ6GT0XQJ;r~x ziR4P5S7eLf58``q%Nz!fGE#QXWBC0_+qD9WWP-EjjJx*j%?ufyIQ&`93LlLn2E8VD z9z6&auj5XVSOKUZw^((JQ2Z9dtIxRz;?5>JQ*yBV@S?!KFT#l zpR!-?N2z>t0^%kVl;WG~X7bL%bHP{4RtI=|;+x=S$nRK7kOy&1AK+7eR?aW=m)feN z$#1Jmgq7%`uk-{)Xz2}WXbfK(fXQ}6K%S`@;|GZiXo+p{tWvk5V`5FHYGJkWJHTn; zB?p^mXES6xe8c*X!3s;pq}7h9GoUZC_lVC(0PqYgwX zWwh7=*1Wh1#5X&Aim}cRK_NiPnm!rWKJkpJarTTwuUj&v(GN6vB}b|N>8z7xa|G2? zJsb-)ICz>dM1pfxhN$C*6rf@b0yKLE;kzenm}yi*w8czAqtQYuc@}10`})F7YmD^c z%F?Y5o3&>ub*AzS74L8BnU$SQGr2y3Dtb7{Uh<~UPj2HnL` z+t=X^BpJ=NiZDrwnJ{c%-r50#`9ctESK-CwxbX(~igUWfs<*f*mwtpi1$(D>22pWZ z{lSj_(ArmTm11^=(k3ons|+s_LX_9Y9Mv|Npe#tgq99_E0{2)~g%VR7b|XZi1MaM= zB6ALFtigu0o#R#v*04xsaSXnUN(weatJWY;?|`D_q5#p{1*V+~PBb=fGNdmxukmNVZ>i0s-!U{QP3_+Jk5o=U2_jT_! zNvQ{Yt!bo)6hWO`GX$~g5?dnpEfHhF5%|Ig&Cw9%Z4!`V-g=(=Xgs@1?dl|9ejw(0 z8&{GXOcbu{8Cnc#S;>5p;xi}3 zLf9n3zk@u-_>&sVgmiY%s^WmI($5L9^F)6Z%F2qj&kR;e2BtY_531)|j#gN8=;=1n zivQ$6iOXwkTXZfW$?F`q@_`MrmlmuPn`+~LI<3!Z6D@HJXqm;~Bz-OyGfz=0a7ICz zHShX3Sn!Ew7tkfoQ6Rk9hg)WV@dy&$ahioH!MJoPtjY5hyI~YXc$g&Fc;KFxZB#TH zhbRT;d2>#lu(z%ixdnmFc~?}V8(~_I!AdeO{|Fe@xN-j(cZgw*7L(VKd)qOi!a3Sx zsl19=`$|3D9rA&HWSJ4!I#bisn)I?fMS_~l&M24)bWFp)j2P+Z_RfZtOozQLl zO^ynIg{xfpg$n12XHMw0Y{{anP?)iGF=(|^%;+)5W7|5vr02|>YUR#tJkFkcT2k4{ zO%1QEu#CxkiFDwcjMU59lz3f{IUgZhfKmGM=8d(jAq9P3+s~!z>t>w8{cEJt<@U3` zylI$dd~!TlX!zykl7eZswoHqEqsbAc^JpNh(Vcshx`@OvJWVo~n#1R1+PkqEe9ZRJ z`OdyxYquZ3_l4UBtWe8^dtr9G6HLri7vi75q_E(4WtA~2u{(wf)|VrZC`J~cQYofC zX#DAhsV4_S?YJ7q-$%wzWSs^`5oQ>evaF7jy=p4^gQ^FBFF`f+pX$N?1OM~C)YAW; z2ebX3(}Vx-SN*^7h5i>(=pSt8A7AMIfekSdFfsox*3f@%W`LRgzto2R$H)ACYr`xI z|C=`4rK)bbDTd_pT6-pHug74OqdS;SOUEABk!SiKjMD)063oaUJayz}OY*f|Wv5hUNk1~96 zF|r3t?aj7mmoc~!h8MAh!V2}cq_utPjh78_NIf-GMu`s;3C}{e1!{<`;Uhb3)_-|o zNKbn=$U^6J9F6)lqHiF=cBz+j7#QYO5%mccd%wB2tJ+)GopKeORc=Oxfhvm0JNqg^ z*7m`91bsyTwejfggc5aV2bF=pPbhfL*6(H@0$;&rAEIKi&JJwA^f6;P)vXCQTETH! zI9S|v539287oTX%vwHejkz#G>((omsu(WKfJmK;~qM1r*N?O7yn}^f89lz2ZR=Wj9 z|2VI1x;D09WtNX5ACjD8v2IYpOk&1)0%l;19QBOBm>^>inAsR0 zNLx>IY!ua4qBbo@DjL_qu)LyY9MMPg-0uWf#Bl4R!^DBf4e? z3z%o~HE_uK?=0MGnWHiG&*$c6BGaDkW<>+dd;uELFQFN_?7eH+p1F(Gw5-hrr2N|) zwjKxQ+f!G~M#s8clj5|Yv02^T2bNJ2bYWu`)wfttbYtT@`{H$A1EXT@Hts_UHg2q$ zzOeFL003QjUQ-d)S_$NzQ~(lMEj2Qk6hYK_bY>nG3~E3K-Cy_27=~~L`*p;Qw4JHW z_C=pqf9>*k(%JW%9T9&gjIUn6kuQByDU`VQih!czPwhW9T?@Ssb8K4vMO4ANatP80 zYq?URF&-xB;oT0ROU=avt4L++8qggOs@DyRUtM)sn;;=!$3?5%m1EW*?jjvY%Q@_J zcMe}y_8{W6qM-M(WQySUIJC^)Aids*{EnT|gL`JhTYtop|VVD0_sb%C_8DCax zGpe;xDPp?B){@m)Wi+{WmPA2@-1-o4GCU6A*pNo@V@8=vx|DDhtQ#VpW|COV$Q=Sb zaHa33?t1%2&=k%i6^g)Dt7nB8p~l{{Zk?Cg zuw7#gd5fk&98reMsnsw4P(%|&|4Iv!5Og4cNpnWZicA0l+|alXSVLe=__d^J5bTh` zgh)s^hRnu%Y~c%aKcdeZ0(0t{J7OO7YV-+S=%vuM-K#*Zb+-X!^!=_~dshtqgzl$Z zmctj5)#z?1Mz*>pD;4o?9K!A1oN5NVPTC+v0_z+8<8SD&4q!Fv)J$H2LLJwDou2m* z*IWja2C?AfUSGaMBxVI%={j@PNYLV9ULU99HS;04BPRbn&n`HmiciQkw*F;{ip?e# z{{Bj6<}Ns^Xvg8sia?CDA*A+h2LouX4IWU3$=>*A9}u|*v&;aJDrK5f!TU;i9*qps zze@2W!!}!^TK|U{4AV5y82g~%&5{cI{VMFe`jKS(p3L$mzw#zOw*WQ!{O&K5sBJOs zM{fvg=JN!X>PP$1x#Xr;lkm-@gt(MAxa?iB@6tFwphb3>Egr?T#bE{)o41G8zWZx< z|ITUc2g=@@ZXrJUY*ltzLaJKm>GnRd|o0Z@D%VQCX)F2&^2B5|d!$QS&c z-!M+SOUMd8STPP9S;S)^dor#msUWR{xY(}8xYn5(H}c-eSEfhfq4>0LVyl%aNdg9> z?%cO0`PI`T*y#-dT-T`nN8iKSg69BF4=f`qCPJyz6dA5wBgsxj zPX!s!S^^rLL%F>2(U4wVmldn5V z9h9T-x%b_#v3F=Je)Jqu^lsD-f%w|_(TUeBx#!#Lm?7a#oTXeBIqZ(T^}I&?_3VyasVxsLw&2idhE zGlFr(|84^UpEGRhz+uS#IHUW9hea|)Dr~i%GyXc1T8eY_=f=2FXso-Ej?-`Bs)AXT z#ATdY{<$m49QR%u;X;rz!r;`~aJpcEBQ8L9NLSQ7-Pom9NLUPN(dc@{;?O$Z4!iY1 z5pq+zNCxjLw`7rQUzMky{M$(P_D+z`H*c6Lwn|EBDMGj_0*#fS&{+*qIkaPK zZX`3sR^Qdp!CWYDsP@2?7@)b5krqIF0e}l2mSTa&@Z@_Lc;uuQL>dKYSW1y9!xlBE zw=viJl-_7Vpx?l8XG=D8(VeQLm_$((sx~?HtgXnbXi-$1$28;L;fnQFz=;=2!d1J` zV_EE5=J4RqOM&X1I~lqR(C?ly78h}R6W}kdX;=Bp@ThY_!O7A1xe^a&dmD?vbqcBa|7*ufsv`CFbX810rVOOv6jE@&Je^d_A}c)Fd3TUdzx zh|BSg{W_Je&z1KroqCO1Q965Lh}yUaZ*$(2kZ#MfE_@~;E|dqGOP|qesgJEL)&1;)igxX^pDl6D{W!sR zoMu2(GT+MTkRo^Q-g3!VfkSb|rw1*P=c1r;8b2Bn|oWes=fR@ zr^|^-{xD-E%PylD#c$}?E1ESb8LuMVsVL3SRSMh12KqKA{mRvVKse8$gb=ZfL8AL= z;6h}9{nPD#q!I*A1j7?4f9UR)7l>Q!gKmFNy_*0`o2(pMOo0bO#bgNj8bF0P)X`(a zrYQ&Fq>kzjeRF-5Rb$CqSL^|DT~cCAT$R0Rk6bzrJUW9ueMM)epL%7h_=3=mm1|$%2X6XywkN7M_CZ^R+dukvQy8>1$81FNr^l;ilD(t4nn12T&bZ^XzL{s8~ zZT4?>BQB-)pZJLu@-cR9Z!)r61Czy2)kfSIfYaGal*?J{q|`dwLn%_kFr--l3+Mci z_Zm-P0>DScG3V&C=(I47AMEZ%qst ze>>{uot+1RMa&3hAwG|pQ^qbG{5T^f%QKNO>2D!a2`~RmhOD844o%lke=zDliRJ&- z4>(znriQAA6mYF3v#)5C-ujp4`Pp~j!6eotL}TYL%jQe=ow`NCLTVTbSKrcP-ALvS z7%K7Hsjbh1?vG`A!~!~;vmZzWY8piFq$L7#t-Hep{__+9v&l~seAQxvo9f!CZ&HiQ zNoAG4(3ISG)1oC$zmmPKR&A2#Bi?Jv>Jw{DEc3ga8svPM;IW7pWYA`5ZI)}xj<0V? z)TF0$cLC79b@!-480i>pqVK(#*=f=L-35~4D8A293d6yjpAObplDiv8Y2JdjT&*a= zq%|&jkR-0t1$(Hxt`=Y%lZA90+SVbU&N32CAg%(Km1RA$Z|>)O@>uC< zm`v)X;6kr=!Q0o5!Eor9#N$Bjb}@|^Zd*WOWU2NVaKDlqvEvNTB;E6_HOq4iSIngd53uq_3e;Kwr19Ly(9c}cu(w}; z09IbRwJcd~!fdDrx>KNncJH#-5xY#6=e}}WugR9h7l)UrZal9SrGyq@5qz-oPT5!$ zxR8Kdtb;?dZk0nQHJJkyOFtlMcl(R1ha-SUBpx+=$g#dbyMSl8u-gX7PKpt_=}TNv zrdYm-)^nUZ&6%#QPWt3st=P?@h6_sZ5}4}fYNC&5`=3{`ApLu7n<%@CZp4b@GMBD%@Qov?Ml>`L8~i0Twt)wA+2GPhO;d{*GopAV50 zr8=1`zcJ2INj$%PjlM*e^=zZp_$55kx1uTQXpoxi0R~7deb!xNk=%BFrs@T-*Nl;6 ztc=)@MX$!ou3wrWv}>nPC#RCexZ9Rc*NEsO<60X2$$Ag)g^(0?gXe;GSre81G1eXhXUr@VSrjJYOI#n4u>+m z-y2NnQ9U??Fo}h37{3X$nkD_HZ`MeG@J7k)nhb1 z7~CFH$>EdrLKB?@Js3!wF+lo-5X|ha5q><3M%V%?BLWl+j{3|t8eZ_G3*{*ij`I3_ zr7FvRuGs8Z_SuPZVJtfu&eF#%X=8q-@Gi(96^b!?YZggAFa6p_6)Ul1|ENN64@v1d&JF+_#aKnl#@dSdS`RP(+alNAVUKUqKCs$ zO?RSNZ=Jh%1_yP>E<(>~3Xqr`+0p1;!y|VvB*hwspF9p6dF`$SE}GuhaqJo2lP$86<#VC;u2Cg%JC!n1OW*zDR8GAT*_-J_ZG+l!sxrHPNS za5P0063o=4y*631W7+?nyHzV%0aM<*K!WighGtAURz55!RFuaN1HnuG9LF` z2KPJpd4xEwy?HxUZfQ8M4@4)!Bh*;J4kl4Uk3rn^NR>2Uml~VuA9cFa|JMC&JFwEimg2E6eAq<5JpGmljG)hmbNPkI?e|vd`ejR>fySc2*?e)38Fm@a8ew^0T8Hu#r-D%_J#Ajwf z!=t1Mu5H=&KFPnGNI%$OyB}4e^`hp=g>uiGaDEj^-!g2!lPxZV4G7s90mWVys^Mrg~}U6`AOF2M@SYk_S5$?8;Clp`9s0FfNy{6xXn5SBoIn*Qd~j>e#Ft;(HIze17Q zAg_r-)gRU7n+A5JlWuagYQ;;J?B?%#=C?^IR{A90Ow(zw(Za#|%#1te>4~}B%jb5! zHBy#sCLhSm&oAWZEeQAbSb7J;B%)ovK=93<`F)JWkB@eH&<}AZDsy#llPGTr9^FV_BEd<~yf>u_P1}*Wn zi@|?FL4(~Hq^u;(09E_8N2@nKh5jmq8Q^-T#EcLd+B@Yiwj z5C2!Q?BH%}dE7KARBY^|fSYm;n-TD41R?{w!0%{F%gr#?x8-g5wO4J_>E750C0Tg$yY~SPe?0*#L3H z%N`1^7#vf3mPiV3e(1n;ZrwM_aTgG5OKl{er~wZ2UMOCt3ASfG6np~sJ9)R1ujSXv zAU`(K44IR;Bclh%Dy6S>+W1kwrg=J)ql{|Q*15g0+PFcA!p7XQkTk_^&-Xzu5Db8Z z3-N#2xWN7&8W;Y9cKttf#k*nt*KY7%p!5Ihx&$d>8&fAU z0v2}G|BZK3rFtv7DTVYiqg#)ESix|=5tCR^0TQIbgBn55y-4MO55o!>yoN~l)cyNo z;_7o18`QFpO^G_Xlb!8;l5T1edkP+ke)0V|*qAuW#G-)Di!&>;)W7e=tB{_tiyO5t zUncjc$-*pKobju)=)@UPOzc(GRM8;M8S=L>@UmZBp(Gir>CUtOY|{D%;x!c&;IABK)jVM^=Q4)!k|5(e9%!h7+UUC;<~=9*h#>uf3kY!V4+4 z(TNbNbmUZ(IY72?Wln$imRpY(V+%BUq4J#!_ADM^?8;Aw;Uzg|Z|5i-uCIF84sSqy zCjPjc0dadUIE4Q|5e?moaVJCMUg<|VOtZSTZ0A(EMvRKVvb*x`!p<>IjrBMg*Ww@6 zm2y}gk9-;$Q8~T^BqxBCrQdor%Q=dic*SYu;;94{|WvoU)W`Z=D!N(@-P zpP2kodbepZKk0J?el>9|&GAfv_Y}4&4iUg0{3z?OX9J6&$b|YkL zxo(|D2dGRf!-nOsHpkl2=WGJq$x4xJ_B!g&5HX0xhClJB(MNEAM^$rxY(CB{V9=FB zn!F@_!lH3z@JRc>O8$7`B3~2pVia6IPdHqd1HYsidXf1=A2NB?nGpK2gcrCvD@S_1 zqpVzzCC>IN1N@8~8jjUZ^5?Zj;$yU#!JyAGrN+`OOVJ2bsJdz(Z5O6-TwuPh+=6^% zHi+_X+Yo-&xQY>n=-GOP@)XY!3Iiv1TK}fe94H8yAue@DOnUjbbXKj#Dk0!SmnQw5 z@N|jyy_yNlvtvd%ph?NotR>`E@@w&ojjX5Icq>ZBY-@OYXs)7+qQpDypy2JTT{wKu zF)Qb}7FE=ZNJrs6BcPfC`0cGvGFVc&kE8^0$DGEm5Kvjndz}9UC zABpjDkPGXw=U2m8##%vro7+KN=;y#lGHuqo%!UD{oxEd@TlQ*LgThRd&#FTEjs3lJ z@FHHE6Jl@kVirZ$K?Ru>P9R!Vlw{PN0D)Jv=AypOKzZ-B*nPkzeWn8c$u&Ww?M9yf zqjgC~v9JcEL^D{dr%$eS_%?7xE-yUHbQ1CJHy#MDS>{S=&7CMwX+tiFMAvwqTy)?z zdG^e6S!<^lkw%1uG?#{B1nb1DK?Nqk#>oiFvW#U^4Xe7IQdtOhHIdG6aKHh-Dp}4* zeHD1%sV?6>cm4yP5fUJF$k7+<*ih0x2%9Q{?}D}0gE{Q5s*Uo3psD3~FX@9!U*o!n zk6sW6GK{0xRe5a1OZn>A6O_Ti^2l3(@9#3XCepZ}!(6BQHV7uuOGP?JV=06eRNY-S zm`7^4)3(hHav`%M*<^%nK99|9)T!2VBZ4rswN2L;{m_`w=Ek{|s+IfFOa6UZA${c4 znIhB1ltw-D4q!mn6CK-jxna&MCB4v9&`CO@Txv>wvFGGt=l1mE<*T~OTWR=ck|ZNa zKzr9)@|%kWz6|kJHZhJu+YS1aCZ(iOw5-O{4DM<>x5SXvA$PlrpOfvCQ*Kqn>&2df z8E9c|$DSLDVz!DaHrLC4`QnF+SGCyreCVel+#Pi+fd z@02K?af({aF>_4>E?7}{@%+uX;mebTEeCiEt*>eIoAEIz%Kdpm_?I@2)zKU z{%g^K#W-y?jrzkNDsu%9!kb-5>`cUb7U;#EC-|gVGakGc3b2w z;`M3u08Re=__QEsjBF(XY%8-I%&1~ts zS6x+mGV=xdJmUeXfM`eyX2=195I_@!NYE?v$I0$Po?Q)nIJYphaY~9gK@Vg*MSA=8u7@J%%ck9B z@6DiV${!-SIwS@b`I?!#BrfaYl(KtHajfa?ZnOQ&6g?2!?D%}v}%R1gYV#q3pT*8Xh8Ppoz{l`n$&4b~q}M#qiKkW?)A~ z(-$(LktnebHnpAwOkHi`mrLiNrRXs>k2TkP@(os3O7n94!31<&*N@RMU00;^|8Z28 zffSmSIB%A3PgX4kR5t~bpjInc{k0HWCxi*zp18`4zmTL?s;ySj;nM)M$d*kAK&}{2 zV=YcDzXj$@o0^c=`QXVf4zLLNMT<4vhC2h@M2kRP6mO#OwbG_*@@dyL+k~b-m}k%N zV`t?T&}DH zq6Y%-sgD9-BByHAxn{YxbsC#^(3$h<+m15USyqDzV{l)v=PKNHJYlG6_~;JOg|YZe zx2c#wGOR1f_+g)O6B_Z%Bk}uf`_Kr+*OqQ>UIW(6Zk7a3CmtCyo;HY{WsGGZcCq1L zHP=kDx-s$_o3>lV)ctRU+2S@&k$g|mRxvPoD>4aR`m5D}zK!RQk=eFbkLmFrp##bM zB|%+z#SCCG2c4IE0)KcLqTXm`<7Y~qF^$iGLx)R{emZw9L{3Imy85y^Y6|IuZuM#{ zTO+lCMb+xNHxUA)7B25v20E1)VsGoeA7`|LUFM`w$z7L&6l9O37zrM)3hkcciz3@i zgdYLjT>X$9pBELzljTVG#+xmh(x@e8ohuu;-6enGWGPi>*p!6Fv-x(k)o?biQD z^`}%P@*53xM17VIM{7G0tfZ+_F3Oaoy?#SsOBx_?$>&usm*`B3-W{f3d8oIE#sFE8 zujh{aCj8_OxXlI0$DDs6Q1dZj=osQIXQRuJC;Q?|i4s&oz(cWUtQF48ca(bO+6Ck| zpsNS~O$WEJ7qi}InyhVuK>m7NqoXDnbc&;|<-9?%M99vS6}OhNEaHSVjw&3Chxq}j zCmM=I*-KP70{IAI8G_fPHpqE}x#kpoxYFuZ5pDXTDFkr88mguEH4zcs|E*W2nLXZ7 z#zPS``=P8lTsZJT{`2W=XTpO!eREU3;TjMm7nJP|>HJiBcI;B2N$(Xb;+Izmm z))wwiNXJ4cHR0^=4F}l-;SkOiD^}a(Qbq2ho(K~<^Oag!8$MSv#Ijb61&n%^+E$U{ z%Madh*!>i<2=q$mc{fXylo!WQen+WUH^9I0$q zB%)?@iPAY|3CWi12wV-NAY&)sC;o4HP=Ijr!+r2$@i*rUAVuD7_d|V~MToWx+f7R7 zjNXBwWFW3xGV4AN8;zJHx7>t~UdaZc4}%8B53>&LXBiw5tz38*%PDkG1v}kIrDH*x zPtKnY<18|`!>fLmLoh3GnhcKN_E9fh`r*h!bMX``hr|=GlNYA!U;f&Tqs39C3yis6 zng_F9nu938b-!w|GB3SaPrmNzNAMls=Ydv#(KYeZ)h-`(|MIq&UQlEwF*vAGtZAfJ zZyVwBi#9qjO=?u2P!E{b~BZ!O823EfDHDnC2P*&t|F<+IB`nKaXKYp4eEC~ zGGD$gqZtySmqbcf(*4yKV z*y2FhD$j{2v9f)xFt)@SaKn~UraiPk28k`XNPN9tIt|V1+<19#@@*Zn(BayFCU^EJ z^pn9$K)9^7xT%eL5NI#`Cac8ycO!Z+=ZIDQu`JBy`Mf2nD!s$r z2jWUOoy^-TNM_Un^$+(6dSUtI)i~HS5xL8XlS+3wU-O(OIe915ET&S!e3RKnp-K+1 z3V$@#qlKb9slLjw+(AeRgL6s3idq(b`=)tDu#*xR=|2dy_F8>gjHU9|?T_&espryV zml*8iN0$MNM+K-MxVE1yoe<}PHrSr6qcV%?HMzoH6)df?4qC&f?pGFONqhHQ1m1ZUU!2 zvY@xTra?V6dMi?ftD>y-YO8c($p^SH`C39vuQZjd(2jNOZGZE4Ao8MA`&m=59(|et z8_Uh%EoL$FMy@o16?7B=qUd8L3YyN)N&60PLTo*YNh64agn^i{8iBn!L4U?4gH05pa2~;IQt{)o9F2E*m$RU))&V(A!geJ zOv92EO5HE=b|2%pib3|NH;JU+&5=n1IuKG$5%z1u};J! zJd|WY6@?YX{BrMjyh(C!FZ*I8gk(w~v6=m*Divvlz)tWb6m!s*FZL-ngVDSW#o|j; zv(rz|e!WrkQs)B3vd@7GZUxLPZp^Myx1CbQdRoTBg(s@p@}<5%CTsg+$0q(yU; zEI+Aw<+L(T=>FBWhhPpgEGqW5D24B-wS-o;Q!V zC+k#IyJ$ur9r7pv(LtmaIyBVH9)U0Eban2otjQjMjU;Bx|kcyJEsXy?Taw%YcjPAJbLKxy z0iIV(arlrXO31K{E*QHgec5}f85yyWtKc4R+x_~mkuvgeRbmw%uaD>dj4 z3yK`j-!g3Kn#0htlj1Y}&~L%B!~mPND~#V*Fs>`3Cg9F6T`_5Tva)(QHTldfb^F>VVi z4VruI|K_)ev#k7EZ?zQIjJC$Ge$fgMtct#6%m4 zE_~l6U3&$d{IIior3$ynfN}#WaoE(=yURLZ*g!taP2(E#{;oK#aH?n-Z*K7)UeKfz z;NH?2<}^>gBDP18V*0dbs8(Uy2ArGy`Li4#zbBl z@ovCl@9?_3;O+d^m*ZN8I@K#UHMP;Q_1ngjP8AL?Hug1@iLdASPVZReFt?P`TiH6| z*rRyu^kBJ2T`k${<59cqJ()=^FA7cyJA#`#hjP3mE%n&ZgCe+X{Lp&Z(L8QMVP@*j zVpnNhsQ3racZPJ1*BM}+Yo!7>6mtTnPDgae4>N4rvpiU8zo>v((#iKpZ(>EjpR_Ju*KLWE8ag5G$2{t?S9BjM0N zE_YnEx_0j2-R9Zm2_zhDPDBU7nR?3V$>nY5@wlJ) z`g)9vTx2sPW9a>IaB#7R(b?J|BV%cO6&24S32x8MWa#x~S#;CrUm5CIN-tj|so7in zIMXd${1dClbV01fSO|w#j5%G%n3FbtS{7Dn($pLo>vEr{eRWNQ?}qvP`JyTu&j=+P zw|7j8y#3=MtjDMkl#0TqWDg{#Hwz@UC31*#T&2MjJ7PEaLWremuP^d6b+0iHu1iy5 zpRxa8sy5s8YuRYl8yA+6!q^$CbVQTsqJOlxYL=DXB}<(;e2=)@@@2Ft&*)0n5a-$PcqrW6)Pg3{+Zf`!tzoFvHf9M%A{#W zWqvyGYyj+bh*xs4vYNFUN6rwkC}tM+XiwUYUJ~G-J53t3cX4gMI~VgvaLz??aV*D1 ze`sQJZY!E@416}Av$#*mlFK)aLMy9-;3&@O^a57HBpv7S=1GG|e-qR#1QF%1cPer% z(TqFV61J|>WffeKp(|j^1=>Bi$zhKZ8xayzNIqke2?9*^_(itEq7W&-YW3|}xI2Zo z8l4Y|0yinlJS{9;Qh5F#i47+b1YE2otr>aZu5lS z6vU=?eiP@exa+*xGE*&h@}@ZCbIuus-@20E1ypU7bJkZ@>|ZQ=+OZy|QMvf?#5wD< z`MRbBI9C@ynjQRw-qY>FX?H4j3bKaeo*B>qpcnI(mpazs>^!*~%FGH`v9EW02*9s{ z5&nAqTUKRd+%LSSTrPfyI=7e@(?F7mi1^NrRz4YWf|Sw$RlZcP(061t6%mEl5m)(W zkGcQn4x#wYyChH zmDE8URi4!K-1l{ozqs`DaMG~L6)!R#0-f-0*bd_)NfWPuDir!(NJt28Y*<86tFDr{$BX*~VwEkB_u9LnwQj$$E9L5nbgb`qgZ|H204rD#=EegRo_5`F~ z7gu77rJp9ema?A7ci+a&%=W!9l?MK#P3Xmsk@>&*O9zwW)CcH85kCV*u`AzAT8eH& z6dXMcJM*IKyB*6qB1Il&I_v;|r#3vGq{P&g>mU(r8FqXh??9K@W0?~0W1tKqNO%Bl z(I$%f{K37Z%B&sq#frg()K7VD_Qc?oQw*i3W+^LY;R)@D7)GDEeg*~_vx}RyIh3wl z6O$vYJP^RMjuzmaer{E-6H2O6vn__nY{;qM_t-r|#tgkT^c#AWzOe-9!(K39M#JoC zSBHk2Lwy?%!+rdg>Q=O_riU$zm+?%TwnU?rDYqh$7ZRl$n3u_bgU$%XU!SWw8aC_v zI_3&@KB?ee3hXYYug75)k^FE}adNE;{UWR)s}dzk zxr}R-k;Z^|m=h93cGu6%!AN6`Y_B=+a6=OUzna!FLG{tf3{n-=5y5!MrtCI3Or{1- z)M$-T^=jDi%q2yyp!1lfV~X?q_BCMgDSqpT`dbPn1Po%uY=)^lY|yZk?Zzj_85Ev3 zNKnx?%E21~D-l8K$U>ppoaQxGb4?;etE$i?XPz!49VvWYQmdHh0z602M68^wI2&9M zUFm~E-&!XrU8ld8)Xd$eQ+xYyYx{KK2m4@;Vvd?v=MZ?DWqIG+utA!Y4J|P4RV2b+hoF69~Ofn9glD2>^7}`C#Dqy3zc)>0U%pS+apYmQ!GU?*9Zhji`7#g)TTDK4N=k$k^Y9r`9Je4ll*2jeRjgD5gIXu zEXcRG^4px)Qm5n4<3E$2%-(QR^@Mz`wUle;f{234wZJs6K1#t*-1L0fW$$}kLJV)aLMT(Nj}Nu#z++Q_eK!L zd+5+Fj^)EO zc)aUHJvzoobytUw_COnxWj}53B+u)R-@l19Nk_Eb5}{os-3^J9q;8|< zWtcJ^#w9Wk2pAc(K?TJ|%E)tFIlfW~wk&`tFGN1T+4rAG!IL|dPx)qj>PTDPEwi`H z)Ex@-XDJk}(EHTJ&~aeatO{W{&TIx7^@}@&T+G5T$`75KE1k=T3e-8KTCz>{bdy&_ zK013(mw+fsmi1_~%>2({it5ov*smA6ixsOn^3bD(XN>rC`rzphnk%+n3jV-b10CNI z-*yqgu2a0r_y-49A_Na+E3IRM>y8kMCqcQy1W*Kybvf-LVt*V?hlEK>G!dOBgjtP| zwDdC3J-eChYRw3WBrDE}M73CGQPpRs4$CVo5oVboMqXbCuu%x|; z=TuRn2W~3rP#Pq~Rz+iaElJkbl7oS2b9j`3cZTg0?5tB_PQ&YihyPn=ni@d}>@-lA z!Zix`w`Zn-LcvctsPXSe&52R{H*0ZjIOy6wcNV%;@2 z3DIPQU2q#kmZHg=5FHJ3-_{J#zuY=@w5or1uVvkg^BPxF4yc{{j2SQM^?ApCKZbXz z1*atIs~P|&lH`5X?>OK}bW-~#KDBXSbIhNGi6QwFe*+SN{-jX&RKYd3eG%(X3CVTh zAdi1L^biGoP6>U>@d?``rZdH%TEoW0z=9OaHF5G$cc4!pVD;&dhN_R^1uJ#mFPX$X z`zX}Ryh~E@rOw_AZDIaiAx&Of8+Vn3i@NDSwtAhuz{JXt(QwIV0#h_3kf@&E&n4iF z&p|8b<@f zy@Eu{1fV8A(?(m9WRvB_P8W@S(8Y5?$9jEh2=^WE$vYC^JDhH(LOCHn#Xs1>pM%=M zx@t~$&=b99_vP+2e=aN%uf3zpE}?-I07g{uy6k_A3R;>FNOwKIQ@qXQ?-ajNV@4IH zhoZK4%aR&ws7K8n9xr8333Axyo-brETq_n+Rh0edopD*NxU`jZN9H~sHgG1nROZMo zT_Sbdqg3K@{hQbfvBKvtgooa`XBBddG+T<3B1mCr%lm9 zo4njPlo%F4KWIHwzEF0@p(?)@Abuf*v$?xOjM#dKI+ieUWiopmPj?zvlxgHDl`FT? zaR4AuYZ%QDINmDack4GXUu;)&tfqabRO3-w(8Oz*QDH2unnda0FjItw*_O$1)NJ>? zI)|fXvZNA1+SDocwzK~4w5UsF>{8U_nL=Y^KRTiHRxAQ~+7^&HU}P^@Cd|>>K}+3! zD88Auf!pjz>~cDNCptvh*7{?acKI?Z6nJ0+o*%9_pvQ0-_#12h`**N^L~etCuyHZC zLYSQj;@<_B;tLQRR!25eMAsgV(k^=h3*2%V(DS}dbm+O&31x=KtvrO!TMaUR!RwM# ztTW=^uuP#M7AzpM=^mKP!B(~DqNk#tO#+VjIuCbL(?v+@!b8njEapU*ccsH4q&Y7X%djeyt2$B zD!=*ORZ*_n_Y2$0>GA>qD;|oA#Mxna;WXuVB{>wp6fXvCtwc0}ItX+}f9~p{!L0d34 zv!iT$-XoYre(>bT*>hy@{TILnx8rB4=6}wZ7MLX48getF>6btInM+>B(hu&yD@DP*3#BW)M5A|Av@(;Qj zMOJ;JVXgI_Q3M1h@wKgcWs#nC=?4F!hvd(%EZpZwspt)Le2G9ErQ&3CY0QVAUoTW_ zslOk#YVn&{7OtkAQF^f_qCNN4ECTEf-zmLh%s?C8Kbo{Tdp%DO!I}7i>nk^lXcUU# zI98FTz~lkg7)+yZK*+@6d{d4!2l(DCo0OZde^PK3SW4mJvd#Nscns|^%&XW;q7#%A zzzIx^8n|MbUsO(8;x;4D!UelLM;EFrG-x;^eR2WgU(^705EL;w^pU*eo?r!#4e9lT z5KyH+R9*89W2*O#znW~K?XuTOPy2!g=+qJd)lI0Fi&-DN~vQ_&qcT;SiE$_NTk^j*DC>&KW!68%JD+r6oUjm3uChx&%=P zj2(-3lRCDrQ%NWa?kmT@1yszAOJGUEs%5-3ly%D{%t17 z>WfuMfSYEIpgUiX$IcKkW<0lSqOp~Fx1gKYdV>D)!XT*v^C8uwziYQogPo`CSER{ z9ds$ncxnmPQ$=Bknj@%Oy2T3yJuIS+Gxt}J?=MX7UEC35QcIri?i{6COhwYkcpB9b z-iPW~g)D6xu!E@FYOW73f&Z4}wlU=q` zrEQa@O|QrR;qlbCprxWTdH&t|gqN6i9|q6odMh=+*qwc1h{MeZelyFXQ4H$9p$MRp zM!{QF33du9MC#3V*z}z*wuQ4^C)8LuwoSD2Hgeo46C zEYTH^s(x;sZu17B3qrzwA?kxi%?mg;*St-8DBSKn@DP!%%5twuS-GMcc@-OU!cVbO zw{eOD;muHEOG^;{Sic5ERJ)QQ)(==lfbdc4a{`^aLl*K={)^CJ>+L?NhM)+McSR26FF82hC?L4+fc`i9~c)zl&P(1(>PugQ<|>T^Y^D$g zIVO-E!I4E5@FBjutlR)$d5m5%608HV+^);VVb$#5!i1#G22zi)RR^ZIDVZSTA(u^5 z1}sP-^}6kU6od5%yGO5wzA{QbbkWzC#)X6AHJux;-&JklO7n)_B>QSg+r-^J9E&1S zwNkxzIXaYkP_AzjMc1WNwNdSGJ9k@fzNjmf)s4YfM>T3V7S!Z`5%}kVg&*N@FGeg! zfG|`0;$M|#Kh^5{}MnN+mY7#jvQZQC2J9IjInB8HE(6! zx;q3gXXNW6aPbmaCriLWe~nx@a5{5Ynwny) z{#fK8!KVNsM1Ge-Rv1f;Ot&>wC>2_@=p?S5S6eHkpgY1DS2LShq`(pUFUTWe+%u$D zpPOXy22z#@-zJdb)SB{?3Xivh@|S`SyfHTt97dXD74)*A-8;!GI_Ph&1l)V?qA<%J z9ZozEmF9m;OKB}?{sqCnT0TK-45v+|tfMO}ivrmI z^w!Wtc!99RDkF~dATFXCQ>+`74+Be_5BEn)&+k{!;%LW96)UU<0~;H`b=IC~@2XLj zTJxlw$c+isQr%KpM>TEsk#l{{&$8?}ZBoSu>2|EGp|aO|qA#_saA#n=vZBqIC5>&p zGuZT;6GnC8=-w?%T%P^F8&(GeRsiwxI9n^|z~H(;O?2w`?AU$`KI({l+<^GC8sjJo z$!wMSY!=_RVSg`xofVU=)I^AQac@#408`u^88Cj^@gv-oLBJ>DU(I>`1W=0itIc>y zJ74;husd8W7#12X=#VgE8Fk=h}K#LsdWpGs?W^FL+l7thd42E>kqSH4H<5i>wWq2M=z!$W`;+ z|N8wQg8nu@Eeh_}Eup(thB|$H_Jyc%!3NbwZ+}5%=LZAt0%Sb}`BRUsA?!5Tdj&z{ z(+s2_3Y-s z?0VbE#7c{O=uhLUC@v|!+?T;G9*Q}r>nW{=J^4!KOS+xCt{lHXtOE`Nj?rxG*X0Y_ z{hr{%`r_`N+c8LkZ{6iVz7t)hEHmUWz*Sm73 zp9@uVZHR~XwuAa)5;;PFqQ1VI`!HmeaWl_xq*rjiR9LT^``er@O>^q$n;ToAS{;o> zqcHX1>h9RORa}w$XnY2jTW{W^g1IuaLA6A+Z|s+@&*c+qkCTt7hlaLs>eNHr%ii{KPsgh zIzhaG<8rVIkKZvB0%6Vr!W;qpNKH|tqXhS-QA8=8-7{jsa%2n33SbvD%(9J_7G+4- zfDB*Zn5c{vB&LMS7BpuRX`u`6uGkU7>fGzN(b)z4jkyom0<_Y;p2}yG1rM z7!$f{fJKT?u%~bxI9{?6R~<=TSDO-(}j!)rgV+p+{}zK3ho)OAg41gM}|7_Nt;GrDEr+tunM43nSHHb z*tG(uZ|>|Lp*Iiyi}T$}HJr{8%{P?w&RYE>ar8IW*x6oWT7z&gza4hN;7z~*O4!Fu z_i+m!7wj^x{L=$kq9uucPXq}ah1LT2D!m|F74}Z}DT&8uRAcX2*tb9>@+^nD5~n;l ze~}*|yF)sq(fm6q46Zl5>FP#z)(Aw2O~;a9oSHi1*PMQ8tVd5)!CoN^3!sclt9|Qr zIYKjZ${A)79F9H6xB<`RRThxxnXq#-$Rsats?ul_T$LqMuewwWJw|c3k&VY5?ZTDG zU6q;3A;oi2WzmA^AHI+jZH_m1t6L}wQ35$xn-+IZ{OLjWd|*>2b>RK=7z|^t`t?>v zVd>beiWqTR((6)-nkoq^4W3SjS%%`j*F&Z+s2H?+qoT&<3CeQr&9pLsEP3$jK(h6_ zkV7Vl&QX*w@=p?QTlmn*UJ{Yj4_pk+9ySIB>xlsjYPH=3o<_ebseDmZIKNVrhZgv` z9Q5KFu18ox>d>~T+4`@uNG&m$VY5juYAKhqY8j-xJoEkC^8xR7Sbx8DuGg%DNv)-p zTB=2-FRmYv4_Dv8<7jfZk8~ZAVsE>wT=AlJxarD9Ws$D*mZWH=lSA( zn{XbnhG+I{$oXpdtMT=pYt*{!M}eb(vpG|g$9ibwvX0ZxF;fEgQxkqnj96fQlXAxn z0jV)#SOaJrR~;^FLy9#o-YzH2bX*|I8RHpmYBB@3du%xsy`b}dE@17!w#Q>z$R%dv?4U#s?QGG zFjavM6J8A$=oh3l#JeH5u}_SR##Yl`YIVHcS}WvBd<{OsL~Cxf>q?qY_o2YGT#MbX zaJIaGqW1l|!}TfKou*EAu4l$M7Vhm{M_ugTxZjoqc0;-0hPPv`*Gve5bkZ>~!mx+A zQ=uc|%T*%?G8_v`WaoS+FIxz1$Y`vYpJ&NQ(OIl0#Sg$JY`SM_6;-Q}3PkF)K$J+4 zSDxxV0_&>KrTj+a*0QL(1r%zFnh$C)8-69)qD;7RK)2T`+!|_m9ssPhP0cLX`qpU$ zc-kkg&H@RLwoR$b_tUPfTUC`-;)Tb-9iATc(VT57Va#`2+)l?#Ky_Mhr)T9)epQ;c ztDA{gQsU4BamIw(Z3!VErj$3wCX-{NF^Rq!FSe_u{PhyRkH1@H`rOFwP|aQGy4?By zdWWFtoBxO(x)~-&T+rPBC3rEwfeJ;$WEU8a(%`*H#~!*64;3dP3ewN;66YN3(<+UM zi6KjhkhgW)7N%^yDKMYXuGlZ+2WB00*siyJ8F3TmwsrSW8q{H5ZHWJdY#8kvg_9)7Bfok6!;S^rZ@pOXYnK#?60rLDB5TCjk|M;qYT+<*dys9TT zHKz6T80?gX?t|Uhwjy`!$EbcUK)c)rz-^E^azS_3XY4-dV0n>nkzw`)3!fkD3bYi9 z^ArGq8Cj#IA?cjvrWANNl!DkG$%rg-0ql)Y^bQz;V;+VU5@$6i7A)XD=!9D_m$g#* zLFp`K9Kps?Zq|{cC3*|C9Q!}t2PlWwks~P*d26ee&m6Tl?%Yg^Ug*~R%Y;JF=%jMc3y-wyt(Gu{R(mbnmMVH1WJ+T zDpIXP%hD(jA#sW9bJH>}7*34XqUmE&P-?uR-k@$zykw*V*)~z~ti$DI=^0y%0i!pa zJH-Mkpu98Eq)qykHIiHsC7VcmyGw?!Ho_sOx$VruWoeQi~B6 zY3_wi#n|x>A0mW5&WWq8?wcf8DLb~kY17m4B}pZwq*1$yRvTHyoN3BxRyA()>OMuU zjU>+oV~BV%Ck9##SZ*p8uT0`&*48N*YF;ovqH1UenMm_Se_P)Koxyi>aL*02$d!+I zK6%_8BPS~r_rSzKi&_X}Ct?Fjh8@BSyqP&PsAUiiF9(N+?_)bu2^qbiaJ-^4I`<3G zZnCC+67-F@wSuFt5wHg&ySzOj!5?YW;4sWQNw+GZcQ1ZemGdlza9US{tF`RFe;@1x zkd>R>Kd*V)?Q`=^h3iWEPt-lv%*UtA%?Q|&?%yXDbe2l3owr&-x6XoseIsvR5PKHZ zp2v*Dci+z8<4rOBbCo)Y2cu$NO5^l7B16L0j*H$@j=XUfp#Yu%6`j!uNn;z|^}uf4>>IvOLEc1C0hupmy+0ns$+|ZGRnfiQ&4_C5U-(+ZnV}IB5%+3vH=z*!{nkh zVq))hs?sEj+qF(?U}<=`?(_!7K3vy!eooS<pzyNai{szyML4x-WdKqBTo=8`FEnJ1>QNu`G(`k@OSAFT_vK1&5sMl z5R{5%-+m!iLxz648$i<=Pe#j(19bmp`U3l;{W#t6J8{7Y7DJ;zNOrm!$1PCA!EIA2 zu+2<`rrln`C@RUjRo-80`piNr{prBV`&v|j%_yGJPn0l2Let{}6ebe?}Oq3ml8iMC}FXua+N9)Fh%d7H{m=l$Rb+wV&ZMS5j3iPiKh z=POQf?BNH`(xHuS9K_+zY;KI?mJ*b{2MUeP2#wQGF_>~})}j3xLIcspwV-2Og0~Y5 zW^pCJL7KBCIcq%Ot-#W!RWB1X>Iz~TQl?9N(Pdv5y)kM&Bk7nhOJ#B^jT%#Db4}xy z$orohfYaE$(rCX-^u6^-`R`S%7sjOuSZKk8+rT^pjuX32NDje$*PN!HdgoL#Z4>JeV>u|z)Yb5o$!PzzJQ}F!lLPsXH zr1aasO>;SA(7hDMS&X0g?Bi+CGPbY1`D=q`E&f~vYu3)!*kpC5qGbwZ`OMy7Olblg zl<>kdDHaKu+$P@Rf1WDxG*L{p*6fR0@*13)GE_`)wl*caBByKz6WyxE<1T7aA3Ry? z$QWBoc~vw7lln+&FAdFG07EY26@J^fEIlx5Z(T0?3a<7eo%Iq94%^iR7nI;JwKp5(LA}-%`Qb*C5;$VP3Pj{s*&D4oqsEaHFpwTJx*FUf z+43AyX&uc#$*G>O%r|q?CA(K7lh_H*FWoLK_(`0aD?z%Nk`Ei0Po`5u*%;o*HSU)} z2>Q;j`s6P*1iP(n4$!cBa=x+9970T>5;t41LWLW<>h^xT<&pL>3$?@K*N?km3h*^u zV-YWs-v{~Lk2S_Kw|#?lt$Z|@ZklLNEmCabuG+i{eXb{Ifbg_~b?<(0pr_T0OeVNo z39gY0^lpY?30E5Dt97)uyF1XMD#H27!tF8JkdK`EBMv*C^EkZCzaQfn-kBI8te{a3 zVEv{JWc|*#)3SZ5YJ9=Gt#zO2s}YpJG(79Q*n*kfs3%JsA7pxq5rN-O`98CQwEi;sfZ)WOweUHCyADVmJ!qSE_h}nz?MAHRo$nNa~Mo2x<@g83bW~ z22NP~5Tty8vv68;c1={omx^FrX-h8+B!=;EA@Yq(3uPwhs*kD+&$)uFpcRAesFgA- z!zH?+7vOldoG-)fXv@4DzXhj06a~|qVV^M@g^)m6tZdnS`-xXJoxH4(#17%LLN8{j z@%pqwIxi!F?AxG&WLLGdh4$&D$CVOctL=&*7HNBzLT7nfA5{Yn{!*54=cM?V1aLq? zF85@D5hz3)dNftL7lla9rSl_bej}P>m|y3>x85|`oKBs)&@%_ z)IhtdembCr29H+;uR9dqIozjWNN4pbm<6v?07<()Rlc>JZ`i5D6l5NoXQUFwSDw_` zJw{r&xB=-4$#3wjZeSL@;^Uu0Piu)%_9{_hS*S}S^UmLbgTQ!bRlc&OQ^n|rMQV1% zPH{J5d?7O-or={5pq}~Tf*-cc+FoCb`XOX{S+^&J@T0YrbMRnD8-Sk*`(1s$X#yEHC>SmyMXGaf`-Y|gDkmpkOlDVx z)*r$;jPyxX+}AoQBk?so%*Hyf^}0f~+N@mZ9q+?&LK`mPV|EIb{0N1i^X^k}vs&cZ zak>u2`N?H8HpL}AsHL?egBp7>0lGI9mK&mm>cq^-mhPZ&mKSP}R$+B9HSlX(gADD8 zzD=Oz&Njv5(qz_?UB_Gx7A_qQCPyqovsXWa(sRfcc*)w5l)Y+EYTlmZVfc@~SXtT& z?=G?Z^^>sw88a+#zm8k$JZs<%I_;&lcX#N-$21Z$j`a1|)ST{aMl`d0Ud|5p>h@4< zzE7?`s?QP5fr~%Nw&899^Da~|@OqXJj0aA`Qddf#ctPI<8Gc1S29y|`7%{gEzrJO> zl(D~6ergcsit_Ggb1j$*h^`-{JaU*$z{7~n46!>(l^3iC_r_Al9_kCI?rmtDM8ov6Oo)EYxC3N zNzAfe!|$U9q z*1k~US!cym9-KnG06RmLbajOh)Uau^L$3g@`lq9b6`xG^ooqdw1mD!0yI zyE5eLJX!jSvQ-Bjhld`9e*et~r?)ey`Md6qX)kNw`iFx0`=VUUx&`xMM%U-2+v7g* z<2aL)w&!OreWTsB=j&Si^Xlnh9^~@p9wlllnhoh)E-%_bnMBT8)}vW%_?0clH^c3d z#NvHqNNHK|{qFbBe6bbdoduUHgby4`u4_H+&RbPS9IZcC`Jj>HsS!FoniH_~=}q(X zu-`;fEzz48hyoLaLZ@IYt2efBRV;)J@e(vnOc8s+OR>7i2V>$^<_A7E?42y#Dw@V9 zt^HOMc-x#*XxJYMUUdSGC`4)>pHytl0BxdC+jmhdZ-}Vxx5VazN~BDbCEbnt801e0 zY2IUaYUx&vXT*9gCqdM0*+S=k&%+o?znz`he0XLSd6D(_LT&CjW2MHqdC(UMmT0{Z z%hFnE43jf54B|SoHGeK-U4AO4XBuWgbx3VcQLx==-0C>+Z99RL0Y3u9=$2b>hXk(1#v=>pzfZ3BC1bxT9r#wYJh!>BIqRzFg44`q z=9Bs~vOvG|M)ot`lw`iuuU4x{IR$LY%qJ3Y6ABV5hO!|Zh`TB&O0015WxVR$T-C97Ce>&~~!dVk1 z6J&Idp&*q8Nr+m)?ppmpS0`uz+?@^~tlvFR|1A1DgJm;^V&uO-%nSX!<|$JF_s+v;VKTr$$vx z$Bl8AUx&wPi3%6eT&FHW`sAp~blt|Nv$eYnrwpE1WQqe~d^r;FQxB~RTCWb-*uB&T zQN$+HE#T|zo{@`_7x8u%XHJezR=8NFudjm(MNEuogV>dmkoDum;|kL;t!@ zuHlkgJJF1k)?*^&NH65}>c-~Fo|tf>HdL=%G~5OKALxedLnkTUdeak>~o^L)0i z%tmHF&82m%C?4Rp&Hf*dN|1peGY5B)YF^+20;=7awZlUKIa9Ae$y?gXNXE9iT)VjT z%LJQDug0Ff6s)epKRTlKke{^3Hm-!mSe@S}w(vdqb>onBr}LX-Rz)x^E3bPA++D?B zhRf+L)bTIp53?`6r^GGITk8PEX%MKJsQd(j`dO)%caB^FwqqcnyPFdrw0^gFGL!v{ z)nr~PZs-FncL7c$)s1C|7-0MY>8tuqH&p{nGP;R^E5OgmJn?kh&(`sJe}u4s7{rU! zw8S!tIbiI83T(Sls^QOBJ=Um2VbSDjfrr$JLA2l>A|?Pav0<|XmKB(=tlNjdfi~q; z*yFS1P`@KY_nubFc+>^a!W0ud@jCI9^yPmE_}{==eG2lCSvjk@|9J$M3KwK^fmBj3 zG}x`t_HX)HlTfXYdv^~{@RRYKcDNZMV&u ziDRQW=mvdkgKvj{p16y=Ig#%H$#nxCNMwQ*^Nghh6k)xobeoZ}8}TIH>u=9j)Of&k zw3t1ABntt^8N4N9AFCqrM-Y8{Q9#~byzpVXsB_3!5++w2WB|>^4N=W2P}|@a zgKOZL+NZ+<<)@)dYZ~`IYT#QsMM5?v_oo%)d)vdX0}~J{5`CXaMXRiqY$1Y`%BG6Y zkw*m9{{X^OA}ov`-gHLk4V4v7Fx!>=^At=GdS87tNPhWe=i@urX#8BtB1M%{QAL#l z;)Mu_8F69)OX7{$y=f4eVW=7gxBQdF_f_M{OBd!Nx8(5 zm(E;wmoP7clH}%){udng(k8<;56#hZoS21l5B4XP>| z(2xELgm#|m+aD&Yp5Q-INjBw(1B%tnP{S3DZu0f|&|6&2U~qqG z^HHVIY25=p5}(yJPs`nI+odfzd@4Q!W5n>LdVsyPD_Hwv04@jYOK?(Cvm6(I?9`X z49Fs%-yzimic$QFcksj$D}%GjbYy_15HADG?p%KJIb!gvK&rc91KVh8U5V>@s>)`V zP#Zve<4H@<3yI_hx~}7HC~gvywVZ#BVwNiI>J6gM95U@HTCwHqdPLVzQ9$~aqabNNg7(!Qw@^Ai_)Ls-g57yv70^4G z0~$3)QwHXSdW+0HXU_I(>!l{GjAif|-YU40VIE_58fkCQetCS|G8U&JGr1dUx1#ZY z{0=#nUC3FwWWQ3iEPJ&D6;cw?QtY}_^t%um5DoKffY6GphUaVb2&u5_ zlz6#HZxI^eh(^mksxKZzH>;k^uI}p>tc-FX?q8!DHW&l?Z9-72jj)ZHV+xqX;t=O@ zP<}roRQq&wY_JNf8s%-j5uiB6;7VdpPpx|0gY>Jx{0EcDuG%eKOR=c3xUXRkv>%Q@ zhqM|f-6Ms%fdY={=ZQHS?~b(1$3*4@iLUeHXB)L!S5zjB0~%xPkW_NaqXdin$Oz6s zqg6#7>S3km6gdVGQ+Uh$OxdBIZ_+4WJikDMsXo=$w<|vjZQ9rwnV5}GOuHe)o!6^9 zM}vFiX_QhUG=N>Z-EVMNsphF*wv{ny%+{(eNc=ZH%(MEp6LG(UFi@Jr`)QRyvcG;> zcXxumngN7%;O`T>yb-nt7sCCZgKRxCP}!BXL+7yz#4&|0Tj`4k=l<#jVl&nZak@NJ zdV;>c`jM%emz~2Se`kTnvo@?b{5*1OUMHSoz-{Z@o*@T=Imk)-(K zMk7=h8!1r%zFUlkO65?~@x}*(G${~zdI*Ei#bxxk$72$9jD^DtL*6Hy<5tO*d9U4U zMf&M2W}GuF$2>hAs9Ieze?14J5lEE3FmEv zbx^IOW*Z7LI6X+}(M>sb(H)ij(L+89Vcv?t+P1fJut1lTFhF4s& zfBGuX>FLVF-NlB~=JxY_DAk=gMZm3WQWL!(tK_%m{bU_v~2MAfW*YlJ5}!M%fg zl3Xs5Qm0Bka{}S@OEG zGSri_3O3$RR9ml{|Cx$OdtIVTNKdcvS6d?G;*byb>D0BDrG-eZQgkq=ByRA^`#FI2 zE|xfVcQ%ybWY0KKh zF|3e&*XZ_ve5DG$CKO`)^|&YLH$sIqhT#38`Y7qQ)Q@RT(}@uQnBLeGKs;1;1T6l^ za34hmMi2@WJkFt;+pUycevL7{n0TbGTP~Z;;XDp>PaA^7$9=9{rJb$H#JhdlH(uS? zb$3ahlU7Ip^t%eKZbBVjjd_*$5j((@eV@W&MSZ5uR6KlC0Ai$UyVk+OuIQlLGz#A% zA~M`G-iCk&VCt7e;-%99#5{N%F9-Iuh$G>{oMoL@q?${bZDM8s`A`y85;BBv|JNod z8sY|GZt3+m>>jD089Km%N`e&XF!#*|w*%nEq zkGKzLNs;m`0|gmxju`K*nhOMuVj0F|p37FzS~%4RPffILVC5E(qPE)a=!W#fAO(N^ zEE^S4%oBzg0XdBr4$XMKlYFuwlSESm23q3EG~y4tw{CZx{l>?}prv$^)iK=J0ygFR zd{NAdR;qh0GFevBGfUxV&EuT?D45o{t>{D3jf;?$2l&${Sj|#sm(bzLm0jJNF|(%! z9U_JZtAqV!4##26O=S~D>LqK1nP#eXdgXTywuR`(3MaqXlzO@QN^c}${9;!G)_Do2 z8~KmuR0Su#i{2Bx!`y!@g; zp!QBy5;REQRhKMim`OgE7^PiW=t2I?Z*kK^+^2Z0GmlA)W=*N9ODheH6mRP6Z0u;? z%e?sb>4H`Am?;oxF8p+`dU90iOM6;v0UNGb%D8PSfQ|f#LAIh{kBpmU@!R$naW4}(Wia67*%k0 z)h)dhnxaD|;H*cx-%dtv+O_dCivX;(Fo-+Fb*8us8T%kP7s~SkTubb==L5i zQdu^JJ}1!~jdieC^0jb(iHDPWT9l5LhonswN~ir(xx-abKL7*GTz;Z4JA@#W(4mhJ z88ZGYwi6GXx?hqP%6=tr`=`?zN8lP;WgKHHkn_>0#DKzEv6t2UdrF~@mdP;jn(*RH zv-_-)lOj9}r5i~))M|MPHw9nPhqA_8PP741Z^T@58)aboSnp))-Xapr(1YZQHhO+qP|6XP<4`wr$(CZQHZ&?Vd?ba{G4XWgcohR3(+FRAsG) zZ~foTS`Qp>@fp73=I{cq5|lplCbDqyDHyrl@y?(O*`>6Zl+Rs53tLLCITY&Bn*9W9 zkjs8$j-vLJ>#Ls`#E^I0b)8ZI6+f_zXT7R>L0Yx%Z2sJiu2i~_c`Ksz+$W*#U$62H zD2_CcxiYm>8kN`teq?48l%TsK?0A+il_5>+<6lt_@V<0sF6SUb^ zx_mefZsAEFRZW0Z*)DLMr_t?kv#j5izocofi3?HjKcx@w6x5m0QpMPX(iIFvDAa%= zl0RG2uC58Qbm^CmNnWH}MYok3!u(8V{0vdM>na-)iY~Pg=w>Ei60CUW3a_IRI)Un% z;to%V#?O$&z{iQt1Q52#QDs$^D0>R3le3<)i^i)*=;^4;a<6_9V~5860(m>D>^GiG zM$0S|j)rG|GBna!Rg@w%9&OF0#^;(#RJT}Sjab&El}UZiyoI#`7PuM9Rft?GAzHO^ zc#{D<}FD##nVo$J3&3g=}E z=N63E!T@f?zXUYSpyHYfsVMwG)2;cfJLsBXNzNM#Bah!)_og;TlU|wXEDyg?%t&rTp+|i|-j7W$%etbN1bm(SgdU$`z zDEe^q;bBDG+dzXoAIEW!_FF?Jt|$0K16Z5DCwY3c$B~(28>@c9usIIL0#9u_!7*@q z2QRmEPY~%#3lSiA)zF#6+QXt91E|h}d(-a03BFL+7os zvdmt|F!^IenUR^s-kcODgbEk0K5%VAV>*fP1=WSP{P3QwZ?HgjvvY2FWR*sLHDLcM zV$l<~+;GyWv$zK%hyDm)3i$Z^8pcssbFfPrOkwp;Z&w7DHA{+-lG!OxW&UhEFh$Rw zPtfIE0?~uskXN}aT=Twn^{;znutz(rKiHXVWY%vO(79w<(bAntak(JJbXU4ovIK`e z#lyK3Ow46AH)iXFY$DlS`K-)H?6SQtefR;cBp6ufSKlr^c&~QCiovO? z!F)I)fieaVD#Bqj&7c%uuEqVj$nUiD*L^kYL!N zI_4fPHoOLEjcNm8Ff*n%`kl1ADd8PR6PvPcglJ9?>%TYb_CE;J8*yN3;zU>LBoEiT z6+O~QhxY_7ny+Ax_Y0%6)rI6PGH%M#LED#NfR8m;ab}vRFooMv0ZsUYR6yics!la% zmMTiHcw7*PG2pLYvTnk>PHXaOP5b?@5?Pc}aP(W_P&gywe=9=Q#m>ii$`GoAyM__V zmSRwex4{x+#Y3gH2_L{7GkT*uSSiUA!1fmWVfH>2N6#-JDHpKJx9SX44-2d#?ot$SkVIS+-6Q9ko5i zSPUK+RJXhnl35uR3-i#@k4n!A)yM3XcX@lBNHQkvhiC^K$U@5F!X8te&TRN!!%0je z@()0tVdv>NU?xId_L9vNu@H3y;YiL=n`LxCLPq`l8i%@t`9MW~kMSv3$nl2kfp1s%yjyLZ9p^UTu4|${pzx1>qv<`z(t3r#t43|~8AFCt(54}$ zb{f{0eQD3SIfHwEOR~k9O}Ukt*0=+LHk&2=yWJOIe-QukZv1VV@~J1Pj}-7!OfYE4 zBz!MYqZKgSP}@t+sV&s{=U1ASj5CYzUy`E#vJC!zhK7V3?d%2Z+_mUwf7N=w2P*^P z@5sjSJL=HMm>63a{BN)Rj|kCk%82zp8haG!{&!{Y|5YUEw;BFF%HaPKG5voQ=&}5_ zAn8Bu`F|GZF|srKuOKN?ZOsvD1m#zt_oxI|_;=2E1~TPlqhpHG4A0BfZ(=EC|KnyyJG+Yyt?YF##O=iF_uLR6 ziXyeG-qbv?Op-cv@LPULci3-Y>1i3cTUk<>QD$75y1AyB46m4SY^cyDecF=2qWw&| zoERyg8X@AWlD>!Koh>PR?2B2dF!fQd_($jSld{P!^<#p#=IZM?VzS6b)bw>&SQag( zmzKjYWiq0WoM(fy1_X~d#Ml(J*t3A6P2B>FHlt?U)F}0B5|M;7<2j?5JuM=vwG*hI zFoT(g$P|>E4f|y>>9A3=f zp5_o9L>O0FwmLIn3D0;l%uUpXK}ZSM7wVIz(HLX7s@fXY&dzF5HPj9 zGq_Z}^r?=opZr_alix3WwoYYDndtEPP)hW`IOc4v)TPpu+kX6PSH^d{8m1gT+=2l5 zjIl53_dJMpV31PO=5Hj{iV1X%0nI^H zD`Oo;9`NrSW`X-w{s($$lr!AhRq@aXCbu9CFSdy3-I6n7qZcWM$aauUJ-cdW2&I1!Gz|?mxkD4FG77wj{~;_`24N0Zf~}qv{{l0p)&Op%{lrOlIig+ zJDLUTin8vs5>N@6ecUxh6K@HZ_*49TH#_3HsP`Y*ExXb;OZ%t>bC^pUP24mMiiJIH zrm7@9UCg=*;96n;Y~H+>#3k-9t?^Q7T0|QqmHxbov6@AMSVz3D@;_&(7YX3-un-uXllOpArEBhPJD;-XU)6`lP#qe7jHgztoMa|9Rb5Z=R7ffH!1)ZS}$^dVB zL0?A!>A3o~bnhyz3}k0Q5l7e-X^$t3CWTCI-6evzLcaXxu+rE<0`$8msQNQ0XBC>@ zSFz80tANoG&fJ}?pz5a5d<>{4=c*_gr)IW@sS`H|-XsE#_t%?fXhvZ&E~tZ=K-3FG zkg%U%A2*YH2l|_kbCn;h7ha}vTP~IRNwW`nbxF9fuz@%Ky@dItgpMMelQL$=q?p9G zSgUj}d4ajJJHr^^b#26|I!;YsDCS*jxn~pdxYb+BFUI{M@}(Sy+t&1_ zY)q?auHjYT9Jv=p;L^sc%^#B5>(zrW?w>lBcVO6#`FB+po5U@-2r<*Wy2O#ZstxaB zgft_c6QezB5y6Y~<_=cnViES%1IHQ9$aM2-Q<4zb-8t){t_zFkk53bg^=I=x$;IH8 z=eWGd3;nY@D_rdJ1C-g`KoK{+!Jy6iVKcXN%}k00{pWo3ZZEB5Jq-l2+l8kvU`CGC z$*tL$3z@qN^~9ph#&~3jRsfdX10=QQ1|~g4g-y`v`AC>nZFo?&gcmT}ChLE=bM6WN z-~HEOR6pUe^R1*0X8DGz!YNOgHXRpi)5Wy&&AdDpuUY7ragZ?BDqmhd?KY(WY?-q& zt<-ljaGEMn`}?L~d`2jn=^P3@=?ImtkxxLyW}2Wb!h7aP@1is-(7s|dsDn0x5K22Z zywR6!sAu+lH?Pi~tCZm4yxDl2I~PTQInr?Y^5-#2lbN~iLQmrNxCg|40Oak7r7`SJ zi>z>Y81J3>q=VRjyki3uWHkaEeA#Ts7&Z_5gPRYaPLz=Q#RMQtJt#(>rIi(9ha;bTa z2=NzZ+A3{vnnp5Zi}cN2`7_G}7$2PWZJgEs^S3`2bVmbNTqZLz7JIA3t~%=2jYr)hOksPl6?XO=$BW> zJIKuSJX4z#x6{5VA?(Ew#m=G7+2ksNQU#6@rzEg>o?Tw14)c3SWfcXcF8unA4we+E z-a3-OiZWj9HF=59+U1P(^p6iP^*N$p1Yhd-#_2PNk()DW{>Rj9Fm}oTO`Den>~0G#9XuIudWR&#%nLa%7A``* zN1K}b(F`0;4Qi2|+N?=@(}54EPk66bBzYhk z@rsA_EY=e`kr9gIDiJz%v2v3OdmiNlj%_nECb!xBDB-4vi@F%!hL(_XKU#QL$3VmH z7=Z+e_@^&FhGI-%V;9f+heK^(9I4`}@B`b~>qRfI8R^8g(Q zS}7hws2!-xS3Q>r0_?A>!rnQ0VInQmVD}0pi*@P0vzWz*)%wSvRmX@Pe_P>Ibv)}f&;G@ zEQk?tmCSCQZi$)Nzm9^j9#6yusN>zW41=CqZ^O#l2zMa zqzzqRpNjH~%z@6u_tbErNevGTKMlGjQ#M#`pIbSAF{ZL=BeVVurolVd=k#_9xEn;GEa;0~

N7P%1C<}*wS-Nu-+@Hm@y$7+**?a#WbcJf|SA&q@6 z`<#O?5_-phjy6RTml_L%f?c&NesMJwTo)yqfpa1&iUa>SN^ z0n?okb{7X<46%oB(3{GhC(7dU&T;-2wHnd_rSvW?4UMq&;C~D@q}x_BMCTE}vQ?t1 zQg#MhG})(0E|gP{LR?28?c)g9t%$w0Bfvz6hQIa{3@ISF#bl+EpMV*tQHZ6iVzeiU z;3b!e2<*qXnG7JQ2YZ6s&(k*D44gTH8&qHbyb!0IL!z&`Z$|XlL`<84zH8CXeuiKR z`3Itp97GV9nTDufs7YSP1=my{L|+5StP0E*2127xQTx?eL}uybH?Vq$VzN5b|LZ+X z-Y6rzdaPy*j0~NW3VO+4l@C+C2lAp0omvRRwzQ9r6E2!>u+EdO6`VI&!*b6m!-XBP zWTMV|{HtSF`c7yN(9Y>PCtVN`gkLiU&rrW#f#l+1hp!jmXy}>Be4PKJ*{D4!&$`D_NQ6*!0R&BI1`KGNb6EyL+$>CRq6`*&?&%elw0N=D5j&O{#|COF=KzZ_CpZEoW|m|Zqa z$ipfBax4wlO)yvAJSYo>9%iHLL8C0tO2#cJ<%M_|LQHe1o6qz9`w7fzo9FV+EHIbp z_8DPr(eM3D)BIK>n(&c{18BYPqe-b$VU)~-5u8_Njaoeo?@Up4Ci^+k`l4-eEsGiA z(JWLbElhWO+%ven-WcA#KT`0vyL%+h4@2;_wb!gxRy+)I4<4{rYxeLPGDWgJzCN(3 z&pm*tJA(1?V$*cn>?g<4_%wi%n^oXfD)no<0l=SQlBBfAavZcG2~4Wf+NH|T?ci(& zkPh>*Z5r7?8!Ngm#;?rO{TiZ0)_6tG=genA=T>{^Ax&D~ioyq6*3)GZL&y<;^&>M2 zc_g`H-JJ*@B3~`m&)rVB>ys3BgSA80clCG35eleC&JUnoJHKZ}Wl`l&2#r5f?xQDm z5agt1pm#($5e83v<%k4T%)BHOpo$aw6@(bMlS1ooYwreuOoW07R#@}aeTlVK9qm(Y zyPRLAL1T`W`3BanxaEe$yp!f|5uCOYVCG4(Nv^@pAUct+4%d}9KtzrB$TVS@Hv>up z8lx|RykhuTD*s6Q$u32bSMNu{vGn#vVGLduwLPRtSKWV0K^jh#i3?Og3o@YzGDoP8 z1UDWW$SjJL4`q^SN)u4q{fJ!rOtN@HU@Up#Jh$hJA2o2O13j;iSDpK3m<0!L(;&E4 zCQMC?+^Z%8QI9{D5dCZgZ!gK>A6Igl{Dd6l0`$KM+Q3_U5@T{1jH&6CNMns6nKkbqy5-wMVUImBjk9?~F z&HO>V8&sXMV}jI`VEXG??k4xY<_K07e+pdq>i#ILNif-C0+Y_nXb3o7dJUnxxuCKbk`Khlbn2yWkANK^1=AeBI`XK5ISC!$H%KjhTTZwCn&@=7GIY(sXG znp&Qhqsp^;PJ}_twLpo4Ed@w#Kqui@h{T8iRID)UVIsgqx5#Ov?rM;v4i-)Pk;2Y7 zv(W4vUi9(f^uRGmwfZMNMW|5l4M;wO=kvp)`q!rD1_benkQ$IGdrm}A^`1(k9A|oD z+K+Hkozvy*^JD+ew!uSecbPNgk zfn%rET>pKoA5v`pp|w|)xAPGJN3}8l%Bj94*k$jA_`~0W6cTfrEO5oQX0%;n$rb4r z6JnoW8@{6@t0qQX(x%a2IgQeg)TE8%g5=clY@#Lf5>jTkjcl5zjl%cUsmTTYYQ>Fc zk!^E`t6;Y5a=!1owE7{)xmZZ% zs&K2K$XZ~U2Es}*p7-cpw>IAf4QL_mmaRBd5L2YQb7}wk9gNPxuB^EFjo$Lw9VTFnQaX@F1^|R(?O{(HZa*g@SJ~kHH=XICV2NGE zeNOC1l?ws#&^CI(TD5pIDi8!l(fLdfyM8)0>jGg5-YAg3^2P@F7*U2?l(w!}oR6C% zsi68CJW+<98m{~u)>~&X__#kJD5o1&I>bEu5pkEYHVij_6jC~wMd)$P7<+gXO@EvG z+ES_IbKBFNQ}-E3xYNiRSbM({-N^#{6*anrSADM{K@r=PY3(l>0?4ji?ySTH8#*!G z6Gb(@MPQw`io0)QM_Zt_%!y1%nGp%o`vHl~>C6xN^a ze+he#)c`t97LUS>kkw)rkhGK%qQZfTQr4jnMc-dr9PcsBq!c}g?Ar&)uCo3Ht|p*U zYOS=Es|;(0v30U{46qv781-Nk00gLHeEkLeFc;y;&fPDDP`Asg#cXDNn<}R(3$PMP zK|q!PjSd8!Gd~8-)`X7}+{z-mKwEinA0;r;57Y5gl^Hu@&V^pJ2Qm#RIUpCuc>}PkoUrV|P{GW=`9s1`C$-bx8BnN~%O+mi zS^RaS{W8UW5_939n-QBB)T=6ziZT8VoGD6xIYXadrRQZrI*dmdmY1iX9EPD;!XF^F z&PVfcu;|R=@_1uMS=<`c!UQ9oEAHb$D3yYzdQ18!*l%iHCQeWJ8}iOY_67}fID-=Y zQy!N+!-)bn?QYbjl{~ z&N}~{WRCT}MK=HOF8^m_!@$D)zapE?|GCxg7uiVtVbq9bXM=5{haOA@V)sWRo6yJW z^f0#&Ei`oa$B?qk{-1mO&aW{nkMKt$m^06$bY!zQpG>`6z682FU3@;CzoInDS88@P zJ5|(HHm($pEI;gGHuyAK933ax8ymML7rj4Xs7`eDbkjpNeP7u(rqP;s+;@Dk z=~SP~l-7AL6F8l`;*w1LUTWS9vyO(59>%{%&Vg#qvX75%)EcI@&GgbujL2$h@dx3Jq8-+)ciJ_- z1cw{|vXSS-@Pe({loZ=a=sFMGozGLSW-s9f5&I3aj*uIxvqO77CG^BnbCZ=(b1dENdgc<+fuN{dDb&3*V}tS9z$s@5p8Q<-I#;D*>8=8g zZCb4&%_>$OfDFfvVG9gphfuVOXm_*7St&;ChVk*ssB{yI!gI}fsL zoV|ercn5y_e#wIRzz5oljh*yO3)2pC_9P+hrflTM7^O34h%3O7l%Bvv+&F%(4+~K| zGRT1ykXJnk$2nV<8bzX_p9&^u**<=M6~I}1nD2;)3>FqOJs+qWX0Q8&Oruf|>_u5n z{sa6HzPT>omJjxV&_%xm^L|e=O%+alerciVRSYDcTj^^e*PMQ@Al>RX4oi3jnK1JR z2q*T}rL+U(y)i35nO*4!ZIf8#2)av$s;eG9{LkmKu` zkK)7JxmfVVH!wr=@1KYX1LqzPR{g3rf&)Yqr3I!#>C4`kU+gc3xzfw1(J{Y&)31x8 zy*HhyYenAYWx;^-k33SeS1pmai?AqnqOCOeeL@gNP&+vP6n~$E^qWF(7-y=o z#@qS=zohZx$jCLu;)947j<_kPsk~)}@G`oW+7am2WU*monTAk_vR)W6IEEe;&3Hrv zKX!%;L^n+Nd7yrMEBzyNL%lUR>6HIz@#;^lbgCtq`_YrjvxQh{9-Zp%&4M$^VlZS9Gz-bOV5?3Cy?O0q=1LB^i|p4Q$^{c)Zl1o0G;( zNvC3`OgFO*;EEKy0&e~He%V|K_j~L^K;`CD9RRC=9r<_O1%jPEfbRBl7BcyQ+loh* z0^Ye*WqT#|18@`k**G5WapCTv0tC`jtxNuZ1`+4C1OfIY@A4{)+-Ro!wGz%2(Yf00 zA8(;qP%UUX`_1J_K~AEiLd8G&atm5M7FcJbOBGi8H{-btRVhv4ot z>bGM-yxDSi2vnVFA^r8PLZbZV$~Hs}-uG#UF>k|4;-RQyl)AJZu184o)u>TYT)U9$ zxh((>jxQ@rKKiUY_^z3+q-cln0pbP_!ie@cDo&?COG*y>Z>=GMa))9*l07) z4r{d=@o5MN;9Q_hA`_LL)Dh}$1)kZC)s(Z`!kR*mLIBuoM6JSa21?{RCk&cbXJite zTkEX+lt>89ikU@XVPL&?nxgT!38+7~>~D&MP#>4)hZ^sBmbIdCt->-u`I3M)4nmrs z`=ttATPOgnAJVhZ&NS4Q_JEXt;O*E8Rm`#NEDY!!M+|?TKn4Pcyv^@c7FP33OX4Ft z#Xp|&s}SO);^H6t3yN35G+4-#vGO%q^lOF`tAjc(Dl`y6pH3O4=U7T)^pSSJesmjk znCnbqTPrswOdJeSd5ZL3gh2N;s_O4MrzeI<)BrN)!oFQiFuXk^Vj6u|kf%IWbZJK; zK?rBZgHz=q29byM_hpjBncdsK8U!Q>jKM`G75LiriQ@932lt-!V+IS*jex>xuEb3lRA4>{p6gYj zL?_Evb(7OhS7qvi7k$y~n^;UdH^c}f>{5)RXU?PZ#uZ`Z1F#vIhvH{&41^Ijj&YtT z@|2@wHP0v=43iLe5u%5@qk#;4UOCO(ipv+3$SwElx^64M{;O#OKZKGcr|P_O*O#+N zitZS4>s632gSoS@hrbkf11omHUoK1-3KMq_xc?yx`o!Kmk$*cX9>nZWDzplgT96aJ z%y9bz+X6wBJb~scOr}7k6z(Eh)xO?pN~0Or{ZB{mbe|E8W7HDC!ZLXOC#$Ig`qv;e z{MTQQtQoMN_^}_#|2}B(<~m-VDn9<{{7NuZ$QDB%eE>MVsR7x-Oe(7|UIH*zp86Gb zb@FM@V&#hkr{Bs$kP{?zS^r2OYJ`(Dlm)9U+DLb(u{Vg6lvO01B^^pQw!%!HFIO0` z&jV5!O_}wTzyvWIVC&i_R*_LuR<_Y-HHx^GnkRalU$~|K_m=Pqg$1&g?fj3)tlXBi zYJl}bFE`4_m_dY5gRYwT@QpBWA{wXFrb>2Es$;m}a6MZroYz)9LgID*BgjPg3nm_)DQJF;jLuMadNDjbzpp0cGu3LCCuY2nveK?c z7H$|$*sbj8-HJ(xnTOoTJ4oe_!@{;W# z12TD~xN$35h#E-|Jtnyw5l8Zd6ci;z9-#TrvK-@hElUac-#!5FHn%!gt3+^=C#y01 zq{P~66e&(TM~mCEIrZ= zlR~&U+AT0`7*BEr@?|dt^jG@w@}w<>!Z{K`;-h<^Ddj1bJm0x^v*Ja$n0&GM$~v3M zM8YC|3khS7dBa{q3JAa|f2<86n#vlr3nC!{r+}XAa~UvPHp;u6yp=7ErgFMBC-ewj zSoKYkOVb#8(#z!_GcgnpI#PkY&S2LSjsEVW2MDV13=wD`XuF~NGd>ffIz3;o$w_hn zlmwNYQpm8RfJ;@JQ}hNG_7wn?7+DrUFVP;89QO-) zpKTk+>_+HyzWS5WzMad{H^DCFAy_t#cpI_nQz0msui-^hviTs{MdGr5RwZA1$ogX< z5IA&+LcJypJkdM5tVj<6y}njRGiy!Xj5hti919%ev{4}nLbN`4+4y$=_dI9_syw$i zibQ%e@vk3F{(O81S&*)jPZ1;OEo9NLn|&6Bu~wm%&{HgUBn4IFeh@j%>0)Xa^O3fzmG zNum^H=&Y!SB)|83$~ zJ$;H9ZfQum!!pnQX$Ti$+hVIRGS2Ay9kYgT@XJ$&kVu zb(sO0pPb(i#|QnYX@}JKx{pHBEw&Dam?3T}Z#aq#5e~ zDxCt1MqgOynM{SP9~ICd2Y#Ukm2t@@(qdqG@1z8F0V#Oe0#PkDK*A4qB3t7=%) z&7MD!#Q4zMagLv4EQTf}$wCxixs(t?I)Y{*^z;|W;b$yWQ3d0KrjU$`7SAFh2YNci z}IOvKx}l5~)yyGOj8wy_TZL{`}m|k=l5)-;iMMCpF4R7N^D&JwT+^)D+=L zOB*oqrYVBu0GI5l5=jac#D?E`CMS|dk4uF~H<6n@CN{IMzPwwQ;7lgkZ32DXB*WVY zjAH9B)}SU&T@csiT=Z-v{Vugh-A^gB}AcTLZgI zjhAzCQ@&y51Z@{TMwo{AnlZOC^3*q(e70yT!kQ){WAKwP6Q%O?oHKH~driiD@j8Bz z$ZVo0F}Y5Z%#cLC>@rXoRtVq z5@l*Gv7908+q|0zNGT^4Ei)~58G)Sn7cEzA>OKgINJ@+&nujlXGdzMxii7Fx<U`uqRWnY83~q=K!tYeefj*Ac{ldviggr)3T{E5Ur^5RhTS0=v*Wy10hDWci>~b-xCVzr_?uL|`EgkO;z6~1NFSs9UIVABK>Oz`I06xle^bWz6%TG!~r5b@WA?x7MHh;AAz ztj!eVHE*E&MOiyj9}+-R;dBn&yTW1eGUH4P^d&?Ttz*XbB$H?D^@;Y&9!RrXNdv{A z9(vJbF!_|E*7g~7iH;s@4Mi69j(3=@J%EQ1-RFGhDucNQ*0&il%9p@D3?C^bgtw7xnaS-~v7}AO_wnrH?<@oKNC#Qn1n{glv?x+!6i3ptfCK2J|k_ zSrY~uednIWc2I0}Gm1ucp22(v3=3n%Sb4h|*xe_wT-b@f!yCOBI={}?;Ks+Nx$95! zyhG7D+O@Uk*Md69iZ%1nS~L(tE;g>ixv^^~BGX7~2ljL0FG z!(8TAAH(O-y=IYq3%i9O+`I6=7N15Mi3$!v#N0%n6dK7E_z>>mnD|qXW4*4zGJEfL zeO++0GjNz-xu(ISG;1GXwM5_$NFafbd6@#nIx6&UBI>nYVF~dJDz7PAaop{CuV&xH zZ7!`-F`)XAU5Kai4mH=K`!FqMLQ6hL2$m5}~lFcT*F-!RMnO%(ng zX2L|z@c$Px`L7}`|GgZI?Y{ve|Kq{`kAQ@QiRJ$#NBealIBxvb$*!nPN|lc;BKAkM z(2S@w7s}WmUX>%NKKD%n5%U+?AoObHYd^1;(QcKPf#RF+K>&g=@ob%B@_xBGx%w99 zc5(J}zdk7zoj+Z)q@bN&dN)X@6tljVT^M)CHz@xY=Onjjnp)J8FPZwWzAG5Xe5)hr7vo6mzNLy#z2gh zU2;kqL=;c)Zi*X{d_?i;Zx+_(y`M}uwaBDc-e#EP zB-d5#+D~BK!5+$B6T6*z)Y!vx-KsqK@@5~G*VeCWT5_xCPKR$wOtUgoe2RaL_T3w5 z*kPTbzsr0YcS?b3Z1~pDSo7Aj`G^xKn$o6^O%rf}#q|vBUicV;>9v))SiW|S@rq-M ztxYH1=9i{@R&bg-$au%E^YC6pN^Cj0|Lv^x9D`7fO8u@w0=pw(l<0msW0)>S_Z|oJ zQY-n)w}fzd)!s5)Lj>g=aD+1hUl4$+5ok&fmWyR3(5#qh*XV$%sDKr*=R|5=0&XO! zZmmp57H{WaG{Tl+#-YlU@!n0Y((@Y@%{n?*o{%O?G4*K$m*50ujd9TxyRM;n< z%+T5{@LlX6#K>K1aP}=W+(WZk&z*)Ry6lZ0n*2Y?RYSQdXuP}RkWRU?z7vuqGi3mL zpX00L9L=C?`YQIuMb?&~$YX{I_NY%;wH?GzdhGOxWk5k@m6lYQCn)#iHjTt|6Gs&5hdW|e>!Y)#ac$B%8RA*x zzS*Xrb&N>1%Smah55STA?g+xXvbCV%<5V4>EZu#HR3fp(c5^B=ID_C8Gj^ld_~85A2eTQ zSxkQLs2?5oul{jf*NGD;HBW&$fjWhTjl3r5+{2RxP`N8m2Uec2&Mpa^(nXmkbcf6m z0|AAvrJMu9r-%-!A==t-g6hN*uDW>#`jMP=G+)|<@d@Hcqz+~GqAdgbEAbA5938Rj zAn%2O-jA5VCpomEm4O$u4Fl$cmnBwacT*H~{Dsa4t%d=ic@*S-cJKfSTAApJKL zc|+KZtD=MM+$#DkK#$`^d&3fc<-e?ZXA>zZ$k)=B5M{#}GvRq#^<TqTWcP_(|q^jc1R{ke?opqvH zloDWDD0^LLM^1?Ovln+bPce-8bcBn>!50EFW`ZGCA+=#G3tcfJHDGBQqS6w>SMi+@ zd~nCVK7n+OL~=bCsX=_<@l8ZjoH<;2xyA(SyPU8=^o*!ls|vzr7Cx&PHWXe$*`nY1 zlt*L?;+cB$SK4ly=&$RdS+LF!a1vB`KAo$&b45qIgk!gCxJlpIdKn};DyqW8A0ZR- z2RdvZ+yhaECnwM;1_N%1u@2>pRF0=-P|{HvcSMkG?I(%+6^V&XRXn=(GQew|8u= zH2k-9W?E|Y-L zF3B*E?>Z&-*Qbj*(Yx$9SUKBW`DB-@rQdQ^__B7Y#2}Wd%?L@cNv_Alk>Rw!TcSPA zUa-G>V?0)?!^6S?@N*T{!bY+xe?%G0ZdDUe+)U{CjEuM4(NSA|PJz-$xw~6pa4AA} z?8b`fRtCE&{1V@Y-SLtwnaSi%AkYI7ZLn50$La083pQF}ku$QAQ-pKl=Wcxr4*aD& z^%BB?#GpLIBT+L?wLRdV4DC?s&cpRhueZ_6Jk}yMUh|=yGxr-5DG>#;o-vNnrA_Uh zXOcxdagG=*S6la)@)BTcLN$>x z90A8DaDsKXfX7!u4v+xrykR&uf_{~!%-#lY_U{z9`|Ig=t+O4)nstdyc^AI=Mj{gD zsTzrHs}Y3nx6YLw@@sDG1?dG%+)70bx(URLW|XhY#dEBAE`UV_yaz*kVBDzYW8A2i zNB}k5(vvnQNx*Ae=mBiNFi40WDfsa}$djcjb7?e@y$a;r!CtG{KHcx5xTAB9bq3MIR> z??_?VaH3TIsFbS?3l<*s4bAa%c!`n&*LFd0c!*w9t0+h_WsY3-ki>1-o4{H(LzSRp zCXh}+JFTb7NhELPX2o~I@%XUOpkmumylQ%tW2dGdxUdHIrEm!LD z{d}75T(@Q_%5$`UvpA~Al%_?M;wxdqaS(^H(^V%2TUOw$?!y7-&E+)|1aUuERlo3mW*Q2)aEEAd44%r|}5)vcvHYu8ex8PUaIa3@oFM zEbd04CAf9FARtyQfp94bimhJ|q+@BN!PKsX5^uUDs4Ox|5^oH(7cZcOyra+Gps3cc z9x=g2!fi{m#6*mXLnExc19m6k&w<+%A0JxXtC{QHnO-XumoXK0Zl+9JG(7!f)660@ z(biRX#j5(W1fyWB(*)l56fha~?M$u3=j7aQ?bg|8SRoMgaa2Fr0y^H6{*<#y8;HoE z=_FWq#C+~o0cF!(CmiUV2G)!PC0L)|47kVFiOmslg=U1Cg$x2Xo3)aW21oMnAvzHE ztE=y=RC@J{rC~s_+JDZ4bNive&9On(7!nTkoiBdjhvwoOm)cs}K18dn6`cINSm0T% zGAfGrR@Qatk|j}m$kt%wSO{ zdRSV{xL;*?U2`5!V@R6HP8_Y?1JIgXuuSx0Qpf58Y`)aeOO|>L?h{=7FDa?@{^kqc zXs@1heHlYXHU{xd6^UFOD4NJyv!kAf?ZVSi7)^Z6ATG;lPpHf%P1x$Ax5Y|iKTKNa zO-?F$;~X`YAj_D>W*v(#s3=-eib5Ey7BZR1*Ii1o7pw$1i_qomgoaHP{V^%j0UfPq zT1he(2qYFRe91xPAr>cO?JT1Ux4~1A!;vOE&q0T_h$yW{64VMmW6R&Yct0T( zR9Eb-+oJe6P}u z5mCiCIqga~l5G{cR(5idO@wf0M}R@&t1G)4EfhF+gnENlW3q@m z5&{G7Qk0c&iz(zr1v44($6gpSmQ}I7E!Qaq-F^%g5{Q=yTb06BPhZZ+#97V=5Eyqe z>7-WqLo*VFoffa=xDO&5iLEjM*sK}@QtrTUfNBGfUj1A{Z%ne6DX?ala7cZa2I#6E zWTtv_Gw%Si0-U%uRZLd0X}QgLJz+S+oNH_qLMaFV!xXL24D}()Gxggg0hO@59oOLh~itMMahC?x3Q1{}l9@+@%IKb^)0Dz)-JlFF#X<;ENRy+GYq zhv57kUN-;fbICGLr(S-qrwCYJBoH5in+16`;eAJfS3nx=u8WpJK~>qbrx;CY6yfO$*}HFiU`UMcv`eVaBQBBazZX+@$i}iVEXAoSS>} zvjI-;AsexmZa~xq@jb{!k4bZDb89l(V$>v!P9d&`euq&Po1B00mu=e&en5S~gT62! z(1qu~YzJD%MF+Y0Eb~b!4bXQypZUw(9xy{`>(D=IA<{>{LY2~Wlzp^#Gmrc@@xpI! zR|mtKu1=;J-L6g!PJY%RkDtv!nU||qCiXGW0;+Goin{Z({|-T+S!k+Mt@eyCuQ2E*iKRC zI)_JUFVMx?E&yC;yEuzxW+Trr=QNa(PkkjCkVr@DHXor0oR0Q5{}o<^ox^BVI(i%25qK+KdQw9mr>vFwx=|q z6OsX-S&p=Z6$cL$L63Cegx#Un__)1M*@lzq(ZRcj6mc0Aa}hUED!;_=uBFTIa1G#x zz_W^soTvEg-q1Rm?JSgdw^650mFelF)zUW>w6E@G0U-`H#;%l@Xj)8>wb3*W8`|~9 zjT@(+2}<;}Q9T)HpgYs0mw1ALY^AaHCJ9sCd>SR;z>Kw;zXa@4{|!w=^k#oD!|Z+m zkkY4kUFY@pknT5MdF&YlT$N%f(+vau`eLxz+vkPW_6Y3vQ$e5|<;RR9rhTpJkqnN1 zxFJTy=rz61V(U<(j(>c7kQ_9ii|cQ36-qtJgb=dWgJFyF%12z}QcsmZy1D2ok}o=9 zIe&`E?rn5b2R_t^ixi-})MJp&EjM< z23E%f0czpCqDln<@mLZB(ntG;-B_ zXzfq^pzf5u$3C}?odw1A!H7h)IN`Z+WA`4@4}UyEMJ}WaX#o|>Yg|dys<@4!ZhElw zNt9gt4nM0A{=g^nd;Oc6NS9+gx|>-?E;#{ zN?UX4iLc+ikjI-!071(6bF2m%&P<(X4@Dy0i|Z*zzlS_{NrZ=i>}J!-6uQJ<&1;HV zpNA5|8oWSm7U)-gZ32Whpx@>o&G2YY!MU?1RB5qeL~P@$AUxL>Yfxo`d&%EuWKIR3 zO#YCicCC!$_1^Iyq!kaV4_QwLtGF>!Al{6aDGr#<%O#2Al|PCEZ6?hD;^(gkXX};$ z*(d3yvlpTR8jPe>&Wx&zS55%M&YT|3Z(OiLm8=`>WI>zgJ+o6JUk|N8=Kn(h*bU@F ze|nT=vz_NGB}sNHe}{8xR!8>!D?b|qR}PeV@s8A?ry!aSGh!c!;!0B|JrVKXR`34n zF?h#YAiZF^TZq{ho2cb2C%>!=?gI{_e>coOt*j&@qoW=VDfh^7?$?>vmHseH<_t;P z+AH&+w9VQk$VX6!ktaIv(e#9%pIT)C9zBLX5cCfwW;D`o0RACzyX|(HTFBy|zZIj5 z4ObGDHOuetQ;O~0jaf^OKrKc?L4>2e$8tJxny16(sRsxY$O%ie;yLhlkN(qg{{I9Y{dbdjj{i0h{-1f-8UN2jxKV9A=D!l*e>EqmKuWcHahrv7Fav(P zD1`6~I21^GkaqZ`2C>FwBFOj?G0*1<7u8%oM69X$_j~bV^&Mw`GUbvjTY9?fNVOU| zyXq~SNbSy_xBr`zwzh3c8|C2Bm0`S@2i?$5G*vGW%1> zt_$C>0Kdyv0RsQbchlztqSdb9luep&Sa4ghCfvWw$n-Qje)+?AGe^-G?<}9Rb@#@| zN=)Jk&e8Wa?Cw`ay~?2r_V*fFkwDyTCC#SR0(rg3?WX8g%5KLu$mquHNt+0@``}47 z!zYAH2}Iv?Dh)v(PARgjBuMm2+)$!hS09_8zMmF3C zj}Cupp~%QDAc&!v1IZ|}eI{*%OjgJx0I2oTsFs(c+r_Iy|Kq|&|Gsbat2o4CqF3qu zwHAgIW;xvC(5=qzB%-O}AH*Xt&Y*4!T#ubP7KLFyD1s~C-s6LSG)84ra zZ=kxQ&gTMl*drK`8e?h6pr-ZXY{|xxGNsLVTXvzUhx0SRcy&7+8S*w;pa)w z@?wm=ptL+WQ(?&!zf%vtWu!Bkj*GgMXXkf}m@H`tOmdLtiJwTSDZ8KhM=xBdwifbA z#0r8y*u#;~6eP}m`R)K(Gnua}RV&wE{JB+H%vO#wrC>e@h(X0IkT^X$Gg$~mf2rF& zyhWHib|o&-%2QR-&m$vZa>aTyj|1w%0Hv24z`)~Y>v_cf*p3_u^1dbKbANJ_6dZA* zM_yBnNQDkXram1)*On863tMA&a^#=8S2sEQw@$AfdQZU|APW`?dLoHkZTR8QC`O3* z#n4OCw^+GfQfRh@hP4gPoSv}g(Jq1z1iMl{0tI4 zSn(=QJNwvGL4@ygFA5zo26c-`L`#FsZz*mdl}1}C)|LUliVSfqZD<=D{9k*UF^3iA zDHOgcaZU2H%Dm{#$Cd?cc6wLZL0sV$ZbuVOudlawl8Z|nFV!tZ7M$$i1w$zoL-EBB z`e3P%5vA2fLg0fDS!Y4Y8`7mNF&!Puu zLea5IsQDpOP^#ERGYH%iqU;riynb$DFuQ*r2is0?p2foh>IljLVYjUM5PP74 z2KK>ZKvFl&8}(zK2IEUy4@Ufda~n)OMl*DQQsq zID)gS9S-)%@5QZX9}EtdKcg#yQTmnCNsb|9eEG>tVeYvcLX{qPmL@r1>I$8RDc1fk zffZdY1N*IYpyq+&@FL$&;nix`GNBB@+Fag)#2U{0!av$P2B^h36}+2@#Mw7^%!q=uUeFuo4)un$)3o$<<{Q%Wi%sG zvkl?=V{I`DA?3P>C&HS_>0N1?JI~JcqdV;gBC}!e8%>9{tyYdT zjW{69^{$-X;HP)uDoF14ttvUga^%nRjRF@3OA(d1y$V7_gl1zj9_TQ}XKsfAXTq{| z&GthC0pz@`!pvPWPJQwOJ3w(Bp8u5~PXhfXM0_|;QXp!Z1^R33SSSMAbWO{HffyRK z(id1 z-8zKi`?R;<-=?N|NHn(MUqp(z0kbyzl`Z&*Q8yx!<_+r&Lnf`smVfl8 z8PXFlXR`V5-~fj)vFbe_XDvme_NN=cPbj3UEHXue5qpv1Ao4T*P3`c=iRZn=iiyk$ zx8;1q8oiz_{O)yIr~95uorE-<4fOJH!1#)%lWv>C>u0v?Y~blGbw%ZfDYq4g&&z6v zksRF*kCGwTh8k;_HN05c4pX)~4}4DFFJdv?3G)r_fRv(|LR2lTt3XzciH_v%)T)uCi+VoUCd(7ciC%k2ROep+<2&EX=ap;oOy5clT ziZq|zmq9mW1KG2DYgXFSC{m0^e#)v8bv0HTh%>Drs{7oMr{dA7sfOVJOW!yUx0usY zT0|PU*UpA#-)92L0JYX}MXIws-r98TwEdF!vqAKwNC z&KgTTgEwThdO#iQ!+nF%CT~(CE;CHOOk@6*&o3bt)uT_XI#5Z)fXaJBWp|L%0EAx^ z$r@Xb40j>z-JVjyP6g@F9b=S<=I-$t0I}a6h)IE%4zD zV!IMY9^%1Eb~A_=D5F95k4!MpBy1#f#Y*p95p8KzscTeLL=@`Tzu|H>dd1l5MF*5r z8mCu=q?b~P>B1ZsO(t?AWC&15He5`?rVi0xKc{qf4i0zsq;oXtD)0vg(>4nKvI)r1rQ-CY`@5Hdx{<(n6ydvPITzxeTeZQJ=m&!u zYSZO~mhCkJOGFuXKY8z%WX@Zev0|D+viNi^=qPzu9e0WbjrMnh$CAiL9kkK@#Rby3 zjL>-mArE4qfy4Y>;MpkoPvCfQ0WCh4CCgq6wv&ZtaN){p2uXVeei)_Fz>x#L|7N1; zTD}v8$?nGC%AdRlZdxGP&4Aws9IB-4nd`cAG<99w3^mz0JkU^fH0^d5TQ4d{gwMNQ zeo}@4hiURs(GV(=W5gG~6jp4IC-)BY*HMf{o>8tcAs%1ojomPoZF^W)i7}JrO6aB1 zl8aJU*Fr-_apk=8z1OJILP;z_94&^S*i=t>PnS&tBJ#~0_IzB1O2zj79tSsLj=7>rr2nTtoj!!?aOv7S3r!uCSQ)*{|mZI{Ew1FNG?Xs*|z90Q7rW@BQakEPT0YuVit zox%VCkO?w&3qo&rWw$2ROiZQS{~Lfx^tB^=(Rd*9w%=J98>6RG zPZf)!)bt!rZEKi?#G-#v87$cWT(r;aZIX6~ZjWN4E1HOhy7+qhmg^-KlA&<-C^Gj3 zkTTRQBO-Rm=8mjfZjZ88B~(Tw-I++Et0DT-I_dRcnmlWsjU+=l9DD6EXf9`%H1(lD zHx6XMY{)JG6O=1H@?%aR8TUTB1Th777$ag*2DhF=kIp%WB*;8NuK6x)i*Z32M;>s#F|wRw;)^o5TH+f@v_$^p7IG6;9q|WVYJh6))e% zPca4;aqd#&8?=UM%)0l&fudni_sA#83R#sVO$cU*%Rbm4Hn|}`+vz(EQ8xC|^Hqq~ z<4x@I<9=ZRqo<2y?CUT!GWBV7aZx5c=Y6N$-L{3}*iLV<%ACaMUpdvULHeLj39AvO;RT1%K#AP+K-f>l!7gJI8R}o3HiAtHP!~cp}crpe?wbrOsO? zt{YE|skdxN-P3=1V}JYDP6SLOiYsMC1rSwsKjVEWHVyKwCm2A77596S147M&#%8?N zY%TebJfH4BYuqw{S;)mkgf}K_q#VMjZUgXP73hTce~mSgXgza|U68}N?6s3$54vF5 zmH~E{LtK0AU@4bfLC_=8X;v2Hi$$~$0su3Ln%@X^)qyU29^pK_+aaDv4+bO0lrN1d zMuQcl~gS{$4*4-Rp)qmuwkM-5$t2^VtO_)pYJ>EnAFraLmKg{N5 z(F!dLHjY|nXA~!0GaNPs=Q$-8#$Se#!7Y3yWBU_Z0AZzP-4wt+k}@ z+ezTalxvmed5P;l-70jy-X6QdRG`E7N(w6iG8gX4%}=X1V|3;`Dn-{966|+UYG>`U zP+Qcfw*+qI5vob>qSzh=yY;7)YlgyFpI;v#^O!u_iwgn*IR&eF{D9sP@b5cXI_La9 zg8MBTVn$0nj+~jFRUG=IqhWKJc$)H$Tvw~fp4mJfbX^#Vl2X*Iv zHHlaw=u7y#WaWI6&^{4M*(EL|yKT+=%`(xw39k-K@Rhw()c9R~rw%z22u~LXAA=XZ z*=-}8nbfR1AFYREQ5jSV*p@-P(&Q~9{xxDBZQ!5&y4#(6n9tBvjgy!yrepIjE6HBO z#QAF;5t7z$k{b1s-*bBsn$efj zm(xZsmae4d+OeIb$Y=2ID;YkPowp3dDoML6ksFRTByMKAb)udwV7}if&s}ZELL~1x5p^YYVr>)+FB+-(mfAQq1Y0Ua-rTBJ_4m z#N12lcOoXDWFIA!U;2kT&zpyG2jJWNC7Me0KH6}VUb0RX`oRX zZ0{?OaYX#OK^t|L<)polfL{oidBM+g*P93?@Ej1(MSfl&t%ca!1g}G2LsmJJ02wkf zMXq{hn|)RrU6Bo}-DbC>?GyNc&3wof+oq<~{wB9Y6S`{UFw_nDFzLG*wN><;*hjvf zKeFMVTN?Ez{A!1Tj?BN@h5p@-BDoZuObVWHAerrE&LZKVj5VU01 zzc|Fb6LwhOeN4%34t!zVWUsRWkl}^mjM2jSSAVB3(oTNUlc;$rOgR`)Oa|l(8Mi0G z9j<--Ur``ANVpMe&0tLiz1WBq&3?^IEa^4vzyT*KYi_x${}41IHbSBmFU3oK;oG~E z<{}Km8^5kfd#k=?d4|dY1(;KE5&4K>eIxfhnLst9BqMvL{lTMTOJa|81+72)+TtFiU$iO2H$ePZbW2XtsYMMk8{Gly=66D@o1;+r%xO z>BrTK8JJHG=P8%2JT*7=w@JlGFwLY7)CdOONPlO9rMyS^)wkCb+F+T@4Ff~Y$j z(^1)u=47shQdG%o!=;+VrbGY8iR=BI{{7H05BnL1B${g7DP?{es838x6&Bg6k4sLe z%HbY(rG((E*&;VLPjr>(3^KpQD({DzsKm>9Qd>7?LxbhLDEOP~=(aer482p1|M?$$ z$`qkKIyf>GQoot=$0h{~Mj}irtOKzZ8}ZA2HOjJs9W%RI-gtqZ{`?bLq>*y7un|94 z^weU#PQB{MgDe7RrOE0`FqKA%4HydWE(m|_G&~fp9WtU~d-4IVeP3O}wF=~xu0z}! zq{Z&9L70R$FOaL&#G-Y4#xY5Y9dr``Urae+Mdp^kf{Mx9&rgqIT$5d&1XO4! z$p7YvrhM>Ko;j6WbjXsKd4Fx9 zw{c>dYX$Yw`7$F!!BAGt+0> zO6UlBTh9apB$j;rYICQS_AO*kKx->NOkhAKobzahFtZ6-A1X_!XB{Y5Zh*_Lt{%HS~aQxcgKw+?JN(P$swj^7GnV-X9zHC|N4tscT500=Ok8N>wwY4gE9f z0wIl+ioiv{4t?2O`Ux1GsJL3s~jTwR13XG9H!edlU8Bny>!X-sU zh%g=pggNd6d;I={+nRpX+1j(xlS!%6JuBhD{QZM=Z%L=n(W6%RNqppm zbdM(et#h4Y?yJ;h*{YV@Cv}Q?eC5w}YI55fIYv_3QEuV7`xo95JceNq{Mh^aRSOxx zUmw-8WM>E<%$2|$%;*M|PKwD1x)hA5z8KGy5yb-Y+e1hUVvQGTqA?qOop@pvL(KF^?M+8|18+GkC~xWx95Jp$$-8GqVj=;iz-uYaFL>E-H*@ObWlEI*WW z<7|8wG3lhy>rw=B-bfqX+j&pXSf$H0ouMp0P3!i5^CsMi)48luZp(g_C^u^=>tvKy z0swzTkG?X9%Px_8W@4t@ZRT(6#y2;vpFT*?D)F>!WvJnM+>TGm@t@XoW@2$-8n)~T zNIM4TTd}qHgktW)Qk`RKic@woNp;#ZL4iFhnB z68ls9dR@ZGP0)y4Xpw1n<3{UqtsEG55M6nkWa=W0?zX^aw8{b9>FZu7z@lp6SZXIW zZ^U3rU+BpjO@X9~nCJ0Qipzu+cY2wE%?|X=W(|QsM^3&U0ztiUpEBaxw?RF{2#7Wn zC^3<%m)o)K7hq8^J*;sX(zc+@dqtw2maz$mWZ93z4XM<2OtAhUP&=T_@*8ft3B#VZ z?oh|YiW?IrKgwjMz0n#zCu%5JoL1!$6;4&UKPhx6hb_qyj%YL(mXvwbnu|McAuBE8 z3ohWtCh`PERf`rIfLnW>KPeo~(+)U$Gl@C>@HXF@hBK0Noj><) zw!;jEP19zL@gDX)P!l6I11?hNKS916x&iMVQpn&Rn|La#6R4W%L=V z>}Ok|5197DmVC|xm=#WTd!T7wJ1`nLtdm>9h5*3n7r_E#3bTOj7Qg%QR|LecaGuSuICvexu*)MklzPP%^Qn5hRl>bj zq4l2i=Hl!QE6{-&hX##}7ZaKc^go+A3JSMIW9MygiXw&?bku;+ssXGON}AZQ_ny(6aR(6b!&PTa|-c1#&s$wcgEJ#$F}hJL33;oxxLmN zz0qB_H_95&Vi;Ap6s~~eU%J=UCi@(iti?l7@BVOM|NHyw2SCKthX#tonNNcXW!W;aP6&xDsGyRktN^jS z^iWrvv;iNIvUdQd@+)t-N@CXBz7}^(>A<0?1ufbnM3p}D^?|4eJmQz$3t09mC{mXrhK;tH8jVHnuG#2c0uo3P4JRDht_~_NQIKAP5 z*)mXT^yn(v$&e?*5LI#7vC}%WJ90rTWYaJ;QB}EJ{BkwYJUQG+{4|yGENT5@?(6o_ z#z+EGMCf~P#k*fmbtkCvP}Iyp$gvH69sWBm4dMt?gwDw;5XwHWPIUxOjldk1lU2%} z5|aH0-_rP$<_mR{d~j21s4Tlq*;4nctLPBJbs5{lm5s_y}?lnDV&kU zK8eL04__CdOLZ!)c0^C?0SgT*F!6qch%n3b{S=!`iF2bBcYTv%5eiC8H=o>GjY}RV zpBu#Sp96IW6B&p))#URI26?g(SbhEwZUva=e#Yl=f!BwW;2u8B}#@_fwO8PK(mA@J<^8HusWf$iLc+Gr@ka{iShbOb9 z%x!x+xMuqVyM=^Cumxi1v2PT$QlH>Irl;lR2al*XXQu1;pwqu2(J zlB75bG*}-RuOKGkriP-N7@1w0^eS*W)??dIpc4|KTFC;}C!y;?)%zu{CY%*Nse&7j z<{=N4bTPWU%V9(hC()&U3wGNFOsV=r9iN!j3j@WN4rH#Q!^}Dv4+HT^BPiFV03otz z$?K;PI^rp$IH~5cN@&;Znu9j5`9l!$px>82E!AVMBjghCSRl!sG@<8_thIs6Bi?=N zhSbIMu>iz?S6cFz6!_ddlLa_HH-qUV-esuVy2lSqh>m>WYpx;syp%z8Jwdi)DuQny z3ODWAcGP(l1swc}F6=ip(|*r8=I}%2ueied^b?`V2ir5Z=~Erqq4Wu@LjgMZwMyswF2;uFIGF8Mha!#svX2C%D3?skqIl z;wEMp9B#tI+joHdanHHn6K|5@a_7wYgFt)AbQ<2@)JjL9bXw0|a7;cDorSEN2Ae>P zE*XbFt@lZx`yI%MlNu_>t>VC4s2Ji%+g84DyhTt=4_JNmdb~S)eH>aWqW-x;u%nym zc;revt*lK~VM8&N=&%JEE#B*YU8m6CVz)ID+uu0#F}9$#B72$Z;%QBNzB0Mio%g?% z8xKj;G{`Z9LA{G86M)vOl%sT7Nl`2^K@0pTehE9FjBMQV+-My2|WEc#fD=j%@;`zi|5HSA+ zU_Pv)Br(Rx#g`pvyF;lh$HLa*vXt0Kz#!*;8QI$7whgVd9fYR@80b7PT<3^3dzxv> zi0$7!^26K$}M*KlI90*;_sb`*@RLac^S#eJz8&v6J#&|z4CXp{TP<6jv+~N%hca8YX3$%F~UMqafJi{66za2qqr2{ z0&9>XgRmcWWHY$&_ZqKvxbVRU7XF1f`IwUo>{PF98|)FV;=D&UNvbyhHfuMeX@6{Y z7)wrgFcn|7SMbbo8i!Fd_PFh?bDN=43XRm}qqlI7nanju5J^Dv(MH@RS_fIFHhTch zh-{{1uO+I6B#I}1JR7sX1OVh1bu<6y{wEz>B6Zjw0SW@XT7R}>$dI z63(NcqTZlULW2t&6w>Ku-r7~?2C`OX_zi`&*^ToQ&8XTD!fsngWtk0V3S%S&f|{9G zWZZt}Q_t?-GVf*)Bt?=smP}SdF4W8JQIXH-QttVXp)!ZJ@&t32}UVq^YW-kwrTE56OJU+KNC8Zsg z)P3Ytzr^Uxp>IEX=AO7){d5GS>uTt4F^})TaJb}&(LYdhI{ET&caxLK5-Vhh*J?)6;4C@K4 zRj-t3u?|Cz1qPc5;?E%e0Ai!e&RgDgGxT;Q0;2Wsm+6;|avC zc<4=DlguFA6<@td-teNErpFq8Yra=m$_Gd`XNp75ce=hY+*>pf*K5LA%~|zbwLQ1E zcRc>!pnON3GcQ0N7WjPQFl|>7BbzpNHp-~3b|E~p9jl{?tkyyU-R>G&LewiQNL!P3a>G$G?&k%L8hED1CYoioB33Q zw^%WUyEKh9t4!ljUWsKp9?vSyzU_Mc{Bag;@vo0*%{&OMz$BETSEQZle%ojw2=Wr_ z(G9EaU@Sj?)bJ8@W!GQH=#V>;4brk44b)nnl{;zZ@&?5#sy9av#zMos?(&H@_jZNP zyV592TfrO4J$6nf{65G}Pzg5^S4BbG4TGkw-AYX}PJr~Xrs9>Z_e2NUkyrbuRAjiQ zY(gv^^*YYFx2c>~KLoMNQjX>&1dq5Auvl0F>Pp|(fbELuoi2}Fq5i{UtTz&`~xI7)EbO4!QpupOXQWQomU zC_6UuI`ozV;v(OJQy}SEqg@RCf)}DNHn)qX#6({UZudv`!Y|o%yFuEjkAVzMukUvr zXUdM2oVZ1#u8Ws3AgLodhRaDU5jR&eHAVD#7w|sV z*-7;w?rh=2J>6IPCd^POZ2xupow44O@iI2tw(3c@yr8j}&5zQxLdx>F0l!aC!}}CU zkT(^191JNL&}%l8f5uK6rv%e4TH`foLh8pBq56qQ9RDH8_LIkoU9;^|FLNI_b-x27 zsCCxScknHlGlUqR!HA<;FiBfQJcT@uVzctSp8EdnXi+vIc{NAgNB+nZFA11GStF4z zr!MlMw??5b3fEt_A-(ISp}67cE};3fixRtyYLFmCu2X-v!b)ej;*f9ak0(YqSkC=1KHWnX&OQCR#y&f=+VrkYoUxA z+g$#@Nu)34Tr#pWid{Ep*+f>@i{pULEOs z7i&uJ8s5~3qfY`bQ*bh9B7Xp6T}*xPQ5upC@4K^!23&2p1fB*da&hQm3Xviee(~lW z9zbm|_dMyUT$ug5Ku5%@90j-YJN7alp`b*?9{h>i!==e@)Z*!ElML^&DiC`@HB+s? z2u-v4F=mo~0Pjbwd@LhzBAsC>ZL)i9k2tgU>w^|Yth=#ri=xgn0ljUSg!bi5QjT7s zW7@kEJ`bmt1N+%RfBqVFZ)>=y|GG$BU7k(a(^EZwi_QF}8u=mwYp*1}xe2Y5*&1wX%Y|LFJeR3k>G=C&h^;&u(?92uDgo}hZhsgZ9vaGkN!zo0i2iRc zZmoy+q*%K@m{cOq#0VObyq_ZTHY33IidMqjQYhu+M#b+3rokjs;uzWAv9nzMi7a-V znj;UG`)tYO5Eb~qUP8EhCOwy)Xj|F)wDw)0qIFxwIN?V3-ytEe;hz|7CnF(C!J`g^ z!17?1A;<>QxiUIT^8+AtIVz;HGR=i=EpvkFOFF^XfYm+$DmuaiT2T6&D>%Ijwhz+Q zoo!J8Itb>V(kJ`GkePDX*pQAvniC2WTe1~ijh3M+Q?qc1rf9kX+$VI&PcqcBEZ>YY zN{4;@fe}uG!|)l$IW&#hn{&MhSR`wl@xm0ip+tcmW8(jAqaa~Tn<~~Et@TK^MQ%#G zM>?>%w%lDF4|;y|+}e*DdH=C<`A>RoW`_SqjZOdmgWuslvx@%T`5jmp{@d#1f28DQ zWn^Ld->a8GH4Ueq>cw}tChaF>B#!EnY*i}DCwpB{k0GARbXu#?y5_x*Z3JpIM(*{x0*)iCrp#}b}M zY7&X2%zrSiR~d7zgfBZ8OKpNCzsF=2c{x`ycFZ!BZ-HfIU4KE4PZi6Vxzm!mtzu(y zSce-^_ioN*l(-B3r3dp#W0qLsNfI()jU*e{s*f_)hbFjZoBvJs<&$L2oE+}RIc9d| z=EagO7RmqAMH1dn$z;YS8zsVmN{gwwb?0}UZ^EuvoWf-zJWgJv8MiI&A#AfzYDc>q z3Nh8mO0fcu!R8anKO{j&jdqeIZUcjh^7p6X8)FY)ex;|+8X&$I4Z^ztsoC#L%fp%U zs?w->^1~4pL@*ubvO>b@Hid&Bm|Mu)ZBztoWPGPJyJpfV^L24S8-VtJYdVSu+ zF-KB5h1mpocM2*Myx0b#LgqoXErY;T8yfS|ZqeFoS9w~=$7i0@=_y^JtETEKi10)wSATdh`7e%$@cAFINZ>@w#~C`+qP}nwr$(y*|u%lJ12i7sXxhA zH@A^Wr7;_;w;HqRoi*Mu#`B}eJ8>_}?<`wg?qY2oql`JUt~#g1?qfy0E+7a@)^^Zk z)Cn>`4wlXio7rmfbDD-MYJg{<-&lSkIy8dM&zoI;7KPx=2X=BxS*2_vjzeb#z=Qmb z;4yh#5Rlbk(sJJ!*EVKaME-~hqhSVdc9 z%Zfc*65|f=kd~V-61%gWrao#NrE$p^g~kZRzjhn9`;5z8M5cO(EN*na3&NNX-nyhu zDt3|@n+&{#XMdJwwh zeI1^nVFI~Gm%g?l4}B;ddkG%@=Jd-(_7hp5pLW6C`UayNcmT7uRK3fw?Y_Aa^%q;%se?{&ovxRKnC8Nb4^)JdheRJj zHWAtxa4g64v_Y@CiO%oM>%*!sPv8-{(IM%*mxXBy8@2>%8%0S(>UW+1uQkTZW1IZU z`&mR1#v%`Ze_?!VxAWYcJ~X!5am7-|Tv7_W0qTHV8Q94V;w0t1(y(9@R(;!0(^H4c z6}+pS!PSpPxO=>C(2n?A3lEYP`>#lHFmS5x0W|@d+~HS>*czKU0uIauOWnx?mR|$a z>y7J#3mowl{+(dpDsJ&;G3>O!D&>Y?@io>#gV15v?bk8~AGzuj)}`Wc@p%O(a3Kgd zXX-wh@GPdvV-q>=yMbAB-4TsJ-b7f#q50^g$_Ahko1Q>d*oOtf(`h%)PNC>hvPJl! z=BB@RcxxXO$EdG-7u^Ngfjds8%dVz~zdO+4^6Kab0nFVf0DF_5jE20hGGuqkli*wn zVL%NUojsou*$t1k?I(_`` zZ*hajJMOBU)6h{Tks0=#GEHqA%!9;o5*S{p)aoA`@m^wy=&BAVFH&PGvMNKgBhm-y zMYf{}(mHc6(4Q2L(kfF(D%WcZiE=CYFHITJN4%QcjnKTBAkg8Ox`L8xqm!sc0!3w; zATL4@j;9bxdzk~V!ZDe-l_G)WSwmLRu+p@gA1!j;wEWy^`Ot6U3yjQZWtjur?dbHLZ=g_nVS(>WQ`s^QC+6TQ1yW+}l61QL{av8-%NS23CUfxpWo3 ztw5C@ZoEj~=w;dr_&nug>UCIlIPV|wv&Kkg8R>&p!!#7o_j4;)s}2ikUJ(L${b6#E*iOIHP90{%%)MJVJo);(+B(3CeC$Ud7_DW3NzfXIUxIoAG7q&7>S%UhLqwmSyhCYD>0 zAwBq$;*a8K0H^x{MgH$SfDt*ws_16AlrwcM?n6J_=YHiz+E}WTW+yY#?ROoKz|V)3 z<9<6-5_BK35X7C<*B$se7uoO&;v6l*tMcZrDo%PU0D$p`@6NUX!I3xy`MSA+o%{yJ z;_u&oSnoM_avNh(X8i;8qWfMs;0!^=1^$Cdi3g zJsrx9q7`3$0b2|jtC3$*aVFcE$0YyoX$Z3RFR)yGZN2%!^o+}Ah0VUamVTPo+7SxK zgu04|jiC$VW2`!qb$mbK8tFqysZG4EeI;wHh-~cGQi_?S*o>)*s0s&JY3YD1){9iJ zj*JjoLiEfFa7fU`;&T{?4n~jvu81EqD$V%YlgN=qodN>J6m`hKfD6? z_+|rF0PbeBd#J%`KUS{;st=sUyYv&Nr)kuy=^;AGhDu*1v}L6R|4Z8py>uetR6A+b zq#%jURN9zFJ@+A@Nf_bsMX84syz)8t!VR06$JuAi+Ed9oAPX{O3<6vQ%SJ!xgx`Np z!jNq=^|p%RYh&nGL*M89`?yhw)|+!(dA0T2&O#{z9SOx8^ro^vPN%u7TOm8cQ^|Pc zaslnI=SlT100W!5Fp~Jj6coBb4wiO?uWoS&c06@_QYwJe#9qnL;)wdupB8O;6tqhl z_3qGH$yOGf%#X#4B5H2d)X6IPX3$nfjag|pgUq9E=EiFj?qt2UIF1j#b4zKIbhWl=R}WFaixnUJ zdSt1`PS^m5Wv{l0T8W?jvle&67aRT{Ti5ruDmA~{Q@BPZek+9}w@R8uR9uQ)2T z9f2T0lr;d-$KwyZeHhZuSD^(KI3tJxG&=SANK?78O9fH}t;;i4$UlOG@TNjv+JNl{ z2GE5*Ih{cF3t;1JG+ursauBwMB=YuY@s{^S0u4U8#PH}P$j^8*q+TOvShps_3~C~O zY`BvHYvH*HIfX*37)8K!s>L`XIv9ht&dL9hRC0lPXy6#mVqXPYo!s;)%G{Y-KvfD| zrTd84K)kL5=gcpCVr<14>(a!AWE4Oj8_00G+ZfqCM;PN6EpgNfX&mF10FVFx?Zk;2 z%Wg7DMm-R-%Tl5O3?rNB)Ef2aa-y09&+9BB9F zG|c3#CYE5ZPFSDGPi<%&rJ}3f*?Xv=;l|vBoTeCuY5B%8Ta_v@eIjLE6A~`vL)!Wt z(%hboUVcm=I(ZZeMjs^O=8Oo(dghz3f)(umHw)Du4`AN@8IObj9X>l%#A*uRLE)7o zN0dnPrRvD^@~(9pRjY-CR?}XmhrrHHS)A78G$l(m6n=1sQCD2nj?Hd(PH@SmQ(oVa z%in*S?>=D(Pv86w5}4&&3~zYr{jGoY-kOktWSShVF^9JD_~w+g#uWAEa?HQVLFsWc z*Q zI1yisGVX!}nRgp#690-EWANoSMZaDTZAeg^wV(|i3aM5ZuigL+DC3&AUFd-H11uSo z(kFCdx~*~sWbl@%+IhiW`6C^?jy}XYnb?Nt&dFw)_1#H+HPU(uVIpY%PuaXXZDM=9 zJ&a7ow%0F=tqU9q>fHi;4Om;iopD!OvcXXtRj-LfdRU8I>LP4H!#Cs0s<#_k00WI? z=!)yBe=bfe;%h%0qL~K)pUl%1h>D#sT-sgprB}YnRO7LP6s`e9ML*esg}0pG_9^H( z@F-sg;>iNBScDCkjr?mEkO-0XuNojV04ttzjC-~*8oVO8PC1LzVwLqVdymf2A45k^ z-zy|BIl&ehtbRcENEz8KYWuURu=shto#DUFq;j7i%Qa8B8{?1 zu5ruSg#n`ao;M*5(W(M}deNUT_kz3w^uDl4F78qjIEvMQRyg+G&|Z+B)C9qx7SsPi7e+g2u@CImB(GXR#GQRY zkB2UOvY&`}4#-y2H!{6!s2;1Vy{*obz%5;K5&``3G&Up}o z7yj`>o&_kyP>V`|(PkU>6f~~ZvbRBXm`X)uWKU~5wuJfOwNnvt1tMcqKuONQ;F_Bx z-E{*nCu|)8V8}HLmD-};v!URU@8=V$qd_4gN4xPoG-LpzKnrULPeh?nOk<&EL49PM zJ&d%d1lYziuiGL221c<)UwtVq3~&)uaOtn{`K4{^Od9i)KO%)e-Om%zn0C@;gl*72 zX80DoXsGn$pU}X6<|5(qfl8({@L?>SiD2w(EkstJbeC+iOxafjaPSfd$SeX?F);DBy{tEF3miX$v0atuPt9bTwTmf>m&I16 z>z=sIj=Vnj$%J0%ltBbYMf(c zwdhp`A^7WAIr(ECK z{bM&CPk3hj^AuG0wi7~dRFt)JxDOi@Tk6;@f0+(8--(tL;`&kgyp*?akkO3jK=x$p z?wj{QFITW8d5F&vPJ>G7)7-JHQ)S{UX_^d8Cc6ZLQl9)Mk!wwl*tw8Pl>i<$YJ@)$ zYKi!)aFi?z@rgHXy8A=W6iv_Ujh?d=jnlUnFYW>$2OPervx&tut`f0IX^?NsPR$U> zXbPKu>J*F_bZwaNO}|jOeih7#XbeqS+rQyqli|{}M)Q1S!h3t`O8mF`^LVAFz02=D z?_bjoTx7KUf7DR_6C;r0D& zriEE>h_Or@U`CG^v1Cm0{}p1XIKUZQ{rF`1c>Ow6D124&^1&5ikyupc1Nt84 zr&qB;N-uWMTw&l(0`HD%Z1->2;FC4@La7L2u&q4`lg4$%KXw2+)OsgpyFsH9sybtO?^{bft8fUH#{M=jC(aQRw4k{V?^eB!U?2FFd7|z@Uoe{h&Sb8L&vJa3KOw!4V@(@?=Pj^jfLPB#{jF~E zJc2`NY<`}MW{SlM$Z^3zS^94#S3BOyp6S@!u=0W6)2*P`@k5K}7|NkZAGZqoO49A1 zaQqPRT=C032=>uB=hbp9CZGpk0QCOEMQm-`gCNNFwsSax-WPVYKNWPZOgP?a= z@Qh?CEd{RI7KNr3_LK0GXCI4`W3%hwra-IN$y3_0pu6WxK7-nPDO|sW9)ug1R>%m6 zPFTvBtz#RD)i|1*%20N^g%`k5I)oyg(p8+PXgCv#rmCP<|0}Opw;7(W?<}W%SmU^b7+MVrUPPr0y zleH#!&d4(TiuSg;Te-q=p_50AO*1rr*R{1Bl^#jgA&o!72+A>^moM4Tk{no=&q2bwnJ13anc9XZ2byV zLF%Bowu1Bv`CYnlG||i2u>b_Bfi+*6t!*V?J z9K_~?Un7`sa1+)z+!T=A2U_r^YzQp7iGC#)hp~X;x~gBScrC`K?~fD)Sh$mVJxUF( z$iL8fQQ@LPcw_#HG(w%&aI@CwQvp#?J%ku%>UL;Wr4ons#A~O}-3BShpVU{hDmj&o z4X_47vTW+Tl47bmEw5%ME%Gjd2DRq?)pqOr^Mg-qSTnN68>%im>U4x1UQ}F2kgjH0 zxFd42J2YvWLwt(>d3D(MC8AMrP}teo z%xB>jj2hV~2!qG)*ic)#MXsrHRvK_ZWekpf6(JJOy|);rhlyi$3G$aaBeigy{IBaG{&P*7AKg{$S|1R zDI~5%qkG)pzGRY`eSf|Su_36N!u<-P4BAhW*ChG?t?)UfMP@gwm>kmx5eY^R@Ss1h z38oGWRj-P)f7mAXMg0hmAAY5{86YlkfX@8;Zz1)@*rzF4)sD!oSsL=qQY8wv341%& zrs-9z`y4G$$t^=*DTI8U^fVrLo6D zy{isA&dS=N<9PU_AD4_g%;&dOOC*$5a$3x!;MMD^Sy?;uV?WuuUNoC!CK>jRny9v= z+6(14RA&F!6i8`X4(^NA{&q%7hG-c4@X!_sCzL1oQ5}0fv%6p14Kar3jVh)59hP5& zNwk)H7Bcwh577{o!+v}eQpR>YgbN*da|tN>4qWeH+U=X?^aPLIhm<>2`pX!1a%t=7 zw+yk+GbvCY2f}NcEu2xh+QOVi=f1MRWxvC5V#h>EVH{gw@yDjEXAVx9MvKn3wZ`Z) z_gnQ51EzBOLyQZ|njDmxZPOQiFJLUzzhY4w2-wo=ctorkr_>^r=!^R2OV*}bR+EVl zD=hJ2C{c@KQ)q&b>mzFYO)ud`)KKo!|Jr4TCh0?HrRG#^P&MvrE=7*Iwwp$v($TR> zQt^UjU+$q?JCB5zp286iRqEM1MCxdYdyce!bLPs=xvo4%0&1mJQkpi4p8iJ?7#&lg&*VWA7ay!613_VcFZO|C+nCty3&x9wh+d z1!uh2SkuXhP9f0U7dWnoiCw>Mgilyz!wRb_Mm{<9sep~@Qp+lzrQLVz)Ek5-UzUw5 zD4#)xF%CTsnR}cjiwYKRi1B@fFvRn3_wFyD_3fMVyutF+Fj;zPZcu_K&K`CvaXoq= z1lt;hH8LbqNbox?k&0=jn?Q=m3a42Rey(fvY|vi96~IkAW^#% zZN34!Fdpn~$+nsx#!T0~JhJ)7jYQhWpA>Abp~RL*(ENeG=Z);$o!YaN!8G<9lAF}n zdWXs6)_%7o{8}`2o!<24$5%4WU5i2;!{`-`je*$GR6d;?D_(!9#r!Ck9Fuy%U zpVI-Ad|w#gzvN{koL?>VOs}p7CY{c+wwoc~q{vA6~1VokHVLVCGp=LVZ;Its|xj^A3_Pf&+NbVk|_5!bnzj|4Ni@m`Ut4*%d zp#~cmXAhVvbZHAUSeGoprw!_k6_a0}*kvtoq%O5e`op7OU3e#90+!=Q@nb^{h9_w& zB!POWja1R6lTLQp6ugahFSGVizk*@}edqQZG7oyx{s}P}Io^JHPa;h82ZkpRNB`?+ z>&c6Qi^b2iwadID=TPV)xtCs6{mI+^g^yCm88!jc&=_7vfqIu|WTrjn3^=S zA$t9Q2@3;HD?2r7q#u}{pUBuiL@Nq<=K+m~!Uj%B&QG)gOe3H0dyvbS5VCB!^(MV{ z#I)d$jd!W^)+>}K=<=wbx565cv&8j|jMkw^VN1)r>8!4tywm7=MW8g_F3+1D6dO?~ z8X(18t}w0Itvjy0eU9oBx{O)=l|w=AbmL!E9Px4e%8)*F$WgMWpaupJNNUrPV z`Z7J8!Hl-8I7b`9U1i-;|F(f0WUp(oL{B@oiHkc+a>vChTzWdVn0A7|;0-zTSWS^n zbz|lvvP$M9huy7;WFjbe4(q{+C0X;g;`jv%^y=)7H+`U#iEUAPJz2 zbpE=bS(ND-%4jZ%L9d@*_|`6k)nsK<I=_We9PV(D9sJ{o*r;u-hKGLD z6z`5S^n-_SQnnH9bmXkB-h^ALTOb|ur-KCAeiD5nY%8q{@v!zYXW1*O6Xy8hddmBB2oK9 zE4Renkt_1R6H%c43*vO=T`qxt-WKqB#PFWK5o|_wnL`DFcoQ|s~o-W*!MM6 z)&>nGsyb4wg0j$`Jb$xiQhl#YDO(PI2|9>u)%DzQi&}C+fVAe4u6Xw}hP@aL;{VcP7ZjTxWP5%IkiQSlpNTc$ zk}*mWv-867mZgJ07zbJJHSfE#cGnNZg{uwG82{FP8ul#$FhM73c=*22ak`k#SQw7M zU2)qkKzG2?VGZ5};K-zl zse~n~lt4t2R)%ejN70Wn5h{iw-kEy&M6t#lB?racVoTBA)d&@@gTd19ziD`+5^Z1) z{MT6a8D>|2V3~Au{i@y6F>^A-bYUrkbR}xLWdO$jm?p2U*yEF40b!v03FRY@a|Fko zb4Xx6DDHX4o&rX!N=7KtK1)7*QwuSLnBRg-0U9w2TfiFFk{eGyd8+@KS2auQZ)K14LiUWk zMlvhf5e+mMDawh>S+CZ&dha5=WMpH%DyvdNn{q$@vq18Db`bEUC+9GL5DegBI8W|BiD!)e5thjK|6f=l zE7Si-Df_P<|9^xfGIKKjUzD<`*i8XAE8lE!|Pqa!T zqcSB==`v-BZ=a~6o-q230~nyEQpr+^2fi8J*R9pCs?*z%DD>Ig9uF_tm4oA{)m6LU z<;NidT1SUB_ZCgF%NCR{tpfbgk~+h@Yj(qyT-U6!8k9}%oPUjB=5>5D7xYuhvNTV- zH0V(cDlzSPwGTu|h7O8`p2;5$`sVSYl>VNEYdKlZ=DEFKE#K>o z;BQ_&DaK8W*6y!f%pO}7;m1CCZiH)H6>Q*rLCmIoe4Qli^rA;`TXA?K9!}-bUkYz? zc3lMoHP%Ld9nAQ$Jb>27@1|0Bu%))V6h#w1SX%Tt2(A#a>7^#c#6Tu72LPMkoTdKq zeoc|FtU~H+MIG4_tIGT~rLZ8le5$q~D*ac`X|1O6(b1t8>{Qq1w~0S1F}B1^!siqIc>;M#bkN-3dQ!WrDbpa z%O)&0V;PI9_2AOjA|;t^OcPnOmpS?#Kz0QYG$x9;P{fRdY7%2XCLi(CNF!{5V#ruq z6QXe(N@FC2Ax}aH!Cp-Guj$-AC2wPqD|!F3&slAWyp36|*=M2+z#{<~v+A(Px|5R# zwp2OpNe)nWUb$}+RZ`X@a6(k5jF}wUre1d5F1oSO&nMFi!al$?cCj4$*gT)F8e>1E z*R^wU^C}t%yQwE!Ed16!^g5LJ0H? zLkKgA%ZGkbD*uAZMSX&tz-E`K#L31DCOJUi3GHhnoC!oD>>a(PcvbO65t^cOOZx;c z#DO*G93th3Yy&9L9a-a`SdcRxzo$BltdmOoqM=zRn=hNyIs5R|`e#otXPsl<{ zeD1n$KFXQJe_#GB%|V56+(Jz?4m<0tEg2yOaC`;ct^i?e%lVTA``>^eOY19MnWuve z((;RDSw)3`Og=W9y;>jZ1=Rn=YEl4RE6c&D6@l>F{UuZH2dNSBV%jk_@H}-Iyd$AP zdN~M7n(YMm@j60_jyiVKHYvtF%aeOK?v0@FoSlHKF1jd!%Wk7(GsmfJR!U4*aFwJq zS7Pflo3s3DX^3~W?~_h4|KxGcnQlu_38}}K#vvvpv68A8<$7hkMQU~ZNO(0f7IYlf zS#1PTUk|XEkuDc84m?792w{CA?%kGiv7-%pmX1H*D=}vS=ZRdY>qiyHXmK7V5TZAs zZ@e>JsPxgA_3Vn!{C&S~Q3#2R%)OWd zyhJid39AC6jkgpmQ;1N^5{!0qaB)i6-4uF$Sn5u8_U#k# z{0qaOP>`tj=%k0_B>Rtq&JjR&hhQS->k8Lwt7>5-Onr67fm9e<19y(#_O_VXh_!{9 z{97Z)gOYl=!JL@}1~-GCgIRullWs3Qh%q5RX33Yxp)U>Pvr?yYU0qVXO`-N&sE`gw zqzLK_2Ji7@A7qrm&g>#fk*6q4+-fw=8lrbIW4v z>rK#0_n6!b3W4y%*xaqKRbwjwqAaH4vU*^7? zmG2qg%@Pj(^8Q7t4(xCz-!tqvsRkU6B+K#_iZ%lZzsm{?ZE)6K14%!H3k{PFcxy-6 zw8=%cIB9r|70TluzjIIlC#Tpl5z}ac?)R6l=q_6UoRjP2eGS#HvhoO7+sd!xa`^CS-t6*vre_q8>B-NMT`}5i7F`AA-cGUtSGUS)}01f+kZ6$|fQmwhR&Y`xLlmY04c|R76wpNh4-vLpqbO+*& z?5bzxELbO=gFCLlmvzfEF5RDl7aXcTRYt6#U=s?}oY7omye!?=?i$4P%!Q-jT=H1> z8GF|&f*q~UY~uO-${2ZwF_~N$wj@#-lCmXgDg4q(Co^$`qDq;P%huCk*g^zycM09m zag#jMRXK#kj=yaPiC-DP&e!Lto5jv9j*HkqGnesX>XZWb=>?5Y&T+OWwA@SV4bA8T zeae1$c|6ch_w})~QlLWMii^o5 zj^x0WjxEl@*`3XylhTvlv$TYz`SJx_>g}O^wSw+{CeYm+0A+PgFSnIY)wRnZCas%l zeq<%&zowzS;8paecTnVNi|zL?upy?)Ie6Jhlle%P!#_sfY=HA6{lL=C`wC#=fd~Th z7ogyPX^o_=Wl$nkif;jBrO_%~jt5pt|3F-8yCb9eoFu4IjGRs~Wj_>eG~(D= zqg)tdoO)I@?R_4Roj3IurHj{y-{SaPW;B$h8_`Imh!NO?ni(h9R6&QAZq3I2!!2R@ zU4202bV+*%VQX9-juFr?i==zgRe{f zownWhvasNaB09vslHyYMvSiO_(;Qs?{L!|h6`O}ljW|1<->HS9Y6EF${Stmn51I(| z>cnl+B<@|yJC(SgVLbk<4D?LF(7Vhb(9=w4Y#o3G!ix?dL zTP7C4G$)phW4bnVkssdMj-rKTF@l*O%5nm4@DSlJ>d;VX6&jb-l`HuA-t-p%;2(=l z8$5C%XCpeeYKwHXY(82U2{|Q(F58AtQb9l2iLKSPd5`;^!15Hdu4>6)2x62YmaH{; zOo;@HDB?sofcRSg$Jkn5enG%LJOHsm(_v_aS|Q2Fp)73N96`ZW9pM1yQP*oYss)1x z%s%Ek5$+ciIJyPX0R?n0dCNZuweOy2pJOTq74>sJjWPzlV9%uZUX0{j3Di-Dv3c52 zxL1t5o5L#Fu8gBD8AO?D7~j4QCt%|wS5C$h+|~~bBgJXif|(-;1z6v5@;l?fX`KT} z8A`6b6TrJPY5r5eG2U%XP>hvaAON_JT;`J2oXnt}=H+R5q1%+)A4Cpr;Ftp5&q4Qv z#|A_YjY} z6&H$0xh$xLkZ5mYuswYo`kZ^5@TG&z`huEM9|i3LUt!ueYjuB)Wls$5UGMoXUMHc3(Qi7UnOAIvB6%N#A1R6opYAwV2LLo?DP%Pt}ykT#0A`FDVKgMFEkP{7}eR zu2y*=zx%&aQZjy7*EQUnp9i(IGp%iIRk{I=b7OPcD7 zTRlM_cf0s-jc&X2u`c8uby_tOIp3(w;Hy2^JyC?$$YsOFYopYC`99CAQKkD$u-z%W z-_K>ce#Xda`r2F@ZMdAhIbVIbyLuS%!T1@Lx*~70zihEOq(uEtgx9;2a(?f=HrXxx z+jCXc+!wGrQE@)mR4OK;7Y|)e?o}TTI^B!s)02qWO+r85 zd}n`${QxG750BqReB1wYe}~8gfm2M9rvCxq9n1%WUl7+Xc1C=MXi79Ld`4!E+zGiA zYzxHhLE0C1PI-so3B?nF3B?36O-s-wFbgpIf1EskJb^HPu>M{^A7C%gC&iQeaX}3| z1-<|MWCRg`o4`flB>SNHq;OI=%5zcRB*Q_0AFrdDsePPX4K-2E)Ozbio|;S##0Sl< z?^!#uabV}b&WM@?HT~Z|yN7oi6%2h;rnU8DR1zCXAB?k0kRELDn&bXWlM?oz&+O9^ zzF3Ro)73Gaq4b^FxIDY`eXjOq=-sQjf4(q7QN-f^c*XvwFlkI2%*-tR+kImsU}a-u z{69%U-YJmEC}PO|Ri&P(Itl{914eG9=%&aqeOT~?p%^@OqTyIEZQ~^nk&$MG43MHD z#O?uYdm*ni6pV!mf`F*>Jf=E#x+8k`Z=?>8pX}q0ejdNfkGd)@E^2DC-gcE(2mqD? zGz1WE7pvXJR_Psav+C{9Ffou3xMe4I6GR%Nmt-#@khz$vhc12k! zKub=*bIlRaxp)exFB}N@3IGCeXhlOpgLoQE4}gQ@kKVmS@4-^+Z7*B913r24j1G&A zL{f4NzeEDmeP{OtgvpJkVEvM2H=kp{(orr>rCk8;J?`B+bR=Y3Rn|&$uVX+Qs3Wm? zD5nhOZ~)rZ8Xb7tj6AOE<*jDz_#?aI@Zl$hNa6XYY7sU4{;*Y7`kf$%fnBO7*{sqC zAUXY!10#S8HW0Il6TlzfuBq?huE|kqRA7eGWpM4g_zYF$F#Z`M)02z-4z%4-;P5kX zarJ=cGA@ae#)0yfkFR0$NXV?RnmVwjnJwDd+m>Cc_vKo%i&efsp)pTj5^R~>J}8f3 z`0Tb15{rJURyzlasWqBy_uthvT`zf`KJ)uhzp*)7ZjfgiHC}PKJ)Yn%kWfFBc6~p3 z@EC7@^9O`N;jsA(jUl3;V4>r}ad^ort(~Xa?;DWGWFxb9OfH(wnR~x&PhRhveBbWN zg4g+HGq~v;egZ?Hd?hryjn5m8Cn%{^YXe!WR%_&BHtQW0PiW7z+H7_Ox!taJn%s7O zfWhH$XE+>L9#@U}aA&z3kYscCl5(70v~6{N-l5T<_ZE(+)#^}n!?N0xr);bc8Pa~f zgnZu0xB}q4_cmYgnFRs3;Hk!jShC2ULG zoWeb#d$8wJ&7~WgnmVHCSfaqX#Ndq~D_UQhUK?B6<=9Hs*S6iVM3Tlzs+!nVUR~-Z z$-v6uV{~B;NgwP1wPUv{0*cIEQr<#=ACa;sexr~{S&7U;s+m?qO755hGO0)`y;6Rm z&X{C8ZcePzR<@;r|Lbe&=S2P}?o`e>$g{%JYvIj2>umIq{j`0Kc^-?qUpH6V;I-j% z?fU}v68l2;k`HAk)-j~;ELH+VfDtka0GQ3RSYXAax!C)5u-6By3CB zmh@doAu{2Rt(cgtDN~`#S|VV?e~2JUdCpt1k*(;HRFJtKuB47i`VO2NxT_?osF-qn zOL^=l$<9&oa!VPKRm4$}kez7ON$F$zvGdf3OUpr8zuItlZNo|G=Vj)#3e}OAc!)<& z9uk#0RqS@G%vh=j-F-ooc~^;FfLV%JiCKsVBCji-tA+$C-`H_P>3@yT|Bbr!Qt#3P zy2iE1wa&HiWuv#zTmQb!*VfY1((=Bsp?pG>t5bs9F70!r%{o)ReZV~xi5z7Hgd&0} zLqF3jvdgK^J^rFGzfx#y)#&mMB;oHOW#XJr<`U=v@~Wx+T~kxdms*<&5S3SwGqSoc zxiGk}X4uHm?5-~FQ<_@N_8j2Z=9rdQV_Gq`48zA&WUKmG4roc$n^9j0o#7s~?@-NtyHGQNKLWZ%7B$9! z>qh7MYb7FEa$D^xkaD9%8?}dze{FEBQmbc44dAT8%r&=M-FS0LA3NXh3TnB(nz= zfwM1Hk0QAbN)wEd9yNYDbXpJBIz;UbS!V!z72FgL+og{Z{0AvmkSfZxzzdI& z{mK}aJCvM}kae&p%O2)*DE~g~R)`lxL9{4~0bK5gQ+kv~dfe$fkmsY9kRY?}Fi>}J z+C7wRi1Zf(|LEu%$juONwjO!uATlYcW4zGx0MtZqiqfNm856G9u0!ap};k@YWmBukEXhH0JeCaqU(a|it7^C zH~Oh(+|}h8PyilI30cQ!msOqXOT}uhgKEv!Tn+@pHVy~iz`a(wEwAQCtxdB_JePem zGp)9j04)TZa*96mT`%@L?;HHrM+w=)*}w02NwzzgZYMnx4EWPxNfzEWemP=~7J#(H zBF*WkbBdaxQx>2##d&9D>k?p-Gfd*H2?LE)FbUhkwu{p&Y1~J$9a1-`UPrneayMyy zI3JS6Z_#7u&CDPu#3O(a#K!^JUj$-lhcm!9_ZiOx@qdh zs~)hrCTklmuh6=tZ6_}uLc1yLCN>}NJ;ZiWUXOe-NbtwQ9umB1^2W^``C@zM`4zk&ZGm^~!QO2OdZ3i^Y9LSRKJS)%De(YVK> zHVV3q19B3gABE1kTZ{vHcwp+HJqY?z0Du-Cc*BJhKzQ#jv2I5kQ0vB~h1Ge0zJc|I z6w1SV<#Tw0lUl1S&OWiz|D}G+jAy|ldPbD|LrDQ^l24Ny^dJvN^@p?^=7&n@od8Kx z2t{}ZBRoJI1Nu;(N7_GPTpvkVG}a%8luCHXJe~ns^NE4lbm%G_*vXJ?IwsEmZ#wFo zfgi0uP#uDQY)~EKH$?A1?TytpXxC7ICe+s%JnGO*9Z1TMk|xHao<=$VU!+?-=(xUH zoqELpw3=ci3f8b_EjXo~>B9)MLBo2WQXRI+2(~(6*NC<{#^nzDKI%>7OUoLyFJiZW zZe{3WO~4v?a|Esd8QYN9I$EZll5OZ@4M@w7+B(Ljp0;%ez&Z}Mp4hdJbp};%27N#l zlW+~TtLt9~=A}P(4cf~H|LT7MNkF#0i=o&L`{Mu{h=Xu2hKW65FAl+>I1Gp52pox{ zFdQQ=5=Uc{%V!p&aSW}cb+n!~&_>#XF&K+uaU71v2{;ia;bfeGKjKuJhSPBd&ZNz> zg?^!5Z4cYi_OiWgAKRDi(mlFQNjB8>v;FM=JJ1fYgKd}{Vu#unHr1xtm-dx?ZQs~* zjKf(t8|UC$oQLyq0WQQvxEPnPaUHJ54Y(0E;bxct zGa(LU!EBfVb73CLhXs@s7Q!M}3`<}sEQ95+0#@P{%0}5Khj~LgX&1lAZ}HpwAAX15 z)s=K*?XRoos=Au4u50L;`g>hV*Vc9P54x_dr|atmx}k2Q8|x-^m>o_J>0fq7^inaAddd1{`S=O)>tm=`7$9>HUH0#D67ww3(`Q$+@^$hNZ`>Wcypj#!58x%dg4gf{QXwtNM;l<+SX7-0SOwdi}iq-T-f)H^>|8g?U4~q24fWxHrNZ>5cNjy$CPT8|_7T z(cTy@#*6jFdgHwD-UM%=chK%R!|mY`5E&)bp6q%cV?(B`O~+|!M?lj zNz>c^-~adQb8}C3XSvq3ttiK4DXx=VtS5PG6DEf2-JDz8}I^pwm`9 zr?MlgEEm4>PJGckD?^scDKC+=XS02AJU6qf0ITcdw%ZBhvM-r8;DZ>jLaZKZ!*+;d zcE!=4rpm8|`ARY6n0$;SLNgb4PL_xHv&O6i3vw~7bFm&}*SVjn>$}aqWVKmaH*1uY0$3ZU`0rBF53h*uQxmnyuh81NEoFT(p)T7uEw~iDiyxh)SNg}^omYJ6M&KK`i zUW`>_by$7p%2<}*Y9m#V#1bwap!NCrn)>?s!hI`!2Yh$jo_@jnSTi?f5DRAiVZ7>tqPnj5 zIrrYTyLJvDqck*##BUHqmN~W>RA`srLC1Q`<~G zjJ1uQ(bl(s&VttQkItl{W16bdYMN>63}(`4NZSNWoCw?V-U5MiCewX8chA?|bKbe< zp8LBIdaGv%>F$Kxv|5Mgc^!U9)qfsh&;z}MqTh$V6Au535b0c8h;Ces-@z?}U(XRz z{UcsyEiA%*&8~5kH z{dj<|_#r~lT@=kFLcH(dhjiwDLYbj7(+QqV=W^cg8C%cV*)Hm+XV^J*k)C(hO?Hd@ zmEEOI@_^g9gPuIXH8p$*U%{W|TliMKji07`UgdX8#F;J%MUi+(91~{=XZ=$=kWvWK z9F%@4-IeZIfX>`U=`8D@ZXdJUwsPu{tF7CtFIab2&)dMJ+Ri{H?T#qD>6i~&K{t*Y zcnSW7$GL-@#s+qR?i^`63)b;p;Gd*g_#tyM9qZU+{wejN%`l0d!U4J)ohQt43ti#_ z9)XLrllHQ8Y>P<8C&Vc+h?@una@GgO*~f+-i$k0sZ=31P`dwT^R6E^?4l@T_Wk+ch zHc;0)Y)N7VXx(3d0#*a1xY$@5_Ak0c?FT#c!?m!l8=KM;5L zV!oR2)rJ4LJD#O8fm7{2&i?=_@JF=!uQ3-aW>3TG{CD^d=*H(oJMW+;L{?IEnh@IlTr+Rslr)tro?uC^V3(8C9 z&zn1EcFC;bBG=3rg^v{EPgnDt%CxE9n39{5os~Ixl4D|qT~1G%keZU5WV2c%T3m!8 zzZwWDdO=th1!_%AvB9em5=6!b!n#7Dz<3*737clhcuNmiuKtRpCt>LswM1EQgS)s$ z@vDk{&8I3cY;Ft^z0aqH6usZ1>r7e{n9KxXoKBjd__I2EijHB$uLm}FX#TK|{x6!6 z>{Y$1l8cKVnw&yp3Q>Bdx;~1Ti_j!kroS@Ez&3%R(sNXwU(Z&3MhH63_eWOh4UIv+ zFW2b|6&LB~ZBtuyP^Q>W@vc`BF*rP;?E^B*ZGPH(WsVmi$krhFm zM?!`VyNmq#^vvh_vc6>L&ojKiU1PPmT=QqGQ4Chob}9Oi#^6}3(-=b``VX4R@&jQl zK(6;1SS4q6oD%EdD!fO>hNv&2pw6$SckQ_~irCXhyIXRx5_#MdcD_T=f zb?Q~QYAE8H5_N#KbZb|(N68+qDK3i2_Cz+LY3aj6>V&bxs!^RundSynyL2?2Xhftg zrZUi#HiaSys`MfYjA7LR(ApM|8GS-Xv-Fj;3~TfxZ&;Hn4Y@I2m-1y*(e42)yW0QJ zcu8bfV#$~9fk7I@FLXwB^ePl+p}v#_DLJffMj+|XaM$-XPCq!xYQq zrj{yk#i+5t1XFd9PhX2!$tz=48pVuG%cVi0WGXWV)5;*sv@ge4?D(=Y3u#rkrj=_ zd-vq(fxRJmi4Lr!YGqIzRdIJ?)PuX1H3xfS0A+Vmu#+M4hO0x->7)zxC;%Q)$_%L? zG#JHTpcbjnJDJV2&+YL5Y&W&S6qtNl48fGyMq~(WF_w_Y2}cE{BM*U&wwOq0JR{bE zWVVECd&0VK*xE)K+0gU?wQ?|(iI34LyiLKe^_ z<((jj7|!bEkZd)Ga|qcsi)82-aP)R1J$Wh1CEs@sy6fcucio^Hs)&{!(lBSX)9$qA z(|{E5Lxo>{=#k(HP{d`!-COZ1mg~|D@;Q+J+#INaXFOSel~BUn(+Y2wPAlP%In921 z>a=8rF?Ogk8CVP}yAdnqaw0t001lC-%sp12xN;twpyVENC?ea_`kO2l#ZotTzrS9- zZ~WLZDoPRqR1LW0{=xndcL|Lonlsxa;XK6oi}<{`bRaT|npaTnm^^Q8Sy}1)0yWQK z`C8pnapC9}OX84U6YQwo_iE(S=AGKlt4gcd7y8O8TNkmuuPRo%O+}d{>A`2Bc*dJQ zXef9^+Zcyuf3mG95V=+7t!cUP@YWdlkGC!RX5=sRK9Up8LczOO23?jU*x+${;Hbpb zODG8xC>1h9pWqH5xP**G5NKuMRgMQ(AxJklFQhd)Z-s2jlP?)L>Z_CcpvvV2dC={W z`{aJ0j8vdKBeP;x+ANp!efjq;yD6YNVao=bSU%6nQKZg)yL1ij!i;fG0Jz-oVc#jI$g$hRdQgMjZEB z>iP%z<$*z{sxln4V20hntQMS|o~NOjjWVZRw7^^eXuGxwWh&Yij6 z_xt_6-`#X&9X^LUui{cX2MClKyMoKX*l}p0sLNpUS(t&Nlr%#jMFkrs^&K3d!epnmbrT})3(mh zt#NdR+IFfY*~9Q&$^KTtdnsf&A;Il^U{1q^Gy^Rc6Q47#VH;qVpu{V}53Fl@`@5q#BiAmPQBxb7H?FpDN>LvE zrVH2g){lI6``(>cZ_8p#U1*%J=%oh29C&L>>8w|yS0v1PK$tGWDphEcnDQ*C#bhRk z06z|o=cke9d4^Z1x)26qj6tIQCu%6(#W5-uQu92gQi0ZrJmN6sCQH3EOlEcpunk1! zE&xszq}c5)!tP&d{|)9T0HG%yOQFmT>GVVznWx=A2q^=wcDq5r_zE%r6CfUu8#`ln z(;6{5#+9)s)=mGi>X`!tM@G8}A45j7qsHrf(&Ue2b`c}?N|OCcC3 z7)3J#KJ##AF)1E1 z1#*QItO>3N1aSGEj7`fL&c0Et$xgKUJra6yLJsa6AHjK?Kw~~9tn7;IFeE0L+V4q zN%c8(pPHf7rE20~{cJt6LA_6SPk3LrC@3*eBDF$bd4?lOo>2)bQmX|u62iD&G*PsX zqG&?3(< z49~&A^Ksm$)f`#|Wek&99SIx=2ohBZ;07!jHDIXe)F6Z)%Ym}%0G_*nIC`D{l3Od^ ze+#$p*nsNxLM4hI0NE{+(AB7{{RqY+w-Ruc0EaBPD6qnAu={WxmB*%2lmV0ZlcMiB zsQevgd+a@vitD0RaaD-g_UOgm$C`|Tz0PE^8T3YjL2tHd zWH{cV)fs5T^;{6+)K+U$Z(A|R)y{FxS~%0DzrHilf1jyy)8N5-M# z5Tbq2h>XO-IJ2bYBefa;rYB#qP4U=E2 z6sH|ovaM=T%gDFBBA3#mf3F<1zPSC$j#zZ(x)0~zKj@vxF%8eGy1KM_$Ak$ga_3-d zb573HGw;N{+w;o#`Cu{7VaVKO;OkIe>~F=y5y_>=BuV0|MY=e%2DJ2R(WcgUwaL}G zVEUS@#w^CJ%pY2U7NVfG$=sCAnoS5Su9&IPc~NExa@nZ+=2FvVR-1vb+jzm;n(0@x znylF=e!=1nlZIo{2V9HnS>#>>bdC1ikH|T34|Jk9TXB5dvgqb}eX@jNM(ay?kvCHP!FGe&)X&d$8)k zSGPNFRla{jyQX5@gXqngcNYGwyrJzDw5UD(z4QjiiUknmMf*F`Y=EU?DGwS5a;4Oy zNPxFAsn*gnDVIXBv;PTR4M@Y6o%S{hx<>9CXV+GA8t&yv5ebh z6wLkvXR4Dp!`Rbd^@GhD7s~he0abY?ZGPTb@VF;M0X+93KLiG4%^fL}^lU}EJ-OXj zLWFNnz07g>%J&u+j6VvTlrFhv#q-rOb?UF`zC3evZQb*Z+}O<!CSOsaAPqS2%D`dRE|@YD;ux^Bc&eTrF5h!(`>5yK+eySvjAVTEm^>=ss4mk zWbrusChM@^fJzNE^T+to{v^QMfyWI2+M5C}=8R`j|G3jT41*wptZ7K|ySj?;Ja&7YpQJNc#k8{Xc1<{#S^JiDW!Bsi*Q)x2ChSyx>?Yr})FBWA7s@;}FR z$L`(#*Ui|S`ic+8-R1)?UtB!x_3>g&o0PBBa7m>d@{Z&wQH6@Jf+?nDb46x%D2kad z*%VTaSSeXI*&z+M6YyE`>2hDniq(PRqGon?KRP7)E)+)J((CE7u(Jt>JjEy|C8-1R z44&|~Vk?Cua|oL(MHik8Jz};fpbA`Jqlr~X7i08iG8aB&E~!THen;Xdq}N&&fg{PP zg+?0*$ksV`m?0l0Vw@PJE{_l9C0#mI2LsZR!gA{1En1c zRf-iMxA^_{E|B0j&P{gr_AWR3ec$i(%@@8Q&|py^6PPVEk8DRZp^#D1HZ_>!OH(!{-LOYNJU`!LFH+hiyHFn0>+2y0jg1So zH1Wu6k7B=L@{}@MbpN`pWm^jmC;#@D>!rt5bXqUK*vQTIpr+3tCrGeg>@w4`C=yYYC8ju>f+)M4PDzwKOwpWM zotVTR21O*NE=f+}6od#RkO>HuJOU+DbKU^sR%C;T8T^LnmLyn`D3YB&^E|UQm@L$; zqF_@>CubQ*3{tY+b3yp?c)4}?$r}1uU0hxrCoZhs0KOmtMAvOsr^ugQ`=#<%9 z#>KUO9~w)#3XX@4hXsEk97>cG_*GU~q52b{a5$2Syt>~=B+AQ?P#iLFM?xTxu#xZ~ zIZ!EQ$QIM(u0*BxmUfhWr&K5{&EQjJBn(*?DWQ-O4zE%?s2Wg-(iL_jPR|{Q!?U%& z+j)3p%N-F$yTb2h?WH7{MG#ExN~LlsvlbgQfe0B%k{~N^BPSpR zHEO`aIE0K=SaIHdGS%5TbKSGwe&V?c&s)F16{p^qu;_c%Z!Y24>+WiQeCpGOt@W(m z;eBv(Yfol;`Hrrhvpsai_t#EdP;q0kqP47^{%AL_z5nJ#_GjQiG3qILM$W|_<0Ikg2p z4~QrpLtf2aZ`263k;f#_Yiq3V?%+ae*J*YncY3KRsyLX3aOb{u$dT$BSE+Hei-?|Wdy zEAzVdzxj0M2J5|#cdVRM-#lSf+mjv5TdXYW4@CPezj(kpbLOc?V0YLTubSC;W7omA zq5+uJLa6=#RIj2Tb5fF2&j6eVA%2oX+}Bt!)x0W#rGjD(70 zX%LB6%#g3X&X}OkK|P!Kd_)#H5P z`SCmW?7QvR+oR_YXvxAG?do}rpU&s^oiQcmv0%GeUL-~p*p6%H(Rfx}L}`3D`y8*W zYESl2sOyi(*FzHv(i%g! zq=-gQI1!6R^WG4R_#1tj+_3~QNCIPVT$P)Kt3<_L=_3l!Ac9Ud10_Y3;~lu#fgN=e zTBK2GIO@1o+M1Y3Y6Ez7j__abcPH`fT$)1A3j~{v3>C8x|FG-MDI-^aByKRMD8yss zWnRr!$~`of=LH}K4`P1W94Bj^>al*i#TwYT?i2j*Uw(M)yWxT8v6uR+Pk;LUz*`?o zB~y22_s#0~^~)Gx86Wul(l@siZ2i%G>*cd&&aK81IWFcQB+51;J~U?viYzngPyy-! z6RgyBs|HziyrFR00=yn&f?X#Bacg0Zz5JmKy$A z9QPY^9xk+7jHs{f7e@7Qm4VM?-XoZ*tvC-F2KN{ zwmX#}$CBhoU3ZV?YYeAFEnW^KSSNUPfM5Iy>=O6D^A@0=n59o>c)Z8-%<*)1mU;HN zGA;?}SfwtvJEA&uRdwPHlp*WQLeWXYDzD;lDQomELLb`wce!P zt8df=eV#fl;ndWCI?j>qvQeJA1#+PF$}9N?ZXYwHOHIJ|UUv@V9N>AE^EZe#h`F@; zYboC-V4=AGi1x^WDGx`3h3_Bxu=<02NBZ$T*Mo_3?;42>wV4qp|SLy;xQTuuj! zOJ#x$=Y%XFnPqT;>2fU_rD{iU1LW`O_MD-81mcy-4F{!CfHNCxa&JqnSdKs$&MXf_ zNlwXtLpgOoB-0+4Z>nO@>8(>@PJ7q;gXsoU5`(@(ox%@r>#qmljB<->D{mTFHf`bj zUkV9duns3%IhZlna2#U_o;b9bhOnM}2!DRsYPH_^8sK>{8O-h*-cBw;P$=b?z7MiW z4Rnp619{*Rk+o4@5@qoB({Ye@IO!&?6! z{|0xu{;BOu3qXOc!*c~mi`mpygzIU8)S%RB%~G?H*6#7O(l*~W>9>R~xm)RScDWY& zy8MfadVFh&o~7&lLwD5%H*sCj_uguEwc6EcwX4;qB}nq zF>wnaxb0w^5(*evNLw&CsbNgoNjp=gX%mu`j48sd?2rVSFd=j%rTi&LnwoYTnr7l* z=s08`mfZVRvJL6Pvi3e{HM?)mz4zR6oQKty)hp_dKhWbJ@{=68r)>zV4JCcaPP_Dy z;fE<8D`G)hH{ihPGJ~)PlGus~>=ZIdlSiR8SvW9&9FPDx%$*rOi&%JDpnIc?1sIRx zfdeJzCDEZcowDZAb=B?hdi4(3DumPHkEU4F8BXI;V~q~xgRpE!)mK&`?A?qjJ`hrxS~ z0mBQmdj(w=yxwjWdYJN3Sw-B8dWjj0T3Lz9F|kMN6`5A?hvJaPh%tYipZG7@U=!`o z?cG9{J;IV^FuttMFN?Yt8r^#rJNqcXf<7~aO2zJf(xdX%tgnX8L_uR8p8|#`f|9Gw2CHTB=vV&vGUOjOv z!#oAk;GNHLW!DR1_cAB;pE%bxwhpRw6I81V)vDo*M$2|)2fIsVYUFkDX0}D%r?Atd zYH5>mhi!*=kQ}n}R)Cn79g1Ris+yu`ie1aModn!u<6Ur?D0X{@Cty$sq?%B<#WzTr zU1=btc1eQV+wEz5+we;;PTMggOrlp6BuSx5 z(|jJ>JDJZsBObgfWx0m!Q^GbW&QsQdh$a}%9CVOFnngOev6;S2xbpSS+wPk-H&Ax^ zjqJOB${zb>!cj2@l=uGFiA}#7IL~ajy_osh)!%nr8v6-gP!H4M8PoCj(JzhUOP1pr znW4?oc4~)Ii>&w^nj$NDKqF4S!;#O9Q;9%}BcIyaPGr>E&T{wn`l8HkGJpQkhB$<#Q<2+u&An-VT=gn+xbirKmI> zE|^_FVg;89t`;x_Y0{ahxd5q9J_9Nr&5TxnIcaJe8J)By&YGAqtPE37^G<{|Aq1_O zce$xxtBOybMqeP;5{XI^WuA{upGBfYJk@j_^F^_@M2m`#oF%JH?>RXzXYSA|bsIPA zx&E`%%~t%H=vv#|_}setlS|`o{;GEM!$-%_3%9c8@%w7!Lr<^##l}T7$>!yy_dffr zw*Kaw7a9fKu^>8sZRL{c#>7Kq!G{-@R{gyB`|oUhkD@;gb^cqZa~|~=i2%W26y_6P z;uyh-Ifj%{zt|kUV$Wx~2$@RD+Yn_^;TJEsR>8jAo!bJ&z9rMKYDPu@Br+LZe0Y?2wKO`VG%Is zr+@US<%p$byGbEZ@teF?)(#gww>CLO$zb1DJz4TBVGx9L|gmE2E>s zX7kl$rYwgBh9inAc{|>ZyMrHOPk$K9w(`q6Z~eIw?lj(!Z6(i}J6LZ7q1}KTK#VgM zz#sY|f>qWM;dq7X1vkj1EVvhBH`~wfi!5jWoYGJqv(oyX!%)jNhetsA&`tdR9&i)% zJ(O2<1begFf*;})e-GmBY-=Z1)d_RDVf1 zSAA>~=N*3EyYpS{>^q9pmbxbR3)M6+S01Df}|ws7-buD=E^yTH6O zI1)JTCL;^~orLueWJll`F^AajNOGt{O8YO;gG)x+2){CR0ag)W*+8D|4W(0prMg=L z@>p&H@d|zBXfO#ipxIcKlPK^Du#_pZy!y=gU-T~7zjh|BnP-1G_I&eE|M{u^9JstK z;hOGtoHx(ZmN%T-JF9W+Pu^bBzGVIf9V=d5W;IEkd6QznqWYwK^4-;Qw$^MN{m+Zl zMXO8jU9-$fk=11j*44d-0OLx)crMB8D1aWt8?t@S26M@Q@mGg-*biDxTLvs_z9kxp zg{the_69rK;>R?oVV({CNh|FR(yZ4;Q2~q;5NZk%H68SNSU9l+-t)D;)X=tgB@&T*D;lE_m75wuL`v{0*Z z8s!)G=jGS346Nc%^7+{~K_#+Sb5L4l#KA%cudfjQWvpH!=khW}l{87H?bK)U$F|B5?}0*{)vt+u#|z_`^%xruycCqxbe6IItfW^)p!Ipx!CG z=-mP2fz$_!vyxTT0k3$Pl^BnUZZ!3aA4{A=Qat%wz+NRSmsmx`QS28A?6pFJV3>xB zgce7F`(>X&^JxP( zlu^K89fYBgA+q`z@Cyuxg0%0}_dbbJWcNcE1jsDvbxMzPWJ&=HiK6A#Pahxbez5CG z{jT28&)*p>EZ8*f=NtC7Z>ZSZIQPWaJ74@BSM*$@rhh*NU)a)G)B4``FCL!O`6ZdK zO@K!Q?79o(p-%^pA8_CS5HD#R4uVR8pu&dpI-Q*^#_6ic2C40HU3SqLU0~dq-I2{8 zaxcosMzj@M%pMe!@fwIPSjLOt34@n0IoSo4SFAmddaaDlYvNR31_a<&<2i~iOAB~> z=D6xBL1x*!)qDq#Di3PqX?jG`{7A#2lLJIr9!aK#^gslYG8iFLX-<(?2V8;hsy!i# z!ui=WQ?Ne`7E3SwNE>}{;knBjPhoWIcYl{2eapPOKG{1Oq<)MKY~FqmH(J~7H{IHI z23K|8zrJXx*LCcT7Tn@C9XQ$pQ<6l8o(-MBfv&_i1vnhW`NlHtj_rMMXkO7R+P%UA}$76*mplyH%L$eN0BinX`-Y!Eqvu?NB zd50r`cxF4K+$bq#{gl$H@}G5q+KlU9L*p{+5X?<6oMn8CR}QM!5LK?L`a4|(N7(Y7mHD^!a=-d!(LHf zy&kjE$-7($9_|CQcy*78y=qi#Rd1?Hor)27YCjd~6`OC5v6EG66 zP!d*UK@~~_tqx#?1{;AA`)M+T?}B%JEssQ6zD*`m&DaG3o{{le`bmczF1ez}Noc8K zP8ykRw1%+)(ILry%t}kRKE)ALWg)+k!7VKvH_@fVv_z$8Yg1Im|5RO~rk$tqLX#G~ zH8&cz9_l{z)%*8%|2Y+W`^!M{XZu;<6$znui)JzF%XL0cR)iUQS96 z1w5KjGBwU|IXYm=$Op^O#AtWapIO!Zs;{lD!!x&X-P!tybzrYI*41=2PyN-%A*!t_ zSTbwlxvQg7fxI(eNP>VfjW`^Q3-8cZ=zH{cG{ckDx*$5Wq?&K#Z}GI3kMiC8hx|qU zG0!3c!(bYqgjgM>I4;0og6rd8KBmQ(czH;Fb#A_vzA9Dt;i?jbgEf$T%Tt&> zyQAr|nz@x%$gQ3U`m3`pe=IWovEm1Nlo2X&9L|IvGBliFoH|8PxU`tVwqhDT6X}hN zR^INr%?#hT@zBO-5C2LyJO?=ZEMRNI8wQZ@_?vjXQ7-Wr;)a#XCZ?15HFLti@eDT8 z0s55iweX!_Xyn`J4wWTP{m%OxyD@JhN8$>SpswrmGGj#@iI}>@K8D82wy5>xdb6g zk(DetEQu~j5*1kz!2qllxLfRO1zuDOWeF}%5+{vl7T;VVV4=Ipyfd7YeVz_DZaQ*9 z5*GM?iSBfp1hWKZXuz`u&6friu;^b{r5uKPIATsPo8)k%G$$h&v{I7cB;>dpU&th^ z9W=~Lq0ka>n3K2~TzdH$p^s9NvE!33{y0w5zOppl2WiT?+Ip_uuo8#6D$$*XDmWyEY-Mt(twt7$ z*$1Cvr7>K;>(#%W~Gd&$W`z@wsc7d;<2m?hHC<(r4%aHT=>4;)SnPf*H$dpQ^V0*t; zwnxvWebrmA;#5QP4)?rE%{z8@_x2uePL0ny-w=MY_b{CjoAvY6p%y-Jp*_*EWO?(J zju+Yoe@Lz+3S#kPr+zj#NIt98W5%)zKTTz2e6$kI(u*D$bMvJ#iG)eMTuy4_1X*BN zNjAxy+Ap;0V4rv7TbhmYctIRE;`N$mWzfnt^Q7qVxjCXSm}VF9R|};&Da=^ zR>e^c9mqEQF@rdB$TZ?i8(1}Ev_>O{KZi9q=J2FgMbG+bJB|RHi%gtDp+NBg$(zr&AmasYgeCbi1{8-`bZt zmQ}m;{cGlTx0m6AxZ=+F$9Jxzes_NL$NLW-FKO(W-n@9vf&4vtkZR#)!2UE8 zL{E)SwVvRY*cZ85?ZQj$GQFCgWv_J$1^fhi)Lp^H?E+1Li_L@0k6{Qb%w2XXGYRgNfFVU;pRIL!%lzP=nr@7QGBh zfFx$_g&NxcwlPE%B0}~Z%VnbOP||hd(sO#l!MdY2*PK3+xZcuvQOoIg?Zl1kjnx}h zOii^2zdqFT+Mn*8O+7k0`{TjuT|GQ48SQ3OIxOpl=Md--5ex z_V{+@aeh`r07@q-A{tD5p2?`vHU}+6tC1LD5RjJ^lqYNVk+)k;{@x zY<7E?T3zs(t1FVN&?>rgqS8XU&1O^V_Ij$cS>d_@n3U2gI)^T$aEQ3spo$g{A~aZN zrPND*L8I}V4ZW6ijA2~A>mv_GqUvymW3|G(fKdo?QMiT$BVED+Wdet>YotR+ zq9l@UkN^14o#X%5)^zHHaVJuDds9c>ZK^xhy0dBN^oFv+&V66s`ve=O-&*sVr_;FU zCy(sLbnCl^UYUDjeWoXHivd|XdSY}b+)m}7ykFr(tH*j){*?ba|CAFWq>!J4%gGG9 z3Gcy@%}zL#0B)IbP%n#WhM4xWy#sE@u+bP&n8C9%n+Pd^b-hN^21frF^eU}f97<5r z?Qi$tI2ty56E$#Fu>3xR;0#^CjEUR4;L}!5+Puem&9TRy@$H3~dJz5IMlb^O5Pv}) zhD6RQF>&KS+)j_LJ6TsgXJ*Nyr8g@V@sTgPHjX_X`Xco(m0)uG!GQ*tc02^5 zXiv+gqq1ax4i0Eu$cUAYB0)yePE|K|JUiKb6?CAV+Kt?KMGHH}kBii)~& z#;u*P<#OK!FA8RAqRx>$cJ_tMKkRy?Hld8>_=_K zoadBZj=3@BZ%#04%%L1Ra;U|c1#%Ck+8=A+usw9WqaUY`ljL4<)hm`H$?dVOSARuv zfvmYm0g%-EVjwG3_9~o`BzrIAPP&vG1!$sA2A%*O>^Z>ji4VrB0GCR7i?OFbGWS^) zt8j)ZN}Uy4sTAe_20#cu@K1U9O=F^O``*0075C=#_%C*O3yR_g4{2qE)!{9qr5g*I zQ(L+Rd)qvL5bSRo@M!8*=0v<$r8f3vg7`89wLS_qm(hd$XI}y$hIxND>k% zNCKPK6m}X`MAg54zcY=Wenv(w+V8`S zJ9MfjI?oN`zOO9!q=+#ip$p8XgkL1C6UZkPJm_G6d~WRh2$G zg!E8^^nl@3C0?PWNdi$ep6{Zl3)5WAo*kVneica0sk2YLI=TJGOWF6|x8UVR^MjLC zANliJA6(qlSp5cDn_Tg==~dMaJhLpimHq|=BqgsyyKMxgoct&@Kf6fE^W4j0p2eQ; zYFmtU&rj%HevFzbO17X}#489&H=|5f0=lliH=UJH5`cI!bX`a^j-suW=$6jFMh;|K zZ62LLKc`YN-A)-znZ2}zZ6I#ktV>=`3<;;J1OX!L=wm`_tZHaUAhjLVd3LCrmafQ` z%KXr^QBiy?-v4f$FIc{W)}KoLST0N+Tm8qDSJ<ZZ1RpSqVLE{>~=J!q%X>wA2xoBh6rd4j?V6(G4rs>TIhC+d` z6N!XGk*ab9B`gl_2=V$ufo$70%}_n(!gIg3J`jkg^%27Ty{v%**xF-}iJ?#=yVmZd z$BD@rxHJG<5q!PNJt{h7VH2nXv79BJB*c)Qq%zVkJisqs~Y;=`4(| zo%cz&#v1tyTn&M$p)_MdE^Rcs(ykQYVtF_9_4T0{zkcB&iiFZc3rPqb1(70LTtfXg zE~UaERio6~ynlwD$#<08mHb74&Stg@97+EBy<(Y7tr#7Y3r7n^hwrFse0(h{Ne*rN z_2$p$Uv7NFn(z7PV^1eLkoQwb#8M5o_fc;wkZsv{HY@VQ?8SDYZ=-g_R&7^eeCf;O zsu46mnu>J9R81qYf||rIbj~FNlgI1znIbmuHzPih2lK za|V!Uy5 zlTfFlOXN-9G(dL79?A>OFk_xr@I|f|9y2Rwgm{Trk)`Uok>&Mjgys-G)g_;0m1*99 zrg^ixT(hJs9TCmBq3T@9^9#l1rTBVztwDR)Dv2Uv7^j_vuycHnpS3K*&E)cZn9Yj2oSL4@(@A z)lMz0bjq+}S%h^;aoR~7PyaQscZSmi-S}l}X{}_HShf6UnKlkuSlU00UMcM_#pSo9 z{q6^~3b`mocIi$EM17>wOx zj4n~PAmGMn+xBUlwr$(CZR2g9w(aiIwr$(CZ5z{f?vKfr+{sL(lB(3tUCGW~d+oIz z7~u)#v>xC;kV7fz-I6(ZEA7fup@u&=A-Xa3=pP=n)NVjjqtDrEB&pjY!PdM1?btb< z-R?5jDZrxDapm#cy}~@4b1=NDoMwN@ zm8r)EcXZ^)0$EOSIfKl{-@iuf(TsruSfmgts+|o_v6hGGCMGC`u2TvxSZoM4*zWkn z5V5Ca?K;hsak~dV^xQQ8kd1_p;-M4CwKf+*{_EyFb3_V+3uBDvaEaL&j2`dU?Ug6_ z4Df5=hXOBM{q+>zFYXb}xl$=B+HN)}!;Wa<1k}q($c=&kb-Q`J8HL}NkOM6-2LW`o zKERa{g{DTPueiEy7s(<*?xa72NP2c|2AXXZQvSCY4?P5N=XBl`CpR+8R_T-~mM#_4 z(kOeqy9-;GQfbKLnJJbb`GEaW5HS|*vD%@f|BuxGcpTj+2FE_ zUr?RVlVal5fb~+9uCnvCe3V-cqs?i#u%|wykf+U-MDJ9+C0jo%(B}wpAe*TZLB+{- zTkW^$zz@bzjQouc_o?!$s1?;DtcE%Si|7qWRp1!Qgb^$gtW_bs0>*RV>zb+sgaU~J zB@cp^>fdhpc4%v?s%dLs?|R8vr_K#Hem}h}Z;)?TZ|HVd^r^1&=(5p_jAtZGcv6_D z#uW+n091)g1sElPpDwRP@$ys*F-*p3?y6+Q_;2U*OM#Xc8ew1HAHE=fMsvBnXUmoC zVJFI!?jW8roBUr!IRT$+57Pte8a+M}UJ=gN&rLD{cdo0&Aj_QhL4=N=A5kC(AcploBw^noFt8vM7d%hf*#fQ z+_iK7oj)^p@V83hBhNs=1r{gWIEdR4%ANmyggjux zvo+craP53{8}jYEM)ZJr2A=`--e0u!(Br@Ay2+mFLja3}} z-riq5ftNAo2IfJQ5dI@Xbnau7XRJ#C--jH+;wLmP1sRKn6b&*Y1T6vylZ4HXZ!wXS zfosV%^hW|y6iAM5*@=`VMCz^iqhEt+pnL50w)O6$8pa<9l*tz9g@dBon-H1Nh z#>X?y89uylj3%Q$>{ryN`-!_J1#LnNKB)sX-wW%&D!?*&;GeAFTe9z_dmQD3d16{K z_QY%|y7!pQGM4ym;2wQ>sLtzmvB9+n>fOi==f4eyG=5nI6r21}2e*7N>)yh6)M#YF z*8)fZ$V|_-jSfkNPV>%{bH?hnc;dL~-4M6KHLkPXy6TjEZzgVnoaXVCf1%f3MKtET zm$(s+>s2o5>oJWtGV1FPSgge_5=7A5Ik5#8Spqg$`&9La{7-O6@7xqgRLDl%F&GBWN0RJ zsbGT<4}*5Xh$x<5NT|g$S1kvz6FQ<@HovtW*ggZF?&8Jk6_$;FHI|Z{k{$T{bqt$2 zTo~tCzWh?cAZt`G#8K>3X7k}2-+h+z zXD6Gw$-zAWHtOohn;s$Yz7o#Wr>8TktTwWB3og8nTb-`CJw-x;KJgWPoGuW=VyKO8 z^k@O;$Uaf7I?So`3S}E%*kj@Pw+Cx>Cs85mRtFKDHU1#$WKM5_B7yer(~@hX&X6Z~ zS$+fu_$>;JlSvi`_2K+0sSCDC-O`DMZDG$gu}SpmiHqgTlc{=!l0Gf{r#7!!o=dL2 z$mi|2kU)IJI6S#;|3;Zh1l&u-Y3QACd_$%8%87+Y(0lp)Hmz)n2DHY zOJdP@s$0N?l%90P)FaUGHquw+s`b4K+G}N?a!byh)_w(D^sQOy!z28>!`{VhdrlT>aR zL(#xjechl}j?lFN?uugCkoC5x1I&(LN<@6ptM|ln_WIi`Sc|Kq)bAFxeT=BldpjwK zvmn%VzF3UT$$>K!M}o)2t-p%eD$qow#hhqZ`xR*SQC%3_&7onG?n z{IfVJj%yN_0D|{|^jWEDVi!08rmg&CnD;H>pDy~O-*CYQ^Gkt_Vlz>Wplf8kbbZHx z3Jv!$ujDp>PScGfdRdu58`y2N*)FUt@lMbVfrEwNoe#vv*Bd>4(o~o?P^i~~_kTP` zrtX|Jk#3g20N!FBxu;4^_g@B(?@`eJi;kyV!)uM_WkQ)a?&n*+i# zxzk+p(F^x<@8||v&UY)jSRfhuMul)pW~I9usv` z2r?G68c3IB#JF||?iS2kU{euYeGT`7m&X& zza@Pdq>4%K4}o`PrX?3W3%ra_eAVy+ReG9*u7sy8F5@7Ho-63}lL+Ljb_E0@N0u>RO%7I1F}D zH~VkN0X!p_GpD_$>K6V>>C)ZKvm#PT4~BJw-S^jfV`h6RtjxiP{kP;+zEz7A0i!5e z>rAT{G}>KZscdC};0(yej7Jb|7M)g>%)zHdhtZZ4i-6s+zqniRQh?dYv`+3)7n~4x z{?589J!%7}T8$peN-@%n#M7Sa!zbYxISF@CplA>9Vu#H60Sl!gdj4TfNE!s7fgb9M z2F8H3CxahP)6)P15T9Fp7n6{y^IG;h?@8+CrPU3&;h8rO&+O-TnrmidrwnpK^DF)Z z`+7@dd~W9=+X@>Y)Eb001lQD0oqR%W=Of#SgA#JXc49+d3lGPF5!R%aIol~1oqtA8 z+2M9xBs|Ju>gz7w6W>D~Gx%pu_i1(8z1@zGeWGuXzZy_FRlepe&hTW zaxZUBX4>>mkCxb3yRyqGARB&>AgR8u$A@WH2=gv!xJMCsPF5xK$>L8pKfyC|=~s@! zTYHkT2@@Zo*ADr2Q`x==g>Rt4z<)GvJffn*rhrG9Qa!k}KrJAlRMeFLH$Z!?hK!Rv z(c|VnIB>1W?w+WHZRq^~jvgMGCu~OuF$uZvYscS!F6BS#E#(YuMXTuv<*aM!En>m# z{v114TNXUCbH}65*GR9_>UK}yQXUbB5th#wJ5O7rrumj&pUt|a?>S6c)gD^# z@gQa?5Az%ymPdl!=39%e8yem@q){v(tIf7AWEGa|!Cl|6aRR(+1tAYIZYjJS5^ryT zlL-U6YV-aNPvnw0JJoX=Ie!3mRYe_}XE`___AmYyOfT2 ze8G1kN2awRk^Zd(yveMz$=i+Er95A^Cnxh4a3pWxDuHn)vSQmv>#92JsOL&cvhu7o z$8R6QOUmX~rls&<MT$q&*F13lsTiU#aE-XmFvuU`8cdwV@ytk%D8_kT$%#Z&<=R9!LfO`fR3o23fNXwkMi zdB{xU*RlUSEW^6OxrQixWUBub_ldHbh!eb~;JyHP`nSQYCdx`WWi$zX-mR7B`}@y9 zat$`eqC~JwsS5#z#F9=%30p`%n+)L2d#_gVO`}UR3jQfn0zdwoqZ@iEtV?PHr>_$| z#*MDfDR`FQO(NgT1nutkwcMX)*<i#>T-2!`^pRbD6(w zV}`$XJ=i!ilyZi>S&wF0<6DIq#3tgh<`@eZv`ZW^shB$6VCzb^7@ejKJ)pZ;bB;!M z8ME zWeJys(AE?2F3{Fj>zLePrhb;bUCRDZ8g)~7%$o!U#1;CR&`X_>kF@<;nirLaT!-IL zKm;fFY-C#NJgnw4)~G0lJ|c`UE_W}cl;_lqjxoefUKhhFbhlrOti$JGp5Mz(4^ktq zQMsi~ufCV<4D0p4bggO}62DLF4)&F7RJ#qHVLc$Ep<_s5`ZY%6CUkKA?MgeK9#%45 z+x~nvyqbc9(~Af!p74n{>E03nJLe_9H@3L~-bO3jb>_?RMXnI~kdf35QP#_%3M(Pc z81|q_NiFB#9Rn=0jVCCCam@7}&4OzPZhrE=D}S@JlJ9wm0A(B4>hoPD(Y>amN=~{7 zQ0#9A&hv`Lqco**^wLu*>Fc#az9M-BpdECht^kkSj$&J0IZY*tb)ItbLC_|3dpQ|P%m~2uIt>RFZ@P^d;26hoiBy?( zti9V}+w#_?(&cx^GNN#94`vOv#FcL{8nX@Y#d3@s_gFrcWbRKSn9Z^*mlHkf5TR`F z)J=K`4|(wvW_U@vdeGFEv{653rhbPqyl1YOqTOrJU$a&hYxHO4cur1;O;}83&h3D` zIO>(c$|@c|i-S~k{dp;dg?~dje>JV{7Q8z2_Ju*GVBe+-izB)6$^`pKC#<1JG-DHH z88qQT)sjwCd-QsJf6@T0V z*cz-;-XAQD2a`?WC~(;CqN79M0`1X30%!N)KquiN1b1ygm{Gcgh2CUTlD2;Ar4tG* zP3d8DOVAd{WJc8b#5%v!5s9WqP?Q(k*tnpL*P@B`$8P*D3mLvEUeZ`Ao-y*uuL&6Db&aqOEX&y#Kfz~Y_qwX;q(|5X>_3_2*xB9Pa;0ysb zdxZrt?dT4g+f-+=W#$-1J@SX=z9Ko|?#CH-(xs}goBLF|VQ={ZpKe*`jI6-=B~Z_wKJ*!DKwr>XAS`Rk_Q^O4bXZfK zDX2G>)0N$4#twI?VttQ_0@TXx^TruWI6iFacbk8qn`7qjw8z}>-1d>IeNg~(ej%Mp z8=Ky@Bd3)w+iAyCaox{!$er!o4+KqsS#QHLhJ#->gcP81FG|J<+d@yb9W!((Vu8&i zy)?!$_JTee6@I*TK^0HhQ?Ht>Bxe{y4pZ-)D319V0m77 zSPiut4K7E5*W${#aN67&$<28Fz7gY`VSLYPYfVu72|Sm3RAXIOg5~8~v_0>~JR8?; zC;%_QeSPPd z;H%h#@Q}lO(J4r1jB*LcSg<>?@McKkz^m|C#2QTals#rJbt$(wJ5H+GSgT39*PpJn zTg=%tJJNso3=Uk>JCCZ@AV<`@A)(1CyInuWdoapkTJyYW;*XaLSUQj*o7BUJ*{uB zk_m+z*-Zsks9NSTY zRJ^<4cy2EBo!e~V-n$V*`zr7HqaTcTTACq7MwQryUyqD@<6Gl!)kC|C7Ls-cP-_j6 zsjiE8bqT*&D|deDG4je;5wP468m)yq+;)+<)T7D|EIerV)8+NI z)qerpH)x$MC4GlsoF^i{?0}zLRhLxu3VwZM%a$th=5@!^gS#c>`+1zY8Wa(#e4c~40 z6R#7&=nZ~vbb9wNxKf^DJ7C{GmBXEeqxd=@@x$4rnP)Eau-Q^8ho{00ggQ zh2tE*J1+h=f!#}u&c6`i@e((&9FBjqN z@*BkBTYI(o>?7M@2uNZ}CD2#_&Z3`69g_mrXTG5z&+?-Y4#H*_oZ zS5^2or$XQ=zn-A=<#21w`Ux4%;YapMk*>gg6dyZ8?D7NNR8F1rn(b6Cn*sFS#$iee z)H&HqO5IPFLE#KNq3U6G=#7lb<44`&c&k5^3%bMv-d|hl5@qZ;HDqT$i;S;S>?A&= zEDz5cT?lXGs`pH{nq!_SIwc@$MEz-wHknm!(O%8z8JYBdm(EpK!A>&oSRzqbsDqof zMJ?-tx8Hp&16j8+p2EH}rwiMTt|#P~CU4^(RqiBZ-QM{GbQ_Vu5XKbmhV}!o@K=N*j=W0+a!tF!S{k$dzR%EUo3epb7?O7)eo}L-O-17F) zgq4O-k`j@Uc*T{`N&n;sD$hzOdk{@N*a$N{A*$rtk_|D#Ja4XE?=Uqdo@`YLJ8hGe z_2ODe^=yZovF^15UV=%C4x8*=AebreDtwyPM3_6Y3KPeP|3(h`e?Oooh5O~^P1-{G zjAJD|n4?q?OFJz|PTfOo^UY!{{T3X!(b^(FMktBpB%|9n@~xO9*Ry9`PUK9TQQn>z z+amrnD4Ca@*skDK>r9_Oqh%N|wMjOoxnSuCz1Brm32i6N%A9OZp3vT<6HmtiR6XkeL$;t1)j=e8lNvBn(#j(6ck zv06Rsd5Xb?JU*?Iw8Qz|65Y|blTA%0Fu*9U0HzYe@Q^wY;cD10GOSuw{sAVUF^lAF zJ@2nf*3GCIC!r!0Q(kXVGDS>&P_>@3IfUI*;4=A7dA8?JEp%g^iKl2_{Y^N-EgK;r z_Z@><=xQS%v)L?1MMGD?rm*r4Ug$M@tb8Qgixc z3!au8#8^dUrsq0FJ)63W0@p_0JF|N`i4GJMss_q~)|Yq#*U-EAhPOu&OIXAia``Gw zc$3!SRt?|YHUDY6xYtVAHS|Dhaq^S?2K1(7F%5G45g6cK?lw*xBmOKINUgwR;rE5Ur^Tx$r}%9+gj`ZA1>VHV|9o1rVH5|JjfMbszlmG5Z4U?7}3{Xe`EZz zZoq|Z>y8R#D#tNoE2F?V|IH0T(XFvHeZ2oA9)>t+L}sw-xq2AltPo#^pu75hsm`H^ z_5J=%>Gox!8T@LPbJP@9vg3f2WJnI0Y55e5jJSTrj^z4%bffV0d91bNY5u7eP5njb z_GO69nQ-dxhS9yYyO2lrnx9!LXn02Ss1XD$4RGzDHa;9)_z^9{2t}n<(1nEWY9&mpq;bG1-Ay~%)G|J zR7t%$>dJCE$H8`SN=<7iC7h6w5Mp#Qx!Tq{J7o{%yqP~BvHg@NZ;yS%-BP5 zY+lTkJM%s!#Azf;(K3Dzu41Wjq9~u!&5dmZ?7`R}@)NO>CXTdj0aU`Zlew@$yv~X` zsqpvewz{MWH_2-I1@$`>*HBd*=|%A%#EO%7Bh{!Pbz%Nu!XV|NA9;$6*(BzMMpN8h z^%Z25f5ec}^haXFOM9xW-AQ}8SM@tYS*S}c9rGNIg!cTRyYi( z!-ZVSiXS8{+WVOdQyjQD#OqLhS!rAWqk}0TLO$&MI_X3W&LgTdN+u?@8_-?J8|kn;G%+*bd#cG|PTF?n ztx?$~n^7#v6ZVYBC6oiqz#1%QAUWZsh$vRjt64;ch^5kT;pq~?OhcLUqkDJ>iA=TM zb!`mEb1J-9cI+tFIYTxMud3tYlsAgTE8quLz@O3tUg_iC->4*xk zkR9<=RoED>2ETTxM9BGNgG=vRJ+z8;9>x}kM-ciG9TapX5pGpdCH*^oIZZ6C+U5ij z_48Os=ct+=8(5RjE~RU)Kn&}~AgWnsv3k$2UNyLHT*lau8G;R@qq+c~WgGwgMGRVe zX;tg{fXLUO(!X9BTDp3a-0x@tHv53c16-m9e2M4!{c2-;Zz@dIEUst z{*H@-EoEpGa?~r;IRXj%T)M}j4J>MAe~~lkP`@JjdGl@2=vYN?&ozxCItqtOMJ3i- z-agvEe{xis$5!PI9Txn&s^*omSxbB^&} z;I;j>)ji02(`+s>8+NK|9+T5eM5U0~vLxGL0XpjyV;VZ{G4Sgupv9`-($<6q4UI`t|mRGNo51a#5 zZtl5e#F6Yr301unr1P6wOP@RbKiOw$e!xKAHxUy5<2bYYe~mLe6C>;Y!3NnG8UDk! z%uM!BMm0n3DR1kx^E^rGz2zTZca|I9@h1#$$VcW^$X7shL9qk&-*p8S5mu&GxP_FO z=;}yHIku&DNNcw2Sh9-JVA%s0$nPVeIS>l6675~~Jotc~99{CgZ~5GpS(cq;eCd9- zm0JP<_W)7(g|tX0K?IW~if$Xn5v2b9Z9={VT1?vp?1u!zOP+A&czD=9UkTKO>xXIB zSZo@T;mCv5gFE)ITB;#cu|~cu2oxX*6l7&V88#Y2?}fzw!tL5gWI;VMx&DBEKb}eu zo1B$Fa2)$J^wAHbRAjaqkNi*D;upo$(8ua(*y|JiCtNdd)%vQBhmWDFr2D{2)WkMW zu7*uB&4dbhzoB0{Z*~VjAe`skfR5&V`xjwvPeR~^L2hng&aAyFhFyc!7o&PBt>)Ni z1Fiu zV??L=R1$u463x)|8?YZ^GW>c{?f~OnpZ^CWN75krjqyVLhb#ifji-#^4{Ro?nd5a-LHSp)s>{iu2SXowCw)XTjCLi5?OUjn8-V1S) z@B-q4majABJF0d&9m*C)0%Z(`Cu}w&+!p=i?;}`lo&e7LC75ZitW~vH-T9L|E_=2_ zuQcSzw^>|dT2lpd_Kukkd#Jg@N6il1v975MsfxB2h0Io$ErX+^GRjEFB#|}qy;R@O zJ=-OFir4+Dg3fdC=qh8Mq{s`c=4?teJjZm)`CF@T$qtv zWwBIwRE~H*A+r@;JMMJTUt1}A|MK$j1J8)rXxG7(p_VeOqbBBN(S}){(_}20cCMIN zTLqQJFwYznd0(=`&TFTCHm#rB*cwHTUZybWNI@`xLGlK<9;$>#30 zOkVI^x|<`W$OSAn?=KWr6XWXEJ%2G_yQ*%>aviIXuFjHyr};dy@0^e8%cCkHn3F#y z&Zb6X+kE|22d6}){!ZZ*Z(2A_xtVe?WnoP@o0ZLo_HR$ohW0)MXKhMNt5+sn!XeUh zF{V#wQF|s$gv!7)idrhcqpGVI;cQd~`94N&ZaN)vo&Aj2Z0nL{biNopPiCN8sGI?m ztXH?MWG`Cz)Xz_TWLI+oO2i%vzDLjB-B$Pk+sn0n@a4|xzSGxVUZ-Z~&-9ztq0G|y zG6qFNX{WE%b-|3+ir1b%*LvL9&()U-F_#bVfLG+Eo;%Q_wBW`zj00+{TfU3<921LO#?rUalfgX`^~ zruxBJAQ5_?w*}C&gR^3xWp2b;pcn1I=5mp~z|ILl=ZH}1RxeT!4)p_ZYx+UdAtMMe z?p7jy4)sy^k=CFl_cO9XX8ePMUfuWt@(IYqnzw%hm1hT_PE`F zm+dLw`+rLhp*9%)@iZcr?ssN3G`k4U*~MQlWP9j^ofx<}iRfQto)~&H7veh7M|cR- zsloBu!)ftbbf;tf$0wN@5wSzsvct=+AjAnAtXY0zhdATSsH%mHmx#5IBE;M$mORqQDN^nmacf42F-Xe!?6fV;Iv#EE1?#4$`cZv22tQKl-k`~dqkTbrD1M8@_v zMqqg@=JJlFcF4H}P~!~$TF6u3r@9LGEHHCwaE%B4n5i@-TyfxOhBM?R9v}j~u>ZvV z%7!+6ee^O9>A?nDBHz3LQ9^7cjyX6wFaH$t3SUiX`=8M%`x`Bu9QlkoXPj)FgJ2>e zP2`L<#uZd!fKmy{*i0Nqx!?5| zqGZkHZOO7k%;q_qY26esDF@8&m?KzTE8fw~lP!}ilC7XwMAChkvIzhjl*353G2_kct?wp(|IEtO)dM$y>O}ux7|e z8&Wfnopp8Zy#ti&|NO^KpXz^A^>;zQP#0-I#Mm{|4#?U6Z%@s~|9^XQRSn^l8NgIq zjnI``EzsS)i!I>Gdz{)aIQAsAeRd8^w!M`ta7qsC)?`K|PFUpoCNQgtP4Sf`IIF5n zFwE=%uCZZ^63iG5Q)04q#WC~Cr^gR&;Gw2d{ARICD_DE5F2NlASx8gjW{FH|So@JK zLmc~AP*cNG$aizR58Mba!g685gu( zBiU23M-Z}JQE>sHAt+zraumz0ZxG+jTMe{2wn|}At9VA*sm6dr#{{lgj0JU_&%Z$zcqWz z=pF@j@ZsHGnL*Mc0ZQ@^bwm(nf;=OC=k39#`Z(ATFm{Nw1IF_hwEfHF39$L`nS-qC z@of2dQTd5b1!|G%QaX?VF1JG zQ1nG%7X_gOR0t6o2l0W>wY=yOs;3Cgye@bVek4S5&b1SL#5{9C>~L5IOwvCN!nh)W z=)(gJ4uYA&QKU7$--L@s1o@Kt^qpsOLkeqQlLsC55=YQEh}AOD&FFuP8-c;1nGJF{ z=xX=SSA_0j`p2n5<<~H(La|>Est%gFh@0rMR8+y2lX!z!>C067Wl+aC*Vm~Cd8`Fy z9T0s%XC3m@NBJQCg4rG_dV&AK*&cizF!{+#4I|WG4H-H`_PbmA)6}9h4YA&(c}LsS z;^`f7cMUDSf*%`sN%z2~hDxMH;?<%Q>6`t`Dz!MS!}u!+FfFkWEh{TS3;3qa`j97Lxi!nwAq)b4bhQ-S={cvHb`jhn=2YqxS{{t=c(X?m`{6>HehDcb3q5vxmH zFO_ZsV>jYJ;0){sz_cB$Y+-5MZQ6)N0Vs5hb^Ylo>oSLCyyZ@vQOo*GNo+W$93UAV z^PwCbFiI+fpH#%CoIIugnN$poDruk`*GJihaczZX?-Wn>m$(#JM8Tv?P=zwROu?m0 zfTa|DP~N6Y$fXp2u^47Luy0P^DTHFdEc4HTxt}f0bQU*V>Su?aCRgOYVAb}9%&y$(A5!z*V?)?hG0j4j zq6ODwZdRgbyE)tCKm3N2r&%A#;vd(~@D$Nx28mOYoFYM1fi>&Lfb|caF&WFpNtBx` z^$R~C+bn8Fm3uxV0?6^r#5|zzK;y0(c?$CUm-C8o#?V>Nv=HH`MBph>eF~=qOTA(m zqUnezWxAvt|EB1RT_R)-``(Hgb*S&US~FbO3Y&81h}(DA3KHUosdiu=y(3Bfv{T|=r0&DtS(#xcy zPM3pjfa+T1MzE8SG#NU&Zh>Gq|oB{6H0I+ zqz(jQfJ7ZkdegeOer5FB_`dpi3H-$G70a`NZ-~$svf6)%^d#<;$g_rT6w^4ox_=2p zw$j2mhp7%dKEN9Hrzrx@uvnZao6=@1wXP@=s+JG_C)rrqbG*80pr%nC!YpR(_D*-Q{2eDBU!Ul>5tZ7iFUcNJ(tVEn$;yr zRDc#g$+@4)%vkW@k`LA9n8I*{g=#X3me}c7TX0_hjKh-joGn_`vN(C#>n08$od7MQu^NKE&j79WD6&s~e%l5T@u4T-PQkSY;3%ZSR zq$Tiw6i7=CzU%dj6%_DR-&fksRFt~ZFfaxRYgrV2E@6?TA_aa#tOURGUztmO6lvcB!F+R3LXpyq+q}g* z*1X0%$GqE52T$-(!n8IWIr?jQ-%>L}mgu2h6}>RJyG53@!qjMJ6?8C2Nrq|aw5p*= zhDmk88fD59NqZ=@s@{K=!lnmu266_E_h1xAm&#Luh%yZWS14Eoz_gV*^l7M#1OEki zkM<>DlB$Lo_3PtADBDnL$`N}QqmPo;j}9Bdr%6GNa5t1UT4s4_bmr-*oG*eurhDqx zDBG3DoXME>3rqJ+QD?7e1b9kyR&FU=8zQ>)R;|Fb=Ys{-LOcxvV}^q|Ai@vP$*8LkvN6`_ETG*=nHd_Gn;-4KV%t9eza*h~xfMz>NA4VI9o--5;|(^#HlN z#`&w5$s_UVb#LN;iJ>~wgt zK|}Az$rETG>b}>nc72GCdEe&mY#`E}2$lN#ideMT*NW7n8nB8)8eK%Z(oOGS948Msp&oHfb%0PDEcKDx%N+1x944*LBnbMSP2ZAWbK zyj9S9@DAu7ZM(uK3;2C6BAa=^2ajiDb(jl$-mE?@3 zM`6_+HFWQ|3cNHs{bHy&m@-fI!q}EwoojbTx-i8Kh-l1*^5(*u{FWTP$zqPX&TIT2 ztlSSd0qaW9J$OG^|IqTx$T=u}vCvpoGIsf9nJiKoftwpBfA!E9FCMkb4jfbufT=;n zFvOzmbJUKMvZqwlC#CH_YzfFd{LVXmQTubldA8SB)<-wrT82FC8HpH3==B_eC7N`pi@uWB27LIo( z8MMVxtEOCekJImnw`v{V%Y5r=L-X#0WoU6H3!dTtc*QY*JR^pWpjJfBYvU}{JULH3AWzCC0=eH zPIr4VgnOJ-6uyw{z6tU%mmPP(q>-r`1dHLME=M}&>g-&vz;n(Md4zQXtOaoZ<;TZP zZ1(|yQo3UX1SN@yXpa9h@XV)bYj^H2Eve*Dhjdp$%tsC|hB29zz zn=P9e@c+K~5Dt2`jhm^R4%^EJ@!np*_|bmz3pxecp`(u9i||SZL&fHrhx1Lyw~be& z!?xD^oJk+<{WsA2enS*#$MGt$00!&P?Ql`}>$n?%v%jhix+ha^Z zNYf9+fRq-jHxfZs8tg__NvSR?3stuQm!o@EOJ>3qxpj)wt9mIs!vrYGG;(e-`2_)i zrQ3OsK%sIcG1kNmOCvKD7^wL>47|XkWmr{BCJ0qf*uH4s6ic+Z*xK}HJYa(?hLlSe zl1YVfCi942s{(T_|>K*%D8Smj5<3Mvt+#~9kctVn;Bm80n^x;))@)Y4P+}Hg!h)VHD!1k_MJzG;)(FAi`Q-ani zNhXBl%P_En>WjA;Fvg*u-n(ed&$TZHSE>`7_z5(;9D{eWXy7t;HpjD>dQajrSrx($ z6djEZ)i>7ht_7|p>sOqp!Q$Q4O(m?O-0a>E4x%$lHLj))x+B%Bei&Y~E;m!N?U*#3 z>wYe7Q*KsN^p2+Gp?0*Iz)KyYOhvxaXo4E>Vx5eF9t33Z^d*IT{TK;IQZ#>Y83JS# zQsN=mMC@m=&16-&Y~wJ??6c-K@Em&?6A0WhdV~3l=nNq!CpWIjFT}q74U7cEEWgc-AjIIV;Ie3M^^`RxUlEYXKp*`R-g=1>`&Si^?@kaU zm{|UlD9N3bW-lp$c0rfUqTflugS;!yWnPUJI4YjS35nyPJ1-Vbhv%u{6G5o3hzR0h z2cJa63fxlo%%OPy65^gr-^lNlkI@Cap+IP)5K)-Tjlm^Jw~ojQ72WJru2;@7EF%>l zWz#HcsDq@^1>O8uqPf&bQ--NFt5%py!+S-{332fn4#y1X5sfjgdy?)Ub3LfQdw;HU9ece$=uHEDvzu#k>$#{m|t3v>&6TIx`A3< zC`W~zF}XV}7zedIr*oNJU7wRkPIC|(X%Lq&y>_GP2zF9w5N&YY*d(UsWvvQ~o2^`r|eI-&rMJCJYO*KGL~3(Y>1ta--lldJI_jH=T= z5wY~M32Fc67c*@Xi>L&0TK^FKK35DE4~w<_RVQ$XX`A`4qK(H_Mbun+Io;X6i;p=X zjyd}^pE zKVt||oxwviN;^FtTydN8Ej4~d(`bhQ12}pe(ys6|$#N$k%`Fo$`c%$-LD&cAiUFtt z)Dz14!RlNbX?L1R22$@>B{|YcCM-7Y$&3*~%#Und#XZl+MHW<3!%K~?+Q5WrgqFzI zGt2{gb|j#$u0Oy6B@b)JRB#r|j<^k|`asY|CK9FfPaF!}tQ&rpSZ8xXh=-{HV6y>( zo;z^6(6pr9UP#_mADT$Chb6UdR)8I0*vhJAg;0@6s+kh1+Y86LDET_wGY!jF2seDx ziaH_GL}N^#zG9k#QYrE?pie#aJs@CAfiXaE6w-U5-=pP!aduWQbudx8E>NH?R@~Xe z9g4fVyK8ZGDQw)G;_mM5?(VJ|-?%$$IN#Mt{^Y+nImuki#mt&yUCd-n-u1kfy&rvE zwn(H7bZBFN)jO-2gd@sj(EUC(eJDSCAshV<)`yEoUIaPX00l)CaH!Ag( znA?;#>d1^?dzH1&6F!NN7D|+JG^fy-j~xkLkJk(IF+zpzMeTw{FSrbZNCoeg@x|TI zB(Zbj@EMKkh3xG2A#iiAN2$3T@amNNTW& zv6S5Kf(hN=RY!JzLP(Gv{C%zJQ=9+LB?CKG<$+y30zjb~od}OO+4#ESkG^kUv2aCI z-#>abg%b0V&fymM&BbvDgQv}L?}Z_$vx)|?EIa17zF$5fnZhwg3^D{fPTxQ{zC@uu zPwRs(XFZ>-*CQN_{Z;+*SyYeF2XGB-Ju`Z^gNx`r&+5B&wEJ(n&kw+FI4!8$7FA`Ta|LFIK3uP7}v!NA4%{;5(XxbX|ho zU=Ysz`Qbz`O3Jj$j4ro|Mr**6l%6-tKkkY=;0dZ zVg4|ZAh-k1lnR@98)V?+THZrkRuh8Ty7&gy8Eo)=K#U=(z98YgVcP(tc<(p<)=$#w zq%ZXTxMp|c&53>(v~>Jo$;(1?BFaM*V1}-1>0Jn^d5cmG9euJlgAcIodgBmZZFTGE z9NTwbPB>5TIq;>x8h~-@x27M){yj=F^we)bXPFceE-uim?UbX;XU*tF1IB?tH9E`1 zl?@$PLtn8UtIJ(R&pPPa?g>OSBJSP+ah9%N(yYv=fXHTFTvJ^oXg_FG?O`cVbr&w6 zCJ-V&o_PK;Edg$Wl5%O;pP5rqWk0=`(b! zJl5a#``M|c(ZLBF{8!iWg{9dKw)7R9#T|QK-#NWomI3Kv@X`Ds&lu$ zbdUh2hyIxZ z`9)Y!CMFuWjdE=L3T%4J1X?6-@rOZEt&Qqt#$x!Jm#Ir9vW+Xti!(f1=PL zkd5QG4VR>8_Epb7oKa1z=!CjeY6VpV3%`+x<8YdA+18o*PE%D0Rhs_%Qxx4_r7|=U zFYq%`dVJ(@2W{*`kgxzim%yhjcb{(OX}u@>%jnCNtv@X2(xaz5j0I>~%0a#?3ldyr zQ-x{z_GZjZw*#^Y(mzs+%+%F~Yb8k+EQdv%hwrg`6HkuX5fxvs+hP%tYKd{%57~}z`h8!sqyRf$xlCHE~{>QVu`b2W#c#ek0ZKcIR)l<6ORAczK z6bGfT20lOY#D6LVT{unsV`waSyTSDi>+`l{Vmeu!?rh7RRfF)__o<5Pllo$)-=hNL zJAqo4RuDz33%RL&iCp;@&+^Vd(;f5$+M8dQ^0!dAA9uYxfn44Oe50HGd=Y?Z-M)B0 zZ|k_6y5ib@tf=t*$Zx?TeeU!VKo+4;l=EHUIWFZCrp}L`nap6_;uT3~G+M84Rbu;D zw4z-7-}PfbYT24Chu_C?|4>hKMhR{3MaAFAkn@`2H+(9REYy#`d;-?zE*70A4c+m> zT%aO0aim~;{c=p7agO!AeSg(*wnwGz@UwO8@+FSA6`bI+I@PmHsU|bxpHeS-+J4b> ztxxdj#E(kxH;n5xvIPzroMO29qZrt~IT#da-Yw<~LVNVaQx-gl`8DQoGJS_5cn%ga zs1;nG#1cy+l+#}~1^MYyuq@l^h3PbMyr)TS!_9IrpKb_h7JQ??-mLlxg{qsh*b9=W zMF*&NW8^;$yt~5T_Pg#HZ5O{V^uNVY_dq>nc&qb!>>!+Lus^_<8qWp#$<_3Cv+v~e z+L>-(ZX&>LEWvvsdptO3N4%fIv7e@tDKi$~-N2;(Nxg>mV28wfT~J6ml1#6p&t-b` zNjEz$#-ILi0&dNqg>K)mMm$fTsosOwtEAr$n5K)3POz`%fr-U=s8$HXgUyh5gkswyo* zTR{#f!TRPL=0EL zEizrPO7Tx;Ll=G=6cd!XEYGQ$v(1VomE!KD|KW3*`uY^oooGkLzBvkO4d|v7$gB8O z@DX*UIlx}~S;>^41k^={s39IP^u~SBY^iMf<*b*_-b&HNK$rcq5uUC5^ef$79Ktfs zy+s3IbrpZ;8g>N^MzGHd~XQKt9%g<`4AW3}PMv|4jH=#3>QS z=EXYtRafC_}wQJkxoTkO&}L>L8M|pFTrA#izd) znLp%t8M3X1%DYC)09wHV-ch)v?+=v^E%>Q6C_Qn zHpGAOamL>Z$qsDIQC`Uf6lJL|dLyZY+eKjUg%O|X)QBKDW<3;L+V($inczToD*9CA z6cH@l@mLi3BfWnNJ0AT^JA5el z0?q^<0S^z2)3CN}A7Kx6(oV(37v82Cbron&2^Rm#{bf{tH5a5D_FZjY40&=0kf!*= z6yv}(8fkLdlEretZJJF9n_0)4Zru1-3`~k`8N=aewLWp}1+mF{vCmWY-NQZ#MJu?8 z@7{SztFtXjeSf!WLUD{zdZV=LO8@{R++gC0N$v0y<>B(G=m;IpB7mHXkP z;{@`ZvCWh~w)#Zo$(&sK(1DWg#~VYc)%3zw+j60e7}8M8|DHsD8Kfqba?ER2#m)N( zX~PutEjM*`_ndWp#p4sXf=+q(J3fOR6ZtbKwGXQ$ zwp)xjzl1&#@f^W8Iy?r~^YPI6s?y^?`9gOsa#wW4xav5XF(kWZTF!#_EA4|XTbIk{ z(3khQmc>RthKVw<&+0zNszexdkdg22a27>Tqw63mkF$~pxQJb$5g56V-Lvv4LH%Nx zuwS;s&~f^>jKC|_Q_nwYrzmlN4ZH3_tS=#j%zVanO634ss*N z!ZG@+*WZI=gPc`%`t;*TCi3n0u8$>dYV`XyAn%B&CNQ~?d2PV?vd$v8#jj(!puZHv^EYe>02O^mK%)w6wMm)CiFB*McWIG;j}xuanP&XJLpf4mAIr{P9Z@76eb2$XHBKNDhw5Xv%l3NHNZJh9 zYq4CFsgsdjg3#5)(T!fY++gz;V@IUAR*I|E`W=Pj_u(Xp9_V(P&-2y|$HskV0rVxU zf#x-zo~A4GgSvt7ecvixr;qN2yXUVSZ56lm`ub4Z{?3B%4p5w*UwuGd+jsB84&9UA z(T=~S`yGv}+d+y0Ay+$eERqlX>JmJ)TSkmFohvz8!<-&C;1Rf09~=ush*XvP;2q2C zr0XDC$V@!e`j^ZBQ+PA6`fVx{7$nV{AA_Y&L8o89ys&RPDH+D6c!9#|90ofXgf2Fm+hh<9OG^v%C^3f@3Z236f%+?Ca8UjpBP0M zSDI+Lbl{O&J_@)wg2}*llZKPmPpPbL)9UmVaojW*Y!y3x4UclmVIL{WQV&pnqHYz% zBI*R4I?i@rV~p99=&jFBm~4dEJ-;C+XPpKO%$ROblJOWJcrSKdXX+ASADwKqY2T3C zB{*erf}^bZ85cYAy1ErpoYYpl=^N%5aZZc29j=Yd+isFaG$wk%4k82Uc;W;yC)x4p@Lr zBnL8I>SO4gry-pwZ|P(o&+SgmCSS)@`9AK8d)X+c9-2$Ra&cO7ol{wIB?xgPzD0d+ z)U6&BQ5S;Df33bwtbp>W>C-Z2=jt-+X#kx&gAu!f7!?|PvW7}NsghQA`41V0!Ow}E zUU)Iw+Zzn~58HiAB>>3l6jTeQ9*R`fXENPWV>a)|%PGCW#OeArp7XGt$%UF+SF&44 z>cC>@670kmV+hi@hoW@+g>rm(aLuyA5oT1)KjqnD@8Ktk%L7Emw&~77<(YJv-+*W2 zi=NP@=ByUCAK^2o0QCZi@D(atUxd1SCY2Ir0=*v^`-cJ=-oy8UZD5rm&`fK9rEc!WYuaG+54J&DJ6bLpB!2%F~->Y{Gh z_f`7M6(FWwJN*iy8+eD~NfM^crHSN$;n60+{!eIlXY6;bZeD~orS!QxJi?>9VM8cfFK$`zSP94hC+}S^@H-6w8ad}rrxJcVNWBHgcZWZ>)G(^2ZK%C7;{;0=tJIr1G zG#rX;`%T#bs< zPLy%~dfig@P?W(W4n9wQ>mTD$t&)k&nXZ5PvUoP6S6SaSf*S??gYO6+JAZWkj?Hms zAJu~*a(yjSkF(f?L??3pp2J1ijyt?0q9*gvJzbQ^0E(|?acd#s3Bfo6=_7VFd(T3Q zVV|q}Po&8*lax;yp>3}UkCyC*5MPSK8pTt1vqjLKHp!p37$wVi)XC<8d^jeet4A%i zLSLPY38Dw29Jlsczak|mrtxM@51AUT)9D^VlLqa{{<($VguV{QB z_#Bx;0}l%Sm7QasCCCF+S{U#UG3?okX3pcD3+rR1%;=ivzz=K2+>uVs;~eZ2k@J~b zEr$<|@d^m};BnT0;celRdBINT7hfHMy`i5If<EIM1W$tH+nZI0G3|8v{LsbW)9KYh>Y10>?LCendRxclwkImr&n zOV#6)#7UU^X0GL>EB(eDl@U8QHT4zs&V5~zAb0ZUKB|8!Vv`~IpvuN6ddgspDwOuq zkz>rpJ!A3_+$YDXP>^x>bG!r(Cx?tfp`>OGv6Xxfod)>{RSTI>O|?KLc!PQZz2mt$ zWMNvk`WINBcXj$_>~AxeH;no0fzPeVwg?tpdP^{p(GdP%rT$^eV9Ivxg-va#1CcO) z5Z`MdS)IJyT-|jzclTLl%gYtkhf0|t!;)J1=Mh)>XL;PgPj^H&D#Lei=S_c=)&oKC z(;&H?eW4yL4t6w`)HLEq>(j(Ho*4dz6ICYNKh*6rV5BdH`X8Qc6hm9DkR!PoG-O8@ zH`?Hd>G;X8ksWW}A#gPXhe;t@Q}lb?)VgcslzkxcGM|n9{f|Sd43UOT{L7)YKt(|K zFhtqwB&oOLI*;Y3XHu)wV`bd&8n3GbszJjUou7xfsn_LiD3tg0e%Cbde>&jwl^cl6 zW=k4Kq03QT-GV{3E6R=|7v>!eKWbP&q95S(tUrIdW;kV;46=%5UAdjEymf~dc(j~W zZYn{>b%c?3@K;4HvE)>W|upqDm3m|zFR+EH~3#dUa1~*FeL-6 zg^(Qcq({I5v?;V(j?8-C=lz3aguats%`T}4I|e%fJGR&QtDoKO$-wq6ICmXhgP#iS zqt%g6<{qg}ofvfA>$n4)rRDvaHV^gw7|`XBHl7v6?+elvUK+mPOjO$wW2J)4i8=wEVOK%(|y5}sC2_)0w$+Rty=5qcE zY~lHC31uqZ&#JR#>n3sSMpa18kiciwlHbeHu@!tva3}5=BfHllbxHW#4nyhq*PcgK zzu`551i7ef33mzhk%-DYHNz=hb=ua8r6u zy?~qCzFm}XpShE%**`Wsm2$&_5k535pEQ8$Y$jQ!m^}suk~N|4XAU(UPZi)^ydl9E|M6wgRaw@px3EyosWUAY6a>mX*!)DE0mb?H1g~>G zD~w}o+8c+(c;y;I3fs=;`-V>gS~fJshuk@Pz5+N=U*fqt!xW+)Z~X{ig)5 z?TfjR9@Mjm`;{G<>d(^AfnW0h7y$tfLKUdSrbepLbE1O5rHVr|SR$%|2>E`&&!sMC zhExR?C~l&G1u;W)G4vN0b&BPqztw56i1B9gkYki#n?Y?r4mtr;#S)&oskWI0aQDm{ zo2}GAo}q>mtF-j(V`t%uYJHDcAM~RV{DC=M3f5)Pe1FN05G6N#;mVs+JE{QCDPe!Q z3z?pbcZXqD6y?_5YE}>X%UPa#{5Db{K<-~m41dgBY;WwGR{FM%52>*aO}5QT!h2zB z&0+{Zik@HUg2}otnXPi~{bjMGwd3fi7TM=ZWIRjB;XHC1udhI{djl>e;}Y9}mpZiZ zwn3b?LZT6=bL{tv&Ld_-wXx40!KgD#s0c{pd-fK8;3hu=1KhyHQ=`fts!_Qw&~kur#*6(7(g)Sf|)md>DTF@BwJ z;}OUcCUN69Wp;vQv&ceX-uuMNY)ZBXWiQsB*(0S}cth~f^F;F5B}lSYL$n&F0>I1R z`*xOBSg*r$ZSIp{wWZ^9gFkCqIL55ZMc_58N1T;xF&~1?7EQ zex>4}Tzvxh4Eg7UUFyVb7c>#it_@Id@N92={cpPN3(}o0Ip#N%b-OselkLt~#`3hA z#G^*SCeaWHRuw0@kx9Cb8s}2cJ0NprG&ibH4FYU5b6ueOQ1OL(+vvQqI;5;RRqXR= z(jr*sT#crooQU|^Vt1w=`}fURZU)m*zXjE6Qy*4t;o8Of_u(s}+7w)plqvGae)o3& zBO=@Fe@k;ZhD|8Z-cZD#o1QrLsF~pt>h8{X0Ti50)(Bywh;OR;=CtX^k+A&XOZh3D zPnj<2$#Gbd;Oh@*TsQ=X&wvZfHGx)3>@1nQ_N5>|n|urk`)%>1Fhla)Kf-)?$*YK( zC_Gc6-)SB9_Qw_`H7JEX2oKT9n9b-0e{}a{HE<<*oak5hzmjubBCB7CKkjl{+MnSc zl+0<)^UQw20&7|A!qp4hSxue8@gF7Cu8Cd&agMtil|!_(=pF78P3#c(1A=8g7tVpD zEqa6i4svXyT(3aHCGPDKpJIv=>}*EtkS)uNEH9aN>O_^J{+GS2;k+Rz@9L9jBU77PC0j&WXZ^!YE?SvMs9GTR8=IwzgWpnAY zeSF;)vu7^nyY$IN{XbLdaR6z)i$=O-LP%BTx6U>V{dffCNMHr-MgD zj@uk;qGfi=V9wrc&h2(B_5lBC52oJck`Gx5wrzYn-NlE@#t<_?HCVp~(<59!t@szV zkluAbX0X@KVR)5V@46_z-F0MsE8CV-97fv~&FYE9j&I)S-JM9@1I!n!5d2nHEJ1@& zE^oHq${RQGy5Ogzv{CNX6#zL%V%p!D8W7#7y3n`(OvqMGhVyG6ic;ns{O9`%)~#v% zU`N(_url6eq}RWeTYfDgJHKx{DUI7lQ zKI4H-`PA_&HU;h7hb#Ck2Oq6(TUCig| zD)=r9w6IQe3y(87*Vfi*3EhkqNU~_R3v}JO>os*6OfHJNBeEvEQa9*Aqh|8%vWH?i z7W`c;g1Khd>a2Gk{RA>Td+5ly?QD%VUr$>rZ4)##T0VRtqiUPayr{Acp{=n$nPSJ< z+8_TgrdfM7e9qNyZ~3H~k5pWgF0d`KKDayfJT$Z4n{VMZd}y4x^567uifTv&XvOv0rC-LM_@gO_&9>F^i=F9gB7qv?CMMMV zL;h^rk;b)Q0GCnWnh?kE-pU*;T@^!f;yrAo9(=JdMa7+RkK2uK$cGm~#deUS>aw z9+iF4Pst%xZnB{nGo)jIM?3(I&rnid+ZeNG7orUko@Ech5VC%pi{!c<>Q?TU&H&t)%EPafI9wE9?Zjs z@(5^8$yi@sfS*v6=+#wW?|KlBbAuF9dMCJ9>WF>TO?!3R-nEBn&$v4s9XZE#ogH9}q{;J-cw|*F(LA*DV!q#L9te(q!q_XT z9iL|jZT-Z__^A*gA>|&#KPmSmO5o${GtlCGZWr@h=UT1zh}Zyo`LMZpI=i1c#Y>Cu zOm`r2*(;6rm;igwet=@SSNCm(tJ8l_=FvN+&tr>%(qa;I@;|swLl}NWn|u19{4>kB zpGLq@fJ&V84$=tRd(C$tpw}bj^YelU^v%Aeb2_i#bmE&V`qdFbTQtr+9*aSCZw>W8 z3NB#!9k6Q(qpFrRd;{LT%XVhakP}nUQgKpB&=U)S6aBNqj4kvJb5Kx%9o|j1QSqi> zDVc0Gte(Cn#n!=?-o5^sRL=cPvuTUI1Zi2*xn5aX%v3H~ai!DT7rf~_H=Nea((}@j z1Mbe5dE-?sO_8obh0%}#D>lm|hOO=Icp(bxsnZNEo#* zaglg=VTQXf-37MFW79nu-&cdY<)}ET0{_odGOb}7Evxk7FT+U;OJ*3ZZta-=+3mb5 z;C}Ljz7YCl*C#d^SempN(CQnA&u0o>>?hI4OrK;z%!k7%aok53In9QG)EywMnJWxhPx4 zM&;#SDoaG`=jKt?v!+hi-aqoRA)#J=u5SVDzW!OwVBRV|?kmQGN&@}*XUPlry4I(c-&<@HV-x3du; z<1KugyRVO?^q-&RYd<>t8<#GNS48L&TidrE#kv%(d49XCs@g1* zW&^zjR_RZ0m%7$(JHEZ6Bg21xKa{=D;mK8*P~KWY@i1(=$I#{#gPtwiVmU*SyunBk`& zCNG8!HdQel$?Ep}Xinh1A~ahczrXi&u5HTdN*J;$#L*U>-?Pf5c^~fbf}{W+NQZ{W zt~@{4eGcT9P+lqQvF{X3zp2$Yl@+1!I$R8$5CzqQ@u=^gp~o63U_901Kg~Lf_mE+I z8>Sxr8)Hu{8JtG_bj&EzszudR$GFu$eA`8~jvBc7$Xxhm$;%hJ z1{=akw(%e1^}F#;dXLw7W9)l365Vmvvz`4!DXIpICND9gDqg;6Oj)0D{~SnFNVrns z9ei;wzCbAH>mxfgz6WEJ5{6z;UUk|5@n%aaYxQnaLc8CT3s{dJ2@ z6-r)9$gZ?am@k`S9(j_Wup_q$XFu@wSWM5H75$P`eiWA~U}*UJ%+>7HKSaR488J$( zleJs^_au+gV_Z$dlUmg7Am-ElDb1O;)$F%C#J$|*riZ{%{4n{@?rS7g;lK)xfWLcl zh%J*JS1JxsbtZXi4qK)n8J{@H_u8@WuMX8Sc>$Mx%Bctffg%pFRYzU=^b@(?u-Y)% zc)!5Px2v)Dx|N2u{X=Zfo$kM~jmpcWGA`8(eEWsR{~xv=#d(LsmiumMsumyZ4Y`C&aTEI@nDrzDaIgL@y3%o&T)xl@z2)SGKLU`NGgS2fJE~S(!5H#(76YGL@zn zNETNYvDmY;3kk3l_j@&GOmuUcNT)D7+eAYY%ltHut9qDD)xohRJWR zYu9HaI-;yh34K6&XOHEU<_~XiX}ur5^sMdhVHtT9+=%dwinCw|y(7A))QWnkzn+%X zTZOgpg?VxU$Psi&-*(ikIqAf za(LlF<%Tp=$6>r>*eR0%OL%iwQQsTGWIvW-Nn7Q4;aHK4BTV2FaJrqftaCYs$`J=W z)>2YsT}xUj-!0eunX*Ts_v8Al*x|8Z^(?D1l7(z~)Qry+Y`2(}Kn4w}&X}8g?HOyc zjGrDhAd{X!-Udt?25}|0>(03mJ$T&y=r$@^)(ctVwDYIC(>2n{NFINJlt8@gz1dY}WM#{|_Lgk22M#Iw`mxfRyg7ZjLDfp=OYbQef~rBD zzF<=8O=O!h!WG)QMU#>(j(Yc8)-;^m^5HQXJICnYb0xUdsV&_eTu)giLt3fQ3=%>_ zEqSWr@6(W;KRxhCGWHIRCA_Evm=k1xpL~e38XX5ILf2AU9#5$d6K;M7T}?Abwjziz z&qMJXuF|}7sWGr^D_HUnn$_9Q7=}`!&B!O3T+vvwfV2uVINh82#dBihXzJuoD2zpx z#BR#C{P9moCco>NfVzi3Kc1RL$*vf2SH3N`Q-YH}7YfL>bjShii0@EGpm{e^D*S1? ztdMHk`3~&LyY;S35z4D%HL1#l7E*iI&0F$5 zC-8>3uv_i`MbMp{Cl_!BL~P1$3Iba9^blnvx-VdTU3gZ_l|!%F)qwauP6$wypGEA0 zyPw=vf`i2jQMJC~ul#z*r%DI#*qzq*i|Wy1)WXW*`Rf@@C}_=UN8TL8OnN5+}EDSgJAJmwA*411Me<<-APGw0r_`^R~?DvEqY z?|yf?Yq7td)CX%}mbD9Om-`|d%QP*A22FUi;r@^rE4&c+W{|b7eb@JksZ@CMn=~Pe zMI}EYx>FgPV;)?f4T%^-crxtUo?3_o6--|(X3^$*aXa(K&%~bG?YBi7BHjP^i{9u@ z^80IfAEY;9aQ;k?%i=5AxkKBrCBkMJTG_8N$%3HZZE@e_4N=^AkzRP&StuGoq4=N2 za43OYxdekdzP-0o>I!nrON%gj$h7oB?w;S-)^bYX#eDFFy-jhh?vC@B5?_uTujK|K zD66=eIj*N1689{4&Pxm7B)F0|w{!6}q#NypybGHrR0DXXYcGszaULhAVwHZr{x;gy zaIh-~LmGHQzb}neG`qnOb6mELYRSdUC-iC{9QME;GK2qeTlM-#)5s@2L!LtZ4q*Nr zYe`ZEI|o={izqT=7X%j;${e||l&(DYIk~Dh@{Lm~4CJmt zL&Nq7?c!;}lu~*nMmnDVEvbmZm;4RHgN{L(*x|~}W(0=`-M1Q+p24ni&bm-r(B9PHUb!oEK7oigCVAulSR6b{n z2w7b4DSENs@dU+o!!MQU&8{bL@Xtnazs<3;#atzWtS$K(_jHy6Rm;6B#8JFU&jwnj za7IoGlDHFGTl!7~tJS!_0nl5HRAb*;(hM&kWE2{IDGxWeqV;4OHRtW}Ifi~}npo1TWGER<|7mA@9=->@Vk~3=$)}Vp>(*>KAcW*0*g;?sHGWE*@60fzBEtX~s`UU%Oc; ze7Gq1pJ(&lAr9djx%0B_I{{&lF|#y!-R_(Ju839+zZZfy?NUZ0GH=I-iBSN|2S5Mr z{SzU=n^Vid*SSrB(-sfnh0BJMkg&NO4b$Ui+xxc-&-a4zm-h)+&+&KjjIY`$);VjW zd$}OR!y>w*w4c1Z4AH_UBkW(O)u3CYUCt^N4f=wwlY-t%=cA7qI8icZof9+db!~Bq zTIcn?`UHJ}qa@n;)kf)Nd@?@i(g@hy`D2^-xyEeT^_uxBZWE+^nt}U(aZj{d~m(ZTk(H9`O|I50+a(SlsMNa@;j> zJMlD)L^ustnSh}_%)Ub*gX`>Ej#R+?*M`8$TowzIQ=uQrl{MIAZb2jue^}sE!WV<5 z9+;W)-mIpaaGA2$I`F1{++2tsq_5X~7kVgmv=J7G?`pHu7zom|!UWvt_r@gPu6ZBm zL@Q&Z&q?Y9dbHNg(X}Kd1V>{qP4rlJLjJs*7zl?CmN?BMV`!vRl&4S4mv1GN_xpKN zjb~OzaAYieNIRF)ARD)E9p=y`-EsePkNN|lVsZd>dIVA)iPFHB340{q__5wi$!R9= zWXWf`YM-g7;K!s!S_w@tH1wkEWB(@d+r16_Wa$0E1e3Dyzry?2|DWJ}9BlsslK5{c zBJlUm;Hx_f=QaJr(yH}vT6X%no_|G~ zYX{(lhQxiGl#B&FF@qHj4VVc1TV3O3_a@nZ&jsWWx2D76#A)IkG`yWvz~M&XRjS6Xw>=d zXH+WLbTOud4&Sc{Xl^bO%&g43Qwt)+*(jwZSdK-X*Ha7t!pN-asmK)L3LmozWo zBW)K3_1vx#U3fl(i$YpT8iQh~TsDB}fd#O&a?(ilR~((gnmP$o7~24+gqJhHo&e=k zl>+(k`wO?e5BvX`S&sjw%rgCE=lH)^L?-s%Y%KpH)tM>Q|1dN#N9=p-W@MjSW`O2y zZfhRr&Tb*5?rDU{dVl_&hg@s-12K_k>3;1deT_@~xne#zh;yetM~27ttFJHYrzowu z@QBR#=o@*cn^Hhm(=C-ANNVMxoG=?0R-I$0Y~VHXVXJZuutsLF zJP>P_zsTbDGMuWt%q%g7Cq7+ zO|3--|)^n6Nx}wxH`LpmU3Y#w_)mC4pPR9F9#M09<^|ebSUz}x$CSvUM)JsP( zXpQfFUEKSA;t52<(?*WHBAya0^j)^xDW53Fq zDXV}*Bj>T48Ua?>=Zu%OiddFitZ`eeNxv(T?re$A=ZnXn@SITt6}FP+7!AxjQii4B9~hEIu&!J}V2 z$G+Z~2*Wb(u9=W{o8&u>4!(}DBK-?TiIAiyhNXhxO(PIc$UjF|W$hzm7N zrML}~2rH=dEsT z7ASHtDr^6GWU4d&dMGM<|N8G#8UD=Q6Q7_Dy#?2x6Q5uXVFcRLj9BCwBNbaVR1~9}Wm|eNBx0 za`;>E5^7w+--%K25@sAVcM~Ns7RnTk3IIP&>31uY>-B>w2X5Tl@Aiu#bI`3;E&=Q~ z*zfk2A`$dB*#GvoV)vIs3BOyhT;3mvBYwA>irHVr69heeP$|G1$_TzND|SOC8VkPA zD0ago{uhK!F&k!l#Xp`r(f-S!N3It-6$pB~#s3ysF$U)Ft711y;(wb_sY?8A^>S7H zobaeXFysG);a8mgatJTTg^=hh=z&Z1-@ziex?jd)zXg9#nUsH;+1K9Pk4Tu?CN=Aq zohPV?Egkcecsf^}8|&_t7fO}K(~7}I%B}4gUVXm`MkrCp{QKQk!!nx6`U)4BJK~0T5hPWvT8v z^D*u-xvs^i6UsJIYY0?ab~5LU*NFGWG72&Ii z~%fu|ce9YP&^|1!iz_$|%>k&3G5bmJkT+W4WhvI%?cUi#Q@BI2&gp)Lf5vc+! zWujp-`zA5%>aTk>$yUv&Ss8xTxwv+ih!ZJZpH@BHPLHI7|74v^sMsi9P8Ug$r1J;t zzH13|d+8NyAzCW@7mj{>?O^IAsAe*xZ1OT%I-HcNS8NnI+liXW#GB?76-%~`(d{Q- zj@Og_wpDy_<5Zz{n4Yzh>1m?@GV?XBnQu$9HaBXU2?E{oR)!Qj=g1p%W3rHJsuWs@ zD}hY_=i@qx7x*1mbg9^KR=06Ox=X@+!J_(|%4>hC>K*y#x9F^!+-DSKPE5=5qN6#p z9z;7)S@vSTlJrR`(4>^RV=?A{n$KfY&8=p$t!FsIqqNOWhR!ZeS=yI(^~ReDAXLt5 z>6)>gh9l8NlaK3lKUe<7V3%%2H-lb7N; zmE~ZNc?4?&(J6cyt9Ui?yFriiDoxMHtU_esad)DGC<<@fqY z0oZ3wOyXEhU|u7DIWqRP7J@PS(5qn%xm9fY(V8%nQVIF3l(J}L+)wlU^ARz^b{zDd zbsAC5IU7GM6EUz{dCct*)a5J^Jz0g;e=S?NZQXHlwb#VAQ`u1#QE!Ja9cV;CxFx%c zx>*#^foavwo!OZ;c0>4u?XM2eVSlQv8CzOqhLH-}UU$^%g@`o()u zP%m)sgX4CZr98rVYw79ps4C;{Qd2bxCD}CILx`Svj*CYLd!~1gp7(ZF0GA_r4Z_uZ z=Uhegsz)+D-!SJ@kPo5#w`%+s{49-qk52rW*4MMlKv%*mbYmt)*%=vH%S=|ObP`i3 z87V2{6TRoUkOt>$N^qC!^u%t|x0qb(s5^*~7-%4XiOOnjkU(Xy{wy<(NV()%OIiEd zQ>J~_g2EHWxxk`^RII)PruS0@xUT2pwE zK;4mU2H!9Zz4-B6X9i4fsGV>4@mlYI+qnn-V$#2H2sXg^IG?)`AXLp%P!3 zpY;x>;S0p}`iXA_I{PbcfPM^93+}aLugDIOi(AwUdLuws0o4DD^XmESMej&$(qL#) z0;(eyn0$CM>uvLG!z`w#hGpb;vr{F1=}irZGal`6O9I_6@^YLdQoaZM)L~^XMQ+hM z%gt0Y-EbnsvPbb%PQI<=#JdpgJb_A5-SUq{uGg;{W?0sn<>$sS>GzkFHH~)Vl;$Z* zjD@%+OeM8T9SXCLCMY^nSA3R8ca|H8cVj(CLz_kJjMgd{MqMes`i0*3L3{#87ZfI1 z(wq5{?_}?08qve(c-be20(7FK+J@2Wt=>h8-`Ci1Q`_}2q?ignY zBJ_IRkjIA9f*1Ge54hLtmT8l@nb$v8k#semExo?@E*rfuy`Rw7!~^WZ*uPs|u-;xY z_VHD=rPaN3)`|CRMJ!rB>iPY;S+fh-3tyriHhxF`ABxUA8mj+|wrqneLzuB;>_daWFoR)+S$}@_+;i?f_m6w- zJ?Hs+&ig*k>&3g6>l+~suS9i8emT$bDU?n72H+CI9k+E#a&Dk?)`0h$R3YD=`loh< zKTqvSf09y{dIs>{lsymsYE0xKgp;Uu{2DcozsAExVd0%@x85g+ksgacQhra)#j7je zKcXX=7xpH6Bc3xv7ld(w;Ei({1ll2zQS_SNat`wN*f1OaH>x5cm7EQn`O))%ImAGD zRe5cPC=E#w&c`>*HX0hH{iNS2v@@*1!6yZZCe zXSiFRYm)JkEuyQrIMlHQ)V<&Hxx&Z>_*oGnX@q2k|8H?n5Bv}1Z<@ZV1`Ge?&YtkX z8fQ@UAYb!A=e`d-krriM%4LN;4duEy(iQp$YFQ8C7>5h5tf}NW+jxHk53e9M!Au+a zDxzqFC6l&HeIg`9Su**jzoys+=mACek19y~Gi33tlz5*XgAg>C)U$+Jvkga}bTluR zEdmiGF6wor$rF4+@!=e;K~^TNM6FQ>x&Hw;?c)6@9zWKechrR8+ee%a z>$KszkHARlCT#{lQ4j2vWXPr1kO@A!12`4qe5pe7-v;SZ*Er1$HlLY!7iKbC4I{ z&B=y0_qBP>2DE_Y)!htDKUSyZfzTwSo+d$kn{y2F{`EI_?LUGDy(_KpwDogDqa3}iyJ`JipDv_pHAII3{N|d1v79VOQIrUCSA7Z!eO%1Ah4emJh=Nw5q5*pr| z`C&c0A8fd`f1w0s72<-ckY|4KX11=;49hq|FeIqqK2M^C6`F`tq#=LrYNTRhP01p2 zy}OG6>rzS^G$VChPoUIvgwQXyin#=vr-Ia{aQh%Qe>iyhaC7U^p%9UF+TlDGwbz<2 z4t^vQcZL4Z*_ty{SMAOUZoieMv-04FIwY_BUS2eOI$s4|`DvQaEX;6d709g+VboV| z6&ud2goB}h1h#Km>xNywLSnwc(rHq_K^WBo8x~)s+Xa^)9a!}hmOfzBmU#wzA~<}& zbKfGz8af$N{f_1`MiqdGGxOIW0rd%U2CvS9=fA97a{aG(P?<YM(~HD0Dl&iaePrW_be+*2^)R+9rWLOp9h?)28L6-KKH^Vi#YgSzQNj=d-;Tmql^QvC{XOF%OpC4cbinQXn0b8UOB z-Y$ibe|J1=H^I`TCCBvSp+b#5MB%cmWdWHm+L^L)hbogIks)i&jPlu5pL=^Y{^!ik zc+XACOt@D$KsRT$DccgO{@)IZhDGNOvfRe>wpU^{WEG8I{RY*bp>8h+vZLnMhy{6E zyUts*Sz|q|&bih*R;|Z!;w!3ZL&kB4-Z%RiVnh6fs}fdFBgK3&XL(h;>~Ym;)p-k< zK;2pNb&Lz!4qmMho{3-RH}GC@ZWiGv3>3i(C*eXgu*#%{{|hg3o=%x2R|}{b5ptB= ze*-*7FLS_Y2;QG6$oc5*K6@QJ08*_~%Atp~S)}5lDOnUb!L`L!qOf-u2t^AY^zBy| zTCeNM&I|YA0w|twAvvM(;UcV5H73D@*KdzQ zjnj?|D7bu;lcbl2^QGjek3j8`tDaW)YwCVpQJyIw)@`#2#9e(A{nh5}HRh-8jn(om z&lz9-T?s$7UyP4vs5AhNC8z#;vfz5zuK(d@3wT?Z1Ih<(+kq$_cx;WnvRtY}^HJJ=Mx`2VSKkTRD_K zjsqWbPQ|+!MMC@>s<88NNjp{|%&gc7xxU$&+sjU6Etguyj@~sq0soF#M%@UW6*Cy~ zV5-N}nymr-t(`}j?L@gxCWr>k7UbI5%Rw!1h$Cc_Lz(s-%DXomo?QLdjZ^tpjce#F z`eeSNm5+D4OvLwRu_k`1YU7`jEzYdxW3P+r?nWXe(}5TE4sI4(m57Wu)93$DzfOp0 zLLXHdD>K%o5nySSNi*Fiuje2SY>@VBvDlmK2S$l|v-Q()+9!6Y<%pyIxXJQekbF7iERxm81b~yq}b%Q$U};W z#njQ+Q@ms>u%$JH8t(RoVT`KWOO&3uP+ocdBX+m`3XRTY0nrV zee4@gsUNh*P6DE~xl-k_q9l!>e?D>}%z%VcaOvk6gtFe4Hm0Q^(Pz4HXMF;{xgs&e zNtd=D$?r%IKtum>(NXLQ-sqaTQ}#)P(H&fvjsI(b1}4tCC5g+<Wi1{G72(l=t82;SDm=uZkUI+&jDML~o+VG4}zK8gKNK{DWLhhYwy8cf)&!h1fJy z4s8Weu2B5t=_H6}_P~Z2mx}2{(PoAJwz!dOYa_pZ zaQ{FV*+s|O(vYjj?3~F4ZLOaB2zd(4@0v7N?Og|&AFi>)70t&=7;L^fAOfMyX95M=}UN$|xgpy|tFEwRfv z1zpjkP;vsczcV+ulPo{hYdF6k{^w1>zap~1~$L;zduUxkp{`rKB zKJS2MEnz>?LNWTMowC)RPp?REdh{@t4TU)Gkyv}Y@Cz-2VTEtFiUwj>tex3%1Tk5% z>P)NcJ;;@RtNUP!z0YTFd?=dyaz1Pu!xXRy}GsJ*}L4QiG?87TanY#w@WS8 zJVs;Xi);CuA~y_&##4y~^PvGUA+wSKrgM7B$@W<4AN=OOCh~EYawuIq{3KzUdlyo1 zfuZ^L@AeNv#I1_=V}fPk)q~l&Dl1iDGcN=~lg%m=a&5mS+AYeOmIIe7M{d(m&-qBF zZ1;Mi)t7?Hbm{WK;zKWtOkBuWNcw=&Rq5!8n6{H?PpFbeN{iKI<(0uwov@Q?OS+mn zml|Sa*PgZ(-51|dX^C}kB16^AuF4x{xCFZvEDaJ|Y`^*T_b6~IYPiCQ&ue7=$_9TQf%S$a@TQQRBMH1I zZ;n)}aJX{9yUc5QnT2(snHRj$D(}(9KXuS0L1}wv{?hOF*R6SrOLZj+N z!f?qCq=reqnLy5y8n^I^K!xx^Ki&sB;>Sqzbu~hadyb{?l)MHbhszR{aIq~*^pX*2q*o+#4-Ttb+@uy=u`ozRAF##kg(F+qsjW*lTVKWYEu0>=NZ z#3W!gw=+`GiF~+O)fDoCP`(>V{i!}Wqd%=LHG!@3iTA~5*Zs`NhSoLlBC7H5sHv5v z$#8A65h^*ODPNlT-QU6=Rp{(bFDG96PS?JVk)zp01*laSr)t&~t=Jn5PjLv3f207_Zcy=z@k#3#`>=(js@q&YlIlmw315F}i+| z>U#n#q@Brl_(F}fZc^N&%88x`ge4gMJ|AYFQKhs?dRwBGNXq@i(OYg35$TOIJ~5g5 zZCu7!N>eadpf8;sNs4Q2pC}UIJ%UXa!R>#h5Hjk24CRru2x*!FtS5gUSQfIR9KqqR z6{z`P;)$D_5;odu3C~7bWW`g4yxh3)OrFlXsS;&z`$JN70*AEGtsDg6v$R6IX32S~nC1+}2>cPU-4(wL!02}e zCFI%I3Zz5XD7Q{kH>kS?Ggo6;V_DO1UM3iisX_0AGhFVwPrQ%zJy|;jJ-GFnC@}=a zO|v8K4?=81BMDtKb%nT}8@h5h!ST+z<$o=HXlkDfw*c5c8q=?(!?<#{l3gacp&4UC zFVMkRSrW#+!Eb_Xato`@WCPDm6=>ip+Wuzv)`+ys)O@9uF7%CP9_OS`q}_9JrxxZX zdeAe1VmWGzx{aN+>j~j{HxIR;wGuC_|Jz%@_vx9~Xa1MJH678=e!VVnd`W9PQb>-? zxu6YjM_>D3{V59eYNl`JW3HDURq}1l%Kh;xN#)D#*(I2KQ4*~mGQ77&bdhQs?p#4E zma!&%qDqLT;eqkG>I|cQ<7@j1XFIqUP>9!GkOzWQ*H6V?lC*vmKda2mNT9`B3yK?Y z)~o6_#mkUViNHZq_6yWAXU;`PjFKNPEbqvSpZnCFbYEBul->YMC$H*m2D!}}E?EWP zjK}FWMJNXLkSBItmH^`yVxb9*WVhLv)O}fQgkN<~zVJ&xhHV3G`{%rMje-+O2~Qmg zKOFq5lH^7hHD?`fiC1Wwwk<-Y2rbLyn&)(sgfqnYLTRj`+(Ns2IkZ|}^W!NA?Xc%- zH&pc@W#XEDyR<6*wA#c7>kQUNoAoO%zjYlXIC$Cz|GL$o#PF_qlT#87NziSQCbLfT zWyI}~A5ax&N~sOjB4MeCs%ZiLX=>RMG|kS0CwlJ%#lE9at2%E<)bmP)H=4~rS*wgo zsk-NGS7E+XS7U!52WRsb7RJJ01htOp}wNSB-j@=O8cs5T@0fb&HC z=ve+1@{S0qqomuo5SwH*J#j(Owx$^yGNAcW)N~bgD^}2R^YSd9COjZT4N}!F!k9@G z{}>sPqb0zNxF`h&TZY)tGWWTQ&PZ{Ws?MK&rpmFYFDCZ zu|YrvD0*lMvEG7NaX)<@M6Ah@2DdG)H=^u2{n<+=< zuQ#N+yb}w`km_TUcxzjwEkAPK6yfcWoUWs%5Vp-Y`)$r+RPI4Ff*r5*78&)N>S*xB zr!V|F$*9%CMq{-@x{vD-cR*HUo3e=*JJJ{7I)VJafCt^X+ItdLfLrO;-|VYt8yFqA z0c-!(ACl|1>`HPNlN!5_gFFf1x)*jiDa&TdSN>_SNJ)Wv?z2QU-Aq=mHD_G>qycuc5w)XktOL6Z>BA=(fW7L25)why99fn?>8E+3W#0=YSGq)($+U%!pMH;-O z8ae;EkitRsLY#-*$m$I5)x_F$sFlzR8A!%Vzi-;EBs9neBuWM3n9sn*GNv^Wn7X-| zIo4cxx9P0-k+PAOQDbMVreA$voCS#r2`)B`4UGSW?*7YTJmgK=w#if`H7zr~=#-W1 zMZ(9vD(_5cr!u-7uxE(^jA{3D|L7o0-&w5@Fj}8<4RS&*s0urJ>e&{85>-J;?E)8& zn|LHyN3j-}OkZ?Q^`oV~u_6t@@y~OvU~z#HFUJVGXJ&I}jF6rH-1lmV@Je==lN^nv zAG#&Nn#Z{opimeG`k__6-B?(MjZ%HCk{k^Cx302Rd=3Y#3C%~hYcr~RcX(&ZMe>N{ z2=~H8{+5kPvv?`YB4{X_Xp_=S1(B&c1kjF5#)C)rBdK9mnnTBCciKYKb28vtUtSYBjqxr8Le#}YnKZ=)hc$WE zwg+yT&SmWkG(Mk#1wonuO>pLNf9Yk3d(>exBQCgy!8vA(w_!z2)RiH-8SFg;GzJ#4 za;izm-6}3Ey=6>03SWpYU1jJv&0HoxW{l1Irg-&V4g0-SgI>7{h|V`T|Ai-vr4@VA z22ZOcitL2Nq!L@`zpR8}n1~ZO01kujoovOq&2VFB{GDB#_zUJjMl-7E)Rk$q)Vdiv zIq3!M)iqKO-Z##!=?^1~N!ixsLri#)$9iXeUgP?#b9-tkAeZ?`ox?DmxkZ8w3D z6Ex>_O^x8HPG@LKwGmiCG#blTnbl3L&C>TOHOBwDhXKdzETDmv$=D&Ba3gg;iJf&7 zY4>O#JTqkYp!C5Cjs1RA=UX{xJBRrww}4|UMhb6Sql3gJi>W+}12!e0Iax&txTW^w=*{tFk&(01D(gelLgNq;lWu2_XET z5u;Vpy`}1&_sDFh#~or}T=n}VowC*aXaKpjc7jTbfRm2Y;S8ilW(p|{XlBy}AXP!6 zUGI4c_dv0MPb;2P2KgZl#>z`}>-SYOdGGS)+H4IyCS)AR@49!m7*HosFt0uWztx9R z?!A*B0Z#mLO8jMJ4D&*b}ZxXJGb4QmrEE&XBgz5^^HT-tP}WkJ`! z^5%dG*nM)=p~=x>p-sTDzkuc3;0yRJ05cjSta{kjBtA;=L8 zv)NG%X8gRF%y#NyG#78@Y?hM>HB-ZXVNaR*>fe+uw5L>M>)9-aTN@Tt)2Ad6CAu=5 z_?AQW<{baR-_qE6GjRfJBnC<5ytw{K)^I+cheTWF1`(^gl}bz z&t8~Zik8iReFV$~*BQmvZ`}+3@GdRBmJtpyt~SCAF%w9xyS7s6hJd|nQ7jmc;0E&= z(zxnI7(?x!tBtoh4EjqKh0mT{V}Us#>JQzqL*WwXyO*5c2MQk`E0ZR4%6j(no%Xk* zn9B_}gwEgAO{w7Yx_C@yYF=Vq7lbc=+V%N3ZH`fQ63Q;vQQn@qE6aW()OOd%aK$3g z1P>=AZi+PomiEE-E;;e?@Z-Xr$}Ph>ne5;1q9|}-IiJHDL)m;wGO_vhIxn#xka{ic*R`i?B~GDH6P!}m;9 zq%zRO+S60zgFpLIlhNIK_n9FBSKN%1!Z!^1c;oH5fz!Jc;6$TddLSqOB~!}TXrk4P z82|HEncWs5Uw4gN0N~3||DXe5<%BMA9>UrEa*k*8B_~(ay>uWda&0@Ye&>{$1$Br? zvAtU66BaTQZj+lcow#|a;aT%tuJo{$T_++z!H?e>?BeA_;e>@@c99gy#{5 z_lC!Zo6lqw?x?Qy+&k>m+IdRwtkk_=>dA61cQSZXe_`Gvq^So1t{J};ivnT*s*CxF zRmjmQ`jKullRl;D)fkZKKL79TLre-)H7$|KQ$qT21vxYF6)eXEZ-D0 z=zm_lX7C;j)Z6L@NBdy^1;^O+QJz@C78@$@Bjfy8L=fY-=hHF6oq?)5oJcC~KMk;& zez;VeaQL^Prtl27V!R?S@ZWfZnSgLMizC0r? zd=3Zkuk4gPSa#&~h$6wtiB*(#^hoY~X?IG-^8oA4v}=%Km$Uylp|cY>cDND|eH&M&a=Z^k+Kwm5P%ZESi*`M*zy+V|tmK|`b zPiCzs@pc*bG&>px+zc1HI(x1zdCbpw2rj;E5&??)COowI4X6Q#f?u6p=f*PDLyl-;%A#;_seokk(rFpYIee>pRfT2YI^j%XSb@mgH?>UUwvE8At=l7#U; zGRmzReca~_b!fI6Bm*I@6ywYHM z-1bvMm{dkL)`e<9(n~hklHF%;@4HG}c3++$ zkIlno@1T4)ivO&xOp{||F|lAX!bkdmrGTz&hsX-_dmvnSFvC~OB#mJ>@jR>k3F$N4 zbHwefwW;#v9!q^Mn%AU=V=b>#kKK!W=4Z&8Xtg9SU{Cl?=?zh`*Qb?Cez@hAc#nTA zgN7I_%aM*;=%oKp_3Gz$`TJOeGbs$&E267;j$xG!nmRQ>|GC_VUcuF@}0NDG3Vit``50h)qvmnp` z;q;3k+uZw{MV5YL6Ko`AOi1F5uetolHfq|&&Q@RV=5!yT zOmv%qVcRpB4hG>fk?|9*q8ZA5;^95=fOJ@0a&CV}*>h7`!y>RkuEo&HFg|&$o>Prl zg1A3Jwx1jIMU})Dy=pBHOSBB3L}L_VGk@U?0|@4&pVGV`qq`+WC_v6s1%54(|0HjZ zpY@c1_cq?6R&`raY_l8y>i;1rr$lxSX4ifT0J_aAt1^Z*mW!ET<;@EtaMwcj`{7G2 z0j)RXs`(&m1-}9i9^Y8Y`wFx_i`+o|WUK&E7T}syC7^oc7FlR*Vue=<%UVVJ_!)5R z*Qx&M6xW5RLi)$(<^J7ME;rO}KtxyzlHk~P+y4El*FKO$+_%rxC98>gceDxG0 z^d}db6kJM|JJss@=WELZBJeVv$R@C+^`r&xc3wXX_e{Dh+;ea&Mc_R)c(^Jt_;}Aj z#s>Q(k^{G9RfUZjzTX=uxY{dTe7Zn}A<_@+>8^96D+W;HBGOfb*5t1+5c zF{^As)%IGTsKrz&C%0H#HA0@2Yk)w^K=h~RcA^p5d>r`+;kR@T2KnY*AKri)afr|f zkB6%7^qqY#X_Z|uOqR4Zxx$kEt^xc62(j+;(?M=gwGlMcAqq*l{6ZwLf(ddX%{ex2 z1jTR&6fnbRPQ!7=JZr5JFVhJ>&+<9GO*G z*^n4mkwaTML2_BrOEr|tV{-cIhU-q8#QlozB;0IKdZfE>x~~8vUXDGh@{d)Z40!{) zu50`n0f6lkSGTJZL)qtBr|rK@jcP3w_z&O6l>i0+Gi(xq<#eS4uMu)+xknN#D{#Jd zo;gQ*r;{(sG>iJKU3h18o>WRj5yRJ-QHDQ-b98#Z3yL#~VW?+}wHgF1vi4_uwk83P zr0p{kcHCN^`U>;`;jW*oXT03)&4l47nFRsZuE>Nn>r<6e_uIMbeqUIyRd-(S22+0Q zmkzN(wY3CrhZzp74`;CdWKyliBH$GQ8|%Z2kI!D!nQi;ec3a44X)t2AGQGM#gm}G| z{Mx#25E5E?TiUmJ8Me`;rf{lD^+fd-lA=s5@%B2HBH}}EG>KTey&l0hk8WA8o@^p_ zMrF$lOEzvy=}NMm_F0nFwezvexGhydFC6f$&8yt11XI92hzoX@*!Xxk6K$~$A*_7D z4TZZ3E`1r%RFv)h-QCe5xthMdy&ZS8)4+Z(3(#W4^cNs^>zNH7_1{Ls3Y>S}YJ|S= zAD{imS0SND6$4$^l0a;q8~G{BoV`sp96akw`1W-ByJe#bYDL2IGKYO1w<*qLI;{XX zh)NuYDbQknnTllHcfTx0t_-FoGUMZ@J9~C3&?5Y{5a%nj)n1=KW|X1{U9^_Tq{U`m zLe?%p5%ad(X2)^0jkkcQzvX_0kB4ME!-==Fe&J|*prv(YtyE3!J>o#e45|?21aoYQ z9{{y;DlN@{#rQ(9-HN0=TX&>4U#54?7fsTNk(D_N&=Y(iEcAOo*yqHaOfvLaWyQeu zpRLwWA&U6UOHp#TIlTDgVBv~#_aSs-u6@W~T%_Og+t2EzpSWf*uZ9SeMi^qe!7`!r z2FlafmJcAQeO3lZlJyxWk7`B?nt0xov0$7QGSwsuM}B<@Fs_V+^@X=REqOuI?IIUc z=ataC8#kM~hP?X&HRe$VAKf&Hm8HB^&Pj$;3EJP-+zAA93vmd80x6 z1jOre6#|@FQX@bZr-`j2B(ehRrTM&E!`E9Dh6>xtJ)*W;SFIXYHU@gz{Z$F;nq!fvY=V~% zf@?SFUY6Nai^W*XH?C|8MXrA;$n83Ai< zteCLQaBHRd_DK2g55ZXQ1xSu|OYBZgr!0l$`?!h@=_{vT|6F(hwePSU^Fd)PSi6>rWL2tC_?r`oZ@{`}r>0h+@SdTZ0b ze|%V|4wxEd`IyaR&42V9nGK?N*Ut&653pRB(R?fM*Reb7C|BjERkc-)1t+QZT}-SfQ$OZ#}NM${zd3D7d(Ax-@Q zwEK{U3>oocZAH6tOEF^<qH+f}x{eu2Yqx4#AQkMy?)_G!K_mwaV+`TYS)E%3x zBdpk(4N3EEQNww3E}J-^Pjeq(tY*A~Yq;^)lQ|@BNNPC0UB1RgT4!&Sv|<`F-kRV_ z3WPKJKat@qT{%!e%MW3~HlXchiZDCu?}l$WxNR%LjhsFxo}_rtgCpuIr+6?$l{ zfxWY|%2rm>oXK5vEvTgEC#!Bk;qHL#vPF#%Y#6ywPCacC$a2~{_o}T!?q5i3#pcQC zXMrt0+ND-z+J3P>;q(I@Ip#@{w$G_=2h?yYd;!I!R>Qro3cq zjqJ#-{BPWs3CDK%Vg3d4aY>4|Y8Mmlb(5~v=@EBqRyEpt*Xi*%kFAM{|#W@uG7^Z@Jb zJ>D5I>xwV(TUw=z7FJS;#p|^91wY1|Y=JZ~;1-Q#uguLBO)zhES*SbtB#?PU@^wkC}jm)IAoL0VQ3QH`^R_`i09FTXblk5lD}A6b-&mRX;i6l*ki8gk75 ze}ND%@cE&QNo*E>Uwd)MV#$R{DkdxFjg#LdxJeH9JdrF)@?l{A<IG0fe*j~8 z_2Hg7DJL0are@-7RHf68S50+LTfkGfQ0(sN?~^Fh9g{wtn?PuIM){(jQ^ycUtTa-I zes7cRU+WCMW^f_hs1#ov!>hB)sjn|k9`W>>O@3-ps9OjA*UZ;uJqO4W@fMje_Q{vq z=0lPU`d+&a%U0hcY5y$VU9rQ8sw%tkH6Lwm=N|n7{X`?t2*)SA4q_(nxGSM{r*a1u zAMa297}q`=d$iS?(Tt@Fj+%A^e3CbD5Vi;;nB?}!ui_8-9UhBPr=mORdQ7DaP~v+m zA2|v4K2Dz-w5K|fr#Nd<=u*`yHfK0z#E?e^oBPGmE*@HM){Ad*sZ&0r?=LqN4wh!p?WC7=Ct!?f@$k$*A{+Z%Ni#&SW;L~K%6F!rM3dnY^Z*~QZM?>C^^p2; z0gB>I3mSaqLZ@KN2G5DF_#5blZVT(qYf(bubU43*N_7QCloG+}LdzKKV z&q^qgFs?TAmV1jxxc%g^5wyy*!9AfnPfM?o15M}Eb!QLN{H8%eGTU8ogNRSVQma;B zgQ2I5-)~C2D7_Zyj;m>_mfMUv_BzukALl)ju*+k&APnt@QnTp@gvjM z8pA#AGH6JqLk@4F^-9*}FOR{G8y#M719i)i&hb;bO!H%Jh?mMee-kwh*4yA`FT=M* z4hozo#Kf5PNF3?1p5tqg(*L_76R-Kw#ao=|>Hw5mR`swr^xIVAgsU(gs1Sagv33qD zOhd(03M$?%`DFU@*2#ch!oJS}2rm8W*RiGNbOmRX&fGDYs0bz<8Z&b(3;QDMbh1&e z(`YOJ{5mSXv}4M_9t%*zcR6_+4O{wT@k4POXLw%IPi{k#ohNSKI?Aj`rrG}#o9bnP z)mZQ{oiFd8@kHl6o29bI>}E{syXCpu)UPr>QkQ0Iu2X$wog+9Uk>o*=_T1?;#m)O$ z_fXw$UN-VB%YAjyT<$S+U?=v>$Y=={mRHewm9vj;OaI-i0}FMc0xkYD`lmMXWxHOYfbT? z5-P1`2>}zpBSM%nfShWUv)10YL+zJ zG$`bRylueK41M>Qk^a;F<(IvVl2d)4LzvI_MbW|wI6BvHZWZ?vk}Fm{6P7*`-^lpm zkZB?NiblQcZzn+-gs zyjj-@&5w)+A~cN06?2Lya>qyY?0>0;v`<J(&KzxBvI& zzbB**vzzIVnHJI?BcgzGn%>F}CM2TgTg%JUJ;T<<@6AfCR&EWFZ3*g8M;BlH~b>XYEs zc+Ccdrfp-f)je1dIqJQJ&veHLhrR`E^ocnrYB5y zJB-CY_WR?74|OW1M-9FyB1#Z*`%&^&2jib1jg9p)E*%6=M!@61uHd30MfkrMFV95( zetc!2Yhi$>F3>I43VAVnT{8aunfMz8Ktq7ty@g(dZShBPe=;VK%-5rmr>ebH!YQaS zjR1hqp4Z7z2lw|j{hz=G*XQ=Wy!QIz?I~1sV%`2$>axYeO~KEG6H@M-n`^(W6+=~b zX&7R1cvrH%I!<)SGM@e@7%T2T6;#I2S0`?+5&kszOfq~%Db?|drx?cc1>6o+Z^;$* zcM2EEx*P`J@}{-VU8)~*W<4KNdK-s_KK^HSUGf6m(QK9My_F@3K1c4{&N}XsO7|!2 z3-x+Ky2%ztWvd%Di;Ux{ke(H$1QLybH~GMmT>~`a7clNq?(j{vyxtvg^enbNw$Ku? zZhQA#x@Pl|e&KeuJV-07sVvXb%6ayROuv~*1~m7GX*9y-H?5A0i}=S2gVW46=MhU+ zZ)p4&D#h1mz}%YLmkP?S=$q0}MpE$@P?iZdyOT|tl&j<@Du!mm6;16w(~~CC=SvcJ z*QO`YvX-t;`sA^;mEA9VSYVs+F)0QM88ID`yDkcgR#mE)Al<#+BrY6 zm2~_>!JqT)+>?@n}3yyd9PYF+n(*_Qy?SCmcD8{52+ z8smuf!PE1WU_iMuijK@J@Q7+EKTp(z15a)*F}C91W^x1G|Oe) zS#0ehoLan_Fxgo*XjwB5G<-BambI1Our_qm#dh}6$jvd^Tz0B*jcYtC^6cP_-h-DS zjOvJ=JPcx@%^~dZ(@-xSwWSGyq;T6_I;N_tK5}?_B=*5kwZS8Y-~JdzebG&dI&|zg z-_;jZo}TxL#x4~59!qz+^ZkKunZvnLS08?EG=Fr}|LVoDQ75a?(>Hx5Co|`uOHd3e z<>M)(;=j!wfj~;XJ`kIop-+gL$X-o`21=#(Z)Wa7Ph-k}tp8Hg%Jd#WuEFcjnsLrj zi~pSax-+6VY0cVlfhqG`PH?K99yF9UF}eM7V70!Hd!qHIOIouA0-{RE$&Q`Lsk|RQ z(-Vr>k+wiKEt7(noP%}2Lu3DzHP&~2z^`IrIOAv)@R3IfX( ze${)YH8V?w-;v~0Z1%%>w?~j@cny3E^A_} zf2Sr~h2?B1A2k5(G#~T297EM}&ibX1d6ukOS3A`GYO)6QTFG9~#a40`&C;}mg3h9LY^gsG?pe**=^8Lq8P(|+uTj_*nR z(RdyG%6>Kx#y;PTyqq2X26|?FUxF#yVMxNwIe*ko*wX0f01<`4&hD6AU%E1hik>~O z9i3FKUPW_Qv^HA`-Z-`3&Q~&5AE4Fq*62NW#9owS?JO* zq&L*gcOI$0_B&=IiVb%V=x>8Fugqzg&z5#@{6wS^ZxecP@ z^0^CxrO^ZYH98%TQqqjb#%=whIl!Cf(BtfM@e6@Y{ zE#>I8-0$o<9-2 zxcUB;WeI!k28}b$yfkLUY22JWdmVmm0euy zX8ZxuvFmT*KSn=vvc@&$oP{V;z8MC1iE60|dYtwCuQi!1*&3UQS%>OR1zw;>Ve~6Q zOe4$P^Ns$KfukVTN z$}j1^1#jNjm38Ubo8(LcX3x}Op0+N{obyciT>IWimXV=K0Xi~-I)midj-lN95YuO3 z{}|x5Nr98R8{@TGwj1l!KbnNK#vmHqh*QT4xPLc{e+H~)wH$f=E4dqVdaOk9^mR3I zVO|=<{mo2MUh5Hmh#4Kx|6Bz@h~5)vt1q87&TJ3WXB>D&;cI$G;G6K@017ZE5&i0) z-ETJtEXwxyS-|z4mHD4AilYnUF|LeDqZ4DWA^p$w{)LOMLr>Ew?-C8q(Y(_E`}0*t z;Y|--3bhWTPGIK}rVdQ~eQ)Xiks#)o5{(cF@}0idGw>fZE@~Q_N?h~TPXZFve0DtV#ev%M_Nx5>0R^zlLlv46jKTo zC{j~Da2YiXU$^#V+=7btf0@ZJDy?oihH7@LcsgA+Ln)+>rQhHzjy5Ium$qx6rc3Wr zXwr-qlhsX(Xm5xtKA)h>7|zm9$kFbLPQ|J6{svfg!1m3k{;9lwGVmG=^pSgGTODUU z*Jj&xTwAd9-)wq_`>9@J8mHyDR^N1A!GDr!&8+}PP@kxMNhNj~dJC>+R{D?nY;@@r z!~;ob=zipk_#HL5#O8`US;7y+Pc1g-+=29|E>l0X}i!Qc0F}=ou z@!|1f)C=y@$!2rCkKMONG;^zJcH#*gc=%6Xe{qYwhEd6se#Lr5B8$OjXqm2-qH=Zd z!ren-0cWPxV4V;@m}pmRELksp=U2kJmWc4Lz)tC*d+(CHOQJO^t#-_3cCp78Fx1*W z2oE$(yM$jQ?4@dlO?A*^KkNY&i2x{wpBQjvJ@{d9yvbE3jVD(t$JZNp zX+0|;=hMEoNaUZyd(yews8HFs+gfir)4O-?7tE%7Ll`FFwS^U6oA;d2O%YY^sSgYl zLT*=Ix{xfQC9IjS0$tiTeWbfG$JZW57;v$b0_g*;Bve&%G~+kjI_UFGqvs1fPA{h2aeo+=JNa^?~N3nl)>= z%YG-9GDXKJnIFanJNdeS9#N;aU)m#_xK^@F1qvPH%^mbf^2ef2>ey!#T4$O;u`U;O zbOwO+{93%n4UOB}!ukF?Rwzv z`X5!WR@fMwzD)OcQt#Cb4}6foGeO-jY)-0bo=w}cu9AC-xsGVT8=%PkXhE2t)B=!t zr&9p@Bsgf;pd+r~Jmwp?dJt8)B> zf@@G}fXrv3u3X2U!0CWt)xTPUx6Pc5`GH##mMjQW?BB2^xdsG~c-t4QQz6W)Xt(#5 zieZt;Eo%S9!rx6h07meG|6ceHJ^ocCB1!XS|G(_@-*tFSx858q{!G=lxFig8e9OJu z%y!Uup5R-5rex_>IXkC30C{vFT%wsX@2_u=(p|-Ai+)U8vGSJ1!NV=?R^`h}<}KT- zfoXe>%Xj#BhP6)}4710|1_y4rS@I{TYIVrz3FEo?v3F)v7FwZR-|E}FWkJ6tM4e4l zA1;?y9v7^eX6^26+`mF>(6qiQu5e~pHD~Q*aza=oZ0sACJ|=AJmUqTjCBLbVsDRiz zSoPD{vkkNsmPzcy`&ySf2Zr5xyeg2y4RuO2_07fGmhPF^-f7MK=Dyh$sCR4|`i#G5 z0L@UgMr2FGXxsMrX75f%c9372PiZ5llcDE?D^C|Lb{@t~D7pbDt?ag3)GBW&HVbL0 zCTrYMhsbBcze(boPtx(_2Pmnx2<`H=+Ye{gs;k1`42`zM`K(dGGcd(-W@O}!v|MOt zbfJ!6aqp-@McGsa0FKzvLv%%$XlQ8ZQXI(M{5U|<61yN-vhiO16lkRg+)rIr-k2-@QDXgG z(x$6*5l0BdQ}_*+MA5gQ{C9jA`>{&_`ZR+@g_`H4{%^BQXGp~@rnNY{J*{4|0?S4H zCH#aP24XKRsoMnLP~3XPlkFWsHmDW4pe7uM9Xx6>c!v8bw~IEx+%9J>0*ZL4vZod~mBM{e(q0S=@53?s{oFzU1??I&( zXC?>V+D=6cetpSMuJy&8&|nMq(uz^P%^e**o;0gRRt8&fCo;PQ=fnq2lZgx64Iw@Z>EqeWNtKgb9oCFZX5VLF~61&Zz3TI0oR7Q0T{?Q}p(2zM9^UzH!FT z`*deGITfsc_cfB(IZ{|!_(xwTYZ%xi4sLh#cZO%_n262+o`Jp%Lv)O7J3w?vyWxtC zu1l{}c@I?WT&1mulh{33Z_5zAF z*xzYLWVM~K=qC?kXsFq{=mbZ66^5av{L2uPJpY#vl^lRS$Nqe8hzoTC9fkSLJg?HB z7vC^wjuw~0&n${ZnR7{V{Rqd@~ZpKV6>5!S?{sy$%xTP<$bKmG$&*7}q zkwIn~p_~=KB~FP$8*A!po~dx`aZCP1eK(5~b_;Z1)HNB^SHg{sQx()~z4E0~)m1nw z_ol^<$B&?s1Ho~gosgT6FG%XyX)F{W4L80L1=mk#b&5?|x$BVV5k?!7pQ_hMx2IUS z&3_%Vw7wbI$TXgSm>t4>0B)U-j^fvj(udr7`XF~T6;o4Jy}^aPp?|BN;mlPPzAscC z+>lv`8F5!7EuizNwFLZ}GzS!QsB zWn~j*6Z6-kV}XvEVTrW(!vui}jIY_Ue=L z@a8L;-3bGOYV3q2OK~`vd6D5nFQft&@&%=@=pIvdMq%*UT0P|P%CjMf?|Z-11rWm| zKEI-F2tn6;c3=d!`aB!c0C+B15K4W#7Gga=iLMfTelXRaDl5jRqMyRw^Mxmzo43e8 zj?7lJi(`Dp5#0CrHsWqzvE}i?(WXumGqWCjzLTi$d|z0JY?+gjav15*h7)L5gl`Yp zH>+7$$ekYwNV%)1)u4k0IONt_<*w8(j`l9Jc&fr?6IBEjQ4VUF zu~X_6O}>H*7{yNZD~MO=O<_{M!Y3Q+{{^3HtbYe6Cl43zPlU3v{yT{FW$4)vHP(l` zz_YAG1`0-IM~a}4j>9N@83t_Mj0^=I6^BnraAD$EK0j@dKQO*^MYn2HnUJ(Pt3X?@ z44Fi{j?@zLqoNkcs;^V>yeeIzMem zw!bum8oAgl*!OYJu92cIMas>_xy)hq9iUIhm!pN}>acn*?(-t|jyPfGM{T5cK5J42 z%}d<*_g_zN`THGW-kkPYFTVUZlpDk&8KljnGfj^sbQF*x(LRZ-ks^u~;+w&CJj)My zKUA>PEx5ZZZSe&AcIVLEYe;VZ;C-|D$Wx+RNLUvyo}OBgI*sf7`O@Z%cM|Rkg9jH! z68_-B9kC3<_yjX1Q7TjH2BSBZaq*z_XC*T(N8C;hg(F%cU9rasK73c#9dV|e^NG+9 z?E`MXS+2_Y?@qnnje)NzzlaZ1#eP^e&Gbsa)J}4^_|9q@Or$DSr#hq}&M+PGE_bP9 z|1zUuTna^A+G6KN@ciJreICy<4d+!!!GYwV9sCm0M`dCYQ^GV8yl8-kW4WkB1;CjD z>rpCj8EPosZQNr$4t1yPt%+ZsrSK4)_UM_8OuqU6fY;1w$$&S+Ac}K&sC>Tkj=iUl{FUqk>1b!l$4afTB?qpK{?a{= zpF-;ZZ7f~Pu`qOO{YWua$eCp{TKr&9+Q1M|g(Xv~X8v7{scxxmxm3dk-SPq4*ZF3g zBRrl_qE^vcH$}pqp80A7dNhkzSbW-m-){RyN3-=M@KWD--H(4;>L1^`Jzd~VO~ugR zKRYX9VR`X>To}!U8T)oKS4P6z+2k&m+mPS!{BXPX?csDhBlUW!O2573=`jE8B=d9m zy@1lejdf=5#QgP4QI&qjgM*q@sDbz648jMIsO)i=z8~D@zM}%89=n4J3str(wpIFi z*;$<(O+wyYP9JV3BU2lTEQ*8;o_0dZG&k0C+n%2-9xs+|Psb;V6gxVbngzXmZr3t0 zMrVpNadr-be+*`5RtYz|j}J~(b`pIu$m;m=^5_MmbIX2qeCnOM-Mc<#8OUypecs@1 zyj$aoc7UsVc6m4&KYjkbPa@pj*6evo0t&^`_SCQY@xiZ#1w#X39ukV#-m3taPnPFj;(U#?Dy?IO3|9+&DPD4#Yxu&$XG$J`!U8B6R zyk+`mq?Dk-cGb6NF1pP2ON+x?v<7!2sCq!1TYIhPNUDrLbIsCa=ckgc%V{&2RU7mN z$JcykQmY+!JG?409RzoByhlfaS@hCtPo`GqJ_8Sgr;8Me%a2l=R_F1R^XvKTIv+lD z3Yx?;Ol)MaN$VWgO{V8pwA_8>T`skn#Q)GW)-X4xzL3QoTG?{f$Lk!6T2@w8Dd>W% z2kOu1u+&O1OI%a$!yRGE(eli}6i8F}rzRxd4^Z=*{Hm5aOi)&*+;&5J=IBn4>)=A) z<-j_(s%7rzPQ6ikt@3;=^)l|zY$NskL87a$tI)f9lfPv?b&fN~e3{sw#+BATuycx{ zsJd=^HxR$@up+lJbPUY+q^N(eQEt0#|8}kIh^s6^bIsi4x^$)7R^KIKj;X9td#(1U z^jDdT_hmX7di5>GB?PlamG>e_WvyAaxjJjN5-4j&XEYAkJ6?0APMK9L-Z9tejXG=E z8?7um*fQad1B;LrL>Sh@b<^Lh0=P506)xv{Eyk}jKFEVybjEKr_{YDkzdzvJ(K%(K z@h;OlXtS$d$^22#FtN1p{+<_17p28y0!;IRJcK6yMEd6YB3?Y*Q-OoPGQIsI`}*Td ztV-7mjNZ935?N4NSfamn5Ey=u_Ki1K(zY=nFJ?Vj&m;EUNL%7=<)$LTN(rKrZs+)XY?ixcJAE*46p)1QjF=*{N=hO*tj`F6orJn& zJxwgzfw7f%XJ)atE}ifcZLDnwCatX1k+Da?Ay`*cUP&8B4)FaSg313zdG|-bz%q&4 zpLC;*VU?>c=XU>~{6gk`QQdl$djLBS4M(T3)$;9jTn% z8XR^``R4kjF|+EGg6eZxMcn+qfzLn{$`(i!K>XWwlIe{I3 zPe5gk_AIqPpMWnyRU;VUbTPMKA^g;}*V}Ayt^(VF`g;R+2<%rZuk>HFy>egktK!%4 zZv}S~Yzo2}V@T6vtuoa2=vJq#Qqs?D6Z6=M)_CfS4a!wA>ge$bet^Hm>SFNId{y;I zpMsN|GjGA~3VzQ;wSxtkN7KG?Qx{{c$4oxc{z{)e7|8ItDo&rQUCb$XAATI`qgA0+ zq1HZ@woz-3Yw#)j3RVMygl1SJs-B0u=3wnrPi4lrw};{1g?S7T3rA1fKSEEn&u>u{ zuqqjJH7zU0AMe*UTY6lAkKq^U>)o;kup$^RHEAoAbmuBe*UCTKI#wfZjYcbmvsE%lW;03w?w% zOHj=1E69yQhPqDLCh8t|0lkIPLlDFbYlpg?`Fr8~azM6K)Fbc;dJkzt$McbMp{x0! zwF%4>;skmTshYr$yUW&Z?X0~pqtk;xi95$uWX-Py%mv~IdKRe|RH0>HL)ql+CH#OKM(E_3y;jEBK-Du?%^hsGMKxe&0X!rGCkxQERVj>ix6qmtN<4N!YkE(lybRKxde5$X`DdN#1*S#oBc)@ddfTp4+c& zwe-4#9wRRhRkn6+J+^Z@g`Od=eY$rz@Lv6k=)42`7Ws&1mcQ6d={#rsr;Md7j?d7o z>&$NrtQEo)<^*|>sG6VUK)>DUuXT?D9tL_!XF02)&4G?~0=j%kZaHTnYog7^?a$p! zfetV`$OA-Ct)989RkV;xM78_^ZtiDorTkS#$TLKR9}ch<{9Eh-cDg_A)WF3IQoD1Y zN6Y0;Ewb!SzxV1l-Vj|7`x9;J*=0%x;$O{YFcC9S5SNn?Gm;XQ6BAEAo;x2K)FioA z$GBIAx%YhtM*oetMjk3RD|@*;Qb$|0V;Fy&LUjsqSMOcnI7az)eBWis4%xXmX^or5 z(jC1t@Vc6lCh>OqvC@C*=KK9*^yT64S~x4~!Lg0Vs~Y;nx@vCJj%9!4g;#^yiyoa!+lW~m;%a^mz_v@3hZ6qZg!phe^Ir~o+ zV~4(=CIgljCY&RE{1FHBgMGGKCM#}Zx5kt4CP>a{t#dn z))C0#Nyr~VxM3?`IDod}ep&Ga!kiEggCiYj(jUJKYY*i9LGTz29PrNX0BnTWwQ<)H zEJPm-I8(G-u3FkMawibfMK7)^@Z~fBRzQJWxwHw&qGtz8DQX*&k&CV6xX1}&qX!1` z@+$!gVODLN&mPAIer>;(hu*DnyvJvcPFttv%_#)TguQFy(8gzoPLdMY$)28EwAf`o z!@G_0kP&52M`RDc>x|MLV5UfQ7%kqjNrBMEtB6vU zqTfkU9>FyWViWQ}*!5GEqA-b%AL22^WP`@@U-jCVJBvlqv~DoY$I2+@BB3>j0`%Y- zL@^Iw+r1@J>Q6J40A%6HM^Q+Pd+Wp zK-p!s#i@^6l04aVnQqb2`+Vlw0+t^+)qjxZRMR}9tIJG}lNdSFzfNxF&{(W9#Pe+3A8s6;rxO=f?>@Cdrg-8RddB6$v_5Ox_3r zNmJWcJk-zMm2YT&FGm|o)#R+`Knu{~Vc_kGTi0AP-|e6G=DPhvLxrYOh1&fre?!P4Ik+&*AolcQ&u+B0& zU|cchCV`a$?lmNU1%`L^8RW4zq|nMnQT3o3H1C;oX^}HtCLhYoQktU!!c!$=jj7@j zc-|yYN;x77`^EH0!E>op#|K1XT7NdAfFhuSv4S6Z%`0%(^%0y+B`!W73e)s6DFqZB z9qnsTQFwS2WDU%zxPTB$j?Xz{PzSU;(%ro96Uz26j@3baZkTQPn?z9OJoq!-^u26_81A1bKy^PM{{>i7|=~nZo)bl0}nA z0D=fZPu>V^$OgQh@~!i{3Z6}*P|qwt5+!Ae? zo#-wQ3F^GtFrXVU5Dppxks4QyH4Ws9spt*r{BMOnq=maiY@p8nqWV*sB$zKX`Lo?0 zs=u|3klp}&HUF^MO-koRw$Hq~N~Nwi3$mY(h^hF-Q{wA&JaNp8>E}UmL5y$yuNB2T zF~2&+5eM8rejX$dd_3%yRuuHyoxYACcD?zWKS(IJa|kA_$nE)M+9{g&{f$KaAfDjp zp{SH1z%yw2I+9rbW;bsTTd?lXzrXd%ww_vimf+_@ILTNVPp;{}@GO~|*W`$vxYLPY zc+g82N>f%TgM9@uuv8r*3N#0&JeLFLIgxRcX zucIzgF=9G3D=)u&joRYwiGoCXc@){fD8L~RtaDFQqcr=zQG~TIPMg3Zz+L1n#dq1B zw$)76k3xe6hazN*f9a4P8jHn)sF=--7)#7eY3R=4_?=c%oGoO_EebcJND((A6cRBU zTu5^0;?tLnL}~=zMqDHJADEyEb!$cvMzHgqKNLEfj|`WXpY;1-P1gn);&%iz5pZvd zfmbAP4-`%JB%sJ3oTvBtT<2)2zN|xMDT9#@1&@HXBG~VOwjWsp-lnk#Xr#o3t&3lK zp(tL)5A*X6-*eQoUo4iiUzp~$8-yL9wefRT-fvkGE4S8Nd7#Mee98)DdQ=1*6~kh% ze&)V>d3^b$38!2z`>rNAdyg>^$M^PdvZ~{Qlat4fA1J;+d)xDN@=m#x6-2? zp{aE-l@>&66MWi}d@b2-$}!i-!so8fQU_PIlPJO*Lcpn;3-Rk-6ebkmFQCHRh4}4O z=<@*6Ym`o?Z(EI|f*EK=4+&Sny3CU&M~psJr6U_9J^?0|9pwgdL>*VmJ@T4U6CQGv{L3Z^~tM91`3QWJZt7Xej;_MSWpiOMp4rp1^XAtD}%du_P zSXA%)$0CFKNv}0rgNP)PRhhnadl^?(QNR?anleYnFkFgKFy+y^G=yVX> z+PY%EX6Nhse0LkmZD-))^|F1}wUXiMb8d@b&<|R_Sm}Lwf*N-^n9^?A8Inp|Kz zdZ()>419b-K-pN^@a2mQHxS=}Q=80nMZR^i%oIQ1<(SMpCTxk#jl~rXPd_joXioEB zHqVL#W%vJ*Rm|O4nDVZi7t*xKE~}rMTRwPy>QsN%to^840jg$)<8$P^5ff+Szt83zts{k%%TF21~rx z;N8DTg8f1d;o_%2;hR{s7dX~ej4@w@eu-kX|3?(F|Ce2|@)UkMLTS{XmysY>!_^x# zVe?o1;kzOi5J9HWLEtbUY`rDV?WNr4l71cFgoKTDXDeA*mHW1mCjjX_yfX^Nn0AjE zBdxYdqvST@a!Gpca%)Ctb0=QZ@wu*dw(PP_V-3StJCc=A*)HB+hp?m^%Vg{^d!%5UDewYMN``&2aj4j z0?E2I5wBgO2+dtnutL*&Bf!|*D7IOhCJejAz9F$YWrd_SPqDHu*rui5zfVi&evD&W zh`H=aOjpDV+PSf3gHg4{vHMO{3Zj@J%Yoe3q7G- z`z)w=!;y{^HKQ_UcPaLkK^Ddq2uI6U4j!G&YIh(KR(QDT5nhb|`Z*3*WA9V2r5(9?K=%Y)3$`4=8rB-#8tw#p zk)rwt##-Y~UG%uvrz+)&j}*08ZF>v4%DqYZd>_ry=X*tu}~NMi8(lu<@POf2-I z*piZC1^3U)XL7lX#E0#J5TrD20D8zKthjv;8BY%?p%H8h>(4q0#BQ{Z&D9sB{W75K zntrvcAz3wZHCZ)XHC45ap}`Dz0Cqr)zo9iLE&=QS^dH&%0_+6)2*<+L77?z6VHN?N ziYb%pm|>3_m|v3+xKIO-f(#+Z7DZtH$O1$EweC-1TCNKyApQr)c&H4R?tRf}4^(Sn z$bV$lWtk|qF!$u*&W0~e@V2Q1#5;y>)j#@4KA4jr4ZkUhl0aMXxW8WYv{-+K<9cjE zwvuU6v3|F2Jnm&rG;Zv0%N64A$%fHh@;Xab(}`!nGOOD~wO~To=34g#y2w*YTuJDA zy0S2EO4kef(*Zb>h_{a>(QV&Z@<}Sw^M6ld0ob>%TD(=IDeVm=P|z6v*GdG zB_!M0%{goL?(T7B_k~+{1zW9?k#%eQt1U zz_2{rRW?9osvOB;r5BpJ&Gv%Yr1sKCEo;s!pRL@GKCm67!H$uO_q(&&OHVN&g*GBR zj39#NM94H@3L6(Ydf>=#kBJhmMYq}nW17*SIz82Dshak_MnTMOp^TZlP^lWXZK>M8 zSi8*L(^{FD>%2wsk=&9ll;)Ucw;D8jAzQ5>JVj8CxC ztK9H~j&}hinRS~o_Sj>vZY*hdLT#J(~L)!3fWy!4QOqoEH z3H3A=?RcrNRU7TOYd}I@m}r(x->1!)*6W9r7dWsW2lO5uIHSxq5V~bSKPUIsOOIaG z$-*0@kyY*H$*dS+X>crybk(SfR3Pl@fPQYO+A2|@xnTndg1V7|um9!VYAO6iw?V9WzEXuPHit@&P)f_Dp{I>SH9}&zdEItN3j80?Yc! zN_|xDmnh}*D8k1lLp{`pu&6q3g!*ODCY-@22qK0h`v{>U$Go7q4 z?M1ho773Uz_3OA9mBIGAUY(sWcSbbx4S&)*JW<1#uQkIy?_uJ5yXyxTfou0F|a2EggE`Xf-=cSAC#bwOb?83wp59{4b* z!>Tlsf>`ihS-(w*N*q1pPX_f@7Th`S^h>}e$>qOO{&?|4r~5pFsbUIG$Cms#Su9G9OsWu-LNzR2b5X|) zV_O1#m?d~ORqRTZ?4ckIsPfu}jCgo!DrEl%uZwYYE1g6uW}Y7W^cnn0 z1a^ddW3`z3YckA2RQQ+3Cr!|(ivD?B@|Sq!{C~tNfa^bdjg_ag+9ru21{;{k&`!mi zUM{BO+4zAwC?|_{XDFbm$w9F z$Ks3-4oyWAA(eNf6z`oQa(bP2P+%RAf;-R3-WM{OY=^4MOa&6hD?V<-rc69ot8HRJ zRHr~?R`^D&qy=Kw{Z>#7L1iwHFN7- z(#qgwjc^bn#O>gF6`*S^0DLb_-{0{&ey|NvkV=!56CEP08@X(*E>jrayZRhg_DxH= z7Nb0MnQ3J3L43uya`7LyfqH_Be5lb*t90ycCyD*nX@e6S7tegv=eQ->A+~2=&DDN#I z=_EF2f4SOUc{=W8GKHT!KeK-f!?CYDLunk`33mxtgCu~=fYgEHXQ{pozzR?g;0(}% zJcewA% zzIdVB-O%0C-Sf96qn((NW43ZevXv~>X!$z7r4>AeD2yKWcu1Wnj70zNWx+6^bG+6L ziwTyFF8pcszFDolS@!{uXUNY#7Oo*}lNy4(0He?~waq@yHxq6${UYq)hVJnvMCY{^ z{C^2iuKxj|yzFfMnD~O6JpZF(XSqhJt-2^8FqtV=#I3zy!HP}>0y8X>oLF5#)c+8b z$#-%Q7A^pj4SkL;k(an?@IbdH8zAk8To?Z##>svNRgY&OZjr~O9BRIy#&z23ka3;( zs6R3nj|Zg|R>72Ch;9EOna9kXc7n6PFVtO}qE||87lp(j4o2HzZUcavHSQN8!V(AJ zvY#%#4|$o>_0DjcE*3-zT2n)FxEvz}5+Pe6^b(xZ70?kQ)`7NcBr;QMI5`3(KV zN8eFAY=vYyJsk9=Wp zk(^D=J2ls%8!|u55$|0Q4V8-CoSWO*yBIA~H0TuYeBK`pb&F-;9?Eui*wDA_*jzh2 zT-)3K(bAl;3EeFS$qjeb7E0jOBxaA3m`X;_?Gn%mXN$TjZlCxLe`~b@HfBN5Kp=4A z_9c7lexuVH`p4amA3MGu11JkOnKj`m(R68=elvt}u)a^Cv1Q?RK~HivSJj8Yc5GM6 zW@<7t5yvf#9O8xR$hPZ2@)i#!*+JiNrVG3vpgkcc(Z&Zq4f{L zhR~d8qDbaSfsWK^Z;;GY0@G&=sX3o75frUWK3fepr9@c`d+8^5iY7QP;Vpnzx3lKaE-Qd-PvAHDXza-!%pg0Joq}|6uzl16G{{mC) zKb}w7*!~MlQv_oZMG-+OODRe@<)>@6+I$6|=hILHHzi3-%tJnj(N2pKU2$?rZgk9U z54O}x&%5@zn`RxmuNGebmoG<5S5FDl8X_4d`E8;Y>G_ht=;%N;xsHWmJ)u+0bpOV@wlT4{Wth5feMq(FI+y%jq! z^aB96m|}df=+f1-GK3*ROn(*jwcy=(Kjs{5$hXvH=O_bfGfw4GV}vD3fb?F!tLmtN zQ2;%^Tw2rj(|^ZT&{u0P13T>}mj3A60`b(Of)|u2db7 zxXwIcz-C^~fyrLdi8&<|D-{MyK=<0(@~anC;9!a=YolNylDh;8bS!TFCYrMK=7dg7 zcxmO5mW^p^@r6VfPA^5S3gTo?r76!%b(S@J>03EvNq`l^OKrg5V*e(9Ar>z7t%saD zW7OH%*+tFm&(SkW|F_X|=eSoe6CCAx@76P2vbqrQS?nM>0)>W@b(A~n_HY;u=vB}* zyvuQ=Ot}8^e`Qo@N&#^H#P-Cz;M;tB9=C|T4o_avPzt~NIJj5b4BfeWe1SiG$S|1S zPhP~mH0(=6V-fSZik!v=EHfNrM3KUZ?*h9jbUOLWn=(;rj=y( zf82-~t!|K7$kkWW7kJiJ6@f2VzXa-^UX=PjZ{+a)38<{x{{^TTtudGYR3KI;YEJ#5 zQ7e@*94aX>-(?u;Z`(LP!Mzs9H5mpO^7PY+GKU4{+mkt55KK)>>tB0KtRH!0=OfV= z+E|mXkA+FpNm6E@kk>s>)@nPG6AYqtH@l#&#yiAuYTJ^}7h+s;;lx{xhMDRl4q1Od zeQQG#kK`{=ibW-^r+gibW0bdY7BTc}o3{#%5PP!h{5lD1SO-mqw|~He$+rv~b5g0RNZ|!#zbP*c7mT z*iFO{=Uqb}@ne4$T#&0M#Oz`ll%b!{KNs}uhSnx6T%x~24aDoRfAYdn6(VMN<$@a zMPmB!9t^waLk3cVgRMAK20gOqnL&!3zTPmvt+TUZ-?~MtNWGeWX2~ReRt?)*sYbE$ zG|9IPX5L9Rm@=O5RDyc(s$`16ZJ1XYLj`emwz25-V&U4k5*12$8nnvC5duH&Qim+n zG=d|B%!7v#BXoCrd|b81f_95N=>kvYJ0g`=NYa?tn{3V9ia1$xCJ*<>Oqu!DR0@UY zG^*i=C4IwcVg~fN=Mi2`6C=WVYHWJ+>CDM;sWOF+89-^!5V{d|@cx&`{L?#y|38rV z$Knxy{XZi!NrOK&34jP>pvx7>=nE&3J;cuu5pdpC{zOZQN|d*^!A^|dl&m3_cs)Mh z4T?Z~I-d6U1$4Uc()@tpIn%KliH*A&V1-a4xSl*;Yn(5B%^K~}{0-$Y8+lQMIOR%K zu!J2yeE77NDOO!`D)lCAe#D${s^y96kMf?Cw-R}uC>^!&{LY;mIF7cJK#N0)!l3YCHe$aSI^Z#N>4@)HHU(SEe1YJ zVP1e#?F?MBX;Ix>*e3->6^kN_430%QXfPt7Jr1B?c4l!K>+yK0o*Kj)HCIhc`|Oxf zML9e^L%6630l@M^91&kAT(ozIjuyK<+Z~&p#aeXd23SYx$_21AeG5&cc6)`3JW9E5 z<3bUlnMY#mPE+lwzGc?yn6uo@q@^_{ve!qgpQkW(|HkdqKGDG|`Lx8!pM>NRTJoSoAxspC%77vVDKt zUK4DhxVaf%?$y}V+*91C4Hd=}a5ek}-Ur%UwV{036S5kr-~R6#b}sX=KzJ^UOBGv( zU&3;v-OZ0vCEIXj#ez|F_-6*C8i)F_k;L%V1{qFVW)p>DOG&&LY!<5f)+3q8kWP|9 z@DGJ_IsnNx?3JJKG`~hMyc;NZS+DHF)7*|?a2P1yxlVgx9q0sG5QlAAmZGKWO-|a9 z8EGO%DS4+klp7Z-rtmF9&uD{^A-6ACXr|DpeEnJiepU;v{o)ffER%1wrRZ}d>h>#abaIe$wjhjhK}YK~V40mR2Xt?`lmjd? zEfMi6qeXk$XQy@}9J{eO@^q`AqLT)4;#&bkd=@4lBlx|ful}H3tc#&qh~DO8CcUmcCB#V(?yAv;BoX2 z1WMg8BjGQ#a`aB!Ghae>Ck{+>z2y#(7V}KS1!{h@-n|{3RD);Ww-cDyH(A2>G!D*Tmo@LIeN?eTb>PMZ`dw&Y%A6V&k{ zu}N*_r)v z&xq8%(22rtcSb+yZZk;av>1cW zf8n!V>?6cA23KyB8Wvk0c2bk@8j+ja;yYP_i6S}9C|Y-mi_#`WO$7phLwLDEW>{>Z z#NCi2rIaxfriJb`v*YS^_8Bcrv(%bYOKUU!(O`PtR6QQRYZuXb{Qt-nZa(L>xCZkPxa&C{3T5QWR3fEp;JVC+67kBC34hsnX*s65rQ<}PQc zc24obB)M;1YbMMHc#YZ%v_VHu6FteHH-^h_ZRBDpU6&ifA0?^?mRCz7q$kKh3zT{c zg2y-N%RvK;sYQZFUuqOG@S&qs`*Pwla5-vW2oUgb-fg96jGq~b<_F+%l!l#dIbn#$ znWOMmdvm+CpkwjtxqUY-DpRUa&4wTtsYJx8xZw2S2S~ewi{___K}8Q~Tq~40fX*MB zVc_R*L=TjbGFeR7;3{xB=5Dn>#5Qh+$G_+6;}Wy$%iB>riLyy7+kD-%S7}dO9=4^# zXotA7S{8^`?ae13R9<9ZMo5S|b&Eg)T-$k|5Zhzi5YEcZdaVx{20>HDpF>cV0r?<8E!}QGoZfqJ<4`dn zcwVe4^&zTg@oOc(Wgt`A)6LzZ9U3NjLXg4pj~kdxH$}zHC%cC?RKg{@G|Bm?GF~d- ziu9LnsDw)TXp-&xR0tXSyZ?oiFYt$rP9GBiGuwX7i7Vp7$w-1T;UDOC6Xd2DlLR=1 z`&hWPWm0s96Byn)QpqwSO(wH8qf=}4?8>A8_w4R~3wC!OFMn)UPwyxRAou@d!~e+j z?|f&8RlVfF{K>F>vVy95%xAOjnV){^;$s##=uEoE*GcH%YUIi?lrrHGbn&#`7E>Kh zWZy{8h0{`@QBjFC<9u{v;n>r+9BH5W+!{@XBd*FE@Bsyp@%g{_BK;Yk zpf%qAys)duZkx4RLHJf(eBc&-chlR~ zV>NB4z+=AX!$n-o;OMj>c#<0Yw-mMUf-&6aJDE}wudOJhrO04>im=s$%u=2p7QSNe zxswVO?1+CkaK6Yb0^kB{7?mVVaAyl@B``ix#HYt%Dj4j31Y z4goA?UeD+C`~3HKk9o~K*UWXzTyxKIU-#T| zQet|P&0>(J)g*ct^0v=i(i$ijhdSj8>l$thpp%U^PEfZEaIZ%4J5Vq^Xw;R>e8m%{m)MmM`%kl);@5~hoawV)1+X8$KNauy^;4~8fa)_YPhO%2*fc}#bel< z*+~{uBKEEtN-^!t)IBmZg(|89G+@%tfS5MOywEf!c?==ESo!EtHE=Y~(#Oq;(~x1Q z&E=7)k9XtU>W8i8YLNq~Nvr}s6%|_2z(iW68L`Fn_9Rt1eqK}Xj;Ll>v~77BM=e)- zCZINOdz$Fg)I?Ew@YnTG-uG)273n+X_R*v+uuOi=`;B1_lRJ+c?YEIP-yz}02hE_F zM8A1Uwt=#>N$a2wXfPEg;A#KG%SoM}zhNesDNo1K*zC-^DL!1Y1+s^ zDb*>xo>Fk3`+~rX{mrmUJ64o_oU<*(7B0*NuLbX~EinHEu$0o!SgXk}!8}<+#>HLR zyxt|xRKoh)QFlk1EShIozlUNrbmvcRCIP2vFe)6q^v5py-)utq#dh?c-o+%=#NJS$ zP_o9f=8!D6$1zhKKmo_}UuEU{lw+2oN>fSxZeupkFU^sNq*j(^K|-AA<+ayQp3RJX z$r6sf@4c+EH~czaF=u1^RGo{JKAp%?evf+79X5d4{4hbMd9mH#*hEE!E*;Ek(nVquoX9)mQnH*_uZz z$*`{_`Po%6TP}{9^eH_&5*{ewXsHyjIBLd1l%?>n>je9Y(qi63(X*!WOhSok3ztL^ zebPO_k;fT5!mhHZFvG{*L{o@W`CN?4W~E_MafOeG0;HRBz9Mcc+w0_FtM zZ(YlN(g*x{**%O`?0g{CFk!1eBURyvpE&%Q@67` z(aehN2;`}K&+6Kd?$68+R4pYVrR%Lkr8E?EGb(`Y5#74~sR>>`o<&`>KH7LpXY5W( zK@0Vag?gIx3yrHcF`xXXAwxE77Z492os zIE0iOM-)sq(u|BmjPb5QLX2*g-PLJ6dVh7PfK!o+`i!kM$9A3f=}0hENn1%kDd-K| z$9!n~7RO)QM{R)uZZq<_ib!kVp>(NsG5C*N^1s<}^h=lg59Zu>V3iBZqURFgbuzTz z&(X@_mcZ*#)-L-s+AWvAj5T1e(Q5@o7c`jeBQ_`oX5|c z5A+Hbw?59TCXQtS=2qc7HvAJAU@6jR z;eMcSBNOo~Q*)sk8c>a&RGpRTv2&5>GPQ)Ybv0Xj4l<5W@tRkohV}gFa%?ILJ|#vC z>Xn-Fcxya&<$lZ0@i=#WPX6SV9iKjWKOVIHuHE=MZ%U;TnTQ6J3gJeUyvhbTpX3iz z`tOiY5}NLj+;h-I7S2Zv@qWC|dlJT`)jhm89#vhluvEKy_mr{mwIbf&v(@vq0qL z6Z(^=So&KH%)x8Srk~Hn;=L0zJ{r)5UYgo3r$wQ>h>I}Q?#dBQDe-+kf8hH>jh6a_WLk<+`v&a4ktam zjH~%DMsZ_9P}FVbGbVXOJvoO9dd`Nc7qNw?izRbeaGZFNX-37_AFFUI&*`=rs`Fkq z10n#}95D>A?r3r}d+}6pr0PYyV#BftAV`S9p_7EaEkpO{MG~gBCm9iCQuP7-&R5Q6 zw=*Ruj`Xgb?t+?kG0cUjqAKa^dBEunZp%@}vIdhW%7JYWi%l8Gw+x7POra6La`(1c zz|QvKjA+vE_WI&RcfQQf*2>qVk2LC+PHf}+0>T}N8YW(hHYi*VWjn24b=?LM5h(J& zD&MxH{`)eQagnVB5;F0bHE8`}#MU7m>wDQnomQwG+{kAU-h-L$L>Sia>iII10`mEtS1V%vlg9Cg2L%KZ@L z{DXUew;QLPfIw^0sU zpmXgY>9x1*d(O3`H78{7G!A!p@s=mJW@b>3Dzzq~j+=4z3;3tZeQf0FMISFuF6km)BAOO3 zGOePw9yBwD1v@3g1$6buFNsvBzJ(0Ddn&;~(ykAaUqU!!rWkLQwcRoB-WZ}yGdI80 zMU!f`Op{v2T-sW5xl6&b+f-rcazUnFlSSsbMs$KeT{497!JJ#M<%1>t z-wC#}cT4Je=p{4C9-18oVWFoN5tu7w&SS8QTHkH4-y0&(GeQ9lHNSMX=&G5>n z*1E{pAfc@rV~RC}KKa9gGu@k4ShYpgO04SEH`^am=TEGCw%+jy3>+|vrb+T){rovF z-^}E*jU}1Eu^1u~67r9a#|7qGWv&P4CfVFe=3_VC~>B-guC>5GP4b z%1p{k0bu=dW}~CQ1?~WMcohs_coMr@LAx1)`zVchumj-*AzC4+3v)5fg*S z!Q^5VR|eRtLDir#JmQGApV8ytUwKkaJ=lYM7t!PuG&nW(r=mxz`7c2)euKDzDpVEv z@({L}{6$iW+>Tsu83i7+-*H)O!cUadN9mSa)P5k_M7fA`594v*JDM2Z&#GRK+k>kd z0EqR6cd8_Jk65q)+v>vKlRc%sz@yeA_)M$6awoQ&oe zp6#BTdg8lBj7JU{zq~)Rb@~axbb0OLKQ7Atn{8?$aN+N}N#TOP7tGoq;4Q)5oaAef z{Nmb2BO0Y(C52=iznlPCs^AO6PcF|tIWSIx{6y7H@#S1BuJ7($TfJ8CHOGA1{UrF( ztz&_2+|AlxPOROrJrgXScBe^Pn*|GLPbg3HhXf3^Lb7OAvZqUowbI0eH zrJ6A_(mtOm69*;Ae4K}y%Dqqa@iy09e!)N2;MYpHl; z#0&d8aAe4@%UG%@}ClkNyUu!(z zwlKMJ)lX{p2K!7clZ@{ zs$$uEV<}-<)hkC_kEP({rqJbOl@0bSx#8K+ZQe@*xgC4*&T@;YZH|;1WjMc}E2gga zsKJ;77rlAUn_`U zHX{x75i#T^L{?sCZu+|8VxPjqz?%1tr?S^G++8q-gt=RwDx0t|gG?2HPqRvmMvI$F zVoEmRX^ro>z1$>zbI08r^{~mQgfF>h!3cGyHeRVvv>0YGS^})g^O-b+VjU@Zs3c?3 znIs;tPm+jVh|OSUAUS;Db!bpRD8HtdeW9E_MXFh6{DnMPM0mzgxkB0eL)?T~l=kYf z`Ug@8JF9nY^aU@y#9FOe(vI~ESFc;2IiD1?8$oG-$Dm$#eMH&Zl|oQ2s5h?XJJ?|b zP6u8y;ZcvrVF1b{GY3ld5K{bCn1UqE!>g-_pBx5oYwHAv=^Ik7+ihYFcs*g-#RlPq z?5jOg##iP3(`Lzaw2t)|h z^dcXI{J?=S?n~U!$LuQ(&+kXxO3MK(0hSAU@Z3)b${*}K`~%8b2?qwK5(!s$^5$A! zTc%X;>ib}(Gc;M^3qs*uI;)1n`>yh+T8B=Y)`#pxrCCoEor8Ow$(wurS}LXLw8ZdA z9Uu4AelGnJm_Fl6ujNzBxb(>}j+vVL@dfT>Gg8_6uEXIEbjH8md5%PvR`s}4xFYkw z-3I8?C{6vV4m@RC+>U(k7^S?@7QI*B;^10JoRx_V-=Y!6QX<&8p=hQE&4##wV*YLf zIyFMGJI;ZrED@(+<{9Te1#g$@{roERB89=ig*-MO0sGd~?dq92?D*!jh*RBhXr^n< zwdy&gEsFEBPc;rf&KVnKal|L-SjqdnRoUXWoCLM1_vN3`m+7Nz)!>3;R);O>4HqF5 z*)MV)p#+@?YCp*&g}~as>%5K2y?1-#wq>&$eT4W(zP}hw)J@b` z)c#BKWquMyDh8_KRL7{usmQc@JkGkAxaqj5x>J=%kz54PdiIjM5>&jgs6K~8= zB@*J%Ce<&xphq8{o54e*#GSzn4U#pKHMIETpmUwD>=(ol?xKD~0>q66m*@f2@5t0s zz*p?{`P&3J-=ULBs!Fy80)<#_hM#?8j9Vbe;eNBS$&NY%vX z9v{m6i5y{$Qyi!0zae44MnH$hQD08)ckp+f0;Go;gnR>@ULZ{Ki6{&h_kI9WU~q#h z{#Qix8wkkh@cfD`u#E(MTNf=Z_*t%J{k= zQBD{f$OdEQ;3@_F{J0JbazIOgjfJ$JT5bv$dk0m24~)LQwgJlD2_=RG%Se++`ilFy zxVZq_K)x={uAbt)QeY$+Yl9I7!uV(i7_^%N=OhJ|!xKOzS~?&FtOo`pCII6{L7^~^ zh?oEz2}O&d#rQyQC|nQ%6@y2k{)PVaXm%lZ}NaEDX={b z=Ozw;`1tq;_y`JMJ?tPbF)=X+6b^yI`GFMto_?-4q%Xg#C;J|g?|c+7o+u9oH=G03 z6@=%Dw847eq`+XjpdWwVD(2$$Ly)Vdz-}c4P*@j;FVYPH6M#bgCX<%d|2vzD%O7*1 zQ9rV|d3iYRRtk-RV4N{77+0JpAQAS*d~W;n@k=oQ0+31Y?=k`H_Dzew=kndlwyXR- zok#*rF0O?|JJ|Xu0!I)@yg z7!MF!5M+z>02yOF(0g^-pZZruT3X_YSdyAU;fD#rQ2Yp# z7?d9g144qf7+Z{ujVQ`SSY(&&uX+E%SIyNEhjc|@zVpSvMG>v%7gy6dj z5cB)&+@^M!LB#yu|5k;cg~bmR;?77{J1MX)KN@3;^m4|5A;0n1E%>iYb_?;lJbW3@KL?KAxco0m z@@J{|@}TfN3G4BPvi#Z-fJ%O9MOw?j2?Nq`_H#kH{*%W1qdZBV&BS#)uxKw7#zT5< zs0aEFNYlZ_1L@%hbRhv@0hpk$B))NfCfwJw_;?MBpAXQ_dU;^a{pKU&$|4tBmjK>74nai`>(qGRo6e#z&}d-@7?vUy8e*{{!!w8 z@2>xE>LUC3@C+Q(Dh2id9*zI_c)st8!@oVmRZ!^17ltAT1n}}hP~`7ke%wrKcLhHE z4YO{<-kV#kqx)EYRfEo5ff-yXZ$UsKI=^~<(C`LVG;LE-WnSNUUh|xzIfuhVIgZ@U z7tEe5WO?Z*d`chDbWa7?>i9+sHY+39tOPT2w+*_Fg4m(_7s zE~l+;{Fox8T_N!chb{37A$G-z`lzO;L) znlbbm(a8Rx&VvNYQK;0^5ECSlb*A$KGzNf&53_3PB~NXM0>skxCC>kF%^ zggqWeTll52m{3rwuxsYr$)H;kGMnSWJ0}9!DulRwZEiiP%c{xA6>-?E`M~F%EUG2! zR==`z;6)VCoA(7vw6#5cCY|@6Hf-BYU?z|yOEg2>(&m2IXcKNzZWALh*5Qdy1zFo< zt8exBjSFH${2Kjw{H&g3ikG;~7cQj&U?Ou5?Yr5RwhIy8LBEDwjFNnQYt;QDE(C=@Z-8u=&4d|k!?)!~pVA`<`e8Kfjt=P$E&+6l>aA5X1aq_{14 zu+a52!N&P4YA(DtX~;UC<-2t#M)O*MCE4*&s`v@XE8a>9VF^8V0*933p2@npzt&tpuVZDkN6vy^mT+m^!UsYFA`jb?0l~rg7-*n z%7WleJqfYz+rYo=Nh06hBErOWH(mZ+H$u0UlGQ`$!bgms+e+A9zfZ~ozSyWlPDC_u z|B=n>)m9;;jnzCbxN@suL_%+pan!j~)hJDdT`BxAAul!%)h}v_>Xw~h?UMMMHya6t z4k2%xpw^X6vdFveLQ^wAFQBcQW+J;h>htKB9XkPiFj`n?!wRcRk4${NLQ&JM5fOYnAarFcVL3BJYXa^MVl0TU4w7FCjmDhUh0q$S~il@Tf`q5y>{ ziwG$q6hsk9qJmOu4! z{4w~eZ$AuaqKC1C7@NaDf*_dXPiv+9&?iF;RYP66nu!|Y9IZov6GNL;bQq)(DWiSd zk*;F3#Ef{3WeC@6uCP>w_6wgKN# z*1njXdo-x*cdUz%mn(?)E76BWgAUDBYwc8jvjLT_v}rZz)1N@?k_FuYM64G$wKk=X zo@{(Ja8V}VfiSf+MG&H(du+A4*02m4An%JvTI9<;43thCgMksN2<-6|GZuqi|y{sMVdVl~~vo??uwm97o*7~-sBvzzZ4K@^JB zs!L&WB{4XwA)m09((+#08Pdhq`s+hqNAeWfiM89S*K4)dnX0XqkavtLUT?l}_WfAr z@Pnk=PluaJIx|i`HGk&B;kr=Ba9kv}`{+r7%2x9mv#>K5NGGd>0<@c1@bXTW>v) zLJrS|*Ek2xSQgR+&PCi5n9EX6)gfJ8AP_^w*gMA2ow&EnygX?)&d1Yyh}zY z7Hn1xmDUWJxJM$9c=Kt=c2oPw%?)bf(Z-XTSmxAJ-R24HuQRL}>)REKbo8g^d$?yq zvo_Rq19NZJ>KPbVa~GD-^%zG*P4gN^USPg+U(kB%*jWOd hElTr0j1GV$(F5n}fw83|gTaI;$v8Na&H%sc`hP|!Gs6G? literal 0 HcmV?d00001 diff --git a/files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Poster Abstracts.pdf b/files.transfemscience.org/pdfs/wpath-symposia-materials/USPATH 2023 Symposium Poster Abstracts.pdf new file mode 100644 index 0000000000000000000000000000000000000000..f3f297eac80464fe1ecbef9e2d0e2ef7884e430d GIT binary patch literal 789666 zcmb4p1yo&2wk;A|gF6I5a5%UGcXxMp=RmOFPH=a3cXxMpcemjF$?bmsb&ql1>;Lx{ z=alY}Rcp>wRcn*V3JTNE)3P9tZtqOYAi&bo)3Xr)h-~!D5jZ*NB+aai^z6-CjSPwC z=_H9*+1OcFSmCmSP!AOHZM7Xq-;v$8TV^78{2=$ZLh8JSpw1o`NhxV7lStPPEvHU6491Jj?R zvCYR6=~+JpDNiS9WNiX8C1R)lGa{$IX2}Milee(}{;9+MR~>~95q+eX80ZvTY>ntt z<&BK#R5a*`7>VdVWZ(d_H`230fHhs$*EiHf*45S5)l~x{#y;>8GeI75Cy+b`i;`s4 zbz)P^V@o`P_}1YqhFzIV07!uug*;hPfcT2tVgfSsu7JS^pl7ITg$M?>>g0bjdHDW{ z#OnnLlB0r5g#h~@=YRI|Pl-DK_3VMp_D04CumA*DQc@uqVFcKJuEL)+V50x;H4q@8 z2Qae#t&BfPSU%SNA3|UOu+b?HeJH`dO-ff+7c83so*EuLI|a)R3z-+1ydSm~50jVE z7*ev+XO#YMV@r3c)4@wDM32z72mA^$pCy0-il5+;?9&SUstvNzCaSJ>FLJl;Zl|4> z8FY6k^mdHOmGy;q`m{>Is`Q>{5$R_rtLkTjv<%r5Y5&JP^KRQ z93Qd5!uiUL|IUaElCFChatmYGNMKzwo43& z5vdtk@m^c{S+0~gl1*)Ix$OM1}tCAOn zO1zi`?ZStL$4BQkzAK-m845l2CNyIo2ZX`9brnM z*JJ(Bu%FTg9|&vQ_XN0Our8qiF}`GvbZ<@eetxhZ8XM}&yhlrKX`sKf-32idCXxq* z27oZ>(^dbCX8#j*|HV;y)+Xd{?;t`T(jYV-N+1dpbW(cu7Joqe!6$#BAM6FRcQpDS z5h){}o}nI4kBFWP@E34p^-PQ;^;~Qmfpjv~M*komx<8o?A9~OJhY98B6h2-y04mxW z8T|!%1^~lf*?%Ej;G;218W zdjDhT2gQDj<)baYKjtoPdQA_~9{YW;|dC;?+csRI{=B882>LTF))1CAm)Fx^)VC$pw++fQ?82=c^YKq?nMaBI6)!ixDA3@m6k;C%*b^P8>{+z^z zd=E6lolT&($xFho8=48s153cfgpHu!uwc}}KL#c}eolDb8H?m8ZgWK~rzuSexzFqu z@V3;JBkGpUK%Jb^bB)sdF}p&Zrmh>#>~*;8`a4hH!!18Lj@xW8jqgG zL-Or&F8kIj-5Fo?X`sZC=*S#OBpvf^^w;X)vIFyJ`7c#RI5m3vC{==Jq8EVHwJE5wSZuau36tINx_oQHDy)a^ZnbyI=D#@4B(x?~$ zKF-KnnL_yU&d3?HE*kh8=@|yr>h^@PN**ZwNs8I=s*(#cOl%)KLCEVn;-34`a-jes zk*F@GD7(0?_d|6W6FHg4P`sZ53iP%saxeS^YT=;vt4M5h1GjjQ?>V0fd&_*($Z@6+ zk)6=FL4wEEdk+_lEf(%OCW*!oIoIJ37WT%U93@sOs#^rCdolx2f1iUl&oy}T@~!n- zHV$EgH1OpPEk7eKQKa#Ezslmsd`>%jlzVEJZ#Psq*?iadu*0`eOILr(Rt$d#cq&BzX&)ojzW}#@!Zz!k3Ffwg1etK|v zUrCJ+pdSfEYB-4ZCaTf@ufQ_3NpD}cqs!(7_vJqYOt_=c5j{IMY@GioNG&i(mrmKR`V)@3aO`8V zPXxILKaspdy+M2C@^lj(MO=#f4@sJCjU(J-uDLg9(P-_Cr>vn z3`hxIc9onlJt43_=tN|O|6X$$|6eqhnT6@U`Svf(HDBRHgV=0K|D(Bs^Q%n@kb1VK zpIQ%*9G^j|nVcZ%z8bo0HC*7OMe-wvg-69++wsO+AU+E$NYlP^-`&znpRYQNVcER? zEY11eC$VBQ(#>qe_0v7Yb78@J@b}H-m0imA?PS_>DYe!ciB_xBP7jw=${Sin&CAMS zZ`B#?`O(7p!|CsxpIC3b7N_4DY*WH4w%K2E=;ki#nuQZ4BHHkhfo*97bVo^^KVID7 zr_itON$DLodRJuU>`I#@Mu&x-EHxj~xl^c}#yl6S`Ua#Ao_;VJ8+oT-hTf3vkzS)T z>C#5VsYQh?MXHQa?J{5EJjOkuy9~4ntTSFjZ6t0)ZX}^L-rP7lb8-<7$V3DVxEV)K zkNV&xf-{T}7|YZIF3p_k-7&c(zQ((RN=5{Vm?C5OL3;E3Z$V?0uE17+4}w1~EDM@7 z`J${TMj|*X{32kIa1-eU>H+)}^o`fki|6l?acv>mMitpAOC^U&ca*MwliX7dDT~#h zsF%0STNH1K)2I5A@k;}{o*@~*IA=+h<$nrxlmp7<4{0zYR%>Vz?IzTdUSEhkTdSP& zW`=gSCqkdN!;cCRBMKgWbskMRU0r{|ed@|9xQuy4*98H)`-=Scy7y-j@gG@}m5uRV zbGxtkg5p2-})Eh zS7WRL<6?yP^|nAD8$o&mk?+n<%oK8VPy2+Iz&pt{i#- z;No8bKqZD1`Cnf1rjLztr;#TbsE0lS0>UHNdLw?tbU&1es`0n3TE<&&93XGt0-V-7 zgBm3r<4Ee>_IZYawd~cD`QG7SIO5{^J&PIn(pBs(GCh|kBd8}=S0`QW4nS~Xwr0Ao zw6o0iRG)xqV#IbJ#HiEAqvXVpqjj#KdGOR*^MF3<@v6hS8+eYJ&eY1B;$CCu6`yq2 zKy=QOr$h&U_l}=Wu;THskd0Vmp3s-HPSr%-;l?e#Xeuc_Gplm_bJv$}(m1m@3JIpV zVr$jxLL8EKTT2BlyC0n`cG!_1p}*6I<6C(6Q)>jH3Gkiy2n<5Lq=98|RU--Qbg_?h z&+T8TPo-jX>BaJ|2xRA;LQ#-%i9d?viQ%S(wiz^=iH?tl5 zqx^mfH{zV81Ln(V4ur{5pPBj-Ca4}tHyfXT5awO8MEddhLxipuTGR4@Iqn!EKOOw{dRvY^mgp*>CUR=B68(TjmT0r$zrARDmp1CeW!GDTs={m=>9uZd(LP6 zXgIbk7eV`z=cI;5t{Ux7&+?F0p-fS^JoE*R&$Sl!;tl6&Tyk=DTq(=u%VVEX{P^Hq zpjVsP@t~0Pn+&hBFTVt!fkqjZUY%hk*OycuDoXa84N{Zf*$SpmSe9jIKIg4XFT#iL^id9&b$AVNo4t(zTn zg{3iB5dW}hD}VQxg^FXN3Q41uBYu3i5mm_$vFnZzJCpWd2_13??_GAN3oac#X5F5m2J*V>9YOs9_;?b?CjO+;i%W z_8#*Z(nmq}<(T}z+V?R`$ObP{CpOn6OTTKDT@VAs1Kev3zpP#r5zMv53nc}qScTlB zI2OwA$~{?1k14%pX~~(TtqBa~;2=T8^!q3C5*L3q1x_k5WH{Pf9I$(GPmTGPeRj)f z-(e;om8J&CXkh8W_?~|f+L!TZoGwT}0uXgx=jRi~MQ(5vaJd&yf~oQSn|#bK=X{aV zgbPypLk%L7F>sPLuB+C3-}voTwFp!~$aXh2S1e?k&|sKLcTpr#9mB$?fI~CAc{v;@ z6=<&}oSO#6-hka*<`X6@?1z-i+xZdmL;p}ZYUO^nV+m-?LD>_c>wNBLrDA8bUBaVc zXB8FVn&x2$l_rK}`D!2%^N(35|L^i)n6t3SgYLgZtdA*m37B7F*M| z7wOj7Wgevo+Ja|td2)Eos`3t^4n$vN$ViVYtpzA>SB(W$n^gR4qh|*2?3IQi$Q1>* z8jDdn!!^Ss?^XqaUSWp>^GIXxE~l#b*_c?V8;T9t9FT`m6#`}u8z2P3YVNEX45vFi zme>-;@y&m*36sdX9zmC`DeZXoL*1*bJmtDH^?ZFL3YT#)$L=)ut1zDU%~LZSLG-nb zH^$^~*>s*W+L~V^fTd7H8@WU;CeV1*MPTw4Cw160q>lU8K~-?q{cL5g`)KwZ7UP#J zyznMLOaQm!L(61bAU@6MX+3|L_tOs^J}2Y=6Ol2{2(%)&YOANs>1kg0t@D#fVO|30 zu(fU-P)LyPV?q3X4~sv?-T!QDSONbE3%`GX1$c}()%b!e+TpUEs<*z-$;zZ}GMjaP zAj`aw*88hqaBgaD5A9>7=<(H6RI!b4F_Wu0mTVqv3CwKC)ct7@C>(n_)}ZS%ql$tS z-yM|***W+<29y4_>4~;+2CQX652S&2)+3TNeatRjBQbOfe; z!U|nVt6^-8GU22Xyk>;%Su<7aZhb$K7(3mibQ}}xXN}U}ll#aZF5<%_9VbopM;PFhh@KF1n{MCRbH#pvI8No#hBwLD)KCX9n_Nf1P5b;<{fx4}5FMjm zL{Z8zQWX3>2yY1fVTee2(ar>)tiZ$R7iAbku<|N3I&E$I z?ctCokD@YzuSqt5(h_GKDtZNdlA!2;s2&^ETPlu)fgV5B6liY6LV030p8*Vi>G zB^3*Rz|c^c1=Erfu$R)(4O~K@;MfBTbzv>8T}V(DHL06k166DJXYg5s5nY%B?dz!M z!|D+we?CHRZBIw+3h6;EggJfa7kov3mKtoNy9UiM!0lV4fXz|g><`YoZmfDLUISA4 zF0Ezho-|ffFOh5?I={_mNCFssJce@OF(pZU^YcKG{*~=?T{{%DzE58FvdM#qVTyD; zw8Pd$q!*uB!|1miDpzx2fpX!#VEL}*h?pbjj0dG?#ypp`R&3mN!xd+bK5jy)4SHOs z5twBbLT@r!$x-*|%w|!Rzm#g=`o&pZGdtAA!Fk=?Rud?39Y=oaoqo4hH1*&_-Yx=f9LiR)1s3M5W=tnVJIz6r!9uHKeF)K(e%}&-0fzzkF1oMbZ zhzr!H@yY$EPt>%%qpKG}Q}QUXBHAsNpRtRLGfU%8!(_N6#H*+&_aCyQzY0euMm4{M zB9p`N-{?naMYrsp%MLqlOHQUuF8)*`g=4)gmRwTRmQ|36W7?*I&bv!xNsdrDg@W{l z({dm$1nD%QWicDBS!IrQpSGbseTPgF5G*b9C_-U6Z8|UB%KB`#sc!9x(D~aqTB&4w z7?0z@DXfX3ULDS@gd>iu8s(B-HOa^aul7`f)_*6xoNoEQ|9XPuklKa zdnHo|=j;HIBZ6dOfzXg=(!fa#HLqKuM1-_Qelvx%a<{!pc6W?rZM(M%q1|7W6qQmV z=&bpsF^Ac#TLd0~2qDuwyTBXx_fJ?LOAT57!)fJTyk`H)wu<53PRhW4wI4MW?Bff_ zXotxk_5)1lK%?1LxkNg&pC#Ft@BV}=n6SF-G3HO}6|MWeJ3CsB8N|d*d6-)r~PTJ&!{Ua&gMsQKGqNM zccFL{Q~`HTzACo8L=)plw^OsSR}ej)0Se^^c^hGyFTxRc7>MAb9I6IHcWd|22IPUFweWPV1!89(943DmE2r;4GRV(PMD>`gCQGhOwMmsDc4B!xZGhc_M zsYlvSHB*Vc$kf};G})im%aON~Jy54Lh3Hvd_`O^%9T;#?-QY2#+e%UEJ5vZqjw zB~aBa39HzhClbrcR^PSY$0GnU+(~gVj|q}c5Xm0@BpV1O%Lb^Ch%>vzJ!-`wo??KN$r?Hi}3kr11 zy4tx5Nh6^aZwmZuMER+8M?2;S(DqPG#-dyiA;W`o!Mz7b<}@r1ts^0J=7A|#=Kg|+ z24;?V>+-Fs1$73k^R1=A$i1Ej8{39k$|`o%;+U#SUMB^9u zJToyF@eY%d10ALvGg(c&O2l?jvL)b;B82apy(F%57pis4t_WZ!>S5$x>C&e(7CyO` zvS`5+JWoLf5Pfy+blQrG94LUJA!igS^u*<{%1bHrKY^?FZu6+RWQ_2<>4lH;%pb#2 zncIkL2&yRy-(ih3$8Id7Ub|HJxc`*A=^Ffdi}1&r@gFS$GuyxItztj0vCND7apV}C zir1$Kklj?J5YN;0ofU}fVbKPltk;Q)rMx|z541u#4P}wdw_IQCkEQ5c-|kBn=UZb) zEOD-KVve`R%@tecR`LuVD{v+7x35&28(*2GzyRS6%X7c=#N0+OY);eHo=S%Fb?!oC%mDGKGJO8}q0C#uZPbf)EtwGm z?(1}t?Di?G_BnIxN^o!hMHHSrzp|CRp&-hIs88k->f-X$*!M^DaX1Q&MK^5G6PAF` zA6waKLKsgwPcj>O z8m0vVbP~L{Fb$F;@ixfvWm#pcW_9nXN-^ktO(>lT({65QNM|DM{8WXNvJ|sH)0ZXJ zbhLo1hgogq$D!rR8pXcb`O~}858UD)))&Qy43P6m^6aXDMrPB`!K=S5oefXi2-Xx) ztPZ>0k{l+;5YDvl@;0%{ZyfqB=DEPoUT6=mjy7Qu&fC;S&KL%89t7ZL_N zhD=jqkF*yJq*a)+=$KGev^<=M657GHiDrlqDB|N2*4*KElxp~x!C4s~Jpq|RMlviO zL;G(8PLV}oKb@%nnF$9tX`h7;2nSMM5@Ww2}=dn9iy<%<{Lg z%ceRh#)4-C;fHG(mcXfv#80}EOwD;pe3~o#2?+>w>%>mqw~7(k3YkR_T&kd%0A9sZb#Cq(B-hc zP!L+6n87vn?w*X2HzJ?@jVE1W-_qWJ15ja{XV!$!EQz|Twn=f z1Q?c#1<+9@tHt6%pvihcr7+RuU}*|3?-qM$B$^~G2i|xFc7PPrxrmoFpqNq?BufTg z`0}9WvC_TBg(pwYdtySl*^mMQ2Y$ll8+P#}!&;O&=4LG|dl{3SNofd0x5SBMVe+MK z6t>*NP%=lg!dUejeugM5D((bL1IHk3NR1XRgUK3aZwa%ed2hsgITV7OQYg*q*eu%sA@5kSjYa!}v75OJy=PsYXU|f@ zSvQ5faHk&4qU3<*XY60;b|yWe`$Hf`ya$depjEv-}C3maJ=F4rL|u|HQS7(AVt%|KkvfmypKZ5Ublk^2#ZL^#yB>< z>wuXSvFG{v4d_uiVZP9lSy|E=!%4#QjkDZdhU=aXjP^wT<0jexD2!wJ#BbtudV0Ay z`Vtt?n1OiMEP$*mODSmD3#5;{$nH5&FBJ3}mLMr!O;q2bKIQ;Ar1rePxMQf$VlnDh z{sN7}N6@c(MTG?($vlGdA_juXrt~U|&uxy?!Ag7JAs!6Sm{0g;u@73r4KE$s`?JED zM>Uyh)>$`WoYQb|wyD?MS?|o$Yds^jyYh&!V7-E)DGdDJa6F&BU9(J zZ<5*Y@Pu*gc!vUqM8x4VJgn?Md|wG9{K=`mTevCn#_c-F)9>-L)Odx;oxx^iFG}7H zoq|F@&up(gdvlnG&1hgUmX3PAx9W0@N&RwsA{4rV+WvSD-J3TOU!j^*OX=b`oIG21 zGHyEDF6@!ZUebRfUCU5|Rn83@NjOJ`F99^WL@^c{@v zboWUlRA{y-%e%In3cEm1mK58pH~)mXZ)enKuPE|wo&&T`eQ__L#q#Ofl^rU!D;DtS z0Ej1&^}>nqS4UFB!qLsr%;xl-Z>!o>H)=|vECi|aiflXVkKoZ>B^x9&;skPw^JsbU z>16+S=zBi9c~<)!e={v>=66%XB%Mqo6^kJ@kQ*vrXBeL@K0(^DD$g?fttoI-;+*V0 zA#gBeSJlNEkIp7Cbk78GYI1nf0DvPIU>y(@Kp!9$AlM_^!<{oc_=_e?TiC|HEywWG z@Khhq8lE}ex#WfG1pyW!c3xbgPX$J{nX)aGh*Vun79|c{yt-O@NYOslJx`Rq zOjEI(YHyfp&zoY9sgr3CO&^v~C^0|9*eUE{KgMcMJ3TE$EAfmC>kV!xacp3I1;g;f z2G`r0RFDqV-70rRqZ$9L89U zYDc9dy#CfjlKxz;%+gkdRKV8BvdA*3yap)BYNsy@-ll4?jHsKaBV(iBIKRGrj+HRWYP# z*{GxKYi@GVu~L^(mr@?1%rvg3`B5e_R*I8OZ{a!%UkFnQQwd)KU-wDvN!?WgjE0Lk zjapa&O2PszDI>9LKX5-|l!r|ui7q8{%w)`ewb^jpfZLM5oWPL46cKu^LOlfEScttX{sjXa_2 zG)|p7&>y6xk5~aG=wVWsuF3r#me`*oHnFg4W@15A+tGZrddRYl?SQ*NeR3JtS2lP? zyFdrz3_YG550WmkNLE_dcSKqnYzUjXwF@cNsabfAP`I1cDI zN*X0S3;R(nD>Jskw3QujYOG&f;i@P@H(=#HJDto2iQx5!x-tEl<2QI+K=ZR%r@G`$=T~p-3#XKFZ6)pKPbqF zaoyo(a|s<`7d>r?S|m!u99)^@%`$@_UQlN0mxk3835mEYykZ7*mJ2`pRb@IF_lP{y zX$wMo+Im^QjUwf4%7cR!iXsqEjuteh}N-GA(M*&u6RBpFh1l6FRj34C~$cj@VgMdt^f`g#Suw&G!#KQW%Pns zaS47NBglX~D5`Qusg;95nRlWn%sQ9>Ci(?6P60wm9$jfh3QbPLHIPHjqorN6!g-;!)ZH;Fp*OuuD`pgzH< zBxiPJiMu`nUl&RZ@q4fRl3x5kc%{2jEWUzBiNT_sawqH(j8imvmBK00_nz@;eW&m= zlZ|S)Q{t9h+8U};%9eg{Rf?AJ;Y9@HamrbQW8pfjGvqJPg(whmG$F*OT7qGRl;%RL z%0tDf%q@M^HQ!HZTkd(1Pj0A6PC|Ab9PVAl+1)mNUO1dXpvi(7Vc5=_&f??*u}xer zDwe5BB`5YPNu>@5;_;>i!kedtiH)jDsjST9izT!7vk?<#XJ->jd$HZ9m6UjPdR)6z zEgY1L7ZE#ZqnE%H3u-Cm9Y<3tB+Q{ZD#evp95**-QO-&^O03mOs}+094MySh-7ea~=vlN5}*oO0Twb4;vySu|zF0IQ{^ia4YSPVzYfOoq|QC#GDzwF@zi`dovx zixZCaT>Z6+Hs&u5l{jQ7<}Gg2+oTUpz}mDiA*CV2Zvr~8+vIGfQ+jx;EFK!H7QWv| zzm|K*bX4$6wt$&{AAkvY!+Fnm>$hoKOc5Tpxn`_aARYQXMRJ!$97f#8y;i*mdKO36 z!4KGjTMve@h3~L?<2s;9?|zluN0Z)Tl1AExf~(Z9MRXdlJoRQ@WPIS**QYxT`&mhM z*Ym~(0<}$q_e;Q*9Imx?P_WUa3wJmdbS6w6Gbrr~h!58b!utpfx9gNkG6-kxr>?7mm9j8^jYAK}EBUskM zVcypJd?mBBs^Ze?d99Ol#|>9gB@JffvfIJo+T+rJdDN4lIP`gSkZvFZC|_hIFF2UD z6*D*_lqR${D3W`SmuOIRvH(}1OJf|xR{ zXaJh1Ka*%+ek5qpx4;$q@3h<3nxhR((HFMp9tdia@W}#jrZ8oh%(dS2lZffQcMpUw zko%pQ&Zz4?E&xJ|PJY!-p?WaXeKva7)B_inZZDvoy&0D#oZ%gtFfZsb+Z3E(CYRLd zJ;a<5ea@f~m&Ebgq|`kl&JY#)?AkrJs@|+u80-Dwt-eam3ugiMm)zW)fvRE5s-Y3O z5T&u{H&uv)Bhc8vGM7caqHhgC44*{)1h+}a&dDdg;rCDG5 z2ilFC^w<+~Of7q>1g$_L>sNZl=zT|Z8GGTGdq!;;yMHm|jGA81*rc;=Xl&BlV7P>~kurq{&tTz5 z?3i*&Wd`49xCVQO#F#QjWo^tTCimZ)alCpPPfEHbX=m|Fm)zitWiK4b+(7PjnX7_Z z=;7}QfR+aGFLom7l34nTRYKHvvn(Qh*CiX<57ZoEej(_XAiSiFIgx_-`T6O`;mD*) zRz(wr^>2dpF~Z;4>jTe^AcV12lG$PmL*M#xyJ>6~czjmAAyD@5SE*8?kMxO0knb~l3;oE7ZqL~O)k)x~h zI@(DnhENvzwAdn@_kcS?&&iT}A3QJ;;qDE5gkHEZ@aUF#OhN_F@zQYmaD2FqHYqq! zLG@se`9HOJMKWj^4@p+>Nkcx#K-bg()(fG-z1M_s=$nqj$zM1 zx^Ahvv==b~%&}b<7j=vw6t!>aL-uN4sP?$jXijz+Nn@2ufBja<4Z%RCRPHPKG^ffe z7fh*^R}75Hs#bKEldn}MQ_`5@b5zt)RGE`9f>Y#D3_mWiSE8HKxRv{<#51RZAPYW6 z#H@-SCol(K)(n#+nImUjhAXCbkL7uM=kCU!PJKVi=`Rj8k4`SmzoLi2+gsEd5@Nee zgOqNKIn3oak`9R3s|79xXe}-s9UFdclGZWFWSqr5`sMhIBPO+I9B3k3_*D^u5=qI= z+P|3po*#+7E{m+6p<6Tu0ej&gKYeLOiurj=@4D)7)ZO~c`pu}FVI%osEMgtrCjUN! zbtL8Nb!p^!{xRm&>`n4r$upj3CF5k`KH+iX75z>8-Rd3RGcMzx;%?!=;?>ckU1zi6 z9(HVEzwxmz70{6!vmeWDHJ(_rpGv`SAXU|*D?TcuU{0IF;IO1guOijdWL%ztyRO;3 z+22^DT;JsG*qk2ESiV+t-rGO;4BkfhDpfFFu5E{c`){~VeEE7P{ut;(#B`y58rb))=_`WeZ zO327Q@w`fQ|Ks90{l4|U{rnM;$#=BHxKeAZ+AsA4Ymyq%+%0vQah1V^!wiXak(cSry%ze z@(%v*W|%+w8V+R?1w~Q~m|_s+(j}vc81The$C`LWTt3q|g*#Bq_}h$VS2vuJJP*S! zF}}22f^R|fF!qG@Ao-gteOdVtly2M96TUeg4vZyNRxr!(-5-Eq;~RjZLZE{Cj_=eD zWL{eZJ?FjFvz4~B1~4{G;!w#LFe2&D72urCyy&f8nG zIIcEZ*J@0ZU9i~VHq%>^G*sc9I58)E8)-doa%gE0vqohdw>s`m`C?o+#PVMZwrXtc z(BPl4ncs9|9k4QUw)d@>W^LWNI%PY*nagLwmoCvaEAt|1ApJ78fb&dEyR&3h>CO^K z<5H7ul~H^0x|MQWLR+aKS!JzcOUOA&J62_81b%;tj}mblZv4X@W2)|yUd?~98(jkD zy3MPZSh~QoMdauk|MEdE$U31NK{4C0de!WtH9xELG23aaBD41W*p6?c z8Rkn};7x=tY}c+1FQv*c;<7ca9G_Lwl_@^Yn&C|cb`6rSu-zk*(1(j}vOv5qSy#r&0_%Zs73WJw!ad;Jml>ZoMcTMM zob|CeNi8!a#lP8KEf;l6zebQO5ouIj0i;=LX5khAnF?do{F8Ox(YP`k6)2tsbU>f4 zrd65Kyak8yK(di>69p4t61s7onh`fk$rw(}d?{lGV@9IPm}^a!Wo+4Q$#25nP)kDX zq%FhN)h#Onl1wp%<*EASDb3Qs!7MYQK*pX?rkYVp#(`007vuDGi6|^NS5%>5EFYhn z5&CmQO@XDiw2%#|^6d{F+4(zS_Sg;7cmNBhXy7Bg(qSf7VKJ(ruZLJk)_%Mkf!Ynr z`Dg(!vH#Tw?+8=Q;gB;}&d21L_u?$?7;kIC|1O1OVyldOSDx#bmn#zs(=M7P{b@>x zIaFN%1-Ofqetv(8`3&&}IXh0^((TEID8!eAn2++F)qeOMwtdxaKf9nrTi6=2-bp!g zwTojqp;XM)O5zNU^(*7_r7gj$OpI{M1iv{(0q<#QE6h7>TO|cDWS& z$LFc$jEvI+S;tcP&o$+__`1Wiy@otm`+(QQjZL0>QFC#vstjVvJ$-CfdXgIs;{4Bf zs^-2r!ZV;8(gj(dNWoJal4RS@Pa5x>N_n4-A#7N;##Ua?*2tb@TqGUuzRR<1SJx6R z1JRP1VAE_V?}a_TtCz-ID3F#Wf{f%^_PRkBclc<#VLlx)G-+EYO_ZumzIw9w{PL}FFy}>k>d`099DKzWlH4O6jDYNA|tS8plnfYL^&MY@5`g?JJuI)_cIV5;0s38dS|IP!dZz;PXC-IG?QRxcL4Y(#tH z^kOio=FJZoo{yD_O({4xLP9+Q=mi{22AAq`C=`2RX$M$*{{~PWwL3 zv?;lM2rr%gdtZv+U5z+g)Bwc`d*fsb>SM+<8HIeLP}!bTvQST-kh>7sBaKvGPuZQ2j6_o!w`cI*1mF9t73nVy2Ym5v6$&yWoC>r0S!P7p_)1 z)D^>O*U}jma!Os;u{=CaNU7CI|+Qzr0@y)#BQJTJyE);W@ia zh^?TNg={;gyXoL_VujRGnQoa4Yww{Y)c0>Nq_2a|3!-}&w}-!Ti<^Ft^1!b*E9CK! zHzTxyH^o5<>cO@-s9C%)97Z{MV@pCG7RHMwg0&%1-|5PDq!byG=b7T4b>Hg1qKjW- z2|pR7?VyTM56KlX%X6MbEe=npwj3$GEvZEpTCPUc;8|&@o}(2Ki_#*inwc-tK-=uA zta9=Kxy@o{=0ZO+Qx?Y=KJ0=9+uc=|pm9Z(MJt3OjPB+=E4DEfQ-@#99$8DePrLu{ zg0l(~vJ!T+Khm7yEk5t>edl?2b7Qq>eI8#~==gDVysv?KQbIMK7m67_p7C7I&VE&P zRW%j0r652CC4$i})J@ko#YGy<_`^ZDSUs}IS!M-s_WVx`e` zOzRnBLgI@tX5!|~F6&?quV&_`cZ!`hun*v%10eH`vP6BS`%HR^UxbvK>y9we%&^8S z6kuyB%Wn>%3TiGK7by62n-D4K_zZnV21PKz`1X7h%$c8&#>~i3ROwkl~v(x zkd_(h>zK7uDm2IoYSkb24$Mn5#uX^x&F5O(+{q1h4vy=~EWbdT<;!;)Ndd1QK5Q+b zoyov~daQQvZ!j4!8F4%vj_SK;2RM3i973#X7KqeR4I`7?RzFKxR#umu8INgEehg)E zq|6p-rJrBP4{9~GtrE1-JlwmFO7n?{^L&8KjJ!q_2>(K3;QHi-ZsQGB9c zL1n069dP!?o&fe#Jw%WZVSJ%wT_KuAQ$9PzIjQ5fYJdXyZ4ZAU@WYvoI{9HoaqD0yp&rV!VijP0BHl|C{G8Kx`6I=neA*;w^7=Bm3~B z_j{N2{bNli(8*(oSZJYWz{#ly;`*^iN*iB)$cNNI9zU8%&GrjL1(QF!eq9YO;(Da$ zah*CFm>LCnVr=4Z>XnAZ)a|=MQT_cdi{SG(^))FL^V)3#8s|{AvvT;4YY&c=+S6un zI3)QoRyKtTqMfPeycjS6OkI=x&9XBtg8hs#dQ^VpO|VE$?xOH|XmiKKfIt%y&-PFL z1EiLU`5ev5dNf<*X3Oc=A-uja?a8^@tTSG<^%+@+2nDTbRM&r{Mo*N8}qsQw&yMk0S9SF~txttHh%hyvVALE{UjC+h4 zAlay_Yz~@Xz>*8j8~RXNO!u>q79TWxm^}hHl}!}zIsk4s#1N;jU&wAOEgFL&=oeG( z^&8r70I;0i8KZiwI|{*9zE#X>Z2nz8*T2~i{VRLfa<2D*rsW2&?nK6ezY1exrKOb& z5tdFZ5q%$_wpmy3tD7j=xAcPq_!2F96U;B*>j|;!JS_R zx4^T--B;b?Q3t=kZXeaSg1v9EAwFISR9I#`*0xLdLg+X@g0S!k!nAG>`nfYk2U@0* zEtS%iY;n^q_>vgPC_4Q%*CF7r>Ts>5whD31xrG<`^;tUdj-F91~QLm z?`Ap2e5Wn`bwkC-`o|4sifOQ?t;i7m?Z~H5AxpJ1t(ir~71NN|$5gGwl^l292-v-u z7l+M7_OaqPhDPXvF-d>0Eo$VTx?_<@!dco5cBSFW{v6GQ-gSEQ0Ka6fEWs{bcaBmH z5xf*OS%FK=PZ}iD&|FJiC#W>n&GZKoCWs+CK%*a@fuD6)!u+$+tzs7_=*oW`v=IJ0 zHvnlB2*nUcK9L{%VoR?AriaxY;s0dp40VCv8^7>4X6>tUI{!)q)ku}yBQg`B*uW<^ z9IVQ}shd;wJAeDP+fIl9?^hJ-0tsQw#Y-yL60o0fp@_50+0iJUCA8*2e2GSFM+3aw zyG+C3eA=C#7gqurP{!M`gYLC@FvEl7`bd4om<7AHAvW{7az_Dx$K9*$YBo&WEayv~ zCT!>m7_~e*t3@G+TZ5j3jICmIgD!XG%*8Npkl$+~TW$`|R9oot>@BuxzMXfW#DPAS z0t~P@MG>T}xUdVkNMm1NA)SnJ{lHtW9EJG1w8Y-HUPym!BVEbGGS7Pc>cHbE@L+%2 zAF*SCseA%U-Wj;@OCRL(%^GYc`n`i`jQolk)oDQPefa%%{Y}m$31A_>WBeRz9+BT| zq5)}78q&gTVocztO{ygv#ihtsFF62~`Li1nN|X_dKgo``NG(oWwryk5k?O$EVMZk$ zRzfAVL~5_r8LMX+b0@a1TTVNZa=*U<<%@Q>fG=tq3CYWM4|v=F``0 zGhU6$5~Iot7fHT&#g6y3Y1>vn4>!U0#fCIdftt#F9@}FG)gD94S&}N%!_-MN&&;p7yBj>rrE} zqLLi!bo`RIB0L@zpm{>>_n-8L#``j6|s-tXR!DcQ2 z`LK5or1poeNLWTu#s*jNp4PwufvQ(rT*@*TRC5ehwPFm^X#L6N&)REU5e>FpyFFJn zys_^815rS(zYL=oR%UQ=uybU<7#uutBGCX~p)yH2G?>(f^yHw-zri$>^|UV2r2cQZ zt3J4iY1be(!t z#%KF+V?RExK1Ex<+TX8M;^=_hfow3Yu@JjXDrukL>Zetg<&Z%RWU00VNH{LV-Y|RW+Im;xlpa3+PaJd^WylbC4Iqx=S;8ZjNWweq|Gm zW~OBMQ8bY2$Js%UB9DP&CRRUk>s)?p<3Vy5Kw6rd;m3KY&@Bsv{U|3LItw=Wv80Di z6zqQF;AnT}~;QS6GlAWN;MY|8sBO>4Bc{ONR~)Em#t z3vQIs$u-qAx|&lTUA;Vc;~Ku&_S%uwwv)ZBU$(Nw2mi*sr*F|4*YR)KUOU`IZ_rG) zW$v~<1fKPyWvCDjXkPtoyQ@WNakq!tBZs7)MgD>e1Ia&?$d4kOg`_j-Kq?uN@OJl( zR3f<)X(wXNrreZBYf@`6+2d{Tkv-^p66tYw`p6mATN3F^=?Rb?zB7ru7q}K8G3i%6 zGU>hMB+nO4O5}NWLzFZ`aAkCBA$dGn<0lo;N*~GbmiS4~_gH|S?Cg~6FwY~OBqh57 zk`xF`^4U(F&kkmaI6pI`lo5P~lGE$9JDMCr4kqGI9K`Wa@=*`=OpqESN&b3DOCT91 z7Z+#N4VkfdD7P-aVQyzp^NIPGs*Q^?wbL{4S{Oi{M&;A-@_3geoMnMn;w)ud7CMM! znxNtKkq??5eM$-jjl+`9=aN01WHIb=<%62p`!c(g?|d zuQvwKYl|*)k*ICq3Swpn3lR|t7UUNe1!=DZi5?dgxmiwfb3t54qa~( z>JQrQ9B91oR{hHNPYqmF|ADz|`Q4mN4L{ibf|{~t&9-kmu_HYlSEv_{eW&+_8_%Dw zuRrn9tKGMrYUy2h;MWr!fBK0!yrnJU%1eiyIr=zraLse&>$cUcPFuHhwgA6c)&E5G zl?DXxtN~&OX2BaY9y%L_22?#R(i8MS~UtjEapLwA3L+WC9GsoU@%e ztUYe_3z{w&P7DZVOzAh2tzxMy3qGqaNe`t9+z+2ro zh3{j_y_>UN{js`d;N4%Sel>vpN23JenKDR*NQ^wVlHxx)$`3La#xXR=)LACx{xv3w zWHSi&$E;ROm>x5mHQ`gm%JXEi)#3;GIcJ~Onr4+pG{;usg658NWXlf);Tx6Ql1n7B z9gvOEmWSFqrfMqQS2yC1@tvu626}2f_-gj%J@qryK=oFbdh%z`+k%i!jxo6HW{zX^9(aVqZWFC$li<{Gi~;kkUO-3;II;6G3-!wz zK(_sgS^ox7Y>s>+%T0$9B}m20>@+QiYRiBQ?d}rzf%CPI4!Jo9;F4rFn9Wu_<956B zK+qz>n74|0QBZh2J#oYv%M)XHwrC^-&>qHzPi3Ye_8KROF{SM_1#C-Zax~8!9p!4t}E4D z1eUATEaXSKjpTuW*{$bT<8H9i13lhdPSz7bWD{j1IAm?bOj*24oGvRvks09p8Hnsl zw2b6AO6t+!T@3O7S?A?NBM}N^8&EZz04Ul=tto-lBM*kZ19J=%s|L@%Quc=C|&I!$adwKLOV zT&qsv8cB)?mZZqzSgas}hP+4&l!^lIoYZiIMHgcms`5%8b;O!q30BBEo&jxE;0dym zyZ~&mT(gVZM4A{xm?-We!k%bW!nnwI^e-7_}Ih z`#ULt=w=cYdj~Odw?~{MWMb~N5^$CrXE0#~nF|bI_96^rBV;95%QJToxeI7LGY&62 zqwVl4sOjQj0(rE4tNnf=<3p`H3bo7v23?e`&-AHVWc{aKI-wHY43)4=e+9BaGFGVu z!-TAQ8uFDlMW=VBn9Xh|*zal?fC`FCQ-INiOmqfGCKL1~I)@?v{}^;JII(u-VfN9T zW?(0l?(_-d5>2?L$b!JqEk!zmM3ag3bZ&9WhkGhd>ew#QEp%INSoB6t@Q^i*Z@JdW zt9(y8wz{^;n|zI2qfqbI|UYW+QpvW2E-elo8&|GL*bUyyQtC%ac%~g zkO|yViQIFa0fvNm`93luGgcH^rMuOrq^9TRKqfPa@CLJjhd(VWG|t^kEWA`{?DN}9 zCes8~#wu+VK}ZOYCO{aiw6)UuTrt5;0YqQr7M3Ez{8E%yda)AqrCfi7#t$4F%690f zSlg_L^QOSH&8YTmvg&PR!Zry69TZw|wRDai zT-CesYs*FtU0J>R?D2K$jvrsY?#Uz_B@+4S$@aeVgWspq>5opmHAoJm-~8eZSxT1O zeqjq>{7=ww-2;rN#D@s$Q*%3a0@cZu-~?(W7rCU^rL7`%ik;F1x{L00OD84b5nM7A zJu=ZK8Buw5RXitw@D}L7HLhR~+_D24t|o`8kHZzRWfvkC9mH|;6=|{!y{U}P^5L^& z5|?e6%7xx@q>;QTWT;|A=0x}pe88SnXlg>4!2T3WmE*IaQKiJ=vSryrG!N#w2}}|< zO_1@@@_@^w)B%0f(tG`LMi;*MmzgW2wU4eVdH3;=cGyEBRJQ_|v*;9Fo0*F81auY+ z23;)-3n~!c!EM{4>kwHX*}_7N-~h|QZ!OaY-&h*%&`QxESd$uw#7p!5rSTGUZC7wX zGcOA>5n$C#_&!{NB}{V@YKB4igto^Ypw2wkY_AcdEmjEshtKYXM#`$nIKAHXaBl07zA^CmRkaEfWv8g4A` z9Sl-S)!i=Fh*=ae%_6s11Wf5JGDT+TDSD)@IY0s_5*@&G3b?R7LN#?#xvP2QuI9>} zwW{5bQ6O3@c``)5FT@3%G}u~TpozBA<#Yp;=sEfjG=jT+!HYDB&0RI}FRxAzQ|R)N z*8`4ia141y#j+)9dt$n&7weYp`sIT=f&zu=hN}l&PQ5m?2}zQC5vmrCmcQ46HG zzl&-i#;Z4!tzId0LpRJD2|!l4BVnik(B%OG*a=?eP6t@ckQPAhfW+1ZH>CnVVl}y& zrxM=6sEy|vH3fntQ?0=VQdO=pzvj18wJL0xl2v8ORjiz8(L%7AaUF{=u2dpQaCqfR z(c_W1HRjYqML;v1DoHz|2HDS0<3-IZKBDv403S5nyZ_#ob2*)u(wA`QKT zqvRZE02^?@_U4qKXIhH+a*g>_z|KII-)~k)5Dj)!G3fZrFh`Wh5mhs@7D0vnF9DaVWkogMs8Z^4 zp#v~Pn1b&@d0Ay^f61QC4W|#kQadkXc)L?umc6he)L(k*-Iqr?mvn6ENq>Izg9qdX z(Y;%LzG>Z|(A)IoR~B#Dyg5E_>G|G{_Wd)g_jX=L|MMouhEN0ys6&sY3XGbFyz_$g z;6ItP_qQ@vRzPG&NnB3g$!Uud$d0zSoWPS)8z)fQ*}-lnP#kr3yK`f*(&Tmm*$G@u z;BkVij@k9C# zv2{kZ1kC35`$6`;z6k6q1N&+uKqs!)-r9s%Ha#Iq#l?;Ih&BKsjIl$S?M-MKpH66Y zWkM@6;W|CR)v_(Cnv;Hn>ev}g^0-6>eM!wAS{Ff+94W1?t*yyuDKsdgHc%Tb4~PLm z-z4E+<)?D`VcVpo{3H%1a!Tn^3On574Ara4n_qK&2b?fb{*dsnkYO7W z!$5M#akC9B(|-Q`RMG0LMWC-})87}?P48~8FVE1Aq?lh`bYT^{fk&p{HHCJE$!eXDy$wG6Nl@&&WsGfST3 zJqJ1|a$ZAbTLJA&Th3?+g2{qD@EcM%!*JoS-;}uBHJRT4hYcQ(}}_6&ATrU_sSoQ|9XOK)VIGj ze0X1Pb5jBR$I0}nMd`brT-x1x4YofYkQN5rEEXOnf6Y_Q5IZ za+wukszrnf9gP<6wR9_@BXlBMHzT~)ieww3%U3Szzj7dy9MgxB2%+hng=DT`hvyc~ zjepx%81EE2ln(bYqa(i3{gU~rdy9G1eWf6v#PJNLWGKMZQjTUWhEXa10+;nPqp+|T z8AUIeLdA3zNl?3lfr?4^smQ}mMIL@Cx^<2pod`Nm73}TKAbM`SXBu!+L!adoo#oK5 z1*|#5pJS1P&6*!yM5hIc1^B2)0j@ccq7U^|=US(XR_5bvEF+v; zFd<<%aGga1);}d)9xqKf=)wn}cDBU^2$5Abm1ByrSg4F+D#T(km&};_KTOqR&_tBV zDZFcPDX5MH+OP65A)wczR+3O2*2H^#(P>X~w$5q!E}e7!`TmLT{dV)8)7KAd`~1{r z6ZOqI7rc1n@Y*#eq;L6_&6+>!(c6Dq{GIf_ez$#WJ$Z_(Bga2@=fnG-B~P@a-hS)! zX*i|lKrajAW03pT5N)<^m=Ov7s9W-Ys30-TqD1m&tXmW*9!oQKwIVI@ySqJq6Pf{) z?Nn@n%W|>-db>hjwtyGt)=y$Q_(IK1YcEKTJtS!`Itly)FfEBDY!fUOz z39GBFH0%;Y*MIr07TBh)GkhNRo_p&Id0@k4_$VCE-o{yYKHO z@jd+Un~0)?P&HXlHRDkjO(9nv*G-R(vdvO1W63ecH>tgfj+PwF_vw7OPyC}#l$zuw)>2dU&hpwq-W8Kc9oakd?a7p7ouZibku}}<_M&`yQGRk!cYS`FkAuO*<;G|Eh_7?% z$F|l8f#L5Qw`pHfnQRiN306qzPSd7V z)CzrBH)O6<&_Z@L^G*`9;LTvUf)-dBEmU!bf(r{Prl*=Q+bScN8JC&H2I^|fBnMhHT$aPb}rm;{N&DU@6znz*ViArdF$Bf*NP_( z?7KJuHvjUWkMN?kyLUbN^S!%=Mru13yt94h`^UMTUYx2d6P1ugQCCUSYB`|p1s>4$ zhXR&dnx+ZHohA|vnB_%eaQ*uHPrP)<6G1$-OIC^SOCC{+|6|v&dp)sLS^7rSkE?@E z`>pUZ{w3knwAsHgxF)$J3W8lGu+#+t3p$y{sC zg4WtqP+(U5Po20+7H|1*GslYPlXu;006!-YPtDyE`|;l3;H@ zO|7`8K?tCvxsn11IUhAuLJ7|_Xa2VUChgRZNX7Ibu6*!`0Qg>yLAaa30^UA>`<9db z_7w{|>MC*Ng^j&KSh;d2{;REDzxDf@q(aaT1jA+JT+8A{Twq2}LiSl%QjrCBp)44yi3t%a_fdHD$6_(s5Q`1H8;ik? z?X)nOe16Ce=tJBw?w`Z3i0t_6{^+MpUS;F+3bM#Fu2~$oPcI zFxu3beNJ}a9 z{Se(Q6Dl*R68QpYgdZqrJVPvY9@jyKT4(vt349_Xk)SF?F;DLnWl5ueVU&9YlvNh2 zjl&}lOvO7M@{F3YElmQ>A~IvtA|l*rWibF#tV)E8eHi;%=+&VFC1l5Oe7HL?koc&Z z-|bDfORAQbxZ7(*ltnVblHx!G6cXTqA^Bl2Oosvs50{eB+KWh{|f? zaPN8kq9UX!Ff&Ol2X9y2)65vbFgV@J96`AmyVI)D$WDE10$;q6t6Cp~Y30}&C3f#b8}6! z%zVzdZ2bCsV_C?9J?q1%yASlk+djy0)EEZ#iNeVQ{oL{J)8Hm}pe8tz?lFuEghE!1 znwgQL7A&ZRpN_X{LPaa4�WisU_K}af2;!M7xN>v5l`|(?2!;!pz@2-*!0ApY^Y+ zpJCLvYiVVW^u_SHeDC_&>RFMuS5~h(+WCe*cJtml%ir2O|0m0v6R+`l9vOxLY>>|b zqFm%fo}1Yd5eAO7x!XB1G&**q&C6+H$sYIAt7?k2nUoqRF!N#Rl1E7yfMrb6K1^Nv ztvyL}dlEmMWX=@*EB@2~>8XLnQd>Bksex<{94lLgYdG#m&)S3%$Q=VQP(<_8~bRd@riteT{i9;nkqNodQxYs)lL}?^amLaTn zG9(w(oDNx%^bD8E6h()z%5()I1lw3{F6t z#d083ziSap$a$;*V`!FF51~~G{aKxKO}Zt~PGHJDj4iEBzpUKSX{U~L{@rjZ*A%i% z*{%@fW%u7cOEPH|yxuHYSy{acPg_rmAv&58_MnNV1b@NN+|L1K6>Az>EJ<_1_2JdwHpgxUTNm6S zw>Ut#jAdWU12*DNV1E=Ch3ns9@1Ow)tZ z09>0Gy*7~MjRN3*baAb-K2XSX-iWcjkwL3~+dk&ymX9$G1g7#xnSdV4AY{N|Au1O&eN)MG0}5xEO4}&`1OqsZvu^)G9!ll%f_0L3LtLL=s@vz34NB7Oth?(g& zTv$4nCI{pfWHC)lF*qnlH_{AMgxiG<$yyckpTixRhL{L#NsNTT5FF~D6=Dq-P$9Lh zXpOHhTsUz#iq-> zXw~9GQ~QhsKi`(`<&U==dvfvq+KM;3RvcVX&CYlEmN!50^rYL}qJ8>Pv*$ls4KOVq z{eXW4I!PE!A=Pzw8D1HNmN|NLfM5;ST+MukL^@OBSO)!ZUAT+c6yCw?;$LT9aU5d@ z9Dj72VJ?OL8+JLhuqzy9tAt8dRf%5uu%p$p(A!%4UH+-?kF=j^yV#eVyGnY{KHTGa z$LVG~Oi=ZxK@Mc)^$=ALxEzZ~o(*zt4a8 z{F|h|?}i@M4!kddycjN6(@Rm4WU$kvMv558KY>O5aV+u|SX4@Ykx^-el)g+UAuEIr za)4f;q@o=nSQ=I>SXG72B@h@R3y?~^Z&H0?k?K>6RFN+rmATDMU{dwere`ztY)F&@ ziI+Hu6N&@D02XWtXn?{BUZ2P3_OU{U^+%EBgi}B&i6WokiZYPDWU>l=HlS?iAftXU z)l8Q8eSV+j^cj=?99_{JSP42f85erInE<&UX7ZO1Gg-ces@WSKH(6k&pxF|(Z1asv zcPSaM&%8uci{}v|TTpU$sg?n!H)?ZzrZ+_Mrc}Fk7rU$Uu4A{ub z-zYX^6r1fLD!>EK{94Dl4dbBg|HLC>qkz~=`O4pghSIp`o@iWxnaltpI{}HK6p7D4 zpnV>J9`+x1F5|vj3wiq)y}9M^q^m$*kAc3%(W~^`gCS4IiE zrBGAoB;SJ9bXA~=umyJ50y|s~)o?;rkWvs;MJ4~H6epHFK0#EQ)$C0ZNtHrLEDu#! zf)Kz7d(sx+&{CA+U+2n0CBc&75>~J$)VMcMnvmjLqC6gOgrkhF$Q^|bd)&GRyD~l= zMI|;MyT=8mh#ZYFF&0h?`A#4`%q8i95hL`6>FOw(iN&H$#Ly~6$SFiY#*cOgvgUR> z{Z!JORMKmv)Ec!+9y)lM==!v{Yl5=-{NjTcq+JjN5O)s5y}`vkidSvVpXolI-!ssU zTHf1(&f5;taK}96s+(V+ayrM38f&7D+S3a zg~P3qE{fpBKB6T6!S#%d8Zwm{vcb`d880NRR=bs4vx0k49=1A zRN$fRgM5-nzHz<4XG)RoK)R#FvBa_3!8Nu8lG#qHGmP~Hqnse1Tac$&=~Q+KZ4d~o zHmg8ZGmZ|HWf0hHiN}(AL4dGiuLpgyzp4*SxZ_UR2xn_8q6Cg|* z0CN_#5X}3r_5Q3CV9^AEh2X0WbBz0}061gC@KN4wG)xwP!bfi#`Jf*)<0Gv^>o5;k z_D`Q#N7vdqV|`$%u~tqp*7CTqh9kxr2+}oE6a5oIWSRk-8%951my!tv6;u6FpTsMKb@=xMCAXC*F zuo2N4M8N?rQY6b0N?aaS;__ID%Lzrf4=(h#N(tNG=(Pdz`ZOSKZ8O>e4Gf=4u4H_q zSZ!I|jdXX$-Qr&2=G-VjEU?vMuUYl{zS&IXYDX-%hShB6&BAm511NPi!^25H3KZ!u zpePq{w3os=Qmm4ulXN%uh-Ivw2Ecg)p}Z{7ctBje?2(m~Lv1HFo;;1Z13f=(TDzXT zey4cwPb)8wo(hv8Kc8p@UO;h;uw@M?NuE)mOcUyrhn0ow7WNz~KBK(Lz6;igs6MrP zmHamDdH%QDHHlX^G>tpUVVNj`tVQcsot(gq_uEq%x!MnV$y_*m1il7ipC~J`r0^`q>Ad3MdDwv>2_6t7MPYc%A)prUR$;LXG29@Y zktv$Wqi(*Be~Z7!bNn2MT(eCTkuG+LeIhFk;w}C6R48aoHvP+veAma!Q4eI$bOY3n z=CYl`H{c+RB~9cfohAop%X9pLN#{@0Q?Le-90a1IrlmBR+ZXue+`iCb?R~hZFVoTv z63&gDpWb#*z)cJ2W~ATlBG8Ux{16DL(^V&_PPI-Zk)i^n8RH4sl4HaI_GMgh8DKoQ zIK`2pER+ILUpV4}(3cWO3T#?RD)Xecj3-4>aySm5H#J7hWE;6N>RgjeGM&KS5ZqD_ zI2KYt)svf`p0&`bYfTQLD1u+n_0kYNkHp-|c;hIOyEy_vItic4{qD{$@s(?N&ZtGM z3TlyO_R(6jBMhC3XC$5bALCUY8?|}H{l2!(zO&Ev`9AFX$mK3~I3XznLP#(~!mS2c z2!XCsj*xHyiBWATbc8>uQdE&?>%ulxsZ^zO12)uEO~s~`KtdKemQ`#(yMAbcvbIcR zRiWJ&JF<%KJXQuLlwnesNU56;)-u=CPGb$KG|u{p?G# zh3~)37FUXHq$Tl)2H020( zTM5$Qnw+QvLo`l-l0pG(x#l#GO4iA1UX@utgRtnA6h`#pfaIeZq?HBe^D!zw8f@mu zvGUGucssx4?z|ax^Cn$DZzm_Ucix!{=?3)Hg$R>$@#WMCRJ?t3W$DV%m8Yvn(4Hd| zrl}Z07m0r~1p4Xp7oe*^{sMBWB01n%QdvBbGXcF-r3){E<0>%6z+nc+#>uzQf_}*f zTwruY!v!Z;j^947UG!@iMD{Y(JVi%7pp?6rVwID)BuF|t8LWyCoD{i72C}o3a{rv0o7!u{(I564-~IWA_Ss#bNeE!KY(Y zQReX&gb0grFgTAFp%mo@)CZ7*Fcw9BKmwCg6pi$0gFdKZeF6`Ieas)>GvYX!KPvkJ zfii3Z0SaWtUkGFzd8dS=3D~xRB=}uC4i^AEn<`EfJIrb79f`OG64a5Xy8XCF@Y~U$RsAHit5=C84LyEp2own} z;5A*ZNFYY(ul4o*hLIt7h%@gpc;?+jix#Z~p_1WUL$y!^XKox(0^}vg4Y@rxmbI08 zvUYGB%6406X{Y7r9C$jXEG%oc4HQ95AQupINjgEI=e#1yB33EU7SJCz4P;TwXlqAV zh+`;+Livu?xuW!pm>1&ilP?98R(U`JvG z7KV5aC<~dX013xLXSoeWI61c57M&KiY_SD!BTO794rPm5lBYRZI#SLSln8vn&$0$q^xtXXdp`wTui6o6=lH)WkA{kPWd&wA6{-CgiVJ2~=#tE$suQr@S zFW>85qxFQ=hx?56W+AaA`6J^wti{tTtEVM@^p30p$q~TPQg~VVDs!=`5R6Pi(Wy=f{REr=-EI(&t_j$O$ z_^Na_p4tfJxXR5o#cmR9R(Z3P_W%;=(yJiA#Q~;REDj`(NcuS2a%{8YXX8+ekRi)l z+C+UbtTEXZPLD<~m#fR;c8yuk!h~9}m8)YmqFt!%4Yd65vC`OY-!4rIpFuSjK0wLs ze}C$&(gplF+JX+eR(j#$hozs7otrzagbeR=G^pO47XUku_eORlKmWN*i!nQf>zc zE|A0AVYdi_!x2S>1ao||qCmru3H8WkN{yzam1#HIVx%$jC7TUF-L|mRs<(34gLw9y z?#+AFUMrm~?Ls?VJy={h|9hn$@Dqx@X>7}h()9E%S+slSy6;AV40ND(=1Kk<@F&VN zV3u~^nf2DsEF3r6qgYCDwOlTliquAOzD9nI(PS;*JB-EFN`9r$X%+dNT(9+Qeh2#) zznk67Kg0Zl{RMNFJPhPZ^P&}(OcVt#8cEu4u;-k4Nt-hx zW+T6t=P(;*WuD~d~0w*$!gN?W`>%l1N!6;iHZq@>WkSctYOgep1zDn`gxA}UT zuHEI)#AEByt0BYILCtj=;u8~Epq!N%$uVNNjlom=!YwtKLVbzOYr#FL0?3Put3z4-o-qx9Yin z4Q;az9(exur%SKC{0drjmgvC4(^rPK90vNoSNaGgFMe}f|E2@QrXhPr|0G)X{(I;f z6Td6H@cwA&!yh*n_al1*1)eTlD8Vn6-l|^`CwM#r?*A)L1e2-5J1HKsx}+ezE!9{1 zptz-$^J_G$(p8{q9!!chDoFZ63fU_puh7S5K02x=TH$*AXkC44h}_rIw`%39TE4>j zzZ|Wx-1qSNTKP)eJDpI>QdXo^WWFw~OKnMQ^FOL=SDy&%QlAaJq>ihfDxattXn7{2 zMnWMqq{@ChiL;4Vz^8|_pv;?of6Pe4)5gh}$qEP!NCi;>2*Y5qbyVj}K%ye1@4#)k z3b$zwx1)u$rR?_+q!R4X`HGqR*8E_e&DWV8PE8M|W<~DIyOlfN z|I8-2CBqf>p?cTtPG_#%#XmM(MAIN!R=uXCX}GbQ0oVvoKBUZT;vd&e5hZM@{zn2s z5kiU+5FOQ4wZ$QQF^LdpfM!?)l1L(Mhajuy@KKzUt<^=~QwyI;_*k19@y87yf+KB? z#~GwT>Oggr7-fAW(WAM^E=z1I7LE9Xm=QC=Id(1vh0Rg5C32g~9>PC7^~c9v|8sXk z&&rvp*LogaGbh{iH+1NUy{n#mzBG@YSbb*uf9S6E*ru*Ke9yV}*yp}{ANF-_Y%n*( zb`nw(z#)%<6o-Z|$|#9|kOVBULB=Skh4Cs>OjO%oJldjZ?OJIMRY;RIi3vyu8J#-D zP+PQhle!AlKiH%RQE1210b(l`j*f)BE#-pb)UY^*l+Gi?noUJkEnQX30qJ$NC zjd7eLGIAmj75(Vc2o%Y)idh`;i1oBhw~LQ>E|W@zbd}Uho1Tc%U_cUa0Hu;M;aq?u z;+a^EY3NnR9=D@H2C=TdZzxRUp&m4ZwxQ!FfX30OoR&#=;qao>?1u@Hw9a0!OMyFh zT88>?uUsGGiuxdPvW)e~X`ul%u-F+2;nfZ7etZcx#OBp#k2x0AStS?)!?ID@W}OfF zl+7!E&4h0F^>h_06xDM#to7BNUw)mLm07f}``pRy-G=3Agnx4)-*}xJ?y;2uk+XP@ z01iOwn%_R9aa8%jSA6^&ilaV2e#nEU307aJDGSx^%KG zou1#^(vk%MgQ0n>T&?&JRy~agdxh zPX6N5TkUP=_KkGx&8aw>UkFZ6BU*ptRI9!-69Vx_#e)8mlyKL>=f_`o$tX%{x@ZDcY8~sv0y-cMj z6G}AfG&f5NXt(q<-EI7w+%$rkfUR--_L+bj`I2EqDg+VXhB?v~Nn^%qcGCdvgr@+-IzI!U%Jr%AUrR<)H z#C}5I?x~dBQ^`9E1}fdNG0#-A+=L#jvRk;_;kOBmtWOA7u(o4c1G0csw!R&H(}uEE zsb8B9(Jm5=f-o#;=;Fr0!;k({c(Co_l9T(djFIz?PG2iLI`In9Z;2}&o%!wAuU|wF zwhJ<(ux{7|1wZ98m^@Ls=>WF|2|&qmXvLz_$p>XDKy~695Ukh?$}w0DUrZb->p-6T zwCsA6DmY8wGXUp7TC<9z}z|UT(XIvSwg*-Qkt|m+K_gb9+r=57qrhc)zf-3EMb-6 zqQ9Jzk)}eV!0>UF*4yFJiY$ASL?|T!h!2wp#zcmny5%VXm4_)B#+1=Vt#9w4=m0%V z;Wa`z9p~!X*JJc5{u#!Yov}R9L+~6jM2?dS@gxxe^D75Sx-@evIrW8Rv2*S#QPtj z{j+Dx%%EfMPFy7CA6`AM?S&Vlh6mluP@sL;&C);q598f$1cP%6_6`(SqDZKMWya)0 zd4~9<8Juqh=OM5*P~w}YR1mL7Xzqq02k?75RfXUyI46w?ei{`9tWACdKT|wUIL>AJ z8icgfV5i-7p#{9E#a${av6k9P+3mNkYQ+%ux&fhD%W+!Cl`(o!S&dv*%ljfgASEFfne+*sKZEb38e|gjW~{LYqFeh zY=E|<8HQ(C5!1A6S);B)49kRK43|Vi*E9@S1{%OMxwdUt0*zHw#mr6_^$H%WSg+u~ zGba$#JLY)^q3Y^!bo6wwdC14AmrumpiHTVCg!|0m;jSCyj=?NFShE24XYpry`=RBt z8xQUGS^n4nv^*3tFI|Ge!b==g9)RWs(A=sJg{`%6C@U=X`<;d=nBa+161mSMVri=SPMP$jlXm$e<-!{6BZ0DX_`CX4HxYLE zN%^rBBR8uL0%kRes<^>!2)ChDv5mILZTgd;`F3kqvBRES(`>Ut2t0WNM!hu3rI9kP z-U>isvqW~-gZ8L6Ej0w|)mfpm-6B0npH$g5eub`*@^qa#7+Pg-Lc`Ltbc?zE0A%Q#rCE^EqwJ_s zc7%fY-w_5%npHKyiI}cp1y%=G#0oKF1_Z2w#bA&pP?+%*Xi=1B9+WA|2m+fZLLLhn zAzeqNsatk9tirZoT@|&kqN0F_!?F?%dx8uWEsI#!Jxz>gnh5qHiWrA=UDE{G z=4m+%LmgZHKfCd|bdGwn-06eWjzMlt9`l-dO7v zs;VS3r46iX(<-&o)WU`;m?rkes;bqbeeqEsaY$O&iY7Fvt2)poRSjBE#b8tu5ok)Q z!eVF7`}$16RB1~5`thCb{M`FIzmI3CSw1MAl{tADO;0}QD#^4XgRP%hc7vD zGZP7h{un1pVr`lu_$!)MBeTWXA_NqI#k(-LSGWsq40#&c_W20Ha^ktAZ&iey+d}1m zhzC==gNgee2QVoMmmDQxqeR5k%my2#j7#GUc3t(2hiyF7V2gq=s zofEY=czLz3k*f=YjWwbK5ywNMz{Sq;0NgWRD{5nW4PqMOIYlNBOCq(-fMazA93v46 z(cLIr3fnDc?0*N7hAA(Qt^~VDWsaEIG+NZT8fqoBucBT<@}n&)?nmu^E0GD$9aHJ=N2r8c~%|7UoaDu~i5j$aLR zyEYLp2xhN28U%a<7LF`%>XQkR!ubsxn>rD!9rM7FoKZ-DbsAkkz^Sl13piiW=%&@rAHk3 z6`2K4OgdggQJWd=k#UF^M%#c{LX>)SQ!9XjU&* z-~LHvp&Z0He^sgWF1IWZ+?PNAL!-SKXpaudLnjPSk?5j|ltfih`S*Z+xrI4IZP59P1^Hoo7NSZairjBuGf)A6&Mf}J2qgaEGjtu#jf?UtIHo= zNAbaRYo9>T%jGHdIc}ixz)LUfK8TLbPn3T~W`jCKfw{4qenp>W$WTjOIloQ!m)L1w17JN( zciqD-Vv5I#7A+8)h}+1F6S}%I8L`;}Es{m~56Z#FFtJUJf=9*zMB}5F6vXO!#5_jb34abhnd$u1Vb=Y4SVNIxmhuKc*;8;9o zAyyZ##dreH>mK|LFSG%d(0&DxVTYRGvZLag!=?of2pwC_%|Vam?mQvPIwu)ODpeX~ zG{i$NK8hHU9i1xc{P9qWKONeSUZ0t%jCdYCbZh1i+_Jqgf=VMzsQ;Ze)Bz$>QWQMYPDDFGqF+Z2cbtlx?l>1Y-|^Sbryb%q!l-F_VGcZi ziiZLLvI;6$v&4#QCQ;0YnO1jK#^&wr2l@W)g1E(cMjWyBsC(59)LY(LmcK6p8>^>U zGe&PbXg=Bbd?(u(O=)@UfcBQQpb2kj$F&<8r=6~m@Kixl2>}6){#7EJq>&_mo$!zb zoCGWO`Cv`D3Za>l|0fHY7Uhg-_V9$+T{T@=!R(ghwL|8iU^Ggq;XVtqu3hepa!Thm zeH(M%Qd`I@e6>V3=BpCpCtLP=>-BybdRw3R0nhR;`ELuoKacNT)bI|@m= zl_m_I=S$@0Tc_E_9If49l6tZ^*^@k;6l~y(lBTgk$?1iUtHJ5o1U6Aft{~?fZ&ORA z$3APbZ`;T=;Af`D%?*)0z9SWkHZzeD-Car5hPqUhm>hp0)%rd@kJ%W`V-^Qp-oiom z0_@&rc>!x=`!VHzY?6lqX;G>xxIB&20PEyQ@QQo%FBhq|I5rFG94tD}1vyciovWS9 zmC1VbDwChhU$OGD@bQYDaPs2CWAK?!AtDk&1b{L;u#ClwHB2#_WvQyxIn6Db8iiW7 z%UmywImI-LXpkZY%1o#wl?M3u;pVnK4R-__wPDy$erEmd{_L|Cx1;pBeJ_8%@r1ea!jJbI9@Hfx zaVBa!b?*7cd!HK_{$;Z9M?()Bd3DndHw86seQTS%bJ?0LW9HcYhn#I2mVfW&e_ma4 z5Bjtts&@>e`nNu|dChkj!0~H<;}~#>&NQ+CisK(3LG`r?Sz(n*EAB~^I z7GjZRA>~U2dxX5t5jOe;g=d6|jbHG$byW{(Jdkli6pWi3ifW1pX!z=m$ugk@YiKZQ zn&%`6X6pq7>58LlRbEl}m_r&xp_o-n8iR?TrU8PR6blLg1pxsBpHUEyBLqJXeFtRN zZ9;#w2~QRLX(r%yD8ti}P8~#)OL=k?ljdq2&Q*Kfi4?dtmOYEmLG%D)K%BoeI)QE? zK8EsWGvZ)osZh{DFz+-Hcp=)|NGCT$0n*)wb~hPsN(5H)t6`EdGD*HDNPZPXn%4JG z*<9N7yK)0Mv@<<+1)9HnHy}vI!@r;OcGcF5?Sh6bAz9Z#(6y7Jn!@7-DgoHT67J7i zHW5hTRzQFJE7QGAY)EHX675{jAibH*knTmxepA|Y@~PuvPUYXfKl3b`8T#p-qrZA_ z&r#vM@)rj-ANcd`%8km$Z=#>SKeYd&4=?=bBhaqFh0nQJ(2aU_Th+}N3pZ>2SQgza zm1=>n7U;Erl;~a35+_+|X)@Z&KI9|xImo=ga10-aDjqY+D@Y4@M6%Z&y4U|@yKG>a zIL|o#zIV1S_vO2@&v&tXiQ^~fo>>eR&7I6n z_APmzx-TYG$WdVh^9;MfzfM{$cgy>wBm7a}h$I=(7U{1H8?0TTJgdB*unGnnaKy=W&O zKVyuYpiTD(J0(41r?hLh)unI^T%tO2sK~xUr4^&ndc=x&@Q!%Wj+Ee?%tz|`Ih^3y zIED+72XF#;07qS!Y%sl@lS;>jn;6fYA)%*ChNGk|tm&9n*U`BMCQ&@xH~BI6bYh94prU!;L^Q+uleeg_dib@jJ~jF+q?T-TJaiw**w;dtFZ7MW;P$( z6JNRN^rwIN-H(Bk?V#MtKuQfr8K$J%C@?-bC1>S_WPgj^Vl8Cm3v=~(*3-19 zy=e6%F8D8ozldH9U)67#|A=0tL^Ki!J4P_t5hG0H#xwQuc;f-4Mebmx%kBCj)DRGGo(J>2qt)3tWt@aKV9z8X96=+!m{X}RhwR)H7n3>i8UIy zks!LH6gkBuWm_gRg+}FM3$b|ccvo$}O{|ZylAXNl%nKLSt+?=F@n;hb57oT4ZvC$g zJilSjmS1lF@7`UQ{YmFkCOFv6gwFlpw`VV%J43v=1H8E!SQ!Du8E(=~AS=QwU<>{N zzd&5ZuJk|4FB2;wB>mB?hQgUksw#`TH-!G|AJhk8zKNj+q7$vDp_#F%R%ht(=v?cG z(D!3cSQ`QxA_L4orHTx!$fh~RC>pB`*07Wv>TZ=$RbSi^ICO$}mz-74#rhoDY89CC zMi@9|g2HZ%sLJ$IMe93Wj5Hk?B55z_m`pT6)+dvYO*$r%hw=^MvOO}EV+r_nI5j3q zK97;unZOC-q!);f=8epVAE?2SPpcK4PpkEuQ$H^2>BW;-2~&=p=W5C%WKjvZP_w9b z3@Rj$(EV0huxAcYhn=N@oCdncwV5S@9fFW}g`%sF8|uno5+jL-aDk>s+_fg|R3U0n z-QWiPrc%*|&Lfz%e5ye-Ca+SF+N3gJRuz2V65fP3#hXyVTWHFX#f1sBmYGoKDnp!# zGR;WSxuiiPhm&Jyykr-jNZpWJX6QWH~C%QViQ+iu| zN3Mv;jdD-4FY1euCMIHuY*mHKN{S`m2xIGE9~(fzE*!9l&9Q*#s)*X`>C)Yg{E<%WP1 zQ#5Gsv>(D~s0DZ~Pytho%7@}e3n+1HV|(1@&DaKntcf2%f)QpJm==0hu>nCj&Nf3s zvD?rL%~=_(t|ilwozx2K0HY#470E>Ev=4Xf3ddetKjZQE$L!7P$_^N1CS{$RN>!ygU`gg^4 zJ(UJm);-uTqhUvScbaQWwvKH}w~Ot`>0{?7=Z}4cTbf)twwUft zUuw9Pyis?vK{Jg&bERKm|km1f)UB2G6FDS zlnVmX9xq0W3|vS^RaTxiv1&SI(d;&TY3L%eAWdD!q%LHRxR6O*$TaA0&|uev$Xx;Q z-E|?8jJ@PQn_!rOWsDju{hw0aT&v&|s!e!;On8D!lmuz!6ZNN*e&w<NBeGL!$*L5KtVp5Gq)=y4qIP<1l9-b{Ym_WqGu_EmE%zsCP?R_W zIY7)6LYXV%Ge@}61;Gf?5FAp2MJR0fX_AK>mujIpwhDGV5D7O@c7)xj)Q$DPC?E(( z&NL0voiiH%A&l!=W=lrX>8u(qGq0x(ip|s3ZrWBE#Or%LyY+)lUj6vF{mVYv{hP0U zzJJrk1Mfe#;lQJ@&Q$Z0izfB_6z9Hp6XWe~cHdobr+>q**>RurojP~=>}kT2tq8H# zAVcZ+_e7^3Ap_2L#LTiVmpMVQO(|asJDoit`{<>J8O@p%nxyHhA0x%`bGj%<_vIO> zOjVMXZJdU@l;WLCYj&8&eLOa3m@yn8Aij~l>qI>K@!@|u8fg_zhdVw-?t`lXu9$e8 zhzY*mafd}-AnYK&A0^%7XBh-cX0|okW85;B)y8h4#~3zz2BUi-(mkQ*p1$-H<(i|y z@@~PVpc*(dUm_nt5_MQoI3}f;J91W#RUu!AWP|Qth!~15hK{4NA`j20EYH|oc8+K# zr$Tl6epT77Y31CZa0(8&918}5Tq+ol;#jT#f+0Ydy%_-lu^m4u3P@o6K(40VRelb8 zL!yf=Iw2ZHM61)NTmlhoYwwTx)_>5^yKd#2S9359e)D=^-`hh=m_1vcpZD6Pp_4$Z zZ6FBv31&8q5r`TNGeT*HSg#0p1qa2{C~Y!^9N;w^mDT>T+UM21c}6VlKkF3%ui&5< zdFW8tbTwN0%W9uj!$WV*_A-;lBtyP{TggE}k_sU*#v&$B0flu@iiNOAbU9FyG_Q$H<$AMb3_MUW33DKv z(X=rgHR(Bhvo7hZ2JNf{y1}GKH&`X~5UYgV$SR?SSQ&JMJ$ao^6TLPX`+f7qrE{dK z$C&TxH8$*6e|bd6^~~g;7*GeRqgoNOwRO}`y1b58jG7k3&>W;jWJmBi9u*dsXu_1C z>s@uwtkHv|%2sNH+WDM-ip6A@8wX1Z-&wY^NDM)8^12?(?pA=qRnl}RC#vNTG0kq&6Z%b2tU!xPq@#) z8HzE%v|Zf@bfEWWecC?haqT1NV=BKwQJS{M8Kr~XtLDO+!~M9Q_R0O~0sI7cQT-$R z6aEXmM6byIrPr0XrD;Txut=$_stO#aijt9OOqQvHafWCyLNpE994iR=mrz-OX&`8L z3e~tO!Hg1QnZl0ZDM&n`Z150MHwHmU_q#y%X{>t>>qK792-Wtf(!SCoZX_>e5CX5A z6E=fVL;Jg{`8eYI6gWQxt`vgBhmyrdk-|q&Z76)PdE>W&%;dzZSm-RvPjlHq&&;*# z3``*dzCkp)%w)$X`CJwsFy4aI&PD*pz*MD6;;$1_yl+dN8{VX%CiOWWB&>!qZ*E)-l5=+2tu~-*>fxG64HoN&>6OMN|D)bA5 z3aUsT?CZES8mKlFumU3$Q*V^!a;BB+s0>roiclKKpn&MrD+{~OAI>ct{UJGd^G$SY zVekBQvFQg3TcMAhh56ae^bkFB`}FJ%-+fjtnTgd)?=S(EOuE3k-Zs}xOECXbw6_ERds&zoTY$~+ke)nO*|;>E*^O*8OLe4cT$z2^?I zYf{j>;#JD_Y>Axw-&ZOwm$pD2OH1ElmFYetL<3?Lj6qfan*rPqc*6Ao>;!OK0JH1; z;?)PR6To!=94aqVaX5e@0bCQn(Lh`?0@w;*Gk~K3gB~>NRsfp;90oCF#Zjgz0Ce`R zZjT;r%iv4+l6o=uj}-Zk%%#Mnl1i(#lTsxq-B?fKEMdurrt4}A?Q{l>WyUjN28L`T zGiD+aGjf(x!6JmQhEU2Od+H)#G49jt}axD$z!O#X;%?+cmi?lTfb@y=QpoTrU$+>{EJfG_OCwEiCbRieRNyj$=8n0uMmGd_-N+~ zFV7zqi~ILK^sArG|IJUYm!Yo{=rZeTH%cTL6@O<;86QjkjLu4PQHq&ASO&a(!a%BuBZ1D3R3mJCKC;~AiPh%mRp+@?=ebp{=2o5S zoxY4;!3xWBtIl&P9AEb+rt{pYvs}wZweCXpEb9n<^j@3kYaPq5_N*-q+vD~zd)mgf zB(}yAKKBwn8xy|oN^pgqE19OJzjuzV+LGvM2BIsj=<&2`!N-|}CtMZw-lQ>C2m}W& z%wFShcF`Z;i%}6w1WUBJnOk`_K}}UtG+C3V(PGkwgK9LZLc5i~yAfs{99Io%2_Tn5 zEKVunQ7S+u7HyM@xHS6G<7dBl^dUnlt=xV8W52~MhhN(;+_UDu{A1$5?+$ezIyL_$ z45{_yPw)z0OIWByWyY7|ahv_aQ4k)kDK$)ib}&@S|6s{lZD=FCU&+&c<=b?pqO=*E zR%c?Zy}{UIZAxsg2grc>uu-rIiHGeWGNf)dhOD8)c6%R+tCWPdN?XVlZEI*y+Cg?` zgCQ+hk7W}SGS(d&Ix(MO99L-Q8u{3A$7PgqINfAOf2>-7Y<5;QDraX)te6~dyUhSA zDhJ$qvWiBQXWCZDNRSOVB}?)fuqWT=cwSz89+Z+@qc^78RsoLqB&&wCh{ra!8+t$p zMQWJQE>VNN`%Yur*UfQ3zGuSMcAL>ERUn5W?!Zw)V=%FDzn` zF_JBSJuNKemynyu&43jc0Rzb#p!x`TMBPTVshHV3E>sh`IVF9*G^p!137|NLIhDMi zWV8d1gm{cXL=vJg9+|ixt$+C^Z~q-7p1k_g^9wVt7e@~kC!ZfJicz%UXL}be&cAo{ zN2n2nPrZBU%-iq21OL+K!cN=_tg?hg^dVQF?}v|^1$pWEC3IOB>r9)XOazD$s0G#pMgv^DCcz@bDP96W6qf+%8>OUx2NyG-(a)%n!UYXz zxPnNll!xeWkuvRwYJ*0#sX%Q|j9ypM@9<~&3;Z^ReGQ{qFkxldW%V+;HfvC!aVlHNbl3Eh8O--#7Kl zp&d6Cx_)}*%x~X2_u+f!Yo28o_B5bFB|OE(yv`6&IFjPZ+(K?8_Xsz_c?8ufcm-cb z6?}}#OC(ALj40%Gd5Jff2$2w*RP7D`ziX<)ICv<>-{M*6wq!h% zHzWF-rR^W;?kM{p%PK`8M*6+|LciEA^~?RfLGPe2C=N=4 z@}O@#GoB4(GwE!4R(HBj{D$;!=Hc8(Y9u|H-Xp#&@6PRQ|IwU-;!orQ*@L;U%)1#a zXNS3@U8L+HZ5MP5E@;v&Qg)HHi{|6gf35}Nl|FB_O%^#bk!j+jj%M>X`+6;Dv?ESh zjHkRGQ41j!xmbtPViGfL)IyPR5pORdJsA<} zh%{kn2xlXKcNz)2%TVxF85(td@aY1o9W<3^Ls`Wtf0z)vDvW#&X8Z8h`;6s}l zkr%;d6s`_0qlTVdTwegbbVSOlkR@?o_3HXyrIYF{?CVK-g53-+*wnh^^=sML@svB< zo>7&c5>i~Aq%RR=gd86w?%8mNhv99jKNV$?DWB|}B}PduD~O%~7iC(MW=sVI1u}$n zpkXv$*t&HqfmZnQRB!RqpPw#2%=Iri-u+X+w{*mRHPFe-?OQ)8>s`ZF^3?w0yx=@;_X; z;2*r*bWYC7Zq-d7%G+ zo>Z(kB&JIXHuv|v^0haCt$O zV<0~4;}7#E`3c^`qdP>k;4ODZi_gbVHFy*fD$7_}RBn zl=UlANl24Grd8-aQ_{ePHT)K=n&$9i+Kgbt>RMYwuYpXPHSDyWqsJijSU*1f_nL%F z)~QD8D9RGrXFZIK)=|SH?5r+hyW#!6YCdfFv`$XyL|VnJb-7KLF%AM@goH35TogFLHV(p!aS-UF1Q91B;G?Nu5Lldmz~Z!o zWya$B9cvBTLn9w@5d8n|&oU9X@YP<+JW!f3ImPb__*f6`^?2Q0mq+2`DC6_0QHB9R z$mh3$mqS>LgSBu$9GvrWK!)a_FsP!50|>NsQ3zxK1SJ)AJF-DH)~@R2^Q#XmSEO-C zeRRc&9rMOt9$)gk7* z=reo`dwpeQxxID`BS3m)MqGDn^=noQBS50w#*0T-cHvjQUen!PM)Z1!M`YZB*G*V= z8h4+&v+&6o<&!h8EzoOWm!ikI+=NN06%ke2r&a_l7%O}6z=Bkb!I?D9FyfCjA>LYM za&VwIPe`_v84V8b?&I3ixsEcEfI~o@#pHyHSotsA)gBwgamHt6-?OtjyK`&%&UX&S zmBSYfVM{icBUIi(DjpUx350Sar>0V6grFhx0Ra&p5{;8Iij;p6XjN5er2yp&@bul&>3TZ{t>-R zZ=(0;UGyQnk0$9tm=2AjMw&zOX&3E9A+@wnG()?v7BD47;ddnpukmmPL_52q@zKV;Bep zIc=JRVBMgWg0R-cFw2->7+QxcVvXYDaHt*9hz3?@rAdf0_NRZ7aGq#ROqHfe&GCux zk`%g9>vk`fT-FU?t6y7`?|=Ss|Dw3O6hZz1d+jRCf_om7inwMcN3_abN0^nAH5Yfp z8k?4M#X2zlZF$GV@$8&<{_ffGGwS@Q!&`T5+)ZAJP^lxNodHw|?d}CYRvnQpAo5}a zF&4qC0z$?rF7K&T-`8q}PU`qnroXBq7|kHq)2n%f4o0=BHT`8B%5Kdb+Qesih*>?% znI4iAYQuZLiz>s@tA?)D{mOz-)k3EWQ>s40S-pp-)kdGH_b_I9P^hiVOs(0FC}n2# zxKn?JTC<@?x|UpJU}kQ$>j(9jsWW!Pd(Xm1PPFkMDm=3}B#)u-~tuko-Cl5K3vyD{cn&yUII zARR!;H8fj4HSz#2P#>mbt^cI|ny<*o>2d_OBZgLMhA)ZDnlrc4OSQC0rSb3Z%$#|h zs?MyKp0pA|Q<19MmhGCtLop>VQfAU_ap$3|vB1o`ooKPK%zVUsR9U5m#yYddUddPa zYsHiNak1U_uDMn0)%O`cG|%ei_=xyizi;JiKZkNotDEDkqAgg8y2KvyMe~UACOd|Y zljHWU*)ST>&$(CC8~Wd^JL(<&iI~*Cv{JS%N6ezqi%M6o$YWWGYFJ59m#YH#reS6c zo^?eQA=gkG%(Bkt^o_7f(wGC$VSzNTgM*k(ZGS$^`y18A=~Mm=f4~2VPkpLFtdQGL z*_fH7E=5UiTYeJ$^4=SlM@2frKN$v!rU923nnkH;Ge$k%2L;hHs38G~z?!g+ayR`4 z-!RjLFGOB50!=eq*ypU{29D#JKIeIA2Jkr2>X8f)YzWolK69ODcmgzlX&QzMZGv;x zMKrkQIrwSkS?7?W0Gf}5G~G+_PI{0MI!c}htzIAR^bh*Pmv^?O;it7{A^0f}{EiLd zd$D_cQBsjuH(4shAt`{r41%Tj$MwkPRS%dtu0};aD*M;X4u}t40G0i&ciC{gH-iJQc3rvU$i!voyIdeH#+W+u;A#hEO|C3xFzKTKyG!PIcD%pM?l;ZNO;9 zQT^NvJ*PSz+cLZH_JEPDGzw^ZXm%sKeFRc2_#iONwbMqs{LE>zl$@)4zW&Af<4v<4 z_or_U(zKdJvK=BnUinn?((5ClfEL0DF<>B8fJqmtg6R8_4P-V}!lmMa+0Os_NqUIb zA=V@*;%iE)f_uv6&zt7_unDUOdWZ5jP%{VN%jwa z^%tpXIp~@H0CRXGU(qwpOeFT|>|xDRDo{CFpfqr7>ngEyqC4OUJRaqyZTZL>{H92l zaDjOyQP8C@S)V9u;cuvKm`B~8@=Mw!{gUx6w|LlCXjWoYgVXFS#>?y%@N2f&CcdQ> zjiSBTeG?y{N9;3XlwGyoasTAqRNk}x>iom|h>Dt5+YAYx#~o0^x(utXw78ClgD557 zoRX0Ng0Q0Uk_`KFT`^3{!n$s0ssd>e2aV}q&K(bO3ec^#!aS;T!l`!!U9pIlMOJ{2 zr4Z+egPkl>0>%_-S&Bk*&jDXUv{zuU#yP+;lz&IJ4uljW!qn-{5t;0t((ir{~|eD{$f@8 zijMnbHuYz`wpcDn%*`!7rhEpNYbI|?%nib>Rd_XERimM1G}a6b66Io@;H#AF)>@sK z!Rq~4Rj0T$!>JiE!KuBf4r}&5ux_CNS8OGf;6k_cSSWbf4q3Vi??hX^`Brm$tU2My zi^TdwM6t<1p2A$N`wvouT(F6sq)O<7fT47*z0;G0!7S0}#6_#!%37TzY>BhjJ?h&z zk&CTvEQ(^R*sx7(i*0MztM7L9`ul=?4L^2X@n03M#$FDN(Bt+6@4SC5_>_JUeC|wn zUj);sheRyyx+|Wjx65RBQnd;v;%DbkjDD@9VHqSt!AXryYt`;u~wN$cFAK# zuY)9jZ1Z67$in5ToBa8jUH;zhZ{;&{@*fVBcYI@B`~FRx<*g^Y+`Qy=-lFEFj{fL{ z{kzHb`&Un{C~lBml7q;69lXTFpG97R<2BftFt7izUF|_pU1$7!-@SM5-DMwl-z*^R zvao;)Tx1_ey~?$XkJthlG`>P&G|se?fF#;BaT?6i=_DzMCDSJP11Ff0m`;sSBDP74 zV(OzqO)72LNvcf8WX!ZwXJnXA-KF2TNVT2b*}dnxuXE1*-QV~7e#i8ghVyRE5S~%c z12vvtk_y%D4J!q(n3i>Pbi!CkK{=LLHMI`vYy+1(PeA6XaYXeek%||&z)>UWsRR6))rN}A zRsu-=1A&Z*1@D*Q^zOF%DM|Sn&1%}IxYLG1;QAH05y|o!+{74@>0*Fil#3kuoWPuh zbF*`|^Qu#F^5=^ACFc%idko+pgC^F&rkTKU`Dqq%sXHQEKI4rOR6F$sbzIHx;8I+j z;9SYD`ti7~eqOIDiv*;-tOFBAngrmrzG;f5? z4bWmzNFf<@aS(1cmyhJvS(QNkBJPe42l=V53|pWMee}-@+!9#oCx5_3Mt(@B9&F=l zJ!weL4!2o2o8m;Kni?*yDX>H%sfZusbRyy}!~GAh&o&7UWR7<{(h7gyD=3z|-_P8; z%lay@WF1zDcMCgNfOT<}7?ieRAV0?!5FO#TeIcbBgvo1+8O|KC;%eABYGJb9P?;CPeKiIpQi zh$iQF8W)c0>4Mf;Ha*S0Iel3ylulrbtswf#?0I&LNRn?jaV&B*f)N{A5l4s|#UfVD z$QHGv_)~i*OTLf}&{M0;r#>N)FqRqsfY|JFp>63;)%%81HE#mS~JC?i+* zw?iw)f5kVL{oO&cD3yk(zq`!-e$2+Gzj+1~{X!!Uu&gcQ)ze`k5*CW>G$R3TO(`Bv zrKpc5r!Na*W*_Ts_VF3@F^8%EY!4CKbKUMGfEd2*RZ@(JOql+sbXhu2o@_2lGXsv8 zUo`!Srzg;p_e$ZXp3%T)-lv7iv5KRW7%MHWEU%8w?-$<4dDHPu{I~Hx#ckV^>iOCO z+71mhGOYu#%A_`gTa39?6~3yfipq-kymG0kdVY5u={p zT@YbK-9=c`!>Tkb-4q5_xFg&ZzCv!cCzozGtmLS?VZuV*#MWrP#x1N00`G`MZ7Ll} zzek5*SVkT(zSk^%7D(3ccMkl zaI>am>NIl=5v-$TPZcFCSAC#DoBNGNjFtLgC@C&k6!VlgV^~rc3&dMOwOP$Mu$pq)P_H^TBI+OhxZwI6>RsQeKB{b^0hHOf<| z+FHekL|Cq3RVn#$sQ@Hsnh7`k&83}ok}?5mM33KxVzj6jQ%O&8ut-F|&m$&kian_$ z7K1xd6A1Wy7Mao|7>t(2N@LNe+f9j+N>b89aq@j=J$owq^2w9gmrwr=THo)@ogx9-~5tvemMKmhr`*QojL{I z9{v!%JN(1G?8p22vVZLFhj`z9(E6@_DO6N$uix;L;t5rE_U`^^tRUMDXYN=~TvtG^ zbwNCUP0|Sx+wXA(9;M~Z>49JG z%<-$Ns0gebr-XKw1d_`+Wp_vpn_X$Q*rp_KKzlvDfcr=u)~Z}x$>v|8ku&-Pjjr)P zZQ(jg=eTPmd3ADwVQq6Ll4O$wq@zP^RPMBRqNYZp(x7o>xv4I=6YhvV;sy%guh~xM zJ^0(O$BzZtQ5t|sGT5cs#JmfK(YG4+gkhRWMRot>S~d2<6wc01rkYa^R1qlH~J(7K_+_dgiL|85t zzQji9jEQB&#In)E@~U#xhoFED$K)|Dek6b7#Si2Uy!f{KwijQMU-RN#d9N3rke~44 zc6qxOw<+6v*sL_)#L{KY5t#2SFGtVrAW)qICn#^p{6sYn#K?32r%SgJqNR@DVzK}n zP{&S0L1zSNDJeHVtBEIZR-d@UQRHBfC*Uy&HAgWsKHL5`oc}?xvy+fD;Z$VV=e0W+ zRW$ZLaPnmH$riaZovuyX7Oy)#H@>MNof7^$8;D;KgbP=fFAv<;d@JHUdAD#4R-4T1 znW>k%l;;$5D3Foif_z2B_vCXjzAFDx#*P2xzS@JbIQ!+&F4w8RnXge9)p+ADUgEsE_IZINd`Z3|&*HqO~S*8W;(GZZ>Q zb%=L3@19-IZTHm3qd)UMvC$?gSb~3*k>NX=ja?lB{5ItYvCpUnkIyK-0ESP*i#A@pXVdsSi(7iIWyV|D2ioQ5x;9%=Tea+(R71IX{4#a8l#LBF! z^!`J>uzvldp?&&{LwxWfhiF|}`>DdH%!}+0*YN!*==MS`MZXs9Ww0CXwj-=c zN?-|?(2vAC+ui*p>F-dwEOtJ^ULMArxxiMe@gU?ZU>?TALQVt9wPvc&nw>g)homyB zU(R}9hAZb_o-O#E4ZES}m!aJkewdI^z#w3RI7s+WM{hxn!~T~9_YE}DO5Ss5Pw?OM z>23sloEHwP`BPws$Z#$}Muhq1N0|?E^)xDhECLdNhs67|Mt+Gj#Oqb#66p-^j^p$v zV2WH$3((i#=OUw#c5xq=uTboC$k(Vwzebbr?FF+6`&f>6rvNu-oVY?`%we<%{F;IJ zOM$(Z^RJ2z%V{yz9}Af#FDVXf1$JPqzj<-u*q~pEb6tqFZgD=qei1Mm=TZW!W`D5$ zIF31=yO!UXfw8R^vy1_KyaM*loMaoe$6Ui)9@gEKREIH@i0cJN2?W>&4~l0l@a;X! zlK_}NKVU3y38({#fXTo-UdTQyiev-NFw)S8_i}PR1Sh$p5(lP&zuic zB9AJRJV<5CS@zG992e%AiV1SUm6>6C9j|f(QYRYXa=pxxUMxa#CGEqUkDE`Trqs|J z`8ArOf0v$=f2SGxNE&O5hYtI}*u$cY7TQgehO>MC{a1amnqjqQtBfY>vjOpJp*@J{ zS7nPBEL$|gXmBnYq@6Sx#5Yy@F6oEX6#T}L5&rGJ)!z@qS)&0pv%&eqXmK3u=Vi_b zt4$jZ4D=-QKLSdCQFgLcZ5L_BtUQV~iLL=_We!a?a%iG#!ubSH=aCE0=NTW-+j=F= zy2bguRzf8Lb65d-LR6uqVJ&f%${0L9ySB_-^3(tnLTYXke?$*Hs~Yo}||yw|o5b@pP4spWXeu^h|S|wC#<{{?-bO3X_4!d0T1$KSaeZ7+&L4H-BHdUbJkm7%V)2=sQ zKhL4A19}N!)IfcV62!1b?R|y}*4T2+AHAN2Ge^vwsKfl8*hw$RWSVIfQ6+Sh2I?f% z-45MmnxOJPb_BQC*Hk;ov{6^q>v2rNZEK%cx4@I3u)m6VU1%4nK+i{RZAJSt+=CdW)@XF*GUOZ@qwK<v(9A|)wxeRj?^|m%pZ#@b6{;>1)jYQATn`a4_lazWD$pF~m^#+LvvRb3my70cr%m zW0idmn$6(cWr#-nUIRkkC(umB?YL4p$5r1I{O+BPcP{?(fqyCTG);v}f}9Mw2r}1` z;W_KiTffe$C0&j2RUjHL&*L4Ejdx@V-Y1Vx8Bqsn z$*pm~4^W2|L!N^Uw|D1Apa z`!9%YUIPvV?c3{tRcQYMz|t1Jca?e9Pa zAV&kSz`s~8_u#6EJC6Ty&nrP_c!W-p0-*!Nw5gz((MqKSBZh~F(2yXMg32YuDyU!` zi!D+?6G2-MOHq+QREhywI`~9qXsZQ5Mf(R;r&b+a4$>JM5k?Kk>F2j+&&|yVNkq9b zpZVV1vwL>WzJA~BN&S_I`jIyG&@-;5zJGjK#k0($pC#xv^w-Hd#Fy51K0DFmT_c|V z&eXGaiMASz19zr<_`WUKcb|^#II%LH&DprsVH2LRtNLj5vg)6Wf3#}uZ^p;cu1GJm-Q(!%r2C@BWOPGZ`bPM>a!{0cF(+%h9Ud-*XJ zTE-~JSbVy47Q4T4EN>@9XUFNUn~vjrOx};BTnR>m+mxg)ZQ}zvNq6RRPdAwrCq|Ni>+Kc^6u@q-W?7P!N?-uUUE#5!wLvkNy_M1&JMwe#8IZ$e2=sGyYnb8-B zQQ`fh7v`Rn^4!f*PP!h5i{Wrc>ofF%oO?x5C&DJucaZMxzHZ81X-Rjso|EfV{kidn zjF~wH@6-Ov5V#0>!e3!dJlA@Mr0owLjB?jA^Zz)tmixd}Ft&L^GESzO@v z;M^V|f8zgLXcx2#=levcjUx%V^H|x$a)xxj%fFGkuQREcroK zsUvnSCWe;qd?j`3N%uwzgZ}b3?|F{;%QOb~pAZKp6A$w=cF=B(tbyw&dxiUnJm8!q zBYDq2cfS-^J=bfLt2JKvgQdI1Jo3JamKxoUH=ZUVVL0y_rm@D^$Qn6FUE)uwKwfml z%Zu(NnaBIKbZL+^c{^oIZdxjHZz6w-W$i=Iffr(=|A z2w#g-X4@ElOD5*m$Ta#nT*uUm?KGL_Eacv&F->k$>-ZRMrF=??+@ru6(taweuOgV7 zdWZ6B*rRjVE383x1)ixvmRKkot~d3rH}yvPRWO`>)l#n^JkWyN*+O{0t(K(*#!Kff zRS-Up&P%;YTSFz^jNg3vbdOAOufh+B6f=(c-Gy!``MN$Q0rL;PB0bQ2yHzt*BdC`z zW6U?=shq(gJj-=1Qh&v`*|Nd2QW=b3y`CkN-c}jt+<<@i8)sb~=58$WnlFo;ebUdp zP-Z$kB(3CBhI?|3pg46U^%42+pvy_u$<)+aGM({S1lPk-zPr(|8?ONDmm4j!lvG2` zw|V{^OtJs_M*qnhD$f|=cQnZQEGQT5gT~YYv|S)4IKav+3%~j?QV(s-n^ovd~=`Z8%@0}ErbsIg!(0D zRSV5eM}#k-e};Eqr|p;i?`OwDzxi2xSIfB|U$_r(W?UsgtS$%|B6V+*apuf@qgAZB z(VU0-WrI2ILe9QnQto%dhdd$`>KpV7_hy;$%e*wPN$@9l1>+Y!5YPRm6nO__hC5eA zI?v#XM{(ZLhWiKkslHp!ZS@?^-Euih&=|(Ksj=`f&fK~#PZ|HxoiYXPhxGSB+0LD< z-n&wAsP6}ZN#93Ye^hSuZj%MMb7Z^!F@4=DwZy9ue})Y8?vT;(-PWHYd0tn1fz{kq zGBfx-`3=(FJtTed>hN`M$^^#j2XWi6*Kz|XAYbR~MZ5msWEqSzeWt(oFxM@^kKvh2 zy#5(uk~aMrukq7;Qe0<|h_F$$2-qf%W@AjxW+xW$v?nWsz-htSa(fAz=vdUW| z_pl}gCw)!qqcWbtGjm)Ww~_fCRO4sn`>kgA4KwcKk9B)Xnb(`OgYRggwogHC*+AK4 zv7ZgL%hJk&^Zs!BEQK9@GM+v|6gKBM`g5b(|?qmQ^&vSmq%8eU7o#sX~ z)kEyZGROSW^sq|9Vt6IvNnx#w^wY$n+#{8Fp6VdPfOkzZL<0x;<6@fWphv?D zef^P@!MlsGDvs-bvkKzH9(SMLpy};R?YyOp*Qg>5$*wX+>4zuTu4h9l0__S&%O%_g z(ju3cIlMu$njM8FP6(>nChFk9cbW|sCa8wueu{O@-UC^{%qXki<7)H@~&Cs;}zm?+JJe!pzk2siGCtLAI7py$h_ zRL;Tkl}FDtm-m(%yTZGql6rRW% z%~$x0_6cKmfn4|^Yb#OV=xd5a(eLm~BCZj-Tezp`CHuNz*b|UWlyAW=|1}uGuFaR( zQ0vGEFcZP$Z`uSBYvu#6^RP*-D|`skH=JVcI&L({CYlqD>AN2>@$+9tt|DFTULh}u z)UrB{0&mxH%D)0B>l|1f=$J{E`Ti-_zaWl8so8LwH}hdW@bw>^KRLMUo6 zt>Ye~yooLjVa5Xv;=SRXh~bXPW@ui7P9HL%#Y?i|n6lZXKJx8709n6u=GlM#S`}qM zZ;Q4evywoH?magDcxCU1cU_^gZl^d9yQjFJri@uoAbpBZb}UL1HK618$F#C-COfDG zw<#1sI;_J@n^eE7egtf1Yy*isO%_T-2Q3MrtOtWQo-i+(CH9o;uAogB~F^< zLx&;W%@73)#0!Pz28-(c3rrr0mDf6dEmhR}YY+h|Mur4M_?wt7S6vh=tkEu)&yMm5 zJWGCE?;JEj87E3%r={m%tK*`6wmR!<`txMd=H`X%i^>h|j7kRf z2EovzAvp75%4KrR%bt2GK??msKPOj|tGko|)uMkneTy2Mg;oSzz^AoEd19b}38Yh5 z5BewKBIAwvdFlj8oOX{=-14>ZXV1p8mwlZB0{X~9>%vB+iBhP-^sDEo9&1Im{g2KKl=CLYORno@Li1S;3`ASD&D2=L z*NQC3#2fVaXw*5%69fhW8x*a*ixsK;MYPG#Ic-zv0%RKX7xS&9`0N+$yzPUBwJ z=w`CjO47{ipfu%9n4S&+_7P69A{sf6*vRab_~XLPysZV8cok91Gt0NJ3gsjtm{Tp4 zzja^k;4!7g;n^lok3B@*B0sTimFl?3cj+#cd;=`giB(nD2 zz&^5K*`0ykbt&x-Q|ub4+;C4e1C;T`f1ny4v+Qx2`*25jh)1KK3Ti4Ic}?iQ{t>&O zrhlx>Y+uG`uBjMizEn9J&Wn&bmYWZuUnJH>S-of40Q>4Cc~t6^n&(Y{QUtt*1zyQz zbi;V>7n}|@HY6q7_*T=}+gZJ|VD$H^V(T}O8i$3AYf#f+JkQqOyuBYTwMm^ezpr#& zYcRY|C3||tDNl^U+!}T>gAg51eLX3jO3QZB*eC5M3@E2K$VS6FjEe5|q-1kYgL#5N zGao(f%)p%?+0q|LkcML%OYzbiN)CihWrp3Mw;~)*yV>wYe=Xa9_W;-IFSyR`d!Hcx#MApAEx?HwN@V*pq1i^-!%0!i+E6Gg|t&PGF|rw4fsoQbGsxv+<1Uo3N!1a5oci6gy=Hi79uX%28v- zTjT419ifVhw{6!+O7Zjp#b zenB+K%)IX&ZsGfE zCUH%E*d(xb`KuJNS``D{J|4Jg-~@(j=4DRMixfWsU6IfbhQIOMKK;@ED(1ar9#}f! z+pF+iE=kOsLPr07!Na!TCRXWoDFldMLo!?qHkxeVy>AHa^~ufi+NVV7MsIYb$scAD ze}4nDlSo&NOg*qX4&2nuAnimL7Pzs>ab!*u61@wa;TLa&tvRzfR&G%6vK}mpb)*cW zniwT*9Q7RVOm5A$trreu@b|R1>R?xc>$E4#a!hftj(MJ7O|tV9x4(=Q;WFp2{_&wQ zf=qYhH*EGXF^u|2RiZ44EBJOk@hp389z}FCif91F=>p$?wT@T+;HLiRVC;9{Qb1~U z?aAj3aCW%G?LuUoaT$ePmn8J~gp+Rg;p|9w4}DqoKC@URPiUK#XB1h{*mnxP*rr^% zG>S0WIrO>wOuc!Fwb``3{-&(}K#WkU<=W~bx?a{&)4S5wx(P>0j=s^0e}CQ>ZwHJ% z)vvot98>B;8g=$>h<@I1X2DmP4_75mB)A2<{q9ppX@&ee$t3j=yoQKdg?=przE%r{ zyI_y`>2hb1)`aG!^L0RBK7wTE%b0Ru`EPUH9*NyyeATvK>~3MN2VmAU)G5R};W)(D zYhAk`IVJ3a?91L6hN|XTISha32$31w3{1zrtAaNxo)^gUMUBX`O!7wAPz7Vb)N0pz zOEuBOD_>ZfuLmOk;msCJ_7fyI&kLbVPTy=X(tboJqyIvhpYf1-@3^`=!Lhy9!dJt> zjZ3>W8I&r4ZLpY|&Y0xJoM^=s{ai_CDsTvhY~l?(@PF$(?35g6nPyz{4;KXhR7YND zo~#eGd1g5D@LDvj4e^T4*;lCwdsIj**c(vw_Y^*#|1Eks8E@Aeg@Z-rOPWV4@fIRT zBb;@tx&tgciL<=@E-3WPp>9iLP2~m=QqhRlSA^YHe@}cOy}A?HN+Jx-w8kp$zWn}*SD$vsmdj3EjoUHvuPy(-krCgQ?{+ zJ{i@-XT|e5wozOzIdIGHKGJmEayv8L8SJoa2346BMAI2;h**)aroWWGMZW|x1=0@j zu_k#RDcHTJ1w598c(1)3YiU;G6g?y`DEdyk4b_MSh<^QsT+z9Morc^Q?ihuiMg;J; zP@ub=!^Q%Igj#C^4t(Mg&QRp%lh0k5gi7q19KVE0*nrj`*=6FJ^kp}NnLbnABFtgG z-WBK^f&NxPci0{fVip!^5)D0{Mpzm^25~92PC~1&bF>wGx)00nq`Wz@A(HqgIlVR^w%&p2VQIPuWS0f5=bxi2B8ajWsvUf z;L2hb#3#MY?<*nrEPVIYlu>Ka^?2fScVtMZ%;+A!S3C_tCSSK}p{;5IAsI&m?jW}8 z;d9R)>wLV*?qt08A5i6;z!RR~kClf4PMc{)$m(0_Xcf|nT; zUxk)zG#+_!WauD)JlX$$V~v3+x974d*%&%(N=Sb%AB#(pF3Yet!vt)UZ}tdM_&aoq zps5c@_L6wVf^Y^e%Z?)wx!W`&7ThDEM{x>ymg~K4oMtrJ$w&LiKy1NF<%i;Mag4q8IxxoB{S8k-){hS4zQR zfco5e2>L?G3Gw}(gon_bzuDGlFw#@xE_uR>!A7LjSp^3p<1>j9a__U4aStd(*00wi zT@-2yA=+|j?9uO%7j>}oVV8r4UQlTpLHFJY&wtIhhmq5wCB_~Qw9Y4tyfB#wea0rJ zT#a!5Z6xISt&CCBfrc_B|L)KclIg>6{v;8Fr>=~xIr*e-HN-%kpZ^P@j2Y9Y3QSr{ zWqL!TN@|qflbV!Ryp`pe-Y~H6U@+UZE}mM1U{oJ~fmWZaPF$PWh&Rp`+-xB1oI9Vm zZEa#f-9w;iqbIrE>-W+EeSukGi)jft7{lF0l>T>k;8>(>aYyVdqDx05a(Wz`=kjjK zv8EczFwnYFCB{B^Lzo-s&*iduDk3CRbSdV|WN_0VG%t1)nKV#?)Io?y4Qp(REdeBC zTy#vDE=JzBDohj@bHs;}41pb?%P}HF4=pfDW@M-^wWvk@lN4_YCdZ;gCUaQ9wsuGnGx zNot9FAR!%BnooGN@uqXOgaIs_gheRHVqmy8X$Q@8pR`A(dLcggez5^> zvO&HYQbD4kgPjOPXcwm#x9!0xoip0qNO_)eyF*0z{mQ3VQZvCwHZJLCiq>K zOvO%^^8?a-97ECsjXNe-H&C5~QRnNOdXr;VBspVP!b5&~&+gCtnwR9f%9xzzx!U{@ zW&Aax(`6&i8F5<3jKORF=z{C3NaY4Txu8Ih05Q5r5b3A@u`liltaWE+L2#3?YmEeF}I7ffrU1Oq3LM-O+-9!8+ z0O8~0d`{sv{Z*DwpEl8{jz8RJ&@Ejn8tNcE-eW`V&)60@^xjS#O!A-as+~ZRz@I!( zU8ubn8()$@-gOwsUq1m^wSoVLu)Y51#xgxz9rLD^8YOqJ|8ia=zeeSG>lbBcm+5HR zcMq4)3>VEJeW5YF9GRap~iIcm(1x}Rcl4*R|}W9#(0az zL@3RupJ&WN9{!9>9#RcCE0>MNAIu)n#xu*7)yxnfYHrSI0g5k@%*crFIFDTsch7gV z_J)nv9^KeCfe51q_+*m&j{7LmCuux+RKexxnf6ouzCj}<$gI)&7$RphyZsXmv&iwxST1b`<2fZ`{7?6>bo}nK`x`e0ep1W4PLn3xc zyObtJeGE2bE$bWk@QLQQIm^crZ>mHnXa`AJifm=Js#LFQA>ckAwZ5bwqzyQhe4XuU z)1A1Z+PxJYI*}=JHtQnTBR7_)8MDNJMii94Pey^Qoaz|JhRpF1W#ol} z5g4sc5DV_08o|e*0=6a!twlGG^jpn6a z|4}J!99|k?7+-H)vJNTMTp@iT_JLL1UVlsMgPmg9zr9h)8x~WEA!z#+bBwb%W}FkF zjX`A_cC{bU9jV-R>_g3d0@z7op)T3hAckd_cIM0Qq#?+Hw&55#*uAJ1h=~w1!GI+`0t||F85y`qq_pAAI7o+P+ zXE`KO0|zfuk2EwfW`hFC>@q8k6AAAcOjR0+l-`yt^xx~iDbPCZ=t)-aFKJHb1#y6m zkiXeHp4bNO*Lwyd{Bvuf7jsWy&hOKZ!zfBtvKJ{N?;;+wGC8Uw9S!fFZ<^bA6x-J? zc~)~a66QQ-3#WT9q|sYQ4X;gYL!R^&Y|%%1R?`G1IzW(;C;ko$pOTEf%j`E# zvfnj9-a%V>!CH0ykg%ovf?!AMjkM^1DW20--JNuDtviVH(E1{CNCqN}+nu}w<~W#K zyZkTUo+undOmpv7w;yse`74BIGhN&fusxGNv@0os4nz2iR3>~{n1k-)j|Qfj*2oA( zi8eDgQb89v_o~v8^OhcPQux@qwO7oUbO49?K(5o2>_*x-${r<*2~$B- zx$&B{iUV9h!kCei)rf60%uv!JR$H`4n{v1ctg>N1Rjp>wBg!5V44P^+(?pVS8+04U zOwg-5-MSUVQPxy>&4_?0cCr->%gv$5K#tKH=JcfKivii~`8{lqV~F;`y(7qPRP}Y$ zbzK72MpaY9%QAlQ_MEhstX-1;S@cUYnwUr939G!)x3E1QO>$jk4a@#7b(fzCzRAKi zoPTU4!?_HSi0Yl1RV#6jmSO9#Z5;Q!*s~{{_u~)UZKGoHXujhu1MRXa-k7BG~xR{(Fk~6!z_D|n4OLIS{xvD0? ziI`bB8rjo{Sn4?%2^ksK7#h(@8Cjb+n&LAuvoNv!-wQoHD zP`!Z;=a)2kmK={tO~L}Cg81T;cO4*dSW_GfZbmidY~EYo-3F*xpXPFi%7N|ZK?%|kR7`@E+?>mM!FA zckfa*6Ah_2I%@jJm6q>G55X^1r4oDrD(gRjuaxVo$pYZ|O4{mjN5yg#nlbIDTA4$s z+`%*R{xBl282AA{nNIpi2Sm_wk9h-L{L&>zvKfPfDon4oRsIopAp>uBm~VD^ruO&p zMfU#`wgD{grctJKR1Q`z$rokZZ0+qTul3hvtCN*&UVPbjxZzygp~bzb=&bGQPwABE zt?et^`2+YopUbt1mz@6XiwEx=?=MJLY~=60UEZIg8ob{a9Mt;-F(EOp8>2EjILz*o zCOI)UXc$3s`6DBP(y43|v^)fM_lbpN3&mtJsq7Zc6~=TR~J1qGCH?Y{lXE9 z$%eFA&0H2k<4P4PhBaC(-k>a2+x5&Q8_zhLE=TDuH)|a-t3LQQy5D&NqS3fiJ^9Rh8UHfdTI|lm#~|aw#RrS!h!qsl&!5a|o|P&RDv6_>l|2gBk5(BL zSjKmZaUX8mDNDyI94fjsc`ADw|AE_v&H*;l=hzfoPxZwguaSp8UoT%TFXa+-6ZJKw4C(f-Nr-bOeSb1vjK&vdHx8gbE#hNcWKZ={s@ zg-RI6F2GUJDz!?G2vf6oeg5lC%PtX}gcda=oNCbi4g(ZsQOMMx5qv!Zco!K7L;?ic z@0S$JB$Ov@Q<9-sE%Ka@U1lOFiWpka#{A2?!x_oWr*@`3SzE`Zn@NA-P8eMY4Uk3;WRa6taPo zU8X*9$*BcPI$GMpRL!%~0kYmpGvum=eYn>Z=;hvXd3&AH%*6mEdAIXuH1UX(XnI8c z12AuoOq(LezDLx^9Q|0)(oyF!)a=&0(ix=_N;^Ytb?5c@58ftOUa!K_0)a0Lifid{ zQOiFj?)dV2aZB5pV>2pCRMeVKhOWZe?da2#Y)3ACi9^~GTXmlHYb)CA>%w~EdK(`= z6Chy~cl91H-85l&VeY(QsA8gGQ=<){c+&2^@~SLTb&S!_uHm$E9(%59(drb-Jh?uB zX%1KC+~C}ZS#?!aRb}X=U#I3>|7qHGgK5-e%5K4KKylavldP2-kj$U_o$Q^g8!@L} z3-(=`J>!Cynm9?KH_u7`^c~|S{S%9~3`mbkhf9Box_C;TsR_Q};skjY&E}AX6>tqdtKJp+tX{ijv~vTpexM7i)P zZee*1D3MX*T;aKprU4G(ppiwU6?{^BskMy90(<^08Ri1nwVN7Kps zvk@Ea_Nmjq;u<)@#=q8>tVkT2F0?8qdSS|Kl^azW5`bWpwMk2rDDLGC72xZ~HV*KVA z7>XR#J-*Dn0L?f5_F}s9JjHz;OQLwm8EjUOK8NT|JYCZe|DgiseZhmGz|~j|2ze~+ ztnepfjU67m7-1T$VWFgBTD2^NR*{8cmbL63@B{%;$^!fHT#54h4D$TnkEl+C(yze0 z^EAnQ$+c3=i8KZiYN#50%JoW?%o+prYwFF?u*Mf_5Qp_qmPi|u&9zn3Ayx((YrmTl zuJqd`E29-g8n!IqHzuCzzAk|#3?S8bI0t_>5M7pX@Mn!i*MTUHMmHc;hGrR-teQCo zXBiD$Vt*uOnUGw9bd1v0OJ7;a_8dYj)l~k*6E=nU1hEdA>S;{A8kRvi5 zLd}3A+-Z2;@~ClIW_QUcfXEla&+{kd!~cu^ zYgpjdoJWnFFAy*%OLUqqpoS%1EL2+)Xo0@@PAXHJAU>vE0rW~X@$qpap> zRg)_H=-KRNr@-h%IS%!aQ}_1n=p{HOqAk^tGuJI4)+H$HF*)q1V97U-lsjSC6G_js z8e4E3CtNo8Ec25%g##{U^DHvytcOLnV+hR&@T}5|GvcgD1;=vh>IKJkseSb7l9LN? z_dM-FvNRr~PJXnD7mjkfhPjG0@R`e4k0MR@1R|bwxqT!ve;~RsD@$NMJ^ZcPqiZgq|HX{?*(iGU3RsT>AUhZ062D7i?IMj*WI!z8_ zuflj3;9W+1)$;!C^<(=5dGH52e8841x;KsuTJ!)NJL15WOZpe8orCm&vD=JLwpA|iX>JhkB1lB#{O@9r5%0vDb%a$#cH7k2D z=e2DRmZK5=w8uib!B!JxmBTW3#dy07cVl^#sB+ZPszi%<6`69@)8hCq3mPE3c7I=d zG1**Tzusnbpa4+Xz+PWS9w9zrAvGETO#Mn_Wzxlf_dhUjxdcr9!+#*}^q#6`A=gFlIs21*k>?muDgBb7>j_ zPI9@wA$$DR{z7gCw&>DM2E5e*q4pE1!b;w1s6tQNa(?3a^y1x-ePYDy(Ya##3?aE9 z%IukO1(?*K&*(vAkH~lW8o44&+#zZYQ>pr?+;MF8X1K!G9N=_DB)QH^4O4c;z~2%m z9}rdcjnrZ*i^;sJM#vZjMh*_Y3>DJwk;Y1Xg%^^C7o(SpK2aoN$_knbMNvfWmq9TXfk`-`kjOC< z$x;=)-$ASRj`rB1~KFa z#|Mq<0Go&|LL`d)+@<~>w?Mc8%v|v}hY$5cc!z?XsTOZgD|ZUs$6%8%vY;_}sM< zTtOy;_|(7xp}A;(|?m_dE;|}ganwjEjH*0~1Lwn&lf#laN_=7pF?;7g`F{W+gLczQ6X(?8F028&?KasWAnw^Gn(`^(xx z!c6oMKco|4wlV4QgkwXtH0h067*0;DENrrwvjbS$U^b#m`e`tee8!=)V=4Hg;Bi5e zJghv8ym48jQ~pv?MH6bGNT&5zyC|FdDQlbXHIv_IF;gbT4i7F5bPq{y%bqsgkHsF0 zohqGa+tfER+TAV7IfpV&Ca*Q`j9+Ts*gn}ki#o@2FDkD#A2+X5U!FcmJ?lCLHBT^~ z0zO$PhTbeAlXSUe3xM#fLckE}}c3wJnW^OzcCh-%@Q|czxk1p?>1GW09O;zftHsYL7ILD)#4KB-_ znLFBXELLhQ)|)QbPFfRAGHvg(@G=voDNY(4hS@JN9i}6&_KRCdtU22rS=ULARogaw zyL0KzENBa_5&=7GA*Pr(x&J$}w{{&nI7}!~b`IR8TQ+AK_blo|E-5_5RE+8`akDYI z={$X0C0wOn{cic4XPg zulX9-{xaTLOUOjDHe#Kx+81e? zvyRkQsybG7G1$Vi2DBt+7|u`XK9IF!ZERod4!7M|TeU>LHDKrmr|TKFV(4kJ5^c3x zbGLM7>^eJjw2fK2w1i}wcJDqra<*q}PFtt+F7z@U^ZniRIIJV%I-`*BNJiTaawp;1 z5QNUY2=W+)am`klr#eb{9(OhBve$N_>#x{VdYlKrXw0z(X#i;ebpT0QR<+1v=Et`0 z_Rm?ry0m-d_{jW{j&|Vlr1~9kGl+24#YPz&c0eeT`R8pP(oS9zF-6$#Ra_H+H=-h6 zRugH3Khqdria}EcUQJkJ%oGE3y6~Kd8~yUEvg5QGe+GzKw!~ND$_a7{;qz7GD%>w9XxSlu06H*=7{8zPOU)fUmUWiI^M1F&$3C$X6~+SGhehrHQ{hs6M)q z>SFAjfuD37%@8#9#Lv6b2RP{Zl<*6_mJH}Uky;z+GORJ!k9VL7;l8;u=;OEQ0!X8o zk?{qGadfo>gA+HS$_nevnGoa5QVY1UEIRoVwv|+xIp<)X2A@6OplKEoN{h@9RA8Q=#$m@-- zInK%`-jZyiqiZtbn1)?knk9~OoZUDd(C#)O#k?@-$T%>`bdwItDEZG2ICB%FC_W@l zLils;bF(Y^V}55c=ueyNoDDVNx_?N@Y3TjxC9%}$|lW9af5r)zo-M$SyghG*n2T8d(kMW~${;1M?k zRC${pQ0O99`%);UgZf1Ogcl6=P;}G<#PyMc&k@xoCgiTrba@!_J-pi-dF&}An8!9m zo!+!-;|ZCk5P9OES!{%xoI5%N>ZjtTM-2V&6YQnr{5@rpdHd+tklP*kcXS>`smGM6 zNAJo+A?`f`vRUkPDbZG9m${Qitsko&4mHJabHd_0#{?{U(K`O1H@XkBQaUf;kT{#W zfAe5TWQ%omQ|Ah=kf9M&+X)_THq3pyq3m1z#{pW93#wF%tdcRbH~_FS$9tA7_Oeh$ zLt=2G**Zb)I-KqaLAFbwAI>H26ldil#2L*~NPRg%jg;CK<#f+K6K{#W!M(N z=#)O1KxNd-Rix?_?ygdFUOK1x_f(QYVuU<~`M73A%N0Fl|HX|NEtJ|$luJI(y!~B? zd!eq+f49b)?1vz!1bWerRG!1U@P=TT?;%H7E*5PL89P^jyi0C5B|J$g0~=*gUAq}J{UhMhDr!M%MwrE3yU z(o3Azk=Ws1W$8FZ*|i}1hRFo7BPTaORK1n)GBIXpfFjkRNK(~3f7J^8@?K|B!NZfn z*CL`actyMtJobj67F3;pHtZQlj|b(U_o-?1pj{|e`1c7S!mMuLDz!v~BW*ucl3E=9 z@!e{OVd*{(a|-{Zr0d;DXjNpWY*Bblqqdxyt2gycad4*OS#qpYA+#x$4l?+;#ayKH z17EZ(){&T(kkA6^tf}8Bk+Xy3I4VF`rcMG8?VglUsHaC<(v>YHk4AIQXLoEfbm1(K zoGQT$g869$YKVj_>;{oAw~R7MyI`m5m84yaHQ=9fi_}ks(+tD;k+FR;XC7(!8)p{a zFG7(!srmRJMOm!vb4rcl9tp%RqUx47g(@dTbYa9CcRk;8TD%<;Z4MQ$4gXuoVsXZs zsOL8_MA97Tsr9cWKYi#q5|6v~S0!HZEeJ`(ymQ*cka<&v(w5nodzH6^ua-}_NA7H| z{-!r5A28v|K_tN0-(gRVnY3BGjGdW>AFV#7@jMO9>64E~dMe_Nx79ZwY>DXbM7AKvTflLkLVFf1(c6KpnKOMMV@Sf_rJA9Nf7C@66&R7sZI zK;jP~t0qGLT9O$+obGI1e69R9K%(S$rI~k{U|p)w(Q>{}{Nnqx-g=$MtSs1+EXq;c z6qDkv?k3Bxzi{frg!@2C{lsm^Bv4E%9RQqMkd+s|eaag}ahr2_S;cLp>Z z`cxD_>42NO@CFpth2Dti(*tQ}gSdrBT;@zixJQ^(R|@&KkYu>CH`550stYnWF*}Qs zP{ze2h*R*&s%k^Se@6xaGrkdA0r&3_E1(V5um+7%>@NK-wQw&Ic?FSdWXY8j zqGn_J%@Ti|Z(j30jLZ3Iu$WKt?wX6=6T^3&%bvQr?I_icuK;j&ncD2~ z7b9lLy{qilH@KkSJ~a4HyQ<$NIJa~ya#)x-VlC2f@f41O?g+HuJjg#(gu(kGl`EM$ zanY2;sB!OBu!DZe$-Vj*21Q#N10Y@fv@Fl8?V!k@sFao1xYl>5Ub8~3K;a6xNCF6p zO!qCO<3s#-k(|Y3&yX;GrDmeQ;HGz1I@gho#!8-~7jGEvx^H!-1{FMzV{W`5xdFt8 zrm3}uaM_9DNQ`S&l_*Oa892SciEX{iH)_OfUT{zOb)J%wu;^&lQLj!cL$@jAP^9ez zFZS3lH>~mz^TGtq7Ro`z5*wW=tdiU76-EaWzdq*xrdVT zhb)A@3feSQ*y0!KS+Rh0pfF>iRr=C$IQS@DWIs;58uSVZEvjY`N^e9xZG16qr`!qO; z+68Qyza%mBh*Q2%bZev%a~UZGZnvSqCoKNVIBC=KGpbDaf@4jNe@|4)*CK_eHEVxr zbGJ3XE;5Vw+!HAW890RfgXZY%AFwNs-W@Ill~l<-o*r!!!mWu_?4zj;ZOv-;vD60Q z91mcVjE+O0S*;#ByOl1D-0{F13@nPaZX6=k$4Z80p+km6r0TcmQt5iHbN(D)_V~Q$ zb1?j6C8JHO-qPnn%a8%>%pUbs&6N3QY1tK`Mi@Yrl`rV6jj%ZTpt`J+PLQ#c@6oQD z(;2Y-GT`&@KQ@~dvJf0edKPz{e~$GsHDF6_I9koTBKDXcCP>zwCcQ;Pb(gY=;F3Y0 z3loq%MJSc+rK18#!klz~9|FJcGW$p>jq7?8pw|L3-1i??3c^X!(i(<))pqR;5AIxQ zoT9D?w7qB+F35GebbS>2X;j2KVD5ZGd#3b2lg`|bMMpZiU3&o&W{6;>^O)b!!(mPO%dC(z!cm6<+7Pc67cL-GX$Zx?J0`OZ$r?mCL zQBi7JtQjs7TNiifVSBx^?Z&3gEzp^qzJzdD{GOd0X)7CkvrOyyR~EZWYODL8bxsa1 zk+o%L58P?_rMa_xwupr=PELU<9ycPDu0COQ@+_+=oUF?wyev2RCoH9&8r&Z5DxZ~* z9`Bo&k!`o0xq^>=`P&ZRo$9j{Wsi27_ZiOUo2{oW1qB<=M&2jsowYO_ zEitX>Gx$WJtpt;1h-i6_7e4j05L2a8TvQH4s(JB5s|>d zDp1j;)RA5MI>kl@m;3en@wQrVR2(^$oHX7f zDIH*#U>k^yufSaq9`WltDc=vOFI->0eTY}LCgp(!|!QiZ-1DYry>fWe;z`!xuU=WBt@IIl zEq@cUiR(qQ{tGNs)8+FX$3V9lvBB`;f2G>2o}D$IUaL#CK7zKaV64~HgA>Olx6;Lq zbmp!X*Z`}>x+p5r5|7z3itHKnCyUwf~b6s(j&|IU;;T9@t+Bv^h^kv%|z-_%rLv|GN7}Su)Pt_Bzrxl19^; zP%iUB;WDH4E^I#t#Ss2kYqQ-(>vd#p0u}SXsyFHo#U8y=uO5}67c;aJJySrhUkX?- z4Wm*&dI%rS%PNXq*{5C}I3N<9Snro>I-DW4HPaRRbu%7I&A=rF@>0DRRDFEsPZ|wQ zRu#pxICzllm-pZKy$VLbG%Q0(a$kND^*@2E8GmU7B99;np})gl)sCrJC%heS1Cn%q zwNODyRahJL;CLvrvzGY|1nH(%&|UDp)Un>QMS_)0Z|1TzV=YVTHR@zEthJA<`)jl* z=M61We2VW@EOEGG^>8$5YVB$7>EP~5ikFcP5Ff4?HX9Y+mTnSuiqfi2L!BJ**iYFD zw-Q!_vtE*HI~HqTUD%?zDRg4jk6aB__r-Ast?JsK3@!2wFHyY{rp$c1bUzITLh3&a zkNhE*AiXn;(NJQOyhbmi9D{IVAk47{pNkOKc}(o{ zBDIDx2j(=a#6u*67@Oi0WK@s-Cn|l3Uj!aC^L(D{@KD%H7?}`Jz_Dz|6*nQIq{)>z z5V#Rb{i=xWYqZFdjy+|`m=3NB*4IoK@)B-EiAPGS6-D$9O03xO>EvLZz=*c`=R&`% z!EA^!Z0)Bz*B8ivEUGMD!5CL0B_z&my$~PsMG&L+2L}}Qhe`8^;*9c8qb1<)lLlCK zqPg!KwXUGGfBHk-9=u$Pl~B)HOxoxxc7DK7tH1IpjraCTRIDbx_qTjH?+iEU&jK7C zV3R5HltFsuT^CCL)|2h2!p%lEQ=}Bf&S!G#!mPJzlvS@W6+(0z3b{0SIDse-9qXXhyH|{7 z02&|$rwFX*3r~_|FtyGwcM!f+@Yg#9S%5@9x>Ya0eng0>j<6<2Wuf-_BaA)oDZ|1< zfB=AFBfvtIwI+Nq-1#A~>+(yj8jtO&^kPrcD%Dw`1t z#O8{pVCNn79ICg75lDq9er~5xo`O0BI$kDR{Gn)Rz9im=Zy5Ew*x-zVc7PpW*$OB)R5eWwYi^tDve{&Z)n)WP8fNC=W-z>O$g9&-S3rg);R#I+ zL5oeSh7heOmmxmU<5vWUktlcOt*j&u~Dri>(yas zZ2&DE)vKx1ZwNKt3Al35oFY&tWJPol_DY*7YqxIs!Iq`{&E&?=*Ao{nJB8`WCjGq( z!drq%e$>?5*tj}E?(28&#`Rl$?LRwv6|`6bh))15dQdJptxa7eZsZ&J1HKlvg+FR* zb#~c0)YHyx^^#N0ViW2NWvjcLe4zBWxKrp7Tuw3Pbtr)_n3e%y4nP!0+2v3q9w89} zut=&*z?#q_WCTV?$j{6%Imf%D-RyOuiv@!SN&5w z;p>)bLq~SZ``(Im3+An(^K%x=Jv_8sAH4E+{T8mnFW~+7sZ$TWeBs5ddz*Ie1eMl6 z{dz&AB6_|H(ad#il3gvbihl7CT4JqWtHoCFZSj4vPqap0ox^Y_B*sM&7t6#dkr9n2 z7Ec;Y7Jj{x5KK8<;-NI#;vDAEWT|E&RSahQGKP+B1chlv(m*{9nK7#jn9{)ypFIYh zSC)kkPsHIUu3^qJ-2MsH|H%!Ur$;dR=Z*Sfy7Me9Ae--kCg*29ryk(ji=wCi%k2ex zFjSP6&fL+~z?Tc^1?R`?#~j_LY;x^Vm^?H=N}#FIqv&yIEq#)Qt|+S^zcK%S{Id7A z@=@+LbJMwX!5zlC71DY$0JGKwvvK z(T3(jaIwKAP&*MeA7kRC0W)AH=BF00Lz5CZ4G=o%*qH!L_|$v?F%Bt|;h&*x3PU_? zGccV1NhThcltLz0>)y9Aj7h0A`;oNPynEj{=bqDUYtQN^ zHbP5}M=B#Y(u+61C_AP~j_lZCPtt?CJjmnWM1POqA&wo72a(2KpR1WBzv<==LfRPbI>VJ_o}6iLl-_dg$00ngmR9 zA{<7;6Cc%mF5j<5LEA70vBU1sM zSxc7IG&Zo#$UF7hE?wHTpffb)$nsCL7gqGOo<`GW%&wbJSy!KWbm=cvwluEXK;7x% zusc~pZ2YVGlZn=HYlEpxSTDR!-WPUQcGwOwhuMRc9_t6Tlgv5mF`G4Jn`x>s*IBD< z^)^0-v^usrKbJ0Nk%cytCa2du8px@piAf}%0>q?EmUMDPMN}zX7Hv?ta z^4B-4OF|dVf_eEDR{&@?FcH6sN~oK$ujfD-Rd zXBeEAeFZ;NR?*ehY(Vsp_{OkI{p?3<4h@i9X4pIIzRz%k)VSl5&*o z_i`icE1c!h(fu?w!XQrF`a()wON8Z8-DU$~^C>)k;Qlz>{qZc6fo}|=s@vItHH&__ z(XDAFUkMSy;;9Z|O%~uHD!D%EDf|(LDj?O4yib*`9iD|+O z>;ke-Xf%GwW=`S3%7}x*B7_%=sw?*~qdt^fxiMn^vnI$hx0=cpzx{00pDBxJoFJVF({B8rMh5sSTe1jE4-q5`=l$25E1 zy}+3RD20)novL`U;fZS?s?gtf+0=eO>u7NCVLd{2tUS>X$)*>BR94n;;zZi%d?3a| zbBqa7i&MVWR9(I|Z+b0QeRfdWFL1`*K@B=Ju#e|TN`_o|+T;6tEWD7<#m3ADpciXYuo|W$p$TmUA3Lpl%3m5ZA9`ohF!fsGt8gxWc4Dk25>WfCy z$h1g(WN{=J*%;}H2udUhlAPsN7{wL^bKZkrJ5V&H`d++CLBvTk-wvnkH8d+#Mh{(3 z^^jv9OzzJuwbPK}qL<`88_hK}@X#;~NcSoedbQ7}Kwqf&_KnTM_r#V5&=Ma+r?JHo zD4q)o@&Up_Zwm4^<0*gG)ls{su6<+Tot7!uRn3fo$M=MOJga=ls84qyxhp)WT7Bgl z>CJt9YhB~+aN&{F^FMAj3z$2l?IGf)1MXGT_x)srl%N8kTccax2)+o@ zE4@ijc|bHC5}wOfsL=Wpr^A`HNLGnTEf+`LN!s~uw0~-^qBaym=J)20)&Aky-tz7z zXS!N;V)t`5zd~=ITJ#dy)H!?aQ%lxJuQs-nxjbovMlsYH4JKS5zW)tyRDJ*SrAX5@@3cIP*Nn?^$rP`7{r1+vRnyfOQ zP>M=eq9{}zio*L4q*XQ}3L~e(AyX?%U-@YeJ%%Z607Y-&+z;!2-cw&xykP2@x!Y0~ zQ1J5=#gpsG%3iE~>>%m&6dc#C|M}pWu6gAlFL!)kyhWaQa_7!N3uFt$$R^PIn^38V z*{D7$5U^_jUiK0cCEYMah{$pQjIdD*m>9vpm$P`XkpbK1Qp{1a3Nefm6_B_ng#=WT zF}xyu1Hspo>4D&fv?9Q#+)@I30$Py=XvGpxq%qNP;QM?-$0ja5@D;w2QrK~%_dD&Q zJ6iJ{Sp61Q{aRSP$ShIguzH>Z42lpHjtZ9rZnUsbz=FV}OAulGalR5%ql$&th+T>) zYQm-m*Kd5-`V(ckFHM!nbny>c-xjt%H4)EGy-nA){kzn!X=mpG`#uKtDWGsqmE@J@ z%`~(KEg9>CwHfQ2YuzI6yYJ;blQAM z`b@emSy&IRP`0UFSE-l!O^lGkQ^bohC7fJdX+t*3HXCJI$WfHZGB7uC>fqx-c_#KM z3JWFsqu?}i3cHLb)95uujjWNf&bO-b0oKvtrCa^Y`n*W956IVVrPHH1T&4@2PCzu? zX9WiOM*tY*;tAsvZis_+Nv2+CJR8TW5?bfMYue7;#}5DMZ^(+qjne+^-IY9k^~)oP zkA8&RcTzpI>;HrrFI+|Q>z=uKuK2~3x4+fyYImQB^+KI=R)lnXzN-dAju=@i8Uvi% z4IzSMctT(+4T1pZB!a^KMGqOTseaWw&0KG07n_r2OriQ;va1F*isK6J%=dOWQUkaktSD_7 znqsgE7#9-K&`7juLlwkND=MeZg3{6=HKhc&b>HmS1k$r_W^Xmxoq6wj-}}Bk?+LH! z#YQ&SC!h&s;ky3*0$g{)y&P|uFvy&{cqJ}gNwy8h=}UMWhs52#*HH)H<~hP0QDoYt7nq zP3_cxIWbWfCKr&R98g9SazgU4Jk)9Ur7COHspH99H+GcT8fl|i*1>M&{3i%!EBcMEKPikUsdGTWYZQkTSriJp?gIY=B@<?Dz6O;%MM;t9i>2Gsm!fF(g) zNqMEzEw!V?dXjHfcj|rW0riARzo-9Hy{g{OKn;$L3{GE^<`NE*;G#&MDV`%;WEa`R zd&NF7OimH;J~>V92r^TAmEd)t#86pF<1!bm`smfcfKjUtjb62Ld`7KW;SIsy3D&9! zBTx%FIX&o$W@j^;oneJL!yZuK=4ofy8!1;pjR^IalNzI zSp&@^vmSpx^XogC@qzz1k3uH*089T^+plQKOgpxaN(`%@FBGO~F^b8(vDc>_y_bL; ziKTg&F$lZWmAePtH=^yoJ?FoYWr1qJ7!E5Q9I*|96tiN3sK5=-P;5S7Mp`6hRHxl& zj?MO)6UyN(3_4)w690z)%_&3D<>sqqY6t*+#�K21 z(ph+}I*ZR0OV|>=RM3c+Vy5v7HO;F5L+tnqkcHz$!telXJZuMmuWVST*sw@RA3 z%_7$SD*7c7h@xZ8HRqyp$@w!dPlQ~(Rj)!kAAw7g1RAxCg~oD&G#i}; z?lVppIIBb$AA6`<^JYUsny2pTR^py+1tt#q)p)~#UoOu}KLVUoRkgKT9v&i;#gXh@ zBQ^(AutXLkCysE58rSNTxpY+LuIfB&RI*N^(mmMBSb3T?z@U*3NfDc<^<)c(sy;Tr zE))GE`H20Ikp!8-(xjR#V6TzAtdI1w1LQqsNCj;3hbq(9hJnh;^G->naY7C>SP6G_ z*u0=TjTghiJ5d5JMLEv7%s~LaWb*N?dUEW} zEUEpMfo{73y3MELDR0}AB`jjB@$WHWhW})c6@ofIo=uXi|dK_ z^*D}O$vy@7z;sl&Io~!oq2q(Q(#&-TjjltuR(nknVq*)q%rtmNslBo`NI^jd|?9+xr1sD6b4mJ66Gw0M_Im^peJhE_=SGajyqfdmq<|-v%OgDAKw-)p& zy}{j~-C@1W+7xb0bcrsr+v*PXPn5%jq7l=59gofLW?nVb}&3ej=# z1d!&*A^iBE;sp;(=2%9|=TGAy)L{F_8P1D~^P@>Tx4#qx#-bU>qNUU>U0&K;+F9CH zswYaXm*Ud=WS zC^HH{P3nc?Fp{FJXxbQ#axKtp(~FbSL)z3eooniB^T_soXTP%- zB+{hD2aODwDNt_OFIM^H_?FPs#%j+#{+8KSc-TD8h0b&lW+5@ntT*d@lv&&#G=sjN zHO-vnd(5}qY_~oZMjLO7ZisjD|507-!BJIb{G4;oJ@>uY%|7q0sWgp?3S8?cqaKQaymQ7O{$ zXzd^!OCv4prr)`{K)9QG9(Q)K=YHSs`+mRQ^XB>zrbI%DUgVqOd&>8$Z>#TBpXjp; zJ!BYqksdapk+Psagj+(pLL?MIRw)NEKst+i@qtRj0WS@nN`@Q&)F*jJmm-m9uvC~x z948RCgLkKstoY}L9Y>F}tX|%e`_<6OxsNTa`{cvrb&t##v;VT#|Hz4-y?*+hn)The zzv2hFn@h7hgxO;jetXtpUF14x*2pFLC7^#iKIu+980ahcUFCb@sT7pL(O@(jOSX!w zl~1x~j3+D4=tGX)tj_bzvzwhC>Pw54l|Ej%Z2Z$D>q|OI^sjuCe=Cj*s#?wu9 zlXJvA;?Q=x-C1X^bI#l69hOwb8Ds1*POXu4>eYHIS3fXuVWX9-jy`^W90esJPa!ifdKxF5=Jr?)r3iX4I-Neg|ulqp#+I2n8(!Kx_2KlvFIqONz4{go;i#1RD7bp{x|vnuYw+IppL%fw{UP^xZU~>fXY=!` zn$j~9#S^E@U$v+0-KAfiFxtOgZP%vDs+K-6@WPr;e}pl|*LYxygHXc~TIo7fN{Xh$ zMx{;ZP&O$N!y+l80+EocM5A%KmMbAV!Bv@L;S^fSs|dCM!PiLINC(+OC^6;i+l8z& zEqsSSR_Yp{zOr>Ne5ZBVg#ugDdBy-Jy}C3E0`FX|f&L;ln;yM>{l@)psx83fW8hRK z+UV9uvZP3UXd=pVdAcGkQ0DtP{o4ZD!(EX#{0AbZ!xz~w(+ph)yDOCi6!kM?|UW=*IB)azGZ{~8> zKkjT^(lu|*FhqT11Ulzjct3`HJxIVZ_yIthXA9=WC#MJHAv{FR&@-aQEyy$CHrz>G zrrX7xvMeBtRmt4uw8&3m$wU!07L~J^XgXT}SriDdFbY9(nLw!}vXCe;p^tpe)fkdR z3JMn!v7anK6bccbtx>#|cF=S5GfHV6)?9V1&>@@?J_9=jwb~2c07KA^HAKh~S4m-v zP3f^h-)zX5P+^&CnM^Wv<+k3xa<|&Qqh$ws{CO4I3j%g7*qn?fVLd8C;8IbhH1AG{ zmc53*g?|hLG&%ckvH!-qbn5>e;&_!1l3w7x5s$dVNg>HB?Hd|}Kx!@ojzI)_U=~Kr z`^;)k=9gV1UXoT#81!2^#CIa^hs}|aG__!mz{)W_j>5`VRHjJ(P%rCWDgRZ!(#2!q zarKz~F**g#aY+9hT~w5A`l{HizOEmlJ>ns?SN}6rCQ@6hQZ2oUZV|iGU+QxH<@d|j zXE3e{e5HBwp}+!+UnxKGj-I?H+~J0~L;L~XX-q&^0vo7!E)Y<7#|3(Hl-Pe%qoUO} zlIme#0{ccLx!)C#ZjC~K%0zLJriL_4RhT4MvJ#SIg=)H9u#4~`f{qBLx*)2Wq{vK` zB(VSz&o~09LgiP1FYLo9SGCxHHsDqPAoy0dpbcPxP2(0G;$}lO6OU!HaWk8V&4z-% zbQ=}^!pA#3`~|!b1-LnE7>$>^r@YJY%wc=M8StT5XClT)@Cq!4 z^D9)97d0^4U7ba6S0udC7L{)}N^pR!I*Lb`jU`SREktqCcMxwov zBwL8|k>~+@TktLIQFwg((A!P_g_u8^pMaAJ=p4Sl!C71z@Lk#{(Fb$PTY!SC z+aUY@$RUZ6KwVx40wj{Xj2Gi({3xE6y+|GxnzDzIFSftA|<$wl)K>eq%x>zCeD!C6s+(zRHo=@CGKjCT8k!V zG$pt~qtF7s^QdQM0aEJCw{KA++_U|e;Ur%IH3E(M|Ic)_1~+kC;k_$qSK9Zkv@5M% zXk+<>493>l#@N9NHs)c#rUBOi6hi_AHJ#Wd?Esmfcmgq`Es#*!6aodNyqdO?#Eh{G zp)gDX`P0b^nbOzLOf!_!p`Kwno?;qH?zt;F?GN2!?Otp5e&;*i`OZUooe_LsNFxY6 zfeO~wBU-+vhec4 zzeu0So@%{W|7KB_zOAUg=&1gq;Dz8w=uYtC5JyqGs!_UDOqHrBeJ9yZUZ4i4+Z1=h z{F6jR;*}M086US2bIrK*ObIM{#O#hw#>sed1fOu8Aezrc5D}3g??;|SoRLTwN)i@a z%>%y9u)=bKVTB}E0zuOlCciW2q&c1`!{mT_c7)q@gdJtD!?JvAw4%se>M7w8uQ!b) zq!^4Y9-16J&2QNAD+N{x``?=Cn*8XBpya^<9Mg_IHkcw6d+cWi5KX`pbAtN7KqBNr@#tpL^n1>W!h?@DE>K8LrXY&CLS`*B@#L z7skSCmel3$DwToa`nvYYqMG4=lx8zB|2d|F*6DuB+L{$8ulf zp5`9s{=6Y|lAL|MwdeFNube%F{nR=*djnL0PW;VU(;=pml(t>WC>d=}V7LA@`8Ic3 zx*hm~bT2SUjk-s@qv{0Zo$sBmu25EJ&4Cn`;phcQjaCzI>~!rE54ifpH}p%&MQud6 zqIm?Hp&?VSjik>Ml03emM@>75vdLdXPJ#i<6qzL~*h*Nik4U}=JiQ7Q#tFA#ej4Gc z$RNsj{0DEeg1rxhXv3!mJMvJj!h>IW)mUPDECG|>c=`b_Hanh3K+N|oz|@|s@~o<^ zabeOCfFw}SS&@4ryx5xAv-hR8E*1F_pt-q81tbA_mTkl>!xuLuKH@Be4 zIT4KtFA|W)wSe8`Y2LhP%~4WRib*MXw)_;RG2!v_MEj!T0*A>hP)&V>qlsIgHtEMb z9-mDY7PH0@SXvMv6^y@B;ENDuiYOAnBbYmeTaR?qe|^H+3eYNO=^+UO@a<>LvLwZ&zZ+dm}!TsB|95}fl zg^CgQRiqyyrOBRmSH67y+|b$6aNb35-eTa2j|iimj}Q{nNi$n}+;f8eiFCSWvMH)J)K650YO^8Q zU`N3ZkvwE^qM)=1n*>q_D7cke(L*LmDg@pWiJ5kMrZgWDbMi3|wxcD2oSwm6PlDI( zR1|>uvXfN;816Vr69y_*^CT*dc1F9Sr=!lOXt*t2Gy(8wHB4Z{)0kA_P@H3p8#^pt zz$)=I1gxkC3rKJPYqjl-8nSR7YsbyYutUKw1Dlj-sm5_&X6yL0k+uJUfE!9Je(3=} z4)0&~FbnOki;M=_>ZTrG1x?$J7c4+Yzz-Gh;{^-A%6qf&dJyLwi3Hf|q&=;IS|CjE z7!0VGr?PH!&YUr6U}zUq?nv?_61yS=ZyfV zYBK3lG+FS9gd}(oA(1|hTVzouJH?VLP6R_CS=7*!hBW*&D#7nQhM%UqKE{)5aJRbK z+zxk%R4#YQq&$qA7B6^@!v|dYg+D44mpP^ zO#dhBm$M%}0LiiGYr9hd+f)3(4tl!9_1d~6W_+2#ZKYj_OgV+SoZqGSXZn5>NZ2%i z{Z)qS6Uc%X7zMBIe_FO1EpkUn+F!0I^zz@kd2i1P2;KOo577&It{ut!>+{Kdo3l!g&B}6m})#5}-i_v2FujncA&@RmtCp+ZrvI|VM*C#7phmS-e1~uZKJq+Vh88H1U zQ{?tovAFr32TlE#?rIN;;=bei+xPD6-urIv1?MftEytnIu!z*Nw>Ia+#~4rX1qlUH zB@$BwTTMD?B9jmmbxKW&5Y)ifjFQHQR5SzWbmBCfnvR{Roi=|oZK^X(1~U^zoW?T` zSo+;P5RKD;z1`p5-tKt7Z#c@$tjzgu__=Y2sbtD4HfdUt24o0?LfiwTteSL38;9tv zgTLEyVoiZQHgD~c%+5-E3}nHl{mWYqc1<0{zjLO(D&4t%>T>`Mwf!nI;#oK(Fa~>O z6yxB{QVu?)aaj&;=Z3gT+*R%-M}@g2ZXY)QCn$nuFz{-?Vj6Z8yAHo>08KWgo{?VX8Iie9{&M%h5v}>Yr)mvBIDyS^d@#M zO})ciBge@}@-|I9$~?+8)6bJf$m8S*s*mnt`dB_pI_U(Npi1ddrj#ugSCOkI9yBS( zb1YBs96^&7ilhN0X0fmgPw>2j9KnC21*meiCd?pan}}Ots2xLLcwxVgdTvHy8@T=U zT$>L%%5a@nK9lfg_)WuOvdP(QBBnn$&qY)$QD-E#0jBzHP}GJB%==Ep(TV(M1*+G( z(aZW@_1iB|?@s2>Uj1iNKR_RM>Sy86bJ?sN#VCkT+{h)BrSNuYh`K~wrEXGGm};W- zQ3G&-0!Rc%G9res*{orH@`0?)gEqgWh%-2l%577{$P zS5OI+Refqv8ehgP^QDV~c|>`DlZtr$ei+YI2}mP)H+q zMzaNiv4Rks+Z94hAryjh7m8ys#ZX-5F-$Q<2$wSU+Cq451uj*zrLZMoiz=$3eRqjk zuKY#0rVutIth6fxrp!|+lxc-j{3ZWM&YGzFNKE8sWikhR50sPxlbW1sUAx)7sc{&N z=4^y`?oJrAgc7cZ$M8pz>5?R`*~-e@R-WtX7Z7pyQuDEj%&EusoGO9dE>PAk-o8K| zD@-k1x_!PrM#hf5xqicj^^K3Gd#CE~#@81lmmfZ+<9OzHeOadCwW&$S*->NKLC(Bb zzvg3HlB=HG&XOY}f^6B-Y})pjoubXr=3uNMEm$ldRdE#aV&-VW&@|lS|BW`@5)-UO zd__^XJK+R00W5d_gfk=cz>v!~#;nSX+&9w9Ai-4ec+L{$VNx-0>4*#v8Z%r64 zJiBdCw&T1WCSxZqJiNW*Ib*J^1O3_uNJVfvJ=*dcXpFt%y5k`)<2NYW>8Jc0UT5Fv z+UTwG_29j9FWV!Ga3A9Tr2fTyD2!2K^bOH|hP{ISnSP)Bqd@IpJLwLVaF|tSk&FNWXmZmi~Un^x*4*g99f92MxT3^{2@m zz-tG8(x)w0lt^ffRdx-u%Ri`+xZ4K}c*Vm6Q-)W046r`| z*d15_c2cW$CUI3%-O12OJT0c(D?@B+7!|M{Nv)&m_)X$QSDjQB*jR9yKOOp#%ZYc~ zf&;S#jUbQ~j}Ziyg|XRb9~iPiXB?bq%;B(^s;SG4?16AzCgtwI|HZf9C)#EL&_cEF z&8`-y#ot^20YDDg6ghb(YN#Bf&e>FAMfDqv7xx@O#HFW>ClR4fyu7u!vt!GaSM;ZG z?<2Jb`;i?1$J9S|^6Lz7;aB~qhRz*-+fe8SFpQ`+vp=Yn^iYViqFSn%+CvfL&dt{C z)>bFUb2cF?;9bJBfTx5t0xpc;&uDRmfet5dnlHgPJ6FNAawHen=j?aljm~|}bIz+y z(rL$Hh%hSv$J@~W!ja#R8bzVJ3~#%qp>qxX)p;Qf!GQj*c_?2DZP=a zzu_NR1eFjmyZWvqryXd(=;?=dq?_tCJ+fr+x^gnsvm;$~d%@CQ>$d=71$49>FqY!K z*Dlcxx`~;4j-K8Ak&bV>sZ^cpT<;bT+Uy3=Ij*A<_ZDO~j$9YB`6_}+( zS~MMdQr;Rn;5^{oFTWJ!s$e4--A zvRuSOWv%ST!n5w5diKWmlpgeSl=gYLOE1V5io|x*B^~j-R{Cb?P#G;nyjrA4^=hH8 z8up@VV0tRqNVd4E7%$d*1!{4i%$Sc7@J_Z2Rg|IfGE`O=set0DL=kL;o6J32l4oX4 z1ZGY=J7R=<68Hu*dfWKS3{A8dD`28=EH5UsDjFdgc~MMW7|BG|qdI9TYLRk?M-om3 zA~Ig$5(T^@&`2UOQ)0;mP$1)Cz%{|YA>e1XhPL1+CQn~6JV#_Czn4d*uMZbSjrH~6 za5TU62h6n=go7O-S}14aUh$XmALPHwbVL?Jk_=!ot_G_#{LQd5KLz`tVUGWvxt5Dn zW3Lqe`(vmAX()@xCe)555P?D6XHgR(%`07AxDp|4HAbRFa)QJS2wn|t?X8qFxUZza zO(m_WT9vfK0{AG7!w1~gCWWO&X_rJw8v+{emo0#@f$0D~1HLWsMMIv=KS>zN|M6Yz zu~B7Z{Cwx0`#9&`dEYxPDoiPz4$PKmooUN->&|r%D3rp2AdEV@1VzP_UE7t=tRU?E zVZn|2@ImS;u!+egtjR)KmV#@7N(3}UL@|IE8&lVnNVeJ3QX-xDojXMnqu$K@&N=ta zy}9Rm{J!6BDm&lbC$cqX)NYn*nz9d%N@eB8k-9CJyX}ZvOe^Z!^`qp(nOK-IA(H!;j0`r{29W3%Ts(t(m%9%CSQ|k9_1?UwP}r z7g`^AbWyZnp;Py%bv;&CcWH{Ccoj0TMeNI~h}U;BY>s#KwRPJ0P3J2yrxB;-=p+c~0aA$-xtd z68H}{6Iar)@K&c}AG6=El^ymW`(^uzJ!z}N4%#WZ#b$OQIdJ>|o$5K+fjIFn;>1~E z&z)aU?&`gdOlqpq6`V>)XhDQU%*DS>Adw2?19(V`0jD8kdp?axr=`)Qp@z16TVsem zd){oSYg!lIxqtn$MUy}G93)wKyt?K2Y~6yJ%krC6wSE(RHU69LSC627zKSUGVU|XQ z^j$Z$E%fQoQB~nuLhGVkp&r^3`U}-P?H6KZlnBSR1=k{W+Hr^kNPpDhNl}=?n*TpM zi5veSNCr$AVEk_hSZgx>!H+8SZJM{uHY7*hw%gm~RN2t^quo!QSPzLsn@ipO%OG)V z>(0kd9Hqyr@$p>`Z`?Zp=TTJQK22nTAH{u|u)uZHOfpx{rO~7@q(O;weFR5O&ZUx_ zg>N&^6w@$-Wuj)KVI|3vVlinpFPawC_M{tqU#cL8YT6`WHj-s#fpnUKgx4TxRDjR& z-evMwfdS#55kX3&E(~K<664|mH*6BYOu;#&py8Ysee#KTU8Z3A7WrCyu8;X*v1Cw` z#72~1W34Shedz zZ+mNxp-XxmE&_gnSK3)@Sh7y>sE7JUti7YXBZ3m_Omz!1UFwW!{@~A{zKY(P{nP1H z(dK5lu;x>aif9G;)Pg^_t>{@nG%9qJFCbC6kcHHwZu5mAWLe>?lGPf_qEghlm2PcF z8Pd34?sVTnYtV%zV=CjOVAcYXWKq@T3E@~)1Ie%^wV7u`lhsN()JOPgvWBivyY;nv z9~of#)B!#q_F04EFdI}4^TT4$x z_x%d7Quvf&5em#wRAK7e&5356!4Fx zAmO`k7LqlxkxcZ?CgZcS$;52D7DZBvUuj-u1-rZt!e7X)fL#MtP*6Bm$j5ee5MwZr>i2~~sE7=C|Q)a9eTUc3qlI;-#a6o*6 z9o5f?YwVV|FMJBqbuOYT#g>UYD~Z*NJ1ikO#Rl=Dc#WN5m&G*WI_`EP9G6voeFPaY zlTF;QLIq$#XEJg)7=#;&^u(J>n+tOa$f+BME-5H!%56%ys+s2e?MV~l)Q#b7Gfh;R z5LHuEWS9o$CQ--eo?$J|ad1sz*GAtl-?&flDe^MSoAPpa65WMNHbq(pBfI`xzkOJ* zQ+E=*!OFBZBe@zTq8U_|XS03T!2=ftm&fO4AQO~GQ_JqtB87=8H#m$V@p3}OwbIwu z57Okpiz~>eT5z!X3T%7pXRxk11V^f`UB5{is8YQJOR9YK*RZyFMpnGPx`}PZs79bL z8qTN?kz0>jfr1hB1q!+}nlx$@uTfc1ix5dwO=CXOuLUWIXe>e*W)aG;$POfcWAFyT zV8EC2XGqFvadtS$B*Lx7kkSP?y5YKo1qbVe6%{w0C>)dlfhLzzZ$*L1RTzrIt!pnx zFQR6%FU)t?Z0~FWtwh6FuYk~7{k_4d2~?|(JwrNA+(YBqBC$OOW^u7D^Y-Q&M7Kd*6o+(T3FGkh# zJM?}KdPl>T86Z2Hb6bO{1;^;&!&7$o8)b_@w-D!m*t2ePAF*w(T1c+$CQRs$@WmcZ$c{zr# z-RFghV&4{K(F|I6`aGN~lYASrcWAoWR_}n`p09Tn!;3p}t&dfYC{I;C`_kSz82LS1 z{(MdW`qzuqhrXlV#c0gkhZF2+x}PYd{B2)Nb)Ezk~>C?j;F*0CiFqy=ROYpoWm1gj|1p+M_r?G!=dQjN9NaV&@mk+zQD z5)xj2=YH>Ho-aTE?LU1pzd3im=iYnnJ?8~-Q68_zo?xSOM(L?U3Da#W`1%P}&&Oz6 zaME{Q*1h@oMgpUE@(19-uWA1H#=ZLLv$(Ser27&A`oa0u`h)MCd)v5vWy9<$=X={` zRZr`B+v(#+hoRi=R9I`g-#LNg@hY#9b{q7?Da6Fpszd^jyp3ab-<&sKf2MOr^m}0E zfG#RuyJy#Fjg3vs`I4D#JicXmKrry&a2b*>jg5`7@^j-PzEhU?QIXw0Vy$d+o|9>A zrF;dh47$izZ>x;6-jf@sn*u|eE^@lNPReP2JNZiFeRlt_nf4X%0GtokKu@?Hu8SBA zgXyyk)-uM;I*yS$WpYp_mok^Y68JVO@+xF8bxZyJa;ugz*L=q4PI?*TtNgXHkaP|8 zW3{c3+P^}+NqrIN`@D)U45}rdOh`9V-jVt5Rh^MNnZMGl4EK^ghp~rIKL=TkEQ|E* zWYRmek6Ej(ajvG>pV^czgi$aLu4jL=e{cGoNxqu&3Fy@hc_N(bigcsR0Q*vT9C;q| z4~f<-X5Fl#WliXBbUHNUs$UXx(sk{II(R9eTbk<6Q7M-@=bQ7>HJ=2R*mZIl`*Kj% zbufW3pE33@UUdjRK%VLDBG#;wTVOJCZ;SUy_lEpX&UFlJoAf@g zulK+t_Mir)tA5O1tb5M6e_~Y}e1x`dGtboubDn8n?YVQ6+v)#9#m=VjGaZ8vDS)XuMIy!eiaI!4i>7t!7b2V+c1B7+P63Mip{8Ps(q+!cw3FF zj#k}sYcO|VUUX-EK>zEZGxYM;$qf;`Xsi2ktJ0xjL0fvhG;Rj|clT zuU00K-s9DWA?vwU??ljG^@gsor2GlE3(m=$Yt>|?SQ~?K$@fL}!Bn?YF7`^LpPQ9I zZU-r4pL$SU?q6lz-35%l)oPGx&g*AE2kGwY=51sy`!)On==jKM5_a@Cn@ihLEMt33 zOSKt&caa{lGxu&2Y=$=?{s}v<$DweQ`UZWUjep>chU&;(?`pBnZL$*i^VmL9cKV}~ zeFkZ}OiT4G`o0_A!aZfK>UjP7KI$8%Z=}9+>igpMX_@H1n789^<{hq+anZdlgx*lh z7+a!uWHUcK`?#a;`>%wXgF)eDXM4EWUlu+TObMU$H-szMi^3M4n$5jsdY@uns{5pV zG4`WgPnj6KXUk1n<~M${!n_0G&*c71mRlM3dG)J$51p0VJNA?D?sgxR@4Gu>0lMco zkLAkU(K1}$M0W;h%6ZeZ{sd=%sUPKjBs1JX(hnn7$SHmxGyFekpRmr9?ab9_nKw?B zVt2*vT=})PUdHHI={oES!|i(Z-1&mcU9yT`sULbQcN(e%%eY{oDHQJ9QW-qd4j}{vnW-oM1|5X!ji1#|}e<^on+RO6H*}PBtr6Axf zF>|e#>oTQg-(BOcKjeNiU}NP{<((RSX6%1m7&?vIp$6`kVo}#YI(rSWg1b~@_9rLj z>HTpUq=VWB>nk(yL<2UyMyC6zVNH272!vnOvf-ywrru-+r=`+8IIlU#b-Ejr{>)v>E-N|tDR4c z|C!^pmwu*QNBsEvGSVGO|E!F6pOEoRNV*d&#vbYCZIp4|cZjoYVw?!OFMZm{NPiyb zV(vQa%p9MF!xVR>l$d@AjIJ@N^8*Q;7qhCLU=OM<>7>4@Ym1(dj)&6EtW(FOpK0?C z8O%Pt2|aT1;I($O)WZGt8^qyRnQbizH?hfArWl&cyR)q-7zwUBTUH~_L+*ikSP5I; zU+#tSQ^w9BpVa>X#r`927n1rl@CSG+u1lix9I8Bt`);@?nfFShzhW2hrWbv_&a_`G z7r1wDHoe15iZesnEB?t+$lqh3y@T=!`la$-FInnNrR^wj+S2Jr@byXTV`*}Y@p&LS z9tCeEWLK5kuk+MDe-ZtT2hR5t=xz4@e))#6q4&kNgYZRbi`-in>kzPjh>@^n6Zu5INRcT$qr4q}25DOKFJXbGPp)zWZm%citgpE|Y?^Oy1e_y-k z1b1gUY=yu4Pv^nTEx}eHUx?{mA>MeLSoJ~vv!0V`k>)Cq15b-I-OM}0JJs|kW#y!M zB0q#qlubh7jSjp`dKz`FLLJ=io+fuhakRY!R9wloH;M%a8Z5X3cY-?vcL~9QL*wo) z!QC2ng1bv_cXxMpZyX+(|IFOE-*?x%@2&Sc7Y_O89F&gn7(qf3?T2R456 z@Hvt>?MGJB6TJPDBQG7K5~62_*l17a2H1uSP~?;qtu32@6A1$mKWar_Ucvw})RX5_ zPX+FHb@1oB!o-(i-GE+_z&qq;+a28({s`r)E&X2;-KqO2FM%AU*cnE+OwZ*g8D8p4 zFA2tE*&al@OJ$@l9uaquXi}qB)j=NTR!)}l($d(89LcJ)-OD)qqLbZAH{|IxZ}%iX z-)=a*0*u17qiIIGRzvr{QLPD@-C#B@p(CQ9NH`j`Vr*<*j_7`s$-_O>cppkhk@t?$V;Cp)Xmk z4?p+=FrqqG~a}3>jO;6$WRCOa=YgZQWm0)d7HSn6(vcc->>T9J2 zl1lfatE%fo1bV0Yx;E=^L^n)8^>mv-at`TLL2OjtYd~ZN5mw5Thc1j+m)Ca&LZad# zu83FA>f@Qk- z2|lPn?|gKLyL!j1!QM-YO^S;zbYoH4VNS`f9$azXF0btQ)^p3YCXGFfa-Kc4?LB#} zk!*ToGErWAxToaMKa#bTwmjn5OIM%SQzoo3ay;eVRZoq3`HaQYiS(=ZUi~US|Crr_ zxV+Wwxh>`P;ON<1?Q_OX8oT7BO2^@6aDu`%g;Tc>fIy7eie9Lerb!y&lvv=0-GtQMHj^gSQN&IYL;79<}H za3Hf#H+5pB{e*JEs>E24x=N>?+1wsw&giJR#+>%rP>mh~oIWF6P#;?Wq}>MTk^LN4 z`-u|qG$>TMzPvm#Nneaj+`2A-zFGyD-|_=bI+T;Xc*$W}#K-wR>Ki2Apvy)z?q4Zj z4#)R}LQBw{)vH|&v1*ao#I=l(n$#@q7Nkf|I!rk+7!}8`?wLYxw;i1qLykNg+r&5? zNP_Z0Zq8!fN-RyXUEA?q`&U~tIq`&#c(U73)?Er=ZdsW{+@tA}K5GayMy@Q?PBQFU z^r;&FSQ)uzB0Lut8kTrR)1;U_KHBnSe3YztzpOtd<2yXZEb0mNc52j&GA2UYgnN0V zJkV8G(x*pZ$AZl*~tecYcJ84e@m8Z_H@Psm}8V5XAyWY^7^+2=O8xlO@EtH3gPeRlBk{nFgDlYPasqa?2gPUoF zpYpasyVjbaM4wkCWVYI&zTduYCZxV0GxasYoAkMX!(vFwo`sW5Ux4@Oqx<%AOy$tQ z8bIqcWN%x$_xp%98#5lCJ>a3*C-``VqHx&1&h&9luwjv5cXP05_bs5?AkTM9eATbQ zu*P#4r=0}9qv8pD^|nHEOoQ@lVemv;(UjX69S;XP^Ki3W^&dw#gt_=|wUP19hc_{% zJMF?9JFPgQmQU0z&HHRTU_aftXfEA-v_DNc$(iFExvp6ny1DqZ=R%Q8KR)-|R?)-I z@3|UWzkwXeqMXl5V5WLgJG(aul>J_L$ajQ{yG?O;CTNJ}uGHvn%<({}u#(BQ+)8or z2;#lRd4MX_IS|2fiF;DNzF;2Jb$i-{XproKT@@-HukY2I!FwrYlC4w&M261@u@ayo zMh|Qd?b<6hPI{TxtH%3Ho#$VugMj;vm-RonTPe^w#dq`O27&tyFSiC97e!1|a;tS4 zLcKW;{ba#1uVUn4FjU$^yx%n629hu}X;_aJZU*LqXFK~oHl39j8JP_CY5Pn#jt*lk zfvcMWDorU?Vj!!c?yo2A23j3p;kGBw;ZA4zY?Ty)TIb2&;d#H~%jB=}VdFh1LbF5$ z*Imj zJrV&ioFZa5^gMcF?JUJ@mQf}X&)u`7OgzgpafOoh58{Q=PH_Yi-zG(FzO%$s7rKUH z;e(=D3t2ny+2h&=*qqwq?^<*?SPhZZ&R7!%b5nK)zsR5Mq7IsAsK2n^c9xbQy(ab0 zYaaY!Ez7nTBec7zpX_UjxH{K%GUA`MpXDpBN`4VMvTrG|Z>)7l$>zWM-qPj12c+f2 zI~ssL!8%?i9eZ{s6Rl0 z&eTeEslCFoI{GmEJbd2mJEt{BZ z$l+VC6Sjfn*)P>n!dS9n6=vp>s`J!=*f6zGo{2UDc_W;?oJJNgz+<5@9sJ zHQ%@TiHYvkRzxo)!X0OVbZ@Wyg-cFIxGfGWid#GuP7STIEYx(Caxsz-#uk{Dsojz+ zwL`r}G>^XKVQij{rJZk3@Im1@i${p3rqK^hJ@>7bokHCV?%)RmI7d@UoJ&5hF0zK6 z3Rg)NqcG+9gdN)U2u_l<8PUPIyjDw&cRBniF>nAnYdmY($l44S@Rtu~)pV~0Y@Ym7 z-^7tawsH#XT-6zK-0cUm*Nw|g^(aJA&cwylZ{9(_IUEst+rs=Y4M$&NUaI$<6~xQT zgUD0PE4y*d2{wySIPG>@M3F}g@{Dg$=o2&uC1bOEFFe#1ghA|fi4^Qh{077V~D-hl$xh}b9I?+uuOw{X})F9C{$mVfq=cq{mBw)gi za$pV@ByQq$uZ6D}=Mh{-_dT#8t;Qd@hgLSecM#wEr_<%XQvz6CFeJd(o0rFXU=bUX zos4{jAh37i0D8{lQO}c{KYW1vMAN2zUvkxA&& zS{+vilc_p2pl8tdqC-`Y|!Cb>s1bs^S%knQs+s>mqioK&2chyzoibl=L&(VGEk0 z#L%dMWf#{VMl*xlJXNj0sdQ_S#M0jT6a$OAMYfi}d74|vyH7XYQ09sDC{dR&QC&H_ z67)_xA>W%@f)XFd&A8LLe~tD%1y=3SgI1L#(^mx^!c7^pLNww=dF+{Xr%>Z#>?a?d%ZF{g7Llh`T1 z$GGP9IRD0aE#GT}wH~e(1TUFrW;9j)(j({2#lghkir4mDk-gD+oA6zyWNwy#^4x9D z0gcnnee)gWde^6QQ>z5&u%~CsUd!;iq%2pr@_yx!1;t6nL{E`uEtqw(dE_(qBs&H% zm*wj^cjJWhX!ZKLhMG1S&tCgQUTp6Ys3N_GbUs(OGI0Ut zHQZFDN4?g}6HIR%8#+tkZ48+}I&lbW%+Y38O@2+SiOyU3v6zy%ZV6$Zog}aolj%~g znsR(Rk_|*ZXdAaZ8Wh!QQa7^?Fs#Kr41+5~mULl;owE(*8Ap6eB~UQ?C{bFCP;Z0v3!xmu1*44CocD2~xFlB5ao@qE2n-iBmP0gQENyPWbCM z4|AU=NceYF@VBcuuOH=S(WDIS=Kxj&6dxBqVTa94t%(iSg|_-D9EJm4%EnG5__1>ysEhpO}O@=a>S>Pe5fL@#(rHv z?#sm1v>a!>T)n^K%GGm_Cf1&vE7L^P>{7Jn{U(v|&9BUX+ObSR^^q;H{?u3Vb-UH+ z9UTRzB|i<&pm>yetfA~@1az|u7;-LVw;OL^ciHwX!hF3rjlXDITNQjzWG*)z-bW~{ zx0~^t;c|5DKg>HrK5scZH(F&jdM%X*dSj%v$2adB1} zd`3RzGiYSppQjYk<=XzjXYbAT)$KicXJ&zAZcEb|M$6V(oKq>jcy1Z*G_){6==ORn zTWHdU)daPAHURb&a?Wgv@Q|*Q+g5?5X((>%yL_=<+$PnNuN_IBqXdwq3rFH}FF%5m z&!p@#zJWSVed}eQZMAUFy+RR)_?!C7fNrUJ3rIJgQCvGTu#Sys)ula?*QxiBo^^=q z{g1BNw{CFZtZZ3CF+(net zk5^>VoTub^UW3B|2uTgxTs>r@wK9#v%-`lpZWQnCZSXMz=dUl$YjrSP4)}99eqk*r z1sD>VKEv{>_a~?JFpT>4P*2^MGkkpY+8cR&0RTeQD)SCQy~u1%ugK3JMqjnu$h}fo z#Y9tb=bI%D(rtpTFXbd7+B672djrXtB4J)kJb*{~I0x)AiSqSN0|VDNe2LPjovNwX zGpm3qB>+x%A%0OGU2JgvWCey8=BB9Y~W#sWtS8o`*a8;iq)t7Gj>fjpr z^ukS6yDDQ_Sl0n&RLTRsG<oPtO1JbRm~_NCX%rP}12Q{t>N5ym3$#)%Aly1WjoNW6 z8L4XbQlfr(QLtJwO95$jC)NhP7@`BxJLeoplv6{NNtIIX$t2CSf6WH_w>cRO;pJ1B zv#jhC>A*T2V%-|CZ4DEt@VUd=_+Nbeg3L92Q)E3!2Qb>>tv~;gm-Atw-OScw$;0;n5G~IjG@O|Ldw=zZd+Hh?E zVH$;j>MUWHR#C^*BI zBASt!uh5LOetL3U&CPczQ;jvtk^cHV$h;~XFYc1bDR`qow#A@pIY-P*WCy$lRGk`0 z`ErMAkn6Iy=u~XGOpy`jqvDoEOMFKjstLO?K&`uhcu3uA>q|Q7dmQN=g3*bb%x0b+q%B=7+aVfD{fgu|m zbgbYNCT&9qgjraMi)H`Cs~@K=+HCUc%0;2~4jxp61-EA`ch@Z^mu3hkHfyImHs8*#>O?&9!vCAN8W-q8@ ztbe2INr2o{?9S6}{`h7W0TdN?oi?IcJlaH4(^Oi&qXzJZ!i6krnxyDz>WgZky59* zHIMZ@N-L%YL`VDJN~ZfznN#^ih=EfrvW7UkWwBy+S;17!Siy#pF>xn}(_=d$%jg!Q zL8sZ(%=3Hnf1Vr`fj`p>jt`+71#4|jAgZC9Q~7Nt8@)|v3Up2Esxyv1JOj4O%~gA z?Q?3uGf^}nSOnV2BmIO&P}?ShFuoPaN+iQwoJz2AIaHz>;@kAGAi@6XJsRO%%%EAi zHg3W$6-&aJBa}Vx;rdUK*B|DC(vB0Js(ixpYg;mmuc))U$^0U%fv;c2yAYlNjJY=v z^jf$p2)QFa__v9$_%-ui7-fm^m*0O$YKd9-#qD@DZOnobE}A{@|NQHv`~rpUh1xBJ zAj_yQ8S7nPiX+;Lxl#EP#B}iC0goh7Q0<_?J!|Zjk^IB$t7@V2vBGFMS5J(mJ>E8) zm!WiRA>JpMuxq6m;$7Ppim}_TMh@9~%ths%?N^+OgrFztyGNe4jLdHtyJn`YiQh9( z3G+_FFbHOEx1VMr2*&=5TaZ@7!q2y@Ur%!j5R4hS3Oprjm*CypoD2ivQwp!;K?Y4~!x z)>$z#MI=Vye!Y_RX2xL>K(|RbI|yZ3bb{I~w4af`jl2O_qBde$^9uW`+b3hR!>;}4 zQpQ>|r?N^^img(`g6|>w;l($Di?Di;0x93)^K5}CUj#=e z?N*DG*)PvDcp2cBr>7{0vm@rCC5+%;sv_o72Mm}SR6iw2lw&wjlLY|XMB!Z+x3|-l zJt-=c@1E7uHd2|%9Szd#g-xLWFibr@;szknE#mY6f_{ncs12c(tZ&J!ta_C3gApO6 zmG(SnYoW7ZOxY%twTb;hNyOO$&EhKrMx-%lDZs8meV%yK)iA7>jvV3)s@+YbVR2pB zcspUnG;7-|qPa>sV(1tfiZmy-pyn-DqqT|{agO)VMKvLQF_C+~?+ssA#X70FfrU?t z-apUlI?{?yG??NK7h@&J9EDf4V=fI$8Nc@TppLexT9)^REqkcH4zYWr39j9}(y+gP zff&MEU`!}VTTd9r{V|Mm(E6#fMqQC@WecCyGIo9O93Hn0_%E%Cn%jeSPxGDjwVxJ3 zDLWbZ2_GqIV>-sJ?CvN(-!&*WG%;E}-b>koufv1qg7tw@gtjRbU8KyC%?FSTHjWgJ z95j6AKn4|o%8W)XhMs77Wm}B-j`*lk#^OuBzb&jHVl1s>mo!yOYF2l%94q%Xf@lBO zJAu%K>T55~#Ce~VtL@F%eh>eY)710DZweN@BH?`MuB<{{3)1cf$>WsjkjX>KoPvLe zY@8|Pz=0gq43j5Z5!fIR77S)PYsC*H%E-6!8)?F85_(Uh{2S2WnVNxC>0LiAtmNDG zNFXQLl;Mh6?p>+Ijny2ZyplS9Oo+7l8iEVW=YMib#tN`SY5%#7cQh6AP*NUZ(mHuR6CC5dy@+Bgju zHc@DqeJmKGvXPromAxnFAr?aK`&@8Yv#l7c^2z7v+#9Oab}5YEkJ+WtEP9U-yhICI zNqzMm!sDdO00Y`qql>lfB(4mX*&IKzO)m=-_FQ9*Wm|!QKXfCJySPi}AKp8oan!y~ zoraP%g^-Y0KO}iUcTMk1wDgRsau3UEXS}?RvakuF`X$c^DEMtYw^x|nn*rlgem@GydQZhTeVbd@w*6+QhNjl0Q?F_C$^ zn5}=kF3EOp&DDjCVKYZXTN7f0`{hW#v1<4Mf_t25KirP$5JWDkbEfG^V{>4q`=WTu+quDQ&!3A z|Lmt0`4~cr{uYspR;tGIRuujjB#7cqT!j9WGE4p~LhV1y4)?Z^bf>)EPgo%o<&e+l zx|DB`IAR15tdI%?RrxTm-4_YJ(NAx>Q{X@$pQw2C9QI8R>B`KXsO* zA(`80iJFVg%Q~Cj&Wf(f22bK3{Svx5HrB1J58gZn2c8BO2Ob_0J-!RarS2pl>T4z1=!mHp?`v+pK9^Ycwwg?a;;G?7t$L?3xr{>YSOdgPy=&VoIfgS_rxjukk0<4)%BjZ!}x(g>QvFewpchQHEBRYe4)q;MbD|lK#m-dNv_RtK5)NC zN|+Aj@fJGgb$}52LPqf!;i2cfbd@o_CMo!ZqA(#~hrk;Xug?2?4C7%yS55#Ke-^oM z`%RAfT`J4tJFpW*pHYk6-Z&(l9QA7LV zl~jb%17cu&4?^mG<3Fv)%0f3 zb0pg&S>4VgM6@P;au$AwbiR)6R8+t+fl{+-wIB%fon)50Ove!wzkG}$un zv+%0zTPx~KSn6JFE7s141Q0Lu0$^B`V;O!~k+gl71n=lQ`DjvOyAz5^25=0v49?>| zX}%}**&b~HkqI6wIi2QC<&@rt=Fm;@Oxr&xx<~3Yt0gz7EFH}ty~r>bToH0lHp?m2 zaZO5i(&TE_B*a4Zqy#Zg-S|v`fJcp!QCJu!Wk(k*`nU=KD;mhy?_qtULs2yQt<$^x z5X=-O?sWspzJ0JKV7QP&TTa@h35P0lsNw=>Z;U4J@R zM4l(Z-ac%;tBS{}hBup4Tt29EMQaUqZp7l$6?=_4I+dk=>?TM{`;fLktU}r-#zEbQ z5=}#GDpM^X27PT}_IpWz!-=#dS5QsJ3W)4h|g; z)XzxTee_^FeJ4zbjwm7m`)Wk27`Yo@T43Q?QT_bhLlu!Vt6>0>Wa*ofALRgyD6pB? zVfCZBzdD**`FBwbre#r7m94w3+Y%_gavBN4F`A~ixS<`Uto|fyK_E|}3xOnc>Wx4)uhh?G+a#lybO*&5npxv$jnn zKFD=m*@lDb>%sb9V0>}^sWjxHfnQLfB7WlT|v8z=4j-d zF3TGF(d_7vQ1!woW^JJ=Lqj)W`H?)v1+4h~Ti+|$KfrHkK!WpjBEvJ+;M}2dYLJ(Bb7yotI&Ok%CX#B)}CzliVz$cOu+*T0};-^ zQs3@vhJ~&L;#Oprm;#N6J%mO)rZQP==rrEkC>ZeU_$Y){0@#L6ITU}Ub62LwbEB%}}MA3pr{=%^UK9V#Zyo5RF^ zEBo93=^*~!{=n-B7!(-gYdaVUEVu~74@fX#FmM!b2o#9dZtyHHFbME>;9!uy8UBxh zfd+?!dIt;f9u6KH>@Dpr5&W;TcVLiE&@d3-uy2VU-bzA(LqS0zKz%^geait30SN|$ z@(vpH6C(_oz*lr)U095dBuom*Hr~;(6PSWOC$UJ$m{~*>m2Bm7|w%p_>@vt#1?8?cguSrr2NbT$$9DjrL`3r4KY}|hbTvc83 zAIyJ4p8N~*{|@AEPg_g3yJ*V=5`EFxx>rAplggjY5C~uuvBQdv=pdGQ?{H= zTw||%^+v@F=MO4k|HViAij?E(GS`8o8>>pI#_}Hr~{ezFXMfEz+ z#+>9o#Pz2re~arcKK@-?fAR4@i0dyh{}flvzl!TmM*atJ{Z%XfF0Mao(6TcpS0^QCH{Bq`acubKeX#lM*dy9nnA38SV{cSziHQBR#JEPziHP$ z#Pt^+|E^tb$437L#`u3IuD`VF&sO4pHpZ*@(f=5u#s6ZAP=DEcQMxzVAI2o{X0jH% z|7Ehkkd=qOa}`{_|Epd4?>ZQ(d^S%0UnVQ_w^09SvN>-i`zMvRhT#vBP5aYi-TuX7 z{}yW9-b?ZWfo98D};(Pq_63h&)}@tQ2cTT?4ks2aAzi2 z1Pp;-70vgWwJa;8M-iLbC6$QJlMWC~IpYuECjGyVnBj%;u1hPpYHwPT@=XVLN2Y={ z!bp=0ErmjU@Gd6Kk=a|GE}2xj4a-f;a{|5aTO3M7E7b^%0jcMo8Gmrq4~X$VH6a_# zn~6{>;@!ebHCshVuadwbPKQLC5UiT#4J>z=)LdDnnTXaL~`&cFekXP^hUpQ*17~v+1_OFjj~U z3Mi)^6+8xO&7jK*1rrk3EexwE9qQ_Z2Wb!rOz<_TbuNg&Gdx>{3`!QM;(M=GFt*lj zB@?~+g`WX}Srr+g4y)LOtSThoVPcL> zHgFGS87s#vuj{#rI~KgKM9blg0yORUl*a+T@Ltk50SZkXQu$Ewm&I%d%ffw;o$!i~ z`GwmV^!>*<~#`W4SCNV5yW$lnA0n(Cf%ZgMm*$rL8SSk0D$i($vR*Z2cZqgf;_L zHSW=MLPvj;%$;2@FL9%x%dyeq9rG*ki&v6a>C6r|<2iGj740+EQ2%CPV@G!!-}_!z zR|%s!4lx6FsmBezhxeZNIB@pj7B7Qa9lj-R!rXqyL+fzMcJj!nFvcMQ^boHFrmqj- zJT12^VsUfCzx;KEOQ;e@tM4G$v>{4e2K`e%Sl#g(E9=ZF60W(feAC9R*OTf8PWW!! zKbI{VHzeBmKI7Nc=UNH-rK!Dwop5>F%TS-^goM|NtCLn?g`ck?Hj1fG6pfzp%6Y*7 zRd|N`x^gx>bJ*ANTHe$9L!m?~l`}s0g92AoiY`dMil75U(7#IjYd~=oqB(wyT7toy zI;FGuG-k}-v{oj6+}=F&@z<=t-GS^=hJ{A->0GHqP}`CjL>W) z7nD8OO%pe1uBCNAk89((*kI*_fz!J5T-@4^DY$?Vjb9>#1R3gAyjPWObYR;L8aS z*-Py~6n=Ue$&*f(aguxypC6+a8%OkrRh2W{Nr;m-KW=a|2SD3FUY4wT+ihkyGyKaF zPxcLm`-ewmg4L(4Mr94#MGp@`B}r0~r^y~#DfYbiL9bv|7%|9FxO}f*a_XxhkGq7I zy(}dt6EkxGT}E86`)D&-p_&#t=MFIeNYNlsPej*ok2JjCEAbwSQZ`?Kwuit1^`Z2h zIJ+~nWZ~23rI5?{td#!JEo2K>EVrzz z>7U9OER*clHiZbqviVHwZs}wd8zRnK$aJ{ZizjYbh0Tb{e|Dht{8J2|kB?m{)GK{c zOdkHN=aUj%uM_|1VrMP*_fuv(Cp0`jGu5SrQxJ}JN{~raza9^Y6Rs#Sztwr3eLHi! zrHOxFeg4?Q3aUeHU2R-#z|9VLUzft7{^NYfD+L!^(@x%zp~-STVnf{>CSA(d4azfq zTLF0l^MSIae7RM-Z7Y9=sCk06HJGJ#3?*NpYblM7MD{okXg6VH8+Zr#ly2fwDwh-Y zc^?}p1VgMV@M zlds$&_gB8-_}kCS!~;JP*e1(A<3_-)+w`b96_zVI#jG5#)3`KkD6d$wbbR%v_nquRe?kmvB0uf79SwkHOqLKQrBm=S>g?^O@#L#7ZzXB z39F8Bv7##TU8J+^Gqk69&YVuMos+8vZUUB?aN^q`gDJ4U9OsY^al)1)O2$ge253tQ zH1A}y@i<%NPffxWv0o#>pnj{$;EyC zEQ+ULLBhIxQL#yv=K70-1QII@Ld>Pid8Xt>Hq`NDbFzyMqq@;&43Lg*(dyc-Lb0R8 z&WP4mm;S*e52Q7Vb+W#YW}z3Xgd(`GP8~)`DB9#t-Ke>wiI#(JIcCg~#`GwYj%!%g zd|n%hMqGDIn@44^ne&UYk1G!FFW6I@CPS0GKsSBOcx?)P)#RR3|%5YOgGr@)~Y`E-qJo z3?!?twYKZbTO)2sc#iWJd6{kb+^pOxh0A}FesvQ43IglXnzrYR(Ovwe(`57dPP{EZS1k*T8>%p$1B6%?+*Vx zP#{aw;pGXGS}<1$-*iTL+voRV)H-;~iHnSg!)lcM3AgK-m9gztaUSWeZ~%9 zC3EDkky|P5y}wRL@j(>74%&4Ur~b%!5!~wGlU|=JwhbSQR34Jd3*zd< zr;Qn|;Z4>zrMhUeiQ^YSqJ`LltP>M~y;?7PXpk zxwsWO5lRpI(ZPX_sQ-E}l&h#;#gSlmo%}}+S8D^I(LvYTte~i`yR9Q|A5biGy+p4x6*P*7`3}RJ$lLo(~ zw2nO&<&$NpxP~uDHSo(BWL3W7su8|~_Ec@LYHW0~PL0R0;}$b``tff565#~-ka>8w zYY1(^?S+x;;gS7~3l=$xd_f={bJ)EJUs}-&qMHyd^For=0-Y!L^N%*I5hYM^PrdqJ z{0~;Wai{~1Gyz_vP+*Fo7lg~5w> zjYP{&)*G76c*S|x&W^K-wFzpU&Engp^37=S`&0)Z#pt17)N!r#z`#CtIa=ujF?xq1 zVuL{xsF}6SXyv-5&WJViG9_SBFS`k#Q^ z>N7euE~V^U64Q@~Gu&r{n&h|hU=udKpj(F(Nhq$13OGrMXsy@JUbP}iT) zbsM(_9NvE97=Q_)jSlEID^9nQb3Gz&u%-VhZcrP}RqXB?^<9d)Utkjwe|2SfcGUP` zUO$v$OM})s-o#LBb^07U|mg@CpVK`++^@XGcFB5d!n@r&8pk$E+22vtw47 zti=;PI>Dhbbs0YF-b<@)W}a*)n;|Ido4kB(qg}W9CC$8+MYred<^Z$KA42#oO{8CY zn<{&AXHp=8K?8Z@eda9zJ;yTvBPQL=Y>ZGxs$iE5WI56G&Q{E*eS^l?rLhI`>Y~2k zmjX6mHQ^L^jQ#d#PVYUofRXOLTqGd6{O5`%2k&zG_Y<|dp&n*g`^v7KKgpUyO`PC# zHxdgEm-V;2djwMy7r|jHJPFcCooJe}6*fkK7u{BTm+-lbcSQYb9s}y9Gbw_+ zmx`K#&N-K9TB46=>erLGg8;w$eZ{DYvyr4rm|#I2xzKYiDK(mfi@ZYGk>49DG)1)< z)y3C+#C@x%`vn~60*ESMYSJI{%^gRFs#4ei)m3W}1);EhD9gh?^^NDIp*x78J~M9@ zrjVIbFQ&+5Bhy212n_LDwhwNmXe_{xAsu)fDkp&6w}QAv_d~B~+8!0#JW4Gcs{w$; zLJNK1!AUc=23SFPORM6=09Nmb_JT}&q(NzZUBpHi)a84oel#rkU+ok;1&)53YlUjZ0l35b>?i89SaSgADhpT%#MkJ^F0*Afr7+RyoNZB+SR zJ!0pB>eLS1a+=(HdCahtMWik3K(_BkB&pD&H7?kv5BR3p*LoWX63!;*s)r4)M!zP( zZxzYTt@Rb%(u_xc+kX~(6gs1s`KkhjbXe*Pq|6GDc+;z#e+GQs9v@YJGdmf0M}vhi z!Ru{q5~TVKotI}Nhycwgdo0(X`r$BS6}XG&=b!UD`TnMkk>)?A>Pu=`7Rp40Bt|*L zoVI1QZx6w3NayTWN2bGR%WOycNMFG!m)}YK)Mwbq_%V}n6KgsfHH;fPmq~l#X6m46 zpP1Abs&QT~Xf3vFF%lUQXW~RdQe1TU6}qwfZ}E(s2>&QSpFa z-*VB7LljBTjdM8z89eS=H}+jUDZ4n=g;I6t?YkrzU*#?0_LlM%NgHIR(vtkhuWXv8 zMMF_Mf*V^-_6}hAb!Jv}2RCkK`{&=`leaMJ+nXhYZA95y0uvrqC;zJ3vU$rMNHr1s@zr(pd(U$Sq%ToL52DTvOOKBYQL zN7RxKm*`=FUA&G<9Qhl)D*L0y5%O(KRY`#7#E6Cy(jzSG*A~(v^ z`$nw7F1swl>mY? zBN{i}$(s3g`_jBl9VSzwT$=AEdZ@Ex_>&Qmj|O|hAMnFT9&Yt?8fjoK-KGcqCxJ1U@^(&+cipNaV)Peqv2VoOTeS)ojcaZQu1y z@5cUdItycaYr2kD0``?_ge4Npg2?@QPb<4y@ZOEp*nj{VmkLF~^RGu+N(hDM;IAyLG!j^~CNIW0r@ckja zwLN0$`5)H#&}09u8Y&IX?F+I`79?{F!;X_|8%JO0L;UKbC|AH3IlzE6K<-M#P|ax# zV!q8{4{p1e$_W0vyD&VIcoK>PD-yM_KNzpc@Tce#`@7!aenV9FxWKw1@!672Ld;@5 z3FWez1n+}~?8OSToNgc2z~oJmCA>&MfscMTeBKc<9`un->NetXn6mHo!URLr3dM%R z#l)L-r7T!RpXcP-JjQg#`rBI=Rw?1QeKTJHv?-4_@kH?*31SG@n14iq36GBYRa7=* z+N1v+hw_%I_vj&*fX(6N<5Az}M8s~N$NG`IYn>*ng>wov6Pi&?%#v@R7|OK0gv!YyrE zR{hc)t!$O?_)DJ%$y9yGa$kM(%m7T0z>D}Aq_+4 z0HUkO=CqOo{yp}b_z2doU-5os{Fq*J$7CBcNxcFT4rYm#KLUWpe?gGWfAiJjUjFxN2~ZEwv(&DQ zbRJWh1oG`-92fFtF$HFTXP0BJAtXX|fUN_APnAkB^E5sv;sAd6{9iOM`H*7yFF5^& z^WFaovHqL$DZc_^YZd=TWdDC;P2;%Y{|U?gfZQW=a3`+kgGxAisqp_7E&nC;zmNTY zeq6lh)Bi)-{{@BAx|d!sL{iy}KI{LA&%Y}?5~VzV_#dLya}CPh>2r2Lj|-Zi|AMO8 z#bMO$D*s)7WRgm}SFuNYlyo1d;AjF&fi4kC#LB8M|rRq{#C&aF# z#;vZp)0iRE*QTp+Q9#ft*@`rhC+r_aXJ_fbVOOt?^ewswp{V6#P8&*oF}z7Ag3BvlmjR9|spbo24f^|e-=SD?`Fn56WKZx+Om{|36I3TOIK zsP-aCR&}Ywew~0#SIuh!OGXP(oX2~?IoDDh%tAxD?u_)sSjDPhC!yB+Y6Q@7kkT`C z4c^QF**YaD2e=F_WWG(;=NRGc!szD+saQH&ER!#r9I)EO=4?}Aqo4My)Ppix@ukS9 z6?gR*W|2jB(T*5#GBX)tMFp=ZwyXbPu8&_h`T4Ag{n6)F3r}n@NmR+Ocv5e<0bWwN z&LI>LOYg4gf2DFfyxw-}uh4fvS&gD|cpHE{5}FMOhF3aP(Be~+)O5d3x;?yyz(=5B zNzJ?KMq^VUz!&y30De}4XLi9!x4DBbTV45$$#&I2;)2W9s|E#T&+}T*x(u8a#WnnN zd_%zN5Uz(pPq_xQsw#)RVR>GV(2Mz}y!O)+`Cb=XhjJgoE=KN+h z^)#JDsU-bt)@Tu5UqJdl0G(B7={!xOVUVfHrc-UMyPdYXfMNj93%5a8gWce)rncrN zge#qwr(vAVCSjEE)A2XgR*CRA81J$6uOv`5KW*RG5XZTU?O16}i- zjJ>@+qo;|UcL{pcB~)dr(W;Xls+`}`FyLmr&Dx~4^6si#DM-}V+F_Nw>}mO$kXIwV_Ap4gz}7wND%B;` zHFkQX3~@TqaeHLfu(af*Y$E&Kw1cIDP6c=qk&l}wr|RkGV@TlpOp`cQPE=|s!Kh(u zxuG#bgifcbVTM8KQ-&w3Y{r@fq5ari%<$LxTMmAu{HacBjhNQrx_bR~vqVgNTS3|v zgGvYDkR0b|861BNbeXM3{XdIZVp(oS?4q+@m4_|fowWUkxn25MEf?Ei=2pUfWyIuz z3LJWH{;eOd;Ce=JQGEpormPd!z5W0FV&2?>_FJWg&L)sLF=`sV|@QzTe|zavzm zwK}yJdr+qNv7#i&-;^#DN?+L!$uU;6aEop%UKb`cIuRc;ld1{0q=W!~z9??w-^O}p zKNLSwzHOyNR@1gMXTWt2{K*M^s#?!6n@E0!>A!AC%SBmc$bS{KBW?O=AH zerv(o2RlB-tebC>hHy7H#`Vmj=i0n&Z`tk*QG`@WZ28+L7j&8+reqm}i`}CyOeh{T z#JH&2XP*~z(wG3lS*hE=5;Biw*myH(awO5_l_iT^(Z2f2ZTGCE(`Z70c4(<9-% zrEXEF@u^GA9M=9Wu1KlF9PljM%;B9?AZ>|5p4eui+}ana0CTDFNf!J`{wl!ZTf_rx z3buypS^gm1iDMNuMzEo-GNuAHIcExzp5+ES?-DBS(2^1m0%)IClF<}`UF~UpJ_C+y zpblf*+0 z(9hTC{;J^}Dv3vTafmM?gwK4Xi_aWBc3F15qg z3uOyBZDjf@+#NY1{mTH<(D0GbUq9=hhtgqfN8=bFeCX1X;p3YhGw{vI-DXhRM&=4m zTTwRZx;f{<)1KnUgxCA7@yTz#uj}z|dON$Mj@yHEW@T11o?iq&L9J+8b&anhRwIG2 zKc;zjalVoX)4fn>N0LlFZdT=@)61HM54?4m#~Gzh%TU~ZyjILLBr~*-3H!K&f=|xG z_jP)+N;k2pXK=Z&@UkgNBro=I=q1irA)|R8qb_IUO8)^kX|xru-!rL}2TzTmRUa2>tqK=)jk00zvHB863SlPn;0%2ZX@C%5oS4OV7V4OOx0kA;_~JrKPA z4F1pkW>D~kJ7FP#w)n&t~Y`ngZvQ3s&?uft{}uPEnR z)SuGUS2hfI$l5#r4N*DENk7mA+nzaC=jxZ+LXMN~-uuIm>CbVTS6|=DvOYMTf2-Lj zTGFNceYkKL9ZRk;gP~7^zXFVs00tS*pZ-oIzN*(=h9yk;;;$pbmmWt ztyiJ-GE&4Laz}`S!AFH*zEkzu&;VXf*?v+tY1}biTh<bWIUniomnW$OS9DGQ87TR}Rw%KoF!ia_Zq_IVidmkc^0lFn# zUnDVJt!T-!HhrqPDZR&U>g_7Dp$6@yP(?Kg)p%j*Cy6(sCc+YuTveA|ERxa(=&lkA zX!b}s5AIl;YS^3%<|^|r;uPalCK|WX^4aO-Key`ugyEm3umbU`QbiUi1nTW9Wao9Mu!ZT58nlrD7E{cbem zcFymzT*HJ#eTj@B`mAhN3Mo)zZ^Hvi4YKSGH;5rI6={l(aw^TXq@l%l-ATALP@4<7&ik)4!bz9Kr zh6mBQL%h36=n$_lRuwjN!oF^f)tft0R(95WVfA4r+L5fo$uy`K?PwwfR)^$Ay!f5N zDM$I!x4ev~PJJ?;ZYMLSN}&NF{vcdayN)oKb@!wwE>ayZ0}9we5)_z2@Hx_4MP-HN z5l?)oWAc_&ihLdY<&|BLzkpyJ1de?vya4*ah1ZSASgP|KBzlA(Z1GA+NT4Jp8qS2qEYTY@+BGVix%+TsDsONUnRU@dR`I5b@TJ>3?|c!Fuoq&rdoj^n zHd?aj5uWXgPQLkgTyqL2dh=q!tWY@grQ;7Z$f~Snf8dF2`ix`Rsu0+h6~sAyw5sZO zYiOZfNJbXFH&6tWDeNe#X;cQOHwnb3=5}JE<2_x7IT#084XMQl{iJd_%EG=4Igo+7 zaZkSqx}GEO>1Zqc2-Qv&eCH%T&7|c2eB}q3REJninCwksq)Sp^N(O5JE|CORrOOFVD@&n*=EPU4%b5(}p4re26OYm@P+y-qWqDB!;xf zAQazUzcNk83hrH%zFQRG=1|U-E3-w2WOGsqa2Z4NLG_GC5~A$nHzg?LnqfQ8a#Jz4 z#>#f&hSGLqY|59ESfs0FDC16|s-D|mjd1IfN9zC!m7T7Eyw|$8CU=?X7K~W`$;?^P z$|snM2JcZ!7m=D~ZbRA^i}c$OcFa>(83Aj=kP90m;iK#>UnYQqT{&Dvj2pUhp}8s86L>)2)lPWd z!g}(l&3^Kt8H2z#NKK5Cd zbj0Af0dUv!b!fF*m5Ym^>RMTE)nNJA{mW1VSfQyoDyB59=G>T&8NHpw5Uk(;j@I#aioU-6?OL;BIJ#KYoI1F0{bUJvb&dIi=g7ket&$Bb@3lg zm$%0cP&c23rZ;8kx~_b?_V(lhW1SYQ9U`$igIJ>sti%x@uuoCN8Ck+m$B*mwd&dqDXW_>!>Vtn2W-7g5VH zcMg93cV`sS7@{@3T$V6S2&~3suZue#CQmMi$M}g(7!6tcs)2l|Xrdm-B|6jEa4p(9 zjlf)(wzqLyO7Z|@PN)E8RH=Z_QT@+6Kh~Ma30pC5Nl6q{ETa0W`W%SFwJM_4Pp5{OpZFFYxiT-=&V7(A+q7aXlz=95U$nc6TcG zZrpt2aPp>-BGj21Jw9{!vNrxjfS*gP<$+@!`$4UG_5%`_?k{voFgWAm1%RyvDy zJR+rQC_dkp{@CHhx6Sgxb}Lgn?HS7S%;@Q&=p+2r76Lw9MSa~d5N zkVGPPVO7HDmvo?T0CzU1bSZx=c1uG;@1UY^6r-yn@zf$Hu*j>+jjV}J+=#o~5%l%gh%PC%yD?efbS_iu7@4y_J6X!ME^&E9Tb5k)q!h zmisgL@g4Rqx@~b7&&TDR&-#l}yxxvFRsDQW24?$1CEnu`hM!KlObQi;(kvdE+`cq> zA{Ku&Sig&M+G%dIeLd@qJQmkqeJDRe%9e&fp}FBJsA+G?|ukxyXXME{&<5VvH8+rT1R{57>*-_TF8_Bi$@t}wF z-PFJj$Cl9B*B{bjPcsm4%AGI4ocibm3CJY)4{=Mu`pn>WF0R~Pg)fyYArIj4zs9l( zEd_ID;6GF6FNKOKXS1L! zaaBn%tg*}=j{8*g_so~#1b(z~Meu`-8VmRkT;`s&a^qS0XY2>b7Z+%^nwm>12HSdZ zqo9;8KuRrJ>4%jSahUFuXYtE5v0shWxfYIMf|lp-0@}y&k2&Kai|NB49}Zv>9uX2w zy9}k>NeLSVD9QF0Z*Z*RiR`USa(_+<8S{rD#|`Jp&B&K3)P!>3uF%d>lqSA-yZSrB7|jza%~PfKMk#Qh)5H=E z^`?hp2w)0fh4Hz=hH#3Qva_h-Q-jp>#&5g!U=^F;u)m5=29BDl&FlW_9-!2D14`EC zpfYJ^t#L-GcvKMzq5-xAfyoxNpU2NfD%*nII5eBQB#bL#D`Vxx##c6#CY~#dCthYY zv@$;Fg7lp)@mU6+@hkqwX?XkSU04DwhJx-XN#^Ek&^D-=U1gO<7$HpG}PFM{(7#B#*S0%12{ z1Dq)-2rY7r$1EzZ>Q41dvkjwRuI{wt4zBLU__D7Jnn0YJ)#G3PW4pm)TGUM(lOKgy z|Hg3cN7=8HN(ajKueF9K%t5v=${y*ThHwd{Fm&btYMyZ-;wFIjb{2RgMcVZ6dvC4VniBE6@zeDb8nUgu_QR{H1RK9q z{ga*pk7lnat9gGj+oj?q5p?JI{ea*~;r>TS?1r7M9+E40ue8#pD|7kYJqK`Ac_)Ff z!^e^&SDKiG`rbnBQ$K}j6Z>n$N?h$&tZlBz6)HYUKvMJ+dJMvf@e*5giD`aW*t2$N z(p~N>f#E%l*WcgC1=SIam`FOFa7*Q9@XobehJ?gL>{pM%RUVgMV;w|rR6XMUs40((QhxHBjw zqoWgr)>&Zc9`zXMy5cdtfk8E+>Wtg`9*WbS+n1A{i!YP*$?%buy;u^@Y#hj2med;y zhoGM?%Wz?RC>w-6E5qRNjC8$N8rT=yRsu7rei!|W$TJKxH&Y!sWZVJ0@#x+smmWK( zGH6Gp|HX0$lDVcz_0=63>+UeiMJOo%Ff5i1o!`!&fud&;9%VdmbS<%|xO9P2ZhPZ4 z#P>yAVC$u0I%L*y3=4RgE}*tOSeID&uFXIRus6$O(p@|1V*Rn+iIw39hq7^oM8?ms z_c<#yvjVG>yBHxRiJZ(+B~M`Ny5u>!`$PU=ph__?K(4TNhKRr6^hmx(N|9LX9oqa=DksnM=MSnF z>(q@t(7eAapZ9in&Cu7=-|psvhNu-+|+{iy5o1Kk=wMY1$j@+dTrs``s;7 zvnb_JD(>i`Jrw&qq*oa_E=ss*X}^~jz~G3Rc}MR~?VyS+p~|eSSzxooH_oFsNwhas zMh6Emc5YkxM_B8$RATEDnBn9CGF&%JMBz-0isC61gE&1Sk*;TPEyq|x%Q`Ozn5TIKbyEn(r2nsgp?VTq+x(Uu*mYK7Ht&AEOBZ+ zt8e56+2@0P21A?Up^;VD#%}EChXG8+_I~Nc=5gKKz-D1FHF6jN`qJSx(QMURLo_(Q z8!>T#i@txGwjz1DuXJUr7!Z!8l7SK|BhmMV(rUD9ogJx3NeT>L?j%CeijYQTOckm_ zNBg#H6+WGvbat*Q)p&TkWHmRS|D&TQb5sX)5`KI$*_?Wq5^F=*tDCbbbEYr)tL8ah zdUtZh3zN+X%nYkD;IKW|q7C%^)mm@+Y0(N_NMh`rIEjMr<_1e1``c@1FfTV?-ud7tQ^#_zcZFYp4%%P4(3 zEu^oxg>sxqWA|rRnu$S6d-_hYQButSn>7ZPJV*Xh>o29>eDnEstWfLXst8)(HFFrg z$cCy&wR8s5Og>(ookpYL79S6L?AObij}OAZ%g?S4`0MN4M7baGG|#;2d-By{+G#wc z#)-eX)tUNwkJ+~oHa?ggGm0>pr-d-r<@qS!MKec7GsBrvh(L>rNFD@@6|O~(z^)1@UieW7R}AQi+sh63m1o7ojJ1l)K@)Ca)NnF z@}^jGR#<-Do3j~M(y!H~qeF5_%} zrfHx8u=9pv-!3|r3f&kY^~L^Duuq;^3kZ1viTnHzFVHvBTRlMMtV1gj!e~XS>2! z)Zg1Kzq!(v-a6WqK!1pXV7RuCeO;%$-p@Jd9F#gZhmf<5odKPV_wC*oU^fdVRaN1UgP8%6 z**CZyAEPBm@kg<~^wA)8ct>TF?olT}hBe0zFKf?xmilqp_ zigsT3F8Qsx-7mwBhTq`>cH0V>l^XU{k8YWg(zOJ{49+Tg;=;c++$z$RyE@7oSr?&c zWlS5=*z(CAi@XnqL-hD5ZS+BxJ+n{PCBn*qVAxGe4=P$4w*+r3Y$5bnMy{oJl4VI% zW{Y`tf#TrSX26HE^6J}L@s;Ft4JTKbtF_S;vmQa2I3kCj1vXnRDj zh}^ABvF$vzwo8SXUi0a@);U{i;nYyxA$A6zqYCwR>}R&O_CaXuO%ZZD-m~_=w!M6b ztvhFq)^6WcX?JhR2j!rZ61vMEM;lU~bHv(9(AZb6vq0D=b+p*$|Me$P z>gaP&BJ|m_7_rU)DA{`Y^iR}((>`UQ9X6SG+Ckq;2gkxNELulBG)GFiK+P%*gA^Lv zT_7F)Dg>AoWDzU`r<21S_EAk`JSBLAOGT98%KVX zL7`anOtSpC*vyIRO@7{yg(UHTo9M%4myQ$N6|1B>_gzq0#jqvUvk?x-z5L%-GeO=8 z@-JB57Eu<*q&fIH_En?868bGBuBmc$x((Z3tYfC_*Hufmni*WoD{Yr@nnOY={sE}y zd^>0F`P2?>%osuM%qD;b2$mTKIP z7XZj;FaZsZ1I&@8#L2WF1By2A}?zIlQDbKLSd1 zaBz0{<$9BR7s@)d=^toxt362mB*<)q;1)Xt0O+vuW#nt?5^PuK%MPYnbgNJkrOOX0+`1kqjoNSUJM4yxI4b=6P{u5GG-(UF^AICE7CM! zBE-Ifow5^7Xmpx{^yl|kXgrUmmJ6xV0F}j-99XI%GK^)koS%xR;&wS3Cipo0; zzEQ!j7YoIirX=_wiVxGN+VV$zx8EWjq~v-@j1qJg57RbcuGt9T zy%UbYliZcK)5C@q5>>2QW69~KB zG4{J9pN0C1&P2tDcHy>}fluO<&WL3KJa!=QX2eE?tV=|QFUdrnV~2vqw}K|JQDxRk zC24^Xn_h@;Vv=fYO|Wc7T@Cs<{F^VL zuNGJ1+#Lh;RXFyCyWNV@cS|!zMd{2uo#&ewJWW)50S=+sFo;2__OID0-@rvg-FZL< zw}61>A%^t&yR^dz9F6=hOz+3V*b>F<>^I{wVlkw@%Bd!42BSAN@9bLy$ockWq}8OQ z;-1vFE-$O?6g?v_zAufC>9m!w-eZ;dxzu^SqruL7(;$}8JE%A|%PAdOqi_}VsL@%o zyeg9BYg4)WbOR;-nTuEYeQR%j2l7p-{#8=X$|h~muU_c|*|%2`Ki4H!GNO?I&1Hr2 ztDhfxlM~?mbw1p8egrGznwW@xcD| zE=jPfT{{WXb!lCIDQoZPKLFYQ&(V+RF}rPK3M*#lZ$qfsj9u?MH1O)6WUbL(W@}cT z{y|_z&sl^_4`T{>!xX$~9 z==NdJDxV6ydAf{#F4_{u<2s(Y|Dh4R(p0$k+b2SdDq%tCA}HO688ERcFp9-NC%a_N z@W2qCX$K*=AY+bqudgz@gU_q#T3jh{p@sGPra3LlE&o~hKeh(d>5HL-S6E}#;8M7F zsuk@rn2JdupH6$Yk)6K@z| zZh{Fl8d}Bt+H^(REr4=2HS=lyfI75re3%wFH+X&pOmmOhknOg#wc*SlTmfpkFD>0u z3#?`sQ5}ojaOvE{P^}kO9VO^3_4&-_12xBTyOCzBU#OKg4L~zOu0^l_PgI*!lmWC& zOxIczO$%Z+pJtMd=phr6mFMZ5o;|Lv^|b586Wi2emHa%eNy1%l2CR=W88Rcz_7rj?Q0RS`*=Fe=3)KWs5qNd^hafx^92jr`yjMcqMex`?C;ng9yi3b^^w(3a|^VA*4nnxo^~d%2vq?@35q(fd8|2${qV zO()Ms2XTM{Qsxh%31-xuwwftB7HxAkyMB@%An8X4)6Y}Uh**(9a8x=$$Y~$ml@&}c z4Hb+O#-;dB_~POgsxrTqL_&g+tgBB2x<7p^njBLB_E}H-l&yp2iG}C4-WKcp9?LJt z5v^CK{#9Jtav>60=1A{)m~0!XbjVx$vG#4^*w^|4k?=L*z?HQGz!&VB$?k?52E$?bZgLg5D_bNyW&R zPcM=x>WfvzTJKD~ov*(;)Y}fmngxRI8tu9+bN~fNk`zW^q7o;LH|9s1DaT00;BP$# zZR=7t%pWT^w;4c;f6kA_wX1n6j&tnXiUp}-om{X) ziUJ<*vYOqT^J%v^Gc`?dS`689l|3+$i{c%IB-kWBz2)gk+uH|Iq)2Ai>M%$TWy*m; z+Y$4u(gMb?AITUJB7vbhUGk;iQ*FV*?JK(j)8NvjTHObWr6q&%STT^YJN3`Ev@?pA z+n*AvBukfO8UyNFWlYfRFY+De+4 zGh?R%=~%aQVkY&&0v@(SCw=jdw|u#;a_8pQy~)8_1BT2YD~oO&41EanrSd2Ia$?JkS7F4@J~^uI6uP@l(+tYio>$Dc|$O}b0H=uejS z>exT^jI`#oRR0?~F)D^K(+YLYkqW%tERR#ylg$k`Y%AnkK*=9unkdkc^8-xhnD;wN zc8|>274T$ycxhfs@nzKeq!c>^j)8go4?6_K2sGH5xQFTRLb3CHzkhYHEVgzrvU>KQ zR>`QR`?&=Q9lzLZXzR#clXl!qMu?D&oD5Z9H{0gkSr>IdioJ^yUTU{>iitxe-7d}W zj5Z|^qWw5O9Wt4ZSee6~P)-+=x@N59EuU~$pZ|b1(!Q!ZLAR}F9N78ACo+?Z1{uKZ zT$>KA{LogCWnd5(i*DspAd=4<_ap@_08{KoirwbYpJ4tCDr8nm$m`CRbgN_T z)i{5ij3swyplQo&)szw*8-0E?Gk1K%(77bC(4D)TgYr@e@_^ZwH~IKCJlGX&oiS2c zS`z-@KPcG|2-NA4dF? zODQE%vClM-2g$b~SpA+u^|g#-M&YUCjMQR5+1C8p+RMhZzc$LIuKZWIKN83D7rs46 zE#9E+rA?J@r7fo%&s<9%`xi9+5?%}b2jHMl0J^ofZN9_cdJJ85=1myi>ai9T%(Egt z>^BtzR3NvSvKT4<#xSM)17J&im{!Vf^|!rieOcP-t(+};ir!I{68;06PWdyv_i*ZL z?ehaD4K7cpX(QZ`7OyrtmMRlWCYnlg+qX$#7tY^x@|`a@K6EKSyFc5~)1y%DXkWV5 zJs~L$hG-Q@8;dTI?r*alJnD(I9)}Y{i4FQe>TSri;;Ak}_=9`WHv|Gk(Gr2|u1P}7 z3{y5h`~W+YcA2+aaHJN1yO=F%%RZ1}?R`QK)3=A4**rhfBEDPw8-^Na@bk}!IgZxmc)KiR) z{kKrRp2xXlw^j}0sf3(7B~ufVL|2TDW?)6K^wO5qXKmR;&0ln`xb1B=t^P0`QI1_n z;WRRo=zkHJ3%|8EwfD)WSEzw%6j$GC<`Xzzhf4xF$I!GUv&SeUM%o)N$1i^)uEgt6ALJTbNq7E6#SN&M#nuuI#P4s2*8-2*$>n|ePXU1D4>NwMI0 zg?Wd#q0STHV`X9$yr?7KQ8F5{sr6~uypQ8i(8-=APCD~D{}i0Cy(C^ZZdz$-U(aDE zCU`tZz76c%F!lslCg{5DlniR(W)M5^d;wxQrvfT_)^4QFozO?*8MF@k=p5BwRi176 z`YUa^9pztRW@&EeboZ38r=mN(sfdF5K7J=;cfz}C^l-_Sv3>2SBKF7HSkcq241!PQ zQC@_M-}IHMSl2%p@V4>D_uvl_B|dwniAO7;`Hu6X^I~xU(syY@>B^GVg|wdVqeMl`C}Ak zr7>o1SK&PQEboGIkP_yp-;;geMz3tgmf@j_N5p=tYeb5H7bE-I8DsT{5AMlA)|N#K zt~ptCIMuR)ZlsrLu0w&;GyT?A@hKNXzc=-}S9^=|_a0l{&I0d9QOY~y%?PZj(C|=1 z0A|n`hZ5>3hq+%Ya#t)(qKVsKc$15kX;**yc0Nj*#L=%&vi=z)Q=mLQU}&9n*YkQE zuT|$y^XHBXd(lh@z%qhQo_4qQWlb96rzjC2X|$CWAn6IS?IM;L z>g-S9ylAk17EVnOQl(Gtg*c|!(_vah{g8NEP&{x!v_LVGHwYz|o*b127Hjr)WEa%? zo1lHqm=Q%1IXT!ZQEjUJah~zBT*K^Y!RWlrRt0-#YhXeT^`)8!RBZ+3_nrE!3fq-VI(hLxMU$MsN+LqB-LaLUC zt2*k?K3}-pyB~sWC)rZ@rpqja!?2^}uY~ht;>0TkU$Pk}k{JuxBH*-#F;X@{xp>@h#HL38W=w z(qU|&vvjiA?2&Q!5^P^y=fWpuSNAi|xGX3)#Jph>@iHz%9ON*j9U}pd z>2`!IJ2^hrAk1TL=t{Jp*;BD=!q-bE#YsH&bqHDL-p_R*?hU>{`8jmGfw=x1xC7mS zJSE<7@p1gNe0DsOMpbd?B;%8?_{~olp@p?!!il`ma@vuSfpBICN-0e!tjn<*C5O*4 zsjeS`9o?hD^@1{}ueqO-hsJxlGe(cqN}HlagY8+D*m`(uS*VQ__p0T@;X}55hFXV~ zbBhN|(;KG_3#f_ZGBz^h#eo#De*o;*A%as@v1OTT)E(LD@(&kjW}*8M<41-+qKgEE zS0=0(9WXz|aNvb*j80b_&%J13p_{5)ei@JIJ8FTg%5bJ^gs^J9Yk&WG?YLE9Rx-6s z#1Yu8Nz?i&pUk)9`c(nLH3j_9?yk*?Fce&KW?K3c~cx7fb?kFsY7kM)X_v z2w1`mulay5?;T??LfhNG0)uKWSB}A^b#tKhA6xT74vum2)&4GYobL|-9Wijy#9iy9){=H?qe}nAlHL*m# zqg$)H{|^)pE6QxPTqy6iRGcok7WPLk9KDk)y)U8RtEkaQ3$`}lK@71mV{1Q*@Vw>m zD<$dQtx3tRm*?D7(RfC}F;8TEZ6AFU%&t`Fp?{|7XHnW`cP2c$lncDPUU`~D_gxeD z=Z|^z;%S6AY%r^Q&2;U)!x_TIno+gmMl$a^k@r_7SeY38&UyF-gb0jG;)nDx{=R07 zlJLM@dN{_42GNjn)zGoM`Z>75xG>0MBKqRazd(qh^BEP%?&C3|uP#cSL>;BH2W@0} z)a5F8A4<0QWf)e&OPf1oA#rZt0pD}l$8N!*MH&t&X;aA?!_Oa0YB@370Dkujs@CPn zr-*yIa%m(}rRJH~Y5G7ut&Gr9HUz^%PEMT0*IJK<6Oksg8qh0YJ1!Cwg8Q8bw^kZU zU-#>pBD=ZvyUeQkkjNPZR*2w`|C7q13w^^dwF}&xq}LA-$z4yFfo|;r3bjQyDT1Hd z7Th3``AUz*_lVGwU5pVWiQTkd1}7Q~wwV?XG@8ejAgQkgvQyf>1>t}T$qz%_TDfbb zA>E7ditFaEVTl8&Q49rOD9DyU}$ zZVQGncZH&YIex^49EBWe5hR|MtxobKRyZ|o3U73#UCdu53hMVi&!BzxOkeJ{#oy#l zZDfhgdPMr6_LKqqfuexXLn|&}Cx0Sp<5a`@oeVwc*EjMJbgVmhPHg57G) zCPL3m^XpgNyjBPN&h57>qr|0hug!gtgr-43Z$DEh##38kXyf9<<89!h{bot_DW+ z7?~MRM6@p0Hli;*g>{R#({mfM*Of zovu>i$j%-P_vq)w-fP;9*Q8m&j}x2#*9oCtZvR;e>X9ay}AHC^MJFim)BuvZugmYNs(cQ!!~<- zC(>`)@1+>@66?u+#X+@uU;URo|JP{g-ToCQWfRP?!2x<`F>J|cZB3Xtc3cvF4LY(2 z@VmDS_@pb@cKssvXMLg5go=zjf6!2XvY?(hzd5q(YqeZ%y)lF7oR4%ZlaV}KhPI(m zksDI;70$I_2@SN}gTVSp8=z2dT+bqei+Fwk^9Z|9qem6%eZCrHyGWt*ZR%%lrA|U;xwe{u^xra=u zp@`FkNRFocaZI#X@5;J)Z9p=$(Hi^AS*0Ev+o6SNKr&n-C;ItGv*H4KLuY%q>kZTr zyR#u*fxsCuVd!U+8NP>!0XU+wa|1kk5Yh&Je&B>N7=kAxFE?L%IA`W$4s_AD zQ_c=Pmx`K$&Lp%LQrCXLDebDjoPI`U|2Azed{3D4GuI-f2Gk<`8E%Hr5)+fT+SZ1U zO-E&Bm`qedGPNineWcD9MhJIaRjH!bC_XkVR0Sc3jnFj7P%37a!k3!idOL4FcN`?! zw!DJUtXQ*~5?AvAqWh2ND?h*k$rOUIXM^<$dt#|UD_@Db<3zn zsCr;Z71uCZj0gj;$NU|ysZcc8uF`qUB^Z)XvGsNIjF<1IT~p?_(Z0bRcyaSto1O=D z2tIRqW~KzG!caZ^?MBy?pnwvr>~p^({m0i0&N)Htjv~vha%xZc)dE5ZK`$Q3Ec`K6QW6oej+z8#VU?rGViV zC&oFC*+v#k$xcDJC*HeO<^XYK>^uk6H@otf0O2nqWgB9-H_a^{Y+8Shz?<&{KOb?0&l32`B}Ddt@rCH&f{3ZAdTR|vpEV&1kq1Bh&j25LFdQB!)O{RYf`X2;Ns9(?63GYowWm|> zP1}k;NkfCMHgQzG)ld|DPVk+^GD19i!(b8PvP?GCB%2pj2@z_t^Zu9wpFZ5617w>H z)Qe1j7ZefF#r2*iz}H`0DW@cu5o;IT9zuX~B_#x3o~9|v{Gu7(v8 z^cLQdj3BCQn>GFClP*(J^^VQ z75PpdRhN3^uh-{ia(&|Km??mcEXkw|-dLb| zhv}xP;tvNB)je2+Q5$Q>9{-8<=F*^NfVT4vfs7GAo@qE0d3pFVtB=ydmo$90>F|cN z|C;KJ<$_o7@?6`NQ-hwDpj6%Lyg-hVZOKZC5%C{es$i40HDw%Y7bbZSdWUpk9#G&N&_15kMf$w6zbRccpxI#UG zF}ZbM{44<~T~xZ8Rke*?_0H}Y?WTjXvH@XW;ddUw8L7Nd)N% zNLP04OJfNtPb$xfHiRBNt% zsR0gnKx14;JVAyY(BvrZrf__rZa(#!6Kg%r$B_iAA%@*|LWXd14y%A3~oZS`x-1id#;JQn_Jx%l2OgS0{BMCm>$u`junUKyW;@ z6=$!%H5C{4;jW-!;MRXaoQs|m#5UiZ62q4GhWcyXH8v?}FZT82w0FmbI)xQ4>mhC3#di1{ZE{34( z(nFk!oV4ms3b}+{4c;tyw9e@Y%7y=nXOKGqxE2M0E;u{7DZj@pl&hv{Gg*8N z9(5wT5>tpIiI5sGJn=h*7xA*w7XYZ`1YgW%`x6%}n{S0RaRI@7qxz8 z${V4>h8tRYMwx*8%o}BAKN{8|>cMx`DYlgu^Bqla+MrC1#|${6B@Xjoyfb(Fmuz>q zU&w`)ZPaEv0ze34SMsmAr0NaOt$)q`a}i5AW_$O^C#>GhFF9QLhc@cHfU;pJs+e__ zQ~-WWKe3Tq^kU7q_r;H2J;U5#`4zX;JuBfz1Dn0NQ&2niaL|?LItfu8*p4co zBWF|7eDtPQLw>_d*dWRaCFNU%~fd!D4eQJznHG zo({<2iOfM!UE>Ww8?!mSc@l9Jz*wassSR7Jm2&gu>U*yM2+^4F^fVKJZ|pANNhgHH z!b-W)%@k>6Jqn4$y$ycdWG$%v-+@&Gj6P$%{*4!jVZpUVYiFFBgIG2oOXWh`L?&Us zCj$N`h^$*beXHgt(vfjK$C{%rWA3E?d@^?M{YlERpu9jijzh&O4?EZXD-PxW<4MK^ zN>mTZnXFqr(U5hfYeSM-q`}}3j{Tg*%*+gOK&`geW<5AeSO}E{6SV+533iotj*hBq zuCm=K#^;FYsADMyL2Dt)89jAl3Zozz^Ogzc1);DH+Cg@};OLDV!wp^RynNYX>f_ES z5ljD!W%A76=ye?Y6kU?D6Hw+;lJ3UA=}J?Xy~CoXZA&>vkk9aG;o)IK()43*wj;JZ z>ex6wNY?T-@eUy-7V3jH`M%NL-p5V2O!{<1!HL$~@!K$!ad#Y8r5Vtqa3iSiB4!(- zJ|x)s9k&>L$iRX6iX{wMlcFrB^ORY`5xr=OL1KaUZIsCB3txz3)bE5sTio(&^qK?8i7QCX|@` zFHw|3z1vn;gN&2O*t-*qe#DjFK&xkP54@lh;_Kj88GFaXw6S z=Hnov6adQ3WNKse&!o&J>MN}z3w)%B?7=pw6&xWiKv6hgOo8qO7F&r1`s`I2wP&hp z$8FHi#J@3|>d$!a;z*vYXMFeve4WUxsvjRI3$%j1qc3J~rpgG2Mbk+q`kItuY;yK} zn`w7!zwnOo5}^JP;dk??8uCfF8PA5{zEe;7$#196o$_9J2fS@2Co=D3SGaN<-6e|0_fH8j z`}jkBgPG%8J-aGh3FO8^=qMmsha&%HV|PpYHHm4Not3oKo@0-KcnH|kwkBQ39Ia9x z1+6J}Ob!6-u1q%&N--+B(V4pDokb5M7nr&13zd3`lRkcU<1^keo(Fzj9 z%(Y8uUO6;%PJUW)g^8pS5V2XZBVB{KbNPe{S)0?jSdDg*@cz85lrFGjVb(t{*Pgdk zsYs3`ABAZcEU8sPxfk|nhXsPD)ui=hk;pD4M2m9gg03Ai>+}W_i1(oCa0_^^LYqa(XWzFivL;oe{|~q+koh%H3@W|??MJDc8J%22%>EIu%xx06Gp{&3%;)?+Z0aUr*8T5z-k)thi}{C+^SS-F zxImGMeWMI5HJX_!TRYd!1zF=xw5 zQP|aPDhUfo>q>(@C5w-I3@O`Wt`jx*ib^smX3KJmq0?WGa()YYtGb_ZlE|AlW7~4h z!o`tWBg{_&JoG*Rnumm)4Zf-u!>mPD$S4uyA6PZnQ2|!gkHs^e88YA#=`2LN2j?97 z`G%PAMYF}i>_E&yS#Bq8mj*9Y=a%^ZY*(@*IT}JKrk0*p`O?{xvBT_KnzI_!-)1lO z{GNXAro?&3Dm~Vw&o=X*^q$f_r3vPv!A{nWL^|~-_53o9=)Wm%6m+%`j?BB9c{L}J zaUJR!R8gUC2_lhP!o14Is*;ghQt28Ra)bQf2P<&uKhQ{TFl6Y+okfW)o z*Z1-X(^vfn^*P!yAfG~wV|%FL$gejH71&PNEkSuP4uog~;w&>bfe@1+dr-;}_fB{? zY!Q2_CeAh=gA5pbFbCp)9Iy=(k5ymxph!qZE+kA*MIBp1fi081f@6_d$088wF79x* zC!Cy&fr1y9Nt}9DAbq$BcAJ@2v*)L@UyyBr&cr8X5&hDjN_05J;gqqZXt(P(1R@0D z<;*G(pu^lRYCRWU<&zBW9&C6P+EwqTQ+aH77&)%oM`-?2L)|=O_srBk7A6aL=G|^f zLm^{$7Md`h*Fq+sSHm5j0_Q41;RWOC`bUgKYD+s?fp@LzCxUZem#IBOVplae&i1Jn z2poO~<0GvO+eo#THl28JJCda(GP1jC!rHG&BvUBpvEiC?j8z@X$jlKrOCJ)Z2B+M) z=y0FmGmnz7;!mT*g=XZj#V1@<)NbsrMdtV9rNrG`7!!5v({dQZhzeS7l3p=vWLUj! zB_48ojhC`VB{*3RHQkR^EjQHzm)xBF_P%-qNTd_ls|g?V&d69=1^OPLiBG|(6yVKl z$jX4?;yAl*>*BjWMneVtsi-n45Em~`-^WjibIM^I6s5*zw&iEzZY=5+^t7UpO=j#O zB?$*EGX)L+N$g%NzDq zhT1q(H!cT-11ppr_jr(zke%^tBTlW{0x9T|1Z%kiiHPr*S^V;jv0yudAH%uYKa}0l zi(`GHXxVqwQ?w218W1Gd_|Wu|&JyL}{C4@r8&tWGJfl5(5zi$SWF6t*P z2>1gQH7ESq5lkTRy4 zPL%y-^ylVE6TViwwG@ao>i2FLIxE&r8dE{(%Ez+6mCCT(F4pwXafi3(R!;)l&e5Mv#xTLPcrneq9E(&e5wQK$vJ zI(Gm&D?X#-wU5^`Bb+%ZGh8?KA6!#nUJVG>e;6x)$+ z=}1L(7S5bDidj(LQ=PJx0mCe$*tHj3MB{AB%PCX7&uReq4#L#^ZI-{-7I-@*=h-6vt!(~uPGqp9u_LVU+m6%@ zB3B%b7yX`SU}ujiIMxAr>FAy_ESe!AREGyGJZuJoqV#C2Kt9K4H6Q8`Qa`O`5ZISY z5sSd>)Tyz!{}a zi(V++w8_tK+u>)#@j~5W$&k46#Rz^gVw0(%Z!TA^|H?ag%jp$p(#PDf_$@o zjJdq8T8L(qL30WbL=Kzoz%RC6YF-WFKzJq}`4nDzhL#BO9E8)-D_TzR<*TIQURQGU zlFgFs&$j3MVEes&{V$_j-to5D8_znKvQxMjb zg60dYkCoco-@?v0zY8g_eYbPW(L977U9YtRJ5Gm5VMl1~2;jtGgEnbzzu$kVL}r3B z30NVqjcrON$&MhuzHbA~G-#;GchgZN&{&EdLA2>Qg*-uEFemiG%i)^fWXc244FHmW zFexR~^x6=9s3KPwe`fB4S$8DY0NE#JG{}b2xgvAQ_HxL(XcS;8NTob7p1M_VcHNP+%VOT zZzAoKVuXe=7Lvo)WX4o3$+RRsz6~SAPXw6MaLGimc(s53XYv0oX^f+YHTR95V9)Ol zeI@^wF8=>p)kI$}{J%nojPX$b_#JQ&ZuoyF(Y4Xr;b(9Gga4gZWTMi{Os;tiz`(h+ z_-bN;?g53t_;2nqw6Y9L^sSh`5wNWFLPN&Im-P3+lWu9 zIP6d_Lw?g}y!1g>^lV4a^OyPL)7yG}l5^QBj(2rE8DpeZIitcaU8&pDwR`4O2bCW} zb9bdPz(BnCG?=5R%6xy_o1*?@DaIrFa#7pM^N$PRzpVaxQ~z!1_46O9t5CSfOzV)V zOjn(vG3kF?IsW`7CV%5`UH6JR61RQZSvC6dl0QmyLX^{3o%rLe6QLUTZ5bJWTp2bO zVlW&Lvf^aWU+*ELyW5V81At@a{&n_P+;|n_w|lk#%~0mDY6A4XcAyH`b4jla`k}bJ zIlfSmYL`CBVsmmEY=l;ZG*58FJDI(Fn+PS%-<$D06 z78|$cd9fuoB-Yf+vCo4g2^0tUdGF!1DCDFXUal`fW6V6Hh(bA0rUh?z=K^ z-~1my!*if2>0m5(A`uz}42~Qv@UY>m4MyL{@^XLZ)MGLB%9*wKqUXc5e6TmkHb7nq z@|7{KmW6<$E&C*OWbvJMw3TD zcaPNth^oH?TggJD-*(bX-ZJy%2G_$ zjQESn=yJpWY=hVZQobsLPdb`^>FAJ4EEojsccOHaJof-yJ6s8bhqslNCRV!H8&T?P z)G9Y*(G9`N9u^xtUV<)O+^kDGQv2t}%)4iBL6#~U7D4dNbLIYH>XmxFJJ5k6&i)|A z#5#T0&JPQ#mipZz+=jt?;t)Ek9tvqMf}1QGkwn8{YI0@hlOb0y})vn!g9kJt*A#PB-(#p@Kl+%azGMek>4hZD-II7Sk9v>hT>*hM>-J!=U zYggza5rpexXnI#gy)h!I&boxp6pgP%Gu8$MA2;*nzXd9htqSZb=*x#UV|H}gFs!G! ziO|`|ZT=TiA?_s=>as2j2XrOXuQ4%sZL`#?!A&yCe5hQ9U6|mFxfjGy&e!xB6YcP#9_Y|q z2@MHYXJW;l72R>U)S72PFeigR=G44F=*06el00@1#ar8}V$RY50xo&y0K#-u)ZH%F z7!6sKhl4v6jlfx>x44u~92jio_{x93m=UgCM`F`u0;P0OO5ADeE}s}qK`D28)|v^| z=c6CI1iJmLbH;%m(8qX?8_*d3NeYW2+)NaX~nW5 z3dS_z%yCHSF7tBg8{RR31d)3eJeJ!kV zPHmOlXT|!l=*Bp4^=EWeUV0jF zOIih#;&2uZiPKnmu?&-2nZFb?XVrpZMu;vU2m!y5(oF)UK2CG}3npo| zcSi(lq8xV|rrsGU9g>7V!AYY{N!rZ9$G$_21_ZK%_+vyGRIJ0eSe=sj$zUqzE1zp_ zRM+@&Ig8YBu2g4?JcUPBr(>TAfsaoincr)h#SogSRmEx39}P{y^@i&0hV>Fex5|XI z46?INBDlr~x3da3;M~Emf`{W}EwIUZ35y`#aP{M8rs9$>73YJXCQ&~4u$x0QbtE9S zBhWENF4yF*z|K;J|5-9wsjU!n^PTjaBCI1lCLbN9IU>XtxU}f~5gqtY{BM78gQI9n z%9yH1=9Wl&hneZRt0JjePLR9?Wr}5rwik;A_dyL`4i6XW*48%J>|X%|C%=h7-Vf0l z?OiEw%F%Kc;DX!@>M+}6A?tR4Fp5$>)MB$w!=b$&-I1(41^24dTOBGS+p~9D9o$yB zjhM`wh$@~;^Lm&(ecBXG1;n>>Wh!l^8jhaYsGki4edUs)849jDz_ROt*`egj4z&hZ z*s23HrMp2S#|)Hlju6ej(@Ie2eY}Xry3W9UTKRHOI;_m0xusn#E*rv>4$+c_OUVk2ZR z7x?&Vy(=Imq97@Uwz|z7;LJZ$NXM&~k0PsZWFTEQ@ zi0aGewsnK!4S?d>BKrGdW-OBVMgx&xd892AZC>W;qygvhTGde3Fa@tn_3tV{AV?j_jO4oO7_R<^*6=Obe6*@xITloJLj+v`ws5oszl;@U%92WX?*UQ@; z{6zFB#|?MgnAqE2`Q2Rc6jr+TAIDR47JN<2^9RcI5-?kL#}JTEYtT#xm$mjKZL&^y zHE?xy{cs45Gmf)mX0uL-gpMD`!0UD-oTW1@J7fx^G5`MSUCQ$`-i0O;K(6}n`$-`Q zkJUY$jG=EmZvng`4L*2xCkJwJ=nH%MRY)`HB@5xNiB{9f52Y|JcmWZ^Rt}GYcMFX>o~wQT$h< zf<@eDO+*G+_CW@Zpn#mXoam@Y_Fy*#la6JX?b!JJ=I*;&PJ!tMseNU>4lDSo&FJiT zc7`Me6)AAtXq?uqeCar{I%J@g)unM$!>Q4xv8a1d$#`@zVN>&+fF@KD!9Rg@5DZ-U zq#35s8oHYQ-m`vTu{eyrr@to-HZxp`8lzV()4*c_Y7*o>d|mSLuHpCcBK+hzvt1=L zM-7bb?UgiNJRipPER1l?rq(r7pRl?;MjOm35N>JjzgSQ9f1NfSpZp&~=%T*Xv|6S`vXB~a^Jf}vpE~*u{XDM zmm60ipQ{o(3suY4qlPm=ToS8Z)Rvsf(N7U~+6Pun?qzFN*>YlmMXQifJEVLWuA?wa zr(<(;?3?hyH!E53O?NqT5ux*U^)yN8+pW>NIvahFpQ0))OyYj}eWb1d1Kccy8abZsCzxYatA(lBqaf0V@?pKPRUK9(n+ywAL7a)I>A%#<=yC_t^JR zzhiwBjp+?ekm_A8%02ZlVnI&_w6dI8QdPSNFgq3O!tDyZuNXw@yrRe;xDf$T&ff4| zsX0i?IU6C<(6qDCMbXh->mISVdL91p_e<}JIFCHL0&}mm(2xv%TUc)KH*~@T3l41^ zY33tYZ>Af!d1BD~u{G)5qQ2mmDdtt}Sw3N;`O~FnOjn#JKT=;DPkl@Fuf;ykge!U5 z+u_fyYWt$e@9+w^26I_$I>XF5jjZO{WyEG5dX5R>q>^B-uz^WktRpA@1+Du_LB;!G z>_T9Sb|sxK2A|H`(Gm-nN!g!=3ey|3eN`h=Vk$7-SJK4`v2j$=1LK?HyPY@Lx`fqQ zJP%~YTwa`XTDe$xy^yu^by5gDdD8$PkBl|A%+y3%Yv9Y$3>Lm|?y3FwknHAAd=Rn_ zfXY{0g7XoTr_;)fdLr-&je@?KbOgV6d$j}FM?-RNLB;&PE5Q<24(U2Z+zTRdUPfInTv%Cl4bJC(S+BwQ|EFqYFxg{&ub_R1^MH z{;JG}v_$Q>P+8DbWW=*629j94`;cz@4ISI?yzY%Y4O?lwy~l!yx8XU)*sM`t)rQfu zI$(~dyd$;2gH@)Ar}h1=V(bM!C-lc!k&e3q*$UXjLiwdLxfTw;`nsUU-=C{3!0qsu&<# zebxjKcyyB{GL*$n0RJwsP8J1}(!f1pcP6mg>>RekDZY(Q0 zawg#Y9T|lKOWf3sCkAc)&0m+bZK!yj3gW?f&Q8}t-o$pFTB+6!{3r^(hHvFCwdd8_gs zMOr7dQM;r#kuT`m(OS%^*p8aZQ&G-xAA4=TC6GQD_=Mc-3!Lp?LeeyXk^C^?Zp#h- z2#9LxegEcV(t4kfJqcWqO?V`>yzYR~Nb95DE+sA|$hy_ro0g0`*aC%Ca6is%>A`E> zA}hPB)Xb5wTsi)9+8vZecf~oV{-Z6T&E3j3&fzdZ)8y{h>nZCv;NOLnIn_gk#O>S3uBCQ!sY^ZWrp=wFh&T@o*P{Iwv=91$-bi3r z22QA|j7UKq_N22lt>>D0u@{yAyF^!l$Up}uOB1M=N@R>^Uk)|-19EYs^JpoB4GmdH?;0NOY#YyMv2_2;_vyZmy za$o)fc;OQXz`=&6wT^2;G6`r>5bydC=RzGzXD)ft(xrDe3Far{=t=dw(6y3hAKgd+kmE>D}=7}#e|tlSJF1+e^lJq zTm_g+drIL!<9EG?;pgev0_rN=B}Z!{09*uD?@E4NYhEee*$2#ke;0LQHK6ftVQ051 zF5~ue2Io{IQ?HA|pr=&?l?ml{Y0V-Bbq-CpLOe84utn5H+gD`3o}lV{UL=kV+;JBS z#=X!=xRSA0-lCp%wC^3J9R~P?wV;+8&9qV9)(&b{N59B?=ZBmGcjiM1kyZ9duoIxF z)2>XWpYTQRodvXpWgfE%zs_iWOHj*hW9+!4t{hHe8xn7TMU8c~QQ2h8bS%-r z3N*}DUdBv>&s%{EaO{xVk(UpR8hxD-tYJ)XkYHle;XCFC$0w{p+NFSb`*OSVd4Up% zgjkJHU{yzoO<|aX!Fg?*Dm6{?5KvP9OLu_D9QNBcUh(2yZsYD~PvXIJ(vu~sslJfN zz|sv@0ak@S;9EH6;j!N!hU~gS=at4pbv4*0Gfw?2BvtsmaK5M}j5Y%mzG4zg4jU^wzd?Vhcnth2XWi_oH7AWWHJ-vKxhTKiuVEJ$=*!-mzjPtRs((tcVtN|IC6` zQJ0Ta;V~buw(`-?h-p2$O5FN-KYqi$HT4YP`$n+{7K!Pv1GVC=-3qs&8H*O0P`T?a zXfZR6`5+8XvD0!wT5>!1OpD1O*^!AbE#7%`kVDA79LMM|U{c~ukzQk-j+~A*_)^i^ z2U{9AHw#RNgzvt7+R7dc5qHxBu{s^{n6(CGg1F1_Q3&L{fVkK+d7V7d`#K$ZwM*j; zWpl(3&~JAzL+rDj;f863a>X64EQ0utM%~9ips26)qf0RNbWd(q2t(IV++D{5)y=Wk zQ8m%xmPj5CT$$I8vj#2LZx z^u@xexN}0FYKC@cT97{=Uy7n)NKjXQk}04w3HAj3EAX=Nv@Q3i9TgE)Anbs2ie`b>%B{u- z0aQ8;wx^+QvIAF1Q*sf3n&Wy&fFUBA6~JG@sPh2k=#*jieZ0^~;h-p(O8iA!tn~fN zaxH!ORY|Qi(XBJkBHK!VbbKzOH5Ut|wX!~KYWwF^j{q$_z7~3po>qw=Gq`3nr&U9U zlHNYMWYBl07&r|BX3jSM60YRor$rd!?^9hTU14#fV_+&(BOm|WgF8}UPAVAiMlZ<$ z0C@hq(n8yHlP4+7voqt^qmY<2KA^jn+V}ZCouq-2TI*a3E)zaGaE3)t2Zl9}?%u+=P}Q=8Prisb zCW<}q?R4Scjfl485EB=hO<;S^8qbaCEsiy@Sa2rmR_%%aOC)vs@Rf)nWjN7EHjhc17IILIoxR=F7Y}CT zirmN8h)<7pC^LU!Dj!+5k#)Dd&uj3pxALeE>(yn!{}oAz!O>(Mjf54j{^u!k=sI1C zk<>42W{b&0zp&ajgt^gefH> zgUB@#Y>qy_{t7B)pm>`nQRY;^#6)>s?shLB#Bw>TEk6D*%Y_*L#_WlaZ~GD75~d&- zu1;f2o8TPQiDpDkGfJ_sPPDH3&dAp@qrUA9gSzr@3{9|cOLWm*7ddaC z$ZNa&Jz`+nK^MRbacsM(-%VS%supez(chHpdV(*h>ykl=UubRqtscB96s@l>*YcNu zAIKMAzZ555Bdl$M7g>$Z#d(#dYh+g#md%>^s=2+V$ZId;a>LK!?Wpz5HrvOmCv4Oc zQPAFDk#?hgzY{5t;2WvstM5PUlImr*9U7sLF?%U#j%Qf0@Bn$erB&^Dg?_k;_52$ke3-K(>nE;6 zRYrV(^#=r-+GbWomXCqdeS4-+??CLZ{WA?$;*NAr=Y_hb7RdmmLeN|5&qx3aqQxV0 zN%a(w4z{8Y6@3Zd9U(S<3lM>S>wq@P?(1GI?}|+Mjw-Lf+*S)}Mu|^Br~mxVvdPNZ zU1_tw-Hv~rp4~I}6O+@5ioe};h3^-z#h)SIG66jiTXn1?L2JciV_dWK0j%xa{#w6T zFX3iOQe>-NUj<_sALqN?28iwTOh>7`=>5w^OEnJE;*k2JH}bBsF8+#k*{W%&t+t>S zFD5d_C%uctF59a5aFG*EzmkJQb7LdrcrE?C&v_JsJ?vPRoCukTj4;Y&gxo)N)u8kyl$U^ z0PvsqjQ{J91&{zp>==$pV%Ienxa5B12v9t4(;R;k99!S~AzY41fbPx=cl)>>mz4>o z-+dY6lw;EU<)|Lrk3#AUF$l~a3| zvVS|I~Qfy1|(*mR+thr;Ye_XD!AAw zM@H@Gj+h1VF)0{V>@BheQTX6*q;smvf!%!{70!=ZdhPcb&&Ki3Z*;`i}1xnAQln zbETRX`ve^GrF=F#sy^A>?N{Y@+JJW+nbj_G-I z=mYc4DNoL>4n+XhLYW|EKFwd@1o%_mw2;I8U=*^p0J`u@qPPbykd`elL1({LxhLh2 z3N;2^taeB=AFoQfJj>$)es)lp>(MZwL5iu0<3;=|MN#c--ySx~f@~=JvTa%%mqr$f z|Accd)I;-TIz!>t)fb*tVGGh&H%r}eC!a?1Q>31kTOgmZKa&C2e+-jjSe_moy{%^N z)~)@Gx%tPR(ned$7t5DKUCm2vKi%XOSRlSoXAV$JzV8T^WYLP;K2pZ0hb|YEd z{Wr6$A-)4~x}-SUCW^Lrq07`0XP2Nc;o~3|ND#h9u^N&nu59VKh;TQFV(7)JQE#8r z)(r7bsqAhHZhb4}l%S+4RCXy4S?<1ZmOE2>QcME= zq&*K3S$%YqvsrUVnk2OlmYia9`0q-j0Tc~-w#G4who^)q%m9>aarP7Nd94CJUf54$ zeI*Q{8Lin>DDsRgRuW~0vzr0F;+47BJ#(c`&0gHw%(XnR<-8L2kJqJ}9}xb82O0l7 zlqe}DQY^O6sm10m0GBS*s)hHC6zuvbIo}pWA$w89E{WyQ{*V24y^;o+ld}oag(msR z0$~FRX;hQXxj>Z6~Yo5YW5B2IRC;F|g(t4Eri(V45rywtO2t|{=W{xeO z5b?N}(K|se0pLl60uD*^*A;OJX*t=UR^hxxdA)$VyeKMjciW{mt9wT$Iw4+{LPv?a z%nnJMEnH8tX@jV`atqB1$ZLkdQymtAXB4F(mHbf zr_T-a`Ewdkf1}+LNu9*ar_@fTz{j{T+dh>|s%lxgs^7LO5SeV|?6^Ot_ezC+Qd}Ev zV(#k;Hz{;Vx2ApzzFLq>%=iP(xcHd0RrGz?r-V=+D+bLRVrwf7u%I73Ye=0jCpOv| zW(R*ysztX3*FS%5s;n%Op+${WQ*Aga3!*VNGpIT^Z`ZcG81VWsC~L&Y`#!Le)gXe* z6NAlTNsO-W&TV+jem;9{15c686(1!t7v|uRM)-+ZM=2?^$h&j3ZSrsQm90qo&h7JR zcY7GUI6g5q;R?T;*OmB`f^1}A{NPx2&e&a1YJXBD-9k3J3zC{EH z#4$~vy~f?FV6{4=?o5dN>d%4p+c<+*am@|+(q^T>D#ZvhPsi$BN%qq?05Nl_MDfd3 z4eo&%=vTF^--FrTFlFFSs1H)J0y6 zKIpf|8m-5IheXC)aEegC99eD^n)^l0Y!U+^J%Y@6_VgZhtZ%4BKNN(3GszBB*%$u; z-`3jVRsMGB{F(Yf;Gn$dx<;U*e31}f{ukp7UZMka0RZ2{M?J6zf+Re8jsrcsV zQLn$q$Mj&wv&=<)b?A+nKQCT?c^3Ouqtvc1cervdTlVyBSohLZeV{ff_OfsJk}%y` zIeQ9#_K({MgixDeZnw5x7MFky<`jo13WN86D72BN2%u7HeSy_~Ny~ zm)W^g}vZ9hhmfP{-cZkon+IXg11>}7ez;6|qfrZX2~DwagQf{iwJu$v>_I6^-J zB6;?B6ZLnT2J&;8@cL#ew|tse4PKC8Z}CIF`|%l9l~`+?~DkX>kFEHQC`D68uL88(P9tmRyw{ zM8@_Wsi+bQ9feyr{U%%9#?+>FcrB;I7HmIqS;dRlZ6c+?vtR{t0%u8Lq z-~4$lvl{53>{RLcka1r(BD3K)O<$Nh1twBsmW-ph7u5jB?^wI$9~F&IybDNK)yC^x z#N>nQi<0G=u3Y?PHPQ>3g?S7mr?yXQ{l_z@Weos$Xzej$s<=pi&*W*N_%7GFu!HVz zTgRh)FVDZ*8oZaTLTiWL>59}jg<#A^9c-qk%w?f>mksG(g+(*%+Vfh^0z)F%N<%j{ z`fqL;0yb>q4ZTWY>%0zgxU+NrW!8MOF445M{K%x71tSSDQ{JJAXZWdm4SvHou)LCjz^|bt?xbTR zzqL<#PgQbZ)V5xVCd9P+>_B$WD%rd!NDBP3ov!UU1+3iuH zGFmf=Q2}(vT0U1ZW-ry!-$_tw#hA(gb;=?>kfkm~!;tuIeY?H8@FWO<5Rpwdf#Gz* zjCjQft^~!ndz;4K=@?HHSl9iv_`D(M@Sb*{=M2vjqby<)2auf@s4pY)CrHeTQ`@tl zx^@w#k{D7D;AmT08mjvKiW4%Dr#O1bVO|YPqF~#5f|UO7p40QJv0MUaLQZGtR@j2_ zpadyC^)vN{K^=4K2N>yVYCmN0ED7P`s$Tq<>mVYE9utp$`;i2-M~B1T#+wyS&j7;^>6;^^>$}PhlL6UdQnrLF93iyO)&L|v!(vtgE(Y5{hqH7 zd`;Ig)>KHXr;yZ4D2MRd9iZ%)BGez8oTR$pE^Nur^_7YLi#s$@xOBlO@xnHQ<>y#Y z0$$c2Q?SAvm8RtX0JxaG3d>23{yKQurFm2=M^`nN!Pb$q$kW+rVuA-C^4pbt@@|#J zvoi!QoW|zJ3J=vHMhFOjH1EnRS{~YUBn$HzqSL{~7M!Qr>Gn6s$)|*9X&RxbL zV)TK$F_-<1;NWHUre^anfn<$XELa$xU}n<>|LJN*gM;Um65QX7o>bThoMS~?&bX8)G*+%20B#*3C_^-12up=1>( z7gz&`Nm}bzcb^4T<9NP6oW4s3!`WprVfAXCV`eG?)k>3@lC~z}QKInyh|WV<5JO|T z%se~OLY;#uhoz|UD2c+)7_(AGP1=_zxOMl!tGm`g{M>=I(6Z|N57CH2I;`yO&LuDG zqR~tqUNuOw%xRwn^nH!^K9yN`SdiMi(^m>LbE6GJ2OEkKlilVfLhzA;b?%Ced7)bu zZHA1X9gv-$RlK;m`ZID{hNCin*evLab$2=bB4U4@wwygFP?qP6i>9u8GL4Clz4713 z15pj~wO#klUDj1H?nCC1J&Ej5rO^lZ5siJgmA-|-O`dl|pL;e~#idj?yGJ+TdFvSc3;4MiFVP`abXKx4J(f_FA*m)q~I};ff}$p zM2L&NU-imqSICu6TfU|>k1%U`YCy4eX#5Y&>b7UEB=az$R$<_>-61fNt#ryt(6y6? zr17Hxv#h-cs1R-YaSGOF7`9n;ulPgLbxJCVHzWH-^1%mkUly-F7j;+C;n=>cA7JS+{Pu>u^yaTU#wAbk{EUP;^+gXLG!^UrWP>wC# z(rmvHW6yqkbMdlF0*h;!gqW5gbl-q8d-xD`~C`HV!n! z5({6RQ&!PZ!~`&o*IZ&enQ6Y85s+WeUOm<1bjqQrn;S%+z zG%PCV-|dSHpPMy`DuXBR3Hj%#T$dBlU>$Y5-IJw*+}%Gsn8iucRPlD~S}y!86@L3C zMlw%u@00ultF2hPjhf*Xc?CpW7-$ros4e1mS9Ucv<#oD=N7CNBGRTJ zBEXb91gi|7nI0QwTdTt<@dP3}C_}*Y-i)blCi}%Sy!@R;<@bxx4Kx3#MVMQCxA>yb zuBStnA?^$a#Godp>C`ZRzqX)SYp}}Qj31bobE$WRJ9c!%@K3Q~U~RdP({7Ypb6}!- z&8T~f30?+iOE*3NR}#<^vUvZ%+d@w(a9ZkHUi#DwjU-;0D@aYR*lPiAeFfA5Z(BTm z*e>5EYzj=p4b-@Ek^-+>>;@@htLEx2C-YsP+-u ztL|X}FLp9@JBT+uuQ0;M|BG-)W;Evv3wd@GL90A{q!7)B%m37&+bR0Zqn<1KJI-H$ zZFHP$F$F1S`Z}xr>b6(g#ttd=b>hiIGJ3IR{AvT^bS+x_?OaX_*95DqDQ78dh_AHnbc|3ZnhM1S>J)w-fkCJ=+;*5ji7pCB z3||HLTCr7y-rXCsRaRkr)-~Lc?ok`3uLz8IVHVx+B;x4^Is22f*~i1FWv}fHSwi=MvgIf&}I;ylbc#3K(046|Bm0saoe$iNk=IQaWgE9d zkIMDmN}JopYzCOL`%K0x<@jq}hgFvn@J!sYRc!cfF|MMr`#o>rvT%`*>T**^akW)@ z=oHp`Uey^67V9&M_&Z8FHi< z@G_Vf4gMi)?(|s$&`b+@e|EG$MV@Mv>bBwujY`vBE?SVzZW?&;&-IZ*zO0$POabX? zL_U&gyBIi1#QBxvN2XUTb5PZKpS}Yh6Kq8jbI_esFVZ{^$QtTA zmqb;UF~q=6zt@+}1QbG3PkPP@2dLp1D|^DqZ68wYOBOEuPs-HpAnW6XSR-tc zHKzPKJI)>5E&llV%fd6Xs;iApUockf!RF|yyb=i{S9mNVf zUl!+1?uGx8*Zk#qRVP)VQ27^Y{J34@vX>7gkQxp8BHvFxBwskxOPFo{)*g!FdbWgi z2%4NG<5+3+Vj8XDkuXtGyJtqKat#hp1H7mwE~t((*HeC|5jhc<(C_CzkiV%*lbhHP z_m;+Fu+Slp$!=Xo7WW}66~ZKEO?VGG+KTTH2ic1B{g+RijC_GHCnEcWG}!DYGfde0 z6s-vrpcREo6oqc?8#vq%Ppk(+D9Wls+dC?AYO471={~4d+2GY?=gpQl)6OHEkF26; zM+gJNw(_)ld8Y?D&_vkqrDVHu&kEfy z#uU2L?bac}ew6y9XT_x}|5}?6O&O2_t|u{ks3$SzvugLt$y1Qq5P%XrZRv@=%U(B2 zMOHyORw>dqH_f4HHGmAko^pm9)*2ktF|;J(uYxabdx#?bheX=a%lKW{M?G#u*vg}5 zfqlK1i3TC=L{t@RgXO8@X4E)|iBpZ$s}Nep(pEd{F%@3m8A}!&AD-}AA@{$@H5To6 zOv->b_{GEJk3d@c>w}g`)#41$CPVXUR-vNxwNS?~6Dd zCSKApM^7`V9GJQ$LP@IhrL-5lyg7#F!%gjB2^Kr3{7iCXa^h(R zDO4!l9NUolwb2D5#@K4}_Qu`RF<)MthZw91w9-u=# zUt#>>$&a54CSUd?-8yvFyJj98gB__BO`IGkL?12ZQ!IPcURCO^O=?AYGQ?Be0Tj%l$KKF%B|8! zx=cIKAixv3GLbH#SH$tlDk1Z-_QZO zJ}c0njmwRF(IQsH+G`+Ck4V2?R*U9?sHQni+pm~n-w(De`QyL8)Uafsz6=#hHyxFq zrFu#~nDNMT79Bmce+#1H$=woqpCC_7eG~YLfF+mWq23v*0~T)^uR>0&P=n%wVq+MX z(3A>iSPYj1d6^8&-qf;ysX8BV2m%7#vU1mL^4}2^t&ggk3|`qpjKy#()~~zfYg&G) zwwESOkILHq5PZ-|AtyAR@5=WBWnwrO>s@gEWP&0mb2u0L>XjfNOoHZM(RQYkLvLv> zW3Ex5J~|VU%9=CP=sSdHAcdGitAJ4?)Nvm$nUnDTMRC)_Z#>!NUSuzA^WqVc6A~%g zwa@(_Ri5!KK%4<#_>-YjcuUi3AJ3k-lV~i$h-&wRSgPrdsqb~zoUHCBI*mMBjAV|)-%k=g&wkAAdRQTK4^#_q zh9tA(jrk8|$PQ8)1Pf@rh`gR=JHDAnsC%H5xQ3bRNf2Lr{CFhgiu|bQsvtqgKOf z06r)Cl<2la2@F-`bW{8I>gCUtRFw+rSh_+Ne%$Nb$W}u4>R_>UmNenRhU=q>DD3;T z6FOQ7Ypip-xeRZ+wWilgqfEVogcbd-T87y9WMoPkz^qV7T2D|=Fj7!T9;t`LwA@!w zsQP*)IUy@PtG@1fLWL2LkUBxO`J9B37irHXP(W`AoiUqb%?2k;ES1yz8J-`n62&E( z5MqP+Ro|+(?HX&u!L+Sgg`Cq@7$eNr!iDC}C(w2}sp{Vd9w3gk+q2 z*PLJBMmmx_f1vwln`_H)sH=m)nr{Dt%a`WcMx%>BZ)tZy;t;}yN(RsaTYzO6r2SfV z_VsE&^DN6w<(Hbu-Pv-SCf&b;bz)V-vH?pAEor=K_Cv@$rP4Y^M zei&yAaa)xqMrBo^(@1?42c(sPiNadVCSh~8<4W)h4FWXgP{E*ONO`RF{GCZ@XLBdB z2W}h7eF^@w^TJ~sxvVZV?YIx7H|7=B-7TfTo({Ndu>!75cP-7iptaEvKPWK5{1z5I zIq$KXMr7SaA076zf^cp1AdTUvjvJHi=-ATw)3_$X=xQezO%XVteYoU`3h*I$1NWEd z+TT(Sn7_PBHUdfB({RVJVVxJI*hCV#Fh$~Py4X^`CP(tjk@qjQXM>NpeW)B-WQq^% zH(hnuruDLI`s`i>_I6%1O!&o>E%VrQeUE436Cw~){}^!mz24lg9G}j-g5HIMYVAH3 zkoI#NerP3HfSN|ic6<0=IKtoz@k-0}m%7eSS?Am*D&jA^I--%{sq#G>#0f%-WikdH zWO|+WL2_G65##pcucckJYLUFrSE^qe&3$m0p9OwJU>PSW8SDfh1q**BXRMc4tf%ry{!tM+-B{L!>W z0%-$@4&hT<#ljO6*Lx2$`^Kh;9ju&jSx0Mw->}pDysM)8f<^kjg;1rIJ##+TXu_Hx z>b{=G^-VQyyJA*s=p?4b%l4hu6{AZoRUL5Y^(QA%b%>W0Fn-RID%aK3#GuIt4 zGal?2%CHXF=D~*H2HljGUd%U-&u&xPuF$CipE3uj{8c{R>QDUKle55AO#2Ov!=w^^ zs;8vNC#{!ufXqR_I`YF;61_orpI{My@~FU4q_J^z#Pr(P z7o`&EU;dk_?PlAlPw$~?TbZkOz#XvLMjoJh-qL_-rz?MB;LwRJLN2H7}^}S*YAEH)jfvBW#sSce!bHkH=QMBie7axr96;1nli?JE? zR_)>`5O1u*N@K`yeA#i-))+X&IZ%uvlLKTR=y1eN_#P8#DD6O*=5(ZXG7)Uj1AVtj z)w^8J{`*CLCeRnpTx$Ly71~2HUmB*P9ds!YiD#9^$#?qJjP4qZW2%^(VGR-}zt}Cf zA=}}^(~bpw?xAwL9`!5upzdjDbKT5(1Nh8OMST;o!)D88Kpw#<+( zx`a3c%p-);qVL-C6e4i5r?~l#g7EfQppdR_B7`bN=8mtC?NuvV17Ryb7Rn5SMsQL+ zm1(aY!HYC~Vq2Vgccgk4lwV7W-fj8I8amab5t1>xiL2bI@2QeRv#}q*!%X~uySFOKJwaz@d zQ`TZWl4X=J<*&bC%}co8NQAk-Wrlkilo`L$i&wY~fFL3%gVz&15kjRyQRO7V` znUrNeX0q#vDkuYCn2VZedRc-grYY4FvxhU9I1jgPU@OA10T$&LfToP-OV1EbdP;6c zpKE9qcydo(>Gfd4(?;RgK;Pl>hv?Y23u_d;b=X_-2Pr(6RCIgo=~JyeFUpo_kXR{5$Y7;C^p74{#vfD2JWH_=hT#Xz zN^&J{=cSahcE<&bIoBVcqW;wlYqNDEXbW-@#-j*WnFBHfeT(l^L1($*$K(hNKQ@!G zcDb9HNn8)hg_=Ggah~-%^A0|cm-S@m6P#iuqU;BGp&XNM03~n0ost?=dU93+ZhX zY`LiGvuy>o588aWBFJJ(NsfiG^)7#Nb56M+O| zkB1xAbb4Vj1CRlpPWUidftpJ7vANM)Yh;?Ok+~feGsolgXRU=j6#?<{dG3XWcoG5H zF>QUCOx6!4m(R{3Z(j0nGCBqH3j(u!U3tsieto`bgSVix@UmuEq$Ng7p`npi7ubk$ zI2e1TEUwFzyR|)rxaZrRi+MQ2TyU$pv!Q1bAeYs~;!!f^M9P;%Gt0G_mb90U@(6Bx zBg42e3L4vZh2hyM;$?B*OH+|#iQjj=|7G-GU$Ox97Nr}E@vY0wtIS;PUNoGE@Ac<&Sj02~02L!SdKHUG+@vDZ_Yf=DOkR zsSN6>)jUsK(LQEt;PKM;Q$hO+qc)ZOjqy&AoJHYuU>LLOhh9ByttCsIjo5k?wQLm= z;zD5nk$6JX9cNwe+(Q40PR;*CbJgt*`fuXw;vbr)QzT$IudTkj&@@Y`tP!92_b8|ysJ3lZ z#w=MSmm|!P3e*uDf*$7L2lFgkRaYL^+pHV4uck48b<0!ck@vMoinh8L-tFp8Z%Hyo zla6&`o{BeyNp(r2#UhNYeP0(ZGtLmel5{nuF+lB^YWj8P&*fhS#OWYv4$OGEU;>#< zDYubnm*ZhTvjt-==UG4iaDu=;Bo%Nb&N(}9ms)3e*5cBm%HL^T%?y_G$?rK7617HpGEweC=NMy%*}k7j!*ntiM2`K-$Ol`5xbv z4rAK4p>E7}9!y5YW3@JCs(6o&3&uKYQ*FCK(M$Q`N1pldxEb$wb5~QcO=C(IN4RiO9`QrtGA&@oeOROVbffjm zx9Tb8Cga6lQ*BZ_Lyg(EBh{voZ2`&fjc4_7HIR}`-syYxvX@jkPRT=fZSrh{=)#sI zh^(@3`~B=^(&!}owJfwDRJq;n`QXz~T99YC7IrEj0KkBLkR~*Jln3!BSFTnk=Cb@^ z4-%~=@K4E=y3TkIqv_A%(KFfBabvmB$D5m@uN%pFR?^QY$A@KFD^{LwME)^}tCsKX zz$qUczew|C@{%6&N^#vF28dR1f>5kgF^*$Xrn$@I&6$Nmbk5*vbeGCw&(?=Yi zJM}Fa!zwsea&IiOQrKNAg3H@Dfa1~V4)n&{dRrNN0eG?~=+sXW z=YLd|0tuT3DRlt6Z`5w-77A=d?Pq5`OyH#bV9TQuzhVX3U*h=Z%v2l%%RZFe$~8QK z4_~0+xjaWvRE#t7#Uj**dh?*&L|x?@ur_2ay{$WJXfV^PDjpE%tJQNVc%Ky3ckz20 z;R8yBr^_g@v4IS<*BR!WcU--PmxeM0x|Pgst+@f z>ocO92MDaOs*;Rto>aZ*_4L>r6uhNXFRTgVeu9amUwrLFVe83CNLcR;VBwuPpz(8C z(H?)z5E|IUBlo@yOV)4wc=Vkf+ZAJrK>(Ns!_kYBN+3>G9&r~ltp9b{A2mvUW74p)9B)d~7KYB^fJ=a>g zcL+Hl1T{oY(6-3NPBv^`dMJevock{%XoTj(ZNpVG4j~W?u-A)-K(DG<4hnJ~XA^wi zqlPsqpy2`bgGN5{D zBC(&J@qeLo|9>3ejQ&Nj@#7V86&)OMx;L%rh}AXSk1?U*PRx#*A_7E;5$wOh_mJc} zdHN2jTrOR422VhLmctV3m=#?!gr}ASm|IH*)fsfPmKrAIM;7>EGGk&%Fg5u$v}WTL zW!SLFI=U(527+77b)oq~>K+JyDD2^s_O;4Vqf=0KmjqaO3q4}ZjZtsivS$9mc3H%d z@k3i{Cl^asSBJ~K-QN-tbqC%wGBrx+SekQp$GvqD{LLTy^k`P-Y~J$%WnLq$HIVkk zairx#mj5|DrEce<-1hZ2vZ##vJSXM3=|HXWV|#O=jsHXd38-5mw5lWF)ZS#}mA%_r zOwztbGqt-)2?Z5Zoa^PP%}pWvIrVS7h;2X5ni=x$M7x05pyPacH2olCx*dP13G ztPuxmD3>Bi!5AI9!EGxa;f7Bh5cxyx1*%l3XV=%+5maI)zsX}hrp%EkStIlLdam?> z9jzdjI%!tj!cUXDv8*Gcab||0l)N|!RBIK+wsA&@E7Q-e-NB-2plrnd%0LB9vW{#3 zxjDg7ozXd5gzLA2EneA(>H52|W2oU#uLcpYY17`)D3oj30S-7A0Eu)Qc+e9w1h;o^ z%Z6#yx?=5FK3_S|UWx^>^e~_$_;1vGJlFb zk0@ALm_xnkuklGj?QEf0GW%PTPG ziY}zkyDgiy*Q{3LCx`K#KUdF4rL;h}iLKV$SS;=@>aCn`F7!CrR;3dDO2O0*wzv|Q81#9!EMivMNxqUmTP^dl|x zdrMbQbCB=GcO#HCVz7gk<`YzW_Cf&Qs6W?}r$~2SmGM9=2n^sCI?J0&+*r3n^_&-t z!jmQUr;ODa)S)6~&>`JxLQ9!midC2|9~@e)t1-kW^+I7vQAAXGxkMy{yl^2r@qDNo z7!tdszQJTs!vIzLx(-+u>YT)^qniv?Pd3W*y?Jj0deWyDgH6CN(e960E0SDz4ryd~ zff?RrMH;Sq6YcZZ`HJvO`-RoXlBe>`U}FI;wHUk?`@;+q4lq5JK<_%CsH~xCt^TI^ zzV07Irw03$LPea&n{n|6unP5yl*wJVPl!4{AQ+H#B_u?mEuv|>_GqP4otL%>o{D_%M-cUmKX#^(g z;d-UoME7J7$Qqx4r7pWRx4qh!zEA2tv(=rH6XPCg$1Y6q?Ut)EY8~r7FPWu44W7PP z$s4KaSQhtzc$rD|8-2eOITU=s3x!b6l6gONu7LM;#%x7VMtA6*30{ZvbrP>zpbjnE zJVwSWQ6_dE8VuxK<)WedSTe64Ip<}&!Nni?;Wh##+OQhnjHR|w9}VXGc{X&W>|RNY zIXpH^es*jyE$~*9E*7}ErM4aG+S%ES zwNQFnLkZ=$6d6b=((MDs@hEI1#Hg~)oD*g_{+PK~Ij)I;84G;mo}_h@+l?O(0y#>m zb~um-Z9X}I;=zHP*&{RSxnAOt0o6m)0GQz#%Cv#H}>@ZS-Hf#e(tpG zGG^_g%Eq)OENcZwM;h2Susm1$kjiK^PV|2g7*AD~R(?l^9Q zo60V}h{{(MrtN{rY~0r7m)h6h=A5AJF-!TmaGXw@;4D*R*${#jHc4M@?_v;IL^VWV ztnw`6^dn~vPjFnkSkX6!#s>6GwTJr!pB&^=oGEOykDh}Z^^P**OPbb_8TS4mI4v|6 zb38WKA=YExpjtOYv{338ug7N39Vv$vkE$)SrT@S?2YFvHaap?{#w#D-lg&j@g+<&h z%Kx2vcGSwmzK;?ZNe~GM(`DQlcNpsq))Ka2~Q&;i=l=7)@ng$(} z5`6XX@TgTk`|Ad6h`OXarOXTpRSJt-(CamECX(NHS`Ni^Qyjl2zcEits7p~8ySv* z5_Uy%ZVHN2npBZz%qI*3h%T1@SCK8}@-=D^N53`$}g6 zotfq?RdmCN!ZvNPxgmPt@Vq#lz;NxTfWCIN@UCcq_j1zsO{xCI5DQcazjD*XtbMv= zAiC>p%x3l~2T?oPL0R10-rht%guVTUC5&7kMAdD=6vMau=f9YN|KE+7!)ZuGK1EaY z`8)}va@%~{!FMZ0S&+~l7fnkx%OSBm*u6k0J!1Jqt6h@2v<}TJhI=R>zY{e#5wR=(me- zkr`(++8cuX*)_lJk2fFw23{UyvZTGbPxzEe?9IA#pci@j@Z$sV3qY|^i5QESbo@4M zkFH#o8MH*7Aa3ON@C_teY0L1X&b2%HFbkaudFfFFCTEJQCKwh#e^vR|@yVE+&Sdl>{Njbzt=PvHrCWBl5+$gwD6Lx4QxM?EM`UGHs;sXr^3AI)mjoJC|byF~twwbfciMB?c%CkCx-cx_E z(uEJw%@ygwW^Itc^xEPDNyt(z_13>``_8)tO~~3}9R!X;1oh_~B(nuXElWoy)Kd&G z^2%EqE(3rx8XI6BL^-RnDlMm-4zdQmDWgySLOEdsK05`mHLF)pw5erkdC-5>Q_I~9 z(7Y7l!@%C-URf_KQOmQ<{kC>hKl7D3ImCa=RHB#R5h&7EnaqT+%vnY(+?~~i{G~71 z#9G&Esn;%@H!mc}MF}Zp;I&beSzaDf41D^rrBkjB^zg?%0x~Q&YR1+G2|424N2_h` zCp|cUSEY2?DWAONuiBH}pABHVZdlD!C%E#(urncmABJC$$34ZA@_l&`g6F)o?fbg( zR=Nq)H++RK<5WceGsP-Gx!u6n9mvz1&b|vP8N}TouNa9dL=kG<*sdt=eC&&L*25% z2lK_SY{!txEcKf*neKm?hLdF|o4a;d(WI-}X^QJlO&37xJ?qXl=!H=D^knqb0>E<2 zg#<%z=8B{;SRW%ueyyl`9+q8DABi}$>yg?hAMg+$>)BS`HhSbDZv}5CBdJH}iR1L% zNS+UvhVi?1t;=SJYzY`ZdUF^UK@ZB8cbyFKOj)7Jc*Xu|kF3WDr*B0*O=I6}F@lg7 zN(6q-T^IsOo4X}Gq24StbG|f(M-%Wl8c6cpR&Ba*Q2otMcwoSDb~>P>M(t*O>W5Fz z^@zR7U$DK%yOU~1`>#EjE^l)}wkIBWvr-7XFf`H;L|%;P&Yi|7Bi`D1HMSlwj&etV zky@mnC&fU*Ko?3-)Z5@oZN(0mq#pIx4RzSVg~gb>TsqGD6f5?iPy*k1V}y_3Yzau!-DS&#rEhIXrgdXla%FO1q*zp zGNW=>5kYEg7%y$_lRDb&k$bO^*{VnZqpMHThiEb|nN7Sdruj8^T80M@3h+zsJ^rAT z%NPHA0fzHJypT+*F37iDx9?SkBT`YXTKvWG8aPmVlgFH0^ZS*;9cs}g@$FrOxYp*r zj)ZjV&dG9C(4+?^8Q7PG=}B#+$BRX&yK6O6g#4sVi@GvMb#;p0i=n*dvouFIjE%h~ zhnE81QsZU4{OfbSPt+t4We zg>$tDLrQM~>-hPW7b zn3_B6pSqalwBrc+dy~t`Tsd0_upR{y_TH?RLFiFg&Z9B$>29T7c_`Y*QLv3YAam`t zcDLyIGpsYpVui(pf=R1_1W&?FV5PNKj!=(~;puuk9!Ok9axluTCVh8ZEdx~;(@0pN zyC>obtt)>gCKBBqQnDD}ads8tiPfP$d234+dci%ty58}IkmM^u@3Eq&S_9m=UPJ#f zS2}(|!*nSStmE{eJ(;@865gtl&3iH~qNi!h0FG4hDB&L1YgHRYK?u+oa}i}i;seT_ zx^y^NJm4C|a4MI`ENeeA$)KPd^u-u#>2%=9qt)fnx!W&eQ5f1q81PxwV_kV^)NxZ0 z&k#JX3*|}}V_J~ppu!DqD_|$4cs8{>CBQLf)GHeK;~Ol2lQG9n?12|j34h29Foa`c zM!%7i-++{f37&+Cfda{NWsxJd@~lFzpfTbtCe(>9oAf)`#hF0s`NN#c23jW;{p;~f!qAaY!NnMG)%y9pVs6faP$36 zUu}%~nnOyK{k6>8Oxw-#JP0i+FlCu;)NTxHRb|P~jk^*01(ZMqKU{>xeOs zka@02oeGT~?E#kWOjqea$&g{&X7SqkplQ?bftOVXQdCRBNrumg%iVvMb6v>O!qk?KO_t5=FdgHksVvpjdkhb9$RyQSNiThK`DcK~b)xi^QzXt}HXhy{3*#8s8yClTJ zT(xEBHT(uWshGO&&LaHL-*rY%OLZOOkJjZYod@9ru6M)8okmxM@ZzlVd@fGJpLTw z>O$eIxq!7qack6Jun^rlZ*6wy7_qz@D_#3{$xDRQX+KlR%spp;GmRLFsYRyqg5f)` zRt1BNfJF0kSEszlSJNa%)G?Tl?sFIgLDhYqUN1qlba15WdpQ55bSj=vkCBV;7T>3) zD6PFWSI)aXFtqsj_2S_*GbuSZV|clHloH4Z@&H@`@})pJA6!DO6~~%kreN;Hk{ccG zTD?*^>wo99e;vBrml1ZA{d$tVZGW1_+?@aT$M5P}#7XRV!qsIrW#{c+#`~8Pcqx~`Iuk26ovSK?XmBq+$cGF6n>`~(JS%0wEAD5_0m;O)P zzW*`a{2fyW^V43>b7SoBsgGq-uk+30FszQgMttz-tu*8lRQ^%e`km_k2GLmbL?lD> z$J_GHs^X8ku>T0dBFF8D`ghn3Z(Xb_0e@HG|3*9izd@W=fBKJD85J$qlRlKA}Wc`{>S9%xe}wV@{haV|IOa%Tq)W-;VSv}Ex&i~RR1G?l@s9p zn=fPENf0#wCHuH}809YiX#L+rt>_hTvat9~U*To?n~jdFTIp%UtbayqmBqgAE`qq1 zMTTxXN00sv04G4W+2v^uy6X#c!ms|zjI%UrQE6?<*#9Jlv+o_PS$ zYVhDh3vcWZ(jJ?ilJ5IBln_zJciZ^YFXY_IOn;v+P27-{%gL=t2oYW=>ckGdvx%Qn zJGeXgYnd{v^&6;I?CUE20RzTL`fg=Vp5r;TKh*~VBAtxhnxoiG18Si=(NZlyuLS3eL6{>QlbVWE3hROwwqeT` zU~a=ZrB#I#e#!v)&X%2B>43#jum?IF&gnH?8O|D09bq`oa>ciWd{@~ZuM=i9T5J-j zpQ<5IJ21!cvBh(}kSq8Cifdk@j5((?d(`_gh$^uNX_%T9i{AFW&kc*qF! z-Zi&hParkp!QsuyK^CtvVmO8esFB=J=Ji^Hx~FL6S}D!z+$L9-q9L?XVftz$gPDLF zJyjlKON%+0R>^u!8y~Tj^OiSae|;LB$SBii>Mq7q9%05E0k@dC0S*xv=w3cEM2b^j zWq-Y%p-mcdv0}bc7Xl_yOxBo)-01O&K}-yx;^vZXced?|t~nvrhITQ7;>Ay=S7qkh zzM_FFp(zbf%mb5Lg@L!Tybo|BDCVnko66Xr=RG>9Nus*m9&K)lFOSd9xDPg06kA)! zBca}tD!kl678WlP0Ftr8|H0 ziJJEkbl~C~sl1gTLA0BmlY%9)y*55j57;rNuK44uz54KMy6hKh6sqnN&)Q|J?`6{w z!^v)SJ^dLCfg+u(95-I;?(Ivn#{`a4DO0h)5eg?@a%88By!FKy4h&cOm96zF%>EDb zx53uQhQ$e`_WB#%fS0GWYbAPQQ44@DSoN?69=OP7Go_ngO@<2%Wxtmp|CQC>dGYCl z@7-iJL1kkb!%+e`7J58Bd^GI~8I_#a;4$QX?&&#o&WNnuYmB}#KGJ*IZ+R~1{1=5w z_oQjM@_x+zQQrHnL8FA|*P#1QTdP|sF2wlak8%aa!6y(~XX?MuK7`cjbMXX$9gt>ZTWA z$Xpx36p{h#ZpxVYNb43$*Y(*Zjf}{Get3nN8( zo(uou&BhS_&~~5ya=I6hU><64Zk$uUc=T!KYYtAr`J;?gqICFW#%Hvl7!{$hXuBcE z`QtdKsX`^br5D|`Hzhbldc@&O;Qj%Fz;vuD)lVOqYhK*W&@(hklOZ`K-`O!U?E}>l zC5)r$f1;~zB90`aak!}ZR^*aMuMK2gGDgWf1EI-!2ae26?u;&pcoqIOg zH+$~OP>=a#B{3^Mz+k1AEqc!Swrj`ES1)EP=Y#2GGw`QjWomxAlyE6oP*l3L zwewdJ#3CQv#S+&<(!MR&SZ_UyQKtn65&rq|Io^=rDN_VtWZ!gSNoVF&KE#sWZ&&36Y6YzdY0?1Kmpe8)=#S_m z9tfyvD~qRw&;|0uTIIgaK76c*ffb6%Q6i~hd{Zu&aBd#hyYpxe-Q}%p z?GeP3F-7;)OYes(t(R*gsQ2N{MM5x-5qDv8ZX153H#*q`qa0i8IUDlTFAp$!9+~ ze^qG!D*)0IKz&Jzi^iqs;mH=8o=u@Xvvj6)ZH{+h{wcQ zKhF5wMw?Zp3#@Z+L0#D1Z$Al3rx&F*a;BGz)SYG$F;}$-nJ^h(vPWs*INFc)@S~Uf z5O}CZ5Y{yF$c60kD_rAAzL?04YJV20qrhwC`M zeQ;G4-6AsJT7E03Qc1JO$FctZF!#>EwM37%XPn&R#^Wv&bKEU}lfN2ysbD&bkEAKOR7XtaWKvpYCw1*x3Y9+RmE%=IJ&R>e`YDpGw zpfwb-%i21YEpfXHiBq>JrHASQdK9}RSaXYvud4YB^36@WWLP#q1=k}aqir{51I_Uo zX$sGutw;>ES(R}|&h-rJ^NYD;81_)1{$mI^l4Zr3dk4a!QqR*cmWr3cVX>tZsb!g! zW>2QJ8H$@_b8|o(JA$Qnh69>>eQ(_Plp*pjfmqbsxD z_SpT9m+DgOBmL+Ka!XU74i6~Xm~61bLZ#bJJ4v{~hZA9yl9m=h9DN84SpkH6{5NP=uz-Wg>y&GhOGgJWd>~~tfWN6*b)Lhbz(>e3 z1u&K6=LhG#YA>jcIo>j??sv6L3JD1hM067|9YkKHnCF=2CjtC~+--S7@Q|J19YIK# zk->!Vz-YfFdpc#s#N;|SXvQO&2t16@PtZ{h!~Fla3;h4$!4dL7UdO@nQAXLsN5T7n zQEnj>6;(%CDsxVNNbrNeV*o+yLa>eg+oc!W*cf*$4k0z5PZ2isA4T9F#r9hoCl_B% z%DXFwpd8w#gGT$$|F3%T{=cD&BB1|+1!X#lCIxXfJmqjDobfUJjAnx4b~~Mb=9{!E zjz)YC{n@?600?8kL~_8S7k_R4hK%A=8E(WPjd)ouL!j*k+?d*{f0Ptahm-->o^$nD z;S46F*&vTm9K0K1`-{ZqkKS6v#czf|(PM+C;GyI7n}!#dTqz+Nrx;OP+vaUC4T<9a zCa@Fh4iqQ8BBr*pttlFq8zf?a8$&=2aj=8nHNFZ~w|gzE;E@=bz<<2VH+nwy;bvFRB5Lwkxcvs>#zeJm-00AC<#jn6Jgol;`IawfH&{xBsf_ zp0wXpRa=vXI&1h2E|T_(h8AO(ZSh6+9gu1Q zx{;w|ep8Y4rXT>jipmeJPhz`O^&6B1f(KyGfx)-9zTPJgj9gS}8iPFqZaMyr$8N8o zwmXR0{?$9+UOQ4pdAGnr2T7cSW4t+>93(gl$(3g}^PGI;v?`(qlE06XwYzkLr|g;V6&YDZ*z*FQ%KL6jRE^VeqFfgWZ`5*(Vr>-Ju)4xI`D(GYRu)8d60*rkpF5!Y zDOsi=d9h{aP+fo%)KiQ=N8ndDazU=8V;yn(?~tN%DYjSSn{uOa;)2k}pN36^=L=iE z*q-v@H;HRb7}-Gp{{MY&`~MZY{%1{`#qV9~c4<#1IF=%Y*`K3)l<>D7_zk!}a$RCe z^TWgEjT_f185i2>Ml3WZNgo zv8J7CM=2R*JR94T$mb|;0hH#~49Um-deM9Bsj=&`qxThf39vPC1_Ov*a+gEWRw+Ei z@Li$X5?MKfL%E^IT?Gc^V6q?vYqUbd6Y+)HT*iY=Fi|pp1>&&3s5MctqtZ4LMln%p z^?{CKqB670x;QQ0l54a=x%ltK#{tJ>?n}@_$*$3=ZW#~CwFn}2QM~W>mI}Y9A zs$NUL8O3r6;+|7-^#x_-M3r3@nZxD3m(nh?9cBq=qBylB)@ZOY%f;UsFo(;?in^3{ zm<5i@`HK>M)}SGcZHye99E|m?p?~LW4J@GP@#ygWGv(r<6|}W+GPZGY#AEnfr$8&{ zU~4B}>!wLZLx=aDfrXyocg)KEJJzO^Ha0TX|GzDj(|7o-2#=ng?)R&|RVf%d+B!QJ z8aw{(MdWuczY`@Ty5Dl9|E*j}iT-zik?lVl^Zb5j6>OdKos9A5Xce6toDH4+xB49M z=xLSo4IF6|X_egVjA`ZcO^tbY{*Q+I=b-=hhKQJ3IT<_9idg;DA!KZ5Yh+9-Wo%>W zWcJ$zHdY><|NR$$6bsK%U9-UyMe$xyU7P?g(o?vMj?_o1Blg^#gfJYGg8P>fO42FB zP^e>2e(-uzn&K%-y_J;IwW{Q*x}-hL{<64nHFP9;cfNEqwG?Vu4_B+(+uehJn!0f% zKxE+QNv}DH8mVOUBJd*@+Y>(J)riy>{J#FFQEZS*bv&VEbrCs}2)m%pAUk;I!=V{D zwsL00J~LF59w>5gBQpg@%(>1|ew;La%RoaMT(CNlI`DlYojc~r;g z{v(ui(X8>q+P_)!aHy5WUM&ULtuUl{h;>uCu!!{C8DWP{!ZE7_zAkH8Qnjxr*^A-h z?8X(yq&uT3$s7FWPF@sDF?Zii-j>kYxl(^Ygj2#87(p0Jb>9@0G#=sUpBo%iG7d;YeuDNzqJQ zcx*&|7uuI)1fwo;=2}iJSMc*=W534WZWHdaFJaq)b04*QaWfg4(yCfov0iZ?*_Y|v zfbDGs@y@ZDQCUA5$qpg=H@!spE?Z-Yguq8X!XU>846MB} z_x;YkB1Q*&O%fpxOvBR_N6jLGxRje0p5_Pcw$Z8@sTHon#$CT&o+bHJd?Y_k8rhag z4yUYVvn=OhkXAs$ZUkMeTO$?Co=xnt>Cuhf2!3UdZY|ks9JsJLCHe~*E(Wmj#2Fkc z?T}PxXhbdRjp~`f5CvAIyI^WOjJWAL1=z;jlLt9V`6%7mNmO!R+lcuv0F9Vx_uBeb z%B+h-S>LVl<%QCHSwbS0t3%#M*~;BebpmwXZcE^=$`Mx+u3box-5?RmKVPFlUlkE8 zd?<)xBr&q^6T@I)h+2LnmiC z8;)+xw7|$#Pwtb3(QQ!zg*`E_awcKAUcsA6f$-7P>U&ihO!Gc4Mq_?8G2GLo1go55 zYwc3}rBo{i`(ygUiKa~FcME$K=zThxS^_d{)nOn7HXZd|nxIKTXSNN7BdwyP6@U}+ zj~}k=!X``X+_^$Zam+AzMB0+zlM6o_$j#m4u?stzS$-XMNPhWPc{-D1IU(Kd+<~q& zPgJ1}V)qa2M|bEkQx|D5KTtmfP5276iXPx42uKqGG42`OjBb33;#&G^$1|suQph{? zWv&c)J-YDOrx39mA}>fL5Rz39+#-uAlhL;+9Mn}oqthwe$Z`k-osa{TTgjrO>nq?I z?Z^+is-7fEIdXGrGi)31G+!Ce4wiZ#fab7*tLQ(cHf>J`PIQ7MdW|<`tyCoL+<(Cj zCNpw}fpb=u$V=@)M*MsQhwTLi<%6kzm@On1_EpU~)jy3TFbR!j{@Di^BQ`#um}jzF zU9Qe#@mhU}1dzn%=EcQ_R}rXXkvoj)YwM8oTGB*S5Nd*7Y&^-k!2!z9IlNI>ve|{8ph%K?RvPHxVUu(r(1FU^cysk zpb7NhM1hgIDEGcZ)%Y|U-cJAu;X8r@W)4XazHZ`1v#Qe zeiIq4xthC$+%;?^CG6F5mdxbJ6|h6~9j{ zBqhxY;I(Bh&p#iRb$md`)sOoK;g}ED4-9@&g3E!`U*m9X^!PkfGZavWVQB(TB*;iI z27@K7We)hTYh=z#GEGgo<2LoAJo|4Qz4FA3dKlmO@DxAb5Rkk%X(YWyFk_Oj*x88x zOA`nQrXJx;)A4XU(qD8a;E&v=;Fp?(<6ns`(kej20rqKI3oU@+PO&}5)$qC{G+t!a z8DQ)QvOnC!SD1WRtIhU)GPy!laDGW1c<86tkZVn3YD?GX7v5J^*_`xooQW(Xcy)CH zvg$WJ#dG(B1ov+GBC8BstDJ7<#UIPwXv7@q?&j6aZ#E4tVjRurrV#Fbu zQ?3p6E&(3?MP%i59Vm@E?VS5@O{RC~l0$ zKWuh@qndslavX*vi?+`JIuXRVDM*nxnLD5y@$W|Bn~$Cj?0dS&xiP}RwF~MtKZ&Vz zwfTJK(#K{_nF}E3naqCDolXW$Z9$~t79C*%NS?7*=_{n8EOJFPFEknR-wHm*-ZZPR ziy@oQhxjIT`O{|X2iu+K{r!}!`42djDM^+R9st}1aX=2RHA7+@V`j=*Wyk%?{zk)J zq3QhGptE7iGWwIG!Aj?_d`WVt;mQ{E#-?WQzk8sFk6fwU(YY|)uqHsL@9s{U3%7uM zBAok}G$UMUwn|qM@NFpUDIBAHAyu6%uEzXxq|@c!-JDyte(W(PiCD|wp&#oKU&-|l zjr%I56zSffaYv^I9#AQM%1)4}?j4JjTr7vpp5$`4&e8^}SHkuLX;Za)KKSaiNwY`5 zU*njO9B)Egn1SrJ;qv(o%6}_D4bI86w6K}BNvO}3NRYM*(P^s(I`}pbgN<`O9$y2b z`xDe{g}KKPZ=gq9*(V%B(o-5Y+C5MhW|IAPIH?xhi=LhE{@c66zr%3T^W5gg^eq}2 z8;Pd@ZCDc~K;S+84;*)i|AL@j8@3FgsRd>?UQ(J?x#PH0wtqP&V{@I<6a$^I|4>kQ zqS}1yrqP=+tVV(k7M9pcnu(@q7yg}Q^ddkZ7@L*d(YTh!hOph4kYgvWTZ`!FXGR z#$AEKC@Vc$=j{}L>`SWj%dpVDLDLTWs!W=oCY_dsyRFzP*lAacXE$moMV-S#$LDx@C7#>*!Z$T7SrZ-_kA=`kGVPl`#M27aE3!eCG@>31x@a|fZ zi2g}c3Q6R%R!$8Iv*0=Jf4C!lU4~eG2Is!c7-y$C0jF!J=hbVQ6Tt%-g&<$iI62arVTk2h(jEg>&YVck!FzbU z{Z1lCtM*F+MOPy?22o2`TIyAm{MA0=kqK@_Qj1%1zyp}O`a{uV z{%WUdm67RKheNrGsCo0Jh9;coGVmnQm4v2!X@+Bf;Bt5 zFF>sEGWV$y<4C8?0`v-F5iYTBf&yBUg(ZivA%l|WKRyb_KJVdOsv2=lpZ!ttNnWwJ~ZUg*E(cv;ll0`fum z2OU_R%&I)sENll<_QRmn6vKE)$d19-VV7`%*FO*u9%!TyMN3an_(-fhq;aoV7{BRy z4*^}&vbtk`)Uqwo5j0Gt;hG}BQa=^iP~jeri$(Zt z`mZndyOB{*q3vYb_dtta|tPah@W-m|4{|-MiIKZC%l50%yDRl4p>wBGZ5eT9V;fs0$C|clo=|j zFmvCv6>mLDF>_Ooh1Cuj;MFkV480WUaP7fEVBKI`M;6uR~o74mG#{d`mdGYUawZk3khZ|4!2J6k7 zIAkT`hv(UOkjZ8y>orR8`2>0|&jBNY(-OebqVJdAB{)^#RZ2e3w!_kL#O4<`R6l3V zuLOnDCw&d8KtHSpC|m1c*?z~tncxS()skj0u-_a{ZrdRQxGPunU3-JbPJ&zE5H#|P zfEI0qeC!!ZBVv}M-F6@Q#^41@9yj@AEkT*DVK_Qs${u=5+C=$ugwPxr;}5aSHFgiq zY0_-_cc`d$ZTRBdjh*zI-|YqNdo~QZd3mRW^qabZ@O%FWu_2^WO=6Dext|_G?1=y= z4zLGC-YB~_Cec0q^`Wi|2^22qR(4X;%^{tgOSVH%9m(H#x6*8Q-BC~gMgECd)YWqH zJ=0fWpdO$Uv5B5os8!MoHIbK?FN7QYmbP;k+CX&ICvsJWikS>vD06(i06xn3bY+R+ zjYYn)ggcZKkI>uHM6Wypd7ag-#a-XxH)z}%OzsuIKSAKF2Q1+p`QYGb$D^6+Cf4)y z`nKO=6oAg7*%WP7hmmJi@r;SkNc#=Arv|c2_uB5vy(UIReyN9_^TwEWoJn`_YjPA+ z+muc?+8QhL0!B>t!(MDff<$P2zVCzke3zjJ& zu;1jSG!;t62GiIiH^usF6vpL@o?b3iS{-i|+wHCnt{*pjl;f+7MyQv|a|%Y4dD~C) z;thR)+;4`&y4Y?d`Wc|<>GoAd(?yPtT8Dg<8m?B-;?6I8t}ZCp-jGmlH!&!kkB{|6 zQzsT1oEpykqLU6;UTy;-g{v9$XfM`%L^znz0B8(C#2K4B{)n8ZTQU-zkiTsM0DxaP zSNsGC>(vKf%$zCA0CO(K9Q7#~*%`J=1yo(+EyJWxV%SsF0)_jZ~# z9pR8e##z!~(aM{PU9L`#D51vXJElrXNlru?Zxv`fhm~ndhb+dFX95#xlM`RpeAJ-X zs}rMa@lkOAj9%jyzu~E98pY>tyAEgb3Bjj200&T&`c&^bE zLto)a8+-bMjxm9So|jj5*@j~KR3PBEV2<_p&8zHD79Ah}p@{#2E|kE+2l|=r=jYJKaK`B53JhK0T1tA@eewt%`V}T7(Hr=&mXNVVv`v{wn*U2dDwYJv&Gayo&r| z#^*VqE|t2=6wsKz@IQy~2qF-m!ax`QqBTv}?Cog|pc8Z=73$1HEcq@FR{;xio zJzYFZ2P$|~t8k;!fey72SR>>p-|Gug$q$|q`=;egF7)Q^x4YB51Q!U;A*W)^rQ1E6 zXZ{J<__{_ZhiXMEJ#yILs`<~8eja4TndmU=7|yFhn7`&tcyc_&a4DE^(P+P3tTg3U z)kfP!9=%;BMmGI0o>w;+C@4EVE<;cguUv=!3`tm+QPl#nKr*=J!{i`vU;tGsLC1oE z`H{@4K_iPc2#xDxSfOQ`XVrF}NyKKYW>TK=sD}N*oVJBPIFg4ZAw^+C$uYGt3ohoC zfsPAgi>yzCID%#f<$65DbK4OFXvvlRjA3HtKNy2o3Kp+qMz5cz)GDvQRksGII0ge) z!&|Hl5eSEcLV4Ey2r?mT!@kQoik0xq!VABjAU_BoX$-qX=$?A~S1o0qx|8m3`sZ*} zOjiOm7$R5bf1QQQeNC+ed*!F3-2DMcu=E@LEE^)wm~o_CWMf?`i=o8TchvBZOE?Gq z_ToD*Oq@s1Mf~#YG@BNxoB=L2si8_4iPPf-!Ajmo>c1{n1yVJck| z#KyMZu(e*?cLbi;EG=}mvaNgB;O7b)*(&o090OUQ4AzB&owwD0c6t`-mP1RC?yOf! zVO9!ezrA)py9kXKOnji}c}6c{kTg2>uLntsO0<>KXn240$>uj+_Sn0H*}o&@C04rV zoqhuh?svm96iya6irzPqyVaysiBq?r0p`#cg2sxdxa67^x+4DZ?^zXMDZ=ga4+u8- z-Sshvo`qKe6V0#xDrAoF8;gssY0jWJ?;1v9m=7eF52%<9!suko2tAX9n<3|ZDC6Xy zu@MRH&MJ$xTAPh+E$2<23BDCsG}nww8{5A;n;SiiNfB|U%Rg)#<365RgdXa~eaET# zI+cahp6(aHi)=NO$<9dWa?qsd4NQfK(E3<@B{`I|s0(ijJM5{Prj)JL^d4tRUL9N> zXX+{-I0~)2rS7H^uDEP6(*4e+JWDS`*!DuN(-NEY!nfaEcMA3Mm*NOkS0asBVFZ` zC5`uPj}Ppkz9L`n{j2=|>9AZ}OAIr?3^^qVUhei>2^6iSluA8Rxv1jFsDM+k!VKiq zrZlSXTVE1@S8+aWcq|mSWdh)8_$-{9lVDqj(JCEO)e^3~xVs_a(ejm1D)L-~4z&`G zG-9LOoz5f<-+Vh$vQ(KlX}zp7)-;l~6GyNkahg7k6A5@Y<~2}xVVk-D3&8$ka?OL2 z+(UM625(iGoWlXC6T`E~nl)Yoa5!yF%svFEnuc}u0tg7&`8E-xA1`h{95+lTr#qa3a)`gG!;>C|81foJv+DcokdLWX`?Psb7>EY*6C-;;wvTN4o z(!%?)vz@8)`B(R6!fIXVDrWeKs0Me%ybjmYpxo>|xrb)%s!3`y<$F-WicbN^{v@TR16ezg&3)}GvM z;ZV<*d40byx5!kpvv<|csnl=|^S2F+u9iJ(TZ}NqS|$U@*b0%l=jTKU8iRN1ezjTE z0Rz}d72dACi*nDd05;&CrXP-ob){Gxcz#eHuO{DWW$!SzKoK27y-oWl3;sJ=s}z$7 zqU7MId4oUd6^#AM1D#`9apLcz2|KGoYS!~bK|*9WsSxUr;dM0j2OsGEgS&icgSJ85 zFYw{$C5Q$;^lnq#_d*}|h$)u(P7;GVr1@xE=56=cgw|=f96td@~pY@X& zHBwn!Y_zyzRVAvy_RkryBULeKPf&NUZwBd9)(PvV$`A1Cm?i9ncxAR;*Y2#1^eU=% zcFypYcgrDO^UgeGVrv{w{m1=vWK@K2SzchEmGz*hV|3bkuRj6jFOuL{E$t*I&C}hR z7)J+-av~OHAYGuB%cjW_&~3hdt{Y?H9xL{2$}H?b_Yci4zk6@byV6lG?m8`*^M5#W zja0r*f#wq((MQ>jvx7ys^u$JJb&c&(RUJHIXB zfr>23pL-k*qY#UJ*g9j0)(J}9VV2-;W9Mq30aiV2FjfhnP)cx3UN<-de^NK=cqYY} z{1dGYkOKgVM-~xe7$Sj_n-Jv*T(q625p7~YH0pB?DAt=h>PT!s7z39Hd((KD5069W zUo11d{3-1-3bPdYVQZy5E#SE?gsy*@Fng7&xNAlsCC5MfswX7~iMUJGLNa}q=$0%x zN=2nVmCAkd{EXF0L3mqaSajqm$W2TF(8;r62jkq-*8ll9!ZVZrK4`>6>91Fl|E03x zI5hivj+#WUlSN05YTpJecp1$mkBC!oo^;ne`|5HDZKdKogBN+8(jp*zUYBG^F-FM3 zejv{r7dFC@*84c`9GADb4MP(ElaE(+>_32U<{D-@t8Qq{4>};B`}Q>)BebN zWc(Q7x)A+p+O}fPdf$u3uBLe<2~u^^sAhuAL9r%Q*{TF(oV(SIsF;z3Qzq$#Cv!|h-WJljo?nATdg4vbX$p-iBP&~^Hj4CQl zgvDFGD!pJKQO+i5p~+~zJ_++DhVWdRa-e}|qn2zdv&_Y4b8`Rk+;SzT3UnEHJRULH zj;DIvzy&d1(p;2r@fgdqIh!p1VqwOB6#8xg(5l|06oORYJkyuy<1XNrrBzaIFfq}>Lu8ggtBTG&VV5&CJSca~F z&j?;*E726MPkBB<(k?T&pE;FkZLe6PEBnByjDv@yhV3Rz6|KZdheyAlOc)dQ@yjo}Y$kdm zG~nYs(8c$Ia`Enh!6POGih-Ik@0MFf1Q3d;O;P`Rgrw~DG#WFj1)h)mzQhP_x*hZ- z9IO7HRZq`ZXXlUDNAB4rlad{i<0`t0=IH)K9^KSdK{b^P!tSa zDyM_^T-p`d<*iY*^(E>NXWMGDDn`i^(@2sLb?}&94O8zX2V=B8fVU1vFmC=XLCvR# z#t!0DpaqL$9k5#?!3l(Wrm$876G#O>Fha)Cxaifk%j8*}Gv9~940q2GOGEbl`S^#n zo8=pjQO(JL@iXiXWBIc~=JPR5>%$&E_4I0ZLbt2`G}`L&DM=sssN=c&wIp9x;C3)1 z^h4CEX09tzfA3M+p3I_#!lkCS2toB;t2G@jArjV>DY1i01bJQUdM%{+(I^^0N_4dqEHUaJ52P}bs9lT1oczoF<>*-}>%Sfj2Nk${ zeO&anuUybipXE#?D;wwHhKXq9Odpu+OG!tJ8<^^MQ%tmbJtZ0iFlHd#8`Qykio>;R zKT!=Wdc}<5L01byP#2Sb-vJDbu&7OtY6X;hKD`0?<>unT%?HcsGWJ+krMjZj{a%X? zDU8Nuw)jHHX)GD&wo>+|rBtJ`t}SKz|B8yUp4=stqGpXoF_9*&r&M3?2-DP)Z^ex| zUN%MvP|AX-;Z?WW{$q2!IZv4178eI z)teo2YW4jAA{A32Orz(JNlz()LUkajrIeLDX@TZ9jYHRN%!9>gyM_oBPTxvItp7J~ zQ$llg-y$-^tJglwnQq~1F<*!4Lz2j3XNU9YPrV|JwSi29;Ui*aYTgbnwfK(ooizJp zxW5ta|A7c(?tVcpD!C~F3PI&pPS)eb)|7$h(_NfR^qnWyq)WuouGF#$QTveq<9B<07-PzOzT&M`JTE-A=s zY=X|#Z?hiXo#6ABJMv287Di1R&sUOxJ2AfIdF12{I|QPHci`$z3u#U;)_m69_p=H9 zy89&XlM2O?isUSK5iTFi0(0h2Rc{2&fyE!icwAqv0PWOlKzWeik&r$}HwtU5TCI9q zFNOwSX^Bf$UCb+L;}Nj>@Y=GoA6}z<@Mp%8tk}g0XY-n$etK8#BHh4${0;^{CJSy7 zHVPnAu`jqM8bqEc_^lF$*w_fI*1C?WG7cB8Zzhi^|IkOqf>;zUarwJ_q}B zkO>1|oK&{VVu4+`cN_1y3^TF5tR(LZARL=5#WBD=={NQZp6GIpj;sNY3Z<}(ez9-n zR&*67;Z>_cBfs{rZjeJV!DG+1z=HcgWFHSH2Q6Eqd1E{YUbN#qO$VBCT;m;~d0@K< zGI$~1!KLSqaADeI!h!|Vzk6jHX`nJ8F*vg-0 zgl^sgn(}L1xj9e=e+<2<6M)zvEe)1DpVZtocZE!|PUFdo#4zB5kfQN*&hYy>@p}q^ z<16KcJNA#0tHah|qF2J}qj=?Z;*+)h=vr%6^@}}U;18w*mEjHv87YbQUCV!bl*jGw zTh2dS}a?BVRV;WM=6;JIYtGi_Jz@Il?+imCY&&*JkUv+ zI17k~8>7g8JF$z*sStS_;PYb8d-wr$hs<9t?M%{=bg}2w$gLm;%o90BN()Yi2hQWT zpsA@|DEfn_90kW-V6fJjy3b3$>8A|o@ODFRJuVpS{NbR^4*}Y~_51rFEO$E}RbBr2 zJfPBSmMMLUv_yRninU%4gm%z)d(|H+Qy5#L=fk-i&BEV;i(PT4GF?)AyYms9f8~xT z!5_oA$Pri|9=RzB|Cm%TQ)+0qUGam0%1;UN8kjz72T_`I+ynR_!~(D>RC+958Y3={ zte5v|Bd=pr3<{0!5Wlq-&k7Vt|D|VfkrwTy#1HSx-A{k{31`k=lS6ksjS^*4eSaYI zQ9w?EsHi2h;d`wQtR>uz7t>?pow#UapQs{!bwieDVyi%oL}#SIEVbx`ywoQ#-aq{# z_=-J#`Uf=rC?)(5W-d?#Y}9q;7GJ<{kp*M{Znb*JcBe;%EuGF9Ih?C?To5+gqjzNP zb+)lC2&f(TI+ockAOSvnZ2r2-w(l%B`|5oT{<2=BoVS3Mf!Ea5 z>#re!`=oBA-D0!dG(AdV7&gsUQ6%x;OIXAax91~VD2}qHjI%f+O|F}k;HsYWh=5<{ z+$JYai4T|()i`xzg=$JWk$Ru<$au7Z@vPYb|J#j-Lz1X62?N4%_Zi5L{QBP=;31t= zlg6PFKEljmMN~i>$}7oi6$F4?2z0zm&|w7@e`ax4xTx;6!%#<9_oGa*-c1FpzaW-d z!N|#x5di`h;78hYbI(~<-g($wXbZrVj#AkbgcOkqxZ*c9s0h+cXLICp)2i-Ob1Ob^ zyTo*RJv;VdUh*$^ws;T4M0xt5vqc8ek)(@K{aUl`+H9}v05+xYsu(@g4EqwsZTIKz z0^J_ol|J8ZPftUglGUz0Z%0$b>Y6l+#rB7dph@#u^!c=e{F}n-RRz;nTUvE%jEdde z--_ttRV6CVYIU2PL!_;*L)0)f@i3o8)XT9mr}nGYm)LvH9vqn`lUKG*Fr|)vEXg)& zL=C{%57>&uE7qe)m&0U94J7W={z0xN?b?91-~!y085udrZ4v{d=eSn)b$Dk!Lj5y; zAk2bpx7D;rnA)`lHTwwgipc1R%LBBPlcc(6Lp0|}YZH@5Tg7A2<5TSH3mx66gEDTsl=4uw@BXXFf1F5?Heaka6s8=+|8?iJDa`-rKTwCHPnp zSq&pGK)aIx8vWypUq~z9t{=M^WObbq|Hp$F zHW#B^oyf!7p8sJoxo2(CU`1oftV8ZSxQYePN6(e^vd|;AMJruta*EAFwnBHRXFSG! zxdqngTCnL`{-)JX)5PQSm{kLeX!~xM^%I^moq3^)BEf^EJtuN-%F!{==jwY~Dl)nK z(Z~E))Ou&B*m+6s;Hn(o;a~$B+s%}~RyyreH5)Zry)7SF)$0k|QJa|7J+60^Psk?8 zT%TwyBdL9hSR4#AOpg0gq}{#pdr#sp>tNj8<eFeJm%0dMa#+cCRbA7Y!~wMb*AKZhazsa zu@`19SYV+^x^(6NUOgNhKadp&2dPv1^judFR=2An;3-GZ5tIR(6iDTjA%ROy)+nF+ zsqojZ)Q076f+f0gHAA$_M70k+XSQ0gyUF*t+2ONWq5TAQgRXjVyI?cBlS7J`m_LUq z5w`p4gI8svM*5=POPEKCi=;X7kNn2NWV_v_i#LZLrxD9yJg2)(yC+OLutVi}##e`o z5dagWSTwngH(H*V`=rNka|zw#18=9wq=W0sL(LTG<$8A|N68)xht&eVN?B*#Yn8xN zPQh|m76r-BVjdb=PK%`JYczItI$E_JrwZ{O}p_Wa6w%-hIbr<|YPK z7D3_bHr!nEW~=y(caP=wlTK<&CYKd(EJ#E=u3uR@;h3|@QYcHW&8oMAd8rf@BuZNv z4o?1q`_TwgW9mvr$bBjZKr}Y+DOYRs)fdiDUx+&$gI*18uJSQ~BNHcp{9NXPg#`s! zsbQ{68nmh`lb8>a_HSNF7Bt>SDJ$CXvAR?(1c7WJER*1~mc?Gvxw=Xe!6(8T)6%cG zBBm7ffU2k)nsmsF69U3%hvnOdUQNEQp0exk0jv_>3Y7XdXL{(DpWATkw~dCFZ&xwq zw1FkgX{hJ^<3m}0gaM@R6~zx8YLW);3<|@|+r+(&1x7V0|1mCG^cU*9I0I+!1Was* zdm8QqE+^Nl5&8XTfG~gI+k(4x(!!7x4j$P^=*|%cEY>G;@*rnJ9;_szk85lOv|@hk zqq+-@W5$_qSYppn?a2aHjt;%WqKj8_^7YdFk}n7vK>37b;s1beF#i_}_-}-R`?}sMRMslwA2zF8WTC22gmajaHEyPPvU)Sm zsuWIgO&^B8pI;i^=0E?!HoD831iN1@PO-k+gFlS-$RDekYGnUx-CS+`6m$GItE{g) zk5D~iE^0nBtDJ1OoTQ{bv3B*IXx^CqX#6;(a5h$t9Upg?Upl&))M);ET#i^?l(gx9 z)SzxVU)UMPrY$U}GM5G(4|kQ+m3p)FW+<;oWWzRcF`96D|owFUZk#LA0LtaG}6bQxJY`9;d6x6eD($NA&~do0)`=0 zY9~1@rO6`kDjo zC#;rt%Nm`jB7J9iqJ`!pZXs|ie&1Gd+Zy{P6micu`K(MTXTo{ynNsn# z4{5=QnG)@AMSH&aXlJxbrcU+Br$%jzt}wA)rnP$B{#faqB!h_n+KW}D zORT-RtLSx>yfxM%^yS2J8c(OE&7`7*PMhkfcs`B-chS0H2fwmDgi_zv9go*^P{&6S z+sD4bdIP0cIn01fqf$6P4fq42Q2jo90|4w5B^#!-i*{L;F?08l87j?Nw+DEtMe{~6 zUcK&@7c#wyVpucTSfRrM?s%0g=n4nSpoc(Hfr{24&vOi}(+&uXuzy+vcuThvS*$$^ z<8uQR?=&q(^#{+rMQsTN@2Ma2BUxRalz%jB1lr3oa+@009jp289NDhPlkMkEJ~)+2 z7!QNXf}#Pn-}S7@s*Be-S3p3EpV1BZngM~LSgqXRn8^)DItPsCD4xvp0()PsERx-j zp4-jO3zD4lt##ud*E(rQOO%pMxK=zgA@L8WeGLJeV+pNv2|5Rlx)Z@_9ix5&|9TlT z7S0`fi$OOhNfiYQk(^Of3uy(+XT7V6H=pTh&#n<=$es(z3KhO&zL5sxLo{E+dx)!^ zs0)|fDzLKr(=Nid_`bp|3IPNRUAZ;15g0w&By7~&*86?DVqS<)X7w> zU@VZL{q{|uBOf5oNJs!iSjKR?e8O{oHZxkdzUEWk&-N6?k0HgT@l0*U5qMzTc<~%< z?^gC@Faas>&%Hf{;&QoNNuSXU`de${&gLp_O&JfjdBf}3O~e6sMq9;&RG?U==0 zr}XNIGH>hvlF%m~wr~i8kL;m393AumWY^2|xpbqL$zHFq`Blsz4c8gbeY%`foyBmOX zh|NolTS{t-;yFe&zc*}|MfXV!WjZ_v&oMgsY&fSx{3qbhV0!6 ztyRDW-;!=Nj#j3vr!>3-dh?(OhD>{of9BvNfq&@JS+aieQ67~H2$X+7)PEJ}jIY_y z>B=Zy0BBmj4$WR#HIaYbMW0|}SY`-1GlR0QN|d zVW3G79t7P9=GR)fF7P`>!5sPaMDKX#Pq%nppT!WQmfuqbaI?qR$Qm5hgxGfd@|K3- zqaoEv8+G}qm%Q2kn)9^*%Q%4*ZR#hapn7Fl1cMmkU388h%AEL}-4439;q!8^%oHlE zn2qD=xzF%}NzjBdYvvVzCIS_CFX|i8Bw{#@T?Dv4ty+l;UnkbTK;7_0;32Q{xKc~K z;gq~@1dRvZ?Q$YedshI5g~B_>62fJaxq_Fe;d@4bFS>W7Y^H&sNwtgW0{tx(ehI7Y zhqF5kUU|(fgC2Ys%z8Rm>zWL@@4z$N!xD(OSyOJOJ`oHl zsm8V>=uK6a$4B(!RUp^k0DTKXs_r2bZchD+Nc_%ta{0|S9{+R#y!IFtz~rb}olA(f z;skE8q?6>+&y6*5XNdq+h=(#`Ars1d?uGkT)5$9ohJdK<%wO;+OoR#{OamYjY&xzS zS?)I-qV;7=D2UmcvcIW5bQSS6_}0)PAvb+o{L9nJfZj%)S}a^1H7=ZvfLHT|4NOR> zva0MntgMJG8qA3)+q`=pM9PGEk3Is7iti;F+Eq+kb}hWw0Dqq->Y#Q-zi?n!DL7ej zd#0MGHu(f84!uYqX*|!lc|ashmKO0d2c+7DO^^A;=JoneCijuT%x%SRG6?8R+$#Lg z;~%&9a0~Kds|7AJ5WcPBhDL{0sNL>1?LUmsE;p&H5?PNG-~Ok#)18DkLhZL)lLrdR z#W!8WFP6`#k}WE7jKv59(p}45@FB*^$SIDpJN}5)@&U^UvRen+aL;%exO@O(QUF8( zH%3R>n%em$iP72NK#U#P3{DOc4Uf&Hb|AXbszuTl6Gwi`yelT==CV}mYM@|$Qqz^l z(iFjLLCq3A(j6Z;qG;Y*WzY;@&Ms3Jp z?EIIK-UlLcD~o>#g`)}?7JC@j5ZPZrdoJjK)oN}{?$5A97?3oFA3>ao=7+a~OTD8Q z-E8ZBA>0El{w%9N?5U7I_he`a<{4O~)1KPdp@AjwpnJ~SoOaoHM+Bme$QV%4zvon_ zYUVH-tKr9I|F!H59mp6wjgMIzwxf)5%#Zv4FwHj-C($muQ~_JXlgq+dCvGYbLc^x~ zgpe;*g|QdY#IYvbR2HO4X6A8?_gJ*Yff2gE?!uqgxR_0i9j(e0&sjCPi8@?-?CdG1I z(Pg3%3uCYE1n^NfPsuWj#zOps=2&ssbZ24S9P{mb{XI__C8@C{7h^^1XA71B8LCLY zEdxhN$qeo2+o+9PSBF$jdhL?WP&{CHL1H0Y#*>@%61INzvUZSp2l#N;vUR?IUvk4K z-%V5GX?uG>%-LBKF36W$VT5C$VrvYTtyH`9=Ws~RLKZxCstbO~Ei#{T<5w$egu0#T zav>Jq=Y{=+xXl=jeMWrG+K||#zYdKOHswO^(P6NK)trI|*e#DL__H8x)38g<4FcTa z?i&P$SkWo*b(L3bab#8a-Zzq^>E{y?In6nX4_#;4`EHKQB7pS#fuU^uY-vONt8dm@ z%?9^$`ae6{)?{t>{>px0_YVwF6 zBLV4xk`5{I!$i3ZrE2E<0L0}+kaVyw0WB^(Ac2z}O@E^t!fT@AvBQz@3PC9Ah1QU{ zIanD}MlyB5+G;q?E21vbuQbXP#OUNgS+SGX9dKugb*iUxw4Ai+#v!qNgVUTe($t`)xNxQw3KctK&r=2;8&I zmh+h^g=0HoBllZ~isK826Gr+?KdM!$J>q50_&SuZw4?PXsWKPI~H|!va_w8 zs%g+MK3^G6S(g;fpMsr%{t#^%0GHf7INi(oX|05em;)Qn~k-jkKWHTKP zh9H0x3L2dC&4DyrS0Q?$$KgjUoHN527$09ZQY#g=c#^I4awJ*II&V(0GC!H-*>q`q z&rX5E3(K=cW_(oK9Vsfld1AG%J^bH?@cf@bH}DrBYO_X0-jbsSU2ku~fTl?oJZC`N zrQYtwaZG0WL%TMQTBhF|GahptM>YbZXfaqyIEX+G*r>$jzL~t9Sf8fw_2!443qg$w zleyz*mtMYVWigh={Y+WBWeO8dNy&pq3i-02g~ST;g8+s5n7nb{YQGx?muJg27bJ71 zaa}p^+oG)T$+5OhHn&;#eOFKj4 zgomER2^f4FujW{nVQ3`Wg?;u#H%ojmJzkIhMROS9OhU2KCv;1OC?y%^AAALh%ySy^PaByYOq`}t?tK`s zPBK}kg5^1#&D~|mlddjaFPw_sAk*<{_!D|#qHPLBkvoTKtb9{l8h-k7n@<7ZchnH) zY}~}K052j&z<|_BxXlO*qYY=J^CpfOr!{&jyj!Z9qPs!!=Q{5mgq= zzFMn5=%g$Uoj$Sdeb4@i#{Dv3skK&k<;VAr5=XYh$v=3h!jf9RY;spi%|i{1gfn!n zD5L->%tz=J{&6|bMQMuCIDz2-k=#y@8aY<RK4Sv1~jjXWr3-m;*b0e6arEvpa_+`!$U?O4-Zyh*Gue%B5eWI zz1i@f(flLdeBNj&f(F1cuxKGMZR%kiU#Oj0%Rf0;MvvtE6>CF2i@4;rrBC)`?oq-A z{Em~C<2>AnlNo#hDx===61x*bO?-KenK))5=)vl zH%4uQXWK0P+F64pT9G31*G|Kj`lnaM7M_7abli|hYrGX11}L4uuqvU-~B2W^V(yX-TFCYxE3^l{%&{ zgM_Dv#GK;H>E_bzNO_~{uZe*kEYu88y1_7 zgE;BTyvyxx#PU^)Qe*nH!Ud}P zb99kj%^JEyyQRy&M?h>I9dBDdAGwJiY;>%2WNlS;?K&V=BtN~!o;K@ktUO#ts)`pk zRO86}be!lzYyu-_z7dIbYC_d8XZAr>)1l=t=NP`});(q9Y;6|fY0BsN7GB76K%Hpl zWD45wn^}{+1*(Tmv5!7fJZDKCJYGJD^*@Pgp<@41~vwt5(AVnv5vC=$dMRz~lEf=ao6^nWr z)00;M@%c9y)i-;qO#*DZ_!s*Zm0D*S4d|%JqZ;?8d|6=`T!yz@FQEd7bejZDNyIvb z(Y|poSVyLqT3v)}%QpRsM>sDcxY+23$_8vz{HWJIj62jp80mnjW&+wV*xM{;TEP_; zk*@+YC8TG`qbdtkC2QiQ23@RztE~w&Ek(%93P=>qdP(;m)AW_<|2%a?*{DuqLfK=A zSSU?`s{A&@*wVDL{JlM#C0j|X>#g*{mrV%Y6vZr0?{a?XZnQo4z=XLl#;GB3mIqHvx^$!q>mkJv#0CoXAiN=I|%@ugTx@(MNr*#8y zfGC)|*}yq^sY+(#42K$dP z_iDF){MwF}nYq>Hx}TQef%1e8dyfG2_8St*G+{`VWz7jxpeDkPX# z_|X#nMamGT2~{!SlLbqXk*k9zb@sV9EX3a9HdpmLnGt;T(|V(JSFAlJ}PjB*J79c$LF!{RrawREN=^bCUwwj{F~ZLH+a(R zI(kY%RrQ*BphL7qGeppW;f)pqwjqwFe18(crI;L2NNngd?vwZwj9_t(y!_;b671Z+ zDs(>>61bKc5doW}_- z2OD2;oNX(nlR*rfxLGb!E2+jrS`vdoTePN@p`0veS=7%}+XVhFfZu|{&`0D!$2S?z znQZu&zbw2fYuCs{iRs|o^Ju+VdKES&uwt=cCxesbY_3pd@V|vcWOxTvj#r`av{bDF z_dzC7^-_>2gl+7d4vNClk9%U$$&hs5dB`8W=<~Y>|I#*6+T(7IeZ*L?Q0i(Ms3uZu zig0|>v@V9sTxlkHKV#B?G`{e@zD6KAsnpzg+Yr+RV{-LUl@y8P0S++x5? zcvWw7LGVpt=t?5;3xv!>fYEj?#35p=p>yPf>RtrHw$yD6luGkzqz)aNs}mGYaiu}x zUc-3idf<=Q6?qTVaTj4*qrv7)EPb~kN zT>n1~@PEwp*%+Arhg|<(ecSP<9nmMRu3xIMI(g(kXVJ7t#c4v-#!_cvl0uHzBVRh* z*)U<+lLPte3K-#hsa-tv$2b!xK=kdxNw#mV&*LlW{b8()9pCqZLh)fq?vCFV!EX2V ztzvxm@9hki%pwc=msSD(a@Cz-+O=ha?8@bdMN*VZDwzxA>lk}povqqcO}k}p?W#s% zM3wGh(zj1bZPFiY-b&QZ5RP)aM-nyuow`+S2Uh1o4PDgFu`-jQih`54D!<#`Pcof9 z3kJrPYnDZMTkL9vEx&6O>PsYh>#TWo6p4so<43~uc@$JXg$xBzCIy~6Jk_acup-;7 z;XWOz6@1pAXxQv~spk%hJs-WOO`5qjFP>kP<`ned{;tVnC_dxdvVrMjh^S4VJ3!fhYbWy!U=F5ela0@G%RYWNwl&htxx~QHJ z(D)=iI}5Qv^_a!zH9bQDZkHfB*|)rlbYrBzvp=-`6ibHjN7BFIn!)|&X{TJ$qZ|Z^ z4|$kfS=3I7Q1B+&6?auGwRekKq@`+}f(UmOPly$^Idq7oKOE^#(>a=$I>o52ep*mC zQU1jK`pAq#1B&ahOIA~o*ZjTZJt3Sc9nd!K0y6gd#Mi#aJsHN(6r2}K6YlnPpv8_f z=6w$t(4QRzO?WV!$AJ|*>pROz&H!LHpEGEN8v9HUpY^2bY=n+ka0-A1>yGAt=v{X@ z0^TAC#U3A6hsclEt77q$W=K#AY!zJQBGO26h}9q|-Rb}pUrj`?n$*gypI?jWlkFmbvH>^+N1Hf~Fj;f8jN^#0pT^K! zis?{omJctt>Z{(S>V^PmF+R~@YWQQ8V8ep-EBRYQ6;iBoiT#^&^vJT1 z%zjFvLwCy{A<%UpY8O&X!HzWnN`vt8xf&CmKz9*@B2#1V>l6dRYNm@@uV>eF^t_%Afs}qW!wt{&ebZ&bT+7TTWpj%JLClUPhFaAm7 z$sEHX0b$c3)9%JEy8|D!$IjC|zUf9#K-T6d6G4MG?1x2hZ(p->v>EDui%Pxc)C-fI zJ#f29@7w0duGE&qa}J#j*)~dBzv@=ad;}Hz3ERN~>cLu|5s1l*qfIrG5zgPkWau(O zYKLMCvKva%W$hmlx;CP~@&5#$;M+2O2JZt* zSd#{*0&&Nr3C0=ngd86@8-(pJ73C0tr@iLCDE60x%Nw-^8f0CA7H&~jrGTVufah8(##n$RwY&MB4Q|fG`w_++@^xakjpg3wZ2Txj1D}o*ChSE zzao<@{XGfuI!PThEMJLpi#JJHlyBK6vw#D0nYL&kqlj zq_xNtM-@Wrs_Y$`U1<|_!-Kr%em$C5xt&|xN}5!G0u@Q(n6TKQPV!~V2}wRfFpj~@Ok`~kpZ$au@Z$GaASr2y zuJ+u&`2zCl3JmOQ-&K&r4^ZJ8cUc0Ylsv&Ev}X%25fcFx%f|fkE`zO@!JuR}DzkX?Cuqcy)sdJ10(1rVN#hl~uVJD=q;I@z$S+xTSmVN!o&mApK=Awvvrr(s8!q?7?& zKGCM_)EwSl-_+3f7+z?P?CdgS znQ1oM@=%N%nD8iAbW!|IQ}WT1#R8{_Qg6475Y>TL3v^efn!H>?wC^yF^U?#z6Ntq_ zHW2n3({aWig3PF}5H@YFQlMQc+}?bmwNmdsQIyQ&{65`cu(f(8*pqfCD0SCiFDv0`&4nibMkw#J{bY!75Ch=2w>SQxY2=#cohNL>xbxGhVfXB~z*Qa-eDMrx*6pi* z>^Q=)ck&aZ9#=W;d~{Q;T?h&@6ZE#6kdv3vPCy@201u&2z{enHM#?BvgHUBTN-7r5_6Mk+-UbCyTAf_M zc&)pGX`8zCA;RK(dz$WohY?Q~E%EApFeV%Yo{JM-+mpknnI4jVFJTO-h~-}eDz^b# zzD=U*G6K%J=zOrdF}U7=cb*a!VX+Ymhmijp)Fb4gdL%ygWNB^cUnuAwLdZ7}U@%9P z8G_s0LmbunMcw&GqME@nuP)xMSWzfK>N=XJ zqM7(OP9N_tj}-=hoRRe4?c>?;_6!u?_()Q@Fr_og`=%}8KQ|nhG^lffe= z8#fZAc6Ru6rMiP za-1G{$uL!|dB{)PhffJTJw(c@N1}qNL{{=aZk2?XR#K$K8;&v7`zg_4(N= zD9;RA6g1l#>~DMIE|uAd;oo7crEUg@N3E^I?!#|+ce(^z^mlFY)F+pp(@!4=P}%D~ zL|CsQNo_rvI8=GW^LfV={!=Dwh{SAA2{xqCiWOdRbS^CDq@-z46U)v8aNZzA*B3q; zLkR&^>|r;%mxW1O-lAU>#gc+Jjx4XC%6W!41DvBU#E#-(-?AZv5dbOHeu{OeSOk2N zbEa7e$Uq?9);~{0>>QwFmF{PBjQAJXE9^u2vL}YE;-`Rgz8anG%FLY6$YJl(3H;vC4h6Z?RYJ!ap2r#Lk2qPt=R_wv-R0G8X~;=|Ud{ov zR}V@jLK)>WTlRS_J(!3r81gyB1^)TgEPadG4}*VBn+BeI?79%!wuxjGZsY^Nv zGF3`=&3sEdOy*FXZ_i7@Lp&5xqZyd+cDAsM?~SNKyYgvV!*=2`VuzY~;yo;5aqWS! z-TJd&r=y=OY#y>I+8p`3BaN0vB@Fd9sCKY){II{^(uD=bmFcGZ;-{of8ojB~KyltV zlW%ZOb25?7N5Rqbu}@|PKu#+^PfrB5n9Zxrr=zzgP+8Nf;7nL&z%+P?OEleB(!=AB zqj=REgW%A(8p=&G?t&i!@Zp%zv$Q3W!WELB`7~gpbrr+eG(#@O`Mn8uU&5I|9$D0g zD5Zc8za^FoD#HK(-s+1|3WX?*OSs(s;_xpCCv@|rKMVv_Kcq4lw!F^53LfeSyD8gc z4V_Ynnf;D$Gb!YJYSp-e^cY3_=!as5B8Oo*_2=*}t;#WGFRFE%4fh_pDqzIxlrCI! zFmD!|ZWj;%JMW@}v=T<^L)4wmcoe`SLraX=Hovn{+F&DW8_@`wDLTUEz~xDRZ(cHi z2!%P8fI3*BJxi}#XP8?N892AVIf`_FCyl0Ct zXajyw%!A9pQ9f)0CQ8soio^}tGB;&vfrs^tbKu;Sm@g3+OAYb3gt9X(ddbY;v1l+a zkeU|nQ^UB4e-*bXp?_}P7&BX-=&FDsVIPX=EikFZgBJ5cQuD7%mjv08=!PWu9xMQY z62Wf)H4ahyJ|y$eUDm?e9MU^b{J*>$_zs>f2J@X^k=eC1?*{>t$?*Qi@3RkklsTx}KTm1O{;wTFkZm;Ghkq5f<9B^Ms){&$D`MxlO0W40*8H~qt%mKv`ul{x0s1zdR3`(G z%ns=hq>mFLZC{$LLLt>6jJpqP!C2%D$ODjrp#~EvYp z@2oL1XvlBEXUj$ToE-Wx{W{z*-aL$A-o-A^aY*}y0C&Dg zz>D0`z-l}_RdBTZ)SSotaFGY5u+OY${#~@WE-RYpZPTo`YU2Q6`wsE14g5_o!RU&r zlO`lK7)(cEAT=ry*npq;zmczSZ62{gzo_zG)NnFLWBF5U6E->?9!mla0KAZ9EogmS z$;mTyn)T!7a|8jW_~T83xKgNPxJ5T9d!-(z4lq;KT;eU>=7M37RGj>ngYM9)wj145 z5=c_{;A01p8ta8KF=6OvWCBGljx(HBY9_6M(2W~dtQUK8nHsPdvw z6vxUjQ~i2IS)9;S%Ev9-M1c(0-2oSv3|(s@AP}oY#I5lC6p&=u`Ap+oeIySUsUAYc z{Y=pt!xs!{Nw{tze-b_WV?kDa+0u|$F3d>>I2FQDbYa_m^YYIfFctjtUnc)+mMkkB zRDn1UDKU1W1)Ov)#stur3E*$EJ{-m?gHVQJjw&=iP@}5nc2ekMTk*_kCz?49=!W5- zMiZR<4EgWRhR_t9qk3_f*zaR{CUMx}vCh}^AxgB!l}yTPx!XcW1P|ee7!^4E4x3-G zv24SI4xN}*th-P+w70KA46~6DMwkZr8JwBb+Gk$UfAeXQ0nU6*UCqu0ln?kX{FlNkII@?#(x{YLepeE=r(ut!SdcX`}0+`Y>K271}OOC43=yC{6 z3J@Yt1rfFSL-cjMyu&0wj*rw>DFLAiRY`1%`EhLiy`5LYmv?S zS*wgXEbyp7vy_qUci*+6)-DoRHB=P7?%`juZ)QS*q z3k>M8utuPC`V|3lPM*X#iWX&(y{KwNYDk-1QqKH>)|f+y_%P5`~z~QJhqX`TlpguIB9wbibb1l0X;h3v1Q6?<@D_!g02YrLdL|=9XLT#=Nn= zw$WBRo>e{_t3`yG=m=ck9%5yDVqF@byolLNN5cAYM?gsZ6{1fC;uX_eB37#Xp$aR& z!!&W8Yo8)9@q>iDqV{yI-HoGdbzk9g6iJiVDwh01lyg+oOqgY|-yCS+qD_{mAR~T` zo;14I+CA@D{(u0G1Y^|y6H>wX-$MQWN-7xtiznj$%CORZ?j!xLl@$NQLh+AI{D+d_ zzxpZuV_50`h$>kBH>l!2Pw;WO(*UjMEBm)V-(O;4H!9TD-JT+zjgrt zS05gy>;UJ6Pv)TJY$NhmUBuq2oAY*gnU;U7_3w5+If!3c(oxa*arJR|Qt0;eaeBKQ zsu3T_Vz;x~i>S(a;X=(&-_x5}B9U=w*oFELqUDWHX{;RKQR$kg6QM)X$XqT_$FJqn z`DL0)Qq=y}J4jJJ)U@rJKK;imuD&+9SLL36p?m%f7S5e|G&V|ko-kykeU{{z{_6h9 zfG2DaC_44>b;(9LmiV=*tr@odovV0XB+={S&8ziOIXI?*DTp0^!K~q#J(Y6l{CJ}d zqnll)L0d#cO#E zhi@~h(wkZJF|Fe(Pa3QkZz`^3N{jl~&_)>vbZoG=UNMmZj1sI&YAoTK)Hz+iQL3Cw zeb$ZJHxcT?v%Wrb%0)kgrc&^FgY2z}Hsr%LOQEqE_PBfe$-k@JUx2wxUNjN5KEG;@ z$-jDji)MXNOGm}7fHcvqPHfbK`f1l(KPvC`!aUibelec|Lh(fD#B_817Ib}1dX2EF z^@Zi#7?H4~NNGMAu-%WlK{%j3j5WXa{fe9=8o%-Ke40RnaX9)jLyUB!A07|s2n&RO z4c2OnvC+yyw|mDX1f~$m{)S>LM-2{H9VTp$dCk!PQOrNDh0WEpq|&y&sF0STzUNs| z44gIV`;+z2wsG(hT7N>WXiotcSwTP#+N3Jfay-xTtQSEb&N#AW=eaz9+Z7{Qk;p<% zZ_rUBQq1qV020q^#-v<_=??>P25rJm(CZHoKz1sN?6fF6gOef5KAAjP_QFiWN55FC z4Z@Qn?r~(;=I}~@aDfosQD)h-?+SsA3VAyuJ)v=OBLWOK&4Yt%36QlL5Zf!geuYa0 znt+_`ywDMyNvCiLt9XsQhzKdW7`J-(m;~IR?6y({ljy*!QX}+~wL^O-E&r$;|2hW& zaVKCm=C*-gb^UVB6Hl4~zIc2Aw%i0QUUO9|;p6Ws-XKJNNn&XE{aAVTZ2-SL-*^ln z;QOw7I^`cJ>_MSx3F-bupxI}r+XY#7?)D5PU{z#^EZ5fi3Zp;|K_Ve0VK=fpSyfB} zY}?bf5)qZfyf-}`Y-tgB+ zoRP@(HoWR}B{M6u1e#buc)BQ?HZdgYGn&9OL#0E+klV(>D%m8}c9D-`ar7ogf|52$ zoJAI5h}@MOi3|q8seKphB*jJ_QO+I~6w?h{JR4l~Rr9(!Yn?A1lRySSSwe`hHg%{n zh~+bwb`1;+W33<6JJtkRtyM`KhFhvZU%@8>5jP=5hK0&qlsr9#f-=?sCs{2~Ke?(2 z>F=I&CC0bx@&%y!DIqYJKNuftZ19^dnTo?i4frdm-k|L~u&AS=FP;bVZ1^T;_}p6T zw4Vz})XdFz_$+}!o*4-sp|&~?4{B4P!@0zoLE<`lZek4JA9SdMg2spZc|xD`l@mZP zY#AmRtei*M=B={h?Lqwvnk##G|LHE#oO#@lIp!d-*3}qvPjxp`_m0lu`-Zu_8wcDm zMYV0d$J~6=aB%~JDFyNo&pU~xJG2FN_=vH7_#`)c1;$-|2h6zb zxDr8}Z@v_aFw?DW2OPt{PM0rsMt zw;<)jlhY+WTZ?>PEIbTS;CjpBFE0S?VuEkTDRT`D6-9V1)&pqyQsEK1{u*a{lW%Mq zd91v2Zi?AtL>Q?LIJ`#!Np}T~SMZpfG)W-6Xe0@ILuBzW?^^F0xkek<=(KSYTq(Q; zkO05M)3w0iY8s?4%Ty-qwy2w$jbQ+DOkMU^cltKPkZ^3&K1pLq^aW5;=yHlM_-LSA z12lsYsORx#PG5~%ws~#fyNw2Ih&6p$R5Xj!#ndSWec0!9Vxtf}chWm2=03lL(Rb2Q zN%Vwz!IZ!Am}KijPlj$noNY^$3i*;-dqCp4Ps`v8HX}^?iF3`-3ImZE&ZB6isiF)u z>?qE=NK`^3QheL*R0joHgDP8++8;ND=pODf>RGgRAlXxkQ-WJ#9)Bg%~jtp10s+#*V*@jXyiDGm>P6b9c*;kgI=2U8AADVkhBOwt zP(Qx6P5rm-V|!IiFVPUINmwrI+nmOUeYhUu!ZDZp#ZpB5V%8l+;_@mcb)9&lkFnmS zbo90)vQ>JqFjUy?a3KtUMYQO$Vt_JNPTihD&H&K)*z!}!QGNtSP1-ZJMb{pVGz%}P zg-8ZX1XVxAc-D?7_mAjls5dAXvt79{Y(d}H{JH>YhS|Zrx+g$k2zHwh!REL5J3pxVIL259MoUwPUeD^ttYff47bzf_lfZB@qU z!UT>eQ~NXmzz68SKg&j&!Qa=$LUnOS@UxXU3Dy8Zg|;Gvkce-N1UIl=a0^QC*U3gclBr(lbL zYINb0X2C{jkXqw;YO>9TcN@s%rwMWJ9OZfp7{^UJ?-0-5c+H9&Vl?J=h;w_kJG4j} zTAo6ROT5jCf2^zlM!5Lve6o}*0$;s26=#K02e^^$A!=&RMyhm$9?m+Ig5==$~&JJc?3mk6EQALzMIFgV`I%c^Vvy=>S-Hd zgZ(ozE!aPAQAr25GPy+%hw1x?Tosd4~Oayfkln0@0Y_y zAjPOaMMf1u<*y6RL;?cHo#|Ltl7pbuKd=2Z=(^0v5NkZ==q<3y6-Po;k!ql^vZ~+> zj#(p)lNq#@?vF%-2nmu1&DY;wy}7>il<|{rPu%j2G?d(aIoxudEy9?#CZGev3@4O} z(b!>CjO}lB^tQ^E2^8MY>&*+g_USxRcolN& zmVT6{FS<#Pz@b9TjQ%mFaGFEYkhM$TY!yF)c_&D+D#6{KlQ~V^oNAjWiDmd#bRA&N zOQ#nc=9}251D?1=|9%tfefoXTE(4{~5X)8k! z)ke}WiR$iJ)`|GH1|E1WJ2IXPDTo>n!MYq2s zkzEi!n#z3oWC5TPS*$CLm$AR2~=04wo6=F(g zRJALgX=TvqWNy<;2Es7X79(4?)J{un-LWb{g~usja=mnUp%FRld#Z?34sXFE$=`K3 zj|JnW5Gu*1`;V8PFwV&wv4w=F%&xcVvh8mD-K+<%IOWTl>1+qDzlh*F9$GcC*+F5g zL$dWix=M!i3v9(Cz%qBJPI&{|k^y*ROzy^ikP!xNdM-w8Ekl3pIDIV~D z!9Nx!-9r5?Xs`D@`X;+Yk`s7V!+d?(N_FzgN*x18!1766^zURFKMcF(Q-@3VmYT47 z;S?dv<#b>OMcpAF@HoV3=u52gtcHvgkE|{TfX3~A>_@c<(xwOotHO#+{(Juvr|(x% znE1g|K-1ZaICOsM%uc9QEEDXRIOA=rQ0LaqXmZR6Yg7^0eTu%vn_SN|N^+;J-0Xc2 z+W(z*jj~<%S18%#d?zC#gyyiN97a_~gAcgv%6yR?BhZwydgnQw%@>PW2Y&K1Tk@WW zdeZb*dhr1^8`4%Vb8P>qB~NJyl>g|4cshO!kU4(Aan-i|Z}7Oo9LPN4aXbF(HvAL| z^QVLEEi-zH{8@1cfm!-kDp3aEXuG_uZQ2Gjcpy0G1z-+z}QD-EA8B5X?L7{t?}Y9{TQJ@Ct6RkMN&K4 zq@Z(K_Oq79tClxgY4(d`0n=m95N#P>wbn~pICJfo9TE~tM48%AB6FA zO}>dL+5^;P3-4_Rgoq2pI$b)n_Vlh*EY~?+e{h|*iuxJ12^%vx&|M4NyTrwGKX{CJ z>pexc))KFO>wX&biL-eNB%(z$#k&tRnttIZ+hHPcsR>Pkm^|S&kqZdM;SzcC9k*}= zg8T-&+K>NSk_cU~-6onw=$sX0W+|6@^Dek$0Gnl55G?NQaJd1F^C58$*MxVoBO@8u zLm{(d;vFLWWg!SoNP1Yno#Sr^=?*KhLSNu3h*(!z?cy+hn2@xdpWK0XZ&~ghbnGt6 zSH(9sUYQJ++YcX0W?v#cZ|(<}%>&{ID$Ltj zF2ynytkH&=&K=^+E61F3hL`|wb}tO11@N#XE9VMf+}@y`HH{2GLlF%S@Sy3*9$XX$ zW3e=?mRvip&Zs@^H<8wet*p$ zp|vZJTq7IlH=MarJ^wr%BLrg#@V(-%;RFoWT==y{xEpingLKzBf@$Mn5fo=GP zhmJ(T9gzBm#d}VRE@vdClHzAX5dIR%r*;U6SOVRj7d9GjvDZb?&LJy4^%uAmSHiNphrqe+K8c4$ zcNxpvc*V)nu2xsBEY7}W(GxIqW`?zSOnjlq$yy9VVUNVN#+83)nUy=+dUIl!k@=3X57K%%GJdKPb5gC|ib> z%ujc1%W#nlu_15m z!D_3U<9Txa(XaG2CG;scniw?ImNCXF6*mPfv>DrN(M2g>;^FqK#N**p===Nm{(gZk zR;keU^ZJ$War^CET8@uTrZo({@Q(hp-Eux10j^RrNyWT~4_}YQ=;EN9W(jHF5T}ig zlX_Z0&ZgVR<)-#EUg2rt6jeOKq+?|L^aehNaONy!6MMG;8u>;WFsi{Zhg_4ta$Ef;gD|{_pOd}di7)qT}?%TH@*`u67TY1Sw zeS!y-lN>v*rV&)MT0(k*ln`b9W_)2{y$N5eR3&qj@C$IuM#@p*8k)%6_J148e9!;LC1##Gfj zSgdh#8p%|6>lB2SqVKyIiG;CBeROLMu%5o`wvc5IW}Ck_g}3RJBRqW%P&xmwNxvuA z&Hx@bIf+NdC(Pq07{|%YMPUky@P|B-BHw+uD?m{JO=LK@>4}lA-qcQ0cW;$1a-Fi~ zV$KBM%e#2Z0Ax7wHMgNSd(C310q!*j7z-)NO;EkCVN6lhqU6JnbZ#0$zsAeY*%Z9=JBTud!d^5l1RmTI}UDelGUm_NQCOk1yuRUp*={;SVE?$bj6@v&ro zx+=wz3XF*s$xpuEiDnIMbAi3vaPzB6`MCY=@&7eVAP48#|0n#0@qeZiXZ%li@_(mm z^1lQ)LQH!9q~e_aMZ)pF6pa6WEuOIb?`Y0{9OwT`bJ$rq|NBL$YBeppt#MS}x4QH+ z&|;!u4`fO(L4XliHVu~80}7pHS$qm7>5>R>6I@bzKc6#4x_^LQqs@njH*>1P`;2?< z-x~|g9+bJtm8x)!r{MVe( z=+_(jtc|cjiK`Ed)!XUa-c?DX5z;xrrAiUg((C&~DfQjuHrurfK5k(i&Ee>qGFQ9o z5W_o4MsPyGuv15#2|pxi64|tbd23B8JWF&+5a5zBK?@`Eux;sCD8xx*uWBvrcG<qPN21sM&BsZh8wE8Cx1AC!k(_vJe18Le6xc*77^6RgO60qgqd! z&bnc9l@y$sBw78E2kIM_g34*a$rc@I^VfpU(6T@)+nR`R5MUW9;i7(u_YKo@oNRt! zl&Bzn`G%Q$`_YV6YIS? z^PO(fPqOaGsIA4fE3+x$F6RO0BKg##T-ygKfS~fCqID4d1^HH?jVab3^%Qfxq-Qvs zIcfSvxD<>a#warxH3$RLexXrH21tLEScL@fAxjk=IsrWM4d=;nPltEU=pXh|dHRk6 zoVMYX>-ZjwFgZbZi1vb<-5d|Xnf-#S^Nkw8I2@?gcio#FF#hry_LbbG)RLbX8$o+9 z1|!H$$a_)CA`7U7dUnw{R}H|wZEd@RW{+I4^z}#N!#&8|v>sG3FEOdj$1Ro%H*&b1 z$}nBYsWjMYK<>i~4=eo9v;C%%FtgH4Max+xb_rOxskl1TvYfmcxpNsR0{)D+BFguB z&Uoi_Gqhm47|XS&tLq9J`Q*lrLNZK}4WYkF*{XSyoz0?Z16YzWSRLt;qu`S!f@`3xocAd_{tGHz7V z^6cf~IjV*qmE&Rz=+^J}a?N_rM;xx9dB3uTq?(YLx3aVqr8Dn=v7gDomxA@wc|s@^ z@jzIhjbk;&R+%f#J*_@Mk^ryK4kvn=hA}!Z_5`N^aRCP>?C4J9JmQplF2g@qN(H!cN%>nc!e?vX{a`VvM80*w7f5ARnx7G`1zN zl#wW9ZdutK36{U*k(5=7z}ERD;Mj_jv>g#oT>(T>a}L|aM%xJ8KY61jJKS}?CtEG{ z4 z5|n@RCiv;>$;U~z@cox6q`!LSZ`6#Rx2;L)LD#Ni)JSQhR1mIJO=cyAFUPcyKt%&k z*j@j$BJc?L$ai@Tfge}}gB~WMwhyul=1v0-J&yRo>@cVcu$yH;B zC@jPHB+5jMbrGgK{sDAX%m0jZeec1U;GhOF-9aktGW*pmc8duFc;-N2K6^#0PwA+!1XnC9B?=bqRCT z4bj2INcF7j&s+-oCzNgZexX-1b(KFtuFgVsr%d@^P64rkq7$tCJjiUpm z5$>oyF?@SChT@gbEq48_57+fSXG~C7MeY4Eyv1{C^&eBb7&eo?65fLk9;-yZLg%EV zv$!F&NWr71Xdo#1yh$Vvn4(Z9YvpCEy(I2nu`u{ft!R5b@O#j+yq8;A#K77EC~STd zQO`f!F{vO>*jbp0AUAsV2ZUlNhItt#KMSOo^K#KtGSTctgQ8sF8CbHKn`sDA zXn9QnD@UN3<2g&2I$%XT_=R7T1>(<)SXiP-7*dMLa~<{d|B|x0^<+p;h~F%#tF)(` zQ<}t_h?u9S>zDp|fvNUqRd^EfUnrmDs4P%7dCKt<)cXW}$=RFG;WI;Tdgy*v;e^yb z`-0_3DJjtpjKRE3>|mmQj9oI=v%cHDeswgPF?BsYzcEaG1-hXMTM)fzdqpQetAsVu zSQ5ZIIh+}|yVfNYN`8YOXiFq{=EO}eCqhBza8hzG{7ma&73ASd0*6}o?t zX<(pJzAy3iAPj0FPoPuJ;XX-@v!;e(8{3|ZJ4R~#8u;GxH}m9gjU_Tz<&$~x`&dYd z)&WEbH%jXd2>;MdUbN3mJoD50;5>Hcr*N@(E2S>RJKz)ZoZJZ0#q-2i=&VSuv-WTI zx};8YgEHm@%W-?*cGrQ^5<219{c}4&+6R-PoOn~6f5z@O+KXxSpi2gqBSwI7+7&j#Lp^2s0UsxVhJ!}@HqmT z2KE{Zx9=UT{sr=YZmrY z$~IIv?V~uZDa(Ft5x3mZ-myzDDglJJ(;=~9|+*$o80+COtS6Qy}Z|g zeACZhIcWi>{mG0G?LLkxAWG$|vgtVby*h|=abR@f#pBXWO2*$_(|LeBPO%>An*|Um z#QVY{%K*q11qmyg9#|f8AlFQ8>8Q`W+)B<|4f#_*(}Krm@r5x z3?8KS-f zW;3XY;9WE-W9?YU;uF9i=Z3MU$vVk4_m_Y2kne#Bk-k+pPp$RMEeiY4*58pG=3I@j zVuSk7N^qk#?|<+i99`EJB!&oWj`!+sPgTH#=Lz)gkRN_V0*nVTHKZYZu zhd%fJopdA>>?){~;w{h>%1=0F85o%=!d3^PfpMbKg`?#o*CqVpxMBz;?%1F}>q3!@ zA%B%T-W_K?>JE`x_2B-a1riW~oKH|LvMGF84HpI0O!_^}I~T(j^Aiw%WQ|O#5=k3& zkQN@!-=Nx#lsu>p!)&EcorX+>TE)TPYAf*!T`pD+@?2e)7QKBON@|{iia%J+ciBup zll(2u^!N_6%Ra`0$Ni{uqwF4U)>&5dhQ=jVQmasBELdSS%qxPXAP+?@2Zd_c9kBHL zr$SSltUn1`7wq=b__OTCg^*0JwAaE})t{15ybVzpP)u62RaEh}K1$8C z-r{D*Vq*K`nX;uEv%hR#{Mj_=0RM;iLG9YY{j?F-KTGYpBKWJZsi1Fx@3S=%ecE)( zKa?DlcQ|Eccdr&o?-fnMC-7(4&xcM|_=xzUPJ#2@A`iqn3w%2?=}r_sA2+Leo`0bJ zsar&0FFXllllnMaG1N~{u>${LP0XqZcir!)z=R7oxE7Plz7rP8grTl#uxEsd$ur(^l>a#^W_t zg%TpIJc6mRsdy23(htZHTalHfJw$A;U7X>I!6zAP0s#Eh^McK^TmZ{@SX%9oJIc;Z zsp*-w`#=!YY?+ZntMSrXBY`Rd>7i%BHlau6SiWpf_xZB6qD`7$1edc!KX+g%_pNJU zN6WmBu!5ft1X|B=*d?)rM@Wm>hR)fT-X~&!2^rpI-NWa2?*8N}SKPg;>I2lPg?-XB zugqI3qqP0Tsw*aAs&){{3qvlIF%C9j5X%?1)TesH1^@2)`tO5iwJ zEGHmSxCna34eA=wtWW^>o3|#zJ#hwc*sNot>Gh~bO)IwKUxWN*i zBBA;*AUA9)plaCJ%SRI0_}AhRTRXnwF@WS0Sd|BZ(-C}WLh#GwLu$U(n4riY`wk=R zNAdu=jIgsAR&a~W!zpxwDe0N!wp(&84NH==e*ek!Suco};xum7TZ)$ExJHQi>57!~ z(mC`H*=Z!U7JE$mw$-8nf;bNEZ-9M}49q(Y&!_}-NkC|VL#At}$R7z9E(I$KE`!Cl z`oL-eL|YYBYI`!s78}VQ1jdDGe#n7=n&AMAbFK;yU*l>uKc5boFCmg!sh-8B#MgQD z+*($&VAeJRhoCkm1jvmvp;0KK4JMkB=J6R1W*lo!7^#ilzfM(btLO_PSXyoVezYDfI5Rd(bVS6pMq*>uasDFEy zo_v(VWjkN=b1!d+Mo4hNx;W&}n-ProgcVC3AAS!?5H>wxYrV@NiO>|t!qzuxoEncb z$dM5o#&Dt}WoZHlPFqP}HMVCUF^5tpR;

`UVmzprqmZ>3@0o9bt)0I(H5}#al1}x>4!6F`_y{RQ6Z>#2}T4 ze$lF*me|yu>Y-6@u1C!0CF7yDxu`^ywFiQqWQynzK0ShK<#_;``mmWcc3Hu-4|~B~ z?$Jg;7{-`FvRqyf8AFMsnv-gBXLtb9zI}j-Jz|2>`g;jNy6%>~B?S2|Ud!lXzqme# zAOrrHs9yu+pJdtmqQ1VrGKc3!5pH}N-tcbt+E$3H@Q;Gyz8_hRJ9QP0mxYzMubDAb_gd6^j5D1}etry!7 zhn*Z0xrV6qjQrAnq?jgTN|lE*G`j($6c*bsEXT2$jpDS{XqE~y--X>;nVW2hciVkN z^xD>Tq#+(i#WX3E8cs^u)~ZJ0ZATzj#tV*+zYD0uzn{5-&%eD&1s4{^nIzy#yZY22 zh8Jl^$(pky7DwyEqN)y#Bd)wD%#=AQcN%p!Oudh(JK#0o-*0 z+7AMXiIZ_5UJCqYTkbqN6VNfzu5AZGaFcomumsAWL{AFF9%K^IO{zHe-wr91S2UID zFsr=fs4&hYwxLR*pXQ`rWsEWUO0HWDgiTf*74RAa)gu}PB(}sBz-f)@3g>C2591)p zPo9{p!92<*`S(#xjB_XRrwp(YHs!4*4p7P2(pq5kw|?wRwFGn!+m(=pem>%be#MT4vKH#faaKSYm(qfb@)C z;t$+1O&Djda+HR9O=-Ku-uZ;{J&zx_FByV?!q!5Ru4AMg4&kp-7aG>Y=sjv^qf)y| ziHyTNg{@ZBjS!qt=P)uqRVuNqS8C*Ls;261sz%K}oD=p{sZ{lQTRsMYPvT5afG?fn z6-}wR-Y26SnuAOW7Gfvi-=%#jXQ&(!GUOaQvrObko3?@`Rdoo)n`FNkJ(6doNdyZQ z_u@gq>Z+{|;_+~%v;@psW6IIx8x;@|4$xhD;-K2JUK1P!m8vo=Q_q)} z4q==q1MXAp7Py#DZw^Is)<9T{+0V{Q2ArELGY(0CtvQ%z*7{w&c^%hHP?PJ?b5u~n zLSBMxW1_syO;2nNdjAq-EC$ z5R1hic{JpyXWk3i4iITlcuN2|$~)u6$C{yJ`=7(n_g4<)1}*O>r)xYJ;WJs~Qv{<) z1`D6su!pJhL4=E*O+*1+i;?UM3VPfwmcsaD!OH0DD(*ZW6)qa4UJYK)HxuU%qVzID zuIA5&mZJnbCscjM@D6zl+I5QRQS2h{3c)Z5nZFl0O){%RGUAH+Z{hNKQ=+G*nk|*N zg^wE82f72gu7DugYd%QsF)n{{i92C{iRcS5+F_0uL7_g3H1mu`BlCV}Nq$hAzL@;N zl4Y(l4c7LR#ZP|4{=XY$HmHL@4Y&=&QgOrWV{c1|!uat`$P%M3D3-`1k(TQQaABah zjr=cGA81@!nVAyVmZOc7S_KeQa_P~vbwH~}TPoP9`Ba|gS<$*+gG9AtIW{5w#vd0| zySo&02QP^OljSxbRbTJ|@b1eRb_%B|8;xAMPI7Tu#7zOD@(TTU#XnaY&-CcjrKKEN z-6Q1I>QH`L%GzgrjUJBv2Z4G@q2Ji5coQMZbm%gW%*7t7SbCp-MamGZ=O|_p z1<#aPZGa7rDf&H;G`~{yLW_QIfdiTQ6D>#)TU#`g+*x?;%B0p*nc|$s4-XWdn>~_C z%=qO|aXxlBO(6wcT4rlxr?}_y_?S#sP6=ZWZ^9{Xi^c);$YV#iC7=3wt&bz^g8O(N zfQJ2cv5OZfYNaVC$(kwEAn_m-LFC`W!J^6Fvf7T)6Mq|AQkeZ8eeLu1);3@K%Mirsg=*d7so~sEU;E}v<8*YeacrJ;AtfrWdu=m;zMe*EL_PSOfczZht z2c3(7qYnIJL9nmHS~40Z%jg;8LlMN~?h@rFdO!JktpgR>Uh-9GvS~MSokYuvOdYUv z0$ZN#oX`SAwEAyfGUH8lVOXy;Gl(M1Vnd2l(tqIJe=uesXl-!5LBtwT24G~1g;8v- zg~XY$nHZE)v@#9;kx`nsM<_&ca=Iq!qWUU-jbav1Wr$)@WZY zxFYJM^Jel-1@51}VMs>1(#MmMi$T(&Ki0b9EX;t54Pd!Fp}?u5a;2o(4Sspx3j)D` zmB`SlhQ#zag|j$Q*D~U`_yArC^X<$Y1z$(@04cG2t$PGJ=l!Ujsk^Aevlm^$*b}iw z!`orwU2*KVLA-Vn?slB@!qFf7>rouq9y4Jg(l02^vAcEZaHI--+g$JViP|=It#lWD z3LblbjE@VQvQ-81VGKSzK@xeWSe*I7)%c99h{|3iDiq5VHjSPwCME4j0c#@-bOK$x zhOr=2*ni9~-XQ4oX$kjB8UkcWQb$W0y><=Yb!T9p0J4hJ{yP_{~Mu%&&746d(6)>St!!ZE-IxBk!FUHOg!PecZe~JF%&%G>6 zI2(t@LkW%?9#PP7S-$xzD-)|k4Dz)9Ed3By25KXVBHApW->#1&Uj&5c))Gt zRr<>r@~5*_m8j)p>Ey19Fi_k;@RpMtpaJV`_PFt~;PQ=``JD~#F%9Rz~(fIX5-SWh+%R$g4+}N8Dn+K5vuh9i@2m z8au|_V@^__^7j(fTO12>01IuZmpFq{2FPC_p)viDLNsF< zb@h=;X3&*G9B_O<(ysH7*(ev^JS5n9v{(h=&!(kURb7EhiIlL#<(%&O*Oi^rp&Z{RyiTHYn#ulf?|pP~eEH0IeLFo( zJGEyJq4s+_J|5}d@b1+pCPo2#G_go3f7PR+_`K7bjaM)EKU;pNNGh6IDp5DAWpBs$ z;mQA#tew4IzY+lYa!SP5SdBE5%qDo)%!|f7?&W=5bJbrD@VY4{xA+ZRrMy9@{)XI$ zDfME?OBKmZ#cX6?>h9NJ$}?q{7(J=+r|(vc;ii-uVP_tCQ$tM9>tX4p%(bG69S>Si z51+-%=a{O!eX>7&BlwbI6ycC4VUt|_#qpr=BalySI9Kl$(wT>=+Z(p#`K`a_I|^9p ze&fdV_{A2GrX>CWCzTkWN@Rd%Jv_oM?PN=zob}tU zyOYKD#Eaq4iy?StQ~4VugMyip6_~}b7)VX*T>UE4ZF%u9?%u>ICwVk2v(mK5`nt&P zFBy{xK(?UcTDerE5T`qPgJ65FC>nw1d>(^J3?1Oc>az#;{TZ*XK%Edo#MVF9k_e{3>r_xRBXY|(+uc3Ku z6e-M=O4)kGWn%?=3f#KnvQrrm$eiC_1DLPC#GetKDZ)zdP(49VpT(C=j9mvxpF!vC ziwZAACD8;1xkrg{DfcVKxcX7hRlEHDRlTVZGIq8vKM;t4uU_sO;e^US(1aFIEz$d3 z7`4QH>IDN48e_!>)PgKVf6Av2+A7pynQK-Rr@VZs)Riu5ZINu_1@Caf7f|xe6g!%C zZ<%Hf{#LXZ(V3ohReQaMnA2ubL-XF9|vLd9tf6?jt zeP)S5xzwganY7iE$QP5(kdx>3U!=?4>C>P*17t>~%}2YQobSVgzVHaFsJp|~`|12H ze$&SxLU8@dy1&DpE_9S&o_v=Ze&H&8b?I=qSOr1v+qpGBycc-0OP2v(_7^W1>}=F= zELzh9L`@}!cfrzi2*gz&zV*|+1%tZd*XNZ)HfHCh4puYG(@0NemLbg%OdGN-W1uQ0 zcRH^}@;o)6ruik4VR%6IlRZPuhM^-xAhn)giI)^L8DH&na-RMTRFWdzkr+>PZ1ki@ zqBQ`e8wz;=mXeT3&46;`_nukOMlTzL4G2c@^ZYgaK?}0OBdsJk8H;I$(LOO26?u6L z_b}CN_S!D9@X)-$NU3vXTM$it3-!C28nuhNr_M50suokEHJ8aA0r!aT+1kPZRI{@BScU?u{4h^5(ZdKTEWaA z70rlKXA*UV2NkB4iDtDl-Wh^@~zYwrH(}W9sX+;VP|r!;n9;hD&g=V-hSML+LvGR#Zvn zGT_Sx>_@3fD|1qc49=hj{%zl)CLBZy5BO&y^(1RwaXk5*k?GYA*@~s__8(_SSEYF9 zgqz^`MlH^(b-bVJ4$9Ys4{+#YOw}Y7k7EMu5F8-~77jV$*8*_EZFQFrex}GSr|67h zKye(T*k0H#^WQ{94x6x0dUW*yRF4>?M{6_h3VzrPFmv+^6M+sGNjY{c6!m^e9C9ur zYywWhW#mx@MO4sr7Cfw5??~Sc{aFTBz^uFsjJuTm1iJx1qjLnJ4% z*4>Vv6l^&13e|qEqPNqLh{Y{c3FAe%KhVed8i7z^@%9&gC1ONoHE zFy+s4qM4K~L#b7+p%>Yg)_sB1O**IsbdhFOI9~QBOsvck0fUGQh{y2c7C2>e(!Yvq z+_{)LONZ*(^m%bhu0&ZC+wiS`Mrf4dE{)IPrcN%dxT%MyyhhAf3_QXf`Ey9ypvq+L zb?M;|MlM{T`veT(uFS1-*jvcsL?TXxg$GPdhOi@_UGT&dFB%nK&b~l26999wuAkEk z$<3aPW)vs98doFZ$ATicu9j%-{%C5VdKk1315NCgP?qwVno>YX#_|(ks{S80vP;&6 zRel5n#c23aH3noSsa5`H*}&VJTf5xHASt-1L)TRUF5O4#hXmEpqg&i;gLLsK+nJWV zGdjGIo>>|Dur1liU@|*x1l0`q&Sgi2>_oeh{jA={HBe;$+@f*Z=QV-Gj)^#yfwmdK zBJG^H_7dBmVp)VftU85I$>M7$zYzpS#x)LwI6L7s!mi(LQ}M{X^^(Vl<2J+HXTBp?-gtnr+&nO0s{T9tIM z;+J%f@dlx8<~_LZLcgNm86};C3}U56sT*Wv%-gciL1N>spR=hg|MUEO_)vPLp!l!+ z2}o#$7bE}Fa-OR{+OUpOfqs8Pt(r@zs#dMNFV?)7m-D-t_0{{1@jUwzhi&Z09ygXk7SDgLdjnNk z#yE+xz{fI>(XywhusN=9(OvRw|6r?)tn~wA?=DD|G?ES1 z(t1C%6!XHq$agyC+LFjH(^Gfqd!Y}=WV7YiUR-8qq>5uDisW}yl$Iypb?4d|$>L0q zY=w*EZbb1Lqj+W#?yn}#YKhR`(p~*EkEN_Yh;D=ZDz8JyqyI=9;cQ3EWcB9m%Dl@w z8RO3LQUMjOtp_oQdzO!5a+Ro*6kDH}$GTCuv9ssn#~+gjB6Kbe^;Cp} zkGLKBL?^sv6&3xgb~&^$_>PhJN|(uMQ7|->FfWoOg;JsU+zFQmw$9_=21IsO`Ap7& zhlH1k)NzTffWlwGs#LZkNf{bMt^`PM-$#iE7R_9Ez~Na=XW&$+kZ4Zz5cT{(-n0qz z_@8jx^YIT%)iQ4%4YeAR8``m@-TUw~LNYhB?|wKgY%Z!{-4~pchIup~`?i>c!5@x=cTY+X~_e8omRZ96ZgUUlHK_(*H0FuL*rNz5 zAxJ9l8heL9ib@tRS(5_6R*HprxU_dcqGMS2JWWp#EgQxh5zPb^Bm9hyxndiG2^?W) z5qzBy;^89Z&S_h3!m=kSuu99>CK}f8O$#}x0*=Y--yfWed&ncm%Ftfu;Ftz?XBa5T z&nZh0S}tp(pxcorh=mrPN@SybnQfR4qn{Kch<;;Y8D9OWF_y@n;4#o$6uj}b<46jS z%+1}0vC}5L(N+MhC8^>Q#+&CwlQ}!a3|HBDa>kp#@FaJ{9cDQS=}FdY$>W-Mtkd5 zBZ2adwCsluh(jv$$9){S^O1-FzC(EwI75CR$+_7vW=#Fwv@MGh zztU_ee%s8b4ctH?x~C1f!-;&{jWL19+br~&!P%&M{-g^%J;c70TuQ!n8tp8@(NRzf z_U=v^CDnFu_6#l8pfAtB@#Zyni@)wcq;Z3Zf}=Mlw{mb#O);6|#7)?U2mFo&r21xF zj0P^oU$P#_tw0H5kMi2(E|#Urp#(^nAffXN8k;2{U9y!?R#MO6iq&+g9i>F%tCqSUbY7MP(Er00CinKYE)I=e%}J-TS6Lt>mtVlW^6#30Hy(8K`P`zem5Y-aN zqyw0{s%MDGojkxDitkP9O5p8RGc$IDC0$o>0%|%>JG`0hSvl$xNKSUqFwY{LP&P zR4UnLpgousvjMj=3HEfVvFIWI|6WoK(&Ix@n+lOB6heB9dCb>Uz06*ihU+SVD&B+s zCuF~{z=p3~SrW$s*J0_yU9*Yo3mYIFOa#F0q5brJ`nv#?*8Z0n=^#@?yNrmR2a=fM z@z?srYLDAh=P_TNxMpXAowWHDYt-p7ZB->XC7~j=q6-N_#Y$8$QkmDD|G`+iklPu! zRDsL^@lpd(LshpWj*7OO5u8Yo(forodmU#o4zuN^a;G7EU^o+}H;|d*b{7clQz9#p z(N0iy4RNaUbSJ#@9RM|)=Y_wko*;)AL z*dR*FRCMg$d?eu1K95P)VR!p!To78ymr7#j3{tpvz#@!9Ws2jJQI2lXe{PO8J`hap z%H#+JtNkPX94H{4- zwKwayfh5UuVfhMTSl!Z@tbHrzy9|JhYU3KG?gX*-`n{XvOF1|Sro%f5w$ZqjEB%6l>8@r<7kG`-DwzJofxo!7 zAkP}+lr3I!g^<)Tm@a$=F@8WRtdfgA^)DywI0~o*u>BI9jbe5Go++m2Z9Anz$<$~auilKArvxYeayLFR7!HLiae{I=9(Bb1s zSvO;5hHY!E$Ba63sRM$60+JCpUv2s6h6gd=8(4-XNyotAPEv;FbU(QS&5jl?5jv^v zyWUk}Z^lCW9F<>Ht*9bpAR%HvF2s3A^B)insxxyf8eJgHLv6{0z0P-_yYQy5!^4@p z_QOsEYj-R9k1;yToD&M2Q}o2<)r~?~3GD+TT}eA1bK_E8r!Y3xHZfPLq_b4j%f*|H ziedzM8S&x@ww+UsNb5DVx?rv5G5}TujCBrHe>{qjh%hg#&K<<&(^JqrcUWAzDX|~p`H613{ua+R zOYy}=k%h_e%e7fZ_WB~B@Fzs)D|{no`XBP~%&F362{zJmzi4J2sz|_Xe${C6pdPxD zM!rru8r^@(C9+4RHVJn%2^@b%gQ(Ij3&yLz+?RqQP1hi50_PR)UFHKzdNGj1*EY> zuIdx7ehZamzDbxJvR%0;h2rVqwN{1y z*mKCSewzHR%8via-^=zt=E;~5?yRzf|&fm+$`v3Fy{wq7;Hb>BWclDSUz(to1 z9Nm*tih&Q>%<+aIwCs>DT?yI_(l^|P4Z37_zF%@OoHAfbwyg=?Nh7l-+r3YDc0GJu z9Nsj&AEuA1{_6DrLSCOYPZ@eJFw)f2LgEiD2E`IE#OP|D4PzAahUjBj^xEZpUitU6if0bD$ts0h0@BXg#bmtlD^;tQ>X*z*uF@NP87?pW& zr1?GDM9nZ<8C2pL=JAH)8){8gvW=|AEOEM*;y3>7^c3_YQ>eF6Hqg<8yuMtA(KxkP z*lhO>>wbt!zs>CaO1#o$N$0d~eYN0L)oXSsM?Wkb)BS!#ei<5v5M+D z-KqLQ)MOTw^5qh{i}_RXWWRlqqK?O6B?A9<`qTmNVQphLpMmCR)k_)Rb+ZLI-%gkE zw8$@sBlgjcr||&);?9C^y}H)BP4^i#eX?Kf$qjHT1a5T=lPdD}Ld*GC|B6|m7HY*i ztB&2d6*C{h!zQK#+jb7(crxEq(=6PhmkT?184FC{M=*q{OKg^pnc;pp$v2NU>+PsB za^pSkfqvf@z|YPbf3qcx1IG3sq6sUew&REaRod3S8P%12U%?CN*$tzVOftk9*^RBn z^=czfX0FJV2V_v8Io+$a*jn@9n!}z-%_m~=za}U44U{fInosA4# zmYeL@R?JC^;%o0(ePTL}q*?1g^cSx+hTYr*z$@F+kq2)r84?e&5^dRDsR}~JYd|pJ z;{~S(;Jq~<&WW!L7$#0pAXpO%d1?Ndf=j8hJ~yb2`-cTdp9839}lRcA23lEdYIa51;pje zdBsMZd6zh-W=O~Q56LznYPc7&nd2^hhpS^uHFC#>@4?^vLtjQp&wOOA!1&~G{t%G} zo$^Koyj`kraBR9h{cO#QUpQ@Rci7(0z*u7^EARzFksQekYPPeF*wA1#Ou5Cg4*<8? z$SIyD=8H8L9YJJ}y&I7#(mwGjcJ?U%v&LG$3|jGNcn1$AC2Er1v!u}3D#yyUqK3Qm zu;3<&i$l#V;_50HUX}-n{8P9HRb2kkvNtOuTTLkOfXSq0sAOMC@$)hPZ^77hr0P)E zvy6en(yRI{9GFl>Zhda)ceo$AfUvz0^|$S~4;i%k-9X2>QSI*xtf8n^yFqhO^WG97 zs%c7#JLqE@mufP(tRSM#yXbqhY@yji3=B`X908m9meu!!X+b zt3zm+nCtO*)iO+N=>s*#sZW7h!_zIdh*aj9khNAr=Ec5)BV0OZx zXz*ChRFf5j`Np2C(rlZ|r9)Qh@(mRXvQ&tzd?f z2x@TOGtBVDAH(;;oxZ7$isaZQ z+Pua&T38hEwS;hXb<(w9dQ3uBU|M}iN(J+gZ2owvT@&?!hzFUH;WTn(u?4jTJTB{C zcWF%h1%9o&Ux)Grfk!sciM#Hys!}G9EI_BQM%qdzbQvKg28ZK4EQ3Xh+IHW(wPXU= zqVxHCzale+CA``Sto|A?64={TEM4=3zD{KoVXoB?8dn6?P3e>7EzNZ#>ms*sCL+U6 z=raYrx(B;Jry@pu&SmmK$f$Cq2b&jE2;#MOB50GMU^w(;-E`%`h6iqX2!&#Se7@}i zW--qJ6MI{bu?lbr?zLP*Y@COdR~VgBZH7ARIW6mS;#6$nD_)ypSg6Q&b(ef*vH0d6 zqCG(v>M(?b3U~W)kCOKzV6(8Q+EhGUeBj1Wds8 z&*~GTs)MNv_U+~73C_r*X**5EYjPlYh@SET2WHud4|k6ja|LcuLTCE!aq^k?^i9Xy zKbFsR>VNg;mpn8kQN$j~OTqC5mSW!S*K5OXtNia?gx<54MS+F}aDhwv1wB-J1v!yE zUuc@$wT_OCY+uTz+SWoVfj_E};dLA$c8%rC(*Cj(DryS6LnM#seMl?7Vhy@N+;}>S zPKM+Log!K^+1z`o36vNQj%Yw${NtFV#@hFiFr9sfmV?@-?Z(Od8Ryt^hr)ew$8(+e zMI_-=u$=B&pMT@S|0kQ!@(K;liiK{Ia#_jN{A(RmEkNAesM)5+fCWSYSrLcFUNiNc zJ?9shRhMX5Dh02pWbxM`eQa9;h^@23V7TK7tH!#+3GXl-*}}%_EgJ!t&>1*4>HQa_l9^{5_!TFPDP_zmEVBN zT^i8b)K8|oLhCILJqlY z=Na7$9`F^~xEdoZSMpLOh(u-5IC^7tBW(^UYPLAde4Q3D1`kT^sME8|9N~MTMuD!{%2fXEzD(AO%*>Stn zF1b_R?LQ5(rJ;U>SXHbWaGjW8!tY1x8-TjJzgP@Lvu_|ql8`X7kP#b2E+9B_RN@9% zZM|bWi%@Uk1$T;8^{6~!SiupDLpM!&QbkO0y~7VQ&4kr0Rq<)p=D$o&Gc z;7OrS>@#$8EiLP$2!dJa3V^bkuk)sASV*t+-|XX~AQ}`cYt$SO`D`WU+%uko}mb_`4+o?a6q68-ru`+p~evYy(^or!)L=WVDjIYGX z+eUU0IKG6;P2xu7fd%OrdYZm8Ey+LBYQ@JK`%kwEIH1pY4aDy!21F%tyT0RgPL}WD zi}=ASz4xs=2THzY9n}PG9TD4ftDo5|`aW-;S6V4$hVjW?b+n#?A{+jju^r6)Bc+Z2 z4)&P$6GtA`1Ce?g$WBf{1_T2hU2_`AV*s6n=@7EWPNE#nd(N5Y-E#h(7?U?}#w|nc zu{EG-mzwboCK>EMK`i!*kZo@==nVqI$Q8R-+=I3J#HnRsMB}(BE5yUW)k?RQzf(h7 zFLR;G!^z=1cY7Bx=1DBg9|Tzer*-jhIqJSaoN z;M}sgEG+MQpM~%0jL7eHLc$u6;BG%W=ivIzZCRg_ZfIk7xDR23a3FV%EC#?H3!@DD zfh)0gVAuTCHoe5NO5J4|l=s9Q5Dv490(*|X4KO0F&|eINOG_|EawmJk@fXZNX81h} zxg;w`g(P$YN;06+*wI?RzrVv=A2WiFS~Rb(E6$&VaK_$=URelddnHSu#kMZXfdglD zyo-M^0t`Jq%#n#+Oqg`hY@Oi-lAyOiU?QjlSycc*H{L8H)n0Q97ylPQbrOqv56ZXP8=eecx6KNAin{41)gb zSJ5RDR-(+lqD*db2pTe-U(w?Y*90~W!}11cdEZj|IWs0s|Af=l&!Hn@Zfpr2mq>O? zUBkTIs+QB$Z|exWf;G|;>1r8Hkb@v)1fo#{15R@s_e5jzgcZ^4j$A1f0`MI`GfL9L zS`rM30y&I1xCbits-PQSYS{H0M z;dK8#^kO-QnyUI}DASj5h{La)t5&&0sy`n2XSwZxUi5u#2U~MEW0+%2o1))VxU!tZ@6))>wTr4`hha=5tY<~&bJ#k&r-{4uo&Wp&9r9T}K z-VUK?FxTE`eR!*@4O7Ngd6qAN`p$6JTshGRQ9dAXyZ;E3&g4u$za^v9Zz)hEgOo<` z$;XwDQRg6@49liFhau5EH(yL|;o|(|#fqMMi)*8>srKI3KK{ja=6rpUf{phyQc=@1 zz>)K9qlGbM6jzmW$NV=>Cnq2ziDH{d7;WB<$Xol-Y@MEJRKQpXv9$g5hBZkFdzK`n zDsApOS0^yG;CId9%2@C?Va>_l`1w+I7h#^`NLE5jgMe?-h%F-0`0@nqgRtnt;wIF8beGjJ~SxQ-u;+wj5ZDq@3n=}?swY7>LKg7hb(z4GNd>y z>G`^BB*uQEZ~i_ksqTKbm!HOEe(eM*v>^d;KBY+5O?{Fr=CPAHOM18i3rkFA+ZnAu zm+H6I1+7e}IbjE^r(Q!$&B0Wmyk<|V7;bviag|$0w3HlE3g-fxm#{mkp~4PoL7AG* z`3Lro;zkRco8TIQqQe2-VDzeId=9a5XVwwW+LL{dIA(XS?cWm# zJ&UxVIE#8V$vKqnf4Cizs$ASfiS@VSp%BAb;720-&4Q7*r=xg3e0D7#VuHv6EmV_e zLD(oMnxM#B%gezJdGXk}O=-P~k?1zRsI<|iOeEDoZ%v9|Bq*lb=|8W+{Ox$gbJwMH z#f%by7Kt)GGTCzz8NE#xm|6%b6(#?ualk$tT&;BZ`nWc=^{}EmoJe{pLWhyr>Q`sFUaZr^*+365pue+^Qq+zKPjZJ{bz1^qct1NTsBH?Qo=V-67ZeFH5 zo-RiWf}s^TXLLAP*!S!!`EF-85#*u4M?Ab6AHmq0C0+P!txZ$&`u=@!#B1erlYwcy z9LjT?#o5l$+r$uQJ@a`^VR zi8vsc#rlVODMBSZ7^}~(1}O&}{kQ8umyX`FEDydRltQZ|v-9T6>6>}a*oTQu&OX9G z+*sWCes6!rm*NnfcPH9Kf1DM5_%zv@Tt4n)^PC?YWf*3!1~al0q4JxTe3+c>|Nd0- zcD}p9Ag)V%+$Pj{LnQkIW4{>(RPZ;KKkT3-j=i ze{e-@Q2?nn>1edj!Bt4%5bKYZg0fcB z-oi~>!W5Fkm}My<{GIb#zx~Crp;?>;3yeG?(ssjqV~T=R8i`Lk$n&3mGieV8ZOx(G zy|v7EYv88LDgSTPS<7z+D{GP%@;2#0w^12QI1?eHY1kNNdF6*Ks!j2JtR5VhM6i%I zm07EH1JPUE7Z8XIE4r|R;jx`4a@bOLkHakglgS$uBS ziAl`^cDA;jO*^E>^W1?iVNOFInJDw_fxzc&%EMb5EgOMrMNk8a*0W0Oz3Qo0KlQ!h zw4M?>BCi^_L0$l7u{S7xig?0NkzN}j_dKhOtN5@vW0hgex{#HpmK8(6-HLh+Gq5w` zS;M0v6Z_}&87eVGdn$xr7m%sdPoXA6N@T23Wr@w^Kg(1nzMlBz_soI=9>&2O7Z9t6 zY)l2Kguw>n_Gx~~Wc@t%C&<%M`Gs^!L%$sGr6@!spGBZ(PN>?!|| zVS_)d2Ods>%@`bdKw=nCnH)2ESwxD(=-c~aNo7YzSn-iuF018pN$qL2XM3CbozUm~ zWYp#*2L~}q@Av!tiKcd!IxTZT)NompMXIR=5ju?l|KkD&lfr3Cx~XUDmnH1{iN=PC zVMAwIo^=xQ^ssU34@m~Q1sVB;6?0BRglwrtLh3ulJ9f_*Lz9N}Q>t^V+R)5*dE7X@ zttQzbF-p>n(2v$xcic0#m&%V<{l}98!#Q{BA%U1;-=Bjf9jqme?jmLy#2ef7!#kJz z*wF6*`MOxDJ zsAIQI;w22Lz#bD4rU3wJx55)%4+8!`h~AvNcb|r9#ERBm7K869t%kPwgg$_a@z6?! zz}|pn{tJ$FAl*NAF@x=|qw_>An?tJ}#>^>A)9NU>tBk&%mq-xl^-iRa%RzJqeC0l5gYUnH^rG?=hCP^qqO$ zvetKhlPq#pHp-XLtG~cTZ0E;P+7@CAx<=?aV5ptW%&cnc4D8&D2n<~bn5boGiLqqRL;Fh?-RAE5}| zCF(frgK=F)8$FpUur%kSv5E?oEeI2MGJuoj}!JnEcy1QV}6?W7bc zkHFfcPr&_|C$NPE28x~mChlY@hd$jrOmu{2=8y&5SpIa2O#ZBkEL_chU57}B-pwmR z^qK^c)>C0jXh2r~*}P4dPt+i%k}n^qNIiqNnQkkqSG;OV$zYEU z=T%Bfi$DQI<0kT6fiVNwhqe|7Ybp0)2sWt*Y8EJ^GGz~Z8zo&{j2T|blj4Ik7<4-i6Bp7#jXqlz|)JtHFn|MVAaZ5zf|FVMZ4Wavt^VDn+!p)e(g zyiwZh^oB$YBB+)Aw;w(YFY9oZuBif&*BfdBM(oPbF#V#3 zj(sQQo25M$`0;hMD5XGjbA8wZx`-ZZBz%C;uOFa%D8%p>0}N&NV?r1q>0n>qZzxapR%W#Lph!%3kYi@B8OXE%MNCk#XFM7&}QD2(H%sE0D2)nU>a{+B-69jy{zs3{{g#&^PuPqKcOQCqxM%w@{UbO^=d zA4n~48VNIkN^BFmnR`|nj)L5NINM5LB78;K!|GOPx6E*oojLgjJm_VtGk%9GRHv^i zuv@fSHsS%h-Ux+Gv#}V*4Jj*oX-)Yyx%IWtXf5Ecfj4*Mu0eKWTQq%;w|Z4W3EI=9 z*%~~I=yhCccLgVsk-{#~8UCzgbOK__tq>DdOw#JgKqvcd4v53UW5M% zrw-cbqZ8Z8>>LpdQ^~*So5dFRe4l=#GsnSfLS*reG`3SZa1E<8|@6m0BuH{14U$+a%5 zSHy@Ee)&A)l5V{xyoWny4<9R90N@S8WQ1tRNw^v}8zK<*S}@NgR*cC(Y&`{wxS1_^ z6}Tl`BR>5mEyvjYP;C@RN>p>?2As7yzcGxXP?&}{bQpt}JIx1B3oOMd=7kUSsevek za8&RY*~&CC+;=r0=RjW=-PZ}C`Bt6p5^4hSt{2ljdVVDi_V|Iq;he?=DpDYcNz zLRHh7p1t-F&z5)^F&|I~v+s%z3<&-7Trv#$uqQ5&T!8C_ z!E#pfpc0@SAjKvvxmqFSdYg+@$X_dv$yNsKW#9#cBVGI*G~#l~iw*t$HhzGjs8gpIIF}_Lg_tVPeoWPE^F87wgSf zI^*5#j=-N@B(Hm2n>5`Thisi=HE9bHuoxwAJ@Zu}O)a;4IXyMj+<@uy&6A};32@^E zX|G6%^K_mI==LqbU`9z)^Axi4X=Plo-2NeN_;~E^Vxstgpa9c-y07W?O^w0Y) z_EOqQX(QI%lvyt_UxwduaZ?e%bLg4#Jz;&*F(~(g&1vgoD@}d;>0BK_Rz6%+b1Nku zL*73ynC|g1foU#L@88E^MUUwn3F#FH)^2LdEZ>eE-FOb-@p{3B^MEgC?-W)R5GN{M z^w`O!nF~duobr}1?W*XM*j!k7uwS?g?XPk*P=ohOiX_s&z%FI7E@dhFY0&e~u#8_A z_$@OhPV0)1l-+EHpU(X6e#>Lt>qw^=mBFvR-!CIjzEYlvqjvA2W3XTsUBKwI(zkVqv|lgAc^2~S_57S3Zlt-3OA6f zWrDW@JdwcuOQDUCW`U69n1wGr!<6q5D4GR}qOEG^`53}iCqNda{qwIs?L`5)6@horeRaczlmU|M$W z1;S^k1L za>EmKy%{+-nYpcxIMkiaRfL#o^# zKV_gQezbUdY7|=qeUw#xCPB*YuYJKex(Acdc4bn=p2()w57W=Y4NlV?s2cb19VW1Z zw05&;mmTWm-o2k*S^Dr}CU0b0-lwN&G<`-At2))ypYGED-u%LevnkOY81-F_peU`Y zDiR_TifI7HWfH{Nse1E#DJc~v31{SEcX+BM7$ZfoWA)UH-sdq|swgRj)`ym2ET^~O z-p4E2^j9R86a8@gWTa{_l(kN}Z0E1&SFcNCvFg{0*LiEcXox0uOiHOGe!bUUO?nj< zeBfuJJF$Z=cgSNNro}zO*~2k5waKy1M61c1Q*kpMC$MIc8kxkG$`WaY5K|7wn~`h@ zqp<`mecQ;k)BZ1anN_g@HfO19!{n|!BIUxkA~YUJGaUU@vk4!?1MLXCE1 z4v#9h=>rKVnmn9zE%4~hsMQ8(?^l)GI_}K1yv+KRvbJs+aoC@@iFy#Ij_luwr50Va zWK)}p!)53oDvw*e?i3%|M_zHp`8$B2ewjLTv+@!hcWdnb{Ii*rfb-SCb4yT zisTXJuZEU&CkY!pq}R zt*O3FT(~#hPXrIn;p+c=9l?L!k%SsF+eX@r70w)&j%WM2sHg!cKRK&BLqtUZqpJSa zzDS4B@Cri5OzEGwf6_~d zZDZhg=z35SxiJ)}W0tNg)Hs#ntT?$gXY0F#K=CbMt>J2gZ=$8G|NQB|JI)f(D~j|! zXVqVv|MnUno5oj6T@~*3yhSvaBYRcK0_m&dCOqpy)^S9?mdS3Ms-VkZJL#s5zfWHKCFO(ae&*U9N-U@hG`+o$mk^$0i&)%&)|A!nq^b{;U6r4 zS9s8l){}@dvzJ16^I}b2vC4)_f^%< ze0Az%S#sC0?H8a7s;^USzg=WIpGQe4)sXgb&U>OBg_4skdC*AMlkbj?LWgU~6;?e1 zU3H6*`N~fWkLb{VEjkw=@E8u)pUk;)%@6hInJvf*N^`3*lPKf_f)f#Y@ku8f9C4@) zjA_Rl!9j^wPVQ;J33bs85v9);$F_%ss1wn@cB-k8vIpsG14u1HlZVSCA)Ux`cIZZh8Fyq>%@VmN& z$UZg!S47bE7qjQqUwoL0A+PJ=e?Lv=atH|Cxag~Gxi3_0YkX{xPW`(M1BM_<DAoRq{`<pj;Ybb(G=yH8%t>18DV#X*Vf1S$suOu0c!O>U9Hd2&&Ze5BBT} zsQ&VSO^0wO4vxlr)3?&H`4`kG(bRK zc|%oMB7DYfHfQP#zk-d#WXD|x0KD{aoP z0=NjLu9YeNT?YCnTk?(>?9NPhGN~ldP+!R`N;sV^20P%MTiN@8_1cLTpTc{kol$hA zVG-<8Z8)G3(7Bu-Z{|{PNTHyJ!J`V%$6fvkX=HV9yQ3W z#s5~V6eIF#dp~-CK!L!(vJ(HRH2%NR3bX$YYK8xkilk)XWar{&Wa7lj%OGxN>-_Jf zqQdz91@QlG8vmcs{C}6mvoQX5Y5f1CR+yFXe^2AP)YkuLh0*^bjh|FOQice|3!Xfr z)^IjdpcNxy$$&J$Cj=%=K?aVs*eLS;dUQ;?fsh=QveXrYIy8C>J|(0r(w^#25JE;XdLmCvI|G7}JMaFnf+K4@^ z-e26K+wO+@?*1%mWMgU>*^o6cB(9^Pe%i{N60QGyB8^>`@Io3b*~sUsUaI|NJK3Zi zY}%^r$-)C$Y&TKMb1YX;U0&GUbN@G^Q?Lw@rp)#|7lC@3`b$oIo|6MNV9qP{u z#w{qatFMoLjPoXx4*#J5h+;7PN%}_G2+mqxC6q1Fgm8i!jV#^P$J{^D{mIMtQH6Pg zcJ~WAb*qtzG1(-{f0_DG3Abj+fGM;XB+*QX9HoL6toC#Wkv!s>sEWKI?_CzEEylTfLD_aW*E6d8SC% zfsszudu!Zyw81*!d?q~XbQXho!{m)?r;lievN3}e9O?k#l38Q8;v(K2@C1q_NF`Qz zu%s`??Seo7YACKtKr7U4)>L3=TwF0_a^F6~h|@=bR|`G_i1X)C|7w;e40xAq8CjSu zYLv|GVchzzY}nbBW5SV$pw62g2ZNN9rHEITaQOXgK&eDcSGlf^_CgC`Q@f44DsL=4 zOg~;@Y;+Uw22aBH={5Eg6wxL!^_~fA-e{zkTW}6AF$xEs%Qv>nH(g}|XeL`jb6IJg;Ek0h=L~1p2faa3dIP&D12rNAv}l3I$=JlSFTfq$aI%{O0k}#3W-qK(gX6J_UZqXLItQ2*Oxm!|0?t=QDif( zNq}bxrRk};NmTf`5y`RHo@Jq3XNbHO4X2=s+2D4 z7psp-a?xpb+)%SP#GYrwEd-SxvXqGME(PosBx9842qh3PEP1NQgyA_0Cg~(XsMnnsFW^Fvbw%|SCJzw-Ax8i0h*@)f2XRfH!W;cyEJ!DTVmO|Dv3Cz z7|rN<=6XHwm?|1VySQiHmG2(1sB*#Rf=`Kwx*x1u6J5Zpq~-e(7^xM^Yw}j%OAm81 zN6`Yj9tEhKm*(NjpI?9pQDw<0++sMG5Gq9#3?K;cg(S5MLR({*z{5$R9SYp!)^B2* zkYFWtz1A#i_%nF+?d9^3#qmV``T>Js3AOwfBdA@#K%Eu1Wocihp0czdtuI!#+Zm_r!K4bxVO{$e=~>~Q1p_Qje@kjFK8@m(nA2^PgeHGFn& zzjn>!)oK9XP(h6J*znEnkwyF(SsDO>cf`5k)&{E0$-_BWR_i%h$rA1ji!A@>mDhzi zGSSF1YF+DGueE<1n7Mq-#bFUZ!kMmwW;cECF5D;8c-QnARf!XCkHe%_K2Xd`gY#7x zGYN$fe4`NwS^3Eh7lf)xJDfR=KZM)rE*ppdbNTTSXEd){-=c`&< ziRjmVD)4N>-BL93#?$){L5p2%TA90``|;30df$sO;*xcRGDlDrWXFJ}o2AN3df`N> zFvSog{b@{Zo`ojBngL@)2`#`SDQW=7tk{mAEG_Pon(__g!^K4Mj3pYMM@rMYo=fH* z3g#wq1nmo97E%fB{yJmR3#U-D*^M2gm4DTKqArh;S+JFg9{eyC64(z;m6fw_Wr>Tk z_rF^+d-5lJM5L3!GL1-f;;q{1}F5;NB{i~v^s4x7u=fR5I3XVZd zsMNLJg>^wi7Xo>tgGQ5Ju7-$;xkb5@VoyIa{68I^#s4`zp`YzKqC;5r^}^`ICzp}W zL@d*3a;jybT~8@Qja5N{w(lkZN`4CO6Ur!Dw!&4Y1OG} zM^0WY5B=!g#ve7A@-W6DekY1OYbCH{vN7o%{$pg>gtn2<8=@x_fz3%B5lizboGZ#> zsIgE`z{2<B|lpEq*gbB+qld6I6NS(_Kc; zUR*9&HN5V~3&X@%0wm5#Lb;nAh^@8iDKqbQyc6hs?qlE9U4ASZx54AHPy;SlSb zJsuayfSUA)Ypf!AJ+Cq2dEv!--Q#68fC-W|irv$bg#nOTVbDb)&g%|d2^?1@Szqph zcKaKbYx1=p6k`{7P1oV^ng&2LhGJ&x=_DF0yM#rqq1Nvri5n2e3qDkLHl6AwiE5_+ zIoCuq+~Ev-pBYRbfo`BK!@{bilQg%Q%3+k>u5E}d(z()^CmsNXNykLrh#f{#idb%$ zRoh@*LkKxaE8I|WzuHatgj~`CM;2_cv(&#mPDDQX+}0Q(Faf4U=fqn z8PN@=a=`%@&a2K|REvhD+!+|wpwn0KdH>0HU{Z7lz1VmVZ2F}fCMxd;+Gp(@(|(!$smAH}cpbd^RftRPJ`L0-fYu_egU4`{Z{YfAAIYaZUZzm4 zoykn^aGgI3_w4)?0f?leoK6Yc*8ruTd@AR( znfr2uvtbZOk8zu@*qN6RcN^~TX4P!&%>dUVb@GLN!DR%!2`MI_yA4B(_Ko+VLHmf! zWgKswNYxG56? z3@7ebC<-pmb=FmqxZ}pQ5tL{8MC6u)vLN@Z!#7+>ZZib?zon?LlPk3lZ^!N*$LyI^ z>Y3b`5)|m4b3CiyUfYZ#m9Rb@=og_d!i#L-h})T){_FTI+bElRg-GQNs_kB)d` zjg{Lx?k&%a@D+?}xrKEW#Gl)hlmn!@dR`~kbk6G6qrZAym3Y^FHB9z{iR!Jj9emepVicWNbq-|y_9zhdYS z95lMF*eUtp0tJKgv+$kW?ZqRf2n}xnuKYSsU$K$FI+t})PDW;Y=eaCJyf*Q#d|hy! ziScSA0sM-bCoxU4PYU}8| zS48M!+`3pNiFqvksxG_TNGZ3{?wD}lDrK)utwrpOBkE*7VF*-$4t~9$HlrOI?`$@s~0%3Xobp zR^JC5B>s0vPONN-6?HRG351uUeZcv|lk#!f3W@l*Y$`_0INA{ zidu+hAUY{*Fr1{-nlDs7Ayc&R$TAfUl1v5YpUyuyLuB9crlWVZ8(@tJ(lp@XlEE|v zY{dv4uGU;-RYu?7X%xp&=}v5++M>~z+)D*R$kG5I`brek7@vPP=w_UjUvrIEBU;uz zW+GrlM%uGTnkbc;3&#qP#~D5AbABZ34(XSDtCBG@k?)|YY1Qo#-WL-T-$kSxE8^u6 zms8b2d(14K0laD}S?1wo*5rOD7=7~BehT-5Xmt-Zj>^K5!R@5`f<{6Y0-(?(uVkaX z3wf8yG?fw4!eA#9{HS+a#C~v>j^m_YA}^Z#jtceZsGaXOj-&Rf%Ca0w`&hhcsA`xL(ezootGhdiw`(eT&~VLdPc zN>4t@M;ERxHj$$_7k7;(&NavdgY6PP_tNM1$A>XY?CqnG!I^bb(yh#jE`0aBwm?be z8vgZX_QktPG^`*fim6PeJ`36_Ach<~mR+SIOZw-7aiAJHfyyd5K@+uLo<>{agMy9m z*rL{E_E2hr;$*_wy)Se^fg`gsEXL1314JM@jMJX|X)jmrJ%nH2%nb zPepojC0W$Ld@dGDV+(lS`>RM}vv~krot&?8Mvd0*k>i3vWEZLLZY){@k$$gLT}Xme zfNkg~wQ*kEBgYTG-;Ec=h)*-3y~U*G|oHka?E#WyzFo_Vw^BUZUtG!_ziTgCq|4Vr`d{SF#s) zGRqR78+xQTYT6H#yPEr9*|*KO?DC5=8+h(KfrcnG$!fkPS0$E?q!E=boq{_PZ#V{AX~Vd*uKiMpN{Bvffp zWpQd|?`M5FL6~qXZPhP2`^c9E$$OBDc$_U}u9!d5st(Auj|uFO_WRzizR)`?R+8W@ z{nP?jxW9CzQtLMutnL+=xq^n#UqHoBg}@I$iPh>U`lxeq*~ zwsGpAk~5;VFtY%frI`UQO>LWfimpL*Xd@sCv6Gs`VAlpy=JZ`T!;E{lt(_1RmBV1W zGvy`Ri1{64)+9=?rYhJcHa~2ZQQ!KN;|fNc-yQ*)G5kP+D@W*K9c5w5WkJgKvo#Mi zkxxnqXfoD@lO9|$>NUmRosV{iSxZcr;~(Oq*)*wUbJ;nzb?mR1Wzau|QbWmiO5~Pb zX89Mq)3w2oy!JemwfeCoAf-9b0IiwIOjW`7=1M7DZ%Egllbdb4bO0LzR$?FcD%-a? zuEaN#oo9-Pf0W66IRh@KqS}rx%mZ5XRJqhG9-yGjhyo|B8O!TW6mb#8yeqi=Z=Bw{ z-jep&<}uv%HIHMYwnJ&4tDS`FmAxCcgd!1UT;o528s=HvIrV}Z6!TdqR!5r57vwTl zl@)h5K5KUnIV!a(Y`LoS>_aKUoT8oG7zeuaV;L2Y%h@0PTrf`n2N|7K5iAwE#j0c2 z5c&%xwl>ege@B8e9}Tr{T&LwTZ|UkTstdM_c`SdN;$|ZLh%&jg^f*NHy{_q>Xx=gA z_TWPTJ2Q3{q8sZ7+;xKH2`r3+;mK;7^Jp$pb(9$IdGzQv-O7d+-KGxeS z3vB7k&BxJi%eV4#zLK0y9(85NG zBcap1TNaLv*dIIULn9vapFSlJnZWtv6_OKr;-weT?Ilf2!77!&qo`8Th<>G6Xb&cw z6M2pBKGe$t<{2<0srkjdOL#-v^di~U5;Ief(c3PH`<$FoPkCW2E@`r6MZ3=u$q1yK zdV|jNC;#G-_}3l7q?VBxqLpNiiP$kRb$~ah*0_t60UJ|Rwv0G~s;|JnMPyRLKdCOD zQDoYdIiA2zOM%p4o4?4QG0&IIA^4lKaT_IA>o_wtJ`suBPxUZVMsy~&i<`UAAf?VX zi;&x5xv`|urrOxaWX#@sx*F)Tf4%m0${pCS74iDXM1Nyu*7f%uPL2sC^JLY6Yu2?m zs9D{%7Wq6x9Pm$1a#TrWfr?75URxLwhx96cwI^HE9+S}~1HitupvPFt>QJiom8a6Z z@|$bUbodUuJe17^B%LG6F-tOKogTCtQV1JTi8$ZM78#J38GsoP)sjxeuz~s^i?R>W zZ1=J2%UUm}5jQVzvzW6YwQ#tB*u%-09E01)JAcKOI3}tab!mN;!KV*`Ak^y$)7yER zv?}rF9)KsUXXcFHQVv|f{%ktMmL?;8fpQB+9N2T7jwEEEm0FxYgA!X0T9x&X+F<1f zMcz7JTed0Q6kL`c#^WFKt%>R!h3Kc6+c$i6#%6ora+btKgP~9uPRNg-BpNFb*C{m~ ziPUom64*}bM`)^yph3|#UR&JfqS;$C6p8ZPEnHl#`JeZW`V_f*TiHm9T(+^ZXU%x2z%0+IogFQ9_Ux*L0)E zG%SU=3w4i$5qNgI^avm_0=nB6l_B?>%f<{1_^LZ!B+RpYdO{<>*GxERQNfS{O6px z7Q(u)aD|-(VCr8jpgGB(&z_x}y-NGz??%Oey7f5<7nq08q@nA}{FCBUxr!YZ!c#m)H+Hc(+2U-dHH)PrsjMlO!@u4E zhq^3-W{&Xc4=jb5j*34j^LkWi2}Z8KDnYL4S_iwKK^s_0pEVjifxbLfF;(8tPy6-a zyV!u-3dt$0i~bKXD=of5(IXBDcP;&(Un(`*@{mkH^QLSEAm)=ngGF6oS(hIdfU%CG z5$I$hZ&~-Z+aCsI8*ZS--iW7|C@0hPzCjqEjUO|7Q`c%c=HnSx5=(b?wl9V8><%mkPfWEd+EC9tLu zXI8%(sM&KZW=lh%>EpMxDa`G0Zu}x>ua4`@m-(|Mj+#Gz@z|5JN%7e6sW0z*e(>70 zc^Q@uH1-T#ntTMr)z!*fpX$=%N2qUS#d{j1pzpVqyl#l7;$@{dyR4bG_LdFI6g*=O ztH1w5z+#FAC9!+t-0ygrG#up2+4}NxdJTT`b-bJGf7K)~4o=d3r`|qs4iZlmO!;Bx z-fwlmCtM2|pijv$qGls`4}&N69Ko7DRZiq2 z3!fXaT4Ik))K%ksjX)Rhl{ul}L@3<%|7kgYD`F0#GoTK8MOjEiOq(DSHU`(b^He)L zyDiWk0%Eo|Gr{pL>~Tu5az&ydj>wNbM7HPf!soas8gfSIbw4PN^F9(jbL_yCi*9Zn z__G5#|3faRA9}_am2}Y&P_lGXEvLm9og|2tuvHSaOexwa~LI7 zZDm}a>N*!&-J`&xXsxz3?WO|t9=<`gbW;>fT9XwJj$sAd^E#e9OOxS9434zWnIw#D z3a(wkgG0#(y6OYVrw|@Dkj-R}jy~(z;Wabqy)|0`-6>&t)Wfb0_1#SZtRD)Te^dZR zEM+E8=#KmX7Sz4m-tP%E)m`b)`7N&*-$6>hmi!nVh)$|;2=5+>YGjqZIx)wnwLPC@ zxgU-K&+bxO6i4gB!xA;JWqcsPYCDWq6GD zqB&q_N}x$+8==2W9U-FB`SNhxdeZPbf738T=kQ6Bdu%*_th8@aYTFJb>57B6QWLBe z3P=ZtX*FPpMDm()4IQJVSCe1zs9%Poo=|iCqzD31%4-=*SxhoLl&j~-N}Qp8P@Wn~ zeJv&VUWti0GFl5>0EY9gyc8;PhnXT&*GLhSKPhY% zf}DM)&yrkNu28S6phlNTz9;x%XE;=-h=NA@S$lMSheiJd;lU95H@9xZDQ1Yj?H>L# zjwLPjOSs6A_8bu<|71|@LK3I}Z06c-uM4bI%f3=Set8El%h>Sr=vr&DrnsfxCu*3W zCg-(f`$dO^%SS5K?>URwnmVas*GtKY7fwaz-IaUZvS*%8l&$236+DF;>LXXOqB~mWmJ;57x zKucrNZ``@D_n}dz*yf@x8zvGDtiuK&jh-RwIZ+GFnFO!UALOniQ-xPqboge5UMlNg=PIKR zC|)|c(+a%Oh<&_vmTiw9v%u2H{i4u147cs z6>)N{n~fBgZUOD(GkH0#4!!Q>*gy=4a@~<@Lhz8bCg(;fa{-)KgQ5S6w>Etk-B#A0DDmC)5QjoxU zy?gm5y`r#$l0B+EIR|&ld*u+P&mGd3G;5%QH7G44e$3OmTRvA|xJ>Rkjpw?Oi8Ew= z)_)Bt-s5$(ACLS4t_!$zQz6$`U02jjV9@ka0-?Pe^{+sf$;gDy$1 z-n@Dc%Vd@Hbu1DE11=GoJmh|dGgZ3!p~Xi+Y6#<@KTes$n%m3o?cD+C^>BIraq@+7 z{?GLrWi@pYMW(s-6)}nuIx{n?>dCKIUD_F&9jW)Wu8*-gawMC4d`qJ>vEAy}RZ))a z50>RfG8NKz>85_CO5zL&0_cw3g%Wjy27tta&AKz%N8{w)FKK}Fy zS3HC9J|Z`7%%5{|{km;0%+}bHO<$I*zeeu83b+`%^8j7uH~Z&rsTZM=5p4H1<9n86 zECPl(yOvw~7@zaSiylRA4-=!|4#;1Le!EjckRCvI20}u0v_f~TdN)W?QGyTM3PK6F zR1Jlp1wO%#`Hy#h>x~I$?a0s_ zq)j~*rQOu2Fg0zkV%M9zl6`O5>1c9wkuTwXX3nedGi((W{se9@BPeBakKVq=&UuRP z<*F3lJt3`wq4@S=k>|X`;45#SUxb4|Rv`y^to(qxqm%oo0ZUSVN#f_y> zavAtq|H+S09R}>kV@MyK3#1?4Um>xdJ7^~vDm9|8hXmirye->$fn2NOc@H#0q- zi37?>U&CkA0-bgJ0=bTpYU*b6iY zeTlDY&^J8bMLZ_!2jM)}3$e#+mLGRSf-wS}AJAMBg}|NnN39hwIke+Cyy)MKJ){y< z$BpZNe4y4TMkU%+mN1q!X)|Giml~Qg&Yj#8G7Eygs|aYGlZbN*VmLrVv^MQ=K%r=d zOpQ~*A>n3xHlA{HX5gj+?YHsTwsj8WMB4NjF|N<}SD?Ko6%6}T5h`bRf5^G__wFaU zES8r-WX1VoHmJsll4{imj1J1l?dBCZKR8hlbql-RGkmooFC6B3R#MY3kX67N&_D(g z!i~{t%AB_`X0{#)vJ=pTaFG1OB_+)Cwpy7bZd&>2y)n5rqKzpXxnF@o@*H%sDJyvv zecJ_VMI69c!HCCYkAn8b(hF${n}?5smFWJWD^|v9ehbkRxR};QZUx?7%as0-rlNZ| z@@Xy&m)879)rWUAbnI~+n$;JrOe?Led_`9sjLy{C6TO5&;w(XgQs)e)I%WKEz@`OR zq@S{>$L|J`h!>bbpAxu+Hwwjda5YP}wo*lxU363@ANje7d_q*CT9KWG{+2;#4^`h~ zF-*9beP8AQ{@1Q(6u{WP{>S2X$}!0bQ=FA0$p*GCksC~c=9@|zJ28g;;1RBMru5;( zdogJIYkjwp!Nw!m*C{RFS(Lw9k*I8~BWVM7Vz|U1Dqa+O>dZdyu`xP1lJ&l%PTH9P zOiH_x28Yj@=9#aYD7eCN!b+#J5Z+#7F&Z9KWMO4rv~FNvzzl04`WuNn`5M6J;9rVs zS$MG|in~OkFu0~fqWAD2sXrUn0XDGJ{94ZrcYi)oRd}%>12f^t_;x~|8mjT?v-1d~ zhPGXK{E7%zc5Ojxex0>ZK-X!-TBoC`c2(U0DRQi5^?to#ZL926gSup@|6=Ro=|(wB z*#FW+DMSJ4%?&?7>{CSA&(}+5x^Fi)^X)C{cTPvoMb8?QVw~E>zth}N?n2GvtSFZr zrP`pwz9Y$k{d@6;u2hgwmcmR`&>%Ld1bC<4*TqgnOMP*2AZd*A>jkaX8%{qG{c5xu zIYV_~1)al?pT+YCFL-~*f(z)&2tXO#Noh*}TKFQJQ?^p#G~kNAiBk^&65+%%IvYst z$KHc?&#L%H$M>G`KlTGDK=pf8d=2y!X&wosEU6Ge9Fmh6 z+UXuen&KJuOF-EU2Q`k6`F%eCuU%o<-mpt3c%~pYm_sLkCxGmh^`JOi@Isw{1w2jQ zJBo@Ni{YPHEe!Kecwo&=0%>Z8D=`D<^PKrygKA zF3D()Hda^(==dMH;;iH^qov2TVp>v8!e*mFm#KBLt6g*lNz|b8xL5ZN$xnH6bbf_i zo>p+ZO?}^<0)96#YUoMByXemk3teb8J(cZ$>krOl@O-|<>yFPJnd$H8KSJHtZMUgk z&1cwFgr1ILq5F2uZraap+rI>U+{|0QIc- z%BeGSgZwpUz1`K{P$CHpC9Ql}wY}|-MGmSlJNB}{Zn!_*-o5b_ssH@?na6E}8GYH^ z+WEvP4;qi+21WlgUA(|3Ku8=4-?s0f&AZE6B7Xd{;Hz!3-Y#2V+I3wv7xro6oPzT0 zz2*Bp`kz#J(bHt)ze<(=gFyMeu_VI(+SdOAWWx4;&`fr)BD4pnslk z;wq~z@GSRd*VHo@ccvTpzSJzb2V&rS_|-3>09^Jjv`wQh!tPrqFB zdneGMg{aE)d>40<{4{*Iy{6wk+rsUccxY?}x61-Iho83j%;Tu; zb}^)FJZ^-F+R6Rq%Cc`{mE*p%M0dM=j~r~U@0~h1Wed+U6IC;OFM+k(_q}@Mt-DQ3 zkB?nM%rU>@ISr3bpXtW3|E{>vcbCF{aoc^bIeoh9?Xi_&Bfb5O+KmnLyLH>%3tW9F z<9&T~81L~h!H4;ia_ca961RJQz0Ut;l*SjyTh>_uFqM??`^Q{sAUapHhaA6q=^n9JssYe>(z1`c_QnDm9HYFhHD3L!6;S6pCQz2%|p z72`MUaHym1?`*7bd6^0J-l;pxnpSc)p5K9dT{c;`+)*{M_)`D9T@HR1?Lk4I3n2hG zSWE|mARpN>gU+~qMtX8NbYD~(vF^K&NuvtfYB$_0WC~@%ajR!a4Tjlhoi>H$R1i() zrP`G0>!e;bTcZs{m2CTal;&}Xtr@i`@{eKb%UhdYEzaiGBIB1Ur#4srhX*d-`QRj7 zx3>xYhBgnZdgY+fYlx2r@{jXHMwk47@Q4LI*F%GRKzKLFq0Pjjg4+K3SVSG=V>zmH zum0Y_mBzjsZQXgMLOZFS`ED;H(7YE<`NRsY-|%NT76Fsm+}raSYeTB)gXHAA_W^he zrk5UH^jB0x_=xCR|H90cW@S@f2Rj(QwT+!eUil-4WFib9ZVVv{lYXw|QhcJ`L+%2t z4VXvN&Xv|tSwL{sN2H}s3EhAyB`1-k+k$(-to%>8Ugy52M7zjz!}D2nSVPwE1$J*0 zA@fuFC>Ju|2rBBhc)TF#RuN4i*ykZA?-@+&TALYoz?o461!RMkZm92`C~-kYD3xP3 zK%a1I{>Uq^{kC5z-j&v+Al){V=K)#6cN48s@5iEz9;Z?!9%&S_k{AlmfO36TCHz_7 zcOL{w6ezWVn1}!wCS)iyW1+gd1RYE@Fi`@k#N${S1BfmtVB)>P8PFaZuisQTt2cWM zJ7UWlic}2KSzVh1n+ zl$CalKfZjIy2u}Q(`p1^>`GRmx-VGb=3Uu0J$G0pffZK)Q0*1vj`_>@Y%isybHanV zG5yB{+&OQCtGo<-b;*c=hlPrNYbRpM5r1cqTkIW2@kDa5!dMCr_A`M`wB6%5;!6_H zAhN>-ExUf$AVDcrwhQp?K7gvbjIUa4%cR%~M!z#1hL*i!7Gje68Jv_jJs2~a3redA z)hUwlwZP$%d<7=e*UdEV;t2*9cym^kbeXS3;^D0Gec|1cY8M~w(EnUEy+d+a{#8=! zL221G^sR6&jH`=qT*!Wn1Y6aL=eUu`r5f$1AC@Lk^MH4qSg6RKnn|1dEDdzxLdC%j zyLxKVvn#CdKfiUcKX-Dc%`Pllq@~YUK`Hpx z9qYp;X_s@|VMzZ(B-sR3w4mr2_7Y&K{Ny`l4649g3xR_Q=`P3*W;F?170FU|-yoE7 zPVt3O-rQ0A_;Ye7dol37@g;IjzC?5VuQ(XMbVMtgxYG-lUI#g2ihb3MTRz3F^DY15yFdeZaJR}65$t;qNv;0ROVfjjiTCGK7%=jKHuY_ zT@X6n`d6VfZxycv5Y&55_#r|J2mI3#ZA^?SF7s&Yg31yJra(|sDpZ$3UoaUDHrruHpi?$IU{J1_Ro2O3n9Ai?aIkFZABxiw8w(hzHO#Vd(~@{# zI_KxKB=6~!YS)Ty-#7^1J$_CY3>Y9?epD#nu2@gS=yE=BDrScWv7f?r^xIt>U1Gi_ws5qaA8;*j1k)M~D?ft0fXDqb9foWVZ@*%wA>hDk|c${&no@N8@V z%-!gS95(kZX>3}O5sQq9!Va9^2&|0NVvqTQViq=<8=rBXW#GE&GFTO9l||`Av07)L zbYrPdrK(zE+gh>GzL~<1*j!P~Gd@h6&M@E#->icfXLSn*XHobd*(xc;(ju9;PN6z3 zxsSK!BB`XUEJp_K>7q)_tjFy5H-ioQ1rCfL0t#a64eXYR{Gg%?Zv-SkSGDo(08BQB zFPO4==`jpUXoTxBwTo4lVwZ(b~$Awy%}%~N9Y7LIYO7)yc_n5vGKBzq2d+2vx- zCxZ3puom1$O)*J$=WU6I?h7&jJC9E)3#F|)X)Tb$Z&W1}2VF@n^7rccxSa+-+= zd#EQfIy&8*QF|$jn-K7AEe`B^Jod{Sk<)3>s1swntfKlOTP$_h$0@yCHym*{ z{;vDiMOYuZI+&ShR`Ky#P(K&QZM!}r4QfzGr&L_iXT zpHq&eu~9@G6TDG}NAX&9WcSidNv1|+ZwZkbkRCx=W0q73r*+lp7>XnHrCA$RC2NWA z`9V`EmzLFRlibZ%DT1sfc+XD)aY^@LER-ZR)jT^N(`}k6*QTsGx`zoGex!>^wFS}| zAaaIa?A!)er!@kc{~{+wJtf9#2df>P4}KZ#C>>(6^WaazhmP0GaCx$hBQ)iH8lrnj zQ$Uo(sAM$oZfoo#jx1V4YX}N};O3A|%R#5@rG%&s=aJdc*%-2mhb?E~NgYO>q|s+N z?5O~SzPHWLZHU(ExCUuftV|yA@Pkqz;!&3p88^_|yZb-3K&?H9kC0(ASvjnktnwUsf0lg2jsPTi0;i#yFz0bg6(c4Z0Tuso|Een1i(@w;UKA3=SleOdglJVWHJ5zI z*!h=`cOr#_7L|DH<12D#P-x|<)s7DN;Ua65$6k!JWZVQCVjGsZ_Z7wjny15W@GG%!)UsGolYkGYv{SJ0FiIkT zGJLk+$&l?~mg1;1ORNR0Rv4d0QKWrdryV!oXV^Kxy&&#hAd!$=p1CP?xKW;UtkX7YnQ|k9`4N?wwlAA`jx0_J#LL5 z`M9Y|7q^}a^am6Oq)V$Rmo`cv7Nwq?7(4+*BV52nHdrr3zFqxiihs?3mKfRaL8SCw zTufUmlmB%1zNb5*1vic9QBl`al_g3c2#$&bDTZv{KVGqZ3St#Ej^vPLgqJ~vHCkq9dY5+50Xx&+0Z#`;l3Sl zJczV1OMS*1J@0l+nHj=GTsqO5D@xmUqM`29`;lwVIz=Y>j8b`)n5z}YAmEjiLv1sL zNeMed@fOix~mKh)aeK9;Tk@eqxa7UuaQng;T$A`^Exl2*Q zUc2>XNgQ#i-NU&uLR_OAfus1N&nIcM;NPbQ&G*CjU|Wbw*2Hm{*5L?xGxLU522CC2 zYCqHH9cIs|44xkr#UfTyxf&k46jOX$15}C&bpxE(lQ7b#T(hR`L~qD`*8q&?M3e#L zOue7cDWA1(8Mo`Qo;7gImc;CMwY@+RB{S(N1*nE4GB~eB|IF1j z>OojV@Fr?4!?be&DJ{-*#U7C1+|BVwX1(|J!bSpvmG`MPP4c6UEJ1bPUKAr0y)^Uv zoz;rnJZGSHwAoXPT%AG{*@T?kI1r4QC=~O79AUsE-Fiv_2$gzeOUkdtDmH8>RYl7VL0qp+wbARXr%Oo5WtjZDk znj~1~7AAdE%n{N~#~f~b_HyP_{*GgzL4HCS*b7Hre#1W=bN)2~$7Nx-W$ zT>nC0W`9O;^io7W-kCN?Oz^-li>9mz=)(vUbtk^J_CYOtC}QK7H+T+eX+cf4KX;^M z)wOH*IZDoVNxNcM$vKND_yZgp*@z-mRQt2M{ta%{bpb$-+!FNGDQ>q+dLl50rqHCk zk|<-`R3R1l8+h2GzllT>Q8dR%EaO&jGb+LEE~=CuK=DmfaHF|N^o)HA$fg%tr@n^T z{h@?CmH<93-o|(k)YhHSf=)4qHcp0$)Jxe;_*IWM&D+b6=qj)Y zePTe4gMw8N<*W`?TepM=d=f-DJT;VBaRL@Ef)13v-+w69R?YC;AAi&P(9 z*I^w-PUA46xcXy>9+L>lm%vUrnbstOz7`uUKR4EeR?#_PgiseJhtvnZUv`U_O1uQE zi%?!RtjzAOMw)pY?~fmGqtG`fnc`u|Dw!hd9Rs9jBr8ih1TU4)0F9Hx5PDlD5qejw zh~52*rMDvr+BP_FYKFg1Q}Bas=Y+wIS3^1qE4~Ee~EI8sOH_RIkC-J^r@)LxB|=sB|V5 zu9LE1pyar^0R)-@*q)R@0K=3pGeAi1ceg&WHg+lbE4Y`@3B8DuxiMQAgmju%O(n>j zU0{@Ml+i1_1Qj{vOg6p&=^w%L$NERqmc_o5syklTS3pCJ zC{{OUtZ5^%Ve4(uikcl9iM|QB@m>-Sy&*%ymKp+O48{%y1K4wB;RwV=7&)q!FMs?^ zz3%(vGu@gb;}I`$Jl_dX6(F4NXcM7gPzzy(>d2+T_CW*hnY402m~{a_KK7GIkW8Bm z2PjT^K8a;GAgs<01%tQsYftnHJV}w&8lFNT_NP$sX=#k5%+tb6!|E=Uc*dJD5*VJ;A9rUb&6SnlkyT~F@3B?q{hkb$+)DV|XYqdbZE|)(q{=8n zE{?1)$8wBIIYwPe?rRu6h}iL2>LVp{ER_VUfexnU9gl-`ZTC*xwl`Lkuo;yx)+(Ba zQ{BwKo@;U7U)*m{r%#E*3#u_+UC(lk(O>wF@m_Au$UkRO;pdlpg`pztx_F4*o%2ZA z(oLH#ey3@9=MuF)_!=sau)KB-nh@RZs0bDcG9?WI;D#R_-`^JSID9oO;d81&nVkHodI}CR}A{j-`!?{I}FnP1cM5Peybl;9L1?x}5I$5B@-~ZO^$)<4jy)Rp>A? z+r5P)BFsg*7J>8W#gHncu33?XBVCg93o3lTtR<8!17ct2>kK`Cz$R6YJ6gFIDJCO( zogRvpG)kB@S(7NN7OzK^l+H7THN50KWkrk;UldH#yq;vH<=dDOD9MfPW6Clk%6(Lt0oj|^UI zNOaOV$|m-uZMd9af!*2M_{rBj6u3azw&S?y4)cFEY59NU%VlF=WBi|qI{%};&w=GLTemj}bWfy4B9(fb zu@0DNiM|O6g~C13&GIQA9-Tv$x+Iyx_V|CX_D)@*L|vO@W}dWd+qP|=v~AnAZQHhO z+qP}gsk*39-Q%sVy2q%05H~w^#G21~=4EQ?t)OB!bFgtDjx~mvr9B=AO z!W!BrcZz4qSUL2b+vslndojB1W&G2mYx-C)1^H-8WFiuuK78G{`8j^I26I2-`=O`O z$nx8r*?!wmYX|!qLFLPfx9sUV+k&RfYQf=`|^V zl;PePB=LPq(^|_tA)Kdr`e(IJ8-$w9qnOI}>%PI-qD1~Nt))<@@z*rdrv{#iKJe%( z_AiLAE%V&{aSKQYo$rU4h?4bm;ic3Pmrg$h^}%QO=&a{%WqZkPb=}L@YbqT7-T?z< z5cLMTz41aEU%zyGWA1NuEjh5R-7tO}d4|TF9HVm^cUCfv>=?AI7c5J`j2|FDX{t@{ zri#{Y-zo> zxUAGwbcM$Jv$&JD?e_;~S$KANl^Eh2ViWH$s+r3J>sH|nNSRv{MW^VoFw5yyUA$ZW=bTteTWa|Xql@uGGNTAOVA!}(v}I?LM^f~ zv?Bryh?ekPA;vaAhSQIRBu4z~4=lW1>uIJaU1D~ueX`?tNS_uVrhuG&%yOMKGSw8!Zx1M>QDlMYrjD>UOO10=VxnJxP5e_)90J zNu>E|`c_B0I{1V6tsDN>W?(tsBc*R~x>5sSL=5bm`%}76;)2+e41y%vI^;KrSIQ%; zdB+ei!h@t3_+1TIAAD}XeXvNO%^};Ae&z)-y{Q+OF-GczqIQyT+6z(5$K9dQ`6VP( zDG{d}lI_1VSqqNZj66kS_i>E#R*r4pVknwC_?e#aFCQl{!4!G_xJtC!pO^!LLGR`B z_5t8VjnEJ|wPaI=c4;!`3jQS1V|FWH{G^05_0W(#L4p{(0AL3p(1$w$f++xH=|Yr9 z0H|~E3jgxYkDv_$Yx$^&H#*m8qxeaF97j(k2WHfeF1YQontlqA27T%Z9cqI#&WnF_ zjb>+h)<3{9LJv7Rk)*r{pFLZFq{ZsC++#yH3TgE&(ZSA9nh#af<#p)h^xj;_L$4IH zwG7fk+>6RcYJ|wsDT6{;NAfuAUw0%JvMo<9nn(B=4M;V3lpX%#TonM2u4FyXK^HWg z=XgU|e~_LaH%VjanPX`R&^O0cTy{Y`IU?>Gb7-plC%)9z+fZIoB~Au-Uw2wssHhWp zYQ499va3O{ay;|e$P*X-q;e>vAY5m|w-bFi;pO_xJ|y3rM}yBj23F@|Lgv-=Ifs_l z3!i)&1Xu%ZW2Su!fo0)7sn&VJX=*z>-LsFO@>25oHK=JX0ZIb2nWNH%2XMLACs$V> z(!JnpW2~++FP=NiK!yZw77c?Rz#7E=Wy;fWgFsnPw~qQmkk7l>ptvYUhcQ4VkBwx( zkkIE`#uo4oTB>8i`j;A3gFtb=Se&D5m@%r4`Ur?GEFJihPYIXpK3mnFaNZak-)`3So zwMh(D*ntLiCGm{mFi)a^R_i7@f>PH1D$k7!MN>1of7tPZbyj?dVeS$3#HOe+Zbym? zZ^t}=(*y}j_o&c!+NO=FC%~dSz=b+8e6h@=8DG7E=xL^&z{OYk7mVkP@+2!mH>|~1 zuZS6;dX@RF!RwGgr_skE^V@Tnnp=u9Dx6U*0B~0=41j+LvmpD63NR8`1x=Cq?E)v& zv@h=Z69aLMYO!GnJj_$7|J5ISAhPm6(Lze7j#2)(_c7)g{fZ)$LWsmY$jHn}btvD$ z0^CdchDF#vRy?}?Q-JCP_re+CG?)noy8DJC$Y8qg8gXB8-mh}d=mBJEtFuL?(*#~? zM3BPvdq5}Q2T&4xI7B3r$c(UJAo(qAD+rXD@0W&C(qsaRAdi7Z;fJ_I#nm~}yKy{(>m2}KT zL%6T(*iTf&Vs#ZNa0Fc&88XQQ^IewhoFpifsYL~7Rd(^q5z8B`2flUVcwl*AN?~OL za%NqOnsi68;@nl(7H9~23Ap-b!Xad;7TIWL%dg6Ob|m(Q=j|1e>eSD^TY-S z<4}xIQW0@X`Y)HGlT`ktb(ONZC~?ZN*wf)7w-9ERG7`8J87K&Z*eu9t1BF36J8$C0 z@VP`1vKb|3>znor0j0tosbQF>h`?5YxQTIu-02G3h5t;P7u@3q2uO4Z&pjjK!bUI# zOz}v-(d!irw^O>|_IH<;r2f?Jna&z8QOA<=R19a)JK>nVhX>rlQjT1QpA%awDW!)4 z2UP=V-jHowZ*7`ngeMhz#xQJ7;+Q<*hfvcDFhma{pa6XRL=FsS*Qn3FWi66_AQ+!X zd2>OGY*i~&o%3X53)VqM%I%7^!9R_W^Jv0I{qd3#kV6zz)e{sjIE*__B0{DUVkJ-` zJnrC+=D-rNPOYeun&RmHHnYLE>Hj2^2yO>&kX+7LNYZrF;ivjkTp$!=PFX}KN}t{w zJ5u7ncU2M?*K->^^`gKLlmFKv7#@2s3QACD4=hP&-I!1zhEsMW-x5nKl{cAV(BujG z93&KCu^&%R9gScqi!YK@WeBgIy61ud2Xeqce!+MqcCZiBYVkFCe@`eH`KzjfpngC! z>b6!t#UHhC7z*y{gjw%>;0Wx@_UV_QBiwfaLNcO_lU{@j;w5$t6GH402iD@3DQkxq z94#kzIWO*aqnxPd{fR+XV`vR;ryA%2%{6r9X2C?$@MWOi_SfkpTkr>ovY8WTuQE_@K6< zXG?0*d zA>zjDIR=y6{E=)3zlr7nQ-rri#3wLFCFr{Y<2*(w?>ZU>SV?PAA)<+1FN~$cWI$&r{G0-I1>q#XT^z%s7PKsEv)54U1xms1;BxT^u8b zk*j?-y^j)UF6--o#|Y?eb-U}2zBbGemo_inU~Xh`xM_DERXx`cW*{wHK}dRorb(m$ z2>#|M?a{h{LbqS9J87yEv)`1M)B|GRgsdW*@7a%-XEO_1w9&q+k4Ud|*T2Py1d51? zxF8aipyGh^bjlYIVL_Argh)M?blqNWj?>FXBQoelIeTK~*K@~r+C+8qKjQ&+r4po@lv+cSKY7bLLtx;AxC}kc!>si%uz_qq8FST` zWTj68+FrOwqzXKSi#Qfpm@(azMp2maDsUFgVLMzGRl3ApFuu=hw!!!|S7uslaNo!4$N{Yz!>;kq<}-;JRov#qXsk>4_$;tbOdQ30joC6XKkx5hpPhE72g99X zXc=F&sh~pTK#?qRk*Dx5H&v3)x-s64;M{VG*_%e-9}fl!jNw*jJH?%nTpTZa-PH-8 zUWlhjnDEvC;vm*DaAuDM8 zj48!=2ByN(oeiWqz0?*BFi@|I^8=UphsgRLc;Oucv2dw`!X3aWI2m~qsZ~@Qk&Tvy znVMyCA;vV<+?wnWPCP!$GTkxK6$+xxT3?VM5yl`zMf(ZGpLGSc4XNYwGmId>A9ab5v!*Mpk>V;dLfjnmHCN_Pku}M=s4!_XHa2Dz z;1&bLO_t6&U~kT+&v1%C+>U1KHRrBxRMD1TXZMb8BzC%g)`!7~*dcAU!Z$`Dy31CW2+*r}eMq9$-7) z_Cm_waW_bD-#&c?2MZy`QRE1qNJl!=jilf+ynAqSM)%V)Mf(M=-P*qb_`ANe9-O); z=60&Bl^y;sc^FA1hpU~fof9d@?fr43#iLn^6q(9#De)|&qR!Y_(xDXThO>^r6~s=d ztbDwjG(ovk<*Rd4LHByHU+w-j&y77Tq;Z$lh#soWotDcOQJM7Es6!3aJUc=-2s_e0 z#m}ZkKU58d@|i+vckxkDLCLQ;?p}$9Xmj>ilgoeyIDtdze8mV~ZYsMZ(|MYk>+N9R zYgU(l7Q>zY)X{2@*PKM==dcS7jXqEp z&B_7f+o|cxrK!@Ig;9AFRhvS<+1Ot?hh~*w3y2NY@}~;yb65T)K!lV6?Q!7Ha2W2m|C%?%k|7hRn84#v7N}IYn4RaW@x7HX->XcXVz^ZE8sJ z+Lg@pHR6b!T_RDy)0}B+6Tu{2#~b{?aD_wApxvQ~-%PHNJdsZu)w2IJANzJ#IMEqs ze{V>13%>Ak^{4}+BX~K2MT09W0Y9NW+Rtnj1z-kvT|+`tbp-j35dNh`Vs^f(6+|qm zmw?d3QJ-)oMy30RB9|exv7MF}J9OQ}XACn76yr6cqhQ6BbGpD}4K|W19kwXE7MPg2 z{?(3W_c{1h3;{`+=N~1;jEa}xIo2c|LjVph>4&`Lgunun+cXpX8V3Y=L{2l1lbm z@Hz|)Kl!>#v0gg9j=h>G%GFtm!x39;t#I{`)L}hx>Eg}Vb0c6g2Z~1^O3d#?SHNoh zm+A(wPsgV+&%^DFbPK3XZ$oz%OOE?XLU{<}UjTLnv(}%^2R#DI4FOJO0jP3HmA2mO z6q8E0DHNaQfy?Nrcu>|KRPTOI)-n^S5c{@J$d$yzk$Fl$yTJUn9p1Pjvjc6m8=$4e zk0_*AY9N_wwo|LRxnQpQ5PZEY%|fJL6n*xs&l;IhhNa*!`gmq`Fejc6hl*l>(yq3^ z9qU1=*d!Q$X|!(k*a>8cYwKcZrIr;gco3k%uHXIWHcV?`8?KE{hb!)8{ZZG~YoPL< zMUUV(jss98Qg|n}{1JpG=7->so!ln?OAy>Edf~O;JX0Z&A?7IYejgKPFC~$IfDNIm_o(yS85p@4Ews{MBC0)zUW57wFI~b!01LgXfd40q!{q}iU6 zsePB)ssMVQqA-nQ7Cx-jX_e$Q%Z1N!tv?oaw4JwQ7Td5h!;eU5z zV$Xr$3>{j9bQ{hklxCY_4+#kR5Z8GDn?TMY_k`+uy?sTNeZ(~Tblge;YXV1AMDqB4 zEfgA{tw14U2gB0=8VR#xI8rWl+n9iy41ArJ>ZD8D@0qRy?QLpAQIhA9LASSEf}aW! z-GFiv<+R{8)p%vu%<(`18ZR=EAS)14Oau^)>++XoXRD~zKCFKqE-!*??5@_ery;s6 zrn+4*GmR1NRrJm{)wpu;$cb9B2<8!Sn?}a5LUM;{CXLl}FwBgq6cmOpMiCQF%8cZw z7IM?o_PA!jR=?_YkFXt%1SD+GhaLsV%-EI3#xP|Q95uY?j*s4tWtC}>%x+rEkV>H5 zJJih8XlPeq+BY|aoy)3F53kdJvTjyJvD?=QcL|PMpi7)`tZI=`IU1accS^YzhqC0Y zYO%D7=ymdW#?4Msl9%0|?ls_ng6HiLi`QNXopOCR-MNYRuiitLJTP;zUdC_<>5~ky zR>n#^$>wS6nfEamX$cC&Px)UJ{i1-8MR=^jHtvupD%?DbDYc7XNEk=@2v~+V>zKK7 z4Vc@9eb2vv%zTYCw4fSFjFum)nkE1g#Gh8(qligUD z0Xk1ENlBrQ$2RdxH4RxDGk;U~DMe@d;u^4Du_Z4+fh}^t-7J4y?7~!j8xQx$>ZrK) zcrAPjSMQp;-{3qO`mp=Y^((PT)~;i`ZC-VGZJ~(f7u3Hv>VgFc^5TRF8?Fih+CSNw zV8z@?ky!>=D6|6&`Onu$iD`$p@i%2LvrK7SVSxm!+)fd?oDPw$@JYvo%7OiwGSAr| z;*~SLio70Oh-d;RIi?8Rk+~APxGL^}9zF1Y0OO;ouq?Y!v?$-24kXEiw(4yrDGU29Yh?2C)q%G%#9-Y*Z`9?uuY zos+w@O65AeKAz6yGdeY^#T82*FII}E#^uW&qV0Gu^K8wODvm4^*A~B)`O5{Ak?%^? zuBLdiGLDW6>Zr+_yA^}OMGL_yr_-vRlRTY{w<;G~SMTFcAG-G&*00k)Ss%)=F74m9 zvytOnW!D)c$I92+BGx%o)jGr!B&X{ zQa_utBhhRVCbFGliAQgWb_yLhwY*!7G(Dkz2WVQb^;%1{2OOR6Z=ZK(B#(hIX_h`F zRy<5Kc4*W+nV-pZk@Yg{I~aP`VBw3m(v&>wu0LJkRXlS{wFB zyb58}y!IHMvg&0rg1-Lt0MfAm`DO19e>OdV7;oRt+Sjg#m~)u=wwksOU(TBL_BeW> zz^WpIRu*FC%!#7XK06(|e7gPY3wG8~o0|?#g}6G3qWxk8s>J%jQ?Nl{mn+!X41 zbrIqrzHi|ngYY6MtDg-MR=vCRl(2KkMqBiEYXe9^=MzLndjLQlbWH-mgEb6wns`-1 zOyVMb1@UdzeqC@Dw`N^19tdh$^k@X0u?@Vd7{PL#dbvv%Me4rf*mCNLHZ=h~HPj-s zAZ=jK!_9=N`Qe8`PgP<3I3V#*RX9MHoBh@<%w>eC0TAsh=8m0#D)RX8SAfk)d}Idm z$wJ~SJg@mw3hRkT!|u7V3u$OGv4d5q;{1t0T;v|&0Rc%i?xM&rF8w!2d1)CKAGSm# zIS;@h0-^7#aq9j|L)W@}*0u5%(}?yXi!i|E{DCwRDe;zd;V7WNNoDN(^WL7wh~)6y zbgnCV`S+vTSDMe9s5JMHlK&^W(zfg?7fqSLuzv~nx#+@AqLIwoa{HI|^7f1BmE*Rt zSXH~_X}@hs#XpcQzwx)@?!Ha~2)>9S#4@3x1gQ!=5EqJYIlVoc56Wqdo=twE>f{we z>iq!zD91z{tf>a)_j;o)_}ly?=+(ECKyR&ex4`^`7L7+^x1P33Zqq;P_X5f&xy3cEpZqo#H!W(h&82QW5l&^4kbRCV`m9&o-m9A`t zVRm$uqv9EccP-yKdKAF_GXquN1P~h2K1Y2w!}8fp*waH;PJkrcR!JCrVIosuGye0O z`}4!>r8@`&(f6;8mp>4q=FdMyf*IMalZDv*!7;zs&-~$SF#9GqvMnTsIV|~_EXbL! z>|CF5ep+nNZcy%l_r`iwm_O`+y~c!I4I!^oNJ+ayC^h?Ts89d%fA0y+qj(8U;=CBfjxegK!2?tz!2lumyU$X(P*J_SYDC!z2#p z#n3k~u1U`ZakF(dtcR3TI(BTP=F}^w*0W9pTWW67Tww;O-AV|UXi$*eF_b2F4RTr` z7B*eK{bzL8Xn*I+d#17+#7x2Zzk?`H55zIr4fr0vv}l|zDs^i9Q(^!j7Em? zvpi<+lRI8X)CSbG{PpL(`5)!Fo*kEcl3X`_tcmv1)oS8r9#i1i%;p3D%)5 zEK00X&NyOhs*xULE6^6w3z;q9F8p(MhFqZy!GYE_LafTGArL#v^K27eq<;R+8X*D> z*`;}<;*4m(kc#x6nHItYnvUEF1n4wBP1M)&kQ4K-D zWBFB+-#;`YM!YRMz*bU`YoKWIP3e{Wv;{63sy z;aK=Gu7!zeD7YmW-v@0a_d&)#oCG|>sDxt0tvmj@7U|tlHpnKTBtDUf{Olb|d9R}_bi|#EbVjbN81l9ST$Y~%`EOyF(8d-3A23KkdRC0OgOrc7t38M4Xn|oq7R%;$icO3Cw!+uHX z07c7rg(l%l?F0HRIEmonIP>NH+uN(sV$XmZNq!73mGBmY%S-?Sx{oQJmq)lrGa;1P z+UARm)gN3(gb*rVqacjuRt%G8YTb51g>v(i=|PsH-FLpL8NwH=K$_3H!xL;Zii9wR zzPSn7Y!Ss(6~DOr5er^@86AKz(QH56KLT#H_8YNO69!d9MvS)(TG3sXd?+Y93&-vX1Wv~9QI~$O4$bkG`YKwL z+k})PB(G{;ixrcRNKLcJ{YC>w zn=5pdm^Y@zJzMM+$U+Q_;$))`Ya}o!8qnObB;#NvUQxfA8 zRX;n9aQ^m2hYhs~%mrX)-m;pw7wtDz=9_DF3UdUt#j`meje0WVVxD@kuhoR$7idtvXwPog`ts3}wx^DB z_24Midzx?*)}oV}?ZSys|IQpe5MXA5*C17sGQre`SqU*}<`E!;4zh~jVi`W+`1}@^ zCLa3~iCJ9_HAlt(v;c4|y~M@*YY6KFRokV*#-Q@pB2VfRq_d|&%y>Q37f{6%T zE6&X{Dm^Ej#7s=4vjBv2c1kYbm_Oz?xd8OEZ6F`26U6}=+e7~Ad}G|w2)65>dm+qM zY+E#XN8z0~Yi~yY25muFY|P7eqj0uMKAb>jbr14s(25XUsK?1Fu>iq--+m+v8c&Zt zowN3;H2!Gsk13Y)l9Hznib|^_qyZ0K&Dtk2x%u?RLFCKjQQ(U54-P?J(ASukQ-ymJ zsSZM)OB@x$2KJJ53~OLe0({K7lCPM;3zvYdL3<|whj4>*rZOxn>j*!}JTeJ{>@Jpf zuZxF6#5>I+1l;|dz)49>gmJhHjjK(<@EQ4Cll9ICJjUBf!7)<_UI8r8s+Wfe<(>;3 zVKj?yLlyjfU1c6+*1P{P0Qx)a{1EdM7U2DQss4KZU9!8nV{SkwttWg6kDvm!1A_Ak z|CKQ3;~xrUV1x%f%GHDZCd~L;4}8E99E*;&+j<>><*8(%Ggc@u;XWf_Y)APm#$}d) zsmxxg_Z4Uw7Jz0hfLs|ysc3&1c|$6fi8*X$J*!?@2^1WF4*z!lucDb1k(X?4vWjK6 z3{B{|aSEusPB|fY5D+BA; zrEZ_^mx+JlR4QY`ZXQPgxouRWk7pT~3-kIat7mKSMdh|(lG#RM z23O9%9k6bW3{+iuZa`1_`$BGRXt*x>1m1U%v1_(6M6@b4T3))g}nKw zQy}SYJlDZ*gAU20HMYc4O>G&`KD_4H1&lm9wt!~jF@!9+wDcRkF6J4bAHzHhmeqJx zZEnRxaSLeElooh_yc8{+ZqHJ}gaiU-E6#Um@oUmydA=)))xV_p2XO>xB9w_O?weOd z!8dE^s&PDuGwvLeNg0~;k_o6yT!33&bP}&ELHONXxl;fU;pmz#^FOJXWmJh_Gca&j zSPQkh$4n_wD_4vOR-j%gG%B}rJv@I)Np=PvLaC;h*w*y2uEIT|DNNScO2DlY@) z5i^wGoe0WEhZlF$H4zAUvAoFmj1vp|p`iisF4FfD=f+;d6HXA8l+HD+OTZ5xJZ! zDlP7$MBHx65hv;%vLOYwhEsxaKW@WQuKg3Cmx#hpt5Jjx#pEoy#*uTQhBPNGZblcK zLqo@c0~IVbH%Txt&^!O_D?{MYL&8(DYIGqjE6Hc*cKC8=x|tE7Fz=&d=G`<%(!0N7 zG=0SARJjsLX$|n6PZvw@La-gE0y$ZDTn@WV#~X?Zo(#TPMps~(!nl8>q-)NAkzi-6 zwSZ5pW~cf4vUW&dL{!up-+Wn+&45C~Wd{_~2%YWrRc!7!S0$lcG*5%|IzrPN-XuPp z!C}=++o9_OL?7e%M%jhJW%qdLLGkajl?Iq&>t6BdY@2aExrK}CPW;&YV0!fI!3hFh zGDVS1LzFICr5i;kN{u*gs5Q(^VJNLBy>664S;RQ1QDD>ee38_fiK=M@8_Aekr&mHN z$3upiij|21R=57D7(7q(Ayfvt+2?_h+$8!zq8P3cjfrz=3~nR4$8>SWfNeG4$~=9G zMb$|@U{w(7YBF%L?~yC;)Snem6lVs@U!4U_&KgbvS#ewe>}u)#*ap_5D3~DRr$CCh>XOA5}H6Zk`A>+4RKBV?Ef2 zR&}FtJW&Qe~^ZVX@@jJrh^Y+qAC!F|*QV_2cQ>m^}%xXT5_#V~Jc__PnPG@#Sl5H~{Yb1yl`Z z^U$=`H~1Tt$_-l=Ws-HkWvlMn|ANZ9ddG$9la{>Gi4_0?_+VpF`AK0{5D523tD^+S zeieO$r4w$-e14FBiRg82E4x1 zHa>@Ro>CUh`fd;wC8YrMGJ;nmtKG1}vBCQB8T3HgP31M;M{f*etf!<@L{SZHJ&*E)t;|AieF(0J5MrF@NtRQW}ht?Mrr@HL0 zZfY6H+$9ikOu0VNJI}YNFQc}YYgL!vwkaE5I*m$8N=kY1_P>(iR}8+?jV;FeMZF*v zQQl)yj@2MVA5c?fTo305C~?zc3Daq_j4rgCh;OI$vj*A*MtY5mQbVXq(7Z8J*##A$ zCKR59vyD|P<0GXwZ+D7Mnd0`p7FT`saH_Tv+jR?Dh(b*VGfP_0S_I!4h5TW@`nrbC zII{S}ymDg{{a1ib<3f1h4Orxs8zKQM#?!Ordxb|JxH2`wRJU=$Hd?Q(Ym;=5-Bts0y`Z8d47~Dnb=7uezoT)I0!Mr}ikf-W=u)mH9M|xR0#BTF z$uy_O#jsuY#U-_6xC-yk{!Li>o1jluL=p5VDlemG9txcg zM9d;tMyxjI>V02niC?a4j&v@_1N%B(U_)2@nlF+YFFM$rt^|;tRW?hYJ zeH?%-03{zWS(t4N$#36~XtpSUudrhmuNboyDM?T99=Ndhqbb~G<9>Z0)wJ;PDT;wpf9!czu{)m7NIx5_+z{U})=l4p9hBdL z&Ki0BM*{`Xn#t;Tz!N|1c^ocYnJ4#TzJUvud*DuKM+rl-92 ziH9xvxJ4C~|6qT2Z@of4cn7M%gr%q#B8Bft5-;Pu0`AFj-gg%Na5aQbexHLO0 zaLYw^>Cu^E)kY?PEHo4aqar_qQpHFm8F~f#z_2fOAPpfP^?6uRwZwpNsi4K}FT0W! z8}WG`ct63Hrc0Aa{k!n(zF>uJ9TG~yCC=WEI|ipP%()K&QCjTs<`-I^L(*jS*MvIW zzWwL6N4ZHJt#q`muHLz=um4(r+CF%G;*cj0weU5scebs-^9}t2vw6Wy$9kZp7mByl z*Fw4iWm_RQQVyA#zgXqc?_(ufQhkbAl+qcUc`CwV%|zYv`US6v*_L_$P7~vdtMg$M z+4o2+&i;=>6b@4emtiGUD3yRUS|l1Jk+My%P9d74t8l@==f{1DpwsVgD?~Lm!G~ae z#W_|`P$is|#z=El`OkrjghbL^_@_0rtu;4mvM!;QvXKME8k0>s4k+^z;;Pk~Izu?k z*ZngRG42BMo0L7xhNN@TfX?ZLF>w-;VV*_L_haO|G2CbDZyBVF#KEm=TWlQroaT z-dp`2@K>Du{C6;tKJhFvvMxJ&#Ai-kS-*e_zQX>ujbWK)!Mpi9eUu00F6;3yP@Jl| zgRBY-quS(4Z2Qb-M$TqA59%Y9B+>}|)q8}Mvnk2rF*W+{Zcoe#Rr5kpTr-SFOO77d zpdi&f5sZ1k*;LRq0Xp_?xP3UoSKsg-qr7!5cFq(tL&Pb9PbypNKng~9?}X|@*S*ms zU-NoWGu-k0S_~QLB6|Ht@{oNzGQm~pYYx;qDR;sy2;iaG2TcOgbS-x@W%0+HcktUK`bIGEc zuQR79Q|Nd1yvnRWL+0iB+G)jziba9#L_o%chwhB4^)7Qg1LZ{5(L_J?$s~VDlBGRc zc0_w>iJb6zXI?s1Ny$MtpDn)8EB#UEnrsy3g?le#x| z0pi)1lj_=Zv-6zp5^vT44G$~RAxC+7fY;R&iACEN6G|^9d9rxdk>}q29B%s@6tKK1 zJ42dQZ(QK(T=vUoP$>dw#R-k|1y<+%l4bju!|A^6SSG0iwN&{Mra`p@^7AQwkjPZF zU2RGl95qr>-SK2{PE3;AH}O&6_mc;*rs1~w0DG{kdSnyH*NdoJrE`buZcGaA926i- zdi>0{nH6r*%BC;>`f-bA!W>QiN3qn0)z%_(-!L}-oc@yU4wA70sq=Rj;K0%9UvegK zszS914Rn~rNN!YFSkr2`o0V^U;UE}s(sj(0XDlApnZ+5)4k>rd0bqk?>kKXevTsLa zcKKtV=raIXwBN$NWtRQ(!yB`C^{?thuAw1?Hd+5c9;^ML+IVNuN`hc?-EHw%yg(`k z-Ur(egl5g)b6Eq@Fn*O|x1DfpM*gFIc7P`-;Hz zYI&BI;-dO(f&ldeO2|e|+W{4Xr(nKSE?PvlhDW>t@YO65ER72wS3@hy9bF6d=a@PM zL|Z)TQ+nSD7)k7Xum{K>waf)t$5$t;7prAlUFBHvfx##3-yW=dJ>E_r~Oc+H?@9#Ty;4e?h&z7Tb-$12;lycl^IPJsy{lYYIO zWaoQyx2A=n<@!_|gk2qD8SVMz#{K4=pvH=U=GURZ1h*pj+6IwkNE%;nbCDA8Swi@n z;j}v^m8pr~#zEi)4dk7)T#hPNvV$f~##=VViyJW0Xz`7?n&mDp$$pp(vq(Yor|E9W z_j(8r?87}?(cR0L{DlLiI3fSH@`tF;eJ$_eCyOy+{@V;!hDtn8vfmq^+>SJDB887b<96Z^*2m&X*6moGs$`MWOHc`vr?<#j?e4-OK0{)ao#3*gh9 zGi%(_thsin4@xQ(6w{~SB`bCIi7JWXYV7BhYTKZWnX7oFIhQ`8(V5|tXARv^@BgvI2m|BvaBnz9jdAlj%NzkD_B}WaP|}qhBZDF zm~fh5Pi&yU{(HEtAS`w~D9ZE5j?`wX&;lwQC5!`*-O zczbSTt}A*NakQ<>T^TS?8E`>S(PxdMj5_8|kJ`!*kYqilLo3X)5xk3re10b-u7;e{ zN+C-ABtakbPmYVPRT3K0utTa!yeMI(EI*y8^v`ELzz|RSa|@AKVtAjG6+OUzQv*)pYyL%`<`WqP!eY5|RDouZnyv8`V%BylVX_foKYO?sG(H6iap7HAGo^8)`e z*%l;^{2aERz&H;x@$C3QAY4Z&(1+AvS1s`3LyEpFELBp9}{Z;Ie<0@)QDof>2MO`I~K z7>jAtQ6c(B5Lvs_Zzrc6|L20SGV>P=>T5g6y9{MF!~rSu!=D$t!a}494}1ViDi`8D z^EhS^{JUw7?nsAL19C6_$|Irj^|$~(yddRVdcJJ-EDOPe=g5NSI@1`qU3uK|;>@Ci zD2fn<9hF(S1@9S#GFgoHj1z5~xPf;EJ-VhV=p)pUzS(iBcii!%7Lh^j%V!hvSz8!LD%S2kMl5X+nrDi)gm2CR7d@u(AU8${=|f)NpxG`+7~RszHc z?VMz(ux(IAZsoL7T^=-r3k}`A4vrl?MjHs~TvV)j(>S-5`iL%Or{JyF5#u-1f(6lQ zAyqyd0oL>!iC1rI7fn`c3f~)ghO9Ink&UWQE0oLT!v(}jOcP>k#PhBoeO3Ta(2E$i zD~&$l$K+={NI4k~?TYSMaa|i02b%UC)_gPY9zUihKzk`Pf1EMgG>sLZ$Dy5%{ruCF z0V}d71_K5D7XgP7Lw6LtM}LT)n4Jkr*Tkx)IQ@Pe3FbXP3Wn)zyt-AC-PWtV#h>FE zR=ryPFaBNe^#RCbTk}~45=EoRF4$y#LVE%b;81~-UqJ}Qq(X`!aun}WCk$SR!*hXV zf|rj>KVnUZ%G$7>Jk~KUcITB^GdIOQ*ZEMN zeYrVjeQVYgvTO&sg0V_d*#{~Erfu!2TU(Q2FKluCp}hj$MWi=)XAxEEJmmp5m+lIc zvuha5IWs3O+2>7HPd(p97KL(lU=DjW`NDUl{+EOqMs3cetbjbj;G%ys6Bc>(k&TGV z(KUA$MCv&R(KC*U?QOXVIzjD(IP%$OdNOA&toqZcfyw}xGsFSg=in*KoqqA53ve~h z3bhYLP+bsB(^8Kw5R&E{c0h}m7nDHr?Lbz5=L=%*`tnAds2@!FkJDMPKPBr)L{(XW zR7LI}ODF)*C*tD#@Cix$()b=Y28L3eOx$aCutN{Mzbg}dK!B?yW3J%^03CvO5;M-z z_svK<*rwqa;Hu&!m=H+OnT_!$5dS$ljTPV}D5Ml?>2%8*AE}MSpv^P$bX?Ov8%LNIu|6_|Wu?JG2paeHgk)K6G>!5*1fS$JF9IMc_Cb#jMng-W!Z$wLdLgdL~4N{;E)`ba71hM`ZHqts|gwhNXM^ zhP@W-^tD!PY{w|JZS2z+F9}>zOfS>U#gJILb@Qa-&njQ9`jx3qbIrD0*q;a;h{dK$ zeJ4J>LS^8n3)>?FpxP!Yv5xigG*zXH6j4gb=8kNzye*(Bpv9fCy2H<0mu-;E_}T8& z5CD21??6btt_k61jr}2}jmwkugLS$p4r#pgYOV<4N*s_QktbfB<2a`#gI{9e^>ItC zY@WjD17d##9L`s?m1qSNui$d$to*|o0xKnVo5Ogi1nMO7JXe+I(1MU}AUIUQ)In|4 z;p?B_X@`plFE2KXpCoHITmfm$IXiL8sD;h~=2>H%|MB%20E{?o1#FSppIR}3vr)bg zfW;p*s@F4w^lYaB40Kpm@9IG}I02r#lKFQk;7Y5Ze^@_QX z8+#;wJ{vp*5J&=Bp6%p-^%1Ms9)2j}nU5B&2k$=A@o)B$VH`BCXG8P72Dv_xRQdND zxcZJ}o+nNUrg1}`s~`c6_vyeOt2>7#5~!B7YwMLTB{p#6=#~>g!VbsN)^M$9+Iu|p`%FQq?j!UFF&Z1Xma&q?nh+Va)UY#wiu5o5CiH_aQhvkPTh&j8EFJThLIb=rC+ZapEswDmmkb z{Tq_e6?|bDqjr*)2|tts(6A1YqHL5AxN7SrS%>=ZOY{`3qO+)dY&#l|R0A}~JQ_C) zDhW#kd;v($K#TQiC@r$=D%spKX$Dd=vC{MCon%ejt4!F0I6*x)342gTvYTI8ejx{c z0u(cQ*7t@G)L1I2I}k|Uvj&vN)TgEHGL&Kqenb;GIo&j|e|=uFe0)6K_6}B%kCSw>vD=-KlTo1> z7Q(m&5Hs)iszr-g4lfhQRncR^5^|X;>KG3~_`=OW4|_Yrp!U8Oouo9QdMKHOOA zh?EevT@bP|8}Pl@@AGxwhRaP^d|Py7~^O%tJaahKe7hxTe{v7Z{k?9+?O$5@~L@F@OY<}N#)y*53THWca?xv4l<`qD-Q$$XvMoju4*Dt;jy<|@*Hv=3c%EKNl4QJ#Co7-zBPX}~XJf@WsHtm@ z;Dj|`ym7@aAMBe;$5xoxK&0?HRYE($j@#QVujj7dV#Mfb{ zy(G%tN8rmFafI0_FTJtk zIuWCWM&t!MOJ~An%}M>+q@hzHwg_)vq*G~1N3HB{Cp};FZzSdmM-+T&ljpX#dp27w<(AuZ1L)%lT<=cCQH%Z<9?BHIw}w=_Jf8g8E4;FQY(r`K^a zUJxo6;5nZh*1Ec?%Zjj9k+t3D6iq=FkxyI81~@=k_};T}+3r-CKw&Wb{T>_f3c^0v z>y5FB>+@vK+%>Gkx#I8mWnbDzf|-ACDZ$q7%Qf`D?4Lz_b+pqH&XipA|7y|aGgNzZ zN}_ZjC{{;)+Q3)+Nb+fC{$xhmvja&mQ?`a&k@R_sT>)d}S{3FEBh{l*j@!77&e>d2 zql~UI>#a$7G+1gnVr#*2q5~y+>q^Mji}x#|B2KaTDc^*0xqvexnpP&$fH_1 zN%b4bxmf~`QiLbH;Y)?~9{=T*tkoY2N-3w!UG(V^5N({gg=&l#FEe6*1Pao*f*Ps8 zE*-a}_rBTKoYq<6KEH?cGmrSHIwVvssl}MLiio$FL&9<3p`xOCDqJgKU!r^-llx#L z`N!}z54A`=x-MI-WX(tegyg_X5wR#y?B=v&?)OHrRv)8Jn$Z8yXPDzGk4q&yH81JX z4fWC3kimM4bmf$?K9NH-DoY_VFzFM=<2e?-pM%ra^dZ-aHJt}10R&5$NFdhd6B*je zXoOt(x>}g|$YTxULPkkH^ynZkkhjWZIYV5C6tPHq6Yc#@xv1+o zZ0mRums0e?#Or`6gTH&?&FSpOdRiBAsEEfxMxoaoHpZWH)z!&xJ%f?p?k*lV^I_;^ zzn&W?$T%HuHsUg?y;CZ;54H5#q*3o(Kd5TxuFj$Moev)7!V1m8oChbQ1EZEnI*b3V z1Y&;esnAAl!&^4u=h;1^kFVUqiodS#Ouf^%{toHL@nKxRtltae&n&ZB)fHVKuaWK^ z!cgef8d?H}r5@!*QHdrE!QY@GT)EUbUQzmB{YT7Sgo_POZd8Q8zydxjpd3|0U{3sE zGuqPqul=dEmtNL`K=pJ*BsYgkk>K?Y&pq)T?BPk3ykahE8@?(G#W70yIkacf9;r_K z`Av7x$q0*%*M#(CckS?Y&)U&HbK`m_O_(?Jz zLoEH^Mu`@*pCh!!HU6~l93;7=PiawLcLUbK;g;4``w3Jngn^ybj2G{z92oKq@ya-$ z?FdT9a+{3Wq_UEJ%H9(X?lGvC1oPDcb4$PGh+$M^qlIxskd^?)DL+>BxN&jGF+ZO+ zKp@+s(iiq+hcd6rBy+)_KNrT++zvU4*^v=I+<^SDkCwRkI^q*WvrNWTd5x3T5gnsY zB9f|3#;%$=KkEgb8B0pdM@io6MhOn8DhDOpGX)O7Vfok6B2~Et z3Br%x2=%o#sywl0ibV!2%;DIf-NeCrAVbwsOa8mcPe5BOzY;i3 z6_iuJB8^D&g-?S#4m}7z8VM*rF-{vT+gd;`>z{*P^W4$B%`mq-Ok=M3AZt~dZt;TY zO_V6pLeOTR;5?GF-1(wSITqyQ;dO?(BoHtvwct=ZB~*GZ_7;Z z2ie&db9~^rOF^R=F~u7U5KPIDh+>$~>>+hUV-H%Aaa-!VOVOkkU{I2>KVXnZeo-u) zkhv_EOafIe|BLl}Y=Qmz`%p>bKQt%wKJ3GA;ll0fcqdBR-}3u&u0ypvBUqR9+f6LV zLmOi|GLqreiz#JZ7PYV-8G~6%1C6=r08TO~RVK*8Qi`x(8VhCm+CQhV4oV;$%lcC8 zPwbEP_j5f!FaT;|HB0|hit}HIu-X1U6k-3*q&WZYMA)qVU9j^%Ccqt%XEXNF~?0-b~ZeuU=MKASKryn>LH@lk8P$FuoD!dK*o+ zX@nPr`INF(%#+YLEnk}D9OsUIip+XPSZNRQ-g&Vk?f{b1K;)EA{A>)$l(u?^Br&-l z7_4_vG`Aors0pzD6&*+rv#S9)!N3{7?scU=2iG)4$yfJIX|90B_AW#z)YA8+Bvy^d za{!VjH6#xZXL-v%fAehMQP2K&i~YACqRp(wEvbAqEaYh75L-XkS2#k_r-RU=fV(W0 z|J4-*f>2mOFmohINZ5nYUpIG&Yz~f=k-bn!jIr5{<*S!WPsj>rJSSHxv|0%PX%lJ$ zb$c)J z>BGBsWnEAoSsJ1#C5r+itq=8GrmW1syBcoNb~7`Tv-BP#MgkZ?K|JdaqDb_G{wZg) z>ERK%sZjSsxW!b>?ZLgUSsRE5pa8BS>j)P+&l535y7r#91vL9o_aF}}cAW&G34dWG zffBFqu{-)NkfS+rnAi;mIr9AL9=-X1 zM2;?Nv;hW8YiL+*KfT=u)C^GPjig}1iHY%Y6R>5i(sODhkz8ftEr|w7%H#`#FE-sAE5hW@<@2vxvkSSGM2nHCm=+{dK^Vt@2+HzH zqBzL0w6lfTa_>kLIS7)p#E%NO%Fi&Q8i1Ev`T5O55K*Q03mt4EAj1C)+j6=rCIY() zPSM|yURYpa%6F@{nfq&xXF7Fb6M5=8zg~Hgr00TB*>=8B>oVjS7VgGjSP5<39+sV# z*^~2H0dLxh0}${3HFafeP{*v&EvOK7nJi$%)=62fM=zTqYE(u{M=9LOI%dlm8TF$t zDe^|dd4bZ5X;ZpC+ub|NmRbD=U$tMIl8QHUw%=SPWtuUQMaihfK`TA*k!#$J3LCm< zPG`nyao5SEd<;^=nb4>s25gyI+G9lp@dQ0^vzbC`kQzwZ&5R--BH=<6Eiu7B*e$;g zW-Y5flKpznL`5U@`E|P&Fg0Dhw$WmSPghN+F}~f!)suLWPKMf(o{^>;+{SGPD7Ui; z1cwxBVp2Y|8vM^W6v@Je{u`CaI@ox&gCb=$`u!--r)_~A{0oV-Qvoev0=YHQx@FK3 z(2#}pD1=FtD%!9qt~S)^o2*y7kf&$VjqV7eR{mdI)}==<)wg*ZrOU4<=vWyX-67q? z?Jl*HT+D%zkaXz=7gm!LUXM!JPcfOS4;0* zzH~k54+TSdrJu2;A!fSmXc(}jOzhul3;PRVaqIIS;AhzTX40fNMVL**VLZ@efkFFN z6WX@6Y$zXUWKOI4!37ySqH*HxHTf0S5B6ZdJ#-cIF_RvC^=TH@Hi1!PY*h@td11&R z)@EIlS+ojoeYJl=V{(@EYPZ9(eML(EFR9pivsKkMIPC0Aq)-9y=qA0o`=p+eKCMOn zOwBgIOqs=~r5jVszYaZnvd^oYLiGaE$eNM!Cm8G)48QZm)1 zY#^S;T;fm}GiM-f*y<Zz*TSmT)Zm>U{iUPiWL zIymc{-pImIB*qT);Cye`8YDxb;!!1NJrwAC7FnboTB+8&**e^dVmR$^3{ig~K%b3-}l=F(DuR6pPWJsk1L{E$o z_s>TtRNhsRYP>G-^lJz{1oy?Uvj=G{iUw<;b_2olAiT$Z)Icg)rx6A3>eQ(qgdj{= z{d%zps89oG4ou4Yl;DBdJ7t497iYgH5`IxSUyT>}KGRg(Uo^oWsbHFKnnzBt4m1y; zWR+IJ1;xhMpKS)IK`4wD1*#w1#~M}DymR*?BovPsMB__hudBfeN#x}8^xX$wukPR( zaN2}D8iXmfT8u+Sa1(fsv@MuvGO!!cI|{D7FVUKS2Gw^#X1r)qdlZU$;#22|8|@Co zjEg#&J_q%~bMMxSzN4=1wq<-sO0DmK7KIw?rY2W@3V88fCh@0qNuL}$YhsUrK`UQ@ z;$4c7jzz=SxP+wVuswil%Md=#T7*XcU2|^%fCpxU8?iy^O2xckGqP&mM04E)U3{M8 z7?qUL%@ZD(OxXD%2y-58-%WT4dd^>+M}P#-gpKnOg8Z+n7ekDSxK$4sK^DbIuAD}Z z!Uv@zRR&?QSPR(h3Ze`+jqPe5kO=0LOuPG}R4j1-v}~TW0-%agKoiKDHpr(_1Y~c> zpshg?%VYW^uWZS-xh7QTzsja_I3$!elNT<7xGVEt)dV9z}(3BijhWprX< zmRw3>pw$+T{9vZLL1*K`(Wa{_rI~z0wme~{p1;nEb(s@wzeZ2|wiBa5-{70`ZpG?{ za_Q5O&oyD%oCt91l(RG;{_3vH0O3;!w+M-+2)vc;+@{$1)7NZM5OLcA_NE_Z-OJ)hRa$AtV4SJ;2g^GyQMyvH1CQhZg&pOg@faL5=liQN#XRXq##V1j`|DgDW4aA zQqR8I%>eA%cr8GI9!|gCJrUM+VZ7Y0jq$TsqRJlOU5@`eBzYGfNr=$yWCA1r_>-Ng z9U#sX5JSF!Nd5U^7cJ>pq@L~&;g5c{|M1W!{UL}xSda(lMXl0+q2kLDg*MTXDHBMR zg=)f9=FdKSUuq9#$r@CYtP<%rNFHenOEFa2P^)ncHS3Ay!FWYaxsK(*b5H;bJ(S)< z4aFe(?2h-LD1fRBhgxcO4M1F zmz_eB6`VNGUFIx5(N3wJ$g_p{Ya4il;yroeofr-kN$2qW4~$J6e4KlQ#Pn0Dy^o*C zu&ce?_+Y2cELnntl5Kd|V~Gyl{V&gg7a-bE&`uLvJ}gq68S64vVN%6zA(;0*Bq)5A8V2%v14b4=)z?T`@o`L(EUV+4|~acu+BivA~@@$L*VKn zbkdh1<9?Q$GZDeMsbinKe=388OqEVF?O3_POoJ)2(=<=K&%^bO=0NC($(ZJ}sm9=2 z_(?r>?g$2z*)&fK4P~w5%YlIg{8<}vlyD>pAyO!xHFSl;z&Qvx2x21BeY*GLFqWP< zLm0{&+2=ZETg;~wn7i&4GHynh-J)g=qVL@z z@hEvy;g}(1R0IIE=|V|!l_}EhO10*P%EVA>oQhVsN4YDS^&V5$ZNvcbHLXCV7Shna zP(hanzEdycRc38M-c0B<(nRRTYVw&E3&HR+t8(#Fcv!;>!eklhuo2LysYmBH5$LeC zL*Px#O>*pPgZsCbQKtDn{n6(0ZjBh)c@X74ob$E3L`_al<&L%X9ImBZxcb`ql|8+0 zHHc`MH$;f6N!t-AX7mB~K+Ej7wHO;5{avy{Lafr9_ohj#vS zKA=BXBAMSW>-D1wS2LcFqZvS1Oq_#jN;wConeSK8l5pavG7(GWtFN=w5hYV5&cQ77 zjIj=}VtscjfNot#l<;zP&xk3j1M4#{BH6sHzZxQ5G=mAx57y3Fu$C}ieE*cB8c_{O zlsmm+O7?G*&Wfhdp2w&(Q>@;|RyMkOic>#WE73u%N|z`t=up(W#}gPJScE;UU0@mj zq2CNK@-qWHL-T175(gbjTlCH`IYfKcbk1&AYhYk%W{*ujFrf*~v9>o*s^Jnd(m6S*P0yRB@J zCS?Y{tlf1D^lVNUh+StIgPOlvY(lX2ZwMkDRCRYo&S7S#ScSsA#hG{5&=V+<6G$6)ccCoqRED{{EQiF<-D#1GL5O=g|}f;Mj8$+riFCDV@bv zqnac;cVgx982}()8-7{n=orB_4|LVG*L)s9T|jY+V^7@+c!U`5XV&gL|3_Nl6?n)k zU&n0t`=K;pma0NZm!Bo!crzHhP!e-eT4Vv!SdQ|_fbtY1oI}#w?WsQsi&3J2aJ`aV zlZh9k0mHvLkbEtAb0aFIaI0eZiL>joiN%eZNUj)rDn8c_RRK_5zFfe+VKid00XI>n zGlaMfo}sIFDT9-STh0^zdzyp@qFyE%)@PvI6oM(#`z%iHqdO?({AAznTI-NH^)od(3%_7GcNHTG9*B{s$Uvq#twl<{5$Ox~U?W8mIo+#WR zzOheFCxN}yt$^Rqpis}5@{={a$qrwm!4(G@c%omleg&W|lIcY4=RvZ@G{@e^WHsn+ znd6c6KyT;I91Ek@=-?HFod^#5ogvBq9a%l}E8Y;l1-%!UZlERv4}cx?_vv5ds9<$@ zQxk=qaL~8+CT;m3Z3NZ%wq5Y$_X~cM2@Ai6epo&|(~owyh^!y-tK?JllF5cHKL$PY z@J<}x(uOHK$-d*FH!R{~L|dF^FetAUk~Yx;I%edUA800wfsiJIRDG)gQeLp-#rhBq zYi3|`3cXlaSksWm)19;MAN43a8vH85K0dWe2x=AFYF}{u08>w=UD3NSUL{?>LVwsSyV5O6%xg?LAhyNd z4#9wh3+>}?Y^RjNVcdt~2Dm7SGh%WMqMo`!SSWC8bF4}`dfe=A>NMVcrvQJ=g*>GB z9#B<>r!{3MS;DM6kHE=?8?w^bJG<9Q=mm z7}5j!(2uwBmksTa00rZV8N?kssA(w0KG)TMZBNzCA=GP34&gg@I|*xN-Zw$ZEbA)E z4eAC1$b9^C+ZWKp$?2fXrz>`3LZ|JZh#f0RQTX-$5SKIVDVM_t!K*?6Sdj;g!Bm%M zr`5UDTf_>v0`(7+mDD9#uIniFM|@3J&IWG4-U=DPc?&|;1rS5oy~j_66$1DW zNeA5~MZ0!Sv36X^EX2ym0Gj|4ndczknUmUJZ8JKqteL_%U(B&_SDibkXRCET{tm^$ z!pmLn(Rs;-z;C)vbQ{h|Th~7|>$iSIRr?^G9qzG@j^@8CYxp%fgu=Ob`+dc-RL>!t z0p{#g0AeGVW57X0z@Yt}Kf!UgUbxBZ=|Ac!m!*NMxtFZJJ>X0+P1O?V4c1cGPr^?G zORMhkBi_hSQs%tcu20fwUsylkZ&yTihr<++o=L;YwZk2w^-`jy8h5TS2JoKNx4}GLE`D)54rdI#US^NJ|v zNP!6!^Ytj{Whfc*5}jrrXnp8mDa$9YDR{>-nxti`pSfg8ClEfo=JZ2KYjx;i}_9`sCi2QhX#J;>-asuj|QhAys*GxIbFhD~Vir1XR5 z8S2Fonv;KcHo939ncb6@i`1{^cxSpvozm!rD!rwTT{OefywN;zeI<|G(<9crnO2bB zqr~qwrCAO{sD`X7gg0E?rP6CY3K<&SYTlM(@>-B5qv08ZN^8cv47SY=#XTGM(u91& zb_@xAgE=Oz3Ugo04wXYG^SUq6=SL;dAI&f4IE_je*?Q@UO4ggLA?xhQZ`^>iBU8m> zG!bAY-Wj-cSQ~DeRsoRZzwD2yz6oh3Ub=SzKqLKBAcgS4g&Xy(Yw*k+XtNvNx527Cg zfA}cz2z;{(7}5?c({CV=H}(!dDApb*8nPYy;?_&E5$8Bi*XzVhbi89QuW+wDM@lvM zp6=fI37QA|vt!pno6seUgt0L5#4d265QanHSN_4_h#caH9P%TYZ)r}hO}A+msx%-J z=Tku*`!GKhRlPq^!SQRJ6y3C*99@EeowvW@nTNl#s9a*xSly{b30iC?%0d8KLXz7g zxF@N4Oeeh&0@e*j{)+rkOzJkdH3RBLNUcb1nVSluqDr%zRu?RrijlAH25WG97b{Z_P56_}U-jRH zW;FT+MxDK3QE%r2<g5-_)r;bB98>vkHfkBdHuuc3%=sq>HgL-oNSqRN=Bq|{sbMJFqj z`VWHqL?gy3MNwXLMtmAza%DxUjtQ)Rz1w@fscnySE3-YndHe$pYj+rwK)3EMdcVTqwhkQyAnyL2^qT)Gzf_wRQ@tw!yU= zv!1lpQ~Pam-^PiR_djg(H};?Njs2h?-HngWg~T;{b{5BsV}AU(=d8DF!6T#*9P7tX zyrs;1J`E<7F|UKZG>M7T9+)NgV7Jbo#!YvlfdbjFC=Q6moMj`S>N0aikpk&XjDq`O z`{?uQkG|r#@pd#M`EQRwQ?@acH>?{{me#7=D4CYhp2${vmVMT4m^smDQwPH%<3v5q zqaB4~EUb=qOs7&d%EjEm z)L+hy2uq__!$FlQQ5X!Ff5xDx23|gd>1IEw&g@Z{+?Fs*?~l5Ao9;%_A4t{9ZpZu& z)oQuN)xSb{xLatCnl3TUV;0LG_RvkDOTn6_?iKfCHdbDk=!)MdA>jt?)O=KV;^ zkLZU$=}WlL1XqW6g}j!SMbKOUsjrsmQ43PE#NvMOO_SX*zTSXeza5}bEwX_b<5G8N zM(z3lkO44lX|zpT1n!_TlQ<_(8CvnezClz)Uv6?_v47skGGU&}s?a2Db%3+r+WLYI z_7G9g!SEwdv~%IA`%M7ICTF4<8L+V^lpGjT&4JP1ss>R6dtjUXHRKBizt9b}h!AQ4 zORHP1nzT9vuXY|$kG^3HC;6R=+-r`^Ru|XEaFIqjdG@G-`dgqOaM%3|0nC825_~OD z;%WNTOhdB3)VI6borSq8^T>Ep#T1IW4;XOO($Q1SJG_O1m!RgtQ0LcsmeKj^(V!@I z5HWi;6UNQw8HmhPCPjn$w0{(>$i$g7#B@$^E&8|Qs~WkD+UJkv{Cyu-_4DFkbqmom|Xvy z20|{CPXZI6gK9|WP<*QDk8r|Zv+J@!)GG*6pq^@9@0m=BarP^SobCH#Dmm zsU6Rf??oR^UfuE+wt9TAc|7$Dbn|++%*-uhMZGdB zY#h+jlT9KC#_rdy5gg`tB?AtmV)X({hZ3S(XwIFCVFCBgNIluH`(qqgeNZk2xK664%-#!DJC(Y98RsMFKdi>E zt#i5Ju~%9T#8MmDeMiqRp|24|^T@Ypr=3k6>%B^o zRJRh4NN!^NOh8@W4kIv!K1>%ERXOhv*dVKZBhTr|J~O;UC|xCGWZ1z8<@r=ytwK22 zkLI9pTS<5%x*+fY-YqL`DX*$4KLszDE|Iu9QYtxI)oN9TBYAomGGzjAUjefQ1!2$OZ13MbkQ zca4eRsLy0?n@T`V4{65*+8YjXd~u@st6}^NMXt_=P%F^`$iD6UM8b3r_N_H1@s6L8 zCTd1Q{hwk=!7Z)YW;`8^RAE_d9zorR(+L8Hb1Vv+x+~kjL>TcsRhv$dKq)(V5?GVB z{sVaW3jWs<3ynnod-D9E_z*2jrOFD?tisMe9+Sq0J8hL6q3NNeVfU_+-i=8Y{{nV^ z!VQPN|Fw!Z8|vp>e_V>NFFMoYr>3R74bW+^x9{1IpU%Y++io>QSCN-ZtECNVF5}XW zl9$1`W5-?L8o>#_iZ$v76tZQ0j_^zyR*jTb4Os0%_{(}ZQE@A#@m+8)zesd_(r&U) z_W0JBnj>Rt$aCoK)w3}?&6u*)ET?9M4QHX100U#aj5cA!QC}c4joJfDoQYQj0=Bw~ z5iArM+)Q5_M2Z+vcJc=;3a)aLVeNS0cD!N%O;E^tDUbM-*97SV6>BQAYYLp zmkc8wb{=6yKRp(YxfgH%XYWe)f_5B!Fq>#v%|bFLZgGc)i2ZEdz#Q87bg;O=i0QYdr&$x9l z46%|d884Eev>oMdSmnTL;NU!Q(2ta;MBZ!!xsea#6*kU>*pgdte;XH6dt&%+I<2X2 ztCb>VFlCK*?_{o$5K-K8R*DOv;R-aW0E1JAn(th_X2ln4zP$519*fLC)Z`ZfwtyIV z=t_I~RT>@#2j>`AAe5|7@9McIPY{@;J?7`WX`8cP)F{;eR!quW&R($Wz~Ti%Zps9 zpjo2{ogXQviFK5u=#*veDc<8<=piS4Q#SE?WAC&H&0+WC#isa#SF)L0Ot1&L4EVo0 z61=K%QkUW&j`6M*T5B$9Eorr(00b`=v_294HwzEn%BM7U>3JXtWZ>S6>x6MQgy9ul z9)D0m{`3fhPjhNG)>=JYA$x>BaOQ=y@>UZ)oiulDjkqrRwZIAh0^UT^qj5AP4Jx*a z!kZ0E1&$zWr;W%aqcOpDGyrX{`2ig zV$iGeAv+A;C}I3z6jR^CA&UWc6hTaB)}cr8 zqP8$m%<#A_B0q0ozclmirEShZWP%wlwu`td$!{-;Nsld&(u1dP*PE8J)OMN)vwXgt zvk_kIBhztQTj-og?ep{=^C#m3EOcCHmuR$}(J}9tt_+%g5kXP$OQ2lAFy!{j{8kIQ zRhR>GjA)AVPm>V2JVkok=e+MhU%>ZkvkguqUGa6TD4rtfy`Y`RQJUa+Y^fKMh(@r8T> zuZxb?D+az#H2lVEEH68~!p!+RyQO*gPQo)!rctj_2ARaG?W{^cy7Zj&x&eo>m4V7d zs3~Y$v%JTrxYY{c03+#yAo&QpLskh zZK16ubWkA~g0lfJXQPBBG+98yE;^2SQA)AMe<97t=Zk}Y3hQKpW{w*d3wX391JOvr z5F|Ry~yjg@*@PT5!XNp0nFyCjsvJ84=-AJ?}+GtUip(%plB$35;goS(WO?WxB#dSJumW_#$yHw`2t zjX1VLt9xR)3-+h#?CF?*`ri|A+?s5B78l;0=jr2+Nauxb{l ztAkG;kq^5X(IynpC*_)>*Vmf0)a7;^CrR=nw3mR0WIk9#V8d*~iv8D%)OZjN5vF5Q zlb3~Yb_f6-DB2FJgwFvyZ$|a$*&9O1stTN^$ygnz(JahiN>%t@A&~H@{Tr~h&M6OcS~!6%yhxUmm0?7bjGKgk&gpS zF-1%pPFNxOBmJO;8D!j8{@{k{Wdof7neqi^819XFg8&?@9Ly2@*>EQ!=CGv$`0BCz1*06{g zwRi|NYDP5?DIeW4B$LiV1k~X~VuNDTG#kr@pH0kUp!pt>UeL#$zzoo3X3_NH-{ujm zBjbCMQRu`+dNqbvU^BJaGI0Ct83SX;%`D4Z9r1zVg8{BZQO1=QdMD`UqN`o(EDRk? zZOIT7-t&{_4d)@DsHI@4xdgSxyJp(HY2E4%pCf~%aQnPiq*RX+?8d%GnC*m78`TcJ z%)3V0M(4$xQ#y|9Ba2)=p1h!8N^({CLSJ_6>;AL#A8!KhAQ;kr#l8Q-rT=$UEM#Zv z{7b8ye$n>-S|0TONAAu3-*NB%A@4H_Gspjxdq@B0xcZCQV*!LZvt7G8I`k@+Y%Sy^ z1~ybN@6x!X0++H~f;8G04g?1n5T$|N-Q&x(Y>!98OhK$)jeRlOZt*S@$Vx}=jitUU$Xk^k4M&nGzj=z-cb z%s<+%Ch`rPPTUucdr5lv{m$FG7CJE3#>unV+?u$T?xIu7z&DT9QQsLaD2-m!qk7Lw z$++sbqz;8?y7eizkM@DQrW>Mg;FQ2Ho#+QcUMT+_>6DA4z!naxb}(tkN>yzj zMPFS-XY`_of_Nr^CG3#m-Zik;%TrmX;Hka=O!fd|F^v*-hwN#;A>E87qK7?kn2>k? z2oxyW*Y!*`lx@vjcyUnF>+s25&D$~Tw#lGvW~%DrfYZL=ex=*89)U-{4(~}fywi}$ z^g>$e=i^7`n#qeO3kgB`2H(!+G&F=m3l&;Okd#mcsR<;4S1TsHwSk|bfB}-CfXnPp zJ_Rs#ah^`TMP+|C*U~Oii6vcK8tuibZ&n%{L>sueWU5dHhI&}?^>^eo{0H-hKR1*B z0$i~;aB^&sfl^nPGFI>%O+bN9$Vo~J(23Ra|D1G5A7t7MCm~+uQm~?g`Ysa0Scb{#?+cnP|Tv}54@%tYPo=>#KgW)U_utQX7T3^jw{9WfxUVM=L9L_vP z_(+22heg#53g$r`u#QG^LVZMWVgMOruCJB?CD2gjVrUkx)tRBVA3F`D0bmCFS?82h zgGUnK+IE0Y$N&=`sry%kX$F4fq>SiAv0;!amM{lP7r1iCbB(>ykS(d+1ua|+2l|F! zsG5&>yas3)eo(*J!IouuFiLJxw<8u73m}>=sEJo9lXwNP%K+A81h&8JVT|vAuY7GN zpa4oKOH8SRftgj~P5W?Mg}ZB9I??!XJ&P8s zZwA?FPwAi~eNFu_H_@k;M(&NMs*1hiP|&)ZA*P(h;i_Rv08^FXOTzrfV73Gj;n4Qf zFFNR-8Q6>pWKOX%Pax3u(HaJI9Q#8FD}j*B&v$+5hmZm=X789so-=L5m`{P^6OASc%PpR~8LQwo(W% z>ns!6QQA(oKbxs$L#6uf01up=+;|{WuI|iVV%{~&Na4n?D#i)2EOfZ2)Alyy}kg0SY(Hm>^ za3W;2!41oklZ)5AyGfT_*-OGvD!3)mcR|UVF81#R;utH4WpJ9bZxI3RsS3UgkIwPx zCg?dh*%o#32*s1tEWy%*)W2y@>h=^c$`!Aumi929PFeIA$98{v)gXjm~Q5m-4V5tYgZk*##8XUsacZlaxd4%mw)M}T2t$Uh0_Of@+6etu z7g$EBPQe8mao5*=SQil%?VS*k>zxP z&9=?*g>9FAauPlJz=CKKL-O4LdGwZQ5^y`@ryJEA!8V@EyOgq-(onZ4tJ!+ey`dkG zxj?xATX3d=yD1sWdMD@-r1ap5c{<&Sn@A3h`9}JZpMBIK$#=z=7@ADh;^stj~L#fshnFn;%k%-%tgx#_e;u zhkSrgQb!R6J{+?AioK-4Psl0^iK5c12HJY#QVHVCqTH)w)rjHEMVHw|ljBc0+(VVo z-by3h6oipQ%?}+TZ+52W&;><4TTgL@k1n!3&oH+~2)h09znjo-?^mWuh-^kKFFOjx zR)F>uJVK7)Kfas9s5HWP%4!Gq-y;gwV>{qSFt^KJt|H_hDpH268l_iX4!<7OR=%u^ zQ*eU5?IL-M3`2^9ECzHCjcV>fMIr;|(Zy||g=8;!arJJeXMf9>Av!gQAK#O}XqZ`{yZn10iR#MnH!nsP}vQ*#j#qLa;S;?QqXNpf<=LVb$(4Erd)bpeMQZ)rio7=SRX zHi}Vov}FW~=#~Xcz!hkXWd~44NG=2qQQwO)v`jy;^zin3lZD+1-p*o?>v{TFgFQ-! zN|tLku|NVYp_t6oo}+BpmZ(ZeGU}ePwX|rmQ2bzRd>%wFckNjmHW}!lBFOA@YXb?RF=TWajr+qT~rXXM5 z2yPKrq#WuX$6|gge|+K!GW1h+V1)1m-SJii2@P2Ryjw$7U$1z2!(7X*B0M-U4)-2I z8d2Ozix{QX%aWO@g8hE`u*)P>E)50GEs{!N@%<^Iy|yDQEaa>R7f#tfE1!all|ws9 zRAJZ3BimTzC%Dan{$T|xPe1%57Odc0(?VcLX~DnPNf&Svd9#FOgc?N}ce@@M!ZFSZ z>WB$%V5m4Pqzz^_Sh^*y)$5*6B=_y`TKp(>MRCy2l}F-VD8_#RH`|!P7Avb=nd{># zYYr@LO=tNX{Q%=+_sV#}p_yiq)^_h&w}6BT(&uzgq!iB2aXQ9ti+g^MZEvBs)f?;VD5vFKEIG@6M|r5MLm z<1M*~skb?efqV5^PU+MJxy^|@i61TN;G6)68eJ0QSJ$K7|1G`=zBHd-IvVeF8U*_4-z3&N9B-Q0EVF0Z+Z=o+(4nD<2TuXpu#O!KIw9t~jY5Z70oAnq zUub)$CDEb)+cIt2w(ZQ5wr$(CZQHhO+qO^IHu_Zc%Z-le>U$%q|6sqYh_&Y$a}IsP zl>rpJQZ;CCAROEC($nOr9T@k3@-TxDDtIdBU;OE*4)K!@;{gcn;q#tU>chl+N?uu_oYtllK9Ec7K6jY6zh`gv;>YqZAi1T zDfesdZ=kcAATU$$F*zhN2L7VYr*kKgc`6tv5eQp|^e_mW__UV;!wmRL6qXl>1WjM$ z*B>beobHw2OxN=(qv%AV1AM<6hO!?rJ8L}tJ`C7?!5xr^7e0Z?8X-pdUeL-!Jt}zT zg!vdEWpIRh{PtJ8wVD@#Hgi7TMVtY9X)|^dnLB?Zxq?D**yA3uajN2xWdbzVE({mm zZ~ls6YmFW|CC;|${CnqqHi3FabCn|#r62x!k*r@a#ccfCX!wj8h<@8pI|=VZ(sZ$(3v2h> ztqHDR6l-k!Pf|QU94wTKBRWfo6Zy)@aU(TN9OB+9e`WSAu4WH8;sP~k42HK`IK9z& zhGDl3G@X_vf(@Q~g1IzV&gpbrIWgA!4~NK*@1+Y>_F=VXPW zzY@BFONO~P1tzh#0!+OTkq#B%91*=YLq&IY@m&xuMohzp5`Y_COq-`sbZsjm$Boe( zvQGkw8t?XIl#a1tRwR=MYW4z%pNWcQ>O?j!xYY1ZgRN40vX?$6B+Dmof`V*A@^bNN zexk%x5zCjEOM{vfcg+4W&(n0$>*~TG15|AX{7Xb_Vf@Ilf0>=b}9pt%qnVdUw$ z;4HG#znP*~d>nWM{C_6D@kj>h`5+ljDj}osvO1(^6m`DV3$c4=Z8J`^4>GFHwsN}A z7&TTvgh%O=UDNh-EU~p%xURy*>jgpih0|n4qeQ4UT|A=1iE+Fv3(8jK54S^^9K*`A zcnrJ7+km1PK@Tlv=r&J=@})je9`g(T0&WWywz_2+QXrhe?PBmtyxn?*%7kqO(+vVH zI`Xy^*TB?Xs)ffrv@9|ks7>KoNqA9%HE@H~OJX1@CwqxYs0bcBysVclNo!27=!(o`q>pp$vl>44QEy`` z+xvdw5SCdWHS?W2M=f(dhNH=*FZ=cyc3v7s$WMkDLtJE&wjw2q%^DD*%=J8${VrHd zl)@R5?w`Vn#Or@a#>Wiwxe%ZLS&G&CeY2&?oY!h)r{m4&N+`jMpqbjfp3!p4sp#)8 z<|ukTpBdn#Tu#EJ_n5*~dpMLs4h-+f90S((r`*ZLdNdDMRW?Y*V>~8NA@p!Vuz9GK zyNGTc=BOChvohf9K(?H|Ezd$;?yB=PVzkMV6<%$wcf&yDsySNGBO7 zU(G4CwdSoD4LecWSqG95FC!_N=l2;aO`^UTE6?Aln5%&Kzp!8T9ee(L$^InQWW7&w ze3G9(V!i&tU56C(9ghjk)Q>^IF3-evR2iQFtbU<`j?d3De!LG^KPPt_>_6l-N{TQ~ z?%bJg+}6I1{4EQ%Uy+G7*I5^ld*fwUdhc78{u|b6Ij} z&N097ilKN0y8Ay(9XVZjzxI^c@y_%rL2Bt8pJLO=T$%cMi+BwS({sBfbZ(fPfPS^q z4l)9eJKqDYjUUvjN$HteSQlKVgvr3*Umiy=U4NMmB$^B+&pGG%(@;s2u-_~JRBOA? zq%2�JWaY0IBDu>3^0>q`G%Z5BdYGQ~z!_deFs1Ie9cc=u2Fn$h(Vp1cRLbvFUqP ziQYh9q*WjxVvttz`Il}NO~`73k{inoQ7T~g5X_7&S$NO^P8o#K3$&36M6xyV>LzDL z&XhZA*jc}B#(ur|vb-|X|1p#0cq_yG?rbA5ntHjX^;uk;3f0wJ4}&%n!zA#n_%uAQ zzxci4#h2CDeJ0dthR63fS3=O_AqhfakT=ho-5@~^-)a1t5TGrPbaTmYJR}SszpJ2h zH0jA|S-_*!M5Gc*x(E?X`S_{iOMoabH38Q5udl&~qOkOGO{Du;4C;(P^gAsV>q3-$ zDO&vx3r_KnJ~O1h#Zv(qe^6*;<;Go*%Ok2nUUZ-1w7~CYtZ0Dd@hWep=mj`YB6=EN zXKfAXH-o46K*doZ9Mq}jw<$bvT-g@wR}?pq>P;)%sKXSqi_o{oZl*}7UrG&U24fVz z(u@X)&rM|W%QNr4h@j$_JzQl8uGiB1lpfJO8((w=S-dA5_qO9wD4 zX`DSpuc*^hl`zfa4CLS>JiMbo>7FBuqspHA1;)UZ*o$T#dn1Zn?EBImLvGYMn2kUK zM8d?D4LM~le|1O`mU@i%_0J=p2yskr-vrC;TjJX*PyrY8ow3YZS+oZjBOkCDO=5)3 zMRWuSCt^lAY;j|6!zpEWuw2-I!3fw6`Cb8aTq$S`u(@1a@6qw z_+KQ^9RHQUm*aoX;QK#JU~~RAN%Vhy_Ww75&B?_6zYeDq|GP9IOZ>;Bak+>kI=E8{ z-71g($jC4hvKufe5PgoXdBlbqhwOm45z zY%W)~$J?g@?cW}L)KuEV)wyk(e8%QZ&J5b)2$5QsmdT&=g1!~kUY)9q!D-h#wvJ8X zsCUl_*XNDr;?-jZE^f7?CB3B$Pu=o}m%SC|)Z<5KnVYhZ@3r#Tm~_m%Y4KXJX47= z&%~X6cg6l`=|

AE3*UB#kilKxGnkDC4=u3uD@y(Jd%uk^XJ@{I)K*nyZT0)X5yi zpQJ~zud#Ixuyw}5+eIO)JrV}#$bF=GHq6{gBLq~bhrhmj++gE}E=m1)=l-3J8whdU zkb}>i9DB=ugK$XZB(%LzM3}Kc}eO~T*wj+1-f50p&t$;kbh$EfMZIiV%54+q)GW|Uo(<#j5#YH6FSA& zR!igaY^lrL_)jt?yJ94g;Txly)!YKDa3C1tgb%ySyw*b=dzKM&X?Y*xW<Ysxpx-TD|q$$$i+2d``l4->ui z4|KauJ8Y0Xz^I6Z01?VHmK#wn7y!kBDRsAm%(P{(E5djtOc%yss&BbidZf;~B3>U} zQ+a1iK!3)@4OL5~9K-Qe$il9EgmvF7MR?G8I247PV0L>(jrh}y1a|NwT!?@#sUx4~ zbyT9nJ`9eFzuKuzsEBG*xWP>M5W%|Yj||_*IVgLiIP58(Yjif^$uC#~t}|J`-kM6) zG~QYL5Gxz}5eG?1^l3C%iJF@Wd>T?0^EjSIL=9-t;l>V# zbJvfLF6w!wmN$tKNc+Th2X8_<^l8-CU}*A|l047>DFz@e=LxwJY&*E*(t2b|;0$b_ ziPHy(ZmBYqp*q21NMTDBTyN-@0JRUil*Q)7p{#rKXf-=Y+Ba+@Qxrr-sFd_uVEb9x zCM1COccvkkml8iHjE%Q2OiBcC?O6W}7Y7ay3ha#u@j&xnzrKP}Gz)7B+yN>O49b)( zh5BfauG!=6L+MSJrX)K629fZPg9!?!0TG?blrO`-xIX8VEw`JAri8<}cO37m3W+KZ z1}qTDfArr8@%NY$DwUa(NyK`ridnLltAe9tSPW9oM}=>lB- zywcEbMo7b6PuRxszxR;Wr+D+75}hg)GPA7 zVC*1$l?>#j2bu<=6+I&HK~&h&+?%Te4J(gm)m%n0`&;5+vu}tmLi)})ac+c) znGQKq-!An&A8g+9(V#kf8>~wbb-^lbBY}Cz@7bfOC{Oc6FZu(EJ|99(xu>4N&_lfS zHoO}`cu}acM!r5fjLzp@tj#FOhIr_`FG}DZd$PUc1#zR`QK(5(;v=QgO2}pw1eobTc)YBl(8>gK8~2B=>R&&~HU&U!iX zfjSAprV!@eV`dYZ3}}1#-gLP@m8dIl-CtQj*EH0xVbtj@n?cSpDS_kgU5kHp*VM!e@jk12-aVsW^`V=7`(d z@7KxjKXtslrC1cx25*ECyxP3A#2VBF2{i?EfG zPo;#U{8z{sfh`zJm{|S7h%f{(h3CseP(->~w`9?e1ejHh{SOj4Ktd6hUbq@fuquKU za?yabM(pF;@rv!^CNIC-f~Brph@4ym(f-0Z;)J(d#eZljg#bS&%BTR!54L?`wng6# z<23i&kB07|)@}^ujIRvWuI5A&5A9ofFkWGg)FQz(_AZ4Q;_ISo9E#6g>6&_lS3PD> znf&SRLDYcUjm>(ajpx8?fO17FEN?FA41{kSQ}tcfDFM03CJ*kiRvkZqUM|&WjjEe8 zAdue$3b(Q(HkJBbnqp7#pbzkseCBHXX=A1+JhH;puK7fY4vb?S2^XJ;s~+H}C^w2)uiDH~Q4>|LE2lU8PY%PwnP;OBskdm`Y)&&kb1(FcHi zIXpDNQFr}=DZkt)nJe_njI^%=>KGD;`xlDNAw}}dGqEITpwmJ_oOt z0m3UsxSZD9XLh4@t&psT%d=t*uTNDjub1cZ!*dDM^5ZFbnyYo&R5D>$7vW~cf@mp5 z7IPwelKMTx!PED^-U9lS;2X3iRsE^lF_{W{qXAZcp`2yjk8m82&l6#5< zC)`-RhC|j(uLhZ|B0`eNLQV7CieRK?xs22IC+}CjS;ex7n$$wYN4k8x!v@+$vAwwr z7F373$;W5KAey!HqxHuik8~c6)8_Rqez}rACAUA|l2m#}JgEZ!5OtzgLcV~k?)ZV#AVd7ShAN{%-Q}^#+~z*@~WJh3fgrm`X4$Q^m8>8;WL4y{=|>b0UB| zLk27rjDOvk=Hn$(b)BgYaS^vjVCg%7c&Hb!R?`!OZv5zp>yV8_yS<6I_LBJ5Lpwo$ z;7a&^!1R}4y-39a+^QSkl!HMYU7U1<<=wk48S+-8B#zuXL>xLV$D(cZo%WJ=-(p#* zo;7}!`8lWqDnr8s@6_E(auX7kQSv(}2FVpQa;``rq;Mel=Ur^XK^07H4}7IjCx8bi(QNQZIqHyl1O%gcm>~0yh-Pos^?j$G@8pD_lsu3?{U;Re{CZ|Q zDQp+IL6m36VD+LMn(Htxg}_MSfnK5amXBNU9keQO7hDO>-t-8UXz;XfyTJM@<)x5; zr)!Jr+J%-LFyuJ_ro{%B?n8P8|iSB z6gh4IR+fA}0?}&WC<)i&JMrh&GxupZ8=hp?zbZWqv--3tIwyxw+;qShi;_u=g)@eL zT0l2b`o!(WJ#Q0aVLh1OH~;~dk|5(+_GZx>UeI!>RRCPcYSMjOOjY>?=?E|+Gy%$9 zX`GOL5ej4vhUzIpJj`pD7gb9`;M!)ML}M+C3YFAy?g5P+tZSrTI{;?wDBlwSn zNVi0he}d@5pTRHL@(<7)7P9CR2yWs4RRmv+UGVy#wEh0C^5Lc!Sbd^snMIDdm#@eL z_cO6xAt{Rb`v=s{IS(c^@4yf#>Z5Ok2%6~DRcuq$P%*d<28j#a_Nd3vg35vf+=Gfa z>c!x61*K1d!&<&r#khZ6eA&gNR|h^YKuXBNP-uZ;i_rYrLU_0WIWHF&C1u5K3izKw z<@+qvFCS-heoclhMkvC^Bs0*vE%h=||&sWCgvL_mYp5 zzLiD3g^?u$>!iSM{{62NSL!NN>UsggJDQ{LE(C6Z4V_lRiRNKZ*p9>JWt(opQ9&4b z=x-8YeP@sJnA>si3*oeCLlJ80O!bWpkWX(T!!$Z4$OH>9VuR4OLR_`9d2favSR!)# z+o{xuWaw)g0S;-?u#_$yDS~wP(_5Nh(7BSwq^V`M=5S7a)0kdo8J~L10NxM^a%^Vk zYJm|qeuT)i6yasOu=aQj1~g-uCJPm$Q&wxC$;~pKNh7h+y~zic6<^{w10JgL9f3Pd zqA=jesizEyTF+ceFCP54S8P0Ud7Xr->J%n(^gHc`i~kw0Ni`52_Mo$^eqNsScB7T0 z<0YXvMkhZ8oP&I9KAE4XCzAmjbrmY>=%pP=KaE7=W_TArO#_=ge=wLeIdGKA=Mm8s_6ywik%URwz9Z)y)u2=m_!b z%GY^V=a+M@$ynqo3odfk3c)@tSOb*ph4nZJn0|H4a+FcDMI8;JBgG>bQh&KxQa9Sq zd6^W^fGUu6{Wc*mr2)c>PP%B_;T)?;y^!%8?)FMYf~}y##NsaKqd(>E{fKC;ibAj5 z1wl6ivQm&IU@QU>gm}3b?4gtKj+-ZXXQ|NqH+-89DeMGOvVOKh%nuxC)vx$*$KmY= zs{C6Sn=iKBAv{~Ekst&k6?g&>?m~IvYev3Sv=kMW9Z|LDWq=r@%b&3MfF5sfTw{2J z#}Ns38t$$4okYLaUMQqMtpgE7haL3yU%I`f1*Kk|=gl=N?V(;lq z&(#SV{MF~iMtiTzICvKPZf}u~QDm%IJdqXy$M|YXg`Kix$dN~~FQ9gO2ZYO73pSn# zC5rlpVv_ezD?_c~0{!F)bmKUQnfjkFT4C95Y!+X1zvLX{VN3uXs2)~Ma1^Y`q5QgZ z#k(Oe?uSLIbES-#J*d(PI6A}*<+rfO$Wq`p%jjn1bb!Lw2EM$ecGv1R%?)Bz*S(?8 zwaIjvpcB_2j=pdK*eAap=7fO%b2+{?dV!XmfL&zWMYkZStzYr@U@kvbu_HRkgCX>{9NL(6wf zM{Gar8Zv>6aPf|2QE7f*vO(ZlouW0x?L+Ql$$z!uXu(6n?kA9S?yE4}TwQ^GS<*55 zID=R$YWHRzwy#m#+ZpoA^RZv9R!1K|@But7S*;mbhW_go-jRT1v!lF`JH@+zEdbgxg|+)cl>p>+!hnx86HoMWkg z#rj^e2Jek$vuVS~1BPiqplaS^z>1ZRYaXi`Yn_0BFKh3*n}IR{@mYG2P3x?-BdY`l z(?d;S!!a@wqhXrQh>U))?^TjRmr1G;5n52MuHpI@x}LD@D!m#_E_6&Ls}d3(pOZ=qn@k!NBA zQJsq8LJ6HC-FFk)i0CLZIoB!(N;J2+CISpVPjy2J^=47MaA%2X<;M^{`ewT?(+9^x;6M4}`%i2Is> z*2kA_bUS8r0LA64FCstz9Z$zk=S%2WO=`CzZhJkRZtpLW#)qG`^tE&&8&xx8$Q|q3 z*)vTnQ&0^XP~Z8wK4_QDJ<3wdpY>G3|G~7AvW+$UF zeD6q~kel$%P&ITFpJYL2?rKD6+F`$t=tFd~Ebu*(`?_Av(7EXLdahiqgY#U_yxxO+ z4`I{y+1bsQdcwUh8(VFj=wttrYch&@Jt|F-1#k3od}^Vp?5R+M(@8#MA6p*6D%_L& zywI&m7jYBn!%(*@l;KkovxILHhTV7*Ae}>Pm)U#5ZF{YD87?nC)7*s{c1wJFNMSt_ zMYriI1$|)^TpxOFj7WO2`s3M*Zm2*m+uh^^L1$CUaG$Nz+Dnj`(y~_4NzU|i2w>#`W z*VIrnk=FfZu8;x;`GbHGf+S=O^~C{d1iaQ*zdI$)SrJR6!fRsC|au}SN= zS@Y91E>WTZC_}rlh}s970tnD5A*vq#D>eP8=eTay?)xz^8twO}h?Eeu9itA03e*7z z{SIstsL$>l_*(zXTeO=W(;cPRa>_*WZa+4&~T4eA{p09NVEpHFTgp3IPG=(*iv`yCf1>7b- zl)NAQYq^jxMM`JoB)E<5K#GP2Q%lvCHv7c3W{vc;jnkBk!kKC_LnyAMZ?#3sgP)A~ zN|v%eY;ve^y|^0cIDcV1fM!7b$iVK<=Q zQ`BR~B)Aeu_m!($!at$m*PCGok+fMS^)!YhhtZ%Ex|dYi|DZcW6m6p{Yz%nur1hYY z#}vt%sZ+RFU%7L1Rswg&m?9Dr0j$+qRX)uyrac!ea13s+Wk#&G0$n%q+d8-YAXNh*H6YR) z+87>uqqK$6O^=Zs?zPQ$l0MSIv`*DEBGdIg(r6cV$DX+LBfWjDChKg%p0zlC9D}v9 zF0n8PQPodv`p84n4!AsbCNP5%pf4%k#mGC#4W(WCV|oJUgcp-$M;kIeiGXW!sCpmUv7>6 zx?8fegkX_V#IpsvA^G5$oEg3#JRqMReYam=hJA$ewP1ohc<=3S9M<&qEEKY*15T-D7?0tvztl5qrq--JUC<)AnTL-Z}pB z*G9Y3c;ob~&asiK?Qq5E3wg+Dy*q7x{+5PQF>&VxTP!Q^`YjMtspNJZtJMULT7}0L!y+yw zi1xB^=v~sHv&l4!=v@|3+n>j;^THi(CBOh7Z{Y63RO~{Q`GyT(j4R=H9V2w1HDA$7 zs}_Z!diNjQ}tCW-L*^t z9)At0TMk}}2bZT6J%-s6s?9JMH*=KP$ET?Bnd&}xusP+R5mC>chY5oMiLk_HPJiW2 ze|r;79y{s|ERn4r_KCjluu|w{Nx>mnRPQgl>$;4u`((0eRvCdQtG-}jre z(Id2EG)^cNSsO8{Cw%#G2r~1~Pa8Kd&#{_l%axs|6vSBe=l*j^-_)T<^)#-f71hDq z)ppQwzq-GolR}M8LJRR=GoSyA;qSj=Ckw+m?AnE9-^m6gpDtMpja|8~UEOk?8xF9;PO0!8(W`wd3ZGT!dd4k+k*DJW>yaYh9+RGgAeXb$MwE!H>$fYSVifO25PG z0;J1}%7q;Rj=Q7Ez6^T_%oo0ji7WL>peQ zne*jr7huj#IuG0@v~B{^ot|Z2oMe0Sr0N=&0o$#3zXPu#0}$aByoGqk!IBdGRJMaf ze=x;LINgRe)RFGol!qWp7JT4npIcc%d9dR~D!({{gyj&Vi$h71tds*B z%#RKUlH7TS;R@M_qY-|czZE6xa=Y?s%a0kc5{MBUM@;!pyn0XYTF>5zOoqY;jrK$8 z;%YAQ6vcmW2|GbuGT5r5Xe!r&)m+S+T&-Nny@q9ZdePH8VV9gRg9<&j<@e>eno+Mv zrxt40ri`Mee3XFnEmBTNdMBE(>uogAvH6}(G4dH3vTyuMLnK_fCY}35=1r<3RQhEV z4eoyqJM-`Sy-7+r=uv!Sd8XJU0i(RwlKrii*%MNHqaT5nsO=-|sQfWfTnyCuK2;#* z_pwHzZXY&jWXV`!5eYlaoVzY@=s3A-rubd6zsOc(S!pYQJW;1f^QDM@q3{nyTlH*$ zEAW^Xs9yF!8OCS1r?~q1Vsj>B7F-y8ohZyW7d);*LTfUSZ_~Zk}tarXN$t-snm~y!AGt0LZe?2B>DDRIOfDj z!0_Hz68!q^!r13tGSrs=_&KW)FqWzf{4mB0nHp=6Vl1!e5$aS@-@4jD_?Z1OMoK)_FIE}3SpyUb6JA_G-7Y=xx+UmBhm-e1th#8U{=VXpZS zqI|!7#VkCQ^mmo?OZ}z-h1IrKH_DgqcEYSU|eg!gKwxlhvT`V9G*jSau z#qW|@6w~Md^msFvlLP8lvCN=#mY<>vL9#kZ`_Ek*+AV=Ouj;NOLDZ$hVG_S9a##e@ z*swO(GgJ?~*eXQ{nQ^>jBXW(oEVl6ulSC!sA%PLWvIM(b7MAy@C)lK7=&?rAApK9v z2J_Y^aSX{UB>W_y*SK=(xRXQY1srNV!A0)U!zEmdsi+IrHudZXQ9VLf^!y>qrMsj} z<+|BgQWB7tJ^@cGqkVmxDWKs56t;Cm#-M6oD~>Qw-QG*{A`99$w{VHf(^CixYKeay zdCG32P8KfTm_W3tOei`RGU%jGcCp4N$-`-7-?b=QnoiiWL>2TZVFzt{9-!Xwm4-Gm zjBLm2R9Xy2%?H^|B<*{ltQ=`G^RO1FlT(HR$0t`a;=ZNfv6uvQTDBKTEcgQr6A~lnk}^OG1HYfuNwapHGG>A@oU|>+W>Lbysypwj$4h`h+hZA zT%byxCn6iTkB!0TOtRC})(e#D;5VqZmn#VIT4PQ)*$Xq0(z9({rL_=UEbp)@gQCu- z&nl(>aZ*YWH5`2ch{sNoVy}v``@VfS(e=KN$|!RyBYqpMkeI`ilDyQ}gGp-xqjX>ULsCAD_)o`$G-Ss{ zUF~ldU7H)ygwb?vQ9Py8p~9 zdVvURvSYw}ynk4h9@hVU&5tgMJ3al$<9&5yd*zmFJJ%2*b+~lg&6CGNs%e(7bUMyM57b13R`(W* zz~o_pkuYN@!rc=)&5fr}+$W1p0`FPiIY^KD7%(8CvYrw>5xo`zO6kZ}x^wU7(BIlo z0UlGx&iIe))4zWmUFGv1f63;XlN8P*P88h@1~cR}8y!Xxv$qnG1|KNQE7Dd^>Ld<8 zFI?o-`U=!?)IHt!J9T96^LKb&n=9Y)JZ#l+T}Occ1h*IHw~joA}Q11JJPy3xtEvo+<+ep ztK&VL1z;w#77JD~yrkTKMxgMg~g6}J-UO$#ZueWzSJuG^$7wBiM z^01cJ0#f6qEME{PgT6Q2`tvCm4usfS)|sa+`Y<%M8Zr# zMPU`IrX*j5yumXq^9l*IRo^i3hpto}oq=T^%_%NwrPulCP3L4s73jADl?rdpFGO^-D^8NkAW zo-TmpeA$Eq%giCCG**i`ToU*_LfIjxH?myF7g-ys-OWhr!)ebCq#8>}P^jQ}mKSbO zw03NvdVna4kJRJ7rVq|4w&#*}L}`j95_vdkXkELqm{hp{5$-&zXNVStErWHg=xO`) zn+lwkwq>zT@5LR(X3YnrT8#TRQi}yNu*h1_PppAcbu$%AI}W(Gz_!7~DiMZ8RYh&= zm-=d>a304lU}g=nOxf?yyekg$l#z)7xVR7_=LYe_#F4<5)plD#o|Dyi!D&gwTeG52 z(zJrgcZK;|Qm^=MQDtL8birRX}#4I zTK7RXhP@S!w(6LO0w)EN4?m!5v(^~Hivs5p{g;OK6?pKhjaXNZXqfk!{R#u^NjJ;K z0Cmb64}F7j(m9@{IUaGfygj~lqIB8rmVfxSEl&K_2EoHt zjgBSUiNRS;_uD$sYGF2ZY<6jv#y_1LX;maxo`L=LHC}~PCCPDEs{#A~=}Ln8kQ;1&BqD0p;a6X_P_}p{X<{G7*#FpF_ve$T7X-vcI+QT#T6UF1FEX; z#7?mvcuoF~m+TIOvKTn97i5g}LF9Xxd|;;^aXR z#&&#y67$4h(!b}hEXBdcluEjK)m|%%3$?+fWe*WKVP}knPAFoEg#c0}+V1*9dYBYu z0Mpc)!Ei5ut`f+6RR-y?SVC8Q4GmM9PFZFu*f9ZV<^O=XLb)Q z=?_)Gpczn{wn4O!pIA|)t_0wcwc>djqd_Oh0pHgv;;{tpSu+tYt2kZWZL*4{B1$64)*|M>WCJ9jz zIl*~+nTVb_Oevo*3?VH4-jVl*!uvvjA!)Dy?Y&#&0^V6I;pn*ZGti@w`Azhd;u3;EF0v{dTO<+dWSU@{K@#*#mgl{GpP)h>rgblfI!jlH0E= zc*MKaf$wmU>B7^MoC$^<2vS)&t>TjL3$E{UHKx4V*w#L3?;2lY;|oks>+@7OC56Pi z%R~J0T>_W?Ye=L>Ok3>H3kvs3xH2!2Y3nG)pXB2;jO{JwKWkWY!sRn!BDN-%ewM&70f&b5e2yp*k4*;#mFOFQKkttfU>+As(LBq zKFeo~-t|9&oTRY=p%0(zY+mFMzvE!wpQE*k|NbiTJLe_jR z&gfj|jzC64CvVqpHrp`7Yf3nGWuK5?1FFq!-kE`_-}8xd{AR6NyJ3H~O%!B*;Kk5A z7yZeV4GB5Dl-Fci;$Yk1Co)d?B#6mEX5?(j?3k*KVXRRKX>1_osaW+W?dysmYLvsx zM*jiDI5QlsaeVh$L^NJvaBr@yW?pP(`dwV7&7^H7Gi5`u9x!vYD#%)Oj0vWstiHdLey%=06G^s)r`6JJj?U zOWJM1Y=XlS*)d!DrJl?+lHB5-*DmXg@Czb@pN*N##eGula&H+fkQ?c-NnPff=8?TN*LS9Z3QJnkE0XT^NoQj*u|dpAs?UHF1}i3+ zg4;6?Ez>>8sH?fZz1RyJWU99qJ;^0;;=f8r!9Yu7@Hkk2t%@U|yPnO&P(<3L${ZT` zPp@Vqk)HMNzEr{OxdYW%7XI`FEuNoHDFt$<81{DoqaG&`pSGF2xb$Gbx6Uv*w^P z3%QtPXyM{;6}`Y@GR||{GGjj{f-|k59hK~W(Ov;dXzQbEYK*fZ$iJ=X$N_c&5M{=s z1j;vPbR#Zj!>u23j)Q%q7}n0A()1x_TUP7G#P7YxSlhoI6iP5?(NWraFeN(%!(;!l zUd-waS>KaeV7obXb79aIG1R5}s&~=D|GYYWOQVvjy}672NNz2oIVN%PFkRa4BvJST zNt{0ReDywU>%IRc9OA>u_$3EG+6{o=8Nl4Ue~ql`IS+w(VoJMmReR?wg%Nlc>4!C_ znyg-H(_g<$lP^bMD-bo!{ZFepzUjG&P+Zq7B2?|4tHVEL8Yh5Zx7NAL+s*|BGA%g? zBUrX?6vE5UHG^WA>wA;LWiP3%3OQ(%Mz{f8j@jR~UyUu;-ciPwBsb+L3d5@+y*xES ze=U&IOg@%ajKZdQjCMQ|24I~qWQ_m9l5MIC4R7D?9M2k(_{cEQ4uOJ8@A-3k@*ODv z*5ZDzK*Lz|dPNVv1RNIqVu{wVYU<-JgDxixKWm>n zkq@~uW3RQ>XQTH&Ka6F!?@xD;y2$E~;ge=CAb6bTmSHj06XCMM@_+MR>oKY^GZk4h z>xQKmNrtgVEH=X{)Gg7%eW?le0lwS5(M!{`sloQ*yAm+w_g7CZn2E|CY>8A+DW#Uh z%IJq|(rn7saus1C@j0zePc0D_Z$H`mP9GIiet(N^@mc)38a39&O*Gh#FtSG94hSVk|SYpeJr^Lv zUor?x3v7ElLR)n858l)tKt{iYhahwNH}rc1nfNFjF_P3f$N#H?3NyIze!#5>>*6Lo z#eL)TUI9OwrXtTc5|BkB)xXLq-?xBYFfsSf9Oki|nk{(zE@Xdes zhE-qHt>J|oZpt-d=dj#)&PE=!tn9`*ef~&H3p<)EW&+*e`d|$iWyS^@3~RwlTg&cz zWA?e@#j?8VYfi-I6>sgMF8;t>SH{;kx2(&{=I|%yD@G)sl$H3QmM*q@B0)#Nu0=GJ zI6xiS`9hQP4b^N6hDJosW$1@@u}k)J9ilf@_0-wsPJl0t((r&wjugkAWm@j}s&gLv3522LQ*<^Q&xGhFpyZZ&w3r>ZQD^Mj$ zS+{^JBv_eO3|bo-${zBN8qIQ>mz}6xpPdZP;8B9ki(02gz9hgv^%-w4)qU)?G%k9_ zgXDAVhL-ZjszCaAY0{aa*FEiGr7nux>KyfVHb9dvL;*q-s2D6f|$a@z&b_q31+5fbXjti_bQMEA+C3o9-$iuuo0kec(5T#B?+%%U|H8Wn$O(w@=XbyW;U=H=u)%&pZvvv13xUKv8b13O z4P*W?D{cmAb&=&lS>)ln>LQDbLFP?vz-$zG=X26P(zelr7p!h$d@%7A!yNefpl(a7 zXXf~Xhj;rjJf@BL=PVTgX7!bx+0}q@CC6hw@weP@4Y0&*yK}I2L<#XzFh5#abGC(B ziSD}7n43fuDL<8SS2cwjfw0>lOaZ}%4|RxsZYa$u?4jkY%Bhpy$4ujt6_~;pkpLL4 zn-ZE;6HG_WG<)yD^VW3jSs{+|GWuaxa^ZsrEPcOjGam&Tfm=`(G(4ksMA+n?aD}xU zqW;~()ExbWj?WLc6daVQJoz&Z{ZiUZYQ*1S(e38Z?M&gAkDc&FdUn1_yT9f05*)lU z!x%d5&irT3ybpMtpYEtY2Z8%f3b~>LUai*QmCPsC*>a|%FD~dBq zcc&2&Z*83+*9g^+l0XIX2K;yMpEIrWs(LL6C_U-j$wY8S%|Gq5lUWJ*&S;@v@Nz)u zMe#b!U`c7zQV(~e-sa46SGSIICi!9$mxFoorl|&zoOmqqx?W9U2R!S3fJ$v;Qm^LkL`b~+i2^#Em8^DF<&`wM_1st%rPXIx31qn1y&#eCqngr{xa@tUXpNZ ziSh2E$n3G6Pyut|_a!*0pdA)lB$?{o2Jlny+hhIGorQ6;JXnWvs)-`GYFPk%#B+}q zGARl@2s*glf-8#6=vf__wv305pG1q#zIm54%&QOZ6%`F0^5g%&3NxRrT$ubwOO_EW zx;~(_pVI9pp1&~rU9!z5gmsLQaAo0f%Z6DPoZ$H?6lNY5vpQqhF_yYEe37eeWyJ

CdSd6zJmXt1bR+E1&&F3_|!g(w{MI zc$l08!?JFA?!U$`gO&H$ZLQe$+)rtq8)Z~cwNv_{Zh=SqK&G3~i+kB(H6QXBFx|6? zJ3NY}%a2u%F84ggGedtx&mz3H=$n#CotLDtYCq3s=xnHM`pA^0UIyL!AJDCFGlPSr zr4gw|b0bCRH9jekE`4}8RU84QJ&y!fny5Zwly6mdpG0!J{jLn!2&kqgc|*Xq0e#OQ zr}phQ5M)eL;5cjj4;=+b#EvU}XFCs%nR6a$J^46?kvr-Z-Bge|^zn#S)wI!U)aTP` zO`F||^glXKS9~>%o2J52jAtAcs^F-8W;N=Q1iC%5KW_)4t2OEwljZIY;sx|NZ|drs zhQ#0QGH90E5;cEQollMa%pkt*Uluu6$8~&>y)F53Rlc`jpyuhkB5#f_03N^4>HywH z^=W-}4inR;+AY!#>=RycPJ!u3VfYS&*5B^a>Eqyhj3CRY^S#$Ak zY@^vQF}CTlH_vMZo;gHVY$8US5dPt}1XovO!7Bnz=}UDh8u?IaONm_X$>D0k+|Q$S z$vXOR(2J|(9ht9EZp|~5LRmeLKh-27^0?l@0G7ya>4a~_PurO}q;>NR_op;o18rk{ zhE7?{(e_i4O)41A zs}dmx0*LqJRB8(*PV^#fu{=7$(Xb@PBrZYtatng2<+9LIGxpPvkVlTGo*Pqi(yhpDFc zl8c8FRqsIPOBlh1n^2@^^@QfY-mcj&`mHmHn=Rq2eg8!NP^q!r8WJ3qt*VK zZ}@*|O(`03F8@;d0T&umX0*l=p%Ds6G^1**E!k?)(s+z2+?w2iV4}Y;fa|Cy=6h$S zTwk&g1sh*Tg8F0?6kaY?>vwDAXZR~t>u2kB4fHEAy&sOZhke|fTeYWEtJFOx7qwWj z&8%D0kA-^Q%hJXhl@~Mh?edQ^v&x%FXqK!!?$4Ul4Ja3BsF$ohKAc$On#fk;!^d3< z9o9$aaj__ z-Wq?}q|Ev2pEMqNu7MPv;Lk9tKla))?#4B0e;>HV zzT0-sxAMHL9IUb=&)Sv`+%p@T=M(GCMtf=GypvgQZ}V{g$)h`wMWy1jU6H!UnXmLtG88z^c|4v}ZNpbVzi_ z&bBqzCm_Gi#@I8B6bt3Oe%WyEWE%MZ;0EuuIW{j+!mfU7i zgFbfBhM^gI{#B~bfm=!9-l_D5Jo$@CNF&eBy_q@7nq^?$NQXJ-3<5G}4o0-EMlLX$ zHy)O83{l;|0JklKUGu&q{JudZX9o}b+fJ^3cSAu&g)DA+YCLXdiM}Zc!fUruJ1m9w zNX3syw;|uaGJg#MIvK!zYkRX&G_1>1x=NL{!STU+{(MQS`N4W1A<6tXanf=4f<#xqZXpiRV2r1C)3_#t=^ zl(Zemy3-M!H`_{d4cDFO-A#-t6*WFUgVhC#^iqW6fap8eIELDCt}uk-1%|y3+d$Uv z=IN`5nru{y&OE%JT+FH#GWeHCUIkZCk^#T+z90v8&!UpZS)OB_BCg{R(15Qlklvx6 zp+2%VEvkzzkK*{wEL$C*aL{<|(PT!xzDFdi;C>}oCoNB;1G!xxE)MvO5P;-=8LhHe zM=bIMA#!F7N(?#j1qu5@>Yiv?II4Yh{u3!`e+nhA&Hfl_h{v$mjU_ezKVB-5=Qr*evUU;0hLShi1o9J6-=t?WBrJU=RGJO;nC&@ki4Ig%K?2s-*;3 zDAi>>vBB__3$(+J3p4uqm*|OMD3Y-iF{{H(hu0xW{zN>Fk(hN}{3pg#UGvT>4pjpp z2Z2jE+2x(!`cg2s^_aWZCibVjB?M~f&)W4f=yZ!1^0NJsva3?01pNuWMgYnlLqu}6 z3kYc03Syon)BHM|dT?xKtg~F1i?tdBcHyJl1w41N8jQu{OQbk~59vJsGXs%Uo zBgs+4PCNYe!%9ZrI}3qZ3ZPRi!*6-{4H3W#ln_(X{i)XN-VJuI#UL%H^vILDLc8KM#=m* zn5xr(xN&X>)vCMv5}M^Tb6rHHK3zl)W>4tJFwZ-SEPx$G7Lg4DGzo!OM^5np(npd+ z9hX-P4l4zQzkR>-b94L@>kabtdV9MS|NHwE=GCTMDt+)WbDlepk#V1_&TlIz!BDRp zNjhk1ew-%%LmL}nW?Z>OvrY=&otvC}Y%EXj-rw@BLCn9~muDKO)jF@1Hh+-q`&7pi zW#M$<6crMM7VPLZx7+vF?hrhijONZE0>jwEhd-D4E>-U*!wD~}5?Ba1RhTNe}cRUyy!HX+` z1$rc;6-wl} zqU`Svb=z)wO}CqC4@+Q|>aGnCK~qVfof0daU$Wa1o0C|r*cD{~+?o6P;P$MDvi~mU7Y1l8lv znlFe`4cDn3ge4f@zKqNkCcBy_$x3G&Kl0UOC{LIqQ(8+PZmB9ze~K>T^1C0^d@PYl zg~%FRjO)Z)$5cxVr}YifM*y=B3g#&eI5{UBt|;BbRo;<6xqjjOTzb3Hw+{(PcsbJ{81Ng7RWKGXGom;>55*!Fdt z=6I{1e7DTWF?r|8VE=vM3D?2;D=TvN<(>HR&5fn4dmMPramWb?a>}|Z9XhJFZDzAy zwd6ql{2*~FRgm}5*(}Q<*(?(r#?d`9tmgms`=uSovCC|J1gE50iE`6H)oWw_*)a}IC@?7PBwpV|pat;nY!==4I zUqCuHEk$on^qc-y^s4&|cfF5z31%dI&uTpjM_8ktPsZ`cphC~km=yV!_`EkvJA$8K z`ENE2v}Ko+VhC15d|sKxVP&k5oQ(L2!3`^BByK9)Y%2fUi(wzCWP$cyJ(F-oFwz7L;IaY&g;vnbEm-#NDznF&ntRm68Tqq$!wkQ6brQ4P*zA!HX?PxN8 z0jH~KD%T zvu;1yu9@t)4ntl0z)WK$CZ(?H(nFFgq!*fAxd|2Shh^noyBs=#vdtQefuf&xr%{9U z+}1Rg2QiHdUJ*HnV(Ij0-&!033i|mAx7WW2FBWxR9FC1l@lC}yFPVo=s)OX`tRsI~ z;=pMp^3O%ZySZ(Y(kWK^G+YW<3dhvr7&5jYt5#eO+5+Bbk2{A650oWNpwfw51$_ zv@dz@14?*3M?;WhVS+yGfD42P(T&9b?o~rWbCi~bu9T=0ZPz*h^@!4epU%T25+<1b ziJ%B18kG1o%A7XMV~Tm46IW5ww60*}%L)6f?xeyl0ao2xq;9Z$K>0GmPB`Wb{3;|# zHe)FvAVuME5q?qdpU0~!y$- zw&-$~#Z`DQjNuKnzi)F@8se5{L+0?zN9DO6(1o=^oamQRgE80Ct}`PNXJ@!km|t_0 z-D6};(;L&msg{Wcm7+v)uHg_1-eUDs%_$y@=pE5``itcN>=|3YyakSr{?d7VMw-@H zlBV`VI^4~dW@jr1w@e#;Jgpv5tmFmb0_5*w;6gg03eO_vH7|?f0O;`K z(4esU?sx34stk<;O50%Gz1Zk_$ufO?bh`Ac5P=mT`u+BK z{w#aKzC10o!#qT#9WI0}z5kT ztH(_bpt5=flP6b`_n8A}VL4p^WKYgKB)xSEp!D_r zzc5nqdlWM`hXQuNUdmkVnehcQJ8^O|)=Ga=*}Z!2!+VQ=;Q8p)6{6__;m;54k->mY zRycY1q9jbGK$ZHbER@dph^B1)RW}hFh zg@##mmS*0EL8g*ECwv6QM=v6;HzV0X2XtAy zc4^sGU9o@GO`N=LihVzWZ`HsB{0wG!b0u$Ob`o}6Fu1q?);O+z3|U>Gm^pv1L^-rm zGd}6lGpNX}mv@2r_sH~|c4=r#rQ8VEZSh{=6=279DtzIt?Ht`$7tX^ACPI3RklE%v2 zzL~RWt?Jm5QM={mgR&sC;e+H*gr)xmF|o5R7bqP4va0tEcGL3v`d=f?+YuKodvhKA7&P$wI$I*y*m)gn+M4)M;jT z>pVOWEw=gg9*(xVB1usFLXmSqbujO9{aqZV3NK55ISRrKqpy^S=SgE}5q&8TBhK8& zy)jCixMZr+{*ikJT3ss&qmZ^o$>@gtrv;7Epgiav1W~ri#z-c#9;#A`(O8bYUy#st zH5DS`s!p%cnlLmQJ*f?Bz$mu0vy(=BTRgeH(p>lEpS-_ zH!)z`LL9S3U#RRA{8^hOTaAyHhvXyTG6Y2mf#N zACdT6|B=K0zY=G;{zt?4{|a&T|IoW;{U00vRaIspW@fhkfDS1C>s%{3JD8}Lx#}<~ zii$I;nt8hF{TJfp z(@bP)>V-~K25!VX;|Q}M@D&sxt+)3_Sp#z>O&aN=FxZ*Wa>jB6k9<3Mf?g$o@7LG+ zvp3e%%6$J{KF_MTygRlmsnyd@QvV>dl^iXW=On15OX-k5x{ z(5&jr{Xk@_SNau7%{NP=HLTsUQ_i%fA#^`uqB+~w4oLJolRjM@JgUXywKd^cK3-+X zvjcLu%$jvVjdn-)dOOS5tZf80fu z?TdlnakyQaoZi-V+CF%8ZXBdci#PtI0vWBwZ1tFULAGgV4@z!)L%7bZ*rQo3vD+rL zo&JJV<*c~*?xX$U({0)r812Gn31#K+){9Q98M42)ULqnj(9(;!zc*B{kdL3ePN@j{ zslve{_J)@)X-#a-{>tNgWjot!pqK!6j1y|uP?d?1<-CkNT}1rE@|pazhvPxeAn*|s zPj&aJnisEO*H7|Mac!=(q&`$im;5HK6~^^eV+o~}!46HAY!hFAF8xb< zO~#}UMypT4H0CAo@!>j5)XiLt8VyMP{`R$`!}y9jM-E?v&t=OH~h{ zDc#QrX}dh3PbeV#X!hKS;vS%q8k8JV-Q(o zj5y9?rl3)aPL6we1H(P(1&?4Lp&Ti0LF?oxS{X$i(ro_dBQv4eL;rxG$1A9)!w(;$ z@JM{|&rt;M@RPB;5DW6iGUx+~huIN@l5ggOv&MlJoc@@@UX9&O&RxN`TRGTe$-$UT<JNhr}UZy68TGUC6nJou(}O7MK$0c zl^{i{f>qh&0c`vw;~tC9PcSd_tF-H0zm09X?}vNLnqCgyQ%dt$^WCsaFz0N_0MtK~ zPRl7{?82KlOG(o?K6y8uNFdohch&4}VO5V3A`db26J2YOR)4e!nR_P16@n@eL{5>BsV zP=o%dRfmzDbuQ%3OuisgTv@lw0D>vBB2lqpQ#vH&A8)~>+=I*-4%08YJ@_5T34|>J zwZ`7{DM+`b{ucSA&g3u``Q?8bN{)#39ApM_1se;o4KF2}4_sY!5{a+2v9aQQt7o%y zzrz=|i?rRqsbQu5)!P&Lr*Jx*L;m+RLOIBGJXQT;98*DFw zx&v~Z?;(hT?%o#UP;)b}r-B)W+d)op}0|p-Yg#uh5S?$X%6%5n{et?lAFnTDkAUCCiQ1Pc`rD9-msH5Uo zdHz*O641OsPY=kFBrNzyl>vQ8yl{hQ)rfAHW|R!mvUkf-IJ3y%_bOaegMPvAy-7@p zF7Z;6`m1{{YpMN&C|sXHTxZ7YBbrq=(M%^I$1cQ$33W2crUwlBg(=sxg-le@t=lj$ zi&}+ys%yQ{?!2VYgLbuqop;r6{#Vti$A1wIJ_bVIr|ICSQMPH>gXbInfXMn+>M$=^ zw9#$BIX)ZM?m{Qkglj_=tsoc+wzJzPOv7g;gH&1Cb;F*Z~cs4rtrOjdPd2S{!d#9O8Uh*M1ZQ z$l2)gT+W?!@s19zZGAgtkzg-l{Kqy7pJ*Yj&yIpD>L?#laNNy!n2dg;2vFUu%p>1b ze6sl9`FnPW0rPA8+*~(U*XnY_#cs@(ba7PS%0^2gO;8m?w8q*2zmZvoY^dNeFZG5$ zAej^;vE6b_jn6I`Gz3Ek9aeiyxf8akgbGSni_V$tir1;`@=sgGM@l=(hRNvS-g)4U zU7IwZbtT zjE?HBJ@y@@^FWb;))|neM<{hS8_SUe-xne~@qh^BX)5K`M5$&IJ7{;_dSFSnWA!V= z{&MU=+jO?|I6s!vp#FqLFNk)dXf8_Y`)rWhw_j$yJrTFO*#d%&MARo6nT+ea9MMA~ zV#P-;Jg%jH{jQKsRK9Zn<-0mokGW<7rW)flBAE2Iu&B1?^!A@QL`YSdqu0E}Q8yHH zl#$;`1{po)*9?(kN~em@t4lh#wB>OyIdL!rtGQ5zx&C{sJWhlHa#&Em$}{Fl6xKir}V$--1d3(USGXrGl0w>0En1uG_-k7rw5pOic(!5*{e&byUCQJ zk^~pzc>+r&RmyO`9>6zc20{^S4!IKPbA&?aR_M+7CGK?(>TA&elcF^_rDywt2O zP0T+s@t*sg}AXLBBYXFR13r6PtL+X zCJL|3>RrpjdoJhpKe6YjO2RC~)&j$M9$8xnGvp_!Bn0#m1*kuDwlnD_7z`kq&n!1_ z$okCNHg#ZTbK7Ctsl&SEzFj9FWFv@M>2G*gzILV0Ea`L*u+_uHXtKvMf0Rk*`4i}b zTN~=%NI0WwAw5Wc%V!f?xnkc!;ogkOe~M=^PANh&i^eLhE#4H-RCly1xDl*(BnvlX zqYYw=g!o)8y$Dq09*BGR?g9*`O+K zd8-myxktdk`ey+3JaoH5AtR&hTMoQt4xppO2^@S|BZ7~+ z(}}-6*N?Izep2NOwnx6sh`?M_tcY|lniND@jlKiTeY z?NvB&8Pn7Z)3KKQKqv>p8elIrEr3}0$Gd9xrMozyhada`=$W`4+!MdgJXhY;S%NQM z;juQLKxk)uq_1TH3bxNJA(}UKc1r?d0--f*G`2~QmI9v2eu?hRSVe80-EBf@tn&{? zJ&n4W9LFp?$IaDri;vUYj-I~$mTs@lf%^6N`BV1(`qkAG_@;-z5!kF%p<}AImN=)F zs1sSjM;D^S7z~@NYY5Mabj*E!$lMU?;=Pt|7$djoaTZ+JgoI_2^AomN~9S1B{4U-q6CnL(tVqWOx}F9dCr# zie%E+ti`t|^z*!t^l87ec$du@^aUWxpW^!~^)aK@okLYl@7H>>jgE_Pe_Yi^L|k|X zPEF%!=oGtjI%B$ov;-EPUVIfE&JPwVXp50wq1OOKa3=_=2NmgT$Hj2oJgq(nA~F#q zZBSnVrN8M?AHe8r?jfq;ucY>5a*`V+)7k3zWr4AqPyHbWIkXKpol9jo#;ll~)RDFx z6c4=k6oS`p%13gByst(S2^bkYCDnmmn%uP>7$@lW$0u*TPo?#}j}ZXl;T(uw6;4!7 zn6}tH>+k%qy8XQJrs2@2%-xAo7wuDt(9rN`>B(4H?U=WeXT;TmMtK6a zh728{P`igZp1Yetj+=TxGI%)koWSEU)U*Q!;$B26_leJh)uLYvZ8lhd+@jgyF|Dk& z0bOYFIB;kRGk`AnRMIs^1?XZ)q&9!5FFLAxymRlqQOkLy@DmO+PDDs=Qr-MeAz@y-i=x=fexq=$G+g6I zYxlIH6TKPlZ@N6IfejmEmrEg>rSzJF%y6>|V*$TfBGN<&iHjJ{L-`z4V+_T$DX~c9u^``I4c_hTtl_EQ?{EMh4eNZ172vNL^!IDJ2Vo zO|WZYPT2*BjzSgBaZ+-#JLz%#RXPpd^~Du2zb!f>`%V3Mer(oIBbwp_%4n_=M*GcX zj`;5WYBIMhN}dsh;QxwFzXP3ayZxMft`Uj*EaEYYly*Ba@I^CaWst0ts00GtWb9be z`>36cDtbS<2T|;$ojl&-TyI$`l(YzaUz^vJ!9W~L$vn40xxbb+DrEKdKE+YIx|S zBassm-%j-J4)2j(3mDQd%1XBo{wD;*Y40m($ohPv@Cjm$`!)mRREwO~;KUEQ4cagX z4{loyMRC6DFZYp8;^}P;U({5)kVatLR*(k!@+na&3-S1#%3mr%1dEjlO(w>T-AxP0 z6cQ$(tp|N{sn%3cmp5J+cqy@UcM0CS#U%Y{ln`pWUKK1pr4Wk~*`WUjA!BX!mLr6+ zV5r_FoH_x4EWChpAWWQN-hVE*rcx9oass{6ZnoG~dZ}HHgj+1H-G% z4>rI6%EMb)!eU6ONS31$pX?IJN1%OvCOI)>|A#wI^vS_gYmwS2c6#9(<4o7Nsln7( zu5t{aNshjQH(OvRA|7;s#Qyf;NtB*#~Bu$#lPf6+2H<#FL#VZxU<3YloUQHU6BjLWd6%DROhPURcA|9zvHI zN@lIiUP%rW$t=S}L2xmWWuR{c5VbRZ>=REH2%yjd%I%pEoYmA_NLNklf+x7Y)i^jta# z$)t4CB68z(SdzVl>`s?7PL+>E_aPU}W#-z*pQ7xsNNp1pGswGRJ^v=+Wp5p+2WRA9 z{EMEwuw&FR5+W8foL7X-WXXQbzdyV~uANRBY_D2U!w~b1ikiGGpn%_4DQD7+C&sUPL z8!sM@gVD;R@B(^~KiE)fN*z69&tPdaf|b=y#dwS~@cWsB4~~q+wuC7EQ1PfC7ZUf9 zj1lC0;ySK*KpYknwAnqwgSfC}y&X1w2^r{kvJ_1v$e86_QVM`$Qj$6H59Lz*GwJfz z+YmA5V9>HD7B<^O;hdLgxPMSulWM{VK(mrfli4XgKR+IYpBlFEUAIC2D1AE6SCtNf zUb;?EJaNobbsC`U&5M;Zc^QiDrC4*THT{(a^7rR;_cx;H_1%?KRH>}V8uBL7I+3cd zyt5@@7*_%4D;S(5^+EcBW!txB-i23#wk?(fYS~iN3PJ8&@x>B={9qh)Fr=dQx5+SS zq*c2d`Wr8S9BFh^ocU$9(}X68eqF^%yN(CQg{_bp!l&P?xEup`S8dS16H=1pmELax zek?B_Z1X$NmmBxMC;6=+iMHsecu1XIEPG@UC0_g^=9O-+erc;4G=o(Y_lZO3Ia)e8 z#&vFf5#h~)!MU&RVj6AsF{)`;r_nXS?LFOV>UmR>2TPE1``J}b*%#Z^47!9wP&8kN zx1LgPmftbxcpfIro-(jOIib@P_+G|+WSp`{6Gu^OW-MfR!&jjQ8;&r=L~0FL_5R{Q zI6YTiTIVQN5JL${LFx97>#j(O=ffKliU^AV6A?4_f8=5*Gpefo zTQmQsO3QyCtFZkSvdVuy!~a=UVQ2n-5tWzz5taW<3H&1}PpPO&%0jV%29_Kcr`qeU zH{cDYB}=dCP)mkN4Pz9vh?nIlK zF6dqX{4zh?@6M%u+py}EEh?Y9as@PUN;7=J>ge#4A)b7TXl;0kd$#xM1&a|r-w&0b zwrITeT8xkV9X~fKTCCjQkr&_K%OL~z4{!-8L${6}=~vD@_~`xO^7DVNVVO{Y|L6;0 zP$_;!nE8tF7_X2W-G+8Rb9j5+gO}yt8lFDnleZksHu3kab|i_*Ez-kq50J~&RXmmd zLL*Hh>=pRcZfJ9M*?RyDVdt6IE}%cy6)086Y#zd#L58`rWkxgY8szkwuPjW7H22*2 zviR$o?;2DhzpHQH-i66Hs;;{fnak(W4(|*E^4qH@&NAjCuh6gcBV3OiM{H5w7^7uV zTEU9(W&beuuS8xoO8%aTx4^B=*F{0wDx)Dr&l3>0+*QV18Il8~MZ{MffvY0o#wsZ3 zeAvY5U<607W~@upa)+_jX&VslP~b5gmYrlOKh z7LAY$`Dr1`(nc8srnUa-(i@whV;Y9pI6IgV1Jl%`^$b+j>SuE&sDLhg4kd!B%yV(4 z*HApQEUkz@jAk*Z&AY!W?C0inc*GM`+#?-)sLK&$As2q0O`14HY$=0f9gVNkonRLc*5j+yt2oW-#j$u_ zPJx=~#nD?buhUysQ7@ptg2KSesKH&1bGX`nmbcNJo#vO@Q}KUd*L4`;YR zh1Um8#80(Br}`{y{N&`BCSD-DFG-dt*_R1p2~~70eoYL}FYe$~r`Tp#^HrNG&m@Uy zcOsNEVJjE|f-e&qm>H?RTj-MdgbG+^$H?4QpJzW;E zFj%CxV4>qHZG3Ns^+D_JFXWX#n(2o=LIA1NsnmaC?H!v$i5fM_vTfV8amu!B+qP}n zwq2)e+qUiMbNfqAOuTXDPDKBR%#7S?KWk+kYkfy_#IE@}u%}tmczxZe4>Iakvhf?- zw>z_}HgPmQB1qTMd3r|gcgbeMb@bI`2l|heF5=I~*b^ol=aMW@daUgDmfDh_{6d6n z7K%5G$9(TrXmrRgN_a>>H}L|H~u= z3wQ;>9+;=w%wr5jR6Y?pApPdJO)R$?pp6>)7FODIbe|MT?kXW+TLQqN6l9j|NZ4+3 zAVV1Vw|Sg$f24eNTE9Deh9DGZwhH7p{8pSQL)A|h3%Kwfd#W|pkORb2e35*ITlxJY zyYU@7aNkWD`={`7OKsvg6S&ngn^aCxI?$&~i$a|Kc{538ZPHqyv2Tlc90?(@dByhI z3;ZyTmJJ6ITlCduSQWfVL|TPL+-_SSK`NqCD0A2Fe?}!wNTcoQ?*tIM zoPA`v5FLPxp}3;o2~c^1^Qv~0#y4^~sP$6nK6!d%mw@ildU3Y6tD|8WbFbUBo6e<^ z8r6PJN8?iKSzm6Wh$}r5lGIZZ(XsZLPe733`#B0K=rrPpVwY@gLD;&Gvl%=U z=YObh3zMwjhgGx-bTJ^UJKDb=>NyRN!2~{1ci*5i^RUfnK65+)dHhLumt%7VXAv?) zelUGt@R@Cz+Q583_8MRh&VDSd_6{fnJ#Zd$|`)1BTyQ7y+r&*TH5_kf(fKNjYS#h;o68awIr;86C^2uk}^PmTe_jUu#@2(q

6HECxWEjr>rL46jonRPgD?>fp!~x{fry<+t;} zPE8^}#Le$It=YH!KIrof5r^mLM%kCD);})qdv`$M6^IxWuQBq!tj45S3vF$_I*%Cv zXD%TGUri-`@1n{M9xDrT>L-lX6uQJ|9idhpgfTT4j{>Z6O3B)})$RS%e$CpVXcxBi zlytU3o+=VS*-6Kfm7~R5uUuJZAfosBl%hzIDd{>M;f)Oz)%g^igu|~xUzR&v{15An zrXoY-bRMQUZUVi;CNo&1aDC86iozt*x)F}uDOp13!e+z3YML?zR(9$;yVWG6EFErc z2oJr2U-xEl$m9!%Q+xOs`i!N*Z$L}j5PadSM20{z?Ih12NgH@{YK9I{7+47 z6;>2Fc{J^&P}LdINS-i|J%d0lup7|t)N1t@6P!MRpU`3LR_rHJ$vuaj&F3U-+Oa5e zl7{d!LMxve^bYS zm8k^upj@18B7hCgu4&U{Z^A?rAbmFy}MR@7FHw#nyZ zQ6{Nf<{}u_LETAreeo%`1p>DJozS&d@t6wkg>FOnwo^*Qa>7OnL}472E&Je0>117R z6BAL$1_Ir?Yjk7s zDXhmw=;ky%2trno9nd{AEde%_c}NARM{?NQ`xERQvl+wHo?>A!5&k7h-H)CA2&*=tnp?MSv zgKfhyrO6omFRmM=KZHkRGJr#S%og|LdOP8YjcDv|**3wBfTh7Ytwe&VR+!N5TTp^cSQip5c+Mpixto$s z=8!z5yl~Ky)#lLqB3g=FjD{;Fkti zq&_esRL1f}Dy;>+r+>N>8rtO!RFiGT6qw`>9hwTffj@B`s;)cxSVyG9F*dbLR=lHreaOSU==dw$i4e|Wz4^;P+g)^I~_?;3bFYjnX64~aO z#I<|V_E88N=6D%e#foa{j$R+Iz9|C$rN%j*1{olN)9FkOw<_9OeEMwmJ~7AyP6E2( zjQ-9?C}$Mcz{egZwB9FWIMQ3BywMxc7r#YK4QcwZbWrkUXDWbYmBiYk=Q^@z{Pax{2tVnn$crtSrDS zIF8=q$T)PSXGqaEaL!t+af^{>L*oc>_{^zE=53SVvXJT&oUoXC{FC7+%HuU!(;v7i zIHR4zg2wm4xn08o-NW_obTuZ6f{u-8#v4ayR>sh1EzI()n2;5!xHSM`Rj}bkO{XyKP zMdBgynv8^3LRJjH9b;=Sq55|g;-HnMTzW=s&pcbn3JhqIGjD};sLo9vi2QTL50a;N zSQIvhZpf2rlhwKBNYe7xkELdTO!B$I>eOcP_e~fKCB^HG0DnpF&jh&7c?wCdgHStk zl^C}Mq{x04?i&a*jJLhNsefF=K^ds7Uql(02;?d5GUhT_t$fKn!Cc7SbPyIZ=MtEz z>&jOJ(3^+DGe0zr^)oMELSChcyT#sAHL2)BkgqnGIN=kSo<0FLYLpwAcNlZT38Nkh zbod;n!~)*M8Sy!hDP0GZyi4873-rQ3;9?nuJ=|q=i8Q=>v&toHt67yhkA&_+dmGL{ zZVPKX!NItYeUrdR=xKa$j9o=Udmy{gTF#JbFYhWQEJ&&g)*O}ltJ4apC`}EQJlVmt3DIraeCul9%A#mT-fLcecnug&-kh8F%p`j zU3#QQ@@_F(Npc#4o^-P)ESoNuYkJwds@vRdCH}9wqo?;vWR)s>KW|sV+#bI?3h{}w zTWMFv%gcN8BS?54S(EpHvYl+DBdqhX*;Uu^zErDj0P8YyX`@%S9^PShe0JT zqc`_R{MUyf*D*OxIVzbWFXZ(K)(VQxB(^6o&9xo88pgNnREFo_o(D&44-#5RjI36x zfqzCLankhYzt+g`*{z0kbIF}Ko3K8XgGsq}tuOFgZNFA$kzJXX&^driPzNVM+K)Z7 zF1Mu1%WR>*R=cD!D;@SCkYK%l%=jZGjO=kLw&c;;y4u zbqB&`&xRrE_#E`YSbv9R4>lg5@BPRIK9+m@qQvxa6>u)noHDyD?xyfD-iaTf^jKR@I z$gBkb#M~4UA53T|iJR8b*D#HX6kKd^{d_U`8}`%$T@m4L_nlsGK1Z-9$mm=7%hc7tCh3fbpeFUyxfsu%wcHnqY;;|O#kZ< z$JitQ`}On)=-zHDYjH?_15?}vJ;U}^`FAa^p&5wiL;%1undzRtKXViiO(7+gq`uzI zyL{1xqJ#}a2N5i*F*9K$hLyrn1{U_@+E7AIdWvfZjv**+cQz@suEl#k_=fZh@QXvQ zGa=_%Bxv}6O#HEv3H3LGT;bth=*Kp?&~IA*8lbR@xFui^X9Fm}E6Ovr?nf9G!K z&{-CMx8>}53Ce`;22HZUDb5b4@~Wy~se^6iNaVES{!ZMY{tyb>rG(cD>7+^bITb69 z#s5qfQ5!E!g@Fdcrkxx#ix!DkuL)?JwqNF=T?12$xKRs!<)t?Xt8kkeAG}YJKw4RO zLj5h!CN}X0xZGILd%3lU@KEhh#ia}Bwr!ak*GtuDD`57V7d_A--A-w@AKX;CwJK__ zFZ+vct*0PJR(vu#Q{p1aM4bXCi?JL`j6Gzwo+c}}jMqp6J3Nzw>BtZ#&r=UId8A~0 zZhrn@>^u6VJ~EfNw%dMrW+8xYHybvXTa!CI-aznHN%C3!BebmCS16{x>G4WUq+erf z9N_%#OQJ9i#Ta5JpTea8l}LC6GG7cv&Mn3H2a@FW+@{1O0}`;OZGSfVecT6XSb$wH%Qa2~$+P(-{Y5 z%Uz)!IoHGH%Qv(6KKEk0Dd&)o+=g>R0_^t4@q);{iw_6bhp0E79Rk%?C2oNuv z|J>%*hWnt2Y0&B$@!+$?5F7Tt{tSa+(x*nCu5PAg=vRp}VfLL>@FLFPkt~r+z4qzW z-xU+(24U2iQ>*PP!#kf>AM;r^i1{5tDuK|I7nJ+f0FXsBW_bt*m@DP{BSYu~#xuH^ zro@V=XDDcYn%yg4gRRXiuUr7O*emP=2+HwV4NpJRtX-#YN#E!SD{V4a8WQs|A%&RT z=I1{+Wiihs7W14b*l%EoD-U5-iY*kOb|lIsfnV zxf%cWh=>0FU!VKG;ZUsq9f$fK#kkp+IGO&RwyNU)!=a=q$C4qCgP_N2rc1pgOme7J zI~zT+sFPYPB7MX$NQ`zZ}!Y8HWUOCI;`g*-qE9MOv5d?@&pQzVnuR^83MWKa*I=idAmrbMIkNu3A zPeObwGEj#jsl6t{Y;Cn$+^>DBPCRa;n(F&T-}53TbF0+Q?!jkP3DTdn?k>e%siorN zO+yS)_yZfo-bTG9`S*?S?3wr{$3y6vmOB}Kn+mty27kER&iN1?JF~ccV5cA~|g>_&@#*Q#%qQtlAb4+(ne9X6O>WRs#T3b3JEQp|$gfN&uh9L>`iV@l61# z+d}^2{Pt7JNlX;wRq)^#d3DBV_`;~$=H`9bC8Ps7gM(w8^jqLuq10eV>QJDohS$EM zav2bjMRB81^mtLG=@F1V;(stlR?G9Q7C+Z?6{JCDi($#HK$LW+QC1`oG^g#bB! z2OEmyfSy|huE@J5$WgRTtV}K|p)Bqern{mPh0qLNY?U4N@OIx4_kG$-Z`~yAR8u=`x$+Gmm!$Qp;x0-7eYUzJnW-YPljSUGp_sO)dW>G&}&!xZhst z(&I>-aJwqIuZ=Rt&>@{!)Eqle*lF)cd8h-@XmQV_2^77Zy3#v`z_M`l4aG7j9;szT zg$kK+w^i^rIdFKy!ffm>yzVULq>!LrDcN^-#P!%dp96FEWBcMh_8SD;O-kGzNCoe3 zVKoa?sY~iaTuh(7IBG3p!g_e4ka!Svfb$i61VN#XH7*1!Bo-C%q$BnQPXA(As9!G9 zyKr|*rG0kany>j;i7qlD2MQAs{`M|3P=lwK)iW)3v`v_K7&88KVA~L8&5%dE!||@< zF?X|U7UX36pQBv{*Z^pE4j0yC>PysU4+a~vIQ9gWKU zW}4s0Hqepr7UX=W>mK`G86#CAVa$@=vZ|d z?uyZNc*GA)56aeH2Yk^O4=F)udm6frfl(YsyvJ#{yNrp`4B8^xw|r9?fM^(sJW87t zE44dE13%kk@}>N!=RY(|eGa_YMCAE8eB;6Vv(8@D{QP%Ri&#at=Yp?@>ru`i8C?sV z`2@aX!f@u!mAKU&&B$l=inPU9a!U>sj1T&IQZ1}6=9+??CXrys`jQoZ0nEOY)#_dV z869J|?fcPTOKtbk&KwGwJXi&zxkcHeGEhl#JHJ9EKC zW@nV-OG0HA`>|xU!LI>1Y?gojx|ny*!6$MJ;dh|4J>f;b(3n9?1kuEqAXartw+M}4 zNGe>YQ){n`SR%HCUniS{iZ|56Y(UNS7WM)I?#&9G`dK|u2KuPMoLUN+d;&nlU0(WO!?yK znMjq(De)dMAaSv~^%_Uc_0F5KAHd|!!@r2KUbIg zo^Yl*f#I580m#ZDV-&KC&jN8T#i{f>Gm^TA7C1724oB=B_7;$-luXcIExVtG`?d&iVQ44`AB}_`sH7 z)S*j^25i)Fi37Ht8rpH5`1`_inR9UVV_=2dATlxyD%T@HL!R6r74_S=CRe4Hj~Qtjk-e9K2y26YWcfiS8=unC@j0|7#7q?7ZzuiPy{4g>Km3 zTv#%Y02G1}!`82zrkDgBdWZJoGy50{8TcM7jdXH=#`(*pzemFuMN+yvD_(LNEJt3$)6hHpyO@e>8AyYel-YRfep zaF~qx55~UScYbSv8fyPG3*&{R9l-@$MNV##dU8Mfj!cbH#J}7*3e$NEW8(pPUU~=( zG9yk~L2C^n$@0GM=v~Ph1RgZpg^hh_kYhzE>UQxwXeK*Fm*VTl0?cJ6X+>B2e`L@C z9Iux#+pjA8j7qIEC_q(xTGp-uN*x;;?8liWR=zLX&wM2rJB`MHQS$;pnRQB#gXOas z8E0mnVt<0^kL4RaZ9=4y+SSa+`olq{`LUvwQ5aL@Z}TgmdGr7Iw7eN?))N+C*Q=o( z_9ke8D})K)w?q{k5`YXsd?i1MR+VsM3lB@ZcjDkJ-mg~>=o?HY{<;5J@V%`46sHKu zwQdN=C|ydpWV_<_`tZIE7aGMUY0_bN7cmYPrBf#|w}yqdy$fw$PZetMn2~m&EqBS5 z0)XGNwy1x+6>#Q9uws-9rCbbH0u@Xf6+Hc5M>^);TQ*Oz3W|h9h%W{3)e4m1frbwg z!1g*~$pdKPPJ`7ku2PxF3G*0v{+7&h@juBg4u{YOAuUZjdjx4FtZuCOtd!V(?wK?r z_`V6uZe=0bVX^c@T$n!~Pp~~F%$Dh2tnUSZcmf7BVYtFgtfpN#7g{CD7GNV`l!-jm zNnL|6%0<$%x4K262Zy#uFvAG^+0Gn;mx%)H~=h;i8;JgaF`FmCPl7 zHF(E(KT#maCrldK!Dl#t_rd#?4X4GmAK@PdRem{2J_bW4@NuswNP1)duo;aed{PNP z;Ee1FgvlMypYH<7%k3Jo0EK6yghsZsgO6?EQsN>|&;r~^V7df3sRAI`5nF6@6K$Ezt= zKOFK-voCv++ArLxr4~R1p2^v&8@PEY`*UKg%B}~<&enO!J(CkGtDyn58Ig;>rMWPi z8jU;!>W%_ArW-y?{mDhS|Cnl#8?3E zw^RaDUE*1umcLz=jY%VhoE6-sK?nnT+jMnjJzr2mUsUJ@E&&(G}T+y)<^y-*a> zm~EeIgF>M|cfTj(YR9{5QG$KdAUGNNVnsEa&A@I@fQu-fhK?Ac+a#zCmvbNQ8KyWB z1Guj~D5|Uhq)Qj{qQ>P^pun@!3}U-^TZIdypRBQ;m+BIuR`gL^0v0>rpRnM`p+sqK z2?0klzQCx*#1!b_;*Fz!T)hp#be=``$P=nX9N6i6`P1!UISc;c^WXoXpPNsG;`1Op zziwtrR+jiV=kp^qbA9PaBuj?MfW|y+bSRRSVmYtHLj02K>9B#!zrBJ_{#pBrzpS9?L|5;FH)|n9vJ zGG;_T9)OLFRY-dg2U zT`^*?z&<8D%y+n7?WZw0Z+B8K&s_8%KstxSYHJWjXRAEgU zveSiQG`QDNj++H8Vh!@?nS|A%3~}pwwXnbvb85s~2H$1$mA}E4dg<)$^Bkt)vk7`V z5Foi#bHBjDh*VrN=pxzj5?(mhb2Kr!aQ!l{gtEi;rv?+A;V5E>9=^+ok*KR9F!mAEd_eoH@dob{@R z1ujdh`Aatf$+TkNSqA1DnePyRhC<8iilJf`seK78L8z8l71OiFRA{z;xdH{ zraI+EkO)A{6^_y!c^ur@yI?<1;(s`&2EtJ9ooW*|sOVGd-I#@hJZONNSzBR>Y=HS% zQ*O+%ZUvaZwb!tAgnM9`?4t1<#CW;G_En&6uMG_BQ^y*-@&D`rlR2ybx?)b7@5wf` z+4J~wsUyR2(iH%DJ_4%21JmG-5G^;fqFFh*vo&cOsojTr=pJy)@t%?Kz6P@&5F#^1 zH2uQhy_-^z9>lH8F(vOBpBX?;HfQ9UE0{Ed3A+PK4;@{VFbuT@ZMYk}1kFhb7{i_I zJ>=ar!EX(wa~uj-{H1Y=rP6-M8%*cHTMW=76P-+i@(Y{ZCIE$pKm`K|_{5J61+WPB zS~3Gk_3SCqX$w?A3O=IYwi4i>{8u2S!D4%CYkORCr zXKWgiCA7IAppA`Iast>Y+NE!d98tkJ1e(6F8jtVLJV8B)j*&~EDGA?H4?NVlVE4}8 zltZq$ZD|z)x2pJU@DnLfm2QYM;$=E_-|69sLf9oXO&l$%No@Og=xaM8$EXpKbv}vsH$x#E_3B741mMGOTyzgS0BBH8n zvyr*+uT&^@EyvP0dMcZiL+-iGTgxMRzvnS_W*SC9ma8>&+I)>ednS%@0H~BR1$B(q znCi%#R!Sa7xh~qUmazwfM&t~<-(}}|YOVYV{V3iB_0rAK%eh_CMdiq%mEw5y=AT|P zRyYY^M^`+2wX*9~{LNS=GqM(gjf~6_U0p;-FlUibu|BwKdq5}UDm~E`1Sf}Ln5DEq z*RKQy_X#U`g>G59Ie3lxL;?q||D!|#h zPi`kT#z;-A(0M|uI&&8~VM~@JIzVKTV=tzAB6(4~2h`{j%SRUdj((*0krKBhC^c>Q zMf|>DAdGWeb#BC3!HO|VQT*JHWIE!31`w5FtKqG=H;@vur_VLkJ|u~6b{N9lP_{F7 zx;h$)t7snFT#^Za*Rn)NF81lJAt=u7sW5gaj%4pz)oB1N^Lt$#sttCJkIDUYFX@yGU?YQ+Yp{R=TS|=r z61T&99K{KA_z&lvc6ClL6rQ0?6>kyNainG~v_3;{74LJSro*KDx_61JEw?OJtf0%F zL?5(#qCjKo-#6zK*2rFm-QDeZE1|H{5V4@pMQ?>dYtF2=B8;GBiNwIbb|y_eUBg?1 zbpvp+lG41XEELbk`O=%fH*a7&6T=X)b8ZN7ZdJD{*GY0-kt zfTNc$pey%>ds)#LQ3Wck+lJ%`kj*rjjm6cSPa11XZtpe9Qt=lhx;^ce=%;S0&6Pm7 ze|8o}`3?S1f~(q6$1j$UMdnj$f)@7Oa}-M|%QLuwj2F4fY2Cu32tdochzsMM<$#TN zAb&!D8x47^9}&gE(_D{Y>*(~bF89e)$?k3zip(T?RG=Ksg(M21HLe5gSU?}lb~Mg^ zGA%4KDH1B1NJ`LA&M>pxpCNQg+u)ayUNK>tJw6(C}80rYVYsZF9U<(KohGbkcV z`fi4G8X{8h((XhVl04Vi>VA{<1AIJCyZk3i^Pigbod5Tl_Wxg)=0D7Z{tbzk{*8+M ziy!@ywEZ{8hV8#YHvglTJu3$%!~YA}Brb^}`Q+7=kKVwxnd^Ln;>P+1tUcTMLz)l3 z5Av0Zv0CbDT6!U*_w9BX=T=iyFvj`>;8iH6qXchD^TsIKFm%%itVx?24MHp@4wrSe(c88y@`{5soHJ5y2B zicOE+4HK%CrFOfs=pLz6>)YN9t#((tB|i35xl`yOt&ee6N&lYc^*FrQ->%;_SfW<} zn(gD)L1pjB>NV@H%&hg?gR^Nw5!Lbx%cnu_2G-Fozu$U=6gCj_ z#lN)7epbi68Dg$2-+t||e2ZU8w=QDn7&qT+6Z}8Iaqsb&_-CoJ4X0>-eJgJ`7DRL2 z&Env@1~dDcL`;MruAGZRcnWoyXhy6%yg`ib=o%GCL9(hM0I`z03J{|Cg5r>R8sAnYCkZe z-mQ&Q9(#Q^iFK~3-Tw+4%IZPnVd1-pFC)$_X=$R7PSU(z0iVi$1sD)b|LXYwesJ?C z=`7m%sH`1NHeQGkiX9JJzYcRVJvYW9bMcnQ-?xU^Qc!bvSt@h!E* zS&_VlBha5`P~2P1G=cAmNurZtPDeRAe0kS@`eN@WYR1mibU1nFRg(TjunpkKYi>If z(gE%V4~qu?38V)XZHi{O3CwQ7I3r^s3!Z1T&tIuL=h5k$HitW8m1E^G#XO9U*-gko zS-UR{f$znemEQc4#PjBLIbmAaP02LIWcEC0K4q19zFzI=*_QM02k+WbAq1No!cM%U< zM+q+$IZagYqipBoBJeaB@w!4KwS!^<#03tsxdsw!+Qmb*%(jlrjO6*8R**o$A~@w* zn#}qNBbAjKu`tr|i{O;OpZH%{)**eOIzwuUtP(KEf`M>#$9^DgibYgMnVbxpAF2er zK{b-+bo#}-qpAa=*U>Am2gryy%!QHLYq<0UUNbt_*udeD9J1>N=Sr@=Spn@^rc^JV zO+aZyp*+jS5m_TZHPd@sCyRfG$%QjIVo0uNL~Bps6^--L0L{)96Xe{nz*E|2 zT~qN24IPC`o??@wSkRcpsCPys!`^Is%aKd+O5}#m+s+aI#eLOKLT&+YqSMOHZ-Y(} z;{e19-6S|A5Bnu>AqF% zPWkTt!Jf03AYwSxGs>a?*397wq03-SR;c&>C+`#9zmWZlpA*s|b}?qOy9V+RG$V#V zzeQgEGrne0*Rn3Gn_=fR>QMlP6Kq^TLK%rcz|O4f??VsoKrB*hKsT+*O3NO(Oo00FHF#FP8P1KA$1@;` z|8d0PA;K{i&YppnzgBTrxhT7h>iY{1j0T}A9y_1Xr#Rpsu?b=O#`6+>qRuW*`mO|L zg>ZY;LV%$*7eJwr-osT0t<6?$h*@uyPx6KS7{tK@A;Sw@1 zrF1wKQ`LM*ur)S#>WtL`bi^VIzOApcueK3(gzC_!LTH@Vi_24Ktu~vbO}m=21a)&bEoDc zzrEUA>@K8Zis?HGo?Js%_kq9H2=9B^;@YErc$@=J!m}XBq*`FUT}9{ucHiW=od`rNsU-qBoiMZYnD-{&wdc|DgOwpQ z*Db9%dgfaLp8Ah(Th$pgG|StQiaEKdNRL)c!~8BXw946f1?^E`Gq^k2V6;GoB%aW- zmc+p|yv?bW?u#)&?ACPB6kt!Fh)lNKJqlB0?>j_e{$s}XE^#&x-X8~(M}nVx&LPk6OsCTi+NZd0R2l1fG0PAIcswA8aU&X!|D%wi5KKdUV8ZwF~y z%iL1~T9Y;Iilh;}2q&~jQ4TN|Tz@o^{d#n!_$TE^@V<~)vIcBnjsseBy<$W-?n?fk z-T_X-eeW}&srVKQ0#X1VIHfwYx2K^hNHruLZk*{`N{ui=SzAQu=AG>&Y0vrzz>owT zeGNA)<$%S=M)zn}SNhOUs_z;=R-1Eod-34qZOiKFEr2jxZAB26gEGOlh|{Q^kn;7P zkCuiQxaypDyTf*)QzX~#m0OaWMvUhW@Let~+sNb|-yC{2w*0iGwgGjtRgGFWMCK~S zxF=j|*U?T-CBSg=KB@Ag&dAUs}^$tEy~L{Ftq zRPi6HV-&@Sa(^bu)0UDv5N8D1x!5-u>tAtgQ5e;Zb~R*yvA`d2cF^$92>%U*Z6P|y zEjFE|EL2+Q*kGuKVDo|lAsoUlO~T^NmNc}1e+kS&xkPPP1ZMZdGmtT;5lvChtHD)| zN_|Tx+V-^Gu{Tdz~1aO+kVou`ieVPdBzDPI~6`8dkUSBkNzoo=Z zVjAiU!ULQHPkg|A_Vz_eVwJVEjp^TMu-_(5U>$$so0Z4Fg*GUAr1M9)SQ%uD3xX8S z5aAT8kK=wZTBV>6n~MKgiv|UC5oA!{+Buee?Q#?+$KKq8<|f#nFMvv^R7H<~?1kwt zRw$sg!qmwtnW))OJt`ol?<|v3j>|jtDc7Eg=|-)4#vdW%u%67VBcAF`2vquu4_xlq zP;T#RJFQHZb%P)5y}en~+`_X{b>^vd>2}jWfZIWU;sHX>(b6oEUz>-ysG-^ww+Vp& zl+XFMN6p?j3?F70Q)SIt0k1O5Vb-x}okX?|){^iF5Sx&-WsV`M3=1Jji8~SCm0ncs zx?OQYVvD&2>BT{xu0ZI=1jt;A#CG{e1_SQ-CsECw7)O65u!>-v3<*lmZ7g}dl&2sT zG-_l4wT5Mz=OOX8$s6)gq{SH2m(pB7aP`rI96BBM>+5onE1>=FhPSP!IzSYAujl2sKcEipR+Pt zOh}dLK;}evkPNG3+}Aa-@PNtPVJ%*JHkKJ06EZePcudSdGl?a+tU1Hc_== zfo}Ghw>8T`CsLY1+V%*6ev&Jf-R@{;hj?Ek0+FRwC?(eoKpdCdkTt`pUi{PB)CJn@ zHxQE}nW|dv(}6-)C5Z`EjgR8)dlC6Jq+o=IEyKHZ0+xvjU$^oS9SxN$o1rZUAyCsw zWv_FfNJ8tk3z+Qz%h06Q?0nGT0Iz7=uy8I@(8ffl5a zTHAH%piU98$TQVkwdI2~Crsh=m0Z=y8D!^V(l6%+D#&RopUE7piEdiICKJBQ) zym-ds?L~;_u#yr%B&(OZEK!UmO?s+|7J|a}cSy5@D#{0uU?r&Fq3Sj<*Ze_&0g)AY zfYZ37eF>3KSpQVyvq!PYQ#`Jvse-q+qFu*%p}_dVH);xop?8sh_lT-|?KTs@RKYhp z1VJ7WR$Q?)$?4;#!Hzm~Lqj zXEUzo2A~7M+Tty6*&LY4_b#BUYNrAJN<|%z)s|3kZR6QB07#KDdb$|-dYG)LT8v^=%GC4oaXQ)A-j;zp&+*UdAdY=M&*D4@vi_T_Lf4t7V3Vl= z7hG1`g-`xCg&y2yD@WfqH%acfz9_YG$5oK=M=cY$vvHy{N>Ke+@BvGj%l)YTRY!i` zq?jUiKx0ON36L)0M>TfxFR4gAwucA1O_VnIy08AyY*%?_&npx$Z88wZ3d-R+lr9Mjroz@6;$?#+ z5W2_`(2w)Sf&mK@6O;zL;Xz&;Ia7cT`SG!V!j?i@ab&@?HSh;p5RBFAzn3^FQ;qA@ ziGgX*L$S`HAwGd6z~uYTVDc5M!2~oWr_i(Ov`kpUmY9DmJ@Vao`~4tU{08jc2{mBE z<4cO+C$$F#(uEx$tIo%Fl1`ObNw}TeaF*h#+qGDV1oSylVvy|0$Zkv=jn~`YTUAIV!S0%ZoN>45#l%nD(Xp2Y5=B*X}lQUfbP7*0v9Ti)RhRVsiG z8j!Y8B6sV7Uu-z`3cK98%n>Bbw5Ir##GOWOt;Wc=$|4Xnmddpt9(ptZQFK)s1xaD1c$HJV>^?aK$tmWSw)$)@o_ug&B;n!zok)qwKv(W1( zjULp+p3)5cg1dxd9Ca{vD+E^`=Tz30%78&xeWFeCTR-v%uydY!ajmaxa5|gOIEE3+ z;Hme=;4a~f24E7$```z4I0=jAjoU-3LI@1nekh}eurvt7v}$H=P+s?~*W@^s5|r|X z#HB?7fY_)&$A!TOu(K9*hA;R7D9Yoj=fyf~vMo|dv)#)y73ZzS!kG!A z6~ zawd~I$(eKK-rRq%ce3;DWIgL$&zz{OMCF*SUjC}>8yCYJZmqgb1HkoWmG!f8G1w|%rC@hy*Xf3Hk2WxbCJUJ!5z&4Gf+%r1{u&LXV~DELf_aZT z)zw$$1A&4-KMuSsim%yL`W9_FyzowxNDe9PCX(w(08V&5#Fh@8((5xpZSsaE04Wz~y{Hwz&q3HKNN%P-g z*@`QY%vrsv2FVJmp}@m|6sMl3xvP}x4H%=EeBLxk!mkb6u9Z(b07N`HtlvN^Tt4{1{%)ww1v-7kJ-Pt5R?!wJ)0 z*^I~}4iM|+DJrsfI?`T{o#RUehpWCaXvY0Z@j^njFOR#0BG!PLRq~C6#nBkvo(#7+ zZz0*0rlo83j-dD4X0fDp7(KUfUe3^3uWO;awu*js&ZX&=3965XO?T8)!bsI{yF~a_ zV#nh7eW=>+BFuAK^dnC(O7LWoXcnZP&hkI;Bfg;#9qW@!7Q|6#yJZ}#JXn#mHp;i9 z5o@!M!Ll@4*IH@4-eFi9j$u?*bb*Gb#Ag*f+Hpk=Sd5eF-`&wBHjZ$?_^mi#BkD;APB&4AOXZiy8zBGa53ro>fYmI6R7^ufeG9nS|*M96BxeLY3$8sN9 zul&r+!~NCi)07xb8}P;wj0U2`%GXxKIcMwDCr-$Ih1<1`W&(Bl+t=)Ixrvelktz&c z$z>Tj(Pq3fewK|wmAB7(H%;a5@Lt4(2};W#NhltQp*yny)C(S)oXpJZ;L_`u;~T$d z=R%;GPiqSglt4x8q#No1A3EwE@fj9FdmhpJ&(gNhee+7%TG-tKD#7U2AkpYuC!qUv zwijL!+v`%&aoMVqU6-9f-!U-=1U+!`P)@|D>XQQ`Wyu2NLzvDn{GQCj_d=cKsp*$u?ePHu6BhA;=fciMFZ0h<9I{)oFk^ zOyZa!GqEfZj&PL{l6bEe9OR=T5nId`s+VK-9;prDdnD{}#9z+Csyn)pNY!#93LwpD zN6}ZdcS8a*0z|T-!2^=4_`lJVzVfzsny!l zEUyo{a4EHK?BvRrty`&^nyVjB7aX$5>j%t}a+iYIzQuAPmL zcuu5M_Hc4@Xq;iz&e@wQoq7`e*2#=;voty0G{$-p@4g^g;`lHhIo{jq%ffg>7n07i zgVQ}V@iy{VH9NCx{9!@UrJ-7-YBT-uKs!8tNgPone|llVq;uK3>7T2tCv99DqjFzZ zi!zt5pht04a*)d6bM3STaP*%=_AHFO;ro8?eI_}Mp|k#V<;bG^8J3zs{}ckpcl#PV zP?+J1vkgb}v$@r2P>OdI0Lp9aR_>Yq>>xY%(zv-EouPT{M(+rYJypA&ZZNj9J z{^L-@+fDMR;2^~o;dMB(Ne3HIyL9&# z96<=;UIbBra8pQstZg~3Q-A842Yd;g9>RTn$*p?u+b;wEp%9_B)!9=QpV!kF@2YKK0ydGk4+rMzsRoH8E#ph0f%#>7o)x(UIv}PSeHDL`tZu6 zP%(T}8pkd6U_4=QG}aH!;kLO4boPdXH!Ng(6jVCWNu==-mUwTag80=Cfw^t|Ll;mj zk0FZzvx?={g?(lC70^jlLfm3VX-(;g;B4nC`b=l6ozM`}PSRLaTw8!KqE#1-A8Ot8 zPcZ5hyoxvkQC=|WT&JBI0Ak4R)iOO>{-Xn_gPI01>(4^uJ+8~&FGx_2+4-?+xfJv~ zyhC-El-ZPrb#H=E0ywIwOY7^S@`DtboSP9~#27XqN+>&?NGbl5h*wdZ8 zR>sQMH7)}nCqml<8|N^c6Xy(6#My<#C)2^{E~UkDk1Zj=vI1|CCCxJsj;=X@29`II zeHi9I7~_kN^&F~pBHYR;=DgPGpCEcWWhxqSa~*40YgWkT2rY*T@j^a`;H7i>Lg7N2 zOLi%JwPiv(jP=Q@G_i$3g%bsQ?CVTpOGxr{#jXi9@i~ZhQMcn*p<|Bt%0Qavx(YveU~@Qy>jCT;O;O?G zQu&RXOv9MxHHV+1k8pgx*m}+*fe%y4M zKbqH=S9dtctCxr1PJ}b7Rzuf%_7$a6RQTj^DAYDY^!ui9N5cq3juvN~_g@mcRry(h z)fbEZ;Tj?R51nJrb75)Tg)lPJ?#V{3 zVAQwq-#a{kzH9EhnYnOCay|Q0_TPa=<&5|*R_s;{%clKqccMYf%=cxcRPB7y)Z$zu zEWI5wM4*Sd@oM(b&CNg=R)&vO4f=IPAV5cTn`?M?qReg(oy+-K9xz}*6WH@4 z{e?2!qQG|VpkGr3M0en=%+;A^rxmzYoLKl%WbNf-ftJsq@)G0C4EBhK`yKZcPtu?f@K$51ZE8%-d(>PR9_h|~9Li}29&JYTYT!#=@4A!~s>>*-57E(w;c?H}s zrCH9n?e4=2UpbloR=_Ch*#a*ZMX4WCvcv`Q_zoEt5Mz(6C_Q(Gug%4CRHd#t0+ej$ zG$%eq*dlE_2nI)k!~Jwui#Rw4|H&((N%G%96SXmd5vHlk!1uo_a*VBu&LF$_ilN}a z1wc`|PY~ev?MA$9LeK#Olg)n<=mmjN?r)Aox(w}FPz!zkRM#aorPo}+m)~uSb4^UR4g!L3m zCxdd_+w~{IE;j`09*cg~XMcLWrgikQ86;{GZ3=fhj~37SwzFu^1OKhg4wdEk8xs2L z>zt?vI+q69qT3h@@qoCiGvE`rjgND7E$}X0os-ejZcm7_f#o2zT80b-Wr0@l zgJC0h6`Ej>)Vj}2y}W}^w^M8;>eLZJ5s>Vf~343*iX>TpO0grM~Ci0{c~Aq;I6%Zuz7Dp&?EUuMrv5=mROF8`K>;dmFHwp+u4gqn> zo^i=dyxEtaRZLkF4yrrw6-2U8L7>xHlA@~))JQF&WMzkh|8XLUjR3}#@b>{QHFE~e z(G2qNe0VZIi7{5JoW*@>l8mLV_Tnt1@Y=v8;4dHFhtEF)IefREDRov!m;dCO=*At` z6{?2hgF}z}CiZ^h4PB2QI(D&g^=5=(49=4}XtHI{I4Xuah_TdlUgR2jjXU?uxkI7hZ_6f#) zw>u;=UNvh?>smi~85~f50fm=rps6Pz5>W3K#7F9gbVYX71hkM-12ceB%JkobDE^cp zE!6@>op1b0mBp!Uf=#J18SK`G{AdvVH^^rg2a@VZ=JGAy%VzsTn`Y*h z>EUVHx|K=lYnxNYhSooeRFPaFf1qlZikxm}kEisqQYj~!^{Hcc$iLKX%*A$~l~z9H#9j{U5k269798^T_g zYzIDGGpKulJ!rha2phC?=K}d;d$Q3lr)y7os3fJ@T@lbT<38$_=$%eDwv%3KO_i)t z2oLu|XWy(es;I}_ZhL^WS9ZH4kd$doQE?6ikC~NEu7|$T6@90uc1(fsla3>J%g7=J z{9Qm(Pft+gzUN@|_IyB7;V$-N;yPV~C-*LCPO zTZ<{|Uc0h+Mud{wx5!+qHVbGjX0WpBJ zc1!h0IG8_nnkgbC)n@g{TJ$JsD5REYTO#{+71Oy4z1k2pZg{E@GcOWzm3clhVBH0I zh4R3cO0OBOF6bo@OgWOD$Un;k-&1`<$<&jQVU@OU58x3bs+3J|;ep+`qy~d{N(qV* zG)K+4Eco>HENob8J$F-g4VFYRiU}$Wl)70xAM6sva!K_URwJ*Oz4cwUaq@5de0hyK zgBkRSK^+gCgIDylvyEY<05e;0$}3gA^!qs2oER{!bq1#J^7xR z80)Ylij*WL?H^mCkctW@|)(d83!5XmJHK) z8D@vHTjA+l#Oe%DGFuwgsOA85?HgUI`<2>1*Ik-VwLyb%r;%nsDau*&LP) zD;H=i;659J6G9Q;f|M-5__yt%BX1nzp}_P*q&Lm|%{OaH#>tpGZ^NH`H+|FPu$rM_ z5J?br!$^(jOhuPCtfrkydq|zZ=;6C$BFWVhNv7A}bZ%D!3+#QUf39lT(5XTW7H>Xo zIdS{~PWBP$YKf**br7Kv7*$4fecXt%HRH8y`?Vt(O7w1K{n=sjZ#X%7LU5+5FM{AK zq7IMa2^b0P$DwdLT)V(b65CK&R%Y0Wj@XNtVp{MC;3ww*cs%8fgk(Hwv5sLCu{$MM z3m3eubH^ZB!aXQq?;8gcyQlMPP|@e0Nms8SdmOtwHzB)Baq0+1HVTjZ6l{R0|3kXR zfuN(yv5_nV8FfNvKMP8s2U{kr5v=N(C*I+?IoJ>VmY=OPfgqI+l;(p=m{xV&ojix z8wYhA8NPf#f0PQ~1mf=z(h*o`mcw80;)0ne^r>-l{?G5^Mje%>V?dwb+w1jiFBie)O(cU?~d*}&0n1$ccLq}LAtFYOIkLjvb(?QYF1qzN z#3%_(aGfc_X4anOh7{ewfb9Ze+mXM+gWGxfdHIRKa43Bt}8~fQto9pshb*CZiL- z+8Ji&lu&X*LqrC3hk3W_8h^*w7zqZYH<%pgJKBAr;9Ku{=>dj9WSc~cC7lc|m4jTj z`y$C+2i@H25Tco1`onw-@^(YO9?NxyOnNC-OUj@!_xnIYN8A{Yzz#DOyi?JleC%vE zD}LL?N|9Wr;yf6mTb2qjTFxs|fxDj(V>M~6% zZDGPxg;ZuiMVhy$K*Bbw73Wrv%GMqG%-kxoI395>3IE*g`jzMt+W3sS^lq_;2i(y zn)pBA1pnVkmj9c&Is1PXBmc)^|IbYoO#g3F#Xp0R4Yt^C?^U(O&4kFf6KyvbSkQ)~ zs%~rxxX^!#QXdRUQR22kn4Bnw=Dj{2ip~`sp-GA434=K|7ZpmUSstAoZcqJPK3^9n z7hlckX>7JTx_ar6YL&}F#->kpj2ThniCa}S(I1BR-i(v?4yK~Wog2QHr=~eFBaI7H zF6gd-nHLu98PQUI%zdy;56dyVuwohvvoZz#HP)m5{9(uVAbpA5*f+mGTfSNBF}C^C zyK&wzlk#;QUl?p1{HgjrH=Gu%LdGwFVQd_gKE3huW@H##_LbWXRT z8ncR8E;ZQabqysh>Pe?idbxh!E2zJ}So6AjGA%I9!h& z$4=1CbXNg(c2I%0zEedpT~Md-Ap6-%FF8z}iG$CI@dN{h9Xj{;4q~-vy_$m-MOf+K zMid^5eIsPP|7V;BlK^g)A$r&h1Criq1g%}PE#M(H@H66FBHx@I(tIo0p`Y{y@gRI} zI)CB%q0O(0s~d#GTEW`4RY4(&e0VCbBr625HzCP(i{5pk6cONg%dq!d>VTsFuiM|t zwjj)3bhIDN`fDR$6Zyg+wjmGDw`BS?xE)#rE4-u({9_LnK@k<24Fo;*oOS z!t8?6gH{&p0xoE4DZMRsQNTYPTjP1iC!_FngH{+ffIyVIi7P}gbP~$TKSs9p9Je8HwKi&6|GqpQdkng zITv*E&;+1IB|9C>XHmx3a*&f=%InQai8!P@+!6~%FLPsMYF`EIWY9s0mJ=M9=o-a2 z29V=#8v`2NJJAwG%&Vn}=EW7+)SE3X9$G8PMuRugScXxCnGUyvA&>+?{3k^%wLeJI znWZPQP#J$Wd*15>kV5B)v2>(3gR03h5@i&D(%dyJI3fq2NG1&2GtM&R=Z{2NYzXJ> zuT{WN$%Dc`J;a=SZc z8&O5KIi@fNXT~&;alcbsawh7Xns*;mj+2BxsTiCVS>H9uv1G?H8qnG`{SP$lFR^o| zmeG=9dPa&jR*>~+A^n+W(ps;Y+!xVknQYs)uBcC{Pd%Lk%qzWD4~tZBuQEkTs3nhh zuYRiTI^n#pAl)aXxSglGPXC?_dO1O5CkR1?x7?a4WBiO3##<+Z6Dq#`yAqr{l^*W9 z?2R|imh$O=rFyYJFL9m zS?sS)9w%~EO^ZT-kWn_S(}M^J<5x*>j370%h=SJ>j1ODESOfsdk6GIRw!_-o`Z5Ea z94703^XzB9osgwVhl>0srG*HP^8an~$u}(oX9LgFz3zMii(7))YI^6yw=idrk9-dKS z4=IL3PG1icnLE6>;pyC}-9A*;`JP%MHz?gP`)ulli*3e=%9|`4cJGro;p7iAxpG!g zP_IB^r_<0zny%#ByN>U-^pI`-M>u;aME^`$l_3XN9-;E|T1ydQx z9p?of!q6wigTbq;-PzF`_9=YH{!VOy`>Z zkDZz=fKSEBAEEy)r@4Lco+R6UA^4y;f}Pk5d`e}M zJTS-&&yKM)1Dy(8HQQ|^jvGe%tUqJOEXiyq(>x_Eno8MQYTx#*kK|9G%M*E>>~#^3 z79EZdA3z?atm+rzHS!3jdBe?6zFI|eWs4AMCf~u}k;5a9yjaIP%W}s2P8ph+*<7{4 zF;z0YQvQx1=riRi@v&}XK*R8#I9V2Pa_crl2_CGN(MY8j##@%Hmm>@TFD5hK4@ptO zaRI()E0ReG%zi3Nl;(=p-8E!lEOMJxP`V*e^Kpf>+jMWvluI>Gk?UO?t}$4ul9otQ zr4SKhjurC)>v=R@vf~gx(7It5n*7&I^CzmLn7DT!`tUdHNLg>f-Z;O|-641o75kcT zc29T?c-s_iG6nxlM8dz?^^=BSLH(}6^nfto9EOWq7FS8%sy!=1hG=k)U03WEoH&)= zAHx7`;FHHQi4fvWMA<^n^qZJ5orJB^MUOU|(?s;si7r014&zjtNF;AZN0T-2*<`h$ zz`=31le5vtlP|jqx>xo`mwOC6yn#WveFJp71(;K@*~W(xEAI4DSbtvxu?O=KDV*K- z)8Qtb{pMB*yRsM4O!I=A_unA9{+9V%6h4zf1fbb&ncd>v+$nY_*P#FRT%288zj)sv*^Zp@$q2}_xI#WiFoUD}&%Pc{^`a_(3ouXt^ zAJGvM4>k(c>F65O+|~5Tsi;v*el;W}+*6#r8#94YPi^53J8{aVg0R5Vigeaw-~y`TPo)gRIUEYFXpmVsA{An?vsq@-n?==3BFSk zDT7Kj>eK>y0ThsE%FP$dD?^ujnM>+b+Ue90G6V^NG!jpPOt?W9 zfgjx++y}*n5V(s}Cd#vw4sj&)cvd+_3axTjJ(U#$UL!J>9wA*crhlcnZpL$tXx+>{ zEnc}X5_mQstqEyB+ru25Ag(k#s*e?1O9+7~(X@T{rwx%cLmIozND+egCMz=F$}s+u z9DSqwe6T7WpiClq%%P??rKpy>5pvLEJ;smNpR_0%gKI{5)ziv^zgwzn!aXU;nTR14 z@QR2xWh&Aoh%ZqHuG@hvO&fRZOum1pb=tFS?Dn;@vn$8Vr)g%GTcs_n3dy^1y5s6? zmWzI4o7u~elK%LEe|5Xi?bcqPHIKg<(%ST0^oZJ9?>$R>6&l@t>olyT`^|5gRylcw z!^=K8duwql#}~3VP+5GjH;L_e+@9t0fdCJhvPODo(`WD71xvoQpyJN6eVPK=QG&>u zF}VpqM*2k8JF%d-Yz^C^)p>nRpnHJXzD~6RqyMxRmhe7>Ig$5HM;WMX*3zEONzJl; zj~3#vl1zGAzi#Z~?D^_!;%tQ!bojX8%DyhoJJA6-(jGrJzoArliMx$9PB=l`7&~#~ z)d}&^g?D5DA23m=ep7pe5On4yF<2jk*`#<5{Yg1)VKXaHrx~qbaYYY=_2G&<^03Hc z>pJT-Y5$=>`{Q$uZGWNU(+E4wo;}@$XN6XivO&xh;f4T5B1pby>kH4~q9D)#en ze@^YHAusOxM)zaZJ(04-9<#^QTabGd+{^`b(kCz(v4>iOqYI9z{fjn{zL87DkBl)8 z5xwZB))ikxW0?o2E$NHM65`Lcv$2V3b%kLMcLI!ap@pUFzDX5h(IeKf%dsnvCdKrJ z9GU|zg?zl4X055PZtWng?spld>WFm;t*`{kL@+))Pg}u&9R}k5 zy9XD?nJ3m*LwA+F`s^a0q0f?x=Rs- zRsXw#P}>>#*c2%=#?8NJE+F)q;}uG><$}eM2|;maIlxARRBtNgr4J!;F@~S0~?y*!n}e^_ag60e+_A?YOL0;zn} zp&+Jyvsv~v0CeTspI5u;$vms})r}=SDU@-)&5%9hsdDy#_n*thN3x#mcn#Ct+R5q1EVa!f zCA?e`?{kiC-8?wr;Cy3ExeMr`e&a($6?VT~dL-L z0cjK){I%4KyFEa^wmY!PRV1))0PlGM0Ibx}66nAyq7~5|waIl$LRsfA0j$^7SPvm2 za>d1vybVi=&;eLf?}q#oTuT`7uD`qt5Kn(;^r|`k6GGarSYX(7hww<2RUR=Dg@^e@ z<_G2p%X2N7C=9E;oaA$W_6m0I0%t`;4zn?Wl%>(eQLzBx$2Lwj!?frT$^=M= zf7G_qD#>e(&FvDBCG6xa&k6{VM3ZX2#CYUTh2}wzIWs{jnRf4OJv&a9REObOH>ie@ z!9_mbA%!pDfJ{BXS$$-fr0ezfq^HowjDCFsfH+H&S+ubtbNfZu+Mm;u1z)rcv5N2@ zi%=g^Tyr&!-51vv+?x$|Pzbr|h~8cv_Y&RXb#)x;qmS)GokEs~{&d_*`50-c#{Z%g zamWTo4WpG*`en{gnGJjls~2Vmmtp#l26T#TQpkg&g3=BQnw+lF6GdW^D#m%-+H(5M z@0MU?iHOz&QD6uj8o0hO5B!Fb5zT7Kh!t{r0x59ZFaMa!%=^L?X~ypJ%TDEnv;IHeHc>9aiTaOuxpA;s_2MLC; zRv_Ppqe{~ckTSUiMw3R@0=l7&aBu@_OUqUi8pqp}Y!m^i`9A1~Vp|Do4KxjRx%#E= z93<%bq6txJy)siQhgk(vB)py2n=S20|BfjkF{4w;h`X zHeJAC2RGKW=Z*Y&zrb4sG zmm@=m_ATuIyw#ffW%M%Q`u+Oum%kg6#^GvfS4;H!gT z!mce2pnxSqRWGXTO(W#yXPJ#0{;PL2O4%at@E$BT02!W81sx2j1)rIa0`Umd8G%mK z{AYA--b0fH%iik}NuyvqFQDyXKC}z+wblrS2gMWxDLWnV5>M49)JJeWY3F0i6BgSI zG=R8BvV>j1qgd+D21)}Y`Wc{Ai~s@TXbO%@XBxbas`suH-5W1ONrvgV$e5tMFY@3U+q(dW70D4td?zLJcCwDs>Gh&-8rJOS|pu^?iFCB{#M3dEK8!{<*rawA>3Om#ZUayIoCnb(O;NLG^ z6;%5th~Lm7Pz3!OEi-AZ{H|qA=O}RTTY1X7%-K||na@m%XC4(=rmxi(H0VD-AO|O5*n6X#R2PAw>vbaX$J@$ zY~|>-7;cB@?>t%X(Ts^Qwi+)=QWuPZO_hI$Sc_q4Tlk3$W|Xt{Z4QTb`>`(w9aS zFXJhpNg2mdIuE8^t|kYgkS~a0i)}DrF{>cq zd=Nz#Wzdc>Y{xOusQ3f(5jQPjr^3#}k?&v0WvPESdyjQiL}_eyzKO5(_tIFEna0B& z!^ka{q0+|(RG(`>+7U{%qqvLhaU!n!{k%f%JR$?bZ-j_D)CrL6_MG zamhWGK4$AobxCEIZ6<|jcU;>tmAMEde%dswX|^vs|F@}^ga!$$K z=~GhdD}XnbYf2~7V&?>O?s+dLX-n_JEya-GE+d*$p`w-MMhsb>7Q>mjGtzr(+qh%(kCsSeU^JjKeF(B-KmZPvJ&`@n&9@K)t8yUY?J zgMI(T^?j0La*hf+mNXfGveQ;T6ZiIg3KVhipUn_mgTl%`r7n4C;d=kI1UB`(-(rm7 z_~3}#AT;ZFPbpJ7Ec0LKLAIS@bpcw%I}D}GfO_>hDUK;I+dbIw8e1h(y8!*z8N)oJ zB-Ea1rGiji$J|m_v%D@WmwIHx=-+BJ(wOeP8e0)|tW7?0E zbSBfpG>vPAY zQ|OgIBqkpg9L}Y$*7n&x1DnetGv?w~C4u(rmSztvBh8XA1(fWYd`;5{FACkl%ONoMTs)WCL9{J$+)T0GF0}@{~>6=M$)HI zYuccG2==u5nJP79W?9eQxQmVXc zWS3cBR;#22NANgL)FhkKw3WFx$f z7Eiif6^+|*1ft!`2Q25HUk_^?>lTSP^@@=Y8wBr)-ZQ0N@>H?knskl}CJEDXt#3cD z{)PBoek zXSfvIU^k%5a=n+X#9Dg9{P6FsDrf_NsBg^7q1n7(ur#A5)b5=flNipbH4UZvK^rzv zti~9qb->jv%AE9~EQGGp$J;BH4tSkvp2&yUVxtdn3tw8%@Wvx$ z&Jd-F6w*O*PVU%kU9ISc2Fe-nSQVWo&0xBNFpYy&wH0CMxOOjvUYaYnHS2*2 zAE}`{SgQlR^48w!QyOnH3MeEdA|X6_bq&U&&-2(!F_|$G^Xj4VkMdK))`t)iS8!mk zQ7v@PwT-##wbKN=g0CmNsYh79%-H7tNw)9>FpZ1bM@2o^UfIBOdq%xX{gYVr)?@<+ zV=jYZs0TLsG>(pHZdu~jCEY_ft*lNSPPP$UoW)`wMi!e&A^8WYwUl`9xa=;Zy{wbr z%HrM!ajqfk8y`!X|1uWa30H2HdA2j!F(nOOTa7}q!@Pal0UUZ%QWG3k61A&BktA(s z%OL@Qd<-B_=D89<%WSebwjFm#uLMU91^z`p1VR09Db)e;kGPI9%Xpkn$-%-9&*RLh zIuT!lIKTBdVuXqU;y~LEZwbJM?1xWPs6GQx*P>gCDR(s?`?3)yGB1;Os8ZwZ9B6Rd zQU|Hce;kPxmHHB5{f0$zD+4Dc{L$@GHdk(W6268f50C=d2!@6=G}}G7q<7% zFmfL=)``uE6^!i8^MRT`@nSrDD94`mUrBkwMr#LH^|=UwlaG`U@f&2;=}C*Sy$?ND z@Mlfi15sL{evu#T44H|vW*ZI4axSBca0sm{1aZxifGKh93M4+1Ba%fUAB-AA&1Oq+ z=UZ9*v^)gR1cTLQV;y;QcOwl;JlN--I5T1emRzLM!d!MZU1Wp~L<<2Ea8PSCu(#_H^!nx(>DuNN7zs+Z;D0EzH$Pr0yWl>PxGSf?eHx?BpP0QxkWT295OOl_ zhEY>g=k6caSklGY63^r!M@q&sV>kdg?_H7}JGwxe&OXm>wFzm;nXWZ>lOD@J4>Y8p zg!pK*7$fWA(41EY{K0~MRrNx1vL6&W??m3Eq^=%BGXU_=rEa-sELN&%(2hmja_LTE zz|u+2Ml*7;++1-%Txdl*@(MI}$2-1zroJZuUc=YdI=1^+DS%lI^bKu(s>tNEIat@e zI#$@IV|;dioVq)gB6kx`z4RN)LJ~l15>G>2u45+wN0tL{HO71u zT2J(uA9Y%iLBZ|}VMKFWGt)tkMp>Mr@e^op`8#aOpQXi%YBGfpjglE-aY51EIjakK zR5rzIDa=HI%t}<`deAMjtU%7{{0D3XBPc&;5qq-)Z?BDJ&I6aL)h30je$n#m>B`Db zGHHg^V82paNMg3rE~X9M3A@D-P~@Le9lJ#sXu?8+eo`X1y72~oD>ESf^*bK_uz0cs zH8nyhEsL-$vaKOLJn80&bfkh0QdozRf>RQCB)_g*{q=z>lYI5hkYFb) zUc}^5oYaLMCynaOrp!p5v&f`Ynw)tV?^OA(&j_N8N-;e zy;bhFAW7LWS{95@!$Fl)Y%{lHhe-21XoXIxIL3Vtx82fN-5LIf5lbT}NJJr*zZMIx zpk77))?Y|xBzh=9fpHL`%OI3w88k<^DFeDqc#FcQt4>ed+~GIAaFEmO_=g+h){B50 z*i$4ePvEURZg!_QyVHO?*o%v01S2-g7dumQVt(n8Gi4b*frcq`%-qn3A~S;lkLliS zAEEot-P+mQF!2;H&I<~}jPGE`4ycwA; z>U|{OpXc3PogLv!MRjqa=<#?99o|X%-&Oy_Tr5Dr;2+ozow2aQol2r3&GBytj%eWN zFl=|%lwAj<6jEXmNdqPSYr&kPpyl54JG8Ux1kYGhO-cq z6~G@fLwskKV5U}Nk_443^R(fHX7+7-x)(Z|*9@A4DsXME?gF;OOM}BU6N7+X;+&4%rrQ9A=e1H$`9Uf~sJHjs$P<EExDI?5zpP|3yyuBb4d{F8Npvq zj?DXhrQ&E3Htvi$#KZT0u7OvJ#c&`dzQmJe*R?0T_fKBtL3By=&gPPDi5m2=(|H8U zS#u7@NI&XyfNqkAs~q-<4c+F~a)?^wq8mxXGui1WtLWna(D(PE6T00EpP(Ncv2xPl zK|2tfm#V!Cex`U#-i;&7ZG2+VlTrNMcM>s_V20!WC@EBN ztaD&fr&G9|U-)eq*=@g(C1NnPpqANKmfy(7dg@c?9s^ke2a674KZOt6>cH4=9-6q3 zx=b{$a%rx|E&0)~@|ovFvHn+qAxEhp`j6FFI%#IYGOETbb*NDzsyRb|aIc(E zP)(WSs%VS!L~WQt2{l!q5esf6WIS!rX_+2h#`#ba+rLd5x~FZu(x(+^oPmdC4}cBa zynEJ8ZGYip9-W(?HA7+E-ukVzYX{Na4hC>K$<$ay&RT%dZfR0Z83cr`hLSz~GBfpz z(W>8mn~0~JYihxq=CPi&v_eTqp){t_eY-=@a0hqT;V^iEKl?1K>2^hK)AQW9Y3}17 z&egg3DkxAhSO^9NqIsvbzI$CuqHvxm(cUD)?b+W2^%L?kgz$AsTba@-O3g6QQ2c_@#7_bGhXZ+bT&fBR4x{iCFo7rlu}>(*%E@SaoZ zcgi?4wCVPHLktk7dLz)w=zp2tFEnDA$R*7zLY&2jucysz73YdhGjnn|oSDaBx>DKf zixBfz+a&2w>fY z7_NFd*qM&|12j8b4?OZ$lQ~U%-RA@xDE=Dtc-UBAq>-s{xz#j##2|3 z9p$LXytGrM2~VYBU)QN5raUN}QB(})QjeSx1~vXoSC~t0wVqbNuymNZUh}2Og7Y^N zQ+!*?AJ}}=hRnX&DMtWUcXo32CQ{^mS$}Q(|Haxn1@{t#>zlD{+qP}ncCusJww>(Q zwrx8*ww+(Fe zlm5$~nyWsH#@iV0;_4+S-*t0fV>MXRgq?;ZT*lQFQ5{|nn~k!DzwtwpoZCUZ}E6 z@eN>%Fvv-psSzSq!oP;vefw~w`$%QELDdrAi-=KclWv^OT;DV5GcT8A2HrBY8sH8t zI?BNV>Y`JN*_J(JHX84FIR{bR{Dd-8#W&LGlC&LR~D=_egx|6g* z=7Oo_Sw#24(D{fCyN;|qB~sJuDg}fJr4SBU?jpR7oRG?!eZ!y zZxrdVSWv2;s;Hfs1(e;~Hkr>_c`IT{e`a=@$lT1(BQM4Da2YNdlzqz)F69x#5(y`| zQ*vI4XVou%*N*g`adL(^+3);}G!OjdUalMfbYH38KDzC@S*w@30D7JaYH;m?2tG-@Qr+5=?*-^YtAUoSmmJ1`p3AaDOCq3M35* zDtsnlOo{2@!<^P5J@`>oITNtgCK9H=RY3e^Ck%);Fwki3qAS_KC)?}R4U~NL@2C_n z7ww%|`W^JWQA8|8qafaAlCsm;dY!kS8`;8NrraiDliB|4!Pn|N#vf>Yd=(DO$(4n2 zdxkaWCZ^LieqOvGq}w(ukdl~gHC*qVEV73H!9f~;PqK*U#Y^D5pvKeu#))fA82O7` z9w-^zheR`+z+>F~7-pyJy;V-!pyA|SO{q|)O^e=XC_>4e7I^i1t?6&QPGZWwl2LS@ zj0)6t`Jy9kgXffpa5|YylgMoM{HV~w-!j;prW8&;VNu)ujMp9QiX;pt+#vBfR&nLi zCg{l)I?^w_B}RDQ)O=;PWHjDx)j-ec#=c{!osdqiFQB4e_OtPb>% za{_HwpVB9vgk|o+-4P|bq@tGAs7b9NRoWso8YU1elC9Pt2o9VWO3AI;tamD(fN8X^ zK;msfaAt;`r=kmN5mLiiZ}A}dY9O(o1Pr<)avQNVCGDo%>E>W^`If;F@gvc#0Qybg z#CT6MO|ucq38k+CssBwThBdm}Vq|fbe9hr<@GI+C3rly@paqO)Q| zs+A6|h94DiQAH#kVsOI_hkaSd?SdYA3Mw3zMK=iAHzPG=Yf!$)rUgPRGgfYMX_4%c zjn)FRIWosu95=5g+!yXdvC8lu4XDd0Nx`ApT!Ag6UC@?Pq}Vxal2ogaz*eA!Xlk4C zbL*p8v7xDZ9GLBwj-KfNcR}ib}bhtpy zg^`ijL&JZRUQR(hoGt4h_|`%~UlZXH8^dFmn8b#Bz1MO7lJaN@lF?K=^BDrA%WNrk zY$`XlJJ+>|k!wUEKaoSBucU-w;%89nBw>NE#+$+R`bRib%s&nf;S`C462Eg5Pdex|i0+YT9do_eGj@%(C!rRF z+OE`S#_$JRA?XWRkPzN%gBp$t989~)QD!Q1kf5kH5ASmuLipHV_{dcqiDJ0RE7c7_ zktko zmP}`#I%L)XF-qG9%zt_8ZMQY5C);RRb*w2TOxRZqnPT8S^mKS4!JLjOtC10G_#)7! zH%wa5#9#NPn~cG=y{;_y`rr7CzigEs9#RHk>UZ_C^7HyR84U#jJf8n<*37=WowNpc zxTs={r@W-BXxCV#E&tSQS9!~4d;m%jW@(W6dVRRULeC7wnLAi9r;d%IXdgBmypd3fqJa0EV9+zYNc)$T+}Zv=DEB?Z2v@bO@HykMTT2( z9cX%0B`leoKtTUz(E`kH27~OBcbk@MTt0p+pelH@n@ee=YT<0Bf;a#_&Ps(Qa1lYK zJA|-(JwmocirM>Flmc)xNF!>Y$61N83x9r{PBjH<{mTRoOrr~|zbSKdx@5-QcaV!W zFC6)${?CaZ^xfY;_q{@W>whP6m`LbXx|g3o9e6DCp6WAF-Rgxo+)DErZs?-#Z|ZM* zUTQhwyNDXG<$?x0BWq_akQzU(PPYeF`5I>g?dF~aQ!ifZ`Sm$2XUfz8u(k{g!|5`8 zE1GAm&40dZqMu|t`CiQXPh&j$bw@KeuO6Gt|1R!a(r)G7XDe!VsGcWQJ#nA|)=o*f zK+{+1cP2j{T6^HeIIN3yaS)bro<)0&V2kVH{MF}s%gG~@`x%?1YImlbr_=*}mgplz za1jt8Id-Ak3WMZjIV`d)>N^j?#f5okEG1{hGAX$@6m=nCm*%|CAzm|a zVALQ2NG;$ubQW4Jq4AN-CMGT08JQiZ^;;97)^o717V)Ln0Pn;314w=Z@7hJAvM?_A zPUU#iQqrfC-^~t^fhNm&Y7XP5{*r+NLZgv#f{cpdh*}`@6+*=}UkiOwV zS)1DBeItqVi*ym90&3&MZ9Q-gLc%T!WqA#9-^2v%&hB zPqkv&;BZ>NqVlUh`Fw?SBSqSYau|HIIC=WrN`D^ z++P}ybV7X@-!W^lq3WrT( zDYRgc3PPCRm5dMO#D$M_-j~qMRac^?kzz}npOyLu%|-^OHoa1t0#GXziqMydiGDGU zO{sIqVf%`-iR8d@RY*#4w@VxK5aY}d;3YC1_U=(RKL9w6e%ENT*hTi@m@-`g(-6?J z{aG%Z$tR%k?TAy-mnbj(vP!vd?n_`A`ixytbtRL3>Aucpi+4u564}C#JpA$1WJU=V zg1hztul*ez);p~Ai3ZysNUUxvd@*m*=O3CdEfo(UStcP^tUt{WIvNd7uC zwjZW&%sBqQ#;rdC6P(UsB+e1(oTZTxp$P0HdIJ^^0uv@7G=%l{`qLP$H|k%2Pd1Y{ z<=p6g(N;dl12n~sY>E}k*_aZ>+t~cf%1;EV)1kSw)2}8HjjgTHy3M+GXeOY(;m5ZB zG9mk~1m(<3|BHt5|1enmuNlhOnf}`Z?0=>xXX0f2&k0!UKLBY<3dQf`AAl4c6G^OF zLIoZIjK-T{#xaN0#1azJix@kpwYy%DC7%i!;*%{8 z)84_?kJXs$kdtNA+50Dk%U*mjHoSYSeGQqI7x%M1Ea{B2pQ^I7y;@KPYYpZ<>CvU}(*zS7HyRkIcE=xpnk?)k z_ZX0^UalB?wM)@uuT0X~ZgIT5TzbF+#2@ryeZ3m8)SYAR6wNTb`f6vbLX!>r+7dfW z9LY|DPILXU=3x)+x^BA~gtJoTl;@IOuj@i%sr{G!tt5?dmN(ryBzgbEyB4vJLRL3U z=*#7N!{D&m-vmH~j=vdd#tN@wYPSSqbycx?(=6t!dVnwy2udDysXwEO1JG^HgG2!iMx8@s~ zxj(dNzTq&21oe|RdCa9OLRbAYYL4xqD)!?yimx^d`*kzVl z;d{PmT76+G4;a0Al6ZbyfBqVJ9IKFvbWP4hB|T(GG_nkegF!`8I%`e|AM=f#-oJbl zSLgay5+mPjucSVQeDhTFG}txAVN)OLac*QDrsJ3IZy`Ir)5Jygu5?;w$pm2FvWKSKk8Xut0ES z`)d4ZixVT>d(kbpja3uMEtss>2}^J9bpMe_H!3MtQGAoMK?p7BEXPI&9|oh z<#Uh6vmHh5g)q@v76kcQ9W=P)NSg<5{~j{6a`L|#1~c)P(eAdjb}?sNAGPx~4_^MB z7dEQ!CMNn?hdG?$UC$CE=jA5Ml@#37+W2GSCu)7$9HNor73-?pB@Z^{Lz3HW{z^(K zYJ;RD+~l#u$U;#L7_8^j0nQMcS{|k4Muap`^_J+I$kV%BJ8p!{uFYyD{Jv||L91sU zu+%ia)nI>!PrB+Xqwj`FJKxu~LRGR42=zUWXu`TzIt@(qET#;X@1NKzg|^oBTT%i) zTHl=S6YN0tvG(ZXm0cT-NN0at^ooJohQR*_)yVpLJ>f1JqfKCfPX%@d-1j zP=lDT1dS|;+IS`aT{Rcde2els_%iO5j*m&R{b*;7K3Z=S1dIY?^~Juiy&;b$o63Fq z-1>X^%>9afnEv8Hsoox|DjfHKBZgkP6L7V0+1``~*ptWgY9_JfMav8#^YNsAcrLA| zJDQ1{GgEgtcjB-}T zx7o#+I!G~`w^QN1V_t{<4|I7G-VuP3PEIdOp;6?g%nwwqaNx112ZpN{)F`&wKRONm z1#`MzIx+m&v(TaEpqAC&jC$#Z%$V+qjHjRP>=D8Ykd@#7pi#w)Nf{>WX&6buz+tDO z$0QU-+xkc+^cDT_-}aiKQ*zigzHYR)f}Jeunb8!;i=0nCJ@yMOPHKCErI`; zb9U-Ew2IMOp>r>eG-n!Ue4UPE6xUXth9#=sb1AjB$+r~+~o zUYpt{d`UZ7_$(^}gGWZajhE;VyvCcQxz`vpO6VVd!HD22m9cidHJ1gOv_p zl}mzQ=CmZyAjT7#;}tTfwq$>-urqf;iZ{?W#@bYCxBA=+1^*T@HLRvet%@gRq5u7oWoD5O^w?XwM!NDuhLVr+{Dhd zQr~)RR;k|c8Eg!qOxEAg+-G7$VUEu-$f*~(j&;8r*;czEhR4vr-6z-6%SBbuCgk&S z42HaHEL;#pnp&j#5F(Oz9ggjZ5#Xq9=yu@8mLXD6T~`iPreHus2aL2}KlV`u6Y&)I z8j{q8>kiv|1>Ahk-=QO0ym)}qfF2413S>@Ph@0euS5dyq^AW~uWGL|;N#^=lJKf=4 z?zl9*PH7_)U+LiTBb4bxVKA`%%3ZeyUP0EP$n-F-{mFBKR5cjb-mzZ8xkHp}zdDUd zZfu5=rD!_6cxZ1X@gtGhB{2Nzk6<;3C<&I_zK!zD7LuQF-ysM=LC9QIs_pG5MB7E; zR}mhv5Z4)XYK=J5Nz-c5o?AmZFtc4%uKOSnO#^FIM){69+6L_ZO-WHHuf5AIO>v|< zw*5OC2tOwM`_228PZ=iuOyw3B|5o@gaJwzW@e=GL!>|eZsI_JE))o13HYQ2dIR_~M zxk!}1%LW_(lpli;N&Nnv@|aGF3-f!kA(l?em&dYc$n|284mdn$WCn6kfH4x)2rI=H zi=7MvU)ZW>;CcWdV$?_1f-30uy8$;$%on7$*{QLVsSNpYJ#Vhn>H4;6(t9>$8%k(= z3-d4^5~z1RBp-@8bxWTxBNR$WnvZZW7>r8rb!(kw{zZ(gg`V!l;9N} zh8=`Q%UVhPFuNJU*Hhn&QFr>V-ys2f`-u4+|KVU1zy*!%=wj2gQzCj*NTNWx3$og!7asVyAr;VyxJ7D1dch%!UqCW^o=@a{q8 zZX!i9Hl-}ynnEm<()4$`k%{N>HzMPJisi2{>>y|(d&LExXK#D4|Gc)PY1*40|>c!)J)uU|wE{Q&j z>8k)?Zw!PU;E6~?c}bTb)zGl0I8OB7VveJ0){M!Ld=av!qO3k*)8X%AZIDt(?#LC_ z!NY>lVg)yq`+Bb|EpB`kbfB>C!W3XZQ&*i;ZIvD|;V3nd3?Kvt61;eb#te*>_eqdY zN=W_Z5siBH*;8WJmU;SxBmb5QH#xtWw=+kppo92$gAczmCFDQpI$>pF$5cp?v5Y9$%5~gs;O5&7zE=Fk#UTYW>27P$dk(0&d1@8jq0;u z$B83cMWieSogbPgTD_;&MDj;KG~sqKcvA;8XLXgghPK!Jra;|xV3rk-5NvI#qNT_K zTX_70?48DycfS;e20Trg5lh5PPkq}=w9?VPJ-r$BV zru)Gvq2T!b->|$&MRfL#gs`#O^j-HqFs*&f8muz37&vvG)p5}HZv7lPnq_l21y1)G zDb59%#+h|R-ZQRm(xnj%-Hz42gAGd3B&bov2ryn;({+iz2Ya2?UIhe9r016;_$^*0 zc(ry+`4lzEOy!5F>hicw288JXClo*oy*~ne(F-P#4$|6X&BRSL#D=(jCos}?#_|ik zv2IO?Qmv5_c08bCxQFC0JdAy_bH8xak?)!4YjmpHw@EypDbhP)6HB>l7@n(%S|#ju z9J{HgDYT2AcJCUT4aWdNp^zTWNFX~J{j~_zQO*~MXh8Xvs--=;GD8r&RAAH7%Ziu% z4vPOx73{4$+*2Jdj63+xQrEb6ka@DsY`1{HVac-fFIc+IbFW7B4n;@E)v{mP->&Cp zPYn2$F;;Bnxd1)!fConXvK2L>bfx+H?f+>jdoFV|mMN}8e^T$;4BT3ClDUeUQ)Y#pP^mFYnBO|Kqm8aG=zl*lu<1nL7ve9 zDD7_DId0a?8XFv+9=e9u9!o3IU&zh{d0aZrZ`jrV%Y zx*Nt5QpJvM-i~$qU{`>rmuh_*cP^~bgH6|2w=2ld(5HK4GROq&HfxX;CUD~CyvZ$T zfFPI?|3w>H#*|7kKQyLXQWC4U!P6PIB$#so7Xd1kzZMXKgV(AVHlc6(gWIW31B%&^ zuEh~<0Q-yqMw|HLn-Z%*In3st#Owh-{miMJ5Ufo;<1gigt!b!(!7Vr`a6 z6!OC{V%I*{zcM-oZ_CO)cCEf;k*o1u8Vxr9FI}?S2CjfT&2C9KWrwdc355@kzgdb| zqJJ?qw+BLYx|ex0Jexe1^3&XtBWnHDbsGd-CBqrAx!@_4{oA%46MgP`EvA z+rOE8?A8cLzv7a{-4s(yw;zK`*ImU=@tg~SEerP??Nd&`WT7u$E+&D@4%ecY^5QfZ zpR$Y8$gC?Pal}xBdcYNHfT`a{I7oIrJi}e%oh|XW!*!{yFbyM+Zv-I>H}1&{S?Z6% z%GYbBnw+MZ9SB}Lc$K#5qL8TC=Axl>c+98mvsdjGGnfz2V$`!ocboba+0KQ)+p?9p zYg?wtjDv{!jR{n0S$Z6)V8HWD;9(gXAjvw#yj740{TtV&kI#BeoUu)SKzXBP3+|F9}u%6tA$aDb%< zx$e+w&}D`wc9l{dhhluUmNVp5(dtx)D(ISq+KarU+qU^zRwSD z0PYlSz_b1VX+md99XFWJzp%`wv_(3xb`7j|XjAbmGj{MXM>*izpjyNl)FL(X;+sR;SnQ8R@ zX4|j0r@WQr0*EtiL@JQEAxfCHuY0E~J?pWYqRS2!fsZ8<;IA1~fd$qTXm=NW`oh-x zU;k1hX?=1V+_w32>e9pc^ynym#T#R)2k<_K?T2E4l(DF}I!0^WXxiZ3k;M=IGcyS! zZHYt+Pmeesl>7IvJ|QDXjpzA5Ie>dxBl5-VpoZTLc@V^vKbx@R0-=)w#lQNszi)sK14sDvRK!58r-QoIN9-< zdL*+E?Z;sQ>&l=vY?rtQIJzAdMMemsJj<2F#79-B$FPV9zB?Z{b!l}hHB zaHs9%qJhOaW3v`olndyQas8wP+}9vK`~IEufUkkqLG2*(oq~Op3XVy}Ke@fADv-d+ zZd+TOC|XAuc64ebl;3bjyri>|c356@&drH++vmoqe<|sJ@u>ggs_lWZZ|{MK1PF-a za(c}6M8=?<37qqvg>kvIoTfzwgLnrs{MIegmNxjJDjv#t$WRhDouKyyKp8e4bRgPf zUv{`H?99`o6P^1jSqD=_3CK0$SH@}fWj{+@i|C-K@R8a#9%I{;q!NUIIuf&q|4AbB z?26qFyHdPjH&CK+_X!8F5jWhlO_+j}E;z;G6 zyqoF&Wqkf!{9nM&|4sk=cPejo=KnU^_#e5vIhfhF|8usHt2yb6D~-_mLHj@@k$F;8 zlNKKzuM}gei(gigwBEeoLKQy&%~H9~Si@o1s^OMSfj+a- z`|j$>GL<5S4^N7vBFX=mdUPck?Ug&cp<~ zEAi-Z!ip7OPjd{{4&s1xIEqGk5M8SojPaWpM{&WkoTJ#OECr8_vHPyrDGkl@0qc~& z2twb^$Dm1#&wcp;E1`or@1iD4fq#f`ZhL5z9qtn=j@{rQZ!B#Cn9$<}6>)>r_?Zau zJ`#X(W4JuS+2n)XQ46u_*t<3wq<_BRh@ZdgKRg+=o)Pt!G)DD%f&JcLPB=x}b;F=H z0(nAfx;=ejF?wFdhUff`2`TfW8};lo88}ha%EnV!RGm!#(M+(wo?*$>m2%6Sxqf7!cl?!Bw#n(fMwbF@~&5u$n39NSJ{pz6?Z7z zoai_!JuvdYAV9-x)uWV1)79Fg2L+a39o&ze6ez%jF{0<8&OBp(7i-#JqZA9auUjW} zj6D6kd$D6IiyB;yAA3A}7Br{d2_TwkMJLtSI}o;pm3yowDZByatPAt1V|_oB@Y>pO zM?OHlJtU#RAExFpJ&T?u^)cX4dJ}RFq9zl$&NBJr?`Z)xZ!vVQ_Xr-2KCTSnBni}c z8Y^3(&kvHdYAg&BQ>mdujr*<;*l?Zh)G1tOCV$%fFG@M<7D&9g1nLuG^eTV783%8W^$rk7d! zuWYoARm-j&0QVm9{d-6*TAD}o?iT<6+0;Z-eW&R80RX?#`~)a=U*vwz)$G7F%7R*& zgeYtr3^dllGnR5>2w>+qno%h|J)U8Ynj2?g=6-9YK1_-JJLxIeCz)(VdB-IP^?-;$ z_t%>X)Me@UIBERKG!49eKw=gn)Kl;qxtx%rvBnb)u9BC^<$v^{aNk=@-@ula_p-JK z*65y{+M1Px1+MMi|%Acww+m_R6-2W^<4+;wH9q8TA2?o%RCWe;f=UyFa= z2w_jGhlSYHPq#NKA2uvx^Y-O&Ejg-zc;2?J#ir4kT`vbJ0i*s)qfQb#Nr9py#hmxp zKHUan^20x%qvVL(VWf=tyy%%V15q`Q~+f-o0xXK*7o>aO|m# zab53LceBDReGv!$qFHUNMa_rzSK};jZ|X&(e@0gyXjW}Ll$#U{?Lt41V2Qxe9? zEEa4(1grGXQHh6q26V*gnFx~AJp9OaWm(DYS{3ab+nr}SPsXSItu2yY@CC^)QjdIs z=mr4;&$f!zH`~W>@%e$vFA1w$a1GAZcqOAqXyNEkpfzYsIdVCDJx|oBc2*e{r6r;B zqgrr-=5NSFYk|*3N0(Mqf4~yxyFH;UfCk@$Ko_Bzr?N++!ku{(UwM@I^HlGJoG?T8 zmxGqz{QcI=7FyYGNfdSbr-X8z9QoXdsI4w=GH62kK?mvPY_UoB&r5KHA%>WKP!ZfP z7ov2ylT?r{G=op)H#xshN6Yc=^#gLiQnyO-R_c9>O!rsp6VqH)94mpH>Kjt|f#{Y? z@`e87T;0gZXKJ6pql*Hw{VR?W2^$p=&`S)8GMig6hd+t4e~sFMR;Bym7@2%F)Es%& zTEgXs9yP1Ip!?sSm!zb?mv*fMRJib@C`AHZu_@?{La37+B1b{fw?Sl=o5edaJ24EO z%1*gUk<<^!DSroI_IvC-+s%(!zTt4dNUbIKF-B82t4x-mT4cMdZlW$ZI7;~k7xDmjmJbOdeHN*P)XU!hnsE4^ViCq48IzO5~9ee%pwL84qNkMOT~o0p8#nK$qg z@Tj2OzctL03G^nsg`x?yhV>i2&ukzTa{n;aWKA)3f^}`zWqNCls=f9-9MXY<&gbUR zNJOBk=0rChsW6B9?jO^r4Ee^f&SZ{UrJyT#TX2ajRfZBy267TR672S`AfcWL|F;=0;Y9~&88Vn!4_ZG_x43iV zp|J&&RxA?qfttaXHK9p+{*vVUdj?|^xpVQy9{bwLA)^nwkOvIgf?;X1wB@M!YY-vl zApJg3-Y6p8*9HVAWAdCOKI^5I=fGaQ3flu#<@eBE{+DBQ${iQ#>ms};`ZTGaI>RYS zOZ~|OV)j3k^O9^01$h0WN{Y}c`I5FyJDrd?X(E*L!$J^(f1JUp1LNPN%KJi#x*T69 zDBDw`4z2MbF{pe6ptoJ^jxij%q6o~lz+|T&`N5`UMuse~7kwEQHDqy`h+8B_Jo=98 zY|G3?r)eR|_jIHzu8|;(TxQj$b%+xq7{&^5hQ%5bhl}@8(h*2BRH0_V3B@$G@48Dv zGR5LCM~706tCDd&sx`1EM~Fr9Af7i3zY7}wM^M9~;5wWT{W**xwBtSrSABAnESJ9?y$ z9Rf;$Hm7N#ePS26WRnNeHYH(Xl3PMh1#D`+V3d(oY7V}G+#Qak`um{Uk9jHcH!-t< zb( zTyadf?Q7wJ3jtaqb}#<+2m7YH00*HOOO+*2ny6%$jWZVM}*Bk!s|eyQLLlh$5}qt}k?bu9A_{0#Wj&HD>t3rujd9QR?u_aV`xO*-_)A&JY! zwfULAI~?q}ne2R#Pg?BySBX-_l$)~2DNJT3Oy-6ussulX(?(-!w=p?N&TOrRELNqM zwb)YO5C%#J&MsW*9AaUYKX%n*BH|Ty+1A+8$3&03eP>=HzK-?dF&X*4i9FHSteb8~ zn15)fMZ=T7;5#es-9LAd+B#V!xUdayBUD!q_Y!w~4c)bo6W0Fb$S{H6u8(itGyqJI zTHyS;?jvQYJtAx#q()4FFb4iqxe}43)mRCsUN9`qJ);Sef346CY+)Y|>H91S|-SrtOyk*+^N!*3+`aC578FYh^Ql zl2aU^-D4|T^0QL_C*1Scs*=d)JI?zK-WE>X;~x5P`!A)%k7Z0hEa|JVa&br-ui#-mOvG=5#q)a`eoP=An? zlkdsbjZB+Ziy1Eh2`>l&7A-X%M03kg24bh9N%BZclDTiHXm=t2(phnyRDOcjJstE^na6qBHt$o%+t8e!n`*`4 z74BirwUs2p8i64O%2lSB5cLzGk|t+~66m1J4#IHLX{B~VW#>oC-7BP_amR>TuA%q6 z&HY^AGH_|mYjsBH1F)-l^DY4BJsH`*xuTld1B3m`KMzd6h4Y<(u@1Wv!s2)eZy`|I zX|ME<0W)5%5amo-N(<3Q4+T^(u5?+s1*jYDwxDi*eTXLb*90HjcOfCuqqXZ1HLUJ3 zG%c(zgc}7M)K1fJCMrA(wiiIQalEoP8@J2!hrQDZRM@+|Y!sbj`RKe{c-k~-J2%%c z9#&J5!jDRT5nm=4#>X$@`^Z=Sy*fpfE1DVxVJSbT?uGqDY$l)0ib`J1(0YU2=a}!0 zN2``@w&z>~KXwt`F2`W^8%PhVf#VFUjQ+w1xKO?$KGquE5yn_1a0){){h5H)jRqeR z;4}!6>B!eUy7O$O*;vUHzGD*b4r0?o^8VML)3&C~2%}crh28q#= z5%+sxWz~8Z%L39{8fAnpro)|r5gIfb;(&v`XoG@~A^9(?ns!iRjvI(CILvu3P&p*R z>4y6GXdOv^%Ry~t5U<;zEYCeul^3=A(!M&LgZW~^A07%eR$TdbbjN^~?CT*);}CDm z6nzK??cI{?Kz5_j1>fz<^%$|cao9k2{YA>yolNkq>~mEnbUR69Kr@w8*ZPPE76-qc zW4qV>CB-#o(Jo?#BbASZ;9#^E!snmfJmvl?xiP!r8eff?0Mjd~W?XAA=^1^1fw$<1Xj`X`2E2!k9w~Sg5iaEz>ASS#X>P7%d9c@HAK( zP6UBVZF^y5sXGz(zuvFSQG7kzcKTxkBfW&t&(@Ps{q>9&kw1NrDM}&rky(^hdYEkvWu-5|7!hzNpX#RgSDh1Ud&W{jo$0uf>(>v#4^RvskkcoSxTx@_RwO2adl_KGv(nJ;&Aky= zl`Aw?=OniUDPhcb(s1r2KBd&!iLz7((2hr#-3Vm^suGWG|UyPuB6I2eXmdU((tRX;x#VXglo#~sMO zsB<`00S=+*-`^#Y|WiF#OJA!fJ0NS-*=G>Xpo6n#yV*1V9>D>~n{^4ilfxd%I zG}nqn2c?KqT^H_h!hdOhOjYfoDj%_Qr&#BoA!iaCY2&CIB8?$hybkB}IdIJAMjoQC zic9tN7yDe-)w@K=oOPp@MM<>pzD}-bl8N>bsAfEMSM|+k;+|eRRUV7uRM2#|=~Jsladh zLIx3e!JaWo@hAZ{5gNa^Z`x=8Q2IPN*e~{VW8$%4Q=QOT*upFT?p5@aTkzIVPjz-e z%7qK=6@UufKy-qDV7@I{@zR?l#+gSQo=Qs;!ApHBxbobx$Krg3v$H|!PzMuG)tWwY zbYbd!w1hu^0_CFdMf>KdL!==r0j z#YNsZ0;LBzzgA)!&ag%(sB%wu!@-{K<(_!l0-}j^ER!mfrRiEH?;2~)+PLB||~ z%N7Uvwx-{P27S@DTFqh9@EQmi$x~IcAIHD1W^Xv?a34ny+%>RW%i+3Qb$+25=)MPc zw?~TK{~kY7KQCQkG-hxXMOMn8E2ttCK_+?plZ9zZb%3GTgQbzfnJR(bn=DEpBG;*C;F01+@R3{_R~ z=R-MY{qwQ7A-G=hqV#)FU!ZlyO%`Wd2n;!wOvP1#3ku9-vLksuCJ~Cype&GqOmT!Oy`2hBkM^23}btjXR}G{YTWr5f`JGWE%_->Ykj2fV8X-m?R8UxQGz zHuTku5L1Id%AkWoeT#NDZF@i*$A+AApgk77BXlciVrKDfoZv5eH6ay0jZv(OF?`=C zvH#b&Iybf~L*a}?joQ*Ug}}zo!jhQTUFfsxe(t1Jjqh>Xc>bU} zr{fsW%qo+d84pGZB+eKwTD!9jDhsDj`>yrDti0`Fr3CRFNiQ@-BG_b@AeQ&hgu$B` z#dgI@Y?tX{{_P%V_wDF$1~`V4zN3?7N~L|(ea9NX>+7`C>*@V=F#sG3C}4d(>%YuN z{*%vK;+L(fxih1Lt+A`Qn7OHgnK`4JxxJ;U6%jN0e~uEYjSBD_fxxhUNM?be{>z*G zk1XQM%uF0?|IZ4{M69fwEdQTXd^NmW)mE{8{9blBQ;?)6$P(d?!z4wBpp}rIjA7*{ zAV5=r2BmTMSrg;69kg|w}=RH><&tPdt|p^%V-tJPrS#qV37Xsm!6X>ycg zbWfjsP$TyV{r0wB`fhd|`YnZkithQy-akD>?)o?Za*5oKUTbm@od#v92pm?&L&-HnWO6--6dnyGt0)Hy2DxWlc-!={eK^K2}{RHAzhzXufnR|mQ z?^s*>S?xFUyU{Ph1o{e}$>bkR$n2j7mbkXyaVYEW`-4v24|LgQ>gSgpU{U(&q4;W*|=wqDt1hxeShoq%dN03j1`oJOU6G^?uFO;GPPX-E^`rpgf z75Y+qRpT{~!#nzeyM)ge*wx&T=?MepnC!>d9 zYi~jADw-a4wyh88n)&axF8#bP-WbgFm_|5}UWrl=1f8WPSLp6o!2ca;Avc6$gFfn1o4h}Ucby@5vR6Z^Ce%!n80;H6 zZr}x8E*({TY`8`aEul~A*<{EA?}@mdi)!ZbhR4$S)Un-Sf-uHRZYv$o* zU`sVcA~5DfT~IZNv>%X+MVmFq)S_^W;yA_}gnUTkq8j%K+UTyvG%#o9R7)m>UfXC= z8%?`y;%6r=vu5}2x|DQ!F_QBemgJYwnw5R?deq#TC~S+L3ZAqt3*6>`!zLM*7-tms zUz!WYZ|jx0qOw(I%(G`XQ#qc+2nNE}0(E(C1!Erq#gl&i-WLeJM7Kb4^@Z@J)+DzH)63$zGsJWtGS@$FS`Z$S*)M>Mm7ccnNja zTq$L9l^3-IRPROFjw05!)HlESAWjt-Mync=>7m_n(6KqA=8WLqG!QFQ9d* zBMN40$rDH2uFrk5jW+&Mq|Ux-!6VA2 zG+(mz;m1*s|Iq~GdJ;>M9l_zVxs2^@337tI^KaB%$GtsVC1)qEH;RirKQ!5it*UfS z5@&N4laP~=xm^6lU*%gtMc%HlRmmLtRVuu{ht$9$7AViY=vyMi4h_?2yK%!j_zg5@ zel|trp)tDTYsmU(IL)(C^%iKR7iFebN!I>Ai19bO*c*1+W`_NNjEee+=_|^oP=&o0 zZr^yIO$q_|GEGAE5VwQ8o=l&8ywrOt=#>>Xjy`u5My%Np`)Y!1UGrBUcwroS@Hx+Iin$=)Udq_2wc82xT^_GFMn^bSvQ~GAxA+v^UA7;aUAw$=a zd|lm}ofm?Zk+2>}rDtrIzi1Yx;f8l0i_4!no04XCyNRm%&?yWSsV`{Ap3KB;o-Y-& zf+|>e*hbl9*@Zf`{z(5+d{6a~(W2)wWS(1@pr{9-seSi5`l5)iK&`0aA9%J9@nYQ0M>R8ln*DrQ? zWMRvY0vMg1l4&%T@1)PNqa%6eppki=oyh=@Kwvb}W%Fn8Mc?1GENty$-T!cL^(6ENgrgZu0FXRuU@c8R5bZnbDyt9RVi@GupFKGKS*2FsI zWauPvec?NrMs-;PDXQokE%O2cy0_4N8knsTj+-W~49&7Osg;L#e*_(MN!;~as_SH3 zwzA11{Nini)EQZbTakwFr{E=%>T7p&pZMp?AUdj!q2Ijbv&8JbfJO3>u&~A$l!(&) zAxex_3xxiaiZs#-5cmrMf!U7&eK?;dmk5QBpq{UUX_*F3X!J|LEp*q+Fyr&Q`T6{Kef7Pzf4+PU3<MQ&*R}U#!>ZgbY0?LToIg=hCr za_4-&MsJt6>szFbjZp~(gf;8QxGq$I%?DjCg*O>}DI0w4Y6BD}Ybb-5oG+8Rx_#5( z(g^Zv^O6B2Ogqvn>cnq`2du&6Pw%C-2q~A!B@kWuU%wWZRuiG9eqj)5>R9B9bjRbz z#RdhyHotW5AThC%P(wXlVP9Pqkj831Aq#Pyj?Bdg5061{&Oha4)3o+pMYt!4N<_oQ zY@3FI5<$h8j$$YYr@)36@shpb&|RP|Z8!h4nU0|lyN}BFv}*UZ(JKd+@9)_a^P$QV zvn1_j+_F0e)W&vmJ@w}Xj7;B}={5oiI#KA)Z;TWgwR3(55R|{Af&CLq*XfiLV0#!v zs_0XE%xtP=e-i~7CEOU%N_WI28fYVIwwO+&rGe$X*3FuC)Ta>oE})of%0<_9o37Q@ zP}+{#As~V+kp28%#g7xK;!F3$`28DEyyQ29kdJLva5}w$MYINMbTV5OYQEz&qAA^#Pv1M%n){A~& zJOy3D9<&jMTL6RLdc{;MeAc^lRpS@;@m0)^Z)B&VqU`!?;}CjnKckyv3;Px|N1no5 zV2Ts-pt{5R{oElnJ8!#q2x2CI<+lS zs%G_8N~|gXdV~LC1MSh1P{3C3ecqtK1Fr`(1xyB78GzeoYk;f}`*rU@Gm9u#AAeQ& zP>@_KXV|S%nezmSte8VGyJ*4gdacy`9Z!^TF`~H zk1}yxxV2Y>@~0gk-v{@OoMBeDPwqt53{MPT)Vx%N5@$HWV}P>mw}8v>T9 z708o5;s$%)`$!J4chHw%_LaEAXn}>nH0gX>>83A*W$>q2!^y8N+FeL7j8V&$52&ka zo|tC31!mY(5%w%)yr-9RnxbL4^49!gIctQGd^|x$)3NELnJ!V``6p>_(Ct52(Sd!b z50HfsdX4XMz-#JkM*uJt! z7D}5|#5#DqrtFaX*&d`^h-4K=9B{t=^lFfiyblxwxEDqDdN=kp#ex>~HQ3FP7KAm3 zO@2Uf%laIiQ&Ws(E+X29`!El7;H4WXEr=V?=KL|!JIp4{`RVj@%P`x1eap3G6Z$>u zk#B>nXqs=Fh1?LNp*CJ4p#G8>+Yf8PhHTNGMYDxH?p3Gh>qh)3;um1EGRTjYg?;X# zt~%A@B3ty2x^fHOHP%M(oy#lIVP@@u#VaBz7Ojdc+_3J9lC-D&2y`lf5$L4oRv#@Tx1WvOXhP3M|pB;=Mx|Ok+Nb6_o-8Z;c zVRLXvq0h3F0`$A)Am2Y7WY7SQIKogyrd)KG4&jH3L9?atz}3TKFSei`&bzK2uE)GFgH^sIh@?ou6Ix5_uv*+Y|Z-#chj zjple@uPGx}S|2>kdGmbRv{?}6jYO9jK9g(_ZD8L$nGzdv{PUS&X*u;VkLu*MZ<3qY zWyb7U>3G1Ka{ep0%{jPjl;{f6V-9AXcsGyD%HXx0Vrlj8E+){mF7qDWhj=f$0r3;J zNA9h+5v`Mt{acK#Aj~Cllfq6($cpC!zKG?K>q~+Nr>-vi=;eF~+^afE%q90j3RJgw z7UNk{w`eW9)_LD`l986tPM(c1elcN6v^%vSbz)hh#5B+fu=St@dPrR~w2*7yHSY3i zbYbT1y%w0uY-1^eEN*`(=`vRS!*8mJ*UZo;v=Qc9a}x*6mKZ5*K*qy^_0q^bFa zom!&tRlXH1zaZ3JY=^B+ncY~-m~r_Tv8Gt&A&L~6`#ks2=vi(ZX5y%3<;~YwHQ#W% zIS3@?9?u1H)J~JXYjc@Xhwt)Fo?Nj34RRjO=+Y@Y@|=O zLz7(w=Db4${q<`t%#U-IY%H`e3k+726QbdDcYF7#&t+_095>J==>k|EYPei99yOmA z=#}wCU*Q^|hTQ54)&gJXH^6MV7Bni5Re(!?u*aLNDDI8YgVH3e){}R{C&Y_sA~S%y z&(#2?4##*V{}WOG;tVDr-DdN-+xqMJWBT<%kdrD7E(BlCE;A7?t^550%`UUE>;0Q8 z)+@N>-yEmMd-z20H>0^%G$n)xXuT(xkqXtQX>1HmoGTA>qaWm-y*r-(2P3TT&3`oR~o;=hyUWW`dhprXVxbss$RVqx9sw(Da zueaValM%2`Iq;w`6d@|J9x?O`fn*vH$ru5&#ox$X2BSa0{dFm6)ri^+`Pv;k(m!F@#!=4+a zHVi{6?L$^amQU}H$n18HSTYF9R9B9#njIn22=8@h$i|=fvsm}x(-xMC)GNdNVMEFD zRf~4n!JIbxlN9Ae(-tx9LyyxI8K6U%!)$RRSHIm?H*t)!yX>xyv-sGsQt6KTtygxH zN74e_u+L@^Kqju{zF2b|YLD=ADHof1L9Xu5eAGj)0}%xgvAzgTh1Y3M!){WEGTC>K zuj#GbK1edeSheC8t>)RueHUlsrxvly??z)bO+)KS@xxOW%}Y6q6}zsH*EPvk9X(&g z7M}TX{bg?K7`V6Jr>>o}8c`-S>qV@yvZQ&?Hs?CanK5$_zxWM4OSWoG4VDGxsHl`D zKCs%wU6YnU#Pi@dW&I1=RqZE9j`qfsuFF(zbP%6I{80x?XYiI|j#xQHoHr_y^ejTS ziKT7=)mo+_6_mlUcab`GTJuQN4;}xoT9=+fEOrw%VG^Y_`gdj}l;kQytWIE@q7N(_ftXQ!!a^KwJuJwB0ng%}3LiK$OR`T?MWaiPkG+Vop88->0%0f5CI(Jhp z-EM(DVcQqxSdF%ya+^54F|Cm#eqw9Zs%A}du_O@hf6yHio^x7X&x!MM4!+i-P~Mf7 zOLmip&LQ@ksvs9`PQaJuwDHIBn5kFbdU1m$T*=u6lxoa=-jqzk3Fjzzv_eYdL%NuC zqt(f=8_Cz9x#wSt-}n$2S>jdq1!6fZX5SUSI^hXV@&}vZJj@S}EM;RDu^FBll52Sx z2K^;zQuQ`Onpn=sB%$KxhB~y0N>tGE`RmD|T3i0J*rA0w-0u0~$+B#}N|NMmYvwoj zSAp-sKTTZu+(!;+V%E|OPn|sfs3n|wpT1>nhcjju=x7-;j2;k+x?1y|phbY-4cr8`@x0SIfB$=5+Ik%2kMrw{ zd)cj3kiCs`ud2?M__A>yXgXE5|Gu{FWbIzWcmmt$J8Yo+=`xPMO+4ueDt0Z1KHa;r*(Zr4RTP6MWVEcLq~5?d?M^qEqn9U;Q2xz%KKsw zi3Snwhj%fFGvfEN#wYWVt}#~d#?tzi+j?4*zb&aWo(l5jl%FRdZ|I#U6OQd-eO{Wm zxUuTK~UUS>-^otxVgHhbB--5)@!vDS!H&I^H-1Yv2$ZgZoS%v zz|J#XQf?9VB*nL*)7tSIO=WfH2dA+vb`0mb6}6Gc8^{?yQKQCwx5b!vF#jY$Z#Bw@ z+M`&Nv~L_^r!+$E0M64<#`Xhi^x87D34{pF6&7QnAqfcYSB7ih&+&vx{z#8I_ zo3t#6wT^d|jY18O`zNnZMM(F}vOMIm{&AvhG?Oq*zVlTnl`=_7BiFo@a_V*A$U#{N z%5{gn2yNwf-8SWpfnNeih1rgEKWEnCm>J-8q%F_A{5{==b;4dV+f)x&%d4-`G@HPc zDhY6ewrEUpOwsC;k67i^8}-oLyPllp#N$7E{@xa^jppvflxwEfUvXz=fA*OpO;kw~ zN%;_q_3@kOu$$^s(hG~+CB6{1K)WJ8tBJ6%n20Ozw(fWr_Qa(s>*Ou?2jf@Qhf^mq z>xG6oqKnuyx|RjHA^S`6kz@U>2ov(VQUcxBwYrDwl!Dwl?Ng1GQUChoMdDf($R!kW>KUa%@6IcO)C=$$DB~t2o1gnnZq26R?OOcxAn|eUF}@7(}I^Qg|nT$DIe~N8;0yjX08)iw0x7l>Dx!} z!)p=P?Y*f@k>202JyZ<+`3J?nuDZtcc7ZTscoSUDfHFH~Mu_`cNgl1CDOPj8Yoeol z{J=6E6yDyMxVN!nSC#AGSwU7vI@gw;#SXC1{J zVQE+Rmc5EE8plo~5@Skd1k5|Lf_+8yi_b`np4gmF_d+#6FK=&$BS*Y;Y=0S7a-QXk z-~nj;9LTIKX0fr*0VAsrUd~0%dj8IzQm54$khyr3$DBUq@Qc?fm#e&s56ZbqZFs|1 zO19XJoiT9MQ_d&P-ZnD78;3D1Rotha>=+=o(3mzorBnLjw(d>J-=r(l@MM=WgwNP# z3(-{|diyZLN8ArGttqf#I? zkp<=7A=ujfQ3C}fX%E!kq5MO#=TM!yHct>jp5ovng;4RyLfqe>K|u&&lmv(+(F9|e zvB64Zv3Dv_$>OI9CnoRP)9r*J*&NxY54o~O&hE2UIe@RHR&T%e_vwFn;+`|td+Bn8 zQz|)wD^=u`9F6^>i}H@S9&TJsF0IWd$W1O`tt>lw!B}UD$!{|GcBvZ2em7gd!LE2% zwZ;>_-ZvEhE>G-38WZ%C`XfrCTAWU?mlFo}YccKdJ=dNi^5N=-k{jkYo)J|9?~?L& zd8y(>jX0;ZqD;QB*0ay9g&!G5n}$-voGn-rQ2dt+LT+kJ2klIYW~EQZ*<{_1Pr^F;~^1u%=yi zjdHiawQ#fF=v3MqC9u~GKRMPhdIm7lf#x-M#sn>%SxnPJ;zL& zaW$#Wd)K&&0GeSHS3381@}vmj>YUt_1N!9j13qigeAx9b-dWL}M#xjGFni(Cq7hcX z)5WATy6Jf@7SYpr9XI8rjby&*BV`J07SVN49ow3ytqLjfeK~Jd(bJ8wNAAZJw&;AD z^(?R*;EA3{x18)=aMS0K6W7sQJ{F~wI&v@iE@p#XLEK4`Y`s=2=XODHTl1PQK0|Sv zZ_&sPopay7OCHDq?heasj=1}#hD;r?AI3;pKuWEN*Rf=8=}5i&q*@0hxBUoN^`PGs zVNe46z~!K ztdF-j`{V2KED4sw-Em!E)bqg)%PL&@#ycu_|Ls!gqMwi$5snd%_pN!*d3oE?xFz)) zGXB^mPhNZWxy7j}7<7g^`jXwSRJqc4Hm?!ncspWk#2LvA+11WHobjKS`7bmMa38uM z9mKpTk(|@hHtlUeJ2WdFOSR%=fK*)xL9*i=fxh~=-Z{#pYcK1@c95k}G0WyZ~ z4BOlkZqH}fC*0KY2b}K1ABX|&cUFR_@Y=3kD*W823V0H3pZqz)%8s|~;YA{^)2XQVjSud(RE=qwv2s=i0@$?!v| z&^TX_3f={VF~Iy*uQ$p)tLK;FCHA1dN!o*UlExKWr| zR;T6cduqpL>#d*{6XWQ0QzbAOkA4x7c1(7^g{%BN#R1+XK00RQFP4|6OheC@nmN%u z>Eh%;ws>3Dm~9$f{49feweL0KsH^X^jjufO>C-dg#B~|C$DF05rG31Uq`|?CM*%1xKx7LQt@HYdmeBZP0sP{^G)A0b*wVg=NemV zTa*8Cx&XFO2h_L%FnAvc0q6!`0Fgc#*mt0t zM{qA&U~S^tvMaxkPs0OqRZ9=1-u4K>g;p({hW`Gt?nkDr0k4z0!hLyp89pCF>BnNb*UrN-D z`AWqzFTVDG%rb!k*BK?w(=6f9K6blmnrubPi=%xfj4p9lI$>CEa zHE`FeJGYXeh12mYtpZdxeDBdy3BF3Xlx0CJHPwn7u8Jckt5`G{`swmR8%q9RyZGa= z@?@DFg)3P(66NwD9J)hh@b4Wdh?n=#+^un1HG@z!sq`!_DrGLosL?M^$L~Y+-iXQX z+He2E$Dcm4c$5c{zpFm59}3bT`t`5R!n!uSal+f+ehBh-&n#)y{95vdiKuph`$EaC zKKQQ0L^RM`IN;%Vt2Wz3-=PkeUrDHjJsrLRjDKD;oP`5UE5@eit!Zoe+8r_(!fJxI zz&wGBL_Y(d;s*)Pe&tsB4ZS!o59%z#kS^Dd!4W+{ef*pRVffmkkBeV%_shsij-t4v@l| z&u9~B2{W9K38{3-{{lWC{0gP~h(rHW9;h4r($JLmBXl31J%D&kxF802)W&nw(WyoV z!cy1qJ!1`^7AN}%h~>9+93x(1U}3^wHy@J!(aE72rk#EABS zi%ty}+93z^!^1Mjmo|Z+Owb!xe4TQk&us1A(9q4x98eQ8>ckyqCSQZ7prL8+-+8iF`FkQK2k-LmvM;K{X%&cY|osaVS#+08< z?pg?SQOQ>>I^QPIcv8!^AU#-7E4QpA3*{ZdVdzGMQ}(x_i>DkmaL4_|y?q`qGQjd3 zF+$N{LJPJtjYf&b|9CtuWb`0K@n-H_=0-g-Z&*j}nZUbdxGj*6ZO^(ILtEP}B1F-7 zbHbcyoo5<2Q+pDXe*sG&{6q0j{Z;y##$n=09K}C)p;PMgFrDTFF)R%S(s#_UPUa4o zm6d3+p2u75Z@DOx=z?&V%=W*mjp66*ddF3C-N_T}N#7-!(nm6R5&I_*1&V`|Y;MQg zYSGp}X)wc!e!S=P8dK_l`>bscJ8|PN{HL(>-#pzm7PxKN*uqzh!MwVY9zBc)VD8ul z8p`IyOmJ}R#;+%5wOba8aJqty+uUfY!jR-jQ3V)_$;9(4FK_s78JWf-6SRx#Ff-Xx zmi1Lg>b`E?!M`f&lWzWj^$SuE(x&F4NHn>DQ=7(CY3SvAqym8gjWchc{g>sq90Uvm z|63g}6EoxgT;!`0-)}X@02_Mk2aUTa?3e-P1{Ii~IF`Su(E{mUL&{3ipqM4R;}?m} zmDUIG`pti<-C?P(bqDpp4Y_F;)SqaaH8_BlKRTbtmAcy{>z!)PonF?|x6MVKrG*t# zK{ba@G!voD!P7anuXxJtHkKpC;lsL(=+Zj$5`(N11agLj1J86~wO5(`+hs(q8hN|) zkz^`&-#O-&>D6qnp^XEFxN!npOj(6cMd%rkDmBToJfPgKj(u>CZc^M49bsD8?fM#< z91!eH(a9j4(-n+k6159;Z5>G%q_C;T|D%d7FSf7$FGq{>za1?xODAU+0w&J?yEK}a znTcMGfQ4Sg)4`Np-pESX#rA&;qs5MkqOAP@1MDX?XHdz6Ea7Lo0%@MnIdCWimPJ_@ zkX}TR9|hdP%d_-?>;^oyh}uWaXO1lv^Byu**dK5*5tBV;WMd{%#PsQ1Rb9o160AdY zo2I!q#)~?nZne1ikBuBh*x~MTk`)Ltzl@9wPyhN{k_f|eb8su6&$+S-gYiyulx5k( z@X+{w0uN-s!N~`z@&g!ZwuR_XPxl9mSe(&wP|`M?3xU*nFqTWnyG}eNe?<0o;_e~MWN)l&>Y`1rAR-HDgWC?mz9Z?{eMh4iHM>f*3XZ};D_~dCNUMxz-IS@ z`iVbm9)#aq%u@D-{|%gwkpi@VWLw$mS3$+BPYYz}IwhJHpylLyeR%(vSc<<)-^=6c zfBO_Nu~gg3=kJ)G!=qcvoLu?1oJcd>AXUw7HPPEssoIfoUX1yvfnt?leyZc&;d?iF zKt#EyBl{-OtCT3mZ)VjXX?Ch4YxkE*w|qQMZ)bke+G~ALdgq4bb@q+jSae1W1BS`@ zRfP2Xo3DNZ<*E29Ars-AWwGRhHKt`xmWg(%+?HuNs!1jBO>9%OY`ojg(EoyMTm_)_ z(=2%3v_P%;E^I#$efzGqqqj(hvp8S#G{dLjT%CKAL*3nXkwgx!kczN^dMuzbZQry9}kVNcJ_nD(h7|xe-fIpc&>c9W+I%FGHKqVAfW^uwwEa zgz5J6O2ycrW~|^JdiMZ;5PL0SG~7dtLp-Z{FhfX$6Or|yXEV9r4{p~ z)5g#?Ke)C5`ml{z*?$*z|Au)Kjg|%s;D3vU`mt&Hm+Q73>$X1$^Vm(HbGrD zLWavm6^b2vc$%*>Vwk1h_Mu!#6=y&KD@R`{)T8^IH9pAiOh)jJC*R1rd&W^jYz7y8%k%?v*|QpkKk@NmC#)x_zku-pU)x8 zHhuW8=V(J^&5thnFEw)`L}--$Is2@x)^@Mr5)0gpu}sKwp9nqxk?!KXETg6nTNnt9 zt(d3wJD*uv-%EfA9e>Z$nw|mkpN2%0!s8Y`WNCDp)TqZOK`|6L&P(qArNotEoy(sz zsNOjl@jrs%CS|vF@DaSNRL^v*6LaMwMmcmT#kE-aJ?vcDmd`#qoyQz<5<`Oc88< zw^=r*6WweNdUr;YShJ6lcduE}&sg!1Kh2>Vw@nxd;Y^|WauRxKPi|#&e>K(bCv*xD*Yi9`j8-)yG!!){w_sZ$CT~l{FB!tgn zu39vUhg(7?MlA&>S>(#rPqLFL?}K974{Ov>QDVXmAD8_;ix_C@>c#hmdr6+fY3u{L z${Ux1Z;*B})gys7hy-MH$~|{(i2;$>pJ{6|ksAGlwJnUu1)i_4K4W~ji+VD|{C@)U8MmdHEc~-tvyA)( z($_hR+Hy)d_JU<>XPuqSZP#c^B&nK|gzXU?0HGPXUs@Y{i8D+1xo4@;i?TF97YlHY zlerIT&~krLae|y*Cd}EuYNT}-D1eA1nR^trxK$+%8ht#?kWDhymnv1P`5J*!liIj! z6$Z{sg_MAd!2kR!^hb;isZDEwR{)K9X(myFPQ{&??fw1VMdBsH8ccrGXv zqnxNUA%e7@1N_7#7RaNUOkGoQ%8(Ya{A{UN4fbWP9loUtpiqF=59;x6hYkqz+9zN< zd@=*yJu1@JMU&g@KqN(JBa6YMz$N-MQE43;?QmF*IFnA2Y5#8FgC${GNa2#7Eoow= z2>}C$F!7X=L{t47@1mpW))pgl{@+N4rP&h^u`>BaI#-&y?Z8`ZId-XzcpEwAi*bUD`O;{o0x|OEy6c4&&JZ~+# z(XFwD>fD{B6+=rxEX@^%2Ewtbz!zKI)sJcA(4i7N=qxS2v-%0ne*>9S(Dtq5>q*!w1+4ZnoZTB?-WTk)xfGmJwX+Fq4MfO4OVaETvlAj1 zPq{K2=mg;#{Bp%45;&CzN&sp@GHOBP{d1)I4&HIFfyiY;7a+RZ$UX7~$4;n8nsZBL z=zvb@!j0Ntmqe7MCU)yG;*r5jsm@0U&_KsQ7ss)=e%7@s{8w5G*13aEa5U46rO28< z!>Cu_29jR(-Rt^R+xY}W5DC1+p)@T7!+X8;`vC3`QKh_5*e)=@%ohZ&z1f>eA1Mwi z96~^~8IONh)v&UU9-7JfRFZ54Bq{)Me2uOFq`E5+J|01XQ;1&6627!a_0d^F6NHPn z`kY!uhj=Mu55tyxg-v{E(G(XH=pd2i?w#XzvK}2n^A)6UB6@1PwXAlNks+?8+$CzG zv|>r4ji1$;E>Eng6mJky?O5IWP7_i4J!^g83G1)7(CV)HP^hbMNGNJc7(vV@?AV2Ouly)6}&Sg&B=hwtf0ectbrK zg=GVDd{Lc7DKqGez5CS`+^I?{*x3y0H^@8sUYlZd%|D2gW%$)>ap(i1%ujJ zT)N@kRWY76z>QLU)=!DqO&)S}Ov^F+icy|X%ay;{XKJCW`Hz=)XSWp-l}b6aqW(xt4c|%RVfCS5b_z0P zfk!(D6?#thZ8m6_?eGYx*T>TmP*iX8YLXy*zNm8G*^k;zB+D9Hn7zQ@1vro zRa~RTNR$+R4?+?SR3NQOn&dxrteg`4CEzZqLxQB}eeCKSv9m&x_O=R|+ckH`pMbQi zeXe~T7lu2wlu8^)^%Lk@c;aHw2UZ5EZG@f47|_GnPpyGhyEzz7>=DRqwXwnZ*{qa2 zIs%xo>#k1*(5CMLl^qE?{*k^uM}9iH4wl#jyDf2l?@5bh;$>pA(8b7d|LyVJyeOYiDcbrB=LS(-qR0Cb-UZA}Nngqr_JMhTo$riOe zh5?-r`vmed<|D8@P9p7po|H(DEfFu$NH0Y#N~?TzEJh^=;iplOi6h5~KP1I60F0!1 zA}uR1uAiJ&K>RHilQOzQaZ&QDNW@u|fCtKwD-ylwOU=W4S|bWFBH*^F^&5z)sE^WW z=FdZU>Ndf_*&F5m^-ZZvZC*isC@$k0{*ie849|%Z*3K1^Sbwf+0_U)DKC-{@D_~Mi zWP>Kj=vhBqjt9!T@-uFHUg}R1oQp{wOmwxp=eWVH&}h~`(={+ZdRw2!EsY%Dws6$O zojkGtt9994d~`E*z;TyyF+j){jQ)^k`j|TBEmlxAC51FE)HIRbUd815~_|(ZQ!7Ju=zy+j|o_tRY?h!!K zyy@Q-Cj1$rHhtt=^}G{}8ilw_c+a~-B*&4kEHCi-RhU5A8)dDOYSc>4qH6$mZyTai zhmSEuJZ?8GP}-;lXMCyl0iMC#rFcJlhpuWb2JYpY6jPn(VDdiB_wW+r_z+SY#o<`^0uMqzw>s2*>tV|}6sf_e!zC5mu`X}R zEpYt-o!G8`fWxVQ08mTX?QVlYWEw9=;WNt3KS~88QKpdo+%I?)m3%*wMnIYQ4#QX| zuU;fyHBey%QYrAijt=BLi|`ADpp!4WMMRwv@S?iFe(@S4y3|mi2wgNbe-QFoNm_b( z8x3qunU~Pn4VrY|px=ttDMG!Kx7MIPhQ)$Z1(Ky&0@avk9Lt9!<0yDX&j#4Jr5-*C z^pGTmksaJTI8t=g5tr=h9SZ|Q)(-jDlV8oymitIGmcV=M?cxTJ4qgpmTgosG&qx!n zkc5W1!9vx@6SW`|ld$LU!92cYi|YwEM~UnEf*xp%M5AAV7k4}tU{=&o-ieC0)N*69 z345X}&7RM5(Ns205Y^WtN?bS4tKbJF$WK%UNm@hj$NbP&CW3$6`gpr{lQ+d0REU15 z#O2*{tEo%;fJ0@Kq~bmOW=wUK5a--colvIS4QkxLD>+KIxvcBcYwab>N?=8MmHjEu7caW+|W>0cw#u|N^psT8bWWJj9M z^-rJn)%C=U+KFG{g?1HD$s58*)5CYuI_CWYOdI^tymM|#!q6?XQE%V9WL%ihnaUiJ z+K`N|O2H;-=E_@SiKUWczJ?gHUyXh{=1CgWYQ9@UGSTUdB&~=b&fAil>Ewu=uML`y zI+v@w5E*fz%}^u+Xc|zGaKl5don$98p-H}cF`u0XBvy)op(xi-9R$xoJIai(cT`I} zGv5@D2gxxh)&*|2z5X;e=dfKqp-}=`Drmo?@7N=FIFyeUqhB8*0GE->m;aMWH}S}W zsHfg4K6>4YhlgMB9?ZoqZ?^8$qH@%jH(Q%on4BUeot*0F=2UR>miskvyzW%f!zPZ< z%cXtXnjbp}gXYBC?5R41I?}ooUYh>8z(hrlu9=VC#HG!SoQYSs2A`Nb>}rXU@l{@P z89dX~bnOBJ%fKg>Qet?>>}RBJM=l0c{;c(U`g>cOd85YkZ+8JH%ubnKrpC63v$fp% z^%Q7~C!(@%@ZmRHxu1fA#N+kwMyLx*fhUHdQZ9;krSR&ymnE^Kf11Y3gpFMNhXGKD zUhNdjY7z1P^X(v zx8wDOq+NSo_hy?r){gVNZaZt}q4T}hxmp5mLk*q<<|qGyjftp=Q1PDLHDTX{zLw2X zjX`<}UR!xWZ8P@{mCdNO+oR#R4FwZtTW?_Mj+4V{vg+g${WLkGmbARAJgp-Krn*U4 zA@e_C-PVHhdGC#8N67ecI~v3$egpcdAL3kT=!Z0h(>O6}&8e-T25XN7=f#pDn*J7D zy(d1eDxkmwZvH?lEg^PwUJDBh!CMm?Yv`VlVoc|g1{huuM;=TBcO&EhB|3=&)PqrP)B@5^PnppbP%hCCL5>zu7fa=PJA9t@vR`gT z(T{5ZIT0!!4~vzJt9$EFlaneYdv}YCq8UZyD5>f~{AKFT1#)LnG)m1IJha6cW|m5* zdrr?6gBOQ7WFcw3+4O3XWMpL7gLT^p*Xd@av)+SBQ+KH24q zm{O{*hTA<=U^1|6+jI*r-TCkzg-cwOqyPw>8Td+3pA_T$-<`paI}`jmDYO# zu~!a8ib%sUvm&{h>G(;>os!93-Cr9f65pWoyRy0pvRH8TSh<7PV_tMS+wb(!^_wfb z2O_$Z#C*aKJXJ}^O9x-?LVe~LR|t0oP(!N!58mD(N_4P6*Dc$wUAAp=mu=g&tzEWl z+qP}nwt4EmJ?TN;zGrj?Nmf>}k_@8ty?Fesx0(4j?GGZfNGEQ__~TR)+iisxYM_WH zi*qX9j#ULjI|+&HZ)+g+uZCasB~DxMDmbMCee$uKzs-;&w$*U&2^U^f_=;Fn=iOKXr#AF6jT`)QQs6*-z}9_ zI!9X{jddLg2A|bQ58L;7-Uz=HzefZ0xCW5oZb7I=6v^7@pZQ8AN z4zHGr6pQ*k0gCfHKRARMD3w4xV=WAE8`F?MNgb>Qk9Nm^UvwA!+*h|Tz+3oW9lj2@H%h7T4;_BG& zzQ^$eg`PH>7Q8=H2{(~+z_Z#Iof*27o+D!8KMG2AqU-W7CSE@EMRr79;Y40h^o`}P zGY4ZVsja?LFF{;E-~Y9qk9oMUYGFJUV6ygQEVo(EI%K;%6Meh22Qkc$G^*0sKqurodted=6c$uD49y~?Hiagm62))pQC>nkV$`C~ z9Ov|>OVsi>uTCv(u??KG-FmZ*QA@Vfe=Y~`Yu-;uJ|o{9uK>y>*nh(j)GMp(1${k? zl{;?6^mi!?j8cdFlt@WG3N9r=XSx&}#FX zZtcAEl;FsFaa(EZp^9X)epUq;Z8c!@a+&)Rd z#zw0Dl!^!3@xX4|pc6?(yxAb|?4lQ+biFhh?)gi`D{~Ef80qOFqG*&!6AAA`iu6N2 z=KUlM*sZ>WA4820Q3g>HSeR%Z3B18N>us=yRn15G%HNzb*7DEhvhG?$h^*F2KqMxx zcJHQ$;7#CmuZw_2?W!Nr`kDli({Sy^zX3^oO6VXa2<8Gnrhx5=3|_am=*NXHb}6Ib z=7BvmW_lAVU<|T&a1|Fs0O10^!8?dyk&-9Rk$L0>>d5cH&Sjy|vrJdt- zR;OhsRg;)H0DTa>d6BEdJ15CmLU;f6a&zv@drhl=G3MC+j+)vN_aQ;7EVZu^ zIit`Nr=dO0Fi|rCkc{Yqh(0k$At32rIV>KqGag*vOswHesD93^pKA>Eo;-9($0+5) z`OQeX`cagQ?ZUr*s0aQs+SV=_%Ed&m+29!-ZW%4>B>SW*G+0h1rih8ysr%8I`fdpo_WY(uvtv|4+|6@l48OKRbh!HtZ}$kRw)t z@yR-9$@0=>fkIz7K%vqYRHA@q>jzm~iE(^Yy`iHX15P%abWpv-czrKKk)eZt;nsHg zjiKeIB~oXbm~g^z=j_9$aK|o3 z!@P`uSU$F{@KWx+3i}U11Ww|+SFKdp6TuQ%5ju-s{9uUn9_dBnv(xz%Y&V26`eOaI z#s;Jf82xG674qdx1v!(j-C}0<#?{?rt+nJQiTdu=WjnSNJL?0+oCxOQUo7NILe|nV zw5%8WzPvm3sx3~>BLU<(M#iSv;_=l*c#P0QYa2yit*FciF{I7FW5K6RR7_8joNOS7 z+j_Bc1H;hoPhvpMZOQwg$}v?$RN@}OUFNx3%t2m{KqdHp6 z>}BHyPW7UR+==W9B?NfyG}HFZYL19>c?j=cYt0`kn%*If)To)Yby=at$LBkfOnIN4 zJglBZh^E0sfwUKz#!MXB-ar8DgVWp?(E{)qaj^Udb2YFn<=ptU%!SoqdnlMyCkV%8 z&aQ9{!g_vHk5CgOhu$-Y>)ZnmKD|}LK5$PrdgpMzFqI-Ex`2Eq=ZIN;Y>2dbN0soG z^ERizgdv_|^5a)=P|c9l+(~W6^Htf~WsIl7Y4Iwu$KLf(uu4_AoqnwVvmi%*ADCp%dwj7HD5#J5{kr=c>BM2 z7v6T0{KpA04CY!dFbI|F%i-^y+2!Fd69Yr8>F?86Im{ZkQ>*a=Il9g~e4KayLj73J zN@}O?=+1GYq6@5xScBjzm=j-j;XCJ3Z1pn6=sErAt3fZTo;~-V$8#&+$z$_$Zae2@ zxAw=i+2A3|9!h{PKpKb2M}dcYYL|u(A?QS#_BudCq0}-d)SUJPCp<98A1%PK;Z2`Q z^T?sI%l9n=psEhg7AAM#Uam|PeGja)I&9+Y{krZng*Tg(JCcljDs5F|pRC8cHSr2R zn*V4>b9@cYb>Yw$JG68kaGc%wWN@9iYIGQDY#S8w2Qx!Ve3McFZXH%aGP34Lsi3-k z>SXL*a+^u1=P!II?r729oVkp>YN38oI&ay4d!}z2t2=LaTKwIF)ymknQQ8A)d}}R} z(PmyoxANAvlXJi8X6HJt8gorPte|{WsaK|N*as74c;5vhZ&XYc-;S*p0Q95`N#F=_ z+6Vj!El-}~9$nYQse=M%eDAg@Iui=^JG%J|nX z2|;e)6co1pGz?I|PBxIFy3ONj;U-=C0)*&hzmDiof5IlCJJ1NQr%j55o2Q%t#x$0KA`VC9T*>+IL1mNW)lqe44TD0pz-!h(xCmu>9YIXMHD~%GX9Edc8ct$o4cwPhi zEO&CA1VH`}!RBq}7@CFuE9c2#!x~FG|K=^+N7ECL$>@R97#!HmYG!zK^&kxA63i!` ze;CR{+QM*x>Fwi6a_J0OT;2bHILyFRRW*zAB+>55zvbI{q{{iUHMbqz%lE@~qkS;` ziL>BaFiS-4+Py*YNgagVX#fY*}cczcekMg2_I$K1hEk0t=;iy9KIAdo#UqWn=HmR~Un3D@b z5De({?d87)RDZxYqU~3UXmw)eFoOIIm;#$8&Ye3p4%%7!1t>jZey2naC6Z#zUsi=T zXH5%kHbZn@P1dcFr_vGhURZdtF@)k%k9AcfSL872T1?HK)B&ZLi*lzrQNbgnJ1N4&SY|dS zDJ8@QMXe!1{iKYl5^z&x*_!CxX-h`kk>#Ph=-p?VVswEvS~>F*X*jwrkR6ri)LCalCiC5XbF@{SjJ;lbj2fYvf_3rRoE@m zaP_KtctN*AxfK*Hyn03WBE(0$txPQep{nIV2iS*8u2N?T zLz^mxR#iXe@=*UteLvx7F*t$zEvt&(ei~9tft|-`Zq{jqt9{wnzisfgl%{fDx7PuH z-B`}(t6g65!A4hluZx3 zH_td%5Zo*%=OtfU+@%mM{0?h2Bsf7rFP#-bgm9_!A{Pvq#6*!aHr`Qb4?AjWBV8k) zh_0p#+pe*`eBJUuC26lm-;-8mWAe2&MX+mtDY|2&p-4s=j)9zl=_Xh6+%(~hXwxvP zKfFU=jCOERgVLw@u&NG)_UX&hOYb(?ImRv9_u;#tDh!-88}~X^`~N(ZwyypAc7yUU z*hgNlPFBq<+Y!s9%5do$*1$7pE4hAf`~){SJ~_xmj{Pb32LM`x?{K@Wir67A*q}*a zj-XSv32=ra>E7*b3)$g1?VWZvG3lIvA(O(XhEFkuNd)>i6hzaiYJZzxM+~hTB>ePS z>L!+SAxdI~bsW$1C#YI&uZCKCL=Ft93?pnYj)XI@z|H|JQOlY!zp!Ko8Bj@r0=@=l zPsXHjG!plZl~CW~0oJ%fZuQMOIJhaBw3#zYvUBD?_A~w|YypR!$uRS;KlczU@wm}0 z%c?HO6d~xQiT8Tpxbi)^1Gl=j-8r!JL0~a&*IKB2tEU|R#Z-95GKRJmcX|NtY!g7X zuJ2xUlnq|>z0Uiw8ro}seX@Lv`L!NYL8ftP#AFdK2tX0ezOpyyywa^3FK`%H96EdV zhT}rW{gQwU(9U+or8vE2vnbj$?P5|EX0gz8l5xbeU;tmtAd3*>RN(onbA|QtXn|lt z{gH9uF!EZVM>CnEawsnJifO9%OMUXG42BM6f;FW51j?3#t;y8pF;B!=eMoRu9X>;0 zLfv5db=YM4?!K}Xtn030pQ3HK5y}`Ro25Z8MSg^4Cr=T1Pi73i)08`Bdk%Vb)jeur6eM-0!iOqJ%^E;|G;os24T3|w*I?J@kb~Q znoAj6kWZ$r=+D8Op_Lh|U{l>M$=TM*%*+Yb`22jJD|ug=k{(7jEe~O68bb8`P{f`S zfy#4FQs;9MY~_)9a@wefQ8?+5LgTy`zO}v@0ROm+@Md5A*SK31wuw^4rBAC>pez z+Y(NdQJUM#pcu2Db~qi?Xv)ZJ%E%%JIbbAPYTAQw2d*G*xe!aV8Rk1^)|G1s0~PWn z>d=)SMxBk}ahuwt2xKYG*e)_tWcqtOM9J@%*gr$vwbgu z*mfYyf?{ukO(Y@PZwRVy4(9WSur zEZ&guGk18XQO!=u*8=6d@?ugc@pjXyGKL(M*TyN)C45xj578uLz{=~sXj^)yQMCGB zyryd)H#ZC&rYWGdIrf7^Ob|r041E+>9R|#VL;48WRZcdcbiP-1t^i0S(6bldq-^G3 z@L_ux9)Oj{YIrPsG%$lzVO0lDXXb9^XrQz{R&IWvR_{e(o>OQVyT69i&k;ovxFaAz zXvI6pmpTtNnitJ1OYZq*fQ}EYpx|&ugO##UqsZdT{-uvYg8{kLu@_^XoS3&-DCH;( z&X(eOdR8obmIU7@Sq5n<+ZZ^A0glv~`$&Kxzc1Rm5;hBW4@_>o)SWRImv<@tr`4J1}M+nF9-sw9|=)U9# ziH$}h#|(x;LLeYx_`W$IB_AfG%|6Tgniasq(m;QJ!rHLopfqaf2dpKSOQ@xSgAjSc zzt|1y!*ov5N-&CgW@I$&c z9EHw2peV*8@+E2qk;4}m+;$}SAG+Mmf4}Lu(?MLy9%?bcY2-^Jqnq}pY;T@RJ( zM;o*qM+`i!N9kQ-4>zKm3N1eMMr_xw2i%>^l9e!LIET55#Isi(cgJ~u$%0-3dy zD|0AaFlEr#v>py5*VhyIqb1}nki4K|-$pBThWy6j>tj3Q+8^a4fX@>dilUSTodpno z44V4VEbnAAb!!OT==MMPLPh%#maw2fWu6ASCLE08sN%+q36;4vdpJj(Rwch?JB_=I z$H`OPtHO6Ytovv$)_bh&lBiowN4Q$RZ!%~ag+3>AAgJN0<*Z-^vO(R$0#eHE-+XRc zC_S1g8R6)bniA%o3L?gw%w2njNGpBL+z^Z}jdrj@$paZMs;cMm3D zQYV&7qRsK)vp6l^s)-@88y9Aof%~3hydI=jXRcr|PnPtYRu)cY{?{g7V>vYbC$oh? z$-93EG$>+z(9!`6efY-gSb25ycvQ7YmwM#g&gJ3!=Qn?FgsfQmKPn{uBe|C0{||EQ z|Ke%?UkvQO*#~_CM>@s-ia^Nen;P@-!W!Ec{YT|t_$9=MYj5(vJbs1Qh*9sJPOpaBKbggoPZ;Ytnwrvs;W1=IpwBO-9|7pt)ji!nGBY z6%L*^M;A|PZ=O&4LvKeJuILu!I$a*#cOqF?H7kn07WSz%<_sCCrfwDF_b2J9`X#NO z3fB$Y2tk^AbJi8hj)s^5*8@t;GI_Ra6DF4S56jL`N|y7d9!D07&6U898xQUYG>@4o zuKA9kX`1Yd7)cfn9@+-MD2tY*%vro2CtubB@$3wuJ(7RDaN2KPpE*xGk-8jj#$M@v zTtzH8zYiwcRaax)MQzaT2{SHaJroPRG-Ak@Tvv>;livSs`EaY7wE2i^oc%*NPLrOP zIL}u37|7D0nVPAx_^IeApVND}&|dZ7YUa|=Ijz1LR$*zZhlgK&);oebkJ!Qi{kGlm zakkXapU-o7F6EtbS=I7&=|JuAjR0RQ+Qe+OJ)tQ_vt3FFY}wgz!piP&y*af#^>t19 z7I=R1@7$)$ARixQW67gVU0Ule>K`iJfnBwDc#6wc@UXW+;VV>qS7UH?^&mL9Od8FO zj{CDZ(tM=bc^qwgIWu!G*3aAd5Y0AiEwP?VcUn;SYd*Lo{tLISuLJ}9TQKv6op1K@ zIdhfpxoA{tl2A&=N zr8Jd#;`!seb^2zZ=kECBn|M{l-pyggO~t^L9YWNH?3d7i`wWBi7}CxMwFvcLeEn8A z@o?flPB=mMdVuKpaefAV5la^{(?A6!R$^hnFJ8Ow>VoHX3liu_X7VST)Zb4z&;0;e zgpG4g#(J*{67*IiK1dieuf3F|NuT1EzISG90`G9aJcSHxhGyX!mEEnp+-`9vXjS|@ z7|!wwq9P%X-g|9)q@%kt$We2s%s9mna3KOROj;Gss_{VM;ud`%vOlo@Ms#1dD8{r1}%}4UYd&W zki*gYZlOVj$q-Q2{qMbqITb4EzM2SuCqU8By>|nS9W7@!;>=`rqN*U`jBeMyHkOne zKz&cRI;r_iZfvap41`HD;=9YDvnC8;A~4PL?Dzjb^HK;;baTgEAz`YeLgUwLJIMu1guA92lfkhTJZ0*1c6*b z{b;#8R3-BUmy(~|-e9Fb=~c!76>9X& zzC1xI9oY!P(wN(S^4DD;#i_yL%6g;ud7hsvW~@0r>+}FYB{dS`E6hBp4(E;3mYkPc z(bNn|sPvPgaJ5fY*5Y;^F+`JCDH!}H?U3WUo-N5I7t1H2msx?KA88(i zj{$foDTWghepDteNQ0*Vnrd*b>%}*S2X&4shXQnxZ;Qi#u=GlsQq`hJNJvshE=4KL zHqyFv+KRQ)*|Wzz+i2@WHT>d(llss z1>@C9IvTFqrfr*5q3*cfB!u&|7?XmDYp~+*L?DP5At-D(06r`#qf!<0jdBc>ZqXrV z%e*v>zkuld^RR+&PeLAXWo2F#(|j#^V3sXe?<@ECwqUS#y7i$7g%~u>WX`w|Jged{ zOUeTvnB;Is2jUE5f4&g9{YvG3BKg4XUHn@*@nk*;MMkHT_?h4*f2dyOD=&6mWbm}r zU%~TGbFMyjn-#qm1#vzgOC@VpLBHmkaNaiaOepML+(UbPe zfh>lH-Kgs(eB0pPa2op*;)d`*@fxu*>v|I>7^mqxtGe?owyKZHk!`6L`} zMuU%&_?QSmghu||f^)Qa7#G6P9tGlkLuw+3a399thc*GEkc0~KH5ZhllA0vdFkb8u zV1&JKFeVVMjxwv3E8?O21NHOvA6%^dkJcK-!|{w>rG82gCSBaGWe<8F>IOw5w@oL! zO(*ZP6p^grLPt8KTRHyUgAu#0v`O-k`adWiP7v(#_AgU z^O7Kh;y2NC0VC35pwX_9Kw>=-5K9b*T53!3u?i0VqD6q5V+AcL=fB=AOYHqPPn8*` zcLYMD14wkveQ;&bY$U?p*O)gnPe5VS@*|%KkYc$2dQ@_yu>4CI3}pd&@ctSQOKF@! zC%?f@3((qx=F)Pwe+oGw)FK%#^Qh=o)f@0ai)BHM|MQIXz(EEat$k1{)E8(RMVqk8 z%;kVAxB_rXv1g-J_uZ}{*$9_JJ=(v2&Y*zldP2|W^)i2ku{q;y_1NgB@y;!YFJDrH znza22yW~=nlKplFP09Bt2?1-*AH-BP;m?&PlryznP z&FdDZS+d6(fJYIgNE*N2;)w!i%XSt_%&{X;(w0PZ}na>k+ z3S)?Oi#{KhNR-e~QNntt|0oRqw=W&|ar!8@P+piFY)5Sy7gK5$BiCeYF|@l2WXCHR z>VaekAgvsL6U*KrXW0dQG!m=?NrW=yL|7mX3dtKok2;C?WRrdtK)n9R6X6-i|9na! zXz+oWPI6aW4NKf4$}$g& zT+$AIpUyjMmE}d?^Pe@{pCmAi-b>gQhpvMmIp^9<_9|07Due2II^A=(l!}siAq7-Y zl&s$AgR~kgr5ID*VO}~%M8JM$=C)$ENBkJy?0#@33H3oxEJy0{EWW!j98}GjcX{jh zdU75O3op`xeDbdRSbeG5XT&#EQThyIFn${>eJ6m(3dj`H9#XKrb`WQ4C%Jo>nI(Sa z;mwLrKTO9j?yOu(efXT}EVLt{9Wtx!u{wg*&|~R{GT6t-S&3beq|gTT3;0auQYC1b z;BZv*H`H6cWgvG}I<#&SH_x}<|HB?tI-N}2Zgr`i=}h6xkWY779Yv8$Yo6|;%9hD-BAD;BD3Lit11>^Zm`p|+t( zA(k;Gq?wGu^M0QOo?f!JP7S@NWY&02b8EC@+)>72H{@)x_*v^x2&Xd~HjbUvs;=bu zNTMWU$fo^NYzySa2y)S|U8pbDUa+7T4Kmb!v&b8vj^O7%<7kyTKdLl6K(hh6Q06wD zHh_e}FYK&}n6Z7EFXKv}{A8SgQ(@}Z--fkfVuemkzJ3Hrm!|##>Qj~P827TXC zYqLzwC#)%b8MtiKXqbN~O=BLEeArX;eH6~3HG^RWOp24Rk|zf&W1f0l;3Iu~iI(4( zBUyq&43#A+5sa@G^@{GbDBWuQK3f^N37DN~(Di9~uldc09G--*uH>Zar70QpU zyzgl?+D;n(md#C#BcTH;hoOV?@q7sj)JmoF)}m`2UX@~-{`JNIh$QRDOLPMRVmIIK zD+elgg1mFn`tV(@ux^PW3hVx$dY{t@HJtV~GXkECkB7iAhZWbsx6={XPhDKk)HhhD z{qgxwaBgom9UR@}4m&@S)RxKOe9DRf?>zm279_sVNANf4SY_WV zfGWdK{Nzm%ecwUB^xwWx6En&07jhpfz|&;6+Z4V#zYzBfuzq$GZbUM8k3<8~T|QB& zdPwhyhF{x{zX3VAVgdx41bBJsu{3 zmI(Pr*bFEtJBqoza64DG?Sr(@FsA6cY%bdp6fr@8Doy#<*#uiW{CKZ7!0~vH)<3T# zd{stc;=Y>P%jVD_D2dFY8>(G{-CP()l%Al#R^YU%^ICd~LD3kRP#?D#Cxx~cTZ%Ko zc#seHE!ka%n{=jxiKw#!aViM<*{{Jibn?Zd0kpp`f#k?;dET3;(in1WS2b6zd= z9`@!H>u$175mK@UFisU~2H!v;YqUHTw)!VhM5X5LeS~y*l1wbRGVbztfZacB39)3x ziVc;vLllJiFLaZR!BiH`?NLJnTuCUQto-M=1>OkTt`s~po64)x_vh}cZRbYR(=bUC!!z&W_{3k~1YkeV z>yYgVzSRXGDyD0$z&0hIAXfs5>K!On$i2R00|92WS?pS&H<7s8Xuw{@jnuJbe(1IS zw-5kNr)>(iZF}d{fsPVpbuQ%NBy6ajo~~i!@@%GZ!RdmNl#=tch?Vnycsg3yI+-zVFR$8Wuzoj5PP7*C1$ioQ`lS?kgI(T@_<)E zAYqj-j4)1-G`&Ph$D6NAi|Gg)uXC+KR1};b9JHEa{^Yk8Y^+#`vt1GBCWEG%8w_4` zgTT8D_b2E9`{8P^rz$qLE|98dHk2|kgmSZveLq29iJH!&2+t7^eji|fLgK`bM9Jy-78?$kNJuksK6PEM|eHXFc48h4k zbVQS52fY4bT@(?VhRUk(f^0G(36J38SNX*gp9&+lSIUIv8=MQi(x%9oF(dIXj{2R#DgBe9572<8mm{G_a@QeV%ZDizABJ_S(UeRDQ4U|8;gOE6a``Yap@No20s5>!6ggL^YLW`=|7^46JV zBr5;&a&lyqz2P!WT1o4SHW?G4ZV~WERrOQcq(=K^s_k2sPB-mm>EWmK=XA13r;+cQ zCj*@{Up3{uX&tYfB_-J;x_-m%tc)kuH}xy2Z3g>04Gq=T+fh;k(6b`vjKo8rs(RXv z3U?*0X6T|q_w3($Ff6aDPCA{rKJT4mk8n(il@)9IPl!~mo))6-nNy0opK`sk^OVb{ z2wUmO^#m5{1?rl!_k@c*=W6%G5~^)?o@RcmR#uj#&^%*VM&_Jdm5S*lc!>sQ{tkOm zU))+pSnoRVCVufm0n(8Gly|`Sv3lI0vkjp#I!f8Zw6u!#By1LE6C%To%a(6hEe}~% z{2?~6p@ek9Sx?q7h zt0UO~B=MBCb294s>(rz)uo-`qE&ql}+Dx0V#L56Kr&Ux{*zfR@;?Z_Q%X(B>R*%f2 zZr0`GHVQ}FQW}rTU|2o%>a*k|BM(Z-drBU%x3A~xgIn%Hr9}EM7h%>3^u<1M6*rL> z#@t>Zi*smG5g?nzdA8%`YH{5ftaTKuX8JcVYzB2i`UIhekgUL3zSv_9JqCeCKHJ57 zu5;Wx1Hd`*6eWheM|G%waIZ#J-s~d^qEvn-iN%!zJ)^IznmD3Vm(zXC-A5()GCQ*) z^#DnSL&yOWmaCAT1`pU*qs%>tIY~f&f&1imKfvZc4xv=&ZYRn~^)j640RA2u8js3! zJ=H9wecr}-;$+%L_#CN~Bu$uw6&G4!mx8FADR`<5b~BY7Z>I@(rfhfzi9mIpJm236 z3JH$5qNMIdVAo8}0TnfTNn4dVg|dWV>XedEKlhi3STjzaWZ7Wynk!CL9qYffTY ze}oHD9YO+aW6Fo5fbkoln0@id`GxdYEpPHUsuew90zU?oOeg{oHSbz#@1~4Z6ZK<=4!$`EXOuL9xW8zMI zqKMxRf^x50BeM$IN4Gew(MqMTpO$z?njm4Y)!btYK#tc#HJ2&kZVVyoS6uLWNA z)^~42+LR>ZWNko9Rs(msmEd~eD3;RPZ~BB5&(lmbvmX5|vzc)k$7!9y!Jg6|`4a&Y z{X7~It390(jenu05T!?ih_h=~*PV*5%rj5&ybt$3RFm=o-YU? zq0~X>vhxq24idbNuo6E=-0l`W#+npi$-B<=vLF>k{x1POzw$}njNKDH!`NhsxCTwy zo(P1?i%nb1C8}EKK})I(!a_7;z;!Z6U#+z(yo(xP0r`tI-i5Y{9U)N~z;agvyWdDr zj{t*vDiG0Cv0@Kj$*mpylA}pGGnv@>7cUX?ZSu{$PtDOaPLY722y(Ko3dOGN#|mCeeE)L%9ek#C}E~NoyCsP!lI8B5Y3+PFS6R= zpFGpxN7v53OxRnm0#;ltc}aTZo%)I!3`}`}n@i=Wu5iPiA-TGTsk#hu0=JeQi6m@^ zGOIM|^UKu4`Eb|5qGAxzE#fAWC=pK!$*r$I*QC;@eD@laApPz9IdyDw-t{j+1b<`| zn)u4mv9=e!8>X4Qo<>~@rHAxP~EUW#6R6&C|Aotp4JCmDH5QCKG{v#@~9Zn?McTY zoKP!9$w)2;aB}G#AQ`}$umwkh;sg~1NnVsv1LjU=k-m>QLk*AJ=}eR{hIZp!a5_SL zn+nVAC`AJ@m>^UUnqT4gAMVIC=PZf>1xoFW;e0AJsanttVwOL&Yb+NJa;;=@QT)S( z=?}6V!0n*a=l`gT{5MwZe{1{s4{TO}PRPO5PSDm(lb)6y|34Ee1LNdEH^j|R)1!G5BX9q)LM{aI9k>6IK-^G6^Bh0^t{ymkF62tG#O#f-s z`p?S$U3P@!e^p8TuYkF%Of0PbT_x%KPx@BuKiQGT2_PhT1GgTSdO)NNWH&&=fT-uO zHSl38$+af2zUFz1y6r42n)Pnvk_qKM zECzQc4oS@NlxVgo=80iLw&$*ip}}TLLgjp=Lpf*@%4Iz!Imz!7syiby7W$q&T1y7{ z-x42&+=u=$8xjPzi;l(cop~wu9$J%@lPV0iC%uCpr19o!X6YQt8+8XQy2%F-n$|(< z-&>hfA2kPo-{q05M0_FHEmuZAy`@*A_WUW6ezaqc3{;NM5*o>D@3j>}#vi@WTQmu!vwiqf z>zdOYW=U(o->aY@Wm#dCDcwvfx~h+lr8cq^i~@snEL^n%2*;SG_TQ?44+lRk&e`(_h;P!RhQg_MT>nks~xgDCeR$f zZ^*SALe}5mX3VLp*I4d@Ck-zOEpaQ!-yH7*iEwKr6!7&XSmI`DH<;x3X(3d|QY#Lx z;@wtis-=|wDkyqaMeFfK*TbZqJRZdJghJ~vGFL{(xq>0r0<$uXy}*U}Isy`M5Yj5Z zNQ^{M6I}e(0Snb5G2SDHg}nInfAGHBgXf zpCW1NwwNfCeLF{Bp$CRKj^B}!E!30^L@7~6S$T_5tb9#Z$OQ6lwVVgA4s3x%5TCt9 z@n;%4jbyC~gVHkIdQU7a(^P~w#;lt#6TrlvPhhnd5K(Msare31&z8j)1(^;CdY{0^ zR4x`wZAWQf=jp)6K+Mk+R!;9Kj5Z0_TwjKb^uuuhWCUoJUsO}@kXVVlkWOAa;d2_9 zdJCs+?GI0UnNVg4M{h(YZZK#r8|i+W~yzX+dqBWbHJC^swQ#3Mjx$?E&@2 zHm2ci!Ef;sAjmwlRol{F7@0zf#D7`tr=?HMD5ayLIe|(>FefKKu{f9?nhXpHCSt9$ z;3#M1HU{=E_0-!XN)p3LoCZWZx1z%gVrE_rC>DCdw-4a3qpSJ4WaKnIU?~gZ_r4LS z#Ka)R-CQ$ivgC@pJb*>UTg!(B1Fr||kBk!HGmbSZlRte_h)b4NHl-W;i@(-4AH*-b z-v_@4VCN1z3DVPzmWU5%2Cdb4w_eVdd?;yTOjYY`&uOFwW5uH5Pr%Qg6!FyQK& z%MmP^0$zXd{YoGAS30g6MBB36FyfZb@}a3Zsr?oyCN1wIc4paXLzdK!R*Jy3QRLC2 zAybZ$-g#{Cet8mEv@vY|v+!=cIGgx)EJA-ptMCtau@l+fDyvF&h0TvA9;}=EQI2ij z6@qc=hOh$z++boWwRkNllO;~cY&syHLz%V7j)ECV0{QYXu9^blva5)v*0{5uq~i6# zPsM7I0|WVs1<6!2VYjZZlfyH3uVwoz*7%Gf-yUcv57aPJc^>PiL6gAe=4e|UFplrYy#_Y}zWv8%`fb(?1N|w!t0W(9Kkz<;NlWp13>Lp+O$HMn z(W9sG9J}9ZuI1ECEP{^$<4?2$DXr)x#lLMI7%qeB zNVx)m_Yfq`lJpCn19|3c6_d`Y%{$gkf@()q*i7B*@B~%7!Hbm|T3NbjVbbkRch};b zs+BNQO^!$m)Dpp1o2~H%YTHPP5>l=K#%PJH1q0ZU3*)@0R_*9u7kavzsR_E{BR!q@ zkexQ2{jgdNQk`+~Y6ZB_bh}O*NWQYHxeGf>YM3A%_9)8?6l}=sXD$MDjl8;}BCHMJ zA&{DnJ{*q9)ITiHD}ttZYGGqfbvNENsq2!4vG)5pv**g% zzD+Q2N7TlzzR#DwHm00$B4 zC2&6@N5fZD?xQeniAc#?Q0+ETAP=sg4}gvHX5qZX#uE@Aax##Ln^2FuElb;nJXdqKJ-w&gTKj``{`+Z^4aWD zxEh}9V`;*K=o!8l`XeXxX}4P)ct5w!5O6X4 z8&_JwZsOSnF*U#SaN#|oJe8~A0q!G|+Qke4!r&*NpB=nP#anx4Xm+!gX~4Ed&PKP% zYDus;{pANolsd>of@?MqKxpu)dAVXwW0SS$jX;O^+Ahhg)JXz*Yw`q>17cj+e5P_i zj$%^;6JGVu;`BEe_cTxijEzkiYzIv^)z(E#h1{;Yt~Xd7x?Q$dgVgMLl#uQ~j%YN6 zsm+y5e4@YLStw(Srp4^=1S)q;QV*$|CR;t(y`?bgokUGhMVM%>%0xICwX4T#>nk&HMJ!+$aqDj=jm7E#Lvvs(V za@ZEjUC$%#59BSzTuh!l;P}>kgCG6lZO~N7@of-r5U_H62|MqOX3jkhV$L)5ENVr_ zth>5P6Ngohj_I}lMW(aeVtlqd>hW}dV@THh2Byc8tZ?b+w{=kbQ|kODSp{E^(>EaH z+N5WAbu^U!7(7StdditPChdHzuC%IwfA7R6-`sEW`Cv9EN>X@)>>+H@t!ls9XlQ>d z5~KSeAF<^Tv0t(Av^s=JoFm0$*QvnNn8hiXq$zu0a7~7itLC$jbG%CTJ!Tl0|=_qRQf zRIzy4v6+K~^mIIRh20(wwOfhZh*fgKP(Lj3cfpP?C24S%5o}CK@fIN8o-1G48rVit z>J=R+aW$Ib?DTLZ4#gH}lV%^@D@|ZOvJZE!%cmP)$K~;OGLsimFXGF2JgCl*FhJ)> z%y%#H%w8$@jF^8$?Rmo79>=vj!I-RUE0qUg}x;7r4Mu2+f zF}h|z@Wsb$8OfjAQ0F<(J5m>R+Neq=Hx#3760Hu{+kc~<^XGuBre+Uh%O<+`%rWt& z!$r(f=fpFTD&5aooqyUR#C`pGhu4bfTjc3ol%S``WB>M&>h95?P2%F_6Jjy@iT6sM zMl>jLxWH7Xul17~-MXH__*AqmMgdaKjORq!E)gxUJI9Rqm}B+ROo;eN$1H}~=DUOy z*wq43*u1C}WBj3Zg2Ubx_Kprf+JT=b(Y(2RLDovJ@itL8k%@4mlxY4J!$bWXx6@IR z@9{ubX8Oj|$}*ҫ|eK6$Ob(6yps3Pecrd>h*)8V~XHs3U!{{Wdt2b7otIF5JP zS;jT&rjz#X;gijZZ_!M;hqTS;3M)KwWwFdQgUrYijSa^#P36_I@eTI2P%6)MmNQE< za3nqnn<`-&GnLVq!4Z>@Ce(5|u~7qs1G7V$Yi;gIGtXs_hDw>jZZDzxi?mX8%qlx3 z3hhuGjvZa?XNh#P%(jH9a^22xwtWco$c4S=U|aoXIqHLn%ibHg#{$>gK!>5Ngo0Bc z`Ec}zcnT0qYYP)op;f-R!NVvTT1G}!+9H@rv3;F<|8P=%m!?5su2kx^jZ+l(eLezPdxA%nlS~q^On^34v zc<+f?TroT1k{$uoX(2FhR@?vexnY>j?I#($;h&meO=@h$_6+;VBc|DTvPqb}rx_Gy z0`P`rWM)4{I96N2)?EK^13fY5q^^7Ir>vR}`~*6Zx^!>&8wEgxOcJaQF3<`W{a^ur z8)mV28Lz-9M@G+F>9CooE6E~oWFU5lqo>`9FI!`p#GLXIcJo~;WgShZ3V=CyAPZmR z8IK~zXB`{;Nh;^qI7()Fn3>nVOlIMExHbp>&LATW;rU~1_7@~dRA=xBgT=g2ySg|v z!o0B*T7c|!;$iGkNaVJ8YQ$#nFubSl@}!3YJ3 z|KaVOf-H~YeY>`eX?IWCwr$()-L`Gpwr$(CIn8O??##(erS8o=ImxX`)#O?11_~ zL|A87UAR}R@QMJ~n}Wi=EH}ljg!N z3w&LK=o8Gld}MrYE9cp^=><_b8XLIpC@DkP@cJ|Y+oO!_1xr2@0uUsWmgwtVc{0ZYr6<@Mc0ka?GJAhieYMc?A4G};eCPoWB z6jPMOH{{hVz=NnjmUef|H)qf7BV{ZGD5;J7gyUxBQYQFBpjgt6GLN{j&X>w3N0I%; zWE{H#8|gWOEMYkCYCS@Aa@1i`&{92Hh%ertAW@kqsHf_=Z2?$K5FMCT&sVJJpxI3M zSHzy%xD+Bb{OZ7M1$~0K@(9&moc^qeEY1e)ie4|qUWnA0FY_Ryg_UNoC|Q8Iot|q` zKOcGH{&yGkcC|9oQn_-mmbT`4bxo%_y7CbeWSL_EsFYD%4}+ca>OZ0#wC&P3oVmd| zY52r&jnDU#YKU|ESdexDH}-%?{Q}64IUV)-6Tni1IS$9&Fj9@?O+PjGfC!tL4|-WG z8wF`f6}ZyJPp#ROgl;-C%@^qsLK3&hP)fClRLjUNhr|x6U|Xm|YQk~&6l=7Q%dD!; zpU}#YaI{93?1X~#WTQcj(tpbMVBG~kG&8@ zYmqm3d=mpn2+ZM5R1PpphOS^BM*#zGdO)MYeh~zsGf>{&MZjv?aGK+#2{tLxjM_6C)|S0u)*e1{qVMBgj)PHxFE!)a~QiT-_(1D4SFNsywk!d(?Jm7%}m~hLUs($u% zfO39>a>i!b6AUroEd~e!q{O%jjACY#)D;2sdPY71)uulTQWOj5UiD4cDO@G{AYUVc zq6qU!?L0gZq$PeT+LPST;OIkdj@vQs{>OfLoV;7n<3@J|m9bNMN4MLOg4{rdP`gf{ zH>d)BXuW5n61W8O{Eq^K6MiOe(b~$%$Dr-3$Jm45NCrTLJ`LdiDfRj9>Lvdj_4$uV z$NxXn=l=vf|3Q8J8v^<-SHjr-OVaaS*F|Iiwr0-ezuA~L{|6stSY6g>O9G+iME%ib zq$Zp&D^E&RHpQ46)$A~OO3{=$Wdv%f;d;?N4ra*uY71#xT8W>YA>T$aq>JNBQoU&`4Vrbh%yDU z=AGFScO2CosNCkZS=mB*)wtnpO~qQ;7%j^y@}M={d!XC5N9)S|=K`D()LQ-IkWv(^qqalV{y#w5#)-^ z$Lby&!giraY)6cDzBGnYAcuH{R(A4?D#%Ku2MKfoB?cNk<8rzK@jAz=b6kq$v3y&p zBD2gR`=}*7tM~%f`Kz*^s+Oacx)(A7@Y}ZQyDCWeD@DDIn=LeNTI)%2K7_+suW@>X ztC#ifG;}hfaO`+6fxbv565A=?*r%J#1C}jsM6+=l-JixiZ`VEya;QhzAXr_(3$|XP z2=o_emb&FKX6M`(Zx*v9{X37)GIr{mO!;4bph}w&Cavsb0WLbKl;|nd!)~aPqeK&J z$s;bgF)%H^i{8o=0u&a7$kES9gvpiLPfjFsDVWcwWIFePM&BR=*rB~uE+8FK^zn=WYSFdXW*^rT0O72D*55_} zju1#XB2;GaGE|U_OOMS{n9x!;xu4nj-D4H_9UOb^S&D_a>?LcqAcNuQ_iywg%$IQ4 zkVmKpzisWJA<+o#w*(X}@p;+;EO18fElLhru3MLvak}OreBId&I|j0R#-KKHf9KS* zy)=L4Dlsr<)^Zj}FT-0!!oB+!JZ(MKe$67YyW72XLz}a_yd?J%mWQb66j73SIkusa zdH47|>jLfLIaUxn6ue|6PX2JxwJQyeei0+Mqtq$`La1Z)^eAS`TnygR5tiRAVncxv zG&8V!yM(-55xHqnW5A;guf8g2mmWLRn@flno?+$;)>~{XRbjO|V%Cn3i@G9s_K9em zfBP{xw8;JocGFg;fA?O~UJO_qhb}OxLuPu!&ggvmWxbhEme8_jtbK`tLqt}?ZW{@1 za+{nl>=>q$d|2R1ciggUH=j3V_sSD^$qg64rjZR+`*uur?}+TPtzNz`_OOzGLP{2Z zJViJG8qnxWARz{vH#hV!9f6y4#%vt9yw{QNo??Mb5M2@Of{pk~QWxv}nk`TB7IkgU zw8!8L#KTavChQ@|fhMpB7=0~7D0NO7LX`;^)N z%p^7ixFmm&I!v=%u-aNu0YV%oT=g@a%#|y{htSE&Gnn-w;z1>o3Dl?L1M|?-2(fap zs#i6?d)4WvBjJV6VL<2#?{Z!r4NrcDb;X3Og^g2tm3h*fSI6P;*J0cGh{#dPttHDL zN?j`2GF`odM;jj5(kG@?g7GY(}x>2>(9F2_O zA>L{ujHmV1lA{Z%I=rRsef;v5G~V|-z=c)cIMGr(I>PQ46ok!+VcrIV=a^^apVyuy z?ax!4fkWQHqfu71LSFp7vntA4axF6{5W~PUHKw-bk1ACtQVUnYg#3B~$ zLVz4JNH#_of>=->YctGi9$sq=;2S6j)o7P+M^4Hyu(iG>kdefBuHeOgF%STo=4s{% zcFq`+)ccWGVNF_>tNEa7h3-`rk+Y^<-HyqM*~&gbjBsM4^0V&NL^%OkpK~Q{JMk?t6P=Y5}YEf2S3o*8s>h^n^ z2}d}bV`A1Kxq38@0K2ee${{>+_bJ*Fp>27@OrV=+Lt-j_Q8q;?A9xQj`{!L)A#~~2 zw;DsB%;w3P+hVd?YtQMN8Dst74O9mFQc`OWa}&I9R$ZsmGk9j~4VY}j{DMVNwJm)D zV*_8vA2o?g*Wu7~ZOGtWf3yIPrcUw7*ELzXBKqrEkYPp_)t;Dfju9o4Ip3p1H;|!z zvR~kkas09QT;idan$b7Ns}wt48|^Ggc6{Oib|qbMDg+J;@`i$q^4YCjC{1p+0vase zt#-!*d&_(3_bNcGAGMTJl}4qDB<+Bpiy8PS*UiWH@ofQ@mp!yA67toQT%j3k1s<}m zuAx*(st%HvT2-8&ZI+9welVRLgxhG1LBOxJdp&9)A#k>vtKc$8_WehiV&M0| zN zG0?Hr5o@v~?Z4MSQ!=UexnwN(xJZ*Ce~HJhwfcrii^HXcO6Ii(=U44(%57?#02=cT zJU3aV-2#4ZSZHE^VrN_Y*p5)(rqt9>n|-!ljU?#eB4$klJaAVNN70<_jcnps!^=2| zf3fpT0wH=~RBw7Q(pjVHm5_*cY1Cm*H*|j4M~|$ymwn zs-=eAN$sCOJ^cJ+^v#vvVlPiE^JSn8n*I~BufgntDx1_$?3`dBBfxnGuJ&fQL% z8F9FNccL?JrMawIu_e3`gdO=$DyK9Hnpykx57-_??LWHOt`hqR-st&IiJ$T+zJ!M2 zzED;V-Sb96HbizhZ!1x4G#ms|ikSxGsHzp0Cx@&FRA57+jfF8`|Mn?{I-1Tb3PmIV z-!5_O+NsLdp}ndwV6j$7J4N}|$k~d5B^WJIfq85{N&^Y1$e^}SAZ$JhFR9zv_1HSP}Ve;FtVLB8nTz7T%V-wEm!#kWe(ErXzgI%=U;A zdK*bkK{8F7Z-8{fg`3(*Q#z&);+S&6JUEL746Mf7Q$7U;jLl#5$H>{|mBq=;)6ekA zUgS$;b{Ozl+dpEdK`EhxV;as*v-2~vCvzI72E8J}{mEgMV%ojr@;#y*<~?~GJchL^ zLshPAHl}|bacG!hu0St9{b=jL$%73S z=E}#uMWZTYe7x^U2$>$%K#P|H_h|#sBfJdL-DSGJau38^iPA<%2E}4!b6BjvgD`<$ z%F^DPfAUi%ww3K@V_jy&*>Zgx@>HRO$_n*J(u5(5h%iMR%9CrJDG3H(A#a;R(N~Pf z$Aq-&&V+D|ek|tQ#E*34;#jUJb#=3u`^l}{ici|J?0XTjc`{3zwvu%Kf5tspZX_IX z1iJZ(>Vnyu*jT-@B7*YG7aG7azzb{iL*6eo>1OLCE%B~8N+jstc$$c*0bVW>S1l&a zJWT*%Vj{DqQf&>jZE?I#Q*)np&#pGOdb@l<%Dn-qy#+x!*-xd>h~EHoDW2L@d{Y8n z?KjGy7USQyeBYiCe%ER>;$vYS?SRO>#aV*GI6purl(fZI*Xs$UNd6PO9DT<)r{mu| zVVG?zDNp#sJ8xU22_Kb_(XV2i(j`@{*(BhCn+HAvTW;iczx}`%rT$<^;BZ*K z_$Zn#)}3ZuD>l**S6 zu@&MMC>VJ?N`;f`M#U0Z6x}I6F1qDVE6$Dvw|M;HUuOOkK<$X?c`~Fef zug8Qfe4=I-?fPTlzn2MuK4B7Uc6eB#Z1YK~7Y-i!C&(q(GMEK_p#@?hn}pNNUP#i9 zzj%NH(Iq+c^g$|=xt;d+>SoHwL5z4beVK@dMlkT1plN6ZpV>0k0Gx<4?GZem1|z?6UlQ7?`+*c?uE<8KhU;;ceZ|D)rEti>wJ0 zr;4!#t`?);OJEmKM8BFQne>c`x9VrewhjMGc0B{rA$mhL?LvH8qZWJMIVZdy9`>+j z@@=fXk=jkUpsE!R^!7lyeRN1CVjz)eG+=p{f^C)SWx3C!-z9|4GMv$kfKiG@&XABC zspX)UE!-u1ItYNecs65(GgOi#p{+zNrG&nTbQi-7`l}=#Pm9YUu+>^7M(It%dWwlL zWffK%P65tcW6W}B^IakS`m^4%Nv(`jLf6Z+?NED2Sm7pOGv~{MxVjWWYf-u951=-7 zm>q~a%P{>~G@pf`*VThAIlCFZ7UX!vt;KvilvPc6(_=V`4(BqYN6h>eoWW_a*KL9{ zTUj$Dd9pn=plm8Xvk;33v`@fX(oV@3{sPkya?bX-gBuemAVH&(GZjiqa@dQIKT?hz z)V`~}T+tjcr5l)Wd@^>ru;pu`Q&^SdA;;66D9VfIyWHvFu|jDJQm*Lr`(j^A^ zG}ydkU}tk0tc))~p6Q73olnbey~hHxLGN|1)47`A&}FsOrrTp+J)0-x$OfHa zPeh~)pb(QlKAdHWWUb)|vZM9p-{LD%l~-O>dY&g0Ams)8c19CtHx#l~mSMeq)>=G7 zt)@S287-Y3uX-uBkjm`(n2-u#mqR#1>G=%a?ROWB6TbOw3HjX{CX3W=oi8%E+&U%y z6nldHZChHI{nW~An&v3^93d#5j*wW+@)&pqi%X;7Q}O5ugbNd8Avs&i0fNFB8jNu= zkUK`K=#CBvm)4=B;d0>9oj7-D+OYZ=7IC|xskTe$9X%(}mn0;ERk)m(*XkH=G#}KM zBs(|*)b!&amo<+i8xBG)DnnUjMkci-^^cfQj0h7Ui?PKz9m~-3Tl7!c6~}wmn95Gd zEp)=g`dtU>?T@6p9`YNfP0Gt2)=M?X!)?qZCe_nZ$9C$OLR| z7Y8&&{k%mGSbxC{CAvkgl>DYni0`;2uWLJh!_4=meiX6|`9;p8Ysq6Z(Gkk=-b@9! z9nl0-S&5bU4qEnk%wlzz?BwXoXZTTMQ@V=2BF4*G+T^9PQ_F;!#Jj|~)e1IYfo#gq znIRHLlP7JP-&lqV{j4hRWY$%U}voUCVrE($6` zSQ52{gOvIL+$^3mB%&mj$};9OS<>I`1H(-_P{iaSlH($QlqEX;>r&23oWoUeRLGM3GRecmvQqhPZ&=l6QxwY( zxV`TegnAyNIOCP;7~;8xKu^s~jxRelBgb7#G;>2p{}I;dL^0xc*-thyd_C3spseL% zW`JLPeL-5b^3}<9E&L?rdPcZvMYt$mb)}K|HM5ZQ%dQ7=FQIR2vC;Pd;>&icuxyC7 zsLSi5c$Lmf)wB|O&a5{dfNxrMN)9ES@fC(lH8~ob1T{^^o-<7kuDi-^7#}Q^#6v33 zKYNgoaEllw*99~!fud(GnXycx;A9wifY8hu7H*cAUMKB#y<^F-BK{vU`;}Ftqw>it z)3jkwfV*eXw4bN-4cXTTGWvSWmsz+hXsOxikNClw#4AK&#X*vVg(|Brk;RStVj~N=f zY#>(a(JL?=m{cKc7+UANc{ST7{jxHLui#s}c_4}&+q09R_qbt;fbjfH`y;byrTvx2 zTY9X;F*RR$85(PCDt_i)G9%{Jn4iVw*?4 z=2sXD7~1wp3b`MWm##_*BI+EoV1t!kUn#O8+Y71+AT}gDzPI8%7I11>O}sm-FGe4I|lw>*e9dz5Lj7 z-n?J&!W>CWJ*TRP8{xu9$9cyvdg_u}%JA{|6SyH-o|k%5_VVh!)3CBHDDq9>hH32Q z*P>7SCv>=cO%)-AnAzn^h0TLSWVuR-Zy6TG7Qgx@P_N_6 z=jg6+^WD>wD;BXp;LY#Fli{+OraXhw0oKmfTn0ms!1#Il3N1XBN>4>U4z->ga~`rR zjiNof4a}W?KA^7^3a0ra-DEM-=-?{l`sJ$`e@%9!TohJNVWURBI9wENUM&&)ItjIm z>ezR6S@NvoAh~VNMqp?yzser0Qxxh|XAxomLdB>YP;Em(XCp(hasn9#b34MZW|OqQ z5##p@2z;vW5d&_#gSLb4IEdANW_*$6pt@iHye_$BO>_8mSyoRr`bX=HD+KHF3So-g z^|9ryG5XWxq{=jCY=C>kOU6hmJ%V3)5Q9VxdPg;8|EA(inv|H6<>J#T{dgyIkjA)! zhZgyK64(-z0?4s(SA$45{;?mH2$}2^8ADt_zg7KuTaiEBm}{H+ChrH@6dY0h&v*^f ze@HU_Q{jc_|HCHt|E;AX%%sooFXZwc18V;v=KTBpfAE_BLfQFWi*>XAS8V5h|Hl6p zTW3s6|GmZYuc4>3{m2^U$enp*%c_yzE(+7A88U(&GNUX z(8babf0W-9VAR2xt8P(C{;mU@UNvxQIuQ@p)Iv3-`;leATz=4V80uCfT2LAeiENmS z`Pv(}j|w`mM~Cu|gJ&hd?jy|B6mh9J+u~x}Hj7-9)^`HiHpZugnI?hsWpwhwl7E!S^R;haHjn&x-n?#uT z!j~ToW3e&a?ss?Xqo*Y^af&%)@RDHsngp@b<5n==B{1490HpqU*g$kXHDt;tQ#J{$ zc|sE0rSQ-beX^LK!R4rd)+X%~8y~bc)hu4g=4i6ZV2+Tu6wedaa{P017EYI7Rv1fs z9*OaywCQjm?NLN_Z5_taGh~a@%>S`oDXyvGZnquF<-H{if!l}L=^8J$zP|~%;kid7 zjSNCUUlOk8=w?`PCXVJxDR4qDEctDq%X~#>-+{)Kv<+or`{k|i9cj&*W|cS1So}A< zjml06r#q)x6#B1;>h(nB_9RuXNdy_$WAI*cXuee>SKFyKAO{l#N#j&H6#Im#ViD`0 zY?!0%`EQSphp|4wGpUWc1&?dytTMi3HIGc$vIX0UOnqI_#IkS)cr`IMBsx1M)HZwt zd@9f+^5x<}c~XGXBEj@J56Q%dSv3oGkh1{L5%cyj{O?0B4Arlsaj8(krnJ2?p^I!l zj1Mu~n6Ta6%vQ;?D6qRkR(jE~9@Nr9gw`GXQ;e2dEE9GvD$Azzn|H3Z3yRh-KrYR; z7`hhZ9#7tmNYC~`&7+3(`2OEpkAr&C>LVVmYfGbNO|Ivrzgl%zv$Cx47H@uZaPIth zfn=Ljy0V$dS0LG2M9~N=0j$r(|7E$q^9?n1b6X?c6Ew+8c9|P^xWLxh#-7}H@U2$@ zdH$p~9*JZgBQXE#-(ns+pZ}!*L&p3(Sd*rI>nLTCnX?-Qv!-v+Up*);u^RG=(X=ty zHuT>R`Kq|x>v(5M530xc`NFJnX^a|OdbT1%t!b#->);G1}Nbk#zQ z3jDG>88U{`p?h0&5i0hd12Cs7?Z9aB$xozesYuvJ$Xp9+Jbut+9ITwvP28Q_kxj%L zs=wl!sZXbha@9={ zEwgGP@;ub*F-#acMI^iMS!X4T@Fe!&>43>ueRxAeGft49T8?3uDw1phj1j>Lw#SZW z;E)tJ$VmF40o7XI%ODWen=XsXil_Zq4^J zp6zjl95uDp2rJNK?8_5i?B`zIdT4T$8%`5qR6KNLq8DvzKpxc-G}INAb#Z(yh_|0b zlLI=nuP^I&lj^11?^^@(eb%f-`U$B;#{RSI;{qr$zyo_}`;**V@N5rR=s!7){&(r!ni$v^vtG zzth}5t<~iXy$s6a>MM&QxOp~&h@7mc4Ei&JLyorNF=R&p&5@vDfu@+cY&Q)GP>k|> zi;}M&o+ZpV&tOMZxtnz+v7gbj><|q-u8{y+iy-yP znxES^tIlJHo5{sd262!y?3>X1K3uOp=4DlJ&d$o8z0sm!+BS;+=IwUPU2<{MS+C%V zUvB(;V;8=0q>35!SNEHMm%O~+*i1*$vDt{XyP0go+T%~eNrvRpNBJNiAr)>hLWgOn zP)^EU3U9XhkV4q6zKQ%YtKE+X*~f^TUj+Ij*a$|Z6YXP4Opa2L+(-@Pa>O?22ZtuZ zSW7Njy>CI%Oz~6VWyN{9M9(Z`TeIIIW6Yxw_2V=Es@zxmV- zhd_j%whtG$fyZ-f^JcqoBkM2*4uKj#B{yNor6LKuV*$xhOK5ObnXh#eFcQ;hQ$uFu zPA!%r20JPysSJ-P{Mz|w3>U?QUT2P?P7R}G;~R%hMJIBa?x!W4Vf##J{|tvU%cc01 z!8yV{E_@Wevw4~kL%IRW`Dy{iHr`}@Mp!!Zd;MJqARF>Bm8g_6BaP~58Y0))$?6GS zBri}sp`g~edvZhXD=#2@Lj4TxSUCl*RQbKyEeL(OGhAI> zmie>;+ncaQP^|j4Y*^%WY zOW1`Iroh^kkR3WLleSs=ud2{qykXsEf{4LkH8k;8Bx1skp+E8_%b;s0!}Bnu7OlX# z?Fa^R)f~yG&NC@FRUNK|Z=2M#88O1}VYPQ>^QSfuhI4O!)E4VH9~2(D~#xGNg?y1Lc6LjE9)CjAJT13+s;v(+=H~~sq0J_2 z6?e-+eH@XgW^27KhV^}$Q1ngw1aORM;Pvb{jDxc1K4IXY-y}lc#i%wrJ}D7|KamMV zAvhphNUf`5FjBeF@KzMPg0yW&=79{`3I8(iYYl3MJ_st&Y#5tbnlLD+E>{+i>?~ov z4rXsspJN?g8&j5oZryWkG!ToY=u?NYo6tRpb^1pxprW+__5L}vqfY9o%@STjS1f+s(Zy40Qa6ynYob$bio z#qBe)up#Ip;3JHK5dSCI>oWe~g@IAsqm>kZLmTv&g;ImnB5~y)lSP#*2c2Xy26+5M zuO(2)Iu+)mrF~@+KL*n$Wxytf?u+J!o`_FS42q}umL8D;;4{=N*q@*rKX{vD->Gkv zAAdJ)p(218H+16JBiIM?c?+fJF96qFS)smr5;Fg4msSu+qKwrSv*JnkTPVO?PielB zFGpMyn^VH<6SaQmrPc*36J&N5V&iDIyVJkQU_BVxBy!6#QysEL8973S5k-nFgVSL0 zh?=|Hicb-?89`}J{cC-MbKy^(Y%D%!p(tbeyMqTg+I*cUic>UA~iod z=J5N3(i(vXG&dq%f&eIkDT%$uB;X!(KmJ&ZtqCR|Tvpa=6(u3e3V+~R&^001+N>rf zr5K7&Z@kq(f<$C{QV1`@Tk?0Jz52?~u2|57I;GlSZl+fOoZ0y#?(jc}y^$044LgL` z!xa5-9%9>xhtb)Zr_M;IJmUk|mZQpYZ#<^{SBl)m;$F^Z_l$<}>AZm%Jz15+=RcN<6Q zPlU>wi*A-tf2|%iOw}4Z_@)G6h?V|C>Sq*mx9F+8TD(YB{GZ%$o5Px`kPt5uNtT#Yw4H zRC$&5)pN}x3l|+;5j>iaKPGg`1p}i#O~1G=2}&oS7j&0(brKpz%P>c0RTY_#rTC6N z+^de8U$7FC$5`*)q;yQ4Dx>1TtR`8F15*Q>*t4GtT_@8->@ilu78J_YCU_4Du?=;4v?{v% z>moS6nNs8_kd&2v--YLQ7vspe^6?{E1opQTCXD0@_S+bN*KlRyoRVvzL|%u6f9wik zTkLjtb*9O)ddJ%@HhDs5dXgA467`tWA&2rQp|kZjN?eWGaKE$t_e zm(PdkkzVq2|Jo&0|9*A?NuU=LLHC2&VW`Y22Ea<;RKoPkhT$2nDvTN5^Nfxt+k8>O z&=TMZIAoX~)-JmuKM-Tt2M`F=B@3GzA03sb_rQvycSmMj;od<1FqTr5qF37MusJSOdGUKz(-4(DDG-GG6IHF?Pex5#(w1)Uo+{yr; zX)RLz3U7mY{5!0XNHYC%gWX#Fw_}d=t|?lq2vsZ>Le-A%K)`kK=TAihRp)Hsk|zzv zB5ZPgq(rFctw-W|_8i0df;?o2QKQMX#QW$BOFf;c2_kJn-%38q3t3*x5@RQQyU_sXh_QZY;>t0y|j+cYk6~?{7tz4|3^l$5GDc zjd^TOJk~WiGd3&@T@3CD$T+aJYSt%^+$?J1mEK;_!2L)$q3h4rNMQK-p6E+bX9Vk<(4PQjzROsDIEp2RJKI(-+vuq z25k!$YR;yP+9MJ0Xz^59A{5$`xvpKQ(pz<2-qB28EP7Wyq)H5tiuRw(on-%dIKfiI zR6eQ`fr0!*COJs*Xx(q9qWW3G6VT2z4`&#+S$0{cHzmAC>uE62ENgb)N&uf|je%^s z658hxl1)rX_-$;Bzcd>iQiPplwztRVAi^Q@FJM#WbXhUNEgB{@{gaQ2=;_mbqwtg% zqRl0YN`@Ritx3zGtet{nXYv?0jw%!^BK?=qu`w<@b3dbPW$XSN&3`lMuo~TF*7~l+f5sa8)rMDsaUC*~`dq$I65+Bua@b&XFOJZwhuUl#Dw#dz=$jkVB zWujKfpJIfvn|Aq=uD1wzoxSd+)Rkq@g%8}u^LpWSOk5`g5Z=2I-cU;_cU+tt zS{R-6+aQ-zb?T+eO$}eR-x29*`$`mzDYt%{6tk~o^rv$>^EFYabOC2Yka`g{wB-vU z`k>SiSH_M|vS{FXBE807WF*STb)L%6>=MU|AXm54+>NC&%7%-=MqzEz4(yfB!g7-< zatDKcdeu|;Z&;v7oCt1#{m~)9{u?RY82dCe>6`=>se4%n3Gnt;Vo?~jIG+Ybx9qAF zckRLaFv}*Ygt~_E7>C7#}V`LSaPV}Hs1Rne%_nYmA0+h z4_M@>>~yX^x|g2Rx^wasKF6BG^rpJvG0q8HYL<(gV!}>wnWDTa*^OPcOVOmq*D2cW zf_ajZPgWeZHYv?E)?XcNsY9>ST6;p{N%#cSEEM8ER>dL>28dT?f6Q0>< z{)NisMLrUgLiLG8w!@v#(v=w6K%*CbF?ITlKeUM^hQas#=?D(1BMrOtU#V#&pZr63 zr<%-C!ieY}T%oC%h{N;SE}I7C_ScJ;5qtSvLFb{@Z6)_|GZ*t8y?x)Y_H|aX14Boa zPL!D)d?)-!t)p(q?c~>o6p z!8$ZxWSJQ-j9uv$aJ4+cE*_(7FKU(XglW9wSTX@TPKKlR(bszD&_lardz`7~ zwniZ_Zf+{sJ@pMF*Kc*?(^vNL2u%*8zjkIZSf8Uj#uBT?YexMnE-o1T8|5H}- zAISgkwuKvif3E&`(v%R;kKn#ip!cnKaARwy3iNKb=Laf|-zN!-Vp*c@<9EV2rUo#VXZ?{6CVB)mGaVH&0fjy z=!__2*K45lF1>KG79;3_wM$?feu`e zmRL^p3MrgOM~9}hN((`V4}d!WP$$D6zX!QD(xoLk+-pU?%fUpfGl7Ogze7a~$FpuC z-T&nK|KTDC?vHYlr@%zp<6sB02Be`w+mSk1pJ$rPb2cndt>3us+QQYBl?ceVGAFG! zDxH+YucwwgM*3K&3!=xOa(5>8u!ZP&l1lzc?7fW{lB~+B#_&!Ql1}+^ci)@Vn3`SH zf+-uH(2S0X5E_ zO$O)k7g>X#iL|MB`5}hjdtr_*mDMya0hN&K<#%sxu|7pVVLc${Ga_IO@eZRFl+pmh zXfJP`G~!Gbx0dxz_(qXm^|?euTM}V#5Gy&~G})DbmV1?OWlmqBjQYEe>;arF+Y#@F zxk13j;$khn`MJ=~m|e%brY6FY+;W|0e>x|MFzIC&?U;~onlCayV7`C<6Dz+z@DJkv zD37q1+{aVU^kG{>PWVls7-t118O+(ulId&ls3`_V^x={J@~V|5CfT^@aD5P8WJ}zE zIT+T6lA~k29@oLU3~_(t)*JgFe*lcAJ`t|iF6JrmP%6K?WxU6_tGmXOQjf-M{U}q$ zdT?iO!X|$t* z7r{FVByH_thbTZfNe8D$+Jt!2C`L*3cWg|7p&Rc8(Vx={L|$HIR1E_$^7)QUx&CU} zTpppBXd&F3tOsGk{CFvPQ_W(l*zVAFL?%geT1hyaY_ZB7-?yf#Bq{SZgdb zGFsWef0_7t42hx?QAlI_u>UhVu^|*g*F=Wr385?q1QRI)pMTK3+hQls17UEV;!bGQoPnxM@TZ zuG~XN5%wYT_jWIatv!P-^9W(bJJcgGEYWW`QfU3!^iPK<3100#*%t+={1`Oi$pk=t z1R=Uhe$-tbxKYNQdpP&W6H9%=Fbi;>!N_A1!7)Z5i35xcW-6>z{7LuDh9>OHW1P0a z1&HHzvln|1p(CaWuanneeyoo~l z;s!u#3^iq_`ax|5^1&ykcqgedT%?kj$p!bW3$?V|cH7KF2WWmZk9OBf=&%T>UG%2u zEmyuoI2hbOC{R4iyPh({P+~m9r^#xuS5~HJgefpJc~8bePSVt|tlFurd0&gOo*i*2 zTB%Bwd|7re#_@l}ZtaTYwA}5DIxWxtoG6kzCm4&r+mbsgmdd{MaWP`O%OIG9s`qUG zcZUEAqF`yEdNc$B>v`#UgR$?a*ram{!&wniIv0*xdR-!u?-6hLS|bk@LC9h-?JoJm zjP0sjd)Ek5+NdW87Z8kqyk8aBqJ?dnOF5le=yexVcqbde-X6{cZgzFR>wZvpPgcJA zUM8!4$$H@#`TnzNW!!^w*0)zs#ZJZ!wDxPcy>S_I89Z1-zWvU*oa}V-|$Ib)g5RmY+__`Wj<}Z9}y=}+#==0 z($Yk5?$>3Lc&Q~d0>kG^AFFQ)&+9p}wsnT0@7ElP=?sfJ+dZTG?*bYr z-)N{fb?E=px5zXF26@CcP?=VP#(32dqIV#ORks-;Ue>I9*^hlcB2lMT8s04$eSmif zO1KpFTmzO-A`=*+`E}occTjC zhaP?TP>A58l!UiCbif^WmYy3+3%}E*JB2hR5G-0uRR5HZ(XA$_?xi(~nbT#{5?5xi z%O;>!TQd3+W5?u}lqOgJDV3StZ3AgjY<{)uIZX@w^tu!|7KmQ(HUHYEyYc zBx>V~M^SO2MN=_qqnhH-4LAm%PqRsyY0+TWS?~eKQ2B|Hg18ubmd}!zsZONj@-bCM zF9a?FxHejVyON(=;^XR)2>Ve9PKTP%A_=N1zc7c{X!D7WC*#`KfMm(VbAMKq68>%_P_ohuQK9L`chO&APD@K6FIN*4s}2m?bfAYpqg&#@K*GvY zO?NUN3tWU`X^X-y-KrX8X7BkY4|VB?l_Y)!UGzv`_ZLr3r^Q=WI}oat7W7%aC)S<1 z@kYz}k2AS(_=1M5c|7W@$-xhJUp+O6vDG-B)7yuyx8l7(f9IwkslJkl1u?zzcplj( zZYFFEX64A<6JK~DH~OG%y|B4&^Y|4sDUz%AIDiw@qjq<)Z1_p|rtGW{LZs^}2DdhQ zkA9RFER}Sh0tzmO`kkvLoSFA>+f|MiSM)qct^RUuwIE-0lzVSzbnj`pZq-{Vz6s*a z62yp)Z++IekDYp74p^5m;mJrF@txclncPznze?EeeH_zulusGDwrGr6pjV#Ud5Lrz9u_ zl5g>%oT7c(c}{d+ie8vc4isxiRwEb4$;{*Q<#0W2w=twJDQcr@Gw*&ztEeLkjB5Y< zUC?pvwx$$);_eNIT@@CHEUJQKg^n8n%=nAOtnqq&63now04b?dQ}EQ$+aq~1m7cDx z(4zP>&orE!&F;vvMw0lA?7%Kom|SPopfL;zD$9;eUm%*JW6d^)_8NEt3AuS(rQB+2 zOVjasB=AK&hm>4IvOVs>dhWqD4yk!Xj-MEJis7WPRNdb@@7q%crkHd)qE+acvfO2` z*)~A^j>d#BHt;>zy-CPR$0InTzl_r^w>DA#hXPqf&?f@*xcF%_m`XP(8`uaJ%Nk`tZi*vyq;^iuE#m`Z7S(DEg0k0f; zSKZmYhj3W%OV@SJ3(nq#>w}`-d1KvL-VSh4$>W~J#bTPRUZt27(*=CglN*907!IVW zlTXG6TOz)xmGxaR%Kzba%*b?C7-oFv5zqeq@?AtTg18zBiGdw zN&zUy82#EAARJ*kkM~WhqL%hf@G15Z8(`O{RgyG;+Jv2`Ik-PnTnD`!bI~YsBz$_<$VD!etBjIo;t{ET>7=MkV%)+IJ<NyMwWAiCUb;XCD zliY8>;>*UUa*>MlSv`m>pRf{GZsZ%AGR7F$I|z{R9cOt^K71f}8l$!mZRugBB-QUj zb4-~onK_^<$?EkF#|AjLV{&e-fV*YmL3_}XLn{Kf`a*6rr$Ydtq)ULpu&f)8M1;%1 zM>AS;)DSy|EbkpRRSd|$&_&RgpW^x5BjyXeZ>R~Hk7|H(7M^c^(%N_1q;@Vi-%L2B zO_vw!I7rDsg;KFo)KEdHf3tNFNA#KdgPgc7N?IF*AXeTiRMQ1^0KKfP&9TxzNmhHo z2Yy(o(!|aA768T!*sDu&#&Z`JgE=Xu9R~0Y=E}JqiQs7TjsotEkXz-m- zJ>NdhY}35q7SE&BDH9O~{goGJj=YrKa;=wg5w+jbv?FV)#nkve<$$acJl>qL_*H9y zFFvfFbk%P2s-V$q|32I+N;phX5KzNkUQN3@LCXl%^5nM@Jf@PfaPJUaC%m4@|}$2x6C50aGzt6 zh`S|-v-SNXeIUCL`|};8rZcf(4nsVCye#R+y6UUU6DX<1`xWXH9s&ysGUhT#KJ{a2 znSs{&6inB72qpyf!c&GBu9>+niZv#|-B|0TN1sDN!}RL7fsmQNP3lC0qYd1^Tl{A- zSayVyR_3TRaKz@u#_mk^{)WD3oJQ%FrR+sU_Pqt$Bqo=zyj)+(=NO3_kIO<5(mb09 zP|zx|9&Yl!&!Z$l$nYYIbRy^XzBH7<3jklg?b_n|+MSG2i!^^qzRvyr7(8^Kik_Q) zhc^3;C5+F0H##stfUra-*MWkRgOH;kc?Q{(iDi=J5NRb}1%PEfq$qP{nzp}V5w z{JR^{*YrHP8+0g3r^PO>h|MpjTVm^AtVsoBxt3pw-knuk?7>c$2mqFX=hlJfA2V~w zk4M@JM(B}^8pMpy;1TAQq6+qb4851iN_b8EeThn(d0_V|ZJ7i-(r<^J(d62BR_CrW zO_}ks)}Gi^u{XS3BY$&*X>*Qr9`=qD94kdJ%Z37$-@oIn(&)ufsmI>|q$aE|-)gb2 zOmr>wPKD%zzGwsZ(^G&Pdb%kPu|ikondZ(2cCw}&8d_K7^`in#W}cANjIl{s0v>7* zdgN=V<-E$bl^|9(qOIZl=jV7t2VX%kVSs~pc-1RciK+8<&^=5!r8+tWB%HY}_Sv$n zR4I2GSoH7TOLZRdiPS!f?Kv0lK-X~CKulD@jzrum*4R7bh|97-Dul0>k>L@6Hk^VN zQ#)3GkM!M*evCU(>NTcmcW6NXjrf2hi(3$aPSDP8&!ruQoY|Dg)Th=HgxlFDtT%zk zKkFdJFq~BggMwmNR$xfefW-q{Ls*Ml8fME6`@$}ADl@`EL@`%G->BT!-?_E5%Vmph zrH;g>%+XNYILbi@3WY*4%UVofuz2=tx5di0%#zelY1InDJoEO$mPs?Z)_CJRJ3a_L z-IX=t%JH-&XANsj7|6`%zXVao(@U`boEv>~Kb4fnoAPH&Ns=Udaw7t$&4FD*9QS#e zY+gtHE$mR<%@}W1XAc@_E`dPlGDJ{nfwFW1pIOdrS+^e#1%{MloV|JA^`1wUsIneM z`mjh-Hq>G&o!zGbn`;Cn(D24(@xAU#sOYfqhkaMNh}Q78HdLb`(-r%f7*izguzI%k z*u%}w!>cyC;L zx%I$oo}=4M{T{H--Sri$7$iAd5QuMMm{f1}pGo1j1|*emU~Fl?#I7tuV*P?EF~YiQ zL-c~vqrQEV{2s#F&ArQ3`|(0Xt3`BJRZB^Y4E>1ySn0w#BO=TNLNjw zmbV0Luw#@^I9Q6n?%#W_gt?-VDx#GTcmTTTdcdf78jUrnmSKL1QjZ1=bYuM*|3sE5 z1>z@-1|JFhA&tG*#vEp!uV~nknv?#&-2j$z!yt zZc5)?TpkfFZI$%j0B%twDEs{h0TU7vCwK%&h4A=MIAW6)Vv1srcXf|rgA8(#_VxA# z>~M>_<{N$`6zkVnj^q z$bgdGU<5`6xaBv7PVQ6LtY{`Ef&*);2c)V30Qph4PuWADVPC-Hoouk&6)7c%(M)9t zF_00i=4@LB*&XI@ePkWs)UpH^PYv&=-A+vf*JjI~LC@ze%f5fm07w<9DF0(A@gD{B z4F4Ae^#8{Jj{oD##y|bMoP({QqOp@Et(=eut&*{ullFh(q-Xzci-`YvmH$BzLHGZf z(@=NZ6hZJ=tvwT^Hx?M$!#k5Go=~0GNwU;tc}#G_s5 z5eD*S|9Jbjtktcdt>Nj5<<;r-eZFC)+AGb~>GAo4s(Sehq@Z?7a}sG(FITq{;3LMU z<{PZsK=Hf~?5RefRuWk>rSIML_Wj_(LYoLhvl){s)99XDWM}>}c>GMo$QyzKBgptU z`=N_^60(G)MN+wx)n)U8Mhl|5;mj$}T}lNj&4$Z~a)%E&G9FXB7j!0}FaW0SSf%9?Y`JI+LDaT(-0Wxe79 zX3o9feMH20(Sv=f{jOxS-m=B}`)b9$7B;1v@{gK(Vp;Db6UvjFc^1}E!U$tW0el<(r4n{E<4t_Jtq;2FTE@38% zu3Wn-V=oU5X2m8Jl^P3e5g!IfDX_019SGB5teKthmF<-l$A`dRBqQw#q9bSA;A+P^XvH%v>4q0vuMq{%P8{k0Z(CQqPsW#HJf7|FrpbNYtO0fk)MEf48k14KMX(5keOcVL!Q7&c@j zJMbIt{np#B_-PYh@C*WYA!HB3fVPTm#vhE^e8TH|uHHXNOyZlRtjaVA;atK=OK;S# zI@#X_AV=jW-#XffK|j+o4fyn>enJIBB%9X8=5VI~f?X8-sZ2$KNWF!qriL6jmfs;M zA7)u*I;R;6dlYvgqKX0-sGJ!yL6qROrN`C?e5W@VCT_ilxLC4M2~V4i@wv!o9l=py z%`!GGl(D+xs1A**X=!9$^aT7|C|-emR-oba*^k=*PnTOE%=0)Nf$q!S&sMM(inPSN zN_J5!SA!%^#vMssh9rR)_}wl{qq>^AJlhk9_G4tp-YBn$stgNfh1U!qY!VZcjvCY1 z25p*aFuf<(+rQF>G3(G!-iB^qbDZZ+w*LqneuVBZEK^cQiC@Yu(b`QRx>5`i#Cnwt z85S9_fFn)_1yjELF~S?u5@m<*8J7Y74y^)ecCE`1FLdr~#nxS%13xj*iz;Eainc~) zYe)O`;u^b)$rfeYBHvW|TXlbT^Twdu*a||pS%TqD`;W46o@DXVeoOb-_uh<0I}B4R z!F;#h4C0Psk@RS8dNyr%P>Eb@aZD`DbS$iFL-`NzZ(d)|s z$@lqmuYJUykz_8DZDRBNL$~OAQX~71?0C^y!r&?6bqB;el9JbAJeMs~vVk=em!3Zu z+A=CWv=jz$dR%7MLBme3QyfV&%V3jeqqT8ur`M59O|5>Bg<=y?vGrCoS~DXpk0*ly zGbgOR;Erh>w`~E#;Bx+$nnEJ6`sZqvv#%dYwST31ckzZrC)RMAeJupES92ZRM z=PvKyb$obLQS8j)q@(yzh3HW_zIfmc_j4F>7&Fgi{P^}t1z6;s_QWwN@brD;66La~ zEd!U5*drnf+F%&{{N;{KV~k1yj@J<}#2_$A3L7tVB{0S!ajMI5*&8ebhG*<#kH5VJ zR|kMg+2o2_{v1^6LwpzX#2c-Lelrp==Mf`Gqi%a&%00^p9)(AaOOTfb|w zSx`R|k~zA3on(H2#6e5X36mb1H%w>`>m?vz4jRzgR^%W}x)StMae$sDlDd%E{$ zE-mR#64Qhb%ls0upH=@rfkjn4G5H41S=JjwyrQXV=roB9?! zmIWwg6A2CgLsn-Y^hWgNf1hvGPf%R?@CbEVuq|V1_sb+SHcGu2iFC!qy&N-EC-=w)R&#Md4{}*d|(Mhi59>HW;6l( zQ1tqiFp_i_zfL9tUCna`IPd|83PQr*8#C6B=*V>{t|tstEi&v|W(WsuMX|JiwZ5rs z1pm1OR&P8(d}gpO>1dSpO1R}7eM&c`xf$4vUw3%~2cHU^d3z?{`}Jq|yo`Ned25ky z2JSO=4=S0XW=ycgZX;&e^s>DZTm3UO@ANT{8cVNMV;*S&mphJ|0~CIh)euzi@L9o^ zEI%m1s2KQ$n_iN#eHd*|TH*o%W{OE3B|^+jPfF&AY-q9vx)K)jMk7Y>PVAAHcB>sz zL<-xw#1G8zuxvU+Nh?GOs~G`p60HjfhWQ+BZ52&Grp^wOyPl;R_B@!Tpeey#TUJ(H z*k+Ib-o@Mti_E-|(8RE(IFa~Fshf&cO+44IUh%J1R(1gD2qyy~tR+vquZLRBy5)L1+|Ia}~BkvvAyq22}b*o_3hajiO%s!uP zu0{A1y!`%Vkb*2f+IEn2HaV9?LBJq@Di4aIf%G$x3plgVC>!-urFvYwGE~B~(wkQzhHvxviiRl21;*=(-3a+GP!UWN= z3-s~Vzp?K-PJ7KoUIOOXCMxQpjskKYT)2Ls0l$Xb8!m?|31^+X1-d9|fGcKh>6!=3 zabh}nfI-YG8dri}0^v(haM0pI=%&rOy;nCCip$GMM!=s&>4GoC7fbC#Wh)?d8O-s; zL|`AcQ*Q;QbI#}wG@g>+3(pT4lA)gKv{7pYT=ZoQ5ErPRT#Ah=!pe+fBim|k@Maj*-0tlg+~b-HsM6?=)D)}-<%T#9_aHL9vIl2eD2oY62w{4 z05$2uX@x4#^w9^CJBH-@aNUi%)lx5q)*sYJjFbjdWq6}cG72)-7Wew}hZemi<+WIH zgGqBg)0m7#>iapudge-@(UH$v+V%lAiG<3(SrADghRjHE)*wGwbW6NIEqr zw2W^zmuOryg%DpGsT4W?qK`)$w}>wLaK40qXQ8_4-&NgxjxVKApkQa1r$s%T?=P-d z)ZhkIUE!w&YtCE*CJ^m(Vw-DDL@C_Q_E zg5NP)V_Pveay=*V2Wn1{=^R@oDUpa2D(4=rjzw-uWsZM>Vst4}5x}sHJQezL6}|Hq zx$CE?82nWzlVy+=nPb$Wx+!9N<O}-!nz+|pzL`QS_{_YzcrqVpHA90+dH7tXQiUT|Es z?IT9!u3oot%|+Sbgwz=`tG+Fjc|lT;Ct+D~6KLJANe>y)F9%UAtK9d{`?#gyH@2q8 zw75%eUQI=xOxg{Ake@uhejhRLR=-b55HmK4=PZ2U{qF@v)K4O9-IgSt^GqDg`1GCaS(G5tG0OZoQLH z(PK>mCu{xgk~AeN0hx=befv6;mV^<`%Xz8dLO*HZ?WN42Wz7x|YzF{yZ5fH@EUwD> zWiImw9g7Ggt~L^!XyS%Ne%LDdKYdM?y7`8l%R}V^_+oeQP)7MmAQ^nBsZgInCbeuYa#+4W9WvCPyy!H!vPSjmWxxE|KK&M|k=qqs+vc{e zT2r_)Kvl*lbY|rV>cdGd9teY{ zp`eO?R?UgJk#6_3U*m|$lHJey5!PaULaO*^US4-$g)I_LOSq& z^5rc-Mpl3HD=ECL?2hf}0N~^VpzImzuku9bv`km}*?+-tlwiUKa1Q~LCTO5ZL&%D` z4DSSy_+?qezo0I$td6ct$hgIF*Vg8?SNm$Z&Xakwwvk^4s&g5N~9b2bvG|=gnwWnb>a5SuC*`_;gEOSu= zq=P&WHC%IszIU9~3t8hdohEuL0P>>%K>#0!mRyY)23)rtkTEV+;@%ps+iBQO+h_yJ z8~nV9%im!LA6M-Msu}IT7db{^T9k>PiG~}_dNDI5iStP|w~Dn_N^}SlUp|^oEP!Lm zTb9Gh$XZ&;$WEt>sL-;oh^45h9ilfJj0|pEjL27+h{#9d-Of*dix|&J-ghg%Ejx_1 z8syokIMrOVmyG&XEn9&U%1xpFndi;0o4Q9>xX{mo;CT_)Ab1!Vz4;MD#-aZ{Pm|Ty zO^ZXls7s8RJ2x_|QtehleQs5&RW14h*L94sS1^OnVJ6CJgaDn;Zp>|yw;c1EP%LcR z=V=B+0X;!CbH2m?8wurd0B7)JwHvTJj30+BQ0yKEZ#3ioCrarFw^ zS2k$EPbQK@LNH6R$zkAT0+R(nPdk8yUh4$QReZgTfje7b-p*>+Zt85R4{X72#!oBW z?wOR|uMS_V(AD>G^(Cm+eKP1gVp`WrPK#1M8P{IFZGQ#@Hw#K-FSD?`ycJQ9AFRU3 zX#br_zxIE&N zHb{aI4Pb~zjU67ZCr{ALD9bK3hcl=52C}q&9eVN?#U!Qr8Y;T0Mul^VC4Cvc!fsc=M@;w-9ck1#X8q2se{~l%X>5PBUu53}e~=qpPOG=5jANcj(6{tkl|rVMcDJvc%rAPKcWqbt{( zYM(8WSN%5fH53hCr?VS@6#?94ZGkRp=2U$NEG6<*{4Fb(H2jVp13^OS> z2j5S#6SE5z@La-pVTxXF>^xp!u%T~pJa05uZX2HBo`+|>GGIC%ur>vl6Z*|MRjrmG z$VBOGzOWrvnn)0hxtdpch3OU)hc`^04KreEZ2yY-5{F4PwDa~fa<$deZ!KafVgp`8 zGAfS!!u^-TT~6pp60%CTd~w*A^LSiC9XkFS6r=?sTXdn%9P1z1uov)tl*Xn;jpeTk zX!)Cb$1Sf*haen%p5CIJNBA3y)VqH>S<#L)1~M0i?X*I+&`OX1L&TZ1YgG7S9tKoB z8SbCHWAV_tXm|(+dZ2-?q5wcdlp^zAHk{C=5wc?5>4{k(A+gZ?BKbZED*g1ySH%m{q>I4KI_vCK37s{q zCW`#2C+5P53U5$FJb9&WG|s%TlbznKg^Lz2F3-Rvzd$vRkxe%=y`Og$m{s&G2$B+E z<`)FIt0Yo;`c6GF$G8euR@?vLKAGuhI{(Mo;6K{g8U8QY+5aD|)BhiKb{4w-wlDY} z+1Z&{SeXC!!G$DMO~=g^1fSR1zD4x&D4|Ch^2G5dTj{Nlm{Ap+nYL4Z6#emXVF#;m z^Uur3VI2U0hDEM;5dZCAou2O(Hy=B<;+v<@%4i{kJC}Y^<5ndWog4A3ZEl z`>cw0f&NJKj~bKtDy74@lmkWqVg6Onp0sJM z5F+*N)$1Umx0z&k+o*06@w9pIUad(E(;in=8cz7Af5qA(n(U@W<)^mHZ(4i!r_TYE zH?jJvX&|(5Ti6QO) zy8}BZZ<39m^pq3aE(VRsKb3ay9?C}x0&mL;JI1lB-_pZ}$&|V(OS`b&OZw4(mOZ*b zd<5f{m8vS>@RHGslOX^x&e5bXN3A~#up=o@kzVD{&l&VgsMYK3Xh`m3CampYXR2Mo#`+Ea)VCGba44M*CVlL#g0 zOUoXviGx0}Wvp8TaJKiO`ixS&e`@&G|CFC}iEmGAkSAhYGiGYnfhZ@0i52#8tkOqE z-gTj-8biW9bfnjFm>MAfl|;0o|3d8hLeJM$AdaPS@u8X$`IA$SCL4d0il2X^UOn9| zLrs@u5G||A9Ydzh&8lIgtz)=0xF0J}G82qz;b0cj7bipb(BF_iz71I>ZJ772zNy?+ zysXw}Gf|LYR~?m2%wY!YY5*i;MyrNNQYpVQYY45TW>gZO8VSsJxPL*yqVG@}?xAAT zno9)(Yj0L#F(5_Cj!V$2*d~a_edsf1Pf5&V4DTOhf>}~DWMd{C)xXUrRAyS(0dStU z*+hDl)MB0_GI0&<{u2O&!KR2LfmQW^g}_KrMisYqbe$^V(Hu5cLBL5soZ!D zI-7OPlONmds}R>CQAU9G2Bf)6F8+=alC(=j5-&JPvMoh3SEvMTK@TQjj#1l~I{SuH zkPd?C3!T7N0XqLQ=%{HkeSYC5isVq~P^7ZhvbPzar_XNN^zbVe%Xm-+A+v5P1d|OF zQG_maUXZ{B7+~e}kBC3F2AItj?wvKA-g32thB?89tOM|PpR^QbnoRzEdefhDfO_Kj zbT7ux65i--KF{$n_(k2KJ+SfIH#Z#NGu{y;NPo)T3h+=LDd?uB$qb z#q`a`OOin{B*Z*(2k$Gh+HCcZ5klh2X%%r!=Pj&W~v2PN@T7 zRm})aHp;}~@?hDiF}V6^zWGYr0r>_%(BSQ+w84rJ`{k!qxW;5e(%scSv+)l$lQkrJ z$V_S;sb@t}2MQeZ#EFl;I8ZsQwag7~DhpOE@Hk@5-^tDhu^r~UNzLvmEzGOm(*M#OGmAm>KS8#<#4p_@cTwka3*<>cSZ z&yIOIrGw(=J#CIwySNdi5SK@434=(pXkD^do$IP=AfTK{uLh0b#huoY1t^9Vc4Vbx zs@ynvIa8(y=k)KsW)wGFf#7@^WIOYAbf8AG-Qj#l~5oKS&Yr$%81VVZM9;Y8II{phC{hki#@fIJ=|AD1J#vG zpuj!Dm_*no81xtNQ@L+nh)v~FZY5+q9D1>EQEWE%iZk-nF12F6F7 zF*a*}k+<1YAH#=1gd;S%J$Ud0;<1%$SC^T|J5FI4t6t149)_VwwuK-P23vGZGk+^1 z)hOJbrus#%CwO6AK;pocVEx+bTcnum0c^m(MZ{WrIc7$9u*=oc66T%}%&v_Fo<7YJ zTk;M4Sj<~=^wP37ArK+q!lTR=`imkLX||)O37Rni(2`t|K1T2;XI!@@T>NW=7eTcb zL*HP-Q zY>ptB4tk~5@XV?92Gcg>DK9KGq-Q;~_SvpG1xp z>?%<&SI4+3VMMtA2>VhAkUwI03qjK3PqEpu=R!NT&WB9#`bt~NhJ7s_oK9-70HrZw z5Nypuvq9#!3ySnyCf?zA*HOA8U73*Tb{Te2u_FVxhVToX+l_4GB{I5w<_@vf>J9cT z_60C7wM(C`p{S&%r4>rJJXpB{8(ukG9GWrWapE{`Z&mGqS+n?sI9Ng{VL?GCfAjFk zQ409vVS*oSlv9*KLT-o6^#fb`Ugry|FNzAOx~gVeC<5z67Sv!`fX1ovj};UtDOmb* zIjPZC%WNiZT>(G#%9F3Elld|ey0o5ID(7yRvs4W7*W{O(QL}wsN)Vlc;(8rPtc?M#_u3GrMMH&l3GkQ=N#>$y2(sSICm*fD{IL+Y zaOAz(uXfR{FgefAEHNP%@#VlLl&MQwZ!l9PUuCZHt0=D|9WjG>*ad$!sNB#c3ZWw! zg7}X3Miul8XV+mt#pg(B}=>%yD4B@Yf*t0oXvf%sKeNBk6;>ccLjO76^UCQT}_mfeGd?8+m-0fdrbc zIB+v@hG2VDf?=18SL(&tpMH4UXB7-FMf?l(yy<%cI650r!#naN=3-zt}3mk^&aZ`Ll7bB5q zq!%@!n;p;D6C&&hRt2+G8s;RLJ7e5eb&4REeW(cRTM@xRs}q3OfrbJb42vkBI|I3D zp}g-`B4+PYnO^G5`8^;856%I=v&-6}*=!}B_HI=?4*KgMlMZ|c;uyS2;bmCyGZ>@Y zM*u%7)Y_oPz#}7pLBTKxLI!d)4-U&B26*Fm{f;3bczv+suN~ccR_XBiI9AH_lOsCrXl+yN-c=f5aCn#^%v5lshwCARNj(#ouP_N+8%m!5(l3 z03|tH6Wk(&c2ZSspS&bJO&_#x$tWK$PGG-Ztf*!VR&LoY8P~iXQz~C z#eq+B{@M}e?E549kPCOR=27)7ZHy5M5C&A!BTfLc!1(^BY(zQb#c#>0vc?zpDPaL7 zAjb?$O-v4{AplR$sDjx66{2!2(s6X2V<8GZP_UnFw0XpCG&<1)LSeVQ3LUs2O}Yl?&V8uR zT4FLVqFA9x-87YIEn#$;kH<;)1Ds3ErupJ zpXtEckr3aTiWS#%}T$Rziy+>3}1;B?0-hR7eEFt{jFB{b@&K;JN9} z5%Kf^*96RZ7Z7dc57MV^gZ2T1lJ*!*dx#^Q|C`Tbo_zpfT8!3D_l>63y|-|P&Meir zWKj%Xv|S>-J)+|^o!8Jy1@a}dVvQ0U+DE?m!lk=*Jzc%OHI=bt9JZ0Nw};E~7V7%5 ze}=o@Hwt|&kE(I>Xgm(yo7V`e*}!ZQf-JDITd$QO6VL2Uh1`1BF#$RIYgd4D3ZXU(j>)riXw*ieeHRC zNEFFY9}!=o`7ofkyrnO!20@zJPeayZ0wGZe-CbNwk2v_wN#_c zHcEv+#j9?@WXS4WLGRwyAe$RauiqPnW2!U+?AeMVJ!iyj;hAVeq21A|q67X*{ z;*DJS&Df>E>1@4_d2g^_qO)@it_LJU@BT$qZ9~l{%q(CFsYcT@qEO54vu$YmpRQLJ z^x|Kx_7}hOvC+s9aGme|HL(L`=P#5p1FK9DbQggLY1PDtcAsDkAajp?`PRQ5B@v}W zIxR}_p!)XP^y{D9pi#u9&Q2c_`+WF16t@h$#G)7`*xrN{Y3}QH&(i}$_iQ*X^ zclPfmaYRgamT>h1;@qnWN6=IFQqe+9mu}N1$qT5HxwnW0XdILVQeiRJdhB$2c{qC(J6GiN-O3*}k#UzI zRg--n`UZOr8!V3V`G^Ucg(G2Q`iW%k%09`X63TVxf$6svrtg&Z3o}yrsZvddr_v?q z4DYGPg%*VCf)~u6QtNan_!^p~?~}-a5@A`cLu-*I*qwJUm4iT95@LWro*pfxS~kXC zz8No@TfOvdFUjmp^zY+SRSVS;K=S390mGE>jM{g+0fszt>$=7vwV zm$~L0S65jnKDHzkS1?wk$4&d$z6BuOZuVrOlqJ-1Y?(S~A&U z*1Z*w&EMuLNmCfj5#3aQwvG0QSf-`HhDca3vL_}8Y^O0p&$U31?vU^COV z-vqV8E!b~WOnp+^JvhCu?_2h=HpO2Zn&l_ShdOq&yb9#{@0>L_fA|h%ql+;+3V06b z4+XO}m9qUkfjBMfQL53S_?9xxFe=HCrBU1NkE`3e_$}y0lxbr-M26pT%MQi4Um=R^ z7TG*{Bb8Gg4(kMK7^e3&Q16prl6l|jtES4(@QkfTQoSjKg%eea9;~jKZ7z@ePFHDv zDEk1wk-ED6V}$-6Ro4vv7gg8)9})V0zybYts%sYd|28)NAE~bY@qSqU_t-p3b@Sh; z8^QZk^{KEa%Xao%tFcNPaY{M!tM~DD1bo}JDl~%d5BQq)cDzVI@ zv6H4$CflQ(le1T0HYZ!R$Kz3hdin8`R<~Ed^t5wZ;n>2}vt=q}QsUZXDIlk((z-=E zv)826a|6jDk+!kf-IdLg*ORffp*jQmbkeHWM7MW}RlV3G`@K`8aikXJXLs5w*?KC6 z^H=;-7w3D@vC%Exg!a@}rA+<0b%S>5K=ijUm-b=H2SJxX=yWbw_VjoCd+{SVQFo=Z z*x9t?q_cM>%QIM$3AWuk9(8?#DqTAI{?bBcjq{@RWPxFF`O4nsYXl$MEcyZ+xxO$I;T@d4V$ z;f)=8yHsU0-T|29`y5PDeNR(rR`U5DUe6V5A2(QwpQkmo(}-g4%hw0-?9Vbb`;fnr zq3GA&-aTt;$*7K~QM~83n!m4uSuNzao{lD^T1_az$<-AC>xrtE5d);R+oUf0nVmUa zHTFR&(XJz;rMBzDLjk<hlv@V#0~MgEg6eaV&DYI_C-@Y`+WY? z+IquFpJV|ywcc(5e=j=S?TD9lh-W7K#nm_-rS);ymPflgg3qylmMx7m90lHshaP57 z&siJ(?vjaQv>^aZ_v`N=zeo&He|)4+$}rny+aygfq5BFu8~rL%HhWsr-GjYDmO>z9 zDEd(j%T<6Vk)c1j>z(RF_RizouHnsM-(s*?{B+&mMEl9VSa=r=oF!!pr&vd8ScJI;mX{ZAh z+ujUWwoI?~M|YN_NGabPBNW#lKzDKVI%u_pS2phY2K9yQC%!g>LZY# z3QM&nB0i4i^l}zS}t&heGLas8RD$smw}+80C~K(oEI#{@@3h-8;|yp;{diw$RgB^?CQt z?1J2j<85F)#)S6U7~?!+d0A!pAf+~(K5c%gl5X9}7jw8dKSw8!Nn}Q|<2_#QelfTw z(JkthOJqQ*+|cR+40N)2g2-Kfdn&dq3l|`T8^smi4MedBG}-@z8xv}vaT+7;Lk<1c zKQ0Gyy4NxxqVz}puKGiCJj;q(ecWs*oFHimjs+M;$%2uG9}z)FIImE^11oxr9i68Z zakBg9Q9&StP%7a}Y6Q#pZ+7tJv>-4;yM*DEak>3FaRFPlZsc9%-}e_EHx-ax1!c29 zGTKi{o;8bx-6!ZKxlsyO&xF`;VrXU3L|Qa;PO5RNZL3yYhe7R0+?ZYlzH=jN9rX+U zS3myA1c!M`-?q;sXn_2|zXNHjYF5SeM_5gU5k_|cIry(9PE50CIc)IYnC3fHTF7wX z&<_KhEeh+r`_dn{xjm>eguw!$H#3)TMdU@q)VFCSp~x^1Ci!NB9rSUwlzwb41dC4CJti3m3h;Nb<9`nv6;xhYQ}J ze2^3%)lv5Ei1%*nq-)q(ZZ~4FZa9jl4R(pwfFHAN5cx_hFH|OyKzD-Ds!{M+nwIkk zlf^VWknDrNCExgy7A7U~!Z9;#$jVru4%y?hW>xeQ3l@sI$O=UhfIm9Kt^um*iycHs zYxaiyd>AZ2gaF|9j^@$!N&EfYPkt{6eK3*W!XVmBw@OS8;=HD9jAdef1vg|6MFwKh z+7z>FIjI5u{6u$E$j~reB99%XP|m}ZEED>M6{jvWFON`BEKq_x6|$Zr0E5Xfg%^+Z zUm|&}BHK;+M3&<9J&S~$Ty^Oq`sAu~ESeLqAghrp8FP=vYe4a26gN}X7Y_Q7aLDp9 zmhg)ijZzmcN3>|`INv!Zb^%r-BPn=0MCL%E-qB%VR+%zP(~U%R-bHoN6jsc`Wg2|K zJI4`_fW;z?JP<8JyFSKRpJ7nxOcwMgbCvfysq3K!S9v_jPwDKXiWR$X4V8(F+9e;T z8KB|l@Cy!h)XpC!1&P-SGO4(MR10bZCo+M;8)^UlS!lnH*)bt?2w^{ zE@9GS48B}dsKA)71|Iyye((T_V$Np}cE@i&-x7ZES9__j+k>?{P2C}22JKD38%?~4 zAo&u>aM9cz`fjQJUN$B)Es2a|to=hYn|A!+VtQOW5!4U?*G^dg%aI3m)R$aH>!y!o z^3@vw{#$asc$?g43nX>Chc4YopT%5lki$!Xcd2Ef9BV(do#QYL^-Oz?`dp|{W68%* zNX2d{f@1$|5V`?rnpOJdzs5Pfhx2ibVa{}5osIX5DJxL!kkWv1tUwM$2&7q*AD~#} zp2;9!kt@Y3K|UTnvd0VIz7I_v=5GmBWhH&5 zj`q{5+w<==pnkF5^f;+*uUD;Lo6qPuyWHjy%Tt#Ye5CrEboG8z~>UwR83)KBj8 zKpl@RpUZi2w3Uy8k!GtdYO!jfiH4m*DjfSU)Ryv#T3(xB5=vqk9O98eEg+5X#Em`& zt&dO}0zLc;_{Jh!6!ik-Vby`$KUG*5@~WkRy&O>9N2DN;&NQ1KN5(Gd3(@_mWr1O zZ#>m~z)5>_snA+VRR1^Lyc2yWR>gV_8nQ16fzSof2!QW=jqeE#lA$zzaUr;`3qX|b z#_6G)lr>Y2$e}aFpiXsg)itCWY0pt=7@KW3>dAJ!&`{|8N6`$XzK*x$DjB$Fxk!!z3 z$cio0I*S<=7C7s`Sk@dwfBflI zr0)EKP)wyi!l@?Ka9h%#=-_gVx4`!dG;FWt8m!jibLg5;z8p!TqCjhY4CCo~_@&S< zeM-u(H~CBnAvx%-`bvm4>LmnfPeK8KR9g8DE>eDjbG}KRzFPSmwrq!zoe#jm%;HvJ zmm*?^1P_0fv^4XY?omASUNkK;zK5oknYOgUE-AXodYR5QRTB^bA(yx4qkf&TZjt2< zbVTU%&=flc@1AD~3s4Ug5s{?}H@|MlkH@Z$!b-lQ0~1aVAL*pQLFBt|SXpi5z!lMC`0^(an%4f?Y0~ zJK2|p@LDqwnfKg3fiF2Hpn~CiT9Q8pFhR487xJUdt`L2s7hH=aeE!7p)A%4hPdRagoQrH4M`~g-tfY8UO_~=OLgReZJCI{E~rC2CV&op_PKzB zOfI6vV}utucqX^GT+b96wL|_90i4fVK*Dn*R(qJLOGm#!4rd6bWWeoxP(DjGVrWP% zCA`;~iTOa{s-!BIJ~-N5y_{n7P_x9}%o>5RX9zEqc?w+aoj|I2V!~KUBpn610ib*b z)h}uhPjRBCx&uTuvz%W=JzHK|9K|=@UZXs%3WNI@y>2l@5}=eKC`i;QJ`(y?cSef) zT5SjAA7Aqm9kY|E4HEhK!;YNGS6}iqssLV?(9Ln>@HvjT0#OzNJ~AQzU{bMCK@+|R zJrL1vL{lQ9BNIh_3Zx93ChFTxeDB~s2={k75o9SGbSZ8IpD!tv=G5cgG1t2=xycHo#my)ibkRXRpZ<)98%auEfwEYvw^S5Y%`#J zS5N2Ko!qUe*IRkJnL2uvN zv??+-#>qh{>pz~QEq2h+v-NKv(ZDnZfy(A}p4_8t>kqkH4KrlQvhzJcf>xNrL$Oci zxq^{4RyPsAJf~L7w7J~QT!@Nxr3M_7N>l-*0s7zzVQ{n1b>gvChfb(9`y#Z)xSL^I ze_uV~_ZU4~8xeSf=eAo<6m~#j;%nRLzD!?}9qyD|YQH2Yqr^4DUf2TQh0bWK$s7yA zh0=w^+-+7v=+p)r!9pYkXGLUm4uRO+bDZHcG2o`qI_O5&aVw%zc1ptZ?+3D(^$ElH z`c(=Ykn1@Tc=@Cw5FI|z2i)s6gj9juIdo0nql5?H#Foc)_9RQceCaQbk8>$|Lq%s>4uA`;3+0JHsI0$|(yCpPS z#9Jq(Y=z@JAm6?B)6y)tBHlt!HcE*Iz@~)z%PpglF44#Ye!*C__66dGo#zXa+bvh+Ue+|04Qpw*5rQ@=s!Q_yO1G<7rKHA!vbbxve6%kFjE zRlkX3Yd1of2BHGNwr|%X2qXqXdkju84`1Zn^cjGDTCwNGU`m%#$BZN-{d$~<>I&8W z1Xr`8kh(WjZY=l}h2K9)cSrIfSfmt=_6$6YBy2W8DdH-ysYQ)h%u z1ai<-^lqV1$M*1Ts)6=Y7xcb(DXWxKxhA0+dMU~llB_??i)AShM~eShjitV5&wB2$ z%2O-ra4o)HBgZ4jxKR_!|2F$RdU#HXSOy%NlTUCETjPFvsZs_n*&rT&xZ!VD^rm_D z-*<03=3J_MVpG{bqzr`4vuAU*VpIdatWB3ii-3SHRan%O7M(6iq={_ab2bvBD2Rpk zBFe(x2Wu76O4OzfT4{hfvNU0Hqy~cPr*MVt6Q(+5%@D=|ujE!Iiei{ySa+VxC@q>P z20V4E{|Ul`-3SdP)kjJ%m?7J83ye4#tpxe)6L^647sA{LG&le81BYy3hQ)yJ@?(En zg}W*X4TS>x$Lu4mqjt6mD(8FmLXBEjrG>#2dJ8Y5wo33Z`^(!5lQ#kD!}C6-*kYm}C4R43hZ57;;9Xrb6Wwr29#&*_e9xq_}TC|p9)R`QsG<|By6(HBnvBrmY+ zS2E$Ot+?zL$WM*ba8JB>hUfFJ6xw&$Z=kb9$`|AOEaJW3CTZ?qMg)=wd|Zeu>2jiMccV;J##WxQE}B_VIiT z#L!2SkLE11)7F$bstef4Xm|J^HNCVJ8u!F36fM65H|y;arkMO7Oxvf6N;x0?UQpB2 z*Wbn|>l-(uk$;ZDv5{sSQp@;pxM++}&J)nCp)La`H4o!Ft$Sg`Ptcu%#P)BWGxz5F z)@yLK$CUO1?aU}nGW80fnS_;uNCJ`*e7Q?~w_w{;2aturKc<;eav!@zQ7VsmKXaq1 z8`G4YjhZMAk-q=lQ8S_Ay|4Z2aRZW$@i00zil9dtfXwM06a50QA8IF*aDN}-oaH2$ z6yI(bx}T;Q1nVF>W@E)nF+hdD&3yX(KlZUJBX`)Bjn*C@5>6u1*=XuGWk&&@Kw3b4?8ip$?a( z0i^R>|YQ?VMlA1l8MMJEa!u9 z5RP$clEKb_6YHACIHMfxQ-9cuJfso5C_er;)cgF?61N0aZU@(Ael`z1k56fhV{HSW zf5???mGy0ia~+SM^EW0pts$mVx_zesr44d9ZqEdxmg&lJ{z+x0IY*2-6=oU9ebmJCWcJ1R59&`@tDr`nyo?c)10Is5Sv zI#qrt93G$k>frlZBvZ;4gL=ofdptl(afZOUf{mTy*=3R(Ui*x_%(-#~0nReIvU~xL z%M~oU+}UFzTdynJub|Z8Bgu30YDBfiRv%PZ(Yq#}boGb_i6O5!Q3TCX&!u5wC2-^A z5i*9MT8;=a5Y~MSo_cw&QCBLJ9zN0wc*L`1pDLvsXbF2bW9M#L*Ssa~W*&RDl5I^C z4?M=q+yj9Yzg(?Gv+nulN$%YiEWDCV=*Q^Umxr#mPKU88k}-9;mM#`L%Pl@EYip^e znIawM24r_RX8}A920LME_zshou~ZH369D{#1`Btmsa zh(bA*$l{^G4g@ijC#Tt>fH5>I!a}hA%#Y0=RPsgIft6k@nG0}r^3(knngM{fqDSjL z3m%yNQ)e^t|3_!@e?NHmj~;^mGwX+q>Awmg{^uJ0@2npV_WvLq7*gN-U(x~Ts<9ME zLojwD+AgZJRyMg*B-J$g4ITj?8cIaK6pNdU&*x0-{0@MUjOVhK;i7-mf!XuLa(Vx? zoZQ{|=;+7G$#``d)7xGD_D&P?(`?xZj!hpf?NZ4ssMZeii*TPO=<4K7lWLXPm0qfT zsys5&8Me))&0*I^&km~O9NNxwQhBIW53O2{G>BGjU~p z)m#;)M?o;n$wl|cj*V3$$urM2W8z z>!^TLFW`=2ZSRahA-o56j+*Jjtv`7CfR79Ltx zxB8R7?|L283&g;OLnZNjy6sDgBY4FwWvqSPAk zp$PAgc4B~cGq}v4fPE;;_i%?o2rRDb#xtW|(+(ub8cypxmnoce-s+Z%>A&9*LKj*a z>AsEeXNQKDh&cS=KNu%2a5YF^jJJJ%#blNw$)Jd2KTY^Au{Q!*PBvsOiDx4xU-ayh zjl$leU|lfNXN_426R@-8k@Gf)=w)I8mi#OR-!*?{f6B|b`Rfg1ZumuDtOCy>YQD$L z3cr0ys`<{PVV)f0waT#J_soplHi%axp4UX?JHG6&OPU1Xx@dWwP09vL)ze(r4Er{T zu#%LPfuZZ4DBI!%vP5QQ@aPsw<A>!dj z_8A|-nHaD-XEgS!P6mL&MBGFVBMkxXu`R&m5Uxo+X7_~N z#LK1x=Mld1u_h$hhL=M)fca?!vjo76LP2Q_N(89{omfwP_bv|?%>L`x!6j3@+CW6} z*56{h*ar=a(6zB$3gcHJvlWhggb+nuhFk!1#01MTB1=u`lrjg*KabHiKHD@7i*?jU zoTGGZAKuvjN4c(Vl{C}|(n{_1^uA`C3+{-2dTfM)eY$%ep4_d%4u2=6Jry>O_HnUp zdMeq!WJuoYOZv`fo_&hnotsr6ewFKfz?Z^5+_MT1g{}=Ovz|DN$(>F?tv)=3Nf}bL zlz&j=k-HLBh-U$h+~7SMHl@fWjknIwOpTt?jK!k%li7egtd{2UJQozI3BwzpoHZi` z*&Kd83o!m#AoRX+g)#ht@v(-DfF~L~gjRJh*UTZEQA*vaUqs8T^cVK~6<0-AgGWfa ztpIA=`HHV@c!zw&B*fmA7PSR5*LWJc>u( z)-4Yml~Md`ppY){QFkSFo2WSjBQGnqZEk9YlaA=tOWFCGsB%14XC5o$?a1Xif zf&y_c?vG(-QMwg0D`b^GX|KEM&QkU=qb>Q){hJoSeLGU&ogP6#Pq}PL496PF9p9d{ zbtzeDA7g7hzW?PGpN-Mck)!`@);Xp!UnCkb?GvM3riqK9#y-#1eB;W_u@ou0cn~?_ zsoy>$y-X59kurN^UoOALjctDZm&mMx> zjM=w`05zRqxHTUTBF2w_lR`cRu`~Hs1)#>qW`rO;NdOdG#IwMm!gm!aSKTLdzD?q) z$>#s4%rwfj99T=JQxX(>~8ggYo%kL z;${8Ag{Ug3c%PC8oSZcUjgi^5x5v#b3kem;q>f^5P<^GoG_gY&Tn#ROZeqy~xqma%{ zR*F0+ef&62*ZeXd8;;jS+$#aUH74%)CgKX-dq}1bH0XgRsd(}lOXwt#m)EZMzGs?| zMOb2UX+SAYO9Ux;Vj+=zD)%X~K87y}8E3Suay~9u{H}=?ikz`agj@Va`RuC=ihVJ7 z%Yc*@Y5+Lp*48zhvL7Zi&orQK?yz*nbB6xsY(7-aOzG8@U9P5K33l~6{0BC7IOouj zGe;)&%Czcd`N~EacNzb)Q&5ZR|>+-gE5w@%Mh7AV( zHF>XC(yH*l-1q#bB^Jx?K=39#Ie?4ZKw-_5Qak90JKF8A&RW%&nATb7?YgpQ6pVWX zN3F?Ac9$Xks2RLp3B7G-D_-l2%y?_58}F_SNOH-?kz5L&*~ULykc%|AgD!4o5C$^~5N6(^^lFjP;~+(kT&m%g!{2PSr{IWVp{--;_#%7_+8AV@4GrI;6oAy`tPv zP+9wTMP0=JajF5gsk-FF@Mc^aGUUZxo~9OuKXYMF1&S{aKP#fSDiGaFD*RFYbSc7L zxO=m5NO>&TagHPSW}&qx`LF7&zj;yTav_Ds-}MR7slcxi1|xj zk!^~?2!iC(Q>yLRQ>=7sZy0FLX}0KI6aaAUBG4?@ONcE#DwAT&0lW5(pS(8lwJquq z2FRBf8#3p9{8_r&tL!~|lLmEmVb6Bs?cP3Yr~Jz}t;{F9bDOpa5iXQoa7@<87R5zGB&QQp02$^!buCppSr|yF6bp3KB3HO;i`RVh z(x{%&N!5w1%y(|wMooz1mDWw=tv0(Qtok3EawER#k55~W5L>E{{6nPv6x-$F-n=|W zUb7q{2-WowmAs$S4G<}5p86Ben98xc-RZm?RF0?P;pDbIlJC2aSa3}&xwtGc3Cq>r1yenojl2osjV|Gxf zv-^XVbuYNxZW>G+z{z}&OxX}^mzTVL*#uQhLQvg2oBd5B7cZi@I(E(2)z@!qdc<~f zboBFmzmI}^`S}i~ezs|nq;+G8!4XZ#4tV0DW==Wtpc_Xilfw3XFIULYr-<~?v(m0- zhj%~OPxj=<2!9E_rLgz;H>aaOn>(;W$2O^2`0{SpQKiChWTFX-2dfC)c!IwedW}HO zg)}}-RX*M2SkMz}H^pW1+GOd#Ova|QzzYr*?7?dRijeiJPo!-^K?gI;dmmtX9w(bA zXzXT;j@NQF5D1a^D0>F4-f*q0e}sm?L}{hTnB&W;rr_u7ZI$P#Vt1E7Usf;h15~g_Xk>RK~Xqvk0N) zEiZzFTxXiU*L(V4VZZP6{SzGhcvM=ewQ;!m|P;=eS{szm*G~2(gn71bf9^F8MThy0$4t3u9nP$un=o7gDQ2_Zq+w*G^H%**1itu*cqy8) zPZiXeni$q^@iO9d?32Wq@?pnKdpkE*_(m5D$h>?;V&%T}Pu~loSi^bQxAF=^1<+t; z)t;Vm9G&MBH))D{9 zL)sTv>a<RdaFRV+kvY32}MNsR?l#Vx~Na8!7E`Fvl~Qe->+jY zICaXdM3*12%J%c!7_s8F1_bRvGF$&l;uCCkmL4JgHBu1990ujUP$xAvwmcJxFe_er zDr}89K7%$ES7tB?{E~=~w7ZJPtlTZ-!(d~CnfSb_C5!z3!@?-*&{>@Ni|k-2(A1`N!6youG=)P| zGBcI^z2BLsG9yhA(*#LTgYBrOQab8)ZP@J6$uCKdtFB2Y{%@A!q|$eAC*1+^$Ak|E zObaPI8}{eZX>2i-sfaH%`VT%c_371YbY}jc^r-G#vbcLIG~3U;07NLAvSoXPP)<+vmC zj^JKSUZ>hni9f^-(}|p^)$+Sh=fW9Z`5|Huto#)RWqif2RIEQu?pKfJr0BW0%;BRx zb3OIEN|gB~W4oJ0>+*42sJp%&(b44O0WYV&d*J4hxpWlV_%n+> zm3PUgsxy;~es+9PtoWGIqbWni!fdIs75&VzgIR{f9)nl|E}MSfKkIZDag z-piFSc6DYigMmBVgZ>1+zI}L5*nj$4if@trHMvybf&RCz7EFLyAB%V*%W4o^kHald$`GWI&xyXvk0<2V zQ<*XovAu|M#HpDh0oU>rLm86qhy$a^ZnJlu%5i|R-lnGr5>})jLi4%(nJ2q;ABSqB zd~WJ<-$P`u%sA~T&AURgT3!vkO)29-SbCWu+eoAmds@AK;NE)K4}!WE%h?K55}`pt zt0^-;1*2R4VOxA|N@QJ3DIWTvk90~P^ww82M>!pzdX?edbjI{=&t}!jUe9kKJ$-VK z?yaSH*v#SInj;7Pdv$&+|56zHNNY@w>#Bdnjq&7P%ZsH(SNV}-YZ6}PbEu4fCL%FX z&A2w#y}5V6TmK||Q)p;fk&@1VMeRMj7oy0=t-7hG8(7eM)R!6h8%MceCY^>bGi|O4B@5_ig<% zLYk_!nU?<+e-v_gOU*fN^qyHSg!G5b1}#ft&6WfeSbBg|YHivyhbaa=MHl=h9@gv_ zf(3Vv2k5f}pqPf+qQnGyj5CoqT5gAjX`$HR?_V|R4cnpy0u2nPo`FIc6#W~N-C*!J z0hbmsrOf)HNqigMW3`Ur zYf8;kL$5T9WeTDrvp)Z53fs^k%!*h3y0=Jy;L_$;^5-otNm4$vI&ocaL!Y`7gAI*-)uBX<;ARni#7XVx>FYfMVDhA8k@d@r1R zYCMheE0W}BBvP_=Q_NF9x=f8`V_KWVZAUgdb>09c#NboKx*P>~jvJ$z=>FF>q`14_ zaNVi)iNYiz5+!}NRjE!&Kmj9U(;o(CYq@~3X}Smk4w$}`t*ve2sK#^@ntS<^kZU-$ zMH#U&566zwmO@CZiFj2Yyv_yYi8sNHqMwEOXHI8^7Rk#(3|dSvX)wj_%nVc#0SC69 zB`=jrS>+(@3QX=v0JrgwcPP^a!dU=KG~0JdXSH@~nekV@u_nJ0I8G5xCf68?O*Snr zNGhCs`^!5#_E{-yLNF8sK);2MONS^0_rtMB#WQa2B_O(MidMbzPaa3m1GF;W5$YNE z&Gj5v0HO`h6iz@<9-Ko8iGWl&^aJ)=x_zpgc*dqBqagev#N41Vexu8eT=qm^op#E0 z+r=gYHK?|51HvuwUkU>=BIdu(c2hFoeWUP(f4V1L@`dAr?St?UC|>A;Be z+?na^?1vU#)ZUu9d}J7%2;NOH)g1Jw2xJecVzRQx)vFUI#1DRc`qfpXz&hQG+tUk&|_yge;I3~E5Xjq{@H z0zX?RmB(L?g1a+_m5pDV2lSqcO%WcL#V~<~Nh5p0fTfir*#wcs8lj<1v8v%?JEPK& zO_5N1VE^bnpfK6W7i<{7i*SDt#$Hge(c_m^)Z9G8jwUfK<+O}d$=7~|WS%)lR_LO8 zgJuO0kiWM4F>S#}0y^3;t%}PX{yZnxv;>->Dmu=vUzh8WP}&L|rm|-nv!=n3C%72IMU5U97e*Q*@oSiAPw<3hO=bXcd%hA(u<89 zKaqnJJF%(B>`uHkzf1bvQ2FP3ZBf4M!dko(|IG2yMPT1bK{<$NgK_-d>E}KP4;0_x zhMlftzk@$H*ii0m-#>jOfw}%=HXX6q-Ssv5`%eQjxLQqma0qg8u%|MVV-uuSsF8nst<-cz5^$-m#!jt=$yj!u45MvfjHK3+sGFX@vS zBu1WX?9s&>X-1yZcl(+&MWTde4I8$3Qj`-UaZxff?B4lgtBaX2XhsV>cI8bx6T?S_ zT+&4%GCgwUqA5}1ho9&E>A!RCBo5*>ajW9x^F-+%4LjKp=MVn<&yhRG;*B(hv*qL9 z-G`GdY^!ZM>s?c~(OT%p^XguNu_Zg17wEAc^v}O(t$Y{6OLZFRPqk<#lC)|@gZe5p z0k{+Cs>Bu@#a*E#ZI2M?B>=)$UdrEv!HNAf7s!0|HN*EVtr1d;9USGry~j~1TiL~G zpGW6nV*7yN%9ZrKLh9J2qD-sQsfQB!iY(fIC))=FGj$SmFJ-3COQ#$J(v1(^`~K5Sx)A=` zlpyO{oxTPQY_z=w{;JR&v_Y2LK|O}{^Y(+a_wVkOc~p3)*%G zR?C^rvrgYJbS%+KDb1{mqX~~DoPx)2jR;PMbQ-%<(&Y;(63ese%u1HDtRAZqbJ*k3 z9W?MhT;V;+piaS8piT%FOp3~=BE)uoAKG8cEy5rQ{MSxMUq4)X$@i5#Ru#{qR zLKX2d{;599N@JF0TlR36MzrawGknhwnce=V3rWvM^^Z~C0X-H|P}KAXbz|xus-y}D zLz3;Cu34-eDT}K^DjPg8#!WN%5PX7JkD*2D(Ag>qFk}>5um1fm?9t;LQbCl=a{z{M zc!Gk#G_lQ5)w8uO&%@u$B2d0-mB8dIWF;`s9d*H~5iW zQ_Hp+!_=)1!n#bG?oL8P69Nxq2{|*DvJw!n?o@O5JcMh`bbLrn;U+0aOX4t#^E66e z^Iiz4Eym?{a*k0M0BnS8Q^iSUCBAMEVQq689t+SNLtBlXs)3?%go}YpZ9eTx1&&2d zVq>?F;6?>YjXASH;?@$D79NkZjlK$>U~vda7Q(?~lQO>F%;11$5cQ_ybH-oxm=1$? zl2lhHxj2~xKmaE~X-thhT|YRJr;Dq~pDKIDH47we#YSn9@y-E{Qiv^cpW^Y+!}^?n z*ol)Ys_zP??c<_&eZt;=o*Obfj)4@u@4-rl7j<{C!a-Zmfa$sBYFw2j`0niJmmqdUjxQ z&CUm%&2rvgnZfCg3Y)~;T%K2C(?iH6JF;r!p_So1w!4of3GuGryFx!)`b;>;GANlb6i2=#CyO+Z1P(;ttcoL1;Wc$Kp*9*sQDOoeLPJxBtzb%rQsVm zK-ai3K;-wZ$5C=8_h^Itq9aqGOHVrZnRHRJVs2HDgy8=(kLA8*tPo218XZkLaQZFkGf!BIBAcZ!UnXc1KN+P;uFSSfkI=_Y0CB;-cj-Knc`GV>69ONd# zNG49MWDIja|0n|$B=>0?oJC3e8jG`)DQcg&kk}ksK27{4)7jR#XlT9pj5|2PX7C<9 zwn8*6aG=Y~AE3v4A6g+RV~UcX9)+e%+mAvkylGktb8XPtgByrac~^Xva;QWzZ~3D) zXO-39?(;k7mFEd9xJ9|xTka|nC4^uthiDfa&hE~%#;x|_2#It=kng{pB;lH-G}W-Q%R=VZOY8%G*qBLWkXTZrr`Z7J$>%Hb*F&THBc zds-@=z-bS`uzCR_t{T1e444mU`o{tM0-^DlRJpy7r+(Pk^GlkPgs2xn(X7M(JofFC z)5xJi&l#_^W*oCTW-yOP-OGNS0tjr|<12s_@jf{(4R$35JuTWVEK`GS41(zbiNu-; zkDYa*g-WT@#29Dut>AT#;6-Ei*y8l!*s0vjELgv%OF(D1*%bG))gW;6h3_gG<`ueAXvYfjIzrzSm@9ySZl5^*pTZyn9kyOYAfDe zVde0Rn*sJHA26w5L)n!S7Z>(91-a}}y>J!VYY2gMEiS0JM0ua4Wl)4JR%gd!btLx8 zd{X)3*ow+FDt^ZyM(M(;mXM`q!&;h%P(T80aVSTb*7uI_n19ID&Wvyhl3*oBn2cNMzAUcR#*B{7|R@N_c8L=!qdP8;TqpwJ?TZ`_+yCjrG!AqLcY z(68?N86|2_Re{>2l5!wd7d}>@L#2v)n#KEeO)FwllDvx4k~wdBmX^x+*}d#|Wn#Bj z8rCCM%CqcC;u^H+$o5NfUz>s5hf8Ih_A*dM5&87;g9r4ltA`Ajqt(^lkX!V#)+TD_JSsqwYELGY_k-mRIsxHs@rJ zU85wspK-R}^tVrZme@4Ps34orEs2@pK8Ib0l%PK4B^kmJ3_IDlRr5~f6o+?IwvhSH zbiW$FWF;X(W9^?f^@u)9DyYuAj|eq8juCUi*Xd%Xyq*=`%0*vDm)!`h?0?v?QUir?jr{*}OSQ#@4Xi)r_uW22j837lh3F-tz?QY|bU zX+VSd-*EKD66H_9;EL9|mHJ>ncYPbu<2isY)l<^6N?IH@Tv z_gdQ~D(uF~MfF_MXnNwid$Bcjbw0i~36PS|)V6``8ij|PsLt4aQwQ+Swdd5GA(oED z%VdK)3Vgr$4_2CXn^HxeKA>!sNajW%9tZ@?)UqSWsa1|iQM}^=8v#HvRU-fxytv1ZVL`?9LmNDq^=yJushGE3b;A3^wo8w+Q6{ zWKY-q5xkEcSHX%*n5t_pdZ|;s^}>f=pZ@Js6=bisw1w|nKvSm8HfZw)g&$RGpxr_( z0mSz$3SdhoTFm1o`#bCh;Cx4%QdB_vwi-eDCr%W|6Tb> zH}8uRhGrTyw!{3}byn$8Q@yE-TR-PVzg?_R239}kGruNJ`fxv!x6^|)u^M?6-_97x8Kl9v(5cI5vxWnip>}P0R9Azlu4LKA$wIX#LK~y6r!XLDV zTr*)0{ypfEc0JhX;^-tjX!$2xzk|GmQa^&q!KPO(8u;u=UF|9??C4;xuecJN>`N1+ z(W}jkU7_)F7G-{lix^ld+Q5{?D)skL>eO^}`v;?`Jnfaq_yfk}=L9Ix((XZ3^neW? zb*j_fJ4Z=`%ULDiE%l}@lvCj=Q!tLVT}B!{NW+DD|5$?W={N>W9~t_S(+Msr^D`4I z5y9HA)-EPeD4Jo$3{4Ab`_umj_T8ahFd?GK0;TLO(PfaDZlqXH+(9f|Og+;Br zPjZ)nJQoA}m+vm=BOh+K1)%I*q^3Y|I`zkwR1%PWB0p)D8RKDyIXu1m4K zQDan49-y)fNUjx+_XG!HC8aS3G~Fjzl*p3a-AOAH4z;EJIe-UXD2XO@F zoiN(N8fX=2UF@C_Upf8e8uUckY0l`tCZIW)6ccg>Gx82zLbim5=1a&oNL+jvjRp6| z7yYI=NEFG1mA_dHoDvRnB&Uv=t`z7q4=N28O_HC7@?~E*jrwbiR3zS_4m7ks3!aq7@MD%udl{5txr}iLh72r$g;z-S@K>Y25FN1w zU`(7M=u?idFvzr;gTiPo=+ad!c%5Z>oE1fbv?uG(mvpp`K4RfK-A|uzX6Bx2Lw+<( zF-AhN9O?gPEqCRr+rHl$!rEdsB zVCbHD*K1Q^^{^Rq5wc~dEls2pOG8n3ZCSo_y&O|#l+u^mCrJFZ`Q!3_gxsGa{+vGD z4YrSGo%*I}b~o+JXy!XcfKk%|A}b5S$?Q}6xOL7Ybt7lX;g39Nrc{u*_ZTO+jdP5L zG|YcLvrW0=yRX^`(el*dAQixdO;xcrBzY7Cn<%Cw{hq0Ty}i$5SA}joxAeV-gBPwL z`*q*SG*94v$zX2sUR)gGcSu<~Ttla1ld74`3|fOZPOme4&)(u0(3s>#kI22U9lz`^ zw&_cbG-?1hTU6SZi6zX~u~fo-cvTp1V&l0COP?MLO+K0AQB-0=5jJLsfv-nQeUDW8 zUqe6`zNfyM8AN`T$4YKdkNehPAALC?CW5l8#g_r~DmCh2ycp=xf2QUKkfI3gn( z%{vVYcbShWbsYq9)4vb6i^4fwz2ZHzDkhF0Di|@T(xv`RNTy-mlB_eN&$3U^w@xl@ z4gAi+SKy08Svij}zSVHMBneR=m5JkQf3y(4~x~s85z)cKwI#e2HQ` zoG$a27|J;4Nho3@C@C|dp-p<&@L7N6P`ZaTFR>!x6tDwh>rr2pC(=V$PuxO2gTGrx zen11Lw`LwR1g0jS^h+PUT}8K`^KxI$I#+7DmO^mW`CPXA$?^CxPB)uro~Fxe-c}}? zwm)B;$Gc|FO9_vZNX}g+&nku9sgiKd{vy@9K_@b4hl?qf)M7=i8bdG6JB2W6s+Aq^ zld)xKPYE+48xBzt9Hi;D+-cMg=)h}sg3L)4O#~|%3PD(L$l-_z*dIcOrYe$wb!G-u z1yUU`KcHRt>SGBy)HMkzYg(W4F$qEw$WIoBh-8;B%{uJ@SUbw#=W=mq)(a>vfIO^Xg0XYw!0@Z#3_z*W z6g-|QDdFr>BBOSW$hBazPVu$*Ir-WlBdu$tJu087;0r$4Y@V>jVDK&#&z*+?`!j(R z^!mM)B=hiLgLx*>U~B6bUPpKar7_K((~#)LHg^q7u!=#|G^WQ%ZOw* z*P7TFI~k%e6hdJ>wQ5Je_TiG)g7Ayh*@mXX4+n1O2vF!=eASV(Thf8wE3!xP*i6U9 z!s1-;Foyyf1~%kqL|w-)NupA6$px=r0izShoeiU;lLJgrk*ROr9}g!a^{EIA_XU6a_xe|i>Gj=PQHTOcuY zir98}72?HCER1DBMXUYp_CHvAr)JT@XuEdV=3cgK+qP}nwr$(CZR};+wvFtQlZT}0 z+}xxpZ}T6_@%27NYqV zp32k_Mh#A8(x=T;0MjN3m$vae9LNz#F6vA5TlQF7`CC!GZeNsRZH6isp2@4y=9E$XNX_YOL9>%a~5jfIgAvki12GWnueCvoW^}P-q(u`3gXO=k)EH7-WRhqs!I<(J?P>+$Y&F0kFbOsDt zza?HWb$g5U=YkF~S<+@yuCXT-&!b~a_zurafl4z&zY+GWO>1-Sj9mS6|C@B5b(pQ& zq6Uz{f4Aj6TlSNhUxw_~A&ID@ennRad;v(}GxgDeA=?2Q?~DUM_Z6Ej2KBkN;w{-G zpdLvhPC$R=zh>)RsCT5(ffKLBPt%Eq*F$@KAB`TSFWq*(^!xz+FQj!1Vu6G5r72EinJb!Gq$z69Wc(28REn9{sy8_`gvMvoim0>xTa` z#V{+w|8jOvtfu3%*@@`$PZ=O(Hq3=MM5my5@-j2-XnQ4l)!vvWOL`7Wy^yRGrEK(g zQrg$6eg)1i{*u#5hXe@}HFC4w1YUNTw7Pn6ny05nOE;rj==*;BWL+VvTelh^x%_cs zoINa&Sn(`65QOnjdvf2+tc2{HZfcoH>Y!2nd~@{oi~)0Y>5Kxi%%M`$#|7`$p;VM5 zdMNyZGjh}XRL ziH26q2As)SKKZ14ug%uz_bq&5b6b-kZnww*YG)MeU+;NAmupH zE+gJU{?Py%rvMQ!3$VKTyIl$AA@bN)t zmANlTSA$L(;5BFt+*T-oeAzGvYmm9VxNE8^Hb^k0Cj)^)2_qa1ftuEdr!An*F`{R` z!$Sa?Q*Q|QCSMThWBeoQJGKS-!~0O2#Wd469|dU=-aQUM{f|U42+a;d1cMl)srKWE zV+l5B%v+nmtta9^y+C@Q0ACodS&;wLsB^Xhb7H!xjL5NZ#V`rnh5=_xna0iQP+J=Q zU^cxJk3ni7eUPYze*^O-Sdal`on6aMFfjFRdmXINpOj9ynKa zap)cOxExC7UcSvfnOD|@_~I3ofiA3rs!hCegxRCNNPrQrw0~~^9@vYV7$Z`d6~VZ8 zlDT>44n80*j(2%sj*W`8Fx;g-L}v9ZgDV=4mQ(Hix%MMyW6ViOUGLC*f-Ij;u#+Jl1N}#-j)$GW06j#2Wx5 z_$PqHf1=FuiYe5)&bbVt^;6dl9EU$KxUs~`M)pSB!42&u7>~EA`56#uF0=@y4aFI) zC>IbC%f%#|hE)E|w5p2)b~%AQ0$yrBj2yMWlhp@BMUy)1f5;Y`5xGA4l_L8Va^d+E za=}q%C2nv)+HHZvD3rpsRa{0n=UggANyI{++pH3O$ZX32ke;X?8|Zhm2-&>0n$V6yoW#wV-t};Kf6K)TZca8>vsRZ zb`bGXeMca_DAZ<7Dyq7j0Tl6BvT{P?PtZ7RVT$4l%lq7H)xU99ecxf&H19-qE<&cf zwL1$*PeCj)K2f^VvvuZCeGC804y3+x*(4)bKKT|@E-_5}Hp%T3K5SU&iua}q9us?( z4Wv?z-n`5m#xP0L?SPBGtnAd(Ni_SYcsq_1`o-v9BE7i zQvAA-FDL#rXlm9OD}6=gk27EI(QYSzCQ5cev0SfjBhZXhGW zNu%8L`A5{M-J!@GFbjfNG$U%!Epuo*-fFFgxkH9bmygpMkPj1RE8xS&C zG8TK+10@#|BKXG;>WUeops1f`DNuBoNsY#Y?Ga!LigxM+(+K}y$9sYUAL)>!sDTpK zsbZ{zW|QpGPJUy9UFBE8E=$BhFnvO3*-uu#5rg{->@|QB&}GH(@UdPLZlE8wvbzPD6)H(!xCL z4+(e6a3X(Kmz^Z1Va`lsCiVgW$!P9uQB@#=&y3C_q%rX#8H zrqF2KA`7yjj@=s_aa@t~b%|Q{7}9-+pibz&(!%ACB`x6DTX&c;IwY`~!%di1>0)Qicm+jOjz7}MRd5I_gd zf{dsdxqJTQ$q#wuG8z+4x1GeXBojnk$ad_->t%SUCYj8^E|w{apB~Y}khZg9hwH;b zO~2UnwJs@h3%$U!kT)7Zvm`^*%U4aq3#8A0iBiYELou9ZJO_bo1!b;|CPY~c%^VLk z-P|HAZbhZGgY2#+NT+2Q5%Mw!54SF<=!6W^Fc()D>--La$in%!M7pdnK#mC!`3KdC zTY;h^6#r;KR!%Y`MJ?VakXSawwib@RMc}|zHEAzK>OnrnmE7&qP)bnWuz&`)4$Tg` z)+746aDW*`p-n-^THz3)9^wXk3$ULX7yZ#tT@B4_<2@1gD3|N%9bJ#4o08vxXGC)@ z=>@vltq}aQU%^N1#F#pYTc8jJUe`g)Z8@kqziCN~ftXmj-Eoc^I#ku_G5K0v=oYzy zdk!sA@0?g~XYBfA&7=i#w1C}!1;Faw_p9>I5KImzJ0*X%VAW)>7u-}s3A z<&xGLHx}_UkNTGBG|iU!QAy0>>NZO8IDh@wDJxD=i?<0J@~u!8K;^Fx7b1k{e$f=H z;+1e;V@_|mMD_5U$nL-Rs?}uTHpdZrZtKkPArQbZYTpPVU|6BojPShEhu1LP5|PD@ z#Dmlc0qdgK`*>wsm#Z!;C7IwH8^n;-b@1wRd(@VQ>1=7OSFt=L|E?PdPiO_pUjKrz z8x(jZ_GXBaT=e1)yar?bS%w;AYT>bQ8=4>xXc>UBV6)z}h;^ zhs(&YeMfhbj@~!W&thF(l3FIUVy!3BF_$!D(Nj&`v`Va#CD|?fXSaXnYdIoXWm{M{ zcbi2yLuPr*IJG(5DO}k{?5nT3{Fo~0j+9;$RIaLCv+V%r{%T&?UohgJcOCGQ#g<^S zp1m*cN_U>s_v{LfdBd!QO9k;TsQx0gx=0(fB(eF?JAqWCS~^+|QUSYXi#fzU6qfSq zD|WxTTmYH&>Qx7K5-_xvJfn_v#Z@*F3%bQU5YYgcLBFAEUO@vlRkp=Yu65MV>^%z= zdoUP{MS@#04Qn9^RCAU{f7wLu@OXeVIF1zpTH>vo^#d9={i+D7C&vc=JDg5Qj*^{8 zg0jLXD&MtQTzXa_9(>kX2t+Xg(y1*bYX^3r=6vlz}>TM(nWifmQ;oM+Hc8atm z3cK{j)ew9i(l_C5P&6&^5RFUq6nc-*rk9sDzev_VSn;@iW))wAq3~ip-#L}EMDzu= ziS#5Go?$y^3|VBQ2pA~FKsZ@1nNTlQ;NSWO#4r?jkW5<6 za$6E?4LrS~5VtL(9pnZuf98JJ?><7RB6%;}JB&gqAOzVQ`cr}NYZqTxYkoy8lb}N5 z%|*oqvtP&Qj_=)5?Z0pg7}c!F<@;mI4WKs2s>SGRh|ec?ddj*Y9R`48jU6)=-5sS_ zS*z!!oZ^=!T@`9rndRPzVzb%ByV=cQ!?d~LtF9pCZfw8GAsXq>j`?|Dk7uiYA2{KE zF2SE#((Ythb6RiEGnN?t`LG?M(Ze0$yyr6T@kGTHjsnfSuWZHw#MT|n?|cx{zR8jH z-XOLFVNs}fo7F3Nwj_K6Wc+KQaMoh#3{_Mmt3H|{9V<(fH}tf$Ss6VtP%t|paE%bg zh}>@Cearx_^u7vi9BWvbjI4qC(wO@t?XZK$4NI`ZbS+It7pvCUtYeIJ_c`*1C4bn7 zm+71<4h`8;X}{*&B|86@Zc%_5FMlIh$hh(Nwh`CCn77yP7#afR&$;m_jC5w-ABH*D z2G1XS`m#@qy4rCckP4K)h*v{){OKmi4Or_ql~Mi3syMx`bP20q_eJ|*&Q!6!mOD@! zoK#2$)Z9=nbQ}eE0ieQIi%Uhsqf)t7!iJEdm^V~oz7+BLXWjOED}?;M zGrg&yt{a#HktJTC9VTTfAj1UK`Gvg>YR#Psa^$$;-1&ujIZFV>c=Bbw%T4(Xzu4oF z$I1NKsr@;uKkYIegaeE1Qdbz}ym&4Ceo!5+G-<$0t`q+otwxeef3qhboNq&2pPffM z9>IH(L}1e0PG80=KBcHr{v3&;r31%|pb^lzX*`;2tttO4u}~E54kY0wyS@r^Prlyn zyzRgF2L^Zq2c=sBD7PE5=16VZu6vCS#8MxDfu+AJ7OpF&v<@61Sq^fXcZC0hL1=I| zz%vZepLfBcPXXd~aP4P+dM4_!k-CYce6h|0&I=T0-g>11ejm*nDun-Fu0+#w3aB#Q zaTz8w%f7`lJVeF{;m`8mtGNHdX0#oxv9{S|DDn@%JI3F0YGB=dq%C zRW)^+)ISF-Nq#!Q)CYS72g=lx4wh^a8O&m)nqRioPk2u)EJkqnv9IrDq2RXPn;{wV&8fOt;YU*b36|mn9RbM3uXx==q zV71eLu6%&)^9E$Ks)kO0^8;#YURMiP70-16SHuSp^%=}P`7g>1;FhNa1CfAJvNj{UC~6JdGu|j|(E;XC3xyxTHxVumVoTT|6;{+bR@-!Wn(|Rj@+2@v&^SngyWI7RaXX~VL!J^n+1K&ZSfJjpbi#On@^ykQf)IS4(7ctAS+ zqa)-Qt{`PYNRu0RJ@bFEkb3R=F=5o2y;fAlAuq~Aa*1p$hCIOa`PMOWSJ{4T`%43R zCp!axu@PeO<0Oi_)JIhdHg`1)h?{n1``s%z8rMWJ&PoNlfe>T|SP{^H0pNylUlVOv zfF>+d4C+Pl(sX0EsZLXTC0xPw8-~33GQzcAbBBKFYxVo?dx5Oo5~k1D6hj)Ff=*&& z*eS>)w41CGt6DgJ4MsKq!mpqNm`j?By|s1e3Jg!#6+V>TPN^`Cf1+#al$(Bzx4Bm2 zL|Nvg4`>U$r_4}1+f;z6pF#87>uqiNaQ1%S+hyLWXyJMKvE;UU5aes3XoNa35fNdR;1vros0U+yqwQxuZ zo7U+?A{c>&@DN^6y*Br^m!giM=ux747{IMu(QdTFAX;Q2(Nnge^YZ81OqMwSf1%J7V$`F@XW;nH*j!op-}nEB#s5b}{-1&Q z|7}Lj^1sc<|Btk~tQ-vgi&nSz-%9?bI+E|HT6UQZb4ZA@vs{THXnKwTGDHe{h9t>n zKE6Q{U<6>c^vSB->v*!RkzC-Qyw~OC*&d~bIPlw05f<{tEK;Gce^vvlt5#57O)21iAu`AY_#MDhl z+FQqZ&x>IneU}twci8|HrnN;pTld`$(iA|@CCR& zRCPsvWZMq05L2q#4)HV58p%JUAX|V|+Ui}%0@N82#Z^5PVeM$>=`_ZOx6XiI)kjzJ`C0iBa#xzgG!ds7@NaIACf* zR_CT}K_BZ)#@dw0%2c;RV1o}4QD1~inzcmL$=?kXRW@{NN6`sw2FaL?x^vy;txkIzz zF^aH%UNM7awE)c-bVdtFO>{%gE-fhsv)cDUw}k8CX_{iafN@7|l4WTkt&7fu*-5-~ z5WHK8p45wvY#mof5H{__4xKgk{N&%PlgW&^spq*;)u5`Gc-4SwlHwtDdG|5^IX*uTHZGTnn#3X&oCe@wNMl-H(c4h7geIX|@N3`vg|$N^L9G>U*Ycf+ACX zcD+}g6;Tzp8p8ww>KemPL!QB7xCeM{9bF-&w%rK(j_9ecQd_6CH6Dcnh;9@$b#^>r z2I;|eKAKDXvlVmN6!ZHAZxI+g)sKT6iBfc^YO&5;(c}9lg3TH zrER&`gOcG97hdQ7Jp{!JsRN9v3HuMNDfMor2G*CXGxKu$4FFZw#Mr4vMQ*0twsD%D z(o3hwGX4IV`64v=4i$#JBhT7!F>&{Q!tLyF@@ucYo~`7(MbLT5VVQR8O7n!+J2##9 z%Yxs|z#WPAZe)Zy9RO|PSiLSK4#z7qzAn&RNC=`CSq-lS&j4OF7UN&ewCA|SKw>ButJ&xZeF|v(6=7s~hyG;4 z7Ki3*$ikUZee-y2IkhY(&hF5Zz`&@ej9C#~iLGwY(!eq>@}1nEoh(dAOGIX)Y!nWT zYaAK3%KsL{Jg{xT6FC9*D*`$I*wNQg<46Ayg8RKw3DS7XY!pSUm5%<-uHsBfm}bE> zbDw&|nFyY||%V^QY*LfJ$qe)$c&ClY0ieLugFgw* z`?B0Hw=oS{5#7|dwBIqenHBdbr`%jIG%A`+uT5oMX6E@vvysWxzTrT$6Enr{F!*fM z6~|k0tgIE4V<4iNeF29_AT^andp;SADEz}EG#h5j6&bbn=DgW`UcT>NUT~gUAv*p+ zXGyY~Tioaz&wie&jCO#0^q!$)ReHuWPfiFO!vALJ^c!0c16woO+Qb``+nj6ig1=#D zZic(*B|`xcGshxoO64w1Ji$+x3yUS=H36<;TWf2MZEg$EU)b{QIs*FyJCbwUZN)|E zNk*af0Gm}|R! zbys9C9;MxE`s88pxF#jlFu9NfcKUXWCxO*`Q_x9YHgXAc+I)iz)!bpFSreu6Arq!D zMw_TcfWRQh!+-=}+4G05!R+(^loz4G`|Nj9b~PbGGtK)T_idR6`+6@hVBQ!iYI9$; z{@HC~64p*Gn;FRua#-Ni(D@x#MCZU!k#Ev0pQBJfc1;BowQipY0f&BP7774~W5^>j z|DDPaA`&yT7=b%M+DXG}xt$KCI-Jxw$yhUpi2Yedw)%5{>Ox0^GxmYTxnXH8I=5<$ z^^qM@{@Cjv8~VK4hKo?^a4m^f4t3sA{wuRDxa_)Q(1MDDQ7v??TdC(us8VXhTvxop z`wB_$Apqj3A=sS|(i-gzF`2y_^9{qYLuOdN>5m?XMB*JUY=N>*g{*i_TMi@g^&+$v zx^oqaB?{(*5E!PIA`PeV1d2ZX~-?4!kkk ziB8E29Jf?rxy#(ck}27E7u3N=DnvM@=n)Ml!?lGL!vwn?>aYGKeIHXJFScV5>31iP zhgGR}ZJ z20X5V{-PS?0J`CoMx2e;00tk50Jt)Hbj3`e9yeTJiyA5iJVUC^T2btai)h4pFXQ~px=u{ ziv3EXa)7O*r20n{i-gRo#JKpHdws)235*_r3$fL6Y)67un6-IEIYFWhR&BUYqHaWr zOo?udUPVrx%sJbi6l)fjr**n`lH?7VXVA4adOg<;VqX#7&;klDJT#v|>z{-BZj9~a z@|-BoFIPpJGT2Dzg3GYsS>K2Lk;LpWh7|uY zUU)f5XrhG@z$Bo`A{=py20y-d-@Sak&H$O`rznPK^L3aOrRq(?+~mbFxpEo&%C zsf{ru-7ozEixLuc(M)dDZUzz4R@zg+QZ*%$5sgD}^%E%b4EuI_KAehEGW9LOuAH%+ z&sZj`o@P3^7&vKi^)~io5jqxs|4muW$?GW@?QrM+y5{d$Oz<7Q`Lq082QpIAtaf+4 z?+lGzTdC`v^q0l?-LW)m+1Sg9xiQBPl*5w`R6#Cn6Fp2QdE9K3?9X8MbD`-a297>4$r`f%4?oDiH)J)0M*HQPx94zM z{omvlfkngVz(twQjo*hh+f^_wSsTfaeRE&5f9xcH$MD$OCaR&=_oUv)4Y z58I=oYMGGaYv^bCh|L%-XU6%=_TI>a0Po^p!?f}mUl`MQ_v7f}((bbwP@ShyR97@6 z&1NA{>%o*s(HxG&TcB(I-r4n#WO^Y}ywBrnz*%vQAjZ%B?p=*DHeGv>5?#`C3j4eTo+x=WPFm z9#+t;+u@{g)F%j|9y_B^BmveZ49oycV{SNx7=DLE^`fmeCTr&~4IY0w-+|Ucly_2K z;8_RnfthMrn~CK@!4%g-R|EcPtaQICtkudPHmeMR>~r1L=;(;@U0{fBTiDyA`Ep0f z(#SJBpa<(`p~`A@g&&C7@DG8Ya zj=bbbi5;|RTbuJ}^BNY&JwuFK#ut>H%!+Qu4RtGXBZ55ywvob$nLm_BLPTvcYy>WY z=OyCGQ6;s4EHWxMVw0!LWXdyEabdI2W<8noA-Ed6X8z>9$>`Hgyu?V}XWfU91oGK> z8}7qnLa^oD$Mh@T+#|+emd(ztcm9KT1X92(NHv&K1Q=_ML%2^<#@&b@@=K=5HQ_MP zox`%n!EP2yp|rpY8!>^GWBOhEuZN~j_lTd-#wkR9nm+6Iafjk#*W~$Y1QH}d0}Axb zh+;a$G&{+&UIkcrUip3cS2}gX!q%B61IrGuCcWyNzwJ#z0v65JUXyhw$%m)=XGLW( zFvzTAxiH;!IEZtQUhvgjCnF?q5-6`_vB!m$+LXSRm6Yve^xnw@dSBCb6OH-@Hw&z# zX(Yh-d((Qh>{`{I(yY@Zb@3|2i#6)uKpC`MN*Z;3VXQF68DyJBsRiBytmz*>7F!Wcp2x%OFRiKKB z&QqzVUy_O4>LiRA0?re=UXMYv5mZAAi@p#0_DPgSC6}?CVL&A0TEQ9<(zTU6&*g%%E2jS=p zfAJ2O9c~NN=rxnYOXPIDe?wV#ZsHjuYZD+|C%yk{KaGWS+E`0C!5k`m{p?y@*VFC( ztJ~}C@cMC`RXt&AYr88w%j=yV<0LAf!^K64uY*2gRGRW*PkjF_9`GwUgVWm;sY+&{ zF6W$6>DenU^<+h9KLA-43bYn|ESm3PQ)UF1m?N}QW9Y&qFp`zh`40o*Q6lBrI4R$> zk`;fGI$(#kIZmV5m1PtYhjIW3b?QIYjf8OISG}?QX>{rmfVkVOV9!tGYbbdyChkWl zJum~ed@NXDe=IalxUJ|ZLf<*^`<+r1p2AE;>D!ktsG3iM_zcov4ziH?82a$~I#K%G zr@so#21-T>)1lxM2zoF?k{5Gdn^qae?~L-*bRd#^q@^0)rF|O>8){}nU$)g4lM#MHg^Zm0|{9g zpBw|$Q*bD(4+Fv5n-9Z@pBgG^xWZfH21%=vaWk8E!CPVZS;9x{On6s;GQU@YHEQO_ z7m&*hqv&zc{WL%UgiFmoxC`;Br#^%WB$%LSN|S{MMtwp#wk}nX&d5B3@D1R^@J=TJ z=TQcEjRB7WrD@Ou7wQenIZh9hGB(xoIDYGUN{Cq5pERHtM`VIna5qhs*i^g1q)(F> zjJsDjv^MDKyyF^ZD=vut4UgHgy)&zbT=7L#5Cz0--Z5zXNMs@{@i@Q_vatKE_;L-1 zB;qY9!X;Q6=2T9gvod&_ZvQU)k26lC(0|B$u`LbvfB` zY#W_Tk(KA0pybVs&(?RT{a>=yF00oBIzInY9@9c)M2-ir@Ka(Xz(CsyYxxvLDI}XF z#OMjdK&;a=q=FxwO^j8VGRtWV61oEq3H=Y@-(IJPqpn|}IE^3uw*ZY)X;}TZ&~4Ne zcbN_ksa@}}@9cqm(;$;-WZ7jIHNoq=++*)t*cA`X0PPb|L^7M?qjMta4CbUWTs%B4 zye2Y)%j8AY;L1Vee{dk`NKrn(Wqo-PDXM@LoC%He_+`Uo^1#{XMpZaoOUSpQ^czjRe^@q6mWlw+ z6k=3@y9@sOLYaN3W}BRTwPCo$BN@kGJ4}59%X8uxM{;5nZk(5JKbnjg{n5GbVwHQi_&r^aek3!pTn ztU+8Ga&D}dxpaGAQ@VjG6Z(1&J4^xQ-`+;Mda-$y^qO7%0MB!?B^kD?g~DF{r(`pV zS-O#8OBIAB=Jd{Zvd;_h8_}%z2$73omnmI2@ zIV4?Qj80u4A~$RT z6?7w^JT)jLgmpqCQ3~S*>@|IZBJf8moFy=2&F^P%1^@b%tPmqpXFXg5usIb7~gKB`P5Y^WWaC%nY`o6d|uh4T-KMrrT*RrreXn zWw^O>EKrP64giqD)p2IcrGFM(0DNivYe>C1`@CMj4-o2PeP}eeMhh_sdVm(A352`( zI|6RLj8R&v7)@9GOpD?th3o7E@@eKKF-W^LAq6ajgrx(?vY=#P50D}!a5F7mad0w^ zjF5KLfuAah(7xBIU)=0UYCQw{P9?l{X`FxSA>83X^v;|M-3UE-9O4b$yW)`UKni9) zqP~s9M|Xpb)iqJuH!C+MFI8Ud?b|hd*4hbOV`F79+FQ3y=r@l(2+fo?45xkq8e~ngr-YSU5F3rt-XF@Hm1*7`R@4;zan#b|tZ{fnwz1vSdBd>8E zdd43}gg+jwd!r4k*){00iJi4=_R&jHjWH2aaDkh-&pedNZR)8WXSmX5*4F>3lN5N} zE&|R4FxQ-QtL9aGm=!bL$&jtC1%-|b34bR4H4iCLr7#7VOX!NlB4yu^!oKD|k36f1 zN{pd7_I}OouhTY3asP5#XR5oX)}OS+d|-gh!Qhe3Wx`y0#p*C3d5Zr7o^rFDTUs#gTkpL>6|kU^l7h-Lz>Xbx zWBvM%-}?u^|D)Rezbp>_OK~{U|3h*3|7UUdpIza9c~A4NEmX8~HgGn9eLc62dv zmN#(x@25VjtpD3$@c&F4&dkE`KeM|2iNh7K#?X9DsXi1c8-q^>Av?5d2ls|~8G?Zw zwJ98N!AcX@O-+;gha38SoL_gmo<)!%W}|34KN{<-YQ9Z9?A;4=dpNndJp3w2FP<;i z%E&JE>^ri{rD<;AM3e4~6RVDE8u_Lc&|Ch{nOZV4bZysp)Sj#xb5kuhatM4g--+B+YysriOE@;P|{s^W!)Y==}?#J#KR z!izz7SSw9Ly_)*nye^W;bSW=SwzM$n#g3k6H6;{n=h>!(Vl3Ba)&FjEy`l9=>7FeW zd831$=Xy0}-^?{iNGx#zln#^h8U z>DCN~=%yYy&}?emhXMbj!2J0!d#?jlg4Zy(G$_2vJ=dm@lll3?FVlJ@sKjQu#ItRMk?V>d>dUcb-){!vCto`rst>(m~V;YFcNfWBTmkrJtex^}2hRLhG>$ zrZx|b#tiuTs~R&0LDV}w>Yll|Sqsj$7LEl@w_6q$Yo;+_7kibJu+9I(SqpN))&2O zx*lGgdD>tZ{ME!~0hdW!7D#sqSIVPPC0OJ4k=^+bgSxNA_*&~XV(+2z0{m0OR`&6;O@KDb$}y!*b6;^ey_H(lxMv)oTyxbZN0M*mD1G}IL& z5nBFdKz>%jDVf%vQT6YB{^`7DwcA1~4CF+|0n%Q3)=)6%vJ&QbE?;@*HDv(whyBcwA(yj8%U9OIl;`#}e5ofvdJ? z4$L%A>vqgeNgy?U_hoPzZK4$wo1CRE4n_|&U1*B991#QhFY>5P8S|RoDebQW^bLB1 z414Qhitt;al|4;Pp+8o!MF@tHY?I0+Cz=95i1*{r1cyrNAiO$(1H{bO%eQ z==}~Gu3#rkBTf!9Zlfud*27~%rd|2Wd{UEBBWx(mX@=HYWg?XbzJ*yutkZL)fK-^y zw7E4Y=eCrz15qRj3_8Zql%^OSufFPvG1AnSyx$DjTs&q!+3TbBRXpD=R`^T8U+1~8 z&QA>`abc$OZ%?6?#f3F5!5UxEzctw5vNq&HVjpL?z7HkP0pOx|(F3f!@^a~znHeMi z!nFP4BG)ilUIp!%LgATD#$rpQ3$Rplx82H*53KTAR5qSk%zs>09z4VrQwoDyK5Y7- zL*s%8h!Q?F<@HtctzV}LCoXxfr4aAP^;HP41FFr?PRTdgla-)K$Ym1`+e;1c_PUWy zZ->GlW5l~o3%Bogp7TNbtGjg^=J@9?&6sJ2z38lr>H2#I@B!%~0&|__YFcuaE5X^o z-reXi>OaG&c-mgfIQT7bMu2($5nax_Q~U#9kiAc1R(OpXQ|Qc*vcVyUgp3@%l0@XJ zu6=-bCfy{BpPLq?8dPxiaJ*Z@Yl}BXc72AmJ#L55+yes4OtCEVTR?LNGp%p z%kedA)qIoO<34zY&6!l6T zG}cCOLWENIApi_iL|yaWS9rG%QMKUM35z$`G?a@VQej9|2?!Gyrje4Y9NCMtJ^18T z&Sg=Wz+T*S)^aLm{`>qY5mSn^LMUNCOBZRbnvg3fU{#WF#nV&My(C_A876Z>O(A3< zo+TWWR@n(?^|a7lxsx%;UagqO-$YrnGIPotoH3pHCmF?!CVevFR5p@+VPek&iZ9C( z2!Nm+-h}@%LSKGdldw9_@IapIYaBjmXc}zYBa+fIO&=)jXj7Z8vSzJhgAk6gm_jLm z-gDGY!3eg@}ty z;gPJSU$M{BQhI^Ac`3J0{3ow$h_=g7snyI+S=`j;FR1 z`nhd0!41(h zg(O-2#Y>yzn9G_3S@DTyG+%yX_uxpGdEacDdu$Z*Z|wdv37+$0e~vcMv0#vpLe@{y^0{?e zV0sHJoJbPBIcq@e+_+N>G>g*$y))|_5 zT+6^%AK{}-l}jN#rYnkOieMiR!0jh;I*rc`d?2PMCAac zr3kVCBuFp);{-dSSLKwRH*kfI#}YI?4yjoCA%>Uw9#;enOmhw%M*jI77$(wM%d;cb zEsXw|c2LaO>aHYwoTAws?^gD_9icnBfyOl`QiO;V1>DsG=hiAHiWvsAbh}pbZMmQ)8;f~ZNPkw#hv8=WYf=v;uO9lJvLXaRn9;s;Dzsk5+I~xELO6Qy2jTi zup;(CEk$zxtotnI$x`ymc>@?fV@p+ZtP$=Z;bC~+M95}3#Y-VwfWcGL^z!7fugY_z7?^ER`xpImH$Q@Jw*o%}1bSz6vw zM1Hi4Fk${`MgeBePZmTM_Vh?gNCkwyNO>Fw1{M815k#xtl7b>V)*iYb)o7hIDa-{c z>IEXA8%-9KK^}>DG+;M6B(C@P0CwV#9x%WXsX9!dSf&!*SqKR9{z2|segM+m`P96h zNt<&5K(}xQis?Jd8>%F>Sn`02(3?UpBpFD_F9mTZJ0M)UO@o*t*j<~+Up!7V4V(S! zjJeeNyp<-#N#gn122DraZky!pgEgb*A|gcE_N-=L0-v8nqp@hM9~8GrdNEqR)F&rF zTinTgk!;OGxhSMUg27 z;=Rxq#1+x*?C3BenVA8%niE?79;miV#ieqou*^0rVYQavg;7ghg&0*5PCR53lwc8K z2CbBg{Yb1?&Dn6HSJC+c{ziyjkZ%HT2`J|5Cu_rnsCR1yy`Ncy z*MMhj2}_*Y14OE!?8)pZa4H>_%Sa$=PCD7!oOdXNpUI6x}fjSeC zEmhHsJ8q-e|Hj%oM2QkbYno}>wr$(CZQHhWZyGmk+qP}nwozGClkV!*?{)R6L7Yhp zPK;vhwSRmj*k3gE(GMyRGsn|e?SalsV<`=l5^a?mT!xVkvi$raCH44s5UZV{axva| z-F5w8dLTro>Wlm_hp`ScI)pkSF99uQwR16@;c^t3vB6>%&{o?)%sEG*lB+T}Z2UU< zWa1_4V{dO~Pe&saCdoQFojp!F%NHz|wO;tWEBx0tmh z7A1qm2q299Sm*}+3gY3MFZAU{IU;<3;NmJZ7TBQa5J38A{^kPQE)ND=LAH=8>`gWT zPcLyLId7CfM}G6bl_q_<#!4G824 zwa7}nPhrC@1xTo39q?qOa7#pT7H!#kpK>;_LdHe6d_cpvJlw&RZb#SaSZLvBlDv>= z84>u)l}K_PDv~lRwzP_BI{{iz&ne>uDC%KQ#gV!VVZeh5n5bOM(n-J}PHOoe3k`Wm z`7$Gm-`ZuYEO%_;c3A=5=*soIo}LEGx6JsVALa2h;yi|0+O-5O`3&<(@lH5r!K1Gw{KV;R5EeW4Sn2 z)EW-Dg&x?Y9EpSmM8AjJXT|ZrvDh}aKzNOaoP;R<67kMOJs(A>xdRFfW;oR`(pm#b zYqe`vQ}i6Br`1wCLqzW)>2#D=(V_G5qLE8!CCCZ zD>Q=uGKg+&ki3TXE6|&twaE3QFweTx2mxJ_xDWMg+;H=*aQYGdTYq2nLhmz(b`(gk z^JH8GYD%T%Y!aV(DncT~x3D55Jq(D-!-C*W^H5;Qn4aAxb6aI16)3QCFq!44lsQ8+ z)oa{5e8|vO-d_pbU$LMa0!X)N>UAsWDy?q8m@6~_GrGMjSjR~yikf3a1Oaq+g6QCy z1N)n{qA11ovcX}dojs82-3Ps)HKPa!H;odZC9N6~C$rOU?lp>@@Q$0a1;HL%Mi6XO zPiT-_Tgytt+6pWJ5#Vx*T5#@M;nm0Oz31jumsVst9ra;|(Tf6*rgit|U4_k#YZ0u; zmm)ip(WCx`l+@h6WznKM)L-2O0A7%uyWR?sfqq+50A*v^c*l%I+T-qfJ8v?qHIVB5 zrT3*HHbWL3e^O%i$)JvC3MPvEL&%I)s;a|o7}z|L5{@O1f*^Jssaz4%{DyuV+=_xK z;}BVzK)GRp!Sg7}FKHd>q~L&SFY7AaYNL>$yQEY+a~mu*CBw-hSL+>``RvWnqXlvq z5jI}ht*9*(A~tuTf*iAQg+2i$D41hn#B&`X%QdN{y_0TgEkkPFiHaCp4OVvIc#iDb z0wpn>>!Suiip())nN{wzJJe)gq!3=F6h0}9a}mbp!=Bl27Mn3vc#?-LHDfkWzvy;4 z@MP-b;+2@0lcT5a*C{oAxWE6E{Oe^b32xBd!AFeTCM6dtahXFf>z3io(sQFb?-!j| zuIeo_^6^!pV=BJvI2f`y0;1D_`nuax-JSFQ+~;@uHs=1Ua~a>(o5)*bLZ1sWN!pZBxecpLBTp$XMmCGShZLGPZ4y(m+xFIaNjls@u9S- z2N5#YBy07ja7T5Cg%Qd7PbtV2AR)8TjYj5MLW?rd?$MIC;o_B=3Hny0Wmd1kzg_9^CEKr34mI8)ftWyY6Wmt2S5Y>Q1Oa5ON zUQP9she#YcLn+5J;IV;I(9*HI8^Bu8FQ*F(_=vl{N{-)*7Ur~z`si`4g>ml|cK#hiNE)T;jclh5iXKTVB*=6K;_pO=7O zM4%$NB?Ox8YXnj^j`<1j6y|ibN%2v+bj*dFdLNF#WQ6KaSh1DN(oHfjR)>`9A$M(e6= z7fub-@ks+2?#Q`oZ*-j(-74*Xs*OmIuB-jP9jqK`DVACWk@mkO>*9_?ya9hQ#v6Ck z2)jKS2zJHmoLOe7VK4N<H$m%OeoCqG6UwY8V-HH2s4O`rgNGuxq=4L`)9;k_3VMB-? z8u_V}4>Pvwh`;cRWBP80wR5z-wX2_xM@g+xwxwV*`co*z=+)yS*4VXPBOe;S%Ml}T zt}XR^#rci(k^Ghjtzc%Gl?21Ge*yyE*kuVP!5uuyO1YU8p&MgYK8*6Uf1d*c^MmuJ;4pc7xan-ky6G$E zpI)1_jpHf`SRC}-LS>gg*VYW?QAW;B-)~E)Ddz(=-*a=%C|+6>`5b*JKgLXCtxRN~ z6NMIO>_JXr782n}WSBd3dm8V;wdMVLIetCM2nqcP?>Aju9*;VwTXOj#v0)%>Jk<~; zfE`D+heV(VS^iMTN)6fx<8ty=p$RroxH+3<>ZrBYA+Gz){tE~ z;X&D+CHxiV=}gptgo>Y0Esj{<3SkE1r$ZaWLJj=V5=-~(bP_I2bNeg)%qWhsJm9pEu(Umkbu3zRAL|6_p z36^A2B+ryMFr(v4Y2=pzEdw{~#8ZFmicMuW3CNDBzVJJN6FB2kdsqBVKlTDXPt5Bs ztJi?F{S4;HEJKH@l1r;^vHov`r`Ta}*XNWms9|9=@>m2+b)N%WI3?|=vdj4`rnFJy zekzUkY~np|2p&Z^u*!+l9rnf&FeD=80i}^nJCY#(N``k*xWBZGXuJDGnLjTz&gAv1 z!HyFPm>I}!pJcl=q(UO`eC~zamsuHrIduW?%C&|n7L=-n&P98CR>Bm8)BXx4wywd< zjHYMFVa(MbBz#v0_n-3yGSUs@yAVJVCP2%(3tfRi{hEsPs)4L{mTC)FJ9&FsxGA|z zoN}%WrGfdEZx70Re#>ry+f!>*u4Z`)_9;GDXd*J$GR%~c`*nO-j!BG>|M-`*U^^Ni zF`dV`QfTgjhgJb9b3id@Er-m@sw%@S!x$dU&N{39dh68hE3(ZbB1oz3Ohf1! z$s^U0+G4-y@#qjtG7wY~Xah!<>!z{*_}M$Q0)fiGwG zXC=MYH+_bDPkBE_HW_ZMr|IVlDa!C9D%_vDk-VskFy|*a|HELvRPlE z$JK3PNo=i&%IPSzL~l@vMQ(c3+~CQ57Nv_CEtTtwv?Mp>^13Vso_ki>Q6JawOU9%D za!fL#5jSIPHPWHo)5gMqu(HfC0BnE|Cr8U=Ilx}YQ(9Q;Z3orbMy|FRL7xt#fPztq~MzaFEyGi%3dyG#Zq71$|VRFB>|qk!(4{UXoeG&gzn?ts_3M zvINe?H^!eIZtG%*@e?noEy8T&H{_n8WF_~xV*sqq!k$zit=8eR>Hw!#x`oMO;LvGs zZfk{YV1)=XGI3+U_Pv)lPS~hix1eo3VAw=ci9Wi)9d_3o))v)E$d|XT)|N__Q0tGnr74cJq$CwmBSS$k`+`kCZE88MEVB4hs9E_R3g1S!}RZe|e7WQ36znq~Wv!C!D9z{C-9`wX^)D(O`*_(^B&x}?TlilOablfk z-5yDT4yv3PgPU?p0oR%f_x@ZvvnXzMW5YFs3Ev+u_c2NGKEBZz?*_Nqa)8dsz7@M^ zuj=F8%d0iblpVc92&4)epK$?gvOn*y5kOi^MaS@H%0B2`CerJdBS|r{4*t zX6WOkB()*BO=2h<-rV`gt_>!{(WzQ=45QU1l9BNN9(%9nf-9iIca|y!qd*pi4#?rn{JY_Fe7O-Z&1) znmsOJU~~*p_2LPcq=?jJm7VsO&>^MHUCdPL<*i#JEZ)IJdbV{o~kY(K};y=0Q6_T~e)B>5 zun{+O9?tv}NcSad0LtvlP}Zio%56Y>Xp*|sUc?L^jY6A1sX;TTL!vf&Oj% zr7$9+c}MfJPS4v9WH5z*VO|!`A||&Gm#;Q6;UzJAU@;be^?G$6L-y=6*}JQRBGq*= zGCNKE`E92n>&V5Nggw}-E5C6Vge~vmCCd4$&NUDbjxF9hYq~^qYB$_R7`373i@67u zP<~n2jyHH5C7zRz#=t`0s+mY4r!`(xAWAKC=}%G9yww^{{9avS0ir>oWpPT#sXoAv z8y$~PixyVpdygz`1KUNd$EKy_*!|y2p31I?Mk+d2iQ!5*=t|_W3ZCECy=+(;RAyUu z@jSNF7G-%#b{$u2vcJCF^$l!pr0u;N#AcG>qBSbC8NG=}K!@YsV;dvMu}>8&E+ysA zxmwJl+A}yecv+hRmwTy<^1?i1nziK`-zQ4x)fZD80&J9hW^VlOAoAb^Fs05*6mk!w zqnXDg`WB2#2mjJ^-LG2rk$?J12Ds|yqo#fzQSWH}nF(}?U^nf;Z#A3SLhV(|0N(Ov zKE)M;$66|5LhY3>mX3f!1BVO$w8*?wG)5(IE;XQqgKWlh;jT3>CB*58^Br{`GlS$M zSPP?m>zEWHv6R`$QE2zOaMz)>_A^Z&6wB=^*${2?OK=TJobtEPfi|;w>8TQoFP*N!XQoK|Ds*Cb2?#%~{ZHP9|DZ+!|#h~$fba9uL zIhm1)CzKmpe9k4>#2y2-7v|}vBB5$7W_w*t(jsHuIW})Gu^glEKgif3;>sH-6Ug5_ zk0yGCd9~=2AJyz&tVZc|p%(hitpkei&{@^sAD`vFEp>EI%KNCr)51G1Qgu(^ieWEd z15|OUSJ8SN!bzK8gQ$|mhK`EL3w4ACZTb7kyOF_|C!Tx)STd|37aV9Q1KqV9IE;z4 zn?}~3w5XK`j6Y;GsCY^~Gt}5>z6$gY`wvb59Hk#3gnH73B$vp%>D*8Tai%cguPQr< zpNqgPk4nomi;~3K+$IWG9f4}-s;%gPSibLo=YWZiBNKGUoVCBMwUu~08VFRGla@vY ztk^0%=Dc@lGrk5=uca21Z}Mkml;^d?_TWRcK%O^iOay={B&iS%{ae&;W;{nQTMWc| z3$IQhiZ0gz|K9iZL2*Gm#MF~^4%)!FKBj_GEb}=CTC{?*pe`Nx8&NU_QmznbZV*Is z(#){ZcuCs1x@`Df8=1vQY~<4Qa|4aGY=}@+EZQ3|DVNX@alREIZS~VM=pFzBRH?qv z3LQZbqF{-lLIh6=AwzF#QV{wJBET+Bh&W&8%VU&mjdo8j3nLx0y;p}e`kRpswV?w3 z=Gu?rb$9>s)d3GQBY4yrMi0ahO+eg>8=o;!c%H!e{J4e+P_vPme>8)~&$27$lZ2k*}z3caCk&!80M z0-Mj9(2Ai%i}$(CC;-|pZE=ZF)w1lsBeFMLu^y%hO|yE(xQxb#5yCa=VMzNeC*U&Uq8#yueP@!aKPu0Hsdd#?peubiqWzLFfk$;ee4t-o;}x8_esvfVn#H;bdSv^Iq=L4vN8-vt zj&W!TH}Z~Zax{e-inI}lNKFX;qyb7#{z^w{=EHR$*)Oo1-{SK=zApY2R#`nOY7s+s zu#lX#F4tWelO3-Z=Zt{AG})4Q71{x+34H_$aVze#08hhG0S(bLwL5M@ne8jWqTVjZ zq`;b5A|Sc=$Wq*5*_;B|SbGbY`ktDQ!la9OBaUzj%^4{leiKxb*d5^v&7fhg z1y(5sWpf^)`MlIEC`SVkH3*Ha`_kPKKm2>dOqv)~0ouu^O>HG@4N#iHhmr)N*U$gTT=EB931@baCVBO`mjrE9UKnTS1~R9^a_( z?M9|EBwz||e@vNbAID`zAkR zfl7ya-&jXu8?a!U(lw8yuzE~}@~gCc%M!T$lzdKwS66C&6H_b=5v0-YB)$xLy$7AN zI&Q&n&on0eiTz63I0;lxt7}wIIPVyK|5>4t>DXiQ8bD}SK0c=~AH-$eG=)5T75wek zz7b3x0&S2TG*MdKT|YsV0FR#-GQ!*v%>id@sO~&&+eXe{lhOv19T2S$9EEKJI%$gv z&I`vv{C8m3{=;4kr>1B?Bzp;Wrb?1?0mmjkuAwqvt@&%47Ji(x}PC7MuAk>(tDMeZR)i9{z;59U#m4wHx9wiXLXGY#KG3E81JY6w3N4zz6>}c)NS; zS&llYp0Uv2QnU0v;E@aXf13YV?G3GasgVmD+cVneai9OiR-TwJ=EZ?)arON93A*0U zyOcKpU--KLm^S|k(rAL;{)KnL+mqGGwV2R`8C7hFR_| zE6noik7Gg!$Vvgzsx&m1$QC_T==VvtS*B!$#qwuS>){_bkD6W{OBs71X`oHy*|~QG zH!=#(6NXrW!O24CBkG!babre_@V`e0G>W%RxU#~Q9I%u(ES3S+nuQcI>ioxGn7ece zPJw^fU+C&nc1%{85XpcvmRRb=Z5z1VcBtF8v!(a1K^=eUAA5~m&CX6*mgmRwxtWKX zdkaf7AiTLSx!M3C^!uX?n#*785TC^NDBXvniM-|54|`q|ldKqOFPz+MexG~zp7-!7 ze+hmMUa?C$`77ir_L}5 zks+oS#bx9kOo050eZmRClZsw;sudQ*6)RpaZCrFgP`v~O?}(D3a7$5fsQ`zk&V=PVL<6Z8ZddX|uE^{-9ny^;e@Dca*P(xnm&%i298AX8 zvvzA?iu`{>WwSB-FZO%84K6g_8TDJ+OTj9QB%3u+ zMS@6XXD0^9;NcSBOe4Isi1>}+gt^75LVbRcmr!&{xtUIuYLbMH`e&`^l8b@^>$~Hr zyQ8%sDVd>-mXZo)N0&}Lc~QFM7x4ufE>`~QK@k5hgb5o?_8hrAaZ=G_`36tQ<&AcCUqi3_7dwB7-Od)P#~VEL)^nQPteCRX?5jtPb0B@tafuBD6;&E@u_kN? z#h70oym%-t35{Y)zSy!4m13qx8eZ!njf{erYxsIA9_~!CRgV+>Ga%}5Qc#Rsnwap9 z*AiYl=&R*U=fGc&jV`~%spU_T++TOQINE|ZJecc(YRrxwl(%odo(n9lusXi6@OnzV z{P5*d`rOT3@XTkhs~I{HE0`r#E4!T>$7`{Ca;sWBn=>UD#~OUp1mo>*3FxrsTDcDD zvvjHm^d6p3^p(So?e*62RfK3(Q9~t@k#86p`6(Ki$KU2zTJLS!B?TKNi=jp0$Be(; zPCw`SmxMXs2{M60AeGGEgKk0Cnby=v&FuejH_Z7rng6S=c%Ja6uNCA??;$&XVbe$) zE^#yr?!n(!kBpZy$}~Ufj}8BbpAecvH#Hj`oE)KOVU)+XnweCgJ6YSLnXp`=?z>=! zU-OY`a5T0u+wXE#blYK|`Dk%i`c5s5TN|B9+?eKNu=X3I?8ACEIN8fgk#_#pmzS2C zx}!g2or3O|CE+k`ensY9;B7}?jJ73LWAphrgznC!Aw>OvNhuu(h8(j>AG`mNurQ3H z*O!1;rI8wi5i$){4xkz8TIaY;&Wy*9x7{~iErxxP@IoHetI(KAIcBv zq1Kn+5I8n{+06)?+sA3UEW&50+6eATX|P19ypY4u@_?@mx0#oZkq5!|eWO}BxDb%O0jKxb@q@tZ$2FN>=v!Z-}drUS9%$YpU z++@P98FV}#c06m8E$oJF%nnXFd)ZQB99^bp{>{z)8c^c>x|7AoTD-r**OvgN*L-`w z%ELmL1;mBoW2H`0N!7+5>nvDJwMY12fzNZ_L>=hP(2Y?5=3sXEVyVv$ZTzTUlm?6-MV zO3usFq3D)^)QtrM*EuWJz{yER38LQqGb^(EY~0w zHHP^U>ntO>`=WHlGWd(;*6tf%W&UYLmYh@bn?gvjWowQIepSn%hI>w0m3ZHS;aW)j zqH!~@on53^hC41E9D08Y$kE+&XTkf1pcMpSt3>1MBmQ0~?^7NM036uN=^s=9C6I4x zfrNz203gOO=07S}&lNVwM9Nv;MPJMqz_I#>lfW-W*(#XYdq9Rq`9pl^24a`g~wJ*2X6bs7;U`A;l$T$C<%o{oOK1`t&t6P^yz`V*tT7xXkJ@SIAVubygIDG>64=N1mWjN#l(ilUGO zgshuvCYu+SOtMdAXWR3fEKITiA3eq29s~OKl{)tkMT`jyBuZi%tl*(>C>)3BDm54| zv0)pr)yYw;LzyiwUuh$y9hMU|P|XNy^Yw|dn0|KNsOhEy2k(B*XH~dkYHxgq zobeNscn50w^={0*X?OuK&D8AuNZOf>E(E0u-#IpkQF=L)p1bM1uVZkncRmjk*rB43 z|HCrAn0z(1$rxJo_z8V_VR>}HdagF~s_VDpV*|&oJ#N^ZwEKLtuJf08q{8*E*9IwQ zGj@Gk#)V(=BJgPu8*I=grWnc%t}}NT-A}YURKZrM`NlgfEK2V%PXa{~w+AL3T^E?* z2$kc9#q_EA%&gs<6~!S3q6J%Lf!T+NTo%A;=psHQ*t_ zFo*%(1_=08|=(43}H9jsT){UdJgUL2 zT7A-Mpgst?duiHcN`K=#re%w?g9)f{_l+ES3J}~cc2M!*ejLQLwKx8d8Jiv1lcnq4 zS7>B(h%Z8B7rVw>DUSfWcbQ3Qk`@*=MXY~*J4)x^>PEBQ#?jB#tsIo;^!0A9pIN>r zV`%WpL1=CKkZ~XeuE^I}-{On28@9W3PpL9zyOG!XKK@HL?2#&hdMbi zgcnjtk}b>6jVA$4Qri(&Cd8e?krRHhD%|J>Sf4TidJ1j7Sfgp&bMDc&j>$~{bZB)YPiyEkOVa!FnZRU9i;)j;T zW1ISVU}LWS{l(9PrAugw6UA_Joq*k5(b`(gJlcbUlFs>YE4u zeL?S39SDq`fff`8v+cvTD|sy=GIEu^h#CZ0UCz#=U0Vqb6l5#Od(PgAq$2Y7SSU^i zrlJe7&F+t~Tp>B#q}yu^p~JQZ4HH}@L(An^-B@o&C|+Kt%&G2Do)3|=79xbTak*@! z9Nd+)=%6CXM;Mi!0j9x7kON~@JY>=z%W82r03$aew{)Uc5dhSdpR4_1s$8A)rw6@E z4eCO%1r8lTNh2e;VuYrp>m4ZV8SDlGtvCXf^<7${yMNlrJ~DNLXAhigdGAq@d*B57 z77(@_Q?~sy2nwHf85$b}dwqbqerN70(2h9Mc>GDRuYww`cZ%dZ%(3}!Y{@tC{XjyFi? zpH;x*0Ql{%_?Y!t z{CoAJxARYpj&Wr1soIIFDFsJ4rgTv6dZFCK7JqXak|cj=d0Qp|e$|Izhy?5}Y%ta;r+^4U~yc zNiW`@GSv8LWw9otmBq6bRh;?Cg5&X;|SUz4!<~^asls^3S}sabF0;FfyLV zA?VH@bl1z#WJ#n@)uT<|cd+E#mo$?jgGC+%a8-dvIg@h421&6MZ=^5*DS9{u?%Xcb z>>J7F>Ryhd$fk8uskjtP#f1@NFBN-})nr1feSCOSn^2Y5+d9eST+>T;)}*clRPbI#qeM76 zsU%QHK7dp^lDVMphRvb)rf6R@Z&@r6PgFp$emJAJj21=J;HbeG*r8&A%bmPM|7^(@ z>w28qBPHEqc`mVvZs}Z3-fvvYX-AQ7WZ6Ix==5uTXYT~cZu^I!TBcir$5YYrmGN~a zD*Y%Uoz+ZK8wF@t*=DJoW`zo%}fudyb<( z)bKah@GI`ufW0iJnSjK#)AFQ=LA-{cOIcOuOGfq*zx&cLs&N~oX^HQe{R7_5g^oz9 z8}9{q+khNR=Z)T57w48fi!|XG%tuvIn(W) z2hJfzl1L=kS(3IEEXN2lb zk`J7=3#}Q!7{UlM9nd4*B_`TkXbg=HX$ueh^DFqwgcEtIEJ>^yZ z@zC&@Mkr0Ty}}H2u%OuyMV~68y#5YusdFY;PSSzo{j+E@11g0FR!L#63<=ga<{2Hs z%g`sSaxFT{RI50k_-xW?s|>D+Sw3tb#`uyD1~erKhXz3iqdF#(my{R4fs2edrL@b4 zovQH>fHPaE;OF=c@+L2cqIV4x(-@bRv`dS!wfee}OC$VDI8N}9mb{?DgmzXHqhLJi zV5dS}FK?rfnWghmfQdnCbrqCOKA1^y^vo-~ofi6$VA9Y_8GIv#1i zb2ta~yYLf?m=|#(wB^dQb_hWwh6idR39t#igO@QW=wSOE)b|CKdt7syw3U_SW=i7e zdZUaVRHe$uq+Z5x&;0AZIC;)}N_I%~HIQ1JHI0Ph2xI=RmO8Z_S>0y`Z`sUo4E%5d__@R5xu!*DFCC+!{(40 zPhA-#*hACr;E@@g$XUyztri+%UAsNxLkFwu5Ds3hJTSZcqBEZhNgDzwdueA}$es7PA>oN{3)4EWHrtX9D6Qdra$v(;D|`)@K#^NPoyi8$cT*6moN(I&BK|+tc zA&g_zUOw`d*~EN4H1^Bbr;Y^| z&mmfb!8mFJntWRT!B&ae9G`s2o?}LwX-_gPD8GeOhc8vDP%3Kudaux1p!W)xCt!CS zZarxJ#y~Yb8U@@1Z=O)bi_cL;-Jc9jY9nm;Z=$g`B3J=hoTCB$01Zh;JbmQ3Fb9T4 zH6`beBu{n#8KgN-x)2Q16Z7Z`@>>bh-R%b(ZPSfv=S%1m;FNm%D&}J$t76?~R1FOW zgcUCuh*Ns&9xt(NtuX1!xO@}ul$ZsWom`Ht(BCZBty%WlS2&Cy#tVfEd{_{TC(18e z+XB5bxme=~8KA@Vo!$2KVGD*PFl+k;^JQZUp$IPyoA<~OGi*~qEC>l5PLuE~xK=o2 z;!{`aP*Jx*sw-M;(MV-Yl~|Q)j-lzOZQ9)>il#+?G^v-XofSlhF4`C&c>u z=o}y{QP1f5-Y`>q>2N(Yipn5bV23n!K8X5{Bw3b~In%awsf4AfATOYd6220lD|>dm z#1s{G#sz?dOO5(WB}$FjfMrdBTxt{h+y*)~eFdF`5rUvPzJ|oCF~Z7)@;dMufLNFj z{c)n%6Yx{ZPo@LZC$V@YsRG?>d;#vc@~z5Dz!W*`_1W^}s^nT#a0Yp?mfdeH57l+% z5@6aPoA_Q?Hku&bM0LR_tPB9KaPH%XO=x>J0;o}Tc&vsr4MRltL$9ZD>M5&d2}uge zVYL4F6h%r&cP>aCqPt=KQS~!H{o%u8wxt9-Wc{u*NBAg=9RSr< zI&EB`7Q_{3KJ9@=z`-K5t}Yn5BZiv|xY>Hv&i&QsCcR{sx=@ZyVeXs=Vz9oQ_6&s> zFaZ1f5k1@1DMg+UuQ0KbWS(b~gpOh0b*HUsh?30&YpZr%2XrZ_+-aW8G-$lQ&Ytd0 zUe8A_BjN80H^-a0=_V6nldV0XpC6{qOf7Q8X7`=r%35t(D5Qo=2?CHh5RBA}`sHu!svxn={|&KIofgqSLvTUf#&r&6{yr)TzRG z{vDMLtfpR?nf%09S`2DO-3BNuzKzy&Hr(E=FV7&4@n3RQ+ojrRoE$HGp!#;OR#0<` zA+u-oXjJgJvcJKbi(d`F`_!RSpYQDb_zwsBcSpZ<0^5ILUAIF0edCxYMXJ0+2rp0cRW<aizD^{0>c1%=6C>v@lWqz0XdN3jA^uYJoFOjV6{Bv2im3%A z^a-2z<)T%boX(uDgh_QHHkK_}rNXu}UXq7N9+rJmrkRDNw5M~`Y&4@~HvNPj8^5|# zllKHJT4vYVVqc~Xgt6nEXXT-n)c0>ut)(X2N55z5e6>X*vZeH7zK3f)Uen{yw&#lP z^m6ola_1|hNxLLj(~P%&M9jO^$;YaUY!N_8s-zotG-C@&lU#09)`K}?ol?}^(Y`BB zbG)irbUi1J)KNMQjOi=yc-Z|q+Ikl9b}EZcK(1HNS4n=xo9LalZLEKn*{P)7`mYzs zXeX1`4@|YtTy7@Q9v7@(A;1%21epM1J@rc3#&>l@JGHbn{E0VU2^K?hU<63Ko$UR* z4Dt%gQuBM*cIU=Ec++bZl38`WxO?}y))GAl&*)B3E;`;H=@{=)r+{-t{!!pa%z<`| z_$H}$o=C4&xO;6W)j$uVRV`S3X<$5z^jo-BP^X^fMDA-_gNw_qGmOIFjj7q#uKF2h zm!Yh+fbBjOWGR|jO+L~t`$c|@Ei7^QPv-R#|CvkxPrj6!RP1!-k`S$-7;90Nv{Xu` zacSf6kx4<@FRs=8aI5WclPoIuaxiXrd^R@c*DFt@j&+$}cPrb@)7xJ6_Z|RChAZ?R zL&y|X|27cXEu955W-C{f%54n_)}3W}()sh|B)z zO+9BDNie9mt*CWRz`vNxPmy{V^fGc6&erW1Z=l$SG+#{h7*mwa5+AE%6S-XDHC!Z` zN|i2dVjuG<`-3OuX-A>l8%@SVt&__R^4>I1_b9zR7s+W&U3bunpcrE6zS{Ez_hj(^ z!gYYoJE}wsd&=9MvU+JaiP9|*Y2k4#=&KtouHf>KHXh%f;?5s{4hMm_aqbm}9BoPv zuoUmw4HIEo;GD0?CuVv)c+WyraU)#BJ94vLZXg zL;Qp_IDCS0s*F$D#SgzdIlOD1`|=V(VDbyx$zx6J%z^Ew1DR?&PB;JOZPJZc(^f)v3b-V+nMF2IhPY~JJpO(=@Sj18mJAV3V_%}=6|E1 z#2oW$%FI0Oj%;KrkJdu9=O-Xn0rX6%Zs6+W&RU9tCtf$WKZ!fwh_c(5fI}K~t;}tT z(k&i3sz<1e2#ZP(x{ufDKPwzQjA#5;8V zIme@cj^>xt+ht{&2|TGu{!8gk+4(pEusY>|YKzk}C8;VDraHI7&P&)k)fzH~=CZG4 zh7ZTcD&TC!tZg-y87My3wLu5RUQ)i1`@v$l%#NO)q0V=5QU8~(_8{Lp9+b~V)J*Q; zbO}UhV~TJLUNcMnX?+Cwd1?)&otl=$B_G*726kTifkfqZwqpgI(QF^%zQ#pcAEY=q zxf`ALH%Wtax8GO%kT#1B58je`89A;cOoC5v_tLVLIjnM~#}HndeUj&HU#|mYUnR@=-CJ??oaa=RZ$>BRwa@f$dUo!?dHGgEBPlHh z-NtKbDu!}|h?D@v#*C;|8v*QigMhR#7$b$pg1}T`0^_qWZm*)GS}PgDO!!3O>tWOQ z<%y^_dlC}dB;{%9=MBeTxY>z`@ob^;y+C&poT2_?Rf!)g0lHOKZj+0T+)?9`*en7$ z6xj=+NG5Asv)Sio!BZNv+qy)G5sviJ2iuFK=Htov>0m*B?g)w_mGpahh1yFzqo0HL zUeA6u@!5w}?CnQAWfc3z!ZN(-QEVh1Jzx?v1;A{I&%_<_kiPM*l(GpdaV*}jHW}*Xp`H}^2e);)iSA` zt0#Y8kvnCKF+9E&n7d|igJr~hiD;N`c02R>!%_o-Ij32>g?U12ad{}v3?7_F{tneX^{pZog%$MX@BV z8GG{7b-}kmQJ^F4tGbXwxnlSu)&?ES4KM^f&c%}|QWgP&_xXqqNtg8mb2&2`1E^`ar zjBe0<%uD=nAZK0yWkG&xNe3B{ViYjdS3I*ui~$GyQsEN^$7*e*vfT_mK*GA*p9u_5 z%N=&Dpd4|bA+;!@sbL3>_{z(9yx?-aTs}a8B?x;rm|;*!^({U54TPL7^HB#PL83YY zxh>yKV>=&>z*oe=Z2;K3LYYawOq%iVhp>{Ad-7eIOUX~P&bMe8#-x6mzf7bMT{MMpos{FF`+O4-J zcL9u~Y-~7hqP#=L#5V#dkR)>Ynmgn8QLn{uO}!Fd!i$w}EIzG3|Ag4|X7x{mBmj296@-^nsrWV#2O z%Sps*Jb>HFZDwJKzOnKZLhXhd4AV+{gu$TjIA_k>t3~U!N;dVjo#a7@^I`0T6ZI{e zom@qnOtW{)oZ+a?R~Q+85fdp}8Hc6~dong<1O;GJ)uPLRn^(i5I?bpmVaTN<;JaHRFT)8$gZfA#?j0)6J-=tF{V8#YaKB{=(XsY1`t8! zN`Hc*ODFv8vRmOsNh)e>x0|B8(`>pL6SqjebgA`0s?TZ~zzuyKj;j)~14*K+p z>;VGscd|uEp6qOWx#fZT7SE5TH%CuKW#s3p^~Vg&tXZcL)wiCEd$E)bLy2D>^`Qrn zsxjk|{o-o5?Mvm#%z?kx+ttSvRaHQHYXX#AZcJG2V{Z{c`;-clIm zMUn%IZ`&m6`90;+EAZ^Ags6KqRsILju{|T~+HiPI90Pv%ukT8u;t3QFFMJ(%70$~v zK#~dKYHj`+L}9-S(EEQQXSOiG9K+OLfF@N`LznB*Dmj`GO4W^FJ@7H%+pY0n0Gs*GQBj5i~N}21}+# zxc_QT|EY3?iBW;iN{vdYv(WHX8ucBf9|&9M0a5Miu>s5-ZNKaYs zPb9|9tL^j}b z6f^#W%33YgX{(Z~RRt#NxlrImgzlQfbAgcs;Bc8l)nW;fEc~-4QpZK_7vs2zp1ppe z*({&$2JD5GaT%;{&q!tJKcex%^mFg_&<(KcFTP}x0-UdZ4Wf+v09d8#>On_=kTf9# z$YR!^U4|jiVV9tNDk!5W5y*tps_G zOx$Zz&~+@VhY={~{9dx!t;Tu&XBTQm57*lry`Iykz5q>LGy6i%x ziuSXTP5~2wMsiaLgzIVtm;$iFqvj_@AT^$~#vHDNNdED#KwtzR+HCcejbOU7rRc#% zyGSW&&A3;q>n1B-7S{Pw)(7BJ^aLJmH;jqvBE0A|TPsTsLQP2iYNVG)wqfj28JCxp zVO1YW7QA1 zWIs*2J4+~!W5jw3DRCU3y|V(@Xk9q2!V>Om{5M#8C4njL!IaOv=B`7P;GSS%WJcn% z0`9vKz>%L89V!7&j%Ml>hTm5mi#e*(S*PMU&yS0vFS|16(CYc={QmgKs8nvL$$Zw_ z%!Y3^g>J{I_JEsJgctst2pIZs!eJ45k!@owE9!0DIvbfEA8tCUsG5en+5Q@B^pI(5 zpI>wBCQ0}fo*a0y;OTVSKtszpqY2VnoeQP|@?=xc=0Me*``h8k(*W4}(Tt&5hJar7 z@eK55nq3dZ(dp-+M3Y@t4BP{s*SIz3qb&6OueIN)YhD&nR(%00wpRNiNB`|gdwgC; zp&LpdZ7BN7$zMia2Ql=VX;Nud!;76)=^4JM*UF}KyShIyvz6!Tuw$>;Fht{tIV+$B z3w4p~DDBw%l1D9YmV9jZv)i{-m{~qWBuUKAiPnQ`=G@=iip;^cxH;sPwmYGHEy~{1 zpW}QBrYNTsx1}DAc+0L1nK6~fRNHMTlSv;1aNN&a)<;~?RXX~SaEt8nkqg6)N{Tdg z;i0I%Lyh4mHTjeTP5bg}ycShM#8#Qz+~bvndpDiIJdXx3r+7&rUrUZuAViBKT5N56 zBz65=4K9(nT}Cbet5`<-D}XT-Ze_0`o7JL>{3qLzYSC7{H#xwIY79;K7$HgOqv6YJ zNRF^32V)ek$W@d0f1UXbRBk2hc{w37k39{zf$5OOqNL`Cj#uW-ll*~O(AA5z;=9NS zW!+{%8{vq@u~%udK{{RRqUG_Q7*{YfgewQeS2lUL0(MF8Lc_Zwkos z)-WWTq*&lyQ<~s*-Gg5|Mz%4dIHyu3@(!i+3-8coWRs+*^ywmTl=0!tnS6aOmT0WP z;el87ivQj34N@gKVYOEtQIm(AU52Tc*f z&MZb#gFOWyObE67m?+#}z;a~r;I;s!SJBD`2Newnpe+~m%} zuvx$#Ds2WJQ|};~@$Q0O@-;*T!H#ju)t_>pSDwS?lM@dA+&C)kS^dI`txFiO-&L&p z0kkyTN>VyLWdR7lI7fMBU-AtI86j)!BP>52j$n3Qc-o1w5PnTw9wiAs_ zoFQoJ$`%8Juj55Vn1RYm!@g2P7)<{muKVrqWT=sz6}J zS^hy*&4pL^2!t0^49}e-7x?noBER64R;inSlyTNY-k)=lVe+D6PNrJsyV{FA-~y%@ za5BpkziUi6AcpJ>l1t}r^kms7xl-p<7{;cyhWT-HYs{-EUqqL@>C%@8h$K6dc)ocJ zrH42L%z}Fzka0xTR^JxlN`&>kq!Ig93j%@5kRa@SEk>39hGaihwyL=WqsqorkvM+f z?Ryso01Tkn&HD8p=grZ(&^s+Q{Xyf|UP&HAVjx;h}ZYQ}V`N>xmGA4aHw^E>)8P(a9H8oO9 zADMA!f3W}jw)olG=*gI?I^f~IlXsn0-{XJteD8kb@r5&iF~XmIHl>MfXMg5xCq-n` z^5aF>>8Vty>O9&umU6V-gjbe-Y3|>Bo?lJLOq~k5>t#uLo#qZ3344WLVD zN~7<|f-OF*-p9oFEit8mOm1Qfo4)=9*qw6iu5LRoHEZ989_@w+1E)J(N$y^xT9U71 z%ZQOyeMf(;EVrs$E~fgXdS0#on$6q*tYhR$9HCm_3^jHLQ|!JDr8kA;$8l#}_^T-h z=qcB4L!;PTt73MRpw#Wya;8|{3OszHWCBRs1qj*J43;+uT00b@wFH~j#*05k$zcL< zq2OtdOgK%Bun@+Jz<6i)H4Z3_D=jWs4!ut__66$rok`#==qDV-)?dv3`T-G4T#CWz zr1HC#DJ3PrwSArHy`g%Cx6Kx%8l!X-!*UYV-xS805Ne(~DTj$;5OFS2p9s zIi4W>71^^N_Z2=5#_f)D`|dj#jpR!1=to?F*T1~7IB7?gDz=G*uq2`QTg^q0URtm8 z9Sca~Gn=8gngPGyN*Rbk72dEfe8I5I+@-C16iT1l-$_jAr!L|b*?y@SEa1ChCgrnJ zlg#BOCDC$|F32hm5qso=h>P3re(T_LdT+RXASf;-u^Cfc-S}8Y-^(w-np&cG;A%@;PGanBh ztmN}d;AErhH1+NKd%mT-rOfKZ=a$sqQH0+c+=0mKz3!&N4)c*AXYmv5|c;z3bI_5b-eo_`(%e9-=pxAPfI)t2&H9pKj zeC$>YR9RKVjO%x=dW@OL&3w~0KPmq`I#S6Y3nJ^O7HI&)UsHy?zs5fZ9c6T%#f+4O zS@h|1NC~zoyi(gf5{_Z@yv4Bp%tAkR@yG8PmVNf`aa^lzySJ79M5?-!rNTn13lAP+ z25SW=%Ya3Ekq0x>ZZJ#E{mL4#_sDOWDUF10S}SsFl8Q!uhl~Qw<0}Gnp z#5IakCLdJ6FD7ed@QY3LFbW+g%*c5)_*2N)-Jqx3oy4&!0-f{ESoy8fv?7h4G@QRLS2QSdJ}BH3GvvZq)Qr6D?xOkk1*+3 z`AmbsCq2j&VGdkmMB^_!zd+dzd}BJNO-~lZQ$QUj;IdUy3p&<0D|)bj%2h%LC#@DE z#5jBngKU^x#|kg>FCfx7?)bw0t8;K-85As{1l8D(E>X~V;ME|;NfYog;SvW#MvmwB zyu~UzORIe;-vf)7Pe*jKPfN9UOQig+Os}gt5uu;HDOQU;hn7nq$L`g2A-rU z6I$N`U$zc5Td-8qna-@Nz=*D0CN3A>md`>{Fm75Yi@E6)^)~=>k{Wu8&q<%uo61dJ zNIG{Dowi0fzOuk|qh*T}x$H#0ZV=Xf&Z5~!m~8@!x^3=-nm*h#J`}B0sZfy?3j+?D zffNQoz}PAJ+dewoa{MI&UszX5H}zjH2rV8zU&keWt$MS6qFrc~-e}F9CSh5c6NtU| zd4hxW5c*_Kd;7dz&G*M$6hT~Ig|7(ty5r#O4u=T&is60X5W9w?xo{fB+~eX8l^~wB zkN8OhBu>}NoE(!k@w#?l>ITFBJ*O}Mj(w9oOhftN!zpgHa`RZ~C}E42S7i*F*7j*p z1kXuJI`uYIjJ*cK{3-uVQ#a19sq$G{6L08soz~UON zj&&nNNQdpA1CWP@igJ_Oy*Pm&FyJ5>^Y0Efl6C=~3h6SMc#^W6-DXkM5cUYO_A zLZnP`V#O3=i(S*C0{l%v6w#uN5Ae%xFnSuPtd>h*`YkBXQICx#_5MRY(!9}6j3h&& zkj^pu42({S$=0J}Jxp$^J$J$=WdVv!JbA$-S8)SX=q0um;cIzxw4<(y+Ef_A2a{E? zY!n&QG^xksLvIv}^~x5*g1p0JLsqCGV6r4DF72!1f8QibDh4DYoxMkOEmPJb2yMFr z2>JxPYh_(31e@LQ>2i_NPW>A7$Nh0-b@=u*%e*ZmgT|va>vX2YVJBZQ`!X6YLN|Pt zmzv&CJuM&)xxYIz)hTbYu5FQt>pJY5iAi`bma(tPU^aCs_d-wHT3|XEe@uSn)=*|z zDx=wS-4;whV~}!YUx*P;ot5smIJu_J`JA zwhcu9zMlFOj|{Ci1p0?XMC%mVKlYRGmgQU*3+P8I$V7Dr&@D^{ z7$0&xufLpit;ek~Bp22YZh-7pi66#c{(Zy>Ux_@*N|J`#RfS?g7A|diu3f+?G zb~Dazn9=7?blU8S^?Qg$jGj@n2Zs-H@S*t+Y+Z$qcGs+%GC{ z1-lDza7?1_P(&Gpu6iE}w>_(G+&={6xZ5);6<=+_zFUrpQx6&UTlOuuu%KdHPAjr& z#9$y}|A;+R6Sp$&7#%EIng?}TnGe;Qcr1fA@oDc=AS zJr5kk2?v4(!_)^OTFkA07i7bYji}goQ2;x+H0hbr0Gp|SfjQDLJI>Ad)~LlLSkD-Z z5>2dG0gPM4!u4)awxulu5n>M?Afi;~@YxEe#-@=ZOglK5~6 z@0<_6uwVkg3nQ>KhzgAld|xNG9b2fQ>8Aw2GO?S5B?3ggibuxBc;6o0bOC&RqunY< zOrc10kKLBsu-W*kX2+ugdGn{~pcC8gBUm=}05x;$^)uyRQduzw_?j-jFb7eWu>>PW zaf-uM30rMNL_$tRXZpNaw1HA~qW}K%C7D^Ci?S%p7S~E;-Ctt4G#kE`Q%=(*z??!4 zd9a0(pQl3&^JZa18?UVXs<=P6knwpu3Htc?WLGy&JFQgU|GGQuc>h-ipwKyhU%cqy z-^|N@8Uz!c3Ys!2U%K~H!k#u?@<*vO1YQvjFULC{-ZUeO`ipvuKyBLErta+Cm2K8W zSHfv~CY4MT{lgIEqr9(-Oita?$Mozik6HKEb3bO?uy=OVti-$bB6e{M^FJj?+wM)AufVlwKS6P7jYmBw{=;^U z0q~!kRP!{l4=jEa^r?FK#Y^afi%R-;f?Qat1M>*er^z|Whd`TfCAQ`(VZeJ}d)&DQ z@rGGQJr*U8g*o+he>6!{D;k%XDw-3#Y$UlBtE8pNppiqSa`RC|BtNgTwT_$V4}HkX zs8&!X8fXq_8XuVgJ79$Dgu0-Qx^O+z3* zn$0KkC4tcCIjrSdu91o&xIV>-#BCp6#>uQrQKLaG%IHfkqTP9obdC&dAHLBaQnC_1 zo4jeE9Zu|6emGUp#wqHd%~J6qtA1`LNz>}k$1B}Kpy{R?n60Feoy;0BrT>in1?VBK zfZdNEbatRLC(rv)NRNFaC7kBZz8O-LTJ&9?klSqjb?MbN~XB&y(* z0^N3}BC(@+N|EI?B!p#KBO>=Htikr=(ELsqIj9lbpP+$2&N;^&vZnxBw(+^uK1hwRmqq3PmbsZvr^yM@F|C^%C+1U%RjUJtZnBut8>~u_otkiP^;bs|y z*(4kes8NZg;u-HO_ISBdfXv{vdbq3C>tdS@^1YYonGXaAA}U;il7>x!Pn-TMk0Q@4 z3I?)NF>5cjY;O&JjfR%(hI{oeP^zf!b5=X=aMz3mG++|)RHi@w^b;5@2~~2cAE?`LMet{hI?IB~eAkU` zFR1$Zun{rZOc${6Kxo_s7m&-97RQ!D*^u``bZO9Lmz$IAVWDWVLTj=op4FO5D#J&C z)t!tud#r^KblazFk?%QUw)skfUca#EIen%yJaguL zJz86{tCfXjVTZrd_F(W}rb`_=RiaUZyvjYp(>XJ$#qKp&Q7c6~C4LTf6LFR}yT6_u z9(D`^6X9gNEk+3TrINH94k^X6UKRM{Jyg;pY5PnQ)*e8Elz|NBm(r3V{vch?=dV%> zHp&_Tl_Q0W3T)+wTS^qB&yfS*qI^cOCaQ!!&JxwzVNfOb%D--@xZRO9NQk?7PJln+ z#d2_+aE}OS-L=>e+Vnp3KmK@dD|Px}?sTpB+y1!@E-gaGbF{H`Le(r}un{n2RN-j2p@1DF^!i5ZUzRhx9zA7R^&}|4)AB<2uGm0( zi=7hLlJrI>+N8%1BZS1d-EgC41i;3iaX9LwA<{ERDN}Lz`Q)y9QRu3n8KXQgCY?wg z%Y02~+&@)uslJ@Cu9VM9`TX82FNM$G{Z+fD72$I-A{5Q6*&^I8aHPkiTvadTe}CObAols5BZ`o1 za>+#XK+ZJS&vq0lcf5>ic(1pu^*F<(D`JLRI=-TFQfCmIp#abb_QlXTL<3hkwN=RK zqMQ+*x5mHL?#doBPnE)VAgw$?uEtCxMk9{F1F#G6%;9JsQ_dwCJau%7;IzOV=AR0U z3NR9jvzKs;5-^H2cEJ;z(EaEEVZvb=KfooE$8fVVV*PE@MUP3vbh z@@UdSnb4RL`co_;-M9C6K4#JZ_uvQl;JPQQ{~)b?!U1k@-V=vch$8&BN*OIh58W21 zDr)+h$GNgLFBlJ3Z0%62V)qU}f-L1aQL4~jW_o&GH)z6#%(L!vfp;bZ>ywKrGI8Qe z-gW<_Edym;Wc7Eyx7h4Vw#RP0SWP1M6;{cu74$mao9BQecaifFNE=~&R1{~Uof>_` zFqo`0*}zI)XR*cr{n4$&%T}Q=x%^ zsj)4H-~mH)V;oh`{S}n7PzYiBR@>9r@_GDUih%mC)87Ax3;v^vmgRrYMf-oi1^++e z>gNqxIFwbJ?$e{f)4M#w5|I&-;HpDkS+J!$p2IeK{f+E60g-yfDAbh5K+ z)gt1Jp5IBN4oDEQjJz-i8Dqs z(p{$gP8BQihF82NM_^{Z7~?Em@^gN@p6il^DdwTf=DnXyrJOLyrLwpdsYJKUNok{$ z85iNTbll93d`4EqAIVyS<|}7fauijDRT~H>;V%@r_l9;)6)W|*jhh;qkw3+ol`uFL zs4zr;`}QHfXBD@2Jx?ei8dr$2UVQN=afgPs(&^WF0YM?zI`ZO;jMf$0wWCS(J^bAU z$Ujn9_WE3lP3k34+MdGI;MuANgIN=qYMCjUqYDequ(Uhv_RxEcyw85F;oZ$^ zyx4+c!vh?rBrP@&WUa4wHO@FvxB`gx^|qYTa}y#%c|VPiTHps4q5N}uWjPS1GmS?A z_jdlpu4`ew5r&)Z0k1;y6#gn&y^X1TF~w0K2Ve)^YJb_u*M%MK8-hA0M0Z3-H3mB> zKByS>_AbE~Y6^2z6P9TZFFO*U6vIqDfc6JXUE{qzmWM;*LfC&(n_b>_FpfPWu+l`K zi(YK73SvlRtD&ZRK)F~`P{<{Gy5u1~vHX#gjBD9b38gS9enC+HdFOqQhOZcbT5HQ* zf5`~5c1f}x;PD~N+|>BFvVK9mqoFWCMP^b4G!1#mY7*_6og0C7A~uM)_^F^(y-gHN z?wh^0#8JZ^Yitq&r6IZjkOc9scJ^>v+wkhyOG3&|9FFRINjC|^nalIXT0rbd_?5+0 z=@&SnzaxLPnS|_e8^53)2@VNiF+yehrurafFWdN0uPqmb+}v$Gu4gv<%D`KkFLY1yfe|WKh>p2Z7^#2dbt0z5U>>@|$DyB6D1@n9m?}b=_M*bz-i!tO zT8g8c8}ywj5@Ju0bXA5GYy~+Jz~oAhe<&Y#tZu}M9?CP*NhStzGOHUM zL4n}~;je8a6ame%dBtJj8d`+sZfNj$m0fF-QqIJX&`)?d9PEapnRKztuVVY{(djxF^L=-EF6`oJkO$&K(RitN=P_|6IHST| zn!dOVtUOzPb7e8utiqw3%dXOXcI;|c#%pI3>QQJo_Y!oi(8l8D43ye8ipKRdw0oMS7(9S^;KkoDt{d%b|gM2R)H?p@TB!99ikbUd|fHM%4c zw!GF0DP&5yQP5%(rThxOCV^9 zk-3mDKx+>JiGq7prJ>GA)@W$+zoFPDb=K4yrC2}x6$#L}M8tP;bksR(>nN)lsL+Dq zNDIh?PKG=a<&aD{`XQr-4yB%QMUT)mW-YeV_eKqHk~d6smUr2Oc!@*(-|yad?u7d& za^5X;j&@zUpp3g(%Dm{5!6~uulwfmbrt*4W^fXlYk$12%waCSJpdt_4&{$!SF^{+3 zWK?dlnkso1RjNZNrrp0=p%!C{sD}?mEH#{_W_WC!z5dFT?a4phl~A>9dpM{%8HvwZ zzd;)->Hdb3HT9rs>7M3~oTux_`0}-NTQ&5JNf%RaIV`|ecDMDmFFeZ*bljn@c#l5u zW!reET+ZLoShsIv!6QX)Q!i)9=2$|x&~whw0$n^VVe#f04|&ba=K;! zr>?%3O`jv~nLc6gt~5Ih(8)(d*jW24y!CmQ3XMswvcPLFJ`x&5qA~jh>ZJ6~h{cPv zuf|!x+aVd`bX9@zcg;3L1lz#rR7%ndlFTr7D7VXNxAJ@xhjrz)L?dgb7$}wkP|+VUrX;pPJj3cO8rJjU2FV zAOvJs2;2Yk%5C2~B(JA_y(*MNK%eDXX$|DU1n$GiF=Zz#b43CH``|yFLNp$t?Is8b zgSMREO?Nx^cmbxz&TS!ANZnzEmaj}G} zLh2otWsy334igMc|9%I&oqWf5YFD5Nt!@v+r`M6(gk@=J9ZK0nHnex;T`6*;L`#OM zNJ*;ZF^Gv`@%Qev>G2UeM~U&%-L-&NGreRey9bFn@_JpBU@y%h*~&>`etChXqI}C< zFq}u_RVsv(`uUIKVvM%5o>~yCn0DnBJ?VzYm z7n=O>jKxFl#(`14NEKgyei>B^dN7qc=MFggO=6;UpwQ}4Au@nECpaBn@z;wbs%R#| zJ<5T*%b}zS-xoS;Tr?Xeht#QT&ptZ~W0xqt2uSA`!(huLi}ulA7JH-=k-ZrkwoL}R z`@%JzEwt{VMGZsEHIrPk{9{Hm*YZ|fyF_M&SQ%{g$q)5+2|}a%AG0 znk5F!RI)|zWp)Kxx{@-z6&`=@ay7vHT zd{+V6BK9Njk?+(^{IX(b0Oa-rQ^{)k3EwFuHVID%NSyITn%adjPsfl@N4WOS2l_SF zj<|h*5(YOGSPvzy7cY-^Xj&>*A_VuuNvfHxY?)L=K~t2oRYnE0e_jVFcx&;1i3xuK z%{|thRzVbtmF}URI43{;NNl_%iBPJott_!%V|Q*XkI%l@BAKB?F@XEje&B@N1U994 z_n?(ui@MgG))<!1X0PyTQ|B> zZ*wyVO4lr(Mw$dC&QtE)5gG^H{-wnilVHsBbn3=fE*CV>z2U2I>V`|}uj85goV%G! zwK+XO?9TvtBEb8;r|CMAhCFf%CKL5G+J;i_n{&WF7u7MD)%Yt%Mm>(!sLdI(tWwqU zRrwqV*N0Yqr7-^S1t7F9S}jG^SS*5a{@6XySrZw5#`6l;x8b0Qfo9LEG*~p1RT9wj zr3J#{5k<+Vp{2Ls@A3HgTob}(fS=lTP91KE>!Cohp^70Gsv^n1fPk8P)}H3A706M> z0scmT0-S9PHd(Ab>COGtYhm5L5Hhsi*$M>q1G${3GSHEOQKq%@6T$$INcuWq@fUAu z9zpC1xVA1FP%r39P#=qI^dzMoTZft*dYfeeLz_$)YGywQuqM3(+K-;f=!!J9yqBmctioorkdPrdbLUwP7%po z*iJ@cTBeceq$Ew9H&24UrN=`5^(H(2ZWI6At(oP(-+5Cf`#n7K^S10|F>QaaKl>_b zx04lM0<-U+(wNzWWFZ)@wf8jeJwdH$p<)qf|acVzep$hqTP6 zFwQt|JV{{bM5l_C7!e$9-uQD3S7>_|2>*2vrf4y|O|>m#-%S1h{Qz1)(T6xFGzNz^ zy@tD)A?g}PmmnB){xS_46<5+_Lf9WaHZy@fUCB!F)t{1kvO?TNM3mj0`w#%W;nGN_ ze5MW;{}2P)l-j1q+Hfx%8Gy|_DE==mfk@=hu=_9~YVx|MaN82^_+>s1gsVSJ4%eS^ zmdcp3E`dRp>l5w8($4~EgV2IxyhT*!kH5&G4yQ6C|ED**KdqpAWC8z=Zeku*~UXxIthLqW@t~u#!)}w zREnx<)t3rIG=xiYk6iQR{H$8i6>RG8+`^?(Pg!n&%djz{UTMO8@|z| z;ovOx%jp^W#NeQJ$T;jL-U<{&OE^|wPn1*~47YWSD@VBqP;tk~I%{|5xJn{ZX2^Y` z(hrgcHKi1W6S|&JtppJVCj!PiEv`}8C;0br2XRZu!JMe{=b>>9Jb$AO+yoxW>AK1k zoPE3nLIP8#w+^GA}oomI{JYDja~2mbG6mI21LWp4+ZFlD~Zuih21lle*Ax8O)%&K|vxGdWg?XO1m+g{Q_f6b}x z5gEdLP)YiJvr)>YBL6L8tKllY#)<(H6-b0CWAeKqUf@{&bEnhXcFu(YNa$l|xBq19 zQ7SOX3-F{xv=>*F%Q{*`j@jQ4a!^pX#5WseW08fA5;sc*#L!N4vohv93)2Xn{@WKY zzjWM`n=&Rfz(HMW+sZmmqn1ix_b_{^OqGU?d@u=nS@`5X;4FAUKM@E#h1{vxKlYk zcKgFEkb6ah2s|sqaLydf3vKeGv{f9vXH%YAVL5m#brH;k6DNCYCy^sqf37yBzMO#&9O4r95pZZ9p&6-I`x+?Es)w9r@E*6@95^6T6deJDV+bMg%2)5Ok zS5RiWxZUt)H#i@zqq*xnikEQ681HOx?sHy5vzKa0D-?AJF_r#ET+px1AUA=exrI*imYB>*Imcl#? zm}}C_HmK-SHi4y@_%IGU@cxe=)@(jbF&#}L&Y*F(g*M8fRBOpHz z+mJg4GXUYXWxsr$p$p6-%d@~<9eTW9+f2i+3>(stsBOgSsh&K1$;2Rxr=nBPtpTF3 z6{{hK0HcLl_SeEX|DfJe(?BMN_ZxHY8$_aJJ!H+g@_ffJqsoNA3kK7Z(G=K5Q-BAa z-mB@w8_>chHFNfABK*$^jGcW+^J0*Wnj~Hj8sl`L3+7KWptFw*!j0aNkq7=O%m zPRDE8D4PQgaSL#@Eg4=gaKnNqGTsm^`L~=XQ@Yq&6J7dAs>vv#!O@5ZqI(A6FOf1m zIMn*Eg6i;pSbzTkP~v*7wyohiKkE}X-PE^>;Lk%+0MHQZ3=Lco2Gn#Ras{S0Po4MH zdshnd$Ag{LzWIb!A8AK8tFbJYD?_z?Yt=YSXgTwV7G{VK^7F0T? zyN-9XR}*Ty}q~ek_q*T&)Yh^4SG9UN7K>++wmve1*y^s(e)3(clgWc z0SPhFh&^20cVNQjyQ!S9>h1?>@WYIj6yNB@?gHL?M;(7f7Is5_nY8!Ah-Ffe)pEsa zd9X_M`~G&nqd(b{nYxSZj?Zz>+S0_hmRAhld-|btFfc6h7q0F$QxCTNThSF`+U3<< zt~*e4dXNV)G86AkGsL@8L*t&ua*L$dAnJtP;=r>N@$>v}Gn83iKX?qH<4>Ak$%H?- zTls8CS!sxp%p>m~i+bXSpcvu)?OXSW7U+68R=fE3)L0-%f#n1EY(rCil4OIK*p!oj zrc}YQ&BjUGXeZ-tIoo9X-;{rv>6%>LDUcnur1^F5)7ypLFU82@%nzj3XkSqgl=3O6 zcZ>k;S&pDba63*;rcvu!PN-X{Kp(AYth`u(^%P&2w;F8U8$s*zN(7r(BHES^o4xZR z?GXA|fK)JnCkFWe7E(k??az)(A%0{yyTmq zg%Vn-67l_X&W`*Yn4Fnthtn*!1^9rrfclhrR$OdhD@28Jr35;h>xTir8-%O(#}K;V zaS=DGIy3Pb2MD7Kxb4re^l8_D0g3Xw#(DvK4SvIsS5#-nNtiR24mrLiQwQ)|QdXL3 zNI%+nbK1W4PqKa?830!7?9TraKwdG1|8w6D2Rq|`1t`_(n~s}*5q(zGr;6g42)6_~QB)-hSE^_i)z+O8V{*VH zf+b8v{TpPsCsxfpKbX+to7-IVA?z6z7gra{=ugDS*)N`+Ok6#9RU^2#yVCV4i;~`X z6e}`!@naG>B$-(IlXJrCFp7RdDUlXHWVz`eU7O&@bKyC-#;5!k?w^%s(!>ERsi%Y0W6Rv`|3$>apR@ zb9~BHJjKD(pQBc~FOJ1g-T|^&(rqjFaD#-jW_Ykt?yTR|Xl-mg1WWRWR(uDdX!Vr) zQ+g%yB<+WwYjBiy*WlEu-(#NCV_L)~yP4scCL|`-rR-(Nk+8SMZ?1JID+!g)3Z^K( z7v6fUwuP^SM1M1X9g`{MdaIYcD~G}rt=HHViaKC%WD=7(JO#O*-~YWdqi8SdSch{+ z0GjqeJ>6J#~i8k5d!-N{!XB-nN!ITzp zO3Yd$WI>Rh*j^Si9z-v;c&z=g0`OIW4*4d?$+-926%SC6?n}BG4!bR$aza3J%KlIW zKsK_B&@6wNRo^E+Xd!YrqP`^>m~y75xT~dd2c_7R=T?IRQCxgMH?muiwQenb9Z>Qn|4NMnkt8s8>v+w47O; zSyYF#@CH$mXc?bG1IR^6)gyLG{aoFxyK-X>;Ju}W8aRl3Nsr6m4%EV9g#>Tk%${#LC#L#dBHf5oI`Q|sJ}jvgJ=%}cii`)eSPBf#I8c>o!+9I!oFXbep>)Pa7RDL*Dzp=;NNK_l^I~oBh#C<1pkb&F7 zo#8Cw;5J2EwfO}pVi&7uOsnl+Q3b2Jg0MM|kY=u+ai;+esygU?U~u-CY*PWej+btZ zvhEnCpmdut&*8dTX}N7rS0Ef&1Tp1E8^0e@D+h?A^UUx-gIYidtpwNM#7`aD@QWgh zK$t)ad<{E63m%whqAy-&ySZl|PgQeNY9VPFhF|{=bMLe)3J_)4ZriqP+qP}n=GnGw z+cwU&ZQHidr~7u?sE(+psE2;&kI0N%Yvvpy5YV171Q|dGf&xh-&B)wn|HtkE`A~yQ z&_G0we!4x)Y|fCbaGsdh`c`&LP%{>!#Xt72N@+By z*~#;D`AP{lXRCa1F=_qyS*7IS>dFYp`q8uUcluU#2?{WDV2FOvlW{(dqfSZXJ#m3r z3IL7ko1#AuNnnqWs?S|p$7f&|T<6L$0j`_nbFg`5>S>dnMY=Xv=zg-Yz^c)=V))J>&JtTr1C~xFsV()MGpF^w zUxL+Lu3d8{)iVF!ZL`@2O6w@KE%%Aj~c|xXJ}&rrSpAaS1pm;ONW11<@Tk#tF|SD}vV;FHcGRRnB50ceTc!J$UL6 z>2C;qjIlDV{HT>YQUQLs?|2Z_z=dqXO7zNdwS9ookEJ?V_?d=6gCu2T&J`3Wlq4Oj zBW5tP8(KP(t+TX7Vu>Fh=Rwi9AMAJ!-&_Te=mxfWGZosc>5>YcrmMVB)FGoiizG&4 zZDHhLWO&kxJ&+`|(4^h{+!4D3I&-!=0A~XbLE5d*oAyOwJi)k>L|9`W$tsctzu+>^ z?VYL_fvgqys`^9e1wjH;rQRmy*gm2%&A+KI_BBd!q6LV)CA_?oX$NLD4Ut!s>2h(&025*VItW(Un4RK9>oowWxis zN(11~l;Q91>%TQ3JKD;mR(?dHNARs4a0^KMO&+G!x9f(Vdy0SP9A2{y+!{uOq50vA zq^aL1WoKVZLi=(9_JZT?uO4WpDr?Q5SAq<fyaix1a52J)pwV8ADN+f$KY zL6+#J2k98TbX$Q}+!p|w(L>;$R=B@9ZmZ8!FH8F5{OV|{9E}d7U!B(b@=VnS zBr$iVXcRT@&S#Mv+O&%|g1k5q?UgK7!edlO#H@iW0@qOPnDHdCBSA9hx5HZR>jA!4 zS&5A=J61CsX(yn^75l3XT4Y62%p|9n%A0!@?NC=kWV-ltgSFtgLZ8xLr=|Gfz;Q9= zmkOV&ifwg-%wc*`lyj<)LR>DhYc}|EGio8N2T)%`;t$qf!1nc>xh)y>`OyWt#*6kU@BBs z6W%{Zk}C=8)Dar7UKR@6FS22oV^-|JTM`3b|Bg|+JqvtO&(5_a;!Zo{E~OArpl+I(f*2Dl57SZY>(p#C;p z;ICEY1tm|pXsR6-aE;|~Nz}vfgiARqgOf;f715EO#cC4I2`>Me+!O5CwYjlN@K#VA zc@2H_VBW+u(X!upyfr#SmehJu;ZSs#5HyAkMWigrwk8OZ1`2kRCXw7I7a^G*Pxop! zBKd5)D`TKgj-UTn9o`+-L2?$G+~6^VC#R^}fOCZq*)Hu|l`hb4<(_ z%Gmdw>d3A~CDM0A%9t{A*azD~ZPC-%55et(3YV16`Q2LePjKZHrz9~-FsK81-dlS8 zHOx|9Fs?XaT?6LpVx8T;TrIRO&u!;#yW!79{!2i60HdvWQ@PW$+aBU9B_Wx1PlAnK zc@{|RB_0Y;Pd>cHe4lAYl-b!x`{jGo{H40vH4bbm@K$selR=8MGe=B%8Lyveb`FhE z3Ei>_wT-Wk^_p%$RJY%T-mUzg2L=}-b*5t2qOll69IV&)6F?eIJR|I~%-nZmKrIOHdPCqE#qq}EGR@~tO#X#2z-dz&-qguwqSKNkggRgjCBunQtP2B- zT%r>IkPC3*`;M~=2Jo~CC6TAOeejoi``qQMmuD{lkKgU>UWDFinI2&ZYYU2e#303! zMwXnm-|jWBhCHm+$5O`tyI^qpRj}60wMeNKd!EX zotP@ru4yOe4m;!V#yG^GNY4Jl@07Z1+~Ejf&!_qmssHHMoKX@I=_q6U&b^s0#*hTq z7@_xmG|K|eB)mu!XtsWyo!fHNg`E=frLtU6Lgv+n$Ma5=d9Jb-q8i`a=Dfk7tsoTH zmAhJIIIE>+1r*PemCrhIi$Cwkq%j)h-x||_Q{-k*B!iKwNFX{)dIJ^(YZ+~E{D}&@Hu(nRSv_s z`h)3qOZQngGk|-t3oi@KyG{RK!qp3@mf?PCV8tbP|iFJxbw?V z!1X_|)-qIy4jif=v+lsnmlj67IfZ>LZIp^oMody~ov%;zEcn$eSjVA;i=_euR$qAD zJ&+{uyPg1C^Qv-^R6g&;o_Zk-W$ey=xhzf5lITN)PR|v!=cS+-LL0cf7a1-ve({UC z30$qV4UNyNqbop1?*WE_Qa8moHY#y2U_w zx^~xYqeu63S@|kQnhbzxhmf?a22X-yaLCJiq9l;hMdNSwJeU;~clt3J%6QKEQZO(Q zfdxT9U;9E1c=gf|1h_ER(qv`aRE{P9m16*RvH&peTm_1;l&_^Nc)y%~R?J9`&G#es z9@&OVBQ4X}Wbcz`@)c+HmRGNX=GiQE9?;TxsraIGQIZ8zB{1)`Q_CI4GV!!RU4plW(()ndntvrOF@}jj`-OZXPy$w z$1xiedYYtyBU{K#Rb1a>G_%jf;&FKCl?5>!9*EFcWIJ6r$6OwB6vU9yiO-LIUn6i+ z8ExLGV#37Nb+Cn5|0vj{`v8FPUlZzmA;Soo)A;F(m!-j)mB;C#XPHfdHa>y5n}V)- z$Dc>hzS|xvY1SoWEObk=blyMw;>li9X{|Ae8%v0w;8DWTKNCF0(DAqANLVAVw_T_vdgTijMqn@D zbBSf0$##foT^Kmejej{|)aKc6u}?qaZk8)D^xM0FyGjmqoH-4o0%Cg_Q#~q`LW8NA zCLJMQvfw$RB`HN`isRLs4Cwflpx6v|U9sA`id}6``OAdP^)y$kQ4&yW5f{zF%R>qi z4r$DQFfl(P2h*^lK>K%nRcL74Fi;;N4!Da;LfPowh>eb6luk91sIb9DM3U@EzYS1o z)|oK9uehUUWC7t}212g;sAf3uGjKneFKQUuD7v1^whh;yX*5$=-imEjDMcVdh_|O@ zw1M@WPh4=$MJS8g_8T?Uf$#@0fktRNuHIIn=nw5@nw<&lkt6N|cMs7vOaRn+4_(|{ zlr!W}Y%wKU*EXwgqxX0`$a=-9sB-H3!ae*-1L?eCQ0v){9P zyFS&QNxEP?!IWxRwPmtI(nz;F?LP$ zMV|$JEz{bNBfq#l0u`V#^vInz;X{Sh0wO)M>A_gw5nSTI8{cMEc2p1XvAppyPOb^d z)OAEAnRV_qedhUvQCI{>m5;xGh!l+WMBtde@xsFnulOK0P#9mA>VQMqo?sFS!+$Ud zvH{iGW-1PEn}JQ`&P1?727gOWx<&<2LTyE@T7ie*crz!#R|qJ7z{avQ&BZi2tJsLN zVIf$%jFyMW$FWI|1*&H_=0?TRSz_rnusk&S0it_!|Mv zJqb1;$LN99yb){)*iFytdcm?BgoxzZA~boFgU`4%deMM%yEh?3h%K~2xa}n81~%uA zWv}!>fwG8Gp!d)?=7wtN)`V^RHBO2!dE4Q1_J7)ArMs~@B3h7aF+#O_F6`Xb;!9B} z+au~}=Vz7bj%lI7ZcsK10f~+KAPW*QM5sL{Nw8cNsb&#;+~oUdt;KL$8(+hgzfaN2*-%@ElV8{N9&$vA4Ws7nwHns zQm|5+DZ(gYoKF3Gkm-Eo)A-(`t!169{V@W?DvoCOF^=ctS5$VFtg-tu7wb;LJjxh- z)MnJX5`y7=;w2}K%?9K08!_4$=)n(S=o>6@hbD?O``M{N5%`q&1GQu>A_A{Pzm@h%NGO%sv^t?&7!b(;=|hG#r2y{KpA zd!t`l)W)|Lc;qx?Z<*ch6;gwd)+B{%Xw|x4t*ch2^>21F?R$TxzupdCU+w*Rn2#sE zo)%}_emsLH_aD>b3wu@5 zKhEK+kz+WG*{AS)IU6~R=mb7J5%+&L$y@FtP8LbbS7@*K{$Mmop7j@;eP7;jSH8(^zO}wiCO`Ay6V$o>m4MY_^y_AvHdjI$$9ftXSvk1Ndv!`)_grl z@Fq5E4Z_XOKDRg%$`UfzyBf2`REr1nKd?7BMZPZ|z(N5e(H1JnOXmIk4Us!id`673 za=8SFtHZgRek#d(npO9XgJ2HM1K^gtG%aN+VAayA`aG9fD$` zG>>pn!vuN88jQzEa)8|GuJWmGEfmiqRKyh;o@;kzE#ldE^uev^f=ceKnt=s&b5ZZ!NwlcuwhA%WhI$nl19`%;l%m_7v} znvWtxp&U)fAD^|ibya-}syQ@eUL;Z0(>k-cTrV6Nn|{@J{CfS|T)b$E?hl6d?-SP6 z^JI(?!pEOy7-A1JBFAOQ!9AV{M&{cQ1~Jqw%akISB8rHRla6P?wr{)`WC}&DBGrQo zF(n%|^egM-{PlaKAG>EC&&n3T%eEnkoRWG>5 z1y@W@S}_^OP8x7DmfzHZ`C)#yB}bdc?M6v5miTErNKwADAYJpct?p699hyH;Kl56} z@}8T?Y?>i_5EiPV_L`p>XN?9NiJxC>h)`}sptnA6LPBt2g(|5wPuv7 z3|4u+f&)+b%eI_?Bksha7G(u-ywoJJeMtr^$A@#as-i<4WLRrYGCBWm(G)8+A(YTG zf6toj8~~={tcf7zie@_1p9yr;A4mqpBRfF>y4oykfbQ}AAd?V9nmt6A4FX9{UFbuT ztlY80Ex#ley&wa_sn^FT8Cs^FeIfc{<-^b7z1Td2Za*DWDDjPYbH0#0lf`!xOR$2_ zG4#cQ4Wo>E!F;D3a&b(c&VP!W5~Xv6*R2R|6;jA!iDq)b%Ro?_z8AQ9@Y>Iy?AckU zF8%=<{0w79y{tC|{-u{G4dTmJz}Ulaj4H-@Q<2B2X|Io#qg)czgKw`MULS9 z`;&mDF+9HULs2<6=fp}m6#N=z&gS{>1MD+2p@OrYHcc~BOgK-tUB~1~> zCm{a%DIh*RYWGcRP5ERb@DO7%bhfPzS zVhxmh!KqgG$P3m^G(gBD8vG4?6w*{Ov`q6^&3$db+G4>~E(}(qz_5TB5vLGG(+(xW zqgSEj-yI12)I@0Ydy3(q#yD5Kt}=O5Pad&0qAxd;uU+E~VQR||R*@17ah9TRv&&--5IIOMiy(@f%W4K& zFQx2*NU5i(8OC-4vnRq51&a0f#iL@%w3+87Xn1h4F6pXkW$KS*)ac@pJOptD0r8ZO zGK`sumixU5I2o}C5Ru{>mdmdE@PaD)lm<-HgV1Q0XS25LURD-)#J+-|45}~6&vff2OvpHmHyRR=x1*$x*H|_ES z*}uA3e#{DNmFQdPv^nowzSooc3bDU5)UlUv0;q=~RxNTAt z&OSm#1dE|OLYBD|4^?70`YkET5wf38lE-cWC}JYQ+gM(+#Mf6`VnX+4%hT1LG?eYM znWIa={_f|uE&UpPLun%l>bk5>{do*+K`g@MfoUdd4rFpaErQ*DI4O!06aEkt?-)tl zVS!$q{T!qS$+u206y&XdoUJ)5Q6@ueLE31y7@!+mo}sGLUhK-yCz4JL^1)lTDUzeC z(9+_uUn|KhAnH9(cg~W;V8sypHj$m=Jk7?oEpi()*{KJ7)NRq4-?@PXnxxTDOBIdx zNhnsvRX!uIOii-qg~Ar>Y6M9v_n|J@pPt&5;c->g#8 zS)&Ugo(wdaf^kEU3!PL&%?}lIn)HuvCP_Wd18xqmyiESG2}yMit>kquDW9Mvd%p^W zP7D;lp-eTAd``neOP7|&TEG|=qL*xG#uBIGdH)WOUYD9rSfr-nU)i3zofH$=)^Dwu1p%_{|qMSuO8zakgcY;kJuXgwa; zFgrh3Vw2;QK=o9K^@%x9@9Iq>MM$L+_U>$j>bTBMkoc>$D&d-~1C~>7URNpp8Nr<7 zDe)Z9{4S)MeqHRr?QuDe^|25Rp6rObem{>nREU6kC=ojn4p-Bvmx~*b^WApv{`lQg zv}mjtj!q93x7;;Og6N-mDGPvgASldicriu{TCK3c(u5sFZKROYo53MaWI3)RD^`D= z(TZLhJH5Q()TeoZ*^9W+XrhtS-B?1Y7Of70SLKp7S#rh*dU+oC(T5b3jFEX~ys*KS z$}n}ko8F^`O&VSk^e41!8CTF=mOIt$;p0jKg~U^Z}NM z@~E9t9jc~cTXEjWEHW*rC!Fd`O7ddW8M#qe7!ZQU*j%-=!j{+))AX31EdeRy*`m=p zB&qdRbu~CR=woD_)h21vW7^HWRmSln{=W2HnD+O=n%r!C7%UQV_?Rt{GEa=r5))PO zL~$wus32gYOt7%>bHoxK0^EE@0IJ+E6w#a{1)Iw}Ag|NleEU!)8N=ldIBE{_CSjd( zuKJ~Ayt#aV_D!W|pG5SPLYfl4Mc@fd2jQ{|Tg_&rkd3tbolcj-_*QKs6RBv95nbET z1%$Gf#E9BVpk6(+iBuh~A>^V}KiZ%E@nM-<0;9#LEHt}8K)0J{zqOSPiUBNWXiTyN3j~Qo?+}yfc!2l$7!ANV>%pmx{NMvu7EFZh^m=`YfGOI0Ih=6 zGZbge4=XZaZe1lKEWZgxtJ<)t+@H4aTDzdwCIlP>zVJ+HLrh=}XA(G5VEev2vy+kq zz=vdPCc%vlnMR~?(<@g(Qftnd=2?6LW_O7yZ>^c{+vayX=*>tRD#cZ()ag|W=n*&s z*XezjPwm7YsQBL}9E41JQf}V{PE&>Q^ZD#IYE@2Sf93i5k|Mvb^gfmGbkyp~o70#A|tT6pl6${HmU|}=b z%5hU$nc7PVBe}ppu6yr8P1Y>F(0PE?IEls-JRA{Kp!S>;KyYG?aa?zk0eHRylRPm4 zdL+W!{NBxRf&rhntRy6QHNgk7Uwm!*)5{Wx{m%42Jr1J84Pi{Yu8-ddN8kno!R%Z` zmnojM-HVWgWREb>IshAE5Y5T<^fj+Gf!h}#EPqa5h`PIjleJV-QL0}yx1E(CP#LYV zn*?sRpuH(X#qrhpv*~AAjjc1Ut66lcG9dW)$w8^af$tu(%vnJ4wh7T~`n#Wr{@U_i zwF5@;Hz3hcY+m69_k63RkOB3EmEMEXI+UH5MH1&Wr6;gcNb(ht97g`S;|9>4A(kyE ztQ!pI4en(5I@kKp!ADC|orGHNc5Qq`8TQ{gBQ}&H=Kj7Mj zV2f4K@!IA#*6!VuhQ38i_abg$At~*K5Yo^mRkqUy+2TzYz)^Xo94(KS)fYNl_ZUU} zn&wXpjbBouyK!c%A&)hJ!qXYvzgy0<6Ha;0^c90_md z^E1pz16bN{iV3&UIn=d==DZz=rpkzO@D+-1g1y%u+||CmQ$|`54Dg5c6`1F9VPPRc zsL-ZIGVWcGY~h|g@}|kJ*EGJ1H6eJG&-{gZVtleT6d-)In`Yf_1Osg*%aJMbohJWQ zk?>ow=gT*tLXrBYa2+=z>RVxfc1Ya@h$P>4EOMi-N^<90vYbBkk;=1qLtc__G2IQr zTCOBnn)Zy}z@OT|PQ|=YiirNjgcaB{T&$_L3Q80|CzqaBTy|HYEfYWZ@!{vc>~VLx zt1|?)p4URInS&`lQaUc(K4hh&g*$8R1y%2m907dk_KPDyYhT?P=+^t4=Wa)8*kogv zC_O%~u|MwYJ;&JHLg`??om^pHBB;7BoL}n$VWYjdSQA+UV^?uPA|t~fEwrGF`Mn*6 z+3$whHj8Q~d*z?`1E*((RtUx+D0mEP3YmnSz`4f3L8W|Y>rl*_5X2-3P+Yp`e_Nly(P3{tSdlfMEasL;_m{yo9ax~1H0ere zEM--EGu#APwlTe?6ZvFLG)gGfoPvki#7;{9b7^Cu6R#vxB{N3ISBpl;GILk{U!LwS z?a9^Q`;Th9x=snVyycl)x+qGZnlG1O?x1k7bv1@0`XQmAuo|KEN@4OhYhUpdpTdu0 zutPj=^5qOT9?8WCDJ1*nCaCyJUMvH${Gv-cg^; zm|9S5>!?+XN|WuM6IjVoJ}GmomN|&^I@+yX@ez{AIB>}#CS8X*#>fR_`=RK2mCPY8 z662huqcv|uBI6U&Q4)->)r9wXZB|QucH+&>{YWljD4u)ty7AUTXmMI4A!qf%a>D0i zYPlbnS!>8_N$c%|4>^)D0-y!agoX8#CTM69bv|i~1IXBDhI`=O7_l7HT))eZ;HBe` z4qL*_8^0s+3)d8jM-;hOOvP+>(D;KQiZnJ0^GyYSKhewN@ic=5QI^6(I^%N#`Y6Y9 z&S)o>d>Pqk!e(5^F=nb&h^xt}J9@J4Atzl0_p-N)&XU7Bl6(M_N5$mG!=OSSV7Ka} zl*LSyoV2J>MJ%wtJ>p`3(oGt?5t2DUN>)!@V<`7-SDvp0rUs_GaBu&ZQ5GNwJT7?eyT4hYg>fWZ=cbKrJvs{e|?aOQcIjW#ycm=8bjThgKg-MtyN{QbUKH)tiiW8qU%@2uizHcCNi-( ztWGjW**bnLCt*tBHt8{w?&D;zxUIu7vb7XI7ChMoM*n(Y6U~fw44E2`N>AmXNA}KT z{=$Ex7B7wQWJfKou)5zFsK2ChIrX}}X3+LN)PB*p5ry`@a$;67>6 zeXLKU|907cItLgJIPQvKfZKtD=8OhO@c;{V%L z_l`kG`WXbUL<k)*_9Gryh4`xe?HE~Z;izU*H zkdf6XN2%p2g4_L)l&c9H9;bbPfZsk1lY(MYi|x7<5O`hSLnOnz7b5W*dt(P8Av@BH zSSnc+6R!`)P8^3C;H*B4?24zP^*W;0&&Af)-BZl_d0AQAjJ{s_#MjqjQ`GtTv#Zs} z{)a_bb-Efy!S0CX3{8)QHcxw){??%Ujo~fc z0yzH$a9md2!pVTSS-`B?_&Ju@%k%xX7nfLYVZ;zs^L|7wc%G7Q5+1hWu2X_sFlN0% zIm8o6tS|g`2I6i83QESAH!L`r!JfGZpUE+2Q<12`(PR&2s5nfALosvcH-g+?P1SUS zbv)VW2k=z96O|sxS*sa!YE?wx1=o7=aZw``eQUPnwXPyA5t8CRNvz5Jtb$>whk{%l z(FN|>$NhAMTaXtIw0JfJAoA7*W%Y@)+!i##Bhzh|Hh*~mRsfC7 zd4~=-3(!Kl%W;*@HmgSIP47F>T&TYbyHMMo%V#?P-#AplZ9!9_SUGV$+FM43=#fIC zSTzU82F$$Ds&mFS#ME;1 z^bpgM$05TR)N6jc@v9e>FN9+TD_db=Zs9Mrr$(yrs(-kkJ7(aVfi{t|o=xE|R0@=fAB=;svpBRQ;mN*j@3eU1xbN)8pSPA2N(2;O`X1^x z24Thtcp&Z*=d=96SQ=tw-m_C3&?pe9P`*H@vrZ3B0FPO<$+YPG`_ny!EbOqV$ z(xjavS^C~9o@@T`sN!-c=-fh=Q3Phcx^PsZURff!#>~l=*dj-_ktYke~(ej ze(869)N2}pk-oNv@e$iC=7n^{_0t5$s56iuLTy2hprVaMX{OB&my~`bkI)wQ8e)q@ zq`S|eIVmwu<0Jue^G7i+E_@Cp5IFHUyMl4h8YuNfeKL8L8=q&U3684fIpGqrv$GiQ zdadIhY_CxcMO!gi4EwYWe15#VBR9Bqnb}bRX0+$miehW#8$;PW=hs6kuSuL99yxM? zg~7@Dg744l-eIj@jNjDNy7NT(DSh((R__j3I{LRZYUh!bdVXmi-{G!qEco6LV;j5G zY@ze0)#eY>o^e0@2QvHZj_LJdP(Rz9_M*Rs;InV&or|b>KY9JQdEa8c91HiL%V0?w=*8g=b6|Q+v_b}e01OLok;3GS56;Hw50>{lDiAk zPoVm_;vrRortB_SbSt+vzMKjBBi%_O;AIC&I$#zv55+W%7QwmtzjylofJ=?G>Q?`0 zRPdkrfm#1Qsqg=beF2vLGAj7*`GMJ(SpH*F@UJhBxY>^Q54f~Pt2BHNj;@$!eOP(V zfo^YQW6oQ_0a&oX>s^@ zxhl=7HkaS;{y~bjqrD@eN@d%}gDH#r(X-UfF2$EYdUuISGtG*PUH?^nQigWXQwi|Vw2sovOcL>iw4Tu($?nh%{688JAMrM_y!M! z<|k85%FBN24r`v5`exmC+%uhO(&l5X$@zvmv3EAMW-94%QP10FbK7ed>!QX}#?5k5%juhYkNru3Z{L@zmERv8#C5NPDRuaEh19D7=+nT6X2!2qzTT|c@3_v| zHMPk0L1ngPU#2MgGyH00%Utn!Cv{sktTP_`2%j9%s%5`~Ngv%#1U|ZqzZl+7S-q`_ zb?=&fSu;$Zcm36C7z`xO=IX}Jo`+FPF&F0vBk0Em;uqtN0b;}K$xPO6zxf@dOUKFK z{)ru|bu%CJW9X8c!A2%`MEY5Wyx!iMlE1cc8TOX$O3lPcEIg`n_uJydS+nxz1A$ea{j^neBs!a5O zPrpJhgvP9-X}BAXiIhgk^BX1%x|(S&k74IDZJO>Hihe~oHSc-T*Q4MY-tvkSZ!%n0 zA~&$GH0tEew~1Cxf3>7NTaWMur!3P3b7MKq+l(Dm>hM8F{I=Q124B;xlV$j-wjCincFrsI%&oh+GgZy zIebYry1=KGBR5u=V`0Zh;HL3l?4B0}#z_+~l>}9*lcw$;AF|0i%FdL^&JcWOg6_w2 zj1Mx>Djv_5o8kX3=V)u+{FO;tX<7NAwe>z%=YG9)>#SGx@jGp8zA-)2(@PgUJcCwW zP5E59(a^+Q_|LTqfhMp;)&U*$#@Vp@WKylBQOEHT8_)=dG=&WFch8!MNVw{%J zzkUpp+8WI?u2SeR*z$$$v&NYY=@_h84)EApg{*mMH8tRjYnJbUh<@-6C?+x;MA+TJ~4`3Qcb0VeAvK@P0>3Fl0X-4dZV(i|xn;otKh_3-yHQmkW*OPFK((l61rLdlZ+)@CCamG%M zuuz=?eEA2wVz@8pB8Z%+2Y|K(MsThb@M)K&PFE&8s5NwK)Xy}rZ${x32uu)@)c7bo zvuYND;u=h<4eu>$({}J0Gnh`LoBNBb21W{##bxl$CV@ICk{?S9qv#lHJ>5M8C$WB( zAIRJc8s)l=re`D-IHWYtgNnkhO>R3aJoF2CO?*+427gQ53iko_{t_~LKT-9PU`Qk& zyu5@SR3Pfen`03&ZouXvFpnyX%Tjv1#i<64dMR*+cV^`4O^y_hC`{^ReV#+o@M&U? zdZjt9^n(7~cl8{4un@8_{O<`15?t3_NcH3rr}YPzZO&RQ1_1`O(|>|4lOIxiqh~ln z7c~4by!nH)4$W5?r3Qzk7=0G=Ob@Fzs`dUuqO+BKCfZ9 z*HM~e25k^qSS&`%>q;?|u0(Kx}+a4e`A#AyO)G=Y|;yXIk5)Y z<^1`U?fx9RMakZqvUz5oMh~34Il&(TS6k|VjyKcHh5XY%gZjMOG6<=@6m>rDZefZ4&fGD#|)_1%L@sBw(0br1!0D;M!}Z!92K2a7KReZ z1av@Co-I6Qs;3l`&WB>jp?YJjGQSIj)7<5Oj}dbhtTuW0*seF#2;u`OQr8u+j&Y$n3?wd{?_C~5ntK4T}0pK}B^ zqB&RMxlbf{NC^NhZx0xZ7Ew~G3|5b8&WKi*5}Y+x)X2XLEV&j+e#I=j`TO<0(9j9j zM)9`Bhg%uC9_wzcu32$BM8T-yJ%?FmjX%^gBrXs!4Hg#&7comW3aaXabW7)$bCX^T z1nZNB25<_Yp32+v_ysbC#Z$vu=_N#$7}t*Esgpdg7|Ht(F$AYR9HvZ4^iVNS{X_H!Z`@CJBGoEi|~5U#HM{+F=odXrZ02>i0eh-6L3w#@X2 zJ{iunCQCK0yi@)CqX6ydF7=ntVq!Gvo^$A}Ia%h`F*M&n=D+|?$&F!T@T5Jbo?A$` zlpu&viNeeIcuSxmCjH%83ijLkVvD*uDE|3eYK5B(Ki)t{?-V3X0l|@wZA85L)qAQN ze*~_^cImAA#k%zy`Yf^YvP(GKifCV`<17z-7#6tF9fJk3HZH}4mb<~wipqc45I_LM z;p!8i)LyiP+_d8^&s;L5($+a~b@_^mn)JjM1$$%75|>9~w@jXW=f)@%JqfL8Mutd~{CQFjx%v5+^7sJn%S@^B%nE4;pzqK-@NYY*_ z-jyaNu(uTO_S&8AUNIn~!t0y_Kpmu}y)Xth zqpCIxC(?(>Nfug03znoN+lpfyi&upTY6PVgZO&3)tW2HP5Xa?tWuq*W)dS#?pJR_j zl28*+--Of^Ti;5E&onh{q#7`*#9Zn>I%%8gziLg)eCApO^&@d|v{BLaZi;2EjHpOp z8ZtB<#9=*;4($*CWFdsmfSE}7vuaAR%2ocS7)IzY#+A~z=PC|S6?yY12Z&PqV^B>T zto6*d@csfLtt_02Jt<0%ct26-DWw)5609FfDx7x}q=L@979QoQ0*6)8K>Gttr^&4$ z+p#puI|+2uuE;Y29`(AS6CKIl)rc6Ttyg!WdBGxOsvUzLt~vt(d8nx+D6XG>lpi$ZIdqC&=Gm1#1S5!UI!As~NunHG-YusLv*JW(Hp!&u=8cs2?K{ z)}b-#c`?j#2*%-dZsZ*=gVHn+Xc)%+7Y~SkuRJGBXx`k5p`14~-}~KeM19i{IB>*= z@lJxy{nVLp_6!3bhnqg+%tUATrtI126ZA+tz);SgNn`{|{?H!BrX_H#8=4t3zsOS* z)+5^j3g6C!=pCyPAJ%zEER<1)kS*IV&zzia0Z-VqYy+(IC+yj3({>Z0 z@b){>H+nN2v5qK+z#q9w)SrU^3EfvhkHV3*Dn_C|HSz7XtIK(Py`+3iG>;_FJBQQx zB%6AU$$syY-J9o;yT&Ejm)bNVlw)RmWX(nY*J|N|bkYe&fcA=S4zbc3fz8x=^3o7R zyGaO<`YH9jP*odh2mvBVacumWiLtdueJ=1H6GzhW0 z6g{lKacKX&Xd9ZNpULV0-HPZJ3f(*HgE5L*-3&en^Fd~no?Rl~^ikk30eX!>^0L&+Y;xUnA+7#cn<>|e zaN)J7ha>?}-djVhmfV<)Fs&Bfpfm8o?I5CmFdc{x;h`!1~*j2B;T z6q{@k6|KXpa@Q%%_#y@ENAES%)7JA&rARW`Aty9P`?d}YpL<=f8Sdyc5K&+uR_XCtErstvXK zJm{7>z4*Ir;ewuB#8~N8?xY|T1GaSlY!w#1$v^GP^qzEP)D-_tuJu9r-ZLy|py-+c z1Q>P{-U@xhg8j{VX1WNDZ8*-?!Mml5)e+Vk2%ixKm5JYMieLe(#3~Ta|MG#3k!Br| z2hIiephDO9+IM&tJY?;l^0yRI>y^bTV9_!)t!WYvaq}=9HxL`GL7VOwZFG)Z>m^IU zc^(vY=j6D-$X=vjHh&HB9RUQ!Hf71wQka__JA4@28*39mPEN804Paui*~Q4Y=Dg19 zFqUI<{^c-+T20!VFUAt#ovFg=ApDe=T|E`l^qBa)WQ@c{>!MDg3qPVXOzw5Q^|4qk zYkb?x63zf&Q_m<2wHM%3kXon*K$RWtKy7!#p*rz_g0YNQY6UPm*R1p(@g3lM1rt>u z3}8afm&t1`h0qQ6W(P(`R7(%MRq(jMY(oK8H9 zH_A}ABiETm<-A`(5KZ2(SJW9XG!hp zk;BqR^&K{huM_WXt>Mx%%)9wkhmbhaLY-3QNp}v=jS$utdVO#a2^0HWp9SUd9#r80 zyUz_;I89*nS3z1B4W4}+{BkdqUKfT3^4&rJWJ;DQNenSbnAN|?1XibUHvb7htcNPd zq|PVD#iHhm^1?(7oqzpLs)@55>Yr!1hRoL!dqn8(^r~K-LF2>(f^@>r-t73V2=xmf zMcKW}7e~&b=q>INh!_8He;nYR@a!nF!-1&-Q%C8f<<#S|F=7~ypN5e6ggrItYvb{t z1CV1)ChJN?=2Jek*i25=T5KDgr>@?nW@P~7u9udZ^IfP@i0gigF&vO6O(uIGEV0Rn zEhK3tS` z?fE+%oyOv9RX~*^s!?WB9@Hwd`rYD@83wyRN&Q$iAkbA{gJk^j3SpnQDX( z|2cnuN0?s6Uu!0KC6>6dh)bLCh5g zI4T}cW8_uiOx|Hsg_SV5{`ZbZG+gr7`K<+0f^=Z#O_OFo15F$=kQBmRvMSulNTl0H zsieoJlunm!^wtcZ%_!ZMFl}EJ)u(!TP0e+3!ZSLB3dN+4!y^|veuuP!gk8rWT0A66 ze`V~z%&3LQMcFCKXc{Vw6;)}x^r(`*guN|LS@EA9m!BA|l5vZw!AX)X7<m{DXNQ*fHk~w9>1&Ro6 z&?s20!gIXLs}kl4rpEnAiF=YwzjYPYw-MXrp7Xw;JFjG|8sBT&)0JfwlvMPgQm09i z*^e5u11SV7fRE#W$VFWmnbk`Wao`V74*5k8ABE%S3U!Ro)Vn@-vpp@ z(^gk2m;nBAYLvDoc9`jv#0Sayr_y4{^yqwoT?{mp;?OK(f`y0LRBJLN>2(5U)tJ|} z@OO47-9xAokAcMke>)Z}q#>Vykqp_T?$0^tsOp$05eU#SzQ2ZZPZ2pYOsX!>>ip?c zk80O=)9za;N*bRkYw1BYN?%T>XA&Te#ELSoTwrSsohsbcfoQvYW02 z6e&&oQIgW%ZugyZFt#60L85k~R{{BYUsUmvuK0_(wyS{9l@2DFtk{+?&C(bamw>zr zNnBW%pKrt&GfP8N1W8LTl~P{XNegR2X$;D`^zKSCURg}{kg!feEJ-$1%4wFl0g@SD z&@Q!w6P!8x=MbT%H>?24Zxx%RH+9fViF(t89zSVDW=`^-|H0ci1Zf&|Te{M$v~AnAZQJITR;6v*woz%@wrx9a z^^J~>e{iFtNBz#u?46x;_S$PbqgP7o`ZQA|>!0Vbi^)Ewd?(IYo=f7|^88aje?Lm= zS)E%-mSv2MN@_K0rkuZw{-wk8OFtzNy=A@lrd zU|sD6y2e<#xM|t@j#s_htR1c*-%VMx)DpUVuj23q|Ww9f=rt94d(EFY>b+ zmHdD>E87*@!Zz`C9upM--oqktZ3k}UUdoi%pvGQVCk=9(WQ^{dN+)59=iv80Jwph?_irnXpBcnS9B~!uSp>wlQ2GMS{zGm z0cA5d8cA$QVY1m;4-c5OYh`XJhuaSV9+nm2=PfvRRstR>8+J)Q z-Zqz1K7i;&^8S@NN$FvQiJgDc5?UL^V%75~+b?^Dp8@CXEg}Hkp!ihx6E=DG97y1f zV9;-OB8RG}>XLGOsh&*NP;G#Y9;A}#tP_oD`?SlLC;2l=XndO{zy6ZFTXi$HsD-n- zIT!_TgX5HLxh|f!xMLTPV_UV9Z+CX)MOqY7NS?7kJAj#j8^C6-(w}f7WI3c6C+5@g zrIV}7G}=vz7M322}!|QS9~d+e2N6adagZxx(yZE4Q%rEs?vPJ&7G3 zY!26-@8!?ISY({T?*vtx=Q#g+gs(*?Ylqul>!&y-rS4y!C%%8I_ESgV2T_WPHhvc& z!3lc!jz941%A-gjGo6|E(RS{yydG(JkD1F<1_mq&3K)%yI#K0N65ZB1YNd-B99 z6K6XKq2nQ1*0Jy)`!LNRjWU*abkkJP)JjSpew}D!^DC)*lVHgZiRPq^IW^y#=TA^G z?~kpf`dD91OmV_+N&HoGs_tZ9U_tr}Ir|TJZX;PX%OUeEr)`^uWAf8wHl6rq_M{{-2M+etvz>GWrKW5GRJ*cQz1I zyb+<22#t&&T9IMPLDZAF6ePe`$&u_;$>_`hj+)2#Vq23@#-ctx=H++;PfOfG-?Jze z#tYtYj^dm~Pvu`5$31MnNc=LK5B~P>+nH%&bHa z07MZURywM14OI@w9nt2NC=zJE1ae1buzQC(Z^n*4{CRM;5Ne?t?y1dcG~J`$?*y2Y z?|eMVXUF*aK1FyXXaB`X??Vt^FOK#5`Le3^EW!sPt1>U?=}owYKLKbPCbSVEDk(d9 z5hu!S&agW z7X+HAMiZOH4BO9CFQPEm&tB(H1eWG}1;FTwPM>THP! zCpKzMkQXyPm=qdg4`qf++LYu0GqPa;8}00g67$3b?vFDT89M@S?e~&0<7LkK%rl8k zP7?rhVoa%G=#x+&Uf}B7e&>75v4eD|d@dzuRg{h}&9n-HUs!wIKgBXfcz&Y`BcH=< zrT3!xDQi%kd-@MU>z8X&=+dDMrK~!$pRNHHF+Q8dq98a}O#$HzWxps(YEFuantj7q zO!llL=HzcU5Tjht#!1}@o+dC>#dDyQhP}s2QEW7*GD6p%`dq6feODKuL!J-7rK$@J z+k^C)Qu%tJbuhq2{t%FrTj<=*oI@qHw+%phD?Xw@N@qgCAp;@!c*4tJ&7l!R;(1)= zTHSP+^n{WKU0@fW6hLUX-Z&p}l3u1zxMOCm(0DNKUZ@hPX=C zjU`gR1A_e}RVh&FGn!~BA?-q}jJo44u*AaXM_}L9^OS}gRQ< zMS6zioGK0_=E_aeGqWfNr7~J%!8@2bGq0@9mkD;??xl5BSH8({#dV~<4PXKq82g4`9KdU zxTzmjK0lC8T*ONLIXcr}N`}U`B7*3JxDik5NZT{c_{OF!(lntqCF>O8`cpfQ0rZ)V zB9IU(iboJz*fzPUWdm_uN=%D0xJf4P<-Y3-3OlmC`Y{74i%!a?+4pftKS(@L%ApS< zMCm!Xbi^mC9co!ZXv~W>0WleXD^fI4!?kZ0lP^H?gJ$x3l!1$A1>%w8kAzL;KD|L9 zqU=CA4(;N1Kp|l{WG9X{Tmw2hd2a2!fSgWTm-^*ZGcj)hBjjo0eSK<8tY=8o_Zlw7 zOae+sZH(1eog!2N;Ck~00fuYN6Y}8&#R3h@0(kK&kn0y+#w`sVb0-lUup>7Xc3Ni^ zGi+HtnoDda&PRCu9kZ7-CYt5~{?CYKGwp~i@tm6<*!J@JYT}*?N6mV5g2`J$xQS@O zi_$a`3aupp($<@iWl=bEECwE&_Ij-!vrQ(j*e3LdY+0uoLlm41&wx z!wo0$f8vN-Ub)G3_(pKjRY^@J3fJn)l}Xx=l*6+2_@sD2*87m#=kCmy&|3XVoqvqp zq*Z|IKuiRp=tN1^Z_e5ljJ!lyrgYX>L4~gwothBE=XG69LT}EXCiiuyFGs9F)yJ4; zM3D1Oe&9}#uQR#S4#*lh%izlIZ1keZtA_J8?g+F)iGsIhgJC+wzF*xnMMz{PNMjY%NPPIs*Zo z=H`A>*o)SG2_SUSfD%Yrj&8%KU1UP%b6Ul(1F7HdHwV@3?}w~Ag}OXK%^~zNu1lU^ zIv1f`-0rbIXxiV?o^|`(e(FuxKbH9K(7l&{?acJrf{tFAzCdrk4 z;LTrqDmhHi0XWZmEI~W(ZGm#H?3?f3ui~9*ir_o?y~6VL{Yg$ni}ff%X57a|STm(u zSwp%OGTKhFVaIwGh3Hv{e(rG|`{QlkFN1y@C@b0-(a(}&R*EuUm3El@caY2&Y=5*e z_&4ptF)7FrH4P6NI@b6+GH!#U1O6;WxFxMJ_&p#ydzJNn|-pYL*=}c0Zm&Y!k4k9q3c4nkFhvfu5e#JhNWWrQpK8S zpfW?7U8#k2)_4{OE^#!Bw4XqRwN;tCAupewjo_W4Lrp%)WrsZ zDLgmb{RT|*%NF&#)hX3A1GLBLjgvw`pjy?XJ>s}xyaK8W2A)OT{ObRhZ;YZTVB$#x=Q$L^PC&uu}WSfE2S~pC8b6WuPxBi0(V9yargI9xG1tY zADyM;A!g!fHnG6!r8UrB4Zb)yy)%=jVg6ZS{Fd(j$-)ZQ>c;2@azpB$y*rJ;O|x61 zMfn0d0tZ9+i!D^FtON#0Ng_NbfBd;JxaA-{(`~}~uWj2Ei!&YDIcCf}+X zTpD}gYo##R+45K(WCdJJ{MFj{uuSsdi+pu{fS>#Ij8*`JOqMNmKP7Xb;Zft(J1_0qEOf?6lj(eDAi09q8<~$!Sp~ zCzuqvOR?@j>LA|{4H!!W*BLkEt~~RqmH+B{yW2XpK9^7`N(j!#pHXxhTsEBbP7t(R zR-AKM6C`+*5r^jld;&uqCX_1=K1(Q%W|tlEf|vpIM2BN|F!h5)LzAEr z#^fK1FR)+foi&+A`C3AMtV3JD)U%i6*wGw2VdzlGmTWpA(UnQF`%P)^y-k0%h!joZ zH->?QC5N98f+@+Oj%HQ#2UdYnCJI=?h0%7sk#wmGIU&4ZyG&Z4@U5-4{ZsVwmf1e@ z=mpR=)7&Pt@s`0{#W8!8?j;VP?pYy6$F&g4kXj*o*~bSiliQ4k?s*K4GG7VJx?CYR z;40d6QIdfnJ)l~A{{nY-SMT;9>VRAN=evHtdZKOU#asA-V?M9Y==(y&oL(c9he*@klMq@@i$x z1tz)ev=6NE9*#ryyCFMX~j2C!$D2N!TCfmh*t{gkrETnfOLDF(Rqa_5DY zDD7Nje_S8>kSzL|sN>8iDs*V@rvF=#O|Qp(T3+^O_(BMM>KW|i78 zr%vlpX~6u(DZ;ObO=`h}S^#{;^qnXx;mv*suUVBtc=-+z)Kq+AcJ)`0mTOdK81`lg zTE+aXtTNly=F54rm~t@=ej z^s0-3Be!$vm`-}hP%j_eaG)hh0XeY9+bb2vzaCh!xxjeNTpsnVtr=Y{q_1xnq#zma zES5c|_x6IDHo)CQynF^9HbcY%l&mi)kHgv{27rjcX6DJ?{ zPX3u>CHCr|j!Ky&A+QbRGoxeBkCC8?@S$Gu9veJZ!aHU{#Yf&^z(BwIJDoR-o9b$W zRtKw-zcvmD?ek&qwb)AzImqF_sD=_-K&i68XOkVGcq6z}>8dBtEFTVL6;ER_7erc% zxRHUQ#gnQ>xECx&ix3{=NW>N|!5`1{!hi=YlODEzn&+xT;1V(E{M+3-SfY5rR@HC@ zr!aSZ_Qma_jXT;#FgQK8LsW{Nb|uRD(_hLjxqpO;okjc1GQ)$IEBBDCs?eBFwJ#{Go_bu)od=TeRhJW6d4w`ir?f-?anwh_5KIVLDVkW za0QSu)g!BX09tWQr+0ApV}x>&XFeiH=SQZgxkavi*zhh;s~cP64R6Bi9sFdr z&n+UZwJ;>_zhgz5FPEPxyqteM?n8fp{2G_nf&L#oj{gy{%=-TivCRCxen5#{MTL=o zk@5fVmYE2c82+15!1wQ?SF#5f0!#@Q=#>FZF2(=_L#O`+8L+ecU;U2%C)_d<69e0S zZvRKAPdIJ1AZ=YxdpcK!yo8`YIqA`ftEMD{COSz;nwgvTA)aA=SdE6GuHWrI#9o6S z6dBo*z=nwzeq=3dt^AFg;P(9fykDA{&>lZKKYxD?p`&yAn+3hz)g|#jGlP0{9S)Ie zk!h=*bnMxTTa8*B$)l~>#I4(@_nA^ewJ~4dgOdPAr?tF`D-uB7(Yk7$LR>6FzecNS+F>b~~rOr~}Cp#1C8Tj@&so?}X zSNiI080<-6$JeHguB{_&> zepKg|TSRvI@?6R@>{ImqtLavz{>>^7fB=nAlmeJhJO%pO7?lP>tC8Oqepg?N?f-GJ zzG@>Id6VAQgT;rDyY%7P3paZSNv}-3>P4Lvo-@gzP-&x_j0U+hzvg>M>RpPbXe|uF z&rxdPp_oxh-@L7I|F1xRM}DLuzq?R`8=M4);K%F)RuBHMqdLvH8?Y}>uVFM9daigy zC@#yrpU;y&wM)9)WUP;nTgA!)lYCrGdcfB)I2 zpkjBd-BE9()d!0T;s|o7bn+QDI_++*LhlBXN0`;y*E)M}3$n|L_rb5B;^mH~Hq;$2e)XJg_BBc=?MSWaY znnwi?fv*#C-P=;Eo`{vgl9wfHU=TgBvPwZJmMn;ub@v^mSS5yZt&MAEUm6=JlP;oF z1=55~GD{wxYA~%FzRqvT1G;;l02mmXJ~O}SntaKl&AyQQHgVgG?Q%|Oyr4@m^nyIh zdY1T&z)7ZJTC~(ATs<&v%)#6+Nj){-m4YY4!GS6=7~$mq;da?)0-D7SRH7(_Zs?*G zJZQsLsE0s#C&fO@bRQBO<|eM9P@b2^gyD>G0ZJD!&467GeRz5quJfS;6lWrgQ#b%k zdhCpNt62r-LAxD+lDo(I92ispt2-yFR|;YM)ghVh56kx>C9e(am@9#k)6`ZEsNech zhhT2=lG`OjB}C=C86~Ps3N!$m^Y!8#i@$J>LS|N#bxJ1h7jbE6Hc!ELJes zd#ibu*Zzn#KW>sC+hM`ql|3}$Eq7YJi5k444w+J>*|RUMWCJmwl?r7MiI|mZF3rmvnv#mLWmpj9q{)n!W9nB>*AN ze$Rp@k-bHi2oBYj*>WTk6pBJk@SCunQ=8{Y*}MLObH1^HMwz)yp(^Fb&%uuKq!TOx zw_s9?N4(QAigaJ(V879o>d<6HJ-m1jz zXzMIInW5L;>g+5IsHv&3pW3ubz0m*LnqrsCNpuuXm-$A3yVkJY@#szL!9JrFQr@n3 z@nMp#N!tXruuF!&b;!-W_E&QIc2cW~p8nNohie|W`haR;Me01&+U~6lVvZ>Uyy4-@ z@DH{)SohPm4KIiD4-xg_-g4<#fj1K%YWjw1ee z5%On%rtQ>i5Lr-gBs&QbBSv(mV*}6}6gEoq#6w#_BFu%O=t(~c8sH&$0=XaM_HO4Z z{BzSedOz?{1YHYUm*SI>)R=o)MTSVA>%~)Lolhg&yFe+^%a$OA?}v>UHN}?eaFbUF z4gIQGJ*IXrw)-7|w~M+WNMF=OQnP1rc9kJff#qmB|d`<9j$#Ty!cl^G){)1ego8iD(A7 z35SP(aP|#nS-3Kyl2X!o$d~aTEPPxWT)Aj~STVxbT=$vrPPW9fYuIVw_(XV|%b-sf z|I5=KrcUe5rI<6Z^i-lbHvOo*J2~WGuKqSl%dMh%)iy|DyIoP%A3ygb)|O_4;QFT% zlIF9LWLi$ix z#L9b_>Xn2_g-;~Va=b?5*DVlZg>wbOF(+wEJI-^NQEcc5Tzcp?&6qdNksn8*aCoC!>qr65TqrBZ^wkuW$jJ1e~*>)D4Xn zjGcyN2%acRGA3A3&g{7df70LQ0oyod=Wf0U7#eTQ zw%dD!TKc!k4ksC=`=51Uptjc*<8m^#78_ z#XrKhz9_bNLGAv4pe5t!t3ap@A!`1X2yf7zN*vw9eAPGP!A!%5DC0XkMI_BT#r=D2t z%3yY_y2kE*U&-w;?p)D*BO3hTs}0TjpY$8se-NI;ENuX$PV{0n|HP7rsjX1)1UOnbT9_}pyyesxuRfB@Z!VqzqS$6RCmy`b;17Cj8HP;P)`vQ0!w zNdZBD08mV1Xczeye7vg?yt4Gl%QqgOC3#PH0w2E-Nv3Xof-N-Izv)4AT%%h{RdJ@T z@srcJ!=KtAy?JVg_P%V*V)o;ce>zwT&V3Ha%fq656A}CTciNVqz zY#H<8nFaY$2feEq8VSf*t_sKc{XkDIThg5)ba3l%Og7K)TBoM#-%c_%pnlpU{NQD- zg-~~I_cz`qjKuS&M>$j00d4!A-c>S5d?Lk8zELfm`Lly*V0SFTcs zSmGvlhvjaUul0rhoRYRZ1=gi+Bnah8@Lm7PH$8k4HEKDmC;7ao^dL1JSk=A+u!_>mrcEa2?bXmxFK zZG>ku&2kbXY52~d{F-$O4nvbroGfY&RoB#f*@)BPZPsq`mTzpS;+sTU!Lp9D#mL1) zcG}Ahp#$NDyJ>81&%UOv z*+*GeIgxo%^H68s2GF6CQ!7(eY*?E_uG$c6ldfRRyFp)jxb+5_Gp2qQ{mD|hAB#$n z-(gbQr8m-51KIrSxmW>R1IdRR5a&!N*IZpuF1&b%*37iX^wjoV?y1^UzFaBKVj&i* z6|YsbEFFn#Rcy^xEm1l9Y(=iUX!Q`F6<#t|Qd|$Kp+FWkR(s|m2?x{?)CU-O7t~Mhw^ugqTIgc)nZI^Dhaqa5O z#;3lw?Y_(2UH_%~+-E3#_tMXPDAM?48^P_(k6L<0$y(&ed$&A})eSGoiQliv;pOE; zMSb}ZxMHGG+PY&A)Q|soh4rP})BUOL95mi7mE3FPylw+-*Hw1wwPVl4(dA=nZhfq| zyt&XS(JFN1eWe?8v%2e}m|O1)>Q=#10v@a9A}co~m(6GGu~-wf4qQ91%C-uqJ+E8%q?op)=Oyy5tJ^Pr4)6@Fp)nQys&$6PbIB^ZxY<7`{oUDbOcX74V zpq@)uQ2eSP+B0x6p{A|1^wIKi^(c<&4dXNMMfD|jX6kcs9M&DpC+a8Vr~0GuGl^iu zfNk`f^13Zwq3JEeC|1{o0@0^0w?Q=7ujp_}0$eD37s zuO%KUN3>@>**^cwB*q&AzeG(@ZpT7G;3QnaMQ^^42h_Vemyofib zm|)0+@&KSMEsR+~2iu@f5aM{67g4Hv9u^7##^D7vL2k`kImE#SL>6e2&IO)9Y4k~F zWO@;XS`md>8H8G$n9`#FPx8&p!k&4nJ|g`4e(A&LKrk*rVrGB>#Zwu|u%fwBq4Ka2mcdz)PMLJ~Tu>`c6|sl+u;yR}Wfg+4&99Dsi^sq99-qSE#4?A_eK zzlxtUKk)hO?75zpZz7)0%E9i^fo?{7#qH^N zgS_MiejwicQX39D-6uSB#{k3YqjE=yCCnc@D7ys>$rpo{S4;4xN(Kn1Vj-nPgUja+ zEu0=;!j3dz_@6K!%^0KT^;&d>33djl-Z_oJsMm4nRVU$S=uy(v!CCLJR)w$Bqiy%D zyCYxh(pE*b*5hsWy}P4h@ABG&z0@P}^$x!x;O`lGBaQZ#zQSf2D0|0D)p2(B#@2)R z2GG`{whXhqQV#E$ucGmfXn2QT-NLl`Z_L^rvbkoq$!?k1IkyIH%-bHdxNfvD+G(>d z+n%(zakt@a$=R8=Ms6(mB);t5+;4Zn-%NbmeS81Hr{JET`}E-pgFhC2Rlpkwz1#B! zjXfa-;Rp5Ihaz~R$Qc!XVB`rWe?Z9@UvTG|*-ht(H2=}po)WsR7;}Er;EOrA=i$pa zc>vZMCBG%oquEA?5m3}@3xFZ4fJ9QFKqPCr4MJ3VCDIWIlRzXb0P%zGg!_bqvp@ye zn}w_>(?SU1^3PSRva02(n69WiFX^bnLvZlq>RRNkC_N{2tK6=LJ+FK(|F-&rRkmLC zvRJG7+X8xO>BA}xt16@{pGxkx^1u=#YOPoWDEXMA<9rrua+z2qBb6j+r3(2DB_Lu^ z_6cdZvR1WYTt$;g`>4#3O8%%4*t~>FMbxU`-vaO=ifYC9B8zH`Ss65|^pu+OA`h!R ztxDt)QnL)LI`xuOvs$$}_7YjMsI4;hB3*5b`b^~w>z}E*A?s7t0*-iEr$LR?L)H-1 zIykKXa0>|Be3(c7mpmLTLF_R976h29d=Nmu^eq`6ur-gn^EdAJZR+i8NsG`=K?U zDh;@3g4^pr)x2ay5+qOu1|1lMqL9xDG@?*EjG8D=?ugV$!tRI^QASbHX_ZZ5WD<={ zJFsSwo=r04!>yYsVOgVtX z_b{>o8gFsrdJWsaTMemg0oTnF%0;URVjZ~_h-kmLq1IUvw?iF5*}9Z>ChW!u2q zcIh?)KW=~F^%J`T%VRQ*^{1KfMH5o}D za zV?R~D%XK9bH$?4Q5=R%sQuwp=(V1DG*p`T_3l&;YN9WrniEL1&yDC6m6{)O?S~g|Q zTf&>p>WvrqB#C}dX2L1J;TF{c!iMJz$BT)R#KkRna0|V;P( zFYhl)==I#c&Gv^=psCW(rayRdLY^{_r%<#drAnD*7h zZQL(nm!z0wL0wgK7&NfRK##u7-9rOO2c^-Fz()gK5%?uX&osP$RbuYEQsn1zT$1D$ zDA^SYE+Ny4nq1VC1OrCvwso~fs%UQ4R+tO{Gro|uR#n@N!(*`$TNjfOG(%EZGD%Jy7Q2Fp)|+Inx`)B4id&y!_dbwFfy50B`tg<0q zhWK&4hfz+3`Eh%6lOo$XxUH)8lv*pRjV!kH#@cgB;FSgU+H_0gl~w2lBHQ+KQ{$!Q z-^mrI|IUcRQ-OY4s={Ns_gbvK`D82-)JTjDPY{&o0w;xEu2^oWa(>I!O@gEsdR z>kBQnoyHly%+Vn_*CH(e6$EUmFfgyaoEphX+HhSJ1TXgCa8}^wkfgjskIOBRVUwJ6 zNgP?m=bEvsH<)Gln}@d=8RkKgbTG4gO_K)MobP3nbZ_U)EQZoaOXuM%){{vO=RO@4 zx4?lZUgxn*cK86|0OD-S5*8AgA~}hzI8VYSVXRX~^Acuh@pB5?YGXi^-Ton$G(dT4 zGQB$Uf&;f!yNz{A#5{(1CH-X5tsx6+TF5*;@#?TGaP!Sh&_T#SS~>6J+{3ebdLHIc zs7u1HwDxcF=DJ-1_v+Twwc|@i>K64d<9eG}L%NaEq*0=ENQdpF3A?git$myDX3M|X zmsTtz{1oxSst%iafN_BFQ|z^ZTbf~Zweur?7yNF;$097V@)YvJqOExicqzB^76bbP zhVzu|%{6nkfMOnp0ul%2E13hA1D^xuEzK>@EzvF0E!8d8t@&=P0=EGBN3vZtvP*(pVWNxnmR#!!E<)o^2QSnA zcNP4`kZF6Q<@MLbp0G`9Y#j*SaLg;H@-3xnzxgU=t}(i|fB7rY!Y!)n&`Mg2pCP*< z+}}uoOTuwuc|*gHUzem*2KN4|;*girR7U)YP#-Y;Kmm??w7Z85++_u8z&I2+(k27fWY!}WS|Kx#TbqV*d7tFtgb z#0j>c2*Tm`2j7Ks%Ew3%fT9VkHQ-F@gXVyv-UF=)=ozqj#aiy=H^9vbdUAkf>$O~k zG~Z?B(6-Z>m0SfqF<{pDGqcx;Ybd_1=-Py9JmTab23|9Y22<0UY{5rc0G1@InIsEi z$*8_}t`lwTq*^1WZ3$spN^gmMb;wXNI|e2Po7>UYj~%W@aoZr=PV#wz#2-GY zRx^ov`rsfMCz36}s`FKwV$|lfv}7+hBQhOe*$*u2#_Kn;ViXWjm7s8ojkv^$KM7+` z>UrY%_n~-V$me`KW#G>!dGp90!*c3#Ng-B`5uP0>XbX#*f}AYdYg21$YYS^5=>rcq z6Am~6v=#8K3WNc1a3AyD<=r)#>D-Rob`zAFIW_aB9WtrjTi$2g*E|8C4+eOHyqtld zj$~U!xo70>@L#7FXBT@Hlgh6kIg`fjR9^z@r*vO}FW%YSlnvcB1lZ$ZOgd~Sh)hai zV-}di#-_+?D#v5q)>SrU(XC`!iKbamt>79U)q4%W$(FzC#YRD?SG0^|m6ue1t12%k zHJbvFlrdNru}YC?ZJ8!KiCj19Y0y`zFI!*8U(i!P2rA&w{K@kZ1QS3|K%@c!3WO(l z?E?pcvv4qNu%X@YVZjd+2Wn!D)BSI7;%pxKH%i?c_05wGjogsuXC@h>st|g3r3gMH_Z_#JyN!q~2V)wseK%D*HEOlb$)BU8h1p5-&OUK8+?} zs6ixUyw)UL7n2`#$`O2eP?Jb*@W5sc_#_N8i&`r}EsZom1p9A0uKCCY?Iq~n;;nHz z*`;zZ1$PA#1t|q@g$k{r2Gtm?DyM%6RfSf0VhOrgsamOWiBYvELN#2gaJj<8s%yQB zt$gYnrdifjoqJI(xfFWQ&_x7SHMl~>RuNmJo2zJ?XKlnIA@vm1v((%pU9b9qXGZ?C zxuci4TZ4Xun`bZff|YAWxkrM2VS~5yrfp>_m#6ZkgMBmeJwjV@XHoviw6)+{lYeeS zXSwy!xfay>y~TG=RiJGJIJy(f;<8zgcjgCB3#r6&q%4~j{t$Fyh?TLNbK4~wB>CJl z!>~s-#_Ste`nmkG^B6_XTzp)%W(}9Y<2-oD2*I;Z7(g6Ym~A@kWFFi&uX$AEy3Apn z?K16Y9@sedHo11_eQonhRS;NiX4J{_ieJ5iwK?b#JR_BY-|#!ZHT6z~U&AzhB+7Qv za-O9a4pN$l4K6zOszw-TtRXrZ)QDgYRbp{=@LxxflEs2T9?wEbZ?bFvtfg>{PjFJn z0@FfMFyOv09qMdWhKq$+iGKJS)|Ek9ICF>^3>)K<}%jG-bdzbzc{yT*3IN+Y| zJ@{poT1Tm-qERK2ih55+4Xqclx*GJ6*7;pz@oxWj$0cE-8SNx#9H%A?MEGYXb7k>mI8)#1MV;vK-} zfW{@r@7c%D(I@s8Xnlm|f!WdT;v}ONv+dB@DZ1?s=NOw6=T;!kLw1u2pRet$$47uK zHuKuSLzSBxJ7GUsdYC%L>`U>Z*c~)IN2Z@xTj&Q%rB@86dl)xg2wRZ4S;SMq;~#UM z*P!fyw#Hwbr6M+`tEa-JWKN~7B8#bBT6uNOz6ke}X;o@frduJY(iCgqjeey64_sGW zz;Rt_$$eFze#(2EFPoQB3<5~<6^ha;)?W~P$JaZ!z?mqU^v!^lB$M(>>1OgpksoKI zgDObBE7W52DnRDu+4Yi@%{@T3`RfE;a%9-^{3%RW- z5sP5}ZS)TLsjAEM|p7e?qU=wK2yS2XKk(1A3+9@ChOa9Ut zC3|P%4X*gTV7Bh0Y$qKfHLJEB!o@GlZ6{%$J9stth5JsoJn&+{ewB}JpvxofRhqYh z{t9o2e>IY^*RUn<3=<)(U($Li$|XpCMjAhX(O_mul9}ooKR|eB07A5xbW)$(!`g1c z8?)+R6E0I^?a!aiZsbB1tK*E!LQAcN+m;-y%v6uesPQNwg4U`%$nSq_eq?6BhVS*j z^pLg7!HU|2*cIv7mByg3u&-g%05BrZ4ppxD7pJz!jv8fuj0ojw{TIoqJf_ z;4jXdbKFD*@R|C^&%zWqMJ2EZ6#}4>y~E{{rFPj9een1)`ox_^F|zX;H3)n1oH;D@ z2C_wc;VzS5-$Qz7zF9qSc~%1O{vLUd3h2fp+A zguS?Q?7sdfnFA&o!94W%htdA{ap&w7pu&~Vm#&r6Z)8{OS)}ZW?!*&OYmr2nj@~4l zA~EmVk<3><^V>+>)pq%siSfS+Jo5wZ$n`ysSEW{mUQMdbX+R9qbsF3=h`ASJg zjo4uA>Ri-R(os33sM{c^fVzlAj8+xX5G>waRGIMLg(k>=5J>|sb8LWHAQFWz^fObsrC zl}MzO##)0X5kyS5DxJa==vg6jN|a>O~zkQVbv&DP>saKGH}y;y@J$wnzW@@XA!xa?qbQSP#V@O)<~frPmUxc z{cpz9varqbJ3JMF6Mp5Ku%TM@fQGb}9dJ13C!Maex0Hik&;6VUNroWwSB-plBF~^s z2Eoic=*}+T{=-`vy|yyYIncnqZOD-I;sI{HfNt}c4I&+9YI2#b4$_R2(*SWtY$_Gb z*ryu2N}YSGns(r2WG+7cD63g*)Z-xdEBkuttS}+9eKt5ukN{{wy2ij5{jwlGmLNhP z&u?4s%7xIh0(K4PUo3ioeQ?6CW3a|jaf&1It1XA@%^ zEH|gs0POTlcsAm&0+kSCF?;?@%)4hJpJ(fkl@VaFdGm9z+_B1{zpIxMY18CpD1`_c zC|6ZXv7Mv(RhVqGTZc=)d93@z?2E#?LhYav)awehm-cGNYjybgGf3oD4dDsC{^T%*g%l$t2JP_oVE+#mW8Xw;Lwmj(R z;fw`osg0D>4IlN+{%Zze0-X`4ScPg+|2#0|5iIB?EFQKTYsH-uxUS;r4TPoXs)T9D zEYhBVeT+APX{Hu}Wdq}8c5SsjdKB*%+YBPR=?Ir=b)vaUlE1n1ruIrmLBwrKCT{AP zTo>ibKASV^877R$Z(PKJmrG(eZl1;}D>_=nL>W>eUPxmC1dJ##u#-dG5~ovLP+bFM zFVH6&(b3ya-gfZK613UB8B7a9is)?Zq``}(aJPojA|*C9Eu&URv>E0N$jk-JqAW## z{MR|g1*a{t_EOgSP+)v+H2zS~6@dXGc+-%^_eM0PiPR@e_3JE)BpVg{S|gyWBk`|t z1*$WGiPT>hl1n4_1_ne%$roR6PDs+0X~EUNRwdECXSQZ zBe89OWhLy7CH!%d(Xg7a7|tK7cZUl+(V?9|IBo>K$q37<+`ynEUPZUJV7Y~Z>JxIQ!gl) zekxAE#`lzrhzri>5+krPp?T$UvnWNXl>7IN#|`R2Xjc=cd~2Un#ofvAEq%bY(6`7h zdXqbiqz^$|aD44U`;pG}vU<0F%k)EZ$~C6SXAN09sZd!jQKnLc`Zu<gAMKugAeZRdT@7lmfd8Ny>EMydy`IA{rjmN zI-N@OSHExfl^dB>4OWDpBhwdQe^s<&YlZ-Rsh4Q2TbIfE@o%#Hz8$I-ggP_`z^TzG znVju|e+#>PhLiM>5`O%sJ!4fjF2R zA|)zhIho+{KZM<}5D3;#Fc2h4c*hlH^&4|-tL|VR7uL5RIH<^@+oq&eYdXC~VA049 zrhPL;G1|gBbk=bxMrrOGNWm&OiPjYYZ5z5!`RKHfgqeMw-D_=#xMLfZMZ>@+-1OO{tu9dX@c_>i;963<;msU4EGDP@KJpNQ+kBg_ zgFk}7Cw6}4LqFb}dtR5h#}@VniLaJBL;MW#ffX7ryz!&t+aW;SQ79|j58eIBw?iTz@FTNmq<+Z6dc-V2ExR*@-5s5lr^ zHuTH_UftFXs!!$@$D#GMYemlE_A+`+lr2L!Ij@|VChE3p6_#!MUh2B1^x<~57utQ7 z3=GEP8h3FG&c14{_xSI}-+5JBJD6zv_S@CYd*tG0^XE!u^YIw0A$}HQ_S9wL#Lu7Un|xAiR?U z|6~iban#jv>;N*N-UAjTvk&gnJy9sibV?+;qG}KLzuWO_wLt>!7sG!uR{#~FMgV&*XX0OFf0R$doBHbEROxB@<| zxw3M#QZoOY%-t5g_CW8jU4ggsg!sd+<&xyC3mNi6Fm^Z|ecJV2`>eOj%>ekvexf)Lij@g*c|DEsKd#yn`o^Xfj_g{WZ`YRGzM3rhAMcfro-nVE^$*^TAZaDtJ>(#d1zD-~4s%5Ut z1aFlD!u7;#l2C@po@>b1GW|tvmg|QcC9F7f#BG*f*DPLyKl$nTKuC9o8o5N@M}cjf zz}t2HuT9~Pt^bhwh2GeILH+t5>07xuENC{+V?vKnXEZH&{HM7r1EM0jHpbS6~6O1qD5 zLFGa9NTU{01a)W-`BuHp8d;8aL=kNv1WJ*@YgB7MyNO+xP;7GxYWk{KzBWpuNmaX; zE}I|gxKDhJw88*<(UP^;^E{{o>0L?jXWXtPt}_qZgDpkvFB|X0XNz1?jN2G{ zZ0DBrAOglY^ha1h3S=Z$F2Iide(H|!OLj{1rqO(N^M{v+U4Om$GowfU3>RLg zU$<@>%#zNp0h#(jsfmCr^$PfP%sDi@h-F60bG9*)C>*Ba=)-!bvoNdF^T3T^317PL zDdcWRZNM7kk{OlP1Uxi)vch)|l)mKsGW(o0h(k%yF_ zG8dKv)Up+(^tyC9zuadI!c(ZdU(KI&uKT7sE95x)31`pAJtZYAKAcvJa)kJPt=$NlY3*{B=AAx(|`0d%j}Y#a_pEQw-~bd z>E;R`RhRjPN1GA&jy4KfapzOzna#9zro4|{W1q^b5a(nt<$QEE?wen|*6)TKbQBi# ztoFY>{Qbxi4915n3i3jq(KEHrhxYNbNuGgtn2om zcMz6+YL!t7qG4B0vtBS(A=4X-E=u0~iWT*ue~{lAN>Nr2gSON9f{%FBM$gBK#qG|I zja88>x3=5ymS{~SVIO}KqAn?Wq=g~N4{XP$AV6T?qXgNF`^r7b;%i_=CI3|}f2W?# z^FPKkWQPB?;6zVCWFrHicf0-XmlY6Rr_Ra!4C`7II?f3C2H-1#xD7agF36}1tD{{>MYQgllo8T~m zU`%5^1s1ES``hcco_0h$Jzka7zp(&;`TN#a`>v$0n9|Io@9Y!S#%0&e3ku@}8S*yB z^OcqZlwV5+%Y`J?w*86eZnHy8(4Rkwa$XF-O`4-~S|m8X z8&!uVdWS#W6kyeohOO!Mv7XSkX>j&_K%b zQ2K7xi_QMsKb-z|g~k+lbltPD-*86vaiLmW#K$GeTZ`i0aV6qdDUZxu;`m?<^MXDp zT1I6Zkh?3k^c2_mDPVhl-0U^9!Lvr28Ly+~@x=pt)v9J=rPDH4Nv3h2%zH?fz+H~v zk$~r+??5mP&bu&<-eImCZvantYcl7IZ0&mfSv&+=yPat7T+EUcI(ro~ElV!WMN%vO z<%qT4(6X|75?Z0YF1%HIW#bkuB?*mcPIu>6?d15e=zzarIY?Y;@f1DRc-k)k@q#i2 zyDDg*Kd5kQ0##V$k@7r$**7VEpvYU}V1w}9fmh*nM2S>Mxdb4LE)eEgyvIUUAVSK_ z9sh*l@#c4hHV$LTT&1lAnw$sfzUyrBKbPdkEKAu=kPhRO!cJ!zG2rCY z6yZpLEM7sN#;c`g`f;yd_rHu&wfPF$KIk2z0>#h5h1RtqohPP^3saU%FKHuul`f2W z)yK>+G!>o!Phvb2PbFS{)35&?i-QTL;r5NJ3^%CYD&ifxO>I{(+A5O=#$Fl>D6JYM zG}+{Rw>_ZRh+GOxf{*zoO4@nGT83)Btn~Pt+C7xmjQwe8IxXjyoxO3gHPhRhLYB@| zy)zG5Irvs~HfcR2E?+$`HUjc=-H4kM+$uZxoAmnSaL)Vtd`;ANy*I_=bM&7kK2$pq zD)yEZ?TNh^Pqq2mNzC}pD&F3wOwdjbI!nq*}_n6spk7} zeL#_0bu1k7muaiM+f}>R62s0PfYMHFX#zf_s2S^O-#K|C&xa(w5K4SwXJ?&sCQLgsU!+F-Rxy{P}KbZJJiMMO71n+4WJnLZwdHO zA|K~nsfF262GNqPtFCi7W#xt8zO>PW#Kw(1Jo6xM%xCV)JGvH;&)EC2iFIRALALQZ z^RDZBNvnZRvIFnS`X8q6jX6X{<<4_xvy}_!RTo}4c^BHKf_}kqd7Q5D7Vc)X$NDxe z)~53!((z62Y*q=UU}lJ8OTFF=Jf5(V7H-PKuGA^cIc9qHSZ7Dm>R$9!Vw3P)Za38w z5xG-bEj(4D3c=H;w{9?Img=MZ*YCZPh5_p*=2y9Bjcp4TXJhnMM$;?hFq3mtyQ;pa z%*e~`w>TU(0?FMASPD`I*_8+bbzQ7e!4Alh-lt2$UF2DE0)8uzp2bqJE##}ji};BG z>IM@D9Nnu;{y*=QZVlU#G74Fyzbgqc0wt!iTwgin=&}AtJBy7d+nK7>L|M$4ZK<#% z`_m5U76^C+Tu5wQAhZ;Ve{&nW!{NCS4~}K-D(ci@NF4W~kta&60~x>fZYhU_(I~vB zjm%&?5tU-47dKZvsSmXlbjnCtPyRM_kzX`lbcZH5w3gThn%erN&=$Gjk?91hRb1R0 z8tTR=J5MG;Y=n+rjNM^$w$1x_Gp|et3^2znwP-s0%=Aiop2Rmj8(j`Ax2U(C_t*%n zq7aGB$sRM(WPh zJ~oXpCp#8H@3h3GU#v7%6n@DNaYsG0i1H|EN|(c{N3)-`x!3v9?-d){QqhbEoguoT z8pY~XvR;+@+=-&SnzVcqcLZ5}8QQ58VR!Xaf`7=};#p;JqJcw$SGX*Ctul@C%E&D5 zE^q32y1;`8pfuaLW9x7x@Xgl|n9>N%bTdJf3ofa~LKEbe%9%UsAQ*mw(kMN^;!1d- zP+RPly&Y}_^1Pj0UQ{_>F-$PM)|;!Sz1FvU>49a@-yyw4SrMi(HhAC~(1yLXt@i=H z=G;3$RF!c-UHVTfJ2OI)e!Y)qdwi+I9o6lnr|otKDwE46pDq7Ox6je=+Zm?Bxn+2)HVSV)^1f0L4MV$+aI8dfj{sbGsS`0mhdO)3SzlV z!1@9}kohm8G3JH!wAb%68GlED)+{6bbQwuX;6SxM`z9jv`foEWKW7u)uT>6b`FQ3H z$k!P-7XG<()~AFUetQ0O^odpm_j|nOi7kL&>dPk1y|*?$8p!QENG=jZpnLI08S>au z)ffe1iE>LHdhcPEP#t$QX48a)KCxg~GQ>IlFy}!-nzMiEk~thtEkWjz1bREhsgWC? zdSe2g>Qjtw)JN<*JxnU)9w*((nb^MXFw<)@=m|(=D;B(pxF=c5_f2>7QNfYi|NSBZ zBQQ6^P3idekZ<-q>Q4M-?Ch~`|7PrWRg2ERq0j7YMm*o_ZW`~fsM`qN3kaa}MxBF@ zI?OGBmjX<+)=%nOK%^0xP~pDicEC1^OC%Au#Bv=;_4H*O4!95ENwlL|l90XP&9s!7R075byoJ(>y2f;YC) zFp30of&^3eBi4EEW)7gq0x8=rWyG&oeGk^1gU-6{qLZfu{4R z8|OsD`Mf76bYAuwv@6jqs`yXy6ZOCwRjX@n`Vn47q0<(#hpVTE<3NbZqmplB>wC zz4wl9zWk`lkM#5=amb6jDcR-zO5u7JR>Hu1nAA*tDI!|4JK8_ z1rZ}YBkgM3p|)_#a_;GD_5noLp z_|TIlJgthIUQM)lsxeki1XKz$Wn|0slRajcBCmyB+1}x1B6j%h@?c?c zZb$RTUE=J^4Vse;Z2WgqMI-g5EPd&08`ORxORv=i9_ZhVb~O2w(iq(5-01q(@-7H| zFV)#woSX03V?tO=r|ShDnGZGW zKZl{4YEzS3ig>@yOnJZ0OsTH_D9yP~J!;kN<+a7}{163u?SK{|%z6QFLy>5*ZMdU& zgmieD2Z}f$Qu&aX}cx1q8g;`6{&w!o&muy6O(c4v!}!Q~Uy zmQ%3=Id`txZ#ACU#y2{~;X1~H+S|OiE6yVdY!zT*l+QI}uX~^u+k3fYmO@{O z$#!JxW1bxsBeCG4(sy_KgP*$F4PEZ$@fWd%m2Fo$gOP9sJFDbrbb9Me=oge2bf*bf zc^AYlp*!DRKXHeGCB`_LoeHm)3H0jGh}CV21#tuFW4twgsJSf5gLC=L~x=jqpMBg>0MZ!s@uq3v`C;-zadf;gJ@Aa z9)^0$qWSQnu&Cz3Th0@P?G^5S>t3%dRL~iefx5zPWM5hfxR_*;y%jqxuKVbGR-rz& zUo0nVN!(r$!CgX({|pYfO6vR4K`Qk+%8`NFpvj1I6x^~o=A#Nny0jbeyX=|xmNL~J zH#39lWKYi(pjjtD+3V-g@7J^VS^3sue?_eJPIvrR%*fg;ZQq)Exom#b?icVNOPBek zv77(8ua{BIqNuQ`k$tE$Yki@+zw?%QXqAy*3U&n~Al_jtjOnWiE;JG7I0ibdn3EGT zNi}*)iyIT=s75vra2C|W%3EWA=}(u?PuI(pO^w@hrP!Lj%w@6k5l}>eK70U3# z_}Nmj-Dz%M0pl2>OJmmiMMM^gdKQbt&_p+2D=)to92If;*6h2A6b;0cg){gapOMuy z^j@TAs!IdRt+x_+mOgF>tX)TU%-s>v0|5OtfsVe#LXGtP)da><+_Lqz6Ve$67$vJN z2uZrkCd6HV63EE+pe_-E`B+`}smZ&E@y%AuAs&l_3K6*a&kt^4lSnP*U~}~;(U9bw z0}fH-B0|Kp3U=nv_%7j#bljB7#sl_k4W5NN=K2wtUL#@C3M15faA5UFVetw>;=K4# z_Y$EOa&<8u>~s4>o6c^#GlsXxuz+b^hNW)_

1DuDJ0T3I+q*qDW<7Sck&G^O!Ee zJdNiRLsI_)Q6axgnd%#b!Fo*WzEqKQa8(QtW};(F9KsbH(sVjB~A1w}+%_^?Dk z$mPHgZ#Lc3iX_Mv1PUERHLz-5RlL)v&1UnLeIe_#c`-wI0~7a(6FI~rcHCF@6GLcl}E`q7FMs2YMHfUb=8D?oc@J#%=clOvQ~4>K=1edjK|yio#hNX-aCu%2|7J> z7F`D{R()^6{TlBfx=1U_%xAvY^ovr%C{ke=))YeQ@tspQa1qfV{mDu02_l$Lfy3q< zJw2{H3S{Duc}@22Pl)o!bJ%hHyr1!5vIQ&lgH+)~EbK8U`O#yib4%qOhh^4qy7`&a$C{|%E!D=`T4tIXl)jhDHu6HzQ5gU7tjxq=^CVr3B*6ZHn)P)TS(`2?-AqZqkcZN6 zhVOE#BF^9AY7BnrId#C!>apiFZmc@wN@;UZ-2My4f40xkqqnt3Cc37& z;2qgEFV1uF7~4^4r9d33OAh5qFZtqlIt}eR=rVySFyQN2KzOi(SatI5b(Y=vLLu7Q=FR7kmNt|-xxfn!*j-9B3vLW*DmG;Ip48ms^j-fo z!}(j7zy!qJS5tZScVj8^xHW5#{}~n7_qt19T{A0&)O3*QZxpwAx?`Gt*E06)HQK`} zVa0({RO9Wv(SVSF<4Oa{o#ev&he>Qoco0E>cYl^NaN~JG?83H$`|N`f$;BQQup{d? zrgh}A56^5vyVrW0kXYrmn8skgM5*DarF#%Q1N4~O|9}Pg;%#%i2J{?I>o=5%%4!UB zyug4TdFElnd))p>l;#DD(}RP3S1pX+@&ud!&!Pb+D#JkY0b&`-|zFOcpm)$*(0 zvO~WAUaP>~e#D8opo83Mc_~;_fLXDcC^HDk93@BN7x1Ib~U}Ae^e3F5YgT<(#jk}Dbgjg=LzKbtr<(7HohI+4fasZO1w_f;!fRrZq@8g>kY-^vJ^NA;H<~vNR`>z;JA@0E}Y3cLOwpr zBtBS@t)$2AJFRwNdzT8$AKv_KY|Hq3%%cF-%!=7q3c$gwbPny*R&beX_2Ln~6XjHp z$S*FY^Ro6GmdH%dV0Z4?_Pa>tPQgTP(#kjY>vp5yCdjQNKHf=K)O^O-In3NKsrUzQ`XxOV z&2;08YsW^N9COxZaXN=IH>JCM#MA5=&o(GTkCYf}j$fyYa3-u`hJ+14n9{vO(C ztz};eKg%tNnJhr3?>41;dD%eK0ol8!qU8w=12^q)(7%oBoC_9qwZ(ie)mKeCf;W~V zZ41{mt?SN}eRi*-oHS0=(GK~3v|(8XRhBUHPv3c+Tm+4SBTxh`s(-x*@#gRz#3@b6 znU2M;g<_)5G!5dQL=s|vWE$qr8Y*M+D?SF@yzSsTJgwc&4!FCN?b;gG-Bz!%&XQ-Z zpbCG^X+_5ja$0wNHe82YTC2PpfP1K~W8CtC-*L~SXvSvl4XShQ?4~Vq2E6JRG#0E* z8wH>p3D^4Zy$Rflnh~9TZTEDLFRzp7ofgg%n)^ysEsHhCweGw05kb8RtuZ(eKPKbX ze2}VC>Tbvr;b4!%Gfr?#L^=tTqQ6KTqm1aLS4e|+0*i@9OUW*Tc}@fEYJRXF>8uUz z2F#1FRKS_Vt}6^|?%dChrJ9`&_8BDZS+P!7uAB$J<$c-jK3;OHfVggIOu8Xt8ijJ+ zTRha-tu4nDh{xiy9wns{(wdE6Cm$-uwJD{I-1ec4>rooWIbW2Lh#tb>hA>ZWJ@kJP zpZIy*yn*d%%6vKq#>}+|%wi0cR}@G4^e0jwUwu#h^x?vGDj1YI6G#?$b>Mh!_O|7H z`E|S^U8Xkl{B2KfC;%E8Q7{-8)!`80L0Hrh;-Ocl1c3$!T`Bv)F|~ACe&BmBVzmV2 z352dUA@|BKmK@km$LM~~nb zr)Nf4psx9A{e5L{jBLR>X&p&JFrp;nHS@3cg5#k3$(03LW~VP~;r5*uYUOf*>s_5! z5BvcjmE}&bYR8!Fu9P(zpUFUm(Q#U_PchDpQLw&4w$UUjxOYx=C8)}>%w$+UGj9Fky`*#8T|7)TqOV!q*K&QMyEr4RN+t=mV-XZX%p zqnltTWthhUNd+}J?@BjJcM&ccID7o|kH#^Az0OE#GwGSvXT-gZ<^$p$_J;gMALDP4 zbSH()#oPeyRi)>iyj{?N<^}%%w@2JkcvdUi-|=Ga#{!T={}9t?g&A0g&On|%;&oF zANd_?!DT$>T<^RV49@(xJrjq_kT`;r58)GgAkkYBHqT%#PN0Wn8pJT!8NJPhL6I^(joxU1%CqSllbhA6HL>xa8i`%MN>k z0sAU0(Q~FTTMHYkCFCgo7dE%c{@;eM!TOddJnlK87ybSu#A3+#mO!|_TJ#gI&4MSN zW>-sEA|zhR8FkEGsL5qZTZuC?TtE1Cl7E@@N?%Mav)o1?w|p-bY7;}b3`Duy{khz^ zH;hUR!a1N%P-?7Y4j%qhH_wLyZOcMe=7-Q$|yu6io7LmMFA+p z7hmoW2SA@~XMs3%ZUYt-) zGXwvYUXN)?!*6z%B=9-$?bcF0jR4 zMC)dk6V0N)cwi70OBj%T2w1FsEKY?ZF)*MStV3|SwV!z;gnsZ@{L*xG@6o5>1d{}| z7>WpK?OPhHwJ-&$K|JV1yg*x=U^^lkkH2cZlBr+t^8NuCPG33-WktI2M*a}?riMjS zf4A`=A61Zq4YUPr88WTV7P$1-Q%NEi?G%d-$N=}WrEr#z+L7}Sv1VxhC3 z*mEJthnyhy>-Gl`P6#`vJiM((5B{PtM=aj0TeIvet>#3xa?FM` zP6#hOw1Ol!&~@EE;Jl~RNeVICc)QzCIsB|m+o83pk|SK}@jM7l-)zdp#9QQ=SGmz| z4XlM=BtL72tXcif8s4$ZI7aMR*C*0ZE%ch7;<#V!(T~T@INYB)rnXK|Qu|QX_CAU= zHtkPg*L^Pz=^%~#;h~?#UUJd7@lCK0oe%-FiGIu9sPs^2GCOonD2aQ5k;zw-(ns;R z;ZFgcCW7J}2EmL;BJF<4`KUL2b#7gIZpKQ)d$+a_5ryV9w%0S!p)Jsa|2ae43^6{H& z9P@gMP)~h@flOvJ-9emY_=Alc>UjdFSd}s=2oMC(A0Ny*td$+Z2fowdksDXiTRC7o zLxU_r2izm`KeZx%&A z?=(BSlfZG4=B0LYQ=K`HW*zcMo{l=if|EecgXUo6SO`?dL@lRV3f`w+|24>gmvX&m9<2wk_d-Efs zQvZ>u(RMy{+}NvMQu!Xoik5X|$#=j<-IRVaI>zIj$)u@iC9TSibN}jTK(%urt*Fxw zpw5WrY+1ggWRFcFEp>upZTlwV*>Z=mm%L!UV$z3@k~lIpXgH?(i`fU^*aF zH5YB>iT=E1Ha5?s+>UWRirogakWPTRNL?SA!;V*jtlz(OU_uyfl3mxR_gGXpK<}4? ze4Xv0$n+04@$u%H`b;)TjYvK6j^thM5A<5j$lK2$`Zb|zO!srgwEluiQhkL7DJ(d! z(U$2#3`9z5#PkAy2rkfvg50Qm*A2Eie7rZo<83c|b;xSs4CjBKvhIIp?t9|@a+~r% zV%fj!^T{j?piE+dSYsYA0+PKs+4_kx`1tj}wfs9vA@0gHT_0cFUFS;Rq(cz{}iX&u0J=(IUY+BwA=0&;?3+9!pa*IegP<(gZYsy?-K_9R@ z8kf$nlCS!Y!-$AqH2n6xWK|T$Qn2Ez08`sw&flo%P*kZo3i-xo&OqeNe8kW|nP_a< zs59Hi6KB5w+D=M!^G4$cK1VjR9UJ^0VD=9@ns5Za($Nm=jBdFXi3^fr{u6_3M?lXn4_#b>J3T>q0V@v3^5cX@H+tm`@ zz|Q(DjL0jJu$u05^CvOGj`#jddQ$4sV}0EnqkC22(sq(EQ_-HvGu6IQ8v@|O--e8mFq`AcBT5Z zGCJK0O_mR3)R}+jsL!d-i@+V=PrXpT;B&aZ*-iIN<^%r;|HFptwO!$x`qabL&&p*H z!n~`@Ic%@b2^e_yddjdcI_ikW=FpQV*Vz-NLS3cOINWXK`HXFn7hFlZ)!6ar;O;U$ zT^8-Pz(b?AF_|XuynOsk&8-@xS}iLucwIs?xoq~LO}LU4;2u_$e?iorxl^4p^0w7- zD^S1g{q|ObIk42$b7vjXHHmE>KGKR3ni+wirt$N_Ux7yyvmyMKH$W*m$afBM?_(B^ z96eHuG+y%mPZ<8tYEUlR5v`y5srSdL{FA#wS!$Dv%jSD(G(U=`1~vEN8Btl)F!$l; zvk{KfUU8sX=dG#T6lN#(@a-1e<;3EX^^@uLE?w@nV^ax_vYHg`CWBeDHvL<&3BgXx z*SaZuoTGY)`t&C#d|2n3{J~d)N)EdGq7rF#t#NW2#ipoIfRk#eC)d#CI zKZlmI+LUCn^o)N#>D=NUbheZ`ogdSGmQM~@n7@bbyG&{8_TGY8l;tS!7H2c^D4!SOW{|BiYz|wMT4S3fWE+3% zFDTIocWhW@Po$o;J9E5{%CJu@&Lax(JXL%@rgcic`t2$AbO}i%4(hO>e_$EdNAk0xMcrdp4`Qpa{U7%4Reh2vnz zk!Q$K$=b1DIvZEc=^T(N7jY0xdM#SXE@>sc4*F(f0ZN-P6Wr)C*h1-M@WUCc>*NJ6 z>H+R+_m%@JPpWGpX}UcuNCWtP@^_cTFWbv&-AsLo4_9II~bF}|><>q!-rvJ|W7;nHWPFI+^A=Y7$7dUer1U0#^ zndvM?p&ZeHB|2|ESPh=7*>kcDL$Z~{!>3zP4tThUi@TU~#l;<>;!rM@NdVMdE4`>$@8&Ye+ zYx3=)m5O=){Mch=B){Hkg6bmcqLmA@t*9!WXS^!IpwE?Ws2!zaXQXKUwD4NmVw{yE zf7NyNc8siIU4_&TtqRip+5+jsZ3?x^GE@kZAwD4?07jFX0bPN7>BKm-yFatNzHHc@&>eDq*8;XlAeAUhC&_&{_b7=)mOqy@tbSBLJzVG2`#R)>!s zNFPieN*_oc#wK)35>4z13p$)F6={t`^b{YlrqkyN2BL9C8Ns0xd`; zg^-1jMY6;AU_8;Up?4jJOn?$3aYBS)_yK&-%P7lm%LvO*%SfK6*I!JrcKwEYf!-wk zp|3F47DGA2{vodr*WN=H#1BH}VW%OlKd$kHs!801{a~IbcIAhVhunq;fCfT-$WJ(? zc)P{G93el%7J@p=Z4vw6wQo;orU<*?Kq8?|lopseoa;|<5D7TY2e0nyHNy}m2{^!q z;F^6%gTx?k4e^O(mvShTSP#e~VjtoIG4u6_Z`T=!N1PMt1M9@UI}2107Wn!Ey}JWE zAzl>W5D|bCUd~s#w@l*4HH#DfU!{kL(06g-Z~00emUDu*|4-BZE#@#^6dN6OC_Eb~}T2eh=?Bkv#%9Pv4GnEYT8jA2e> z4rb1Bq;=qkVNP~W?@1dg*&U~3ruA5-0Yn160zM(aI8@B?yOo2?@|*mFEU^}Vtx5@2 z#A>{LYKtUhaTaMDvNg2mue~@F=MfYkMu45a&eSIG?#Skd#`vQqP&k9X559=|iwhE- zj2`w<@7Hbs^Z_-zJ~Vkl1f2j>W9Syve+=V_0xq08{QgmXsX7-wH_Y4nO&pv~kOocw z`GCc>1o577`(dXZH2aPokMt|_xQ?MpEbK|v?48 zJFXq(fqcGu_#LBjzJDGOwK=tM#ix4jGp4y1)5%(T!YIR=0v zBtj8^Lg+$YQKKoNAXNA^A&YQind*LVrpcpwU35f~hHZFXu!oWZH=v{>nKm?hEd0;7 zpW52OBre9X(&-|5JA}^D9M6XBh8b|$Xg3FGGUFO4hY^|nd2K${ba6LK308}f3Ba&kHfI@7v6mQj{r<(4L~ zI?X!CIz>WFVv8G!8*=Bp75sFwCesw%Oqz6(bjEbbbXxaL8Vd(W{Z!d_*%Vn8e!XF_ z+1VIbAb^vff0%1nbJhe1IooSqF_4z6ZQ4L?KuAO}8IuI~$-iv+mrp>JMU_PiJ!x0U z$?Q0QPe7Ap=+=b_%B&8;$--YsP|84xNXo&pDwSM9Kuf{1J)B(U{FL#C@`(0`^oV{q zfoWYzKubcZ$ma+#okwqjT5d*Iz~0-FOw?Q|xgoJ3xq*3IU}nWdVuPgLMdID7nPq)P zN@i9sxdEt?Krt@I`N5<(zFSdR5Q+FK_h31*gf;&vSju!Il|Wvd zPVxAlH=kJFT11yM7vFB(O6t$9AMYWjfuX$WQW&pYL>D}lWWyw*&!VR`6zybzG>iFU zJTIqVYS&3zN*Sk->|R1Dl{B24s+uyKov50inxy(uFJ7?Ff@05X!oqZ-*sRWpC7RJw zI-8D;hD-{Wl+u?uAzzSmG)C%JRL>fj>_KiXB_;LM^B)BYm)R6aWc(7vv{SL%IUu2% zilU!FK{9GM>(|}{DT`&YCb{&Vr*8!7w-H?g>vvuF%g;IZAA#U2Jd-Y#dj!7$1&_YR zxW_;nu=6`A$|XUk*(;vUcw;r!2fD$gv(Jyje1F_onGa~99WtMxrBBOJqD|ikaK8H$ z<3{)Dedn{zJ?=As*Xo8smsxcQxDP3|dKKf&=5G|8Zr9ing}473=^z%Dz~mLTH_=-~ zN3-9+hK!)y*CLexNyh?`wO4~lzia{P7HD3n3;Ca6KsH%p$d5z!g zpdB;Kkt_6l?J?cxG#e5Vgr7t=Ke3#DW*(R`gU3qLp8+M`eZ5p;1sJTe1lX;E1*Wxy za}4i}cak-TEWTr#h{6nDlYy}bMmTMsMpANsIUqq6!6bi9u*M(FIck#-W)`*{Y-6+u#siRm3Cf zUmdaR_mFX@nMIYtGTFB1(;+CVN~wF4R;$`}@6(HE!+IdDl9V#g z-Lv*%SisR?TsV&OXOKSKCXPNlMg= zcAjM1n|@p9MYPgZk}FNuwl==*+}2**{e88NZp2QZo2R!szeq`@Yb&kE%EB`1M$OLe z8(zmIi`165YC81PXEodK2^i`%TP;jqNTwU*kW@g%5{vci92^XdH;K`i!Kil%Zi%$& z^vXEtJjok9=00veZs5Wn*`jvQ^g$MAClimW71RG_Qqh@)+xUjuX5ajII$O}p$%-F( zDF43BGk;NY#1S2DDpRZF(^L@Vms4r&`r+?0nH7IQa{)?A?Uzxv*Wca&g9^(HciEU( zaG$a=2R(N+F0Wcr9^(X^@Qy&E3L9N;H}6lSA9qA|;P)>dAA-DWDU#Z6BBRg@t1N^& zKYzer2TuU|4U-ig zDt{OuYf4ODbr^8}6By-Y8O>oC^Swbtra_1$BOfQ@&(~K=fVgD@YzYcc!X@r;9^>(* zT010@b^Z_QZL{_eEG4M6jZI_hBPBym1z z66D&;e=!Nv5Llq!#ISB+yU;Kkc?Z z?U7Gg3jEn*g4bk>AhHCITZ%x^jC0kDX4i~S(~QK_j5X7YqR<5V(u{yfi}Os2=1z;z zN{hrvi?vFN;=F>@AN(#mKrTC1cY;N|&}IBa_rJWAe_4Y1?j2x^qIe1s#V=F~M}7aL zpD_3T=HdGR%NY+vDTQtQsg{#}zinyXjCmOy-xb#wnKypDFgj&`2@ z&+Fp+a?9I|==Wn4bIRaN)V(&?aM+qP}nwrwXJ+qP}nwrxJ)6I+w- z%=ymLOuaRA{()V!uU+@Ou-CeNR>03~-G3lIqR=El|05;hzgSwf1{N?}T(tieN(96I zhQiW{ov|3i`#XHaGlb;|7qON}EZ2`YN^$V?ap-to z<$FPHG;52s^$)$6FWWu}lQR$=z<0Lp4@ZNmy|rbKF#i+oE#3aqJbWB&_KKi7&6SP& znQdSFRP}Mx&xFl;JDBlAU-A?awGbM{3EM66FwZnY=fXdi(&e=41pf+E{}T(>Q^3s9 z_XFl2e}q{*#L8U67^4h!GC`>%_MP`5cX-TOU8R_MyEv}EEoMVt46utcW<42SER#D- z2J-#eOpKi5Z#mTiVegN%VOzTYC=|p0RVWd22S+D7mjA|T(6h19%HYw{D!JPk)5;oH zC^}jHFRX^yHdTz|AAdfips#VNh*(c=BXELJ;-&r|5%4*K_z2iYxMB6fo*9vrofozz zEl*#)QU4$Ld4(#BnAo@o+d1M&O(xyvy>Z8*4%QF~V-tC{Z!+? z-p~+yjDXG<{tMl}-Z>Z6_wyxqTlGd~`BwY}!XUcR?rl)O)aw+l)SldV>F)r~n~479 z-kxxV1q00J5k~!y0<2otC#uyldUjt<&LzWRK9~p^+N%}m&8JXhQ0h4XJY2@Ve37$3 zE=2~{&Uh?J5k?@qs;P#+q>>1Iz|nqa>DizBN5Po>e+kCM#!UDBky+U28JPb!0iBe8 zt0{>heBw_1v&2FxITMeVdx}LDq7QE&FzB@9zX{F9;-4!$Aq&li+%Jl+F>#evk%p${n6u)l$3(vU_5Qf=ack|Z>+I~Ttoo&0Q-Oo@!$c~GPsq*aBiPYW zN8Pm2%h1ls%OG=r_01lW?>D$b;7|$Cxj?BUh&6(ozM{XOnt{Au<4-??S|n)9r1aga z|9*YZePA{{~*qxE>)}Mi?QEt*9n17ZX`)Xjivhp^9Nl9cce4IS~<-vg}d@@@| zd0|-r;6UCCpg*h)Hibm>yy4-9>Bg^DL`R5Wv0d8C6Z2$$4YG`+79P&8i3KaP1Wy3b zSQq1F?~bVi;Xo-M1X?+hisjr-YpzOc z$;ogNIAfRmn^%ZIA*N1bd&vxUBFoTbv7cOAaZZn;CrqSoXHfeMWX8a_4U7|q3rsp< z(w6#*ZqThp)|`5l@tS5JJsD4&sn@WhkG#i2-9uVZQPOi;`n6! zz+H{EqP?u`SfgB{c4?M;3vtQls_v@uPWP_%ZtG&gS^Ze`Sn;SKivIcPA=nj!Q{KXQEqZR>E-1U4a;E-@|B>o5(fbwf zxeDhK=fn7({0i~rYZ%eQU6=H!`>qaBXZ);akyQ=@+9N7Q4C-6ym($`p^DwrwvkQ~7 zrz)Y_^%YCDc7WlXjLtPeObOHPJ7 z+4@AJ9AW;f>>T%Kx>g~@UB&3RRgh| z)fM7a;`u#reYbt?J>FzN-r%017D;Mt?^-uBfM9THE#4s2G)c2#zGkE(E_Nj6Qu^{w zqg3bBkz`zaOLs_~r((bKc9Pf|H^q@zvx$SIOJmnlHIEBLTDZ`R)`iSHKa6>BeST_W zli$4*i85vrZ#ax7j%qjpsepqdTW%9?cpSf0jQsX!pP5j`4nFAFu3{c%u-DC%_x2Ob@4IisbT7=QS7M^?x``~EFWRD zNMf~cW3^~xwJ>G1C}yhnU`&!32t z*sIu&U~dksJX3xK_hfYJ^7QnOi?GxwQL*Z3l~OkCSB&l4S?4 zZTDN-9(~IWTy+k6WfqZj7IX#PPZM%P`o7=#zVF-Uoc0>InBpg>J)HcouJPY)VQ3sY z6u2AmZc(gmK`tD9NFTnRK7(>di13DN*#=-f!)EV@u${eXor7$h0th;oAD^sJy;rG` z2!;CL@^t9onDfZsvT7ypOz|IPNGpXx7*n52!B|Ym)>b9}NTsB5kiPz|*U!sY(N5evc+7UqH+xJJwA z6Nhl4!#*_Q7^HVfH9UnJnUnuajJD^(2H-pShs=x1THSMxnH7KP)^>Qdx8`kFrxh*u={`G?a)N+kVY=}I7eZd1ux_{Ct+I%FT^;zs^*y5?mOs|O z!3w%2%}aSt<<_U7aJe`N3E>Jf#id&^_3b~+i zG31K#v*7kJo73p_Zz^BM8St#Ry#QG5dDiWbi&HLoR_BqQU2b~T=8>mUu6owwaS;6M z`QGKz+7oj;tHs+N!&K+j$>)>%&jg}lRw-Si%KTSTUh`r!ha4$}Fc0`Cb-Bn=*{`KS z4W*1TIqh=MhcXc6LXpMPbU8%}k*PB9rb3m)Y>s(343PnIu&9FR#h`Y1*E4?ZGSr9S z?t9oS$*Z}y#hBLxh(6yp9yF%Lq)JAy) z%;Bf7-y)w&E?q39*q=fO2C~e@Ih%E1PcvF!IU-?ss-Zcb@I15d60mg9J97}~LgB{L zq6CgXp3TKtuMaUB+%oAnM6UDy`*4dSWh7x7ll=y<2vTSCh z+XY=uakh#zopNwi7g(YYPV=}87p&{2YE7++xlJ1`+%v3cSFt?jj^{x|SL|n4k_h{gC~q^ED@+wiIw#;WOBF9NsVhiYWLT9MIuurqC3%p@o@IEM z>p>Ofktd22i(zCKm>X0}Dmn_Lr)A7C_t9$&$_{CR|OfqR5~gnaz{2>l4-K=-#2 zqmdsG8s?QBEWkmzT0Fc^BE3*D*hnJTNHY3RBKuI%4@n{pY2w@Fp7khsGnvyt6*%VY zjt6%X$CXTatCT(F=#Ec&l+>Bb3h4(b@SCiaEKGqcih(S`fh-29G*qHAlHxkI4>Fem z8tk7inHSg%N_ifKMJ|a&9?MxS%~>7~MlL=^9({T)d3qkZMlP{N9`kxG^?Dxnwg`li z5UG<0s*^CQlPKK15beDP?)?y_8|u}b_r0L6*FU%$c%ETWw12Yne*@^y1nH0l=&%Us z5DMrp4Czn~=x`9P(Mb#tct(u8{CIa`o)JGIdv<%QHcsN}SQOI!BKf zOewo)!L3;az|Ii>IFrh*X>jwKJ`UmtK|R&dsl0Own+6oM|MQ&-dat0_-*KX+U088% z>+Ykxm)0q>y`k{VP(A1D6xlgydc~<(cyjOZ>BYPk+%CnvA^AvUJtyrH<~^!A?37)y>XE7%R?j&kcf`losjqLl&nkisjJTgG52B<%$f;+ahK$j~cO z_F9~0sN^N`+nW0M&%2s!JL=xlH9=RJP9p0>#G{EP{Wccua>n_P`(5Y9wioTT<}R_@ zpDrQWxht?faJ?jFTyQ<0&b0pUNB7QWz2n}I&R^uBzFbZrjZ>vs&RC$$uwGZ)9Cm@H zldG63;c6}cF;C3Ke*C6N%0+VY@KkF2>!@`z6>j1VrX*&YeYwlIICIKzjNIUU6={w0g**k@`mlU^_G`AKdxfe+vb5=#` z;0(T^x^Umv9`!E}qZB)bE%W!8_!WGP6hVRxDaFktaN+sc~GN}gRMK4%p|#AK3b8db{c<-=QFl9t9PrH+t*B~yYyXt?vu|JC)|zmU4MI0&wy?U zcMtCN6@0&we_PKslywpF80JaDjj&68+ssx9uMhJ)>TbXDMyHdtFXM#RElejq<)X-~ zOeZ}B=z7!h)bYCY4vce%gNh4}lZYFSqlhbyv-lMAP2^q2J&1W2d9nX=>N)<&R1XQ#4Z_C0V$Ek4YhUcmbG1zS2E%qDUH-vpmZyg-%rWUe$o5+m>ZC zs~qf+JpQYxl2Fm;Mw~0b6v0#%MI6faO}lNPB+RTN3bPo=6QZG`ycpe$=Kb3_-!`9S zTZp?e==Hmxic5}DF$)|v^DlP8yvjvSF96rbN7g8SStprFzyC92 zi$>g5$-Hj{Ki@-=fxz5@p5D()xwIa1*Xk9v<)+zVsNSWh-s7;@CGi=g-W-;FM(^2G zeGlHbfdKB(d=Bb9V?JHO0S`cM_Th03bh-3texV7+wEd2EN5i%nFL`Fl*=vBl^?m=I zB5?AGc1M?_AM~1(%>hR<2?SRsTMe9Ppwoq9`NIN;@Cp-tX3*7_M=`Wd))P-QFi+N3 z?;c-y=Gf6=Pc{WtF(OtmK~^zlRxyQHHlkiO!CpSfs2pig%Yj*qjap5WUQM*U!)7sb zY}S)(Hn42g*K9WQbkP&-o_Jaf%X;DAJsf!t%(-RsnWlXv?%7}YeuZ03m%XQpahr>2 zoQpA?iz%Lq37?A@5Uf#ttVw*Vaeb_5c&ssbtSNe|3H!(cw_(ShqzryxQU(l)spCw= zi~$L$V^lK7NHRxEG63l5L#pXxtmz}JX~0jKLjn^=`V>3z6nl16J7QIP<`p~Y6?<;S zRzFPZ!l?Q=mf_)bwupwC&B3Y7{wfq(M5}yawR~dr`XaURBK3CTRicSTsthYdt8(dv z)6KptmI0G>stjvKtLmu(7Mqrr=3bO_f{Es#=E3B322C4EtD>s47;}b^qjPjDa2#(yTq5ammv4`_jxYEZ04CXz|@~( z;k$VEwN3*a=9)C!w3R8$W9hqO_l-`&ZRVb4D2<@X{^Snj!P{D^ic(?~`ifTNehTxX zdM;|(i46+t7qxB`^oq(O(Q~FO&=EyF76%vqUjm> zTe0>GIwIp_VM%igBEu58r=)M2P~$%Ac&83>ETb&qaZUB=%@Y{nN#BH5mT?tz;&Y>f zi`b=l9hWg2cA^ks!S8#ITyE5hAi}s^Dj|(Q(qsZlJh3gF=#EH+WK<|D#kgKeWmH0) zK+-rBIwcPQU(q-=a6%8AAg*4qSuCAMGEqn}GBWn1UJPaYXBtt0ad_YuA3EL#abLUj zR@~p;N!9bx{+Ev~|F-&I8#&jr3Onv&vt45EKt?5b-zTt^fHe&HDFtXtm{A0l?x@6K`9qmC}mm5NtX*ZmBB6*c^u0A zr=l%=T~5770kXtbIo&hS5Az=|g>)D~ zd;e9n$%W_YGi4Hxhv$QPBOnE&o4L^U`pO z(rAp*FpbjhWFo@jTGX3~PmoE#kcnTBNzk#8PqIGeAeIZ)Wg5} zBv|jiQ*uawISB7LxDWatpzy)`kRy7~eR4v2Xu*UC@}VNoB6>t3_$USRzYOVN?a^X> zr-r&o^&1iCK@}Td6dV3BF+edfghil76;BO$QTrF97C5BlU!)d%q~@0-CIY3R&+Hx# zx2#w7GW)*l73h3y$YJawT5=ls!ktwj>6BExK;16+bc)YiOnMK>U4nZG{s9dRA$2(9 zQE2f0hKl)GNoTX zxw--K9Z-D#*K>fLeSrH+>ND7Lji|G`;}({41C>^}s)y=gM>9P|@)dMvr!zfrW$)u+ zY(UpAWTW*jODpz|y}k>8;G&NO)p*Z9D^t==oMtHdVrW|{-Fx*ruT_6MaL~%8ynfS) zqqH}!?pJQZPz7LUC0N>9R}VP1;k-F|+w{V;!LuHJ_wF+69c}uk+mKt1SvHe5>^)(3 zVX;QB+Ylk_O@aN|ZI}>_uE0L-Z{XPRU)Up_&6GELUz}c0_DBeOHn?Mau0%pNG&q1* z^uAg29z0jPs6AE8F+ErEh&@&e;5S#?fjffiF<5rL;-!R5aYOB0w8g_^nFNmeviaYAu}#7jn7Er`UN~shv zVZcJ)H5j!YD~!=~LR}6MBBh%KEM4Sq*#9 zU2^F`dJ#Qh*?Fz70PfjVd0=I<O00IjX^l)8zxF6BC@m@%iYf=Y~<;zB9j+th-v% zyvkP1;AKL)-P9#Bl0uXrMP|yT&U#7WvffzhykK;#6aNsum;y7&24ZsQ+~6W8_Tx7h z^*Rrds9}H{B?tnS5;E%V-}WrvjbjOfO`!w?8u+Du;qLvx5PpXfAmf9v?D(3v7-lFP zg_T4sLSv`>t0JR&&F5r(Hzru+;r5Cof zQSGRN0R$kAJb#It25U+!$5YUS=P0fzo0v!R7-j1 zRgNWVAd@BLDlDu1qk5N)s*v4}XY0z&z$KKGvz7Jp9fFLne_lAERc=@AS1-Igd8<9! z;h*$Mk=yV~%byr8`c(BE3Z9suSNI1xL+`}zS>4>W&pUfPLcX1kEhk4yb7renL=x*4_6V)tAC=v$@OCM zQ8}m{0=efXWjE!sgMS&paO4s!HVbCeU1=b(#!?V>h16G8*4O|S2_1nxjkUsK`>6%Y zFzmHVBT$%RH^urYAs51cn8*MJS&Z-#HF9$+H49MIqGj5qs*&8=VZzYMhe>Oz*czHp zFJ~N-s`eHukAarbF>avrdKW~kl0?cOEy;z5tE!3-p#6s)R4<11);}l29|Y6Pjf42o z)B<7eVuXYH+;qCQWf>)PcvZxxf8qkR{+;#&nO9d))riv9HmQ7kj;ji|7#UBh`p-yK z5Ue5CUTEJWXK-ZLFNBqss>rM{Xo2tt1S!5~r~@gYWI+Q9=r%D(T>*6F121Dv#;3-u62+%aEcke)AxTqRWiYKIrBMePt~ zbCJJ9dF?5vY%u+|e+mxc_nJ49m{2Ol*_Rc9CSE7~aXpicRNgbPX%Kx`_pqNKGQ;WV zjF+_Wl29p}rrv)(B_A&;rz|b~t>Nm4E#Qv~^>O*Rx!}@Ga@ztsI8+B&!g7~hyctI# zGBc47o)ey(WV=6bG*B&NSrf=aq-fa%#zoO+gxj;ooV}*rTDDdzzWQcND;Yw`gK9> za{6X{PH$c_fFEO)vP?B$SlQQmoF>%&+#S5{PxiTTy5$3UpYt9w!tX1s?IVg0=3ZJ_ z^!nNhv8^g|!f`>OXvGU;63KeseWJGVUQ6U2J1i8FVLHzZrh}_MSO?g-7_8jPyL-!7 z>p$fQeSefJ(o6paFES?9%bf&9Wu_|MRFE8wBL!k6GV7Bj<>Wv`28}}dhgj?i{RsNI zQ0S#$p<(q4Q$45lgWHsGSl9%nWKT4Oj*@zE88NV|h0fYVwbyoRez9Zl>2>wdLm1cB zPHjy$X}esD{2=;kbkvQ+&f9kx7Bf!|nW4Y&OrjtWJ8@$nJkH8L{PfhnhoCS!Ij*wH z0L!U$J3^tv@7OGz0TTHE`KDgPIT7YWfs?Gs8qBn`qP#Pt#q^&Q1j3A`&0q8L8f2yb zi_1q>&?p)^?tzl4OGKvu-LhL0rAsBh+i^PYaC%XjymhJ;Ek(q8=6V)UVu53sQt+8O z40cTi))EPS!%7I&6&+VcrJs2WacKOZhL6%6^vjQzAG)Aj(R{uZYh_V<;m&Y2y|}$~ z6q@5MdPR}&Mo3x8g%wtVEmf=ees^(h#hX2MM?^oJO>f&BITKRGFSD7K6X+xA^uep5mbyYa~X?^Da6J%o$p6_#A?c9 zlT0;c{o@;tEu8oBpf7$rT4$hsG}wqiY1Lo}QSp&~2hO{)FloHB*es&}CQm!nOl>`= z%=|5W8m&jJnKrmlZW-Gdqrop6ff7tbu`hEvhT0|M zrhS!?B*=$AJ@KE~V22E5oXn2`0_Ss)zl>xk>=Y|lIj9ffgt>noWZ@k|NYyS;Ng$@&( zZ6(C-7~CwqKq&y@mAW3_=?vJVrw`xvo9{1^^Qh*#5qhgn%VSsiLAEA9zOAJx_|+EP zZ9E>mNDkdtGTk^J4?4`}8W{ZN8eTo8Di$a4Q2#7&NL_Sz<0rpDVpi-dy4Vk4{u?KiSN|B?{{JJJiv9K5}ojmqA7Q@)&Ye^b~s-#W@ zEctl9n%O3AqL3u{?$kjRD(V zHd{}sT$!u&_P+HmR4M|!ejiGRLFYb?zTI8mgHz6?`h(AFPU|VxXm=wx-j5zscNfL6 zbLxjXf;DM3`g%ccHtJOycYtk;o9vtS{FOsP=|zk}%fX@rylrFw??5Sbz|got@s-bO zd#b2VM4iZqn?@J&!{hL*O|LlU7H?!AgZmOb1%FX?_&O(o`FZGxqx|ou`w$II>eUzE z!{KSvhK8qRE`QFdVBeFWksLFIA`RLtv_X@w08c+JX**h8F;jkO%&gsBvr9f6{@;*9 zkq32~8N7G=zuHy1dw+Q}e?y~Z63rB|h6)v%L6Sn|pO3z>xncu9Lv9@4%Fo*SpIxWd z09sMu;kR_ENRA-a%1dLv`Ja(blz7URY;=b8Gu6b59J?U6ti|`mG zdqLj%)JN*>S<>D-6Ol|ppA6VS&#kYJgy10PY+cd}mmzm^#7t)nk%Cv!GL-KM`*&1L zEi6~tI*>y+z7nmmkUwiCoZT$hyBc@7>1xv%w18IO^3g?=>?NRa8x$bNl)V}oc zhhmg%+YF2O&!liIU7fe%S!cZ1LhU4IHFG;T$a_dV!iVJSOOQ#5{+07HR9o-LHQ#X5V%^}QP9Z1gjIDZ*^-$huLjrA`EU*oYJK&tlHsOAUXs z2X3LV%TT2l{W={0h+VZj1i|gS$YFyizUG7*FPSe}engk>`N0y$<)D~BEJD0w@UJ(` zi%$&z2!57lY7j_y!psV|buBQP8Yq~xYXP-N5x82(YB2EEU;={Q3Ol;loz372PeZ3} z?_BGP!Gr>rp$fHDp{h^f9N}zAL`j`hz7oSM#Y-upK(E3IDZ`x1Wm}}lf@BEm3v67O z`mBmVNz<}+)eA1{%>MDA?=LB){j&OCEzjaBy~!8{oWCK&Uw02f*6oCwZn;l8A=G$5 zZ!V1zFJD&nu~#vKp;uHtpR;B@r^hc%r{e6T{1#@V^BmjikslLAzK*l7{1;PX3oI`l zC{WXqi~Lq7{>|r6uh7aSAW!MQ{-|?iGq|%G z{KRkUG#Dsbyy3uUlAzyyXSb-7SWI1!GkpJpd`vA>KTbdPj7<>*8d@KmH^?^F;e?T- z!YqF9oJMxg5ixm{Kff8(c5GLuiF|?SKX*@$er!x6w)IYpy)5&>*gL7_j$!zE-L(|@e%nloIVN|I$7-8nBPaJjHC2!&Q{56jrg&gCvKGX zkBq~gdNzFxoiZa+9FL46a*}anhWk73teK~73b#Vrq_?ru(ip8nQ40?$z9*=%}(&LCBSY>6R>e9cjaAV;~C2UNY>G z7*Fp(%X{oI>XYoS1BHIqmQ!6s1<m>;y@%veVQ-+ zutr3${xvOpv5zYlcUk#eDBglKhH) z*%-H_-UznPu>@^ByKc$mNJnh@E*vLef3bjHP8V+nXn;QA%%c~5FgIgpByCA^o^)N` zqcifQ2a7lgyqHaa`jL@F2D#KnoIKJMcynDgXu4mN=;7W?4} zOEA+OiZRs2Y#UD~Hfu`Zw(K#TFsQ~Z3rD!7^G}$=$9J+Rdl(Hs1|V=@xy=$~@6J59 z${lu(ez*)xVn**dyRliX+1a_PEMA$~a70^{l142pU!a~LD@y$0FN0D z5KWOT zF<%CV)lGlIygR^6m$MyQ(*iECVQ17t0l!kg$^|&LCC7iTgttWQvNx&r^6jyYGrZ1SEKO%R_Z^JgJ{TQvB-gD)NgLsHrfIQ?T&U$J80b{qz*5#gm>X_k?83#ny}IJ{kfo`} z6%JrkehtSC9q)QLiiOadl%DsKeu;qTDqk1+O|^W&F$FUCW?ViIshDVP`3qhPGN_{vNBwPqUAn!u;-KyBK<54?NaIAcbXIc)!>YgsedmP#1IgviWTv)O8{@FbAbm zZm`BF6HFQQo5D*L=l69VZ6@GDW*a}F9NNhiSp=O6bf>eJHCW&NH1&Ofer-`i(IKBj zsQ{z8Ur@Z0Ut02I=SYFvU-;8AAxx2IC@+Db^l=Gf#5oee{esh5{jq(o9Vz8)pFgLL zsL~|8cuwgp?~2O}1rtqa^JGCaJiiCjL_WBpnkSanQ)8Ar1tP3zUccnMcX&$5ud92o zvg(ntQi{)Zu^N|4?me-ooq4^-or9)q*8niKFL;xTv$Za@6s?+fH@3Bx6$TBG6=|xr zz{iLW?#(0hbj-KB<5jFrMohF8vc!n_jo>Ty1^`C;{;oGF88K`xjze%WPs`E+>KEEg>^R zH;W;b8}}>7!}&y1+AgX%WLZ9+vs({8Ie(lbBUKRU!O+W=lKqID3BGx1RA>u0@Z~)o zQyNn=$1BZgXsf>?@r?DlgTH4x|0|>knIhn67Hp;*>@BweA7bpcY>|3|A;3~Iwn(?1 zX$3`dti$G0dd~~da#~}kU1)HC8QQ!-Bk5%DDqZrKm#f-%@Q4Ak^w$Sn@UyzHry26i z7N5JbSegoiYLOGaBGP(-g%cb1aZiOu55HvSPGoG9*}MmKt*WKLC`|cn@yWjxf0fTB z*uMenW*=5)W|Yo316;-NYGD%VSrIv&N+_Bo^)3Zyq{tk-PqS>6P1}1@E3gg~)GjSP zQosc?Xd@b5ko$UWp|0@Hh@^Au1)JMt;juQKFu{^FMAH)pAZIjVH25LT*NywR8aJYy zs?8V0N6%nK$sAH#rSFhETY|>R{9V=s?qGV;Y0s_bB@Z%ZfU9UiM5M4RQ16S-^0n@% z*WCp#l-`8{T6%Gyc>~eepd1Zo;%k`)Vq@3XrX-0~N7?_V;Tw94&I*jC3&}zo-t<6T z4I2;k>l2RrZI-yvsl{#ZI&VvDdiv4W0#nvEa)}=a*r$&iD|yD{DoW~WTfeMr>1|O@ zaPx1*C4uY&8*}m8ZS-beSSNitHybpKT+oTqsnUUbY{1RA_Wd!OYP!E}b$o{#d8g}? zso=8H%QC+_`bDI_qZ05Gp1zx};u*_zn=7#aWJb1rIuna6kCDOW7GplhEV^1%9KF{O zcOO*OJUCjz_#n_9aHywVh%&Dy?vV7vzKk*Ztz{8yKjY^e_GLhVVH=j7>rBJna7!xWM02mko)>4G4*!;6(`Y#Ige}x>1;}L|%vz6r)tMe-nawjU)RugsI|B1$8vXozT$;_uGorqc zWGdKNl0!Pup`BqJ9?nh(SpB5N%?B}Q5V@2>cD;840;pHt=E%Q#r>$Nn?<7cB!mo?^ zI9C~_5*4afZg+n>rZ}8MkeYdj7@sMSCl&PjyT_9lzVUuZg(GTIKtgd;54t)R_99 zAB`5J>={nij_HbioI6BBPe0s>$O>KdMc+`yem9St>WaTDrszT#?_wr5?maUdNsM*8KDB=ga!i*?CUQ^dZw$XGz@-ov+5hr8b+uWUCt?k5=Ux z_~z1JMg+4#sUgF1Xx=^Dw2$Dpso6k^zWvQx_IvOtz4 zQlAHoPS%S7G&Do=rl_Hs*`0#H+bvr6*viX0D%bkYl~Uip;*0`nqd?u- z=56~2`jINRYWd{Om@7`f75B4T6c1X_c>sE)ogBb-;Ti*4h%MIyqq7k&2cc`wM+wFienI5N}H2am(hOvEL=1dQtC8Nf8Jpv_F z3Ke!USw)TSQTTR5oi1R?^MNGSn80+dp#P9}SPKHOYE1>kwlbi+G+{`sP(^5!->z8~Dfh zL+dPx=At9zj=bNNU=m$UmiG;kN34==>O{E9_Hv%;4&19^7C)ZZ@_GmD{V&fn!#mLP znA0B4^raZ{0Oo8j*fKo7=ia^|hkIhq+NaPDqJA%e8<1md}~gXL664 z1MBVQuLCHf%KFTV3s;qc%(;^H+I%yZg0Tb5CI*O3a* z&!Kd(VQGg<$I+p)Jw# zp{s4nV>77Y1@Vok;7jx5jmB~|t1$F=#G_5DqqF<=Ov4& ze*D}yl0zEKBkHa7Hn=_gY;!umLAHtpaJupUMpt@2jSOjgc1-^PMIL+gAQ{Mh6sD=n}Oo@UimH!xB1Um)zKr_X0SymM9Hk5E^H^3aJ zz4M*T*_QWzKz6YM<;AT;umouneGZfjs04#)p6y$gj6$918OfWlW6LTz23DzAl?=Wn zuj|(btMv?CF^1u%+^1spZ6hMt5HR;92P^h;Eczb-(URov5)T57790Ourctzrk}XD= z02{}>3rY{(W?Q;z6ilNTGFj`o(8KTH3S6j;Dn-sijtwv9WWw&Tgs0`a9zl`gOGYvt zG7Y0e)Lh4gzJUaF74XX|7<(H9fJ^~y({6(gIv`o}Lra*W@6w;a9v`m+@h=_WhQ*XHzBswsd9avzgTsZ@pVRT!qi$rC=!g-)^FR{S%&b;Sk;Uail$e%S0W81dvbl99@5@zh?Rsmi=Xrj=q6mLQajN)t?)ujP?{fNwf#E$AW5qC5-it?E8b3BEosvUh zuZ}tb`H&J+(gOhGoBEY;W>|b;)E}t`_py{kYcG@!2?rB>JlSug>0xb6l_cK6557{t#rqu-9nQTr2XkMwK~%WX1kn z)oq487(T?Y%JdkshUmWiD6acRRNs*fWVmH1bG!TNP z2VN1u%n$#f8WsP`{y$uIC%B&Qmt8JHl9o#-dlYMkHX(XW_zfsLLAqj!%0Vrry~?D~ z`tW)3J>*fO<)RCM8SOlmg(N}XyhNGEJuId`?89k)^m87mufT8+!PTP=@X9C^Ym$3M zFyzB|iNIScxIs*SwCTN@UWwX`c|`u_!amB&=1f%&gd$?2zj-&|CHxWuwcHQ3ZHtaY zh&Dk_L4zW~)$8iC4f{CDP@>bUE>a?;D6UZ5(z^?h(jI!N@=4aI<JTNV0vvg@Nzy|LijSy3BPvh-dwdWL;gkk!IH(DpHp!a{&o zI{W2hF&Byd!0m_y!<(1?b#r&;_~h!UxtihxBIQ>F!u7w(2hMGQ5+QmR$Mw@!B0}3X z=4IpD8+2od>~!S)!%XT(1DbQUtyyu}&XS3RA6ZO?#ZeqRZCQu9cQwdY8@o!yz+qTQ zC5BawG#L{wt*rGc-jtu_G>hxGDQRWZ42%!lTn}p3b9%rKtGKpchX5Z_%8Eej3u$lc zHT-@q!11khe9)cD;E>Cl)B>5~s%jA`0pu-W(;Twa?{;kTLil$jA*8Zyx8AIpy>528 zTK;LImrvvJ?o<7Vw+zN)%b=61+S00EX9e;5&`0)zBSds<>&~OVONT2|j<}+9p(G-N zC5#y=RK4*pSgUYxDnk`z%K-^=4M1_&U)CJnd_hw9q`yCKR0iXUAaNxunAFRgEo&Ih z5%MDAEMX<48nxjVO=W!_UhZYsGyZCtx3Y9`J**8ieO@h}R0ry8uUm)}*dH<&%@0l> z-$ipOx{+txosS8Ue#h0E?gRXit6+!H_pV zgEX(|H&~?nN_u#AeRYzz(2?GDk7xGygJP4Q+#sHGV_Vg5(Nh}*5YUoY#QDH~k!6Tj z`Y-mqPIX|ZVQmwpUzR4-w}d6Cm9TYOr_jp1iJr~WGv}ab6)nj7In56F!_Jz?iS7Qe z(W|(93e!AVJ%il{>|u-se&sa&zWV|&%|txA#60D8D=6e*u%L4|l~_xP$kd%*ZaVsL zif&vwH82kdbv|nYJ{NSuO=>6Sl;9BC_c2FlJyI)Dn@gGstNPk_6QbX?N7C*3vgol9~Z=AuPOQVv#mUgAxCWU8k|J(l@z zQj-}w_FXupLiNq2Xs0f;%)F@4LlDA)Y^E#yp)U!)CqHw&IX`djLnPm8SIxlq{F1Tt z?`Wtr3qGUne zj~~dzphyZhGjsGe&8&#X;)vZr;x8EJ{p=BtYSlDcq$#-*AI(#i*{3R=aKhbAAWz!?I8W z>kG-=F}igDQ(2-X(+d2Lcri@qmHg%vRB{qul%?sJ5**_u6*m^ZrDWI1+MzbuTl@hueU!8?my1YRTO4BC#z0hqr6+2GkkVuv7zV8c`ZgW=lwGKAZ&wS zTd@Rzu(h2~>l33c25OaVDUNw9qvu!V`zs7o7wS}mbV|GlnoFLlS4*%1p8C=Ja4iN` zPV~Ec-1%C+yX3tuE{=9HiM(joS&Y>*+22&gYBq2t%_>zuTna}colkr6-q^mCJIhbu z4_Ud*Y=yhl_oaK~`hTuDoKHL^1QqOv5*BQq8SJcX?zD1%*2s4}(;B%N-Y!|GO6@Es zH9Dgn5~HAtPS6X-^UaZ6j=9VH8t{Pl3(aU&5^l5oQl`In{ z12jsCY9T6JkpZcb%?xyaC&HViA`$9BP`+;;S4jbXP?kePtOO64!=LVHP^xQohu4Su z-;Q5@T{5lg5C6cBFvjb$mbrq0dp^EYM<;vujzT=^7s;_-`WiD?zNih~=<33X~*g96x_vDz0; zrM95-eE00>$DFLzil(i7{-%CfGY#m{}3{agfSEq2~j7x#!wExfO3}(Bf*B;Y!D&+Scnzz9)jcxo-)3 ztj&CULON@ga(Zk0E7iF+3}6ZL_+=0WwTV>Vri(WdM#0+D_RR7l1AnXB6lftjDbXqK zvmg{!rxCHHy%3u@-l2_njG~}{{jLRqGnEc(BY#2sm_ut=;vtxpf zV}1OyoEKJ8Vh#8fk`Zs%3!{LrEMZw$lcVc5W6MZph5Ii5=KTKEf84tUt!WZjo)(MT zBGs-qFPVqT&uL4D3%y87sP$sGSqp$J`mf)*ezYVt@D9FbI1$(@pc+u}BS}KLi!=;w zSyM){Y*Bjs%6NewO{kqZM-!A?hxRVUgGeExlFg~=iQ##3)G50`RudG#YTJ~F*M9I> zYzVX6)#tBhrEQW~?T~6Yu^Nqj3xjq}v*KWKDtey1jiEELBU03h$vL-4vbe5y;(|Ii zHsZJ@;sD+?&!V=;MIaa~R1IBz`H-Fe1)WBMjEzh^*jrc`%2?S^c{nC^0SskS@& zjNN;)D((~Ji&zt59~@mh^r-frtA@9ENU)~^$Fs1wKI)ynUP7$UgN1uW(NVSOCQ@5H1)OH65qgWYZ8N;%XHRjzBrb57 zMp8vsBNjA8JLF)|=9}n#<}lu7yT@dDh*ZS*P`rH--S>Y*d>Tj;^&nQzMNK<)>eKKY)!xmM{-x z{*NugEBTx*BJs~Qph>pTj7i;vvNfIZCV+%aU&A#Z%^K&$2}SW8vD zh}3FRO5duQM={;zaa+b&*+)=OX#4BmiC_+AOl3RfD*CgeY==Pcg)I`5D z%(;@@Vzod^KSkn}w{veY1Ac#&_p1yiw}*>mK6AH8pdJZJ6q_W>t9iCCFyFgGcG@PB z<$>sq-9=^Z2b(x|NngClLoB3=A}vS)qNc8UUPo@jNl9OYs{i=>IuRfrK5_TRAv9Qu zR@==<**0g#g*G`VVwq5`)t%)~-jiex?T*I1ny6&=1NK&S!F^NQQIw`!*FY-J58Km_%P8 zU1MJw{31(hyj(})u`tdI(AM@gExw~W^HPqV-^|bA%WnOUHhytPvrvd7QMVLElj(w? zkTkxl-7{QNohN|L7bS?5-EdZkDj6oVN9C!y+%(<;?V7OP%NE#)uK&9rxxS(_p#TR` zoe<#I2t-D^Wm%s^F5x{XTx}Yf#78zz7@HHGYiKRv}+6g z`klw%^2F%uw*iztWWRSLld8B8e;$}p##(+LZn zE^B2Qyor~14ICu1oC<4EC}@pN(J7<+p6pjnWoO^rNP-FDy>q-SlAWLP@l-~d#EdI{ zBI}bwo#*ZO^4AOG+>h!&Y>n=yY-jxmh$5A!c=&L*^GUM7b+^!KR}<``c~ z_Y(c#5%lhy#N|XnhH9k96a->^Yl za-d2TNL1R8dEUT0Wle!aGT%-*OFWiNiAOSqFZxC-r6v(ZF0s$_tUvR%TL6F+$j*6< zSJfK%wma=IGLOYzM{IYwiCLoTn?mhuF!Q`ya6+6yJkJ^0`BE^->4#rQ=gOSJfzWdg zA=vUvi;vObgr{FcqXG8o_;)&r7wgHZRTt>F@-AMU@CTpIcuYJkWL`nqC{?FQ7l2F{ z=M}YH{CiH?0@KikI%eqK&Zyf>82Z38eWP{0Or^Lf%FxM?M%C**Un-S|?!{UFg!A} zH)pq=ekSi{3`6e;n*ggm1nj@tcBi=1n!#T)*y8|0G&;o(dYwMsStD8pqHmSvRg z3eii&nBk<$<7WEQZN2?g4uCl@Yh&N%8H+O83q-xi>7ojlvu+laEy<>*G#BnHigdG? zJh|TBrrnxECoPkjVS?tfgiHRqPM$u>EY;F{u;(JbKn=Ft2;8 z%o5=lL^7LG?lu&k`zCl46WC><>j>oWrawD+<(^-@3=IHLIn0jOy-I_n%+H~2Fk2SL zkHah3Pl)sdjDciY0qZr~i}x*o?_WA7`tn(Uutr9S4!M=cxA>>O=1|)ZhMnJbci)Mi z0Qaw7&a*xGSDP~V$M`<_dt0%F@@!%XdK!4g03nKgA=>1d4qC_Hl)t=EDge-7DLMe44s%RpkVIOO89!o%Q(S$}3d)hS1JoAA`7?wO7pp^960sIn77z%&R*Y zW;UW<4JMbn0(LG^LOapMWsgm53^OIjgPicDQ&-7XGiegmI^_z`ykBrx$fqBlb$V%!a0(Lem|P5J7HcBWoPl7koUK3Eqo@2$$1 z1Y*gePMyv*h!zQ*k9^nIJ7Qqn@7p}DRis!p+~msuOY#@sdkgRy6AjtsnsDV)+IaQ- zm96y<4_OQwq3|2V0RSW8euUVnTqnCI9>7xrdw_MF2>>mFI-`n%%5&U8n$*q!o<#^6 zLpU;FL~)~J z@C$A#8-?}pSR*qfd-*%0w*mZo9~Md3!NU%dYNC@=!=$(WS)`VvVmWe|SLQWQO-5cI zBXsWlNb`k*pDe|TkGmG${lh;m8h_3szAY)OcKPt5IXI!L)GJItJ;D>ETA5(GsY^Js zDJ|;@<8qfz}21E9H*tKfZbSh;pY(WU`DGRq!CcP0}Caz8rb`L@(t&yg>uxvcGXuCiZ?t zdsBdG0+=&2_48dJ50!=(v9c&D?dg|Jxyr~v>hqIP1udl!=(toMW>Vza<;qx5BN_EFYi7z(%EEwD(o>pcJs0!tJTS9o4;4 z|03V|{Gm4ig!16=359a_Px+4@{qm7yFO<1 z52n>H-0(j-(mcVQLU{LTk=UqYiM2R=%9fgB7Q(1og2c6weqW&_At_*t==cif;d_6V zi4mtt(};G%%Z<%wSFd1})_R`(t|_qpmHbCh6-Bc7ZQL76QZsP2mnfU#0hE#UlCe4d zdhp^Y)=y;~>B5^gleKUsQ&2)Ev_^k%?}G8edF*RoMisi^*bILEY%}-6%DQ#%y~RdCoE4MHPEu zY%=WWdngfJJCj>(vg-or~W_$X7tkwg_xhRBa07ArgwTXXn9|q@{bz8oH4CmdGn4_9Q0IP5Y!- zW)l^Wt6Pal8dR5GN{%FX+x{h$*O`E?c*ni~(GAtZ%X;4p&Zt4Dyt23#gK~grCSL}R zTbnbn09|c78EAz;tOw>Oj5cjBOD*tR>^@+o2O#>Ky2kdWPx&O--XMd=tL*m5QNK^g z;_R~Zra5CQ2N# z6z(m?DkpE5@Oq1L?|}~zmsSFdfNkmnxO?$ewg4ZorH*JvQZngGzT}%_U}pU5=+;sq z#U?9mjWV;GfN{jM8?Yjy!-q>8%VXuz=8R0B4Z-+iU`cCWy?*8`VB`GI?MR`B?`bw> zgo$0MRwZSPKA{FO^9E`UQ9On}+J>@S_gvrU{f_@S6tpLkF>Ox409dx-nbszGSP?J+ z_R|c#e&D-|kBs3(F4&?jOg%P-&4xc5&qR9_6RgQ8SYv!dcU^YCYqmytpMUW1--vpc;XBi6QX6YvJhR5wedw6WOEgA#>Mw) z7ahY(IZ;SO8Xtt%ox?r`czq%xk68LsyiUH8sda%KiAD@TBY)~BTv!4P6v<6wizk=S@j(fG>r6lv%ro94gr8Mc*=f73% z_bE%Pq6RI{2=*a1an~N$Xq^gMuMclTxO}fzxWMTU9@O0Yen^_~%mv;8zwOoE)i8y1 zT%lA;oC(ypjhg(uKFvlPQ#X^>6oUp7;xU1vOcNVb%Zpe^(;+F$Gl>pJDFj87|)-Mt@v#9y)S$3XtYO7HvV>7!-BFc#bC)@dYPDn4G4?7ld4OqKiv= zzVW}91d5iZ#KUH};Cf%1GM=u;nGgR`JC4gymo9xyBP*_(;km^0tl?tXML7k+pIh8$ zJS%!2h^{syBDD&bKhjH)yHcJ8U;iylZo4zo`o|;VL_kMcu71ly>4L)`@)qdu9I~os zi)K{u#tve6w5@HM?}uX>dW&(IdK>k?@Hx7eZ?P?qcSAmL*@Gi$4Y>nf9b%o;3GYk` zS)67jX{yo6&0AXZb=aqdh3a zhTclBc*2x6HppQ;4s9q-y@Z3)oA(BGOqo~qnmhs!H0svjt(c9+&Fu=L3>uPK&iVwh ze#sPQ{1bkLbCo7Dx5!WP+{!3~l>c0x)SL|L#(au?#xMpaAWWt>bvS)0 zN%L`i>oz4y_nBGkgFWXSJN~u|U1vc*HQG{yJ=V9ZP#k;2=9eW@OA#JqBsjyn77YLG zwtK>S*AR%kKasl^4PB}W^d8iPjvf;p)W&{{*b}VPAnfB;jQjH-Sz^3DqQV~(+&!yY zzLQULdkdUhGH|GmO5mNx`FT0v&5Txi<)$hJnZTg02zKHSy*#Iz85@`JCS&R^;N}Lt zd9tZ#{Fnrk##2n8;0me4xO*v+FR=BuRaQDOEd0YQEv~vArP00o8nZd|AueZYB4MM` z>&n^&JBefgKx{a#oZi6ens%{%;^wJba;zX=dvy@usWfil@R>bba%AD@ZR}sXw2|`- zSu7Yeh@m-k>T_wg9-42Qs||ST>dDh>wTB%%{ZbQdo;0@1GvEVL|HrP*?M^tRvQ$*n zFd4mggc&QGA*nT$srOb@K^m2bS!$ng0n^Caj*8vgp@A76tHWECwgH*|xgSa?(NET= zUo5GuX8U^Q-xqDZ>a34RWygbR772nwdg=tK%quq6(%ZxGy8zwcKqmdQ(S%~|&x8a# zXPd8d35W9yezrdXT5fKpJON87l*SdlPDF=4G;XHK0L_^mFz+{z&-ArzZA2^U^LcDzhWxvP@yu%AZ0VV}glj9lF>gE{vzf|BMnXE$UGbJW$e$6nGZGMelV!!YlLuLc9rO*O@4q@A}J;tplRKZ)1D} z_|Y5hf+rGz?h0|=u9AEdAy`DF+$fK0D;`?^)9*fPFb{;0SRDu;nR4)udFaO)8J({Q#@tbK^@mCJBphNHZ z1F*f1jA?fYr|3S$fH@od1az9@duaCr@g2TaGmWN;`{dn0^b&&PtmiM^Y;GAVS*P;f z2~^i^irnR?C4NlGXH=jJ0r-Z%BGEE^ck{dnZpsdj#!!c9{SF3rOZXo+x|Y36_#Hzy z&UU>_&g6C;B@nvI+6kb1p5v*n_Ov?xdHT|Kw3V?_uu$}i!;>-D9oF=KhtnL`!*xnW zi&+047qcGew%QTBi+q12xBtLAD(&*w=US(B!Z&syKwQj zxQII5xv+7WTel+LqM_N)D_ZimQ0F?l*!uOPE22BdH9Ks3zpYSQEu)CX0^Lv(RP4g6 zbkQCe-mN}2h-joGkvIer6I+v-Ym^bH06>0!QA7T#gO(uv^%5^V5?oPC04(rKLDeoaPcxS4Lk7bB#?O%n{_81&6^VH(X6w;)}b zjEW>;=Z<0a{RiR6b@MjzrCbrb-{ke+ro|BMg83b)NC}VAM*fb`z)^!O#NmRAInai7 zkB8t8FhDyfuCfI7N-VvG4KBV#O!ho#m;Z<)u5rdqjkF*`MT;?AkkB+EI`nXEUT(T( zVh1dNNsL@~(xq?Lt`6jkiQGQp)`xO(MSP?6oZCAb+7!S=b_ySZO>=%`kxwFj**)Nj8Tsx?3j~hmq@=4o@(Lwn%yre8)R$ zwuYZ6-S_~{(lo72+E?m%UgsrqFi-ga4gJc zbF}*vG5$<2O_?v+RQq_DxueEjD?}ZQI^$awo76y&z|8`{sfL?UmX)K#nU+d5v5eK^ z9iqgQd+{@0sqON0Z(Nw84GZ;bJ9YBSu6P#S=4``#$|KzK(P`Mp?B~Wsg#2stp_6y| zdHdiqm8AW~VP{+5Y4zCkvgGeIu1(+Nx9~|xW8FlvAg#{qO~JqWZ&N{$>}YYudP82j znDOqm=~n!`@A!RCW|4R`2PB&(lHyx9Gx_B-N3ve7FGYPS%Q2~ zO75Dxe_{3+?^n=#z*6_!c;M`s*d6AGF)U#F>Y%Pu-WbgI!Sz#}PQ12aWI?}ifVqs# zKN3SDeG%|x7ira6v%c}GaiKN)>VcuDv;T`H3q^)86G(UT^pr87tD!3`sJbTM*xF}P z!H97akb3%R2&6P$!b?>UFL|P!L~Xa_4>P&}Y-j`{Mxs$NCtKRc2b&@c#$fw`Zn1WM z+(m+3ZLB_-L*u-%s-_!nvr4^AzdJ`KcQ@E$yX@ExC(w?FoW7tLgJMNY1Ske6jE_37 zZ7I2**`0WngCT+B50~X>TfX>L-HTP1UR*KevxmIRW(67FYld-ym}|R1VkHiE10d7E zkT=GF-NZig1Dw3+0Uo?%wKa3(+E?O9d4`{>OTjqNe)5Aw*v4LA&c;yOo=inpcDTqa zAXBd)7mq|HVB|K}TErc8*R#yj$OkLFRn3bT?IF<+eNTGdn`2BHsTmIHqb=(A(_U^H z%K_{dN1P?7!z5A>zo+iN2E?=z*p#y*6a?v!yRE*~&;p+<5h|iD{ z7?5;2N>+KS_BZ5)ZSkq)6^VU|>V@U3#_b790?-U$@B*v&w7yejms9So@>)P^;Npv| za#1BO(veEd0B&3E?$}(RjZso^CX!&wa{wf4?%>~EcJ#6e70FfJbmVP=!->E86My|+ zc$|S2LizuEZhH>FIj@8$OhGa91QVT4eW&s3W;b9%08_6RQqKQ7f|j>z2zvF*H30!!d^VcfyCKCMc0NM+;S zvA^9GoBO`XR1*l@7jQfir`eJT4~t@pg~sA1R$HU!VGl^NXrkuQh$`qy4dB1SX%Pz3 zU%S)gIxfrBr6nuXX*!{RX}W3E7y{UYOM!>dsu^148r`gsUde#TyUM+q`hCLvQZK5P zd@FNiIz#>dzV9W64{L;Ht8EI7_9nkrbkV6sslFjm!((9uu}BMx1@Q%xI2}Ou<*a== z#u+mSMvziW&F?Z9ykC!0f;^(!i3mhXJtst!8aSo70wk+s!B(W#CMrvmjV~* zDyojs+whq&=`KYNsbjH%!z7@}bJ$Fsv;qxZ;cf9uOcJ4zhvu<_w1BFIphd&XoAgKV ztzJP}(uMMK`izY@8_@PPQQbzivAhF1=^rlOt?K z|LE?Rm}AGubjB;G^eS4vcQ&1toxaWAQJz|zoSsYs_ZPb=w6fV|Sz#6prhhwgWxFFQ zA#pJimd@0wtFp~DkXoJlxYWK7Qqpt77dTwgGh7Z5vj@;I=n3r`y5rm?TeY-xYIDqs zg$aj7AxcCwsG+H=82GVP{`@6g#4eO2X@26o^4?=wgC@BfXohM`OK~?Hna*xBzi_1_ zOJUP`EPMW-%OF3qlJ-7*95e~`1c6^crw^-(*sGkhyz)NFbsnN^ze6DU8pCSsWH_bQ z#pcc*R(2+Q@U6d(F&ZPsc`3qMc0*o5hmxikN_6YFN*d(r;>u4Bb3N#!PUy^ZWHgy% z@dw-ooB!@?LptEG`mJ6i^-!rldoAng{-&t_8nx>y*MzBiEvebqR}ce&K$h~GtSnY* z;<5V-<}Z?1hGcM!qK%qZJl#mBSgRA<%Y=V;P7T{aBiyyHj=wacp8dX*xg@EsAq{={ zCS?@D^dK=MlKKKK)#{n$B0lsy2f>Oo94wIGooyo)#^njLA#pu&vPSdyYu`9OBWE3U z?3-M{>O!uA+Hm9V(@1|prx;UX&Pczz&~2CSPVT**RN4nNS4g0}WQlypU@Dtx3te#e zS8ZcW$~>w?qYAR~8+Ed7bSBlYj`oeI=!WAp$NM+awJ~ERqoL{W`xn#OgEO5De$-*Y z8_6xzGCiHnXy*t}5Z-E8xbZ7@Hk~0!{>;chfOhTiL9}J+ zam}be_TL5jQ>L27Qb*LeH5Andv@i{Z{HX(<6=GS&Mh|CMKk>!z2AtwpBh<1Ff&H@M zxvGaCjOVdqhMM7%nlj7=Vnn>!#~n>s>GbZ3>XfavNMwox_hHG^vvss1!(90ni3GDz zdCq>^NY0nXL;DFb&>Cy~ElAaQ$#E>eE#`gJp#5-`DWmmXnt_xl(!Lp`qpN#Opv&r4 zwhwasz`dm!2_`VaXm*4hGtv4Lp3tI+%Ie3ZnX8ovy(N0hV!r~7J`}dYsg#L;P6;tE zBItn1c+nRrj82M0voBItql`2cBE08s9Sf03?Dxm{$6IhaPL|!V(R1@ShWFeIx#Dq` z-)&(DsUnVV#D-|4%d37UH|mucUVh^rK+Al0M&ZZB*0kI8 zcU93})A6WxY^93%Khp&^IEXX60|0A}m*|N`?FtZUSpg5~v{B;y zaSl>_@omn&LSRBH44FY|{*E9SuE!iN&hgFDUf6J13!v0z{gf@{spwnK$&OF@zoO~Q z?53L&WPc*Yb$g1EF5G%2=%ZPrqJom=oEhf3DTq;I!s;6+Pn*{wJ@$O9}=>YW2{YSeeOU3d@{6x}qWZvSC1FV)B_MZtp-4i}8V&&Y9O=_8IQ>s~)+x|7x3g=xp*l$HTG|mp5mzYHo15B3#j=H}gaews3xJ1mCg}gb$94 z4oc8at5WfW%ZhAD0L--Rn7YQs)i?P{E)yuNbp@Dg+i&l)E=^KB@RwQH_*NtDJD3V| z5$As@Gz>qm>7JfoI9H-$l@$eF!sEh^Gw+5_$R|FZD2g{eA0US7@Z@4mMBRNQIY{?QkIRHS;N|d`(}G8n~0a^TC@Y}<5|b?&+m&FjORd#NCP_PVP+2zFk5{HmO{S(;jU(o~(1xuMr~2?PN> z6^g7596`3|@5&tKgR;jT5c(f8zLgkHfX<-nL;KQ-r5$$8O<|p%K~FY6M&16}EbYTE za^;G55-O>S9%X*52%pORdMAHlq7L9i_EawNSW6<*2pUql2&1|ARX}(hOL^bYMy!r$ zEQXdqDd&uJvxj;?2$lhEIUVj(Vtq>T`36AsI3x0OAZDe=lTp;iixX;kkm6MIR>yKQrAD4eFVbR8=@s8q_ zLUcJXZS1mQI%hd&&<;~CmzxQ%|F+^@AviYMu3dOAt<2VRFtx)fMw*TaueP8>$|mXW z0zn!jj0F=ZO?ajOkBN)H`-f9F>aHWvmA%`ln!P>m6hTKvARr&)RbJDXZ8owU>h^`f z-UvEH%$36)h{q^uujH+2VKafqij86RGJrKrA(WT9aQO`RDx~1#{#MK$LWlJ}UgV}c zZJpYZA)sV<#5fvQbi#9y1we|0v^!yd*OC z5dv&6x=A^Vo&K&vvi)HT>dNBc#Wgp!AoIy!8VG`bH4r7gT{E{4WS36y&pK>Z_7RQ7_ty&>s#uYp5LkYz}I=KT-xHc5*ox zK;bGzl9}k>aI~FfcbRr7*a5tq)FZTxTnYRi0+{Q$DrcB&q9K2Cb)6>L2e;M} z|1Wdhs*KO~$D8f*HnQ)spymRE7=&!PDi0^^pi)M+LUoQw}2#?lvpX2hB zXDJB@wLBD`-~5V?5*@A_q_u6C8P7$Ihw=yIWWRsgp%Da8;Z(&$$;ho`3Fr+Tu0cbF z&kjZ@Jgm}XLwU-pmlt&aQybkyS4C#JNH!0#Q_WRiRW;}LEz!^Bs%JXKi{kPFwbjUn zf1-c z#6{y64%=(dSzk7*ja<{R;su39K&egJy@G_m?DleMbQZVU@k)hf46p;}$=~Rf-N|r! zDzG)+7od;(dL65wPrz;MjxXL%Nk$Qc&&Caql|ET=u&C+>JG=VI6eYkh|FkT|4i@1u%yuHHR98#S88W9n4PyOEZPlkG+W$YZnWCG zL}z86Kl2_&thX5WBt6^#?d~sDeZRonAYf#(W)*QU*){QUJ4)pi9P7Q#%grn~8dkMi^i|wW z=sSWowC$?grrM4~?pVF!`Na&%!Lu?1rFo5{YunDv_!IaY1W@=Q1T6SOJnY;UMFU#1 zI49-1)?0I#QCSL{o}9axVLzlrB?J5Z=3vi9p^%Ojo3k?ij4BkjB3+SWD#T@pTpsi? zj;k45vOHtHj^q>XbXemw)n)Z@6l*im&C>1DyQ(Bx#9nMJR7npq=czR}wVMP@+}laL z26$l_G*?A2tSt5{PA?8D7V-8P96V^eD`~-_hg{dzW|6iqbPceO6~MGdM?6-3#q^#} zJ~3pI&&u=pN3R+&r;JBdfUeV7v4-@b>Y4nOtgbNIK&ZV*E!|gNvSM2y*!J)3-}=nO z(Ub^z0fh%mM;4);6qS}jN+R=ZIkmJ)*{=caXP#h5X&hv#`S`>Wo^!RtU>-DTs^ge{ za}Oj12&7|6ud&KG`L`YUbMGVtq8hdNth&nZldfiypp7(dH<|BJ-#Sv1E6W$_0d*+hJqo~Ai$1>k4Eb$KvY(Bz2j}Y zK{hw4t^hYKHYztj8}b{`8`$8w4fFQtjiS%)u}z0fyMp>2b(&U*xn$aa&|tKULpo)*ERH9A?w35ALYC*xOk7z> z<%*6O&r?j{SPee2n3d_tXv6Td>>AJduuS|azCMx}0=jGe7R);rj?(WX5{M6m9h#=t zR&*ADQrK12Nsj}i!`=;O;D31=RzT6XbWv;l_4O)mt2oT>G^K-sq%nv5q1iDL%pdyo z?5?=OuY!iGS}tkvBwOKm6=aDFD#q6#x-xSk+(S6KW>i*&e?9tu#5rYzVo72)*`aKY zfk_QXS_)M7;opL~?My37Ax&`&EFoTwiNlPIcuuH)Nz1@SqlCUDgleC7%GZC zsFc~ygg^A{HIgiIkP7`bkN6HO<_GuNdLX+Z`~N{yoBV_29WCGhJec7f&0+Y%u|Jcd z8sL9SGn$upF(pAEsdFOyF*ZRFnsfZmy^i0p5%NkuvI<$8lR+dggn2_H zOl&=DuabuV0ivzXxRt{j68fz^ufP~b5~AH*FMoyWlxs7pUReGK^GDk3-5W2zu3hlc zPXnWb_16I9%E#rt0o~q|CwPN>t5?#Geu26a-)#dNS+6YLUEdqT&XIywp3NPBNA`~p z@TJ~+0{F`N-T~)hVE+sYg$%t%_^X;GX8_i?*8kys;#8=f+ikYnuwB$M2>3DN3gI4}9d= zDw#4|e~+>*>NYKMi{8=iv;+7-;}OBX12e5~iv`smVe}81OuzQN{=Sy~!65mRr?O1v z`xke|_{_c3)5^A$#RAQTeyxTJJ_llITZbK3Xb3mG=7&ERO^uTad?&qhphnvYs3u}g zMI|4G&Ieomr!|3#!-Pz-?2H?}!cHj;y9u6~4U<&lgS-(|{)aA5-c$Ww%$c9svNC_D z=<@dK{ncj_ZtKp-piIqi$l8W0Ycmj%*9UB8$5~T80h28<7s;M``Yj3F0K8+;;TzI=G$6Ze;bE2q3YM^swihMn*IoavkSIn>}1q7-V6gowiUIWns0F_GNa% znUO$_673In2J!5GGlrNL69z?Xi9JTnV6h|yc_eOGu3BWcOVgG+n~VT`7?=-cx+*Ns~+&0xKjKV&L zJFf4D!4(H@R@XlG(No{w{1W+uctA+P#2R#V_!}B#-#;B0nB`ORQSa1~l678ITQb;4cxqzKi8xKMFZK zB1tdV7Ixtn>ZfZQu#s3Wi=L1s1}ZD!jtXl1g4@r5R1K6?#CcUKycU9v^pgzruR%d% zLixUH$SeCdY}gQ0Ry_JIBssO{+@Dy+@7lMFG-iEgsZdTv^y5+4zX``9o)`r%yZtr4 z3JmpXLVpAq>}Wi)`2=hlDbWV|IKxHkx@khn7*WwinO4)v`Von>YX~RD*_RL~0!=S53v!{|q@9A7Z7O56M>h|OO3b%`bfZ^G%k00J=&l%kv#|bZCj2&zY9o-|DGWq%6 z)YO(a{ljPTFRK3Af5Si=@S}&masHs(Hp%oC*ip?4o^^l)6ovQLW>?{G^uGvvkrg1%p@ z89QZ5SvPph0j81+*|#^_0i$xzT{pnWfuM2-vH1tbwpl6!3ki~0kM(EaKWiQWlZb)Y z`%@D^#*m8kvz(CXJD8*5%Tyr%5grSyt`WPd)mI{)kj?odXVdelvZK=0^vX)Bqx5G_ zJ(rt0>4VQC30 zoEUxMq$&rStlVrjYd#6Ow1`FOxvl3Eo^+GSna&G{LMJ=r>#QuU&N#5H&l)kK&#Hz~ zKO|S5L?Ck0{R4=>+`BNvO283b7c%m za5lZllGs}w!23W6XeUCQSo-?%`nI{43$ya9iEGVS01I~JjCMP=oNa~GVtQsmX1c2@ z9E(^f7qvgD=GGtR_9~HGa~3S%v{sBa;%#||vu1|NR#jbIh=+8cgr94bT?M;c+;rMX zbz%vV577Gjd`*4*d||$oz5~8HZco2peyo`rGl>0%@oEo>>N?}!ch23t%R{(}ATQh8 z^$IaAh(-lOA{&<7K?zh8<1W=?7gSK|Bh}!eR*kliULQ&8jFYBnwTX{ZEq6hfg&4=b z`iLb>W2R%%G_f;i?L_)ew5E~We&;R_XlFXTcjxZ+I_LY&cfNDZ?>q-V8r2p;x_hCO zX6q=u$Kc0Q{ap}-Zs;Kt{VDv3aQHt7kv@rYu@qO~H*hQA*G@vJzrhdKau#GiVZB`A z_2m0aLTDAzLTQuqK?EYjkpq!X#+$p<2KxbhwxRx;ztQdcThB! z3Gse}x9QBkOPQfG(+QqT=klbXGq#2`v3<0oo@brx620%U57~A02X>QolFzxFr_wu# za7`s&z?bn2d@J9^ck*+T&#U}~i8zy`DN>&F9qE+RMmXy;>2pg0VVc91*DNN|=rF#oVyJ(Jkr_*l9mpL+fM^->__ECviK!%@W~R9Auy3T+3!yWmVuM>|izg zD)!OJyF~R;h0SaZHqcG!7Ttz!u_aK=_QD%dljTD?shn72X{P!E=?0(AR}sE?`@imv zZFDAZs{Lp9FJT$}fL4DmbHaSK0gmx^@Go!?cSudVnWEgvB-~4D;XHKkN+|)#;Ud2X zm+>tB9Xg>++KTJ(aMUxn9PV3BOF!cwOQAF|`flW7x}Cir?P33bqUgJPNu&vnN}04S zchKtnCS@oA&QbfLv}2qG8&Ns59uHByrqSLON2}aRJJ&Pt9NwiBvzM||h*O}3O@g)T zX<46c^2&HS@_C(+j5M z=Q*c7G3D{xoXOfGhx*u8zcMj9D>EZ~LR#wh6uXj~G%hhAKF%gvEi}0Zc^=IhP>tMx zA?0e7mHC3#f+Prz5(EsDMBcGBh8i%<)UlQ>vRw5amadqkYs3;2wG>M8^Hh(f8od>o z8pirsAJGRZG{0)}n{>5FOSvX9ju?l7TBx3k<_guofa)>4EzPfHQH0wj#L9XYin3_^><4 zZ-tS*y)WZSmO4*y`}U32W^>(>v04?ZuJ2Qg6Scn4T8H@h{nQ7wWjWq}?j_d;L>4m& zC=e087)oqVD>aXh1lFiVoK~(i>uUluAz8Wsi?%u1v$9;>(HoHEQS~~X<}k{#HGi;T zVki~#McXY;Q3Ml6ehnUs< zVHY$IW9+W=#dsAOvfIH`;Pe|TAT(EoHEBzPX7{jWqp^cR0sv53I?i>3ca1# zO#AF^7r<^)E13e5Zww=tGTX2Wp)t&2G9~6H*L36}(9sx{Vj9=5wL~&oOtw2_J!Qz+ zMjAzEdVscaFqN@KY!&W0-{^WU7nwibv?Ls50Xi6ESP)|PHclh3EVH6^ut;H?c9BE8 zEQn5oOq<=VQ3gt@2TP%hXyp-oW=wb39rhghAVvI0#2RLMD2MTW2TOWL7o>qsmYKY6dxn#` zuO8@E=+_TrWizJZa%A>dDMf`vGp)eVl<~OW*seX#zH{)!$QLb}BDLtlwRiF4uUoHw zJ5mx^@W)73v-Hxz&1ijbljU0EY~;wjNT9d%`cC{g zc7B2jFi2yc5xI`d1VZAV#$}%@&z7l&IBt_H9IR{PFx%4}2RzJPccn0f9*E~{%!6%E z9l!3D$o9ZsACys+`<2oM{r2=Zm@)^HUx{#L7R{8cR++N0!TDa!q*sFWExElNCyyk2 z%@HQQ&tsTfVC!g}RhNR_0@lV~w@}BKQcHO(#eK?yJ}Bs)F@1cILw-J&P07JV%p5YiL`)PBrKv+I5g`rGq);Q_zQx&_*V{|R(buB4`FzSXT|By&xPip8rxUOQ z5O+}Rl#t0ikO)Lo0QE4~FZw7gqq324CN}fbV~_4+SU&q#8dci&qkooOwp^i$*JRk} zN?V$`MShvk@V^N!_vk3DI*#AR+c^yII z$Rjp_w4~TWIf@5J0~Oi^I7JY8pgu~dXShP|~r9c&EYY`R5 z#^2opr2f-P=H9z|vXlG!{XXCC@2-JuyTnM9@gbh?zjP302WGDx7VGrKT~e(s*T3P? zoZaXyu-eKVjI*dCvQj5dV&+iU(DIxTsb2oYVqvFT;qmi0cqCBSmL&Y3B`v{}IhHgw zz;TI}DPBcJTH(^hhLLIWv#IKMl?cTbzq5Gl<_$A{bZ+Y0ohzT)_1AsF#w=@_`Dn-T z`4c)a)3S~DTsMB~!s;flu!vPS36mNPO^(7RhCXnCfQ&bf^#q%KrW99R_ zXXMGOLnZKa2Zg%WD#Q57rLBbzt2(hXE-|F7a7y^XH=B2+U%V%gxxo!=863M;!R}qO8kTJc=anV`iVRd2ffkqq4=nTwzj<k5y7j_9mYr*7@x zY9jq_LViDB-S9*W?eLmpQ6!=)OHA?k1yR=geo2%AOws+@{Fpe9o2cZsB*{j#=RK=B?d>d%lAi74@WgRrFiu^HU0PiuO0_h1@gKiz?%Vfw zoWt*BT)Cl@b>C>hy9=|)82rdvn^*1yg1Y-JveV!f<*4i6Rv8EL{qGzM7%2;8PXmB- zM>kT21KPIvTc1&llweynskU-@6J4eYx@MJz%5*c3(Kf3%vx)0KFo&tMY?z>+c1ZqL zJS)(ymDYjB)Js@ORcQBCrtam~T+pwzESUn`Ww0D(roQF8-gnJ_7{Ol$;3--H0EELL ziaW^AgK4)x2usz~aYqsj3v3}RynbwMVaHpAe-=($eFKkvAG_hhm4`MKKHk0Q?E}wT zCqj9la0@r#5%?)gFWz|F=z8{p*9z~wd-d0xoH@{m4?vXz$U&REiD3tVtl$H(9BYL2 zGfN2IfI}3lR>W|5Ma-$k^^Vlcu%qkI0dt5sF2)H$f*IXS1dtr5lc!Zd2a`M_fa>9Y zG`Wvp49?Ir%}#>+TQKOQg{$T|x4&$%51j`u(ECu9bq<;Vgxu1yB$;f)ZbLXqLKXp? zi1DG^2KmL6R8t*y=imn1-8Ey`k7q90`|`KuZ7jTb>Dd*N)6JtM&v~@9d26AMb%$eJ zSD)TrICG{W8s1%L#)nOucXP*qS7KqP)?A2wKSZyhUT;j2)Y4JJljafTqlBnTRs^}k zFDS}jpdxcY01~2tn*gAFiknc8EFD847W3r(!;A?EJw^zuy-G!Z4=U|NgB(Z$YVsHT zv1!q5Z=9-s_&;-;a>pH$EBM>zlRB)gwVWSFQFdSiOdwO)LD%FaBW1Y+iUtbVl3Y4) z&&7>GRs7ZuTj_-Ot^7mu`*GI2r|`Kw1+trW*Ax90MHkq2(8(hx3UnI)d~*y(>tGIX z`?Pt3<1}#g?}3GCm0MQD=unf+5Uz^Q7^+M-vDl#2W6@y7+^jhXxHW#bt8PZ-iLiD3OUp%b$uzIq8Ms2o78*o)B#ys=da$tceDY$q7QDp z@4O6*u-ksX6EJAATqj99(xsvhcWSB)-5kPAwkVb=0TALnG)SA{WOc{#!mC>gJ=>pn zAJ6~O5B~jlWl!w*ce@Igcm28NmA{N5<97G`WOD1Tp2rBwc>nL0y!=dP+jDyh&%b@< z-IaJW&mQ;NMZgV3PkV~au!3`puzY{d!RoqHakk^d*{iWaDMINWL68|j6G$dRp>#)) z4dj{e9JEjPTO(4H(&6dbg(4^0x821Fga&Z@KPk8S=$$4C9{}Mr!hvQfZaiLijk_K^ zaXR=?1MHWfrJnuC?Fdi^hGcdOdVH-{E)}=-No>UdY>(ht^eNW4KJp?V0FcvjKmdRu@B*WU!EQ1k4Q+&Rt zs#&V4@uq2qEO-LLc4#(Hw01cGaA0Da3DYoC)#n3R6vd~=dA#%x!x$+fk4JkTLDX(5 zp^#$RTbQD0oVnU$syK&+7H2Q3=_##V?Naxtbg{ZhJ*!f+K9Y-&$g4isL^~YfwkQtU z#7HZ{jFm++HDv2**bX=SlovY5TQV*)cxzfRU`qd`yKG>aIL|o#zIXOr&L4MYpJOME zKjV)$c7j9VI5sWV5Jve9tR-;>PQq7cMkz7hq^JT)Ay6nF0*F;3sZ>hZLdVKi0(3NE z43MU(lhC@hQp={4O;r)21G++D_Pl3@z^290y_Y-7cklE3pXdL30_}e#NAZVLyO>P% zlc?nru*=;0B=ZmXO1>!fuP083PDQ9-IKTxIlh<1?R3LajRw-Gl-iJ`xL-fuElc;My;)>lz2FKIKHXZ9v4c3EN7lB%NP^*L&##>j> zYn1DGI?C7cEy`AYqo^#>RB0CJ)~ME~w^7@*Yz~B&hzK*N}^WEmYqhewy9VH z+@?gW*2YqRO%$Y>BCf*D)ks=#F6Gl|G?06(wiiE$n>8Foy@DZO8uF{0M)Qzk}croJO0US|>B)#&uZaLQA!$<{Vu8B3l^W>~T)H8`C%@ztdQ^)NyGI`BldNz-D zlJY9wAs0u!kiGP`Y+8|=N|EF;_N@HlB%dSbMwT41K9#ae!JZZ!Douz5llcf%6bRJI zqk!DRAcrK25@Zp}>05*=e*0r;g15Y&_|(Ppr@u>g&JPQLbINl=Uk)By^nTxEy79pz zy5`0QyFVLz9b#}ETy7M&oQUk`K-^qJ`P9^UX^Vl%BZxBsJ2LvI#gL77oeeH95@#_= z1r~)5PtL28z{zMjw^YlS{S2uvcO)dQ1%>h&ht~{k1PYk#)cMO0^ks}f4q|LGGn5B? zkvP%%?JKNEuO*b10M6Mj zQ=S>U6_4~Nj!IOCG)7t{ZPzP!(JV+JFXk3Vl+G*&S(WNUC$u`0ZR4BgCl)MI!V8iqVl_HxVB5roMk zo!}msi+D2lI%&ySE|VUBUIJH8i@LgAoSIrSVb`AY-VI&2`of7{L|XQyJCx_9{O09` z3+>|s=g@KLr`hi&CpQG(RhnVfpTn+A$c=8tH#rH;TOAr*s7{SZ7Z>$-z^e`LExn+oJ-pYh)|N(Mhx@`KY!dEM__M2{5DHEU{nx0o>Y=D zQ&~ukp(z7_yj)iq8XAryqa-yXk@g2+bdiu&jiWL#ZHAaGIdfs@cjr`img^7#+9y8Bh8dna`+WQ+)rENcj(LXl%Q|ZQ~F-2;$(#L zk0ynvf=7+MV)dJwE#zOZ&=+!8$}CjS@|op^g|_rkZ=8%?g;a?5z|!sx-3-CRa6t=M-COC;2K5Hm|+*@)sofk3i?| zfX-Re6%Q9s*nu2u7?7OiaxgL~%M8P@EYYhS69^^E%vl(cF;ru* zg@ULIodCRra9=)?BlF+xJ^-d+{>!R2Ki=!09NPtASw4@Fop4i%wF)E}SSP>MY&kJ_d2l#IbsF%!&*=F~ZtI2EB1 zzgiLWd9}2FJT{jvKucOxx!D&8l&G{|tXiYnZo;OYOLjBsRh8RmwJ9MOv9T9liraz? z#v2wKHk1%uZ7$07$QIY>L&zrDmfL9C1!^70*b7I}y>BK1GwvsEiO|9C&KQC-B9qvy zq2$0eK2wQEZeiJ764hjd1ETRT(9mU-RE6DDvTj_33|mB0V%C8Qwg< zsjFpE(}H)Zih(=s){Ou9`mXP~nu5z$T*IddJKlU9o7ZmbJou~CP?;+s)<)2C0ooZ? zMd?<`4E8b4SNkP}EDX%WE=S*ila(vO@od&FRT5n?P3_&F~6qKHaM6)t=#5BX6)4 zv##9d_&T03m~ikvY*%Y+Q|B4}Zs%$r``AA5u>}cNX1iUaMEenf4gyO&aJ^){NFdilTR>U zja!`B=V3sA>L*JG@LqHRrX%jWO92cYq56AA_h0I{x9Q@FO{a?2J}8dMu9^MQ(R1g@bI)7Rci!KOH;?wd zx%UusNgg3O71Bc(U9{IEB%H=$Jq^;$&`m>#;8buzkTQ@MRz`zm;cx)+Gs0V0fwVNjz`mqEL9h-tyDvN9zcZbu610>9${9rY38l&O5S z8`Ne*8oM>Z&2B;8)Z8k08Xs%)L7-EC3(Ju72OIQDlAt#>O1c|j3p~b#67@NVSwJnx zQ4%R9C20PWBe5e^B=>5^^lcR{HPzJ{k;}2mpU{K5_ZOD8#C{d2>*(D5a3yC@U2zfH z4h*V9IUGBKQf^0$?{n9uIft6LVvje*6BcPu7N%CDy6c2wW?UUf29ssYsL^5&L9(W) zs?oHTjzpsg)dXiWaTS7bh`_&p+s>tIWu3t zUxRmkr4ME{f0NG_I-R+)B;y0l;y}Kc51uH(Y3X3jvzcSG!cdgh>C-=zT?u!(IAfY3 zge~5<_4OkFvE{k-A5*!CY8zY&;5F4O*;5i&*3kBe`m{I3st}UBGLKT zj_xxr-Yy%nVcO!4*6m$8K@*=uZz7~*HNt@-( z;In7tvjLHLn2#7RY7lBh2#G`zZdOyg-h`$bnx==qTe-_>z-UE*^L9%dYL!R?_#VVO;C;tvqY6g4241U~ZB5*5Go0Nc9T(W2 z2iqNPg<-!fy`v8mEK~qZ8!|BOF(viBL&CM2T{veQm|Dm$vVV zZ|mI|n>lUSi51mLz+SH|Tez!p;=6-yk!`!HYNxC^`Iq8EAn!BKBvpVjMG~&D)eq=J zdYgVrnZony4{9dX&Q-dV0fkyhjnbnWSNfGliiiZpFa;f z6;P9;^-R$n)Idl04@TezyV(FE%=Y+e*=sxxvl4J6&@zP#AOTsVm)UckYIeS+G^d)G z-IR2$PClD*Pkk*FaB8ICC75vEij8yE(KYUBmOiQ&{G+k&Iaep570sEEkH!B}qmoeZ z*SjO~w%q&I>@Qx~+`X+?)IOjW4N z82lg;Wu(d)k~9wmfIUR_v_sBAnwR^Ho@pG+H1d4r;T5%RHZR<_tO)c^$2!Ih-qeDQr=oe9AFn8W;{y>O|3=L+4zfIwwz2{l5Ga9rpY9tjemw1kn9&OtYT z*p#jxl7k@XN7oVQMg!1Hwg;x4mzkTrmkdvM!0Aqx(#Vbko6!)Z5vR0s_3jE3Mne=voWjm2P#BeZfv=}q_?wB~le``#_IG$a9OxY$cLHvB0?0=3n(*=c zRzPMdLSi>~W;LE=Khqk(SzA$Sd$MN}{n_j0rNnI_9xx9ij)jj^9?zaN#p%8_d7*Dn zaHVf+R#b4MTzbtLe3LY&9X()f`D2*Bc->0HCokV-i-}i1ULuwyd~6 z7)*o=!{7%74uy=QB}Of;*U@aT+8V>hqHG`jo2?msCD?B0D5Qr7Oh9XG&5G$`+QCdM z-69r0u@KR#+n?ZK1_~3`Ekh4+$#K=#eY(taiRo@f?mor3lU?936k%YH1xkW%`by+{ za{E}ZGhDJW5M*+aBiQEumFbT^jv=0~U03ldRdreJ))WWS0q~Y`lZ@UhQ4W^188|qoI1(N)K*{&9#sLm_=|M#(b zAIsi*+2>szyUSyFDvUf9>{iwwDjHC6+^#YkP(Y2y&q|27D9gta-+xolnQ5nc}ZGj*&wmAEk(`>rb?=`u<6W9 zDaYbvd=e`UgNiMK<`W45EA1V4yL~V2L;rN^RJ+Gef*0a-@_M_DbK`i0qLXZtqQvM^ zmW@eK_ocHrjiQo?jJ(T%9CZ%LF-*DrX^0ptMFFF=M`Ko*B#Re$l#)s46r~6^<~(PF zan$IB{?|ki!VN*4h&d_k3@eaZqofy`5*QNA_d<*ffox2V3Z(<@n?c8{?zGdj;DR&G zP;bq#v5hBB1uivrTu{`u#m6sq*H^SRy%1?;KRCR4@$KK9j(l~x`fB(RUAb-M+@-i~ zsHeB`;P0bbNY?_+5}NXN^7L-LmpjNax;SgxY3@4nCG(ipd8kaL1Q$~a@pily>x~jc ziR1 zooz^Sr=*q`7?(k$lR&AUGT4@8tudiAjI$h0lb&^EiAgR$q=GFtcbGcl=W)mr_v{_1TiHos}NabEA^QbTd&LvT#2r9YfjZvC_Em5+qMayv)1Tx z$Cu`f%i(dw22Q3FybdgTG=gF6G{J_Gm{nAm;YrIN!AsK(y@!Bjfx#p{7PB^}o)v@n z-GPpdwDic|GRxIbPGO!Dg0C%#Z^=X(&nZu z{4g{@n)VR@2<>n&I}r1>ts$Vci<}T|E5tb~-E@Ho+?SU`gr)DEua&HY%W%V`@JYrK z9;(09dWhPk^>YH;uNV4p!2kDru3{O3bcGF$rZo_M)*X>=7KK_s9yZk-j zp2?V~MNfAjss3`vc(PbYt6)cS=SeiVwRkL+Q!x}s^`7xpUo(F4G00-&0RA~vDHh9N4Fu-GFT zcU-%64a)TSUk9H z{@44N43$+9xyyJWsgbGV+O;n?QQ6^%?Z4Um0RR2TU#OPZXE(eWK1z5WMV2u;0DCh! z=3nlz=8JxV-`XRvyg`h!@-`t`EQ!-`93N*i>Jhde6Xs}1mJ9SoNUO#;qo9}RI1bPk z1YXApw95o4DH}2T8igQ_N2x=|g6RtYlsuj{kq5L)7$-VG1PLu$!s=*?L)IvoHhW~| z8t2nSO7X(Bz^-_;ae`qYJS>(Jc~f!=XJ6=FYFF@IKM2>ZIo41XS$j@a-L>nPtnl3v zC+P1ysXE`Lb&2!{{c5Z7Wu4@E$f+D6pLg1>ULy6A&i-FKxgB07+|fS)2g<|ql`{Mlc1j0u9(H zv+VnQDNMv5E;ef~^KBNRUUFDk|*$*1q>#E{B(P{NtN%?{)TL z?X}llYn>Hlf!AE>{VEb$SGgY9UGQYLt69SM$NVzqI(Q100EU6Npb~rumV!Sqev;1B zH8Lo3{A3HcHz+ha*l%!9Ew6zgw1@h2GA!(h9@SE)bA6Fs$cM1jz;J~WBQNFqI%I?3 z*XiF)dmi%)?YC&3Ow4hFwKvc{g!~59`5{<|-m|?;j4dvSekI*!Q(drr&7Dc#OMc?_?4IZh+^FCZWEaJR{L z|L5Fao!l1emD?3bahhVMV$OKbFO{iDG0&st%3w9~=x0zSef=lo2i`Hs<=bz=#c~9> zxYvXK%5!eLJQ}u@b@*2i>n{aWtU1~GLaE%r{El{=y>bQZzXIL6U1TS<4R2ssVvfwf z?%(KpVE#@}>r^{QAj~gk|0!y7y?3YZ#6H#;z?c!B74my6$_SKQ!j3wPvUN zaOf$Pp=rO(Ky`><{VWY@`xUYcYy?}thuCZ`=tKJ#U=_%xpJeZ*_)$CSulS7mru7ee zL;YXx%KB{T41=tX**D_^%)gvl)5KnRglYFjy2QuZ0-TMKeE<7hUpeLEf*Pkuq6s-*vHV!~a%<%wg{}`z$nvApd@k-w z5l8+SXN~!3pR%m}tTFgZHoJJgi#0cBe75<47;Rzw)hx^S=N2h}Z;kx(bU!sKv;4E3 z^_#~1GR`))5Z|MBs&6AYzs5(6aT+5v&beKk_R;t_pPKLF@J^Q6IJ`}Y({FnrSO7-y ztsQ#)i+B5=#xnMLKkP3f!#Cv~?@B2Ni`lPU?hbRL8Rz~ylT(MA`gA_MAMN>D=LFeDIz;5q6W(%z8QoR+;J_ zz9FCboH1B#bN;+29_!sFXPM6uyEy+Q+3T-iOmq1(*s5p22A%Dh2HUw6=6AYQqR_1I z_shuORb;@Mf_e<=?Hb&T&UH+hG6M?UQWvo9UDdwU`BFJy%JcdC|2 z)ia4cW@q@c-LJRRLF<$F@nWUiP;VtJliI^w;~B z%5ra&B)rwK%F5r7*3NPBrTd;a>@OjYbvN7n+46*cm*jXa$_w86=0Et1r}Kij)L(7P z$Jo6;Sg&yE@XtbdD*S`=XZ^=@9C*}QZT2esKIUUPFAG-J2r-@AzS7aVP4ZM<+Wk+{ z7hN-Y&ZbUM9nYelp4+a=JRRddE;nMQU7&4>PY%f9%f1D6WwGAFF79-h=7n%NF|U@` zH<+5`5-DfRV*Y7&t)$}AgUH74 zeJ%2>@Mikg!qp<*90V7qaH28%7?=v?g90Ea{(5&xAM;CiIx^P#W)X9~pr1o~DL4)e zfv3U4%=w7#KLvg1PXYI+Z=X@ueD8ereD-ZQE05*!4)?`#(zoX5J}3MTz#4OP%8^q=w#Hj8Xmo+wOJht&D&9)9m#l_DwhrqLlgU2)$YdjykzTy93jAuVyPha?R35SQz)pEYJRN}&LcNdOPfwnT^t@IuM}aYovMR5VDn3% z%w$fH=3MgnW@?%}92oE+URHamWnnnr81 zFjK3g&m8wntDl&anrE{2jpii_xYHxzXX>*Hys>n??~>+eXRqV3{x{;jcl!Uw2!E)l z^`@IwGPPzg%v-TY+c>UEv=`UV`CM-@dLy)FTfZr@HtnT#5NMc|DJBLLGFj^=TMHZn zm+(*1)#$%fXN%G3;>xrBA(={lYP1&q)dKWzKhV0-yaNu?Pxv#X6SczlG;YBM8rnI_ zQ#D1{5_GfnE~S=Sm4$=YtcltUO!5nuQy@2Ue>>dUO|Cl;43NR@W|M>Mt^rrFMo)6$ z5L>H>*^ZxYhj;r|$s+5YBLMdg-lo45RD&BqYip~f>~RTo+2~ZQ;|?+{bU$yAJ>#z# zr?ulliLo*+(F0V=xL`Q;TE*L}q$YA@Sa3D}qZ@c@pRh)*T57C2to8@^;^Y9_L!ObsWfBpGUvGaUk#e z9rQSto!i8Lyv=#^=obg_esMjB+f!2Y*h$TM)NXPU{5aeM)>{4_w5h{HYs|)}F?JmF zqBH`%!9SU=b?0;76L6R@)4)1F&2>_1#r>cTLvkvvKTfpHpX=?o|gEg)SZm;q8vyc$FX5XIsV1U?7| zvXOkC5Gx!W@kmG|ap~OCZ=dh`?z&uYrnTy>^OzLBeCxBcuIv{vL2G-*8O1o&V#I=kv{8rilON zgxoj%8InEfD)@gi)J6Maq;+l1SC`LsXV3u*1}tF`U_1RLt$$PE7z)*DZ4IY_!V`{YL5!&}5& z@E6Uyx}Q6p{^`^^Ca-4v(=rJg?}0bG(M|l2qOF(Jfv+| zTy1E`Cv#*Luh;YE$a`|Why1s-oW5avWLSm|$9(b&($wL%AI0DByc-i+)2CuS8}sN~ z$=E?!Bj(69p-ig}7pfoU$_%gm64_8~nR#ciJcD1G4|8Pqm|r&}BmP|y$!^H)*kUPi zCGx=>-ahF|Ysn$R8EU~;CMyy`-~3o+YQv0-czLFN%8~X?tbfdp_Quf|flXPmMuE;f>w}w+ za!~C(B~@TkmaMTT3G0Jg1eNSt$-Y;y-&N?l9euYmPx*g6zy^B8O{r$~jJ28z>qV(N zph)GhPaboYu+I`J_bOt$$99bE5}z-lbG(1F?*Dp^UNJGh9yD|>|F3h`r+YTwCHE;O zi6r%n{PRqm)o$orE^mN|!AHoC;4H)^#;%P}`(=I<#jOeM59JLok+HiX)PBJaW}5>R z(YL-u1^Yf19AaS*Y>O4`i%UX!89OF=3mj@b8cb z3iP`;LP3O1U^($G4PFOj*klblO$#Ay74FsM4`2iR+oC-8UG{~4r(X%Vs>StDds)au z(~IKR>l(Am-(Y^NyunMzb(S*~!+nb73U`b2QNDowZ@UHZRr-3kv!#vl4{sGHv3#%x zvJ>b31Y5MkE>qm4wr#xazlF7KBDdUxY$ZGFJ(Wmne>OD{(#F{^F1FLXz@6S6bJ`79 zUu_Ea(KX*mjN)vsh)LG8=Jm5&FSA^USc7RVA zbDlizPT~Kv;7Zx&R>)$%wH$@#jt6s`H;G{zWxn&MTuXno+aiQhfG-xvaJP+2h0b5* zOrzh(wax@&JNn;|3gok3wR1w6CuYea)|%;VAog7&4?BBhr#nN&yPc$+b5h=Oo1n`S zndde!pNTQ=C#IWKjBmoY+uTlO4P(CVHZn&T(~L1C{tEbVPg&^Kk>~eH60W|=|F;bE zd*SN^X1}*w?&E%c1?DQa-_P-p$1rCtX+!INs8XyyQ*nA}TmLz^b1MT|r56a-k z=Lf+_k0uAm~xDXrK_XfwsxAC=J-W0hcYrUy{xm=^%2cN!M-*eb!jIJaW*(_c0lUjW17W%rm zU5ODBqy!Y>H#a-;rN6~Vut7SY!y0T#Eo+_xd0;AcU4);XhfjBA%})4XWBy;NJTr{( z#3}9x-)YuRZfl4WG?c>|8t*QUGW5wupNG-yIRCj1{7$5gtwZxHryNax6ZGvuf5@>k zE@>=7TCP=Srn-R{k;~nvg>1gZ$KUd*&2H>749o}5fUTfCxIC&Ox*%^$J|UM9YZ^zf zuMO*WMyC%VyLD85#n-xK_<78?V?HSIfL9|!+^N(|-J~e0WiCVR1WN(+OjAY-n)^*}1n+_^V1w2*+~r2KONNY{Q;cX)v!L6yZQHiZ)3$Bf zwr$%wZQHhOyL--kn8}^V&E!v3WoJKEJ?yos>ie2vlL@E3BU;pAXe6HHCF*sl?n9*9 z8n0wz!ggibyxnpK&U4M-Ym0kB+Zchj^^Cev_Ym7K?b-yi4Ly~6=#PKf;(PDu(0w}j zAMqMo=9S-;kjKLMgY<#i7rg$kdEp-W{LDU1969(wbGAoR-^)+x#Dpq{=cX>#4)W^J zyNN#!sNcN%duiG_KNL&M4rO`5tfM6dhH&YAR{x@8x$MYSfa<15?igT7T=gzXD-t^! zUrBbbIwZ5}5?y05$G7t!Y;IlPmi0CzdmIvVgtaXm{DM?i|2#LBdOpoPV@!*Q*>1eqqbMwNs^z|Y`ps$OGyTf>3&8clgURJZ{eiH&1) zw$<{=f*C*I+nAnf_FoT`d3UUHk9|PpFc0E1eu$q=oYlV8{cS4sgX_@ycBQ{gGPa$Q z1M7%@=54#pe*I4OydnEkIJY+2Y#XjR(YIJNBJoHxP9!|%h}#l5Nwkvm zYfRvg`S-KtO)6pcGll3j=;8Ieo^xDVg!k(PxaiGRekX z(%moTs=YTk_D&Rc1mzyaV*n)eLHE<+L$`Ab>?``RGrF2|blmCUdTsFbh2&bi^qT*X zk8h&QI1_7D@`39(_h!|sHZtKeA5Gb#@J8qUMFLQdANzN zRkAbhpF?ma08txZ>PEQFLdgWN6UN}u6y(dTXyrUW=jE`+`jQpoT6M=FYyHM! zrR6^Jo5<$V#(iA3#Cq2M8-&mK#E^V8;`E4O_lCe`pynk<-DZ_hC+;|PlF!M#6kmY; z9gGuI-5TXRvFE$TdRGW#L5_|U?ET|i&b}M$tun`zrU5NdSrvM;IpO69xT~}HO6pT7 zyK%MAnjMS6?;j=Jd%uf7Zjlbwfi|;-;}U(YRC0l@yq~8u%f~L<`a^H}Wb=Tuhqnz= zTr_GSfxf5Jx6FDyrE$x`2=5w>da5Zi43g>_yCK*oQJXUsDXs| zS+RVsw1UCB9u+)$Adcmz1x9Jxw*2_LD=DFrgY=b^3h4v5WwLlpj z`y(o&c;1@7Y{9;ca`#ULPblOZVq9O`3c&&u;-7I|yO&=m!bX99-ZXW* z#^RWPe?$dG`=SoH>?RwB8J_U;ZaBsd*P;}=w7u712gK49+#xqk!p!Voq-M!@=XW#rD-`tltxS#&W?JRyFh@eM#@-V~xMJ1AxkPL7%s~9NFPk`+kvT#!08ND#+C!*m**}|O*E1t|G*++WSLZhgMu%;^o ze_rZ01rvOI>Fk7Y9`N*|#d?^*%(BJ00K1u?CR+wSE3H;CdYMVs!%6d%c#IQ>)_x&I z2*m(})N*;yXgiSN3|%A%8eyp;853$5%^<+zV5JzJv=rk0t|;o`NxcseWXc1ES2b^* zfyDCFgde6d>(q0-KW9qitJuZ$obt>Ldc!T*%VFa##U~801g8Y&NaGtQ?@h=&dSURw z9CU>uM!^VzK0M=!O9i_CZ(|(6#i9#2v&yKp#>NmM8Qqj*t+4tuvE%stQe}%hW5799 z>e!aQX2fr{QDvUFXKC%i!q7r~W}VD(<1MH)wi>5wHL4QzDO0ZzKbeD!qsu_0PLbwj zLuGfFrMr2)T*m?->fdujmn9b!-#|{sZ$os~y8|9$kHjK~CX>J_g-Xj((L*B^t{`UhwWOO$*#=yw!WHZkC^2~Sr2{1X3BH1LZ<;ic8nO>$Vs-^tDgEHT&f~P z;;l*n64ldGP^_SNeO@PW@k^}j#!>|#%gS14@-2x|U&|r~H=%YiBsef4TTS9ik%}c* zk*ov3I7J&rL4unO*%(6l8?s{_GL_Eb{ruJRyOF<;vrgTiSoA0lLbfC+m!VxE40y5Q zkW{#Y^q3IhNbji3WLt`CHtrTYIN{OR$uRZ4qR%O2mB~2zeX=9Kgmr`nb#6s1X}VkZ zZ;P`^XS2Vf5ASOFV5hF&X3VgI+&W;yoT}k=v zCe{|SH_9}JY`rqJHn$5+?iLpCMW~zOc#e_k6vpb3rie+?TARMKmu;=nN{XL4%28?K z?OlcHC8KF22i3I|98NM+bTkRiY%RMz3Z?8V=y8%IVW=ew!nH*o)<(#q?ouJ!m}v11 z#*_`^-pXEiTYs9Sb{aLLy?(7CJ8u~^)r&%|HJ1>yM$8)8%}SKd+2vAV4=msAlA+Qn z?NgyfE9wP8wiiqCzO&{VBW#Mo58k?3?yC>mUA8D3j7jaLp#VEul^2wNA@4`-Tf;?3 zVxTu*dH?*up;GbBL&c6&0zcc-y-uZ?9>L3jklrZdDZg~+`l z#Luu;82YzQ0{9f;C)Vwr{R_;m|McF=3Y%MG+uR^nF}qy8Mq<-7_5i$HXn6bI4UehE zwtVgwh?6`7-D07#C9(%`oQ58YY7(>9WaCV!-c}UA#`(^NM^Q=H>}ZLNFF>t6no6f3 z@8;guCQfp7M4WPckSZ#Qz9i|~nDi?lOpE6$I}DpgdvBixUjF`05)bcmp9S6qk8fa5 zlCRS2IoekQe)91ItH)>EoQPP5h|WfP+l6IpS zm}lB*sSml0p6OOa_-liK7=x>m3XjQ(pb_tJX4&z8ax==^PV|qp{N1tI7g=8zV1ogW0YzAchdiG9h}e19~|6HK6Xvky8i!dHCK>j4-{ zRzxN%>MfZ~%uWnB7-*1*94?ZxXpY$Lw%Prug<+C%@Ioaa3xP26=P3omB>1?&j@V5h z-sr7h1u)~p$%hI#mzQc44cT55J-=Gm%~im?Gdu>YJc_)X7wnvFAx;H&@vh$T(j{Bv zZk_b0lG#ayG_CMAR^vwi#bxulR0BvtAyN=mtW+ULxW0jxRudD3DjqMrKrjG0uB3MV zBf6dKKS8&%Fth)6RJ(T4w$z{iLdfkSidO}CBHMb7B1Fgr)zbieHJ?DHwN;<(09*Ij zW+%Bg3QY6+z>IYdvgzZpX*cAy`NQfOyB2?@5BkQL{5L1t&ec}|^m-SA&1y8i{Gy*z zbr_BO^yZ|+)2Qs)tAh&!X&Wb5wxC5>N1O`Hx#dR5%=%f`{>BZK#Q5qwcb z#_&M1ZyuXxW!UM*nJiz+w)IByPE12I=_#j4X3uk3fvtD-V87WijSjRj zZ>d$n``nLK+eGVj&wI6zDk??p^aAZY?K_&ccn@&h81-Fd7Z`s$eqY?t(?aD@F6j%+ z=@Dl;0s0=PN5)#?Na0B85t8*d+SM3bwK3@8;=tm<{}c0z{fqO{{nPXP{r&$!@Qm^f zWd-^o9&80bd2=BMafjjSjp2LcPd`g zTq*gGvIXV+ivRuE<~*qIEdxJ7odfj9-8s!U!qU2^m~n!dv;q3-l^N>GPyyY0rR5I@ zkSnv9`akBL{Xfb*JIDW(`{ZfMLk5(PS6?XFP0@y$U68;6N$fF0-}EUSeTypP9t8#ba})TlN}o}oo6?(8q8e+ax9cpX1Pc|X@tvjqIx!?*Lg zo;(r4N~z`_9QF^@xZTStbPr1}&gO<4*|@Z|N4w$M(X)_$&fj!X^KYAKZ2XI#gC<$T zJSpp!`wFJrw%_HL(rag1zKi(Os`f4lV@1*pA!>8@Yorv?C%E~tGiug9LSTu^k`gwg ztm3l5)MEm5@j)C>2Q-cTI|NTGo(n=yLV`sEigOeaFH4iTZ;Nlr6y_)g`^eXXTUc9E zPcWWPyg|7_v-xE!@v_C7EwW|0f|dFuWX#f1SfEjXV*Q2riuKa?P_Bvug3^IlZD?)t zriH9ea5jXA^&|!o1Bt==JG8I1W5bD2|2EO-z~JHF|9^3*Aup9ku_{?W<4)dM!Pcwq zWRr%I^0+-xpuY3t!E=BTRkv<+LpanRU6gxbliOVTs;3v^fFXL7>9?*22nNvo@q6?? z7753HQY6ewjLdBR$L+w*!obe?e-(`i%y5`?sTK(UtYT%pWAJ>wA*bja1a8JNrHJhZMof{@UlnMhZ#n^8_e06)z@wx3tRym zz{%{4W6_czSLayZYQ7$0lxbZKr-=}C>^TPrg^gLQGs?HoGs)?`Mx>tK0U=|RIXH6up_2YgT{(hNxLJ4F-G*Y0vztMar zkbmS%YHZx~g-kPJ|D2uhUT5=1C00{9GoTu0lI0sV^Mh3vCAp%^^H^`liBw^T0G_bo ztpYdou65yYz)v0g)A@a~`0K2R53hx_-P3KKXo1^<#JoWyNQ|2PF(9_o??>73KwOu> zy0t4dZ$k9>r=&E%&eU*aO5LO2QcixSO)b>SJ=9u;5Qc{tbx$^+jbTLB$D*r1#Rz9i z4|3Er{X6AiTJuikx)=U6)-_9SH3(B``pA6^{b(n#hh3+SOs8m*B^=#n?E6mq;4&rJ zJ*8}nmcic$?#eUDM`2u;As5cEq8o07BC5g^(_+mI`$!_~B8t~lKB|Z%KpdizWonu^ zeKy5LrEy7yGh|RohBKOmQn}5x%VI~2b^pdXx){FbEc9_p{|aw3#3EL~4)!RC`4bH9 z5Q_5@OR*@_B0{U;wey97cor9NbuHKP?)H~Bm4P+|zZ}L1WB@ZQ4cPq9N1G7)xx|4* z@(InvFe*EWpmi;;0$@1$wW|7?Xn5WLkxKK(wMA{ag=fFlI`lDWXpglk){P>Xc-aE4 zTOe;_T>Q1C0{UERC!!l<&QA^BAMks#Jdg*I`R;W zgS4kf2v4mT!*RKXWk{=(*SO>M?L*#^-$AbtS!PxI@OyoBw;!k$MW}PiK_`$5+PvtRC_GtMI(05G_OR*vfV0?_ z@)rTI2|Ok__?U49_2gO=R!6{jd{?1$rD#U9Q=w{Ecfs|-i{-6l8*RY~dLY8nefRaN z(XHOoVDE$|HACHAJ$YI|bx(MnfZjX7%ltHU*D#Icb9W09{)S#EpTx4|?OD)Qp?P&T_l_sgA zlaBRP%Bm?>?pJ86a$UNg>z@}1*v(G8ID+~265{A4j~6K64RR!u<`0@Vrr)#UfHEjK zl!xgwY0;F6&MH(iLn8}V(ArdBjJ^Zhg}v!RCuFc>IVljo@y(k=%6WN6t6uGuaSzwz znogvoDQFSfXbLza5Q5fEJ{$8QlgjQ&xaw)HP0m7@BjCX$|0wGMdD@`Pk46B7gI&h#_)3~HX<5?iP+vjaXQe^(P=B7ESWsLA%GpM~P-T)7pkll(noJ8+; zrH|nj=ANtEAV)Hnr(1b5xiu`BH_IT%QY;Kabi%zJD*sr^FzybJH9#n+a8KW$z|?VKAHMZEhN%RN zVvX8a&uPTEAwr3^a_XUdL}7+KM+;FEwfKL|MpX*cDDdmU{*%JKX4Po3d$l{ZzbKcf z&gQYV6?R$6onL8?4(}9Zge*R4|MOsFGuU3;Eg4YuO5t%C-{l7Y`(`As_3G{NLEbww zbmx7E%GBk?;<2GNK9*el9 zfxQq9R-kY?tiepUb27VvF;oi^(E?|&AOS^m4wH4Pa~a~b1iZWcn68|B03+YzvCOSu z+bP))b~4)_z1@H|_s3W!CGDU5WcfemXBI(T8fw5RYFSz(D_O%>HJ77^?BJczFdA-{zMw-xvJMggi6wMs;@3Tfe2zLK(vDz*x1 z3{@Zz;EwO<%uV2O7*`zksmmz31Ow=mwhumptGr1>35t&xn*(v&kJ^&%*vHe{^s z3ybNI#^!EbV=`W$vfn1Mvh(yuG$HWQa&KK(aTE$?srLv(F%M-K)*I;>8_Z_}IfZD~ zce?UhyYwD6n;lnHlJj?S;eOCv1L6={&Y6YqTajYsUKD4NEMS9~_#s?v1EouDhK<-j zs?t!0;=xihvRUg8rJMZu*pa9h_!ZXXs-`bh%Em>&Aun6qH~tl77{9j!K3-0=6|ib0 z#^!#5OZwm~)njD5&NjYVg%V=opR_$9%DChZ$cQj&H<&n@L{F~MXF_Vw5UZfp#E-;9 zGNAdh-*rm0w`9+V*+E-T_G>&N-X161o|*3WPaH#xa?rdmr zmfvjHqZ85l_p&2sQ0Qjo~i)O*S|g6PQ+st&u%9?5bzQdx6MYB8qLEmNWMn|=)kd^aS{ zUXlyMpWk3c60Z#k&eSXMLw`#@`YHd*eGA-nxcLewK1YUZD4e(^y7i z1XIGLM1)v`))>UiPe}9P)zW0XEFf#O5I}Or9mvdkkYbu-jC7j<(=N zX(T%ZA32*f#6O}$E$}&@98xh|amdnVQb3u|*nx9Q<2n|%NS`IcArejmHA1iCX3$*k z`D#rI9`gxK->hBBD(E0(!J`tJ;z>5FGr(pguMkD+Phq^j_8~^d51~6To}$o@yv_=x zpvm!cgbNuIbNP*igcDi4AuuJT1k$kFgKHGUvo2p0zqJ&xa(D~!q5{h|u_{@E8?Eh> z2O3$nxC#?9!ntW1-b%^LrPi91Ni|v^Iqwl*3#!JdLdYr!O|0lst9^i1AnK(~uBQB& z!ESAQ(>3oQUYl@b+^&q$T%$F`t0j+&mVBdO(7ypR=aUhz_Qpx~AQ=fu9d!lD-rxlQEz*7#F=jF7u@@Ob}UMHHEZn3qyB_JMT!_L2b_Hda)&i zMy=U}GI2qC3d|iS%Yj%FwVoX%OBP{^c9@U<{B4jUwFDB62qeOa<>f9cLDGa`4UQvP zt2FhxTaMj-D=w?BjpjJS6uciLx4{+C6I(3Z&|PXWI>*e3tdf1d5y|s*9^`hVuw`Cu zbUs4Rj)oP&xX`lca0%ygm&5k-43%>oJ=14D#Nphl4TrN(27fXKB2tnWLJAlZ$|@u? zn(tuDU_yupS23~JMnm&PYMI#1%#bLkwTNUZkEoEV>O%-796(Yyg7`2Z3I92;Xz4XI zPTE-$j&#pu#xcm7qk=BFT912CyMb;=$va2p^ zIB4B}!Y{0~v>3>?%_ot<26*7bK6E0EQyn07UB2rdqyp;HK;b;;pVpq5e4&x@7JWG> zo-}2BY**8!*>kD0U)f9IrB1x$@`e2VV)9E|#-7;T0q+J+=I;K)e`@6GoA6=LY7-%z zmw-|jVgfQOLh7dzCNMToj3&Cl?F}pEGaPXwcv= zr1vjzE_V2fk$23K38@*hm9?uE8%x-r%a8Vc((r_oMK(YaAr2Ud0bybNh6035xOw$7 zLo`n&4-Hh7#``Yob^uuh%eM(54qBg06Cp;jWQh<;X|T`|Qcd+kf!w3NRu926=qc51 z-Q8Pvzo$k1$0X|~*2i+g1u?5Q7F;EHH+fLTg)%ESw$cUXdDg@FUK=(2zr~C?s@v7w zM7~6RsGowyhN}hJ68o?ab%^~8eU}iwMgnNG{aKClkPZtmvWwi;EJdGBG=4MRVfuGB z@VN?-GkWg>h#uyBzYA8gAw6vmJn8^SZ{*dpP_Wx;FFkxBkM2aE0eY+e1w@fDU*VlNQKFp;ZL}lB1arWGq6aW5!wc zUHH~H4_h$F`^?Px%(zO>_JxQ4=eF|?xAi}XaDY{H3gM@vf-lSo zcV3!dAeoHpP(kMXI9WP+cuL4W{I{;MvxYIQBraV1Ih@AJO~0T``W4M>7su;*)`q@a zZ_B0U_|%J^Ba-pSu<4%2ae6_lfh`C1IF4ffBkhC)}X?g;mrltD1Wf2t0 z@MQ4>qDH7F#Fgz39UGvMIZA?jwt56u!gSVl#W!FHG`HlGP=u?&+w2UjP!V#c+wYSp z&ev?On^!MyI7H;Xe^Ci`c-nM&kx8Ns33o|PR>%B9YarOJU6jXFJ`9-KO$|H$wmX5JY@h%PQ86 z6c(t{R1O!SAk$(MiEYg!w#l=B+7m<(m%VWz>a9u2q~Bt;e@5=zV25=!46X9*gW1!B z@$gBr6@fI~Tc?4_u_mG#)2@Svj$krj$_{wRLBzMh1e_FOT@~!Oenm zxMVIvS*0uA8`Ssm{dl3Qz&41XaO>g{`hnmxH!dgD*X(StVCi3La== z-dGXS7(+aTLY=`H16iyoNmNYOH&)^yS*}$7&G6SEBnGfVK$+taOU(X)8367dUA5!+7?|JfZQoT>a?8h5#|nBwcWYZ`1t8)YpctKGe!-O zX+CDo4*-j}*X9XZTTA-VeW7Jc28uU zzUKptoa+*J0UCyOrl+`z(CQu1n9y7oe8KA+I6^;<8j&Zx5V#;HRZw|(uYjsH#!#z3 zDg09iMl==w$1^n>6p-|-{!%y*L}yMVFPXIJ!({z5RW|ed@oXe*l@0MrIXs&_>QYD8 zWs=&o5_g>I-wwoL0MSu+sqlFz}!y)YoFbg56Q7x!0w*{7(se* z9D0bxflb#gf-$JNr2u{ZBKBD&V2Ht5EN^Uwsi)z={q(`{89PZO9@BJ;3dDFI0~3)x zFEI|-<*y2{a4MdWv3%b218tT?L}!bL$FDQDN!QeFL>{a!;LmuUKb7bG;qMs~upa|* z4DQR#LZ%GHnqUZV*hk8pCk9FBrN^NT2AJQe!FKK1srEy#cc7rEYgX5?FL+vw+)HNR zlC(r*En{Kj*NFSVM0@7f5CLHr7pId^&g9un?Qk0I{7>22R=ERach4RRnxN8*O9MWX_Ni+@sQ@^83b)Rd%aoW4P^ididAiiAAF}{@^9`FGnFE)a z1ZE?k@CE6JECH`2_3-K!f3!HPhe-^$4MUFsf}UG762-Myzx=%+kKU=(^#)|a#C7|P zIV1!66gY|l$tyI!HtzyjX?=Kg=-p&JZby$!B>Wavy3re6K5h!&#q7hnomTg>z`e4t zq{qs7F~4UX=EYa(Z?C&yH+zuYszmspygH=YO`YcYkh~+v&H)^ADOy0JxtKR7NxieO zKsJ?;TAE$I@yj9W`lumnf+sb*AbDm*n(7M__L{4$)ESaL6Tic~0I_-4)dFM)lFGc- z@)r1V6y4vy)*IYkSm-4KUB>GJ%L`Sf9J4=Cp8l+w+y2m4`P+K53wtgsw)ib!e#^fU z;d$fh@qxtpA?}$Fy#+v)11%>?%YS>~3zytm%2DTk8aueOBt=s{B)1z4aRNd=@;Pg| zzb1pOi0Ah`1ZRRD$Wsfw=VgzUuSPjeqqpYC!7=af(%fL6weo*074d5U*vpNXFde!G z^s0v+(29)HAH|k~)5N_%JwCEQgl;?TjFlY|4+2FQ+!xE|&1S)z46ufPx`Ts11pY$=vB~k{{cLS87@%uLc9Yy}p8lz^&T8-)zz0qXgcH7p zFl1QVx72RVnB8O14PI;yTU?YrxJGxbo^=_sOs2ZX`L847Qn~Gj>~C4_NV`d-igtUQ zg?Rr)e?VzCL=8uDJzB6ZmAFh!?v+FKUuSsa=%wDw0NH?DW?*}f-fIorA6;~Kj^k$( z8k&5Os5P-_g5v~S;eG9TN1X_YYdK3|>29)F1XWv3Miv5Y>``Fy!^Ir;EhVYmX&LCF zq$HAARA84ex%iGI@(bkyvlgShveMSHzqp*#UJUgZLNl4gcC_0k&|sB~p46=iL) zNKG2!OB0b$aO8QVI}Z z`@$FkgdAtsx_0}<*hv$mOlF=e-#++{Wg}ucJYi#N5W)`3uhdAH#-utkTgE(nGK37PxBbXOqxp$o~(m8gOkCc!F z*7H=6PEr~ZM%QoXb#v;t08BCr$uy zVU|^Qa3;u}97h)_P^2vlTtu}1X^Cn%FZ($hoU7zVwYl{7(eJ1e{5U@k4ZNnw)E7y# zV*5^@$&>9Wph*+qm@7Iy`h^^J5}YZOpyV{1^kL#WK+ev%qb zIYmlIJ#y*am&*k9xUHc)yf!pIEFcn}4!AQdk>EeSC)F&G)jEu0$ zttRm=*_r`qv+`B21<}VQXS!!+884cbW9xcfh3R{CIZwHFF|lm=(XTv;aozGhZzjF+ zU-@`{0-7~GkRuN(Xp%m;$C(`{z;?WOCK0k!)fkNnJZq3^#Ip`I=VRaE<^<1+?Pa*h zpDcRkYYVaO(W#}%g=h#rqLY6ilN%XE<{KHtk4@H6mg=h? z`UPi#mC=S3Sick|6;i%UH51RS_V56#J*krv?EwMAZtOW>gEfA`q}O2~+DCU|OH9VN z=It;lF@W*6S3z@&Ao|YfRP2N2jeQ~bWC#ZE8onB!n2P$V({<@XyD3ZkNKjZZup)g1 z^;-Qr9%Fs3m)Y;O_FwOhH0)&YeUFFuxmLC}-WPk3m0stA^!Dt!eURxdyL~+-_I<>! z;$Cvw>~4GdP;L<@WVk7!@edmRbw(^w_B)zca{Z6sFd+F04bI$Lb>#;@acOvb;b)rQ zR7b+^_ZwN<(9s^@_%blT^@8&Zo-dt$%r&;`Em)7Tqu8^_QdgKmLukj)en2E5y|#Sp z`*MNxo8!fxDl^o%mx?y23KbK^)I!U)FhPsx7 zNvV|Pm60OE!o?F*G?GB&%Q@7w|IoM_3UNfp;-*5-${rYU#)}~IZfsz=e*>5qb&u`+ zjird?ZjI&G52}}iC%GIP-Zx}MA>pE|lUZS(u{NHrqEgA_3I6qI{Qk7bVx!yn`wCCL z*4=J#+wk|jhW|#>d*Y{?1tpUHBh=?uZPey-X!TN_b!EEud!y!)6%u3$Ct&Cufv7Z} zn@5*0E;)bcQZ#T(i0l&ys!%ueP;k)tj*pbbU_4dqsGRIWLN~w(@b36QbM~!=;kL+! zPwxi?zHihPU`d18NhKaykU9>KJ~ROv`AgW59h(NGK{o=(?pr4@IAOL#$vb$$pO{O) zj3VO`2ay`@-{&!Y5A{`isN8y!UR#TDbXHOPbR46tJ@nxT&VqmFL7_qr1&Q~A!F#2Q zaRfq$&=S6+rDpunlI+C~OiP#U?B1J>9GJiS0+i995d+oUnW|=J0;{uvjSmbMKfOb+%3B;z*!2{fwfG#o9uuWmU^_CPx)5kaBj`J90;! z%M8G(HRy*Kdr;FMsK4MDX!=xXSqq(@0LDE2#+W3gGy?FMYH;rxZvU5@DX(0QyX)S6-Fd ztY6iumInE>x+7t~EM-sKSFF(X;E~OlV%|gbdR+V{JU2sdi8Z*HdCWmM5}s08z*m2!GQ=n#(`7Mo?f)#L9Y|GDeyQr-cFx=|8eojkIH zd=f;cq(hbnpyG?9A94q*DeMxy`ufa&t(B-nOQ%lBDZ&NdV?8&`#xsK2OEsTHD<>yi zw(H3;Rn6^EeG`b*8Y9pf(x5xg!%ZB_r@>{Up%xL7;W(OKPhjjI5~r0!Rq0JqK`atp zGoWf$=|13C<1At$nt%@A;3D(>{TQ0b-4oNIJzUVdvF!b*SqCEsJ(op=9e~<5PNh+N zfsr0?ry;McH`=cZsMSjHDZ<6kSx=V?o$Sqi_+3m1w)3PU*$sle3|Y@_8Mx1~zI94j zx$KQT!9rM#Y#S?K8r{r+X5lg_(w}S<)b+ zE<3ZGdNm1Qc)s<|<&rumcyX-`y0~jdd;&2^ zA%v;m18CmDp8}v~_>K$yc*qhO`j?*bSZ@1yXxo&Osx3ln(QNw+4YkJ{1TmXOVwMHKaV_aHd@8O61`nyG8Sw^C4N`v}bLbi`0l=LI)_B_hwkh}lc^SR%2 z>&?ggvfhxx0U3KZ#0cjgWFIh6ax9L?QlZX6bO!+=6##=|j=4Pql{t}b9U{3|Y+Gp_ zwo+3KF%d@s%*GU~-Wd~68ChvAp^~P`fXG_ZOofoxeS6An^rMb6db{rS;&c1T^N->! z7&pg5J5mG4#gRlG{1R+lzG6>CeQ7CKV;(*%L83}_ost4JJC+4-nGzQEo=na`u3Qwd ztH7p#y__AX4*O0+vPlw9hEx%=(r1MLEHti;OgRz>DrNqeC(Npk^vlrK(lf|=PhUi+Y){Fr}jzki%-N5ni?=2I3=`Vb}VFInU% zc-zyMeDgxlObzJw@$GF0^1D4E*YUm90Ta-OJz~(qulPk+0zPFO3?>;)A}pq4%*I%O zkrEvTW=9I2Zwyt^Sd&DFe))m-fKJ{7T3wp#POUz3O5)g;Yx%=NW0&(6d=CNAyf?YG*!`oncUTy-Sub12`- zYBq`Nv?_OBC)13p-E>Z0wfb#T*7}-~Gs(4Z4tt+L-p1!=G3mq}zbu5@_O+}Km?tqOFhl(LbcAKo8$c;u#sz{5WgN-t*e2aR5&%InN$RMf-sUKua84>6c zZp%4y#Y-5ZgjztEd#8{`V%pP@tCC(nQChjv$n!;>+7+wi$fal>_7?HbS5@MQ*NPW7 zDe=S1!VOAF%NSMfMb4q|Z+4k6m(rYB6K*W5CLPIQT_oi0K}5nCkI(xR`f3|{kAeZ$ zb6kck0f%u_$)MsZmj*-FRL&aFbmB2M%b*V_PE?DJeQAby&Ha-+zyhkE7gD_ z_i=>c01I6<${?Y!ULwIz&~)%o1+0RJ3wFck36mRU=dIVtlHfF2g)@8*DjJTh7H6g1 zQGLq+Wi&;YLC1rTfh*ErJmIxqo@E=@ilNcG0gkS~SvRJ&Nid~PlC-0s4Y)foCrDw^ zkua7#(KRc!0JSiAmBAmww%~N@BEk#*%jv*&x8psmO%D@6KBm{n#_(&8ddMT_7K7jQ z<*3qWD5_Kcl*0k(|=%#%v{udY}H4AAX7~RY&my%`DM$t{e>)LD8;6-}npNbqR)N-Q5 z0dLG^WEBIA*6y7AiT-7{&Tc8R?nW9%0X`~EO4RE+74}LT1oM?KW7rf#J}I6>$|T$e zU(8s@aV`tCTn)i-K2Lw8$h!8bA-M!LL6&uTxG1AShhDT zL^^doEc3h&K;zCCAPAlWp|3l>aEwt7bpN~F(JQ<_d4$V8u33G442c8#m!~qu2>YZ# z=D(d8E}&UUIs=bN{dfq3eo9ILMp)}|3nBgqWKRvBw>|Q$@-a*QJbZLp{NNo2gSbBb z_?^#gr~MGR93DCl&~c6qwJ~)DUv|yh*RaPk`oi5!1%Qslb+k_sgGsO+W<3VoPCCN! zi<2`t&%I2(xZacJQ9!ht!{HlA(b{uvj+cz~?h|Vg^qk20w zu+3j_q_KLm({8Of>bq3_tQji9a$OxHNEgn5+smh>b7 z6Vgn#>805_ZZ)4kfuNT@wk#{6h%B~l(?A&h5hw{fL^P+Mwr!dbx~I>^R%pPE)l??p z5=k>@`AdVoXr$6mx|Wch4k*L?3*dSqRlot8sDBc?#^TL?S)IMGkc>Gqx5`X%7*>Zl z1phi|{jT9PqlaBCIc}<^lxif2>P&n&Q&MPFB8?Oy@o${BD^<#48k*$Msq};dc9XuM zorBUpD(R1Q#!zEW@jjjeSFK1UTM-6^Lf|K~99hC#fVv)|BHab^Byxm2zo;x8U=eT_ zv28R2Jlzfb+YroS_?c_^^m!P0EkDcHeME4j<+HFi(xF)UOh0>5rW%m1-x~K&S?u!w z+u@!}N&jv8{vdPyc`gh>6||DN=gs==5S8x| z>n%JzZ_6WP-3g4C6)tvCQ|Bk}w^wh1PKW(PYl9d4bgp3S@Svx+gQehXW9<6wq5o*7 z|0rTQK9`yxZ}ccXLE%MYWX*xLqIDcj%$!6qSvK4(Tl=4;h1r8my}G0(hga}b_yzb2iLIK zP!*~kl$(pnt3{wlhk|+|VibO0miH2gpKXj^!S062K1q{Xtve!^FD{{5l-S&51^oi$Aj$>{Pe!uYnN3!TxNH0deBw zpu`%CKc67Z-xJ`a+^c02K`23&LbXOkxG+H?qxD`&fBn0Yl%+B!Wy=fq`V)Uy`x}4V z#INm$>Dy|qg}j{h=Q3t&bLrLD)}HUp)3zSk+`qraJ+VH1n@sobLn*6c^s}zl-EXgx z=yZX4=hN6>(&+9RNATqTA;Ry74+uwy3UB`6K3SAqxac+ zkkqXL>I&f}P2+1;*q1G`!@8T!S1mCOKL_CG>LN?Cr&;#_F9tn2qzQM2CUKu>$+Y*c z$=`9;jR7_XJcnDQtuxl_m@3-0@)8*Q()UsSVNbytiIG zLlQ}bpZ7T~9?yKgudl!SIV-xR^q-}U3fvgbsg$kFnI54!xN8{NWzN)L{|iSzxW9tO z#S_x;V9*Ti2>yj(L)FXGXVq;gt75PLcS0i~i|T}B?Lj^0DjI~arm8X;U!wy{Z~fQh>jMkovp5$4LN zVj-c2DSBnWpE4(B$%|xbi%=KoxiFb7$A(KHU^aiW;@10@@BMrIS1-T!MdFCP?Xg|& z9Q^U>SMf{M$pKt}rFSv2{mB0KnziRX{p0U`1f*;OOjf}CFK^0;gpn;Qyx|V zO-7Tmlvyk-G!{8eGfxIqiYtsxr$6yo;8NsE`+DTMam)I7%K@Fub`G}4QCjS6!loxfHb*2rrd zln|Y};zwBmNml}&$Dt6CWRH}xpn9Zi$%bdpNiNw$EFL`GQyXv-8{@2Gr>{J}?b628 zpS{@mv&qLss@~nW=~suJ-@JdvFL(dq(8dVP`C?8RpF5Ly6~R@!^TjIn-YG& zp5nBI=fql_1>wi-h0YV<@5i2SHuIaKL(EXQhD@v~mNnn(G}oD|>8N|O9*xm7F78MI zI?cR8&Z_TX{Vr{_2F!Uq0vxkIVS{6;vPvdM%U9m9g5@d@N&8606rvHbK81vA(lLcR zRIF>r^(t72CE(k!)Px-QJV|0_0w>Hfejq+kFtcNRp!svDR_6P(Rx7x*4LM&gzRZf4 za?=H&szgE#m5>KDhl*H<(q88N+ZV+fJ7X9cV;=vF!lW0s?t0ApXVC7%@4o2cMBU|T*4uI_lESrODlGd zTxJ#orx#w{@-{A52l{XVGD;BF-~02u|7cZ5POrkR@0hvj5CYeUfDF3>pCSt{qx!2f zM6BAA?MB9zZ9&L&Mv#1grRGKCGQj)bF3+K6y0kEDGDHbx^} zvrZNwE@%0TvwR>}UZ-H*u~Hmjnb*M8h!Cbs&yi0z?Id!05Vl={Alp>{LC7GAMD^qf zswPlE89FLaDABlPkj^4+n4`sCX%d8D_#~ai4wTy;;nOIIhOmUn)9Im7M!?{p-Og)y z3W{&i-*ljsmV7=x0;HIsLxX4j5Jp3t7X`iyrW#EQ$C1vfah%5KhV9#N8W6HRejG_= zgk@k_=v&M3l6s1r3Jt|xL$fqzW%Zh-Y*TJpGq3}UiuhDC8?Dhl*tahddvVk3$K%td zE_`@kfPHg!*P2}0((o^&w$AVEzWWs6#6$NMuwMfwDp3P7k@l%mmIFpcP8qZ1Sq3jw z*cBOhf|042AvYV}mD`Mh@Tj~>9+v(U4Na=a)IC`9VBPGxJ(-@2(41_Z*pg|J+mf>; zE>13<_>8b3xng2xraN=F?nd%v&8<4!GWqB!=4fBN6A@_A(W+1*%{kpv&@k#UTU{;S zII1+O+6hW#G@Hswz=&}!NKpH{7&9_(At_Z}e$m33wokTvE) z7Ih)Zr1zk~o(qv*@#MSbLKYc&$$_@OFo#PRHC+6k!Gg6x#VJ&s@CBLh1(_%c(kdis z&#D9J6?IhQ5^9S&4>F#Q6}9M8lL{)uiW(!bQ>)3UREMlcrOu>MXHxBSW3&afb4Mm}`VG*T`p{aHR`^5u_nFq$Z0{#0k(O4?7;LhU(;6*mXV{ zsi*9ScvGnt>w!@~5RjZ@nU*(a)&W8o&$q0mtZvX*HBw?;PaTn`&fKtdS9u6;>ivB1 z2cNw1(Q}7Ze%|w&uYZ1M>z2dsJ-7Mrqp=04sZTyOt@o!m|K%GP?|!5E?&>=On}5wV zeA0jR!nu#n5uWTsh`j+B%D}%TI{grtaK58fj)l3*4Uuh1aZT(j_O!y$OHs?tS!H@q zH`oA1suK_lSqk2lXM!cF3i{c`tt$jmqML2bjf%Km#3l_hrb`4Q*3)-`h(|m%`VUtp ztrF>QC&tL{;OdYkCea{bg70^{VNsL_JIMVLq?_VglYq&}HRpQGL6cc$_L#lqsL7d( z;fu)dg<|;nGE$Ult_I5+giS$JaA>X~jv$FTEGb-z(##t<%gCw_S0vf6Hy9#@;)|i< z=-lYH=a-je?5=d4XeX~hb^Cr*r9IQidqd$29QHUC;zL3z#0TS8DFcEbKv;S^0tDi8 z{Ddqai46d`8vE7;1nduq9=hm+Xqr*IMyGP&qx#Oi7y387-`=-z&HPvLFb@9nwT^>t zjVx#O?|gpIt6N9T0JV03AmA3vYyu+@H5_B4;tsKX!TW^(MXODlj3Ed34M!z)prq#f zy05^<#r`s7*^!jGo$^*Co~k;7ck-j zJSXu&>VI^XYitzP8HVS~oSB`=?s{f+cXsUYWzDii&6Wgg6UVOG9Tx}@1d{~1vcXm& z1Ze@g#oW_~Hfb(So2sR#5ox6sXc4K>AHnMtI5buLBgqdgirbW4QgKrVO++18Dsq#6 z?S9{x9Wypy@SbmGXZEb;yyyAeSLEnHdWasQ!}JoBhUpmPIhvv)a6~D3bCepLmKtSJ zqbhy{%9YZX0w(?2ft7Eb~A3i=^7tm%ZDMbAqa(#JNmQ z6=#{8Vv8CQ0!ZqmVzEfCz4zXY1g*RA0c;b{i|`rfMH5V>7KlVzTZ}zKCBOhVP}5sE zXxau!ej%3VUJ0j|81SO1*M}lTk#OI>=h2j^$r;lA7Z~TU^TjfnD z6{~HOho;5`&3TP*)mRZmQ)DM<*$MY~I3rOiQmIK>hgb$_AQHi9b zx===LmL5=YkyVjS+9`E}I+eZjDe)J|yV76i-=r(jC!zmIpUVkTRYgIdyd;GbMTP@K zmNOwK9tueUr5RC;i=wK6Jg7`y-9;%R14THM4v{if5h*UBI7h~#L<*cTkI@VB(>^fZ znvW{Yr)COz!NTD}L2s74fgOd}FraxiXFGwU zc%y5cr$mlhFk3v{%3k2E@q&#v|7XDQE+^fcEHq$M+Bz_=P`H};0sH1_pEKtV+ zHeV0aW}r3#bu3`)f+o)l)JC9=0E}^QOG z+)tuR3?5}-gi$6C`oNMI=-^Np1_}(nk1<5L2W`2uZET;MwzoUnNZ!uubBM!ca;9f; z*i3NzscYa&4zqraiZeM#Rc1z=FwW^CYZ(mtNkB|OLT=?od+0MLgx zzJ^0c3k=d#w?R70_JLJ$oHvW5t#I9qGwbQeKk9LNZf1z=8LVA4Gt@9gu#)8$J#dl* zoq!viXkWT<$<@AXK=jsDa1X$HeH56E7Q#2C;drbr9yT0eMiRa;CEW~?g~hC{b*v7_~IE^bh0xn?cw^Pn|B?k`QE8t zzdo4m`r6i?7dtjQ{A>%Yd!_yH^&KbQI6g6t|5eZ9Ew3DzIKUV7?0MvuKb!ccpL(vs zzP89!+}CbQ6r>pcJAFw1Q22LjOc;+z6#c;*(Ct$?c~u{=FWFNzP08_S+%h5c5Xp+D zk!UzNBl<)GJ3l%deJb|Fw1-`C5V5#~!o!t@a`Nm_2M$Ti_cKmajd_SEJ?oE{hR*yl5C6 zfA1W5)LD_o2t*!Q;_jrt?585w4s}p4)w$LwCQ zSJ|NVn!VNrdpAiak{DShtP$6!>%u+4MscIs6IPRzG-LoF<88sF6Za*?>XHmyJs+Rz zxF{)y$t?t_0aptu8_$OH(%G>hE+#9O-NphJl@-i;;)+J+W*Qejzzpf3R7eQ@0p?`$ z9M6XqUIbF&HClDLaRJm(Uu02VTTxGKZX4_YE*vdGqsgciW}>QOqKYz6dGKQJ<}4;F z7p6uk@?5y|xt#yG$ipH065PUy#->us@1CI~y)WAh_OyGZzPQ|IZWOFQ9~ek{eV=H$eGh;{`}7AQ}8GCPi~^M zpemEACg&K1c7*l$`d9T8I?bhyrTCiEm%{0)`b2%z*Q>Us_NC;OWQ(&rx!mcL*M+;1 zUCw5COL&vso800Ir{0gBx6fC+UwtKhrTS88DrKcgES6%f9^%<3>n5Qm*}U`O(`$cvuW@wOp5MQ=WBb75Ch?Cydi2pBPrdrv$r~>}+%j=PICA#w z)8|f~`a5v-1&-t21=ScN#5D7j`(i|=BuyLXV!E0>N&nAw)yK9~UGaOL-`BlUK$0wn&3s3t&LC7{x(sX|0TsDDgjX?D(idG2GIlsy0Ze4c&pxxaIMzq40X znWZzGMG_W^kdRKp;p30(f{dM0clW0 z6@Sf@h{O{$FimcZkGvhU=Ft0xJu@OVPgQJLKX^d)BS`RcWNTV{+jGRR8AU z<QMy$^0s| zo~-tN7HgN5V#dE=S#v%NoC@e2R7@p9>v z@^tZ?Vyf)h^}G+deNga$h`|HR`=Hwg1s}AZS^UI}cMNUQOFagcGr8h2Io#KtIU~L5 z=AB;TNvG3vHaXvOe&@XJs4=J0dBFM9kvp9y9m#nUXtWF%{whqS=iDTQo7AO}NzYS> zP?Jg&N6BQWK?OsjR)f;MvG!f2pce-upe1%r< zr}1kl=nn9^1;DQX@R`VD<&XZMPmfkIVl7>zN@GXuTuo}$4%VcaNhvLmwCDdt`Q*G~ zfWC_WSBPL17nxhq*wkpQ5EHF1CN>hwVSEhDS`rr$i{dI`hOjKE*J-WMSpHK&aq^Ie zb3IBaw8rs08?FR26O^PnKesZSbctQ_>(IkXz#ACortNxMVx+(5DU``BZTOzj`& zIsWc*o7Q}z^7L&7-rQ!LG#=VHHIYj7XAl4B+0mWv9(ez6^oF+kC+}H%LwCBT_RT{Z zM;qwdYENl00fYFWc2Ya1o!3+i^&izj^YmYUFK19SG!zoyL=hlUHE-(htS8zD zKB>|01~mkZ8YFw(n<>moSBBBu4KEC%TwC?J`5qWO-~VM#g+Q@u zGrK}z(6>;{WxFVkM64)hLcF<(6sXr~{YzG_$Hqe~4p`j-b!!k*rrSy)A0#vLt>N$Q z>OFjT`t<2UwcPR23+9dYoRIE%oNBwSKJoa%@eREh)R`ZH&Rmp>uW8O9{rLZj{0L}`nO(nbvz6Qylnx^0{&Bbf3wntYsXSSQO*9Acj9J`~nlxB$IGi zY@;*s?Z8<>?-8c{f5t}7MBu?UhduKk+Dt|^qmfudQZ-%G6&*%L*~pTJZe1F#IcC2WF&HL4zi`IG{k+fS^DLNKm(++OZp~L>y{PeR$`~o6PV`*xJ2$ z^Rd-4&(Ey;!KQ(Sq-PeUpSXTx^KDNam4?2$04xA1gf0UMxO5k?;0-9#rNf*VmC$E+ zM@$w!YaO@lV~7ChX+>NKl=>GQh6s?Tvv~8AB;9=b9j>kDgzG9*IZ>FdP)R9Z^(p<; zkLS#f=b$XmYhjkMvjYkxd25KHYDcUgmWsDEbi7C)RnzcFmtG;_uP*E8YLGHqgp+6a zo(4(51>Rk7e^l;kkQ`iM#&S|-MLt9Z_&PGeN9m}vRlkGXOYfC->O0wfvXAbQ9@h7> zef$VLB0U;LJIoITB7BPaNqWL7)H-y`qv3*xxjm32*9j}yON?9VPH)E$5qG; z{LfYAs-(Z!6fDZRgIv?~9>$Z5aT1awaK=eWVIdssw604MRW;5+gev_8HS)Uay6hm6 z*cqBV?J5TqNde@toaEAc__Mzto#!*o!uY~?COv;?9E~n|-R3ZASrgjU5v8wsxy^Qg0m=DU9_G^*((PVbxMDGb=O;$dOFk9&(B`n zEf*IK-}k`nKa`FNR;q+3v%t!@^7$LUtQI4qz{s}*#SB3=kA#NdmAol0)xP2bRci4w zwD|89gUK}po9fbBp#oS6WsCo6Q90`4nbFv_h`4ysw)Po z@>^#VwzTw2%xFc#{k!6)S`pf{2o87soyk6iK`9@IxZL^<*~bu(^M|WE>@2zz`bleN z@-^&L?^#@pYYA~wh5Hj%pz{YaMno9f%WfEvl{35#&do$k@xeK_ACcvX_uL9mV!%8^ z)flifVyM`04U0-Lmo1KOEMJE$uxxX4=0|hp2h}<34p;za*GSMmrD921k(YC6y|vvs zW`%HbDz4z7P-xi)7782d>}r^8?Im;?U%0cKg@&veETLwZ6IWy+t6>(7>T#1KLP@Pn z&xYHh1=6Ec^lG$02DDZB>gd|gi0Wz^^jpI>$40F6@$IoK@%#TnceTexah&m)*}Z+t zK4y1s58un-?D+7JvvO8#V;@}P#n2XlESmr!M{**OS_p&|oVKZ;E)XdVNmqr6QuLLujk(Lp4YQeC{`Ucebh2eaz18?Ck7(^L@YH z?~}ivY;|@^d*rVwXQeSV;@p((s42}(p_I{RrdXqsaXV1E^L6D#<%n=tKZcK!q%pD<^!*t)0hG1@Bpu11G_HUyR`BI0FU*{& z3x3j@Nl(GS@2yF`m!&ftG0znO0pKz@pi-)6x=t95iC2R!ff3%{NHmx11O3tb7*rIGfhO@ zTb6;JGR zZSj+eNcU8s5Qd}x4i18a@by{bvno4G9am7%_R9m^^8xYR3wY%L(>gDkR*s*%&d)U` z7p^-=R-E*DH$66FB=iJ%Yvvjxl-D5sFAt$+mT=3Ns z6mh@MDBv}v@v(tUv1Q=w5856YIZ+xKA6Wb$(8cSM_PgZE(?=#Qku7(wkpAJj?{QVj zK+pUen8PCJvYs*Kkl31K4|VRL01xL2ln}$3Bob93k^!N>!hUX=N&C@Y*Z9JOIhfT) zvJw|2y^-uD_L}&ba@71DI~O=7os%b+%De^Hs1Q^`M$~Gu7gS;;k?JC(3dFcz zU?ZsuuC5DIRRw`amI1MbXpe)P)y7`Ep0cMTb+1Q3GMw?GUTME1NTXzhXC{Qbq`n7C zzuN9U&oxA0s;nYFL|7kNQ^o6rdjg4zh(aYy3g5KOBmVo09Z>x6D3@^IF_Tkr6;~TF z!?jtB+gq#6>h(2Q0Zx8@x-M&Ra-pFtuCL3gUOZd%rhK6fr9qs4`}u0b(|z-CaRiI& zYZ9)cvY<;qjC?Z#59dn-?sIjewZcEZ=c447+~)>i)yll;>Xk~UT3Jx7FpwxenS`JdI*zVu68`{-TXB+!za1y>QPMfgz#^VIO4fT?r{g(fv-7q?oKf60!f-wM zY>e_I-)3GyZ`ONsp;w>L2`oU@V1|K(Nas*2(GOGtCYi{PDO-Kp~a&+B8*Y$ThrI*ooR@MU?a~Y+xb4H z*Fh3Mwz9kduJM>pg8DYK9@Adf!1#=C=yn#awYJha#Ei zbU0d!M6JrD2n%v6It{kRT*#DVWC4;O7#>MjgfvWOIkQ6wsH*4%P&gC4)RJ+sX*-*_ z1P2%g<2HT>b!~NG_->nk@6HGlk$hTuY7lqgWkaPccP}2}$gp4d4_+JiEd=Eu zf5uC`p&V3*q2Os5esR0=eSAaD_Qi&Y zrg$=jm5yF2&n0w!TPv(`jU>r<`Ogy%Jl@paDv0Ob|Iv%N-o>A*d3+;`Su0MEZwEFb z0eyzg;Vg)Sa~^ZtR@{b2G=L)Fz|;IcCavoz(_I9|jGY4M7S8a5FW6QWswKO`i9?6b z%nW*X=7ty#Y$l7)N-&R%{(x>Ggrc57c6DIXv5b)A1b3Vz@1Vs9ltQ5m`mBULjeeg; zDt-PAeUgJ~cTP}lL$bBm!pO4z%YD@c zRdHSMv%7cqJ)@5AiO&|PqN1WA--5*&c^cyfR*jkm79}R?MB~He!zMKujTlrgO53EB zAsPuVSP__NB1s98RMMG*kdE4>MQvmA;m5QIAx*8?i3GO4bKfp`E;d@H{iko{_kMfN z-gED{=bm%!UC(fj=1ES7Rz|Ch<`uu!gAXEAe*dTj>p^&>RyJqhuag`hIcii39n+c>ROlpN?y+ z`Ef9BM|4v8>P^oC_dPYFsOzl0?cmW(f7!9UI>LLpytexv+J=J1S8QFep|pElebrNS zPp;Yj9c*}4y)jG;7%w3HzUA*vikdV)iB=L7&80M|BPjEpybdMt7#4+uR0Ewk;-E2X z3+En@i)g_Em)~AKV9I58l$-chbuM;1^U1B}KfQXWYqf{m3(@R@{;UDGrgqP#J3Mst z(A6hAp>e`~-crL7sTn;ute&EK#Cq}pb6i8|hk7_uR>0-V45!UiOjF|;&#~gQoX99E4CjvYjC{kLeSZOh<@E%Nsn7@eSzzmCLW1MYx zp9#HDXcyvn2<$Mx1Ar00Shb!q)IszbI1%g539TDwp*6hbo;AUK%ckB4**G^GnDccY zM$IrUfcu2m=0u?bbF@?{00)66V4-@9)`{Ky2tO@F8rIF&kP#x!liC&Qw}s@jN4pdJ0+?!DDj1 zaLmG%7wxe*r#NP8mhl~wasL^wlVhrfk$a+@X0Z)22N7E~bKb#b&WBPpK*f^lsgPrq z?X#Kv!m%cOf}F5;O4wSHWR8F}q8KaI3vIT2(Zg$~8e`sTtUyhvpxNRFG+TRyR*27O zhBl58^d!iz9`rq|w$mbaGo@lL7oh!|gUcAMHf62ejCIz*pKY`cK7ClUsUt<3qU&|$ z$2uvkdY$^DeD1|gD9xdF%#84N|Ec^|pq|w0P&4byPxLm^#Co3PoN%=(Nx*QMA%6)d z0LHuHlrncvX>tovz_XvY5dQ0I{gkO%aS=%`kLy>2uAs1#6viZNV1 zx=$@dO~YL3Nh)OU_~3`a;^>-~bH7YrYjz(O?7lcih5x3s->4h@-iP$w)pM zxIWAC0W})fZpG``p7?B~{otK;d^+NEts_4BIpfmF@@zqUxAPQp?XcI+^^t2F*GR5& zTxab5P7c$5TCGJKa~(cLxmI3}w2%cG&sw>UI*k3!F->EpdBA8eYqWu8jgf-q(|~Rs zfG;-moT*F9ZtFZ9XP>1ZIrX*AQ9YH`S@o=1)|-p;GkK0?OZ)m5hiJ3jiG4>6l=fCw zIS7Bk?x46AKHo#Tu#QNr2>A#(u#9~o_X1aGJ{R~*)ON$qd=`~Zq4pl`3#^+;UU^<* zQVwiyl`@>E%q-J$sLE)k6cIqJZKhScSG*3khxgw7DD`*yP$$|bSsX+kAKiw2719TO zIw0eMb%R9g3)f0=A!g^J506(Vb^J8Y@<+Awh1ADggkzX}fiVpqEt2<%c6vb%P!4ja z(p5l}MgTeIqZ*8{A9`7A3-pG_^LjTeMSc~dHWj1hkc|Iavs0_XdN!c016l!mR7c;` z3*f_`T>A_WsRE&;__33Q6TRDByHe(3g*{7rb;b~iV?@t+`Hk2Z4^&8^)u^3 ztl)xa9@jjy2|P(nrFStyUp(^}`l{GM4~T3^(UOt7UWymLL#}>7d$j?yT)abjMI-Iv zwuqpy+F`7}0e4H5pP;)~uD*+Q8Rd#8&@ZO%i{-Rldl9ks2f9t%kG+PT{v*W6DCl3r zxE7Ril&fVUx3=T?3!H=KC+BD|=P<-b?$GAZ<4TR$1SijQV0L(0q$wML1d&F+ z1h(LL0{Bxlw={YW*oLv2!AJPJfT2#ObY{rPfimDX_PcQKJlB(lLyt0>u4%uF zvj$KunN195fA~2a^QDX1%_at7F^gerra`X9Xpj~Q`7r1?+Ikf7>17(Fk@?RX+4Ob5 zFFDMQ{_r*0`vD$&6F3vb!1H?k+$ndqo%?#Dwt9q?hr^D8o_KhcrZPk(`UB3kyOpLg zj5qP_&E9Qs;0DO0@!B4?2{9PkyKO9>ScWXI{Q`I6MAp&kG(I>{egYS;y6tM$ATw=7lX5G4$oO<-a2J=ExBGF zM{XqlyD|TtfZTZpXaU~(U(clwVioWJ#u?m0GI5V=!~J9_6%uu!mVB8A{2X=YZty9{ zaC&!-1N!6H3)yP$KBCUcczy)(wh&BJL{WuxuZ)E36-(D`jkh?Y-}yGt)l0ykkbY+^ zuolmM2XLNu{u%rRxD5S2f!g00u(8l)?9r zUf-erb-w=h$IUYCEGuDWG`I=8(fJK=(`@hO4cPguVekKqShv07Klmfvsk9*cSZ#d?_sS5@6{{P*77k{}IB z(n(Ub4iwX-f@Vf5l@^Q`77?K_K_~^3M~Y=p(K;5VNCiv;ZB;BqMFuyDL0UT~Dl$V` z7X%gUA5@)MWn^)X&gh6RY9P0t-?`_$yxb5n2yf;yzjw|(`||sJk4RB$8Bf0ISJlp{ zU$NSLgYTK~)H1H=W?VLIfkHTSmMsFZSh4+zOn0HJn z^EOH)=|&(fhQlDE->?^??iNWO4Udz)opd+%O;h$NOQy5)oIJOx&y7B0&5R$sN5?ON z;Uee(e}lR4Uh5l@zW1bwy86y_Cx=JeU69a#o!ax|2G~ftkaQuwxXAC0-ySZ1=Kmeo z0&D^PeFD_u%g1}$!{hz}Q)Ud`s@y#LmUU(7t?M zN!>=$#n_UdpFB=G&r^T7#sL3w;^0K$VZO!=`mK{SFq^VhxSz}YP8S(LI|JOkQe^G9 zUb9@S@yZ`0-8ANr_kC=+v3t?RQ)C1TqrIUTYn%<7k^R&q{-ld!t20ivx=+b`+Iza7 zN!H|Vmo<4Asm{AiR{Bk{(pfEw$y*)#URL`R(x7d`aaCht{2wuu3VNHEKbLfwwN>$) zlbXPcZ;Fg1EU5!|ZCam&fq^LZt(|L_~q1I*m5HET7TdWACD%n?oH3=-j6 zo^z4vE7r}H4W5(gU^wTsi&T4?WPo!W`sMHVx?b$v81}VL7CRqFANN9;;dGablBy1O zr4C_H>Pq?(^54VWOS(ZOr{9sOtk)u#1Iw6qvtcJ%0k|*MTV^Whrqp-&{sBy~|9eOO z$r~b@4RISyvMvY8g&#q4`hNPZl1%z}`dG_Y=*Q{C{YyZdYb@oqpONlF?pRwcNkUz< zgOiZ2_IpWeepwRo)m9}Tzv=|z=%`#rhOgV?cHPG8H*{O5fU*4y;Ew%ng! z6+8f6K$Qib7fz#01NMKg4konHvIE;o%rEXITme6Tx~MO$+wx-6x54(=vMH*6d?WU? zMEcusAnMQbt-f~)wm&>*=htZaeL5O@%Zk?WExn>SntD&S5<2iR>i5Ogw9@iyMEDZ+ zFYrEWx8u_Pee8PZoS)OSTK$52?LLUlm@Y!BE()3=>)tA3jn93nO{}`!_`|)j-uSx^ z-#1h${jTVchowq&gZgl9rYXPN%MhCceS%gndSQ=v?kiI2?U!lpJQ?9^Mi-C7-_nQs zNBOz7t$tfIhjXV~4&yb3;WsrFUWU(YD0s%`mu{3PazAFg56Cv&Y>nPklA^vJ3?h9G zas3gw#k*A&WT*>#&LKj$@w@PLNKP10N`nd8($~=5@YK8RA_K6N~nq*+`OF7SLkbzz;dsKmL z-p4v$DFv~`w{Ht(NZ?Hlo6&BMxU-C2?BQ;Z5~Cf6U0EBq(Il(9MRFHsVo*}o#5yXg zDLk{swQ(QW`Cv7EX6J8hj@~fqPW~9TSSq|?&JMbxowZ{Mie)`zm&bZG*d}8F2fI${ z{X3+_yPS3DDK)`M(jyotC92PY!05WU8l%0h(4sXmkiEGCcvFPG0`6Zp$=>lB*}r#S z3YT%J%>&)@unYOMwl3epUq|l@Q-*KhGW-7$OC~C#b&vnomREn!V)-z_yhHls>Qtjg zBW>N*W_7(eKh>Sug#PTv>K*2c^vvqvSWmXME3mWTG&=7??&y8g?FW9Wqm!1hE72$m zBWtvw+9#}iOwXEXy`;_R>JDs2`ZY(#M)xeXk*;2vuv4ua80+iKY*v4_v0-S_-^%Ls z&TO6J8{KJba5w%C4H{dUUzlV4cJHTLYxYDOt7BEak73>Kbl0LqPlBF1#lM|1(3U#I zxmT_^5k8Sb3FfrL>iiDz|3E#+>zgDztT5)^MT8Go4p|;moRo;--kT&mY|yvc3Gg4L zU&uQrBG?gO^#4g<4J06v=Jhbv*I0N`P#H?_sbzUg7%K6)$Lkoc3v)Zbyk}*{9QSYA zJ>7jg-F-Pz^FGZGsw7UHhn^K;#QNPSz)7uIlYO7(6KCq2q{_imEv^y}ec-U58WXW?t! zZD;|YuO*fpmbH=g3;&A!v03LK@&fkBTzK2|QM61HC&MSK-c}tuKceO1D8F@FvF~-h zWFE~@s=C1)E~Q4lTq_Mw>Kx)bdVx7KI#=&{pUV)eGh>i1c(nz(#asUB)}> zbMAMAEOBdDCs0jf_UTn(fR=yN)GxDsv0VFdX5+{IBYo3{D91PIHEJ8)GqON+k;99^ zyMl8ufwB|Ae>tnLqby&-JjPom*QS@qIZnM)rr$>I6qA1gT*v2~RY@kjSu$wi4DChbcAGj8zGPDWG<{{9D%zu5nwOG; zqHv1sf1mG5skaT`MtiA4QCsF)TqeJ@Oz>N&E~uAkXEAm#I^yDROX{Eubtg-A_OvUU z&tC7c?+1N1y#=gRxQ6u3^d_06I0t2n;lXf=b2eD(ZIo-hpU64harD9aoP#|w)H^B< zdBddKA5R>6O6E(>&%H4`#<{CW?+$mR)-#qI{Hvrm{}ma@9!j2;wKly0u&G)TkAyQV zDPCK$A!?I%hhy)W(Ye70SxiOgi=zdK ztrV5eDbkKpMJQTzG`4>7`aAc%U6;jn?M!#(Kj+fY zC)h1t@55DaLoVM;3GeU};^|?HtxyZ9#_Y0Q(Yh92`uaPp$x<4AJ1eM5{iWdNpq6o0 zQ^#DYi1hfainR6)#s9nQ+$9$}7l1K5k2$r?d5#Qm(%E_s%2YMV8USESaRt$iA?1(NZWis}Ef z{)Dd@IZj^L>2>Uo+!=rn=Pb1OF?Rp%ugNwN9$m?^Wl+do{{^?)g%uT&tXF zat2yd>ooZ0I^`B?uZ*%j4>%~&Z6L};_8D+TB|cUfYo4v4A*WPIjx~z4tO#KD_V*f2 z$`3fp7RGx@`HcJ<@KuT3H{dVpK)^xPU+I%X4>&F(xeLz*Ftynhlbb#bc+zkoJgv`K zyM*;qZ@q)?#pT)bQm8GrX4q$vHk&RCzu6job87#3xyso`oUG&QG$-$oA?^&xOVwQ> zqjdk>w@kfK&3n}#U+R3#d73B9IdMjHXri|zl35ox-Ex(lt@~{$(A>p7?FI+Z?3@55 zPwPG&MVIB0cPE%R;5f!FB2IfkKeaw7CQg5rs{N9+T(Z^>xy)HB8|)j=LL;O)%=gcx z)wdfI8fWfa*{C&}TK;>9e$_$VFgauw*biO??}CHiu*esG=1gbkzNG4*heXGG+C9vE z?UtO_1S$4*1bW53Q*MbgOT7Z$Rx0@aS1EK#G1MCemw^g!HK+Dy%*w$3hQ9}?uogwfX{^*?7R{f2YC3C@49)VaIl zX7^Q@>wYX9IknP(U2R)(nR~fxV2$5%ZjrdwY3Pb(E0=mLArr|D`DmXe^~Lx@e|=}} z?Lufed5*R`6?Z0H4N!X7@WM?^in1*AzZF z*>AIlN$6f?LiaX_{BWPY0=n<%FzcTGM@zPGM<;lL8LO23KSoz-jMRbM689c8XH{UANgI4H05m8sfOEmw z;eW$G4HybWg>AJ1%su|P(EI*%@v-5Abga$><%0~2%>2(e%kN5WD}R8A);#P+^Bm1K zj&hXpQ#O#tHYNEha}MP)1sWhf#cSzUC)3mR-|W5fF8SymvPR+Mp=r9M$$dkbta5n0 zoN>$LJWvYef)St}CD=g=Zuq5eonJ#}dnb}8+W=p$0#6-gg&qO5g)BhAq*lH(nc{-IX6J9e*}7A=%M zIr-$-edrL?GIiMX=&uFDDwO-vu52Io3mn+fQ zN0`4#wNoVS?^E5%e6v*-G1fe9v~=cO?LQx@^$YTP$w=a?>ZF?WpjeU3=-|!V8S|g? zwWd&qZI&Tv|5b-}NNAJ)|G?NDSqn}F{Q~QMVhxk~cy5TSq*mC8F5YRhNN+TBp~4yD z|4X5J{@>u-DFYSu5za8}IcvSR>11Tqan2@q0;Jj*bya4ami3No=k6(z_oPAM3Sy`< z(3fgY9K}w;eu8}hOa)hDJZr3X1lBJD1HtqV4`yIEegA|#A5dG9zrFMe$*64%~nlgrIOI z?$w<2TBWc1Ylr>J$KEqrjVpz#R$Ho;Uw5T*769|{{`SrB`{*VqqN%tBsVDFqyQI-` zNB_+4Sqf z-qC;V9B7e|8g~rkZE>vLfFG59YyU>5U7uLbr=lNw#|t^dyB>~P(M(^c_%566nq&6z z`g7b-PH_cFRSC!r`A+A{8!*#y48;+OEbq%Bo-a@Fp2;KfI;6i`YoN2wG|%cemF>cw zZ?*e4Gw^!;3FQK4RQZxX;?ir;K8G%yTAaPQ?%B*?kNB0~2cs`e4u#Rf=Rr0ajH&T> z6V(0}d0A5p+7vW+N%bnU>EYnxI2|>K99~*+VuYkdm?+#SUsqvVmu_rU_*NvfJ90}p zyJS2!ctq$vxpa;Cv*ue@JA+>wi>$-kRIS;8-!Q5THe0=8u4hu~Ph>@fOIxliI_SHa zZL2wmREW=2vX51lEyNbVv+mRif}gpRlX!sMdA2-5(xH?#nj22X#3@l#8KSDrzTuVN z*^p9FgwZ)#kIpo3hdZr3Xc{|2$LIq_7}u z*L4?0>-~L6mCUv7%Z)nV`&$8ToHa-n$?jE#gg@_)edxt3etndporfupHmK5gZX7!C z);8iRJ$sI3LL;2JdT6!s?clrW=T`IX>(Ravd zPwd-;XU_7i7XrWsZUh$Qz$JLsyNy9AcgEL&)<|h?!=RI|MfpdwKl!`$&=BF&SuyVZp z*`lhJqaqlmW)gCUT|;aVJ?{;vvUT9FMLnh5Ml;BTZ8ef#$ydVMF~`J_!%h2MD0h82 zrEMDvRe&<1+ZK`z!K;Tl(MmK%7hMP}aR(rDR>6c~XF~5n?~+X`sBA2$WESN-QC%NX zAnkt#@COK@G~k^C0wSk9;xBkQC!y82*q_ithMB+kqb`=HOA6AVLNq+(Q+UeYq%DVijD#n8W)9LzJ^pcE`T9(pH5g9I* zc?45Nt*(;NEZapiUta`Q8$Cpo*VG(YRvn|V!a;TT6Z)EMPMlbQ0~xyHTgV>H3}p(u zkQ{UMeXWYuhUU^#=y07Xm7a3q&yXb(j1`tXm6IoLufG{c+Bo9(=*f{76@Sp?+@f<} z-@kP;_#A6i$bFHA{HCfk3CUDL^iCj^uww6eqpxv|`ov=fJYD^ib6GF;rA(k!rpn5h z<>r{0bM?CsYeJSB+|G#2(k)t@>s<@!YFoLq?092L?B?XxGdi~7O{mvp14k_d(NRJa zO?-?`HAV|>=y$78Rk^$1&rMQ;Y_r~~F8u-xIl_G-0%(F!;%9x0Y79f979pXz}0@%#Geb1$x_(md78 z%Xun#_|-{{MAFO;k09|GKQfe@syr^99_t+heVsTfao`z^wxm3UrH$^dUEOA z?Yq7rn?dD&)umtT&v@X46^FF0;?#oD5^5bl?vFk9R1(@=h?|zUFOE$WiSs-K(|CXh zN4|x@~3cFYeh>v-|tQAelQ{&UnfPcz~HeFvK6qYF^VufFMXdfZlPG3$Kw9c$i4uO zppQO<4zJ*;oZB49;V|S(-#pUU`Ydu7cJ~UF2Q`p5!UskTw&jfq*8uaapbCOAJLlST zfDc6YAQe~mGF#|Z+@=6rmbaEHZv{jF-cVm)%KVTS5h%QI=VPJkv?UM?zP$v%NrP6{ z0~|UrT|rf{Pbho~d!gpRG%V0m$O~bWk!dfk>saTF>KAfcZ(oIYwG85XE<<~8ej5V& z*6!8PP;CI_0$mn$I`uB{I0M1l?r`1ypjJz!`i=59kA=TP8D-Z&%fJXmA?L^lUU2-b>+$p?O7j5#g6W8G5%EgYL1jl$1D>C2v-9L7`e1cgzAXyt;8Sc$ zj|E1p!d~%oa59}sM}+=kc}T%4q8_Jv#b^Gh^85wGMm4C2o5P3dsLgdC1eu=@tY(pwDlcw%1c}%2591gX^^ZUSUNBotgbB zt)$^E(`b^VXh}NpQ&{>IF=31W$ZTUfY06Sn_EDdQ(QvAm1UX4|s39fm%9ryZm>|zh zY?U0*E3M>JJj{`u#W4AIL?gm2t=>omiik{;TeYHGNLA*Xr3Ghf!4{nN!BKm53ZVDw z5Rk(ciQQ1`8H>2Ja+Ac!>^Jsj)R#QO*+(V5u8vcajHf){|H44^-qtiVr;qRqThha3 zXFi@gjek&8Bfrb75z$elu4t#hS=ejnAly@UaLDH11>FeY0P5)2m;UOROj&X<2e&79 zv?l|-r|&`9vX^B`_f4fojwOe5tErIHTXqI#W<6`MiB=4;Ao|gObs2NaJtuXWOv{is z-5uTT#-_c@T7yaAqm)3*>)49B?3dJ>9TokEdF5lvge3@pCCcWQ4$7?q$^hkZ7oXbT z{bwD|^zunMa+PzLFy2YluLp#xdbCFDrbprV8P4<#*qU>lWzbI8n9`p-bAKupFH2@> zXFFBg#$n(0rhsRX4ZP&q%zMErkZxi)7*yoXU zm?(6XJ(HDrNPVJ2%#W8dBwDKdc8n$gb|D=_i~Ilcv@%_ z#ELt?k3 z($T^TFyXF|+;deJgCdj_@{%SfPd^$Y*nH_*3UxH7wBwRqP*0OP$nCW$@5-xeruWeV zs|9ls(JaiuJkC|gPkH#f!V7nd)meg(Gcx3B zYD=cvMu@1DSSkcqKWH4AMCI(@0FZhzun~G2qd=FCdd-o?6mGCOb||;ldbRn&zV0c; zW^b}tvSA9mTZW5RLL)*|y z)9Cf76UUMPx|ZRLk{S0GGG!i9YQQz1DpQ5jd7CA381dWNuxz|i<~vgJuP!BzGz!1y z;qw}_JIWgeU6JK&8xr&L{UPt6I3a*%ypV6(9qe5L7OzK2(3tL2@stv*iGcbI-|7&7ghP$5hCzSt;<~EG zp`Uwf&UNfWKSMK~Smu_Cu0UJ~`>kO^ttaqPyGKnru^!>R%GLOtN80YCUxCC!4ofXW z-6)djt6R0}!h;h=e1_hIk1I0{&RzB_uf3(g-m2^o#SGsgHBG2-$d&b8`E$153Vz@Q z2ni>AW^4YNUZY`uQ_&=zYD^}B1VQQhRsHQ`?&>O6muw>%|?skj*)-o zo5d31_m?I%klddF?f1l*RY_tPV~`ScP-~hl%nWHhoygwYY75)f4s3t){rW0a_8g3< zVP?%~M*>Y-lYD)_9%pK{q+O`p0s!`!*axU?Lzn;yxJ#=55{4(Ltr2<%qGez8+>f4-L$v zgy^gSQMH#bd~M5n{l}Hutr0I@WOGWN#26*U8JhB+lzl2st%qO zyw6jL&!zW8zc8(=)n8f(Zz9XSR?Q!yI+M~s zx7>f|L_Vk}Q_d@@^^rDvE_NiweyfN?aeQ`Sl{&tHoO)+;zKFBWGQPml)qRfoX14K* z_=fIfmL$7FDhs@R;>&9q^Y<(lbn>Qw6*H`|xt^^vP?quU<=-#eNu-p$X#6U}cy=PQ zJ!b~?nRou{e7gD`(hPWoBe`QGn)N8RVzAd|ij}RqaTn&&LhG{=rj<3XLIOqNUOy{$%5#-=6xQQE z+Me4!us#VMsK^{=5x%xk-;N98FjeMGF>(w;el^Zo#-HX0zgME8DRg6{IzhDu5$zbJ z$Jmoi?I8z?nyEtqrVPk)3C)qs~76C>fIeaX7U?jn|-# zw46ow)vZ%rN=%<*Xa3zy5WmGe6JttF5u0q~fzyF?MUm5iHm$w=SfOX7YeoGWez^9+ zz7zOL!~Tt=tn&lsz2Sv!uH(tr+1S4IOj5Ip_UTzr(%kyh(fR(E>eblU*-`1BGG{^F z>w1KBWo2i7+PU?)3s<`@PeQR>YWBBlo%aj((ZS{DZx-r}OH{ zT<=AZ)dl+np|w*bB7?`A)8Wa^!)eZfhrLUEZT$s{)^X8|^UcZ)CS3{bf@SJ_{mwd5 zd`bJrS81n@N&5B_TOZ+>okxPEd=0JMP4$26H%ur`(qEw5Sr7K>u1!>VL$C5~$IWqU zr`x44PiL^xUK8D2B6a6kwS%-eYdpPK-sV>&OC`;k{DLo%6Xkv4&hBHqfR3F6PP5Xfuv?Y(s3ZEE|4_aGJ);w43M-E z8SjM321xn_NGf8Lz|=DfBy|9iZU4JfjC_!qX@*1s+ z0bICiyHTYg1E_;M`+cQ_u9jT0nwsT^JPUa0&3yUTm$jINM(ohJg2L!6pOGX3o<9?o zC-#RuQjD8ie5)_`35h>oky==W*a8-y2%R8Uh9;PeL`mLWf(_;`K`a9+pb#7>=z^w~ ziG)R-K_W=9EYNb~`SQ{)Ec8V%V=xx*Y_?N4F>Q{Emh^bMBi2k5OqL9IP?6`zau8^L zSYD7`m!PaSRp{UTVEq2|&|&u@Eq- z`C=v@MswU@4lk+_jDS7-#YlFa68s`Su1d3J|wSmwAUOOGPc(z>}P9LeW7w^~cFk5azuL!89TN z;86OIN7LWWeX6vXNBtEm+~@B>&sBU1pEzLc2^xsvwQ2^`!aAexn;Fc#s7}09B%Kk> ztsgAq@GpfmMjv>VtQ3X{Q3h**KJ@HE0ThTKdet)wp9(c9T1Z%8@4Ku{g>JC8_# z8xNbe5(x8mxG(|nC2@tx`zOG@Z;qB9dYaYIfX$=!k{z7(FZfaZ04m!wNYBq$?0N(f zXwWeIBG!ke-w-NjbZBsBfFlbl_v8M5j(}hiFVVvwMhp ze}=tF1l))9M<4<5k^zbdiix2FTWF)$d14LoN&~T_(6dpY;fDW>MU{#AWXa}#*zG`5J>t_dI!ID~QX`pdzamnF**7L@qQ!0_a~6(Iz;1rPIw&g-7SXBuPOwQQn`rX4nj1@kM&lc19; z$Y*3xGQEoo_U9qXA|{6G#=8@B3(F!R1{Y^R&&144BC+ zzrZZC4wy*TU+_xrbs+ywQ4V1pJTi`Bbu1zNnY15C9M$_0^fU1vX^j97-@jgqDG+Xb zpoFrFVA6KaFPYBHF})BfLlGL2>>qwTQ!TcO0^k}?@Fyc-Jr{npK3St{Q z&%=AY+xE6?JJjL@r$fijt`iRFwiBn4BlJ&H8ub<(hdC!AI@F~;@#(cV4*QHdq`Qtg zY}sO<=0gFG?8G;aj$rAm8ND=f%i0>d8+z*sJSeVUxoCZHC6iM5oS!+nxBt`Yq<5pI zFHk>kwSWWvPd?oM&``4?(uCI@60tR{o;W7H8*xZ~Gve^s2bK9F6myOkKC5&DpQ&5j z)z=m2SOV)fmOE`R@sUjFsE^t>WMTZln1L*V&PB`C8(vlwW%-@%{9~?P*Tx$sz3d!s zSG!M-x2@PM5sPxX8s`X|NAh;O_N;Qe4kD~`_D+wjyw2RbT$mdcWK?Fn_8WLT+%NSi z?@O-luNf^5!Y2+YI`8uK#>RrS`uB@#=LnpOye>=$^}A*Ho&wjPpHZfzG9F(qao^td z?R4g?<&RzEkGYL++l_C#jhk_sm#3AxB@U{;o;Ri6z~30;?Zx&RWft5Hb>SjS7zoZ{ zZrKdQ;v)4P2u>Z5m6YM9ZUZpEjKz^>7eB;O^*CT^SP~Q`nn2-&Y4;pXw7V}|epky6wxWmh>TR2qgTLO|G zIo$1Y&`qnB5AXLK&;lfGH9$5VUMkiS zRVvm8N>OuS*yhG)YIdM5aoY&XVY^&c!G;+f*2=Cg0NY}J*=OGzGbV)1(t~QctQp<1 zg_VmNS(B5C6jL3`6B7wv6w3BX>y!nnO|(Z;6}5%fogV_!E}r(PGcIWreh+wi7{VG$ zhmYMda1Z;MyJJ24UhATT``PQgDLD(}}%_#)rGZ)}#fm>yx{P zN@JIc0Fd_+{WmiwBdD?OJ#jUiKc!{bhKJj;3=X@77uq|dWjcnRTW31%E2q>dZCH&} ztN+b8j_>xcy~MtAIfpuXD|_BG0L2F31Z@Gki#ADKe3R_?xhUnWeGWm(>%m;4eAwo{ z8E;Q84^ur|z!eW!A+&)8UlI^LDJW)*!ta+m0x;DP0tQ%W?V_neHJ(RB_qgC&)QX2SGY}pN))iyIUwMwl+ zLL=r)TLF_FM;>`7$7|eZj?yo|0j_F(9OFY~(nN6iFUV*t)ZROc79Km2bQ))gyxSqtMqjgrKWW)2#h6%2p3qn8LU~d+-(A=1%ye)qus#R!Fuf0AFi+>* zR|~a2;e?8oU(jC9_*UsFcue_|3oyqy&0_Ky%~Of?(vbP8F8Uhu8O>s_8BGV9cbcbK z7CW-ZXSC(f)yAJw`aH=4`~1dqBV8e2s6R=Y`3bCZigR?~okIBa0Z^pYl~ASD(XR|J zisEE_LlV>Mv2aqJSl8JK^(oJq4fxtNI|&dc3u}C++A!%KXqP(dQfnc=>(o2)*iO0j z$=u+j!e>1exIi)>xJ9FFr|f(pu-@H*Y!Lolhe=HKuxo2|KkHDW=y{0;axm{|GMa&O ztfAf-mL1nm73#w8_< zxQCB!wN?^FFwDPpJ6pS7+lt$lN^Pti*&`)i$h#TYyQ*uJY^uohP6A_t+@0_v#BsU0 zyq-%^IN>!0EO_0Yop7hkrwnSxhCM{wwccQwgN;MdLRerH3pL4ry6YOuLU>9KP5f-6 z>94r$wz|2Y+1$xT=KJcPL*x;uLN-5xRu(9R^;N36H@@<&KP~kD(QZL#UL{W8frt*$ zIYyEq@a-02yuv;wPE9RA8b~1Vf<6u+`q?m+3g#;mCge8=KR19TGC;s&g33jzCh|vs zP6rp<^hV+$@(%}RgV?PhxEb13)ZcT{k1*0~g4Kl*ob*9*BJ#(F{=BxJ&m=_s} zaHGZJFUaDH6hpn}{6A_hfbGB5-u$?da1HjSB3>fdiV&poWaOY7Y%;KQEQ*em z@&Ptfpm+;@>wW)pB1E23-BcDUvOwf1I*ff^@bjsu@aI#q%~UE10`nNSSm3m#;$%J5 z-l%Ks-2$Z?KBXvY(sS>q4y1GO^n(haAScxzCk&}_u8f@!Lfaj&X7jeE@nY212W>gb zT}jt!5Cr6ubjIp(RYN}Hs@C@B!Sbc5pqE)|DOmuU^B0ES?L&(~EpDo!Pxvt^iE!-B ziM=9;wSC#?Co$DI6aC~$Q72mKdZ`yo@gbX;ec8x-+is~upDKv9+02cRBL$P^lHH&Y zK;d6#tkOY%_Q>2UG}PaH-929#Y;0_}x~e36xIAs$!=}L)JXqPgqG4En%Qu&rmP+pg zn-6F4*gB$2(iMy8h+!^5(H1QR6gRyGwmXhK@IKOyt&jHLYrfmNv$>lz#%#Wdot1^g zyA#Y>!nD+eTUq5qomiN^8};|R^Cc0f32+V7i%GvR)L|R47k^_M-Z&%D48XV7h^bjD zT>~%Z6~(__Ba-Ls4CYQt@k+(d0*I;pacze4g57LpFEmG}qDofTir?KBezIQ8?_r{jG|! z{y(ZH%YXCBI6tn|>ZJgZu$Q4A^pFhy$6B#3$snN1#JzzgBG0{(i52cs%|g8AV*BER zb>^mam{~{W9JAkk)(=l$n>{*|$BkfZdpd{}^~M-Msl7B%bg?=J#%XB~qvFlenSdNY z$mHh*O>ZI$`wL3GRKK3UV-ZRlH@$O@puHXElxY4GDzV#|h>MfXb`F-qXE5-@ws}i> zInbW{y-?eGI$9KwO@a*buqJq6_W6Vlv|^ecRnh2uNZOCMiWPZq1COHu)9W&Hshpv} z*ke`Ug*a_>E_d%2!-T49xLz`#S0RSK3v+rh{cOh8HRyQ0if6xI1V>cem^HNFEn8g) zbaDd)S2(_Bs@b5ymfTJ{ZEHr3??7Irk`KvPrY=>{6l2VU8CH)u`_r`sqeVL$-ehk( zr@aJ!qjOv;6}TrcdCmeaFGlF84qA}kwNkvol~*MT4`vgRMMGuwG5bLJ@lY;H&*wc@ zvKl5dW`eHyhl%w=$weJ|4Ia6uf;UzM<#{-P$IqHJ-<=I*e3<11vnttDLyNIr$@jI> zW%5yfwd9CtTHEO_J~J?{)oL681AjK9@9U`HCZ%4y3D6a!$DKLanBJe|TYP7Pfw9+$ zf9QIH#B0}y1-|bbB-&)$ppzj?-XJF+LsjW#ZG~_khR5e|b9A}9m!qOhphd9HnB2DE z>{aD1Oq!;Q7*snmL#gcV9iqc-|3#3;%rx*f`CxF z(cKSb`QbA1<{{1N?l!#gqOwx^VNl~?Q;T&1ZX9|X#tGR1$pXa!d6!~xgKysclFH5u ztbQIM9*V#9nJyT))CYf<7)Boy3b_^tiG=4csGIzJR+Q_xZ5nsUN?>fhj=q`@xDZJY z>JYVwPX>3ELW;PdF*%lei5m8aq>%h!d>I9hD4<&)g!v>%(#WF+qr_w48JW3=jhxZ= z&-9SBp0mt)LKmi;l^X^B>qrZC^{UT6=td%567rDDQ*g#d7 ziIxN#)QVT&`D9F6vX&%8un{IP@3#(xo*i+~ar&06j$!cqEwfr0D*Egb zy3#h95nQT4?u4COmA0_SHzp=AotuyY@(alj@{4^fI{HIZ0TYaHv*3;i=n(ZK*!lSh zSQbsXtzhNK98chEAfCW;d`JfNDqW$4TtV}_k8|DfM=R`~^wi2D@)S$-k;UwMu=6PP z!^J4uMKcR38lN>0tY+7(;eu%$7w1Q5kim)Ko!x{snltJCvLqwB*vKud2H@H3k$7qX z=d>)YjuFEQBgC1+7^8ypsA#x75w*|tJ*=BPbx*ZS%Y9T$ztAc(6uKJ1uz76)=W&YA z(kE!k*}|BJgN7MhLXE522mb}BWAUX<(`wT@8_^t$Cw&NHBv=Hhc+ICDdb(Dh>W^35 z_#9`@LG^^>=}21`TYRY7Vm4Yaj{MMvUrcCAVf?`Z!}!DO?v{^TY0e?^fbJ9Qp6*B% zCW{Vi9#j*aCvO}^=C!aG9Vf-z>_3WTm^?*z@+qK@JS~7ZJ$dpXQBDiGDNiMyUsU`4 zc4H@gVZOorYO6J*m)G5QhXmVg9t!^6lwHlZ9 zb$aR@m3GNrO;=nKfsbW2rou|hK;lphREYLG+TNg-;)^3YVlDc%-T;?sBnHgoHNiTK z;CQ$ryCq`*m)2kT>&HUqP6atE%WbA>3I(Y3V0JMkQ6@=?3$W51_A%W3>EUt;Fl5x} zk}F<)BQjem8*4G$p}rYvtQ$S-)ON{(slQgaRO_z^l#Y^t)Pk);uR^<|vVl7s@v34A z@auhWSjO0uhzKa{Wle^yLvx|Ap+1yfR9;kXY?wHe=7@cr^Y!56^&R155C}L(xBL{- zZ#9+uf2FC+fA(eptpCmLVU=1dC17tBJznmEdBns{x&K!X$mR54F?4x3A}-&&dn^4tDk;0Hf5JPPge=t$k{I~XK%J(s0feT;`5VEdEObAF}#CM>mHu4i{ADA zyKGPV(Gbf*M1pU&4MM~Ijo~`z=1>iCEc8n57`ZPW~dmZor|h)m2h!VP;-9} z(xIH7QERfGZxEdUYXwlINyIFE97c6lU70vS(C9O2Oodu0rkuELnBweb&Jf~C;zoB3 zQGG!apU6(s1iL)KBh5;KklfNSkrn!y@h1p)EQn1|aV%sBSSG{SrrKJUeMZo4j2wuQ zf{+B)IRv}vs?IVXrzEqwl7aVhoyaNbaWqWU@Se!8O8b4qCtU_}C%*B%3O$uN5&e6)+`TF{FUGloa`^pgw z8GEm+MC*{oq@ahbD*90HnaaU5QUG(%2+&N zxbU3)SHf*(k;A!@F|Td3Hd|fO5jO(vKU`t;J7=D(%!N!ad|oRjE`m>ceRnH*+1lS9 z|3G2Og_1-14B-cSuGBkHf+8m?&a02=h-U*{ z2OoBDZkp^hw_>2s36*BL9T)O^AQ$J6BKR0NhQefTO<+L5pC~t&)T79ILflPm_o;65 zB>h-nP}n}txX{$Gbvap~Ya^@*RGlX`{zNp08rT#ZDY^p|fcK`zl?xx7Z zfWXMaSswrKFUmq@4CW^v+OtSsw6qsMl|iPkudZ06eB!OPXJ?O}pk=UbcvRB0TH`c6 zp88o^z9fdlo8CF+f~~uw*0uffb3}L5-Qvlu;-U&q0txO_o35?MrN|s1Ed*EY)s@Iz zoVTnk<_7m-cNebwBtb$lK~IBt@Q>}fW{3%cG!U+~AzBl4I8dJ&`z}c_Cc^|WH``EP z4L}e^@?&~6dfsnC=GZ?t&pzC(6s0XdH#XMa9WMkv*~nW(=Ei5jJ9g;mCAJRoz_U{m zbq?~3wP^Pd+x;~GL|z1U&61wU@ot<9<Z8 zM;MbJ8-Z7eEY=7cao)@=JzjK4$#_mg2}N2$tJ*C-Bv6b_9-NO(i(TAUAF?}Pvj_=s zQY<86xktkmVqIf=VjJU-<$)KsYX1^v$Fr^k{S);Cy6NW_^sUcjz`a0@Lsvb7uU&SDc%_s}+b0rrgXV~Q%aq-MTXh{8! zE=TAgW5PBA%a-GB%M-%T;q*$-aREEbMxAv70OKR&PGPk-iORHQCi$v$RRyY}hYfl@ zxrXf-qLwrmtgp06TudE1&{*A4xj%jy_OwdO=->bnhn8QwT`h6qpN~@lo>xZIIqlVc zzcB_P0)D*xoc2r17#P2vvT>jNGqzeMmp5v4ZGCzbY@@Mn%h+hmK1JB?yq$R~0&fkJ zzg=A-pE-^V=V9vFVK!=FK4CVxX+Dt=n_Z+C5<>5}_bLoWU(>pb7K2qqPCfZOa}gy? zDX7?D|9D}$Vd8j08D435gL2eW%{<3*WtF)}3-eb1+3|_tU_ZT;go&9~U%8%&?TEV) z_>j^|8m1IZ%1m+jdZtbQTzL_Id%Q}cZm)_&D|xo_d@e}YWkskMx6bTP<$cS4G8K~$ zw(3d{NIJb~I2N3_VK|0GUR|ISNL$GFz*f=inX<9ey)&IBFBChLIUIFiG8L~qf1kR0 z9-(qD?{Qw4qkX$`wNYtYs+hhHJXXN^E6il9T~eB@qO-YebOrt zKE2EJyrPHq;mqkp{$BUj_m2LJwT)iYid;qMDwsk z5teiCA+f)jWqvWOuX1fedPPGBWA6<@dS!lpJtQPYr0mL4nCC1^Z&f;7 z7o@!Y#kqZvxm!T6UO=&4K>ylqihB?)BC1#B*T_}|DfwNG4|_u{pI6hId{%cp3Tx`r z^w=|7tK!z0Z-5^yLge?V<8{B;zM0@}cztnnzPi_X@c?{Ac@JLNtSieMJZ61e7Eu6~ zzM(}Zrg5^q-^Ak8+eQz0oW&yFC9~Of53K)Vn_#y}g$ahQT z13r|#5iMl`@YAV$=zuCVuD&ruGN`e#8Me-o1W+UIKP*Tc-R!kjrl1-im`#v2->qWM z3iE7HNN@{p_+n7DrYDmixH_QYkQh3ke_e|wZ=QK041sbzhuQ?e{{SvbX77ClrWdFC z3&w0gKYQy1>K(j(eRJ*sNM`y8Uj|U*d!|`&vaj0JAcvp+1PeLH!KZ`y+Db?Re?kU2 zXXSxS@C5}KY7|Vjzkwi=X52l2ceo>0LDGY_ZWhSbtr&U`RmyzSahM%{#}+Q)q)6$m zk9MFXGJkpsvVHTUsBN00ut2SVnen$2WFk(Cl*%yxZDG?*Dwh7{-wjIo$V*`mtxeO; zr8_sJ7lYaZGvaUB!lL`0QToi6byEf8%->CrS2vka28;3*>4Iq~WxCt~f+s%2vxQGL ztyp%Fk_?rdWhwDcDyLsSjDt8CNd}tIAGHN$$={}h`O)8nf@fqgx)Zq{xxYG{v+z%t zahkcVGk>-1{SIIl(B~1Z)!rQIKk#YoJJxC(X6=5!${_sJBdjoyD)GJ}8}DzJz2dP? zwoA5q351nSxb$~uF%Z4td<4eNaII}JSv6UmT$yda^Z5(6HR+7v;o_2Fodo{`|CtB& z;EHUT*Lhk5;ljh3)6GFpP;F4!{OtV0;ep-F;nLj3#)ETe!}ZZw(8Uq$Yp;hSU>C2P z^V90@+A5Bp*1Jdh=^&B2ow5Uo;eQ$-N4IOk1bRBg6THM0J?_#5? zZ*J&7q-SVsYQ;-(P}@jCWNN@mqQWZ8C~YHTXkz-p&CXEKP3EP(o4G!x0SP}JERPG9 zi=~YvP#TeorG=F}mkTe6u7S0lAs5j7=*>Vv^o_*9oR>u4F@Q)_T8>D_+Rl)OlO8~) z&&UWMV&|l1(q%N@FyN#mVqyf22Qe};09fb%04@M07YiHFAAcl#us|1&oq-XTg0Scx z@d596NlY9ZY`7R0oSmKNotf#a?Ti@!oSd8tz+b~mOmsjBI(t_u2VECBD|^!KLVm~* zHni8bGqrIrwYDO9l&h;}?dZTuLh=~VpMQTmn5E615n0*Oe|t!JeQQew7hM|$06ina zzhIJ<{;%0AEq}{tp#LYEjia5#w}&#&XE3xdv^2DGum{En_${B!Px~xGQ zT#Sr748KtRm9O7q2-z7vPJ8*S4CcSd_=)lt89(0S-%I%=C4ap2-)Mi4^DPEzyO-A1 z7JLHwcGh~j4n%UoqSCtNhIT|u%tS`kc0?-Hb_U;{>1XP{3zC-R61LWNd@Ln#VLnGk zQv)t$P6J&=BNh%i77k`MIu=9V3&{!K(5GW&G&0l&uyPpcu`_)W`*+@d$Q8G;chI%c zH~b;jKwqB)z-eemrw8EBrDFjw8PMr+=mF>ex@-U=19k&uBW8{ta)09ehg^F{Ju^dn zho4FqSkB+{OwrKx@4i0*EKK=;Nq$rrpzAMzkHO!3|IYX$5&w*c$3UM8n6s9;4t%;c zHWsG(x{tcZ0DM__82$?SD}qOQ2U7g?vlIukk&m!Qiio;}pqAPHTsV)CU4Xm#I@;+Qeyes&4Gs8&xgM(>;Mz?VCZNT{ z`c3RVsQxb9g-giV(niWF$*%uo*T0nm{}%Co-md>-*T0nm{}%Co-md@OvJ3XF-ZOA^ zKQDf zCf~>`WD*f(niC7u}a@LkMR;qRp7&=Fs+zB=_5q5FMd@P#P zp)nvv_YYky{ID6!ANW1v>U&mTVa)W>2;5jIU%{{RjjcJ;YNCPj z#jOL8rQq?QJcLMX3Nf$a-$>qNEDg|Wo~N%p+rTRs4bB$rLlMYVy5q$94ecx7`Q+Rl!^I_rv-= zM}u5cNz|;N+UTSe^p%)?NrYBTkU}G!$ZkctG{Y_`7oxmDi?Dz!D1~KgibMCxSrj&| zyaK+MbhI2H6Mf!ls7max(0R_mlXPf6FWMAJfGt|%S+gPSM~P3}k)7ZJP-(GHnB=E1UTv2&>;50?~~TA}oRez%Bwn zfSHw1kcm}Bt&FUR z006+_#0iBTCBq6Fpi;252JRaJ06cygQeaRtbu)at`$stSfi3@YjXB4#3h=3fJB zCiA;7{3eR>XdMThFnTdx>0K`xvgF!cQ9+0RkdwKTE#M&0xqKxB*Vt!n+HEq44O8_&u}|@NeRz3+JxwMQd>8~b^n+pNsL&{Ya$a(iVe^ES zC+*!7qGm@eV$(>j^Osv`lVmBICvI>XC!tLJ=&#JJ{1bZ`bk0s_Pe6GJ$`cRk9gay{ zmm?DSrQN5%PU>y ztttP%_5TjqF0sp*PEkokQED15m!Y8_qylYbDp#I+H2Zt?Y-{`Jry+>qAZ1P#k=MwwR}8e8jXx2 z;M}Yo`Q+sAS`Mx(D-Q>MmMxBm*TPW=Ogf!J$Lr$YGAdpb$DolYR03WHN2K8m;cF6w z42SBttvDi+PQ_7~44S!u0w2rO76Ibe|M>hoSaw5CVvzWF2t)sfG#vH`=Q@0jK_dKp zj!Y+wyN*N!I{rGxWYEW-qY(*|zs`|}%yH+)1SW0#bz~x$G@ceRkxnCwzn4U&{B<3P z!Tbx4Or-vG9hpiYj>n_Znd93=AyNLKk3yr9{<@CFpo~99B~TgEanGPq2^7X(=g4#r z1oUsDKd4m3U(cY@$p1J8Vle(*8a(B%b4=>^KBCeIl=07{5vY{$eFSiS@d}#D7~c*W zgZ7sUF&PBX_~$YiM8f#z!a4f*=Q0^2=D4;I2?X+Z`6Cj^@R0wu7oB5_>t7;~LLiNM z2Am@@#_`4EHkrx|c+xk;b)`NFp-E%NmhHBK`FY63F;?`babq zeH<+eGLbZ1SK%CuIPSUV-1z6hIXY=vU&1*CVO+m4$Rr|l9G~GFiS!pOBr92NBXyoxa$N>E%kK-vi#~e>Hg~lX~ zrw`6C$Jr7F1?=>AnkjVJU+sl+f3=rFr<2FGjY4M-$MYG?>0k8Gh!pa8T4+SDI^%dn z`&<4PG$MVx&cHcvIpgmok^i#o1UhrPoDv9_6B@B$ULIBs&MXh)*9^d=;mC9f6|e8+ z=7qc&@Cv7o*KoCS!x71d3Us8hRZfYjrlvwtVyMB@6cU4=L{U^yR8=8S6^W`OWkpp5 zIT}fostDGXrmRe*C^D#uR4Sd!Agid-s7yLRRaLmW`V& z3$Fp+kjZ#0maDzjb{v(#B;yTmR4R?6py27{!LoAUWcblW+R!H=BRODGaJq?TH)pCMd#NV(cntW~i{(o!J((A+)x5n*8r%Bp9vVa)=ksC=?$2 znZP0REtn@l{LT&06?bI>SIT>A@OpCL+uFySrz(G#Ps?Md1c!NxI-fkF$F=Tp#?9lG zHO?gIX!onER2lfRCyRIH@3th7G>PJQKNgylhwL5@@K~zrb)X^8ftqI^q~4%#h3Bn| zecKHKTft0L&h~_Y%P}TW4pe;b0soT+WK}=XYAq|weDrSe@_oE*e*5adldr7OPS*P@ z;Z8d-Qzv%5qVV%Mhi6fG_pEr_w)v&00@Ju+YC^nfj`Tgl;%?b!{@VxQGI1($kL{|1 z=St2t`1oAtoAa`TDoZyme|Sz2mz6;aY1gkTU1@EmtjhPIzoxId^qx+g)%hJ;?7U32 zov~3Ln4Ln|5s`WMq`ZqynIU($!;+m3yJVe;{6E!A+nieG944hmcQfm_CZk|~=YGHI z=diL$J29VKYYY4>1w`Na7hLzgkkVSPB1D(h6;Hb)dNBTR{;H*J2a}ht-G4RANm?w^ zmhiyp(jt)-uAXqKcesz7D`Z6s*6_K=<>Y*!$_C?zl+24Se43Vhs|hUI z@%8KbY`WI$@C@R$yac_VNNb_TjW*8DTTT2c9{H@XIlSkyc9+u6P1%+Y1;rJUY?5!C zlFb!9lj5g-EY!w(U;7ga-gon_T|BuitUW8}M#7+b?NcZGv;xm=UBm zS8Tp;)Ajmyg%#H;uF5Jb(V5vaaB*2raV4JPWGg|Kp8HDR(;&$u;8E2pv4)0{^7e1? z*ZX?RjmqMR8M`~0^cr)@8hxwF&ylQ@A0?QklxS>#&_SV?{m|=@377E zb*Wc)n|HoRVyEV_i#n$U@VxYO{uU119VbjmdJdT6)Gzj_ zI`R9=ujef*H`HtW`q+B@iC{>Kc|)cn-)H8HGlSvF^S{@`eT&AsMLmx@!t$sd*qr7e z``$~b1<$LHnEmz3iJ3X^wK$G*6%Qtcv%-*fmTPA<%F!Q6z#wXw62J+-<4EoD2%GIo- zJYAT7@*DkSno#_e*_&OSL`8OJdtbGX<YyorMo{a9X_dV&mp6@kKjAoPJp8AFxXF z=CVn;dNSW2`q!G>YnG{RxpLf~u+&Ot^-c{gCClde-^*(651ih*_*PCe?z`vi++Q<4 z?TB<*o%OOOWi6jc^y19S<+*q8Jd2EFV>0Xh6xe9)7!WV}5K}I5Gt%I`W0vU=osCkN zpL?rzjZIqN(*y=B{epVW7@#FWevU3-ISOj{g4>(#q?a>Zd_j}hH`_p%?nf(5~i&Gn4 z8CXT`KJcmP;bo`0ys5sw`*!{~>ANMfpJwUU9G;)y1z4zO`y{d;=ZY6wr&%N@NE4L$I{)GZ_dIxpMv-D8Cil+@H#iPB0?33apdQ7gwI^g_Xp2@t$wg8a-WJD)tvUIN%+FU8cD|Ty}JGOuGL0< zvo3#lKELhgy?GdIO+6aq44K(PdY2;3(Gyis}??w_SqS3Rbb&)w59bs{}$(_ z`VPU5UU9yK3fIcroAy_g%kAsGf1LC)SXJF_zWwgxjiJAY>loGruYxY@n!2)@(da-s zZ|rQ2t4uz0;>7u|y{BKb-O^K?pLlw1%cmbXox5o=HhoWDE#`dnJhw-6{Vi+T#XH^d z_xwx=j*08)4cN*0y}51b-LGlS@@;z(A8+{ai=6t1l*xUKG$@vzgP z_n5OVqN|ZK@U^8%LMTX{ep4l&Y00C|fm(&kjmdr=&R8t_{=MKr|I_R^h3<8>SxrK| zUM#P!udAAG=X`p%w>G7$SIhNK*ZIiojS1)Te9k@qwaN6Y2u~FF?EL3Srrj>jU$gAD zrthoEH&P3IE0EtmyLZWf?xrV74?-*qZ-+ecZ~GLvwcOwBc?<8LXuq3rnznl8@e`e| zDxMc>Co$94Gi_g<)LXA{@{O6K+&#nZ2HQ4DmD9x){``s!YArk9|AVfzX0Wf^{`rkn zyVu^${I0q?#H6x0b>-r$Q^vK`g9$J9r5=o5z16|~S)0GJ+4rI^`ejGE@xJ)H<8L&V z=P;c6`!@I7-dXY5e&<|PPU6F$HS5Z(zV7b{vswGttzvh~iQiY1AM6;6Un^>xChMEm z-e*)3DPA-8;7mEO$6XyB$1>e{<$dmds<9WTjknJeXZqerwz0%HeyGvCD<2TBq4{!= z`BjtC3TxgARras>;2L`UX>y7Eoi~FoZQi}#B60e(hjrKQ8S!g3UwhdfP;c}~+}OwQ zLtI_6!S2-U(z}giB4rKyU&!VwxI1r?_!OVNXeDjid2(;5S8Z0$@jMRmXR$RV`D>#R z9$FN{Qg>)rJ)hZGd^JB`v2u3!F{)ap0Qqsi!iV3TkGkau9Z)rEjv653y&(8l&uc!k zN1S@rIZ1%tSEGN^CHahAXC;@^_v9w8yD_DoaRjs9k6R1rVzcbl@ujZ5n=OIA{Mym4 z_J?(=!Nt8FpLX2&q#$Z_{V_Td0>h!q^vHm8BPkGv$=|PMw9zE&!vx}U~ zOnQ_p{Ys(+9^Lc3yYY8xM``cfu9x1P51zJ^*cZGSkW16d4~pqI^2dH{L5@%UA*t4I z@;9Z=ZT{k2m;Cl@<1H(ASsUp1vbJ)t)_{DsDfg4{ehpIUaDtw+r5u(x|`xxKAHDt zZbw^gTglOv-1A>p`!s~k1Me@y!$>Bl9%2UEM+GY?qXI$i)E~lBExG`fX z&#Xg1uLYlG&APXG>*GP6EWu3|UG_vgS+sDrWL$>d&t)8OF29PF7H=Yl)u=^1@=4~c zQr=7ppWh*WYDXkJbEP#oLE`wf3w|sij-Lmq^|{v3cT`1 zwA%$gOZj{}Vinpa=Cs}HUZqpGwCL}bcDc^ej@>G;n?reNs3TBvSlQmE^8MUU{)D>K z0mrkI&6IZ1%+{J{m7ck4Q{Ws=WHpyxGZO09C7f4!{m>!O(nQ&JJ9yuV&DzLNuCLud z^GGe`B+W=7ncp~knecvk8KWpjw?WBeS++6RQgv>n%|5RM=KXs&RsC7y@5t*ty{(*Q zp69n-dmTyr8&!FRyvKLOp9tH}(=59)%{AVBUh}SHYmL_VXXVX1_Uz*aJ`o-1n4D0} zW!4qEvdM(^3M=lo=UUGT(U{?7^|{QY?_N!AVbjjhy6#Jqj)24>cmtOEL zz56n6?_C~Su7pQdWM?`4YPVMI$8FRrI!|6ze+&1ZSnKnA;j51psFt^OyqR$^e}n0Tr`mN2E*3J{q5m)K@@Z#F*Q$OXR=WOV(So$lb z`Xz(Mxm5DX?E{v&k2TYY?nUQ6mkU-0D`)&(zOQoE!dwn3vv$352jzJNE(Xk<3wI8< z&1=I&G{3rk>tat7@$g%lh@Spmd3UC@&$9^)o_;`}I+C#2^_|z$SekjR+TBxare}YJ z>Ry=P9BEkO9%e1P=KYRt$JdtSv;BFSqt_KRI#_dW2(b&-R55m#lN#ir{GPb}y~;6- z8=Ggy&<-fgU(rRU^b~MQ?`fNL?c|eWLS(LU!rnPkpD(}5B6+SGToOm_SJs->F3huQ zR<1{i!~XbX-nQx0`}WUgDZW}G-|eDy)O2w|m5JyHFRtj|jt+jyjHUJ2E*74e2k`Uv zMpu_`ExDc^`Yb#lF(5_msq+4$8R@4MTq2t$t-70~-S^;`^Q!lHk_xEQu-`%)!9B{^Q-CJifdo5U&`BYZH8iUt)O92 z?W?+T*ZN&vXdYTu#J4E-$k$GsHE~b8PBgbe|4w^3)&fx;m8#NrFIIWCi(0OH5OcwR zXMge%y1cx6_Vw$AwBD^r-@bg&)P3?u=65##)zqlKu3yzRJNSbN#1<_0P3+ly_fK%w z596~>zTqoN;DC#%(c!L44CI&2yzE)_qQNyPw#riNy`6{FRx-!*C))G z<5_)hPsV|)B>}{6*`+EtJ>f$$v@P~roqoi|qs!;bDVRtuQEUA<)X ztW?~LFb`9b^d_7#r^ivQX>z2vsQHVd8sxq_^P{B6K1j9>QIlU0aAnJDON-X#YTuL{ zbF>BTbL*Bwxy(BsUDSRked&V2~O5~yi8wXHZMBm^ySPw32=L}r3V!^Mu zRs2Cp-8|25TNQOx7fqW6|-`8#aVx)-I*VNtr!O??0J*;$gl~7DYW0i?zXsEHX z`W|zqdrkvKp13axC{7g&XxUz|<#4_60%5T&dx`>%wOFMJYX?##r!St{wEx$#`n{)P z(BstW8kvIVo=)R8M#)dVXo9 zG9}~!=Q?ihg{CQXXBr<3yh%S-W|b(Sut!BkX7R7<*Y%FCNR!#4GWD~8G49+A#pA-6 z9Lm$hg3m3{n?0pG_{b(xViU)H;R^!E0pT0uEK4P2{FaFe#1!ohdihKEX~Ai4PM6yVW)qm98cU8(dz_dS z!I&LzLS^HOR2=bL(Q#>U-PeuBXUYjACaPC+eZM03#)|G|eExRJ51JH#xu-OM5WP%U zZpNm=VufzfDTzNDsi%ZL7YKweUM9hlT4=WZD2Hx@34ti^`<2=viO|A$fgLvODU6$u zKliGAwxP{YTU9vc%=t7y5e{7)!zk^Fv?Kg+)@P?}H@$8pg>(F>_SH?%X;Ygu*OmP| zUzfxMNMBT`;G0{UG2L3WFqK2gXnWZ53-=5UdOlVx-)>WKeD9{c%k>NO!;Ga5G&0Vd zNNm2M#cX`}+Bx-&?KtQ>Bn9Pbl z_nk}U$Ld+ta0blwc%c<8cV!_}wrD>&u2IKQ;|#B{k|{MePVZv3k<#LJhp!7}&Ru$; zPv?tKie~S<02_nZJEzlm=5{i7xra7b$;iJ+k??(Ut}0S$$_+8Yj_s+1muFPf=^nbw z{ZK7_hqA-N3k$CH_Y^+Gr3G_(CTm>G?ZnlTWL;O!xJg?-=r^_JNH|JKqPj@>>=f0=97^ zKhd^t!aC{G+coPnqc1c+TIX^7{k9o#A{u?6rBU~GU+)QzrncCw{TM5`R9>LF&_erp z$XYATf?7Mgq!#m$gjQ9SK7@4h3_XI^py z;@tL~gG6xbwa-r9SoPobF4wtoS4w#xnm0XN#i6zemUr=0mxp|+#; zU2KZd;F2$glg&S}7G4mvpglTr}YO?a74w}v0 zPD$>XkjhoLJ(T0>o0b~SbMPv!v~EtBEtN&M=7A$Z zO8uW1cvoAN-&Uw8kZ~k3jbJ{Ui)Rvsst{0c#~bc+XJLf_{Fbdm90^B+s`;4weC<`f zDY#kF6jxgR;hT5#@Lc_+J1Y3z#OF0=tXvhK;v%+vc11Fi64L5-qUOaD>{HdkL}kz6 z)9eFYc(Rb>MrA`5E+^p2{Z*9HSG zs0YDy8?ftWY_tvNI;gdy2EjKZxQT|{1P5ev!0x;a1{8D|VmG>sim&}?IZjE9%4ie^9X&92uA$^jlix$pV9fD`>}JwjYj9u zGls6mu0zM@HN*fK4McaSu|^syhHhGJHde?=semcdwsHqqA#9~mC`j#xjerc10Y@?v zB032j1n=z6$P^7Eui@iy_W?2@l7T@FV^c_ESq6iIlK~xb9UefzV1W}b4G4opkmv<43?fWuATvn7G%Ah>=umQJ z!-6sUi`;*}k`OG$1q>X6CCP$!7)2$^(qRSyM(YGY$p{qnI1z)!K*_R90`PW(1<-kj z*OOrZ1;H{gSo$yvsIpWv*JXqSG+EjR>;$Q$0xS`AD-oj^qn0iU(_6su4|A3QasX3c zCc^|8f<;{blSGE8MN$p3VMbt?vUCQ_*qRJ19l=6>}9~4d!xG_zsBE`sqMg@v;)O>7ccMnuX>!ju=InGH*k zB~!+98FVHYqkiJlBIO0&g%kqGIUANL3t{0Xu{2paxU$I*iBfXn zk>aAkA_y1iHbg5GP++p*2q+j^CJa?30gBWXA~ys&>>R0NI`W32s2~Px*_tq^NNcgN zFO0E=Nrlla5!vfu2GA%dLYxe(NNLGf&tq&D?kqCm0K^AO@D3CvSr&7^6!#reDGU#>6(tZL>>O2CDp&#H*?|#YCJn;wvBUx{bBF~KVk;Tx zD@Y?kMa*Th0FE(~;l2X%0&6oc#!d_ssVfXS5GrCXLWKblHY6BkEER$!H0gg5s7PHY znCrs$z(ys4Qll2LX@vzPLndp&-G$VZf~hOU2R168G1$>85-gZVFN^YA6BjKq(pL(m zuNWWLs1z8?Agv#!l`4ytjZA_ANMFJDBiS0!R~RwCa+WcubQma13Ki)qHu{8R1S7pg zm!(1i64A=$07DinpO^#(kit?hg~j;5<^V$$W{;0S1&cMTToY1RGE!Og_!i>>h6>>e z5vJ;o@D+|x@^s>S1reaY*bvw{q61WLeK2N5;W1iL1R*AbNZ3dh#CU??F$JkC1yfm! zy~D(UcNk>>gyb-CViP+d7EqANQZSXp*vm$RF~WaX0Ha4(jWY=rAe99Nf<$XXWx;|G z#|kX4hfbZ0Xi<>LQZdeAd|=ZGVh^i4M!O4zNJxMus3c40^DJvH8E7A zvQ*5=Vtinuf~OuUuYk%nHxunG=q$)yA+`=nD+O{;WRTWTFG~mU1yUy!7E_VVf_p~& zg(w}S7Oj;Vku8W8Nnjl&F0oXkvtUvX>adBS0tzf`8iNWs6G*R50u|{jWZDqwFc+v0 zbAn|22bF=Pye7<9q_Z@PwHP1R9DpnVHX0go2M{hYV0GifC6@)!b9Nl zD6J6Lq4ju^-~iHD8e6-N?P8-sXbF-z(pwNNVZ(w6GXSY9M7>D1MpPC+=tQ=8!PEfa z8Zs>Fn*;-p%F;09!kEh@6@p7_Bs3HeKwN_s0ZxJeNM*q{AzBf0*{I;Fhr(hMYf~Wt zp+f?A5~xUJA^u0Gh`AUlia5aWjj$EP3Yc@4C|`lC6ecDC2pM6bp%^R^8>6z2oqoKfrCSC7LzS->%-kOAqz`G8ViYUMCveWsQ|(r4G(E7_}`JBXkw^HW9e9b zVa#Qd3PVmTtve*J;D2F>;A9wpG?tEOEXG_mD)QB1>;QO5w9ax8Y(**y<{mhJF&9Gx z6exB8$`GyK(_rc6WKfaHf`}qi#9cNj2?F7aG+|VvvUE&kG48TaK?a~WJ<0+2eo}r57=T9Vz<}X63$mDybihhHLy2P;>yoHg zHfrLLF&(Ka9aCAX*Vxpe2yP6qXvBenq=~YCjx-jMJgB=yG!~ol6V9`mK6`L?B z(pX6TAk+~jieuPxeS2{cO z1}tMYA2EWC^7%ukFi!{k7HS|u|BF--%GqIkFaiqdN@s`K@F2EnL4F1nr$hVUYTy=< zH&{Uo4*^YsMCW)05FtDxVnqdr8c0lF08mO{A{s|>@Mu_zhDF#w7OV51lo9MLfqB@8 z4rCdGtuV4cj2{VzNH8{ph#LyI(6=B{z-UlkFtz?qfPsKX z0E}f{QDL0TURd1@6oci0Jpq7192tTwD)=%P6y?Dh`M+=>et-xEZa@_|APM1;5iU{! z;N>tb^f?1+(||(*ivDwvWMrLnH$byg|+#2`QG40i_0G10<4= ztpt{gZ#o-L2GU-@cw`AcyHGM1lodS}Q3taIu;e(%{m@heCNvidJ)!p}Rx<%lK*0va z7>xkRZZaA4nEHQA(m;V={V* ziZ7_0fICbf6?&I}gnYQ!kZqR*%gWaOiMAUx9M}c8$O~Zff-u6VF}R@AC^W|CohU9i zL6jB-T&#=W0~N|UFsvFS7Yr{6qJl}mf)_;m1lVEIiYBTMpvoRz>1qR$0y%WU+cZf3AfIDmh(bOO+WX0IHzy^pjVJncy!Gf28Y!!kX zHh~o2DvZEJVIk&V!i-Bcwf}Hk|KbAZEEO{hBc&+Vvk1zO2xhp~z(X>i_a@V8AY-VN zVEEvL{tnqGWSU^M&5+*8z%DLu_&=K#CWt5nd=@IhP_e*ew6=wE!{Dz+$plYBhB4Np z$OPS`VzJ9;c?$x0EC)T@dhlCRsP;?>7E~9R5@`N#`za7`F@`$}(*=jIr0Sw_3>BOF zGNv8{RvScf6c?UL2D&H32Bf-JU4FD81&@K!E(Qx|R4ikRjwfyq$VhP^<^bjnD=rl! zcgGS7Dvc7RlOh%=F6K~2N>a!!A|(JAsK!B1L;;;fX#*KD$O}}(Ct|-)O$KZ!kULV8 zLUxhBHdjNqD6@qL!^Ckx7AV+&W7vwLv;f)%3G)sx?+E5Hf`VY=qs$>hHRA(=f7lsR zltE4qs2z5`$lAh)dkh!A+M*c?li>m?%TU?FCTxzy^V6 zkc-BlXaW}I(ZOOcA(EPae^i)z2BZNhkJ#W8 zP0Yn`NiZs%h&Uh>#-fmsaupg6GTCK>AzbiGXg)gNqMX{_gXe!3GAdGGEDRYbSV4FI zVL9ryVR~UeO2I5KG;E^uA{EBM5bCfBqqGqbGdV-J6mX|7%Wrb@A|1v82Ji+DoTC@a ziicr3j65N5hC&cz#h}8C2BI)M;4j|7CU!%a05ne?C1`-NDBnxK4ckVPx?u|#^c?cQ zCP}B=@7_VgNbK?iTn!{`1IfT z{-|7oQkwue?9L#q1DOL5DkzGOz`a8bpGik`v5A8s&BgG5e{4zt6!Nn`8LG5^#R1m_ zxgL}+gdD{`>MAmSQ;PH!!yBmpL7-13qZw8Jikc6RGz_Ou(h|h?A4$r8fFh;E@J1>? zC>)21zz8TL92jWF%}IbFjm7Ywx7p1HA4W#=V1_A$Arr)dJm3r)6fGlQ zf-sGMLRf-LIh;5s(p3x(B9>8+Vo!enNrS`$RH|S_3F;_F(N1U{It?i*hBs3Efr%kd zM1$rdtpHFIk-~U|4LYHD-87`77~W{{2lCr!OU*H$u+bxW2v9m9P-s0n8#mldXg&ZF zv!j@vf&xJdGvc>M$nOH15UbD&eg205L`51ZM&)Ql37j<<#&{#7LSV<92QXn$k)C3B zqlF(Z$w;Jzd5Ti#*xZ5%Vl_7zS-fal-%0QksVRmxTJ}LBMrxrfYwchQlzFB9#%|1h8jSiD2p_R-F)y}a6H7*i3vYa zQw(pUk^~@RlyMkdG6T*AqSr}v6jDX4} zxY=hS9mT4>*c-+G7*5f#xo&I|1y+#+!PR6yk(OeWGwcn4A`rCO`f&e)7=TO-g(nk| zR3=hWh#bN2jpP9!VFey)6ci+tjQQ({ia!(SDON27^0gLJlJ*-?k?c6+Euod;%R$d+sep(KmXh#Ub zR@4N<9E?pve`Ux>2w}Gr>~>g>KYTS5V_|o7?Ccf?Td(aS=dsnpXg3k`Z_JJ&X!DDq zeNPlM3~+W<&Ymp1k~UrkQR9qPR)ps=VU`MkgxA#@`dU{{8@4qtP{j5^!5e5>c{;)M zt}OQ6CL?=q;BBl%Z+3HM-~6A4qs=z{uZPpA|DO+r8~^!Gv=PYv{!rlf|JO6oegAwU z+AU@1k^k7NerT6^80V5lx4%&j?TCNwxM+jOfv!L4?V@@YeNOU5EV&kIH7{un=}7ny zUYmfW9uZVp?492MPFs9GMV)QrC)~&V=+Db_T->nD`{&C%`f0aqGEs}n6?S(&N#AI^ zXkCGSzb*3s_1N|OH)aoh+Z>lfPcPg3YhE1v4>N6r4E0A^Nx_RdYw{HW?+n!Hmbv|U zWF2VJFCqOW$mi$Ffh%&q-TU8u`|NqR@9pZ>#o1lXLB4l3+IPJR@cmg)k?xyiap%`^ z`^-#*Uj@HjINx|xR?}^4qwalGuf9sz+!XJWRUBs_d)Gqtbbep+gErlePkwSOz1xeL z8){36`__Gl|Lsu|6kr~iWl_-Z@%``fmqoZ6Jo4qui>|~4ak{wNkU68UK01GyWHHy{ zi+sJ-F0ymY>dQ@>bZ6)_2tKQ6FykwVseHUg^jXO1(wGC(<%)NNuTvA49oiRVta;Uz zJKy&$b8>uOl~Z86qV#jHw7u`f5`Mp$2aJM;y;Vy6<&uwB!2RO)@6OR4!24sE60n zzg^{c_xgJ3pS5mk&t!!JTQtNr%JU>CY>ySZY zyw4qNr*B!(JGXMaeh{mzoH6f^;0)U}mwD4Vj}hzkYTi+Db-7ICT`ASn?|5Ol{7_d&)+*L9A|CZ~KF*O2TB*4?wam#3H}ke%uawnt z^%I(LzbodbDm~X|Id|a@1|j`tuSOsJX}b4hGICJoIjz zCg-ag)Qkf=)U6D(!hcvwthv55oabC?FxlOxNPX@Zqo&eB7tUJTblf)0+V0mLR$ty! z{3B;pNu1rfFD8pf3JwoGib+-9;<)+tz*7g@tkN~d77FLwZaiMMIhnSJtYNij%K`q% zLj}oqRtUUwII^h2Kvcgc{ZDO%1a(|PcS&Xz{trws;c|=itl@t z&Rt#CBshcTTvwhcBg}+EnClkmyujz!p-n1N@$FGZ?elNk*~C9>jblXfPh*;kQcC)o zG)=dfJ*8&5_ICsrSIo9u#E4&X_&o74Yw@{Gn(o;M$#K_ooT)pD+esiY2%BozGrz_Qh&wo7=p-_6My-{J``YZ1(l49q@e&5g>cIUY(IejSqN>-`z~-fP6ZUYGOt+UfoM?T`2NWky!1N5hmhEWhlnt<#?q`;aH$x5rQT zzoU5ZVujtN$l5>F$t#j9%WAv7x5Bi>F2J;SU&xg?Ny0fHTHY6ycX+952`Wd|%`|Aa z$&*gV(6AIO@p-5h7p`fO>K)S%apAPx0i~2Di|%u^KPcJ#W+1h1*P$5S>9-vF%4ctM z^u;Hi>e+KM@oRC<%w~Lk36mrNm)@qgLn!V}Vo?9K2 zq=)-&>diSXQX?G@Wk_jQyLI}Et=?)2->;X_om+S~%lCw29oMX!D7PQJXJZ-JhMF(F z-bmG28ZIUhc<~iQ`Y0!l#PJ6U^ViYyQg0W{DJt7F^%S>)Uo7)6ODlb^>YpXY`O9i* zXSFY1B(~_&$Jq5Lu1?v}0qvVhInyLswjP=xU-5o$+Apy{Nhh6{?`j5)Dj^!nZq{mk zTM(KkZQEdWvHqRf#)3W8jpusYBcCtljX3O?5KFyxzPY38UE{nAEf;5lE5~^&j+mD_ zUo&Wb)VRMPDeTYl!!Acmf;H_+?3$`mv!V{)7+BLA65Dc0-Q;C|dZxHWb6@+j>`znP zum6_s#2r4*124Y1HhJ2`Ep^GNase_X$5jhwo_q7DsXshV?2i0TmW|(AHPess%AUq+ zzEG8KZ+*UYt9#OHp&+K?re6_z#4673J!Ev&)xPR+zGB|#*6Uj;c7|_ZhHugL_Tg{r z&A6yq8QZI*zPotC6z}*x-WOX!o|k0xCFISktz7uICU<)0#>1zW@ge8JUN*l}Fqy4M zETx8OTr)da+4<|r3?+`Pj<4<>e>!C2f){@6II*^Go78~5VY^@pPWx42DkGaN%2SVL zm^(l1I_a@k*FhtExo?|?f6vEnwcXD*34PY3M$Zqla=KUD-_+7m*W@B1_Plz3E14%& zMa-c)@~2FiPm-twpMfQ_PX-s^|Y-Qb6bIa zIZy85tQWZR{EIks;@^D}tvDtv5=yVSE#*O@tXrKfuD-`dw}x|?D@j10*EV>|l}jI| z{4uZZ%kaIOSjUtKFxL$=tC0&eXc3`X)P6B_cv@WZAxtLk_5Jq6C(|~mJDPvC4mISU zN4(?iYJI*aIJCJTmQTNamG;1IpPGON8A{h1<>GF08?Ewl7MJ^RNho5E!s)q>_S`%v zx$~R1fgzW5?J-IJZB;QrWbs@Plc(8TR{i37Rt^z$i3Hn44_1q>KVn(PzpZ_cS5;-R z_fIw=%d3mWB`!YtrK09VZPR~WmHc+$!#0y!DN!9KU&VFX@pus2tm6VYJspge zI!iy};;46OJL@gB+G4Ic<3toWB=Bmlu~h_F4I*WM?WZ{?QRb@+QQstLD0$fmbhz_VW;pcD7DwYhm3txf0i~+%I71+h(DRAJvB8rUCb;t=s~p4Q|=ldNadjS!U>M7hRof z#JM;3fRT;Z6}{#A^*Uk$?<`lhHF5j#^SgI~RxVM+YqikFOWmJI36|XFS{xFj*OpDs zE_h>kPidw+=Rk$&;VpcEkB;gkDDx-Na-D^?Tb~SeaWnNRY`R@lD8{u}RoaZgRTZef z^Q36iGH4T-?^Y?if2pw)=jHC7}HXl-#L4ksCUR1 zebVYbZSZAgbk5QBCwZBi0#2@iv4x&DoP!tjJIHJ+=C3AlNxYk(CnLIu@QI%AQHl25 zCgoT3*9QgnGOrsv^fJ#qpt5yd`fSfB1gciz#&?Zt8e>x24n_PN{1{yyb4-l<+sa+X zZ_|~tsg2i;+y7b8xyT;J%*{HpS-W)FAmeSVLb2Kwd+CJ+fon>*qpzeXJ+itk=*6dU zVyAu~AtBZ1dY@LkXzUV6vFnK``UgmVxTPjKDhVti=$M35yvu*iMRz8368aE4> zCvR8eC-^;??*BCS(%YGO&Sl5j+{`(m@;0BU*8lNi*1eC9cYU4Z7isY31XpsT)?Uka z_11@4_q9Yaex7cj?b2dk z#XaTk{T>0o4KC|t&|eP*IwekVy0J3bIaOiqRH@TOvOlWpx^Q;Pn)2eyH~9%6Wl`b% zu3uJt&yP@SKiAB|VaCsT*w;CWztXVa&4YaNY1!K&zB=S>4~_bgo3ZQ9lpWRAWP)a{ z{1E^8JmFGTmBryw$)g4-=HHl7iI*azBXlZ$N=vM>lFMgC+}nF}pgHGs(9VG;A{m?3 z48%XnaKG7m(um1dXZelzw62F&Ip*XkJKsZwf!x|mgNro}i4Lx&k1LNX+Dm`5L*>vm z>7QFyTq!S_6+bPsuI>SoQ$}9-ShCO=a>Z@$!fOxTSAB^sHGR{*`MW|J-xq#UpW9mV z`JQn_+m$72+XrV^&RM$JSkcKTRqYF5l~*cB*2w45<(50u+jo^2rnWlzf1cKop+4=p zU%Yi(NqnyQ>~zV+AB7VtG(z4SIGq(OZsXeueuQ zU`xrXmp-N=xwf`XjyI}$#ZmVrTGkzz_m{Iu$g131R@7X2_b{&9TW#0-iyV*7Dz41t z9I!4j7CYMbYZq1gg~ZBckJv!&qiglg7n<0chOCy6o}R6|diGq6^t~Td)qI=2mM73X z5^#0DZ67|q=Gpu0Xb~gQTii;2`5T^xT=7zKjBA1_P3C=`V_H|p9p17qc$aC7n%?J2 zmySxFa#6Zz3l6z;L5GFj#>+>!J=5b<-AEP&WyMR4b{^6-E?UQm_OXe+nf>U6Nl}+{ zjjzbpNY(z6D)l-`T~tc<=HtG@flqmxP>J!gNQ&vu~CHW3T?c2c=xMo8UB<&W@x z<&x6|kM2m?+8^<;Inpc6nIN{OJbZmCFUQr$^{sTSRM%PhZo)Nmp0ANgt&vLBDMuP5 zm%9oJK3P=+?_vka;avKWTbmyF=`8uIw&eHOBmPA7d;#^BKU3U(S-nn+@^6c}*|XvK z&y8Li;&st;WA_tK@C#T1OC35#=A zUtYmIuPv!+`bw=Xs(M&ddIKqGqedQhW?y*%|a?2t|_ptx#&Vk;QW4Crr zrdx8M9G@rqw+@H5c7`>(qlqXbD^C{M$`-F>yunCWYqdJd*@xxjU}L4j@@8on8hF{t zDA}s|;ZIHSwZ(R$#c0BEm#{rCMld3J{D0^h zn3RW|XP{qDhK-MD|9OqSgMEyakuYEl1)9ExUUXQvjs1c!j)|)E=(kAWKXe9u=M+-? zaFPkNP53=i^az-C#DJ%VOUw*_BqtO@EyPD!gRue z+H7&zTVd~VEQwy7Jh~RF{JpmdcK+EXpUW*M$#bQ#CTiP)KhM5#eHGlgC9XctVVgl~ z);rH$t`DTwha%=nA1)xyTi{zPsoTB^x31PerM=_scQ5?ajZOtgbKb8KUCGT?l;&O< zAgmy0uOGWZJB}y4Ji-0prTufWMe2(jvk8!_Gdf{3`r7ET`VQ+AZ&w2U{h4+reHut6< z=}XQ_#SeywX7zaa@+bK)4wfwcO}t_Cu|IoPU$(ql?l*U_k|=lX-yNi!ZF#g4*2!+) z`|=B>$IF(T>UFvEs^Ulbt=8A#ce`xdi#<*moSXm5UHp@TmiO-28pn!lK3~Z3yA)fM z^T#}AZ`tAW*8Ed37YZv(M0PI~Ybspb&GSnsXsTQ3)-S7n&i$o!IN7K)afM?XlQ~ng zg~Kdn;}`PJ`FEDM6_(3HufDV@W7XJ~lE{^qx#jXay^^Oo?s?5&aQ%>N%&Srqnb~Q6 z#kVQi*Rof!YNplV>4AD{R-ZUl$zz|Eec$B6CHKw$!{NUB_l`R~qP8yZh`fE!%qDY5 z!#@rc);`E4_f}NVZC=j`9R09H>;(KSjoirVrQ8cScy0cIzsBLTCFreLoMK-;(r-f61KTwE*Thz*;V3+|WCE zp?NZ6U&HsIbL_j=ce2kj!37}1u`jfS8!d+&HoI(mbOkz#tSojlJPTbpeAUQZ=sGx$ zEHZWuJ`d9X^kP(?cZ4MEKJH!L{gs2#O%49#m9@=m> z><^8qbx2x}i2?sG=4Xr*J#EmA_e>fIuWaS6&T_Ed?ge}x;E_W`-^hTcLqBh9?>X#h zmC&BA0@0~0L(~xncn$ao0|y&LS9@pn#`7$f&1gqAb`cO=I~ot* zjfYwVQ_=s!g|WY9FvJB0Wh@tna0DR+Y?v>J_e2~2<89nrT&(chce-z9x#Im<9&UIq zUwCbYA6mfM!7l~i?HqhqctyMtUKy`~SH-L0)$tm5Ej*Mo@w#|DJp3{P-Vkqu-;Cda zH(52xW7tsPpFD8pSu+T#BTn-I)G05KRST+pAHyP{{3GnlQ55Utk>(vDvt$LuaOx-qoGEOW{UdmwZ`Fhw_z>lm4}}+9IV( z2cEt@w`KRw&b#aW4E+A~y&>z*w~`OtS*vupckd(}yB+5oOHaznQIIdl|MK+t##6;} zb=_pwY{b_pCxvraCdA$lho6KUyw@rr{$|dOfDfrHl?)qic5)(PD`MUfH52ER!NgHGMt3PgA95@PJY@%x-*}W72l1r2B-eRL4ls{?SCjl*srQ&S z`Ng)^%cpnxDo@u?|G>A%G-;QE;G)g=Zs{fQq+{nDlM=6gc=;pVE&cRi=_TSt;$JU& z(@J{9Hah5VxYb^gHQ4Kp8mnh`TKiY|%We7IIA^VK9e;u$!Nzk2`AS;z)m8kDZc9J0y}B=M&l|I5PnmBP z?`%TPw7)p9(!VYK_L`s3?*-((U6o9~iK|!IYqiOF`4x9_w_h_fqF%0OjF2>3zDIf` z#dfCT_D|$e!y7a9ym^?FaME&W$%ji44@?{cZYagfKY38ve9_abm$?5QVeb?xO4u!n zPOoX(wr$(CZQHi(HEr9rZQC~Q`uDjfcb{bE+@#Z;e&~K0`9`WnRgHLbW)`q%qgfJv z8bLM%7<3eo6>!DC-f-6kR>nN`!gb3C#9KpX19{bCX{{J{;TJ_Re9d)24*mG)%nbhG zlw%A9D%MocqHKEA@|Y`HVk~Z+KJ+6N8v6^dD!L-pV*s52;YlidCk$2U_)?HE7DmZ< zc(^AEnQ~mSRRh6DYfGM|5X#iLi`0Urc31XZDoEix&W?2zk@exigRF#&-YAjhS+hw^74Kh^It+?kt){d9z8I$(*>C3hWO z?t`ggc120Pi7*Xk*RW=Kt7wGfPe|e)25-Owzm(hPM}RW9dxw%y)OpA_tguc4==fzas;h3~wpRBl zSf~?c7@X*N7~JKsJ!#{J6s?5xn_|#Fmg3ZW*bH~!y|L3OsgIo^^cG<9C0OC*a7xX! z;8q&CpIY+KFMV`QAQ$|XhtGlzAZgnHDFr}D%>)7s8{H`j>I=3C6npD(DU6umB6c=B zo(8rFAgqC_CLm03%>=QVe-^>p)Ik<-L?%CR>+4<$O%1< zXv9THN3_75a6A+PZxq9}j4}GnQ3+aBME5PN&l(7rQ#3_6K}0E%!CkZpF!`mFO(|KW z^-lpx2!T_u6|OPc%SBX~5!pUpQWav1D-o^LW0csHqCMy8s$g9Ve+~BIIDl}7Azh|G z%HJS4kfXKh7t$Pn#KfIz&wg3dF_i?!2g9>NLxl$l^#t}&k!ds6UQoLhbi)P(6t<-D z=~hw&F=?GJ_j~7>mb^i)(hH-BHKU;Eyw+_i3G9esH^h!C4e6GVcURM0H6v<@8v^&z zeC#|%t&cm!SK>=6T^7;xs1(>zOrn3Fa}7{0MX9v?N^E=D?*=alJLFBX!_Fk5<{!6T z*`JPy`VFL>?Tt^RLs;#v$ArpVFHpeI&C-O*8)g@6Vx7$$aJTkUL{-(q?9x7|3Y4ZO;)WjWinyfu7F zh+-_E@a7!UH}MXF;&hHFc2-u`m;dfLFY-a(l!-D&1^I!)hBjK=+*h`|GcQzbr|71# zqj|2IkxphOe8$My_mlIeL?^;Hh9ULj_;My@zgx6;ft9;r7j1aNTlTgJNX7*v`_hY_ zTf{dk;;Y=^79Fj^D83hxQG7ooDgQnsDgQJiC7Xc6qs?~ff_g7kuyGF5tJ8BXJ!KQ- zt1u|#VcyLTdWR*}#?w(6>cYuo5o>6(vbBY?8fmz-^~i{|_gvKaGf0Si)1-r-w{bnA zVWpG#jc7$l4&(Ld-MHlU98h*t7MZ4w#$+AC zq$tZ$d9J!V5~(zN>yhwXyF3yny0(g6Xb@ks_1OAaBq&n?dvA&eadD@0iU4D=Cw-Kg z<2zPUGf|8EGCRayIsBfR1bQGkWwYDi*7*o`8w!ey+*bq%Ag{Lp=(0#sYv)m+p~A%o zSob^Qpe0XSiMfC}8iR>_g_l1}Y)tkXR({Pw2T^C{%sR<6z3j*xTk^5t+rm(6$VbDvM^YXx$Ipn2nwix_ zxC+aE>Ng@ap7ED0NlyX_vviy@W*mu#?RPh2@kRs_}HqcPs}xoX@iRgyE+Ui1&ai z{-6XFeRGIR&`BnGLrNqT66c_t^9l$W^%je-2qjKv{O8hDCFUSsXgDO5cqW(d6-m4z zmT+NKYSb%{_%@MwXe50{k(nqgFqtRTB4ClYSuXmopNI$~HsUvXfsW4x9#wX?PBuH` z)d{t$mdN+$){qHQq>p9sk%^a4uNJe0EKW)~Mg(u-hed5)TdN{izO`rbKBQ1m=9Qohe>+{ zQktf6JjR7%N1B^g69O=?O>7ba77snqG_yZ9w7=EwIzNo0l zdtX-3s?C-0lZHv@9AbzxU3&&CFAC~}Esd8nB7&Q06c1s0&lW(Mm7#;Zn8szHeG_(r z_2%=)C;l=m36ji%(x}44_aZc`6{|N1nE1$m6ZFI`=PE#qSHg95Jln%5Mi6S-ktI-M`GAvTToeBCNAlPA_l|DJ$}xylxsKYAuyJ4 zBV{ik5uu^5PoQxu65L*MhW5vz_tzYVq(C*z)|@+A@`}nw=OWQ#@RTM({`p#5$9+lz zqi(16?UiPvxXXf8!J;>`Jl0gBrFt|zd63Sc)O;aUL8XDjr&DqkuQ>}1#Z+9ri9!Ug zQM5Rv$gWlV-O}Ti<)TL_dZ5egcu2?v09r#Y+OP%u%z+Xv{h~D-deySlFwfH54mld^ z^BLU5@P1_1oTTT5FJ2&&p=93_qpTbO<|r;}Z?LsWcd1T{SDbH^OK5pNZUZB9 zi@BfD>ivC@;yaczPDA(!knZj7hB(AghT~<|D2}=8_aKjsiFDsehN*mgawJi|>Nt`^JlC6{W9qvV#+GF8}PKToy zyqLn%B!{QXQ@?dRoBZIH@M2j8^j$M_-1^Y(2!n?a`gf$z2)F%K3{u^~zlAl0CvyX@ zMeIvQYkKOVbo^mLbXz@!v4MN~GvORSCRXaUl#;g*1?sKRDckZ~G>E>why@mDGbLlM9;6s$F`mRqzKhe=rFdm3P5MblPSv7Sz? zq;0dv10m>WFBILo#;VQp<+i2n0neO{c|s_J;?E9u^=Fh1OIspsjmE%yp*JxHM&WMY zFyP>|F=SornUd$Y6eJQ1AudZ!L@D+-=ni{yvK#!Afd{E1gG;5zS*HvjM-c?Q{fAh0 z;(!cigf9<( ztsW)y4fle&o?P;(WVYK+5_KGv-0OsaK)Ki#A4n(5<(GP5^RNNf+J&Q=MX5uUE@uJm zs@x8{E+`WayHY+eKC&8qxt4EoG_Vs1=ieIk0YHXVv5CE30w=#1-`u461Q~$m+$4$N zSh3!WB!PpSYYMX8uRs5dkB`od$NL{y)c+<9|G!WZ|Lg<*CpEDdt1^n>&8IgXC;G6y zSb0mMkvc%4fEa#gkI2Wa8cgaB0bB^6n%FC+@_gen1AqZGIk5;1am~4y=2EFy+5LF4 zJd-Mq)I;lP0m0MZqh$#0?{MFaW1t>r(mE>zg=23QReKD1^KAUiON%Ne`-yX)9H10mb;nreKFmMHk+H>>!j!7;`(}X+`IkSZtvy9 z@?5-ZNt@O%bThrYmAc^Y0B5$_))*%DT(c6*rT#~D<( zj|CgGVt}FN#U%g>t+PuQZ%1sA!|&qs+4Yp9IaLn2)}WjrB?~k5xV(C@Ruh)!Yk@1M z6;A5$T*x~yJ9i+=T}v-Dl51!5XYpq_eC*BfK<`m%>U<=kACTiS?mf&K-^j}J4zy6| zN>bF&L^niR&0d-Fed9~Vt?LgGEPJjmijQlF(52LkO28QoR-FaKPC;cg^>*P3A8NRc z^L)yZHq>;tN5|((_YMPX^z393`~6$0z4wchIQvf#G-o&#wqocRMgd|XlVc|bl@vqO zHfSP3TT~K(1-hr^keH(z4+7?=$zcryMLW+XEiby=Ga}QGzW>s5$SzWClIw!v< zwoo$8slFeS!$1_uNS!;mypALw`IuzU`1)%^C=0v!@LGbx8p3HXH$v*rgp{gv8L>Nz zPy>qD7^}4~E4Qz(cc8pqfj3LP&pw_@EeT$c7eHc<`Jkfyx@Ldn`oH?5xKOqrp=B8l? z(4f)z9VC2gUdLa*;Hze4w;FRU_u&qg?bGKt3tCkjW@Y(;^18gxi2kBXL@1g~5HTyY z=wiT;*cfpfN-u2Ao>@0?0b*->`RbK+GtkFAz)=&US<4X=tl3&QqNC1+YaESjgVF#4 zHfbW*vy4C9V0M>u!49-qQ(^@+1v4!!bQo?pV%;TMG>^BODw(l`|rc8M3Pa@U4p3ujL>O>uvy?5 zlSBxC;gIQ(dQgu6Uj2rS9J2n#)YR7jb9!2PHAf7tFcXHMWmT?kQ^~dHM&hE-SWJ8Fd&&LB-KB z8BK?T(sUNUUdQNcRq$w_|A5zP8*NdFB^CQAHSS_?HjBYv4^{goCt>e<-f!eKJVQ4ex6_#ODXG0_7lQkk1tkb`=Yu1c844%0B(|LAEj|f}CoIAm3K1 z;kxIxm;LK)$;a(a0t5E@%XZYNuz1^CC0gxnkJrb@cM4_k?&0~Zo8v(X-FEk6)FhkS zkMBQy)8K9Fh;Mq<0y_{`h5oSrC8i!j9>fr+&9M`ypzKM(q?Z$ctvLppy<{J?Pcjxc zF6Hzk!6@BQQtdl3X)p)?(`POt5UYSl<%y0Gijd$_UM0EZR0B^vYYZd|!4-%^%pVV! z4=vEf`Oz{{<&@|jU`^J1`Ehba!)U_te8v7y^5o8BE}OkM` zhfP9~2U2+b6Fuh3``9TzV|%63H;FN6#0 zP+#zvVg{Ds)DWYhU=&`n07Pp&U_Jn+CCg3vrOHwpqU81*+^7a~2VIOc@e&5}pyph3 zNV3(Z1(+%QYH76n{PlT1IGq|McHfbyS$$tgIIKV{cB^=Wcqn`#1=fzRfP_5O7R%XFl7r&=$S@+B zIltN7dvFj;CJZ2L5cl}Dv9>=UfjCnB62`!kNc0}KKK3CJjo5AmJY%A+Nk6Qjfi+o1 zM~@|S753%sYa_IHU~oPu?=Wg;u=OBUlb|ZpbPPlm1ZLEI06-`#n>;2|*a9>j^j>{q zMDl#r=-MWA&;isEFXi;|P4u)ChUS{V^q$j#luJ`EF*Bgyc!85=$XP~Uz^m)43W(z| z1tN;bR+V4fBSqfF6Fk)q+z*`5=!2rXT51{jf3iavY{wN!7|o}OS5-3RI~@K%*2d_o zFp6;oV;Ptu4>!fD6;v{#$eGO`J~sHWO)mgD;LbdP@KQB}Gz=J6>X^k`kuH}LDo@nG zl8yxA0MUi2$gq?gSR+Ht=#+s*7L03bWfT>U0N7_*d%ie;M_#fu_gYmE41k+|M3vSD zU`eL{8qGhw_2`c%6=y#VhtAjEaYaJOtHJId3Za)q?gfu4sbf!&{RQ`iO06lC%=cud zJj^26As3nWd4L*mHgilSEz(VZP-)y+hXB-JI{*yyY8i!#t2DuGLN zXI+kE1Nm2PHoF|r8iMcv&xP-{lyQ{BrVG;5jnv9aF(vNT98gJ!0Xm$NbBhXnnHr3_ ze;!!a+w|V^>gXd;6t*8xGPWz;#NDYI`QY+e`kBC(Re0P4SZtUzY;k$mU@AGaP`J(1 z#C(h`#Et<1onLu{NkN{&a*4f7p8hV0=}~>?4WS6DE}1r z+PdS`{cVkXGyakt{Bh$GL*KsL$He|l>$JIUt^RIl-fel=T=Cu9u+#edt!!?r)y?bY z>nZ7X`==0$R>Xs+euPJ{S}ultv>#`|;q6Q#i@_mV4o|9MsCRB1(Ixg~E*3=M|Ep4u z4x0=*A;PJd;U9~xESUHgwM@xd8Ub#Yp8d01Wv4*}K@AO((Xe&C+;oi}9n58>E zx&*-8oLm2!iftnE_O%)NDq4v5FdyU(i zr~{^AY$AvCGiH^jXe^W*s;kXCU#_2EJUVTb$SPwsIn|urw8w|*J#~I0vaO(s&mS^u#*pd@O9bk* zNSvx{3rU1(cMzzGY*@`Jx;toGseLr;$;J1#gG`flrXY@u)hCK_l+(i`E8Uut+S=%Z zqaVvoGHlNMnS9R7dU82X|fCo%YeYtRZ>*SX@;UC{eguNA=;gZqczq`A>TR(yzJ>w9uogL>;L9zQ#-NlpSAF&9|J8xk& zoyrAOeAU){^PnWIKkU-C4)BBKf08>=X$J)oOVWlI@{^&=lV|0*3+shVAL1@UW$ z+GgWqMsPOL*30Z&b-1g|@aJc^i6;9Xe8zw@O8l(b;E6)z#vZ;Qn7p|LLFDJpH$~); zbbwC!c|CNWLb%f3f+bG92l&gOVm%3kNt0N7&-#kLB4>}qM{uO+sK$c~Fqj~NoUqU< zywTkev4ZXNdA^d!ObnVVb^y9ce%xPjI2PHH{9k>reN^ks#^y8b8=@3y(hP-D_lV{g z_g-(|gEmH=A!I$N1v$>4J_MU6Z@sh!N_(G=rI^+4fBe~~adWXivo46X9wUpgcm|Ao zb$>Dbu1YshyV*OLwlj1D>48IPYBn-a-iSJR;--ihdPAUW?PJGDLMMh-tqxm}1`(^r zrqjf#bc^Qr!|PCPPs#d6#6f}fOVtG}w~!l|*TruzH`o0$D+`3%R8-~jqe~*ptT4~P zzz_tH5%*RI{GsBe6J?~OdVs@ap)?KV9@eWc)cPBVA)g`c+>#(DOuQU43Ngd)PuT6; zmOt1I3O`kaG!K;dBx7R0nN?+1zO+$>&WZpFB23PUY05|J*~1dyfQi*MxHf~M^cc>JS#;_ zD?QQJsw`JRECeL`%Zmq(DcI8)V{*$B%I6Lr#8sa$O z3eg-)pJ=z&xde8hg}NywOXJX_|3}n3B|eabv;cP!%;Di90O-X(I*~JW0=u#$x4;LU@-4nzZx|CT1kSs zr1Rpz$^vNJ^48Dc<&B}h!Ole-~#-w`QX9A+fAYi?iM!_}NwJY~!_YG&DlWmU9) z%H^q9prLEc@&<>6jF%b9K*CNQokjUfKqLk?>yBKq5LM*Kqm|(X2~J3hd@Ctt45`N zit*l)4qPqyunUS+&uSf~4o~7&>lsB7!AxCU8S+;+j~~ZRUJk zG@C}tX9{0qGg!I;5EdzIGFVK_P6hMITg?FbLh)9IW^t8kYkTbgyc+~RW`ByKEj3zSrC zSh`%H&u&ih%7XPlQb!xrVw|=L-?|?Y{ZuvAZV<4b5FeK{ZQ2wUZmHXAz5lMltD5zZ z{U7&Ev`8*OLei2g&r= zOm*tx`24i=_V3R_D<6)WUGL}HxgOu|+t1?tG@IRS_vdx*C|?)%zx0Q6o+T?DZM^1I z2X(Kq6_2mS>)p6kzwdj$-tW`J`|H-*pDx$;@Azg1jb5vU)OEPZIF6O0*I(brfH$8; zx*p!HH7VCLiO!~%M4qq5_rIH~TvF$B>6bL=+-6?3z9DK)1Pxzkx)vR{mT?SA`zbFC zO1W2cg|#d_Cq7^2=V6Ddou$@1yJGH^(5sV5_glJZ=~CDBiZ%w(Z!6#5yd~v&L?v%G z>W138j=DNK5!a^CDv$KgNLFD4UI$Nab`+R?nFn$T*mD(qnsLKhD|I^kc9-hpu56+= znJtv8=Fr8gHx<~AnNA)}5f7f;Sq2izkXHG)PB2n5rF*LkLVr#+2ME50rq9UF)0IHc z(0&?go^K(T(hg{;~R)M2?{W|J1P!CUX|og~qx0vhlG3%L~eM47Q$d9ARiFNf$yu1Tm=h7cJH z>^B1=?m;?C?dc1(m=5n;VbJF!jb}E?TuO+(kpZA9Pqs#kl4Y^iR7txF*%dVl3c1E) z!W;9)4j0ZlR?ee@xAR)b681xMi7ys50IosC82PrOMSJWQd9RA+vOtWa!=9l z!PJ=W3)l@n>h357;JG?Wkv0^(2du{cU{f40aw+Pj10#;|0DTcn&}n9ivBcVowZtHi z4Gx%h0|v4>zDGcO^-qDo2qhrBJ?Asdj?|<3&NGa!jGv zjtX`*+jrMeAcO~E&safmRmpwN*l$9xJ($6 zk_r3A8^D@f6>aW*Ml?n5<#nMyZ^#7PKN34sP+=0kb^U#s#r3>c^x0iCG1LkiqGgXp z>3p834HD9OZ(4gL;RXQ!a5F@bYc}pmL<}qfRm7RaT^ zHWwAe8aqsQ3IusJ&dtfTa5YwH%E!d z0M3$sjGr*m9Wq@pYBOtaMR_xdBAPrh7{|dbR7`{n8cyR*aM8r}O_nT1?5VJB)ci`+p1ceesAf-6ct-{FA}0Ysl23soTqbS)b4#3NDu3~QF0DKcupfBP zu)HKANY6i@d1j<5*x#wWJW1t74FQ9kAb9j|BZEnh)yk@59lN;SCR-2Y&la%{sG7W= zazmOKgUEOC5}`YS-8M-v+@ylhwNZ>k9*4>6e3jmQ_{pFBwamkp9E^+-j3^3}0sl|M zMeEyUtoiqx(<7(M!-l9+^VeKia^$YGX-!1e{ZWV48LH+6x>8kpBQ10Xu`J}JHC?lj z^;Ir3rWXGXk!a978vGze=1;6K{)_Huxh0kH@FjXxFH&v`gm$c4o3A0!Xvb+*8-PG; z0_=KyM?_c1X*&l=uT~7A=7($Mr5GfOOd~_r z&Pkmu=sYZLrpi0Sg)aX1dXF6#<*Rh^B?w-_DtU5gZmQf&WGvYG+;QAlYzuX{(P9Lo z!O~N88Q{w3yd5sYWo~MysGyQ#S0OMiJHHd3u1f7&A1BzQrI4!JkuRAj*{&;V3`dgq z5clkJZ8fHV%xuO?2$_j<{#aK`Sz`>Y0l+eKNKZ>1pURkpR0O)lY z`>Dw;RgUcjw`^fBxh(0Ew$X>~50_E%AMag0PvKpcX4S$>xY$f_Z<@xBE{W#M!kH242 z#(a6QW+bT5h1YQjb9JUp%EK~_JfF9mx7 zbjTC)W+$qIPA#V=m$DgiIEPg&N~?O8dX%klP^4md@X#Cjka_f6hVRL z;E}*uX$DfQJ57z_2G3Te*eS_eJvduNeRf2vnQ+caGpm)R+ha!MOPl(C!Zq_Q^;?tA z&T6ixGrp}6p;F$=kvW+Z*v_skD4Y}_qqCX;Hz49oeA_Z|lY{NdMC%U3!cxXe>A_7} zT#JoO%9qSMo;TL!NTP!$V$IOQShZtjkPUL3F{k`S)LjQAeB@g~WTZSBnzEb^DG)Xu zzkr7JEU7bxA&C4#)C_LNeM-%kR@Nd~yc#)Z2bn-+NuvL&(@n5CtLI9w#X3s0#v+f6 zGzv-WQLGasR*M>n&_Ql|t4Gd?>MD_HOzzmu#ISed036tn05)%Pk!sl79BR;zDG)ta z*m; zOy)C-amMxPPapT?dqTk6y-{F&`@32oPdc-BgnL3D+Xr>he5ujl!lUXm5h!U z45WP}^Jx0fBg75SKCS?i zq?sUwR7&(Jmo630qY;VKPTBhZj@j|~FV=GFb}L5e&mocLsZCTCfi5C39v!>rRL-xTVYW0dDMxJc$}Dnh@{3-RmcGDlO4fdE_V zqPanMd?znFYCbn@S|dgEv1s>PofLz%x>uA;I|X?m=3DOFoYU?B-G{Fji>%Q(tzxEX zw4)BCYjb3;nI*OQ}yyT}2IS~_NZAe&1uJa6Q6+;z61cw5_%H>|{o>m!a>0HB+IB`C+R+fhp2~E#4BvZ2eR0y&b4}BidDW(E%zM=!$yG^D9K2=F^K|& zQDT*IXyO|+)1X;J-HgvJLdjsG85vEtZIDj{J4lq!hQz0g6gZkCo@JboShn9ZDxVzC z4^JWgcug&DA4B)~gS&Vk<0cq{g&cYgf43USRs_DpnF= z0;!xTz4Ao-Q~Tbckkj26qS)cMd^H2-%c_Dr?@)f8 z4=oTT$K1;;pd7I*E?N=QLWpK`Npw(dk@caRu-^twzs7lJu_HU?I*pQS zc}Nw#Z2k2|=Z;CFkQo5i-&YF6cXg@NAnD(OV9qqnNf|MbPU*`Cs*A^F?vrb$k16rO z7)h`_UQqx-WW|w0tZ|mKYFLI>oe&Y=q2k5n!StxE8`~f@UEK&bTKk7ms)_SdKV!l) z*SAJHGf^D`^Q>}Q{&RS<)YG00i9jAMZ=v~whaa1yhMc+_N@#eD*V`~L1|%{&(Qxzo!nJqJgcM$v?Z-f35ZSx6kNb2;_f%(VzU5~=RITpk0b5>*XjBn5A%O#My}K*V|64DwqDh;@#=Ik zo>N6r>FayOHOyEf<-uYlq( z?Oz`tokY^O3f)1AR$=cC`IzPU%HH?Yyr-=3sL@{6O0~tx8y{y)1OVWMk{mT zNcxk&f|Op0twq=D&?rsRpO3UUX03Ui2~h$LRm^}7co%D;Qgs#6Kq#FFG_HL3;asEg zWjXtd#0aJ}ITp^GE-H>{JB(qN@`^2OQ_enKRR+LX>S+zG zET~#T5yb}v%8hV9;n^7ZFA}Ic9psbx%<`%e*OEn4|2VnMq&NiUKn(SUKr2gahL>Fs z^3|vmDxK!Y)@Y+y(6?I7(J~gxIHISWv}qrPa-vOky^&LsQUhl=RDnZC(WOjjkK?;I zxFSh5#+Fo)iVXPjfoTuRvz1(0Ys=BtoN*bI9Y9?P@Hud8>I$24LA;CzD z>lX_bNM=~=m;7N1uofC9V~k2KFT_?x#0y=9bn@>Gv_otVEsZb31fmRD(dW_G?+%O5 z;b4f`I9^40AKY$ryS?>&w@SKYP zhXTy@mDZIVNs!7sQ}(CJ7CI&)wJaWOb-R$6N$t18qhE($;>b8w59%5yHrZxoC2`>C z(JK8yEUmlE04z<{Fu>e9oujW^Vwy`>XIS#dGa75#W*`%)cdZ%cate(z^Z|4Qcx+yZI??dfFK1fBCtrb2|7tE1T)ZJlEqZ7VWpVtfg8+C zP4seB!Ls_L^)lB98 zC>7bH_q0q9{lgV%mdWP1dSayM`q^2`9cz)* zi*gO)ZYMEpwmO$CBKW26f|C>xFa=IuObepAFOP9g!^i#v z>AXtZ+MAHcB>@u2$>H|g+zV7FX=bbL-iKB7ER^7K#9-sYG?4=3X1Xpy^Q{YWQ=tfWaJ=A!nl3HeP~z+T!7o~EnU5~rT;7asjI&rX=s{Bd~LSeSm79D zk&3MbPa&o#rY`=rB-D;1WpQND!bAF&`X2W1iXzX}JG!a}bi5cLQpm;__fggpU*${y z!m@3q{vlFe?bopxq8jO#K%mjtqUNH0OIeVHOYHr^y;S^2Qe9cvBb&7)q{@{PG7yld zL}9~TMwwN|y9}Y<*K$p+YL?4|vt!to)#)pw$UH1%X}Y={r+VgIF7e=#i_z>}AcZWu zMq&8m{Rd0yREtTX$d)IQ zE_#29E-sh&){-EZdbrDdlgU!*ZEP56rx8EJA2oRVe*LYNp&Gf1&v>YNaxQVL)A7QT zt1K>c_0leg?C3D$5KHwK$}bJN%6%#02C<4}WA(zcZ6ztax0%eK_)5L|fN40bshB=xMmcB}7g6a(7;8ML| zq_sQ~k&6^t!&jNOxNbgJArDwffo+La_aA4sAHVOw=;KyPRV1M?Q5{1M)G38% zS`*JTsn^&uD9`p63k;J8Y1PR_p}w-lx?@uW0PhJx4xR^y2GT325Ws!W0sd$HB=crA zp-xH2E2dY+p%OATv`}vaH^n2;hHL1&^_7&k25l`*i3Q#$IeMQmUTsFFq>{4*4tm%F zGx~@&kd&F);vUkr*xrh&BdXRjnO{ULP(NQ^z?Y{SLh^!C5JVx{I>bJbjri;b3z4L+ z?~m`xP-S6cl7A~e#uN7?ypJ2eP%>Ka{}5sYJI1#rJ6}V}Z9lmG#?a$!e7GJzVh1)MNa;g!=8h`;|-ijoG^>%i>XO&TeVkp7<4Qn6`R>2(6;A15K*5MrfGH z$Qz{~(ooa(+O_L>?FysxBn>n+E!h9OhuwnmE)vs2@PI$nRQsKkj0{Mq==?>>`RX`q zV&lQJc7IOWL0Ws7=wRt^VCT%=5V|;^Hu>zhyKKMm7uH!PB`SgCiDvs!^uXT1uXBAn z;65=|etuM;`o4pF-d$WZeCOH6^=uVekBGl*&sSF0)8$3ovvlz()OFUTdH44B?7L_A zKv90+1E)(8VlzY!ZAnCIqWfk`CBS9RRdT#%>oul92KP59n-H=WYSdYQw3O|dFbNPu zrx*Ea#xIz;d+V61xsbXh;slm`nh24wv@{@F(0Nc#!l*|b*t9$`m-35$-smzZqrEV} zIv$QY;cLY59>7`8)FNe!CWIuebbPC4-_4St*ufqVTE^@xDJ**O9sSb$b}R`X%FK=C*yJm{Rzp}>Y4fym zre3-qWACt*9hiC*@!lc2Jp!idMBHG{pHm2O286!}a&_mtgj6dgg3rH?5N*xHeU$Wt zW^0jp%lnaD*JTi#M0GWfA=&1d)gzfh4RrCBtwy8nnM<8%p9ju$GNc@i#d+jtCFZEbyef@#0M|ED5~W1|a-jV4%!%Uuo5GpDPv~i^mdWwtwgl zu%$!;O)K!w*=gujFh!v1TbU*IHjE5s`7+8xd;3zKp|rCggZic-fm!-<=((}_@uGjn zD(2CvH~%Id7f&yj0kFfk#G@xx<|?n*?oa5cS=Cm8EYFkJkn&!|!n#zP4|^~G*;Lcj zCCJJkCFAZDtABtN2ze z1ewV%{U1C$dOW{H6QR>+(c4SlxkjKc6?tE~3iZu5(yh4$VfaYigZNQW&s{Onz?d!W zXFis8Q!C=7XiWDpicE3a2mSmBtf7#?B+~ z>&)U^8PbqL(8{=V1^#k?!|dKm$4J-+8w9aDdM z|2r%$2cb3ppJ4HSrF#AU!c%4@j{gImZmCUH5RW2k@79*#o#jT4i5UmNt2el@in{NI z+zVof=ZPK1=7J=0P>Z9f* zUq25U4EF@fxr75-aQOdzaH`l^IgqEs(ivHwb8@z1JOK>Yq)sc$y01tASb6%docbU^ z^1i$JZN(k*9OO0e?&7Q);KtX!`~JyL6c^9;SsfIFoo=hQ+#=6`Y{ksOWJ^Vc3l|*9 zKJ@G-sGeYHiCF(23`CkEQpqNtZsm|{+cXraaHv1{V6MyU1gSNLgBa{sA^<6J+!{^- zeXR_pMroOA>yq^{CwXi0M{zk?b#50Ts7A+c))6nk2LypDv3(on9D4SvrQ7ZCetziW z^KS3eO#X8W9vT-{HAFyXx9#V|5=rzyC?A-JiDl7F5Bp`ZQHhO+qS#xF59+kqs!>B?dmdK_1@>)x6irzy!+l8IU*~@ z%DEykVnxl2ocXWscNVjx-s}%rxKfQ-sN&z#U_VU&ZbeoXn!xKG9KHvi;e5oggjOwX z>c?Q;i@h&m*5Qh7ItZF;wB_}>y*WI`WhKG5nAVSxDxh%`&@m>dz)v)RhuPB@SNtJX z&jKJ(31*fl&aN+;LmAizI$NilLQ*&t70wqoU{$C|Fj|hW0~LgMhe@{E#l^t~(=^u0 z3`>?nVM8WSm!=|n>x;P3VlTqSLAcgtz(E!7u$ddE0ug%^*oPkMSdVxCi~tY>0@0w* zG_l(I%iS++s+Y-4f0W6X_>0Oag}7{2}3Wd*KYvHaTw zNEli};S?om;t$MN$#Ads+nN4ZdkP}lr^Qb3*OgXR&4ql8fPtg!@c@;NsEtgT#@fqMn;#$Cf#(^BIa>N3^5AG+Ie0^*ddACkQE@H;2kZORDgi2=g5SU zdXg26S;5}sd}U)&caJxoKIU&u?W6S2TC_svV2xLnXZ{`;Iz~W7w}x z590Im65h(&*=|$V$F{Z3m)L!8M`1aS0+L!unwK^St{)NyQxVTV#i*dl@OR)`+os!J z86o7AJxz^6I*5c?F)g=$#apff0}_e@w|8|2mbNMDXBsuw2n+oDv1#4Leg>PArm5aJ zi|KkQu5u)d(UM8{?QOrHh3~lpj&n@#N~Sxcp1pE-XTD(3C+1!u-X=-ZOvqua_u+da z2DTh~=_VJ`#{7FlI~?Dj@-s@(?7>b^z4k;**LqF%nF0L@4^>(s_x_!gln@x=eLeXK z^y{cDXO)Sm^27~#+0hQ@C=sb_t8C~uBTv(zBly?z3lUm!e7JoliB zW**U3;e0vO2`?xQ9-f|zT>5e(%_d&LwL+RfNPrFy$!W(|2p zi@PjmV^A(qE;dPgL=suH@k`{h3VSg_j^zu^__TY%T_k<>_M`7WSxM$4LRU@ZG0b}X zJ1X^Mowd2V>9FRIHv`9fN#x4qYpOSOK#Io?5l=^`dtjH_Xh*OW&gvrw7cK6$pCnc~ zG(Hik9`7<&Csmg2-Y+fv#=%a8aZd}KCn%S5lI)UxC}5kSI9T za3=Xm=sTiZvSZJIs8+zUJqjKT7m9=T<516bU@kCm*jY&$Mf$Ct4i6qG=*RPH!wli?~v40_O zdtbbk%hX?$se-0|Z31v{O8T?SVO_>*seFl6bvt=BvvuYd{^~l!sdAOwzjN18-AtSwV zhVilb#U;9_tJP3?k)FTVON-*G!vpF1!8trw%6LN=L=wh*PcCu83%pcdKTqlYrJ*NRWs z>tcqy8BEeqxqs}jz*)PEyy1JVA6EUuy)njY2fmQC4sqfKcTZm9u5LQr13)o6IjwnE zM+GEEQ%TbURW=~G6~t<-V6@-d_sV5xd(s#|xSy$ma%UGu$IwcG99y2zJ|53?CUBQx zgpD86A08i#)!*GUOm`m*+)f+cPM=+hxH~jvXUgzqch_{+#wRB4zL4*GRKq7?9Q&%< zSNt%|XmYnIweB?(A)}|vehV>C?Q5E7xzPt1+I8o3VTouG#1vA4nkj{(Qjl>AA*_z) z@M2a$NiLAjwuqe8w$JUozKt$4y~C9sYkA!;M3XZ=0)b%NPtXkGzbrajb+oY4o|pMW z^lN;zNSgX?gy21ewPj&aFWFa}r4!DIcC?q03l1lOBS=sPWE_|WhE5EK%Rcm=$JX zqei(al-=^Jb>sq57lLEnH_8U3Lmqo=^Q6?YxwXChLpWIu6182@~4> zP&KS{>b>ZS(m7M%(<;_fsNI(pRNpR|PU2Q*Zq8n#SH}m}Hg(CvZn$*!;*4DIvi*Fi0UO^f(OvLVEFJOuLNB{3tpAMagAXN$!^i7+!K zT%Z(~4T-d~sw@(vxA`mN);jh16R?rddKgU2E#H`0rqUf!qkoO?SEiy8S567l*0!32 z3wjV=wCJ@2)oEtaVN3L z=l7g_7RmSl(Ud-L%5nIib>V_QiodP=WTgsTC$Vbn`xoS zyRIbllW-~XyQYHWYxsP8cCv>0(koSmCO0XgCeosE#eQ_-Sz4MbM^hD^b$wND#*Kt& zrN};c0)roVUy!{*=5?1p5o9%;c@F5nz)MM?8w>f>G&~ZqSk=f7di}S$X5y>wtOj5% z{jO6kmGTd7D`mE{!@1?(JGE6Ysy8p(>}_+SN~POZTvU&f!H#o&{jYPbWMzH5bLz#^&Q z#4z1^Rjb`p%j)@+(}5i1SWqM*>73^;&(bWJ$AgE%a$t=7j4&z~ks~mT{WT<;91d|z zP-SQ|oqRut*q&(Xz^n*GoC-^OM}Mm!!lpKGQHg>;xAqX(=72{w6I#&OKgKuFackOb zE|{#?MU>0;N~qYi%VC>np-V(F-5(gWwVnAT+~x<2&~x;tU;gGb%^bvnqdsshr=-4+ zA~8v7Fd)h>D@d3lZpyKZjiQt8s4?dgSI0z27WkKSAuH6o+h~q2IB`P|YHRLZIALcU z?gq7kS~vQ_zUM!`+pmjpXRGp8F8|2?nYs%ZYb1Ts(H`{Pq9K+yenh){vhI-?_D)Zx ziWwUot;Qth=sQ|x6nz@XY>1n4V{2>Yjnt-N2zj&D?a_F$sf;A`b$ z*e1r18M~==3?(%m6}5_=HH7hTW1PFGYM<1jnN6!-Sv>6;d|nkv{bWP@Yp5gJU2v6C zQqXU+Tk7+R=u51tieRvAH;-hmT4v%Q|IlsWkA-Ajyj|PpX;IBgE5!3l-mbUz$5UmE zgNS>O)`;AtZ|@R{0cQa^s7o$=bmdTDjCeYtU7ZJ5c>bQSW_5?9f(p=$hV27N?0i3w z=2+YIV2P)(Ruc>W;K{8qXqTsj%hl+w)$%aSYZ)bS2Fv{LCHmOot?o zBChyTcLmh&1tegm!b7AtB6m$DI3R;FAtuUD5R#YGhwr2SglI-U_7N``Y)%Iqy9UEH zhJ^fWpbRuGS^6g=m?7Q9K8XPC3F5cx@{W;OWL>%Gv5OLj%talQy>O@>r46C(Q)K?sc zQbZ3fOu7sBzqo7S^X{un)}jEWWYjf|Uy(UNx`k1uGG2Egh7|D=Iavz0+-NIonostA z0tbT;j+I`SB!p1z@g~ELQqqKmqu19*+CW}}5ol|1 z48_oD$nZhGj;It}@z#yn>hPlxZ=OE;QxkJ%=&5e`aAxApcVhW zl6e1j{BOqar)l>;D8awm|Kt$=Ui%jY@n^*Ewtq(c+3z1M|AO;n`@cax|8K;r^k2dH zc%P=ce;)8(i29$r-+v+K{to)Lvq;bI7wEJ5za#ZO;mv=04p}~__Kcq#``^p&Bl+)- ze`57nnSQ_a`}xnc{~q~g%Wn$)@3r4_d{(AU$}$`CA87sGWMziW*M9HuH#Pq^1^E+u z{3m_?pIGHTaQc6A`lR>&ft~&*P@m=B_s9C_)crXYpIiTYN1r43Pjdi}UiwQu3{Mx&Z9aQ5M8v$%Xc@7*B2FxXBt<#@Q~ zW3HrqFs=o<9iZjsx|eA;$c(b6MBECjx+k$rXBo@<&8jEqbFST4&nMRX$DZjG6uOOx z;D(>>XtiD&dP^$n4Q7gI0{=qN6zbG}Em^2pNxv5xRGTCoRGw&4C${`u9@rN)6YRRF z%1g9~vzx5-qz;g|&ECzK&!ut`^gZhx=RK>D%fg+*lg)GSSIMdRQht@GHu^ODX|kxL z7}#lb*QpJ;_&Bw7*BwTiRp|CHuL?JKK=LJxBqa0b^6Rw zpN_E7|F^EU|1g66-R-Zm<iNN{u5!_MA!Tulx<@-Lo0pj|A5)%r~MPGE&2yqTY^^dzrnRX(b}~7w1%{w zNN!qlS}R&>S{qthT02@tS|?g(S{GXPzk;_vN#}nDH~%D>Q!_Ap9yR@^`!)Ngzs4Ua z@!#3ze*tex8~*{{{x|OSpVlJ3v+3W`&i^eb|Bm}7_WbX-+syyp;PX#R)n6odf0>;4 z`$PA?OjZ8fWJSo_#KhRa*v8QK(+!25_H%%=|NLD1XODl`>OTdApBK@8PGXEqj7{~A@6h-LVl&#g(yF4y?4}rIv=M;9>4|YQU6$}dNr3>il)V5UqwS+XB0JI^54M^Hv zbXs1u*;s~qtRB8Lr+C=HJInac6_mjNERVLao>W4yl)C3%T?bK$g0#5l+Dr@qebDw! zG8eButWfu+&9b@P)#>f{a&mvV`F`W$c^iSt^ZJxtz3JWJdp(%mY}@_G1&32UtRMUO zP$8Rox|p_~YSDdoGm*dk@p$0+z}o%vjJx@9-v2gEyZLUR{&ecS-ulkCerMHs%zbz` zUF-F6VM4m84qlpW8BZZ_bdWnwsDcDVzj%>Qz81J2b z5YpV(?9FEMtWb&{Qz3-`MKf1RuTWVcA1mIdd)?SrTth@{O!8#l!@*%)L%vMQEsbf+ zS{_-9*lQ#(m!X2HMw8n5Gp zTUgO=2a+ig%*iCtC(k1uK?`Igp-vl?Rbi@}sg`vbD;Lt@cucbL0dW~z-(krW^J=QL z$&8jKGM{wc^k?;&t^Bd;yxL$XFMr_pAZ*~zpVyRCtmSY@fQbZxDXdu)i!PE}&Oicv zBd$AXb1^;~z1mR$rDkkHPsWQqTTw@R;oDjC(ZDGqZ6F$ZX1x?YW8ZdJKAV9UlyOYQ0IlqB@Lir1`sr$p)jw`{y#~wMMM? z1x$~RZQ0X4U*F8_q1iS!I?e3)#AX=i4a`Pyf*dP9Mm zJr7DoQt=i{lwLH5rg z&_AtSr1*}nQwKWQWGmRzQGqHmf@1CIb?G3OJZ=k!pBp_ zMLt%iL{6jKIee`z&j=iJ1$WI`?scIvR9bU~vKl6?sR=wt+6^1HaM-^VBP5xZrFwcn zDxZ-5O1WC4k#r7R=8dfR(sIBJ&{l|BLH1HbG?(&5;*t^F&U z1$Fe-I5+dvs>OHV=ypHyy1{INi8_mFQJpq!=L1Q1_Iia%?0Uvxue+oK@~mWvsUnhw zg&h2qZ!*OFBgfrTYWEM_EjgAEAZSa>etqp@pTcLQl0RI@^zG^9nHmC_op9gQ}=j70Ke|AHg8$ zKh)GU?7oEP4OJ<0f89B0SphD z_?B1~B7z1{q6H#`fM+$l09~8D4W}jHTZJ%Y;;I9=)ax z_S%?ZQ;LOfFr$Vy&?FvXAx47rpIFq(0#TgXhfV-y_|wZtn2|<{7u`Vl>Tk|>E*m15 z96_v+JUTunh;TJcctI$Z9w4%Q4@Z|uTp%MFn(`bStZ3>?jpVBpC=_CWNs^?CPY4MB zA$%#16o^_U?Ke3{E3c31U7^<03z@gaQrW=$p|lxeZ7@1=6_SYQBzoLqcExv(DjriI z-2>B=En&3ad_FdnuuSP49E-jlDT&dlC3xc+gjIY}W^^M?SsMf^R9exk)E)0gGL6ET z21=;kOwxt>m`Ohmw0l~HV}$w%BOa8^byK2&D`KbTkdZbRjy}2&N;>ySB)XvdBUd5E z&~%AnP?uh6OfG$;-SKgL`dSC&M%J}pPn1vkI8mn6m@@OL$EcBPFo=?Q*T5!N@u=WO z;mgm6&A}@U8Ai)#Qs}+^L%PELLA|3(nl)?NcVUHqj7u;8$))@Kg=ER%*G)1Yw`->% zvn-g#p&KAM^mD3T_;@f! zolx}Ff2F4KFwU8pJWoh{G*2k`h)mpd3rJan(t^<^g7oEg#HWr0sCA{z>*yZ#FX=_l zP|hAQ9!ADF-WeKz)y(&yR;|RP?$xcriGoerO6iXitI& z@SU=a;cn2)81plOeGELUW|FzoU{9DSx^4ij+CxyC<+SR%5!AA3xpU2i9$z6zzP}Gp zI3f>?HI*kBbNXB04kk5en0~33r*XbR?{I}Zk zN`*mTky}PCwO{it?xtrM{kO{Q=LmC%7Tr7AJ743V>|1W$00UT2SiyN~WN}{7`x0*$ zN`#m;OndWQ3T?LPT2DUaYUiQT+v@7-JBbA4u!g*$3V_LZ}v44>iRseNt&7Q z(RCj>NKW&Y04;aR-3a(eRTyVh)hvSgNfr$8QJxlK(VN9Sl`I>SKla0=)Z?o)=s%3S zjNxY55Cc!w#*1x(&e^nOaWMdE7}C?2p941>XbHE)NHVT(l{EcYqU7={K;emK8nF5B zZ0Z2gd)Rku3-WdmE96T?axaeTd=^>}W_Rq2hO`q1jbx~*MPcDU(n0Pfyu*Um0P8_C zxXl<94R+BI=t4z#$iSkUpe1EB4SaV=AXH0*UBOs~c@xNqy`2uT<3;g;y86Z$(|a(6tFI`{DqR zmL-5TM;J=;Yj(*KwSz6MN_4DZRR_>rD?{+5&zt? zdp$X4ANM?=aSpX8najQ>pYe3`Zd!_hy@Xv77Y&6G&_-^PgwsbZMqKmCYy~oX9?u`n zzF5%?B_yQ?C2Ytq(~yWZaYfp=@NeqUQu32;a-%TMbLYxbRrB!~^#2hpc_zh8qmV&K zWQ!FNQ%AW!xl4Vn&E#BJodFf$ANewgrha#BFncjC zv_l0ha~_8?&@CfZeA#Y}+Q9}|cD?~q)QEJ}(|OvMw1>Nyeo=iYqkmh3NQL}>hvhzM z3%Gi;xUi9kQE9nGL0Z4b#{SmjaQ4%@D&48V2BReI^Z>wtF9G>u;)~Xmjimoj9Mt2> z(*AJ9+?n~v8+%!&qf!Dn2rllz9@fH?{5jUbd$v4G-OmhlAVTeEto9wo+0L~i2O&%5 zM33A`ZDaHtnanF0c~nVyBg&maG0wX5>#TQX8|ir`q;1{Ech~Kvbf1onuwnHwavvC1 zw^Vyy)wzLjXk&ZX%*BkPpdXsf&6dbj5UQ9XqjN8@%8N`^BxkPr{B^~XuK4#yI{nkg ztw5?%HHf9s^QiN-@8As}w;J!r6Eq+2_2an4E>C+CG`=w_b@ZAtCcGw16BDqE_5DL< zcKufDsc*0*<1qF60QLK6M9*O>=O+$gV8x1DI^|dyGGJ*2(2CzRjuCEgz?}eKKTDC%XYBs=AUJYp%o+S8_npnfkB<(xb(zp;H zm?sG?D#wA5A;o}A$Hgy(sw`Q%iQzqG7W!q6Eam`zDIv;=G;^^0F!vERH}kn;$m%cSzu#n zhvm|Z(4RzVM6F0SS3QlULiRd-G+@tKJf+DSf#ZUg znlbgIIQN@0b8b#GBkMLP7#B>$W804TvV`R(vue%ZLkKM#uJ8S}OUu*Np{wuf`~G_S zdFO+TPRHZ5?J8?wSnZ&ST@>JaD}c6G%rVX6+3POL{**+M1k26jQo3UdO(#LJNIoUEFN?!%+`aB`&SK}HM?S-m5=15|FCzQeC zXr|U|D{*HiV+nfW3XK(v3V0B3F__XabKM(5r$ti~YjE0m5kpuB9uWq(eZzS}Zq8Mysz3CMR z%KO#EdPp|0llxv>(0F2mZ7&I7Ua)QmzC%UV#fMgecB|(co6-+(Q6t}5*A*q92au|7 zss6&yY7ni?A~BRa-OhqaK-yMK2}DEWFQy4vjkcy%Z+Af52>z=>@G9aSa+r_a zGEYN3=6mmlLW-xP_<*|Z{>;1^gK1uek(hRwM5R#&YqB`txwX8fG%NIm4S%y}Y0svF zJPyPn#7hown@~|I&}QkFmPe)W&kp%moH+<+;@)6TUKHLvF6tW*P&!Kww7iu&7eBL+ zOgC0w!jd^5|KtKXWpg2Mu^i;{$S~I;k{3>1zqVxuV1v+cr)RZ0pR^OxIn1KYsAduO zD#;A8FCK-!Nr#Qni2fvztv}sssmrH2-Rh1dv!|#PehwKh;^q>VYYfM^={3Dz9I90D z!>ln3*2+-lzuFq}l(I2iG`gD~%?eq;G%W5(i>*O8n3Z2I#!BJO?pS3+W+3T|CFQ@yC=?L7Km1`zk=f~{Jqs9O@^A&DB%@&9DbQb!UV-{JFFx_MNFxdY$@_?yDoVf$1(4q9OtP@*4X6c1Dda0>j}$w|Y%|Jk#y*PnBDo!m#M=YrZl^bvhfW}_ zn(C}Ls?ahE!r3@tgjRfX%&ZY)f7C+7k>R}{Dhm5U@`Ge3hSH(tm&qIM`sXSL?d+vg zObtY9d4^9k?4T9CKZYS`DF`sb>e!|-r*74~Nmz5UIlJNX?8{uqFJ9hIBc?V~u8Iv# z%!3y0q{I-=kHZl+pC#;-&Vc|Xsa;VW0JtFx0x`d018WQrtVb9*%Z&~zM}96X-)V3I zNC=#wy|+@oK_|f50T{6fW7916hJ#UvlxCEolh0OeD1^E*Bcu zLs_T73UCbKai}rK*R+B>OV0@I9>mh-;4dmj=s;W zj4slenW^|rjxIV^edUo6DKVQI?oLz=57FDtyvTUrW<-YdTt~qqtF{kefGBq>L$E}H zZW9@BPc<)2kY~>w>zlG6R57Zoq*Mq73a;L?j$0$Zy=5r)H zwxFbJ+J!s^e$J@v=wG0$YKQCE5;Q9QBBaf}4PbtA>j|{E6G13(L7R`&jETyxuh`Umq@s~rY+%j zVwBlhp=!3wl_Y+cbPECg0w$ZWJIjM(r%0d`iBrxSo$D*C81E6mS8I0d?{P{$aDTbMBs59;fvHR&G692kItqW_G7AMR>K_@21YtJN1d7(<8rZ zdON&DhfMg#Y~Nf~^}BaQWFCTatA=|zL^Lt3?@Qb--njn~3CInBIHuQSBHI$iX<9-`!3(K=Jkd;e&l|FE4B(d_}u?(%x+ce!3)E$8)ecE4Q->3$nY4=&w~ z&@B6c^5N9-v{zpDc4ZoEXx-kq3+%t3%SuF5Exyd2Y_C*}lZ7;UwOqP-p5D)jrmNfL z*c3ra<1N+lxHStl+@igvqr;Bd6tStLlUi@l-qIDx18IYnt*f(dxk}^nF}mN}+|B9b z^%AjhySA-!dy*K=TEdgPw`D-|Ab9ORnqhJ1B5cEhx+|q!;^;R;s(Ki^Ht=<~X z0V!NO)yl7`HgPq{t3G&PPZfBtS%17Q=%_Hupsx?ux<->z3V98u`Lv9Q>nqCYPvIkV z>r_YyKgqK~W|0@5XlNnBf>OM;f}hLA+yTwl)jgvMBJgQRJv6t)+bughrwWIR(Pmdg15PQF8u7s2sSWPup)7dVyjss zZlv*v6M^N1os%Nk<4*x^tS*n8T?@Y-W;-$W9W-lXEoOg^gCcKWIL&1n~7iz!vFZK@H?v-7~QEr7s+xdXH5`uO_1I3REBQ@(?6KKQ;OOZ)6@-Gc-2 z2HJ##U3fj$+#$OZt^^~7G%0YEMm2n6^OxwNxP$jQG+08(pN*$2`u3yj5%qc*EHa?m zv%?W0)`x}&?LU%v*l{#zPEOhW$nM8JTE#N-LT9L&=5N`kQm2q~fo z{40w4j!#yJ1T%|aun;H|ab8mJ0l}&HIgSDd&M-9dBx~qTu-vCiu5Wbi_0drGL{+Y2 zw*cg>$3z1iGn>G6jt7v4j?ye%S2UMU)WG)P)MB-L##E4#M?Y3MS*2q6oeS787X1Pd=X9@f;_#7CBQp-m|E zVc3gry^5)VjYM|!u@m`@o$jz|yV^7hS5Fjb3%%mBM?}sD_phRHX}}iZAD|!sxlWA} zA3Mn3jGdIKd@vfg5|Q7Xp#$X3;fU53hJ<~eb#00ut2fNVqwH_OD#8vs9^Bcg;*?Gj z-7s9%Cj50iaY5dfA@_y*Xr>0wwh51kT{Ir6-yo)f%`WkWY}6268;^peeb;PIqoc`W z8whE9d&a;JrwApAf{Ap5Kgd~LMqkVF zSwX1}kO8djocHR>xfqAt%Pihr0mT)MBUp*xER*9gBb1%McFU2vu8}GZj zArBv3AJ^+Irn&2{dv}}Nmwo}G*E>`eEhj!a@8^>HhiJN)KiaNvvz!k+-lLNB^k-r) zi8R#r2zkMpTe*UpKYx&h+mGu}d8*or=T%gQkb?}%2;+IX^wYdi;-?f{$(Lc<2igI} z2HaBuV?TgvLks3jEEv-~Vr|tZ5DJ+Y#7w1$QwcdW&Tc>xu3~dlwB#&)`3& zi}hb`fPnSgR36^>?w)qZT|Kuwe6nKI;5+AoNX z$y(0OA^V+S5d?A>s}oR%U^Yzaaw& zP(Z&_!3g6pj7N)1+BQ6YOaEE(5sBV2D40B#2N6Ls=hr~fF?s_2m5JMY!3@yGZX)X< zuVD~@VHH5_*Dk?hc}lJ5C`)*lF+A9*GXlXF90!h~dYcQY)7XNqmGZ>5+|#(ghr z1|l1tlp_tWQ9^fTPdgPt+8A|$FtJ>*c`d@ftYZ{U>EQQym8RjWz3Z{ zZJSl2a_Hm%4Cb*F;{y(%x?|SqXV_tq> zS&*yW7enoo9uT~PtHI}bKobz$@7cccudW?0Dcm6dN`e`Sf;i~Sa;#|$ZF5M@2o2~R z15lRLq`NMMt_38bMNE*%q_#$FJt=gTtrj&b2zV3Ql!klX0nv}dh*bn zO`%|moPY(pDY2x~3!cW$lK4$R9=q(oxaEYzsU0^)m7K1E4S4v*b%nY1yAkAj*9k`o zrfCd>Sx;`N^OmoJj`MDed5`0Y)C9kqqRG6j>+EI@;_+ipf0(otV1DQG@%y?s$o^`b zu6%JO2GzGLV|AKkLfkg@)u;Q5Q`QI9&9(KcDc`sIbJxT6%WiL}%@l2P&IED;c6zN| z$RJ+=5ZnPIwmeHu3zOTRrRGDYHty5GW3LwxEp79=>|y;l)>OBuS}~*kOPc`YAsE7BZs;5@QyJF&~uq zAFn%ix_=cvJ}|kc{cZj2w>sp1tiLg^vCz>fIvY5Bif;Z;U(gHwRX|~-3?rwgis}=y zw~p5+OU$EWaEk-phQ#!(EcAn{+Y+H-8swFq5IBraFFxh5+h&1);N-}nJ(`mtT!s3S zqfxkFr>bqa(xtTRXWh9|rhsrp-h87QPL|W!ZH@C%s!Y7=Me9SxW#-HJ<=RySPw1|@ zj?52fZ$f%*l1cd!N4HFnd+1?EQ4g1-X1j@uzP&_^&^*|~1$>WRiSLLcdV_Y}`w0a6 z*i3xVnDZR3`v|!i(XnjYypg!-4a=!&I<;fxS}JGC2Bgw;Q7Sr(D>}+1s7bWWWa{Ny zI-;qfPmSd{YufS`O`h1nD#j+}rL)Of@@ud${pWKe*~$5A+~L~SZRf$!4DIbgxkXZR6$3+QAa{w`UW11g8G^wsjL- z61izQ6Et=$oi26zz`H6*)pnfR!Bc?M^=tc2=xfHbj;{hJ`!<8(oMgmq$-~=^n+_H$ zvrMPU-z%&p(W{X;!r2TW4%y>&LG3f*4hh(4e)gz4ud!jH{jg79w?Q2yw%3CEF?rC! z?m?qDJbCyi5nXR4WNKIKXxX~HhV4V(o6?QR#6d=CrajHAonq54RkfOLxghz>@J6m5 zDo2ck#IcNgU<3z~0K@$42Q*wDOz(a#X<+u<_~}D4ytbG{DCypvq+m^LoA|lK&N2Ez zLHT02rpF;@6Wwz3B%(~nI-nDS(p5F0nT%dCe$UOz5FPfY>4`3pbx;~9=6sui-1@pfPa*P_RrQAq5q2!r72R4*bDMzAg%x zkU?ALjq01w7h~L=JmctagQIF+4$w`5K|+(-3S7+$!}P{rwx!{-VIk5TAYsW;;Ibf? zru6o4xaeAdZa9@rGVA~3qK%eFw%^0T!Uz%H)`;3V{T7)e=S-_chio-8#kiG3XNf7L z4vvbH@y4j8+5I?~*aGAb)%*Ci6aved4dMI!XVg9$Dq+3dvj(G3?Kr2*+gmNfa%sof z5}J}!+;C*uWMn2DZbl}rp$LDZ^N{Cyx{Xzm`dwgo&m56PZAGy?POU#$)Th`vZB6z4Rd0erYl=W}&r*_mF z({hm+k>g)AR1&WkxlTv*UJL%8l z%zos%mr^1(sHzhR45cN%OHPrMcMyNBNAUGENA`xFTeu3;+l+g89_oC^u`|28pZN95 zuh<`S0|^3N`ZLgdBqHg#)5J*elpWZtj zlZ)Do8tUy;Arowy!{1X#)w65;#m17|E^o28sh4kz;ekSLk%4g8q*1y=zlL_2q(=|* zVyLvUqB3jqR~B`LQ$oPf77XdC_)c7GFoh?d>Bv>=|rGU_e17 z2b8gy7*gzDoO%NFHw>k|1072lBFn%_;FF68qVvIg6^ALgzxD)lVFZ5`G;o@#GWL8+ z6Vkf0eLIoe-mLCGc@Sl6+<~KRJWS{8=VyJ`WLw1=G5+qONYKy>qnqV8nGt^(ojj;T zutn}Vo^}8Iw(|Xe+|_*mP3acGAdo-fBB)KYkI^Yzjh@|0Ln{~tOvLYp*UYq{|OI3ERFDC)?ZSky7SYUhC{A& zJa#%I1}SCcV?%WNshs?dyD4fnQY+IHC~Fn=y2D$F%z`~jUuk+VTYzoM3?G?d@k4iC z&#$@dHkN#1esYD=fHD4R%>k8MVgZa9rem>y81rFFS>De)jCM)sYU^S#EVV_N(j|{s z4NdyR#^5#3ec*>a)Re*PHDIN6x>;-5i#@j@*zST8*AA_W>7}`pzHw*GNs<3lWyB?_ z&0gYl(6_YFx}oNJHM4r~;)&^!^%Iwh;vL6rRdmTHkXABj|OMCAu?1AU&3&tX}8Z|au z&$3$R(B_U7RsbN0;XpHR6T;00#2XFnoK5H;3J5U^QkTNCy?ex371+gArlG2I_Bv(Q zGHrzaC{cj=dQ2PTTkbk_ZHtmda5Lu)Rqu7gP!UIymNuf$+2SiZE*->Bh@z^6GOX}guiM^#^F!uqA z1Ljvk;^NBpMSYEO?nH_GQ7jgzq#@q~hwFD!r#+jIb77-BFFPOJ)?d1QTt0Z>0Ac(% zINyhoHwHwhjNrlp&!dwKWfJo;l*^(e5S2C?88sIZM8{_j-v1G=c%h6nj8TRV4?4m} z??GD3V7M)41bwFf{~~!7EcBzw8>@?y8;Z%uaQ4kg32pftMXQFZ-n?1gk>9;Euv>)Q zJAXvj=(|oDx+cA{{?m=EPCT^_M(lOAT+Z9m9nhzFq%phD9A-|4$@}abk#SqzxDSPq~ z^k91X8rTb{OtZf3sj-n*8RHkyQaVO(Ln+2Kg853_gZS@XPZH1*e@+}L8Pn92z#9UH z7N_HQMzI35m-J`KRUBU6XaO z%g>388OjWrzAU)j2lg89GIhiS_2r&4n@fMKZnw_bi1hsRDGAqL{f~ty{464xT`Y{= z04xo;i&HzZPO_MUdoBY&ko2Dhiod;f$dENV;O>u`U9qAR-C5)&gMW7Mr?|h{h>K z<;MMQgrcXXv{&X0nqFr%tN?E#tow((wB`+Fd32=lq3+v4l^NkEnNog3uc{OUO4})= zcJI7i!&`X?+NcPFkxp}zPIpO1W_!LIh(C!$F>yXk6DN^FH?G@8mQbG?WE~!-kE4Ry zv)E;ghT18R!PZW;F(s3iaB+EMvfvV%4<3QZY1B`QKK^cQ2evPDjS9vKT)1fy-&YWLJe5XXb4O;rGd7n^K zu?=?=XV;%sC%%!pOA|b^q zuI+w04diV|ONBeF8b(M|q4~qZ9mAIZoNy#|g9EK8u*1m%(0VVI`Ye6SyH z5?rr)v!o*S)9v?y;q$}{TH=47Wx`2{J-FGLBt&1vVul_}Wy3|=@oWKB-O*U{OQ%PB z*!uDc7_*I1G00&d3HqzxohgMxj!Zh=O(GwpAth-RtReng=G2^UKUNz;5%Iecv7mYx zm1^Dh$uSq>W(PI)ybP6_#P)DSCZyc~WCU81u$TeRTJcv&FKU@^3wcVMvXUk%j)B9j zn7NOf4}BPB*~-#IiQ5Gy>pT|Wh?yeGQH?SdP0q4RNHw$?{H@##jio#JXSFx#H`-?* z?>ZjU4=LUP+@&8!Xuk;F(sc4a3O46(Pk((2L9ikE${6{-_*oZ!mm*3 zh(BQ7iufZYmG%0!ZkL~&4wWXfrb_ba1j!M<>Z{VL*lNLr(N-LdMKbRMKk$HLG^P=W zvS|dnanTsY`Vh2(!eaPaq5h-M*6iEjtHrC|c$XK`^>i~wW@*eEg-wBW702N4o6)5^ z5LgxB*pje)87{!m$D8z8_2CuJ`^flc|Ii2^|ESb2+@8Nad48mXz{-`VO0X=((voPY z-&`@du-NJ!_QGxKwo1>LVwidZa>BY7NcBKu#$>t1uxZ3}kNb6tFy+OnBdfD+(e-Sx zB??jmsv1NzwvFJ5*xA}0vROW9zIBUz-F2GNJOg9FJvkbUBcQ8k_`O>Owd?fNO1;%- zc>fHkZL}KKo8r1%k_rG$D+n_^M6P)J zhb;3d(QijR?)_{Dbn(WjmSE;YXEWhERUNZ(MpF->oTiGVoM+I{-3&;`%u6zm zbc=bK`7iQixT6>k3Epn3k|dP>er>cM%gc1^GQJ7W#3!6me|_WL?{m>SK<_TRQb)(# z&3#HTf;sGUWNEC=A)?G`jcEz3`81;fbp&IE(tJ^y*KlOymYL)vLb8v3OYOx%1HV}j zj2{i}2Nn%G4trxPTp850uZimSgbj-QCrz-wi=4*`fDixxJj zl07Sq#A4G*niV>_K01H9bsIHhaiecHAP z196o1<|FA_>7VHz;dfgKq!3rdJf#U&1J|o_dnG;Dg*ZOg1sUDD?!SJv5g`fk?x4=7 zMlmBS-3a(1vKV382I`LWlh>ia7!iAex$Q7i`8VGP-~}1KU<-tPKU4F53B04a4z&IX zbaTQA7R3ZKwB!e@KXZBaj>kR@De+ zNEA;l%vQ=DJ040p9_Nod8xonIPxL`tFgpsnyeNP|yB^e44A*r)y$y$VU-kydw~t{3 zz0-(@VMnSH&Y=H_E3Q#b@gk(V9x+*%`)SxW`vb#>31LVWFKl_w5HC>F0SjRixeoVf zM+z?_id!LWWP8_!3&LQu{swk55~e(ukqLy98K$Toc-f&nd%%k^xnseed%(9ev>#)V z?6!J^*fkO~S!~=9@o`6PP4=mDYcUKEsk+y+!O%L6zZiFK!z2m7Ruc+Q6Vp7QL7(it zQ|*u-SCcVQQ$SafMrfD4Dm`}&vQt4_W5WhDy`!Y1B>jF%!fl z5j~u2=*1%nIuzp8G#_KaW*{{sGgl_+rkmM?Br(VyMNg-;NKgpPre9X(br8-`xEyxd zE5s2k#j(ne>N#M%8*+8fC=F-b^J33@rxMa7k$=x0skmiPFHKO-sgzKLJfk`ulQ-Sp z_^U;+AiEgSF#&JQ<$~HdWX7(MLlJ43ONFs47O`PDjtO3x~}?M0!PZ433zN*j5CVMAn}SX&@0S1Y2XhfxJqa zD%_H~I?#c87#s;n45?lN+kyB37);nkc|u_YT#Tc2ZDQ?uS|}2kk6+T$^J1LW!hGv( zE9>pb>)Gw=>#HP)Zwt#LhGW8A4x6CA$enF_lGK9>alzt|ThV23gt;`#7m8G zJ*U)$<)mfeDl7I@m=5KORVIp>UOqq4^P?m7+9zlm7=EG4l<hEhwgRTZaO%~6$Q!_sptSl`3uIvncX|0_L87; z`KmGGDWBgIah()zlASBI+qIW!U-HT1$w5B$SX+U+tm|OX{z2uVwA`flqwGWDp{|PG zo^d7W3B`s3umAAE%qxV}!Hgo*(u!K+VwWoR2uAl0>TeTg7lp<8j?mZzeV;J93ZITr zU!C3}&J#D6u9^~5=bvR&s0HUI9UZv}i;pge`la`e65SE>jdnFUzkC$tg+D^?t5`QP zcBh<6xwEp5v!Ao4_pEfXpL3oRA{Q2|j>LGB6`B@iPEVX2=W}Kh`u@c3TIYK6>&GRT z@@lj;*SCbmEc7n-{`ISKvDMR=r8oM>Wl@cuXE2BJ*u&%=)(E_BMXNnpJNWq? zSirh<-dbSF%LDQHz(;{`YnN~TfJ<>5-?hv~k^j2ys-g1{t#i}YkTZ+mh`}@a=(NH$ zDzi-DR8n4X{}@c$)^mYwK~lcVsVjB)7qFH(kFD))vpjPxtbL@fJM7njsCHo%x~yw? za+SYb5li9-X*pg>nN(zMhP*siQ}G1^x`uBDrLT$)TPk* zOb+||lB2?TrjU^=zPc#7Qh1ZSO)Bj*iNgv90M7Niik0bPlJ#} zOTeqE>sripVR`#w*=RI;v;%=xf5Rp4m7H^`#A9#oo*a`dKg1e?Ud4%wzn8>gS6v#X zR$Af5UPtj{jqLB=D|@GtR^Zje>P>5h@i3M-H=O}nB{5CX4a4TrSl6;OP{$F~1$6cD zEFoDWuJa6kp7|412Vi{t5h5cA5fXOVp`mke6YDN1_>$vq7AOn6p`ly-gH^vsQ4}U{ zcA`x`7QVxB6cpdWOd=aDw-^j<*^lE)Ax?5)fMlXlBC4I-0Hrt?-gi^1;qQf(WLJzC zg#j8`vqu(00*%xtE8cY)|C4Hit~)k(vPm4`ke3W-dm(sLBuaL`oS0coL^pzB0|e!h zaHGIAg5q71tsorC67GW-#W4Qf1clU*`688UB$WKOlt=h66Ko?hqP%v15)6(L9!h@0Zf#qf*TxY zE+N(%c!WJ9gng*kJyg6whwQ#Gu2&zF8*GJLwwWDUW)zM+*zfDjO>=G_|4P*6k682{ z5$Zo;*ndQUR1JFC_I0j=%ey0H)q`K}gT8|k?$xeD#@#Tt?Aouy;;%&Li6qN{q*w<2 zhE}?nBU-7W@E@)Sn=H~pS;mhEzzSwzgD^u5a11YeL-vtJRf0|#%=CvDW(P(W%|wdg zDUS+9f^PmpR17Wo2duS-Io zmd!a?ch7o&*;yj=AXv^cf&#A$^#pqYx_d6Gr3evFNC+_TZ(Fru8#3exBra#jjHjCA zMvVv;W%a;)WUx>Pwo|+{=Vu=)>zBrURijz>g19jyBGe?9DN9~CWSPkY{y2PyC#&UT zrz8*eIxw_ML__guNJ~19hxJ66Z}_+cw$J5c^fAokoaTMN1P$ULexRj2wEJ> zBi(j;_31wllKXR&FO*->lyu%wBzk!OUL3OVoBkkFJ05~zTzoK*rAt`xQqC_`kc*m} zB0U=={Pwl0qCZg1ua1a(1QTjZeK5+CrWf%@t$pnndH#4eqJfoVLk7{0iJL+ypsVXf zxr>pDnvs!0F?avWK>!_%);|(6u@>Wwda;m_n4K_*MYN1!_|14jq>FKj@&m4TtXq=Y z?BS+NM$sn#g5}g4Ib-P#z|T?wm_%AkGb&T-^=6OMVh~j;mEW-zZU+}%qCXL#PMxJx zr8+xcOH@vZBLxSHeU#x%_RzdPhqTl=Bv~31GZN2Za?3Kd&CNQU?S+|tymGwqybYW? zJ}Ya&Oyf0bms%#ub!>8;M9`l}SLuYiz|xxDwdQ97cC!{~-!V7;f~+sPgkHD%>IMR@ zx4YV+iaORu5DulkNb8f$#Y4t<&aubC!_JEk!F=}}C9;ifs+%vzDOm$6E=jQjXR|4= z=9NfnmI^_@iTQcjkrF^sqTU(Pk{qdi)*__vl;h;npCq*OJs51|>-GAz_xkONSCB9c z*&hI^WaXiD+ELZj^j`9B%hCZ0^#YepHGMdMo|X2Bkj;{JWZdYYMf3yViG}P2_nmu zXwiyI?m-|e5tFD)5{VdP2UEX(SC}A{xPs>qE5?Exhwfo6CE;*O+4@XCS6=h6e$M#0 zJGw6T02oWJud2(HD;(9qP`Bq^YWd~W;hGi~+vY?|Qz}726O|mECdUP6Y_w|s+-WE( zdqd=Vy%Ui!;kC&<)6XomaHCh77~XfmJ?6Z~zFt-bM3vFQD9EZ!*Rf^o$Xzcbk0o8b6RGbE;-GP)--S$7|P!nvoiCA-s%X zM^Alky1Uz5+@Ix>`tF17kdB1n@%6GI$on}j`6X^Y7k9Elohlhbbn<*QiQGxdi#Tvc zL<8?AgcJkOL7d_jN_-&6@)|)W_zv06V+5rY5WXh)p7@#8k}oOShundYvnG^VM*ony z=HBwh#Bxr!DI;U`?YQp4Nlia96nftn;YlPRW*%)XqNs{MtTkbj~0iF9EOpi}~UNuG8a7-Io0eyLNSy`&IQ6@Wa6d zFZ!=a5$8LO3(!O%{5p^yh_;YVz+wKVeb_rB@yLa!BF-$tPtdAH-(wmU<&0b|>~$4` z>(j&9g{G0pwNT5kLD)s}&7l_Ij?#&hSi!7A|Ka}^24vP#7CP3D_$MeLy2?Sh$^pAN zd-8U)ggR7`MCEWuFT9YbX_S1Qoq*UZFi~uc?@~dgLV~PkYs4 zFGep&v3E+i}zF)YR$piRPrk&iL?AuvBkBd49thHK- zDV)#8P-nZ}?<~^?2M=ARt&2_BS2sc^xeFRp+xF~p3^k~$3DE2mf&4!N zhYC|fhVD{;f z&mJVyNVG23>&VGqnA|ca0>8JekGp3xbim%<8PzxYd*3n z%ThYh5i^=DFZ7?C&b49exjY2K+p-%z-Uc<8*WCE1EmdnQ#ca3VnsL&cOPFnzSK+3( z6gAkXEyYZ9C~N&6sQnMusjiAz$YMVS(J(p!XK)XI)!zxkY}@%yb{baq24qOKaY(#B z#Mwh0R%rpGx)l6H0@zyHKNBOr6ug|;6@n+gE+6s)91tMv&uk8(f$R59ZRCozW+40* zHfV*o{1RyhLHILM6^0E+UWj%M+8LBzh;a@P4kVhLBWfbk6j>tK^eLYOKPX}+gLqwS zfJrmyT7T`Q{k65dO?8LE;Y3X3QcKLkQS0`Mo!>#i)3nW!tv+9w!|>T(TAVDu6&Lg4 z5UERA7siDD@?0?hz(DH`zVqoJ|y2OLI#v_{m$! zim#|mE{t@f_{fZ$Q(oXv?S2&SAirt778h(a8a4<2wGlwYZeLn_1!5&UKQNW<_R85N zH zYK#c`DYW~z*?Y|ZEv*jp63q;LFZqIO?M{8~oaZT+E*G#M6J|N21_-V{e&0f$(T+M$ zFQ&lQ!@P)?Q+b2)O&p>Wh)W-gA%7kI3M3wg0+5A&l#oO!!q|NOBdR38H`ffyLDnI* zWak6a?W!RyR(qow9#sRA(XT04sejoRO~NHk>L{UGq@F?owb*#R*f>y4EisG;zX|uc;T&wdk=RS55}20(GEXrfZqLc6>s2mfJU^n zy4KBdFBt9kJU-Gs9v%e|bbaCua`>Nu*k?jN9v*a>Uhmy%zrrqv5B)l1YJ1zyltm&3 z5bdw|0GsR8X2a%yHkH*Sy_}U_O4|yA(UOO!w~CPAT_)pmyjUk;2E1y#jU#LIRn!=UP-g!5XKJ z=$U)DTRA9jqiaNW%gK&d0vREssSA}Mr*n#l&9LlHS9@ux<)5Q!*g$oc>&yJvkGR`A z;Ml^B{TDBhynzj{AsxD@4Jk)%7xbSopJ;#l!O zvREb)dKI{!5;PEw7E)&r`gxZ69Yc~}7PxeCG;Pz!*k&bK!?rZvZLiMpn8oDrcf-bU zv*!=r?b+w&w?8G@zqPq~8$1WxO6m9Q_jrrsx1Ux3F^I7^9Nu57=a`DLzh$gq-XjA4 zz|+doYsY6lgL2LwMrB<6*>W1u-uF=vyJwwEr;knkK*ydLiIPlF6yH@<-YzS=si5+v zfys*;_@6eiOzis@=;$$7kyka4cImz{l$#1LZyMk{ng7M^zNvu-q$ur+!kImfgr>ja zgqDlQNlpnb5^Ip=igrb>1X+sXNq*0@64I5cK@tsO2xZMHY2&RD0|s@UQmN8vgK(BxHf&W=EV0t~NvF`)j3jY+ zGhDst>K^%U72+_%GGo?*)kFLVUkP0aLo(TgUd2zgHj$E!&Pa&IPy(O@!VfLrHZ{k@ zvC+RAz5MO{!LrZzjzWKtscPP2HIp8S-ffD0eYTT#^33mHGvEHVlcBQPn)5E77%^x( zC`0Rp>uNSItcNoj1v)V{$coEQ$=OplJyc;ojv$B!{MEz901*4I(sz=p=lNJY+k{Y^ zYrnG`!?88Eoq8SMd18+xnUMO%vP~+>$3eT#&jL@e6Cd5}#isadiL4IqznL zyI}Joy}1~7v+N}eF#8_*nYr~Gy^ZrlWKgz$l`iU0B(*`M!nlW|BfzPnp$jqrM0F2r zhJ+2859iMU^d0@XiL(Goegw9r7NSSn2Fb?&Y6dC?7orEU23CUg*9KbrFLVg{4P+5e zR<^^zO~f*%eAVP{%t6#q%QJ=kf>lx|u?JK_tI6kE{}*~t{syN7+8bdsx6;#5;S}66 z)z0^kvVop=6(8@lVcR^e(F!Hd+DSWQQMgxmtzUz_>6wL-s9OEmlvwP;1v2FA+&5;>U6X%f-dgAK*_ zZ&D3E6%5 zF|dqd(DRmy6?)OZj)^wt%*XRFXt)2F(7ZiM8w#&cUzk2MuzJ+-Ks(;5m{z>L*neg3 z$`h`H;B)(02uXX$(aYhU-BcL0*5hA}Zpp=d?|A9dxecU#*OQ2aJ6UUu*lTfmW@Oun zscS>lh?o;k5+eB&asp2c8p~ zO^iTF`{C%QM&KI$TnJ)~!7mn24G`^d-JI&(w>|-W@5T%d?{0~Phwf=^D!{5QY+A!?;gxb&aN_f>~qe>3Bzo8XtOzOC$)`Mz4$yWb6c>7n( z{`jK-96E)`sG@L`^}+q<**%nCc5WZrlTS3x;^g*4eh5d5)EL*8aPK)Bb^f*FyK$d6 z?1*iDIz3h+xJirQ6h`!F;J?E|+<*AN63P3d@XzRIX&Ocp7zidhOUKLs2^6VYK~96V zIXTKX=xIXlx$GaVS3CVRH9?SJt=R=xC#g@VsjfZIwR{UA1}pCO5cmVNn_c6zThV!w+eehm7TaZ7?-G~6 z?2`q%g@-t@UkjF<57gJ(ilb^Zy6y3Pvbo(YZcz^C+OY{LfGpl@ydjvv1lw`V0JoBO z$CMtull8~P%fe`ehf9&||0#Rp-|PvWx#S^dU|(g<4F;efyiI+=3+_{ve~tE#6WF8r z-_YP6PX6E%9xXE zcIy+{KlkqgS!n_QRQh6t^^ia0&%G^9U!aQi9xk#Dc2ytML3-;poa(9TT6UAv0FsZ@ z3Li*?Tg=#>?nech&sX$c-uJoFtiK7|bq$@O%3e<&*^P{<2zUj-c#S7FUBWKhIrsJ? zHVnKX9`bbGYnSx(syoA^tTJc}PSfgePOHg7Hup@T(I(=UH>R)E^s14T!E>zZkv(Zn zMMnx8!ZKg`<3+CvUspurn6Fd*D6>Tlr91>Ij?7wGWM*Dt^ZTBvy0B|;lfIs}_v2Ms zMUC+BwC=sVqx0C;yV?WdBy}2HMh{%b98;kV%#;bF*8$ciL5NP?0V;yd?-YHe&Cq4Zrc z@H-q2wxYBDQCey(a6Mc80x>KLDnl$5I?@HydziS-iN!=xrHZrW8S>PkWfi#^zAm~X zQF7Y#zTaQ~*l~JAEX;22wc=)VpN5W3-Fkua)JA^~1~1NVhiT@{tu{ z)aoY{k_r?w`(i4rf|Wb?trSSGN;pn#poV&WItDv5@_1a~{CmCPpX*+tudqZyco(n5&r+_ve|Md!J+8?bpi;2*saJ7X)kWKBFWqWFm*NiKa%CK>~{pd zr=~wIr9Y9cjq!W$Ck;#u1eKMANmcTrVvY$B`O9($Jr4nt0rq?Mq~p_z?<*gEGjd;- z8KQfAr>7AYO!G8ftkogcN1CsBM4oBxuwK!pbZPX1o0xo6pYlFwqbrBI5)&@iGs~g( zX4Ht=?8_!{zNN!+s#+$_4gQu0JT;YEY5hY$7EIMKI`8x~4d_*w@*=sZh+oQ&pkbk{ zmFwVF6X7VjobyozM-h$L7|Jv<)3M}1=Mc}2k57Bh)1-tDxPh{B!mwCu=f-+7Z}lks@Y@3rW^f5S<#D|Ej>e(rbYxjkUQe=noc zv$=ZSY4lmqFH_1!e+rwtsM+i~vJPU8e{%A|KU?u3F_;`qXp_09o#0(@Epp7pOPT$g z0(i5oq?}$6+(6f9|59GyaJ-A!ySE@7&5{&AAow#=AVJxXC%_J3IDbIZA|uuWN-{*C#UgEo11@Ug$& zJ7hzw{pDn-cg1fiuK8L0v`KqMvOBzv1wKEIIWsp$@}Ah+b$WU|7hXCd5HIFu;J-{} zlC3{S1i1w(D3)fq>+GNQy%ckj2}(>3RO&FAfozf^M4%7b4iHk50`IL7uW(LkN=|D6 z{#pMw*`@wYM6{M5(~uBH0}VhC{bwou=Ya5RJ9s>jLshsJG*E$Ie?{h<|6rq={*~KR zO=lzT_(iTpSC7Ol%AQfXs0JC->`g?g@z;y!l#Bf>mEW?i;U-A%fRj6PCa|}6n(a|; zvZ>|6sYQU<=6E8krB-kd$F9MlYB%{|fi+*WyF9>q*vy8dG0*z5XjO6i!xFyuJrHWH z*k}@LO)5X;{~@RUBlu?z~QE5xI^Cy(wq&-jnlv~`MKx2DaOb}0irBn2=0hdBE$@^P@ z$e|i$0xkSsH2uAuu#Zg=pV^hZ2CWC8LsO#?imXVSA_*ueBA*TI;&53fw#qLCk>%-g zeo&pyRq;Ma(e5%w;Hv_Dt({Q^@rllOeD(*jjgNaxCi|jCozpGt+t-cKrPe^Rqbbn} z+Qo<^w(8c*5W8G?2aTd@@(ZkZ1Ddqf7t%Xp#2AtMQ*l>Ow|F%;@)5fn#&S=1DHBSC0h zp`eoMSii-7W|$2D^PocAoV$ieny~X^BKsoeZOhrhu+8Lb_O50ufmQCO)wpIeXDtNC zc!Vqi+y_`{IrET<||>$ctJ^v?=pZ#Q(Mtm0?AL}9-6I%(;}Za!QzZ1QRd zuAlT^eA%rhJUumdX?dSGad_#zcI3hP-d;tjGV&Qz$8P)F{MdGSGq1f$^?Adds?uB2 z+IjS(n1l%@2FJ#muthVGQWr{bh(BMQ{D7jb}DmLoQ7HI_w9#R(vt-2_`oe|CI&AwVD z3&4F&_h=$|$XUzo&$E7U7bk=(e1VD_{7=p2i>C~F!Th!LkfE-s?g)WG+9>-X91~~G z;}$Cz7%$Ki!<8hpz(d(qNe;n9##!2>$#<5h+sXcxe$AktwwS%+&OBlL77eIek^~c8 z;z!(fr_`?|WrbBb0dz2?<3Jg5GC0lEARYwb*V3=0X*~}0ODv=6Hq5;bF5pAAm9|H zVBRn<4ZltIe|s3q)Ty}9ZCWer^B(S<6@nI1w*C@qCI=X$QXv71+L2fvG~T;WR+uX= zlKFMGd@Li|A~|dzRnSR#RetN=_q2{Pf_z+<9tM`>W%BwM4+e_UT3r2BUw z&HiF36pynt4~^>GUCVa67w2j))@xDU=xX=%RrhhO*VS{54y(uAgGb4BR!farz302m zDl8$5{#>WlPrcPqYT5!lqe{Xj3633*qXiD+95IG-Jq#(@Ul~Nx7sn?+i9EY_lssBSlM6Ro8f?~Y<34iyR~jzbb98bX3%1`~k`_@6dd zON3}BzHJpu&Vkm{s5#yqBlvG%oi>sN?0~iK4|=HIA$>ake{cx>8{DXQBP)hlRc;t! z95*&X64lXMWJYc*1Dcza*n;9G(g~!^PVSet!bzsiw+ES8K4XA=Ket z@kk2#J+LBBb>DrTuzysFYT=P{1#=K5V>VAH$-bpE^Cx0-nwy$sfdIhb*5;P>#Y-ML zh*!z;eLplcH8k|+dXuI>&y&`Be8WSd&BWbR(c3d2Z;RiT^0>4$;@zLZ=E0+);=frl z_ex$DvUAIA;$n-kLs?0T^yCK0hy=OV5q`z#=;Bd0sEJimx<8K)CtDx%mua_tnt-pc8<7VH$}mZcShi$2aInlsjI54v;bL2m z?%SGX$3!S0YQ`#<_g%Cc?u>p2 zj6w9}lzUx}>L+pY6qDh)JKEo4odkkG>Hu=o*+TW)J-26J-O1 zQYgIX)SuLASz-FI2H|E*VeiPURKEuUx-RK*`DwGG}1#zT9y69V{tjZqU3$e=Q*y zKe@J#ABqB`!n_@^VF`*dKDbQj+>Y_0;f+_u2A*t6(Dut)abD1WxV)`UiCn8S$8y9 zbcoa`Bl8g}%$g8fS&o(uJEDd=>W_NZ`~7wo=F(?BUx}ZJ7r9~aAh(`hIk4bC{p*`} zt-vpIpYYps_(gdic#i4cw{Y6zu;C8$D3?NfMpv4ffUb*nkKg-flV`5`yp7JY6(9K( z%AUC8p}O{TIemqNn~uxHU!G(qG-{O_62!&Bx1FQ&V5^QdP+ygz>d!5!u#Ov?KxZZ0 z{g{@aXOtN=@CchWqq>I$xcS|$By89H^&ImuJ>XuDcH8c^Xw`3h0%olcjv`r@t}j7; z2m`D)h;(?A9qR2R1jbI_jEDbShRDcjkVS`ZoLQ52hFk`Q(jQ%_i9`YHN_NL z+E@l_$dm3mq2wFUPXj2d51ne4c+2MUxXrQi{9H(%I%S7ENpz|we3l){V`k&=zDDc* zZt(^^%K%vWSln)2LpGt`!o3+!qx8N$#SUI$Eo(b4-d4zGXlE9xwU5Y;AnfhCeV#Am z?*l|5jCuVn{ONW$h!BOm?4ev4ZoCR}VXv;ccivZE8>+*c##blT#TpnyWFQ^ ztXaqnXJ`}m^=6!WsKD+5Jo@0GH}_xt@dV(r??yz{$@q@J6qF!s!+J2ESV~Ov@VQJ* z1GH&Gy*h{L`_|Q96fm!EoZ2mGQMMVDH?Je(5zXo{u)_RwVzF8v5exj(ZoI>m3HMte zc|zh!Zp?B&5t?n*>jknL=Qz;!)5C8~87cjr`kXUE>^Gk$Uq*g@Rs5ihxV9}4jedo{ z)xl3O$;O!44D@h{hPPao)oB-OEl@;%8@#_=^Y9&Vgq>rUfv$!1L2m3VuTBQdlMRZp z)VM*dqSku&d;8%dQ9U(J|9PIDkQ>l`9>Wl~kYGy{ zdw|R#-U!Z!EI}k=zt(*Z zfeX~{`*C9*2T-#CoNR;(=rV9}Qay!Rp4W?<;H7Ai81!h&{@ySWjt%fBz*y!FXWiC< zxnY#{0Uw;Le=Z|(rhe46jk4%QK036Kc7GQsnM(9~NhRh1 zLn_)?zo7W`m-+}K5ecG}lWEsw0Y`YnqgV?N^8td)nuyhY3ToDUFzun%+uE*g$Iqwl z@t$j(HD&f!*fvkY!RIdkVq1f5;`5~4OZp{Jk^4U8o)xciY}+iuW%uiFb;vr*HYo4C zg(={r1+`@!N{H2M#~H^h_?8|Y{P`^r@8^h*TU$T;{nn@wb%GWZf*{gY5&Of zc@`i5MlpZiXSKM#+UoXtzR3N^z3Cp)SEDRhZJxT8OSgA{J$COY<&Wf#@Zo*w+rs8E zKRair^kJOUx1QY$(=*G3T!rudlzm*dM>?dnUVn1A*(+Hq;?3vx3V?vWo_w;^{&b-B z`utL##5u0Dd}L?ASpvwfr&M_I)w2-iT#!__ah$-BYw&@v!NQdHoqrFeFBo_ z%6OOhOUG8@nXj53l7HO`TJE$3%K&$RrJwpwSoxwkE1nsqmI>0{>rrtjbZd5OYBFK* zwn5h8GUJNMQhbt5qn?E^5t_-J#Q=%xE0G`;j5n$Kj%%{l?d3$V_P#XM!Itv@-vZw* zrE`|ig2=C$3*}y>Pe|;r6`iv(edhJ3Mn<=Uuz`|?<~Nw@n3SHmpj&kMPixwhlR=rw;D#@_W2k@b zU`P$%Q$qVi*xq`Lqda}L>cS#OD^aRsJ~95)f>JkYpG^5KIA;E39YNMxAYZ)zz@{XY&NLs*Ox$>H*l+9Uye737z4SNQU^ThySlcU7))Td|! z{+|B4mc{rr{zd-M8r(`;zRb0Tu_X-<9>G}oZk*M@_J+Vn-=u<=~A9Pc~SGI zv|h+zdrf!Ksx+G!%4eq(->##OwrYzumxn^MuNf@^?vKlC>igeP+qR0DzVP2DD<1i+ z3>CY8It#mC^}_^5j=}BwCZD*lZMR99F<)B9$+RuH)B4{crk*%%;op6gzkDfF--TI5 z4X7Aw^v`EWt|UL@0QC%ac~6{QMNZ~DJc!rw8ONKHZm+|RX)~H{?Z4+($`0^E|jP@JN3-x&{Dz@M&RVR;>`%aGv5euQL?f@33hQ6V#u{j_#jvWH_p zqYPJ$xG!vi1<6o^DBv0sCn{Jr04~O8jP$R<*nl*>SpIVXy{i+OhS~ z#P({5Vcy1&MC)gej3pD z;2=59bnNj!=AM59E%}5z}M3#%ko#x#>tgoO;|}h z|Kj8;68|a*_d`x9AWkv;TH~~`gPHw!qWDPd%hI6fFC_&beKPlvx3Y$TxSM&guo08j zr(h+ciC_{Q_|HGYVAbeszaawnLK?lYat+)y&IcV+I%$@;FP;OAfX(&#y~~CVFx4|{ z+6GONRB1FraPn!`x1lx#`Aw@jRbe)XS!O)dAllm#k2g%Of-|DO20S(x#1Bx#HHu8J zeB(l4>J2DbvdL$$W;ta{+l@U`jHbz+PltFI<57;QHi#V0^q#RZVl}#{T~#Jb@&*{q z3~lqA!|_vu<4t1H1eQ#x%%`BG_X3hf@8=Xe5{L1BB;ST7TSO;gBgJis+1+9J`ib&A ziAcUdWxfJCtF3J35+}idpUi9DUV2gsQ$8KzZAPib{D3|gVXPUtLgtQA;bVp8p?rMJ z@NgyN=};b7iK>q>i{4iBT;ZMDCr><&Cd05l%Jq;MY2g_>y4tPbs&tcZMqF|GF4VOO zX6z4>uKG~&nt`B9Z1Oel#s;0{2d`eit&vcD8gyNB#Nwoh?md?FbL(1N{+PAM6^J8JoH_0rMJ%wF%ZM_O5BcnlZKp-Vlz&IBX*_p1}mnP;MT$+4$Z7eaMeF`}1}6zwc@BsbAsMN_=Doo{xTCs$r)EPF+;I7!>4 zIhy?grWp41w0Z^atZXfBg6`RF>9UuFc50AOdusNWLOXZ#QH}H9u6VR4$+O@FTJHw>#C%b@ zG&{q7!0a$%W${|$B!{z-)Smqou{6yxv=ts(ZnSlr4z-*#YyG-`4cVz(W87V~4#{od zqO!+9PH#~&q}Atht9Y+#SDT39M|J)y_zqd?;AvD~+Uspx{EqrMQT(N2!&e$+BWC5& z$OrVA%_Ohr1LwkK&US+Q>HK68z3SfDIJAX7`11#(izRQ?bEoRF&E1B{9qf@0DV#-@ zlzHR%c2g*96=NQYohQfA=ciE5tO~{Nj>y_GP zt(b$I;Ref6S%kgm1WZoWhy6%xD$Bc9+3RxmRDxUEeWb1?Mu^q%^BUzAYs{r|6`wm> zaRSu%Z9!AXeyCx})yxF5SwXeKQmN>i0wSkxC zoMO_S0jVHnRB0@TA;og^K`d1CN)RPbG&BY6O$lt&(%Rq-65?V?YB#&6$Q}a9N^_Ov za3p+SVo3ea%D~D(O33Jx$*tGKC3P58&z~;USyk6t+p8AWPEV_xoX12y)JlHYmWNjC zSfttrY-lq#pfO&c@{R#=5kDzB*a(TW!A&C+VMU$MEV)rF|K5O{d1+U30{w&yaLw{Z zfDMR+^tT;fC9e(8dEYReq(+hU!?bcs;p-S*>m;mHj*|?~Z9krlmRXu_Ji9K_2lr!@ zZ#0`srPpb(U2XW!29QUB)QgUqKol7yg8!Nd>JWw(wbSJJXEuRGlLr+k>Iq}_!6LXx zftB1-COJiH6Wa_@doP!YHzDwtP4(U;Gv%n2oi}*lCcwPRJIO)HDf%dneH3Q7WFF7{ zl~vv;u%&e=n@%^3|A9|>>1AqpLvCFXdX(r7PLerWE7lMz+ToAlMo)T&vE2*H8HbZ8 zmp|G2b6KN>+@t*^JQ7Z^qKfSQAA4T`mB*5;iv@Q=a1S2b-66QUySsZ52<|Qc0t9!r zA9r_mcXtWApL5R4Idkva_ttys&RTQV3-zxq>#o}U_3oh_jR# zyD3PqgvsN~HJ6#VX-J8^W`|?WQ!#e+QmgmYkWb@`)5^%EhuYuc3e?w<>r?YFIrbReh6v(ZZ&bL(DM& zzp8HMW}%heG5rQB_nvsTG2pzhRz|ziO`CcbVwls^v~ARa{x(rSDkcfuHNkfn=5L%+ti*-X=XuFl|uZTp>L)n_>q{ z9~jqrIyty6=QbrqZw}ZSH(gXZF6}-{RbL3D+euq~#|oaRmiR&UAwe%(+-BEpmN_7q zlt{Nr(GYVD=Ian@t$qqVK*!PfP)YK}h3ssg*JsR@6Fx6ODy; zCl=^DY#P%Fpxlg4lGmMtcMn&PZL@snG|nw9m_TFq-3p5$iY)U$R5U?Zl@pl{8xx*P zqJIIq?-!&3!%xfHmGaRUePgMwQ8guHa3DTZ$ujdEC8O1;g!rNzNaZjO0@%CWT5_izu?alxwkzm0fZCVaNfSVR;p@R@j_J%tg6}LK336g{>T_MUy#qj zj!>KWYVzUH;n5~8@eAX0%d{(xphRF?SR5{VG}ce2!H|$H&J~Na;9=*T3Yi_oI8rAm z%$TTHdge^`@YyN%PO)^p&^dsb>(ScW$*vmD%L`x3Q|kUGrJ~2^WpwPPnpw(bjNZL8 zYMq-I;i;H3W_6c?1qaT2>PHpq10uZZaS(*)&!T2wWM&~!^M(k_V(&EiMpj`<#v!f8 zWkz7|#^fva{73BC!*QJiRGoxeulQ*%#?YF_aJ+$*3`KPdoP5>$N$Zsglj(}E{M!`< z1>xhBkrEYqjq7nqax}8H3c?fOb%TrSSb8?FwL%Z+WoEc^RF31(Wuma-B@jvzb-xf8 zU%da~P@DYT8SZdZiqxhpJn4gJVk$j4+vdBakVQMLlPI(y=B2Mq+gFTuw+4_Wol;AY z>JArfAV>y?_#K^Y5RMFyh@1=rkqnTLhM?(fg51F(Zm^+Pp?O$=rsWW$1O29y3G42F zPupsrG0ss7&lq*ui_|E|GiT2sRT%Is%iq}=;H`9ckkO;yY#UX>ywZ2|s8_mKt$ID@ zKHpZLHEsR4BI51ny@O~vr@UEX@`|7<$9OC!(A@xO>6m4wFwO70gA}uSySl;U6=`?} z+Ivpo6N5Gl^Ylgc9LJ}ZfIXP+976`>y=6aH($L!(6TBH?s!6rT{o+wbt3G&E14CAQ zMUzS_1Xj~`n&qUL6)cP8G>a8HT;(KH^TBERS*aXH9i>M-Cr9mCI~C-f6>N`Z#5zMQ zN4?LuZIW)3P>dOGaJ$-ZI|LE8=@ECKb$SLlVnlGeso7Hu-AKzerf~-?-Dt`-**)0P zyRRm;AQH;scy&gDud2d8A=O93;TeXYRjR(k13t4kFy@_+$!re;zSdo^u8eTGk>{P$ zt_*tu{T4Yuo^DF5jH-VdhPor%JtN{B5@S!iyrXz&zxN7z+1k`eX#ln_bVP_S=ToraMr+EwQJh3_CWyZG4}e(fc>I4g|NClK5+?PbpCD zL4o%Ok!KXG+pbUPy?5Y|mtxOd8SYntQKpBjTdXfYs!a=4d-_{cy4vMktT@oCP=^;iP0EI z;3|o6DoLOmh%p>UkbHXR`a-?>B6a0K-kjsWX3~dzrwGYpm-zl(B9qxi3@c8ABTnp% zk}#=~D7umei;@_^lrYVdDBhF^&y*NAvoHy>C>pZ}6SEjxwJ>$HC{DEqSG5?FlQ6lH zD29^=o0AyQl`!3vC;`yM%vCQ4d>0{n4>Ei=J$x?#=I3b4uj8106_|nNNuPp~{QHx> z6eI=gC!sJRG704xs`SARAtr}&5J}Rr8DZ_{^S;v~dZ*8jphuaY&!M76s-n*_qenBN z&%>%m!m7_yt4Cd{&*h>=?xN53+=c)2wRtY^C;O*Xd*nbnOyE7xYllm2hni=HZF+_@ zvVl9Y2}ZktO1lYLx`AD~32C$O&Sn$wxm$aw)0?|Zh`Ym(yIqmH(-F`n3Fxo{v}*!7 zJ-yn*ygE$1+I{arZ0{ln;Po-T{4j%rAGCuXg%0cc7&b%^HeePuf*IDY7B-xL8EB6c zd7k_UCOIfL*#$$@;A7(2$i zJG*5c+P*x6e^pBoQH$$V`$no3lcSc>S_MB?i91*YMqPe6Is;uOk?_11h;AY@P#lo+G5G!#h()#9ascT}Mz1 z2NVoPm_!GxM8`L(4(O_m2(u1&vyR|w4rpwSaCHtib&gQ34j8V13nsGpb~mrL1Ao2? z;sr9&C3NHkX5=M=?8RHzOZb;{^>m>1=rs|Y4P%{kWt~mul{M*=4eOQlR=}VqU=+%$ zPt0qG+-tzpYXrlqU)5`v&1=xrYZU3JPxfhu?kQ6DK793FhzOP>D5jWSA6;f0T>u4L zJQ`g@9$k7IU5Ei)vOMXD7tmt|zCwr}6do8bft>}v|#*Z+ehcGUOFlqM_XfdHc9=n7AyT~593??OCJf)a2 zrO-U36f31bJ*9*rrN}*{?2Sggh(FAi;da7&Z@Ugx=2@YkymQ6S4yK-T69+mWmg)uS1PAhIs{kp8CUAMR~an_ zsV#?rLbyHjG>e}*IlpyseIenDA>j(i=1j@v3NYkMFnlEMwb$x(^dh$tBzG_%w^tx{ zbjY)l$aApBv)9OT^f0v(HFYpCwO289blJ6&*>$klJs*AUc266<|5*fA|J~P-2*U*h z!?QXq9AGRIFeeF^8U!p+115?9 z3zmSHL%<3SU_2EtuL+o51T1p_CYu0@z8;Y;7doexJ_Kj0yn8~tMQGX%XAM$Cec_cIf? zA{0et3PSHf^nu-gu=jHlcp?;tqW}2zJz@-mxSx^01))e3<45!#h!YUzeog`pghEm0 zzDlaDUXvy`Klo2*?G+}PZ*`pLIn8m}-V>P%GJXF+^L;LaX5*tk?Pq>Xv%$R|o~P|c z>0{!OnKVv7>#r-G-j&;G56|bz&8J1COC2!PY5zy=P{u70EPK+iDS;47j7L_=B5n+~jt|%5rbwoCWU_0)+`(1sspOY$(+4=d4Z43Dopj?IT}$Q;HFX3XU2ouy+`Rhu@6v6QXX03v2DAy@joYISvMb>wLEq`EQLu9pD9>n;&j`kUO? zPS=~YM$iF~ueO`|0`KTmFHm>~l)b`=8Ui9OVR-v%w0iUIm^0R^ydp*~-?a24-ZAQ~ z7kP!3T_Uvf*WIzMt~Yr_o?e3c^hMq=@U7=Pg=JjA`Sh3Fv9zw&Jw>cuLOu6o+%fsC zmpz5IULrmBx8AY6thYYNdRM1E6lOdW2_uun7fPYT7YQC(exj=R%sM5ypq6T;Xq`J; z^R;$LWkF-nOw&5=xW>`4&9u*gE|ggmq-9XR0YBak zKj$FCX?^V6PG|oJrT73#e^IJJ`9hU&3lx$K@R^<~rW2$k5B=`5A-X?DEq zbBoCePMKcIFJu-m@HN!A^-|6hnLj>AtK=yh#L$Q>rx2@}8^=v6Nl!Xmn+2F0K&0iz zGD}uDSIUeRq+~awh=N-bQ6;uJaq1!|^6p`ThXv9j|}m}Ws-rtoJ% z{jN$ZCIvLuSa`RW6qnB9j4L0x)CvV4%Nk!z)2xe1&pPwtU~fxJ_M=8DNw$zYIh2-j zv$4}nf_w%Ycma2Qiz}b<(rv2Dc4jfJ87;cn@>*~CPfUbnhNBfs1RwZCwh`9GG^ZZt z##k~OIBoW?70eHY_7`&FNka=Tox?6UVOF^vFx1TV9NK)QincO!Y^Jdplh>K^d}%j4 zwulX}hz*kyIHZ#}Io++?v4PJt4ar6hOy<|7G1sOO8hgZ=ds)+`#HoQXDzl!@5|s_B zAu}(B6gVnYG*XP3^~=3q3%|YF*c1YgubEwXev1yQtkqLs3aJKg?6}D~3jFBIBK^Qf zM09GOVbRmL5RY^e9YSbs!*TjqOycK>qvU-LkAlw7QSiqlM(xw^s2g@i8#i{sBmR>C zz<5JvChP$0WZ(8#^Z6W^Ik|Cn)qb2I`L}}HR7MYg@@au99*Lq3-U%7XyKDVu*wDuE zJ^0Xo^776s$`4EBmOL_K>nSFt-EqaqBh9>*g&&TcjAD3JN^A!&$&7O+V+Xk$HC+bE zo9oQQTQU`xOuwhHZj$b+Ii$#MurKG{rVJTrFNQJgvva@^-?z|k?K&B+I1JvX0936; zf;C>qsxQXqEXW^{Yj0<}?Hz9tRJuL1Mir@5SeHIbRDhNs?)80|d1wBE2J1uJR~fZt zC;pQ7n@ZylO=r<)QAN;W*!*Qlpb61X!!L94Y~S~Ztts&-tPyUwLcY$BhPso`?0^4^ zA^;w}vnD0t$oMXQ0J}3huSB?_^5Q&K)2gC!KGnp{)z9p72~6lqmPKgpOXM-tp$x8S z$8Ho%D5y|vy05+LjT2wY+Iy#oOj*=iF85>-gEw4r?+lN|&JN3FsOHZ=YU-69lt`7u z5#YNqXK#a#Ak+!wkx|Nu&&oc)!TYMgzP#Q2f$0;no`>lJIe_($`Np0scuk-@V@ zuR>?m08#61D~+uFS6)`oVn=Et5xONk!+ja>teeIqH7TI3ijYr<~*n9=a5E$4+Z?a7X?EYgQ0 z6j-;mkoBn^e**yHQMuAd{SJ6+rePt+Bu6oVJMb7)*f zSR-*b4xgi8yredj6tjvL0vjLBDc+SKQ6b z;o;ggT{#^bpCuh+1=8@Ly?$`&=h(5Fe$ku8>F$)=kj4sryzyYv!-99q)!$chvvg~> zTjvGBqgF+TpJT*p-S{n%U6OL*Mk!E<8!e6%N9)F%3d|f)E5eX6Os#57&wCn5nEH#P zYmgXyB|Ft;W|V|*VePJY-FM%Fzn9JsP39#=*dwkn^;ztHSDZlExIOH59KE-`*l_16 zR^{HOYV!?n-pP7>f9)qs(|>ub@T}pO143;r8GYv1K^)_=PRdLspKiB!&xl|3QClm4 zi511RSHhY^8bB0+Vuv+QcsL!2r|sgGgn2qtIWsd9`l5!`fff>F7{wcly;^A2WN7V+1S!M zOc$c}gNpJweA82N8I~TI`>L)Y_Z>ofa9ict$oF8=(fgky28q+LVy|N{M$E+=u+S`s zEJru{2Lqmlfpg z*Oba(=w5YZDKTqSL3;|$n!>esuH?$axOY}{l}dfhnUilQXXZrhb#4eY+zA~qxwDDs z-B=144CfAmO863)S1{#*>J#!jD1Oz-zO^smYU;lmCG2zeT&le6POCxZ>uV+=wv~`! z!PFxiOgCYp6*d3C*w?Bo!fo_yVq~=HQszq>87M*(l`Ub0z5>BTTCYLOR0f6=;|LR* zd}9yGpyKe?jD-`*r|hHjI|iAzhrxRkoq@=>2W8T9V1qlCUqlyTmp+M6Wq!M1xn^!I zW!j`<8e{aoK^$8FU0C8zC1DO3L;aM1#Xj{VAwE;v%nSp2;p^-OSi)$xh_J@B?)LWg z8C}W)YK?{$orafuVS@O;)A+zhi3|DTekA3rKK^LA=uBd%=xE}G_i51$<@wY?cuR9|&-=Jw-F$VBG%&+#+W!K|8h%>(4Rm29Ux$U>GV8I{km zD`7^@t9#yBTdId!F=-b1XFMLM=izHNR@Pm+*8&g2vUlms%lmwEV*dN7jBdDC+0Gb3d4D+2> z`9_c!W^_kT??zBHy8#4=111AiL?4{NwMq`7T*2Gvv%5R3NjT|NiwEh+^xVW09rK0R zsYxaD%gtCJ=}2at86}oj!_mW$k6kNYD0vY)?Xp!h`708=LSxwEq0<=3!zC}7&B73N zwK}#}vA`EwJhFLjWw%((TjygY#a4MAPW)^Myl%(qkgS@^ny0;oogQ;kMQ7)HlX>A^?elA(g54J=D8WJ0)YQtO> z357WIj6gP z=`)FSQAP~&^XGUU?9vBGZP<4qPYO*YnKHL@`E+od9If;LnDae!XMj(b&!U5TX7@N= z&!8E<&2aZ20%oOAwtx;T>ZC*T%Njw}wu{*0{#uNzNo%_9R<6i90YNLCGpRO5Iz20i zo+tY)WW6Syu54^bO6m`ASQ?9hR5vtmb^uvc3Ts`)=vumhxvCHF7d(}vmN!N}RUd=Y z027j08fCV%F;MUE6ymPgg9RdE0Yz6P8i{X(eNdQj_i&Lm!=8%@2UX%#o2ZKjCo4Os z#nKY8Ppm^Ym)|;<;W}$XG}aLvIBD;~+gTHpKRH-tA%n3&M6~Y_MVJKHsOfN0QwMCT zl{!_l;@=`{Bvs|_0hQVvQ4{;%d~c5Zj5ZuWT%kyG}_jc)S&6l6HESW z6gJt=lfoZk=%B(1$gUo_+mD0RHA)IN!O;o6l~A0* z&mad{rmUv~#IsO+S&7f}o*dU-0WhDM4V&uB;D&wSPL5)ZB#ANoKFnr*TgobYY^`1Q zA~;zSe3OV1H>?BAVUD_0#5dIvf$kpHUz8gYG)*qt6>a+9U=DShQ-Dm8xn`Un@6DEab^7A?JcmnrrqOvDM%TD&U6-7_* zb@<@5Ki^)E&&)9OTas*B9GW8AXrHf+y6?doa>_H+_)FF+m}}PaA;Z{zAe4dVvexA< zmJhcf9Se?37RG>eQVgbz*|V^xB`!Lvm;!nUKS- zeE;>WJrsfcaQU|o#clZ<6CDLYnCKvWej>u&i`l&KX8w&G?zz<6@1A9oG`P&=G^+m5XRlRqd9nPsc|OVYgE+^N`x3tAR) zM93u7juQ?F2{MVWGY0t-wBHqAI?-nMKv)P5h2<-oKz8Y;Mq;h%*v5N(#O>ijA8m5d zO^;vHR`HU)-8gP-_+c5~+CbIKJ3IPFtbICgEpnlxa^2#!kW0)d-CEK$QkvL+%gdzg z~3b=ydwC{7m@O3P+29XTtnC|4^Hp_@6oPvOjlPg-))Bc$xZt;0y( zQ*_!SQrA+9ro~E!e1RMVUd9(WNYlF=Ay!cN`#$kp_+^E6jHOxFIU}b{p&lm?d8>`4 zS1nOUu+9Mk8RWVui!Wq(7x}}Jfe%-w$7P|!7;GN3^E1PTKl@AjGoDKpSmwy*k(olP zhEmK`eV22GkFVUg!&y6r#Fcn+y1%}!Z3r#IY5ob2x_NZ+4jT0Fx^KAeKpt*L=&foL zLpV_;*-1}J!@#+ACf6n18g;%045f}V#Shw~Zbl^>(ibC#kKOqdyEw5bDb8~h5^N9d zKLxvC#>EpiBq&**P+tdoYZjiUy&AQ zP2Oc9kG8cW^d9sQdDT#od&&a25#9s@k0iS`-;;@^|NE-zZ#7-80g~7yUvzxjU z3%Sq}V!DT2m~G*UFlnMy6k>>}#a6#7U6T>8Q^2a=8pB&Gr@k)}_t+T*XzF?u&-4mfKP_^4G4l((EnR-t++90ub3JoDbI$KvuUH?FcSGccN(UePyxZou zUSGWU^|TTnqXlmD>uHDUdefQq9j(`ER@qBhwI!t>lhfk+j(T$0OODTI(j=85JU4vz z#2t>M&EfjX2N|Su0F_1ZSj{|XfbYEVqj!Vv^24L^{d;`dvP83>()jeQ;RgGPp$nsA z(t8Q+8+=(`bJ^%gk;g-A4eO#8ZgS^Krxn$GAmgksf!tXIFfv8yK!aGxT~g>*D#-f6A%HJYC0y{rgBR?Ey8hJz> z3HYDv?Go!A&6Th^4ulp+UB9yS*)_{E7B_5egmg$*zr6Oz^VvUxddA3ulN%>DUOJ*| zU|t>fOkNc)cnj$2C)+l*HJmeqJ4mnpkVR{OS@pN=U|UZ;lXfHHMoWho^*8OPI;;CL zsAY6Nd|-d~ta2#%llA#Ogu{yUx#Hdc(<*$N(&6X%GrT)QFQ^vq)z84Iw8r%h+4Y7q zEjL{@@p=)oAgu9UY7vwov9;0t=kQ}C%0uW07`*-rBu~V@hlB9B7wEr-{Oi0E%+=pQE9Tz= zyIbs*?4q!b_P0D)WisA1qcca1q9b#ai$lPY@o;YzY&w_UYFv|3He~a8gpd3zoyE_0 zP_3idt&gRvyMC+6ezvUvMmvxWbnX?h1j1^?6WW!&+?u41N&qCKjm~4~G#Jr@x8~mI zr7vfHXFKwmWuOI!Um4Kh>bbUN5us%u;gq)k5xjx8%kW9rg`?`b3(!BaFUkvjdq zxiAeO?!ww7cwv%>IvUp|7ac?qWW-k&?R}02;hJ#r$Z!!Y z&ER-#E}Lv}u`Vi7_h`PeslRjP8u&PhlznB^SiI*Fhb7Aw_dJ5*0$|&7vz-ABMfVZlzv2 zvcIN)RU&1Z7?XIdd#+CgS(_M}5xQ4gJ`CgMq4vG2kz6f_F?g$kS6t6NQ$4PmaR;+N znZI-Td`q!ocX|4mzuAN}f4(f-x_KHH?!`5bpMaMmHmTej$+)>6IFUL_pskqE(8xL& z%#(BAsND5Vf;)E8G~fY{y03F*q5UrPlD#N)dXRVU(#rXH3}%Y{8l9@T#<@H-b3t|( zPV%1LEaPXwR7v;z;Q6ic`-q4mBFWi6DbAs9KeGoATQeeB%X~abFN#YqucF+sOnC8o z;I;W$p7uhDIphdZ1poFAb(I5TuC9Yl#Xm-jwVhk*MwudIjp9jf&7tAj;H}41atGiq zBgX#3o)`mtQ;Rb?v@qBntwEREqJZ3?RcfjdZ`bBaL7KYs`_Wdbx?Y^R0|?dIjWqUt z*2T@{TkfI0)CHvsT*0)+FOSLqd()!#sDxUM}5m0nA%vJqKLso7f@O^>`SjSs%6bUxCD2la)G zINGA!wI2wO^cRr2g=9WhrEVcT7S915N|t~GnxGe25hl8-Vf`gZI)Jij;Ih{vW3o@v zUCZ#nft@E{_~9IHc6QLK3d6Tvh&Oel2r7-50G3HIH4`}H1T@xsNz(ivs9c=-ZdCbo zKt&keE9UrwRv}RI!>w74t$n*}1IJ#McWb}SgirV9We&yJv>aZIJk+-P3O@M5k&80x zYUxHjCF`hrrR_6zlY=+U$I!SGfyq4v>LBU2g78EpZ!ESShG69|(z5Xnvfo)`6BW9Q zeKKuh%kO<1csDo>GI_DT;|AFu7Ckctbg~E9%iMVsxTK{qJ@>lYUyE7`%P%26zlSg* z921-_RL)U}Csx5P>s|5Q>vVIKlF!KpyUvs~bKNXgaXDVQMnx@Hg*)$11(J(Q=RoLg zhnA8#c0IgIy$~*zh-^P>xeLMNa$TzfzrqdzBZdun<%UnxnY7Y|S{<|$*)Gp#G%-y8 zqNG=|xE)KI>XYmPPZ;?Y_G%R6C0w7iX~=2AWy!e$2{cEWX0$a#9DR+&R&`EFXY$nJ z6Q|QGPDbX6`?-4oRVl-xWYW7jD(NO7ibYCAM;}ogkHO697!FWl0+AMHttsCZm$iW$ z`4Q!}Lx;74vO^%uokzAYn6+1nd~Ffb%`6*J-BXlR|H}I{O8Knl{5hvLgGR#CwR^VK zc36wi$k{Pb;Y+y9rDR>wl>2#FlR4S6)r$2kvtyY}?Y9-}W}T+l73WrUV>DM{4DF1{ zh!05pE9KO;eKx}dW8Ywhy`&Qkjb?R*n%3&HJlPianr>=HOly}v72OUPaAn(H0~+t+ zKKM>=SP!UBx}93P(4sF89Ih{iul8zY_$=9YKd>y^-=R6|DscFER`Dm?B8!-u4lOUv zTkOw;s`kcWf&W}jUtFE<-vv*BpECMR2F`+&-%lvrW48^Zb&e=R4+*8`;N3`JO3pT8 zQB1-3vmX6C@G4N759Co#@_>9PK)jr%Xa+-FC%&YUKZ;+k-X!+9Mnp&2u4he8tn^a( zxv&kqY~6)rd`6wpkPOjFu4ZrYw#f(NrX6`o529xcvs!N<>x-&00Nf55n;ukbNbGk& zsjtu@$}-tNJ1LgM@O5A+T56VEOfir@ZzAsSj13QzVWJa3|I0i#kR1^bICwI zw<1V9EVSOTUEnBsDj8C5*n=}S9wzuAMRk#|Czh9(D|($Gas7d>aJf}iF*|*0SKa+W zhzr|?S7U3wQP2G8UN0@f=+~MT|!su9|%&23)Oguj)GI@=gJncLbZ0e#&QGSbPsmh$qxwrXo&fxyJd z!SYYr`t8{N>$X_`Z0o;v{rUgu`ICk2pE~|z`?Jsg+VLj?2Rl8TqO*Y$5CytdC>VtP z>iE-289`2I7Tss?r0Ec;1#EDU(8@(Ocw4MfVoFWghKshHK&* z#%ZZZ6$XFNA0e1QVJRuq;i5ehBnw@4Lemj~XlTU?)xj>PhN)5qS4+e0CLZ|tX(LXn zBTcv8JV#txJx^RunV@qq+x6(#VFwdSH5Ayh`Ab6c^>uSh8y524B_#MatA{qb4|@c4 zD8h4(cUf03K7)9(DlXPJ6G#5U9}Rk`vd&5(?ArUN(rG9OhCm~r>nyG2Zt(nc)Elop zKVKCmvcmthFs|Ca!@~Qcdyg&_G%LiH^zs8|s?dXjxC;L$R3#w``YbL2MtLuy?reWQ z{4$MGm{L_RWr@sD0_ZyC`~g%!dj*A>NISnm)${v!yYRwdhXi(XjLgT*kls^e2?7%g zRpooCX$I5gJP{(9msITn$WD9SCHP-{N2%@4k65MM$fRpi9Z zo}&t%UER#RMLs*4_=p$S49Np5;t4VLP;xQ--2}=pzbeW1F+;19>DN+llR`%-5PjY5 zfF&ZXhGRo;gtx_cM!(EXvdJD-vp8Z+XINq7F&JQ^Vfne_r1b6myHLLmq39JVHxcU0 zqdhp*^;MZ!{V!2F-V0=0UNEA>SOY&+1+6IC>0?5fl2a?<*wa?9Z7!E{cI5V z4UTB?6qt$*oJuFx8W{j9)?wb z`ePI%=-fvYRGX~8r}}Z)n$O{7@6~)DXRtHDtuAaM0Cl%}Cx?%*-?wm~d)w0CbLZ)? z>eeN^Dxotx#}O^(`CN5=9#6-~$|#k#z0o*iqglWen?k5%NRflLZ--VA(gHgTtVu#b zPe5A7m18Kj+H)`z7#}#O{;K|H+q~7r7%*xTD3&Oo4EywKm;{p5>99qYgOPDmQI|>s zPO>Zp#rF}C^-|HQJN4d>uIG8q`(!ve4oB$oHsYY!a6pJ4S1yyrpiGz_J3C^5 zwKNPj1V@5{$7!5BMil_GX{|m#ja~q;Do%(|jS!Ir0K%43^WHid_^pod4#PtZavcbn zH|Pw657xj3@Pu)`b}TH|WaG89Oui#*DGsRIj}MbY0JHSngQkg%wi@_EXTh&fj0)c& z9C!n~DB7MBlLU?=s&w*oH|L;Oqst(RSO?0@Wd6_fFJvQk@GdH3=~2|@S1Zq zJcrB1pQ9E(dnP;81Ye;Lao`8QZq|{V#H^F@K}M{1yj}Y0IPTv(2REhQoT}Hp+SWAs zc^bZZ$I4X&_MM0RLK@dkdIZ?kXUqF)oj@mLj3o!K_Y2(8vr9J5(eRd-M&Ht9W4=`o zL!sfRxn?-O@uLssK%eP+I2EF@aWG;+icA*J6(6w&^k-;(>!3uVcjGqO_!XBSs{*-jeaQEr}-GdN7QtVs*p%_o`FbI)bi zyVrs(>(K8_^rN*Mo!rYp~llWR7_^k?S#PK^}HaBa_c zah%k>Mys#votko>Z0)vTHoIkgYb*XhXN&1y^s9M8s~8XriU>>RLERBH_TYMb6jHR5 zrlNj!4yF5A)nsSr=i?EFm$ScFX}q>=G%3L%A6wXMqxrdUFmml37z?$^<8*v5oWa?2 z)Hrr0rsT9o1j>)J|7A!gMipVp4te)QaSiQ**r)8 zN5_;)4SUobLmz4>>#qPG`x__ZEV2NEsy+>)pD@hcBTX1OY6{aVa;#%bs?__~msBch0lnw8tuS_xI`f zO;DCiWNn9wtqY~z<18o}WCAB!)Y^F3cxiZ7T*x?{#=2s+>dmVtT-)1flpbUZoWw6s ze_0-7W~YDur^_SuKbHi8=1z`s#tuTZ)^@fw#x_ob>~uo5R<;g`cKU|Kbi&3i=7z>% z4*KqNf2ThGBR?|iQ6~<52aHuw$gVpcQO900ds3(CkJ!G zKb(mZGB7bRGt>oL~dHDr}6_r)hHMMp14UO#`on75My?y-y z;}erp(=)Sk^9$=6n_JsEyLU|K?l%UFKGxc}T@_JXI%^a)441e1Qsl6ZyWI-cyBQSy|j|!i{4Sj||HU!)F8ld2YK6Q&v(P_Vc^fI1t zIpBZF6DfCq7k%n6TTI;gmN&J8OE~1#rFYC3Ayok&catV-tW5AOCCDl!g_M+8Lc%OA zZk&=bOF>ciM{cmVH0rP7Uzq&M6vBK{XMhTyhR0Q9KAyZgFZ-}`%pmeDuVLwOQn;w zM3Vko{twT!C$dxdPDqA`TgRG>P#R9Tu)lu45cqdMz$F)3rfey_5P8qcYgG4$D!R2^ z8gQ&@ls%P+zs{OklRmaNm5o2QC^O|TSRUqSxW&0!aKpf30D#}~eVNR-!=EjVofn1N za0#AC`=-B$b6UBaZEui1w{_Bg^o_F`ZHb)lQDBbU`J+(1^!PDf1BXN=;@a5l{)x0= zQ)cF}v|jtK-!BCIEf7!`MpBu*#<3d51lDi4tgn1{{`tE^TIh)Cum_@wpC-o=!>{iiz^eEQ&XjL8#+_h zWqLU{1PhgHROJ26vfx}uFVh)!1VRf&Tp^G*R%MDSKfVD@WFHn_6%f5#$$5bO=f$iI zlNX5=q=@5gdI`BikFgk}xD1aPGt3H>*Tj4z;ouYAVSV_(sHSFAUf!>-AJfrE`ZeHJ z@h?pN6$$}-Dy6dWz@K^)kwU|to7XNlCZd;UG7S1T0A*e-p}L3*bt3;T0i*C}`HglF zF=wtojKEVPU|aaEv|s|L>oY)I7h6!3fV{Vg;|eBc@Qke&suYN_*_x(5l0WQatz|(z zQg9%s*2zQcfm*oc%|qz*MFbB7?fkUfX1B&}hs%zL3-znue=HtQAFtU7_!jaM0}as( zZ%UAll_+DoJRGUO`a)zeZ z(ikbfTe21izf?_}aq+&0aW7b)y6}N!C-6n$-?jVSSitn8bvVi@nw_CZ$%&do4!dsXc_$054_w`_R>P%xSlBS9mJAi`ev5t5BD9~l`7X1o2{1K z6d5SfobrFXV-Q#{0&4N)QLFNiQfz|eo7pJAD95@6?qdyT2`*3E?s?i-g}A&rw!>=g zEGaa^rANfP>fq%Gt{vfesbITg)OAME4kJnbzC@U4S~OxUvR}o&F!@&~#6I2+nUm-} zPlW~MZiW*Qlbej1s{*Ry5%S|xOJoJr#cyaQau3gNA&-s$kJ{5~ITUleGw99oyljPT zSaZIwuNd$Ti_shD*%VD1cgvL!KOWgylpom3+Bm`)u*TrYz#NarS0#+MQ)Qs6;s%%UiQHXOqx4PV*C|hAigj5$@Z(IU&D3V`O&-j#4BEms@)~wo3%m5G zb)JF_PeuP<#lJB57byhuPgNUbOs7b(Sx=*!&L3X37F@FU1;AORuDRf*0{G?E&2E?T zsrHTMqvI}T<89YiZ`(-V>nD%R3`-V`8OlqZyxFtS;wPMe78PP4>5~OF^*`XWAJ845QHmAiV1g2PqOuuI8Uw0;%;!sK705L25Kn!-gXIt2?C*&BH! z2g^m>I#eD$WwYbDA?am>*FJsYG@7Hxe84Xq&s+t>oH&2zxpo%yKzVU)%W+l6*LN3g zzAFmTC}pttmHdUnf2$J6H%#z2<)=j-26Y`pDu>DR6}c~f0>3sq`#-(V{eP_YeVPBK z{3DJ(`A0&Ee~^rXq}3(q#0gFGtsIT%B>#vN>69GwZ5-|N9gJ-Z-G3t{(}_9QI@|q) zq0L55|7UZ8w$3(2jzD%dGaDNlkh%SP{GVChA~vraroXYkf&2Z&2LD^EP4^G1aHhX! z9X0%=`se&AAzNFA-y{c~&7acz6Up6x zTq`3@CkJO^!q?58vJx`=4ut}pqM5#txsB=Xl=goRi}6pf1O;u~G-;R^*;v_u{k_I) ze~JHA0c_sf%E{P)P87)PGX8`5_1h(QMd0;9D*TP&#m-JAtq;i4oXBfl z8^{oIv~_kcGs>nHVRCODFP*6WqswPDe&_CO@3g7q8YG)js6u)V8v_I z9~^a2TLI-8*n={~q zS4@GJ(@8m7o7>nrnmhfWsM7k5mj3|$U#t@RmHjURJQaN_Iw65q(*ty}a(}3atei9< z1D&G4Z&#U4@wK(r-d=lG`29}!JA!nE`oA6fPx$|A^nbBm@Y?I|H<+L_-Jjjk)3VcZ zaB#5yZ~F%BZ}SIN?;ra8`@#RT^S>B8_$PWKWo%;#Wc#tQF){t2L<~Uc9|sfbU$3l} zGK^ceDz?w4>qw2OL+o7l&lj!t32LYi0w^%;P84{OTpx`@1ci|;f@x+@s|$l54UaTw zgo3q^xtOXGQlqpyr&jcq7EfufojARBmUe;e!Mt}LM|pOCzFf8xP-YvPgH8~QXM2|Q z2-wx&g!S$H$lt2rxK#ihhos2M63YX6|F}4AfD4z5kag%)1evDewYOTTpPNef)a(4+ zNnFrMX()BrPv|pMVgm*HXSC9XLgR*_w5Yh0od_HU>DaFIae3%^6$s{&QTwVN`PD|V zZh3E(_B*p;3@me;2iM)W_&?(F0-c^g0d|6pBhI(t)Lgy0M0Be7-e04G(({j79SrW< zlonxrB1Gw6ic^ijmCgazTogJzSmEIW@&x_RYN0tzoBU!g7+35x*n9H9()>pF93V<@ zsTh5|$Ujh!Uf@~^fSOvlL3O|A!sbMOs-y_K$ZxZHfx)NmK+`$fA*aq{Ec{MY2sC%s z2F0TPrHARRBka|t+?gNWK^D+P5h&Og(1IYQG;$x8ZHS3kgkCkjWVIl)MmEC2hEVn9 zbfg#sCo%jw&_`Mj|EnjaCoF<>y1fYeJ4~K&xQw;3y>Q;WP@lWE8SA!tk)W7;o^xR( za}lR!JPvkm$?dW8q5`Yf{T$gNCF?(h)`wBwVLXQy-GR=Yla!t(8n)AHT|UQFpvq(V zv;Q!7-_n6?)y9_esle^?{2iEV1uoq=EQ8t?F}E;-rB0@ycCRG?vUlr_!W)*{0w2;l zLx?_hs>SL3FY4YpEXuCy8>UlAVn9MtK)O2w>29Q97^EAdQxv3QKqQouk`if#W@x05 zkQlnV!EaEnxS#ua-uFJP70+MWuUC)_Yx~?viAF zk?%Fajh@29U(pgMkiH_2Z)J+=60~o_weL{fZgadQ^t}T&d;h`<;k642v>btuD`Kd{ zQn?il{(%Mu|Ij9r2*`;(|B`Igb(5MXU-}svZ;^R3+{EHTH~{#xz8n8@hhK$y3CUIm ze}y3hiNMn=CK8UY4BI$al|tf^oE!HL)nOGMRxm3ai#*;2TXFY;%F=sDi*B z+l&ze)Xxncu{&z#7wzVAt*;H1AeH}!XoFD^C5W177u|OKpY?g zc7MP$@|3>B2Fp8+{Hd#NA6-r?yS)4yADX>bHwcbC86@fM_S{Hm63B`5uQnVsS;+9` zGX|j_1cBd1v(oZ>jeq6S)E;-MV-Bn`8Vr}k;(<1_Tula zo=VGvrnDBA6u-vLj`5#AMmQJ3iqI9bci_n3Iw*CH)#LeLTSD zM<2~mlg;^x4@o9QR7%=#1K$qdRz!+fpcikM)YP+spn?n9Q=!`wTlyQZLLR3~F?5ms z3%tHP%%}09o(amQ2};|Ka5?JQ9GCVJzHC35{H7LQ$x+wU3kkpJSaMIA(GQavR^`)G z(WYL}LY&K<$!=Pg4AZ8Us*rRiGN(=NN&xQ`P}eJ+t&59&czrC-r!&9_z%G1CHL7;} zGINAySbDMMNz zCvmB8A^x}le@bgnQ~3SRr&Zwu6|^y35sS3XqVSn5=w*rrABXq@^Jk2$%115BBln-P zhNEdwFkmnfbz&fQYSH54#V0A|Scfyo0IdZXMllq#0@dO0T`EP9W4WdEMYkg*`q<#u zqC#b_V%x&$qL@Ri+oIB<*A2bWWMIbKo;=r7nl601aGnnG`}aaGwtBhmaoq#6EZ1-w zmTGH_^KzL|rPLk16zvH}ltZ@uAj&q>{drq#ROgi_2OPNXFo9;sdA7VG&Q8!=&`Quo zP{yN>>QkPF_WK9w2zL>-xvQSU}&r=PZ#tg?MWlrG?N$Y&dSH9hir zEM{5@eY$szIZ0TPG;GxKGDcYA`I`^yRiU1mdY550w$ToU!tHA!^DY$WkvoECaUC&f z4Q@0Q5k08sOSPCZ)r5>@guQw6I9Yi*avvnI2i{7yNkZ|2J$8guMyK)%z@j!=QtfzS z3f2;rbW+L@}gwBz^k zM@Vzujc7}#pEd=7+fsqxtFuKH7pe4RplC;651>*jx|3EtKFz)SvEd2g0QA5W|Qh-QDlpvGUN>j)#kz6N@ zceCK5%vR%7RQ}fj2cNfJdc|ZA4Mon?+W7SbL|qx8?;1DNKIgJh5PZfzWN~pVmcQ0_ z=&2X}oh0g8xZ;t;>{ovnCmOT?=oSA7`&D2*Q<*FYxZ|75>Zit6SK0M1)cR<(D0H`4 zN(Az^+mT;L4qHkqdFcCdeVGs-sg^6zuyeP5Y%+5Wp zDUze7k4FYJFw~hz6d|AA!uEWgeW=IX zn|*yvK4r~chJ7fID24oC&r1I5hS__Ak6gW5C)Zv3ei+|+)KhTyT{EAZdl(^BF032* zdG4b3@F&rmaWAevLtFpmjx%4mDJGf)dWy~A%8#G_9m`1W+2Cq;{zC48G9xi5s~M6( z)jjJkPMkCS{GGZMTw81>mzSkJD<-0P7aG?)VWu2LM*0N?`U{hKjiT?u=XICP73dAt zZ;Q)MI~cF8uFKB9PS?L2)hkzg^iGS_w%Zz~Pw6uggN#jr432$qRHzKIfj7MRmKSMF zkKO}_bq@w(1{#ZbOutN4xu&@BWEOj2;*t0RU;M~~^j7YEtp4ISukGYTTjOz_+WNI( z@!g;?BYMLr?w3zm_Zw~o_X*VYW^)^Q`KGr0Mkc3T>|b~Huk>{F?qUkm0Vb_qrOa^m znG-5GR|aYF(v2<}SEMhM;TtoAHm~aLn@ZUWvRm;gDD1ryZBX6K9kpkvv?0~GrFgF! z)4{>4cj5Zt`e^t3^;}0Vd-KXdc??bFPO_Ai6OAYaVQjJaG>J#b}+Sm zCWkdAU1*IZ#(YfnhC*{Wx5r@LsXA@v{In|V23=zH#q-8%;1DB)pfz8@;T~$I$ zag_4+Jlqds7N|#U*#P}I``R-Fp5Y!=D`X!O4gi*hmR|=R$#}k6f*{d{1rxoZH^%mQ zCqnF6al^MusS(i9geYF)N?^pXpR?@R?~yg(m@~mzP|XNca7@$Uvr}JhF;)DOUc9EC%7D z1;OFQ4*n0I?gFNr7DLb)eHhP%hw{>Cv37 zttjfTVW~UjZtsID22B+@!Q=cd8aBb2w;f5D3_dXwKUL z>@5*Er7qv=(#~X(gP6+fUDXE^4xEqrf0$LOPFkX`4b?&TvWZy@Zti*TjgmxLRv)mS zJIIaR9I|F{%9}}^%c@#p<|pP%VU2DZ1Vs?}igAp9Ys(1z{Lvtu2LUf25n2UT*vLKV`oRl>RCz6lTM>f$%!ja z0}9ag6r6AGRT7@QUcTKcN9?ze2}G#G8NvC6lon>-ix0dG!i6=(S=?E-C!rgi*-Y_)8KYVW-}y3gpv2iKEa<_WF7kXAIR0A ztrJOzyHHw_>l0>@AEYDyn6QIzsrQeQ`rh+Qe_Nx~MH-+!Zw1~Ded15y0-*&it9{Ai zVE>GJNVCB?6z<0~vO4kP)rY?LddnD5jNVjagF)*ciA(&ohPXP(Cy(_eq*k$46dxtj z(H_aHcD4`ace3GZcXsX4izD2k`6Um=@_nEfz8vZ9CkVhj$EnqrM@vSw(YWm{8b>bp z#631L^i0S}a+YaT^;{JD78jUK9^lOL5e@KyhOw|zF4t7aTBVn3onPZSSMqt*tM(Qm zXEHA(-&^)*a4j8-_ruBHB7yA*5zqC#&TT&l(@kK074NI7Zeqjgf36S`$v2Z)4d7!P#E%*~o^~|ua%V+-p|0J<>|Bjowu3Qxmv|9LyN2XHM;56FW^VxoCY|GEP6V zY}oToc}6+&Gn?I{2}>bWcS;ia#!=W(O|QRpW~ki?n|I6?o9Fdc*m+$rC5G>q?hvbO zfr1OyPaWP#=X#rD6&yyZ(+dpQK-ER<~iyk_107MCsC2AB;nIcFR3QMDQ^g{Vpk)Y!gR&S#t zRX0XM&x5rjWoOW zmB6{2sW{EU0M%y3_!Qo?vTr#9Vq3lgtr3nxT0Ex#9)oo+W;T1?xnzh!uLD)P>I7$m zDsCwF14-(dnky`CHO^HpqZFKuJSGdi=VprBlxiqAY^qp|<*Huq>n`D)az*&x>n)PO z&Pe|_g8hk2KpW^&$gpx#M3%uHb5l&9YSnlp2HBcB!yQ;zw>cBzQrY7<&3w;k3X%T7 zwVHJHAYJl@h`au(=|v(;#fx0Ez4+E{Ha-CT{cEz>XR&5bGqMei4)GO5_nx!D3K4IJ z#-1Jb!}<51!K~KF?7mrzC2_+z^ep!J^*u?)r{d3t2I@So%{S4GQVG+!w(9z*+;2Q) zZ`Zl^jwk{pE)^y!U|)>)0*65viC5e5fwJxsfpg;I55xO$UU9z%7;~SL{!qmn;3`HB z$b1P2kXw=GJ6n0stmtaPav+k8{at}<@wMOc;Ik}c*muCW;e}X#fG_wQwVSMJblz9! z&3?qtC9nziptgDAE#~T|ro-184mU?}HABYd22@9xvd!Jkb4&B0V#F)A)?9}67Mf<* zMnM86sLI7CR$Ok@?^P$XeD(XDJN_`f<^#WQXW2ooMb506k6^fkosZ|lUh<&$*{!{2 z2>XsWc!77Y_iY_XoXYO3jyQ0c8$Dp6=^agnEdzhE%oWk8Gu8#-R$0ZfspQ3myPI7-$UNt<9?2h2XAnB77 zB5W$#%ld*T;_g5mt5?o!3Tyl9mojwWDE_ICE*vIEmNKT~6t28i6sbU&!=AP>_T~Mz zhUQN$R#Dm(rr=LAK6+8jG|&sDC4ipNKmfDG?6*r^QI?N|88Vd}z0WDHct{D|29Bh; zc16d0YPx)b-<=a%lwGPVdmay&rCr)2Z@InB)1t3)OZ*YL*Z@8DR;7c?(8o?4#BEpT zZJf@gZTkR>1757Kd2~-84a9C808bIDVpuuPTJUQJHbyHvloBCp2jiT2 z?LMuI@)8)y(6_4Rr2bE%R_&CJ6-Yi3@6}A9_-%FG3y~`DOscziZk}nD@lhX$)*m8z zPISY^Q5ISVoLzZq#(Tr}x-9gW!n{xIde=^v-XcQ5+~8isL&E0rnjhtRZ`jia$rI|X z!gDT!x$F~WLJccM;kvq|Vyb4x>4bb)r2*WL<2q!)=aMrhfS5n_*$ukWx<=U3ZWV55T(4T*lAFOtC6+i|aRa?4< zGyKz&rzaYp-d?HVn2eK<(|pcCbikm`-gP^eB4^ytjTG)dS98cRfqaafkr{a#K6+&N z=34SOrel7dasbTT6s@;8!_m5V=~%M25mR+Y#`Mxcu&&Zo^CC$haTnKa;*;SV#h|0{ zXGdvYH$y=u2Uv&t`#?um{mIJeFaD$TtL6Fp?$VDLUz?63cYZ1ssH&+dHFiQDn=@^& z^fca>T^%P+n=yPq-n(U>D>fED_sLkIJ^933dTOGv2qd=3D-gEhfTJ>C_h6a|*YII~ zmHg&%Kp~icoBWgZs^aI8xH0F;@GP*s|Rjk?m#PRwnzB4${*QO_YE(guyEYt-U8Wmd+dOWJCdrhHNrt1+5KF zk0a!0FKwG5!2V1umYLeUUSxy&X>U2rBvRR?HqD{P+~|Sy8Ga?rMWa+Ec@#aPVM{tc zu>WSxQ>8pT_(yZz-{NCGaRc6kz~tiQzP4y8kkx^78Re-{ryMT=K#{;1$3Pr|?`^a|auHZzg$=y(h@s25zQPz6+Yk{43AK z9>jfT(z`Q~Y5q+586Q(wUrt9_ndQ$iY(LBV%-3>v1-S#Q|FGTNwV?Ma3?~mKCx?Q& zxxEeWiQ{v75H&oSw>!u|mztmRm#y%Q^llKYHqP!&t{nQm$HvD6kF$BlmY>1S1vvi} z8T7xm*KrH|EjXuqgi-v=n|5maS9|_%>g+k*Y_v)}LCQn#?xdR97MILUEG_4<*p~So z@Z4gf4NLfa)Q>&EUM-K(MkVTbn3=8eS0N|5n0B!TFG-vRBTvvucs451^hO1q$lsqF zeOq4UCxG$kNr1YmvP($kFfJQ=m|rAG&XIt=U&baw_a#*u-sw6ak$SRO1zk?cqegzQ zkaSRSujcnW8<}^_gzvQ^r~0ov*t_nLK);ekMK@=CMUB3H43=g7Ium$t!rwPN=qI4D zj`NTm3rlLRnn#OTHnQ^-Ec5 z&_4ax(kW52{9L_e@f)36Z2UA&V9zXIH~i@Q`U@utHL=>k-=&YWBQo+IrSJc&D+Jfy zTp@lNS9t{axc{`8>#HdL5(gEKySb&gyZK*+R#7iuF9&CM&{lJ5F9&-^H(@U^TJyV* ztHSXA?~*xaseh8V+lkTsjKxZ=ucA&Z?c@rg7GmdO19HNx^a4Wc=7N^I0(?BI)ZCoh zJRF=n9Nau?oPxr9{K7l})W08EaV%<4S4%5l&8M=zTZ4ZSqqTN-cNXU0c=6%|`wJd+ zC)ej3TyVQI2PZcNH#Zxcg3Zm_(cRpO&C!kSu8LoE{2|rw82;3Eb(&i^dAN(w(!%qp ze^(B4b^Eh&M>qDL!(sZ=9-Lrow z4DzzE`biC^_?HsS)=utDZq`oD|6K0R?0;(tJ^}w+#LL|IpNLgd{>S7F4*$|GH+N0Y zUtIo|vHa11+nvwIpKcm(a=O2>!p&XA6VBRyV#YsLAma(wr~gugCGgMk&K|DzKPTA| z$N{nkIlxKpxX<-3eTK6{^G;>{Hxu|rv#vjBewBpJwy-Y9)eSBXVzk`soIgi!m#As} z0YQ;Lm!s%-ua);gOT? z`pd$@{a3oRxvTT9I)r%tO#SI*a@RpE2PY?YYq-q*z2TqEMXF9VZXivNrN>WX3pf+_ z{wytR?Ft9LfNw=lEI_Wm8rA%l^8cPM_4j;To9B-3l>&O=0Qa5w~8n{Md zCyzd&jYlZ7hZ?bU;)i^Y977H6SOyFy}9J-BJJQ&>z%r(x2VZ=HeCR;TOIu zEbw>gKNS8S^#4)qPOjQcPWFGOd-Xrm8nv_*AGL}(5I)s#HTOsNRaAtZIsrZIma)Q9 zF#AxP+v*WQ1h6xSl>0(oC+JEUEVHI;%ySw?9z4K7~x&2U!{_6TuxNv!b zEM?&<>*uEPQ_l+9{KJ4`Wu*E3rvsw?Ro?P{iJ89(JN+-SgX3;v{bOYEHg53KqW90F zU%Raq$mQ3!UtjHQevX(L-Yk4;5H|m#+gn`jQ&U%dEz&iHSJ z3UqSx1i8XB!@mv}?y?HsX5fyKaLr-`7YypZ*#+!y!=W0e^N(_a@^hh{@9&FIezWT zf7`!)5&Z442;atjrNJ+u;#lw!f82k?vHt0%&h$j z^Dq4K-yfv^-3oppxunC9TnI2wRZ(V<;Ycos1c*okNIyCdvk?#wQ4xPWzkkJoj)IDY zfeA-&!9u`BL_k9RmH8X*1qBru4IK#)0gm7T2YW$6L_$SEK|w-8!bC;HeGbQfK_Ngu zMY~VK^#q-eRs(~`+=V-sm`)1*Lj%oLOcDS+kHzrf0V#vD>wXB?BSu~=VCc()?9XlO zBUlgMKrp{hV17fu{6>KJjsNlo`pYlmmp^b{{(ya{{0;i@8}a22yq7=WUj77ofe#!R z3Ep26bWAjKbYu_$e1HVVG${AEo}g+F(we&jw-Ry3R}f2SCS+CaqtRKoX15KG97t=0 zB#thU&;#8=jQjfF2NNre?jp=Nj= z^F?BmUVE0U_rw((@rMq?`guJ?g`s4a`xgPJu}5tdV$K)e*rx0oM?|Nbq@~s(;K5>} zwi|*0^@_MqmR;eSidn^%q*d%!FHkK!V>f(Z;hJ%cr5o7DRh$%tRACE=7WJrfqm3lx zFe>)&84qYr41T3kgDIHO<(vCAnM8)c!lxy&BiYNDPeh}f^8{+=gg{p#vZBwz-h>8- zETOm2#%tZHj;EbnpK)X*pY=5Z)bZuFR%U`+wxb=x@ah0_L63=+!h`a8RX`X3S6m;% zd?e;jBwes$|DuoK$7(?~&EB0O?&ins{Shy)kAYwD`luvr&$xs+kczBBSPQ?@6H{`G z{Xh`)F=PokOead!m!)4gMz0VI57!J8=CDHmzmYF`<^|y2h-HvR*-Rfvv7=)lFb4+6 zqPVRnlP13nB(mJ4Ffxqo!%xIgZ+^#xNiILL>(W0ksWhB#eZHKyc^xB;XKHD(q~o?( zOBp*!RVHcDfo5(o|Guf>)V_FWd`hxk%&NQT;M8IAN%5i~b2)31F{8Gy=PemFTIXW|es-7_v*FXH^#rRiYU%v5oa zJnaKYf}FA^Id+8UVE2TkB$kuo`H8b~+3LGKSN0lyh&YZ(D5i)utF1Ji#)9EiOqLtV zS4P`%jcv7R(Ow9+b)v(?l_O>n?)}|4TZ8;@4;lwC3EdMFVvrRNJ3KtWkf-*97JqGy z;C}p#!va?{!j$-{PAdI6;>O8!#Uefg`(lOsjZvg4=2k3?Ptrv;uki;i#>6uyC&Wls zjbACan$!C-J|?BF%8h03QTzBjgpQUdsMn|OgUu6Gkp)H~C6teCxHFjL`F~pTtyZW97zW z>B0vYbODuYyYQWBf#!KZc-&&sAx85D$T2iNO+1E?Cg)q+7yi)~Up~dOnh-Bu!d|n# zYhrP{uK3E`XsV{{4l!*h3YjdYR24^3Tz;!OWN<`Sb?IHvae&3wCcx4IxPq-LozQp6 z9$j;7UeH}kF5mNl7~j`i$A0e%grm?g%g_fktGl~7PSb_N zV(njm{c6eNYqbWV4^A~3!CQk=X^{tm;=Ov6%^7_&Q{++pNoANu9iKKW>~Rjdbe797 z`7XbAokG7hB`qZ&$c^Eu+56)|z?%v!aBt@Mc`D*{h4%37x;3g-94Up2>KuD9p;(tv zmtY2!*p&-d`A8$fqlEH~Q;sfiHdDnNTnpIvmEc-V*l}L`Sn;>ut#G3$O+}*;`Wj#0 zl&RwRP>XqISuBk&W@%9_iRkUNJkmmLwC19htIKzt9wT77W7E0B&_j?3qgRf_hX#`y zE==sa5!t6m*ZNU@fF7Q5S4S_1uqj7WgIY0VP$M&I|Hu8)wfhK-reh~6ib~8CPFv7& zh{9v-0viO1wB1WsUXRM5NMBXrCZ$8nm|bIgj}*qN8skw%6!ucxaEsBr8Q={1v=kxf z^9s-~B!?m;E*A%rDL1C$BYI{N7gS#Hh<5on2=Qy8V}=B)Cxznj7k}Q0qR3bc`haT> z2Ct{|l`ZUk4F(e(LA{Hv2_iUYGA)!h2b=pZL+l#`)TJMOIuNnN&siV!>iPCW3Av|M zFmZ%P3~S#tRe)H#nNqA`_!G-+gy1K%K5U;LnrL*Xn3Yl@Ea_`0sj^!^V7Km&9+UVn?vfvN44%uc&$*PM`sCdQJF>rc4SsO#YH? z6O&Nw0~9i&`t+BKW0yt=0Gq=eh9J>ksIquF?Ed3(ga=Wd}N;s8Y^L~W^v>f_jGn)+!(4#~AOn3Xq zTCBSM%-L_UJ?8zwlL24E*z4XL8`VB}jZ}#!3MIX!7X6Sukdgj-L zInAnfv=yVgU0)sMm4N?%n}So*>k2lJS{bnu0&p`^qC(v}*e8r}HBLd4%1b6V{gXK8x|$qRt(zBI%h0Yl8)CqfAe zl1`prDXp?Egmfm|pg##V+E8ZJN-I<~Ch$s(GmH%Jsz&pc(*z~$hR8-0nAZgzf4ZSI z_uWk!sZ7=!l)n#|s%LNUT0_E*F|X7u&`tm{ewy-xGRWU6O_Z`!uLzPPj~=Q~cD-i{ zi7@HspW3c=MXiIjlq%`@So^hvR2g?`LH5~yyb_JNq|_WIFe=D-FWD z2Q6?UI2H|@>|MZ?Kt4#9KpO-%vnRFCmNIjHh7i=6!U%rK1Nz?Ourp9Fwuh)oY)T79 zxPWts0%gUbv6Ob{#AE1T%Zews-Lu>ZKmqGqS8PRhIi;-VF;-@uM0_&SO1c21@6{u8 zW*2IC$&9o)0#+BSIE6;8EF=S{_r-2&*Ev#JN}5zfS;pt`YS7cYu{Vq$4xuPmv-4DK zhniOLxpPBe=%mM}JuI^(aoX?IH=qzgGd418!x)SDCKrMU6peo&KyCtVn|&;Ce=U@bJuxlTcYOo`C5 zBULZq-HP)97XUc96EQWClQc&sGlq+9z8Cu7wTt{a8T#+AjaWVI#&=2P^=n?#7Lwx! zEd6{Mb(SE3JvVz#gB(;sfYm_ZCZu z@@q2n8z{>2nMwD97!%qdIhgOAKv8{~^VEgrJV{UdnlNYbB2CLLfo*zy(_QUjtV+{8 zr#}!>1yOy{3#?x@N64Wgk8_5bX}*k^fW=H1EHahf|2iW{dg9XrTRGgZiv+G5UZRFo z9A5Z5YNt@<0B}!|K+(27G%+vS^Wbh|*(r;agr5$!xu)&lVB2-2aw zdD0POPu!kl!JI4xO9Wo;t79>YGk%xTnrx~VIbbX*&<`qKy%{(-=D<|=;Lzu}Xyb2|ZoW8XW_69xAOl z0-B4{{lWgs^$OL=b_WsfTIv{Rct~b*@+t&miJlxbeae}ZGjxkFVr}Zrq$%V^#d6pS zme*1|sVOVEPItrJFh$U>L#7IXB*kRsK4leNc%=z$b+t-p+$&c{h0@QUzGC{UsH5Db zJF8EgnF68q3j4}zwC8MQ(&(}iKB>jBIYOi|(_{qv3MeF6z6f$WPM60De`^ejqjf+# zKXJdGxCz+l5;QL5=KSnlL+SF>h#j?*zu?j7)-klWbMwg-`hjl+v@eC7n1N^(At2{| z*iiyyYs`Ki@ehPoA{yXTei8vEKfgv((UuR64sF-iu)L+)=K^M39s8_4aCuYD(?|+Z zLO?x$rF_U^V>N6`Zi0&VJ}gCpUruhdSsiFd#KiW6xbqMNJF6$@XI+LysW|kC4^_oX z*|}9#LS8sXjC2IU?OL4S+QCirnVfF-s7)9IN-UD_eN3YijTB>Pl_bD)+!tmCJAUNK zq|$YKjpbVM2(L5pCrH++F%ZCr&W?SJuHJ9RfTAZ?u<@xE7C(k18Y{|*IHg~#PJN>> zPvAES(sx`snDsq@PM0C{c?`;dz6^w78%%D+J^--OpO?uz;8TBCJ=`Tc?vE~W(;TLN z2&*N%1klV7Z|doy1P@t3Ti7Fvl(P~8*?sVZgSOS!Tkqc%RQz@~tCsgN`SQq*3 z!`_ z##?Y1Jj~!}I*y7GVlT#cS<$<#PruDR69T47JnaaTAs{cyQ;3KT-K9WsXx)g>s|lrH zm^$>%`s(9_K%r=a_J)MB-m1rglVBYIyhwAKq@Nzu$fTW0wO0z*>7J{8 zSYqeqDoACJsq(2vX>O$BXuHS~enU8g$&$QUMteSppzM=ReU@ z)O$RP9?|abnC(h>c0p5$FCRmz-he#7E+4=y#m4Afhyb@8=7J zNQUH{&icl$4XN-b0=B(9zJ^V@tH#&MbyFhVdWD0Bx$Cd%tTe+5ejr4C^_SQ^gMLdX zuOC&f6tWVCkG_4qciN%q6Cd^RhC+Fn*;UR}*bF^KQcXiD7s<(d`n0JW^J&=<-qMXUolLpp-0qbvP0okNXv#OQ9=K5X5T-nCa_9D!28Q>2fj zP4n4fzbqP7Ukm-WMgaDTnv~DBvjnw--)~%c?$^InB5@{lN5?1WjpHz6Em@ju7F@7} zDA}Y0tV%b;q*RMK8wWEln(^!4be8#^w5*KeBYNn^ECMIXR>F+{W*jEQwQMcR@Lla( zN9&{Xptvc!5);tO8``(hlgHFGo6mrxZCPrkG0P!VajI|9UzYZo{!-yqa6fG6GQj~Q z^X)n6S7xc~L8MorZm~Ei)1^Dg{E=>F9iXob*sW5AMkgNs9#dzoS*9M9#8phv9|&k_2qvektd<3onuMCG;x3xi zhO<;`qbP6Gvo;t4mGtRp#Y3*|c2n#Th60gq;8v4#3MH`YD0Wd?uOrU31JF;(5KB@k zj6MO6mE<_aAv_W!Kgo!ZbHB&Gdigzs`mtpN?Q_;AOKTMDlSj$~#!pTmqG5*@4C$Z3 zH)bA6U3e?-7Ymq7K)*szy`P1IU@V+gi?fF9v+N!^btca_#K@ZxA0iC4IIQ0IAGC5d zIgG^!t80_H&127Lhgxdce1tpMeb8j(@WVYLEXpW(xw48@JuA8LShL6rnuxvp(Yaa# ze7IJ7w`rRs?~Fd=NCAm8RkU3M3fTJq`YvkMDB>Wda!6C>Jtn1y0H}9LWG#Zh)Q(?b^0b7gG|S4M?1{+@ znn^Rnu%iiu8?P!Y_y$RmoRVI&5d{ktW1GN_I{^GS z_vTPC)G{adG;iL1Cv0AX;y0N-C?V#z6R>whx}fKKTB9nmqz+(albIrH7!7$q1fu7t z`V@UY8_TT)(50VusSrPp*woGYO8Y5DOt1q#*LXQ8fWXXURp(HKK?a<>dLE}~1jw(; zH=L?qyDm3;h6TWnbCP?sOByrvjz|-N70VWcHhH=eixGBetu~hM`2O~jraDrh!s(0= zOJ~Is{tjF1J|;BPoUNGYMwXgnd`AGu)(JEce5|yRY=ILFgJ11Ij4v3%Mr-^$4YC>h zcrJn*$Q_&mS^ZErA{3V6WDyx7BcnX9!CkgVadCK5-=~gImrF%X6KiHDtJoEnV?K?= z`5(-3+!ub$;lWQXPaSg}hq}n}MRYOzUX%A+j1eHH^a~%2PIZU^j0&xH8{8G$FA2`l%R%{cSa{+m*jYSYYa!qekDNCPNGi!VcyhoRNSKbMKQJ5#a4(x zhe*1jliw5_%N}dXv8tT-`8Jo7E&V_yWOZF=T~6>U+r+)H`NxQ8)_t*1w3*{Cd(lZH zG}U5#1NP)oii7rokHsoril;eNTdOB;I(s%+#OEru%bw!sLD@uIia4+ou7EA$EetJk zw%b{8Nb=4Kbx7xj+VR-wuXs`8(lS3p0%vw>D=${U)X(?<{FLxFOKns2r@FjM3bPn> z$Yp{D?ra_%*%zU&8ayS&V`AQjsQDa{$^lYI$tNUp1K;?-vK@0Cp@e3gmEIc2D(=kN z#b3Y@K#H=)lVmj9MC`XW2cydD6yIXLDa2#wM&oQxp1~-Uv!?r`^eg2^@6mr(+m8Rb z#3PbJx&wDTt!1m!61ohLspv7);-@dOZuRUgX^eE+i8Yu1%12q8s^tr1ob&&IFdPe# zL0NC=3aZfvzp_UUsZr%CNfr{_fP77>G! z2g3aar_dOFW4?0Dys&(42Arw_6vIfv!VdEp=E~j7HfROe6#tgb6nTDq6e)L)z0hgM4; zf=;;;>%+I;dd#5faORlI0)K~xUk|=P#((G&d<+fqYwYcLynRoAD*8tMoFj`~TcfrT zU$<*5{}Fb$DL+XA<%fNzU0nE9xzl4Jz#%3KYk?RoMMomVV4xRnik}~J0SdjHG)Tzp zh0Z#Z%9FM5;XimL#wLPzE*mN`;hk?&0%T)+z8r{a$w6I>D7<${x^DnwBVut>Ajtn>u3 zH7WXeDFT1kzIk{L8fUz~RtT)sf(WBbLp& z<<~XaOY$04;4TKA=+da%*;o8q5r|=@g@CsfA+j#63Hqoc%}oc>3u(Uh=hHcp%t_5! z$W10XRPE21l@?hqQZ;Ib>N8(brF4)*EVrG zk{8`MtTe(uy%ge~{yCG(Tkz`fIq@#{V6V0ZMY^k098t3~IXmunorTC1FdV#j@E}A1 zaN-UTrEv$CUk*ScW7tkR9F3(6aYRIr*qoa{EXf@@qkhX*E0Q$BB>7rbf%ToG60-7rJIUy#ydI{bg^<^nK zj%N^BT0kF+{3sUCx0l)_hNRcG{k#Su+}mhMDJQt&6Cc{s!Ll;fj03+m`@!FeV1U<6 zp3vosqv>_}pqxSbzSfh;ldcQvg}JiILlap#QkQG#W+(-84r9j}(8$#UT4`{XV-&!V zk!}OcWhhlliVGueJ-^-PuA%TUtrEKL60{l-P4q@3O^>_Gm8^E8Mah$9vztJiId!lk z&!DM#&r(eJz$Kq1KV2<}7H{_zt72eC&BEFM-|{>S29l9qiJzY%)uTEmXkuDOl|h7Y zOs!rf804e%3Q&c;uIR`rj@n8s)f4gD7la7k(^xYSx15?XLLQ}BHhpe7WT1do`{_o) z-hY^#r|pzQaX%{p;j+x$%ce|5W_~R!Dc%BI-O0~;xb$-#S^<8Ep2H9+EJxGI7?{?- z?l1s1)CsW~uO^kq%O4li33TAv9usBdJ%3D8G&55wI1Jy&8C;3HUo9NO@EIdD)i+UDu88@X0Pz<-N~^NmgiaHg;Qcb zR&2Y7NJXW}Cre*RhmK68y0BCZ5~G;8Osr9n^d1w{v5dW>6whg@Ah6iuJ{>oVYw8T9 zHl?zJzkMO>eX*}5$WU~DLw>dJaf`{kri&mJ?Mg3Zfcdn5hlbrO`S+>w=t+cLQwADp zql4CR!Ei7u1I=kruN-ACgqB8$rAnuoKEZpN>!EBDp2_6Nh>!eQO|>Y$@tSJVLab7G zwIF!fuFxXvO(r5##Yl+pS*ENZL382NJ@;CLr@6syt;;jt&*M0-_M!PlzMjzXM$>zF z`tzS^NzXBi66%bTJJO6S^o@GgU;5Oz?8G9N0_YPW6CZrJx~X81TGiv=l%)F{N%Ey) z;+Y8{_VO2kEJ;#FmaB@d`E?sKuF5?*bqHLP2b0n)i3ax-_#W)oNqp~`g;j)UP-wGP zU2Leo8R*0J5`dy(HIOE)*3}zN38FVm|3GLU@L^?^d1l;YgG8H3VX``V1si?^-cv@) zlXPPpG&rR)>L+qGB0qTLUhs;+!xoT6OyRSJ8uD4V>jl@N$<|c-x-9B<`t9DU+yocc zzEkP$vV9SeAN@X4A8mj#a;HuAgJ;s=M|>?r55=g6VZ{R89SSaoWT_ojg%-6^(1Tti zKGPqg0<1N@GHwl1hWY&I4d9@v?=yL{jOeu{XX0=RZXoJ0O=_+M>Q`*|Hi;QFBkQ=B zecKoo@8El6K0|5W#LkVvUJ$kIiQsQkwg<&7skG2z*2f94T+eTxr{eS49UsZacv~ck z0Qzj?ehSTVX9R7x6IrZZr6chN$0ENuu0n-+i>7>@GK>t+-z1{{fxvwm#Xd6FN?wQ# z5od5kEh}0FiVQSks81aekG^K_+`-p2XraOs+<$9=_WGP1mxQ(iu^eURHd!2<`?!WZ zqqsv|Xja)=$;~NWY=Fc>%RD07nEr|Ta+tx`w2eZ)o(LX;x1}_QL?(>0yiA_#gy(NnN0?&eWvw*%>2*re|i%8uhtDf9GBaU@r!1CpQ^NoBUY`Adj?z@&n;L zK}U83jSBB4!IGkn-mH?#Glh(Kkck$ZK@H60dsgmAZf|HU408-!&@UxD+qhRicJ}o> zU^My$LQ+aKP5+AhLhMl$0R;@iuA4BDMF+nZsdCucAkW>@7f6mcbucRBG6o?TdRK3t zPyVQD^=Cr@!NQmKiCzhQm;7$Zd>$<3jQvKC7d+NU@8XE1HkRhmVHP%qU)Raq0Wsc& zZpA8rd^1@aME5wcR6e=X-%c&_0|wo5^VMi1Fe!p99PuWpHfsm4VY)Txv;cbSWJ;lp z*hsy$?A_1Z9Xr%l>2h)G%ivuS+U=pynXMSCb@qf^7K;hSbJ#>_N>FSs$u;c{1V49( zalEvA?wr@wUMyT6c}5Y^l$Te)2;v~&N@lUn8?M6lobBN+pRx--6V%LF++Sg3(CFNt zcg5(y)eNe~ke)KErZXuG$*?RJYp~#M!Y(BEFe`jaM^L6WN;=KT=I4WT;l|}tKRuPi zfpy-X7wHz868TliVEG^x(D5!29;!Ipd+j4=OQ5? z*^8i&dv{;BcbJSmx=183WFwO4js2_qy;XfCiI)~S6ul>+166U}Xy+TnZ8_t3_eG|R z%IjKpFaY@X5$PW{vQX0u zit(lSyq%u?&TD9k)znFbLVt;oSvt#~7@Mrhx=U^$#H)k-etkb-NMmN&|3}eTMm72O zad>nLl?Ew^(J?@2P(Xn(x_dNAH%dwk$&sVwPnXn?mafsFARvtH?hp{4J#Tlv**W() zzxaNx>vNyDD4EpU+y{dGW_Qp{h^-ZYv`24(M7`T2mnYcztq!x0v_Y7!f6x}44t5-YD?8OvTC zuTN+Nh8vI-F??R*)Or@VB3hyuSuSyFJFutKvvu<)sH^>#qJZbxnUMn5ig*a6=PIeZ z(b=dCW@&DV?o0i!Z`bTIK!=5T+;NB$`pf2h{Tz^yEEqVjTGAC13>=2NbeM(R+|rHC zt4*QM-C(2hQSY8@mfk->Mx_3-e?2$AMp>Y1$$0qLUDq-b_Giin?7Q3bP}s&^_ph@B zhq4znJslK+vOZ& z#>20vNI*zM>xKmn=HNk~v$djn>7Px4kF>w8`>UN+2dS(wtFKN&!soa_<@TJ<8zRH6 z7lw5P<#u{k+H1SS`~hBWi$rF&ed;wD5ST{DKY($X&ApG@x_?*K^~VrY$(W(ALSla;9Jq?WCd8%1P*5Y&L$l_jre74Jt`Cv`qeq z-NMMFvkzWUW>lV=4h)21FSv?HZAQp107@bl_z=5BWEF6VxhZg@Gldv`Zdg^eBxy45 zPpYK6KO-ceUVY;PO4T2H{nUj<<3MDxv_*{WSCs?cOMn)u={0&V`&_oB!dU4VyrDvW zUW7bW1%_|2)#w^@)g2;kC1Ip-8ROsZY_VzYevGtOUtSJZHQ8tfp7#)UDYyL#nJ*yJ z7NJ~$Uy=sA^;J6Oi_H)GybflWF-Ix1EiIQopWeNO)u)zE+Q_%^hvo*vv1Dvh5keECS2=aB%)$kO{CI1aEW2L`4**I|C0&ZY{OzsV(_z)qe`m4RK2pXj!!#Oe#Y z(=?s>T2~XAuDND5R>qPdk*8bne8#uk_m(cfz(U1`sIL>a#-H`$!sSj+fs^l5J6+#I zyY4LvqZQ(E_is&ywpe9D59v4-Sfa{fi1Zh@JksDr9G7+ zKB(7h8Wft)&kwHT-NY%D#sGV}?Rmm2?qaZcm!Vv4Tdn9;^ZaOA{c!NCB8g(xEJBqH zN>=NtIo?pdNX~wU37eTakp;h|BhDjdzCw^R4veFIBLS@79S8jq`>NdRV;H7Sd%oZ3<_r`hl~ z!D~q_%s)WRGojD~S>2{w6eyLwAt-DBH3TfY6#I$%$j>Q}`YgSyOl}ZRGrdf@X(Rew znx}cRFEuduG5>eNO7FHq6RJ@vf0fx8bg2{}bs|-1MZ)?AlJjE5CaSOYVRuXvm9!id zy8dHnj_Rv!RrG0sSG$Qy2Zh*qdW-#~nrwzK#6}}bqDitG^JU&aBl&R{Fb@^Yn)8qGBqFk;O}T1Xu| zdoJ$F3ZTYjLUmF+x&E~~1e2N9tnM0#;!TpU1{1+j6?;+_zlTX$^kd30$H*08n6P+IPi)}f3f+oDpaPpPEwAzo+_>!m+y4=GUJBy>4v?xf+A)sw(m5lNE7Vw=hOfs@2C|oboQ=< zSc1w%WLDECD%0XW-m)aX=v2pHqB1LdTbU|g6Ci_qKSx^TRJ;6$1m*pPQ;lO>nz!PA z=fu<5wcY#v@`kH-8n#=t_#S`t5PvX!p|6Z`q9|Sl(A@g+hO-f`>eGuM$Uq0z zKw2GhfF

&)ILNS1jePC!mN+D?t15GH~x#81v4pOBV_P7tn1k6@FAF?G0aoYXn7~Gm5JZj!ggswuopgNsK@ArqgTu5}L z>@>tHq%k;NB+Ms`J3s8&cxAsa`gRYz=g$wsn+!f(1@5ZaCC#ryB)&HK*%n3E|DQ{c zX(#ezh~}!|0z3LH0bmwYFf2D`bfe!Sn`zg}(McW1{%K>=t1j%q+N*1s%~%}-oowgi z%n&B+x1=I<5=!PWA8M(u4RKFY61!F<3D8e(9J)s_W&!Iqs^kXl$mA7Mj1+hq;Z@l4 zN=fh%k@NbFF7)cSWe&LB`|F~{m31M|jK$tOyfsFi$@bt&7L3I#^us!36qp2N(gRw4 zW^aj`IxKoR{*ZTbp=Um#rN_rtf#?3QiPP3vd9ASV?WxdW_hgHXSu>%7tB_U9EIFw(XXjfq%kC⁢gS>`hMLR;XcG7!@R5k|>e+oneecS&`OhyN^0apf8)N~B8!gBI`}85(R_)@Wj#hL(!3hDc zX{1tHg>IAUY>R-F1X{S5kTNxMxJ~PqXgceO5cYQAqua4ddU|e0G*|cceVOG#xP3R{)lc=Fs3o)NHrvh^FTNU&E%hqD7LJmbW_6!;BO3;6 z!HKWl1%nu$KX#ASq!$|GqwFhB;c(7CZDF}UmN@<{s3oJ$7fMWF9Hpk*g~4$NC*?Lz zPu$Qq0HzEZE`FCc3Vu=g+navagd$6Yu={j^oBB$dp+aUhi@rR5c#DPLc#87EgE|;g z^J8ZCoHQ&=negXq6Gr7nG;*h0L5*`9WX};p+*W}*E4iUV;OA5-G4{E;KCa;MS@~hi zf;uDHqA8_H1ywu3o)sg$Fu&*tR>o!0A4?JR(5QzHt+CGCT|5|PqP&0BOxt7nyUB4R zTI==)+1Vgd5_+Vjp(9nB`h+XXsqpVkZ#72L)K3ou)>B--@Cnx+-6N(&V~k-ed4!UJ z7ByU7tm~}3vAfn3Y+KDX**rz7bg|9`IMX$1kvrfB&6qt#kTI$?g==*%0SGA6FPFD}l(RD53zv0>BG>zU!V*B`;+x741 zq*I)*bd9@+Kkgtj^Upqd8xg_gu|1yhu98NgBb3Z#?1|Z(ZMkp@K1hs41eFx3ATOTs zft!-hbzCKrYvf>I3vhwww-WJDyYb|;qhkEDhO;oTIMwsFvuIxPu?ysl5Uv{85Ur)~ zTzR|QrS)N=d;ONKi9?L>bBLi4-p_z1r63#+b4nhk%>T5suedN~9jN(FBCs#nFWMRV zyqLlTcO`efd`kP#sMMP@kV&4={7fB^k84!0>7E>{X6*+$4Vk$=J=>wkf1@FlTCE*P zAOMZvV1ajbrPJE*ZEDnAc)yEvOhs#LHo(FG1S;xWyPHzfUM0elLQ^g0-Uw;?Bc*@8 zUa7F`rz2*Z@myR6tX81soWdxh#cv)Ggc#dli`I1WDw>JGX1A6rBYXvm-|@+`-p=H& z{3MZ64XJajV|qSzEWs1f@KyGKV88Rs`ur~ZMCbSD-`2s;J?K2!7)9JgEN{&IO0LgX z#4zrC`@|XZq$89GHn%}ipYhG$D620owwT;>dx1q#@iLO-v~q7JvbA&Ny5+%m%iibB zP0bUcG{t5;8=hFSI^^X|@RI#MW%_2RTzCVX7erJLiVGu6yL!g;H@kW4U zK!iUAOM2_@^D^#iwC%~>Sat-y%gZWsdu0(qT!(6s%Q`V{pK!e$uHh`+^;$c|>{r1Y7X=Ps(U1|( z*m^0CM&4e4XNd6J%-D2E1Azp9;vrdfF|wJ}81ONVT<)Yw(5^&pprh$=F-zu}ksTM) z1TTj~JoZ*a+tD=@Gk4;vXh38a`=aH{1me|B>F!>(9aG}5q$*^73aV37FnKxx$6M&y zMpQ0o*{mhw4rQp(`!bKj`7}{VmI=ZP6=*m2ZG=R|!1i7>)$*Y{nCAOe=FpjugbAJ9 zm2)Ci*u&L+OfOT6h8HM$l|s;lgmq0`d5;LM-Y+In7m~3DuDj}#noqW5FL9UwEk0Y;2Raf2s_CiXsJ6sPDI3Q#F{*zZLATQdSQ+n3qd8spq&Tq zLa|Z?ni*#hv z(V_c$|L`KTRVqBODgxx9V6NG1E;Oft?gz=d(P3gK-LP(drG)XbAiqxd_^$g~T2z;M zF#nGEqEcux2D`vmg4c-wnBc@tX*k21QMV2e!RNpfO2ynG-U)87PH*hC@C)t zAmPFr1p|^&vh?hNSB7Y}mEPr_J<4tHhS#Zo1?iHA$^7z~uaCnlbfKTCM(sLiI5?c< zH$py~&`fiwk0h4~QM?zCjW~>N7Cp;SjZp;R*MWjPe^j=TMK;<}ltga^m_2hq zPP%|x zYZqTro?4p4;-sRjkR=zZ@Zc&fbuZl2K|Mhm*>72!KXQov7<_Qx|;pR5(y!@A*v(frVieAvk@JC*kzHk*ynU%1> za+{M>2Svy*A^Uip>()J)-vF~J2|~NXfb=lXJPtP7e*#C27nM^SC-iLi($*a(D!`~e zzlo=3Oe0D?(3Iv3A}jG=#ps)V#T6pBxm}O&odfointV@_1L2KVPd$U4(V-aMjMPib zr=t$PGhv+uK<8BNghPVqPUq*o=8#t*FTFE*zKoQjvqb`dIaI@S$B1a;1(;=-Jvbu2eY z;?(wjn4j)kV|OvMa#e!ZiCw7f>r5>+JC=NcFTxe|Ip5Dll z(lumEq5xe`-{zgdH!>@9~JmgOCXA<74L(yC6UgiVyE7+pE`qlb_@!o_L7lW@pB1?QAC zH{tnGdpnhpdH=qsh3eM(|B9Y^_*^hBzOV`n;Sm+gyS1Ca!GzT|}{oz!f3&8#gZ=QJqDsN$Qf z?hgVpp&#E$YQxL-K2;ZnX4zMn@XpA1VwXmj7on8HoPsgO>UQwg!WPY4YPKog7|irB z6Aw0rC{E?Aj_Y6%8GXvPjqgiGS?U=ZmW;_hT)mu&p2qPTQR;c&kcRXzOyWta?qQwp zYa%JpDV=BA6K-yNp`$ZxFxcPi_uNbIfnt1u(;r89Qe#z|*U2z@qg+=J7{V&E-ijRS zRTWfEUH)E=RJKOT{sRdK0JeyJ{|ye zH><0Vm;CZHF|E{>(L(}I?(_6J@de82HR_#jHlH>>DPza7Rq$Q}Yb|?w@0mbKl%BgP zGoVx2`#Hgslf8uD69wu3`i(bj&4o-8xc14%q{YWS(3=yw;XA93d3gR)3HV0`m@kS-_|cstF>;PKlr=p=BClDe&MtGA!w%B&^Yieki+$G zAr2d$(IL2%#?_RXeMc?lXVJw%jP~;>etN8D19O+Jv|N-|N=q;IB+hB#S+?{+V-a-4x;gg z7C$cdbXT~Q&e9JlP++*A6ehmCn{mmOO(n4A+4Cs=e>$jufhg=ESaA%*@yDCD~ znIXVl(8yWEHsmx%Yydl0px?7ueNAcofrPR`r~v5#AiR$c&a73Fhi3JapLIJh9WqBr zT0{){g|ep06&}ojB2hc;2w>U)xk3Hpg|M#u@J7CFk1>i?PDFE1|GDqSo}W)$q7yaj z$W%(Z7v|yxXsE0;RLnSIHbm7!(>Khh0u+8LOvbc%#^x$nGlpICd-G`zLG{CpE5sH2 z)^0YCle~GIZG3)jJ^Wz=)j^bll;qz%oZgNxGrUN-(+ImGQ=g3VUwqMM=ATT%mUbuD z_EA>dj7=$vT-3DiM>wMgQ7%vA^iob$hUUtMiBS{BJ6+1`(zIs^3JsPWH6E`OnKxOJ z8MGm|{{Z#*Yw|_BuhKa%2cH}p58U_YcWUHu_?|~PmlGjAbVNzw1awxd(T_5Z^)G6C zV+v9{c-NJmnIX{I|F~>Fk%_L_%R+sZy#;Yi)b%<@{_@4hQMAUjGRdK>HGzog!cYi#TUUgZ^iDj*)!_{r?A$Y@4Bce%q^axmyCr9i-n7pLaW zbdqqf%%w$5c6RFg+5{eeG-Ki>R?^FHDsf$jA#T20pZqo9v#FtP-^@B^n=)tNfc&x1 zVpW7?$}3dkn*bDpa`66Ie$kw`zo-jv$w&Vfo4!-erMVsWMNQ>3SwCiBnJKDP0XDWZ zjHcaY+CWa%7W%$|qgHM1iY?<(f-FOX6yN#=4!OdU$IV4%5-hJ# z7)=8b`dD(GLClzX?>Ssx|6PqlZL2bR!qO{_xrl<4{M)Wk|)k>|@Y}ci=Wv zi=5|7fc3EP@za(3&Rt6Htdi?v3A97_h5;STAO zvogMlureZ^oTIbo{8xPwns{l&B{!zv8@1)V6M|Uwj4m#x{+or$!8w91?nhYmfL{(` zE{Psi{GAAC-OcoHp6CrG)&S$@F)`E*yvGY@v#`JY$HQMc<$2?2Z#uo5q7WMg%2vtE!F z!Sq*PszHvwqG*j_@6t9ij&D!Ug745TVme1cWm>W)HlC+0i^2a1wLKtDXi617YfG zJn$qUP(t^K7L#kgeWi|GM(i&20q#fGEZOU&8 zhtLjjYv!UnjXrN0yld}7(>d7Nh8i1hdSw-(Z%J-03m&I%|`i@lAeqU@jAngv< z5~n{9rw03!?wpH2kvv~t?F(8FF|8>MD_)>DT7%3d-joA7-UCh7`cD(Rgc8(Bd@d~o zetzYBKz?$@lI!JBZ9*Nx*~+8OpP7ItzLm=E%qr)%!e)gRfodSQG;YPzZep8E@5RfX zxprfKH-3Ba23@+IPwi-yJliZ)%+-MCmP9pN*TBmr_VQ7o-#Sp<=b?0t&aSLH9pjyu zkEW|K#p^v%>Q#XvY_Y|xIY)Mvx2;)Ro2o*6iJHjD^kpxDw0}9KldwH``}&3^lbitQF-@);{?=z-2l<_V zPyZ|VkOWP$HX*z7IlV<|mKiT1+kTAKHmMYAGkx;#?*zTq?v06*h3d1WI2fE$Gv2xh zxhH<@-K`QWWw2Dvy>a!cTiyfsN?Jw_Tv#)I>h+23pS0K6OcHz{0yj>-y0fXdjVef~ z*54(y!BsNnvI1D-RP}Vu?Un@T1zD#tU*o5E?y@QQ{+oR{`ZOW5u5NIYpVR}srV9N1 z-j$A7Z9w@-(ysDqQ-mMo@^0b!T)C&+O*yAl@L`bdj> za@A)p{=oJ@S)=Nj>efed0N2C}O(LDj2eMVd6=O_#mpk_Hy0y$vD|&N?K{43r|0g}u zw>`X(%8}3sAyp7dX8f66!y_Y=cu}{drKXj~xq%_~{xV<)-T){?oD&%X@RewiCS|9) zu=gW?3kbY7e>m_Bo}CgW(dFt*^rd5NJ4HC?=i6&N6_c1SKvTBjVXnH&$;nEH$KsGXYD+;u$bk@|p=l zFcDu}(RDol+C}{J?BQ#Hk)jevks)FC=kcT9Ix%Q{e3=@bhe?Qfbs6ClA#mS_76jtfkWk1c@}p-+aH=ntv~4;b`~Fl zMq1Jeb4SW1G1qthuYee~Lprc3=4t65fcAl(ImKjhKGi)WcFH}1y|ttbOcHb;!t$67 z$jj2-Ezjm<7qE+%*ws7BVZ*)?&%n!D+nR*H&prr$@wmE;^PnI{_=>+JtQgL|cxNM_ zXYuLW(y(yjNXOc(Wt;s@dM}kOxch=W8Wq5jG4;Lee&xNG<}CLRlZp%JQ{otld9{>* zPV9^;W6)jrQQ5D=_}UC9(1Pbwybm3yHip-L5DOpyvsCk(8RxK71k7Rl{h4j4f&YES z8oEZQqLvX8ARKT0p0vD3U;5;N54t99YJxQiUG%v;Q02Y;)DSIhX51q4b-iB9`wcAc z*a2g{&oTY$&(SI4bb{QH`ZagBdx`!s3}YUsDk?d}IwQP{ltZQ%#(w}ZHU4PxqNq)c zA(rk-EM?6W7zHC@#&?upKgcZnd%i9>zHYz=&x|27Q5Z|w)Tz`Z#yT>P;2rSPpwHA4z%Tphsg zFtLrb{UTbpO}rq_==U}c-6JfP6cuV2pn9bF;_0-n%MT?sZ_kgVgcZuvW3}1CGxd#* zgt7Lyz6it`X#M9^E6ui`nL`Crpn+E?Wzh}5Y-FLaIHoJa4tjA z88-2y^2S`J7nm;8YLb1+zUX*%VZZac#ytgJV4<4!=3rHOErg&v}{hDU06iV(~sc2`$ffweRykQmj!}8l#ZN}xky*WbFHeU9k-idq zI!E5>nU*sS5tpfRbG4G}Pv#T0=1lp_nWEP%E;v=z1agcMV&ddXU{Au?!sCo-LE9_0 zL^>6Ny7)hSXT}2#Y2@j(kq_t`eYkycwq}^6{RYhMuYWX8_y6e5uZTZ|)y9DOQQ`Ie z9qRPZLc(B+TLfz4$*1(4mg5isRM6F|c%Es>!EWiK`my@<$#x<>{2;tNv%p!tpy^9^ z_qA-U8n*$k$o`jgLh^mfQ96esR<`2O3fKWCDktMw`|1w!3hbDU5NW=WeP0>N_7V4O zI#`4zbmic{Xqjc8sx9jXmLwacN>c;;{n}@pg;!;=<6{tniFiFBGnC#3jo*7g0@>r# z4QhQhEkL89sQePw$DC@MJpoob;zOw?C4 zN)LB!<}vcDlk;R1EfnCei!!oC8749EFkW9aPcg%L-m|vV2latMyuK_7l$8Z}sIvn; z|BP8fHiJ;%`k?~>6bKwfq3D+b6aFU2Yoz*w;%oPwiMGDyDf4O#&J0WMQ45|{(zc&~ zwb_0QWdWw>WJL{%a}IoCA9we~=ux2($LEY?49@+P=M-K_Ng?B1qtQ&9TADp-URmnr z)pzDN$3b}diZ64%nn35Eakv!=J(7)ts!s8hZPX;Rm`+LNn&F!$CC{q3vVx@^FiUz8#I1zPeDV`i;nn&pzMS8CzQ zpU9tw7<+l$e9|o^%(DuKJXa#h9XhLw!NIB-Ml*03$8$~JEYQ=qsB%U5ThD057>^&2 zJ=VRf$_qg}s1pP0ky7~lOwS{9I~#MDW1CgRoA!ZZ)ooN`^`DiIAgI{uSAfT{G6wl} z^QW%?oNluq*TscW`sXn*#M~#FG$lV%e@+knqEKlOn^;nrCHlrR3uMa*7nD%Gk4@&K z8jEF{$^qJR!3sRJc7Bfhr=k1Firk(5u8xP3T+u08$|TIDY44Q)^k*R(hmZZsFPL*g zNigu=V&vKBv?ne02*P7$qNXy-Q}OeJ+VvBrymxQKE>h%mXO~*kQ?jZ zsGjtPZ5EozE}M%{_BW&*$2U29*pMWb%yfTEjg4rgpci=;k;n?R8`)an46o&B7C%OW znac&T*2SY%&J+$4IlU=UsP(;GGg{U*fu^B}iX8$@6a6_6ZmuCJ>Ot!8Ddk<$p}i`Q zS*mO4Oe2a`ts+dCI!{!#j+BZmq>Pz{@kQjsN=gM*`~d_Ut8 zOF7M#Z2qEwbQMqE(^CA_kMIaaZ5(_%{2fsK*`Ckx(!Mj}S)ME|9YVA#-BG*_!)!Ri z>WQ$SQy7%0QM8m+jxK@MkgRwgBhCh9v%b>vFQ{!M;lCHhiIyOmvpqKXuukHlA7YbL zY()+X(1^Wi;sD3-W~t|-8J!$M8>X_Gb%zpA1_Oyq%Qvga&na+eB5>gC*Zj}loC!Fx zOpPD9m-7C4^lLt|{!ZAc%D*GwIJ!rdyuH`(jXv&PUv7X=DCpAeO~$iOPb^$P+2XG= z|6A2!WMO3Pzx`nxye0`29~Fr|AawhMZdkmcO+zqMv7R zW_8DEgC>bmPv30)19(5ggFoPD{75T~J80i_GnE_bEYx4$QzYH1iQ&Y_qc=$zFkM0X z1E|@kglbH?fPi3EDZN$g*X5hM6(FQUT@9sA?+K<8Z)DOnmwOHX@F6EppWbrC_s>@vd zO+{E_or~}Oq&LEbI;GS9)Z8r)2()C0swGh!8+tU*lm|XUL}2MrZ>MgVGaNeZ1(pr- zj2c&Cj2pkRZwD3|fQt>6C*My!B`?27n6>`n(|>5SsJLCrs~^pxlz!c^UAvtq3cZuQ z^2V(gW%Qi9L@z$o^-1ciekZ_ehFZJ1V}p^Vbc7^R5P&Q(R8vf`YMn?QM7yMeJw7ij z>k<|~$-XeKc<_N*WOs)?k&K+;$L_DO+8Zt{HeiJ4rp3tnk_rk$`*kOgH`ahw^oyU25Eq zWNhaw)NA*=w~|N%2CpPnlIRkCNjEY@|Mw~Hzb*=fq|%`l4Ru4-O&0~cXQW>aVuVNI zD-Ew<`N5vY>Mc977ydd)3CBY_a;ViWK95HF~8U|_HKQMbID>G!}Z+OC}D4<%dZ+cFl#3GA<5x z+?Odo@kAqgO(i!K7^pbhf zDe0*TEUwz(1)4cY+-QQoH*X?Bkz2Ma$qbpvOodPN#ips6(7Q2s_VVVklngNkcJD?- z+Y-8S=GL?q)9eO%|7d=HF^amXNK6XOVDSS#1&tgtTV0sMO6SqtLZ#!Cw@m!_gr@8J z&sDAcpRoU>W`#a?9w{ zvL`)05)wJ-?Y3l6FNv$L(cZHom6yc}(UiKdpX&!xI2o77ZyxLs-^B+APj-s^w4C}; zr>yJRf(iDV%rB6P%-n`~EqE2MhK01Rqm=37Ks8UY`xs8{itF&#JK@Ss@at`T$whE+ zE$jNqz?EIx*19hngSbR9*Mk55mG|$%L6u*ObqWpezlFlC@q;~CU24qFDcY3IAwrL* z*c&^zdKXc@NyYO5YMvY9C!qkw7RX2AQ7_+FN)G(QGdN#9sH*JD?-)7^QhTb8zh%i; zX`;`D)Q|A~=n{Z?X2er@P1rP)iQ#4L#*P~1H&-id!_|hgw1${`Q;f3mOOrWY)Mrsk zWD+|^*t6QUh>-G9ep59df28l=yc|jZKOG`cTF+%S${70sc>eyKoH;XsZpOL^EQu*(`BeEf;lF{dM)6{o&>qE%j9*#}BcH%YhmE}q*bh<8{ zPxmSoW-MeY->cFHjWn<1ecD9`iRpGjcXw?=NiyBMzKk~;1JD21_WrRXB$$8_7hA>A z8@lV}m|-U+*8Kz|rKI{<>Q#(h&kvbe<^H02%5iUWI6st6Z9Qe4YopzEz1dAPGj*YR z+&5U!?zmZ=Kv2y*m$5j+z9_<5*-njXLaWPxI=jY}Vx=Ypik(uF$GA#DXF2^@yl~z+ zd=13v(Xw7nV7L_2dT8-cNu4ZC^rDgPWbwDYWI;I{-CZjo^qg&g1F97-tl zn14>wQ&FDo8MZoRM->K`_#l33+hkr#>QphZF2tPV+f!IUY^xC30ZTV|={q6{zG-@0BQ7rZ+i8;sRstYyT1 zx1tu}k9T`|)U1 zq-&iH&h5xK>F(NEtG0IgwYVvgcC~M?2$=3(1i-E}rpYj=7ZJj268Dm6I^Ay>;rXkWA zbytd)rSS``*FCyXF%a5nO5-A3BX5r`mq4TnpLhB%Y9nRZedp`m>w2Aw$H{E}YoI~xx(2cGFFu?KB*0WRHrEh(=h zG=;R5nWpWK`!J-6)I1QN3cBpXQVp%M$`$@9d);`bJ6|+GU0aq#QAJh_EQxj|5nl9j z|22VLSgTAyU%zx`ubEqLio(b{C)UVNzwPjF4wNu29vl0_ycwT|eg;OsL7@=lsfkAPb7=L{BZc!Y~+ zm@A@>?&+o%O--pj@~^Ca(9&Uyno-zhK)|r=JVlcTEhrB2SET3NVsLI`v4M1@Xe-!* zIlwdetfmLL`yBTt{U)rWsZOqCKiX1LsKnkPHsH^flqv}kn81hiWxRAKw=Cz2KjC8$ zmpR6`FC!=z?A7@kw9o7Bc9T@6j__hDART;|b!_nLe`puCDN-rf;gs z_q9{_hwaAG@5-f5ERbno?^`5xL>Mb-B1(eJfhH=nvdc^xu#pD`1Ho^pLD-hFEN;j5 zv>f%hs1x8rw6|du#NcB>8(^ z6j}oqp7LT1^2^|=@gE@gl+9_QmFrIw-z@ve!hfYQkKokBW2QF!XNI$A1PoZ>;o@~szR|el3(T>n z!|3tyj$ldhEGI8)`I69KtjZd#gq(;3=#3%oSWm z9*9Pjfcq-2O1am^iAM7l{(oAcl_a#l-yW-CGrOZAuxfT&lV8l5mFY939&9VzjCT9P zTFbBw=(|A9RkGV(RWu5?vSvh>XQW3H`wsv`Cnsin!PF;e&bE~^V`2OG+6-R)xcaB` zk5#y_MSdN;jw9idLjmWP^jp*kz8NUPe}F1waa!!LYD?QFzj!=T)6x;~5aEp>^P{IW zIR+kxiP?@)npxj-UCD&B+|+>?&fB#AtlU3x3fdI}fud7u6q;5)dQ(@e;j;lrZB5wxAD=aMnsiPpM120Q}E^ z^Rx8PKY&FRqj6hjZ)E=t{2@WxCI$$*bcmS?eN)LAF?_K9?PeV2Mfj4s8|G7Hu=xCG z*;#*CD3A?zaM|1&srr+ua*O||UX<%<++PUG+&TNc=rzk*U6SN5R^}P@twq$T6@Sw- zn{S**Kn%=?AbdL1>75zsldPF6p~qm_%;d|J-92^oLOoBFKdn^dN3q zU~X!FGnOYA^(oUNjwOw<)gxjdXr<8=4*ezs&-%GR(Oh2?E5`LO`m--Tgv3YG#ls-X z+6KJn`IJ<9S8dnH=2CpYIGyhL*u}%t&l0zz$Cx8^T60)Sa`SME&c%n@@j2=H$0}@u zi&$q*age;&yXS`(Y33#;jZ(EoS%Dma7*5O|Z@?${hNEVMU;y1D%jPSLRLj=W;W?)m zscU7$L?pI}Zk|@sXOtF{r9am;h2{muQ=0;3s|H z_HG8n3pd@rN&~2CCH{%b(tv6uJ3yS5j-+NA(a7Wh8$8O(Og)l?>YjvROBfOf~rpQ~R%( zX?2_U!q0t95>wB_@`ZBG+k`)O%U_CMxNauNLlTyWKOnWc|2vu2rHLEWDYA%sQgW(L zelTdz)1;MLKvctS0hW)L$Li7T5|h|6#;uX3ZMHj>;H{5By^Ee$y?oeCf@`K(GV4o9 zG6Uk`sSH(9j|jT0=h#2of^jNw;ebD|NDue$dCWp zxdy4jYhGp~5v`kK<09Vn*V!`0v;Dbj?gNd+Rj(yUZzCFKI{vmM*gUU)C`!8q1L9@tfV`h&lGA^YyE{}?~j8oikaoDEL{YuAZ_ z_j=YlWn(NF76Y_DRUWwxZq1z#oRGZSTp(9MZT&^fk+%q)SU%aS>6;cPjM2ZbNedhE@S8}bMt$SvUW04|&$Uh_fJoOgyDwW6A>`6ga z^8)ZOip7z4!6G$iAa$c)PD^Tl_-~(HkdM0h{l+Mk0`Cw_ zX?DdZH zC;yJE&MDm*zw- z>)rp@&Wb~C^ds|s6`u~#GiC|B67Vqgv$zP|ONJ;u|Eg}Fk=K3JCp_mB$g$lyGtdOZje^GmlPCOkS<|aIs}%Kl1^zPlt#ke zJOAVT4$sUybKlo>o^%)Y|8DkCIEiwcu%9_#rM`O_i3a8!44Xj=e`?t}k3gY46OnvU z!!TlBTi=mVR&>pMAnw>URz-n0b%xWoY#2$NB_K(=m2b8h_DA!z`{@CNpF&c=|Pb6B#oCU)3TWT(-L3juW(iSQ!cl)~5I;3hn*zJsM<9+9`k z8~uo`l^aM?@c6u5=N+r{9Hyx2m)!B*so^Wg`@tmX$4_8B^&ggO{TGg9;2(4UM**8I zlVcO5x_#Js?6~+k6s(y0-fv?ioeptF&!D{(a_pYnW7puRIvJHe zbCt)&5&}@`E~%le3DC;Zr_6I=`Qp|1C!Rp@TtAaMPOeYQ+SXN3cWUE{jdmOq#WO;P zMG?Ve@F!Ebn%dIs3KJ8Ab1@^wwU4BlYS@PD(^+e&+cxA!s=crX*j)_G70`$b9caDo zB8b(G;{TF5Pb+mAl*wmGX!|bA58y&YBlS~T1jdNA4qP=Si#>H$jsg!+Oa#+13!cB< zXKL$(*LV`XG}+B^%O5;sSU63SLF(wVUmjLyJuMg(J6*ZZE#NHv_%uj?r7VTMzWl+-LRt-T38{*izcU@F5hNTg1sh9S5m!CF zm1)I7N#yS18gDPgsqw^=Vvd8CZj3z1BsAYMw&QIqIp^88{!FatY_oZ7_i>dte=1^; zt$fnpX+tK95sP_(XG(rQ6ZiwpOrvexA5?sqII)1@YFG%>tN6~ceVLEqwYpF0NaX5& zLU{hAnp1>4b*C-RA^Z8#VN~*cV^8hNTmKcZ-BoR3cPcWa!Y5`W%})fsL8-=^4nycf z70Eo1LQyY&{D%HzjXCl>9mJn6rrs@N`0*pgav4kVVIgHEGRKB2j#E3b;tL*up@O=c z#XpmMyIw0 zU_6+7An^AM8C%A5OdyYtDyPd2;ZlNIju*vQ<%6`UKjSOd^T~34%ke~U^i1)Vjxrfg z#8n$CZTq66gcB<0VUw9cy89X4_MJMrZjt;FcumR^AOVn~mk#)P2y4QMg=bzb7!&g`|h4)Q3 zoE;g`Yr%qY3B_nompGldf9vCh#k(C#E)()dlm2R?T zyFHS+A%W9EqhM1WM7NO;?Ytbo+w|`HMS1gjO0m(gFFUcakFt6!+w%da|B5h#RRVhYf#gd>&n*Nt+4=-|3L{h%!>47> z=#~GUDaga3c@lhqNbA?MddqzU@e=YpH|1a15VBK#B{ndI49X$v4heqbyX!d3mm;p8 zN<`b-cKxr~7le}Lrm5mv3?~_b#Yl9+0rcnKTOx{r=p;`&MM(Zuxs~{^m?5mIS;D<9 zumzW~FRsk^r9ng5&KR3;m@Y#L1;8TwTDgy$aU#)^+RN%`VF(ob`yW=@0#KaJ&Zyi+ zXo2(c1=|yt&^L|7ZWW+NQ4i`mtn;ukdEJq}oC@Va14F*`3bG#o@dvk<2D>_2&HGuG z_srHIJ~(IU)@FVYcwQ7N&-1r7xDNa5h6ScSQyZH(|9Kk(lrMDZ>9-g#Gli#P@1gx4^~4OPU1YIO-;rkCD0Nq{@q>j zG+?IWbig6911rsikF_)pay>?XD*FDtF?&iobi7BY*sY-Y9N)`CEnd|&&0d(@La>+V z>ct+$G!t&S>b2BiCE673cHN&|9M^bM&VJ7Rvd26!bOI$c_e(V?^5E<&XW2$TgLE78 zsit9jB=cF!bQa^sVG0|No1TESv}XbFWl5efrUajCxsQyU4K>qid_3z; zMriK0#jIJU@}gAon~L0f4nqm%*c6)}``T1e12^P}df1S>HCZx>gXj6eIWk80WxnG8 z4}w;e!j0t!D~u|oP2GY-&XN~qQc4y9BE2%|?6g|g5=(2^5hxw5M0(RLKe@)ce4**_ zE1cIi?YDDYUPvRg%ZH8ByTv*S+-VOv3 zIc)z_dWz9BUQ6OL&T>q8NuoP+O%jB=jB8MlGo(86B~!^#w~Vdamtv?kKMKFITFpY0 zpN92YWVRxn2vJ(k%D;jhAcp0!Y3aL<7 zSp%x!&eIhhCm+kLLgdm>@j+O_KJbPO?;zvVA7NL+|3SCFFMrE~J{PF-4kfZcJaQgF zxnK`T9Z-6t5763rh$ry3N*Oc~=^wi-#55-$^$4gHevl5Ne5R+$_)S%fe-hr}>YrsiL-ee! zdxX?WP5)iOadO^*E_&o#F0JYH2)-@Bm9^*G&5cQ2azfs&oCceIW9`&;89{5&$&8l< z;|wFEJwj5<&A(HM!DC`vV7es+SOg?6d!FEMxhrHqa*C*~`)=z(YD=s8G{RtnPaw+A{9qnX9-fOhf{cMrM#AL;sRbSR5KxgO^g#@09l&8S~Q{SwRt+5bi7e}x_5H9qJYlR?6$Q#_kW2ByReT2NqQM3A3Pngcw}AO zykmpJdCOb5-g>tGiDr7xmfJUGYx^htc^kJ)sl6tpjpnyzr-AWUCFBpiN=#jHK9uIX zl0(lJwoEOIGtWrWjpBCW(RtF?(F_yeyVIc>SvwM)(=(1fpW@6H(H%06X0b;1N9JvJ zXT?3sO)y9rNg2fkF38s$JW1-rT8cZGKOOXfXu9pgoe6nko=WJAIKxbGagxAuUBktV^8ot#j5q2^@-NGdHc1 zT^8tF&PMXYLqVcdVs9CbLPa_$v1m^>~+HY4=<8 z=J0QMHW5UON~H6#&J>fH((>4kQ1VIH-}0_5-?#(n8Gdulb}n|H z#`E^c6$t+L1_NpJ)#QC|prQ5T>GGSdpC>^Z#N&-`p{o=ddHcu(o)_JOD^z}&sKT=T zOGzoliyuFSO>3+aT5az|AE_dRV+IZtm=obwz>#~BB8NPi*!7iLF5`L=^F;HcHXgc{ z7T0$=oV%rx8HM@b+v_?-pyw-E74g+megfzoO$jFZ7&$)A-;^tbvI6yEO@k_illslg zt^YJ5_q?8Bks#963KNLiN#)8 z=bempBsa}I z%q~K_CTdJ?!5kHgzf;8OzH*z%jj=5CCh*d>*4wxTKQw&HE3^N}pWN}%FAdL=rtw%_ z{V*9zr?Wzl zm^cS_y@j>8{#I<=UCGQy>p8fo^<~XSN*M>vGaV_OOS@;<14s{fIi`X?_9R6Rs=$m< zhu2zDUm5N^lYe@z7vC@y8oh|g>_*n3A2BQa!9=R^^*uGM9qBg_#4s(KP^*moP9d zQ1q=A-E9>chlA2nIZa>n2k!kzNDPK#M~sfDGnlx4^`6jszHm!?>Kzy#jSUi!gKun2 zE?Q*QX+6a!87hjhxUB&qJ9u>o>86fie^Yn_BKyq`?@t#Rw^x1MPWdTEKb4}D6;Qa{ z+FZ26Z8Y4qjI4>Jg`9ec_E5GX1}lx)=_MBaXI`mi^*GDtew{?zp!b+o-}}1^F(ajk zYh|MR$T1**n%y9FK^{D}>*6iZ8KuC>I1%AuxwOx-ea~nU$gh=U6j<^@TH-}FwX2p~ z<&Mf3@^qrH=QR4eYZ*%^o8{p3!@^#PCDf`U^xm53iOYc%!=;}*cDK}diPgxivzw<2 zFy)>qKNptN6IvmGO@Ves?a+9Iff$W}DV!FpGx^iAzdQy^jwzCdu3p9!Ry_vc?-q8T z;1|4l{rOZW+4zA1E%#EFf%swn{Xm`7IIsbpt@^C(utGhu5k?)sMp|CkGb_}vJxw`MJ!UsCZ_ zp-ixyz=)@&P@}@Z+0VRjMuge?zWW2fb~wP7tLLFpXYuOyVFnn8s_e5+Vl!d(k;aOP zRNUa@`<%Er<)(u9d8DcFyR+)xrE6T&^Rcd&&0=;r%4e?R}Yy)E{n5hX%~3D7ib&h1e+aE&PaA%<5Vl;0aPqP{Eie|9w{ zd+L$z>_Y1(8<6^C``t}iHLHiEjC1R>Zo^~t1)2133+6QqhpQ5x_aX_Imw3+OkTEF1 zyp3DLM_pHq8h}CZ|l5aSI#cLQlJEwBE6@ahY9RcgY>{Cmhw#vZ7p{e>E1-nUS^RcfQEEZY+RD1y>9QHxyND&Zd38?JC7iHjy-X%n_XA>1lE;4SdvrR`wWE$c zX^qc?%bOecb#nlQ%nrP|18)3lzQ3LcOdS@%TRmW9W5CQoq2t*~~d_ z7Su$AT2>wb+@i+1uflwPvQmfcO!6zQT4tCKe^^6S_uzypJQ83`wgnY`JV)G4krzd+ z8Gxzsv%+8cr|ib2Y5o>%C$o$K)S(QPzVDGg;y739!JRd5&tVG3KOtWdJG32fKw76h7B8m1j_xwkh#qf1;$>_3hTjfuOhH8Q+wW$Ebyt z3%;RSG(-02ti&S(%S#(m1VjB8UZL3D>Sdj2wMLs~J&=enHZ#k=-Cxb(lX3sXt` zd{NF{H0PPlp7`nD3@+N!JF>qy-6~$~*F2Eaic4`zc|AS%c%O2UXYvJ~1oK(aUt$$G+mwl3n5MKMQx4{Y5~zR!L8CJlY|SAx57bYwh|PV@mB* zHVm83VT%_LD0ms+oh()n1O+t(CT5U3T(UgRl4Guw13D(~tY%kzHFi}+JHl3T=1~Yi z#Zw%CR(WqezTYdvZY+-tPfyHipPI5HSM<9<;w>1kS}w`Zspq=Mv*T5qZ*_5w38e*x zTjm)Z6KX-paU+mHXeV~|8`cP%_25mm0d{L*Z-mq7%-UOm!@A8Y`TDL>$iUMt`aIfh zl_ji_qdO)m2yl1vAKpHu3$@ayg@Vl=4dDhFUMma9Q4|n*JrW&Dva&==BL)13{&&$` z7xiiC6?(iTuG}-B-wxvl2n^tZL>ATtFK@F2RJU9pzWX9wQa!DxvbZJHR&+hBM1K?! zC?g>=+L>nMTW1Q;#t@k-x&XGla>Pnw%Sq^4`v%3}nOgSeSq1drq+WtyKU0EeCSXdJ zv@U1ulJKSDVC!%U^Ao)`H$8FaxxoAo*?rD1cDUsB-KLSgl5rJLqvoJwBaei+$@L!9 zg-4ON;uLFP2RrFk!4s+G2_TZpNmSlCT=4hJgxCH5e%6cAQw_0%(+vOq>DnccVy&?s zzoEN99irNl>$YoF8llvY`3j6T-BKHkhxM){e-S?E0(Gn;mac#fh&4&6b-32_O0Cmb z7><2)5I4D6fv0(Y;?XxSA%W3|*>~cT7ahc6yXM+hF2^kTTkctLjr%F9Wjc_!3f>q! zs6HQVyL&#mQ9)U5ter*dZu|Xt(tOeI9Is=}xE;aw@ccDk158 zNz2-tIMjNK4$J0yulkBB1$+L{<(4Y#ezJ3*Dc^(^NTdopYHr_Dl4i|2aXF|=agNUL zS^&WCObd5>`?-J}RD(K)+Hv<=eu}Gl7Pa?ME4@>)3cqw3>NKqXQ9VYb$eS||-+>3# z82Ji$2{5gdZgQ=ybn$}YxIOBv`Y>HmIKR{zw+wYA$OZ%&7a06dve+S8j{Oaajjxt; z)PINgP_qa>HcHIT%~|TPuAuuHWa+T3^XJD1<=$(8Jw|0A^|m8Ngz9!CwT%JxL%?#0sH>-NdhhT9FrB(kZ3twN(@2gCi%kgytu0fUmt@ z_^Fq=QSnn&tVrVDw1B{1DTyoHlfB%eS8dBv0`=UAvUJH~LWA$VmBC;UgYIcokSP&4 zVd*h?!I2u-W%y&Rg(y})LXp); zPTG$p^WZ)M$rAbsJK)qymF||>sn?-f7iwU%lu0Kfyap6l=q?Np=W{#~q4S{|BAygIm&uX*w(aRyJzdksZYGP_K zYP)W}vN_Aip5LM?=x#&`6OnS`yOG6Xgp7atMPh~3D=TrI+2#QBh{vveb37K8%*$-U zqUNsM&+EDfGigp*pG}SwMQb@qKrXv2e2K+2j167h(Sf|@{sFS12p~YHI0LR<@E1 zG7th0nfg$sk+BtT7dv2JCZX*j_RMqe%MWS65H)-lq17jm_eP5ym*$V{gzr!146i&8 zDk3=?b*&0GJ$FD7awBH#?W}y$l;&yq^G4xoy4Yx4pGAK^+*A$ogvX0r(y`W3$b7v| zSuPpDAnT}kM&(-B3ut^(JD%p~lZ-b#4c%QbQ_9K*#kv}nOoQ+Bj5D0zE%FV+?wp5K z&v>ybBV%&sy}#nnhbGIC3Ry#K5q&SXUX#VK*xy9?)L&s*Xsse425qrDI`n~8x7af{ z=uDe8unzQ?lQgzZaHfMi@Fb)gD_|ieU(t{|T@vuOWCVXy{mBWNSAgE1l7qdFmT`<> z0#LkiqV0}Rlg0sXHJTK?UN?PnBa&o1FhhiD42_d3sq-aR4YD(e!A(BsbgV$+1j-r` z0N*MO4{I=(dNu!tQGta7Bg z>RxH}-NK)ku~jKGc8PWVH)yn-D1?_X7a0$oY|HkwZTkj^v&!L*Mky%eC!AmbRwX~Y zUuX%UTIXEnNZup_E<+uBPAUiMgD3xAJ}cFo!AUpFI~1nW1EK$wUG))!Dn#|CqlhHM zQk#%XhN|2iVfnZd;{?zG5s2)Vm~h;M^b9?LcCt|U{qJV!xZC--Ktg?|HVX-LbWt@p zX_;APZ2oNNVWC~sQyx74PF1W2^p*|7zRu;n=;VH~!kb-AKSC>#DLBByy!uHdmy|s> z>zj`3?+QuhQE6CqSw_jntc=euIzP7|oJs0f|APDJ5Hr~}&W{OR_%`Kxo6C7g}S*^Y+aSRbw~)=;o@RQ*FHSnz1_w8I9Y3c zn7Y16AytT|g=-5imqwTN=`rb?(&#pU-cbxnC;jDB@4TaIvldh;c~ozs-aLPh4B_-y z(9iQTs|PjcgtC}@!=@nYQMB$$H?wuya{4EDf$5Lz98t=_aJ!wU<<<@?VXWzAP}m~VwhAvzo^r31aTMP=gt;YGs!_7HWVfX5wRXvdii4ba zS!$ntlAyol!|n_nf_x-1r&W2hG)!x2N&jlrG&e%FyJ&iku_4+S?fnC%tfC~}NA;+$ zKP~vdW4L&TjC$1pm}rt9X8@3OY3R?Lu`u_Sru8m~q23MEfskzJsqeXdTV zF4u2lTQAr~qCtuFyw$U1{xTYm6kTsc1SQxnSO{ZPcKzk!VE6ys-M!3|%RiVSX~A8Y zERo^t&inmtIVvSe-CFuE;}wg^!usg*swgkfeH)8ik@S##@+ulicxP+F;X31v?rX~~ zHv^6sNw<2))=Ecq(P$>(P|LpUZfVE;f1@2S|a>_L@1MquQmHPuizn0ayU zGce;jL?&>gJDrR_;SY!1LiY-9?n)5X>ii?dblU~9!U?N=>*xdyHBV9Rcx0WYrzABG${~0@KY=;zTT3ks(zcLy}ezgYH zCU1pe%c*xxf@qZW}iKdlES`H3%z|e)Ru}g`1`LH|*z6j2C3`@9c{- z8F+m z_%m-kKDUpx`k)ZqmRB;`kgPPKGKAr5EG0`oBGMBF;*7ph*t~i*!Puk}w};e?`$FFF z&hC+8Xp2=28z;$Dwn2eIs)1_$5B7`$#;%(i6u4)-)2FgfHMPf7*|`IC$RztN;BQgT zo_frH3!Y~qvN{ob&+J5Z4eVJIENE*BW^q#HD2BT?wk@_+N0-Y@(`x-#Fa-31Ez%_}4@oRwB-g7Gzb2`=PQ zS^I$~wvkS85=%kxA<6zLKSwOF1Rxi(D7oDxPHEv=(vs3zqCI6B1>-88`q%{ zc3DnJu1qVT??MHSw%-_PJL+;pko5G&<2{J#+VGyZzrn`UYTLTG zDeKO2GWMHx>Crhoz@&m-4s?e4f_h+zMqiNZMO;=11x#KG$)20 zYh>q|Y+*Ks1mXOt^Gs*RW{tb_-|AjwChv6qCsud(Hfx}*P7kpT>rKF|bb#;h~a3ghnh5RZlIkECK*c5Ok%gl#=?WAVcU=^mw= zzLy7EGjMBm)tYRsQ@N_qz6ephii9Iw5=|)@3zUA4yRG1b^EBW73^k+Fe`1n|(r+V$ z^*RMYn0>qD?rhyO#T+%j`KjmgKWVh1C}B1?*i~fZ1H?3R!5%Ifjw=TCO&-wm&>a&_>`EcbtPTv*h5t+PVYmXvXe<#2}KlKW&CfK>@Xl*w=69e4P+BD z+NQnj1%GN@2i@`qx$azrk{lTBPpzBYT-~ zH1DN_+4iPfwjK((Znz{jsPt{#QG%Ay^QSYS85UN;H_{V6xRtQjdeu|QGe@q!U;D;i zje_ShmcP)+X<}Zl<;Hsg71wnwv}SGp^++S z4mS8h5{$p!38uuxTsbV}Dpf#s)bT%51g|G*&Vu@rFP4?Zsi5iaIqHZ*8`%3-gm??$ zkL5YMV^+3ouoAe>rFLpr{Y;28c#N@Bq04>iUC;47l$_2 z4~`!ubXlCN9yNcLiy3r9spo|j9hJ7ERuk2803f1ZLfkP{ z8W2}K+kcF#mwOOSUIB-nStP%1R3?nEEI@p?>DCNRSK85>LD8_xkBKIH z2W2}Av3y4KIgiD#wN35WJ$lovHv(&I`*Gd+|AdF?))Hiz601!MVW{i=$gE%71~GGa z4t!;S>YORH^8k-Wh`ilaW4e1pjDR^f0SBGfpgqqao&iq^=hUeHrYcxlC=@tZLQ53G z5n&l{mK}50PDzQMydUrhf14+*C3Wgc{+MIkAv>cm)+$>Tcf7)M6^QvArc7q6HE9|h z;m^m4h9{1?*!M|Vwp8aE5$WDHy{N{ItM8`Ur`J`qwtp$$K#N|zskt-xgP2q=1zMe= z9J*&;T*TW7g_CR$b#48{Ac-wx7@n}`IKntvyKNUf3y4!dz=m?3aIEYZX*$iTs>XdfdIrG5o zuN11n;OM`eEY6)Z#sz!k4n}TBCU@6RgwK5K)Awmxx`1h&1_H8E01H`=^x&ymM}l~d z(SU>0A_J7G~&yJF6IPHG{4rM@#p3^!!0?H~_5WwA?|m9Sa#jaeTlqUad9|#{{c#e(2jI&wc*?hEELG} zR$wvmU+uKi(&x|@0zUM`Y$e|P2YjTh4;%zP4}sjGku@JYuQ<@-v$6BM4?MzWCS zcf%WSS#jX;5L)=T5f~+{2Xvd?rgSeej%-9P z%jT*n9q?sLS39 zKTFb(x!T-hYojxrveM&}h+Aj4)h}GeWK+x$Hq~}*Nbna2I#A3KlpPfue1+)^`6;uH zR-<4*EeZOg8 zKSs|n*LDJUcZCZf;)xRb7snlmi?lXKh#5gbS;zQ=HqO^!fu27v;4A4e*s*6L`vwv0 z%BXw^F>C>aemJhD)7{oLE#DdKc;j1D>4SuYR(*G!)-D2pHhyGk$IjvoOp{`%qbet{GMc$PWozdIx3fvU6{dIM|l#;oQqyt^(KXvMs*&~F+JnJXl>XwqMdI!?UF98 zSDTS&sj$%`%_ISLlIg0Sv%KsFpXo~juDDTzdBh;TH&jjZyf$8uFo{j8dKpl3gb66Y z@}%E%U;-8mRD8B0&Bh)BuZ1#W8}c@e{P8&n+jp;m6TR9v4v3^cZ>MOF=Z=Ku0S+5z zk{}L}tIINU>}4;j@_T|&l%>4&nca>r@=Jp7DvRn{!DA1G#1L)AA-H*Mn!2t4e7Cnh zCbs418Z$`{udunZqD}jqdel2?lmam+($TTzJ<7)VRef4)r_6#qFcXe_&Wu-j( zM<|{UHe$F`DaOo5*sX)gLwG(hsKcZ2PHxXz^>Ha7OR7n}|6b|o*`JT4o|Sw@jhPah za15{)n{1Vv_I!~xk@te4DQt6V-(oL%)l`?EFY(LN1GD`*Pj;oBgLCSR5r)+4C+O8M zS9Lx%R5#3R^x2O*D*xDZbXQ-Ah**$1E|ERizAI zLRwT+VHL8-ySDF#26N2=lj8>dkE7AvBIQo8l_i49$*-0fRf@dCt&|)1v)-H(Y2}8| zoc;lAZV;IpE)uXItKXV%q6lMZ5t+lSbnsy`v#icG5*WwS(HVT zSCIWCc$|Yy`}D`xr=M7L$|ddKubLbBdE+?4RKHTj8-^-mv{yW0qU^+~UFIlI_F}Qt zVMtx-0WKJb6O_fc+@Ge{)Piu6hCScYi#nDhu&q|>j8Cx1prHaS_;zd2io8pZLLkP1 zjR!|T_HL`sSk&h~EGE#XIsclk2DZA{7gybb{i%8O&Vj>C zNM`8@sA2{XG4cP-nO0ExQNHZB?F(d3S)p**>?w*0TfRtk-KJv+j!pHLZFMUlf8|IP zLVG8_1~4YV%Pp*VIxomm>&bvX@he@A!aWF;4DXYbEDd(wocdH6Cp6d976t9V6zj%9 zoyf7+1eIugigV4K{TCD12Jkd)$LG;yu0UOjI(v>&7&+=3@W-#%M(71y$X|JBKaUx< z;OE-{37wVAHD56$<-hiysg+}P zgQ8RMlRz|*%^4+0Aj}4LHPALv;YQHh=f--iLUjnNusBU7#M}C~*LnKRsyNGxxG`E{fEl zp2?tF9+Hs6d@kG>%^}_vBo_V^zp%h7w{VRyJL$v`KsVJ;Tj29R^4G4qo{#cx+HyIH z4V~Aqf4;iink<<+?6t9Zv&6x5z4C|~z(6B@x+2F3t@XMl10X&aJv4Q8fUWYI`(9u^ zvdm10Bo|lrV;`DQp=bR2!fN3Uoo?H$5CXfxH4zuioKRDjJn#d~VH(DW#7RO|F4hVH z=OC89PawU5Z)C2OB@ssLg7k_pN-urnN6Ylqy%rAMfnZF`(8uAi2J=_5k#6(Kv^ji{F+b zUs(io&hjLg;#x{3kcBotM$!_-D8LtdA3VJ=C>buWz^(D@m&Mo0Zu8s0_UW!|B;D}C zrgKYe?WA*DC6H;OC1+^04)w9 zcauv{_+!9)^Sw=YV<%qC1xsBJc)udatosxkI2Z@i8;(;5t;Xj~9F#PEvtr7v|E!~= zV=bLP5uuIrL|B&sUy6Ra`crm|x9PTfFoY4YoWVUefX0aL`8b0m)TKG{e8qmcgTQx{ z&y==MT|ZJH|J;i%(L*I$%g59+t|Xo&_2@j1(A^G@-R0*jdXbQ=W}}&QAeH$H?Nq^^ z%B0z3Gn01p!_!usCFJ86V%e^lH9eGmi~T|bXWOCMeQ0mJ0p99v%%T$>QiE~bgOt~W z{CN~`n*O)uFZofAAJTYCSHIiO+YM~ZpYxARZL|%Two1|fnMGj@326a+3FH@6z!rv@ zf0U)<{_oH}F&>^pm6%(NO4=f3$JwSjUWPbWUX1n`S9fW4*$sjuKQpYCJs&adWZBKi zLx)tXwz#hdzANygu+@JQ+1}|jxR!-(kPBWgXC^?L27o>qs&^{MzN@F4J5rS&Znb({ z0H$}yw31@XFN6n?1Y@hJPkFx~S*e`^4TG-^lOwDg)vLIZ3ns-;P^1NuJ3QyOMYp5R zJ-Mil4Iex5miqGf!Y^=i-#`Dqae77$N#U#*V2NBD?{rvbsRm&yD%@TvK%swsm*G|! zHTBYuR&g$pkkoZUp1Sw~n%q8AhcGxl)$!s@q1b|FFofe#a(_ zr{SvHb1!$e^QauHYcE{H3XO^6bkL}-pL|%y{@sl@`r)>QFPU7ZRgSw{FQ@EM_=qyd$6eg&3gkYV=ej+WAzHT&+M>i5A^vx3ZyS`YfctUQ_?l)Pd?(uR6ZZ_tGVPn#*@4 zN1|TN>D=jR^44Q~G4=RS44{YK$x#NOT#lzzG!8~Fk#$<1*FOelf%}Sgxe3QK!x60w z;O5g^LynWS?^B4RnXGpjR=~fb6zBkPKBY|&ZQVRE{cw6D{Jw${`s#TRwL2MpN{jhc z!->Th;+NT*c#Pd+Z203pQhyMqZ!G&6p8Uk~1Cr8iDV!mAZ!((5R%j_O?B<0X|6ye_ z!fsmfc5}UcR8VL&^*l(d{fD)USu6_SU2c`VuZFSOMHH&CkcYWIz#|!a8y9OYc>=B| zepuZD7OrUF$|~Nqmjs;=%{Q2@pn*BMa85;uR-l|K$LU3aY*dr0X$e8;|H2A_0+SyV zdNJQA;n(DHc06(aVLkZ|>l>u+s7(UK9YJR$h1EIg?Y+#Tbn~srl6UeqAzh?#()!@S z>1bO>`kyYS0a1sfo~)gSBc&#FF{kLQp+8pNkxEaORLqYNi-u4nw2@l||Lw2ocYt!@t9Sw$UO5mG9(twD09JEmU!JQi@IP?c;OVO~@4u}%rIGzbm z5^$fc`hD8D!i2JLzMNY0bT*}`@)>x6r~HAFV+^D_4{w9?EJkN7*KEuR?N z{Jpk&99DR7Acx;k2Xy*JQ=+1_U;d@MTQZUqEJOhBQd0yFvqIIIheLS(j4_Mzt8|hU zdU<6$NE^S~>Uk_nwdRJY0R9|ymF+=0u&8CXL#X`e_o`OV(JK+zaMc!|B&x6)1Tp5V zT0|PXZ26>ng^55}v|cwVaF~zv=QlqnTVLDhloU8}nTDiSwJwOTqzd)|T_VmvgUG3w z{yQp94yMnaLP9+&&r~D)e4q}YHNk*Nu1h}GDjH+N9J;O4z|%b2mJx?TziC`qX0ny! zFCUZR9TEbro#OJO{txSe?|KE-9L8?sd4GZa&W~@Q8>s>EcK|{olpL%kMu45#gfuyS zCu`pW?qB4NV@dH^>}^;%Pu8p92cQjZJhp zIR@M)@%pY%Jm^?t{#Yv}B&-NQ`0Zu5jQJj!y37D=E|FUD&{>hwM;xvS^p11%N%-|;WKepj=5!v?|I*vtt4 zPdaYAwwx2C=o_4CeI5)5z=`PV?Pmfc-2HKCzn8-w- zDUcDDU*z$Nv9=>)IN_M6_0MlicC8!jq<1_KQJvs8WwC;1 zik}E{MBszQO`tglYpWK0#ZNl}F7D(`f9bal5e0k-py^oWmC5R{TFS;1wk8Ror(X(K zz|*()$7gq#(lqyT)hC5MRg<95b>a;Tan>g>4TX=r;C30)QcfQkbxwX-LnzsUr%7j} zhhC)HHp#bLO7znkEpwIV8>#3OmoNG@eS9&>LJ4l}kOVM{hJ#7P%B}`davy=_p1Us? zX>J*)u}@-Oon3)My;UTxhq_?yD6W>HY6KMNtpDRnKJc&1x}nv2+2YzC07@Og3#)?y z?`2 z#y)iGf+e87KXz+Mf1djoUoonUmeA@>Wl-9Q-D?V3axvBP#DEii^FGPXhuOvL2W2AQ zh3m2E*sbKi=lv;cVLscUk0>PjBjRqk%THCUvjV1z7>!x@A zCvNOZ$7n~BXHPT_?zg582@@7z1dykmdYieMr>cj(l5Z+5(#yY~i_ z(4bD>!WsU)^{5&yUAn++#%G@)UDXpQL+cWQvrw(hnnH_o|o?LGL4tEO!x_g14t!abZQ}$fueR2DKv#kwb<-^MwZ^% z2eDVFR`gm?#_5M-cYz!7&iOvbcV}P6=srK5+9ag`(H=~#T<<>N$vKzCmRwAf=$>vl zbF9%a9buy8O)?2C5gJqRYGg<86wusWHw0;R1tb2jk-QY{XM(5O56Sq7-pwxTv5l!1 zHqd3d<{7vcox@Sg=MO`F5K#6pd@AtDv@d$=BLLY9g{fPDvAGUP9C7Mn)Dd^&fXc)I zrRU?ww2~sR{D=?+ILp+o{=ChlP0BGt1v;TlaUQYeGo+pusV*e#8e8}u$PizC1GMXD zhB5}{qjjBf{g>N4wc;3NhMbpv1Ct;An{1qR%;s_w6I-%&IesqS#LR)oRok<+FG?BY z478b(1=c%4-~#PkZ_5WJ`V1oLcHPV}BrfgAn z*^B@zU5Lw!URyIwPauX;e!l5grMjobO?ywvD4I)5eE=Td`hw8ss-KFaqj*_rnNtP9 zIew^8Pk3BR_$Gx9qpOloOnilz&h(KoF-qOAm(*{o5p+5Q@*u&aP~Q6WC<%Hn*Xx-M zaA0RWm*U!BiF-wPtQ8lEMUDJ@r|7wI?So;0Oime_MANj*5DzZRsKF=j;&Nd|@yTss zHe?wvxRODiEmt7SL+Pqk3TE6@4ZQWG=DO|7)WpQ+!O*sPg`XBB_28@$`{^*zlr**b zojS*N_v$1!Ne$k>MCVLKel1v-Uy*e_^Mh=**#) zMrhH!%G59Xm5aDlJud~O7Ye$1zT2M&&KVwu$%J|hTMxKqtX04~Dbw&w!}ZeISmTb6 z(1n_V3`(j7yjJiLN8erjrJ3b+Xm^z6(C!a>__(LWo7zzve{v&-_+^!b6LZTg zUQD2wGMUqc9)7xMb>k9v^&FTgZ5wjzhP7j=xQVj!L`f@4cDJ4>m2NrQcbU8E-tT`z zL3#gMh81k6IMx)=!mM)nA1DD4Xk(H~s$mdrE#~xD(}0dP zx_H?MxFML~!i>sgG(&t22?7yg2GSQTa}*crTDx1rBZ3m&ZhDQfE!?zn%NOiAJP|@0+q9Caz8f2&TRhn8n}(Ik^vLBdEA+brm8(5*lmp?Ok$R@ zFox8{tJuG`an@jV*XVELiKg!tsxE!Reb&&jqafn)9`^f^k}fvnXR`bKSDVIt=kuNJ$NGP*6(oByNXD zxG(zh)_yN_R$V7q$*U>6w0D9LXq~Pza;)g&b!n}TJ-2gpiFH&<_1adt{o>55w#fS8 z=>>Co>|XzXy&i>x#3d&GxQ*lB$L^LHDVyiLa&Vqp{cM1hL)6fO>b4>&U-MQgKrI+u zg9T*e%#Zg9%pL?i5S`Xs@1qJ%35#L$XTq0WW&Ws$6A<$3J7|+6a#lEgf4y&l>Mku) zCEHI=5BC_WEpX2)Dt7eI8Jk^dZu?t5!Jq87mAiLU7sI@=F^H*=wtCaul23L;EVCHl z>ai)*n^LMC0U<1px!f0w*{rqoN9;DJ9Hz(nfX6J3D;oD?tha_UyfW5DfAib)_>Qhc zz8q#6r9K-(om~m&TyFz3zlPXxDu-${S-g%UrU(yPgrhe(&DH|-D!ZO3*i%SAbn0~A zQArle3Cww*bd693k6p^+{(z_V46H3A5&)L5*E}roiYhMh|a#%?*+%H z*;1|@dkR^E%UH8Iw+Y^wRPb6!xYM|_SLP8vdz*Tm(OM#@k~!aEk>4!s5yLcx_hm<* zyk#XY(KUhv&@%qXXIIH9P*hOtn`*~hW@-?-*4uZcTn8qm?z)25BPkG zSRGKE!g(7hf)*G^WZH;i{j(y3XN83U;eDu?C8wevKAqLvPP1ebR}cDd=FJI1xr8V2 z`2vt!KNrzh$q(Z@c}o=%)h>cDa}WZr2Lz_2v`T?TtA?`UOM^2C zQ(;h?{g737mm24^s=8BSPQxYmHwJ-5(ZT=O3{Ey$)wL|!+XD3VWL94xZ?xqLvu(4P zj&8wN1D)fCwg}I@3~7^#rUD_lE9E-68M$L%@@jR%<*$)I)yQG41 zq0a84=i7L`_-lk4cOQhC*`vgLW=Uxd6~FQ-9mu(g;-ba8^i%+x;{;872Bs_^P}{$~8)L$y8f%{7Wtg5{DDzm`W})XUDug#7{=uVYJlStFf!W2>Jbm=%;?8)@kj`* z5ha{XYnSH^i%So5F4qj)Pl)=#9L=qy==|9xG1Z8Nt$CJ~;~K@zw6&f0P)?}D&%M^CaC~O5y7j&g) zCP?7&+R=`7372zL_9S0Oj3=>5FVbNjI0*KvBsDbevsnub`G!qh{XN|du-c4lmW)h? z86~^Em~Q6es_-lmj}|HLB}y@kV);gyR0<+&=1V5G%{Od!|0iD$heaI26E(yl9_;>YxOa#g_;6;&R97sNeWv4S5>WDe#gB;Vp=(BtIJMbk z>GfAU9xtau_xl4?qU;Xri!Ti_or->kt{2gA?g!!GD;4y`XMR>|+iFqJts=ewFd>XA zMP^!=eN=*PB@5TppA8#|{5x>ubU>|aEdRY-)~0_MC?2?@cp5(yUSk@q{cnuCrKh*$ z-Z_a)g8dTZ&xgiG2>7t2Sos^PcaP1ucE&*xwD)S{sOOO7@Ybp`RbLS@Nw&oIt(VZS zgUu1<78=-G0YUZY{&iG;y@ias8WiY~GwCU&8I<}w!l$to&Vb!()^Fn|C9fJtEwaEq z4E8=}_Z&AoaA6Fwkl+6IALzvoio#E-t0K=$zl|9T{?8rIE~L)Rg*r4bOZeMIJhT6N z(SCwjxksb&wae%u8SNw#H+V%$!!j6LD5t)pnJwZ{pzzQ z!oW|{cp!}FAL|dowi1$sFijpWn#hVUiMX&JUrE{$DV2u89K+Xje5M72EGlRVFq(k( ziw8a=z-c1~s?*Wbb`+~b(hxO+H~Hw@zG_JN*DyPiTDrBmS|ZiR{8vs?oUmp@em0|D zKQldm$xiEXq81z`{iC>jMYmG~)0&E!f&;m9o4ViGapeBIG;^BJ;%pBTKLoeu+Pc={ z&CEZ?IW=Y!Hq7jCX^i`%Uit_xIg$B?1r?Bqo>(hFb!qW5pKTf8t1r$Gf{MIKp3)|c zawL=M;&DCru;lSrUN0%xNXn6{D6kBAaI=H#5&cFD)K<9vc1Y^;r%{a-*kFd>p8NPVrO>vZRY#zqjK72 zX`v`uBec0%d8|-An#%W4oW~p!0a?J>^v7Al}pNl&_5gUTi`4|jl#kt8pVEz z;@fu9i>_xvsXgy5?RbcAe?*{kf5fh%P7~%vH-+t;ypUm5*)?vE!v*SerWF8Nd}-37 zsQ8Ox*);TrYcvj`89Rx-v^&S=6$dRM%8n39>5-bQH^PE6V7}00i;A}Xwsa{I-g2y{ zj|C0K(jQ#D376vO+0|R2NR8(8+7DfFW3B9gp9uH{*cCxc|4dK4@!*%LVJQQRwB09| z=!1!Q&B9_aVtf&mT2J9=mRC`;D!)BXUjQotShdj^DBuO{b^)DA$ zRBdO3MNgwm{OHEMJl=WCviBa902ErUu*&Zabc-B$b`HPs^H(t9I} zkIi3*iTNk3t+L>whaC`_rhVL7GAXWXzRl7P#EJwOj;KYe-c^FcENfH_Wj>FxjMbWt zaveZuQUdz=dKf+2yny&{I=wCDSt?A_I%MM9O}#(-N*@H{N~pl%q5rsonm%qJA`q1# zgj~HHfB0?{ll-i(yXJrA2uHN)3mBc9#{#oAG*Z7s3Ku67i^{oRoc%lFgxd+<>9-l$ zJzQjcWle0+>8?{3E|FB0%@kA_|CsMgf@kTEI(Lu7Dl5?@^IXe?DANC4m^5@FD* zIQR+g&xWKyD=MhqgBp)-J2+gLJOmtSvPi$Ix5JmHKq6HSFc(E#A^u|I6yf z1o|Tpv&){VdeaStPv2vu3*s!>-%f;!GqqoXCgTNCY22nG-{Nmz0M#GO)x#e0F84H} zchR?%po|5(BOuIjL&-nYlv&h9E-(4}o6q6OQ)^9V#)_hZ@EK;RHJogx-LX@-wHvta zNvwrG_3_JPg!kQ@?pl4fsHuKAcEl%)|E&aVzZ933?6X(-`RDL!kl#^oKw{9eZmfLu zQbiNB$9GNv!{*|{POf6ru_XM`o&pOW%qPXI5qj56%}NU2rUZMG*T31s?%DOCg<@Rw#!1pp?a2SPZCRRX*Iz&J%#F9{;1;tA@Az@=0kX zF5?e?({kmwo43P0{5L(>=1>-;naKG#&XpkU?ld^uwcI8;Mn7<5uJl1O=zg=D+uW6% zJB;MYQRk_c2>v9&HaHO&(Q|l6KT|IX957jb0ZChJhRE3I!BlrZnUAVzC^Hr=xi=qR zR;lnv9z8RljheWXbKN)UuEPNZvFpL6_7CbfmMSCAmz(zU)_DGwdj%#4(>oLH%~TxV z|4R2>bU4yT{UM+U(aOeRy#X5bZnOR)6}AYjw|c5$^6|+*<~tNw6YAm=}U51aT?2N3#P7nmce7cc%*zBD!+cZb9SR2YOKql(8b_OatE>=vQ?Jhyieg%t6>J9&(YK1I8{M4b7^%F6Z4XfxsG z@v}{d#1w4Y!e&VQF9#1ukqXn$ERJ|{ zam?khxc?rzYv#EDC1p`*$Tzfar22XHLDn08ZA973kv#gT;ZS!Q#=XEJTZm2e6(<{K zQipvVOi>$lG~~@Mj;FBS~?^MRM3C^?L)VH_K9#Vl@Xq zean_wbrP>qp};3+unXJeAN!g0dk(1?5qzNxBQ9Ql>z6d+X}*iwB_?cMv;kl-#nck1 zV;g7JzLk$nZJ1D@l=lVE^YjE?1Db7g!Z`nCWEPN}5yuLszx|6bHgP%=9->3#rU=rz zCJ%@eyv<)~*}xniV&>hM(R!)GIWiC}nuZWS-{Wm==l7dccEoqlr~Nzke8Ira-z%xm)V~*yryM2W%Kyd4H~Z2U!wSs7bRGQm$bIz+ZY3nt;6e5yGNwKI#qA+0 zd7ZhVX-afXt@*Wq#Eiil4`W9ovgz=H@N(EK1?Bt1&mmCWud3d*T-h0MgJAe7GjR}< zyXqt)No5R1w&D9=OG=`%E90V$`3d}9Vr7z2mey8zSU3%zdbeA!;@iS(y+jw2+HBGE zfOlr2EtNY7WlUSvuMl^0$f>V{j_xD9p#p=WKeU4q-QPjY_|rxCc@hqf8ogzKkP<$s z>sP0^2XBhnHm`~Sxy`@BfJvg=FWgeXCsUpxjgd#zCKe0WUn0(3-~F^y3vNQ{W8JnX zUT&<}WAsz!UZgF}8T|x09KfOm>h1g<2wf&h{>fOjGSc4}@@tS_ zf1j~wJ7meEuHM}|@|F?R1AcJ77J` zC?kNWFRRUyiyu3q&<6jWuZa{&v8XJ2N6&de1d&HZT^SdoZ_>}5RT26PUm-YzX!bp zxLY(knq;R>J+n*yutWJocWtepBWf=)Dhw)jYz{qEROkX2= zKh~Y<2bU6}22TGyev})y>IV}~f9s}o$?ZkI&9W~Jk9+CItHoB7fb_#3kdb(rl|EIY z6qm&bUR;hxVUkpBO&E0q3oht^$3;?CjHMlK$H#7Y@meSQk3tJDUyAzs`&tixow_Xo z>Yn0Eve?TbzN8LCd7S;`%0iAIXE<8a1YH4UpH?3c%q+J~=vvBx!5 zuH>qfdVFv0BsQ!eGOl>Vyg*NP(W)oN7t_#z4|)CI3QtL0y`FfM6&}PN-WEJ*H_2*H z-Afeo890c~`T!4O+;qMuW-B~bqx1BXPeS5mZhl@#6m=XWj}MsKi;{jXTnZKX*KYNV zF&l}`F;ODPu0-a!i>qI`rxA*7T1+Fg{NPPzCYfFyR70Q4!~x$NYnt4!gf&A;)Y8k~ zisZLl7lf1x|E@Qi{Bk+(1bLBf^m$hsk)zDf0CuzMr zGzI4al~hX9jt6l+pUoorm%tL|823UU{s^e5PIXVqBWA@ID*jR0i$bKn+x))Ag-~o~ zlU4D>3NPtWnGX^k0ItC9qdDpQ{qR?+i?K|eiib3Vs!Psl_fU8^<}fm;aP-O9ol8^N zZ0ixiHi$oIVbN-~^OWPftcA$~2=vvo3!`3icFZ4g`FCo%pFEQCq0^gGN zE*BBuF-a=v6C}@2NN{=lG=l?H?L>VbKTmW_$iEvYsZ{UL{7lc zBjf&rkhewBAG*b6J)INV8{F`G;G$30oHhNw@bwyi9GVE8vKzLw9VYJULALfA#0yy) zDgXI9&-i|#Z*>kyo&c?T&;?E@9SX-SefZ4$rqE+P@I1uEWn)=Q;RLAP{QW%woXzHA zSKW3`9}xM#p)kG|e5ax6B*H;fSO0;yWyLL<$=+YDvo1R@Z8txkQgY4x$639-j12G6o?*-E=J1Zll>6UC*o=QOTVZUwh%*FeQ2SYDI&V0Mbxu%dWg1K+fIr ziNR04m{GVK@j2}gVL=`{r%ze?a9uvrnQ*L7K`5%7Q&qlmNHEC0O}}-XJ5r#_sG7~^ zSrRbj&L$PkLLa5lzEoBuu_5mDvPXpKLqR6}jbGS}9=&DPV2bz+e22TaPp$Pi->A3Q zIXk$uI0vB5R%B}9gj39wd|DR@=WxuF{CiR368Cg^%4LJBfcS18dYm*W=7T{C86F_k z>B__ne}OGwbEthtraf*jWbx%C)tQbY?L<^ zMVxdgc)?uH>$=aY{n+T)mVDtQ-}n-s+wws2VG`dRjVV#Ha$Wzf6AP5jdFf*MuS_qO zOmno!m`JQ4*HKrC=6q(dw#dOENa^ZNWJpMQN3(xIH;^vYn5_`PeGl!;El~|*2=DxVwM0*bg|HY zNM1z+F43H0B)%x(4;(O*Qb?YR)Aq{L(4=U~mKYn%;s0@VL7M)?&0~{{zW>~v&1_b6 zmWN8*0_ENCtNXH<4 zWZu+>8;|PyblT4DX(ZXLff*=v`UBu2qeEG$9teeBp(;<`2LSJU_8_rjiaJ3gmtW^C zZl+IjB-*iaxWyHVdQ*_P{Tjl9S4A0y8Ry@zl+rh3P7(`U?^KJ+_G^~(Nad$f=`%2Y zv+O8PEQ05TAy~cI5D_VzZ(=v^VZ0G^;f0^qlYs2n24J={X{4{+<;RDoZwn{;{8c zd1{++d2De?{!a1--h{K2k7vMtzN?(gYG|~z5&6?%COVzc`|-8T$ltX`PrBZno>FvX zc5^lH%|yl*vpa!-r7eP8m+VMDkPgCma&g-$u>>qjl+r!WyQtOC6s!Kg_Za|EPW9kW z{Wm|q`e=J99xyPT*^QoiAJ z)>WrOWwvWz%_pIF0UF$G_K*=6#@h@}kkOfBh#V zMlk3U=^)G&wc%G`Tc5%Hp5jh)4AjO|db3cPt65wre^GxNQXMN#q^zJ}muK|qP77QC zLY8&Ogcdo}XfYcOP`qk;C2=pGV3lRanm9vql4aYt*tqGZ26_Xx$TY;i25l-1mIhG6IAid&h*=rGoRH+lmT@&r#~23M*itm8w{OfrAKzURG=v;OT` z5D0MIv5KbanQ)g(_UhTDpif*9#Nx2SX`%wuAgti6HwjaTE65kegqj|7zA)ib`egTfUAOG*3;8s1Q6ZUSuY&(Xdi=u=h<| z;ybFV@80y-vpX+|>J#|YPITYiZs3Ivv&W8d*Is&2Hk540FU>~r;Vz=}Phr%FCX_Gd zl0>V`t_AiUyVn?N#U!ucIBrln^j)#M_1X1a^e&`7U^JLbZK9?{Sbt zM689b5pl_%^ugL!+24(2#;<|Z=2EtB0)RC8Dz(W>qciX$I0PlE18ivRIzEk55#9M6 zKg;+dASA7_t#L_8mb<&%Lv`)(3+NrcK8088I}k1y2AL(C>|J7ZRv_6zEj1^Ro(gMwlpM6m z>Ig@d%oRHXaB&=d%cuLpcP&ZNuVdq?(R9UV&D@vp-I^wTQEDk&76?84%Ct7R$@V?g zQ~5aUDr>Nv{jgDZ?;WSlV`^{SJ)p3KU{60QY)(3ATf@NQ!xIT{nU9Oij_iRu_^xO{ zO_Cm!x=T5K484gZ+q?&9gTmlO$V)k5X*@-N&YLjg1M%!LX}JBa<&O1GL-i;a`Jq%c zbu)G2(ee&Rf|sD_$O+dv86aKD!BP5%@gpJry+xLhsPQCOlb`mKiCH@bK|UCaFi+l2Ws# z^W)j|jkk79swRqJM1sKSgO$`91LNo#Pv$Y`&(b*{CP+~-`t!ZU+GAn3XXhB%%~mF! z3hwj339=N5jv+NrV1HHLO0ZbN>7k-vJrY?5ZDESDU>dm+UG@hh8G-&?9mR4OiFFc5 zfOtOydjjnH-&#sf73)+;BwO98PbvLLnxEuSEwdmibHl4_fBu6Sy6NwV64c}AiWHYA z6}@BQeIYBx-_};Q=XSPA8L!S^qWdk;k*{dtfaAzNgNUOyYWxpX7(zHnwDmDs&7^E4 z5z)sj!ROo^dFR3DbdQHsix)RO(|Pkx*(MK}EIE>H z+4j%Nqd3-w1C;lT58pFUsLz`$+-TLmEIpHFDwq9SBRKx9Vn$+$%8A;&J!X4Jbf=38 z?;$V8+>md8t#6!APr%0Y3CG8hWXJCs4t|a(P)jFji9Cp+m1}&i-_MLe< z%RpW!p!9TJYGc0m;?>L`}_n~OJ=c<9IkQn7sbxvJZcb{SI2Pr+GS{zHnyG1^S149xsQ~S!#lU>Y47r>H+DR{J zYvxXn-1xtigHg0T5b3mf8-+s`WR{e0>~;rN;hRxc{G&8|Rk~9GI*#%}RYa}*33_OqB&qdznj5UE zY2G&o0iQ&C(O2(0MyjbE^Epb?E>Ld_a((#IehrOJcCI7;U0r1a z0-;slzu=h{ZTv)#T)RGsEq88l?q=f|iZ_r$9PWfOr=omIjVh+Lb`GA-R+)}Atc;&6 z)L;}~PZ%E|O z_bu=96s|}Bp;8w1kiQ8gCaz|S7;a{QebhhGy0jkRnyrME7}z6KoQx~OH5l;$MC4p9#KT3 zuS*YA`=PWQ2c`V^OhAHW<%sF+N6=*p+)Jzz;ne8d1mO!8{G;rPnFJR)eo%jJ5>(s| zUO4!P8%q7v6(^D4+ z0?m+KgHnRv0@F4hVhwvfXR=?4ccR+$uxjUEruO?>LeGnG3$e`V z0;a3=a-yf6*CMq^-}ulp~rDl9np)EJsQ z4#`gJAvpLKuRBR%UL!QaCECbKMUN+2!SW3f0aFw|wW1};lIicL;JW(=cXy!SbcN?wZC+arkzLIR;@`URqONz9YX^XG;IASbH+@_Slr_)NJ5P^|DMe)FQsXQ5 z?tQ6Qw5XAV`Ju1(CsSX`T9?X!(;-i-A;yU@kHSMZTXukwSO(Y5Bh$Zq`748$|EdC^ z{qGFGsb?drE`NUStU@%SC9F1m9qj~r>zidKJ$HUY3VHU|hi+(r6eNKptyF~Zwy&t> zvacB8Gdz&6#_C#P*-u5hH3%QXnkJQsO&w-XYP0Nd1@0VsA1X`!A_6v&Z@;qdPS?oP zXtq^gxhV*f#3hSGmMC0gwy!WTC0XT?3yR=3kc8t8XY;FB<(mpHL1!OA(u2`Obk5l#zolN}pE$ zI`mQaH&&=n#?Lm-XwZsJn=IlIlgm}1LI+oUxiwPwSoo(0;C?*#j)3+mjyV$zb?XmG zKLCf5;clh1ZWWdu+78Na@vM(dO=xl7)u%Kaht!|4dw3Q8%lo8ZjGuJb)Pt#J6V98H zGz+|givI_CYGY^QjlsLLWDv?^s7cZvVxdWstNNSmOLs1I*!b5))1BVqKajm)lSNuf zH(X_k!$S9ou7_i&n5@fgw}nNHQl9?(GPF-=zQT4uHhtEmc(=CV4hPYbT(L&prXoEF zc-P5(e`Y!}!yXL`#FwAD-s)t^sw-b+V#SR%v=VcvIH%>_!yR2^sCUjCr33{WB za4Kf-&C5w{gt)XL7cloAJFaL~$^!R_A+|)vcJ=en&*qXfvv`$of|UAm1p`&>SbSGk zooLdFiM13i=7X>1UEc&}y?!&yWx874 zf0%(z7weFp{#831C9}vX6hx-)#q_Bv%C3$L8SLL4!)rd(3KbfC zFMrGAk?U>R{oibt28n3BndWT@I6G*SLDaiy>G7~vW%-i?zQPOOO>nit6qXr?V^vIu zA9l=y3G{>G!tA}mzqycll#`|oygtj!8NME_lLItkhN90UUfj#pvuFQKD_ zGXh`VSA61O7RJm1+<6(6&uekx)=$7-@DgB~)rd58UKT(N?*2(!7`KscC5Tsr>RR8I zH!$DoWT&Qd4s6S?`jPc3wVdN={oYU9_pPHL^zHXV0cYwk8-m0il4md`A#bq*|H4 zi>%O^n5f~+hxF`PQ8uK_&%nt?8e_3r-`hbJ;3exk7sM4jnIP#^sxW>g>5?Q9uuMoH zBth%2Q?jzB)YVBI64Co?Kmwov_7n>=0~^nOK(u*cI-520O%ITuJu?{tS2EZ&5wdsaG?}5Tb38T3IHhyvEPv3^ z+Bf}M*K7d_|Nk}r11nlCgDnL*B0TykA(dFb^midsKA4q~;TZMYke%q8PqzgyF1{~;$i9i%Cu^}`u@u%Q;{dMzS=)tcG*1nwFaC6rEmnt&4@+LtTcJmn8r=jE z2YBBMMDQ5){=qFx6tU$RhJR~|lRn}DFKkMyk($md45cHsaEer7y)j4A6QuQS+bJxvRR6YmyzueSzza6$w-|Ib(|@(nSZ=5;D#K_V-NkGQ53Ji%QHcB#35~RhBEq4~p`O#AUmh#QB;N4aXfqh%)Y-`t zw6Vq%0OEa|?2fvDykO6PU8b6_d8}MwJn@lS%gxa~R$`P=6uJRwHBh>U(_Y z0fzSI!#?KAH=jZEV^hd@4=lS@PIM9Y!&&zgjXIKp&0PMR&YGduq{(42w43xo&282} z7kAio4gT-zJtk*2`u2xz$WI5dmoU2`r(xF29wy4wRmv@c*BS-}-@NXxU>2GCuH`;( zGGpFepj1z~ojs4B5Y?z)Bjb1|DyiD;<8A$7UmRKLj-^&Fk+(lZUFMWE`Xj`Gc9i=i@V;($$3=-bGVoN_s{ zo0B)2rLOD-Ao-K>XTj>t4S2!4Xediuw+~l9eftI`s{nu z9f!?}UT8mfsdB?*sva7=X8jv5wW zJpR^~`YjlI(XHeb?310e7s1Kyft9(2M@g5 zg1yLIb_nU$y}9!^Ht+*hu~ttn(K=#%qq}H$(u--xlfJMXnmhc#hQgDB)xAaLHq{AO zP)Ql(h%u9eM;iv=linD~$jekqBWs6wyW{@+8@__4gF2~nFLnOVaSPjJH{GRr!z~`9 zbL#e6l{+bi{@%tMCyU}36)Jrhy@&i5>JuTqg^~^H%@r(p9ntOQ8Vk8ep^?UO6 zgsB#q_kui%s0{lFO{%V*?h>cXi|^YjGycTj{WYh9gj-{0;Vd)cxKX_A4(s^c_-KN!3?p&mN{--8Ub3!f@e{9UGhV0gC0e^kltJs&0IFgvBJ}RB+gMN#Hgk z?}BXI3;6WbDRQDDV}DcK)aP;0?oZNLGR6!Xv|&a~{A*}lR6QqcY>+s3#ZJ<2h%{$u zKk=+Hs;Ahs-FT|rYB7`#^*L-|9cE!DR6j0IpY&|-An}7e?Ud7)W=-RQJyY2`<$Ljm zAha16^l-Ai6AhD(iFn7y`OXO^LAA-!UN-W9jL;}Ea{h0_qo4~kHx`4z1LaK^POvi% zbGl>lCZFX_q%Ml5WPdbe`fxH*GuQq0(1Nq{ea48*mCHju+>s_MvS+yJv5^1)&FS-& z7BqMMa2?PYiwf;H1#fYv9Z_o#G&P%(y>9Lbc?T5K=mhh54NE}hDLBWdvf$1G?Y55>|0`j%@WGFEK-yC}@V*(XVT zqT3?U~ld?M9LADDMBLT z=FRM}ccP6j?IBZ2^o^zHvL20f36P$O4Hx_g;hK8&$~9B8 z`si$Htq6_v)$YJ0dNd~;j>GkZSG@eCt<9dvU)QudTkto6wRiJ=;mHEY1NxHV|EGG1 zvil@EC(Ue<{XqB*Q-}KASv}BmBh@I0lmfn+wNYAC zmifoPHw!-ZP3&!JXhVv9WBnwfxMHbbNHdn&(p82M(wX*Xlzr*@*Rwlt4tQt%Ia5_y z1^#1@;ySZth7P$Ku0(*lP33SupY|U>7&nqsX8o>nJRzQ~ofcgGG2qKjny|yB4SXqu z)-@GT;u|aBPOn~8=%T5fB8M0^+vhZg91MKwLe0iC&^KyziqUN6#_vjRB zZLr1(4wcSoqaVcmPtx2|*RAF5!vxYqn3eIEb31%<@lLWm6r1txCQwjxz|Yfc43`M? z-_u~*`Bhev4HR*KHH-q~1V0P_%tCK5RS~u1O3xu6G3B=}|Ih=XShnt&LdFr;prg7W z^l2p|f*=lF@Zd3NHtM;T6`C|`+NkGn zO(5lR-q>=8Z7od{25@w<$K$+;fO_5)~gBDA2&|Zl&r%k98n6rXt^b)Mr+H z^%ooB96E){W+u@~zla8ana&b4xp&>I?2}CNJ1jnr+sa{#c_J7;*vk~%fb@dG6xxOvHwM@-bikBVryA6#uhi`v&G7fN3REJmJiy@OV~Jlr0L+( z_d|XJZ%4!D9m9n_Ai-WEfed9zMpOvj9jS=NNIB9aM&T#HR<6{_I_`h)PPZM^36 zrV)#U^<@eUf3>=Sj>>u49(BQ{hXAzTye0dBm2H`mDDHjAIeM`+?7)f++RaaW!Fh?;?-BN*CEy74Z>nuP$EMB@{R*}SzH=d6N*DQ4HvWoUhlA%IS;<4Hi3se5Nc)~Uzw`|I54UbJ`P6iTjjp$k*q zdVCRXu$lh0nS2Rr>XfY+3CFSgYW?YLeW@e12*jROGkiK96klZjCY5^YXHs8+PLRV| z4rKGGmQaaxdzJV(#RVpYq4tBSG}oZJu)8kuyfzeZqFxjy@Ru>NYin*}2dcy!5r0&P zE^}9}hD#bSa_jUBLP_oDEm!6ua+BpwDXCuCCiz8IOD6O*^tKp>_<+8J2oTK?QHrR2?h@e z{{cQQG*ceb8I)SjXG!=_ar^+dYHj1un3D9Q(ZEM!7fU;cL<}256-~(pnZEUS91E6N z_3xv!cHEq?ym1bYLN8LzM?u;axqN227|CHhGF4G&O3QsH*Txw_yMeXW+7z!l3AawmXctEB4IU12_g% zRUG(PCjT1yCauh#D14HmnR^Gj)s%M9$i^qo1nVk#yC?SM^k3fBX@FmCMO0*o`LRjU zVfoteVy%xNC*E)CYiTc*Zo_rOpd}S&Z!0tIiSfjypBiqE z)4VKj>R6uHy|Mlars!DY{z+`!e)TGQRTQ2S`;42Zcwj%6aws{^hi_hEcc&;#{p}pS zhno<0_08HReVnC27Y+<*fbt*5HXs6emODo?0qP)5;{o+P+_Jt%9 zfe{xT4us!@h~8trT4=IGO56x4CLJ!V9-YaC#t;Yv#l}j@n>WcYS*AZf`SV=sLNfrI ze{3a_d$$dj`S_+~yZS%CXL&!CqEXRNwN=#Z@9Upk5WZbe;&-RsW`aeu)VT#Sc!ysu zpC*8A(?BN9kML;}f^v5Zr^iq#9;eoRJqeKlIg?>O%X8BI8~gEHS3f0mtLxS{dTVYX zl)zCf(IB9_G-e`?d`~1>bdja;r~1z@kPfXu#!s=7LTY8jIrcJ5n#4K{WM;ZgR@jFY zgc?Hi3D5eeB~yIOMRY)%yXqE@kZ}g9VoTrX1mqA>g95 zRj70Q7%_o51Y(s#N2s;zVJ@<(zAi%sUDLd1XsWGoc~O zCnp!CRaO9Ml!SViE2z_~QBz+xmSt^Sg~p~II$j^Lzs$M1Jg!L)=L>OqlgR36q?yj7}m8--k{ zfC<+;ZX(HxA5>KJ8T73t)BJ{=fvMz9Sy-|%*2TxqDDpkLO{?LcD~-Ck%D?fm0{)dK zF$onRcL1kuu@m*wdQK?hU1fPR06}L6;3cYp|Gh&Vs6_7` zSoISpwM%&pH^AnK@3MWwI$}MNpd}M zu?$-{b45+I2P=VWYbnq(tLvCa_cppoi&@V~Mm=hztrEwoju&uVFVlM@RGWjk3(?%7 zh-Io%oJi`tZOid}nKT_kbMwCBa8N;sS%Y0DQo5|I(X5$|`mp&FZ4(=Mu@2VpS`n-x z)m&s2eYzZcGlwz8(MrsPVGfG;HXapw(;^$}iQ3XP-Da^Ew19{pP-CSAbvceI-}-|V zHf$=*R<0Uq@a?)q6xY|r~-lo>}NyI_l{>(bg=O>Tk?Fa4 zka>svP=^l~mfP?WDXcnAOWc04V%i!ym72BHYhr|?J5O{&2M48MZI~>Ag?iM9Nd$?B zOy9ln?biBs-LpivN1_5eycU}`;i0f()X0jrD{bUdxaME9k_fYV*47A49DdxgUQvP< z_AwGs6RcQ7@gnAPdd_?p6K3z{&Y!!lgA-f8oP@f?8D%V$3$wiud?c+WoaB8jTXc=J zUG(R~R?;;?M@SSqV|+8=C4F2d)GSZgau3HuqBrV&!mEF*vk8F6$vZg^Kc_~L?`MH> zr;tEQ9rO`3RE$BoZ}sG{r$UYROyxl2f^@IQrpSP9%pE43b|1hXGOh#EDkdD0!^TVr z0+0gm`arjdS*)KCu}k2eV&`Jw#;+kW!r{~vF79DecwB$Cu4Y)Qm7;UqFcI!pJ1Dq+??UVliZ;*GG zzB$2Z^Cwj4;Yvsl<`f-2?Ri%;EiP1%S2Eccz_Vtn88V0ALT5dAPTasRzAR-0+09v|1l7iKBT`p~7Xmo5Fk>PuqjdcI z3msPZnFqq7)iEHtmn2&O4k|Dd5`PshF&4j<>&_U+&ZW@lg9TOPfXt>3{&J?_{ydVy zAa)bmg2xlVr~zY1lPkJi_$Swv-?FtlA4Rw|o%;1SvANCGEz@9sIL9@cEXoy`f>mG zTt_xJUc#$g=U_EayuoGRxH*dfr#Zn8@t>*P$EaVgi@&Njoi9i}$Y8rRif)Oh6qrRDDWA6|js9N0%{T28o?&Fhrf3if=B%4D?k+iVX8cS+xjI726UB%@@ zNg_9p00L!~w&vMIR+WuQu11k{qa{hkN6RtlJ?r`VBDJg;JE6CroS9DPb(=s9C(+Jw zArqyc-s2gx_8^0(ftt~w2BU}!)=Pu9H107a`#df#)ZeG~u}J|j$dsTAM?P>*`i zm_TgsEQj<$h$Z$rg(e$gqQ`(lt5-m+h>22CW=35zZ-;Dnp_rc)P^&9^NaZoM#R**Z zwV->UU`Jv-+tR6x>9O%<Aa-*8c5P8)7qjdH$@@a*HD>;5?FWv;A+_ z%0bzJ(a#Z@kl|pFg3)(xO;iS;$sOCYU++yPc!s9+A|&$|xe+U*V|~PLHypfX9$e0Q z$uLpwB_DAaX_+TFSf@(t$&5yq#Jgyw4uM;RmL)g++J zLT75$EEP{I>9@Sy80fvY@fnR9M;YL;^@nYI@%qmmk?XKqQ{(bnu@DpCAnOHhWmUy; zT@T}@ZAgXixkR^MdPdSGFk6&)I59Jbm9hh|Z1#5m5Jct)t;|z0TE)(ApS)8|Os~WJ z5Ae;|n@j|vDVkCC!l?~FhK!fKaG|2Ge=R+%Ni{EO9>FZy9c^Xbtkx&y;Hd18lsG+g%jS^hVe!P1_ z`R4PM0j%`r-rEcuJ(q}3^le>DC!JSh3hV{B(<{fX8QlO=G+!F%*0$+(^Gcv+!KMjY zOn+Y%KGbyQ*EK&I05$cz&c7E-cq*y{%YE(ykm;n4YlYUOEpr;S1V$pKYSSgl=A1z+ zkP|Eybc|#t?z6ouRkTHgE~@X|$gJPOARzPIS3SAV)k?n7a=Z?1yyvs?c`DJ<2E>0k zIQ}8SkQ<>N$HTuKz15t=5&v}}augb_scjw2$4e=M5{jMrj!R=ks0fSV{^unih*y{O z2+JtuO6`zYQAT~@f)KlvA7T{|;feis2YvqdSuAOX!G6Hr3S3t$eB4=c?+$6fu^)q) z<5M)Ki`7*Y$9XMN6#7+zN`9z=e6pwq)5%Vh|7BN=CT(Gb3{&C%^PfPP3u5+|)b}h4!>sOl*&2-y8ATPln z*Ta}VY1Q)?-Q-yb4HLV1g_+LNhigQ&YHMC>N&1Lsy5hk)P!Zx|+a$XPz^o_iB-z%}?<<8~1Zi z_=R95d2Ms#qO(6EuwWhP58!o5mR>tV@irod<3#2c+B0UJ^1Z!^wDav``xfj^Rx={v z;bP+z(mNNs3ZJ`1tg-W};~d2egm-1xW#&L#C|wp%eNUqj^Op!7lwMz=e_30JZ*U`x zo+?q9wH`@IK3peoWG2+#oD~?cr{-$in_dZ=Pg@!wX_%vq&+%7T9AIB!)9zYU9UW1I zL9ee934Zy@Z-z*ugcLf#MAqCUSyawD5y{aNp)7WCa{O57DpO*yQx!^3elf)cziI2m zdR$1s_6&?u^(o@Z;UF6}MZ7nV33m(dOzSx&HtrvRDW7V0ed; z0SBFgb2{FRXaeaDJ-^>*s-v-rKb@1+-vo)C^x}DL@J5A84C_AKJ&W{<9rUlaE>i)q zRc%NFqQI^D35AjZ8hd98ti!4L=p~(>YA!$eBV8$DPTb@q#E80vqxI#uvVh% z20B)QgJB&ma$pFVjU6>EdD@~doFMg>16ur1a=>*+Q=N_zd+1Y8SmI`mGQNBEA z*GN`JuJopi`R>EP2tGoQcCJ_?uwzT=AN^)vJEff&4#>_{20H`3I%q=!)4{AKb!O8!(vx`}L_}=QG4}buMR9&T{!U!%(qxQ1 zef=&l6H=C9-SxMoZG+S)4vfUidLRrd9?0Uh9~1?Or;5P|k#xPnBF*J$eBl?n7-3&f zn_a0J7UCi}@_jAENDeX2@%#Ymr6uz#o~1~!O{I~WW>6EVsBMY0+VSWeO2uyLe)643 znWpWuOQYvOGU?wkB+`YpLp5Kd$wj|PAJPXbwkZDj(SapOHhz5eYDhWd;yroK<%?ji z%s^8q*j%hLiJhl1v-lVc^jd}sN$9RqgJtu@S{=d%83>4TAO>eB_kVWO#H~rzKbxfE z({09mP8LTTGn3Np0kU?>pzl(GDN1=2-)R6VnD&R0F%Otb-ZHV^G;$I>h%yPjoO>rj1pZadU+&-k!`!6v)oic8Za=)1~alV)CZ1v}7!TslO8~ zRaLuc(V-($PHMS73cbUtER0&pA#Sfu03!s=fww$oF(9eNBO>}!cF&)J8*oRLzAip# zyz(n_S1qg8QU{tczGld`neDNw$6)J80a>jvYxxhB;9>IF9im&0N!M0C*T`TBPFuW{ zJ!7I-=Jy2|NAp2Nj?u4YUDGZVPJTv|)7ylI6H+|6L_T~A4iV7WYKtVWU-;y2EyZ$u z5(u#BitvL}0F#C&?Mr`=TR2h|cdC%CBeX6P=Clg9ciNlMxWf%tR91eI3i4DO%Ch0tbr4ZB1o}&+Gy`$6x z9+8yk(t(+zNE}(0OHQ(Rh)8G%SZB3}p%}t(N)N{>K)>ic?B9vP9gyQs4! z!k3JDtIFv0kqFTr!s`uW&{qS}A!t?f!o4Tp*4BhC$A_l8U}=$?(Y*TC6GIhwp0orf z8X`A*t5tkHXu~S)w0aHEWh;_4LLcl(M|R+wd|9| z!xqPtE93`dJk4T)@VamDuo7ZNaJfKQ#`l2Pjo1+JDabKR>DFWgbACJ)H#0VUP-+&8 zN;GR1b`A1~jy4!6vPG3`s3%MjHR}ZbVGktDnSd6*=Hz3`ozpWeM{x50I5%|eRpP=ZiN?C?2zj9W&3i}&e+ zRjNLqH+Hp|K7M3)y~yEZ60ZQqLfUs4-V~?1N55I02d|;33@cclySQs{W`&5eaXNGp z`Sb&lBF#*t*|N?XZ|&w_v7)s2lUANbiaC`Z3Rz-z3Ic{6SNViX#FY)UnU?Rufet#X ziu~&&284ASGxwae(obeJ>UyBBUSze~wWsHEY-ibpavIBx6g@Jb`(w9c9HMqITOvok zRK|2&XK4b?F2wQGcg{N}Vpf7Va=Qn{@Qs(e;o1I{Pk(MXBpXo&2EQ3)$P<)HRF7rd zj8W$vtQIVI12M+YN#`fV1z zk$)Oia+>ML&3Ivb*xnKTZ!V`;X|qRWMD+S_wAG4P6eqT(vxuAXp3MP;PvvA67kiY5 zxZ1)eQwkZE$jS};XNoO%P7Sq**z7n&r0ve!f4C1ogiLsX`^@0OzJ{X*ScCQZxDJE2 zZ*V!nGT4cd1G9rw?i7+WtWP3W>u2u%nI;n8!ELHU83|%6adSmywy_BpfPhsO!FjDk|5GR4l8c7trya^UQ5FyU83PsYsGdklRg_-d2KKRm#3x_8s|st8;1$? zm{hbAZQ~-#MY{eo%jFzDl;<9KC^|C4x0YS)Aw&Y8g(Vnn^re5QF1K6y=Qfp|Uj|01hy6af2K>G5JXpP8y#l`WEKvc7A@qf<^K? zEwlDOh<0gQPLx|qc2G@aqUV(>0=-2E*6yE`XJlSRQUUlEUKXmaOL2M;-ctHYp?e`a zGG4Z}4(>(bOlGawL604NR~FnpDOxI;TR3oW)liJK(ka>l09smMIVkH3pifKLl z@3M8Q&R#%N16MT|MPv@}>g;qEX{M{>85v*ysQWWzxqgcl>k=BFTvi=magU1djw;sJ(?x{QbD6?wkv%S4{;` z-~&m{?XyX&8Iy&#Y-%wgVZs}HD$NAZL|E*Vji;K~$7ez`^I@beuGhEF#MS@@+AsX- zcxf+S{y$>5kVl@;rSGoL>Kb542=(J9x~Bj`(1^B?L5 zxSbJ{{ebvbnQfON5SBc4>);Py5Z$mn^mA;zXjZ*INBWW<9)Yi=_F#RH7_{F zm5`&M_Uhtw9iL>OUD(hcQfi-hF`W{G9m1WVUBp@<*Q9DaNV}CSWiOi)6=FxmeI6vh zKxZGuSRf-TPvMus+htD;b5R40o)_x##x+W;(JZAb?>jg^slL!NQk6}70!2r7jm~ur$Zs0VI zB%2K|s^5_XwoUW}#5)M@E;hWLVRj3`%tx-JIQ$+|ZQVH5o2-!?K@EY3O$kzIT6RdJ z8c)tpHP}l87vb*)^8F7F8Zut9x;B=G;Qhd~HBXXuxTy4amPtd_z9r7Fzt+#gqhP%OrxJ zw_R-#f*i*I+lL7_%fV{%9uk>;s}qARc@%R83B_2qj8(G!2+XWq*V@@*LnSd;W&Ni= zBMsq0{yF_IUxMv5GDes?dh2JFM*{ST^BJCtmPK6^wxfdTr?nY zFBb=S|8GUo8tLdY?s82|o}p{6cH2&Xj_zB9qz_Dm)6-G(FAF{DkQdxqw3y6M5K9CB zT+L&1SFS%j<51<`HWWp$ zb5)1C?0&3K6tPUx-PD#47MJ|c!^dp55V(r`51@ft9!*nY_?rH)m0HmFKPHD8ugW3S zPG8QJKC36a76wC$5r3)+Ys$K&r{+DVLfZgB1W1c&t+t`MsL%8Muv0NDQ@4v{xAQeC z%}BAT^uDiZMv@asovbkB@t%|-FsoFWNk|u;rP8h4xUTnJMMEuyhK8@SaHg>l?memW+WEAgQdabXalDCUqrKFX9sUBuP z<dP4Q>h~tx#wXLgMT+yATZt@=Kjc(NlA!%>f)cETgugxdeC`UnjoGm< zn^!@~i(Pf<_^Vv0U8O_keV^Vwy0CszPxEKE(O8XIW07U!SbX?36cr9v=L}!m5Fnz@ z63QPg4vZP$9nsfjxxVALrn$S-^fqUX=7lSETw}QSpO*czGXSvtWA8rz>9DUDnP_H6 zG^o9>n7!=wWyt3`NH=(qDIU|!22e)-0+wWz_Qo4I^JcB$sc>`n8c}qmcws%Ce!wW2 z-%neF0}wP6pYG!wa>E18T;*?7(-F9lvr5{WozC-M4X`P_SHW*{xgjmm4e*bE1{OPGTq-?L*|g zo%QYGa_pyX3AKj8 zh4e`jWmxXf&uJ9~SOZ;l`}*bI?+(g|#b`$gk%vj&xI+$NnT{KHICQVFcx1XY4zT%9_F(39Z1-U znD5%IVUMt8thu0#WfB6jABnhm%{D1ox8D2>O)qAg25)!exz=ap1~7Z{TR%6T%2F4| z8w^e}Fa;sEt~&5S%rqtozG7!4+@)V-Q(Kmn%8{MURFHfMszLJCiNhh>6cre;jw!{Q z9|3fd%rA238%8Ihi0j7L5S09e>|}IT3WSQSafu*wrv2OQAC!ejV_19ybE3+IJneed zC~FG4#{y8kUm_ukqv%GdkK`IC{hv*hx zZH+e>I3kAkZ{2AsX~HO{o-X;qAV>a5`sJ=*!kN0>6jJIBh@K4j2zF~^imUGE4Lahe zEk1o7*ysP7&i&Dx-MG(qW3s2Eq-`_R(MIm|0Rc^oKZK;YBbyQL-$-s9bT}0o7?G983JdaZ4pzB{y+x#^y8>ZZR;x@| zA{ojS^KCb2J1U4eMKlYLpR1(@!$tli2^JfLyj?9(An*WLu7T-kPe-Tz-3RN4M$Yz3 zX!LEoTB>~HF^5@X28nRJ?|_&Da4yqkMlSA!oa|7xc~A%**elH}(BoNaz6$n-7R(41 zXt3MWC6YYUv|&;fTFE1i>}mR9*ptxhH6H7`KLz%XTsvV$d2^lTvt3&7k#x&_Scp~MIB@F6tBf)! z-efsbvS92biux~(6k8=QD|Y4jmRo}a*qfWl$=4ml5-LmPI~R_U9k9?$_f6CaZv3E3 zw{d5OIBc|{B|UPmR(-sCh-I{AT0Zk!_NS7sml%-G)S~0eXTnU_c%*-`-K*q!4vMnD zeH!dMTB=$uz){ZB!$tjQ+-o>K5aG#rTK)?teUK){%KQK%E^dX&DysIA3?OjYM zUn8TgF3^9q|4TkNwB26M)0jY8YX{%S9-nvmrHni2>zBEQDa%aw`S_+R5x|FIes7*C z`vOJPX)8{!*R4v*Umje|#P+=D z3cv!OH^HA5=Ml+VOWHFXsrK-4$HLg6VGT9qMgv!;hjZrTy&|Mw?MSupL_5isKlCic zd-+w=^#XUx@e#uc`7_(6Jm@h=vh4%y!_b&(LA+>ibfB-YaI+1m#>bJf~UP<8OP?94BZ z4^MR^QP71e4z>MiYg&|}mRrmY0v-(aU%6M9S7fd3CSYNrWuo89Y@EzlRc`#@dnz~S zbfD&7&$V_E6;|P9_@~h+{qiu6q+k-nMI zIruIDtK}Gm_Ib9Y@6f0o;45r%4}Zyhnwyjy9+@Ewiob zL_VeFCOPK5bYzlZ^P@lPp|OP|77;n;8)@WG*{wWy;HZZ=3=121)FpQv1I#^NXVDT?fuY{KM?;-O;)^6lCXN$Y#1?lg@-bch>-DU&GzW_?u!(1g>LS4_edwX;SnQsp z{xWDX=rquJSG!lFpS&h4|BWa4=mY2f_X^vg(7wnnqo6YUIlS%;8N?bvKqQy`P=)VO za_KHS#GwYpB|`E zhcd4uU7&3y+JxbU>HgOGJa42}tOPU^1*?skg-w|sUxa`V%fWzCWer1I>a`x4H)O=j z!VA|iMMJ5*d=ADoiyWFx%eAAm!4h^hI0i*?e3CW+-1;?hw!UYd#4#yOWS#)Tvw5z#7YKG0igB;e+dI4Owk^2$wS44| z!q1*-6pwTQfTKQ^0$?Ni*6J@=@MbBrvX>-3zV=qS-;1adyqQ%UtpGkH#CdaW5&cnV z@$Dir4sgQD%!7y5=FuO0idEekv_U~mdT6r1H~!!Hvah#0IC*?5H`&a*m-&5(oWyYd zV2x-6?Glfkww^ufE|9AtTBo~*F?mq72jzKMIV8{S1osI4b;U{vTqP}~AH>?^A;}S{ zyOMS7DCs?WQ6`BD#u{UB=T(|yx`3qlWJAV(#262)EBiqJG(rzq91BL!KSX zt3K<=M|`?Wgk$7~PHe}04tWB#7XM8B(L{P0@|rLe0H<^kyZx zXtk1&%xA78c3|2!YuJn`30DrcIIIQPc$iQW549&bgmJ@_Rt#U?16J0s0s%^I%eG8l z9TlY#t6c&K?DG=~kmnFn^(Rrn+077a_FFznWPz<_LS&M`1!wLPN*ylEAhOUgz-?wW zNCB!@$+#S@2kO+QtNrxiElcXdQW;=sOGoWmDLwe_Kc$4Moj2PhL=$d1T=eL1Am3OF z_bi!W4aOy9gOI|-tx5T;P`s1Zml&*fQ*9{Gxihn>M=8sXkr1ntk2av<_D&;V7nm?h zJaKoKWf?l@nH?8`XUi2i7?ry8ui0fr@@QX*9FoUp5R&Q%PO?Cb*ahJ9+h>x@Q7%V% zSe?~T5w1bK zt1sFG0UVGmB6Lh8UXNz~VeZHAli7ixZ1`7LU}^&Iue#NN7AX)qZ#mdI6`|k;RG3}< z!FY$6bQpLHoJ^y}^IS<*6;)1%?78VD-7C>F4tsF8!F~gX15vVGR__bvZ_DffSwOtI zzi?&5S%fK*-^Ds@k|ox|M7!Q!+rd6i~|bhKqUF`sk+>m9s}%<;C8T|*>y#0TX>@&IkR zn>WQ%g!tI;jt&814K$PA0)oA_R5#a3pVT78OI%3aQ+JAKiiSi`WUosxmNRfbsqGe| ztR^HQtv=Ss5<euS-C!dtV7LjMuT8wxZAsM9#9u#=lH8H;Pwg**b`0Q zmAF#-gBTA!NMd)-2a}D?tjxu45scH+tbLL3Q4ms7tMKDz$sel?<_X}~8|!a;$p>UZ z7>GB=7hTbtn-1B5>x#NxTN_VB8U{VoHDqYQ>;EN)gq1!mV|jy%*-wC-0sm-0&WsHP z`e+VFW#~F&oS-kgMgL?(>FYlYZAXL9eaSy4AbC}FP`rw)GP-R_g$fOn%x_e$rrW`y z-zshas8@Fgc_hVT#Ue6W&L%FEf0^L5$|_3DHptkr*t&eOL;9?98&}gE4@TkU>;s&S zSh;!!9KvAYglOoQT`gg6th3tr6k`+EoNVvU-*fq z(#8dI;JSy#-s4y9PcqrfC-U5NYvH2=YZYyA-LA$kao5exG{tkD?Uz5gp`79AD?|n_ zrJvdO3Je97vQH*CS%taJ?*L6rb1K9TCbAvsTMf2)o9PfEhVr-4^vqQ@WT}pfa0rL2R@mXf3R5hpJ z6o*D+v{hdW@Qi>$W%+SjLA|6i_Jv-%V!!#IARM1Es0!g=f(Pf-V7(FB` zSHAr8sYaD<3*pLaPl1Ct$;)YX`Z)|@@9bHU5dob%%&w%C6n>uF8h9vOXZsc&0YPmhp!jA{?~m`>XG+R@(4^R;mX`4yC){ogPh5L zvyMa61AXw|!A6}gMopUe&qi{{kLKfoWXo0evwmYdxQpS7q1F%0!+`IMv=_8id%b-- z?jz;FnSmMeNsBHuVC>*@3MFOLgP(|-C$@ll=4PTW(ngk5yZ4?|fkEkqLtKKgJZrGK z6|lq*UyrM0ycPkY0Gdk$1p^E>H0I#3KsVcmz>#Ja)mOYQ|X!Bdbr%p>BvmQ4NKtgqUONye0 zS^hr5B?$l2R~w_9c*EBv9O9f2ceG1IVIwEs(B+G{;&CFpTAQ7vmk9tpUB5wQ=7w#gXVcxhm zzgodfVA`>gKZA`2*ww@`2!H4_7Y6Gw1p;WYvYHeLjXW7k7oeGHdHq=u%u{&b$Su@_8bcXQ-oBow_fmbW|{ zg{0$Z)AyI{@&9I!B^PK>Ha5=CcJ68xX%fw-U?Vh7Nu}n~O_b6IxDXmqJukvWB2^_L zjha|doYv7fLt1-g)?d6YkNn+E5sCnu;)4L%Gc>5E^w zFAGgL#MjUZ=)oiMk=-;k)XiwbZ^?~^@fq-H zciqr_X{^Y$dVA@%RaY&njecN7b@Y=*S~-}?4xMMrSFL%6Mh4!|C5MlXW}TKVQwXR)5mn^@oO-1gcH zgkp%7l6CYz=SF30BO0A|m%`g4DGRicsVESx2nW0dkZcd#u<}KLIp|d5M?xevGh!j@ zoJd!7%YWZ^$tQtE6+|uV!&2D&WX=04jMtA&N!P75d@l=!ViuJh{w6Y-#wB0u^M1TZ zI&ET@AggtyU*mlT%hkhOs-BC}3I{kT8BK)-dsz)Ip6?Myn^KYMubx-rrX9IWCNv?> zTwX?82WSNaou5{2v=az#{;(~Ur2#7E)`l;L_wW@LX;>e?0XBU{$D{r+VP9sfw$8nP zjh4Fadh72Jb$1J^C?$IyrK)NiFQ!fAr*=o?I$h;jvJ~1W-&7xjMthKUfpG9e#*8%f z#x_jTyc4sR>o`7DCqv1{?$PtZEGGaEW<0ivy;P(A8j`+ZQC{T+{HYOc8^&{IsVYim zWhi)JgNR8P@lf4Bxltl$dHw@EMX)q8&Uq>F&V=?Q1ZS!?Nd zsoh^TGRn#kakC3_uT7;B95z2zYdsOHZ3w%OLakUfgNjGhyhZ4x-$dP7DvAQAXFTwO zT=JvaJVVwrA1NQp_cKbu(L4(H$YQT}+GYW3X@H2qAfwPkvP?4+7ygPOHbvno3(<+W z(-*Hc`}EAY^|RjArIrSNGSAna!MEMkwOj=2!;kC5pMPYvH;{$=2?H~QhLk?Vh6gCq zn5NgO@7(C0XxwjT=)n$(0KJ}$^OD7+bApU^v%*|-hP^O*P7&s~$<(tMm+C}xK9*ik zicg^rwbgT-m$JOALWs%XtMUNQiRmemnl1JmSPj*WQ7m<9UY{?L|7^0-R`8!-&RS{2 z_%}K=z@QVYAfC3+(*#(%8}{FPUY!~I=TQ8&G&2EQX#6Q6`|AQ93;W^!Ks}P~_*Q+b zUtrB!QmO~sYLkUi-=b4lOk<6f0MYKGVG!fDmSS2+f!VApvCRv2#|d{(3H+Qn`| zpTebpZXx^j#F0$xxJkjm1j33WtG1QQ3j?fGv{&!tBCMWdE; zeo#c98J!V7TdEl~kvjD{y!;clOTa7b`WT+-0%t(E7cTyDLTjsLi;~6F-)kamNb7#5 zXgxhA7Ud0UKE=bVd6!?59cQ_^cKIqgShPvF`Qy;>t_2KMKP(-K`s6LK@I>EsX_>Rg z&Vws&76%1mva}f+Qe-|@+9ZX5A+ZC`H&xNVj^C39>bQvGfRo^i@5d{b%e1XG?g3nY(fze8%W@g7Nc)``Ce zAfcRPHT_fV^~&e*7HVUTM6~ue{M`)w*FizOx!>ki3e7AgANDj&EE9X_55NS1sR}JR zqP5z0KO~in@wAVGyMd3-@WCmewA01JUopXAeyFCM!d~0QhLrWD&mJIjX%el z`gCgq>%Him7gkbE`p(OHME@CeI)(cTnZK7@C{P+d%MHFFlO|Ys5TsHnH0u5P$v)BwGsGNEr8sEgy4?JG3Y=1@gSquqUoVO^iSwkoPpG`gs9L(C=3YxsSq zDHLiFWY3CXo-G%#cx~ds=}e6jJeEhc}&t6-|Tqzc<5I9kwU(^C} zMVD9-pbRN``sbX^tiBxV7e_C{)Ba~OU03zL*&j&t-?3j=3*~j*kfZM7K3G5d?tZku zNJCdqdMTETi#==Z0;mjR<9kO04q7+gCUFtF11ovVBGW5mN5DE~gwseFWi!JmJHl-$ z67tT2iaXNig`ZVp4an!Vt5=oF*e{J=HGP9fxdQ{5-Hr3h8OEqMq|6wFnwZIyu~(haY^h>K2*ll$C=9JZkgG;A(bA zVjH%qAr56|IQ37AX}0US*9&#L_4cwww-~)<95)fs3!29IYMtIkc2Aw5SnrmCegC|K z5Yv2)enu%nj~(itPWnj7ZQT7TdV*)2*_gaC*0u1*F|4deQ2H>wTceHi)tU|$wnao161ioYC$J23S+&i+F zNxYHzI#c&WM7b_}rHChPK(}wJg_P~@+~pv-A^EGY+7{qB+!Gh?=Ky!C&@kwdRfS5i z>yOg&O8JzY+`SlD5&c=^~ zEHxpuC2>$A4QO-BIAHc8!ZGg(#@Dmmh$Ij}e^!o#D2Gd13e@Ac)7Q}68N1^~n~g5K z)X36$1qYz#$Raj*cMJ2JZdQicH!&(d-lzxg?!G+6v{#;_+&;Bca~Jr7TBonEe;6(l z&nUq0-pKhh#f)Y5E1=q^CG@mbqyw$#6hv(%G7Ma<<*GAF_s+NAErJB~3GS;{Gj zA-cS36o+^7mUL4Bi}Dv<&;R|qyP~holT~~tjq7kgH7&H8dv~x{rp!C?+QigJ*d+E# z7mybEuc*lNpazE{L8N+135~Bw>rQzt!NKk@K2=T;n?ZEX@a`jXx*KjUG*~ z@!6Q=F~;v%EdX+cXGCE;Szma?pR2YsJ_4B54%Z5WK|qts5S zU-fX-o~mh)LM<1lu8)c1^%P*K%Q!A#+(Y<$NdST@w_YU3)+C>yjOm-JYAXI==46H{ z?bHxTN{J)DX40=Ff}+)5-i>_GP7?oCq}RO&o5rxj&f28-=6rGSc5~iBz>BX8?W;4p zQ2Mv|ymA*Dul}4u>20xWX}Zac8fo)^Uzzaxx}*O54W)}s6uTStu~Pt+k4H!YvL@B* z!X_g@A_D|qcB|PSTgCj7I;x3ssh(F?yX8%d9Qd+lk*i#nk%c4kRAFklawMMEVci@- zlf5MF<#uaG7sR$K?8oQ)m~hc2-GBQfu@CbsA>AbMBKk>+7ZN}#&peEAv6@01*;)kE zD(KO4J5C^k_YT$_OwwhLG4sp;4E;rBVgVJ-4nJjL<3;P`_`3%*)6gNOlup7+jh&@3 z&vja2)6M7~_J`xPH`RKzd~QXfA%a3ndAFj!f87We4O{5tfA~q0j7^yK!wJ5`=%}j+?-5FZ`gg1|E}1uAQ=PEQs;NNr z9sYJzBe!2h0DCj6pw`|arTq94zzV%oBVsX;XF2rKy7sS9)4kgTlJ7^60(pv@*P8#Q zrbe-pEePQ|S*wd%?gq@0PI1$>!@J1ELZYxxS^N_|Mc_;h3^I6mW8}&RVsQdqOQsyj zTFA*?XA`>!+;x_cwVXv4jcij2o7VQy?fwUPMBBu8R@WeZ5Kn*0U2P(VSNM^g$;SQh zSzVPbRD)|0OF}b64zm40dP$7tpD0~(IJsgd4`=Sa=wZQC78zfhCJ2FfjSzl3`Sgx*+E9z0qcQw5j?Sf0_V~2V){Lf5P*>HZAmJb+mQ=GUNlSS^$^xN%NkW?}Jr{ zA`V&v%7r)cgV>@`(kqR>{f1*gwxUW%VWo6j3u6kX@c)L_RS&Mk^_d)aYxrx`2&+%>uzs$gG#F#AE2yzAO2-2@?V(Hg%_eD8zKk80wFyo(AhclfPSMdVI6?kqXZbq^lMe0!324*Ojp( z0#ddf{sp>u<;L3En2`=q=srLi`-#(mvbEtE+6JG{*|a>@-XRq+V)_b8kAxmBZE;YZ zT;{)zZ@&5subSFNFt94msp_OWVZ}-m7NEIplpJa!HPeyfrH}0uTMjTnq_53;KAx)V z;*nmMb8b2e7G%$kjZsrG2XBV*1>Z#`%NcU!>g2PBwgpL{wgg@Xyiip*wgc#LKt_Ef zz+foqprikuL`F*ry1#IDRA1JeoG2V)(BH$NRSSLo_xz^!m|9Cccbl&Kn@_tN#X!P< zP4il#Fg9+dVQRTr+cow|V#j}=(HI;%58mB$1}f`fWxh7xfF~8r+oQ`blP)^~@gaWq zmpt4El2>N={8wPfHCEwMDnLE6+5u{a`Ek+<)|g)Ff^(FP*cQtt8NtDj85;1DgI$mm zP#g?R>7N?z*h+f4(_C9yyZ`r$uZP{FhFIAyT~LAiYp>EVRCJ`1BzcQ_^0{?hIKevl zDUaoVaP!2BWLHtNw@}AJqqa@*1)lal$6>NUellaphniwzK1 z51Rj-m1}XS2WSs7Hy$|o~W^B4uPx?{v0P> z|IKxHHIShtg;gP`9FOl8mQh7f3)Ggo-2~2Q1mBWORVlFqsCgZMR(yA!fLe{@Bs^yj z6dCX2V+0(F2+hI`pbA* zV7b?R(MMZ8a9z^xe?|!Gz2x1NJUwdCs3r1W?AUtw0=+hRWnss6rWOc7Mg9ba# z+_;M;PPXAbNN7obLqz}gKwlw5&Da@pEt-)>MWymgU|km+OLKrOC#LA{GD+A>sJk?` zpYU*dfqAJqAR{4X^rUH(DO$T#6;X$MP~+QWt;rZgNQnJ9a;4#oa4NNw?Dr@01dY!h z54Aiu95@L3GW=1_2viB%080K9q)5Jw%)1I1;h&Atsep^QsrdZNiilHE;)9Aq>I(+K z1Kjst#&iHYh!_Ooq-%Osj?_UO$1CBqG&M@#JGJxSXryJ7XhN_g{#8G0HwR;@ z*+qx^YMcy+2a2Ky&c3*eF~7B&ILI)wONw*qR*2rZ-erC%o0vVEkS-mEZ;<2<;_p68 zV57ywd!}{XJXRJ%}rNI>OsWa5>!|6ME+I_VoO~Z z<}!3-^6Pj3q@V}L<~stsfg|uQH@H!Yx(BR_MNea>e|El$sFT5Lu@PmQXw8*?(bYuk52<# zH`*+LK)>#}hzXg#!a$Q+oE(w;mx`mII`Gp^Skq4(O_;EYP@vly=a)4>7sP@sKh7G( zhdPk5|Dw6$zY%6(u2=$WkhV2O&}Y?gKH_Dd@BHaLfLQPaar2^Q34aogkb97f9~63; z@OV1Z?k%^L>QF?AEcAA5l|0F7+>JNVk!~Jx>1E>vux8Z;miZPgDv(EQdbvO_319v8 z}ob1ZZ+AYm38t%#0u3o~y2No8(`Z~spcm9_5k;L0G zC}-J8iwJDA2q_>@9G-AWCjwCkGy~e@lK1mO6)geysC?qORkXLgCAa z&`~wvVo;jH2PP18K~P?7lH+BEA&6Yx=@tg-A z<{DFfqP^s#hxhME`7MDI)1HQR>%dsGd8fH-KRbug)iYiMx8dHEq(ySOPB1dx>5)%p zLpLO}oqr-B9cqQWp%Lu<;!idcq@L5P#B$5~;mPYnBZcg=<~mTjZ`lkB!l*SeQkBHH zp4j76YYDI)-}a7tBVuY`qoCU_z#7LclkT{4j8i6xs|Pm(dsOs?9* z(Q+@=$67EB-HU;b#^f!0uad00JUL6G1odot{=Ej+XgDp2m%$Ly*JL!fu=XieR1;y` zqRVtduyaCAaaxsdNrwJQ_c1m_hz*esx#QZilI8uB=fhR?Y?50N^x|dQeejc6>IaNb zHu1c&=aLSM@~&C8p=*FiHl&9BdAh4&g&X*DsLTH1VIZ%%j`%>*rsV)0T5j!#%vE!;ZU?Tu-Z zOiP$m!qNysPkBvHMqc zSQ#8(_Kox+2yK->ysgX)vK4Uc1@jy&(*7e4@C5MAC6u>jA@7uhW3iosI^4R1TPgV3 z$F_J0?Qj#js^F-zoV325@|m*TJ48j??4{-ci12N%c#`+U)uIOf-ZKk??^E>KguMLT zRJ;E>2(@k&N_328KPLRRZ@@8B;TWN2&SLZE2GTqI0osVM7J^|H`#7Vl1Sh0~Cc_kvYDK3MRd?|S{V??DlG+<}&C z0Hy5GxU(#FgMLr)cJkBJ_~Xxsb}g|p!s(@4p9_u~m;Kj+99YYXpA{ddshW*{%dLaS zNSZQzA{vOCsB_ZkE%gzOV5L{COS1aK?gr<5mwmvV<1Jj~+(nGjO&cM&{Pvx!nWm=B zh{54@O6_jeZ7;-^Fjc5ew43f?t_ocmM`Fem%IX;lNu~iW(L3LJb&9^izWydr{aA5= zPA`0}_Kn&q06v-5H-w_n1WD|MFq8@MVH|w(-6hbI29Oqm@NmidI?gA5znm6Efu0y};JJ4C#gPP@ zP@1p#Y%c_*%q_WNqWmIibhCbQXmd+r-o$+_)9{u^&{G-@Ln zf)oN)0aSS^Uq}(RynbA_SqWdBv8H+Y8I(q5t6E_vI#mr0gDKP?LWz4WW~RSYQT#|( z7{DVH3vCaG6L8m4Rw}%<5?u^gO>l?r2hGW(3nqt(+$(Kt+4Kw&&rb7myJZS7o(#O3 zlb+MP`D4u$%Lbf3-Jf#aLGf2M@6XpQ?9FWv3dyv#7n47~2Kv+`aLP-? zU2NJu_QpG$B`=!13|WuJ=~FR5JfH;Wxw6*;T7NTosPDIce6*Sxs!kKs*be(!y=L6Q zZHtAmN1XbPG;w{<^Bxeni}0+Xia1j@$5g14-c@hBHNzZJ?`M)e^Sxnq3`$Q&0JiKV zp!i8N)b9?0{e8rDJBf)R&WWl2p`{VLH*H_b8A3V8Az$}Gj+{mYDiN1q`DwZ4tY0cWbvV958p;f?L?Q?wHmP&4jtJ@?RfQ zxC-_D`@LDsd~|Y`Y2=_KdP?C&!OsASM;X=9r0Wzo+3qV|^AS34SN93Rmlu0^g$^}Y zXwDFKH{XbiUQq}NQ^+>I5#7pla9#Y+2|mXTE8OV6AZ-HLGT_G)M)NrL$JV}#W2=mI zrb8F|PhIRJlsj6QO#M0B_inszeO;+S1HR3jSu z<^~;EjzdF%`{DfeT4;A@1L{}hq>a}N8>@kjnu}!XHPh-3rmPxz7peyaoeYMhtJZKQ zmE(jM^H*)vgmtIJ4EJF)G<%BT85S@ z5rZj&AI)Y3aW#0-Pq3UzmOLD7)~tfaEB+xfa}6%RBG$78KUlmwrADm$CcNvn=d>JvaLUj{0W_&i0o4S)qW&F#Dk!G;-sj; zqa~bfrZ~$|*Eq-@;1<#;*_u@FkX7@2gx#_j8xNP)B0G>qQ!F4YXGlJvpv}$k3SHZb z>(KeaB}s8u^mSrk!j;Vi%_IlpW3=;k#j@EoMJZ7PIo6JqSBcTGw@N#eL`*|78do6m zx2as(s*4OClnK26kjWoUWh_(#?qG%>iveFtMCD~qHFc`&jWDJjZPin&46;X5>yJPc z??(LpBsh7h-rEn3>mIo-5-MpyAKaep0fj|~&{X}9H_G|jn?5w_;kQH%e`RaM9kw|W zoPc-BPqq_cQU+LqEQFmAp{%$9CP;$c04jLjbd+bl+eO<&o4s`0rrfl*Mqlr96hG1= z7mN7^^Q*}Y4=XQQ3SRz`Sr&}VF{OJFpN{e#PD&lsntL$jz_5$X9ONQRq?f;==8w99 z4Ci~MzR;dAM9M(F+W`NlG+)M)Z<6>7k%MY$uT8CuQ^>K{-Nd{MB7d8uBSIv-i6Uco z59H4tvFYSn%(S_v2dbBY;AegnUEczZK(!(ax1#40#94okXWd5M6$u-vrOv4)91A8R z7YN%l_O+J9&>5figmvMhN-yj93=D;ufY-Pr9GU3(pJ$CC5$giq)1kh9k$#FH9BFLj3t ze4?UMqf=#ZVWaM)b!+bpe!NusFgkhQ)IgV$j?LfIYhRI5pU>^@yQZlh1KnjJg8L-m zhWq|J{m?&)6NP=-dlWQHMeoR3?IwMuw&SO$7Vd9SReSN}(wMd8Ekuv;U9fv^xj$)sujEJ7W3_rcKWw>?Q(bLYb=1HQ(ETh&6#c_ zbfD2Cb()}T-Z&^4*=t&9emaP~7E=2EUV>Qw_MhniX@=vbb2Kr=JkEtyQxM5C>li{3 z2x&JB)=vpFN{?MxodePoGQHf)dP0ysj~WQw@yRM|X>?+JjhGvzVVa_IY(4lr)Oobc z;xyE;j{M4$w5(jgfIH7vnd!^%=gYHk-iQXC zA()+xG#k3$rc=yIcxK9h08*osYa-E<0mBz{d}JopE&F}wk|K{FXppz>Z1;((dU6`s zKV^;VX_6jl(|ijX63`5ebd7J?iC~sEAKGEIIy5IBhO-(6W(~g6w&BKvHB9ipZB` zxfQt0um+Tw1|sv#)EZ9!krp0V^lpwea9)^U zJ%FZS>^c$wZ}$AHEYTTV>rj&6O`YfDgMmbMMRh)Ncs)FuxL@HP{Ue_n!sj_%3pNSO<3X+hC)<^wC6z)go@)cXPCd<~Ia=H{7 ztmOZ#ZRukgPh~H==BoR@6D(RcJh`NgC^o?TEjy2NaaT7m?Mp-?Sr)oqichH&4Q!JNtykK_ad~~Y=-i=}m#;}OPKCy&nvn-%alESl+wO#bjaYhQB73pm#@W3PH{fPJk zLYLw{noZ_Sv(G0654s!x>2>jpXS}gAljXc4=ym#ChIy!ASt&)Woudes%056~9_ql? z*?G`<&#E|KP4LzY;4fQpmZc8GQQ|L@0QDlmb1z;9jakpuxyx?!+@PSHS}KSOkdx%8 z{&q!{+cdAh{Da&U-?fhtA9*=)vj{B}c1jF&km9)t$7ItPm4PmR@@uvo}J>TOBM^<56I{D%>ION2(sziOU?>l_N@r0;OZGCq;=UWq9WBHr24H zBA)U^E!*E9x3iKKhz3$^2mgcpcZ=Dg;IS#ZSJ~5~?hgJ%PsRBvM#_|d$x})643UGG zkcQTUQHHnBPS;uR9UqkJS76cbn+%b|biz^i+_?oaHF-gtn0U8dG@tS6M;5U|7bl{d zf_ML>FBuAyHzkaN*y98|R0YKV)?__bS7kn@bBvb4Nr26}7^6y!HkuE`*>#}Gde-Ls zU$0$>YcF0}46{eIF)1AZXtXl2!Y4U~8FM?aepPo)&H+KFGceb{lQT18k+vLoOf6Qz z1zNahfD@Bl5N4dju3*{T{QU0*Ta1m326BGml5f~nx65SlG&)K4FdH^rpJmV$TC}nm z7ufkEvLjzpz)8oy343($7{Thf!8SOH)Jb6crtq6!f0aSfIIt)6cu`Y_Js`ZVbun93 zJy{JN=PgjHm+tMtc2wDSZ?nOvFz#)p^LZv~*k~Berx1TWEc<(_N7j+hgJA_|%9NT* zokJCF0=hN4bW}JZpcAf2(1!Ez52lioi`qtG9y3%wEf<=vQC+Z^ z?XQt0ZLV{3Q9{aOattD9I_s5YQzvUrT$GQ-dDn$=h3@lUK#D%t4LG)ROkr#qXxRdM z%(4rU$y@Vfx^8}$29b4KSPX18wuatFA{zm;GKVMWVRo?`jSn{&xcHL+)7^EGwy4aP z*6X*F8Dv!>5q{SEfdK{A1?r46(WWmzrQ=;y7+0bFoleKFlhmv(*%_!|2=O=arnG}+Jzp*CbWbU ze#4S)1T*0APjcMcXv6VZPAS&6?m@?Q0E60%KYYa&+zfKFy|r6-dv5)9D@GR6SB4?4 zrcW3a_uM8tA;Kyt4=*3FlNpR`VcFO?1!cG&_?)U33V>Qo=L!F6`~tuQw6+}XlU>^< zdG`bofQOlpc&*z{rH@iU*BWMM;<*7J$$xcHc3V&*p>e+}%(cAB8L$u@bH zd)qNuN%iHms3ZT)qsdnO1l+9msf(1bog>Xg@su^Ey|!WeYpjV)lTgq;K;6V4o_l1< z@yuZVBjQfU- z!nRSA0cL0UiSAhEYt!0Gv$Oy%{Z_LWmRJiWZY(e){`H^!J>6XXglO{!D7SCAQgixk zLlxRoUY1vW6Hi@@w%*AI;j(fU-Jr_QD*Tg2G0QuA^Y2}}{~9YKRc1#x<|w8MJv>L& zKH!7=ro2QD;JKfWCfu4>t(0l(&Ar$cCMAX*-j$j0eJaU{WpX6(I_>bm_X@AKx>ld_ zD~laCQQ6XYim7`(D3eBXH~LYk^6(4dPaZ3OO#lQVu33njCZmbU)^Kguf#YI!P{B=( zWdEQnYp6USYuNRx6XkoG{gk!F*o@CQleKYWxC;+X{=i#-@0ypzDi?;YUrlSDO@}q!l#cFO|8)QtXUo7~B4h(H_Cc9^E{8CvSN{V5xCDg_BNLlA)?z z@bWKK3^fRFAA*t7{og9<+u+YvW_#l)@;$(y;mDolVsnHJ* zasLfo4HPb(iB_#7nf&CJ?WRK+;hr<ginKlGUrN~5eyl!>+w`3 zLyAlsa!Ez&j^MNSL?r4XatNAxW{Y8lM52oT-DG_i&26|e5q4Wu(A<9XfG&YzSU~BL zvW=Zq+vmlb^PSI%NLWg@-uczKCd4pYsNYy8t@ssPC67ExUnJFJHS56*E&qzQ(4c3Z zyRvLvtJ6lPr7a+0iqRHU*|i~?Wb6O=Wf*|a?&Vvu6vqS(42i}Swy1J@=xRw~ib>+# z@v3gSTkN>le9H^@FV2HNp*< zI8Y@dtccC?r6suIM-4?dHf^{DlAxIE`v?P^xOsJHLwz_Ks6E8|0{U~hKk-qTU7DhDX?1tX1oJffZ(_c* ziM#0Bvo+;bz;maFw&nRI#iJ0@bCCZc&-qc0dXIs3WEdm-DB!^rs;uyS-t&?pp8T5~ z_W?M-n$vtp+Deim0H%W2fcwduh63*!i`rtZj4^PEzA%xF=3dsaxU(Mx-&WvBH(`II zSF`1Js#{ewDX&qHx;uJ{hL69=&~SE&@xjOaclFkDN46ffZ?1K6cPK;? z4_(H{BBa#{h02I-mP&Rn(X~aS#C_^LdN3@JE1)PR<*>e^qp@NlpmDbcA28cm7;R?7 zpItr%yfQ-nWTs{nlGT{=9*74pUrzz3SrglBOe!R4}9*~dRh&*I1v z6Qf361Q=d$@P41B0RzNTpo0fw-KbVaBqDU+IZ~@aW{LK=3G?9gLM>S#9{+8OygudC z8sVlK>7-9Y+ua7mq+Uzclzh%6LLVC-)0gGUqP1F5ez~Z!D)Q*fYh76fou3gS4V8BU zDN0!Mqe*a#2;Ph_i>mHd!)GdStIvhNEY#9YJ~nXx655WhWEA^5-+ML|<7Yq? z0ipiZ+HWbP_=+gzSfVsW=uQOcF-F(D1({(pe3?Z;u#|A)|3F1zwNir04q+#_ zB{yNQJlK7q{H-e(Fk>RhGgUkTn+yi?H3|OfiG2?%@;o{TgI?gBI^k)l3cpB3yI7o(G=FxT?@xgn3ro^r?en#-%h98OHD_OHEu z+|m&3W(-6{?w^ zyvv-0wn8?%m2cm&V?EjT6D*I~Nmpnx?>j@DB4=5ImR&*`B^~Yj4{9@>X{KATmk|{i z;U9#I#uPxcvCZ5&H6&B;mF=jB?G1jIT+!ZvUJ7?WAShETjW(#6CLiGs(R&VGb-WF3 zev&@h1+2PoJ_3`?dNHUe1e*tXvg=BNe|JFXc2zB;3;&VU{V&PMi#M?sks`06J?JCC z9D5kUAxi?ecKzFKC!6YX;A4SkzN6#K%+W&1u@4c`pDY-?0;D2uq9j}?T1el>9&0{J zVn9?ei`Y0WS&LAyUYE04qMfm`&+I8)@~ER z&5nk?3orTVK>9MoHi7Q)d#x$gL<4lsCf!`0G>V1ONQYB6Ptru|4p7Wp2{wx!fgs0} zq~L!26R>k#8mNt)+?rt9Dd?8elFmsz~jD@pel5XrL}nvSuC^Bo(gg)PYJ`G;qs zw|REY`>zO}~%mGKIWxE%IOpcX>g)0)YniYRs5VBeP#|7tL z?N|a!$_xGzw~M{d)R$qhJj7)OLBB-d7e<%h{xMqIShJ8ChF(Z_as^8pWlvF}Q&&O{ zfQ2~LPQqRox)`t0I|=(-$7N&XSkno1j3(kFLDxH^$fL(pFUG1pYx4>4F6OPNI`nAH#x8+{PN>tY8n3nNe1x_ z01|G3%wJ)FwIy3VP_%m+aMG|^b=41*jQIcZ=X`^LmGYaKsi)NaB1HtDkub6qi_DFO zT9WbrsA$+Jt`i@^wOK(;A{X~dK%HEY_)EbtZl^=xQX%ml_1K#Jq~_2{D@HBs^xd1s0i-{i@^6HRCIBY504S~wbYx`*NL9y z8DzTQ6c@{xM~C%6LUcONox`Q8H#~8%cU`zaZe4+QY~r*OPm?|QIn&tXMJRDsn@^f` zqc5!b&)0C~K#Bt!9gIlyPmkc>LWT%DFKTt+?UFj#iCPr2X|bBq<|xwR1tf9&Z+(Dj zrExPs9?+6FoSlMWio&5r-WLj?j!&vZV|WXNa8SM}S*{3cJ|$RwXZorBaEWCN6$QsL zyu@W^Yb7nsPI3E=Vf3}^``ltEYgj_jYVOU?XX?nXfMox=7N?Q$KNx(1!zdD4N}OEp zWm$*u+N22?BJ|9WYk(ie32eX7P#y_&6{&6b55%X6{kZ?%bPv1zr@&3?6G^ODG~Vbq zM+uFu-G`}R>rP`4`cImTlKkz}3)V|>dBm*v(#G-O2vIb+I@a54nwD53b*Q58&<*i; zLR_H!;*=*8mmp`&^q=n;e1Nx32Cx-|!}8wUT^ME}7Bf7x!yu%cgzz>Vsf zXbh#1p4u#O1^DJ9;5#2?BqrZ$s;+By$J+QOxck@aMvn?^vpZ5}eMp?$W%BNA!AB?k zd86*Rpj8merusIXBQA}DKM37{VkK+-QYS~So>(7;bLnV)w^t1^n|%esR$*|#^+v~* zJ+gI+bnXs<*4@{*y8TS9B1;-!OdBEb=3bzTy$C`b>Ot`QOJg#oMmS`Ebyf(U|Mnq0 z_sCSb{l&}x&RHTvbCp~bUZ2#V1Bl$(lclyM>0kxBA9w8zQ5w4ga-;PrL8vm2=t^Ph;{e;&$WgYP--4<&t z9FvweJ7|u>+AiE0?cS6W${{fY5w_*yUs7(NhUB@FzfvSUt>B(g;X~;`ury45l28rM@@iG&5M})}@ z>Qd3}oK8n+B-l(27PPG?(i(fy+rg01T~3@lAK{Pd(B+JKX{myaFA~ufFV~oSe^C^! z$Xd0}^LUKujy(@gW*?U_?T=l??uUtJ28zPk6Sw)Fp){|PRWxJ1j)}hrcX2fOH_mt_ zP#9WzRbW^;T_dcxo=`Ge8zgjFh__mt`*Dcxd?%VFDTIvutHm5n+mpe!OB!h_{*dTJ1hOjih-|Sr}tl z_wMhPg$LAbUbU2{fR2OFe;{M-mh41nnZ<_lvHS<(!Z_lB-4$6nv#=!e27B0*=gt$*?I>oP8c~}vGiIB?jRiTf1c~E+T{||FD_B41?H@!I229HZ}!KoH^ZWMH$UUCmyOB|KKn)8?Yo;W#`v93?@3?$lzhg61iPXs zGA`uN`lm)>S~e~8vzZ-|8?l_?)=2#(sT$z(>4=2li6b0{d~}iq;yGr1P_Lvt+#OC3 zZEa@N{ek3#+x-V3!dZFn57?Z5^NwkJeAMUgQA>%%rlA$S`!$gCfP-RTl=~jLlBcz; zZsCDHlzC9trbk<{0^v+`I(FL2BAeVS@ZVI!i5lUg9*FC^vj{jO>sc2uHD~69jXq1; z5`FXu#3|@}dI(S|eB`j>GB_%F_m{*UWKQ#?;=atPeR2U^Mi7w@Klgmjf}L0xS>E6u z0ZacqYk`x_;XZuP2Q1NFuj*F?Y$oa@h&g?cbjUS%>JI*E0b4~gRkM1hP*a>XSr053 zSun|$<9$B4W@&9ZaWwWu5Z-SNn6?(|8Cz=+Ba6OR!xY6H>)3~RO@6NVWjSF)oY>cD z!YtKj1}(9%-Ah5Ty6363DdRMBrbpt5me*?N=&STl;3a1TY-nM$Gh?vRGN_W`tM#xO z0hnMhJtM21&>+?|JGJCffZ`6HD_P_=eQisP z_}`u4c!BbfiGtb`^I^Qr#7h>3h)pk$2u_FpPA=K6COeMocN^#u(d)EUya68Pm9t~c zS<;idD|DV>Y=j#iRQqW~5kYHphn8|%zSe3EXMuOKVxUD`$Rg(^Qw`y~$HRry9XbQ@ zZsAL-AE_HUG4Z21lU~&@VDoN{*PivQf|~$*;*Eu);jP` zi4R%VFZ0k^kLtYH=5A25>T_r=ua&Tfdzea5!3WwAD> zddruWuTA=;rKiGQyZ;Ih_dxI?jHbigsHnbW#Cb5EhaEQup8~iJIynX_{0hYG z>;XFUgn@k~iIvWcwVkici?zN%>JKXCK3UXsvUf}uK-K81qfrKz|D))<1EK!^IDU4V zWFOg_%^3+<*;^q(wnNF@6 zm=14dw`FOHWRq-TyKn$;sr~fL5dC%5Rx-4}Yq@2Zd3O??*};3%U8NwL<14G(Y#rDW z4y+YFVQWk^dQ9uUdUFl$UG0|XI}n=UO(3oC_1yLK?pC5{&zuJF=co_hvw}t2l6nj^ zXVr73d&0I&44r=8a&ZO)Fe{z4Dou#44jWYDvdr8^rFfqIqRmWoLz}7kmEJ>JBLVK8 zk9v-Eqh71Y=7;BF8PkuHU_4=@ixE=qb-M3EPq!nntNN#C%}SIxRr3`>k1x^vSwBZh z<)Zd4Ra@z>n$kS!%A}FqD}SWOn?9cL8n0JieD|%GlrTgVS>A(JPLH)kREk40BomwH&9fQ@UTtTD z5kq2|6dJq>Wtuyd2#*LD4G;ZMIU9vf30$?~;63!d!Ea1e$Il!$7gdF7cLDv^i`n|w zgWI61=gT)NLX=agw#|k`Rn_2)=8t}srwa)7$DkTlSkb$*?<3qV@Y3~z8Dt%++6C&J zuI;B&dc3?zB-dWJT8istya+LayV{F|c3|;_Z3$Q8q-yreqvOh*dG>bqIq4tH%S+U$ z_O`CmL=!f^pc&hBOe*|QLfndlEmQKgZ|?=pr+Ylx!19Q`x#a`EfsQkC`J4Y$*jV&? zhwihX72m71?P5sQ-Kyc(kKeOBMHKFMH}DBCmZ5Wm^z4*Vn;)&%oIhE>6U0;a&W~D((v8e;+%LKPa#rZ?v;!;FXDs4yHQ=kXWMY z)dg2o_Aj^-%&l*Z$5OTg-P|6U@D{Qw6@%GSpD}5mVkmJK_SDz;n ze<_xywOl2ZO_XW(DoIofskGr#L>*xe0azqB`IBoS}m`Q zc!`^EC3#sN)3b0o@Hs_JMH3jRiht!3xxWXupoRgK7R`orvN?WZ<|uKvIkx4P&SNh4 z&CA>;vo?|@Y{B*xg3GjbeL6f{e%#~V{gmqK*o#xXyZ2Oorebp~ThtOPCD+X-K3c_e z51RF)Nqso#X_PDeQ2IoC&t`pOL1EODM|V|m;ccrjldMVi8(W=^4-cV1TAU4~B_S6# zmnuoQtu3#@(nrKUymxZ8H_(pISf=*7t^e%TUfb*T*An6y%t{M!k=WBGH1>BB+8gO+ zS(p~a`+d3Zz=1}nW4MS{)>kWDMx?gDg$M#nXi(Tvv$>1YtP`$tPRkUf|j!UK<=h5w}gjFj^(5)LX&Gm%=^%J z1Ru2>ZT?f^iql`W1N1f~7FmYVTX{V{?ji?45DMn!O%3(W4j8>#{*bsYv!}pa1PveU z#+!d@a*;xpH!;KiHcwSUVm~6w!m~P0hApG3S4bkU=Meth#^_gztWFqqqWPu&K;hwC zw-Y9f*ch3$GJQLdA-Ku*+&2SYW+zJ0V|Vzr9l4i9e4dY5dyT+=bt%gqkv|VmGudvn z1zpq^lq~B{M*d!AVTq! zPiyqqXatxk<@^+^82dC>Q^+5H-vH87+O4@fjB(5C=sEzCL(Oz=cuAAm# zDq~&rp%|KXh_A@e(Lr@bac$UkQ<&6nOxQ$9u}ik)gAU>x7o;e(jtTtXk|!;vyJv=P z-Ji8vz5F9&58;?@6J5_8F1_D+t?Ewuu;DVT71G5cn)*~fyk?+Ya8?KkSIWpAL_XHtC-X?9tAJm>+%(r?#ZjmMtS5IWJPK&AublAI%eb?^T7y;beNihSE3fF~?6 zWad^vYMjg1n4|=it4evW+|QPJM`Uc;@TC48qlcC_xBreTGuHvjpSCcg7QMB{_ae8! z5`u0Q@@E4QcONv;HMu&Q%YlM7mkmSNXL+W|%^4k%sy07&9W226%+kGf7oxH4LXhlp zK%@??MfK?#jz`&eMnYPSzc+xLFJOn>M#KMsylyuj){^aFLi8%~XmxFetcz;bt(Q3# z8t$rsKbhpEZzK~ziF(ZC;dHR9oG+^3Wgl}%U8AW6v7n$^#?@cw@v$t9w zkHfdqA&=rB&h?%nLlPe3xm!lkT^u4~$h41sk~XZ2?gyGiR@$>?LevHhuKo5NOyVu zW(^h+GX3f8+24fA;siHZ4+@AJr8kr~(dvT!alPBfAet!Om|nD4oYrB*7d0sSv95-? z6)}xfi@~smChUF+S80g-W`Lv~Lc;F|z)^P%uR4NFhNmAb24 znT0$j8Yhm~N1nK}oKHnOkJ(%r9Ls$0Xs;qVDpG}5$8TeRB*G$3(2W7N!AdFHGFK0X znZD`p|CH<=Ke=iqWn+9c&?vZcxlyW~IbOwScZvDr$k=n*zLx3GFy=YezDt_YWSFAN zpU^AU)%X_>m|8F}-(?yY;-`lDS&HKpf(EjvgoO=Z`_w%7F9dER;0vqtjNj8^|CJPH zjV7AjQQY_H0_eLKaOGw)C{Kq>4|J!tTSWr3Qhnd{HA{oq6WK|ycdp zWx$jvHS%0}wj|<<(rB<9Bw^p2wYHxJvroH(KT0@ykj8ktF*Nu_lu^+0aH4}ir)OIr z5OhOn%Wk5bJ+Hj=rr|($Kq6=~%*j>eQEn~wi_wwiz8&A?h$;4N6jmvCU-LY;h4+9v zi&6Ysr@=BvOWqH7XQ`Sw`g#9`=Wp{*K^HuUPn&LaBs}8c@q6VQee(it8%a2>f)5q=60)wQCkWaG9VFN45Tup6hkp}9BBGcgrLSLEglf26GOdG`7Hv%pPcV}ytZ*OzIy5uL7 zXd@NNOtn{ZyIx%#uY4p+DZau>CihbpO9Zk$a~T53(Wk1XPc$B zmFW2!t}mqK4B}?#`rfo#c-A?Cx<-gRw3i+~?p8((jQX7LX{oVA8!vwEYGX+WZRjNn z^@at)*=!qwysK4Y?REHnl;h=ee~r7K{|{ATwZrmjHwaD8v$DPsG7ZAx|ExvdKeEk# zq4+oZib{R2IeS#MSzuwU0DX!yXsHOzO|?8Sx?DsCJqdSi60Z*B7fVU)rI_?Ys-H_l zWQ)8mRTs;&y8w0)fGnFVgeGz@M88&0luGK%MzmyUWsN|#1)USh5NC^dZ9EXDHc4QA zo$}PQ>)VZVqhh`z<{gQA#obAUO2f<{=z^@!nGobxH$~eMB8XiknSn456iCVVtX6}o z%(kgwX?9T{qUDz30sW%_qqC`$^j$hQf7_G8Wd^Ci_L`D~c?sHSC1FTOtMNl;KS~_` zv`3{opIM6B>!L5vtM@ba9fvXYJAhAaZ==>lCCIW9UF%9dN@3`;6Q#dpu^8}R!e$As z6!+puMAxfX&J=D5B==4`zvKIKl8-jXTe9tGh^fyuujgXDQLCw5y~FwI3+w9v#J_$3cVs3bmRL=-F5e8GU!F&&PTFrGP2Zt_gDodwMUR*$;gwQ z*eeV@M@pGWxXPGJ`O>-A{! zDC;dRcH}@>0P*oag8@}R#fz%vV8mN5-|+_N14#07MVt5eF7sYm|K9e~lWj?N|D(87 zzsckdL@4DqA!=hYS4`_q6?HLQ7@TP7quuX;P6GK3*eAohe;PBA?4QTKF$+Z$`4j)W z)ps0;KNN|Ro9-TC$yWX?Wv43I(XCuyw*)!PzR$JNrAljA6f+G_mir*sydlZ7P|}=8 zG3Dl;BCd_5TJ1l3sb>|Fu}#}aRbi$+9IlV8TI$={{|_FT$S*l2ind`AxpFZ9_yrI|B~FR7U; zcO7r)+Eev5s=pu28mMqk3>Lb!=giaJGXuTjDo$pMC#7Jv^Ps$5RY|Mmuq_LGCFwjD zY|PlG=A|>sem6Y7f{qAQBqe!;e*N|dldL#`CMrmt`rfBX<4QIkEvhAE)@Mf*lj+~oGaUV!0Tclcyzg6BHfiiEL`5xbDWPTYW#U#igf zb*#INusI!SE9?!Y497-zp(Y4ywPLy1C_+C zD;#g(lYsufh0VlL9fpr|2n9lY^GJ0i6Te^B#NPNs3q_TgkB8Kehs4K6?>{{FH6puT zzh0w~xDK?!mDzXNnb3lF#Wmf6LGkae8$vKm12p}_Rjy*`^qW5($ue?Ux6OM_#NbHC z8DDXLuiq=;Q$=fGm9aO<@~4iPeaHBZ3?s7L!M`2HK+PpZ>6iN+kA$43sNM4yWeeTh z4$SUJk!CAcuD%cv>t$RpRi{lKEXt(BZ~!E>S3JC?PWJAvl4sr4bHW2f3(zO%=(}>% zFnM?T29+_04T-EhPtcPM&$&;acfoep(}dpl%=VwxZ&RUxQo$bRjB4dW3#WWv=CMs{ zy|^yk#RI%rr{k}w>em8=eDos%`@Ib(p_o~KSefO}eke1gy_b-GZGn9VOnw^(?hSA5 zy>fJ)pOIzR^7qyCZN#R4B4rYNfYa*K`%l5`Ke zZu%WMEgw(Dp(eMs%*CAWLjg$^a1TakYA-5kH1Y6f&v*Pg-Aflu;E(gWL8ruTSN-`x`)L0ggCDVD)ixNZDCO2-R;a#067 ztAI9INPJ>mPbHi`CIH6h_W4E=xdOEp!;mJyvWJFx_a09f3>zL=|&?afI0D0_^A|5gr1BWGm4V(5zeV zr_5YQz8*oOLV87H=iF|n&L7x0;M54_0z&Hw9%?WK zHO*ootL4NP7DwbGb)4N!efvSU=?hHjb%wk`o(rW{9u9fWW#V4vms)khgT$vB4Iq05 zg*D`$qL-3I;cuqo)^aaq_8Z?xr|XIV0Ahas?2&9zRY+wI&9iXXX30~I*KU>eVIPQfk5Vz4^DHLtjka0QpoO7b&2*u?DZcq6j^MqbMnD&;ex)BFbLo@L541q+` z>V-i;3C~_mg$RI}hkjJ%Q;@ZJFTIk;@h~HH1+^(uVm!1%-sij5(8Byf@V9|FUv9w& z2a_iP@n@}E4%};~hTfUdO=h(>;q(0J;5#hckz_N)LXm9TOp+5xu8dl+@}-wi8;Q?q zouxHf1f6)znzKM>re0jhhLYBWQyu(7= zNB3pQJ(fagZDB04Z&!aWw>nfamVX^07Gg60AIRS$9MF{O-QyHJn2lxN6E3)CNiN6z zCcvS{&t^lM{cz8oZ<#HZ!bg^r4#BXWv^h0jMGd`37>PEQLOpkmG8X?#!NJCKOq#TB zYgeLsOPnSB*@hY00#`WVjYP3wy6LNUmY|PyjjPwG@ZOF7LYFOb5)uukpY?F0(@7<{ z`ag!67Mw_j=YB?6IQ>=yvJT>!`>9U8t@VKbV@%n6qg3PAfML4d>hi0qFe-F0%H-ulo1mbI`qAF{H1Y}ek zxjz!iF6#VlCG|J?^matIwvIQVs7%D>c6~?FezaY`LbV6a1MMU$mLBVCy{`J0QJ!jx z(<};lMRhK3XmbmYMH0pS@Ns1v!}{2I<7Dmd`&}-qk_?8^kf>RnEHm2>42yVNHqke% z$girY zU~r+(`R|~7{($*oR!i3X?3JGpwMqF$ zQ6}@Q17$!|dzD5i$Yd=r{JjUF+?X_?CG%|Tiu_(_ z`xrw_^-PlXe+e^Ezd)9W+(;a!{uXI%RW`@rr(45a9VBN!DY)twwjl7rc@Y~8L%_F2 z+s+z_S5(52zV7mf-#u>|c!VzOf=5(|z7vDVp1dlN@A<|hzZgEPe&{VJ6%mt=1PxY} zVimD)+p~x3?y!FUC>dUB2 zv_uD~6XBwMBA>7e!1Wi@4+Pbl`SdNBo4D;R{tu8~)vt`P)Mwu}Rj(nb=KV_Lu;e}u z^%x}K_^BQnf{QP|(yO(CgCBTo~edCYs6)IREZ>znhSl^$K)bBpcCXZX{Q@H7QtRt%OGl&^L3g$3?tu&y?C2n2I6RHyetCi6z1t_gTpVu-LPcC15Yim`e z66Ba==~M9V>@8iOn7`cN@h{-8&`K%$eygC?Jv*k+C*t@FV{hyKl2KJzOYgRi@=cFY zh)w%#B0qu*6$7IC&zgVh`RXDeQvE5*0XKaw| zrNayeqC^vy%?ICn2&Vo(mjrKJ?I&=^z&N+ix?k$qzP7FuJ-g|EW7{{yusAx}u1dUk zMCsB6&J+uwd_hjfra9x3hYxd-z9$?&ZS(%)_3$_)MKV)qR}IqY9l&#Eo^Py;v;xY>SJW%bQB#a(1RJ^`2JA= z_9a^~IogTkc;b>}UDzRE#uS1u6vtIYXe-$>+-)$uCJ7%=EHryhGuvYm3>>oB8v@y` zwI{<=RF?E)V-n#3#A#=p5P>8k(L{#|%=;f60p)zskD=SN&!3_*RDXTP{l)K5kJ76i z*=lGXC$wCMr!q|ZSqAEz(kuHVubULrPvOMCEVY{-k@r|Cj;3e5Rpqw5Zpp@!0M$#S zv9Kf{y3P6Eed&Los(|~A4o#)EKd zrir+{jpfkGoMgMnJhDR0nRW)=2to~)hb|)xZRhv|Rdegc@35vO-1|OAZG>ZV`a*Nt z>W(uaw$MDFaeN2!AUBbERQ5!POh zNEu(M68oS?mo)3p=#P3at@~?fmc$L<3Bz{im~DFOp3PXFIRf%F_4Glx@l`!5JB^kP zAP%)_hiGnnx=lTb5WA&3T>+jE_}xU}zxd?_>v z{z`w!yJG}|B|re3^}TF1HRw!p<5uY7=3P{+{jH)|WP!^V3_Cird7IMAT97RUQ4Li|{bC%WyJ(ZKYshGi^ zSiCZ5G})6nso!>LB|qQZ!6lB(J6V{3lV!7si6U^dJ>h;;phk)2{`d5RF2U3V_)3-S zRFB#F&Cr)Rd8J@q0=wp7Af3xZ&af%kwiVRTd?ej1YtNT$IW^#eKin{QwsL{f)KAp4 zBi|4sOSsMm4{x`B{x1D*IVUdL6B(00>FU%;KLDGNvTC3Ib%KkA6?>EY6@Rkn-NDh{ zQj~GBR>~70-BZHD?Z$4!aDK-oRJ4>In#-|Qr7ZSFNOl)_+P<>1FkAQ1pPG_$!<1$> z5C@a)u9QyF$5o!P;Q->O9X2UmSM+DJ-p)y|eYe7R*J#gwGZ@{kv=-XXW+=$hary3N zFe5Ky(C?y&zp>5C9}(ECoN(c{@}Y&MD&K2UB~vji%%hD&dRGW9m*`$A2h>0~-W?qo zvi?!^5$Mb9?mrm>4nv7swrL~*Ja7FaG4Ie3zO156_+x#oyX|Z(KPcx_@>zaMZ?#H{ z1Yh}^{#FVn!uVYPL1D^-J)^#DcE8Z0&J2gT0ij(-cY96_NWHQHVipxWCZGSpIFzqj zrQqdd>gZM?lQjJoF{5Z;eQ#FJmiR%V^uRYzv!-6lh#&w)0t+oi5dRB_y%Jjs`Vt}V z_r`Ziy23X`DW8bNIkdsTpVmXd0Z4-MrDbX+Y*!F?LTAr(^N25YC)Y-b853QvCFox# zb3zfGS+Eb0#X!Tdo?9XbCe>VUWHT)x7*NZCUZ5pAK)ea3-oZjTVbn{$rt3}3t1~Uf zdoH$*JS`}>vs!zj^-CA5u2{C1*otKJZ#|*omOddTEE;tkf2Imjv5+1=2~pppF(xe3w;sLG}%lSS`KFAPnn49gm%3Cehl+s%0R%&`NJ4m zlz}n=r!?Ppf$8QEGktCkP3uGyJ~bK#*ju4c33h@6+Eh;jOKNEutK59x&^;pBKk4-} zS%;`iwoUQXRr6L@W>XgUI$z+P<|v)%eS^RbhVYP=eMycZ_O7KeKlw;)*#a}3eB+X> zb~$!@`4a!tY}~xUwGEE2x#M9ZO?w=0sAt?Npxj@?_Pcl2Lv^!!TUeYSmx}!W%4TDY zoaw!Phqv&XV8F?TX3z(!wwAAxD}4MA2h`Qxd*=m)^h)qT>N2|yzpOLCM66+3w2xBQ zE2O1k^(p8TBE_|&Jd`x+!{;9szNhmu`*HZm82^zYL#B6|Ecz(}aejGg+p$HS#>lqZ zDbsKCcg-lBp5Zgez{Qkk(_}vV^?zuB8I2xGA?8Sfjq~(1iZs^bo+s~m{RdUxd^#{l z@vs%n+IXr%G^h2wWG9R|#PCJsI~c9SkIXA4zLAyeMY2DUmTAfD#noaRsu@mwfdqsn z2aP zg+u2I6T!6s2~+XWi99Lue@}4}6oJ3%%TT|*hHQEcvqXvp;3{Eij~MGt@Ebba}6n@cO&k#ilJ)JaG1XC}?0U_6%l3 z>`TdOBNme++a%XbB4EPPlq;@jw%_`03SpU*v{KB7meZffdI%|Kpk!WaRgw@f?(Nb6 zrRi;(ksQ(8@MYX<=r=8Ae_zp*xe(Sfw4d~)VlWs?h?aXFt!u1zeleihSmsx2i65#P zXYibOJ^Sa+S}UqQUZ60o@p)mggGbz)ucGc8)k?78m$B$)-ETRl}f?Xuy#=UUSm7RfHOj`++EP2Lu2s-AIGcZ{Z)s$}~95VgWqSToH^< zI2X;`{fuR>&?=Qy;&ZFK-+q%SUkgv}9%`=+mq+x6gDaUVXNqHN1qKgbp!jr`-{gPDM(52531e&35#Wz+zGq>$nqWfpOkFV=mg^(y)#f)Mz>-Ddv3)jbw-z(D_aPTzLMIm@|_?8vug55 zVv;(Hy?xl!r*5h=UDtu7=%3|jfemf@Amzy%dl8ltUYK18>f5UAD){8!Y2XQ{n7&AM zzqp1h3rL#0s_SJkz%TD+5TT|>OtV81h5C6Tg&$Zi4V>YcIwwvWTd0np-TF)G-tP0G zVQV!gcDmJ^BxaUb-{y^6PBo6kjA{$V%f)2Uuf9@kaO|usCviR<7Wg?$dGNf1;ML zVFWJnMsT%bxb53o=izU8Uwwf?$4_w!$j%AXOT zr3kgHN_H&-iOkU{$t<%ZpaYT0j^Y+{*?>kY3|WUZudbcoCOhQpMk&b(qRU$GG}GY?A?i)=N?W}6wiohwH13nKR2@=&6>tkQ{Z@#CYZbmrD~jJc)< zjM&OICv#B0*R)LKY>@f8$j`BD;^Xvge6St~DHSshmegnK@VNyc_HVQSHii1bK?hPL zsw5o5oxHa{+0(6CWse~im;hjmiRk#8Zo-+Rk@#BBNk6UHwl7jOVXA9(xZJjYXu0~5wanWz8!!#_sL=F& zHN@Pwo)rO}pWV}bV4F9QatUQZ>#fIvRx)aEmFg>;S%E3VC69$ttpJ~bbbAuoWIT~k zI0%aD0wy%Trp_-)-8sX$dgjRky=FP$p`ptI3)q9kuOs0N4ohaxw==XvY6wZ3xad0t zZm$5_;*IX_pE{KJ3;cbNV3$WCF3mrp{+n%otbHPlG8$Ba@XmJMSDI}8@XlqVmXldM zsZR|Nv*&y6X3N~jq=y!!w##2@+*@uu#FdWh*%-=}2_fKUy8a(M{ffo|&1$(-h; z=fsGem2)9oOgn$R_dXn(u<56jALjDAO64tV09=B-+8otpHOP*ypiS<)7iJlJ!BxUL z-Y$M@v%SUtcHEWXm=5P2gmc+Vd*xhi*sVkURN`(lb1#0G{WP`TXsjpu11&viD>tc< zrS;`n+E^3hUVaQT?k}tO7*|xa@|R9(Tb0LOI1N1vqZhjV_-EYf`y*DlDzwd~eS&%0 z?-K_2mjtDMPTal=MXSc7)qU|2$F%$bp4!j$E)3FHoj+qaQe9-_WGR5t&~5{aM+&-v zKRsN9sGu%LI8i@e9MAb?O_zkspF{nKnjU(DlQ!7+Y3^VrOef3cMmsnb&;P)y<+e=P z{sZZ25lfTNEk~{)Qhj`XJcw^<>i+0f?0V zQ@QL424g^2W+(3}z$)x6=MM2s^I3X<>@&vL588`teJV_#Dpt%6UgEPHv{(w~ddl2f zYsvY@)uqdGi>Bi3(tDl3c0qWeWfE+kK=Ik*DU+r^^_pNCPx<&RW;XsHR{LVQbd>41 zhSXn|sEMR@U7Oc_ymGc8excY?3sLo@9gr_LA9rVTJ(^hmHHwtLt5uYH5S zeI9LL#zk=`K})GcRFpzYx$oS5jN=uFPkAgUgD~l!zW(&L=t?}{80=*1;-e|>^ppO9 zE>)O)gP?KP`{9Ta9;e|tnE3KG5FIq36FyI_Fpd8BOvBgLClAPF@%X$YTa+SG`S!_4 zJKbjVVm)D{@f)#%)7A`;@SW0XcE5ni};>7!Ku2%Qa2~2-L z5;$y^q66akN~>ABIYL@Dh)<-53uI5zoi62({yt!vm6@5x9W5R%Rc(4*oZJwkm-SkX zDChh!A}WV8+ITLp?ml-=pqK{b?TaXFeDOOMA})R1pn-7}w}eJ7nAG&9!}VBPCKUP9 z=|GJ`-1i_7e@bbiGB%sp(LeN+hyCrz9Uvj%)b*k>VZvL4S(XyJz=>hGBxrr3Zb;)R zpzletM)tFBRc7u(#JeLmT!RSitzT4n0Y~eXZt(ZVE#6ejR3Q}2z~eU&PMOLdYi)|v zlVkSsJP2Er@0zVTfne9rd4Xul+x;~-zfKy18DjK%&2=y9+cyt(lg7#nr}&jBy^>s~SkpG6#kJaUX+$a7|`jlsMTaVBKpFpb(+#GgU1!zpx~^v|hp&$<%;@ zbX_WiDnf<6MpOZgy4dY5>P_wUXp@GmUwIqR7;72|n}C=53+0nYNL-v(^t1fK=TZ8%b+EHK+5Z)}N4B*H=t8X|N8X^cB21kX`qtPMbUJtx+oH8z=27l-Q+ewK5{H2_%JHez>^xrLj^XqY zkF!)!M(x8b+}!LUYr-NLUk(X&ajHtmibSj(WTGZZN%j9#m+9eAnYlvpE%o6(zXo$B zsvk6rJQ|e)35aeRfPu&Hk1vw{an2x5!IwJuKHV({C;w4O`~O5usmb-^or&D}w5rfrGac*J^FDM0Yjy zd@_$7h)2HT1WGtNo_BeCGVAZFccqtR*6RNQz2|@scf)VBpX6qnOMBJooYISRcqkG} zZHAbV=X;Cp*|{!O$twxlVOZ7+?Lq2i?0PNb(6bI3d=9`}F`VN`SHf4u$5u8qcikLM zp*O`jM*Ktlia%Hf=!<#cI4^%cW|9)UTBm_T?7JUeSdLzH3YdD9cxX8n_zY%nb#NFm zt^TB9weqOzp!A&CP1cK-Y@5{@HP%tlgE$Qt1X5srWyF|p9x^Rxg>r{{e$5@9^UduX zS2-7=Ne7wz3?+RecSyyW#Lb4M)`MtZ&#Qb3=HHG7o)Mc%x) z{lBVtglob+XSUzoZlQMP_&S#R=;(P{HdY~ z_;a!_ef!;n^pf3PEXNl?USck}XV=J|o&@Q?hFuWE#&F=l=iB;&hiBI0+rSt+B}~*i`Qig$c4Lj(@RKF(6*jh<{S1v%C zkd2kHOcD^t)^LIo_r@%9jMtpnEaeqDTg`^1XI!d$2Clp`QsC*SI=j;oCC?Xeo=QRo z4=0j74rYmyHb`qmC|U%>VNQMVqSJVLQWtoj$QP~QKw0j!LOU1Ks=k_-B>jMwm%iKw zz?$9G(C!a~c?$Hi=1;DD!#O-0L$=sp{q^A1td?gtZ@)Gu5c!a!yIJgHMW!MrKDVma z5$Ae(=B}`{OeECfqIPgp8qOspCHkc^Pidm}Dc-Sc71)DpYjSHf9+iHwCcb!7m0`aw z^;xnzHgHZ}w^zBKGwQwUlOGw)xR|j0C+Y`pt_((6uIC2=S#pK6-@h4urke#arDUey zNMLKRiEV$M(@!od2GL8!la8NfMJbaUL7t#kjs$w{nq_Gg}~WuK=_#QmvGH`{C< zh8;tz%-Zz%-(){Fup5BCa^lxtkOUXGUAjEY8I6)`NfsY$o*Y2^{2c4T`#_OWAfkv? z$QpeOm?ZcBZnb9n?`x=N-qRJ|ZT0}%QjTa`{9^bkkryVGsCnb%Z$Llf?ry7N1$L*s zidUV|!U6mrh!g+2TCtW)XbN#sLXlaj2oemQ?N<0&2v|6*er75~c93fetTh@2O;e@s z2@_X7(rA2_Xs6XmIB%BJ$cyg&6#S{|@1Th*Uo9p)qQnC$mfGOkFsnz`WAR)p{d7pPO-Hqfc9evQQ56 zdXHd?agn+t%j~z!)_W6%QqP*_H9nKp*wK8;u&q1EDw3dmq9-D%!A+I+XjV>;lL4IB zzbD+sv~1F3MMRoi4vbdTaak_V#lWgq*XOn|YCW}NF)Wu^5Ib;oNktXOSdFtkdpNBk zCywO7A3m1F@7XL~V|>|ciKPF5G|zh_gf>BjxpkigoIj;8l?>3FU&Ax?_m2V>`KzC> zij-mm2!Qq>5##(O)Lq#0F(~i6$3aR6Mb~U-7pS3Yta?Xo?Obj9&yj;eJX^AG$y4>; z!qnLTrep_t1En=;@dUA`hRj<(l8N*j;gRRSN4M;FtJ9s4bk{fs4+(c`0*AbnkG@sD z8sELQ;;2+cm4;|wn+f%ssL)h|5$Wnm7US+Ii+TU<%mEloDbh?nO1>^GtbVav&}UiS z_%)pTh*#bDTZjVxX>EXJvR=zxnin~DXgg2r%%osaX|^#DDMoIymuLph(yOhe_wt2P zAs;%68*#SUzf3P(3w||4CUC_sA-L1vJ(vzGHwsqLmT#&3@VPQ!Phkb|u9GaRHDqR% zGy0)sJ$aUkF_2%|Ny%A(LLO{PI|1(g+z5=XV@Awow+|0rUBs9oqfoEsf`T=@ zq%Fzj3Dr@dfnW&}a$j zQxN7!&^549sD4BN{l4eqtkaI+t~qBpP1wJeZ}(%!Jl#@u)0x@}wDq`Kh0G6R&*OwV zCkqacZB_Pn4Cp5dPA52+diqboQQT7zo*O9E*58q2hu+~4;OyK%`k~c5F`8A?mgdt& z3ydfz6zb1={~SmWFgnKsp4|nKATV@eUQ^Bf)N8m9%cZSB(Ufz*QKZ!!W=)sql$BYkY@Z${*5r> z|5zOpo>F>G+nj7hT1=-Kcy-S#G}h8)%b0?wW-;H_rgt0TJh}((elYzIPyB3$2qS;l z7MM4-|GGrW**dm-^+p#rINde^0bi}sYo8=QOX}_zze979P`hcqfx- zh(ILOJxA9%1e_-a?pl?F*5 z+TiXr=L5Za7QNx9V_~L7aSc)nXqos7KGO`?Av#5%e(>;l@S2JR=V83?E5);pIqhqV zF)o3KgPuF?N503hs9jAKVG|A7Cj9JQL$YKp8z1W0^bX|vw|Q=;jf6RUd~FYi9dXa4 zmk4uL;L4eMcrwv)4)ahY&+BrJs67e0*G8KCT#PYW$14`UhhlLHO5Ky{6Ie87UH*jB z8vJUo*5~PRV11UapgVaWElOOuZ^mxT+3gaJPnZx0S<8a*80R=dVo%2Q^SQ*MCDV&; z5!ts1as)Lz%IvCA=$FRPH=~RXmFt%|b0)$)JU`e9N`3_;&-i@cD6qyO*4oH4DTxuY z6d4mI25$#`eqFk}RNs0tVhv5-yj}OENa`@$*X7;Ubj1Dt{b;dxc zTf^pjk;_)?zmcg`Vf^nqGs{xksy{iX^nu!X+~I|?_H?y|c4jdyK@=}Yg_RigV@YDk zrY%fvYmc>Y+jtp!Z~q5UQGvqL0Dp2VU*vqtjSwO&q99?wD4%sJPk>H0TJ(PXfiJ$s zXm;q0mHY?4>4el51jLG6&{}w=?O;&v*(ux>^5)@B?ZHXd5@uu+r~lo3l8Al zina>Ym)Bgfl6BlMfUoLKg=?agUL=3=y`Ic;#+W|hE7aVu{|qf?npb+CKv>QQ50&gn zI#`Sfb^6jgWM;Q;y2fSLNa3`SWP&=+n-6tA&PYOi@4FCVbCy1&${6NeSmq)@ugcl1 z6O1c|sakqX5%ZT@Rw0I!-5R5lGRbX5Kg=VGzd*;!(jmgNR3J`r`e&p61_A&y&w9EA zep)|1cN9SeKZ5{yq}X=Q;Os-8Pc=Ua2jJ6`r^mA#2}EAMT+YrR)J?Ki4;1eZ<98fj zx;abO^ua=XTgKn;FG@w$=Dp2vn~h$>PF(SkKZaDeEsM?SL%(_EpL~3h=th44 zr+6p(i#;n4A7pDG*tyNXGan*|?B~#wh$(9PG}TN`G)klvivRS;pt>(&Y z12BXt*kee#f}D#aVp%?ChPojV7y1dy03-Xm#7^Ay^IReX8<8WfRUX`ZTDBeEZSq&B zBI0%fv?!A2 zpGU-NSmmfuzBj5w*4_Slot33EG7SDDlWEfNrJ6PKU`?Q+^DSARfna0ES%z?cF|Lc$ zU8U8*$&9da7k~VbDe2X-HtWuC&P_728i57+u(xBJefg4`ZIAD&y3iT))Y4G&c!W{f zGT*WZZ}qIY1u+(j?8aY6nyicNjS2CMXOkSC*EF?; zW_!n1iSGEK8*O=C+m~IPE=fs{r24|gPBco)wwf@1fgc~ar0_?G8&BX~;6DV1m0Hn$ zqY&EtIkCsvEk%U1z;7NFh2qY0%0ej1k;^!e(^meksLoWF?zLZE#6M@ zUj^{$R(SN1LH|g`mN~cbiIKPGUT=D5(lBe$Tc zH5MVE&%AkhuEhC{UQ&N!os?j8SGyi6=W1KwZHM`1S-@6fNBXF?x?Fk+2~v!a$eel*$^A1^D8}Qs$2~Yt?ch#}{bT?_b%8 zz&qg2zpT2J1iN$wJfUzY!ZlS<#wqOVxjZ($h$2!<-B!JBI_; z0j4DTbjSU5ks^)d)U|Cp%bm`8A)O2ls->Ku9w4G@&*PhYEfFwTY0{S=jGSH2-Sr=A z?oTeZ_#6$Mldv+(!m4p=@|{Ho_8!otxMh`xy(^?+H6PAi{v@y1GZnJ{OLs&E#tOXV zF8kXi?pgZmKadCY3esf&_JOKq(ZvPyZ1$n`s*vqgE>3pHDdm=+8}_1Ao(Gux7HP7% ziF5{IwyK9K`}WRIVj&|aUHLl&!IkzJ%OPF~QQ!eX9-bv?_o%}ag*_bMQSjwDC()>C z3OlQ2!)Z~Y|H*ZKiti$h8J0>DRiSyZ@@pKi@a>zyFU>LWQ{v+k!bxX7>SdJ`-UJJ%fijl(l^kyOIR%@OV0^khS>WK?yEN6B$L}%)0E2-4J;x%HdAFfpQj@t{|eLSZzkrd6PkN=w|IvT`Y+TA_~ z2N}Kt%(VLK&xuw`-CfT^Ro3GxFL#qi5cDIi;Jo(TzsU*~2~S`^-V(bLq%VNl++%dI z{yJj)`d63?)V0K{L}5^fxX#6{fnZej8-jiwuKI&*gjJhYF{bvg>yG|Bg0e(%<*l1n zoOWOBgLGtlumKjPO7=ib)8x( z8atR?uQm80l^{2avMF%)ibYw-3e>zg9icLpYnni^DLtaw%WBOnGov2Ko!(ozp zp&iQDEsz~CO(@V3Ai=p6nV`I(;!;UXR0Z>%;(EEj`T z-Jtd6#jmti%gql04-y*TCM#M-cznoH)$NlrH-BEAUkaA+hJQlxx~S{nNxn?iN8T_zB?u&@BDxQU%$FYsQX%92@>PlBK~~_W}fc zom;9--!KsWl<)1^m9%F&)->7>pJ{^a>W11B-?D*Rlm@;yBus&J?*+%K(sg!2h8WPp#=C}; zL^y2z(;66hyjZ8X$oR%*oy`ESpXY<`O*Jt6L!=Z2VY_pZ+c`5%zOPe^nl<`Iqv{U* z&*9;>_jcZDuGEjzjP4{Fv?nI5-#7QV5tj|k(N2$?mQ92X5lnAM-pxLdIsgsiT1NVf zHYDs~9%8&q9n6vQm}Fi_ja68Yu#szT@Po0G1r>K{v*E%&%`${MILsL0C5q^YbZqiC zzTRR;%=4DCgUkQBJ*(_Vr#Cv4Vj`;``Z2;f~gsUmi*8ELmQawPClzpp3)v#0>rkFoaZ zR2GhqB*Enuz4MItn(48-lGgP_R5HX#|JQPEn!3s6`HAo+P6#VS&nD&qvhVM8h91iu ze{?gxrsAD6TP=I&U2fG_NBi!PWEyq3>_&i!D80fL;#1~_CXJF|wp@-?$_PlCp`M$< z26vh4^au8F*LqE`2Ckm+e6g}{C+YjV%dfSJ{3KP%k_@1hM?_!Pe1oH4iQy=LT5q1+ z;URvg@4SLF-aDb@0p0*MYK_DqiB1y0NU%9FwZHDv6ZbXL4+bJrt zj_tRfZbql>kcm<`Hv$d}yo&9pk4m=R^L!Ia@rKxalkjL;W7e*@P}-AKvR6`{!Vvf; zF#{GG*ci`__}0am(|Wx1Cj3R!xuA>HoA&Xa;=8YmzM5qm2ix2@d8}yRR#oyf1@<2VSRERkTX5KR1wOE4`+wrq_8PBgmVHOPR-<^vZW92dlYhxHb*kADL-J%-gsGkXe^#n(x zsyJ456k7Kyx)GdV*hYYYKr$ zl`_tZ8U~eJpv8FRGke`M!9{)y1$jSu&0V zQx8kCt-f2sbgOiz_O~$)4)F>f02aNAQYw#WdH@mbhc44mm7jHVpYnSx)ML@j?m3NC z2vSV!+}UMcdK|p10Q(Mr;)-dla#NIbnWqgDBrGi(wF9O#_qe-`yEtfF$`q2SQzDN3o#t=88qyM3&rurV`$A;ndFN!{9$rBx)s%BmUg+Ru+ch}H1Yk@S_UG*aXX0;_yg!ropj8H(#NdeB!!6Z zO(3{5%J#oM*78jrzcq~IZxfg3kpn8mE`o1aXv-_IB|utBKshs%`@M!6Qc+{}!MuXW z04WYUP2TOO@$_qOlsr$I6J^B>qLB+6OeUfv>mK4|P1sR0u+KGuS0ruaSr{kJYQmCQ zt9=+wNeqG{_IrQD6SmAwkZJm*1>}>!wOD{Qd_+Vt+s4;J3dK!C=0JpHE;HNf_=PZoW8z#2<|#wcosWIi!J;`S$yN7-|qqm7Wgv)`19f ziLiSBhjng{p1&9ShQ!qtt6@E_P5zdr8Xtjg&}?MqT87)&8y=kc4F?__%DJ0D4%7JM z;N?mq!Fbh=N&5QzJRxBM&iHn7y4sYduKY1^#N&_JXSBmO(6D209}PQrun`JqB+bn` z-hW1V`6CWeH%()P=Cj01GQMUiZZAadGqtwS{5?x6ZBy;@44MY{M|=|cOsyYIIU9h@ z=xl_So*n;VjE=yRL^JxjRfZRZ_W&r^-#8Ax9Yvub*wfJQxN(*!5H9)^zc z8mBBjRXh6Hvb>_H(&=Aw0QcH8Igt9Q`S-&dcpUqSC;l?yAdl+TUx68u*`ndxHoqKP zqnH1*O3e?2xb&3qQS(o0){|${n|8mGb;umr_2x8%ei7neQn7BRbzJiJf3IP<=YUnv z;_*0@&eD^iU;K(ZevDOv7Zg}EA~XHnKDpuylIr26Vp%{oPqSQTm9o>3uq9;6;3>XG zPV+s{JjF1>?Bi=uTtS7M#_w!mqwJDerL`(FOIUGDyEl@6w`3`)sSZl7lI+e^i-%4{ zrc7Axem^QM0wD=0vTaYf)*)q^9yL_-b3O4& z=zC8#7!fvBz=mh`i#8Xul3H#G>4#OWa71IZ{i8i82Ypl>xnW~VkPAtJ*erupY7AW@ zqRcBvETc3~w%pr|C83$z%Ls)nzt3s$*e1Urjn%eAIsG)?&NZe;pdjf@sqEQLh~ecG zt}7P>!innWh)bILmic7zg})T6!9b>hVZ{W=xq>Idmu{*m%3mphPORj{LNf-F;LffD zW)?#|%kpA9RziIl+kIX+=G5l9+tL~NJ<5gI><_lj;?`1|h?x3`USLYFZNL3U(N|-stYsr8o z2<0?;);d=3hcH7Tx5Im44plA9K+QOj$)!>mI9HjC`GVr6hXY?cQIb^R1ZMB|htQ>s z8>H&fC)XP;&+0u9_Gw1uCuLpv37R-P@N9qs!Q%f@8DdSL^*=;M(d>Q+T4UG}v&cd)2pV>o$ zJrtRC;fH8(FX1)ilz2}Mwt<`ihW_|zORZ#R=1YFb*^ z&+fr8sFewoU8caEP-Cd{ucFl4aByLJ3DU=uebV*M8Zk_yyp;J>6tzbsL)8W;q71)H z&*+H%I`GGcw%X+KKDOKR2BqVDx8eISV1)?PlxHt~(sVGpl}9?C^1jnFv%zqD9f(HO zAYonyY^G7ZFblklHbu@qLks6=&(uDli}M1nA>+Z#Wk{|#`GxHQ;_8LQOx4{WM>qdN zs^=a5h94XzZ682G&0O7{g>s`5<3r#?syz@i+k zgyc!@foW5r-+J~|#cM5BLdZ{2R}4)B%4lFtiDog$jXu*T;Ms3qw40wbuy~kVDMGB& z64-wA;SzFEyv^`c&`jA*(?2Ao$L@=idl`xOKWTH3`u?dV`&@4aO6krXdGx~S3CxLhlE9j#fT-34T>qkxagVPnGOP}(K$-W< z-xeTl@G*0Q?nV^7aXB&MaB>!nn0v5)DL)xkH|$#}AEG6bSyF3w#ZTc$wp@!R(l1U zFTog)g=YFr5D zcYb*~pc5ybvv02_z|mF_IkI9a1Q;x7D$|%th_J(RT|@i_t41XkSqqs375WyKh#qB% zwZYup3mObUtlyZFMV34s5ZtxR;L8A=jK1UM2!*Q*Z;#=Ata{daDJxwosE0Var=T7% zZ2p@aMpA_>RGk-*xSW^1A_Ny<*4~*cCwfpev)8Q6GR~gzrFUkJ**W?P+}S(mQ2zF+#Yy3>wB{juim}`W z7uN2R1l-Zc0UXHX;qSp}#oaUbO3+~3VONICd#axic8(A*Po(MO z@0L0VRXF!G0<#&#;EW5lk`(9u%exmAAv3_7rWn=|#cRFUOZ`UPK~**f!%~ZRp5WYD z^N-AHEP-!bFuT;&N(8M`v~cc_%9Z({+xH?vvyR(|NKUcyL#ST~D9BWbJww58RDyv9 zYYv|&wx2=Jl~Sp``HJh!`?mE>KPQ{4@O)5TEXT*p4{Xkv*}WM)r$h0vaLtwBWmzFhqPcb`Cl_Gi~hM- zNg*D*)Nay$-tNSI+kxg{?YEF%aeQOxMU%;F4R8ca3zC|3vSMl&q4q+9=YB@r{j%f9 z?XFDJh=rZy&6)iC+Qy}hqC~neq)HP`G_@e4xSvUHkFonKwn;y)s2Gwr-`;l0s>7&&>bHak{PE%B(a5ol6j6!|^*Hw)As z6p#~ZFJf`bFhhguyD@0G&(V~gJ-9*Cd=%wWn4x``VD;|v-*kz0jiW4otg8bLxtz1o zg}y!_h7aSdB}Y2$4c^D7&T^~SZ`B^yrLhJugw?kz^3l~6%FW~aSxfe#;T6^@P5t#K zVDyEzvF-fvgLQ@BB9^qwPxCQ+b{vWQ`I_y0_9 z-y#mYFC(vC8XA2@O)|X*XWQR4_vQUw+h?j`p}|HH*~fWHKC98e@{%5>nRf`yibH|h z#sp9(I7<#+&Snvg=AI4*ETpXVuEaC4(#+n0jq(Rhacmk}S^2vvuoEv03YN!D0YD=~ z2WB9-XpLcKb`o<9DzkgEJI91TRR$yKTS)~oHt{BVe^7ofRYwjiu=`X`JDBKvV7lm4 zK`vLqrz^&bgYjc>kV7U>Cvp&BfgZmh>SE}fWFW7-!Ak(>R=p$? z9n`4Bu8fedqUkw;?e)k;RN;(XuN%u|6lh?;`h3zVpNDP~n&w9zn~mTq;=I*j%+tIS zD-ztVi&N~1m5p4z-7{H$TZ3qGp5|XcQ1@flYbE)2gU9V8=!Rud6yaAwwebZI@1D)HzbcTC^b?w(~xHmPHQpga%)C$hyRD4gK}{f_aWc01bUUtYK6c zKLs1K>}h5d9=M&f;wuQM*<7N4(mq>`!2RszZPR2Or+Tv(=$osQxKpgL?7sMRChg0> z9*^`{-SPRmf>N)2lO;J*6eY;|d0tAZwYC~{01?;(t1jB-3bk0}YniDhB(_2^L@`W- z=(HJQd(f5PP@ts;4Ww~&TNeC>;rJwi{O3+uRq&*yCsbmB6{?rrYH03%Dt>YnzoRYW z@y4U!<1!gh^f_tq()OmaJlR!&yw+Wkzfftoi%v>l}VU+N@x*^V?8w5*`ftMsJ0>T4COLSYKAS z$hv6tn1rSh{X1Xdb-yj(z5;4qH=1Gl`VwnS{4BL9h^%9Ff+hETg)0W`%n=;94(}1? z(UCKX-?T@a`*?-t9Yl^PXtSnJwL;}5#flf|5zdvZ{@FI^vt)1jQUr;=k6e; zR|MLiUiZjOASaSrdbzDtk|6Fd^Ls73JJ)LmZ)BD#732$6fW@N*ObY)XA>T>qdeprR z*X*ln$EXB_f6>jurgJvs&`GoM9*v8Z)sUB~zua#{B4MXsm+bm_)ce)6Bb0(r+|lN- zvk{9{2_}2h`QfdSmJF@cnUlvNh{m!ccQ68%j;B)YMd8>pvTcUtQb2`MLc%ga(IFhC zG_G%LxDK0dm35K!u__783Z-ayQ^0s9(#W7*_jglCH0jMdyNPhQQ1HbLcEJ&#-IRrK!E+H|9ZF)NO+;ZhYNu z8Z>su8q+Bf3lxp~+GbAx$NVRGqE3PIVt@Z$-=-iRO$TY^=4Dd z7RRKk(8$rYD}Yo@*7LX0%d>{;nN>vFQQDWqkPOz>;~qQ<1P2bQw@31${7F0Yqjc2z z5mZk@!-U(3vy95v-=M8(5p8nkr#{3eBYcwqX=!gI6h}R38brA(;zy&8>vs%HarR4`8oXA7Hwq=TU0~;sHg|9<qxpLV zv_yZHMJgFI{>u9P3l!AEJxP7cjK2RaZ=ZP-(qznHMFk2F!*k~|s+#=f5h3DK==$A;w^Tn!f1l#8Fk!YzH&U$xu$!}`)f{bU4* z1F{pHbV>V`uA7sV{w?g&5rGI`=#xLco}7%`rs4lVefp>tjbOb9?G^odvYoWn$_dg} zGg&WJrgc5}^8y5XM$4Id{5FM9F?qKHy94~jmfo=h`hETOW~A5z)vCVE_+CWsd;&&# z1t*ChQ$QgQj^8Bz!p?l&39wbXxZE>GmCosCoJhfqUg+XLrIO;)Y<1a`f#0g}*vpJN zMw&NWs9ii9U)g_QBHKdFrZqVBhgPi{A;rN;mqH>Rb382u<5(UM8&XlbEDhduYd>OQ z?8|f>N^TE6+9N%&HoP`)cD79o{r?Yb+Ab?%e)=3W1MOaf`X_U<_W}zSAHD(6O0^F^ zavbvi(T)&@m|effmC2!UW(zU$ozfDj4Rd#8VAAPKrY^=|FEkWASI7NDr1ANHL<;T2 z@~k0|E@tj`)Gkzib<3-zT{54xb=aZ4!Dv?99*cpr-;DS|zzyhIHGIn9#AyEhH|qN! zlgK%7ZV%kl`k!MzZB24|w}(%vMnol^&OGvNH^8*QTm==>#?}Ma(+%cHQVur9%FiWz6X$H<@D2;QeRYOv~jMacw$=?`{A&T zJo#-6D@$&mV72dJK1VDt&gxQxf~3P%E!>=hdgn9%ts`W`djb?}5#yPhSe4x}!aPRS zrB<85F3p8;q2l;5tTXOZW|LNBgt)D)jB?!d9JP~1n)ijTd>j$=1bDEI2@^_t4vU@S z|MRhMd^t9Es|B&GbjK6dQ3?|69*T+zJ`YE3j1wdDV;-S~KMn^QCM(I;usc3LlzE}L z=f)~M29`xuIVaz-_kYB<8WZ06*!Gb|uzS;nJlHUSw*ub49JniJn+EzKPynC%cRces&j>I@c{U5dA1AXY@LG0;7c*V2PLWml0E6cIcKd!sw;hOd|aF5fcj?pik7D@O>*y>ko6 z3D$#TL-&Fj&YRJ&XN$4-i~&-n*q`eRoU71rr;PslZ6|jQdvvftA;X#2<&KwLtt;-p zjn-mk!O@z_&jw0pyP6aowq_Mppr)jDaBG! zW%F-xa6E-O$3ksexX6_EEe8GR%JeKhi`3+vKjt0}=|QufUlnh|Pp;~gZi z8*8p=pY`q$XyOZz_1zw6AqT+{jWPb@c#FSD;m1DHDf3DRatRYIh0iZ;_=~Xu0X3J} z8=j?ME6#E>OfvsIn_)Ti#Y|d<`7iH7sd|YEn7rvkJ9)~n|JUe7Y-ZmW?hdIbE(<9F z2m?V;($)PMGyS)vZmL9cJ%#@;8l3IECLIGUalCq-0+phivk}YgcZD?b|6zcD2K=58 zbSq*2-bW?D+VhB*s&%4txrT^N!3lA4iM{)T<`#-7)5@Ms4PRGM&Zr^C$=o+0fxJuW zY*7PP1^2vmhX+#2+vF#KKn#{Q71ijlVQKAXnJ{YC2o_U@ef)cyEsHy17kFwlfp<}^ z=+Ifad3*WGz*n?eQ@!E6h96@_$c3~+bwS6@iUDDFL5Xqp%*qz?I|Q?pw#+P-B`L^( zHETSB(mv;J>?4r+7~u%2v79DBgMWJm`=3IDm8XQR$<3qwh`Ai^J=KfvXw;~cxkYnRh1B!S8M6w96 z*N-!xb>_Vn!78CW*g-DT&P!VFsjM!>mt6hLg{1xv4I6BUMQM|*4vM|$>{BGBQw-3D zJ{D~?cTbOHX?#6t?e|Bo&g+LblyU?eR==qQqw{$RwJrwbq8?hB6v*qSe{{z*n8+Ag z7akmJHOl@;jp*3;snZjJA67rqS>%6`P)4HpVBK6XLSt&HXsgQ*L5?pHZ?84){WYqqE)H=F$ztPnZ9PzJ=Yt#56`s!s zWiu0Ba$_3IJ}o;-b@K7-{qNVDZ!trR7c#?1j^7i-rdKTJ!d@Xl)3hFW>m{!G!@dhD zUFQZ#@@ZEE&M=Nvd64NJMC4r6*S!+m_YPf6<>TE@9<)TPF=3m>1)$#y1y8WP*^4Fn zPW(h|*?+Js;_%%8i+Sjq_XuJr`gC)}>r|up_E!cEq@bR69WF4*Bs5bkvtN(&XTjNBcbh5{!tYiD|@Y1Rif4xdnW1VpgX=+3gx*Og-H( zqvLnO{Rx0*kfTLQJ0)W+6`(6(%G8l;sjh3_vthx5E2l184k}o+&ht$hM}y~d%AVGf zFEh2Lo7UH|jdeeF@OX>@oQnvIEtF9X`L~#J)3>`3PAmJ3Zm%JyWbYGG7A#r*ijL$NRqf#Q&eDAGlw{GZ0oJ8vqIdQ2|h zQsz@H;0Q)Sli43qy{@v;vp;@%=UR@Agl{gy=TAZTX2P4e3KL^L+qrrH6X^W}m@C^e zNk>IT2E~V~e`Z&yyX_%PEF}fnZ#v_N`cf)>h2LgVV@GX3m|o=z64&BjNJpO~(C?7D zcPDjCLl5;y0>oEbGf;M^^pk?!K_cL>n8BJv35`lSX2C`z`4x~*D=1TYF!w~);N%ij z%%EhMkOe9m3q>XDJI^wS;x4Vik2R;`SiL`|f6Z0dF@UlJoTV1nwg>85u#Fxnr<=hS zJ(j>vII>0Dsz=ye6klFZyFYw>P;P~|*hrdt)#2%^)z}Z>Nr(efhrR}@XSA`S)i1c= z0__RwwFff|av*EU%o)CWr&oLd?W_uKd!%9~JO1T3Rsd7?;Y!@U=f|2G)1-OqjAN9P zEJh&=50q&tLIlDcyvL$hu9+au>o(fEA2!dMIQ*#o!w_bUBCv$FL7wO!wmuN=PXEY4 z@pCJmI50NeYF^2bXzWpxzs5(6T~~QlkPcBhV8#O|!Fa;mWZM)9l;>&aHYE##1|+p- z?iyA2x>~RZ43etDa!aJ0nDta9Q@92J=VgQTJKrg9bz#cDw0fJ6mXkDlW6XJ2q5a0x zm>F_O5y=Ini7dZ|{t|-vXCeA@aewxPs^=Qd&{(Hv)hAI86{YkolkdbX2p89WBJ_+{ z_^$CsdJTwb4Qes-tQM9Ay>`A5DwrhpIg4EVp-~5q_~5c@Eb0wC_OQFeCw?PVae&0C zYJ!q93rr-m?r^R%`1e7wXCLe-Z2r(HszqNZOn71Xe*GWz!&9K=p1QF;)Y5}3Ktr~5iW&^u6RW*sV9tDNihBsx~cb7+5qt9 z7qgv37}bN87pTlC%;0Ku9?^{fXXPR9_3 zD1PfMzMbro+kI+gd;L*+zE(c?jvhktRxp0M=kM4MLv2>1_rG~yHOCPK5yGV6)BKo; zjUDoIjG40eR>BiWrv<0@S1mYGv-92O#GMKa zqrm)v9sDB}Gcjri+>u_sg{wj5ueGWin-)qI)@3Gi5e}|iYZT(2vz<#u#C{9Nrq`tm zTC0QBx2B8=w`WGP#u${h^XI)}DW?}sQgJ=6)e{Y;bhK_w{kJBIfGQLSU$8m7M>BmO zg(amJ(_d@3IH<_QMtWILEIZ1dqTC$^Hn?_yY7Ad$WYC4@#uuuq(db*c*p$*T8pjH$ z^WEx8ac3$(L5O>%{F`cQ)f*+c18Ng6tUYW)NCFQ(m1z|kJ!dYA;-SlqyJ^}21ZU}$`#b)ras7LK zfc=kn{!oOnZpD8|YiU}9g*XNQX+lWeR1q0KJx}66agx4~*TbS-HjP2R0%R zNb#l@p*}OXYig#oF4`QG%U>7a>bhPiO`?YizG;0ZgG7e&75v`!EDdZdq{?O}W%tKi znFWVp@JV#Fyt~O*ZG#`(+gz1Fe4HqO)O&9?D)pxw?yu=&SH3yj9fa6WCdR{4STd8p zu*K4}EL?8kHkX5Eceq5@^Jnb-s^A@<+@OVIJ73^hG1;+W70+9d{Lsgezt<@9`6rI? zP`>q#TKSXb_EkZ>lO?zB(?lyiX%j=T)J#;O_Qxe%FYoQ0J4Uf}ar3@LzpBaD=~y`R zSUPhHD>3a)r+8hnYUIDP@s?-_b%Bbj6vF1<(LW-0Y+_Tz={1;V1o1?~G;sH442<3X z8O@l!mVA&t7G}EW{w!%$0p-BKb@mFeM*MIcJ>qEG>@AP;jaQ+zrhOJgdjGIhfE$t? zx!8O|@e}JL%Y7n|9R1*sN9JoSMpLDu$8LVpJS?ZG?r;)0+vI0G*eJSKGBI1U%;;!1 zV#S^n+%jUF;xlnOSk{EhPHn10+%4CShB0qpdtBH%BllzKFe#B!KFJk?T{GTqZLa~` zl1x%#B)+vBE5+zH*Q^%Rfyhu@3?dBe070Lh{D&!P5t1$MLj6I4qR3-nzl-C%?!NAy z^FTw+$oI#tIKSGCEQ7`BS}(;{?qUjcXZL2_<|Om9c9eHn&cS*znM0F3CQC{9?X^=_ z?gc2@JF@asJ9q&dZg$TRBIT#aO{~LzI!G26ya<%X?5u(DG=C)$yXI zyL+ikvI>T^;<8HpXgZ1tzLS%?3CQ!T0`U%^F*#QGIU4ApA7_5Bg?-}DTdJx`<76Xz zLpK7hbIW3{TI*<5pN|!$mYHqsM;xirg1o|g0NHo8AT75h-rbXCuNK_+uCH#;0u(=I zM~DA`9}Tb<8XNGvZ@P+PC?x!F))*TTavp(AFb~tmZOcaH1Jul=5aA++gvP0qEnM-) z4oHMa<6b}0AEarsEPoVP#PlY#ss{E5=AdjvE+4N2hbF9znNz5fZ;;JcWX@CM8IV_e zQyyL`Hrq)DHsh8H?2&QJb}klbGE#{d;UyzIzUkHW%kSt9rNo*KJ zs?aR!h`y4|5r3hrjZ;GyQ)uGMIo;7_iP$?xC{!?DsGR;j)pKB;bG`cQ6N&E3h|19$ zBxQFS%aV9W$iKjBYRU#ATVIR}>Cdyvvov@)dB^XJbnUj4pPScK!P-Ks5WI^ZgVFwm zA7)ASUe9#0g$rGo{4&hUXG-C)MJAT@z#Q1mO7cNi^)kO7|-jYlRK*=WLR>4E7HJ`wK zRl&2)y!03FTH-iX9ZB;bynhg4A4D>(%&xBlK&8KlC}&!g=X>pO2M~WN zaHj5>r1EfEe5<27HF5uyLn%tN9ZU$9-ib(d&?dLR6t(gc z$f&p)L&M59ot`(>>&pHKTL*u;wO90`WA%P@F&DmP`YClF(n2V;T9+fF?$i-V8HFyP)-k zA$h={spnsQxURgoVawR|n`vp4jN>IJQch&BVcyuU$Ks=_%;v;^w z9%&1I3d_Hx9-eOx^F^PUC#!$%S-A77Go+E?P=Z|M>~sR&=Da7wNkh$Mzq0G%dIh}I zq=_W3%V3+4E(s(%%25vb(hegz`*f!98|F`b)8+MofgK20k87onZVWcP)y0#IyYsX> zBOa@#+bH^2S<<;d6{rz5;VQm4n*zMvOqk|W+8&Fgw(vmDz=WU8Mrw>1y5j0B6j_WO zV%E7+of#6a6fN~IfUBl7$RlwlqLLhTUML$*4bnm#I&<(Fu=&T0Xl5gd?L3d#jV1E0 z5q&@07|Jbt1ShCR2ufq&8seykMq9URz8F6aDOuQ~$oD!0Q+6s$*p@56-EM4^f*f~5 zbZQ(>e3IWGQi^Mp&)M+HBh0Y(&&qIR&c}*h~*}9; zSF?`c%XE`R=ERNCM;RF@WnUy9w&7^`7zD zpy^4VR3le9mZ3`LcfYOof~=^hc8Xi!L~dSu_Rna=(31s*kJx^LeW|YK=<($5g7r6t z5*BEmG|r1|wn-!imtNk<(YlNHi5D7VzFJGV$B)M201D7AYty<7nw= zUcFiiS2%SC9v{XVqOn6w7jcFM`P_-n)*k&RECOpJ)!xt;q;yz;M8I_odv}pSb>6d< zo_8@47cSqmiDld;q%XfqG$kz4u@zl9JnHJH+7#iO>n4ijnb_h@touEHmay0-e(BD8Fc?lWTY-^rDoQg zMB0am5^tAGH#N86XuuQoKB zQ2I0^RyJKaE%a%A>;b4c z!aDRr?h=j6QXkLurtGw-xr6Eswpjsrgg_tLoaAknTMx-DQkG<1#Ny$dP53oxal_ku z#Gl9jE$!a45n^=%fV5Iw8|E`IuFn>p>b{q;m;K#245Zuy7`1j5gxf)Fq27#Dq&74l z3Wh;~mTVYs9j3cRyUWGAkbYoAKG#ct1r`sp#mRL_voB(5>yfn)KiV34a#BOE_qlPN z8LLYmdrg?EF&p>$5jx3Ut%lKlLew~@R73N2$b-|%^w`E)0&mo)IW64cO zs2&6Q`B48x2Z`oVmCC)s3d^U2X~|rTHf~w!gDCo=GT0B-wVWOPa7*xVx9RamW{QsC z4u}CVa15mCzMSS!I;a~ecwz2u7MhTxOrPg;;JVM&<<7W!aWgx;&9w~ z(U0z_g{-0Q^zjsWJ~c&#|1e4jai1u8~v7v zG9;J8n41{BO%g_Y08MuH*-2`=UGciu;{9)a_Nz|bqw|Hjp}R*bcsIvo_;iqk(>caCOHOHu9R)7`OX3gcsR{Zo>+uZz_x zL0XG38j%J1C8bG4=Wh>zG&GBheRo%-Y~pfsw5M{gc{uWc_uhFd?pk5h4CjMsuXY$+ z9%SG**B>m>QW^;)%>e*jbj~g@G=CrErabgBRC5yP1#=b=O%n0O2c5WSPAer$rsLT_ zBNd#*f!i48it-Ch?R9oO-ptbXYf1vCiLrCmvI{z=^Dj?MQdJr%Ax3mn6d6oA`WWDe zZp1SORZI@gKMrAWCa#eK;d2~OVg`NEmF~JlZCIn#i0VE z_U}1*B@nl=(%a}XZ8+su;(dozrgZqR4zFO+X4=;(J`EbVA2GuU_L#kr=Rb>hhWN{* zXVQK<9h3JGwk!v4K1aF z+kBYy9DZ5_lH`mqYi@{9bVZ=hnBIXjKn+fX8~u&1KLIEA?IODMC_UY<)THu8gE+FmL&XW`Agi{sO-_n&+wPDW7uV;Q;!jDQjprWFB)!$l^& z?`BVPG$Jb%htgg$0o>TKvAt(1+25UBE;>EhVq`5B2Qyai+tA|?`8RpeHNwLXlYaA3 zMB0~w_|9r_QV#2)rjYZCY5_`llad z5xrZwtPes|jA-5i1=t8S%45elAW{Lv(;^rbKq?+UC%)%5S9(p^tTaX7==y0sJ@v(W=Jdi}Pxc!#^Hfqf`cd6ALQ6^amLnan6CCx@lr16Y%_xqw|ht>;M0_ zStF%ri59V2HImX=HHy{>YLuczROmuT>{(QdA|e%(R#DVmEfRajY*p2Y9n{{dwEg_< z_xEqk$vHVE_rCAzK3~u0lDT zBCreiP$tqu2~CtMdX7$`?45gKUPk?pPz9bDKinHHE371}rIHvTsTdY1u4NJND zn`vn6;%>rxK=H#4Oyzl*HrO>y(uqcho$H~L0YPG!k~#TnGs&oZ=SIHMXRg}$G?n4#x=2LC!%Ej#=O9GgQqtWx2fU(#Xe|6;j+Qi3 z2>}6XVa4ywHifb~e|kQa+cMX5N}Fhj+(~yo`Xn^Q)#Yrro1&pAv?C$*%7?A@Y0yjA zf>GzXNsh9JsR_ONcGp-Xq z-_Z`?IC}nsgg$eZZOD;YRQRS@M?7Q1JLjI%l#+qCK4rOEK-R!sl%cCERV5zUrHxSCuO5LYq^BzQ!daJo270x`+UArR{vDmEu^9H_9ST*XA_SPRedUFN#xk?~(cSjk!Xfnq9 zT6b?Lf=)y+ZCn5WxQyniQ5jD@;S7#Eo_t2ULVAymzpse8IWE|o$HRYh0>to&+#+o6 zC+!Gsx}10s*=n1T_oPeP)9tUkj03BPfIQs|aY@8MZNG0X8`PjPt*;Nw}RVu1UTf6;I-8Y?qEL-jQ z+v@7Rel^8!yCTH@t{aBAi#h^eFJ8B}i}XGxT(CqPxx( z1pjp@AyDhHscbeK%p}d6AsYU0%j!?F9W0dqb{j7~-DNzbKMx_g^b+7(H81p!jRC)@)BLu;Z{Ymv5J6*%c`m za!X(Mbb)NAvq9J!CT!><130nx6w3eY6!+PG_(=C!l|=!dPG0#-8U+#vknzRg$yZk6EE* zY`5_k!sW{a$Vzmphc8%J1D51%GM1-f{$)7mRhUxU)g%62w~EAIgHq21-U+z3m~Z2} zi@;YW1l(u6N5_sRoqdP?U_>I#=|{S zrU!wHi;z6}O9?^Cj5{XiKKg#}FZ^G?o^@q2nJVj#TVr`JPU}U$5}5yVhtU#(!2S5y zn}$!MZ`;#q24L%4XC1FxtF8gzkI2TJwRv;4gsigdBy9v2q4!c7(vbs8854@kk-IKr zT;K+sOBF{S@u%BzE-l`n5v-c5ZhDzdll$;W>qGJkK;e6;LKl!puU_v|x(#BA!cF+Cb+FjdAV~TKFD-L0@Rqqli;bn8 zwusL`LU4w)2EXG&$IzcbA0s{Nk*205M5B-zMRLsUlH5b<6Gk@@Kp?w|pM&-uQmWOuaA1 zEaf4j{947uNh^ixj(sw)HQJhRQAd>R4xx!{&%}DO zr@r`GWOM4z=CoZL)Y0ot*kyG{;TiN8(~u3_6;U!L>87O>xEdMcrP3$A`Sk0EG8nWw z5dLN}AcZyA0Rk;|F_64bc+9wpN|Au~&%<1P&W!>eRO~*I}hv|kIWii-8UeP%ACIC)G zP(oyB_Iz9|?=MMN zo56bcjwvF9CdbPRg$_}CbM|(}K%j7=gy!*3<_ZsA+x9jtVa-|uV>pv_=T;f@IoJvU zXtjnJeLU2PI8Y5SZPy-jhTIsc@0H2UlUb7Wuci5K0y60owF0BFb$!wjuWXn6M}NQ5 zwa;u==bt`-ZYg@Cxt+8|g@ubqwBJIsfASQGpPZwWjYyVsMk^*>wtZ+Y*;lv5sZN)~ zOUtDYj?CZ1s0Y3`Tm&JrABU!*@TM1a#reDE&y-MXorBU0Be8iK3>$nc#ob4D?2SaE zs^6#e_Ocew#wwCEJd>_G)$RQrxc48Og+!v>!WrBbs7FCH_q!f@ruo^jiNB&4hX5*O z5ErXQ@J)>qmE+qdv4-L}E9Z-z>D^;BT`}%H_PHDeFRmYz+#6_niyh&lZ)S5f@|T)6 z%~&3RalcdWGHBrZ2xt&@Ei4~LLGL-{j5jdR6|q!k<37Vo2K*#%RZ`fqp;XH)x}#=s z-!Wq@o^R<10zny@Wc?8*%%!<@vo}E#c@Cx8wDAvn3yMPu4HQ3;$W#QzghYW#>&4k$ z#@9EEWNt8i5*~|n_2se{2X$XQKd-lN>DB08{XI(5^<17faREBV_`lFs>o`NlzMU;b zHa=ZxX57p%P*yQ#Jxsntnq6f_v5IGArLTI~)$d=DTv$wX72#zVeUKFA7`@e~?xC3A zLdWqcRHN$ZGyBx#`*$(j-+wz{9Y&AExz>Ge5GNj6k8c>v)UljiBmE&!E~mU@g0kJT zC_yn}TRCtJzUx8t`8+x=LfXU};E~w?SQMQl+t9D3X@xAV<&^RD5z>%;H38#0p& zz?CY8Nzyt!_R?ZFt~QB%dWN}p&^x#=kV|DSh*z%;Y3eI<=u^8;D>=Xr&fw9jXl0>R z-T3c!>qOC-m~e~JGdx^uUfF1pV! zipJCPrc26*x5`Dh;dGY`LwK)n0pq|c{NZNrvWKPHrN`(nQc_+Yw@I%3(xiLwwWMAx zWwLWCr~9S%?40oP}VmnTSc)*hvI)O~+IaRPE=z=~gcH*0#!EdfzgVa|qk$ei5))hOr)&@~3{4t-f${#CCQrga~_{A$m&!N!A zc~9z(v#-GJd^AprlW=;is_|8Wx6VF8&7*!L1zsx*RT5zWO~mn^<$d7Y$z_RjyJ6ru zW0^^?x}e1WA+K8Cqe6p8nn712^C4)rTb-BTaD@Hni}`?MKR;)YlP8YD;+6yZD*Ta451qz7c>ZTs*dT9ZVZH1Ijw`d=#(paPu=B;k#Nocc*X^#7>eZdl`KdX7 zrU%9ja`1dVYX2K2V66Hp-^SJ8w)lzpeL8=~sXh}u>V4(S43qELy>P>J)|7LkxuZ@q z%T0_oOfYT;MQUnJpTpk393|jvhvYVqfB_R4X~m`%A#q7sw<)gE31%%yVkmt_7tmDU z9tc`GNbHlCw9I7m2HLsP5ikPE*Uh8FvsUx119LCHBkVKwr}M5m-Cg0y#VoMb?tAfj z1MCXUK80i}HN(nmOhw~nO6rKF}!0+vQU*<>nl0uWpJe*m^gsLJhvtnM)ynTAljYOLsxIg#UtHa?8kS_x0JaF04UvZzzAGd zG`XH0nYYRDglXJvHA&ZC*ZlSe$vF!H*yZtTF74^T20MuAS$UTj@fI@(mMY-9%>#JJVsbrYrOiwQZ?+{ER7L&6MG$$ zlirsn+?gtCil%bCVb`0!Zu=MrFQ+O<)%}>|O5@3|tlq#2=s9Q2aoIpVxa)t&z$>r7 z-~Y@oS$9zq6gE^jfKC_B*SJXbidy41+8BjkVxGM|MC0L)cF(A*=A#{g#;{!L@$pI# zDOYt5;aEYmO!m*A3PMCmWa}iQtg3G_n5-Tn6*Lu36^5m?=l@l%&N5`^KKUIAYS-ge zIMDEiGy+FrWm9*n)Pw$uz5i^Etnp2vPdRl6d<&G-q}MAj-OhY^0o14L7UMwB1aUWO zSz!uh^k{rO$h!NUbZ3@lDRJ`cwtGmU zBg8lBZv9+Ui^e$(P_MlN{jwB@A)6~$IM~^0pzoksR{c`#pMXZaQPSuTmIV~u{Z24$cHoj{Ef^G zEN4w2F5qt&3%m;cP{7J*rW)gt_56y&Jpse@;PJ_Sf2)RM2%;f;z5z7SU)RCE4q>Dd z;=Ybqgw=H16V^s_D*y%?krcRmg)QIHDB0^nd=7WP_cb zU^n1PB)-oFjGtb9gAfIEHoozedGTMLL%tRDr4MCWmUWRQ2{L$`0S3GyLx)m{$%em9 zQ{G;hCkvJlMK|$-H*>?Md{(<}#{zvq64fzJ6@XT*IwtfsmFG))#8~xH$)7(j1>*AX zgT3I><2I44D7tTCnE)#ypPO20%Qi*zH+0%Gt4K)dM%+gc=BG-|Q2Fl?(|X@|8h^8i zzQ@)@$uy7htb_bcU^nLVZy}drc-VKEEt?X)&kF0D@EaZnuDN6=!Q4QH;zFyywoFD)dP9dfhW`{! zECB!aeKa&DGK(Rir)NB-izli-~zQOA3mpbX;L| zynR!-KzEszLwP*Z)Ss~))iDBX&~g}nxzVzh1Yx?!YJ3+x(~dIYPx@wsOytCO#WMLf z{us}hDQ6U3G*Q9YT(C-~U7^=WwZ$~V`yI4Z1Xe|H<*cZ0<$_QCf~0Mb`@seiVIF^4 zTkZc<{;i06RgLAdHO$KVdgGS!l4p&n5pw>4Yi|L`2(wfhWWV7B@ak`2JEHp+^%Q5q z3E`V9l|Wi?@gw~;|74xW*7yn76s?jZ>dRiWp)U!lLpa|CVCMmj_2(TVV&6WxC5lZv z_B%}o5prF1K6Qp>hR=E$de*9ct?zZ2mQ&$yQA@{|QZK&l@iqzc%BOpmehgvTKB8#< zvf2-il^LK*r`=09CnT_eo)7w+%iwj+*3eA1^|OHEzwy_7S}8eV0||zF4<}Jt+c?3v z7mxbHoFW)DnX!~R##;FasY}a*uyW@&-P%qwpHW#SztIdXlDhW>{H|lB=qJZ%x1bB_ zDOF^zx`&B;Z48fowcIiGQ7yLzzq#*_sy7#J!x$1`-+Vr^{Eb@ciobLT7k}2j@v~9H z^W3#uaeEQDKv>~^@UG5m#{TUP)jNDubxdnetL)YH8^Dy^6x?ozQze9MVEfMD2 z31}?Qs!-yn)pwWuB`yIh-{H%LDq@!+j}W~eHF(T$NiYH^GPYkj1&5buV9UM;05Uo8 zTiF~*Hfr3Md1U9~?{|hE{Fd7*_{IxEggJ^oKEa<|c3&m~zj1e}*NM%Mjs<8zJ7=v0 zEa{pI49FS{$oF8QGu4Wp9F6?$(N0-amk2>qxZ{^#GbppJ$$WCSpPnL=t`iAh4xdriXXGw8G8jD=Rb|V z3$wEB*B4-242OAB8SC?MLEwXwweR1WwvHCsrw~B!Ht#&>ceZ5eom=NbJpNA23b7~W z{`$B~B1Woe*iHOL#}Ph4o$(n_VH?V(D72L@bt!Uv)VV%yZFw7 zPDG4=jSXPG)3kmo8n~}4Z{!WUT~+|U&|STfi)TzdOScSwjLo}13y2e!%G$3V#!r24 zL*kMRzrV@d6LDo9+EW&YglbXV1LZp=zPMWwy*v;Tve51>X63>47kcX*6>krPO+)nT zl`PId6Ym$l-gGtu|Bsc}(@-3~2mS6mg$@ZYF1ic$z-^cn7xIZ3)ERp#G;qiix_u5r zjOIGz@lWXzhc<-3bzB^AUAAF(JLNJXKo>gX zpDWT%0Uqi|38mpwrMg|pjeJn?S87@PF@&IoOk>_Vt-e&>r)@q0oC|bKpe6PB?;HI! zhGGj8h>Fh1rBn;5S(W_M8_(&a6qgD}5EKIc4`iWz$QWIBzM=(MVh|H7!>o?ie07i1(AErrmH+ zw9=uE&+v_rYOH;zN;b(LDbsY z#CgF3M=Q|>63!-hJRZ0uG-F%Hjqa+q2IQ9pl!;yhU+gvl!U)3pOu;Ar{YSUb>AF6q zu)cv7s|U#XyzFW;!XeepcQPwh)}&seeA6lH6?X>K=lX<<&By#t5?jgIi=lcd&;iRf zylnHPFV5oiC$z*%I0Yy$&+T90Nl`P3Y%r8Ly9-qJ#qjPkJkXbYtYVT~Rax^5axym! zZ>MvJzf8$vV6>mID^UOLUwk?!a8o8n=cDg-+Zk0Feh{A!0ACHV>3r<& zk1?t0mFb$d3mv~YY`R5p`#JO(6rU-8T-w`hc$t?poy6t{?Y~T~Hv=@i8ai;1_;|Re zy4|W*tz~}0dE8lr5g`H1j_I7Tft3EGopIvT)`XBonatlW>d4L8-vAK}V+<8T$O~CU ziIbI-nk5~LD^?M~mHYRj9%^j&ox&it8uXTXk=^fst{!;QE>u*n26p9FvVRg~MQFEgCGl7W>DAcE%%Hv^UQ zh_~XtBaB{olP9T`P7+C`H)huPslj{b9Umx&vt;o`10`S_rkSlq8(!LR$4+N^F^bmL zv1B4wiCc!CR;;Z~_vLW6N5|Bc?!g)0w|;CAXV=|vCd98)-zOTlYvB6%Zg4#Bb3svc zj2wplKsZ%{2q~E|D^bcIJe!s_EgI=)WB#qy#BIQ>;5WB9jQ~h4?sQdx{0#! z{#JI|qdTUQ1)ao8oI#{!w1YEk=tnN%K1Y7+XRyAVPk8vIKY~KXrQ3ka-T^1M6WdjU zbhI{Bj5Fvb(a^$A`0~z{ z^lW)EIrQO~v)^TNGBzZcJIYz8NUnU=v{_=n-~J$^2JwBk#E48Ow5^M1J45Eu_z>(C zp2b=R1h@;^Qu^tjHbVUN8{$f!dH zS{Psw!(%?$J4)%bZvA@G;3*V@tXyjQ#3m6TBG?z8Y$ev!oW60}Qi6^oE!~Lg>ZR7t zes6I%l7=3nKEKSmw?=P4|Mz6gdK3YGJ(+dB7JJklw_)YzePsm|y5C>0LqMRI@-VC3 zdyA%CbfS;X2-wEhiseLLyy>z!(AarpPob!N*UjN_$JM|D>9+ z+@%VEC#^5DpD_zoRY@vK_FqKB2w!OnnRMY@W`F(`@$<_~NDy)c&r5rLsVe)WD7i|I zG5CP;cFZ;Eg7d=j$ln;aRj9H^n7F5V@UR2sISOy0FBpC^`jAJ*|19DDHv z*|8Qfx$^@1-<8$U>_(&xU}h(P7J0rxUd)ME?uSMIzG> z0edF0@14Y))_K4A`t39x34;&C&Y}86ossOnDxWp?S%?b17mCT?wp;Ub4-o1NnZHu; zS>eIWzJR)H>Hp{q&S(?FA89++FXp7|^l1y*2i&Wm#}2F3MQ}@+7SEb@YjRBc!550* zOgdc=YNmC~8i`}!8!49?KWIA|D0`NR_sUeR7!Fil42>D47dfU(h+;9XPbj@OdKX^MHipx{-DX$t*l;X7F8qsI>!CNsl9uc{8b6y=9Ry`S48#7XVsJITMYx{Rv}APF0BDsj zXOklLBwwmi`CE&X=>+mmQ2#5;SnV`sO0URR{UyfWdDv8s%of*et3P!m^u!A_y^IBU z$qxZ=U@qW#_mn+{j72Vp2_vEfak~;R|L|QCB4gXW-1iDSaH{|{$y81K;yV@%0P)m6^s!| z%WoXxM>^%_kevbe_w^ zrcF2G(9$ZK1Xm8ei1hSa_whO|K1DRbFFI9uFMqH9elfD;q-nPovta@H;&tWO_xG`) zrF2K93+jC+oFYQgbg47Ow@zuhX?OX#eYDO|@>|aCNin()WQs)lw)A$TE$V9?r)(XG ze_t^z&^jO)IT;Fv1^fQuz9>@=>*#n_HV>~Vo?S%~V$pKAH!bIB^VkXaD$pH8h44<<1|_uDd1V*Q zeJEFVsMB3_*>fLu-1N#mLk>5j|3tsetE#RjGNcdvs@~W94OCQOB?$SKf26Wg69j1( zQG;jeo?sKVSoS;7zVi|*1oi3%eHSupl83@?|E-#WCw5}zU+_ZKa`KdwAOPU-yyOkd zuj1(#e}GsBf1mHCaNT1Sa@3SAh-tuf+bVr#nl$9&ThrJbxURaPp*`WFHp+^_^s z=5A8GDAhX4H(}iR0-pg7lJC@&lM_;fu6+Fp(po3_;%WmZONF93P+qS%Kb{@OK9N*X z)`e50+iJ!hW-|;E^6Yny){`O}T>vA|Pra3RUO7@ltp>t%u^ybrxHF3K+XBb{;9Agt zce0d~Szd*=cei@t*r0k^4a7JhrUW#*jq`O7fbO=6O$1l1*PonB_+25U%KmZiK>bB8 ztciNRZ|vvs^B(Nl^xUHrQ~*A=bc3#1-sRTGF-ksW7PBkR!$y6=+=S4^Ia~jL$c&{w zen|eC<93E5)PqV(*#R2p(Gdkygm~yBt2Fa>cb=z-Iru^=c}_5ps|hh2_Bm*FSnJm& zF7gm_6S`JN>DD(i#IzkQmgy=ps?)V3}f_Oqay3U6t1L`Hv zo()S2M>?5zjTN=rmtTbc4%t@`yEUn$RHwtKf$ckS!8kLgz(Tuc8+guDup!JNd5Y)o zhU&AB_B{*4PFd48hB-T7sIQ~H?tKtoSUfvwzRh5*a3#4+r{@?m3a-@rC6rnipO4{n zf|rPYFkjttHxO`z1XmDxNqw)^E(z?9LC&=wSzn2Zpi|&kLJ6$KU74^~9cnBctW~u^ z2|@qL@4Pru*e8M1Y{YAtKcs3X*=LsLa)DHptuzuVfWsmh)d)vosL8Qn{g0hmLP8i0 z`-dq3AMtviBm?oXs-d8rTROk51UBN^tfIGqap^1MfGa7Is;>ie--di&)d<**jkBO@ z%;Rp%vPtJ-n8In+QQA6TcE$p*tXJ^ksc5l(InP z@vr9FtMFeRS#+1UQ>w*5l}zEck)^}r^Vp3C^}h-9O(~4SV}k$D$p&V*H_Jv9-`4eJ ztSFNB<0ODVe|42|r@Z(V#Q)kL`Bck|%cPAT5C;ZtxRb-HVm`lLt7WW-F+!4wt=z7= zBKys-Xv`&%rC}Kwj!AipY_3MVMj^W^oxP2(A08HV> zZ;o23gy8Jd%S@q~KCvD{k97tvI?Y^9XVV`SpO~cvR79%Ka7Gr>gWH4Dtdo7^7bmwc zhMK1R?1QM#Q-DubDHHP`QAfuh;YQ*GySlM)XR{Nt)ICEQ);XnHwwt=W*-*FS&IQTt z4={v)^%IQ~21(7-Q;);WH`2;KuwShSdI?;`!aK*4+Q4N0L}%UnuEg0Ze5=PI=ci^( z4+9y>a7x-iaPQ?wti1q3aDv|p2OX*9iGbI{9Dzsa^1u^2I(wP4f^_}w$0&gwuWIt? zRARP(J*62uj&yk#&=s$^@v;QM(;Vw?HK74jvjNppC$1e_hU4RFTLryEL&(iPfC9>J zz^DM|$KncHujvJ6ap^n2X7+1lgye~1$9hua;Wg{)mzgd)bF`#tI6`}C7Zq${TkhBg zz71*mfufu2WK6oryLWVy!pq{>w0k(#7I=`kK_^$LrvVz443u}D&Z>xc_CY2R5>eeJY4P zC^c>o9pYzC;vmj_^sE#h3nB;lODmhhEh`^?@$S|fXvTik($?bGl6yQ#p$f6UVjbF< z527bo7-xaxV_JI#O;AiNDk;m5Y4YS?gt%Kk)@QTj-~4>zTMncBO6Coi+?sVva+T^=!1$_dnOqfuH9*nHyV|`@}@dTqT=eiFIbOysC)K!JisMg zTGs7#f}Y!N|DZdT`Ty$0w|;$qcltyov{ncVd5v#gX*21@sq{Ob8Y`V)-)bdS;oKuy zGM#AI*kh5KoXqveEqpm6!%0;jE8}KpYs5jb#Nch{tH)@|NB)VI!k<;*t#BqX=L^_9Hnpj3_4fG z$G;JWU|Di3s{L2Bi7~YZhNLgnf{kzbPP}0Gbm%H5fC)yfI1E%=U;3a}ni!_pNgGGN zs(Y%i7SRi{*s>qLX+u-}6ZGgAYxm4j{w%gC2_KeO;al#xSHVNOd1(2xV9=IQP0|6H zs;tl=eIOoWvAX=Gw<0j&H3CG<{t8;SMb%2$CIj6oN zV~^&#qd4~SXGZJGSot;tqw6MPSG~eIM%zrIYVTNgNTReWf?jKpMzGEa&aj}o$S<#* zl5b_#Sz6X^?Bw3qO==IOr4sui&jfB|PrO#WN*jOq0TSM5_-kL3PTbR>qvBD6tZh@ru5!r8!%_BhH4cMLLID-qQ!K9DAZ3@ku zFX<$%r7r329`x-ncjq+D-Cr0;`c_l5p>uKs!~E=ATj(BL;|SL%!|g$h(yqfJ1fwmG zHJf1x@;f|DSFJOiJUz@!#*8Xgk=Nb*bapOQqvEb`(bt{m*rCaq;{qSObQmqa8d`GNz!|W1 zUrf#-Ccm7iP&Z@Ix27T~1wfc``$+_&TG0oTq2@RQe+TcY)A#itA0Sb37+td1^}4#Q zD3M%KhO_Rpy~fl-WhqM90xl3Y>~~90UZzp}CX)mD7_<9QTfF#<7=uaMqzeBIcE~>U zT`ud#raA_@ZD7P)N$D=^HYee46JCaCV5LMVu1g-34-LpUoBZYf9VqHc*Wq>SmYLmD zzi@NBi813e=kjf=1inA)lMpmbF}6rnd=Bk43+Y=_415F{5k9#A<|{9AenlKt11_<=P8@t?Nz^^VlP6jKF}?y-*wA z0j&ea^Ry%s3u6SD%7Nn4hnm>Eovl0ut7zIL`ZsWI!vEnA8X5nHX7qeCVVzU!16*?P zY-D#UEgb>hW0y{I6cn&)0WgN%jIMw7P?H)BkWbsVa7R+Pp;#~bIr_UoO<{GE3HT!K zQU=&syY;0tOIg*ZPSXIx8qw&67HjRWtQwa*)WH5}yE(d|*HR|#GX zeL3d~`aM@@zbw?)4DhSV6QYZ>?LQB@#K&M+awi5lQFW8`5Ro^$mR?RF^n*cf5LxtDZpTq!en7 zSzOxm_>EPhFGiIeV#&v5f2=@s_Eaz6nBs)CTH0~Wr=X}#?{W6rmL;9LfkTukAtieKHKoDaBO)dWtY2K_l3XVGJ4d?D@;2d z^c}QmjqkFouS*ku<%f!%Mo+<5?a%k$CO+#>h$q~JTu?b+7D&j$Xe~=+-GI!!Iop-; z>yPB@KU=CpAy))o0P*az)ZXB*;pz`(X+pJ!EQ|_h=N`UeoIIje12`^YP0NPY!s@Ch zfg^#p;1Vn&Rfz>{IMs93U6MpL7VpRbdZ5ZWHYLO68io}mE8kfm+W+6kXoqOicIX%* zlL(lqTf1SPOzo{zMKG_wz;_CG@G)i5-a5b_NRE6}C9+ZrBLtR~hWnFUO}e)04@k5> z4Q)ookCsmkLmEr$yjg#@*v$%6fb$dMp2)S;0P$^bnQ zA*RpX!MKyvkY=77EwO32Ljd2^|AP*2xF_WYSf`pLS5naw2}dBA3AMh;%qmd(YKY$5 z2hfGx^|T6p;e*2h04uiUYeBB?r8INa_FC zb}W;nEdtOal5`f!CEv2g*a_@tlYve$>o<@E1E$PF4fL+e((YE??=+6CvdyH(9ca(} zBl$uJ7H|VDy5y1AyPqsogF7)J5ONV+ld1rl{9;;2Fa`qPuRxJ74L`^`=sK z5?GcO1Qw(7L9)4C26nv%m4e(oE#AZ9DZJc*X?emjUkoo?%Xu88nZ82Y0S#SXeWH_1 zFumVVuJP8f?aI}Oe5P>O`QNh4WT7f`(JAZHR0Tigs?!5L3fa;HdjRK;VO65jrRapE zpNfXcbON@^?|949^TEiUD>79?|4VZ~6P5olaPVK{fqxg1nrO8T`Ywt2D|roP>0EkO zW*_M`E3{M}b=m&k6U8V89a4+=$eZrlmzI1#P^)+444gsS%bV*5ow*qaEmL(_HdV&G{LtI=!hnH_i^ofuH$78bbJn&abZm zSMEA_0`IUn_xrO5$BvSPT%U`fOO>3kAL~i4TtkO-td^%l{goJKnWuUhw?=ZN#y;PM zTlah36&TM1(Fi?`F)#(@srl$pA;HWdpkzjq!*Q9-sIRHL$4Z4de6qvp@WlRnm9aQ= zRaUnB@9wBhBi=eFBTAY%qt{6(^Bv|oJ`W1|0k4da4!y@fzy7URRnBo4)K4Ni zm{Ye+=_%W4~YG z60D*DZ3OGsvBB_$d?N>f+OC(ja!pm6b2`M(+;^#M>P)MtA_-jG(nxi$b}0MCe=6w% zW_hn1R+g#|wA*`z94G-C=YgWJ9N$k*4}J-|I{v~=6wkTXN=zwpWS{qXWNi{4^X*+F zeqlg2oMV>T#o-C|@4kuH`wy{oGUEUj*T()Je(u8yUIkt`FM5gu>~3j;Y@|l9T_7Ff z0f1-PEWZy@&@+Bw?hG~1kfTCe2l6-#W~v_Uc}#sw3JJPGz6wn#Gmt9%ho25#lV97i zFwDV9gjV>72r#+84eCv|i>^rR|2FmB`91_cpfS>jRT<`VzqED)4m)nsL z`eJ!K9~r?^{14gR{-zBwUDXNmCBy%P-4kJ+8Fxk(qNCJ~PUH5DOa8Rv>P3_VAc_j3CNY*xiTUyb;tvhkzSnpgk7uQT9GHvK#jfx?f6&~T7Zvq zsc#rBi)aCwzOdB|ZfDlIsSl-jW*j!CNqdx5ofQK7P)aKZ&sH_*ne;gLMoU)NM;DM- zQ#r4P9|X{~T?2=&))o?;_sXZB&w^V@AWK-z=Q3Z2=eq7Plw$8M=83_AGYOORJ`;m8<@$g}J&{x0a-5Sm-9M!y5|92@NWwy}mZy7NPbs zT4QBQHFv##MBx=WP(oS4kN^0iBRFs0(tvsNXx@}8w26Cl3FVWwcmJBFEMZ<>aNo0B zGS+OF_*I9RN_#GY;`ln{4_cMU`fVITz!%cJg#Vcp=60RCYEh%4wN^T|W>;3l&8|D5 zmmp~9#Y)obs1;Rmh`0_toXI0B(bwKi=ua+%<~P=yhlyT2YO1Hr$u=?v6GHpF7RCg* zlSF+4n~6^Up3JxMvDA$T=^Q*-&$ZlqMtctPZg>&@Kba4dy5K%uU3UV zhz9D?ozsGy^pG4|j6(!`J9zk7CuD-+y+;orv65!BJU$iJ%LHN>d!$I1EGc z1yLWxYbonuGo7^dp6@==lJFnoDb{i8te4M_1iD=d2XCCMt!4R;wlcY?TeGj>tMxPL zSCQr+dL{8$L7jDF#nl&A9#kd2l!fy*e*?s~@Vj`WqjTdaiud6EbW*|v;+wwG2Dfq5 z6*qO3f8epVF&bJn`$^SXWJM*!$ZW|M)EX4^iG0UC2-P?UAV$C6Ix9EbS2+T=y)>0< zm;NVuk~;GjpxAzvFjAzX-XD&_)79C-hqAr5>Sd#EX(9zwNei@n3fa2a-%+B><|BS< zlAoTeFN8j_f;>Z9O$9$~OmxaVS7)IoQU80%`Y+;`p;FyPIMQLrH`wJC0p#BW9miYtz#Y@&A0g*d7X;D;fM zPZp+d*>6zjaS(z0v08~bk))ovgPsQs)w7k_6WGfVn@PZM^zqQ!4MM3oMG~42qpq4I z`?$v;O-es4WK9~7fD%9xryriZ`$Gr{pR4^NA>gaov6*BYRZ);1INn76XLoPUI(_-x zWP{;(m}j{r;)!EFVz^G?@EYK$wDzelVh#A$7*cOP@hba5=p4X0=%B%nh4&5m?}M5;u!w{Z~NlMUe?7()1AqyU(()_GHG~A;P-Yg$Z2FHbT7%gC z#jsdH9=aKkF9LdW#3IDZCez;er+%kRU+M1&;c>vZ^_bM*DCiVJs8Y@D7-nu-+$%~= zy2xmfTIL2Azzohy4UQ?L4Y%JC;Ia)4YH+rhzIVTu7l|))jpfmr{buCs6!UV3VA=N# z%rKNmj|xr*`q_ak%U#vLM00mPT4*K6p;Rb={tjUGCix}H-mnYz>y&CWvD?m`h5i=i z%C-Ra-H`HF*P<72bZt~gYYxxg5@hY*O^*szxurmN?gzH5fMSdA2*}sd#L7 z8+!A}1!JDQ=r?E~n5)o*r6h%A#O+$E18aRTq2WmFH5Q9tT8D{`Opha>Q0z0fu`x4L zzFW7a96bJ6#KrPiz$B21wGVg>(-ZY|Z@(^HT@xWT7yRztbD~tKk^^#pt1d-I_pdn6 z3eQ;R@cN_AqTA1-dxI;E=YAj$J2kFIJe=^}SL${F`A$pU(Cha*NrfrUmbIyD6K8;UN?b7HdxnP<5$kE` z4t-WaUgz8O7DHi4AZzl{%dli7-o19wro@H?^^%!1*TFU0NwM82=M8BL`(GosO4%k6oPAR(C18*E!*=RFk zU@r6iAsCIy%Y-tUQJ-G}B$5yx`e_V_4MNS6L0Qs411MTjz1Z#LkqK?N@#})|$ow6Q ziFdQ94$(_RC;;G7X-F%en&kC;aXNlzCyrR)>;^~mElE^aY+~*zZPqsZy(ZWuLs4N~ z3`_tSKIV5Ttl8}$V+Sg#tm=reU$sSRBTy6|oaCUCdn^~?6g!o?danQQn4)pzxPZ8I zmErE9(NZLHOxVc@mg>+e{Q@7`tyiV~G7-n2IQ~*`<00!My+sHcc^zk>IA*|b|Ltq8 z{O#U@q(Vw}Moa;lR+0YH?sSau!;N67FuPkb0MRLm3b%=$Em!vjdj$QG?Q7kz+XV6t znD)c3Mo|fGez%2Nyk`L>E7=Ewf50l&xCbF4x;z5*|HP9F>}z(cuU~ztNRQabqCY-G zraPwfI;IvF#$UMIA7=P3EhH2)uvq><{?45Am1$1R@a9$aJ>rwQ-1X7s&H(AZTIVb; zC9f#adeqiv_KC^^_-`rtr%1`xT53EHL2C<@Nx>2NI^QpiaOw-mPe~cpql(^t%uv+5 z+G?NG==`Kc>sOoOQ|Gxn4D0AI5*2vVnXNP5pZ4zIU2=I_fV6C@@@p=&mjE}?r}tDXr7OW)2V z?gmT*2F0CsO}%HvwpM#}{Olv*N}NjZlh@i@Ov%9u+QwVCu$1&(X?41bZW!>N$N$_7 zMhoM|($~!SBxG$;W&BoyX+uA^e0!gYe$t=nGCj|Mt@{2VUU7?TYB}_~`bMJ`5RD4m zUACIX>^#~k6=zuE_a3Yo;v&oB!bNTQ9sB`X*}sh-oi!(@WWVPO4%+b(=&SS20Pggi zQi8bBz6)z;6R-qrc1!CmUexFAp@y5+Posb7)x$)6aZZ+=c)Rx{Gt(7G3hg_$ty9wa zM6axSlkB)vV2_rL2Mil~7N>eN?p;`?Ty_o3@HHY7T%$MtQw@&)i|%E*{wjj2G2<;A zH-XjE9876nuUv6lF5VwixWsgAwg`A*OuHRoEm4$${r#WDvc-B7rprRBs{tI^lUyCfMjVU(%zP;6}T zH*L6!VkjB%tgk+AAXiJ7q2OeLd0u_E<-K)s`xaSy@Z=isf=nDQgvzg7W z8quLC{1zuzMjvus2nhuJJYMF%x65OAErJyuc~t*5`m-lb$2Ndt z1Rd;DXe1eOvqw9av4<(b9Z1jiFQg?KH2rR>ng^|>1ssJ$uvjx4l)bo>wlCJQ~J0V8ZefX?PiUFFQSKjQJBRlv4VsriZe|l=o?g2F4Co0q*n#=9Hb# zU|LbluP69A0e#4auHUp3GlIWkLM}vi;v0AyIeM~n1~tkNt0}NGa7B7?{*%?{)-d-g zcbD`QN)cfX8+_^R_p_J9GWAK|MUS8EW0TC=?p#0Eukl!`NbDPzS}aU4Qm*mvkmx0e zp^pU*Elf3Y?k|Hsi;hc)&7Z+svHS`Ta+F(LJ&z6 z1jbNezyJ{#sgy7}Mt7(9`JM0YZ@8|r>ul#a&vU=;`*l;~L}#L$UEYv`fT8r7p*qrO zDPJy?dXa+RnddK69_CFB2j4H#OEr^n{6KUD@^n++8NYZWBF?or&xh%$_U!X$=Z>bg zJG6l0r)ZEX@E>T7&Z0iH{z31*p1W0oAmMq;a#DtrEY)d)EO4ZehuSg5ky6C%79wq2 zgXcK9kr{dIE01lKBs%{z1zU0Ue>u1Vci?hn@{$x+uiXZO!1*|-bRGQ`*c*trylge= ziP??UtD;fjdRa++U#@aHpCC*>7>K+8RXNV z8r96hyr=xAZ<3XPY;yp+Z>_D9NER{yai->pc&4&HD(tlZJ9uHBTp-@zrTSriR8lW$ zqoccAQoK0fG8E9MewOm;eptUKa;e`K<~okn{(kY3}a;%lMxn<1eoubZ3? zs`yIUYlM?5r=#>6N$rDXYRfeiI?qeqrbpTavoFfDm44c+8qFz;aMQz&om>LNsjl<1TCtSTR6KgH7kp#xN#Kyk zh3Q}PYkLZO@;rMk-2SJIkLa7S*YU)6Abz;{G3(MWTDZJX&`$53bmPtnKuA#G>V2AK z_H6iiskoYf&gK{qRbWlm_dO?Nj%AQm%yZy;JN80w^Q*4*A0zEwChQoY*(>01FG;Vt zFNTzE@*55`KHWs=nZQ0j_$B`1g`Z|9W;$H=EW-$XG;G%Un#2d0m8?>~u;TP_&NQ{Y zTlxIqf_@*E+a+`elVp0L`(3)XVjAw&x<`P;ua?r@Hv9hNg$YQDhU&^SPLUa+@9fe% zVn$80-VfuopX2rckBy=Kc(ayXPiqP+N%QxqcL{j)AqycdD^@-Z?Z3x3Ch|R8>kJrK z9%Y?C7nB_}zhP@qT!+sNi(^&-#kSBd-7|-BZ}=mLB!MzPu{#yg=(sF*P=dGn5$WfX zGD-u;9_G;9kH>u4s!nw+Yld&lIgJ%y|2I(0g=jhT?v^G&dccRQHD~vL#sQLuoF5!R%iveK`y1om# z+PG0&aT-}U{Qj;+<2r9>(EQw2GyC7g`K@b&8MdRbj3UL~V=`itYAprNgMYwXO~EMO;z6{UGHN-w~K4@wp-`8 zH84Vuqxk+y+6&}gtJ*GAgye0-9hvXrCPo#YdhREF2JMD6=|;3+tdDpp`K8&wE$B5PW@Fu8*!>mISvVd&G(b~JfdCd zzghq3Z0$=fQif1`d~J4PNuB><+;3JtnK$$ZQR^dF9G>YH?aRYOOor(2_YM-7os*d& z!=$Gr9U*fHeQtkkj%5jhkcnS?Yj(2TA53P6m!cbHkBs?o2YtL@B}ejrT!8>z(5Lk+ z_nfsUTPG_e2H;`OO&zNue@dt>7J|r@X-b#LdC5-={%=H^*aFFMNJ$wcTS}f?{YyL* zUD4gYS7FS*jZ5($uF3YwsnVU*FgbT`6!`sbuW;9Q@h;hDdT{1lRIvRpWIzs4D7<@7 zL%SM1#r5h_E(SYGza4JI|8W8+)>&}a%bNJG@X$PQbH~+Ex0puRrr;WJNxxT#I=*~u)w{O^Idi>uWm96OTptV8!cG5#F37=xY z7tk!4X^#@AR=ZGaU;K8dXxhn*ffbOPtLoenEv6xe*gUPs;ZR5|2p;+$Xb2@F-c0V+ z!kE@1lKg`S4VYNg;A*)T33g#bQgFnxIc^It7(iv)Zn6&Gy23;slrpx6M|JRTbGw~g z3SjO*>4ib>nxuK$E=fcBfjOb~YBCKZzJsj``MH*?Us}&P>A!nLF_CZsV03)sz$FYG zANJexvR7DhQcZ-wo2Zx0fzdRe#pRd2ex>>qNWe%SsjG(m)D60^*7IHM z@0gwhzy}_A(2#ObEF>wLjdfxL;U1f~TI@T!!-l$5Ni46G!@=?3~4UfoTvt-;skX z*mk6B7iAmx!7C6?r?W#)c|QQbIsCv14a$Yf?EyxC1GAVf37$>NTcOrFz~9kpArm3upGVk)cgORB z*cxvpKuN+p-=burJWn)FUN!y;d=&VC+#j46#EO$dFZ>58Qgc4$eiFjgjPChREY?G6 z4aHX`M+R2U;UoYoy(~*VW>#9+bdy z8@JTZL?w>g=>7Z|>A5Am=&NI%!zL}g@OZ_2H~D>$=LfS)bi=I!sC(@`4>)Z{??;A3 zOa#UDbm+bmIBKyq0mhUWZa~4kL8xi|E-B0e(q4O*uLQ3We~#9%5gJr3p%Z_0gcbG? z_A2S)T#{%RZ%he)m46155W-gy+i26r2R)~_s_0g*q8Fx`@4kF=cL^!(15YHqm!U6) zc0Y6pVk*ttg$uCPiBLw}u$tp$?hgf*#6h-{L2LeLyc*OddFRt|0;#Xk zxfSJtq^Bi%4J@jga~v8Qc%l2?f{#wA?{9hOS)LH28mY1TPOI_O_glAQxmWf5>4vH0(iAN!QKkccj zkY1;_0w$-DG_#CAa7Bzi*rKJFTe#Q#F?5B=NP$OWjY`SjHl@F;K^g-GnftQ_f|~9T z^M(aQImWBx)_SXfXTJ#L_$N_J_`N;@Xv3k47o;jG&qjKr#LcQ-X!|#JHUVgxe?!^D zmKi?QYSh*B7Z|U0HMcL779VS$3MN%{bGrb&dyI^6q91w-(!HmzbynO^?QNvUXi?MxiyDTeL((5+Xj*1wJ^15h7Dzk-~xo>NTe+H<*^Pa;%Ue&pPz*MTei)W@;=}`Hp zf<2wG#yypsjNCm%D{i^8bHZ2G@gpy}mbN9hoEnfuYvKHQKC$RyH2Y!vI$i>m^^HZB z&t2w(Y=?&1m}sXEqXgR~XJn&-(N|eth(o*NmB($MuBshT?Uxb8169+9C_Xb>&4kY_ zMNuAlo_e1Avwdwcgz5Z7L7*_?J~Znfn6tey)>JG zr#Q&Ong`PbO>7X4_%oGLJv~u+f`HTDRK>Z;>(Wi!Af%@=#3t0G5w_^gYb{5DN5jpF*|14p@s`BJ}Hl zbCa zi1qKK_BEOYC7jzw*3YgoCRjY0%*?ql@q|o|zTn@MhuVye!kZ*Bld^CLTVM8=o@*_9 z;xoGAX*?Ua%=`Z=g(vJ=KW-2TbdO>Ynz~B3L)Lo?e%ydY;2~Df&|?spf8Pk9IlkuE z4K8p9vFc(Dsa(d{1aqAofib0CrR5IEy;*1u;AtIFk@)L5K_|-&z3wi%SegXnqA#o& z6NG!WZ$l*0IEzk=p6zuw6gv>nhqh@7*CV{!AOL|YX5B%QQ7BABrabwVr~`^1V7fehf*Lv5?3A#U zugPx~1t%ByzPUQ^_i^P$CP!T`GQav$oV@Bm@e%t2@<S*nV7WUNGoF&lR7KHyk(BPBEG4bbjf2$>5q--v!UO0(Lm5S)|hF; zE!*9BSK6KtMeE~lFgPOpmB8UR%Ed>xO5bk&SXND+6N&CK_>K>N8MR~(bucTJy{*$Iy*Y;l!ETJ@^xi4|&cGQ+%gbsek za}d1MgSfv&L)CA6X8-Pi-#BzRhpGDDU1`NLpzyA74JY!~%s_Vk2kQ|n4$*$j_Em>H ztqsHS(Ap(L_k=f`Uz@zEpIQ!gx%l8x@-ua42>ip3)rXY2xmXy(>qlL(rGP ziRV^x8^rB2e?l-vZW z@%}6xtyv_Ecwp;C{RlroT8rLf57}qA%WnRaz9ZE{4qG*R%y>RhE;}zf`Ioy&=%y4- zf?ZOkjagQnf=j>imwBDC6w8bX8l9@(?uImGM5)+`|~5=RPp@pk&H&??F$IFGWM zqW{f%VXl%cHC||K(m5CLs8Q1F!yT2W(%(9K6xt`-R_3!?&&E04MU~tq=|dirytn0> zj^X-r8I1~3gB0b6Z4RNG_#fe>{xtg$5IpcBAgRAEqsDRGhR9v>9CKaE#W z1dW8>5)8rswnS)-kEI{-Q=C~}Ez98^F-{ca@{& zh{B0m57aS#^XOGGt=&cWBApyIZ7EWJhH7H_fyB?e0d^gS{uVV!*pT_@!Kfm%7K zbvZ_2cC;bBzafUUE`A&>*Wcu8vsv89%P^pfWg%D;hB7vrb};cNk(--KLHMua_n0@| zw}|_KUp@yF)bn)_k5Zan@d65rIC~@*fqjXPW zF$tRAioAYia*;ULYH(}a)}kUzXl#BX4Ifgd#7ufeRB zEo<3ixsLtC0)i@3?`5aQtCiwe=pTJ7(a!-KNvjb1Fhk*b^9TIy@YxzGoPln>>zS(X zDW!wmoN5doyhQ=Sy__9-{ zPPB#oPTRjz7Lj54x=f^SO3l&XTRpQ+JC`aIUr8I#u8$+S@NNg&53a#kdQURBJjLb6 zHQQDbJav8Zu$xf03Sgh`rFWuCQn`B7ALeYL60)K`3LcHrmH@Mke=NYE+aoMQSqG71pa)u7(?&ek00Etl4~U_x^Yi)t>C zcm$SH{a)H!x+30oaP?v7cU0{1^)~=5u zZ@ml@B-a$JTT1ZUPOcz-6Qz66=>R$CrVEO8<~}4vKnetQ;onW(hheZ z)_QlywYI;x=@xANj@4Lm{P|=|d;`|d_hM1T;fZ)= zTnNFSYe|Y-y-wapcWJm=)%Mm&?p{5<@$lTfbYq?e``rJSS*{xY+y0!?ydm>v(Y%iE zN^8hD#q0#T7XE-e8?DaXoy&UBP4WL%Q1TryH=E!`TfoRIe|nzCC)_Xd%J?E}e-=w8 zIcFT}!0?0DU#21Z2CW0dEnv+O+Qi>ZyuW2OVpI@pC;r1f1M}YyKE-jkd!RPJwf7PC zauRhRScWyK;rh&vqiy1e0P;W3qvS@0;-hGhm+Qhr?RXtnJ^2jHX5=p}rYqIHY14{y z4G_C>4Z&mHe%vUf(bcN`Y0g)IFrw`(PH6h3^Nq93Lc{nWhpGMmbW~4+5|WVc4}op7 zOTl|sp6I|8fqI?0lP4WH5XmxXBEBy>JEJk_XUen5F+x#_Sh^(ym19{H|4S}4G@66W zp$_SjlQsU;*TQ1t4GV}=6&LdQqun9PYev~L&2P6IDB!3%dEYzMvaR=V-FF<=1pGo`V-xz(R{1uIt;uK7`Plg1h>YX>8Go=P}PHs3BLW+o(o)q))m}=|-AL zzw2@exdaY!N{GpYCM^CPSNM9OMIHf95EI^>Jv%c-FI2Kgl9xPPyf0|ZDlX(x#r39x$(_d^Ie)v<&IRcTP;)5$;5fA-((FAA6yPo6Z-2RaZYOM zoGO=ev?yNCRu6u+``gOCA~JB8GyWg*kDnSfnfBobj3Z0!{;B3bi0H4)=~|eGUiY|) zJV%sbUT}KaWogWwsZ?{mU50@7rTJDgqNhnPmm{ZhVemk-IuOGMdqN-4@fcECWujw}J3XF*?MMHgtC2 zjA}J}8keW!x>D5uGlPBLacm~iD0z3mph8%&*tl@ zT4r9Bp%k_$9ejm!zX+$1W?HpfdY^fZ7q!qSmO%O0SNT`mJribY3q${@V+i2`2j<(M z9wn@bI7)r(ld`zcgH1wz5Io8xeT2)$xuWOQ`(3cRs0kckUA&e2HXTs%%m~w?1VEH8 z4}r;v;Y&&{AlB_D;I5hrxJh?3mr6ZM0v-KrIwR{BTji6sjHLTg%N=;iC@^xDq;B+n z$g5^S%Lz+TpuIbAF{Dp!)u*cGW|R>ttD7#5(K;g-lG&>q)4FK4XX8_VNk6_0kycwQ z%)hja#hvU(pFS4*G^%^UW-X>FF<|Lqi#$^XURx}6Z9Pb7@D$jV39lnH^>c-zBK4dKPp6HKmMoe zsNFztZVcZ^i>kHmp5@d}${AbdT%vt}8HJ=>8AUQhq3f@aOY^N*_&Y)NE6+?rJ6a;Z z6xcCxc#-RYujuMQ(O7F>GzhnplK&~%x8cC&L@Aj-Tc!xr6N27i(+{pSLZ(FBcCw%! zMM>py6C+c-H}E-_e^@*C3sF*hkR z&pe*(b6h>(s5UcD5s2T!8TU77f6UHIihNtNL;jkR71;jID0xfvuy#CFwRoKC3A84v zkxvucWsj4t7Wi1%r79`tn?czNqzJA2==?<1=UR_R^SXNx4b(?v+UgXu1g?Y)+>qZa zlL$@0&a#$bTFV>sxO1ityTxO!8PBzlDjC@7!8(7CNrYKF+>dSv8~kEoxt2`#gA{b1r#`Xed~~zk3SiIq578j6tGV97 zT9C0=d!pW-!v>S@n96iXlRhw)A@yRZ zkd$hSv$j-ftlTos4F$Rxyv8Nrod+L7bc9Z(J2FTUui)9vTyqPCwpWyg0MFSznu@10IEx04tRtg%xLmq34`Nkx=S4y<$TuXwd|D@exjQOb3ZVQW(VVpr@MuY-T8v#~hBdV>;t2syoHBa{I_ z=67M7IvnPtos5`O7~P2oW#>CSJ5@Eo1k!Ijn!WC_XR&oE#tKY zJpNH~u${~~BHsDJj`e=3)?VA>_Ea`Gl& zCCn99_O9aIi1t72`x?R$)!P)o$g`v8NH(K}9$n^=N!Ek|s7vsO@P**7svK>0RIzI} z)smf|k;$_XT*w<^3cs2%7OvIZW$uWR!x7xsllCR&LCkzBBTQ`T9) zHLvz1!KhgGx0F^eeZdYnARkO1s7h%PYSA~J;v05PJ2c9o&5mBg`W2^#k>7H@>4|di zbAgB~Jh)Yq_1w2L*m8`}_QSA28`%$%=Q66vI5wXqlG!+_Q4}V~1wrq8da1D!6oOdZL8h@$yE)9&ANhN8ro*m%?!yDr686qZ+x1 zUiF zFeR#^`~ZT?r&lq<+NJ(2vu%~Fw=PNTW+l3Y92*qwd=}AGs18pK5kX0t;bIvLvgf#I z7ybR6c=MFh$J{w9SZD4D$d2@Am0CvWLxg}oh!P?Pp-A*taG25@{w%h2nO5O zEonfp!?aeT9TTnLBODOPXtR1UPB|~RiBUf;;-$={=q`t6u_g1QT0`s6Q+_nj1?usL zsSoEmI=74Z2DJ_UZx|=K86eB3|ND_!!^rbTH7m8Z9tVs@Sk6!7f9BSx5@P&Zjj|B{ zm4K*$-cSbwBkmjn;;CIE%0{`k16~{O{}ySSPB_t+}3G z=SZmz{E=yeIRtaYz{6zleUf*)y$OZU>`y+YKl z8^bP&kt19wh1p^kat|nf_G;$7wIu)}c|4Ww(d*2YS2mLgYZN|&0=E`P^!ln>d^yZV zV*G$mAo*MtI zsd4A?Ng!93nz}mc?%-APX|_)RsdByaqo9&gLJFQrqiV3F!ynNZKfB@T986l3H5rf+4Dy$WwdkST-e`Riz=oHU z_T9IzN$pST?m&+HFOj6zF^3h?9Vj)&33gU!ZUcs?MvY9%44VGO!EkoKPT2s3_s8?n z6x96V8LzEGdG#QDq9A`N9W;^p=M;y@V6*l@a0$AmNyBva`vppmv{e}Nnz89^&aEY* zk{Yo0Z@Ct}NKu1D%6hn7Y!sDXu2Z$pjOT(An(M`T&S9;!0k9Fa;sdJ$mW>s)ei-=D~{Q9?Jr~JIQL6{VHal z{OrvlbXyhqy3k9ucQlE=$fiSM>r|N_pBd71-Up6_i;bGOZIZB>nj;v4m6}g~h~{4a zRf?W@#FGNEJN&d?55$bIy9wCysxBNx$3cWZEZ76^Jgu3*YK(He-y&=%Wl#1#ZVmAq zOlw?^I?1UqhEFq&)dNYmHM;HE_O;rt5+sQqOGIL#*NOweCj#?LNkczXH-*_e-z{|i z&`PY`HeBNAd}OzS-doTlfg^J!h@-X4c`!?K%Dutzl*Fx&(&#*#@kLWFj$F*6>tx=S zaK|LFuWwYmUSxyshgD@8VZy9)7#Ff#;siH$ttPby(i`?Z5sjotV-d(r3^FesU_s3M zorfj6qj>#V>&xFJ&W>R(N!iG!eHRL+5VP78(8FY9ULU$kLBr`=?v5;g^JB$fg*}4S zhFL%3KadjX3zEF~t!DCkGAE96H;yXd&sM+PU61L~Ktg1Q?kdwS6#&6*of>>S$lkXj zwP=@JDpj_hZSe#Q?2z`5h@an>)Whn8W)w;5G5d^WOnyl-fBW8YN90a%N~$65q_O@7 zV&#vL7_H+Ia%lqUe~a=mVFhAbv?@CCOI48>m2t1?+{5w8QrfG{Isr-Cpj*{E{LLd`U!R}7mw<6JD;O$o#9fq~w4QrzRS7`^ zZXAFa${~fj$tz~#$iJt23(;UpVv=7AHu?GUt5O!on)Ffors)L2G}MT!K7IS#K4wqs z`#nPQ_fH#(QxUCGTz4k4hciUQo0xD)fe@C~I)1d0TZVGt8&`ub?(0YbK<&7Iyr^=O zev$M9Su{3tM2LXRqt^xEe{U?YyPnj^^Fa*o;%k)~u0OG?XS9gktz+>gPRxG?+dkGQ z01;ez@#rCs$BVKMV7Y|et0FH1XQnMfBEu8_chsGzjhdnh1NQtt0DyA=I}tFbuT~1j zaEnA*lk2d~?@X)D17K~up40NdX;(j70mLXzy_u|=!CJE|u=a-P%Kk3dJ37^~WnW%z zIRR~f&9T0=zxzGbx(3z7U5|8ScN(y*@(cdp;x7<>C)sNUgoNT3**z;w5#-x?aQhL&&UDQ_>O_Q5(-3+yTat->#_i!aD$22D+eSL*^DS~`=CW#U-Jok!rz@_N z^M%b%^9$R(@yECJplVWD`thZ9J>T7^{f*|{RG~EX7<8>qPS1r z(Lc+ns&uS51g|K%$y%ovUx-TPQTDukQz%H^IKGK`1euZYODKAd$(9QnU?)zoZ9=+*wbO2XpPIDXZUWgWo@6V%UNO5pX0a4i8c z^Dt(7<{01AFV&h9`r$X60^!E&$2-#f80{HR`8IQzH0I-tpiKYBG z(kh8rsLD&iKU5CUJ*y2&)2wlcB`rlKP@OvM_V2bJ=VJn$ngGnB7;P8G&_#DEwBxkHoz4;lF%*e<>=jWP!7)q9)6ggq z^wWKn?Iu-yH`hMz+@;tX_TNZ@Qysq#MbtFWJh@?{=(#!rzQQ5(MUvWPlP9)b{!+6; zb6i%`Q0N;2XmO0)%^g*1?N?QW9laoYA!`Fl5E_rOOyWKir^$SN#s6}SOLx6SKdT*U z{@9Lt^w}OEf_a`d&@@WBGj9Iib8Qo8sw@^bCT>g&p;ue4$2cr6i@U{pgD#zXRDDuqzuMeT6$~2c35)|EWBZH>PkcprASM&T+WzL?uz+NWW|vK*B?LBXO&!w%!va66etKq z95TKv@!Nx(_!%GyEcTW1NUFg!ygPSp8)Z_-Ps9)Kl}$5ck`ksqDUh3$bdGUlF$`e*`V1Rhu0hnC~gsuNgTa>?~k_@$k=EW!?a&?~c~A>0nVIr)yaD z3Z$b7Vex|JRu~P-74Qy7nAEoZHD&knvn;7aS!~`xP=?{=g1YTGb&D#!wGMJVP=NcZ ztmi1|H#Y;G0)2ExGEHa0HLrdZ1u5zJnrD2zEi7*Eb?Z@}#eQN^{ zarWA-Lw6}jNlu{|E}k6_N-!}ynK?OlvG!_#+cVf7bWes`WOVAJUd;Of%wBMr*u{HO znR`;QR>b^|`3hnMJI+!1>!Jbz*t`B)Q&U_^$S8D0d>wD)kztntpIP97P`tt7qvoiR zlpw$$_r)8-Wv|VUiZj26Q`z5Vz)2z)Q1_EAZ@Ig-sPOgmH0~u14}4F@qd;6gxiz5m zh*k^xmy>c{&~4NMqg-ei|5E`n8r!oL;(4Ih`+h-hJNm3))o4!GibJ^ZC~N6+?zpCF zZc3zXLpnu9(WXq@Y`}o!3zHX zQd}L}%XN%+CLK6@plg4~l-7So!mC_?#L=E1pHQ{?d=_qH;Np1K8N730pP!`tIwRZh z`n7a+GB5I@Yip{+-D0@UV1rms9}TrZm|K|L2FTEjD6k?dY6t-++KL};!#&i}!Rx@b+lq?~{22p5|g^Z1hn0(=T2*{dx|yXzhj

wK z(qVAr_I6S^D_`X}YLk#d)z`l>_k;g@)!-8kr(qlwVE^=@WG_b_3ms(iuJrfQ&;efo zKfiKe}6+j2#D6#?=)Qfsa76xEE`(<-WcEc+a7pv@11Wf(*-H2 z(cFyqUNhYE8zV#9+G*`CWm_Z6yyF`YQ}J;KuAxrFYu~RrCtg(AO{adLMWOEN7j$=y zo!whT`K9Dc70*GQD*7~sOh>_dO6h}=9o$r$S45$}4o=Vb`aa7N1wNZSt+<+?ULveR z>35Evthl^#?%L`57ZOURpLNe*ubtV&yc+u-2*Txn=6Z!FsW_xs%$jmeJt8RBKHxg{=7hqC1g4`E8`XGUmWbq`%Wg3j?<9LB420cHI6lCAqmXjlKvAs4lg8axv z3ua7X8&=K^i_p9JjsLDhr~I0Ob=L^o<(k;%tDb#TB4zhiv5W!X0Alp_!iNb3vIN^=&AxKxEx88Gd`50#!5$f+e}Y~x}&_Vl_xfA;RClV9PD~~f2dIbwGrmzXC`+|fZV@8wT%T0 zT~m0t{GQCrX3KkJi1}uGR%&dk9B259i<;9w7GSUc{aZm)4^%@gC;Ts9vp8nI!pyup zXNF(!h1E80LjnZ`A&=ggK|g3uG`GvXBT~-`NTC#>pC`g%#}WS)x{%gRNL2ApSIP- z_^512c2RW}*w>E-`MkFME;+w(V`W2n!Kds!uOB5JZ(h2mTNZ8`RT=_`w@cpUyX{et zDK?nj+Q)&GkoFy7U{=a?=D9Y-^+eK3_W&&LMBF0uN2@XFli8rrSWh{)5>X%ugQ<>9N08wSd_eAq>`9)Ju{5Q+xq?R$lo$(pA`JuY@_{*d#Gr0yp zY6C_ON9Kibx1F$Sic@teH;@{Fh8kV>U&dKbo~!6=Ut;&Y`1#givfZW}PEOdQ-ta%SdwE~nblmVfNmyE@No<13PSWGM zJ0xH8CJg2tm(L=8KdVz9)5gUi5;!rV0ML;6zfs)v;jYvY;WT%v2Lq_(Byr~SA8Z0W zV4X&p(#TDFj{@I+0V%?I4#B*6l)`N{nDR4$bC!ly-}&cP*^g;9XasynfFig;;f-|K zxhC#1`)aB7?4dde648}#{$W}KRMu*Bbo#&ghZ3f*g9VMK_E7akc2bT}!~^7d$s=ef zxnPseU5;i8zY(9L4IKx`rbsV*0M|Idpm?C>xty3bLUU}|I(pkBpyb;7Wu`dscPg@IzfZ`WvZM9`Av=C~4|MQ-T> zii9V6?@t8$97QT7=ZC`7FuDg>K zaA}Gi>bjlGE8+$$vLAh1A{<*&$V(#@mL)$Q)8m^ZeaFX%x$_j^I)k#FaS3Q~cHAuH zg*{>9NoyB%J0S;IYmWi+T*VKlJnI9ruPY7RgU*TPDffCzKfPZSOQ_e=F zvmp7BnWH3k&krm<}AF&Qr!+1B9|yVa>4aP$m3p8dL6fz^_4#v8ANy zpJg?lCJ^|IS8cd}l#W{q;58!dy>Zhv973_kU+{X7#J2pe8zdEQ4s`B#_E>{jy5IFX z7>~m9Ke~iKI$%o{6X5D)%?ftF08Y8!gTcsU=KiFhY_tTL#~NcB5AUg-it7lfvmRw5 zJ23Uaj4B;0OQje>NC4f%g7;m&na{<063*8{%sdsVepNE|-CeYr28BD)=1zh+c z92BckzO|g|MyR=|0NqlIcxvAx6RGPDUz@VOs{v-z(^q2ew?JCRHgcAK#G@+Mfzb4j zc*p_M#{xoOz!S-XQK<}8s(Fr^2c)&y@rkU5a&|qh%sH2)fw2K@dkev(k)#{pKY4Nr z{EVf8_8T;qx@k#!$qkpLM_pep6y)eTEEITQ(?s7EW!@mJmZ#kddAV@%vN%H2!lJYXf#z5DrkOglC;7T*YxUJx~!0Pps7`6JcD z$!aeXLm)$BzS1;9dbzt?SJ)rm0?;4+FYZE{-^-7mbH;80p9&ZLSeQM#+JBZ7aC*jc zl$^@ACo_xoPepTmgzIp1{8@TuDZGom*gD&*jK*0>2ZS|8PrpAOh^q;LM9X+ON=j;-2 zcXs-wHGCA;hCQ@Gt`Inm3`*srAZGoR8{JD%i%S5T^aGP5UZ51aB4NDd{hdePL1j3Q zJ1(<||KO)r^oywyz1=yrJ$JgumBcu0AU1j)8%+@A3JWkmVsTS6J z3e14hR!ia6yY%~OF#M@oTFPr?Dx%BArXmNqf!FJBc)ZH~;VaAs6O2TTextgb>0?>B z#=PLc_Sionw?`jjlt#hLLvIK$EohuRjg!#VwtzQAL`YR~Ha2bA^zv1H7Tk3qlPL{0+$vXb6|G;z1OnKK$Jpf{~qKVklX z$k1|OzT?8a8RCQUM3Bm)BRX|ce_Z5wXpZs~~i%(SdJ6p}Ux)%0-zA0h@3Su80@Aq1OSz3k_5C4y&^A4x_fB(33tfP!@ zls&`YoTx}f2pJ6thaBhN(6aX~>lERb$4CiLp>W7JHsM&6%wvyZuWX|F{$8KopIxrH zy3X->zwY;aKkvtb-~cl){w4WsAzwK$EQc{mM02~n3iAe5GfA^Be|2F(Zm#!6S(_WQ z%J3&rW^RMtqB8tY^H+54ne)E=l4RcX+Cs)i7rj|_%S;pQKPyhBrM)R~EQVrR&95e3s5MTm_|-2D}U=@6UZ*;**QQ$SD_Z_^9zs6`L~1#?v>1 zE5vc#f622y`KlNo>x$t1*cuJ`;I6V<>cF6Tv<_}BmH_%%7Ccx;X5oV=a)ROr}No0zXJr}(;u%GILq(2cFK$?>g+nuJ&IX zzmWl@!XEGEX6yEn<>}FOAa~K;f=)u0hX8}M;i`d_t?}++C(S>ra`SYLhvzo5)yeO9 zVS!DB7#(Tn-!LVykr|aSzbi5WVLpIWX$ytq4BrdC1~fhIhpqQn6>oS6qDMWtQvp{5pkW7#}lC-_F?Y z8O|z!s~f67*?3ca3;Fn>zm$4?Nscf=$?KH=y-Hj73GXKvoomke-1@de13$OTyQrCS zzBDTo&^wTjbmPay>306;<8aD__mE(P^ScaXCUS~(AjWem{U^N5qchyZ=nFlWrBQ>p zuDi2YWJTv!M!rVF4Sh}LotCoeWMTO*AS&yCs!2MlqXErUnzapUxFjRimT+M_0Hs_ERVrq5dTv#>aE6f(gGMGBm|ZXmE@keRc^$&OoMAhY)o1$V{ls*Mnj#*KPN^+2 z1PfnlyxfeE%x3g*>!gLe}ujKLzJ#?GA4?rK~R?>qekbVsp#(mHbF zwNE`W%&LAc$v;T%ja6(okQEUleP`bVUf+1tF5m%41-IB;WwLqDx?A&9Gb3e0)Of2h z^no;S{Bap+@n{hiRjTKHZB}LctsxK^w|hg||Jr<|n~Vpnl$uP;`%{cSoYO5Z@k}8E zhTy5;(#oN)v7#09e9l{KAL-dO0<(LNhx{EXr^6#qpmc>+@IN}|30#a|p-#EU;-&CI zvH2bC#&JK2M|}qNd=f%HW|0m$J}oru+vT-|QBCAGt8-xk(fnG3H?sV>YrEC`i@_(; zA9g69Rs0&YYl4{UHBw~(&BMr%5zEZjb&?nw40#GA+#1;2R;{3?kqJJw-AfmXYRq+c z_ngN?80tMS4`b$QE1++`t^gkrew)o;!G_tS{Bx;W#-b`_k)bDfLvP+i<^VT!bc`xK z=^a~hd?4jIL&cRh{^$xxdUa)zPW}}B7f?jUAw=O5W;Yh=l#{+ZMKKB!zlsq%jEu}a zF{0h*IDBB@<4C1r?mPz_fAW}uftJKholr6*5i(vQAAz833wc9H=ODX1@>XNp2^Lu& zw5Y$mMcR8y))I@jc7X{p!QmjG66z~V2bPn~=-IxX>j=PTPZW>a|B8;*Cn?^*DZW@8 zZu!=*&G_jhgIoFyxL)p8LDD`lI51tg2X2Cq7&<%sN{XIF_mYJ;R$0Z4&*tN=m{-!e3rmYu-Ld84I!-Fb4%$?J z`PWThduQ5Q!C)Q3Kb!EIBzyM>Y(Qr4^gNGM7z?1$%)ycydig{S>B{CN0YMD@)oB~+ z=%S1H%ehO@@#RO~Y~?lAWn-Qh1E@&9Jcw^Z!R9~v@;#@@1WiQ(njuALG9a!s*56B8 z3c61zt5+)8<$h@$;}9Su(hAyGrQxTs`c9KNW3B)4^xGRV_CI4`QgcOT7AtCO0NqJN zSZNd*_tkfIDIoL{pX-S(MTBzsY*7-$Jh@?{Z}_kh5O-vIM!M*si<&(X(_kYFVLb0D zYi73Q*+&CO(C(d+7w)=QCwr8BvJC8^a<#_gE_ntpo>r3% z6&lHU(<}**9Z@|7$l}s_CM0XrTcuym8r3jo_%Z%v)_gjwET1ABv_anM3wr9V?2RdF zZF>E`+Bm8$i?R8W@G%{SucdooluYx8yoLJC3TZ+geZ%i2P0v}b+V72D-nkfWND5aA z?NQ2VGO?0HnO9ZX#Rzv;ekDM4k2Fe4v>vF0zB@1b)0bQg-JXzbA+B@96-~Wsfi&R3bZzBAJr~+qN4;6>^lQu!_!$2A zO5&2CK4VJVzrB(3o(r*&;6#e(0+=ihym2eODco}q^H*t5cNt-JgYQ~$Q5%<=kQ5Sm2m4rytZRPs%wO)mv(4=E8pQsRpijeh|MI@VHBT*crx78wtglDKYIs>3mSTDb4!=oAU`sSFhW$+<0R4;4~Z4 zR^A9m+r*XCeuH-#Q(Oq+0z?w#g-Buz^G@oyozL>WbyyjPeuV@k`M-I_7ETSDG)Jcl zyw=lQzKXI)R?~5+&KG$;-6Tr)o=7!!#cLY7xdGw?tL+P9UBBQ>m^Wrb_*X)@W9!it zD2?eV@uc}u2{-a36G5ib+Tzn^mDT~$J1t39S&{ld=j4V+>r5?==lP6qYF32i`HvJm z*>rQeR(%%F^^xjnQLcI*b%cwVS8zL1_rMW&d5kv{yq9o5O@^tB{BO9r+>%n~Gz7|T zaC5B0tFU)-HSOdQx#vv{Nkuq%qPjay z-p>CjvoBlo+H5MVBk?6<^^SJxW*H#xCz8FxP2N4QheDV-Zp8{(iMme`?1O~mF4j;P z&Z|xwXzFOtmaz|Q0d~ZRF4qQ+dj>SaSR-hL71dxq2yjlWa{qJjYm6Vsm{(Spr_#5l64em1(tJ&zojKE!>7vAo)?pYFfikN9tFzCh_~81jv{dj>M4N;f?OghE?h zJN-m^!ExW%r+-2i4x9q??abyAjWj*i0q5wttb#V38uCz zJw3F%>9sms5$RY-+CuBCCb!z&SbILiB%NNWO2G#xI@D&&8%S7MYP%KO5jaNWc-vYV zZ&G{fQYWVVcqSD1BzL|yKnge``N4alw-Yx{gVf7eoP3XP^PeBbN^J;=TWmQ-FHNs9 zDI#SL{Qc_{`tx6<9}Igo1U;8&{rX;$8K&m+Om!{30VNjEJQ=V-NGCy448P9`1U^yp zYk01OMnr#>FaO-6gIAT#o>Nls(&irzMjte4U=qn~;e1SOavT8-8yg8a_$}xf zSmpKm<*QnC^~pkefI`$J>#ZXP&J7M<_VWm{&bTU{^QB@_)4;DsSlc}0X?>|FnG4?X zjaP!7-(9I1a0ob_lXO~MtkJRLa1|bM3}mY;J$g0(LU>ju((3QUV>hbr82$^`^@Z!8 zbE1vS(afq1-x{f#s62LyGYlmKRZ(jIBF-vrs(WkkdUqkipAE`gIPu$gXOA%C(?G@* zf+2p{Hcw|&*}$)?yz)30D{|&S?IV1*lN;VmA0OT%97E}Oq2$f(XcrzU7~xJmU9%@} zcLCeq%cwGsxC+gVofc`EG`MN)n-Ww;MYyOGYS8af!Vou8iQ0kJ&d8}U$<1Jek&qEq zB2Gpn#cg;E7&1!2YORv4x-*6uK3M$s+QU|J)v$I$Q3q#dfrC=Ou#*#fP#%v4m4ycCNutg`BKCRU+>oiJrFtK!z~p;;-f9h0$B}Zj#j@-q1N%G`0O7U(i3guL-#n z5_~4GWaClCf)q8rW0>x(OF)6~N^uNMU}9#^o_YWV0n(LbovVb-H{q5yoa;ib&hdOp zos>1UEG$Y>>-%U!ohG-13d!jk)z0kSjF(WW)>S}yj|=ldW{T1p>`ht46<#N+zxMoz zmn~{a`v^C<`9`}&rgd_AN#FOEF~C_!OzBNb<5~J|xNymK#|;{BR2Z*4=0)#eA_4iF zOlO)-T=GoH4Q+hSk>K8{=q$RF;I&Hr-cbMWo9HKJS9#WDfVJ||f}!iXk5i;9<4sPF z9Mfh-F^tgTCy`$wa`~!+SPifSv_V=Ye!0HH@q}k$ zUghS|r^j-yRD;q)8DTQ(b(wcZHN!-1@jwVG%%wZ~gE$AX_#Yj!d6U#8Mlm5`rY`v? z$z#M#?Yw;rnNmChlgp4bqdaE1Kk52i6PnJq^2V>t;kv^IPqz;urM_4V>X6&HW^elh z-K}U$W(40@{S}!dVFZt7mFD;5A8y(#AErg{z4{}Xt(T^%9jpYgKvyy!VV047QKB-U zLgdB*0cYe9VuJ? z=LX73QV=o>Y$b_@oa#3SGc?~+D4N(E7iDC>Fw~FY&QHF)*%T!b(B$Ib2AcPG8&;oi z71EV8)Si9=veU;8_0n#5l_%1ZXzpU%3A#t6r>E@i`kIeH1$|t6TpIA34_~hG#dlLl zFzgRe9gOZjorPnQ;;d7-H_Vh~;hXKldcQrUvdA{&8_S+swOf@Q^s5dN_LXG7VG}t6 z?M;T|lXV$3ah)oS8eU1C6B{Lx&OR1&Ke_8Zoxnz<*+A!d>^=mlkRM3=!IjlZz-qln z?ukuv3%5Q~Tmp1wSeq`r%Da@x&|(`-PClRs$I4EIn#DZ1sc$W9PG`jsuv7wevt(A3 zbHYA8zP+Sgqv5%6vVBlo*iF1@?68-0TpjvMAwW!yjd-vqBPS)xkFof?%H&IFGu{yo zdf?^0JlUtD>dX-eUBS<3g*wvjZ+f2P0-cec7a+H)z#MUIUBEW~O{$@eJgZ0vDxZ*Ym?3!uhA0OknVIZE z%A^ni@3g7WCsr89Km=>rb8&$`3n3QN@8x-tl|4Cj-7dfzJfi}$6@&L)X4Ov0OoH_@ z3T|nVwx8^2NH;pD!%h!N#?Hx_JwPw{V|5ZY)D0y;T7}h?;k8Mi8AZyGYvoG>@`rcy zz5zpBTWgDAL%3=gh0~TrcW1XQox32cOqIX-N`icbIQ zk4jnz*=DzH)Q*s_Z{QEb`D56}ox!Q$Se^?st;R167e#Hz;k zHriD{lbkW&JslrF$i3@-WyRAD;kh%PfoZWm^L#>0BUZFZ3rkw>H50hzyLR%0i}fJ06b*5*Gi&>rloJU-6G!tds%hS%$H{kmI_Mcx0=#hq8j zH&S;{QO5s>y?Sjq*v~&)srw;A-ADDsOw5 z3G4}&Cf2*3c9qx|W2FeNC>%iI$b98IyZpC~pQDeV13|)sLh2-Qz zvXDeXQz)}d*pQkLe3qN;tc(*do9bX<27oE!HOE_DfFDornU)Ygj&Q@!qd#wF-x z3F>)br$*EHBzIIJ2v^?`M2W@CX!%02`q!~@k?Vs|DK1EY{&)cl=;S9qRnL~^dep?6cS6v7)F$S8$YZDEz zsXgMjGdVUJQiKN2S@lwFjdbgfQO6`nR$cVefwPq_rMWd3Cg9gqsZe)EtgH+?z6t`) zHO0Tud2sA;g_5hcMjTBuHIlkqQ^rq;orryT&xJf$Q;mJEMLaOF%|2_1w5nzyI%fkN zy`doSysG-GlDbfv+9Xi-{^Y5@dDc%EDlX~zLWfY`|0KgE9GrkcAh~B55mhV)JHJa4`51$d%+~%S`S+b4W8n#|RXRw-fx)!ozDk)= z#8suGgdG~OdnQ@qz=T*vd+pbFIt!^??`P_7^<0d$unDFy9`}v-2GJf$bIVuF3Nk#B4Kque7lzHuPC~Hs@}`O{QHl%!j&hL;=8Te%qZ?)1@58dGew(U^%t^jqegY4 zN=Jkl@;uSBI6aNB`N$T@hGSYk8G2M9J&R|(Gj`1-n9;0p9r{|HRoQ2wS|kNNGqe(G zYQ!e~vf?R^i_+YQ{-1LyD2ur2d%;^uJG&M;-@dTOE2we@)5_}c3ub5Y)nlcHXK!3j z@J8l5Y1EO;;DwgSXu;p0Y8u4TE_3wiOm2(_an;g$2L;PHFmgTf(_%sx8gnryRuAg@ zA?=S`&@4QkqM@yDdA_a*qFayR+0x2v@@gwi`}JUr}*c+-p|m= zq(e||6{h<&RVN)>6JQq_upuvcYYVI4-x@)4QQ}U}K^wEx54yJ<0gW2AT#X+xZyUx` zMHp&K9a1vW?U0;oa#}-84D+!BrTN0E>c~73aX}Nz*MVkAzHzMH+a7}cL~T7IF91;zeLpLPID?(3YZgtLCiw<~zRkz7f>uZ|kRrZOBJQ zC{jK$xUYb(5JY?d8(LzT_s7}VIca3VQwy{Vrb7)=k5U-Ud z_(IsXq~hPrGf)nUsSXn2KE{?&ZX&oS)20_?C%EMI=a9-{SOxV{^-1pU)rjlTN)}wN zg}ZGYfh5ws7v~vHp#Ml&{RqVngZufI{sIO`;f~hf%34}nkzZq%p3^%EsbqJL58R1$ z5ZT{RPyKh^AA+5j(e$^M$4qhjb2EhhHg84?JRX?#R_#Ak2x2&Zy?WB5P);1L%cAv5 zhr(a|khQFj^yY#9o>IANZ2EBO$AJ3smpS|}(lr+#P+2RAMQ0Ula8zpm+3&_PIXimP zTGt7!vipC1RoY*YE0o~4<+Ay>$Nl9->ZP|erfo>U+;%~+xb}79Wx9&{6O*5T-?q6l z2QqsntyoEap8@iN1&n$6!~-%TF7QD3=@L&-G!;SNULc`#&h4>4%$4zRkgJVG-~v(DC6g)X`Ndz+?3Ty|LO{7I~tc(;{A zrIE4R(0sg@VwE~Szw;gr5W&5&0O-{tGP(_-cMAMz;;kD ztTXb)7dSdA?cRSYD7xEs&l2VnRlV&A;aErPPl3E!g`$eh*X||6kKDIH-nOPm6(w;k zL%z=v?1Pyg^Tt1fc$CW5_icmDBuM)z*C+R!dyDjx>DFmtDbdO*Va0^+I@;H4(KU?- zgMsLF2K;H|ct6r}52(ZH%WAriueyyU1pHS$S7-3wpJejc*xUV)75*F&%u^$+=<)Lf zp&OcL#FCvc>kB#W=ji%kz?sK=(4PWyfe_#LDQhN2p0_cE2NXTsq!&)#A3uE{LS+tk7LR?2)HcO3Tj=$k?10B-nLEL^Os`P+rYP_pZY8LoY zz9@*i6gxGk)LW7VOUv@x>KU|g{R}GiQde2Io1Zy3{E9IYz#Eqi4LD#tJ8q}B8E{A` z2a@cSmAhpfy2J(wI7WX8Q!2V&X?)?!Q>SnLqjLn9c*KJc zvltnlJt}V;r{N0F(bj&0&fqoAf7^R&QRIG`=p#Ct9#c(Rz?MB{%(36T`{j?W=IX|pk7hjtz+!CFe7}~ z*1_z7sha4EUEuzERf;qbICD9s@@sJ99wq8qYHo3^Igi0I$|H_PfJ$rcJCk=fUuTGa zbN@Wk9;peKLJiSXlg8^%Qhdy+`@gu5`rfAOD@!EQ*o0fc1a4ugcJ@*_JEIpHsq%=T z6LPcQsqw%imn%)u8PlazSC~;by4wv7mdbc12NxFLAA)Ri7j3ihynFXKH7HV~9@km} z!`k0#^7Jy82FX`z)Q%kY3zk7P6=BlO43eYWJfix6*e-Y;6Th1hvThNpq2t0(B$F`8 z(Cm`m1FbBpGZVB3l${RNLf7PhNFqQt5SLZaqC>5UUj?bOmBj{eKUMr$m8Xi;$M=tZ z2SUGEu(IU(^Oq+DIQVv!lMFhwVM~AolmZe4bo*pW3l)Ch?;6B5-SzTGBE3`@*cpeF z*DEuCJqcFkkxEh@+S#f3WB98dD`kwELAX)kyza6oxmKw>yyiqGfPEEq#lc!d4Xe_Y z;_a5PMVxuE+C4HUfBmwltD^v_uv>!9g1!rk-9I}HCmtKFqwOQaZd z!@@43aqQ4!BgnzDNH4wxJHBuu^u-_1rm8ELg?Tb_9hK@%mqO^?f~-hu|06YvF%nS4 zD~VxKsHP(mUofrQjLpCK*-HR3kp=EF<2cBylytK{!(7|gA;nI1AC1v}5gcV-Juq+t z%JSH;c1en0jCt1PDPZiK^(mQ^^}k+eUA_D4jtwmWX0q(>;fJ?`k+i1K0rfHH)obVQ zj&5(G&{&a(MuPL8y;0?FmaN#P>jB2AuvSz`H#$qPv=h{k7l7_$W-|TFjIZYQ&N8Ic zfa8;S;;k6K$Ld)&CJqtb`AisxvGG%)-0Gezma*(w_l-)@1>;`#EWd?(e+4VLS8D>@ zVJWN9l;MqgEY~Hc%9d@jU%u<6?!aQs8m@;Qdi1JOYTUjPMy8w{e8aw;y3M7ky@m^& z!Nv8I#0SWoaf?znKnNy*YIy_YS&l}OpZZ`|S?e9WXRC*Bn^B!}Cj5;jEen>ye3L>I zp9)rPgoN0@D?8K_%9%_mH){VKMSp>8I{nN~b@dgjDr9*bD2Ui3zx$Mpecx-E%(mj< zpA73Mzqk<}cD2U5hu(darUQ^dK4Zx8U)%4qp1J=tSptUEv8f5<3E4A{r(J822bsrjy@yZ)M__a$d9AMD}k?Hdh$$}pI5L5bw8Ns zmFZ~Jsc>$_=NQ-bP6GBMkc;gc7NwyALNoXfo(HG@)f~bwQGy#F4}|xP(YBik^ej~F zL0lJB>Q}8ccZw%j2o%om0*E_|WML`kPlf<+kDGgkABtn|@c=GpW&pDEVP8169w+_D z&Gko>rfrhb-#cdmMyus2ym1?#F{h1DO`DY5y46e~gU+Guc1z%WkBJ*(LchW0yJ_J? zwC>8)3JR;R_I#-4_t*iSY}jMQz#Qg#lo6pCBxK)q!90mDydNtVsx*VuMr)LZ-c%Kv z7i~iO)X^cfbqhuhJikz%0kq-_?9I>4G=JI8M=n>nhXGDg#P|R<>jH~NLz0PHiuC72Odt6_w&$BnKVJ}7R}$FzD!2NkMl_xG<_s8Z6QIa zgw(Ik8&P>Ew%xfTidcj_YOxoe@V7dhu~ni_GpH~8)8DOHh0+p$s(Bxs^O!Hw|9%@4 zifgTpO3y^l)uuPJ0H)Zo@mYUpR1MDUwiZ?oSuSVE6lSd-10IGubCh1YZhFQea4BPT z=P}%N1tp-1TPJF~owssN|6FJ1F8!j_xR7y173%B78w!3Nvd9Kq1 z?=@; zc?IZcMasI5)%h1&4m#0Qt8`$rI z^v~;|Z@jhl8NckfT&0boZ%7ZZWph>VFbGCY6RIg~2t!+lLwcEe+Z8R4n7as%?M%`a zm$j(l1iu5F_SDb?96t>a+g+1}82vC;yHC9i3F1XU5*4;->vixZZ)y3 zcR7cWqBjwF3goBl!waQ$N_*XL(YBove1d73KgR#lJ9n`7%IXFCMR5M-nJ4bY@W588 zD1KVt{j_7NUwA}t<9B3&x${J@Ntx4F>uP=$IO6?v&>XYYbvC*}GNr}K*f5;q40mtc z@dfgda4#~~cW2%vnRmlfcO0ZtcXhW&Z70dXz2B?d6zB!!iGyC4VN=OCK{;j$*gCF5 zD3!&(hWZ{f32*O2OOqni-rOm8p#&&vQhBfTceL-M_Fqja6Y{f9a0=zA>6}f8nv_Vs zRrflmMgq3y9iyL3JHGxKH#C4!(bu)snb7=8nmeito%&SpLdv^p(sSpC6__Q;4RVrj ze%fjPi4(V4#~xk#A;%vq)3IXc;cs&}Gk_pKaYPgmD;~Iiv(9eneDU{FIcp$?vFd`{FTB(M}6361N_squ3hq1731*=7<2; z!m#;*ak+7eiX2By;;l|bZt_+whdQGFMx!$S1;4l2T1PMP&Gx*KUK(l3DxgQB4>h-^ zZ#VEJkIFihG330A*S)ZkQCyptiIgM4PGWZ6fjnL#ts4M}UHAj-ey%$v0G3k;*kD!LLDl@xY09T{%Bly>8Nn~m36`4ms&?lo zfAjn*^42A&FVDj$FO?!Eevo)-5ckga>;2l_d6{$4r@ERnPi=2OOU+9;xz!)o6`fjV zRwJ%e5_euHnLd0RBh3R^;UVaHJ7%X~FluMjD9{(< zK&SE%1Ll1~WC=GSbFv|2{eA~!EqbKD!_mSir3ca_bV94|hqV+BlolC4%Px>uaws_^ zXdchw@TQ<-^P+G7PC+s2?%yQ*EZLuU{x4;Zk{NLXX}4;qi{_D-gSy5p?9rL6~oTx&oxX(gEG z`Iyd?=QiHMWFC6^mydrK5h-OOF5G-nZ9`I=7D4Jn`-C>0^3;*5TS)cTP+)Q>M z{9(imh;r4?A-n?#l01pwf#N}-N`2)=(O9kw;;-+t4oxg0G}DP{HdP$?%zjz~VMv^0 zWeHK{6Z5#^4gMI0wyIAlOuSDU`TXuVao3_~p z*hKO34*T5K*5dqCXpsr2j?x&kK2H1^E8}3GGmbcF%dZ`lYI8vo^fDTuEqBDN=j9oJ zgA5qW?F@<|^PX0?414#19kQYACp+Bsj=OAL!!^gWg?ZgIQlio>SQ`Konco3qfhpnq z_*p6)c&XjlQd#R~xUbW(U(;}cThKDk?Yg7Tp)Ka+PB60V{wE0Q&GPD2+4(@C#J*rP zvf$XP>!kZk84&)MhuV8qRnK)*v~)lOAs##?P@c3XGu1@%r^F5|@CLF=apZ{J5!gd) z)b8?+aF}PivEaZXd>H@{c%%(&ysg|OomD|uln2|p`&6vcyp}?88P#+e?xVv(HwdZrv2&6gaZXIxZp>O(=F%tq z(WWfr%&S3ft2Cs8;eCYVZ;Ox$w6=p}*loQ_G_!e}6u%XDxse5OI z5m%0Btqp9>*D}KNx^sM0NLPLbpUFj=)Vm1qv16NOo%(n5+Y_2s5U$v1W8FZ|x|>+9H4BAvw@-w6&TYja zzpTs`DQLsXCIG!`mWK?@C!BC*g*M06|C1y*T(U*#+GW}D9(NatVvZ8o%r2FB73mS! z#L{6fuzh_6`qSaM;x)YrFGT|GRk9znXYj0vVYez%)8JpymT3!oO*VR<2EsD8a+EM4 ztXCp&D*Y;%P5D|HBKSV#bqEvED7MthU6Ct3LZ$f*40w{T3=Qo_q7V6jln5mJ5F}Sp zG>{4>OSRq6uHzr88?~VEsKifo!!l%0XVf21+Czz=NKFb10*5R;*B0+^WmJ?j=P8$j7qo{Yv z2Fdr;rEA=`NnOxM*q+;vy1S!x{omVH@m+G)KE{7ESa6OE#w~R6)OPFAiws+8RA6SN zsJ{b%^$vY|=2TsT>%aPt#?cTSL4g*b`=G1VR;pYzSJYxsDh5!GJ@F{*yDy6rUr1FC z?o;~f;hC(4Qa0J3Dm*~N&PYr7RglL*uW!8$VqdoovThdF4QmhbzZT-v2njq@*?`7= z24`)))VWLY5mVB45S&_Y!e`dEnqb5CDAGOy&{vJaoab!ge{52U$;6H5=dykoU zBoGeKE9H3qS)i?1c|7Ylp0sl`8LXu6F*o0pmPSk22=Ttq7)C5V%j79>Oi`^Q33w%| zAz~TTNtxF@9n7h;iPZ;YZ_GT?#qm_0yg%p(8h{DwMvwaQ;yDbiFK#Jt>Ksy@7p=X+ z#0$h{6w3U4p>xnCy+*kQcK0yKI7Kfy`8!QjTAaiVi=lTWg`T*Trar>a4B7B3lxj$A zTtd3hjyM7{ji9BeIEL<9?QxFSgpdGqBW9&gPqtZ+A|*Wi6)Y(`n>C4DHMljWS>pcx zxLGGz?hmPcN)V&-YrhgMnLRIEjM04&g%=)K4W_N!W0vMFhI0;MBfkUsa5!{bg4gW( zLWzq4@;iWwLWiz%i)IO!7Ps(Mepi2tuJJ-ITG6cD)Fus#3%3tmNO=|3m|+Fk#O5?! z#qiWfJ?W>b;J5FB_D^oFhLy^HdaujLG+wH*INbK~Qu6zsOt1&)nwtjdcId>KcCIA8 z>q-o5mz$nTNe8l7BL}a z95VfLRjRU*d|o#z5TCks9KS23Ifw5Wr z?m5W=rnI&1YCnURmh0ZRc%Rv=IsgGynN|JS2i7urV`#;{H#QRV(-oCbt@6?qS`OP@ z#Rn9g`UsR^`a<|)gtW#UWvt|{dA92AVGTxyU&^;(dn)z~Dn=sn^hQf9nzKYJu`#M3 zI_X;e^b2qrWsHBfgk-i}a_O`%w}Kv0oD*vdztv;-AJS!?I#Q|9!tnLEr|F?;Y5={D zaHV|js!LPOTgND)nlg=vgN+2VLL)?uFrc>dh^#8}SBXPT_h`Wpa8<2qS5grvQQneP{iC^ztu7nD` z z(+iNKVsVM)CP`4%8X^wA9z(7nnZ^rKhI$pY7(^w~yy1L_n-Gsx%ryvy_$c zp$jHZcg(es9E>&g;_PawzuZ9_4!&ko&o&w=aiH^Od*=u#1G3bHB?8asvRpyxi3+bz z`oic_XM!ETJ@s7O4~YI`|0X>$bZLBAgs;zSZRLhP(}(vXW>>+sWqLt*gI+OvqTkMq z&$YV*r=a21gY8U4NNBrZW&CqZ1YX8so3duj#Uc#>+qtJTplgDVnOwL-4&U19A;lye zGD8uh8*i3eu?Kycv(Of;M@g32rt|~Hq`8@B^!sN+MMa#3YtwH-Lh7q}*6KQV4yDs3 zT>$+L6-y1|W2P-`s_Q2(f)bJPWJ9t@nQ0zr_TLah;`f z*LANn;nV8G?J^AXg35Go;RI_Li0SI#{|eQaDMxL&-B<@WQ$0j}M~NecN;TN*Cv9W! z--Pawxo6_D2nq;kXu`1NFXGT_{^|J%&eNwabg6v3HC}DR44r6 z$D>t22!m`3eZesvdH)1o>I|Cx3x5@6+IW@7m1&@KS8gAX?iouP7fqW&7q|b**n-S= zV!u}~O;+^Qd1*Bst#~GuC>t&I9CxTUae`fQWkiIMD0}z8+8zZTnB=2gK<_B8J+Gq1 z0Fw^McvBSirXgsbqH~i8DGybCiQmi4E_DgXcYm@57p(Xt-Z_>B2(X~K+&!NbX57Lm z>>A>Qs$FgT{ng9xY`zXqvVo?fxVP8p`a(3$3rUFB!qa|S9AuQ_^4q5rU2tp4{rE=Z z4ebemvtb(;4p5~gg~1o>+<=#Lb&dz0{v#ontBDp$>Q1?wE|y|GJ>tfRnZb48JI|&^ z^xPHfU^N4KACkhQ%GM!Ic_Y}TQz-w%F`-Kt{g?bnP=|V(_Zpbif6SJFY#z{HLN;~Z zLwDzc%OkB(L z8`^C6_RB3&q_jYq=eJA2pm0yO^&ad;5pqUw>h5gBgYi9Pl~?N?2L5SwK%z)?9+&&5imOnH37Z9ls7CpDSIEQ7tc< zl=NOl_8aHc+2nJ_-hyoOsC<*H{J)+EdqbK3z|=}-9YpHgv>jP+Sl z)a_vCF$(@=UHk>)X*PJyT}K5h?F>ydLp>&ctt)jeN4?@cpOJ0b^0a#G>Cs9+i|?wr z&=s5{+?8FcW;;;Cnf6@K&mcO%1;9;S-sLUe%3?Wwt!JFbOUl31C25EbJ3T)BUJ?}7 zaMJ>}Zf!-6>P9u$_bF_8De^>zu*=7xN^`_~M7aqM+;zWjHHVr28ot}`)*rWjj!~xO zcN7y??{@EVmg^#g!X3D_k?L5w0S}+XBT#IiIx|n=)w<}u%gKH z%qMABJ>%;e^VyMcLFDg^nYfp4u34QO$pI1+^E`1lhp5|u`X^R_*_%WAt4vQn#QD=r zO}zHvUGUR|GUUyD^;acP+CyMYS-mXI`!gH{Gx@2h=2;?XB8h;A_y`lx@cSEk*o{JR zbtS2PiyWdHxQf1@kTa3eLMh9OHVXN+T*rUFJa@>lL1@04j$A45h;D|sjR%KrQz3fB zcVxP%Ah@TWf<1qMAM>PKzVWf={Ds_PC0-|77g6j|zeyg!q5 zSi_4E5x$+xedR!hI~SC$nP8|hF_`W-d8Xc`BI=E6OB6MK%#)^fX@+;r)D7EsPHV`Z z5Q42sM+sLh-l7U%gqjg_r(ORW_iNW{CW(H0b42*mv z{*6DLV3byx`aOL=!S=`9r&<|X*(O!^9sd|9j!(Q#`=<^lb+XxX@TONuhAt<41XhZ4 z5Nz*eSWw2;AI@MJarG7~HJR_hSpM7T7#S4XP0O+Enn~xZze;D}L%WW?5UVim8ye#x zkUUH-%n zDOL>wQ|<_G5C#KLeo#ps^XI|_8rc7%=&Zww=` zlk`@YXPzXO6lnY>tEh+ykuikVeu)e=>v zaYC(hGohL4Bdj)=VOVGfE3Ib9FXHvQ#1CRf`&fj>-ly)s~1N@Y%Rp6@&C9A zHNBIUl{Kt3Zlr4s=t%F-bbUdajXAq2$0eXwor53Nxvk`aNq}FLu(fabYWRMa%dvH# zJ}i5EYiH_e=3;;k=r(QGD?%^i6v;ozMph&(<2Qgi&d!omKZBo8Ap2;P=DQnt5a=?m zHwTU*Md80eWBvx&*pf(rO5kWWxUtQBs-Mxa3yFqe*wG{-@XQ@It|uJ+~jVY`m((e)W6>Dw*zg9N9 zE^dKHQ%4Ka4SHk{XiyV`TE2IN9BQ?%G11p6=G-2tiSzcDturqI(W#x&+F`)|L?+6` z7<_(~VylGI*pQv~KrYU9N`m&Sq&<+Yj9pKp>=$%XJ7ZS}Q5?V){bQ6ro@RlPBCK?c znV&Vth4GltZ}7>4JD`@~2I(V+UT@+gZ0#&S3hXpnQWu3q(Zf2%`t01eR;$i`MGhVd zU=(e+)`J5#{!Oj)X27-%{suwPX9OXd&q6|48FENc=my*19=(9aX0%?Y_ZpIi^`2Se zAT0OZNB$3v-7DnPIEeGezP94W~k-YEqtX&n+UCE&KV2@jLN z4DnILikk}$on3IfK1(6GbSPsBqjlsdeQ!I&yo<(_%Y?S4H{gn_mMs7h7P>eH$Da}G zM@ZKSUb78O3${q~Zp~!Ok;9s%bqK~dvY7)4UGn)Z%A9Lwh6y3INMB}+AmeDhYWCJ5 z-Gju!_wQ5OIyvg)FQ{{zJMJE=0rsGAW>R#%A$*i3{|dwYc;v^B%ime0luCA>(fIhN zmjk}hg1dC!D*_;NvzFCTXmgu_1T#75tw!+ zQT*SDeXwH7!W-D^Km)cQPWbOch7t26ghr4%bn>p8`nwR&a!*e5e+! zwtY(GF~_@BsX|){&y_k!`yCdqySf8O@b!zXWx;L!_#2)TlVjP)m^#Jt4bbSwuU8yc z1B!&x<@G6S;M5MHB0VD=US3Qn5VBL-&$WHeeSly9Uhs(IZSs0b;6 z#F67Vm$udW0R~1Je(+UnvLA0)mgP!lS3RQ!pV|)jB^F~p1luPg+dMpnDGHh1Ax?}q z347yJWbXeUcn(3SIbp$U)`cz`==??_>-N2lAt*|6F(noXQ48OP ztsk2^wAzBol7R?m=-NJdBsb=UWvqiHh9#dA*!OJ%jHS=mpX%Jgx^++DA}vPiQ={XU zQ5}Gl>DQo88zC2z6wt`UBz_jrHetj>rwK24IdpF|Ysd-*{{7s0HE3eF+3uw6krSQrV|l-Z~zc=ta#VWM^HOkI?<_1Qp0+;^3)8VBCT>aIIAu zIZkiSE%R3YsyZmg50F*LEb~v6|7^-0fL7x|FR)rMz4|Xa!kcCItbJVX$xUae?TWYo zlhmcqcC#_Igur60A5P34KlCt8Bj*#%9|ceDE*1Ad$1o^B3^Jg2vBs#D_kAZ&+wzQQ zr7s;=DK3na3iy-AeCSoJ+-=;%&{M7ZHvIas@d-9daNM(C;8TXW_i8fm-6V)25V$gz z2NDXlCzF4=(IYr;3u+g&h^K9iqB6w9SS#>h1oi&fA@|DLl6MlUodCl=RrDK9O zGyDs%>$#GnBNf^eLKY_QGG+>=H)tx7vF97eS2|oO2r%<}ziwqiJ2Iq8o+mph?P|qI zN!o)Y3;*(@j01PK-D%5WR<^9nhdxiBM~#6}7IYt1O<)QghN?W+|KM+8BlsxS~^#S zq}d$sB!x_X1*vXgJNVYgNIkB$Hp@t|<^|2I|FWHjSI7`)^=F$(%}8oj`imR^ve&7# z!haY%mb9UqiYehgnVv#&qpJkv>po-RqyvR?SSaEZPr-!(?kniBd8LIak0_zlEsnRV z7>lnAkaLjWBV|!WJRgxJ07xsfMc_8tP|0~w-v^*@{aD(jgLYhw-{gX$5~Mrz8E1HnALghdp@<^6s}^l73{9QoB(i+ z4}s*ZsnSks*6J+Y4R9^D#_jcZL7N4o;jgm#yR{CEfdwj-l0zG?wtdkPot7T2_J0gD z?5G~9plf$-@^B*k^Qk1iFj4IjDoma^t@x4Hk(}5_*dJJ?cJOTzHW{K?%(wFB`MOua zwR(=*+z&g&a6^S!(cFun>|djR%sYdzZEas9Jtapr`k(+mHUbopxb1*=u2t`TTCUC)0bFQw{#Kl&{4TaU-MTmsRGxB#k+nb1c{W6Vz<4yd z6dCEpI`XNye!boi_h@q9XAT+dF&b`Wb+-$)X66Ig`gHE@4B1Hdy$%Opc*nK7z0)QQ zJXP9LdyG+7cY+~Fbk1kHxCrXaySuCjyK{+eN+uW%dblU9TMawsz)6}fG(_A==I*W| zgqAfth?SFZ#sn+uZhuJE#l?~e?BEwJSdd}6IG=1Bt##2_e`L|vAPMWQ_Zr^YmGUPg zceehDIIhRdc}m3PL~N?9c!NgeDAs$Tp=b0%MW=AELpPj$XvD_=$y za2;&lbk6QLCFJ0tEvm<>tpnQtrRq5Y>q{CbH~V4GC1BSnXL40bk7{B4sGC9%a}@vR zJU7!w4PL}=8aqiY_EDVU$<-#PzjJQ`(w|JOXxw9jlZjbRU8n+Jx3Q4l>4-WZE`Cp{ zvfTolvTVIB20t0$JdVvIFx?%zAv93zs$A^wDyFp zTYNVSu5?BFvnp*Cg(sw_T~Y1GCa+s+{(QYj>)@fFsnzuNy@p ze;6ZN4CqFgfb{+v7jabJ^IP3wRNJnvXX+)ZFIomlegks^GE2~h4Xn)(d@wq|j}@l` zdR`r|_y2$`xTej4yZ1A>);Af;*OEgDp0e3kJz9=}}uN$AP{ zVLM%Uncu#lZ1AbU|EKw&I0H=GN?q}c*7L&{La?sOgP(t{3WZGd{@(&(c+TPAt0PMN zSQpfZ8zRRpnyon^d>f28$3)hi55E{>(kbqaB?FmvO2tfCy?d+sY)z^OX<4!ow8pSw zk;50}$w!nv8v6XeEySdKG>0%JbgC3OIRQlOj01CoZQ!B7xhqJt0zY=T&t=>)$!EAb zz{Kht?TmA8kU6pdo;uTzqBMSIG;Yktu1@Kgt8$JHSu3F|PqI74#jNF3K;p9NAM9io z#j*e1T`K|cbKwPZ=#R~VX(oyeP`eG7t$Rfl^+=6=!Xw+7_vzL1QC=Mk6Q2j*KdWg* zpa7DNI3I*o0w)G?Q47;8!OXYBm`L`n2f>RAy;!@;8I@2Te46_JEVZhXJ-p|B(_<%Y zLBxElfyr#9#Co+05>|KFjxf-Wn*AgB4#_gVMnDPVzuE6646vqUcg_f%AZ9n`bwKEn z<@9%OB+!g(Kw>v_-fiz!+GJLIW~5!n{9H0jh?LnQ7popoyW1wUj6`m(p&3T2L5|_> z6iSE)IjMa6gP0+^GYXpVU-GNRFj}Eb${l|-&pN9)X_0^DJwf}rmPVwkTI)Yl@qj82 zuUuVg+?$uU(t+4Z4B%=-s+H<=-~TW$h{%T?w#Kvkxaw1NUqo^rf}1B(Bpm1D!Ie6P z3Wv%wDQ^B#{8|jqjF9i%B~2;Mqi|d8J5#H)DEWlb2zvZ7ahqBf=l7+mG-))WYU0^_ zYl!792oI9`;lDau@q{4x z3z}swY^-lt+(QxS%iif}#}1{kE|*D!%7V)Zpep+`uF27e5rDq!PtWC*10k>_ql+P;Z)Rv`RGFjD%fFH%g-(&>>hfZ3O!P=N{ z4?uUthL<4v)vdD>qJ zk%5QR2o=cFY*d?VoxwMk>#X&jW`(_0EUk4u0TU?s&E<0p7Ymf8pwfe4po?PmA%i%B zG|VdWCjVOPqjp}(KW1T)yR*hV+grS8mL6?m^@~_mF^%~sb=&VyACvBo6vwf8Oh}V% z%u%02e{aL2?0u5*4VN6UmeDme;^T@D3Va?44R29m`|~5Y*&grqQK4zPcFF2Axk!3N zz?t6x${bzQhq5$%m_AmL0WHB@X*Cli$Wi%6YfR!^6xmE}d=$4xN#$7}glvgdcG2J| z^@H6V(1MD9l-4=cv53HdlaxPj=5X%7$eJuk7bUL?PKqS)><$II>`qo!j-FMqHQyvZ z56m?#^GS~)_vhxKm85?13eS+N-t9{|9#kM%Tqp^)9ND&Rw|;e3bY(@=1Qy_Oc%KbO z>1|uuMHhQ2<|cKg*e6?D12x&BgKcKFZ$(4_3fg0Vw-De7ol6}xD8WR@&xefx#c{i~ zLG1!C#vIoM7T6rqDEz&#a#C6*7w^EV43J5lXcJMxQSeYo^{Onq+eY~k@}P`NC`358 zuUj_u0EiPkJeE!XlcnnD`%(dn)ldFWM_R5025nCS{L5K8@<`S<)a&%1Cqcjj_94A( z$fnYRxSjd`*!Vf+Ax}bfu9e;>G3+X7{^W1){8A&Zo!KvVr!PYF=F{t zNx%Sf9{h%Z%TQ^zSTA@e&@z;Ull_CJr?&= zmHOZOsr){H_26cCoJv%-D->E_eZSR96x|eJYDCe-_tiB>5lwT!sbE|g_}btzRep90 zVBoV>+eh%B+XS}U>utk=07Z(!)Qi5~oFf*hYctmc99jq(Z|o^zOkadn%$=oFfVM=_8i%Nl{+PX z1))FI(GmBA7ODc2Cv&mg zi5|K6S+r9YsU1AqHE~?VGV9TPegQ0h(FIB!m?Ajo1Pyz@fW_)(%@6bXiiFuNF{@pN zl7IQZ+B*LqMhEtzMktR7-cg-5*}j={1PEe&1KXfz$D?qe)d6Fqn?w-+%~A6AbCwEf z7!+iR@Fy}>7$}7k9d)cw(Z)YOLF`?e^&2-3K*ZKsD+X*nBaS~P7is;mZdu{(DTFc8 z=AhbWKlZy>mr)x6#AV5ExPr;;1Q*YHxJ{`NEy4y}NsIcmtaciAQ`kzB zT6myyul19Si}=EvO)*>S2!Kq}jN9L4<6bUj&T$d%l^<-^is?TH7=(V^#k$NbSij62G`v+9ID%?yk!cmQ-$B@KQ7)mGVccN?v(Q!RkRok^2=^6i5iCj0GHcPHe5rqed> z=i!f7pb*7a004BhOf2P05dxOT(U|RO1){OTWzBzxi(`t8lD5)eho$fH*#DfEbY?)Hj2{0r*UHsDAo4Qb?Z*U4Z|ad#!5ZS{g36 zeM$LSlBDCjERrZG^ErWcp4~_Lh^ea9mV4N)EXv63ZdaC=-k~Oiv<-M%$|*NWkD9uh5HBsql%OBU^$ozOBL)r}3E1Wx@3deuyid6qPwU?G&Ei)w?pb8>@e3DUjPl?f(<;|84#&nk z9Ur)xzyFv_nPw;84xD&sK?C|S!_)1@--o_^0iLtN&ypRG-JUXLk6l`U`0v8=ypWedRqnl(`EuVoSrn*xHzBOpH6Y z9eO@|tGFvHkIggB1;9<(`=|@05@CaGiZ>s~Sf#`fJEXG^O6uVj zn&&eMpDfe%9K}b_{O+V&07p`4nW`+yZvXjXzkIZ%Wh_qSiOskSyFwQa>Z|bAYEi{W zzZjPuN9{-LZQr*TZvVft`%f|Gk8`5Q`9G6ei9e;d&$ESfQ2=zbEG+j}JTQYtu3bs? z|9*O9JxMzo1E-_$ONxe6cl)J|PUJonIX&MqAyHZe%paXC=)f7yRAhRR!!}pfUWjj= zcUEYum?4-0K=p8jX8C?7V7&O2Wu+{0w>_gzV5|9Ks$CPyIX7s{ z`RUP8rxXm>e%Lgp+LmE9UBR15S$&^S5u^JiWCRcoK$@0I3pKH#uQ8Kt*#jc+LVQ|S zPw8IYX_iIaZSnx5dkI*n4q+Ji>jaU&JzC4tl21R9XBfCIHi#R{CS$7QR$uE2W7Q&6wWh3tYv8= z8`i;}V)>rjm22ULy6Wi6+es$2oln>1gIUE{q&3fM+Lscn>oqX--dC>(_u4JQQ7?^Y zhgt2&e)O-|oqaum4Sr?{{^8ZA7Sb4OlAOC;FTdfub!-~D4nWuXs)u!|>9PNDTCJR& z{oi0Rm`(y8ZDHBkY$J(Te@{}T=NH8rdIo&He796!(;Jrq<4^w!crc!XY>L~Y91umg* zu5GQD3kjsa3nm$UO)WKSR`vv!C+!UenH%+Xi-i}_{iv0mQXIR<;@|x0$GSl8nhoE? z!Pli;nmJ5B_TM78dvw%I+s=LZE8_5X3huwlSLZ?R%h5z-=ibTd^)FW2@NrA&@kO8K ze?8yG8p42ULPluiNq*H|Z7ngRfue{GN144Po*s0W`=B8Js&=s?Ua9Z9Aj_p~3iwSO z3j3*NWC~k&caM4+3&=crpC zR}ys%&YY@olgy>yPwq2r1i#K%c2G)|Lq>YJb!E#~lC?^C;1p5*s;qTj3W_6e zmCO&QcC92?tH(PfZ2NPfhswa1m5Dp9 zdHJ%kwYF|bPMMb~=f!fdzNe(s-My#$1BWwdrF+jZDL}zo$GzQ6{n3=#mW}F~V@Pe| zv*z%Ptu^;N6g-#2ov_*n&R*iS;!_R_MbO7te&^p|jcGoS`oLi^zXeRrSqJ5^wciCH zKf3=Fz-sRJD8^pm;H_78pnXqLzFYHK*M!bW2a1Zk2B#9mBXi==4g1(X#xdjFcP>KIpzfPND1~z7_I@ zGms4Vk)lLtP^)hu0bo4JC&4^xHt?nr1Aw}W05A(*B#Gb)u@)(=vt!udnc}~_)sq%) zQH(;s3f#fzsWQkr*yB%93CJN>+qe^wHS`g)^svM2`qY^)9274}-0MCj>fYF_s}U9o zHy)BdzUcHe7jDDbNTvyr$mNyCyB)t)u2$17hXhJ6fJ;V6Y9*FcanZNUr;IT1ar&lj zjfQT6JYN8z6=-{ZYzey)$69jkwJ&{rkr{t2_vUSj*mk|+^ES5ck#KBxjNtR+sB0gU zkRmH(-cgBgrMo-0SAAjx#v33UYQM7qnJG%GfQWHe02cioe8*uItqHXS)kWO;aTyEe zHu#L=8dVClNQ*{Dn~OC^x&m)GvU7*oYW@QJ%-GZ^UGJ-oS|wPtDHhmRBX?2CY~o%F zEmHL6Oj$?rhsLnCJSOCJ)iVI{WZ$Y}wU}ZFUq{;-fd(}gt5O@u*ptOXg0cRR0%rept?94hiIdlGd_PQS%6zA4fXVcrMkHmYvwnC<RNY**g`IFO3+-K<>K=yl$jR59jL~h1+sO z{D%5O@(Y00(Jv>SzgVKR{M!N3$g;^mkv=9 zw*HmDU`A<^V_GZuO&({L+hV=srLem8&MSDf_nj$y1?Q72W@W^r z-N9QE6DP*c5gJ0IlpOCr*w8vUHFxd-#ML!3y z-r1Z%;k-qnf8Tul>biAc)z7CJtw%c54P>X`1fcx}fPeVo{Hm&mpW@!*E!%Pg?)kno zS$m-Klz@3C)B|W{D*?0fe`>6zH&m<#j6&)8e``yGvPAb)I-ft$-LZ0LO~nZ-bp`x0 zaTeKX`kZ7q*dt~@vBa)#kKF}u77#s{?PGpxapl=MJ^f0(dAUXO2E714Z}O7aWYbia z10ev8s;Iu?s1Z$3oi4ffC)|%6rU%fvg?ssqype@n8Zbyz%to97-((C2V3Gme|#G=h~1H+qi(HtzJTk3qlbf-z~e_4W(zhW-+RtL zPs7-F5&VSw^LyY$5aX`{NfO+p_IOLIhY>Hg+7Fgogl_4SE)UFbFP@t}_xz*gCt;U^whpGX`uR_P^HC-=0YmZG& z(M{1u9N9bmJxPA=ua_Oi_KJXPjZ7SFCv+Ik3+FmGav5!nZ)BC`fd1kTb7bV7zTbkU zW`RqaoydbZVs~Dh_dFE~?TM;&#|aI6SU0BCaGAz16*!#7n$ho|Yb?4NvmdhexZJ7` zSJX?j;Bm44_@YpT!Q|Aku;DAvoWtnDX|zab6_UO7|SY3Y4y1hE)`p~8J%mSB6;=Y*or8! z&9PRu4$kgvL~U(_p?tms(`kolFXSlHNi6s*0~BGX&hFdWW{hB=3f=&}gH<)Zq#Pe! zxUw;l8U28ugcl4hf`wL9zG3)>D=foOioHSglCOJKNWOXl;N{=ZQ9-}TQU^G|B8|!J zDY8}==?n|Y>1;$n`0V9~b0QZoJE@-{Hr?hkl0d3ggG)_QTjTr2sxdD*|4GH& zU7mtaDrUIGjo!IXlixU}q*e^OsY$eS}(99Ps59j6#l z`U~n!_0fE~dNCF;^pQrd_2>)3ko%LozdVPNYIw7p@;XQ;^@ZK_YWk&>_Uc=h=ThD{ z`pGUAuaL%@29Hk)GfZ~ZsEzeO=9zo(t$#kf;*@7vRSmP=GAdAUp$pGXvXYNC`<&Z? zWDO#=jOFb{jLpa zR#@E_f(hbv+bN(wWjsHJ6y#WnR>J$MItsU{&_qu)ebQ|OOl+ZYSEtmtuq*jJ!!4Nn z2%RUCW^waB42>XgLsy|v`@5t&w=zs<*FM?~Y^rMc;*pFxbOrZ;^lEDew4cvW`%cjw z5}o--X2QHT&6Hn{5pyOOU?ay1PiyXZ7)VpuJ4mL}=(gO>uP_l-l26yvx?h0|H}lhL zU{|qM>rNjek7#q!*buRP3HVysD9%;}lh%JplHPNu*mczffYmo6eXn#;zwNoDm;5UV zrhkZ1>GWkxp>;t3qcB?$sgGWNNQP~c;Z?=E!vsA@^i)H1##xd}XsZo57egu&(mf{r z-%-v<&DF{tn(^vkT6EkwJF0y0Ii$@KnfhC`qjUZkgBbomp}+_&T9D}+Zyff_y!Ot{ z8-{M5pxE6N|q-)`>tPTK0QUWG9B@rD(I6ZZ}UEZbU43T=)`!e|Ll;x zkIr;ZDc@`Y%Seq#BdLLxrS*YL7`lSJs!!W+MU?0hZcSm*6D&|LTy7#pmmQI z$Ap}bI9tE^)i#gzAVFWh0Ym-9nB{892#77cJHkCB(gFynF#bfHK1~3+vZeT9CLHQL zXw$H&m)qk0n3Fr{{m5DA#U-fkD%8F}3w5vtv3^oo*4{V(?u8@stAp`%FJPXM_T3$r z{#ZIYnNX`}fc(}9ymA3%#!H?*=L&Q0l@w1qlz1Z9T}^wBzpjMPTvi+4)=L7=0t ze_ivfoIGBE&f#U?<5$I|0!a z86ES8*D3X4`~06e6gk3N2?;S3k?7h%dN@xrwITo5`NaiTZ@}}0ZL=FLWBsnRf3p8r z_H}d+?Bb-zEz`6BvvYIq-~5ITl9kAVZYAj!?+h3jVzbWeRpht`d7+9xT-Tkf^#{Ai z&Vrq?yhjRHmABc6J|>PHC}kP4TrM_Dw2Yef-TnUoM%8*WfznBkGnYOi+%UyW-k94U z3+t77Nn>PK3(LQ-yZfMYp1LF?25rY5YamCh81VD zxQ0q>kIPnA($BqV3XFDZhq70Zk4_Fr{8MwbH$5ag;AcEd<@AX{c{JW9?`d?BHPVI~ z$TpzcYcSEj4F<)-K5`5P9kvV^sL)5`@2qo*5>vQ&qqcyG(hYgcL(|}+$>%0k;s?D? z$(DMP19gNtP-TEpwcFppr7My*DK+J2DA}EGt$brilJtnA_$sTLSW2*vVK}1CU~uhs zA3I~3xh%ju7ft$0`0YEtYsFo%($QOKak1zukp%cOJ+zAl8k%%6&7}6=7?`aMwTkkEYd)F0CMs< zGocRU-RCPCvV@kXL4V@S=6dQlFIDRzvXLMV@h-|w;4@xqsQ#u>#n{&6fY$~G2hZ1> z5$HC>6A+~tSu%VNntLF8Q&nD(9j~cx>~$NN$yJ~lrgQ|V_5Wk171N%HP4*AemWI!B z-X}SDi2JNurRE^{*L~F{02FG4w&FZ+U z+IH3Hg;4wHzx!U*!vk`+$gQU>PxiAg`@hr3uaSk=zLOx$9AXIy$}>A3-ii=Ay2Vdv zmaP2Po~e#tw1U?>HOUgbpj&)cpPrd!YcCI+$H({wcaK|?oebc}KO!R0B&&>46E<1V zv(dfvzC}BX%@LF3I1$^XJHD=GlU{%7yNoA3TFzbZsfmY2sJ++o>(h##ygtfS|6!n+ z7{Lgz0=qHcC#n~yc}o+&*Sq~VY|&J7V`a%a`%B(zIrN!flZ^jiNcoZE;6~~1=oO_M z>QK|m`kvTN0pHIsygi-yQ9RD-vk{G~d~|*onI>Y1A-eiwqg!!#S-RMIp?}P0f>ux> zdBJhaKIOAYp7*;ICCTQQ;7fk5pm}qgrdc^UQ9xiQc3I{%x74f~agAKIuePFl>$sXW zU|0S*S`lyBHhAe^jUm0w)iJPAA-?jb`oMmf!en|f&1E;^9Zsl{bk>#`PN8gx!z1fq z$IBVqjdW8k7EUPO?}gCm(QfKU0!W?RXklqzMk;liYERd z<9y(1c)&A=TJFq02Q1+7e`&!)K~i!}yo!@}W?!ZV8p{eD-0w`ys~>FiFf{Z{k}yNl z1Z)EL(u3E?Ej9Xgq=K74G^Y~SC&`pkozMD>FwzI+M1gBirAy;>T1LmjLhPY7;KJ{R zKm8Rei~B|;sHItkNHqEf$Ayr}q;){Yh>xgPUX^Gp5xcb3eXYuF>&0u(Z8 zrR!8gynB2XsF!X~@k!P{>MJ34PZuo38?GoRt2P_|4N|$FcllipOZ^of#RQ7|kx0uN zaVrpdw~+Xn$4IdGgfcOZz2WcqhW;yg|9|Yy-fC0SHR{RiQt%S75hVCj`8X zDhfh{y33`RrUcc6fkTR)bZ6>0f*Ar1WBi6+_|BY34RO~rwu&Sr2xS@Zv}1MP?}U&} z(JEcZKb2SH#5AD`ts3QXx8t9h|GlC~R!*j=S3IkotmcpI+sA-UoTME5d8dWhP1|2fB~9ygD3_T8AsU>*dC&B8 zntWz{JG~MnQ8!eBPF3%GWJ;Gz7Vp0xN!|}hbucN(mfLayZ0NJ(xw6BcfgwZ>quc6y z%)Cu7IU8zqKYms8AmkfhRuQ-?4&)$WF<9xdn)9%Ym8RWZ@HVC#_Gcx(aGQqww2d;8 zh+Q7duVen)*&Y06-M^t>&2gG(F-qy6zgt&iCE|tcm4%n31m8M5-Zr8}Wg}^bS$Byc zk4Mhkn4tgZOGz(GR%P4Ueote0is&@E){^&O-4^!gHYCrD`FqGASczE>ZcSMl^ z@b=5IAf$Q1qbpYu1ni3q?Anq-kI&oITqz@@6jw}$m|nOKQS!A!vDTDz_BOh<=g zb+3}yv-@lc+P&rt>6r84vqv3i#g=LdDtwnhOn z{)ZuXt;6DIH*5qzXqwWgvp^OPo^;Z#n zj|zIUXQt}!-39x^LV0C5NX!4j7)b$VK#*zFJF*R~`GBoHqW1=y+P%!}ufmgCw4mcm zx#!E56c|KuG>O$c7TE9sg%wYzwg=#LR#AO)M{hNLv5(_LjvD_r<@4FeiM%|!+p-=S zifD*6wU5pPwWR-~F_c4+dufS55YL8oCCuVhsA=TqExvh?AP7U)^3?aW*z&4B=1Czc zE{9`~9KiIe#LVM0->T$o(RkAJ`;_48FE`i(zTwk?wRg&|0?l#~RU4Nh@EJB$xxDB; z8*>yF66^qhPV=RdOCa>a1Jm@Y9DY>&b@6Z;6VpPnf*|*Q^#;$7D@7zb;1f|^`;B@2 z;<6oYL0aH_ndf_kYEEg*xSjV2^;37}y~dgX2FZknJQe@k294GlrKN&x{DpMo%PP0C zKXWfkX5~J3vJxZ?5gBw-AJ_QZFx_3nSvzIz?QYfM`UQsT9t)1ESm6&F8cK1My6|Ep zgW+Ps?az$kP1vdxb4KR@YNLoPAiZVv!oU1XH@9-eV7o>2*8u`U<`3b65|d54l?Tg@ z%_L7&2oy{>ydm842KUL8RkyeOB}KZ~@b9m#iTXxt06`6u0+->>`u*;NtMEDYeVN(S(0fY9}QFP z+7WNwM(364x68_#Nuc@Qe4p;s)Tx9khfj1v@Ak}8YswWfvzCY7Py~C&CfPRLPR3`@ z9SAkwo8=OcgYY}z0QktKH*l0Mg|MbCU2=7w)VrF}2yH2w)CrwaH$DTpVP|O5d6b(9 z*Xy@Oahha4@~vguGNzy8^85Dm#G3BSZH!yEW0tI*#03T{44PZ`(rn|N105i4A&4L6 z=b&|zq=_UMuOgfTAb!_Y+tL!k`Yhxc7a5*}{g27E zic?VrHMA76v<^>1Rv+))^KxVTVHkm6lx8fQB-?tTUR4Na4y>$50&BReF3S5-6av)| zwXp8mi(^&H0|(0QaiZp)T<0lNgp}xW#zp%TVf*5;iKvjt}NZEba|!IySPz>#sfuPw?K}GUbP`I zeHQF zg_}QtF^%t4bl*jq(R%|OlEfoFhU4aEF6txLa39OkQ68LEGc$1l#aJFC@P+&nysSDK%UtX8g1WQ7IVoLSzfCK<{P7A7GUQRDMx*eh6N!*S5dk6t^TXs8Qjrc8E90Z2f7=1pooFt5tW=^!A$wg~FfSv{HU4k>X0*;{CFCq9bq$d7F+nUizqReu;i%J{!Ij z=4`bY`=avh;}NA~b!F^~L|t?j28b*uxDY8t89CEm*cdwfkRd(&lF+4=PLWz4)V$IB zcWH@SCf|B9wrp<-Y4n`+JeaEvLS-T_v;4ubv(Vj*JB%{v=|jNmXI}-iEGN6@j>TRxe+#^b>}xke9rIzATwYIAx}Dd8bO;3r-2 zS2KFi$_5-5s=M>ILfaEu;a{5Me?7B`wawOXNE$+J&WW7O*hHFvNqT)gP*P{~5d|GD z8|_kkKrtsp&l5`gmbA~=93tnj?V~}z{bQ=)Fe0=VGSj1}NUwp&W6~A%JHk$LbKT%)nn!-h|43pSCO`aJMWW&A=e^02h`==z$Bd&Gz+rU7gVkBG7BY26NYNB;dHJ6sekRzfYNoyUT zh~2XNHdsp6ujt#&bm!%i+GpC7oX`Dn=CP8Z5;Ml0tIZJ=F!0uVSFcr3==18g>3?D; zo*T~=D_@GZn^{^9FE?{$USk6iBAj&zPL-*bB}|3~wt6F4@oyX$co@^?rlSli3u)Cx z=<1RVHsbIj{~%~XxLdiW4bLE>Y~l)6O)x31Z!g`OT7e|#6Hx_yM)SkggQ}8rxM^WQ z9lfdhKXxeoUNVEhsDq{d7k+N3Z)mO*FDjG#BBuFGN44F`kQy$Rtyh<=d?!C99_i`5 zlPxNo=j#u1H{vDUJeg5-biNhbFQQ%!_oumV)KK83^Qx$hv3uzu3uvmp<-kBopHF{D z1(E8r%BWV$Mw14epvBpLK>cpD!syHtXB^vOcE@8M6Yf<+E5oX&L)HM)H*f*8<*saeHBqRnTPW)DA=w2;7eIGqEV zGEbV-wK^)fH<7LB9ZBhYNDM9IMAu#t_$omg zlhCDwhq1&^r4*aVK2toBy27V(78fMjj6&x^lhLI*XBi!SOKIn%Rf5G+#)&wVZLsBG~Cg z3*>Rgp^n93ypfLyT>wh>qj25;W_#b$Yk!v<11fP$u4x->b12xoE`O^Y%90BHj6o2% zeZ_vZ9OJoMfWAFkC4+g$&b*#(IO%+Rx&eJ$%AJWax{cN&Z$polC2><5EtW(LyKvpy zeKE-}qv+)*^N_?+DO9_jZHVSnoe^B?Cx(s_=g32FJw5U8bgxAMxryVL0E$a0hQHGt zW`!rC74_tfMu@AetZXl1+V;o6;dpSxbd8qIP}g$Cf3Kw742Hf%&KfnxxPFr)%A!*E4hZ@dx3F} zS2GLa6?IzxPdB*h(;qKoc#Sw4Zd4z_dS4$YTFG64fT~>WV#kl!$0bM`E6ahkit}U7 zu=``+in@QD#{9`5^fTjX`rhwV#J$)^!wsYkqmHzB?};sc_G2s$0MdY%n;6| zLi7>se=u>!OnsOxG7!E9iVzf`EP40GnSzfh@g*iv`CK3Y{ZVX>(t|(C7^4VwXqFkkLWIraZ&>)nXZZ0ivwgPp0)ss~fes#gUqH8g;v zHg0cm*V`VNgs5@=yiU$ZTdz<;+SbHt!zoQSl2G}9eA2+%_v4o-nGl%z9W*mm%2I-znC8;$d`4DAu?+ z2(^|&1p~D$5EgGzGmDTtuZGx4*>ywIr#c~P$s|*lO5bR)d*2UfxHw2ls!}59lgx@) zURM^|bsSuNcsgMusx_7UODxn19+-d$JGP4pV~1TpB}*aH5ziVDrC9OzBmB6Fqg@v- zE1ntHnWK7p8vq*jw|sk$Y`X<3n>2vHWb?lb$Oq|;GN~nTT|pC~ElQ9Y#4>|_;f_Tm z$tgs6oKk`kUIE~+H~u)7HFTQmH5$^(xg%#`!64#MPE=*^nR5)*OxX-?6T=z50l%In zYaw!9HcSyyv}hG)2=&wTkUYMX z0_(J%Ffj>^9m++T>9dHM6 z;}WPcq#2%CYTh=cz0q##`yoeMNYe^8)0E6I%4(OJWBGuusW(|vd;b6oc3&TE!l3A9 z?bxKADP=~NFYxU^=9f-Wf}nA+s%jZe=guU;K68FQ=Cuoqqm(zXgWgbfwj)yarcX4>QZ}rPE*k#-0KWvdSuThv z<5<OI09%9KA295`dS=iRQyFH=XB&`$!{2iZdr{D*rB5)GG_HiKE>abj zeVbr5V0q^ehpCMb2x+NmW7I0XU=;O`ow26xQ<45$6HWP2{6-K|E7d-X-$C;YR;xH6 zf*wu1zn&)P!U6aq2XbPrjo-|J$@Rja)F|YiZ_d~x8B5;GtBe`FOh_e&l}*-ge`N7+ zaq5H>Cs}gVrSl32jG=?F_2$^*%I?sRKxy*lf02Y0Sczu8s@?JKV!mjF9;Sj1H|8Rb zY?9vWPd4q2dipr{KsstNWQezhU`r;TN89OFgx{r~XC=`g}Baj90 z;V{09lP0Fl7M`XmWu|EM0OiQ*ewN1|uO4&@l}2eMXrdHB8DwqEZmLwT_2Z;NN^!5P zzE4LKLwms*MQdAy;2e6*&}b^2TP6!Cto1@CrVpSu#m5u}@>(Cw+7qDbQo(nvQ8asbE6krGp_d(&p$-t?gQ zBmtR)tVdvbW9d^4wSrjLVH9)7(!KPdWqVl2u&v>CPl+ zP(Mp*nFp0cK$A=YNpd{E*B8G76A*-qy6T_lDx$7LmO5~DsRws+-y9H%qjI_BdYd=X zbH^T6If0#t^4WJs$sI@U#13F~sOC7gL~F==S)r|lM9ttd)d?t#C5zP?1K!`W&+q)O z1L%>WWlE@asH01rLn@@S(}@AF3=Oa|o6Qy;iTZO@%S9iPSf4o)5z7ng{{VOOVKyR$ zZ4(+*AxSlO$}?(6Wu%Ndk5MSyEp84V!!gXUQq=+C$ZMCiJGfIJjra3&a7VTp5>m%g z0Z1z}=3_?$m7v8mEy!hSl^ub^UXvD4j39N&kI5Bs%JHVqUf;8O-=;b>l#IgxqL?>_ znWa4<)z``?p|ESnHiABw1mh&Y*&pc87Yy$s)0q_nEe(5SHB}Y`V>ej$bNn$iI<*{b zqH`J$`c#H!EMvO$H}7ME+T$oUfwEzpRi`cG0GmJ-?QeV&GJUh9oUPfI+nEg_O6+&>p_elZ!UV(M;z zqp>Kg%LCNxxR6{H9CQGC;v(}4zKkM{RiaL1N|VL56eDPmkT~|^3hGyL5e=pxHRoDa zBFMxr%~)rXaU`l<*R{p*B`VK#%JkC+cVCxf=<=A@slCyM;sfi445~({eOf?-)V0vS ze4+%ZZFWD3;|DeJlfINC^wmjbNSkptz5f7)CIt#uSG9@3y?`gV=sx)M4qFSVH_P4J z1{_@WKWu!xA{XB>XLe{+K?3A`G4kbjba>?jAmxL}dgJawt#?uw5!rn955;6^UB~79U)5n6B~wnWUv^hnPk}DxQRU{{W*Bg9v8} zudC@zjV97Ky|LIbxi(Dmy+qsEJ_1+{EqrvjB`?dVpD(syP{a<#-3Z6T&6kUfT=C{k zDk?~FrsCq<9+>iBeX3nW3_FzC#hU(~r@lVT3+$`vfVr}*9kGf(s zTsnw1N;Ne+6m{)Ol(y(rG%g(6teZyVzk6VsRVBAURiq7qk42jK3=*cDlmYmZU#1Jx zSuN;@)hb-hjnuf1j=OF<Nd-ca_-i)vR)HVK-f|i~mAMA@2?lGW- z%BP0`3*`Bs3md>e2a*W67RQ-Xxw#}&d6h?*uiet>?Z!HV!Cquy3y*XgTK)0dsPe9>9OhP8{{RRV-S6#=OQCpJ zcU?b6p<>b*da#6!mRk&F(%Tdt=KL=(6^&3Y2$CII%bGd)pkr3)xB~uUUy$AqWpGyW8oGVi#bqlL?_@ zMhvRL>gnuyUmPhSE|yVMW;slvrjEKuWMVZx~aXadJcWDA*Mp(q?GAQk5cz!-~en5 zhB+Vw=rX;nFU&||V|}2pvAx$E%r4R@S)+;X3bnx?TwGY==-qr0xoWCw9Z0h5Aavs% zLhKdPQilx01haDg0DMH}DPrl)8nc(k>hP^pOnD40Y(237Y@!-+q}8?gO+>)asgB^> z5nvC~9ONos@SJq%%;>7kR#I9?&=TPncI564weY_d%OkMvRsx!$(Nij63N$oS*}s^%jWjeX8T1-s>vi`hz6owE&0IQ;WY1IK1szI>1zUu@_eR{G z_jkc<;x0?-VA_~v@OLqdnezO?IpMz%jyn7Oa7#FpYJ@mD*)r8=4CaDS9YhNnoBGgh zzuyM49M>o+VM|n3Fv};5+EB}4SJbu!*kHbyW4m)I@xtOd6>7arS(MqPh%23DbdOTs zpqioSqaZJx9@$&m?d@;liwhWH=}VvTbVwknilyZ;xk423$^7v=5Tlt~WN3KO8j4Z~l*Yq~VFhh#-@ow0q_3LLz1BxZ9XVy0ibpb^GwXhs@)u45 z7rMUUZ} z*X@qM-FW7g7$Z?-_6k81Cw%VyU#8ak-yD}_QZbnX6VK^NXe;8P5mWAeD%WH0y8i&= z#|{hXXCMQ;DXgwcx!vi|sv2ep-t2Aud~>Sl?~A64j=q_sgn6%bYcjX{z47Hnz?H=c zflcy^rmbYD43-VM$-lYia1)%Y6b01dPtZ+INRicnJnG$l-R*_%3H30gG_z9FdBiZ< z5!Jqph#?m$El&*8$n7g5DYydH^d6Y%R89-nrWET7Kmx=MBrhX(Tz4uk0%=H=mPw*blL97f9VmfhSoCM$_ZX!GeHjj5zkTsFqy$3&)8m&_=mmQVwp00SJA>w%P*IC(s`Mjl;-!MHzca=FZA z3Rbh(T&UU)8(Y8I1JuzSNbHLK9BEn_l%FxFjCrw=Rx{k;E-I;;E1nAv0(rtGW)j6w z`naQ5hXukdjuwk2S|*9$VNmQC3UYvLZlsKNE6Gi30Hv%lI)M;QIPQ92hUkQ-6e}>y zDmN*yBFSu7n$nk}*LQTyvx<7VN9K z{SD7J_F;G_%4C|2>FcVDz!U&RM_tw*iyi8r%5+Y7bXyUlk9D@2^R#h}NQE^q3*ALM zMJa-=oPg2tdA>YEkrz%GbT!$u()ocE*-I%s*!zC$Lg-Sq_fEC*OPWDRHB});iTsz5 z)70B|>-5A*awR&}(X15lnqa&3`bGZ$75ih*zCBeEt4cZ_Ev9zb%r``*kp1vL2x3>M ztKOAjmW;ea9$k(7KF1wG^qxu2Dy5^SN|mbHD4Z4`b?2ct@Q7V%qkkfPYDm$y$q6M# z_=BMQvCu=fE<(4?if626^X^1yorl*SL?|42u5{F}8fuz%k>qD3!k^iEdQ<>eD9CB0 zM{x{_jIk2U_3e*WtZADh(?waAQko^Slg&4pNH(}Q4L-%%reD)C1^u5iAdhcz)Z@@$c;@CzZL7W1hoQPOqJ^rd z9;sxEEM`AW({XHg<14yi>DCzwqNGR?OB*ro?}*AeS0$yLX?Fx)OWcote0Zc_QVK0m zTam>iR1T#a0%IcfC%z*z$(cifk0;U+EnTQCZ4M)kp z>g67x>Id+#zy_KlrA>8FZ#(9?weGu57wwON9-${x;YC?l8W@E{jSCQ23s@7|_hLGN zLMDKfGm}T=(^RB1&>31-go^jDx8Lc7Cb$MAHEklJl@*!HUTqC^O!KUA71+f556SN2sgG@nyn*U3~MUDS8=p^*eGwU&%g1+?5cg^&Du-yY>5dMV0L9&6>m#H&Qt+7yNV z0Cza}wR_RRXRfYEtt8QqSMb;i{d!~7GiZlukh8@qv~41i_9_qJ2Oml-QUQ04nPGTG znxkkp_r1BkA$yd;fCVL_&uQqsSTSb@fB?TgOa|u4m=F|~FVuN;V;G@vbz``ZVh`5~ z-$1uieL8_V&m>in1&!?1>+T0^LK_Nxl1lMBYfh@kAec7b0sVq4f8Bh03+FoNqH4(C ze=Qe#+T?rvaVtWB#WsUIe)t^i1YYB{u_+LsB}w$AS4&w?A)U&?g5}uQ8w17rU|Nqm zYP$q(o3&d_+q0FNZLbP49Rr0v3+fWB2L%@zpwc*EMQFA2x4K8J0z# zbG^$D+!j4>$Wlw*`AL^Gib92@y}`Hw*pniMFe$>GwwXvJ5MK6DIme-ea$ExQHGLWq z;>vH&822d(2RIeZT-G{b8D(}YV58XE9^{qaa!QqpC`qK;_5>171mmIES8$FmFMl4y|*)&!AjH?|}Nau=A_a!A{QH)D?+x(Ujb ztW}_+o=XR^f_r!VtU_BCU1mSW?3EMAQ2tzIloMD@hi5NPami0W&xTr3AWOI z%Yn@zrVj;imS|#*@UT&PgKoI^G^q%+mq?9dWNl5z_F~K}_O?233#O93wDk>hGI}mS z`roD@h2CZSsWn5tl<%-5g5KY|9GfqFW!hZ1>C!2k1&Vy38FnWBnE<8+EHyS@JaJ~3RW!yGhC>Eqf( z)Zx5C)A5x_vv_}4x4+`!>M$puKawP4Y4cExSEw@BWBH7qQlXcEDTnJ7f$Ps~8A}4= zsvfQ}yC!ISSDq*q2%?S&t;~Tgr1$$^&x1ih98&Eci@CB5q@>|_Ctw5k;%4ynh0mmt zq51Z%&9lirzKkAOxdl)u=HA_UVCGW{(G2$&DA&tJ2;OEsz8b`W2h!M>-3~+~*@`Vh zu}bXH$sLs#l1;xnO-jl)6qVG5GO;1P{cu*OawTwi90qa#bp-7k@sC2}72cYqOdBt^ zc)1p}@#^MMbp2}Vjld{xW$TYk*V&~eNkcS=$iF*Vt?|@C@>7*9BxE#?9?}52TH@UG z#6+W5%)t$Ho~979QqoK0pdXD*?r}2$`R&;Xj-t((;W1|Od8*d9KARqHM|)ca27;G9 zmug4-w&u@OQuR5NLq#RG3t2mh+x%;P3`*93fO&P)A2rQwQ6o`?Qs`r1Ixug16wwJ| zf!lS~hdHRBrH+=Ko&2Ch*?M1_(`AunkVRL-YC|l9pTqt(AufW9Ya}L0 zT&u~Vtfy+Y*>~We*b#N%xl#P$o+)IJ z9&;$+t_`s;GNF43Pq_wrCSD+gP&7v8o=CPlaFyd-3EH+w9YX}_yTq5d7O>+H0R??f zhlnaF`6QGgLa3$*6b<9Ad=Vi8X%?F~gWj9UIgYLwTaZXnO^v%>A1OhZ1$THVl9iKqkP*t2 z>@oB&h#)0&loizS)7C2qsdf}72SRO+oL9_agmS#485K<>C1p~{63WV@la6akfjgb~O&d1|$HXz%RfLs&S7)^RhETNuU z;VbhYO9B(J{F1wR;wQ+6L;)+6K3Pwax=9vi^XkEhf;ul2$3UIbZXK#a5`6q35aJ|Y zY;Dy0W5v-?$mw2BHRn>YN9Y5w0{r9E30>=nrGgYCNp6Y!@#^wYIVfO>8N?*WMb$%Y z7ZyBwW9-nn$tne_JWk0xE~b%lXymEP5=2*~PeJme1%Th$_x$nms=$+??UbgL#MA)4~KU3pz;KqF&&8`{H(Sc7uBaHBK6GoBa@sSu2fCkuGtUPF|W_V3bVOk$s?fr>~NbITOxPE@Vz0EphUU~2Fs;n={9!#q zoU2_nZ@>sx_zcJj$L+%_(|kB_90+`e2w)gDOEi z1Q~8=48B-ot5QXcl%6eoMCUGrE^0*r|x=L!>ix=%2r^XVw#F9kvLIXv#~`|pW*R578IbIh_D?70@6 zS{91P7t9Cthx&2Qs0!p!gw0ACmaGY3^G4oocw_8wFm$L$jZ^IT{26*}dU)BJ(g$D< zQTb!oT)831EB;?PRVluelaNK!9>W}vqG`H$%_?DC$qbw3Spy*+l^^0?wmtz*E1fL0 z{{SxOQp^4F#Xx7=6Tb%>5TDI%^Qxj(AhECA-%jYt?~>xN-d4MkN%Qv$UY z+OkI0Q|t~t3(}QjH8iz3b5ssxrI&4&sd4X*iG>h7Ulkp!RyFk!*KJyPlpemdbJO?Y zc9jFfmG?3&mD9rT#?KSkNF1NOBn#=wqT@AXQhc$7(jX);0@mGb2iM;m!k;-(T5}#* zMdwthSkDSuyEjW>G)Qy>8+j*%Y9tYWh`WhDwY#wW*pvn2q|jF=m~3J;k1b-eE{XlaV4Fo2uVmmDw0Hj^&F2ZawXM8PF90s24eNJ;8%A?PF_`$oI#6 z8A7_E;qu~C-xHxx#m_kGSwuvoG1HjUrE$M%n*rYV;$?gSR=#Y>5&RuJClM7pN^n;B zW%6CrT;Fx=*8`C#wz?8(r>ADIoHe@h-1Ntp3hSmxrukZBTTD!(*nn?fanPnp@Yex( zpFDy96g$dAhuag3I*ZbPNGkOyhUIx8+#c7*Lkx#@FOqFKhM~PckT~UgVorfVaU`U* zS^i*IyoQmLl#7f=CH-hKlNjWQER{b(6}KZchEaq4d9eNGWckFO=0KY;w6(ESDGEZUylsRofjY&OGLxXhd>S zm)b478+7h*_Ep&_B|SuH<)fGo+*q5RwmB+FW>b_=(8oCQNx1-@rSTKzWKaogkY$iF zOBLOlfx83Uc1TGjt(ukN*%AvL8r+O{7=|@rH`3+NyHrn8F>f*M>ZfTV=y5I1i-6?) zlGVdWIgGpcNBkQx+(%n;h#y8&?W+r`=Mqm)S8)oZfj?2-^Tz^=F2!rEkya!=dzy>8 zix1#yHc)8uXwog7S0d)a_HbXLD8*&fbtI8Q6&M9PjCttG(}`Y&rLJN^)Dgv( z({8`dA9^rR^u;mFzHnuznb?AEEyg7j^60$Iz11Zq*y3t+ELU~<983a;y?u(NB=Xm4 zC{Rlhc>rVL*-`YFSMt;Xe8QfCeXb8|d>XlRP`JHa!iy`5n}hr@&}xL#1$vgY2PB(W z1^7KN?n1f`2@$C^05J8er|{p~raBB=XA6vVjDV?A=_GzEdy#vbFaOph2x_KASuQNY zpP}vfV?vco0WPJc*b0%e?6x@iRFJ+TqMgZSJMZad_wA30>S1+uDI&3vM($Z}U`h7J zfqj`KksTN+5Epkm`{UK&E99^G)`(nK1Alyaq9uEX7m;2%5JQt%6;+J zg~=%zmV~Hi$s?;AN&@M3@`T6Op4j?V(!4IoJk8u#ZRfr?a9qlC6=H@ZSyYe!wT1fP zHQHMg#&9G_0a7@>81RMi;XY+3Mn?4@zR(-KJcaRGBB(B#kKrSgwXA#N)$m^03!Uh_ zRPcLaAWH*F0i32~x^eI6{uW_uO)~z3~`crh14YMv_?6bp)GYaG`L7 z)l(BkXEE-Lxv?JjloUIJr0qutyCseL6~w@lJAg^#t)R;`{-9j(a5=su3?)Wh8oE>F zNmzhKC=GH5ZU`9o(kf=wofDijRPfzZ!#A>?_#Ckm*REUSu5zjmJqFujlGt9CW=g!a zX;4T?1pqhLW9XI1?MaWzw1lg&S-1zd_s2rPb7GTK)vyvOCiGGc4`}++(fUQ#Zx$Bz z$J#GiWj!vpI(HOPIDyh7ZQ%sO<1^vBS=1c*DOwUDi1OID>>coGhbJ+bJro+jZY%d*k(^O>p+;>Xi|b{up}s40tI zbf%J}GTLzzMS|}1dbqLck0DA7ST6ZRT$EBg$plSy{7k*iOh)jgq+qFzLnxMd*-be4 z=@r6pWF%VOz??6r6MQL~sWnYpv~g0j$Pvl^00y6jwgrnO!NyncjMCQT8tgF*9yBW4O^jRdUhm9M)!{Fq z;L|hN_|0wpa%{*x88t0ts?#}6qR!f{EUnGy=xdUkn4igOmt}L_%d`=I$K3#Spn`J5 z_K-Z)mcQI>S|c%VEd=S<*B{MGyg~R_&2rxmb=I5EdCO5`SvG2DU`on>@*mYKmu5Xr ztc(*^iwbs${iJy%cptep;^~Kj0^3g0=A;>y!{(fz@LN`Ro2a3$IqpfA)8&!Cvjl=$ z$f(jX4#i2^{xz{a3mxeM_IduqmyB?cgzEF`jX!E7(CNx8Ih18Ic|@+%O-BUrqwwkH zpmG@ZJoEL&p~4*u1gwvU(uY7z;Yztv6I@!x{BwS|vl^44LDA2C$!!c$hg2bpmjiGf zkPp5FeQ*&tdKZn+Yfk04hDOso4jav}+&COx{J2k2rhQe%4@aZ%Q%YHyrAo>5sL{Mvmf1$0EP36sLN$_^-@9%9#oso;yR0Cr4o=m zS$L`yAIvbR79!_x$H8+6kqk^6JS@^lVy4`O`eH)$$O+0iIc1VMlMs0oO1rlW#v{zV z3|=S64q-fXuON+M=n&nQi*?76r-)BGm5$d|Pyjsj$E&r%X(aL-z;}71FFwN`1;Ij% zXO+)GI!`g(9N=wG39;$h3@JS%twqGjSEe$?ksbi1DHsrUf;~O0e0utdN_626;^!J0qk&48=#z2@=VrPqiCj$-4^HG{9-T{#Y6u9MpJ4ERgwbm)RIN5 zZZC;*LKW2WD2`*Nnu@k4b12D+k|h5C8;fAZIzkQ9$ki!=Dta`ibdVV=L_mK_9m<5+ zbV`~kxPz>lDkE#kyDfGfTzmrfIemI@sVQDq+$e~WP`$VxOmrCqM(WZ#lxBtzFPw!8 zmR7JGfaq~42zJ$#(g3uO2&FADNI*YNra2{g*IT@=HKrM%s7S5|K)Y>wSmTsT-`Km= zW^V8;3#thGw7DEL?cX0nsWZ)z+?q)08_SXQFOVlw3>M2{w~hc9=f`CADk z{{RbnT;Kfo^oa|Q(Yo)RX=coRZD4ZJGll@3mg$bzjb4gUCi5 z@hMO?$rhuHC{~szuEuF@&3k~naxv=!t}0nI=2eX>VmGN-5hSvYw@h>!3NuwZ%QTs# z6VlW;MtcQe`$2iOI{|oKm?i`B6!0|216fY%byey8SdtV(!0t#PtlT1zPoN94H@C3I z*;E;)yL7GzBMOBhRat?tC!fn67O92oG*S$oQf7HPj~yLb4@m|#8Xs`0mH>Ai{c!`Z;OLGRlHF0Zhg)T}@Ke{o@dGSl(89%jm<-X` z6Vu3)?@gLZQh+RIQHinp`(h%@tKm~J`qBAU3Jh)TG06+k=}QuMQa&at^(NThwpU^B zx{Aa_P19~;f7-`A8vCS3o~jzOVkR;&wX9A)=*st|P3uugoPY$R+Qj=}euYG8uj%uD zC7CV+yKiE9W46+T0jvUVlD0Q0iy;nH>^}JKqh55Nq;qG_0tn$okSVjb-=-xL6fUn8 zUt3c~PV}c>@qh?D@#({^Js~WMP|~owzQi2uy^Y(gzjh;a0u+L>b=?(oVWV)$s#pSf zAACiU5drDCh`l#0Q@D~^z~6(8i)C_Nl~z^Jg$!zx5FT-8D@eD|vgr zSa}WANXJ5%TzWuXW6cqnLT)MUt8sjGX~LD2B`EU@gVf$yl5PUnoN*ARFI;1iHuXk; z*p)0tIE~6iR0+ljL1t~YL2KOGr?w&?OVYwx8VJLUg$3=oh0E$$v=mBLo7@Zc7t!j+;q%YZTbogkmO+N`~C5Z@25x*z8hJn#q=W(&j`* zkqV2SdmnrhDIiWHg8?pF*sus2ccZE6$6MpWNp`EYD)s96WkOd_;5oPmI3A;G@!K5bQim@Jq7~f~-k`*Rd*kIHaoKl9N`PJ4X(y47vMCz% z|JO0>E|QkL$>;1bpsHA3BzWYIgnkG4G3xarkqb;WxY)!Feev@7d2&g3&fBRx+WZWB zyj($8&emi6 zDJN+J+m3y)(?W^md5QK$8Nh3Cz_qdSf{a@0)RQZdV#-up5N-SM$WjWIUDP-mqY!3P_h}3mb#F*9&ZX3iT;`6!AKj;`LaJwnF+0KfO+#nM+okkv?HmJdR<(PR5vMmTYS zD4I;pmVS%!-J@9wfNnuIwjt?MofH-4^ld+mLV=t;Em@jaTw3t}P1eeI!Jz{ERJIKE zo8@J-CFfNo2ke|k0hI&dEQV3$KRZL1L9uDgNl=@=3b=1ozV{d-LY!#xBE zc4(utrA>hYsmGHlM_XM}vdAel>WFLEu{5pKCR2`m}SByoyDc7RF(Mef7= zn2|(W1&U)d=@QgWC|8}Xi(|IH^!ws)pwj6^Pm>x~Mo;iDf?N@QQx1QYJad<(_I6W;iduaq7m50dMZ9Wk0%Kvn&6 zl>nX#eK9f=vQK*U?v&Del#%&v2^S{*q3w@Cj&j(pGshEwC~_TJX(PGsk4c5$Y_6&v zkd(go+RR7W{W$YgAZ#TwnF)|UJw*d`=rPo3+TmAo0DI%cFu6o7Gq=4?74%r^vR>K_TL=h@7@rf(rrg^U-xw2Z;AAZ-zY9xwe ze90LSLcUC(6b)iIw_f<0~2pHU{I9#qk`yAlXvgJ(j+BSwZgh(53+r0M%{0s$D%4tBrOEc<<46Y3pv&S4Fk24v7%uBBL8aU)Y zl3$`ZaHibitHp%0_!Vj4rsuW?(yNtMixk?UMP>7*m!>ruuUzISNlO)6wxF7t2o%&s zf5sRqU0aTL?~LCUhYZX#hUcFUKABp74aLi;Lt=8%`d;tNQx6g~o}Qub&pgnT`Kr-s z4A)U*dCpw~$jXw%8%8dyIN+%ScH`dxU|3qhAo}wIK`n5f9N$7ei8Z4T3!Kn0A6s8t zkGHWU&Ad+1`X^E3Ra0gYPPF;8JzaBBt3JdR-)nMIAH{Ch$E@Lwep!fVX)*XIuMzvF zpz39_>oLH7Gl2u%p?bTI;@eO#k+3O z!`~9%aKjBCZy!Ydm0aW4{{VztoNed(6n8)IgFCEhc^4te(NYNGkt!vUBqcylR46{! zy5RVyK+p=#@fdqal% zrDi0-8BZnMP7~2wK^=;Dk!JZutf2iXkmfOFR6_e&o*!`xy?2Spi9lb1`f7x2g;J z!!%}}$O`gyQaalm1ql+qMO#mq80D!|T75nEC3JI!ojJeb$;j+yOZx-rp{)`mL zu%LS-bI7xJ^GV^$W}C^KK=mH`dV`LMTxGS?h)^zGl~OE>3!4I>;Z6Gff7On2%J8*w z&vfeN5k~V=v%FvsE!TmL>C}Y{S~3vwe5F=IG%dZOd%BZiJ?(?@*(q}hXv}J9c5Mf0Gji?u0H}se}|&$kE71TgDdl+%4A< z87t<9DLj&HR7m6}W0CyH;sB`rr` zD$Q1^%JGCk1>QA;k;t`RqM zx$BQwg{W=f5;&tYm9isFLd_MO2SQIK*p^gL4kwrkisar=g$&+mN=w_aud&CHxNSU^ zIxd-Q3^nzVrC3u87cuQ?0DFHda^j_?0X^C-%Qu$tGI9yA7q|Lx!A4UzUd*8;x+T=7 zD$Rf0h><1aq>lr)lwo3=+$tN8ar8>!qlgHRkoc=zL27!){N!6D_SvjEpSB@=5Wc65 z+mbS6x|%HNAk?){Nq#I(sc+ceV@fql1$^2WUTSJ)RvWgJL)hOR1_jWlS0!Q`TXEcX z1vu<6MrvIti^`|o7?ox>BOehf&XVao^3$__g7qsY-TU#=SXYLoVv#)HNh7?aS+BML z^FR#0!>Ztr#R)vp89{~CTltc!>?mpUaIM1(Q`gtGJ(>3iQELg=sQo6UAs1ukqj z>T%-ax>rAxNhM)YKpQ|?3v=5aE&=A8sHclB+Z1wd1bUD4Viz`4!lW({N~WR2aQbb1 zr>E58=v?Ny=~$GtDm#6COPKqR*W4z1eTK#N4JVOYtTw$I}u8%VY^& zVvc8N2!OaC7UuT0J+g{P*(wp5xLGPAVR2<6*kgiYMdO5vq;eHau@PoPHowy!0V{&| zT;ZxGvnEE@Ov;ul>p4ufUVUoxSUh`oh{&H2P&DRoLB zcJj8O6=Bt_etYBMrp%N<2$chFx8;shjVu4qF4dU|hd>8HMXl2s94b;uW|MP+7}(2u zuf9Ho;a*+0q9YemZW#2(%bA71)ViZ99j(9zZNbMuvb`5gwJ}tI=>kJzz&Pv$%jad; zT~Q)30~hp=9&O(eFE&b`Z!kG1HVc)xu_GL)rdOFKN7)}Ck2b#+$Dyl-I4^3^7}_|j ztPek2a!TkgGY5^rBKm*~*7nE1E?cViCTDqLf;1(_+&2f;brZ!5A?hQ@3*1gJdD5r%cc`5{9)le2*dS2Z>JapPbuU%9o?1RP(saMRX zjiY9;B#~{zi;xGm*Nl5p3}JnT#fF>qBerYfM}c{5L^(!#C19)(M>v>JO+0K^Tqu&C z(hbKK{PACY613Yy>(ePZ>4u}mzX&JG4sBDI=G1EQG!fFnMd!`}{?S;uRU_Y%`D3p{ zsx`XwVrdbn@JC+>Yy3Rdlru-Z^(zC{33!D%j49q0qZ}rE_UDXNoa%|Fa0MgH^d?1|O7#_V)|JJJEW1s=+TvEZ z!E*2&bqmbACdsM;ta*z9S`r!IiUJRh##*`z}S~)cHQ~4RBb>>T}o)oRV zgYWz?XQ5QQT`8>Gss%k4mtxms=e32$wiyE{OUjNlbHy_xk&vViw)gFVp#hp#%8A-E zx;P|TliZw0z`1jwH%(PCswbMDhE^kO@BU0r3Jlj@Wz8ilK#S9Ug{^KmIQA5U$(u0N z$wLxT!12!}(`z?3=lNnYNfz3+LQ1Eot5H<(dG&;nKs;Lfe(ZG+y#`ZComW4atIv+QZ#W;q&%s9a$ABT8d8Vw&yEJ-O=Z>~tCI%aj z5>)*KzSy0i1oC_mhs-K!6i5f^r5j2z9{qabupx3xizaF~p!s%s>R~jHNWzs0A4@g5 zTkVf!a0H8|I-I(ZiqBIK@>xdU00DjPYZ3JK%B7iPKsm?xxf|#bJG$4gn5Bv;hxab zO!;u8CMTJLTW!~Hu{X!9DjK3voX0PawOrFG4WS<6oAn>ni6utn#Gd5)rrJF7IesKl5^V|-gD!^evK>p}-DNE#GE1h?x~Fa0 zSDoYE?m$3)jusv`-LK;calwzq_fMEya-SEo3gz7no2G$5Cu>#9xclDVepujf!OQa3 zui+VV_eYsa8^wCLlppPOl}_>qTB#3C=N}F>-?5bwxMb+P)cC2I&`A~ow zpf^2xbjL%CwMK9SsiHp|D(NezsLdTcI@awGs5{Awum;EJ&O2`!Ym7##hu}*FZMRlW zF@U7|X_tI%6rm#4Rs#5X*JcyV0a1`(Xq%RXSQ%;HX91s*4S*-5vE(kd{%!!x=jCHrZJugvY zyrl_~oZhB*=&9LexFD}k7U!R)IVQ?LB&MBZ;s!yZnhEM_60vQL)&j-jQt*y9w+%Fh6>46=@0MH^u5;sk`Hm1+=X051P&Zjq-<6vN|lX7v?uI~Q;Y$C>DI&UQN z2UJnk>NSyPTB4ehA%+TgsA+Qg$?6w{VvB=W(y1x6)pAi!gE79$+&K?T~~I72FJzm|%u&1zqD(7fcr#Wp1m9Y1|!Bn%F~3 zOat09MGUHXO#XtBzaz|G%;=5Gb5gi;+H6YS@mzNYrYvE>+9i%{lv=+rtzyqac0#jS zV1E^dTo3{brRKI8w?8U(?knqVqS*Eq$;LU;F_=LlC4vKH+hK9_$Am7DmlMz!>8RPI zN$w8gxm2FE_Q#9m98Eh{M_9Ac&UkxG9jprdKaM_MN|*+XT4vrtumKgi0x$kte7=>% z8d`f0Si> z>|%;U+)20q{mwXDl+9B|9D-3SD$>Tm$2RSb+M{rko`*E~(B@#tDsUG3Tm8cxl@uo} z){ZxXw(Zt?pGXHEN{$m;xfWMJU;0S{87yu=vfTB=z^+Uuv`FGC==)W`Zbsm5?d^|A zUjV)cWhPmrhzQlV7q#z?g7k?|Ly&%t%o{PICAWgcJNNI2`c7zPQ{6;0W~R}S30A97 z(`DI!v6301ecW~%0p$H~Ln`Ih-v~;WZ2thVP+qshO*Gr0ioM!3=t2>4I+1WV!Gjdu ze@vw(1o`!Th)UPQjW8#ISF9sqar&lmO}MyRd~q#q>(4`Z**Ik$A?W$0N2%0NQ>QHA zT3OAx?8*;6d_??HPUFQA%oD*DQ+$ucJqsl^VNE`%h9B0037I6j+WiL4=YUOSoyUSZ z(cC7<_G*Q$g(r$)u`u%~>H^v}PThtIra{p|QKSw^Fv}{T{`wnT?o~yDIU@ywDPx*c zts^vWWs%fIhB+CQMef%;Vluh{08sNOp{SK!@ThhXFKwXz0G|>8WgJ0V40WG1Jd?+= z8BtYFZuhtF$HcE-%6O;DrJ${bP!*O00V8#~mhJY$WuU1`iy}2%Dy1~_5>-^i^72#y z&wsB^=Z@ON8LNKX(!7?3FrufZsfw%hHY}tYT;r076(A*9o<{l2Br?)e80TSm2H)S0 zT46_1tSq6`)GUury-1QGK{mC=Y)%k$EPIzV%w?^Tl_YB-7PvkBzm`4%6kQ~h^0mQp z2H_-DQjh*IZkX&S-g6j8=SU_o$2CpSLl%s62K*6@f)(Hs1jei6bu<+;-f~3Va>=o7 zE=U*W9R`)oa9bcGQO7jVZc3B1+%#-D0qu{X7a5Df_fG2?h|GK4k2`xP>3`pk6ts*d z46>i}lvNR|O3rU(?_r2sQPfO@{K*7x?K_fGa;&l&Erq&bGEq>!p)E|z!ESnur;WJv z4^bwI^=jj1F4qR!TkDRY0?`G0K~+yAk4Y(}JY1l+9N!&JV&fqPs$i+cQQ{SC3oKQr zl>jgJOWEu_@!_Q^R^p2+M_s@lDJ+-3}878w1D4J zY)AkqDLXGOS$&GqKI7oWOKP$ZE^_gX~qW1+Y`P&^43Nrc8B&=6?5t4RxaH_j|w-E4G1=nU6MixKKOfpBaU zPfx9}Vh*JW; z|Is0e`QX=UYJ;67T9km7Ylb}mHy7=XvM&qL_=%{ARe>dsHupZ*;D}OZ zl%W-)K3t&y1G&2!d;4S1x);@Qf*7fbnEgbXfx7m-BvI&)R!oWNw)azV57+#d^e%K> zK4q?()H1gx=q-+g)N+zS(S=zIgffyqwfMd|Aw&(+htB-A$3<2R&r2S05p1a?D-RpC zG;+ zS9X#UZR~diwU0l$jCRun4E6$~COV2-z8UCHRiy3hYNAv^1)3OOP|*8OsGQ472AXt-P8u`20kh4<~8zkn(N{FHY9S z4&iLrDXDQsI%V2Nno(2ZwSHj|K}k_jN=O1na!uQ~=N=9o(XuDuBd0XU4~ZG(T~+7B zIIco0WBe=u>(A2!95Z1+{BiG2RUSM{CRm18e5(Pt$-3-&eJzh$gbRw8@=E01D`r18 z7^=$EVYujhTTiwm^l%VP#F@I0<-R23`N67LV=zk};0}0xwg>lP&V++yFs>Y$qw!KW zA!#eJ!4k&(5w~tp#r~JX!i1>XiV=3Gg+`!#c+yoNP>t0p%^*tbxJ~95suYH1J;?U^ z8J-^_OZ>~EImBF%tRaDfZ@TENE?I3-p+Y`l<5@i~)*`m!6ipUD>0plY5df-Pq`sN&1rOkt&Y zWn|g~!fgcH;y~pQYFDRWtgFrCj%d`<(}Hax+!iBnBl__ph=d#x?&PmHtqGYyS+Xg4 z+VF#6VbbFsv`A6ZFlUlQnr0GK%_U4~1A}1_ivXZwwvCqr&DRdiKDT0&9jL#uuGS;WZbG6_jh6R6R5qYPHQX z?2v{ekX&9?^ zaYwv#A7_!fxpz?H}QO=lP7z2gxTM6bff}rB1bDsBVUUC5#>4FuF|;< zP2uUNsEK9#VR_FMV-(4Cg6W~$76|0a~TtB`+Slk_d89_a|Y9X*%tA?u`*U@ z$#kcJ-Za(bni7sI$0F2Pc;#~yS)PsxwT#G=^(*W2i*DP-<~Qw&KMKW+K@J9FgYCDH zt^LvPZ$xfZjG@_}^Joq0drT+t&l`D#om8rlk9(->r|Jju#>m@&+_9#%b=FMw9$#*0 z@Jr+ve53{=W?^gJ9+0PK0Xx^cdnI>(byAWY7FU&h<31 z&q-A_RZk=B^5Z*ZWj%@Qd@QYx4X_KkR11ufpwZIBOk`wFG`j%I-lo5MpL|!V*K_qL zqbY{y6U>w#vN&DAc~iTgA4~x^ zy_p(Vs)3-Cec|1MtPWD zq(Ch?6UVM+A~hfFjm@|RoGhz~WiMFA(tH59_j5)zfpWNcZ^90p@aHXqSA0NgSn}AZ zNpq7?%92ycdiin_W|y$q1-UjS3%XjEiw>wd80&o&9`cC*FinXZ%mMmP&&2QShErsj zYiVx*G@UM<%T+cU%34tjr?4=>y)Vx#(~Eb(bhvvcnRdIGl6(0s9QW1IeUQ=J&$q#6 zE_qp=>+Hfz<5FhTS*~FzyH8m$m4*8Y@CVRf$6^4m5WH?5E~Zz}r}m)zT7&&83~I_? z))d)Smpd@@l2+uOw@h}|!t*R`EBcliyq>Zg&n~N)hPoZHLsLsLLn<)t9eD%awj}9u z2p|!-Hy+MtcT*E0L%EB6KWSPc;NSK~H3mgUnrp?Jk{w%;NWN6HVgS`a8-ip;^h_;& ze-{`IrUX0GKf!js4%td7WxM`!bn$Ai)SnKz3&p7C*Ix`8>Kv0cYe`X)8LvYpeUnnS zFA+BODmm$FNrvK8aE<_iN69yM@!TP6;oDG1BKwa}{{RP?6=t3#XI>X(YmxZJqb10* z31srdcT7y#O-h?tgn*S>o7`WH;9~EB<5ck$m^+QfdO=?VSakCq-z||wY`@K>`On9Dh6rIAAr0rDU~PPSy_BR%>na%31xDuG$5Z?TzdUl|0d~Q4n?Dn} zcAF^i5o&&R7~s#EB8v72M5q-Bke=QB&p1nqs41DvGMeG(mxu}(on%R;Y3nA*wPr`E zHWsTM3zXYKoRnx??Nd+7+6R-tR7UtIEoPC*aTe3-8rzVC9bXMHk3l{drLCOl0i4YVj zvUzi96~yceHbPHA7pTE)OHW$-lg6B{o9F&y##?GMepUD?Ila5|$EAzvWSjC%?W}6% zoXby61Sf`1!(q_z`C>eXw!D)m2BFLZ^Cswa2@nNfZ;zUytY^g_rn{p2O+WQgb)l${+}|YQCm?_NKAngs{!e;zB@y>i^%15(g>EO z1(G+3L9?DN!yim9TMhyWNj#HflL({{v=RcrfU^Q|*#L_uq_o1|@Vx@8q>|FG9M4~N`iMP87!Ra` z+^`fW)bwdbG(v>0s=$D4g6WynD8)3k;YU~|$7$wtD(W^V;CtYsqDeEVP-fWY$hi!p zlEBmhAk_a~Cb?Sj=V3}Rx4)TI8*4OKgXXsHhfpfg12P|x{#Y`0i5J*TU*Ch7+ z*z7t~Zl%$UU<2<{e6LwgK^EE7nm29RiMy5^fbV=pSt!GafiY`eU!!zJrp&1`7}e=2 z6U=KCNjPv%QEt}9Fh;26)(_D4?euJxh7{6lb6`h*!+!Yig)lHu^_0w;)|pf%^ji0~ z^28>}P-HJgnpstt(zB_t=e9frasexh!IX{Hxc~u=rdLr5gh5ce?{XMzBKEbh?84_Q z(}vihNa7Nzp;m6Z_UVYhUXZ%ez#R<9Q*ENe-tBCAnryxSHq1jt-dwwRv)T(`45_n464i_*eo*R{sD-JBd&_MvLV<&RF$D3=gZV`NxDW7*m4C z_K>rSUiZDR8-kZSuX0-ATL#x0z=`Av_rBW&zBz^D%Hd5cRAs}jlm+k2 z_XCccB}C!{m#E+r;GZrrxb6b>^y7$Ji!V~oMy%|NOETG2IrR*B0bb_;AahYvgv%LQ z3j#%r$G#+$$-3=Mf~ZW$<-~>0^o+CG89+f8yPI_#F(43x%$lO9FfeH2C8J`$K%IY%Cy7xx(6|}5 zRJ_j2icQr|;o}{|D8uh7iwWmhUMJkGa(%e=$I>@ZUL-Ds!Po;R-kU)t+fF{2UTnF> zk4faTgh=Xo19Dd#M5q9OC$%XDYRJs&mtx4bwXg4p$Wt)JyRS4=5>rWNNp^5a3VZ!= z!<#yyX}S%RnwLCk)`lt9%JT1W4?ms-G~qC9T=qLJw8t-kWR<5o7?HG&q?~X;Ixh18 zx_2^B-M3Du&r5d4nF{wXU;omS%TqW&(nbhkIvi?I3p*uzmZb!{nLT@Yo>YDR0IMFv zp4sC7#t%^W*30U=;)gRVXdQnsNhujwe_QdB8@zNP)X zaqd;vd@tiuO5R~4rNFu#`1%gZ;_z1o%zwTFNUE`z_$M9ZP?sjz=ilX~<8VnVKZZR4 zd>oZLCKU5GF&Erg-3N1s98uI+Dj%6@Dth|FN=mSiMs7vzzTHkZXiR`nYRD>TFSvbt7$j%EJg?Ep?T5Deq5rq zf*iR-gd|t`E-4E|8Muxo%%aLb4-BDwK~fw+my~;${+ucmP>Lc2p~w3~}vlKvURs!D0|) z?g>bm8+nq&wTEzT$mx$@6&tD++^0H9#VH$28Q*euFI#rUE(&JVCh4xKH4;3MD{N!9 z5%{+bnDhk$oqqM!o;h<>k=~^4QPTddI%BAX>u>RwXeWk>NYNu{M;q?F57gu6T{Zbn zcbam|D`?V^YG@-QHJOd>2ha?02(aKS_PS=J%;b3zo|RcZWey5hTknquQnk{EZn4yu zn(EI92VibU9k3x6N40d+KQ&Syl9I$0Uos^=rBm4c>~I1rI+0ONMVc&>K&g-?LU|VV z$Am)lu9VLEAV(YjUV$ME$Vb_QX)6)h5cbNT{k~Y3YpWzM{k1963!&0Yr?BUzy7*vlc?jBibeQ z9N<%`VLGIA8IX#e!bfQdDpS3Wx7!_tt{mkK&a(BUkj#&}kQ;I3Z-N0rmFA|5(a{Nf zhL%{^KJ`59?T$f}(1j#IYw0ri<#NDTtp4X5E{T;Bnx0?MQpZ3TE0SD~!aeaM%HknR z>hoCXAXwrfXhJ1x*zs(76g6FyK~7l936?-uN>0Y>!NEbvc?VR1erAF8BnM#xJ2L*y z(;XYGQ|4e))58=6&k8=|^uX23 zYo_Uz4W!$Blovwy+pK8CTT*FyH!WhqzIhfvs!IkaIkR!o+ZnGL#J3h9y{kvz6(5Be zy{Vdi8LKo5J}YNhrkBg9)^zl+rw#Ja4ifag{8UtGe_Y;vNJuO)ruXaqFgPHL%wtEc zGw1ODH^L2)u|>k8o_$9aW$?|L#!b{;;#)*&3fd|?SC&*%M@Nyy)tQ!DwGNc^f(G*t zv`OhC8)D7C38hjZbovB&B>w<(U{s=d#71p5nAg~=o}TevS880o9MLpQ8A+D+deEM4 z_{B*CV``_y0RluX%}?RkPNQ9u#V3h+v}}LvPKp@;ARw$ZuffOy^r`?9?SU$Juv~| zBa-dda(7W9r?V7wnpjqPha+^7NxYAx@TRUQ)i+bpq8p$}&Rty|{qV*uYksqflYr)I ziqR_+wTjgQQNt8S0R&0QHMzj=Q-LeXZYl{LNGoy&LU96~AtWQqVEhLIfotQ5UoNWy z%eq!=mgKhsk8XYO$#f}0C4W+k(>|_`EYmq1Zh2iG0b`}6^L7)^u~0&R&*I~+wi8#z z)1)q7`+kknN;qdZTdgnfWtU_*c-0;}Ybp%CEZDLxTMX?;B2mdnHx(rZvPR*sxHFj}6ZC^3I`AwEF z{RKhkKs|;HHS+qR7mcDmHT)y?uN2u)7gC;+WxsFB0~bm(Hf*GcO9cwuy()u}IQ}?~ zRX0b?N&G+2nybZJz~!1ZB9}Ol>KW8+f&j$X-cG}V&LG5AW*^ruOu!Ay;~Ibk&bRtg z3RH`P=mcwFerI0+s=Km(V~0~qrzDnLV@XY@iwPEvNC=`!0(_Q~axdBX9{5{NiQlZq zZ^r7h@Q-&jXzyH9b~zHSslG0K6FSPS}j0D`0Ue_lIl z$g<(qO?e(;o9Jx9pE%Qbtxi{%qxveTCTQG!4&J|G#tV^9L&T2VJ-Z$(QC?eA?ULf5b@Ej-Z*}Pt;5EIb@PBmR zfWt2Bgd5+f?anW_ZaGG?Y+#K>LT^6j=@YK^+!KT_sU2aNMMY+M~ z*WYgZTiX--DNCA*(I3f5sI|6d4IO(d?{B~0$Q^k;HSR2us;kI&iR#%%+hC127ME$SBp zo5(B=(;bc@PjbHWXL3z7+J|BzidnJjV@{*Ms}$UPN$DkLbUYS zb2X7d7Ybp#rH4(Uy}ROO@j63w1xz!P5)DONmXlJs4rX1;LLz8?SsC|X*kV(~D4o=2 z4Czyhx5Wx{gvDK^bD;64MP#Mk&cm+J?b6sB@hV)@t-+Pnqs0ufG>k_cnA9@L0Sdn+ zszVE09o;{#9}X!?n)%pA0GlejPp0`uX-1yTT1cH(g@QF-qBC2$rq)p{O5K}_Uanzm9z{d{aw7IUEgm#HeX{>ZsVLMmmdTOc*6;n}})4{Y~ z=)1Z7*w47VZk5D^e&975hm6~zeILolOu2O>D5m*!cxR@ii~_eD9tSq-?TRiSyRCS( zz6EYLOs;4nbLJCPS6dco;>MwwYGbNOeK(i8sM#orpfCc~{3I?osw4>(mr3S&F$f&F zTbDpQ+~pPch@JB-E2J{ESQ2W@W0rwVtf*&=P0KQlPhM@)9bp}oNs*P6<~c(EKK}q} zgBMHhj3VGvq zrq(7t+}E|*IvZYYdt|uJ(z74KKN>VfPoy&4C75P2&6&lT=5_PD5Xw{g>RuGTP6vMX z#@E1xM+x1n_b<&nTxQL@IoI|pFOs_KKP4e(Y7=xo^&-G?jSn=cP;HV(vZ&*NN_vSF z8Kq)EfseDVg&?GK)Z&c*+>TKPH@)qM$(1M(WW$(d6*E*(OB|b3#qB`Ty7lf%V z&r*n{OYR7!>-5KfE*)ezq|0NZdV-U$lwG8>oi2L}7z$YSWwK~mp-U^WF4lX4Zk9gS znW9kS#ksB#9g$BQeuk6MUfkIAwmxx%AQGSF${xEfqlsle&=ATPShyXr0I3LrLBuAr z1$|m4>XlC6&+p^%$6}~a8ZJ#zWwpg+c_~^YNd@Imeb|sy2vbDvy|n_gQ`E~VENr$h zk;(gGp;lK8r25JfXO*n{P_e5P^sW3cEXaieMn`5F@5vFe-E$;jDthQV`0eO&d9mw%wg+=L zCiJUhFz;_PL7>d3Dg-8)s4n6`P2T;n39>bWY^Hfi)$Cii@}B5;w|oflieOGvjUSfE z)ZUo54eoIpWll^e)6Gd)5n&quE*SlBI8l-k2-Y%JZQF3SBKE|p70jO|>f4H`2WU6G zJqzew450(b_a!=wI@Ci~m*G!KnkxLgFckWW%&$c9MP?Zb?>8kwF%Orc5tZq61*kjC` zmmMN`%OH)n$t%YaD)7gx{+Nl}l+6)zx)qL74*7zO-;1#WrXuiC4syM%Z5=W^i89I% z`mOl7n`4Zn%3}1AOv(;wK|Zc*Me*K37u_h;aH!2%r}dtg)t22k$8BLzI;4c%B(Ql= zxCeM77x(tWfv|&ff=tgW`Nth5v01J+B@n1Aay7{@|G9oY+ zxv^f@>Lq+!WUm2<*hD*{AcA*vIPFB^E5L;SaJS#pcOC)9(xS=j*>iaO#a;3{OoS2u zy8UtVFF?KaOKHk)GpV-Tz*v)r$|ZzMh5aK6X7hG}Ww`o_`{T%zOvU-Gd&G#l({y6u z!><_oEGYBH_N7s{s8GTS0mYlI82T5Pm;cis&qoAN-U}m}U61u+PXw&=fHY0AJ@IY8meuYyobdUDhGSLq6>cv(R)sF8u>5IHx*4=Pl2sH=*&Lluxj zfE6k%I2|wsQ>rMsLLTbe{-qH7+&1-Y!k9skj$s8NtKF<)tFAJPctu?2;gzk6H|W58kDa- z)I6x7N;;aLl3oayZQaz~_QBIBOS+`}2_EKHq>^3$^(qg3#}YzRpDAxhgG)Pe|NDOtW!=Wq%E>^fT{6et z&aGrd205Yis|y=}*BwMCV5M}_vaKtvUD*_nq<=@7W0GY|3@+7k#RV)Y8ylF(Qo`UB z>HF`Gg6KLDojoNupi<OAAeYP@aN@yO^}rllTcDy$pIWxnElzS#Ou&tNIz zFOM#-mOn8FF`co-4@-6atbK62XbF2|DVRfE`>o{hi3>yJZ<UH|h7)|Aq0Tee^J=iVQ%Xl1*|`k6XRL2j5v#WZ?zbIrSmRi@9T@Re zUKK(*$H7JP?}q#7ILkQa~qci}rtaDIiI`X=Cj#R`p9UcM{Dw2U|;zSC*SOGQ;z;H2P4phfoFP12Y z2&CJf;^bScu{bDKHGH}T04drm16s!a09XCfd@1F28_&&-!r-jH#Mo zc`(a9!ll&(xgz774oaFOH$j?3m}W_lWK?tJnar)VDJh|OP0#d*^q~5;<=+6}agD>b zGl-67?K9nUejf8=TCx#vXQ`KqDhusxNSy17Uqcxfb zr=A3!N}-%Vfo;E(x(*VNc4u0)ZQXizEPs`3Y_M#c8M0ABjqP2 z@ydMw8z05i+;_(>s@fu6?6ak$p5P??9q^dZ!%T~jUVo>2`R2It+$Xx5&| za-AEON0j6lMK)VW001R4K`-rcKNb;#mqy&`NzCKgNxyK~@QWikml-^?1GsJc$!M3< z3vTsagZ1~vm-eX$l+T}JIbNyD>M~sSD}yx4>Xf9E^(YxE!>S&texn>VsbTZYl#b#r z;lAsV*wE$k?2XoO__6(txB>kq;Vx`ql|vaaOxA7C6g{ct9UHBKcKq>Y!|^iV51NCR z0j~WH1D2&HtAzyEWb6}=_zSnb;BFRS>&-ct=sLE@wO&V8l4eo4-4#ScBb)vxU!$So z*8aRaqTyOyOot8P#CL;mP#BNBm~f6p#2)7hAAc|uU*tT+dj?Z$sROU&-x6nDhQO5T zq%}sS@Uu3DJ<_?|UQJqq{533vHy`N97~$0a07bYw;%vg8hY9!i9gz7qAEbDXv@JEz zf7uAq-X-NLqkMhRRMiyq5tyXSscC%Z3GC8Rk5p&fqUqNQ-+_*^43XOo_U@t1W)A)> z_WhwwYyJ{j^f1+b4_fXl&myP-ag$a!sfEb=Nd&=6u^;hY>3*1uV_ipjHj)~9Wc?ga|vk#dkF6vc6g{C zOPG&$f}CcWM_J}yF4Ltl%SR$qK_qjlCzwBJT|0I*=cXmhgm8rrkIk%FEWVPW zk`~D!N^71kemM8Q<>W7nB=hBZ$1$e_)5GV( zBADe`l!i5BKek_j5AVmpz(}X%$+_T8szMv zT{M*`kWjnW234-|*}a&nb-#OJR=vk%4piC?h|(G3&L5df`AX#UweEI2H1)E` zk;Z_AJ03nwt>2EA8JKY6aiO1}k2PSW#~(?dqhsVpnuz#gs&yZSdXHXeJi9BPuU$^w zYQr?rqQpa)3I>QC4^MtE(8FeHN67?zGNt~A99;KB-uArz00p7GNjARLI;&f1y%DPB z%5v&;)6;yyQ9)5GkWVea+)RKG?eE4t7!c6lJ~#u|WpMuhx)(gOpNQu>=Ql5!oA{CA z2Bz@~Olq8nX-aISqcKzEO$B>P8y0KW7xgcDgU7c_Pfr9G`Hf8d0C^~D{nAu>a-A~A z(F&?)9}KCqogz(NN|RSL%gP&dfhOYp@o=I@(#t!=83cCw)q&93tuk8Jvi!ivX(YIY zR2TBt^jul+IEz75+U!N?wDi>xMOd=!SW8J@ZtOje-w(4-iU_mlN<^tGO*Bfk6%pNl z=sus8J(ylQz06m+Hnt(C zY>TA83MJ5LdOXsqsbtHefJJqSaJvP!U*Ujqrh(GAjJ_&gD>L&hRn6i9@egs2AxH$L zIh5wmqr%8(818gYX9oT8^pLo439mTP6qUgXu~-_xf&5BGL;UeGYLpFpGhBrEoh#5( zn4y=`8}V^+z<0wYI>{U9T;NK9F}?tQ(rL? zN{j)FbwB9AY4(vQX@&4wR;nq@Z+H`bl3`aT%t0#x3jQR&`7s0O z2O_E0a}Dn>jk;e}(`rLe1u7qyOKw?Bw*!8Eh61TbvgxH7!li<9&0~g%S7Zz8>Otdo zu*WR9Q##3nRH{lH;W4NdEBz+H1SknymUxcBV?v!I zf0)M^&daATYNOeN@z%(LaWN>q;5L!d_umAtLKWt2xYI6P1Cbnr_6LjK`QxK15JaZh zi36pQEs1*qd9fIfHAGz@c&3V0MpDJBMagTAram@ZG#FhTk8EXxiW!fqo@_m_^se&2 zT)d=5UoCky^%MN@)F^`X)Wwn2Lf9R|AHp&6@}`mYvPV-<3~duXF4hDCVb8WC0YK*m z8A)EPU7j0mjZfmgOXK3j;C$PX>}%3A*c86bY)&J}rOpx`(xvt?)2goF-yLLJnv!gm zwS7(G-4tRo_2-OzkS`rjgpO?0;slEYAamEICFsFJ8iWLxW)iaQ-DmG%)7u?o3Ig=9 z3bvV4N}-E`W7DOt{PE!syKBj^=_X{+vcnRqs*acBV}jKnedCh)Dq3PoMt=9UJt2JO z9oN}&2;GteYVR?pD|qA`m-?~hi=%xsT%@j)PXSHNfe35$7q?t=8VFn$l9imr zB6J>J@Vwo6oOl?$>0qukIh|Q@V~IkZKyJAEqeH%_ofrSqoK0WnNc-YeWpUN4K>A}) z$g{~^r>v%7a^}i^-E2m>Oxdn!3PO;?1GAQ83~WgP`1OF5>xGcklf=5Xm&~ur7A972 z)*y72C4mgLCYD9N6S1Z#k(&z!D&<;t^gPC)iC?bSii2{R_2F|0Dr{s(1+#f`gQz#%JjJnodEF3D;tX=`SVm=r^`P3#FhF$?Pk zrWi~ya7O(hl{QU93I%19$GT?%!pFDs!gs$hm1L(t02f-xerBi7ZWUK*-=QB|atiFw z1#_dMi!DW(7=bdeA5Zsli9_W;>H~D!Q}+AaVJEMqM05@q^D*PNSlG{az{aeT2Kz6XESsu9@)hN z3&Yw=jx55*racFe`P9prH@aU8GrG%JD&F3ekGMZyzC3Z+cE;v8l8v%WGzQ8Lt(|*= zkF-ZIvRBsv@^5yv%7QxmhB*a%<^|%Cp4A(H0TFpeHZ6}FSB(ixMJa@dS;8#8g#rEe z@G0^|*Lr$M84_4GwbH}`?T=T@7WS^NWs77q6zk*)h) z#~hb0AurA8BZiU)2_0OH-)wwiRr5iZ z>|7W9U{|1+vqw;lo{`1xesSc@*FLJ?Jh`Ec7AI%{tVQ^~JSspzQf)n!Kt*dfWRgHa z3*1}j_s0%$?X5`Z>mH5d5>qpvZ!2%tvB#^z=u2}A)7DW4VG9&@^DZt0$A7i4;`q4i znPaaRwDCk2$Y>@dc8hLR?mqbFh+GFsbIv9(!qp7>RFSj~#eQy1JcSd|Y?m{hodQWt z8_Z(MG5kXxLgW}oBZ$jynPu*MgxM#8m10hMHPt{{GJE7b?qX zly8!0>IhI&cCaLq+QSgyaRQS`-(+qd0_yNKI`}H1@hhp~(X>=P7UY#rC&&epQcb)5 z4(1AaH@?o7#&ueus7s2v)2112O1JoNuCs3r^#v|{lg`3ej@gxN7Fe6o=xx^P$I}45 z;TQ)cqE(SnQ~rd{a-t>E+L0DS2*rgBS>d5#ez+1;ghF(xhs!Fc$J5ky-~N0M*2)#d zb228)vl1MeZtM@&?}@`yWZ8HTF=6GYW7C0fG44rR=1VFSeqs@{78V@v2OSUJ9fm^i zy*5ox<;c&s$pm^-8;jri@K_25U4I26ZZ=V2dv-nVj)LLNvih{r4drB0VR7zp?5F{i z^KoR}oJaw<{*d~8Mm?44h0CresLYfDAkV9-knV5M*?FElr||Lt=YxDkUIwe?w7Gv} zuOD3vm$@WaJ?$IN<93PxJN0WY0q@l&%Y zKhPv`-w?W}+I$y5mqkwt{uQ&I5Zbb{#XVb;>CBdm_O&iko2Q#FP)obYjC`~Mf=>qj z08CeShCSiIw8m4-!hM5JYHx#}$m_}F3PGHFW_T&^yG1UK@K;aCsB7X^jk9KyH87O% ze?CPrOb64^?bic0g=Re^LUVkgeZW|FYM2aJjEw>ZFEyNgDR{T9JbSGfhP>1h*Q#5~ zqKQm2kel{`Fc*$JU2u4KraGbzK5N!d&FdLaII>iwLkkV77`PU>_r3xz&2y?WQv*cr zO-T$Z3mw;M@<$l-lvO5XvUJngZegnH;>k3|Rau+n5?Bampl92-^>$yvKKyadOmR`d zkj(c6_v(895=rnyvVd`cetd^%J1raVkNX~8X^%DWPc{xXagtHDmvhCIX}Z{V1CMMV ztHj*zP;_JEI1Z5a3xlgBoquKP%$N0Z-^gyr!hP4zCjk7;qa`#=bnG`ce#G#UZi(P8GC-HV%p!TkRKk9lZRg2m2aA8${m(KnQJMHxnKp9;i?&agx~%c9U9e8vHM#V+JuTlBJU0~2 zYJz_WqW&$^_lqT%j5bTRQ}J9$Z-F;&c7n@2GmN&Pk20Go&a(Q9qcf-U$wgZe!!^bE z0k|WM2;kw%JzUIidwGv{IqWHRd&8t2NA&I!9Zpcti4s0di(kJS+a0mep{gMw@UO=G zTj369b3GrZ>hg(Ofam)`#TVYO^Hs4hHoBe%jKqMA~R6${2_xU>uKAY+|R8_G>MVrSX(9clbSD00-RaLnJabS5J@xjBmuXyCXL!F|&O0@XUU9FI54Gj+`=3@WcnB|6ojnSom{DnAns z+4i~j$D)yH;MNG2TbyMy6_jNv$I92Me5rC4&a1i8*ZmRg?~fluxpFIo);!iHW~<{6HwdUYe4E6?L#^tw&v{YBPAKqn9Xc3^7~o|80NQ?#TD!|8wkIUZ@WC{}Uk+fjQ^xf4%ZUX-RmJDNI z4Cl?0V^fO25r>m<4+i$Pd=}oRLYB>uKSApm<&E;mi7Qvk0=`Bvm0%(XNDx`c3};uMEht7!}U0y^=@ysFGHlfK~#<6!aqOBrV9T6GwK0U`bqx)Mm}+}>5YOB7OiP$-bnsHM^fcMYwqI$ zOeR1|j_33_g(9T%@w|~Yq<}hmkF^+eUsu>`;1}j?ci6ul)J20Ipp^j)| zAVvw12UY{NIRX?_h$70pO<0xH6>^&uF2cvCTl7C{Gj53swNpIqhLQx!-62#)j19}~ zZF}REo2eYjCMtS)9yeNaVpYb_2k|)h&jVG}HqX$d{{Y&eyl;6#wQ?%6DxIpJdwqTI z1K%Y$Z4le{DMd9TQ16Hq1fW|N{j5VWh|4KPRV`9WBvPP0SvK9kwmB=ppxLfzJX2;g z<8qd7NmKZ5++dI-1i9u6E?G#HvZ5MVm-M>rH#R4ZxRs_5&IH(|9L9z6x!D#??7oz_ zxY|w*Yo!3@K}@xD(ZR7*13mZ1J%`gBf`)xCyTwkFj}V>~dU=T@iM5p5raGBI<-PP@ z+0I)99Fr{yG?19X1Aa%fzS!_Nd{_j=i41UhBY>86*ch?oi-X2JmGef)D?=1e!wDyl zSo*Jic*mi0mIl1n5lJL+1V&N2vFtJNUPfOOqLVpnx>@{?+jbN(#z;5%TOLHIMSPwb z_^A#-uX7x+Vunb3_zAFS2`mZd#{Ssl)WKd;#THsDi?lg~9%JQ{u32RKPZ;`jz~p62 zIza8ysm#SP$>l(s+TlwJl^;*OJj*v<7s78f)q*l+a_U8j-sAGbt!UYCoTLjKP-Ij(uMHR%yV~b>O9C(*b5F-Upfyd!E^kM;D9vb;csz%sb%(87Z^z;}1 z07fKh!BN)3I*^E8!DE$2mOSGlQHAl_q@W*i)J9u#lG5Embnk{B%Z zW-I9W8{?+D5~Ju`8oH_)d!2>l<9HujMoOKH%ig^=qEM<@7$Ga|pziQ{Vd)h@8 zBEgrh=Z`^9hR&&C#v)6qF(ZOVzf5wb4dl7UP)u@z8*C@AvBxAz>>Zc#yPFu$Ce`4c zxb|Uv1Pdhl+Bpy@CPoJ24#yqp5a5%hyRR__{cYKUsQs#?!F7mxfaMX;-XNBsEkF-U6cm1$hgqdAmMS1;?J3=pewZY};yLh}U^ zORSl*8b+2emdhFQOq+ow)$D*Vu+{saVz|BO>5Q(g(YY=~SCTsH{YEw;Z^8op) z9@GNGOLh9X-T|Z~F6Qq>L7{sf$YLjbp#AGIHBq_2} z9Lfaq%K3m?us1ds5bBttv+0LX&C}R-Vw8}Pu zE&w>~l#sP+$b>t}A(t`CnkmY`6WmDc>05mc2p|m-=DJFd(P@?&0q z6~{esD*}R`P+e;6NkJ=8x|rTo_7bWzg-57cr@gW9FuQFjx>p=+RS=^zamh0qt4MZ`xbPUd>L$yCw321-G;Tur zHmpi+yN){sSJ_}BFC@mCmS$Tn$51#J^?9gYX=yyDf{AtuUy*CyA4>3xFX$$!E4-rz z7ge`)9S$IPL{cOoep8$+WjaSIlOS6;w>B7B;R%>Bo@b{uw5*cu3AgoT-mj)U1{bA4 zGkl_|g=nP=9ulQw7qfGMK|{PiO0qen0h)P&!ma|KKC27k;<;gqr^@Q;T<%iHq%>Rv zakSiYBi|kiDKkyeK3z#!1k=~oi^UiwBYW8Y0J_-vWpX*Mxqe?$p1}1rj1~~ZgDCy~ z0M(Bs7tl_rUSC~9RUJaZC{Z1k^@G#b9~JOUkj|8|%?IKILvFQ?BepnFuUUp^N+DQG zH!_Wi0kZ?|k3#XzgxN($TN_URibq<5d*9T)-!Rjo|Yd0+=O0h9}i->yBfh_K3?)JU04I*1`j6U!Tg?n7Igc)l%!)16QAFw#jm zT4-a0$uk>RD);B}$I_-_C0C#A+4P=On|Q09ZYYL)pGwfa(qyV(bgc>dHUoymKZ;_* z-IQ(i@>bjx9E}~TG;=zNs_Kf0+UIHNs+s1NMwp?n{s)?E)u3{w_XKmOtONit3m2kAKLz*+!9pYmBJ}5OQpcu z$hE(AB>_UZRfwvcWD;!(LFC%xd*iUYUY1`r2~OWrIP~7?2lTPp@p7z0jol;lAmy#l zn-AxYR}K=rvI)SPrd z6^5n(>I^PG{Q2j$B6yY4Oe$I8H;%qHWmQc>pKI*t?{bc{u88aI3K9HzVmO3wx&!AP zA!?06cV>EvFsncC{baHa;`sG@39f)oP#bjeY;$HC&er-H6Z~-l-3n$hQ9DiK-djcj zdWi%O1&7m*>%v?`Nlqv-5pJHEGdA0Sv;s&Shg;!dX2#uo4%Jmr<+L$9Rb4}cf*4hc zF+Byx3->%@#}L3?;s6?x{MYs-44`Tpqf@8t*;y!8m9*D4!a>^%J z>L!eG7Diu6U%4END1Q>o{q`Uk`{RM126?&%Z#MMl3N|8KH3!x4cKwS>bQX}&-WAdQ ziP70b9#aS#nV}!wH6P=JLnK>9Adh8ZQ&FKpEMIAubS2T^>n1&>W~lsw(Dc#QJ~$!$F+Ht z+?U0yq(i^vQLo#6JQY|Bf;<=98;;B1t*4M5@3@#A`-i9Z;x3V{9^Pfd#vDEx;VKRiU*jJ!FrH<^XonB%BWPZE4C(7rWgkCy9Pq710|Uex5!ieXRdA$;fI-;r<_~hrPZz!cb#{b?w>Qu^v>KZx zNZtNUc>-n>(c0v0K8ZjVU{yGqwxB(R}rN13C&rif)ONvt_`egeYgw(@6cjy zju6JCW$KqpcwaAt-=<;l8orZM!&tB;K+qDNTS^DaI}VBgxl}B|-3~s9T$dD6)A|0H z@taN4cz07hZT%W@6(5_$H=g?Dvs zvK>#L{AkK3d^OE8x{B(_6r>LLvAtVl7FNI092Mlkt-9yH{Ex#d;%t*r z>tjzePIgHST|BYKmf?rDU*nH~UCgT|tMWZPCxwraS7zcGe6eT@HNP%iVp;bqG+&6R z1dcjlAlNJEgr`a8x(~)ZI~Rv_x!jeL{GXVW?@rK~YRFE=<&7JitPii~aVrEa9P$-i z)P4}?%_o>tWZAcfGEwGKa(Pq5CQ~_7Hn_8|P$c6B7YRfdflgMjn zvpO#n=?zsZi8MszRqA&ky|1$0k?W31_Da2{R_X5&X`fQ$IlOh1bnrtSWg0;61JrLZ zxCCyo=e@D!RT*?7@w}g^oDVoLx~=#AQ17Ri z7xMhtEk{ZKWm&M#=LyGnATGm-? z-ejmEJ;KU*ZTG}*r*=VaHl}jUBnQ;r zOcv4)f(E6Eg=Y|D@tTNeqH1?6OI+OC+!OiW#yFI!qgr%NG`e29ID;%ik&QGqj!TPz z4?n{kn$at!&@TWf4ndZ#Sy@ns=^`T#2U0z-E8i)t3OyQhuc?NLZPPjRkS?O!V0lEs zZ>E}#zOrhHSgybY3{N~`qdTvcN1C>iHG!v%gccU{TIA!{RO z=SLl!udAM;9tj5P=W_}(1x&Kim?|PJvAHM*Bm@48cL-U`mC{PhG&2wxHvr1qdVAj< zIN5pvosBJ!=7}_M7pIYi@710gcWe#Q5Q}aZu2AgHNJ*!mSt5U$PC#blr}{A?Yf6dO zLd`CtGLottkwY(TxBC4rf`LFkn&K(hl+>h)2>bBI9Ri_qPNK_!EgN~#s;Js`5ceNT zW1yjvsU9i5k1=eNr0`C}$i~*>8{&MR>XwS8oxz#<6z+?}N#T_v%&38fw2Ie1o;Y<0 z(Hl>Q5$otw(k)#}PymJFC-DU)$De#d(IZA6J4CjlHFacvB>^CQ6VEu5F>?BZByU$y zBw{pfuX0J}?TH%D6g?p#$qaQ;0VUX>-Rc{=4!HD%^*^U|)>&_IvYRltJG*0orI<;1 zXL;W5y+SI5;^Uz|za1}}B%cNMX^o;*7VEmg!yjgq!DW)9iKC61cc`%2b8ayiH&X!u z+OM+N6@j^sgVg^3EOfm9k=wfCOB8h@$zfs??hJZgrLoJM3R-OrASo3-TTx2{QZt38 z9Y8#hiq0ywVqsnIG;*{`b%mMXF91;hU|QqUz;ze~N?_K26K;6~H59c`qCAyr&;)UY)iFak&=4f@}&?!z&NOCN&(SxU6lM?DQ9)@D*O+QDMK zLQXz*DCid+gaDGeX2@%5E8(D%lNe-XKZU#g>={Q98t9VaC}y0x#=MkTi&RZRDWcAj z&Ol!}GkwF{{{Xw+4G3$*wIu0XO~J0@FV9smwdE?zJfZ_D-rk#WjsRVk8D3TQv1qoq z=m9+a#yVaDIxh&)NWp}JDljJI&u;hHF|d&rSp!L%>UQL$ z{{W=uph1>N63T=ZGW(xwKwFyWfP7gv=*Nblx8@auCMA7~)E~d@z;!tzD4A0E7I{`& z(Q3m4U_75L*7vdc;u+ZG47Q;(WdWLZFSC{9lEY_!n>d*9!- z4PspIo8V{7HZ&*!P)e=u?TLbfB$ZCn)x`Ob+-?*l?Q3J$3Tl0-Lsy$VT4YLhCOw_G zusDts#-wPY^$aRtgo>AIo39_g`mx+7O-#wWvs4&j5trHtJ+ai$wQo)=tR*|IRtRT zU2J`@kcd`VdMPzDTPW(Jc0%_A3+*Dre*8kDQSnl*Qx}~WcMG@+an$$0EnE_!8jCWP z2csnsB;}W zV%CqP*QO;1T7zZY@v`ON36_w>wS=7m4w&*6F$?;tyhlWWoQS22mE)z2?fkLZY`G~r zQOlmv#aMwvv8Y4-TuL7b15YxBJQJeSMBzZ>`L@4IPTGh9+@=nQRh(yTvJUmpA|Q?tZM`_UMX z8ogXXy6Plxa$9u-TwlG1`-VLnR;Ooxg~7lur9!V*(}(i4L`Z}O+ww5Uf34f6+rBt= z6R3H3uW8_#)$R=ES;sc`b#yA%B>8zwGN*2<-w^tH`#coG4&Gl$9^|NM4-klwL9UgN z_}VghZ%O|E6#mckg;c5YIsQ{D zhQLUaCNiH(1m@WIaZ|~3aM}Al-N7x7QFw_2ZATub$|Z!M4Ze|!bJPz;KKMxTU3w*= ze%`{p(`x?!5-1=L4NH`yAxf-EK+M)Z?-=vpBdjk*6YchDYlkt{sUdIESyDN(Z(24g z!~L$#Esp*ZJeR`*+xGdX!lzewkyW@hf0MM92rWQCDc_Qq`{5|r8qOP=QhX!Li`Vwe z;w=I^apzf9!pgUjlI%&~55aMMp4{_}{u1n7vxJY7@1x17=RD55SwcG)9Sb!xZQqCN@o@a`W$xz7q#!;o*V1li&U^eav;=iuru$N19jAK=MYD#|)Wo zlF~;d!oJ1;>_5`z-R-Yi-Ff86=4kV4oPzdUJ9D42`-d~iYW)j!>sRnbKc#W>| zTCBQyOsr9PBA%+Eju}!&<9m-=4&;yEalzsvNV(GTrWjcLkcZmCN6+E~K0{BMR8mJp zmD8myH9ZqZBPk!GNaeb2az?tdOF5cLo4#X|fntGu#jZa1>8C1$iB8#WcTJtsM^{XW5>;T~ zxZ1$jsU3*5uyaiKpPD zD<7t4UFMFOnvz<&nV2jvM7!jbk3~fNqx8jV6hmZ^02-5F;(2rCpW!LzHtbi^!cT#H zN3URyHP+Q%+V)*5d5cRBWXz;Od5zWmF>nvmV!2m|Tkk+yq@*b@OMP`Aw=}LJ0@B%-{GodwAE9!zZrMr+#bC!qP1f4nZ?dOg_b-6 zbRC-ZmD?#ui!^c?dvzzi=@*STKB~{OUUW1*Y;vtbO$*i0&Z@8G2mz7fv-(uJf;V>Q z-ycv7dzxGf2LeDPwgKCV+GQ5kUnnE53~3`U4kp&$NbJ{S75F^yn=tX)!rehrsWWj; zsI>gGk=Iu&G4Fz$rsyYV#{{D*3l6r$nzjM7+~$nY{rDXqkkSOf)aW(mZO}Ao)IA%B z68AZUfMp#hachTVoDXihs9(Tu#1?(y4tJ{bUbD?pHq0rL=Q4`lmsnb&k_kMyueX9q zm30TFKIa6#2+%}G&e^`LcphyfM~HK%wZxX3l?!cVmL97}9gb-P_JlUj9~D}gEb#-x zYRy-hK6l~Xm6mF0rH3wy&Ql}#G@$GOzZJ#L^l%k?ICE(=qFmxLSP*H6)^v#pi|CT- z=2=Wr%Lj1q7+x$4*p+NN8u+sC-^X1?9+T2-nl5Q1GR~3LQivikM7LrauFyU3Jzf}T z5Fo>hW&{v5F%7=SZ=_}pIf2R==*s4}w751~m;iMOAD{ercrm53&(L#bd5uYiPbQ+a zmXt|H3x+CHnDRh3xg9YhI9r_1;L=1$B!EoLf!Eu0EobBi?#RW7#BtN{`{pNZBUW^gg;Xd->#cE`G- z4NjVwYe){W#6rp@x0bp#RAWi>TZfHc`vezR%grOj9+ zEVNYSrDS3Q^&hfTy8ST#;f2nIusD$CTPqAi5_4;=$^lrGl3p7R3^{|tvzdVm1lkU^ zL`=R6voNKCvW^9MYRDm~hE1h+$1vQiLFjGNVJ|?(2@SJ=BdeCcxv}6{QAVq@Cg8#E z_5|oDY0mWWmu>nH#yT`xpbMPmntaHD#W^v=5Ug^Mv~h5z*gJ>P4X6l9apan2SL6#^ z&h4qS42*wRb1LJz>*u%f#?wdD3ot0%;a`piCAL?eshXYGBGj41hwdMzZkU8M4wgef9DshV2;>BU7LqOp9NYtrvM&ir#!&<; z8aZOKSTw#;Exy(RzB$Uf0PL1UMv+Lz<>=>?WVDY_K@`s4Tfeu{9>S4&NKqt}j9GbZ zY(`T67CpGfL5uA0zonz7k}E`%kP<%}6fwfYeM;lpfks^m(WR22Rch&Du9M5!?L9h4 zVl7~#^taO*+ErHPm_v%^muDo~Jl3I`V$@)riFU*Drc zHAIpn6t#_S*HutQG1$BX^>r5Mj|*i-(iGnLB@Bx4%ct^5PTL6+Dv1bd^|0&tFfztLQczv_h-wD#n(pWuM=H@yc~n>KG^%ynaxVv zF*`0)RcSYfXt#I|TTcOcMCXNmOK>uSw>z`AK6dSuO`&N7EeoTXdE0puS{;MkU2ieSo<5|Cs%3R8&3@O?4=Lmra|SFsmOCzNo-g{8ndnMz#iki zA~jphNNJFiRs2Ed%D9q~^j3T#0IMI90!6jBHtId`A4)l|9Za1QO?Qmi7Pfd*KTjgY zgd(O`T!#aT5zt_U;#xH*H{r{aLHtw53#&&#nz&_c(o06j1NQvSI3#0R%?@yNcO!7|E-Z|toVvT-VHfgDxkjE>iS9T}a`QqQl9Jdz3 zy7kn`c7KSiCsZQ&ytg;p2oHR!W^0bNBd6z&Ju!oSqEu#skL`q`F!+km?1(6GEbJ<` zspQL?p%&)KG0?^^YJVjR`Xp#C_`}Ubr}2-&{{Td@Q|bz5klgRerDR}#q6bTV8{%Jt z+Bf`^A;6R0_{>OV@q0>0OjMNl%!2nD^0^R|`?e$;PMP2G6mG$|e~x0~Pvdr$Nq%Aq zY|`mucz!{Ew|k!W_u&?E{Dm38xL;n(?MZ5UUec>Pl6<~whCyYCXh=mTrs8@7k3JA* zKgnF26a8rL&dVivXO22&FKFRP4A`)1)VIrUBOP`g<4O;n0D~y5y=(Pnx2xE-G$zry- zBw|7#4nbe6bae<}Z^R3=)SqkPlF|_j#Wtp+y?3R}s7$j(6-g*mw&re!xF1Y*=D=ODuyHL0 z%grXFp^=ge{O~Rp+r9D2n-^U(6w)C$Wx2HtMR(}xnx=($beTC)*6H-e50E8GMZ%-9 z&c+jJYB6c#c-f$gnAx`6-uxfW5xL;qOu+XIEhR+K?NX~5LwHz! z9D6Io!fFd9%_JYA2bf9=ESrg2e++$|7r7A%wH7o55HxBmJ@3#D;g5skRm0f< z4KtjeveQ(^O(cxM*670g1NXs#WbGc6ZQQ9Vb^R5~=#`VVCzo-lnn=|x-^ zBYW~uShFg3vq^Qt{y;D>XZ!$H$CcWl4g|o#1!*H404d$)Q-0} zA;dL(M3=Tgb7b3fDC2PeALouuK)MVf+}C8GsD)g4WE*|{pNnqvfsT56F8vTpg(Qznw2X)gI9@i|%1QqK zCIfaM7I5&sE?bvFxhm-kN~D5EOnK6k*GAq;|JScj#|Fx@QFl&(jrR_EeX+2TRyx?( zbb+KI60t9qd;LJ^hzLc~a(>9O_-J<|&}@}~R6kyA`|%s8N-dS4KS!u4;-zILa|Q=z z+XI?t!H7}{c?NeuB+*J!p>!Y880Rc0I!wVtYqMmks5E9Ug`*2%IX1x!Zs=0@OgTJ{ zmu6Jx4#I@)8+&4Dl@wikt(9F~p@2K4wfc}R#j*1Eh1x1{P$iqp0D)o;2OlmX$)pAo zEDBUy8?F0exKP2_D4>n9>Y7QaMVT&9cYY;2V~3k5*e)d%v~&6Ol~pwnd2a|RsQh|O z$RhzbrYxs7DW6rz9c=F)O~y3@uss3b;#OHi_9#_9mmO4Z8|{iAZabc*5*I>%u{hFD zQ`EebO4fF3Dj$D*aOYVQMv$3BdR&^>Y`INK`Dsw2%wgYm`7olXPgvC;%Ce@)sGy>! zm5N1WRwma`h2+X;!(`!IzMUDwM`>F$o4Ov@_z7N@fvRh#tzRTaNEVnB`S8 zv8=L^M5OK>!~Mq{h2xvL`4Zv&IhW`LQI|>jNIVoMCg8O{*Yl!+6QSXn6 z_=O^%ibOtTEh&h~cDmoc`SHnJ!i9L3Jh>$mHeW)qoa;E9a{Rs)UEt3$u-r$oj(+yS z+*U84X(Lq64a3E6SSszUJYj>vjYp+4u3010WjS3ebh@GwZ|~Zv7>Ue;{?c_@bQsU7 zJ3N!AR{C_{TSYghqmL%9l8T0`Rb_S8sLJa3w2>PzUVEnC4ZfJ|m0$o+m8in_QTEQ4 z{jqcGNBMBYg)eg#8AOrAaUGbO6ZFK|A=kLoV02&&>`vj>uljM(E5f_5^Fp#V;NV{^0p-m7&#{fM+4BA%}L~rX(1r1tajlTrUH`dS{TvHKt%sVdTZQDC>J; zp^I{ZpbOMq574x~Ds^69BWOP}tmb1y zEo-E4e8XkRB8?a?0>MBBspk@Ot~;n6(3P%1seERuuhbf!Q$*R8PCvC+qobr+b%vWR za7wuSrY-wj?TEcG%(N)_AXjJbS=vd`Jwr4ydP_HyuX`JCKDh94CoYZ{Bo$r}!I#ZP z4EnmRi{=~4js8{{(n%QD2H(=>xaoqKi*ZnzKqqP~Gpjs1Ii(c_t&3)K7M`q4K^>xa z*m-iG?8<*@61NmsyvQ^grkZaBvub5Xpw)5hipmM1h@FFyEP9)h&wMMXh%UO6QvpOZ zrkttp{(1Uyb=^DJ*)I} zF0aVs%BKpfF7Zj!tb?H#>3pkChWg7n&^m&eNM!PJT#{|B7y`9017fTXP(~xDBzEk( zYoT52^|Hm54QG-M_wVXP4OarFAEWC{gQEe_So(+Oj;OroR}}*5Q|L!nmg;&n?iqc@ z(+mP0A$T#!(Z>r}WFqQGu-Y*)h=uH=(tuUP#}~cVjCiAk_w}2`;u#Hr+t~YzcvnO( z;GTb&vPZR4^&;f`amw(7l~LqiE;gy)^tL=J$X#;)Wh=JKK;+)|;Hg^F%Tp058CVl|HgkmjDC-g90a%_e3^&t%ary~R*Xs!9@7Sz7@s~8t{uTU1@q0{Z^^f#+ zy2~VJ(bS@Ry>UFm2U#PM>OJmpb;9-7B*sZ${7Gwp`Jy~m%y`aiJs{~CCL**tle_Fg zqj^sn$HTni;F~b;S6*aOOC?Talhg{aR4oiuvO~4$n{Q&0Zn5ZB98#=t4K4=eUd~`< zEcSpw@m(?W!-YJ(N^?cWHlQ>-JF-h%1F=bR{S4Ye;KN<&3b++(b#`-0TFx)#8dR&> z5I620c^=~g(5arOgX+1g9n1zu>?D-C6ENnu+o7#d!z`TjY6o2I?2$aIt#`pq9=ne$ z$*Z+~ipc3Ss^oH0!Z0_Qg<1nv(%BwjkR z>K8OUrNB}ljC+Gn3&a4?B^rbKLXjFc~76{45LYFsmv&nsw${A zGor;XBu5|&NFD9;!3=1`7Q5A{mn&of!UWtC&es|!g;7O>Fq2KC&T(tp%FGWULz-Ka z&}UHuZi*it8Fqxqd?oPLS9pD;vh1Q9?y?$`nu3*Kc_C;W%yORONGyKX=LJaAAQ2ME zlO&Te2L09}Uj-FhU0f|XlH%@;r5LalB)CKd+06h!5-yGZ02~@SPw8KW+|HvS)3iBk zwb5y#TQwClaLG~T`A@n+pNN(tuh-uk;Q(b;#?kB{(msH>#n*LKVl$l5DrFp;D>M&a z5UU@J`Y`y7;rGHWoTrkW3XIz=siKNXld>N&M=2V+cJtWsT>{@I>|6vgj&ly=$=IQ4Y8`BqmFC=G8(>QDMH^7dDxjah7>O~HBQ;@J5@Os`(C9BiX$ zzfdl1+a9hLrCp2WIOLzgMZeyU+aD=c@`(s?uX!(Z4fsgzMm}E!+Al4Ijlm$6u(-ZF zUN4Tx0;HwDU_b)*z47Xf7c__$l1Tt%>POQbDCKw*-!h(IdyD!h>Z zJ+atci7V{Q`oOY&!i59&N$>qw@q4Q06r?E%g!A0;G3hIn>UhwPHD$LT6MNt3j#mUE z?@qhPMkwB%Eq&c_^5Rk_hOtXM5NX&SRX3TmbH&fooP999$tqPxp!LN?JJhCGPGP29 z%p$BpLN`taPp$AF#9kAc7;y`U(R%zkn6ip#H-9QI2P;Q5&C#ubP|>S0BPFZno4ZwQPLVbuBwu*L`r~aBoy+jj~I!# z^#$8=?{4_$;-fUh3UhtF)$BMHWk+W@}qRMO!b+$pU=5QL^n$7VeB} zJ@4NhdTeZ@Z8%Zmp>@;`5}cUcNy$G(~k!U^DpiXp&?2OjS1qG0?MrOWa}?aR}LPC`w%?hq}y1 z8;W{T2shs+r;fK@<&H-XotL8z+LOM5)qX-eDMtHGtp!Nl2hk62<&MrQotMI#ZoSlK zO<4o4n@LX5Ft}x_Rs^1c-`Cso$A=nuDS8>*ddl+cQ>62(lRm7|37X|OU0ih)^fA^z zpFaTnRO}`6+r7^Q+~eVkCuQ$L3N0>VxyEm(>LR5~oK|KPRrHx>n35U_S+@C9`=j(( zc9J&n>f;PqQg=$KHVW+3HE$ekB&tz)By~S*7Su5*JQXhckE^LZp?q|_TmfX<>PT^?qcbrQDUVg9qfIwI&JyeTxkBay; zB+GNEy)|07#WJL!m?cUPe>y(keSNTQ9}&@^D^XTLqf6!bi!W^FOuC<&j7j9Pa}(R} zx7V&LSbS`or5L;hdCROJU+CJ}FtoD9QdK0o1HeB_Iq88avT&|wgW8^`@`uf%NVXMy z+#S~4k9t7cuKf^^YbL6kuBR)ObgPZGgJrS3*R}E4tCmB_ih4!iK`D2px+i1wJ)jmA5fIah94;$`SViRyuu2|ppKRnjt$#pW?x?)?l=gTP8!)A zsj`SJX*{&%V6@0h!#6uedtx^|5lW782&Ja9zE?!)m{Qb9A+?l)v;+0`!pfCPtW}1F z95Y0pGtAbGJCCm%xKsI0WL`qrkb<I{;H9+Meu|=wk!on}%js`0-*49vHxlNVLO%q; zE+qE)2;gA9EB1p4&<4&mRe-Aq_{nOJuQy% zuSG$+;QI2GiHx*#e=xlXBG&fDnOCNwOCO2V?pVh{sH3;r9CS)&R68chuMsOe!d8J) z9&L{@g&eQ{&;ki!BuP4(?IO;*f76Y8tbw3vbxLAu5hOB487e}?#^a1eLLr4BmH@gy zMZYst@d-_(B;RLDc?;JC{YYvHnA`@9Sl!9B`hP5VS4=-be#>*`$xTy0e^AU-h40rK zmQB>{sRM5?`D940{l!25zKzHk_7Jl3Jt@NPob!?puy;h>O&~O7)jy zZBa9M_D!ep5qr4lk29}@I8l7kndoPziDd?7J%zU0{I|s5*$VdRlGRWM5hRs?k$?rq z^2b@_aN1-ioQ|C;t0@ISpDrED3k!i@Kb{A0`c%wpnL8Lx#60k!%LD({wWhQYB!0MN-T?E z!&ve^Ja*TEb-|`eNvSEMrmBlDrj!^_M(ZEI)*Kvm45*7?catzQ`D<4#TD(qoNOxPy zwM3m1Og(aH&1Hy~&e=Kqe`E{s3 zrNAMiHW&6MqhsP%aVxB9p=4J#bx?RV^$!04o;+O!FH{xN@D9O^Z|6* zgd;Az@v}>KcbLINpUo{WsDsXqRi$}Q$fSmd+koE3*yEmn72B&5Wd+o}IAnTWkHei? z9ZDu!sM|FaOd>K!i%3j&P&}~Qs*O2_ zM^MYWDF?A%=Yl#Q7rDtrt!3jrpYZ5qv+6pTDdWshg8Z~5W{Hy5SGVE4?mhYT#BRck zRE(>#haZdI4P=fq{V6%HVpPzu1oRyCIFF$LOlrz(rOYyXr%FrW7N4hr zOqaVA2iOjA_CTX`L`Iv$?JK7=reCh>VyK|YH5Fl~pU8yID5#hRY1|Hq#1+Sf3JQ!> zgv}qtzlCt!27KU!xc=~&mz$dt^u4&pg9HZazM52PSA0`=Uz$_KS3a6q7n2-WeL%g1 z!3FpP5!(~CfNG4oQ42QL)LGVm$~E&tI?~chPHN;4nMtE}^4hCv`kTsgwZP~t?}?2N zLWeXc)Snc76esIq)(&g{*(Om`I0F1!8yrMiFxT}0`|ltkh{s4qeNL%R+h|aw6ZnJXPd6bdX=D~sY{n!wxniG7Gqz=^)?p6pcgxr2uiO8TAs%nXlucX9Y&2ekk z5Kjl~h?KCTItw_j@c#fc{@L`{f|D>`G9x0ws%DN>4CyKUiLm_fUE)-YLDevM`KOo) z-4?e7Bzt|!QoJnj7C#s?-8Owfk;79H7;`!{U}UD85(=;#H(0Rx98)XNah$q{%st1( z53yZ|Z88D4BFEqCL<*>DVM#o-g`C@Hkg!0%?>L3*e$hR%Gpx#{3QD~(RIcob)~u#SSw%Y@ z-lba}-235`I@Lp5(U5eFEp*Se{gdrbhSLSI9&*$#Y1l}(J%-1@O#UN0AgB0<(lz=^ zGoBh3l4xpaD!j1bigYW=s``qR^tZjowhN(&sY$`YI=dYrAdj2xLi#%k3rv>2&W~7t zbAmqzMY|IpjUEZj;?ITjo)=T*@#PS~1q4f0Q*=^%ngBOOzlCILwTC?Ok8stULCt{B z1BBiICowVNN|nrQPLaexwS=mbrT+l2-JeobWfYpb#YpqrH%%hE`6Vqy zbuvpBJfapGBRrcNFs+Yi642JTn>*Jc`)z&a!9*VGhdQ(RhpOhWjm^~pODYms8xhGb z%zgy5mSr1hI*%B9?FSWORnz2?{KT~pN4V{c44oNP%W=hp@f*02Zh@iVA;zRMc7}^j za+nYaY0m0y9cGqNbI1^5rIPHEpgId97sQXl1l~93ofD!mJl>ZhpwhzB@yZEFM!^^W z4sHhHbJUZ8aJb5tXgyZ|*R;#BlIJ+OewZBPby|%&!R>x=(o|!mt&js6;0LgUF8GA- zYf^aQ;jI>ck36NMo-fh9eQ6A1sah2B)D;|pcszSzEH*jxT-P`><(cb5^-No`Vs~6s zp-P~rI?WX(`EEMxsi$wyg<8kqJ5uTlyTKg3msV54-W)}1`A%c1kt!B=-3L%?EN|3b z1iy$>%HSH@?rWMl`b&u)r@>0fbi>+nJ_DHiq9xH!qq~lWmw8iviO+?~ABddeCDioQ zF=UzbB(%*_Qn8(tQO3&57z=uXT&earhtq0bD?!fE9M`*ixpRZg_Zz_Eqol?#HMyM> z+#JU@Et(uoNg9q_vaLk*6>}+JO&hk@)s>mH-4R!H{rLQ`UnS+EstiDrX@CZsXr*N^ zH|O-Yx;~ZSHLiPxjyr7@^%8H`bB;@2Iu8XbwK!2OX9`p`5+hbEJjNAgDy=9(v=Ta8 z@qf#{8DQAjC^XhN6=ul7eV_iuh}*9=e&-t3y`OpD{o^7Qt*j z=e{($bpawY%Gml=b%?{7W)8QNG*&aKe9!8}{{V1B{>KekAMa>B>c~YxwH*h+I z?xP<{>V$Ug5-pqkolaTA8@)7dKBLQf5NJ$7mf%`eWtvFD(=^q&!%ayAo_}G3t!!yuXnS*wIL1 z`%HMpC45@B7^I3`V>jaGum{^81=CwAsEElShCU;3L3KQje0bugZ8U>9)ESnWnRsHf*BllHvB)H0DC1lq97{`MV;l^f|e}TD+Z#Tpdzv-r^~4#o!|2A$NMAmHkCq?|weV9rR__UuOY7Lq$@=1fi-oYh4oK zpJR_Y2NlmuIia?=s;tu4wGMkDiUp;PPdDZ!5ed)%c=_ty-=01gcMk+LO3k{S(Ps3S z>@<~mOO}qiYXwjPsbvJG9eQKOVcb^?c#9`7Ph6H0(NvP%f^a&E9C$G9QfCNNtCuv= znWkT!`A<(z5=dQVvd1u8r(g%Gdt0Un=$A4SmY-2YUrj|{Oogaw$haWxj#oGG?0R+W zkDW<#(g9?%RpnKZ<<(J16trSQDZS3cP~1RVx`PUO0afkGD(xaK@R06-J^JCf5K-47BFqrHXjUNQ`~Masln{hKx2r7O%0r zq?PTp6pv6hC$2q}*lO;OB9>+ak;TRO{&@72=2iV9MHNS-k-8}CM@)Gu;ui;u22iWh z@sZCs`d0vGq-?5)oyIW#0JJ@dk)9$2pC8jONBM_d|I|Qd+ z4k)Rsvk9WAggO{l7QOF<*vCK#)&`$h87S#sp@M2y07&^O80+`KvhtsXrVRHcgHTaP z3~_$B5VAjTN4`31`L76-3dnT+ZA!GXrmaVtAoTklrxF*1##JHLc?Dxem6Xtl0)QF7 z{bl+e<&RrZ7Y?LX%>hi5^cB@sVC?o}Bh)_l@z+yQ5EQz#IP=j6f92B_cOxFsNP_*f}0R>Oj5L7B=3n>O>jAbhx?c5R%OZUWK%dE1P^Bk4)7+EE$ zmNsi!%NH2wuR}hPX4M%{T(UT1ebA=`*jcVU@W%~O9Fk)xNRCJaO-z)tR4YnIQ@KeO z9N!jj>UaT2wH8VZG90uJK?Y-MhD&pAz6LduE{1eoa_uaV(?aFRW?Q$e z);`$treAagfB(@H{DM)_*1dPEIx9k#>CgGbHF;T}qdKO#jINN&m+V6FNfU0rKuO~q znu=!Ng6&yHK1v{0iC=gE-Nrg=r9oPerx2R_i5M0u<%0IVztbL-0A}mUsNB#jOce4* zVsYtRh3+ttRHSl;U5ZNEra443sWwfS&iREOm`eay516?}-6~F`ZJ%Dg>`m?OEi4 zdG|Qw#Y)O^bU}(-zOIEbC{pzjeiz&7`{8?p8BOTMh^e6TxH` zqf}=z$k64n(8-l;%cMaaM2hxjTZ@Z+&)*W}lsRpcN%42Xy>sGbZhuB)l+a{ZTtXTu zcBxQRLh|-*u52!GPRC)MT_6)Ym8S)ZV_F7?DVumPtaLRa=lR_&Jb8Q}S=}aAVYm$=})9HFSKSoI~e4y33QpB>p`DBgQf&;MT{=*ZnFB~N=n@md=hV|Jn z(p2=dPn!zI%V4Q8E2>kN(ZiB^*y4PP=9sdT=`6loe~}EoUFmqKDIDA*F_CX-9_XTO4J!)h2i4w6U)tf_;Zf21@KgwiIt^bJN=lv{ zWpKPww}NuCOo!BUBLG_4ir=$Z=ih<`JB2e_D9hniv&`}cVABoZ?M_vbNVCN7<~4HF z)5}dzEj$Y(yolTJ1RecYkTy`{!G!?v7s34{r}YJGE}ih6w@_uwu}u|KE_pI6W>gH( zSSh(f#r>>1V}jN2Dj>ca<#IzHkH9SHoGBvt^uPo5+0G(xh3uu-E?ZTQtvJg3DbBK4 zIbW*Uo#`kToxrx*rk5GG0E#GLbtjrG@He2i70lj_RXfEdb$}| zikjTL00teW@enPx-7bCbE`E(q5)@WH9P}D5ms6dZN|Jo4n4TFwR?EY7JcEXm-y(US z-q4gkjUF4oSjVa(aDV_rasuC9!OkZRLzV@`r^fFNg1aWBRxHYPtTGD@_d7A}szGF` zPZ|6+GcTK}<6z6d5y;4(cKjS1cuMSmzn{h*4CRekHH1THCu2b-#^3u?o-wMU!FZBdjTN+>wX(l0}Q&B09ov;@yWGU-_n?fwpU;Tl=z$B z;E+W&t%5ON>gJxI`Bw0<^6C6`N53(CWPn@5#guuRAeidKTT?dOF5ipH| zF3{B@sP$At2m8~IG1$d0ScmwskCWFg;UimkKCkL72gPrQaVn!_`W_N)cZq5q*Z%++ zUd?Y|k9{qT+21yo>n_>C!Q1kx{-W_Oi$4)7xdut2iRdI1prc>D!uyBV^v7oq-DTf0 zk^Ji}hYn@LeqCSGT^GfVh<(LhF3~NuzY5f{miHEC>F;cH>227%`&YX!KqsNz)2~LpG!A<(sHuLTN%a6SzAC>%5e_3`oLl4IMs-AS0-|o@l z>V<0DSTMTtGr0b@|fteT)wiPYP_zLUu04;r_CkF zBoo&D*tJpqmm_`TOd0Pd#uj0VIq#*&gRQ>SO|WY%8#*krYTUU&wbogJOL8w_r?|c! zwaT_a{%upGqfic{qb1b&c9m{NQ~g*Z6&6+fORcnws9p6n3X%(1rcl-#5(j)qE9g$~ zYHb@!0zF2q%U9+I5h1Hx!v6rYM{DEk%kGVLi&SYuo#~_1xoa|o2W?W^UiV}4_s7N3 zxXPBxtMpncsnywK$l3s^Uoer>kES`%a2X|gq19SMrKHvwVki~>)F?ma$5N!|m(mnEyI)Ou!1ELwt(X3!PVW&L3t`iykG4N7Fqa(_a}sA!P7@MM{L zTHm*i7g;+Jij2o2jBHHuisgV(CrfVcYra01T;vPb%rd*k&7D%Aw$pi|u|D6AzC4x2 zNlB*6^2rtd0N2Vw>ek{|$P3(lJar4lQ_8wLnOI0~ol*;%hFZAfHn-g4!U#|hzKXoL zqJf(?qjqTxh^dbD9WE{{k0uvO%Nl6Mo%&jlK|hGjmKOUyKFql$7pF=B>OV-*1t7NL zQk!`liGDHEuZ7YGQiJfWaYS}5;67?Q5^rEVey*RF=Z^_ewvz3(ib&CaOXcmkxeHYu zqAgXE~w~@P$o8WVQbQX?=Ww{4w>{Btqb|S#Jv_b(gRV zRX@I?R#E*X8}adBE7^pPF{Q|BB9e-?QDw6Em)yTM8v}j=FDKM5i1Lt%r&cbYG#{Yy ztg|=MS&nlw*+yqHP}F>*Z+a;sB*#@Bm(`H8*Kc^#Zi5=1Oy$}WG_S~W z9~U#!tVdrhA*HH#rb$3#ZQ^TKs{+Q{96;gNp*0no*4ZvgMd2G{S*CF%R0ss8HHt=@57ex=Q*gzGyeb-Ybfdy%a%3~)y)KuJ=q%Z$ZSYFgKHCxycenuSEn?! zbW+Dr;;i)%sN9BJuC_?`5&`@~+l%wtA9yI7C0Xqms5EZ4(&s|fYDqI%i4X*u3L2KNmgUob)qYL5#kbS`OAkm?^7j$2brB1hzWwRGdkkwl2#!uxiR z*Ea5PBq`=JP4MYG8p~e=PmIe^zB3w0`a3d_P=X0^Jzkq}el2`+m3SVHxdyV*I-g6g zht)dDY~p&mqts>e6%Y!4B&$I(2~=(<0ao`7j|hd#pw4&U9TtesrN}d{7R3!@E`=g$ zO7@CKUd*IQzJYK^Be59p+%AKmA9Z$rr<`a#S*LYn59uu-Sq&t0W}aG@YFbmdA(dnG zs*)I7@nYEZwhMwcOr9usuU$dnzJB_au_dYg_NA?gDt|2kBw^9by(Et`f_m63@X3bA zCk@dSDWaYgrh;2VLUoJ+FwJV5DIL!Cmv82deTJYBc_9@lB>_ zD(GYaqK>ACl*a4<9<7bn+l(a~LC*NUVc=7rN2jc>xnINntkr2#Hl6r}(>dzUg<1TX zXA22819=eoM?HJn>4^Rla50j8-N6ztO(Jt7&G5K3p7`8^Ld z=L}hks7Qt-@1otxdeWIrXQJ}t$aC82diuEJx1Ub?&?xD(zQ1f}7&1#l>$;}mMpqtN zDfM+SY8Iu6B8wbNX&jp#pXS2=P)-t}8J0snM$*KfNxJTjeyiMKP-R5n34TMU-zsWl zDvcK4dj1pb`D5Z2t#(wqQst{MK4B5_C3!(@jrdgGllI3=vL3T$>IEvBLeDrWyMV&i z!3-&FL8PS9D@@Zmizj&d5IwQc3z7`4EFg$U1uB?Cyt0G1-|6j-rFQ^nx^>C&YMjEZ zo|yp(z=6Mm$6P|FRR4nvTCJA;VwwMNb>M-}A&I5{+ajKZSJWH?F8zIoPWA zJq7Ta8f3>MV!(*{Jkd6yH4-Dl`;F{A*TVGNF7&k0d8LD(er}}Lk?r~8lB5bZ9WZR^ zq!I$kgrq>xDBqlnx(kX28o6E=t!E1yV`iXI!%#|EB)cHFW} zP~f%rZF*_B=N@|7K|rkb8f z5>*Hgs-E|~@KRk=T`3TwuvFU`+QG=MKKS`W0_h!mi5t^-@AK3 zNK+a>+7x3m%i^GtR7pJ!>ftSYpo|#DZj@G_8dEK8D+&DCcp2kiv>V>X6K6v717*&t zGfgaiGZ-(j+k12Gj^k|2HNFW8a z*6;iA6fcP>47E*CqA8G;3QIMua&3Hexm_~t)iR_(NCX=-x?B9X@>jvKRJJ5sqDKMS z=AAFop#K1I#6+S+Fqo(yj%tU3M9>_w~?i{qToq-_x7@-%$3xy21FHCdJ!2IAhp z9x%GSSp_}9;iAgkILvn zOI=``@+v8-Du8G2zARP7Gm$6=5no zx{<1BDrsksE0(g0`fPc`z)A&09#bi0h1hvwkNwg~}x0-pF=qcZ;h67@z^r}Ygn zlPG9jvRI6t;a-`Q(RTM6tjF5eqy5u>DSJnOiC2HQ(V6gXZ_=%A#dm`cd_m~vk1Gl_ zCP5st>tXJN8(K;qI$#FPX(% zR|%6Wt0tE?qIKtMpD3_S(n5V#{{R%?&d0&*i+6MG{RvQ`Xg$8&{E^>2mWRXq!SW2# zIEp%F0(`!zQ~J57TwPsH_@co396G~R1S-{R8EHw5v(np84NXQuu(Kq;i`@QrJEa`Z z=Lk;gqGFC-S1U?naMw~KW5LI!nv9jwJeGy$Syq{g zE%y@4Z+^gjSm&b!dJ64NlF%mSktBH-kXXvr2zo8MTOV{mb{xGOHiEH2B6^9Gp7qatW2XB__3T!zcgTz**YSCW;iI5Tnmy-^N0ASugArrx$J-KRh09EMr7e-=1GM_#!46oK0%FO^W!s%kIZ!lcecm&vkdD$+P)QsoF>S;^q_>GsE=b25`0ii)3Vm?aTA@A> znx4reKviIDwJxV=zj27jUlP6yu8L`zQ!RDHm=B$k%OG^Je>@8IuUc1%ET#o5BD93N zZU#wr?X~#>x7XhhF6L6StePr#RkX;IxplvC=wp0g&*VONH( zGZL+=W0L-v6!zM2&Q&N1s%Y&?op^Vs`#Nzr2fe+YK~-227EtQuEN77A4__R`{Un(8Tc!gV;*%b_R8)*vPDY=*1=DeF=Hx34};o1$H;{zq_~}a-olc}@$ZupxBX7O9~Y67mNZf@B|sM=em(RCkF);(U3T0< zvqYQnAbZ+~o*VpQWg6>KWZ4dB;HHPmVXvH1$5}y^GS5#efQZ={*r*|`*Pm=A$Ke{v zZgX{x-!fIxgcrKAL(70VTpQSp8Q86)RT5CNl(n?19yf4pW&ne01Nn65FO0>cw$2M_ zb9zp*NWQVpLpMCT7xeY%Bf_#%%2l{ss7=21?THB-kAnHM<8;0($|}9*(de9$lnV&IWiK&jLuGb@o{D5_XD-PvEy)WpIFCZs(Gc3uN=HtPsw;66}|z; z-eLGy$@hU^24w1-d#F=<5$KNjPWkUqdPiXJV-j=mgWybJ-|AS%L+&5+ke1f(#?HRj z=-|)Fcg}L@xU$_N#f|+1IK}a8@c!&pe}#Ojk+^wzqa$CpEfM1o90UGSzH`)v8$T!J zGxP+ZelY$YkUV4ITPP}|l)h(sdwRT{d*iP_cglCqdhxi@K2OZ2=Dx-8XYlmEvwSP% z-k?mD&A9&ndHqRmZiXGL@Cj82NNxgn3{ul{y{-x!+iygWAynnSDILBj${vA)AeAFJ0IXC7tdH(=Z zzry;fDEMMvEn?r>1dKrLMboJ5j>iv+=c)75qY^g*!Hr*OekT4HDd3KtZ-!$aKvYWk z)A@`KAh!dYcHZ{s6{=Mg{u*i!0yh}*#{_}x$j1%g?r+Db z^Us(nA&74w;>NC$d_sICQhJl&!!Rs*EZNiTvFZDG^k7c!sq_B;xe8|DS-2hyZ|Mu# zd`bK%s1E-C4KwrUu+ANq{{ULYhli8#>U{OVuTNq54gDo{{{U2v!cvB}!+l=!#g1%t zkKXv>;P(%X{{R}1w<(iao)0q~M$ilR@4EYWS%Q#vL-KgBI$`Qy()f6I6A zlliNjm7KpIc{y{R$8Us|m8EZoOxz<9MYF=A{xTlJ5)2dmTl^pW!uZx_FUbDwHn)y{ z2rhW|e9rpx{@CCCUx|Gc-!1+w{^3MxH()$l{nGN@GkhWvTm4V@`tW*cN9$v5H{0#r z_O?3oXAg|;Z2n^O;u=IleUbUfIg@y~@U`TzukZ&vX?)3ch&5#GACwAM^G90Ku|APyBNpbWR(%c*o|hy&!y+{NL`ERq>{hqh5I;v7X z^_+3gIo}!IJNuQ;#RmLF{NL`9m^^d%PL9fc9Wz(|0Bx$J>VMuwIrK*#jPITO%Hi0M zPpaRW{N)lfUcLBR)-hEKzu~_(nyLT~%O;?fQsu4&*SPxM+QS|m9aQM!<5E8|>!XbV z#5ef4{fXZ@q44gppseuMLe}W`$dPO5Gg(?@k(X!;o0+UX5WnqySYb|yrXZR7cLW3K z=H=kH(~7l-Eb~%5yS*a2f3@7+-%Ndx2`lSmnS}947wHOmh)Cb%v^IhvHd_qmTg*^%?an{6jHz%$n=$E;QU%sM7Nu`zvW{&C_NKxNuw*gPR zvFAj+1g{lPPgmzO#*$TaP!;JTBEtTbPi%ZCfV(8GenUVNpo)@|h?zG-NRa{!uBP3G zYCj9h7t+TpNy-$9))4mlC|sM==P-9KA-}l5C=kU0C1L zyEy{fj`;hd3&|_*_r(?780eua%oXYA(mSIITHp&Qw@%piqYLRP?6B25jPk8C(``^1 zNL8M|aG|}wo;h_eqz*}>$>OYpr^r#l3oE*%Hr4YG+%<<62cbOscf@@hD9hK`AeyS6 zO<7GrJyebBnp#AXR|H#Y7WFUy3k(v_xGVaW3aV0KjMJn@3mD;p%S9LH2XCnDk5@^- zb14B;3cH*U=4}0wk3#4eNTV|#NVcVr5*+j*`1NpXy|qicsHi-zHqo&H;~Yeic_x0>6Oj>h-IG_FE&*8tPu=B*Z?&^c`HJ5t2aPI=f()cr;*RLWOS zNkc5-OIK;r43A7CQf^2WKTKFK&jnTSbciyd(^O9)tf=B9Q+p9&0KOQ)R$aQ2R#yI= zf}T+-qeU8n#rJ#v04#e8qBC45gfZ;%qpJI_79#x^eX$~meWk6c%id3ykVy{1y-(t9 z*ZwCSggcigXQQWRg!D-0;G`zkXs^x3=lroK6QT%~gLIoR$Yi2ur6ihqroHcec)7=5 z%7UdU&c!v<6{mD)ho#uq+w3vw?!v)M>U9%QwKQ~>kya%B`C(uf-s|~d9Eip`6kFy0 z07z9Vd-qK{HOT4jh~DtfjHYuHVsy&U<@tO;5k$CS=&RtE_1c2YnV!u)k zY;+VcC~d9lB%p*rM%$fTNgJ+L=y1-1ERy1J1*QUnXF0U>6_m!FO`=Fq9_GU5@m~gj zmvoZ8N0iG|m_e3>4DBHF^#w@39^EkwM?fgL8mlP}%jHxQRByI8)wdpRX6gM{th(ft zaH1@nB%97fmNC$NBiwe!D5y-2SVNt#1#!*oewg$H84|rjlFmO6S8i{+x7!o6AfDM! z&0D4uF-EDR+?6nkk_E49GQ-u%VJfeO8lg5>TLkq_6?zgaW+d9@4*-={t75!0MKw!S zz!A_b#7%pE+*=-!gp{a8^zbQok*W9|Ve8LN+tviRjAPZXp zR4@~28zZe1RJ4@T@e(3sKp9)8IIq3AjH?rLU;on-Qqh`9u?tGFK;#p1YYTKZ)f}^o z$jzkbsNtrSsh?u8K9x5Y7*A7GYQr9?Y^teBB%P%f3VkjG?|!)8qBAH4u}V23f~qOp zyOrD(yAP-5iCFX{N_mu;f{f*PWN}S8?5JJwhF@6!0Cn*%NTD4%nJy2J0lz)W<)XcM!w;xb;Jodu`0kabkKO>3uQs z`XLbVDWR>Q*uGp7ejTT+hhN`_%A6#EcaJ-TWJ0XT<$~XY`(u*31x<9OOGhkutn7lK zNgblxMb#K{Z{da2YDJSOEtIP$$`Y0HIVtAzUIst~?#kre-<|&eh8I{h_aFclp{3K^%Qd-A|o>HA$aF#$8CD&qfq*| zjVz`h!2=%R#1YhExs~)T)HRQk&F6_3tzlu?z5f7)B71WLOCOb32TuD zMkd?I;{O1{3P^&RW{{et(^Pq*xv5zrB^6{9(6MDA7nt9Ce+R}9q^J{@Cr@lQ^gh}4Im%{J~fv|&ZS`tmVK z`=>KY=X;gU?ri<={weo`qN-L0Sz%)vMt5yNZdCDqufNvV#8?X*BT@PUt#GnL7=vr~ zXggL$d~*06x(iW7;yz1He4kNHY4cim*K~B*go-~~^hw3}{+;n>!Pe>99?rwNd@OuY zykkp)JeoH?A(Svi{Ag{+VcCa6er^r$*gH0f zR*6!?$i8|nps^tRaXNw$*(p+gD49bcV0MFVQTNA-uqAb*fERUi$q69M&&*3)5E7jJaK_vo^TI8ymeeI8z$x3-j9RLWbpxB#|dB;I;<7M-Qa8Mpo zx3)b)5ewq6t3?xT+>8J>w&C0NW7X2{98xi94BLFOa-n*UsmCRH45jT(9hTc{-nY5G z80B(G<12)ha8)MTO~0j&S74pj#q%2F&e;I~FVo*2F2PDX-z>x}y39#`V~>})m&QR< zjAUi?0s#8<$0dC-y+QiO;#C$@xIX0Za52GLh4M)4V-$d?KdWLcLi-=KAaGqbRG6#S z%Ar^)*c){`-}hi}5f?}rC6!4IeBovsSa5mA(F#c@FXJ|VsnywZdV?#c^0R!JH7g;HP^Y^8itmRvM=zbaF#aU#NdmqyJMibb;62Jg#8^J+F5UiBRh8%Q^3cik{1EeQc6_w zs44c+fq6E0x3@SPwiKYIT-K4PDqa>lm>x(s>xhV5N_~!)QBz9qN+k@OI~xIfb{M|S zbYCecjI`+(qgEhp+{crA5*a90)H4gC(e4q4qywAqZH~G%#$(M#;PlnCfdhHt3+nEg z;S4xRB2Y;5(j`O$tdQ-M4eWPDL$C1`{P3KN(mvPf`K<|uD9kp3JHZFYj}^H(Z&Smo z^!}dIu+OzK9KHsXRPdDwHcY>hf`2?^_^Kw8%Xu8XHETF$io?DL?jn51@J~@kDYPpf zCdGm8Y(Nn+y8A6T&B9PLvO<&I2Ox8{LA8pW&0=hDT>~xxcU*^L>wUR-tYFn%CF=a2 zIL~q<)tTg!R5jHQMH$Uzut;2@^kHrQ#+)#r;6NH~C1N<7W9e0Ub3V>G)SlaN)kpIm z7d1V6Fu?kgIAIAAMkUQ9kyVF6s!8Nyp@AEQ`ymcEtwC(=_R93WFY4(PH|l)S;F8{5 zW1wP4JcR0a9dQxCwYxMaTg9qduHz&RYP3HOI)7MrqnNIwn^NWmhb*g#I)#>~xsvB| zMgi-<=M|nX`gDHxkU7r0jic@KEAIp8F&}+(M?*<&U5e1ks!DS-v&9MA?o((s^xx7g z?g#V5K(GTo5U)YxTEGn>wIuTC(|tLFt*$M*9$CFrE%je3XsIQIQ6awJw42{=*B?Eg z*e|KQ({!quL|7w)ZXz?ZeqHe^IVkEj^18K2RdfmFCC5KpbvIsRo3C@T-6KW{<#;Ej z+Z?*<(3a#>%TZFa(-CP7#{^wX!MGoOG3^o76U-s8Mi_q-tQXWYjZ;^g&LA?|Fsogl zaJH4WAHN$O8KN89J;8ov#X3p+Vxg7L$YCT>n8-ITgI!Dnv=p8t4-8CTJhivp*T;~& zmBO~4$($v}BzM14jv;z3pXwp3N z&R;4OzHk9fRUeNk_QX!71xm-I($jBgS!o&|tF*4}mc$NhDf3E>!5bM@YVPEEdfy%Z zp>v@zzW9Nn%1KiDk{hW^T_-Ca6VWnNl$f%rW6YiQb6S5XhSr?UE`;SMgWcc!lYjIzCDG* ziJr~Z47JCTIy%bEKMvEtw_D?eTp}C{+eObXj!0vGy8bYISLFWyqY=2GT-Z(WL?cL! z?yG!y3@FO}fD7&eoOTSa6sJq-ip?XK)8o?9_+BUkHdkUJmG94=RQBM!m5+n3+~Eq*cRUoYT( zU1EihC|iODYoF`KtI#EVBoiEn2HpE^aq5%>?YU_j$z~^LvE%c{A$-2PbJMBc#n#1o z+#hUuSA`{Y5{Tju?NBY!%uiqH$0bI)qVp)=1 zT|!T|%TFwKWa7r(d~z4kl%3!>Ni3lPi}eQGaq(WH(5p)@K2@1xvETSe{+2mWkqeqe z*YeTSuRn|LkC&3ZOwPV(YadWiZk+q#MG3lZNd$guCy58`9*6Dr$Jtkzml$s3mR?Q0 zU)A~Jk{6>@_DO28+KPO_j;JK?IAmedo(iz;4e`NhARDV2;G1a*+AT|4ky1&P=Q-0; zCUHR{-X?l`vdswW7?MxF7>%rgj}Oct6LYEKtybG0QaW3$`~LHWbnLkyeDe)dG|t;x zSfi^8@GZ_JFNF)J=1>h=quW1WB{VTW6opnrwZQIws|;!4iv&Ui_!hY(rSQI)X~>?j z_geQ+U>IUgPCTIw{vI2m8)`i>nPn603S?408Uj~u<%V=|0pnD%rV-6d^mS`a>l~DY zqp?yzDtYVI1P2cE5u%#w^64p50n*#llgh357@4jKZAws-)8{H^<$|^%VQsq_{HqJ} z9q;{E^o!YWEFh#3N-cF?KvBu${_fc8FkWO%nrAPDzPc)T<33Rv?#Aj*WBFny)P*%B zN+;!+RR&2{y9B$nLi06F_7!}r4|Do z!uD5ay+I6O>^dp-AdGsVbD;`#rckjpb!2&hqtrUc(2;(CE*s&!RbR!Kbf}&|1QnI5 z1jEiL8C2u;hd3$7K&Q0Tu%@Qd{!C>W0Vt8w@W*HaciWqN@C|JWX@nrSM`|`fm&9d~ zNn3kZDL1$`>5A!A$|)6QnUb8DMD75w3413v^dh2DT}33(Zk6Q(*j-nfFMMHvutG(&GcWm_r;Ezq$++S zb(3mM8yN(?q6NcZU{E9}W>Wxan4zc}spO2cy~yeO@flMv0NX$$zc0B(SCgB;^4^G` zmiG4M#{*RsO=ug0Wy~g3o%glxVh_;sge6$RSO3%nv#neC?kvSNy^kt={{TE|1!gV1 z(HB9~pU{#d1x&ZHg}O@J4j<-OLKvWaM3Bgqa>xQ zl`46To+aJ58-pPIk&h*GMboCBnufLtIfMpJE7c0#+qT-vkAtCj;Jc(1`MofbBs6|x zO~vnKw+s2>wz^7)|q>b!<|!%%p)NZ?%Bn8xAo2rB|NYuPIt+rKXt_q`d`=?r({Sl^aA9L!{Pz zRct9D?cKFq*k6{!E^U;}FjKa$$!Mx!d8378b@ekK+Ii`S*ySVHx((M;47Hfaa*lzn zPapyhI3i^Z=EkaXmg}0smQheDEub4?bI#CMwf_K)1vEi2x^5tga#G0ie8Or8DyLAJ zZ?)CAVmcf|SOO$homUy_<;@<8P* z;a|vQilNFXu-a~TusyH*F^GqUeLnTD7MAPwuuZzNOJy4W03^+{zIjjP<=Le>!%)Ap z0R*e3_~>j`>w{?3$){(58XvbbGsIu$=R0`$FVEkIo*w3Y4eGr2LT475qc3G@Iop9# zMB{WakEt9t_`u@OYGwh$eR~Mh4$fWWS8CJi5H$F|i?se0p!gwnYnQK`e?ekH8!+$p z$H2;r(M^+3F3uy5lj%Fxt~!I~ zYp%HHB~1Jx@h>v)gIQ_aS(CFZMpaU^0VC(mg!*TIgTmgY4ZGu+l_3l5Iu?y)4i8aa zIKBI0)yh~)%XaeZa;inIW6nNb730fj-d1!V#y_Kedt>Fv7D}n$5j0aQ+b)bxr@t8Z zA09~StI3faUc_#dip~s81vKN-}72LFnPR@C?{qf@P zwR{klJOS$J2NsN59;pK744b705IwKAo83RnkC(-F*-+@-lH+yCd#FFvj|pDF{x9Z< z(832J)9yQd>~kyFO3YEkv|8bk#Vyn8`D2o~(Q~GdI*8&@6dk3Xf!~}&<q;%%hai(6yP*00F#Z(N$b=b`{U_S2vn=a zj{@^X%;(KC%^|3!tR8Hz$M}`{v0tI@kAYr70MenQ$rY2 z1$k>SZo?nJcUivjtyFA7rS_YWm$kd!`te!^f3=mQh_Z8`C+1@F2~+0AoBh3O&-H$I zE{M4A3L_EW`W6p(ga`KPs#9nK^sRls?P*_+>-_PtP%sB@SQil=f2kiV`61i-NHLC0 z@I#yu8jUl}Ia8xY6x?5UQTF6u3Xi|rk|L7|(+`5_;-}KOlAb|!lCqjbw_n08@WqZn_BNRg=hLB3{<^$5$FJByPK|z~~uR zivfFkW5QQ1os*tQM47VFNf~(BIZCMDmk4Y>K5_OO%|YCJkl2>}?3Ijqb_C5^QWlIN z&sSF}q8<|N+20aP0~{Q6^py#+aEOw`L#F3Y);e+*4cMnYXc3PBj$-7VJF zz6$|DM5OwvHi9}zl|rQ$T;H%5il~63rc&&#BbY^+N{Z~Q2sb|Vz)sZ{qJmKY9YlMH zP#ASK>5qU>I7*VsSrt`k`EJ)vK_>k6!AvrTErlwMHfy!dta^{R#PGQ`P}oD#Hf2IC zcd2zg#9rUe1G>s^WG`BdiI$d%Qm22CHy^Gcb=P4zJv-4-!zxM0r&c5Hd`i&=*uHXT z%L!_B*y8PWH^E@pMpC-kV>VP}u`L?|e0ck{eA9Hcib0)L(EuH{T?+jG-I*J2e)kESO<#;eeIcai{2oZB8s;3mph1T__K5F5{p zh(5<0=!+Tzr#H))XlNMNt%xVs@qvj<946{5G$mt+`C>-UI~!x-VMJP_box6!sfA>x z%Bm!U^SxpvdHZ5u<-utQM0y)PRSq(Gf}oB>E!VasULwbYm714A=I}G*^(KO%SmT`@ zG87kWp}G6xf>#Bq{Y&NvB#q+Py~We_kLnos70GJ* zaVkub6krub*Cg~O+wYGTw=3w5ZKR+JVae;e>5mHP7qVn20l2dpKOMclEO@ys-69n0 zPA0iKRNQ;pwXx)=;#U@p6g-V3w=v@U_Un&9QIL|dy9Kf5TaDI?ADb_rJ=-NYL!pgyHPaeR6al=N38 zAs3iHvy)icSVvKqMz)e$ol^s7x82Gg=pU!wH?0P5mQ znmC5v)sWnuYvaL*dgS1kc2KP6!uaK;tEr*1a>Rv?Mh{~DnX}Z5(o``)@o;C1NC9J75=e~Nrmkpbv}l&hBc@y zSGXYs(2Fr3TM^}ya4Hp^>q)Z!Y3UR#IUPHb+Z_rk<6TSiK2=$kWyR)ZNhKwfeSyF) z5>skUkfo9|lB9dv(hZI|%BGbU)H;$JsW#JJ&qfy>>U!X+bP~)(eS#Rt7wLItcYTh) zvc!9n(+0N5Nh(XH=&C5`rFDe_*D5S*dFyO?T)quUG{kdK%brg(eq``OUKo0_NpJxA zd*8LNC1YgA1?wX0>dcXuF3e+z*z~&*au2>T-#tQz|888kRch zSfqCwfZBg7CaHuZr}Xg>HDCYL2GL6s)h!cAvN^yC;cs$#V_740mo&kGmB&?8lhsOy zSwh|-0JXS}}zDhRVLVSIdta^X!KJrq(^ zR8#H>ShM}@iG!3SsCSwgVM#n5VO5rW$PZxMFk?y;>;*^achjfJGhDF>r?Fo5{ur82 zMw}^S9-5@8fzmqClSLCeX={Q;K9#^0QF_YL6%-80zHZ_j$m(&}DhE2rJk*jhiG!WZ zU_j_E(;Wp0=8{iMP?IE6p0jDH|fW>

$F@bGm+R8sJabv>Q&1G1} z;j)rK7f8z@!sM4LUz0OfvoH08F`wJi&;9pcSQzeN@8j%$fKx+cbOwsjlgxb_8+rsNZb`iT>8Ig zOR83D3>%U1K|bJBH~8J~R*S_=Bl>GA%xI$3I${~>VO6M%%UwVQ>0n@lmLkBdx^wS_ z%zvYfu^R^og9N}Mv=TfDh*5LFhPn;f;?n?$v5-2h)4wW*{5||B_-U*>FwxqBSZJuT z4BIxOYMO^;c;rpex~M#ZeX0-B2{9PQ(|fYL@tA-b>i{55hQx#HDrY=aiDLoE!gEsu z%bFZ@&dBuGi^{EeG^O#*&d@Fu9=GK!ZNsN1852 z@XPU05mo-xaw!NNrfkxfk8lpzMTo!dBL%yOful+8Z2oXb-9U41+xQ8^J{mqK7`Zw- zO*1yz6PrcoBL35N`uk&_g+B$~Gx^Gc(SHfQZ{RLN;h*B1647ZrJ8*8p^p!h?BiISQ zeeu!aV0>46&*uxDM4yh|x9}3^ej5HM;b)xaJc4&4g&B-YgX$1X$JZQ=E)T?igMXZ_ z4iY{)e%=9pP4MaQW3^)%7a<@J`=hLcp1lhhyMGLJIFQ+uK5FyPC*!qui{ba;zveeK zfyiV8kU_72N66~muI-Oc68s9EHE?jz@tVG;!|%mO^f!l@3$2J7^C$=(<0}cG~E6kaXH5Z{73i+UJN(k zG$-cp6XLF@nVZ9$g)X~HV=<*d-%~|DvE)}Nd=vPqq)#n8EXv+83XQe2ZzvZxy9fMO_pH-i5F6%7&@d?=%Gwp7`f(j%z<02|lM`{VC~LHMumV)WsF-M>Hig8Ti( zeki<&75pQoHU|D)YeotCUGe9_0Q^_@wMH=UyMB82{lh*dr%^0^6Vb#}gZkXskiYI% z=kv#hhz*+Wn7wuzw0Idxf4FbN{Fgu6vo2pU!NX?sVXgGD@sB+|ek;CW`M62kc>cng zD*O=mo28K;ZwhFbN_HsyD@xpb!{d{T{1<%1+i+yu7TdNwg8q}?{{Z5NU(8PnsH{!) zjMkXnxAge7A~@6XUHn--;uqeIIk)F8@9qupI;99c^3T(U>yAb?ek;F< zf9o%fACYg*Ug^9A_@B$#nso4diN+^w86poJ;d{R7%0(+V^#6*-26w=cXLCq11VKd8pjc+2Dedx(co2 zs`+`AIExzsI}VuaVhB<60H=6-Jk1Pb9KlvSrMVx=9{N$_rSw3e>*0+>Ebvu)$hPpu zjw}u#b!lCUI7>DDm!yvrp|u#XFP$J zHKH6HJz>jD70QfArYEp<3vQhV@B7X1Sh;ei3x2aj|q*MK>q-&1Tp9d zVPa3y6Ev2c`-bb637+pTsaAR6?}9@$&0jt6^TZme=Bk{{K3hs!j#p#aXCHQl!JTdUPmadOZ_+hV%H7p(E%wby*d2T6j=28@Q(_1Tb`+yAO3{k0PuN z##LsSkM;-tviUELni7x!E`rvIyc@Lv41afAbld|ChF{~``m2MFt8)+Vp;O3}%zQw2 zeJZb)q;-^R#ET59i4*Fi_r!;XjUm6sxAjzX@%5cOT80G2L04|YJJWgH7NN?MHK3-g zrh-`{L`wL)s-RZf$eoG5=Y@}FMq=IsJKO?#9$f_5S`0>5p3RhsLA7J@%Odf+i}G>H zjhE8C)4N4bLj$w}VQ+kMn(OD83F9G(Hq5Ca^4yj)7G*Xj(X$SJD|>U#Y;#P*rX~R~ z&uIF7ggzp29^fOK*-=jdz8G@dd84J*6+R`@WUZLyRZz7J7D{WK870_NLvqZw1&aDW zH^t8t$Gs8x2y1c%ftxk@pvcQ_YQU5go-OS5Jq+5|bxgFLd^#RI+}yaJ!W?O#um zQfgD1(`J-rwwkV5FP7XdVgipz=JzAN2c|4I9x8EdkU4j5l;ZeDL2^asl-rzl*;iAb zYN%xuA2Ol91%QtH-}>;&r71T+0#%=6ty@htY9tnc;zv>SKjz2XDPMFzr)l(5x#bmB zVAAcm|%uSGQy&UCxwx$Ie8JBpW-Lh639 z4c7kvdBlO}T8)C9Tf@rAO1T;5ja(ZQw?Zw6dQ6Lu$x;ENvzM9J%!NR|Pp267(qm;Y z!iY>&o*m{wf0}xfC5Kyae%OKa`xi~43DY{#&zn+jSqPGfl(P}|THQuD71!A=k>&bY zqg2qvBr+JHh5)YQToO7j^Tf=oqNvzOD0CKPut*i+;eD(?IGADx*+Z67lv+DAdSgh9 z8!M-N$LWp^B=S-UYlcgtDzy8FD_Q&H#kVBj^oRdqbwXE@iJQdYO7f_DJESTNFy}${M{uZI~+Z%P!0|NNbe+@^g zD^{dS;GV6Khy@*T+1F_wO_=cUdILwd=ctYjpwuOwr*&tPO#TaN2=@RCpQ2`K5IX)2 z*q)yhr02`y;v9n%GvCKYM_OgFGa_%EYYT@FfXAh`!Y4A;pt+R%l zAn==1vLGIGf1>3Lxc!r-7~t_bKP{+{!z&#c<<)i0Zt}_>!R=kg`fv9$$nSv6MC3evFWNciE2z6QX`QO5yk#gI2DwXL_-e8N3hG zthe5lqm*3!&Bo4{=Lhe=x;D#d0SonQoMYj|DEzkk@#ebpM>l7D#V_!~#oWhAYOJ;<(7Ejv zSDMt*(q^#BLr_dn$o4Zt#1B%E57=UM@d{6~UMI25KIPkJ5vV>Q7Jx;V!3)a?TgB!` zu(3iJqPYreeZaZ;lZI`&1a?KQ?stibRW{}aU*IL=!L6H zJY5Ji2Zl8?(F&ZF{#NU>Ps@*c95khi4zX3b*dp76Fov40X{tigIGR6CsM^DvG;5F< z2u;iL+^1rh1aZeAwJ} zvA*%|Z+v=LE2?KHluOAqgfqtwa28n(*W6i%wT18vN-3obU7<-SGq^>1M@MR+=V^5W zZTGvl>a$dl(3 z@yS<1nb5zO@<^#XK>B>H_$UGpPpO?d=XxtH%)-?@=s8y38M)j&vFmD0y+qwb#Ht`{Sh?88Ad-2vbgfvNZ1f&W-P|nu3u|LEY+WY4Ysjm zE!(CfAr4gDwn{9@CRV5=BwtiO5D!Ccar0LtL1I{HXPFiOE!cTrn^<(Wg6`4YKs`Y(ZNmQmd=)8L_g$4l zo>-PqKIRU+xH$Q6<;_ag`H@pZ11ANyTK30k6rRRkJjhtO`g!OqG09!TF0si!kV_59 zqU&RBaRZUmYGhI!EvwE)ER%U{GQ4&XvATxtf0h8NL_IgB#2gWaPHUvj;*n=ap(O3{ z`;a?~DzAsgY@JZW3WDlOO;*(pQy-VIXomQn--uhL1Iq~cmGz)p(vj+2Zd?%YmEz;6 zIGvSp6b*LBRo_?X=F`&(sJ8sPw?3Y1O}HPw7F<1UkScB_mRqP^`IVzbTSm+offhFH zgGoRFq>rf+ET%Bf?gfeGw`@RLDt?+1y6b(B!5u_?X3@BtUdN1fDXuz6Q2kL?HeoF_ zSZhZlgMq;V1hhgC=2Lj41|k&hCGG?AaoUKkl^K;xN@HkLo&d15z46E^sj}GnkjbC2tlL#HD>T-tJE`yFsbl+T@MG}n1Pccp9RwJvu-S3tvOMv^87{{VGs938`II-Ni> zYo(*C-mv!+9xtjk>ZGWm%yPP!sNBUPM=Wm>l_Kgv0QKV= z3o3M@IJj^J+NrK&_ZR+wI+E4vjLu0?j#c5J3DSCt?t*stb#O2F_f|r z0X`;EELx*bw2Kru&2cPkVOKD{{{Y^xK2UZ_3y(Cu4MVF$uM|1PVkAzxYi0z0$MGnn z4$G4B%`9DOt|^t|T}PWn2MzuI08kI`e0*q*OU{_{UnB7YTfH=uLsaJeQ1r3=B~kwX zFUNt4yu_yO?vbligD$AeK_CKuNK|ug_q=dI7y$tpR7nx|Cix=&Qu)?|ctHM4d90FC4Bjda?FV!2PN zH9a#gnVsec&I1qc*|`V(>k-5*vz}}EKM?g@F(oxFW~ba&&Oejmk`%3~=IB%9KZ-i` z2$h#tXDb;z70hZtzx;0>bW*zXr}Il?@f*Z>3d-8AJ7T|uze!Zy$J^JB1{u7RXAIMsR4lEwC%%BKGSf5(qH5H?Z_Q~93+mZ!y?aX+SAW1PLXH_Ylyi0%0C z$3)&s(};Q9$t+$Z>p55j)p@yMK;tr~=Klcicx+1qm5m4es>y^)Mk}Kp8X^k`yk}K^oO5}?`)|H_?52d=&9;Py3Yrh{{UrLzIyS* zg!|$s0O+SKF{$xW9V4rAN}QK9)H$wcS(?^D=}catcd3yfv9RAEEo05T*yxqZM1}V$ z*Ko)4D72DtH*?Pi+YuM9VMrqJH!g-a!&6Sks&2b@Cmv=}f=cB_tyff3QP5CjbyYQ0 zlL~rRVL)V(N8loZ)tjLF@e|$}2{r>%OIlY?6to7c)3gxeT8B;6WVwxHO(c}CR#_TI z=SEP<2keu_++*rhTKlxfT-0QUT{Wh8OQj{F$!3aTloYVWNL#A9i#Y!Pjb8*X<`99X zB+80K;*M54xZ{FTZhsAjKKPW-Py&>{iFs{6Qec^6Qcl%NjyfNwTngqwKMZV&{{Ror zQ)`WNmsL}v#}-(IX(W|+^9SIu?0VZ39yCoVaDQ}gZ@jHH?pBvf@<8=kO47{wO0#-_ zSt}ch-12?-?}{yVINTlo0GVnyY??-*eW|7MI_4YRsg!^%xqoN2IdxZ^(L$3(%fYU# zR!y}^;m-gITK#bsO73gijTz?FLgx*%}30F#ec=MxjD3&$~}Oe(RMd~(xi ze8VuxA1KXS(bUTsdTOYZ9iw(q+e({W*wHBPV)ln-)GV8b{n0j!S2HG&w61f1WIh=j z5te6&IO|gjAIs7)KfsRpX>)$)+JAHWh3$W`6g59qycZWw z9ZqsYTS(CvVa+u>(SEl)t0{6pE)=bewtzbfDs$@8zGU=Kq|@q;7437~OSvO#)}gI- zU)FQ^p4g8)T_;7~Lqz;h;FU+IH9Pr9K5HXd#1?JF{MyG8vaLuGd8mCFh|#JKRhj0J zNid$MH|q&Q%P}N?2keY>(vme^bR&}N)ss|58EJ{P z0I#?`@#b?EE1rxEl*2`t>#7lFs5?CH2>_b|Ym1IX;c@NHIF}B?P{j9lnIEMAjRBes zN9ZUE@VD`W;g^B>3~0?;K4(Rl<$1npWE7cks74c17ay%g1Eq)MjSjC3b#h%M9h9~s zK+xU$mK<@-rPYsDGfulX&fD>nC*u#|Q^B7d@@+Gj>Fm=pI)hKtNbw2si4adqQExIM zA&@AufO!X|9APlVi(*fVc_kI`ZK!na*UeC=d_~KqKmtyofL*~iE&Gd(IXvL3r3h}B zGiFMxr!<}bZRXRR+cw_Mz&~r_&{w69h@G59p_&(mE8D`lsW=qnOTO*g}?eS;d=0bHl{AxNj;F*7o^Vhs#S`&da1ZrjC%RW* zg?x`QqpGLP#Wc$%>L)uDy+9HGzvpao5WE+%R|aHswv5XjqBaX%cR-xJ)H_e{#LRRk zT*+K={dJRW;6Bj2*>7?&A*dHU8C@S<H>`kW^e+%sm9$j@>cAMeLze5w1a_^NR2Ymc8VrM*KdF-EZ~&tV+U! ztZtaREAi9BF9fBjsLrvCutIPMqSC*u6pFXR1? zzlfO)hl)9uO&lbz}~DF@xua^W#gg8-4I`9T_yg=2gEB& zQz7v~H3nw8C}{R69g%ifdh!N1^md=y3+&6Y{{Ung;us9x3LZ`N01F0M&Dkx(2VaFI9gZpAgkCm|w*l*31C(c}U;AV+S1! zI9~@9(hrZ{hATOx8w{wWA2C*_GSEkvK8?YAw&JtGao>=5z>#}XnDuo z5DVe6+J|dh8c%hj7QBx23M;@9W-WQU-{{X&){6wBVx|U^of5LS4{t)Bdj4!1l zAK3x;h+}{5tD6!zx9UInRzAuXlD&_Q&xl%rcX+Ftt@yH-NAVGicv=FUokBDN!~^e7 zm7g0Q5K-mZZwkHyt%Ndh*|M!_{xc%7?r z2;M6E{n;eAzQr6L**kjT+Rhrr838L5vnbU{ree{Cu#_(n+Qj?emW!s8j-r-jRPv@- zx3E@I`#)TC3h~^zl_dyr0$WQ*K9dgqW7fxZz*bQg*G9aD6OF3mc1G z-{ivRglZn@Y6_gk^%PM0ID$jKnD;_HExDxk3b$Ad*^Ssi>uyq)?YE!X3eg99;IlIE1+wmdVpB)88+aeDb%< zE3qQOlpe?15f|oDv6fAhbTCL#Xd&Db@&L7oC+t0I!N#80H9 z^nl?7NBmOAW|E4Tsnk3z&gE{MI$^E^#Q1rnc<~0vD7k-|OXp0DZTl__+l)AvNvx7I zBQJ@hj?Ecus?08axbP_4cSsCj!!tSS(%6(Jb7ox?qW=H{L9&g=Eq_qNfq5&_NRiN) z)=%%IYcRE~k7amtN$K6CXq8`i0NjrFjM;k8E3^`W9HL1I5NrcK&DU{t@>TefyiWPvH530EKT6GQSbB{Z*PSU-D6BDVj^|xu_rGi{#A9<&ENcjMR<=oLp0FhKNdr#)YucEg=a&})na(f)5!5Wa>#Ec# zHdL0LFjTXXZsO#d8+XF@b*?v)<1yrsG-Lt1zhXp;S&q@o&nLbi3V2B$bdKRvEr;SA zaS_#b5EFdoeYhb&=Zm)(9;a@KW-pX(#%Ssl$nwtQHn9bJpXK@D05=;69pHuSK_HHH zJ=?4={>WZ{i$?gvCTB-XVx!b_l=-0kiK%;~Kp#-b3Hyv}95Sy-OId>>xR25bqv9Av zMxO9{+a5$JIi11gJxdTlRu{k94yc(+_=6@>CRo91X{0BGYyRPbLakH~RD&g)$x&B4 zym^<~Z=pCLiUOq2rX_+o7C3 zw&8n=+ow2zdRqzeBn$F&q}&iV`ri2MwpyHc?Nqn0bEy@l+y81&gh z3?}U4`MGLJKttyc6dQwYY)0cNuw_ZBs0=!HFR8ZWGIjip1|sPBvUt#0wRTgG=agw0 zy)I`gDIqIzOhmHV?Q@SFGc=m65*XKCU;9B-HL!~JlVCSMCkC{<0VT0 z!<+J3>&6*TsdOztl>@73qo$goIO4OZumIQ$H&BqDbd)VqQ%@9%tXf1DCzEs23vpT_ zs0kKV@8QEFhb+(aT{SFTP=L`*DiLwZJ&67|%zo(IJsj-g`Kw?1lj^nH^55xKQ&K_< z4Ih{R+)aSBu1Uf?MaQ*Wu(l()M8wQM2uUCXH^2eWWXdfojMFe8z;5Ima^>>^amwmi z31ITUW-_MHy8f%;T5p0o!iu1uXjr|gm?p2(ZlI!ko(!y2JcR~$|PqRhqYY)=N(KYSa2 zJ!tPsIE{q;uCh-`n7>QvNZmuoGYZnc@_)j$xyG_C2jYeK;}g_#hv7L-8!M%+psb{p zlrg9$YXQhMI3c1C1eFxgx;~FAs?v4Rupu=rQ3k>R;MFGk-?gwVFRI5Mz<<>!yf7|% zM)}zvI4iIHl6^fzPvQ=h%Cbzp3J9}Yx8~}MQ3Vpb6N0SDK7*6q_>TtYX&s~K2+T{I z@G}|L-l(UGRk>b&o>Ik>!60f%3Ro%&HPT5DePl0SIQ{r&Or%vCvU|xqG^eShrj*ug z4!7HG1@Y!p5HPvtJ{i%_r9bz^;PY+i)4l%yhCYou$GuCN?ci32`~diMr{~nZFy;Bq zO-Y-4r6ySLy-hrGZS$!gcF`vTk8XIvOl@4QXy;A;09YruO0H!$!H>SOerZ|Jlv7br zQD+*1IgS2V5Wkak zy_c~3u_Az&MM^&k)slZAtQIOSb?Q%CeGHjS~_=;(%*|~FH!7z zet6)&DIbgnh0l;(=C_FR3rIdWv|gOi{uX#g7M93p@_925%Eky)1H9CUArckqc{%6Y z;Rg?>UzOXIg6{o1ldN+xy~E_Vx7mL+o_-)tmd8tw|tAOYAt$XA2*?c7dZ?xVy0`?B@5S*M5LB%x9&Cf=CSbM~7W~FMB3Ee~ zLuARoJdQs2j0>-n@)RGXpjJ@9qvdUTVr9usIfXc?Ngz~3E=pJnA90R|lsv&vDl$e< zUkJA3bq{~&+>SqX2hmHqjY}5I#GW|XJ;xZ~NEEXn0Vs1hE&q)67nMVHtl}6`Fs@KrV~?LOBIxuRY?F_rX^~T!c)b3Mr5hHWQSgaUdOg3B0~Eu zuA+3!w<)Vm@yG%6_cy@vvhZl5YK3_t+r9C^jX&kFlS4b$Z5?m<+Y+^Rvg1yMC<`a! zYg_DbAQGZnrejZ01EB$hgMSQiLi8?qvNTmQp3HB5d*TwkNudBb3tr<9yG0{4Q>kQW zrJ$xfq-9vB>UVL0!Gv_?D^UCm@gcR3h51gBsDJN`9alXxZcUrzDx1%Ve}iGa38Fel z)_ByO;^^GN6MKn__q~SLcU``a*!Mjis zN<2hG(LM@_NldLw$t}rA06jhMq_nj&r&l^dm}P%3uL0_-xh!vRG3Z2sn5o$9G4O#0 zKF9Bg7sRCX6&_GkLfen-vFmJnqASd47ndB7x~|8&oBQMC=}uL#Q%?lIu#qM1Ik6w< z#B0RDT8@!oqM`nHiLMMXlHH+rA`f3GGAuQKuu#9;-B`sTPVLS$hz-iJAhwik>N7$`Y9vhGKeQZXu<@ z$=(L22$7m*nNCz;@~RcQ@FUxP{C}4T4Kl1v#SIe4XTBF4MYU_ZU^HAz^)IZ=+!Hz$G-n@o+V^4R#OemK;(|L#D(`<78NbX zC#W_}>vYJFUl9%V%#^O=!>dAAGpC3*g?7ut!%aYLM5M|1vd{dAkH(&|52yv$s zn}Hgy5=Z5$zm<5D`dEvNxamhLrbC`oWV2ofi$Lw^+T33J;A*twBk(5j z7d=Pc1+}t)d&o~YZm$&76}f#Z9?SdM}LR55wgGPjnq@`!O%W<{&0{r4) zP^~M*q^pV;%`7%(K`i7B19!)C%#{UG1Gz&1l3lGB0gpW`bj0MS8*siU-o{sAi~+Fv z411Y-2|Q4wOXkZvI!ND!-48hMxpS5;%_;LK>0K<2hBe%;YhLHRBXLrxVlDxOi+Zh?E3PUdXIsv;5l z`Le420P93!!$IWSj}iyHblhDrp`XPB`+-b#wDimoA08hLl6ad>qO&;l zUPYGIPzm9rrmxH+iL1n|=52u7?_yWdqZf`FRoEt+&|3yTGYJ86F>Y>9>r}O%Y5dC# z^_?Y7TV0w_R>kDiQ@M^*?u@)!7Yrl8Xdu{u2}cra0t`sy-cakzWIKViiMadQ48c_@ zfiHrpWQ-V)8=mI`g9u2J_A{!&s~f~N+$rZBbfI)uRCcnSWR`890Q?Z9_xs`(y-dnx z5=I6!cMON+``D23U3(-W2sKY}d#FX-=+ZbXjEP1zI-GTF|x-HT*Kn!dYi*@?rtjmn4 z=9Z?UgekGMz13XW-)wdqyeukN`e!tX#o&zhu{?9r9h$%|x)M_^cGbDR_+cH?f*DT( z>4=?JDI148)OY0MjD~;4dtUg9q*L?-C8Jkag9B#Y(;kANZ9AzLhOfkwVW&0 zyc{L%+5R-0`sqf2_*Ts_yyr@0Sb2j&W?}V&AvpLOrm2yqZyvlpxoxEdeL+xu+c4YVMvl+nA10wk2dVOEAM9Vce@*Z8-ENTt=77};mA#}Jz^nO`NDL@2-& zCiWkDUmTYRUbIPG=-FZHz}n!OaCkjii{sjB=LuCaF!(Q_)LE5&YQ8k-JiY5CmQzbp zQ2zik8%V{9xLz(V&9SUuIDj;pFgwW}=9P`{9t!G}oJUE2>O;<|ZJ*#TDTFbp@#jb+ zfL~#fPM-Jw0Cn(K;zMk|J>RO9JML_g`={}A$G)oTPw*?0AhbR_X(DYC9o+>3}mGi8>$P9RD=trn@wM3%%)~l>qbXjD5*Nx8x%fYwpTpqY0o+BU{^?-r| zi&_^f!V{@&iQEHs7ic^8Lai(CXQ(x%TbAn09j$cLRSsnoo@vcSK8un@p!fR*RHy8i%H zK0H~V>$mT;eBPoQEW73SQmN*U=N|@sD_1Nr{{U?|5>S#Xpss$1K?nSPg7zGH0mVnd7(5D?u z!vn?!IL6ng*n$IIBRd@9F{V;uOZXz&hU&SZZuXn8&Cniw>V@f_hV0|SsG!LPth?u;s#tPsj|&w zp(I*e>Kc6H#_Tt7xDNQ{pB$upXE1kEVF-8dx!K>vRZh`-DR`?)(rwk=9E&Ib9Qm7{ zueK%lW{1lj4r1frnfYJERY{`wE%7rnrq1XpwbzIA{{W<+FvzgxhF5slfdlhZVPZPk1#cbDs9!kNF}#uy@c-@qw8V4BCDKi97BeadDwZX!=io`^S>2n zVAeW+S!nmKR`RRpE9&HiN=ZMVBLWePx)tLc*5a+hn0YhW=C*TV;aT93fL5GpnPwA6ZLT(>UB zWuTMvR$=Ez$RErt<=ogOd;8;;aW+)QL;%;xCG^RHGQi96jN7mjT|6W;%o8;O8YY|C zEb#A*-Lj;buS-edKCRYSW>1@Cab;P~b5&m!cQtA)GC@|w(O%xJ4^e{#H=`491&GS% z1adlQ61;WMhitYkhE6!)$hj{{W27 z*H9b_c{}Dm^cC)#;V;FyDvZpEttRo-Q^`(3>S|>UWKxO_?nR4SgVw^>m*FP3MBI@i zKA1Kk+M0uw$}@#+?Cl8kAGjmrj%eNS5s^{p4*;|WglAA?bLxDh^2y<+TD0=(epIlK z##^WyfJysf+#V!8Ts~8rV8|JXF(TIAy%Ov>bQnIXMZq4Z19hDqDfm5|PmyGqtwi+8 zo#$Dc)CVMnRhFh05DzY?-5rL&5LXonxa-#*kt&c&K?n0zgRTE|P zqH!MYP5#%%Yr{yVWz8MrSz45U$Ep6TbV`TOoK#|AQw+69vx&{Q@6GW6DrV9;B=u0a zk(k>2aqZjsvB_PUWF@Hk>DrxmV`6Re$89UDk)n`LXC^44r)quVaeQ}|b>OC4yk{AV zxs@WtS~!nMqw*!tMwzC0apxZ>YL&5y()HbBrmmWz>{D*4%iwKM42OzqiyN1mg9~O z-ycHs6!SpD7LBYy0ZoOL#`uhd)TWu}o5_|cjubK2`);IrW9VN@C5u-rRRT`2@{F++ z>=1P$?~Yfi?9qgfm>*~$S#jd{CrSxC)R88q-DNkpxH##n;@M1@g&i$KQLA1hd#s=@ z1%0q(7i2P)VyNa2H&y#T$lFR)M+s$;jzV5Gy~qcm{{S3WsMYBNsx~T*LSaU#iMKFwcIMpvcEnDl zD3)TNsXThT!BtX#IE{*nw@y0S0>29>wJs$#MQuHw#hcU!&7L)|AfBe!UsDc7ior&> zBUI&{O$J>_Sv-4zP1d5+@Fy(~w3F*qqe{3IJ> z(=UnA#6*h*;utEa7RN&Z3Ld8w>`}baHLT5N`HGm8E^ZKYKj^_tq8Xx4`tGT8#xD!V z7?LF*ErrOv?|e=I6q0pcM2Z#SEX9r1J=oR?Mf1jA^SjaOS?lnAFm5iV&|3(g?lnez^1rQHOF}GI?7yiZ~01 zrB^#`{TzBkDd?FOTq>w4vZ?2Sr~+S*!ERZ9tF9v;BZ7R>8iu}}raDMj{Dv0U*?s>2 zeg%C!(G05z^HWbPUdq>S%LIz0ck(|k%N#PA_0>}*bEuM`gDGZ4vNskS+XMzEO-V}f zjOr|~Rlo=_Fe__xEo^*PrDLH+q04_uW=lx~gl=G2?Z98IC74k-W+_!=9F&=Xp{JBh zu$}yDdc z6-$K99x{;t#rFFPSa&~`C7E9}wq4My&V&bVHMT0A;P=F2!j-L3>2&^IkkdSpNxncX zht%wPfU~DI^ z4mWD7<1W$hY7E0poZL)bGRo%iYNA+nwUxidy}vwCe&~)?1NdB|E587CSIkYh#=Zp; zwU>oj7sJZjq77H$pNK{CdA?qjS+xT}9FiM;A~-?F1e|5naSm}gTE{`qQwH43trm?E zM8FVEwIg5Pj!Ium@QvXY4D*3F438JHW~n3ceh}Ro``8RZPx*IUkS9t~mHj#`&sz;=%bKDPM*) zJ#3yd!@jm}B|6GH4)CujgbEJ|@->gTwHiAMcP#s_{4o=_gWaxo4%&_|xor%V2QTmg zeZVKB@S8v|D-VY`2v2jBQ?dN6n2*xl?FoU+=gm(9d}H9aKZIT$75@OAXQvz+^~vdp z{QVqaPfx1R5_}$fmnNL*=O)R#Ch+DoWj+{b!W)89DW(Va?Bfws$5fAv^PHt+82HXe zU&7B1*%2GVtva9*6pW^vvfG=I0PHX;v5#v|ch>m6aGH|LvoR6k6;JMu4k@@f zx{&Gci1SqYLutAplWHA9nku|>ZYdBEa3ysle^xBbFtb;SA*@deLL1CgJFHgLA4_6v z(uZJAP}EVXI5JqPz=luPBS zUdjh-Nzy`$01U3*IZREKVPye%7>U&-Oh|G^TO~OMYu$p}abeFN*N8JIDU6{Mv&|h2 zX;Y%_-a<^El?`+~bE?b{#q;0yvG(mxsp^{fYEb=lq z0f``XALsY{u_UGi;Do9y)gX{0r5v@!;D3fAnNjBfB&wc{M0ep>5CBun!M`875mhr` z&O8d0jse-7q#vLYQ&EU^$c&_wV*SL317fjP80sXJ z2>`r&$e(($;qVNsOAeu|cZ0-_a-DcD@OeezMINc1n_E)knPy8>PX=iwVxePUB1bir zQb0gO#s0Vv*t(S(Si!tzej-Hx= zEYn8M98n@Kol`|46#x&!#FNtZ?|dY033EV(G{CttIi^m%_FQ^voz`=oJ&qb}qUR=e z;I%jEW6bm-umF@Y(2u`NbyJ1EX1D3`UJO&6@v40Er!UR?Cyq!HE~(M2GsvbmspO+( zWmeSYGm5omcmRV3SeX{zy;;<+?5=ku%GFnYTCeCz6AqL1NR=hO1 ztr`aXGKx(;fljZakdOhjMGo70bAlVfjQ;?A(_aih+0_>`&h&I!VyCOpXz`y!Vzz}q z_8^Xz$KM3LKfdYj%gsnDcGN!KBp~tQGs<%fKbJ+6zEN3JGfGF2EV8PaNl`}a%tU=x zrSJwf4bf8)*0jm>W0B;nyaB}2cdZ>8y=mq-p(dh+Zz@p)XkJriJuQB?4!oNVL);b9 z4*-&M2FeZk2D4~aMclTr2a9&T0Tdkxk;JxAdW^3zap|WLxUe>R4ZZD-Iwx+s6_~z^ zpEmOnF$gF@u--4z>xo%G&M+4}Gf*ac8nq3BE@aIyf%|)goazfbE)LUr3W7G2Mh|UtZ-QUJIsE#8DK0QB~Psusu zdMCksXe*yiX`HgYNLT)h>grm=bhhq*{XMXsABwMrF)qJpKJ?EChNDs5?jdyk;o3%kI)7>rF=Oa&nwgvf z+UFjgCy3q0!FtRU9h%={{&L|bf!a(M+FcbBs*|`0obm6@JRDCD+m|_fa8w^`t@)qM zRPQO$i<41DN0H@ePe;9q#$+U^-rZoM`?^Omks_6WV(^q1K%Dxi-qmrycL-mpA{+4u~$)N zFij;ImUjR);6gVb0uN9xiSTW6UI`YIyBJ#L5j%Y!Xi5GBA4k>rSDI65Dx93vQEGhO z<{`{yf-=5jid3q~MZvM@?Tbb`0BgLvC_PG1Ka2d!7Nx`u2NvccUs7Y9bNW@fmnZPH zxERcON^n46Jn9xv&lgho5OA^#Ugxx0*W{wtVq%;Au>iBf}ItM za!Bi8hqCx%L!8j(Kpd?;NUSp$_LmVPMf*&Jq#qA{ANXseygJgEZFW(Wu&kwA*Ng5r}Y z(vX5rsxQ&8^VgD%_3w{raN3WvsmM^b9S8gI-q}eiG{=RL$Yh%((h^E|X&dAVFg$X1 z^Zi)o;QEXZDZo4-LCUW}eVUTTuBYhj*2qEYgYz zvpY>k*4DFJgL7;CcmbR>&bX$?*n>Z^(3bSh=Tq4?)UP!9N5isAFlCxd2?4lSXsu)4 zsmHJ3PCpU8*jbSBHd|b?3K2|YDA5~&VI_t7gY-C_o&*Ee zYi!pMc_Gab574>vr#M4g`;aaO1bD0_@WaF1BdTE0*;Q^xBz(&=r=ylgcdX($W^KeU zA&$|-`daum6^g9KytU4=0qh1F*6lrO574YWheR|0(P1Qyr|E^e(P+I2sZT{VQ>EpO zk_4uV)wKhQ z@a_o0{)o~6JDcU854D>UjvY|y#;$%6VfgM`-$nRs)iP}u;PQ7ST5oT;Jw5wkcHkfK zTDkZ^j`;3Wm*YD_=-Pcj;gO3-<#L(f%oQ3q)I%&oZImp2h8HA*`?2r`4mzDl*Dmlv zYl1Dr8FyTZG&oF1B>RG{blMX`>505L)~S`QUoLT|>+&kNLlvbf1aZ7iXXOZHS|F8lWZtEp5P!OTF1q{{TMIIzK(jwKWxWHeVdMl?_TsQx#lo zG?Q#TNtKn`a;tO%3tap0_YcDsJWiUAAK0hj+(MmZ7<9W&XYE*fJVPoim(-Ex)5!3% zqXLbz+Tf1Zx~!4L&{G9zc|#?Ymv9%o*z!0Sm8d5+*U?NfEdd=qsQnEDrJ+b8sFk~* zWDdanuZe9d;sG|%M`}eiJe3hcP$Y>-3g`MG5*MO^Q4G}nS_x$iE$JS^92c&01j#ng zU(1z9B-u}FL|-Z?%v1K9)9~sVT}1M;M=b>jsfdn_%IY?sxIe=mO8ANJPxI)yY@bR{ zXH~?lPHIV}OV}8Jv2V=(04#J2E@H|m&{N0dA2eK>n;c1Ek2>_RO>49yaB50SsvuG}q>iFNdx8oAPv?)KP>v8( zdP-UtD7*~I(sFi%_;NRio(j&)Z5|<&D!?o_v4b~2?M)T`sDGCk>qMH`P zfzXD~rWa5OhLuA%tXSL;*yEh&uven+$i?Jk78bb2E;1KQ2^CBm66$wu9Y<_H(u&Jv zHO;iNRO_S`iJhM|rxG!@JGbpN{n+hrTc?VZ)@5|sdUvCv4t%~O+%4<3s~i<4My(IR z#_u;?+iP#7p|fqht&0Z+J%3`U@iA+5qx!^Hm?vxcL0|U6rZfmtxm--l?SC!7LA9H0 z?|$kEz3qrv64mnoy;V=^DdmYi{gsfSlMy3V@|`nPTQ@VKb0{ci#U1hY-Xr^Q2Qp8b~tu)Vi2= znJ?DZ`XzMIlfw*<#;+Oe)SPzw#Y~#L4O` zLi5_#kOcrTbxPYW6H_d)${p=yPU77yk0KY*BFl=?s|AcJ7mw8B_89P@soEE+WSt0_ zmZYMy5qtEvClMBeV5n2QHl?kgieoH>c&F;O`-|h;i@ubN)Ma1giD>t>_S{z7i~C|g z6j_q^pb~oBPb8Zj7+c#P5WFTAD2Z~C!6P!OF!h{y3!KuqBP2#uAgr5Gd%DDdkV;rBpK3)U5`Q^bSN<_}W>%6mb)22O8#JMcLoV!Jhu0ts6Y<#;6 zFuZ)ksU6IOgMK^X#n}+NGBL3bMs5c!*B>rd|I!V43sCJbvJvT9@w(ke#*_-8)TY0e zFY=1nNLel}PgBQCN(v96fV*X`qN*B*QJOg0%8-u45s!-Yn_)^P%v&;#Gn6ly)b0Wk z*+@U+#BhuSM>5RLS{jHYMMNa}u5H1`rK`-*qM7O$VW(To3VywR2t7gQam!hC3!f-% z3~`9zSK(gvw?T=QLqw}AicH>jr>2Y&6xj3^`r;QDMbl|2X-`7BPFiUubS6b2Qik_D zf0rB+Dq`4PGF-RF%~GnUfeCXYcKk=!V0xxP`MRQl&6ierl2ru(+Qug~x$I5=awq_} z=9GD6X-f1`D#N^O0S^`(Iqi-?A$uW2Dky7n8Ywc7wOXBR3lnX?dpFY9=oRCNndERw zl+!^3?YhvhZf-Y$-1o;hC3+tLLv;3Om*!c{V-{n)SgD0n8wXL(Pku4+VcB}xgLL6b z^DA9Eh9@-g3lnm-wf*rYM=Oq%K_<*6%Co1Ml42Ds3lnfh*X@q_C|vY}sYa&Ml$nJ2 ze1wK5Lpf2wJYr^uLp~E$ajB{6;|UV%uq0cHW3Zufa|ITl%bPiosOcz#wG0f4x%Te& z7r`AM3IRZ!5(=!gvXWB`T`RAb&c*dApKJHWO?YzP;m+%v%1asc5ZiWbwYWI%q}g@Q z%5u~3QVB%zw&j6N&`<4uxMCW*DHzzYmg@YvEanacqFK^n@opchy}={>IP<4cj4UZ{gxO6+Cy9DW zvRF}8QCN_IINT#rLHqW_Pws`_(;e#3!D;2Fik}?56ViB};cj(Y^LbP0C7&{;+Bst6 zBgWrC5AeosfyEkCBxyNM@QXscRixU?EOvxAgUQWlAxr)eYNf95E5k|ZThu7$j0Wqn zIoK)t5&W=&im*1T{{XJP+{5OXaMu^Kb2RCadq^Y6A6O*OyLq6Vz;?o+5SzgTInWYm z(YkVOZG22LP*l|@W6x8_;DK+xIdGD>NM%5(2zCPg_QYgDl4T{4PUcd;Ev{^FJI1oB1;1iD zV&i}(qj={-+~uYyB-q0XbYZSq-rWtc*bsxbi+#AnR54<{i0n=T z;jC{cOX3z+NV(lD6$leW1v)R1Mf|IQb^MP%o(&d2fT9_GjGp2)q%wJqNIN<&VUA@* z0BF7D+7_}=vY#y=BdYG(Zl=c^XIv3CMV||PA8LGF)N$##X8jK&d1F@@*#ibteSmE} zf2#x6t|*Bq=MBL6Y0EiaYNphhB271{axA*KsU(j}Qr9S{HU*{Xy*mIujtFf`;zsBU zMjxYgU0|E@RckuS{{Tx(TQm|Zrdi%oEv;}(?TH1Dbp@9!k1dGT#~f7ma;E;B-+nP0 ziiM#+)ae;bX_hKWsRR%cZO_{flywAq@Xz7Ks=rIr_>KBnDs{^11N^H+y5%p`zh~+1 z`C(J|kPpb5d>(o{=Xp#S-dB}no*6||6>rPuS;l=|HC-%&tt?NrGOgG+Kf@0LtdzB+ z?H*_)N2b1RaL`d+H3H)Mg~TFyMng^%l7)?!dDU$Yc$dIG1EnQ zUnt8_3{59x^IvGW>^=SQ8=a67$P?@nDMnXJiZWQY?@oD?&p!l^uxtZ&9g5A`WW~lI2Peq$cM9>|P#2U(ONwyvejywIO zD0Mo2CAPP)1~r82mHA4)sHpB7Brm|iTF{`lvx(4)*e)9)f5X)rbM`n8TTG}&e_?5 zJ*8{ka?Q&`<=yU|2v@46X^er?`-^??R4yj!?ACz2rAw3}VzVb-e0Q2uc>rDwOO^yK z#;`xX9*08oG$y)h$jnRKxAX@b19dx%my<;kRLd^*XFsyX+uI*y6Dy+g5W11)%N%5F zj0^R@BOe=>QOpTXnpF8YtvFCvZ`?z4vW?%>iSU-F2YQ1Rb2O|+rPA4EqtEq7sgH9m zXIZq4oXXhK+Tt3~r%-vU0;n0CY3mg&o5Kw?Cg|Ff-EX+5Ad_!#k3-$fLDkbJ@m_Lm z6O(0gWEs6BFPBjkd6dT!DKVnC?nyX5o|D;@wfumJtse}KI){4C5y zqRUx>NioqG@QIS^uz3!9cjJsKtF2C1-9I%s$2uunWY|!P^h7$l2{L)C-_CRiT5M7=YaZB96QInDT|AnzK2pzy=ZsEPwOlG zAKBTOX|yzcW50D+!(5+#d{%1^Y5xEMpVxA{U|a*A{dxZYRfs3z_MD{D`VYYxO7@hy zOQ=WcpJ4JtoB942JBJuH+s!Eq=qN=Y$m?)W0VEK(6n*3H)VQYCJg8we^{nXJ1bvy^RALGH5HKxVOWAql^@5yGWD^@7a=rSdNe6~s3A4ATNt0#}7h*_K z4*-+i*jbKjI9uia0D_fe;X>v%=)b^%6ZqdmwY~{xdK#eMw!5w@%*2)t03Mrk9Amr# zqCXa=)(LMEGT}di?<%up{txNOsA=U?mNsSQY|<$``+f0aYtP%cSKh&X@`M_{N7H0E zgiu8kj{uYgx!%k_r6q0Z^`E?Sh8dBqe_Q7X!^@a0J?7p29mewdD)A+NARRKvcWww)9=#0oJq zSq4JW1{qZlNWeR;#O^%(@i{60(1+PxMHKN9H90bFH|^8>xbb$@h2pm;j%Sa^rf9$< zHILIAsbDthd*S~8fEv5ShtKBI8EQ`!Qyg>Dth1~|RlxwLZ^V5q)2HWw--&As6k9NE zs!1G^{ccS>Gv+zG^?qGV9V*edcjwYJl^*>tQy-X5G#RD2L8`o!UZMwzkd<+E+x72) zfKWN2Q(Z<`8kh2vuna}J0zL5?j4wk0PSiSnO6XPurapYGs)XFF$+fumzf*x~zaW%T zC};I`*&Q=41NAqBbTyG`DtMzg#SmI`icst~*_DmDcI$zt;@ek6?k585J)OFOc!xzA zCRdaRJjKiDB3Svk-EGhN+xcLrAf@7%P--lIGR9?ri#ii?+Z>Wt#esaO$)cyKf+0*@ zPTlG|4}5tgNzsCcS_{B!QR1s+a%q}4+M1F4sakn9D1V{AwQ)_Qs&|9obunWzbc>=D zE}4@k%rvTITOxfqOHz}I?%d?Fi#M<*60){oBXpvr9*x;f$Y9lPT|3pioXqcbz3gxP zOJnI@Ia)u4LJ@WHu(_6=g#!k$RR-*TmMnZ3{{Vbd9xBeMRt_t$SBY7M&;vIH!;AiS z(Uld#7sRcWE!3(6amo*Cg{Z$>5D0vf{KPi%Su<<)~1%S8zUR08wR7)*QL7H36);7Jkwgi3{6!wNcA(EwE+udbDQ8c?yBc0(vRd1#{h+crbPFUEI9Ib&t++)JIUFs(Q&&mO{zx)f%a#YgMO3>iox=rPa`xtR%L1)dn*Mrk&Z z6c)9B>^<@J>ylt6jWv+2eDPE<5l80jW&2_ZkI7`li!%UGA2~`rD+JW^@v^kMZ@sU4 z3=U*)5TIE!ki|UDUmLPiF6eH0J^JJ6TsSF?YfP0f(-R9MyVNAAdLXrd{y5~WWCW8U zf(-jGtfHyj!EIn##n@kfdthgXx{;?cm}axlWwlh9OT>vApbaA%l|IDx#Bpg|W{W7c zud59xprCW-C4!J_qVZef#%X`?GVsx0^B-{RnbNGJtDqci3$B|}uA zifLVj{er}OaWHHyftAZL&FbqLbJj^KrwZGzaqMyFQIv(}{YyIA%p%2lo_gXUQFK^c zqFE%7#qvSv*-(pb3T<<5Yz%P?X@pq8yqU{y(v7|vd_Ly>DrNE4)8`cVU}}eq3W`^9 z6>aJu5!V&`Zx`t706+uhc3h@RJ~qz|Rd~KEE!KbzngSSjx;)gX~ThaTiTmzt`%0T4<~T zay7GK(bD>;`{o}mA;J^w++k^a2u%RGc%dke9$A57$JYch!9wwM)>cFZ)wRb#k6uJB zT4i&Thfh-6``Y;B$C~&EO{@zN3s??<*1iXoGH;eIRo$$=*JEr(OdFe9-W1aU!|e*1 zd~)eL>o}_LVyi34YOAT}GjBSoNFa9+p>*{*Kx_q%Tw5@Y6xefEI}YI9)0qiLhNFQU zV$4Gv;hQf|FoWNyP2M`?HL_^UT*iUsHIl^i@h~DuLW|v0fJnrgF~z1_G%!1W5$`GY z7Iu1BTP}cPj?zplx`V=fZQ`X=Gv!)Rwd2bn21-*C3BM6Okll}KV(#p7TC%5LUePdj z)fDMGFxR({4Ypu#12TeTVsR77!*f`Rd(8`3h3Q)GpdgdbCpfEAKpZ7 z{{R(9?~Z;EVO)+CRBV~@zYKgu2juEJJE@EEY085JxV~)-}pJ3zps58Q z(StOHc;@GhxBRfL7l`R>**xG8?T{6hgyDu8GoD*;HwWVmO04+Xr!_&;`PQAF(>aAj zeqkf|NfkGkH3-pDyr%xf{v;( zle`SumG+*7{TB(cXRKT_w?8!D^#1l3V|@(rS&uG))m|s&NkfrjwG}5WEM7H?u>~5& z;B-Gu*s`}4DYQyR?h@mqc%z0*;cmOgtD=cCE^Z<*S>NPaX6tr1mApZVgTb6^3slZc zAFf&iiL_>A_`;GYTcN){Vc#DfAjQDobq3?X4YThEd`GFuYpGL1X0d}?ODK{`axWT5 zxU%2&K*05Ql{V^NLH6Y%&2{iiMqFMZesflj{CqHN0pSxn5UHqO1QB8n%BZpW+#FT- zaLGY~Q_#QJ3?tr~;n|k6r{z=n#Z{d%r8BL4;Qs)R+H+53(`H$-XS!OdDk^YVX(NON za*8^Tyy30_vuQzh?``Mu>T(4`#c2{r9O_1z#V&o4hqby3#QKdvJ$dk(Q!Gycsv>3V zTpI!}_PxI>5;%oDbA4~sNy|Y$<1~-jy)J?AP&DNDNvauku-zVBz}$|6{{TF8c!e@7 z;p3b2RBm9~^FK&Qv`2(qCfDYAE`_`=)KuRssPg*ho}(<9C?kd`Ztl}Jq*xwrfh*T; zSGW*QM(Byuiwl9OGJ}I0(rpeGwYzLj*rEr=2kSg_@k!x$?kIA%EW^+UrvQex80x06 z&a0=tBW>WBaQiWz)|>UJThGNjc@32d|59af1bB zjoN;9>LE+#W8;_g(z@RZJWs2q%b`9LYUWycm6gk6GISotemXS+v@QIv)Lk*)9S??I z)iau_dQv) zi=sq^>l;rZd8=nSF_Dhu<#`1DL-WD{-+H(QFX$q=d2Mn?C$1y`cv5+(QI%iKA%{VG zV}i(ChbK(Bbw={$h`dB~Q^>bp-VO+)`+*-|hpH_z^iJd0vNKuyH~6hrs&l-?n?PpO zG?jH#4^K2Srbylsq!3%`cxnNN`5gT zuHOxF-Nk)2p>9VwBylQy{{SW5s*t;dyd6I+pRSy#eib}q*)snCa}4yB78jyxcQ?0u za(Ih3HiPkB`U0As4ei(tQucn5uUEovg__^P+>=sL>K!MTWfN9BEfA@vA&E=e*z~wz ziccJWO8IP&lxPU|tvBv*!IZk$T5}$(gX3;$&`XwA6h2)Pjkk^vi=VBrTom0JIa|e6 zOqVr$88%|8ccZ8hTkxv2?cW~s4`pmr9Mf>^ z_LU}fkYKlM;c}n{_3{*DZN*ODL0k5*$F$FXh=tukJ3I`fv#3F^rO95nl$8jbS0fWd zif^^}{n+L#z0MSmN`^VTAthI9Zn+oVU~WG6mkaBJCM=AHv@D0yS_@cb*{-b3@;woq z=M*yMHK8gp$`+}KWLaO(%)R->j%&0AjKkD!v)jlOhS#D)-eXt0muE5&E&MR?8tvwI zQL6x+Kw-a-vhHO42_tjZ@9+Is=h7SUoB3a=hv-hR^?zA6(Rf$lZ_3iqe{&5>PJc{g z^*(h*S0r&pu~Z|H?c0HYYSv?A#lp>YleK_MTp3AihK4 z&xur&vqvw5I+!$L)<#y~EyerbhjA7QW^d(ws$M9#oj#}OE5>Q0d`M_$iuhruLPaVw zGi8s^9@Yn+Y((sBHv=wc_VXOty7YH8@v-?Fm89?|OzIrBN_@im82MHnC+;}z?re94&gghYqr{xxqdPp{3X=MRjTyG z1SENtT0=L6B-{9;YGw$(?XPQKdYwm9Kh<6bd0`%9I>fM=B0qa?)0nFBmFV9QDY9IS z33LW|JQN;eMPtk52Xe?sKVnY@4*n3N3`p3CoelN}wNwrr*?VP9sd628K+f{`X{l5= zx)GJi=Etq=(;j>yPvtk-N4y2)OerJT%gluseKD;na@|o){m(Tpn!X37g-%U2(=4n4 zU60`a_rxa`PcS*zt>xE_#V0~q2_ryxay*Gw58}R-w=b#qf1$3YF;_vNj1^EgyTtKE z11leJM@%QE;QC~ZGBPa|=^Y*F(SZcHVzrPIX-)t=syOl@=TL4&Z+YHtwj|~ znPn?g%92RqY8cn9hkA$8hXZ7Z4e-3prsobDG zOHv8w2N-(Hb0Y3<)8q=Sj43*YeI8^e{U3lHCuQ{lNxU`Gh&CQSLew6{-EqtKg)ys| zJ-o*-5wxfl{8t+vllsd;z65+Z)_Qwi*5+D^NamSE92ze;%jKUkqIyJm9J{Kf{{X~K z)2HSzs-`8EhXW?2pVrEKLByGYCD?sqYNL@TG4QjPO+~4^FfswK=M^aDeT-@y!r$ML z0sG;7SB6w`jP*q`Zqb*`THhv=cE9Tt5zh2ZwV*l1UY;K6DP@B@%_V7I%H)y;SE*-G zjoet@2D2AUt!U26F{0)TgmNo5I9HSEolc*$B{_Wtwx=#1!_85$RpQw^hVAqn@!zM@ zA0D62{^d+?uR1l~N1Kyj$@QHK`KmXEdYF0i@*5GZ$ z?Y_Zw+7G`}&Qq*%>?K@(5HkAAi^Bf^g{?iBQN1o>4JKjc(n}cyctY3$X8RA!L!U+<&z_nvHRN|`baCEf~pJ0(BB-sAGZ{0&Zw$plX{>x$w1B*S9b!lIdHgnHjG%<8oa+9NxkEvyDgT9|U# zW{rU!kgebPu;bF&1j?^`8&S^62Hl=$kCfWKz-$szb&*80K?Rjtg14eJm=}{3+xazF8lN z-gZHlWl-icH1I1^hvRwy|T-`Ln5++RH^L8!z~; zj{Xp)clWNT@XDb2lkD>$SiLjh#;g4a@`ug$V>JzUXQrMic_c{{Ko(M-o;bs2@dhwSD!Onk7DfD{LuX4zPLHH( z+Ar{AnieHkb~xa1N^66|-n?g8A2X+|%cO%x<~~f9F7eR0B=86%bpF4~9{eXyUQ6#l zs1=~_11i)RR2q&rH1yQ;*|fyLUz&{@AqP$qfUNpyJsNHq@a;snSwt4MCde zdcEHrr$$Ty(k;$(lTQUkdMIej*BggW^i-UiDD#sEM!jJS} zl4SG2RA}~&Z);;qYR?~Hkvhj3kc?f!5&2`J4Tg)KlE$5-nJxh(MeW8q0#`3Kk}R2( zQmW2nBn|)z!29A@gafakwxi^@lmYgwW7a*1Q zwk8EGB3Gf8EW13^Dgh-=vs;WynGX6H^;||-=Aug}Cfsf-VSD48%i&KqSf?{aV?iX$ zMTc7w2>M$P7XxK6wbE!}Rt+ptumh+di~DuQCD6KTI^iRc7tD5&U5w#ZXTMxd422m0 z8=Y6D25(4Ki)S1C?T-rWu8op~fQCj-QyvdCIB0!WnR#a*m8=Ml^W zDY|CQs~zV<9XbuGWk5IwwXrBsR1gwX&9fMsD=qH6phr)(J%l8{UZ5F-6m4Hg0_@&* zHT^^195^n3O%;>NT@RSY&6Kb^uj&IHfESWejzd6my2~twbW6JA@_wJg9{{|$Un&bz zR?9Syd0Qm4`tHPw?4>k5Wi?G)u4(qEVa>XWdNHZ#UXK`Qr$g>BLr8Uy7YSl5Ke8n?gXs3~ZNZfX~ zxxWNk1HOoMsETb(nXieunmnH~mXpQYs%nVyc;1Ssb}cXH`}(P>7>2ardN^wn_QYcj z(4_>qmq_C(9X-a$MA`$OZ zzQ0_$rXLS89FmtcGi`OxVlvW60lm}#(fQ-v&5AuIL!gtCwB`-TCgV)u!rjTmR<-Tk zMv*_7T7Hz_lBR1%mQu&5q|0A63H|x{CL;w4%iWPMvtSLxSm6 zX%--k#T80U8!nSgOy))N0bn_~wXrEJJFf#s*(EbUWg=B&_rH8|W!_WVlg~6emvpM9 zu{|%_969Y?fKz<3Q<>qD&sW;PjlT`Y@xS>nGu+u1-A>k+HrZAWikh88sPzt*N^cW0 zjW?83(oGzYWlEqsAh?r{Rn5pZ_Tv_Rgv(@>=CI3m2m@URos<|Z76_KOvB2I1Gc(&z zIwCd-pLm1ea^+EF*{XP>sO#n|M3U50+?BYt)%}z2@5ifuP$ z?wfpJ`JtoO5?>CqPHCFz)UK!3+0dtsoQkO0sz~LO4uf(qupifgtKu8cz-ZTH1v&+_ zL#4(6>db>Ne-AZiV9~VHk)V%N>d4|Pxroh+sB`@t+nV0jwiODeneb1UNVI6v?DGY9 z8a|-7W8w~~Yshw?%s2zY`~H5N0K#Wh zBS$$D<~LH-Pi95#Z68xD(p_h&n|a(qW;3e~rN_2B6&wu7@e;fYX&$S8AvNaS6VIIG z8ID^&h&rMY@XI6;Hf2&-T@%{J1^(Ve_#DWVC6a-?=0_Ik|G@d6PMb2g2a37|47& z&Z5b3$}0Z=5cM@xa>g22g?z|_5DvvLbH~@5R%_RE<`O>!Bo5@*P-n(#Tp(YmC+G=% zH;47`M#y|X)&T?DC+Rs}K7VG%)^YVZrl{BQ50MMDP-ApsBeyE&Hi4_GHkV%O7X`NL zi!qWl7wvP%wmuFZ$L1e0RL)~|YX^2z8u5?Ad1&Y|%JbrGuQO847AWd!qLa%lYm;ch zIpc!F?dRVOY1a%I1I|Gm+IXdvaHZ#1<(DEEcxR!r2(`ronI^Z*W2UF`YO@8JPa;}| zb+I5q1Z3X+qt8r3h^#6wwT(XGeVNlo zz>Z9FYX1NlX*bnUwQ0#$&7_p2LJ*hT8vty1#}(VtFfdQ|(e-uy{n*d{{RGeE+5>knj((c+gQkVhTBn`OClQ(Z0G>EHt&yK z1H@;kbM6Ip9t3qMYp{Z{Q{z3MsPVtVZV!_AHd=*AHgn`y5>M@Mi#s0;X%b?rPX41u z?Ox#lb6|^fW9w8}OW@9zi&pqe;d4)(=b2)rMFIuNYvra45t`e~T}bVJbBe>71Ifwj1wl;>67hwMnV<<}A#gpcpan*5RG zx*22CrjW0LIa1jUt=A37v0X!$jy}G;bn4`o&rtsW0iU3+n$|Y?DO;a!h(kXYv|T2K z)9_Z(XIhH8%&w-0MVw}}b#Psqs7c8iy|E57nzX}-f2`d=9QgpPpL6aVA!uzO)hDa3 zh02Rn)KaATT7BCGtbzDgb|i8BObA{9+re5G3xvn%NFOk!-cerVfnjC6?f#r{YKc+` zXI13Y!4OhGxfeb0;c#9C5|u7%MGP&m*+=3eDd5=m9X~vE(ligZ=sru%jni@V_o4h+ zJ61|wY`@1%SC`XN@+o7aNfJH8`eSp*QQHqFW3sde2fwEBdZ_UX33WnqM}-6R>4WW+ zSyizCCUrDMc6(fGZtI=kLb9;`vTwYIP=peG|WeDNmzTIe-+5#^$mwe3Ew6d$F+)MqvNT` z=qIAhbzN4ZsA)I+^z^9%*j~$I>udMIw_<6$oT34XU(A%^jurIUGZ~4$Qcj;B0HjY{ zO6sdoQRuiTE$aO75vT^JfX7X|S5KRuX@q8>>_8&o`0J!;I;i?L0Wh3$I{I3C)|@3>ND^?p<&b>7iTidn&&xrZC{*9Un;Jek8>v2 z#o7`#fDa)1@z)LU`I}QST;|0pBdRCjPnyUW26sqlnw1^a?Rg$b*i(2(OB8O=>m6UY zi1jvmTXnYv!+!w#VSKoVH7a`{7y~E!?wVOm;k_&qM)B)iTP(?PqFmZ{jGJ^So72>u-CSBp* zh=zSjoMwu;docksDUw7|B0P&C^ZWW>su*!dlbz<@AGO0pBLK|Nm7}aZQ41(O5D>-U zH-q!;WN9g?6Y$w~m>bo(L9=^b4Drq_FYLrqGBv$SzG;J84G?4ZBkv1plSbxCD3(2E zskoF#u^GXN!M_E9a)$ikvfK%X=_`Ugo*u-fGk!%suv{k5ImE9iI@?r6WOsWfDJ79r;b-w#w!}f(MYEmB(mx}ckiq7eJ>s?DBHzdneNdST_00W$O>2Ce%(k_9_fh21!RNJg<*^GnJVS8-?{{VjY3D_b}_vKx7 za*Sdr$M@YIU_SNf^aV%+wyo6$%4}OQn%3hUdLiDWZ=Agq+xy)gnmm(+Tcza6hGkba zdz{w+Ls%9H`ne{G{zHBc-Ou%4iWq#Pob?C|cdli+D6trTKmnA;U7o0e>nt4bUNnMV z4XPwUlMP8J1joFQ^G)gW{u_5E>FtKRN#Eb5(a^BSF{6K-Il)*0>Gi5WI%ws*)!GiG zs;afqQ)lq3?$Q*3wCzjwj^NmRFsiN)mlq0^V3~mZB`T$jYXIs}J?)dSM7kQd6pAff zsbVNNV^*w9{mUmfiL@LIs@5JdrhYM`e|^#UiNt9f+<>v`T}c__Zdu`WzqkcD;%Zdt z2>bPIb?_)diD&P0d!hoS-x;tRu73(CB&(XHb5~!sdXfz6_7`Vh2PfMMLr8C|UDP){ z>%1Go>Kg&2o9d3`U7)3sZ5yMhsWUp7Nr#9c^%UdEbdb}F?Hh&fZ)4L0QmNJX{^qCb zya_(2(?iyMiZI8g^Lb=uPZV`JpmIF1Q5udf&)~q+>sx&WiMgOAa<|wIg~8D*gHPv> zBFdg5>SndVpP7h`eZfv~+iSS)*HoeRsmKO$pDV8>p0C~Ay zr;Bsb6I894hSxe>!`zj&j5tX!H6Q~$@(R3CY0XB`?j9%VRbW__j(<(~usj}^N75b1 z@O%FNNLE2fj?u08to;EtRph#a*=6xxSB7Q-^;4BnJ&x45`db__vAFAdUVlA$>?TVGnG2lBJ6}JF@4}3i7qzP+C=4UbQl2v)wQJj$CI|yNp z?xH(*6Qs38KAo)0>ikL1<&LIc)SoXriwsIZyEJR*FVgn(@r79GxsO+>2g#fJ2u*NU zX28+YI))F-Mr6}Dy7_D#hG-tEC$}f+ zB@d#ri4T(}in`7yoD#lN@o&HQ%wrCZm@1U`rKCntsxwMst~1KID#*=4M$(BOS9{zQU{sNB zV0q&WsnrZ<8Cqj|-`JMF4g<-TOj*58&=K#zO&y=UnT~nJvtO&1gb?s?!W5` zCsFkGI8o4nBdsS(6Ye1v{5uGc8y)bt*5p}{shG#Abs9q9RpSz$DN2LLvVPV1`(iwe z0xxZ4r_7Z&!c#Yf?eWwnSLg)K@_f!Ct@HXxDXHa}GHTc*(M`bs1J4*Q2Igki#>Kj* z>fyj?00BFK40}~j$Y?d5XfhnPD)AREN~-Cjf}U!I2Vqc|7+$aP@}3^OcxmKy60> zr*tEC!ih7~cz`1W#|;ew$@L|GAG@4cI7O-|o;=u}wbhTU%HXGv#wu9aFEeRdb>|v8 zDk>FvKv*Ui%r!wy;5g_7iNyURCEXJ77TE(aQpyh2+-v~H9W*a`4Axwx@+m`FRa6!% z%cf!6(*+djHq#i`Ro^`Jo{sy z=~McvoYd2Kf+Rck0c(zN?85INQ}S(41ZKsXp|!eo$C-lYFqPgKRY~J`)E%d7yIc?Hj=)8(=mo^IACnp~Q6h*OR zx%VXx<&wC-7#+tAl*YM{76wd!n4{qPSYC=#QlDj#bN&dbTvtlqGsF! zO_JfQJj!Hw9jbiS+ON9S1CRj0)PCt4J!KpCc-cwmV-=87)$CyM-G#@uwloYLGp1m7 zHD9koA%*StK@c-0^&;SOw>UgHP{p}d^ok{#8C%Q^wAhyPk?oIVcm$Q^1&H0_M=o5A zs=Ytck0pHDC9*)#p_0*oaHT-E`;It9fo0NKNvZ8p5EN0uuVarFV5D;sCfbp@z+932 zFRne6?CuwZ0n>A!^CcsnrSa6SLuTvkOSFwDf(F6>H?^_!uE@IOP+k@aTpNIY1^VOV z%Yk42)sIzVWy^|cdW4P146(6QQpWpu_P!r_OL?K4LC0jD`%kW=Si~_&vOADDHz(fs zow&BQbSv;La&C_$uBn}sDb0cPS#M+Y#Dg5rqZ~2G+6=C0I@OTVSfIHDZPOn5dsjn+ zxj$vn)zwQhRdB{Br36_cv+m~B#D1RDC&7hA8%t-VK~+x&npMgoNSzn!j{XvAwlyt9){Ji%OlGJn1RtIMBI@Q!I$f5F1gRCjGJvzpoq~Al2F7r((R* zWFMrm_^2u%sq><_j(AX)W?s99{hpV{p9q1Xgz)LHDXO<8j=~5uPLz-vj_PO62f%qF8CZTQQ0<04`m9 zF27H|Y35Qi->*~17#rLjVY2(3-i3fFP*2& zDJ6;vdDA@Vk#cR-zP&Nw;}fEg@SqdcYvHiV>T=3l(>SAssz885vn7t}5a+Uwsl-Q% zmG8krUP)e~&{C+ADy^uA)*`MYq?At+@(8r6#rWh7nB(CRx)=}>F09g-hIbqrG_?8B zsYqjnB8UZrw>wBcD{KfW^of-gYPn^M# z)KE8qxkM8@>dThHo>Kh1NF)9XJk|kSe-7TZ>5qV4bkMrw{t@bW3T)OU@KYels@9ws zen&f}D_zL_RJUMLj!Selu*a*m)lIrK^*EQy2l0rHM;!1vF4ni_gf2{it0B8V_qvsmD$PCvnhZ^VG!#C6A! z3U*fQQ*R5rIL`9TWur41-339DQ&GtvxUYsu>6wts$gZu_7JZMWtdUu4V307Oj zePf;YXQ8z|w9^??C4GKM(a$wLU>L;I!S*{1jHi031XzwQif$T%YE%t&j&@VtVm^=) z8kJp5gpN)k@#=z4(J60(x~ikaT?eIgwq=*o(p6_v&pW|N7(jt!WL=xf8xSwl^Mx4N z8D9P3qub!n-!f77O2(r^>kT^3tR#I9h`}QOFUzW%^2A>NhV2@oZg)@Fd=QmZSd~T3 zLDvP)U>kEoR3(2Hlh(}`AU8{5Rxonrz78oUi5*#jivoQ%z9VZsg)P??RB^k@3ww^3 z;mrkgnhYje#S;)?Pfy|{0l4UT{RzO32hs0D5hLx`sHev6f2g#EsPLAfBC8Nl*G_0E zqcO!Ixt3(Im2gKZdw0d72Zp6pkIvaGp_#q~{$wbr;%ZXKl*3(!4R>fQC&@;BDybsN z^4zj0BXo{D&_(7(yqkh{9svps{+`&M0?{#|s6*MWH3)l^scv(n0J{2(`b8kxK$(mMgyy*swI@p>sFM)4MK>1$dz!t;JDv+0jbDre%4 z1pwle&+doCgUNZN@e{?OZT-L0$r4C`;t|F-7hnkdJ;m>VYSX5{>S~X}<10PFYFm3k zJ@~muBGnBHa&^mc@>=%wyee6(Vc!T`K+#?)R55RoR6|wQ>e?C~4sz`&s^-cF%j#NV z3EEmuH=n)68R2q~))UDi;y9YDXv*Ty1>gfbwNND1J}*jq_&iRpQj#(f&9`pT&pq(X zwAy|utk&Xn#+3|qv5CVp*Pb$E(VD06O0Go!T%v7YNgwXMBs3fHQqjjN=w0~@N56*6 zNv`ufeNUBY&1F}e(8-bJRml}Zo|Tq3iBq?~Q-%1PrqK~T;;kGr9Z}73aho?_HE`sF zejJz*Y@Rc_<=ZiP52zqOZ$o-ESmdWL+r#4744 z2y+UEp@KF|v8Z!pTZ6#Ej6Oo&RZuJO3Zcdy^aJk&HOa61YgLY*c&C^!dsu~!cjxHA z*&2Q-81X8jNg>u5Z%?$*}zQA(i0*q=b z*1IRB)R~@JT{R_bE?8V&xjpBcdQq4yTc%N3R z=!JG9DuHY)2;1tmEJA}tg9nPBSI1Ta_0GEhJ?Yl7S$M|Nl>X{fQkxD^mI(IW>9hFb zvq7IBs4>K=AKe}KDl3}!qvG~Um&=+ri4|1~PdpJka>R_Sxx$XAz#Z+^1HTDMw^i&A zNfzgo%2s3R0zUY48pkooX=lfTW*-VXCz0%A{@60tX&2I5$xFG&;8+&Dv0LFz%|X4a zc^$>APU+VssWWo=Us>w3cw?(G?G51<#HN3z^BFSi%7$$_^0kql*2J?qq>8O$Vpih) zu-5|Cxy_%DKfxS?<26h~>gRiyfi(UuWU2(eB_+X2<3Of|wFZ-ilU+q}7;_f7rCjq%pP z9~^u_f)!Hq`94mre)6uq7i-$g2e~=G>bAb0R9}@mPc!}Vq zU*O#iht%_AlsTS{qN|<=Rd$)nx;qfS+qJPL3&FMRIj{R%tDI`76^I=Cf~+-v8~#4P z8Ux~Ob8P_u3m@S;@#w?xfu|ZO4}e~ z5x8<*N9YIMtcQa>B>0uB^X$td*V^*CHldFMl48vY@Jknv(v6_*u_3yf{rSawi2afKRn?|opFck(z(lY{95&u~ zQZ5EO%DXO=^6vKoX>vu}4%p)7MdanWT}4h-Mn&Ww#dYJH5kx_b(4wgE6ZX|&pNak= zYb>W)>Z&ZeSY~k3(pOZhD-C3*ii+fg3%FX>#-)eBv5f;L({+jQd__ZEq&UWFM{q-x z@qb>)FPZ(h=7q}GxvZ0Qk6w2hV6R4G`lG=h7`mEga#I(JTJ5)gzsoiBDK|B4O@}>C zUYO<77=9?zbjpq@p!n{v6(t76swfTv58!g>wbrf zQaMRz`|Qkjg{b|@VqW%UaVBe8KpGCfIjeU0O&kM=cwM0_+vtA3<;6(RX!~|6 z*Gla^+NEPFiJ6AN4S{R>416gC$*NcLWe~|9F#-YH2=*TM_|Xxf_*N^G5^ai4Eff}Q ztHsDC1A%KVPN4Ut5*K0>BMs%)Fe9n|05&BuO5huJrHx4=NUkk$V{kfKwmuCjjKf6b zrl65CcqAg>nAu!idJs*&JWYmgU%^F*a4aLU-G3#P+B?PX6*OjNsx-!m*Y!CjS5KSf zG9^4=8ZjfvOBH8RYuI$gqSmwlZ;IXFVOXaTQSe8ubrZ<>qIExy-w~AvvJV&~UAF)= zJSO0E=gT+5-CkczrN!>j-V9Br;?Lq1hMFwWZxf}frKhf?f=X#9=?9o3lpzH9KZo;hi@qiJX_R<5r}Q4Me2$h~4^5d&ki{D-%G0tE!bEGI zYg?(ocv?*$k|$4jNO-+RHmLx|>&@hkBaTNsuf7ixgySkhBmZ8kR^S079o7|8Wf z9PZ|m)%;2PLuKra-Y?a$k$|wLrm(pN{{Y~)>5q#TZI|hV&@MZxKk)71*NA>1>Fg2zCU>JNk^Piw~Se{K3x&0^2@KUXJBkBf2!lYArz^|1-tWc zxku7#h%jyeJ`w!t+5A=JIfkQehphU(raFq;&q+;NRVh$`=9V4qc8{Uy?{nV>YqO$h zY5nb-wCNohD}EKlu5bpzqle_Q`Jq>cUMlO43%nrk_Nzqd3Y|MPVVh^tSIJ6tNiWJO z?A&Z_w!a7{~u4*`)SGq5aUms?cC>O;F_6_OWQYJV2)0}YX3>pun6s&P7>U<6O{{Z5TirygB zWV**&)Mpu0W}VLJmMMfl3E+sLn<9o5z4-RRj8zs`!2}mf8TgJqN!A)#*AsCpkK-FZ zM4)fOB@}b#z8_M}FmSo_#4CbQO|!Y#VhzbYu5gzU1D>U#haqyTq!>N*Zj-G)iO;Q?jIV^$vj)JZ8adY+EQ`*jg>J&0kk3*K@R} z0(^S-{{StQ`=?cP;I%Cn9DPhb%dQC+Mh%x9u-E8?KFEG5{vvf{JxydjEmg;|IT@Gb zX^>hqEOw74sROnIsM>ASyN`Mzo*OXrw7-{{w%Y#yT4$ah_(Sm7sPPl)O5Ev?}oHEkVMXZb64C}vzSB@I>ST+r||>D_Eo8a#2L^9U<*SHjmhXd zvGn)89*PWT^+ubeuE*7BC!}_~f%mS*#Ge^5)s4TpL$8{4?ebzazdZtdG0T|2@kfI9 z;Tp%|oAY4uM-L7&{Y{_f9~j23&c8~@K}SaLNXo0Vrmd0n zzl5rtUHJ)>yk7C0<2Ca5i9J+s)YHW*dm@YQOE;WTh~43-mJAM7`MqD z<#xLo&zARug{88ewyiPK+35WjxYobMsT+BAysZYl{)pdCFt5dDDXgzD_iBC1~D|YyzzFP8mUK#wR0^bi{{5r zBG|>7X|>m;0<2gBb#9+BeR-^N3XnWs-YD${wUSS4(r>ehTa=USss7p7veGaQd8XGm$tRE;`5|9~aGH%lqFS9F%%3x-^P+C3 z6^JN*B?t4wED%TIew5;=mXF0g=PJkI>cbC-y7=ufUpc5M6klk)t&1HufY#41GO}EC zFTOj&+!1@>ijKWkURBaW(#ah)A@X6nIrZ3XQHHoIYjEz8t5}>Vc!X7x#Z3A0s%<}+ zX)4HO^rJ}htRpdyEJObQKW;GnzjO>2l!p<)-0cD-O-)aiRl!a#9OUi@(UJ=BadU#( z_d!VfWEa4%*eFi6)*5#qNt(8!Q*TB6&LXMDDZF(|mG{ApWyny>?^?lIK^jst zbudb$M5BP~$4|F7uGiuv`W4Wj8zG#ObYo(~9c~WwUVq#$2*kUZ^P_Jh)m5kDt}@L; z%O1rZpxg@{pPoHtDZr@ThX&~RqIE?sdLgB#5g>(DH!Rkbw%kl$$nt+;Q`16JckELX<~CQ!PoFwH5bW}YT#XQ`AIkF~CDNAJZ}t|9d&F|kFm zkZztU+*PS0!j?Dkged(*T`p%gpGeVe2GSC?JBMH2iO639o%0oV z1T{|@h*YJcBG*0bjzNOE03z;|&S1`3ByuVGDj+tuBdPqcd*J+EC=GVWP9q67T%ptu zXEn7^)0cIpGDO9Pr+S{v-xk5eskJBcQ&g#?E=4oaLsFDIcUHI#)LsnzTksNG|>=J-ucp@}NOW!B1|x`$c#U7=L|jq#N$s-}fyN?CI8 zGeZoZFfs_jjyjO1chihYD#hhT(UW2mXN583y3UtW<}`jOWVCgZzF`Yr0ogo3cX{Zh zNT0p7b@%OwMNHR~6PuRMpxPJ2oj;vxe5*@lwd=Q(pfH5oky5g=QXiF0H_a91uVyFRHeNZUYz@5m)46)@HRy9 zT&sLBsmOI?+AeKp@^p2LJhXYeOiM4V3AAsts)5*Cj=1^GGZMaZWu8hEp|i~qPo3)R z6XJfSjwxv>!e#k|ATcFeQJ|2zNTq<|h5(*}A9REmC3HlI0YSV#)qWbmN1xE>?OT}4 z)Te1McyRy8LjJO;EtH&I`>}(^0Hv4 z@dLv*uhe>HG4rW%BCyYsR8XzSsz7&%8~Q$#xBJ#RH3IiM=%94oBYC73`pE@%^9ICfOsV%_W*?NbzJP#A? zL`fsqkoYfC;e-DGbR531Bg`Pm^IE55t3xc3(5j(OoQ7prB~%VB4g@tOz>e8PhegWu zmH3nJ*<87nXHS)CT()eoMr46})maDOA{Yah*=~4J2_H-2<~gAJYa!|vYt{Y_nilw- zn&@oXEYaD%gvvE`SMyc#HFWi%_S91ZU}KFMM^O8=l?tn2d*6#V!@Drw#R}27tyQ|O zHj+;yR8_PJ!~-qXQ}+Y+eeZ(TWh>8fOs77}sq*@j%uvL}K=9Pb19_ld)KrU(I(Ns) z3#62~gD4c0nIVrej*h5_Dosq%iHw_gG0DGjgJaYDnE8Dtbjy|0WcgXnsq%=cj8j4j zER`}(AU3w)<`RE)KA2KU@1}EFJfY2PEE$~ngfKe7WR|uzDH$g19TT9 zKsM=#Gc*O@Cz^fFpo2NDuAei5GD&MuH^T&ztPD_C9fQ(8F1QGpQsyhxeVowMRnQjs z=@&1jM2X^QgChZ8zg&6@E}BS2j{$Q^n(r07JT)tr7?N4UTf^-V7+9Y(fAF{06+STO zX#8NTJT~EIN5nw+p9#EOh}aL%m8<|32F<|!c&%W_>16z-{bs8Jn=SqYU+^cWx5BNL zz|Ra7AN6N1dy(0^=i~Ciekpp7jXG+-nv1{yTHeZ3exOIy+&u-ayP-d9FKvaBCnrp= zba0?8)2+WeO+r9J*12BXlHP!S7w^YYb@W+z-La$~fGxH!*o*}^i1pTxM&xr+~1IT;IsJfXFgGpy( zf~aJoVr_AAGV%}C4lsu^$BIS8*)+s+2yIE4($eP?sI0!V2X^kbv9zjNsS!QuU0<3* zG_pn-HT4fx?!9r*A`n8EQM|i3iW+M18*i0mTW$3p#crR^09PQ0PB2Y}g=G9&o+Q=i zsWfbbUamZhnUfDv0_O(t?fVl@Ze&7bR%*%a>KDE5R&gB!282g)mZHCF=N} zBsR+{;*KiWC7lNPi3t)o1P-1504z7BP%4dKHeGd9L?5HojZ_x8Zys_laqdPXbHPhJ z9!fs^JXTX56mqvo;%S#o=7tpxvJN08kfin;VP$Y0D0!3Y_XTl#<(>!LR7Y55uvJy+1rwxBnY~hNGNKV@?4*u8u;&gS zdlp?-^^baTdiqlZIF7b2Km^`c#~^e2csx2+AQc>wGo+V0pp|MV?iGl<@s4=zNf_d$ zmPAq<`GsnHIG&b&4RiApyQUhPoyyylV=)fn(r;ta6^Hdnm7wA89m*H2BUQ?EB<&)g z{Tgf}HdYs22j3Fm<1j0_qTbb9{{TqSOoxOe_*l-UUO zd4;SW91HWF4R}h^n=sCD0!Zz8E^qg?D||dfCjKM-pjIkCbf@v#_1vk}nw5uve-vQZ zLrJCFDHrsbm0RJ*4{W`^h~Mx+hvR|({ukA115{^uXX%<_9b^GSAQSTu6MJnv$F>>t znXlwexm2_H`^r@wX_b};GZ>rF#gNoS6odZvk281pH2JRpl^meX=zd=&SnDBok5FZe z<@w0Y6iyBJC))vH8b~_&kJLxSDc%9?4{iQ4ey~=vc1;{eWCPP6YbpAIZ)`bh&m@e~GNzdXS$;*H<>>}< zPg4Nc?Kb5_Qb*t=i0OfGGDe5MN@Ik8;c?ug@Burk<)siZgiTk8u|l z0Nmc){`k+h>l_->2iDw2C9(a?y{;|*k5uSE_bc^O=2?}W(Q5#pabfksR~yQ;G(dn? zDUG;_GDEexUf*BK9J>B1ruMG0ULPPWmuvcky89o`9cG9DdlRa9%NR*r5Piz6D7d#_ z$-y+P;W|ndrJHZH!ufkZC+V|qvkcF2IH)R3u9HF?9BvnSeF%SR;bc`Ho=FI38>b2>Vk%>0-2Wv^T8H~LYYXUiaEA}DP%(;2eFmENzw~>F#8cSrgw)lh1VYre5 zpZ#_J0Gg(hnu9DiCb|S&x3`}ai5KZ-$8trW_z6mbz$ycsX4Erjis<93iP}uUjF{t^ zHgW{u+zXrFX0_S(^TF@o&}&>wIifu<^%Muwqo{e4a3)izCw`8+&%X2E`3O zt`Djemxms#{sX_k9EM*JIh8#WUJ6fA;wAp)uq-al1<9-65_NSlCr#>nwi`!nm>w*1NpVg?7d?QN< z)!rXQ6^gc;%?zD*Wuugi2V0xk_)2W|o>dRh3bE8@-Y1nY?o`Vl)Hzb*nIvyl6cWcg zzGA$pBv$hnlEby`EsINmY3E_I>=tg)2=G&ieNUABn2~==(=>9Tg6%Q^#m{mv$tRKU zY4TqLgE-Ezxw6e!wzi(qQohDnqhj~;*+t1G1DPfu>NNy!+M7^wMb9JjtKH+}B|c-2 z{4-Q~q+jhKNWoKLN>htmeF*0W@lPZk)`{?_RgVe*d!s<}9xQL@RqMuSq8LZ+L?!=lJ2D4=_!>(v)#_#!`Mr_m!X3^G7>EhN3XBBB`^3&~wukCcm*( zoFu76mCf>s3QDSaxE5(8zm+JIDU9=D&s+ZhRtBjzw%%b+PhC~{{>IC!-Yjp0m6|;( zsKcs|%5IHo+uZg0VQwPUJC{fCZdNQSMnXZ*)BgYkV&m}Ok& z;qFsAF5aOg>;gKQb{Cza(b?& z%487`zn#Fs+D0esxJ)r@mPg=^a<3E`ih>yQsd>P3qm3jgeLIRT;`-kBvX_bOK0#+g z3~%0v{{W|{Wu=d7t9!5qaJTUz9dw~^DG-K7H;pn~OR}at%T*8yy-OI`(%V+%{SVs! z*6Ulp+*3R)kF(wt#Q2fS3|jNcR|LhUvR2qs?ke!|Hy*dQL50=&*Y5WPcEVl0-+4l< zPnZbmvT_|@L6S(mxd25Wi3)B-uXADA*zXE1knusXi)gIImTD?XR?|kpcHA1GE>GM) z7W&}uNLAOb&SVwR%$}W@sE-N>ulnhlk{T9=@a~ptZdf+_w9t0;2!m+;JU16?earE4C1eR>qSnm z$sDPfQnZe}5&XalpP(FmcwPu5-JbBDICTd7Q|@xFel~i1Q1K|D6mQd$+Wo?>H~Jgg zV#eXsZ}7eAB*k8%ygk8LpMiRaGW_>mPSqlwNixb}5zUdvm#_QH?}d2BMqlB6Y7?Wk zv0e(zUp8%0D4jlPA_uIv^pV!r{r>=-D{jRX7)1(Geo1X^Yf(#1p)$3SFhKK7n&5R7 z0QCCeQ&r3h!Aunxi&Nxzu$8ktJ(pEU8U0GjN|(Bx_8zZ$5Jw%m^@qfVn}h}}nMIXE z_<+v7cB3Yl@`_Bhh&-VlhB(4Z2sSJtvahff1apgPE&``i8--nKUQD7-Ooz&pIZ{7n z=lZZlhyYTmIiRPaiK%L~9puUw{{V%*TYd2v5p~!Ifs^G~HB{7#U%H+x>nV6w%w_iU z_rSF~(+o3ZS~~9y{4v#0M?CZr<__q)r;hP8m)%EvA$~t0g=MEe6zP`uRi*N%=cl3h zx^B4A!LjG3zg!U7iDgEKQ5{E_!A(n1G`?&=1sjU+ zLFh1DGnpx<&`M#``pTb9<`7RbrRI*(DLg4dZ%^*T?F3(v9n1*FrUp%@>T`WTsq(0* zXzC>&EioHph%Z8Y>`xe!9M>zDgeBDZy)?~LQ5{E?h|L^vbliZOH`e&}B|zaS4?&#P zW(o5&n^|MJ62|`kyB!f|L*xm|FR6~AI;yGsxLmHpb~Xk1;~a*<g6j{gA50X!6AD1xT7RLe^X1&xwj z%B|&gzf*{tTPEs%MrlzT{{T3POy)6CC!ZW>o^z2CT=B~tpyGB`F3_n45OPIahs2r% z%BmoOS!5OQkp%4&fkc1~7lH53<%wI1$aRQP3?bx&acY`+MVl;|tc8+KHJI=ikALHa zBN$z9SBDNcBA14>bON-;6-LMz_p-)#VtU^m9DAF(^kG5SS$Z1nIXtt{W_1adT$2>C zp$dMbfIsKQ!-~9KSB}B8K1t!OpUtTY#jf&*5>R%{D-{?20BS(K8_?tLXD<{f;eq-g z=ZHE|gTnl_gE6VjmprAC#z``GjZ;QDGe$WJ$0T8(`=ke0@IX}IXH8R{mhid_V?hpR zGl=Nom~Ifv3c7CfDLc6qz3h5l9)Coj_OBVhgOlx7f;BTZE2*f+04P3ft_OU5{Sl5z ze}F*UfB)C@P2p~vq>`Tcbi8GJqOruP!2sZ1#^hfVaPqE%FR9^nM@o_WrcNPE=k-eh zuGha-;90+(IuC`(zN@`gf?8WNl`194;A)tT>&;CQu|3Y_`*y_5sz+iT5}C9O1W+o| zP(o}iWkmy?-)=d#(;PaY^f4rdK*3irnx>dXI;WPCGZkpp+Bf`4KiZyq^cagVE8@Pl zhqPn$Q)V+&L$=H(sg|J^>O9A9;0NcAbHe3)pFmK_62T7V1KIw(yb^efjL9q=0g;a zDkI283cR}kZ*zmtxuGqG!F;fYqIl*jxRwO<2e8MB?B#f;@Ow=V0Y2<>X!$w{zk1a^GtVeOr<$wtU+f^);#+$-TF-I@S86kv2 z_`^%-YuxbO{Qh|4It&waG#KWT)aZP+y1o{NH;N-o50wJLJ(U9Y3;iSC-xIeITVPa0 zy^H04hfwE|8BI!pBG}Rf1=xpJP*$v9C11o;i3l0M*zt3Ntfj7YS_*e z6_4fPXjQC5&j+pl0EP%|Hg`f61jm_Vi#=*GNUs=BfQXR*ACMQs=Aq`ifNY3*KPaoD z)L9Kgwb4k?NKA2s3QE`x-EDj*;!h+u@rSsk{65Y^j~ex!jnaBcKg;|>e9}ChJ&sJe zNivE?shteBH`={8CzJNVJRs>R29pGkL68Sj=De23n6#?}R~l{3AjOC>Y~WgK&`$iU zyZ9}Y>CH3Y{+h~krCn`qM@#}VhLakpH8m5M?P-uN24~CHEPf*d-E_axDf*KW$?CBDv zgGdw`ZZ;fnZ^gE?N^E1yW(Wsx57KYW=xO2P4V(U%2QHz_ zyqaibS}NychCt4#a##8{{y63JdKl#?o%k}Gg8sG@TW-$qZ^UhzCaN^ ztKaE~Ml2m4{jNVc>TiM^;c@o%74YPhk1>@zE7H#+ey&NIF_y%2ASnCe#$v$u-2N~3 zYsYX|I(;$uiOP#0%xLFnD10>1biy%Zkjp85uU@}Qap|Cqeu(ochj6CTKhHiv3Vcaw zhSZY@Jg+`FG?G|hTPm;gRQm&LOxI>?yK+3#y$~9FlRrW;czdMh)Hw!EELu-0%{HXF zYBL&#iK2`!Bt}#GZ^eIMfs39=14*~qLXhC;J)<`+Q{+?ocz;sW4LrUb=?NWH`<+{djg}{8lb@?Bf>5H{{Sf3B-}|7ka+9)cEq@u6ZpPC4NT@BMT?cy zt?=V2te#os@QX_30;AN`Q%vGn9IxV#9*le25z@re0Co@G3HLZcFW{OECT8U58h!04 zjeIwzREpjSXxS8cSz9)c5WnqM8xMPZFiku`B1!zGe!7%!ngYi+%xCH@L&G|GCoG-> zXuYvqtNxa2fydBs?TOAH#gBx%{{V&s!QnI-em7@PpQyQN9KNq8(~`w5lgf0&DO*k> zrON8wXyh`nQq8}myIZZ!0;=+4$1Z+vcak8`Z8!jv-T?OiqFO$bXL-cbM=GMuN9gJ1 zS{k-wj-}(bpt|%N+~4Vl!;WBe_W3V*HoDF*58IJadAu@`R)|aBj+5DO>s;P#z%A^f zZ$Z?4SSQj*ALIW3l~8;eNShybn-aLZHIiEhycN=Hz#I9Q-2P&L?SE`?+(d)?{&foB z*a~bmC$=NWi`93BbLG@&H9vw{N}*N5yhk>bq%1GBlsBcAazH(8h#y|kPFNa@(|EU5 zpz)bs93v(KndcjK(>_Xh@#QuA9ng`9=tH$9MQ-~tDAc5AeKVkv^!!G#En2f5iK!y z8^x#Zx+vX7n22-r8d9b0{`%QcpN!v_i^ff8WC*n~Y5bhY68htYPc5$+H*mJ#cNf8w z=OZ&~(qBlNtn+6iZ2Qr#?v7Oi~ z44o6L!S)zUM;7`|c2?^5&(C+^v2k9T3!R*}Mp(+$pWNBd4qKdOi(a9BhF>!y^NKKUR z4Z7hc6~;QXILl&haDBw9U))c=NsYh_-&g@TR;Z?3&0}Do1{|*(i}&~Z@B@Ze z?h53?ntRW3O#x?+GP5rK0Ih~TXx)7Cv?WqR;IfI+ixw<;W48s!J&WXS>%D$uZ?v*9 zw;`>GSbozVwR;?p4CdO3nA9~N!!Di9q4Q)vrR50EJ6v6)FVVVv{{SpnDAWR&xbde@ z``kW-TgB0LN_DszRi*rtu7ft!g^Rbsc9yo#!OK7|_V>h{D2+#jC;qa7pme~^{B1Af zmp0UTsnc=zN7JofTG1?P)1f{{UR&aD|}w zXrapDl!D_elgi#j`l^HP#s0WmiDMmn%@h4jq0_zS$_;%hOTUhyHSPf{kHn7=fNwj% z+Mws~6s%I=eTdnCMHa`d+y4Mkcj+mEYP(aKKd(|N`k%z@e`bYz3az;1w$`evep@l& zpuzFm{8djS>8SbMHk!1T7uUWZ)P*11CZ*64f9GVXSEnC?92_+_YUcj{6Hxo~UYhT2 zoR99*M=pB!DZZP`vn9VrN#r*N z+@D`-23sA&p1fiu(o-EXd5Abew|(!{*!TjtE?qK5Q<sJN2 z2#$)DrQ_oM2_H(z4GK=E{Mo0asp^KGjoJ#ak$gMk=)Ru|d^ox0-=eBEoAZ8TKVNJK z(_#(fzdo<)sYVwM7d1X*KQ<*4{{Rlz6k8>42fRKl8!L%v=_P@IQ@9YMo`hfS1|oJV z5N1nsKe|;Lem&Gai9x2uroX+?JNF1#0@Rmq;8*xJ4)*W$eUX!`o&%U013P{qwx#Ee+jDO(K=&2mY*e9#M*%w%nD>btBq6} zgKqxA75q!;H2v;9YLhh!K0BjFws+?WT8yUWo|7~~Jytc}5xl`uNxmKONiVy>Uk{q& zk_kY^=%G0L@F!1S@PEsSo>f$R4jfoIq<>mx>LhY}I%H-RjQAm-H!r9Um~anHq$e2c zVk;Bze~+vDs`a!m{-Hvz!y z_c)!es%JEMr%I21FO>I3geU{)u(Y(e!@=t?H?v?TRhVB1m1dvBUj=2j@}-VSNBxk+ zp>Vs0^iLq+z9qmHo>f?UGiChXk7rttov65eNj_^&kHfA=($p64b3tx*cP%HHcarRV zU*jI9?~3TJh!%#}M_RR3+!8;1JmhZRw}M_D$>|}BNhQGc z>M=WUSdc6!{{S6O`|7C$DkplM#nM0FWg?5=uOp4#SUeB#`*{OscBm>xvAH81{2_{b zG>Uuv>r|nB zGJztQopLkl9{&J&QsJ5$NgpZt`qpmnr9TTgB7?*)2#fzarMeHS5;H)an3W(wQV`)5wlWd{#<@xrqR@=o)l!<_a~%@Z&^)sqk;ZLIv#0 zLp_gU)$iLJ9wmwv%Fh?S_0WQa5%Hb;T{G{dS2y^1r-Uxw2D~y=CdT=E&2Mfu~Aj;z}!|7ufUk&^% zvVnDMo^>RC*47hs_PECf8DD(A#z*H}NJBnVPnyrwUE}aA*bx30cv_52qGigYa;xsv z^`>(n>XIE9!Xx4s!gFh9yJ88{7;QmN*iVVC{=QU;;Y^|9n z;k01dHGW0+T#Ow>?`t~oA+OMvYFoJ{l4XL+(l~-lhH3ydJ&L`=4Q7F)r;e7Ip_jx= zseWFw{tL9fEcWw1#rMJVTw23FCI0|R4`@uEMYUYP9~<+#iXhVEd72iAqr*)D70Bf` z?Jdtd{{U7MRK(uL-RAVbaG1RB`b>{vYdTYcgFumQhDWk`~C>yvbc9U5e%TDj5F&6N2egbI1cp z6Q_|YvqV!DpAiT@;TaX#)f7@Bay?WGB!PwEW+}qI_=JvdJ!clqQypUpMp6|uR$VkE zZZ47OT>~EbGpVJNxwmWFeK8=ZP}qSzrkMA6p&f%~Z-ABNZ4;;}PRVr7hvqdSX_AUV z!0q_^Vn&zmm*+J@@O3@2e8h&UL}wB(YE2vA+%w+(f9Uy$^z-Sn@ZQHCbdLt{*$*B| z(ZZ>V-^Hi_F;+56wA4!#%5P&R3YR9pTY-W|C8AC9bCnxFrtG7U+BqVx zhgm}B`cqG45$SA)G%P1tkJEJTGXSr(HY$+3*{{3UTfPH(oWf$}Ok9s~36H__>j9p0 z+x8VJZ6+e}o}a_N590#+fXSQvnA0UB2>Pc z(>W^sgO%U(4qx)dVuTb)1I_r$bnIZ&DoGgq&z+` zf_#|jsp@2uMRR3ya0&Zk%;lCks80`~@_ldOJ?0b zYW-|)`C>QJJNbF9z6_zZZ<@Ou2cJaJFZP+Bz*H_8j+$kaY&wE_{(NE=)O1_R$$3Ws zMVG&bgctFmN!wCTe9TeFFX*auW{s~J?cM1E+a5ILXeZ?lG)bfZIY-4lNQvRbQC*zr zJf5d7)B1BTj#Dt6Z0;gi7UXS9cI*5x>r15RuKxhEFFh8OKr@3eu%9BPCrWAqaZjT( zEK#Qsv(vLFTMzdPcxn;L!aT`bI|V>m4~UP=T+>KuDHs*ex(IDMw!JG3p5Ig39X6pi zjXx1~+$9zZNbdgt8lQC5QJ&@LsTVTJ@;t5ya>~N1kwjx=Z!L)PZ`DWhIQua&dk-%q zHD+N+w`ih<8#h@ zQ}GeP1rlbGUygxL5A@;l4^h3x-m*+!ijGz%;JYQu^K9c;E@T3VY6zrT`hzU4A}#dU zxEw9Vv^oLp@AHFf8k%aE zm5UJSh1Y2ZlWv&tzk3;CSH#J(Vb+?PF32)!+S*K#o;eV0S!4t-Vz$3N{{Yp4sK(8` zlALq$w(B)>mWsM6`iUkl3Wj7rE`fEwgjx( zCKNSVG2rf9CSj%M3`h)+T^X%#;Bq23zI90qT8{+^-Zj&XoPZw z>$7QNG&Iq?*WB!^EL?Z72MJ$rkE9`5y)&z`__BdbU6#?**)3zB6r`O*RoK9UwghZ)wN(yUV4?HvRHJYxbgz1W= zKdq~wUGbY6*uq$<_54Z)*R~6zjgHR66RDx*LEuhLqN|NXFNoBW(e7U{KhRV4}9Tm9*==&L#v_DD?6rL{Ml%U`2SZ7fy^ zEIwS(sC=`wZM{qGMVEEP#b)4(1Hkvhjm&iM zQMlO@^yaKxU6<2UK^K~{6SHWwi0yBoIEB?ObZ#6%cv=|bRW6OX-mjs@oghV$zyHuF z)Mt5wQd`V6llGBsYx`n_(iLxjo2AV&6?+Qe7=A6u&4xYc3il`}15{>JPG<8KRvaz8 zHy_uIB(F5GQp;AWBS{&E?%`LCPrf`W(7Zeq6{l@UI{>lg_hZb(a+_z%Y3b8{%sP^6 z0*m95W#~(Cti5Stc?`}$Jd!$J9OfM1a6(=v=_vgXQb|$f24f)>=ZtgH4T6Y*hdw0u zsRxGC&{D2izI|rs)IV#lU*m@Od#e62v0;TxGu?Tqs_Log(=(DJ^8*Bju(05LIKk!6 zk#y#4r`7)e5ZU5Wq%)n-n1o(&J8XJh_>yIGac&AbORKYNk_qZE+Tjz-%EgfGE=lK~ z&jLMm++&d%tHw;_V}QVl0Rd+77VWyjk%)<1dQ*yt<{mO?6HtvEVlu?n@1YE#`er;W5D_L#|Z#!n%ZPoKUTqc+E5>UzT2anuAP$U(91+$MeT*6S^VJAq3OJoTo9)#+;$5k*cI6 zB6#@ReTUxI?6m6(jZ~sNKUrGaeqoIK21k2Xf<=$MApov}lJO2@ldz6bL}tp{Q-AI~ zvDL<_+_JmZQq@T$Y=9(dV_?3bKDhcxTqMgKYdgBhx||Spm9f9q9xs%gYnw0;tZ^Wb z05-Q(9e;K`E?vwndC}ibzBN|b%50*?^2bE43#B*J&Sig|m(;SW zdh5nY^IGYa%f6B|DjW_=d)w)39uCP<>KU?$_z9}BjMv7045X^fCzYkm*;p6!1Taa# zObv@@=$=m5KCo5{3AnWD?kiqALGdb+!MvL`)w$@JT&9L(N|vRFODZI?1Pmf>4=0j( zVyfCtto*DJT=xJi5xF_7+2XBzBUsX1XcNC7@@~25zYr<>Ny;+aQFQ?q>^aF zau~tdcPj7=$3cX+lKO5VE?999Xaq!omfQU)))XC)H( z(kcXKrqv|Ko=2x|HewF$m|=!-ExHd705(nxUwK>fD%(jXj>Hgg4s5z9yDY#ZY#{@Tq^xbUGmSXtB@J+L3>&;)s4PM~D?U!hU5_o<(sQq%ch4n<(A{EWe%NyHxH2pa3h|dUb%04KM=#HTpYuLl)Bk4ry4-#|l z7c{LdqLWHeVDhUQwb zv%|WWbrxHdjML=cl_!MMigxl?dWdq3(!-8FKHSm5wd4teNyIvp+9oE_1p8AAUml7H zb@1lBkf0y)wo}`!yo33B;kn?{{!&8kx@R|55JteX`Gv{8I^bjx9}Y7a7pQm50ysaF zKO+&I1x);7;GjQsBpD1oIe$q>>;5|1&A_<%el%DjH@0OjALhE0`ZEVSldDP?D>bg^&=0B+|5 z;c(5wv8+1}GNj`*jW|5q@9;8|$NiL=rXU{$w>^OL=8}%U^zzRGwhj0igvnLUPABE* zzenW05A34M12oCxU;PiVuXUTYRr||qTB{^62O(M+dC?Tuxd8v}7 zrW#*8b2)azW_3kj=^Tsmd=BmrNKROsr%C17h^2@xARdwl1LAMh^FqIk$}yIB->;%+ z31~8Gp5S*S8;kpaYaDWE76!MQ$o!U{B;Ny5F`t!4Mw_~*+qoSd;>A82G$(`FaOg>O zA4Ol0m`I+n-s34;CwpyBa-t|%`~f8l;Y@ZZ@zoWwl81&5cqz_x2K7y5cJ z*T9r?>c{YxqZsq@&vrzkF8IEw_>MDaYL5=%$Y6(MOI4+GvpO<5vVes}_iZ?@al9ii zbc357vvi*|dHa}is#Py@ZMSu{#1XtW>b}@ zQG11!%h!Qvzn(dF38Z#Xx9-NXt(CfkYknAfNYuVDwxG>3c&Vu=GR1&@dlpj8=V`yK zuWJi^@lE5HHqmo(lfIq``M`LsOm#A9GzoMF_MdXL4VM^X4l@aC$Ohfa3E&JNV@Nu> z>d(_=+gtg0FDXk>;kH-Efd>G&x&8R`Nzj??UV_oG@N)WwRT9@q9l7DJjxrOgjP@^! zz|apAj+|_YsV6NU68f06t?h`~EM${?)UGl?5vIv%QbP-rlY5f8gNEsjvI$XUE9G4s z+7^Wy>TlF{$B$&hE~&mXUh?d&Hmra$4ZJfkZd6}_5AerS@cEqteYEpjRjNZzary-L zDl4FVI5i)`R9eeM(&-GpIiQbGW|c5aQzWs=4AV)67t&&Uo@gPxV&ke-4@x z!Mu|u(lBSqnrWFUT+L9>vWTi0D+W+_)~)z|a6F0=mtWZzY$(!LKh z?iECD-nwOa$8X9;9}4~}vrmZZgT>67FwyIf)nxisw=sodt7)Q^H&%!%?gGqNfgb$( zU^=`xte3RNEOhus=|)h*65t(Uox9I9Q2rAlHG1p8$7l?Y(o$4RcJ_E_o<%2v$smjU zF%?=t?s(@^M}(gw^_2^04qXvNXn(SQsA?O`rtp52u^r@8noP=aWFd&%=~0FwgVJxU ztoHAHyVYH|w-ITM!Uwz+-aqV{>sohjH^D5tfKLfsP%ZCrLB#Fhv`5+MLyLGH8|Sn2 zSI7R!Hl{_ESv(r0jwDuTnR5x)ssYa%MmRh+i;OlTkS{&kuYD!@oX{kjwCE>b6W_(& zef__;fclt3l+CDeEWMSYD7*}-v0m_e-wam z8~lF)!}+CoKiOT+o=D?|!i=PD01+j9VZHsVO}b(;!f3EbYkw&cG1-sD@hl&htnb5@ z#=dLg-nNTI<{Ao{PYSHFGp&ZE8kwheG}P?uyIZjs0;UC^W@K18Vr|uTG+@O743{5P zF4OVb$)RU|gLD+R{dSwnD`2x#=kgVicri?CoE8VDDo3^zV%lZUb*9jKTG8gLG;1}y zy=t0wm2owf_DpkKKc4CwvOfu+tA{MjE3)BIb4erf8k%N{aUM|Rw(dNhxNhDROo5wl z4*QAQy;BA}w@KeZ(YfZ*n&JM*wyD|XFM;&30Bz{a z^;ZV|$?m6?R*DYI0XKWzfYu{I6>dkWzme{81h> zcz@uIw_L1c{{W`59NaZ0o91~fPx_|X_7~l@{{Tz{h{6gn5u>!7qnfmEx}77Pt+MMM zg~LP+$l$F+=Uqe`qzW)GBeZwgVpn`TPUMIv|g>wr; z-}ERHe;1nB*$4MA$|XWL{`i~KZuj4Ueg~l8&fKL$e(9?dF}eNHe2gWd<115TVmf#5 zk0}W4a;sN1=6m0Rb7Sp}PY9v}2p#NRpSnuK>G^-$A|6fR^?!>xFU0za-5VZBQK#r> zq-uC(c~WnfokEE>^(p~wFe|uwDLO$KY#}&-hIw4FPM1fLretPc>22IF z>)_S{>kk%3n3YyMezDP?mHfpn9~k~2nC<<_a$^n1+bpv%WBnoP#G?Sg@tgBMyFxqe zhP2p6@c#h0NGkp{HKB@0rSQWfSRvcyx;;muo^5FWzqP^Xj}8fkac)ii=%T3c`tEQ5 zPd>Nv1upU0R!wUGiZULrAF7ff&Y2^jmPuQn0EGH2c~X}=co?DI>| z&i0?+x<9LVla)aDs z$Vw=9&qB1?gC;80l6;nisz4g!eLyb9`oAnHbs@BLUO3x;J`%t+HjzZ1nO;m1}8oz!IfO!%ecO(Z&cfTrLq zv%4?xVTK~ARP+;M*=bKIp7thnU>UAY0Dn9#tAlMLEhK^tz2RFhIQL>0 z+~5P9x_1;O@WySD=!Irz)Mhkd>G+IoKO}uHJViiZ}+e2#fhUU8s5Y8ipVi<2BW+^!5jV%^#)g`wGMSAZ%`sy>NTYfPXKv} z$N6Adj1D4ppClQp8fvX3b*!|wt(JqaB zioUxqrD>qmv&jl6W?kx5NXg-D-qyZ8r9uP(hpUWiO0AwS_`hGCQ7sE*?KWH;)!-1V zoDzRm5XWLlS|s*{bFgbp>C`i(!m|V0ruC`gGu>CZxzi4F3Qihc7e` z<+I5owG07H2sh`p4LsB!eJGWZXg8^eU|NKxsM+TN1(*@r^T2Kd+@qKwdxuQs@XVFQ zaMDD5Va>NF=KlbD1AwYQ5K~47y1gD9YkcP=)3jBUc`>BPrU%NegpVY*OEEndoF+I} zx^qhrWiF)gCFvXHQmx!E7LktfJ%!u)u>)|~ZV`Ptk!L!pJkE+o%qe7e%I=Yp5J^xk zemH3_)o@|1X<*6#-+!dtsw_@MF_h8yh14IkmAr7+azbl@f zFrv)w3```v>FP14?xVTG2B0NJ^8B^(IB8Yp-vxavwNx&`%`9m%Kz9zua5(cSg~c;u z`MzVPt7)T+jWf!!4=Ih&fHuF=9_3t0OI;kW$uzZfD6z`d+Z*3=dw(2Cz=m+TgI45g zPaR5ARiiAdtRi7zq?3FQ3X`KLd~r}@v~r#%tK5K~Haz=dr66P}WhGrkNfgm4#}mv0 z?U#}-Yg_M#9#p}o!IVW+n`E-oQ_;DRKvv?#k5g}_7!swzlv?Qyhp1e;IC-b7ij+Ot zNT+SCJ6(PLzm^ugrV&hht6!(bP$~F9YHbtqU%OQ>uZ}R9Z8t&`IYzSOQvXPG^6<5Y7sud-Qij*q= zZS8z|Y9>vmEC11zXIiohz5f8$6coEtcb6;dV{3lSC^`A7A4$nWvR@W5`uxr5k|@z9 zV2LZW*P-u-x=Y73(5on+MMNrtB|c+IE0yyYB#26>JwOC>wmX3N41}xB2hK~MJPrbgE{;Y6pye3l0y6n3pf+=f-l#r;; zW9mNO;5w%&=mJ;Sb1bc3dYLOD^47$F;@A5QnBrtg@Vo>%)gC$Inpvsi`H=o?!UXjd zJb#x5vXO90YF84gSBgF(LE>CcQq|MLA*S5$NTSk%$6w)w*m)Kzv5j_VRns-Es>>1x z*~1m!G8=c~V8)vzQ7f^_&T^NQR{`u5O8P-P$;V5L*BVMW^upED)m49jZ|`{T>1FrF z6D3Wa$+h)eeq!ckF0}7!vJQlGBkhjz1U#Q=dWL9n`Dv=+SCUXm0^^ss>M`M7wnBW! z(etEw>WQ6aEXoiL6cg#=zfW<1Y9@5u8mlqk7M}4NBCdlpq|uqG(5SSPvqY;)JhloLR0;8cBo&W`cOvs6o(?$g$~T&L(9bHd2g9Dx7#z z;yz!cwYEvB^C?9@r>HVX7SX(284snox!u&_O0?a`_#-g&K`Tr29(|)cU!|zbbna^6 zLg&niR|U|5Znqu1v0kpst}`ROH*A5;Ip&#OWt7Ou%uPLkRs(S3rN#$`E~FHOZBbD# zn;fYU%A6Or(o~Oc%LTR8To$g>+450Cc_3Lgt$-rp#~lipL@pdteSUFCUmQ|2e(p+=3LOs{!!U;huGr_^Y6E zYKZnj9%N@|&n#EUll-__j;;+d-N|SlI3Fcu!BZgr00gZ)_=#Vf@QcNu$N>EhR=_yu zFSvg$FslqAr1PlL`Cxe~0X<&&Z~BflFJ|=uuLdh(IHtob*4lFOz5fvaQm78lS5^VQ3wXMOx z(|@-xh}3<#6-B;1p)|FA3y0Y0K6IQF<#tOOTpri{IJn@Mm5x8|)&Brp3DReVf4iz* zP^A9=5LI4&UjrqNmzWs=0?bK9w;!M9fw1n(2Zy*TO;P9XRd2-zqdEswMD1x-Dl!4; zNvTqA{4ry}`oU88<(RYPNyFuFBB2E)BL3#rx94nIkCM)6y6Wd?EQ2nSCdl4OMSq*5 zEXLP6tau-6DR2RL2`V7;)b#mYX&8xMQ7}bvzN9Ka3_q9WfShLCzC~I%Yj5G^6`lBp zoYm{vIhjhU>HL@`-U_gQ0#Eb6kN^?O%&TPy1KaN?KUDy(O(#!O0gT6)`D_oQ0Vh%S z?}juqNVvG_NcllUvILAlTNje9%OL@X2E+5g%_^QZBPJDl*xc zoEIBFRouq=LFsP4TVX{l2ZDWw5nnZGfA9O2mv<@a6)| z>-yzLDQW5ArHS4M$Y|HqVbuNb#ia~&O|w(LGfG&>DU7LZgOhH0VkeYc0%cj9B{XNk zqfSFd5Y@1^mPZ!(en|UqinUQQ-n5E$E&NcSy7qA{Us+6%osSEvu;4K~^Z5)&!43*% zj;ZlMI?)9-X_q7$R2Xhlr?(v9#@&`0paoa-W`^nRob>U}_1T%1ZwAPAKL&7y_$ zzNR8HGDH=F4xp@yZ{utL^AB(1eruCTCK`JH_l2uJ9DAy~0?-mTyr(wO@{4u5(Uxm{ zZcY+#cJyqHVEt76;M9B%mfxbHs#-!+982wvw-EiP}m05)J^X^oElz)P2uV6FEil{Ab1aQwKo36&KXfvo$kR!t_6w5t#astFu2L)G-cuePyv1YP0llov7pvl^~0g7_s)T#BQ+%x5%Qf^vcpNfW>ICe-L0} z);zI?{xoaihxbA=e8csawZFM)W}5&zJ-4Rp=2t#c`&O%=yH2Pz<0DP0#0u*kq7Y zkJ$DEtn4(?u(QODZ$z)!tX{ctBhO)ugC8bm@IS$vkKt|l9`EoFhT6uh=J3zM1)4w#>dfhU(dn|S8u|eG z-yQJlX10g)D7dhaJBpw_BNjRRKw-xPKo)Bo;@M8DfT_iVO_Mf8QhM0T<<(P=NV(vQ z3yFP^R7{(#IQSpC_~)aghC+Ag%}M2(e$b<9VM86&cX9fUOlFa;1hkr$Tp$I|YHabs-uFK}CI0}9EWzI3 zsc*x$nbzejinSpzqq&cFU)(K^b14~2q&ZWhxx~`5ZfPOe=xdS%?e^=1_?OuIw+Wsa zms{GcbTBLU5AeuD+ijfcsJT5=rjQVE=MgeI59TJE9K}cW7WRGr7~$hYT!OQYC+vlX`k zb`Jjl(z*D0#*k(O(3AQexm2n3lk)G${=6yp$GrQ~tVp+l5YS3#Y4m|&7<`l_;9ksP zAIBCVVEFk3KznsltgfP2Ra#Yd2yWM3PTOOmy@PN#{KQ2Z1($#g?Mik z>iriiu84mz*}++^5TCif*9ux;{{X`tO3dM%qq*MVs{a6wu}d$DJ|lzZEt<;G zG4zLK0f__X4>+?h^&5HhzOh)&JPwt>c6)+FqM`j|L}?%j@r5oJZeFJAe!V+l8lyOb zt>-GbRlYf7`j<6{v)v<-&{Jj92}1y-rv%ibWC1jx{{Rf5>DQlOj*Ek~N~%>P5S#Pw z5_J7uUnl5rf}NsxN-Efb*SY#z6E%ZmnbiuYIre1~sYeAb;YAzG?n~VAaKVg8tJLSB zjV(T58?;qz<J?pt4rd*XOQiw?!}OlRLOoWx}Z(-W!wg9LKV#iL0RCCw=01f^i_*0fs>KchM%=0U0 zX;MbYs#>D1HmWvV&;;C70rj_HF$u#MlVs7>(KNy0E?YyVmnqa|Gp))JMrF#WQ3?sq z`yduawd{Wo>(KTEonam8mpDRSMV@J=%cHGis)^)Ki3{!oFHz|t`@OpT@yTG(MCaKK zGanUmYH71tOrJAxMPE#5{E4n#o){2%6UGQ-A_bSMsXhs}CeP_sf(m-%1*z>HCg$D1 z_Qye-(V3(vCSy^P>A7hVnl-9Q)3}Cf?IO*zk8Drsp-WQ+wDDAGTIx|*mBmc7(F$bp zW7re{b!&F!*Z0Ro$~cr<%{)!h+3$q;-d9JEQNdYI)RdIUNL(RF zO}U5&3zv9JKDL!1qne(YqGSv{W~0eha5)!l?ai%@7$rP*2u#8#WgiM>T8OGBbu3vO zeI?_}>FOqpmg&)yH&91$^ubMoZB#F!2Fj>-nWk!VrmUAv3D&kmF%dmInkOa2tVi+3 zF&+qPle8-lU!CQ8vRu9_$08Kjq#;L{8T1gKSe!)i4y%_jImwt+<(Z^X(N=*Lz#2c< zzt;nuR4>vH{{Ua-^x4H%%uBRNpR0BQXaJ9Vd_sYy63-4br20+>DCwswNb+2`ZOS(v zZr{HEVrZ8X!w*sdv~-%sFU+EyD78Z7bqe3DiD?>{p#*R@Gq&#jpa)LqN(fjH}8m|bze-NzlnM)JIy3X^0?UVHrlUp7+|_CYc&=s7pPx{nP#BK zb2pN?C7`TOi5#xG(fKzG?esrfcZhhlQ)R$YuM_fpbE)B?i}Za7jG0|sDlW{3I3xF- zJ7QcrH!3HUUnukaQKll17bcQWTVr`*=kI(F<}v%i;047sB#=rc%}ntF(l#6h`s3qB z5e*B*^$Ia%8jC27mOIn{ThvD1d?=|%gQ9NNNMHZb0q9LRsQx4KJi?lfFpa9RT6kKj zO47x4$~KMd?$_h&aYJ=8B6m)xzR-zT$H8}rD??3DlOpbMI&#@ z{$RT`8t#4yX_ovMc$Jk@(6oLfIl{ct^8IA(*FKQ+%u zm`Wdbo#BS3@T)M&sdYsx8|zY|$S^;g7(~0t4ezw`hHRi%Af&a7lpM@vUotP3kz&6a znEuV}{ISpwlUALPuPpGSwwJBdl7ML`Ljf}$Bz3o?e!Svnktjh-?uHMXE?)_np+Y;g zqd+b#Ym5DQVkVeh8gh;P4fq8w#1(y9Q|HGmrpgsW&kojb%r1C-Ey%|Vsn&zMqN&l4 zqBCgRt1r%KGAzGQQ^=51)KWcEs*AQ*UE^jUcpjzXj@KRW%be+j&q4u}V7wyuS<1XX z%X2!M%Uk@caYz*=%S*^+#^r{!U+*nKS|Yw2TgVm`lI6HgF*SvTdPV~4Sod0^7H zUXlxyQ)$e$fJOrCq^F9SMg&`P?d6XhPxay#;hIgr@J$(5l%VC6bS&(U#>lp^@XK!3 zwmfbW4V0ZBD0`^ExCK^8xJNHD`t7sjM+fx3e!)H*7L zqMtR({JIn+%*Z^;wXf)9CxOog-w_&lc3c{ghnh#k?61TqK3gP_rH?O>iuttWB3*ie ze%BoPmkR86BAGIAaj|;UOeNLK6-7P_o zOQ;LOmW;w^mPdG^c~6+JkkP2y%XcIUOlcj!zckH`1Z!k<@Snp!5Ar(H&2RL(o8ALRS4{WY*JnBMXk_|d*MbdiyG2uI9t^MeQmV!PB4`oTmxIxI-bN>@h?xl zy3m@-OiP>4WmOsOT`eqiHT5Y;0G3iOx!8aRAdRP!Y$K%d9h%vLnCK; z1yq&50H`Eei-2#*Nr88J{kj6peb+{u6aJFb1fLF{w+-WCh{i?p^ITlf?a{BzEI?g7_DQcmN z$ypUE)fl{~Re>=_>Lb(5u;zv*qj0pOINT7$OHBA7B;OBS6H}tZ-Zxd1X5-1yS%chy zIlpV$kG3o$9^>&xkL?Pu{shuBaQk-@PRKHE4>B5ROtKFa>m-7WB#9nPFIt2vo0IAX z3u@PSGXugr-k39lQ)u3IpYf@UbU%hsiQ<#R%F4PqS(-#TdaV}hdo_R^`r+o{{R~E6wEbtUr`E^1i2*`gaA=pPz6bBc??&m@A+aT*38N69JlTz z9@b^*_^8I7()w#Z$})Pa?^V`hlEG754LGLDq|6pk=6Z#r{3oUF(~J-?9SMjg!$|WX zLx{nO?HQ&F>DddVABGwlm*y3GUCgK6`np8)X<`fYJ$*O3gZ<&ds++JTuBd!+9sR}<8RW~?Bm@Yuhjiybqo*(Pk)dop+^Qm zO`z8($TcNSaws!+E2=7AE1rN}QWs~JIxnRAf_igqFuJu^HxcaeB|F26_x(O#D4l*) zN1oRvUsIU91vHe^EiFKS>P!I?Z6X-`Psy+Y5gbHl5qSx04%Hv2@TbGdn%Jt}#QNbF zP@*Q%`G705dXE6u6VBWo{Cz=SCr^{+LaLq`P2+ywAX4}|JJ5B;7~%0JFn5mrukA}P z5jviMK?A2Z_s6v{l^d&mr|Yi13_E^*>ZXj(!JQRPm*%uJ9w*ia>cH9#n68CO?gdc0 z0tX;+c);%BPt~lFFCAN-o!{iW_$4da6sG`R8a}v!hVCI+|Voji_VM`6-++oHGi#nvWtjUy{%O5v3 z^_w4VN)92ypHxkah}H#|M!D(jm6U5zq@)cA*UXGo28*q7F&-200#<{wh ze>4c}wREN2F0nBK!k`}ZCq?i-!n8JT68uDRi?vmBQ|`BMaGd^l@MGFWtnmK;CM%zT zs`CEYJgJrICGa1@Xv9!eYX1NdD(GOUg0BJuZIW?K6p&ht#39MX!GhFW~jOjNU4 znRsZ*OUWYrM^ndqD67V)QX~*uBse*Rg7C(f`Jyk)A4`K(09-WW%36BX%;$^ksb6)U zhdv!@Y>&hGZ0A<$`bzyRlQu|_WjbBuYPgzKm6%59!OT>UMMz7nPQKa>9e zsuy1bVjJ20l0U-Am*~w0;iiW*St*hTpwyWs==xwh#k&a=6c!763?t&$ zs&!Z{EOw77uUBum+7;=(_Yr=+ZhwH)VXGO2%UaGAxxe-OJ9fgW+q>@9dv->B^ z0raXftaL}i9%G(nm72d->WU2RS><}VdMX>!tcKUve1m_lIJn@kRgEzM*NZUwp4FJ~ z3=Jb$#E=g1>ff78k6}?kpneb!4Xw4Y?|;#pSatsZU>H1BuNr+}2f?)b>J=?49VT2B-|(>?$s(VIz94)z zctHkh2AS0wj&IU2qSZ@Tma{q7#Hd}WEG}@nA40Au^@G2)x7_t+;kD^u8d}oLM9)s{ zeCdcpG4V6u6Y=_YII@m+Wm4ID?&IoC5_}Nxv%YgbU0B`4newUp%D>5!p}r)%7nP9) zuFSU)esZaW{@ff$ctgjI5r%6;tzuzvs_Q(QvGB>;(?yAU>%(&n-t$dYfV3|sjG7xIbLgM;guESk_Ux@ zFeCyT3!4tu0;V0;4W0{QYw5~f$8kRU(gie>0xwh{#L}V<5X%`xu$y!Y4X}kvP`~hAy-h+MMW5mHV|6C zs05OF;cZ?hO@l+gEjgu=mA209Xq< zm+({~o8hy-WK)bLdp>xNyx^(qnZLvJj=W_ zW{b?Jyi2c(FU=}5SSxb8a}JppP-hshTKKvNH^Ijyns7 z%W}id*L&X_zaCG?_7UzOap(^}8NbG^pXyZb_Jxele++gt z!LD;MjdIkNc14FPptTQz9v;%4)F!@TPTr*ywEKtzSeuc3-Hpx03p_;g6WO9L{maes zdrYpGhl2hd*V43=8AphT7XAB#G{u3r9+7j&{#VC?h&i`hkGYY~eZER&x=TvwEfeBt z(-fK9H5tZHYKG2YR3t#iVh9)9?)>q~F{SRvc8{gO9ymv%iR~Qu9%xPA-86Zgb(P0e zxTRGi#Niv)wcu^Q59x4ih^y5!Nh9UE-iV=u6~rDx-c-(?!Ve8nEVs5dIJN0x0-Xvw0@S= z8Aef4o>S^ct747dj!carWJrPKWb=C-EpKCpS&Qh&2g}V#UxNzZ6C2FWXC%W@@aN$8 znC24Yo+dP=OBIef6}|7#he7O48MBOmZ`4R#_b%Y+>c@M+T;30OUg;bkqx?{HLFjKL zgp}kP5XwOU+`YyuPA|%=}jS}^tXybfRS)da4&v4;uqqDLlZL=wYtsZk7o`zYY+wYpOWrszj#n$s?Id+J!Lb=6-_Kj zJaMr}8BI7=2uJM$dtZZqu~j-O&eto=xyk-zB^p`a9oys)R!@h24OjJ(X|EH*Cg77I z&>M11kx2lkzZd5Qw}}f(0U8*$wIX*0nT=<+$$vrM{{V-ODTOqDiZx0|+-6D$_MUm* zkUuPT>}y@20Cr_kQ{dKu1oq}#Bk)7RJi02Sk4Si%A#e*qqJ_si-|KsS0ggQ^RQnGk zVBviZnLKCBGY zL&47v9vM-*G1sw(Y~kuFBHUZ3+DGCi+Z-MuN%+3m{{RYKQ{gRjqn|%2g%-RW$TFQf zCVNGvG-jj84SgKmbh+_aR#1q{RULcx1GndhDqw!4?D&05<)l@ z%rZz~z#r=`>DSTg44em1-=v zGyN$!iV5LLnU+>WngYRP^FX?>*?yq)Ht&cW($r&JbX3*;C(!F35;GdA3P`8Z^%XJ2 zNF$HRVH&6bxUlLEHW(4nJ)5H5ES1$~87&rPT~TJMc-wSQu;C9p6W^u>kUNxaGOKo| z^D}Juv%0AKidv6Vkp2=l{y1Sp%YjVtNHpDe&ZMo8oW}%3f)Y7vcK#TStFD<-7E(<| zlhNgkL75EMt0R^al1r}96r}zO{#c21(WSYLP%9;lvPy`JG|Cf~Qg;wPqy2d3m|ixD z@lmHBfWuE$J4F~ihEG>ZcEm1lgi9$wRu4;ff1he7BbJvgqs(&XloXa(LP#ZF!fZ&k z1&3^|6zYH@mZs_*Te#u5iJDW+^`D38&oyEr&3)e2_c+a6?99ElfOUfV!@m zJg12(>a^BtNkdYbqN}OPrj7{|cice(uT~=cyWqCc-cr}mAw>TGwi-AZHG;lBB~TVY zGT(Q9+y1O@>PM1|qbfXjPpmS^8cNrTIiRAbsEvU&B^JFSsi%1DaLqC>vHKHlxaFo7KuW2;BY3AzQ>kgF zX)_o^S!AS!Syj0M)&TamTsNnNa2cUO@+DeL39hmoPnR6SFRr4Hz@ch=Nn{{(Wh7eT z`Cv+v`a2N|)`>~8txKb3dT8s8TU;s}kZGibOMPyH+Sl)oS!Kx*q;P3HCnRyS87r8` zxM+6lKU{L=soPjILjTiw_+ytQ(Y_Dn`mT>!WqB;x!n&B8&oM?cwDIN5gt&0zc&*@PUzz1 zz=P8TwZonFMLD@r+?T|SKd2!yW%E^3BEH?nD$EgXKig7^-{^Snj>HwhbEwrh9UbP( zbJ|J;ECs7y<+k4TznTFbONMQWDhfDH4fgZ9*b*zt&XZZ7cPrR8F;g)^%sd*x=up~snx|gNn*&7s6s9~ zo-gfe4C|p?Nmsg$2(yaGgug6W1OT|btXkaSJdmL@0x{{jO+!njMw+S2i{-CS^%0@D z@|cacgXli(pzN*FF0$4j2WZ zUjQBvN1`5tnmnErFg|YIOqv@It>Hv)v1;d{ESSvqS0VA<62p>PlGT zru0KqRRu(w>QxXbs!0$+wjQDC?}oUhF|gK|iJr})=+k7e^|K&;t<=zGP3HWRQmjz~ z^4O9R_T*pbYypu$oi*gzmWH==Eb_fDfTKnep(6b*q;vHn965{Z*-^o>?IV%U(bwhL zdZL#;MiQoDM_kHp{U$@XZa$X!_Q2IFJ9b7=sRc^Uj#;*Emy?{<%Tt)dyHciJWGFfU zY%gp?UU$_rZXy(mCh_(PYIs_%wxG?j#D*iMJX@*$tKwEvg)gL|zk$^`cf^fNbStlA z$Ro-gHOwNGp&^n)a$EHtVHZ=k@ejg!^%#n)YSbaDb6O9qU91jWsfet=*&=5^xO_p- zWM2(gQsK9?v9G@RveY&#API zvdOeW^;s-6W?8d%AOoM8xQf?`4U z6??VTmeGD7(n(FNa@rc)p=x~9{UcZM)a@y`LL|EKM<85Z0Ee9U+F;yfyG%P!BUsD2 zY~}~IDYzlKX1Erz@s?@o9WhBoL8P*JIC5o1Fh@sKcw;8lvGv~m_vYBHV{^IWwYjri zbD5nlJ;~M@0P7ecHp}!UB~0BM39{JL7;xf!-9DBVz+hGQ&4JH0h^*{79Tbltil&wV zjRLZlxP9Hv(+qG-buk26V>2jhLz?5NcX=k&}Qm*nKdh1an9xH4z_F2nB`jAvgSnIXQ-)M{Cre2X2zbT`Ikd2#PrbIRJsy;P%HN zv5{dCG&8YXI+!9S?JBB#PUcxmI)g%{WSLZR)YH}ZCb2=Addi!8qEUx8gOsX>3K0^NE2;`pBg2p5kJ zww#k3TY)$NVOGj8E`YVf!Ttc*Y-}wEV$8{+_v!rqxO6=mP(*rkd@QuIfh0rxq zO#=9plqpl{zn}x{ZJw|8*z8~`eS|NM6rkPz04;cz;v+zzF-78TT+FIi#Tyq^0>IsX z7VE&oXNJF*(JDWM=yo3WCDa}*>5mW=w=UBfwx2qkY3FCAjFpj9BRhyw{Tt(l;Hos~ z9uTE&I+b8@k>F)gcuCga=-#f>YrYq z@ri~CupQ_hg=mWrFt|zaEu(f8m&EEh7n?bEi_zO^hBvpph4J^H;yLM}@NsNAeky3r zekHVod1XsW;#Dm~W;fVXS)IB7pf_Gl7vlJSBC8zTNg8%YK1ybBTsgQ9uhxjG%qa34 zwA0V%@+sSK8+QhcNH+S6E#dWE%3wCa8*bQ-B%>78ReYPuQLDU2Z3mKOT9Z)c-y@Xe z;UuZ42wcRaf`hd|V{$;_4ruhX%umn{y(_Iwl{qD%%{urh`v>+!JP@6%d`qbYLPxJJ zt5Ck+lAhy_z8nr6RDX>gO1^RQfE`xox>A2+FTmQ82=PW}?S3CEszJrabjPmY)qc%h z4k1hAH7SqdzrkwtghS$(^Cn=Ct5Q^M4Sow;3j@;s09*}Q3tEt#u>#~aoaw)YsLD9H zbw~lM1duP2$R%|FVGM{`d=0I;;Z~uNH?Byzkldf7SN<- zMZqK3gT5pDQs|EcGny=iU221rR#nm^Y$~*mIy4Tl$IpU*2_MA5%f*#4%9dgI zVl%@l9)1m7H;FK9^uiu^i}4-d?~i#m_N$`x?3LM*)YH~^Qswi-vKnXJ_Alud;B$qT z`VYdiIlzz|xQ~kEc>A2L%JocS9Y<(n?42trDr*^LZK=D}U@k`kjtC!L&k75Pi`yuV zV!f~i%t^lK0H(|yMJ-nY$Jb}em0){%gX5TYKcZB!-bcZCf1L=#PYc~J4cpN zPK@2cw5%K37Mwo=byf#;Z}Nn!*BQs@(x_Nw+^5Mi50AYCQ6iZsYQlvo2k4r8z;*-% zAc2BEq4UX}3?6C$_fJe)t@%sJe0X?$byJtlz%eX8K~d}@>Zkel$KL_CY|j=obUx{+ za(DL6A`vUY--#@z#wv`)mrPKqOF;+BO4T_{EO3~M1PTHJ$-fuHcZy&tVW5#t^YIz9 zb{=Zg!SU4b*?`Ofq9Z|p_7jQ;>X^Bv7CB8E}57LE{t{F{xPdSMyqCSjfpXXpyh z$~3@?&iT&$b>>XxI9;3a>IODj-hvJ<>`G!`R-m*tH|h^1??l1zoIi&D0Mb_qoZ~!_ zX%JD-v}5q@qKNgi!h)TC*!0w@4YJ4LuG>zS-QPLui%DNPR54n3F6+5tg(KtY5DtF$ zY!(xsSgt=7 z1$vW~&w-f7Z<;w({{UoP!Dx0j_WhX1q>D!uOEF-6zpNPToEoY4$Hk~Ki>I&N{&DgJ zbYJX`cr55zJ#U*Q_^p*rtXuEq8+~ydP7_(6<#CwULFT(?OEW2WWliC>@8FzN>Qtz1*BCPsuP=B_{T`W~t8H$?F7a>TTT6Hi zU6j*nePdUa$(zGG^o1$pnKr_~A9m7h>O6b%?T1(_C3@EnHsqC7t4WeFuy>(4e`Gho zsNToL3fnL|47ROEVc!1$Ts0gfu``{@KS-mvr}q8{To3j}JR1Tf{^^zFhykSi8&m~_ z`hpMn@z=pshLs)cmG7ibk=BlNhC1j zn+}*z+O?cOH5^P2bor@jvXepT00ECbHBG1f$j5_pl@e0cYwX@BAbBE{PFqmGIx!3` zI)Hj&)klTZH!gj~(dLu88%3wpXM*D=_D8%48+U8`;Mo4gS5R;J@h`zIKN_b003~=h zjWO|A<33Bn{{UpGz*S#Pu+P}v_HvnSZbwUz&G9(lFSHly7sV`Fe{ihXy!k#l6&k$Bs?y;r9DXyuAt?Aze3t%K=qW7U z*)H%lKuYKOlJ>A4px64Ual^PxL!+Jf3RdxE4~XB&{Z%W_KO4Rmc)y=z+EYvF4CnO4 zdwF!GyDTuo@>=_M2_D3NeXyq=!|Kqdn=`E8%gHjrW0_sim9POPUAw?mo(OXZ**bIB1cr!!Y^naN`1tUf!`%Bd(^=+cpZ=4| z=Xz?dlgeV2A2~Q+ujj7o9{WY{XT$KSwU{5A-gJ*OTC2s_2?2oj&ytUSzLxkVNC!04 z4b9K`%@7=a#f%s@HAC^;`94U0h8jK~@Sip9f3ij3X;Ey`P?A>X{b#kg@BQ)LwXw^% zEl-r=;|fOcfa3+9ZB?4^uf>e3#;k|?Ytq&Aa^-VNBnoPwXrvOv2JlppIJoF>T&^ln zd1)rVYG+ksqV_$lbT_Qf?yqSg{=^jc>(o`+L&3Rogg$!3sB%Q8M(1=J+1Wt2m`vZ_Si9KIK%@=lQFF|?oI5vawL?dn_a=%(Ock-*)k z`&cK3?y8-Gh1(!^Nrmx#Is7!(wv#zR4ZvC;LHY~6J@_7=UJts8XKCz-P80b3r+jJB z8u#=RRj{sCmKp0!Yylg}l2na)G3v+oVj7qi(${}4+L_^at1(R?BI3~+&*(vK2{6#*T_rhk}NW&b*k}t>c%i)s7jH{h5Mnw5QN44*` zTye%4{1Z@GV!>Dc0HQihyl!@J_X55r#|MQnDKa*GptZ`S7~#H`d~kRp`O5J9(y(X; ziy!)n*!bG;p+d%|QVAWvGCUE53fx@Wlfk!4eegrtKb?0^?uD)*KoiQDKJXz!{BV%A zs-vihOVih7l(i5R7LirSJ74ZSUzx)9Qpgj>)Rzw8eW^}O@dJ_gJ&3f zQ~Z*vI10>!5Z>H(#F%^m#5lpw1U@T_vkcLiY<3ctC&rJ5YJp|_HM{|IIcgrms|mi{ zu{hu)?t-cJO-ZI9+Hxb@y+!e@;j_o<8SIWvt`y6V0rlKw_QziVJDTOcbo8dpaU-$i zN-{qlw9kv#4!_H^-8NuiqR6W1Y7JZ~1fEw4LhW|-T#Iz#_~7v8VV&L&ynd8z9w^LU zw8%G*MxgWVRlCB>Na1$TjDpH_1&y_z~_RP z_0cr`=v!3f4L9dbe`4$7B}>h!C?qT!=dxNFh@?ELM`BlT?89-mz7`rpw)cbXOsUm7 zcBDE>;zLjPEs@h@nZV5+YPsqvq8WWMNU|f9Q+9S8Ht}zBf~j!xi;@g!=7g=qDd8cn zX(svtV@^rv{CaqI`qVVqfo=dXwKPGm&pwy!g4_2#KqEe=WA{x!Y)^YnnneEq9J&U{ zAC;)(POEBo!3VXj{jnGHJs%xR-?~Z;+xuLjUxfZX|dr%y;O5dMb*QXUXcC7EuLC?nuqz zEV3RD_a6TMTrA6!>-LbHRAkM$sy~(jQ>4Mv(&=o|5P^v2gvoJChZc8<; z2p#^H!OYPhs3CEv&gF_HH4+C+zL1C2ZpQ?HDj*3ky3%S2s!DWWQ0yEI8>n1O(THDW zEijy8&tk5QGgli(sQhkg0f_Q0%}LcPlR6t36_ldx1yp_>a3y5N4(U!*6U#?DH4{fs z5~~M7R^^EPu5h*HY?`u>B@yVd?B6-dD>EFbnx?54{G|}XB+Qca^@!Do1Fs_7U;`6$ zeLN|6@m5zn@Y^WX*%pM!GJJxjlTu~=V`rIzM|f-L-Y{0)t6n$c`c(A2`w|OCfQqQx zh7jX0prObnuAyjPCWfcwB&T%SB#gs}KB0#==S2j{KKwA{9u#M~nzurDlUpCpY6=Q^ zYFxIV8CB}U<(1-f=**T2?{B6fbvgC30rHw8gR*0WoVE=oleZhfGI-bhje1;-WXyCT z%8^DI(JYN4iyMohbtmb8oktOeJ#(I)G9lfPr)#NJ^?Ik4(yBEl!^em^hccqcNTzt1IefUxp@$2| z=uS9$VaDG~rVV`Pr&<1x$~10Ko@xzSNNK4kl_lE?ZmO>H3aWW*SdMz~It+ZuQf|Bs zc39&(K&QoJZ9Bc8tTli zC6Rpjk|=7XD;#phOBQp^(t4hozPMonebA70NGF>urIu)_B93N^-XK%(TbA~0;W~dKvctF73_=(jSu4Cf&{*s{-+%{d}%YGRm%LJ3;8hRQ@B`)yDlc0^6ZDX_! z57ZDXh|B3~BgOCf7iEr0#;f=%()0e0t;n?e6>*}mT3ouOr5S7p^}!C-JoM@@IH69c z%yS>%zkd*-A;BxG*FOu|vrlK5gGlJwO!AjcM-5JDDJg0w9+s2L2xQwbF5tY~R2FX7 z@!T$u5f0nqzxCJ6bB?79a}O6kvHt*=Oe-ofJh)Vm%M6z=iSBxm0xsk4d!OISYJ5Gd z5DTv#y1m+e3dmPhGta_Oyqm|LfekrHRUTQDQ9!bT=EO3J^=VCy;w(7_5Z2)|@dOuU zwx4`>{N>=pI&JQSL;fHXfS_JY3Y2=OGBYbw~p9wS`m_7t&G&$y7OIJKOr6jS+wbb!R6H6OM z466-+lHr+DqVS+z_-TN`GYw3(<}@V9ldqCl#WD42!D$V70`6y42H&9vd{Ow*r)i?k zG#`#xtyN;v(a9c9B@h(OSPwlX-Atc_&pbt}uB+8Kw3>zLB#vF#kcLu3V{Bj~NQ<>p01d89&wMGUWTRDvDQTnJT;i;IM(T6~U%gsnv_4Kma(r_5L*3_$ia7RShv zWj?_a70$_f$^axWzve#J`FNgl?AIrTXr#($<%mTbX**2&#FBR*e`J3@%N+$7YDHVA zC9MASh5VFt0jIF>q0t*T~e zYF+jOb%}&ycl&ZU?g7Ug9&0FG_z3ghuZI%&?UL3@TSt~wYJEMK*5#G-RW;uuG%pL2 z8^m^#<;fn#1aM97h+l&t!UXujE}5q0^^9`r=KY8T<8GzXdNWvRJqZ3Dh&2vZ8t=@E z)@Y`hHFRKO07{2{Q`Xontqg)szEXP614J97uQ@hBTb5MG6wjZ>Msp~n0i%{mbGb;r zOI+A}a64_HROgnaSi)s_bo6vZN26?NNZL5yaqWo!Lz5~alG5f;$r7qZI)KeMUO@K# zymkbrg6g@IB?r!Y-8^bYVy(BQwk8yi#;g>Q9caw4Mu{8TT)ywZ2T$LK&KwoM#Sm1A zi#?v9N}z{f2i6+bI2F{OrVXnr>8%-~ZB7;3;HMH}%aV<;`*-nOsPRh0skLj^8r<1hGL^p!-32jm4~eSVK4o2Ya35;oOe&k1}U(mn!Y z)tN?=qWv3|%TXnC=+c%!E2{a9S%@kuqn>~aSa@~=(dVxEh52ss2>=KJz$N&sS;Rqb zXo2xW19hE$5x?0W@CP%e&onk+ljd5=6sQnPlo3brtt>9Cl0#7Pt;)Fcvi{KH4l2=X zL(CyC_=nPXa|h`0P`?g-IWkImOq0QUlflgABFl4(x#=>QTD}^mN_zB^B}9M&)wi=< zi3az@cOP1vJUhco^+@@|H_bW2&~-|I#9TN#vfXQY6x-qlK;?Ra!L50cXAt@0DajVD z2OUzcFGX18R_$`U{TSkvfU0P`5$iR~%kzT|&{ewc4_X6{_qnI!Nh)dfu0@< zGjEQpvAx^=3_XGS4xdY5XBKbYYDe#``n1yy9O7xW`rCb^yZM!pL_=ja76#WiP$P8O zVK2*oST3v1^L}rF=)e|SRWee50J|0D{Ntc6DmBJX3vWTs-q_{FO6VrZp=nL-Nk3db z;VO2RO^a!o}722eT;7|&axlV@&5*ECsw0cOk)c_Sgo$$8`?7$xX03~k4 zpK$k;R6IhBB+;4w0G`8Z{Gyex{b`bQP&xjM_kLKg-~r4bRd~3XL@LiVjLVv$DrKi0 zTdK3ku}MDUeer9P&1BDD8z~3(GRdAfL~t#_f~-Q^j6_~}q9_119xLuyqw=`osLW)` zQb(g8q+|`O!2Z>{U>fxt1ZIh!aaJr9CYORhwna&?1O&{C^50S1-9%iN=J5L=T*4X?L<&l+X4`TsIAQk3hNGLhiLK17 z9*UxmAn=MhN-fM&R5U|>K z*!8ze5cA0@2V`%TOJ$O1+`}=FBl9$offEne+{2TEjH>RC0l5j?A5_mPFVi=L&hu!k zEh)1Za(tzU`kG}o{O^q7m?C@C7fGOz-rug( z`gP7_-&eIl+smig0N@WTY(LuD6sn>Pxijj8Yr?i0;{O1wRyzLxWTPsjuJKdD{{Wnc z9-XwsK@0nP(pf(j)1Oc0i=F_(9sD0PP{f|Ux5-gVuT12%RN>^KjI+qgeU`PpxNO%- z6sCOVOy#sxl079PUUJNUT;A)u)%N2Z%I%jb&wM-OG&yFp)N7Yfdg04pnAxtO9fi-> zcf}9xgq)1!(k)Z&Unno>Wt3Q0YN>whDOSY-I9pCP*Q z_Z5l0KEWIwE9+`{V63Aum?1vfLH>Bvu>PZamJP(OS>5B@5FnkR-PExDI58$6Dx>uY z*^TUnZN2U>!;v(eTC`8#6az=%JkCYFTPuqH0JV3KuW$IyDPMF30G%?w-o>Z=$~e8J z@u~j+fw^cj^NXth)@Z;1y79&FQ6_ZL`GUSQ5%%l}IcT9OmM%!SH?d!~BbeEAK{sC| zsYf9rl(Maw>?}oy$3@(V^fzAOn^H~fS`qgHHuA(@n{jXBh+1`pJBFRXFQyYqA#i}) z4a{4=(-Mg)7eHSljF~LP2!AX)R?oI6Fy8i$%`QxT~&HQ2J zzH_X5kGQOe*HJ}Z;+DQ9l^I_>uNzo!2JT1i=kvy-&sD#QJk}A7y+{5z`mI&NJBcIB zD-cE^MU;($fEM^L=#$J8Yh1pHT_c;wX^^^8O7Xc*R{&ba3IqD%@rRmZPf_2Be3$8a zO1YCD((ooYvAK5?f(E{>n|BkjCr&vPaIxmlBr@9Za?74^Y_9&BI5(` z>i+#rT)^=j^m_>lb-ooMNAOF+J&gx5bK{i9uX*oR2Sto=SmD3b{hdv~mc?ZeKO!9excVrls-6!y1SoLM2St zGXY}F^1c4pO^-6dIaH(dihqaK`yEfsTfs*Zja3h*6Xy=2kHy9+bXs!{#{A^^vFe`X z`RMV|hAF&H@oIIah=HgXN%nn%%(wg1@qeIYjqC^OIZ*T`y+dTlGVdx7DdH^3r21@r zxHJ{PGQ3k|6i=MPPOwH{WgC#M91(#lMpN8ZQ~?eLw0qXT`~}&35Xoaj9$IGk+MvG{ z6>?hGsqr97oPPn+i(cGck%tTx_Ir@elH$AS8fsLAl&oq)I)h=&{jtSM4-mVAGbqsTNy{glICFc7U`<$A*GpZ2OF;TcaUzh{* zW~Y&Cf8$tOZ2R-_3d2}tY<>^vL2R~&Qc~%!KAt=I5i4vLQUU?{@b*D6v$xA^r}P|Tcli`e5_1p6 zZ@ep4<8=OhsmPj1#GCY{Mq`RKw!rZ4N%wAUJ6jd{$ErVp^+M7pU-G@^Rja8f8k

r&8yv-|t=;|-V8nB2|x9Yv>YB-vK zHq#=wl~mq4{{Xw|j|?KIOrvLkp=on}6&5OWSpNXDdWDy72*k43U$w^J`Qi$jc=;=z z4FI1J?kH=Ziiv3)I>gDB*99SWjwvPdTfY_`OJPGjZxrlVqr1&l&21bbNl-~1*ue@) zfp1Z@@ol2BUMM=mpbb4hk<~`q?ga6EgkZZ@@zwl4ID~aNjQ&eU;BC>ec%=%X?1wgWZBM49C6n^X_sxCXc%D!RP2tSN{ z!3Omd@We8m>%&1V#oKkTVSnnucrh+jo-rV*L#XBpo>uJ^R-AEuI^xD66%2za$7U}N z%h1bo02qfWYY;Fq(+Wjf--QrHpz#lR*c&aTkOf*vLY*FuX zJlAbFTvX-IDe~280}FJxYmeV^im_}T60Q$!s;YcJKq>rJ*DBjtrK*jXTkr!4T>gL6 zi(Ml$+u1%#I>fiGd=`m#f2*|ymiTG#TE8c&L~&hF4M1)hT7A+0tMyCn`vZZEKD)^M z`SbKDJ|x(FBTy&B%}bin=J}>#WQifqWlE`wJ=DI?q_5J}{O^WjLan{X8&9V*U1+s1 zWO{}gT5_%>ilA=u4ZjHXxy0-U7aYhJN1$_PYbA=JK~Bj2Q@ef@BK(i03rUnkU%YJk!nCXKmu?eu5J8m|+ zeZ~Xm$SJ)yWe|kkDe12lUscbTczc~LTbD@$2<;m~=9VCr1WDCNwir_C?J0d@B~Xoh zo@*^XoL5b%^2y<@G7}{3im53a2L(Mm_O>Pr+!Y0tf$$SrY28-_V;-u^X>$7dW?GtT z(W$}Asoo$8Jv^uIynRQ%<$){EH7%#M{g&p4!{Wvq&*<}3Gc*3kK5wJ6wpo*C%>J)c zX1Qm~#B-eD0STXb5{)!t@fBZ4ZuU4Jhe$IKH@&pA)K0`Q_Sd_~53_F{6XJ3#l5Y~F z&GJn9ER}@~cA1aMfHM*UyB?SC@6Wb7bL8C3tXEB{BEbgrUxb?LQVNq%U0ZnB{Hm!X zx1Mjg8OQXPFu-kL+(_h$ZD7!fdS6IZYJDY9r1iF8J3x`FGO+bJl{=K5a4nA-VA#Z5 z4qJJnS=JM(l-Fuc5MavV$#SiKTNMUf8pTZXwD3ku3O0qa17Zh!bxqD@=GM2j%}N+M zkVi!2t*3Qt8PjGO&sEmZ%#z7ZO-&_oC@pse;ZSY@zydKPO1b@L1DMrt85%2-;@8Dq zlLjXJ5vXz#GRUu&XL&5D>G_%HWiB7l@^*u^>Qp4 z*B2u8HeZOPQLbwk0duFE03v2U=DZaI7i^hzK8w`46Ir*1qe@Ml)yBSTO-mYustFWw z7Ed^YeW8Nbo02Wt9hy#I%0`;P>>5F@`F2suOu(T6rTeg}ae<0^;D?1U2B= z5T&wZ1$CuvTk#{PPITEiL|ELJD48H{V7Ya z5HGT#V>73sp`oLOmMABtRuWXA0$;D;djoF0NjJYZCQ_QNH7B(=)9Qmg9JEbH)ec!C zj&hbDbReGnMkJYBMnJo*L=+V=8u+AyLIFEPw_IPJwg+)cDVh2a=fO12HI{D{pVOIp zW_i9~tZ6CPf~Y~&nU6&m7dT0Y#Pl6#*3%h`od6OpRnr8(;3R?Gt@`{f_`Q<^pHpR; ze@?`tq;gm42%?HvIQ$IkIr>=j$4z_OBrt)bJO;XVAQDqR+5lbu05lUF@R~J0!$*#~ zR)$R8KMtw0sCRBja-7~7r7;n4BB9zDd);sRuRStds3Ww*eF_XmM&D7v)1(3j_Wi7* zRURGqmy**^Hf`a3eKKZQg*H`9Bi2Get*Ua6tE!X3Fyx*V-1W!9G+O+RH5tn{@w|T2 zSQpC7!I~2^lsoA%1lppKj&S|FO~TQ z-o+E~GvVXLj|lXpbE~yhOOrNJl}G2)Hd|cs%&?N6$PttR2I2O@JUd-eR*`K;Xqn}e z&Yu`VRp{C}ub#*w-m3L&c2gdCrrSBGoMrI0omS8{>sR*G!uL1p?Sg|crG}y8r=B5F zS@XW6yjDTnHfda{W|)Q$RPH*d?qD`#xUmK2%h$+tP77073S zk~wa7f^0bJ`?1(^kSG;j%0lI1tz#qYA>(@pg_>J&4DKMfq*dWKAOlZ7=pS zb64?SAo0^f=2_)$={&}+n!WQQEvs2-p)m<}cPP++PjGOZ_yJMI`AtdpIw3Kc7lH_3yrKQG{<`G zgUe0(747huGVL|5v<6w0QUpKSWutNUg%PHgVjr#UPu~;_c`sw!en9^K1g5QcH%o_k z`mS1s<5X2O{vPxn>I61>Xmez@i3e9)U-HbyNNAdqfIz97*{A}*WcU+_qTa^9jxY(#EF z_a5{_s=4u};P$ZbHzd$AX>5jE%k(a8wN+|>dSG=`3_Fkr=GeI4ozSq7(*})3$P;qw zcW9KF!!tl25muY7V$IDl&(;WAUbs<)aHj#p zNSzGY-oB{*6W9uTxB*m z5_zN?M-1wehyd-PhfDDD;QCXA?1s#K|(6}jDOU(W4&aywz@;&jgIKlm-@;<-Q7 z_zB{TD$KHI`C^fP+M>Fdi`v7Y$Zc=0zB@R^oz#^0ML}@aE*VdPekEmzD67(Pfh@sg z26(?#fPz@r{+I@>cD!n=TtA1@4!Axld*gmnnoX;ycG0pZGjfftb1GQ+_4JtsOi0{IPN;_Pn$5OUVelWp{d=bMrbU?NnF3|>RM}o@OC?iQ zQn%}CDOw~PO@12O*xLbBt{}#xIl=Jyl+2N2-JfCdyh63TAQO`9(E0wcy#CU9q#mVa9s z61odH@mIo~Wuvt0aZ8!z@lvHaPb$M7>ZVy*@;{|+7Tn?24#ad0nA~#G;Oa*-vl`6p zI(n|we+Q5&EnDFG;t6Y^tp3pQ-$Wr8OQz`H6I_fAUIR8 zX#O*oV-lJVgx`oLURM6nvUqm`wPe(ENY_2Xd4~A!IB!1;pRT?*GCnhZw*LSoQ++?d zcaBxmf1;~0JdTbDD&U%0nKd07Dg>2eK7hoNbpTrdR(NMvW^so@M@Ok?0_LENZxW}c zLI{!~TQDk<0D^yV>|29S-!#Hm6fBPnNWn;C-Vs&8u;BM1-HF9X&*=bhi7XQw#f|qi zR$5~&nr1N~3`rt=t37@;z8$sSjGDVgYAqa@RMF-6JhT(XUz$ThCz$fHjh=BElE;g5 zH@{JfCJPkbQ0^NZuGzj(9Mx|Zg(T)5Dcd~q`5^r&qe1Xx;}s=5RPUE*bSV3aonJ(y zt_P%xoHrFg(f)cR02ZiplktEa)n-XBr7$uQZDL0wpP}R%VzDp)-HV-BTW5|mzw3m1pTk{DlxCV1-wY{XIJViTai}eP*GRZv&Z^FGD>M$z$qdy z4Tl)eFgW1)Vs`Cl_mHx#E5b`^k__hlrBuhT5$sSy{fv(l_YnEsm0O$K=PSqja|il+ z2l*ohnMwx+cgmmaHBaV*t{?1X_^D3KZ9%0Z+@*aP!dze8>M_Hy%{pKEBMO?I2NTwG z2>$?R^>tP+z)ytzW8gI=su}HOQC0d{3VL`yN9GAB203?wVeNB@w;O*>HW1fp_HJAH z74PnKg9a{1Ioj(|sM|C+Z?CMZK**}yS$=X2%Ajp&&~yUlk}Z5zjXV0y(0pccR_9d% z;=ATMb1S`0nX6wcB(Rrt3;>xJ8+EY+L9-Nz;eGvWvZ_aAc4T(9BFTX>EeeVpNwaqI&6_po`DT&ae0jEMt~r%?OAQz~DAe-I(c>awY|--qHU;_?l( zL_3pl<;MVUJ6{2sjLn#ALG`KXE;aH;F}+gK9dJkY-9fKl*TrpanvE$koQ8=jA*&Qr zRMf_zox{U7kbz61E!C8sgcFJ(&<;X1n~hbeo15H|ahG1jO@1~$AN4PdIhKUZ@(kxD z%U2)9fL#zBhm08T2*Hp)A_Wh3dWm6GNySv*=`^ZqWu71bCwLF1K>i!G-QO<0usq_*O zLjt;)7?KDk)=%GojyjOJC&bbpo~IO?Hh0ad`l`@;A$&IK{{RN{=3%L|R)42!A)6Knl@ zLeb6V*xd_l7Uh9nEPp$XwiDr9k<-bgx<;TkRKpO=;J40ubn#e^nEVEKjJ27pIc~Pm z-!9eF6)}pu%gd?#dzZ9}wAhY^7P@>+nF4hH5AWJrTYlwV_%@?-1ou*RlIouWJ}N>s zRBQbK2_B#%%?;1)OiS>UBfg*2X)nGHtMXm^Q_`AWfnOD9o_gljS_G_-GWzo%QG+Q2 z3n=Es;{Mozwlsv!{B-{;r6Y?{Nv|L|Rj$SVOE9y-1UF&@6 zlf<11LrtFMQ&y}wzH{VN#AG|Ry7^;mul2>h4a6zbV3T`;)*R0;RbICYsZ5-q#D7{o zN*Ncz7POsd_xQQtlKCWUwxAEY?h1?B`tWe7!|KWIsKNQDae=AwUHnu307y=h-w4{W zinVJGi+&o&!5Dc_=gA)8L9yjeLIuA(LgFe~;&(Lxw87D;X5pPo%Y*De5lzjwGA>D4 zKk%QR-@=~`sdS}Yp~^J{OcnK&Pg9asEmbfzOl2xvK;#l}R>fD(QQJ$Yz?raMXxMy} zV8c?%*2ZA~gPFN+naL$#*39qJEQa?9QWGJrfWd=u;c{Vn+?|)!$_k+7E zle3T2a!ptQ8D=|oXM3BT*4f9g`h$tti4h=2jBVUg z&p;2qTll#1620bM4H=~HFQ4N-hf%amxWt*EVaI*JIr@&+^x^^5^QT*XnxZ^9PggMK z)E;j}Edk-KTcR?*5nDC!Uq@F}YD}gYDro4lP!&x(d6A!3920PU_*+{PLre_;u$MTv zk)#30r&v5Nqo!g>8ioegJ6^HohyEJ)V!3{0mcC`K^wkw3Lo`)PGg!{UBrcX;pe!$d z1~61MYunb<%zOa@TODqly{%}MK{<38dwW7@kKvkVsp#pS#{C5!%UuvjS-FC#+Ae+U z1{?ZYXF=fi$M_jlC-BytGn?vZw0l1ICKQH00ji?myl?RQE%t^r1mAl!FI&SHK3{_y{HkD|;kGK;e9n@8A2bfi;5WKdFdz#t`)~-yPR9wb`f3k#6YR1N z;NS)G>$@5Jq4w;Ez9(dPMth%SGi3fDY3kUMD2j?%Q!zxRf_em4?8Nl*0T%r5mc3Gb zDLu@nJ>Y*jwc(s1L5oLNhkGED%T?gidG=qBJRUIUjH~47+8Vg(tCmr{*tPDY7O*zK zSbFeo4dYzx=lCv^uO7faX$}JOU`Ela+3!sBpAK~SWiY>wngGJm7xR{(i&&m)s{63R z(xTDyy#D}&B{c9XI)@YZjMH!3e9Gxn@byPi8VNokbQ;CKayWT6{$RcB_s8CqHjky_ z{3%W7aid-H8T_g!_-ElhO`%s^Hf!Uyi>x{RpPML%QdKN$t$U;0-pgx{Zad?LVrKEA z+FoXVv5rXWJB=f7<8X9f0s#~K_<5lQgYeFiCd?>5On8T+A)$&H;BvXrG>sd;(1YoW zf%u6wI9xF~t{Um&=D3dzs(8`_3DL3DG{-Y0UA(AXtRk__ywO{{Rarvy9=btR`F}>olDo+X9Ty{1WMD$C|$o`Yk#zyzagJ zq+)Z$3$2su{{SWubHIaiEBf^E2_Hyo-IRo8k;D$i=P!e#y@Y3k(5GKzevc^1AH6`r4P z2WznE2ptdM!piu9O@#da0MHehh>yX!`4_P5DhZi*Tas#6=%D`WI!`a2l?a*{>l#Tf zen2RpO~4%q!4xY#h|F8{zd=fIm|>4bkwkZebZiBrzq_eLu>qqBW4iD#u~?06zMQx%XIu!Q^$NM&AHNc&pyn) z)cx6_z|UX1W2A(}~>$vKfVeD3i76U(^JbRQn4|TQF|UZJ@GuCoO2=GZJS3m1W->9og)Fx zO!9hT+Ac{wvB4{# z48kHuqw8`Q;;F8qF^c5#3k#B`f>hh5(*aaWD1z5rTK@nK{A(T^vq$3|X_&w&BJi72PYSEbXZbgZ1q*Y1;FTiRB#&%D)^bjR z2)bg@{{Rrt>r*5ee?n$?oorDWhNOXnl{3POLplNbDn*awjzGLZ@znEfqk5;}J0{NS z{{Xd3S>T>~B=rGWDmj+bBoKCx58)hK9>5$i3=yot0ioX0EgO)@Datb%nlT)eExB%uP^tuk+_)f}w%dtlR%=|=F~IuM z8jIO|SQj%fZS5V~`6xD5sys*WgIIXYpgdyJplN)Xmo=-%vmcT2HVSDiPVvvQ@81|# zy~W!90F=(E%Ab49CLVjD7dbL@fPru4RVzzrtdd;2EX*jfIH_a^vPjg*(X-43)^Ze+ zxb{472jrwfz&(-dMmWWk>n6&MTX-mQjMMdh&Tz!t}^U~syL$11MA zE^55Sn=s2Gj(t&(I0PiJW|cJZPVx01tnLbn{?G%S{Nt)E=;VRkfT>tFRTrq#8mly_ zgEy00<~8;3NfSdob!#<5XoJ$DYS^gha0%yCFECJD#qk#mF+U z!wVDmRx{~UHBZGwiV+GMyHpk*boN41CCBb7dC#;AcJ&3=)bIo&b2ks3ZCM zZ8D1t#Ikv{Q6rTm;FUcw@OdlO2w(r!&ut%^S!a_el# z$!qCq9b}e0g^O)tW69}nrV5lOXaPv_%+`9p?=^U-Y@jb4{`mJY`K@w6nb*yj*BrXG zH1jSHz4rzd;^W)sIX$rjS6W8hv1EM~5}BNP!>mcJplU#=D5v7IBYW|A`eX&@Qy)GKpv#h|t>0F`cjBRo{_%i<$T zcx_waKAKvJ48|yH=muAwTB4Gwt^l*eFj&B}WRAaylngMbh$0S_jb?B3A;WU+meBlO z(&!%t>h!Lb%1YJbP{pV6+2^f9nn+fhqSmtP;lbpmzdi92D~2{Q`1h!YC1zHy)LO4J z)A?N`Ua-xls);XCD5|hClekEsKq^^Qe|Y_yMy+2*&>m6>0N6nS=S zRV58Q4J~~{er;3~(7H$&nY~_RmvKGsfNS-w8rV*=_R&vH9At=zMW2XIjLH0L(|Y5= z?3+V3=-l#?EG_C$=_9T2W5eTE*4XK90Ec}!y3U%P13X8of_m?j zqNt#S6dBT?A9z*dB96c3#}CA2y6`l@miR2$KCFh5!|g>+RRd==(Pglss||vsiU|Si z6!U>9VgMG^dC^Lh{7U5#Xs;5pn1roUNtaR3WE4hlOC(e@=>>s3L1iR;@z|@My$4)n zRQFKl#sTCw9&?)wg2a1Z))a=JNPj|7n3;@)q-7T;t&vIt2Grmi4nbF4ek%NI3gE$M%yHNi>uUAv2RfGBX8Lq&N*E+>P?wt)Ol`QPghM+ zuRMg10OrQrW9U=F1t8E_-cyohIX+>k@+8kPN34#XzKBfFNYP4mlCFTAz}mvx`;2n& zWKJHSp0I{kUJ#P&pG!@}x6VTN_g29sgBwj3gh9mZI^=jFdK+3QA z_O7VU0-VLm3fE+xcCCqi8vlIxgHaMbdE){LNS=i;8^t%GW|<#5~%ErB{g?UZ|1Wp~Re zqbT7Ir4J_F_@0Gf7THHtyA-rk!cg8$57QEg!0w{RLgZwDS8GYo8*yxWULqGkg*HoD z1ZMtWTMKeJ-vb(fOevC(ii9?FB}hMxz#CtvzqTSUbW?_%4>eRiEOIlevn?1W)w$&j zCFZ9zIaN`oiP=!Fd#6`6Jbm$Er^H=E7dI=3VY`ID5n*wx-(43tP8!Zn=-+y= z(&0jx4iTp1rj}E*(r+79MF2M7w0}tOfcwO4U|A+%kl~0AcbhEE9H_~^VNwb3o7ID-1&JiIi*4D zw2uH!yp+2t@S8?vlT_3upPv3+`L^aYDPitCYv1pK=-1BOC++x%ddHzMNWU>2VLH#? z#-5rsjkL8yLT#ZR^n~P={gZPqJpuf&C=VNb6Zwckj%V+U`*@VG{0`Ho^E>Hj*|r7S zC3Qnww+a9f`wM`g@M77s$AUpq;69F|3M;f@ZIQy1dfKl^wd@p2j%#8c zNQ)Reqs>any)ByL;Jz4mf0ub{7M!UN$?5VEuBo=M>en-lmhICJKM^KeU4O*=1$#(7 zAUJrW>EMoxp4AX!S%ajGNOjGtU-f_OeDXc`>N{ZeJ%Hex;w&`#8?T+%gEDUzH`HGO@!@fIL8h-(g zO4`=B{dlqKj$cxw*nI$dz(cq<<$*k>$u$1}aZL$JRMCHGwO*D5m9q-+K_jQCbNOL? ze0$pHgB!+A&`~t$2$11DxtH1eGSF2KypN*lkyUmpOPJQJjr$nt6xjW5j#-O0vD;7& zK0qlBA3m-d={{-r_$Q%^d*RTNOLXUEX_>9b9ZNMsU-H9Fna6L*K(dBgXGjl$ni3U4 z-W{~F00{|OUf=`T%`ac)k4H(%=!NuO*3o&W@E1V6Bxo*b7*Pf$Igxo(9 z(o&KxNhiGOtJwN~eK+K#*}WAWrJ<3XCX-Z|`m zEG#k&(54@SKMHB(Pb0(l#^teQ&1%T8{{U@KZh7c1d#TiU9amf2gl;OJ)&BrQu3zd^ z@TNVM@a`)p=XHF?uls6@dT{l5JKG3`4K@!HA!{h zJVdTrh;A{ItCOSe=+x#*gr-e4e~KLH_{09|nIh zP15`)_+SB(`<7+F*zVXQ34h2-Yke^{K~gk-jaUA%gVV|Q?)ksW6cfc?2(+$&)AHt- z27=4-+U@a29F)lrU<(WW+Z%!Qz7}JtWp7v=cX@x%NmgzHUDayk%uTlthLy62;fu+E z+m$4i>F<0AP{0s5c6}Qws|IHoDJ@QID!4IFRkg*J%2jnIz4sAs%O4tq?0grErUv3W zSJup>f*@NisCFlnRU5yFKf@miglv3Qoftca>`rv~h(o=pm@rXga5r<<+Y<-Hgu?&2_$18!=9}gs222?+omj-COEbL`YD}z!Ar5#SV%de zsyC`V&uI2aX-^1z7N}%YudALge`{99=|0#j(y9%Ir|-YRti@@e@o6zmB$Iev9tO?xtuN3NzJg$mug|OR z=?o%9hR8BK3qe(uvPL}#vy(qrg3*T+7!NyS^%}DL!0T6q;(bQ zujUFVn3Wa^YCrglv6y{cdJRHi2S6kN?X#v0dBo}tTM_u++esp@%HHqGs{Wv@D|+jBN_fZf}nMeER`bUY|nv zQs(C((VIu%Vsfun?t3505c(7TN97+UAYH^69=Y%Y``Wn6qP!+jJk39%L3Y{cY@oM2 z0NhQ<_8j7IhIsg~WAV?KE5_s5XnCEa5#$upE2M)hrHYd;%eog8t4ZrZ9L}tr*1inld|=n(rN6(K})FVvdJNIB_Yio5fiH0qRv9KulZbi;HJ^( z937NM(th2EeQZN%Ot^{Un9hdq-GZ>wdQ4bwBabgzgWJ+bwirJQ=Ula+1l}SC#&Yil zitzeKjLVW~K^g+3)KLJVxVn*!Jq(|U)AsKQLB#;k?hD3CrnEj+Srpk8Tam3`z5f75 z%}&#Kf9+!=+usW@Saz~Ht(?L)`XtIdnAca;&OYTkifP@S%cGDnB$C8fkO{C1M;7Ow zY;wZsJyWgZhW!W0a{R5;!@&yU$owtMT6*ay^zB6Rvk7E*>G!kV#JMsLRrvZ_28;u0 zUm!j2au?xOGQs2xp*S5S;h05t%e2ryHt&{tUf+2RI~*~;y|?GP^o7{tZXdco!EriI z!m4#L2(+YYVq5#_p31$?sqJrka_$*S{6>%AzxhGtx*Tclws-i6Qk;@3qb#CD$RnaO zB;5{QBFRqR_f|qw{cVN)8)*_61aAbNdMrHE)@NxDlIqpd6H!yet3OAr1hRmGHFQd5 zmx~S3kej`)`Cyi`RJ3rs@Xx{g zw|sKqbOUBZ^sil0YF466nM#^c$6xmx=UjG2HV)Y-(0b(#tYe;isNSl%)wp8?SVa|ynd4fIY ziB&aQ%W*}?uq(I@zQ+I>uO>q_ylLAXLSn!hx`WR{;necXbD9k+C0^nkGc%Q~MgF3w zi9dcEVKCJk*{0G5VT+{rj9W87C&GM^XUaSpRaKiW&}+|k$t*sc6N5bpzbAb3Kc%xt zcjYgV<=za!rJpbG_yPSU$%q4vmge~EVC#>H@0@&>j>I=|@2Aa4H1#f?rl)q&S$0zu z1ITYCP$`5A*5>~JE9fT`s_iuD8wr-o5_$7aC=lk{oerwB{C5wS@K#Y<6l)Udtv!9r zHkIEe;=f`qd|9|V+~z*q{;QJAWj30vlkrE^Vyg0F9v4+qZCtZT#~A>d%}cPG4qtya zz4{z3Z9GH3g8c@hk8;vFd^-ijJ8S*-<>sBKw5Nv;xW_@Fcpj#TN>Xjxb>uvI@G%8k zJ}ix0^Pl=ciI|)@&@;d=r;R_PbY)IwEgX7ZN9HGKcaE4rGpV->0uy2P>wxM$y(13J zd#Y3(=OU>#m2DtLCO7mIG5*oC9LrB!WqBQPC%+~VC(4c}u=EPkrLHEUT z6N`Cwt$)U;=0bT-1kfS`K+&}S05-{1f2XttpK24HWjaSImUbRc%xP)jSsT9A5uOG6 z`{A||r>W}wXa16v)ih~XkIARzkqoQBq&{rbIvO3P($V~{Q}q#x{&;BYHX+)`?t73U z9fxLsPirapF7iX*^g&)s%R`m9A^!lqcW(USID}xa69AtVIY#ayKRX{F(*sMSUl5jgK)zp4+J@|TYmTlqYqRFZJGp{Vr*Z6#st8KKj)N#lH zfGk0aZNa`8iWsVbN9QD^_*z|4^_mx^tnj{~M~0(1&>^fDlggs8J%#+M56kn%zJZB9 zXD=O%!jTap@!FEs>YoZ>Mx<=dK}jG`NRFD6KF~q7^^8Yh-@ZO}3b+t|J$*|Pg_vpl zwkcj$r!>}Y6*YAZp40Vov#B)GrdLeRNTi=wAuZT}Z)_-adVt>1ZT!>bv5pobj=~SQ zH)>;|w6atG0Bls6PbTxdP(1m4JVnLqEo8YK_UVII%C-A_zDO#rqd;dfdt8C_;A{D8O3twGs*I~HsnJyJ!D!`% z1|V42g0Y^s`P@3Fzmv-Q;ffj(PjyBFyG&{=51v*mISp=^&MSqUSShI@V;JVaL5y@5 zS%{|k5J(s12-CeXql#uE9HzrewE@?hcPaAa`F!hd&^dW8)QUJ2d-6RTALowxVr>mm zTwgP-+bcc3FqV%k*VzOVS$uG!$fo-q_}A!By11D=<~hXmPcwAH$Js#g&wrI{vL zb?*q1n!`z*{3v)IOIbOkk##+Aq?A~nF&1)Dp2bPQ`JC5Ofgru}^J%QF9s`4a5uRuf ztLSswx8&Mt>S}60)=i;7lbcxmf6Ia?Xgif{_bKg^>uh+pu%e*dsC=oT;NGrl`rPQn~{bJEJ*{;{5jeTOVeH8zy9_ zc2VL+XP8Mn4q;OXNgIZ>?ESIfaVWMtr#W-F_RT1a*{VvkbJA5Rd0_9Bo%hD1Hyds& z-$Q}&&5r20Rm)1y&3pZkX4QTW<=SgXR8(X-5EU5=@lt16iV$ z;Yyo=dkb>|DVF%Jo5UpFMZ5Wj#pN^j3svJxI$bKWItprNb2@gwme z4X(CRLhvb70oPZ=N-j?w&Tap;5yH79Z@pUeOUACQ!$Nc zzSh=$+Nz0Pm-xw?Hd&Q;O_A2-QGBH#%qS+ymX<0x8Eqo&sz_eJ!zf@`c;o7_i$Nq3 zL^NsR*nE=;$1io4PZ~Tu_>%B5Pd1{e)07hB>{2=Z07pyn^;Gw<+~Fe(tGJaVMS%bk zc*OK54asjQ=4YvKs3WVks4e29Z-_DF{vR)h^t5u#sxtS?^3;YFj(8%CiV-j% zY;vS=^yePbrbLmqcal+5$wNxXDDv7!W|J?F{;&@^{Ej&L@qwCV>xIgWwrOhVprm$R zJBK#0+1Hbt|rk))hg3^d&+{YT(sr%txn9r zYbO!OCGW&Q{wDtb7rz+p5fcmT1y+9JGsEvy_MG{&+{EW6*uU- z%u7-8bnc;>b+*W?$LZ+=es}_**&9XKOs#aG_=@>TT4j{eBeZJlhxSW${=d%>9HDzI zeb@ij%-oANgM75~EjWS|XKl37^j=uqqgCSF+XxJ{|TJuzCvEm&SEhFib zh2%9UTAp-qLM&QH$n=BHLV6yZ{ij|Mkv~9^;NN z!>bXhMLkm?dlq<`a2*c^p&r=dIX-c$eYH|krtTiQW!jNXD^k`t`Dv0*!z@mOd0Yz`mqlBJXGG2@)c(Ihw=Xa!+maa_G95vRb<(KqgJn>iZ_mt zmR?9P^b9UXu;BN{b!mVsG_mF2xB#COBk;>zjcG}y4)`R^viVk~j+{abL8yrBQeAyp za6Vp=%g}PC4~t!S{nfJUq6)me9KTTHby7UB!5xyL%s{Q?6UidnU!~3tXaGkfw-9Ae zI_#=k=&W+ZoDvEI`;_jRBcYV4 z&0idXoi{t)!*|#1iNRjAp+Tx>^6J@TZ<<)jlG{Mx!1nv&qGb(EQfij@p#)U&tg$ym z>9*FsAVkVvL69spG1MhlU}Yha{3x*J^2a3+6J*z`GTE}JOp#6)FeiF9;$N;l0dgCa zMkLLrr}806p(3!jTUee9KCa0_phFEWL-u6u!wTwxVR=S(`{h`BO}tg&ldWTft*4) zsB=DS8gzzwnC5%gMCxwJc>r4x86^_N6*#1s0m>5=?M3z7b_heF|wb)@LHZk=f<1oz8m%PNz(5#aDpftpf zDe_UThCN%E_>bXEl+}8Iv{&Yp;-u8h=%Vcutr))EFSSL_Ti*fkEGuYKdmE!(Kpd>o zuKJ_!HH}6zkp#4R$nr-OWO%J%V!oS>dh>+#gxDBPQ~_2tWdh}m{{V&!p>f`!s%0s< zw(G_&arD8_avHd8335~bJKFg8w{p4#A({DBR8l$S-%LQ|C<&kl*hVDVzmf;vjy}BG z^TY%xq_h*+<`#Z`WD=TsSbQnZD6=W4CxbP57LEqmg(Q(>FMsK;Pqp!P;U%tPn&BYR zf3!#GLOHK%gPQ0fy&!v9>7S~MawnfV?Nw*ktV)X|ih^uEJD;h=M-C@lK>9BWLnhss zoCk1m{U{&tLji-reM3@`G*xR+mU%Kn%#Mon0bA6hTd2j)f(SQNKe{@O=v)Npc<&1~ zS0>bASSg!XW@^l;MXTko;9H~O-p7qHv%zGJVLG|m`2?x-{-{Tgoo$(xPL{5g=l8xl zwwYSKZ9l?t`9+lKI`y7&tTQkoUD6pV5=T^YK}?-BB*In{x0~nx7}sm0Q(yu4cWgYa|!@dir}} z;2ZcYS=kZsowEB=rS&}!Y30>)#dZJ7wZ;b3WHC0tTps_<$CjSwWB@=v`UJa3(- z{4>_mtGY=BT_KI*I~+dc0fD&bb9@oQnjGu%L}K63w2{c~3mfCfv+0%;8m}{1WC6vi zCD;|YzYmMptF&mcoJ&YPyY)J~ai_|&=hR7&zOKw!414^=t(%W=`0?wikS!i5Zf9s* z;y)PqCHa;`np0&N?OJM_*7Px!2-ULel!gM<-`2#O4b$duX$>H`qCVZrts3GS@dD6E z8jWRsk31HqT1^F{AQPEK=#06H&C5z!6(z~Jxngd9_{=FES^xmO<_F^uIH2m2*d zxsGAto`RyJ&8p~;z6t{g$|ox|{t~KIsB=V+Ge1Kd zl>^Ik)@xp*omrZwQboRYYw!n8Rv2gOYKBaD&W*b19d@72sgTZfPG-oA175mq#2(*| z9(0kjSIs|!@1Cr0!rcvZ7PrntUUykov1MLlDLq5XpRHlRS10-+*2PbcRn1M77kSh1 zO22)|(wDrFPgH7Wa4*z+2(4UQ>yh80yNeqldj{uur9G4?- z?aXepXZs&{WDI;l%oRUd1r-EHNdyIz+_mrTuwtRd-C_8z_pxbza**7>Zu)-ei$ILw z$X11aSO?*?x_vQ8bFb|8Eif`XKS@da+IN-&@@-`*O|OWYK_C#jf-aUuhMvRAQ5iig z+W4Ac+bB<1BtJ6qOIWEWy08iubYG?+6(pF^P0_@7`6WB&dDOhf2bXQYb^2qlNjFi; za`>gPt5e3LA#$SNDC>Tw9TH>3aNCrYhu51>sfop;iTUsAUO#p|qGqdm$Gu4FQ!&W< zmN@vsr)V_?idy+X6^ZkzwT{NceODv*<5Z$QhS;9tf#}zS7U?h8h?AyIa+5^J;`F5@1 z_$Z;Jq3|2S(Mt}`Ix3op2q&2yXWUKx*rjnQnV$2xtoiVPuNC%Rkb!#jyNh z9ChS5d8OSGM&C&u_(agzPE+G2 zgmoexGv_O-7^I7J4+In7**O8O1;z>Koy~M9x03mn_+67#X7scop6KOCVD>h+ z9X{8@55zs7!PxtgIyib{iEis@f3fEjd3S>*2oNZXQD*U9xd|rKzu01x#b27Ei5EQ- z{{R-$?+7}r8wS2Vj&fc7ktp|kJ!(M2f6nhCH^2NkEyixbVU z-=sWlq3D`Tg0!Cp`adnwy7N&*O#`gMPx*^;dn~eZ{Du+n8qcWK=H~CJub*?&8o>Oz zo{oNczx0g%0N+f@aq_jQZZ0ffldsc^Rgd<3xSc!O#sMrvCeQ;?h8#TH$X^jn* zX8LpSIb(u;r<&mRdZ_fCs;jHfi?h5;g zJyQeZ`@;O~XL)o~xu$TkQiWBjsR?zplt{o2%GlK@K3drMAz&D~aQ6~5bG_w85;|5b z=^Z_>He!{MCq!1z8gDMmT`)WpwTri!H%swY|;H=ZxOBtVz_qr@d}?Q4AIW8r?fv{K~U@ zY-G81b^WDDm`1W1c&gSuKf)xgq<-zc#}*D7Sg=^?s=RuO2)G70_Ws36vOf-V=3`G# zXQB%rYbhLb7_if<=M7eV>TTrTWTaV_hx&ewJ=jM_$F?>rPv%xtM%V>dj-|u4SY(25$t(K~t1PmC>a#)5`P_3pknA z{3Vo*y>aM)qBPbnZzWOlYKpo^D9j5Py{@Uks-8dtupZdxH3Uy;YpK+;v&6qQv?E-4 zL9+wXoD$U$CvB5PZK$&utBlhya==}-fC%k-W2s#Mm?SA*Br?fTt^*Nk5$PizO5jRS zPX%>*`I3Y}7kU%JSYkIK11^i67iW21ORTi^apESNpHXRwR(UEi>S?^UXAAnN0NlIw zH#;saFMz5$FYU|pr}zM4+_f7b_`LXX9yaG5D$4oROPJo^!%ZSQ zQg2wrOh!d0t283yo3Li!4sZi%I+3|B90mSO&zhC^Z2B)=4*XU4%ah5bV$L=GU7cmr zH6!%8*Jb|z>!j3dLpln8Zzzlw+rqW~0HxSk{7T0wNH-0L(nmB%!GXQJ_EuY1e0=Gz z(Ynf$!&=#=%#5n}RaHz+@~i@Z-_Q63|E?#w;TGccoS8x?$Rn za;hH^8qSyEJ5%UgT_2qUxkgDX9$^E3pWkxGWOjrD%xAIU{@C)SH>7S@f?|9=-%1xO zs@a<9ukD%%pcP6MA_9@cjkx|;mYJ0+X($wWc+opA=`~RZD#cGfTpHHG^izVQbh-S~ zAc~^7mM9SUM6K`l!3`^{s!I&%o4#8f=$P+T^H>6IJ+IRe#h1d#&sZ&PQ$sQN&={Ng zZOWe9W0PRIi9^h%RYPA*5<^O&RFDnlsUxYvipp?d88f{4hcS|xSn0%;f;DE6UsmCJ z;98ZSuX7du&<18-7aF#U$)bxS%jjuC1QhX7#9?ZFL5TT^N!+*Q;Evd-vDtK9G!kW5 z8eMR6?ISLh%V}t6^wnhq^sPfr6A+11F8fO{=W*u140TQLExKyKm|X%guLE>$Qod4U z(guiaSp=3B?QxF}TU9e@h3os0>0G`V>c^rpd2zdtw=7vfJOS4q1_jsFo#2Wn~|Pa&9fgKBnHVYedY+dsMF+gEUr|i2owc)+nC%1ETekahy>dBoy|M@QjFP>9W9+!mnO?wa{+JCXtDrr$sKxj!6PUi8GKrIMm-Dg+2U@C%e7WX zQ<-I{l4{Jp8Z5zMnVP0JppeZT#OTL$@ynie1V=c(x5;|I0+iAGDCxRIq=0LD+)EJK zIW$mS%QIa0`JzM>3D&<1dZ#JODf7J(np9@Z3fszg7Mih%we2E-x27d+ zG88WmResKMU00;_5vA0*Mqy5B5t06OGW^?{Og|UY^tvEvi{e%<%xxmrOVA;nn_}L#G4V2wUGAu#%yTT`J<-*4)R{ZTUY{zek^K4;1C*P0w>|IghI#CkJ(;fvZ#Ij_V_4v+m1U`c zcLs#|3jIEp9AoUtK8;7K=Ap@DLs3FlG4ux(8&7<3o)?`8MGa(h^_10cEu)%Y8WGBp zc-wE!5xk8;DwP6k6{FJL31-k{`7~OJfhWqdZR|X=d1E_40mtm#{C$oCbEXrjIAF~c z#-q~tHb+5El+fu)GO$k^sXVYO(ua?s-rvU_izBjG3U$AUIWA9GozV?7l|fZrLr+xn z@$Op>#E14t@9$ylf$G%S7r~IKuZ0y7*Lca{)kR#%G;(SvF6eK6)yNbNwgAO|DAfE< z&T40b9d`Ghs#e%|x+6Lp#bF|n4xY`2PHYjZF;`&$=ay!BbG8%MC8O=}N(X!r?UTT* z7O_aO0rQ*f)nCtRgZASdaf#`w&b=qmk&u{Rf4X4_&~}d`h{VP6L%+;z!-J zRF-7+7yOC9ID$@^-`tyU)*RwzZC0WD(W!=kqL+8-;X+sTz(8;Ng|Uv*GVAMk_LaBM zZ&WI|@jIH+Q0LlY>{Laks7=LLjov^=vV+$e9|9vKwvRQP{n9bcFsltFprR90ZK(?J zxi&FKK)2UtHvSm2dbgcb6VYC50q{>*#;?n!p_P7nd&ri$!zF^WH$(+)U5;RR@ZtN*(YnDyO%7e^{Z##gy9@tBcIU9eL-_BNk6NM$j-_$zyg{T>3 z$m(DdM0T{GwfMKMs~_EbSLqNO)7$!0!lj14XbT^_Rm>!!)!rr3RZ3%(v)Z}DeoMaP zG7t)s2a9{+*G}zhZam7(u{cKuI>*DcFjZ?<)}Eaqc^t+SNEFi&EIaxzR(Q0J5(m91 zb{WTG;<-txAo<*)cXhgRdiPKGI@zgD< zB+X=zS=8O4VaFs3+Z7HYmDMfs8$Xn_E*nkM>52JH@?57hNptHE8hXU~ZH406dXEgQsMysQb%#vxND-x_Mce!N&SKRmf zuqy};X`Ng=)ZU2ZvC=*%U!uqD>1pX8LyOo;k zFonMv`z7!v#K^$&3(-?~U@0eh)J8$z9-QLO!fT37>ll|b4)Z7+V6i`eQ)&3C0I79e zUGr3urfG7t@u5>sIsITz3h^24IK`ptc$pd#c>>-k90#5C*@uwirjhFGrjB%Knwdg{ zyCc$6f(iCMS8NKBzWj*o8q~PF9fRb(x#XN~!W&yUDmg)%Kv<3Qp4)RlF-iF%LG-Z^F6+TMcNcX>9 z1}Kx5HaBZev=wA$#^;^?09jw&4&BGZzbNdtHDRl4-cUR`+1{Q)~SlF$6BJEk$ZhN)>1Ms33{tT#eQ?G?qoxG=gk z%k!D~LK7~~@0#W7H_afbreRMFWkZ)z2k6?-yXk)`5%jZeug_=eu9_ofeAg=%@WUlU zy6-rvYAUE{&O{J2v~$3oYBvk|)n9YS#e0mn3T%=+bD;;~o&O_U`Z`D)Bn8 z1YcuY^T)0vY`zT}F7Q;;2?3fWbrw-%Zg0~bhaJ}sU?F^@SC&eaFtl#68*c=0^u9Y` z1fK=#?Ex;785u*MYcAk_o;y0Ipf57iF?iVtL-pXX9ufhso+dJdT!(;M!5S zZ_Y^G*A1QXRF;EHYH^WP<%2`&Lp1cV!Yz~3?JVQd)-lEU-~&!72NyB}+HPlm=S46% zz<|878C?WgezJw~F=x5<8R^)H2fBjq`+r=foh zbrnc_^1iY;sWQ2yg`$>Lb+fOe@NdVyE*N@(vl`&x>NFXhLqzG`tH%!UA}6eO1KvXQ zO`$wOG`AiS>f;%)47ohuUz`%sGzGtv`U;QHUN4vOsrk8jrttH`HOwBRJSWxrnioyK zp=aXiKqu+XIOe4?buEBI*~Z)aRW&*;pI1;vtxr-dqn6G5CTYy$NBA|NGEDm_smk*@ z7^)+vrK^a=DuXkXB~Kt5;+c)9nxma~=^YXXv<_e^4jfnmwJKoT8;0LPP|xGjNBv)3+*O+zT7~bBhheq)8jG`fc$LCX>F-r{?wAqrvYL zYG9R9!VO%z*4vvXH?hCD7=_g%cKphoO;ZLqZTVEcSs4BsJSOoUDDg|e>g>nEock)v z@@k5yDys7e7m6T~!>}8IeY@KV@pVI5>xVeHoHPdshu_u%N!c;ONiswR)2a{ODT|g{ zLT5#`aa0IuV{O(%nMq;^8$k!Reg&`76?V8a;LU@Z@4wL~_cmJ}f_d^h))e^Z;2(+^ z=ZYRBXIVFgS>|z;=9#Ru6tz?ohFBUS_QU(3 zeZzi7FTx|}L&$s%@qQShDd8Te-6f5VUUplj^szsrHNPA3YW}L}w5LyfA^GdwFM>WV z(Poj?{{V6wOe2hX!JzeV&$;7_M^d|7BQO(bEUCSYt?fqBX{Kfei|Ky4)o+3=7pS~H z@Tg_lqb8}!E2?vh#4%bpw!0=rbs2ksv-` z&aZR1pOlb)WG0-=@bjv6rR4oBk&$3Yzn(y_9r?HChddS-LEogm%z9D9nbHsk$v*b1 z&B;6^@eePdf}QjRa9VODh5k{>6lJ&GjU7bZJWUrpkOszmrDUyd!@r9;_D2;R4~Kc3Ps_BC`Ku6E z+ttG%BwP`T<{KSMZ}b!HSr#vcJ@PH7)Pe6qq40C#X6qjgGgDv*RgFov+jlrW;Tl~3 z042#e;T2i1@Ou%5OZ+wX#g$|^)?YVKrxY-!Dbiqo32B_dHsrL^N98s8OG{~NuQ1D=hNhP)r-r7MMhwx&i()wXi}l4O zsLD;XFFx06;h%bLPtF>k_UCG!G()n|1kh z{*TuWuoc=Nr0UVJJoy5uyncxQJMhlna^^y>De&pzFr}`DcuA<$rInp6O-=#1J#Q_} z8|DB+{zLx&QBgC4C$#)_e!5XN!}p98*=o_n;U1*(g@cx*g;S0Xsiz+OvEguir%%9t z>aR%+zvr{{(VM_;1H3`dy5db!sx(ezk!7&tvd}Ti7CStSRE1LIlY@M-;-) zLD)^4eajlhVTh>k@0Mflj5fDug%e+azZ`lG3^R{S`iQvw(%`R7XFthz=t<8G`(|hB zq9%>_Pw}TIddMHb?A@MvIqBD!6>lQ#yBQ_hVSm0C)x>u=O1ZW{t{Zi zKLx(z3HX=r=U8}&QKm+c$R*A`MQT!_2w7FtBr3s%@)xn|hMYF21hvzppcC#$IMoL@ zNRJa7m3gH2Z1IMQnq;c*^0A9^85I=co;vM&dtuqc3Sv6i{D-PruunJY`(<>k_-XNi zqK(l!IH(TgZXUiB>EH48HpGV(3HaYJ%aMbrKNs5w>EKs{diz6X_4$sa)2Aw?pDq-U zxSknFV0SRMC#e{&@i&U4p|h)|K_3+JSN;qO8xD=MGtF6=dD@}?Y&R*nQ^S5NC1H{L zA0=pT%6vz-toHcR0v`~xt&f%)Cq~)Si@E-Iw($1#ANb7rs*S{7HCyjfs%nakwg z2YwJw9EDmZ}qnO-m3!%v&B(G3_e6<}Z0gEd+5>EmIlfnF6vuq$jw(J#)<2bCOXPEAU@0&K0Ug zrH-A{dSGy6jr}z6ovAIksLZ@Z&*g$ZT;&_t zC##%SfJ{O%pbe@!j6_VYRQtnhoiz@m$ujzsbxPWZY2A+?BOXn=4lt)3SEFpF_#7s4 zE?OH)@VBI>vl%I#DJG;g5r@nKHhsU3aqa9ePJTY2I;(4N?Fmg^!tRRAUIff3D_$7E zN0yf{htdyz0l!Z8jAN=(Gvz9AOce8${3hudBNJ1}S5p)+Z&>H4RX$qsF3JZ?MC^0i zXJf6Qb{HC+>3kf~6xydVhcQV<%fPCe9hS=~?mvgGZnz)PTqUI2^r-+{^M8g6lT=Gg zl(q6l3~U^EGK4O?SxGpWmL{b;HV8b>kHazMO8(Bi6;`PtT)S4wmF#XAW=D{bZ%bSo z{#f>vch6a@Bei+xl*WoDsC+6qB8|gVEmM*a&qCz>)vP% zvsO~1p=qLLln#uh*ZtUP+*mpx9YZPs=NWZoRXtpr8|C5*ffRFMIKx^;IFuDmsZf0> zoXDl5^DhlNfwmFN$sl52qf zDkLS9qCWj_qM^F#RGt_qGI-;sX*mnK)OqItlD@M4(axCa-6Dn@<_0e{#B!*0Bp6%3| znHGcX*cC zo0lJ8(MO4>YZ!|Lk7?CqXN!4;qRus~bo!Gn^D|0`yw+geWN>b=2&_~Rse36T@CG}o z?8f`0nR2K_3^L_;P+6Pehfsy(3o;lHI zoX%{?>8T)UIAorp6mo(RZ-`oX z(pga;mZu?6IB7qm!>8m;@J&XvUL&(KC>lZ*`2C`MQ}8D%@Z&hH@zS#}I+r~eHDrsG z!yP>&PHpDKmMp{&ZVv~8+Y^cznoJvVbo*CbCN;Dc?TD#ii?xppSFflQ9m=wg67#I%TWOCHGr4m;IhNPgWtm*^)55dVG%i*; zm38R0v2S)K6TP4q??d^j>8ySc^;IoD&S}idX7GZ=;SFk~P;Lq@?RU4^5C%Z92BsQH zuae{$){Xtp-a&z&A4;oUFnoMwS=LG6?qlH2 zV7UubOIS0yJi{)Kq+UkUSk>JYISuz;%5r%ZvBT!HQ3A!ME{rnYw_;h=sRXH3NAdlX z(d0GNULfah`gy76hK83WqHos9;kGc?8(|ICaU=td@RbXUo35N}sMfvslAFYAhCH)2 z(^NFMg@aFDOZu7Rx&HuUj>CAhyrmTmDItRmV6lSQZ)EO;hRZSWbB?OZdfI}GkYU{~AZl9hw6^}Sfu*~d~T%z#* z0K;01E^^upE%KC*Ry9&eWb-Fh9>u*@;9@sFHOgX4CYn5hSLU;}XOj4xPfeG^e7NbQ z%Lows`I(-4h!NN7=ye^?bbKMEzzFKPBc=eRbiprB(jzFr?-)gxL9lh*9#Llk9 z>OU=bDY%_fbH+b~JnukhyuUxsyiJQYt;_7NTdQ92@f_GH%5x; zkj5-8#m}bXfzR*2?Ghk!T{y+g+_jIks3-9qt#$rEQKs^ZAC>8<{IaeW6=P6A=DJN4 zu49v%ToMPQ_UYcv%w;MqEUF1<9av~}_t#C77;Ftn$E2oV!lBI%dj>-h>hG+|7v)e% z9W%)@sz?+TR2Poz$yDd?f=C@Ybj4rC9bHTl``q+X{xuc zmeq9Psu6y>p>7y``eD5qxnQ8N6tgse%k8*Pqm}rd1&lfW0EdR$pZD#mkT~SoNWa?; z8Hfi-@Td>Im{j&~=R2Q(C*1Yk9GAsH?$hVG3v(UFMw(W6J-Z8iF%3*W{4e7eKQT@? zc?L5${{RL50IrqClK7khPY!RPURx2d^!SVi9N4hwY(gprYcM&~rhW9t_aZ$PExOxm z@%ib1Q`fsj`K?VXxrB@wVMd!F-P84Bvhl_$n1+J$mrnWjTiCAD23Ct5wVyImtpyH$ zT~jE?bL_7xtUyNm$0|zIE8GJA0Eg>tynA5Y9Qb@6t{d-Tr|3wytqzjlliUgS5R}J~ z_@^fL*TfAZY%Xo3;jkC&i$_cw{z}i}k^zEnxy|z*`sq?>-xFKSiVqNUxmP3pm1s+Y z-?-xu^wa)IJgF&87jv8DyZJ!6$CP-DPdzcJ@dHjzO%#eIrKHo))5z)H^?;ik4^iNb z-|Lh96pO=9%4EzQV2^!NNi_=cd4cT8$^Ox{Ej{NuhrNVlD6hLDBDCyA}@)}JSPHazaRMr;$ zH^Ggl&Bx_4^%uVfIM{xF@_~EGqSjH*B5GZ4L7r2T1_ zaq8Qh!S?{3U}zdG>sgEy1hKK6C+T)T&cI%AhVI)lwyPY!A-YP8N?`Hfmn zQs|E)fkIrczu_GRa64ZKcx~xP`9?YA*dF8_F}Z4KvX@s!G^tSyB=ID#5m+RWB%KmN z(V96uEC=*YTpsxo1OoyjPW{C%b8`!eZ>;?YZ5D~wku+!fqU8x-Kf&n=1bcl5=rCLB zRJiFIugUBmfQ0Dj>5=|5UcIK5@fJfNpT(LW8-No_&<(5Gn;b`-&C;OoXY&Q&r$m0{ z@8evQRcUQ<@G3##lu^pPCQUs+EJuIA+ux||k0z_Xb`G(z5T~ZfAH6&H)8?mHY?4yZ z(?ytO@l{lLVPu?@Lo}V(t%a}c)7t~ER zkWCViB(hLLT2D&_5`G@{BkApl90_FlFnop5jNiguz3lyhVjWRQSx# za!Y)+PeBTmJ%U!>2q!*vUVQRYFa~lO9z- zmK}ifb|1eV8ntKp^}jUv5WDDb(M3R8-L^ z^Dk>j0*AjGV0>*#k71gCf@iPVn1qcr>hD_t}>g6BK(W{RTS|_xJ|iwmA>8wvvxR{qyzQ~$27&~?cjWrQRVTzdYQkqZy7S&pDbo3 z8d);JS|Qn8z&nrl-SF=ZSO$w93fVs<40)<%I|5wt=wbYNIi2n48!M0L4~cl}pWWLh zX1#$l4Po^jj<_SzhbMm@{mK*I`5ICFBm7l#HJ=g^6BB$vP=YxmWrQ{R+Uv;22NxS3 z97p#H!NSP+v`_XA@j{s^r1*f$Uu9R1d2Hc(Pn3gi-ktFi_=9vU{@?w=I*$!|Zr0N9 zq5dcmgvoqqR#E-i@|ej`NnDvWkba~KVlPW?$sRb5?h)?7zAn){v_HjH2(nKZp+mFB zoUPEYSz>IaGOF#=gJX_{IfQ82e^>tDeduqQEgl$u@m0a{zZaPpFOPX~RW>UgP=?=7 z039(Gr&IYO!nFQkkl|*!LGNAkXJyKtH==@}1J$5+VYHLS1fHGv;@$D{DmOO2XxG7cQkl!AD|r3AsdvN1 zn9SK#DKgoh5Yv|R6#{srwaLAOt={}uvvKt)L1$JN+1B!1dl0kU zFNb5Q9KbuQ>z%CLuZNnjk$88hS(G=AI?s9JgHb>S{<>h{#cIc`^}k(LU4*6&sM{q? z;kKih8*h#}*;#*SYG??*()52%e0<&~Q{`+-b@u)rYT)7N{Dz_?O39bdLrqnlPny*! zv({C*8Ra9p`Dm+uu*G!Z0g_#ql1$%z@>4-fw?F`kLP4nV3Y}L^6d8WD&UEU>>Ur`? zh~kz;{)_pMNpLO4OI-E82jMFgnQ1oVK13jK6oa*BJ?ak^h8g=A8~e9wy`UQtSw_Tu zLX>fXy*{J>>+uVL*0hY_#jRPv}7q_A5hKgj)5qx*~J0eyZg z>!#V;J{TlN5rOnZ|DkHr8Lx>Lo^VNKZeA3f z^!3o~0G%1*l_`G#XJH%1;-`pkgtdfuvtORabO#eMlUuPp)Z9Ngdg@@>DgH`TOW^fJ zT{IPk#I1KBhCu#RR%yN&faBYu^Cs=A z0NeP!{f``b3B7wz~ z3`_wyX@z*nBstmd>d#^dySm>J+{C2o;6)`gtgGTLi1C&sm<;vJ$?NL*QV->cTE_f` ze8c3q&gXvj^A|+$GB!S1c%kA#k;qTe_W*XdYD`O&x@C8WDku#elBffAJLq!|vTp+ONhB{8y4J!ez;e*% ztRr&G+_|=lh03I!qT*>sj13){tlND+_kFmO5jS z95iR-DT5j}9w|K!hO~MRNXy46Re8r^qs_KvktR&96*bi_DYRn@@j=~-Ek2TLY(=h85r=*zX zC28M!nhKd|q+r}_EfE(SbAFhbh%UIBasd0mT+{*%XuNAaN<97n<*~;904qtTt$Vfe zoWYzM+}Mc+7-nAcez&oM^AId;7TOu(K5LangBfuKG+j)wmbF4nn`RO#r}RKGaBwwR zuQBUev4_Yh*-DdU10?cFvX2Pz4J}(9V@*MsM5;Iw=2g=s{C{eWt(D_Ey*DT_Jj80_}~W+ZR}GC0!(kJh1Pg0lGYjO-kUlS%1e_^ znbt(DbI1s;%lm-CYFU5+{uzAKJuoNYc>d74$>82o99~-;N{L{0zHeIFNbDE4*Alo- z${#UwE6IV;{k%%$KY;pPt~<|3pHwu8cQa=dyAf^GSEc^==$ISY_sOytzdNVzY3n4W z%W^6>D6;6~5Wqa8GfdM;Ks{O8l5n8Cpxb-xzj8g{$5e+o(sUZyWTmcZ^?^AnLsHN) zpJyx7aru6D?uia|{t@O1^wcz)JzwE|(2;*}O(__ePFbBSs-oeunv=8}*nx3ia8U&O zuVWA9pdF1Q-Sqpu#H0}TH>D_?IX{Zy;KBKdR^tPHH87V_ z_;IE5ja?k{5oS?IxX6n(Wi;`V-_l9ImE74H_{We6Og&Rr7%e}Fr196qB%WuISndab zVb<8-IBcgZfV1D@X(p)GIzVs~Wg7+hpIJDzU=LB$>H{P5AI?~W7k>VJVTWxPNT1Zj|ccdF!+mDyEH^|e!^l+PnHaG|j( zr2hby5CR?mkBU9X40BEUX!Gi&sF*seueK=f>MlA9Vo*y2FGM0dx>qpBVErYV(A7fw zNP%4)5rF7!dfMZsz9E@XOd+;m;trtLu+#zN2{`23DfYf66hXT4GMmMjz_7%D?;L{f z>h*%w{{V5oPGJViu-Qr{)^ch0nu*!GqZQ(kpVHgCiTh$!wnVO6)m<~4Lrs`ZQ}X6e z?I9K?cL%Az*A@mgLQ7e@uUS@aR`RVAQ%1m!UDwnUW4HA}@{pB1rK3qU#a5t$a~qBY zz~k?Mx5gAWY!MAAeXjI1 zb!9ya^vzQvG^(;gxSIoOwa;5)=20T>xh_)7vq~nMk)e3xl9ka!yI~%M@ZVEPw0g>V?7J&?iuu%3=4nYBF9V|coOoTC zaReqTx_Bj~uAH54QWFY4npD$OPr9P6Q6NyQZ*h+r zhb4di(yFrSeIu%j(Pos=&``ojT9HLl)bntu8xw!A#%a*Lkr4!*PjBf7umG+a158Ov zt@NIAp=MgyY3tGHWvY&%k^>~14>_JN+bj+2mmRQWEKvt5wYK2Q z`D*ENYm19mW1gI_#XlLtBskoDyqj^- z{IO;wu_k9|UONV5PO`6sNb5AMW`F(CXQ0ory11q}Q`0n|f)QXGFgs7U>EE^v!nv<( znVaf`sYfY*iTQ?@@!f0pW!??t`IHi(6|93grHsynM=V+Qi}wxFw|sWoI3j20l?#L~ zGx$;C_M)1b&+u0(pq7qUs%h#fwGAV%XpZkLHrz-p*bcVGwJ_jbXShLJ7po0H@f}aA zD6%a706Xx!WDj}%LAgYMQwG>OTNg3aQyRWv~pUWMW0$|^}Pq#E1*kVGho-=BH z8@yVm$S5iNH=>(NQ&cr}TS-$;tz43?8|9Glk_&J;TMYdqHHEDj>b(@?f>LT~Um2vR z`HbgD)6mnptZ`KSmT8_jfc;v!4tYM_*jn2SQ3evdVNv4#i3%&Uu3w)^QyR$<B>G^Z5ZKiUJt23#oo5mHWsf}&0WS_)fSD9dSgx97=SLV z#;y3R%d|dYLzC&>53{XJL@C1x%z_$EmVoj4uqq~qi*N|rY%#+!oj$BIW#^%uUd#9) z-qP#M&Z|9sDs?Wi_=Q}CpHBEmnB{c26;zcp0;y>rw3Ap&lX+DQ5LP^!Se$oQijEmX zYdzMLJtk$<3v^zT@h?aUicGh{`YJm4k)oF~tQ57BF-S-I5}Ct`0y*Z~U{=x$x#w=} zmyWuD=06XfGfpJ=ypJiJ^VQ?!U*+8M3uaS*G$TX{h&nyi{k&m;-&r z!HR$nwis2H^YH+Cmz3R?_R0wOP4M~RHbbtoc70n7EHO}LRFbgyjp$<`gMM}`h1mFQ zHv%NQ29FmH(3@cnXM#2->bYwli~6fH(7JC~>iml*Ox~v?iRy-4@|e}&Rg}sHuVJqH<$X z3+*L$b7R)$3%HIH;c7jOGFa#bNf}x}jkQd0m77tGEwFPzjz&l$+7XE&LuR(+Hx^^X z@T35lW`yaMz@jD{EZqUP=LFGY2?`3%GM3Fx1ci&-*b8z;^2GT=wOj|3)h!)7ptqKH z0y(+tN5CnTv z?k0RZ!lXYOdcQF6_b>44JIm=Ks)SZmQPiZjzWIPEK^;5d&%k+apTn&cnrhs#nmH;cB!NV8-J+AuZG(VC?frPP@SGcKxK4>b7sZ@C zCy*u>ec@C=@vGttO0L>7CT}nunWy(#A+-dJu z!j2fLD^j1*s?!LI3-EXCzaHOyabIW!&^e!Zm2fU0nT_o~p=U0;_@nVNLh9{Rr}7N9 zCZ3Ne%q6Bt=c8wkl{W;RJD$GSxZ&^=LjfX5ouy`cLyuSK3qTo1H6A|~UNTOnZl2S! z7CX%6E?~ruubqND5{TIN2unU4#G7VpY?HsmUyQQUMAKwCZbp*eESY0jg}J)nmfh{-!ItAgj{pKrY_FGP;IZ^vd3|3R^)i6 z#Q3D~u3H%BG89HqE+}q3yzl28dL;<>$`i(MKPV35(VhHQ_{~k1)EQ}VZz42p@@O~PvRt@cb;(V6_i(+-nF@FgI&25K=+vm|5MrzeVRaKSIR8Qp#MqWtN zk_FAL-x+O2HjphE7gRr%;pDGW++IoL1I8r#(+7@v%Co|+4fSrc$(06WltBy98I#P6 zNhEyMn73HA zCU+yrP_K-jVrw8n)xL)9@ciJRw#HR zTdq6E(mR(qov})(VWfHK*{Q=u&Wg%=fA`ZB^+cU(1WP z`^Ff04L(Y|?kQ9lpQ0D^e-)lA&R7j;R7$C9?2om-#QNjIfv3qyPl;7|iP>DAgFg~A zXNvi@s*_gda%L2neqJ_tsK4Q*dnLAk>~T=zm^xJQz>L|xjK8I5Uvil0mD>ErM^pUu zcvmW-f;dEoOB;*d*pbr|zJ;JideX&L8Sg90G3{X5$>4xJ|M0)4?SH^-O6B)1LXeR7mG+?3RVk^cY? z3>(m}Y>@P>KjRbCAI3+-Hem%-LU^s1TArR-mq%Jrb&Ox9m2cmHYV>X)rLr90Jat8~ zk#Ht`P)?Du-|r0Ssxz$>qO(f*O;v7Vlu=hzRLF`RNvBbJ>_uMuTN$N#L8NX=oJs7? zK=&)ttoIEdf%zc$s!jcnFB5h5h1DJxr-vE*`6QXh%%G`ibc~r^DI+O=F&mj;VN})7g65kQ^t0vDC>i|Mk$%>xghfsf2huP`htGW37 z$`HpyNbzFfn0!inM^gaxJ}K8mgb}z$00dh6+ApR)&d-ziYv<;emi)zOz6-o&@nc>1 zub1h~bFF92a@w4qFw7PyRxpIYbX)C3=l9_^5unPAYlWfr>uc3=X@RQdhvtI~1VD)E zwZELT`zMYny6Q-s6KlCvTMPF**d8r>R`9{O#kY+kZ>2D9K`dHQebvU3p2+CbsyU z_>zB?LE?Q*<_6nhfDg><=M%#@JLfMtM}7~?U(kF?{6*GFQAsC?)oAFAA+&LJ2cZeU zz_n_zqT$+nzR*0;Y|KIRbU(SzZ-Un^gl$`#Ywrg%ex=lznandv)~*v&zvGc(osl;i z3y`2(E)PwwGUL;4ZA@MKq9A|hxy2fCV zT!ZO~-@GNQd*a=0N5${aB{dv=Ps|=`&3BLA5maa@Dm+=uIX1eqf5Xv;%ubj5cPU#? zk*M%v5nJKc$6pxrABvtFd$A9 zSab0aVvTZfuUTKzPIZb+`6wuFTp+{9=8m*1C^MAfCxH?RyOhB0~pPW@T zty1S1Jhlg6%?gi>Ul1)4RK?>Ca>(SKDjT`_E)L8G#ZVICzt9J{agWEph&qaerhgan zbYgfdQO7(2Y`uvX;q}_lcG~{py=^k@jeR|`7N>j(>m5_#ABK6>b*yy^+2&@M^-TiL zRm;Z|2%~6g3xaNbm&G%Sv~-Rmc2oBs(yiDcax!-n53%LHnwS3oWC+MU9d(07O0dkb zN8G%6MMqox4h-OTB4gGX{wvbXEl|@VEY3%1-qndzdA7f+N`E6?=EzFMp$&APDB3s! zrGUkixqeG^@(E$Z)!pvf+@3162Z`BM*N?=4mNp7b?v}UbivIu-VD04TG^7?W(fY?)8d!s!tMAYDwZoY{mH6 zYos$Ir~6tS)wt{dmW$EG7#Zx4aKE zGb%jXJ@eVzRk7Ruky1zOCW_5f_4#mbJyP%t_A>XkPP!w z&$?=aWoRTr#)dToQmQPMSyl>SI*;^EGH=76bH*`;GhZ_>IB8A*-r&UUhq+9{v%3whF%yjUIccvkK~YGMVZlj%v4< zNXu@j>~Cv~BjSx?+T5)TA^MNSD)aX|=hJh^aUirr{xFrJ*)l`(ahb~#D3w|@Bo_rp z0^p8ETvc%N#Pzvccn^Beu@Xdx?>*&XB~oh&$*Zel*7>YSHfvb|LYai&l~O{tw*Hpj zeX*f})_?;?sv=e+i_9G9bG>7{CrET&t&A2L?>Jt(evz8z>-h08f8ez$=^Wi0?`)=} z%JqE9UmSYxIlM4SBL~c8vu#ps`2LuPyl&Q`@Zi7WxNGh!R{R?R9}jddnIU&H?sjca5rq?5< z)21ir@(ZacGckoRq-|phNl%#y*~%{Hqo|n3s!w5ZZEIi}wHgyoLOUj!Dpu6VK2cKs zMQNXU9i1cYE#LaF)8CV=w(H+PChA|L^oPle$?N3vq>YM32)HZS=KB zcVHO)$RHcyHq{OjBgJxXE*4H&Z%1n#QJO4Nx^A|Oqa?qX6GohME4T~&e=I`!t&2Dr zVmb}h!8Iw;XIZ+K8b+!XzN5OX(&%;Y_3-VY{8`gFwxd|M^=i>B*=?R*&ASK&lJ_91Feh=FNQy%*ptw3^!{(y~nSa#g#>B+-D-l#c8ha3|8j z#{v3Tb%{oFAy28iJ<0P7-n%P`eAOhPnc$Sw(_Wrd41G|)O}^ZN?SO07%NJ5IkQ*W; zN5giks-7&ydaAtMC68@AM6WGDhCV-5H@g)Bk52$w_X_H-BEd-wNh`bp)TjaqdC?7s zElT$N;}JBwlIyCI%iyki1bbef!s~BIS3qy=e03&n7orr8De&i2)8%!!WKu?DXWWwS zDt*r^KpcDGH!^Pv(h~%J6ZnBF(3(m~XN`{aWvC)9I3-z08@|}=3q&6U=3o*u(w-pX zbq(cE=7pL=yvEWHe*1dc5f+WZhquXjm=yC-sI|UE>kB<>NpW*LPAq^+h4LHXS)Q zc}BNJEusRWb0{>P6vLRU#axD6#Y(u{wR>}k{t%0(O(o|p@EX4IRHkID<(9Bi^=-#r z31$n9gp{GQ9acaVDQk>kV{y1xpL}xMNPdAuQl3=@%uv!yV)?M!MX&qtdoDCU5WoM^ zCoObYc@*;Jz>EH^o(My@H?Tg8Vr{Rtl&f&2n6v!XP-ZU;6j|IbAOm7g6iNyGovewt zeq4Lw#^TFQ*}t`TXoVSqeQTD%Q3RT*8qZ$i8HyG$eVb=C{rH*K!tFia`@viaKrZvw z_@eQHr!@{-vc#dxb@3v{P=~6k#~T$tkq7d`^f3V0<08ZLm!ED;vAqr)9# zTyknHMKm+f13ZgEPR+a#bL#z)Z`TaVsZ}v2vIME=hqqyVX zp_1i5-RZa6^TX#;(82Ia4N12p0sjD0-^0Z`?>rgScGWhv=Z>g`9e@N72=~X$qc?-% zpmW!0{xN(FLr)xeK6g;tfe##VhHHI*xjoN(5OC@o%bj1wmxB){_r93a6%&R&WHH4! zvEtv5F)jcw_PvE9)V1EOoDueEP+;`{%>^v7H zxC@m>#)e@ec3%YRL;}qSD*;fyLS@Ikf?p~QZML0>l#0&0`vH&h^+H}GY=wj@Ws zcw^e#hxkK}4hX46E>bDJGIg}n?HBhRw2=TywPY-+zT@?R-^UURBKOi$J$J^2x~OPs z4}#=LopB-l&pJkbaOn)t82K zo;!-rUlL+UZ6V@F&ys7of4AS$EU`0TnRa2Sy~lNnNYWBjohHt$jt-#Q|@ux8p8$MflkssJ=o zHRp8GDhn@b5zpTd9T82vl`Q_qL^tr;NzTL4`TP-|%E$QP<-ywyY5WSF;DdYY_WuA> z!~Xz+sXZK#%#q0}yMs>-(`(p>lw0z}E{?bD_m!bLvzbA^iUK6?YgQDJ!{&1Ph8;+d zUf8{GA6ZrY=s&)l_=nyWY|_;Vdg>WNTzPA{GHeH=bBm*_vUk&w_T&`$I{JAeX$`?Q z0AAqzzSxb$2xt_=ljd{MLsYcNU6Q6U57C~-_+To4IA85zoN(G%Y7X$V98-v(pck_= zPz4^qpg+u6;}A2+Xkr8PawA3zO{H4FV8`Z4}h3q?^(ayD4A8~ zPgNy5&1c-+qkD3c7$H|d94+GA!t?FK#6MX zmh1Y47sYFc9-;hZd)2#wpT2(u-r}^|EvAZ^wwZw>txR`csc=RUvNQhx3-gM;y~WIq z!R`wo{6}N`ws@eMPng;4?Q34c7a9f_JHI*0BjOb1qnDjCnnMABB)Pgy> zEF~F)@qG4OG=Qo`Sg29RJYp)JZ(=5um9+Rxs%p%aRnCkU$C|oWwVK;;OX7ka58w}Z zT8{=ldq$rbWP&dZb?3}T#`#>K6??HG@qGq3;rDQ!W6cxAJzI9HmX5h1rO3>U<|4rm zyL;{J^c}HxbEDdPmQ7G~l>Y!L&fr+pUzJmEe)q>cDiqVYi01WzrzO=YDivcCvakg8 zCD(z0!Rxp2f|;WzKa1uU=qJO6RM7eo@z|V;EFjFPXWUDa(2Ok@;i<{&=F+8h#^v%H2fHZ|kr6?pa~|km<}m zF8ETY5U|rVz=r5UO*i>5cfuH9C*-s9l}`}d&-woVny3a>J3_MgFi6&&!BP0RJm8U7 zC`$-|*b{zbGu6{oZb`N)^SE5!9y+i#Q*>l(kADmk%Qn8PaT6ANmuIM2!CQm*Ulpz_ z@4dI4dwkNgAGwf0bla*vuv!e$3U-M~dcuA$f37Nl+H>F775E9B^Y32QaxI;>b9-WP zA$Yx{X;7c7B~Ujv{ut@EUP@O;qt1*g5WClE{cbIZMXtDcv6YEG67n=&F>5=3q}Ot9 zVSg=p<5R%9??9|CiaZQMhc#Df(6q81w`SxXI^meQt2fR>6+Gix@|Ezlba{c$i0iG}7E(0;A#82$zvfo|C71>tc@ zX+RZF`K+7O#fMAsG22I2E*xYSs9&eg1|I$z_-C?R;OX43U)=d%TkbpKImH=wi@vc}1`e~k$JA<} zzu7geN-4Y*l36^Yil;PYbI@O40R8c8;i74s`iJW^Rk31fUw60MR(9mNi!P;X&EBdw zzgWQCfl>)19(rE{K^uLfsagR0cBcIMR%KNYswH$S=>#vBw&UCPNuof|;trPq6exuPiXzN~n^w02CE!NXpS2Lz# z&`1euTHG7rt%JQlPLt*nY-jh|hi97nxay4Nj*mLm6tY#t3k^$|$>qwySc5y*^Y4rM zXDeV5GB-};R;JmTfqnaeUk#%k-5YK*`1 zwP||#V4p7G8R{b!ZKMD>JoA8Y6rAB^&BweVsSpjwh&nB+_!HRw01v(&584l!1{SwJ zGWI{6@m%6|sNug#XXdpz!k()?tkRFlP~Ys4FoVHLDOixP>I}K0JZ-nC*S;9=dyoWb z{dLhM;%>Pov164ktIMOzYATyErIBPHAT=nU06wH!76@?J!u+RTk^%|Tc&E(ATjdR8 zlQyN1_L~7w8z?=w-;W3IVj^T%^!+=?O1J*Y6@CN z={(wmzTvpu?Rx=>05NX=0D1t?Cr*Area|!cXBB={V5+5o^3Cplc0HN)71*NTvbBE) z*{pS5BIYw1gEGmd%nc#~>6EatoBakW+(W9ygU$Z{P^}ArvU85cePy9^nSiFAp;8ko zMM+X(QaZVb)qi=#a*N^d*nQ4dEM+rNnLYmiL0I2QpJn-WTbI(+mRTUJsPwR6%1orN zJ3;74wl0Oaqw!nr3m>Z7vO7wU&8>1JX}rpvpR5MvDUH8!e>_Y9OU*KNOq1&Ds3v~D zJT^^E{!OEDUG|?yvT@t4Im$^y(QZ?xKXF=%;ZOJHhx!GhEUdX&d5G)kSvkGymFDSbOC4C@(4_<$EAMkM_xl_LB zTQEfW!$B&QQ0pohGf+NpV)LYOjU;j^5p&Jh0gDS~y;7=S4yHttsDo6=6jDj?14CJI!C^4?Nb*6KJscg5;+07j6p{B9BLd1(e`U{1Zt zP<7^4z>=$LFbo1C5p(?``y!(X-7A=Wap+V2B9A(=QUE_fvWOhjyil(=A1LlMzT=Ae5!{V zkck$OVmRx6MmP@+`9C>|AA@T*Ry*b&C1U;?^H^%Nq>><>o(hT*i6vDms2)`usA2_y zzZkFa7Km-dpRosS#ij5%PNv68NS5vh-?d(Ntf-5$PTp&IeX zX8Sn)yfvopzBot6{{RVU%(2^kDEF06@}XU*R;w*swV8vl63G*;;I|wx>(d^*1^{Po zAgkoUyuS_EmW0%~=4+T|8C^D7W}r$V1W~k6Z>9u1+%P-X4#43yHk+RfI)0RP8lYji zIA{%R;WvnN`JSH2DCMW9f@X@1>JZ5+>b+PNP;3uNlh+Ax^bH10#()vD{>5a%Ru6TN zQa=cE!Y1#Mgh-pWF^ckEzuOhZ)NpKOCM_qiHv)D`;_!P;$qIy`f>&=_7Hbi1ml*k( zqgCtxkW1l?Sq#8EBz|8|t0jR0*x+*K1AlxeEV$J8E2D2?luZ<~U5v5S%FHj^Ex^H! z#yO%d;STrcqsu8w-UI20VOZnLD}+Q^<+n|7*o&JCdMg>tm=5NTCE;S>{lRqlv~s0< z=gGF!ORI6#)3)ml;C4S;Nz=G|YJJ%clKN+56{z@Qqn2dywWUXt2`wD* z%G@5TS$eVh^!)Mnr=RM5@JGFHS~(vD{J#k~9%N)ntnwM*A(TWJmE;ZGo8KQdA5&-3 zor3H!q+B^e&%mCV^45wvC70#cqBPm09~45N_;{Zs z`D%Q(Q#~@%0I-H3?7qxME=C4CMx@=%zVi#bplrF%;ID~PjZ-FH;%PCx*urV!Wdwc@ zyOQ=7I6Kqb7ic}Aq)Hwe_7a$>{2uY5DPDN|UY?XWKdXymKsOe;6!j0L2yYPN&+Vtl zanX;kgx@cPemK)CvQ6U6Rb=1nW}|PCj1MF#h5Ugc-=03J#4UD^2C-Dn(!FgV?d+BP zRpC#MaZ$U&;^ zt9(cK{poX0B`k5q3F=5*qI2Tli z8f~uKTwU04+kuFEJ*^TcxN_^RGWO4eDSLP;;x$^M%i=b39Nu2RBh)J(C;UZ3;C)*H zyNbEmut(z&?IT6oX$^|$2g5gr5yGNR7^_yV@i&-}%#x`i)3QLpK<{R`ztaUAV_bi} z*`=bR$J4s=qV4)6b^icTCakKR-8I!1c?dF0DS_?C*k1QPYkOiAVrBaw<7+w(Rk63g8lTYk~mo)fH zGs2NYu9}8<7=E}>`HX(azaKLcSbEtbw>Rht7tsSn7_RterOD)mId%PP)iKJc=0O*d zj!*RC^<44Dxcu?M_>33#cxvoi@oWgjC5-P-Rvu{uXA6L@C z*kgpoibh^RX^Dx~ZBpDtEr!cF^1U-tnk3RxMr4sCXxOtdHPj9md*a&cMqe)Er=ctV z)KJ-T=FE|Z8g1JI5{|x*Nk41j^XnzLE67Q!>zg!}EvbJk+6f94Ceemc2dnpDP~tUS z*nwM)qKC2Oi*b!8m+N z*kRY?xOfEs{7cjNN5%aA05H$<8i}%fO*Ao6eAkuc#AAlReI1Rhf4IZAc35I?G8UNER69OWa?}JoAS5UMolem=W4ELe-+{^9x`gk<9JrN zY-HYT80+^Pe>^tP0!mF=;@+mNV$xQC-r!hq{_Zi`T?>Qa)e5EaSzLo|PdFnv zLAsDDydEQJk{K5{oiF=Axx^*KMp)iS&X>duQ!rS6O-NGz0JPvAxxOZ8C}**}l%|5O zQ0CId2-LwPost;9omYFvcB(TUN`iWm&|e)m2M+`L6qKEo>wZ2O{uVR`h8jOBPY`PI z9Y?71aH9SF~R%DN700t+H#`w87ba8mFO9WNFYNzMKZA|yw zpH-Xn-7_2gKA8Aa?OmEtZJgX#* zzI$h8BF*sH<~!osaIsa=gmk zOUr6Z%oZm$sp)PeY;+3vH?eg5^`XHr@t zvTw4rI&x+La)~#KL?P$H?wQhBH$Y{1HigfsbG(au)il+WG|x>VZ+}oJAW|$xu)sLl z&V5&x5L{i>hUK^bXiJXV`;$B~3s}*XA)+rbB%d^Cx6G8gt*lMG@U6mAAYnPtI(cqY zZoC72*1BF+^kvHuKNE zIC+4iV3L`sWLJ%eUUw)gI*<=R^~4NvDa`X#v*Q;x@am@`(^`98L7X?AP->_@MN=7( zXI=-GuaVr^+T|lB7__ zzNCa@#E2cx~DgRwgdrTzf1aw#t#X65GqVLUx`eloyzn}xLc?k3t|`JjOqt> zMf&PSeb3CEulC>7UZ{L1@J=Z_*mA!SS_L=q8iiB_9D>i>VmD)s?$`R)=^+(Mf#tZ% zVn2NIVzF6k($##uMpX>yNU*4dYE-1a4@eFVdv&%mdhLpY4&Sw{>{qrPt>a;7^8rCT zL(tkUT-DQ0tF->6%;uz0ktUzmcA>S)Z|rP3dmLG~E-=xNF{duxV5;{P;e!*)#F6eH zKq2ry!dgXnDRgIvw`0g3F1#Pv7wwBM;(vwi@?xwv?szol+m2-W-nhSmUJ|rxPcMfa zCCG^WVZ8LfvwuYK{!DZ@h37PTJlMJZhrtmI*X{eDL_G_lG!~208D?jud@=wU*|`U>7+;LVXJ@ZHVQXL6O!+2wE)&qyxDl1t8)^Mi`--+P&LOEs z+pKa<9 za$34SkeWl)kz{pY`QP%zhK4(;1Dz2uV14Z>v5eqdBgtR~G+5^C{5GZvF9y6Prc*T^ zg?=eWp?3cO&ciPjA4M_~`>{K*ZGE%-0DGyFv*0Jv_^s}}y|q_G@Mps*0*JgS@kNuZ z*EFFr2LAwPU#Gq}80Nb9zTd?upTS*Bdae6^Wk(MS@;y7Fp{~jF=7rR{ZW)NFl1)W4 z6B(S`dKv<3diD1f?}QvisB^>|@(+fefZcp_RxTGw%w#wL8b|o|`6=G5%V5s39LAEm zidy<<<1151O)AGM(D8Iue@J7;TtSC#$z`Fsh*NQ^M04B>n|>j`5MT zZ=F!8eE{TeJALtK^wx`){lAJ-O1v!8CAk`J@;~^(?-zqU8OF$`z)ujtj2|p6prPr< zTNCue4#zk5&$saoZ*h`w%G58g*KOL%spt8o$0f^{6L7}03QeZ??n_;P{R!)5MG)j04z>N z1(&(S7dCdbcFZTASefyZUR;iJO~^Oyk0s+>OlR3HXOK^yW%-3MhJ3D?aRl{1 zn}v>6AyI<>K|L*oI7)_tgM|9c)5ox&@f3woc;8W&dn7FWi{V>AM#bj%U)NzeZW^wX zo|gP8AieF2+xXax506RbhgF7f`g5y1T4TTp$H_cX{402KIK4l^KDJ8(e=}6Y747$s z-}1nNjrLE^{zNH`2A?{AHQ&moB=}hH_b!qKPlioPIoytX&04OvQVpDLHv_31?T8)5 zou1}${87}8z6gVxlQ*FFdW%U_6li13DfLA8hm*hhQ6Iz) ze{3t_d_~pScDmOZ>!8=YT0ZCac%xQZQHStbORRgYRDzy43=kHxvH^AgfKPj0wh*zf z1jVgxdYSgE1=^i_bzR7n+)C&Ii;G^?#M-W8Y`=oY9PJkd)&%j6;uoN$5F>&D00?c~ zlY4FFq2nD5M04!(@?1I~_bU0SX|%Iv*@Z@F@ZT=Ctf^xpxw21Dv6*<<0y?O-ez>u4 z>|>h9nCl(t4{$2A#Q0+>JQz1<(v}eDbdl7TO0meG0Um2=vi)JsQlFt7Qa$334-DTMYNvYU?ZREgL}@g*~v-&0KhimyKIYN>`CivbETJ>h5am^M#PE{ z$hGm|vh|>ySC*Bs`pRjfj56*}4ULB5VokdYc+yzlPc`FO3ruSV-VnpV{{RT#)-}E@ zW)(gj>Ah1VnvEciT<&?P$|A&E?Rb@#FHYEd=}(3Rl0aaXBt*IKqnpd9B{x~nvoY69TT>k+5P>^&C(p~cz z{FzH%;k-7@pAViGF;(0*XH}_who{Q5{{TFA+*61ok|bD%J74nSUS2Dg(Pzqazp1eQ z0EJmv%{v8sK3hQzepy47O-zc5N0&;{(!i=L5+-CqRDZP?uR(|)2qpj|*z=O>_>{@H zMueR;k0lE6UqYV{X=y3fNon0i@NjAMB(ud%fZNp@Q=_g9 zUYN^#-@yR;!9j>V9V;lN+@1;eP`+R)Z(o?+-Mu26!SCPl!(&jLT+_<$AK~eHTL#Xk zJQ_bSD5&rQHK+>`_#NRps03ZBYlrX@pyD=?0K7m$zb;7dd;b9SLYTOGs-DK5%u{a< zd@$5H7doY_rtsIp%#H_B6-`!0EmKycf6-4m1zvB@sC2^YP;-DFi4Gc)ZM;oqUzLiM zm}%A3J%A6O1!Ut^6B}+&qz*a*`Cs|{@e2Va*`qf6`&6WYB0oy3TART-n#|gI%&Wt1 z4=UlDyUA6Z#XD9>A!BwTAXMMIutgI1Gndve*C*WJ3NXeGjZ}94N79)ez#a9G>ee2D~U*WEW3Pa;m{w|sKf%GGWgvxVlpDB+o%`*IxE-<#(Y4RjwqDZ@J zR^(wpF3jNUzOnUV$e*PaLt6!<$MKVnxyUBenLL?tWtl!^#nG0ZJb=$bar;bwi?HpE zgPbESSsyFO3sRe1>raGF(t`4MJD-V?Nc4Awin~IVI$)N++`b$7O<*o5&wMUD7LUrS zYL7myD>R9}*wh8B${NOesQDEbwGm4T2f zWcpQ0lWs5Ho~Hi*TnCWo%TCIoub|I2raApG0wBx#!9@SE6~xbg7Z(EY5xGy z)s+waGc&K22h#n1m@@}a^z#^|WyEe)n3?p8pf3)6D)cX4S zd*km&c^4G^e0@1ArSv>FHtCPE%AoT^{ST678h)O79L_v~D8p}xEk8iiG|H!`XqcZ- z`gD7_Pq;MqP$@jv_b=#0y zd_ecKtH;5uo8|&c*qhst9tlkOe~5{{%*?bl@^>U>O$$G@+!JH&4_p!H4WCqaxxdMk z8#r?buykK%kMO{rataM?PnaX-`G%X4m7^v>mSpQgBDZA{FI#Ef~|w5T_7I`@~9Gs>U>Em@zLrn9p){L)29%EJN3kZ zzhiCqO#Vp@`~@?vZ_EBwcuJoWR!c{m=+$G(mD5oXxAwaJSomVc$#1oX{46N`4sSPm zUO&TEN=p3uF_U&{m{LnngopVmaRoaO(`paHgf%O<&M^=1vdpI$YN+Ov(Wex8aG%^?kbjSZ{@^l*xnN9$=-ItRrf+4BtpEA64!8 zWi`p1_?cd0VXE|m@S$5Inm(S)MgIU~w-{pHBsOb*CjS81%20SSTN9h-RsL0Usmwf9 zSi+r2q+w%XsG2&PXdj#7)5IglGZSy$bl>+;?g?qsz9z_uv1?r>q>ZINwF)^2W8US~ z{{U`nj=euFt!eq6$u28!T4eQe58>5y{{W4$Zl62xQ6BB$PMTQ&Dm<+TLv{Sj-_?(5 zadrXfH1>5rl0Y|tnKI&RVtQZwQhmxxlx8(mG?Bh}nbTM1A&8Q$nvp2uaoW&F=}*h9 zD?KA>^{gc5BHqR|S}4$UAQ~^#?fl|h?eN_r&Z_gsTAqD5tK-S0jY)Q!FOIn+9C}Jf zM&A75dR4_EGxqTWdsi>Riml4w@A4r>C(XQ1aAiI(<)S~t`!ux|3;i41-ro2zyiufC zz4woGGCha}@UY*DZM}cx0!*35ifjTmjkNU96S+d^S~KYF)21e;#M`(7z0>{{7jEG* zqXF-qI;nP1n``RIx=+(yE-rtU+==K;OHW87kGJb1^$TJu+(ETEqA$z*Xj0MP!j19) z-Tpb=N?;8#xiG&sKAYWs!u;R?0WpUVs1L^+g|%jh+}BY@F;WlUv)zII7`E`=Ro}t) zl}6(b*S3ET+!KO`>pl#$_%bPKUl5Q>Ym%Gq&mAvuhVWtkR%H-pQ`A$0c;{lMpxhUPkK6nGFg7y| z9>($xF?iH{IwP?4jWVykhWN33$2ZSEwjDfME=4CVT1SjkSl-*w$OMnBDwQz7kY;3Z zh`IKw12L$(FOHfjC}DPjwO(MP4Ep9 z&k}1>esAN3iO47>t*4jGbo>y4Zy~Yt?y$AbzZmNegap`o3?Jw1QNM|TAyvG~;TMn5bvroq}f{^edtTCzdzN5Sk4%PyTUS-KVxqhMe1J>{5H&HjcGN8Q&{9( zHdO(*9`|m3ocm#0_-^EWPG8!H7~pqO2{ks7*(A-K(d|#f%6Eb7a=manu+1F2RKpQE zBx$L%#Eg{``QBc^fe1vq7@piV1#T8yBP{Hu70&5N&hqz(jCqD$@B2z;99y}zB{UpF z^*dz3_oVOeNvbslSsOsfH31Aj+|zA9f7@g3fVL0b{(ASMAB2$SI{K4KLsLCUQ<)W6 z)(T0y(#i$H52+XX;I@v8!^3+6Ox*MALB6D17e(b#jML-GR#iz-bjO3T*HT6ZS?eN{ zTmnY@fF8Cs#j>6OgV%jFxa|{dw--v=UGCAYgjet@;-fV2Qo6e?)tU|sH1yGlW2l%< z3QkS^Bg{}c4xac;#BhwE7h}VxK@kz!b)TUyqfokJ5ggTsZC{ocq!CX{1Y{RJdZJ93_7L-SgSJq?y=o&Nw3+GdM4%-&S0k2QiFK}#%$(t?ylJSGGm zv{;eI>9?DP4~4O!Tyt1Ub6bCn250D1N*J2qu=h)(_eUV6Sw&1421NCG=fvF$C2CD7 ztK}6-1T_~V#-cZs_DDxy#1rzYb?e%67)=l}grbcqMv$u^Gd` zgO&(h`bbEisGz5D8O&jIXY`ejk}c0s*Ym*5pc`osrM8kU;J$Tm+vw`ppzl{9|LsnFWDbEtCF^)>Y7CBeu zr$XDJ+?TKizd_%=6S2KwNVHD+jWq8%u3qwNtK{DkzADgFDrQkq2&!ut5+RrDT4;oX zMY>(>akj+t#lNFvR@uaL0Wr~=oosG&OI|O{PxCB`Dw3*tyvHM@lCrhFW_cm>#_~u7 z*+;RqDh$R|_^)&Vel}mAF2HXk|J6%DswJeBCW=u_=-Id~`#Bo7&vJP@}4ND zeCXsflnq%*yX1Y5oy50O#v+3=$$Cn7gHO;)M<1V;#{x)h0b-u*i&ze8*rn8z@_QNWc^(L*_lb;Y(Gwg;{_u`7~Ss%naMrItE~ zo=-7ZcV59Sk9||ka!jX;zbmb!rGg1(^X#X{vyOyt4f=iY+l1Z}McG#kDWz*_G~RWe zRp<0soOF`P9zCWis0crVgZQm(z3|GVAVh&0eJT!;>DxqWNNXtrQq{Mbw&6?GagDH_rpJi>M+Ax_#DVS^gFPvI)o3Y=pGzQ<}iI{27%jPXXsGY!U7{jSM_)HIJ{J(%;Xwsf*jK;k&9E* zikQ{Bv&i0{?kAq3t+8*R$C~zx&3G_064TqM@=9vppxB|lVesXxG>r9hxt5=mO&A5G z3%Lt)+s`KWHlG@%=-a{)Y)21q7FAbKLpEEPRY5Eb6UOCP8FsKf*2D2sJOVUdQl?ti zI<9$ERaKhQMGR?e=HT;g2h$xk>*v%A3zb}z5J+Q^Ms|RZ8+#qL_C2xbE2cw)^G+IX zB&*fgoiz+R$x_>QxhC9R&Gy)GtlH&g*I73n9rBq2{={@Vn@Chn(YP+cOFrK1teCUZ!#m*bn>!1lj5sd0Lw(x@ic zE%TbJydX<~?LSq^^cSx6l^2Ip`lnTAg85!h%~4n*rWH=HmkH^OxMR4Ey+1rr#Wz)c zR*b}*E&0|~z(8b^9a1;a0Y0tvO!_0lOpnD(o;^*ZDg|CuD->B;oKv4Lel;jK1#iv0 z@VgaF^xj%VQrNY({97hiR|m8olq74WgVw&vOk}7~pelk5#}~r)6Jj}pb3~XSP4NL50-*a6Tm9C<>O4Kz#=zCAdxv;?RMxnZx3%!^hvD5=fG(Hu3`=MN_X_|g=|Xt^HFOawCDoP55mi6%N~YnhVhK;M#lzrg zzbR4=-7N!n8tx@{o8v>n$rkCVb3ZXnw)~X7pns#go<6vV+#a^hMYHaY4o;1md_}^u z<6A@0#v{x124_5y5T-e4q>K`Oo*{n-tObnN%9wHdE8GDBX3!$&y#;+nVNFR@<`|l( z7FBi}g>l9H;`q$!64zYbNcJn$H}rycf$Z5ub!Uy4FM_qSM^V<*#};Cjjp-vU`%=Q; zK^L|0Y2g?OwcJZjFEwA{+)kDiqd#m|o?Mi1J~@0ePnnsstmKpURM9nv>3eU*tZ+)Z zxmBO{Nr&b1JS39*bogt%K+SX6RGvV~lFNH?KUg|qPk}0Yr3m||pgu3x{RK(%cg0SO z@h3T<(;9xiH+t;CU6G|tD#aVv5_$6vZ>MZ5;v71y76(j#;XRU^aQ-(#6#Sq;i5l(R z0n1fH@n2lXYA57Vp!ybi$FC&APA}fC=Vj+N&Oa@pYke9&?-N{MM&C zTG|SSibG3746ttm-o>X@{pvAgp~2r!Nj=K3jpOuaJg|v~opT({&k>Q_@KcGX9W>V=B%G77Fd`Z_~Ca z+(QEVBjC86^=-g$3V6z4%>%#@?^FG0RSuie*`{+*JgWv@3sqDYMcBrz$OHWN=LL`srz{vM%l#h-t z4UPW*Rj5#l+xyZx8}~MwzBoJu-2L8YU+AWvFUUS?gr6L~AH_{9f(=0K0kZtEDCBTM z8LSW7V0xc(u6Tg!_<1Rr_f1Dw(1ZQ=Ke1{TgcUJr{ST*e#(9F~6sb^xTX}&V_T9IO z{f;Uad?BXN9B$XtZ_RmU=B{hv^SqXe7(UylZxA#5yTZ*SpX(a&Q#~F{Olqfw5Io5M zV4+m83NL=A4X|84rgv1JtK%b4%~EK8vX$XQR55wlb5ur!Lpf6k0l%Se{{T+C@oGE_ z=t=OYKe1PaJ*N4!{-k`DPxsTW21*GVE7fYm{{VxuCvWCooN@38=I@@qJU|V{jVCT| z{ggilmNxP-9ZKw20p=KyMacCQ40s>M9y@`!1D7!{ZPG_-mY)%6aF;X!K%R*2-n15u z39D%G`tP5VEmb@pq z;eRv8D795KZ(sUqntF(TMzRKtA(LmQI}7f=7WO!OgyAl&a_4Qlb4qa-@Y`wp4BxR= z3cu{5cxx~s9Wko`Q|V-u1tfhzV{9@!7x10)&}SYw{{U-*-2VXCN$~CWDAF3DMgxLs zDS~CJa00{$x`Y8^znW%@o9}$t$b{~K}jTa2`|p> zAPz0>$Mxf;u!m~CH31O{n(O}ni@5wJ)mi41lTB7vJskU5XtP;q!vdiH0E5~<>-pmI zfZ-v`4lW{j7*s5O-8i98v!k57fcw-G{C-iRlA0E;s02QBDg3_&d^GqWzbN>bOOM@* z+oSx3uj;Rl$SZdj(G`Y3ET8M-#ZgDF3I2?E@I!uAzsY>hyA6du$Z9rt2k{9nj=9cj zmqDj$GNhu*&09H#rf|A96weQF0iuV@48ZbkR=R!v=YR$rU$j5`!0I|)~Fl(Fi zD=zY82+@VjCRoDRLpu|0NA+T`OSH`IY^yT^B67B5&YnxtkfY}9oU z5VjtE#gsYw1-I7xUvT^-g@Bi80QM95Rx8GMtxlZfv2S2H_xCAc{{UrXtBBLVXidiJ zHhWXk>HY811&$9vAb%39?*8CC%j17#PPoSNp9SDp&|i7aYBr8QyMKFqYz6IekDI}0 zIDy(fN4NRcp9oiIlc(rfo1wFW)|yLA>Sv~wgy)nIR|+?6%}?hKz*@i?U#+ieUlbQo z3>PyFb9@@&E!q6)?AnFIx8&veS{>$qKNdd{m46F#T0*{uN~WNbKbo!`vsJx1$K-81 z6h^x>_~~mLS-5u(ZDB4kWP^zD2U8`j*204>n< z+6oMeRl`#}byU^TOz{{aXJ%m{EycLwrSPAL@W#_mTnQ^J`GU{pg`O6 z(v+~dHyba&9lB$OaH?P%w@rLPk(m02<$b60EeQC1@j`DL^afF{DsmWdbDB?898|DO z(kT?~(U}2Y4=3N-6)b)i(ca+#&TJ99i~AL?4_LT1WXoFPKZH-{O&=6KGFSXMcz$)( zTa&??Ofw34CZ?-mAw`u>>j_^~{Wcc&!Q3wbF$VnIKSEQ)@lL1etnMG#V$SITJl+*$ zKCA8i{G4<4>u+pY2Loo7@m2H0>T^B|pZn`}aO4&6uPM3oi`P&1vG2f)9J~atM--{e z%6;Ky_DA(Ei(1c1=+EwTlu@R2T?G?Pl~b3C&0wX){Wk;Ot`+eP8YxqA!S!_+CS=4X zSPWy|PzMtbVXvCWX_?*&&Twmjr>u?4)}eTl2*-t`UxLY)lt#o@kajiOi`nNh4SFv}{McyW;7D z;Z(~5iP!LXDt&GvQO+Vz#y{+%>v;=77lj!qexq$gK{or~@xtjH{{STq>9t1x08B59 z{gclSN)=BGvMAgi!qZfdgNDC8EnD zpv>1Sjv5WY8*FOrxHn5~7Wu`D(k&X#=vJI1b5X74;Q74im-MdR9B1YJ z9{fOc^p$+J#C5o-U+cCRaEfA~6QFZR_BeTLC(1-E;mw`-Exuaq<5ESoqJZA0X7ZbrmffR23Clsi7#~M!a2#H|zO+cuB=L zeKs^Xr*rOBE(^sf)^mf~vu`u;hhSF^C(Ehos%gC~VHB>6ruW$yU;y_v#Xk*97Xi(u z-mZ9>#+w}N!9MkxRsR4P-X+m3T-13!P_&UxENb#n-S)=ppf{*oi*t=8mkFfc3Hc#p z*q%FF5_AK!k8+Ry0IT!Fmml-2$c?xslZzJ$!ZN6reY91sIgP17kjs+x^RR=-RoZ`yPaJC*)*3vHMg)du z%Ayv(I|FX%iwMEc8!AcSRfWTcj(ufxm*V5c7$A`vgCRgJ2^mympg-ep$EOQKY`*wb zzPX$EXs6&mj-Dg|WmKdY&-=(71KDkpPEK(TsbP{4*#Zb`S>332#ZO$~Dl9KasX zXY?yi2I4iUIoaTjjFA(pfHm(|TPUX$RdmSerAx6TfVfSif#;`eSJ_B7#`<^zWq7R& zY1Bgiw&uk9)@Elv6rL(mR%WJ}izJ$smb#{nDXKE?^D@UF05b*`7C5-l!cl8LB2Mcy z#&L{IH@XX0Ce6Q+=P$&si|SFoLFuk-ZMkOzAEy5R^k9!eq4HAS=!+6}Z{;ry@k8SJ zO(bcS>GWvhEZ^P%f`QL>`e1ip=nX-=t=fN?OwKilsBM&6x6NNa3A0-5RiU)@b)8d2 zxrKT?M2`vtiItdvwLvzujwu+54W#!qpul+-@LFaPtKQIDMCB76C|U6@;wGx_s*_ID zX&C6Fn=+bOcZ#N%PBx@_xKc;f_;teY6zdXRJCZInj;%$%dV=ZRbnsOS{9Aa+?JB`T zl7Masu2`IY@^NWy3WIHz=#@!-8pTbV->1!eZ;PKBXjvGxTTV9Z{{Wp_TYru^^jZVr z{SdhLXA*TS`h18-FNd!hd_?hISVNZTx|&F6DJdnY+f77}mtkNzPk*i}JYx?@p{2U# z9_4o6n7Y+-=L0T55kDw%C0zB2FFDj&%1y$L&#!x56_^D5xs`7u$7l1EpZ@?HZ44Tl zM7_5IM^$nCA-cqW99(!S^oeXa4%@(oAXdFBFr_#cZV9IN$K2zr!>iG^L)QE zm8n6MsOxF}00~q8{w4IBSTM&nyq0CfoGCXkFeLY05Zf#8-&nnLbrm`%K3M~j?+qNK zh0kk%IKhsj=(Wd>lBD`|A@SKAlRrWrr-xdGiR33i=hfarsV^ldSx94kED8F4cpK4b zJG0y7xExZ3ncMkFZJPKeSqvFgX_RTq%8llM-lmdBCN&iDh8~v$071VP;n+&L7RX%u zJBOrwac)_+QoRwOYx3H&Rb8iZX0B+sGr-qG{+7iD)9rt*7UFn)cL)qI*okM|9u?S%C>9e3!*F8=_cyePLwJV8Fm0WQyVZla^h z>Hh#l>Ac@CnHt_y6l|Ms+?h7qeXoxweazNz>okGdqJQ0H8QoCh;t2LYC?lLh<0hw_ zPHUp`xzrodnBYjlDd-3<^cb^J`=2z&Rk6>tEI)KqUMD}%Q2UsnRh}Mr(V0mw{?ao^ z5S^wsMdsvicE7!_aNy1t$cOlTf%yLbkyFix<=`uLiQ&FWsHroZ4VuSMUsX>vB8YCX zLZfVv+>!;py?-o6ir`gVdaXUMjBnjW8i?04{sZmw1TgWdR%)ub(j3c1=Gi`3GL&f^ zouABdJw)sT5KaXg9;F+&85&ADhaRI`NPBOyjzi&_UkyA^OHSp`Wtm-NO+IBzL~}#B zDPsvLrTG>hSm0`{B*AU(^d>CEwD0cnR!>WKgxW5mt18Z^RK+zMQ{}UxE5`m}`c<3X z-xb_X4i#bG-!vZ|*qudz}6V-yy*~BWvv<~ z3QAgpnw{xqynWVuFRmK3F)LFP#mVBBBv z5p3xV0W{up=Z4x>*j+%B8fDEzd|Nt4n?MKEJdHUdcn(%@X*y8i%P zD~@<`rNZSGFqg+eTbx5Oyn=Y)D;&XnS5wFYVh6dj&9ySRH%n`CO66$djTEd%vD*7~ z?d@--BV`smN!1KqTV?;&8%a%5Dl)`(qW&xJLgN$!1$C6|NvXscWOQir#OUVb3FUpb z$Bw2+w(E?^;wkI11@b9mX(MGNyux=NJv#kxK7@|Kx|G3@SLRSuW>Gw)(mJ5AH|+Ua zM(h4}#MMJUY-<->%%WpaQ|9$?!!=BFmI`8X(nH;C-?k%YldLa^g%-`Ujb>8QNn7Qt z5;Fknz$5BAeK8~uJ*q6|J>nj7CX>r0o-k#JN&xCE6k*N|he(s-DnM0PwUvBRSIq>{ zEEORB*94wySH3L64%-dFQs>Gpcn_V@WclQAXYN#ItSPd}mh{6-D|9mbIpg!f{B8@ba+|9$sPfva0pewLmdq+3u2!L>s*0+O_e5TyitYLpu>JV2;xK`& z+SLf^>7c)is{?BSY^1r9%aK+Jdc4_biiIwc3#kALUkZH}R`!+ONF_@0t#3=1)6E2a zLNcodk*pcx`d|96A;Ol}FCA0_^%i+dDCyfJ%_=EsV|?n0hX#3!iXWW3mX_bhe=bPZcxO zUKaRg@e@rJq}7^Gtl`=P0B^dMj-7ZT-aLw09+paH0SI)NS{9>F~T&esjdDO zb>5G9o!UP!%m9qZ=j6~fV@VJon>>*MRDslglNNk05p83Yt`Z{0k`AUAwL170reM<% z*1mhE>Z8mh^wa#rPYWs$ZNXdvZg4(75=oX2K;_MNSP3#GMJv^w3*@q88MREWBGo*N zGSpt_9fkI{(BJrAJTDSana+qn8-=nSsfWG~~%0{oq} z$E3(yg=+j4(HY)XS3FfQ%|iu6H=b$;+Zl)gPd}b2d`}kF07b}jA}BPID4$d_eCDBY z?2s)@FO+QZHP57uLGOiwEig;1bM&GPs$-odQ6her&9d|!O&Ze6N4DXL@X}kkJX-^` z&L=B84<+fcMMa&^=TtGQL_A5gY2s0|B96p++pZ?c>Sp@$=AzCDsD3ygE`L6h9Rh0h#t^WXqRaX!PE9HgS zZ|`z=9dT4QvamMSPFZYaB7NtPdtjOaC@YGFO6sy~1hX5FZaZHR8!v#B;(f~yF@b;S zeKGTmm(4dwr;$<;;@fxx`;&+rV5Mlfj+OFIZdGM+cqiP8U|`txk2FxZRHOSMH0As; z(+bLl`icZjZbs!Jj9oY(hXeREea%bp5a!e$hll?F1qybEjXg3wk-kEjCS%uXMxzxr z!<;)?=2nV9U_Xp}kb~kyV2i?SVG{lo6xIW)4>V%c!GI3{YOCC8^q)T<`7Gbm`9@r) zYS5~wrdDQ7fSAWWmM_fucUed_kG6qF^cJ4V>oS8qOkQlwF;1MS0mBS(^DByHC>|dt_;*oF zOjf2zs#Tg+zETl5eZaR~@oK@)_ zw~v@wOT;kuA9Be*6QHJ_Soo(?G$68PdqE=P9hlH4n-3p(Stk`ge1CZQp;X$%f%OC- zR?)PG3XVA^oE+^Bf~`!Wt!7h}(B^dLu!#|!cP0AV3V$bNS|bT)$aI5dU|a) ztRaq_B8+C#prHM^3XkRec&70(X6AaW_ql7_DYHxw@}KT%HF&)4{v7N0lWM5TW@cO1 zovY2h*Th^jL+817#e}d=GwxX>M@L5o@U-xTjcha+&16MLq|l zGI)2PHXW*R45_Wt)$-~O^2HbnyYcFMcPGy$G4CoP@mlE*f*vVw9JWg+vHCLD{#V6= zg1fAN#R7ef`lWt!=w659@~DkBrRiV|{xRAvadLL5u-1?P{1NU>^?7buV{`J0wMXH{ zfP_erp?TUu*>!723VK>DgOE3_A_uHIeyLJHi}N1!`nAg!epRQKuS}aOu(xlOOlMUA zF+aVx+^iI>oBHKXd0AQglGs*FbKuN|KQw-d&5K0cfRnZ^SSLdd;oPj9 z1-e)Rd{#K1nqR{F*DW*dc#z{fyw;1u<{CvDMSiX#mB2e>UXh%!Ffu0B^WJ%HzEKEPwLIWIvb%jyv_NZ^K4YZH%y zf$(2AMVE?6Z!JWTuw>X4-&}Chb<@R@lx$W;uqByx*!C93u%gv@*s1tQkPaLJZZYv+ zOs;hDpsIyb5>NQfI?3-347E9plm%MRjHO$7`{{VtOE&Op|;YM126#ZtZ-x3Ep%sjg?rumwe5eYWA z{7Z9Va&X|fe%+-nh5et&9B@Z6MdgyrN2bGR7>1&ifmyGB8jE=Gq*u~XOsh8oXyjft zCjS6?VNN^LAJ-Y~a&LznSN^WrNO3unsD-qlIQJK(;z@W;8x4l{5+6#Lq+$1KbY zG?a?tdD|ZV`>5mc!_e{cpLs(%nYVEFB|48Wl+(zqv=9Y|H|j<@bHbXNVOW2InSAdP zA&jt)Hb+~ze%7`XaS$HS_}`l4a^S`@ekl6EXzoD+$51ZUU9v5Kw$M}Gwkeoa79Vfb zS8P$t(gv~l%MG*PFv&A$ole!P%m^UgkC}UO-x{7B)*p)Ba9EBZgiP~yysGaEgxna( zxxLSPGXYmvW7@1|hFg;+%vob0UKv!A&<(6^f2#;_H6X`mR%|wa_xp<0j|FWfhPnb! z8vg*J+^TnAXK)Gq++#n-+NbcUePXtJ6M<|GlFzDxpBU8=u3h1SlDmdwS;1=`@M90S zLy2kpS9`*${m=~n`D5HwHq&*n#APy)%+J()v1HB<+p$qz!am)p^0vM?a%|EVXSDJw zc}0c6aCrUL@y-eXOp{=Ye-DVzc%P!n24|BfuZ;2NzmN%RAjVb9&gZw><#6C_haI}7 z-WG>x_`t294R=>@xDk8bi~j%&Bck|l`*T_ib7R~+%N%Ru^yl$)*`HV2oAKrgV&)B- z_>K3KlJO8rkBXDYnx#069&xwrw9c##uIASw*b<|! z_U03uEdw*i6YN?w;Dv9_cx&POf^Q>rB;J5`Zc!=k`E{hx%^MbJumz* zVa>~sREm@d_LQSH&cyWWlhj5S^#czoN)wjk!RIBd@lcZ%=j0XWp5A`- zL4G+MCeO4LKJea69b-8QYhAj33|=@_sP5&SarT*Pejm9_eg|_Zsy!*Lx&{x5-(;_Pb2_`{FDsi@j#{=|{DOSO>FtlY2J&d|h0(0z zp?9`d1DMvIEe&L$Nxt7TxyQnrM$KOIr0bb3hf(HK>*W0Wo>t-vZu{5s4aPY*c9SqX z7k-lRBQv9A63+ClkksOFsC2CrU~aDwYI$yZmXCvq_BZZ#4_wJ?9%Thb=9uA*6zrR8-^=(xW6uVS0*ig!(}WLkk;oV~U0|?lrPaKOZG~;Qs)2Po_Tn zTI=rDNbW83PWoHJ9bcwp$SL!z^DNA%ayqc|IgJS-e<_8ejn&j1M^3h}#&N_x-M9`#xWUZft}MNY-E?u%q;$Hn zmN(P&m6dHnmF5j1)e>&-ZUb$H_}qbjor5thg0X7ei?L-(O_al~q@Q3tpb4Bl@-g+QfJ3h1jai!kY;@qba*O z<0V9%9_Dk=R6_3cafGE%e^n&PEnquezvYf#V!(9R5k5b$Ob%3U(=VN7f1;==;({co ziJ2FD*&g4A^0p9S7{-Sdog9j5`J*0}%bzbbiioKVx3$mWWFP6pV;fVXjor73C{zF_ z{Z4g~XEHTK9a1_EL-Wzs@ej)eGYM6I2ut0FY_I><2v9>MW~Q!^TGnW$qga-iO}5kq z<%s%=V;^yvU_>i^VJc-R8d%X{jD#&?acldZ;f3D4{?=U*opQ=bn!?p|tYnSN%wXH6 z1b$-p@xp8ukeT#N25p^G>VK7%6ou-NDuiadir!GNkGQq)bw+^Jej zF)u+Pg^>@TNFWu&cxGnTbqRDM4vfuKv^!T+3W{a*gl>Ql&A!L^;s$kH2Sp2>RXp)q z#1UH_Ym!sNvM47ZL0g7WO^Eizw*^Be4jLr&jH<^~PasqtX@xIvZE?@PwjPHdRG&^( z#`(rwme*9NggVNXHXDaa9@rMR>XH#Ok;5?0&Q~P4l_SX0D+TA((BH4+#uGA(fYOa7 zR3|d=7c$kE$IPuwrk={=oBCIe%Ln=}V7i3VGK(4?SS2KtUq49&bs6&F;$5y^cOg$= zdSON*4h_d@A+IG_yvmm$%IGr8!W_E4P1RIOWQuB!H6s9D@%IhGW2)UOjzCqH)-DHKpqw5l$N|E{ zkE8alg+f)y@S8o=`A&z+a_S8JrzR7~wN*KWRXUla^K1|@$s2&68=C-rxCOPHLZNjt z4J5So&Wdw!d#a_bYX1O6)}~1^pNrcO}T2O?j zooxkfZIaf{sWM#BhK^J(NYs(E>6r`dx-2N{!FVlk#~2}_qj1PtPvICNx^3-Vddd-| zJ_%s)H_ran^-|K-#TrdMTbk4Sol2yaAb~3@SlEyXi{ayVyW3|nW8-Gm%hliPW#H6(8@E=&zof#O(u@aa@Uz6 zER)n+msrTLLx1Jl6~{S`cSzTF1u$uClwOVKn>vD$fz2d2T@^$rB7y?>g-+f&leYvJ zERrWN)0}?Q#KBM0nRPaOlGVhA=IoLQB$@n@x9WE{wj$1Hyhx749N7iddVM<_S#$)k zPf%qyQZL-E*Z1MeL4D68G9P&M)HPa{EzI(~wxGhabiX*#s}yR1`0U@&wXKGj2XzQ1 zxkr^9d?ujDDZD}Owpu!WCTgtijovOws)2IApUV}jbDZi`XF$XCg0%2}Gh31Ru3NdP zaw@G;ORjQi3Ya0O%reZiNmk=h(&igU8 zpH{#UbeZbkYoIT}?}R#=z@H6r{S&JqhCIp)!m_bNJnKAuROM}EUO#640G>GF_>qdL z>VOa(mL!9qiI$QSygi|;U$IcRS-><6R#?*j0mVJ@AHZo-|o6rWO)9pT&Ps z!K|{4*IjqDlr@MP-yM>7T!G1bnZqi)WM2H-Uyr6ed9|0VP17uLC{C)x_O~MgI^j;< zYCdBDwg$P~YySXNARLh($_e~hcq5*8-=i`tr%zW<($r;ng4atOWn6U2Dk}cTkbp?B z+KJn>8cqb zTAav6sWn5aaYyC8`?E0?9CgKu1zcf>anmsKNw}3hnw!8davh1~$y3(&O4m8G5xqvP z(!hi;x~6$bR>5ouCGT_Xiz(u58VgS_J?eqzFd&QmBl$1wKk$F7^yC#3a%$};39~J; zs2B!6(z|dvbjLM#n@Q91n7F0G$rt*MN@Ms^)l{`FHAbw`FC46*Mj6}}QV2Iy1l)UI zcjKD|CSzxhBz_kJTHtSPOnSHh<)o;frWKIRsSHrF)5s)={IS(oV>qhFd6?frI;}>N zL1z1E2=}0mjNT3Aek^7=5z2FHrzndoS=LFjYQ=&!^DX!{bt9fWqZaN9k8U1VXT!x) zxaJAfh;Y*L)hCxE3a0p4&nTmr4~Y61NIOmQ=SDa9*xSP&TCC)$!8g?boG&6g}i^Waf?

AUGNY7Qzbvg-i!Rb%ZpS{NZ`%dFfog-JB}wb0%kt$ZEKxxuoTz49 z#2@zG)q&Vt<87CwfeBG;xJPklh)X*D5o6qY;vt)LI1A*G)5qjV1hJIiEbqYwrar!l z<^7oD63Y{cT3BRvBWkeyUAneCWlW~#7bHrGX8J0C&`9m4sV0(EMv>Y-Q0B(R1hW)N ztn(W}^C;bU&(e<|%jANFh6O<%rX_8yzTH9XY)MBm-6nijBtjT|pBZLO&{ZsxO;i~b z3Yj*R`ivjZW_7mJeCvdVOJ#CWQ5LPthFm2jmI>~%$_4)b2tRyFRq|j7kD*18Oeu1z zEUPYB$}Pe+DrIzHkA2?bsJXy}<;EPk%A%PzNtm{_t)5X^3{|M9Emb7V42q5GMY-GDUuUVNsdM~19?437zl9;;s_BNDa%!t%_>&6 zBFa*rpq`A!9JFzZpi(_fpKEjZVJ2(X_bJ?E1bj-;bk%fo(26*#;dS%rs-Yy$5$?NJ zlhkzf!)zsdht|I87mFdDlht%XDyqtA(zZH^6$!FHRGZ%XH#a<5_&&WCW)B;n3E4wp zhD{+HwNsg(idjtFQa$dC-Mx+uci(N?pmVlRT=zMTI+nJohBtsjf<%`5xxWD5rc=ve z7lGR;&Wxzc^Q||U(dRi!%?zxs^8{J8wf_JQy{&+;Eev=qH$(!ZwAyK-%UX(o+LDGP zM_EnMc0BG|j@T9TrP6LxtxvSsolc$dDhisMt_0qW9R97X!Dc^PMD~id(3RnGf1}Pd z2DG7$zbwlns;Y^^i6RTe$$p``*bZ?4q{=Rb9j?2b)Xq&omt~tGuB=GvSwqZ)`B!eE z0AzXf8`ar;0I&bl%ufy^(pqx1rk7n%zH36{NdEvYFt{psRon>Y>+OoJFQs^zCokK{ z4N4oXi$L`^j6NR!0BKrmQ|OwCtcr?OWXR1#NM8H~k=`~&A4^<*c+Kc=YVE|-d8`B8 z&^kgS?_upnIb2)DgUbRHiQ=3}B1%U(os2_Y@Y4FC= zrX29sJ)#S;+{ZNsP3+kMwe*zP1oe3p7Gpe&DmTsO*pB}IO~Bu-9$_WmR4p1nypI$+ z-ga6O;djMleHVw7x+hLiQ0ctprku0aMGREGH1VaDM`Z%+ZEk(eDpmMtr&BYW=e5of z2dx)5e;1M{VkNMIxlfN0P~^E*mrSyqa@t8+t1w-`=d7)e-d8s03BA4l04x<#hL@K( zID+FX8#SWC*}989$p%fQw4HWum{!nKm`xLajX$tFjlR>F` zQlB`>qoA+Ja_aEq>M1IN8D0w*)nts8MSZvS7dOQZ4T_NevD%L^|hL z9gwE3*F94&5i~Y!MVEZmb0LwTc*N8*7~Zl4=q83i%RRc2&9Q#KV``;TQMDj z+Po%2@=|Yy{YzEj?sGjZc}E>=)O1ovHYkco+A(LdjgCx!ugUXmJ(9?BOum+(Ga3X<)h$*700{1?NayR1umYp#7SwlKkXqnm zWd>|}y^G>R`%@05rOh)h2Bu;tF!)2w4bs%0q zY!Y;m1HH}*g4k@80MYtGPwU*fG1hrZRWfIpcoR(|@`j8(hz%MJmg!^eFkUMZ{4<3o z$42o0j@1)yaICk(&xR9tvEjz0Ou{ixb3;_Lw7=lqnzNMNz}ygfaBcbF7Zt=i4~l4} z+p(fZxh>aC^tzgpWu%o+Grx#!bK&QQ*{_0Go@WcuWp(RMu@6IIf>SSwZ+r1SkY;;vLh7_x)k~kw%BSYrxxjc*guom)Gty7r+oV(mY$zrGBp{&*SW4PXty=+U~&WauaUrOMIKd7&d7^-0+L&|QU&^U!>ko+W^vUIlPN+hkLEH= z#+s%?Ki;ydlx61Q4JwgQvCVT)!aLE!N@sbOjC!(@Dtd_NW12!!c-pE(yZvygwGoA< zm@kMb%j(0H_2n;b z^hJF{RFu^55R;Y>HtSu895wyV<=+S4a6mMN3zMpbNHDqO*>!HV&1*FkJm)B|PXI)X-`S>YpRYbk3lTn=KJ3o~zATY2hr~q=7$J z}_$G>sZVQwP3 z1A(LqK{uU>oHEx{qr=@TG@6pXJxRuU(M)Q7Mv}I^C*LVD z7{E62$se+N{#bic50$gH8uMHiT{`?lR^~ODyyVnmE>9?pXi^YX1{NFHZ~itu;mm7U zn{aNVY-*v|PD2i#hPEugF3NbzS(uMGkL(L~!4IjP;RszOP^Q09MdoUiUHhS{{XYj6=U$uam~qa z=0PP+X#5t{)n0y~$g;CW^2i<I`%i6bqIoBg$YaV&(&e)A5f8P@!rieAYK~{EaufkE>dy#clB%k= zEY0SP;a$_K+_5(1#A0eV=>RxuqWI}yDzs+#iAR^F}0 z{rL8qG8h^a$p~i!4ODa^H}bs55>p+=W&?}h(&0H kCWV(B8zo^k;|BX88_lRa-$f&4^gj7_MK;AJaqFkKJrRUldy4 z0kp0h{G1C4%^F42)eMhKf4NR({)Oc!PO9aLh=Npx*m?dT4^fNm*&ayd3?Kqq6MZNopE+IXAj$1oI)nXKZ-%PIlFnB{xF(H9n%C)wsOTx2{Pm%t^42M(a*|XyvWpSh z0URq?ePcn*Z~<^p9brM5XYHHOP?f1P3MAgDM)CVwK@BN*uQ(G&K;yi7ad`%*rlUAFnuJhXsSIWKEY; zgaA&LQrwq6lYqLzHGERsp%LLH+GWgU4qh3;iBnaj2T8eLe8521g#_M_6Z z8lHk2*C_dflBSBL;t4m{1#P_B?Sz%_T{|Dqm~>eCe0`Tvv9Rmtua}IP!%69=Xra(_C0W4)X0@%G&xigSK1B~lw-)MmAhl~d76 zEa@Bhm2xJ*f2hUOVA{bX?_iRbsO2_cnQItl%Y@NWq#K1?GmWb+);9i^7$mW@I`MO% zT(nA!)#&W6IgY9%jk4#aj65=iExFeH$J-LNvzSEQeuX$0TjnRd>&ztjIG8 ziU?hmY2+by3vXUI{P6OVgTOtDkkP*CZ<1vmeKj_H^3p}Jq$}?H76X@CHs%C!Ty@s zZR^{b>t*(Inwbvg5q!bSIxDTFqyqJe>7Qr9Ik;3H8L%TiBDT!`mxD#IxtDz zM~CfQ5p-B)lJNc_`N$b0~x3)N`P%zkf(e&TRbqcHN zESkIYcgp25O(WzLD@jjEL1`YHxGqmyCjj5y4Cqw_(tbFV8Rf}z%WCN|I<}WJs%4wY zRHyWi41X&M#D*0e6! zXND_2e+_0uTGce!ls;8bO02C*I3mCX{gc>^pPoLejSXZvdc3=TV)RqwqWb42&oo}7 zmo3b5N?N*nsgzVh6ipPcd4Ld%Tk&vuj2TJIsM|Dx?r3VF6hBeb3Yh1wTKU$Rr)tu{ z2rS}2Y(oLq+XYi@f-Vp$YnEksRd!jF=8h$$k{{KNTPV0DpXR7%J0@#dI&sil`xY0Tz1ytIcj@?J}uGqPFI$F;w&61pio0kVPakc4`N zP)(<@iQn{k`Re|u01m?a`Rm3TQ>W6pWdv-X`F!(JWv`g$Ii~trt8InBRv%!0s|7ux zVWQ)8$SbaWLixo79;DLJno|tI0*b^LN{*)A?&lv;c2^cuy}gA<4(P>~#~w{RC4DH8 zj#*)k%yd%9<$&L7{{W49;Y;P?E3X9m7eK;=_=T3%=aZU=CW2_tdLvcaFzLzn!FX2+ zV<=x2N|{v9<++FUwN*349X%W;<|0(HIk2_Q^4x|syQm_C(d%382v51sh{>=o9$c|wpSf@>|Jzdjg*Yyu1XxsInoa`GbZ@wicc*O zl!JF2{)4|bT=%l0U+v2IFu+>`oRI)o}Qzk4eh8 zH^g3>%+a&>tLEcwo@xAB(ixPfW6dYL9ipk0CssX+Ar|T15jn1H%U(N)9^^}LAoB4N zpXoeD$>QAf+Q%}41`;uR>V2U59nWL*9OLekn|<(jlc#$5?_nPo*$QD#;~ix&SElhY zy%tLqN#&(wHs_BqFZ_A$+a0$QN3|-bI~HYW&227KS4U7<3F=l$M-=K>Fyz@wfJYyE zS?gi?Kta+(^NZ-AWr*)vN#T}9MO~xlpHb;;F`w7g5iE~UxmuhzNY&$gzzk5SklBbM zF^tbGF}8$CvpSG;8IJ&c>S;EH(K&)WEq8}GHAE#!5lxxY$K|=}wVac{>5kawGSECK zyZf&t3-F?*r|1LRp-bQog3!Qk;nrpuT=`~~IA?nvq#1obY!&IR7cQyY6y5J?9Prk+ zLOf^5Hbd~;;TnS!SzfxOEXF`mx(O9}a4bh(rYAV;!$6>NBb<;~CTp&SSkJA4!LIsYdSLcEPxMT?=}?J*pCA z8nm0x$&x`wPU)P?jHa#^a~M^>JdT$BI9Fan%a2q=it+$Oik!|WrBlw170zh!;B$?b-8aIJGB2q61c znWZeqwQ+;iGXqx)%wiQS!=twWZTnXD$2DkX)JK~17)Y~9EZa-9MsWG##|<^)bpVDS z`vvCy*2ipfYV~s6dJtb)=Q+Hv;2=f_b1mBS%Y_Uy&Ezdi8Z48fNn)dKe23o~tT zQ>f#pmZ6ymQi40~0Coe~*kH^!rJ{kt3WG^qRPe(S&dR9EwMQNQ0FDg|8ul*Q&Wq;-nv&AJ}t zI`da$)Sue@Dg6`jl8;3y^+W05y}7})Ftprrku&r!8f^+Qnrd9ulB#Iu%HgSSd6koM zH*1scf*VPsYP^CM|JBI)9}Kgc`f8WRiE)@P+u+Qh?|e8vD?#rcR33 zXsoxx&kiz*8m&jGtE=-_DM+r!X3MHJ(YZXLIEX2~a!(vvt}6JK*Top5zy@Ov1}97Q zqT0aGeNclp(+Qr-RjYL7o_wZ`M{!3GX&r7jxMyPf`WpZ(d^e|CBvYvD$9qTZLcB@{ z>1{Jvt@T|tO_)@y6}3~U8D=|tyPIxudE>qC;0Zpii)FE=5G}AiA_-qldM(&mfbfHZUcXp z8LtxKbSUGR%GsMqpviMfTQ=pciPa1#dnKp^N8w(v@Yv<_y8fPee9pW|)by<)zYaYm z*?lT*PaUyu^!hldGz_(|d&C)tp5!5-S+1#1hnn*?)A^2NrR!c8p`<2ih$>|CJbVUJ zVa4ok$F?KI;Tu>AfD%oFY)*vscI>%ng9}0Pj{>wejD8jAitQ&fQau%OY?dmoC`6S! z$nr=2%VKS}zb6!yaVoq!HA<3P3!6|IoTJqsZVBBo=!HdGaxV%rwN_oJ+d0d8>9We> zNlhRYimjuu;d|~Ex%&>-VPA^YYpHZ(0aBQIfw^qzXT!lm=;HITA836Alxod;9!~ij zSv>%Os;a5$=lOW@FD8%xXJEnr$y8bTBsWLAIE4p-%ij%5n`M znEcO%)s-22VzsL2hGR6;%%aeLdoKqt@9B zdKN6WRmmixNac(XDFWbvN7VPh)o^s^zo&7IeoKJsLXvoSoKN7!qe@!Yr=-kj%Xu@? z$S(^KeXhL-JaxnvszV=6L}fEGy6&0CRhX&xhSR#14DOFHh*D;K@)mranSp@e?`LI+}w_K^|d4n(4<1)zmTVr*zr)%&eZ1!Qc)_ z>w>TpsL*vn0c}Ar^Su6#HPhHg)>UH4v#Od6Yg3VUc#=sLXE)2zLo?btkSwwjzyRL& z=q>MyMM`1RgR2?J0VjCg5N)Pr6pBw4yj9Rz%C?^_mS}S-IYc#-`DilJR7#33v?x2i z#Yg$a}P-Ypnr^z2NudJ&TbpYZp@T=Ajtk3wZ*Ol9;EjFT?QBAzA{LfcYH zNL7m{KE12zx#zWe;B$mI=$Gbq_u&LKM#fIs=!_VN)F=;$z9>N1RV=zU!?`q;K%7x| zwW4Xyd$NR53FCrK7R2;$jWq~;Oz*Z~CBkpH+;0jhkCY|TRnh8tjHato(WHf?B*h@J z$OWu$!mCX%LoRvte=^~&z0nU{tTJUw9bz=a>n#lulDB|cY63cS!u&Mm>e#`*YA_V< zpz>IU=aT%rI-bG+)E^C>GndEBBB8Jp1Hj&44- z;}WuwjIg{VN%YpGtj+1*a>@~3^=vqC&j4U*xNy@8sj~N(=GnGmJwl-051VNn&Da6f z*zi+hZ@L_kowC?6?66A;z+OtY*=3X-Lvj4E6Wr(Pwu_P!c0Dl?RJ)^Zj$TB|%Oeh# z{{Sa^5$OgO0g{wg<(X}0Ltjv}O#>*BVGolcj(7+1$1SQxf+y)kuxz3qr=Fswt1rrO zpP5L3Xr5tnVeD{kM`;j$=Jch*AYrxry8GwYv~T2CrH58X|&|2OFb(?ODrNtp{A+1j!wsV{{Rt&RA`!m#_BOhn*|E+=U2s-X0^5X zoF<`UhDF@+HsEY*OLyki!FZ}A!zexKT7xZuGwH2Ysk~FG%CZ_f{#t2>vZXV5NgxM> zA-@p=3g3ri08UKS`xO&k7FH)Q&BmP6b(ucD)6?Zr)KVf-{K^DPv89CSqy7}N@AVi| zFyu5AI&Xg+mxQW~s&ff*xHAgOmnoR4JEGQkyU0~GC?obbdr6^?99K;@Or8^GJ8P*j z>bh!q5~5+brchZ*o^DT0xSJbGaBT~sAlX|jW8$?PBz4+;wjmr9~lDi`nXi#J4D3L2Eop$~Hh-!UuOi`$GG z)XI>6rQRFI6>g!*=_+fgDPgIZB6(@KkOn=0;NVn$|6RJy=J}?&#a)#YqIR-urwv7SgTkj=LY-% z?{4^dF`|(Hz(KW;{Ldv7(LO2X(Pu4`W+-bSbn+#RL=F%y7qRxf39o=@Y_{8lz$aBV z@m`uNyDiIQ$x1+J(NCi)C^NcC!4MUo5Do9i_TG3O`X4O$r zDG+ZvJA?K;#x1l7EfcCPi=-xeuP~P`l*f(o)94*A6f zNv;~JQrDwHEfr0gX5Ny>>FBvUaCzt33o(LOVYrknQVVPmSHnEZStePjwKh|iLz~mp z%`8)q%hNP%v>rGJSDrAt5Y|XxF#>zkL_!zp{SINAG+Au2R@O#y1rP$tvBr1E#@!Tg zf@tC=xLex1Y^2)5R%D(hh$G7~_^2xi!3?q+lO=!!xyMwfI}C4easrbnX_AgU7WhY< z=q0R1f)#qDLrY%v2*8__H~L!%vAE{fgWuKmA{t3W?NOmC^$i|U^=$r4Jz7-7Q%>s2 zCW!IJu;&VB;sqjN(lk?DOOsqjSzgh{8$6y_R*<6Yb88Y$*4P2qQX40nso3zM$*1!D zQ3}PIL|kgPI;I@kOn-6=<_iA+(J5O`M(P=5JJhv-{=5-R zzooVYq@m5qhU=|gQ>$ub&1fjnik4>o009%&M&99jV7e4VKB+ff1|rvm*>0uRDM~12 zS|)@QceUBje$e`hVO}xpr6As65ERcf(zRM5SJc_Aqgsr@oyyb2PU`+*9yZ8}$UQpX zc2*U-fwnrYijUXoxoF^m6*VHRQ|7cZ=go4bn-%sK{IMvaC%VCMqFy3u7gu8FHo z=JI9Pl&uq@`Ref#AoQqi{{VbTR-R^~Ue2iOQ>`7TskB{O+h+4;m6Z#Q2HTsTRiS2)GoMWo( z=)~pZg)EdO&$E2`yELfN6q4*wF^W2ZEE#>v{cy&c8UUzyDMMi`(fW5Ypv`Ks>b%|! zv7uQ}U(9Ax*522|RqC|2Fc+IH+N60lRgh*mre~Da(@9N9OCHsfr{XPfVfVPiRb2J} z@NT384O28ZJuin+&q*xyhIx#!NP4OZ01hT|&LaEnxFvI?)p~lPH5FovRaNsGQ%Ej= z+uObSW8+2f8*Za>fC^<>T~$$#yfFNS0_z)2cPHfmsEI_Sx=McI{GVR+4K+RMKq7f zJ9&J9r0uce_hPMy;tj)r(FYf1k_&H@y2rNtiJdGqYn49Go&i;9TBoYel`z-mnIL`X z=PN~+LT|C-Vd+M1uOkYb#eFUtQLxv5L^fUkCvE540xO`)ai~Dt+a=Xne>BfEjdRoG zIm}hDMVL_4)!wO%LEGii0qJD5&Hngw+O+C4QtLQDg3*^q)Oeww%ozg$>;gG)XSMu&tVfa{{R$y!TuJ*3T)|yP;4gL{{Uj}8C?8m zrpq++6#1CS8d)l!in4}wYsENg?b?5(?}_lByQ*wA3Tq`E9sH$MZ1#95@Ed9S_^wqykaD;rmF(7N*pKlCjFp zE7Q3>Fb*gh&4CjJCrv_?ha!de#jJGijI`8Q^)_8LUtd=S`lyU7vMF9YVYz0q^V-(; z#Q1i)i-<9=#nV88#NO(-Qe-*3Y;aQOw-e5%<{73QS-0&Ev9Z1!8m%ASniQf_loXk! zVFZ*~gD#4Y%O~p05^v;mHu{_5BKEfQ&)BZOl+WVkb*E*@p{K~Dl;#w>Vwp@*Dc+VH zPX`^~={z2`g-rVhK&*o^s?wDwFwEeR7-v(lp#WL!*N?w^H+w~4mA8a8h?Asq`nt+D zsgkBy6=o(G?`GOh0l#+`2E8#oyQvz8`7X4nnx>{&o#j^Qj#u%?YzI>eBFaGYUDDaV z=~~RID9l-6rp=~WNAqLcyQICZ?a0En(#vtOlsF;QuhwyB{QAF6)xeP^UnH?Gb+BNz z+Q>bK>4WKEOWQoqwI3EjIPd)r7>zqDrzz{f0BBdI(FRcAL2zF&#}bR$PWA> zxhPAX_<@$w%axqEh0#DCFtWbkAR@<(*k?-&TnwA8TP~Q{8hkf=#;Ix^io8+L)wQ57 zi;-{%Tqni`w!}0YOC{mKF)m*fhO%%{nF6hV$ z>06;Zaz6N~v>J|<>-tl9169vU=J^!N(NfaHsR7(WCHe2i<&QBmsPfAXc)_G8=?ccil5O63kll%3(hC!Q zoZH;s+BI6?e5CWv=G$*toEYyTxq41rjrj>(vk!vo=8V;k?Vn0!WFImp$hY3bkx(!J>#Eq@UT0hs(D`0bjbR8r{dlQ)P)%D!HCODH3;TP3$~ z$2cOGXw#(r3tId9^X^eO;STEl8az^~q-redz}-X^KTrDIR|7{Sx{?-Uzte+kF*tgR zIhyT$T_;boEs*(|bx^r}4s||XPSVZbwyIc|hHwfzh@$@hv>yHbxZ&9Pt-f}M-=eAH z2hzH2Hk}gek4|c@4kXF=Lev-a5NE`U6o=x!)onBBgXe!kH%1Q$d$n^SP zXYkTA%n?-aLh*j&pcGcab5y|2jYY&*fb zr6hx@T~I=HuFkUgsqKV*w_wfVpgxjFWQ@G32zY8>u5T8ezlyqIEdEKLZu^trXq+XPUe*$!@{ zM^Kdzpw_u&lAOm&R+ZF~sw}HLJ(xEns>%HQ_`y!Y8oJot7tMN^W|=Hnhz!RpRHBAh z!xU)CMh{|^BF+5&04xVd=9Qgw)Jlrh>SWUJ%avx5eA3Kpl>v)bn{vuY=xuxwDH?|} zY)83z(4X^tGgDtn4r5c8Q^_krsbm(4z#AKOHaLa2fZH^0^r?CoLTXM=I@>23@UT(EWPj#=JXwsNC36X!K~zDJiFH!Ga`;(No2AU@yo7eK7&A zl#v%+0VtK6Ww})~8X=iui_qjtDf2DbfiwI;md$T^F!d|JKWY z32U`bs);ndc`XT#iD!;9Ym3+|JNsg<#2HABzO)d2DKHllLD_8|g*sC=&GHY^ zS=%LOijKA%+B)CWIyi*+Qrv;TW6ikfjERj8#1=8VMwXD~y4Rb1A3}Fgu*v4Jhe~JJ z{(DOm$o0)1Wl6Z|0Pt~G=P9wceq zQ(c{BnyR*`GaSL*jyiD}c&Q371yN5y$g_Pf-w&zq>Xpp~gS5LfY`B3pf%2_pwM|cRY#attHzm~Ok>OQLbH`(c_PYeMi@1?iZso4!C-aRHTwi90oDj_ z;jW6-Ili#3(=>6<^Llnvt7xfeT_cj1N*8*lU>fW6HW&B9EN(7~X*R2_Ds@D+F$O-4 z#qBm6(aBg}iZ2~WR=ewm+E=kJ+iO%xE& z#{#3EWmZ2mF;xtqPvKG5sp*b5ReVk{qOV6xG4f0scnz+gs=&)ii1;^OL8$yliz$Mr zMVHjlO0iEdTeB44IBqu)z#WDeactBuMob%iBJhRr+xDqNQ%{q8spVrr!sl=CVf^LH^o6UpMsiO z#O&Iu#4Lifs;O%y-7FB6{Y;3qWhJaY2ep9X4Dg&*rUj!9SV3s9`9t}<)CP`oAqR4w zhWyjSEp?b_Jc4zfG>!k(ri6o=VH02C6*^!qpFAY^Ju26X^({MMsj+Y+e9^g2b#N{UKsN%pf!2}5) z{R&EyNVg;s@c#fgtk4vBrhAr(c`D=vHAzqFqA~(EC-}pU;fA=XZNz13v={at=0k~U zvi=2AR8nNQxzBTHsI#*J_jRLri-Ze;DpTvxcgNqcfPGiC_(BB=`!R8w7RytZ9M zeB4T1CRv}e=J{+79W^TNnl(@r zm2OS%*y0-4moQ~@$u)Dr%L6o|t|mVY%0yxAw#oK@PZGIN4U6VV6Ug#Bz+kFp7y$NO`4T2_W9U zk9<3za$MiDnuOHZH)%|>Fhq`_D;`K79#YB%)hs$#eKFNi(|FfzOW8y{F{+wLrW4hN zhL-N`+*!f3upLSw7lfw?^Z4~HcMTp;?;A0-$@ICk$QaBBC2`NnO48?}*q8WC9AEoY#z& zSO#N3S(Tw!r?o=DPe>eGhWhh}-7T@yBT^k{qp0+Gn!75UDkjZYonQ^QVkF!H?R%fy ziNnjF9WUggL!7@~$2NCK1i1`!r)tMMuqz$T2pfoR;cQND{X%nh1QW&4-lryvR#nwO zDXM3URI+;ARQA7YDP?02ZK{JJ3;3gvOO(mJIxjIMP=-SLLfmjq+YT@_gS9#!>b4bD z*I6ZQQj~_cF6l<}b$!6EY*_Hm2Svsh+^B|E3ue_6)GHv2Nd78pN#$}kj4zy~Thlxy8id?`!h!Dc|3&-xofvlQPIVqSrs>67@rL=@~ zwAsB@saPxO;1UW*VriA`JtVUJ8{fVcVT;-#Bua?fSyT&^s(9G?SesmS>}}f)#)??# zrTMmMC8L6a!s3pp%+Nx@ISxPS+ zfO#bL7Q{Hm0Ky502-9+}wyV@xqDfaI!>{;+==4*Z>Kcx)JWY zA(pH0UKPnAgD-eizF7d6uK_?D-{^2{3=z*KK%sl!La*6|eVAmmBQr|KzG|gT?P?pCf$Ha)r4Z=d) z2f+@a9{j^i)L<3gSXSz2@(jWX*f*sy4HZjuc>0DP!yaMTPd&9WD~A&!mgrNOYdq&U z$fCYm8nrdrYM&?)K>%Fe+zz;9PJ7r<`NxWRT8WP%tg|~AtZ#|-q@DCCt*iZbu*in zR8-FNZi%Ue4A)O>NoXP=QWm*(0{3sG7c#v@^gSJ4>U_;)%S_vY zRW+lE&CnmGY%;5d==#hTUdkfmnj1yx*)w)$mUO3?>DEOakJW)@M(#QOSOTsltr+c6 zvY6QowO4}FPg6sbY4v$4YMqKnEPw){*A_n4!T5e6;4?o#=A@T2^H7~-;Rb)<+yQf% z2lD6TB~Dj^&nx+1gE2wo$_G5=zvm^&}PY%&h1MoZmEeJg>>W4Ox?L%P zp?k?a=+)uJjM;NiXF0}UmpVllFrhsbH@IXz;@xnk6@egzw_SaTW&$-ss=o#(HGX9! zevhb;5?efRM1V#mZbI%o0ppw&%z38VwE~(+v`Rm|RjI3V+?sP%$g~v{Hfa2+o#%n+ z^)Fl7k=qF!QH^+YJIeT30(6aDq0I9f#o){(rJ<#T#FH>D8x`xx>4x>%zyynx@Fb&l zRh#7T+td3eo|fYS z*Tgoat&VP7n<*Y=6N(rsv)GYKPSN>y{6}#EkEl3-q&Vean2WARl^fJrMFhB*D(|dgHd|`G4UoUQU`na;T%S?s&oe1sm87Sdh95{-)qPEG z@vqO@9pPTsEPe0md)H*ZNU|CVDyqkz&a%0n)Xfo`1-bLnn-E7!_s2DA5CLPNo?(7V z=7OY^x(0nbGVMvG*ksw93eM4%GCZZYAggh6+W3LEu~u0AvnI#1FH1QneFud(ywo|R zWleI4swFe|QLTbX{Ezh|Dz2Y7aGP{O)%sJ)1_TR&?xd44T9i%_3MOG*y`Z0mC$$>O%*!Ye;BH0CC_sD zYFbRG3b!ITN^mTsa&34dAd0qir^?b`4k#|E~}oN^42{kAqD)LMFK}R3I6Vj|H-&M@PNOCPJlx3|$Kqgw5C%c(caEzo_es?(S_1x(z=Zx1+ z`pZtz>q^2XYPQub(B|JI*sNn5fM&3a6TASy+hUHvq5L9)B!0Z6QgGYi!T~ zp54?rrCcwDESjHK)nytRC$G%M&DSF4mmn=YDQ)G`f7Eks!xdgBNScA~47m+shO$VX zpcCMXrhS{F-XrUJ`Yh{TE{>glwVEv0=Jn)^QOXn3bNO>m20xgBP z8$ziNV^ao99b>bSkadEn-X!S;)74c`<|pK4oncoLax2B>k!{0iYZ7m`T-%IUaJ91w zNdrmNHbOW;WXp8rH|VGF;C1@@Vp^35a4jDgO86K{G8~xaSzbw| ztLt8RY6Ovy<-2SnaR>?R(%9myQqo_g(XAP@LyZ}e>Pj5TJf6OmRG>mcP56OOeLH=w z2V5D6eK#}-xz%*h5{lINM>wS!PH9~m(^A$kmMLMZdu>y7-VlO$>N;Q-yf)pOr}ilj z=lgKhIp2s=y=;-xE?R~dq=FF@IEve@P!bCPZhGN^sZ;2LYVB`2d$mg|Nh(tMxg>8g z0Ls%BSC9@G$B}N=zZe~~2p;4KJeLhWttjd<7obRd%*G^nDa5AeN^@X8c0H|!A+mj4 z?I*!^PUp2qyiU(`EOgX=+b)=*rOZ~CO&pYM=0_w?%I-azo^kdblS%5j*0e$KQq%-$ zt45y5WY4FSGy0`!6(#(OZL#ZMds_|aRLDAmt<4U&=US64(h^kV**;uN6p9V^?g~xr zZ;q+cbx|%iQ4@6IqV!&MoX<&^Jlklc{d7RJuEVgzb*r|R?HaF4m1pT?rO7GYt5H!+ zV5G$oE%wZ|DChi9-v~W(mA*bIU_(XKO!$e_&#JWz6>HgLdUOqCw(D2|F=yelvbO!6 zXn4&fMf@_!>!i*it&SE}ht#qW=^c4EBNJ2rg{WjeUNw$kU8M7Bzcy5;nxWcK#O_cV zu=c<8W86DMMvlepDsq`}%*g4AQ<&3c(6p7KWY9*wv{G+x=ZPN9ldBO5S4l7vZ3e5F zn=+`a%Yzx*ZH>sgi|}~IZ=u!7bW&w4M6U{IGddi`vD%z(a#l%P0LabHAoRcWVSY93 zE%y#NZ;44}a`jk|Ua~I=8{tv^_bhsm&v*jDzLu9G11n{#bcKh#K~YKWJRN3(8gxN5Ikw+NHn&6ez%8%7=%N!lXlP@SN=in8ISTJ+)LKF?U!}O*-F;-6G}AN@ z(FpSj#HOTc2XWC`A5p}+JhifUE=UD6=2~km)42^^W0U2}TJRtv$>K_dy}dtP{{U;^ zdR5B$9X~aP=FQ0!pI-3X53Zz8kX#X)bnR zU}f_`I;!E8>YSHZ*RYa_>0QAAULg{YEo*H60qtycR}E7N-Dh>{A1U^?!n~2{mQ^nk zNP_CTp*^mDm$n3F5~v052-Z^?sNP}WeI8#V5@oXpq>50?(kjYNBI9!d*S068#EZcX z7Vm{PrO7`^T@TB#y&J-~LPrwlGTkeB1PJo2_@H!l=nrTBsPjbOd zJ?{zIF8G7jQKWR4=Y*OYHDU`HX`@(C#k--5*q^D#4#(1c<(B7%gY98z>(P$H_!52T z1pYbYk4palq`nw(hMkY3(M<}Ywau=|io^Kh-$ED z8D_{EIrwL&pssZyQAa8=73xS}K|MR;hhu3lSg`gCRaQ^%UMhKbsd_ha)9?q9V5QSv z54r3)jdoe#hJBONOwHx)sda^>KyAG@5ELH1`0BS2$Rb}c)dHpznS zL#X^U@bgyZIdkTpGfhPl1Xal;+^nl_OdC0{9naGrVDXQp+@Rc>+AqI)2BQH>YqS@I z8t>&YjH6TLnr|(j23E{#sUt8<(SNZOP-Pc9hVN`1F%G8bFi9JNeaK?ahFbSaD6 z&RoWgrlwhzn#&>H#m>;mr|^zXPPh)M1!s)9!9L|HPFpTnhJ&cA&oTF9Edqs*vZCR%W<1uSxHlA+65z-RBcP*O?>(EuT3LS#Es;b z!(Q7BiEppJ+ZKv=MuyBK&TXV>k!Ic^XO&VlB~3}5Ew)Xj%muysW2$&YY7|kJUsQb4 zIgNErn9I&#SLHw!L%J_jOhJEc{{TzjGuktdE_riY%x@|STd6XtsOf5}tEQ-qmO|0V zd$ik60mrceoD|9@KrVG}F4f3=^j9arSh8(O0@yhsly^D)Rrn0A6#ZMDVzw(o_9h%{7?WB_D#?dHA>fpoK6cvnT?{ay5qdo^urupsgl z8$2?&^+pfW+~e#%FyaT_1OQF@6ot34miSGm>-;XPi!IDF`qE}~k&q>0wo)bTLH__o z7x4-W#tCbT4qJVp5lH1I=}+MlT1?BYGF@dtGg#+CQ#nbFSk7opuBdVzSYUEywlrOPv%&}JIDRO)DkZ!EGH#VmelE3m)fxUpL= z;kVRa%oRHLkXXlbZKiU>5fRvKNtq|uhN#xJT~t%UFCVkr7nsz~qBQJT3oER#Q^>C} zq(T5i$T@B|j>QXVmU^h$;&z>?_@vG9EkRpd247hW0vVo; zofwv4IgtJ)3uD)%&%P7ku|tHl;LE`?B+a(=`7cdAn_W(+4t4OMq;#}W)4`v_+2uS= z<)^M#MEqPVQQd4w`iw<|`=hIf>lU7jodBN`+@drCEh@BlPcEtO=T_7T+Ios(BvJ_| zV18@zAAoRWxaXMIRV_TdTy@2F!w^%oKY<=j;CCxqQ$HjeX zr83VLXle#%X>tKT`Ce(7Wpfyw8nz64#g;3Qx7%xYz~TA^2IUQyC7=d? zdx8Lyxg+=aN3hp6z^ zN#%LL%p#JKSVZQ6MY9Pk2Jg=JUOM~hDnMZi^!96#c#5*oO_qvzX(N)RWKIO?mTP^_ zZ_g4II+>N`WSr(%XNYqQ(g@|rj$avCb&0G&P6qF(w>ag~O4}V*BIyk#OP6OkZfuoJ zQ6^<(c%7X2ETfz8-yAxjY;s=^quMK3ytAB=qKRod`%}E&88>@wQ|;T@=Mv&D^VZF7 zN@`BLDb;?T%(S&!^*O?b;UoLr$MLPWVeN5%%d-dpGY6WOWqM9r;+~GKnmJ&KRP)78 zEG{&NG-AOUlIsjve+_h37#0GhB+!GQ1d-g{;Y@SZSU6}RBNgZ%gOF&n8L()(lYLVKDdN)hkeAvHdyZDchbUtdxyB1vrk4YmBR81eSD z8yX!3QUq&1LJh|DQsQ?9()MI4PNxiBf@~o^`K;3Iz z{^t_AOX!GjvbuW9O=p_C{Gxv?wfLmQqUP&8m6l)icMPiTs(NX+uEnc@h!{{IGK!Cq1&p%f~3L zQKofGZhKKjOHB27g$PAxlh?sJLtEPfKCLj>&>8waYJ^HGYK=eh^*J6*n9VfVgn&k9 zp^!!;AoCdqp%%axYLE$Nf%3U22$U?(HSS%K=G7TnWivrX8nrysvao3*b>MbBOQD(Y|T~1}onkZP)Q9`?mO~?!T{{VJ8bDmlQZaMoGfENp;)mkq-smQ5o^zTI&IzclKXXUDX!Zd7-w7#_7#JrZm1&8Iv)N70aK_kI0lu=P(C?M^)$Y!Yb7&Regr4 zc9FVQ6>gi?l=MlH1)8QQ%(1dI*^!Uz{RdlOHnOb~*3hp@fmOd>c&VzizG0eVIlN)v z2=T=fhjztojemSuF!)B)XmC*UIqnL9_+_Ls-A@K}Rg_esig;dG(Z}qIoBseiV606> zuz*7Pv>Qf{pZqQHAn4k9<5VH2UpnR)qFGhB9NJjqk%MtrHE8(FR{!29;Zj>Cy< zSJ(#$T{Y8W^OVh+P~`bWMOBwmu4wiQwHz@(K>gHs5@~g}HawRlMtoM5Johh>xaQw0H8Y1wN99Q; zs6OKa;KxQ{CPu4*Wi)tOpK4m{$?|xoNhC^RHuwBN2T;Gi5@TsGt&`1qz;{H5bYj$J zYc_LVRTL#oLi0Gvlxsx8mU#d{Y^a|%5(6=q#iPpGBLE8(jv8$ z%$FDchnVGj#mVKHB*+!D*3~W=?Nm>b_b~Y;K1`t2NSB~0>uQR z$R#jTRaVT@s4mFI_Q>ooTk75g)W)DT0#^smD>HaSH1!W4g@0AewvYD#k9siEE7Huc zy5(8bbTS1m<{i6LT-~Ozn@;9H1G-JoZKnu>tNaPnx)V<6y;r9* z8LRYmrlXF%^9BWG%Y?kzMNVv>o_Y&lI$S}O9hRU1qg>$7(bX<#EptKUE=b?O9w?ZV zC)C=u=Pd-n;@!O7hxxkdD*TA*asMo-kq+zv{p*@zRBqE5-FB4A^UXt%D${2fZeR04y<-4NNgxV}=z6u7bK42r zb5vlHl)fNbhujl8uH==!K`%bR2jq@VuvwWnM@m$1LpZ4g%8w=eQ>vkVKF!gE;w^7 z)y)7n#`ZC$@IsoCnD+p8LywG~4=8*t+b){U(pVNq-l~wB&m6O`WsvfCU_&3c!GCht z=VQm;TX?g8Ed&n3I&TE1v5geZRmfcyPcCtmQ^ip4M^PzMMq&q@ErA;^*7qED!}C)k zj9dwxz=LB>rAQ>tp~-7wxkQ6jJ?Y6&+|2kjBfyITPoS=wH7ksa4Xhr%KF zcbn$)^g5afxQz6>HnLS(0P&s+B!nJ%+wG1jfE*)mrVlDVsVn56Or~0yiskh21*DCo z8+Hc1-M|ap`09|)Wx=dM8|qzg4q06+bu|f36w&Rs%>2C9t+II6GuP)@b1bcwH)>qRGAsod^$?+o zD8JU&iwefmaR5t4y?F7O>ZNMkJ(%S66r(Vaq@7d?Ik*5H!;2LffQv3!Q&5f`A8XjN ztkN8^T2-h1_c4$Su2gaR@T(Pv$lTqkBGNoim&IJYGMvgvVIwoSzaqc`*kP6p*}yBR z41#+Q`ytBctLh#a+OL;TIBQ<#1=V?Oh|0AKbX@Z&O%-g$np3tLY>-?NZ?-$8a{()w zP7ZDNlv42euTjGWZ#6Dl)e%(2qInz^ASo;g->26LF^y!2+I*KT5u%?OjKvcwg1(L8 zj;27<%og`TZ)WxY90=xvFm#CeSAh`nS`31MY{xa4hh+*(Bc^coj!6`90PWYD0OvjM z(c3-{zD*J4`b$UWZB{9r(y>S~DLY}_M_Yb)m!qj!kvc9W6HRpng4NZLP{o+miOaBs zV<+XtsNU5;vq+j{N@s3{Ox7fLmj?f+~?#$HEOrd^@Q*4n(Bx21 z=9G*g%Y##aziUc4D*pgpxMPXHo|7|gn9p}-f`!-p4%dmnHW&W@cT5pe3IVm9<+_=#vbKH@ z>vgL{rOs8RNNJi_U43QtbYH3IidPoFMc95Yp7iSs`PCh=^{38hW2{`c;uBcyk#@NI zkL8NBS2~F;%`j7@vo+J5MpYaa+fGlXp%=s~tVy|DbX|$IN-~izo0n|2D%RlOrc{$+ zqb!9P%$qC9WR6(q=G`*@3}$8<{{Y&KFl`e0mXT@IMnos4&R~+CeJr0Y6zy{8RPG&a z4g?ekH-p@yX-*WLDP(yzS5X>6=FMUrRcn*}*W2rf1_ACmSntVnY6Tg{bs+s0TVGaz z<1Xxqg8rYV?s3(8CtNgJndZJ}w657kp{0tIb29{y#N>diEhW#e>@oFhJDlvDi{;g!k!h(Fh!56-k^J~ zlQm9{)e=JnXsQ?kEEN&)E0NJi?QSoQ!z$9dPk(ywIBtSIAW~{C(y_+LDaw?G^C<<- zm+VJ-0nQrX9KzZ7$5j!TL&|*WdP=&=jG~%3AePYiyS7N3Y*>5W2O43+thpsTwpE{I zSzI&M#`B}pnB7r{b!Gf7Vb`yGa9+lqR@Hh6Ecj`dR_PqdzcZ_d)+3K0W|hM-g6k^mH&F(7VW@rT)z2=;qie>X4pcYOj0V<0x|lp6PNvA|G=vp3 z&7A&_`JKWhl|SIDo4DBi=cX7i<{%A}6)HlkIj4lv=Ta?A0o^O^lB5>6O~-Zb@6FB~ zw;j<~p!1>Tccp(p5eq{xd+{>dp&j~Q>Q(dIMk+YUJ7}4oCeeC|j-HfPNt;uAoK;c+ z7L}R9Gj2UNQoo)T)o?Epvf#Q^cGP-LG1C&mO;*TE$|PSdO~S_3IB81|+P51b`avk; z;LdSXrRQwEqP=5^W(3m)<<+|W@r3+AjjPvIJ zvPM{)$@v^4HCy|mGah}4b4)M)&=l#<1Uw_rQOgEknvRP~oKq884LHh1w8V?WjF5e@oE$Kxs&LM?rf8|i~}Q*{oa$u-?Zl*?+5_Ptadahhf< z1XR*_vKCFHJ1Sbh_Xifr6rDggv}P8D-z021~;mI=b*h9G4PhY7bO%jrUlW;%j{O6pkW%JXW9h@#lSS#HuSp+T`H zuUt&ZM!N`bi`_$Drj=eMORtoi_OhNiB67m0LwSg}we8OqzZeCWA&2z@_7ed3>D?+u zzHU($Jn$DOpG{4vbWXT6x$9b4DAquWQl{5CTh)G}08--a56M}XTYHglEms=1$BHUQ^!t7rMETL4B@e8A)xFb&aopy!oI-OuSBag+>XnkKC zvG{!rWmd4rO3R&7OGZ(@N1(G9-=vmnZMRSk6@AYKVVJ{F&J3#91mG@Uv6+W2n3_qSHF|kL4@S$ut?bU+@jQkr@M#d-NR$IB$-nR*h%AkS0rVfhI;! z4^--PZP2ARo3GVg_d1OnocHsb;Itnap{HRhVk(S(c8v zWTvI7fl{U_nYr@SW8NChNCN6Qp12BzDUNAvGj@x%Vg>&ILL@Ruym@!S4M&a|S25Bx za3++^vfn1EniEJART$Nd&7hxK5pSj`RCvduVgs0ZOu^zNZZg}x_U=sv8#7j4>m3a? zhmNL;H=0T;#wL|zp_V>EqYw#h!MkHfp^52;EW2Pq=RSKBsnqh>L9`aF)LKQVC)4@0 zPF*acY_Cpib{p;=P(~PHX)>W1fH9=5Nh3trT57Y3=-pN2nx;^j--7Zv>QB_;s&K(_ zAPoY9iMqL&1zuy|?G-BLS)D)5$^u11%lJc%r1$DER;U||CK_NHkfM^%fIcMZJkLCk z(aaJ}jAd~EJSpjWcK5@qB_`6io8@c7ynylSS*rf0+e)u@IqmdD!gau|iDDc}V z%rlC5oZ7l2i2##>>9_=ee%H4L3m;!Kv{Htt2gC`k)zL#=9&HU>BvA@T;-^vqDw`-O zI=8v+j;S~_!Mg3nLZvZFoavmz$Z2XRmP9a%p-{kg=dr_**41oE;0OrCqN#J!0hTHg zwy9fbQ@L25rWIB#CRCwV%{@^zoXO%$;(M{Zf$iPy5QPRHHJ=7zR=3|tYWX1Pn^(JJd#Hu{-##whuC+=6k{|M)88n2 zQR0?+O4QV}RaJ2`N+j7FmW_tqjK17p_F-G8(o`m)O}dL*)atB~t253fc{3N0B102x zML;+VJ;o%I@$$cS=+7>|VQmqZ3!ebYm#haT8?eQ={g5 z!_Cw4Nc7Vt<0COrp}!ZHM@&X5f+57EZS#p&wj! z>Y}q`TbF|6$1v_iIv)TAYnU@qR>$&h36?U_Y$5G?56=sq#WFVILkNQ>L^ae}XEe&q zRGF}mRweS1Qrm+8dsz3u^s6<{2IxD32!C5rvQxldLV`XShwUG(4r^moJvKqU>zyq` z5Iz z%nr-5Ot)1W@b5+H%!^*-dQN#N@@l#2B95h1iWP*LvoIY+utql%PNf4<&HzZBYnF?x zTh&^NF3H2u)5T_^Xy94mLB6n9gUI(IoBQJ^!%%fonbX&k2Vt@y&)HF5iLH4ipr?l{ z8JIG{%JR`4#UHoY*5?=Q3x?>g7TEGjDv2lrnz19&vP1e@yweqo(-ie00(lMf@Akva zgYTMKpEU#-M!$#c3!ywfTDY}dpsA#xB5eG1I`MVFFAWX-^#%%E9 z6}6Q))ilJcvZ+QS9!&x$`DcLzCPw>Ttsi zS(S%S*?3#vx#_KIo9Vp6F3#Ou(wQ0=qufV3{!0MSfyPZuF_(#fW1 zq?$=qWU7%H<^cc_3GNOArGh8p+elwF*#bvEjF z9dIkKPNWM(!9vsy1q~wB*>+``=DD_IBg)gAzE~VIV)nVgUXI|<2BZ0xE(eky=UM22 zrRK|>GRP$;yQav@S>$E;zwYg19VtT0x%A^A#1@!_i*q`Ny zD`CZB4%vJGE{;J+d`j^LBiGqpT~SdDLucp!sh@!xgKKp5{=9ob4(dh+s=cJgHtIi> z>g>zIS}Mw1vZ6A%y)Tteq;5V_U#GWRb&yvx$#@yk6DU%?Wbel;dk*KO56~kFG%MNg z{{X0?&oZd8OyXJM`69xac$Uu)w;Ni=k=qo$D@fCJX2r;mbUcu@D4Q0U(yNeXxm;0I z%biYTkquJ@mUnCHZa}|#{#XpwshB#^$+`i&FN`SnhZ-7#PS8=ySy7h9o6?gc`}QklQ|F|SD|62`=l#~h0L-LDnkn)_gmP9-!Y3IvQ9h`zA>NpZWVx{@xWG z>bRX_L6qv;yCTRk+HsXdFlIY9$nu^T?>zDK>4(P*=h7~yddq-9n|P0;axF)g<;Wbv zStQ7^weG7BJB`P0V0&KzVJp6qNjI^9%&%Ppt{SIM=C$IlD$gjSsMGYdQGB&z7FklB zFaeB%_<2g@StC(TyV}P*EF5v zLiSui1wu5phgDjdvbpNK`g$ltwyY61k{L+=6ZN(XtBMrB0_5zwX@CaXs}GUry+u`& z!5meuP_ZqNp}8uH*>`jv*hg0o%*Jd?TauIyX38U->Y9;NCPuram57bqY|;^KYz7Hs z5PHaWIub?j{;MXYi&STIGYUFtm}6xFbgLV*Q>c1w{neS)-uqv@hswL6t`nQOg>oY=O%;4b`@vt-DG* zgU%YlHOe*b3Oe+~JrK)IX#CQOJw=jc`jU>x6Vp{hvoumhqz$RHxgZWN-q<4(ie*fd zDbsQI&2~+!hZP3Ozhxc?>q^P71&GB{N8B)+p?P=Ee9n9G|z>7H9DaP&!8d z;{<@+k2S_p?GvAeGvzNwk?Fd;x;h<6Ra(_KZEZp$Ln5WgK`Q!57PmZF_=gxC3#v(V zJfJ!Z-21E-tom0!?QbsD-==dM`{(7ao~_}kjD;?R8o`3UAuI;MJv(}1u9?&_hGol^ zM~=Qc*M*?#syKL4n`IeRrOT*}j-ON|J)@;hDP?HdMcKUrl~TY1!60$(Y%i~xGdax? z=p&xCQZOMFwa_V`bG=htB#^CTO-%F0O*DthrdN=K5-r)4t<_kPE$xG8S2bGJ!?LtQ z_?vinuStdCO6r5B=%}@2IhaSh-vLLD+H0Ei0s&a`i;90)c3;*FKb(nsLNH< z_;m0Vqr_@l&p6d3DJbhe6s-`wKy^|>#vAg&EM_P$!+t1nJ_3A`3N)=HK{Vfjr(Nl~ zjKe$3Dt6Il6U9V)&}1;jBO!LTa>#G(jw@=RBK-o>hj$PD5J8}`EML)<$)wzGfDMOIs4!jP^Ul|fXs_8g*}2L z_=hXy^;9(3B|B8qWr`qI3%v} zzLZ;E&qVc*_(`7X7~+;GqYErza?(A8uh0(X5mm>snIUojJ9jIir}W&^St>xT*h_D}o`+YEe8K$E{s&x#Tb|~E0Pnmv(&NR+j zlxiAy)u?2uh8g8$w2-^H3TiW;*wJ_h59jv!uyrM#4rp;?K_F<`VD!AjLtdu2Wa2ZRW zie)4PX63jY@jI!Cp|2Nh@66dm_Yi=TI;wobF?u;9G1f;l;+=mOJ(ul=E}{UPp+p`P znTt?nYm?VePU5AiAShJ#Zs+-71E@DRaIlpobT_Q5%qa3Nm8ex}sig)fw{8jtL_XHT z0KoUm+S0jlh7CWNR#MBDPd4{rSi+*$w+(N~_$bu@&@ITQ!B&$^Q|S*7bXHqWl!!9S z;u*eLx(18NjpJU9-tBMagcy+QGvvwCf)UJv2-%=KDbkt&;my-9o@(ueGfd}oJF)H$ z?Ee5>D%kEI{98*5YqEQWY!ptZ)h31qdDb-ucUt!QUNPJFd+D3B$1;cy2SxYiYG+3*tmdYxm zgqRTtxl%`HpW%nt1{at*nDa=n#tNg_lTuN&LgrMtf6Pxr|Xu2|!pjG!dF~Oh3s03#r+l~%A(ilG^gXk{e&84ow( zzBqLVcT`z&?GSG`qJuiBq0C~-#WfvSKQz#tp-O@Hhu^2?hSZNnGLvzqijB^?a)-nR z%VS)shE-_yZ)pNr=0L-!sl8_TY1%CO;nOi8fnN zSn|`viRJ*TPS8EBEpv%zv_2qQHtG`PAJh85bBc**XsRR2WDo#>&HTppzi;#7s+6(} z$4OkwqZUEn{M2+JT;nj>vXd}yLz0AYHlE(r!s@u|^+NBXkh)~%iz16S%IA(bvWY+7 zpb?d{rF}*3`C8vxeCd1&>!r-0qNWq%)zvkTd53TXpM4_1Z%^V)rukGHdXHI)TPeGjKlEtQ@e5#UZ=_w_tjbvwJ zZL1&$m01s}+`JWTqhOKRQ2Mbo9#fTP8FaY>RRX0^>V9rQlHGSJ0<0_mJ$|@g*Ej(jkfbMU?=Q>EMLc?XXRIQa zJw%&IY=7DS4z~K@8gD1puw4L*ULMA|ymWHZvn6yE3oJlKDNeu<)QfR{d@IEg-91u# zJW(xIi%;Y!nCi@d^X)SZV@(Yyccjc*1(*;vO2qyqRsezD6g*9Sj*HDVmYl}oW4o$B zzmhhXmnpB0S!PR>)6JV@`U;AUu8KJ}njjsNk}Tl|;pda>d@A6Whu3yfRON94DW2IK zVoD~s0^nT^sk~K>MQ3_8mm`LsI@CF}RU{eQwG!@Cp^%dCJcon=;9UL_Vc!k?0M!*9 z{;euad8XK&xE!|zMEg{2sip39L(hqd8L2!%)EPEkqM}Ml6^3s+DORY8VKNCtl>rwU zwx4nd!~Pm#kT0kMi6RS!R`Zk-sP|}xaFb;$@Tg3b4buv{(`FxZW6zqbX z)Lc161F!XAFBRggWoFSe8qp#7q#2#9+`VQTmdq;m<5sTBXUpJ6HqGAQ)zbNU<}Uv~uxX zwdJK)Ul~3#wI-p1BZ>u#W^^z|^Vy>_Ekv`Y`z4Xpc@`b|VNMV3ewcKg@z^;cUyF8u zQ%y&!^WPP-Rg!t7udJvA>Kq|?9FBV_JqNxl^ys$=*|6m(c`nsR^p2q(9!pPGNtZQ! zM3++yRU@chad`j)kERE&Na8F=0>(o07*h=+lV#fPGJ=;RT8et8{MqWFXqc*5jE&`i z>f@i`fa}yaVK2LM2b%PClrvw|smy9>UTLc-=}N|}PzteY+<+UAgD|ZjplEgQIw0QL z!jR?q>n%A>U~>GhQchwkBS?J4U`IZzM^b~c2{XwKL=+R#wQoyUhBhG|)anhl0e;`V z4XU#+j>Rj2uo{0Spw^O8W)&1NRnn}UQ`7JAz_o#G-%KT|P|^`Fc3rTkZFZ)~#Cfhw zL#JUWMp_g}UjAseAW7WX_!+dFA;s4+h|MY;Q{nw9K|wZEmPkCZDk@|1HwcN~E&kXe z(v8~VJd}`%d0j?ZkSvu^|AxFEPn_0`-zEQ3eueFK~79cfl!rjDX`Xy$_GQ1D_B0ob0uY ztiwwaK{mi5h0g&v=Kbt2B{#udM5^hh=_mPziRrCoF(6~Ou=oA=VN{5aR}l(DnD}p1 zsv~+j3TBG3KT(d}mQmE7xAo#GSdmHz(QroUP2uK-%rZQeGM_rkhFu5^8blK2L&!Eg zyJ8$>C9ii>PxG&XRKLTI4qlzAt7EKqs3%8^#7J*2xaWh@^1!&PR)Qq^mzfgX9pTn7TFQ0vaG42j;}q+L|J&8Lkw}q z*GQ&oN55}N-<#oisOien){ks*^t=hd06m#U|xs*(`}OH=};Xd@&GU#oSo z?|d!9;Y})Gl>?mJMqP>4euW@-*+{cY^(9Qn<<%0$7VyAAL1fba88x4u3lgPl4i2 z$X`_1wkMSS#T)6~$dT~*9$S&+mANKu4J|%(9dpLXFh{6RMSw&g{t^v{_rk6)9QOyb zxU(oS-Q%CNdrj~mI%+J>P-K;Pl|stZiLP3-{NHOFaO6LksD zI>tQ5R8v-J$prN#o?2oqC%tyUq?ul(q|vqc_NAt$jphxy zBry*%Xq~K0&$spB3Yd3SYiXYo%SAg}0hKq`>5zEGqjI>jT9ksLIIa=p^$0gTB%^>I zZ$v#C{McQDH82&OlHrZ(c7yvA<-z^?D$}3*AL{&ul3F>ldKn^*%$X4+H*x_ZXg!Z7 z7D_*Kbm|atI1>Y{%V<$Q3_+Dm>jbhmf}ytjzUYPj0L3H``C{H6TyJ#%>iDLTNbin< znJS}`Yc=}qHpedtDuO~x*D47&zB^Jcv8ir?;2WRIA1{h^rl&Q4MzIjmFcFc|vFtwh zjF`F^&da}gm;V53H2FikS@X#qM!;4gc>srHab;k;~8aAs8Sj{QBAT25(C|D*`n! z3e^%2vdAs?06hS_KtsPtwgdD|iKV7*q$v}YsmpTt;j7f?M;#=wQ@9NpfVB_BnXT2h z{IL}WxDifC2cFBm)lIXpn`d;nO?6d7QbkcIXw=9zAunRAr={#I`Qp(_B{EyM3*}{X zW@)78moLk+nI)&JXlctLhVuP3+DC5Z2K>6q+IR>&GR8g_?-Eth5&NEo;j@WTMZM)u8G<_Q^s|o^7{D=c3vcsDu*i`({LCb zO})7m#4N-X*zKzCF#^RhR^?iUOVY^{l`6FIOB(#YnaN;DR@wXUGakyPOTk|PAzbIx zby|}w)6nKr^syx@LPwHQwZK&XFc_zJ)okUNZH8a(YUgJ4q#Mkk%TC;zs5~0^nchNFSCt ze3uaO65DucxCFv8==}3Gs-S6ee7%umn0ZqK{4v{*f2#{CQfPNn+yK4lVM_GwqsykA zvN}loh}DWT@~xKU{{V;j@I7h{i8ovdkfQqbD*9O|tFq~hKnfM!H{gamTzhrF7)UlF zlK8q)#*FcwQE9w}oL1!Y)Y)AevnZ%UR`c5Yt1E&Si~d*o;ygwHl^@l0;SkD&p?KB$ zuQ}FJJOzzBQpAl(B_wMLqOb%hQ~+>s)hcagSnO`NbEOKj4~G?+YNDev%_aW;Tw<#8 zV-D9O3%28aIkz{#xSU|AX6QlkT$bOt74)x%8iV3Ci#5%3%<v|mEU+Qp z=vC>vkO=AD0#>fx9~pbqQ|f+sHG{t8-DOUltbH7z%f`CV>doK?Y-Q)v1cT(Hnq zC@qzuC}*Bf;F6B3aL0};dW=)uMbyA(bhI=O@gz7BO@Q9y5!yK;T=~BxQ}dq{+MB~k z@{J#s(N${t{O2{wYja9?A#qtkj#VoWY#JqWJZ<3h!`gU8wx};I4Gn9KY1GU#PO%#H z#>?XQ7SyWYqq6MhM`cvna(YLaO6Pc_X}M603AAOoz55QBX<6;8?vi6I$7l*Bi0?^s zo$Hl_R8?9Ogd;~ja8TG?ay0Gl`~My z2w2_Mk`_bwSaHXD{V_#9bnL@dbr(`SQxY%ZA81F686z;=G5CGr4q@SLbGt8hq4Q9R z${B%JrEqLmA?irKICqM|j9X^JY8)@$Jiz)CIm-={qe9DD;zx_QHoB>XEV`Rd$1Ora zo`jkfI~Z>6Pq%C*;tggG2I?NMtCrl3U_p(Bu%xFhIflzYykzm>T!SppbvbsIt<8>W zUOrBqkw=?!vyj*PF^huD+X?WEIG{aRLX^Dbm<6UX+nk}XRY<%_%WoXDDDlEwM${Cv z*%eF`O-WG$R0AZFLUywW2jb~(rZ0Rxm!OgHgSx z(z!O3%XA%N^jSSjRXggVilVN$m5JFCi!$@cu^qjzrl$<7=Vo?UcdlCPMB9^)4nxBz^5lsTcUg(KBn}TJrY2_$Eg_}aX$D&yhj#1d zR0NppLVpcBOVu!Hs56=gpW#jAwHbC!~@+#fAmIRdEn>6COXYa`#;!tIWSl$3>BRv$T12wpGY>yfa&> zufO>*(`j^4;BHQw!uvXqvSt~FmtURcD;lIJKq@XGNn=L3hi2fOPhWfr=QK!Q@ak5>b(W6s=V45sq;7!F{Ptl*7;EaNm1C60Q~W1;q_ltrJD6hf-b8r zu)dYy!!Td8DUn~^4fyvK5;-aSK$kKKpP5-e<`du?TCJ|BEGT~S;! z2d_x$5HJfgn@A%34{}Bj@eE05fGnkIA!ZAZ&zjU^d7K4NoT9TgSLd7iVOuk`xq|Hy zax8`NdOA85q@=3Lu0=gWbE`<9PvKy_Eq?d{wOquzGr`_;E4`F2Qe-}MZCjS3R?tZC zhq9CM`wjhf9l8Ve7&47e7#v{VWyVG0!l|qD9#5IpW?6xzHG$(;=9l#-!a}Ncw@}?h zvF1I45azX_;Dg&8i^la=_Ml9mt_BdMsWr)m|O$)pjWSgFV2+ayD!tS|3~Y2s-L zZUA1{yY9M#anH2;8GS0gVVcA$CSoKok1QMV2p-(=g%qn7m}_hlx&;!`884Rg4J;wa zEQuoCeA7E#Sc$S#S)ldV5yZ&znfo7fLwy86B3x+xX+!)J9ut z`WIlSrdrg4FiJUL@?#C=qm#K^Slo}L#s#S{BUn-boAoB68c#NwsUS)6=3*j?@Tj== z`{TM4`exr=e3u3#LURpcmq@W@5Y%m+M^Ivf+sjaI*T40CcrBQ6Ew5_qJR_j-d1!L_ zdWw14p%Q3hB2oD7!wubtwh$f~DiRLzkELHJkgxWahfnyImL$}auFyR)%`-VB&u&)Z zsN=pfinLup<)V7BZP>23dV;HciRP0n8=KAjs}aT^kVW-eI6#$Nb@z-_)H&G8GP|Wo zrgIokb=(cW#m51{!QbeyX-=O;tyzs`C0AzMUx8vob23%p@IdKDe>bplJf)WKO6e;GAhPZA#`$ z+MLrx5~CxSpY{8bl1lc+hNVAH>Q{kGvdWCfX3BFKNTaN%xmoHhW{p@}U-z5_@X!lg zVQBB!N)oK^J}Kg`jsJUns45savP|ZGokX*WmzY3s|;t- zN7n~T9?jG;pfpp`oa+01AO-EBCK_PN%`*xdm zzrS2W4&0RPFo!u^Lu7iQIVtAg$`~8m6gXi}XJ>B8Fj4;iS@>O@>V<-AmY7RVAW5Hb zuqUsl>(>bAW0^$5j2#Dx?bOM-NIVOhUuoRaR_WZnc&hRVQl7Snn(s8J!7+i)Kzd+- zkLVrIxXVubrApdXM12?fOHyUOH#9QQ(?qt6NZX3YgKoxC$TuDEw-8%R(K2^F`?hOuIjWojcR z3P@qdBdH7N#vuGQAlG$5z|z*(i0ei7?@zi=;R+Y0s>YJmIfjYVRbFmgF6E-FMg>fA zjmlVeZpQqaGO9f$i)+#yU}f4^x7HTrC~#oGL0w&`XuK<-l94HDDRq?@j1dORERN zxi6?vJpTYapv_>dH8M3taVxTQ8&r?4z4*lRX*q;)yrJBrUKQ#5%TQ*Jttysf1&RS+ z%C;mQd-TBA>dmIoNsVs1q}fN!X-7*@sIsbhIyrLcsgrY4ucyf|rOmziUkNazwwWdz z+0^#RAec{DBgAQ{Dv~0sg+^N<|lAd5#Ry&VhmmcWrpPgQ{(#=bn8Z_#Getm zb0#^x1tV3_r1sGgeQPhs#s25j5<$(nb?plH$V+1;)-}{L#?um z=Sm8iy-6f)l_7yNv7|*vLcD^k+khQy^u?bMg7l)tHQ8Fh7uQ|AkbDsBsU5STDR>9t z)=8J>%Dp2|oz&@lP@K?b(_UdaZzV(dpRz0zujktp-Z{Y?Qn0O*RHdV+w_tUTc}8Ke z05&voA!y$dJV0qqZ>u$I+08W+zbiF04O|ILR^>x3<&8-o`=6*C4g$sStTS8DQKl)E zK?K~lk&WU?k+mJUm{AWHt2HN#v@1nZqP|x#rJbrW`nVjGhLMK$M{)+@SKFnJz7OFv zY4GzRp>Qx94(=O)wy1jUH3iiK%GF}3lgnZ%<9QbE_(@WGceTHcFV!wDq1%#7-b!hi zYv40DQl#Hy_&AvEf3D_KAQ52dg(Yc~(oHXQjb;&jzP^E{I<(NhU?Xio~c?MasB zxm<`VXs1_?%?#0&1g)J^g35b~;JWmMW)OEpX0)S+h<-ZiEp4eM&a-bRWO|gVi6aV9 z2MMsOdq4p{#kI$|!diG1v9Q~7QS_3XJTdW1<(?lQqV5g)Y*krMNOD|oW4WNxz_umLI&%19E>N#gGh9nN|}$%Wbct^EYcj<(dTuMRb@{u z$g1OAyF1;7YjJPS5gbz-02;32DiL^rlgpqgbq#FPV=`*L)KFBT7ua0w3{Z8rHXhh> zNAJ+yS15N>LhO%RSLlr$sx(b)B&{ZUG!m?H$9QA%$zm?u8;gr!q5I*?4Tq8@kxTqM z&1gJ3lB%AoFN#?+N_T_KByWe!;E+c{{!9;2p{sq7Bqdscs-q{4o=m!}<$?(OvH;zG zzq#iFv%d<%`qp-{3NmGfr-mN9b;t_sU)%I+M6nRy2xZnDe8V+ zMZLg4P>(jAmGt%^(*Rw`>#W)aig+ zbt*Y1X_o3N_DwCHQ8W_N)W=ayh|Z+g$0&A;f!^IPbLg|AYqp1dRS!!RPjM>vnz>ah zFjU1f5xK9Vk;=&~>+Mwspcei(h>t~`v9) zz?f@vO)gE9O)%6H*^l?dnE7>7p+lewSf{0~c*1-y7Xq$#`lYe$(MnlmAJKjrW!m>n z&z@zu$)e0M_mZAgXv~Ps7X?ZZ4Y;?r9Ams*J=i*-g|Zw09mRYY92E1xe-ATCnyM_r zJIvxV)O7|}+DJrfq+Z1dCyp?`i(}ZpSio}@n-2vgHpb}VEgqlF>+?GLeIrLLOe~Tv zW)wV*<*ZHDkxi?s4nkPgT*pUJ9n9N#^vmoIwRY9bLmA^>;8a#rAR z#s2>IveD?PF`zpr4zs&=_MqGdC`(_aH9Yd=wHan!YI8b^6;_ASOr@>0kFXeW+)XeY zn!s<)H&7YXPc>x}n#PT?-0~=3tIHK(cA!)norS%2>HeHA!x2E{VR38zSCaU;P-*-( z&a^gfPT6K*`bLdl6(lQ%F+U@aI#`T27`EbBahGoJHTSQ9BSkc!@m7mAqm~_Wnp9Iw z0?NtdAtm0{RpYlz1ndS!14XtZT@ot*E~rL#m(&_siumZ{6mL@^#WN`Yvm4moxfr|B zaM0@lP)#!FP;j?)UI$UnL4wLOl(`*gtU`usdtUhF5aec4odcqx*SU)2P|WLFQE^WS zt;@+`K>iqtqssz{quotIGu*0Nj<%|Xp-N3o?GvHu8BK`9jCNrtif=9wq}o>?&-3ID zm1WY^LrXMrGsd^tK^PjfR#WwiFM2G-%E;?26G^Qn&2vn_%oUW>NihyKhae9~`r%DH zVHzDu;gkymg?54)3muwZ9EN6 zK^SHVHZj^byJDvHjOD}QSS|rkZ5xzT=$hK>=DsQ!sVh}pnkTfIKNsOAp*QB zO@m*X;lt@Q!WX8HDf+WMsnvBfX(cks(Y2LSS&r{=Ikz0*Ceai@x{Nm}JLz8zHI7k{ zW*MbIQi?$gtw~JN#?!o{jutP)YhROqD%4|$+V@fbqxt4hm*?3wp3f((G2HiNvl%LU(!Ei}l!f@48RN2m71pfe}7Ed892#xMa^*0}%7>a|-Ol3pV z00kS;)U_JlGo#C4aZBh6cq~A}7I0Np_)FEgPkE7Llly zvo4Wi%j#g;EIbh*Hv}8@`(ZVD%&Z`bu7E00L73;Y`lgE}uYqHsH0`=n1tE4L@e+No zGnq}a%f-x(H4(j#Y2%Y5)OC3-XPn0lRV1FdFS$07)&SwW=U{kjx)cN=hGD3up^7|{ zAj%xlh}6Yez!;<#?SH-(HjpPf-Er}GDJ4QB*Mm<@HbGHIEmb5zr}=4@(-hL%b1vU| z4!+nd;qwf^Owy#;hOC}wXz67Llu*VPO~S~e_BQtId_dX}CsI_BqdJDRX(($dDQaFx zB8Al?^EVU6Pp4c@Nw>d>>A^t!1krvX=J~E;p6EJU#-ghsRI9CAx}-xiaFzhG0_(j= z;IB8s9wAbYXk+5w#EV-~J8kv~X35iKXSHs-&8O4)h8*^=!KgF&AcHWPokS}=8UT_* zDu-`SKtbuy;;o0n4DB?*ENF3PCVJMq_QLJVo3A>4x*rKElk{aUnvSN81wCDXzTg2{ zpKh4uyAC`}rGUs4A$97@ZscE&rX{6^=v$XT zY~9yV6U{BxIh{_D%&0TkAhfk|QLI(e=cMC{GcR+~pROUoGp1=_xDGja$712e5f4T9 zzV%dkQcSv{YOzBrr1=y{VB6bNH zm%9*VJJxpVy)8?rwXUGc^%j3arzxprGa7Z3qylM&n9;(@r_3Oea!BVE{4H}%iw!op z^4oHWFjC=jFqyR%g%r9-L7U4JT~@g)Qf24H=Q2zjv$$aJ= zQhyG0MpZ?bGG%m?8_|iOf<##x%=TkrZ@+9wi=y|ltVe7vm|)piT(4VDc%2PodG1h@ zQbNX(Wu#Ce^#1@%04~S5!Yb4qhjg^flR1?U&oa7QKbSzYatdmCc*@5e_C!^OQ|x%b zR9$q5VBmj(YY(93?}zwIKx3h;fam~nnU(WGcks4^=GjcOvOtvWo>3U&r(zrC zp$%X`JNrk=L^J8C&6nu> z(z7s*p01tZi+$v%3w?s-=H2>X+wlzzk#ctCq6|f>qbG|dhC`R;6B7)(mZ16p0Q+HM z-jAMTB>^ZbIi7y1)nfO0ft&B10YD)9=%Dp>uh;N zucY7z%HnO?&3suZC9iWFs#VK1d()%RK#LkO4@`wD0-vz{c$*5x4AjZ%W-1faQP?%M zSDwWzjNd9BY>L<1pxklv!G{d$cGTWfQ8!W@Qx=-k^mH<28QRcRWr`j-qa4^9^Yk_s zz_hwbM$M4ze%>pib@L$2broE7HL}bqsFF5#?kw^F_*s639oDACoVp#?lA*EJ*6IqF ze@sx%OH9mLeXqs~${FgNmmy2F=CK-kD}f-EQ?y2~n_JU<{{X`RVQ}3mi9NEsbCAb1 z(>cy>oKtP4j8sofD-7=2Pn2v4`tAO_Fl|<~ldvnmQlXS*nsU6;)`8{uH-ez@kGqfo z$06*fE#kf|Q2fIw&hnZW^NPxt%u|xaHImjhqFH#*>p5@ce`ZF~oOrraNvX-}|*y|3%8HY8))oGhE5YyDs#GJH* zvtH)F@oYW}lQOw$Iilx=>6+&B?@N`+W{sE$Dclc5ziQ-gI^2Rj$FkgBR$bQZMbZXg zYA1kR6YHu_xA&haIUg9h} z1cFa!({*{_V4D?SwAQ!NT7nGLt{n2Vn9vC%H2(lCD(^)$0gEDw->}_b+}{;8;CeCE zaRmCX=DJ5|X(Dc{hmaCCUh>UF9;}J!;i*&=P8DRF>?+o|0JnQ!P{$LH<-X@jbMKYI z+6BTL>+M%r;cY4!%<>nYGwu0_rjPYYC5Hui+THNq3xznBWDV2ew?w9`KrV+lSBaSx zc{J3N+3XEGWXb1=)TxY*#nf@{f@*N;l)A;Pi}i0d$Y;*!a`?`_$;!6x zHDi)E-O%+GVr)R}J@7ji)*RVj+B4?2e^t8psY{AinCJ$|De37lsaB?xCh1WG z-xD4FVf2DHClZISY=)^)%D(D+nWE3DCe9&bT41V^z;0YM@5j@RwefAj)tX>1i}UPN zx`OC`ocMc~WwnN3+G5V&Y+SdYd*_rGs^2UCbvbhHta#=VQ+&@P-Zy)l;L;di8_ZJqiIGxpjtHfTWk#718**N`m$D{O$*Z!c;mh;A z0WM`nB0tMHrJ0fMZ(M8{M;*ERjs(e1)(?g5Swx)&;FSe!MMYk1NPb=59#mE-Ejer7 za3`qy54r548N|&o4L4n~loVgn&}xjNPmtwL98{EwQl4q!-R4Gn6NMGcGuLrBj70v#F_yzy2={JAg*Tucocdb{YW3R_V0lygHgsNBE;;yF3Ny9=CTT^eLWm_=0l3-&bmOJ5Sj6BM;S~dCpEWBg z@>VZFX^lVPCVg35o97e9UX%+~W0p@WJi&x&vAxG3t;f`2yN<5>BLHJTZeT1X$J~o& zSu^TN9Jfv8*@Y%^BI-Qiik#I+OPN6H8brt%IK+{@=3)(j9DCrZ1=X4he)huRCT8G! z2D`6}H?<4=QSj4LOG3Jmw?_W}YgE~k@fabyd2&Z0-5Cic`>k`|k%m|-RWL;`{O~pQ z_00q*8=DH$d?o3O$HZ-WmgxMGH2o7@nL|I9 zR?4mA2v>VDt8iM~FoTPADdr`-7WM8`;ns=Gvi(C_lhW53 zy!t|vA)e(b5<=dc=m&01@UIHS;TYNPPP7}^&MsLE z@9JUSoBnu{3t6_NP2gEelXOw=L&QxO*+pKT)|9m~{Nq2BRRAwEZhrtI{>eRl*jvQ# zb&JF4S~VQU^Le5eMui0R6cbNTo6}Op^-;kiDtcJ5#-tEzy!8CA-igqY7QZP9Bd(e& zU7>thuGZR0OtKtfe`|Ikhtg zL@gs#nAbi_lSQA@X7xFvc~49?q);=9ZX3A(U%y;0#Wj?(RC5}@!J9Vcv&DQbWd+n9 z4745&Rn40ChpA08Fi#*vq+Qd^&BBF#Iv%()3CGV70l0Qtv`&9i1N#tlaQzvR;DbIN zQ|H-MdzR;PnI&rFbrq~B=P@`_8#z?msX$t3;~+l`OY1G^ULbi`UTD78I>$e>qy_z zDwVZ^cd`BU#I9?e&ZUWhxa~>4dL7SBA@b2>c7@b!ZLD}wJMqWmjxt(8fj zXRpxNHff|XI=uT$NAnXTIeVsv399KNG7 zrc0|Z-n&NtUtsqi#{dS0jLmC_mE4hK0ME3{y2CF>;?@x6a5IzWi^?#SKZgGP=jnr} z*63ZBu(Zbet_TQusWYIlcD2iD2`d4|lJ4av$!)gW^2%FBRygRcM52e!7x%?3=J2bN-OwzI+ z!a*eCqfoIL0!yUy|$Cf<$e{jcjUASKn2&0)~G&(;rc7k6bXjB40 zAY>c^RmuU(!<`iUQ4dwa6W@23Zlh>Lo9r%H^%isdF@}^L({3()nq1jFmk; zV?=M05`Sazk@W)&-uMORRSNd|Ell*lc{__8jwpaJU|Xx$${9dz9{}B~7&_ zj(R^t(8U&6mb);GQEB;(AuWI`Ty?^#93HKAOWY!N?c};OfDjZhUr~KrdGX* zTm|339QEykYw!mjRmKN3z{El(=enFhr{1oLlAAD=GNu^p8b;mLK1k{hY%QgQ`|J`& zXzbm4(k5*wr}8R#YUnF;Y#A!mC!aGYWuBh=?@@DpP0!e3Y*lB-EUIcj)aZK`VZjYG z>^jRtwtvQO&iBIEw!Oi+6i{J@7{!#WA@{OJoSjbQ)@;qGsyP9G5Px zOx7&#FqPDxo7QrTW@ zBU-XZ>QbhiqgcV-j)v!<>IdBRUrn^3%`OgL&;VNL?FW*L#Gf=K%=~Z8G?rr~Nl8b& zTBcu^mUvlrmnDf(-EZ{6)^LVbW^*H|AU8-tJ^4`IDWk2;a}7b57+O!6Ei916ZDIiB zMjKTjjca7s4OA&ck&)K6Pdam#Q%SZtB$NB&O3w0pmX24@j`15%z=%mvg0CC}r7Q)%_lVg`b`j-XGufD!Ei#f`g; z_;E}cZ|O#aST7v?l~?f_O3`Ut#8OdaD_lIaX(Ud8`;W^OEG2VUxrl`=7n5VMWYQUg z8CGdaRaHzXA&su_5pd$xwg{@+!WXs1V6EPp@Y5yFggV10%_qvGoJ%B8$Hb5_f~Rlp z!V`&ePD5}CjF=Fq#%}?VsBmo~vwv>8* zGSJjii$f(YcSP$W%_M-v{zx351fN%2S9)gROdg}Q3JkeW{c};`1vN~qlRjNTm%2*} z7TvjHJc0Bd*Mmbn8ZRZ*Tsc?GRh4GCj;r*PG|eS7OFF@@U3LRtNA=;=8jYo6wTj`Q z5g#t4mp9VT_(t9gt^R>Bq?>mZvXvD^un9&UxQrH(7nK%7tw9J5RMl z>U)JDt@!W}KDx7YH) z?)%{mL%hO!(YnT>Y`&)GnTRe}+87P=lFAQL%n&rB{Tx-Bw>!ol(+{ zmW_?m%uyh>;%hgz(;f_CK>)8?Dn+NXEk;KjCT~w(wDCArkTX~iKNsBKYS@8Lmc*UA z7h+Muhs6A^Gm+?;s8dkW9qTC%O68m{0X$A{W3T}wv>pQ+Q?rd>+S^A!1mW%VW*oLmdK#usA_x~hwW7WDpGOn5c(Nqbi%H&wg zs|???#E(jr0N7i$EchD6IyV3u8LnK8J?+?m7trmZ2CH{NFAcI))>*V!CRdm)Q&CuC zXlhw8%dN_#a=(9OCNqEzahb2n`?%+V36<+CqF$!zS*npf4;)C}=O zHg`i+Q}cqdHE=^mBXnE(hxxHzt3dIlx|?7YH>mi_1YQW+OLn7L?ugFYt$2=Y0hMI* z7211IWf^?3QL7|vRSNmwpx~(Ib;$?qiZeJ_aTPPWK2ss?bEa&4Z3)UWM!L9+p?-h! z%@+o1;!dQCO-=evD!R#Lf?8)P(bP&yx`!P$u{Jo@X<~~o>@@~lq6j}EXit)_RAifK ztTv?ZzeiB%VV7r7M-Hd8r}>+$NiSdx&r*5=-uOd@$JMD?S$bP?=405nsYn4QR5ycA z$C_o?CYjV`S@Qgl7*d@@!6->qZ|N23^!)JC(Zd|-wCw7T?`(u2e27B5N0?Q|nbYPv zN+C!I*&Cu*hP|%d*ks0aVx`LZoP%W9u5})DP4bgbJhYjKVzn&`D2}1n55yP0TVLGb zTs0;-K@v7ZW>Z?KN~$_KL7Y{5-<=8;iN6vT1JZuj6gW8bL;$|bx}>#1T9Q*w4(MHI zuE9<1!jgNQEsux-@gs1eA$ijJUVS@5nP+*M5GjhaWi&1fk*T$vfani4_p$cJHR}hE z&?a;%q9iFzG?`C`wDpwjo>oR8eepsRG*ZMsAzJ;o=GYziu=mOd=63B~jTEfttd^T5 zkMu@cO_x>%dlKGh{hPI$vvvalj6;jabBlybo_xF%u!VY$AOa7N}#Pg5XcFdQiSBzMhvlh9t~dI*4IdnwDn0Jn)i6*%$g& z{nx`cJ2O87nVv;^NJ&n0dKwBz>5iJz29mNU_a;|R%CL@EoW&ya9RLU49@E5T_1iy% z*|IY#u-d*n(=+g^D2Frh{K=+yWHF7--dRu@PjD_mpT0P2gh;xk~|K>g{{ta&rk#xF`lyL7vs-`P5KJ9KR+Woxyu6zc$)^@MGN8HK&;fCbW{Q zo?W8rv&_FF%V!YNv49!rQahRd0HQ7ZAb)-FU4AGr&LZY)c_Q+~ls8hXR%?-+AD86j zhJv1{4Md(@rfC(uN((+z`Hct9~!|HfnDa-T6rx`9(fgYxICDunEyEVHlh9Iqr&6&&umkkGJ?NhOc zM_;a~qOI1tXC0^hJQN?al(BhKys>(xkbBv}#O6OjKj_47}RS?nmyxG%56&PmZg?VM2epy#z@_ zA&KUKQL;onvk)h(zL+Rrir~5syHd@lwNqx)uu2|{To{b8>?L`yUw`yrjRvxb1nYTU zOr;QHIh$l{RjMl4V9TRXPJy<_(T~_C+Z>9GW1)iPWpI#n#U=vY0`BX}gr4y1$ zgdK?L4muP?3mr=BMKYZ3I?AeubDX{9R#H5&Snb=~e*6(pmX?_9UnlrzD)QPNn5NVa zoU(1mDff{iByubdTt%2T!5waV*M$PJOxmWlSvS=gg30N2>TSR_?b8k!P6nE(8pR{i z8ClP35x2(tpmjY@za8*3dYK1q%fQJ*00uM*R8EHCAsjKyxbOzTR4^U+7!lQ)>k&@-=5s*r>ir9& zTHE+0itSrO^d45O@RKZfi#RaPCi^bZ!H&|(r2B5;6E*Fk?x1Y*ZgvCopKXxj=iKs=TRFtECsy6hum?7M;}%FQeHVMEShT4(y9G3{dWrXt=@x_@+RgDfX7qR~0qvjOG5 zpBpJ)FSM=3)*Z$?7)F>Gn=&ADk>n*n`u0&+yhY2`Sjm{owNX;ltThr+^R^_6Y;bH% z-;7RhlF&#USKbV3@6iNnO6jO|PlwsfR%2C`&{sg!w9-O>feXn#y{Dsld*IH6%+un! zMdb$f0;{H=k3U+NDKeipl8)3~d34XF%gK#P_mTGL*GL6;O5gcum)FJQ4fw&b+%p zqmgRWMQ0RTBj{l>r0PP?KPO*kwZw93<}x*A;TS0r88(4Bmk<+Iq2B zr)i-nRZjEAcobXpp1wy@)2ke6YBNU5p2ycUuw2!v|of#%{1&W+{s- z&g-VCuWe74H3b|mx*34=$Is*HewM)wq9Al-re;Sq#PdjXc25>!lvUJuon>}jszmh> zAuQ-mdv_P&{{UQfhpJdeA)xYJl`6?}-8Q0ppE{;8Qc%JAnHDI7Q{6owoDt0!FGdd)zmOFt@M0lujdTv$xB=LM^yhn^Vl^n-302oM{%dHSM z?nTqXNbgVdxo(>9tHr9^tzfOx88%-Z%;mMvfmbn>`;n$tK~jK=H?b!izN_)rVBm5& z&JA;1+=FX)@=}hY{1Au5KN)i095uFgtY|1D$Sbp0;99yvVv6uC!0`eFy$S&a9w|vLr*al=8q{g2(lD z3ovxpe)in1Gj-V{>XlVwu;)2meVoNSDU-!K8){}>@Mfg&ipV!M!p84m*mG_; z6|%T84sNjka}n>A!DjRJD*bpn@WYe%X{Y1Vd46QI`i^)V=quJ!98sj|Rb@mfA8@%F zugC|3jI)Y;)6~V*G>b^2)7PEI)CAU^4Yb=kojg@@si&gwM>wg|-Yn$w^*MfL1yxeZ zleD6~stKHe=_ysYFVf?Keoij5+<2`qR|?}TEwlYVM%p{vmDO)V=yDEtqv2kLrO&88 zwI!{}^4a32nO?qgP@Z(ddPb}|wTaz+jeJ-zTtclz6IUypBoI418{uRPMuKdf73R~m zwRv`Ho~;Zzk1mpuHrwVxidSvQH$p(`fu9vXcy41&!PBSH_LVC+PO4p{ejN0smzz#! zIbOD+%GPG4%EID zYpkDHX=r~)WyxBz8O$p@dmXmysEG1-V|#JHzicENZjLgOs8l%~8=*N}y}|Imf@A2V zu6&6b@6jaEOy;Sl!S>6To3*2tMHUkwux%_MKr_iwk zx!ro9&ND1*0NmX9c&>4D!#eHkRcabtQKRc1&#Gkk9O9_8RUU0lPzsI9c4S53;G1In z<3|+3NC0Vo8tQJ?gEu>+4kdQDt?trlzf&1gN5!QKAf^ z_Jad|z8vsu190^!8bCFV0szoJBk7bDCa!p$Z{(o)O=fwj@+tECqgPeIPe&we1q;ox z6_JgsoQreU^1+oF%1#B$nHO|Q7+fIUuG89sCazS}vKnfNf(tzIteb%(2D)xGHu`>j zn&Im)f*kfLiaN})c)Zb7PgN5Ix9qZRE)V1{&$c_G#2W6Y z1R32B*JZL5QqMfbDCt0mg|RDeSP$ZF^}_s(z``Rd7?snV@N6B!;q^q2q&m z4lx1URnB`aZ7n2}fzABoZM#C;*n@NVagJIYF}LVY<@!~__)zgf#BCK*n8Bm7!AVa5 ze?Wl03i*<(~s>EtGl6QGHfJWx2J_OWbox`4zqmk zEUt_QGQZOmQNSf)6Kg3>4VSh50ILJiq~WWwUL%+r{VUADMsq3%YVulIth5ZeW|byr zBo@0~`#&-U3S-E52I4GNg-;>Uxh-uTTRvkMrjnFP`o2D0T5raA?oI(U-U$u7`F_>Z zN_T@oW!YDs4qG%;lr<`nBBKIgkP8#XOaA~?A$Ba(^{pDO9L%bDIh!}r($Gapzoco% z2%)bg)wP&=bi(%aD&}$OAAZU*EShw_Yn164$bMpBTl1NHQ%e{4NfNVx7UlK?l785q z5Xa&MnPKg};NE?~c*`MfQ=jD&)tL^V&R~k7dMN7YvjuXi9a_jpzpMTe9WB!544*~r z4r5J>7WPE@=jc3nXL)i7X=nxgEOV77WHovf<*&1(4+QnY5<9re&U3 zqie$_D(2(2<$|g_v_KY1NKwxTG!+(QuCx5xI;L5vDQV|;>EdmSv$FoE+u3YzRyP%r zi(1nJxCx23l8O;6M7}abmC#jZ@X0zmO%)6jr+hKTe_O~pi(DKoBw&efZN5~@&$&co zr1`!{s=jMaWI1BPMMCp_x?QHqFT)l+I2RwDKBrQgIp*dq^sX|JrIf6`9cryv3sRPg zP*cLqRGzOUctIYM{{RkkKXHLf<0&xdk;myH^eF+zzU4kXRd{g*WhG?|HGCEHa?wc@ zNE;a#?%WCJ!=OE_i5hmb^wtV_89we`$u% z*4OLb2GqpUX$)~C+7d)ha^e?Ekkab7eoHfqi0`^N7C&0si*5G4J*W*cEnXBJugl)bnMd7v~tD+i8m8_5z^m$Lstsgy6JTg zd@B`2;(boL`8vUxEfrNfQ$|dSb&@@x6>r_fE8ho2_a=#d+Ns`ylsbgRUF(;5?1y_0FZyh2i5Pi zW84er;^`Q0aSb*bxNYLRs1LP4JV4Ekn$D!lYF1g{gofQB5VIp#qp2N33mhAQXH39G zq(pKfQS`1}?560$RNfh~X`JgXtjx0-sfk(Akw{88)kg0zPvTGwzMq~Ffr)l@9IXIq z?o)W}UpTi_+Ox#X2TP|jDh);9tzCY7QCB=r=1|n^SYsslN9$qDuuVK2S3X-%2HGc> z7ahy)lttAo*4j%WqmR#_s+L)2Lgp#svmK_!Cjg@F=F4t_9JF-yI-&yUO+ixvMV!!O>e5#-G|vNC+@7o6_~f`A zq1(^)DH)DW-y^zL@;Hk*4-R%wvIjb~syxpd3sajTGdieg$hy9k2DSLzZS{ zj*}~(q^kM3^Cl6j^D`)p%*96+H@O$Mz+85Pd_EoSrx! zai4T%o68u&dfB?#f^`V0cv%v%tHsR9sAttHNnUDb@`+lKl2s%T6lTgSdV_Ag@vLz6 z41z>C;1lANIx`TVI)^n(<)W-+2_r@Xfdz%ff6oR|W=kjzsaA*7G}>yiI+GUmJO+M( z_~#K#&kM(bbww>p;*M9CX~xN8qGMDl490LsP^Yrn0aC%aubJ6!8i+bqOs091WT4k2 zZe2~bO2n}aq~7WY?}fFiWG2vdUiKo6x$t{O>D;+w$|`N^T5As5r%oGe~3l9v`{^{P)j?fN-WMy%Tv=gkm5B0p24@9 z_U-(z&YxMaPA8FGD}(UeXBY?_!p{ zxfo53!H2guMVS0x*EyuY5IU`V@3K0LL|=Vr;Ur%ONKH_yZK7gvHgw)UA}$q%wn;gDn7q)e)H70bvk%riP;fL~C_f^>(N5 z)5L7mbE?fUa(RNfNhLIc%9=z3G4jHCShdf&xxOvn+J#rswtiq<@l#qi3O9<4_QRd#1( zv9_KbVL;=_3$tB1nXX|jXO+@Ov{9nUNIOv5)NTImFu|2_011*zE(Mg;^FQs3>YY!j zV&6uZXEC73p`Coi`KA_um)V1XfmujV%TAxI(}M5CyspHZRVCAzMrE7knPm+mF11C{ zIF*@*4944r?)>x^x7MoGG`eknG(3}FuWnVJWF8D;I+ITPzs%|wYGZL#5VO+E%j#SE zi-K`ReHxhOvZVd*E!(la{oZPDat_^)-iI))*Hv<@ZByo%#Ti+=`i2B7A7lL-H#FOa z76q*`AZaOku5Y@QX0(}|JzRAQQ%_YzNIdf*C=xSRdQH8%Vj53r8XU)~bpx$EinnKe zB30>})~#qjXeWL1M&pnVB|+_n)bN6lFg(9}@QY4V*z zPg9rDRzQgjN1FuGb(vG~BK^hizL_i_kYu(jr6Lg-FbD4i-(>AQFqs=Lag=z2SG`z&BqmnVp$e_~Gc{UxYK#^5yn6tL1rOIbBr95pT zRE4^OxC>jqe016dpIP=NZpG7zA5v)w+TBr>EU1~ZnWKD_94h`nN{N37X6zJP{cyz8 zmSt#&f_r-rR6>{4=qY8Y{?uw{K&x7Y%Z%Hu*FUz6-_^kTU{L$!*ZH>aM#7tFYW&KB z`&rUib;@On23pGZYp{@qk;v=G=J@TkGnMjzO+{6#^Q}dvvik8&HcKPJF6Bjyz~r#M zBz3k4%g}&M^9m=J3O7*}Pmt6@3bbZ0e^|l2O)$5p{%4Fv3#wo38=-T`Se4o4S*R!{ zsj8L*3?-+Wo2XlIKQWFnu+t&D{+-u(kvhJMGtXl4a@weTspSkA$PyMe1oPVXR36$# ztTbO6sOFu~QLb-O=T$USG(@bm3u2yQa(3J8&*g$^;-R({Ixkw;PdVf}Wl7lqSS!HDvWK|ih zL^(}FaR{WW%i1#}Ya)O>YH!yaVk_o&s6(s)c5Z#0i@?zeBTHYX=E)l-m4zKt4%G4) z7ju=3wt_e|;{4)Hjg5Y5nS*VonjPSqDvh7$9J-PW(zhqgYNf7@M>0ax?Fu>;JFU14 z*7q2-Q^c1*a2a-lBY}uQ%{rB_X7GHh1yB@S!)%-6{e3C}vp;n7+mpFGQ+opV|09x0$6wh)VKbw6Xz<&T)| zo~Bdk$L&%IXjwtxzH?1oLs?f)wM$5hBd4{K)H?P24!G!Uk`sv)YDebv^jNEJn_#wHVGWT zY+5zHTlF7oC4Mg`%cymSik+;4gInl&tqY{;b!$B_qt5D01sz1p45>QqnnARF5ws9J z?exU>cN*jXJyqk|3cgU%YcRVo7DZD)K z7gXgLj#mTZ=xU|NGcPE#n^}~kH(yS`rr4@ua=x2tG?x%EmY&TW;F;4mMk;M}8$ne| zS8dWr(j%jV5wRzW4%W4=imRwNgnni6ZA}bue9x9@8);BMJ$u}Y3d#pURGHyHYcuwZ zCG%o=BPv*@m`ERM;fpZS02{BmMBh)VR!HJhrUeav=Xc){93dOscb-$SXL2}qiAAln z8+615mo?#X;aO8w(bUEzP0FSC7Co`uHa0?pl@_LodEt4P+o>TNrOpo|0|5^5hPtwk zHG!*S%bJ*fd$Xx|KVGtqn^(Q?;|k`$&8A`WrSEbdQs&vu%VqWYf}$vVwX}@Swb=Bv zu*}kECA7reQ0D8DwORI8YFawuQI%E$G!+Mt9K?gLW45)Axe)PX9#Wb-NQS>Jg>_AR zVVgCD6cJ14O}4W7f2Hs5iEwUfzVsS0o81oa7g3EZtEJSmu)*h(QpnzGOTktD0CB-} zX!K@8cqmJyO6XD(43xA))K37m(tRv1at0!N%$>rHRd(?sE2zvh1jd4vbaaS2d5yx5 zIRof0=L+x}a-b&YOPJ?bqX>)1BM6UDEG|0R44F;7)hl4?qVmrD z3Ve_eZ${>jX`d!ns;Y%*DiBl}e^iE^$9BL-8~OB;)1F2Z*J-O`76vDp?wgi~_?M_W zHmIV~he_qRwFO*I3QWc7(UMBBv0fvw8PprIT<$xrI2OfLl@cUdd5(Lj-a%FBN~+He zD058SN+GhnjBwSu-bh%F!bjf)z{D1^eNYT@P!kEi!Yuy)HPkt+eQjM!)ufbf43Nxy z1sdS69j$D4#3;6#Kmrb6d!=y8qrO3>AjmQqvRa(lp)&bdrHN6tg)D9X_XD;P)UIk& zk#Z(au@MScOBEdrEH!jlr9D+I%`vwm8=bn0L!tEL45KmLkWTC*R^4dU_qD#f;(tha zwcuLIkPyQ;{X3pj%PZ!2d;%lnqT1x5bY}XS^Ml#Z(-1?HZfgJ4O+`gV;U1TpOTkqg zJ4D7I3yZZ(vVH);y*9P)?TiW!5UkqSN%+9-(Rub-6U@S!a)j;S_KV59AE4K|&VsI) zs&kCJsJx|_U1{fyKMltKG3-6CE;oo&$5f?5E1{0eNzky7f620rpHLII(Ps$JIj4=e zr8P}1O%7e0d7_qNflM^gyk^1JpXmX~#-{93ICDrYE@Vh98HgOC+?P{fdF{F~=RXfV zBWR4~lAgau(pJ-X0%wswT}b>`qRIU{Afd-_xTX@?k$8eKx^|K7@kKh5n1@vw=Q7l~ zuT5!uzfICp(&ZKO^2wJ@ElpI&)@7XcM(BNo@YrD6N}K9A=QG$qc=emex3=m7R!T2? zM0`Nh(Rja><{1qfd1Wr0%izl+iU~eq4T|1lk0W|rQO?jW%G(I|PXlF4Bij3#&ovwc zy56ZXu{l9KrFT~s4iTtT%i=HM4?6MZHp*K)ijVzf4wSWYbl)yrTm!Y!d)mZwzZ~M# z!gyOadkA54IxOqNPKSL`{6-+vGEj1>T4uVIlA9~5l#xpyVI*UK6boPNhN6RM9OHdZ zz!IP6A@9t#vk6PjbxGv|{Q%K5#4C%1{N1%pzLCqZ(6K*65klsEeSfnVxXH zN`c2eL3?1T^aXuL>WC7GX^j=(@bkp%&XMx!+?Jwhy2?7JDyitEot7Ec^^ME=KyBT9 z?TSAT;moMlG2jNc7MC|r4&${MPN`{>TGc-lZ>gv?Hk#EM7NaZ8>eRrr_g95II~1xX zWoW^Etfgr*=lM1+I7%&f<&p|1 zQWjL=HgOn!*16;NH6;DLdkQ#g=p zR|LscZ{}&UZ8MtG9N$~@o#p=>rI9oFNn6^ylReP*vz>q={? z%!4D$V2V%gYT2WW8r#}Qdo8~#4Oddnu}9Ko4qYQUXaYJ1w*uZ%Ew^D zAISb#hOH`ZY@IJ1>)>G@Go+)bT&S%qbxTs@e8g+IC1e1d$J}3xA*Gl|CrI{PO60>_ z*+!v?voEgA5nv$hiCb)&R^XBJ>4F)WnGS1ixCfeuX)QhaKR1kNoYXu8LP#Z((#M}j z`rxchY|Q)PZn=&~i>I>6tgAK7H4dTABGZ)Ab0UK;`yk_m_XL4|xWdduQ1*&++G-bU zHi*A+@D6HK4yVefLCW-AoN4RwMyby}Vxlz?)zeM_$WHFChI_5BGpIS>y0d_7Kq){m z4g^45W{m=cWg71+&4nx(-h!p5T4*JAie&PdGf=^p?mm;pKVmR-Y!llionku87VBN2 zFUwWNZecQbiQ!g`k1iR`m4nEniQzT$kv`_xBLGZlI0OUKcEq?2Ay^!hVa85ZL<1Vn z(F!NFbTXt_HipP_d=j=-GZm;CuJ7hZi`0c4-%iH(g03p1a|CF7JQ36eRsAh=RB29f zq!Pgdfu}MJjBa;y{rLBzz0*;2^{DHAPG!~EloYKt^i+(-IE;hT;&zohAeMiY&5=~; z>0SqwGdUKPR07?Z%OCj84QE&r@@~2|L@Ioy8YXc=NZy83QS<`D;Aaqh{@>WSg#9*6 z2%xW$re>y@ivqaTGcW;zEkq|Y-X`3id2jCE1V zWR;YH62Scq6!8YP6w<+XA$ZdZ=569cwX~Uq4O{J`l5rTTHU=dx=_Q9iG2I*pX%35l zG0qpxbf-+uJfzL)=`xqA0%|CPZBY~MSp}{e?`%a*k*6*n7|e29%7@nI9HU(qqN~m& ziDHgNhCr7MBL2xATXpUE;HKi8hwBE;#CCIELRCld@Y7KWx`}9Wh@)CsaS^pE(?Wc* z>_4OjQ{MjoOnFclAPmefXSIC`q?MIfJ#@>JFY4(^n5sI5W63}9t9|k50pqQ&lJKN@ zmZ2(XCaKNo4JLEutjb8(B&I!BC;M*r_KRS{47Eg5b1*Q}Qp+TugRl+VLATfQ{IFX! zQ4k7^Wx22De<2M_b~a)=?e@gaZ0x>i0W)gJYh|XA7^zptnpKoddww25{{TEoL;z%! z8|oZ0@S7WWL_Vr#|?tVQ4!Ih$fRqTdZfcQzsBx zbpVG>*Z7}7Pnl3uEn`Iz(+YaGNaZoYHi8+sA#Gs4Og1%}gE>e5IL(CJ+WV5%GEpl? z&}QBj(`0#GbdN9Mq_POxeG0CQ=YAl|AC@Es$cYwct zrY$&ZTVDX5=UuggYHWkjSG@5Bf5f9_*Nij`f~6Fo$k8;kOpD33Bqb9vl<#_R`kBcN zENs^O`0xo_fE}pOCyUg5ZEKrf?an$DU7I3hH;XyuTc@e?-5o)OmM3?*ej~ix;1h*w zotUBeEXL?@C1ldGGss(WZ$8BPoEZ?N3>pMV%QN=W+2&TKFHvPkc0#tf0>S?L;0l!b zCLd}KpvpW|+sSCN?JbrrS5v3xbEr@;6IH*e0Noi^_LyG7+w;Xu?qyeI4kCGWB4QKS zsH4aza!F>LX;(d3zbeE043wcaBM;dpccCPNv zIF{O4d4vF8;A*#(PWtu6b^9*e! z&|A^M#5xaqeK57m!&VJ7TJ}Ax12aT6$d(8)7; zf=7OoRSLZesz{AS?V4$B#>RX z4{L3=UU5%n-AkEMAsL!Zph@+d+5DTMjtCaasyC#*A2U4mwt|)+^Hmj9PZMSI`<|gG z(M*j{cJL8U6ZN((HTc76gUB>P;sJ5cAo>D)6dO$DG`e?F)#dqiUmj;qB|)c$&s+Kf z*dOb`m6~eO4sptIgB_?!l<$3!XT)C;DYWaRU6n#0mKQ#FRkVD5$MM44CJ@%^ILz26 zv(17c=v_mec$9-br^;G5a_zB6EDv{fRUVMN@D3u2aNS9npSRMdY@Yia2gdM5{#Z2XsrX`URaqvsi>DW$#V)ik(xX#7DxlB za?pSY4sEvA7YCl04;zT7h<0WHm_cmwkUhls!XlqlXxGFgZ6;NvJU;P%!-_$i)@gcg zlc1@kkUZ-{EJ7xRVvJOU+#6{ZR$s0wcs#&0g~T-KUF!!l$S1buI}x=2xgCo+BUYevZ^YtF%q&78%rVeKEb%1m*_|b7Ys11mTF~^-CMAL z1i>PElG=nyNBR<7N08TN88L=A#NbClhjixs!VXB|n{?wJbiEV9U8Dm$c&{Qwku%}j zR_9uFt+dT{lc2AfqDdY@nKzLC0EE~plw*EQ&`AFPBCa!rWpUC9j%Wws-Lti~Q&MpX z5Ag@&RO=>OkxO|r=xQioJG_>+Ha+dzj32?vx+!_SVgt01-Li(I-DNkQNa`ImM;2dK z49733qK>W;eW6{}@NcEcM0z1D-mmvxhr!#z;BG2fl^ZK(US5p*` zRMN35%2{lzw(q*#aD8fSsL5c5h`(m*jScila=!}o294DEJ5jD-OY(Wmas3>{!@rgZ z1I$i?Wx2n;AgRPD)}>OOQ!S_018LvJ7iO6k+hpBQQ$+dRwyVw=UP)$<8raY34O+je z)HvqcTkC=wIanD!t%2nN6fWICt0?nqvLmZO8mmEmSB>|wWEPob4t2oc;TpYjlot>{1M!Kc$}~sqKiRYsq<=x<1v|8 zkw@y(wZfC_j~z@K!iDt1mCE>k)p<5;NBTcfW%*N5Wl_A|ZAy_=>tn<=b@c;o$B%CH z+;$j;64GxI9iO#&Y6jT&CXC}(RO(2k%Q702pr)Cn`N&HV510EpZ|}wV>y83Sp&!aVYGSXH_IF=fiUyp8nzs}gNwvdCB(l-f^IaL1uO3`Li zI^QNatvXcYUT@ANYD|3PboK3$G0&diidQ|;wOrlZzrqNIju!K zWi?#&Zygc^R;QFX+zSEf7bK1_%7r5FYp$JGXn@-3Dyu3g9)-M`CJpap(lvWB;- zo-eoZ#Pmq`$LtVQDrQMXhwoiQM>b&11x19l9&1>%f3ydC z)7MaCxh8Q;`BaiO%*9k%N|<9ES~qUvo(F74RfWL0;O5#l?_RQ`*?8A=R2h2KCX>&n z%%esEdSpW$z}tf?cI-c%J;SuR4MwyMd#OvIA<=rHGRw5?Y5FdPC8KF$dc!p3>VrfG zH&gdE$JnX??*YW-gA>cKdfJLxN#cv=m9d^iWbxnRQ zNi#tI0JH_U_PF=OcL_+-b4YOOHf`R$szy^Cio4V3?5?M32qS_dkh~=NSV#@}{c&S8 z%WX23#Gn_AdbVuE?<(!>r2_2PCswZynU_pd-r(CKki1o6!fr>de~EuuCI&u{=B_2l-)y*Be=S2BIy zN-XGq2ebV-OPJ~$$z;kZGMN0?VW>ir2%6umLfjE!!0K=|FBBYdkGEnq)Quu1b#r`H z)0rh^m(UqTL766IsL|Ke)y5h&bd|x9CL`1d7wf<~abKlSQgP>%)A~FV#RR-@@fSvF zEf#bxoYOT_G33>2nl(*DYSb2&XOXc=@DzsW*7w6K8yvzPF_=fSLgOeqpfnO?*<>)3A}DMN)FV z`98L-oXss&8zeN+ZA+co*1+!iVu@D>(O`AeG!KO_rOaZeGRaVa2qs;^S8quB;3rax z1V(8{PN=UeiI-F?8Bz_h4V&Ia{gQ^`Z$0tY!?rrYPkb*4^XGD$zfaT7 z;uM0P`^ua#EbPd;91A{4r|tjji0mS$tknzkLxu%X(aY;H;S zy@$Py2WM7X+X3f4p+e>;CUZ|7UsoKo@dTriV;r(NY;;>#l0TLhQkOP2)F7RzdKCFS zNmDqb%w9N1MoD@pHtJ8;5%sDGJ*$ad+4iBxs-qFpRJCeuusB^*T-+iZ>KC z)w)W*ImzK%mW4`g-zjlzyRCI6wT>82sv6^%uUT?{8IFg{2(nH#a8zE%d`IH5W!u z6lKb9;MPHq)aEOwp0FnIDEVj~^<*$00zQVv0b}a9jmkx&FR8Q=iFCPEXJ3>(CTTd4 zl7H36qiHA~avk46#upd0kLvQek`!-K*RE3a13OsehEyeDg}+?gu2<{)a9$jAf?2HH zK=7-Nh?;{i&dn_iB`lQmYK#&&MU}2N7x&{2@YI7YZfz(-Di8WUILq={+G?o&Vwtv^ znJ&=Se$Vg0Qr9>|isn>fx$5$S9Vy!vEH$-XJb_ zpVv=QUp$kVN?2fwG~cWfFAZV&kKK&>2bP!tqfc(yr%G=-U98f5yM;vXZq&Hu9_Xw(-pPuT2#_CY`3slthb} zRtTKW3oixMNcm8E{#dZ#xL2T=E++j}ojZJxZ>^kIcdEIYQ^%LoR#Qb(GXo`zHHhVu zll5+I()Y!shd2a?<`4%|_YutU`U3JolUl-7Je3yfft(uiV;q+!RL>cwt)w+n6)v@b zh?1T)H+aA%;@@s@JQlhfEeck(Na%A4-8N)`mbr>mQ=-(w;Dp-Xw$py%_z}UiyfpAc z0}5r~{<6%xDVl86vdS6$ZZ9QeuBQ{n8oL6(Detr$w(n!x0phUD#*DH=Nq}NVg)1GF z>c{xOpX8n==GlH>p=Wl>Ws07TDkOoar&dVA)Hxs$Tg)eGj>6bYgrMvwBA|jg(&Hj7 zrgO7sgta=GS!rEemgZ2?R%XkmpXMT#Xc|I^5(Q+Lhy{Y!a&UVv^s7@Xmb0YRH0N(( z43g6&PP|N~n^$S<*IZAV!yaX;o+_9jfQZ&VBJsM|blqY5uoeZ~4M9W$mXv}{`L4Y; z6U_xYJg?2BiWnyIUP?r7Ex;@aD;F!ddE{RXacynl1oKdXD$8WPI_Dbdn>9?I!*|Xq zsp-URCR;$Vq;~X%o6=d0fa~?eX0Him9JIQ&P+SZ+#P=ea;^6>Fp*|zh>KwN+dTl|I zO_fvIn=5m7N=rb6|Pn1`@p`O!TgF za-713t&q;Bz_J#$;n4Hi*b==wz`_~UMQr=V3K3sT9z&KDl`%W-`G;UE%zwq^ z-*biZuqH0)(igF5LiLVZ%4(|0XwU>YN;)}VgXUdiHec{Ef)4S!>x7kqshKweWjID0 zzNaGfJN8}|u3Aql)0yUVsp=VH-&9SweMhMF{P6}K5bU{} z?9vG>-ytF=#utUDE@fMx@*KM$Ul3~BQED8rDUy7J@8q*cNm&aIW!r1wMz*a-JE0jV zxxnV#KZpjxW4>J?)Q5VYT zlxi%lmcC4;8oAPnc+xQ6h0(d>`;KwVN=_p_Ss<gN> zZ!rM4xA@p!S?zu12-Uslx^K#3nu{(;s5K|ZW*HpxQJewd4w-%87JK{#UtT`ME z5wdehwo-|fuPUBZs;;Msp#TykG`s2Dh!+FgamEK|*i3e#0a1NFn^kH}M_mqJ>;ASu zPf(UN1!Yp!1LIX%AcY?O6N4$OOsVS3ri$Lsv|P-5f%dw2ASl#l<8klHg5|^ zu)JZ_mPpFnC~H`c+;ItT4qOu`Cz<9{IYYrsUqZF=M<=15rrVA%;*B>vS-g%t&b&F(dA6IYkvBypT;@5Vk-Z@km2bGm-FkHZ z*b8{-y$3Q7(M2AXt`e^KV1M>ay>HL;;gg(d1=Cvyk)pM4MC9GuZk(^F2{L@X~Q{r>=t9zCK=h#*XMZlNW1@dGmz8RS)&#M2k2 zr4)$_sb&!NA5na9gJ5GJniD=HMCT3Eb5m+9H$_WAxprvPau{|=2v$)OpMBkJ^uaV~ z)FjA=j~!PAcF_wesU((Ft(7ehu=MqA{{Yp4f!TAG$k7&@lUQj8>tKeaZ_(2ELY@R^ zBs;xVDuAEzVOgvw)r)nx_I}kSNeCBP^BH`5B{M()Vv8cOl{fzY7z6kA!&X7ij|Bh* zREsFi<7!Z~F?qEGSR};qKBw)7>QlU^+(fHIqv~k2o`s7n&Z~17=F8=8E=;`yghl%z zKzc7;pIlclA=rA^o0jo8ypc_Z1zv_^+FG`6m52ME@{dn?81X{vx%XnQkRdIYp@q(U%CDZGqCZr}vTAMnc zXya)kVbPTjJgFbM6$}>)JtMkMO~Iz~xHCS;2ZJ3OR#6rBEwHZ%lzl7bElc#QYkN zrohtT;sjfs;d4^y{{Tnp87uNEww`?MmKanjieif#tH2j0xF+Ab5n^z`uP(@EnMG23 zg*bvZH3aeL#;a$ksCB1dPK58@z+K0!?k{Wr>7qJF^+7(!M1h{mHhfpnwR#g-XZmiU z0}S*PlEBgT7B?Tj<3qt>eIk=;Ppko4G-MaqL^CQGC}UNXhVHvhToBi0P||*KnNdWA zuf>7H$f99$xZ|9Bx?fsL+kwZnK3)L|VWjko+N|aRD$06ql&5-zH4=!!g#CrTRy~K) z5Y(&D_^6*#B9iHCO*JNMlV%ghlu^=w37$B|C^#)))Zj|=Lz-GHP2yoh8KwZz&ho6niU*S} zlWjdxw)bf`5|$hp9^*x^hyyPbI*kpa;GUw9$Xd9Q|P zTckBMVVh-g*BGmEy4o~~e7TuPf5Pp)GrD>{md{xnv*=|LaBILO#`Gc6eYaD10+sX4k5hnZ&opC$d%spJ^F>z=Gt?{{Dftd#v z#2TF~TUD6+%Td+Mww_oZV3En?k1v!?FUQ>92l^{(HVDiIT2}<+Qfd5ZhgxMZ)Mhk7 zk2K1p-$x`+6jEd8%%`gkx4^@Onh%DML&1@}9fv9B`c$oa>aA@Thz}-Tqq2X9>gsIY zO-(de?nzlp`xv}RV^pg4QX1CoMiL4{7kVd1+@Q7XAZCxi&7nJuZ77NPUI_IU#V(4f zZAn+*)LM3jH&G=G3_BJ%Wu#kPMJ@Q8t<>AF!XJY17<%HXvo)DS0t@1I8SK|{CuxN- ztk*UcYf0YX;!n{8%?JmC2R>>Wyh68H?%k zE}UUi+HF;wXF3j}Ox9D-R^-nqo|I2armB`tFtUi{?4TY;+Xp(6Y1Pcx1nNfi1MS|U zE|uR;c$cWO9Qhq)Uzf!eTT0T#%!=D2Wrj%r33(OcgZd>hw!ojzZw z^W5tpqnG9AXj%-mupG)qARwrC&r9Fbdt#x(_@xWdV`@5c87<7w7lXsiDk+&7?{AZ30GqZ@O{$6pKK(f#VBFxmoub_jqB4b&D$;I$ak*Z zONI7X(Vu1-hflt)(p8xbT~RuDwCzBFxvFy-8S2XdA)KEm$QP`L zoHhH5BjVq5HJMnzEOS~IV?f|`>?TO>Qc1OtuOgAF48Jw=JgL(@<4b z`6qbwffCrmaGSn21>E*7gS#rtamPoD4 zM8sJLJPuCLVT*-2ZFIUIp~xU1=C_PzwY8b1S4_rR zq()0_1YePHYyEJ1$~+b117b&Pe7#d0HyKryWjA9R4sa!7HcP9z@V-*!%L~*&P#A9F z;M&;f^yVRQ>INh!-j~+Z8EkUp@zy)VeZfh%7VY`qN|YqYP}BqoHeIr8&wWjN4OcZM z%#udVg}RI5$5YWjbOa){o2kt*CW+^+64O++(Ch1ycK~17_yVH?^cM@(8BPUU z4;vyN#gUIrBv}SgmS$Pt@@fjG-Ls&#zwW}S(^18YG8D`JYL)4IS019zDKi?nL-KIV zEMg{ZT!p$Y`;pEgt4E??16v}2lxmY$WulIvT*73Ic~P9h5$Ds;56i9sqle6I>f747 zae%Y?UFWqq?xv%xp{#7fE)yb{Tc0hI@*C~j7Ya1P7(;{@_JkpH>a9j!sB8R|6?D)^ zMIwn4%Te+TNY{90AcjIe2)FUX^eB^HZi92B z1~o-iT}w$rndI>$43(eYkedeti|+a#z8X?tGS_UnX@Z?!MC)G#<;pc?Wv4&Z{Yp#} z3}ix+NWd@%cd!@ja4-2|!;=`?lLSegVJ!S9#ckwSK(~+8W(8fooY0@L)F4tKJ-dm*>KF zj(C&iCI|cB3k#c$hQkKoU(*8SjWl0nm2v!Q@!r2&_&-gPRM$Z)v``557b1kM}EP^oENKtq=L+zfL{woC5IseqL(pY)cDtjjViqK&|%i^(2%;hSl{ z?>G?UstcXD1o)`~R9{bcV_RRE)n{3p4@FX?_k|Whq;rq)pBEmN0>3kaP9b9<>goxS>E zM`6uAvXDM(rBY|KFFdpveD(o`N5rh!ZQ+ z+Z`!D9v~8VP1zjSTj`F=mxM1B*<^4_NhqXe0ne#gz!EvOJY)4z!f;&QFZr1=*yo95 zF@|J6i;>XcF-g&w^InH0VOJ@RN@&=KRQi(FJ^2_XB$-|mnKI*<(n(1zOrkl-L&b<* zzq=iDfsUQRh^Rk^x#-i`bh&(qV6^1YPXOxcYX&$o2TP`QZhE2LWgpWklV%wOHlV5x zS6@i$x)~)b+h5X30oi}A1Xj)*STsIL5G6iW>v?M?smUl+jE%BLDnw)$$QCNZ_UVY( zhk=~wxaPhnd6jBh;#}@rzcR}st*5)wR5Xoi5;$@8?S?feu(DcXknT$zNRpXze7cV$ zt2uRK(j2m;FD-VR#yPij`*JZgI)%e9)F>TIGU?0!sX$i0%PqGK zd*AER5>*B5xYc+Vn5i|kVGd~{ew~(@2_!D!HM%mAdwp<6Kr-o|UIBPbUL~E)Xr4VJ+3d?rXZ%m z9#3bvMoCu_!)&uJ$u#u^T{H;<(gO2Ew{tG*dasJ6E~BbEiROx7fTa1ZQ(dW^roNiC zCZwf_WJ)tBjL74?$MQIWjYiS5T+dsVHPeo3r#zc4%QM(h_V5mbAr7-5#3)OI5KA%1w@1auCPf8ZWnD`$)Kwvjtv=37Bm;Rb!1@!6 zvlY>@uo=h=v=0q?7f@nK8fE&|D$`V1r9Pq137xYIi!@a}QKmah$c>{r?!=OAEPnWA z{5hyWWkS*0zjtTpTn7lcuJN;Gm680_Jdr?vym2VFSlsb;U$?Ns(lQ8{HkBJq(I-S{ zI!_X_Xfhe|y2q!6D!R{?W4^r>s^`?G2d4XbV$Dl6CbT%o>v%Mo z1H5jQKIX~`S)Rk0WO5N9r>cdl$`2APt!#SQMURemUO_}^{{RRz&w=@NmhmE{f*CS; z*`S)1beSZMN7@_8bR3SptM$GkIEr}5r=c}4RtS`W0ImZ zc&Z})iy5*@Y~S>e&ij+i52QNWwRX9m=^LQ z*qqYF^cn?R{wV$`BKV6;x>~&#Nt9Pn+(lajL&+n;z!HzYt%&39ac}#d`=9tEWDk+J z%a=*_$_l-2NOb+a)>SJZ&1KW|&{x9>NYNfrMY^yfqc5?(Emc{au%UJApK{#RYO2X6 zj-DlFEL9b3h{XQL>;>>WN@1c2vJuV7ra6v}%&E;h*|CZSswrhH)m!$5*8(!Q(YJ-j zYMSO=8jP}P8of0IO>HY}TFu<3>A0Wqa4T_{q&mmq`S~fsOOb0R(PEl*c;G~$nF7rN z8=Ljqzf3EAdA9dc<%Hp{JRgrMraGf7uZB7{2+c_!_+L$jAAA1*3~`3XX6g}j_D$4- z!2L@-7HL&SnMW*CIfP*rs6=E`Z`f8N@bY{A09FLzxOr$G%Ym5tc1rbz=)bA_G}QS{ zfX*{~zP=eNXeX9h+`nW^^AwEY%^ROkA#ThEu)?f9HkDeyA5?$?<}b^(>(?-b&uWh6 zJ`O`(25F^rG;cjkH8ikOvw^l!svTK+gLW1t>w+n9Le~~mVUXuEkRsND+PpOPN~yBB zvV8vlD)7(5eCiyzsNflxc-zwQJ@$hA&98rJ_rBWPu|Sz-PcU~Bq;I99G<^d z*Js%bFIzQA#~kJ$T@|5>AaF;xQG4N!3@&XT$5;Ymxq9Fw7W@*0%EX~obxYikbPk>+B>B~oaNCB^DRHD=%UP%Fwk>Srm?Mh z*yD*unN0B&A!A|DNLyR{Y!=Ftj#4T~px7>m20v;Lw4G4zQbCmGEj3LhL73(Fl`iON z5>se)$8bPj>0bQdjS}YAxuvAY%k96lKwAoN;TgP~6)%8AP+yyP(R`jH;I`sCeo&yH$oxcVB=$+~PVE-jQy6J@&bgrSvbDbxc(Py4iQc+0hM6t#C=2O!D0J{mX z6lyY{b2rz?7~6!;nP`!oP*XvZM(XuwHx0W**4Mw>98NJg2`-C4zhd_+iz@-(_l>oB zTOg#++MZ?1GP)SNh-s<-F(D$>H~sv3VLuYVnx~|vH|t$?$7Qk6Ro@yaD`3@AQe~8} z&}H=19(5ehAxPyU^-_NJ!~PxvsmrcNf`q6qZ4^sgK6R=pvi$Edsg78k7ABDTNHO|K zk^bx8tSehcWp1*dDXUX1W0_>ILr*?#QAu1WX|sH>jA#zmi^?WK>cf%8@5MV8 zh-F%gYlP)^k=RG`BEv`sC8{&r;%t^`Z2p}qnKn&BGpe)658>Qx>g(^;`aRS{4h=*7t$RxC|5Qvl=u%-okdfdCS9LC zRSg|G%`(QwB&pkbL>0jX{Ng?))(|r@Jh(?^YV4Rj=?=NhUsXphnIKBYUwiqWEYcHh zY@jdh#PlhOR~Nt7DBNdN6QazsjG*Pzdx#KKLo8*JcE)31*6-I7y@AqVdZygrc+;B6 zSBaDvj!CIABP8iFd5l)7F|+0s?n8m~2b^<+s2;%rEu!?sir#!Dc!7{1V9O;H}9 zppZu#TldD$f;V5@$EV)`(Z*C2L2gq?;(I|-+5b{#YWOGc9g~?r<)gq9l8E)Goyn{{Y0jFO_7}8J<^~ugog1lMOXF zEgK*P&g2i;Hu@Y5M*&gQ3tkRcxh8d=Vw4!uR1nlTK5ODWO%AT0(Jxt?wOO9OH=bn? z)I^rBkT>nx>TTIZ9^vXY3jT@JGP7oKKhC3Ykvpno;!RR!wenV&(i)axvcVAjTt#@Y zp7^<8jlBC1lw4%W9#h8d%!_-G?SkeJZ#izCrPBG6h#D-qYfHkNx7>c1hoxxLs2Nxt z)0S1IXqusE^9rK_-)pH`6eF$i3+ot=7Y3<1Sso~K=8~GGpHESgtTP}lRygvB9I^Xg z4DQsgh154%=$bt*n`K!}Wt)j|!pHmW1-{Yr9nJ`*;{=Uu=A;eEQ)NcIq{yW-Sycpe zk;FW>YAP;Vi=I>tg#Q3mK5iVltZY#I7HjCC*~VvIJZ}_^Q_XGV4Z-~HiP*q9VMk4X z9%%|tOFRNWE#y)xFYS(t!t0~}#91V)f_d0G$+_CVoA52u9ks!CP2szDD+S=5g3Yyk zHe;92>e%v#iBibzVJmVtB!CZIy>OR^;#)|9TO??Vr0nQ{nCk6C;LxJUa@}VoW?v+} zWlcRapWd=a8*41c7?0ic!tq6z$#G;D9%zzsuCe5^c$1k`%|(@lt&jWYq$AQJLZpRX zV~F}eg={(2xbZqKK$RtrG0Hq?|BGaSE2!9)@%>go`L54+17kw`3e?G_!0z`Yx= zEX+ZvHvmqZunoERDVx?s4~VY-={y?C^4HBgOUrdtbn!(KD^V8)Y9fL<$@Y#u9MHIlAJta&D=y%vh(Q&Z?(X{ zqO~{mX7O(Y>1mlz4AaBxr^GEonozD~9STrD^HdawDfEjCz;I2^-raEL3t7~_k*xg) z3Ze?E^mKGadYq-$7D=2fPvN*;I(F%YPjiGhLT`22T!3X%l=W2Au}dV0dWhWi_XUz7cp&20>9(sq=c;T}zj?ZIe*I%lbAD#9b=4 zoy>05wTIl|v4qCrv6+EwIj7ZozA-bmfJ|P%zz;Mr_LUvc&8MazcSMqj%iVr<@Gy!shE`{Fy&YdfP0*1EaCAcXIi$!wN~lOD3X9I>Zh)Kj_rk{GaSS()X-IbYjmy1T>hO4sK5GkJth@xADb}jV6w^`<2UD z0hPdJmDy}VFM@lDr4c%gE*SL3!GYK1C)lB24wAcPbQzXzB6Chl(xO1>tJ!*A^2aou z*7)DryQXrK%O;+vcM-(4eV~+MWBGgHQCM!gZXgX;#b=>t>6$i4RFZoGe0#0eE^c`{ zBw30EEh%LWepDVtJ84qU)3I`ntWp(fb|HwfW6~#8(Wjr*N?^_9Sykn7>Zg(P$0nTV zs^Qpi7O_VS3sTgX#Uf=@{$)I?<~qnf0kPZ%+W1q565Hw!BE}A(5~~(>tf;8WD=He7 z<`A!z->Z{>=_j{uz3>2nAPe67kt8WgXH+xS#_~k8^b(IL;AOVi$04ot{x}#@Ic#L} z>|SV^b3ETz>N#houAoMsL1=GatfPe@{{H|>bxxfsV>3)0``2Kknlm}fX~fxXZ02hCNM96cldqZj)+M19l2}56_$o9nl#g zG_v+(SImbct)Evu2kWxxcRAr^a- zS3ysf(AQJVYE=d?YY>EjIKvum1dFp4md{&cBRMki{in^wr z7*SwRF@^6VJ%GRP#cHh<&;$d$l)cO5XW^ANT*|&0NoyjRL3NSCx?J+eq>oVTj+=}& z6LlF7kZH`4k4fdxve!tovP#Pstx*(~WBW)6wZD!#tx(o<0dN-qst2eu6!7~{#^tR; znaV0wr8x-J+DiLdj2A_|kj~bwqjZzR4H=kc^b+TfUnXbf{ezn|^2c~=Kw--e zcU@_9Tp-VL9IC1VDPmx2s!7eiEIu@Y#kW!h18|6o;s#*UvTT)Mc^H-S*bDtTVR*uT zbmoJ&DnX_ERhLg^RQ1}5C(Nd%i~H4tmJzx9EC+jA5Ldv8ts$0^e+@j*wA}?^&EtM(DwIhQ zrd}0zaZg#4gPBg#Q%*dN; ze5}%R5W2}btIDI6zC3Mr5d%$^WrIOK}^_K^+GFHh^R;%Yk5D(iX z+E8*IQGQ! zfNslzhQ1)u(5w-I0~$tkigzt%8@s6b;f@YXf$mVaCtQ;%$}+Z~rH0EpH}|xldRZ;e zzP&Gqs#J62owZ*=l~-xT%$+x)QB)QS7>rxaZhb$WTnx-a4P<+l*=0hr?HdI|QpoW; z%M7YyF_ImcGsz%z>w~D`FB=^fC5SbuGCI8Wn!cWft|c-`u8>R$NOt}!U#+m)4^%LM zM>GrCr8!ndrL(+}x(v<*qn@4(o8#b_ZOb307>v|)H`vT-P1XegMEDj6Qk02aUJg6Lsd*2CK;b=GD7&;n&1K1bpPsivB?C!(OB zo68hP0*81`&FsW+VuWXYH!(gE5sQ@ZsXmYxNI@z7*-~u)$nfJjYY# z`=oZJX)Wbb#s<@2V5AYyb-=iyXtlMmE_D1_Z0_f`YLbwX1GZESLh12?R zWl6Ii(QT_TC~e5nqR#Uq@b}kEtS%1jrM(-%VFcs42*W75I?x z!$D>~9#!ZaHKu7Y-9c5TBdE?Nr>5GI)6+l}H->NMyN*}6!>$Q}s>0fpTwEZKNe0B( zw$O;Ys47$r(NM(G`L%QtR?yH$^wC?*kr1+}DhLcmPCH`MYqh5E9Z=;rx|N{puLg~!%sdXH%(aqMl@)NME@MF&Zj=bf z?e0DMVvUUq;)GEma=KXl->^s0d1s2So+N5YjE0jeu7Wu!+2D$*Im2#eS&%-{>_BdQ z_^g#5mBZX=C^sxieyl;`7W_^> z(V7ValHe?$YnO!4bW%z3P*ps24pkV>6Dlo*iQSK#iaxOeUAt6evQlj8K;~Lzst9PR zBCiuN$GQN_2|cgx?T=ZDZBS;*;@)WVl$2VTX=t;ks&e_V#Zxm&8Dq6YfU)dwn9V!0 zf47>MtO%*AbQWn*mt-+yle`qw1y$Wx#u<1b;Cqgro)uEXv=?X8N17loq2%$)lIwbm ziG@{6Sy}@$OSn1Qm%Y8Y{P4kqRiqvxtV~a5?Oc|^_otIE&9fw-%c)IOT!F+C4*N`z z2HaF`Bb#H&&TAW)#0a?~W1v4uk1VSxCy821M&&hmCSR93(B~pJvlXfUPnS%LH+fD8 zy_@(9ByJX^W0;ZEjI;5g{{T#`i?Z1VGp$vd)KI}wL8%?;Bbn)5GjqNI-iJ~;iyL#? zoHAw|fyP+aFlX?$9u`p-N`&S!>ir-VqG{>>095{TD9f>|ZRxuA@6WyrXr)xZ26VrY z;1Ur-!|iRP{8g`;`=I5qoWh=(Lk&d4lO%CQ%p$q#y4D|jE5u=6gKyql4V#YiQ!Z|z znoBmCY4a$woh)%hQD;?Qe99u~CGiP8B}FxUdzw_s^3v_45=XuoWFV@8^yl)n6k_;Ws#%xw zA7G+yR_aqnnB>`9H2GeAMvj$JOH^xzEhKWWJb#PN<%P9r)Ojza?^Fim6Uf-MJ4dwd7Cau?I2pQe!;u0uf!&yhU7yPketHNo#2D;*{B}8#eg-T$$8sbflAqsAa4U~6Y>CI=Bnw;`YGg+18 zP*3EwRM3=GS&f_~g?X-z$$SVhiQdMNSq*9G})mI^N^$&%Oufn#0mkB<$(i zmzwHjLwrWg>hmgWpDda^-=o=Mgv37-YDZJ`?}MXwTKS?8ReZHkDpku^Hp9q2!xO$6 zsFAw(^-+a9V$3S4=AzEBs%*+gR7DGzm0dRbGX5^zdVY9S=nVo|=_{5H8QL6Ez6)CIIv|b@)S@kkzH1xTKNf@eBnXK;}tU&u;_~1iW z;hfVFA0xX(+jW#K@Y7u7nnFd7GV=Au?OW}qy4C=RS;um9EB6-)eb-A8OGWy4s z7%F0@DCWm2`Z>T8B^oIYkJN=W8X$Y3`L9CAMRrL~f!2Xk*B6pDdnY&dXe?|;0o1i;;J?p*lvw= zy@zcS&1h)48|#U3>e?y^DKpv%8d)fSTDpo5g@976Ac*sR04KG^8sPIa$1@yAcdFNB z9^I5KDxv4vmGaz&G0C#ZsjH6bg9NSRvXRtB+uqo>(xaK-$E(@=`>2&=sIG*hDI`ti zT!{l+S#554#e^{2&4!2`h>0MlZe)8NRKp z)m~imRR#%ZVzNgWuvK0GAJ>RO1AS%78bP`m(B;{LvQ1XdG{h6UvAJS;oD%0YEQ@=C ztQ4fuX4xzo*+YZ|s-;sfV59*c62FeAP=M{P6k^IcX!tkJzVfMZaWj>EY zSZpFDlc}PqcqlxDNSvM0$OA|nMa8esU^;-etWxT!*HqWm*1<(BMJ+HyxLIOA3nH6y zY(-76WHVZZTgJr6oyl(IJqNZ(n>xMdjMAm~U~a zY|5!C>FL)oj&lql_Jg|Hi0l0E)kgwiB}-DE78>lGX|;dJMLjygC5}_M_kT~{5qd6d zPK&lq>dkm%;WMfGiKd77j&r{Rwg0M9~(puQxPSqi4J*ifkhODNS=6- zqC@!Dds_FvJWGT0?3zFVE&(y8?NU>#1_~W(4ONjvt24~UDS~HNspLTowr=0i*!=~p zKKO5hr1sNjd{1GN9dmN3%_Spdl{G`7`iiI)x%*jB!|q%njGUfZQt|mguSU+f>)l=EKOEA_BNA>LaH;Eqo(&aZrYq-m>#jktY>C*U;kQH2`3DPeW>XR*^gXRO~E&~MexeRUw?{Goq5S$I? zU}UcPLK7#8UL(|N>b#Olh~5b@ia4phT?LoYeN2Pc{{S0ftOg0VP~bi}C)%W`Q!xT` zRZ8*i>DqA1s}BpZ>}ziPHUq3sUnL*JVzCr~yZ z?b?r_ZS0rk)9X(RbrmMF(lruGmqiNH$xbCf2Q;D$}#)InKPEqdi^nDfxZT&nG^Sx1jbv zTr0qR(>lFS%5;xMYm*9E*j%8Js1|LP*X6O(Lp21kmv2OpM$5mRgWul$@uIQdlYO+A zgsrXIsa9(qS*Rh>KzCsLY^46GcjmEVHp~z^eO>a3dV*a$H7JxiAK(rnXcLsz?#id2;8mfY^6HCYu^Epkz_g7OeiufYeQ{P8Plg4yJW&LMlRf~Ju|%L@jEPsiHh zt+C@scZ!LE{pgjVv*SuCScWcSMpSRY);F>Gae%QD{)H4ma`A6huA$ExG>b2Wm-SI8 z5G|Cli(l`LXty$lCTmI+LMyc;bP%fEXFikk!Q=`-5E?0kI?nXH9Qk6$Nd-dY)VFH5 z**zXm{jhKwD&Mf^qNi6OlpY|HW7g-KFiZ;ZVlF%5)$%Ur3FM=xhOPjAR*$@u+$=@9 zVO}IiguDV=WgGL~6!OE9L6km2Iz2e^C2Joo*bu>i9eM0U#80A^C~mR%n@r;d}H4>xG;-z&NzJ;G1)m-AZIAH-kPO zYL66hqn0n6VplP>TM!HmJwXUPx#az^&k)7a!#Ym0>aQ70l*3=6vkg5_o@vb931Xg> zXY(Ye2V}?x1~)&55q_ONJQypAfIYkI$wuHoh0nuhsidgXG_=jPF54H7SaWWs$F+$5 zIQtd@gHGmrm%tSQiz=D*1%7KmokveQNXANO00KlDek1RLT~uWNwLs>keJi78I*OuP z$|8#M8Dl6%mfMd4!>9G)Tt#3R17#daG3qRit4LNVIXZEOs=w-P(4ZE##5U-amT62 zmaahi*>^yMU-~@s!BlZ?ZSv{2H8^eLcA(XMPc}nWUzWjB9b~d7*;f+~w&W3J=i9Cs zwxFoc;v)A8l5{+!K<4?10O-uEX_?kD%P-gc7~(@+ z6RfYaI-|~n))_`mH4HkDTQkcUR`l`BvP3J`w_q>%;XQf<(pzN%ZK^Bgy55sHt*M($ zx8Dd&k3mFA1yAS zd7?w*|zh*yvZS==u8fJ2UcOi8N3?3JyeHDFnNvdiot0@aYC?vTqpmJj;ji(d( zR6}0b2X*m)E+tnwT_c)ji&0S0#7#7f3yCLHean8$*8c!ZJL#KF1Z$#{)D5!jU8P~C z%0*<^lxC%UCYPfDeh57dJY{UofD~=1dn9^l1*j%!x_K%fr?d{xo8_FWEB7nemeD6z#1>1iA&{y*o&bB@8(66oDIq(UNR_4y`wH7!j>Q3XSy zBq$7ADPP*Y6}8VATF97%=P}Y+V?U#4v!!`qJt0N8RvpjNraqxr)Qp35=@OeVT{#|^ zqK_)evgC#jF`gNOev%EiKWuScsi<=}-Ao$`)n-i95_xY34##Pc4+8%H<;N_q8?K>4 zH4aTwp*L2@VTJazYHxdVz8FxfC)K&#ctUSYKRt5Bf+-OsQ?|nUkJlaa!JFT8$q6Uu z48o#xrh;at`Fk|TN8$sw=Z^YjfhTkT%t8@Mk)0Wz3njZ9F_BQOLKe+|3hVFz8;-83earLHK`LA98I zh%In=9e$qppEGniE(_&3E?-vk^$j-D<%LsWYdQXp(;SyJKpnqAj6F7I`c-Rb(vo)) zSyEBWiC{+u64As#&E6L|lDa)L@-I(T(1obmXvybjzfa|eU0!5ux|BUia@^)RY{BEM zmh}QX(6-(dOK@=pOG|W9H9+dMEHqh*3Fi^XAz~ye=wf@|=29+bTsYk^Nu#q*6Y7?# z8dEdVD-W34w5oS+sN)9HsnG}scZA(M=I3HYAO?QF@?5<9m)G+uSz3D5egro zyd%l!D_)=nsU+G2k;w`{k_+jVF0{M@q0$rQs;DY=*TN7DilJKn+YPdh1T8w0LhCD08WAGqQ47dLEQ?P=Us9ED<_$+2HDynh zeJsPBzr*<9T}ME^>UN8xF0Z5+giz(VbzoMmx0tN^FW9y4uA75Q#)xW~s{a6#<rh-W5vMHKM-_iB;G5Ntto66_6IDz1~ z!qNhamSQGo37<&l%>|lel=T_bbyr7L_uUd8D{jPn@hxmcR=9??LhCdy z|Iw^|9O>MPR>i2YDv4pGt)y?9rOlm9%xQAM%gN*08J;$~=oZv&j_Q_jn7@+guxz2! zGG=*I2BXVYI7xEc&9+GJ{;bpx+ki2*s8|dAaBG^^mYlg<&|q@X${`}igHcOa4OfNP zMoSf5S(Y5ZWvs2E{aIyo;yb7h*8Yb09w`)0|yKKnLESekSCRS67_NPU(t@ zEVYfHBg~vRx%C(N`*y*&8l|m@kLzw15jtqT_*dcvd!TbrV#=kjg^2U$UKtr=vD^bK zjm7(7Om-QS+jEzZm|ZjwyLg>bSK=;vRi9R5(Bx7|BU48d4FcH^DB6q%CfwtUGsPB$ zgPXQxa^iAm)@4RLq2*Z%6artvz`5;%S_MZ3&D3DZvmXo^i&E=c(x1buw=&D} z{{YenDN4%5T61MmOnz<0;vENkSGd*@l*dd#BoH89Ue677@kLW7LAue(uMWI8@PAHJ z)#{yLRUVemkp%1a?JC?@C+H~V8h7@GLvdN4g`4HV+TQ=eivB8Y1Ou3jSe zgG=HrS4)>7XL_|T|$YSi;B)%f+y+z@U zOqz0BzLvU&Fi2;ksiKn7!{z=Ylz!JvPtzS>aFp?n>4TgLNomc$Xk0zzq7`$4UM6tS z{Qh4ciQKUZ%Xws*k^K?RTv-kqD7Uw@MAxV7Ba>9s*HY@A5Aqpjqk4%l+T5yFYKeqI zda5qpg?T)Vn1dBmHKv_+b%4y*^B{|TE2iH>Q;$IDtr1<2SNM;cOIs1FWu-7Oh#=j~ zrrZc+1M?(|E%eHmoWg@Z-N)k_2_v<9>uQd=Zo5J0jUB0}G>%P6SzDM_il3X9B(&5@ zQ(Y znABG-R23{n$VwkF#{6yLwi{!yby!Q=85-YIdfb!^04X-5&FFK91r+rW)=6Jqu_m4b zNR&dsniO>F#rpf;JUtUkX8^P{mjT&~8_DI^ynD)$R8eI5w;}1r;RQ z3d0`KuYTZ+2-j4?LmFo=%wFziWhQH-8WMv|=^at4C8w`Nsn2rw;Yzyrgvlj14hT|z zYt^@RYhar7s??^=t(sg&Z->2b(|%}2nCL98HL3Hm+}1IhP(`+ydSFmM5zncK>-QL8 zPZs)O9MhHC9p_~euB+FGnr?iqY8k5*X=9XwTbnDFrDSG4s}I_}`r^lgt||f>wSzad zpm!)pJE&G?k>}bnzMfpZzB>9Ulno6^SjTRn>^qB#-vzRxF$1h1jYjt7x`^>hwPusl znmSCoJJpgUeLiLS+H_e-3;-UJZk?8mP@ z*hPe`P@b)Z#ljo>=&H1u2C}Nxi8(97lsD++sidV8-hay1m1>9Bdbv(9{P$}_jBcYrG9 zywFX!jrK;|lf}G~B=GkpCuT0%Lc|!+HA^^BFeS4Q6Yk+qD$80>v)wI$gq(esT61oqR5YU=)Gu72G<tub-ZX*L}Rc65I2W_Ddsn%1b2Oc=mYIT zO+%|Q?8ZEtF_NZ|okS5ei723fw~RBPL6pm&T$%Q-jWTSc`hO$LHSIG*Y8HsK9gzKw3?}p6&Y>8`9vDH+&Mb6mVejVQ9z9OVP5N2XB_IapY3oM43 ztHodK!G%?sUYw1a-;lpgr@k0b!So_ETxL_PHw>v=4E0s8)k0#9a_Dzke^vX83sBky ztCwh+wI|8dRMyFt)*5uDlWV6yLv#IDo|J(F45C^}i0Um*K^wxmVq*K0gLP5V-xFdF zM#)^tN3Aow-n%lYg@UR_DMTx6n{Q#$9?@f3)#wPV;Eb6@SE;FE&7>w5LmQ%>NO?gU z&-+_pXA%x|GnZlyu^7h*x?8JnUz$|rGxK{cf>c_Z#t3V<>SX}FHIBen|6M!G1p z(ItA7t=)0`@{D)w9FQ^C9>o!`M;`}t-es*GuPDk|o|;CF%x0~qNK}<3)-Tlc>4g~T z&7%d=zMc!ZVGA|QJw}z(nT;iMNX|%#XNFKz@nd2-j55PKS70Jy`mUPU2w|ymm~y(< zR+gn^S5FMe6T8dh!%XtRHtS{f33s!0fP>Y+Z&y{$K zkY@QUYSJuGI-;yjt-)i#zt2?r1Xz1ah#y4|FVy4f?4+#}6=AkyKkxAI`duE>j0|6Gi#O zn8@~I7Yl1&3@+UlBxN>ET1E*gb2?g8srhj;1TqnD0mn7WHdj>uAs)ZAS@Njq4F+!o zO&gaoNW)`>3~mZxJDwe=LW^jT>b+5z=2;_UzoqGRyoNInJ6Njz9zQdV=r;2RfFkLi zKzMtm^#ep}vni5RkzkHE+)E@Idrzu#yxIx40efSa25_ubML7bj>+vnoPCJ zBtg#0_F>l&Huv9kAwL^f)khe4EKpwR+}`}#oDwdIX`7=BPlbA;MPxY!u*`C2{RN&W z`5ehdnGW=QjHTD`I6ty~sNq?~GP{j1dd=0m(Jg5gD$4vj__39Eds994@RYwyW%RI>snm8Bku>B2XLcF4ifHPsjK=D+d`D)~{xW6sElVEk)}kG>s?F+_ zH5c@r+zed)=kUjdk_qa_p3Pu*rC6$hrivxtABNcuZA~UaL7YdF=77fam6C;d);WkT z90kKJ<>!(Ot}uTZ;t!?w!p!vcX(g@N=PlHDYHfXzPl=z0%{AdRXBKUywMAB>hcL_J zmaei{Vw}e?ZJ`T96b83ZVQUOD;XFb3rUtk)ZUb6cBbQqKD122Q-4<$1EcsPLj*Vt} zk?t?k7mx$mm$YW^L@y0$Gl=S@mIfX}uoISGw+FB%-|2wyjc$jPm(J`)eL+i=MObp5 zkgJYx7NnwvDp>MJZif6}O(N{MycdP3ha;aoHFb3rloGyIB#RQHq*^ja0jx1I!x|tS zwf>bHC#^-N%4Tp>WvdL%ycr1EyN6DF`r8pwtJQ}{?%i}7DVI`K%}n%^xrFr9lS{)* zOsl>E!~z_zQ)~71#I%4n5(jSU=vR~AC&4No5%r#=gE-3*JJWeyS4`Vn5ffHU!J}5% z=xjyrV}3oaitiV!=7wdE>2Y*!&;)%X4;0r7&3q99;s?gvC#AGTv&nL1qKi08%k)(F z1aY)qB!ke%f$k38ps8g9b7Fa@aDD|^rYV(bhX4U|_U+jkf)5~yuZd`BXw`lG$KQco z7!}i6^|h5->qV@nsH3CHXJEAOs4<#)&|w1P6TI#KspFx;&$>P@Qkiu#EMP5bW{GxZ z1DLox5y(IQzy@_t;il>qDB@sRW<~6Aba8W5#h$G0i*zXUK{}D08i3|4$7rICVWY1#nUD&Kcu3{sOu(C zL77JwEmKb!KDiKq>TSJy3@^a&3PP@Gl{2_bYJ8k-RPK2LODUg*KNNaLRAs-T^?-b; zzM29|lSE7tIIujo3J5q`kNcjlMcJqv%_Q1jf!K?sSP>5JOT2c=GD=x8iK;4NtBOi! zs!|X+jwZ2Egm6IwTG;D>)_p+XmLQhvB$3a>aan*}F8E@s@bgHnXRcC)Ijd{ymKq7A z{{Rb@!m1V8{Qze5bMJvZ>1krId1y7ot!riAZu=NS;T+aU?oPiGny*x93Ov^<)xHvG)w2;&pNR9}AheSD6%lkR!6{c1IiaRKc+5weF9Izq@y+bEYQk|Qi0Pn~^) z*w_PZqv>z2IM*3eR2JKQ)U-?@KAOs@=5bjpiB$BcUc~L{v^32IpH^&T(u!89H!x-(pCqv+u>Qs`{gDyyQahBx_g6{DyN>9cYM z2spO5K~a{S_f8p}v(%F25oP&=LNQPUIg`uUULtHh`0=#amoV9QDB4q2W8p1jI%YL8 zNFYdwG432X^~bHp0|5}(0S=(a8Q`9Far(Z)o^WZcb>~Qm-VA5YljgMWRML5{%n0=@ z#f}%_>1J$&%Z1gV@ZuU@5%o&xOx`q#f~I1s>b!uypg%iX^Tlr)P~howt<|^e<$r3K zf=VxH-x{?SiqbEH)J7-MnG7;CRPpk~=?eoR{{XZX1M|RC==vo#)qAx%ZP&fMi`P2v znRMrf+LyujV$3p%f1b(Zm>QVB31$FaV|F&T-yT-NGZ^T1Rp3~!a~3FXi#{UiUlFBk zPPtU^(NiFg$dPWT9f`l+o_{PGgQCnh$mdBXUT9|-GNHa4Y6x>G492FGSlpwCTAJ2j zzTTz&H^CUXaNr2;@LmPWC(^Zq-CE)OT+m3j zY%d~I?z2zDlgIOAe4jbPtTQ&&wZ)2i4tT(9tY2j0`iRlh;7{l9D%OAVAuP03u6z36Y16dqns!!TE>4Czo*#R9iiDBb&U*B@eJ9=)u* z5L1S0oN1a|{+fxYmKg+~%mS5+w*aUExA}1!82pkAwqFt@cg^*dkj*M{9KNqd(&drS za+A_R-eju1UQ2R%i(A~|&Vrx;!P7e_`ap$xv%~EfsWN$UypuIpgf4d~f&sOO1UDf2 zUkA{{)ujB68m{Cv;RCAPk4^lYMqO0zPb(iXGTg9RUjG0?hXQJn2-8ImuBV#XgHP(u z(UrPODyWH`0M*Lepl~eAJ%=1%dQ}Z64n50(BFn`FR48aFV#|T7s9?8NYdmU44fY)4 zhg6d;w=UK6N?ZCrS0~9z>S|J&c-TBccu!+*rXwbu?GhKDK~}1(QRW$S98%OjoKSwW zmAT*pa(_Hm8%3@pDcnd!i5X4pGt8Clp;bt2+Q zpjubK$3^ozqLuRaR;rbumYA4}ThjKmjr-povE69~W*058j^r7oeo-qLHf8gD45OnD zY)@H%;^?VbC*V$s@Y_+vMVdI7H54jLl+`mIEZeI@qoMo#F-hWhii~bhda0cT&C&j7 z>cllO#ES$0nN=FZpRXPM_^E;qYBfh{vRc^YqN|5B5Kk4`VIGFv&^PYm?}A%YK?S^* zr9Xa~shuH$x?m($4&GZ_F#iA-1D0~pObjIzIlM9@Lqi;a0bV}$z3~fakVlG=R}a$k zIb%lE5^YVpw!N%L?an$B3-nwULRTiTHFRwe+SXw4kf1sMdU4yPJM?laQ0AgRT~zX< zxrD_)VPRqP$7~nMhp3vVa#`x3Ga18qmbhlP+s-F-VAC9wAQX-oS*Q|tV|d+%;o9D- z9CYUgU3sG5nN>ACFm;fpnn;)yz5T`{&n{m~E)ke$qoOcL<;JhHrT+kAp1AAQkXIz9 z`6g<(>SKYC*-0UfOMP%SZbB!ueB*y&jn=hl$bo4VR&=nCHLQKd+XS>UiI{?;&vfaO z!8GxRW{~;oa5s0qwjr$G4DGril8K=-d8vmm3MX5#u@@UhPv3%lW=PQ$Df=nNX>~%^ z)l?{v)F;#q<)YERXZpvF>2apd>-GXzq{fpRz zF3L5u^{jIG9Ij~U7EsQpH*Y7o7>2C?1d}0l*Nv3_06MRiG_1*}-Y0taCqS%*&X%z% z!?ppY10?KMj-{BQZmG&@GVqgCRhT9vT20HncKyB10i{=#i-%BA?Mb6fxXMmsW>uPz zk)kW;lW05}b{t@u6~zZfWzg@V%?0%?Qkn}p$m$Go39A)YklvPJdY`@U%8R`rhmcST zU@I?OTk-;tCdmu5@dgay$Xl;Jd*KZ><}*9Oo>WFZ60|Ja)~83vv&6fIC_9t#i7HqUwZk? z4!BW_gI3jPeD)0HVq*|^hJJc z24kwGtAj8{n3YGWjb%XO+tK)l7UJI6af8H)aZWPnZtc`>Zs@o0+2XE24xP^Q&abY5 zl__FLs2Zx@ub8>KNx6lHUT#6@gq(K)RMcf!Ai7-+gAgNMdOrzR0oFasLG<+|f35OL zx~!VEnu9W?qcT!g%SjB8Mj!@2BpXMV7!Ksz*!IS4Rjk8SYY20LoO3rkOq-eeN^H>Q z17(W7Ir!zRd}YjNXVsO|wKW-2OAIebM-4rSvHV_F<35mXdIQINZ@3&4JTrQLhPVw* z+gok>(h83+GElhcxic4?vxxp?R!|m0!2}Bry}i5J1dKLMQ$h63$`=KBd@$EO9mk+4 zwC~>rrUvS^;&7gFqv;2R?f!nBhHS<*zlq zk2I$|(E42yHq4MvNk>U0`Wj`3?FIqYaUaZLEG`zYIcmIQXq()Ub-#y#`OX_8T30No z(jzde&uFR;=9F@*CaFuBXORdXEA%}&eLk4$6;M~oDUl3#FgJzMXLVb=GS=tA`KsZm z)72TliJy0&w-n~&4#3~|V#STZdPuYK6Mp3Ya_ymfaMXGSRn%%tGnYwA14%0Uvngnm zCLX0KdyqdYdtZmPwJ_JZPs;9GijY%xh*`aExrThk49GM!4$`#<^%#jau=csX?#I|x z3ML~>9nEm_H%(bSN2zEsmdtXMlv7H+MCb|iNZeY(6F#dP=qIc%;5GNC2q0NZH7|@B zqcYMt7lxUnE+NWlOz`b2lOvEgC%+tzvB31ORNGM2Y!F&(bdw9L<{@ZSoS~uB`ZGu6 zx-UCJsVJ$R^t_cYsc9E^YbgGf&_FoPF$CeOJ=I$5jwU`xHq*X-gvby;0YNCnQL3_? zMUv3vZ#{NHTqU_-6C{mo%mDZ1FFY0|?l51>>Lk$~?j{HhjY<8*aV({`@JShJGFOH+gGIUC12M zPG_pF z^2(XxQZMDW=zpx>iga27O-am6fFR}4bkc3FCF812h<%aNNmG*l0ByN7Bpafg#YJIL zy+a!f?0U8AK9|Esv#-%On1F7F%_;-p?t47BI!99*{*%lb<>Do;vvrNW#GBymA4q1A z>a`14$WW~{L7Vt)xm`UaC(KJI-%%B=8pIQP6X~~oW)Eb71OKREQAYp>!Ix{bWQ7ltsvMDAe@|hM$+*qCM@5fHK8NrqQ_DuOEJsD`aO_k=A8H{xE zyBeQ9?IA;ERwVxbl;gLwFvfsrx@%D%O4QM2FBz33k2j#1W1*yy66UHhY}U81_rluY z%+u9AvE>?j$|0=^!s%@{9+aMjeN&#plT-Pwi9_Xr^&81%x`1tC?~3(&M@}3lw>^#d zF2gdWJnvrQ8J$*tm*#P`epei-C?JB-G>DcdBNPDb4c7kHB9;oH8q&yXvXJ6L#*jM> zsv<#1hHI8&BUt1bpD&_^EjeUW+GeVT1rGU@{KRP_KBwn{f9u4|q-qvaVR3eH+Krj& z>EH~T>&ZtTYNGn*$6Z&S(`34pa!P6{m?%b3S(s2kX>j^&C4`tJ zTGO$T2fJNP>&YZpSG{egV~-(&JI-s~qPH+C$qQV`<#boM>woIQj6G?7R<^)>JE7fA zbUV_z9*0ua(NX2KW>X?sUodR_cl2-H2iCxOv%|j*rqo*UvWlBAriv;O`=pfGHbn;Ef5siKn-z={sD}}(DcZtx zPJH-(On1Sh4 zHuR6(f%-0q*}3YxH$yD0il-{nG?57aCUsX9zoCt}!R~N#3H%bFEridm77U|R*Hclp z!vwtU7FW0i!xG_%eK1br+`57UluOFA)mC*xxr`=D4vQM@3d5lKU>cRfOcK6hb0M#Y zA!L#Y>WY+k&+4Ruqm8z;{{Vgs!=6IR+=gtRnwKYRujDEtDyuRJ0B+p%{&+5f!>!2~ zPSz{doy{YprOfFoVDnMX?JO=)yBv91oRC8DqzyGu{JOTIFIhaPN{ieuKgR^Up~m-J zyh-=2)jHccuBZ7*tj1}e2I`LYRU@GoZWzkX&gm~t zM<>fjJh!&uEWq+H+lMtIW(f5~n9@~cRJ8tRd1;h9?HRc&#@v0a&JsPa>4Y}wapAU{ zrKkNXRO2tM+N2040M4FZAxOW}^Z8&rU2Q#K_`VvVnABhyB?dv37XvG+e=-vK?jbv9ig?z6~p ztxuOy&GOY0xs*)8uJYa)&|2G4!(r=j^#=@a^-U;fxKO#MBd05}O*v6pPghXVLdCBe zuQ9mohSgf(pN2Sf^^h+U1;km;*K*W=N@B$&>yeU5z@rinbA*9$5pTy_N~q`{{Vuz zEiI7gsB0bN`8uX@lgkx5OT5&@5_*iT%mR`4Kw@!9!&hrDE^E$EaRtHgqp~!H&e@}0 z$lW+_w1oNNm%;X3KY`jQbmbtAS7cdaHB3;d$yTz)By?iES$A+xQV8ve<`eFXlyL-A zA)=$*Aepf++ijz)iK$03WGvIvT6y+S*$BHLQ&)XtM&PBAI0(P9z;z-sE?- z3#V1MlIV*_fwV7UC`9iA^lo#lbiTZ%r*kM@CR$+ZeNwnA!=8n@k@Xn*xf$AYhTq9V z;~`U>V>imzy&Y~}^7Rz%Qcw?Fw-&?74YY$|hYckc{0h+eS5jtlwfefMvK=iAT0xu| zG%obi@*@P4ki%dPZ&x692Mf4{DfHV668%~tY&F)z!LTGxf|`?a8?Bkt-V|iM4{9AT zB}IK6aiH@Ig1Vb7s+l7*HC)IIE4$pYvZ=Uk2L{SH#RcGiP0O4?YlCvbVcNGqdBG`; zmf95;$-F3*zfFyESDa;8T^?ODvDHyk*2tB07Gq|DEsU(q*PB=$uMNF0Nni!W8wB%< z`5|&y3*yZv>60qGE_PmXOL6~N8 ziuQRXooZyv7|BxAQ889BKE%6Rb{4gpL`_vf!5vu)z?p? zE2;AFR;w$C=+dQRwYxbMx%TV%W86*xo+~S#CC!*1#Ab>2DVbL$nj(gM;?}hIg3NM^ z?yo!*T8;o>p%Fl^Ix2$fBVtOZzeVkZuEW#8gCONGn3FTCd8yjs>!v+5CYp|;S0{^9 zGrnh4N%Gl6lHxk&KjB@I(oZ8DKQL>37{CTkb(dV_Lxy*(X(6G?s;btbE6Ldso{@;U z#dCWo_rK+dx*9~1(bjP!p4Gu5B|atihX$a^#4+UQLkM*;#t<_&7F*o)xg9a~2MB4p zW=S?2jqbX0j48gF@Y7Xzfs|#H^z|}kCQ1c*dMa6cQPajOu&HhX1spHe0aeCR!#T|$ zH0HaAo9=rhNY+SAI$y+?^aII}X4-bH8fv}q8hYw>fO*G;>sw;wv@Fb+uJCZ;|9DD~a6Rk{2>88@jE}*V`A~7Sl);lQ$%NyHHMU zV<0IGU*T$KoTDhK&8kg2Ih<-k6(y|4xC(d|7vx(4RL1nqFefg{*3v`#&%#{NpD3i& zGS$Q~=gmzdieyE2*LX3?F2t~rIUEaqcrBbkfyS1u==01>?H!u0TZW6PY2yciIp$qA zhB-YpeFkw&t3%C|$K{kCsbI1fVbEsTu>-fl@~9g&p#Q4eHCYLob< z;fAKsbJI{|*%7XzrGOgsjT&fTRX|ypkE9MqUcZ(j!r~hI*^E0h4`lhF+}x-|lIL~# zkd@M%Dj-6DQ-UlM3mu?wZkRr$2D7lJb6t9_r_)*7vQG5VL06SXCH-_it6Ovn@Adq# z<6Tjfn>)+)sU}l)vdfdi(@&SjFO@W#4$%~-tfTrTp+4B^g;Ry=AF%8imj4-#3t_xN7(cEw4|2SSE9mxnsv z!);4PlV=$eRF&oiR)8+xhT&O(_UVbvDxGE$39%P8JMFTJ(IBILhgBKBgO!x=>uo6w z23J!%O-q`}iqpK7{{Ulk{hK#`rVwM8-XIS|{LTXG=0BPjz~t2fGu-y0M(eTSCYyoc zp`NBlYF5Ck^zsqBbJuVK4=GXU=z2XuGX?_Ec0U)*MB@fPMZHy+cyUKtPn&7V?B6k> z%)eimWt9%TRWyWLh*R3<_zW+lO1s;Y!J*9n2lm~1Tn)nhk6-BT6H_+HvrNLHOvOtZ z9JWwDS2QS};HC@Ha}Vc^>0qCPA@+GEtVYE}no1Gq1CiCyRYjE0e4Sdz!Rl;4Dx}%D z?0bHAV~Gz07a0d`N;cgQ#%LwV>uF~q8GO6Q_PCLd8z0X205V)0H2o{rSSr=6wS`8d zk1L<&{$`?%KPX1G1zPs7x7cC*3IdTf))2zE0f$a$$z_bS)| z9{mlvk=F*WKsmakUKgqBJMhyp%PAIvCCOGgO4Rb^t&pEAIk~eF(4K9Gsp8u6n4K4( zLLF$|0&5_oY|BvP)dMaKDty95S~O(*BoLMn0&}>*~|* z*?LW(ol3`L=6QrcEryo^V{bMTXMGr1CHH7QegtlcT$DND{i=BT9ce)A{rnoi{MUSon{q_ndB7IHFV7B6tT$LXNYnO4}bGwr^INs zGCMFjjJkNH6kQhz&1wwZnv*-J%c`a;7my^i_%401Ug!%(V0#grASE&b27NhNWpTxp z>vaq)1^)Q)tu*yr=9IHdCSy@iDW#`Mm7MiugHGqrmrD0PPnX8hbI+!*- z>#osmdBV`#ra|VV%$R{P*25X14^FWi%=T~}w+97*4c6yGGmNiw4qjG@8d#9B5#|sS zAFv(9JPpbLE>IGpD@!z6Y1(O62EE+eoBseu>4W4O#neQvl4MzxajAx$a1oSkJFMz` z{(|!Imd#yaGqsCWin5s>Z)m7-f5$GWCfHP?X~{^ z5AVS(!~pLF_1Cy`G%us}CcM^ME;-pk2<^K*bn8zK}FJI?b=h*VK!=^Qd6Z;kd`0>h9;b>o~h!>~FD zT)ewy3bdL>GZ}|QJBRXW_b!ac{Jd4cHhOl{@4T-?qU%aDaxBg=QS0%dkvIQsl82H z1RJQoBX6d|o|qN*hO`;KV)RogU!!#3TO?R|c25L6O0qVYtc--Le8U*J8khJ#roJVvBgNni(nt zhRx@&JJ0gKZK&tm^ZFE4U;onrc$b)F8tXEKdJK{Z`UqeV%ESU>n2Rt_6k5QWa(d$| zz|t6Y#Nd4S$) z>TPkdt^PdtH7AAHhF2_=^UX(@MkkHr9<^KTwYv*q!NNG7rM1u@%_KsKwLG3ESEy*| zYV#9EK%?benF73s5A1_`o`(L|X-Jl~PO_i^6V8zF`@|m!^6cMESWLSY=>GI`1nH#UC_jSb|8^keKcXWZLqi-f> z_Ql73oYB;&wCZl8deg-mvrcG?v%+dxWvtFJdit7Cm?AnQRVSJHwqQBl6aYcvrMuu- z7(-I0q*w!cUta5N`cyUE2US;zsQ6)#UETd0gkkr=tndh zlvT|$8XWH^$_Ag)aAoTRi&gVfuYWROYs&usiRFx44EwKCO1zD&*J5<(fT=q12#%k})RB^-M(C#wwyKtxaJQ96-riW20R24O@h zbFD9};iayQ84T2j^BSKoy@BH2ZkRTuK<=elWVd2eSz$+XFN!+XO15J8OL>#X#i}YC zZocDVxc+#T6@jB(GmB^&?p?9vw+i~_x`J&@TcNb2EmV`zPZSlo*{9r|V>lnGx|QPh z2a(qlDpa}#)vXZVOKJ8&^OV2{fQP;-=m?|LdA$xv^I2}5g<@BLBS^H;FuS34En#p^ zQ-8}2a5%}N9OIe9x;vmQ9ZX6~Nu+!`$uqqr4sEGxXVddTQ7&MSF6yY{^m%?z?h9Y{ zW2WM(RBO7hL2PNHI(=($To!;-<1fl6GyLB-%Q6aRsh=}eL4-NXa{S*o z%vjebs*Ot|ZyN@@N=PIy>4Vz#Q*Tzomuluy%^!`KK7~W4D(U8*E0{EL0K1Le*ZbQ8 z)ZuTgdO&*O>%&wFBR;OwdS$#gsnYobNl#0fBy&KKF4sE_?Z?@H>xEc4RZVQ~ylSJU zY^!!p4o37oMrtI?E8-wi1IzCK5CQLQF=DBoG_t_V_aa$T8x-eRoz>-y9CdW&o^8B| z1=s>H6Dc*~L6PUWAlU$P=AwNqto~+chm|aZ?k&QSdfV@8Ijcvdr5%VyJ{*jmI%Q)~ z%@%%PN2q8OWpoy28+bpv3V3U}G0~oDyhA4Hy5*XkC~N8R(11b4;yPWFU-QL<)JYlq z5VY*AKCsJl?x558355Cbs)}ZfO{KZ%{LQgf!@8w9jt5I0r5%$pSK@woon|_JMd)a^ zRZ->i7Oh85*Tmtjp}w1Kk1$|oeNtnta(*fy+CkAr{5be{)gL)SnX!{BqM6jj)2)@3 z{{V=60O|L~xb8DZ0^eD}kQpOk733v zxN_FFBSaArf_R&i7|J|C%krvv=`tAOmZPRAc68hSvY~xG}$2hC` zB{QTkJb|`)NFB-kSelh+Xq`#~u%;>u&oQV^lZ1pqE$Tdm`hD<2ngO2092A!;l1gn! zmO~ve62&rk{Mb644?VHz{`)7eub?8Qhk9Js>MGo(zC%fuNVU>EK#;AyEXf|>*5>$K zjIL?Z4sTfXdc4Kw*t=-vg?S!dSC-dQ!8`u|d&pgXT1zQjfbKs_VUs_W&=vcohnQ>}1vO=9ruIN+bAAj7aV(WvFk zdg6uD`KsrYkx*)xqVk_=u45b*l?dP|Ym1I~!z`IZ(;vZ65jSs&pX4p5{5Q_(GRQL+ zC(C6EFP$8#ByS6UwIr)p{vOz0SThvKAm$Tc*rjO#AvkKxmqqD%n#$bHvK;v<>Gx9n zlQ4Q}h8wLW?xlX8TyaXJN`MA}*w%LoqkZ84De2|bY$={afYGD0Ec^yh>*wl58&5qs1M1x5*I*3l-QYd43w;^H>~=B z`g>!(k+a9jhwT!SN3*+VCFudGa*6ELz$xGXv#{6-Q zmmzwL7?aMhDsC)s;arm@6uUuI(o<&C;<`pkXJ8+1-}9=(S(~j@}zP&>x#B2o5=OK+qrp7@}#=W@~o#nri!MGlBle86i0XJ z;AaNtT-I5}fgO;ESKQ7&*;`z!$ao1t>YLg1#l>buc|We6vO>^H-8)p@u68 zYc~UTaz{U&8(^yg)fzSo^VM+nZjU}3{5R>p6TBtQH53_y`DU!s9(7e+9MG_is)a`4 z%3G-eo;~muBZ-<7a+4v&vDjQ=%@EpogzTEM_rn!ZWuM#A<^~LkN)bIYg#Nl|SPi1z z(Z3iLw;bzqG1tsTfHCBy6eLc`??`A0GP!nbo=Rk;hC?jW$saOYSOR^$zW9R?iXvLU z2G`_QjHMS#^W57s@ZUentF+uXy#*$4f=XHnmTxV^%I-vO!Ue^x*8c!ZMAkDEOp2Kt zS*abT`HJwIuC}Vh&+$h?L*cGjljnJ@S=VMNnp&mn^2f|23$JifkESX|?qHl*sKCKO zK@-dieKLvkk(T<(t^WWM`qG!h8ht%mk@>X=mQt$JEV6D`?gxZ+4=|{G zXU~C{Kw=%zCVdH*_-1@Rf{#_lQ&X7MO!TH|2T?2vn(0kTN3J|Z zk}uHozH3QDvd2`F2_#!VFrztE95*U2Z>AIC@l2@Bih%1E13siix9whrLAnC?kCGaHEQb8B|zk70+HKwSBF$^%8GHOFch@$D$xkoc3P{3z2y zEt4`b=f<2oaYVnVSs6hBNALCa!dloj;@_AEW@w(x*N&(gWgzhP#hRUCnbLfoWBsmY zGDM1*gG$dy^9XkjH4qYGxVPqU9ey9^;DZlnCescA+8?y9TUKloH^fg5^E~HSX3ecD z=wYI*QC#(TWQ_E(OSG#PnZPRSLG<>%4Z~v^+GC=Z5M!-vd5*~OQ8|;UU#q?!^K7TX zEQ3@2gB0=7)K+}U)>$9qnEwEKgMZp{VlCGZ;dqW}&bck>hLP&@f@FOveupTOJkdTG zX<7EwcNvUR@DVCCGrFhwc1F$;q2?X`}V4PMqp)LlNdT>E4*F$sSx?=)o_=41u zYAsEgRLCO>MA63tF%VshU~ZF+c|Q2>gV5;dG+dVp&et~fFDhz>RGF4Tp5!%^XEL4~ z^<+;bC+I*vtN#EDF{sLv-ULf;KSJX&iPBZq{+XhKJpxE(vKw?N&4S#~keX)Ub26@t zR5yMQS%M~R*F^Sc93p6+VFfX@fL;+C9J0TsvNDpW|pFP8EEw+@0EL+bws}l zGfx0@eJyTFHh`7uXeQq+R%J6Em_fSivVyD>b^w4c&umwCr9LA-we76fAX&O!Y^L99 zCNw%XY810o_#dUT^>$BFqk_^>W+Y28wMeLiU~76~0Jo`6)SF><594*KHR8R?BmMRYrV16fsIGVxi z8O$^WioF|~6Q@0VBei2kW%f)k2xGI-xFNplt#98Od^t@&|8kot`bP+U4XOrtBrwF8Ymeb|u3ND>#*3o- z%RGE}@Vms%3nmik`5Q9QfJBa#3iPVkq8>yL1P6AGW4`ec zgsQ>}?25h^{4?iz-k&XlRZT5EoXshIZicEEc@MYKxqEU(D;z`al9m{pkZLf7xrdk9 zRKpBhBYf)6%G>E~p!&lo&1pS7>|7`^cPRW2aF_Q8-O4UZ(b z?aE;cGL2g!)PY{i@w;B&i-XwnhOeLiw#s10R%655(yj?1pfwcYs;$S8po=p0FK*oP ziuNgjB#RAKbeLnkNi(`UAm8VCS=bnO)Rop)G<60{_gk^r4yfCtP65p#HXc_n>Nd-DYJR! zTGT?wl+Jh^(1F>w>+Oy%!!6Ns371EBqp0*Xe0gr1Ri&0$wnVbPjH+1L>_{Yi@ij~{ zYYfhx4OC^&mw2bDd`r_gqh;F8u12DhZ9_*)_J#b*8>3iVt?knvVQA8Ob1-$Z>j^8; zr}=e$S5cB=^|VsvR4q`UVhvdAtQ57xihU;c?}g>BYs*M&yCYxNzHtEuyhhTaQlsZN z7GChx(U517A{9tZuj%6V>xP&*oflEWk=x|HWA6t<7MCW^WU3j3bm8hGP}gSM%sLD+ z=~)mIu5i#NsPml1LDbXK(&kK3S)+Q0;%hNbL1aH)Z_g15LlI&$20Pcy2)(MZ{NGyF zML`}~)pBMn8&gUZndzyX&Fc&IH@~(QVcgaU2I6PEc;T6G&ioCc%cQDV^U$+G143d= z$t8#3-Pqh?ren#xSevc`VM#JQO-rV9x6V~myVaw#B^X*o1A$}T1Judtt*o{drH(j~ms<8OK;uTI~Do;%_LntA` z9t#XJ!C@m^3V_y5z7+WM`E?d!L0KatvqVbD#`a}BzW2wNz8famE`}lzyTN}GKS@WL zOaWNL`&q%Y+quPmiD0ro8sEtgO0=sbMOig@-%g;RH{L~!__ivqrW>xPnUtqIjtUxS z4KDFk!*l-tMNN-iraYzBARQMnp^;_`lyFO19CAwDgm^{6Ip{w4KP0*vqKuW-AkIHX z%>Mv88l-gXwTT>t_CIT5n)JFc)!lRx-DOr=8-)rRakwjp7{|C>d{-CDsT>y&mI^>4 z?TI=!b6!eNGkPy1l7&GwwXbY((6|-!q_w%H$iS?CNC!6C$Or4&9kQNddGKDTRX2$8 zRi!>#SEnf0!~&&CsabZPaz7XKet4100lyV=)Y(r%ndWt_w6yF)mLt-74{P9H0ULNJ zq7!CfWsW%7X9yuBN?OcK?ffy*4$I}|DO$fa@n$q}M^EcxQ6|C%TMv8^+H>Eslq&h+ zPOE~8I;t%#=cr4o#`lP*{{T-Iuwf{ip$PXX*%oh2Q&CqW(J(6K%Pqhy{dj$n)nwwimUzq-arda2v zX8mL}id`Q4h5Pl#rw^27B#uy|YA?g!mPai%Uzk-UcqO3B z$E=R%K|~D=k)X=69E(rZS5nZ`%)+8+K#HOI-B6B;*YAO`II~UCV@$$yT4}W|>YjljwrTjb>*-E?u8q`r5-hem zE^Hh8Vc!g>V#8ViLAqss|I{4#S)An*^^@u0Ls150N}=XiRf63?K9c^Mk}-|(I&X7& zOv522Bf&LoFf|uV`W}L_R(Ol8ru`8mI%N>WB*I~`+r3-E4i4)M2eu`}JW#{12YS=& zxAQ22FFHbi<)0E%`WI7cEZ&L(nZuaH3>5IO4q`C^r1RI+dk)t6;Od+Y(kWA8jAb%* zlIY)U6k@hQVOQ$^01@i7{-dwd`l}WU|sXR)>Wj9A=5JCu4OCxRM#D%E@c5* z)pZ(XqaxZ!pV+-)L(Cl(fogvcv{!=Ev+047HAIy4DwI;yQ-M(p*6QmsqVDTr0XE~` z6e<`hxYrtli;Kg&k?we9xoD~uapR6zo6kKKO{Ef>KdPuPE@wM$WI}&tKF8Soacif- zoX9V!EC3SNkJ^KK%d|(06_sjl401_i&+B9%%WLTdQ$Neq7~}>y&98MM^Xu=9FxXd8sWQ?WBz8*a&$5VV42xH1*&b1s zY062m{I@W#l_@K#_Q@QQvYW(RdLL{1;H*trbl&GxA@?vEAY1@%{NO8hg> zd_?Jd>s420G3EKB6%}w((^b@}z>z}C7DToAlH05a>M>bvHP|O)84EyZaQMWy0|UE7 zIHDXix~cyF+g)#h5>r!UMtQSJM`)y(3nDV^7HfB2Fz28c@h*&~W2i$;L`m_7;@496 zo1|vRH9ay-EO5parjW8O;6;ND$EE%8&L4;6cp=9qum?rs>SqeB=b2MwxjvrOXwOe2 zUg%_sG+->AkXldizpD*tzdPMX=pc`!Ktv<=fibORHglSOn9DMmB&TSX^o=UX8gaq5 z^qaB59w=@GQtRjp9g%eOOME%i6k2CHs(odv{{TS;W`>tEp{5lPl0maF55l(R_hZ~< z7}jWQHfOZCj(1oNYIb&_=Y)CwW8x2pRsJ1+ZuFU^O;(1fb2X&~Ox1$%9Ijn`R<{;B zVRj=3+H7r5!pD+W0d<%N{$=c!7*Vei^d%pOnZBT#D5!dD^H0o~Vp4?&q#)j`6no#_ z9^kPj1lBeFqvgfK$r5z^3O6%0nuQS1dgCI}`F2l1R_2#gQsyqXwRD_`D3y3~2yWo2V!`FcAdRkGikb+^=xF(o`Z@YI^o z)^&+$_z>k4%QcQ^K}A!iW6g}2R4!+UiLx@a#`|`@3w9Z=aHvE+H02AaJ?eL$GrZHn zDL+iETNZPYXJg8iTBC0y^tv}W z^AvfHte3n;@!a+v{c!rL<*^*Dpd6Lj@J^E_(b-g*i&jG|J5$yq^uk66&+Z6kitukh#J2M!`J4$4EC z;{bu99QYT+B$Gw|`PxFZMP>NbJs!IADj)@haB!~DZ5&GMR> zIECu!V{|1Ah*cbqt~>Eq%BH(Jk7EVMMe4- zJj?8phEp_rOBoj-f$ei^{jm-ykECCUM|`b_S+9d892)6{fXWj$_REHXz0NfEGgA<*2~`?(!^;(CrJt;tB{ z%4yAXUTu?#x>%@|y<=Z7+6LTF4|{eXW42Zf)WVE0G3L57;?9>d=e%oPq|(wv5u%@&;1nhD;OKxUXkN(4RbI$Ip{?Ir;e2UR4> zwFlw)o!W+Ivs!6sr=X{uW~Oq^rbX!B^dj8ivhFFCWEq{;E~He-hbB!iNSP%A!3|lE zNb*U0OB(aQ9nJ7FpVFMiNL>21QawYO(rO2my1sukj0;MkkgTcY{{Tduqnt%erIu*5 z)N?9Fkz_eGpvwhoES0HBHY==#HdkAID|NSEdh>xQ*LxiR#Qh+C)!S);qIr&p)S0e% zPm$0@iB_t$YZk${K*U|zLD&KKPA6_Ml{#jj(@EZWc%tc2B*L&C68``Unma&c`e#xN zXS+JAhKI<>?YNhF?~pOzC%wm~^T5~~d(5+{;6sa`No!9&U7jj;&<#syv-+)Jkmh=8 zG}LtZe>iGarOGmQh=!_*ZHvb))JNVgbGV+IVMD2kP89&o#=&!@Z@+X{_%8EEg;{dn z5wpybD;g_PRWwxDL~RT-s)N!2Jdr`Qx|I1RU000*M|VXByXCHdUMEl~gm&kVW$JQBob!$4?j*GKJ_# z9eY^dY&fLJZ(1F$Z&uU#RA%K2Gc6yJ=i0ML)K8y4X>-O{tC^Q=MLkba7`IeoU=9jy zA@u3Hs|Ao-8W!FmMp*?bt;+PBe~I+@R%Z=HmB`*Fq^MXM%~MiJs_C7` zMx~NAYcmtTV#{r&z~74K$5-jbR#FZfM>LWhCi5kOs{rXU*}DNvu$n$8Gv}?#@=p$O zEn84yr=y{hFs7=FfM66$3mIH~CLKVy9CLs;19hzSf(bbYw_&yII$r&Y+NWTu=3%Al zD779)l~gr3re5A$wJ${pmY^uM?Ta5K#Qy*sS(#WGWXNfoNr5MCp+W=|A&bLy)!L&u zlf&GyuQ84!2nAd%3&kls#UOveSL^SA4me?{0f;SOxv`NJxKj!_&sS9$@mIn6&j_d~ zD|6FGmDOs*)5j*}M;BteamO7oHx1%#;s@_?S~okdD$>cWstu$xop!g#^DO$7j!Md` zp-im|ZUZb}T)mH7zf3c)S-5wGIKXj_AF)t|O~%RohPzPskv$a_Pm@-O+M3Ae6q^pg zb|j84Gn&jOCGH-v*SAF`si0<5nLKgFD#$Z9S%l{IJGu~85`bNCl(gu*2Jns=Z^fLi zKgv@lZw@FkI4Ks@6+&i;sfF%#?eEvF5aKv<*zDr7n==9>p!TK|93x3q3oqB%FsaMo z$!Hrd$`YLz(9GUzz{)PfH@UYzY$2(Ed%-mbbIJ9GR!5pKuK=PQN5Z-Be@~r#0G@+5 ztSu&2Q33r#)T_m&9ovpSJShH%j|_OCTIaLl2UDKDabqz*Yni|~E z7Cfy>%SdDj%*$}WRQEQ;u9p(0m~~HDdc$oYD|=vSh1oViluw>zIka?!gD8#@9Pw91 zH#D3A+FjyYayO_)iTe`>!tD%AHs4)8+70#ZuA5Z`MgmycQ*FEVkqvUg~1% z(>Y6~4zZeiZTdN)n!rYhWha9l3fbB7bgzy&izCcwKqO}QJKWsZ+x1a^c()8}aAjKc z17wK@ZjNX8r??Lo@lfOkK?q%`<*ABjGOW)&f~zOWre~t9RAri~B7G)6E_wT#T;Wp# zZdxFnM!=TAm!3VO!1ikSlx&0-@VDlB9V(bmDdhzpioP>+f;Kl$ zcK03d!L@UOL!^PHHO5sWpwcz@Uawr^Ps<#z(Xb_IA8Jag`$KoXwj(%z`gvX;os>nX zEV(YN@gq~`IlUb8xp|{MGV;n55fMF><8a{r01S2?PKyIbCV430RHm;w&HO{Jr^)pd zc3+y&h*or{nh{LN6ntJXACdg_s(9 zN69i<(iZnSoZzZ-8%8QSHeeU2PA z1lM)1erjgY2IyOo)~vaeD^*VMLedTFyzEkX0fOo_8evT4*;?$gO=*osIckVZa>Ojo z?QtjcSg&rFt<j-#pRk1`EcOr|wEs~O-ne426QsIPTuX51Dw zZKro@;SUt0(rBb<%2m$F_1o$!t*Npnh6>odK}p^S_CDP)PJR!fbiU#djj5YOIik%o zJxFOHd45{)`Bg#GFPKe-q_+WhJ$>-F(q$PU<5A|OnHEtxsyybCP|{@en*|gu8ZRxw zsRNPgUJcK;OdQ&cbu&?;tVAB=8dsWANl^uCm6Yj5<; zqzY+AH89I5W`OU+lc_ri(>0(_+JXKJ)m=@cGii@4xc=| zSqy$#+{XMdC;b@g9J@;Jg$>lBGogxMm$I4L@U8e`?fKz_46pUHQIeP`b1c#$4AN7T zsM-=$9S67=nbewlwo(U1sJ)P8`K@vyOFWRRINwgew%Lg3f36i)U}b`sK2t8HjjCFP zqN<_dk|(jau#kH&`u6UvW<1xf3cq-Tsi~-|+LtK|vd9MXeuw;D&lVgV32eK; zM=@p1W}`IG$(m5A%oG4Xy@B?`;K8!t<`AP%WVw9vx6KAxZ^aoLHtaK|;xt0Q)TsKk zCRtGw(fWjEb=>ksBt2!|Q>4@M`LvmJWHn5SJA-T7a(Tc`s#*v{wSg9&Lu6D`=AkGN z>cors+u4Z(arxmlr9I{+VvOj-DK34TrcBV&x$|LaUQi1%IX?dYObJGxOeahGkp|1A zLo;Oba!S!MNI{iQ&1PZ2xES)k-w&`aMXs9CdfNFLJ&SJidzd#~O}+1lT-LMieTqKR zt0C4^^$_M0R8Y$-EioITKZf_=|&(<_Er(t#yJ@c|UBQ2|Rx3GPli zbZNfpSW8tsBG#?`hr;gO{t7hO%h2HE!k`t zg|2$sUyeKD0tL>c(T2DXWN)Wt_Ex@+tt!0I)OfGrma3Ws)%kv%%jtte$xX6kmLP9- z^n)WZo_QgAb;X_S!r-X_DVMl_KsJxje{X_V>TYpO8SjSP9r%A=S6!TVi<7lvl16EA z?7sC+B!PkbW1v1;G3uwL2&aw2Vp|mHIEXUm9I!hFVjH3iGD^G|eov!x?v>SA*EOSy zPDPt#%av7EiC$T@723}NY$aaD_C@)|Wr(ebtyz?59-E@6oG|r4b)XZxCc`5Hkz%tW z;`=A?o|at&OW^c$br77T<*%rtkjT;%uv1VOuCmw?z^a~kzipfDey$@c&MPo*d;sB; zZ#jE3j^v9H*0g}#FXX74a-T~N#0VNKv_O1mxA)cedrdjiP zIo0y)qU6LJp=GGrd-8gAz5~Z#>Tw4&HqAG4`H*5hgiRWOfmI!6Q&+94b4_VaM@^AS z=d`j@Qnt`cr*-2V$G_C#&qFN$DHE7Ry`yggJFj)`E~3vh9VHb-erHufl8I6$s8?lB z z3Lk&WMq_rKYC(G_@X=W|U6oeR`Or+tWR7SK?>mnEuc_^V8;En<3_yZG=c4-{(QxpZ z3Vi!ZRA@ZzNU7jj*Qi-0w&?Bn3g5WCIpQSIsxb@%oS;Bl)9VOD9Vw_O{2r*xX!6v{ z^SX$TBeg;+!6ZcRcG&vG{{SolR++{C>2m>*9j<^>?dqlf01i4gRcgG~Jj`^pHc3-n zDkrIqpFgKr=n6LCVj{y}u;IH4;!Yt^jB_c!q&-;bnDszI07{SX`gy&3scF#?lY!w-Ho&taw&YtWKPK>?sG`{(RY|GZpKWbAy*!H3 zP)#6+%M!S~iRy7ZXPQ9UoI8^Bw^mohjFZDk?5>_{qOqtm0~(0wivq0T!Is0I9go)t zFconPd^@b$-@o=E9MKEjsL0^Rw3P-)m{v$At0Rthn{Adi0^qN`iRAa=9^tEWwM*JP zQWs2O*2k z#+~EO!4c846%fdLCGgk6%}glsnCh#)NN*6!6l)@h7~5@|paZ3_XyO&IY|KwpqW=IY z4*n3lENe=L=NfCn>OAjPQAt;vH5y4Av{6vR12DDO9oy0XAaV6LE}d%G8bDz6uKjY_ z4~^F?%P6_0be^2mv^jMwxgAW;EKMYDB%CS(U>z6I5A(%q6O5^aaXH!`i33~CiIZuE zStic1?K7eCnrT^NS~_Y;8nTqLIuXE9syG(r_WEP06>DOtn29eLTs7Wj=uy3ag-7*w zhdvs3os+|;GTG}gF+~eaGg2v$W)Xtr1Z~CG4yUFH!{f17N}U^ks9fl|%N@VWpnDqY zgi6W$BJlS!(^+0%vPtqaFeOBL6vS;K->4lhz5G)UDwfMbfgmO= z+X^Q?fcZ?&%TcGykgA_D1#dx;PD0#2D|_|C?c=U*R-_x=HXl#CsLdD%C!FS4&X&ue zs?}MUqs{9p8k&zSh9Jm99ZNXuMXr1PSh3M-E4YeH4r4$i=ePDDAJx?pq0)KIv&z<- zPfS``a__cFg?8jG+SbDJil>Eq^|jY!3z%H17Lo9pyH9G@%kz2~+InV5f4=F}zFbH_ z+sgF6d*aPkh_?|hMI>H3fGJu{a>HNP#JF}BS=z=&WZJfT-iQAtYM;wrdN}P z^3VcX^0ozQx(4Tdq{8vRH|6vDXTGRkTslnR2;yg;bvT?a$K zz47iH&%;xPmYpK`yY8bbl?BxLN}p84UzJfy8|D-&B#Bd`k)idLJ*+zY@MRo9r4Mw$ z=g(+dWt2e4GTk$k!KM~0-{oEm#*%nKi>p*_0LD*sZbksC`kj8P%S?~KJFfD= ztzM1PHQKWxrbMHuoJ&0~{2?TQ?P1&#&OYG0O}K^%PB&1iN`Mt20;diz2PuL^96htcTo%kE1 zG}dOOcyAwNB@QiCyJQ<5B>|usr;>O{kw-l~X-}3#Jg%RtHnQ7`56b|K zB=-WsbX|%tp0gTLkt5~HmaH*6V3<%7xm%zX#|(E#)|J^1hIvavqwC=m)bgs%`zoV& z%LQiqHV4?@l|j4NX-IAgZT^R3#Zzyt;*>y#Ca)2^Bgt!PbiDMU ze8KY!zB;O@JkZiQyg`r_9nT<-raQrL2edpmwYgm#+Q>b+E{z!hFzKHS^WA*Qlw{c= zBjv+%l+>$ggif2v_aqDzR~XtoXADLDY6ju{5GQf(gJ@#Ge?;Ko=+%1aM^$gW8GJUP@jpvf$wNFXsj_;A+A5jT z&4xiQsS6?E%g*n(#XpbZ--W8yku>Twwi=_<(QG8{{UkSr15@vXVQ)TdQm>Qzz!tS)2 zTIIRsit!S!D9W{NkgH6l8rriI5>!A`oyzByV!bW>c;g*_rt;TNF;1&`Mwd=T+=uDC z3&6iQte8e-v_h~ns&tSYAq;P(?wqV=R(QD#O z#?b;A4Y`3R3YIbUx|31(w*^H_JS+2gwJd|n*;tBIO@JV^i6H*~3t@BkX#z%8nfRt1 z{Oioz*BpaMrg2%D=6Y96OO@25Go#c+ER)ecnmn=|6hgw=ufRC+zAK;swO$=MG=LxN zaRGDD=Fu$hJ1x|I3k{uAYFwRlW{s;cR#XhXb0MjSlDCdvyFm3^xB}o}TwW%Z7IO;@ zN~~}Y{W5{MVI!6H@m~UI?3*)vMXY`%^KDhA=yWz+nL$$FXrYRwXtNr4*Zde@JrXjl zuWk<($5kCih6ak2T*73z&`mifK{|IYKs9s-X;VwA{vR`ZnyWIYpCg)eU^kU^X#W5a zjey|&h7S*;#TY{aUl4SGxRvypX6jj|{8G&;CeCX7FwSHrP)?7WrfCKZhi(Y7Y-=Qq`S;2dwhs#B}9zlGXjqcy7Vn?0+Ao{bq`l49vIZ@iEZ*K3Qf zKKL6AUlUg-#5Y1r$OKve6TQ@rXa}pZTjE!XS@(^SXv$vPR<4UhX}q$TvjwLI``M5@hGG>`BP5t_nlE<{twNNZ!QQRwF&MkwhiKxfG zXG{olVp=k`L;DH1@j|uZDdr8nm0W%~Ybi2p=C?}HMnoW^J-a{DMmoPk*O44}@bXSEk}gF0g~PsEV|*m_p3~mr(eluc@?l zQIb?wOPN+j0Ci%i1RK3_IUT*P-wiRfP7a4k@&;duela8f(b`NX>C?_(SsxMn0@5E1 z9wyi6U0;;fRp<=*o+Zn36;+yHT4NjGMEGUm5-5HH-* zAxtTBb~~!Y;f}t`{0`RIhCMw4=UGiz*-Z76!77AmSOCD5vkTbRo7)C)91-GlS}GF9 z2?r^Gu?NLRP2C%;tRx>6I?h3x!I|X*hm1B^9V}usLcIR9M_vHMV13Kb1*Nh`J#tLQ zQdPt`(yD62{wA3-Az4vHQngHHaU&p(M}DifrH@PE?p^5JQ3ODMbb+V61i?D$t;IfR zMdNRVkD{ukl;?B}P}wDQOWt~~kRZ;RyQu_XwL=Opb=^^;)`CNQQ8ONCxf$Est4>L% z4$3M-qiEihnPiu4$3i(OKAdsyhcBmc=@-%$fWU<|%=79ByrK$&LoIjD%3_mbR*^lJ z{XPBg9V#WR)+5budspzu^7@*3YC5_6p*YwJjy8^fdt;$d%_PQ(5)j^f269U8I)!(% zRWO8hdlf>~cDJwx1`Jkl*3u8RWJNp~ebEcXEiIYknUlRW6uG`n<-o?eh#iS=30EVv z$@|+7VJe3=P#h;-N^`@VvO$|<8OCjvO;46Z9QiAxO)UF}sY8Fm9A~YMLyjp{V@$g? zVLJN0E8l|LMU*dEWp%l-Wchwi9b_{^1anU<#lsQmkdNqr(EH%bHBbq2pw7cX2pX6o z%OVT-Z<5EA)8%q%YL}}*UaG0dju(u9c!H-Sb+!1wZN|Ezvj$k{*$7jH0S5Jdgqnvl zW}7UXrK6@n9UN^c-J$kSynkLC;rNRi>uPmT^f^=?LCZ;{A3a>vlA5-eRjJ>3S)!C5 z_A)z;FlH)hftN!*N+M+nv)tCRJglh9D{3UEnrC9uN=aw>l6ssoV{(X6gqtg`pb z_Nr>CIhu_olv)NiDo<9xr|7)cLtA;`4gp|oxjpbm8QUXO&Or*w zYHb6Y=`9#@oQFH7mnEw8JtXX}DwEu9>1&%?3h7jBS9QhLZD%!4<*1dMJF{;0ID7ya zDFZ-K+^17dO9DnDCBq&MvA~rmX1amQzc`cxK(bdzMamI!;=}LT9~B#h{FgbRFgDW1aOyGeT{Y4Zg*8P?uCP;* zcXUzIkPrFs!@%7~kz4-&1hS0hDavyU)I+rywnWS>#>1!YIH~bEjB|kR@v} zYH1cY>L$8y()nJONX4!X+V}#ECJi-2Whuu==91*o{M%MFUiG{vkGYjk^7`YPO9ep@ z3+9MN`Z`9<;-;udBxzpE$t;|4`&)bcabA1+B1QZWASqKvLrk(q95J#5CPa^*bJW|m z1qIGCC&fnKqLkHCc|z2|6%hf*%(qthrhzQfne`1lTx}%-NVCV~qn?G0t+(^N@x=-ba5vvY>x`~>ZeNt< zuv5|2&*n5Ziqajum9Gu)L#@iW^tNo z9G(0vqp!?zVZSh>r8I2Nj*MC6QF6BA4t=qbz1cu70v$Te(aXJBnM!v}()f#_b)6Wb zulR7!DyZ`q*_EKBh2fP+Dt5^Pz#!wHvG>Q#=-bw80wM^_BezFim6z2Rbj&J(hTybv{ZBM1$?v@=xuAWVEVja^^0kPQp6H%4gPXej(>xCFY(UX&MP;nwKl5T5uv8Vyv!}zYtaYL?{c-OMP)a2*5W6%C#H@ zXSkU$A(N&1_CnOCUPDgEtEs*XGMyWvtF=ydSyh!+{JTppphpTBIol$S#e1H;KRhL) z_fqQkj)jdSxvWg-ZhlDGm@wAnRHMS(1*R%y&860LF9jVE2_kszB&fR{5Dwnhz2mWU z00NNf9Zx8ae5EXJG-k^4y)&X?T<=EdeA`iF)bf(mGBl}8NTA=>8iFpjJf4_P`gL&~ zO0Q)yW2!YPuriqnd9E`&w^-)cF0##X=aM?gRe%Zy5l={#u;2hl=c)Fv7V#b>tkUz#9 zA)|HdRCggz}Ofb{a(jt(u0CuQ#ZdJJE_;v5|Jdo9Bw`3>P{u*j6 z37BQMT_r6=9d=!heF)q}VQ~|w5U^-j29`N8A&ZvQVZ{mg{DNWi!mX@zS%V5kBStzC<3V%o* zH-1Fl64oWGCAxy4X_cTkbv{Lr>Fqm`%TMN0Wz};T45@hPeACA9+ztjPZWSL<@0l)d zvM2PWFd7jfJl0x2!t9d2H_K=vsLX0$D5jbsvOrjE+Msn&^}?E1O4!GSJi|mTO+e6t zULEAQZm6bBNvfS-jxExa^VT_7b-9Q6;qE@Os2+}x;>(EjsmM+HEIFK0Ta*3ahVe|c5kV?G}7Zd(>bg$wRB8s>EuAgqI;=O zNftIH_WEEN#-1XsS2Xo>a51kwdM?^X(F<}&sI?!TTRv+zT5a+QaXAYdy>6hB-`fV& z9TYS)LEH%T^IpP^Caa6X;`!|IR83ao`Cdg&l`tmuV0-a`okP-kmWxcUXDWfwW=~&} zRM*sHuTTYB%0T}B2vPlHvF_JA;MX%NgJeVjWe74Anef*k@bkpHt0xut2&hV_8X3(u z>g#CTZTi69&+UrW5UXDZ=VWkfK@+EPGLu8BR3F4Y1v2jqwWeB`byZz%pJ($XN!QM( zNQoCzHX)mjzqSg%@mFIgl0#ci3tk&5+LXgjVkUTtuCjdZHOezBJv8r4m%<>6FRi4J zY!nL_7C;H<#kjy23?r#E&8Pq`GG5niXGP%>R5G7h>upxXC^YguV2!?tAxhEHlBa?< z`fzWfQJ^Kx5%HW~cu|@C3R$kSenqIVY6@J!mMo`V%M_E%OB@8pDF z9F>UpBk;WI?-Wf`)zFN$Ax}E0iH7E@Spfj4{g8&_`{JkfU&KZe4%QG!s^BvR2Ezc% z>zyUC1aD;Tg;E`N9hyMzCda}Q8^!+s6q8+em8>(jj+U1!q0D5;vfnRm=#r2Wb|rfG zhpqjv*MsoyM8i{U!=BLhNk15p8wX6H1-68<9bY{{c|h?3=fzIEG|Y3q5OR7>px}m6HljTvLYcNkaNV^TYfl>+YfldX6t13198(iGPNdue>jOl*`(;Q+G-->hR zz7^1D$$o3ksaR2Gik3qw&Q(iVK-{YihY@h$1qU zMLS1P^1aoG*G=vU2e^!?`s+Q%#ht2~8Yp`iiMi>@2qye{+a&ZK_GK~%a6V-HR&?5O;()bk5`vsf?~?RROxRL zC#Z_IO=ZV4$lf5YJhgGDiIg4Bwn8@p^yzMTj3TD`1+!DC;dt#|LD^Oh9Ar&Y`ASey z`7HowD~!8$Jm7N4w4OM{n}su>2Qi$`M{$%5P^+eELkh;m7iRe}dYkt)#fh)qngq2@ zE9e%R!|aDXqs5`mP#mLd)$5=qpw^^h^lh+M8MTbDcux2K*%KcebqT-Z3b$&l^$tA@yu)+iB`tM zcL4Xo>@{zMX^=-*u5X{{UsPsa6#>dL^iIo{WtF9=rH!YiM&*Gb>HIkOd>UC&S|rpz~_D=kN0tg{7QqWGywSqI*t*iE^0QpdeHhx4P#$WwJ?gUJhclhUt32V{JMo=$`7!= z_2bN5Akl54KP)+?cBvRIC0hRgi7j6yTc8h@64qAA&_L|#dkbwX_W)v__dkctUy!?i z>>sreS>08h`36l#o@dmVZDwY2+If&K&BiRM=GWlxe#aUuT7`@*12(2NK>;OOoj0R2 z{)o*Qhbhb@&NCR*cGPBXzL8mn42(Ems2w=PI}wSgiDqYj){<<`U&qVEGosw4%G70V zH1rUh&N#km;BKZjjIjNnez>F70666)J9SQ46hm0(46{3_S&(e4a+~CkU04Ii`}<*r z4~RaKZ+7k8xHP8fT|b677H^hGO_pa7AbUnx9>HZ6+yU(P9C0d?-!B5&9l>36LDmU4 z@Y60|m!znYW~)?Pv&b)UI2S$obBLYADiU1)G@S;@K|};G@q&f4{!Nk3SwdpW&Soj< zglly)Y@{TE^Bm&I!yYOTvtLTTNw5* z2FBO>;q3~90&VLy$4g2D?S%|oH5FX3M?R#MsTMCX)kTY~hpBI2VmQCOh72{xk{AW` z8Wj-;x1%P`bD8qFC@bijEu;(x0!ZxfT??jM z${kyh=Eo<=yhNyNyXxnsrLMe59^gtA0IZ64k?J`e>{p-Rmj&%MX z_?HfznoQeM=~(oRYa}&u)j?KPwyY~$DMbLRhmm3570S5!4R=63S^6=QhYk+8UCxw>AWY@Fl7}LP#NTlGBZt2G%P)F$`wzguhF{p=x|OGi3~s# z@eR)|5az=OaBgc6xQi}a!U-VULIPykt6XOKj8rgEHjW|>Y>ma8)OHzga zD)nXE(+un3Xi=sOQ0|G%&C#^%#w|_a z)|JkeFssRbNYl-mQ^zC?Stxj@eqKW8wATTYvfAUgBikC43l7l0P07h4)sHuJ#VB(dMT{8Q(q+W zmgx@=G96W|D|9ZeuX+k7pq7FeC13BaJwcKt-{@vW8%b_0aoYns7eUl%itK1}vjXed z2+}#q>C7OK-2{7gQVkX1XOCVr<=LjOG?X-RWPdWR1nQvFc?x7PQ?wqQ*B!5Wcfn-g zaHP{9w2gOPJW-?2z8_HMzcWO0s!1k|q@$KXC#IFye!3Y?O{bgR zfsVLsOhz=a=9$Z9Y8>B^M)R`e<1DJhs6Vs{tgA6m4PK+qo>VBQCFx6%e&g;9dSq$~( zjyjh|=NhW5=%dWnHKc5!zIbF`(bG&%GDRKDiN7FyFm4-#Q>?}bBcpb9hX{OfHWM2q z@2e7hd=O1D?l{UQ7tn8#7sr(bChcz>45+o%0 zZ(ikEZz0whOOATu%W|yBWCog&M{tE?k-aF~k$g*23~Ifu%sMeHBQa~CuG37;@Sq;kxbwdcsB5RO&;z z+9!V#YP6+YJdo(st^Fh&lva7AUZeV6rsUjpz9Ql6uQOXNQaw;0cEXyVZmrRI$-EYx zhr-QGt7pvOZAnVe)lpJz{b{C&gG`$`voiFzvB%HiLD-hkgVB%yF?l)>$TW+d(28Jz zD%yBO@QbhhBsBJ0o_};)t0~f%g(|%|@WO()_8evAugw(!6@Gyw(j_br zqb;?V6J{7M8H%Ng$k`$74u>$yZy?;YpUvsy-%Ij=6U@~ z?lR5mk!bf_Bi-E)8xOt@qeay85ZJlqKmt!~u7@WVB=R$ec}=Kz+qbCWi{agF zCfqDFytVB*sM|(S$0jO$^A-*s$&N#5j(ct{*la0noj! zw0eg#U9OM_Gqf)0^$%BdrC$&}8f0E6P-dBye9+WonQa9`kik3A$+6fSa~zjN%IXG zk4RAc<2Jqf-x@=3)oC_Mvt`r~1kLZ-mlp-|R?}v>B9)9)O_{k;kvgu{Qp3^##FQS| z<{UEK;dzsihIkc4TSFeDIrddM$0-sjx@;=^mSr8u&s3cucItA4 znwvvb)<%m{nwZs`&lHBol<1%ipVx-8@qkH>J(E{luIMXmpJ-AjprUHV-yWdYZNkI~^48 zIEp%nR0xM8T=D$yJtp+h4$z3ONZNwFYMj6q0vRIT6BfB<0Gnb~)C~ZR(e6XmxKN)W zr%^#5db3L##>(LcHg)TJ``ZQw3R_B5Qwl1J*%v%E(OO}$iSmrgRpv`ATrD*fO*4d^ zI)ozV4^4y~Z-6max8}?#h!G%(pR_0k4rsKX_mAEYX?+t(l}(aX$(hzxIhJ~giMKlr zE~Q5uZ^*;G8^j%2W&nfL0wF~18qvB2)M<64$?K((U{#q)AUD`;$iMroh7H6L@f!v3 z;lKm*FS;`zwJeVChIS-^MeGOpaqcR-lzs~a*0%boyc%McHiXeZK!QRG*e!`aOfNOv zPpv9v;hF}TsPFeYeL)nIxfMO@DbDFsw!)wr7QfR4vm4P}=GRDZ7-o?GBUL|xlpiyd z)Yg}oV}M09+lGC-i}%8}@e>3$LS;kfU?~ddyrVG7X4A$Asgja!J+`|Qc$iydo2cWq zAUL-)=bdbbZU_>h8iT_fHK?;zs@iGc6zYXz;0BF$^!%_zE+JBzW3@1E3}Mv)b8ie< zC?u$%lg>qvloELXeem+15Rw5)u^0frNGL}gu$BEQ#YE`^lv3Wh{9QJ7h&zj zCSX4oMe!22=zO*uma1NY5nDIW`P>s_ z*}WBHRTW%+dy!@;!o-2!`mm;!EsmCv1Dfg-+KWimX2B|+Q%Nm4u#z=vZaqjN>HT;C z*rw9z#Dlu@Hc|}#04_v_X@|+I*v2L!@z{0zzpoPE-XC#@OY{@WC ze^qXFi{i}8T`|=P7c`romae3(jtPwUX=ZX!WMNc&1()2lU_H^T#E%1)HMuI#(LHVNXp8)66MWrbD%vt}Vr{`|;yV@3N7lO6zpI z^U#RI##zSQ);C68ztw?7a2<6bYM(u9sLcjrNgB&6Xdyk3c^k1iS)Z)klm*GFQdfpb zN=hZ!GJxJ6ABBdJSWL@C3KbFqN76K1`51fVCp#cQ*2AD zhIJ;m%Kz7o)Z~kmXBmcLmgJ5z4CKc3)ltb|B!JoEW%qt}V-yuLv^CD^v=G*iNr~*z zBFX;%N?V}SSp1*H9Lp|*WR%pIj$InXdUT_%+YoVoNF9qFNbirET(!0^Cc`oFQJ0gl z3wXWa4somWeN=j)mZqiPn18{BP{PN7>FQJt_@55)YJr|$I@3DG=t8{Ct1HvQ`pllU zJEo>3lvD|F`OSqz6p7K}ZlLqjdkkn!z>0yS?jgfs4?kjE(hygzSMf>Wp03F2bgrP* z6`8(QS7mgs*(|{YtfEHs01hW-3!=vdftAg$14!BzX1j=AG;fBp_=8PFP-{grB&=J3 zxdm)F`db2Gah{G$2|BM>%)x2am(bK2Ge=hGOsB+1a)hf$+M_V1giJ_Vw2(R;2w`x0 z<2Qaa)$4SHnT5t#Ex&l>+L<<(0wqzr^F}Ufn8%Z7`kLB`in)z1%ubR=3lhZ@ls81M zz4{DYDdIXdX04D0^{hjWV3FUt1hPy8WM-qyya1%5(pkQPi#-{1Q0J9ZnSDwlxmExp zgUc<&+uqo&y`vuEP*mvL@4be&NC4hIMKtB`Mn&<*!@umk1yo#1y7vviHMqM&fW{h! z;O^bHOXF@q0>Od?_r`*|OMoOKxVyW%1PB&lU+0`NbI!bXzL~k}p83|D@6BG_yEmKa z+SSkg*Ynh>UB4>4qsvhz^#lzogIqR!ost4=T;A#`dg9Ga3hc+ZL>A}T<=Bx3lgVys z%IcdE*Xly^ohnq6Ub4VF)yyLf`3&tZVVRz(XXQ8sq+5~9c9N(Sy0h+*V(&!aa8C+V zFc(ARk}z)!6=Ek`@HF=Uvt;pI_kKp{20VK+uG8s?nHb%4xQE931z)*>7Yuy5>@|-B zv)1UZ$_-8m&-%G;-S!@bO?$|Q4w7ZW1{``> z4^9$_Q@sIWere%IL2kUp88R~1+_}2<%er`;ZAq?eZr z!#cg5ByKk<#$RMK%{q3i1~S%{CC;OVG^V3Yt=nR*>XU~rA09f=)qC zFt-rYvyR0`S{V>CK%KOqC3aM1(Pjo31_ck|&;kPsRxI#eR7RJl#kdpUVLM^Q@7?PP zA$UnUxs^5wIq<&u%swmwwfEV)w5jxp24AhtoYC!EIGE?+y;g7%5cEvXnAYC3$Fi$f z<;|S12l8EGLA%Mpkn^A}0k6#(a02r3^7>^rw5!ml+p#Ub=Q4(cY=hDNe4ls7Vt^Mt zQ7Q!(9#A5i)<5jB$U3t$6Byk0eOSr(9!AB1L1hQck!TzFO;?*gN>`ED`m&k z_E5ZIoJk=hFmR6bK=R8>Bx=YGQR;by=8v7@OR{^{2?lZ6As0q+*W=bUyOR^?(9@n% z_r7SPo4)Vv=Ah<>B-=E(&b}EsV2E0u8Q#g$f6$*ekA5@*(fFV+hF~JW;gCH|9aHL9 z2*vQ6RdZi~#rFBO62;=u!44Pgi7|2eO!~`Wy`a`Q(RHu7kP`gK?%a7?)eSzmk4i=m;v$Fa}> zxZ42md6#;4cWIEl)zUy_G-`+01XTI<%FtNq^E#TKwn5uvFvo~=(Ddo3uVx(~`j9w1 zZ@Fd4aB8=%nD`_-6fob*6XRR4{JiGXiA&5^6U_^A z+BP1uy1V*cpN<%Kt*Qj8pHL17loP#;I==2wd4eOTy8~ZavRd-=DZ!}YUBxkBVAHw0 zF?d&q-<$)p!AY@L69T34tvkcI-|Di{*aAzhO8b~=5w9mOR%#${~&GBS8jQuCwNI>Y%Bqdk3oed82ekTkNHUKQ^g zx*I{Xka?hhKX%7LbS+*%e_AV5mF>#Xc%$rlb62@%Xv}kg)KfO!;Y#eONA(y9q|A5qK9JhdqOY#9yVJO9ZVZcK^klX zs@1RO4+*+#un5%jp6J~y5sW;wFA!(n@#QQJNvdU!&M!@Z*q2EyfO?+U#XGx%iwajB z;87Dz4-IKw5{CV(C^*1hJ-C-{IErMPjEVhJ37@h4{OMNVbk@0h~if5qS|% zD0`caqG5q3VO%Z8m_tEjb!Jb2U~NZ6eZ9hRzJORgF=1ikmaE-^x!ovkM2~mwxz8n4 zDc>l}_}S+QvzG$Uq%-Q5vZN?`mB~U?a|N@eI1i=;)?}edsE5P-IQs z2uzbDW$8>u(`gCo=W19byNj}+tpt|la@%bI4?P*$Iq6o$f%uN`2I_sHjXmsh9dQx- z;o${2xkPqBvQOHy^3~WDa&b<`$&98p46s_r2_LbAfYp0Uv8RPcFNc~75x9$>!Xb8& zIAFvLWafMa?`{fYkwSBP4%aB}LSxY{1YSs=Y78p-G5gs@>8C!mWR?{rc|D|PXgQE@ zW>0$Z>X|b)6LnZiqp;i?5!UM`uO2(4hv!e!LO%jZM?Jf&n~>RtzNF6ixoNzTOGItw z{$S?QpCKGqs#iBG-Mg*PK{pjf*3UWDAu`c)rCrxA#w{Bj5@%g3=?YJQ)A98g=bf)o zF*cFk`%VEjyuf*>wDkPzXA!9;R1nvFvXClh#;&ZvL*7v_35GfbstkxS8MoS?vZ{0e z0k*X^(hMnkxuj+$2-GvNH?nK4&pGsE-SunY7Z{hwT?iKJj)UgfSg|^m&pp{}G4fQC z%-U&7_4H8Y!v%xXmdiI2Vu(?0G^k2XpU+&J9cK53FBV+~*itu>jPO1Gy7?@kt)_b9 zS|=ykzyO+&W5%PT)VarnWWrB1_r=uFEv}zGRPQ4cd-OUET0k0}Dt-_RW(XKIjt!lWP6hhKeEIoKgak_16G4a~)s^sx$ zbh8@Ee8}REg|lOUdbOKziE2Q3p-)IO7=aCV{vL^3d5k=f|@NMhS$ zc52FVf(%Y7CT1BSVp5k+~wRqk&sf&Jo@u+jsnyN+vqw`vUN8vJtmD)>{*NL7$AKeCIO>jb= zDB3RNB*N^C@L~S4w=*NeG?|qNxO_S)^`LGIZnqg4B40UruvEy7i;HFwl)Ii9&h`a1 z@?)i%>u|bFpewk&)zf2ghoD|I6_lQ%AKkb2J_{QV&8U+t3C(4VQL%js+D~14k=V;Y zfoeFjrEn{Z>;K%*$F?Pddq`B*H$^x%!%lENl%q7Q+`iJJI*BJZ?88j#j$sM5n_v>g z0Ja0%n*)(_UMe=gltwvY4OPBlic&pb8KG>gd&Y99fpCy`Jsi6h$<# zTyU)~p(CCUr!)qBzqBJr6&+kQRkbp~HjBLwWW96Ba(e`vxh)^wb&`|N@au)bR_ zPtm@Z&l}@g!{Qg+N`v_xZ-$WPNF6)0MQ7FMKP}nLKlf)9ITK>e#<*4PJ~CGzh$6@} zkbKdDTj}>cCV7@96ka(z(2d#3=c4|N^XOBN86k+XY_ipi96hCz&w7TM-Lpk1VcTuS zvB~N9zy)ITTP==<4>`sjdq4!#I{W#PUwiTjKOfceK1Kl&hi0bYPPdil8?}|Bj2vyh zge?zf%8;Hql*09{j8LGJ{&1O0o0G18&mk+RP|_pI(rpP1(OrC|48%QRY>4pEeLYOr z{>xcOq|~{GgVg$CuL= zF_XxgfnD65nQsRSCpS}1p7iD8hp-Ge-S=J#8#f9sy8KElhwDy?eIL$)4>#rtlQ(YF zkJyZ+#VbdldQ6|}^&o^IP|apaIA#Z|dHQ86)2Ju-Rg|*%Nf>B!YBFb-H zCf=DRX=xrFQS8|bO>07?be~emj2hG8OO9wl62zVc$-H=?E za_=#+oj;b8uHDYRcq}}|b3|H8qf*dPkjt`L>}}q*om>e&@a4QaQs`>w3y_;Old-qA zhUqNGFd$NF(-Y2XsP-{oD%7Ual$fSwGEq}|cX3P|u|ZO0@bW^5eEu0=`lw!@w=!Zv zupOzmkL)6~Pq8%vw(d5+BsdUcwORBAls}&gg3Z*|U#P>k(g5VH#-3*mqmEL1M_E^j z-)$U$C{|L>upq*K?J=H|6TkC<$JPmH{G7FFBXKuy9Bugw2h!>&T`WeTWA$6>A-8j(}hD@5mrNdrX%CLT_IIx=-3Rk$MV{(O*_3i4=?HIjk36mL9cMjIdI!4~`WTl?o^IN&Kuo0QIM9@-kf5UqzKW(yJ?cJ7JUlIeWxPO=z${vN z=ec!oihdNO8fK@4IpfHF;1%y4fihj?&_|V$EY7l0n=<>z?!mopEbvGP{&*rcod5^u z;feVAo>ARN^S0F8>w?RZ7WPV}K{mcUU5ZE4sVWAhJUSY+OxIrvofVH?_)~X1(k`O4zw8NkVFc**fx_TvW}9=)dU;t3mo-PY47gX|7F;G_|=|Ji%tE7NuFdsYSLa32LJ&k-hf;bvqy@qb>s* zjn(T}sePi^tV`VCGxNI6Uu@0i0W8L)Lx9_G&zXk%-(Jz-`17F(kCI>3MW+g^LgZg~5 zx0G*)-5RlTAQGKILt4s>zDcq|n3_Wf65i-bYro`a^+L_yT=1$YeB3NkiLAYm`wX#z z$fsK0$YU|ASziUyvH+T%LC{l;)F_h3 zCN>~Ff@oGjTM82kpYwSLdE%P8ikC##r`xl{s^-RJqLLvWfgJ1;)Ig@l*y6FXptZZE zEmN&fB(&qUR}`=Eim{cAT{Ex4HC6MQsr*y5wEDG`vm_~<4OtSJQY4n$%hX=RdFMS< z4J&i=gdTEmxH%MV!?$U?k^G<%Uwj!m(IKe~Qs;Mgn4Tf8@vc%)Xm9oH=`tdwbnO&8 z7BeeFdKi6)anT_kY`~PF%m)t5AhIYra%Gq8TZ=a*ioK%gdQO`a$(&%sS*WFsLh~Ty zqaqE;(fjuW{aG>Bk5ypAB&&hyAUvjlRPgbrw07C$NJm3QaKT7JnU*k!!e8qmv3YFH z@YUR%0E&zzC)|q~X1+^})&seL^$Kx*;N$2ey!h_>uiTey0dQf~q&XB*zO$NrVwwsy zE%2`wvr15kJN2K3P_P>rOsq7hNS+Q;E8P|YBzJ6Obqr0@cMn)n9)V^^1~I7l5#ybm zK5aP!8Ent3Dv+VOskF0xT&!ekhR z5HNPGIU<44Ty5#n^5`za&QP7tl9jErw&J6(lXM1TRF_BN)1iqB`6U?HB}_pORQ;tIfp1rtw?Y@HJQT&`slJf!MynDOPk|o4f6;Nx+Kw zgpReT_f|F;Vh~q0$w=U&VNnuot!edzRyp-co1oNEoNeMrm$@7h>;cmFLz^kmJv(XL zdb>?1H)g%~?sBtg=hyk}aNQC3bhmD7?YAS^1)IXV&emrV8X{cB;7A5kf7ftRrZJ`N3Me2s`en>_OZ)7cdIcgoc zAF`WD6tHn$rF#1LG|J#)wC)&@|DvJYk6zO1d?$4Z^_$I=BL=6z_}%ie3d3&!+^RiW zEBo)c)ZW&Yz9}%65KYybA5XGL{@^O(d7{Ez9Z>Dzb&s(%A2zD;{Hf2JwU58SG?nn^?K`G?(1=h05o9-C;H{XeLoh7MwZjKxV<{{#9T%MFYFD57nui(*4g`NWOO=`UK zO?{7(t)&;ZjD`8%arNvYVtR3z5q`?kBb9?Llo94YD()DV38=@M^qSJhQY;>{4 zW?mLj*vgyD!aJEeVKux+y0CVmU3sp&kZ6y_aYIxzu1eBsKx%T7k_Rk0gl*MTJTHAO=7?8l~z+`VfpgA9!_V~Hgz zTJK(O?%Cz-Rf5uHIArL!^aY&QFtm9yEt7-fLuI~AFnkeKsHegF}L4a{m~lqMAvCUFuZ z2;Q&b2M@X$bXb#px?Dny7&9uWS;51KYeojHZ=Wmtg-;KZ_*} z5y;Z~(??E@Ig6DbU@8xMGy`J}2)TRJ z<$`9pLCl(T@z0!FiK5(K-T$wa+hjFZzQLw6omN-ZNao|<)|-0Vi-+>A@-U=){;)_c zlD)DjC9_uyr=(fhf+<+$tbL44I2&$*}Ntc^Ss8@vI(!7DwkmR;&wto_$}$H>pQBC#E$AyZ*3Q4 zJ)ZUneLOP$R8*%c*Q-6@5@-GuFV8%b6-1Z4TMsX1iqiI2_qgaqx3SJk5|Scx0wbpn z-g?DcpL*=VYwbJ3wen9gB%7XngF>o~eyP%Z<-2VTpv>x!cY z9SouzqaGxM$tqKC8YLpfaUMrGxp&{1uOn@7*hPmky58$Ifzgwd?a3fQ*_lRVI+D0{ zNa1@7hM%^sjz+E}&!p2*1Fo`xLV7$Ns!?$HKaK z)I~3_tAjO5XdE_E174%ln%mV%ATmOJ&x-=RgS>hZ+T?v;YLqg3$3aP*1i*9qli9Zy z{7N7A7D=zx95Q$G3%W&%^Aq90iEsJMzv_WZvh0E0)2T`yU$l!!q&l9(8#lp~IY01l zFjE2w3zD-^FrpNfrLi9Fl!z1+Iq={+INfw-w?&vwqDrOiZHexc6zJKj5ZafE&u=QA z0~{q)$SjxISeMWoni;qdXfG{{gKrnos9-DFILf9rMTeEHyw+Aul)m)RRmFbf!10tf|G9_oC=Kr7DCW5oobDG-23SqU2={seB76czuW#6PB z?Xr@XqM`RdevVo;wZzLX&3*KiBYh4uYwg^ujXSH-Ak}cj5IH{!d3(W9ty9=5&?*Rg z{&E+tx6S@7*Cea9X^j3{>vY@M%O-HcE|;%JD#5@3@-j9YB{zAigDuz+GkXVz|J7sr z0}(E8+cguUy&(SlV7O} zgaAy+q?A%&$TM6}m6RX1AO6yd8-Id4el>cGoMg*XBYDQx3_)s5{I9mTg#@Y(&N;2tj~u?lh#rm0cvVGL6@0*Ujm(?@>N*paJRFl;qmUSzWip zW9Yg{zk+xug#*emlQi&<0=Hj9kLwM8NR) zYXd#ztQ)2W1|JU(iJKEt--KgU$V4nsbqpDZo*S=JenMc;MV6D9wSlfXw zy2$zYN}UaSBwQ9CaG}<+99%KyX~mb_yR?P`TPBISY*_mIwxIbfkdJilN!eU#DZad{ zs$NN!-8I}W?Z)Tj!!T295$r7mXES;MISPd#rrpt#y*PqSoS;Cq&dr+C!dWdyCZ~;Z zmQ|n;SQSgEntejG6ZoiOPeR%q9_5Ln-kn`_>NbUiNv(<;%!G*Fam)QkM zY>Gg9LC-W7z+hWL1oCRzt9hcK+9c97jg;l~^xmzvYVjj{Hx^giU`hNc7nDsrS%029 zhtS{vgekI3F0=JEF98#vBUt!JkLWgYeo(ip$%P^r>mIj8h(n-Z^(V^{R-i3#UkCPd z?D^i;Bk9cjx}&!8rVdM)hHuedjkGa)8fok6sZ}J^q6&fVb2}b8#dI3W8i(b4W5toZ zbZ>A`qon#qioPKm>cy!)mu{Qej?%cC`(zMom6t*We&I0&=a zv9gzlWV8ruIj(0VEF?=DT_LF0$M{S(YeEIGTI~*4(&W}D?faa$HOa!IsVuqm#xhf! zr$y<+4Ckt!*C{sbgt6$6!mJ-`#FMhzU`}XPseIraKiF~X=Z025{mhu~6B*)))izxE zAG<|sYe~PPs^d>mfb%)Z5qOxPTEJPsbJt(s&b|deE8{zL*lpYVWDu-za7db1+fHL; z@%Gzly$1z7u4YG)$@@Jx83cbyN6u9AYD&GEnx*}&FBKf-2^z;}rK2y4hYeIZ1Wkt& z=!z3i6NANHBaC+lcDbRDVF!>{W?w+3g-ZOJG}91iFM8dhn#DCM8VqnHdM)iEAH;L& zMC31_QJfNY*Wgi4ip6>MSzuM1995T1MYo4IkcO2N zO!1oZ*D!}hm|+DOYpK|VacIwXkK>lPS8Y{tj@w#|u!fZmn<_RMxi3fFc7L%ZNE^lm zjbdUR#R`4XMx4D5ObSt?Eg7?Cz%4Yq#xA&p!=L)1_kyihuep}9&C)7o=!jOa0=R0@ zHgtK?kn{A#2W8zk4YHPoUTwAaUN69WTIDJNUjHq%8X=9B!qIwoqN+mFQ+432>t=nUlxk3H->VX1k|ailT;X@nEhu zq0k%ho`D@-i-($U*W@7ys_{lL8yKN2)~hAM-LsmGCGE9Zdj$1bdxW@Mn%lUev;kqy zWL6dff)MUDDpGp+SI`#XAKTxNnlQgCs>~2gIIAd1oh`Od`AY$S9r}?u`}h|S ztdGCA(64n$vDiQf%qb`%RnJj9PTWD8ALNAY%4f%UkA5Hyer;-x9*+VXbyk)%)C6fN z*zG12ND)G?^P>q-QukIaU8%5Qw+N(jX>c~-4w0VZqQ741-V99diA70vI1*yLJejg+ z=0SbcPhMttN(=G7#$^65JcI5YMMPR+w#%3S$B_d;mQz9-a{h#CyqTeGE_TL6{_8f&@XVy# zCf3CLFt-lFa@Gs!_@d6Fw-nuC_k9W-IYUZPDopFBO>gd{!S*M)-f=|*JkyISG#dRE ze$H661077;f^kX7lttvX3kF;BrkZ9*UKcj3MP&vC+4tFBU`x+PDssCod*}4-N=WY4 zy?+CsK;tmyS)jCzTu)3rETVkXR3;zQj=~ZuZ?)JbjXxE6#Hf!LrxK6fZ-#*pQ(jL2 zAHE_$ai5yqpE*S%FTQxMTiXrC7j??0c!?PuuX*Ps|6q_^Ly;ZQU(_f}Id^qRuD*1K z-oY~2i|6cllRE{jD&pz#JAbm*2vybQ^N?3$*U#ocvkb!{QV5?Q+Mv2+*y3bBP!)Oy z&PW2f?Yu2j>lHj&g$KIw?zczRit>4&<%idhY)2Ed(ho1_efyS1bmYd!ZjQ_vG)PRR zNZ;#Y=b=t|lQMXX1`i5}&+pC_YHM`C= zU!@m~Jg~0P*heK^1rQ!aW2;Z0g2_H{f(6l9lBnP_c8W6Q(5_b%I+2*1vSS8kXksA3N(XPo&vnxMcDk-I8$AG zS$>Vhp`wD4DP|xh)XIGRX#FOjE{_<5bGepWNc&Y2GYNHCbGgAS0^Wc_edCjXQk&&i zN&K!orexxSccn4m@1_Z1>-Hoac;aEk!e;EC)CeqPjYdifscEPvSJ$UfpCeE3`=)oU z4LIiGbATL>GxBBj(#>@ktEw^$Y-5w@V^F2-t@>GRM|jEYG59DL$1u;7mW)*3A^X1R zSDkyC06$Ju_-r)@GP2;Weqb_WKO!nLy;v=g=Et&^W~RFL+=#NE2S@c?IEhBDwpoxF zw#6H(UQAfY#_d1V|5 z(Purf-K-jXl+69I>^faLGH*u6+Cnn{M|Rw$hHSFnQ3!>KSeT$U$vYn|`RLEwsg*(} zeh=Q*0mzzaq?thF%q5!ID9NZVE7A(G(WvyEv@+m#!=X|7_W4Km4XffPI9_MX2I;vE zJ8@YnKLnGS4KRV5jU?^ER6ZQ$WXUGOc^-WLSosP(QUpg zyE#^(W-Mo0FTguu6yk)@!pohaahH8Jboc!H6@S5W%BS$GLRQ!WlS4{EHc6GiN1o+c zk$y2W%^6#;X+zY>21m6FXT%Gco6<%y))4a@LZ%uJ#OJRkwbeNwe6qVxyH(cJf?%e! zu|1LmwmuBRYE}KSC(olZ5gl3y(8!i;QB6KA0 zEOyS1^NxgcN<=U;L&U>n;w^$+^F$l~@uRVN=B#z*S#{M&L$t7IHWY2wO_ME#NMaa5 zEge3#RaG$2#|7-|d>Mp_pWpsMYo!1p9zA)_lN7IO=Ok{T8?E@XYOcmUZ1L6eWp}aj zw%KD{&O-fjgu)M&fOx;dtDttbxeoR{-@u3|;fi3bG?jV5 z4_3Sc0T_`7M``>g$h7<1H?;~0RpSwDPJs@kp1l;cs_Y+hDHJssOd3q5kIg+C!51zB z$D&ag8B6QUILnbztNv9yvm?BxfK+K+WkW>}2M751%v75p%H;%kP{07nVfdHFm|JAG z36gklv*@?7snRh#1u#p6r@iKYfiJ-WvDVi-jh-}#%f!U0-g;@dmPsbtULX5i@ZPoS zXeui*=^}}#fixKuH3~*1%E-aX%h^x5xwf%C<4G6vXJpWN3KiDcemTT@ z`Jj4;a688QRKJpgNF!a*z+tl`a>OG$*XTZ-+rY7<)Se933bB4Cg%tGVB6IuVv{bi% zBZ;|s6>XGgPy1cpDYxq8+EcTb>*;Z_k%nCK#sHtk<3wu2(N`raGKTeN`fW z){PqmQ_3wnJlb%IQ?yAh6-5J)T2Y=Mo|9x2KU$uqs~D(OTh3&mQ&Gw3tDPqgwn^vk zBgMwOeS%KHu+VMyc3YLcpv*O!@IbB>JM705v+O$A@xWTIN?P#SxhX1~-Z#V6sG->= zc^tZ16*5$ZV8l7iORKJ6(>BZF1K2L+2lM7UhT2wDl*DjWB|Xb}{SDDuTPrP3p)` zY33zO`w`dr+S-U(e9c~77~1=)Xl%~;Gy0Jo$Ika|(Xa5{ThxsbvVpNjHaq$g23B6W zC&fIpTl5+`m~C7M1%{=TCP0;rEd3P)qgU+K$Y-vpiX-6=$A=Bpv7% z45T})%uKec-!wq2fC6YGV1i_td;6o@5$hCw^Zw`Z5@BT#1709yhO zjF36i-JoActb>QFA<4fH;>b-UUg-dAt$=hX2&v%En z(-XT>J;X}$h)R)&QjOqhGY;UHbjW`i=IT6XT{H2?+Cx=lF_zD2LRXgQAjL#AH!0Rt zjOi{E<3)ggAYX2yLPvq}K_S+(#080TdIL*`DRtyjZ?S`RQP+q{e%_ zudYabLW&}?UFQU|TiDP6uU=;tr6wm;20|A7i69KNP*;?Tk_g~j-F(UI-0UTr%fdr*)@Y(E1Ch^Pe%_?;zBV=d;A2s ziib00W~-ACtO+-WY(8DG2C6}0HpeQvo;JMVs~$_{FB#tOD=GDfCStXa z2vl#bjVpIEkMY)6Day#qd1i6m$T&J%R6KOp_%uR&4<{|S!u`NrTjxDerc2#&b@e># zNwQpFR*kNGDd7%{)i=}~-w@qd_GEdGjvg@gg7sTcT>mrb%t{ab($PQ-^5yIb1n?_YrjZ5@{RV(O@|K9Sc*{Ir7t4Bo*!Rp6a%RQ>R^Z z3yE$r3NyYJ@7L2U4!8Lu)gOlmg{M?c>lb;Q4^0kDirt2@ZFQ}{=8HA#Sq2N$ISa%v z&Xy;(!&V%LRWlT`HnE7Ed(x1z9}b7rcjUHBLW!Mh_MGRzc9LCmjz$d9lLQ&(3QA>{ zbr$_6-O_T=dDeT`%~7vy_3ej}=kXD?Fm}ur8r0 zuRXy1Y~qWeeGiE?579X+P-Zq;s9{GUmEE~R056R#_uWd*h_5wMR2e=JHG zzF$)}3Cy4?!I^#<8TvAo_^oIxoDiHet= zz!!;5U80Uym#Y%i*@h4rHddn&QbdE;QL5DYh{Gd6-{3uL&H%L{vu7$CM_pHZEXXzI zC6&MmqkfL+xXc1__TBdHaBphWS}h~CRBg21-vKDqJXPDoW5*hzZTxOurddq0yO1d; z1-;vjdni^1I&LWshKiUg^d(e&F(~mPS%TI8lVtPktoU`1;@{RCOl8F>Jjp8P$jmp| zD=FExuR;nET@G~wRJrqcrw)Tn8Hd%}kSw%egXlzPVhP|oAHTz&@zz4!X*U~jPO7mJ zV^dC_P~7dtKQS8;lWwkZJGXU9ip*|j^n22y1ReTxS+1E&(h8sV!dDlaY-RO;ZCofd z#3;HUkFmNusZQl%-KrT25Z+Pj#G^Y6~spV5xb(1%|S%9T8jKHy-WFt{^TCZxSDnxudAFoaAb#)L_!?hc2%5R5glqnUNlSbo{G+<5CX3W z9Zwm0B_6D*KU?AIO4XQxBj*IUL}+7hJ`qq?D~FO5%zwkV z?CCIkJ?bo*8OxX?3Tmg3M7YxtJ0mpDMq|5;~0+Vl3-TC=(Z- z>ztS|CC3Z$WYJ3Jk~OqP&b!J^g5fEVKKRGo!5%eUP*yH#vDvA)$jzuK!zFf$jE`-> zy=_@qcs|1JInFrcGv&HFDv<=%C`4pe3U-yJe_K6`uoV-P;L9o@#UWc}>uv-aaR?3j zWXEM4Rc(>I>N=Dv0JcLsAx=hjs<=j*(RUI}0UxVlPH~=pX>A^Wi(4Rzqb~FssZ~xQ zdok@uK&W69*FqO9W7vDWO`T;OALI`3Etsa9oRm+?azoo+bN_2 zH}XusD=gvLowEo{PYjSx4nCY`V7aXQzK8{Jw({_FhnPG4IC8PD$Kn;>=Aq%D`Ee*J z3Xqa=@iFA!;o;)s<>RFh;O67x6{Haa0y%-a+%z0~ocyrV#sE1xM^A`5K+e(J6Cwk# zbg_Z}GTtIPU$%7Z*%nZl0cL0mMv{QQDHvJ)2vXt=vrf*_uT01X*AfTEMR4Mf@)pr>wO z53%%wrB-x;r551k{xvl$J;=+#)7KROkaKZ&5*PpNC!;GwvF%JfdC0G!0NCT<1x_?_ z@z!y10X4bcq&%b%#6SojUIdUblC&5ILmI&ngQk0As;B4uh#sv_y7D^jyhJBs-lGHz zI5@cP-+$R5z#*e!C;wfe^8RjAX%IjL;%#RMkyh1L1}M^4n>%_y0Ls68f&gH5b7v1% zb9acdr7r;dqtw4xQ(XKH_lWPe?0zxi4+H-8HvU5z;GcU*{@=6vRThGrf>Fgdz1`guyTLn~eTNVF*m|)^l-j z@$l-xgn>ab-}CAsl%3`;Rb*te@zGak=u`}{V0jnuaf&~-2+&f|MFcI*I&Q; zH&^{pyMMdtpP*_Um{0gicE3uDpOaUB7bX<}ASbubFB1FViC_}r;pE}^rxN=c-^2eu zm6*^EzXE|xHUs~er3UF%qwQ;VTt4c5|dWuMdIb<74x7+GWPHg z!+%}?uHoZ^d5zzF$5$qF`oAX-o*!=PZyfU9);vL2&Exq|7k|_|pa2(;{~y=9AFk+6 zt9b(4ztkm|f9C$9fBxMS%l+btf4Q~)*m!I^JQ}EqI&gTqGzEH{6L1RJ!3(nJ_h+5R z=!d;DjN&`XH?O3-D?jqHs6#-N@-_yK>{ zpnr&Pe}-)T;@kg$Gv@h=!-fT?KjV^r@aM?%1Gzp`oFpqobi=pku%`*bWmD6ASCd9upJ$ zmpvxt!{0u?ufie19esZfhk**WfT95phYR<;2W|=u9v&VJ9uWclmn;3)p`)R|BO;+b zKtRU8frCeQfcOCZ0U})dum6W9(t4nYOF&4>osW!&hk%4n3o8UV2`L#JJp&^XGYcyl z4=*2(UqDbuSW-$_MpjNE};u(X0$+t}LKySaOKdU-$b@%0N12@QK5 z9uXN8otTuIlA4yDkqIp*EGjN3Ei136Z)j|4Zh6((*529G-P7CGKQK5nIW;{qJ2$_u zxU{*oy|cTwe{gtoesTHn>iXvP?$iDEB{$Ow0=@76CIi=;bS*nHb$D%3d*v$}Rb&oV1F&#LH>6x}UF~ z7Wm&|0h3{({<*j5;9Q0Ppch_g6y@6hm9hXrZ@m1gYUcOU-zW1vp5}9loOPYBt8>qM zm7k}E&Eh(w^A1n+*34U?*(Y(=|6!pQAX@DxH)f`TRb168(xFP)*n;dBXI?M7y$3i) zTT_qq^W;y1{Btp=*L1u9=dy}W^&adhZplX+#SP5m;XM|cHBRH8V(_8rKQd{$FpgR9 zp)6K-s{VZ{@8jzeGB?l_rTolSx6gsYBJ3tT;L|welfuH`g$(b0I&afSq-y-vrN{T_ z`GneA$-_6)5=W*4c@Ah6B+58ldf|9ITxqmn^_Yy2=IqixPyRH>KNAD-OJ)4#6Xy_c z)CT^?ulf`1<+5jocex|?Y)y2xp4%p)pXp7y`&$I}8>wC%bDzc!cs5~tD zKAm?Znx_StXQOUADJ}QAmd@}KTa>qF^X{+9AwFpLW&^EG=latfNO{vSKT*>>dDSYW zlqk{~SX<{G8U{W`q5rV#XU4ylf%U2c!RavQ=N~_9@Smmw;#L9J>I)UGLsMj6dcL5{ z@`PuB)u0|q+5>xUGQbmclY7m{v#I0PmcjmFC$E}j{ViiecuugJ!C&$$OVGXdzt6xb z(YgjGI)CtMf;Wm$ng7E{?BVaOg(!7Lf6%0J45OX;6E*jfto%bQ<|pc_ z*8)<9;B&N9p7KZt2xq8-HdRHMEhAi;8?(ZK6x{Rk^iP}oTLfY99E9I}{Y08o#^fy9 za`9G1E5+n2_pRsaLPaU<)#;hQY;U!k@MiD+inpvsob~pCfX3XeV{P?LFD37N>u29* z-y?4Mej5f6N~hloEcnbSo<5WkPOqs*UhUYpZI~%%IgNL3r(Wa%r`+_{QzqOpzSI*)>U@)iwNvN980yPTK4|vy}kyO%p zTi;{Ma1x74+#+Un_zr@m3iR$T%ITukV0>ii=w~-gReG#bIIlKd)(PGYtUSkE$ooDA zlWkx`!#F(c$XAk5vU0JS18VbaZRWRMJNwNFimBfCH&1kw$d)88ipO6wirG_S&g3Yn z8|2ilTOE=L%c&(M7yUf=|Fsb?W;{0npEZgXl~$W9Y<47Hvw1aBm0x`*pJc7NQf^f^ zVUVr5iZ5xR)7CszSHOQgHnCL&iu!e^ha~(*SPY(z3%@W0sps`^rt`l zm*T^J%k%$pf9f0$aExHOCcE|gP*3tgjvhC%$AbI+o&)sK{m(omXXV|L%;#A06~?0H zSSB5Qlq(Duwe#Z&!cKjKbAbsLpclfgqPEAs|K{|2Pbcp*g`*8rh_bXO~k9rL3Pse5b!vf1>4Zc3T$|}i;iq)oSz6z=N zz}jc5zd>L3`1_BBf$!RII(owHSe!S&pec9s>QSZeZ0RepnX`wVfl7F}E4LU0V!6e9 z)62P?-ttqzS}CVvGDjxKS}Av^AB+ZR_7qWg6oir_N0P9u5Fp(m_5J7_SwoXx!W&eChBbo0L0-=pdA z_gUC;k9d%FNM8L(V?}$fbgDny$$HbQh)4Fl$W+{v%;}ijNmePwf^E*45Pg|Q7_b=s zb^oCVN~;1`9X>B`m%Z=j>!$_&cUWMYdRDAUxWeaQ=H0iE&tceaiC^~@cECwkY2wROGC@rEo#zisPV&G3F~R1s)XpH3(q`h70%W7`Q^o#?#Q&0~YWS7jpH z$6Tl5>)!f{mp4?DZJ*;{kNhU0R=2O-s!y|(Uuf>K95yR%6`uId(%e=^egKEAm7~1X zdgxa~b*&(Fl<@QPPn-Ok1R?LV@D^D96zt<%aTqd_``|I->{lj(i?fS6@sZC$CO!SH z9%Ia|8qRMo=Vczn^&ZC)8*ByGe4o$zxUZD6Zhpgwl5|2bujs?^_^_mU+{L{JhsL#jml-N_baRsK|k&}O?4Bdh7E2$f0|UdmlG9yQwnCI zw(!y_jmi_N^Yl-f{M!Uk>9O@zuX4+# z)2|$Se{=!?9hvm>+;QmTz{AEYpZ`ley8rz|&;C9L%ky7|Mu z8zLAj@9N4%w?>_EOQm!S-(hmeGDWE2^1?JM41pyxom0D6ZMhUs_t)-{BsKvPp7{)#l5E2o?_{U%2$KTM$zkrWge<2_L z4*2+2?(xsZ9)FMOik?(f?Z{K72zK7VO|K=Ej9)rEdU?S(@q3D2p}pT*3xO@EkL}Qg z-A=2XG3~5pO3`#@(f)Y(QIpZWTL}1t#AaWr zrSS_1u7wLDvkGz}!1ef^Af@{fI_HwiYfqU~@N|3F)vCI5*$3r#t!{VfOg1B*zZL@J z5ABr)@~0#f{+aR~HNd*EhfnKO$FMYUKNp;kk6=8;o$4_TeOkEa6PKpyjdc@mWg)E3 zxF9ej787}Bm2S31v)~iM9(_Vy^#~2ux8XH%TN*O6fR$f);^>YOI4*k$&HPRLdKadDXwjYAOuF}-`<|{f9L-9x$`_TovK&8 z>#em`Rd-MIVn0kz*k-o9T1CbTuroXBzWu>opB@O-uC{i_JBr~=NsR;rU5rVYEpPpF zaG6@tvc9jRc2D>eAf$ z;?veDWATx%(oa^Zv%_jU!8mBiwqA$*5?EQ`@jNf5O6EoSI95k8u@lvhq$?^;rz@@1 z@J&hn?gaNuffXm6cEthPDO z<-a{-R-m}G-zgb7LcF&XK+1Y>4@Jyi#Mr)Z+JRonk3m|?DA0kPm=C{l!q+M7Y#*2& zPHbJjQR!!F9#}6pUO&4OyQMOi;dWk=`kh$7Z> zSVpYQI53UXRK5>MJDbTlP6 zkugTa{O3{ZaGpvxNn>+XkVFj=w8QOXKu-quUD~jj@S(R%l=cqNly=&565f2}IIlL2 zy5BLc>ZAVf0qgPD#Rtq~im9aHX&%IwM*RH#vn!@Brz?D?B3-vU$s*n8ZV$1RZ-zv0 zY7@^E(_8o?&=-V-bSl-jEJP+^f>vxNl<0@u0H2)JW~|MOpz0|5Ql_f)Zy{e6ORfc> z#F!!S&ek>vy;W2{nDcx;daI{@9Q6j%eY1>-^d_;H1!B%6*xNk&y6*A=!#l2y)@oAZ zO~AV&^R(ZGltez9es@i0&NjI?^e&b~a0434;pJ?V&(inHjk-R_K4}C59(o$fd?}uj zofNZrQnklcdO5}0$o_%wSGch2nWGMp0;APcui#b3i{|u6>kPa1@DX9=Vy)HJhtY^~Mu%~n>ZFWY! zWQC#Y5TH8=%*p0DOJnQAo?S5lcrls0^s-!qAqPe>Qf3*}rX8|9A7by9@!v;>Z70}& zAmORtr$mQ+i%E+)U)vyRKf)!A={DNYIj^D4DL?8uk)|7DY1WZMEXwFsTTi^3!X=M* zk480B53`hfwD<3()1i`H{|7Xd+Bqs`so{1{L=4AFGtL~PN%U3g-V)2wlk`Ko{me&1!3f6*Y|cOO2PX~ z<5K1(Jp~E9e!NUlxtK{w%>_V)_tVhXq0Kuk!>|i)-VQzNP|-rZ4vcR2%&tz#0?~kj z!yIhJQxGn1UykaPHR{fOm$gs18Nndq#m3-kq>pwbn?_8bord*LG766Max*;ezMBq-qlk zjawz4Lff?@#qL72LN~_1f^^hS#Q5~-W=*}L)W%{DT~Qjb-ot>tMv<)LRWHF;Q=+nZ zN|hc)UX7h^m+Zz0aAmt4wgX7iiwJZ81%1$m$vlk#C7rE3TMjoVDO(%Nc z2u+ECQRq$9lXG_0kzM!*RSA8VlkI@Ar^*LH#uZDZ4vaLH?RkUa)u$eP4yB%)xXz&S zf+O{~{cf4|T?@I6R~rqR^EIuFymDIi@|TLd2G1&WMik*f>S{;$U6Sds%IL<`_43{| z`liy&sA)qIQWD{y&dR3?Ti3!yWZa*Flz`Ofv|y%~3J^A0N{WrC`a1@ni>17t*6s4R zoat@k<hQY5 zwPD9Nv{ISu)&PmO(QSC!tvxtzC9v3|?kSz?4xD3_sY_L!cn>V7+k3K=bQubC$5lcm z-sM*v4B7OXaaEPslaWsSsTU4zTkfFdVs^f{eeTfAfwB3!Era-YgKg;$M`WCZRYwo! zXGW9ydb|pSl0u+Vb5rYbouvYulenkDwse-bpggAAK!7UUkEWw%HKUtShsrnW*;K)R z?ENwj>^BoGgNm3>MjuS-T=s9T>K5BGn`@0bMXZ_)!Ul9S`ou-DEcSbs>b=O@_+^9Q zhh67=@q!Ly0-@G&<@b-U;A-nJdcYW7=&;3#d>9tWsb+WBF4GzR;`;q)nF%C!SZLgT zDT9N%yPBPq6)R^y>=~O_x|t$tUqyCCFR49v|B~I#lbmyG7k6{E~1N1 z{!Hy?rnnsV7PU2M+7P}z7@C-AA2X-NM^Z&ixGB=_I{%G%ibLjZ$ywQMcYeoc2cUkwC2I_(XWu2#jxRbc56Tf|yIDAuM&~<`dR;`ifotc$3 zx;#VLLzGuxDjTM*ss;kXNuT?saDy8g6sXPb`uTxA0q0q3OQCo=;FcT--6c?1} z59%W*JEcPs8M8H2!Zf84oS3TT}l}r!KV(O0_bvsdzuS74BwDsv~1?4a0rY!V`Q{-6W z@yvN0rlc{2aJ()yqk|7wAq z17o~id0+{VY`2e#yXhA!?vHwg0Cy1DKu|)~+K#%-945lri{Pb`w)f0+b}&P7gf{#; z?z6#)sR~2t>y6#L6Up{wbyLp<$m_gps~%BY%AnlDzre2{SvAhG(Xbvu=5S-AYEom= zbtKZ(iV<(m?RHtWv3+BispOaHNh$JpJiV0(1TSR#SFjz?Qx+EYzHE_`>?ps-&p&)UaV8q zAhpyJy((6VwbZ4?26Q#y=c~p5-5)OQ=EFs&bf_a^)~Alefqf*t4tE_yYMV?sIPurT zmIf2hg_qjZ{0%D(X8dw!_!xF<=|vKh0jP) zYMxmO6X&|u(%E`rGb#KVJ{zuY=IHc^ZHS6&8a{Xi*YFU>x%mi6h^UP_-tRJ7m5$>c zQjf-%n}l=xCDxySKDFg*71E=coh#R*_l{3pqn;oAFmXb&@Q!qK;h}ubpk((|;RhBL zRpYDxZpO2k5`w*Iw}i58L%!Z-)8?ZQ$PkDPR-_d`+yK|1r-}mmi`0${QUa@(UTaoU zGeNAHnS}bfSX-j@&`mslQ3RIhhk?U{SP*jhafzaC0Tajoxw4h}1u5Y0y^1ibt^ zo4BgfbYhfW=@tUxFYefGF@jqLr)5Lw$ydZB@0akPM&Le9un+emg=)nwXMtc5Tvjwe zsnC#mgR<17kNEur>TGV(HxLuR#UZJHV$t&<7QTgf`vJ4+I*rb7B5HRniNv5tRE6L9 z%*d$VTfKd3oQ$55G>ltSNFvkrpl}{GBQM?pV3{J6$LG`zlcYg_`P&C{E<>|LYU(@2 z=21J0I`OO>odXe`SI(ha+2G4+S@jLoW##M7vqJJqd4luHh2EeEfsx1 zt)Urfdttm>Qx3QhxB?^fqjppZoz+T0h8^0QcxkkarRFN2Qw1eH1QCfK0fSFonUHL6 z!s6h!IlG-pJ9Xj~+dEUtlM7wQqA=zjG6_sq{{{~PL?gL=(nn?7VTTe1?r7?1tsZIy zBbD_6d6!34@%=H4nQ2kC7X=3#Nn#U6JTfP>`A9g7jCu>sO&~nY=Mqpf97*5qf{C$@ zcQ4FytJOcv>Z>;>*NbO;w-!I=$Dl=T_}0v(;Z+RL_Hsf@38`$iU#X;0++u6T>o6}= zK~^r>VWQz^9h1QN{vW__aE3Ip933IvI8A=?CUnk|P%?hfCet^{$5gJr$CjvQqoMnI zbCD-HeosiVlrci=IfSYGhOVHK6?~LZ+wnHhy)^ zvhwW#b-kXev)Vl53=W1#>miiPl5yGQ9iFY)w|&{(fpaQ?DFnuX!4w zHucD+99LqN*FxzGn_Oq}jV4`6|E%{D&%f#dCkTS#p3~SlL&MopcTD_~9amPfg-|bH zOU)hCoOi0Q_-&f8CS{wgTBA^(QcI(#P$KGOv5%#9qs%?arS28|Gk5@Wr#7Od>r{g( z*2BIyPkV+B(DJQUaTv*N4?nVX+gJ7nRDKdu31WTv?`S0W%SCmmY$ zWTluxGB3>jH|1?U_?QZ=Zps} zS?edG=ulkhWeI)j!dVrx&m^-yLA4#z+uvZpnYFDv%ttRa=}XTnc210VR1hQ^h%>U& zC`P~L8Q1U!E5k&#*JsRR0U<9YD(fG{G#O3Nh-X5PYF}HyxK; zVWX*~(ad(?M1YjKAUcw9^4KyTTAo(N(<(Xd<{(p{w+$sSSQgtX4Xtf=wiA8w8x%Oq zp}8{!9lAqag^-=Bv}En5K_HfbBVHIJM&@>-E)@EzC>%`|jcv)EwGF2*_=G;>RqXYN z1#xHJw}ciQy<;t<*9Zuq282AtOA>2|#==M@QCmNnWSx)XJgv59Zxkvrl*Wbl+hFY{ zpgTsre$DPAF7sus6UXjypc64z5kD2|LpiHBF=FmaKxv%M;cq{-F<%(O9gnQgjO5|D zRAGdvP7a~mJ)-c zecXx*Z-{=`CKl0d@)fXn?tHMTd~91UgF9v{iJ)Xv?Q(k0zOjpLF`i!q1-MK z8jN){(Mf3kA`;o)2G;H0nE(!I)5l`6j)BvDIx%u4X@i<#@dhJ%9Zxg^&-Gpn&kD`# z!=8k2n!2J^WP}oXbm6~-vDMCGspLrL&nV+OQeZ4QANDrB@gU&bt5s6N#CtPwJHZ($ z>4*i^SHhnuuiW}wt@t5nFP(Pefr0jP?kIVr5%l+rNN7A9ZcB4Z%A6>W6-ebO0(HJj zetcS@E=>%~e1ddc$a*X1Ra0A!dk-R-Gf)MpbAt2^$=NerZ3DaXX!bbP_uT&+tUw5e ziAC=MhA-C5-ZvR5P~6RU=@B!QkEqOlrle}GnT;B}$97nUCaHZZPcH_hra;wAWEnv^ z@}1t!C7B43aZ&j0bLEVM``Or@mpckxy#wW#j3Scjp$)9Zzf%zhLAjCyOe)yXz1r1R zBZITe{Uf$Ym;8fq9?7yB5woI}P@U8@Z{@veY`{R{C9ZqcAr*ZdSw`vhPGC59oUZ}x z`Br`hJE@i+_Ae5VSZF^`@5Ry9dB(&-?l?bOjax2B zT;5KT4y_)EPKx#&Tc5A;dndbN=VEMD6SicJ{a5us=(tvS5}>!*iyD!AZO6uf^vprH zcx=U!9xf90?Dl&VZj7xpuuCM&cG5{K{8ORNe^)im^wuRM`X=?4hXedsos-XQL@eHj z=k|#9=R#CIR*(%>m~6h0V6dJD8B|;CN;**7`3m$`)^*+oz3eyIr@}slpEWs<_z;+C z^jL0k$RY>7wx~U4YcABiwA8jew8D*{NycL;qj3DUnlnopN~wWXZZ@>}7)oEqGZe+A zF-)u2HDYc^;8E0(YrjySQf6e^5nkbwF0Jgb&|Esg4E@jWcFALI5XvOc6shiht zr{UF3%j9gW!?lA59TtZ_y_as9xE_yosXJhpzv{R6w2uDa@6;zHnUIxIYKr7`o^05{ zH03!8FWJxKOI23g=*-O@2Ynq`k*}7*(dVKuJ`9~J8-R1MTfbTL8W;oY-@NXTIr`8c zgWWcq2ry6(BpxtI9vkgL%hhUZj#96xW&BvB)m+RV;2XD1tW9ATvM}bn@$k(A zNZ9&&eFmZ4UtQiKGn8|>7*N5~67=+rcq!^(9P)!S`yK8wt|W_@T3Y-{k7Yl!_-EGX z;smL2;?&Q~w>s0*zW=UC@KX}L=S8?07XU8a+0PZI3dif^n09wPQ*mB2s7Wg#sIwJ6 zg!bM7 zjHohvIpN#-j%shsjY1tu=Xsb(n3`X?$((h>{N{Q9@IxoGG5R^TPLt*aga+wg+hnBB__?T6I|)z;oKsJMeebPD?6;I{ z&riqmC&^LBE${KoqvX1dfabNfPLH{QLT2a^#P>;)tsAqq+Q?y86hJdPMfb)g{4Cu8 z=nQ+mQ-pfV9GF;0oUI#?jDsC8R@Kxlhm!!)ieKMDn51l z?4czQMC3+zJSIrqL?(fZKo3{i{C(@h<70Ezn`=tz8{%CnH1F9f92?G;`|YRL-8l>0 zuL(%4)?DX(bu2ww?%o+)hD66z<&}rt*)_L8Js92tcy8i*-DBt#ck~gGcxu5X6HY>n z_!PH#)EF0Q?)hG{t90o5Z-Du*wI~#HPI`1$h;H@i->5ZgTw!gG20#QU9m&}=D6~es zW475Q(~K0p9Now=u=D8%r?@Fz)R|P6ra3kQ-i-?`KZrf4xki>X6HDi>Xoi#0!!zny zSNw}w@Fh3ATc2F{ ztwFJmWX4F%u~X1R2&sjrqS{e$eoEy+zc*uGm1l2z_*td{iQynVOl@Oq(y({jHvNp2 z?=4G&$!)2gNdj_)%l2`r5iJRTvHrah#BaKK{7k;XB+aFgR5xk!y>ejaeBd%qP_oZ^ z`1~aU51Cx9qWpa(J-J$goTYrQTA-6(qgN3gE$NAlNTW6RG>J;qFM5l;>rTp3>V!}z z?q++vLNBUcijLc>kgk6yS!++c3r`h-pADkdO32AC%HD4|BpK$AyVk3!FC-zUHlaur z)s<-;$GxZCugFs>`{>U{^ncQLMNpr$dbEhUtI6mcy`~Wdw<|0!ePfl(5e};w1q~YO z$2C(_#)`ysLuQdD``>px6M zMoZBd(Gt@#cX^R4D)0F1VEeZnvCTK}P#i^H%kgyCJXXmtLv? zQB3;Q4sV+uLvD@9?LPdJHiJOBMj?q0w*)lJ;3S%|YYzPLZd0#AW5u!=@}zTfW>Qz* zPqJnGW6*;;OwER*{OU839yhgZ9wguyFs1fxX;oI-^uE1Ow1Xc6aglA(QCR__i&;|? zNDinnlkLuIOvf|S)M0;9k)fIx@wGVf?#V3|9LXq;q&LM!8tv|$%kGRR?tIQ$ zbKdo}*P(x6>0xqv3IDL4iiNFf*n5GG%#NNa&YD7Y&4O2Hyh`u2`3IZf;T?>-%RgHj zckFWyaYBZ&f}_{7j>DAa4%9N;Nd?|xTYuOa634I5VAiCC6CDal@=Nmfv%NM)OLeAk6Z|)VS-tl@0wiU#JN7Fg4MKbnYRN6qeDgF$< zygWwd)ANm$vRbF8FV7U$p1(aB$*f}7abIEUm`TP6Lw`=fK2kk|jc9sjX{6A{TR&W$ zl{9W7nvP|!Nnx98q@!7v`56B)rEvmv0(<`) z^#)!1sLrVOa4CynvQHPr5VM9U3oi7q?(Dtc{`@W7yIK$37xZF#h_K#I#_rc4^8hzs zvCl=B)}0g5zMoF5oSSz~E?o&&7YdE#;h7;KbC@R>($pUIo>yU>-LT`Xsx`T7&_0{e z;XpZFYvL8tKjS55aXFiRRIzW|(Ppa52{Bk0#8?hU4_nqe_$&NVo4&)u)rrdXWS)Z| z<$U?q?Dq!F)ulX(OQYb+-!Gi_xWKLf=WrCwV0(JFXHu02^cYPuwP&Oqc8jRVSTiYU zTpZ5)X8ZaJoi?jUNx5T;$Jn>K;IS_DU*zYzvMFWlvJO1`C5PtbY#FMo1t{LOFlp#l zNJyBK)ntiNE-7gMvkq)KUq`8TBqWh$=D1`sB?1hnmfCK-TEujP?2gDoyWYikgE82mb~o)bliytdAr z8;j;Xau(Nj7C34)R|0nQc;?t-eIPP9ea(Ba_hX}n^$TXP?y*LVW*z(V8Iu*w2~f!& zP>9CC!R_UbR^culAMmHTsV7dK7Ufo!S?e6QYRSo|JkT>W>#}|$7(JcmJx5P;UktRz zfyr&^PSaBr3ec)o$m>}yS%=Hzkpp(c_N%h?u7eHPqqAfb7v~o{<+#--5+;8!r0>8?I}EQ$En7RKtG%=&_GKUaHk_P!AN&!NOZMzA%`| zps3s*55H2+NyU~SO>O2QT{!bffO%l z-#&LVwZq7KnNNH#E`Dk~owk$edwD29MQ^r?wTXb^3ky^y<|bxMbElqcls}vqv!=F_ zf5Di{tXKSv_jr@~iGJxH&{7TMZ)gX)(+5NHG{!ee#L_euihb^a`mp!j!IG4_T5|VY zi8k?O=nW51j-+M6)E9mMc+m z^ucW_X5H}9Qtm(FW3Lxk?zbZT%mU#h&fsrk@X#fGT4i=Lc!%+s1xI+wsP`n1@qMd0 zwv~egPmO6)E}znzjpv)m0bVT4y-L_rW)vew097p(X4AU zoBp*3`nk8yq{bM}+P2++XJTZ325{zJAJ%n$*0SfbOFHMxoa6^J`5GK# zyD^R%dsKNvp~Q?yZ_>3*X2V>DziPGY2Rfq2^g6;JU!1gec^F>2)0H+*F|*CVSEsLm zSnvd{QP8RP$Z|4c?aX9K#$NJQS(Eci2L3kd5e?n_a=Cotp8XW*#Q|3#&9NO5Sf1S} z*FwhGl9=T`JMf?z-yLt5j=5H}Bl5PyEwZdxEOlV^L7SeprJ~Y)rPoaY607{wmdJru z`VN{*UU;MDCm|$(MLjJ3t4USOi}5e@mG5DXQjiU`?z{udHNTJ95|`d1W7f9 z-)#5c5~u%0I6*%Q8=5m6)!UgGM@axaV(k_J@>5k=0Gj9`^8MW^g9n)pM)YR;DGgeq z=i_Esr^TLTE)KE zyh|$6*|NGOw&U8W5Jlj5*~x#4aBx0Gvd_ILp6wrrzTr*!apR0CwY${zB_lCdx+mSdjFJ!}#!eZgp%q+n@Q{&vWt zPqm2oxMA7y#oWE2nWdSFj+x>PX^gz1?G7KqtNof$Q_^OF+9=hC(z4emM}3QF^t-2R z3@G-G8)ePtnC3Qfy4cxh(R6m3%IvUsPK7t=XKi*fONt$V<(;Y3lk>x9s2?o2`1?As z$?C2=U8B&cPvy||(hTsULe=}p8hL82DPoV~O*1B^d&*nXnqH(aI~8{r)wrGBu5QY?Jp(`9e^kuR zBi1B0=R9CuxLf=%G1qy(plCODT+XrU+j4IOLEK#QZ1mU9wddK|-MDTB_y?1`k@l!Q z-rwM!Sf$Scg!=_KnwD1gR6DusL?KhOQ5bUpKdFTLo)5~#q`5`a0S#%7Mzp3So$7{; zl+w5!9kwwmYFZ3+*1L>&YfYmb9?sCYd!sNR$xe&)-WJnR25I*%I?DFt_w0Gbkh9h? zKENc#@)=#KYSIA^1>NG5L^N#rE&JGKmP9!YMwEDOXlsLE4)lStWI+89 z_>j&>s*Sbhij}0#bAO7QDvI)FBxwmJ)?`$zDcLbn@V%j~86@?iw0@7acIAP^vR%nJ zb+9&Rv0Pk2;7VV+)3%+StZjGufu5*+I?P;WnQ}ZJQCgNRzoV}`Ek*smeH_$_DtyYHJ@KnB6lE5;MDaIPqv8bA~IEr8_3G1=cwK(dfstuclR%WQ4gO#Ui<3qc_WYvA;J)bCzIAk2Ex2pXa z=?UV=4PBbJzTy&+VOKVY2-T7GD_$5wmja5s~+ zqH0IVs7oDM#tp`axAIH{*#@0xEWS3HkY$T|djgYsbpKpTrm>f5LjLT-m`uX}zhu-@ zhu_DNYQHl0n2g`Y$ZEfS-j=YhOGQ=kWlUd}=q;2q=e_ehv<(Lhii_U<)D`>4|K~c6 z%6Im0Qg`!bLP)iZ3a4%RES)O)Cc&y_trcvdw?!3D5$u*ROW@SJDZNfe3zQMG-Zwq=e-L&bOqMR zjEe940($D??^nNc5HY@#`zNOLObRd^H6j*_2Dv#Oa6i~_u;LFS!@ zTMS#gIC`(+#wB^4F9uy~@4L%vhiSYt$2JWoK1td$Zh3#vi!mJR8f!cW?^yA;*bB;E z75`)T`o%!|m8JF0(TPHatv1I=zGcG~u*FPs;{lCsJDe}La zaVhfu?Tkyr-)CIH;i7^F1Y}w$K{%MpivUv!kzf`o0wyX5hy5Q+>)$6_{$EZlM2TUu zeg5wU5W z*N}jf~2LJ1Uu2xT5f4xmmv&dK8ZZ zM=rRLtV;`??Q<>x=Okih0gXk%2EOgz$($WGt4()@!C?r%6EdqXxK`u#bYDjmM zla`fsb9RBs{z~4ALL#tb!LRYptj{M-fw8o(HT`c(szK?EJy<|a$&=}{e@*-RU)d|M z$ugn5&mi<;bFcolDWQK_2>RzdcaZ1V3CaU44ZjIa|2btBY=9i4KeOvnr_ zw=n1kO7zbyIE#qz&p-vcDFQZ5Ca8mQ2(SS$3r^AkWd3s5e@{rQWqHTrH(9BnRH$(D zNp@d3M^GbnqO%4zTQ!yjtm|tyLn*IWgoQLg5?^zV6QQIs(=eWiHFf%E<`}i-Jk!C>gMXk{io{bp-f| zoh(JJ2@3;ygi%Pagvz175|o3M*mY124$g(j{Ms+_Yab*Bd_}+k5pX`X9FPIhfn&=; zOYA=Q&u!?~uR6dvDCj&;1_jB6kq=ZyV-90eQ7PeNlmKHx%KtP8fsJ}!(OX&2U zu(11~GSD`p0;CR51G^2%BCkma-SBiYvvgCng1A%kuyk}+bb?lab^JW!j6LKIGA66K z*;?B=nL7OMsf5&msDtW<)PZn9cpz**^*`wV6k;*{q6j(;;f0z7=zuK;twZ~No{!!4 zOJ`_5RL9Tq*mBS|^!=$n3I+0~|I}4mQAW#I#n~KWeRXz{G4(LTn7RN{5jGS9-QY=9 zaX45CpkUYq0)ZAp0$+r7AwV|xlM=sT0TeX^M1-Le1rVTH6#=>7VTNKN(5b(^C#Rl> z`6cwXg8nW?*bps@LPIrTqZlL-bkLv_s8UQ2B+7<^Xa-)g0h~$@j!lRDS6DE#n4mCH z6ueGB5D60jy*dnLh=!p+e}+{C(nM4kN@EU^D8s~{AP5~4MIu=Q#6$&wmqV5QRUljt zWE561*75+(pOB%R3Ru8jBntypg#UM#MX{109>7J$FUi74kWu@ul3{4LAPW7z zlZ*zEfvrH2ffb%$hCwuoLG1?EKtm=113ZhMq1@&W8!*^^!iE@DGQ=|+GCZtlz>vbg z#{Vi9IEwIzU|@1!xc`5)Ik+JL2~eC22cV?@5&;8^52OO)hOG1CDCCQXf69Z4ih( zNiA?xG)Nr}N+1Nq&Pl-Q+D;xwqkc#^xWdGXut+<~DfjG!}Q2;jp_@}-86ej|%lE6>} z!g{j$TT$3UKoI1tDBwcCj((ZvUrzluk^iF{$Td+Qd;mb$AEOcMc_3+Q3s*x|CU zAm}+@s1x-eJ^tMB%R7Fa2&6-fDGFQ$Acm^IY7I#j1K31FL7xB|6p{}0UyyX>9Mp>x zLjyO!0yu&EbBDm+&IRHjFBL^X75pLu^fw|X&}#}Hpeq6pq@XJU5f~T{L-q-J323jd z=zodFZiDLnexk7u0)Q8TKto?F9WdxJ6Bs#o+Yz{zgT)T|1yRs}14n^)`dJVv46XkY zG13qP!ag{JZ63%=fti6m8N5Xbj0^xeV0vH+4ZTz8AL3BJV8no_K!?FS0AnGPAqsdA z5b~?RKvN4M01(iNgIfa#79NGjH!p4?Hv_ccj!V4*w#;gP$k&r{8fb*;M@481TY-^ zbpnf+F!JYKU0Vwen?Lts&x5X%pbvD_>}+O7{Fe)5Ia>!0OE)1o2XGZ7V`=VeVfpLb zPr#=U|MhYnh45P4d8gS1@)psd+i&x5IS_xy5^$gXayv~{V-4}1hZ^JhWF}(Acvi{c znd3r0C?$`2bz*U(q@#8urI<+i*VVK|&4SOfjMw`7L!V50I#+YrBzgT9_1<*pP-nSL zS$)A$agAc8m7MSof}@hT1B))7%o-f|U1`^s9I4I{K0dPq!Z}7lPcG(jav4p3e)li$ z?ifnyQ{0F?+II58hmXD2+R~mEmbDZrH|{1Iq5F?MJm1H$-uzVK_x-}4`@x~3bA-?2 zp1aSh;gywJ2$@}f;jIfzS>mS7a{nqA6!pbXj;z^icPo9E5GIeNByVw&F!n+n*N9|# zc8Rj=5XcB*sM;=$E|lr`F@8uXOxqTeTFCh16r#&6Ff`*bvUQ7EJJ>2%kJ~kuE#!KS z@JdJFkGb!N7OAB(o}r^@d(#i5KjbkAZCc#0#`tlwzZP30-usYm{dVfTgI_dPaQ4Ol zZe#QN7tRGyk6qvb=_*8*24nmf)cJ8KuTIf^gE292x`u>oSS5D!NmtA7Io*?5m_M}s zFodc8o@#OIeg$7BmHk_dC}pq0E$T|P+)>7()Y5nTxJt}wElTP2*XXQ?Bt;FZdoHV9 zgBh&ZG|SIg*Xn)P|3sp8c+TrRsea(cV^N-?Oo!DC)U~@}Nd<+;Ss#(o(h=bz2uX__ z4*V7w8J9Dvl6k(;Ugz&95u_x^BFi4XA-_(=O3nmhx$koQ;r-97mswwrzJr;c8qC#e zU!*5}yZAuqR?OA&6b~Y#1KRn{+P+pAEs+_DD~y1B6L~WyPC)S_UE!iKe(e0EPf~8v zgay6(HzbnWnBJ=KXp?q}8E~fIvEX0WE4|hXp#wdye-)ka|PB4vY3z&rymaM*xfA@(@zl0OmTCH>G|Z_D?R1*6A%BQ#qg?A% z4xcGMYFgVdZ@kG||2FO$!~Bb{Ed#nXX`2Unof5f}*U~;c%}s8Ox^rmva%6Oy^;t&* zW%((ap0K!=*E{bb;aBblccL%0<6a;-+I^XN%i{C7W5(6I%(N*_+@|uIJt%XcoBPI8 zAKV-!Um94MmMj+C%;3K%f5GPi?(u9~#Y(bIVI3d$Lg=j;26U5PYmswgzZGs>%*8vQ z5xlZi(Yy?1l%IFfk-gix+dZihinmpnxyw z+nqDKAsyG>Oy2FWObL+hd1|4HGo1S*WTl;TGKqnP#hAme`Ixnzh3~@~{#)9a7IgKM zegUuCGqQTjrpZ%EIr#~+rU_HJwgwDyc;SNNm?=AXL1%^KGyFMTRa? zRSH@bpUz(KVIBz@^|EP5J|x*v82&)_m5#WD!F+OR`rR$X%jXCOZ-u^TSv#MmX(>1r zlxoE2?Tt8ab2c+A`Hb=SQ5VSOj3-M*_BuE?JFELnjjDf4)a|B&%Ct){?DUQugq0Tu zb?tGsPIubezI$W!2PS_u(vq+mL1~z!S}XlnjZjm4_Zg>bP;M2?B0lL@+%QY&q}$E2 zvV$VmV!Y+2o_JqNN+is(+QvEchDyRjm;4EPudAhDkNUNJ1`^L+Ivdu$<3pA<-b~8C z^ga1qXWq}n_rxC3$6g*eh^nAJ7+r6fAZoKbC!fuhB-iF1`5pdXo1g)su~EwCErvWi zY)Vf&%<{^>9Fg+|42V_S+3JPA^UxP7Q0R@DRrE5*Kzr%7loLQzYZYmu^~@_vR*$Pm|E(}z_wD53jiTEb!P-+Nm~ z_`id7g>yJw|C)Ek@p|t#_X{U+nFj9{EvYxpF8xrx;4mgEAKoAM{?^)2_066VA7Tf* zib}@kHer@FhR1%%*Os)BO0~~tptWG@F`1sMBaA;DZ}=4Kc}(fjqg6o%lZ1{)F>uf>@Y!?9-bF-sD(}HG5*gfu2f+)~ZsavSC-Zi+<3#fM$(69HEV$ILn;Oo2*BQ|h;uW1JR@!fa zJ6I^HIbZ3U_#%_&sx|nXa7u6Rd5Ymt@H-9;Moxr_{z9hKcmf^!vTN|L`AYHFE22Mw zNN+Ar-6R$87pRRepAf9g+hTBUob7rkC3L_3jEM7nEy}^I&KGQo|60{(Q%VqjZX`p8 z=^7U6_4$!9=FGID^u+n=iqRO18 z!+3g4fYw+|B`{(bJg=i_+8%XieCFK9JW5=A0Z-a)nMnUNvZ_7Q#82|U==z)YI}QqA zp--(0|Dco$ef-BuMXqt_*h}37hjnfD?+7$MYBNXv=3B;Z=L_vNm>37YZ+g~R`6>z(jLf-v?vBV>s}%EPb}Mp9i@wjTR<+Ah{V!$so`3oZ*Zwz#&VBFdH(N{}HZC|%d=*LU)^~Gyf1w2Tz?a)lNY};p zj)F*%^`6rU6)&O&gLS;VzuM=?T&9cU%!9n ziwH>15Jtis^L*e~%j}r3Z|L~__&_4%>Ryqe5?^AtPI-91JG$FA)Nh5qQN0NpEh|lw zXL~Kc?&bWh(=6kOy4$PI`{QDbw5{&P<;f|d#>wN?b8s{tWHWzoI_upmW0s#A|V@p(Yd%0#>-C+{pfCz7KkqC zSdGn`QtK@p$!Fuem&nmDK6&sg@;zGPW3&bM-#A1#54@z@=LE`X+|G z@3@Qa;N+fXG35oLr0a)`|7uB&UAATZ>XUSul7jQc;QI~huScwzYcoTwEZ^@*xwpZB zsfqAR!*B_Sui^MzP|AH0w#%}-uIwD~R%>vB_4XQ0jw|KHzml%aQ&fMEGhleYa>KcR zvVQO>e&%e<-Er~-)Zxx`zPoSi_+jj)6>Ts)QK!!vGe>b#Sy2X7d&^f4n3h(Ollf6a zv~!Pfhp6X@%00aPay0|Toh;S0kTH_r%hy0M7okvfnL^rN1G_Noi>(&|iAQ)W2wCJv zIfIPy)G*#+>9@I!!rL}$UXl~KKcjUpdrnTA;;sri&rX%3(<*jf?6C+P*AJ@~Mn22v z7#6?BH(~M{l{KFNZ~}1>lZdZnJDS?A-=fE_dLlEeOqRes^yBjnwwgw3g?LKSmuKmp zZ+jhTY3qVJ>~hg`pV{|>y6PW4xZvM-H;CqHOHN+pYsOwlk6eGWP||&wY>j7rW2Gd4 zG(tz=a@TX~>hc!I1ATehT{HAuTy`HNp1Pop{?6Bi%4kc<%-sGG&M5C_`q5y0MKj1s z+7;!hb8F%5dg3L__jS!7qkj+2?$HDX zS~X8bqEAckLYP9fiq^Eh;^ZA!+=n%dXt}1_`LGP{kF=tbYw2@iL^`%(|u73@^4Zx?`Duy=RZRG z7#fU{)f#4JHDC42J#U65@s-~&IPG+0T$Lcb{zc8hFlSF@JJYL@X#r2EGAF>{ZP>%C$=Amz8gFI5+TS-*78*CU2!> zx%i@nL%+}~LGz4WOnMzzV`T%A--~4fjD9;BL#uAb=e>8JbHn1|I`eCD=JT(0&g_hh zQr-!E-sZx?G*)?QVjcGsGu4(H>o#AwO4Z|_;gDF(b4;*gN3tjI3{4$|F^*eFq_*78 z`N(CvQh$ty?OavEe56l|*HyY?tYxrH(b*9!f~#NuMAucoSL(=4R8fDU5Jq(_#FI#- zmt}2r(Ly#YiQk{`i@y5iV)%_iJS2;&t=-Myv#7LOR-F0#EkkPBNQ&rraoT4sUwuMk zxB3l(YGt!U9hj3BXgbTE%d$LIFAIzdz1`(kFs+stW>|G`BT)V7O`fi1rA=8oo6APK zNffZVT`hRLD+`Be-BtQjZWz|Jwh?EgS)5RUM}=DATN!WU^046*XMN{EJ>=5 zSCwjhMzTArU!7Y$=OPD86Xr(t?vaR(y}GQabg$@u4m5K z*tEg~$PxoOBU*3J_9tr1b}F%06mjt}dXi~B(D`K1lx=1q7hz{)oj_FSqdHLgD37d} zUYn1L$jWPJ8Zp1lD$%c$q3kx68Dx3&awzF~6{Tq7BL$4X+7%v6UAUNQY|>rih}n(d z{@nZUr#jg`(3qOEDaXoQyL@r~DtUB~pC8RjH+q$Dk=P%C$$Q z;t7SU!r5Cfz}Njk$qKu9x6oAV_Pf5N z(8GUaegDJeU(7TA`nCG6$2&JAzmZV51QC4MUi`kacqDqI<;(lD?x#XAkNw>IKP>G3 z!St{6l82N}X70LaVx9!aoyjJNdlv2SZR-PR{*!oXF#%t@=x!Y~&uN1o%! zcCXby{#0SElSHs?pty|m58MlpJ_^~{$VTa85O^$Rn%Gw(v9>cY^Ef@#BQ`(2~3p?>}dlYE>tj zt5p>@1|sXktFMi%?P>;_Y|GMei5SS4x@5(FxqG`z+4i&+TS{qRbJ1>3KU$t+V8x}A zAJ$B8wxsCXYAK&DE@SbudXb^1&wVRu7S>n10-old1R|@+t`nonuRD|r>%_9B4(bW! z_FH~3s3xB%vZM`)F6)`m@v14cQGFD8yRY&^osPtgA+f_aZ#HAcPUASQOn`J*fTyr1 z&rSK^W{nDSmV#S5pNe~DH>v&~(!K&Jj%HgI4Z+>r8QdL$ySpa?3^2$bgG+)0m*DR1 z?(Po39TMCn1c-+>$uH+W_uTj1UGL3WFm%_hUAwAxRX4l$S09$E44Yx#e5%k@#0lOU z2h~qLH3j8s>m|!_Vpk9K?Xc%Pl8+T;pgN6@@H2Vyv}I~LQP?`@6Fi6ghMjN{W(JH(%ZprjpTxu&Y979n?QV+v02i+47^fF4zBS(aof zC8Pl9mG>sRx>R6JwgpVNFo#gRI&oY}lLHLfrf;%mBU{QT^S3vUP-UjZjL70`SIxtE-_dp5Ro8BAXT{l&D>uF$z+`%UdbS4|p?yoAN!1St z`<5eCHgQh-mRs;P*E_z=&?ud(k>m;1xM)Z6XT1MQ)nuFYVP zB?-5gW>&pveFIrg<~h$MGM?V&z-RBM8n?H^J53YP#3xdy({BE>l3X|QGYit z@3g%RVrPN3%i%-|dGUynRx{gZ{6L_pM@q)Cs(OZQs?*AJb&QdAwlr42DWmZtOX|xn zpT9Z3p_cga^Gs8S`uVf&$1frDELUOQc8XTTKiwC777BbO`Sl5wWaqM=_Ov1wF5}$H z==!~I^mppvyhN&4U(e4c=geMhZ}WaIx{&$|ynFai)JHApceipDw2GORG)#j*!xS%y zM%7nf&-v-=2rcDvs;LjVAfAc$cc&lU=GF^vRGajE(Rca!z>$yYp#S2_wz~MsZ%G5X zp57Kzd>;G>RI!`6R#u2liOV9l&|XgtjmaEzF^{1P9vl-t+m;MKPJj3E)8*S|lJjx? z`1=>vaA`e?2N@vpU;&Ty^sLoy(x&JenLlFq;&u#dC1Ph=&?V;aJQCSV!xboHPHj+Y zpS>cA!_GyFy0YMU^Ubm@pvBDpe)QA#kb*^f5v-RMT^+q|@4g9rcj@kU{D#O>*l3SY z#}v6W9+JnQ>^`>Bt_nz1LK1r0+4B|7?~doZCd|qCjXIZ|Cee+jk^iAZUr;1wgcW8& zf>Frb$q?ixhYL%fIRwu23y!P%zh@^7b+CK>H)&4)$|{rrLP7EnSjZL(vE?!ZL!=>4 z@ZZOBU>h3{ENjRL1U2R3<^pj79o@OCpIdV}f^C83T))#_{u2IIVE7;V&;K6+!?55z zm#&AUyN?U#w;~?df5wT~^*5a<3`w6Cd4HnO*C21O>mm2#pe4W=+@fMpkWo=JDT#tB z0Z+;@Sl6G678kF@UEbGv+1ehN9h=$O*m6B=FySKWp}^yb>+MChsrZbOzmlQG!QC5B z#*A<_o1LGvKN36kKmN}7E`v4un;y{K-u_|ZjYYuzp~Lf+U?*3P03WOUE5ll@x~;CJ z_EeN-k9SaAO}69Ql{~h`66$@pCq90;kloeY{CRe(Wu&C! zOUIPg)pQP~ah|EE#dC{IGmFf}Gq$>ScD-HVpZ2yEZcUNxbVIoaj?lRXdkwuyTv~2S zb`^GG2WJ4HBQ%1Dn_P1Uc^2MRMHw|8)AIVh48G&~{)O*&>ecs)cdYNKB_xe~MISH1 z4;RNCo$|yvUw+zmPIG=9a6W&z7`m_6_v*6!?#-gxm&u~##n4wNR5hv2bri&T{?rO) z9Z0)XVQ~1TC~ZOpk0!ouzF!{mRG6FErqUo1 z0IEKV-XBd1DW;2$(@+BHSKI-I?ZO|ArWZ@adW>2JH8jQYv=;_*w!aAY65a-SehiMsS#AE z@_%^gDV!0bxL*J6o!A97HO4hF{k~&N^1`UzG7=pk`Iw?_%)+w?lxssEk&p+_XjErD z?=XDeB{waicyUM;wLwH-=I}VTjU47!(8p?L{}6M(IXCrHKC145?KqyCFkA8MqzEV0 zmd%q%FzMb?D|Xn9_HA@KXbFaQ8SjgOyo?Bz((|=he1lO3P1@BxmBK&sKgFFcC_ajg zM`B=z!S5x6v}K+5D$))Mmx<#TaVvOb5l+$-q9&TTSsa=!7Ba{U6QlrC;&SeGRB+8l8(NERZr$ zlo3eWTf6$eqqu@*`VBLS2t2vCQ6SuppWT>ze=6;=)b*}Gt%<>X4R1=oLXV`n0Toli#Ov9c>q@OBXy>Vr3iGcv$2l%2AL988?v?6Rt59Bhx1+@44-P^~ zdV)gw>5bqFB(~5ye;PD3_Uwmm8rUxlkOhdcMf~Dw62@#&eFI^0Xp#P+LmNs8}BN2^~@{YW(TPT)0tW zu`KlIW#7U5+|$I`2LemAMzRDmq~u#P;@mmR87qv1lqMdfnc!G^(*ANxp_Zfy>?xkN zUtRSn8T>+U18b{mD)|wJhXY&|gH+5c@zR1rsy+Ml9C<&Vnf5#w5Ka%+NrX4hw&!OjFrhbafl7R!CInz9e+59sAr3|* z9y?q$5UpnwLF@I4c=+MBZkn!x8yMgEEBZO*vYP^h(%%AwFP{9YbeFJe>rxs#2^-G1 zM#}W@+~2>j?wlsH9?T~*dg8?bZ#Y;>QpcCdT-GJ_$x|Ey7!|1*ktdcK9E_kQCO7Gi zNCgR{43c3L0JG2q_Lmkbr@L`5C<$TV<#peYC7r%BKceEdeOB}B{kYK^C$cwT*ZN`C9qd^ktCjE>pLckwGs2r@rIT0IP(sE)>-_xLlldmn@Nb!BQcRw z`jl(D&(n-Jhj_ws%87JR69(|rN{5;eM+gfpJ9;Io+8Jk4YD`xFAK@}&;}?x_AjbtH zbSYD{oH}!qNUwLXc+%*ZgXs0We%QSZ-$FCe7r{+Z>!&FgPY{CGn7L}DTzemUxOv5p zHW5c*Od2`@i&)Vv*J_FCPVV7)qo+P?C}AY(fg|mb*whyp_8x18s)>kJO{tq=7UDYM zVh0WfGfO$H*WV-1xgvGv!I_%6^Ut7LN<53k<(9kYbsPc!M21AEhx;D` zC@VrmL72#&X?<4|BnAl$j%17akN&%{5>S8g!G6XV|uz1$A23O;wAY$T znC7Wf&0;$23}cLZO+aIV{C+~e&=~b2IUfLDL#@GmX6;#QH!a2LA~J<)1?dpAwrPf7 zD1ARBpUhtQ*%Qnv-h4Su5eBJw&o!wND#15D8+k?QR%^P*KZy+=M-aO)b&!%xDiG_w zGFI&5=~?&A^t2NC+H*-qQF)CR!J4gc{ZO_j;t8~KitfAH#PNMc8GnaJDt4_Uj1QwI z;LVqbZXptyN;|jZl6>47(~Z;Pv|)q4HcqGg~Iw(F<8xi|7~fALyzdsw8iRJxd~2#yU)!c=l1{L(I7zHNB;rjLNg;Gc#@!JA_s@SSg}wC;J2Ox}=0kg-EjOZ8jq+mpAWfI45x zj3j$)+7cvL^gu~(o)QNJ$|7!018p2Lc$w$&%eYlB(h)SR2?UVV#cgjhnpeR5`l&UJ zzz)%M#LQ)%v{LMamZE3VpIF_}@PoqQ(W6rkX)B181jUu;JC}Zl2k&JWyLOS~cB;tk z2jUJ#Rf@2La}AIlc3S9X*&~{~&YSi?j^Bu|WTml>RalLg)dLx;YM%G_3hjL$it~8J zco_yJPn@J+;>Bzel$jceuKmt2_EKQ2?q`q!{+BN+tzY>|x8}au#|*R$dA-Vzc^t3+ zyD-x!aK$)e^B?S$QTM&&+6}S!2`2gG@M-t+eOuo*2%0R3t}kK&DANxP^|N$jG-eUw z94X-wRq4dW@trvg$EN|6Z>c3jx+57r>gVC1j^sv~hqyL;TfEBZ>WXMRVLV`1UwjLt=#&+iH?JMJ)ZI9;^rwu>p zC4AjJkuv!yZR;Z=*u-rK3a{}fzcDlHA04{6U|IJQmaq~TqJt9n&6rp z4I$MF&6L#`!@J%hxUU%I#y6)`mH;Ye!$2v?xo0R3z1NO-gRX7wHa;QwUw)ORuuj8f z&?+ABFX3z5NKQ96VI9C{@6$+D<4dW)wzEFd2&0$7?wEmh5wu7~Os(>EqEy8@4%jmRN>)UYf(pR~yH&OLp2AbeI} zoRmflTfZ2%7#RtoPG>+urv-A1YCO0V9Dm3tJ|;zq_+?q#M(qSN%knKX$MjzNTd6huy=QAb;L_nJhY zINN|c;joEd(qFsovp`=(t{P!mi*62FNGpJ1pmd^P&|7lr>aA1WZ1{G;yH7g^aV$am zmPhpVI+9#@?tPu667Do9sn?T5JD)b!+GL3lr$-7C5=vh_g_lM(CS|Bc>61 zN$lcLas+QVINT(}GO1=^&-KfiI9*@vuzFTo3a&y+#4!I&d^Fe3A4fW4Yt0|&8@oMF zMGDu&7_7nrrQ{qpar&uC&s#bhc?Qj`;3V^P@@(=dvgTTYU)4SD^XUNS;z)S{nm%Mm z_DocztVM)-kl_R=__(AOF^yt9KX;yTrji+Ir82V4!C-}>kqvOPq@&H5#OHtghDRDn zfa?OYl#D=3liim4F(o6By+~xrZ4G_ODD1~2ppctGqEL5pSb)WS&(Z6-H@X9cMDV;I z=&)8xWqBIoVVdwKlUX=Mbk&_?VqG z1)-NG2_^2=ikPpCNM6&i9l@`E@8lf_oQoNM?Mm^kv$OJiVOifi;G>hJCU2XPl2Vh^ zKorV*fwhKM93_{RLsXa#qiz@NXMNcpbC4o&R-7)B zQIG&rBcP703eiNwXsg~!J4?-qFh5oIJ2RI2yc--_>I%sEG0;9iPrhEN{G=~$B6NHX447f!5WJ&aubBFB`9_U zis>%Xwju3`o()(57ZeiQCF8+y(}PSF4$k3pw_7e>oIIcW5S>!^iQBYtXoJH7K5SkY zu&Bza55U4i^r|+{7nh>)+uvGrM`?mb^Y-Dq7 zWvbJwB-ZBz_LaqUfcIT5Q*@~70qS6t#%`g9JnrikOX0N=@)`p%PN`Xjm!^2QQ55Bh zhbx`L_kQVIldMx1&5_i$;*_>&Q6(9gtFqr;ENA;#msf7dG+TbGlYgWh{cQEpNAJm5 z$GdNF7(Mk@&oIo3BSlDjC5gb9JPSie;$msBsPd-4-d8Wb{Xi!$Or9HY^pwnV^X4;< zdCNqc_O^T6_GQdSV?X4Sd3(>KPkg@aN9`-0kBhEtP6mgZ{Jld02Jb(u(KfeJ7H!wz zO$x;Y8tYfQol!%8n-^DIP^(0Euf@l(m@W9^BDU{<{!R#_am(81EjMu^~W0xPlb+uOD-@JKpZ8T3? z70`+`g>3ZjlEx{5QO3*2G7w)KkjT%D85UVGjJaiUjxKRM-Bwcuka#|qd%c9wXYdY>SkCbh&3ZRQQLlp2@XLl-#S0+; z*}ehWs)u6KWPib`dq@Y@F_5Z^q#^h=wg7HJ&3UA>6VlmfzKfnuMuKH?KuvCqrJMEo zNkar*nQJjTLJnusQ-yNcNTZjOOCNF{U##3WR`z^a{g&1C)*06sXi8ES>^`R__yziP zO1nF@ZBr<2g(O0WO`YVh${rOU(;-9%hk;kZ&y5wTR$hka8!B`}qDIT9#K)5@^4ayt z5Do#W_RG*c@=_w`8m^c8G5xo*k426_7j$LE#~+)J%_b&&=++4DDKsQ~GJIjBG zy>dZafL0(bIWBcBAeR*vh|7)(%mw9g=kfq>!N7;VmBG@Yd4Hwk+CpJ)%-`rtnO{&w z4#8g#7+4t$3LyaFRThAuMSejy6@X4)M;{g$Hy{`aa(8zI{BaiS2;!sp6F&))(f~Ta za(j&w^<~xA{ubrX0oi&u0$~ZjFbNoh669`W$EEQrDcSM&DZ@Yd1H;L2DZ2w5!B)}` zTgN}(mLMks7>?$TNb;}Rzl?VSySO{MaT)zN47}Vhde6U-j{mVs!T&zC%*Xw2Imc!R zZ=;52a7M2sM<_OBdB6*$p*TjF90&EU)*Pv6=9LZCNO&IN+umubqO+CvxgL?XnqRgs7d2}f>%JcR{)(~XP~9t#gHE)c4S zMef^ez7MH1t2_sKh_pDoznn>bPN6NPlwT>eCl$LR`f(@rsra~HY;m{SR2cu;sOu3L zN7?MrsR-pgN710xMMGVV{4dyz#S$yxB(HfRa6i^=sBW=)sm|RGV@H z*b0=3GW)~FLa{dT6L_gOw`n}%c)RKPC(f7mUr4?vnGJs(TqSOJwfl`&TQ%!d|Buq2 zfCFK1e>@?FiNYI>0rKmph0mWw_(*9|@-DFd;iufaG0Okxr@v6SzY@M-Ipt~~h^@OF z3`5NGui(9ry4oMtPaWhAw1(js{}sm<_ZIbba&dy4r}1`jgg`~TCFp>#Tad~-paeDD_I=k6&!SeY< zxVU+_czHQs5*$z;h&#}m0|KT0rQ#1Af4LzHp-J;gC(zQ_!(D=o4pvU{S67@|)Ybo1 z4}o(2?ii<)vlEv$(1i<@Z_nlA#P!b_P- z>hJn49&V1myJHQT|BfIhm?#w1D$l<)>0;;X?hLhacKN&7zcu@J@o#hg*%0iq{r6S= z>f3K&n3TG@=)aJ;5_G(Ba)KfP(sDfV3Vi&0JiOAvazgR~()`l0BC;?{hrmCoDMO&{ zK-jA#WjP5tm?BOv*jiNBS^y{lQA+3G>Z_>ZKlt%oI zu~&j&J)GTqexLfob#+0me;oaB=m`Gpvotiny-yTq^$T?@K?enTf~a+bFf825)D@4uk}h2?LXJS zU;738xeoqMh_H1OWw`#lN6E?R{RxZt^PcwmR``392QD2D3^fDx1pRh5FlWeeD>$s*ODvrAuPuS#A2;Df;C?e=|Niy= zMvDy(s|I7zMnOhK!9+(z$H2gZeST4AV`E|cX3)m|^@W9ng^z`S``>+j(Q*HODR|t5 zLxN*`?1#gB3Lg(oj|hhg2agMnfQ#@r3||Nb5C5x+h=0>_qdrAOL3#p@2#0`%{;LR9 z@~=YVCx}Qe%5D@G8}~2nZp2?S;V`yt3fte~1v`SnMaH9jg3lvOrwv5mbq#t-Krhq4 zAghy5Fo25oPyTMcKMB0$w{|EZ+#-`?$ z*0%PJ&cUJKkJm$GiK7PoKYh#f3wF@r@%O zAv~2+{ADrh8vmjjr^Vwzrjyow0>p<=jMKXY&Hw7(FRF2dKe)zu|1wtQe@{2=_78It z3K|A(Lc_u%BBTD3a{PZ}^S?}f+{6mI-)E03(xUE?mis>AUQTxiA1GTcP zM>ilBUsX0b%vNsQ%0q@sAF1WFe)rXQgbQ2}SW$HMNYp+3=+$dbCpR}%-J7fUIA_80 zdmt6+N1jxcAH*fB=oS?XY4_MF?5wBwWO;}`U2g$?DjI-|Bmc^@g!KxEFQo*&(KNRv z=kV&2w>(?OQie+NvpyEKqn+CP>#t4jYudBZ@9T;^YK${HJva)X)5LYGdrFt$6Pl3R zyIg}F4_T5%&=ys*^5^JYyFN^=J^FM%tXpAaEy0D#Q{&VXyRYMR?4hoNmMLZt$K<)A zTFJM&W~=4v?et>kGT7+)%7u3Pak7=9kpfE?S;EodMTRU(cEQ>r+7U_(M-EZTx}w2$ zYa}{>91rliS}Ef^L`v&80xBq4Jw!u_G=hL5>y;`c`+Fz4+Jwed52YDWAHe>teZ-O0_8rg4+w z#bozPAEBnE_RxxxxBW>}^88!oSYUX0u16S!?Hg(RFiIWWF9z~oR#B9xjT$-Yxygmt&n|rXCK7A8qlCk1C4_{m97R_3rdo!EMsA-V6=#de zj?l95vZyMkBM_Da`kAHY>A}-Fwk8IBAC@YfNQh0@LZ1#Ma=YR<*gbv3;nPx=F5)wQ0`mh zmC=IQMzNymG%6~`>&fMlxeAA;Y-^7T&v|0`^mO=R4Wn`sD*-w5RfIleafP-D^Xs8^ zxOMvKn%WdCS#D^xub0N>6PfOpVnwLY7bbi7(6qJ*Kqk=>XLSyGHVM9*Hn z^m!Ru5uK6h16T=DvIno2xv+l?jJc6jH%6J#A5kd07R43uRX{u+R%J5Q)Epn>uRtL zl^E8NAO(hi`A$~->P7CS!+Ml(S!*lX_$pn3wQnsM9h@y>sZC8t9XRY;boI?N%PE=tqI{qBRjMy-fYD#>l~kCM!d)eGDq(Xi7q1RCvW-jN-9)zYTn@m zn4>$=ym?$S|Bzx=8KuZnHKM;@C@DY@m$0mSy2QKU?zo-yT$+kCGi!X$WM%-~oZx)2 zEUIH>xP;abgmOnP;<%0UV(pN5VrNo!rU6kwSpnDdG0yK=JF z7a$I2It$KG)>E4ouDvJUMBtw=sOPw;&Iq^HBA&{mrYC7WaMbC0j3^DR zlkF{4I@p$CEdXyalX%jyeA+tMx!-%&x0o5NgKYX^dAUX=i$jGOGwG8LcACmAsXdC{ zpN6>#*A>{SIJV>Jn93}>BzMIVCMS&;FgUoHeXvM=r;+nPLaD}vj>}`Bk!1mdtn@AXIUoFw@s$ zIYP*9DbEDSX0XdlV4o%3$lNvMJ*J<9-EC6LdTibXKCF=VC05Rdw`Uc{bzYL$8jPBJ zB;2fQ!w)Y{^egQ*4Rs*yR6nZ~6p9oiGDs+D+*EZbP@^q=^|)jTbFJRaJ-awAJ_F0B zQ?f8cSJ459XOyz^O;(PLUjc+19E$itOjNbO_QOxt(`#co?wIPQvc0h7R*E6a=85o3 z_meBu8N)UMX7)v_z-Y`gtk_1z=clG zfpuYp8Od7%PKGb)4w2Nk3M0uBTJ6&<_|VeS^2*)f?F)5He54v^h3uebt(68F2}D)1 zw}e50p|~$Ts6f6SY%m8h2+6rGw^f(NQ!vrg-VzkE`B0Pnh85|uz=Angqceo0DG1U` zY-tKU0DP($4)!L$Z7&D0b;m8~80Y9xuE!P)9#8n8+KYE1h3ibU`x4~08aN-7qdS4M zS|T;2+z=jWmv(liUVCXTZ*N?vjo&6uKuC48UXMAI&XrG>enE)Zgd+&d!h_;?XGI$r z3uRCC|A}HLZE5uV0$4nWD^%7yOpeW95jPEbgP{kDD2wO5y z);6LKeITvRmL>Ege)G&}bcrYhs@z_MV@Q*0GPBzxnyhzrr>NKL*=@jeytmDnsDh6pxkSxP)CvvV)GYTpPyJq~qhViEGlkl~S1|0Z%4~x?ygiQI6xc zQ!S-L=2z>X_VDKwcHMET4nmR?wZZ;`Hb@H4G+6NL+)#7~ORTKWL1)QQ^q|G$>q_GE zs8yERR0UncrbJ`TM@jKYxoWrV*#_Eko0a;Ziaq?bsPF^j0CvT=P~r3FYn|88Db#R; zLw1*Rgd3O@8=R-uDigiPMkuvbi+zy*)m|5|lhqFO7!NLxvdlWT(434sntgOw5p>!Tzh=2UH4Ml;^4Y0Mf%6c>WGgOAnKi#BvGpt7yEuxOUw>U- z-A*qPRmYCex~$&&)iK)MF&Nvp$GTF}Z8U||uT8XRQ&|i@`J;l^x9_1UP9#3yWPr?j zcwlYm4?YOlZIwue1BY%@T+zGNIh9!wqb}Qd8tj4bc^sl=CaP@eOG+kaI`QHUr9WC* zq~7;cXGIG21ntzvU{iukFH~*n#}W&h(`aUuk`w%kJiTfPtY>U9H zOc?70A0*|J&(zm#aaD?Z3N&Jm(X?huQEN?_Qp3k=~O@!()$(aZq?Cbg>8aIiXW zYucdNowlI$%Z3e!gi-GAqK+SJc_u>#gO*G+jcZJY_L6*3TuBsC<#ihuphzqQ%DV+^l9luX znH@5tw}UD3n!%k7Ma}%RlnRZb6x~}@Y53SCHA5+O8(u>TCpCpUo}8=%7BTx!3qmHjS#QyvxJd}!+!J3IwnhvU8UV zYXQ2zA1zh0IpcLu_;fx9DpJU14BXBx?qP`2?-pT4^V4!*)F_(FNogA#dmb4qh>lZQ z$7=GWCeCCh#m6i(^Jq~MShbG40jQ!Z>0d*Ut+ z{i#v5%E)z%iVrFn-CWCzfnjw{>R3-i%}pp4;ZtX(QT5nmiFb zkyn`6S`vHS__-CAV*>XkiIv<=_i&h2nKn>-p0j&3Pm^MG3EgO?tvIf*4XdhcQ-X@z z`y~L4jpu{>=sRUUQ7<&zSmY8-q@eU@2ILdYD%Y7ba1r5*U(C##rgTq2CV!NJ7vJPg zWaiEmJKsb=t^!kpQx1()YGZw+2)5Srl2fjr+H1oNEph!mIyda<-U^&|g7Iy7@l$Vb zZV@3INENKo4Ju>)xrW5GW$1ibxyC7NE^in*ZT6}!u2zFW_q2&j6Dg4EH_NqT#y?g$ zvh__uvOw0n zkU_C#u*Y;0vFMI-)_t=H5YyYQ=ynY09$lDob>7e7I*QWQ1(PI*(DRrPmKRO?cUpqmWn5w zFg(&A_+rFUE?j3*T@dy^fgn5!vWhlyJi<}2#xWPor>o2DG<#d1F0G^PcsQSDq&9)h z{%lPdoRYX#Nji^p33IILZ`i7i=jVXMz!m+;ADu8)fC*Zb` zL?l)Y0CH5xm5gw}3oZqtUba0gNzf=!Sl?)Eg|Ja$L2(Tfc+3RJ3{iU zMSEC5ce+DGJEZYoMzz6@4MBrhBrU&U&6^%2;x)my!p-N#g5dB%3xI0*Ax-O3r1xpn9E(>Yy!m5JEv=F^Fs4iW|G&`xVbH9HX<1U05iW#UD{Y}05O z52TH+dRWfhDKf`$!yn8;L1Wn|5iPuGZ0r?>-M0&k3RPR%z2Y*?+Je^^tRXfC2H1#p z=~+TZBSn^{rXYDE_n66*UFp$ezUa8-1lQ5~tgt1=3l(z3KqpUH%%0@ogBovioe<34 zcq3P^Oe1YsXp2&7*h6cP${C-@?4f#D`QZyKtNn%s^EVsg(&NG*b-UN2My-nb+oW0T z?JbMRw{-VQOpBfL6$E>l=JOBFiPxS3nj#dSq(gi8*joTX}Bdhx9cw4x}u1zOs~ z4Rkdl6@{(fT%Pqc(~mBnK9CgmZzwqq=V0O83P&c~R`Q?J-bGQO>d5G+M=&zrY7aDD zOfcrw3>e?yd&v&BhIgFZ_?vj8xpE}?%X!$hdW^Xprc}_a`z>Hcr{Jt@bZWWoJV^bB zFDnwePTR6g+>=Rk_U+UY889)qFLnI-PTNFG?OTb3=wf6zEo(br6cg1QRg)?IdhBq@ zoIsQM)?$}RRfz{?fWrHa0`^_|WuoQA9glP7JT@{PJ(rq{33UawPQa}C_dR+Qc=nFN zOe`wxCY4JD?9w?Q=n96qQ#nxO4TYmd!8j5HxzDT@q!zXyX;ORLq%(ELp_os;um?uq zf~$uSYkNnLc^?boUVbfwzkd7VXePg{`;S`LkMGtq;wp(yQIp3&6b=shjK-T#3bZWJIV^ zqIOE<=PG;^2@-?_ntX0v68(EXiMKcYoYRt59Do%N$Llipwmcs$L1or9-xl~|`MdLq zm6g=O?$i`>n-hpi!M^vf0=dduw(wL0741m;dR(LK>YS4(mXCU+y@7fo>PQ#;dRv0! zp0@%ct~7!MfQ&7H|KwPfb^ER}ib6-BTOnn{c!wdm$j0I7AfAvI)EZO`M;xWA&z3)~P9F9tU74CrEQHtD!W7Q&Pzmca zsMJx{41@4F$Xyt*x5v#6OC{#G^fV`>FPfV?{j^>`^DGMgeeJoDA-msGa zAH*U>hZG~XZrqMLS|ZZirMi9lH%9mOqT98jd@e_a*IeK)pTyw z)n|1WgfN~QF+MDjxx$OMsYxr?q$WN^M;Laas~!XtcDI)Hjdi61Ki~0NZBplWr&6Nx z88M`!p}DPnRcYShP=;GGOB5hOJ8Y}SaF0vc;_I@$+TETfNfTJre{JPPKIrG<@ZjdUv2DCB*%@Kj<_yZyDs5uZDs+ms`LYNl=hy| z%tt|WW9OJ$T|EWKb@1xhJ!<1Ldm$V1OXhDn^@m!Uos|v>^uuc1bbR6nyU2Kq5<5`_ zjKEDAPIS#~g>~g;88xU&r?VBQ*uTQcC^*&2{8167P#Lt?${I@}2X1>*v`UW*n@o|p zRJ`{BNDR%9WaDeXj;{l=GJ7=SedwEnXpzP32UF#o=_djxJ>nE7jPY=AYExULi!GyV z`bJBNksY)r6-}6`Gq{~oYBP5_bQQLgCGZ-?p$|I>>$~+Proz4F@To>zN~xPcV;d$D z%!RMx>~LpG#98N#IJkB{SvXFOujdssl2HK{{TOp^?!yVx5^&=08cf+ zDNJt1tD?0KZ0=sgnR%qClvGz$o^q$`PNXn)^%6JADVLqD22;URIqEfgB2H*Heov->ZWREh?WNH2XsQU+RJikZ&`SODN#%PDuL78I(8OxA1x-v0Zzzj6F`Tn+EWh1NH*Xni@N`u&)eM}zE#)H;Qwm_wUrV27p3bw|W@V)*J@8sN zuSy5MW5OPmrq2r>wnVg;%%WJBO0QMEevjtTI`tt6@y)X^fN?a0X+*yEQ(+Z40;@_| z0-7&V+Er7-XA|4$EINdR{b+33RUAAsnMoDCLqSf4a(e;#*w3px>P0PV)_N8)ac66V z1)5iWZ2T>d(*nXfTt2G(R$`@-KH$d9#!d9*872s=B$f0?6cu9`v9%yDg_k=!}YN< zzIQ2!9h@{*L2%>_3xbPv17^}~866DZ+7lk;OS6L)?INn)?W|6vdN<^)6H+FfG)B)965qE=GO`ho@aZ;~8DsEH>F6HD#PLt!C2o1a%NV*N26)>S zlvfeA?mp>Rd>7@%4!o!k9u^u_Si)B7aPAlR7wIlpdB^%4+~nu9#n_AsM7&5BUyR`XczaxPirGS1 zhI>TI=|0&QmsBe$)pGGV+HA?*PiH82!Hh2G$}pG}BcNi`x}^1>dov@IUC8N36Mij+ zV|ry*onhQTuS@AXF~Z54?Q_&zX=Vs}PF;{W$-1Lf`F`&;D{j^5E z0w89CU#5ZEYx2Wqa}hOslWj7-4L?I>8HnZ_Ae`%a z+hPS_9fn3Hoa4ryLA2tFradf*95*~ADu?JQh&dRNvHUSRM?5stdC3|KL?O@ML_*sr zX^~heR<-r|RYY%-0Bw%5 zQ!Q%>)Z4O_n@*#;nA`d52a+WP-M#uQwx$py1c_TuvB)-taxDG9Zqlx;MJh#+s~0~O z=`ONAKjB;iE;M!CuwwR-N9|Dp(0d|Lmk_NSK0K)gE*EEv(hE1(ghbz&YPp!3B*)Q* zQya?D^AFTAyAOS+Iz+Z;?NmD&^9qe9=@&Ju=DxsaCoC5=nBmI~v7fI>XE!z{G<47| z1?Ln!f2Cz9K)JZ$P6H#a)2e^j;0lTp& zVm{OHfr&R9ZKKpCOCqZb*(Rulp8T2rhB9Fs9;^gI} z!em!bk5zxUrIb&Y6>MT;UDgkARDf;x3Y~1TrwyVUf<%e?`GR$VCJXp4f>VzAo*{c4 zI$pWvdyZ#W^puX~nH-2vs055(a-dC?uA#wm@L2Mu7$rKpzzfw1r!eQIuGErPPTId%DwC}}4o$}$J`t5j0;{st_}%99p$+#0EA|?9J(eI@`6hPi={G~y z4W3D9l`i}dk!X?H!`-5Q%ic@Kc z=7Hc1HGOV889kfp@LclZah$2*;T5l+tv?P4=0~~}wYw_y=-s1K-_8yE59@;-+u-Ob zG&5taadJQlqXpCLb72O>;SYQE_os)l{P_jEXR3odiXWagsB?EszuR!Q-?&7WQSd6i ztg5{h><|Q7#sv|od4iMMJwoY;yyzuWqJA8JsQT9KPDtO^#ia=a?Ep@h4~Cc1fE01l z^2Jd1OcxDsvJ`NQ0!yC$k!gB2>x`Vdjm_i`5O6xxprUseArB5yvLdx@UcRBp=Vl(N zw=~srvLe0pM0rna+PP1RE8l|Tuzz2>STZM^g-8*;)Hh3MOJJEH8;J*;qNC}9`FERO z2R*Z5(oMK&rI>a_7M9eamwM_boHiPodmk$u+z>e3=0gO_ z@90Z1rcsa<@&~OnybU;-HLI5e*x*1)gOm%kTcEPbIPx9wH>oC#5J)x}8bsUTq_7A< zlk+rFvzI7@bg>dIv76x%It}th{NF#fqs9&)hqN_Sl^Ijoo>|_qa(4YsfS5h04H&5? zaf9kB!>K9ni;<^|n{!PMoH>>pkl%@2jgrT1XeWPBJC=e6E{MuZ;9^UpR}b6Iwr9TcQpy#HE)KPI{PXN9fXw zE({q>eVk#COs=g&K|g@ihvG*MwqNMV^^|z8x@UVrtukO`_N{x7t)*u<`_?_jibQ7=;8r{6Kaz6`=vLr3pQt1l0vp&JbdsL%pL$zSU98>fBq7(f zWi-I?cV2hAE7n!8b!q}oYXt*m2bFVo_I28ZisC|PmR7%pnphT@yzRbJds-vl8J$Qu zSzp4LN!k4IIZb65PjIKH!*2W@=&rQ&$wy=U6tcQ>lc2jfy?&C6R>}7aU_R3uany8m zxroX?i~zKhwme@tMCvz zwMu7mZy|gtPV63AYEe@2TR)@xma~Rtl&@h*{`|h5q%t&CE_&&6N%F$s_J#?!4$4z@ zutVes<7nSZsMhB9x^TD+oUZX`sFcZ?k(?S-%EhtdnF$#)ecRzp;m&60f(jPD_Ches zJnpPlVikoM+Zht25-IIWGyW{u-1+6hSh{xDsfln}FmBd_cTE?4W5jPvs$B4_!{=3B zT$2~mS`vl@iChTDpgCNNqCYqWAUVV$_Ahm?-JToUl9KG5`|@9ye^Kf&Vw!BK?tKQ^ za!m~Xb&R$Xeu2L}&W;5pbC#-)@+<`z?McX;+`u}d+;LhpF;|Grn=A>*ZHIo$cofr+I zgWN2$Dd?zYwFeX8m?NL!CQ6-r?c>U`7|(&F@d-N-3-gRVnJ2J}T$<@rB;vB;PE$ES zXPC8hI&N1YTeEByYd$o?Ctj~LX(}S0sh-jWAURX&hJtJM1M&P;L?8$;AWGsdkXO&w z(@zC2zO0>(VArTyUbe0}GZhl}#M=uOTIrOd_1w8!bMvX=J^@3@-AYQJTWlQj!$vZW z1O22#H>FIW0kp{iKWxmm^3evf=F3Q1|1@ita^)Xl%|-^{HJyCTo*cS{nS-g? zh*D+tRc~7>e$bwpCk*qP0U!1EyW#$M{|%$QuRllb+h=d-M6#&KxZMu~ zr~^G<7H{xB{ZcY8Z5_a9)@9Z2>Ivrxu0KbE272l-M=LaP3RLgv=ryeMgSNYC*CXje zDZK*OD>$<`WsMu_U*9cE>N%DP$QgabB);p(_bgh>-uL;xb!*J+i7%D2Vh5dzI0Ul_ z8gmm;y2{ISxKF~ZmtBhbWr^{x+?K(TMPxz0Bh*w$ZpxaUN{Q2%22`W=EDuQL zQk68;SlORhQ>47MM1*c-4Yz7>%e5t0S;;d;`}9TbSy)QZ_d2;5o6ThCHI;#G$x15- z5lHkVBsNJ0^~VJ=Eo6gvCCk zj-IEp?l2HPo^8qt!A(sqIs8Yrn*oS$8#RcSfLB(|>DkhMa-tbn?Rpi!6=g%Zv^4W`O|x;D?=% z3s`p8%>0$&XVBRQRoJ9K$*)aFC#=rC2!;CW5T+JlCmv4bOJJKjlff5NHxHMJ*Zre& zfGqrNm=hMzDdQN-hPk;(IuP={!fz$O&b>8vKPR!{G&L8*$~Kg5r>-7w&WEiSx=7yG z(QEO2Ai$fz8-EZwM##qGC2xuTd{)#R%7;{vpOiW+QfVOaGHs#$2iu=}8x}t9d%(ws z8fk8BNcNMa6L`<5nF)zcy(2ed&$ePRO~Rfrs(c(DG}Q1M|E~p)&X8hxKU*MDD&@K} zJcDbn`GlVV(*Hw2$+G~SQ4-?`m&G&&x@!)43p_MGIT}XKoUmxN^+cxj(0U?ZCFu#H zA?^DwbLOY|IIYqCRS}dByOH^UK_kY$0-pXbL|!@kIG(Xw|4rJ_yt=7&ZT8Gd_$Z)^ zumPKlvt{;unAots3lCP)d;1rg9cpq}n8fPRZ0px%@u~Mi3&@{qQ=2~a9?nQ~`>ubi zAab7aR8LSG-f!oL?H;f_v;@w9SOnVERody$3FeN;AV%-SJ1r%PnLDV2L)wrviBd0e zdL8Ev)uO+`(HBoRSYo%xzI%F$JWgy^(qnIpZhh0en3|k9G2AOdkkkV${77Vb@$=3% z{oI2KgIKLd!ydKXZ?a+X+tEtx(GO_Z*X&C${I}Q?Q0O0@)2;8L$9+EgyfQcDZ@sS3 zvrTE!1?wL3>Ew?dSTMR2>qdq;mi?kzW%7ZyLJL2O@9=(!YrAgA)ElJhP6=jQx7U&) zHbI83MEg?nZh)N1T_(OAXdO{*rVS?}ryD-~26wSGZdgByXp!ny%<0ueu!eT<5A zlb`v8l})Qg-+2Q!-@Bo{xfRB5hqg^?6bd5#_Gmm-Nl159bJa>ozVq9rf#4$$J9T4} z!95;WI-AWE5?el3Ji))@QB|Y^*MPXn#RC+EZ96d>s7~9qa^VKaon`#6P)D$UHf#28 z!zxAeOWU}W_FnKEOfP;kFThw#Oh$!iH2Ajyj|Y@CNzR9NGN=L!c?UF8P_8Y5J3DH= z3|v{;=vofh^*}>wGp)~!vj$Nh?VbeMjb(2)<27FnMw8b9oF)dK+U>bln0*^0fIfu# ztj#HB+@M|Ry@?xU=6CHDE#nBG3!FvMG6L=>2Js?;|oqBM`+z03Y-mP@2$=1td zkGRqS_(UWRZ-nl|YvoIoA8SYdMLkmb4sNprG4rt@v{X02lFZCO)m5flK)bfPxReCm z0_&V!D!?$@5vPqiOL%{Fz`^yyfy6MWav8dlrb77&q<`_jBvwCW>cU5!aC6uMlZk%^ z$qfL&<%WBDsfN$WqPRdUU-!;AScZ2sJe1U!G&_-pE?*$nPXx}%^qM_uZgp+~a2rdT zGu7VmeKfhdSa(jl?3`uUHKLX+{$qx2;x_T}hD)>Myd#JOgi=5}KE+LO?ywc;_!p$A>v?!>= z>oHOYFZqXI!=_5FT(+^VUcpB@oSRKrop;$tIm|=g*GW5~bQ6?qIz6kSM$S&;jo)^z zOds=CRZ5}UZF!aAm`Q=Io`seMq9rYJ;givn1toUwT3$FE9c2Daa5hmMH)^vASz2Xa zgQ91%Ti~qC8eJBC#J!6df01U53xTxOlx>A1<;jn#lZ?zFV#QW5CDr7d=o_o<&cg8% z=7s(V?pDwRSu+K5&|`%5I=yB6YWv}@0HIHaxvLat@vn>Pv^Et5{`=1VG1SAU-n_AV zxcH$kY*s}3uNZ^qsi}x8SRe%@AIuW5Uu6{OH=%ig8ALmz`a%0r*Z;q2< z8LZe=;`f1%z6Bc>Rq7o}{ugm2nY=)#q{^n+QH%=Ct@*5-pxBO#)>@m&8~>ZcR| z+Z7SN?Y^><(6;!bSl}Jk*Z%SH|3e}A-+{0w!QoBBeE74St>J=$G$tetjz@aMf*?3?Y%@$9zf zJ5B9k`5DfLu%b!hHu-MzTTCKDB6(MTDkc?G6LwibxIPkcG_%!mmo^Apx72=c^W>_y zmrwh(B*_RVOdXPdx;)bjm1S`}jXZEMNf;=Dzzd4B*5&K0DDk8mqj^6S+;*^AhlE$* zzxzLsehu&BLP1pwSu^C$uSV@OpNbYM%B%Gw#RHe!Cf|W}fOiSLzs78awQ!@)sc_$Q zBO5O5M4L4FEI4mGSpilyn9iPG0>4zPq6=5HhMXhfB$AmXUQWC}^>~-|(h1&X^&)d{ zLc#D<-*R{d2?KiX&Aauhdxixtj7pe}R%xppJ6BqE+u~Pr?pTu4Ao&Zz@nC<)>N>xt zcUycCYJNbh7cbT~KV{9o-_y&kiH*zzE-GOd#+9`SH5O-}&x>lC%MS|k|4LKipnaFe z&37AMS^;<-Kfq3Lp95iptGU(;*`{s>6$IuHo`t_?T)E*_`1swR^LuXHTtUcgp{g;m zxs0X@5eXLTnk#PSR8*?#KKt?b31wWqlqb;sEg3+tYwODf6@;IcXS54wraiK8+#8m( zwPWTM@~lz5-#Spxu#1f!0mxm=x`lD`{+nJV)lJ;{b~m+4Cu#j@DasA2F!4Q~QDkux z^6s(hfjXZZq2SI29(ofc*AC-2Q8N)X3e9VS!lHAU%C?%N;Lbu9_A750omT%?eL* zuGq686=26grY6nz<$M5|qEpiS9$yO)t%Jp*SDOVFk%=HD8o0v<$f&XqZRzp;?b4f< zx_QwIxKjW-myxPY9tmhQ4+@+@x_cup6T3bwh1``=;nSr!~{}-!~p>7kiyL z%=b>)wN0y{Onq9c&Iv%B^nSix**kG5FN;_CGBZsYTmqv!2R%^KiScbmo!Wc14RW;M zX;7=t&e=@Cz93jNk-hWRvY-TV4_;H{SC~!*(s}!|)1nsK=2$oca(TG;NW)Ti#BC;J zFPyz5uH@dM?Wt!^>=CN#P_p0AQQKGkSFY$Z`!2!P9yA-xe<)f#^k1qokn! zdP(R!Uc8f2)82qaKh@PCqW+fvUD9^?IR3bqj=3qR<9^Lz5$jSQ!yGF6XtCj!6*2&}1+zMy4Q^1U* z<|eSyt*k!SCzAJ9-jkKz0^Do9FNo_DPQ;9bVECOSueB+t%KJrc)B_6b48%z=+={akjSZ00GxO=SWmXz>l z0Xp1?@p3-*%!DJ5J(bZx=3a8NC zm#xo>-dFfkm|{w8`Dys`D$v6b-w@`KSHf+(oe4@QvbxDGkTGTPu8Bh{c1>|FX^-)< zcqiM7uX1K+sxTSkvF~$!jNfShT>IL@7cYGmz+c|?T+N^za)`e-;7)AH1<}paTnU%E zmNib(ALX4cETn3#?4pHY4<5*6$rS;oc74R--K<1!`ht_f;t8Q~siFQIEb+QB}Q7K)oz z_e0->}V-v&|MSglms0{7K<0x)n|=1*(#gHxT99IEY>(N!54e& z$f5}g8re#pX%ZWI%+sr}JN0jU##OwX$Pu~D*fPy!R>uvyv?qDdGEk%0Kl8?rCaZ`s z;!gCP6O-1QHLfLuSpJKFjFcYp{pz*b>0GeuYH^SGAkNh?gbN=UoS*(o_c9Om+X8L9 z7kXDWZp_l))QZEaEUWIZj*p4S{?HA;c^PJu`-F!CUQdV zbCB=pzf&UH7k;uPx8vJs=S=ALfXVHO4(Rqj>dj95TclMv)G;e&=_jsRv1%TrV?qyf z_XAwy#hL&=MU6LgM$Kin=yN0nMhg9MyXn>;7G772>h#Zv+#0w@4W6-Vn0I0aERkdyD$L4Sue_6Kk&-1XA3CO{$^aJDreD~`8> zd-R3vKJEID`*6$X%-TUAgellH{AxWhRbPYTnQe7agAcO;zXNNZZbbZ;o6^b2EP(gS8)S7cP)m#Vne0()< zD?vHQ-N>8qF*ID+ueWW;YE9Wec`YarwHFXluE}C`JKmjkt{#SBmF6C&YSS}k=;s6( zk6WSs!sDDIqThT)a{ij`_z>S$VAgGQf0K-UibXUCwnYz-)4T2FJ&JW>UH|`yYP7*f z(x;}HX@`@}jS-@>2e}(!RIK`+oN53)Z43dZQZJ_TYDN>HFj0})DrIt!^O@6N zx=3gnL?C!S`X(&Bg5kM4f|B=>QPCQxG8}g0Idkw5uNU9{^zxr-o5%9v@KFXoqf^Js zjJ7Os<-@!~wIod;Eb|E`XS}#{j0>w67M(I=bOVnuXQ4rZ18mbdI!cUAID{)UJj64j z=k!|C+(w+J=?q0VFB037l>l>>i(2+#_nxb+8GA2A#M`F$6`*XvAVa>5j=NBbMfK`? z@xv3%RV7~%b)$|F__aXI>RhDsB7+@m*k{F#08TNbWA6A?>0nYKtR3367$j|7$z`Jq zS+i)5TqRU8yY^T0eIAc*HuuTeBAGc+;{pN6I|`A{D3MI}=oD<~+$?SbGQ?B0H1qfWy&ek(`l zgY25l8GOB9hYlVJxHT$MJKzT;h`%6MlJmHB@)YK+aOB=7fk$VpDXcc$D|Zkw=(;nx)N<9k?kpKyz)OiouwWD#$>Qks9;*Rm#!jl#J; z5472h>og^gWfyA`=!iAdFv8||Hb_>~Hw!Ub?BOoH)~y;W2GAUE5|JwxFXvjkA6XoQ zk(Zw8N_)5gNu`SA?D6?pzvKnUAQp_A9F_+3*hm9Ra@HH zN(uiidk!`${4NaKXw-XATy(EE*T@Y-DSWv-5=)L;K@BWH3>;hh#JsetXUdYZc?TB@ z=OB+MI9%HAgiPZ-ghobA$uKCJIW@1Z2~&Loy(!qb2+aMD&=a5t*xF3dLu3Xrc7@rE zmam_oMb{(2&2%5ca|*I3icdnl14=3r-h}3;5&-ee%0jkzW3lyKJV3MLA85PAg;xqA zeEu6to%t$6UZ;UttmLCUqOryK?s+4ZVs=iq;aX6dhzHtfJx!^$R%c5fxpRYt@xmSB zyY9?UX583<#I}>u?Jtu6yyT=KKLf>D4n=wh;vVeLEzHpn?U`*6b&w@Gmtw z2sCZf$z{duS9660UfL@?5AqO7GU?}v`Q)Tmb@P3p~gGo*| z@Q2R;T(+ewv^s6M4kMMP8O#i+S;O-seE$hu9eH@gCiUp^md7JTzr{n#kRZF^i=4`8 zIGcoyZifxejekBy^x*Wf>iPA#JP0`C6`)@jL|bm25TA(;F##Pviy!{6G(KXw`f8Wy z&0D#$*|47=F*egMGnKLkx3Qc96VsC^a9&h-ynRC^xxz1>6b9L@T*1%=JLO8dYn2>X zm{*+HHqao&hx6DR#Yf@5ABqc0m-qvNCCr^!{u9~#QhNSZa7|C!A(|ANl91`%rbl~l z^#w=8JSo`q&(ev-lX4A>MtYZhOmIZLu&xHGNzAxs)t-&}+7Nn{rjzE%Cg`L#Z`AfA z2;FNC`59G12$~zW)J~?*G9smWy$*0Mn&phoeyrB2YWd++!)R`HwY9BV?nnPL`nRz@ z$_SH{W=K$mBjVkT5mM|iqV#n%tZlCCMQWqII|V{=bP3v4JT{W%FwymXFDL7W5MPll zufbV9z{+r17IRS|2|4)c{cp=EKjVwamwYRlSMWr|Ivl?Cy>sV4f91#mwDDWiDabO*{_Klwpr24(q>#flb$>78 zJ*t{gZ1Zxzi>{-}*guli(_`cE4mEH{-5T$+jW;e5a%d{6T#T~a;kV1FGT9Htqp?9| zWwX?7STBI7-Sna+3lCSlO^;HKSf^#Atg&~SfWy{i*nfC4==)?Yt~wQb_hn#aM0UVV z<>wwG@2DYdU3Ro*os0Ifm)fz$wxzCIldlHd7z+@^?Vwm~j>7Cn20(Lrh^MpV4D!o- zb5l6og;>nl{eI^NrMSU2$Y#FOk}y_NfWUw}^EGg+>gQ*F5u4pA%vG00kP9!uq{8J4B?Gz;! z5LXO7+C5O^c~XB;^1FuYkYYPikbD-VzzZ-3Ns=@>KD;HEI=J9;g}{C{`4giO zH8nri26Hi0m&af2rHnr)By?-G{2_m3y7x1^o>rTyw1i_0VGq|9`bKRZBE?16653S}qw>Wu{MI3`yk&kuMsP3_15;|8m zbZYAa1WKrlOsv;lWaW*#gV-wkj~Ov&IaY~4YzoQvHKPyAJege{KQU?CXAu#zVuvV< zycup4jBC>UBTb;nxmj_CVlt^-4Nn&WB$!4_j@?Y2!xRpm=O-rZL5>na+S z(}}hlQ;&yD0-FrPsVd;FIil*|?E3>U0vpaL5DgYE^uh&o^~^EY2bb zjL@6dkII?P%lhmV+dBjNS^oUxM{3)lX_C{xyvbl^6UdgwT_f^qaO1ptNf~X|#Te$O zY|Ck6)AfI^!ZqU9*T%Y8qyQ3fF%#zae`85d4biSKSmcEO0>^W_C` z3kD)yD|QWX08khxeGP03Tu&9fv zeTLg2M;pu2ozQmvCrVF0;>!8KjMTH9cM6m2On?1nd3BfZN&VJK>E^-ghyRV6J`C$I zS@^#v`mg+}lb%^|br{&1v0VAyw&@8W+f&~3_5a-3*5gmH9I9EPQ2xy5b?6s=_qme6 z%D4tC*wSQjpP0us(~3AHJk4Zp=F@E~m2H**#8X=?-gjvh-y|D?5&O;TGg6}XhOwSP z{s|+x&rd9Wx`e1Z<>@k9^nKh`T0EYnQ{&_L30F|U=m*W8JHSFxcldJQ{o{Yf#JBx5 z)6RBTECx9i!nC3+TgZ=gYHqH$^xbZlM*~a|0Rc3m2cFe3dQGh#Hauag%kbBU6_wt% z9wPlfn?RpywJgcI3zmD6&d69@>ae32#HaPoPL2k_;z10*J zV0LF<|_hJ8NG z6BcKTh_C~vn3P#f?RW5zvfeTP`xfR~-d}S;y-A_GDD&YRdCeZk=MBkmldlQb0qgm2 zH?@;hhf(BNWCi5CFN?G3p*_;nkW0e4tX``*uHq=`lv*D~*!E;LTJ7^>Fvnf&F?3rN z2m#X&+ZMepy)-H7t0mPe$LlFwE2cbzcN zFv*Up;NX~)x4Fubk+EhMajDlGCK-;wT2iax`_tJBFEmcU5Wl^4FCgL-3v|UObr;X5Q}u_f(s};^D>&PFNh^U{N;j z)*ms`9c!}S(KD)DhMY%ar63J8prW6Hb#hr1Up$k1M6%;JOibgiPFv}=YsEkmK8C^Y zG62s9F5byi1_83f)5po?8dgU-)~@xH_bhWu-Ef0nunfsy&03Ufm>wja;y*XSkBfld zk-hZLdeoAcFowJQJUv($jJPxF4mKq{75$IDYHx3Hj;J+XLzTVd7RQoheYjok<6&9H znW3NJW8){?X_c_Z>4*KLjVjiNG~Kfwa>-Mjik=UjXaVUNE-V7Sc#Ra(Y7we6**HsH zRW4iGoi0jMTIfvWVA59^gtO&MPX1wNfEcc!TN0h(K#82~4yjE~8)H3v&R1r_g;sfP ze)-z8T^G+1e+gchi`R#^?LfaR)MImB_hqqVSnR6pwFPw42=f}A!c9wLr+H0{um@6Hg;Tr@Q@bO} zds$Pjsl$zO8f3(5ietOXd@p9Uf2k#|<`2|xZZ0SB& zH}36pvy9H>XMKsneh67XZc?z$b9~lB=r=)=N6mNpOtdIJa&3_rMdbjdo8`3~WGn0L zM8=?h7?)s6@-xRqXE)7KRWA9v=b{wG5m^VRf!9(m?~<2%lKPAQ)oWjdRAX%`xZXLP z`gh0r>?fOIU2!cBc-Ni&$Fg!>wtR1dCvSOPzOW_7@A~uyI3l!!VM>xcqIg0&l`RFs zpHtdL5-SlPMm!z)$m>6gl%uKKPQ%uGcxtArEx;ouL`@!^?O^s z=arfn?v8UZ8{e>RLt8D%=i7*hLVw+si6)ele@RR#TX%Zmy7BQe zxy;bASVMVkAZU{c`1^@pu=K{7r}UkO;$5SWr-vnBWQV~&^GzKua;1A$FV$yAS(Bd4 zV#M3ft#;|#K&)PI%0bv_^*|1K;P!}qlVV24FE+YuP4~2@^tKhw4s&iH% zpuGN;hY=80y{ED#I%_Z@=!v*g(|}j`sP$YO_O0#E%xBV7o02`FgX<{``O$p>-UjX> zHb?osK1nR+X?KTO(S#;t^w^1d=LY|wjTQ{kkfabw%i`=E3V2GYjh${a**#~Qq)vzt zRwcjCHAVal+|(t9QdtP-%elZPi3$E^I{coTdSK?y zjMwdkkh5&yVZF$s9A~`8&RB}Vfn^?pR$t@7F^{_nhk=9@?-^{!wH8>%LQ!AfB&m zQKJiWfP<*vr9p^gUcGGkVq|G8KcDHHfB%s~ly2;kICF|<0T1iHqc{}Dh)0NQLP{SJ zzcn1h+^mJ>9~XYZ1WR$-|2<5+#6{6{i(OWW8UWgd|?!4Dp^1m zCpxk1)M|dF6mqA9zopRkNT%B2{-*6CLDS~T;vs@p-Q|i4H%G#V328s>*&s4X8w^x3 zd7$YL+yX)LW2I&#gugeTp+!l9ALsQ}q~G>*pLp$`s;r{qt(<4k6c}uH2du$Ack>Pz+Vwx~A#Qn~5QhjR8l&EKF!v9?+xVB-usjR(fnx0e` zJomcz;;52TkgG7mfyEg@n|Pw*o4IVO@}@;ar-y8`*}V;mI#DUMYFqn2i|Iu7f8G7d zG{~>!W$m)-#4)?X9(&eq?#Z;rrMMlmpp%Y~w63IETM%CIcgDS_^gF{=A$xPG0#D*X zWc@`~;OVuxN#agft~-tCJQYir+Ou#v;>*W^*&(<&t$7WUvzTqVUl0M|gi2)OSjd~3 zZ&__Z%7E1%(}|8;)FuUhnyk0I8GXa0SwMx57jKg1d_M(xWiW%^)a2FGNA}+o*m16; zr?xjv2RU`pdfs@P&%fIH&?cu>84dg5YVfS<=C0b(0C5Bq4PhxgmG$~Y;fHlkm-I>l zyO0vQV>9zSV~AI2ZY=PxnRRw2XF7IS?UO-H#_`*&{>|knAv-83_8P~@z-XaiEDyAFzh?SsvmK`U8I7uMs(7J*klb{N=1Zumi)V+F3^c9lFdU0_aGyKl zdv{l>4S&q%`e*UhLssvX>RF$TGP?f=r+5={D&sY{M(sOU4!+$O12%5NfudIftWeB+ z`RuYM zwN~aY6mX9>fi|T=KO#+moqDL*@O@tSZ-nL1&Y zc=_Cz=Wk-1IsF!WFrpT+vD#d~;PR-sCPhIlt-zXG4e0gDMm??}fYUj`DnI$5T%XRk zwMN_9eZ&fS4`i!|sM>t{>wd`L^~cbft@yJVRUapj*jT)2^$S-PDXx?m5wO|HXB5Sbz71CLozSzVia9sNeyipNu(Ke0U$mn7Z zYkZEtuQlhBB0G{|gyz}NJjJ@glsjuC}Xy-OGDpkPUr)H{P#W6$9dkY^|9Tn_3qj{pL!jJ_tBTcM*Q&+$Va&)cWtvYz1@Mc zRBk3^F_Xk|!cuMfnx=RuG@8Q-cWetW@XSzBxtn>dT{ZMuZGcM;U;$j8py4(B0}Lwe)jhu+tCg%Ag2o=Kg&+ImuTFu)eFbxDxubYtG|)N#uh+ zWa1)C)uIL|YP!>2@_`jKGO-=748HY@v6so*5|N}coVx1~M8@cW8_UFk;+WcG9x_pl zme{;BJ-U%i7xuSU5MU?At(qYh=TgK=60&?uUlcoaN&^x8L;@TxhQBKoS?lss2 z>IpvQqTfJFKiJH1?`@|#=j47P5tpzpA!eukPGR`njlH$|X8MrVtl^29{pMe^q0vGQ zK! z$7cmud^Dye@#u&aaavT>Yggpw`7 z8d`cWE+WC{t8>aE+ zhFSD;QC00+s|TMe>j&=Y0v0@09>aQkHCUOE$sD#xpLPnTa7LB{Fxpc7cZ`;J1Vy`{ z>bkrUOtGa^5sJ&jrBbDe+s-Z8;I6eXg709h^&ybp2V7xEH7-KHp)2Gxy**1mOgq}4 zgtF##1+&*Z3Y?hkk>N$usRdu~ncBg0C^TA9R4~Jht_`(;a zSJ0xw+^frFNj{n;Ce36)8IKhGE?=bwo?POoK-USxFPc~Ht2%ktvH>pcQE6v|6Y-g; z-@ZL;B+Q9w5uKR0v?rGr@lN}=nWq5Ho#t<9;!!P5`jY-q0<3n$v@tYGi|J;LD`nRa z31W}_e?ulyOzo##U*W`!~iZ@K>s zxq@{j0LTNS{a3;@Sf`)^D$WPg|JsE{SG*nBu`~3>GyE3o&)Ws}w8o2+_A~W8~NJ8(OrO6rj1t7SW)pT{W%n|iO#k8mN z_&O(5-;cS{qH+>2)PxJK>33cd1XaX$pkcgOL{KJm`)y1$=jPOx z3=_q6nO7N1)o-4vwHHm^>? z?d1`NlDC#RU%Lh^BH?9(g_~=*YyBt~suV#LjzoHAiAN{xq}V1#4U}qTR3i~OtKG!j zwD(C>lrqBQjfcs6)3blxx02OvFUKg0^dRIObF>VTru1G^6O(SR48=Z$`i8I7e3?kYGffk%hCKL?kEV=DVe9+;u^b1twEy_~cAtPE*qqGg;$Yzc z_4lb3llPECu|4ds-lgpL90-2Xo@Xsvw3puethKf5EbC`Exl?FX&ww7Wb+lLQ&IHq4 zk;z0SwQz7%Hr2nau_QE;i^?XSMo0(D;m~*J^rPe}m*dR|?S>576R#s%Sh49ZqZisG z<6C}VQ^TSs8l_ebe^xa)fBas~n2-!Il?P5=z9w?)B|jNMv*kVxg<9{U7Tg{Baqm;} zFw2P_ne^$cEVe=pU`xZsgI1H)LnolCXUB=96$RZB zD?wc=T)rb)sp0N-85A5fbdP&2#a4wyc;y=J)f&bA*PpqzQqe`V{239gQ<&l}VKQ$} z)+C{Ma2+AW+H8SLEbYsyMScULj0A@QafCix~4y|*z^6hExCP={O!Frtf_vx>470r zSIoXsp}S(D&YbC25vOT4o1v12Pii(5dQNCNgOILsv=5aQG;Tbb#t>9%(e}0})0TzKlw@d5) zN7-9P#j!o{gGg`)?h@Q(a3{Fy;I4xW?wa84Fu1$BTX2Wq?i!pBAb}(=JLLP`Z}*?w zb9T<@zV@lQRn>iO_jGsF?J9XBf(R04CGu@Y%p;>Xyp!x)*v!2l`HAHVG<6*w$iYN# zV!XCWIB4p0nWIfKs0A8ITqyW4ZfaN0Fp?9o-S#RvzE@Me zLq;h3cwv)7K9P6>l>nnO`4E5Zyv48`eMTC(NUMfMeZona3Irjp5^?9kfkh=*_Dpn| zYjImQkL*%T4hdb>;%Zy~Ehl>z{f(C{H*OZwpgWaa=Y=ETPRW>p#$62LxYlE*#B!mv zGq-%mg$$Ru$*$_W+fxbS4!Cj|$!%2DJ-ZmP#wMq!=B`W|WWwxw$bJ-~(G8iE8v@5R zf8dz4fB$E(Ro9su1Jn|u*?_tbxr0&*IHiJKZtmC&0YA^jq4z1F_QRN=@wUUekhfFA zUfe{upkH8AaDp$}%P2h19C9h+GRJbF0{M2vVyC8F;)+CWZJ&k$#E7b*cCl!ZBy+5g zEsZ5f&stU`Lz1L$*xg)T)6|tMt36ec)zuNi^^3OW32aNI6b%8fj&oT11Z$jUD+%cF$7J>=RPI z_=fOSO0!sxxN28Ee6qG==mHl$x9^zOH1)g^CL_7tx8~^q1Q|h&>*j6A~_VbJfOY5BsX~92s$EUU2HQbW9SH-%lX6$LBxC zO0)8^`K9<77g3+BaTtp5PwX)*=Ue#uT~yg9TlzqZaV8+d3oH#9LB3x7VcN++Kj9(qQ8rc!5$Q{El=@ zTA;&Txf;Yg5W`I_emd90Yvj8ewGat}t{<}VC|leU-Bvr+-dhiciJCM?9-@+Gmm!xg z|0zsMxI95b`;AcQ2hR?7ps-|+X9IHOBeyjYyPW)W6*~89PCLXMe=@S_QXm8=0AbVu z@TG6fE3mHq#xT*m#(@nSQw9s(utPFf4S^hfSMnz}UKo)Cy9TpH6b!kdCxk$Tliq4h z6#2a@h_fECICIY%YEz|OkkVVN`?m$77L;ssW7Z61l9f zwAp%V_KCBU+^I<838jkL`iNF8WW>BIxw0~ONXXJ*$F6flF5KbzLfC_#6-EBUKv3A} z9T`ojj5`hXf>*zWmjRJNr}%+kjBt5e`DdA_DU6hs18p9lI}8rUeFHQ|?F#BOi&oi2~? zbvmNy*4OwGG#I9_92HRAm(j80ca)&O&$aM)?`UrVE{kTj4u9dfC9i|qDu)+aPh7>_ zcsIS}fXg-|z8}Ltk$%jZf_-3oB=obpOUj6g z2=}cgeX;?u08=E@*i^hNaD|(bV}FFG<;j*8SKsr}v>hq#$iC58XyrtL8FM($5__cVF5tS-i^(0H z;}mvyTKAgU@Vwp8f`Te?0|O7?($y@$RYdmXU*Y4g#rU!9h0_|-^VCHT=>!fub*~)p zJ;x=ptx^m)d}ahsaMg_fq-G z4~Rjld7E%*h1f!OL#`|2Qod#jul@cwrib#WvdAjg@&leWm@&`E?65R<;87Q>AE}$t zgX8T>AE{S?XF zPq1hlj$4?hajWZ-r5InzVUA>8RQ|GVrMY&y0ApIg5GNF^o`Q~Wc<#)K91w0A4bEN3MRPij3W& zzA&zJJiEY5inXpd^gUSIXs>oF0|U%>m|JEY!?b;!L;lVy8i>3iiUqFToTL5hM0u9Y z_>I3FqfQPNJ)sI1+_soH)|BOL#kKB;q9P0ZbO4tmg=WZQ56I%W>O|i(M9RfUb{3-T zZrswR7!9YU+hfAUgA8@f+UgLU<=97bM;mPsV4a`yOOpRV3KU=X3Kt8=rM0{ zjq+9)1rQ{B1mXKOk*P;rwe}SBr^(@^+0v^->4bnxdtxJ-i4ztLC6V$d;!$UNlIT4* zQqqeZl9IRP+8u^69!04P0e@EO)B87x48^M44Tj%Zg4@6vk({V?nQlPnL(-Bwhs~zD z3=_Gv4Gyq4 z+)LMX#8W@kq$>sT6p!Hz?;jb(fpo+M_nf8ihN5JsJEeuEnOne)$;DHrqH>AL4ST8c zOruVA&V%=SLvO~0ciQCp{AxTIT`VifCZE5$I|A+3HcP-yDqp;?#{$`=5@h#D?l6IJ zuX5bN`q{SlL5&Lnr7sj{rsD>qquN7ly`<}?*}PQj8b75%k8Sd+$Y+USAl5`5=$IN{ zfFT3F>{~2$?xrDv`zZut9sSAjObSenbi~`t2>b^hWOpFu>LK3pc+GrbXk;Tpb56g9 zv{aE9~t!CBCNS~1`C$im%h&vUfdXKx0NjAh7W zi1M;5Hu9)XWZP$|=YG5_5um1dFt4`N<&t!3o+?k9>{pk@G;L0jhuV{4@j0gZ;8Ur- z!=mqq)UCAQwt74U50HJty$RiU>!*}xv0jqtM38z$Eh{DOJGj}Q;SA?*ADC3VrLip& z=TTRJ->HSO<8D+5-)1BV(qb;DQ(z~B2&8<_)VC}_*JAg4g!B+W!(mrXXPik9JB=r` z_$@@Tm0jvNjVY9Q>X1O4uksPw&2Ld_xyHj;6qlM-5`-XQtutbUyR8m8#^bCumV~#V zD#`m@#fER2GZ=vz`BDH{^R zj>z`rHWPW|$$vuuh+ zUm~P~dW>*C;@h>9^tGln&XciZs?GAmHvi)big1@&xa=Kz&^pZt+IBjX01)b|k0QsoS z>6Du?Jf6jNY3An{$tpLFO>KRbkXTl9pIr+k6W^IZ-)v4p=b}PEoZuuIm00V7N~FG0 z8lyu*t5cT^73H1Cmt1#daubW6mzTzwo?W@uLmjxKo;LZM$9yjyY>X_cmzq*MmVDB5 zWh*@Q81sjckqN~q0ybtY#*N@q>~l*g1M7{?40*N-UtGnZ@2_ZVN*Q%!-?`PCkV`fW zleP-D`;1|T!B?TZZFj)b!|!%mfXtn1Eo7SyZd>5~q}t){ww_k#hQnLBHdUTr(b2qs z7@INK>Q+%GM7EpQw-e+pxH&XSE|ZD5klXvsAc!RVC^m|F>Oib+b%`q{86vXu@t`&6 zwB8bY+l%Lrk8+?FZ%2mGa3U`A;{t3u0^X3G$Vb9TH8!N_8#XhWfG_o5Mq6WzzZ6nk zQrS~-frl=k#u_ImOgU$>LM0^)=e%F1+5R!VmQ@tgYnYK||M} zzP=T5yl$r3muFgE2E6VQ(y5dud zFZ2Stt3xXPEmJ24@GZZ~nzW^J!Z6ViELjUoAGlyJ;Aq?tq>h;AYvy-|cBmwV#Ogd%F0rDZgQNZOI{K|lsgIbE}8UxH_#ukKe{ztzf;!Syh&Et70S zQnB=F&NU9FrPh6h*Rwz7-XTR(o$>aFj4C26e+qr$Tb4YilyHw%FlJPvXS-XR{?bv8 ze!wu&$v}Rp(L+Z`M73}>(B_OyHrNKq;bRFzj+!mf{}fZrn}u@a<`odvQ4CY3H~r4# zNnPf#y)7LuI_;BIXMbcUyRb?VJJGeAYM3HqJz!@+PjVC~scE!%b&&lb0HT=QLlLb@ zlE*^hm)z(=i=1ir*@ampxbiGVkWP)(gue3kTzlDZO=)Rsp0Kgpw0197%O~Wv;0tD^ z_)v$jbD3(*bNR5|JbR>IDo{Ie# z)NgM0xzdt@W*xFdPwQ@=UT3ru7YlB)PR>s7clIP1nGv+}Z*M-W4ICcGo*lN?^6|Sh z%JgB+^Q;Bz?Tk2|1lTR6S{%ZN!OD7(yWt)WZc#pCyUCv9^tj-42DLsd5J8ex-`P3h zSSlFme5*cZSY1<;C9=c$N^nD#u$|`4$R}30rZ~2+;);@_o2eLei7Ilx?big9ASbsb zV2CjLQNn$6h~h|j;)zDbFL5+pU9R?ZK#^pX;l%m z+Bwb|0#3EF*ljvjyfrxJF1p|-9$pRBc@h@n!Cj9&W4ueaY-HpxSC?2lfAiz9?ucRo z!l|#4L$9<3jp2VGqa`17*b?}4O`HV?IANPM(y29%%RR}ae=%rJURJgySn!i{z=&zk zr*T{MA}`LQ8QL!0DzV=YIF)nP8R=OBB6h#LKx*S#Ea!ZrhDdE~6`e0GqgW=6<9m~C z=zfQdP*qrDE zy?$NmnNLcMhu`WsoKOWkLs$Kh3eBqJD-HnGvkK(E9`Gj5W~a-1Y|I4f$s$qED8SBc z>KvSwu>kGz6Uc#OctI}BtNPJ0x|lrqV}^(R8P2~YQQW4cCx{TpPwS?#7&N;8-w zwejyH8}qAYao-Bp$CBni7paN%Qk0m728be)>DBhv)#39?dPu`6zmex(?4E!+2jsvS zsx&TTrY)cjuP!gMCLol-1%kXIQo^-|+02-~=qL|g$+8an81e91)IxTdG3C#Qmt`H^ zDDHxtc=bm@&bm5)cnU`bwi^d(run%6yd~%!k9p(v@#fHA@)20`AktA=FiBTcOPwRn z^ZzqQ*slCd5nBi=LJd<%%KLlq_cumCvyc8*&Z<3h zrW`tV&ob#Qd7@KfTvExVy+xd{ni+YN5~8r^xG+xGTgUiT#5>O+I1gzTdc9B z2t|2TYrUag1#Ga*To;i@AhrlPPJa?w^34&Hhdv+3;J3`3$)VtlXjLu&a_HHw3flUc z@J1N=oYMUkSS6LeH@#kMbFZNgX-g{8y_MIk=IvB4CezXQjiws5CMTVCcgSJ%tIlI%Tt9W~X7O3dNhOZlR5x^{WMgQOJgibA zut8eb(CP19O;hH?p{p{+%iffI=aaOTQYcQV!qz0rVQ8CPnHcO_+** z?`mtpcgD#TWE*nuKh|+-V6G}ETB@%(H>&n+Gj9!St+UN?kEF9>mKVKHx#V$!IwKxZ zvEh}1$ZG5n6XK)$`u)a%+Qwy;wpRk;N^E5YXlSeXEh>4=?{dilXjy_!jECr{K{xA* zXEh+egMF1xuh&1{4RC+r8!R6k}$Y2*}i#F1tMvVGOTH3 zBkEmp<-z@8!6@~tQmfE#6Tx4MZcS+6T-Gw)-HfMp}=ChSm8uLo96m*~W4L1Q(<-%1YnmURa$xmQQMo)

zy%k-sLyOFJ0C&aj)G z(bXumSPkS9R2pp*Eq5H*=xFS6pk)bPU0k}nv`0}OM=(u}1-sTk2A=HLt0Zt}(hES+ zVYvxRlc+Xl^mHq;ZwjhkL7S;id3M`u3niBd0LMfY_uRZW$pWe(YfZ7&|AzL%W80D78d9y z*n3reWM`v}87=qtZJLhrv5neq5shdU;La8p>ri%~E^u?(!5iXl@q0++jJdGg7ev6UPUC-8C(4E;;MzsMc*MHb^0>`EBgNZpB!gb2 zGp#mU9#@TqX_v}ZG62WnPpd|oa*YCVLMt;1d>O8lPP1FK_lt|UHfSJc)?ionVj0|Z zW>wGI-WXCAVPN}DmUCg%7t|IBSCqbB8YyMh;fiiF0IuscpM~3$oeD=vCze06{K07( zshoD&A$vdr9cJM@^VBCTaD~E6NevN->hU=nn)qegcn$tsaJr3t7F&tG5Ql!@T=K$K zK}zdyPTGsIvzGA+%rpEQ_#2(Iv-&iIBQDCSVw~XLRZU`tA?mg zdjc|-evHFu!@yEg?ywZ+vDPc|t-D%Ywxq+A#g4jq!)Q1mJD6ii}{V>;eoN=6NB>N_sKS$|9@ z(Pr70z!$X%2v4MXD66u===QzmeN(kQOS46j;K9P>YtR}`6H#%60g7Kg==}W?%xWQk z<^%6K)jT%i(G?bJ(jBM5T`TqnMmgtPbBI16wvDtSjDOjolcW7bZ3+*wz6P(z)6x|Z z(>F8;O;1*$bz8)eP*Y}3p6}|F z2lP+z5w*QaTOWL*&XZtNiqIv-4q5r$n^hvnObO=O?qO_*-SN4lo_UJn*Rpuq&88Wp zeO-TY`w_3ql+r>fd1g;V=&~962!K05m2RMa#)$+e`x*{) znKabpidmjY%%^{iR_K%vyU<%?5?cDot^Pm>-U+i zwfrHAmdr*-+d6^cMf{~xiQjBho*Lfpd~5D(+1v^(?!{=0DMn5B>hf@xtu{oqIEJo4ib}yxz($Sp{SGqT|+R~rT*v2d@aWt ze6wp_&nx*0Gb%QHQZ$>MIx~ULsQBiLjY}9U#4;Fil7`|!8;r0t ztEhxt8!aV=dj2PhOzI+z&_Cce9{TIxf!dsk`jv;WHMpU1swGK#WdK|1$)G+QaT-hZJkZO0 znjFr~{><^%BP!>8+>u^nDQ6lfk}kxfOiZYQOqyxzI#~#}@}6IZh*LB>EboQ~B(_r< zb_ZYm>*8tDVMk#_Yqum7E986U52u*xi}8IradgnB3A~)PxIEeT$UAtG8=rp@ zAAS@s2cZCxIWE(dhOTL>lvps&r;%s16dk$lfMvq157fIIv5lUgYmZsW)Pr5Uc->*T zP~%!M@tzX!cjIRqzFn2#@n~Ng%yV5mbP0eL3F<1znTXEH;Xgn;3O(J?n9V3JfszcY zgN@Jb1jD3u_DTuL=1f40G!$1#EMJlveVOcjnLv8!5$pTh@*VgkAnd2z$+cDW6~`re zs0%*l6;MDUIke~@6x{rU{|*7fyBJ4t-pAuf><@~d_0tcZNz74=m9bPyOEvW9v|dgH zFgWq4@fr>0hF()hzN(2CWkc0 z%gz!crJ}FIp~<1;X71$fV(tcVvh?N9@`c9ql5=zRbP*H#kCqege-lf%c}P0@7;DSpiPy-k3wu0R*yoZGWwM-S~K4fdbsny)lQBvy%tN$-|wJlM~7i$RXwC z?D7f*Kq0RiA1}{eFm!MHKN%>w`2HeQKvs6<|F2N>SJ^!%Ik^M{{-S{(cV|yGOOX4k zvd#|9ZkjIUmY~0yL#5(>H3hVDO-@Q~K7qgd#l$#dd_3edJLwizik_Nfk**HP7($1Eij?iPFAT1&*BP$C4@CyI{eA3Vq z003~wK=VA%P4Isyw*&wHH6ehH7n;7}_@F5i_nQ9ALvdVC+E>hf_1yo}z4C!>+|UMY zDE(g?lm|DoqgU)}`nQhj-|}nQe|gi|!g8E*(+D^d(DRD-YZMQ_siA#SRer_xFFM$Jasj@7yYD=imWy zIHN!BGY#bwe?@afhU>GO3bRaXi(A?BU1T+r}OnKX!Q-J9G(Q6)#WxSP@#xy<4aLUz-@t zA9uSBo}Oo0{P{(m?Y?*H{4^#zR0on8*bYbDdhenCv5r0~ApNK9&zHW*#c}oWxx@m+ ziQ%2!suw?vvqBOL_8FFa-I~}xf7|QXp_tHlyeB=1=elbz5AZ~msUQRCFAMLFK*Z1GI^5mnF zYtO~fMpzz$2kB(=@A5`ZwvhHj0{;PY9}FI4aO8{qx_RRGN%?zE^Q}M9Rl>q(YTciQ zd#WIRm!A*McMf95C({iPx}QJ&xcn;d`9r|Z%g9^Lnb`4|FNT{`q<_ z*%GYlq?h!i+-UGd>*0Or!LVV-&DZ)Gy4gYsl`F`%=$mDW&wUwGCn9b8M$X2;yZhn? z--|G*=*11&nW|~VP=%)MoHAb0wy?x;52VmFne3txj&SZV3Fxwj@Vl72h_luYYB)gN zpNBt2sC5v89qYM>a5}cFg?1e|+}b;_!Wlc@a&m(G*`;hX6H`9%88($aGI{nZ>KWl~ z)n?Btw5B*z2tn47_Kv!};TMPw+;c3JvJXim1R-n2C*&uG6}um1e6}?EdgoWA*0;sf zijbQ9rlikz5(K*BXWcb1G@6-#z(TiWW zsV2%5bc6y-Efz>u;1RA%5swi^0t7PPS3S|BGYviy;stQ}Gs|!ZIN$}*$_Jx`E|qUj zo+RK$&(6;C(N*I|jMIzUQ7e`6Wqim*&!X(AdbapDtj(1!Gb*@W9%OZ~NrA9mhb0$c zjP6BrTvbs9?_VUIaW#lp>y8+^GM@vDN#0Yyx!5Lv{(jFGw)TO|Ok4(qwJH!?!J#SX z#pU|J%6oCc4Q$cCEeK0RoC||?@+7@1O9ymJpwLe{30JfVZWwXF`pz(+dMQ+annE}P zIBMqkNMAEzHJFya`jWNIX|x52$ecS~wk48OdqS+y?82(Hh7jOkUu$N8lgv^k4=5rH z2zl6VNej_+J~3jrz%_S!?i8GGl8<0(X%erC>AB+GK$wxj#igiuARnZ#1=Cbz%x4nb zfg1^JVzwD>uSW<34?-kGN9*5sxc~)p)!Vf+TA9Yz+$3PhavZBsGvD4*F(^6Os}LN- zRMaP@Ce6=a$RbldZ}1zZp^njEq<^CccvHy41rxKSaKo8%`7G3~MDoS-?kT#YIa@EG z#|c|pyMW2i=ngdl$9YboBc^)(+=XfPUM1c-X^}rlSnq3Ts@X=>l{T{{m7-42``js^ zsR~fw6?bTdl_5U!SfIb<&T6J?(r~Yn!?Z3MSC_T*z?q#O81t;RLsOS$naxC z2lWU|G1#Mx4EjksUoD;B~OazPEMKdhB;;MWi~+Y z)arWGYV#|_4@kX7xWd6hFNS75rjCplFC2$M{zrj0ly~Ma6~P3EX`I}fI&>mTG8i3R z$b4&Pro&w(A_XEAtSGt2kVY$osNog1BS+gmM9Dq)_j(y z7znkAaGq-ic{$i1AxG|Q3k>an>SAu*-C7Y5x(9J$*v!7!brqdzJES*wqjtqnu}=ig zOxE6L2h9FQ_xn9fEjJ~OKGYWXBA!D8=Hd*+ zxj+JolcrOxh#R3J1zM>mlU8c2k3MR4@=v?EVqsp=ilak~RjGyus^EDARV>9(6s?IV z+2j{IfN1p9ta1U4w*st^v-Rk@-5F0NcX-Gyp)g)zfQ06iED)wg9J)kQTw@en8_AMM zUm=VYr&IH6Y=jZr@l?-xN_>y99w~chgTLX}j(rCXit?c1@;_fM*uI+?%CE@2we>9f zG)`kui08z8H1<9YBC}EX6_fizi=bkHA)ef?vgxsW9^a7~f#jlQyr#5)UL;u2sT_@U zbkFeO^aV|+8$%2!9Ueq@2g=^ZX4Lzgn(JfD_A0wKt+baqqocpu0j71H($*MJ0<)|u zw&5J9nGRrwNy`y{O7aGL8>AZffpP7fSkD{9D zS^=$ECxF2NWmuo?S^p5jlF(eHfxM1nFV>bfH%csx)V&vGkz+xxXr zaaoR0d}#b$RC|3b3WW0DpW3vi#TEBFqjZk=MkUx`rN}$CGDi}n3P@^DdTS>QJDqOX zpK={iKcHLl*@)vLMEL?+cbzDr+E#U_OW#&CU#FggAY?Vap@NsGt6$91 z%VmC|)*K1ICq$b6RZoqta(w61!OZ-dG1iz+Xf8?({yVL0wg39(5%K$$+(P0*s8{f* zCrLKimhio+E0?$lKS6m#xnq%d8?oD&Jttqf^wPjT-6WQ6FO>ZwQfaZ1GWf$kLu1&j zo?mYE50#jKJo@$t%MyT`?u(aihctx+OGKhzE8yoPetR({l1Uyh)BdE z+xCaqOT#(Y#D(PN_k^iawP|~lT4=zlK~!<=Tsg`q&oL7tlo^^BWQRvaU5O-bLi@}W z?~IGW+Bu=o1y8PB-iLmE*wTKfPiaXm%ho5dbr)30&L~15hhMk)9UX902=+vx z=%m=rgkD7_g|`7#609R}Bt_9MKyoZC|E=dOhSzy#kpGE{t1h#=^0sRFNLYuUXgpm{ zh{W3E4XT#UVt=>cbxc#S&AlEc(Eq{Ml1oGRr^dvg^7POgEty9t-W zL+SgTwqhXICPTV~RK-`I)N6EF9Y%6Tb$G!WFfvP`S~w4bNAzod5Ti8qlM5Nm+mWO1 z@?!`5>QOO@KOK!qz!dCb<#1x%s(c z7co33MiCdF%Jq}nLGT_wPbc-egaKn3L>(`g%V&1X*)Yvr}!Dw`U z*6!Q6jw0B}R5DfO-+Vlwy*KOOe(2q&^OPsX`p9HBf?8Q?L7(OaIWWKOm%&C-wAzjw z&6Cko<2}U*fw8E|mDX%^ERNBp*?H!4hI%6$DMy+RlN+Rq2CkH5GNs)2Z&7G5R~YHh zso0kFJu~4Zl{sg}XjbLhV9t-*ZnIZ&*Cl$eF<8_a=W_OYWdm|~U1_>QWa!tS+CtY-e3`yr{d{`=OnS(8Ki*%aCP#T=_MS z7}8ot^o3sNF`}h1l5UR*38k86HzN~&KCk?D+eAsQi^XhxO%mgnYy>LcOfp{=0boo= zvSySo5G=y@_DNty#Gb1P-}zzo|sNniDVuDu8s){Id`G zm9NNg%AN`N+}~b{jn`#%#!lJsI`SHHXd#YC(2Sp^K&N?dvvrrB>2(E6IM2*Uto;|!Sa!) z`j-&BB6@Oj_K6C<7dpbWCEjt8D;yFEuQwgIbSuO2MUtC%*OP|> z0!lgBv$EKI?FV#+R_ImWbXH+%OfAOScYZD1;}pPUSNP;nyqMY_&yn8po+5p#-RBP4 zfqClR6l;}6q~)Fz*o$HGl_|T9-@E?wA#P4!t%I|9aM{NI9n_$eqW ztAo^~rTq?m91Y%PvS2?v73at>3pczC*4=l>e{Kn{Nir2AoeDH6m70GZ1<)4=5eLd? z0<}qQ^9z;r7aow4&qGyX#rnP^lij)` zfrtSPv-0TlZ#kS&Iulrzzb3It`iVI=bFhXx8eoY7{Au(2T+m*sYQ`Z->KeOEQf0U}%104+x+~<6u!}sMxYt#MLla)lx?$pm0yo zSdSQIat=3SV%y9xa$Aqg_Wt>hSyXi+u_hj%8F$S)0vNEh3Bvv(JOEHU(XRAVd2EO$ z4DcPOgY)rM0wKh928D|Rg|D24;P=#^vnGAIl4gpg* zG#Zl-SS51?i+hP#Q-YgsJDY<^aiMF z%`^xaE4g(_iCL@=Vpmzd{2n;W{(`i)#9C`1C>IOB!2eDo+fB+j#bvRK0N7*+T0k^Q z!v`F$!K3$^w&orEt~_~?8JWPf_{DB^i~^W?L*xmI{t0I6E%s*9(H|0yO(qjELd{O( z*dM4y0}nxH{x6p<$=037rfBT-*!aw%Yx=1+F3IVzM|d12q=5Sn!h2-Gif^O3?>O%6 z(+>0tuub0`C#n!~sStv)*u6%40=uJ}^Vxq*dNjey7O)?(EQP1E!(dAlX{Jw`L7Vh zZ{Mhr%d*7y@R{8Mf~*TJTR&vH-?QttI`Hy7G{@e!oLYA}Y!ZGStvr5vc&2b*x^*=^ z_%l&L(>xYIX4+o{UdSpc%IhvD+j9bU+mJ}jP7lS4Bstl>?-3iA#HmnlN>d#S$wL#n zKvZHR6f-G=5&2c#!%Xp^k^H{xLDtjdX1+zN;h^k8 z*jCY9JX?$??Eri(RoS5GDQ6LVnqZ}SwGY->VOf#;&h!pr-re=n(aG)S5fTi0^$YB; zN1xvt{qw~7M-tF}cDu2rvGw^~o60w6Gy)jp;z9KH3x1lCqPneFahY$P8qc;)IQ~d~ z9yc8`9Wos;9Vn={Y54p{wrZ%hM1~!|I*4;>DgV9k+Z|qJZ?lSE!hfVbKx*Yv$QJxV z{-H`-q{7|Hs4){WD-=hHXRj`zllC0uf&1N`&(<#;Ca0sLlx>Hl;t7%Q>Ae1&e@;3~ zhy_nxkt&wse0P7f9~xvXd^$1b(m44w{;iKdYp0JJjdnQIc1*va-HIcPxeFS;4I<)0 zD5(LHZ9O^0Z(G~7^$#obl@er?<57BQ-#*{BmTLsnHsmsIH=^_${uyDY=#VcbM1bYW zzM#(Q!MbB#<|sEK<7myI`0WC`|8s8E!n<7}bG{K|QrQ}fUM!7PoE&^@tA!FyMUn$1 zM9C;j6);5(^YJNA)cRT%Egm;lE&#T^!n&5lZP4nqb? zr>s}tTp_?P6yqWEqCLTx2k}zxBKz1TMvrV}i~rMa5;3tUQ>-2IemclBn+@yu1Gb5R zvFG)UA+8L0j#Ox;^4FR$Pf@5JU-2T_w-gyG059yS9=)+K9-E3)1y>0gcHe-iIR}KY zALwF_EUFa_)1)NsB3Gl*?5o$0yQTkVA-y5HyV-5HYX0l^Aakk@$2Kb4FUg-xZ?pPd z;%24r?0d7$8&%S)V8f~{3eQ1@c43QQJ7&AWcm++B*ef57LbN2hcW>|Scww;;+}1e8 zy{SdAAlD;adMbGipT!mA(5hV0s7MoXrYH{vfHQ7w%M1nslrj-{&-GId zRF6lcPX?rdO9$StY0{)n^I%hF1dN1#kY#m=cONrBmN526^4gu?X9UMPXAF1-*lLEQ;bV$8I0EH$UD>#`#bS&W;(6}@95Ri$s7ry$qlh%|&k>i2 zm5sBMzAKrJ2o`fwsY$JWOF)WYx{pX$a1G?CYIP0Z_);T!tU=Zv_x4+`=F%?nTGHFl zU6Ko1PIX?=asnF3#N8EwP&_3t^8$ApQ7wS#vBPYDsf|F>4ljD5L|%H8pd`o5K}FgR zVBr^Ag@4V)`qbY>q@iLem$=Zaef@>=es^Ql5|8*j4xDJY>PE^)dk2oIU9*ax3r`Tk z196N8f}%39S?zrxZKjJk$5T`2Qn;%V3np-A+`Bk|Joj<#^)a^nDa^e(OyewjGwE;L zZL7?Q;lwCVJK3=-#lGc^#LbJ$&iuQBk~|-vbk`5nG)lU?EMP_&Ge%ZPVQ~swH=|d3 zslAXfoMW3W^eKQ^7*j;gEy}N%2(N#bri_k=JEHb@`R7W33@TDO#wrAa7)Rmv^hUAa zu2>Ac2>v$*v05^gti$DL3^%3F$N(RVjIu)#9V*-0b?h^x|BJuf=fshIq8 zN$w-mtafd=?Z-s1()3Jst%`#xDJRMp3lpo$BXh~A8P;v&BKNqs@dKklFJe-^~ee)M@pYS#^&{d)4~ zxAf^B86p_xna2|wp;O!hdNIXu^t=Jf4Ap+bnI*inhP+{ngJUpD=Qf^97pF>rf5YdX z^kGWhbQ|7lV*AebxNUcVBDk7SrNw{X98o`fvnGx|<{NZr+Uj=sWJl{` zNF7`1q2-+jB=MamGs7DT-9jtjPc~zlmX;4Pw_x|j?Rj6cN6tfO-Mw`<{_Yl}t#$B} zG!xn;{gh?7amyp}MbGSoUSuwR&$#@?RWyYZbFPQs1pvA0_Rsag#JI})Gky=x2)$vR z``B@S@h13_hL8Uxg)=3hdI54%i?Xg$y13A+hU)vkzVWCPAct-#*^1eY@t| z-q##-Lv(nSb2`*t?7#HY-WN|xOa_#QwDfj9?Vs|+ixPB)tyI{I=jLSH(+i`+YOr8^x*l>^-En*_{>p5& zH9&FsUf|vjTdXqHX(95XYDhm>&Ibz_bM2@_D}1m4ZD}L@`+@A>ubP_)bPucyhIzOG zEvGl=-)Ux}k@h>POJr0!1|sN|@8!PRH5TL|5R{&&yopOL9%xobHZ zfr_ez%=OOi!BeF5TzE{|L`UCr7sRA~BCGXie7l^QiyT^=-ACSU_W$7W4?kIk!t~P? ze&=sZ*)RojLJPR4l*1K?z%K~D%={;N>ID*Y7HwxC?r-6oNYHuWRlhw^gjn2c;d6-5 z+aRvg-^s5!Aq=xS&i`qs_==M1l*%h$;?2u%@HGvItnTiN2V^b@ry9mWvT$|_`HB?q zg)!d=iL2&!Y)hIS zkN`!VYm|4PiTRex&Bc5u(NhMYq>uA2Gw*ahxl}XvG}rGg;n^jNxUIQJ%;%f=%)lrG zUQ0g+D*njlRAt~Jb`y$BH<(FS^8aR*Iv?HfC0f?(5Iy}XnF9eG*?u#du9_TDypi`l zv7Qj6#wJ&2c%8}A=nUlXSnD6>?`#5O@=tv5w}orf-=^A~3GuO7Wq#r17w!;oYX4vC zy?I=X+xIwbR)`EKBuz-1&O9|rlTx8UD#@u%gXT#}N`oTFlv2`!q!Lm{6G{_8MJ1J? zL<5mBh2PrG=~RaMzFeQ*f8YCh-Fr{xJkMHtuX(M#_TJ7SN5jq+DH{i#H1%3pBHXw5 z5_QX$wcfInt<8tqam{;L#M&q3dzEF@oeNA5UQ+Kq(Dt10a3H5y#eDte^>Ur9>*8#( z`|@K-#>aWgm?*dZtx=m~8DW%+MItq`_0zYRp^KkXv%4IG97S?wXr0}_S|NX=`r+-= zm1f0-0zG%*rrsR?q;Fl(z8R=*5iPVZ3Wk zH_h>Cd?nI(#noQRqhIsNdmjJk-B~H|J1!JWbNS?EfO zD{;>;fc4{+TTw)v%xk@=-C6&8;R-vu>RNA>3y6G#`WaVi4N0IFzygrUmvOT^z zXOCG-E~M0?MK8Fu`01=ePsxk#DO~H(3cb8HW5MSQBKM>+^H!P$Q_YGMa-D^I?U>=( z$4l>bU)gSECidBG>6a{PaojRmcSm3Do97ZHwaL5eJLFeKE0-QvdpF^V-`x`xGRDF& zzS*;tZd4tW*tjpAcSp`!`@IKlES|o#poy&X$-Qz_vxEe%WB1e-dF2moKi?)(BCl7U zb3b`PK_~8AU!%Oqz<};olkDU2W749|+51cj+3~4ds$yTv?c%qMdliV&E9IX~+&t&m zSyt8g3CC0y-X{AgXWZY=sVpYFBUJs9i1z#QAunl%oT-k}Ot4MjB)WE|fpL~s8QJ|#T<$)1zO+$akGn3{80RzT>z;tV!^eXr zFTA^zcfigi;~{HYdF0hu?^uU}7e|i~KT8vF&p5MYD)Gjq=_y;MO(b1y*I{2S4VM>p zIZAR0BI_4rIq!Nlur94%H>@_pexK0Qo@9kFy|dvm)4dXBCaK+WXBU6kt}>h26#GD3 zZtP{fOy-$@__i@dlb(q`x^nk!M4W57ig&)yvL_4fT=Z2Ne^XZW=BQ~cEkhbxVm4=s2iqws3Yft$zuo~d7Z7)lSiRR1~R zsb|^xndd8{)w&k#n5=Cp;=j7;gD2y1+5A+iMBL2?H6Cb9d@Ei<0JCO?BTUK@NV>-+y7{ z#nz9BWiNI2=6C0MxQAq`)r3;VX5D^u=4Pzg-82(o_bifj#H^!~*ky|`WZCtf{jxSVr@uP-n;D_u7wOXI-NK!^8npVMZZ zYUX`nzg_*E68nsMGA$xSWp>fj)eS)tLl0d@_v(6l+wh~Wv9NCFGs_hF{+=iIh}QCx zPba{gGuJ}d?^q<$iTN*|%$%%jSTpTx(n_k^_!+ZSoSxlUaCWM0soLo!rT5-t1+_`% zpMTnZe;Qw=?n-%;F``+w57`wu8XIaQH`cD)VeQB~5_@aU!DrEao3Ec|eY_WXwD*$D zS!bTBaifddJBysM?!O;fAvr6>a_Y+kdZLHbEL5p$n;x0Bsu(PKdfn50mS@|V4`;~1 z`$Kp55o4#c*R1_)T^KGAQ(Ms*G3O+%TDHWc@mBiS{+Uazx8JN8ll$iJ+N5jOJ9uYG zr8_W%_gSaEsn}W`g+Fzwx9!76N>##be_@?{>XR2~ZJ(SO@5z55Xx(S6%|&Vz6;_Jo z=V~gBH`HZS)2{K&(r~>0Tl%@`>eynMyA{!?s{UrV{zoNL7rnW{} zvXG#%%;g8tb7nRA9QMerC?zTPrDUz0-O84feSbDNSNZC_jt7&b?oO4RvQ~fm8I6WB zSvhvNnX^qU6zeVIn^rELl-+H~d*gt9UW9;0#H6yPX}6P7+a`pXwu?X4nRUW$bg1nM z#=#TCjQNF0{HFH7r#I~3%?~_sE`z*echuMink^Em6gRr{zp`}EtT~2Td-~}NAD1;r zQ^WKF#LjGYtEu3L(aH)c`#@|x6?rj4EV>}PqBm8_tnE#mRbY09ic`(UZ4dD|m1hW9 zI&KxjywL)gcKaXS6E>FoIHfOJG*QqwY=)B2_`C7jm&Z>`zT;pVIf*tlWgqK$S#M|h z^?RoH;Iy4CGpC%b&^hoyK%<0W8g~ZD84G6Dg)+O>gp1}aB+V-leCk7LcP@*&%Tu<^qN;ZL zkqhN!6Nu9GwkAu=f)Bn}@n%=#t%$J;9_x*&U1hN<Rp_3WDpBBd z;JAEZlOQuqkoh6-A^({6HskX;8t3hKUb)Gix-}=LcUMRGLmQui$)68eTr0Rb&w2kX z-fN*_E_u0ZxhC@EVdU&7E&Mt!i|WMeAH7@Znqsu&lvAZ`wb_J|@0}#h*rfJVb*c($ zZ0_N!`Ye`d-?NOnsCx9K#0S}cZ;H#6<_(M;HR{{9 zQRqKoM@`wiXAJ5s{l0;pNE+@kRdse`**Rf-^U&97hW|y^sk*0=CF;0EE!(1$;U-i9 zUXSHu!{)w=^~7>}V@LcSnqr4LRnus-|9nLH3DJl;Ze$}Cc^p59V^(uNAQ z+N9G06>}!tIH}3wnKJ3h3+qHF%6RG4F*lF$udy3Lt`^c4OKU4799AC}P6;&KxZgZ+ z&17t*gVU8crE&fj(?z}T+zksuJ^Uj#E~q#=x;Q(b{RF0X6>pXkUI%)Bojh20W442X zvlr||U|HJ3JcinIDZ>y^Pd(cm`mH$~_xhd|9%$c#u8J+o$%*YS;w98rKRApPEO)k= z6ZG`jIoaTi?3|RH-0g<`R<*OXW}__>YdUJPZ_Xf?tDQ ziC=|Zhu6gG;8);R<6+l@B^z&ySAks^x_DK*23{Mlj@QGh;SKQ0cq22;ZVWDt5u-w_ z{Qur@%p@@I+^HcsAgYYys9OpYz zcDeSjK;lY%wR^HQET325OiR7VM$x&I<&n&x-AO!zV6Gql(@(4 z>Fo0=1G2Uzcf%566Ym6O&hc~F+UQcpsJvYB0dKd9Vw!e%myX4ajEJ10XEi zeA_bp)D)59g}0+$wv?VbFiCe^;Zn((wt+Qk#}k zex8_qV8ZAGCH|J)20owZ)wN1%V}qsC<$UMN(Ao6vdG8e7;`Q|E6B7KjGtX@wqf)cb zTh6|6fbdm#VMXP(_%bQK@a(dr0-=zmH5I#f+|AF9w-HKy{cV2G>)UWXmfMlO%;(Qe z6`gNB=6R^J@g<{}u-T9q$f!w>({gvyGMhPn*1Yr;md^{f9UJdn6D6~1%U!9IxP}4M zmahi#18b}*QJ`}N1U zI3F!uDYeQ1IU%2tB;QW&6eES1+q`Y@cgohjVoN=}TK3qpRi7blyE~|#ygu1*3QOp| zj{00x;sp!a%RwQ8lXst~#YZ2K?vb<(@>{W5?7`06mzhY z`Knde=4HIIGy_(yJ3$=4UcNV_9|KaK$fz>J>ac`WD+%_wW?pt$Mck_|; z#d?*`mV|}icU(UZ;`OHJ-u5#0tp3I%QgFsR*MyXY)W`{X;sVv;WX-%qsjuEHk@!uEu5lvdZ$eC&Slz3rzWOvpYuhI zub^;BpZA1ig;Ne?wfn#Nx=A3Xt22H5YI7~2veZ=zcG83oNgcSscj`Pv3~yB0vXZ)_ zMq%TZ($x*it{kHJEc8ik;fV|OoS5Dh>h-~dC;IW4ApE_+B;i}~v_l(LC2ud%in2HE zD}Gr|o0v;#bCVRa-Ne%za=_H5t1sj5b*Hsu#<5F_%QF+Z7BxGm9T}M2NXv=3Znxj? z^#yr_vEtyhGa$LfP9dOAl-^%(aS2}L$Rj5tcdtBaR%I<@Y z1Lw`q+dp>kPK$AE%!{_t$ub86j3~aN&l*qJc_(oCTw(tn@#-XpC+y9yRP4cphs%&10(M5c{zIFSUmfDWop3{9^i>7R>k1DEjdX;zA_tUNUOM^8PC=YcP zGaHNVR=HI1OzeEQUeW6T$tXD}L)$p#viMcfLm9hp#J}pL%ukSWcszR5)Se@a}D}m4)jmYl$z>Q-h=Y z*V9^J&APPbe%rI}Z04nUoMG%f3p^RJ(n1)e%b0%;IjJgPL|d%Y_!KakDMJKg`!# zz`mAwwS3Q}k{2mfiXC$c#974~GV}TT&wS9RP?_N>5hpyw(^pjb!>u5xgXw)^k6a(` z`MAuscg3TuBhi;ETchjUg~oo^A%DUwslYK(w77Ktyp>MY&n4Pskz!piwF$!bqhStO_8^SC5X&@uG(K>U?^f%8)o{JER20B+Gds5c(WC$YoDz?&|$x&wsyT;p5~Ire3!%A8AEnrwcC0g*p5Ga9>!hKaqXJ*5(9)%~ zC2zu?Z`I@9d{uLgv&X^H1bT#eM!H z`6;Yh;o+8y_xnf_nqJAjx$2|TIbA2QzSdRJG0T!aueL|Io!!`uQ|oPy$}^9BBI>BB zE6n?Vu2UJJzTHcrwsh>?B0DRCYTKs~pVU=pBG30ZC>^O#y84ZG&SPHQ{;4JVH`Vg> zGHbt$84=WNelXYK7f}w{{x|5zmEA3|U5o?@6R*N@S;gD8zj!b4Qz20H+y{*S_n zB@jh%aN$Ta656X|;|?Jr+S#}QZT`cN2xL+86YQv@F=68pg$W@h{0dTCN z>A`Zavs8Anap3GmWIL_{q!dovgHWQ8y4ksSIJ@E34^o6mq>PA!(5B0OkA!Id9tqXW zfkJho!KmOad z*YA%lo%Bgkd6t@fci4Cx!<>D$?HlX6`>5jv$nBr=9?qPdXFWZ~p&;sL%E9P}=UOkP z>8^TFd9~`+&D^eyQTrvs@}>^(+q|F9E#hojuy~Vm&P4h7&6~<+_GCAz1U%TX+RHw% z=GE%;UsrFiNvL~e-g%zx^gOdk`Lli@%|Eehfi2$~Lj3;rEc(ZM-qXaA!^+#z&lVi9 zd9(Uh_4Ae&lgH=BC#GLcaeet*WZ(9S1x*)p`BlI2Of{COp3IhIT@;O+9Jt#{x|X-^ zI!jDOX2!&l$xn?m`7|33ZPdOJ1dktZW zxxBFZ%WPWY>F8AL6-$n9CtgzR3*VxBW#O!Id!!DjC#Kr$_a1Zo@q$*t`o~XMb>5ZH zhi|il*4$~)6Uth&f1jCDqTLa@0l(|P_ESDyDpakk^K3tAetu5Qg?pFOm8jp&^q)0g zog_M)5Ia0k(c-elr-sAnzQ^v@sB@m6*VdbkR;yg8>s6TLN!IfUN*|w~2+Rm-E08}}{)iCd=5WGB zi+yBYW>|vRsGX<04NmQ~yI}Y!?xt5_$)(j-a*lNgNa<~O?36&hajoo&?7kRsTS5YZ zl&~~YC8-m3u1|Yd9(hylfNZ*8&?DD{t;?Emh06=y_&Q`->)A!llD~NL{`dupCBCGN zuUM(}>Gg-Fm$$ju-JEWp+}nC4;&r)Wl9Se{8Jmv_+|{2RTa^2?(Q9>Mc;kc>69bE0 z92O(BEj#;S%xlprcAKXbyDSQGb88})?I1s2v{=nfXssJ*;ny|U^yl$!YjsKy$c8)AKqL&sb@mfN`qoQ`5<9~M_JmX0@4JjEsBcW9sV^j z*&?NKQE-_S)pd4ka=}CMS8kS>>q6zt971@#^W*p&cnyuJn{g-K_GY}_sNi$-+?te8 zXBP^xLL&Vb{R0g?`wNsGC{-VroUIyi;ERYE{har>nzo<}|0>1GB&!Q=*9uKOonbUD zU}^sDVw&Kyb3#X-kXgsB)$a`7?$T9YF@KZuy2RL0rA2$fr8frdd_Z_6s>#xlGhjEB z$vW%JiMSKED&@u@r<8%y(_WfPte(lZVKpXwT3LtT!{srp$<`+0cWd3-%in(U(E6~c zm8Bjgj*TiWrL)RJPKGWy9^*mT8yT|g+*SF0K9ZwW-K;HoYxhPj3HuU0bFtt~b-sir zo&r~n&p&)ov3MY$t*GPT^=qHhuM4&i69|u!+MIpNv*s2p*c%b?waK^0H*nIKcZv%H zHAIS;3Rw*wPFIzllFMV^<{f+_dcUxUnyuB#0;oyKH#p^3MF((~W>38pz?q{H*3MCN3)Ej~QCYE!JC`2wK;5FFrCg z7?-eC^J9}?r}KlWSGvqew^{W9XZKH4e1H8_lXVAOs!`lTGVoUU%>yl}Lf#S+G8z2J zPOXMt%d^D}I_#zOd@C!eIaq9WdW~MsO6h*H#`X8CVT90XU}tY6)=EF{f(qofD@GI&m_1 z^IuyDxaTMzjp2XPL=o9+XnpF z<60Ej<8KF@_p`}Hhq+Tk}HbVA6Kpet$lw24?5P$Px^Jxp* zqiQx^$)PQ`v?&?Q52uTC(D(AG*FGw1ed@q8z1Gn%_hJ+^%QIvB#Y#WxqI09Sgqb}b z@2lj0{oC=Sr9M z3?&3MoHM2B_3Q~X{~+yZ7PF&B>eQalSq8PaEQ38F2EBQ<0ypn=%t&&GR=3QK49q?x z`vk7OC|;0yeRh}nk*H1NV?4qqH}kdJo^gug7J52zv!?U*eVZe1T_5kiT%ll1RtUfJ z(v8Wy{+9F3DDTnOC2N)Kb?D6+(I-xdbC`AM$JLm=)V{}=?-$UeY35-GH40GSNQn1) zb%W05p1tvox7AXea;YOrN>*3GN_|BCt3tlfla_P@Opn~HBK7RO)poDDPv>e}QjdQ_ z_k3~o+KY7hnilovFP|P8g^SsB%6Y4EOI%!8@~!xICC_n(Z7dz7j!RJAN!$-k-E#lT zUWN$o<87a{zMX9@C?HBFK5cQjB~p9;%Dcp^k}c*DQZKF>Ge`64_iVQnU7#!7aZci^ zTcVs`oTf(7^fKIT@>Jid;75CGi}W*2HMYI~xZWgA8W&(g^pm=Fzp_iMd*;Zh=?p`! z-k&WFX~ajfvn%9Z+7&o#1ndf!6gXM}>a2H5>fur*NQiUy{7GHa4@+d8nBQp7Wy^GZh`1MO=*fWocq;3-?L%G z_+tsTe2=&Eq-=NEJN0Ty!QuH6gmTu32`tFGo! zkF!^d`j*%_V_-two~*I2=J@wcDxl5mDvWiSmT!9O^R+oTJH~X(ofT30;-uHvFX2}Y zb={S&>^wJrWv|hjTxKw-Y2Qb3we*G!_d%*=pRTsu@e;foMymO{SNx=-W-Yw;0#2BE;&q$Xi-v_)cV5NNLli z{=?DkyDIbEE7d2@6Af85b`Q1SMb2Ai!#(^u>^;}3eaPXH(>^x3&QVxFx*a{E)MNHG z^Ep!v=Ot-bULmc#o;nBI zgRZ?>i<`qPbsgJU*1YF^SI~#6RX3QQr4+MPKb`q`S;{`G9IKi*omI5k4cS8{bPF792svmW9vg zYrME9_K1hQg19pJL3F*&8c`KzH?}BKhKREy5Qw65rVNW=MWIv4%S1^85*be*<4I&3 zfgww!$&%@!ga3#tPJ&PJZdTT^daCM!_~0)Eaa#`$7g;>s%gal~i!9^pW`id(nM^!^ zgeQ@3@C44?8 zB++jGQriNBsb7M!vK)fr;_2pq5!%WU&vsxtqJ=r20`Zq~aT&p*?*;%rz)R#`z64@r zu*PNx;dk$GN$!DnvH9i8?jEXkj{o~z4)x$MHZ1HpBgyy$)7?GPoqmgWD6;+~1ek`# z{~pM%XJF^x;0d0H1+}nWzdqstj`(5P!4X<{z$&W(2g1RzMDVX7QYsvg0Hrh-bEDDZdX+^`*^}iUZ5tUD3tO+1Xkal$HDL55NEPzACJSZ(&=h zyE!{zW)+SbbY~-Lr6A5VS3`DqP+~EACu{cuORSkR3l@!Njk6$G&~X$9BybESla3=3 zEGU*tiY1F+WhsyU>D}Q00d#rJ&sIZ+)nViUX0R<;Ru*(J8Am5sTj4C|6bqaMk!ppb zTT?BGaJm|aO#p`c^!BfSJO6Z!+YnFwo#h-1zX0(oOwe@j53J#U`Qi6r5M17k;LQ&f z1H^hI9H8dx<~`yEL_p*j_1Ui9f6M*B!R|L%Jj7`5N3txeT}9E-*=Y+LZ3w6D0i8#D zKRj&CTL>BF0T3lvhJbbpcSUO?UMv?ESX02xfWvRa**RHZhZBl=IDhvGCc8fY_-8Ec z&ek4YaL%MM>M`M3o56z*MTt~6O->40Lady<+`-Ur;C}zgKZCY}rV|^sl_H+|BKM1b ze#Og{?SyPN0Y{+Wh*Se2LzcjlC4u#&V>X;K0PLwBfym<#^BnB{f8d=v3sjsti9vq; zh<=!FBQzTsLp#vF-?LVn$&GmZpK);Mg!wum&45Uir7~qH6t0*0A9NZX==Xg59Y^#3 z6aRnBI?lJ>Ya>^+f7V`kD@$3<8HtJ`6$Mj=;h%;nik|nd^Kf8)FE5w{P(-c1EkH4jc~o zO9AD4`#nZ^{4WM44^xqa>VuW1CEIOKQQ_oNQ3pEPa~|b>HR4GSS_nsFb( zoNtD~bJPcYYpY0vWazsGZNC?rL4cl4b{>kFPL{TCtnDB~?5km*Lo^;S=npo}CLstgS(h%_$3@1gxOR>-hjoZamp zi5b*S4jqTT{^wT_$51H}RUZ{)NHjPGSO$i}9l>`${|M#RW(ioywRp(z{d-vZ6YsIH z3`-Cye~ugv_VbTpL0JFKrRPV?>d>3||0HK5okvOz^=~DIBTwI(q#^tEqXpwywl(Nn zVI&g2GH>690E2=y80?`2>3@@8#lZ&Ze|?VAVEwO;VGY>7ev0$$_X8f9{4XcTrGUN{ z3)+dW1M2^f2EXau2I&T_L_^jFor8~QpeiSX5#^v4#qeVT9{JF()N~jQW=uKtmBE*O zX8IhbfA`v8i3PgIIaL--J!cC$kff3C|M1KpB+fiW zlv6QV!ub}8wNNO=4^@ickD*#KWU~t5Zcs`7MJ;rUTN*e!TySn+`~vW%l2=>41o>-Ra@~53f3)QHHNNpiwY7!L08W=Fn6$Tm@Fb3zU0}Xuu#<_byLm#d=;Is^C=+i_g*tc-F zIx=x^GP?>1E>eIql+vx-sq?hMTZ#h{Y?&}!AG#090n(U7&lLDP*re%*j?(9lP!leMAP(MGp$Qj45V0LadN3+z^dxfL)kJWJ93E;q0-V8S zPfY}8aORqh&{8t=3>`jm;WI`&1AU_$vZ2HB|LMXB^8dSV;{W=>3Aml%e_l92CH=oE zCx|piNB;KG2|Ur1L1dr{YtZc#a4m!=4!a!!Zk3=j;4jVv6I95NL0ty_M&F^&aPb6u zgf#pvzFf9sCHG z$&jJY!4lv|WSR_-#OpyU)Lz<5fm;|g~f)@TL!=S|sARUrU0x+9O2XzKB z0pmqaf@g;RV&kQO_6~{!(q<}{AH=~w8ZT03WM=>_SDmR07&n9+!$Qme)=~!v{F`=y zh}0Q!WdwLgoq;GQ$b)&&WS|#CltN<2&>&LAL8B^M=<_ovexc4pq|VrVVMGw!K|295 ziwFT=nZPg#8AO-?gdj0VK**m6{41zPnZX*ua7jbT4Ca#van>+gU;r73^dG=Qx{S;= zz~$;P1;_$4AA}2hrhvrIkwpIiT%^iib`e~zDpP0-83tH!&Ug`AU?dY-fd2$8(qt;8 za3roKQy63!A_d76mu=wv;AS@j_xIU`G#T!1LIdV%GKE2tp#pz~0W+C0;Qam!Fw$hq zuM328D$V6MIaxFJo3%c>w?AF0dWP(a^_OtAQnLcl;c z{|zuJajOqU?~2GBqXHNV7w5mhm;z0kAYcVq$D65 zRF2O4zQ~b~M$-^^iJ-P4jQmKArh*42QegalAQ~j3(O}CEV6H|}LDi@uWsVB6LqRdd zp8!Tm&9TO0u2KVWWuWnbLtu;!bnwtj;N>4s0x2~|Ho#R3QUZ)G35%r$m4wPQntw82 zq}8CsKnXHetH}@pfzyWZLF_|;4SH~oAw*kfz)0WWvcezz$1ltq38^&zLV&qy4VFv> z(={$!CQ*h)N38n;xJaw%m{yayT1^I{i>wfLyc7t5=x|5kAHhXRO~>3Fc}S^2`=}Ho z0fPgkfMcO!l==MulaW?qbU=!MXbfHs#?PdRk|1`2*@Js#0u~f8LIcfD#KjSTY$Pay zpn#5uwpI|yNRQ$AIz(Kq9#g>Dqr4m&EG##GPlDH&$Y#P|X}{;{$ViXrm>!e4dJK&( zuzrEK1XQ3w%?kzfRH%<|00YY35C<|+WjdzHWUeYxAbulZ&W%f6a4$rd=%4V7j8qvE z3Xy`V$`o)X4AMw}K#WCR=?~b3G?|XMQ3_X+DKG)(?c`7bDFy|CdO9+3e*ze(G95GX zSh9o(F=#F089BUQ%oK`@6v4-7E4B_?%*1S7vhhZ{rx2ryD*Fabbf zEL%c=v19-)Q5;eYDp+U+N*(`X#7LJ>=m&tY(IUWD5RZ5@C=^s6KZ80b#=mKN$Viz% zYY#J0R=OO@_3Yg0vY1g+|NOW-3ank-r}z1NcD(N)7&iz7(X*5K1Ay zTy3TT91`3TI}8|v8ff!pfRQ$11qo1B0FOxoC<{ljxbz)zN53z_6wqc0mW&gz91IZ! zQ5glwsPu}cNx|~6AL&YlP>jL^!6q`meo;`Jg90i{!Mqv~%exRTFl1PMk4!QugQEEvj80phyMKC(vFX6I}Q^2$Tudiwf2Ae}D;egjz5>K0JL;SX5s?K)I5N zMP>*h3L?P-GawB@O8v82z=6XiGhuOn0{)wf%^dU;)fo^x^j|bcOsNn%z+-W%T)-r# zApbaL62L>z1K2o>IaH*ah$BN;8V)7YOq7?w&AJfNz?k6w;7=j*rh%(L&Xx$pFsQQ+ zV&?w+)0@C2DqQVKqzw+2EA}{;IP$t2spJeE6V@L`i~R(BbSNlBz=#MKR>mP>*$*1{ zATW-!qZfWH>li4=J!l*%($Ksy@}VCP4I#ont`!0|bkQviq9ZD7NkArw3FVTX2#F&C zLqLMyR%}oPDjdN;q?a5V5g} z7$^mlUT8mS3)BHH0+7MHK-mqTLEV;ur7J@z7LE#K2}of?fmI|jicEm+P}ZP=e4{cB zVgQ%yBUv%b9`3IU2uUe0M|cOkBv?<#=ol0%hZ#z}0607ZJ`L3?Ap8VUF(8@%E}`NG z6CH5&pRoa{FuFrb479>@0p;opFr=W(Fg1h?Yy=8sz#0IfU{BqD#s)Dt$1w~gX&7)| z1?t&@u53UCBt?}Y@EnlX{sk@w8Bhd`oXOD45J{nIhKf^Etc(b%07XZLClT>cR?p?j zpK=XsAO*{dhO#+W06>*zm>HNtC^&-RLI^;GJKs@EfGXPm9UE943YIMmrFbBb5N1J= z2lWw92oOl*$APY3T8N;_e}N2{BrMw*%KHE~(2awPfN>47H5pJjSl9(0j1~+3Ga->l z!cw52Y!I*^y1^nXFcR)LM{|R?016v`4eZ$OTfm={4cR3uFB(ecFyLrO8r?t+x{a_A zApL@+X%rbi1oxlk2GUOgAP{80znHriG({w21OP5L5b#fsn*Qj+aHxO`D^c(}M5-_> zGd!fCV9d}vLkS}`QWAvPFmx!tBSOJ%ASh_)K*YZg0?1DR8yeP77Ks5TfDHs}5Q2b5 zKxKahXcJ%qAM_VC5Rz8FhA1?YS^{tg-vKCKgIzS3#RdBfW*@LYo$+tjf~*oJ!9wK3 zY#^3Z0lfhm0RknM8;T!5zLDVl6(NyX;v`)|W{C=piv+O@gdFc6SgPP!QTU02>_8 z1WpK6ZB?3%Hx9AK^p zu%VtE9BhPx${9EeNJ61x@Si1|f(#QU0UZvP05$<>FO-s~$U9NM?~|Y*2arLo`4>hP zl5)U?REa}O_yEA69D$?&Vt5)_!lXbgmjPicV1xYXFSHl3cEED2Cn#Tup!HYCCEehJOGC{69OiL4RT|I4QvH0%Yox(5NLm42O-l3Y)HN_ za$>dug}HPZioB7LMVTa8`~v?D*yyMg;lE1>vP@WBjgfN@8-%q`ScI=>B$QuKpsG!pX-Tx1lew}A*iGED>X0LajaHWt=W|0W%v zBBO*H92OgKk-^f`Xkyk3iY>FI0(&j1rIu^W& z23&*)8jyj#g@^)$956G4j0}Ore@BK)61I+s5tD-q0t{p%P+*H%2T1&%m=`iv&R^#9bINGU|#$Q7I7|2_S>MfWMItWRjq=1K7BgQ2-998sZt43Dn*S zUmyX6xdOJoAtSI1!bre{@F7zIH7BTR!o)~`5)26V4@~e;O$wDz1|LI@qR&vPf=mw< zoQRM{F(8YhA)|z?s$$F;qwN{Kh9BeQj zD0LxhP-H`502K^qEJWA{pjm%`4Vfiuu@qy^AU3oN08>GA0<`dk`hpm!$qoL;gp$mE zmO2`;OV|o3Motbk01h4mVS`pe3>z?y6Ft%Be-jAOkX^!7KQVF+VnbbTKsX48QRxci z26;HD?ZGH$P$c~Cb3=9sTNA~|IfxAsVN{d@JI@JUAhANrTM!shA*}iD$dFya)=4pH za*(0Cio-S#bTl={tB}D5EoTDv{yQ>cm$0={Y>j#l8I)2{s04L0CTex1plUsYN?`XH zXcYe)8?sE;f-1&34mOArP}qK^pu9|61K*QF>VkS6nT+_MVU58 z3XX!7u#jDXK#lk}RbwC{87pC73mX_R@bZ8K$cOqV0TIgI=%~<+){Ic#3&IJ`8T-I7 zW>&gffDIOWFl>DR3Ryw4E`w4?)Jg({Cxi_)wET@oB1;97gSjD0gV-S8MKS?; zK!PF{V1rd+&|`3>PzL`CLLx&2YdnB#D1<_=vGf6@-dOK1I68>a02eIB{db-rJB79? zz_z5}c|k@3pleKqnY< zFp>WlK%w;v$X~bt6a(2MD1pH6hq5{}T3BmA!-vzIkPtx7ivlMYK4{+Gj2{|1h?vLc zMs_&ZmWGiHA~V=;fj*;NXteADAJL!aUo7@RI|!gd5bQ6k6w)F1V?Z|t5%cIn+CoQ7 z49GD+p9`$Gih{9)LO#c46GXxP(NW6_7cBR0+z+n-Xz1r4V)g|+iwP@dpwOC*Iy%s| zXgt5@lR?YN5K+U95w!3N>z@p0=OBTI1BsFNbCD0Oy#KG>5EL9kX%AK}01_Q4gA8cn zAOU#*6p{jLT&PyZ**yTAI}8wLG*Bps1DyaTmWV(s4^1UQm{C-PeF0U)@81Os(9;2} z762TRX@mjA;Px=BcD)9KKM!C0SN|4ge6%9v~++EKrqq6 z2qq%JcLW%u>yN-tA2lQ&AcD|L59ulZgH{d_mds-POo*%`SUX0kBxDb$FB9wu;6X_` zj1j~EoXwA5(cTLpS_DB`1fZ@BV4l#Y@<1_QvN?kmtEAO+W= zVLMi!fC#&rIAFm?09dfte*hNsUSZ)C*7Jc#jlwsm7mNT4p%o3~?SB9k^-*Hx5Y>?} z;X(xu=u{jAi&~dp&)*+`MQxNA<4}V7S z+X%@A>c{=P9brt=L5ZzcLWA!hSd8^(*4*KuTn2{Bf%}`oMGcf3M@GN|0l|i@0w%WM z59|x*2j~&z2mWA>4imLca#Rj$_QF7;#X(eh9~v%@35D^$4;SrMhRw-vzLAqV=UgZ_ z(M5*^N4jj)hNItLhc+}=!3?;T9ep0!=!kR(ZrH;h7;36=Ux471N*??g&UE&$9r^)V z(?&aj(LX~w_QC1?`yDPM=n^9hA5Ob+cfOIa`@G!gehKCQ8gBwb?=ntRo|HB%Q(v;c zP1R;8`_x4%6TQfjsX5x+)(LOxYDUdHqN3s|)v!e1#^_zjUjEy+f60mc;<2dy{w1w* zA3Gb~?A;W4>Hg;q`;$j3)@^%!?Lyw34x5YDC1!jZ_cASNc%JR<^RU3~;cU|FgT*b$ zS5%K$<6l3hi*DaT-S)K09@q(ATeV$X zjq_{~juR#=zL3?1vn@DTZMybr7bU;%ldtEEewlSO(`;s586(?2q0=f$*CnaJ_nM^3 z(XMeRe3#VMKhJM7QO@e^THvhPa_pGz*5Zxv@fRJNrS#b`lGAzaL`lA+Udq`Kk-BeN z*UUr>rMP3dcTaA^FD^Y-@X=g|XH8evZFU2&(^W<8iMX142c zxTxL6*W(TePd+q%p)6D3+^NXq^%w?*F=p9qGEg&`P7|c=^52-P@Y0Z6N{<^l^bY>SZf;{@n}YVx-&e=CO*kQ(n~doLH=H_w>;9X^%CYYG^+dxxDLI zSJ$Op0qK6X^My+0Rrs$L{9JuKe3y;e_2tX<*#eDw!~=2H_KONEGqZ?yy|>P)Lxg0_ zKSz7Zv~#>dF~oo=yI1cLrM(%wXnj-XyOlgKyAJ9|saf)tZF*I@jd$~$jVs5f7J3ZG6SLv8)RLC%bs^2M%PpN2|>~tiDaf^-1^sZqvS3`TR5 zmp)g{`;66>yYw(ZDgU}N*_U)4+LTwQ&J({8ZS>?n=-4jxx#*@~?h-sh8l)arVR(6`6PB-puM^V<)P*TZ`DS729HD!&Ry71q<~x>PS~}Z3yN) zpA2Q@y{(!1ZHE4i`IT1PA}{&HRw+sp%H&bb&7thfTI|LD3AdXT$mo?HH^lMf&DiJ57c zNx9!Wc>VOYg+f-0_S2u0Zg=e%*s-YPl0E;f-O}Se&2ccD9_kdBW3bD0N&C5KC;q68 zyCqiMF|YdHNy(@!Z3RO(xg-RdQZlb#xld*4?q*ZHp+QPo1`q zY|}|hy*e>__JQBi5cA6VPjh>Cc)d1;Wn2&$K-oS11GW+@(-wDweBN~)d8rO-XR=MAGH)E`LiA~jY&qI#;% zw+oP=8~ZGMN0>BfS44u=QS)8KF}0e{O!A2>y7UtYJ~C0|@_v=pJ}VD&#~O|GPC7R+ zOzX6Tca2Q->$O)eEv}pWP&D`O4#S6X%hZnq1aFa`jERp~eXMM)?K};6Z-HJ9v&4ac zQA<|gE(VqIH#_mzF7qy_;`6?gZ(`LfAn02qUiw7;{g|4*vHEg1Mt6j+IW2Fq^XjdD z<$m{1Y_jTG=)mr{oRnW5r*rK1!9tzVbotgr#{%8L*?PMinKsMDge|GNxXec7jX}nA zQ+6Nkz*wQZ>A4eZ7F=C9KIMtzC$VV7!on*>c|2K~8^rFJFKs*Lx!z;n*r{C;>gLuR zd@$+Tww;S)ukmT&?K@r1G$ePtUUqbTcdo{j>gH>_s`l%wY=h2U3!7w@o9Z*~rq;X+ z{SUPdm%q5y%I7FdzcT%9#-T}j(uyuPYzceH4h_ex5TB(MdfCLFsW0o3Q6Jeyi>qyiJY>Uqx8{ZH|OMgnFgstIg)y1i^!g)mB;*$~dJpRB)WJPW;jnUlqct zWg^AQeNQ>wE>=51xHvA(ey;o5D<3ius<}rhrz#(1^S?FT*_GE^nzcgpz|r~#A=59f z)fEaN&!CKn_3StEw`u5_b>rsLIi|s?QejhD^IrK}^@^HzHTUl4!q?e3w(+E?A-;F^#6eN;^ps7erP0qPM-_hCB%-pqLAG#z0?`Hcz+@TE z{>{Ztx>a2=Ci`bZU79KB;_!OlX4I8UCZ40Gcx@!wpAS0zWR0b6$PP8XfYG;J$?%Xr zjUKg3U}?}}*8CN|H48V*njv8?;PqfrcN#BFXlGP+;zHv@DMqAcyJE*8ofuItN_ z-wHjc)=rW*9h(+%Hu9z|-_8I9an%#ND{?;drM-Mcu-zglZ*}qAf%^-cx481y$Xp8c z6Z5%H)AsS{)0;1!5Q|&J9rwNZd=INT=6Zl3%k1jrJ(6o;vXV}=X)WEbbOU|W6Na@) zYIwmhcEf1) zTYL3WeWP*IG4+pGhq`XBm?V5ceIq{YtFBC*IL&zAtfiX-{&L==)5$7nqDD`2$MzEC zrd*hmzPHw)WAifd3-=6_Xv@{-dqSi4$wjD5n78}!1GVloy=5Eu7MA9{v(C_$wBItS zXw4j>85)$8ya@>>^&YLVKcezhY+=NrBmMYb{&FSPWmhwD#Qk1SA*QFP}!P zG1FJeDpz?+Fgn(5_)zUjK}mbs*NqQy?0uaoL-+9)mPdXokFs&=^WWI(IL$QWiGj;T zbDdLb;EL(SX_eId^{bWaqWrXV{jN_L*yU?~B80T(YSq;Y{RupKC&-)-?lpC8RcNyc zs#-KVa4juG)%SAwm^N3#_&r^;m+cqd^`0^pcNLuxvb_K9lSA>#BuC#PDaE#)&&SVT zk3F@y;!f6qDcS3cqezC{Az5b+xFjr|VJ=&D#l8C_KW^*mS%y#BH?5i^v|-Ad@)rxu zKb)eNLu zZoGc5?sgz~xp<>fXOne7){!|2o6B{yvs3o5rIKYeW`0(XqP0Ff=zHg2dSP2fwDuR@ zm`cm~anB8vRAQ%Uzf_g5l61H7{-DMlml>F==+l|9pRqDlzxmKDyKTFKPLg@F!%nY~ z3Exw7hY&9>EqO}+{Q7SWs+AAMrW}xpn%P#*{#fqTaWk1{pxJF8wpG4&mdK4|X-DUz zRZ4A`?3Pt-SKAd99cUZ(O~7J{LQym2iFNhLPU*t9z3CU0#oU=^Hvg_c-*~qRt?P}C zr)Rv;JG-^hPh)pLQ0SD~;x;eaYDLO=n!+5DUf_JJ76+Bg+AkDxSNWB~`ufXnb2o-O ztow2?zQFd8_l-tPyzw@ht{~##lIP2=ADu^$^h?&!jh^?~as35d++&-^`V;ba*z4@> zOw}pv-5R`mRK+HT`IEz!JfD*mo?p1CWE(Bqj$kwDKG`uLIP}h&Uc!VIcT0D4dIn49 zSEVaChs?@P4f!Z*Ui)Tr{m#eU!m4CZqpW-dxqWU>YxT~^}3QZw|v-*#~D-XBQs?>1) zXG0Wya_V#Pr57iB#BJKvqa6G^>H0I#%mtU5-UsL0-1IE-f-CDoZtyJ0O&O8lCG5m` z#R?0IjMTQZ`!hWamAvZ@OiPOE5Mbl>8AT5=T>m0Yd)V~@h$Q1)MgJcFCP3N0oOjtx z$(c4Um_~0J>v97vTDLU|S#e0kiwft~H(FB1MFBANAGcE^Lhmbn*fUe4%Y6j_CCiz; zy>-syIA{JKvL*%h-v)j*-(2Z|)%_N914yqS`(P1p5V{ZD@OwfRqpnF5TDy{Y)z8?i zf9G>BdbHbIMCE;L!$|_dDYNX6VYt`b1H8=M7CMIQ5Hi z>ap6Ke*H|VSN|R|$(cBL1K3(hlTC4$XHEj}%tH9Wlz@6aA)fPV{k_}t6{KYZEy2 z^!?jo2Q^3kIVNnoRmWr451LE5nG0k0+CpJMjX|ibn__mwl-oDY)lY2B?T=6ond;ZK zKfhNmj!z<6fG<2+n0O4!ep0XB{_}?|R(R{QH0O_>aWq9l%||;0RKeF91X-hjdsKCw0^$^a8^pl}H#wWo;wKXW*u9^kBjxqv z49Grim`p%$R|~)rG}sJVBIGbWq5;*3Dx)@Ll{t}}ia@?cH3m_2NS%m2tT6y>RtwvW z2@xY^RtY&1EH9)CTssB3Bd%*T00(nP$H@VIR)dj1u*qmrjP=z53&6AmSbK|;PILg; zPUbM^a#}vf*kT;ALf#ntf5`(G$Sg#biRyQBEk+K*A3JmVv>8Y~GwB663-xHN^3x>~7F^_twUZ7E6! zy2&9hHwn%PapB*#d=fzY9V6B_uoiDCc}5clK^C^!9&CH)+}RZs#AT7&;C;@OzE=fQ z8!f8zEMd7#*ll}={9v)&MjSw37dtDL z?cr)?<$7oHO?@D}^U#!1^APQLh}`-w@;h?+O4u(@h_H-9;#Z10k=Y5+9xdWDl=!D# z>h*)D*YA39He3L-PplLd*9Lw9IWr#2k1!xbcpqW$8R?-oKmqg)Wd|;{0c8i=0(Ix~ zo7X{Iy+wRE!U2RdTjf!hG|C+Uj0MDjEUKCn2V^$|gE|B2tdo_9dWP5)GuKC|ATRFtJ@_H zHfoF(9#?{EZA9DY4G&Fd@<0TiR@(w~Uv$JdP1tVMF2jd4Zcr9Or78%)p z?-Q9-S$XT8((X!lz$`o6nO&6`aU$Zx3F9#KihcMccyYv7!3*%=daGndp0*KM%ZAma zXL{lic*t@fWFS}-*%v@?7-f}>(IBQIX$njfvS2epTNs=TVc4oS;tD%){hzx2H>eA8 zS*^V6|0~|Agejz?h7BONL=W5NwkzEgYlc|2z&5%@IxErmhp6SeXOX34FRL^J)_3B! z-J@NuQc|guLQ`IF0a_EgVct47KrP>34Pm4 z-!Rcu7|xE_aBwt0-N0}w#;RRy$Mziv4~ZE^&D-->=q672cFbnj6}jK{$hYhQkdzW@FCb4`X~_G-Z-0hs2)rxo>L&*~A2W zg89KIOdwe(a3MsuvuLRzHIU~14DHXb*?-!!E-Bcx$+HJXz`C_EP6LEm9OP zqD||$6mbb-b2#@#s==gUz+v|50ljipp?}>UnEMn4PW(dfnrXP_5<}*0%kdM_7B>^#j{iWgXzsaOe>#)%ZfF<%+`H z0Q(Tf4THv?a!qN{9Qu0390tBd5X8O>hFv{mz1N9`t&{tqYd2{<z#H!SHY@q5S>Z}``YOIGpx{s5q#M6vHKSCWGVQUMY+NaD(Uj4-SXsTyU z>bw~$U9on0WOne`VXiIVE_bg~GkQ)n^38mm>ch6MyQ|KM;I`abAg0m&h#Z?{#SGZl zyT>HOx{;Q*5I;r?J;7*}7(?-O=XZj4GKx*nXgfEouL3@u@!EbqRVX@wrc78cjfq=# z+vmPb4jTlDjw-G;M7zB@Hi6GQ(=^WKE0@yShB8 zMEULm3;S!O+o!`6Zo<;mHB*q|;50Tkw z5{({tn_I3ax=N=|)&lzrMGJ-@yGtdNFEo7F>b=jC!C_mU{bSy#rGI(4`WkrYfNJ)awzP)fD> zy`{jfx48NF+<(cIf*22u@T(!zQczHZNY)ue_#cBJ^aoLdtBLTXJ8_!l;>y;A#YYex zJF~anv0$&HSVc)Nl%G+#JCz&+S6a94zvLPKqOmIPV%H5aD@Q)eAFjy5tl^A8Jm)_G z>h;K2RQR)~wa4Dn1DMffp9?=!bbknyk)+47_3)G5=>D03=CCR@_ccWxSLgsFko8Ey z;6AAk2=Pad0$1w%#rko!)LCA_x!&@sVP39udNU+kQ8aIJ0qU75C@q~;lU3Aql_9~^ zee-xLB05!oQG&)~>`v&$6gwpQm2IZz?-_Oa4Z$|3dRKR+*{(@g2KbwU>+;M}{H^2M`;L{vjQ!6@`bubOY2w z0vt2WrrMk2eH^fAg*UCfQu$-T-I9`|S8D;C3uZM6y!k?OSl47;svDaP<9MW-+my<5Ai6Co_vOPKj5AT`1yH#{^t6k~q zCYZ4rCPHo;bOW2){5j$Eu^5j|veQA`KL;i%jeaDS5;A@>;MNYXZ7m}!qeGHtWQ_u5 zpHgc5bb|4vx^cReJtU9v@Xz9WZTHde?a(KNT0WWk6dnUH3yCjYC%5K}$6s z7mX^f?MvKFQa6UhQ6}21B;gMq-8gsXuKZ?YN_o%Mo|g&=jpqbTsR*akVo@rk1dC)E z%XExSvQ$#f-n8^kpXJcU9`Ie4G;H?qx};n*O0c4hj+RkeZP62UcSn3o|K6zT4y<%` z%a}^lJtr^kw3M4}Rb{7GJ1IUx>g{k14F+!ljBC_y%K8zaQQK}l+sW%~+`;E>e*JpM ze_q|c|L!mEzIys@`Rub-4-en`d-(&Iuo@1uXahtX<{wtj|KOEHN4&*$PAY9*4Yg&#$aD1V^Fq8Ff4WY9o2}G z!P1aR0BP8m9ydPY$1(jJ61GhF;RLmZqsbJFydi175(ti|y8;U*OO$=U4f3)>q|-)} zmWsPz5LO-yHQ8m-QbkI3$7~1?x7kfAjW?{8ID-gnfIckJ03VSBLu{jDu@UiUlcheU zWkC3FM~XZyF-9T}6M}%E(cV#1B+)i$sgeGOki#Lev?R75g4*Q`r+GnqHRZPr+9s00 z*pLqkaym>E!GhZ$`4$VaSpiO5WnX}M;Ad|C!XpOFhJdd?bwBD$pflpux& zOwxoF8ECLzSp?v1VLM`*gO8BDs0A!Eq8yQ*X(25E7sDT$*FYShC7o6v zewj=qFrq+(es~7AbgEUHk-sP$RWj&1QLBLB=4}0l$P`glDx>l zm>-QP4OVFmC@uvA0ht2^vQm`vvf7S~T9725frXW}hMb6EKm^AjWm7?5$%ri{{9&q) z0+K5E#b~^mGVsm+Az; z4~t1AZXz2GYm@c9geau67gx!kGPIzH6!20dsX|wuiQ2er5Wv9!3{L`Wz`0U75&_a; zW6+$(0K=&e9gdZ7DM`vqZCIHUST@_U9%uswksR_S91yf5S_apf6fV6DB2X$41gEp1 zKvDS2rT~dK$b6Id3jR7EFGNa`-QK4~M8KuL1R-)mDT5=57OUU{OAAJ2$vSjA(5jII zlS?f}uH#HL@GayY34wq&Ru0A?xq1){#Ds;gk~iLke7jC5BsGPcaeiwzlG~|dll|Dn zrmR?mQj}Nnvp7&#S#ry!R%BD&+y4?@uZI(ESa) z1yw96I=bn}AshAaKak5?(gEzDn-Ish;g)VTLH2!$?77(u*nKhPgZemygEIsxbcau! z$pXg|46-XF1Q!ZWOfot~`zX4iQv8jMA`%b(4nZ1KOI2+kPUv7tbW8K!VMfUBQVk54 zDmRlyiX9qYyCe-fsF<)1xrYQJ2>KD!nfJpX=s+w|m}28|BPE?A!f4?+4%?7!13)A? zn}mob(|UAb1UD?4Rq_h#L-zG-Obo!YnUBKM zLy4q!%&>Sc*s|!T!9`~>LrxGnDw`vwSXiE=@B?K(8n>7j1dM!(UXEM`QoPhWtq5U; zTM}Y=9DT14ToL%V2Zg`b^8*P){{%vvB64+Fp>cr9%_gVnk$j5_IAdbShJ*eTNGdv= zkz~JpG^&&g@!^oC zeAsY5?6`kO+BqEj^_k6psmOy8#0C=#T&Evu0h%U?-G*F!G#$K6HJc^C2TD8xVl)M0! zb5H4o=c!e8Qm=VxA>DYV+X{0e_@}xt?3L$KTL3yV)5L>|C3h?d7<>WGkJjzzv{Wo1 z24XS8fgVXPWr`TX4+I&9quI6WWk#9K(veT$Y)4Z@jteOk2VbW39O}_nUnHXQya8#Q@of{beUwj*&9-(25~Ik$l*Z| zlDDybGS0CNp3H_UOz8HapS|Uhh;L+;7J@5kx81HZR{ z_2iWsQPqJyv)cz){qr>x{No+BNpvGYnkM>q!|fK6a|&Q1F`WvIL>UC2h& zSY3{9ldVHO(*yw`Z~DPzj@?(mZe-yHOB|*y2F~e&31@22y8rsdgqJ%!G^qkqvW-I* z3pyCCG{%0OILr*_uprGP%_q7hh(1&T`D8r(bDHA^icXY?&IbIw(uFB;+R-a`ELrsj zy+$|hbs-VDtn{%^ckDzj;|E}59sN-H0`tkx*b`X7>!}UT`HeW^aGroD?;?4SgOcMd zyPAfPK0VJ=6q)BZwdy^SEt@G}P2N8Kf*B5|wM3 zff#WUIStwi_gKvPwd`U>%&aXh%}xha~&f4DcK>#%QNg`PL1bALUj;sQ9B#uiV0=l+Y~l*rg57+B%yJQ!(vUrf4{tcZjbGdl;p8+G zz+=QONT!3wRb0C|tkzNvv9g0*N0nrvo4kwa+UrdY@V?}K+`TlJO`I=2`Xo9{0`(%yQG_)LXF%v<(0uA)rKrOB*-_mxG zDCs2fuDkrtjN6XNM+~oq?GU@l6qQoXJn8kyY3BQl4AE!cbIed2XiZU@A)kyHW7EgQ z|D4(}1<`M)eMqBkSzBU7sa(4(SX4RED^VuS>N0v{{z;R-xdYq5Som9`1fFYVgV`T#ntL$cdPnWrjt5iBw%mc}j0X%4Bdb3S?DDmmA+DG}sobBRcO zH9b3HfByxNqWyL&)5>KXu1woUm9apmvR(NZN0kjxaLl_9gk*@w<-Eaa_Dd3@2YtEWFVre31`#E)C8lekM)1R`!{ zrrb&7FYGW#S1@7?7|0}Y<`mjW45hkBMrRWX9h-`Nt|S}VR#1N1*o@yGpx#)6X?y|v zh!M6p2y^6%x2Lw$YJtW*}JY9B1-bI+i7eQ%xt| z4o^MFUSd&2Luu_#QR&N=X;Tm+w=#M`Rj?@A)qQ-yv|koS=ng|;6{junT#MAc=^>4> z!h)J~n)+@|Gtj=78D=$?u$w)@?o>GqO)bv&(O0hmoV#+@)Ex`!c8I4w4+dT4Rpe$@ zZR%_p*KrTiyh?FG5vO0w8-LxcH7pk0snjamG)gwz<8A%b^|a+Qp>q~`c!J>_wljW~ zp`c@CUMSE(@SNK2j^p8D8E=-TH7^*aOQOc}{ZiODsUwnB@Y@qDh|_>xPk-z|=t|wV z4Li1peS~KQzv&`17oLD(t;K=k$rk<&!T0*eQLQ~QaM`R_!y#IV9NU$Gfxm;bvL<9NhW_Sxvl z(8ZimX~kJrPfCZaXDZW&tNio_%Pn}h)38?H68&RByJ%0drr!5|BX8Na!?;Xy<|Ul& zuGKR}qrGXSEeBNL`Nd>YQ{lmn-wuBguO8mmr_N44g4B5HNxAFL(Yqua%fZU;jAx5Z zsZ98e(KL;Yn}FwNYW}rL@u?|mvz+5CceVBvs=3x35O}?_^~}B6M4rPPLNm?Q;N3=Z zXXq|wrdXG*rsmktXY#6^4}GZ_GUj`A?WRT4w8!I)Wp2&Oy_WoCV{6{e@HFwLQ5ZD#n@=-)u0D)VI{0Pk*k z-U2!JAJ8aeM*sbRlGXgD7$G@*9)(-n9V^E2+Gf2iEmIE>9N{pd|vuIcf>mFN-L-XnXQvT=P81 zC!F+t`8J&)p9S&&dusS@1@=Qu0v_VCfUxaF2793neBlp594Cc>BdQ4U@>ByuYq7z# z$|KM-!GrXJZV35yBP*y3obN+>=9MoRu+qC~IZ6FiJMP%GJ* z{+KG!7;7B1%1+YG%TJg*ZLn232=GC#EQq&y<=_POy)ua{#*?bbBtV_Bb36b>!b`S_ zx(M`*zL7&yj?g)#(ck!NN)*T)Ye_l_UL;UKy?}O?9XDn@s8bV^T#r_HPzubz6ZH`> zY0^Ae)0C?98j1JpkaaJjQRTm06F^Jr&Z8*nx$%&)A3quao9x#SJeR&Tvs}h7fl-`w zetsM1GNIw_@qc{OzNOFCdfNE=Dkq>^?#bLSyVpOJ#r62ai0fJ1y zWcc=Fd{|t#LL+eWS+vQ5?qK>^RK~3-#La>{`NFA2-^SlAC~eA9^xQa8s8;m4#bz}4 z2>zIHJc1vf5xB0vjPWG|0-FOILWE0G8jFn`EkPKL1>ia23fIIsuY8bHh*n5)lz^dY zEes!`vA(EL9+D;et}pe*)&_g^jl$99ON`lQ39rX9jp`jW*ej%DHRx022gma{6wcb| z9DHE$kjJ`|OdY;(U`EmW+euZ@u37hZDVt>OoGVFTiaAccO3RcJIt4pKLAK}(0+!ZG z95wQ2SBRc+5v6=e(PpUDqe;rp3Svk$TpmgwG%hyj!=!mjXE#Z19Fyvs7nO&ewYlJN zE9w|C>`RFrxoQAAS1R2=49e+p0F+Hi<=FYU2U3{|xdO`CbaD#zptaJ^SKw`>@yxh}Ndtq}C!i0&-Q!^vOSHgY#~{WuD9Af)#l*n_DxD|KYsr zaz$9v)S(1_E>^RJ0#1cAxHraA*Rj=Kg=!Y)ye_*-`n=&jWV(HFAtGMoiY)$$i_bdv zlp7v;BWM?gNu^UNg<5q!tSx+S_D^f94q^+ulByF)-uYlG*xa>_Pk#FK4kQ9><4A0& zaLBR5v^lsZW`&$LxVNS`bdF&qso5&1u;JhorKpln2-JEMg2M_g=b#^TA>Xn$=Uj%` zc_&OQQ5j|*imjJF=Fc+7EKaD`ola&TTn;`b+Lt5nq&7==DvXTVGlNd*!B9g&OS#Tj zt-}r;s(1yf=bn2Yvrf_8lvx0a`N-EtP-U0D%A>#C%WSS61Co*JVbk|2t9u@m1S-*D zrun=>o?(?7NM=SzfAN&OqEUVf!lt;`<-bZ61N=h}Aj|A9Jr8A4>*q0;k*iHWDDnrVEG*DU)KRWS2ud%$mT6oLqfwDmlBWpIk|z?iu9D9-&P7S zJnh?;r_Z;q_mvwUgsld$1s%95hkbE;Oo_{PP`0TAi|$I!zpro+MP;ZBwHka#9ftzgbyBNPA#17hp|i}*bXT0HY$Md& zH2x+vL(;Ts8Xy+LFXauNRAduXpiSsTX$Vn-Fqi?DBe;ij6kh*Q6l*RSr;0k~L7u_{ z$G#g}*!ja{MHn<)p`B26n$I=OCz2$2n{UM~aozQ#t~slM;d2O4?3(Hc{fdbVfG61O zcCD@CwF|y^;;k?4I{&Gqrz>QM)v~Jjw?`qW3^}T-yI7BJ97Ob4tw|f7x*R*T zP-Vh&A;_|@hcl)k@2xHR*qQ_GYWl_9Q0x%BYKsb7ONwEl$}W|fEI#_21*(x_B?sRz z)s{Rd_<=B$z zeI(&JPys|lB@P}Bbf*TtboWA6Vz?MuA6cte2nMR=M_H8RoI32Hwp|^n2oQe!qzYMWf$$)MXe>}@mxwA%Hh+o=!$^}Lg_I>v zm(M>ig_%g87RI-i-?E z{jgxa1r?nC4i#tse-bRPAK-%ip}4?*elFnO$JGe)jjGSRDcROEc9ch+6<8OQAneTSq7AKidvT&1wOyX_w z*5p>|y3HF}9iJRF?9O|(5^5Ma46%23q-V#0T2}rSb;rMSt~!SAcs4-FPv8^GYKl~Y zW!k}@rJUt& zEOlEfME!S(C0ONf*%8+8JMtx2V!k~jSt)q>S!y8mP+{T>oD2NW=5yQ{t;fSJ@+HBAwOH}*Bdx&9342%3u%3NcY7OEA%VAtQFu z@|KEj40PRaTg%d!B=-1&^YZY64KqjRP~xv854DW~hTL!t^kw#S(8#862_1;uqx9Ee z;tp1FF=p_=5FuVR?B1*lN?iV{nr+t`kFXZQF8e1ganVTYi~Tc($T`qILtKy>T{leX zcltT5)}7Bg2HCF`yn{jD2QV;fgmX{SU9l!or zb--Xu9eZyU1a5`pb@{1F6|Z)E1@34k27)zsD7>3%&?(mboHBY|E>DT}Fb)5yAAgW^ zFiQL^X76>s;Ixdgitoyl^>sK>9XDuldII3s!cYc4fI zC=hl}C6gNFRd+pDhTOe|GJX0+4%t=JlZU4`2(<+VHMy9MjoF-U4zXdoeTWOA``xbE z{{i4V(DqmDpo)}G6S>q4(Yj4o4>>h& ztWTMOlb<_MDz0AILg$&m#dt#0qzb#@(D^U1lYZp?dK4m#?I_$VrJ_kgVhp3KETtrW za*#h}kBeIQBpQW1WiuaJ^2KMDH2n}Au?NM;lk!s;#npaC&@GFeI{+z<4%1f#O<*`* zxMkI2hn@}7v%;3ucCBxAEQF8>abztuw5`97>!6-E*f{FpxAA1jF zN4)le;Q$(iPgJ8X*`yHLVo`1uC9=>(Vr4uhceI zzbM>Bc_Z~Z>Iwad2@pN0apNpKyGeXkT$zg}KKkP6^WT2-^3iBy7b-51K8rm&*x){F z3Nl@)6T>AEWPfPMr{;Lf!WE78EG*G^Tv3Q_XKRBdbxWcS+f!G<#?$@|XD1K82CicH zI4z(|mO37q;HvWkuKOn`oXA6>lPDLu8@v6Ws)XT!QL(OW3VmmPKd~An@mUl>?CTiYuXp2Kr zwxt*nqCHtmT7a?7Ss1*FQM=MS0h_-a_$OW@u1)sNie>6?r=&!EUE=hSNxGkD(wG z9Ig4iyOR;axwkpg8r+MNX+_Hwes=oeYfjsqe)MH$NGdu%pU&K`h>^0naJ_D67EuJy zNoSG4hD&V{d6n_@ms#P|`@w)4h4qh?bqQ!zphDcQhl|gsAW@>KI$0aZ>T6Ume1UZ ze>fJ*9|{Zn55j`^E3hC@);a;WVAacOyvmm9(7=MML%pGbnhnSks9;+C<3$DVB+deD zeWR96S6?G|ZVA5b?eL6y;*-lOKUFDft%E1RQ|5%tthzJ!{;vOS+x$P1PhG=zR+X>@ zIPnR(y~cdNb?l;5OAzX}>Wx)Th#G$D#{D?^ck`gYrR0=`UF}>NPrC84Rd~Z?jW?h2 zzP-|)S_n5*{WDBBK?z-w8`%BjV^?Ir??~F^D)si%(3fQBXQ?9CgS8_#&mc9g<3b22 za~N9aIrY%TtTk1h?F@0*+w z2q~>d^e_)c^bYpGBaLxwAE$kYP;vrJANp*qfXhgIs@xCK1iW9>+MUk|jB4 zzL1wWd2>sLHb$auxW#$tOp;6d!FhT3!G@V5bf{#JmR!g-3K;T}InbBc*Fh_oA`WyQ zdXM5+i-|i}$;Ft#2Sbo`*|2-FGAMC5m}<6NZ#*JHFWr}ek~p|%?(@a|8AI@ifv%rn zjdG*whH(+6pW|xX$#)QNfKRpH9SkBfELTCyxhJYxOY2O~>T9;zf;H+w^>XSpC3kZ~SEx^eYCVYo zK`I>lf{V?qAM=(?p2eiE6a-g8rpdB>3F6tou8Ow>yn61P%tj4>Z^~>$HG}1?ikafq zg+sm(TEw@-r;C;1%k*^#zPfHFR$I!_&g}`5_i+F$s4FJ7-~ocMVKgJS)N5#jLj1;Q zFjoGPNJ|DS!*U@>UIB{Q_jFM5e(#aGjV1_*#GG2?d4NREY8Sp~7)=qqHTbSjR2iBi?dM3r z#u4wEnyw`#1+zYte(03ic%(#h8KIm|vV{JNK*IDgCBG&HiD^=Xp4sR2tIZORx>8lZ-M>J7h>( zrPqY1MpEMoV?AwUFABA*{6k4xxL+`ldW96q{}-2J#=x@s6b-9+g^-7;EePegjw(|M zrq>N&PR%YlYPB}l<|d@I^V=}=0w{!`iTq}VxB-2HVpRWsMIZn6g+ksc{%LUC^|PO$ zs3Dy!!UQ(DFPj+pj-}I6@MAxJ_~$S0^Wc7lbo>wnj@LC;-oQQ$vhvG1eqf|UUzB}> zv)3+>w+^)q>q!D-;Dknp}tMYhPXE3z&RRobOD0ND+Y8t>e$zMp7zR4Kf8^K-i! zQz}^7D9KIhk>Kje;F1MQCvsln>Plk3C0JrSuO*E zfBe@MJ3j?O8nKaU{cvgTe$TXLe}%oj!ruRT*oz-8?D_v1_Mo)54`{Dr+U-W2bqHok zS?61rxlkw*RXC*PrLXgiAeEgfi`;(^ zbT{5;rb^aGa>;R=jr1{(kBHekDPGaG_kLIhq*0bx zI7z%%LS2>d$vVtypRdE0H5$9_4dsUqHVE%;i1hlyMLNDpr1Osy>2d$(RNDR;D*d%0 z9e*W}o?j`_`RyX@-!IbZjYyww7wPj!r1$+zm5$%3(*9nh{dcM~xz-C~9yKZ*19K)u z7bE+YEAWq0Xji@K+OWLjXul;|50qdS+fuDWrcHJbASe!HvPoV&%xD{~1i(dl)3|P` zCqaPqZwPI?iOp@q^S1_$4i2yA`XQQ%UGg=(+S28zMv!hO0n zdIm~GMf1=W>@DHkdXFu{Lq&*|;qmafWVr`lS~l6I+`kM07ar8RPD~9vhaa=u#uzDY zo#Sj)=d$@wFqGruLH*%$Cu~9W)*^TNVkl!)?tW*8@9b4Wi-7tCfd}G=FCePlMeUijbl%t5G z1ecES2Ga*}=wZj$2D4|MHQ7G1*Q!;3st=8LC9`fRJJMUXAU|yvmsE=&y=vd}Jx1JC zDP5>Ul}`Rw^dbJt`jFqH5AjX<@Pp+c{@>&w|Dy7ce=2#{KSCbnkCF$A0&#UZ__GiK z{=9|VI+t&ZHu14M*r^_wl9Pxx@?gRonq`yMNf;I0<|d*OgvDg;A|f$-FnJ$rsCU(ai79XqRU zE?#5y&?;xS&r{tggwFi9I4A{f$D_=K*PuD)E+kfYQJm7?_#P3SfjLqYtKrt(`3@ru znoY?pI?zNEn{C!)Q|YqBZE<0C{V2{?M5WG?hL7V?vnRDh)rE(}*BCE}h4N4*oV|3ahxuI`uuQx&Yi2Q2p*r|`x4e9rVD%8EPY*G)G zZmO#p5CN&m0C#4@m3`0}jfK!pmgbc`#LVD0lkr?2m z;Jjo&jt&Sqfs#^HouYMl{afucJjLOg+yw^4g>HEc;%+UO*WHzweCWDDyGLptuQjb` zt*-dtt}doJ9SJpex0QL7O&Ns{CiE3cmUPLLjC8GSuaGSl%sBO8cK)}Q-YHvPDy3YU zKy&3EY&7&k{%mARbBrYdr3`^*@$Lz=0zb2|TfyZI=`?^2R(99a4+jCRpW4BbEYUp^VQ{G#q6W9F@vA<|m0&M-JE@|lEvn|v(I)KWIEleZW%% zL2!bc=tq-+jyTk2Ta;l6CaXz(GyYigM7dHvvvWJLxN}2k2$h};-qV;g6+M0>u zrt^r01QsE0eWbVddT3sf7N&|ut)3` zsuf_CI6B^;joiZOAbCz91eOfYz}e;yGI$m-lSk7PK8ryK+hnVrKKiO=7#);9SD&NC zaSj!dxmeBPYDQGyS9*P}90Z)kTPqs_dH%p~mNN(#7kGt zhttJigG=;|CR_+1zS#?LKSq}VmM{#wo~=@lwk-=Wc>#cXFT5}Kh^V!IFo9~W^XkGP zAAOj=Q~N;>OBqgR-KcMsh)BJ&vMqx)H7yi=o#Z5h*WGB&rS_D&_PwGhPoM8Xvc zs|z0a?*CV`I}Ijp)}tp1V~?XUo@KhL1+Z|c zYnNl8KYSXjh1Tt&a_GKkVr1a{cu%gIB>2f{&ba$_de)Dw2wxQA<~V>GKDeH&@-3LPI^K^e9XY$TdzujK&uSZ zCGMCWf()Fq2;wsg{PSB5t{2MSY`zeuUU=o;L9CE_ku98zbc8c2Vi|#Bx2Mt&Jgn!= zw(+BiM~``r{E=tJMyHEb;}k1DJrzwoJj?Vkq*-yYy5P^$wC3^gP+K{s*Wsu$R>zxu z$Wp#nv1q07Wu5X>uhs2P)-W)<)(F|isG>#{wQa?r(Oz^NWAWMQiS;s~ggN%riyBe3 zYAxJwYJ6hrxNGHC)d@WY0U_?nTtd^HZ_o z3wR*w6aW6_PrtnU>s`Svyq0`G?)wf@utmTIhdwpM1q=1y1aZaCx3iT#(P42l%^tR! zoNp!<-XWUfj+qQ*GI05JE<2(|7$dNu28vX3YaGk(qNltw~j81 zUNQ#fxg$5Bg}6G=UL%*S-zFJZ@59Rh)HP)mZJ|I@1EAAj`s#p;6`!U^d{jfFT&X@f zgVdZn_7nl0oEk4dEO`hNBQxKvQFE*0qX(&r)En1>-bR+?T&(wt0!Y(>-Ti8^$*F}J9-*?>gktBo8`<#Gc2koK3}*dt6FXUFfwD|>hbnV> z)|rP+LUxx{xM!#Ta9=e&ZWTfB?qBhay9eX>?3p=+-3=?B;?l#a+zuZ{s}z8nxy9GlDza)$Su+m8D;t-qsWh)BsX1+^y;=n5LHkth6X%!x&IX zA5c#YmhS^h{Ni))vXQ z#1smNaYb}Q>6wf*1t-Zs(c8efS?y7`kTZF(m=?|^VlH)M8MIXnjDglBG`93am17#5$1+jQ0(d2s&-k zCdh{r8kwwiA*mJAA4mpRQ_coS!?UC80Ku4g4wQ&-UTIjbdEC6cWmp}{)-6oXV8J0k zaMy)PaCdhL?(R--f)g~j1ShxzcXxLW?(Xs}vMu|ZecpTCd!Og~0ZV#TSFP$<)w9Q_ znuD%$78yn4)3A#V!@HAjvl!*Qwz7-W3ast z>i4;vu~lDIsQ~K?f;7Vo<%Ij(3T1Vz9Eyl7t?yC)pv_CzSe-}|UWyd+!URc_-W4b9 zRY6QdqV3Sv$hWtq<`_#@3Z&vq^Iw+29|Ge=1cm#ezlgow;1xfjnsVqX{h-{TAVeeh zZc?7~D?7~fYtd-`fFgYhdrq>QJ@0}>1o4h*6(!R&pNJ3v6heBtGoBzMWW*sv{P3}J zQ$nFSm?fIGwbBG5pXWbqJ{=FVMHxoaFt(JgPp!HGh_Dgl>dAHz1=y6C;c(lnud=af zD1+4CgWW_*B8m1eY9)wYJy6}yh6u&ZQkbjCN9V|Wn>Ta8YdaLN5gBu3!_#T_5#ycQ zwz~+HQsj89K2oiVD`#Sx}<$51b3NnCniz`Z~!)b^ZhwPBDp5Tb*RKL&B<&*%Qu1dClEzGHxdU52g` zrGZRT<2!h<3I@~DhE2=umEQBlI9gj*X!7RC?U3E$#`whkx{dwq(pu=ykS;{rJZ{0J zebd|*86{3W@Zcg4?Ze3PL8;WvO`fiYL2~=LAkB2BGjsBRsby{I`=U}=Z^zriD&WF< zH%{GBn$Ci4ybF|WQOmH7ihu*TR%Mt^SQ0WwHQZWo28QJ0XON) zuRo&Iknt}%+-O_gIh}KWfPg$d|NI9AQlvLK@sifl-oegL*YeKFMe5@$uo|;r{;q?(XjP_V(uH=KA{j>gww9^77*1;{5#l?Ck9H z^z`K9+9=lYip~k zt1Bxj%gf74OG}H3iwg@2^Yim_b91w^vokX@)6>&aQ&W?ZlM@pYogEz=?d|PtZEdZstt~Ar&CShC zO-+rBjSUSA_4W02b#=A1wco#guc@i2uCA`Cs;aE4tf;6cFE1}ED=RH6Eh#A}E-wD| z?ORb%QDI?WK|w)&etuqFUT$t~PEJmCcJ|k=U$e5ZGBYzXGBVQB)6>$@Qd3h?Qc{wW zlarE?5)%`@eEE`)kPsgq9~T!F8yg!F6B8XB9TgP?#9<;LBErMN!@|NsLqkJCLV|;X zKYjWX6ciK~7#I)`;P3D6=jZ3^>+9p=BgbIEdXadC2Ta&U0GfB*hP85$^f4onrz!omy`V+M+nFalKz z8Gv#WbaZq80DzX3mWGCgnwpx5ii(nwl7fPQoSdADjEt0&l!SzYn3$M|h=`Dokbr;y zA0HnN4-Xd?7Y7ID-Me?#*w|QDSeTfYZ{NPfz`#I9NB?(cX9VWT{a0uI%hg3}Btc4# z|DhBxJ^UY~_{0?OjdU&S4FUX80BLJGOI-_q0N+b;Yk-XG??+^0rSRzh3Viquc8-Ps z1u0#7bD*h}Awbd9#tey@zAssQfB)0^ zW7NKAA^p)L0R@1dp_8e;p@5VckR1EH5fZ<@Dgb__54O>@Gqloo{jCWicGiwIzf=dz z(Ei8C`1!3}G=Snu&ITEp&dZj0{Alo z4fU-J3;{pSiT|@*@_^qb5;j)AZ`q3fElct58H=?5@`m=-j&}Nn_P}JufA$RUy@&!G zFh4a=XNnGA{v}(nowdG#p@RlMR!|rqW(iD+%&!GdmC-XZ)PG5XEM^H*k$RDmeK7`_ zD>&*oy!5p&@B;mHeMN&&+vs7u>EIwnx$=6U$5*~QjB6o^oW6b|E!27McehMqIG4Fi z6jlbZD%SPAZf#p@w`!+agvIikG8qHcX^K!}qM1VQbUs?!I07yDonp#=gn>ze{L0(+sm+Jvk^7y0pi@*JJqyO36=>P6+ zKq-TtHT~BP2h^eXS>u0pxL@)>|GzujFZZ0^9qvVWlMx@7Mjx2*o&Lq)fF2LbqYq3e z4wORxrpf=$9{1Bl{`5HZ|6e`sWt{%c9!I$`?u@`9D+<^G>N`(W(g9~V24)pH5Po}o zE)@Kk)?WFx!Cu9Y-qzXC$#Ge}8PSo}@zM72UPS`-1c?>K8QwOMbgC%WU+?39djx`i z_c^9trnVQKd%2=NeeR{N|Ia@6qUZAe=yN|?Apc)aazOEcKWmh+GcdF>wK66bGcdGr z01gWZ;KX2T3XD`-$@vVd^$aP1L)ym1!q5_U7@zL1p#qe&`tv0J;3B`zLkvv6P6Bt& zc(0#;9r{;fgn9&V^AA1x%e45P&kekRvHb3RFWSiLz})J;2Uswo!3N6EiVDW)Psi@i zw!9Sd{^W#+6~V9)HBc3>zN$!s1jMhv3H^oC6ysIVRg`UUoI|tNhS`MpazuoNcT5&+ z9VW})|1jCN+mgh|lXjmUX6NGKZ(mI4oSxX?QG0rBIzMu5xnDXC1R*d$p5ry)XQ=Fm zi%F+YSrm$Qyr4eLyeQ%++@CEUePyn?Fwb#(t zT0}qGPdHHtVCwiwgv2sLKcN0V}wYNg-QSpt+#Ps zdvfaOs@M6IpA&eiU3YZ5?QMiy=z4Z=a&+dp)ewOSYq?;;T%a*6xax_uf{9s}i?#&u z+wt#fwCAvCH9t<%YQQPIUq~ce>TW$!)n>p4w{q@xq@IAhYO~8A_fIJVPoV|#2~uF>XFu+ z?8u(D)ZQYyf;$(1puE8@=66CBirzTTx^)!#!mymzW6++iR^#BR9C643wZY=-W4C=j z(u!?QFT) zIiFhKPe1yef>V3Nomd{^qk1izvK7B?(|p^a!)KxDj~_+Eqf8Yu{9FvmpA9W!et@9* z=8Wuv%?ARgzE59tFSmU24JTo4le^e1dmD3lqFBXIAHQT4vE5?i3i`*zS1DrK8IACZ zZFVg-#wlfv^YTBq*EBuSNKy1HBBiG+Di||5jt$O~O78#o5v`D<;ci{!NZsch#64AD zYQGiYr=O)D&qNuV&frnPqM@R0Ng*%ntFB*db+Mcj4-+irswQ5o&Oz0k0*sxNBeDX& z++Lc0M$~I7aclSF^%wMEmkU$QeP9>w?#WSWW)y=qss!b3els|P@)-E8@|KnC+2;GR zV9ir^#32IS@hm!aOO4k|Dwlgfa@k(#_sm%ao2~P0KY=X|@A2pfFqL;J$2_lt5cpf` zB5JyJ7o6~m$VS2VYl%7s)G#kVCNaFyYK5DcoraFuaLUuO2TK(S&adDa-BGnV{h4`H zP*+pGHod{IojXLIjQ#lF3M(v2xjJT(0N!7;*1 zOn71|EXT&wOal1WEhQyCSCPVlivXMMdgq|G7?PDWz3*uLE$%oMpfyiZtI$-~tlOH+ zii&#W96&`BCHC0a!tN19YsawrBkVDEYcjGhS2KF;zSiOMSEW*Fo@pJ1?m>*uasxD~ zd)#jeT%dsm@uYqqtW8YC02xPMOEbyIV2J3ZgBmTnpF5Tp5@Os}K`-84G0$4CkO#qN zfGJj?n6*b}CPhi$o{|cJQbvvHspIF);bu`xarNJ9fZea@N3JgTnXV^_ANB4lzIDu& zHJWuEtFff2nDsGwXy4T>;kM-{N=FRM^7>K2@6~g9Mda$}aDR>WnVWpN z$~Bx9IHkIPbaLT52?=-@@3rfooM>{X`1*)>OP&@Q2216g1GU`(EyasjedWI09kN%S zG{n&L9+x~Cl26HSTxuOxE3l0}3@^v_ntmr0#HFqKk)RcroXTTT6@dLks;)QWt z%i6^v2R||l(jC>^hzRri&OvkT>Gt4Axjp?Q@Z5v?Eu*B}&JF;nA|vaZBc_w0fq+%H{sK$srQZ~?%Y>MyFKGO{`&yOq9x_5BnvSmsZQaJl$R>m&D^tlbOJ88C7+AfSD9Dy38 zEE`+>h8^enRF(1*pkQMyEen?)&qA4Vi}yW-o4iKjPF^F*xAtAau|Qg!OYWV(5U{j$ ze|fv`DT>tblo=8`c@{F79~TZwwZ@6aJV97(Hp7I1I@`4xO?uo)ZnDJCij2l`QuHvk zT0y0_h^hMXbb$MubEy<>YOL5&%i)Jq`{wi1;}qbZN2%Wwmc%)Q5rCduT`Ac9{E`C_ zvzJm1@;j+Z!11>ec(@<-->$1=Dhe)qN4C|{d56PlJ%=7U-x}|7;t{ehinKk74%;JN z9=1v`A)YUuq~;@mn8yeyhvv-~WW1qGsac?1%dR$)+H7{~Fig>2Wm2*ph!i-*M zD`zWFn{#O>%$IV7UdU>otGRLlYVTWH+mc17GN*%O%nj1?){p~2epR2Ve^Xy>UK|$- zK0PH;f>fmdv}basYFhRf*WTHJvP+}?@jlIB;#ii9Rpah@!E#m)Hc(xCPI|3cpChjB zu3kWZEH^07(NQ%`VR(@!Z^f2#&93>m1~xj07GUg&f_VP+LkCG?L{AEqv0jvz0MFhv z@9S}Be)i=Z`pKd*`lE%B=Ano+A1W!M>fB71FOSW1VKdpNaaD&`AGjF85-W+j9qWlK zt2Jhd*9>S4lY0THX%(y4Fw26sA2<863IXp^>V=d(r>3T5BX(9U&F~DySd!n|Fzgri z(H4HIi7Urp>|NgC1#GNh_U;OAgXar?X%QA#D5(ri~mSNa$S* zd2IWNSPN&M;b_3#vAg;XzSUGe$%K7dJyk_nTXJ&h%^PLKRr%XfRxC*vl6b30N_dVW zD7=-g@+9ezGw}@w@$qXHj!A=`XCwoCAI2-3wpSZI;FS!XnN*Vq)r+guH;SfdRaVPs zE0ruprNyUesZEu8W@S8N^Y$ML)kJl$hQQQYv& zEbGROR`%6NlUB7i^&4L=!iiGTXf_RV(n{8P!i9%O0xK5o?viMf_gi0`4}V3emHudA z>QX17^~r&;1%}rnP}7Hw zt)l3LbD@VVI9#T}vh`H1cZlU|+}Al#v1Yw-Rc2j)j3R^!Rlko=IkoOx?W&38m{s6A zBZrImYFf|)wa9B*;rYb{>qww`WDY*-QeMfez%3CUw!M?ET-k<~amG(hsW z+*HZZG@zt$98cI1$&Jyud*mydjR3=UDCd-8Qc0?hZ9c1!rxKwFU(#(jC0`+YREx*# z;j5B_uD~GcedxOGMbdSNDCQn0Nd(&yj5=BI!KO9R(`;v-9!h4XkAX?~Br+T0{6SXi zY%{^C{KpLx-tuz0m+*$()qZ`uCCT-y%NCA>i6Ne!qtRUC37x8)$7HlZ0!pb0VV$^p zISXSMR}nKIM+@Cn1CczFYZ!Fj`qe2viEc!y{ajIgN??{y;n%Ru(;YM2x4EcMR=i3r+7D`UO@|Jz@H1slIlnz zJkpy)!f*=*&~YPF5t1u-%lJQ0k4k~U$@{AqLfw(LA$UP1tf4=c`{LsgY=BEOiZ%)@ zlGyj!o-w%wJ&0!@se(`VUI&PNAy_1O2sp_lmyRXeLwl5T&}jUiNqB_xQRd;>P1X&~ z>B_plZ6F&4fQ)(EZ>w|T##$TnJrr|a2er0++1n-WWrjyx4=%_Ua-aO*Hc;;&dR6cf zeR|cfG<;6pUzWt0KPA)8zslEdNvSkLf%HawFL-*lJDWnNUr1L`pmFbba zaHi4Q)2!utCcf4w0qmvH*QRR#!NRwSgZkz=ff(wrgS#NO{14Qy-!S}H8N0%{ptQTana0d-v@Vo(o5>7cg>%P;n{<4I%TVVbRrCC4id|-f-TOJzsW?ZnQ5Bc9Ku!rUcKfF)Hjs z%G!vX5=_*hW!^ktr+^O=B3=O192U%*yAd;J%Hh?RjIARs0P1dM^&*+1bg0bLtWLsMfD2cWtr zGY~HS&5j00JG_9{#`gG3K&;rx;U^eL^CEl-RL2Gi1-_gKh&=+22C5wJ-!~bN>eEzL-es0@qwi$f^K25~`neQi?wf6@Yx3gTBchY{84E%5QA}3L^r< z9CR&A_4%xfEeu~s0|!G(Wqek~-%zv{)0ei|nc6s5+x>!i{Q?m4>)IQ>*!^qGFTdZ_ z9(X!2Do27lnSWOQa`2@P3-C$;jkJL1BoO0#DaOR0@khxQ`)Xr^KBO~VmR*-Q&qn2cc^^5ayXh|f}Sv36`#9igpF)m??f6UUIqM} zx7HIg`iS)#6P`&0rGtjAYc!C&YP(EpoXg4Q*CYq*{VlP?Qjj0rs) z<8tNAef*x5Ey|&tbUc4&v)lfayw6UiKSr9bJdgSnNtz`d|R}(VpeYJgga#!;b zXRV?1cv4DywfjGxgu)`;XJT|cBjgp$BGkZm!Q>UKCfGsT7zW@;q_y;T*Siy^O{^?_ zbM!j~B&Xl>d~*&=yS9BNyjFp0eFDVQ|D?yeytg_3VRre2s`$S~shNMl=Kr(n(6jss z9p8cdI`#c~!_QhG z$eHyLEt0RpiXv2!eK)D@2G)-gxWKM0${M&hj73UPt$F%0y5D(x z_#Av2cVgNOOSC-ZCF%>Z2J2tx-h}k5E!89cdIeGk4qwlg?G-d}%YX%b=v^HSN2~9y zKg84n;)LE7U+HtPZY^X+92t3*Q^h^HwGkLDii1mXF-o&AnZauMT;fL1BGD{JYIa{# zUMM@gu})`-wE1Xd`!ME(={OU%^$!{tzL9MDkg##M<#N~MU`&}*f?qJn@8sr} zrri(w{!G@!LYRV5?^}f4K+H(-_=aK{&d2BJV(XHs>KqFmTf05sJiKDq%e$>j^PrzN?|iv)k^td;W38bPR+7q4wk)@y7A!n@#*-Z?=wvJcfQA5Ts%kogR(mV zRqvfTzgP}15*CFl*EyaSneT+9B_*{dVseHX!9kqC=gUutpMA9!{um;Sm)Q9u=8MR= zpokT1A^JIc#ZJ!7=E@abegT);#&$Oj$8g%=KGhEn&h4j9+_Ac2;XyI`=jUbZb#Z1h zj2tm#yp0%znYXTo{`IGB%SKcCRiL?McJzV9;|Av>NcO!H7WO2_iyOO*vTWFqzCo5H zf$zrvqyj;u_CUM`TQ44l5r_jtBZsebpqcJ|qV^jOS>gaxFAN}w^khY%l=lOdd?;4W zSlDdPP@R)kq~q?9hpmc zoN0<9+@}2#r(6YS?C&?Cmz1$LcXWg;T)7h|*7WH7of<|sJnSsK)fYBwfA!Zy|7xk_ zr7tC=?-WsFtJf+`6N#8{Kr8FS>Em)f{Ft#V#-MD@DdPIxv2ywDn|0r8_j#5SgJYp$ z0ri!Gr5(H3(q=@UV^sPR^H<#$L^1J7z2Wh07U~)ADI6<=XrNY&*HlF3$cO z80L{TLlsRnaC?+{)LG+tJ#w$ngoZr7SER=6=6ehQ5Z=+l-=<9Og(=vGV=3vm|BAZZh8rM2Sji| z8AaVOOg-uG$ihZ(39S$VUvGEm!7CgPkOvVa@tvVj3+uq*sC+^WF85^e8x{BrN_-hT zgm?=0NRPJ{Yz~1jBuwriWStu{CSxm19-Ux!190P7c^Fnd$zDBL6AIW&VZP{nr@x-uV!)>z}`FZe5dWd7wjgE#K@)jxu$VKw-wBUdz@tT;xwU992mUC^NwQ z7!2Ghk+LMT=XCw1DNTxRvvEE%Lj-tli4(k4f0QY$EW(@o4oA_DeUOzeLns%wa}&Eu zFu^>bpEW_RkXp^)SU0tBH>S4Q9H!2n!8Lw34!W?@z5dv^?212gH4FH4SR`7w>Hfp8 z_~r5E|2`)BBhCk|(fJ=P$G@x`cz)&qw(qZ?5&9PF;U60KUp*=?G6KiIZz~k&fgZ*B zx2hDC-DMS=(VtS2lUvb+K#2*Ed+#B7iC7V$oJC!z0!6@uTou77ODU_edIjVPGZX~N z3DupaJrz@(JQOFDLQ5)(KOQ(JA5Pc*m~^bqI-IvmojVL`9ZE~~U$QzPuG>y%C= z^G&K2ky_)yISfz#o2l91;(I&p{Di13rfx2p!_pa&vqaRed-`Fs;)QuWMPk?=reSE7 zj>YhKj0>f@Vb|x{$g4|vB}m+9GAEe)_~X|@_l$F*0gz_}86ZjPA8sxz1r~{#W>2fL znu=4&KeaRVwDi<_L-%^0tATUkB0P!OlAP7`oQZ-Eh-b>@cOl?2B`TccZdcqG#FLx& zgAH9pdC^<%B}BB)5Fmm!Oi9GtHPYMGLkuxqNQgKVcyy zSt|P*oDs$-oES8HCcq> z%$&81GwiPG_X#~K-xu!hy_~avi&zg5Vs6yhY~>?T4D_T)Ab9|(d{!17gWq}vbx|RE zAyPZNFj5RCU5U6*Di~SgzF;Ex_c&VLPn>%afe>{7temWJpL8k1!}|aat9SizQDxt_ z)?((}-eQAcfd>h{5+9IbWC)xaJ}bRrf)yA7S<%NgH0Bl822Dy$rpb1!M5r@A{~YHc zSQ}=rs^wOM05je$z(Oo8&BMc&61d!<*UfK(bb^B)wd%+ca}8y3(#gX5@#)^t{8IhH z2_eqCrK~7^oVL2Mr~!I{K=wBDnjoayFIclhe;^ z79QCZGxURq#qMeq7=@~~4^yiVs;E{Dp(CYD)Q=(P=}}VZ>EUym7N7TepefmN5=ecu z-NG@VpmZkWmL`OZo44Y5&l5CgtZ%)8n1H&C)!?U}C>$>kCF_#FVGopW+j6!UTvWRq;ZbwVTv(~0(r(pNJ6H7yd+0f*$*651! z{vvJEa1iN+MXCLU_tNsLj@5`r6`e7n89?;NqJ3?Ouaw z!uz7AMpZZ1ctt|pP1374uc?}YizUxUzv(F25cVTtzKm9q^6gOOEalyFX^5EvBl-rc$7uIfLfQ zzekDrUiJ%KF?ogNlkpJZeBbnUX@Q&GX5K447dPb*UOxVm!y+iD@PYyR^E*hZvJr&v z4x+iXcTfh|b#GHi<-e49I9>#KUGayL5hOlgrZ+E5`5)s>M;GzImTy&>0I@1LRL9w`&Bz8wEJYHdpV(3wuE4(BhPUVc|2G3;KY zoDTb`QFw!EN67vzN{Iwe(nAwOY;TCB53Q3f1_kwe1JWmJ8k)G|u82i{GB;Pw<@b>* zVb`ftWT@3*j@Es;>{Wd|_o8fF&G2&5kj`Y5nN>=U&R~oG4wBDo9{NldKNEg1YYtuK z%JOT{uyvChNo@-*kmKgZt^^L}ru%8_w|;V{0aD+LC54*=A@Q{eSX zW?Fn#+Jhy2jPR9ETkCUCYiIye$T!hwcwbc%#@bsk4c3f`*qC($cW;k2j|UKV#hl!K zp4}E%U$BlK&G=JEhnSs>EiiR{YZN6EvHY^{Yn=mRv{{_T(+=qay|Jmi&ou-D;nfraJKiX zJu2+`S>{O9KEx=5YtJf#p+XrLH!O(XK=TL|XV_CnR2_6-7pgwKt0&;VpI^0-n)U}A zr9M^Ud1YANU4el2qOrU?20Mtvv2JhVDk`A|VBq)6)za_tY^Z3MXbQc3+SYV}-Wn(A zRL<%977m?rP!l|5)TKe2D>Yy=u|Zt^nI+9=gj7Ptxr03q8m-(n9!s23%v9}!;AS;P zN*$Ok2Fnw%Tq!*y19>kL1AJEiY0u9n(uO4e;5|`~ zIHUN)!09Z`_ccPRV@}QbZv&4StxsA|s-)MYF0`5CbS0eqg^wc=+ZW#x^!M_391BAS zaC{Ly%4-`aZFB1~KQ%rB)#ZvatE5~ddPgMsJ;a(}ZD-9p zT2e72v;6~z6lzcFXQMv);#>jlRMLGG@aFuV4NMX4?fSJ54>9K4*l-7Yz$~eMHaod^UfMo}Ln{lx3;>0o zZb!IVnrwy%*CrK!U>^?G)_P4jlp{4iGZ|X1EjDU9sg)Hd>q5g7;6!x?-^*km%r514 z2V#jpVuE2%>Xjz#YtL!`@+dM@?Es#_jHohSrx@Xe-UxbQXd=TG^{S8{bju{Tgw8MV zCRKNZ3YhfAPLQGyi8%*X1!HnRJtls_sM@(I@*@AK>}XHq()H2zDLgDU0=GR4ChM_7 zMa)?2;rjFL=bTpEJCNf22Z4h}kRrw6Do9l@7SMN~xbQY#t|(=^`>Gh|bL}Wv!>}fE zK&TW83*^ata$sTi*S zm57>Em$v-JPf-eyRoj#Jk0f%rs~kjM>Dw@z(1p>?(_`cHs%mX*7W=;tq4RWw(}$9s z*EK?+S&wl1aP7IMxP6EBU1Ytn<6^J{-xAgDw7Jof*F-hqqP?9-*98OMiXPQnULi_zw?Szo7Gfa(`@p0wlk!f&U92`4{ew z?jI2n26`a##PGr;vHcAq`8Vp1`L~@1FYw2&_{dK?8h&dFga0G{$NC@mKYAcX`E%>W z-zmAjNGg_J2!($INB&m--+>Vz9rm&p;C}^-{JwqQ_YF0`qW_5n{DW+JdHu=C0U1FS zeAb`u*)-UI+lPQhw1AxpBmrMYIeJEo-zmbMEFjPnNafM9Y5+MoEqdU)pZ53+bQ&+l zjKDo0K(3Af$npW1J_aCp2>kMo8edpEU|}r=c6{Ilua{bW>8U?x5{;jI_7@xj1i}6b zI**a%Z;Xj%^wJBRCw%M~qFI9>^mV!lpWj^LMDL@jGhQpHzKZHsLHD%<>m-1KE<`{F ztNvCL^uV6tu9eYR1Ezr#qd7-0oK(k>sGdr_u=_Nphuu4ngcImCku%#<% zaJCI9M?Y-__(mma6_h34yI3FbC>vCf44euS6NGu+HyNl7oz&b^pHunB44TglO!mnd z*u?3XBY8o=TO6Q#wUPZ+6Lh5C@T@_5wX3+bz->J0bT*~)Ab7Q>Z$EOj0RoVM(oZ~3 z1|slpf(Ny-T8eud=Zp16v_3oQA0*XIIozMlhDlG@yZ7iC)a;)^w){HSE9#m<|9!Bt z{DKJnU&B5uf53D9E7%9PVdT}X4MaVGxci3&{#OVe&_9{}gniiP8GqSpD;n&fY;K{j zjrr94L!ZN+EdtQflVBg=>2dI*0q6c^w%q=d27}BeYSv#9pB07}5&uw?tbZOvtQKyZ zp%^&;-Vs$!xg0+CO`Me;|3X!@`dnm5;cT|pWBDb9Ql4W{e+K=%w4O16{I*K`BhE+e zm3!{vbI#*eh#;~M5w9>oG(s|a6Xs*`M&pDoaMKr`+i~?yUIjFNg!C@(GP~|9;o9ba z1{oZ$o<*(CSk5>Q-Un6Z$bI8+egae|Kre0yn0CGz;bc4oyXn?`RVJ8ykMo7?f%=oT zY1I?1`obIOce6{5)eT6+E07?puP~ozA84b%@SmGCK|s`%xef7rxxUnhM_4MZez|A| zfE^eC*dE@-YOhJsLydcThV}7KUh?tHfv(^}tp=qpid;+eM@r_LtBD5tKrYpHkM~%M_DtlhbJhoTYk2EA3h7OY6-g81qX|uNto~-WL{XG) zPsQt#NI$lavH^2Q9G+H4+)&J`m6O$n#qhdRl+;_%+0%%*Hdwt9%ahq17kgNJKk8($ z<98g&J0>!nkKFZDI6!G72CgO|{d=!w8#|p@jMn7_H#=Pm!Pf#N_?}O>leu43uNlH} zhYxoT(o){LS(w$kSI!`qD+&9uOymrZ*f))gRJ`Z%hc8b>A(O!ehfMPb#6HDcg|PLv zVRz&cPo>TqoYQJF@*L~5>)ON-&!3q-jS$SbzKvix-^c1kM`E#DejdRvb~Og>n=8A& zh&Y6|{rc)jK6NA=#-Hc|p3skz0n0;IzN*no9b`ccl^8lP^` zwbc<3TArKdVi^*{9j1hZ&>mQ?@@@gmU$pm*%jYxRsbplm3RfK^eg<0|FT#+y)*X|Wl4LMJ8fT6)PLx$zNA?aNDRZ@z$L^vimz2yj)hNET{DEh zEr(l~S3TTyTPwM$8GNet;iR5H1Q@PunO@1OB z?M)U~-=Gg)1%EW_H8Hn}psrS|TwK9$*``^vBB61iULmYNmAUQMlZDf8c9;p2k4SAh zG&P%R7v{7I%~6KXO^w%GT-ND7ELW}CK{v~W2)S}Y5$mkA-O#>9vQm!X?=3zj{H#5} z8|=OhSL`dXSXLq9g$KDG6tulnx}1`X_x9pemz<5M*5=_(~7(fCOYmUGb8eYCRUkLEWF4NG?aSHa(ceEI2vrOn>&*R&Urme!<`u` z-|O7n@YY*3OmJtTf~>(o5}C(~HWqv#(^cgcn?kwjLz@~MM7=zA$!4cTL`WQ0XfIol zZn;dec1N2RX2iMr=Ys5`i@uu5`pJqBeF#NEFV&TS0Lh`cV&WG}bT4W{j^S4^*4DO` zA>Fh!t#+bS1!`sQr}j?79$V>Hh6n4dTqu@DebT^;!BkTau$Qox_|~>hRxT64&BHkx zXKgCY{CyJ=OTY{Jt6b4k*c67OS-plm|J%CEK25yc-bklx#$aK3(oed4h*^5;SsP?c zqG*dVPR_+~kLgDx?_r@*ODy(BPtpq7)*Pn$&WA0WTuj_%PIOoXI97b#Hx1y(Y_O7H zxkgIM>~NL{3aGeOv~|RQU+p6dQ(G-rg6+B zWzwLgnsVJNR#P!D*0F@>=GQC^!tM2tOd>GvSyWFVC=+3%=2v%;u&Ld_FM7bg(dXH}H?%2tbZbU*dAnxtB8BzFGaGq}X9K1@?Oj}EGgbybg zrxM*Q7nHFZ=&QeRF)Xn`i#O4!$eq_ab623CZ|4}LtF5+JB$taN>z}l!u4|Gj_jG^% z<8tr9#jao!J6uf-?TqxIbPLpJrzqX-P1>gDS7b7HrY>2*rU}C=MKe+4OdakP?E5m# z$2SCm9Bps+2;6Evso>JC6FxJy$Mi~2BRCh3>$x5zXlNC5DwTVcXNd>Tom>`q3hme$ zPdsWsJq4r@lFws^hTxV?qC@P*4!rYLf7iw`v!FVDv|)ipRU z&e17d@Z)=!qttw3Zf*j*SG{v8Cz-m{5}V*@fpU%6^Vm?S&*AlvJw0{Sxn|@TQ0}>1 zi9_atc!qn>7|qle^qDjuGnYooCyU?2C)!MMzn)%7G%k=*$}&V5Yp159wVNgT4WI53 z9(Izlqhg%wOyPLG;-^S1V-5gYYT>Ox&(oZ9-OBmdtyelmDk?S<(%U#ayPRTDHCr=jd=3W+0O2VrupOebzyDZB87)@W5f2+>i6cBo{#$M5qYUtG+WCl$5JzXVuBuL4SUnM zQ;zhr+QhN@X&w&8N0~lbxuW^qxh0ScL0NO%)${Nk$jkN~v;c|%MKnl{e$+a-#-0il zBXo+*^91NuSb^x&J?#;Q#!>L0G@r87Q+4(i!OzmHfF)9_B z<;WBC*am18D=JZqPHK6ezq5!9B}4iAc0bv=8?ZY_S_Bbcz!DQ-+i2}2%EE=mI3b;Y zT_`6bN1GSJ@`II^fxgd8_w6(PJQ&X1mwd8KcPYTN$^#+q;)<;KBEK0MU5Wo|JTUUy z0)FK_7@1I47H20rG2VXmABEkgq;EqPy#?E)gWcxX=jOC9h(!HG8L>x7liloG=#&Lf zT6e>dvvEHXniZcysij#<*i=av^Y&)gk6UELZP)2!bd!eRSN8odLJ4Q)^2y*kzGh*0 zlMe0nhzL&f!^%9><6?HLFZf8h1%u?4z9LETl6;~=O*%&kR${%4mbRa}=@BnZ zy-2aBnlesZ;c?1R_duM_dbEIvvN%%}490b8$@wV6x+`mRKMJ^&d7tU7v~(4!$%7%j z#9FkgF5B4)%Z_Vlv5Io6wYp~dy=nhiKFR6QIS-*Zj?l!?e0Qyjl@eGa2F?Vu+kWfzQnYFTm!jqJN%?ge%qdFJs6W@>U;>Ji{L*wUpyf>6I#@ z?tV9a5N|V9{s5k!SVYZI3eeKV_`2lwV?hGl+hNudm!)QFZrBORD(77rNU|#9=$A`( zsqRXI^vma2Kkx?o00mXfbbPwl&%&rKjzj;W)qp=GT$HprG%w$L1VoywPk8}Ew-0}&m(Rj^pEnmTu(QQa*~ zGFy^Me2kzjYQS>GNzwc@2!i#Soc<9QN(>hl-CM!-A77Sv=MSp1-o`22a^dz{5yaMx znG{tkuncdPt4~h(=!jh3Y-HlxdW1O7eqKh5M1aRziowuG5PaiKx-F zCIOK8vL3ajULys$^+uL>7pH%&%&a4~sr@Qc_1T9eS%sN>R|3p0FMw$0cIIsVq{VXY zaDb&2Q?ZsLIX9(1ve|m!b3{#hP=15NH^W3a-w^?tpvhl%+)0EJeTT%*^M^aJ%o+{rx`wJpb?gdOe=GI@@)w<$ay? zb1a)Gs_wj=KK$j!eon_iLI-AeRxVG}7`%+ty+||jptp4N{Qh-Y8sFb@T(@%jsQvbA zh2=({Jo~NoGCW;fyd{v7@BBr(+n9Ve&PKm3?e*y)N{UHOf7u7&TtC5_*$cfQqsUq``A5A2^UYqhyXRbT$yuG(CYe)I=vX^OnCU>pBKCwgL<>c5E z@^uq)F2?Tf-*ho;;uH5umCg50emNVgH+oLI|F&%rv+}~2)#FsU*VJs=^ngAm{>Z9; zhqvxL`{Z`FTr0@;!Y(gM%>kXdb+y)Os*jH!pmue9&3A`^)}{>yl2XFL-}L?7!OL{Y zts!f|3wuHE8FzfX;#`BZ^SqQ*8#>xCj=$-peJ*0Qvsd}C{bfD04$ljmuO<^6VY2zs zmF}vIj+t}bhC4*XePVd5E2w=t%=VSq+xD-D`(Cp&NhR{ubgi6_>2GN+Z!f!ADk&#G zevf{Sod({T)Ak=bK8^fn6fh`no&Bxz!3)|oY^y0eI%}=O+Mwx8J9bvxPUFzosTHnT&cyWH+{_`G?%Sy{*J<^uv}*eEMY1aIIt z44k^j{Z#l8N#?R^d(5V;Idrn_vDfNR)g!e(`Zm$ByT=pVd!OA)GRQ+sHT8aVgI6TX zzWl^*z@9FZ#Fm><)(%f*jqtnS^7?$k%{MDy4?VNG>%XEVYpy}Of zZ>8R{etp+Mj~i;S++YoP!+hMjv1`~H>6O_BoVGW;{rEC4O~o##`+=P*j^@kN7muR% z)Xj;1WEAk=qLys#d9Al!&-baHSr9O;!{=ibTN9@*+}qf=h}3FgUc2UW!TQQB>&`3m z6qeY&@sXc?alq%MOSLgW=rj5sc`pBbaO1}MnJ@iPmz?*kcO7xKVA0U_GRX=V<0W?~Jh9DO1v|+_E?OhRn#p9xUB*?)#)*_}C{gqiM_4jn@tync4gMu8?g> zyt@_)EbR8ETOGZ=?8H*NB{OEIe!KSUu60>wWhJJoKG$d#{09$(`JR59?nn zds+DK)y+FeYSwAP}d-&>o;tr=Z+VZK3%g$@>XY{hBXXi)TY4fbUOuA=7)MR{JXTO_wjQ(M#Zt}qw z<it?5# z*T${tm0@o;Xm8I6HFNe!e)`Ih@cqg$JF)(gw9E+WG4|?pZyh)9j+pHEJX&|A#}}6i z%iirwihp~tcJ#*f8^`SO(b`?)yIgKWgWQVYm)Gs-;h*)OVw;=$RfV|Vt%@GsYxLG{ zvq&?!zj%M@F1K*|a{~$APv=&I9h*09;fcbj2RyYjrfF_pvf@(s{Wq3nm2pW=D|vav zMawrZ(im=9+a!a|6()Am(|kU~|IU>qzW&Rl)5ngeCb{ktR=%t1vDRV{i@U4oSDsZ>iYZw; zr(H?AGKsr86;^i}uz3GiqG{8-CAU7Ou3vlj{+e?ssm#3a z@BXwo#r*5$l;C0-|L`vCPO*O2owD?Hp^)!4h0pLpRm{{0D8^2a+t zfBuCvuboNst6_d~Pli06u--ju#8dO#J4$U6=F3};luBDtOzWx@%dAqpao<*Hfo6K% znhsuF?+-rMe#17`M?ASFH62&CA8=UK%;d#WiC8D;AqCO>JL|28l#lNGb$#s#$-{#V zo}=GeP_cVftbDYpLL=EYwBd2l&_=RODz{5C|4+;hDHXdbc9+T}seb0AAE?+^(WLs> zdw6|WOsSmbez=-8wDF15#pnmJO>l$FRj+j9XI1`9wq6w*dqtZ?C=IHt@!t^sXwfr| z{n^srYrcG$XBqAJB4SLQOHcKm_sI%~>iWOp4x8E>{`mwto7xNg=e@80JAp2C!28!H z(Ai>}$F1IqWQ*-*{=I)Pf7pQj3ZLU`LN^0NN6@>SXn*DxM(|tvobc^BF5ZjOWO10{ zcMq1sUSz+ieb0nxAAcX{y6V;2i`U*Lwu%G@2sJ}gO@I8tqN%8m^qRi4UqnzRAVm>=RTTDmaPYmw2Sj9#NI$_*_| zIQd{!t!6=N=6CmdtpF1*IE`c$3oxIPa%1w>u%iEP+Wlo7|Uvn_9>3jb`sb@WQou2$qwnM1&clU1d z>l(kTdXZ)RwBNg2*o_=0;X8r5@|& zqYivgSaDQCw+|oQX@8-2^$xjpn%?`#-0>Zg7YsShl=qH|WTs&&h zNqe{CljCKLy;y2mYUZaNzAZI^uVuVhZ@xP$EA4aoB_D>*v620^sClp4c|TKa|FrXF zS!W7*W<2SWacxX^=Nn@UJ~CeKTb2K6;X$LPE++rCj*FJcD)QWp8b2(CZaNOXKO_fDKypt~~$IM;yICYfg zosor$q^`gJ{`h>*(_;GY5xaNQjqXz0xxKlJ!O||$^<8M1g{zw4#(CvFG@F`{G}OH7 z+Vv0aXsSA{n9NHG^)2rgEPLi#=DN_QUlpIt*i&1cXc6?fzQ&1_e53gNgdWk_!{cAw zxK$Iho2XPUDXkvRH)C|tRJ|E}`##aW;Ze8pgXgkW4GZ5S8=lD6xbV$H2e|TM8$U9l zZ%N(UryU(4$t7JnuNh7^4E`udRwfRL{%jUAV$e64_})9a$KCA_CqLyuT*?d|bNQFb z>jxK~S19YS+D2!M+MfHameDfHa{AQx%pImY|i+_ z>uzK_R!=$Wbo*G39v2&!I%!$HgX&oFebk4I;V#QMX8dp`QQH4p{kah3iaL$KJ>rxN zFI=~Cde%QP#@Bn2<0ST|z$N;OQ<OEZdlLUx(Z0ON* zW@8peD*C_|wkHpA?sK1BJl0t4jn|&=cN=cT8uQ#Xk9SHR#V9GO{MaYt&{uOeRVRmx zMWv5tFs?+H-70=usj#Q8=bY@8>sg=&J~qS));2a7ycVDLJa=l#jaP>deBthGByOf-}AKOkOQARIWC#xLK+@d09~Z;yS6@!fIT>vKv%_{{d1dhaW9-2z5co;{To5$|lQFK-s(&NJ@x?yynH z{_`(Ak3@vOO|;d^iMspv1uM~P*(S5<_gTwI?~N&`NxE9T;bDKfCmDmPORh5gi#Kl= z`Lvft(}x2U`#*Ue%=_@+hC0<(7>w-hE{aqARl*T0X-&fC>fPVX(dq_o^D>cWN%w>PdVdVVzhf?bmV@4e@^ zSg){|_XlTgT5#^sHrM01^rYo7TN9NZZ^)WBb?KO`UPp$=E8Pn|nO*ks*u7)z7e0(x z)c$$(j!sF(t#Y`fev-Ot`shqkS$L}Z;`Mr~uUbcVp31(Tnf_%=-dXi8y6sr{(6m>oe%-zd->esrb))U`5r!Yqu2Kyb!nm<>9Eg(p*3x~?u3z@U4lE-zpM-JExMZQ z*8j4b?E9CBkFs;3zrPtgxJ!q}n=d@SlY2soC@If7HQm>#sko@-Xh+YZQ{_5xA#z4_ zpG6uEaQH%OY0uQBhokaq z7bYn0af;6TqVYtIY1Se8ae?Pdm5q9b>T*v{_Oa}DuUAf(hj#QEnZsTCbQxGSAHJu5 zSkkSF>Z&*6&(4pCOY7siJf<}M)ll9B(zTzem7yXl(UH}#K+o}`DSWl=>y3>Rgkj3zyx*ur5CaVp32z;(CRS)SLvtjs!ZlM;7o z-F=s#S%&g=PgIQYma5&VpY!}eVnNy5b@O7o7WZFX@bHAusO(kgHLqUMZg%cFR`$_+ z`IqSr^9F?$M1kk&WpZSb}u^P=2PGFfXzpy_|{h|EYNZMIDUM) z=dS}pK3RTg(D8fKb;Y&F$%gL<`MK?Ebja$P8>4MjX1*W}<)sGbePM1n^6uI3!|{tQ z9e(?)_gwEi2aZJqDfjO`$mfemgldy&0GU%?WcuBi9~T&&n9Q!bHa^?&OGKaNy~vZhJ!fPSI+a0+ zXP?f#YPn8fnt3Rj`6R&aKzc$5aiv$Id~VF#DRE^3Z_7nDdw+)p`HR;xG zWUS0sTZ=5CkqYfbx_>EuyKl&GN;(79p7L5BaEXQ~ir>15! ztDE&==`F)oWY}!`9ILBJxAV5(tk`v-a<={5VkP-c#-rk|XIU&Om|^Q?yLyRTey~@s zg+zGmaJ?)0813d0(m7jpcZoF42^?kH$tK-rsh#7P-g?!CkCsdB@744EfVtZi&D?u+ z`X2h^!#B#L-sK%SIz3ijrHFGmPrYMQRPFIt?eB7>QwK5nT~$h&zGwBz9j4^n&6byH zw)VFOV{znG*bEyUI%DdLX?a&Rj68PA=u*R`>(UO1g+t#=Pgl1eZ8tS}YE6tsbyBcf zpY0s)jM^7kxuuW1neCW`lkKKzjahqa>yzY!$=$0OpPWClJ!Qk5RSui86YLL3hW1vR z)aPM`MPKe28(-ojOS2!Q6G|4L!;J4uow)+;QI6{8YrkLmogBGqo~LoqoBUN_P5Q15 zash`V`&e6dUzJc?v%s35^FE$EXmjDMLbT6Zoe{h3=4H&fWzSR9+q{v^?%r5*B=JMZ z#jam#vK13+BofYc>~K8#+SpoWFEZ%8EbBs@{IY>_RwPEymvl?Dpd^aa706tNDM}GP#lIg3^qfVh}WILmd)u;WgC=M&N z^C35HH6iTYY>j;0VO>G`?U7Y;28B4qF+Hu89q;hYdUnFLyCN$to7F1LNhe3&SnYerUVX9C{WTR|tWIAkzc}f-?xhlqgOBUpm8WE+cZnWw zy*4_lq0GJR^5@5mqx4G{TR$84?ir>&?1fc)xmK*gm;E7@o27C-6fwd%W>#sESDfN? zs}v=lWsH0G?&wN;!(p}3gLdtA|30+)*633W!-u%8RrQ{~bV;8cTRRkzQ;Vd7(-?2Z zW*&K8xHKau>R8h3)s3;Ajt{ohj9JW-)XDEq*J)+iR_NK>Mjoz~UG}R>kr%k6v`+n@@`!t{;>N7#lrG3>n z98+F7V)n+d6Q$P5?pWBNaMP6HiN`n{H@;W=a^j26$tS8hr`~t}p0}h_-(gkGi?1Hz zEA@Kxu*|MM{^e+`7F>V3zfgAQ#oeEEi-%u*n0+K{k)z^={%1mppT8g#3>}MXt77gM zX5COKTHziSbMexP;ZqkkozXaO;iUOP(~&nj1szqd8fN&RUx;kDmP?njQ(`lsw?UBB%3BDSb}n8tSBtsP4MO)3T^R zIrT-?o7Pj7c0E$=F>mBG#qwSO7Dt8|uXQrhOuKYzythrHVWf5G_HG>pPu^MIv|*IO znOTQ)=bkk*RNFTGW|tfE-Cn(4WUEf=vbW#a_`Y838&Rd3QWzQM98|X$+*_|@d^+chyI~9*5zsAt^6GV6r2*qw-lbICc@?MWr}B-Ttt|W$X#x-T6nPpD zG3oSyOBXJl^LSGl>qu3TR#SiVZ|v+hN6y)d9=PPZt4dK`0E{09-L3}Qh6qKRo;g&YNlb25J|OE6`6B=ucvaJtnP8u zAhc@rfO{3QrC3X(^5udRLt*+4yzlCn zi=th-yPqEWDOGn$*UpW)eP&hEO9n_JE#@xm?V=_XTCI1l&Uhdxvt@}oF{M*--*Y1$ z%f^KC=_)xux?k@@17g@8W$(wnkiT*9%H5l9n$|}2xZ6~7xawZ}4r;UX!`2c*UksF9 zIXI?ph?%rAOMQy0?DR*9Q))Xd3#RGG?p?g~XzXi__6U~g{B4SNIGGZUR>=fZC|1>f z>TP&u9;~w9Z$mYu$n^Zh8jIL@@4qha^Otv8xWG@KFVDfdD@^!o+V3y$v(Z}5Uq96G z|G>2rrr@h` zO!(>@+&V#DsKeJ&;Ny3Kuii1)zr3CT&%g*iXeV|(g-z{`IPgU%TD*t5FnHtS?-vIN zHb;EL?&s?%_72^XkEw+p*4vjY=e+LlsC^84J*Az@V!FaJ4F&s;d+fgzoev|H#(CWN zXrZ*_a(0i42SQ#>I_ow(iV+nwkCCa>$#2$COQP$sn#(&>rcl>Ys>1o#Q_OcwhU+OA zTUfG**?08F)mx@syt3B3rq+DV^L73m zHrqc`QBjVvu%BM5+HT@Ir)@)3vS&ZZX1&%raW_@P+QRg3YOR#TSlw~@Q8#*D)bE=v z^>pQvPMLl%!yYj^)&t6A}7YmEZwa485dQE-h#E`2)Y`VodooaWE9H^7our0z%Pm%DoX83M{4}Rqbk@Av4LsWCOYn1ZU6<%A_}}IcpVI=LzbTxcc!549 zwy}}P_Sd_cSMe(P$aDMnY{u;52lClgk+n7lUt~RxEH1Lw$*F*^QetS>rExj!7tkQK z_ktY4*dHEAf(K6MlfC`*{e!(RZR8E_a-pZ0c)<<~F5T1H9iG7=+0+jP^@Ah)K~R4o zm{gL6@P`IYqUvGdQkqn8Dl>_TYdQ+npq<05!h35am?qjN>0U-yUK3J z=uwvxi_=o>q)*ytvBPA}jVYC*R3@&tGnC0Z|2k(0Jf-?PZ|>HpYhQ8#=0(*J zOT%9nP3XD(b7xxx`O8hS?Sks1qQ3TAcER7=;;4z|&JhkolA6NwZ#^eFM=coh;LMqg zrn4&ZA}0r$PBwd97j>+z%vdW(!Fxnf+TsrhWBaPCVOqHIQcjQPeR$NF4d3_FuZOqW z4lTLUaQ05a>dBw<_tz~jaL6;9@z8L_D$|@(i*vROdK4Luq*x#6cv4A;sbM)_!`e0O zlSa_51x-_Q-*dRSpzq3}E{iXDTU8%iX)zAInqd1}>u9n0ozZ)T?B*Rx^Do(!Htp55 zEc?YXCk(h_H|Fk`eX1F^UCa-wAL2aQ+xPxPr!)7zTdQp77exQ~FeJNP^IpNZ(IsoQ zG3RHyXBwGb%O4-6ReNXO_jZ@ZkDtEPd(z@`Rr|#5Z}pCEWRrFy%v0ZOc>PVY!@x^l zWxk#Gnm40hMp>ChW>i_!HlM4Ja(A~VD$F?Gy`|#bp_@-V1LXorcLt=t50MKCxHV6+ z@WzfaxuZYK>>GAHWV>%)?;AO%UTQ0z%+d6^u6ERM(Tsqxor9g?GW$M|)=G-rB3arm zLSBB}cLmbP>guN_4X@0*H`(+$Icu*ZGu2Rf=eUePc{NUBd%mA(=5SjoKT$V>?jE#T z;()i*yz3)VB<@~Jos;=Z@pD1u&Jlqn_1(i~M0CD&*tKWX{-|xyHj$Uh7Zs^n%`ehs z%a^j=c6YCQxcls>X~Q#b>{fVRyeQpMW9OZ9_r`OlsoITh|tq@Bp^N56F{U_4yBw&KJE*(0O9R04NRqYYWW`A|P0Y&I%FXw9Z(%m({ek0WrT5iW z4VODH@TuL&n6hVs&nCROZRPbSD`ZPT^w`}}DxV%iC>0S?OYZMayg4V^d;5q(x695g ziQgR&A1TXu6)Men>exy9R$$kl4hAW%%5#&Ao?k7|V5CIkzU_Ga^vnRs+jXDY1x7El z7;WM^*dXoO;C5SzEZO-T<^5-LsGihhxi{IjN8rK6&I)Io=JiW49P%bJ;mfiiB?a1< zgR3W$I7Pji-$gUJV_%1DzOMC;9Ze0VuC40&@T1?iO=sq4CG}D2SatZ|hVpjo&_!Kr zFMi0e?BtSo)UZs#sf!tnyfk9Iovh)AekbRCaCUOG?Q`Ma=)zdb`&Z6Ly)#=pkT+(6=g zyng|^q#wuEbGOef`P>(!6PJ9uCz&5h3s}2vO?SC0^XQe?Q(v1p-(Rs=I&HT3p!{}) zy%$Ia4ZKLWtgNqc-?y=NNzTce?Y~@L#O)uwG`7lu?p(8P-06_hCebraOL5A(bV%rz zE%Dx?X{FUe9jPgG8|Ci3ysdb|-;^Dvb})A6vz0N+>)xyFjJl|8kTv-Guvy_YdD}=k z`RcDj&W-)3aqC6tqmh~^nUTzM{jN0TO-nE=`a(?0x4e02!%Us>(p2fS-2)#T+NSqf zvCpjaQvHe-CEs5dr+;d$`S9g0i4O1l$J$x@cfWXD$1OeSeRg(_BN9>>#6en5Kaua1sua{O7TdGL*(x1-Jcj3fGsguXX*~Z+;QeGapVpHCt_{6L? zd)wdA-COGk$Czi&dOR~oh8NLs@HySon6;O$7IT)=U+OvWStM`3h2h-~F81j6krAj+ z(lljA*|DdyRzK=o8I#)UOs6O1HL>#xk8PJaq3kisYMAYr0PV-7_x)a4viHr&n6Reg z>&cLiC4Rp4yALURSfsZ>bql@N?_qh3YU)9>!BXA^Wn4W1u#dY!xNZr-v^CUbfnoAd1K-6HoA6X$vQ!#^I$T*-A*ZnAiJ zS^wSAf)imu3h}A~#x=fXEIN_R@IP^-FnYgvkBfIpUU&6$W-f}HF`E_>=R}7=Wg-yb}W2u%hR5Q&{sHE+szD)%6V;; znLO^Le(IM{ABQbU-gi%NxeYoq=C1wpE!aUf;$8pHrb^ZIUxqzheJlA=QHHXg?$s;f z`_0?*%$j}k=5XsY?@j~vPrVSPlcjX?t@5iK{a#vUnJ-OG9B8w9SffUClc$~8g&_m? zuIN~BX33BbD}!<(2R5>M6sbpDjJ{m{bq%MN&-1O@WC~8|FEF4_tZ~9fntyA4lZCSp`M@_P!&+fwsBhGHiUr<%KaO;5DHM4!UA9(D1bC~=~ z!*A1qn9EC=<_;b*NXtA|`*VnNLDssCb3=NUZJKJ7Xfd1NwIfDTyJmR2eABYcD|b%+ z9=qK#c>%3#?}ANpT^`shIkBS2Ro*vhzHHO&)bY+ed*72H#(IyrakAos|JjN4)uzs4 z^V<=@v~=w=Uwig>A+0#Sn@V>q3TS5^y-#&~&<=}zo%*ae zcW}OLL+6b9;}6(M#Z9Z++SIgna-mczqwbsS4%x=<5|u&98aqCjOZMwEM!QZzVX2%( zk`rhD*X_wq2iQEhZfYtoko1uDUj4r7BB}W+jwx#G7|FY>sF|~6YEaA!%dOv!RxLbw zUiqVE0gu~fy`*XhuYb*#qoq{?gv8h-;U-K7ENovuz&7Rk6BmLI!PSo zHN6j<{XVd;v)L@po#2Ab*JM=QJeL+f$Z#%d{x6|NmN@~-e5c*6jg4+MsY4)GB*{#g94b9_Nbs-Uo3GqZdqoAt}D&Xb&9eRP68Mfl-- zIG-jqH4r-h^AFQgjUPXTzNXOs0u4T9Ip@;oMB{}?oHz&dw&%4L_8BLf!XLm)P#`bbiI$LKAuiAU}#fmd$FL;&|jn$m|Jm;`!KiYyL z?N%azEL2PVC6h|-_nPFkppCoN*^ zo0dJ_>pmu|X79(8{Eh3k^2#QepI&;J%RIO)$K%mZooBuZrr#KEV#T>H2N|DP9FmfdU0F|8Mmt<9+%M1% zYNLhw`T7TIh3hE0pw~FH;5Yg+U75zu65^wy%zvhnHpR*YtT%{90XruapY^Q`VJ%U)n+L9$FKPOoZ(LrK9W>5)!CI zr^A!i>S2U>K#(WA0>$OhHJEfJQw?&c1xNUYxP+_u2M-ZcLe)ckRTiCzMfJM4284#_ zC@Z6e@PERN`32&J{Dal`om6)V@S}&rLkaK_E&W%80>!xdp%5fMA>x;X+}&_PfuTXZ z{QkJR(RqTWO@pBvhcd+E7Hx5T1I6Cz|1Zx*&Weh+U1r zuwxKfOtzK=OHBj*)zGH@lv5-iQ5^w6b^!stx?w(EA%4Cg0nkO7hB||(t|?YpnCGYB zR`qq2BIVZXC7-+XKW;k{&!Yl1X}~xo|xgYMN|K9!G=0aB*R~@-_Qo zS+V{K>NWQd4sn5CMb*n@yYaXzma7_<=fP5QB}k?k$DQM$M!33Zy0JY-O%FCf)hkw3 zSg)X0Vty+C1-=9T6#$Xw7?Oa%paxHO=qLvPWc>m(#m+%exCqO(Xu(`8nu#ssQ%{!@ zA}&+bhj$&W}NfS>;e z#Qbl#tk`Cf$YuE(K4LCQZJfZ`^uKxyXSWhpXu!y(u4I^sOE}oH<;4kdvRz})0S?D z=0*X*@F=`+bn6oABeDao`1H`+mKG8e%A*@tQIBmI>eJBh&DsW@==Kff!4E4MgKn!Y z$Y*N>b-{~Z{FeA1+%pajF|`c=EzsRu_$31Z1trB=6r1||Yh&Sxjp_MQMJCt>n@y;* z;4OI){nk(?|G_@Eh#71jnw)=SADXcB%#VxzU*yYVm7DHdT&XsYhqKM=9Vn}#X`bAFC+YFse?b+`{!b4 z^+7Z}gb}DI42bLS16X@Z&!anBz871ZT}~RLg;~>eIhyo9!JG66)eh3*otW`3Lw0ct+6N1S{<{kI<0NAn)K1Z#SB|x2HF}$w~|4 z1qBDf0Kj`TkLC)Cr=Bn%_jjj-d53t>f?+k4M}zetS_Bv^R2Uwj{%;p*KwR#^w_ZWt zVuEb-9PdBbdzw9n3gm%Z2l~)LiTt|v+8~$UQ2tQt7cwz$@%-_xl(2lgbwx`1H6vnK zg*tCGpNr6*n$0LOv1YT1Ot0CjXi>k}OnlpHHWzY;W-|%BquG2y$7(j8KQAOKAjqfL zeBS;r8-~oyW^{{yuU<5p%NITT+-$Be7hm5%7x4OKbGn8Gd;9Z(gPYA5?BHXKksc8An$77KfIdRgY&Nmz+H77=UI6Si z2K|O&0)u$Lu*>m#ee(1T2y3=&_XvM@`Mr6cbLY+G`3AsdssHa<+HX`!?Fu%_B@Ye} z|AvVpT=fMs{4G!tgs^6t4swZTHV@CA7v$M|Hdhz$)W0!XK^s4Yd;S3OuVVu=VsJzI zo&iBWjt%%zEL+~JAO9)_Pwu>czw=l@`#%=uxBu6cL^}(@4N<|?xVdQ7K{GU@F`4QN znu-;?yXqej5bUMe>^|xbTe%F_IAyC5u$9Y%O>`{{_Nd?5s}S2^WorCm9b!2}^A3K` zs3m#fUhF^D@;7_2g3ZH;uy5y$(8AEyB{*0&Feo6vLks2-)CS>C=|A!T8kBwhN)@;=$Eq<0iz4|D|fN{ZCZ2cMGc)EB=?N zjd(#YZE-gV3h?8vBLunx1@q7}TSu9iXXAwjuz%zN{E51jw`f0?;t8%JxM;X>d1|gK z7V54$12%U#gc_6SPPn=<87!VAz~f(vi+B>%?k-XkCCrx8E>`?kwFk7?90bh&qWrI# zfy)|yW3_^6eo7ZrL7APHa>S5GxKVEglhA;m2(bhtJ~XWQ5qpr%M5hQ)dhXZIyJ#@gNKGzVjmvg{UtCvr z(u3rYJRZzh{!;w!+X(aG`NLrqge#hAOb#F6;IIfmA)KHpey+c-Bv?4O)rVLYqWhZw zEU5X%qJQ6nn-?70;JNG4soqh4__;`P;qf;;^nXQrzw3U;I>eO!a~DMxBBnhYpO{)K zjsMdg(x1?cguVweli9qWkQVqK__zxUg<)k%*8^euuNT&6Apt+6%=UK|9%;j?GXXHn z5}3PKl|O5>EgSCd1>x4g4mMozfz^Kr?EHEh3(*+HQ-6&;+F}Ny1^eQ#ei{g8=sdjP zoZDnH-~Wenku{;v25aS7<853#dBM62ejpV4!(VfnxdhvL2YbU=Xgf5S1sjDaON6c+ zZ0_U2f0O5*DzgT63k-q*x2_2~4e*PqL^=LikCjU}>VU0xB=0vN8{8ch@U_BpVP8!h z?sdX{$n6Aw6Ez?J2J~02U*z=qX)GWpAL{QNqHE(F&hv$3D6v0@YQ?=1<6EpMN+~wz z%n5qGFjy=Ran#J1L)S3ErTJ;T6$lLGE(Fz!z3teqGt$8a6VtUv`p` zfNhvdh?^JxyiE&b@SA3UkRJpJUSO()b`b)RxOI&Lr#)$c=4t%)`8pHNBvPlKk{|0q zBYIuI`CVZl{$KvKkRfb(fIo%&)J;*wbHK6HmJB#Wh4~T)=8Kyzg2`UqAp$Qn z)e`&jFZlnd4z%>AJJHlYC@((Qe5nv5E}MzghQ_wG!jk+yHD59a#(7K@OIQd|&6n{E z;-P^oE+wFwFNap<#ftICzb*A^U%=9WAACRlAJdr70e@EH-|~kT;Aj5-LSvL?v_xN2 znHFh_D%7@g1^z*shz6H`hPFhW^8aIfQE~9US!E(c|CczKDMI=`#my+JYKfEm*J(^J zcKtJ)>_4b5k)GRLBs1V2SorT%8KveHVPacW7@qq589Eb*vL(p)-=#Gj1{`xY)gibv z109l@?X>xc88F?7i5bBa7HW~hVX3q+fYf2aRcccmCI>V}2=3(m2~%o9uu*EN)e@g$ za$2J~ER{B=Ig$aIgG)$%l;%jmDsIa($88l{wqea7pJR}0q&li=Z5}R}WNVxbdf6(k zqr}qYypDyujsaiYG|*vDp`h*Sj@25sgI=~qcUUZKPj^fd>j-|ZqhkLbpgX2e3oQzE zMC+m*C6+d)J9tV5bjKtSW>QSHecdrA^lOpsm}G1G4vVF&>5f5aAk5?kEt2xuqmr-^KQp#jn^?aRE%uV%nnPXt!a+$b0iw4X#O$d zlva5h*{V?r7D}7cn+A$=cni4AJ6x;ura|FJi~J1>rLF0WAW@LxBPE0J$1H*oloDDp zKxrjZip0{^bjQa^O|*Q;z_H`M)9EnmwaDp2QfX_N<1d0S;DurXm>f`npv|kURjXjo z%hn7nMPg}dy5oBtd_oGmjzf)_+q~*p73vt&tfysOho#ciGzY^6-2Ynp=>qF@;XZ5qJYVj-NgdCf6fGoNEp-D{cVuvFTb<`^1i^^#;E z)#2^LHm^G1x)rM^xPL9v9WK`9bO(Dq!u@duNyUP;uRFYV(-OpN-3GZxENxDAEDq=n zAtpXA(DpUQqQ+A#(Ojzl6APuS=?y)IC=7LY|G3R74w!BQT(&OMVX3q^&GFBq5d1+3 zlbZ9iebu$lpAh1zJn_b3z@L8t1nJFrk~RnURa+(&n_s zLg)Axu#^ef!+V!)-t|NRZISly+Gopr56h*^X^+7I?STUt=y0eRQ`^@aUMp{j?y$SI zNOf2$ZB29Vu!N}&e-TsjkJ&lkP~hGYy|r!$6APuS=?$G}0K9}JqS1N^6++s+&*4J~ zEzuoxvsKX!%cad}PZKR;GWchTIMlei?JG}{QbUWB*Sa%BSS)Q$clH{ zjuc^MZBeYlQfYIV7q-uRb#;2$`1Nr6F|*Bj=vC3?e! zTBJ8zs;%jbjkZ7q-UMeE(7$NiPOklVbd#j>SEz=%utj%dpu*U=c{#iS8cr&p@zK2V- zOnbOko6{a!u)oSbd&#C|oNeFtFsm)n9xl}~?cri=O?ynZ*MrWap#4?&R|rRKUV9=| zTcSNtsTOHZRIJTu500dO_V@==;NL$+dzjT0X%Clbnf7q8Hm5z3e;y3}1>Yn8m@%h_ z)fQK5vKSdVkutitsJr7C9b1@7^NawcUuv*Buj074X^A zHV>Jt`<^0`nhCW`a}*f0QLkh2=jdz-hyF`-$6!(?$y%g529`@((;kC^=IAhwK_g9k zpuf#)57=&1z@w(IEz+JyF8@kOwCO+O5n!E-L{nFN^Q%^S17#a-t>qK3C0YNrGl+C~(Al!keu0bOi zgt{h&rb&=MXu?C4Oh>wjw=cXqMK?ju#TfD2-~kRg|H%@lQv=mWx8(VI!qeys7Rlsl z(yjPU8aqJWY0!KA|HOVf(y3<%gMmH1Vr|ir>WHv~CIxK5ZwCD4@T-U48Z;J{O%W)C zMG;IOP)8=BA_QdPcM}mL5L_ySMPqSr1)7k8D_{eGE8svjTmcsdssbjB1)EfYX5j8E zi$j%XGJv4U!zh^rXMly-fE!rq6B59UCawUuVdDyb8#Yw|6w##0qY{(=pa9%q6I2EH zHL1eDJWQ(uf9KHHFu4-^2G&{p-@3YVA?7Uhgp!{GYiaN`qH>L%exNXI6$9pm}~BP|ViL#ogQA6aH@N1#)4L z{JL$u7{HC7zwlcF2%G>ZEP>rX3X{f$o9KugAP7hi@CF14DS|Eo!2$wTph;uH0*&cah}>+U0RjQsKrj%N zVbL_W)X z0R&YUe3*lS`GiFmj?mN~8$sj1?t_47Pz(pR374BWunR9t(WG%8tB?S0uyR1N9B50J z0^AT(qfj0?E=Yhra=^cY1aQL;*te}0w8vrKBESutNEBuRZZt3fwF#jD%7ER#X;Wb~ zup2lGCnUgbunxg**g`YD9ExY~QnnBfAQ#vT7AG6QBGqXQjfQNX;=dVqq)h4_aEU`z;rh(c)sxgrV}6WTMP zfH5H;A__5vn*$H$!i_Ve50r)&!<_})!o#{a4Kaqh4i>=`LMfDk=0p+$Kj#X86(s>< zaAH;1001>tXxbt04*)6WTqZfH9%7APN{0>K#$Q7+3<;0x%|oa!5le z!FmOk=L*mn^%Z=cD+EVG0b@c3L===0;y$8)G5DCDumSLUE|@e$0b@dsL^+Yfux!Eg zxk6khzQui1yrF50%u^f6a^X;25i&<2u&nH05&eb7L^m4 z2QQ>3P^d6sKsg{pSPEU^g7FD60#o7?m>TqhN(06KM<@z0hP417&J_+gPy@i2a43Q( zU`!au5QXG|MGd0l3L~DmAD9nc*Q@9;aEwqDq1kpoT+yhWGq*BJl1XV!iDHSt8YY>J-4Iv&e z#`D|35fklGLbI4}3+*{}hq+%7I&WdaZItGc@lOTQo7a|gP1U4uuhX?{az=8si0f|`##epcW z_8vYn#R2YiGjp1$Iw2IqOyoZ91fV^&(K?}c(5i&#j-$&cznhb#1-5u#1$|K+;lGKJ4Hi zL4eaiBE>KPjszstR|1?4NJ_>8m^+Y^Y6&n)a9XPG1d2Brczi-Yyb(<+2s8n~SWZAL zsEA^h;71$mw0tDQK1)D05|29w$VFmQA)p`7BxV=-0VHOZA8oMj5YR0W8zKR{BC(Yc zAXpMdKLX@R;^0Ss=tyjnpb!${FaZ)L@gR_ZFhgR~CP1+y9$67!6C{ok1egzrafblg zA~7ftVA3Q82Leos#E?sXQIZ%N2(Ud82ShM^5`!@TS|;&`mjH>97=8$T7qIO4<*@z% zS4kZE2#6~r#t#C3g%qifKMkSmkAOHvVyGk_rjR%oqbl)ekN}q?F?0|BF(k$y0$4;e^EDo`7gV;$Z{aiAMsce|R28KqMhW z4FFh>cnU@UR*-naKmZhyI4lwnMMxZr2?!!24*3MsKw{V-pav474gtAH9JC3jkHjMf zBx;Pe1XNDqkq!Y2lQ>=zz%YqJJpmFSaik|eA|wv<1oWE3kPd5uKvCdAfP6?iBO^d{ zBo2cF=#In#5zsn`0}KJ$A@RV80JV~M;75R3NsPY)gbWgobqKI95~Cskc0*#EBf#EB z9Nh`9Hxdsu2{3jNLp%Z2PGbB=28dypfKUO;)xy|JfFqC?R|#+g5`#MdUP$6`I00Tr zVn8Oq(?|^T1o$M0qW}RuNn)HQ01-$LOada17^#sjh`<-Do5V0p09cS1!wCQjQUrp4 zRHO)|0jWq4@B$iI0$ z5=acOBt!%P<1YyT0p%9VKTsKzPEo)l9v>l=P)$@C8)~8A2x^(Y0E-wTF!+MOidKCP zzXT2iNLB>KY$PiJLot#Efsq7B4oO$oI7p7baR8|e>48cE#xN8k-5?{N(tt4x#o#+4 z=s+q(HXzIh_Jpj3q5##h~WUaJCKwU zB4mKf*jB()a8N)v0a>y9pqD`6o};k9!~lV?2u8%zr~|gSF zVG@FM0pJK#iAcmE1`&RQ!AziO1`|UH!gQz?_Xa>+wB~@28xnDM&@2PZ426nBvkWvN zrAWjf#vBx6fW+N_7y%^i4g?7xv9?fA3_B8E(fP_@cF~kb7-k}96v5F9b7`2d2#Yxl|3}Psl1Bn?#lME(?F*FVk?>U-ehzSuw z24u!PN0SV(X3-=AEpQ0C15pD=+*vfqKr0$lDxXKJJANYWE1G18PEMYOUcOa<7+!xS`%gsx-u z(G&wMJ5gDG)kwh^|;9yXc(i{r}C|cPAKmqf>odMT`thnb;2e5>D4oZSlQRW{x1TcYA z+$w+xkXUg5hN9(57JwflVo9JN!@$FO7Mkmdb&lT*Rvn5mXlYw07l3adapwTO#X5(g z3>>4yc@c*q`vLTZR&no8ltJs_RKXyZp%GruU78wxXMkBCY{JmN6{3&k0kF(0NX!&k%|hE`R9VC$4)px~;5g4hkp}JO3G<>zgEsUi67h&*IXa*L zHDRVuq(S?ARAzKM1M>uq&l0H;#TgjX;H-#49IVm#5FoLjAW;;oS>V0MY=n&fP9dwI zC^%^%QY1hRvI{B=PL7Dw2q?u8X%T=EnK6|U&X0(62*Aj~V?cED1zET-C-5nX(kwtP zmPns~_$-k+0r16p2*Aw}DHlMVCDJWmJWHfnh-EC1W+7a$M2dyT!V>8f0t*YP6_ujc z1iNEl;c7xyL1-oD0XkTO(21fzepsLA1Q83XQxgI*3qvqEYQ(}JP7?+YEUZm{7#3C@ zSTzfq6JQ1cc41>sA07<>xQJy#wPEI=#~9(jl394L1u)3MLoJ98IHrOPqfjJh1}qo_ zA|V0X;9(S4uV_<{KT5(91LS7m@fEUMJbnVhW#QoxL=F@@g>?fvc&G%EM~t+{VDYE} z*(;7t5LHoF7nDcVife|LiXyx)1-KCrz>O%II5%LZq7x2ar=o)qh%?I9z(_^8z(&P# zA#NzJ0s|Gx2E#L~5M-Ws_yyJ}Rsm81ZU@PRay~FkVFkMIAKf<8H6$XCM>h!w^3&B7 zp3{>ti{H1g@W9X$UE@A|?DeQT1?dBCHq|7Mk zom6>n)q%$H15ML&<}{^FYx-X1de@ol_j#}V%XiN%e0}M(F;}hWOGTpI!KNqK=_S1l zrp*mZWcYvMbuRF|^L%A(hqpNrs?R4~^y;A#eNovXZOsLb(+=AgTx)kPz`p*e%eQAK zgKBkMOONzjMegv9C_S|2+^ytcQzy@5?9CtiB4y~P+-vsRKHgbZv+2n*+i8P5Z0nbI zb#bhjJbcrkk>7Qe7d+6-E(%?$loZU&I_d0tT>tsUFNN=}TEE;lC^zHdiGwf0^!Cr2 zwsKzXI@v)L_UTI^#;I$L-DHz^=fU;7tKPXweHZjMOT2P8KY7mfm1?zrWFT|PZ!=h+T#@7S4s7WBtr zkBYbu`QhiE9eb5OV|7)iKJ!{!A9m8v4+b%#j%;-Q7)cnp?|d@0K5@Vkm5s_ntP9nQ zp0DYBbk|cC)ee`fm)zb>S03e(`c=yz>*g$#$iky%J1EReIR9p3-^gXvv;{IeSJV1f zqY)FBiSNCZrH@jqx*ew+d{24A+`*~J4OdsL)@L1#JoKR8g{jhwOzke-F_%U?nf@YY z$-b?xbFSHYFf&qQ`+hy@>r8k&KN6YLZJc>p)mYOdb`#3ioS|u-i*o*)^qh#fnA&+tlsnJpQ(HU&N5b2bG=n7lqgv z2SoHc>3odkURUUAcE8%LwBoIF8C2XkvP&9Awr|w{t1F3_-jR#*xmn61!uSk#aVhqf zz1KC)Vg9utUA?9a+)~=(R*&R)<6M`}<>$CZlwK+cJZ zXKttT;`-T7MA1>TM@>yn;33X zHnS6{BHLBMBemU|D-$Z@7jc%F>C^5RUHg7s-?%<;#oSpdlgqoAjOq9avAet5YwNKD zYxnC;g!bUQ?~Jvw zvagSl&Nn;wrLD@bFdXZrLK=Cf4;XVkbVz5O>fwDs`t|p`*z}~B605Jt56b$xUaQ=C zfAu#H>5KmQ@+ZsuB>x`(d_aT0>L)tTm8i0njau0WaskjC*=4F5GBja8OJ4{wR%G$Y zmTj%v0=;sHB9Ks%Gc#w^;9Fh}26N0dzC6%6Po+(TF>jBCQIWkMP9g(RMhIk?yo z(EOy*jzB!zV$4FJk`^TQfYeF^C#S5FLIn+rrZibfD=-eB&k{OWcbaaYdtL2|T>i>(#)_LRIpf_kcx8hgatHt%Oxj zmHo`SnspV~3lhZ~NK_Jc>QNAxD$g7)vd;v7?NEiw2vCvzW{0(qN2K#$xJ9U+=s;7# zT&v4Z20+@2_>sbjl#@Q(WCoZF%tTZrZ+Q+@`kSSDy~=`-3#GyWlcJ=Rit+=!etRf#z?N>ySDkPD409LRpNLj$(w0$3QK9dnRJWXqD=<)~ouNv#R65S^6w#7z_l| z5P|3<>OhTIvpBlCg)LEo|ebKC0st;P@+$V{Mf!l-}sMxW{T9{a7q{Zwi9r}-$oz}*4PA=<5 z0E~ zCh1ULL)MLr=kzgv4S+b1tL40Ex+^Qf;g?+vW0F1{e=Za7*_cVUQbtMf{2*rHwC2a| zxIjSBF%B^r#zCf+XbGGuqZeM4+p+CZIB3Dz`>yD@Ou(nTr?atShL2X--#4+?V1#p$ z!KE^>RA4WFY)t}42?&gdbPr_SeiWH@&OC2}D^347=sb{pw!(a&H$#NF)jArS-#58w zAcoYLQ&pt(OD~G%Tj32Ec%q*${xD zYS88X%X``E*pb^%cz>UwUZC5he`y;e2(mP0k=X~CF)(!}aOVAie59l*snqE><4$0p zeZ`_kNhA*sg=5K%2%-RKC`Jhg>y*M6fF?N>FT60#81{I%?ay;*bU`=r!a!H(n+r?bCgS)tc|<} z1rnK?UN%1dOK_dJE7 zN{+=1uV@LN86Ecrx>Wj$bt^CQpxuX?q^5x!g;-!!=9_v{zumno!Kj8lrY`WA$W>_P z_eX)l!Po1$U;Yc^UNa3!Vc zO>(Hj35(*Up1vV##cghClB{Xi&@EYKKNUxl9E%^`5zgoQ=()eprP2l6$_o$Sg1bp# zapzgY>Tc6{*1MN`G@7B0DGq!x8aVp_Pz959$_`_u;@l-UR3hW1gWT?7hqd)}9m#|U zdo2*3w z$Q#mIOS!!E$2k@HV|5dWi|}Z z-bi{l5!GDc_RHhzX4J3Q!Vd3?PJVFAU3s&7;oZ0g@#l9XGy(gU5}7ffk_$}1v(%+b8pQyF<3HwY#ZhdzZTMJ(y)bUxx&Al6OL8XdV{(`(zoR0D0e z){}+GGX?30d+~bh))<>WOwyi&G%=3?$;w-_F{0)+d6k@G3Ss&aB+zH_rVC_z{plNu zlt5@MgW}JJFOt}swg%vz+6*->q$*mbi~^Ea)wz>VkJaXFs{~4V%lFg)r`}DlVIKxN z^MPgHi`9^?RR9eE0yR(NR&J<)a23Is$xxazk$Ft+edZ;AIwi63Zc5^Ft0tf^V-7PB zK7wy(KVW}_7p^`DeZ-*v2>6~EBq$va+h?~ z1ef%qRgt$n;lC~WXfV`~>)B^?#B1qCkj#*NQ-tPhn>0B_`cBaOpC?<+Y(%(bTX@}5 zgIwuBYRI*fxmJXPGY^@_uzAl!f^lXdsh5ZBlBPo2y^=2|m{>Wy(em54qNpg?a!7j~TL&i<4CoJO=6x4D>EEAHqZ-qBaZs@%A)VfnA`*NVrMn z$kZ9h#&68NOrTRszU-KhI`*-E@=79j>zZJv0IzJ65V|*#aaQC!=Kqq69@gqIb5Rls zBG)krx=9FBy@ABYi~_naxmI_`4ZP4Zj++Qus&67e*dnp9x`S3Btn6I#_&h?>zaHV! zpMNmh&%ZqgM+~M&-;*o4ELi|a&6`i8f=vv1cJq?+yK_Y^_~|dtef#4-z6m>evwDs= z@&-~Yt?Y_ce6{cq5AXn%0URN%k&S-(ZS*rqN(O5gtJ=PM@hWC=H1u;Zl_hYl-Ny9W zd<$xnUH-b11UpEC5j7$KGX_qvqDJI3gQa^p&Nf0j6&Hx%!$F zTAz(}z*njMGB)od4A@G_Ij3(DXuj5r0=n`(BCg#>ehah|Wd~Nl)S(=%xSt&lb>c#v;SNjPTwnKFSMMiVFc3L`JrJ@1A8$S z;T9f~r{zwv3wx=Ph^WV5y(p07f$&R*v6YY8S4$P}Uovq$6pH}V1zs@Nu0CpI(hR%Cv(_$PaBZ12 zB(@ZtbHkR!%dF7=B%KF)Y9Rzz^mWo%Lu>$V*$-Qm%gq`B+%$EtK9JxvNTKTVW5Uz~ zQcm=bNYe(%_PT{Uh3pOj=(~_nY9i{E0BfeGgS>)Yz0})E_h}lEPW+M~>fADGNEl?y z^23(J%dByzQ6Zu2VB$r7rQxKrhS-oE9fmE-yhg&`1dE2+aEx2y z9s?IC_8px=PcQVv?93eP4ft6~I7O?{QLhj{gmIshPT=3uI`ke6s%&<$cW<>|HMzQI zRXXZblK0a-o58&No|Xcpqq4*ns29yy;wGG;H?-7N(Rp&*NH5-fcuz}hQD5>{u#$em zq_n?_Rwa?Z^reA}`y82i+jrAC>UFFaTU1p`upLrbPRSceY6{@Ae%i+ceR)^wXm|%j zGltp3R|w>%kC*5Tt)pr=I-Ouy-cO7&GM_fl8(J!2FtK9GzuIE$lnh#Nt(^%f>|y)c^YMotw@*KOvDwFSWWO|B*8G5~{fqo+%W>pJg8w>&E}$B| zAO8jnfBOgxtPQve#=`dpHX`{bQdR9$jn$*ZE(VxZQdJZg85tSb!pAalhvK?NahHj5 zI=3x!oaZMEoHTJmaY6#02edr_bh%)L8WqZI{Ck8^zmK%toJzk(kYc295tCJGBq*u&keaoa+}0(V&~&f&cH$Ms?{ zfq48hE(R5*&vC3bZ^sq*EyG)vm$uy^gfx_M-zs+3_IJA}j!(x!%b%|hd!2+<2%ZPN zzXQJ};O=s`Zsv(&O$@FETWmo39?Rw3aQSjq7?xyEoFTJf4fZ5`>{RyzU3rMpzV0=9 zxGQx}?Nt~T(^6s5;c(cMc?dRReb4I1JEJw6)3u&}i&!|iX{W1fq263)>zpxtr=3$h#B zYQ&_utwgVJQMXFpoaM0igCSRm1p&7hJrB}&9?}g(KuVjMbA=Rvk9mOf9^)57 zit}mj8>E<@!e>C54k4W{7zH~NF3#7K%BLXix5pCzTS@s^EC%|D(MlkK@W>H)$`rE{dk_vm|VwwEP3w+M}g~kgYf|@zWi>_U!k9q<|oX|q`%`S#0du0Q?xh*`qSXndU^TmrClgm5W= z$b&_KIkejENri)9a}9a~y*Rk`RZ2~veEJez2MKgy`XLgL^tZ6S5pHr@+3m!lg^f4l z9Ka^ByqL>%0p=;%q$ zTDJreVF5)2hG>sN=_~A^84+)Jm9G`{%tch>F{PZn)@_UdKe$yQ>21xcZF${Dt}(U6 zj8l6|Z;2X#@`XGk!$jh<0v4L6z^7u2&Hc%#585PsknY>!P@~@6P#sz&eV}&^-rN+q zs~;CHCL4cU=+R?hcZ&|Bvuzs1_N;odjjc8AB&-M9v+|}DnsO#{z>>sozoQBXG|!(WycMWDj8UTJjM9_&|Riv#L%Vq%N!VKASM ztvQb^Zl9tVv4wyJH)3nhmjV|IYz#w}BpKLC!eBdz-(zYwb}dYy|E`6|Fq2i_h7 ze{f|5@0k0{;XHf=N}|UfT$YZobYqx6Xj6o*Ro{}R^q=ox*T13z6Y0IHh%S147 zqU6CHal(mdE}TG@wtD1*K?R>A#ms^AK$Ec$^1z9ElDwJ|Rihgxsz^VZ6aMq1!cin_ zEK=c)w1Rl%Y!7&0mMAoO=SMAj7(pRee)b%yUeIOtzN6oRMbVA@elh^>`v%TeY_Yaq zqoW&M2`AQ&sjK#IC){f><2}Fq{HwnH_SZ$eR@gHa>dRv&2UxMP4RqhhR*5iMg8S{4 z)m?x3^KuT=!H}-^Fdu-plgC%1ii)y?rJxGaWIqO#-zwvx-hnE+nBesRsQx^tM(I}4 z>%PXh0C1$pTmdyMd0coksEw+AfnRD=g)+nksLIEDLe0-qb2w^;hT#oAycXY)e;mnu7R_A|s2=C4MyPCymWPa1&YcOg39v>qTi8?XcReo1K6 zlAV7hw&ptqf(ZB46al{#piY&pYH=tph;HD>sDUKE!YJb;%s#dZlmRR&_jS0;tCRx* zaBQl=^QoM^1MUeXQh5UMT_#6`(~!CR!>~|Y`z)ajeXw}j&u_2B9ry9B;qE~v{Rup` z-!=Fq7GP23PWtyfbNQ%O@k>#8Kk$k{c+l@Un4+V37Y`L1q19P$*4o-SB71<{PO4uG z=Fyz{5tc`u3|N}($&5-J%$ORO`n=H{Fk6opc~|5zJw*3)s{RL1)SO3kAl`aR%?ZSv zi+DAvKY*+D466EyX%$@$#y}%^n8w2OkITQWy8I>*k6UH@rc7W(vH8tG8ndA;0$~Zk+{VseKj;d5g~i;7EQ0dUtoxEGlPp*(hTHo0Uy=)HG}O8 ze>5(rYGXO0Ml?9h&kD_d+T!i|Ttk_IMjI@p*973%7SktK$Wdng9r;~P70!U4ctF5Wxiw@h!WJRRIIJ&+#_u2j5oHHQie8CP zM107!&x7)c2_gGd1FR-j#{~>!=;^Q#Fb|~$u#nSG1eHn$RZ;h;Uodq)rYy9Fj%jy| zfHu&+XpfViCDaAB1UgI*2u$&zE?6rI@DW$O5W(c=ad{)5!A%g-_Pt&17IOfdRUD7`JQ z4o(3l?}@|%{E02G#l(G_SRBq9O-~|;O>BskQmIkj7!)k)xFpuv>>C>4(Zu#1wvLs3 zP^!BQx22ZuGT%)&A0<~N9Aqx-lgn+AC*=F=#yPux-_5e(|29VUG?dlU%_twu@=eVw zK-Ik|%?zI%8yn=DnY|_YTrm%&5Orv~&p!sjLFRj>^buw#4XrYQfHeEL9*u6yU&UFK)4(0ZObJd>Ce&0D^sumd zf(t5d4VRm-Vzz#~9qIlEypH}4`{lAD$8ki_eSby&K)3S!*cvtrF9j{EJz{b8s;J}TkXRFNV29?E8MsSl6bX6j*1SI@{yVV zuzoN%P9J=fdqY@~DT~uzxrJ=83f$pZ`+HKB0N*NMg5apGTH^-Y=b)m73ZnxO<|xwH zYVUSa-Y6nhQWJYgZaUb91q>t+9$gBdn+g=Vm>ZuCE=aCYq*EPz`m&R?n$zn3tjh9(-rfQrVWKTK#Hmjyr4@OcrfRhV%9xpdJ|&Zjhqx zh+2jFz6y4w4B=ar;IRXE$h;o>-OSiyh+)eMx-Q^!%O7JG9mak|{i>U86S$m0&z z+N@~V9T%@B&6}DBuQ&58E_HQ!(gnVR!RhS^DX1hG3wR2nnddA7VCMlL4Ag`i!9A>7 zda67O99C#SEh2t%RYm}Ss@#@=!wT2~?Qm5IDsGi~PGvPWUiMrTdEGuaX&$+}@p7}G z0b7c3|K!xu-w!@)SCC4OrnG~AjmjXMCe(*|?gOoV4ALV84S-yfUp)Rga9BY@AT0*% zP|_nH3j+|>f&Bv1CgmQxsJ;WZ4hC86jgxWYB1oE7cb zz9!%%U;t@#Zo5JToHmdBlT&*mlLi;JE0B>O4b@E7DMwEiuq?eyGxyWjG+kgDtrxYz z@^&24&HXesb=E~`eM)PtkQqRr+xvNJFVZMi-cVNKEAVgTb`ncOg1;8we0fJJ?OB-Z z{X8~e5CEX5wSrk8@^0-Wc_~UOZ-9Pw8WdYqn{|6Xk4+y!Y8TPalF(o-r!d?5d2Cn; zOjd|Nj;BmT5~rEFSxo6Su9f7ff^c#|`mJv7rZE$#;jfhzwYh?iAh_H6d2HYYW-Cmi zVHEA<7JEOB4fUpUtrS4bQQ@1}+RrMcVfbaS&>BkZd>Z`^VIbuzkD()RCdRg3!L~R~8tl$WG60&pMg3DH0h!<9H28g4LvBm;Gd0td* zE@2rstWYZOe%ylRK?M6tD>#GCRyh=vltf4f!MU;w99C#@hB$8VbSlNYyrSi2ltYnP z%`p;Q8l*mOSiwNhZpEND^vyZbm9z}(7hsD*!VB6SDF>4rnP^kyfx`+-SBosQ(psup zq3MEo;IM)Lo|=$T`S0@V))6Ff8jEj9(z(7-7Rtu?YfHl%$@8?_Q zib+VF)O48-i@l%M)OAQpi~h4(x*&=e^D=N)q1h|C-cl7+(8`gdLbvzxdVnZm3&|KG zY!jvHw9CM!%g4(vmmm4}`9kF<7pOko&?i)BdjIpU%RjHbGe=BR!>aILPSQ9u)d77+ zF#xAlxh!z-!@yyM2*jkq(|8rc(weU3$NtUvq&@*7W}fHf)LJ|<*IzFgB95gv!JpwD zq5@DD^-M zkw1oK|LyYmYW1u3+HQsu>T>&t%yi`w#Ji?g@rV7<3C#H4+QoX^d+dTborE17LQbw> zJ%s&*I8$KAJhWbgpPmsk50kGHN~VV&S2SS+t$c z{bIKFJ$f-q{Dad5EhrLXDSW@NOHe1QHcPgE!xD#q{faph4x0C9Eojw76&>hBD>bb0 z4JSO{Gz;S}VhNmJvTs^X%kXwe$_BR{y6gP^dQo;)?LX1T^h1`KDh)+_V(8;8^sfm2 zHe}ODQ1?-1hfj4Kc*~gLTaK;=747YV0=l9_pBGhI9}jEpQ7k>A9pbM7tqimk+x&f# z03$6ai#@OXbHNsl5viD6lFKWc=rl#31MkU(X}GefiODS zirl-0JaEJhfB(r|fBoa4)237oPz9sQR4}$vjI;nM_=zjeK{S8($3#o^*MDCgi6h;Q znbEsa#YyhVQfWWlMI`amnJ|+9-B-%bho$`nST0bU#@L=jZx7V>gG+ml{tLL2X%j1L z*anyG6qxjd9hmh|U~;1{ssTyloQC4WK#g{g18gzbZ3mp!6+TF~Al6piq&3`r;N4KH zyB8myuN>UImwFw?4iTRkWV0Wi0FnxMjQH+N-V)VxrM_-ZEllCYD{es@Y|RbSy380b z-cNDK=LOUP7X>wi>tRq23Sc_Z2nUpJVA=+f)h(9RO3l*V1YGRC@F%LzQN4zII#CP< zl<(f;{ZRGykPwu;hb2U=152EB5t}wmt7MArgC%gzHkng2pcYI$AE*8saJqrvw2Sje z6c23t?r{1N`|fZ$u_SN3(^0Mu22O(zof0Nq{8{{-p_K;7`^LFw*+yCc|lhtucs zsXxNBT_Y{mAZjsD=X;pBXYh9e5*PariFQrizql(GB_?2(>l&i&ufJVBUv2a9YBR{m zHC!WezP+~0OqZL5D&#Vs^rtnI?FGf$Y=f@Y*wu<{<;|dUw-_HUzq|%03E#s^PjY3$ zuQCu=l#A5nr+l<~z7D)4QgE{pyl7O)I0L5L(|gWznto4&OX23cU6q%%^3(A74O-xt zSmBlvwD4Zmcepg1t#ELnogc%)Ru@b=fSf#k_w9Y)0cS;NcRbKR_+X!o2Z;4?J}!5Y z-4ND&Q%0LZuE$nNavum@S7iDeF>~uVBJ8p|@E!CNbIc{yPmg%~wwA)j8J4Z3pfC); zWgt5ph-L06Ow|EjCF1EGk{8q2aNQmFrV$6%oX2jH1?17Ux_2hyWYz@WGL*++qxh$% zxCFTLBx7n0bA1et%D4@jr=#vY3I8UZZJ=5$Juso*-8en5`f}Z+$A>p%ng2oj<9F33 zC?qL0-s@ld+7ugJ$|PIQicP@%UTXqnV5~JZY^*F_$Z~CE2YzSy>w^AHR-f=y6=~a2 zO((7Ez5=xyypxjDTZEY&dynvJf;`tKUuzMDgq)61(;P-UM|sG3AduxU;1nlPibNnP zo;P&*wi!Bi5G_N84&oJ^?wq1-+d}jdEpblK^e9Dc7;)MI`vkTJ&isE5X?`%ICTMSh zr`F5PX)?qt5V#ESJxA(jOxmetmXEbHg1TB)B-{stp;(^Dlkh1o=6RL=@?BDJ9s zt;|XK1{BFXnyj_B#JE_mthw9go(>u1^WBwEyNPS@gs9#$!FtW5V=Xv;b83C>1bY@5 zj0$QltLn*RUY9p;TSSnBwfJy?2qLfgPQvMAe;p8!Q+*T>+kBr+7-0v2?%TV;L}!SO z3Fq$Vdtl<6AzqHG=Dd|`r$>;Sr>c)H+^%LkAcop1DtCEebB#o@Hoa{`r&%TJ*_6L& zd0?VMdq9hDEu{d5AizYMCN6^5zZWArqkIK%u#OZf&ls0o4@F&X=k<0*`T>vVJ>Cvb z7Z>hM_-+Mozl1#favv)=x*;w!GrH;T|K+}HawN%ZD7^1eU%>O>qIBjZ+(66ITg^j1*2Z7a>=hhrMfV(QZ{V=WgV;5e1 z!c@z=U>un)a7z(Q!!E1ESmi5fgRc?2RL`GiXW_Lzp zR<>DQ%_@J+)=m{~pZ@%2ME)@Dci+YO`7P2|?h*OpYJbeaD-YRf!*M@`Xtc+qP5dR% z>&*4YYzeW8HDBU#G!VsO8s&^F^$FuB`yuObpP5+;Rc|r&GFN(M*?}I3zE#nZ_Tnz_ zW@WiW@K!#A+!*KKl2_~3)|sTPj^I$x{8Fl7qf(e8hvw5X!mX-p(n>n1Vuc&0=D>~X z*WJQc^gtU$#smLGh*T$(usJ_NG(b8>v8h=4xdA3)k|u;>J%zY9$erYxxg7wW1WzD)mwhhU8c59co{MLX=*etja^fG_yA$@*phJHRU+pT>Whs1iy z%WpeqFzIPuU5YPk@UJeKF%_GBmUGUGXZKXmeYHgLfM;b_zMVN1z_F zeVRMuOZ?h6P!m*8aUKVe>(pf&Fc5v2nm;ziYk4~jjvsdm1OHmy$iW(I8usM&MMI~yfE<<-2|^soWo1|j$2zlY*xcQ!bj zmPPZ1W|7H5Uad&BEVSZ{oCr}*aSm9<*4Kh&Yl{|&e27X|D7GWyo_j?E89Ws?JLHXJ zimSO42gPQDpYqKdo*8r`>{Q(Fj$u;V?4({{kiOc+ThtOR#m&y9MjLrmaJ0EA=sd+G zY~xAz`VJsmgQn<`jsDG~I`~+isOzP;*)udciMxlfh|yu7->JCSxrZin-3E)~Wlpi! zMn)_9Ee@K$>0*cCW-sEPNX?Dm&or3iE5c9B{tBLn09wSghtx#_AyODXo7zLB%mp-u z;%3)E(F8lOgyGJjbIBY_6$EOh{ZyMUjOCo=>? znvo}q#(RU4VBeOehO}T2pBO$jFgnlc7KXh8>V7sFRniygj7F8lS-=QI%h@#5R-u@w zzY=H7t51!#*-j8v+cVd92zDOVEmUyWel{`XT15*^1fv*v(MkeMWME69l?-mGjuSQ2 z+Sj>ixu~lBU}Hxr@ETW&B>{v;v*Pv@xqvz?9N0L%+gds`-6vHz&&Ff+`W_n{fDFGV#7 z7#v6B?9$wh`LwR=JVCxMh zz)j;zhlNLisZ1sH%b)+|9>4zkn^{3?29B!Oyf#;P(0)z^YR|KL%2va_{AFj#{^?)e zzREM#yY6q}xiM$`NUijaOEa%yZ>-GYfVROo(SlgsL}=zMX9m4dKDkk9WPBX7Ip@b= zlqg9W5w;(RaDC_fZ7sZe)%oS85XrY!jrzVQ9U-DkUkK6M$ar}4gMi3Xj>DYCt%pb? zUkp(+nnZ~}^Gf2ub)nIjp7fqLOA_m+>@FG&UOHxz@o2Er@%f{HKVr0QIOV(D_mRYi zNydUBoJCvbA>Zv}vN&xXEgQ9p-bVi^-|f6Q^9mvzYB7Ij6#bO%cF8dMgLtElHx~X8 zRkv=0K={c$Q!7)*vt2TyTfECckpE`qT_MkQ$rLKE-b2{!yx^t~7rSJNtcDT7Zs$?w zQ^>PjlLk8qSc_JAw6 z#oDWL+fol`H!}n22yZs_N)z`SvFv6S0$#zb9#Q}qOr;UaZq+Rka0Rz|5FPMOFP=-$ z2TO%xPMzz5cC}La46U}iFp)K-F2#!nYfp+%Q>HYlFdAGd+bO>|hzK*^v==(7xzMM{ zrFik+a~hl6H=mP0jQ3K!cxa`a7bPuF?1`7WBty4=Pf(2`vfa`L;?2oeJbD2;+Hi!n z_xfLgUp;zBHtn}PwB0-^ykW}5;vof7F@z(u-8w;g%@ynF!TRc07Q?ytX~W9fwI+Q~ zL_y12FruS$3K#OEc=2HQ(S$MzoJMPFO}G><9!#oc>qPNk^mmK1;_g5uVqfj7!ucoo zILUKV9UVeCFTGo_1~=V#b?AlWT0O3KfYEg2)uGqf7TR&g-Ogk!nu1y!xFl4OAs{4j z_Jb@49U}f@jjB||mtz1$%JNd&9Y|X0TW0H9s0MtP6n6*DO*nv{-O;fw&59QX#%R-C z%FZ&nPo#cQ+#RTmY>RBs0aRb!(j~7c=%pg6IAYojH?y0AUOl9U&j`$osCKJR%hMI+ z;?c{?3+Z}X9jroF0$)5jf^6XVh-|k*E&FGvt4B|N*}zwl8mxq<%9>8ai${NeL|ro* z2B!1oMHt-<5MMpWXk{Qq$tCL}RD2GHi20dFY*ezw2NMu}$g365p<954F#5OxW|w?3 zQ+!oYt;SKE&Bjw+uZ2BW0~>2o`luVG_7Dv`X|AZ$g;7_IM?MudI~OB(_y=tKnCRYJ zikqETr?sR)VtZifa(^jqcBWGUmZ3+nR~R!<2y!a!4otvI(&1mhTOz6IP$zi_p45q2 zK%|sPRV??3tfxcnc*74N#HCkKv*~uqcRS(N>>nxF`exJ8)ilX$5|}kJm5!8cFS_LA zI>?k5w`tGnt!$%lg&}hq%K*`39>d&W{$%eImtSM$ZXjT0KnFcMsRC1ns48mAi$a18 zCbc=1OUwjLCl@iV(B%k_T=H@_KW7Qak3ycEZqDc+Z9_E1X3OMeGY4*Jlj9N{o@N89lMmZ?6tFI4HMAj+F7|4XNGA-%?-|Go9?CIUO|g(WUkC> z>~&uE&BRf{gJBKaocGuszY<}QhtEFSy2Xs*a&Vo-7WP5B&9zpkA$=s3@E`WeWjAgl ziK2UdMg4&2d_T6084PCKo8EgdUPu@i{r|w6h$NHAA_a?b*;O8UBUL8JeB8KkNooqrR{X$;L(unu6Ck0iMc0x^6nPbi+! zTs;|8r5gsq-!2f@ASF`l8hc>e8VC@s^iO6no??$F1**inYy0T!Xpg|X?6KXmem>tY zv!XqJ+#axoN43RhnVW(gZU{C7k^)SB%K>bnR1RQAO;zwD0ta&V=6d0M|(X8I-j*X@b4E#3)Z<4vnmK6Oi$)ecW6nbeN^tw$yb23$aoZAD&Wf6y>)Sxo@^w zM6?gCSuab*kn@p>>5_d#>9S~0eOuBb+eZuYzXlkRjx4sKQH%f<5)e`>mYHXrDXk(K zHDEeX${=Iy$mKxTZW|E}%w1C3D3O^oTNxHYI}GLxbuwPj?h%RS=@+~}L0c=G$%ZA- zuEYyYMZ9;T@|Dq^RA}Q>fZON{ZBiJlhET$k(FGpx=!$DUfFv0q_M%O>x?htd6yK^+ zBG~)1B}u@uHj)&9M%;#<)hYGST0|4Qm57+38gp_9dm#UKmp#;b(&`!Ek{@O=ooB>3 z_RrQhE#)N$*ew*7<^O0xgv(Q~a!-l)vk9ev$Yr2ejQJfryJi(UvleGjN1lO{ z({~nD?U{FHp7B!E^E93zKM6{F2cFfRf@dmYPW}cX9PxOy4aaJoYE=h?TBS5LQ=(sP zCRxgADY=_AOc0Ykb{RF2y^Ye)Q#`}LcCHEkVjhaEeFIS9+}rKGezP*w91h(qH?w)U zSM?w*l09rIZey7tw!*KP2eaDF7!U00ow5hFQN!wTGtT9k zv**acTz6NGnLKY|v<5ZRBbvcz@8+%vFPMDj%;KP_zK3U5tb%8TGv_k$%s}aEN1pAN zcW0h)W*g($O<@kox4MBNp8XtV;OkOGr{$tmH|;_m-876Oph_|MDGt-9N{X<#T!(Q2 zWP1T)*CgCJ-$&<^E`&1lV8Y21!q9^qXy27S-kpJ6=@OZkSsB~F2c&%Xt#rpqXChXi zgx6S@m4y^>WUiBp#0Jkkq`HREDJlPbADt7yk#J1}gLfkZ_p-Pn<)esTqafg9y3E^C z@Vp2HS<<9SMtCw^ zkl%4;yH0zj!sKFs&PtEO^C<_{XXKqYxg_fp2-v=YoO0x0X1k8ehz%7=i%(D_3LT8= z6YZ7k%fRta;ffoD_j(z5hl{4wV#>mGN@ef@q0-gide=TL)G&Fty3Q=j_R&u{hD!>0 z%GS$rhWOGGE;FPGCpQQQiNO_uUf9J++NWXadL>>m@{6PkaLH)gB(0;Y4P#u@ugEpn zw4I67>sQt2mC+|}gKWmVQV`H%w$>bs|vI z<1q92o`8PYoDlCvu6&Q?qn>tt56UkL7>d#Ks^o!QR;9o+KB+2@V7?74fnJ7Z=(VNF z%MqLAiA6rQ2doc7FB&C^KK&OrdTRe}$S-UDUkE0l)rwf9iEx|N)>+>eHvhy=#SNvn zvGkO5hb%G)axWh|l`x|2m2+eKwEsk&d>v+jr2|a1e|73k+$gpiQF2&@Khg$`*9wH8 zm<-m`XP=TE6NfJ~=Fj@u3oOpdy;!IEK5Dl#)bc3X1bHGYi`ni(2z{~caHl}LPg$l6G5_Xf;OZ)q8<0^oU2h5x=%oRlCN=qO4HPD@;^!21zlKT|dbg^3fUIfUS!` zu=NDbr!BS~m70%H2mpcrKqn*IhFHz)avEx=Mhuf`6 zkQ@2j?iF4E*9SE#yX{c9v4;=agoVpl@9 zx}-O>yI}vJ=b@C0!rRr~n*Ib#79>(IQlE$irnt3^7EYA3klFbi%9 zed75@fv;5h-jwWuo2N|ap;-A~A3|{NLdmR@wAxo$Yj@3?pQ5p)@v-K(ZQdfv+V~je zhS%c`lwiK}(FuZW>C`HYwP_^Sz6R|m_aGH#CRpUQ-$V1xSDZT$EGogg6095$EMTq= z1y2YTI>7?*Uj&W+KK4-~n8>Sa;;U{L5A~J%R^$BF@mK~~ zlSR1wNto{3dzen4HZG1-=a-EeEtNCcHshuEM;^3Xh)KGXty}oCa}@W^1Zi)yT+Epe zCY!&9_xfq7zZIsaP99f(&QS8Aw%cT=Qz|n%#c~VL4WwXDoaP0(DTBHs$tO(`dzB<_ zZCFbx8{>aXti90`-E-MKjP+bvRtEs_MlEYwiw2@DEo(X1vR+lMmmSzgK<>M&Ujf>B z7TThIq$zt*XjSa{%=1olpY^Nchlx8YrrgP`$i~Uz$*iLQ9YHIP4Xf4$t-KafKwIX8 zTuB{TTSOET+F;H@JAm|Zh~r)%u8I9iKx@xKTWi>`cFW@fj_zIYBkI9x$S!)|w#b$v zJ-~m31zC4qYDbV>j&MBE-fegBD09in$zu8F; zspn9Rg5TDq)d3nBv?0B_q+?F}P;zIjj%Q%w=+qmJLCG-bZ5zZl18GoN}3NTXc6fs~3+9PWfSFv#U(=^hD zUAGd4bprz4!fB6Oh@0Kdi>-Ywxq^}LyjmB!Svg)!IS?XP4c`5J(ZXiTXY z`Pzbt16o^-9FWN$(clQ zVLyKxe){zl`2F=d{PJyh@Ur@jEVMN($RCo>tw|V+7AHrAU_`4`2)5tTB@U-7myPne zsgE0rjmEuL7g*bobXI8^J-4)#kr-Oq9*F$KIv@*F8*Q4gKtJ2q~&lBpSzaBzq93lezI%JVYO`OUMv|@ zTaIwCn`2Siv_p0W^%;&b;?Xxg7qampvcS=~RF!X3WK|5WBhwj+JMf;R?zZo}-UA!FPZv9B$z-ssN5Q^w+fTa@?2SE&r^?LgaXc^!M$bm5aP?Eij;r-dX z$FwiqQ-ttr&c4JYwpPZQTYgXJ|IoGowG594R+0MU>nJ9*apW7w(&Z)Cio?PDs7Qc>&SFQgzcw2fayB4 zUbB6LwgdYN$e!%a0d4-DXp1n$WNXQh=cLsZ!KGDOczr_wNPP{RJXDL_&x_VDVh6S5 zZQ860FI0#CMA+v>?*%mWfHCHE1Q2;y17+)QCg|cxzlv;|k+0<=j!beI6hx>RFwE+U z4nj42G{f(=`Y9+E^m_2>L$$li;`JWkopMfAqUX^^X9%hg7xweF;iq3;5yfAx!!O^4 z2Pb8#DPz%;uG5r2N-|I`83HWr1t4;96@bwy36)~1&fGPAb!?jT3HDMvHhwXboZa#3 zz__pF7s@Yau@MaWL(YBz!T5hfFv3lrRy`2Rhw=f!628$OIhFsx&E?;3DplKO+(}BdLV=|$Y0}moSBT(NuCJ~kI z=$KS{21e(%@0et>n3D-rdj@k=*6&f8Pm%0XS-uLo<}s4{U&5BIW6K;`-tLKfM$)6o zcnWCkb!c0Z<~NYslk}+9z8G74ZX0a3ZuAV=vu+g7!b#c3u!LWsrNj%g?kcp<8a~&u zA8JL|9)eJ-ZC8JLWTSlYW)z!&XMV7F+2(?AEM7u|o9UMXUW-i5f0T)E>?Gq?XEvHPqsJ zK>Ta*MJi=|G%CQ@AIkL;0FKuI?ljhX>szWxM?x-Z7;DAmR312wW^C(m3fwO@m$8T8 z_DZ;j@CUgPIUw?Wy%J8+)c*JjNgue7y?U5WWpEFsd==fJp!;tX>u~iQ+?S5|RH}7A z9;?eUXt#I;SsI`wu%{WBaD}7GVff?r=Rn0Nt{?lSoCjRq7$WQa$<%zi1Kd2Y=G}DD z#B zbC{|*-R^#jSS5%-C&7k;*x3+gupPx>lOJ${QVXUVpa7U?Xo=JlVKR<6bLV%`D~hR3 z&i&GM5~dqtT(+HiC+#Fm5Ks6~PBixi+)u-X54*-QAL853BVK?Hg-;BTDCfQhTya=z z%tN|^ER^vMSh0B|)Z5lJMs1F|AMyhXrZk#@uT@=zV}h>5Hc=}Hd3W%y@kn8)^YdZ- zeqL?6Za*K~?WQNGPywxCJ>7gb?S5Wu!t+<7n-9_M=ap@8?G`%0>w4S^A-p;u;o=ES zc0i^ox~K~HaI^3}4Jb7s3$`NQ{ATvka#b)r7I85>Zf>*vm?0#r17I~1P$mY8n@{d= zR^?p=pX>a5SihfFo0r|^gSU1Tz7i-7U%<&J%P<{4!#W_iK)Rx!;PFkmdmas{V`JK= zv$ou$87r?NI<79{xauwS=tS>{QAQs$H}tA2s&H?&n``zrEufq7cSNPFpJ} z1;~25I$k^7G6GL{;=@isQ2xvlQwJ#QEAJlnRCI)+CbjB(ib!%`+dq9$>xN# zAS&-p(z3IR$j(7;0;3>I@dcK~)Q)uf$Qs;{m1>K3$Jtuh9j^n^fj-k|@!xNAd=BOl zM)k=zojj)->sVS5z>OJbYP|I5F$VP9Aobu*I6S^KBd z_D|o-tNmf;vw#kj;;0X{5TRa7-a15F1UiB@TSS>QDPxaaiwI`wMhOCGX*Xl~oBJx+ zmE$;q_xBb310L4CTn!t7j)E?_6R;j&HVi`l4>%&Tx@+kMJdYlm0uOwg%F3?F$~7Va zjkPD%k34aX^nRNSm$+V_z#2v7iGibzCn9y@6HgR1B(OiDm~B1|GYLlM6SH~tiAJz6 zBH}p0UFHbKh4To{s5OJ0fL?{{j?)MS4n?V&Ho-~}JP@1`OKe zJ{6$Iv_Tw^=!mW_jlO~m3`>J*fa$G%9@1^wa@kcAjG%hfsg)-Od2(EyjI1$<2$gd> zmf5%z`iqfc6tovRAIGJ2T>79L;gQe9viIb$hE*PDW+=D?kl#UTo2e7-!1kgGS9_2M zGSr%0Ij?>F*f3ix-tS&@B^5bI8s9XQMVDa%OOtSY^US_`XE3is&b)ynFK3#7>C$r$ zM^-C2sMr|z0cDBy;F%S`rWy9@a^8fS+#@50-~$%l4x-80YfGV_QF^HfEyJC&T`+G0 zAP@&&^!Zk*6}{sW%-ez%(859xbOGRt)bDF_11H+SWr;67!@d{%&blV#z{ORp8J_T& zx|L_+2#*&LftI%Vf)#YIXf=rgF(tZS-VV|N9SQ*8TVXqmKLyJ^!vN3@tS-KTl>vmT zuSdH$3-P}tZL4CZ17k_Y65HriMF>Ha-eu|Q+6C)AA*|cHZAj)Xm;%V#L9i;YcA=fKY;NG8G&7T)WE ziw3H~qzx#)I6eRa2CeQ~K1&BNq(U4g3@K@yARW>_5Y!KJ5Z<|Myo)MQjIsaTd=NS2 zY8^oxet8a@4(jmBCIx;z3aB$dI@Tb$>Y#XBP7}mOT6=#71<&&ukMshazdw-#;3;H% z@nK_aBrXWi!*g?P1kJlJNswoFIKN_3;X0r|xW>F#&ipL;xpB*buQH$0NLW!mHBAf^ ztqgs45X`4g!n6+~1qCxBejX`klvz6vPO>+&%8`Q3=P12o{~IYN8d&rbnFJF^69Wwb z^GC^i3?=@-c#RB{KzgE}OU5dT3Vg&Mna@#r8U4sWFUh#pJ0(abG?W_#isZ74X+dj7 zvEWk&Pz6sxcqO3Rbxcf2*(l^9JB+S&4tS3{&N40>%*B3yoGqsAx6fHxll6oL`Lka(`aQOiJoTI$oWx`ERr?`*o6Nt&Ygnja$0&wc@*r$K?g@nM>@UPG0 zMgje7guv)C*~hq{$nk1CazMZiz_d|Bcp#$uG2xZ<;j1_;0iy91!DK)o0R{k8rmCpH zInv1(8!aQGJlcSQYXC8i?xn(=$Tb5=pRHot6?mOOS6&XBb_Mi0fE~Sk7tBj|*^HTX zvBWGbU3sy5+7)<>0n?tz?kXhXc=fa^NYDc$9LkG}rd_s1>B{O)Hmiq2Pd?l`?GnU+ zxt+RmB*s0#Uje-ZY`}{NNE2A7YsN4D<_Pns=72vAU2YJ-(?|#iVrZBvk&IX=Y5{Z} z=?bX;EO-FfQN)My?Sh08`?zfGbgc~PraSEt36@Y!-R0bIQ=(7X#DtxG&E+&`+#@T2 zqnh4qc;Atj`*^&NOfJHq=YywRQkQ_jJe61XOxqH4r_GO6?Qcbx&FS2Eo9LME>D0ai zW7=01W}MKv8s!6w#eza_0%!m-*cvx9mtYkUXCbPSz<_4lh>eDU(cCEQ9UrwL)nF<+EY{u;HcV8`=(uRm< zPUY)UCI!g~bo}=8on$3Y*ZX_9E3p&07i_taHpi0V+^=cK9Rf3=m0*nTvJ?3F{(kdJgv?Gu8Mu{N`4Y&h} zMF#$SDUul`rej-Lc1fwLPuny}lBKI(j-M1HR)%d{?UBZ95X)}gw6Cqnrcr-=(4-&% zBUWu5kp4Za*L|h7dDOqSa8jTLQ3>dbU>zVA{33DMltaM&iTZVU1E}&@`6|5P8oN#r z-L9<}0C9-JxUXH*X(ZbRm%z;$I(j_;1MsGojAf%okv73aL)}bZ%Q3HLhEo+e*8~?0 zCJ=j|qaY`_C39HiL%_NSprdsQPUw>YL+|q_K)6ve5O}RkPkv{&z;ItL(P*(%sltB! zVA|J_!ZFou*l(_!HNFVeF}REnNAXuqgv)Ks2*DMJ6v{ifBQUmk78qnJuyts84?l;e$HTZl)4frKG!Ro9sFB(li9~Y^Yi1Jp$&>1Wy*C0S)A>U(sSe;F@ z2(xbxpkX5aKvuFA#(b^LrgAFmH(yK&Tm$t`P|%{61Ginh&&;(Mi7HPd@WVPaN3L=2|C;{F9tIZClYf7=xxlu6Pqd8Vk zkEqjPwNV((hj>WjSU_>}G)2-qGY=Fr5IRGr0EKFmB5Mg&PQm-zKmH^6{7MuX z!HNp(jGBCiCCc~^u)C8OPzAwn(>=?0FK7f&B(SdJVg24tUo{gjG@i=w@4F3V`~5AK zObthfN6LvTK>zU-{jY572G!PDoSG4{Hx?7<^ZxeN-?mS`zPs&@_wDb$ZNI$z^30pT zG2z9+QJMv!A&pb0r-a_DaHAJVR&s?_llT$yL`Wdwg)!9y{n3*qLT^DUh0tV*t{}QxeMZh0*XY zj0O|P*VIx7mDQsGpVyQ$9CSzm$&m>p{x;s8%V+&Pdv3q;Ze|ZpL#khjp}Tul#Tg#i z1JiJ=KGvG(PYA)Pz8f++xwp`{;!-qF_{-vc_Sg6M(KpnBp<`}aqp z`SoJ$e)FJ1a7?7@%(}c#H}Jv$XT$UHr4uTD=!p(%1I%A*00m%Kx&qD=E1(72A?(Mn z7p8X#tmSk)Kj|;b81e~52HL5w*pC0(jf6DJZPqRU1pgW^p0Q4xLmtYIKq9%A%b3Gi zQp+@~l_C#d7eeLP^Jiq5KOFyM{sp3vvp=`Ie!?#(keu9*+yJN#hn(!$Z7ZOolp26l z=i9W)kjTTZ9si%3$gQ*_pNy?;OFLXd2f36tPmi=yWQb;6lWwNF3&YPaA2 zc#~}ttH2?nY7ra`AL>CSTHg-KHRF+R@28)4fR?}g>+NHX9bL5Fy3q;e=_!3p`yb!2 z@neo%`@nwVG)j^m$&3qx4`q}9-Go#Zi3@s8Bo4sZ&;eKn@3!^kKTSgkB&?Pbode*N z4P~V#&*c3ajQuvtA+ck4t^xb;^FDnr@Bi;;qIk}CPt0wLCzt@f9>E0T=*=ybu;Eb% zv<3fS-pMJx@lOy+UA#Yy8F-a5Wo)N8KYSh$u|+zseSknc{W;nxtn;ZCtySXpKR^L1 zi+#?!bO`0KsDFQG^Rt)mOh9H~Bh}kQD>WPeXluB$Vs3>U z1ExY#!X18s?9mdAzcW5`FamN0yl~ES1jC0?ZzX8>Hw7v6kqWCnPgMATM6mTB#n*?N z>P%rQC1DI!N{|P);T&xSZKoz0rWA22AD^VI=VzTV z*1MxZomYX}XP$w&yJ{UW{mH3IUU2Zr0p4%cuE=SLCR&FU1%#Gv1>%Ni?Ba%k98Ijl zGaXB>UPaHa|Db1NN7j1!o`J0U>Y00fvJ@<Jlgm3`(-XBZhR8b>ke418S<&CD}!w<#LB8T%jH z$;T$;lp5}c^GwjlxScxs4%9)n%;v`NYSdDPhQPNuOcW|)2C)cPH?kQSz+zv zUz0x67Bu**Q^byqLf=e$f9S%qLwA)uBS1G*I$AjTOBof_+qCUf81{8|&Y-p8Rmh?= zsF{YlL#>DJiNI>AXt=V90xUNt%j6v`{uXFCqvq!*XR!Xb>yB0`s;CO~DuQ(xo=$}zvM{v za(j~{6>;;v%Ku-w@M3J*&QQ_?)Pj};}f`_fwGB1Dswv}GTuCzw44r@i9DYF!4Ub4-24!K1Xc|{&tiS-{p zUVi`US9tm7*UO(jUakd2%1fdykV9x^LDHg>?IXgbgA+sDo3lYzT+hF$3d zxZ>MqnAH2YWf=Zu+h>3l>Lx8AhB_QRy*e8Q9M%~!$K2EVa5M90h@fi}Zb=cH zO~0E{bd|yLnYY?)!(i|{=j!mvGR8}@fd5C^j!27u(>W(D!PxU2&+W(H-Q(F@XWpi+ zuXl!D+~Z~Q+#at6f8azs9&Mc9Zx<>VuLXo{bjsp2Prq3_vKLPr#XTM*^b8J$ zwbg1$H?o5gx20S1C2^y}*m)63`x)_IqG)n$XX0Y9r;MF@8Mpa)uNb3!!wMIXro|%D zZeHn~Ict%Is1~J4F?De!)rF?s9U^~!IHl5Gl!_M@u23rd8mfdJ;MBzo#|o$WOs%@E zuvv;}YL7hLBGkfWU9~u9XDBx#%Ua9Cg~{uQki}DVZOpHALW0il-YS(Gl*6ZC#%%4B zoL$GXjq%%YpGT+V?Y$F!ATQe}ZVn=J9pA)L^uFV(I|zR!D@PR9sc;>GIO6)XLq_L9 zM!4cd>sRet5?u=7+oAv2%t~&n?A=0!y`7;;e#%?LJCsd(Iz9U$xgJ6}3)7Luhn3CE z)4f+VH&5sN$+8)q+v3L%rWI2x{>9-pHBubD4|RCG#qXbbon?*8Fn7|UM|_0zjCmAr z6L*g~7eA0ltst+HsLa}>vGRTO=7`VAcB>=nRBMi59BbcK4_f?8^+6IqCpe2*IOK*= zN83pdXK;(321$J13J{JaK3x?E1=ooskGP~Nkkdw>4o#Mg+_w3Zf`qM^tyUuwNeBrL zHS6n)Tn&j0U2G~Ae&u6Z{O?8xKGEgk60P|CCE}Jhuj}EY8r{6H3-Xer9hYV8xDeKk zk%Y#N-=PFQ#mx#O23y$5!Ry|^wOI74y5xhd%Er>Ls^_{YJE4p4>bk0pz8#igXtIi~ zhz`}^@affLCgHFnb6|DG;n9}fjZ9A1AyzaYP9C-A=4hgNeKMPBd%S9mWqnsTgqBTb z`~tnTg(4{?7mDx zNf~BHTfZF-XBe^Z-3%^4PG9<=<#Z6M(b8vcWZp`Zn`*H`HSFDfRLPzz%jUf%~|8P6>bL%ExkGWnIy z=@C5CK5!Es9E#%|#K)c%pH6Dl-^#nCPJH^<&gAG}dDJvCvpkwLG{~b=^C+kjFL{(| z9$90~sZW3ZbsD3Qt)m`&`KZ~?l%GVbI^onurFVRkagJvmU*5?U34&pvi=~HiGN~DP zuSPADRzm(ZV%<&{DJeTSxcwAcvGNq_Oi3w(WA7WbVwEB{Gk3!!!)oUNm;a%KY)%JS z$~umHyws{ll@|B>wBTlO*1Pe-QtS#XtPNo4zQBpe&B&^sFRs480*iYVmiF1#DH;cV z*jvaOvhptg0096000030|Lm8|uH48Ch4=jwdI8JD`mb#;!C;mHFEaZ^;tQlZ1IO+tZ@oI{#!mzT@mrhi>NT%?vcOPZ>8vrA=?GzXDM z{2WW3{{8pmwYNXMlj;4(i#>L=)jB!;*=s3B$^a0 zw|^flVaj0^&tEr%*ygm`&WARKmT}Z(jrV@>MP{jS$|cS6nI=G4;8BC*cNhwZC1 zOE;GkCpSw7_Lso_dHFC&PhpZ~4m51C%Q0?P9pt;o*4{>Ms?%|NWCLCJz99-5;pM9=&h~bEdgny?M z4|7}MULc|89y=oNK~-dq!49d;HSCte%(3e0D}PAdmK`r{t`ymkoW3af(@~m3B$bz{ zuRWB^20L`>mkT(_DhAyg>b2dHJeJ#TQ6mUN)0dt&N$$7v4qJ3`wwG#v$C(YWWT3==SoT&l zKRYi|rn$Vg8U^||rk&-Dka&&q`0kNsfnzeHfpmIP2sM$x`v0=6&ckXn79|NV#~S# z%qWeyht3F5Ywv{EDgR%7nclv8VZMBPng06A^z*k3FlT(iYc@)KQII*N`2l5~d8F-i zf--_mWf_^gCLteS=KLRl8IGcXdWG2tyc1ke{W;nz-w4tg>ZNQzgIF_|_yRy{-v`i) z$-MrJPIXeqGEf=uR+A`=gT(yp?wp?}DYe22n(Qvw-?*p}i z8rRIL-F^x6dfe|dxwYhU)>S?P7KhwqZ6Ih`nySEH7^i`B`Yo%^p=ne?)M=jiwkb_# z@=u%Lb^%GH_$3}S^bmK3uiQNZm|YJrlYUXn{@?PnFI-C`xVmef@_lsA>kysvNjpOs zK?kc(r)k&H9%Y$3#UFqfXwo~+17;)ePGHr8%-;^sG{Urms7Rwa`HLX!I}rrG$7P|y z#WCAe!N;<{sHosvS(BXdL=C;NWX^Mj9>H-x<7^jpu78m;_9;aF6=HnU# zK92@1X-aSmg^I4sBGE$SS0Gf5J#Z({bz`C+A?H{#Yi>3xQG791eys z7jpqdxncF>bqB&O${BtO0f&R72g<4Nap0*jW<(UC7-F`!GyNyYyWmUYpqeYaDnTEEX+0wW86oV=NXe72xI+ znjV(eVMTHbwNjJHnl4i>6~rPHHQJ+vXeG^hS=br$1}ohO+hm{-L+P7v0NLqvt!!aj zFQcUgn+z7A0?OhoSVkQ4GE@j8Yp^sXA5}<)VX4c;xdaYUZ-dv%XdyJZMe)10(2`J% zdC7D;)KK*Dp_@?qEEOMh3xi+>OAi)d!)b>CHfpadJ4D?ZI2DbqaUS?Bpe-xhoZYvA z-nBx<*U>_3^wqec`q>uHRk3vq4bBwWgJqtRB&ATh@T}nw^kA`|i>8c?(2BDz!=hjb z+QLnnfb(EHgsdc+ZJnEb5hz26UV}$cuTCda5q8tPtDlo7}=&h`W3`a!NX5uKJch(@Zn2W)(#Ccrx2rcMJ0w65F zk0n~6v=3q2km#sN{pncIE>B_;C&LlS={m=J6NC8CvTSl(E&g@SEO4{F0AMpaW@&bC zA!_HdBe;c5LJWYAoE0%#rdy3^~I1g%J!tmtQEx=%J zQ8@YjRf?+xP<21VY3sbK>oo48fqJW%N2NKNONwR%rp~r6;S)94%Xe#RS_NTkh zbwB)i&=^O7a5qb8IySk~Sis8bJ+jhz0{dBieVYEalhJE5k;3Ao7&C>mY?7u?m0VAB z%F9p#7%~C|6U9Rf5;Glg@kQl%a4j`xYYjd;sgAoz1hLqWc~y^?X&8&GyOKFd zi0hN6xSb61#4L?gBWJ=`Daxh333A}5bgs|RXG|ViC{R@%f>+CFdj%Rc|3G`gEb^T*)e7hUQd!TiLouJ#h=`XqX8Cu&0( zwCa#nFAQ1EW-h*O3r7xe?E0+F#^lj1z@9ROPbQCYDD;-EkHh!-b|6m?Wz*C#zTs;8qIe9A&KPoc2#oCN@Y zLW8!Ewjkwj(zYz(K8vHAyPHL&Ai^F0!StD{UBI#~xhT~=4kAC&80DhMF~J`n#bh$ch@fb`pqrZZni$o( z*hrYD81QK{TxPONfNq}EJU#E<0B)QcbJ$|~WzJ(4dqov3lClX#6jae>@msMs{_II= zE||5S&XSR8n{Qe zgV~Y+Inz@_M4M-|L!9nwpHOq`C;}!R0I|$T9Q8tlTkCm^19vs$_kF#-6^2_NG{qjw z+1zgh3+@L6YtpC9!bIZ_keux6;n98F&;n=z=XF0ON)UhzZxom!N*J&zg0faJW>h8H zJgXfOQXQXYjl@p9ZXv@mr*V{w%)3g9d}dLC6YBQ`vp@SR*)|u!nADl;!2vp;aJV##JFDaJy<(ryE|OS7Enis6$NQ{^nTCQ8rJ2 zmt;5TGli7)yeDx~i>J#@)e81NlwUjBx7(Nf+0kK-dW}E{&ASIMw<)y$&L%+v_pZ6Psr0jNS0Crk7Z0f9E= zd;h-7iT*uovms?95HAZ{LiOUB@H zz{04C{QZyRZ~y$o@Bi~_`Ntp2C`r|e=3{ewOYKSsC5L*B!sV~fv>7QXBjs#_&dq6Z ztRK8c>*4AMCchOS(F0)gSa*p}>sGjw3!mHV&bkd$wZS8|vnh>T- z;FAmJCiFV?o5`WJC5M|s^WR4Vekt6@eZ;4S1S{2FHqgnT9FreVx~*ZnbTjotLyBV2 zLtokq5I$qZ!r0o5Eo5?#5}>c)J00bWpwXgbT^{k1xDV>j+{5wsT2FK`yBj)98mB9;WNhsuZQe|=1jRs9)6lUIjE*CHq<|0Tts=#_*imJ64a zYjP+<64bi1tsOKY2&avpjX@$Dzo+^^n;QS)??upe{(t?r%6#pRg3PNU>*aWGM^1Tw zqe8ZxWfqnAT#N1wrFg6q0-RHc=WM#?;wU^9C*?5@n5L;IQSy@GOj*C~E?0XyXA}K) z&>@(?zbf5uIy8Yq&inyt@5(zRTuizCc+D%>`lfyEPZk(oC$y7-&ZB-}eKhnVij&Y!a&5tC;@(5GwCq7MQNdQm5T%^)ln~OLLgpO#~Wk4 zHE-Qz`;0+Wm-lKG%iA(>&ub>5^+^UmO{jT`zzw1H=0|vXf8xj2lQ8G~4U|Sm`xM$N ze=?zcuT|sUg|XdxcdDOsUV5Uy_eat*h#qJUU7oLn#EQZ>6PvwedRw3LQrh4Wi-0nd zjEG14iE&>~3Z8F0wlG@yv9&ToFmu;9HQ@qnbdkvUva{Yfm4WmF&6|XRX1j|T6a?U% z*zq;f<@%&6@Z9As4SKp{YZ(jAyiE-LdQ$p)=cEM%ku)t*NkTK!LI(^gs&u^;v;EHH zyz|7-Zy{V3)>g3!OYcT5M4?@liEdvr|E^C4#1UiOB2-bP=+MH4Wl{vMr$m_V%sfGB zC5Fd4^E?zoAQ2_VS^yU`uZhmrC!OMG5^(yS zu?9ZuK8kJDRbITFdSkvXO_YGF^6YEsT9fzL7`B95ojw})Li#Aog zz`!+DNlYmxpyRGOUQZeFNW4MTrIqm5T0gU1r+cGxEieG+CG~zweG?z=i+EU{gpH%< zGWr8(!arh}Xy9vt;VNWaPh~SFPy6NCn9BG_p8w}iYtZDvq7*9PelWQ&1TBD8(PrHJnAw@qt{a_{h;m)JMae$SCa~zg(Ky5r0(yj4~g@>NR;&{ zGzcFX4$>lbFMU$&TaTES)Y9uIpB~d4;qmOAcUCq;JGTGVgEOnX9_OY8*<2M3+Mz<`@6pHZ~_!SEI*bs*hu!B|YG_+F+% z*Zh@IA)X~|6~?O(KBF_<+C8gzL|rjR?{YghvS_fVs;|RFm7Cp?@ck3;ZPa1+5W{=w zUAAuu6^dhnvzT?6^EgY!-wEwCM%-2+E`D1w`*X-0$a<7aah!{qJqzZVi)YEw4@!o3 zZfH$~iN-9SG(l?d@T}$u8h6bK*ZH)@h-Mcx2zC{yGb@0rN(P%J6?OBdMd_X}KI!UE z%VO8u4&&uSh+Rr`eQq7ky&LV|er9F9_< zZ@V@|7i`w4yud%9;W)G^+iS6>u!(D|HiUK0%4tX2NYd}b|i9E`Yg(S$`BRa8y=&Ql5 zN>xHs3=B6EJ75myMM55Z2q%9E` zo|3RXapQ0yuGvFcMpbufr}|$!k>lB~^jRE5k=oT*Y0MqXuN*?NUxK9w27e)d*|VK; zw+=GqOa?c3f1#lQK@@E^A({j&9@r2+j0rEmUeVfh0O;)54!K(gr|C$ptTp0*@gfLT zS8!BjYKxAR5+N0o;G)-zcEXNCvu8i^ZtbMNnXp|;{RBhw8_Jjf)XT9rP*9JujVdru zSim)Bz?H0>b>iK#oiSM(vi`E4w^j_6lIc7kT5ALz{&fOw3d+{Yd$nN|!Ux8(Cr!%i z8Asf$J-VG3HQ+FhI=9(@-jr5oRF$R~0UNfeI&9=BHopsgJM!w;j+`tDKTd@8`E}K5 zXjkOYmDUNYpW0GY)t+Tj)h3(K0agPLm<$eP&vwRSjrgOipeA<-HP|NdwwKLa5g3uy ztXKH!5)kT@(J4@E)tw53E7{Jxd$v>V))s%9spYcpi)7fRGo8(XJT7#DmjEOL$XNAb z|6uURl4Z}Q0Wf#ZYR^^6%@NJg%IPYt{#>!i#xs=V=t-h@ddEV zfTkKFv1w2OyRisXC24rb;mK!9mod}V944qO;1QeCK|lw zC6|s^t=$?(a@>0-fv^jTdaglFF@d9-5`b8{v_t-KRd%*knrZ$?{OfNhS3DH7E-4Dt z%PkFj=M?R6vxIs5M%2s|V1`PDy23+!Uhgk5%r5x`kM8$x*Zbc!$J;!T*z7Q0kcR1$ z7XQn9mFq~B+(5s+qJE%f@;+Qaf*^CShSo0#TSm78Y5yNkL^2O%zM9cAAY(Dc^kXrZ zyfPRJ%~187OfBy4ILXBOWeg{a=fGW%76RWDYHPCG;Ml%9%Xz%uJ!kOv0Yf1WbGP8b z2)?8wW4|KbT9>eu+)OKEdCB6Ka??+D<<4xG;>95410wHc6nD;GLT! z@oAttTa|I2^Y@bhJzj94GZP7xGP)KI>}&%Trk0#*CkqAdE6z*=qcU-D9P%V!3%M5F zRbu3|wmIheCU&x%$A$NtEM;d+moNe$%v3y%GmMIt;J8Z#At26zw9VIymp8*WX%k@% zZYQBmHcRhCG6>9@P>Dr5ae7>+)X98yBKA5Acz6keBrpKzSZ&LfVT$o93a6qtnAnHR z9j3PJvY|~XlWSjQ?fv9pj|)3Hxzx_>E>RS8V}i&25(Tnj9AMYI+H0Y(qBywSN0U^u zwoJ}^j;FC@9_;RM(!GP7?Nsp-g+S8q@G4^JJJ`lRwE*^x{5SFmHBjFLI1UCvGD&@4EB6``#Tp>^xc+g&>w))cZ39sYw(mo5 z3;7KVE4VJ%J6j+)1ty2!{RRMz+)$?g7aNz`)`tAtv1D>zp+VwgsIhI877pW6?jMt5`(_O-$6{6MnkCyt3P21DR56-p54)NpDmOgAqhf02 z-|sh#Gx)>BtOXfKihbYn%rUp5whf{H&?4QR@O}vBqgR`qh63Ut%BNnJS1o1pTVH$88%J>Y+YC z&$8@uXnLdsw~uWPI+3k2A?OhFTgK+rm$a5sZmRf1VQ?9W*j_o32Er7jp9UgqpJH+C z5SsnN7XDY;K*LGdCU{47vF{p48y=OLb{@C=yWcXm2Cv9I^TOS32~fm57YL-e#JOJ7 zMvsS~$8G=SHQY_vD3hdfyR}&{^0w|;Eua;D#AI{gX}}f_GZarv8AJbDzN~QIL-Yyu|QQ(9-q(hC{WQ!fEI5AWgN{O3Osv_ygnx z0Hj7|$ryvfJTC{e);7f+mgzW@!sOR0;}hR#nrMDqgSV41M_%tfC8l%rdBaTr zPKO>_9Mi7M*UkCKE;TQ_fVSlt8amVTc+Pk^u@g~HjC~S4uA}J_nFqKP%q^LYja!!X z{>1xecJBwPRE+SL4zV*}vP&=r=jx)KdaOOpDfc?z>D;i8aF3EYP+*d_K_%02S*<2E zBXADmKrbubHwH{b+&F|6#(Sy5k)tKKH9jWAmr{oWZ@Sqr7*iHYUgrP!ZZLswQ`S8w z$su8UpvGTvr4`iE(;J}D7gSx{9k5xlk(DF@0MQ-b`Cs_D-`lBROOxQigTR7%7_p1$ z-Oqa-%?9`?tY$<{5*si*LBJuwYmcSf3@`)WY6)}*d;L`7irF?^wJceT_ZqS~N1bfk zCJAko(v||}b)t;#$2XtQJhaV69Afi;gJ+j;=Gu9x`IOMZjCWeH(6TnEbJVFpTe2V` z2~eOdkz@g_EzzQJ{U$Jcf!G;*qfI8ZS-eZQIa*>+TQHi0l+co0`6&q^F^v&pNLdDZ zNUT0ZiMEUH{p$YLApv(EA+)GG@g+_}2n!ev5}-^!kISF~mJ@;Fn~nj-+n}{B!Bb0y zoz?}b!i1I8Kh^M z66#gLVG6SX~%0Qt`VI5}8uaT9@c0k!8~XisZCgf=?C% zd4$6ILich6_q+rwUbT+aTJS2yP3uwt@hWkaDJ@`btBSG(zZ|DvPrCT!OjKofUP>c= zaYAic@GAtbwJv=ienlTQEemWuZiHXKFsrzyj(jz~(!OHfem)qJKP${@hyeg3+2|xO)$HX z1)jRy6mmo4lj|fi0i1MP|2!O$tVDp4(ttb8DUBl~;tLUdX@D{N%?A8Pu1FTdjkJ>T z+_NN3aJa7D;e)mF=e-ExfF1gBzop0PIPQZ!n6r6V6fWS z%ZLH73mo{@Is$0m=a zM{7Hzgy{PogZPt6UO_$2IK?0ChFXVo9nK*qlmMvE9AYAC%M z3{-KzR#^ru8$o?v6d*vyM(-PgZ;kP`p-U$<}l-~Y(m z9<2}#gMzPU8w08L$VWaBWYO1C@SL{#QTYMu2x!L}unIjkFZ{o^Ni?cWelp-y?~fM^ zaY?|@5U-0#H_>(9D`xxIpit$L#q>X4OukJ6ayX0WfMHI%PC+PAJ4-_8U?PL39Rk0q z+m2MH1Z1eeUhA)I;Rk$yC;ZXs-*SXp%=$AvTl{K(Ytr_#s(=&Mi7;L>&@}(xHS=dI zGxpj5&5Vy3KfP#x@QDTp$XlA#L~y_mG_)>nY#Z#VW;+s2!PXIQFBfeTXdAuOpkTAX zBlT5_tfQnf4XEFcS8$*|Op6={@NsQ`%M-YOi+bZ?%%NNzsy%VawRzq z^mU4NfvzRNzdI3of_281F)~!f#@;_-6C|q&{M3^;+SbbH7V(N7Ab~_;pQZAU>>b<5 zM0G&;tGMN37%M%)Ei5+bqH2m#PTn69=L1FaykF(Ve$pq4yqL8s{CT((SK3v?Oc07o z%(@B_S#~LNa@JES4@x6P_gVX#l5c$MDf#lTGO|`-=3`oc?L=yq4o_U@aeP{4cc>j@ z)_Fuz*g)#lC9hhS@Z}bX?}4&ScskC&%!x|SVY7LVvOM^bmKJ>D!?}q)uz~X*2yi-C z9`bD9)_{)`=7^Z`K}-hJSop2++*MApxsw4BjAACAg!aJ)(Pjcyw~b}y5f*$RHHbZ?k9E#pDtJvI^BPv?Xc4 zi{V#9#B_EPe+3kwFyKl|67|sYz4*j!7UfZ1>*066To`Vl*Llg%&Wc|!bE*~s?DoaGV?0$V|mfsjp@9^j( z0*Wd&XsaTA3T53HG*r3_C?0?eyyA(f4v=Red=}45(tt!mCvW13BqbS7LJP*43)|Ha z=U&ZK4Ji1`WU+La_W_{-2l9V--0MqcC=e3q?+(`x@_A;H^)kvA-G zIeZd7w@OfP)mOyL)Z4`U1l}6&*{i@k-FWUt2k+~H_dk+W%^b1!L%~Gy50l2(&x{98 zepy-NQy?J2L|CC@+jiEb`93RzfqNu571WwE-)Ds|P)|cn2liLy?z7bP2v}l+HR#p& zP&3n@A>-(dm|ka0C8_K#Q}1&_1qv_;y4D@5k`xMn$IPQ@m%3_%}&PH z%||W92{tH^C8^nyv3mJ{leqn`p=msIk2FFbLQe_2OWj< z8-mn^QFu&17Yd}+w>LvquWzrRs~m$dkMv~d0>OP=;2JP{OcHQV7tdH1;LK%Z=(-H# z=7y31e5ej1cXVeF^qyn9{SQJLZx0kC+A8ZWf%XugCWaDibV=O}Y&T%{R4KvcQxthW z1=}rvoyur=wgH29fd)mXW`kh;vc>iWFSdYVt&QSP&}E87e!&Kk48dFcBtP0O(Tef7 zUkED%%+JY?HfVbvfr)=ZSTBbmNK!bu=`|eAGGsO!qM6!9IR(N1rFC@EV9yNkYZ+pk z6?A}?hbWVMOqo6*U?82@FnV1LniJwMyv-wtp{cMxNZ~i4O^axQ{Tn{OnaL)>2V;nu zAQpqo{ld=C|2#p22qDrFM1?<1`5`QzkGw@n3G^dw3DT3Xw!7SKOW9o5hTwi4xU3I} z1h{b6l5Fi`1ezF0hmp*B3CtpYo7v`kw2G+eH)#BS-86LicJ5HsPCb%J8Kkb`^I%G*M8c5So#`eHF zya}zr#wn@FBp<26NSV3z$14|QGSL-8HpmF zVzHhPg;^O_Ek-RZ$JK838fMSDMWu=Mrm$JoOkX3xe2Vg16%*g=nr}fzIe9jt=w#6B z!ZGpfYb02GQ_9asaAopr)!;rVjbe~9Q$IDHz6Fm|^#^WMXx#zV39SP-demd+L=6mg zc(yVzwE}S;6~)BWPDFpBXG_ySqlNcgUQNW)pq2;Ez9^1Q&&F(AQO5WwuvCw^%20M_ zWLUiSHTXVPkcCB6qT7nYzu>zH%B0=$&n9Utv9svD4VzRSQSgV4D{_&^1JqD`gjh1^ z@KJ3(xt3NMp1FMDICY@ixHL`2;u0UCpj2iq#U+(!4y3pNYP9VGHr9_`pprF~4HKAJ zb@&;dLc|!*`BY9(q^}{(ovJ7Jyir^};9C#8%IInoXX|I86pm zfzyK0OF#?#3X>>SCeLT*!Oth%J6PLESGqn-y3+Rr;nX>_PwJ$vBp$!Cx2-|dChbxl z&(K2ilK*RO_|`zI=&Vax?NX3TB*!4Uo=!6Bd0lmt*M8>HimtkP^e#Ky*vtm*yXn{b z=qLR;`{a@}BTi$(zI;k6!m54gK5=DG{vC~fuWy~e(s0c~^DtRraN1#@OqXeB0=#Jx(ps>lI4*9@#o_o|9XSI{m+8cE}tm?Id;G%?33EQt`~3uKa5r!C^`O~?^j??lMC-5_SD)R04j z58x^rD6v8Y*T9|N^4)wTp@Ok=o^s3^!+XZiFl65yW6n3cTNBta<-FFLA(RzoGu4bF z^hjy(TLO{RJteX69Neh+c3ZH*=bUZ|!Hfr3mah^Ple_S-t3;ZK0w0Af8dF2<9dDxz zTB*j0?-B-NFoJh%D(4VL6un8Q4ceLy0+U1pJ6T{-VvZ8VLxjQQ4sq@Eji{6To#S_$vwdW=^fk;Lu!AlJ(GXkK5FhbbJq|+=JDU%~{F!qBBLx zwXH2M=UUJ?nfVH*+>ykuFP-5%#}S*P0p8j+%OMf0NOCN3Bd?i7_{Wl=+Lom+KdM3_ zjiH41|G^q91?)4D7^u4;_Y#VR1NJFNbj;mw`;p66QSY;=2L#YSFkt(me4mLNP3qC{ z`syKQB~W`ieAZKlwbw9vqVPVg`3MxH&j8ln+tJem?`r zuQ+sO+Aa~BU^3+44M>02rwUSZdgfDD@#)O9T_83AWk|#eC1?!)Wt8|3Wlfklv@qpz z!4swe#}uI}KcE-ab%7>;lc6iTc9kM*^q1jH;LSUWoz#|)Ex%AXQF!*h@6lHD=+F79 zqd8{3;;%8`8U}{|v=RD<6QR=OeRrIgKSNVDGg8Dm4k*(aDOya00!qkF=qrIGVyU#i zlBJ%f8J2Zx1ryzjejb*1z0pBpiJGGZ%OL_yj6UcFH&~wCAdFa!-QWb1lv?Ws$wvt$ zPYzMKg1aCoV2IWnhSV7X{19+MwxByr;I4-saD#Au9@==8YAP2Olapxks7P$EbQrpr zHBtSbb>6|>k+Oh)(mMtGdaZX}B(#rtJ5=t#(?e!s3Jgud`Gjw|;Y6t4wukajivK=+ zqcz_I$dPQ+hWA7rM z6X6=@%6i2zPu(^2-;3VC-wE5;D?+0`yFyy{2JN)wt=(V<`Fi#EQ+TGNd?5W~(BGn; z9iFY{fp!}4C(NID=-(U*9T7cGg}1hap@`RWy-$(;0S8?)qCsDV$%3ryKGi$>>i9B*&qBC#~!BQdgD`q@5UqrE~{XBsYPva zz(9+i=3pp~GiCYm!(Y_!^zfsE_lFm6FKSrc;-f=`>chJn)`!Op$ZXW7M$sCVP?jl9 zk2Ah}WXk0&DmIWvzC7Kxemp)k-oy`eIw0phT;us zJ7u-@fw7wP;^;Cn4WP(dYntzZS_sb%ioh+gOc&aO#R z3&bhJUdcE>XBw2mv0hxKCD@oG`%%kaLg&Ejn6L(P{CCru14cPEI*oXe*btC>B@KgE|#CB-JehBE?<{PfTUhLSZ3guG0d8 zLpRB&g@TB7&@$*b@#Bq1zbW({wO^B5=TFSwygbkcjBB*{rfO3TF&Jw}6#L`)koE2VsOFAY; z)5eWqBB${hCa+w2RS8O~NgSS*)S=_srO>_~w^{P667NqETe~Y%NzuJzmP9?pO@k6F zLwT17?gonJvuQUkv-hmSj0Kb@h~aD#k0F^^?wOdUMOXTdaM#_Ts@D>PQN5&@Kq(hG z)=uG;n57qBhUYTb!I%;m?0^FK-W5yAW_y7f+^h-GF|~R(!!;2EKtEh2+8T#t;3hh@msn0mKN)hmXmy5= zcbn{V&W1clqEeXN64POLU$aEM!Qi)JRPiYf5<-BR452fu9}IDr+uobiK%&^{QF z49KD1&5&enUA7A@M~RU^AZn)>CLj=#`m2ydo5wg3{MAK_nnc#+z2j=NNF)OJtuYgL zQZGTWV>?vGAhsd)VKc<~ENtj@j5?g&oq*dz9t;th9A~Vqd)liW8DfP-REBDK?r&=8 zkRY?5tNW=M#|W|zI!o*WYkEu6(O7p9#EodtS@Is#g(1N@D$1g`**VlmK*t3wt$?tl zL0~HCY=`#DDiStB%Cn=~7Z|0d=wfgvwRg5CFPylpwGS z<90|LN_Z@v-wa6tSaQ;|bJUUC3o`16$lMw7A>g&t3g|h_T0lm?S3vAERMn+us-(aX zA2Q|)&mbz6tL%oi__j%@%p{==3_=c&?VkFGSfQ!iO-bSegG5}NC64LxWbU<(NMD6C zs0fMWB;m7>^I(UY{=NM7_WAbd$Dd^R<#(+)n+j%JTnzpomDn*IkyPs%Gm>N80a%Pd ziQ}I2_UWH1r`z|x-Ts9?pHGBuy(EPv&OY(&N}!4rm1N9%e%pE^fyB+%JZ7S{UUIn; zZ=ASg9mONyt{0em0{)2`R6FCCU$3Cx3{4|?owH=w;9w;{VI~RLkdQ?~1R{j_hxu7& zTeffkEwg7S9a)-*-}-_a&Qx@ys}&_iBww$<{(@BaiHVG`vA#f-6O8ppcM&Vn1%yJz zSaJ3jPH22cK4Jy_w8tuUv6{H;dPRRvTzlf<^^GH0S+Dub#GFQQRqc$px4yu}8LCG( z|9?iS^!;zNA@|;XwI=pE-cwH%wjUW;C z#F_!*acl+W6bp%o33Py-k^dcoD`2@PorIo&)uinVJ>hF(HHjXb-Jl81kYk$CF*wbD zv~e079pC`f$Oo5oJdjbxNWZWcfc$zKWJ%Jf*(A_lh-Eu~^PXOeckVsYLb4e`bTQ|@ z!>A2_nwI5ni(Ow)WmD7{vN1DHl_Vb;<}j!rstuCnAfFTQ)O)a0Hr(TP2&KW|>_-bD za-YM2WOie|uV&9kd%C9F3|aEQD=Z6NKcMFxsxj;Pj4^Zf>?@q1WES>=t0-#zpu9}7 zhk&ZDjJ{@eZmYNXW9_NLoJr9c1#A_A~^w$hDAl7y++#i<_JXw_y> zi$Jk+>-jTJ*mDY3vlP9{#+f>gnH!Wk$9>i~nbN*-;Q!Zn{Fxqn$c5o3G@tq_36_7T zu~4VifjVrH8~W7^hsb-J!-h-YGo$13K+tvby3?Wmyr0ioj|zc2)qFGj44z^C2OXN~ zo18Lc2#MgVK>ArONvJpcMDP6WE9njQ0@Ztg?t&M|H0k5Jdj2zoc|NouyjX-FVffHO zp}&-7S0oDKMV~#N8hkQ{7Gc_?PoQ*oPDIUUcgY2Yg6FNm0);_Ww*0A{hSpy_jqVlZ z-Jqa=yI5`(R*k;-$f`egs$<=dEe!K-Yw3uAI46q*>P#v{+YY?~Rq`DJ&_F#|hGNl? z%OJo4r_u|cD@!c&{WBQ|i+*qEZehNwd}Nd9p3PAzR99G>-TG<|L2=$Kic@Hx+J6cY*YL^ikZF&?pfSx+n+J?boOc6J0X~^0xLO?7R`Zb*CM+1^xB)Ej zXt*X9TL{ECSuD;(P7NPgZ-e5b44?uS^V@j0qQ_DkKpP-eup+#eVQ@>mG#Q8rsuj9l zETU(c!+h{tA2mSZ2Ij`Y$u;C71mc`57AGM)d8HMa)syDdz4RyZTXd<8w5_6skRa4Z zTh^#nnhXllOY7e(NL#PpfUL}dXUP zg(-GLY@i6vH00xMQLdRbQqAe*I;7cH{USYNJVMW?x9A~BD~9T^X&T@wb^bMGOjckUL8v;HQFBS3Qsv;6iXr;rQdz%gku^BB3D zP0UBkb;#JeVf`VP3Vfahs_1ew59$MLvcr4-G>ux@?_PfHXN!*ALrG_vDOnY1l|Br- zhvJDY+ELZw7&OB|01H;chLJ@NLNg2fs5V0(| zj1Q7%NBF+&w3?s${W}deK1%7|_D~46%{s;W#FBG*T}1n|h~8-w+L%_yX|eqCCYlVq zbaeyrIU)}1n5rGGbh^y^y1sCmETNCz)GmIc-NU#um2tij|MDUQ<{qOZVuY|Km6!JQ zR&#l*x8bNB-E_3r#Oz-ga`X0CCjpMOX*h`w|C#uCnF)J+VN0P;uWj>TU<6c+8^E_& zN-QtpVosb{1u09U52n5;>PoLh6%Dr1q55(p?$5+0rSO#@THJ69OfIMln-`vGBK&1m z0P73=%Hp}*e881H(A2)!6{(BT@7iQ}Q7d!igoUneB|Nq#QFU=G2*sPgkH)3X_SC~A z^}G1^${=MagTpaLm-Fxf2~QegnMK9=!swpes`t$W8kJ)Z0oe`U!K8MU7yUD5j^F?? zy=G?KY2dEraxpg7v!LJG`RMVI`CZO@Wl&gElp9pS7_&KPrG6$+vdk)FeW7=-%*J{6 z_(+G8lE)3Wp5@c>BB4n0M*y}TKJ+lj9*=mbM7TxT5r%T>VRY;Ittjz zaAMSX7bwfDSk@Q0pcgj274$g0IE(Ing=F<4$d(t0_DCFn@SP#g?}@wAh9oHTmOFPe z>U?BAiKVYpO;ex2teJ{(+=WG>Vegt}nKaP)&>@;^bp&T-O@r;>Dw9F5$gwCR>8D_oyvnF$)>Z3M=^)LE z&_cfiQMFM>s^edQPbzPD%D#tEGWi=r`Jbe#T5l6d&7DctOVWWkW>?x)UXo_1GaUkl zCd!e68)C*8(&3h4yO8Z{A#W)}6Ah<@Ni3Te099vKyBrv#Mjwn>io55tOSO1+- zfl!rk6dy{cDeGi=A5(H8R&T;10wfWX$|w$}*=S8WM(R>~{z5{tMWJP!^_vB) zmx4LTJR~ZF?QpvUji~gx@cd8;vqixs6|9wmF~3+~%p!^mw!0pAeZK-&r z@E@H+N){Q>a%R~K{zB@r#d-<25UTF{MlVHfl4z1HL?&ivJBs;>G#-^qy0>4zezqvu zASRzIzGm~{6die}pCiwvnq(vBex>5cV$m`U+8{Sp`i>q|<1<)Z!SdszXXl4#Uc}#T za6<6L5D%|+iz1^P#pn7YDl+QXy}5KP+c{W04yL>rUSQtwhXQBELFcqiO+dYR9d%S) z1%pWf)DJDC46N)(-%g}Q=faUlHI|r|gxTj-iNIpcaR(c?!F}kIR!_@n?-;ZhiZK`- zoz*8g3omu<=0nh}yrSCF&W?IybWYy8lKTsdFD^WQd)$mfAUPK58!KEyT%=xJ3~@Q`|>^ zaR3n-UG**!HhD4R!?VElXF$Nes0=ysO#?EVIU1ntB~I>M;#nw&z}atkI2@St*E#t? zq*c%`QU3A}0qYC-N`7?B#_ol4R`GR99p|e&SzZLoJc4vYj39ZNHi={+qec&1CNovL6T2rTH3t$p#s>hwp-LEcg?fB zsGzw32#ZnyyV4(BfKKt1Whg}>>Q*{y%dtdq?^%FJ(tOS0B`o0Zq%FeHs^VceqLpW9 zvOL7f`l1qKDSh)Ism_^)&?Q{>nRV3iqO9ipp&RF`clj{|>=P&hBuSJ$5~ei()SM5xc>xc9w_!Szm;QEFj|HMdviGb#&J(&6XFjHs{}1QgaJ$ z=_3vKPYuz8Km~ras_p5gOZt=S`kKX=#y}FnZmgwfj&6>c#L!(nEe}DpzK9T6qV`*J zQcbuBjO~&nVRP4d%ZvJ((^wEPv9fEdQG?j1ch~ZeZ0Fz7i-$mHhhPnD+ z7BEzJ>NY>gjn(U_rIv@fT3=L+l%4v6|AE>c9g9ZOemKro;kUdInM z@XUGOBXrx3PQ8yHfRE~?_t9_AuGX@l_rnL85Mkm8P*>_NJTo%@QT5$ z9F(FAyWm#dn+iZttsq+)PX=2=U}N&u)q1K4Ft1f>vVqqKw!9G!$6ucALj+YB`r zHv@CPuBaUg1sJqqL8{avJM+#_5Ah%6<&tGNszcF!jN(q9a+yDj$K4zA@76v7+ZcQ0 ztJlgzaScL9=OdZxTQ^*{z*jeRsH`hcq#S}-3nuAji;9 zu>RvEVj_M~>SMq~{VQAqiHzD&94K;_si6KCRI!fXb1=UzW1(|O9=kBy(qeg>kv}U$ z?JuD9KuZZ=pCm^Xv~<`&%3qp|@slaqb^Qepet%l-k8eCtKT>rX2BV43eX{pu(!bAX zbDJvTj_;jwHnj%}t?0AA;L$5dAlOS-uZ;pj80VDY8%Lz=y7huGzdxKt!7bqEa9UUv zQ@ccD{(>0$3L)R;5TfCttLF|%%|N5?e+RYw0dkK{H(%IfI3K=Ha8ufrZQ#)Ku5QYn-&r&4Jc-vU-YYpEga%8j<{D*1{4<0w4H1lDyWTcCF!Dv$fx%t)T-` zr1yyY460Xc&4f4EnaFLGH(adS{!f+6U6V{ene_!A(CnB_;WRRBTTh0UBP@9yk2Rvp z!F9ne5&0QyLMapEC&JMgA=uIjcrVOaB9^QCi*h}c0`2D1%5ZydeH$w~e8twR!I);! z0Rv~d-U43>1j8A=i1vXqSjk4B%DRbgPF%SMo=6}HsfYkqIut|+=vpfUq!Ir#Uy?!V zfdv!dhZzg*bNp-e)a&IMZb7qD6Ho|F{t z5}$t1(FMV!T;91p&AfL<4iO)-a)5pYGqV@XYouYstqH$D!oFg}_c^f& z)DSP}z&amCNLeh{wZEX*W9re3(mQn0dU>$8mfR9Abqu{A>$rWHZqI}`Q$~EUnWq2- zM1@C$PV!Q4;s?LQ)3uW>Nzr?tw^cl@kL?3R}KF|sek(jroWK#Wg| zvm~7KWS~QnElpOVeM7K$Tq0!AKoSYGDI&!e`zBQ?c06Pl@&Et~-k)i(>k{b{!T*IF zFm~9igX%`3D_M~@6=NMV3ZCaK$<|5Q&(jv5^!~F(P>UPbmF^LqSlMY8oKeQMrQA

03u8F7Ld|Koio65 zgsG~wh393n3*D;e2;5i(^`pCzAk`((Q)RqWY_<=^NQyLpGTSGOrqn7GVS7N{mR_*s zBvx&VmWWiiz^>jR!GxOa;@u~cbX5Q9kf7w7kn~JL$=)M9S!#?>4I<-Yxq9Ia0d!#K zxn>cFo{@jGE;@FLCI@=5b3~~%dy+ZAtjPUo7u0X|#ni8zl31qB7(EM8y$6m=1%?4J z9LLNPQTNd=#zd?e!{r-2SkwXP496N=i#Fm*gv0`lkW}vx-}iv^GF?hCb_SjM(bcM^ zW@NGdtdX88=P>SGb5{pEZO9fczepR~8jS+6iYhGgtl!fp{^)=?((~E?-+P34>zm+u zwQc~D9TK%hi>GpAL8|w_Syiyag9a^}RR#XN;LY{i3cvP1yKk{KM9>$K&~4;8NA%nv zQL48{H7jMiFjA^oslK1W45-fWN<+Ec0!OasDq`M*=us@{dy4@_MWbh=D-0M>leyExiQe<`24NQBa-#(SA_n}MJLlt+3-b3V>@3FT0w0)^0hlarNzF3=)BNQR1;M#6iuj| zu81HTEYgC}Qv|8Bj$5azSjt%EL05C6Q+9!1`AiM8tu)d#`ZQGhlV;I5W_Es~UKfV!0`>r69hqc&9Fta|o`4*I_652U)W zgzW+=Xb`cP*C~re+h0`MS^)mw9q?D4E}$16h$u~1&?i#xqX2oE3a|*UK9#1?iMZUS zP%b2ZVo`2o5mNg@T76$sO{PJU_}F#Uw$L-nrPe_|p7#`5I-_z;Iw-3)*#DK3tav zZ!x(u`bnym*#pAu$^04zv8bBaC}`rKVA!l>O-8r(0AD*ZDE$LUDKIZ%xBOX7-+$yA z4Mz_12U^NJm@A_g@K7AiugZr0@i*tU1nhW3$vt2vns+206}R>MDGS%LdAX4N9?&BM zO}d{fpLALtR!q#@$-|r)GQ+F&rkP#>WV9K}+yX(DGshTJvYakIxtWxkp!Xh7hKvi{ zKG{5*qr-ybkIYTVr$duL+h&uu1il(G@8UfWPn%djEVJRP1W3}-Ds-ab60jVdshG>( zQQ#a;;{_)VZ|49?YrtzV=H=Hqc&qn7PHB9t7OQSJI%m0U+id8TfJvM`QV6G;LuQ0v zE-Ryf96U|KFe4$i)tKw}6v#H8WV0p!aTg#i(US;lh^t+8S`OZ(%ZB z5n<-z5-7vT@krw`+A&mI;=4HB2~EgIlxtF9&RhyRfiSxy$o(LNlU;E0s{SH zks^gn!@Gdh_MY9@q>q&G?2hj1-i_LR4#X0Nze@Jrp`Pwb-Qeovi9is+jNIHXDw>Kdo=#@}SpvLf>$klE3FFcxgCv$!#&f`#wUOyE6mN0_=E-bXw>nv& zC14dc#c}x{oNV-dvL2Bt=Q%){lF65WQ9zFJ42UY+%@~2KZ4N{MqwD6X!&b4sqs$>Q zp_of&QU(ok!1Cs&Tbj%d7ZJ<)D21i0Sf_a{)&Ex)BeRifE-p! zklw0YH~^s#Yb&R5F=;U_ovuqSWY1gh&Z5>~D0m7pT*GfHyuGhP{(Vv@>Ofku`<^7R z;G}{N!*bUa`%`Q@>!^n9U&hNM%XJ+GqI0jp8>oNSH|z1#x&LY104a&0 zb*ld8Jx0nPh$axog)&Hw+e*1!z3B&92kBj}Eh4D>)4619THv#bgYWNfR+pqUETD~4 zxyeuac3kDk=U2b{h;(yMd+Ppbo6xK;u0F0P^?LOtNsu%WqIoV4{>{<%V?l}UO!K6mx<{m~B^KknLPbkv{CaDQ)N>hr6vezp+O-gAlJXAAj{sIep|&Zi}$FWL2y z64Wjt&BTW1Ka}1)n_d*LYV6`jO(tq-!$|)h$WXq-SN!bgClha8qD7{hpW2L}fskXg zAcRbzyNI93&OQl8C@?{Nm#Wps+>tLxH%3?x1;~CK5!ZDhJtjj$zWNoh%K9cTKZj2( zjI&0tyl<4<;r-{eBYGoql3Hi_64P$_6xm%!rJU)>avYjbpPr;rOOq;fp~vk6ttZwU zb0CYlb_5%dN2hAeg)#M^!B)$75Y3rbd~zL6j+FN17)Hf4t{b3slB-@kH{w>zs4XFF zAb84A%a0wQFP(E7frct%bVFo93sX9;u^>ShJ+3!XV%>!iB$J|4s?vP}RFzjw8N5`X zzai4tWxEPi_qV&G?Bfh3TuciX+32i9#V%c3>>Rs9-i}D!(6_Fy?gg&C`AgkPL@mCs zNJyezt_X0xUB3zlk`(<45Qq7jp_1&AIv(Uy0aQDl^;bD4>$%$+bH9oLl;~cr;(yiO3^O-3Bw{JwEJdGY`LTQ?(-cA| zZl(*59|{k|dVfV~s3)Rb(_5`w=aerSYvWLSJ$K>nB+4jv1`3}Uo zYk2=4KuC5;jI=a#7n%0CqDQngXb;UANN?Yo%A9e0uyu8d*z^ja#jV;b-uwKiC7;?B zjhP0(_NJqjM4g+l%bnFek34r{oN)_d*MO$MjUPuTH{|!``p0~ z=fdjTeG30QPU>H7xbw#oH|R;Jjp3Km@vEYZ6r?EXBIq{mE-k+I`Tu!P1kW_NGhCpG zgO$cua0Uyy&MU}bT$9W!PhXdy+p7 zY5#w9OUKuoOx>+zD}Ja*;C#L&t&Do7n7=3KK@o^J@5mvQVmGeqQ_#@n?_Fzsp48V5 zb3Z?i&GaW*VjFUWA_$M!%J=uJg!%VKsy{>IPS!(@bw83$EZ;hlq}jltvoZ{Hixi#7i3O&NMm@ZCDJO;tgp{D^{>k9&50sO$`=@y><5060;#+ zL%cRj`;GQ8k{iaot&a2J2Ae|Csu~u@d=m35ehFam4;zvvI%~Jnxs0qUN5&ha>S&Bb!wp_MgC z%b$+!2;s_PAcq@*;4STZuFnVs7te6`Odlylr>8q&8;8DD8j6I0qFM%z#e(c2R*65@ zHMt>22tbzTq82hDvswT)gdir|Cs+$YK$7cbr9k#Mn##~6l=M4?OuF0Q#pksF7E?Gd z<$8H)(#@YXNJE)^>V_uWx_Eg%6FzF8qZJpVKmjq0mrAA+i5!kd=u9tK+NP5mVBy3X zC4&uQe6lLdng_UOaM0yTRc!m8Hg)i!F;}Hvpf4X%qpP1srR(7m|sr!L|lz z1IQh_U$&532wc~%K>MzpXuerGm@XS0%r|a;GRN=mUx| zX%f>?h%pul)L^iM=Z+}$eQ?7K@v3dCFy@tS31QvQaa8Bj^XbLswIgyhtFPPQYSt9) z!wRB@V;0NX9Zg3T-Nn%j7|P$b)lb_g`te!`Ok}01#)2UU>PH=(j_!!Xlx-k(VJK#2 zq7SwVMGtmHCW&9E-U)sd4|f^HSbSbPLI`QyOcURcD9Xi3p^|iVbzCB4tDskn z)9J?NwIdc)SS8lQS20t*jBtlq-R?*_dLnf>x&dF?G&Ha-ARzWcj`OjB0)s(jEZB4q zgV8TuZh)MO4LPDfsW`oIA7RU^w~HU7z-TfhU&=WT)#24XvQ#tT_MAPI&gc5&RJ%6 zv~!dk z9*%!r8(`JaRV}j0ymCgr2-irA0((_YHgsFGJgo@YCF`4Je5P{~i#ga#^rEvGds-b= zuZYF9+IDzd4Pf(QTH&aww>z4hSf~ysv}oLb?~9$55x4*W_0Gz3yEJR{VS!;~gaWOP z#W4_8Lkjh3Wr;Xy!H{IzU1nf}v?BlJn@nCB??9R{CM<4b2AKqcGLLy8H3*?H!%?zb zLuo;XzaMraFm%lN2}R6@cCP+-(dV@RGt>ojeLb3U4by~$)=%@^PK=7<{t@T}K%uZW zIA1p;y1G2fGiy^VEAsn|risev43O8*4`D@qzX{EnNtOKq1X%yRA$eO`X&c zI+tgB8P6l1{Jsrg>{%7p2GpXX6?H|jt&{qdM8MDk65Hvl=D&yLR$@fWe)&qo;X=KA zrD_$mUtjsGt>E@iW~iBY)Sjf>pCMU6uhJ$G{@JVZaTJ|hheT&Q7j}bSo0REGguPdQ zaV-sjWV23|8T;Oti_NdIpsfgHQM)0j8Y`)NntqjRJ(=@Jfx97Np=-B?^WCt^fCCqo;RsM=l-Wp!k>VQnsw1io4_Cm7g>ub^niZo zetE$vBx)D6-8HaEnnQ#;V?0OseAS;raslN%8J7(Gr}~9Roh2MioekHs)xU1bTvgfr z_qNP8=;7?diR>RnlUmvDb5AnY>+|Mq)86NaWRp*Kkb(sL;U7~->zDH@ZBPcO zAu`Qxgo7{;eRO|N-h=%74sKRjjKE0s__m~yk^I||fYf^CR97M2MoA%(a>yI3IMeVE zfs6jW4JI{H>Ym%k(BjXAdq>2-x43<7VG&Z(icd zUz)WC6c-4wuIMlpMA;5Th24>V7O7=j$F=gG{Yqs;z>e!AMWd9JsLpA#3o|pI`W%79v47r$fOkZ6~F|x zS`2HdWsgZNdLt+M)*Z+ejv@hswF-|`?i_u7kx?d(CMoJscrv9kbtukG86G7S<4-5* zP#F&-M#K&Dn|JbMpU%ihK6eLV@~fr~h)3z-5(v&d$sGNToRd=N4#lG?*FJ|TgM}X! z%lV90DJO77tk3pfu!7+Q#bYW2yxSM6xi3@-V@SWJkhW>Qk5(Yf?+CxGanP5W$fiQc zw1@JmU2{Ek0Y!n7tQnqAD zH5-M!#6AFRvwnjipdEVhuL)fwJ_0MD_BKy~1?OaY!joV@$0&*H{*H#j$j3$SFFTv7 zUD>V`yu_3#HVnYX+gl+GTY}&xcdMUIXC&LBKM7?_aY_EMGFYi`1#4s}qB3=~e+6b; z^`R~>Qf(P>IVY~4BSdryw7VYv+lTn;@r@jy=Q8Rpvvv{i{MR|TZef4U!B&@RKv}uE z|5(m}Xlx>yo2da+aeDR@&<0DEW{5P~gu+R%m)Yd^o`m=JZ>@9-BSx5`KbXT)G(067(-uYI&qCEV z2DLw1e)!0YsSo`7!$I$!X9ldTiI8JdIPKh?)P7-9Dk$cosRyOL_|c&XoO7AYp-ScY z)g$VQwm!D)4O^`q6pj2^_YUga?nH692&mDPTsjc;#Fl(of+0;k9z}xbHeYD|yo46L zSjUYlf z%cBk~J-lA?dhzqp5SG4S-f}>(68@K~5_#u!P&RDYfs|C!TL1|fu9fakZ;B#{%U(c1 zZIZ^cXqUCgo!8GVy8g3Dn1)B8!ISoY;)Hg|4#hHS)_`Im<`!WTY8RrXawDe@!uGl- zR-#u4s6rdn0!># zFV2WHG6Xq=De?z zv82?^=EUviWvxCoE2Tvg8%~WX59%$HEGoTJ@hC10HGo(L%}ditW94&6i*9!0)WI0_ zqF4uW><(pnO3gp9Qy+3EdKgYnoKOiosr3-XA$=FZ@ZD94>-%J(iTk200 zeqJL*RQfvuhFZdZKbUttsX=sS0R^U3X#tfn_%;lP6*M4Om}DuvOF9vWMA*dk~C}^nmr18qP74MNMkWoJ0KAl zF&SSdKK%$N(0UCZI0vR;>l&PQ*8mo!gn1G#lp8zBFaW?dK6BN z_p$8BC#A-wIf77iX(OOuibMlSKxl1bhkDN?I}2rK{zjU}R3oY?#3`@&?W62{(Gp#O z^@2#%+USDtI6c*X61;QD9>qs(vwWeDyrue}z_Td_6ze|5it)o%-KUjiMNZvE3nD8^kuCM z>P@D6Mw+sK>L8?``Fuv8YLiYVi?^#sH))UjRMtKQK2VRh!t6-hvnE=92CB7&VXXMPWB7MaxG4O zQ09_ncPQ3NXS`9cI7m^4;=_&-ZSLmvV;CtMtXfg>Rp_oU)Gusl9j87mHmBhX0*rke8M9iC|jj58O!tt3K%G?n#U!E=l)W1crJR|GhFmdF;Sb5`n|+ zv%9J>QhRgP)6CUALxi>_CWHrR5^6N}$#{Dh8T>gp4QvfKT$m?o=-oT$gcx8m{moY5 z6W|QQau)6o>G@<{3f&@;-6H%LUw2FGqR^MtJP!2L31kt}lLYHf^lr@-i-USs9Vo7% z9s@#8Io>C9Zq27ITyk@cS>Z8;%=?1;K+NSHsdN~yQPHzU4H_GbsITr{CQ0WED0+xe z)S=#8#4n^D86MST_oG9hZ;eeK6o=HN#AlD{+?HhSIBDwBqd(u1yd=2TR&+5evX1&- zUcJ839;G`BR>#)jU2wbk|7=&uksZqoypI*MfGVJN3uJ%}GJpro;g2E|@;^eEsHK5^ zI+25yjlzxukC5FFKUQVB>t8RIjMHYXrk(?e>m;@AP@nzwZHX_g2b3a;WoGNMpi<8R+^RjU&euj;VvZKCIJ6rrxqSfHp%d2 z=c%^eHhYq+?e^G{I5>uX9wegI93&*yC1_G?#l-KfCY7G$;gY1 zUPU~}T6La~M^_fWan=}_#q7j`L?PSbCuY*IFfC^1ah8^G94CQ+B-K7dp!Rl^?B`iY z+=Im#^!*X;AFIG*Ha#eogz@T&`tS`Pv`M#;xFAsI)FnPhTAgmfX%!Aj1MQ%Ezl(x4 zAsQT+4+d8Y=2UwyAHk(X?RV}DLdso(ngY+rJ$3?U&e&d@lze}b?T-bwi~ypu+8pLH zxwNS46kHU--Eu^g&RINf5peEeKd~ooS$u!A*N?@v%@I%nOA|-MMSYeS?E(eoV0cix z*<`+6YzQ%Rfi26PI)&472^Iz=XsJ3Fn8{-+qZX>QJQpIH=aEz{Yhti;ch6(bumV8F zdRfB+zF9O`uhovd!xul`0$w zPJ*JUUJdUiBNayt*?i&-ygqQFCl=E6lZ#}sjBhMB#wSnA`xGn*qh;N%D0;pRr{1^UA6o)p#puL?PBPyzxR4xK6!U@H(4|D>HNvb&`k6)fy;1 ze{?agE$>mUieF=QXw=0SXP41MeO3oiX>G6vg>c!*@F+08k^GB7Dr9ZufG?#=wgIvll^IYIZ^ ztD(UWYxDNt(lP3DpI6KmLLPzG67+hMo4`8e_5vM6P^m{DR~cAh5{&Plug!;FFV@xdgpNwr`9!68HMy*=Mn zf!Vx2sDfdjRU_(^ksoVUwQ74%+@WQ9)Mo@pDx2L|4uvYsy+#xxB;I=7F2h;6t`N*0 zvi2QM`iP;yS$iW)A3=t+I8;HriVY2idez~N^{X9m4#gQ^x6nm>=9E5iGkUv(7md77 z%(>Qp0(G)EppS*7MXU`DHzpRM`#2nx~H-vg8=I3)YnF?7E98;8COGh(K zAi?MOsq&n-uPG^69qv0-%o&?>kEEjdn|ogs6`Sfy z(nk)jaTe9?eUnrBHzsmA{>F`!pUmzPTe5^Xef%lO*?Y_G7)87Uc^sS^KH5C7cK&70 zs*e1tvuI6iNgl=C(B32JmEXlA=BNS1nbWIBea7J1Y8CU{qbl!?8BvJQDAS{G(=D%^ zU6@Sbs^!OMw`QMXtEf=)2@R{=CG`6X$IEZ8CQq`%@DVaqqZ;&=&Y*^Kbci@bno+%> zh`YK(NcMf{+Qj_RbMtr!{@Hwjrj$vbuAy;D0O+?mwyD0e9 zxVasQ)g$s$FY5_ArVm%otU92oIF#Lsxx7%AS1q7M*%jtcuQ~H$TPJqVw`~F2hZptP zXS^!suEdMNelOz%0zFRtK`9M^$Pq;{*3_evs1{Hb`ngakR3m?MU}~wH(n^nEc6$JLD8y2)NAPf*fP}80?KH+v*PFf z3^Yb{{0?Su%jG^_AZ#M_W=Y{$+an6|dS&*aIInFNJ}8D>+tQ!JBH#A%HNgpdYt3O0 z_tM2O=$ zP`Zc1MGXwEJ!CHGwZ|9FKD&N8ZhUsj+}!xRf4;2=Mpuslr&4`^WFHL|R0=9)Mieib zIy?$ddc8+Rm2J`|n_grt9ifCou&s<`YGbNWh`8zBFNF2rt%06I(JUVnP|pN0R2IGLND>kz%8ik0RcB8oq1m+Hw*&rzL12 z)f>{CCT#{dds`XJ%h!YnT@NzSfrmyNc!Axh;;8RMy2VkpFW)#-y`+#)FL zf`34$B|9k{itY-7;!yCj&w#3+=7U5^z=ZbB*;8~&tTAR;hv!A%toluE?m&`Jm}5GS zWVA+`5hZME?Tck@>o}rMN7QM7B65>PDOZn5X>WC=p)nOP=S`2m49 zO&f#q4!`5S7J&1!kP!zJbbt10BKF;Kf0{8%a@?;afOHX04}$mFr$^a&BLPM4yT$vU z=zVW3pbGzQT?vLUhwV#HL-Q4{RJDCs7LRrk@MzB6{ngr+*rC07O^{4peb09oFqOQ} zNpL-l{?eq_7d2=C2kibc9439_mqca@iZW(!wQwFqloUEgv<+wBjWD7>M%2UeYR&Yc z$BraR@Ohu7SnWXoawPSoD1o(UP=u=}hwng+M#@2gZ9StR%%e35jv^t;$UbdrR=p*y zN8busAyX6CYP0%B@!FknLQ=S!ba(*^NbfgG53UD^ddT~-`wW#;M7;pigrm^wL8_JG z>(K+rV7YVGW}-5NsxsF>!pgpy@pbL~ZEo%?;VCB3j;H$+BQ2aF=QG6^P8J;}C@h8h zw2?CA^pUU>G=_(3)=s?VEhNKu_*D&3WQ6w-pz2w^PLFUnrQ-AmnT)Ss4mYu4V{JN#t|mi=&L!X>L|1t>m0zURgB6CqI|5k{ zE-6a|-1+tA>n&k5kp#?Z$}$flz?^!_!)0YDzQ(}ML9QJn%h5+u#uzM;ohC|1E&O+A z%h6tv(ni$8+2QQm(*#V5z1Otu>48cAk{DZZnwVI%s2xqr{jgLY3zXZT*C6TZNb#DO z+Tp!p_GeIp3Df2Xl0BK6BH^wq;uT@b469-gS?gLL>iS#Sn&FeQmZ^sP&(~YR%0s<~ zuPM^vH5496MNPdzZ5&Cg&ScSZNNjg;^V>@0mM}^NNkbv=gwmYt?*Y1KDYV2d9e=*w z5(^-9TQcv?OO$l;0{S@yG3-iTUnLeU60?RD-#5Qsl9fCyGraWAU;qC4&)47n{tx-} zum674g6^*gXUX`L{>OQ_H-aD- zU#F1C?XUxWJCX%8|p*n=2fh7Qju-I`(aG4+WQJHF5(2}9i#6p*t`L9({|G9 z<-+T+0aM4KH0Y&|pL8$eTrVpzXkCowB~iO3vgdMh14xM;lm}KnSH;na13mOAj6$FVDzKP~{MB;$Xgy6>I1$o*K zy`LVWXg;2H^R@OgLIalAuRFT7C0iWb0Fu&(ZRj_IYD(jJZETR6U9pH%v^JuTn>+F) zO&zZ7Idyn{OOsy@^HKopu>=wK!qbfoDHkP}?*%F+c?EdkS)QPR_Bz9Od474(NygRA=G1WDQuy&md_sV|;ZB{CjX zo}vuq-MphbX^Rm0$IJVfgpl))Yz0_4gI({8gx5~<;E^iO;P^PXBVWc6(tvfWmS2rz zlH8+f&gD!)QdhLcm7%y~DEqRO;qy){{&;(8b_9>PtuW_x zHV+ZEKqxx<#5nwTJ$A%1#SW_yx}3G>yU}HZZYkxs#GcUZ$Zhd-1Kz%n<#+?M_U7xg z(xtS*6%8rZ*jGPy;$w!q}gUT$Q=1lA}>ET z;Q!836!V52@+VJa$&>hAY@*7ln#z(mF0P|yzNV`vD7&GdMq}EFz_rA=9Nhrr1U`{; zxgk}Bk4@@UN7ulyyBhR!ynJ{)Hb8F|`^U2Q381*0HaLnt<^?*0xcImMq@z_lvKs=g zhH|{~nb5YT0zSf!n1iP2dO5ix-!jB68W+dkl&1`h5LlNo>a>p01`Kp&$ku%cWuaR% z%hEcX1YYF@`)hso|;S26FL*^B3cg3k2QJ$Zphn5Str2j z)p;O8t1VY&=4u(!u*zNE@#vU0gpF<@%_m+uqQY4AbK^>#Q?g?MuE=4c*PAojPDxjc zTuML4hIcpC0BL84ywNHmOoB@s8f$O4a@syQ8X;)>T%+$OP(^A%H1x*xm0J>lFya$WQltMk64>36 z0%^&=3kbEgA)@^At7!=?@uEOZ@UJY1+_^76_U-_tbG8*gSokmIH`9)hI8_Ek*3Ip( z;pnwjdSrQ&8^Gl~UmyL>AQ2-oy+W+YV5YtJAbH4m9x^8|NY4zW^x0(knnA2sSt?YB z$5cI4W|T1zW|#S-W0;Pkd-N}ZEyQ#c@Emn3qG^eVGB!jaX|2#L2s7U12s;DhJ;T!7 zbpE5kr+A0d{T$U-%B)2{2iAnwV@GDL>*(9nI2PmW?nprA-EGzgziEBmt<^2XLzL-! z)MfFeLm8ENh_e-Wf64s+-k9WoDcVBE_iv3kmb7ly{CssqWtkn33Oco>pY`x9_^+?& z*vfW)4MDUV_$dE+&6grwUNgcnI(WF(^+hu!Xct>JMTA#Hk{?7r5g#usQ|QWxoh(y4 z%eHWe7LXYG4T-KWSC%O;&0t+DqoHD9ES#dDGGDqPp^h8N_%BR44DxinMH=IH%d)fP zXN7ALe-n+OJ@WbQe;oIi(IJTIQYCoxPD4#IAx{8(X3Rq-WWh@2x%xy?zM67t*4R|^ zzf|qi&Mok}b|F~cr~UXOpneS7($caB74AOB1hyHtr7Awfy<#MWbRlm?dLimu*JRX& zH&l^~PTV1B#+?lsDO1xo*Ip+g<;ndlFZ#r&B{T%2pQlOfZkrp}Kx!0;T-1AMzNq1} zs`y0oT8#``ZInmXYw0|yuk_%2ZdEKS-ApGZZCaIr2t?{curbgC6q|p8HlUgK#WZP{ z*xZl_)?F&8bl<$(F`j7`FtZTlY3HXNA+mx^!lGTsNS9@OAj;8FSt-6L@F(&Hk?1M& z8~muWbBKMKt??dyt zYA0349SEKwtYS^`8+jrnewd{GH!oxXA{s)vFO~93`$)Wyw->Ss#RBD!RUVPo>P)#5 zKN{ZAyV=9VAdF1e1HdO#Mc20Jnq2)Sp^~OO_+j@!CP13LAg{r_YLe9bLf(#`jzGjd zT-SJFqC_Bspno|xtx?*JOhsEu)!@1iJS)Woo_|Bf)j|R48*B>S{g4f9qr^a)h?BL^ zMoHN@khddMp81?sfC{r#w@3zfH)$;}DWX)p%_#--nMA3s_x_81)-Q~HkVY~sxY?fq zIVCmwf$$WA5>?GndkU@_TcpyWSw=Q?$7Q3=zEp`+Czsw4AMrxef96w}ebgDC20Y;< zNiX6wC$y;yqnDEyjgmbP`88bC`zL6yDgujRT11rYUdRUeRgIWLY-*LNMNscQkhix} z;@3zNLd|PsP2W&jC99;GZv~c%r(9NvF}vA`V1vFNkcodo^s9)1hIE@u*4+=;AU;IF zkia>)XMEe$3J3D`>JKVz=51tf)FIGryRKFFPi+AA+pmim218b z`DHF6{hLfRsL*+%Y*yyl?uKkgEMV25TmSJ2(YGg}JkW%k$uZ#)`&Lac%7qX0)(-b- zHa4#gdZUw_19&?SbD3X6IYkqppxq#2W_JM-T}30Ldn$frz*U3?^7e@Shw`%7mE^Xe z@V=j-Uf|mLEvdFaf*{Mli+FDY_M$q0bC7 zTKscYfL+5OP?hr1_4$HrI?ry62FmOBS~Q(na#$1?$XJdeasi>SOS*>ZH41kj!Dx_L zMB}wb{e4*6>8d(cjZ}S|@}PBN3iz5q>ev?Q@VfPfWj9M#AUe~>nYs<1b-BhNAHt{Z z2njd5yI1)bmfiOhM^V5^%NVpF89>@P%Y~-y@EPkm3~_jf=7A$?^drgd=&QSUj^gma zxAAW&9@lYA6&)E)ldZeGqkL$+n(DQ+`jz$S=wk=gY1yBAa;9t^SLws&SU*KE@01$K?`( zpI0r3y~m@vl5#UF-b*=<4JblL&8j|X@}OjT+N|k2c&GWa27g82Ntza~P|<2T6UT?C zRm`VX+fx|cj-U!IDDBm{vDtJR1_#8Ji}Af;SOeed;)4`$)EYiPBE%2l@JYMYhs8gw zY-yaa?hCd7msYN)Al!rM7wCWy*&EWwjRra_yA3-5v3RN`helm&I>WAGr2vkd&CVBi7WX zWw)Fb#^ahL(R}z(y+kFpYAn|9v^&+X_1UYqHEoERT{B-%49=4`=waDk_Uy*#H{z5< zgh{6|#H38i>mFI)2KoXx!RmvStk#F&b<1w#KZ%d?E}n;|;aaBUWs5T}F)LZ<7(0Ze z4nwy*Ye4(j-(LgD)+QbmS%}HlwL^{!b$vDjBN{7=rxmN6c)Ulqj(QD5)QcB4ec^lV z?@nFz$ih38$6fb#w_otJA{pB@9*Nj?Acuds-MSK-{0lovPX(8I6{r=-QVT&vPTv`x6Mbmzj>D5 zZvR^TbNl@!nwi)6f{~4l>G&1Jf5_ec{yjE^<=0z=?2<#+R9phbq89uwmV$!ooPrC& zCj(S|LHTiKOhzm~IR;4(j@)m5`FZ*Ar{CEB$8XEueqR20^FP1e$g*@9e}^SQ)9Imk z|CNy5Z&%W~8}3Jm5iEUc#+94I3-h8H?4Rl9D@EPSA~kDAj(IgaZp$@_UykTNPmzc! z?$;MYY9>dFm(rfT;m5!K6qjHBxY^HP6`TbA*fu;00p%xbMI(MV3z`dL?ZfyC|93^^KdVV! zip(8>SkqZdsKFy=^^=^@59)9rwROu`DOMVXMQF6Tq6L+T2y+plYK>bhsioCcJ$lBn zvAx4G)N4IXtjS(rU<{wnEjkveUmYFl=ahamN$|8k+JoI zjKO7-5G8{k+c7;f`45ZF%qm5TWs{=SoRuJhACXPglB>l+$;reNz1<-Fhh;a5;fG|og4GW)(05N@;^ir!)`7mydqA?Nuq*hMd^r=z?^!G9?yIG2aotrU8)G_7j|eM49jkcX3g2pDDBlN)_wNn z8pq5T7`HJ`!8wwj7edLf`|on*Kd1WAnC_={QZ;-fTKJK&?Sqs7Q!2|E_3D-~V5g-# zExTDZK`LcFXaV>yHmGL|*S$WMSnHcJ@nr5)?t)&krb>JLG9 z#(Ha;ty|LT!Kq=cilYR>elg${r^T7{7LPO0l@3w3PuFQrK|In$VUnM+IWR&)YWu#x z{O6Exc&f0zxT6NqoX$d^!jF8#5Ar480E?jZkVy?oJw_y+!?OD`(~M<#URAo%Vl@U+XQoZdZkE=SL@-A~fyo9OXxWUqGw8-w zm2Ai#Y08+Ug^WcYJ{@O3{-`k;hs)&}#Y@8IwkmZX;9S4$N&6X$Shts+d`g)6g3xX= zVV|)6z_S3&1-MtqDq$$OyiLn)mJQ}rx_F?Ao7nwoWlHN(ZMjuTn0k*wIV>8tMc4WX zKr8?^$sI1&5N5VaB5(-I4!NJ0#hdzi%PhPl-BFdK8_sgy9uW2c=dT^~u$cJdVxTWZ zuQwf*-7G>eu9q7jS!9QHU8#D72i&A?ZTr1(ofv z>}G-AU}+G~Y)WtipmlYQLtP5tSX1XpnI$$(i_h7b<2d7ULp?8-S##qY#v@~aW4by} z;B6|TZ!&gONY5#gBN#_JoUOfuI8*ik->=lM*uC6TXJWjE@Ck!ZSj)I+9et4LxmH`& zC=O9!T{YxsQHsU7;yBXnNGs7@R;|x>&iueF1c_)S*a1LQNn`vrKlU@+q`#JwJL1=P zI12)ZBR?OIdr7%i=iA?JyzSPWi(%EYQv1+`fF&dyCB_oIBzDfW^3*%*N~*`%zSNF* zg7%Y=CZrwCU|E;jfx68yb967SMQTsoOv-~cFk69W*qiuW>GZgYg|}3zPw3Mu>QC6a ziv9U^4Ggiv=FY^P&zDQ1z$g2}-TSQs2bT%NupggHU<+S~n6nj85nR@%KaVW~`sdk+ zq1SN$Ed3z>V*o(vdnzwqN>Chr9bykmt*PQ3pLFBe85&G7k;;#b*{tMlgcc z`HI=5K~*WyD_=a~N^e%N)~IJk0c53T7)UMCLK_$(q8$`dF?Ur-0tZagYJ_++RjFXz zG)jt9yq4;iQ>@&SXh?0wXHmU>i5MzX!=mWvXlWXz$yyceMlW-Qvjrz#3A;ojttnmi z%Z&p~r7#TiOcLPR0frncm8A3JPc!Ts0>{BW34tt%`hU*L9XXa9hoZh#ksByA{~xy_ zdIjw~Uq(M8WzGI0=3F2%tBN)1kS1iPfFwZ>#OGe~iTy#G>CoU)5**VJWLuUG$E9Ic zlZJ3hK0m53!%)U}k33~1tLBNV$0B$|omSR@!P`d%K9pTU>A^FM7|kPI#)9h_c|??W zvckbU*-f|6d4k>Yhn&zQnGLDQpBsmy2hFau$u;{HO6Epu5`)BG1v@P+$NH6tC&i z`sIi1u-<-X+(x!@v?m@{>xa#4b;C_eZd8Xb*fhtuLob(RcMZR!X<3e`g0v@jdYC*+ zuGx%=+4zE*E))IOQEf+1WtqjitzMi+Z?PO19D}&hY6YwxxM|q_c_V`btEXm)<+B7E zN~LM?(ezLcSRf~7_0<$pl2ci8YKCM~_0M11AAkR5{eOOMfBo9N2mjX0{d`-qdpAu} zm7$rIB~UMoLBW-twlz;*bJ=S>#dhpb-UZK@c2w@-#}&wuJit|%GK69DKwpto|C|ZV z!dcx8Q?#VRR-Z+0ejw)YeZ;(UA@3j$eQGyF0-cC@l@zVW1bB>kO_v{A&TCuRO%nxR zY>#G0_CX|@QSy@)_r&9F8oPA7Mxn53@I)So*Ld0I2n~u40b^e4QDrF9qETbU04fg@ zWBwpu%P`S^dLB5tbEE_M%%;j*pM<8{Ia3V`u6x@}K1Bx6%nCRKdTZrnpg z!fUb#lQk!;`O6G*(po1u`jleL$3hN4mFc$Ph*yTi@cn>2qXC8M887TM;e!wYX{|Jt zY%j$Cj=60s0(b!liq?Az<=C;^K-aTf_MSbsM~XewkOyFIv)=bFk+RRFfIHS=lpRQh znA2e_k9%(6-uFZG4CX%HR=lTJMMvK@#x;6@9U>lTYc*~wetUs<#$yx?Z6H&?pc)B> zxy6GkRzh3`d|@aWhFk$m^Hm}G=NS4+9lD)h48?7!4VJP51*N5jLSP z3A6M|CQ53=+$bh90g#282o10-ao|Zyn#-CBDKZp{!p+Oy}4Rt6)bsrb^H;O{7JydJC z-LV%^2RLwjy*THWpf(H^s2Wv=Vwa+qW4+K5J|AKbS$jJ9j1M&nU?_9=5j;`wsLR*44Kc^lTHco9&nP(z0r9*WYUSJ4L9)--N^=d8S&5OoZYe|& zqcceT2SEZ2QW9lMqo$v4StEL0iv0~pH37F}3P^3%k(){CG<0A!Bso#CS}!LRyR|EJ zDM)%>U*!m+`!LqG<@76)KwiY7z(aHtiTw3|v(IJJwhlNqQmAX$VKA4Z*>Z&F2e`a- zUA(}=X3}^AgT$4}4;GXXeg^sFf2_&;Lg zpL037wXF(4nQUfK#e|#cO`P-yQThS;?tD@E!Ahu;5HTXe;-t{{>SWGzhe;4_B@`%$ z)a6#J?y+8qU5cUFJJ!P$DIqtOx8<-iC}bB8j~eS5Ui7H^WlZcVY+&{^C~hVvRkoRG zBj58T{Qzg*0B@pWLkVCwTZ$k}wRs{r3=(FLpCS~JDICeoz~W8$Ep&KjcC!)8s`eZ< zL@>-|b$RCN)Q{DT-HZ~qIv7EW@J~NQGw{&(k|BIWGcy!|+@No8IFdJ+oQ2jV4a0b$ znA{MYJ2bL^&oLc)y6s7!y3OqJgBvnYFu_D-tfbfv$3iZb#*JzO*QqdoI8^4M5_1|r zHaF;yObw%IA4b4<%}XO2^q-l0Pf`fMP6DQ~saJS*Lp+cQC7D{FX*ctWVDlV@Vt3cG z4uQ`y5hW|{S|Cn>Z5+{pWPx6{$qI7p)HpwdNZ6Jn5`#BA9VQ9avlAc2(MH#7W=eK{ zN6Lntd20NskpS`z?{g$$k-2FP$Cr! zu(v8UAYGBprvbc4Y==0v<>5YfC^btOJq@@S!BC4jWibqfqC|THSXWgDPx<+)QkSEE zO0i5UI?KPiVqHM|hs%9f<*VV82gSO8_$!_T06MLF=>2B#RICfQCd8rv=aRR)Zeh49 z)&=?cJ}jI!QLG1f{Z0oJ4=A9N*Q^Soq zq(l+;73mMPsD9a$2knqPn-j1%#gt?+i_*@Jj7k0ZYy0Ex->m=7@9nQ&+c)VZXe-gY zD#bLc6-Xl(S}927ykyZrL|Tj_UI)<-y0J{!AH{TP1PUjq8GQ>jYwyEXmrv}f|7xWI=V{JvaB)LuNe9wN!22tctDsm8(&o>|A`O@ea zgw%8l$pk8FQB6vY^!K9KsGg_mldQ=wR-=590&r-sQLDor+e1UE^q5-ACJ(zUZiu3Z zykeq8GlgSx_gL>5jFOR}uC)^Hp;1rMRgS@ArW~c4c10ATW3!p@3bC7~LcCAtq1|^h zK;dC;TU}s(S3+v}u)yOKIG`$x4vmtdI25D{I5KbyT^s0<=WId@!mu2bl6j?4QAr#c zY*2C`q+<^e7L!owo6T)?Lna7#)dKN@VvfO?l-Gwwj%l^l@SH^e1%N~j)TY_55k=by zs?=!X7OV6M(&|)TVg$NMIku4aU5v0ECW+YMhD;G=z`FlLm9ylN7j6dA384=2KNHyp^4D|6Caqyzb zUiogaFRc?!&6WkpBkLWW#?&V^LN{n9l0dR^2(KDbe*@>s!BPQr#+F)5uoR16IjWbuwU=Tx<#aBj zmvVpVWI@chQu+q~0RR6000960oR>+CGr19k_c}#hKy1##-hkny;e`)SFx(5tM%(uX z{JkJEC8borUq&rdd>IS|V|?tchPvG^HD_02+iK{B+%C05S8Lg7_*N9@-71sg7c-@4O5G@D`8(dkarm&(S<5K$@yTLq8nUy0dEoll1qIU(891i z!S%IA$h(XT_Rc5CR2QOlm4TyMIgp#39nE0enA<{9t}h4|F3FG(ZdB(tX~(MidbSpq^rJdnAoC+%u9g8i(n!WYtK!S}M3 zeJ+*%w$ADUAhAysX{A?lF>6mnX;_Z%iYDdWU-i1ovL zK&YpO#QnpT7Xhu&9@25j{nNQ886m}m+z)H-AIv|AtfS4CdFT5FC!9otDBTao-9NeV zRYYzfx$?vR_YV>I{qpziUza~FrP9UI*h-)!5XFEpb+dqnavs}%{;>pq`}5zz_Rs%b zmOzOiZ=Sy?*lARGo61_RC|C+(r?S58m*4(!PgMV({(brD`upP|k2*^}zok4JlE-ni zRaydSYIbp!1#PEr@g2Dtq6R6XYZB37QrDhBIuu*Cs_)gsVwu_SLum(sj)qLy_fT}K z!=aO;KiToM+ouUpxiV8Qdc5x)qPUOv)pxJi=hAW=(`gbzrOgB>N z7mDgaW*1WH6*6d|IzDxI3A*vXrvJjbOyU)rGe8zU=LCK8uz7rxEz=7P1S7kZ!6$`t@wa;jx}&ZZYm7ap*w#wkqv&9zLI{61~!c z*P2RvD$}E3cUb#@!yrvV*+X~lq03?Pt=Rf5_i?Q zGyjCp;rUMQQWeKOCxqrgo!@&l4^#JkgacV`1GEVVdKdA+@EUru!K(As?!&_^xd_E) zV!BKfWCjh}zRSt^*%xB;l9OD{6!EBueJP`rKXS7Fx{FI!vT!+wLQ2_Oth9*-ax=vG zH8aF3`B;k`Yb~0=urxj|OEd^^a>to!g$qGPXUx_y_sH#?*G`E`r;_H?j;|L|!YxI` za@z1H@6&HxW}m~z6#Us`laP$q;!+lSdbn)-z-8IxI)gYww`o{?DEN#ADwj58sUXg` zC78HM@kj*9CaFdq`HLS?nex^s$*ek+si{35#ctf$k3_s*sQpy(Q)ZHYF`*@CB(=>5 z1uNXZ8A1GJJk@>n?xp$U6%)ymo$9+wmm28H*P44~ZJ9p?HU+PmMqQH0@6nqfK z8rpPLBV*9*AoO*^hCJ|+jJ#=hj!2D7xWC|!i*bT->@l=5v&jr-+_F+Dtukt_KZ zbpS<$gRi7n(cDqjDBBg|#R4C5SKRt(5Z^8&X3-2-I|xbF?a;^A+fD|spJuD3yGB12 zK@U<&Ph{ZA8AFGX10G^=r4~{ZIS}FOtf63v$4;Nf;Pzl}G$Hjngon3^7#h8%D{ZIa zzb?f7iOtDD9MZxQo4YC})mvc?g)dk2Om)&q7ID=pAqk;9@!xsZ2Mb?knmlvH+1T~= z9(z5WfK8&f$T#LNw8Y&Wbo@%p)okF9UWaG;L$orc!(N$fW(%CO+WoN2x_wwLA8+kq zisK#HLSDMU_Imi&2f_BlzAt@gJDFhn?XjW0*oWDqfff!#HgO%*Hwe$z&DLtIa0ZK4pL45= z$&X!UGx+-;qyoS@x%`kxuCq-R~N zZO9GkBMX>*Y1shvX_m>)?|N)#sh)-YQOXA!Zi-&lywc3^X?d!Q1GpKWAc$NQ_9&QQ z>|$3*7bTl|(07uo&TJauRBNql3iU}|&z@af-A)Ej`>geu{0h@cc_z<7W^#A+yP*(b z04XU~57ITtZ3>8p1d;VNQEf`@YuY1ivK;bpK3u1=*VExIi<2Z*s}(+vG^64MsP2_E zadB~OM<0mIUJ4M5O^rg6TO=o#LN%UI58$T0L><`%A~^Y#w5eadoX*}fl}SglV5yNZ z%6CKwfq`OGYH6gS+GNbd-dl}4yzU}No@jENla4rDWI-q>$$Q}u zjo$M7elh;g58zGWCay!P1;FkqSHc+vhwZ?dgwX>viYi_}#Mz>}s|WBV0nm*}RFr#- zu{e9gTA#nO9+rz*x1hddL#-Xan*_PcKVA}g+36yh_QlpY$ZRHOqp3WAvjF8IKCYLI zi0DmLjvk+YH;H7d*??jlKCPHO05P*X&9Y8qz*<*Pk|u^|0AoO$zgCy+bcrurGh`Xv zjV#{Cc2k`0-ixCSXk}-spTJZo(!mH4e61z?g z)|8zG@FqdF!R`U5aeKT7P$xBDY_{CLH(M&kTGGP5F2665f6Z}DTO3R=Y{5t4fg}%X zw!gnTrhu=Vl%7uy3ASEgL{k~BOj`F;n7nxXdVKK4_~pmPE9KH?c_n2xLu#Kg#v&D? zAR~g@tuq%R&zEf5^jN7&lUC1X?=Q3~3_XfRis-|=~f79CYPNVPiKAUPh z@7=z1wV`_4eH4D(N6$1_1LlQAYu=^#YARy#*#=yQ-N>mQbN$SW&)iuL8#VVSpEe#u zH7#vzdp`W(B8`?|Y`pSWZx9TaxBuWH`>bqz_$Z4WEIlRqU03Z{?05Mn{<@D&&l}CO z*B6jx8h)B0qHr3!NpH)dwZ9p*4Ce-9JKK7CD`f@^nQ6i6nPE?T?9U*u%3PIUY=LEDQWy@nh-RJ{a>d}S6 zb@KxxNgaEb=ETi9sPMM#`sb)!m%>w+m}Lh?DDlUEQ2KR*k_Z(l@@giloK9t;&WVR^ z9h4e+bdo=)=4?}kW(MDhi($29ib_*2HO3E(t*K;!28zE}nQX%#iVkK?G~DHz8GF=9 zdr75qI3+DZN#}Cb15r|Srv*x0{weB!-i5bm*FWzOT0{W0Gl?vp6OXUbjPYYiTqkdZNTfnU zQ8VdYu(i_aiJ7Y5wz{9}$Qv23&pXz6k%6s;2|l+G3iguL z49Y4WP}U`bf#jOv4^7Y^*f#3b$hTsH$}UUt-O{r&SUeWMc$}m85sV7GY(BFITI7|Z zXrJh0QItnhPwYE1AcoFxT{691iYU>Mdc5K(oJ}8>ouDc&7k;bwbk*dn%$iYutn@P^GMYIPe0_nN#I#J_!OG;0HA{pPeTlRJL@`0Cjt8OC>#NnR0TxP$; zU4ES#mR$Y*TJ!nQXTq3qy=Be5>*^jx1-LPe$(m7o>!IaM6$7(cOdYn@@hO+@>He^p zUGzHiUkA-Yyk!s8gFiDyANyWjEh#iA*A7Xk}&MxL5o1ftex3G&_pl40wX3eb211t7n7@om#YoD&c8qDl~- zSmWh2i@3u}1G4&=Xh)J$vxvM*WUpg}BLP`cDJb3O6CII~ToR6R=M?K1h(U=^;vmfX zS3%Qa?={ARIlU%E3Wl$Yo|zY9jdj?{mVEaz5XDdVP8a+zJ7xrf8&)XXY@wrza=xB2 z*Ja=Rc#w^6WRFgoZFk6YThB`jB(mC$hk3et)i^x-Zg0_)a%niHaJTf1|ICt126ECt z?aC5>b`rC_S-_H&+t(xLX}G?5tHV0o`;68vV$R7~#@TDjIqmsHN9J5H^rrYYEJZHO zmhAANGxOywq*uu05DMW;mY&w>RjUZ%f{z*QqG2|@N+#THhcaWgK`mPf?L40KpQF;L zi#>G-Q}M2w&TfF*jH(!C)T~UBkLCLHP80nr_PI9$`c-MrQQa&|z@Z(XT+USVK@<4{ znz#boS>pT#51X-Mk<{9&5lxUEwq=3y4mmNLRLU zi)nFU+2uK2Xm|Mlucc1Dzm`%W$;+s`uG|b$DpRWm%3d)Kx^T;@2@KxJ~VE|A`)$=lm4R~`dhb! z)$YV6@`RUSw<}qhRUB{a`pMBQJP}pYcc?BI0h4pF&qzYFA~a{?K=Q4JzSM4*8V|vi zx8U+Ix0V~fTfse*?hA!)AAq|^A>dxs(nO${oq;+)jbYmR4H{IwsNP)|K{tlZ&|2b? zrQ+WD*h{LGGpwoTJ5}WPBc{JdMf)6czWJe%iZQw)7OiPG&`SF!M0fQvV!Er}dDu)a zM}$g3G))~~zlFMy#k<_?&BN%_#nhJsnGaq-rK*Th&E*u6=z;}^&?5b2?^43wbSX)B zvl5-f;r;xG1?lD|UhV_SO%4PJ?X+&{>#957HhEctFsv5#SSQ)bv|4+9LDx)<`Q$5-S+~^PUw`M6hc|rD;P$kPkhRkbTIu<%NX^Rz z_6;h#RZ9Piq;wv(pVe%vXMu8aIQS9FnLdnC@gJ1Ra_xqtf0(8TFGdBxJF&cKMfG*}5yN6sqMt#~O?)@v@gy4Sw*p-bsHJlj>YAEuJ!?uWoOQb=| z-AeIJ5#!@R_fn#epI`b#DRHJ-(>y}`5lzX74Cx2m};I$7>zKT)jxwBv?EfMtnX?T>TW_X4nTBYYM zPY;{%&Q0H?eT%K>wroAenwS3Qw|>YqzRgSf%uC-)!AML{3NKyMenh(NDu_x@E3Nm+7)(v(^N6tVdW^ZQFR67%6iNN zYiG@{-E_svB1!FM-&A7)<2>!zRIbaJH=Nrw(~fh0sLp|N(O2h!a}S!ynZp4CcqW8p&W;p@)G^7 zEVeHfczyk|6z|Y6v~V=ViyAE|Sy02F-YJ9F8g+mGmpWyLMKMC>X6DpIlxjlJ)=LDz zqoZw?T?Gn9?G$p2QiJ2jgJfM~Wjl=k8F^?<91*#*)Ho3JOUd&5fxj7-BU3{YGkH+I zq+S=&_=u)g3$5=!+Nu~d<}g9!)!Op7R0P%!Hpo{OfA z0;VWgGJcs$;&C7zq=#u+Qgsn2R{9Dd^@-FF%xmqN2x(>?#~C;|+(|pKAXgVrt{E1{ zO_}gWko@njJi3_+ID>IpPaA2qJZKm3MU+eAc7v8vt}Z~T)VZOI^T0qg6TCIAWq=Yy zuj($Q9B5E;`iOL`tW`fpCfAG6P6=UGx|X;c6aA(K8|}CVySj)y4Y`Q?KG%(s?{#ex zmtpNBxsHK=5W#~VevlD8y-&1!i zP5uGVfsJa3);+jkyt(1OS<{QR-zJBq$%sSFHA#=TK)e>UFpZex+ zz5UF27jbm3s0Qx)lT%s$&JAnyR%LCKikR`xgyHi{^DhLBQ-C}bOx#7IhbF`YEo;J2 zaSZ!ABv|yfDFy!BH1eSdol0DG=c*&U&b;OUf`GbHryZFI%WRJ$vsj{0#(Nh{v31XW zie@&O)p=)@IA=<&9GNBHe!Z}6Q@<0$JagS|3%0pDj`!3V@grCBsD`wEQe^wT7g4;E zWVTfp$l3TLSX=mu_aw_<+B%^gmIxA|(|#!e>-{ZrL+RICA<1G?alA)1M~^Q>dSXLHY(VLeiz>*3AOs4&B^+A=(*h?-s+F~`O(f7MTCV#c zh#T*mwg)eDD}ajEaRT!Wl6)LOs}jpn{G(0mQ9BAyP6cqrNQQ;Rk1`Vg!IYV5xY}hM zh8WdZob6_MUJrIdq=p+jc9H#xl1}?6-i~b#2F+JM-{zX*^vF@{nJQv>>S17$90npG z9Tljj3OK(d@&ur3w@6@;wAOQKAEThFk=Sn5;`N~E6IzGI# zlV-q2paI=*mU9F>A>+3P=qZyMc8IKuvv}Lh^t~RuQXw@H=XPOQf9@tg^@#FYS3kNv zIMmx)AvqJwhw#63D+GYjG^ZjR*Nf)v{Zj4oQr;^fz~H@P_GFk@D3v_q6xnD}es80; zo3VO5Se!D3NhC#NVlkxZDLX`J#~IY^!Lt5y^NPPsfeGi|`$R}w=(iu^ZPj)&TCWGg zg6!g$v2IKo#Tl(vbp{XO{pt4LSZ_~7?`GOe&d`q)jgI39016wJ=&MOme}AlgdMr9K zsjWVb<(`j1vt7+<-vD4H6DuvOwF)nu3~F}-sI}QOAi2%|l=XW_jwDFj_cIlK&4C>% z1R2`NyYd3RqFslP5s%4S38?T;fm{k_rPC`%<~A@_#wln*o!+U0!=4_)MCj!pw=_l59c#R>Lidunog z-ka~qLVJ%s2U=S_iSY{Xn9|S~F|DJ)ufPQ$+fdgZ%`^VHCy@v5nPgs&4OD#|WU!%x zcv+9$E_+-f>{02zR6gGf^<%W#W|Qv!3ot=iyV*@fR$U;AoNb3O+m8tLpBrp5m2^TM z)26#i>oX}f{LMt>PbP|=w)y^qmjd&eVUBiWDs_Ik(20xOdyFyCp0UQ;khP&cne7Dp zH626N!>7r-Y@x}V)VWC^*OuFZe7cwQrgfYYa$0G7P*48;s1UiI-owp`CPo~y6Y10zY4l-hXRExEwK&E{AvD_X8^+x?gNFPei zH<3nLr4Bqx=dT7R6V?2_e>ydQn`Iin&HoJ_evqoiZjrxZdnX3|cep(q+~DFT5Oaei z4_hAU{7cdvesuk4|BzrWr0hxi|7o7UkoY11nc5d)l(i0PZAn2yqL(ihkPHgHdU1i7 z_AOvHDW@2h_6TYIOj~(9=JnbS7#akwbeb;HxHUaM(Ru6;C{ROvL!ByEK`cl@1llJ8 zL6gz~fDA#@eO*Mkap5{H5hQy_$1X*&XjIWOiA?KYI;h*@xQIjv2gH7kw6w0QUFaEv(62b(r>N8TEA+0pefnK$dg2mzudJ!hH42xQKc zC}+u;CBRM1o`LY3jYD08yufqp+BpKnTc);4H3K#zckC4NQ+CG6V*7FdOEpeO7WOkp zCsQFJjFB^4ghWW_(8Xf`c{CGQ?rR6(Q5!qof1Ry6p;+m6zy9e@t4G~BPeN% z0QfkP5Y}HKmMIU^6w@W66_xgiqRf;K74Q%(GxWBUMa52XEm(=HJ2o|ykB}^r9`*d6 zh&+uDYTw29Chmub88BpF9%;ZTE@H`w14NmTNyx=WRI{K+T{IRLLP>YgTJ09s)V|l- zmyf(G($XbDNp*FLFaYY}Dn8RGh8Do?CynjP1)em75CILfTNTD1=*r;sVb$z$gS6(X z^0sdgkxy2|2>^}iRo~q7&kqFegL(6Y&l^G~JGKWQa+A@#T|_qJ6mK%hv7o^eV;*t2>DV8VZ>XV|3ex^uImFZ8z3?J+KYvw|H>hMeCtP*iUh!zTH{=-T;E? z9@S|6`URZHfdQ{ZA}!S(;^+GHbbZIRB0(taU&_lRxshE5qI0i8E9l_=vmV8pl_z)q zgLe`vQAL&=VNKdimIwkMkeN`t1y}_feeuInu_e5+lIC+~(c?~EkRJe(PYY-XWkn@s zH?ZFL{rLmq-=dca4WJawvqukSm~Sd34UYmZ&Q3u(+)dM5)sY`-RvZj zh${_0Z^V53K!^#=qhL-W2_1k>uRC_Z@ccnS+)BSIql|C${`OL+KwRpB>cB9%;T?Xx zgue-bZ);^z#||#q$OIj_LF7G1WGuw~+?oEkvusLI%yF7XNkHD_6}tv`{-8=e>HIN3 z@#4k!vojTt@ELwv2gs|$7}(b(E0Y8?9O|Udlnz>r{ar6SZwlhLb9WMZia5+j1nP98 z%u6<1^Sle4Tlj!!N2{h2`mf=45ppK1I7qn##;-WT?-%IbgbUOM88zGC4Utd*^2vP| z>Jme%26^tH!`<<5~mU_wa*+RyVft>Oa?9d`Isu(Qg8a@B!(pYrS|MJqZ#P=^wAYee6Q% zd6Q1ZU9)K7@#=lEF(|}n@w{UfbygZT2nD- zPfc-ULh+m&|767n>V0K|k>OBAJ`bFQfy+{Mx}LS<7lFqSO4E zm3QK{iIeFqlPzgE%9&;yei2)G?_dMc@pT-*LY6)Z!y=HnIUxg$iq{XC4NABriQCKE zkz4dW9VJ$mQpof#<;FVL$O4O>IzS_hxm7eT*103Mcu1()Be4KQB8Y6RvL_hRY$UkQrgQ$-WBaHNJxwpJv6f_*y?i!8zyR+oskyT z+AE{jlz!d)kPU+3QrNfW;TT8j+yFG;As;z&(r@Z|6Ri~icXdIxL?hK?oRN9I9P`|f zU)g5MR!y5`D}iCMDuJsLvH)NxR_XmHxAZ@gYv&GrVZAo}CK6j6{v@q2?wT3LqWRm5 z%hCLJUgnPcqW9%Umo%d$OSMdzO}cpZW7uet$YST9j!cb$GC#)7VLMU-P$FTC7c05h zy0>hvqZ3Ls1#0?QJsNGN>AjFX%m}Rg@VJ32A=!GAx;*qTSXCsz!)!C%z>ePjWRUn`kUy}zB!d*Zh07HdGZNuE;Ayqc+bxiB5C?gu|wsrmKHTn7-EDyKj5KhM8K0NW+vvWW5tsK1tY0k0Q5~LJx!YWC?QC zQIG*5&)d3|{MhO6PML@8xHyhvA$ox?%W1Mcb~k3i#5JYc8)Y;EwCX9j-@4I0qdQ$$ z8**?~X~pOIvW1B5Gh_9WjIBaPExC%J!#X1gDw{@yJc!I>isV6iY`W&Ad)A%~)ymow4pd$=EtVY5-iv z%)@s4xXIgGiVD^oQKWGn`@ndcDG%H5J=%_!6tVGh7?43CZ6(;60o5$PBj+#F$&fZ8 zE|^bEVtMm=X4piYey33t7X}somSOuGE2nN5HbcH85za8?YJX?ge~{tOM*B&ZB@?ym zcvWCN1#zHmcs{#GB9^sNGgz98MWaOQ+#sWo`OqFozHuZkSS`Q)!@#!PaA;?@FAZs9i z{LqM(E>G{lw_dLWs~soO&1%p##JdPV2AM4P8)XAglEbXo?=Q$STYJ5V80DkVOGPyF zVDbxKVJbKST!;*EzjQpEJ4VNeJ48ZXWjo?klwQqX_M-W;dLR>pl+_75-(NOBPL8P_$o` znrnkgb{}Mexh%A);_wO~nBqm&6<$-Vh+0r7u{4FH@@5!Q8Kiho!JaM)>7vDbiU4o6 z6P~pC1Sm=e${?z2cR?n2U;D)n<2a@H=OWHohdMM?)r{ED%93D&OTV!6l;|8~d|<=Z z_dMle27bC7=m>0|q>8*ze3m$%^^*ol><1WAE@^(1m<8D(8LdOlwvG%KyUV(ivo6dD z3_NX?s>?_QV|zb@kle5T$jL*)o`YU89Vv*M!z&r}b9sDmbLrVOJP-=}(V*kF6v zDe0yG)TYRnnC-S~O+=OXZn7(>U{`maU&v|IPWG@~Gd|#pbp5#@z68*kDU%|{DPQRn z%GGP(nje#?aizp(yJ5?BS?JBw15?{4$)_XJ5L%4<{o&xF#WS^nu zzK*+UG^{Xy2m{QN@6ElHP5waHtoTTh763i#K-W-RYSLy3LCdORE3Vz4?-+y}{WyY? zqED}mlf@|dTs&A4B}}bgY8x8zw?x_JmMfLJ)Kalb`CiG}%a%hW&rFpMGPRN$#I(}i zp^fN8RiGfFtL9b70;5w2g1=x={UAx3E+I>+bU6&RqQU@5NC?Z)ZB=QuO@Z7+%3(WBT3bho zgiW;s$Q%{2IWV)-hpdbLG8slA`FNJo|0yq%V)dUxKWO zC3RSf4mVjM2x3TN<`?Cp&#hN~?YoB=ak)@t(^3lgD5myF+g({Dak}u%rx;=bv{Qrk zGR#@#I35s$$5;M%rwP-$=7rFw; zlc=@`d1lEFv8BdJ#dIFx&8e=x*Z?kVBO>CeTn)CQ_!g;mSA!C7*+!umkTk->4q>tj zg;a~jdu*A+YGN?6YcvS)-pAHHgSesJVrzDsXqTCS4(~;%>Gb!|!j!vYCv}~gLMsiF z_BE7T93a>|N-}U2Q?+G_;Q<=apngPU+H$EKu?l~W72PnZD)OKrY_oz=smz_{SCZfn z)k}VKBeO13VF@*+DTGL)5m>_IZCXm66&am7m>}ZaOhC7)gl@5_O-XY>?R<5Em_x&Z zh`{ccrw)~#!!b{It@+IgFbRR^YIEHp0h-C_f*ZPHJOv9(CIbq4Dkc^$ z^tNuZ&4Q3cEmBa@{l4@3qHYb4r5Tvt5e#HNkt*selLB!m;+Dg=fyY+{-s!4+2OnFdWq$=fn z_(eD|>c>;~ZQzSk#dv9WtZwLSnw7YUh7p7OHG%7t$GJ1RNl}*0fkdf&T-Uu&9gm~1 zPp>Hj9}q^dg>i;(NV?@%hfV3M#SPh@ zpnKWD{P!iiLtzyXRU@E-QH6uSAnkS^oT{;Gj9{DGl1D~lbS5>^PF=`v7DeB$UdRTa zWh`&=`}gHUPezdi0XBA!9930H>-qGG`(zi0Wj*mP$r0zvI1`8BX|Qs$86^*XuLnUAsOO@*wb~17B2{zPg|lP z6VR%jb|w$XS^4-Aw`VpXM6^R0PC=fx+_ag8c&d7Kzr4}z`4kY+^Q8!n=TlcN z^ftbnBqIT%OME_dc&%|%?Fha57<#6spu{E+oY_z|=q0ntAXQiD7beWYKo41v?d4XU zV*Dze{CFi@!GFOkR-$QDA}HR?x=~49U>>~r5dcJ4^+xLK7YH4nlW|P5V1xI1>(9=_ zXsRNLAV!_+Z;!@CJ5&G0c*ghI02eWy@w22T4oiTzK;Eq3`H3FJ4=B%4hNNmKRZ@in za8AFeqsM_XFHquv!4C*LC-+_eD(*;O&NIp#!_A_M$r>K38@Do4>Mn(<%rW*#-EC;y zdf%>CQ++Q7Oo&^D<0a5lCa0e-eJnogiHu?>-3p%1k$ON$zLlEudn%z_wI-!AEJ0ZF zwB~|n%9hCVK_VBN`~6z6kR&*Pr>+9wKsp4*x3G$35vDGvc1J#eCtx6c*TpgitR#z| z8yaA7<30xl89UDkO&8#Mx1p%G(;X|Q-GPtU;u&rl;r13lN&H3Zc0P6W;>aZxU;`vF zt_M9W)xS@seP@a>K+nmvktkDOhe~Xii#9-JGV|Y)xej$vh3nuKRp|6XG1wF8uBKsJ?N@x zL|4~mKghIE)P-E%3Ao5I*gZ}tM1ByhVG%;QcySC&LLCULP+B)qH~~)eHe};_%xJK4 z%$OR(RB;9YX0Eh)idp+0W{Y-`?z!r#r+J>|RbB`tP1nXtT6(NP=`N<8wo}AP#}VD? z`)+V`;>s}yRhBy9JF+d(!f!)n-;1Wi}tr2qWLizD66+tU{&Z7xBBqxeT@x8{5_r6Y$nNu2308 zve4_ef^uN36M1*)$5dkKCofg|)*U%mn7!xG_A4cO=y*4-mDJPPAV;^RQ5;m$<`_0?E&ipo&yO{}M==P3xH}2nIIo!Ie-y*`9$QHF zYLKZ6DUX{udTA#r-hG186t+q^ff7R;#4HfocciA=x5h&<&Zjaa?vfy^4U2->z?;g- z+2ZWFF@bGIKwSor=S(Xi@CjSq)>4qGA7T|jt#&x(`Cqs==93>&)r@H7OVajnNfvd{ zoJc3fg3>F!wL2E5OkvV^OhP}^p(o~J7dI|U#d9^C5(xc1b>C!jeou7LEt`|67zrEZ zLI!BJZ2G@v(^tAswFrZ2WQd?uW^9{=$(2ZS6ER_3)FYsNQ;#TgMMKsj^@0hau|t>< zgI>t5GYYGyfta{#;`DkeOtp&NjT1_UBqwZUJ`me@Q8lGlRn-ZzNWF7-VFFb3uzR7Q zANxEb!OKXmN-pb&9$4?(GgZ__da<~okO@!^@8{P1?lj}pOqnU)qncruODfteQ{nHK zk_-`SCn2fR+zN2@DCC(tlqT#piM#~O{Qf|U@C)J`3X}s<&9=Y{u9=Nfsu8P-b?yM< zNU0>0wId!vokwzYHa=D_eysbOG6MSKCaxO<%o>k#hkEGbM5&a1Au5eBkkaEQVWJ!; z0|6c7;G)RAsD%m8xkEBDl1@pqGov4?{URD1tZvB0wM2ej6)N(g84!^tSVRC+YE&-= zUhD6@`~vF)45D&&?}fU6-|s7oVHCuui-AQz0uMv&9i;+w* zG?l;3FfRLG`@`f52;KkzPA$pkJ038H5fKF#phu8HFN)v3hhC^J6~Fzi6&Ka@GR5R~ zyE$*&K8rtoQ2fj5pdd>Gc<;&wR=#j&6nDyTWh6Jwva*_$^(<~~K@Givdv%}WPzR{U zTfsFxLrYh=HSPE@_r@3p`uB*YzejW}&=@{cZikHPahEH|teJWavh+skR0KM2|aOPZEf=+f-tx-fnNLemAjG-O*VCimHQ zpN`A)Twv=CZNzz;ioS}dsC&-JH}2tK(c+nj(wxM(*wjs1*+Y-$H8Fc#&i9}(==zp zi)z}_Ac7v~c4q9{eCFeK-#jfbqAkZM?=)H3KYk-Slte^PngZUpZQOq%GX|ZDLGRQ8O?93b+T|-uxH_1{voYE+N z6W^1e9`wdQ(@_RC%Uuqp=Z35@Z<3`}>F$(Pg+M))d6QA=L2)9xuMx*%p-XgpMc!nc zjUY#nZ3ny=h^1F!kE}8vsvNjztaqcuQp`OTzy+)#KzLk`R1oZ!=xseRKAFzI<(SwJ zP6^S8!@w6pY{)7@XGFNibf+@8u6aj<8xt}^o@``hAA-=O0MIzWQj^#sjvzS9xp z-`WXFfJFAaMc7{N!KE3|rt^#o3OrGF4xXPv8xgv21%ZBuAmgSxHOoLxX8POi)aI^9 zhOP;+++C-zm^eU z={b_t1z1Jiq&Rcx&S1L>;;RP|bc~lVeg^8;g>I5zFio`@{Yoe=gDLZ@B1I-r54scA z8zN}FX#h|g8Hd0RoGXkK?M3l&6uQZqt7@tG*j=u{TZ{WH8FlwIb$T>SW}m;1RR;Va zVieQ{Cs0xcoG5zC8Z8A4rzcF&9zl2Jv~Y<`Z&h0&u57sO(KuryB~J<56Y24$M59Y9 z#IQqF8Q7R@|2!&=12A5V*rF1HyYwC#17;a8Y49k+=Hd~+Y%4zpS8K>yLBus^CV`;@ zKZiTxgmCYS=;cu&XUU$J*8?K6>^jBUZJd$rJ$y5!n=Q8|Z!4)WY#$X_W!{7X3iW8G zG$x>_Z{EvL512WAM;Uv#DZ|NPLqTSVH=#;_#nH}SRl1X3JrpU9;0y}Pc1Fqyi;N8^ z{xpmoQch=A4}mvMNT&vmBO&CFN5_@1fMhL1t^kV!ABP@cuM--~wA{NDC>kQi22#}2 zOOPI<+Z9=5s0F(#sdPJ~N#GfdhceY$X1Lm6Xb0D3J|1kEZTp+YRKC`;&x6ukir zHlc11SRxn_8pO9lCOt*QcwCP5%;YVa!Ri`PG+TqaG-{xoa(+g7Jp}<(xFysm$#T(* z+Bt!um^1Q?@n{)Z?JJ;NFquh@<;dAYcF86M=5AD3w=XF z=H`?zFg_nIfBW_J>6b59w*LHb`{~!)KVQnfKVIw�c&WR^6<_Xbac@Av_EC4LYwrJOzeU<}(rQKkagNcDqJPxxUfaQXq=Nfcit&qZaf z_@xJoeZp`LaJo}$I6u=M6WI`Lr-!GM)g98DH_6%(iC1I?O6L33msii#*W|rpam3EZ z#lu(1SfO@_(MQMOW3_&mGV)oae3nk1GE@{$F1acTFxs}1(a)t!AN^yOAm}nV54AK` z*O#Vllr_>tUfE&oM~dtC{$pz+5WTdEeJiMOt*zkO#C6jO%-6?tPRnCgpG0B-GP}Nk z5-aVvA&UqBV>?I5O?s0Hm$vc+KO>U#qb0-i{$poi$e;?b3%vn*%*O1J0XG@rS~55; zTJB*o$Y-0$>gHq+Mb<~1w#i_hDe|GDk4@8BqPSMX!*ti+bq@)Ed{vG+;X(i;+mnwi z+cg*4(?Iu(f#YM3)t)tCONIX*10R+1X<&R%&M76gji7(Vz>%xej-}#2mBCf$gn=sW zDef$5unSqvUkifrVM=puxyP<6uWp!W-5OV{clPSjk1}`a(~`L)aATVmT~3)6*6>W1 zMp8Kd^t=np>LwYQzWT)@RX<=h%oTj>`ts_& z$;G=)UDDy~)DO~O?$lR0)JCmU+@(W&vW<1gd~9C7hHHY$RYy3(24DC-V`}L8`AfRqON@L4r^f9+(4*5Os|+-er)PyHF6EhKF`uOq6BBJ zXqy`>c`DEPj5)Sh1tic!d-pz_c{U(DCFo_1kYKR&;LP_7Y}(9F@WB>*p7I<*YdSPaP}1SAP=b;U11DJ1 z!8|uH`>H-RjcbkLS``md{+q0CVj{A?t#9_J{d9cnu`y^3+EV5}+QO$6)Ug8{yCwyI z)D?(NXRi(^%*fElX15%>d?#XUr$$|Z@5cGFExkpAdKqCG^ zG^0l}(9Wqi;?=q#MFwm;dNdWU1;9g991sj$MHvi*SQP6!+aBmMR!6(J3P{2-8gr95 zcBdv8AQ{`Ii|wvscl#v6+Z{ARCXm#I^DZ#c6Df9~R|5$!*a;G_SJ(mZ_mnB)?nX8Z zYNmv~x1aq*e2fOM^ry(NoEX0oKu?pGl{=2zt&Q;F z^5FD&)3LjIlHuLxOA-EptWlv}<-nItq}YH20K)XhHDN8fT8|*;v;l<_f~%Ud3Il@P zkpv(;bt&GJrxNfo2=aF@<+m~M_E`>)cY|Losk8pN< zzDhHREt;j(S(AqN+Ivu`k0!DeW)H}qrlbj6)jJyX!H{>34kb%6azE>uNtOWw;*bXX zotSI*%`8EzEPHNtC`Z`b25NhBRTb_ESG;CC=DV&6&-xl;&bi*%$PqfD^P6N1i;4b| zGWbU7!`5hx2&jg?az&Pmq*E5~#M>FUr3bj&MPo03;F# zP`#(tfg&^4p6LB(;cG~NC|#?J7@BrzC=WYY_!?NC$|_uRV^Hi$)J<*+UqkYOmViiO z?4ZwTw#>0<#S@9y&}MWnrz)Uk(k(6Oky;0M-8C5n1>@^EmxZs1)YMb8c<=h{u5uZ2 z5B)=TtL*Ac#IEaGKAMvtsRXH-P32IiAo_M%zSx?to^J?ri~`oVzKcesZs1GE0%&eJNGcsFg}y5%b6IXxeHP03#gJSLsAz+p6W@sj<_=mU_T&W1 znyk=>=U!G;7H&&M3T>7|eH9ji*@4<$RW_)W6dr3g95@#dvVkN9!j9x?0-b&sY|~Mg zV(Mp-!!*RyRUtb4XvYLgIBh4P&g?b9#ElVV>0Cu5FHUg0yYUV<_pTxqIwu1pDEr0Y zD+{7Qk&wV|(qhCh+1SV05yxPY7!P~FRu+I=qfO`doRb&Boqir}3q&X&BjI!!ItwhS zPOzutt6H+7;nX9@x?1o61b4Q$X0WZ9(IlJ0U|~zhKsV4$+2n395WKTxd><@Gv8%7S zUQEIep%~W?DNQfNE=taAIg@hlZeJWI8fx=T6VWf^8?(hXYg!5mgybYo-R(BmiW-6r z=)&=#_2KPeG0#Q51n)Vv0n2rvY*M{8G|Glx)a}<6Asj)b<(O4FNP#DKb{K-Yc|eJ-6tGK zd%PVSmiHIYN2D*tG5Of#hTpf(s_LUNt^Z!*^`PLh_hMe{PMOa|U09~2Eb^jw2Hj58 zrVbjwDdRQ%jf4Mf$PserH>rA1YDJjQ zB=VjKUQ&GP^jCxqCh@?EpsDK5-S`4MscY4%9NuVbSfW>093&rkgnzpx!UklPVXsI- zFIn7JB!QY^Tr7S96-gdD8rBt`gG6liwZrg0ctcol(Z0{1wEA3xu)vV!?vG6=T8TYQ zC3|*u4GHj<&Q71fMVhyOE@iWkTYKDT?NiQ*kX4>|+EbZ}HGp$-@9QWE^M-wWetvm^ z?Kz3GD~Ub9ovCD~IzILA~RY8Zp9Y-ziFQSjI)OqznGj=5#MUui`a&y$b z%hY;~GMGU{H0PhAd7Yk$Fg@`p%o*^foeUT|0~KmK0*-TdVNkLDMgrDbKCW7dM~=fh z_7m2QG$t_7R}XUWDsOGl6%eF-BOn1MO}bswbK@}kRd;Fc7K^h@$7Jve{f?^r#@}PT z=VR2I?&eEt>oG4U`mk3TtHVVI3P;k41G0FmZeyPh_CddcZs%I_Sg)CZlWySn!(-Vq z>DN9RK$R&!j+N)CM6T+jOd&);^AL~66Zp?iWaDzGa z7aB?0q|{jr7uH&&w!x&~Guijg6F^se#K#g4%!WRg-&#a>)(*j??l&Gj>lvqq@tLkw zDo8y8XKpB(P~F2YtCI+x7GM%9wmw{z zuApMS*u}1(j2{eq$@+c@e?~qgkC2c&IfRC0>EP@6w5h`KvV0B@pw0aQCck% zO>31;oVv^KB?5N^$LAO@cYQEbltBi-i+9TEJW_O@&BUiX3Ui=-J*jDjUI9`)C6(Gk z9^K)!y8?Tx)V{an)Vnv#DLsG8DC>tp2<9kB{bVDfDW}9TI(E#KQDv@-=AAN~;8=vm z3(Uj{_bFs=n=E>5{$M_;oLqe z7wrn?c8*f$TLPTz2Ar)q($t-R!&r~K$xXqXX*9s5?8MRF+J_v znkh=*J_%7W82-S2%D$BL_oL+FG-9r^6c5|#bF(JpaU_b{prnFAU(v9U&k(jem1NA~Wr5b;8Lk~$~OX}w56m!#1^kFA@~2{cAb zdpLCNWT{8d@A;Mw#3CQrr14(Del+8~utW;&b&bsmipvd_&w;|*?)C+RoE5dKL#KBd z0hizw76{2no`BnJcj$aVDqXrcKnXq7%`stos*tM76gAa$P{=olVgzy*qVyi3vc5Z0 zN0f3S&oPXx2x%6VZM6iKD~6(K+~}#7FZVP|)oQ(OW_&84Y)!y~slJ=OprAdf57No_ zm#Xl8z|;`l!U7>V$x|R>>W8z~jj4MUYv(AV{eYyNN6lsv<{BmyYtO}NQ z{{2{W5mJRA=0~~z6yR3tUgKwczq(&W0ICXwx}WF{|K%`d)>?Zg8k%^nuiZV_NV0uD zfG?F_#8GJVk+Xw5I;3-Sc-BDA(IK)1+D8YahS9;?bZ2)|=iH-;#8a$fxmx;8cmCB! ze@(cfNMO3tLh4;Ux=kO4&RoQ4h`p{%hIHsC&<9! ztHmiuS3g@YE19;-!9u@X_Vu^*`LW*faS4O_HaZEJv^o=y+4o_w)!ib5ge=LEBfctQ z3JE}N@?>#GsPJ*M44eXPY4Ws0<`_Yidp-srW+HpkZ_w#s!V%!Y|Cq0KBw2DB=5{Xx8r+wBA>9~Ot95%Lt zqF2fH!(!Iyme66NI4}XY+N>_%;P7O_2pqCxJw-{?Ve7VxLiXHEUkn7b|1cb^uP>5^ zi3(vzI&A{q4HnJ^Ev-Kiu_>n|tzqGVnpQy3UulgyX`QRTutZBq-YXnymxdbuH`o0!=W4jik_aw=agK$f|O!GoQo@b8HI>gybZT|GNQ|)ZTnM zPGm)zX2}xMSVq|8gIz6V?h^h;I*%5%=GOn`o$WkKxNYhQe=i>59v&92ixe4Hv>(+0 z?TSexm`ndRJU9)n-Ag>w&o*n#8$}-g2u(tx0E9Qh@tn0HWtL~3c10&Oiea~JrEXCi zA0_~n=a&}%pVMd)WS(+TVm+RUvOND;?`8e^LI&zrCSF)r$RWWv@DB=0qed<{a_WwAhTHaqoA2lKq zMnIDs2r^UIBkKQyqOIpB6M{@sb_35#n<^~TQW`m7zanF;5C6Jk>sRG;=Cc^*;&B$k ze|s(tk1e7@YtDEFdgAcWCV;Y~XzNc$s#_%ViuWtlfxukc|xQ&f>;&=@c9>cUcu-awJRc zS@fw5THtb*7fb7#uqcQ={0?{${dU$r)_cC#%vv}$sv+3nn!2fubf@Lj6k^~-G%sUY zKWlGR)tSU8WMsOHv33n*VNOdP@o>L;(#o5Y)+iv0G%JuLjBue{&;pW==-*~&$~GQ3 ze5ueqsHQ( z>}7evVh$h&mUM*RswIGV^JIyDgM$Sef@d`g_40@axe%&lz6%!oXQIE>6lvG8hAi#~ zDPMOL>Gov}-R{veaXWfM)Xh`Oqw%(2jZa5%xGM($H`ZPDAel2;a)1Fy*3ETyc$7}e z2wV>RDr4vvboQ9LgC()*V+ zWYI@LZJ%BjAq>lsh8tRuQ1XVhfM9bywppIl5^^T9ipiLCAQip{i zqLdkn5>oh!xP7%GhFDk7;q6*w+ZoO#_7Hli!hil+QKUV~8dxIUgczPT73uC}O|vL) z2qYUiYrl#xc3RjHGDMU=jd!Ey zX%AWiH0No#>8mH}`~cn|&iQ4CF5Jy1>hYgH@YEw39Vu0c9!@`o|9*`NED>GMnuLl6 z@(emZN&{r}&p#jk`1fz5|G&Q<|N8UsQ%2K7jw7RaN=h7g#}h}piNBC;8z;+r&a<8a zHX0cOAu%aU4B~3Z41D2{AfE@z9ng7gppZO%X~YRl^Me99H-sXEMhG8o8oaU01YB5% zrSM54&53-bno`fndEp+@msm`g^xJt`e|wbU!cAXy+7O?Fz8zyaNJeT@FN6!#1I7v7 z#_MNm5K?O6Z5c)-^#6L03bjww!%U3G+1bX!P8&!1;fn`NYST$Q+uPFGlp{j(M4_p7 zXshC4iSwpV`$qKkFxhtAClPa6I=fOY1Dunu7U%m_mxZrE&MMg|7k5 zf<=;m0X(~-%KOPMKe=7*F*!zTjy80d1=QMUX|)aRjdWuLkkbeC#OwF^9Zw>hBB-Ws zpnhRT3tQqzHPJf&-0b?P32kn$EN|^_SM*kJRuwzmV_eFop>qyFH9{7;S`ZdRW725h zYY-pm(-DMEl96@+GvjZ*0v3hQHufgbe5#smuuSiL*7qukUBtUX#Sj3O$;obcR*N^Z z1`luIfo2EF^ljm5Pz9J*VaW)V?Jjs9M+;vAi;hJ8fW4`Z@!%@$C(Hcic6;M9z)DpR zxke?Yg-)jK+5~Qn9YsOq(ZE)KtHJgIO;SX|Y(br-kvGYwIJc(xb=`xkM{adE#^jMD zDH2urp-CXJbc&+V$&^h0pt$5@o22u3(p3R8 zkx9`rdjJ_@RYW+f9`Sg-8z6SaMRZLy^<+cJ+l*yyNc%M^un;Nq8;zEJI-+O%jKN$* z^HmQuPGo`MaQXt(Vg2WE`~3X!$Lb=*#6hMJ5FBI|WR-#Z()B0i9Q=%R06TH=Rdb)R zlW0TJ5SVY|WBjt;AfG-PpCP1H?ymZ1yib4CVNhhzR(GJpq3Q#BwzY~L5#1vL6 zPXXy%2E1zVf3^5oho2k_dk&6IEuuRsY&p%p*TJ2EV|i*3-B~foyViRh+)>_`EA#cs%_i~B(JL$vl9N2byx${u_Ez-)?C}FtUzaK1c{36e#f1!43^?UW4S!=U|uXh-#LxKa6XsKfq-Wg$W-;6p6)i4us?+ zi?A#y;w33wA!d;j6)`lF$%^6vjNR0rLmr9%53Wj?;^YWgf>K0ua8%Uva8bGj_|156dqbJYdMpT=kC3KAJ)m(dEfvAun{bWDUQxJ2dX3$m!gECv``=HRU!SvRXXf)W4tsAT%GyK(hlR;ASVE zRdp%dAccIx|-%57FO+h5_%aG{2`+(!$K#AFj_vNF1IPgE_t0lQ^7zgfi3SVGU;-5T^H(6Ns z-%dB64?*g^j3yPA7b%B$07U=|pt0RKN!n4HV0lI1?u@LIPV&321ZEumt_jZtIKpe1 zEkFCze4J>uUgXJi^{zFSE3xGXbh%JAlUa6^Vlo>6&}f{7)qP^Es>jFD&&#WQ{&wpj zA{JD zWzN@hy4aq%*uQqWb7;)iT&#a`@p%$w7yB&w_2GuNzu%#6?;B!Cr{wEyXPg$o%SWs0 z9jHiPb-MK@Rp-z@x4RxY2Vw};UDwrddUV|v=pDOm$IQE?I}&r;{{XtcWhy4GxH@E$ zS4*0{ZnoLqF9;TzZuCDdtwS|#w>@@_gN@Z|lJx)XTYb}=vg)5?)k1Q+dHbBhxqiQQ zp+v)c=3%uNoIC97^H{3i>|uQ3A=cO$&D=zFtjWwxlEPx<46K}cF*ti&zvNVYARV&r z-|l=2ZD~a%b(QsH&5Ns{m&`hl6dw&fJep{}nZQ_JmXa%c z`#p&()yXl+iH1jO9o~xHx{9VhYd>Tt$<?Fi z;P^)ijwK4)4FKmtoJrLyGU1lAGsJY`Ab(vW8jZ!MKOM|6?{<)`mxqt`8=H;oHe<8T zBZ2x}55tr7rhsWzy~b5VDcVXs1-g=|J1ET6Q34~KI=!U7MmO7%ow*p8G#Y3D-rNhD z;Ce~Vu6tenNewM{iSA#v?GzujZ4`g=N zw>x}L;#%LzX;nsnh0qX~?G_+*YN(ZO{ilAvm@xPgicI>o<(~zaK6=|NLPjU&2+w@} zZzrK4^wTH|kG8Tv$eFrW7c?_d7x-M$4$|@|*=y&L_~OOukY$*xVOf3XC9@7CKAL!X zKqK5$Tz4OTp(&pE^ZJZ+V7qm4UYbUR)q|$j^+-kifu+(9kZpq1U1H}RGS1?^?yVi4 zx@oQ9At&~>70mw3EP3pS-^+Cr(oN#oVVi_hNVflg9-eosI*dKU8-nKj7r`~gGv~cvN$2%n2;dG zD_FUVl_L4(nSegnx(204pB(oq@a(0ft6b1*60UmH5cKEh);KnV{i5Jo=<4NS=jmC! zl(qF67EERA2v`NoxcQ5U{7SY^`DNv=g8=j$gtQ% zYgm{Kk>ns@SlfQC>0=D!=M?NdEND5>{d8}OZYd?c?4N*#$9YD7mttCB`6-toMW@8lqH?KX9>gqEI+ULT zi{bs-uhBXc%4ryf+MHWXDB$ zh>MQ>Zg&hB64#taI6-(0S6Ff2Y>(=VfObMpA#89Pu zX|m(epgBV8^Je+FqOxDEKk(z;k%&dm+aD7Ymv9CZLdw}4HVCk%`g#byMvbpuu|{Da znXd|@w6RoR<`m2-xFshHq1+icyd3@=smmf%$4gs{1W*F@gy7pL)S>yp7NddaMVcqK~MsIq(t zO}MpQGV8P;fX)STF16h%RNqTxo#xTrA;8nU-@PgrZk=ROfglvd7#OH&HzJwnB(n}B zp@}4>gVG0i%_(tC=nG@feA?%g01%RpNFmlGHcdlGB%3zopTAJ4OHG=~D$7I+@H%OP zQ9K`!1gGj($OEJ2PN}h63s;AT3g?D&y$pkEiM|bz-5qr>qNr;ZrYJ44b-|7#o~}2di*EvF=%bpVC|q&)q0tL7~@s1HCQ-lPnf=h#fAB3pgQW% zM|cv9)$Gxrqi_j6c2*8OBV_+Zhv48nPNNs4V*@TJ^=a~;6>AAbg5*n!V9bwu;&Bg{ z3eWz~0365f01gTCN#Lz{V{9M^eff<#>Nj|AZ#CzC(4pUGcWddaT){He+#4O-1KI>$ zEfVj^hbc*V21GkHWnUzfLluv8+kD7FN`l zHK`txK4Le?LC@F-aR${$?u^W*+)<)4v9h-U2VN-@B`uRlc)+w-GzGNM(BA|2q8vn! z0S-8`)VMzlBYnJ7J3w()FV_wrWAbe7g9?iqcqqnZng~`!OM7juGh+F#-o4Rb*4S9| z9xQ5-*|29;C9@8*22NUAXN7i$stRv(=x4#eYv-WbS(s$@9DRe1I@)SBR^zy|8uT-B zN9=4Ihpk}bl@2k2DPGTF*?tAAmr01)RX#?A2uY~Q+!+x?IlocS7L>f}jpoi~Rq$!> zzv8rVJy;(z1rWAyN@g8p-RoZ6YULt#5C2AoSwII!7e&!b)#`iFGU$BC*w3psRuj{) zDojH{LDtU5(dFvi=^MQWb;C_Oev8|2gqQ{yx!wUT9c93dvuz{ z*k26rlw?$Zo=Ei6RZa!9na-2_4Y?q+v!dsgOBv$aTJf ztOt`1>)Y3_!0|29`0zH!tZYUHlBfx)sPWyZ)lt&jqZCBD#&I+0TafC$bYSoL2P!G_ zMiLR7-cd?2>*EII}l;A#A7QMhBZ^NnKg6Or^Rm!K}i?GIZ5NBX#SN%sSXCTVJKFMxiFX zWY(#uQrCsYRaUYQj4Iq3IjwAz`v|hja>tZVtVP!x*{8^mSk2wa>S$zIuAP-54e;@e&XV;psm0bNnIB-wZ3DVcQ`<}6`8jT}}hVPCIQ zG|Hvs6UX>cT9u|;GhxtSl(A^6wYR#NBvwbGEJWqBa-iBR#Wy<2{5c@^j-$y)g5#@a z8x@Va?@VMd$}bf({HtrmWbSlUhk1)}Gm9CW^< z@MTV(MmN00sO%T-yH11k2b(nKNij?iNA~j7hywTB#7Nw6~R`XP}I+_XR`fs^{ zSh)B`hndK_L$U~hAcGC5U6NUcnTUHP4l5Vn7q^<1I+}^n$~g^~E#N8iGk4U{RJ4?P ztN&77EjhL#`|`WwC> zo->9om7fx#(~^dJG^Yp5OOMH>y;O8akY;xM+b#hHSFDcv!JdrU*Bh_LNuoyz_I%3w zXev4n#t(A0t&O2G1%sl*O_H>inqCl_KV)!V5FwTu4@vSUiIdMjbG10kc6yy2M)+}& z%yx_{_dZ7hvxYp%VOV2Bea7Xpk@S=b)xSN40S}YM1m>$cJLH)hYm=ZSaqf^*V*I&h@l!US z_V8RkZl9{U<4<=`BrGw90gEfee;xEoicFH(j%iIf7FJ*J)uR&4-(H2BBSq)YDOoXy z^7bsNX7=02lVF7u9ZY9aP{}yUDOoWEC0AT?iSF_`Nmfj@@pv>TwLvk1zXya2{`WjP{ED&x1(Ab=uk|ZRej0cRpvn!Fa!eA^A(%xOETru{}98m9T!|#V`|L%fzlFDQz_I6NZ@pNzLP!gUlAMLeEStke5!P zkg8W&`OF2wRCLSVt|S#CQ7PdE2opi#U5l^uD8~GlT*> zT;G6=Q+2ebs6Xuz@?MlbKi#!WNku^d*fUOoeZWjL+zVyv;6WlYN%Y3WP0?cCB!TTP zijp3i(S?%}ZCbo|COcJW(32&4`8dx_uXW_U`TYZXSzvv$B+ym(A(^!WW}IVaP@@E zU(=F^;?c_egu&MvVyPLk4tU>fqYK7LqpKa8J61it)@f4D7^{xfs@Eb#9q9pM1!Au_ zwbC|)KVg_~G*=O)#WJ#peZp9ol;qz<&SX>g6NZ(7xA#d4l(&!ifU&`BIX$#)rumFv z-m%-d%^pl9tqtslJPyf*9ULOw_%lqtML|@ca9x#@7iP>ug-**Sd4BxqJ`z6%U7Fz_2` zYSr{2SQx~Uq$oLVSUcceDggrnwQC{jN?E>S94I&cZNZI(mpBMYpdbmS6=_%rB3`m$ zknmBX^F|sxZOuzoOy@$c?p3thvUthGWwZ>ESqAN3q^GEDmDS=dSuwD~%d1tVCG3Yh z9xzNE7HmFW`o4?u1;ek4mSh8q*I_|!5M$p33*x2BfRpP`kw|OpBZ4+C1hgj50LtyT zW};d($%=XDn#s94Er~&y*k=sih)lJ7ppckx=9&}=!?nvcXRlQ`zH0+4zUPW&r$G?-z9wQU@Tjk(k zA6VJuA9jfSz5rkYb;3EnE9mbze*(|~(qHVwBtQHHnm6V{vSL`o*__{^^1e&S1!INP z)G~TPbh5&Y(Z?ZKF|-4J#u?rBT|rzhw%-DFaYKuy-9c=$U0{fqn1HSgX}h44Avg)n zE$&uK?h*IB8JPl@>7lM)vXTK8KR-<_QppAm1O(b)hYe1iUB$4S~0sbQn+HG zm#mnEYGTHZN6|7?nwQKT<4t5eWgH)W-@W^SdFcrWT77){eHXtAhVkp>a>8JYY14`v zTbpFt(tJcR_G4O+{0@?Uy2}Vf;I9$JqW;>!xcNK!>HF8$KfeC@{m-x8zXV$$l8aZ- z3omm`3qFPfV2%9yZyWBnKmJ9&|Nft^?eE}{@jKw3;$kP$FjEz7l-*n$=*C~~uiyUk zE{NnG{`K|e?ceWTpz`n@L_CG>gsTAq`S=G*8=lj&$VsJmfi^0&@60)Ym+9}g z`!Y)%ALH+2X}?rMsKCQZ^MOUksCmi!8A=Mw;?!(L)ZTV+@zC8QhG{%3J6Vq%Zpb|{ z<0Z2lO1l27k_;5(Hpn^n<{=?wV6E}c#TqcJgr7$Al8YT;z^*ILyQKfaGAbpuLtqfr zfjeLl+tdm6g2XLi-h!-#AfyV})qC6)(eMa7-T=cU@gSG;7lLoM_X&)K6KB4~9*5uS;SB;iF|@`*{QPLkQqOHbYe zE^?MbRhiN+ptOCGz+ke15T#@+BdvAq|M*QEOk%SO_Iv%#FHJ4p;|n6#1ox@M zilLP={lJ82K3wfsYD2D5L4e(qDYM{6oN+GuXtGi+72?fUW^?OPJzzNV<3~M!>VqhZ zsUA?n{cb=AzLf??yiSn49so=KrM%pc8^~cGn)?(wfs6mod7Nw@-#^{g0B5A3>|HBx zxd@RU1_Zhr|4|P#h}DB_%Ni|~AMh@@uR5y+)uSHbJ9H7OVZD(BfYR*4*?<=>sHd(} zYDrCKExdPVXd(+caAk|Q;NxMr+~V}n^sG;05h$n&>QgznY|Oyubg^9B+>IH65dDcO zG&8#B}^du)E3VXDgG!4+_q5$S_0*fTE0Ao>W(#Sd%&?Y@N#zmSF8gwRU= z5gXDQwJ@ZX%B@o5)l_wv0qvZz(CztFz@f@VF#A~J)}Y}e@*jDCTKT8|XsxG#&!6*i zhIOJ2b$GSH%X82CUZ^5XpB^+aH~BX;L$!E533AS+Ei zjknUhU0yZs@VwlBBFgSPTV#mp#v>h;yIHhV;}ttu5)VxRRd*06 z6kRnfSp-q>Z&B;UW;9$)2C74nM{uRx+B>RWI$0A%uSYfRCyfcRrDH9 z%iZpo6s4V^_qDF2xK9vdkK^m8LVCF~RFtW^BHFlFk^Kgf{(C@2&mAY1tKRbAF7y!Q z*&F%qy|I5ES=(~pFDLgET;L}A!d!iA1&j~nLs(N+&MNfczfb#JcxmTjy6tx!8PaQ% zJS=mCiG`=mz?m4iw;vLupF~D6xCB!Pv79wuf=1jK0;NAOuVUs7B!RvU2g$bj#0F`*X$&j?7K!8e5jDAk01z*4{|i zm0iRP7yjW}p_!oaKt~33j!&wOZ0b2d<35!y+)i@5#M8cwIxcE2m9*}dh zN?#it{VWnN3uX9~U1&mi$Tiv*Hl)nPnE~JqQxu>d$P^$ePiIQ!0!*#$v}TO?e6S zL5_rC>WM#{5np8X^dFefe@>BNHDc7Zju53taYK0BT137gaX(6IywQ`_&k}}RKKyP5 zJ!%qE6(uG`=fqZQ8KvYPMVlt7p~d=H6!95iTZeDkWzR{;^F2BobBveHd&x5s;)i?#S#P^mblNf=$r@}+QTn`qC!cvF+vh$pLF?>^Byx~N?AC-nIb z`ZI8Mpoa5h z$z~@?y!U*t==JI&LxV1F54vNr96kL?clL8cg0w5&0Yl~|sv{4+13Zol#dpRrfQHGD zHlDopx0La@y6-=O&sBs}o(|CY#!0{LksBy8$`4}IZqYnpH<{sO2Tq#OSRO|r%B|Wx zKkvAksJCHPE!OQ84D&R+?7)DK*AuqR3_1lZvIN@ZuxL*L5ws_Q`3Qb+LiOExGF?=7 zrpAkFExgdW5B<(3b-M-NiDTN125!?9p!xF9w3a%`cEgB5C|Qi1umnEgHBu}-j`#sjDWFr`e@bIHcnSdr%&H+RkHfx%*>n_l0$dbPbnzqPwnQfTx(MG!eAQK z=kOMK?|xJi@3>dk*T-HFUWI+Q*IZRI_#D0?dy=2Z{y9Oxfr!TcqnLQ)=SfVMo4}-% zmah=YIOiUS=kFQ|XiTk`NE*dNRtF_DgDlJ4_C)EbyhJhUqDd$#q-g6dwW`r}svsax zuq2-rd<^u}aYkd+00a4W^GPA@ao}T0+{vqO-Xoiz(d4jO?q)IF44OsBXx3d`@}%1N zKh_YZ336yAYeDyq(}E8uyPB%zjN}=7&JFI9tnG2gN2O)?x}uJbifjnh;%T{?rAbE> z&_mf~AG=Jc22xS$=5)ZM(5K&hQj7|ckKW{}6A zrr3gz3#aUg8121USYS%)r{!*zq&>_oRl^EvDN=?Eny%VfHBJZEK6&M#XyC&_WDH1B zAUc!Pj?6zHFP~B-TO9I1v8ybb(5I}(8d!5!JhBckLKgmHtcNltF>|c>C!OG*OHF4f z#${1p$ZTrIk0=lY(A}lza0|nI%qbttexmxai(l-_ZM$7HR>kxNOFEev;&?0uq%8wL=FO+0v5?!HH-u#|_v4@qR1 zk7>(vEFUhvEUGp%ypSh~^xMBRo(6xF36|E$+a|9M8y%4AxvW>wr=r$lJD$a=VOj2G z=>%wJM4B37b&Gsb@_QIx_K;C+3`mG9zE^dO)8dgeHO%C3mD-`I)0)RuWvQ|y=>p!v zQORoT!*aK}Onsf<>r^mFtuCKD%NB-Q6lk2v3Rw)}aiww^JgkKo_DQ_E^k3lJt-XK& z34?&=<&kumN4F>_?HPV1s%o^k0Adp~84KvKgqYLT5oA!_hV`EcO_T3oQSc39$PQHouVy*G>$E5X zq`SwtzF71oOK=X$B&iy}<(|wUHnEFZvpi4LmIpVhUo9!v%#v5-PDyC{o?!e+;hTEo zo5!@Px3t`i4TU<#p6?${Y0tj^0096000030|CEA$~sFy!`hZ@S6X{J z6xSuvWDb{^wC0{{Q(kARhvvFQn#3Ae&TELa3B$GQipvTq;yN}(kJI+FHO516zx{su z=klN1AGg}`n$T2kSpr7OT54Nj47{c-|NGar?zg}GBQF2`^XA`EtZ@naZR^TteQ{GG zr!+Qmd4#!qJ#N4K?NM>tU;cah`}X(8jmYISCjJdeE|WMt4{NEdwbZ3@T1v&jpH>bz zGH)DO4Rt}%F@A!;JWK42ecbAa_Bkzj4 zDX@;BQ%df!pxf86hS^+J9FaR-kjL;Tx861K7&eH#@5z?jx$ZW-(oVN{br?rhYJp0x zJR@!nt3Pp=K9?EFJUOhinGT0Vdzg&1+40Eku>K8)MHMWML!VmQJQmtGH10B`x->I$ zBy!UKHIQ7xWaS_?Ni)i0vHFHhgU4ba$KtkytHiuk<=kfS{TdgSm9hphzmTFN?WY{` z&!Nu#nq%WN$J|(qy6on%@eP*&G^NNvaqYuh7S>SWp}CtT7QH7Kl1NS_V>VZlv+V%r zqWKJTEp|EAICR#q?*X;|#R4e0O>X#hkFOUnL!YVJRF~X&dH(1#{~Rm*;Nr6rl)14y zPClEz?lU#6ns{9XL#B15PBp3CHqG5MGj`KVL(;j1Ozd-ATXi`Cpt?%tN?+DEa%hL< zZv7|p=zCP<^gemhY+~Z=8W)!(u0R@sc&(<7m1&>jEI9X4nP>DjV`-)X{#*El%Q`@9 zM(VVNEIGPHbqeR)0d>Kt#5G178A zrjvaQsnE55o=%i^-#cUF;=60&H(W!f$Nv5>d;mA`9HH z27Ooeq91j??E%I7Xm-QBA@D=*(|TbVP$!4VnnL?}ylt1+y%{`i(JA4xJCGz(Kt{(4 zY$b*856gOa{hG zjJJC>NGR|1_dHn;wvyoKAY&-9;>3D-(1N&`8YY|%w%y8worV#mwdHi8Wzn;(QL>_$ z{_KY587o+{xm_Kr7IpuGs3e+18%O>viE z>iS&`HZMQq&uMredXA`i7eJ>_-QbScQrLZ3AKQk$=s+WWm;;C2&S(EB&@|pLMBF)` z3SBqF-4(@|2nU(ioQM!V6T6F4*tNJH%wvzkvbhvGw@(=S*vY8M75ToB@5P@DIbL2-R(Yw%Lk~^vmQU@3g8V9$u&s5s3 zu(Y>q)Otn@<(kkzwutfD(YC(~XETgek6W{mW)tr>??_@p!X)ZfGhQHVh=YJ(YAr-y zw!RMy&a#Mi&xV311Q~Pqeg@1 zY4IhtA#&GnSWH4sDa52Uh4GOdx+`+t6#ELM6N%X+x{66<6NP@iZ#3+OSKrPHoBCm= zNV#VF2{W|sjrO$-XTFZ&2ft;h%`AX)W;nu=G^bx@hHpKYx4$%PUP?!3CJ$;?9hFSP zi?7}H(w-gV>b~AusQOP6M=|ky?9QCk7mbam4HCGB6KOdPVFkWhc$vi0y^?8se9keFGVx^F^Fwt{CE<&)>bIvvekiL2oOfVC7>L`DbP0 z+xTTxV(NLfL=TIHm+CjBuh;qHaeJF!45}4tFuhPRV11$HH4sD^$=ft?nO6+&)Tezz z6~I*!WzO*KeEjYtLRD1Rj6tG6S+wKxlBbUpI+z6$L)3S zwC=)5rVx&Dr*5ZKV;gT%;sUGe`Zr9e-Wnwdx$@0TZ{Tpt|)`Vmwh}BfslV+JDo*C^K!WqP>$3nDS8rF-dbEREz zmpQ{pTVI4Jp^wd)iKoMMpO9!4h^>)P)mhd2A$RO^81p@MC{5XcS1Av@jY)qvW&FBR zqJToL59Ex|TYhBY=%`9nALCL=*!N4aLA9>p4kT|d1ckID=7(LwH3XVb*Wh?g zjT)VF&EdEf#F!ALl{q$H;h{ud07wE`@Z#wE=^F269)Q5Dnug0MRF2+#>%x6P{@8s% zYtM9FR>stg%uovW&W(jGM!bi0ej}`}F_C*-qK0?Gvcwq}SwdD4I%-PpaH4mAUVVNy zqfG!DygiZe3{@_xHr{S=I81>VkQpYoPFT4Kul`sD{+Xn@LZ}-`rR~PTEY$GkupYj{ zS48r=rI-eWhiTxDreRWABzNHjvSuC0@OzU7juKM=Q7CJru|i)4&u%6rjaj1^X|uwL zPHkvWGnqznj0|-1Cnk#@dA`&EBQ#xOcqL8K4mQrl&WUZ?wr$(V#x^#|#>vLElZ|Z~ zn~hFv+uwQK>-zppPfu4@)l}Uz)2f_(>5s8Cw)ppNdIVCs_;=s+xcHn8evs>P9}|W@ zPhL){pw@nllV=ntQlFAB+#Q^py%)ARKRnNLrbdJwNgC$)e^ zl}OyiV%x}aY9GnI}B~yJN&lrb4OQ(BG}pW!Z^Rog$z=m)6wM) z=MHV-xaoA0-He>!Nt>x~$G5{Q;q2-T?nXV(SIu$(zFoWSkR4j>P8LM*URw1qoQHg3 zp;YsEE_{72zxaN6bo{ooq%&L_S8T%Z?DV)pSC&oZ3JG0k%d3v;`!{|46k7m8`eREM&9ya4p#1f2u8Vz-sSCzLjk zFoHaPA5Kt&$rU&mCi5?Ge~X<|Ckd*UfbE2|zxeOn-cS>eJDv2YW%zb3#Em!LzLErH zu3(3DZ(Y1oU+CKhe+h~!5=DEPaS!Jvet(20qmIsnW)vD31L)bLr9};sjxG=z%TrV!d;L@( zGa_3jmr-3%b{{r>t+u)wFUBR)f@XtB;E$%JO9U0v(f>M1kH5eux*2#BFH zi>!Sb8K>H2B-|MQl>yp5X)q2p{wrcCXKg?OML*M-x{3V{nS~6rdqTKHFDk=r_ke%u ziFTPurL_?;FF8cD*OkUxGT$>qh80>AZKEu;+*vdW3v8MIuQTLnh{DO99PSvbhp{r>?EzZ%GT zCgCG>NHy9WPEk}0qSQY5cC-EOpUPDECsNV$pmMb_o(Y$WX4VL;n0lI+`_UXB{ZIeV zpeVhN!1SmQ@3*I%Xv3y4<0it4$8qE+7nSz|+TtzFVJ7 zwaxpy<=kNyxO!v{U02-N%hzpYl~&W^BX1hNr|=YP_xH^9H?HosI!&l!L1+rhmOsBx zZd`TH_95s?kSJm9zO^>%6IX$bna!8_UT3uwymgW3K@mDK+PeQzMh+y`Ft%W$mg0Ez zksAPM2tW4w_}uHOD1Cws_~TBHRoqGO9nY?k~&yBBWwrwRtnV94Wd+CI3-d zycdB7$;ZAW&)*(Bz=l^Ju$9|XLTs4TOi4FHG~fVwJ92$WLQJp%(+TolJfc`6c#2_C zSld{Z)f-7C*()I5890n{u{8&Lp&%beIbjY!|CPWHnl*y&OqHaMokXp?j+P|(R6tm-7gih>49dA5@mt@HALmJ_ zqB@$di)?OE{Q@BohB56RC<^mL7^a7QTDEbeoN1l(ZV>jop-V0!GjpGW2@Y6Zv3W2kY12eXLaLkPqWo$G`wv0GLY#Gi zKa%3n=Zs)dTE0&_Jf-_IY&8qW#sp-8Trh+h5DWjkZ3izXrcsoD`P6hH6!Oy~q+QCt z*4dQzGC{t+smd%4o-uyZ*CU8wgE`4&5#ByP7mMNWtynxnfCCT1IQp5miUHPOOgMNL z@4(|IpSC=T$z?Uacua7P-^P#F!GG!dG<-Rm6FZ~evI!)T!d4XbgaOQ)`)=pCB=6PN zM)4vjY90hZ?&#PlP1u3dK7vZ!KA*C2!t8VkUV(zG;Sxm zi}G-dP|#-8HibMvY)vCPkim%Og|THa_qsqK_asQAezlMhaHxACVZ;DzUc;z|7Z>i} zF=x=G5r!~pfYBt~$P{N-447l^Z2p%CNn#7og)<$ExeCSCh>;>#LRTa|qvsa>rg=6a zNf@tKUm50C-y{!W8Bhis0Oo@g`^_(*93y@zU+H^;ZJ|-^?ASd>rEvW>?%~^owhPw3 z79m$v#xHC&lE=%&81o=r#3ePE>#svAal$O*gSPJ1);A!6x)j;RQ@Mfg!35kanT zDT13b(r74k3{`bc3j_^t`9g0q44;GrUOD;_hjPbyOBqJd0ycMk$a23h%XJ9DCeX62 zEgMjLgX!~eWFO)zMRVRg#od^$4-NWbVjr=lI?dU6+Q93MaagVTN1oju?V}8NJJ7Zl zHkS*1QNe4zlY7HRMCQUmCJIv9=lKw_KA9ZciA|DEI$txBr;I77e-)Z&;xL*J06`xh zvM_x8MAU3x0Zy+3`qF@fqQ9*O#!N2#EMTIiV1i*5;JF%yOp`+un*#kYaEXP`tjg4+ z?O%uJWAexT0H4G-Xl_MJ1CdZ_B6Iau@uTJ zz}ja~5Gc(cZaA$oXe3O|_ zky1#S?TBLd<+X<(DBlv>86B8PiPkA|X{B9xt|X1qyG=VW1nN^5EmDTHdRC7o^*?4^ z2^bl|^b(z4(l%!2Xt^>JR4qS~sINc5bsY9J&AJKG(Q;p$>$+K;PlTsh}nxtbg|CBX-Yv$TV~;!%?)KKS)NW zEorni^PBpl3qfTL(dBiz<(A`ZF&vJ|U%2jZ??t1v`fPWs^UQb^hMCpLO_i7(N0KRB zL>+EbI<&zC|MXbZQ#g?y|GmoR{o8?yF{z61SLIPS24UNSfafYYp=#FHj+Wy|PwsV) z>RRnkCKcy)|Dw!kqU&pAP<+M+i5e45#AIuKl zqKh%F+yWPr-rwckXNJ?GxVl_MN~;V$8C>HZh{Rz(O+52DHPvNz|GqKcPV{@+^E-KC zaMVJZ=L6yH#_Y$>P=EC&U8G<7`(@wYG!NG3#j+i~|6+6051SWr{<>{b|9FU6uWdh1 zzZ`SRc3Ic8|C;q&E*?hmI7oVGk2vL`wyK{GAGwY;iQUmk>2lf-G*%{((CTBU%|82gEB**yK}{ ztcnF#(j0taZHZO|U$t@;;)XrOJPN{eoN6(%3wiM%ZO0?kp-fV3Brr-L{>J?+({7ka zO#N2883#fqCkk;#T#3|yl;-dJLos@Tph7_aD{^HCZvt!Y$ByoIM1MZVShO1TSsC}K z?x#PN{eLcm#eMTy@rB<)BaagXm+hu9H9kPe5txd&bO0V{0^UZ?!{4{Z+L3A!pc|f3 zRrXI&mWNdU@JORIYC1U+5$9*Z`OMU@Djqf230IWlKSM2%7R&UgXliTDKy?|Z4^ws) z{m*mnlStiLq(6zDc>jDg9;ATGcvOJuKH;J@8xht--?w6oEONMYC?2R9}7 zSF+aJ_--(k3`zbg$=gP#Cgj=nI%4rJQwIbZovK?`YdAl(!%~e#n04X2f8JMXmlg}2 zHm3GiD1@*-9@~1ekBuN3nlyZdMmI{4^uy&t@In3bD9QtVUc-~dst$h+`IjHZ{rB-I zPQR5?y;vNQmIAN+D2Usi{r9TyZ~#LXG?b72g(43vQ24+0XE$gs| z&Ld;E)!x*yW92_|Rxt>03tu~nZdd0{pZ6C$F{i#Yng*!|Do=S&cF5vDVvLnA*;0*W z%aw1Pt_2bS?rJr%HN*p2w}hOJ32qI}G?*Fs*ey$|p0;rh|1JOB=Gq&WVea*&9%nbP zu6$66XixQ6wfR{sKas756z|RXU0ZYZ+O=AInwOLDgD4?AuB}HsCH-^+t1+7IX;p(sm^UJUW0(Nz=iG9lw9QS4fw|U6#KeIinb#dT|eVQjYC$4CF5$ zNA+9n0Ym2f4+%Y5onFj_ngwpIlu-&_lyeN`imwi+2%~YYRH24EBYs8%)O)nn^ZRd? zGRQG6sY%_ar0cJLlTC9uG^~bz^qXJ1T|Kf9ZLT1VXO;dSoR zFVkRiNyu3Eu_TUTEn{bNG?H=qio83C`#1ze`9m>6p<()#gx=(%0X2}=7GtGeOy$Z7`%h+lnSsYUx zeAVH0SJ9+|K>9&Zlqy>E;dI{()w)`N%GEbX2KiQ3jgI4v0O!?xx9cn~-92LWmZc68kNV1sS{-JRdzsVbr4nnuRM zb_g=HQTpntOlHyLNo2Zj2tYJ*bO=GP)0Vu@McSWy!p6HBinWI6c-F<{>TfQVrsenI zj&&;ndifjc%ob4n#^jyXaG{b}>_b0l%(0lKK=#tZ z8{Yr4tfi?605&x@P9O-5f|(!%^vwCoy6(Es3oTP`Ih{Y%#GV7hYMK+BfWCQ*i0fdI>%Oj@sQAYiJn~sW~_TAUM{2GdjrkL&m%tT69@fLN{`w0wE z9tMVba;uNvbf_7A%|*bR2TtazrnVJW5AC5qHZh4i{aq zBGU=v=;K^?ybe~62O;}>y%iJUcEdyGTyKk&EZ>xHy_oE4B*RS zQKF~IHBou#Yanc$^<=Jbj&Q$ocRlxOeu3Q{+v)d?!(uLH1f{dIz8k8&v^n~#sCKpm zUxsSs+6}t?8P&9Fv#&4YY+qJmuL(*MBnY~aC~Ead`x$Bm`UT~;o4T@gtA6Xw8i+G} znuT9SaS)F~b z=j90%#%JnpoSJ#9pGXzp!&WjO#Dpsjj1Kn`m9<5GOD5vBk_@osKwLHk-tl=}LKAS{ z)enBR8ev5kKJc0fZ08#Vph{s%U5!q{3>1bn?k1S!===)ZPP*qzzSu=9Rxq-5ih4il z)Lr-?<^K1*x=>5msQ!D#!-mcBXW6PGISYx&k^%1mvSuuilu}ewH6Y6$Hrpe{b@mBC z8>eNIV9Ecw4ng5$@G`C%@FoPVibOzrQTHsV8PDJfFU}H`0dKGaDx5H2zEA2zxDUOF z=Om<>IkkX~`>VTRzMx=%N&-Q_&vP&ufqLNHuKU-Q>&XnMyyCk${v-&);DPec(u!hg zej%XMxVvC<0WGeCg|s}xbfbyq6$+g3$0y2~cyyN5D|WAtg+uXyanxA>avQTIH=TNDd^J-%><)BH=T>jc{TAR|<*-(xwE z(zryM(S<#-i|~Oqkc2K0ZKY|_yfMg*>qS&EzPEjbM+mFo!!>XLwP2wz#=irYz#ngZ zkPsHHzRQqPzKAFfFgAbp7 zBts-!D|!n1;Ngp9F4bm3eI9SVGDi%kh`tnDL}ymB)|^dw|47e#Suved;9Oh6^Yy=# zNZs?SC$YeoLGXT`x#~6jw0SqNTZ|luSWh44W$pa53UqZKvsnI`^6MS=TH^+NN|Nvq zQ9Xy12&vbB^1a=~H9^A=rfm06kFi8o`rk<6$0J*6a%6-|tcp->I{VEvTJ@o6a8^if zDg$ns=~S8nR$*XVT=&>;jU@^b2#}!*r??;`$v-TKhv-`e6#6`FWre*cY?L#=`2k*L z#GJd%H5{{6(4v#7b*;h275m(Z0^Cux-;faVS2zLU)Z`)ulmK@zkp$H}l}j<(t{vi; zB3tzu31GiSeo1N7k3PisKl?Hw*&0-d-u-c$fNvA>A_wczeCum;Fu|_B#b4O3Q+L4D zW@VSEp>F#{?q-Ly=stYy_K=aLDimr>5x-^xET<+xrTM<#;KHt*K0u6Adm!ye7KEGh z1UZ@=i^X6t-vmwNO6eVtc!m-*lyhBJKf(a)cNyvs2loBk@Bnz6e%uAE7#4s4c+r>8LnMep4gF`2DE0uz$BLT1>=`oa7Wz(z0x{^d5(VW zdDaRkoE4+d89RWQ@hDlF^&FfNU__0_r=d50z4=G6CmyvW58?eg@O502KEhB zHtw_u^}IkQ>QR>jr~%_ObH!OHSDBDD5@niag4v){8aEKC`Bdx;bJ8|oU{qv*eQ*wZ zNCQg^N1_Ls^{c5$NW0Zbl&M;q%{#=(m1r81Dew8j$`yWbE6ijnaD$J@p~7y!zSxz# z6>OMb&C+~Vwqt92BnSo?C0eDnjveBKl(MEYf?W}j{PtzLn;=|r7ff$g6l*vDSE!W2 z+b;3k07LmkY|(f`sBp2W zg-3gAGuExwR~e}I9fMmMAG&KC1Nqi*(MR40;I(-4l;0Rry);ox zabt3fgFhEq<%#Kzu=OmG%2}Ca%zciC72^wgPE}q@i6_L}(R3^koVa0|l%r`MbL;n> zvrx}NBdl%q3{rPG$mm9Q?MKTsEgyBts(vMcVL?~Rv_nU?rwe@%v?yOGhyiB~D)SJL z>;B&DP&crt3*kD8+eQs3RNYStTQB8h2|?k`pXGBmx}p%hw76Go1WDo}iOS21EMpIW zlvFsx>|Ry9odU9SF@g8vR%CGcr<<3=QarOqiX}&@R{ei4yaZhg%0qjB{PiDx z*X-U$Jek;8J^PZ3nWRzm{(R^i5KHnI$Q_$-31dy5cP}sJa{*yA>WRPr=a9;^`TgmC zH1@YRmXgSjHD>-7AAG|^$G(X^8@cYMHJZ>Yw0Ip5rnxO}!v{>3mvT)-UTn&(Vjq((*cKjUT5WEQ| zt9Uox-lPxlGQu@Gmr*qp2AFrjUzXL*+y2Lqn-KejZg!k%CRi z7h>vNU{2KO`FQ6!c3IXUiqK^K8x%*8d8FLNNUy4- zg+bAmYVWMyTuUG^)eK5@?}0rBPvPjnvn@k7EC&f;>^RQtWFL^nDq02z)nzSCBqGC2Y2va&q^O>u!WpX$%8 zKY2cV7_X638wCw)0&3S!Myj3A!^QHMwcEJax;2fm^#T>fu*hTYe4hXZA@0jXf9?58 zweuXdqgLc_9%n!OhR=NO!G89nS7y)3S7>R6!JGL3x=eXmR>e(c08c<^y`gUf%q&gjt%@d_o z*AQx?PJbNiWv&3(wN17;8-xHQ*|!ycouTWurxutg4E^@`KPM!W zE&`5p;H#-*oAAG+)n3hkwIwPE^vNev*Jf*$7#mAvI{NYujjqnDFBzT{@2(WYbTE-t zx$0;1A3)#_-cyd?y@>YVgU9jy6B+LE_lVyh!#LSJc-E}B`w9(RT$74u-~dLrpW}TU zb;>qUz`6YGQJSYJALZYuxcgjhp@%>m`lYd~CHoh}cru$z5vfS5SAC4R{j=ZXey--2 zP{#w_$?U>?#-Mjq#p8&1@0%KPDcPkg{%3Z&A`)x7s${Z?i55wqOGe|b;mXUkb0D*i zi-Y2iDdo+L>>CiZ)rB~C+*cey?$}Ge`bytie(qR9cMHXWB$IT#P&DqNh2+6w3aX-o z_WlQCq(Uvu`jR9>xsP37=Olvo1sXYp$Ih)15ma#2K+5{xZ>9W>a%Gh~PdR|n>~1dF z9B|iHAoBrUvPMDj!)JeDb`uVaR~z-2M)$4GYibWVDKKhwk&cN#b+$07;R%advw(yq zb6bBEv*KgZHHe*bxhX6OA|Qn$_+$1w?1DeQC4;IWtQZ8R!~ z21Z7--*8V&H-azE%aX@Ma~0TEp`%vKbI)MNZT)>}SrV42ype=utM62HoZQdubRbUF zWx{V~-PK6J!jj|*z?1GP;(efq%gkd4QF4|oZ@w)wGE55lI6b~icHd@RE@A|UyE7@d zfs;BcvRB-3eqIT=Di59rJ}qj=^n9DFFr-a+f$wRV*CPaKLosp0?U~tYBhD`B8n~DB z34B}GkSf|cu+FH%@Pgr?U#&jgdh9njC%ogQFU8jXth?Cei|oHET{v0rcfsi{H^{Ag zQzHO~&+;<{7*XP=tyd37nwaBU*p`ry)K=zyR9s5^aK;gcuh~0c5%U>4$n-!edP9qojg(IZ`3hm| z>T9>ad+6Y?j8f`B2<}RKLe}8%jAzjT4O^fx&c@kUR$-?m0RWmQK!cm|@2(@XCsLtY zoQr13ohdaDK+=;@Z`r^I8HvgA$@_75ThB>|d#ZipF~!xf%Bt7)4Yc{zeNF3fy#1L9 za&00olPjqz^c*q5VRDm{l2)+?53@yM zspMnWWM*6*s~4NiRT+mrg_!^mT|RRLPs#%+RLV+2nt2(d`}>Ta8k?UdKxSSp_}St2 z+xoNTu9uJK*u~QPx#PuTlTRl zou|}+ISFL%n9G|(;B}D}$1gxkfD`&pRbEs#6WLLM^y6wAd20 zjk}ZFOs%sd9OH=toMq$1QjKS^T;0A!dyQQi*CJ_*R50!z!X^oz;y6^o*Zvg+J;qN& z)57sx17V(&Ycy01vtL|NqYfX`86U~sRZ*XZDtv&F`@^2((g)5I(?XGdSTB?h=?HG`FDH(^8!AsKd_RhqD4v}QxtX2WD%6Ihv1QN~$Dk7%S zKJ)&kOi&UNzpEEDOOj%aUL3zewN9>Ege3nSg#v-Dzr}blx_-%n-q_(|df)2Th zTDD+y*=T;ybH|N6OqwyW~rrPNu6WY>^O}@@m+RD zT~hp3UHJJ~AI;dbf;V(zR)U*t3s)}S{#{UTr6}ZLS{Lzi7c6nFW~=hD2ISYs7VZX? zI6ESTsJQ@1r3O4qm>LkW+-KNVr_Z{B;3Rx`=eLRMwBI8rsut*_BI)+{JL7CVnQJ^@ z@^MqUd8gQF7H!+nZ17C+l(E*aJ*CPqW54e+TN!1km>BgOAtSkYEXQ27Hml)urU()d z-_Z@OU(4hIMm#8RF{L=a`oT$O1J2#bFOLG9aXwtEsqv=jq0}T4;nNaB@M0yUn2f$k znSX3bcy{x0KkrL0ZrBR1DTIhGc`6-Ux36u zM+zo9QX$qjr9DK55saJC+_fLm#v9p<%NzdtK;~Ps7(K%F7Z*f^ZA8hLJ!VkB!syeS z+3{S`AuA%O#s7y(n6h6$W~;nHjZH&PSFdc5ef`X0nKz@0*#OBW4qQyudqIEa zpfTbF5U>B?l23_S*okR~MC-%f`p|*DidXAoq7RpwAboUV;-3!R5CHrhIJ)|%J`Kx4 za|ToNzDtHXEPoD*+|zQ=<6=H8%f5jG&+O9J+E>}# zAFH>edj2_h+`gvG6z~r0D@)_C9~k~J^#7P4DIC_e3f^9KHimola^O~-0raj0J0BTi z!X2l-eRR)I@JX%E_d`fON1#nK>??l{DVS1nW~AMGh{=BQ6COCn=^8E_jI%P zoo)M1^N}0gX%)`8_(L3e_z2uOaz@0~8>h7!nmEJpO}J~LGAZZ%c4?w|Sl?C-jtOqp zBh}Ta$-XFzXm1lliA&R|4W zbVx}MiZ%LiHxt09KAW-tn#@+lY?|f)s_QiX+A}EDyF(XUI;SVzczwQKRMy7Fum)n2 zi@()`WQ)7oh&jfegL(W2a4QFF6^b|_5gM_0Qnl?6AiBC0R}C=F^5N`HHfwY4A4cH@ z%#0irzzaJ3=lG6P@SbX|b=c=kuR`0)N%WJpkVj6Ko=^nDpL916mqVd$0F$dgpnP

4E;q!+#g@6f$#3YN{X$n_Rvr<4xGCmb=i_m_oIq9F*tm#C zMvd7POw)o6!7b$IJNq(m8+OICHd$9q(b)jEA|GoV7S%b8z&&RnGD1#= zho)^M^m`DS0^}e%zKX~I$w)(hAQshh!e<|g5Sbp=!CSxScY|~i5SQ#dg=v^(9Nnnf z+(K?>S-E3_mUkRX-+6crM=kFxO3>LSAxAyjm!49dKZ-3K0Y7Wih{h7w*-{p;U0vyY zE_bUlOltRn%>rEOX^3m4wJV5A;=BSN5OUH{;w*RpwUZGtk=u0S$l$ROu|&IL zJ;92^iu6WKFvp#@3)Vf;SXNVDPywbjO1+0e#oeP5@_Zl5NT-fY=)Uq~iF;(T$yVI!t%#2j9RfWd>SAx!>D6bXI z>Lh;33(IanL-vNID@~(@>A$2Ow{l+q&XaQ-tI(hqHa8xpqkLc7WX?4=eM&@ z&>zbY={I0+s`}gwDhH(vp^9AaE>CGY&Cm>fVcOp>2Of^sy`ij4x&9a%M^!f=7~ZTJ z6QNoop^{3xW%P`;<{tFl_DJsjCb}L^?Xe6-rl?^yCSpRBNTbb2CNpgNLI=}YoSH7L z$hrpgVsvOjm2AL;lm}a1x27YJEtPxp_1lal%P&-3)}L{bw+3VhuAJdNbX*KbmSEyv z=10jB1kFcm?;KG;Z;dLdH7SfrG!+KPmvqQpH~jsr!NCz@L{ctRGI7H)z`!CD#C$_P zF6b!x-qOY${Ly#u3yutBk{NBvLPSvevgONaoT}#AK9d??bKHWuw*^MK4UrfUd|o}3`J}pCL^eR~d19nmTuG9UdyKoNT31&ArfOF&dhk$y)(Jp* zYfIxx*TYIK=&VgceW}k?@LP^qfNsMM$_S#xu39k2 z;(^2?k>;TZ8R9Nz}w!K zUX74I7;Hthigw2@5prw({4-(c4nLVQXi9(Q@1-Nr!+7{l$W1%WpEKWLS!D@OV#MR& zlg8qB!Ecy+8L@%u;blT@HF$S%JM^Lwjn_!xpdY@ZYcw`qkQbzt%T0&r(k;*&i=kSLN%SKrUjrwHCfd4{JTYsrlVcF=l+Zmk5hkY(0m=lA${Xf_xh&u zRI{bU{&zdTRT0FWX$lO|8Nyp~8rs(%5(dT0Z5+)c1}mrJIcZZrpteH1Iv3rNgc33U zi$XjM(Q5e6y&F-`t(sbblPvo>4H##7i|!;ve3IHJyEK-zfpuFH<)7{c$vJ3iVwFH~XgaY+y0Cr0(gRRigGS+yn%aAOX(iRxh5MVQxS z59|g(tH_ynye|1_ZZ6XeKvNO3Z6;ADB+#9Kw{sKz0Hyh@7Vu5ln4%v~R(?NQrJ$K>G& zGRFP=45Il|L(SOb2!3Z^nR5z_auLUCJZlvK548shXEh^Pt_BXsU}GC57hUqMh~BAO zK(5ak@4`)2D=TrV6(8^UfhS_&UQ@@5RsR*IZYMUki)h+E-}2t~n@L6>sSrCYv>pVKG6HL8`TdzOVc}Amy_oCwUM)Q8lP>A$lyvnllX_WMKO^6=`Ylu9M2sm~RFt83K0eSmH3 zqV3c%$k#|Mv;~V!0itCb4&ETBk28}j&26N>k$e2vSIxAh1(5Z>JdxGO|I@72mALs!r$jaTh?`i**9AcO>eJ@< z4a%6-AB19!UKW#g1Bcf)!hS&8|TP}|Az2+idlapdKkjJ(W8iac@>b^Nya z>lmJyt#IzORSFYRVy7flb+-L0wZ{#mV|U;envZEau!FxE@ka|+n{{#^uSZPojgy{OO+yNvt}sSMx=?knV_ynNWFH2fKrDu& zZFDd5G&%tg7+LtL{x(Eh53#Tipgn^2M_5)UG${`*hX;|l!DMxv`UY>+NHja~&vtKXRL_&zd<9|&>3vrWf0Z7+w9aKgWjqfe) z0Ki|BM03pC7ZmpYKO`U!(_G;ty7*lIIHjZqTzef9ECiUhaCo znhY7+Q|~!3a-V3sAijK5et8EG4-(5UhnPFZ5s!Ta`$ejrXr^97#1-RjwrHbC+_-o> zKmED*CG^G6^S&q4d-$YGd(Ls~>44aM@<&wz`bpls0IKid;$xL4(3{H(nD_Z`R(E#Q z8)y>i1@;x0t{(wP>}+YP`89Gc{ zUG5-f*(Z8@2FvBXEWC;5WcZ9ycl_5mezol6L#NA_S*k5Wb;Nyn-uVW#_PNP9ymE=; zRAY+e>HPgD0qBrP1Uf4MHD$xAc$}c0AQg&-Q$Z&GG0RTlm9c*iN;FUit@DjaH=CBC z_qWJ4b$&j7`}e){m=mSWdko#+v;4v9qF8r{%e^*IhC5VH&`}offQ4Xoc zCe`_7n-p7gtk8J3k+YOP+;xOf1J^m`PHE8T;onfU`uQSEd$#C27n{&~Xbp zOMOTr-r#=pGcEXKK3gOte8Wpx+}EomOQ9~9^`{E0^}YHCahX7kMk_fLs-zErVFQDA zn|SfU?AV?@Us#~3&e5wqv>=sx zVT-If+C-yKQrJydxjlund?GR;i?skCja1fEk~i_@dH zU-ir+;4pj$(x3Z4cPyR^yO>ArfR-Etan}gkCYAoJCT#2S;_@ns0#LAsIn51E8+}?- z%wCZje=46YuuqvR{jnJLO#6%6_{~Z}LIITLMl)KhW4E0=)5>ItmNteLWo_3&-A`fE z>bvGdaz;{>n%tNk_9tUBsd(FZhE)eTnv zWHKaeW16iV=;BcEM*ts~b0x)c$Bh|Os((it>adNoNH4+i4*KmJu^ zGlj$^dSS=~!Y}5iQ{a?yk936*zq6m{uAl)T=knZLkj_d=oZpG&UeIcej)ddO@O3*g z^)D(ASoJ+&*O5hWuq@!7`+Oan)&@#}I}mXVln@eB4A%x%<<oKUsd=qr`>&`uX#zxIRRo975e*rJ(-GCJ44*V;YOhoXzBFUh zG(r=O#0=)hoy8jig_5AcP@O6mfc{Qh)W3#X_IJ?6$gpo`_WfkPHEobnGMp+I_8luQ zf-5_hui$|-U-D~V$V>Ux*xXr0I@U19{Ah^HhC67C^hjrn7&;W;k*oC~H*uytDCR*f zu;RZM7c;5D7SPt7_55&qVO~_t+R{wDi}g4jGg>)%*O$Foy)~EoA>cq=W{__3gu_?8 z_hzE7LCUD}^HjA2Y)06&1$blfll+Gj*x3(QRg~cDx+i%7JQ_Q2)zgj&;plYWV0^_l zMa^qt?&;6v<{k_}@is4C`O5dTIECDy>m`f~b&C|Oj!;?;k2p7uI zgOw6d(b%8+m3u5y9l|kDvS3pS@KDk=a(~gOz*Z)(h0t>v1Xi^OlD=IrYiuSW-Cgny z9U_e{osP$gLvHh?UWFv%5s>D@(`VNf)e=AH6$&(?FA`2sVjyo9Mck$UFd+o{t(XOV z>a=3Vkr`vF$rU>arbPuJ-NQ1WZm*QPji_pgC(g~3HuCzc3D}3_r9@elpu(;piQn(oc>HQ?sx8I#w`>S=r{VVwi>pKICQ+7%Tg+m zDSHwq-d{p>KQAOEa`_n$<&+!v1uQvfy$dZZW;iZO@AWE-Y=;c&-Y9x1LEug|dtZS1 z)S2yS2dW|O3o!2#UU@#vWmoc}b_-uO`5cd2y%EYlApa^;JN?x^;q)jkU?>Pvc~)7d z>DTw{Fsh#PuLAWrS9>&_uQWdQ6mH2qPKQ_I*?(4DOiCzcL80Pk`#kZRt;YEhd<-cW zV?%KFH_5O7=)jw>rClA@#Ug>?cxJEGP_$tSrN6ZdglXZQ5;{7sHvSqUaQw|JYFsD+ z3r|Xle0=DTgFD3Ig_RRvFb7>_Rd8w!#;{kh%o@^^TM_#Tgd8 zJ+OTgRl8o_Fn!F{ukvn}e;Ky3+y*+j?<^-DzJZAcjeHL(O+$&8I3)v1y%J(tR3jT! zzQ*|q>vNdfX(8SbT+?R1V6LFR^jpbn;bjj>6$L~%jGJi|yd)05j*H7hO!FcB%h-|O z_}3u{M+~RJf0?49{$kwGdX86(LKo|GZD3%PpAkJ zfRv^n?r2eL)E+cOt99Ms(`s)_GyRBUn^P zboG!fIfklJG-la6F1qA(7rNg4*D^IFAELB{VqkC&PRwFNe;=ro{ILaQtZ(a!ZpqOI zpB1)k&DG`rtq6=xLNUjx707wX<%SZKjlU@DW6~95w6j3JdeicpKt;ioAD+z=%NApW zEzipq*sz>ZE-O8F6-Ev5=^@1g$Avy!M>-1Oh^u?F15*j*#;rDh?n+OqxnH3htgl}& z_3>vo)WsrXt!#oKmD(e2zh);R#OEsS>9sh8ez0LkS4Q8mp@xm=weryclE#cGxtJE;}IEE`P)fIi;IuC(}2idiis{(lYECqC1V;y zb#l>*Qv~OAo+*dX8$s(yDPS{64yH_HVh1~I-I0j4hD!H6T2Vv?WOyezB#tn!K$NAM zDUV+PN-epx_TC{>Edo^*JTW#-jZe0(bR7F9;i znQJr;c`>R2|`68GJ{{`>W z^M0;6q)Yl>T-+hzW=%QP!p%nFCWGR@flsqDsFOJqOOQJv9faT)JLY)`)y`coDFm}R zVceskV#l{lAieXyig@pMV=6|+!P3w3y1Yp^20EyIud#+gXF6RaS{EQ_b-Pmc8FgmW z`5S9x4nq_*78qczHL%?w;y2SjLnoP8fVNEL*!1-nkTi6d_LEqCa8wKL`GY?mxj4- z`g=2G!eUdPr&hspVQKUQa@zxwHA8vjgn&&pvrcu_(5P)D$Su0M2enZKqBU4A6NHZU zoQD$*R2*}qWV&M014;ES>!$)1iA7C3{r#One1dqjr1A7-JW9Lx7tJCb^bReHCfh5E z1qUHxC`HbO!aUP2?rV(15mJjYvE7IbigTo9`G3lkhkbdsmpd@47qzDTZgy}{!qjM(A%-uTy4 zGOZdjQ z7D9a8^X3=}w{ja0?FSejEW2Nf?bJ@Jt;<82mZ1Y$)bxTT$jk|-m`gtu+la+UnP_Co z4xY{Vpw)RhbBNXb<*EHF+2i)Tl07({Vgx=hTT_l%OQP?(jQBVeJw05&66_+}<;yBdiVt(A4hG^+JZL zNy~vKfL}*4=T|wkgn+kSGVmml3RBsf9UUNe=Av{L)9@365ue^?bL27iCBg{;L}?ttoFbSm~tLk@ktXw#60`+9xC~> zF$iynQ;GU6SxZ3o@b*Wp024(1RSt^6jRV;pVi)JpkZ^c8EKoJ}nMGg^4(HZP7eV}w zL?%IkU?#Aa5bGby;qIml;Wy}|K*kj%x<^i7*?18}7;C z|JC&64p^jmuv(5*F6wJe@rzQyC>7YfVi#P4%?oG27M_RBFDoL|9zaH%u!=nfTL}oa zC7R~ACQY(23zGK)mlcJ(25yaNR`6!uFZyA)e-WLldqHuHwEpX zg4U9G>(d68iY})t)ND>tBMr_(j1@emaJBz9cB~k?_t0x6*VA;s3hOVP9Q|4s~^nfScy5H~4HpE?xJ0fcF7QyM^7PZ# zzfp3E9q&;+{lKHP3YVHHhb>o{(d%rQy9uV0-W3z3Y1CX@_0yuW(8*Q+@t%?X-WHNN z9th6XL61#BhE2u##3m}sPQPVA>J=^-8Qj_4)gfedsa=cg|Cjc8P9UWJV2> zANGHIAua{+i9C1VTmC8HD5<*KOX`H>J9ca8SkoLU9Z`? z0_$@dCF2cE7~cpR(vRYLpHTlzhV}Z78E^~N>m|PEiAwAtX=`4iZAZA`~nzmvX&IF4dPw zK?w(6d)`peZWCwQCYMlEFT{{ZR;dqIU=od4$`WZ_rZBy7RC!T_G!e+>kxxZ3jU?Ls zdljYYRKFx(hs6MwhwQ7~6?LbGSpP>r+ZU zkF5;J1k$UECI{|mcV-+TgEgO``)96xT)opOrNz!$Eh+QQL}4&H%t8Fzu;kJgYq9o^ z+1%aC#SIKEk>zK6=x3rp);Cv2u?Eo3nq6RZbGt=>tMH`1pls6IHI&pi_F z#S-tFHe|XB)o)c2hl@@H1}KgFawEa(O}Ns)`jN7fCZ#m0;*wHTb7g}okl?9wl}x6d z=v?3#nO4XS&e+ls?TgqeLp07c&vyF+N#9rv*H)DZOVO`^QUdp0g)~OVGv*%d*~hBx z=ycL?*5UqTYN`Zcqx5@Eb`%F^kvvl&)9 zh?8ie2ddavcC>1-HO*EXE}bWCo;t9Lxm!z}+vMnc4JLEcl8_QAZyr9B?61xyiJ%cD75;-2wRCrYd+Vsk+z9Q=1aED7*jzZZ z)~XBe`<(JfC6lhZobbyfVN96gLZmzgP4R2)pID3T`zi7RLXT2%AOVXw1OmBtlPI1QS}_SUPe5G9<75_SX2!^9Kij0Ee~6-3_%n(Zi@!_;PRbd}c|U;cYJ zSy40s80&KF@3a<%r$#biWdYQyVJ=Rdcm%u)($RK=JtcvFkBIo-eCxZ|IGdKAcOH8nTpW$h9*79BqUY5D5N3mQp&Pf?H^@AnFjhTcT>LUc zZU^)?g<-g%b*G*ye{VDbD~mSj8GDS-OCQXmlpV_0^vPY*tgP7@y*e$WRV$ZwM$535 z$eQ~z=%;sO-!NDkXlP#8UNsF+`&ScbI%Cm2^D9t{I%_Fng1+T}s6+GrDr%CM`uK}} zct{2v9p#J=uk@zCF1rCPS6nffygoZs9#~(nP3EMA0`mt}GP^lIl_JzdP5wtdQ)$70 zHo2||`{GXt+|=%()}^`4zDkW_e7aDia()|VHF?E(`TEsq{7|Dqajq)kRu7BP$=~*& zpxMmMD)!LbN>4H?;`SmIr}XDVMWTB(s?PRQKWwse2Yme)VX9hFKf_nH%R)PY0LOM8 z5pf09{&R-b^i&Yw;aL(7iWI6|BLaEJ6vi~vdGy#U_U`OLf5&otW?gn?f_vebCUq)_ zotR73z_(0o)6jDD6|_TGdZCM}_qeL4dn@AI=!hoBJ-XV(lmcpk9|Cd4=+r{$4N-sH zLiL@t*<=~zpRC{9%Pnc@9DVgJ@LT!_{kBPICA4X&8^2p_hj1>DV#F>12RQcTYUre; zwMSvlDgqs)u0QpP&6G-%wZ?}@k7!(&*=>t~BmK?qD(4bdme8R@7KIzel8!z(TbGOLk@+2Z~ zGPi>5APxTLm3$Z@S|dr@v0JuPi3QVRg241Bd8kw4tj$Ld*q>nd<=BqTksHlvXq3V2 zxTYzcY5d|bOQ%ri@}JgBxhhr8R(=Pgm5J_{y2B2`zQ|A~jvW4RX@}QZDPK5NeX&>- z5Lyl$_!Uj#fWjRhilB5!Td(k@iJ`{&(SFfiY5)eOFV zCDG~3x=jan&FO@KLL>cb$T({oALjBFmWiO6Ln$(s0`W?QhLKIX1WRn2ctWUSb17Po zEA25zQ_Uu$=SVnN7V+{-r`4l2LFyuMw1s{SRbL*_qf)*QM{HiSb@+L4nFk?|&7){sBH3-QZB%q*JqP$0qpH0ld%w!Cx^x)R<^nB8z4g-NJ#w17bYg6i zZ=0_Jtb$rxO0RTe)nA(ytYxgC9BVuZIk!{sHC)^%3EI=0Ip#m_C`n>_oLir`9!XhC zqA17quuiIFHI7N%J4qosR;(7wOKvdo?YK6K)!mZ^hnF{6c9l_+Q{UVkf?eH}I1Ecy zrpfe~$JsoH)}Wr=5yk{TT)WO5zD~STlvhH8MhFQumt+HbPgL%y1R33nlu{1xM9d7+?0)TbNT zFUqsmk@NgcC8b(HR_j5xR_;15$ZD3?D4TSUK;uPvtf3GFY}+RI$maqlcJh$6xENDX z7M#Rc)yV*HD_($dE3XIbecGwuc1442a4H|2tTs?&=Fw<>7!Tu)ZPdyOot&gxs2Ap@ zS?Jl=(mF=7jJf=p#X&iJNkg#%O$2t+P1&>U2k+LlY$a1;OxtrXX2h+e!X6u-lj$`M z$(D>N!2n{D+A3a=!ndb=_Tqgf(Mc7mroUeN!a)4hNpI;q&f`-%W8vgO0EnO|cX{8& zF(h|vB>+ML2n9nvRHg7of(_K&O}kTxZYIaHKSWbF^T7MxYm>f?xZy_FE$7J*%(ae18hdJk2sf0J-m!dvRs3%aKk? zMEyA|j;#GU^`OV4VpwH;H0#6?csHIw84 zME@7#1%=WyVk#Tq99VZMHL{bdgTqa}2HU z_4h39+A71T&s!i|&dBg6te3%vzSgw2A2e>69u}Bw8UB85<`It-I!8Qj<){H{Fa3zw zM8mpmVg77}K+@d12XBtJSvq!+RW&ZYC3Wf^4`dGKNvJa&`JVWChi{H~{*Bes+h-1$ zDs>USX1EFa!R~Q@Y&eB;&Q-32$cDJyQ&N_ENVD+yHg7y(YGJGQLcA$Df37iFp2vc5#VwR=NG;( zy||mhK~CCh&i{T@`UZXs#7+B|dBk$z&KiV!Q-dY}BuxB0^K7o_?B-tow~H9Uw*Aqk z`q|1^lXnSq<3vXj_)%n4BZ3ufYO3p)Z+B(7t+}x-*;&i-lYeU?U2pK)_%Q%oUs!ND zn}6pfz=vE81$mS8QrSE^kkDm-dm2rsxIz>d?v_e9%b76-M(9wJItYV$Dhfm?PCvj? z3JhLk1}PZ?>p_1ml?gQoLKx9TG{kH*=u_f-oSsI78v$OWKsyRT_}l3QMkzg^Bj~%= z5BsmyJWOK>(M_PG3{EP zPf#p|k~O~dpwWStwT=YCGWdGp@){WdH=FWn&rFze;0j+A4Imxu5EI2MUCr>5DJzxq2f@0 zZ;wktCcF*K)~;tBX`+U)PhVm(=!hMG(==twYZXXtBk4qY=+Jr!`ek?NAzUPt@H3 z{TBLtf#OwnadwNP&Hh+~eH)@wUJMNmVV@5I;SZ#40ZtgfMR3QBX}_8x1ghC+}t zGrfV*W~ga+S5X8R^`Nx|owN>ONIG9J4=Gs z+jYD^p;32_L_QkecYq|3M$F~0>soXafJ~ii1E48y>=mG&BKwG~K+(?F-xCRoQ72sc z79bug#KjW?%=amXld8^Na)8p8t%ErycNHA7RkqON5d-HM zGz%C=CVL!nOQt~;WiC)T}E_TZdx2^J;LR^4< zXt9pvyYCr=e)DCK|3=tsh~S@)52~uPh8)V6lXK?4f;8L%D^S3Ry&1{%fXC=XVy&4L9)+B2tfb z4X2CCzGXvUX(XE4V}4`-p&ee#tOe>HR<02n(G$T9%lTwt3~?&MOzC_sAv+Dol8Fh?P`Rd*Wmuc0rzq2gwfp``BT*>w{VG$?V%7B%xdyk;Ms z%3hB2c=&^;5S@$ma0@ZXo8sGm3s28nJH|nV@1xQZFs(cU9WBTPB>hpu(oA~y>*W?I zgV3JH=p}Kzl${)ec3t!R`3-7D_9pcjh26?H@Xfmp0Z9aO7=SCbA zf0IM-nw9urwTeeHz6q;DDyVSo`F%fv1obS85Jf1FyozY|3_9BT#J%^)L_lp%{ZZ6` z`-c`nSfR#T^c?`KX=X~(jejlNE|D=|5F zgG5gDeKm(U9DokXQhuK?an@GjQWXWLe(HA^3|j+@ng5tWp*@Sa*iKD~&&THE_&&rt zI<8O=r9WUgF#)*=PC;2`mMo%iQ)Ld1HAIWhZ>h5sj=^tSB%ucNepF87b2rmnrNYd_ zZ=rJjQ9|$*t$^i0Vvv2TBMBu~WfcFXr8Pa@+YNCFv97bQALOfs!5InD^9;YS4KyHU zKf27!tJXr#@g8OGK$Fn%+viRAQ9}AOlRW)2!p|l{BEEH|pFj|~h;yuixSKEzeBxYZ znYG4eCpf(`F9MfOY|dTOgEM7tzJt2zXrK>m#Z~CY?){v(!Kj@S(!xGf^3)+Q*nWZ_ zx|&|VBxYrdna@Wud;<%qX^;a|LsYXJ{}yQs_WaSj?y23vwq|$Y&pBPh(=vAK^zuzG=Jr?1z?XQ0AtWjUniXXmpPlbfXOJK~(NH6(fmE4RoDP{TE ztx{Esp-w9opzeiCR!$VF6IH%LQX)b zLy*_nFaw6U%Cg;rQki%$O@9P8* zSEeW&JYjl`D7E+YC1T9-scuT^hZ}gAR76}W7a4c)UQ~54Xpam~HX#wdjBJiwS{V`1 zx4hmrq7M{YV&kEYmhU--{f@h9eG*hScY2w(f44Gl#3VKO?RTWx+&g>_{4w9CT`|Oa ztu%#>pNeXv`-h14vSiu`nLLhT3$6|G1CYo*7Pg(ms?<22>nTK>kxv)M^zSWI@zabG zBY8A5Xy?#d$f3bv#Ea1jSEnWRvtwL$WN8$-Xz8{fpcdf&rV$WSBcPKy#(h9@N28l+ zzmGTz?%dFiipDba<+Yky&O@iAn8in;b96jWh6p$%-BoaeQBM@Vl2^|H;N}8F)nQbM zJr*(N=Q|avY@l$Wb?h;9TA9@W46jCxxH79;J@))}MgGq>yh00A9JA(pc(YQ(dK-lh zRJ(j=e-9Ho-236_QvQX+P1+_k@rq52 zVW2)v!X^XO#;T={b(Xt_WKq$4ITTj7wTycYGcDalGJ3SPyYYdys+ixc%!SRqwn73~ zT0?IT(lA_peZ0nPfYd9?mHC@engr5xfGkf=JujDzdTk!PO&VcPQHacPkTIJmNAvRETV}D|>y9-xuFYpU(m)D?j%=Dh3$%YRj!dR_P z{ZM#r2kdWxxugODC;75z+D4(?Xcyvu^Z^+;B!PvTZLU?n=kf7=nwB%Rp|X2r*f~Hu z>df;omY-~-+!N@eMdal0KD(ES4A-y&d6BsPLbf`sCe&FZFQkS6%vcVgV>?}yhWo*e zXEL^I^QE$5!?Kob!~lr3(GZw&16rc!i<$t4nVgxQqhdgF$qjJ(fy&1hFkfq|Bru~@ zy2T&Xq0&C*YFLg9=`Lf29v>iJ+e!GsyTz}a^myUcAP&i4`peLz!{hnnYA{Ai$ zmp&5o?gY3L$O~H>`QUQ|u_=FeHwbp>o};2kquo$4zdeI@Twh}gz-5+t`TJMycgc@@ z$@y62T`|2QRNrV?C>xuKFL7crn33s(V3ie)SCMMq!VDuB(*5p8LLo zMBP*d=*A6jwc&qf+R=_X`d$Hkcy49f_;nI zGeOSi)V(T;PC=RQTn6_aXpYqK`8R(hB*|CLvYWHy7Ar)$v8rtXPHHrmZVy%Nl|A1M zYb^V|F!H@Gu0xKPx4e8hPgfQNfIScrgKsUBM|<91_r0dexGOR=aUTZnGn$txM7FS7 z{hjzui08~6dunbTold=`z0Did!eA0U0bdyJ21j{UrXj{{^;y>uqCZ?z{&M<7Q0Cu` zuV^do${iAW0Gy6NK2ce-_m+5gP&Kk=EYo_57#F_99(4nJ4?8+cU%E|yzqgH<1enX- z2ii_51HwcJa1l7$^H*e~P5{K2NRv<_rk^7ow+f{7QLPi1g6=PK8@R1;7R8vdP7j(x^ZGxJ;`#RCwesN`_p8Qj$4Br~5a z4lp;j7|tFu1n2duh)2P`^J=Dw;v%Wf7iDeoQrv42Vy@5qyuOI@Y#*r9nw3N zw%tS(5D0d9UM_tqE?UF^xo*@_MHO)VJiklYfhxf8xIZKEj0EH~_c#K)ymPPDa+Izd z3)+yyf?2FE5|c&6yvl`^-&JNRok#&LWqG%#7LLoMC^|6!KV>nL@$YA#vWhcMyqK(p z9A}@S?<`LxD;I|UineJ7zjj$dvx1TU;86{jN2&lE28MnVAriAb^)t^Fv3k#A0WNE$ zZyz;T=~cBa=M#U3lcG7Rw(TmbtcCm!?;^djue8%-EKGd>YftA1Vx4vJy6y>5fRux* zda-z-=PIf2T-2a_BYRGS-;MMAwg1WAzYp1a3Zw3~`34vmpiBIUp}$Y7IR2{wjD*hJ zqWBGzN*OSOvE2u~5Qhe0M+DA}#5{|{I#q*e%F9*u6T%y~d8bM~I|-bWrk>1xJ%{~2 zO0g5aLd!B5J;buJc(E!SCj4P$=o!8?9KMmUoF#24V)5vk|NS*|kex^;uy4a+;Pi0? zs=WSjoYL*=XLN%l2MmF`15IIXzoV5BrQ6$nSe#=!jF+im#_jEeXr)deZ`g;_h&?0! zNmwqdE2$az-?s+hKV~z)Tv!Fw%yoKOhKU zPIG{ZQ_~RQ4Qz6D84-}xUMiH$?Uo(}jc48bow;e&8;^D3{Er(d_i;}#)Tc$ZAjeJX zO7&6wN?TP31)2DaQmKp;XhZU`2x?b}j77-L>){Yv)!|XhSYL7tu?WuXJf>{CSj6dY z+A+sN>@Aed@dn-p@4alRghx|Uk^#_FBV7ceZB9#w7vK4(19trpCHmjl%zZ}fzY3O3 zwRWym&fJzbfCh@^M>Ip0e#$*W)3Q@M$`V`UG@20D}+pT$GrpWdTS?OnI3N z<12JSi1*EtmZ{;`eCfThiM3Yta_BX^K~{CeyeH_&cTyre($cbVn}Y7#Bp)h2x(PW> z%22suvE6)8=6vbr%y+0_t42(lU)S%9#Ui1n10HKx3z>BFIJ1ylkm& zWB~6fScm2qH%`|pp1NQ?1t`^xiSTHT*d^epO@$L3v+qA$aoO>Ltw_r_b$~k?eTZy( zt~^px0}$H8mcAlG{m?m04ZvdprKlD0z>y*Yc1ov_ixHeO z)Gia5X#9DAv=q;IEE~#}2b2{#n;*8&(!CbDkED;Az-5lRDnp|kF>bsDCm`Ci$36hydE zkezGDh2dJcQR!g#PC0He>pRYXzAamA$aQ6kLQ`On8&7Xr199!}8zBrlXKlETOiL9% z0EKS72cs8#YPc5fG1EA)Y`X^xgLNt&4pyxzmbhW74dePqg5>n2aUkA?kJazw%Il>p zBTBZadjDtCcp}0wMRc@w>c3oP#;k|0=+p8}{*%Tuh!B0P^e^nViGn@XioNX5vDS3) zMBxy7`rB_)X5C3)9qOjFR>c&dlFwa)*99YW8o-Lb%)u+YlXt;f?x#en$DSaIcIjLA z?Q4xfLOUMC-E*TRuR-&Y0sEmlp-oP1JaQqfL6G&)nKUtZepVwc1Rq74CMAiPAB7wG z+%{D+C7*|*sqPrONA&wkb0PD|-EECTDLi28DsO2&{frc*O9fvR9F^x;Xx2H<=%LSm zpGN<09*Xs-BVyWzYBhn>&h4j;#>@^6L%0}1)JGS0l&UQ(wxIg65J~w)Z(wF+7tkm9 zkq}6!_6+sJ1dT4+*%LkrHg+b)1!xiThS zq^q7G<4EQbk)pQd9jDVSla}6-FhQK;t1Z>ZVM2cVg%1Umv|hozA>dTLOq{5SnzZF} ze8;ZRCZpN!PMj!eR^#$JY57#+dBxWNz|y+8b4^HH*YnGtFi5n7A)a|2_HS*KJRSD=^Zc?NrhMfdfPZyu_Z3xdQ~Y0I7SLvnwU& z5hC#htJ}A2GGW~z{Ho;gQGYWsox@7^emKKCye@-A;`RJdr>W0Kml+EZLwM(+pZll8 z=JG6Lv`>B8+^kwqR$uFtFcB2KVQERJpf39+L;|_hI{Dz&LEB?%(lq1i{LoZ@mX zbqv%vUdwq@T0Uz-Sr7j z$`RIPR%Vcp#a4W&<2$=JN)TQWc|b3i1+%2dg}f^>o8d~i;Iq zDp$PywR=QFSzKi|EN%HE2r@P3HI}j4=F;5FsE)mLrmBRzjK`1h#M;ey7<3NXyS`*$YNUh(g27hvNjvU=u=Lt6a3yDE_O_W^A z=?j1sl1tr(>s@3YHXkQi)4l5Thg}jM0J5s1!l*m>^?yUyRXvF&r(qHRH+=P3R?##w z8*xVgu>WkDc21>p#|3)3$SLE~AJbI_56D zRNYXsae^85n{Rn;)I65tKUoOMVdiw7004qv*=Dc*VaE{euVR;>mJ`ORehmn_pThEy zdjT-uO%7%c8`tSNRdT6UKEsZWS&KVrn!C=N^Ja05k72uWp`Ru#<@R!MD0qIMotl){ z&gS-Vb0{dzRB~zZ@b5%Fejs{dy={(V=5{wGKr&6@t^O(+Ko+hA#L5H!3y*>=o!BD| zq`IefIAml_=zGhjf(T2sEc-M#pVTp#S=#}>@|;cPg)j-_LJPWPP2^buD0e%gZbXo8 zKW3Ev7~-G2pzfs=Tv|M)Qlb*QduJYG)jXr=s7ODV0=mA8;SR*0mrntF{H00I86 z!NE1uzALDUmeCSK;#sVc!Dd!#>r13)p9qsc{!!POlrh97Qolo}KJQJO5cVer_3g#! zUAbuT^-16a&9yOCq3hbkOBi~|04R{8X)O?J_iL-d#7h9L!hnjKK;g`0u6_5u{vVqV zi`spj`^_EU}n(F2)t6F-JI6=IaC9XGO12Lrh zpC+m7tnJP4vrApQ0q6)4wsN7av|5}$q=}+r&B7om?Pbp{0sTMq4W&~9`@Ab{=>J$4 z0o-B=ZxocsFTJ)XTyXz@2)=C3ly^8W9N# zY_)5PM=&|&D;N$M4Wv?+Bu%-kV(lsc5UIN1P-AT@tE%&Mf@lcufzR7U=5Z8|Ny`fE za;ui=9|ejqF@!`N59;hSjS^*m;=Hw!M3 zXrbl1h-5B-$L>pYAY!SL040~uB3pvaTh#^75CiiHni`eXE1-_SOlX$HU=Zum8K7kN zreVkG55Td!5**tyftVlZiJ?*Z|#MN(T_2@~9pc*w#FHjob| z#|xgFeKFP=E!Zmh3?sdw!)tl?)1*JsM;~~hsP?Mvu`+X4+1UP$qo8=9Et)YWm3Lvy zACj{N7;cw=*|`gJ2eRxRD$hr+F$l6jya8gmlR+)Yg4s@woFo@=8@-&Rfbs{^GBHR^;`5S;@S3h#w?>Q9U zY|tV|beGih*Xa0ux95a2tjMfx_eP8z7$z`zEho|>1eF%W0|q1ADLc3kdcqsmUr^<& zwA82l0lA{K$>Q(4yuyr@HPy*0uH;t%Q(N~Bt6I#xx%-+(Vft|u^Pm+U(_u3ZgVOW~rWY#=Q@&PN6lEYW%6EcJxH}GW#=TgV4Okl|YOBa~`rP zR@C$Lh3cnL)eQlHP{h0P^)98tX@h4$(cl9Nq8$&2C#wF6X&SQfJmm(;D=djpM>@_> z>o$N29}SYM^P;>iMd9Ki0=yWcBFkB&?}K$*0CucD2W>;%+D8bL;ZOQs>TrM$OeG?z z(9`6qQDQPGK9Y+YmNG5fZ79af4{)I=EER0NvkF6<01BV0uE+5p4NxhTz|_B&gV203JO4&E*IFpzW~ z9PN2J!0LyPP+#3<(Ay4=lO2Q^MB2)k|8_KcxirJ%Z_axX zbAucWHzLT!jgxbN`6#1RyP2vp!auir1FbakwSW-66A#Il}aB%*w}y#%;* zx?R|8HL9_a|J!@FikFQ26%8nwF!hR=aID@xKvu%sCM*Ob4sxvn(hDp%*MC)tNk;#( zJDsOLbxqii&lp@I;t`?rdb8Q2Hm?8yEL9Sx=X0v|N%0Wt(3^8A?BYW5BKQA^9E_^! zv^*&Zo0C$IPM@`jK}4!k3!rb7N%ETFt5;`@{Ks`~SiNbbqM{;qLKrw<)B~1%(xiJ7 z5&@~jVJUn$>izt`x>Q=S^R_AJ`urAv0{RtI)>tL&)VAWk-w|az%qaEYJlOWV-+;LX z=mJ8aTX_-7MU&~^8`M-n#Au|3%M}o`Rsv3eDF!k(>H7uUz8DUGdMb_OZ6CTedp-0& zTn-2TVsehE_3I-N3aD7S_eP#BfNkmmEOqa+YAOJCq9EeeQ1#@T-v_=k(VcmxmZwf(9SEcW*;Q?*eP{oySK$uTJ6 zhm7Pb!^$;rG@`shXn%DiqvEe|+}p)HMV=b|et8s8*#P0n>TRs+fOEXO{kXq9_p#Nj zL44C=9M-jM#?D+dT=NC@7_*{w)p`dF4wfvP)G<43rC&WnfeJV zVLma~@jJC*wlSUUtq~E^cD@e^d9;=4$euhwgi@1j$uc@+@}Zj1I)^C^C}8qp!DC>G z4A?)rFPLt%s(At`{R@duT%Kr&POWD&dBAQyHEaCD1V&No_B+R?&-ux#;hB$&!UCVb z`1u}S+pg=}@3*SiEmBb@;L>x&AfYMlsNV))LWhN*7*nmAVa`;a^I3TZ^&f26k*FsC zXw^kDE^6VO{zr}Lt+p_&xd42 z-aJ#E&4ytHM7wMp@pyQ`n;9xg4D4saFO~g2X00@>a}M-&2WSmF zNy%hT;+%~Kk=7o&0s!{Mc^u?2r!s^+T9Wf2J~*{hq@6?(vZ@FxX`j5azB`y1F*XyC z2GhIgphPF{&Nm{JW`NOFVu%WpgTPiEoO=OCO6P)AOQTv}p3w|OB{2w-nT-Bu68!-B zT(@4dJnj2SVc@O0u97B?%V-DaK5{8OWAe4NQO|E;-Bmy96H|(y zSq+QgDZ&=(SX1_Qa#j*}D?G%N@zT^Q&#sg|NT^O8|F&Yqkx*3hA~79ODXwlx{=+3} zIa?9d0gl0C^O@0nRB1<}5H@ME-xvH^cj`SafoleJoa77<cy+gDgNYK?(*8t?0;?a=}H2( z=M7ut1o`&B@wxdcgSmkWXwhhDk0^^y^j$ix`g3!$V;DfCcD|o26mmXwV@zd|Bdzm3 zh_m05n1bOk-$!BIqhqDo4tHjtT!`>$Ilg*mp0?|v7* z4xlOQXLe6JBT5c;clvSKp9kyw8ALF`Snl=hL*0Q`u|mG!5h(iT0x(*y%jW9_`oqJn z%~ur)nGbuNowF#6<>&<5*Q}^Av6@*?MMW*Waw;0vN<^>S&^%6_<&ypC>73VPuF;3t z$?VqDIOrllfN0!I1?Ju!56gHC?EjxrW!>o7 zDDb!D%!UYV6mZ3IBbbBk9ZK|MeZydG>0AP%cxoJ58do#bglj}fMfEWI!`u>W7lP_x zF|#$)iAbG};V?fG`&1jK7)&K=Wqpe$c|g(6zwYl^N|Z=pE``;*&levzkTqeHWzWk7 zu`vxBED(((XcqfXJirXT4_Xqf0LH2phl^{@Lu3+*+mH^2KK8h=B_t<9{>9K9q-d{Cqx% zoqIMo7t%nz|F2fe(a_euhb>oS$ry+z!EdStQ|}3do8{#x?N?+VQUsH*+-9D*

vt7{ zFpp<2pjFa_U$ne_?t{yAmvAXo`5gcU1R29BVrI!?o#=fZoIq~K0!+`$x&8k@d4XxG zl$W%i1b}R0?f^PzgTKnR6&}<-lxT|SCf1RLuS(r-H$_-GKOO{vXuzyL zuXvIn?k|Lty~R`_{6$=)A+Os#u|fZqHf_+-de_>fGiHN% zl5P6A4&Dd^<-j0n1jZz+$q|wm-N0X5{6>(s*;u8IB{rsf zdk(_z$r>_J9^tQ?2S=8q25n|m9rD?_Eq>t|RMA>ks9EA7-?fg9vP;xlb=Ks6*t9y{fJ1_*P!y+9XeIFA+hgjDqMof!BkbP^+qE- zAO{ftOXWF;!__XB=Le2|fC|k8rLIaU9%@HVeNlYG)<#iXr?KArpZi^1c4_Hh<)g=* zQc-j;wsLYn+9<7mZAV>Q?+*=f>Q~s$eNm^V!?Wsg?7rXK?D9d;e$;6*nansD5RQlE zNz@(p+_|HL+IJY!bO=;c?FMXA>m&zP_Gp3#VQLfnEO>#*${l0`cC{cXdI=jq$(cQ9 z>iA;-`O6Zm8KhgC9h83<=bf*;=-<`Cc!Gv_h!q)U5v_IN^P&oF>j%ffUApGz zFE+0ou4O?V*zIEDJrDD5=WAZ@-=C`{upSQF{agcfK^FRcLQPJJiw1=%8}_qnqYV+- zfPm%hSU1+^lbhr9Ivl9}%S*1&TJ5bm?eS<0Dev8(YIRyi70UH1hEc_p(G*5%3yQVc z%k01Ret3P^sp(PMMBE-xf4K6=6$%rrS!cCCG(k6O2|%Erxk^7D{+}eTmCb+FJ7a6Z zO?^5Wn(s{bk^R`)1V@sjuDsx2g$oRc~65g zVo-cu9D^>z3(FsQjdXY-c4l&!zYwKK4zqXg$?5CcZ?qG{JdF~p`67O<9iqp z3Ql>kXB6myl)izw`NG5M&_9HYl1zF01nFpim2AFe=M2!A_Cg>DvlLpY-Yu@%*|+UP z0bXSvxB;byt65aDRc_F>4wOQlKH_QG+K%5rn$;*OOthzSiBE!6t#@JU*)>?d#2Ww5 zzW5PCLR4lvo;xy%M_Ueq>@>VyQ?gqj5=)_J0i^bFap^H-D~YB!Jk(O{uPB?0(x-dG zr3r{Pno(Jog}DpQ$tg_Z-LO;9_X3T38|%a>Q!Tsw0~E^qXk}2k>B|OOy}V@yirELb zb^aJwU}kb19m3-Fc zJ;e1~v_~i6)@ZrI&)tzR3hRDR|G9lJU7u{v(daKO%%@Z3GQq6-xH+$>Hc8y&)U0RS z%WYA!Eu@+Ze#H`Z8)W)qbMjA%lZpR0`8W$itMR|8wO6=hf)t(h9WUcCI1whslWuL_ zf8WxMrEi8CzvYlom6v(9seZgULL@edYnxjxeJJPCJ42e!WjF1P?BzB*wb@laGp;Nk zM4aR+9q~71?ucf%%_$}lNX@{h^k<|wYDsJmL@a<|gx2+`too+l#Uh%+5JuJ_(^p1U z;e3y!=64JV2_n7XMxZr|`XOnu#sPYNCkfk-glf$&R_B?1- z!Kk1@{JJXLWmGQ}^!+*#1^ReD3Cz#n+od)$vFQ#I${cuW%zE_BUa zf09l!$JU301&ZZ3n$k6=jwDyeydawhY=*QJU!5PeD;*(@66g z0s-1AoxH zm5Zfk>$_Jz=+mIl^OW?VL>Qm+T5t?LdnEU)RHCQ3tGElZNJoONxFXM|9s;@^x$e86 zyad8-x?zewNID&NrikU>7arK|;b9n2_HL+&ouVR^=;(wAD=f6PT^AOo7S&*IX^ z%N3u0h$?~*!yLD={5k*X8nv;z#bAOlc0a|&fO*8OM5y}FP8k8@& z&UqV!F+D6mFOSc|byI{OpVp{Ew(DM}0j2bKUKWyD?%RCaAH&2>gc0|8rpBzof~&jW z+4%MLW%zqgW39$&7+>$`GUQBJ5>wcU(bNpow=$VU-l20+3u3A3)W7{ePW(ekWl2p= z56f^q$|CHyotTm$^vl*N=GKi^LtoJV*e|jU#MO(uSyx#eyLBq&WdZ4%G>LD(4HMDe zLvnKP_&9D^rg|rp)OeNgL!nvZjv?EzQm3=L@oRcHW@__cfSm^GNXD;YFw~^cbbsrv zsL~_-Va62S8$dT|E>S?an>~C7A@3D4lS%_^oWAt6Cu{@dTJI=Ei+`Apn8f-wQPRH) z6j33&(*Me_3`=hVgE_)xx{47QU`q-~$)D*^jjy6bh<5t}GNns}Ooqa9M!Fde@^BpF z>3(^qn(SB;mL;<~*P_T?J9roVvGu15&n7z!RGq{??vt1Mb&PUT#FXp0w|r4Hn>_bjQ;OdTd$*{~1k} zlN-;3-gim=ie8sZ-?3@s9Y~xwEdLWZ@4egUXG40n(HF*36+`*u9iA>Wacqg5=Kan> zIVQppvZ`Y6`2t70x+gpw3MUm@_~u>eDC2 zrH`Qkx!m(9Yf9fdiZcwU+=Hx^`^58hP%ikppS})@iljO}ynJpo==1?!0C-VYWm-a8 z0s9G6{A<}C4#l&8h%54@T3IgDqV*UFG^FI-eMdbap)E$FTShL(Ml`lT(r50_HLeQCgKjQ1zuy|I|SO=2ZFYyi! zNob1M_Gq4qZK{9hfWq8SXgzz;c!EZ@HnNJWdB7*$p)4Hc4_>iuQUkXocVrH!WO2~R z3jLjwAGL4EgDZ!Q*c6wq(!gI!nDF<#hImU?%?VqClR2H`jH>eC@wYg)vERuQ; z|4Ub|RAeT*im?6;exowKBx4)a1}d+wg97ds#1k8ix$?4R&}OxSmOlgZulA&#inMUH z+FW=8^D-)_N`(Gi(sRe^LHLOZCsBhxV(R%mc-aVcl4(Gv`njx{&CQxJYY@rVM&5-L zc{->Foc|W0aYS>flGx(T;wHl`OJhPZVFB3)k~2@X24TT(lcpu-6OyQc--TB@m|xTb zmhjyR%G^E%eW47dV;N>&ryLnhVN<@?}v58hH2tl#0Hs^cu zBXVd}zk^w!ql1rg)CbaK$qm+P%nlgc8WvCsOt_;Ykrfgp$$ush#c#L2SguEa?aqrF z4Qi&t=4|bs19NYG@+=G&sUB_kj&cVHG~2jw>6E5%qkDM>Ev3O#01A~(PC^}BMG{yv zu5Ddok$#>bQ$Lokg}w1Hz|YMLT~>N%yH<3JqH!uRJp4_=xsXy;T4jV>swU6Cgk zHVtpD#qmq?|D<{5NB1}kwc;$FXW&&Hn&bq$d3iojFle8M5#c>j#r{G#pEN!UyB^#S zh!pNKr);)h=4c5yK`W*eiQeaK?(unjA&|3=X}#-7#3q zzpaZDnEgkw;5>2|+!Op0c~j*?!P_b>0Hn?w&*s~8gRk+60$B`vIz0h;UXBZh5C;dE z`=7QZ>{wtsT>oC>hF~cLyXi*^_FR2Cj%p613ldl+Iy(i?kFe}rsn#wGW-dcHan1-< z)vtkv%*!BzZBfN(2Aai68Hg-kf58B<3S$wK1mdI(D6)7C22&$a_EbeM_X?31JCJRQ&kWPm>|!V;0tYNI0ZgUIp!9*+;B}q;Eem0waI)AgUa} z-m8*_EQ|)kZ;|ymDOZwJ%*Nu{!GZrBxj8iw9^g6;Pegs5PCqfkK9Dsp=DRn`X1+-M zh2?Gk^9i3UX~}`qBfL~Tj3-~6_=gCbXPbZ z#)X1ZwY`ce>bWb$EB_MxSuo4-Oq>xreZrF+_9J!Y){HP8z-`{bfo+X%02ZSMgz*HLNovo07 zeVEEI2&6C~qhI;!1@h{C`L^L!Nhu*tOR|v0bSeYwh31$bE9y$!Zy>ucMH@X3?7jg8 zSbAsyt7lJE&{Sjm;<@WbJsa>EtrFe2zw z*ZnkCh+t0akYYB@>JE^?*A;x4reDjuxWMr)Y|xeYi#O>x$;C9Kv>3Oq|5-Lg5k1m) zAHs2)2#+5kg^3v+$QPL>bY_7mjROj^=cm|JGSX0DwSD$(3E7`Yz4x;OE20-cKl?Xr zzU*9AW4o#44JY2h_vR3Es(UGsq&Rv!*`e@B{)PH8OPqNicsIxyoXEsBHQFm&n3W2E z^o>7r+e2B_j#<=7t#I!jBt%;4_=07&FZ-qOn+uysH~J?{=~3lV!ZvAEJ$FlK4bS`K zNID`TL8j=&N+rjlL5+hqIYXE?s4Wa5sxBo{UnL9;8fTSoY1*j2i&w!dE-)_ruz&;S z1(TNIIVvZoZV{GsT+2H_fg%GGF$E1~mcfdnh7HlSHDS24Q%Z86MFDyN`nuC+&`vI5 zcG@Y+L@*N^`pwsV-J1(*91`eK)4|J1Q9nyHWR5{#6O@XepSsJLr0+wv5m%P=bNadp z&*YDj76;w@()+_?P05f6S~UgZDuJw|Kw~o~+xO>f7QQac-c3<)prW0XO^fjLRQci- z8W}o=WUtcV&7KU1FHrofP6?O_OdB2kBlQaGEB@Wk=qHFs|NA ze!z8dF043RQliBj5|PI3ad;0C5pdh_>QcRuZ>g>>4a$x%)(lT-;%NjgtFV7@<`Yy;vNLpoSgVJ*V^)!9h!PciO zw7ilfC~b$$Bk9H6hryqiV}6k$74uYc)_>d5f+vj+SYc~%uEL=1YZ&`v))*IBGv*6H z6}EwbybtKQtjZ@-wFpazE#O#tv*5l7C8}W3I%pO`NLe!%xw#9MqEV2(soO-u!2%q7Q%P>T~Ki*X^0YLv`tQk!VZa|N&C;Zx-P4H9AM0qaaKu_^M%yqRE zc(tj4#9!un30YvvXb-N^ByP5`Vfr9A10RDEWH(B%p>@a4%Pz7aqoO(pRwE(3fET4} z_8K1sE&n7uf8y07oPLj>*(M&1Pm0FU-Hh(h6Es_;_w1$S2|yQ!HpW*JTJ@48hqUKI zx*?wLgKX|fu-T?#3-@rB;$0p5mBfG(M;!;)qXvTZx$sEvqXFGcCEn!@G{HzEG>nGO z%L(Q5w`#&yk=;0?W%cOcjGeQfr9s#t6a5*}2j^~GDG-2ZH>-Q$>VvRseKG|EvCQ#b zf!inU0fo16j35*;uubXuwOV3fUxcXTdzVkt%QN{aCt0D{)TiQ@N3)%2tgtjqNIo7-}%UoQ6JAwLgq zQZ^gETy6JnhDb@fO~9>u{ElE!O4C+^1`ts@F(l1$$NFXoMqPV7e$F9;)skoI?y?BTqa5sJ0UhA#|Rj^Kf!q~+p z4E;*GWL8~S;>=9T)MN>|v~QSemdUfI_HLIOV2)?TlRY*nG~o2NXd=XN4Mo?$2Arq?{;1uS=@Ae7Ahl6V~M zdOb-M!Die=1r?0i-VSq z#>#YY#rpFe6u|09JTT6>E3XKs!I?OKpz`Ocx&K}hL`aw(FlmxUS|~2S<~Rf$1N#b4 zuF84{M-^0?0*wysyry1mze#6KHb^pDjRTa>%Zwe6VK1D%usX;AdK_IC2HKqkkm#~b z&`1jd289_z5b5mN^0IDl%(O%_A0HYcSD5^-2NzW12~2JVpN1@mCH+?MA%3{Amm%cI zwQ_~*PU}b{SoZTK>g%FXN1!SoLh;2Va8~v@{ZDsgOnoB#$eDg@6~Ttl{xI*##hI4_ za$y!hAxXQc2zN3Eliw*o$7E+Xjk%1vRBEk`*n!DyEwu^$D^eJ0$F~4uLe96*Ef^c(zq5rDlWAJN<`I7O`>)Cg9n=)| zj%u8YaZHjXxc)OAfp6+hH+Jk^{-KffPxS|N|EbY(;1(|kXY^MKpWdkipzI6^d(N~gxFg2HI>Vy8I{?M>=hvi zFMniBW-anQ%1RzH^qq$b@LtRg7X45@i`33aZVf1T%F2vH*%=QdjK^@mc;JMn_*a|! zf(r>B&Ta|(h71kOtO55;9@Bn5jNyOXgc_$+F&KKOdtAbwYrJj{={$B?htB0COL&aq z@*SX&T~pCtq2ZGmD2ZaIk%sLN%VqcVN5aaR6CI?y+lM$z5eb1-H2phWTMo1nc3U!p zMuWDQ=yINWKX5AfL>nIAWCe2kie!D%3upm^Dr@?)mr7zN)}!&_`r)@Nt0{6BdV*e( zQ{}l4QEsl7xM8N8M_%>;{9zWsz>uJXhb2KqNhX4B?~R*elJ}xgN)ZjwVlvqu7rV47 zV~D#(`2swQYHZyE6xB7L%c1pkn#~{F35jRE{_U6oI5@~+X;V4&ZmHMAk1@Vs zZb%9`(Q@JmVG>S=IT&>qPaR6Yo3xj!+>^&SozH#?ktGm-dE!2yc&?35X9KD zgX(G{f9qjzxX{M{D;emnetvSuDXs0e>fqc ziwju~>)$&x!CL8No9+@26QR}0QuwKD=;4t(8!@8HwvwK_!LfwXhau*ibx^g6lq zA|h)l0b7Pc#$xI#^iZrK5trXs=O;^Jg&%l{J&V^Iv7`J^l|WjK)&i^!UaTW=WaKbU zP9{35=p}x74|q6EzP1DJY(hSA(c%u9l=$^Aa2WFZEt@>Su{g*5{ipYzUjn<`{tZx} ze+FL!Kv>GmJu{O7Pt7@x9QH>;gG9PAJJ4^qWc8+5eUlCJ#; zIkn2ojMn36(;Z~PHVvIq*AK9C>#tmRiDyBP?RZ=bZ*bWSN2k{zf70=`bmO=>*|^P# z4P|$1N8c^<TXB)EU@RuL1e}e@&ETN#ZwIanAXz} zNKFf9(he7Y#PS_D8dDi>_UUI%l5dW zlAkEhxlV0y`L~1#P^An=<^=$Zf8AE=B;=nY^%=q$^(aN}{5h^b5}EQQK;bqGObFjH zR*+;VVL83@(gkwEl(kqiN_4Sr+7RCH7Zo|*`>+6Vu1XFkp_O)70H^|C7SV%$#$$}7 zinWfb0LsFx_2y^*aXo@Sj}tgon@h}-gJ(k4@om7>{>s6j0}LOsg?3n+`JTu@f<*n( zvdd0`ek_i(YhYbaDou#eG{b_9KnBqgfMLlm_Ld zcL_?-HVK@UzKZnu=a5d?0>mxo?ThZbqx%{O%QY(z8v|Tm*c}bCGJW3%Qt|$S+E^s< zr*#`2;MkJfg}f6fGWF(&F^e~J=N4!Y9Mh@1d65-_DVsjU)u@LNcv@ub*0->q>s>p2 zVB@&>UC)6eTxUWsaI9=MXo^f0=$=8N{mw~PuPxrinJg!RD;E3!%^4F3d$n~GfWP>) z8#qN)iOF%&;3>PSEPy0HNEUq5$v_bv%oy@>1^tokNEoqQZK)(Vd33+4&$5zm8wRAGrn}O_I=fY6e3d7v7 zlSr5tKk@W7^|M~tnuIf0H+9aP!QY;gmUP%H;I7Vl1Hu^nG>|e{3Kwc_D6%+<2O7(n z9_TO_A)`(@WZLjeWS7t<1!2v;ad{Beo@6-tN{lp4c8Z{%%Qb^pojG>#=of*v4lvt< zMON?oqh8abXAG@3;8L>T7co4M%ous+)cI~Z_2PbDS(p|#jhteH66*{)#tH^(gW{P> zum;r8Sn#vIxJi`yl@I0|4`;;B>->H63C&2bVlQi=Rr+s*p_4~2H9U*V+dv0Zth%ii z{&KIFUk+xi75hK_wM9y#YTN@YzyZbROqNiY%iOc1&hUwJ*n^}Q&!_K0$9pC<(K&7+ zoCHy&CNudx6XLXm>?Z_k_CO0l%M~AneRh_kI)-MreJ;qi=IBB}%ry@^(9}7lzYcNs zs>$Q)7$53QnId)T#)Gg+&YP8$6S#_dLLNlV!@y$QsYZa+wX~nbU6|hFH3Vh0yO~~3T-d|8=$(_Jo5)P=mJPl;=iS__E_^FzFRsifRlGCH7R7=uS-gqL=)BCau$oSf5r!C%3+B)82sv*mzzh*LPQkLMQxKl!z z9$%K%>++*5=E8A|5~&-5xL_nx3)c9)b#{OvCi@gL^;4QlAn_o!)VpVPOrJx8t8qiv zy~6V(M)-YY@a+PFV7?OT#do?sTU z{x3O8iZf;8C>S=Pv_?t4hUB)-LG*=4!{xNqMhNGK+}o@bOgVh#a}wet0&9+|P(V&j z!zSuNuu{w;dunup4zndM{jQSy>CwUff-}`~o_KID+!#LXk$s z5b|G_j)b})SZ^G+aQk|lTyhtPKSEkX!iPGl$z(eOo+r+%kfPUuFFB)Y=C&YUu#AWy zerHnusb=gJm5C`F?gLrKkPOotls&+W6zY59Mqu-`0IrqzQn0u9(1L#69yb;#7t=6< zm!$}|A8W6a^in5ATE=^qw!IUY=otPWm=Z*{R+lOLLHJ?tt@qFs@(lH^bn?Y8Sf|Wc z++UjvvvC}osztk)z9=W=t^lpzzDxTjRFT|#7-Y`$n6zTa!CU(bF+%YE@Ldgaco#w? ziohxO7u_S@|Y=CWyJ^hcFlfuPhDGvf`wWb0)g*54C)KicVW<`r~-aM!(C23iE znYAW0UTv2_T`^Y;#^p;VST97lyLNAA3N-dCk0Fmb-B3YC9Y0S%Q=D9GR;w%Xx03`A z55q^FyVuRdsqL%Pw8qi;z@v!sZF{1a+>?V`rC<`JqGVzQjFJ!Y6J(x&&s@t{YMoMf z*pVT$=v^i-0>EsTgiFr(o;e=6$l?PplEKY?(ND4HH^UG?@Rz0^--lM8B#o}feLO7! z&v#gHihVpt@BB)CmnuNZE3f_5{B06O=0D99A}}i`h%h4X`(Mru_>=Qy!WKj4$rHhc z*V_lv&gaL|=my^}jz~&gG(mfI3t$1ktl>6_v$nzBBqN?0losp*A zkC*U4$-6)wzAiQI7@g8P*6Cx-%S!)q=*Wz6oF%zcMH!ApFQZIUNmu7#pX-wmXKaGF zC0HVc8RxTfb=S@O`+)eQ6w7iEIbc3cExymb_R;w!%nk9Vn{d9hO6o@DJh3Ft=!-9c zB%GPKhbwM{g(cr`+_8W*)i*qLl-V#M31NN$Sr?oiZ6`BK#iNyP}t38m_#BrTeEmU;ck z00=Mrstb_bvj6kfSpMf!*&_M8O3OTR$+o}=iJ64@^_rxEI4N^OCeguy=#)I_n&IEI z2|eFlA3PWe#k8$G6(4y6u1Yjb4wOiYy?+^8lj{kFpH-Mw(tg~5v{gTjkNkesrL4p( ziMj2aj3wXt*lE|LXa=Hk?-*Cw8k~~4KF+Db)hRaIMQU{h6e(P?^m>RN==T_ax&VY) zrnM98b+B~OQ$tJ_8hMAlTEcjhB#*Os8lVzkUGNbLy)65rAF^#(;J~Qu3tHERmA9pL zZ&qjHUYYUl?V-VPIMI&PZBCCSR4~HQ=U1ah_q-0bE;p^pr}9jXMiyd46rWt~w^Sm> zMmhmsJ1yK4Uf$6Q0GejMyPunWq*XSOobhyKYTnR)dH`R2?{jKe=}3LeJ_Nk~tZb+a z&&E~vQW;XE7DQyeNiOfC)G=et9H$C2e&+ev&-?x}6`6M}h4;*97fGwFJ;Z7R6t0o` zNgw^I`~|f>t~WtCuhQ@~o;}a$n|2wzEz|*nny+ zyYGyp2_&B$iy^fiN`{c7(b|q0!*DXRBzl72L0Gr zjS1y}1MBF3OflgpeF$HeqJ2O*KCL)vP%0YzEhOW4dEIW*_qB~jfr(i{y>9?6v9^1B zK&ElL>~Iy5Hgyj`P^v7R(@djI+uE_`{(Ei6=3!yr$K(<3XGrY7M zA9>92sv$|va^*V)q!N}Q@ThUIRQH{P;EVeqDd|?KV!cB0Nzd4zjFKaK+?BR89k}$J zp8#1a76jr6=@(qe0Qv^T!ZP{zOBdgPU7#ko%fu-mLf&(W@_u`)cd}$Jzq2^f^4?RZ z&5){;l1{@ZH-E!Kmu@_j9Z~lPKh2uU zkZV?X=B4>wq~Oia_F^YEBsz;B9O`U|mVDsDwF)OU+1_EmO0w$VFTrZ3=F*j2e4%Qm z%I8S*2PFb7S_Ft(97e#Umr?XanTiONVzG2C2XW!CXha!0oUN`F?dhiAh4!eE5~?um z#y&Ny83Q^Xnl!1!kb0JrLUfB9m+LZBK>*Qw8@T%q)_hzS=vm`U0B{Z)KyTN?q2RXCyXTm7rV}# zqR{(06XrpszaF(L?lqVk0SlwX8>~%~^H?ee0>$R0Ue9;bLDrxCmz`e5;ZU5aTj^LD zX+!`-x)Yy*Q(I`1A25zehO>nmjeb*1jF|oHu#z`2aCj4^;$-)eWdo37YdG27U;FYN|oN}H+)`LR&LCyZBOq|VwzIp6< z(h~+IFbkpu75<&wDqOevp_BIkua~HUXCIE4M9xxc1myMKiyBi*dpiM|hj=wFQwAx9z6E_z z9Eq2pl6w3^DJOK8bS*C-oT2GpYnhm(D!K8agNK{0D^si15nR*goj1a^l~cV-Bhf)6 zg?aO!*hRs6ZRF;=T1UqWOpXH0pN)HgeUVxm^Egj@f(x2y(HE%&Sti~ycIhk5Ti<^? zMDWl?5EiLgagPDghwnvNXAO1Qi`aYvtyJH)N03jyUY6GPCtJAivs&HbFn=(=9DL}H z&1#As9BCd^*f1FSiXdn?FOk~hYaSQrJ@90Ram4k)voMp|C8}jnxFw%<|ER`#`a+WA zToee}qGi=QPT+Z2tIk&Vn$GN$fKg`L6FAmkZDP@HyMXuU3Mq$=M_ii4W!~j`D>o)I#Ie-l<1RyHYFUroh<}4vl0?GoCw}Y7#^(&E zKF%9dS9~&mK7}G8Ud>@Jkmns#%sVLM=;^b2?W-+T_hT@qkl)>@HLaY|F3Pg}U{JH+ z@d=hVd`b;Sy)eIRUQ*4a1INOCD7%Qae#uVfWDrR1LShuN;lFs?E!H zj~gf_D^tzDGYIsgJ6)CPEQpq5zTG=7zQ91W2;zCX2^0<{6h6_Dbgo#;puB4|Z|gca z2)^!sMCc74p-8%_Q;v9vZ|VI*4xe|A2^!~8MDr<}_^iEN9+9yhKZk}xFaO=1AGV{? z`>^hJC3#n3mLI@}_7-s^68as|1S*F_?LsPSiI|hcbwa;6jP&G7+wmvJR2zB>j`;4= zNI4Y;Cb>EEJh<_1XV;o=z&>|Bg~fy?MX+^Qv%&O;9fIS_^OsB;byXWp=fOoVl7dBll+_b%%D{UNEn zCtvqAELe-K6D`l}sw0O&ecW8)Q)Fk;6ll`R9YLImd|knipSei!5jJo*%~P1D=KW&Q zQbu@?9Nxp)34mJQm{M`rDv1u(Ugw+~3X!EWxkVov-2!8oa_!fpw!(uXVM={(_6VA# zI`9~dMb56Zi=`?`(JM1IZx+&j&QF{ZycA_A+OiQY2o3P5Vp8+*u`6Q!<=ZI?oeWg) z-1w=d8n+0J#(ZVp_$euKKyrx#j|r8vALisweAdj(A(*~|Q^-(wi`n#u678K=(+i+K zrhN$$eK?W~Vm$;`9zCUYFijyVd!}r+kFi7`Fn%o5rnab(ZU>C))RO;b4agZA!kRPD zEk!UdLZiH8bz0VWdbSLwTJ7w23f$5M2~zfyaw97xsNOMjWP)Eu44#l-5%!+A4&7F zT$x)797ZxE<%uO6AXeVIzpyili=N)><2QlJ~jB68nk}87AXJjXpY!n z^${{$(ksCJO1}q4^@#nx)ytnjhbe7keu$$-|`C zJR&hG3#lG|;Zcw|C$1rIGo>ZfuB^9wua2drbo3~(*i?tfRuem(r>Greq4m1ySk$LR zei4=&&Jhx9Qv^BDUmO-_av&35KDni8Xc+pF>U$kp04i7YBPLRBgc%1PZb0osB<``+ zMTHVCxVJXFvDW~)c@HWhW{M>W9=%#W1ZQRX!1q4w@9EcJ%nU!L(|*w$XQ>cFl#RcB zU0kaB3urqa_Trl_dYHD!>@T+NE&RfMHWp13bOs-!#Nw4u_H}>OKv1w!voaFP<%gXx z^5f+5oi`Yp3l2<{Z*c)1c(C#w3S?f-hG`ZshQ%BY-Gu`a)v~&U#1mAXc^XQa#@ZJw zOGJ+{CGpz-RQ}F^AuMak_p~d+%U|*ZtW7^0cfo2)+ZNV@4GlmzkHlY1Y5nS-5EpX0 z=|kh34nYm3Xc$%b!9%2kOX$i9ji4cWzLP>(ak-7nu#?&Cn`?*AT%Zzb09snr^|TV- z<{$@`s9)mu5bm7sh?%BkS%t9c@p0AUfNV(QrFhz-?SGn=ET;bz9jeJRFbL^c^G zB-^acLhU!-aBAXU%yGZkb9HC2@CPT%^<(n#O?f`KBoj;ZC`}Mkw;wDL<3|X&smdPA zYB88(Zxv-OMU;!xX6Rd$+`mIiaMW{=V$fs5Ftl`E_4_RCN+u=YlSYrR3+liRs!L;4 z1v;T6ss}{J;`D#>0)P)IkHl00M#o}wlxe$Qkj$2>g%?pXw()-@q-}{-;4u8mHAmm@ zdlRYoq#@+oK#|#UK?-LQFPJt(o;!_kV-{My&y1SN!L6_EAekntcI6G;k&F!=N^N5u zenwwR$k>TTiOHD>bmhHXYcJFnnl+HkLJm-C^V8?5EU$B-IcGee;Mt)*Vv`cR9k`N_ z1oFO=>D-DXmovN;@Zu*BE81jiQsI~dCb8@Eu*|YVrTMswD`z~j_TR^8lO1*;!LWwO zGy93<*-rBvnymze?(btRP!(j>@{oig%w`J^n2*61YVWeiWsxSRcCdZ3XvbNAYeh(?X>VR$o9&4FWy`Qll-AOoN(LFF-JS8Yvj174G-fAW=+);7tE{-EV23yN@2gI!E!fecg{o%nr9s zYQ|y#A!>B>d!jAsJ?6_R2#F63vgi^Drb;8Tahk>!We+%WF3s_tNYesg@19*~%-?oa z$kabdQ}l_{L_1?62b^l2oXOx#xHX%FN>&Tqg`DsMHUXIcEwiNA%nQg;*KCR*R!L|# z4SpmmpGy9tOn1f&2ysgYMGpds4^vX6AP5=)>cx%>7U&+AL&k{&NB$x!M6@7k&oZNa z1}(vV?1zRGnuFHxGW+P)n+90-qji4-=2TSp4PAA-`LS~}mhHU850l3|{To|GMTD-`bz@fy;F8wQ)4Y~UW3 z#fg=E$x(#mU>jQ1t6RjDZzc>YM>drb0(jS>cMIWLgjfC=^nRjOjB+8_&WkvwVA@1R zp8sj|Q{FAO3*r&YxS?=oSbHHfZMG@$ZN8JLo(I1N$`%T5u#BX1bwMaZ6SF z{o&F9O)#M|BLtW+d}X+)Mnb6G%6OE&((5SrH0|vM71Ndwj0-D;ro#H-yf#k}&n6Nu zUfAt~1pPU~ur_p1%tm4_UR{c+6NWdzmROX00|1$FACJRPwGt4~ zORKq+5aV_Vr7^+Z&WWiv%@#*-pqxJQZfkSWiE$Lu_$e^u1cf&?*;|AD zVkDfj^9C?qH7%dQ(5F`Ln7dG{Az)3mC4^N+T&AH51RY35#XDtQ-0Vt|^xPjrx(rrX zzB!|<6_KA)tjL|P-Pheg6&8g~U$c-E(zX^{M9Jn4bs7^3d-iyCE?D|@$n`xzTD&bJ zZynwj4W;+2S;UDUzG#kl)TL%6nB%lJV*{#P?C*oXg<=ngY9Wh<6Q8_)UD@8_%SNr0 zV!ZfCLuxNuj(LzT+l{g+YuU=Q;)EUg?1^I?}w=(Q1?0|!>AW4(lBgo zfY~EetW?;goB!dkiN$mVaL#(rPX;E(B4wDl0+K~20!)PW9tzNv=a2DG0h5~M2V2FX@Um z3}3*UA713I_VjmRfR$Gyc!BEHzqc_i_Q_QC9j0a278(!6i-Ti$ouM#))e7{WYCh4n zQzyuAL&MIK z2DBrAF}Yb@h8Sn*IS!<*uUemfXnADG`-(eDj1g0pT8GsGda zTL)ArQU1veQq9x|xX8nJc*J;R$DB?i``xD8gg=vYoy5ir_s?oqcr-=%W$zv~W9}z{ z!*&X=a><@N2imV8-2|{`(QGhR*Nd@B#-~PE|3NMaSE5PamA~eP(mFyW?t1WSAfTU5 zV=E^vF`n%Q$p%Rf#5?C|ljL@wj9LFOHqP>n`i{wyE+--kcS0~cC<5m)iFG5g_uw#> zK@lzO4;aA;to+5=?Bm<`2*jHhn6G9F|G56chz(DQa_;=vzc}qJQ?1z0Oy7i@hNeG* zX`9pEABIu#Ad%=W@AcqKt8Yf194=UXxN(B&>5duUNY(FGO?Q74O zXq}0=dJy#u>3Zq^WACk_>u8dE!7FBFmMpfInJkvYU@_~887#8UVrFKvz+z@*W@cH; zOx9laeBC{7PQTfief!@2vw4ngrLroaqJEJX5fv3l%r+Wlwak*EjF=eCO9`iH&X+{V z@$Gk&fv58*Di>~$cq{Z5MrTrsed7K(rJ0RdRCx%Dj7ioJe@~NJrzMA%X2_PeDR2hD z54V-~2=FPz6*Lx@m-nH&KFCTNiTS68%G^T4XheB)cWc9WGn)-JMt94M z)gsc@F$l5X@Ou-Defa2hMPNjA#WYG!@q_uI=zAV~<8zJ%C+`QDDFJ1Defsp%bx%cl znd9GX9}dvCQ0x`-ycQ2w>*(1kSnyu*(C6#;X_QJ|(G>lYuMIJj#(pl&ia3~Cc_}~! z?;em;I2$)4I6c)D{lOx3JkG$~y|tn2G1OeUczJ&q?j@yB{3D^pTR zzI#A>;bEt&59`Gf^pA`_f#J=QKr^M*<2UNC zT}f_Wql3>FoJvOx@)Rp3Y}l@{uCgbeghnU6KXG|>{C*$_BN)E?vPrFU`NcfY6J1?- z`cR!WtAF(>OLeL)e-;BCODnvj?>VjlScGmlBqR2geQqfo?=)|C)0*G5FU1P2!M~1bgAk|x0mGuXaiK=OtXnO2d zRuXKNSWR#`QNy+8-WeW8DD=;1*v+FBmyvnxJ!4o-@^wzc0X)IBL1qzrlBF0qZ(;&Y z0O~Y|eANgQ`(7GlGGvBjjWfnwP{=VRNQ<1fuBljgw5WrfNGt1P26Qf;-_VHv$rtpAmm#U9 z%Yv|sS9*ah=9j-#MXD)mjaJM&tiY+woB174w(mJ|fI=J-*yaG{*8l~u$C7B3*MW8lecCP0A6_37N*FxuckZI4cj3l0%r-y{a1Ar!QwXc z%iQ6*9e3ANk6+Z0C|;$=J70!NP)<)*rgOhC%*XB)t(3>Aam&;Ni^EXR4dg+5q&N11 z8rCNEW7o9YTUVIERC8jN9p%{$Iq-Es{&IvRjau1oS4AVM%Tr~}AD0l!!Nbz8_^34K z_JF|;3EhKq)DOEe=I*xW!&A(BB(_BQ6Gh`JC|sg!sVkoLkP&0B@DDq4x`cTN z7I=1NR)G-OzGk*KgG-HVaOz%jad>M;IT-^)?i?KmVAsR1WO5?gxC_&%vtx&;N{(R6 zs#)u@?Tj$=49~r;w?r(OL17(e=Z^x+mzCxmO)t*E9tWB>eU&AJlw+uT;{he~u~79A z!zkgFhsDI`ZK4V%+rm-9L0g2cL+q&zje7G7*T}^`roS6CD@aBOl(7>fgB)3H6by*u zGQ?EGMbWrbfeBsP(YNOkqdKXNM5d0~8NbbL!&CavR&dOj zImh#f!jYFQvogP(wplQ?;CsDwrfwKQv9F7A$~z$sW4e=0oLp`tlL97=3EQKc=R@~o zfAO-zfhZBUH})FQg(daMYW(ugNfa?ZAGU{BD(Du6{H=c`1w+Xl zYxo6_9|fRsw;xZAZoAi)1gtA|Pzxa^wrD3I;+GwVWWs%Q6{N=uozU*@yLroG3Oo<-e%>sLo{2j^YHS-9<^X4IW-PCB+Blsu{$eVVlWm zZ7M)#E1|M%57FbMWs|eI#atb0%;kdETyD$-aiSqcP3G$SEi9H>xd9h8Kfrr%pM8bx z8Et9UFL>Z}pw$Fr1$Gus{SyY9#j(8mnluXFI(^`?f;0FuNKV~?{16;Ck_=pnoiYs) zW_54YN#fx8fo_|8!s*DbyN||*u)37rO3$m3_z;6SyrB{@SDvvcJht}R(Ub!s%9)mG ze=UDp;#BrA?RQlGk(pq5x2Y1i1tJzD^h)n|WV|(aD4~h43QKY6YgvypW7JYCvt8A( zE_MK2d9NRonu$1i#Pkk9MC_Et^fx9L>5^HAz02IHBCe=#OLWZ{6JEzxQ=?Kn>;S7e z3DD)1p#|L$K0Nfbgu0o%jiZ>b89^6V$VfCk;&Z7vQkWyHXa#J?(nhhBpNnfr_En$3 zB~!L(a@riD#q_g>ucbzEKXyc!I?jO}>1mkdumUf#E3_Dtu-@??5jxlK{xa#z|2^*@cA>Gp#v$=tTETCd;5)gwq*$WVIySfNs5~V8o%{ zCCQHv=PV?D-@ZT*fEjaJ=gt494%47^ z%m#zJa03n@?%ZHRNJws1Y~o3qWB4q1Q)KUN{L+kgi?@bEi&bL708XTu?N7E!m6!kl z2j*M@pCOT+!YZU=MWumJ!CUSk!JvawR-*<#Jo! zJd9C7jZ4`O(qlccnvmcaYeN~ZKP9~cHQP5Ttr$T~BWl*UY1PB&Na#y^95Ygf>BY@V z$xp>AezFSYOtmNRb#sC|4%PS9M@0{O(H zSAX8ZeKcc{;%*K=GUR++5s*;y08cr~p@hwlt6m%~irTNSj{dRkhcTLe!b{G6V#4f9pn+gqf>hsnOY zMw_4e>K;0k%FJ;uBuPtXlOdpv(sq?DMZPKhe!$t@#S96(IH3f*OKOFwIh1S7uq$yX z$H{XFy_YqwnB3w76ooabJiNalU8xPNjg4GIp00DTHl!V&6N@Eo!FeY7kTrbV{(9pP zV>j_~)=(-A2#sJR`{vX1xH5*6BRGBztFoM>|7kTNY1P_~gS5ywKfb?a?&QleDR#)F zmih2|n0+Fd3v25%h1qgQ7Cz+wCHYpXQ?X3rb>w57e_lH~l)xB{q=Jsj8s9YTEzHxe zHhtT&>k$3^DWDATs7}+fo-BXa)F}a_ui-$iWYUMUA*_V_)|qPpCs^vs z#ByfYT=d$_HwQt%b!<7)Wb!r#?l|5B52sBiz3yYoaqe8`N>qCs&7nASruQJ+7M^r@Hz+7Dk zT2`&?p;)nzIFIPeDbhD zW3cf~bQ*TnB3Nrnl$B=a{qrJwo(XkG7;!%Okk=X3Jr@iyA^pqGZNq0OMA{>}E={Ga zk>Ebm?1+by2BTb#tj=6d(etjN3nyh)MDYur5uxKDftp$)XsFAxFLPHLkZlVRNb3-#Fn>a_l7^nG6en#5NTGA1r58w zsJE+gpl4Fwie!wvG|tqOtSF8w#5F*@yPMNcpwtJU=sx$UAcF1_!YJ4vijQnXHbrCJ z2WaU-(W%U7BIhqX9*?~Z??pfIvXYCm2tG1M_1y6qlu`u{e6=XDlz`zEp;3B}JH1fy z@&m)@k1`GmA343!WtQHKY=C_obgAF_g4oj~P&@=xiX#i~)ITa2J!aSdYcc1tP`mrB zY?dJ`l_1_XR&|-rgWK5n#-ZO&PdZ z13_aF0#^;a#c+mAta)vrIgQrJb7VqF_)>|D!_>$CrRoX@C^~jnTQ-1EtL}AB*K+>m zN|C1z9EBh#uS6rGc~mi|%sOJrunXA~v$4!qlZ9f6pe_UEqD#fwM`2yG{g6MLCvqsm z6eyIWD-h?$6DYp8B(Qyu%n*DB4>8#L@rh{c5wbQfx6x$!sIX=#*G_mlw@Nb=XXds# zXmwSqYwkqBZSVo*A2IkK07|+@#z;V06DMa!prOs5oSl&+5(_gsDKqJx96vwPr%!fn z+N_Msr0gtgjGWx0oNVl%e>hngSy*+MBrL3*fsRZP)`reNF`%)X36M$B(ay!5l!pV< zf-;jV(ALb^oRpJ=NzTyO(ZWre1yq;$ufKnn*JV-$I@!568Uvj`U5dLoOR6}7ngrz~ zRhUV6c>XjdD9EItU}On2b_Nwo*f5i_FthzzIp~avi;=UtJ&;Ml&e29t@UPo}mkRy3 z$EpY`{RM!&PnxIEJq3_b^IH;!e?ISqhCk{jr4)R&ZH9(teA4mL0YxSJdu&1o0Dl%D z*}tO8pS${tE}|+-V!*E!#z0Xy&Cg8Iq^5?}PC%y5e;rkrR2>a%o$L)Afwso(Osapz z_BYB13jUMIod0a?Z&c=FY4MVk70^WCN9R{U_vRVg4WJ z&Go-VZ#GVzKSKji{6C>At0FVtlW3qdqt}B0MBuFvBO5t_0QqNfCXbg%d{`V*L7mc|XxmejqL6qfY zOLNC5hK7XSek zzzm221E2xk`v5Zl05|{&>Tlir^#cb6Y8?t11{NLx6;uQYU@EWjkMn;&2M3Raj)94V zjf0DaPxgVFf|80F^ooszm5rT)lZ%^&SLBnZn7D+bl(dYJvWlwO7j+FyEkh$?6QHS? zxrL>Jqm#4CS64T84?q9!0f9lmA)#Thaq$U>Ny#axX}Nj%1%*Y$KT1lgYijH28ycIM zTe^FC`}zk4hlWR{XJ+T-7Z#V6SGIR{_x67s93CBCUR~eZ-rYYuK0Uv$0AN8w1_%Ls zeE%_OPzL6G>OU4t|Hp!v|5z~l9}DLGW5M#j02>Qv!v8OUjg*u9Z}U6|bbl5S?LW%| zD+dQ7^S_+;{#)o{1FdNPfS;V9lND&~__x0PzHa>2z$g`Zn*5}KVL?35N)8vyomXDI z%jyPZq>35)S*aUBoL@qcFi|O0WX{ofemM>3I;RGMwLFie)a5C`7%K`F<4o-=HPb9L z1V%=&4J#?-{2t-8IRPga6B{tRS#?VgdQo`3fiA+d&(^%OeK`CG>jPuKhHq zKqzFo=$deSeI50S$l-WZG{Moy35A&dF)|ogaphf_5;`B1I{%?vg_E?*#nExbs9H86 zIx;dcDk^RKS1cK6{ICf#;vwzb!`+=lJ$_^*h9}K4$zn&~Q|nWvHlxLAH3@nc zq9~v(tG)dbpaJx9N8)*t?@H8+)s=G_x0r=zN5g8kh(yKC_%yt=CfkQ9vYs4Qq&BFC zktp7w>abF|Xil+B;e8#eJ%v6xDP%V-hpXVy&?MbN7wlcO=ybr*LXNeJ9}1@4qozEU z_ZN%Zjpo;To+aK!^wmpr)3@HGM%S5ipW!aS-~nEXR{t3%_T6*ZVE*q#egX5^y&og< zxb;dkTwPx}pon&wOoj8kn}CuU_3VYp8%<)@Cyqy*zwDM1rdH-Dx$D0lu6+?R*}xzi zK7wQi(h|0@6I8xCxoqr|M-;eb=Tt9mXb*I^f8@CxVXYwXUmP($s;e}&?!2rwGfOI=&d#%mazjOH#1) zIA0L860%YY)1@zo^O9dJ*RV%TMOa4ge4(+LT9A_19Qn(^^`}G_a&$^n;`+b=n$Mvp zC-6YLw!cif?qp=1ZwBRczus;9`HZCz5DEENKiLI2iiZyppz$ zwi3mWoXqj9F5ITb=7;(#Ep8^Sy1`gCGUR8N-#+Y>MD z&>i7s9>7u-D;dZ?iiV`pJ-D~UemE4_!+t1zy(mgV&?Blys%<6RY-p+`rUF0<9C zob*$VeVZ!WYz7aH*j+^O2`ZUI+Kfd!DGJXof9P^Pdu@w1xC};7b?kdTm+lLy{yH|-p4JF#; zvk7YRa?f^i|EGmeTJALQn+uqJ%d_tsQ+A5Ocd948dgqC7hD;EI;=DB~WVuB;%6Pc< zNtgh9Z*`b(Uw+(67&{xN%E4u%pG`t(C}wR9NN0KTi85qSPn6_xS89q#H1k{EBX%lg zt#{tWx6`0Os94l`I@Q^oMfwK z^;a)s$CIa0+>u6vn1;m27cQl`(DEC3dUft9rqc0M^#E{r$x~NIXGAxnk0Yr=ITBZtlBdbEL6_> zKGL}e2MK@P)aBb0z-g?g-;d~*Sp=mQ)$SAre%eZIxAL@k^*NP)1&~&wY#LagOco#e zf_Lc8Mqd>d2=sH()cIsjO;cC!*`Atxinhp zUg|t>;?PRMzq>pVzMO~^c|G;2ztzv%YxWc``o)f%ZPR=%O}*PMkvVasZ&97aJhl^7 zx`vgR5T@A*qXxxW>{McB*$uNM=)2+1&!TkA+>Mx#UI(q=LaNYiyUbZjI!+v4@#Sbc z9Be3+g{Q^7tITgUf(w{6MbgLllHm-J3YGkjNJ1bkoH=ZyGyy7dQyp7IehMd(V?mz| zkjx!)CoJdXW~OCeU?9%azepc2HSxG(iQ`6eEXg#r_6?oELxd*MEoB8u(|}m=gRqME zBwVWs<cD#)D+Og%co4wH9EF`3YZ#!W=o<0cYy+J#x&pE8kq`n%hlHv8$(FQF=l! zD~o1B9n|b@iOozX+XgPClA5-PHYeTTJn5|jN>uYl=yq9mh@>btG7r)HHNR`Cp=7Qb?uG3KZt#f@pj?xR7XKoR@x8gmYu z4KX1zKLWhvbTTQM{)xxSIa^QK)>DG(D6r=IlSz9>IZ|pbIDtDsoctx6Eo+=OAngWn z!XmQh9fHyHf%SI6+wzxc3S|AuuG1QBuwc-%)vX=PEVC*vgr-WbX9MQ=%<%=O`Rhf- zAj0%1v2Z@GdreK@?;h)CwbTSQ>YS=j@={n}hEX;AQSAsE;?!j~c$?U}%5-|tv*)fm57xXW2|g>X~dpn?h?yccs0*%}4Tl91tzt9D2B@94?{a|`-N-Krk?2Q4$xoyias5NDJ*!}x_Y*V$+EDd;i^z` z6%X-h^U^)*b%uf=)_>8<6HdVEvE553`eLe&8Rs$!lR((X&4>i&QVw2?=H|M9iBXB5UxtQyIn9UeEx+C|CNHQdJcP`=0_^)92RUDAKw6{gH}K{In1K-bHuq z5vID<s;FQ~NCwyF zR$;5fmz{Sq?%m`|zSBqTl4{Qq=RZ+tkLbm>uou-Pi%s(m55W3`8)p!X$}SFU1%`jU z6?%_A=E}-51eSaxK0xLaBM40}y`hfCW-S5>zr_;Mj7y>RdG+mf4IWTHb2IRAL~YS} z+$F2~bV6N~7!);G!B5Cc7b9!BER`15q9Dyki9?GJ>Yl_iM89`VB%9&r8N^D|x-Z3! z-;R2Fi_oWM{RC3B|Ju$10wgby z%95Y{(zX>19c})YUO)X$%t211Y=7)RE;hDKAo~mmGk>=S{d?2ze@iFl;9_I@4>~!^ zA6`-ZuNa8_9ccgPQkRvK9NnEP4n`5tu~+nF7m`axVX{RWnvW_u)@c^PC)UgF$9>c)#-J*kJu3YT zURqJn;e0gn@^FzDVQFOrgNQqoD+=>Dvi!D&g+jai^z@Y1Vy@ZA%+u2o1_s7KEGjB$ zlXkA&YSA_>BO{})+VkOD0L#(A;iyp2PP(F^;{5#F>-M-TIXF1DxVShuS=}cP`jA7h zQY5bJ?mCuTY(_Ego0r$y>+3g42UhE)s%`S1&&GWrvE+%ydq0?1C8CMjT}~DT1|sm2_L#@I zbRk^;(>0vdOQ-|{2!epCZ@-h)_#Ae`rph&IO+kpgy1LpOj82w@f`PHy>=2-%qvPep zXT<33QC3!Vqvz1+^!740Kg6K~V#oIuDZfM(3bUQ;EsOjc>y|q%m^H--{wNZcfcbL?h$!wuwTXAvmXkr0)1cdy@H9#_m z0Yv@Y{e^}nCpTMNFD8ZFK>@W;4;$?^2TTZ~33=k;<8MxvYeB#V@BcjG4~6hJ5R5`% zgtxTbqj5Vbbf9dA{5h)z!`1 zWbO0JG?0JOTXm#58Aju*Nx`d#M_nat90cH3Y%{sCx205mjI($kw5 z`*yhn)+)iQqqPtM@%R8DTBu;NGM=2kxu;*dHwo$ zzU=7eh)%s?kF2g&yV15Av-NDFodD7(u*X+Cu8ZAfh24*qg~j3iba`q}L?Me`v(6l? z{3%J~dpZUwC^W&`52dlx__!+mMi!eKpMwb^!3KsR+u^|$s>JZ^mNK{dqqfAwhsus5 zoXqAtbs_ch>V$$*&mSB?=q1q{fy=EHvs5Ee9L(h6=@>*_pocLtqfAMKO|KUhZeVF` z4GD>nj+~U4>GgbTp-~lfESuSnH2K*&99TwYjuOFS2@n&^6uHJGIC`*oE_!G z7B#_>+4$_C_d4G8^I+DrB5ix;*P4j`9o|nA<#;MNkGo?maX!~`Lb)Q{)~^P6!`5q6 zu@#PoQ)KW6k_-7$Q=tjZgCstX7}SD-8*8DOk3;3iC@5xudCk>RpMp5+#dj@C4#0KT+_LG_Puf@wfoVC8t zGzr6;Tp?drCF(Xnq0CX~6aC;g2zI zXcmi`=EOoQ3@kojGZ5z`GwSBKW=k;8=t(yWc%EPwP7^uYkBybTQ0Ow z@fi$BUvMc3r?&6XZxjx(G7XePS1LLWM;-_GxDYo{KPxtqJ*aVHVa^XQg~k}YVu-U_ zr>sKK+qCL~5<+bf+ExS8EPKmVM9I2UH!eRZp5~g|sSWi7xyDF1QsHRp&M!!pFiDQE zQw7JAoI@p6xbuGReKA;mzA+d9Q<)a3i542E@XpY5uo|qfVe@F=y@LFnBIWgyg7Uuk z(?{7N>AR$Y9tt~`{q>3^i90*m>S2x`=_D3qee*!p$YF<_xsE_JFL*>0*k?lCh9mHl z8mOYu!BioE@uo-m_8l1`*;{i@J_0%`h^IA;<6e=>0y(_TSR(5S6JPEzgB)k1#ASdq zdmGAHvNgFs+I}$W)D_gF$hsYWj$w@~v3g{m%%>IzE7gwZRU3)k5Fc#R>5|iAEgGF< zv(?{NNWphC)7(?-6#Uw-prvhrG+(W9!^>f{P`n0vU>YK^y5*8x?^@Bm2 z)GKxqcCw8?jbq_CLtCa*s(wJ_6v6xLPW@V_`AWgUi-w&&0T;yOuRa(4B z?zemu#3SL}`&g~E=U}t*qoMEe(N;3iFDX|qZml=8w&`R6fwcyTc?-_W%Q+fjogW^ZtMTMA> z8p!r2cX@La2IUkfy>waJ(nh_HqQenw6!l$upe@&*0VZRLBONfT6~bb+USwos&@5gO zDD08L?!RQSS5~??Tug&q<<3wnn$^KYHz>t9um-&O3rL`5s+sRQpAbqHf{>h@YLv@W z9x3VRPkVz=Mw6KutLxEz%@hgZmMD`{B6VzS8ORh{dS%SkJkF1$vMo=CASKTzW~gvw zbq!E6+ao?)qWXmv4bB>fRrn(4qhVmMc|AK?Uj||&+2|{GA~}65|mYTQ^Lj;lu;5cKiSOB z|7h`!rr`CKE}hutO&@AST}a21jb&BW(AaMUXB!6*Tp zTcP{We%jI-#9be81_Wi{DW%xCfDnIk%Y5*aoLEpeY8CdcX^{Ei!Y75iAM?J>(dsE0 zGJokh2{DWek>Fc`cZ?6mr6&CV&x>xCzl+2a^PAi5es4Des9EAt#Ma?tdQjzgUv=>2 zHF+brDdO>I$>3bS*^!cs4TA(>3LetJ!a`G1Q#OF|bJE=0oT{p7Uw?mS&Lbw_w-&?R zAkYHFD(dde(+(UdOEEC1*SfjBJ~We&k`!xR>#@m6A6i+%{eFyz zj4VZumJ>B0nZ(_(qh-z3iJ*SYKzR%JOb;IR8d~~a@+$|Kfy0@DajRb^_4tfmw?rW5 zQ!g($R0;-J%ek@lOBiXsR^#vl}UHI^hNwqxHvy8A1VN$!zhXZmN1C)}Kf2P$cNmng@bLaOXJvml zM)qv6F#jeqOUsWB%S{gCKBXx?0s~-FgOzRRrZT zJVp9GPwsAN!+l{!QB^W$KMr|sU3=)l&CK?{$Uhbs-bxbQ@Ojzw6IUV+ zM!L0ky|81FD)Bd(VrOSx>+ni1{=&k8iHSqP;}{@*a<==^3@(J7iwh*KG4b-IaSTHY z3=W>;8vS^mayeOSce~oz>i$j>)us!2jKz87z|kZDpWlQmVIz>4P#-39J575XbX4SAn zC_ndf`UBD?GWi}rD|ITHS?Tgcab`kvv@El{B94)WYh9X9H^uha;3@&6uSUnWrv{r< zVj*urEUcfVa9KDZ^p6gmc!P9AUA#akL$RD?&|N1<^+I91?>}Dc-o})4BXQZTVG>}7 z4k(hhz{)U#kYE_$k+H>EbxrlI-Y>=i2?Af|*RvHOzOSfOno0)#2(w|MDZX0<)nu2q zw+w3|YO-(MPxoz)C>>01>#k8zH-&Ji%kLgO@-FsmgdE-a8Awk%T_Ky2h;D$66k z(O@b*l<_yT;l=s+#t-M~u;ad=5M-D zCFNtfgrhDD;z&j;_}dHIo9KdA-e@jfExFi3np;z+ne6x!Um%3l1{gxhWD| z7Ia@4P4=KT=UF$?&vz$y0>WssyT8|{d3f-m`{CU-h_u$*J#l2WdSmb;oPGH&>Axkz z8cKbiV1CQn50E^wKl|?XtF*jRb_#Y!=`Bl?dZR;h+jhy(ICC)9KRgjlXS; z9=rGFvn!LAlmn~P0(}Nd>Sgbo0MkMr=`T4}XhQd|`a(ju)v)d=3SL8DKYT+3Gw*0+ z`S|#pKzmU!>MB~t8;BVQYs#XgDQarMk!q!7W=8IATN~uD`G>+up~O-v@8m0bwwrzI z?qj01ID|tj0!f_#M3M6>;t~?9{!d6!vJG0Wkyelx{XT6VwPpBbZ#dp9M?|LG$iuZe znS@hawpmrMzT}&XadU>OO~7=A-5}%J!%$&AIZifl{o|_A&2M~Ejy_{waXMF(5@l9x zk_iP*I9+Roc{ob(s62}*z=tY>7O$7D-~r4#&mgsW`|L*$hr+CumX@2n7rzK3`<`V2 z6fHQ!o7sRv;n}4j<5u`bs&nZZ3#L!xj;Lg?-ZhczvI-xX8=>|Oy=CoIFZQXXl z4Qs(;!xTH}SEO-c?umtzDUTy0J3E)suc(8)5aR@8dMx7gUu10<-!EkrPv(AwStO6f zvpx{vrE6i<)zHxFYfN3w0jz#3YQK2^_TWppx?Bw*!%Is)dXr@??hgR98>~g-_;D^~ z&2|_wMR00#jc#vr7q+*^bmwqyZ{L@yjq5m=nPZSKUWd+}gOYbx(bYXY`G}=F`vGL1 zHdAD3Rtx=5NCXR9(m8F6YJ0ax-^n2%sJ76_0BKoS6B^xx(}MY^;k!oN0cogcu~|BP zE>-d&jQq3@i!4`jeRmBFBp^k$uQnjPR9%*ZYeGVokHAIO)8?n_##6n`Y0ED8Z*O+< zw}!^}9xu^#hPQFXgDON(nehYqyYX~R{noFMRBU>hN~aj9$l=%wRBQ%N{F#;5bE%T$ zlcK@MxwH-ZAPudctSJLhNN``KDTa>IT-;2!_sw0LPiM?#n4nx68=5Zrq`m+r*!8Do zZBQr*xPb$>t%tUic;~h+zP*K-JQ?xr%~)yRkP)y4 z{5aRsDqMWs)CyTuxy)?GShGKXaMg`gd3LJ(b!z>uiit5QZsxMj)2>_x&=tRjxMoIs zSH*=(i&SM>a=5n@7Wg@Ply#~Mz~~j>lf-Xw^Cg@!6gMwfWrEE2?U>;Fz`%Ni$q8s2 zgfzBNm(U`b*gj`w#R%Z4-4Y%lErwwjL9n}vM;O;B|D5y<{pPP{&kv3IP;f@$+}2Lv z$7aQC)(Toln}aYmOs;3XU2*9Rlclh+k4G)i6~!b_oV2G!U#MzdEKmS(&PnQx7cYOp z{dVvshFJG-YR-b(XZ|eZPS>9;sP$wC+_*%ZfhRgDnba>a)M_up><}X@o=2Y(H*&+z zMMl9qA+TT~69=QI^E~q35o6BfgY#z1y0vGt5YeNRMgW&zmwZPcHQ}j}w zy;hRdS!QoGr0xSJg@1&%#3kI4mJuJv3Ii8RpeHj}0520rsp&rflK4m|C+^4s?KPIF z(gnR*3_i#o7Wki0^3HsoJm968E1(vrcNVrhVx$(|Gro_tT(a8o3{ub?WPcOUoe_dp zmMBlzI8SGH+=&~fzP)#Qh3TFcnZK< zc&PaU`t3F;U;km#+G$?b@e{pa#A68B;PV5cB>SxAu_qnQHpaMP+B+p^S?eM_OR46N zP+^*sm6esp5^T?QXjxNbWGL}F5k=&iW=pTbXUX*C$X-jb27lOgpSHqlzo3`57s~TZ&MgLZ4NIMkZDhQP-eb zNg4gT%mC+h6H4}M{`X#n|DAkSqoUQBoz_pv7XiR&`CLZ?hi$}k`Z2^SiRF9wElGL) z;;AHfm9)j^ruO^BYkw-rW!=i7@`*l@q+l0Yseaq35cXyy%B3|i-`VEfsVl^#?+l6H zS>_`^!A$f_zntUc4e(8RRr#eXsU6_!Q)X;@21T+3mjLwqb6mALVQh~6vHTg(R2h+J zNm8A3$^uwZdEh;-l(@$SoFDQn{O*ryhw+_EsJ1&Nx4fqS*v_vzk&t_00Jx4@JkQCs z?mq&4Pa*&C>eH%m1-ne&k6DwvJv9V;b5=b!9@m5JV%o1-ldL;+0JPEWHmwZ~>A`fB zi8_%e)jWV*&UQCPX9=MCmgWCxk_@0Oc_5f)q5!$&sEIu3Rd*T*7#s4UUnU1T#Bc;% zK-qOvkJlVMlm%!1)kXe1-vkAUyRk<8*lS!5-rf=@JK}YFS^_BMWO%4HQGnvE6=Zl| zsc8hy(8x^oY=;?ASqN>9KCK5FaG3tmy8x@XEoqKUYsc9tI9^*j5fF~5ITq-`qmOqY zVen+>qMcv;eCjT7bc4Tx_(qYW#KCtSp@z(awqZ!Rk5`lD}KLZTObq27OE znZNyGp7 z4r~e=A8rOL$=y)^HpkpHRG0hDi+V$48n%i*n?Bw^jN)jLP+*(dBTnPKaYpMO=a=SDPw;AQd3PFW?)7`B% zJqghr7C?qS`+Ge>_qa@%@08N%2K4z-9euA3EPpsFo}e!8x6u8N3#i)x@r_pp#q{fq zcUZuuIZ7JvOGOT%t4!ZenGWl(_YDz)?bUp?J5^dFdy9?+NVEQ5&_yVKd0Y^+K!LRZ&c>Hdb&Sk-gkWU0ta}@ ztX&KM8kWp{Y__dm*$)g9iLYb81GpH@Efyobowa*r&FEdXFnT^bn`?$bgGo^jwDb8^ z3?xMQFm$Y!wOpLn+dds}lK_MP^;hHPG7+rk+&0+C;$2|grYM|`2^-J@*L-w;u`)G%)blc7ogs z+*jgFrA=;dC)7rM^9#ANPaA3oTjT3af+8F0P7xE*ewAOBgb3X$^*CY7fX{Cxx^)2C zFt+d4H{PgOq_me_l3w`-UTCg=>Mjm_P)8y4UAgm;o_rDc$VYiuc2lmduuLCmPgHT(a&QW^^L0C1K_=J?=4rMe{ybz4vkUY|65#M_O615 zmui-+5aoMU;*rDCKJY}yQb!>s^R^r)S`vThg9cS})`-DLt3w@5=6}(6t-Py;7p+Yb}X_U6NT4-qG5Aq1RS|=Pf+yX%ok1dm-l} z3JS+5zk@Osfc=z?ZRqN8;ME6Jc4i&APcnGcZect0@)MAZGi_60to4*s;J(G{&P4P@ zRLIsNFX#lKi>EH@f`p^&+4uf8uX`oYmtI{#tpz&eGr+5i@b~hDbg*B(JH-vQlI}{Cd3^z7NY}g+YWkl_FEWKSL1&{F)SE${ma&4Nk`{>A9)T&K z#bm(E!(=okJj~E6I^t5q_E`J`^A#Tk&|*$p<~6EyQ?{+)yTj( z6AG>&@b}e5<&!hg3Jre%NoIRALA9iZeTCA}x-g{R?$yt9U4_R#ZJ_jUejb&x)#5JW z093)^T`nf5zTql+J+wtPft;t+gK~?wtSsq{=NKd$+DVkeWj5wc1&py07Ol!q`lHYXuEl`1=#~(Sp`Sx zY4gK%hX$9LX>(Ed8ar^gk`_Rg0J~%~kwq%9?>dv)r8Qa^ zASiY>D60G>vY05q+a7S}g7dTOw5Z#Rl|F?74!r7H$+-r%h_Lm>Er|kn80SGdGh+Rj zp*wCIh0VoM+0$r}}IxU)aj@WRjqq=hk4wzHV)lc34mL zahoJE2Q*{^VaU zw%<*zW;xqa;M?^RKI-Zmwu#QI?YQr7WNx^2_(85DIbMSkC12%VLnL$?HyzZ-Aijox0`KK*ctF4oVc(12gRg36q$JkHR`hPVh_Ehg9J! zik8=$WyPevAdAo4s6Ajm)~9T@8SJKOJ{-Io?SM4ydUi$qmjMlx+r-#?eim<3Wd4C`;IC|6u4)d z6lkSj?|s5I_du;E;99`rqWP!N?lKwRhP?s~GVf{J&HKcE)J*q6%1Ikp7--{@fGU_t z1YV_&9VJp;*L-cbfmrkc+> zm~OI-sx=P@O@{6~{(n*S7C>x9(rNcWUZXcc1gLocEoXetWvla~m*x2vkeUjQG9ksZ9}PK=}5CmtSii zMw0HHf5V%;bFaVL@zzpw0&#-!T*VNkhT{AU&wr>c%%$r}OA4zPEQq?ENH+7gZodaz zgmh=(gSs4pW)>zQ?8l6++g3bNgLpx-_2qw*X?lbcSJ37xim`{_F3EtvVAS=b@BwY! zfpGK>ryw8j!qsXeu;p&Hi-A@LZ|=H^ME&*2Iw;>hnt8gjCI@?>t*9;7YI2hZRa~v4TDZ5!KGLQXMXK(`ugW3=7pzgB8Vf_ev>v> zLxB2zmLpyWhUQPOEV^@-@Q9kl4ZA!ZX_z}&6IeuUK6p8ReMFQ$g4`$CAwbq8mS~}@ z$?!}ZUHF_h0UvSDy7?vzAHP<+sVj-L+I(t45$1#q)!Hg4b@+#qZ$NJ5C=@xpMc|O8(Zw641|NDV4ka939Eq}@{nLTf48-uWIUJouzT#_p ze5AAyjmhTWd=7kJPLXS!r^0*2-2Ih;-QK-*66HF9^ph|#1e#wF$k4pYr42Tb*XxX} zqEhYxhMjFOl|S#;=paxK%k&q#3#B+CtWLENWaEWlVOB=*ZR)?)nQsspi6f9Dh}mD@ z$K}{r>Zhk~A-Qd}KP{K=$)D|OBLqvVjslCy0Rd}_Lq^j#+bhL{jq6a->f>1E^I+*FF-mevt zmOzOwoPbNlwJ;`hO9W(!t>x~X>`y|N`ZBE>$QwvaIHNj#z13Q@uyMc0!^rE022B4X zSzwPZeSY%_MkVImKCwumxf-xWltAFHRictb$*7^0kpzdRirH~i1F=t03X^YCF(nf9 zckAeg5uGy``7{tQCSZH4g=W%}Ken&ipZO!Gm}?xf4XFw&qBk2lT6G8PW0LG=Xaj?b z^LITY5mZ~&+P5@u@%Lyei(Y*?X~)w6I*;>EzMzR9im*VRmnS?Yg#8qs-iCPfO>X_B zm%12F31mrrx-fK98S1nYSAdQmk4@TNR@={s^ijm?u>y4{yf;L=oqDqTgKD@zFVa}TAX6L_&lRPpMh$oD5Z_&e*%<~H6yZOE#$FKOMztFPG^jkezQOWU_76Vqn^KV`BV$U;P^Kt+W!raxH5@XLh_;%N zY{C|;Bwy%Z(Zl+RAWoaMG%OSq@$h5I0_~?UXf&PB`EK7}4}|4Q7DDhbOuH+js;}dG zTEDvj>q;)IQ;Kzp6cDztwKR^o9OJCu*2wS3g5Bc2vsyOeY8{_|=)=@t1748$ERVD# zTi||!+ExSbH{-{*A&dK0p3&FQLv>77q4LF833repnLb^A;)@HsmbO$O1Q-)igt@B8 zm)vnD{GjM^Vyb#7QEWRX=)g(M7K8dkK^&sMP+6_d)z2GR^nS5W1^>mrcA=qD=HssN z==sjf&Tm=PJRG<^Q}UE3-8RG+z%G<1jPo&soQSShSmLS&>CP{2(w6u^f)@o1TU;GG zcz2|BsHbF9VVAJZR@B4{k5EKQm{R=JoDj~_Ee{%AbdK6Xnw|2Q!KeAqQUM_I0@&W& z#p$9u(YB#3n?=7bcUyn+GQ}@^V@&j0w5cjy?J70}Nwz?}oKJJS!2fIY+MR|RuI=aG z;eMOwuXgl4^&nZ_Re0v??O;hzE!6uD$kOfS?C#``fdFHZx?a7b*1xz%z{i(qbk~kp zKXiSohB+%Uc2%SZ6KKk5z(iGjfgeR+CEn5Mtet`HDV;PPy=O>SLndF%A>Bk$Bn`*O< z9>aaEZ0I_&aeZ+_#)7EsfY8_Q8=h|L5T+UcMmnK1wKrh?bcY*72xL=IE2u*iw!gS> z;6NPrZ5s+5Zs-i4|xCB9sqaUv_aWOEt`U# zZ+;|95>gH1#WoZ%FNLD{d3)E%P)1yt+TeKpeTPzS@MFx)r+_@iIL;R%3ku9e#TSxxd68S&A2s zAFv`^cWqFLf3B32Lx}*^(H!wT+?2CoKaQX)_I3RQ%)!3@aWmW4h_ks%{VN=BaUalV z-Ow$|yRg{4Tr1jqvHGPs(@VT{ z$mXjYTynL*K=jw+h&T%KoGOQPze0gr&1=J(Vyr-#H2%Tz5Ow&T$)Q?kD zK$<0xtpiAK77q)t@-}gyJM(1g^foXoK=GJNw`RWajr`M{9p=-|JKtsD!yuPo877Lx z+Fu`6MtbPuk&&rvZ7a4CsQU(+)yX;s1EZU*b6U`170_BmRQH|Ww-amTPzuN`^r+c0 z2@A-BzH-7XKS@%VhQx7e?2y45bT$?g;9pXAo%@}ICMiWwGnbXozocN_W52e!!)^7h zl934pAP}c&n%yp0+bulK&q9Q}{-mrS$!0x9@M#>e+d_P}H=!%{@cQ}V7$w2SQ^Y-N zK5#)si*Yp4#XS^k+QY?TK#MR&-gz$nOOwgzk&82fAb2u@gHjxHj9-HnRARSEaQz44 zRx1+aEQ%$KUkVv(G(!=D^>ms)eEHeID6%~<)t<0=-VDEAfV*b)u8?BR)FmPSd?1PZ6< z5>bcq)rJk%Jzs#F8E#3?hBFl(#)FuN*s&W|^}A7;iA=70FM(AArku@f^TJ8zQ&Q^T zc4mczro=d{Nn#~(u%C(J1lzm?l&{5%YEj?So4554_)NI8X6SxainAfsbPx}uZJX*- zEy`XNDNrsh9QVnnAjreSm(rDli2CtNQ0k*RM=3fTG+ZnaMheywMRTQWn5yswQ$YPz&4p?L`!VO~YGXBO434-@s zlqiiBgLhd6Z+KZdSSP<0nEY*0kzl133iJ0ESB`5l6AN1#2Dc}7Lkj_rXO_1&Hy1e5 zzs}Pw_kowubCa)m@;?#=wB3DFGkYOA6NneyV|NT!c15n<2DjdjZ2Yhrj=m1}o(_Cr zDaNU{2cdW?RsE&h(62qgmx{f!#?WZmk=hK51X;XCZ4o`>(BHhFPKyl5V)$9;fh@a8 z!bDdaz%+#A%C~~GxL1kR0IF@>9E|+@UHkAK37g}Xc7@Od`3RAoV1RT6TV6$LomPFp zL;$1m!%~_Zmrl+x|2FPbrV$oFB{=-J^5WqchCWol81KwPr-^efSZ54wYN;5~-n;ig z;x2$^wnTTs;3-x>JMRR~s6$%l+w@MqrcVToxR$ohiT_d|kZ6c3B;5EZ{@Py%&fibS z4SVWv^49pT4Uy#hQ75v_*jubi;A;KDtdHvNKW`?e$94C0v+QN$R+iqQB)+7|MAcwB z$e-7d`CtaO-=ZruV4dBpW#8|8V3WUpS)&4KEf4TA$Q|@F>{A^ zzhytLtq}bjg4T}TepLMZwV8X|j_9ZDMTg6K|H@L@*UnPXaaC*%fP*b&ASxV5X6rtF zY&rL~`iv%0rQ`yIa5rnG^%^j1RM^PXgV(u;M|VQ6^DxGRPee@iWZXg_4@C+^c!byo zZW(~lT|JXtLXRd`*3Ft%J(&u)!U7h(sY?@cQh0WHM&3*6Q9LkP~8D-6uqIklB%QMGaJCU;w(o_VxgV9Yuo9W-{!@MYdy+2>&k zYvffIlqci8a!wT1O-};nW2SXY>ce__gyQSSR5$+wQ@x_;ZMZIRmv1<1fJ8b@uqU#( zZoqa)e~G^@(eh*c^B2&u?4`(M^H@o~W1g68(&DN7VI5|hy5+{;k+97eVg?O7nipd0 z`-!kwqm`cmxnEGNNzX~?g73B$iSA(*$mEnVEKvY=`j#+X3AdBC2lk%X4Yl>%tMibg zZuo>o>V#LkZ}%%V0*l1$BFKhfaZI~@&DX|$El-LY{a2}O{DSYr;KJ_5mxj=K>8WtR z&;at~xO~bH+fnTzS-}#bu}$2{skD-khXv;WF_0mt42%`hNYrx81w^>7cqh z7W zKnURQbe2)S+WL4moh@4Ca+ICzL z3}IJ65SAkf6V^pZCvDyiTqn)6i0-GK3G==hU$=eSI^&oFjX~O#mLa+%QnFIr;`}0^ zf>#E6(mY0ZuUoe=P6O8vFbe`-2tvWI2OWqdF-XXQr-@VRON-7&0u~l;-kr-0`6wLy z(Pnn4s3!i0Fa>3^zN^f%7vvOP1Mjt;?}dEMEO9pDR0MxjSe1ta(FJy}k(HGDGgX6<$n*c8N z8twdbjC{dS)$zIuTbq!OO-nA$^V#j$cX$byQ}UZ-IPqHW!_96)d*{5yxT8&96Sn`J z{>V~2Dr4#^()z7AKxZ7Ka-H6~9Ojcll()uZ7rau3wfa0o_tKVZeV)<$?JZIa&&c3K zr=;cwX@NZ=4ZwhRsr^!p|^2-;?@=e8+RwgoY+g@`8n3gp%2diOI58yerFWgHoOE zqPpYOwDWasI`ecynEDliCaoIyx|~kajuKa%83d4*e6x(Fp2sxD+a`N>=+2^tIUC9O z{U0VVzg-cbE>r9Nx(8ATHX1Q2Y>(eG^VF(daFaz&XGon6^sw2k3Qg~{?e~`zi&v0ffb?cORpkpy?%OA2M0*(&n z#QUUR{4=>Uk|?1)#Q-J)wxHo{`Uo=MulqU^>S|;L=TGa~lEgAD?N# z&Ff$aVrBIT;C!fJZG6koYXz1cEV8jx%bM1s7i7$}GH=YOfSV*ClrCY6!ENhEnl*^$ zZ|ygH6F55^oP#;IPzy(-1re7S_sW*4NZ|CD|J7Z&)ui)%0Ms=SOc$F%XY*i2gqSj^ zBzSmvrr~t0p&)@f^q?lMpb(sk_WS?rhG>!@@#Sl)dHg^Marokg_A3Y z(a4@YpPIP}^8_>EKHr1N9gx|$$&1Vm+cZ+QL?p|L{Zf49&P|ja+Ry>lJ$%h(Nu3I> zRuZD3`B-6?p?|2iFvnMBG&1!9>FP=egeI%HqayTlr&*a&ZR2V7xWIZYJ_{+yZn^h) zS1=fEI>9LXqxLBu)!YnLEi;bqg@@8aU9A;#m0VENw$qudOx5%* zKORQAnDJibn%~{Z(nHR?;(;xVY&jXV*@T|ShT$XRPreZb+Wwp9c?NtvzAO1YjcsQw zUPVQwo?>Zs%fWGZKmkxh0jBX2!+LHD$8Z<_E{M4i%78^(4{LCk%`>V}2{EzI8&SX6ibu z=rJ*TIK`bxbG}R11++9{>c1VwQM0J0i=c03xxV;*#9yh{r7JJvaJ`P=k#RpXxstY! zpdOzBmJdFFKZjV(BSsk|$|p9aH30Qa7m12|RF|5rVVUN*4vTv8UQABTc^`i0>|U1} z#FeD43Rf`ZZP=wr_QZ5jin^NkQfqra)G=4(#?A5ah%59L=`2=j zp$vcgOgLM>l$`#4;zTf?95h_PD?&}YcwQ3XWGh>$^JQLvHqu^1Xu2@~@mM`%G4)Y52Uazs72MY|e;#0V=o`sSj0{3p+ zldr!( zUSKMEF(>Ox^Tx%&AvUFhmvtOD3UGN~s`vJhwvr49c0CF->S}=<8R)#frIYHP=gN;% zqm7w6SKFAsrLNp%JCqwv;LR}zYZfu*;e4eBIZ}-LRw74E>8nkUG|Ueei3dP!zo(<~ zh>H^-WI}56%XJsz1pP!XVzrL>5@PL31Po>C#)?xJG#oToCQMwt-L(#t^|6T}OQVc+ zYsy~+(qq+|F`mn!coaEJzDS}_{}wSg^Bj6uQz&{S>Gv(ln<`cn_!Sc8p%YZn@h(%N z^qovGhYI8jOCGD$#6Em~%|8o!$zXy;MSFfm-!>z|S-yzzv3|yjO6St;ZnlwR3K^w) z+*)sP`Av^u|8;mj5GQv5vi-9p1pbY^i%;Qawkl6Naukf25qSPnhRxxZ1f^ZC29&Gj z5(&KZc|=wXJ(ZYdT2QU;IGh8DB<`f9CYJuT$g%xAVBe6`#;)HU;aPvw3CL=rfn~uQ z`Xrw4x$65Lq2cH+PP$wy8a5%ti=6c62N?%vdP3hwchCbpt(g!UJN6yeJ9OW_l&tJ+ zMCZ=r>Q!IiEhn;2I7b)wLrK8M@ z(3!nh)-@w*^GzN|;f3kS!)Y^L=Qo)g+G{rAsa*OcuXUH!0%3|tQZ!t=|G0WwkOMdQ zYpCF``kk|}zYeL>?)x$qe9=9}MHIK!9wzs7^a^e{Z*sW8`Y(%aYiZXLs8Y0u@RD@# z;c_DpZn-dr&~QVZp6AJb@4HomC+5F4F3erbO;20jI=O9Z_ZW?~vK-2tI1t~IjH@^& zwY^!-qHt@Zqlg^GrKK%2Ge7U(99}Q!XbM70wmbbuo;B8>y@hjlFO%|2Ro^l40xV=^ zq+9~|_6>apr3nkq;Y6I4>+G)N8$B%;An8grmIT<=QFr-*rYe?rrD=QnJa4GKj1@|O zQ#E&mf$g7FxDK~EE&k+VLO!Gs;aRgKjrcNhzV_#*W?1QWV;<=fpPE7j{&e%h@fkpg zO(}G-;L~qsMJ4|^B5DDgI;#mT*d8wq7{>p>3N~Z8PmR zwqN@E9OTUVaOJhDmXY^f>xT%C}+{JO`O-xTGEqbh>Q_5`tWW_g8!?IoXI#c3H$_ zvQF^|Ct%j6dwr3qo{Jm3MP;C3s@oWI&3j%8zJrY^W2T+lOwkA=AKZW5pQv%1d?^51 z#6O%|b?I;RWnmb+j~>_4A1AtylUn;#=%(!v#U7h635W&N3-RhhP;ej z{{f_aRmF+%rsh})-9!IX1X0jFOou1aq+!d8wzufjKFa6XmzLh$2&KE+vV)zeoDc3A{U>S+0Q$A)c`Iny&gu+x>MarU)7#R2)DZPag@!NznIG)ji)V{nO`b z7Wq1o$tC*G)V8W0=6%}Q2Z!LoHiuhJ33}zZMfw(dqMQ)ntUC;MplCCh#6ViV64f#5 zLKr#vDj%ink$vOahV|Hd#;GZfz~4>RtB&q(1*t2cmo`y z&MN*~0JA}l8t2}94}9V|y?FK4}$5R?!^mjwob^JYiHA08}h z&(lT$!Xsz9Dv1gR89mkuqi1ptJ=0;8N-MwIR^wKgZ8Fb`K({c9czw;_D^}@!zP5a{ zv4ou{W-2}E=I|oB{A*WcdqByFD2m(FM1xB=HXtwFm?K4|c}KfAy%u68WuRfpK8Ss{RAv^@sEn13Xfp zeq$2Fsmo=7pFPo=(ZW0+3hPY79Y+=TbasaZ z2DPI2+--OqTAQ()of~Ab9I#h;EdMtSP&>8AymfiHX=?Pm(y4Jr!jXihK`d|N7hI5^ zX99n0?sl~nOcA|^V1AOe2&i>D>K_JA6)rNT#Ub5vVbPXqBN|L$bW|nvcbreH{q-)o z1*O8=o-s-aX5IT{h?onXoy_&-LMqh|i~I)f(QL%mNfPbn+Rs*r8AQN?NupY(Uoq zRC5BrPpnzfVA|;~W?eRIejRpE86B9QaK$IwdJjtaAL~eh-xxp{!W>4nCnZsgHn7VG zPSnwp$TlO%k8GZw&4$ICow@pr?iSZ?uIi}!?RB<0IfU`9e zl&1G+D5Q**14e==6c75TifYXgJ41K_5*fRPxwBm1{xEdtPJv%%lf20|tz|aJ&9U=s zEReUIC<_ap6WYA5Oy++f7#XVtAM9P0->15i;z+hFZzM%BXut(j7*(k$sNQA=(WXs4 zN08Z*2ZTrgt0!Pd92U&2>V7&H=aw0Hp=DGO5TLUWVh}jwyCD>BD(eqYRhN0pO4Ikx z3!dxNmPI z;pI&{v#nfrjqbdjY|U?f6OPFCId8?J zYRX@6r0C$46V#SP>Dt+sk#Ix?Jwup1;}L@-**Uxly0hh&XTg?{`@*6tdibjH9ROBh z5(gd|-)rOBshv>VzULO2+*d!9q9+O6!TNjNZk}tibSflaEdfwt{TNReAHg zSkqN<$RN#+V-gbirK-1KAvM-iRSK^k8|di99zUwFo&;u4(gq=55(y6~n`3pk!He0o zP@9#X$IG=u1~A{UX`j|m*t@}nx~c(*NX-~*ur<88gPCpUP2vTwMFbh->;`=M^;qTM z-xj^y66d#bPvu(jWhSe;E_*qe1U;wqGk6;M75V8vaR$=}JSuRYY9jVyw}N=EjXA$~ zQ044?*xGX>^2>J<4zh|XB1(Srs?w|H7~^t2g582=4QpZc^($nwlq`+2vR)CTt=A>_ z%NqMmO2yB$U(1RX@LroeexB$J_U;n}&RXl~2iszM$hIsmAy*?Oi^3!o zv!sD0e3n!hjp&5TjblppNso!&JKo)^@LnrN7KwUn3u4!wDQOXWtk9vW4RYEt_U7Ow zAfOIl+V@@9mM8XX{aD0gpv|w1sqS0gy)?W#63Dn09=AI-MPNx?dN}S)s z7$F*mn@M)x)1#*I#XsZ=FcRHU9qe&6^cR0cRBiqS<;DcVgvaieG7EZlgcPuOM}5eC zC}nKdzpu>w+IsC$)2^A7SGR0RG!}eoe=HB&x}D|quAWM(dcNbRGM_i5REEn^qZOg; z^K0a^cL|Qw*dtLW*1*fac1Dv{AmGM%h@aNy>-A9UTB%W}=Yl5nd5pRH2Hkk}F67sm zqwU#kRJ}Z2@(Ko%l41%?TuZLwImE&iXtJ?qaiAw2gfCWg#fkRhFxjt-5paKc$Oz-a z9vD`y#rn*uB*r-&eR2dUY)7l(iJ3JeR2cor!fl>OMfATmQDs9?PF$Ce+&G59R2#r zXVzQJGJ~DJJhv;{IESnsMUPz#qhENFjd{7cam)Ab0G6Dmpt%H?E9+iY1kU0 zsB>9$^k#cQDpJ|xowTV{r_R@LNOL6DHpYF^fos!uXAI$MREP}9aB<2~adqu?9h3V# zRJO6E|77goT~%dw`(T^GX2bZo_bK^Q$Vd^1s`O5Gzs>6Nbg5zwDDR{)f^aDM~MTKY$oYgJtRlC zdM-Mew0b#W?cYBl^QTV(k?IC`S+9D$-0*lkjai{h_YVIk%iZo3jypWQNBy;`k;dZA1KgW z-agEU0w_OHO}4V}GhP1&j3EBn^(*I&BH*UaHbt@?T@g z%~TxL02wd>c3mD{RrOx;f4&!YvXVjvU?oIqS**ngjGw$`vaX#j1mj0_F?@+tEW%|d zBKlht-C-6<1!LKnEm$v-|4v>lBBLt+5YtKqJf2y$BBvw_Nm4y^&Igopbyt^62vQpn zSlne=QEKE4rS8z~+d7ZcI%|`*hrR^dXZ&%kIGNq{C<>^S*pP5ZAv{Hh*5*j~h}skL zle9@$eM(9|sR2i-b&Qpc$Myc~2F2z)%B~bta$Wyq8x|D67FB#cQAL;MY%*hv+)& z6Wng_CMR>JVV+30zG2{{DpKlEkbei>i&zcuZYuJKeu(?bsk{ikC)V&Rm7lHibXS23 z5Le#8Vt{^j06X|u+6(b+YOrWe-)K$WzPNfCiFvM=s_*uy>jJD$K}B=w!p7m5Rrr@{ zGRx3n1@t(gl&%|}n);bmEtuxPbTdkV_W@?z+@*p$xeb$+(7pq^JoZu}&Pw_Oy*xk7 z^=^O%$3Wox)4pRe>Ja<1K_lDJr^ge?%2ur3ide2(k`v**CS#>=kDUU@o0MC8{p9q& zzkdlR`IR}SW>SW|kF0F}>JA%mV78odmE&;!4%1g~rH4smz0%TvQNg#DQ5PGc+9LPmSq=-{5Qps%io(J8D&E-@ ze!x8Cbz!N~xc@KrU!r7mixo`Wj%aIcld-PsUvB+}KG73hio%05^Ru)F*d%Kfm~pq` z%SK1)>`Gifw=nFctX#AyJ-%H7h8H*1K_roicT(T`496{^)+jG&{D-cL$+TZ-yAl0F zdaCaMHXc4=f|P~q2ISCYMlG zQ;;8u2ZZ5QQ!c>u58;lmA|zY7^%;bDD*cj|bO3tEy*)U#*&G`DfIz;hP?wUPrrW%E zlc5M|%i)`6`=rwG9%?#X&PQB$I`i%f$k)oAQs|e@PMP-LAD!uiOC_PwS~@Ogs*(Js z6Eq&-dh`#{kHW4m3ItSn${VyV*9Ar2y5%}_qKO2&9B;MMi3Ei=qV)|jPPFTPlJvE1 z(dl5V)P0+S^&6|nn;j5j(m@oWX9XnMuEo0XG?JX$$MORl;Jp%Vd!kc^+sSs(0_G21 zOC{sy6i_`BI7uU(rB%=#>M(a8*+uXLZQuf7t4YnHPF35=p2+8NOA1G>o?AE;|FyHgNuz10To1r{u_Cny`avF}DBX zNbAbs+{*l_KJPy6Vfye+O8lkx zwY2QXrisBDA&EgH?91e5?c-$Hm*Df;btNYr;pAy+oH1#Ol(!QXTnj>;0Df#Eh5hCX z%YzQb0ebb=YO*AG)j&et`~{74%e;(Ch}qzArQ$i@+R3X*NTZewbALVL?#)xpQO^mzDMhfp>jrS+y_8c4ZDrf8a&PQ|@fL^Q6n_Kfl)}?SoO6 zYGmmgCUb%>+~uPNVt<<1Km>pJ)m3<0(`8e}$q}upR!kku=-9n47P9(%#a1;tD8TCE zPYE3ZB;_Qvwx0`Mt8aV6!sZnv7}5D9;`76I0pUGi2_VrerE$Kx-?vRNGki1mP3rK# zxs~U&a|sgbA#or5m7`an&0}nr?>k2u3sfjwv4_qAffHh<^MHqxgXKQzQQ3Z7*QAg7 zx~c_eQs}ru?9QjQh1eh8q+)n8Oh9Y6hFsz#(gI}_o}fB?FjB5v6Bu`X*?qF-r((Ja zn`R12Uuo-_YYa!@Q@}q8mv)@U#1RQ+=1n}3^`UK-P;3)Vw5XAGG^ z3vk??6MwN8Ys7Ywzg)<-=PPj;20TPdf%F-1o~#3)XTC*>QvZH19!+ykS%enxdu!Ga z>9pVwJ0lNf+k$U#sce&NqHnd}tSI?5c>bH@`TiETqwb_I5>~2h7<$8jV3ruPe z1-k(SqfLe(D)yiw(uFWv2wT5-ATu9y=Q@&{_$%724_2d946N5P2is4?x$5<4`&d^g z75OBcx_Tq7#(Ks{_(PKY-_84CrYk-PwO~$;B(AMNC5y z7s2B(qj$fgK1X{6wcfFSC3BLaZ;!R4?-+;rY)9i~& z3nkdwNJD2eA8Kgbf z$}n|h99TDfN9IcqenoUiFvRWc*t7W}*J($^qWdbD^{Ee|A~?Qt8-cgk{sI(BzzbNh zz^kXT7C?lz(xs@O?oNm0FKK^7ZWgD~N+>1WRgEdY4O*#&EmKTIPuB|~iRsJ{yw%!m z*q?0LzzAlF0GqM(L9ee)L>8^^dvCf55&GqEeYW}2sG(r2@Ehe;tbR#&=x!TpRL>c0 z;#JVPa4V-t@T)_cb3y3KzKTc%!w-PWg)reu)w=MxKXrkK`~^RCmEXN?-G*-$#>Zay z-e!BxrTC`N+zpo$M6U}@57>b+^2QKu>_9lcns9%*jKB>;h{%h;n^XV6uZ|<~US8EI zo>=Q|W=PMu3$ISfh}R2VEq!^t%b@%VgYb5gx@)Nku%dTkh{WDHHx~zgF6AGamq9!+#DZ7>Q0_*x^C3qZ`@bCqqpJh zYa;c{(hnRDi5v4-y#)rC3pnWqnXP)*c*E5y?kQ|qcV{YzOt9|@cA9I!BT?1~Luo`2 znHT`LK!<(|96Sz7UI_5Ak9vOJUqlhhTe_Kro5bLOex=J#$2|)D$6i-aw4rEoGOBQa zP2E3mTC$je?wXtqH9}N#9V1!=y^&dPM&&N$81^2{PZ3wUo0wNOEPdv6|sX=~s7ARD)I-R+r19;=B&I35W14KJMOw=E@Y z;UZOi`5wYEkn}D{!uEz>az7Re9_RQOMqIRT1KL zYVFpIhR zcbcETT{HgRB-VWCQkrBiGhfOAn^R0jRSC?gtDariE(F8@&i(iBy|<$&9+RJc&Mrr8 zq+0*Zj%#5t#S7Ztrb?tf5pd~FmriP+@3E@qo%(*JB&B!y8Jn`T06)1sU~SQ$zIijm z;R^D+Bk(%|I{rA)EQNwrmcJ^g-{5d8aDw3V)${jj+%{hZ!8KiD=VEf{7dqCG&JiWYN~VkAx6lsJ;Ijo^u*D?V4{P zI4DeVyD)*70;mQC5q6B?=rC+Dp8|-=;w53aBL)#ewoGF&UQ7<&;ybq@ThT(cLXgp4 zk`CTf*iq>w{Lx`D1`IBr^;`ojYmu!U9uPywAxsz_>|^kZ+q8xJvoKWAVIae_DhHhN z@up-#0Ka0Z$q}HiWkN*fk#g*qxfetbLdxs$SGKck-c`imx$N~nebkUV>#-8dXKLnx zuJ!?kDI=*88K~`9!li|T6-OrzTHV%}JJS=9$H7pmc7Xb5GAO8~esX{zaAB;z36l(nEmM+EMYb|4<&!-EdGo>tmDsUX7E5GI`GklO*BPf zU&ajdAuW7$_rn`Tgb)bWNwntga<8=3zr!{LpQ|uo#Di!uno8r#XEJgv0cuhP_x(Nq z?J5FobeQ1uR7GpR!ZpiHckjyqchzuDIsii#9p=NA|LyzhnCO3rf7BcNk@*Pi_NZB~ z1*iRwg!BLKn*PxLzicuW%MQo?UqQ$ID>3tbL)Gyg=GG4~&3~pE|G&sI|8GNyeXwc% z&ro9jgHDtEKUB>B7t|g9dtkAJ)-)*f52r2#md;|_L(a?k)AWU;USItmob}(TgAf8) zn|vYY?gf07;U9$GyMQ;40eyzm&3-}s{w}`5@O%rU^`3q~SpM$5{qTI_&HpkfU)nmi zp>uamE>Os}V3r*nA0QqT96sdnACC_?dh##btKbO&L;SY!{77g0`Dc?v=FE6!=jB3HQ(PndYB7mH8*vzWtNq z5&vpyANrThIrxu!A>G1-`-k+U`6q2<{v-dDe*0Iq;;(;s#-abnf29ZiQb@S}ut*HR zb1=jeq5}vlR!93kZ?m%nLk%NwWJz_7cllC=f?y6Stt2j@If12+*LQBdu*E8Nvb86GlHc7QWVIVg zk|K_e)Ab7gh@b-dKa>S`H_PJ4st`SBJUYqKCyzwzLjh0_czW4QX4lK~zeJ!Q;9LGQ zS={Ope0ziJiAWCXHe8HseQ3*&ZXtmG4{3iL6?N1#48t_iNJ@7%NJxjk&@f1+B7$@`NC=41DGf4! zgQSFXseph8I0Dik0)t3*eP{5x?&p5jde-{ZyWT%WnRE8pXLp>L`5nVa7jyr|9-Aa+ z=^R05+h2m4DrLkz>|&x3vZ{vr|B|zq$j_cRK}Yk=X6?Q{kdrye&z{a=3XibHBG~r# z9`Aia)HR^JHAGURyB%SV+b-|&^!qB)`4)IX@|x6!R@HUkRQ-el1rx|5OocTgDU~4YvJ?ZG&fJ=_?TE_}C-_&DV>l zvSm>Q{;o|BnCt2u4jzl5P=8|t`LFNhjUKrh~~^4G(rTGsaNmh8@dUd1*nasF{mu(860>bz!(}YiUnc$-pv&w|rR&VDb{Mah%L937G|W28 z%-Nl<2ZkwjY0F>Gr5pjW7w%<+FX?kB^oY9^--U}yhKOD2|DGxe@IoUt$8~90D%pq? z?Z+vN!mJ&YwjH|7q@$32PlAhqK0N9HdT`>2<5~7_-Mx)PH2wy_$;YyTgHTspX(=>< zD$J(YTAonHQei;6g_b2u5B+-cpcxyPeEJoc0Z1Oo_oIWm^Qj%x{aEznb zogXJ+#de18>(B!rl(lOwYWfQC80bkzx49EU3Jm^ zvd4CqJITDZ-)^@pe?Kl|`8kCqn~rbl^T}Z)>A5ZuUO$d)@!jq+HhH>dtUfM~yW(i% za11J|-Jd7q#dczE;OMWpDQnkXSnY0{55~JVp)qP=x=1hApK>YpKVetF^hn{g9iuG# zs&HFcf|Z6g{1p^EH}S;fDh>g^JvNG_osMJb`^jNn52l*{d4jX}25iOGnfr{{$K}50 zT{P-a3<;~91l5#6o0&25b$8}MH2K3q;jX>7CC?3rfN=>K8Sw&SR?%l=4j)x zKf#}J-B9K%Q!d|}N!Ve6yRk#PVWiQ;5DlVEM3^g)E} zBaPQRnEDbcu>_Un#G%ZuP060@p`}-yEa7Z|KeZ=0i+#si`EFTGB&N3l$1gvhI ztODd>$KHV)o;c_3xw}J@6Nc)4arZTs36B;eR8(fLA zNu>bSpDx#aA^#~|h889*zPP(TpUouN{H@KG_LQeGCUXK@uy|93Y^$%?Jp`!sYi2|y zdyd1r{qKKBfD$@SA+24ZJU!Kn zPdTXfdReB449x{EdE>-iKbuQ#A?`em+JwVWZ2>}o?9Ihsh2{cHUOWjfnTncRn>1A7 z=)u|Cwh%R09y^x55Z_rYx6vHuN<+c(Ed@UdlgoHO<^ne7@MdspFx5@4(ZkNTPX{*p zVj635J%2v0bv9>v8LIVL^JJdMMsGF!K3!#(`=BM>!uiT3JTKKT>TpsA@PZ63yrlKt zo+07bNb5N}FB{I-=}_n_803kQFnzX=-a^(1e$8Tdk7Eo_lPhY{dwg{e#9PKb3ve6u zX||uu{%0p&!#?R*cpV*`JfkL0oFrJAiCSCUufoHz3)ap6PJSHApNk`B`xi9EC8G|H zU1|6{%lqA&j)Hhg+2?I9eJ%Q=Es=G(IUNO>Jb03KZcz9K{V7vRDp%HA&QI#{7&491 zlJm1G={IEI*d6J&X|}KYl+V~!H?~q7pGt?(;L#!V@fM~S$oSgR!XEcAe zlN1kJVA$sivn31447^$g*DkDZ{BLXVuia6W`_j6%eZG zXBgG50-pMwmjnhL#5(Kv8G82{;&E`~xp#R02#cEm6?6ar21fo3*!3I!uK`tKL+?od zVNcj+Bk54_v4is+ylxX7o+^s7Qj;t8W63;i4l%W>FRwwfHX}4EX1r|tzX$TfjF!za z<`9ToeOV2bwVCZ1u*5oJZWM9&;AYAH42&K=_y<9E7X|SHK%kaHZ5?lA^Lkbdx;d=} zaOcC)_qUFTa*!T1|MvmTJlJahA@C2v@plmKf0oc9J?e(s{%2s4h_=F`9t`{n;>`m{ zH*S`oApRc%s9k;qaOcAEP)PrS0|g=V3^Ygo4ar$rnRFUtn8AOaZJ2%FO`{B7Ss7zJ z@_EfN5HzlE9kTzmYfnMv3KL%^i@)JlYuwg`^zNy9=jm^j6L*`#wE418pD)UM)ooMO zx=~zUI5&1tA@s9QP^pR`CqY%Sn{u#1ycHOB55u|Ms5uvTNl_tc=Gfy)o-??U>)si7 z>*~ABu>}RsUHjhA$W1EI(h`y2T@2yPye=h-3%3tfWUBZ&*~0r5t(ZEl@I=cgB5EGE z!jOAQ!es7>&~B@HvuQDJS~QiVWbzmB=pO2!;<7t_Q_3xblDB{7wmZuwD4B2)2s8_F zi8(q&CS~*{V7P?jB!TJlwC!Ofz?M-q|G`Bot#*hmRlwU@o}J)Yl;48Ww#hXk<6HOt zGkeD+@)3cQ0e-8#)$T8EN*Ag14-QLSw9yqhuLDD@2_%#~v7=skO1|9Bd`93RKV{;u z;z1i#eKUzK@z@hf^<|2r)Az(@1kM~&igdBx@A$a(4u9W-R`bNm3hO6!7|s>dQ8WMENPy=jNWNrO-n!gz2VD1rS0YA zL;8}dk4dO~J;^aFhfbxs!SQZ_(ofDIS-F~(UJc^Jy(N!FI7`x zrP_>bhC14%wn=QZLLpnN$c6j~V*$0n5`}|*3!x*Fwx!IIV&H&y$2!XzC%$oC)q9Da+QWrXPD<(xUdx3G}k= z#+ocFR1;Ib{dt&{DV8^W%=IAd*O37Gg>Sy_-ue|ievN{Bf?7E1D@ut@Vx!lQ7CaPR zwhSRBo6-+|eYw0xJ|7lF7muNOhs`yFp-lL5(>Qn9OsxLSacJ*A+P)oUGkr6WTI8Gf z1PKL_AFq`xo>B~Msc@fc%0K<}<&=kPHi7=QI{8JMWEaUPH(o=AX7+4n)bp;tfU&$n zvYsE{?w4EH0pa_Yb>AN0&TN3iVqk0er^`K;EM&8URv+9*UqwlEl3oj2S64xcXXS4e zbN=2YiCcX1r`}i;N75(93%*_!_OJ)G$ZSj5Nz!H^=qtMM{Mt79E>v} z<)@F%uCQ(isuFm4$G-Wcn{+pji8_sys>b$jfudrU61R@_0@F@+zK4p-mg)1wjSQUa z73I`VOO(T_zBq4w0X|db@IJ=EKf_k`w0$4G7D2ESGc~dCV)Ucf*tQ)TnW_-g*Exb) z>ymdqM|{Dc#r^w{4{Eqp@{nZvQ)dzpgtEm{!bFHU+=hjM>o>k5eKTQ+*X{J^}mXmV#YA{&DYr|ONSvW$uM*g`PU zS1?er&O!?HRNw_$6mF?I%`bU0wq|wyZiDN6a(EIX%s=?JF)DU<_HvU9Q+V)ukpCdd zIsMIE&dRt};QxKF)O#Ndw&-Mud8eSm_TAlvlM<@EF?0BNlrwFZ;83{Nj+@) zN1gjx z9dKyJ3yn31psumiU(EE*yBH|6h||Jntre{Ym?Y9k9`GIPjgbVBoRXDb2+b=N6>*U2 z1+6S-W*g#j*NWCrUP#HOlV}tCp%vi|Bsiri#SofROfF&|)eBj%k;%5h;H?#@rM!@k zPuJ6?JHYqU4#fKh6rNT@c}Fj3d4Ue@?Jd|a)(DTq9#z>f1L@wKoW0Zk&y9!OX6Yuc~_{+!osQcqL}zSn5%J;l3bn6xCZf}<5 zwoLvbXt_4;nTzIBYXyeh-gMJLKE45WVLA%By2RG(-~=e9iSRfsVgKP;+4IUOzFqEZ z*UY-2s(AXYkNomqxl)C_|;x1+YLUyWh-BSBgS(4 zzwHP4y&mUPyh~1&5_^K%_Gfk7RW9_n`~>uTBHvmmgOd!g{jJY5A4*-0Q+WF7<_5k# zet%`k7*C$wX~*@~D(lgPKT2RSoVOSOZTl4a-?SzlW-tO4t74awk`6Ty87pbaC zY2E`7qBt9>F~T$2ZYch6PZICJiHI(Q3gY+3#*gEWv7C6T{SX`D3Q@#o>ohNMAl1)% zg>x9muVM3^;<|wjek|qdxK{OzbjRVO;yI7l*2Q+m+Kelc)=|C2+X)T}JeM|-pcF$~ zW8raftgG9dd=H%#Bo5_c1&=UJ!#xeN?Rg?xCzae&k==mO$Z!Rbb^I65@4QzL+b1z? z{pS1Mg56^W-)D3;Zx&H&_}Z>jB@s^OUF?1d=c(tHjLOMt@LW*PQam_6zT&-P+2@24 z|7kzO>p6>4P@omI&s3GsSx-+m?+la6DXICX`Do65I2R^eyFY=86`3tW@Iv%sZ>eBF zU!QdmV^Y7P#SvMyKlMImIdP>etnil9ei1*jrogMFvmH;mq!j@DxZJ3Q zsox)R#qT%t@YP^_=5Y6`7bf>IY}Xo}DGPU78V;mQXS@~XwUz(9@8GGG=zPDR<1x;> zO1oACmP`%h4zYsU5zLRnsfrAebbR)3IB|tG!$GJx`r{|IDtkek3C}8wfD_Le&JTQJ zn?IzscdZrTe|lQ8?eTNgd(fVwb{&%s;%&D3kH}m!o2AWUtcwTJADbo>_PyhNYY=xt zmJ>j*BM7Gg5Q#FE?M7+28N5d?=_gH-nEIUGt_R*bdG^1~X)}BLX4ObBSFW!&EbT0& zSJAM2lHP}MRiIU$9DGxloE6%vCZ9KQ8vL;~-Q=g(P%826exiTi^SBs=j?7O1V?EBU z?H~Qk;5(GSS*~ zwe0U&a3M}^h2s5MSaZb-L5d(PJT>>X>Jdd{X(kpe@L&zTp>h4gmTF$o+b-~`iZ^^2 z)`s!3^%#8gWw|#9wiv4THTn^_Z73Y2Qtw_^k7^{z36Oemr@SsJnapi*3|8mU8W%b2 zDdR~=aptM6c(W$+1>S$f5=$2MR64jLKe#EY;XONpA(P8XR+hTd0_@1ZiY^a1??nvh2vP`^A0A6~s2)8=0Fx4xAP_ z+M1QH){0@b2K@W@NB_`=elE4Be)7)Bo~#UQy7u`aD8~;2-y;t`acFH4H^TJ(_g!aQ zE2y}IfHS!;_Gk=y208L=V#P<(KvCZtL{d-1F7=;nG;Cqli$KNqwOEwxqp+ z&>gW%PI>-ZB}w%zgMtI{F9w$}b-EXYjscS^1bPpixK|9ZMUF+5 z_E+PfX{`I`O@Cit+e;6YAa};hor+isJ=W`9le zCQU#wDNmm(li=L7^7v85_r~p=y)VWaGz*DesiF+42EHec1;q7INu($qDt^aai@!Xb zUz=fu>cZ|0q!wxvQO3 z&X9ArZ9Q>w#A>wtO~%TaGltJt(y-=(yJ|l+q8~ZF{*x$k_i5O7%E^2g_ds>N{%@05 z>p6_HnQtBAE4~wa9^jwL_j^13r%a~0&3}IHrEwx-k;Wp2jD&#x*d3#C>X#{ItukBs zr9XB2E&aFKe^FM^%h{wAIs3Vo7nR6YC<#$ume2>9zR~awc5C@NANYmO{9aHer&89h zsfPRNp${;vxpCC)?NzE!IviPgulB4YN;Y`?LDRviY3}h1Q4cl5l{eCU<@L)fmUrY& z%kROca)uhm)hYCxTh<08`#Ues%7{Bg-jvwOwzq(Np&EL z4_@iP%#cN#vJ3IF15In}gR&*7g(2*N8Fwtv5h~`cycA=d}=Y%s( z{Is#cpqE@s3aa_IR~XN}p5SXyXfj6peVVt%7x=`FSs2B{lKr&bsYZ(yj2B=_YYzDvKlwEHy&0h2m6T;}fI~kU|;41g9rNE1RN;dd}I!9z*k%;t_sGiG- z_$*1(eViwXtFMi7X;tqlMX$+cKgi@PcJV8w5hFpM)p75Cim|ER5*~)hV{Y~}Oe45i zHKk>bzQEq!#j`IV_?qlnu!fsUh|V$Z?5tjusl*dOA%S>(@NU9eqxUSIc+P69gY%_T6KJ1>I?uyPkj6d7S(c zyOdC1Bt0X5ll-NsC+(oBWCi+49*d~BPmaa|521l4^e%?<7?dTN0u|{7(Hx9$n3qOg zjMtY0r*5g(ctt##-)z{keDA5(=4VMO?-)55l*aS&?|x#Z(#B9t$E%h!#7JZbz`p%i zk#e4(meOHiinNyc28z#Z*ZO}!jqtdjCp>=$psLB&77(Njlh~#7d?Ohj0^X%);Y6?w z{%XqQ`Nl`DZ?jZn8-0x7{0Uw1E>_j&Msq`+U(&X><9~;<4z5f97-#mr%e>wa?0K!~ z6x`Wi(uN;^MJ|0mW!5`i(N)v?t0WBzvL3Q{tbBgmo@FYR)SSZN0VmL;(aqa>t}L9x zULlNY@$@(G3L5$7VD4^!5ZsH=i(F+9N}Vp6E(N}G_E-Y);309-*f8Uh8FB0Q{$L%W z{nxps82%VqRU4nqiFea}G8;tSn^F_=&vG>h6ye+ve?a)y%@)rZkH4{uTu@duDaQLg z1An0ZX3N;s=6!YVCJ7O#y>ApmU+wS z8UFkW{)~_Pu95tCXDk0o!rP?Eb3)7}Ab##nRt}=4rIs^9*NsPf}&> zJj&5A2@s*$M&FesYyV4yPS;Gau+e`3zx3SQn=4Lw%Gnx!@0r)yD)oK|x-NbF6j+|UF5VAm?#^G=R5>$u+KJoU7{gM4TeXZ!H&0vQK!LHXC8U-{V9NUGhB z{)=TYede%YT@o6&x^J>MYQcQjvhP4k{Y->dXdJzB`VI|wD}}`u=+BUZqt%pXf9FLD z=G}XahF8l%eT(+e-6j@nk0P^_=>mCQ)qL-4tK0Lk4@r0|>v#2FX&gXAYmSAbT1U`zC!3lt!p1%^S+$6K zVt`tNG12;II2ZHVF%{Y}<~Q;S=V_}iyDjmq_MAVlljXlv3y#i8U|u&hXM1LH+-o)szrU|2mi?s?(I z>1wk~E@zzv>^PCPKM}EKT+t_rC>gJOCjZUzbf}XiI*UK0d58X96od;#YFDgK&_01B zWTu_bFV$2SZt!$j>}PhBR_C2)YJuA=e;Ab_AY4UBLUkv>3p0zsw9sGo607~S$2{lP z!d8TYPak1fH>v(k4aV9n)(m4A?twt8JfClSK$6y^+UIyaEd>^yCv zdBur=P3&0g)lZ&CoXk~V9bA4(^%@V2nvNY`&vy@5ixZ@_{*v#a2P?ARW9nQY*Yh>m z`d64qHFAc}mo9KFh6u^jzWt(lDR4FK?|-MoNBm*$at?KS*O}(+m_t4f_mNBbBccCQ z@uw3cTHYhX^atnQs-#$u$bymjPf3+e7`oYqV!ArR_7;LWkryk!9BlXK%JoNI)^=MP z>vJ~*e!PTph_D9L6uqjF6+wvLc2;`gW7gdwnSDqZEuCv(Su}f_rTCOEr+He8?a=wo z5bYW%X|Ax+oRPuX`oMmoLCT(Q?wyem1!oAzDXnJEB|XL?a)}r9n)vn-LM_T2;6kuD zlhHoW@LX<2%-ooCEVZg$9Css);^E%{ChKBY#pk!qq&RE$VRp9Pi!#Aa1E*|Vd3h1M%F|Gdrp>0FTM}2b84JTg`^9$hv{j(n)zLta zP$Ey5%81hG@w`u*e?y4I^=&l$Z=}!RWy~Lzbb372cUW8I?}=`=ex{S|gk9s1I>tJ_ zVK+Q!Ib12a<1>Z+jfXFNpnZ$BpE?9@kw{Tr@U|*XneAkX56jN2UCh~WeeUGICGior zW7+{WH0HcF_{&1*HFl@Uiz1>}!-+AeLz_aJLjQe`HVEgZ;1;$#I)c1gvGB7z6D{0- zK<4!LJI&l%^QO@U1HL@fJK1^|hZy?$Sq3By+EBX31(!1$d0w-7bnCRgD$@N<5Y*_w z7|a2ij=1Dpao812wbQ%9l|_8Xo6xCcZyT%~JX;Tfz!;Y_1k?V-6-z&FvXk+s#DEVR zsZ=0B*ZsA`lP@sREfv8i6yc#30sX^xhLO$7VRRy<_Py1M%#BNrRF`b9#9q;=3ps z(e*p5_@7&rGKpO8_Br2p>nqD?lqA&RnH{z>ayKW4ovRX1)X!x5<>?u(>D>Qa6cdu# zYi^HdgZTV}Dk!?qIiI|v!qi!w$&R7me7BFo3f2E49JgJ07uja3JQvjU#Dm)TWRq(D zJ{dAQGfxPGW2NYY9od|z>jMUhuIjheuC8Yv#AD(fBlh`u_)+uAMK2u4ewuhbV6f?G zdZ+7Zf09dEf8PsvFEgDAkjUzx|4BTK_nmA-e2wjbae0H_WoVKTtHvRrmeZ>rf#gdv zZsQL+Wrim~(=w z8WR9JltFJOl`^H5yj>9~{a1rfwc}OlfX9$1P{ooUabP@LdO^VcIX)dh1C~hmF>Vp2LcIdNn$!m$o4Lr7~1J99Deo_9!h<&Jceg?LwlqYmmg#tlM6Vw5 zcuf4}4a3J)jRqzAm?dCX_i=UE?-kt4 z1XR-xwrUJ35tZF#VA~!XYOmh$=AZOjp;O#_ER*A#HV|bV|5O@0-%>Jgdp|hbZrZ8X zJ+LdUr&Z%XNr&@C9{biCzL5R0xvz=?4qFqaa%|A_&B z&>af^5H!B7zR*_yq*D|0SAoU<-`zh9RagGcmw|7t zAGVN{m6x{?QhVy+WA9}lq~`L_$Nt~##8yHO`=<_$KFkv0B0}2sZVo<<%pxLU_eB2x zf4f&qR8n64zqbYl$Ba4d%H~ z*v7j$yU$MjF9m4yo^%J+R(Wz}6K>RbD)c?HWzI@|PV>5dRPWe}C3|sLwl6tsuZ@u| z?Yw@%aUs9LTeDpEhqZ6RVWr z=+9bO)C;HJmPq>PRsWh%N4mGs)$a-_1w)Uj_M5l@i%w@=A&-z33Ku(Tgnx(y6>jyf zWwF1XhtI#~sZ3fP%-A%kvAS;Cye6GKX9{UBn2x-l5})`xy>hJ0suoLHp10W|bdY-p5zf`DTcO^WQ2P+GTE5er>7$o>yEs`+*Z5F)ytqD;yCxFyYaS z(QqUYl%MI6I})^-X=mYMtUn>h_aeTl7B1ZL)h(`Qy=+$ett(zt%+g>V<@=0dKl_IF z*hIJoqRVJiGA~CmpE{SrDpi8H?Abi^ai;QKPmi;_t(xMp=Vvj|elTF%$5#b>U~<8c zXe&ct>X!Lw6t?4*Q$gt8&qe#4q2~uwtyj$GYQ#TXosyEaGx#-qR0f(1ntpjz7i5oR zdc~qug(fm2ry>ju4ds0QnmydPhM?1%eu#~I+X1e&w_h<<5z8Iv^tCQAFJx(A_+T#8 zML}03!=>BKpU=@Kicds;*3qUccW*Zqe^hQWMwrf-k50kw58i4==1VP))ed=U+>(zW zWO9u^KB(SP>}R#R>tbHPWk#Eju^+J8Wtno5X=lbz%nT!@le(=V$}$?-XhaZT{}Sqc>Ut!2`4%bEg7-4Wvk| z5_5Fk>9F;|;l^r^FR_BdLOoWXfmnTPDRTN(vQgBr^_O+%v8ImTB z3Pb;@(o}i+xHK^6C5>rutm3Sz-%+RAr5D&Yf2r|7VfLhC+%6i?BDrQkW68HXqd%=H z))KUJ##ht%M7`z!wuB8?>eY}QX2raNwckpQyLH^3q)>7&_3{brzGmO=G)NZ+ftdjo zp4#`qDf^GMW*qcf)u>0dU#b5@(@(fa&|?su|!KCDPn&9Jo*E5 z-@Fx-X!2d3lo2Z!O z`E&hUW8$JuGn|n~>;Xr)5^KeWG!e;Zn2G|wbWKB916-q=u?@9)tH{DuepfB=KA|d8 z3FW8Hm=K$G*00bveF+l=-@?aHr|M_>DID{I;nGpPTII7#vn@mH)4J>w=HRk zvJ6U!_{={K`p|N0SIjK3HU0m1)anqM#JD(w5HeH}lx&ceHFDJzH@yEFP%6bSPoIS2 zn0P_NH=-d)kPa+q)FasM=&|hkYMK7wm-8&zg;Klkqn`%jb6`eebMg3NHbinP^*D&0+w{}ou>&!2U*J&zOrz0?NOJO>~hKMU*LXBSTmsv-6 zXX+McJ$}^q-qKoY?g`Mp8p5mIkAtcv*+>kNQ zVBgjbG5wVLQc{tXLM;j*Q9d+iKbW`WBp>Cl=s9=3*Ji?h+>|{}PENjS^rn}e0?m;j zw~i*!3_MLNMJ1LWlc^o2nqMw2&ED5t)k!As{;BN4R>6nZbc1pF)NOCoEd>pm_Wd?@Qd)VemG_o2Q#BVuN{i&o#+@cZ}gN={F8Ma>e1f2?t)xW<*|lV7VW zL}N{cL#+KTk+vU6ofemZB>hZ(3Qm;Fq?P}!m?TYn_qeqYz3~jzL^av*<6c`>O-Uj} z6S*sFzd-%EJm>Fv8lwMXzeGKjctTFdGxbG)h=s*js$7f0?t>lSO5;HX2h*7`B+@)v zN2ZQ9TWzAL=tEWDowfOC{uY06KjOJ4>{a8^CflmAZ~I@$3nsQ>PtXJo@wFa5cWygw zGi*Ky{*1jmR232$ID}>xVyqug8p7Eqpzvm4o#4Hg2*=^YMGKvzyAhVGY`7Jj72tYCqQsZznL?ptAn8~9(u27QAmhjMGRJ=xj_}KPK3m@je|Yvsyl33~n4|Je`sD-9(iS7DGjbmplIXXCy3Lkp}a z%TMZ!kKh8(!h&2TWhWVkYl^vwZ!b|e7dE`#n0$|_w8?(3H7pA)_eBBp+wgD$t9XAs z+Qm<*{D~B0F)5CBE;=`abpZAl#=3}*2P;xlBTEzVy?qEGWSWno8K+BE*uO1eG@Zq8}qGTF) zX%k-?dN^H`mMgUxYNey6_FTRGgdS34VY3+X@fXvYp;A}pwzCd5*o4^M`3@P&N0ewW zPeMX!tjy%|5u0TT)1B5aRvdx&XgLpgedf8V&;q*9vOm{#HPf|O10fp4tJ1nWlw26Jcda)*q=TbRzo|xSCc-%mL6QC-IR`?t zsP+;PdR};K?{~xw#q^2HMf?yOOr|Xocma4%d8D0yKx0@Yhr`1#o0pgm>%Vn?aW`gh z#V7jQm;;1`$}}mo-3f>ka~X72@o=tqIJ)RZmP<7!G(9O@ATkJe@xZP=CMZyiyX&r_ zc|`342)1a%I1L=V70{B}V2;#NxYTYr2DO01tkWAnb25b;5?DhVn>Z9RV7wY}yuDy! zW_F5vr|`AoUJ?Q=e>4bowOhU!wz*3`j{aNV9g{d;wJzUo?C367s^x@rU9vd2IjP%)ok?d!wi?PuII1at`Z z#|IlNVj%R~F~mF(^MT19_F=kSA1+*VkXCMC1cJ&m1axB$y3jA+$w46@?$L<-{k4N6 zXfyL+Lhgry;6Mge@n}&ry_ih%2-Du9cm!zacy5@tbA+${VRF0JeRf@VZIOJo>E4+! zREMA#M3aT{`EsX!`8jiaA!HBVzF2#v;RiT3xf_Q_JyW<^(QQQd@yvM017*O<;t^lWCd7=wW60IExxq za1I_QX1wS>^`^33PGI7v(8AGY-(~_K)R@oF*vpmvPNoVcxrAkYmMi51z*4@YjIz-F zcX7Zf>4>5I8^^=L@$nM^P)v3Vlm*VcZe?yPT>$#aae^nr{DV|<;)Tt31pAvIl{gD2 zDu9FK%lH9{a6)RzS;Cq`fC!}YO^{2(Pk){wfa@r>LaeOW(c$Ry9$H-lc20BZPT>?N z3%W~Vc-*FFofj7C41ydH3$wU;kWW85!*F&S9O0C&R$Y>i$NAg84u3cgJ-eLD0$y9F z1e3lSWh3>75}OpwAQE*|iYwDu^$SiwJfseM#MV&W3#Aa=c3#1&ti zz!r=ziJ_Yy@{%pdq9QLsD(S{SK#01WYb$)VyW0OjAFHxHFESuzM>*&MXmjZD^5x8|*?VA3F$lCcM=K{)Wa+EzynF zu*)I<#uD^k#9ThF5jVO(fg1|p#sSSI6URb8U@SPHA7{P9@hCBODhVtGs+k3bzke{J z2sC#BVPI_>20DbXYj&*|3ay~52gYdt6NE5~gCqmdiAI1L9y~qJ>#WKGWg%AZSgkG~ zHh`Y?ANqqd^9I&N0a*y}Ff~?qc9~*2S#}sKOH9in{GA$E44#Z`c zRu>O|+i@D&5#qr3Fz!+`~i7Otwr=%T-kj?5-4z zIIB~I>pVtLW(CL9>sk@AeubTas_b&*l^lNw2C<@-)#QV;UE9Jphu6Czm?uF z{}NI)Yr*6HO_dB#Ctjr$x;ElZu$C2exVdnk-GvIHzNOY5&O)!RE;BMRzIB~=Z7j>k zu{8qQLm7aI2B;%^ls7j%=)Z_zg-aXqYl9WMI8~0wazuU(g8&j zp;AvZ!t;y)2Eqkpg_h0oWI&$VkUJ#BZy#gEnQPfJGCq9SbQ4$o{~PsNj5uq#ORGs3=eGk%(yX-v*;F zSf+WBkk&tibD;vl_>K3lG={m9>KiBDNEeaO8i+yxL)jusw`&MhltA$9oWh4alBEmI zJDev!{v+;%6P)P0E`wYeB{bhsH%53B&;~2e#z8MgcZ*RfX9Dn#WL{_iz=y9|ZT?Ge|7YV6R^K}}(VHHY_-V7FaX3!ST*8hyGo4#h$+N3#SJbhm&tkxrc)Yo14o|N&5|w% zdWk@*iUI)-rM4xu|G3C*HYXT&Yi1}f$jbxK6E}~m5Gc=Sma~u)jvnG6b2twBiwDJQ z70?56a2!<6c3aVFq zoMf7t(u@l=>k)N8$1Dcv0;QT6GHeDUttO!FIrkMn0xJj%%Ww8speSnxh-qL8fKM~9 z8yc=`63}fp=6#fXq}835qu zQD((_32G(ILbS&?C>27rs`>#!E)+sr?f({M-d$$LblpUPZJ7V6HA^2xW-(q^BDRbD z9Pk4VAQ+vIa!_I7qAJuSQuzPuukM6zkLCt~H(*tEHw9JP#^|An-dWV%5UxXT$OFcb zzIi$UJeYuXJ5o5&lXP^KTlBEsQh*ZQ(o9&@gDwJVV3QUgVF740EBK5w${FHNNIa5T z9Z(p_#xf9~3?u6~MbW^2I7JI&b!+V@C|`l6{R?6!wmhu=ld*kCYY&xa`oT((7l>U? zWYbL!zyhsDOcX-y9ZH9{Q1zyiI?~k{m<}u8xWvig#`6=R5WuGNfM0-KX8A_uEdSNA z@J$toGDrgfUs4a}sLvO`W7ArplL?3*Sx^J(LA8K8bkL|%ecK_CO`OkwrWq)q{RWh9bP0T7DD@5FAlYWNPoV7e3hFEaHb?|D zb^A??+2^3m@Ea8roIt(Eot}`8AlHC{3eokbWJZjNi9Q)&oASU%y6g2(&KkgYV-6Sn zh&DgDcm&$Ujvgvw@La+K^Uh}i{Ieh;w#N9I;sGMi$jC&E$`#@x z8EUXSDu|z@ zN9+KnEaParDYOfq&gWo=_8TgWOD!66rwvVCeY)9;`S91T$I|e_By9N5{%{Hiq#$|t zphPDBK#L)h(a9^KJrWTl2>4KsM)-+?T6W45mI<=Zf0Y5sqV?5y0K+Qt1dQ>3wkjHx zGTBQD5$~l`&s_DM1C@Zn=pzlPQpwSU36`Isf*mnR-T|rRPO3+ds3Uq5(QC@t1t8F+ zioQUcg<9C5M4FIQZquemBG;;)(m>&4D56bdR=*yex8=Bk~5^(#^pe<3X1(}R4PtIHL$4k z((@X)-~}q^Dnj%0)gr4z znqY}ZhFWXc*}(T9u|RmJl2rqAd;b)1M?@a?MBEBIR&V}L~^n{|IcmP6xeyc>) zS02?j?g)hWKOq~)2c?mHJcjX8(9oew@#<#i<+B@iLuG7KyxdVhg-#9BTU6`^5l9Ql zD&Ecg@fZ0&fSbr{!rfLI5C_H`Rm0J&L7)s>WKrOdx1Q!zd0*NT`s&S6vi2V zuZQdIq?liW@Gp-FhEXD@GU**^nu|T-YA6L(?8O zfqqZ{9OR&6adV7;(kda>;rM6&WLn$1EU2>}&~I)mLY+y%!O;QXZTR)yGX=ue06ict z36462$~>FxC4*v~7;2$T*#tnY>~=&cP2@hR2~b1DT0+zdb%X>CO?FqlF@u%{B~lp3 zrYO}aq0W<3Afc|O9R#nka8k@kKtgkfNefDbpgwN}Ay%&yRA|><7pzfdDJan+H3c+4 zP)J9S2;$+*tB=$U`EIfr>_3nSLG^LJ*S=+x{(iF$j59L_Y?#9W>+~u$fMt$>H;GFy z`46=qm&}1^&WghMzh9}ERk(mhu|`;Ck`i*^@^1}JN)RZr0WDufQ-U1f2~O~93^bx- zglLeHlT$aODrIjJs^GP*uK+JM4%~y6J2>c#J2r6Y?3zgMXu8d{`YOV|b^3P3AzB3> zRpk?y6qSv^KXK8%CXc<>z;{38;pszM!l;6%3rXTw4TOpmY(-wUsqNxP!pRmkR z&U%+iO;PF(|Z^)B?B_c`bN-tXS$p6A~C*PTCD>$g|UG3Mwo z$C``$QoP`t_v1+RESLAlM6p9;NwQwU_GRV^tT@RTD=_gzigItlh{7^-{HwnIq)^^^ zh=&4K8;(eL(hUTskEC~wvVZ7v zfTwuArY&h>dbQ5Y!jlmWg3T}QBVS28^XQwUy5@Fsy@~sVGrxTK!;`PR)EN{udg>DQ+37@FejJgFTSJSk%TV4H`n0lf}gRQ zFmJ2=#;HGBF6IZA2hUmCo-UzkQxIhAlBbUk%LZ!>v^~GWy~P;QPrluxGv!0?=LTc< zr%g*~ZACq*wR4eRlwGOtv3Sf*pKLFQK8)?EazZ9vpseLb!Z$dU_;NEhmo9?>=lRyId^{s|+~js=(12&|FwS>9JjaU;5k zKUYD20t^#q*ke`wzZts!ND41MK~M@@uY(Lwa1hCxr==X_pHRQs1ds-SoW$}X6ZEBE|yF_=zMQJJ-CFt)##qf9%#xdmDg`$DD7 zE#N^v$t*)%p!37|Wf*pbA)aXq(;xBiphyf=53}=E+_1gpwh+?&h01#W&?aTGi(vX~lXa4{a+(CZS@R z;EaQ~E7aGIajX*rW>*SGv3N=gF{V;c6S<8OnK4mtbyErHC

RHcipY17pSH#S2t59#oLSD$~^*bJXPh z^@%IDGnzJz`arHD52Me}P3pfX7U}E9;GnN!NvRxyqqZrZmwJzUYQvZJPglDnd}o2O zZ!J>rbl)8}qMNT|sf|RLSGI+Ma?afJxi*~EmxcVUKD|4=F6pwfvY_|w%YwHc{p;l{ z8cla-bh?_o(PEDR%_o2$FZ)Bf3>mExo8Aa+sS@fg|M zao+N=pgQWVqkX4Q?PphB1@z&C7G}(x%u3X62=Vq(0>M&^efxeSl-mJLd~uc2>NI}dZ@TL8Lgk{_z-d|VzJ#egElpplXJOWy z#|!3CjJd;%O@oFOc2AAQsrda!GTq5U@~JEv>E1@HJI$)RtGDsd4FYij{+^ zRcFnKA*A`^S!|F(?u}!f`$DGRC2lx(m zIhVJEa4#R~g*GF^c6gi!ve1~nw5fh&K;B|04N-X7O?-QRc)A!P)6|o`rlNtIN1^m# zK)r^=+L~yn{KfIBxj2Rp^#@NUO?Z4vdHMLA1M-cFv8l{4Zu_Q3RTo9$N*0U>Mq3Ld zS85(hNb56QsM5a~;>=`x%w$d#rUnm6=l?P|H!E<{ zPQnWs4PEJ<+teq~nmCqGulB4OwC@2c=(b}jI35@6R3iwmyIfB!sB_}E)BC5hQ0Wez z{OB@|Z_#<3!r;)bi!4qTFaP8ATlpNu$s!iUqP(%4B45Ad+oKO|jU{$axJqe()~{hZ zpW4BBhVhiqCl1zZLzdri_M!X7c-zM@{8qmq3HV~GI*A7;dcDCvYzp*@#H$<$IW|U6 z$8MwX^NMgk9`LNzGY=@#9$ak;(i+2HQ`;ClVy-p7-}~&0qe8hQF4pWl#z8KurJ|u3 zxQl#;NDhtn31fOFr6&!A1UTzEEU`$g?_ba|ua;Y-+1#?|0Iu3MR@_Of0SO#*WGCRY z5lWkobE$$3Z>9B~9;q#vhxh@{9^i2smM2OYwy}~*aOOLMYo=G+;a1 z-2}AgiWWs2`{hsRm0w?iBOVZhtu^(4X(p>mmEXgepjrY$+nKn0r__)2KTDV0BVNf3+R z`;?>BR-X?kn#QADdY^)f?5n%RtKB@$b|>sG9^glhxad~qz2>kqqc;O-lN^qs6VArL zVbocRURvPqp1zO<~Xv8+I*vA-NMKNVgrs#zH7#`v_7B7?jN?O6fW6CL@v}nq^Q)PGt;{VjHM(lH< zx!3Avh_0E_oe2$PD;2m(P}vEev~f3F$ZOQOvIUsA=ld4?BoG4o>R}mgt7VG}e#C0m zP}%F2j4B}@*Rka3=o#|%-O?CzL6p%98+0!wpRw* zq>8kPMV0tzFU7eZO}#MA3kVkTVoLws1J3(Slpdrw5}C)(5Y(Jx-`IL9<&fv6 zi_Ru&bc2?Uro|`A%Opm!)D3?YODR3&X1E%q+8$~NU3t!~yZ`Y{T7Xuiz#Vt?&AQDY zu-Z!h`y7uadT;8__`WW9LxZc+2$Fqlilf*!?->`-7yEabPH0`@Ph~Kqcc(0>?s-sp zym59bP%6R$lzDDwF^i$kvL&%udueVw6u)3UrulU1hkk>eA6?vU@E_?;>Y>9?n3>^ zj)(fkpNjR*ok4oRXw9G;vdLo-a(&m2lT3<|emkwun zx8e3V_@eZjJ1D;-5@ObM6Z6jf*Aq+~(`9X)s^h|Mld|A%C3h)#PhV|GgM}887p~KS zjJu6SCDm}AuhrE&*CL_a-c(H|M(p_mHKQ_8R@&*9?%0#rgQFIbgv>nUeRHepoF}U6 z4w?=+4*Cv84yF!o9rmOj+A{7!gZMPnk$~8vpTN>$!Sw%BGR^T%OQzLXm{{(!g8%<* z|7QU;^D806-__H97EiOXu{~oJx3o93v}cw#1gon}9Sw!7-dfq3S{T~fn(F_nvYLyN z^C`28u7x49>i>0xH77gEzbdSMj{n>RuwNKh=@|kB;LBqG?6B|s z`h|;&hYKFW{j~?T|7%0~Pap7e20#Y1el`NQ=qMaWyHEfZfZ#%qaFKqtLefAqQ6RtC z4azqS><x%>3RYu)$g_lEI^9!mZoHB(#s|o;+jc;Ns?aB`hK)E}{BHP2a%K$k@cx%+bmDor{mJ zpZ~{zPf^h^v2p1cnOWI6xv=tzN_f@R>Xz2F_Kt6zU5L@K@rlXBrR9~?we^k7!=vMq z)3fu7OI!#DBN8$SCORrAip9+;;@~iV=ssY5eV5>c{2=N*{D-=FHt)ZrHVxrDeVJBL zy0EXH_#rHPkxJjzyR7*U+cTkq8*&p85tC5U+(63C!TB3fQ4mxmWfc(GKY+Efclay3 z;SrI)K>nX09v=A(^Zx?!&q)9i9DN8b5-#u@=o~?W__oVyLnau*O+D`J&q@uHq_J?< zyHsmoO(b}@T~yyXe`8{tvmHHI%N$Or_v@5o8Q1m2kv)!Yl%GpTr+Z%W10l^iplJ{dy^0-1oglh#_9~(Eemj!M{8UyH&@|?ZiH$SN~|OcR+wZ zjd+un`m_jRxut}NY>r=(s!a9&@8n-Y|Nq`_sg(@$zrJ9uaMq?F|Jb;CvAIDW*Rj?g zpW?<)&Nkv9xuZqc>HnMXqDCbbN2}|03;G~^5C2ME_g}Z9&i(IL0^5zj{(pX$)Bg=- ziT>R`B?cqr33=F+itnNBco4Q#QsI}0{2N|HYwi%@7hSGLEV#uuQbFU_@-iIFDU$^( zKX?$35N|%G`Jed9&yV*9@damvvlR__z+doB?f3Qba|!LN%WHYZvMuvB{?@+1-|B|H z-T!(^iW~hgh^6%JA+x>_qd$g>^7ePk6UuPcUmz#^4djL!kY|5^O#2s*-|rXQ&;^7G zq|3kE3C78TU!Cav23Y*`H~PkTSeUOJ2d?8zFI4=%LHjEN_*K2CCU%*~<&uvBw?fqY zq|eSv9DhS{^-F4BX7Q8^oQ9v{chwcOT(F-09@yXKgu)OZ{uy(Pl}bAvlz*~`1EkXoyUf1!HwVa@8`88a!Wkfep&vl}kns0;qQAyjaYBEk`jab_YnUD!Jxlz#jj`mftaKI4OhJ1 z|Hb-$BYn&ttZ&cxcRKz77`Rlo-{lQY+~~YNc%uEc&eKn=|AQxZ|2x1|zW`Y5b*pK2`o_M{_37?yYB`S z>}!T+zqy#SGxYbFKa?@|e(^xRJn`QK>`%e}FIi#zvztF9?~iUUmOK9ByI+O{t+`u> zLtE(3&~v)zzd-n}j!OSvek&TLKL+i$p-}lP;(ud|KWvNYy3tSI4|e)5*7&8cXn*OL z8-bnu?*jWv$AJP%3Nr8C1olS9+z71S;UBW}H{pp+o5sU3dmyNJhW)>Ye|tJ zzs{!q9Eep(W?~rrVq{rMN;X~uu;0NFL`{LpL2`f*zzkpqNWA_x2MDl4b5z-}UN+^J z5nu_)VZHi&6FG+92+{yMP!14yAq@a(0EQsM1p5t2${w<8+&M~$nTp&RY*16bX*mdsp#}DD0WxxZhezQ*85vI zy6xLkq?f?7tFzaABk)56J2Y3^vi6gkym%T zbiDwwGePX=S>$yh098-~;DQ7805OCJSQG3Vyg3BmdI13O4R9#H4{|m6c_|p>&!PVW zfji1e{7et!bG5pbo*IAkiu{2wGzPrXX}n|SxQ`vgZBbCyEa#f&b@v>whlb{(TL7r2 z0|cbtyH7y!FfjiOaCi?wghYs2Q*jK~6hn4o3m{ymAbbYAuk@_}7G&TXV0(&N{S=7> z9EJNnI^ZeDXAq0~8K;zq4-Msh4*z55xfugK(zDin+rAqqOw2ajO6~dKxT5h+4A>I@ zjUNwss{*WqPeNLsl4FWcAZ7tfF62GcAWZDpgL~c}MRXxJ8B|VofLQ00)k!Nzi3YLY zZvLyia&%j5fb$)rJzxz!2&EjjAq6Vn1^xgVk9#B3xzVHe&M!((wj50$7qdA1ID({Fo0r^G~TOa+{=H?3ug_m0Z{;WT6J_A??VPSL69I* zkSgT$AWVN_xggBMOTDKeGIi77doBRLbt#zWE~sMwU|qe^F(A4D9Z3_3^*A4y0~2H@ z5G4V>rZ1Odt2Z2k_~+2G+qdFZ^-K8QQG9YKxE!#n^DioJjR#q6AyM-}YG#UotN90C zA%Paaq9E#A8l)+_&STySUZBGY&wzT<3Qi+A8P*LF5%V55g4~k;?3~pf0FBecyw;o~ z8^s?X{>8x7Ho)Wu$^-y~*WQo>zzuG^!3yN3Rs$yBJGOn*y(j)ZNB=P@+>AX)WyBkD zi_|X*ct3)u=-+KI*^Aw=*(zy{z1ZjD200Mx=p?iyz_RAKv% z)7wNy*qB~uF0J}|UR+O|QbbT?0H-}4U4V425ty#rLn2t;hLVeWSp(ah9B z^Re+8dL!@@#G%1C=mwV?Ibr>>{hWLMMm3H7N65fQOCxT{XQba9kB87t6S6u6-10)N z*t1GPUENI@cojG6qnNtZ&T@5?#%M zh#}Q~4(?B^0yOIc$%p~$8eR>Noy*Vn;>W5XjVw=*I0ZcRX)S6-ZxS*f4&YxqC^R=j znit*QJ&Z;IC4JyO#AZW|S|aS1mi^9Wt$TNX-U7jtR`NAfwJ!B6FO) zudW0U`E=5%Uk;eHVDrZ}`sk{dJ2msK$qFO*e$~m*72IQ7i3NTR&jX!_yQ^+!ZujZAdBLIC+g*95u>qEA%8{~U-e4;AC z1es0rMt+a4OA3B)6_leHBo-FNG99l8YiQBOZ2&K4i4sI=CskmS^`qr`tRy zsvtB4b?akW<=Z(OY>-61xb7F30LQcU*nRV8#n&4*;`7gK$uF!(OB0Z-VH+eF0iZ2x zXnLDfg`|M`s{TExH+J^!N9?^UWKR3{UkAp4OF`ZV9a@3NMvS0oB*#X5M?`~{m&*0| zz1&ks@HK!o0%&JIqX5pia@|H+!A8iIB@(HRzLN4_8Aqe|@faNv^5ZjLFpuW+u@QhEJnf-LCtDE8mc1`eb3FeeYtw^NL%CrCs)y_h zVpO>1@R1F8zhXQ=h9ku#S?*4=GjPi7yR$qV~C3$_D*4s35112c_i zdyB|~nqJe6m-hiQe6K`M!oC4Wtg}y_`)~X*|Nq?d+>q>FC_R$3yK`gy2OhBK0MriX zGwJ|N3ZSk7Dh1NB_gGhr(=+9|BR;o?c`cJtNxf-7GegV+-`l<8I9p7#0T5cNab(a{ieJ@+ENkvi=6KFItQjX-eIXMj=&*9+VA9Kv%7dJqQ4 zIsow_-Lq0qP5g6X^nZen&F&rBAM>Q}Nr2Id9C)b$>AOv)YWpiI`i72#>M%nW&gzjtHSwR>qyG(ckdVt!*W}Qw%)RKH0U(J1@K}d< zWFd>Sz~^j;=4{@dE#B}DfHMj(R?j1C2$IiPgIZl;krP$sJ2DlipA2A+1-cNRZlAFP z&@`)o1R{W35NT=)y<>13dApwXVlH z3hKx-*0LOEq7Ir4hz+PvMS#$SOXqv^{{Nvx`V*T!ea~{xQvk@E)^UA6DW#nOxOS=_ zTV52!5F-epvQg%_H6~LrHlr8R>Beui$Gi^+T1>S97h?d$fxo*hWDBrs$hbA-1gT=- zIsb?~yYTrXOTBL+7w8?JIRTV{A~$ydb3;_n2PJzOxWVzvCH2J*o!?hK1)!5uWbOmE zp1tdTf1~97c|`NyB&gpGPpWSSHXV3Pn3-~##%oY=Ub`{Xy$XRvnggE!^l4W?9w6TS z*b7SourdLv-$J^*9LJ`g+PsC5YrH}N7y!UwM~7??0?Iq1E-BnypVsLCG1bF-D$+)7 zt1JK$yGZp#Q+Ns)uukeFbBf+!a!17xB=nvMk(IO8oQ=PehG4vfc?LSW#k>xnNy!IP zZ2O7haa49j3jGJBit7xWzT`(V#r+(`w`~31NDCY=-kIo9&6x*A?7Z``+<`8cm|E*91ws1YZwnWel?% zR46?BM}qH#N@+)=6=&;V9s!#g}g=`J{5y=Zc84&$?H$=C%b67g9dV z=gEneO}(=s2y!RbmTWyH00AL^BhTI1lb;ywHF`qjw0tTCx4>`HK$OTb5YMk$d zbbHDy1K9}61MhN9`1p*B5?uSi;8O@yjq2=Xhw#aR|iqb>ZYKN+Qm2N=tazPZWnEHhTALmS-{t z>DlYDCohwR*bNTSm?se&F>qUpPQKF3YFE+WxR$trDdB>`cSiAtt#AFi*k-htep82A zm#DH4dl!(bLgQ)VIW30dy+_e`Dk2C`9}oKS`4=01Y~M#}M4j0i1@-_?lW~HC-2L&M zs0s~L=6wji`YS;!P$PjJ833#YJ@5k5=WHM|laTgsxN$XP6pUl+Zan{gZq$F11Ym?mp4&J1q;=1Hn9sDFx^+pLEeVQZ;V1#jW`& zPpr6xP>|_%peBClTw9Sd?Ta&0*wSsa*EKO~x zohxV}zhkIO)URz1O$t0ED)YbR9B5uq*(!4}d+oyfoV(|7q24ej!hM*vnv-)<*f0B2 zSJ@MMgGin#v;BD2um}>Tlm2L5SWe88vpb)2t@-%5qG_e=Z>rvGZKr&oD!|$Rlu``z z!XZ?&E{%<7Kq43#0OWHztjDj=8oWTa6@zh(3nVP_=&6^}1{jlj*;#)B2yuN_1U`FB zv&`dai-{}|1FUM5hH&zLb_w-;FF09+%_Fbg%BnP!R^vIfbl3cA%;lJAPFO2q1DvWqX3B_|#+buBq?n!Ky-ml0VKj*(^ za-um`Ol*Q^JVRXeCzAXG5UXg)aq8*}-DKCDYQ79gk7YEnrIl<0{pog0C9ub8%2X_N z_*HVhQ*mE25ztm<8PSGEIlZ!dvr=tNMNIZ4D>&ThnF3!K?_5A)ngt2`lHBE?n->6V zN|%S#oj&qqS2r4-->nYeXvyY4fWd=o{D9EsYE0b5P1ml^5w{2P<~ zDO=++a)!mU@7cEk=PC+aYa@CDc2T{1mO8K>*PS|!i1cbyh^%NuZ<Y!4 zVtz$zbm8ZA9BjzjE}v*AODCt(W|dyRc7&Z^u9N9uPQ#=L+;up?(b<)0gJ&?~C{88b zx#(nlO`erQ_hP#H5c`d;{B(5sE@@%vy2|Y@Y^BVdt_c?LwiCxc0VNNNIPUZdBU0Rq z7^2m8i6$={^xwcmg5qj?9>&R6Y_HJI6hx`x5Dd91=&hQ?q&YvctYE8&GOZtXMGe`s z!a$0NTk=)$%UMZ8s2eosCuKjw9k!qSxZ>zek0LJV@U@HcOa?CVxvlP8!4qS*FSu!b z$~&(`MRIM<=QQ`}jJi>*BPUJvqBVB{y*f@;MC6llZn8qjaI0|YXG1k*^6RDi`nm4( zS{`vZtz$|AV=#XB?RO8UzO1^xHmSC?!+%|xw>j3?6!Io6Y?!T+toRf= z%T}wsX+dW4^c)7`>^sXlWy_Y*oSI|0rgw-tE)z=%U3j7m4VREhOzMisrB}4DyhiKM zl#Lv9C6uq`&0jc~n9}N7euW^N6-ID;-a4bvxL2Ub{<*kK?xCS1a~oF! zyo#ODA$`HXy84v*SqH;)QAGwT6~=8CT)m%_BD%FqtZe>9`2T3gWW}Vx+Ix-I#n2RJ zqPzElvJ@y7E&u?S3IWKF9A}U~4|-=EH}KR_1<7e0;s<~_f79`#kP62bT!DrN2@FR; zxB4bG`paEKA_e_AP^Y6+{7UEiTd@EN>$^~*JVn`nOVqq)Oj*VD>5n__*P)ofl;+w8 zGS@c+_+rXy)C5GL`dx8Q^JP>kYB@j7@XjfS7}SLaN|Wv#7&*1CO}=F!h(Zm1Lgex~ zTO>mNw*6v+K2aMrQ5$0bbqN)pl$KT3*`(?6vV=Mhu;aPOAC z@{LpKRvw8_Y;84P${F}`pZo2d7|(U zPw(+dnyj}M+R#p`%_-rx|5(~cuPf}oA5(iyQ9>A_w5IAtzzhjajcI0U>I)WIq!KXC zd|W}z)UC17+<>7xRaIh|Wtv3LPno(OIk`JkRC={-8fQgH+^2W8G7ZKt<7P+9?+PPK zR&m0+l*-7+sL!_w@M)(D!S{YxjiE@n0jDJ!{)2<(?ydyv=JAJT)Mt>q*kL7UXi0Zw zL)GhQZj`gbTKt7NttTXuqT4&G3g$45mV#OjZ+_mKs@g?&(S=zXM5y`b+L^+BDCYWV zsH~)2Z8VMVNXa-1j|tw+7A7BUZ+R8^s&93P(O=1J{J6tb6G|Jsbpo#b{K5F^*E3P( z#)ZQk4pKCqtlWW?Vc#eAOVxLL6!r1P!%7m2@_OdXUkpnLr*S;z8e>WxMr3_ly_nh4 zN_>v*8``1wq+VEHd5-RT1>1&6PjcyjY0I4J`9m6z0s4pD^y@A3x)xY5h-}QBH~2V| z-O8qY5}7Bn19zh9Q=i(fD0?N$>JQ`KyZhZvW5>OHK$F5Rz~odi{KXrc;&PMDO!Gcg zja-|E!Z~v`M`H?`t+=%)wR^PQM0moab!==iv)81}OA=b5smx5-mRc4cv;Ez%6f&;u z?o29nvBy}97o%6zClKI(%@=v5gNB6;H@@f$Z%u)XETKhjG?$8xI*DJ3CBB#+=K)ozO5aMe%0GSCbhX#y8E60In zkVe2j;3Jsrs(Z)+55g|YL&wRq22+**WM+;}gi{0kJJ#N>xai*sUQu{|Z9#zRNgCnGxffXW2{Dd{R;Kol!eg(>_TZ5n_8JL$TF!e$L?{EB{VXST*?_ydhx4 z_4-IOBc?zZPnRc>@>0NOPi%&5N(&38x4)tWFQLg;7{bfOuwzkeaS`SMtc70Z- zAJ*W#jn)(S{LL_((OZUM9iC*ER2K8ylfeAqN;PEZna9SCQGbUeo(3j>lUIM+`{AD6#oO{U!s~t#ud6ZaBQj$7(!VVPU zHEmw!S~48}NPl{n*SZprMKz~AaHN%IM+o~QaNq9X;bzKRp0`; z&N`-UM~RFr%MqKjLXT5P+w4_ZACJU)+AAWeIZl$=MnYr@7Gxg%;7in2U>EA-$?0|I z(SlPf?T-xdCQ0&cW&Bk>pi#JfUKrzmtKeOP7dW#9MtFde;{g%C(+K%|bpYn)A@&-# zn!F%0c_u-c4i@u}S^oQ|yPqM~`^Z6FXijbmM3?FS*He2;tBb{(gsICbT}*$^wN{*g z@rj#!!M~N5N4own8d%?HMkPw{X`Loyft*QLEyf`r&%u-@#&5G;#cajaaaWwlo8L5H zth5YYY3Adh0`9tNyKnauB~qN5fJ>HZ&0G;}?Rjlc1y0-b{o~MiW5II2S~J@xi;pkD zqNX?*gcOr$D}+0@XUvZ&on9L1v&Ce^?)HbpCJQZ?*7mD5!g6-q%=ByO4yFg#g!g!p z2wlyfbvpuhZ5$)OOpwN;xF*~ntmZ9r=d`H&-Fi~c@*BRLB^GBMJTvyMBSD0Wg->hP zjLa#E7L_!va!oX%wDWa^NsHEElXg#gDMM)XrjJB@LtILOwU=1tjCyQ{-ZE&b(3sU+ zw}*?q-Bic%kInvyFIxxWXUat|(V{UcTEXM04G%w`F=3_c5!S6X>Hsd;jaQJ>0=`7o zx6Lc(anY6CU5Xo-?ZX~rJe0~rwV3E3_EVkD`cr3IBGY|?-Dl&>{6}1O`QB}PDR%g{ zXWY?%Uhu&0%NA73T;3_$KNs_n<7__``cU$!O*sElZY>3>ax&S4dG5lcCuO10ljPcK z39Yz&>dpujHR*T>&Pa*zw+xi>*~BAZ8g2&e2KGM+SkIMSi*ovci?0e*o;>h1DJ;0A zPs3bTH(IO=-LLYr$MhH9;O$${Q?ALWaW;huWUkCCK zDt+Cp2_(|!_shw0;?0)-DggKAO85yh_r9*%!lE6*WC~c}_Ol7HkZT;s)yjldpty<_ z)OFg|kkd2!av_9SD>b`WgNYP-6*{d1vRnDiIE#{3xvu-~(QGc!BZ{7Pz{ESxES@=P zGZULV{N$+M>b&|R%C)^C!7S_Rlv3@W;p@wUzlsr<$s`SerT|D5BakVF_gtehUX~UB z&zuQ38w^GzP-}E>hvo$Fq6H5M!$0!w&7yMd2%@R&AU)EZa%Uwf1~Z{sJ7Ah|_6wN) zRwcTFqw@_6*B}17H3Y*ZTGIQ%$;)4jX(LLUd-#c&EBi7OYrZlj^NQ(Tk=}+~loC9rEf(o;X*-1$$<-h`hMd@Hu*WPN$Mg0NCghezV_5As0OI*E3@jPnotwdiD#{1bxqSp+TPDmIXZ(6;AK9PnQ(#2nRQk$01G_ zz0U+3lgi4}yY)5RdqH;RkfchVwr(ivELGy|+fy-hR+oicw+oc4lB*#+;FPY{RD+kH zS<~EC9Sd_Wn9C2(GH1}9^*lBt;#20lCm>A5PKU^&t!DXP8@?+ZElkE;c}BrRtDbe0 ze7j7;U22Rps2#DkXs%Si2%nOdk)1IL?_M~m)}#88WCL61-Z=X}p~QgwUI>@kiUV9@ zO7C)nB>iZkti2jmcoCN#k9V;Va9n4X>&B}itg&?ggHfbKAf8PphShu>PU9x8Jau~< za*wz`lPy>BmW+I>actt7jA&Ms0=h0~dl6hq+0;ju!8q&+=`2(ZxJBK09%t|Ojm7k( zL?$bpbH{4zc76met4b4fvk=RmCR1U3NSE<_eDV?_tY~zmvOe0;c>C>}HketGO3nO& z2o@jF1m%}^&=x{fO5F(~G-2z=u!7L&(6%-!RTo<=MuAN3yzhg@{B>)&WIlRhT+>sp zoELLu*S{;RRU=saDK^hSk%w8oT@1J)4|lJ=Q~m}|K;8@pScWHR5XA=CzBkW0q6=7n z!~iJwY+NC|OHs4*!3v$8}LLF3t*sfcq>_ai=vPQuaeWF@tJ1{dfjHDvbf(vd`2VS5?H*L z7b+S5jX!u5}qJ-_*r=?#UMl zno}o|Nys5#v#eMYsG4~qp4e{8&oGd2Y->H_h|_q&?KFKRlT}QG!6?;HUE4pVWc<dg_*t+rj4$O?_}gr|)w@b0X}&Gv8b;BW6)bvhh` zyz?kJE=;=;xSh$g*(>j{99ovTU%jjM$*Jd;eO}yvofEsPIiW2L;{@Ym3=HF-`A-yx ztVmK1kmI*dcY5e$t4WL=tNLw8&cw5|N40OApN!S(_u|T??x|5>6zC|(>=GvBMkT9q zhmMN`nW74u9&tbkmA`9zl8^k}vbLh{uf$rfzu?g`<97Q=GFl4`()r!Z@A^j!!;%NL zs&wu(EhwmytCh%u>xeaDiSF*@9QWlNO_P{51(&_cYntq_b=yAb%e1voQqtR<-*>ao zWb0mcr)bxIyfW@`o-Zvd6HFwLDc(6Df-Bu6ef%i0pD~N(EBFaU7Xw6N;I5m>sAK%- zC`H(6?25&gB8Bjmr0ysr9)594o#G8}j$WL!!`ERg*%(prb1iIa^-i@I;zn!S0bB`S z2JDq(aR1B+^L$gt@FzvP;D?bK4GeKBuQQ@)aX+f8sYwpJIOd2CE0gFI+pIQ*so4%c z)7i?4dPimasJ&h@8KZPPDI3=NN+kf6B!(z@E7O(kL_Z}rf?brmKyk~Y9)H+o`7ka% zuX^mDP^0Gbu<#v1&74(9gRanOK0B@NyNq}DFd0$0$}DXED4F@BCFM1uGScV`HC>mp zi`%CvQ;F$piG0Phj7ts6#hFTQS(M3gfiI_)`0R+n+y(7$4XO5>fkSe-uu}>~#des! z_gWUMTi=9-o;$n)Ahp0j^o5zO7>ZJL(d$KSZ%(`nvN%8(o6wH0I1PkGCk(}K%UW?9 zo^ig~bH^+UZS8dxYY5@3S>=50(OrxEZ0v42gEAXab791mV!~)&j)IM=$Fu{3R=#y^ zyn+;BrmmhuGaV;a>don})uU^CnngEE`^p4nA&zdCBupU>=gm1BKFYPR*^gaNE*rh9 z=`OZttK^C2(%)rY)3hgJ&kP5Q{kqnPWHz&&k%{1alDV(;TjcTrPrub>}|UHsuD5< zZo*>nnKHa9+?~SIlT)wsm)h~P9EGAWaQse0-pt!&Ip+%X#?&_4BD7T6lF47J!J|7= zzbaj{m$J-fF-aPYO(w4=I_AwnlOG@6$(mDtj`C`Ywn>&{fRVCwt;+2*NvAkK_MT`@ zp?5HE#tO0XWI~~&lWER&&3aiKIYN^=U#tZdf+@><`#PL&d^-5SNbj4s0_5!b*-of* zD<4;2PPK7PW8x09G+`<=rIN09Ts;M^v01q*k)k-o?M&y*MuUvWm?#pAc}(+)h`G1r zw>|~JJM5X+`c8E5l$x5ez909enYz%(=1SycomZ&WRa_WH(X-}LLTi;pqg8sI*>NNZ zC{oe&-};zMq!^(WZ+S1UEHdg_Ro=;*er>4IL4XPxLA=u-=aDd7-wC}kIUmE5qS;BR zC~mW&<^%S)YS&9y@png201~g}YZTVzF}78UXKX5QLiw2T%?57_r4)-yN3=c!3&i(j z6reQK)cZ^v9(}!Lh^iHbe{zjabE=P0pbktx_!Axs&&;uY-PEMqr|&(87&%IO*fO7W z3UhYjE8*{xPsB?`?u!gWWInr+;*ObXfiF-`?elzw69R2=xOMdl?k^~=0)}2^h>1XI4!F_o11N4YZCP%>)T3B-%|&9{lyGIc9M~Tk~`MagyYnW2r-0k8kRqWMW6N8uf;nUgX@rH zyN#{RAJ<{zVhZ3pAZkEYZsAxz?478?CV88OMT~rxwQ7%pv6-`((v#j35nNlVQBg*` z{nZEfV~v5`3tGk@xv@*Es$E02xdD0d_~tVP11j!U4FLq`|uPP zX1$Nfa_ZG4$vNiJhN%_B=52aVGjk-ikB)458QkI=(?)fRBjzZ2O8;`W?a4SSWYpH- zNq^Yf44w*dD9UCiVUdyfWimTnT}$pY6FfRi;N)P_<3hh+W<1GpKf5<~rMjkfLq<92 zX%-=lv_t2puSf%$g^MN=5J(J~4l__iSR-B8v$J1@@mM9N~vgP*Z7x15BhdQd9< zK{=lz#V6-jp?JPmQ;BbA>k1W2IZqYgmI6j$y?ssu`4V-A+Ap}|z5R3PrS&Z>Ss|)* z*LI*GYq-5%J<8npLr6%(I=qsev!=k<7?Y8k{_0TyMOMU@NuJ2TAK%)x!b?N_^m69D zZMiENSGN3 zQx?XQQ#n6>zShYxMv^7qa_Y7NO|c-iBW$D8B#RVyFRXgRnITj;WsMW=fgc;hI@#K@ z(KOdn&SFmvx2;t)d#)a>KXn<|Jin5g1V$T5at9u{B~~#o?pjKIyxL_a^p6KT`K_%^ zT0Q&j`<5Y5LoFLL;lp9wnWnndPBzXlMPD^*X`AordsYUFNxx<-q%vPGRF7J)bz{dQz`&8k@lVIUt(g1b z<(*H{>G&m7UFL=6V{GqMqH}cziEK;|xZe`XKOQ>aTl5tKTEFO>t~S@vTGZ=rIf>7a zCLGn|LFDO1p*@YS?pTC5Oy_|YqYni4BjkbshIh5A$BVc$r^ZC+U>{U@^lYaWE9OGzs@y^pLw)Bt(_KF zHa+ZqCBEUt_d}*S2f<&kq%pNC;nZp?ly1^Xs3plQ%)S*eISgYyBkOM)Ay@;7HKq4>aJ00%Y4dZ(_)qQ$>97;wq*Ep>Cj^X7N%(?#{Fp#;f@pL(xItaT zkyD^PqZ&>@c=z;5Tb(WI%?uXFx1+aX_)O9aG$a*oH20R<%A?I4#qBG<^hY-(NG!&T zvGLR~_r|sdkE95Mo z=MXE;UHNv+uhUefvjem>X{XINZaS5@l7$;!S%UcRjGTxJ&kV`dIfpDG+db#R-I>&9 zWNWnk$}m3o>0qa#l$!4G)`P+A8sUA#(&=n8*;_v8rFgl*BH*WYqGnHLrd-we>_|!S z&9ZXG*t$-7$ZlJk&JV-5snpKiU#v1$Tr$0nF+6`ejH7@N*fL!761F^&seIcy!6lQJ zCT`ngCF^UNmCPK~r)s)Fn%IfwUpzcj`^0vTp@fbm-VZy0+IVCMZ+J(V?QA&1 zCI@c8Q&aEXmq_T%O9#Fmd%>9BOPrZHsgPta?l?n6Lt~Ta5BBujsl>ZcA%sUrZxTS`G>GA+iwjknr-SW0#8-^T!8!IlQi z{IJX@E_3nu3Rj_WyI1JD(qz>;M}`8$(B6p4R(){O$h%tYuKxhs=%B@IoCJYCwaKU` z%rXxeWiDXR9jX3g_GDI-9vZx7_H`cI6AtW01kO7XibJ$LlW9@_5!J zFsFUDVfAU(eqI;o0S0Ek=AAG-(_1f&-X(8-;8Iy(?;S5CC3SYG9^TsHYad&NsG`~ zS=2nDavvDP{6xb1Wrg?^wZr@7ffn0(-nJJn>aR3Fgw1PpxPYQyp1at@cM;eGAF%|V4^r-S!e z@>*CGE$Zvs!t>_Wd3dRLBnj-;ue9w*Po(da>b>LE-Hjxra6TsGEkUbfceIMrJ=CC} zrwq&iC-@W+&B|QU(U}yJ^8?dD$Y0}jEw#4JE3nmM9-v9thpDM28BO%QT09v4gc#AD z(5IQ!_xLv9M8ZZDdCElo%uavUWB1gx*N8t{V~nrz=#{9Q-LdA&%~g`_p;{&kT!MWr z)r&lWq4ABTLTQdO59DykqVO(rn?w5_VW$LGOG-*++0h0aw(qDK8=j{h=RJh;Mq<_|I!tg=BoDvmtHjoXU@J5FvDIIlz8~CezgXI7 z*JaaH_Dy`q-e59QE93uQ>$~Hc*tWJKD5xliNN-2!U8Gl0Dbf#+(2Ig}Lhk`Y>0Rj^ zDIt*1d+$Yh3897F3B7myg6H1*-uL^x`;VE)WY3z}E7`Nx-s@SIcBHn; z?*rF!#}1Qzy7FWRk}ZU=L<mi+0lZjy?rStSG+AuIu`*+)d1pLh=PE_qzIn>!Upj)+Xa9 z_<5xyUGlY>(b%=85e?Dj#D;602T5a>kcFrp#d6NNMQ(;sEF`I8pugrtKIYHyPZ-BI zCRkaX(D9%&KTlE2+&``G;#1}mPwOr|;rqTNtS_ni8$bY3Ypy#<@s?A78CE+b1U9^K z{-rHWXON|B6(7&DZ%uAqIqFv_EZHM3^17RN!&`2}7!ITI?#vQ*04fe$B8KeQ!dcI> znnNuUSGkl4~&eQ*iGmVdtBbJqC)gmxQ%2 z=hTgBv7zb=>!rkI#;zXkod?;CDIs=FeJk*p(mtZ%3suFus zim{Fq#5_nE&)1_=d>~_NuA7~&4ocO??@dhsAErzXF%4)@B*yS#!Z5*+iaMJYG@>Q@ zODwkagM~+2$y22n(ezCMk{s3$ex1SOO<6WESX9Sbo+AF7O_tWYTnps~(j)O%X(L$I zn&CaDb-2D2eBMrgmuO(xe8ww*vxVR#;h_}4OPpEnB>@#7O6xYFFkFqfD{U-1|4+gF zLEt|t!uFg*J_wFz6_|VQ+S=t#4ayhq&bY707(n|0&!b|N^6a7xEbbdMsIgXrmkLdN zNb>}cAshX-V}ipg(v$SrG*evMf5dSUwpN_okJeS!l1|Dkc)2L`&uOeJF-CtUCq8t2 zfM=q|Xp${m1m$%zKu09QqlM8p0G>Bd&CQ6?i1l?zQYU4%Ss3d1hn07k0b>*N*+%n) zE}}zb>%O-q^(*UTc^ya)CZJ@QO0tA5nG^a*rk}6;z0eQvWN3xF&Cb>Jj;kA4{aDt? z>1{Y6JI4j#2=lh&ccIHKPw(zS(Ns<|bb^GA#Dp|144b1=Fm|751@z+SKOWQse<(RQ zAmyS^_lGf`F+D@ujf+brE~*A>ABodHwQ{>xcW2*Dr}7$^OQi)8%U_!cuhZ-fPT>~} zg8BJLyEStD2IQCrguRx0|MB!BLpLp|m3#Ii(&eFv#_^7l#jF80(wnl6tw=pxFitmQ z_dwfi8RPR2f8J!tvY>zU@I;kUTCW=@2R(6CF`A;NKsNodx<&BJWJ~TqhD-Dd3lE44 z>rAYIU9Ci;@c3`f@XU_bgyDyt|Ay zH}B%Kly=~!?)TiS&0oPth+X1h`dkmoF+NPdw3MZmo{Bh&At>>7LTh^Vav#3|K-71V z_TxOl*tACfyNTC;Z(%4@yp!?T)P{>=V8l2F@A#uU*)#}y{n>BKA;T;O2X_h@O#>{86yqeWK;MviuX*mW; zDz;pgC6EUe_qBv(HZf8STeP^|UUy)JOXTRz38x%l!HwCv>ho3I28j*220?Zqiy4mw zEE*Cx+BaNr>LVF=6{`4R%3}h<6J9+2H75_gveAVwRX3loWP9E?MToIYEhfTQ;zmSa zL;IHDtZ2>oXSeQ?%)aC+-mPELE;}Cj$_+$$zwRaran?&8DJ>O%Iftlw{0j%6fni@i zC-i2CJHfZRiKtlD_QDhzMv`-<@Wma5torsfyTGOrxXDp?vvdiHOYYA7 zrBXpJ%t>4(S<}?xX18q#)qGm|*4zS})e5<<%z5bszX7;?mwAKxh;T{p^?}l^yGfVo z^3@x$qihOIg8WcUI)T~V0yeogR!#8i0ONGV zRD6%8MA=5#-y0OY-G=R_4W-Mu={iYh?!6!UW6OF3BxvjErgQ~x8Qre<#k`T!%x+%`F(0UwJGCRL%M4$4xR8f)Pu{^RIgyIR#{4 zksTV@y$aXCLLP&&;)yWsWi;PZUhhX#h!|TiYB_j!&wWmjM;=(G?+KAB$jBaI)eJb&Rp? zVXCZ>`_jV`=sAf@PHq|P-xCKhZW?p+e7w-3Y9GDEm)FZYG)^%9C)3M(T4(Z8q1g#e zIk)56bf=5yzv6l7AcP(urp|Uc`Z=CAEnn^SDM9DtT%XeGXYT%$*uoy-b3jw@2mA9- zOEZeGQum2dJ4!V}el!L~EsL(z&#j(4$4ef%5~6}D{a%ONvxR>4ke86~FowSHyYk0>#9P|zYL92MT z=adzLKmQ*8pW%(z!7oPs`FrgNAMR)aK}I%%xrtFn9I4w|sYi4WaixfI$_$`}|9-6s zbtPf6wQ%+`^}YS_w$Q6w<5{y=bbTA$3^XC1W#_FPG>c368v)M(vpTFZ-HDgNWQ&TcQ2mfcqC6o~hzp zG?czX@Fu*v=J-g9Tn5RGk(DK4UE1EH%K`N1hyigY5GJXtZ^&@ZFUqRekT|b?({U&uv+M>! zm26%w`95I=NpWM2m%s02;WJp3L3-+o-vSmaz-*Fvi+~;bc?;2n<0R%ajW_O}+l%FCJEhQ~;NP-p~RTC_|nEMT&4RO_6ysvPr zrL*p>ZMGxBFIS(`JhpE-=Na2O|MXwp&XfCxl3EC``7uJkgIPJn?4dX;pv{;g@1)Lo zRSXg&_*k61a5e}}!s~whf{a3Rp~#@^VT_|)Wqp-pV%W4e=aweA*?8YMd$}?u%Rw)m zUH!T$PTm{0=;WPX?~*&)`Efm-U+z@0Bw`78W$Vr`BZaGX#%seieUY+gQ2a1iF*4o% zlR!%AA|}rSuJJi9{H@iPhLNd%^~r#Xj1kH+VYt-q{Ch~>j)`G0SZO;$7M5@#4~3Bx zl?RncRJ$H1t5pf;)r!t-qUikEwRD+cK79`bS&XQ6C@zmOa+Cgh9)46sC$O;P4aZ2<><<64x7G=m4H$7Le+bJfFO$L%6N~B2< z-xlhD+}FiAy=^4Pga}eLbMw4)#e+;H=xMLHQVq+?JIPXjB{T@T=A?XVdhz-KNP-4c zS%uwB^WDOw8?|l%0idI6^V7J`UkB_+3TCN|BIvlq>h>#*hDAJccgo`CZR|hag|?2Z zs);1O5L6|?{_wBd#n5w}`&gPjt7ZkpOHDkJ?oIr%wr!x+rhXtIW?7W!EMF)rSpAg|_Gn7|+hq z)#8N{pB3}Ggx%M!xGBy9VvG8-*Z5oy0@EzlRQ-z;yFQjgYHz=trza0854DCWWPi2J zJ>3+Y0O|~xd{E9sYQnvQqTZEkh-Z}XX0d!S{0-0p)tWf%yqYT6w+NGHI!jnj9!D}E zZb$}?wz|7MzC3jHP#ms1vPxr|P;iQ_!_*$XqBJr!Mg|RL@Jsja&RkPo50%=lHI5(k z-{OdkLOOt5nh3*2IrTyv1*g=s87PZ~;H4h8TvmqWeubkrj`gC_ye+K2>ye{OlI2mi zf>5NvmkyBnh6cilqp{2JBxzK%sNepjaikX(2#4Bmql1>XYd3J)!c`1n?=^NQ z&P3wOtZ<09vQ+@oDh%^ais~yBF?c`HIh;ln4O4)JFD+e=ex&*qmm!^nH1JmoA>H1+ z$VIMy0nt2@fU(;O`qoV2tWh@&lQaJFF8|k-#;+O=umAuE`U6_PFW%BI)iX`ACt#@= zz8+3#91G2sAngZ6ms%9IEZ-6dJftQ&+5KLDirW&6s5-TM7kppF7c1wXfkd!W#b3H7 zdt2D3Y9u4muwRO$9fb%dtz7M6#*0u`S7u7OF=EVDUz`?n3cNG)3Uoe(v)msiDR77A z74Uov;1Lb$@~vVALBhf&)>$jSss_D>#dE2J?!F%))e`9M-$`g333?{2K~0ChKZEp4S6b?irU+SzhxWY2DsJ(3kDr1+YPa(a;TyzU!uxEIkl7k=PqBTEh{O&m#&Z))m3k$j04HUhFQ zu|Rlvnr85g*eGPT?!Tk*7M>vLE>lpqHa68LyJ}=Z7#8l8&Jj@EKW2IJ>M|}yyI`up z+j)Evp28+qmmIbdi6r>mL*7$s+WJ^!r zT`Blo_d@=fyS^+Ld{v`Z#d)o6nSW`bpfA^*kEB*WgS6w!2>*EgUHRj?LwqzbyxHt7 zC2{8WT*{zg&E)DlP!+*w??%XD>ga(k2q7=q>Sp4ut@-wxp<~WQ*@@5G6u=cczIY)v9g)h(boNn_{vLW<#h>A*6% zhhLkMz7YWzz5Ao4%JT40K3Gt-XaHBJOFdOHGrg@Fy2spVn2KX+G66BIvD4rnxEg|{ zi7bUxB$VV;N=_GBFD2VmF$=14tQ+~AMszE>_+`86ZuX`+@Q|uwu8a9(LED$eSat7+ zbSUh=9G^@7umcM=)Syd9-q5G$?#>n3FJ8*c$6A)<5LKM=8KZr{vc1JRzxwzyGnUV$a=4A z#=QTR^^|s{F%}s7LW0P3ir~x@=loI7m%8aS4Bk0))9Li zIdw$h)5rK7U?21EqY@uBH3grp$}H2~-E$tNB5u#k&|2V|uOOt?=^Y`d^Ev@ZCIncf z+I=!(N3=j*ld?Fr*ha~cuPV}j)+V1 z*TnMZ4LMMhNKuRG)?SKYE~H|2PiX8T)*3;%Vbo(3;cVP~E0&xq>%3MS>3SY7UNE?> zkB-!;8ZRP)XcCV42QTJs*wqz!j;|V72Ev-sXQjuW4@VqQf!T~mRVP&wWtY3EthY;& z<3wL18Ay|~IxXU@-$p*INF663%WaUEy?B{V$_><#V`Gksah&tiltU2S<5l6}19o#N z$#D+;%%yWm!)Tfnkv*GciJn*qMuU9Fw|xjjzjR}Ks=yHg4vAi}9Mmcitn3e!HT?CV zOuf-stCFg6Q)>IirzsIk&pLT|TNlA8I}2wFPCFYCL?RF1X0H2QGu+#Io~7CtKI+-r zq!o8Wdk}v*wahDLM@3T%UoW1XOFI0@*j5i{J;$ zsiKyVdKbAteaJ~;;a7(i>7>`HxlMPe*f{Iujv9Uy3Q?MA2mcLat{!d6H|Q=MbW}ml zK#2arGz(2QFc3;~s5ad$R~SNHA%kQ7U?QYKO-tg1+ zS5oTSmFDxuQo{$--{4rDuUo1;EF8yvpe(Oz z$%C*b_PMI)Xuj)w9q~i{$#&mcNo;yW{kZj>mv?c%_XiOYRb_L3B?Ta?!aguTT)R|e z!wD+x;(fsN#d5)M0<>|F=?_F!91A5f15z(|`|WE|MeEC)LP1&0Kc)?eD>fxGO)uAs z0{Rm(xPZt_*I&83HI%`yw9f*hikQl{Au1)S?!8Tg_rCO}filM$$D!?v<(*4G;`hgdg-|^CzaCwt#uptXt<^&5 zRKQ8H+-eX*x*$>hddB&z3@gQLSg?x>v@tEj${R{8&PVKBN>WAFH})&^l!=DDu~E-U z11Q^*IK`t3D!iTI#Qcq&;y_ujE+;g2SDseR7G^Vf4leQ*_v}VKS{LX#t>3A1RNP+Jw4U>TkIaV#k}DGVHuL>pWSVW&)U1W>;8!Or9h=JCT@)Mc?~#1P%L z4YH7BQ%U_*-%OR9^b25C0}#FA=w}{msno391yA3(E+yH7aEEno)c}Wr27uj}mlduV zTqhnzBn^!GpBJ38r`6ub4i^V&*EBT?ycNj#4d9M3=x%fo3v2HknF%>Rk;`1XbR#HS zvx>sUI$J%a7(fknUq~S588zpxt;&ij`HLU;r3szV`Z;u%tRWo^9Nd6=6Y2_m<*~nd zT^c2FV9x{G(OQ-J9i0~}kUa}9{dT{~qwR<$VXV`m_O$2;a5P+9o-taXhpCp)oo@yV zwy8?q48)Z>)OU4D0Yax;yBS|I zI|-@ih7=Wk2Va*H*SQrr+Dr#}__mr+SRUprZ6J$P4D9ns`EShZCzM76(~4|3-*-el zv-#W7u(-lbg;XGYWzx$DTJ{t{BuCmb5?v9!t#m`_wact|6a*@s!9odC&er=^^7^mb z8|%xdtCei!MkI7Bs{DG!ewK*~66VB&A?_O@R6U(y9IJK`cmy&!`>#BUmx9k<5a2Qd zd?^a9ysA`f=WA@7^C91jGjvG#SjI`l!`lS}?w{*|I6x`06dGZ%83jQ>K?2I(Lqb}D z+S9D8@hJ;t8Ty@OG-6G3^}{9D6n?P~k&XRTM;bo?j#O@ndArd_OUcQaEAG@}Co$zN z`B_AyUmorOwq47^PPebjzk)oq!5>zMQ$d*FE{!nAg-ST|EWUo|J4%K`#Hv1(K1y-Z zg->fqS?tO#L}SZJ{I&J8hxX3vk?ve7k+hX>$^HkEx)mSUoPew3J+^2t#Hi%PL&>My zKwvlH`+2!Ltxss)yj>tmZS7Hl?DZ4=3BFEjw!4>8X0!@O1p9EYq|9l}+ZZ?387S-N zGon_ad7CY3kvgwZ{MJ9^%_mbvrl=VIy zibWwHTO2t~co!cR-@x_FA}pDO-rLuRsB-kLZ7CFxL}weyyLXE5yz7lyNtxUoKOQo{ z7|E+e1WZb3f=|hLK-yXjpt+m7R;uwiz;fCUi-m9t5F4w z@&o7WQ>&P0)tF~>kT~@F9i8nP5q9RfQ@M=alWwHv}X2n+aVuQ14s^WYa!o-b2@0oDq9oL;w z_j5K#LyT3v8tzix00$~uU%)^LW)RU%;`OsA)NRqS&SS^W4$eG|Z)A_l)DIHa*VZPP$# zoOd&LO70<+m_SKy=FD)am(PpN<7>N_@FQt#9Gen@dYty_cfx&6M)EtVCet3jm}wSK zmSIZZAfNWma0PcYp@?4srR{_|4w5YmQGhy&8o$Q$cl(_q`kJ4!5;=XS!VomYq|4T< zh?>!Sx_5DPv9&@NJvU}ILnt3`(Zt?-){B?axlR>C=~?=6Dep{@P$!pOf}cQ3_{P|r zLO+A!$Es+VN}-{meYWa0iusH&p=djP92E3GzEN29D zhQ+a*tbHpc@DdnYNZtLX_a|@m$4J6vQys$e#5HcK|&T=q~gVz zd3|Hby*wP_KMK+n!&@ zB&+(=a}91)4K8w((f>};IOdr-a3d;0rQ;VQ__MFOjvyJ_w|BJ#uk@+Qum|Uxr!P>N9#oWYPE~*0T z@^9d*QZZ?Q#TpgV;wE^sLo;6`+9%@U`dt{ySZem&;zpSD6nexnauiV-!e@aQ) z-=G+@wcT6Bp_iusA{?9*@1VYdd)<>>buC4hUITE#Yz2s&>Gw#I7Lutm*)bk$##`c$ zhyI9vpNZmD!ks=Q=l5i@$9VT=8*r;iT02f{wl-#@bXJdJ8>wfipHC*>*53J#y+x2l zI|$!cvrI6nkl?!)oNdS^W`K;2tKYFbIy5^xNX&w>n5q$>u(2WnGHSba>mlAvKlx^u zV@zvkkhqeD)ReNMoATSXd#9wE;*b!ch@O#)`+8llsaxmz7;QKQB4ca=SaX&+Hrz9MMBg4)y8R&gTnx?aFW^N zrK>X>m6MOmX58zADU0YD**dyzlpa;UfbO;D3)1$Mt6`mbFgrXU$-r<7gosU?V;>d` z=HH7*Wt%&$7RnkIO~tt8P5eB>59q39$V`^tqVC&*Capig#vHl!MiOtQW@zMB5tPTG zlI5H*<}xa_O|*vN5lxgKRXq`dX(+mwQwi~h-j#+SxgN$QpPK%*lPJ69Dt^8%nd(k# z+1p=6gOoWSjYXKE8b$*BAYMZT)dF;tRQXkxYxP8Qn0AJij&S)iPZ-8HaqdI~TAnJ( z9BDg5gAz;M5G82>yF0aYtBItiHZaFpoRVo5xY8vAcP=hWa6>7CSXGFx__NR|95ykU zs?lyuxy~p`y~QQv{4@u_^xcglw7Co>=-oupRScn+t#*T3X&*23^JNKweP`q>e<%C1 z!$-0>(U!mtvuDr%*gc3~91z9B=DM{II282U7k8Y)j` z*HWj~W*>WtunY5FxNJ?_qMY9s>!y>XVo=Eeq7II+E2H7YRaID+h@PILX|CyUu5qwe z^nT<-`FOm`qjGlmxLm@(c|xT}Zeg@bvTK#KP!080UDu{@kzOSyS)Enwy4ttWeZXDbF>?N@H z`A4cwPA98;hMk?^?^jODgjCMZsR<%&=I1obreEOj#Zut1W`y*q!c#4S8|%z%z9J@) z0CCDNmG$P2OI@7y+4^=DWSjFpmMWxcvut-48VCE+<2Q4af1IjKEC#J%k+08a&?m&>IovhKDtwmfC zzhmP@G?H|gKmA1o%Z8Wr5wPa5u4hzYYs$a@^LWH}67Opc<>k+9N0)Vo zCQe{F#F+X+xMJDGZtcAu~6sCj}Gx@&B zuQl=Fpp+ddJRash8v7~P0iuCj`EbtS0f#2rRqDmBB>5;)cJs6hx3NdX3A_!r%vUVT zgSt%*Dr_a8g&fqRHOh$0C<-?L#yC)wJxZ*a_l zMiCfXzU-Agaazk#s5JL%U*+%Km)vS?t+S%#5GGyuT}Qna8G;gp>GMDM`9HBX8ilbR z>6&ZiC#I<%M2JBfQ?#siELZ2N6!;Y6i@K7MIdUyi_zg%q)!db; z6`xHD^e*e|4|rLd1tJ{T<53v6s=1(lu1S3kb*6^Qs9ULd3x&tc7NsvQ zSV|E1<+z~85NRY>;N4`T+~mlm2{{uyslm3w&8=h4Q!pxUTtuT1Oq$IeZx||!gRQK|~K}*LdGXpMBbB)UB4SU5ywK8?-`b3wxVx%;Ae=Wj-ud zp-6t2z|k?`SMg)7(#x@Ff}DI*_WKC(TSqF}N@arsNt0Xg^NjFSVtuQ5IuYy)?^1To zZ_UP=t4P2B?ci?o&Du_%QZoN=-H24ch+gy65i=n-GM~f7@qCh{N%d>}q<0#5Rw;jg zD-6WD14juqUX^-h2zwbYLGwnAw1cxJ=cy`B)P_A;CkjeP5jJ2M(ueEjyavW zh3vr6hehV(+1fAJtkqR$K+hj5DyMiWns(*%%CClOzIuk>E8eYXCEu>;oSSy)9L!%D zovdyk@#F2UD_?SNlRE~-!3wSf>F3_WK>OdL|FO(~YtK@bk~i)P|6Tbp1jU1D~>C}M<$r*`wQ7^0*yk$oZnb*Fa#ok(8hubdmb zIZrp}J^q=dGUHk@y;?-AXuaQPZ;fO`sXQ$(R~K#=SF??L`1Dw7BTlpS+j8YGOJz}O zR)rw5PoZx9DnfH}B`GA$;paJ(hT=#x%v=9^k%&n=lA7t@O3AsH7ilv=ooZGSq(>T> z!R|Oqfzag*-M}uBaQlDX)e(n^C>Uc2Az#+5JM{$lQ zJ+|o+>Q--Ew8&l8tQa${Cq1jKWpbVCND(P1S*LR6?_Bes5uPj!qG8XS^I2XU@~8J- zW6{P`y~`eS*N=&_sx(;EqckgYIn{O3Qk&skVxm;rU z=fbFut|L?zg6{OPCFzvO&sEt2S*ZQGG`iW{;>pqk1lYr}1Vr@H6(OkwJHsA$Eb8tD zpe&^FP34k+yRfQOHoSl`Y^Z7$?Ilh-lIeA(xpP% zPB99QK8?h=jyYQO)KZ^&auJU(E}H>AFr$1I6P=Zlt?8fAkj5qvAyL>lB~&RqI}fvL zf^CkHw8KDkXi(9qe*LKR-psK_?P-ZrzXuBasIQ3JUJajz& z&7lUSA*Y^lvdlov5E-I1)?u}}y67y4=LAP%+F_XDg_UG+Ra#5#xV1}@@c7rF{p`!U zPc^Yo@OjA-?Wy6dj?~ zYG@5rtq0RpRet4fKnA9?fJw~cut#u?upoIwaCeq%$KDRA(>YsjFtbIamw(OmT%0xi zvHq6Q{3n}5X`7%=Bgu9o&*2j=mnEUYeKXg-$&1&4%mK@mED`M{B_OViYUd5&Ea6S>hnoXqM6CeixkpxynfL_>91W@XCy0TBh;XYfZ_r_74n< zn+th1&~m2~yEq{B}n8`>>(b;u9(-LYfi=Za9KFFrcF}7+##wzTrs%f9QC8(qN!Q&7yyZ!dmNfH(Lr` z?8gjDeHi0c4L0RU1{tC4NT_Do>PTRPHIDS@^hb_E50j2$R5}we z3AltjByDNq@U)o*@_{sAq!&_Kq>4d!0O7a=nxcSOsOP4vAir*?HIrjuP*Yn|j{+#E zgr9A%rd_Vri_K}I4Wd$tj;dpNXn)T9%#a*-=8}dDaS)Uib0cn3-=dEMcum^ems z*-Z2-MNu$&aYcl*ygY&R&*Ps~_?fOGk~(l)4>h;KJM8lJ2Dm2!z= z2-%F}vTNmdj{B=U8rCVo3PUl%^FC`;l7UTs*zKt7a!dP(;O9{1qFU z4KkZ)rRAm2*Mw}PS=Oj2-}SjZz_TwsqLDyw`Gre zO3%L zLU7N-;MxJ`bzwvzfda}FupZ2}_JAbG1D*P>UXJR6y}AWD$2yG>VuOY9BJ#&fQ_rdx zs~8KuZ`OJ>Qd)#sgh|^(c-5_g&l>iq=?Xgb5oj@UEx%8CjyX54uEzl%0D!3A_O3F^ zq64Y~k~gDPeIH_@SYda^_wgQL?E^=&*aO^3mtfI)iPlMCRLhU|w^jqWhqp7*52CsF zbZFi80f5K;sUguHtK|9rgs_(xXRXQDrOpsOkviF&*3={6u zeU|!$sTwBK^W4M$)Rn91wePLraJ{K+F=bo*Z&;4&D+f!MSsGGhaEVA|gDAi--ol$o zTgi)UokG`AR?;FS@HtZ{4^7c(`EoYPv@@0@p@>X;E)viMx!1| zNQ_#!u(s1HazXi#k$4GVY4z+X>dD@v(c7h`WwT1Ahri~8otn(@&Y6b-k}+YtQ9I^- zbPvs4FCkH)W)#Ua`5=UD4jh=`n7Yowrl1OOgy`*Z^``vL0@XDY|i!9CObSnP|CM zt^XXdxaQm~P_UbAI1^H`_2x{6kh2sM`tZ1UshkxaekSan4xs4fAF+{Su2$MVPZ|#U z9H~O8dtI{`cS1^1{&ZgLb9;OB$CHmhaMo{tmR%cbMNE5`g42BkN=aqEKHI`R1lv+> zy@`to+b@X+3>mn2+oCL0MOM4^?!0U8Uv6|lpty-0%Z2l$;=rId=WcDPcd+wfLGz13 z8?ekk_-uarL9au_i)LDd8y2UY75g&XlBGG3>$!hK(bm60O#RM&#aU}z#CcG@tq~+D56b=g}d%pPQ3pvIF8CPf^)4@ zkM+Ht*Iu?{J0DRrUI7?6O@)xVUsW_Z+HyN?hVhX#{kN%h|GQAPYp6{KpA^_C36yFXtQuB@HxJ85~>*X6M>_xa0xr>a*%_kPwAwka-RI}}$(kk_U z|JL(td2tg0+`RKL<()_bbuD7{VKx?FJoaxMhccT_MO};HR;!)h?WeJG<|$x33)adY zYtQKyd`vy@JDn{=g->Wy%T4Qw?#$%?u&EHNKj2m*uuXCQcuf1yhx-9{W^8&n=G}Yr z7yzutiAOsB7RPa7=FULVDK^_y%WZ4qJkov$?r`XRBRrcz3<`oL)|eGzlb>~fsz4;X zWzU5B-fC7BDN&K`bwg-^v<5HV@Gh}B5Cwo^*2v}=He*`TdKXnWFH$Xu+LB6{=B{K1 zeAN)qzxc4k|H>_0CtAkD{3h=K6jar`vxJPP><@+h#tXas85q<5WG1_Pf`5u2S79*g z!FiG1ip;iNt3uT--a>o5ln#o8-1#)~Zk_h@H;6$?g1eWJHKOoFN}l1be_!}#{~&#h zP0)$#!V&BeouipNSD=l31*of<4Sv5fU4Q9IST8w@Yc*v%n?pojn-2P| zoC3(b0W^OmZP+LNl6*odT+97MA@f}r9Kk<4aQ_Z=-hK1p+s@8$!4sP1b>F+_%GupJ z6V!<5HoQIpuQJJydS^Rg?!a$%u<7Eo%)~M~2uURvMC@_p0*`C#iRq}M{wU(#8{is6 zy6TUxB?k3BL0q?-!~onegy<_}Uc4A0LxH8_`Oz;dT~hz9f4g7SQs%wK%!AJ=#JVF@ zp~wCm6TR`tU$a0T8?If=iw~h|!TtQDMI6&=JHwHGW}E<8;_M}n(k1o) zp5NpDrA676635eB3iE@S1a&Y={fA7e#jj(Y()Th9u#D&>-;9_Lf>kcQY~Ve;037l} zR^hihcAQYr0cQZ2w-nyokLT5S0QA`1wZU(==2H0onRVW0Fd^L(WCOlhrOuzcqi9+@ z-1CiIcCf{Ft#f4f<<1Ve{KuWnx_)0PwjSuXwq;2Lij^^bpYeMRfEnU%b=~bO{H5(S zEf2tAe=dO#hoSw?p!9D|P!&o_Q`h+M-un6;3i8?i>wL=B!X*sjrR)7<#d#~7+f+~g zQ;70?wZ_|+(UI$oBpg6vR#EOfmo^+WDJaDD37bq4%F&i!r2@cua$;l;nAYq2cS8t+ zM-FHv4@lo8{GRx)9uF8PbrIpUI#q=zy-7|h+L>su`s+ib_q@+vj(vN<_mEL+Ir00C zAF;lRj*+jZQ{aM9pZ~)2A)gJXyrWp~Y4{n| z3&X5%`ZVq$Xv#hGEfhic$T?h5CP))Th$FxF9~TYw7EkV(eN;opp6Yc#8Ba@-{(VzG zjige{&J(Lmu{NGU9L4{yvo*u@5203UcHY_LN#d>z* zDTYW}0pXxF_Hf@q;|2${Q!xX6x)O%~aE`g;CDBn-*Tvaexh$XRfa0aoUHs zeFcE2Kc6MHZ_f(4_)=pT>0Scv;JPHRKYj@8@6lBj7-bMltC{?v?sMZGB)VPY3~=Et zxyK!OK>4>{TC@Q!)7;abFfFTg#?fd1;BKF(Kh)>rso{%n`SAy>k>5isO0Zc)0Dk{! z(w~N5^YihYPo4M1W1fC9+im&z=WPKc>v(|8xU=)bvc$p< zi~KZrz`gLwH(b*}9)=tvd8j@xTe5;&E)F#St1$qfM1D~#o*glv z^t|4uLQ0oLbP*8W)#X$Y=g!Xb6^}E3E9EZ1Y&GJ;*X4WiZ@Iz8&asO32UM+0n<-Iso@PCT%r8H%MaxHjonyKx%6u^b!mI|7DqTCMW zje)E8S3)u8GhY!Ep)y6gAqtC)ci-<~BRbmubM=1?tO`NOU}6M|+CbHy0E2Q-O4jhk*EIQ1pp0q|fCj`abnt|d4(1%N+a5_;3Nyfgp%4mS6Y zFLqom=zqDZ7#}|utqHX{+dzN7>6>d2F06(%+%fnpEmf1-K?ILhQ&TnGppb8yIB=A2 zjQY@HpX_R3>HOigs}ds)egjOGp4#Wf@B7g*JRSLX!%cJdf3+Dm%IVIdMy(BKc}`r? z%66?3ll?tc?zT5X?(G49zjPDcJt3dFs+S^H0m}qF1I7ZRPEd?p(lOp+N2KlhR3JjLh^|$x~%ndl+5)HA`FLll<|A4! z+x}jW0d1N0gD+fN-~LO&KZm!JW`H0g%KI`?v!!e}e5;7+$}+~zn7aE9H=Cs=9HbJ) z{>B=9f69Li5~%+}kGgJ8n8dIa;GKeff!e3o9^}ph8Ebv9jI(gB`qpA3(nX|^=oITn(^f6oEv-m#RvpphW>*WlsV(azVw0SY>V7L1mXHDq%yMYh>b&V*4T!)iM2k4>E@A3abi`bmEcDU@R1+83? zRIu=`RkL5^Z_=dj26J8lgs0_8so8Yq9KC;-$$t1F4z~)xc?aE8^1RpEXCne7G)_hc zk6yMfd0#b@{$9v<0b6MbRr`&m4E=$SseaE_3|tTL6|Ea3j?K`z(?aCC^d4F%FiHa8 z+IXu=CH`}tjRjBYkKjKW-00{~@UGOe!~#Y5wBC32H|mx;O$SM@+^`vCAvfMRUkz^> z83>K4%Y*M61wNFw+nQ?lmgbke%$%Y}Hr~Q>M)vLQ{|Ni%h_YBmEi7jDiP;v&C1+*+ z?n7eDcWNYazF|&Y{)u0p6Ubq}ci(?q^k4mU;{Vc=XqrE*9z|<6Z7Q_mjb%KlGSg?6 zsS7)b-uLGI@qFUgm#RZyZ0$TmDccPk`|00O{|LufDw-g^8^2Tf6mRhRSE1eiN7!2j zMAdx%<9F#61OzEj8l_E>gZ?`5n`vN;)wjO@W72T@uF5))o{$GU zZ@HcC*&>j0fgmfY$qLaZ3C0+Bx+?qfN%9YLxIcl}<%yQ<12nh?|IjoRG}UVA9l^}$ z>}4$|q!w0(UJJ3kyg-PQ1Jn(i?ZA39f-JVVZzq&rTU3G_Z_9>CwNvs>L4U`&pH_FX zeN)?^54F(6T~i)|>i2-9^(hpX;NK)yn&iO0u?Rr-L_dCR0~-RCsk8aV6yWVjOd{-W zmE1sN_uSiXk|qwVlt1W2 zVap6)2!R1NaLonKfdG&B1w8PDL(xW0+UZm9^gqT0bp9#}oBHYOHoa*sGg)nmwh3OY z__w#-i>l;`QU$turhruLECT1yqq+ekm2>(M>%tp>fAS8!VjiJk z8SNOqW4Oyk|EtI!NAyT&bvZVJfOvic*^hHfB8!dmHq~ZMmMVgr-MtZDy0(nyij=t0 z-Uk1bMF2={awY)ReWi09*Cz3EJe};5>up zzr*#+lPp>EMln$m5sXp4htUb!h**~z%{>lOcXxjF$4v==RR`^xKj_YaT1EZdEFv8q>TU+bKjMW zW7_GPc|4sNr4ME=-ZOm~Qbo2P#XUGmFI5BoUWTR(q$9AlK?4{qjvxjAO_@qRIrq#p zG)3M`Ln_6TA(;3Nd$86t`H@p3g`11hB?-F~N~8&?jUGFUU^YF+qUUYa_mteC&^GU> z%4NUhitq>gSzYcc>SI8SKh+u81<@F`Xk*juU-`eTw7`GW#(q3i)z0oAe-WR3&Mix( z+;vIi$v(h>@8)cw!9&%icYmt&GgiG3#)9eFZA;JaI1l5P=gpel#@Xd%H*aGo=vb1} zz68MafN)N#lZMS`8<)g9Dzsk(bl@|$6bWZ@=-r9>BnI1b+3gP$^W@Ahl-~z5?vms? zkwb;5LkGD!?NMz4J?fh&h7R|86y9AO_Kj1XC;ot~F#udQuIH#q#?I0ho=lR|TPT;W zsDwNjO8C*aaZuhQ5q(XqSI%5o7-_!=77iU)dD_!g#%EUpfP_oVKylFShMN7i_-S{) zJgt2)4`s~pM|Z?}!J87Vlv<1HSVGCgHD-!&r9Gm+T>l=V|EoIogAwagGUVSeLx>fg z)Z(PC+t1(h(XZEdb}5yk>i;AAPoSXP3JqxOb~c<1Km$+qODaW)5V_OyqF`ndChCAj zctaAJ$Nt7ml5UT>UA!{?vtxfZP{SQJ-dBNy;5H_v+f_AXcs(Z$9)kmNg=zI#w&o9H zP=4?L5w36tVg?k>`5LRS%;5&HD|*`70Dzp@K>xuVJrW+=yW}^8tA(^zW`PcUEMK{Hv39964O z0A~%A>WfpG#Lw4+gqT|$EsdczyjPka%5l#>W21jlw|??q{pPkr&znWYYAajG7>ji? zjuRB#q(VINzT#Yzze-(%Eb}rMUtrm!hk&xH#0;mMBC>E+!lc3@VH6D z(bs%19gLOQM`A~!44bsf-8c|*r{eKZ+#RunqOf+Lpt}y3< zP-uvUg(4SGVCEQk;~qpg905T;sc6cuB>}9J>x&Q2v5il)C6j91LF0wI0ULUjFApF8 zD(Ke{4dOqht#de^soC~smw|+e!~^0@jAiZO#<+Y|gGX=u6CC588?O8r|Ed`Mq@;cS zg)iK|l<>KbXYTAV?!!+O-Ov_KYC*n#%K4Ex5kfU9JmpKx0rcwaiJ=E|7&~xxEWt9g zxeQ9DP=NkFsjr-YI(eRzIcruxf@oeH_@9+y8_yt^u1j8_Ks6-x${=6-iksQW&Ut$* z?mRy_oBs?~B+b7oFevg(En;@=H^ZCLAOW+2oES9OVna7~xtH1hs6i+qkb;@ybtdUn z&RWPIFvrxD9gM)_T)a1ig7rk8Fn@_4=^p^e|28;WsS8H;1QF z{$2CHG_aj$m-HaOpMwzNI#AF7I zAlvbsEJ565=JTQdLHr*lj-Z-deMv@R)J3#KdIO;W;DT9h;17wyB$iZ`pSUrO(~FEU zG}_T#GRzA~kY9KVt)AaG01-C^O*j}J2&+x}pZvK60Iqzne^(7KxuUb{K=gPsa2(N? z1-o~6@|UDF-xnWM>WA2$KH=X6jV4U-Tv1^G@*A;A#R1qXPsKk<2K$AeMqd_F77~g-<(H)?Zz0%&%UF;Gn!v$gBnAgU{g*1vMl{92Ds9l{JUHyx_pOM zIn$VJ8JH<+3>uwk{4$R>RsR~{te^fyp8}6GR{jG%cUdiC(Kdq8%kA;5G093$K_>4( z*~?lP8y{N$SzI20AJOp>GZ>d_|F9@$vD5@zKcUpE9ng2j0o(XeXT7YnXr8B?sa+4H zf!Rp3K6cjIvo9mU`BlSzJ7TRgc=b&U%cUZJO z?$>cwrdp~%wL+ZR?-sWKQIAlJZ-wZOu2yhac#90x}s!%6iS70b&(Uxcoc`ETPXu@>3I`_FgFZ^=#q2@RL_J>J)}^ zP8}xcOY*C0#w^j@=S;9g(24lZ92V)XL%g}Cd7R_7=OlBkpY6VIIfz99VfOfthFdHc5B1n6dVfN`u7_fTa?wkL^ zk-sn8yt~r+C!4H>2bb4l^0D(edegfy=Ov5?a`#hG!s1UEVY7+9E7)7`3p_cGbvZ$A>SMEqSoN)Z2JZ}|5~kRPQ5jQF}zv*LN>4lD^Dk-i&TWqx%a$%>d8UNfLDKHKVagzD)uaXRkljUa!Tr z4^WbDG*NK07RJ^>@jU^!W>D0VH0`0XNR3s?guj690Lp{~Hq|IHNG_ ze+RVp+wIo`OaLB@0nBuQ>sIm(HErcAooOZw3}tLJotTL0SQ?YW?mG?`b>lY~?iFnV zDKX1!DtS`9%KG_2Q;zrk$G`qRg*w2rVAfNJ?-oN9UupW~!{b^>%JnT`T8IoDG0PYw zH39)DyDn}5z`xgh(wnQT0?v+4G0@2cbHm>BsT)QaXrbTsz4i`p^+){&835$FBk1^2 z6oCO`{du8(iGO}$Y}LA#_Jl0H>HdVj8b6(yocnPM?n?7PfPL|lBOwu(4m_>bFE4jU6b~L~Gg#TYr|AUx$UROioLW;_5ur?TD@WOU#wED`+Nrs@y;;C#_aH<#lrZCx;QARD;AMF>9{DJA ze5$&no#f1@3DEO^WM%+DkaK_9@E68F&DZZ4Wgvi6@@l32PCKH%L#4;$9GxG31a#)h zO6-&sOc>)M+wu!rbx!DURIX8W#a+~b-gW2B)DT?%-QjaPe}NJyK)f*&I8Uq3wlC<> z_E7fo5WkrzKYwi73+|Q~Vp{gGulv~IzEhqAgpD5Geb8%s8&7>nuqkBgJt`37$!R;3 zB?!EG{(sj5mAEn=^Y0484`RlJ^aAPAPywFFSd7G$*;ZxysiUAr>mW?mTAVHuDZ!J| z(2fhr52@m(n`rL6bH*T0W9{6F7f;Y#zAW6nkyA{82ou26an2cUZG;X_IHH|>`DToD zxwCBxY?%@1*aJJYI(D1HY~awJQ!!Vo_fL9wR-Y#3o?`33!LZhJZ74rGJ1%1l{q1oC zlJZ$i@1&YOAP)vqeE_;~EJ46++}QR^ie?mH~|ZUXN2 zmJf~8h^<*w5-~0YNLF_JZ%os3*IyQ)XWk#h5Al1WPg-lbHDwaw{`LDlI%EgfoIs&i zzQgL@T|jpey8ThIU5@oFb588!1s>LvgC_#MQE1BZLRY7h4n=Cw?DK3%>3Ct;8m!u75Ra-5@ z;o!{(tLn!4qGo^@Xis45|Leh5xb#1j5!H&>5@4mIB#26%y;^u5O>SlccuQKV@@ig) zdw2$M7jw@p)z48I>jLXRs0eBrfX8qjeXgAV^4$}SWw4Bqqnv+AsW?Y259T`gJOB%C zZm=>-U($AB2yon-1dUw2!FJb)!E2r^*#`lxlE13;e~#$Vt=$YLN%EDTQA&yY%%7?8 zWgSSxFb4Xx(RLPul{2#97X(6*&6Ju0DQ{e7Qs#kyAF@YWPl^Vy2E2)H0tk3lv{w1 zt2Rz?jTR<&uMC^|OzqPwKWly-Fu z1-Hyi(ywFxn11}%a8IWyCi5Qu7*K zbR>IzhmrRzh|(AUQ#R^BL-~cRQ46!Y=dW{p>m|U4!`~Cl{ss7;m@^2hX(EX9L2@PU zh`{&X0dGSbhUn)J#OjMsD}kZMT0QO!<&qhCzLJEyzXkOb8T~^qk$nlfoyPb+$NxVn z%zj#(6!3w&usf4!*H{UC>#U4L2%r&lw*%Gzo|Sgg(ge{4QNe)M8+*h~4rp47h4Qf# z(~9|OS|m%{WsW39Xz%c+YV8+3Qa5;rx1oKn15RCc0d5pL2tqWYFI{<&=rG~?>;c-F zz<2-g*efSLSye>WQ$}n#Rrg~V&rm{V34P>US~kO;HXOHmTLv&c1m5>YFqRv&1j6$f z^F%q>O=#};*Lo8H7ap?NQ zZ6Z1G=DOBqrM)T;`mgLOUCKbJ=5+mB@o|d%&AO2>HvZG?MRmk;n_<`0;Vtxkx@y#Y zw1Km!^YrB(=9}!GER|V+-cW8nm!c+uAy6UF08L2JADhd+V{`!2cnoUb4^Zlz5Km2f z^5MRrhqG^c+Z&_im0tt&pEW@5b-Mn)b+$oA#U$Mt{bic~{h z=C?AzT|rDcXJx2@oSMS{MspMqNN<~7djNyLv_M$RPP{Rg`E%cdk#FncJ^P`T^nVv3 z7RBfKKSrxGfK^&Kb>YYC-bf_x@J`FT(U#q3TU>W#bm5Q)9&S z-`Q8EBm8nF6vAM)Q~Tm*($t5;rxAR0DMS$|HEj=huNJG=iac=9f?!b5UdsHj1%vBA zR=JGWe*XN5W`3NoQ8ocWt!hvb>pzvC(+edEMJ>JY$6p4sjPgh$@c)nQfSM7rbfO^l z@S)1mwa18?Va(ICNPiqm2+iiH0*4bFTtD|X1?fU z5Ufw6W&HB>Nc?k)X#}ec%JYE|DEUhLL~HCG;%}3`pr#h829z2=9x_~jK2Qg8MB7EV zKx`zTEEx)P*2A#Iom|37v#Ue>@y5Tu3}(laaW1G00PK}l+A->Fq10~Ii4_3!T40au zHKIhjh<4?+HrVwB+JZ6Hj{^n@o(A;;)Jp`s|1sxMr_`F8o`g9=Hc16X zMlLu}CGTjm-n8yVplJb*(MCt;6@GH&3R6Z5lwJ5o_?(!uK>&z?R9ZdUy%AkiIg=@Z z>IyqXJbD*@bT7V14lTBo7lw?_aw?Ix_??BI?@F(|Yyo10m zBRWjd7A|SWpYw$a0*@xjOc1Cnzj&`fD_AAe6^CXLKGecO29_9T5&McD$!& zOhYA!{Uo9Wi@3F%_@8BbTnvr1#x!UG2F_WGOl(xuo#wEb`JX}xZL;nq`c(xHiDJj1 z)kpIQ`uAvMAmgP9<;!69r=w~5lL}@y{5mopu1>XaISSM(#I(ozfBaExj?|naz`6)2 zTrcr5R$MhZpLx9RHU|_D%g4BM4B+seokTt0tKLrZloWjOgZ@|0HfCdwwJQ$0PSe@l zule`^X5o!Lt>_O4pe_j>nNz5z7l+SC;{5t5w_t{@>BB9?0sRT0d=&|2!vna=N($D- zw5Ye11pB+6Qab*)oyh-Z1V{qtL;|h@m}E#O)1>@Ih~T&hjmhXP{m)i%WwbS_|K-#0 zlfFYaxe#n;kmGXvuz_hj+X2cbTIgC9DB0W==>K=E0HUG%#pTQ=q|&&~i4N&(d(D~@h|HB%?9!is4SF_iH`O6Z;RjIKH~{@C#Gb8_J2Plo+2i9*MRhTHeF z{x+SvOAO=!7e_-)byA!EZzc9OnU+%V77k%3dQ(a5B&f59=kd?$*!I9TF{urE-!`UV z0)1;8A#+?sJsDIM4k+L`hy5(Qd`4d*f-E=b=1jEZP4veAE)PK9k4>%MiA@$e4pIw? zW_B-2hj$fvFmWaS!6ZoZdja-<}3 z!*cMQ*MtORzhCBOgq=6ynv>HY6q@MN)jDPT($5Yyg19C)yh+<*+|NK6cZ8&aDaLq7^|j)tK=D*78Z27y~C0I zQ>S0?wTF6~BfvYNy>SjSLAx@2k+Z38BCh8C=GJL!2MFbzZQ~!X@DH?6`wr>vB>Z#l zwV|~9nNH0X6Z*ZBg3?NVHZyh8|R6pmX?gFJ@3bH+Ya=Rdcg#N2E~7RrEB zm|f_IvIAmY(?+c=xEj(!I_mgyc7qfw4_T_g(;({YN?IuH; z#@MfYEzz4fk9kWX=qWp{sT^X8z%m5ngtN-eV(Q7Nm z>AehgYyqE#3%w4LH!x~PI*eE5254V$PNN6n^4~4#p#L<-HcfwZlHW_{`ECq02wQmj zavp8-+c&r|4&?InRWb650hmTGC=SM%9cqw6dCe0W>ndA-x{){!Ui86Y&S{wAov*fg z<|tQ=o*T#aT?yxI-G`vjS*FZ>8^rcOs-YN#`W#%TXa1GVHu)_UC1@Y|;zh3;-`(sS z*#uem%<$ZBGb?b@#(b^4ajX;dP+UH$a7Cax=w>oUR-oLtWMdAfn}GN~>{7#@)WRcF zxA|A@F0kAklkI12U)kAv3#;%TH1eBXNn!qdpE~Nv!3=h@+xZlAxfOY*naW7RvR z?5N5DY%9_v`#FLBNJqB6Tz>*zRidmZpN|EYKe~^BBi8(*HV$q%)i>jAk+{%qYf; z_I2Ia%RhV z&S*R*sc)er7g$xP+3R|lPoqGA{V&VKI7>ss-{Fs=R_>4^bf?Hky+*NT%3ixo&U4+N z+94dUT~jHK=MkYJT(lVu%x7h3Ky4J?IOj|LBo^mbnCkTd>9|D`xf>{>4gwbujQW}-pQI(D`w)vyT*hcXn_U_sTPN)pF*&1fyg<^<-AwvMSOPygA)nZJkqaf2uZEj+zZQUr22;IHKB z3!u+6&W(WPUPxk#UwZmGqxgbaVV^&ao}UA_ZBw$ov)c2K!iD_U*#WkDM|0KCGt%FB zL5>)9tqf{(tIG>untGn`9kqQ-z_&#VL^R`pvZ6Pye@M$1q2FU__Q&+B9R+n!y8_Oi zp#&JI(?Qs`{e|;Iz+7)|GfjrAB+7xqjbnR2cHH+#9n-w^31;gx+@}r?93N!~l(%!y z9FT6}2N;NOMq++QOFV#L-@SmhVsqNf|JW{ujpRnVkEBi7{^p@@q}J(OG8S3t@jkKW zgoA`q7cRCrmtH(U#fr4R@Qq9NlDNSU z*H_A}h64Gilao94k9YgeY(K8%4|!@8a4sdUWGvfz2DZksU80Z9@^LGe(% zty|7gUr(QWt$g4^eLSa9=6Xaxq?@jtSh;n|~{o6Df!#pb0OXE=0O4xrs*yQq*Q- z>a6BVcT_W(rz(k`=@HFt_PZSbmrV0VuM_Y!CM53gDyx?v&11L19jxXrypu}#)Kwq{ zY!JiX602S{-Z>xd4CT^=mYm}Pb=WCxfc3qY7WUjJFm1nRKXof%{)Sjx9!X4d@SkOt#GKy#w^nN_Q+NZ$oz@#Wlu ziOP#d*Vt(8DrHEluBY$4jO{ixhv*8PH&*uY)~{2cdTNLYK|!mDg~s>W2m30At6wBG zkV^&ARJlk$>cL0lpVcTwI!oIwY`hBP`PBplKKa^KinOZWhC%y-h9?`CC>oyn653kW z_FAy^N$;@ST@Eaem|9b9idTfd;r6XzQKl%jL076etpO4sN?Igg^7; zSr)|eI$LRxg)D>qqMRHk3zJrwMIH(ih}T`$Ly?21;h8TR)oT7xQv~2RRpI z`8aFI5SVo2VP79NM!fN~8O~RXD=`DJZ z2`f>0dr8w1>s^6FX&W*Ov@!{3WF~=y?BwjoLQHH`!G`db_tj^G+56_+?|WBvtl&#- zhJ~lk8!|h)nx-t=GxmI`ll#mzITQqp?t)UWX@VGR+<(gWS7ORUx zQ5*dGVl<-FM|SrK+U*_JT$Q<0g|*{0=e!|rcg<1A74tTQMMs3`j}+J!Oe+e;^`$8_ z4$AC4$HmuEtZ;s|i-IBTUl7%8If+*}>p~``Y;4^npoan-2F_;H`<5dr-cepX6&G17d7mylY{*Xxr3#Z1PlAx5Z8@q0m>YVTv3nD0`!!VWrWC z5S$-*HhFZT#El8+JrGg&Y#eKUz)pcgQ$C%ectb=-?v$Z+?YNUpwz|F0a7)F-RryS_ z$FfLqw@Dbe5Vecy%7-gIqkj|c;X(3}IUe(-1$*FWWcMym*1BJk9PEqcBMR(9o5Z*^ zPIwzqyK=d^Pb4aP$D5dJ39XZSq}kL8m6iE|VwLadp^yZ?QRGhQj`g&f4dyI?y+?6o zZ|Q%l@T%?}fDw1ugMQsjK*ZOd_8>eDP}3X77O^Ru0cc{^$3eZ&p>x0`e)5|mCL7b( zmcK_l#h?i==}~hKXg7`CG>;Jh_VveG0T?{53{a8%k8Dw6iJ80edrU;v*XYgH7^=|I zUR?s%H&8YWT)E3r9AV^ZqM3_DOhyDo<`c9ScaL!(E2xRzOHCm!#)zvh0%LX+0Ev{L z*BH#(JF88Cx-e^vUrKOsXHNrbp&_a#0d2dY#E`L~n&9AWPkH+@JqQ{ilUHpMAH!;% zt#Cq{ae%`l9z1^M(I)rHyLMR<(aYN{0%A4=pF6&Dw+)??KuyoJqBHGu1!K=CpNp!b zp+2zzV~1LT5Q!QIyVHl(y!!6$4hfCPsir2FhTHS?2;poCZu~~SXE5FoxG>W3+&!~t zE@t|C`kNlU`1O68LHRoA$RM)^>V=f*DF^2%efCe`Gjp2lK4NkmLv>ATk5{weR{n5t2vfdQ#?~BCu<;M>^W2h-PwcQ(AF&-8xOOkNAKLk z!^U_QQBIqoDA&3&4A+82xulIql}54^xZ3(1BTHF}q}_*_`(TTk^2|k4=U@jF=tTo8 zDf>q9@=h}+_ZXkJ!$xPhvzP>_miO)G-eIQ*CxIpT`1|B!G3wK~@x?o*&l5 zZogiHBoul;_?mASk;*NZ=ha}|xG3;A8>EJ=6Uxt5tzpKD!C=*FBOMLl9jyK2%=uH+ zY44`>TGSv!aHw@JGVDD1Ms&dp%?@NHTzW84`j$)I+NQ^6q4s^Q(uxZa!xomnEIK82 zkpvSQ#-cb4(FAb{q3|(R4?Ooz(tiQ5x7Q}vMQ2|GQZoz(-#bwWR<5g5(ptEe#wD|$ zK%LZ3Jm#nx$ELcRn>{(5Fr4Qm@_zlZVxQk=s`XeexqVWGtnFrqyhcp!oyck<560nU z7H^M$=4w7)i)Rx>E|YIdLlL7ead7{M4+qjUQG>6D1t(348cH{gg{-W^dY4CL^;w zrFizMyx~+9!vR(5_D-|7O24(Gau&^6Z~IDGVJ&xS-t5`b@Tf1I%f$M`i{k98BN%5) zs!`*ya$@3F#tK@)<#WZXbtQeq&3>qKsJ3-a_S1^x*{PcJ-uzGf68uPE_)fJNO}zbq zXhwP~;zMWz*UqnR}QD>?9kYAQ&WxW#=kExNxL3$yVun_Ma65K zaz;~QhdyIGn||9Twi#KTFgz2wy(DoebTA0&_|4goVAxU zTvY`sTG3#Et-*I5uik~yB3(}SNQ6lmjXLvJc5KeIR+G=ho1<5Rsrc_Tyw1IGsFlxZ z7Y;!!ZP}R=%1?2$3p1?$8sV(I>HVlcv^>{wV?u&x`Ecmqh1@zny1qYF z|2oN%d17*2l1cEDzp++zF5J&&a`y9Rf{^+#pRUueH6`vU9Wxgd123#x?%71 zx;OZmfWdvo*;y(`(}suLZA0C#%Tx#CnMgCsYAOG|Tjf{s9zV1E6YP<#o8R{muR)Kz zS04(XR$?{3Sh>&&8R!E?dBj%JFq87QS+QH??0b=$6d~a@bPr8qYh23MMqK6Re{_|cd>pe|M`0WlT_UnVXE;d`Zs7If7OxM)s^vnQE}T15#(N`dw6o{t2qY)K$mlW_+YxR#r@Ywx#E;$vQSpewn) zZf?Z-+|zS-Swq88dNlQQT&ijw^x2fAO?K7R1#?8&;F;Lza5HKm$g817=gc)-r@M5Q za>vZPNqn$>tY&YBPn@dnB)u>~Mi1)c!&48p<$T;vlPC9x1V2w*In~Ml%E40hg>03r zdsSGQ&)e+Tq?w)Qx7t@mYNXtT7Tm2J;TmAm12B6_ebUS|F;Dyt9Rovk_bW!|~XD2e-xgvSWv3qaih>$nB=;wZuWAaF_1ySl({wrmg{^0&0}AItnP)XLz)D z9?IXhz%Y$u_B&CHbd!Y+%k!OQN}EPtBO)HyWXG9vhg#zc*Rxl2WqhBA-e?RKXiv!A zEe+0QkGruU1P@V7rV-7Hu!@@GwrV;XZ1HgNRa;|!-&{*t;NFoP!3&m37gFJJUkJCICbE3G!qew&lOyvO zJa_EO1%6%Ey%(L_Rz0rnR#%;=RFPa@*L`JP< zV@F|OVx#4<&t1GDFVR(-C~^rZhS++q6;C65Dl=K-a(J}e{N%UB0}$0Z z{nxZBYBd5xQW%wgW%bKmbqVzC>?In3yDP4R+~^@hFMBSrp%$h*U&II_3GBFv~NlR1};30_4ouw<;-+i!;}{owUCyi@;D2hec;FReSfj(a()!j-~=$b9DI&%5!|f zhS)7+qPJqSGcy%8#WkeMxQ|Xp8ZFe+&IFqMMq%5t#1k^4;$woZo}X`dr8HCEQl%C5 zOMr>DF9%1D=>)Vz^mX&6NR?_F##Vjdyur%M)}iUKZF8SOcD|EbC_ozs-#&LeX252` zRaP%(5};6ZHKFW!+a00V(PDMLe*=riyngHAR8PN)N$a#`=30I3!GUv?tPZl~`>2=I znvqY=IiK-yrx){mzG3$9utg{2$oeDVZ!~PI(3<K)SHUT z3aqp9GKUr3a1hX)5@F6elVEvU^}sKIl>9|Pa`c*Lh*M{{<&OS%%i%LocU^~!@Us`_ z3B4a`?M>c;?-MVz2)=i8qYy1;78*SF*xKxL;Fm=$dcqk#$D8^@rRLCCr;@Jz)mKLm zsY&x~Z$9hNI~GaaH7h|i3m$_vU#rSIw7J~H_8zz&aqP*mq`o0)?GUXs@>SO;eLf$i zR1;lG(&pn8E>XY9C6=zfvN=`e)_m-#nG(JV+w|k)wiu+U7+g9(JpT)beC@XNT`F_+ z)7f3H&XR^w&grddxScz8?B-@&>r%SONi!B>w1oK~V?_CeI>9APcKXz$Q&FR!8eyU-p!|J@TcmZsb2zNEK)`tm=Jtgh65CdJzjZyT z)Z|TP?Yxg}_N#27MCJ6jDFghNXt7N*G$$7tkqL^HsFb3;Z%@r+u&$vA_J1Z<|Loyy z5rCbA?7;VV8}W7Hj(2|3YQfy(S9z_GPhI6p?kGUk_%)WKeK>3+3k%i^Wwgp%a#OO@nFj_(0hN zi!P}o?yEJ};Il{#>ra|{Xw0A{#!mT9!#eu3yzd+=z}&#ALSkEMvZLHRoA>!8cgWnH zzNE@66)-F;R#DTQe!B)6_2YwigVLQ-`oR#KB)wp=-4zOjHp zO#0;9ZttTwE8mp1&vER*5@P|`xE1)_LP1Zru+wsutH7=781^zYVOHL%;hqmwi_>z0 z3sLc{l&!Y~0xIxa7QeIHb?c4K&o8DgyiQbHoMCOzV%dd}hR;QB2V^qm@;(fXtzI9H z*SO`A=Iid_Ch}6#h0dwq4D2JIror3j5>h~8**)J$F0pxfprNEzb9vTsYyb98grHWY zg_q2oil8Grex`@_CVJv2)Z!BDa%yft3Tc`a7Y6lhVZkqGhUr2&H`SMWe$@mam;X>x`V+rJZW0 zw#LBKww0S3)|H;xnNF8F6X&Hd41Vxhf$)!R9r2bkcDMUohoaEP$_`6)Bb6!xo~}64 zz8_AMj)h25PRJjiGy=n;0;C2_=$1|a&$-)}jYpLVXFW+1X3h*DyWLE~h!JhH)rEKE z*)5IzCmA`_(nf0gqX*wxBv`%mzKE->F*L5@W||J#4Ie;<`9DdSvnTKRJoaT8{2Us5 ztL}AX>f^(-t|i-ZtMfOVq_COV?ySL);C8}KOf~2q#F#2vt?Kz_k`Em zsrvAunm>c`f+^LsszL-VMyO+a<3_~uu%~e0>hhW6TdDbqeI&u7dsEKRFkdy%Q(M1` zeCKM7@V2CCu}aU?VQOyQ;(odOZ-U5@h_A$!5{V<97}(Xz`SUpc;>pFKw$#I_En@Eg_LKm_$joUsl-MtJYdr-^;gx0iD1BbU~(|^dp|F3Xm?bz5K1ag#&Y)t|LU2!myu&EsUe@I1Cpw$C7 z9jTY)HJ=j`<7ykDu7D6SUCzt(#lCi5izq)S^P|l7rM+c-q!+s+0)FFne@4gVtVWq&MJ=; zm7Xl*=7rf;dlV52Yw9$)6uswX3X2pOQXs)qrb(`=t+*H7+%e?y?RNIY=RriF*0L!I zb#CwD8hf|ahvk?0u)gbIHr-+(7Pa2HEN?G|VcFHgN zVA)mrCcAl3YI}dzoIz^kFdlBgg zUpl}-ZC!?)o3hugmyjv8+kcHzfd?X$nfUiD1~)5oJc6S#pVz+v^B$ZlN|pPh4i(GT z$1~QlJ4H$jRczRPtAi`dYe}h*7$rpIm2VVS&)M5=xfo?U(yRZ(-zMsyKo|&1 zc7{G}xlgLE1U>o60K@xZS4|4d6 zb+#PgeP_;7t}@FrS~k6ptEClaWf`DBX-+XP_6#d1d(^(_@}ZXigT2evI*YueH-BWE zRuti>huutM@8G0iQSiCM=2Sg*GYjOXk8McbFmZK!8if>MLlTi0k(V#sNmIzQu4V^) z)}V7zF=1r7&`IO$I@bt4a-lp*Dh;_WuDNS35O`d9(%IX>%{kY&z8BP-uxOz zQ~>;(Y;<;H@X$3XvaP?P@NjF_0}@>rGbEfW?&^(N)8GLo)cfEfZxQkY7B`QTgcdBUc*=E!pE$# zS=>fdyIwR=bjq9|x2}2k^q;BsS+Mu@ZDj`ja8i0aV|f19%CPvJ@hYiZrRyz_=f`P*W2$KTWh1ke*td~OOx5Z zxD+|v$4|e1pSs)$M!nX0BAcnF@?Ey4`B~x0hp=<~jW6e2R8Gx4w=~Xgl%GVWY$*tM zb-Lh@w0qX6*3hM85h-dUbjvG$TQmP?dEu<>gXgw$Ztly~nD$vCwKPO4+f|lPW~H<6 zq&ssns^ng-?5fvYeKV@K1O7E(A=-TC&CWhMt>)E!PR{q1Lz)ZL)u*0~<@J5p$534f zh@lZS%0=yod!<``hKg&6zR5P6k8LHR0KKJ0iWgyRrv)4M zGVX~~(?D5ncj0!~->Fhe5=_iOy5{$jHrmAEb)UvD&*^VZIt0i{cWvG$s)zIOckZ+h zYI)qHD{x|snySep^C7#>IO^WwTB_?9b&Ie4;j8OhTZFH|gGD4lz}@u{m+rS5WY)#* zMpuu4SI<^<&x~$~L(5$ zo|+Ni&j`+btmwEpOffMNx_d_QW~lm^L+eV-uEJi}Y>!3#cNQfV{VuUjCQ7DGNCWGF zIDO;X9Y1-ysv6fCU&RvDdr3|q)NC6q9+0(F7rvDCH2HeF)zGNNk)Nl^GDvjQ0tfTf zi$%3>@yG;~bvKZ@c@frpqll7>QPaec}mPD3z84?_EF$QD1+!zYtvcb%r>!*9FbEqsPM1f5smJggqCt==N4+t=`TQHrIt;E&{h8%5tL2zYbT#EF92atG)vg$@m%-je31S3qHl-#)rEye^C+rOWIOWzG=>cP*=4I?y`FGDL0WaZzROO z34#9JQ*=2uuR6;kz;4)sIkc`8%{EN;v-K=%^}Ny!>ryU@dVf0-Y${m9^R?9|uF2eFLfC#QxAb%THQTnrt0#Y^oN2r;sdtru)S6q9#6MI*X7w#iPHbZ(b`o1aax)USacb~l<4 zY*93ydNwkMprc0jADM%FVjwFg>Fpi z|55ebaZP1w*Ose}s4xgf$5Es=k=`8@kUkKS&=HUtLJu9(L3$hMEilpo2}x)P5SsKJ z3?a18d+)tCUuN!o-}ip|kHZhnNjSTlz1Mm6TI+dw-B51AbMkss-O8gmzu<3A#rl>N zMtfE~-qV~^x(ffu)>xm^x~Gn(-Yb7Z)0B%6es3Y_2GS01tPUUji|{<;`a6Tnx#36u zY7mnofC`c9fpp`uI~ou+`Sb2L=)`dWhN^mBtgkFYkJUyyU8~y!k&2xBsGl zlK!{XxtP*IkFR$<`bEDZB%44poy29_NFgX`&=J6t8chXO>FLP#zCQ9}(#+E|O6>-As$ zzU==aZw~!m^ZZ=iqJ*tlN#YvA2VYzh_<%mVrbwv?9Qf#6addJ`s4#tn=IL}*@BdNo z&uc8)i`@pTN^gHjzeN+K+--CJ|@e|uWZKwDP z&2*{wm$%>U-Ya`tB>C`uP4X{Ajz03wV)Uolq!lk{>R9eg*FXQ34>74GJiR6U@t-PR zyEeS#`?oyv8sAXb{43XITNN?y;(K3}YbLX2i~e03+W!|iNN2pY`B2OChN#28|3qt9 z^yH2FD$iu|)NT>>rSeB~Q2y(;gG@F4PoMN(qlEll&A@i;CvyounvmIfn?{rBqKtl* zr$?vVrQZtjyA_rV`d0o={pbJ4j)cB=Ck_~k(JA=l7bVu)-@g4!>&Ab|N5bUol8#3F z`Y+#~8MEK|pIf5+yzUuxSo{*)gWtaKDnzi54-g{p=|#26wqhar!_ z*Z!VsuHE>Tp3m{MziH`rfA)R*^3wjjUdxMQ?oY+r&;L13tK}hZ5j*nM5>fk8W&F3l zKl4u!u5cL|d-Yp((|*c|2!8&jox(q7|8wg93oH)*|Mgz~<<=+$a!xb7U0S}HU4@?|Ykz7h{YEbI@Lps|-8KMhB? z{m1p<@9Tcb9hkozL2IukuH~OxKrEjgOuqYv`%H6^;rbHk+RiX{tYuyHtH)1%sWv5r zf}eobSIi3 zv*vAEY|yKw<~xN)rnv87x4SlO$`+))6Jys>FfQd=b#8G_NrV?lhbwUS!yx#9iay33 zrpAlvP;GCVhchLlUf{j%e!pAjg*lj`xEt9gG2m0h0%q6S7anBjiI*Sn#^gNP3LSw7 z`$Twi;`3txDo0FJV6mn<&M3{L=Z<*H0r&E=U?$Os3Yd_N=6;E@c!I;10k3G806ym- z1Mg&W$^{D{@oRzf;sS8Q(=N=y&%H;+3&2=Kxa4^K`Y20rnQONscL}enDF&W6IQLch zY*yQ#Sc4l5O|DLm&-RKcw)*#tLk)`rE{rJH|Z zc>{^J@|o~evn9eH5q;83B17HtE5c*_+Fymm#9!$@OeN2R3*yh-Rg?kcgHKV{YIdIF&YN(>Gig|!v)4$$aZr*V3Hk9N*K=2T!^=iF8t**K~ zo*rQ6QExW(KLu$~mxZ#|qYgger1TrJaXYFkhKl%|;VUJ*Lrp%?CH6_DeO+b8XeYT; zRFBX7+rz}CeU8>b=UwgHj*?O`Ko&qtjK6Fyv;J82X4K>b`(`eWl~9&T1EsaW!$DTp z+?Du4b6J2IgLa+?F^EUjcWyxR3q$}F9a79L8KZOZqjK?4C}+RS;=P(BCg#Dg&Ra@i zoa)QydU_3zIYu$x;TRs~fc_EbG~^%iM-lhYvwSRJYn;h4|EeuNI+N133YFdfkLO}h zvn38*`75z)ZA=CodIMh17E`xV;pDO4oP?wTg@A%d>Ibotc3QfO?N?=mT@0=>e%?OB z{ffZ)f#+G0pNGbK6Eh@b1hnt!5gJMc$bRu?nx&;{DYXX7`490>Xma_ z9KayS1zTqCubYR9iz9;G@j#&a(u~fquhp80Y9Y*XoJM^xt|cr4DB-tW(>h ziOq~j`7%3+PaXUvQQ(|gl2YYZrW&VTF);mZrFKYs>5W}41_nU}IHgbZ7a&$ra%qp( z5{;j=;0|S)(-ipSLDiH5q~_gERA(mE=o$|u-RbN%o7;XsP)Q^HL`S=|@zNgr?J8Lp z2K`JLU?icR7DbmDVVoC&-#<&|SB^II3e>Mp9+HZWw_<5T+)Rh-QV4SHzW1jSC?xd5^JofEdDgFC;MhgUi(IqPc!!mZsmAldpw((yV96iH&;CBEXm>)q_fMJA%t?Y#<7Ms36GJtN7V1Ag|@9}uW< zQMLN;7VsqsiB1l=8XzgnX!51xYz|0oQFi~H#NSu=JI|s<+XgT|c4AK1cAX(q$**8_ zZZstM14~|nozIMg0pbx&!uD~1_-0{W;MZ_G|# z@Vb(@FjK?R%7zwX5QYWaS1FwP1}e1cJak!!3#{e%t$$TPtF?%Ix-fOekEdz3_ekfH zu^DE>&zIZ`6YM`yiVssP2FY4;QX~hLHh%Gn%Z|~b78IVbr8-s~5}yrhLCCIx zRFtcA&<22Aw7rA50~-Vk)*8pYr^51**HqC}+?+$<1&pDJIIWi7Qb0Ye1;Lr-bu(c~ zx53(g*l_vFoQfk0w#7qLdOHo`Z3$C&L-LWb(9-r!=s=d!F-FExH~{qFRg-7tzMZH+ zEK1m;KuDyp?tz;n{l$fTePrgq+TFQ1gBuy+vTdk3)rrXpiN@&k-uFQkCUgB;vGahb zL`cZqqQl_^*!0;xotbsMd{*j<6F&VW9?UoizSSI3J5zQwp`>lAAz<2hJS|2B*CpN& z*>irt9w{HhKq(gPx9e#m6fPy*F=Yfb9=}+Qby77fJZ~D5GGn$smPpgn zHUgx=<)n{0kC%&K_m}_Z=v#I!4k-dJ?;A1^99`@6tu<|yy^g><6WQ)d80x(2tC`;v zD|>ym+3^y}VF#+*Lq!IpS^>odbd3SDPIaw?!jsnCv+LXjhgl~n$Scj$6cisx{sBbh zQCf=YA6Adn;s=T4iVs9Ja>Q7Zg7ajxlg-`dk9(k(zSDI_s3D8{%~sL4dicp5??oG@ zGc0G>paiOQW-YYsYh5TH84_SWE~Bc!L^s73pzUV#TUd6z`{n><0kZKA3 zs`0dY`EkbzM5?oQ7bik^cq|lhErX1tI}p8M-H#XXlCWosync-21m%-n8qEiRnR zr<0!*hrBrB&o}{u)L1MA-poH|DmYc)B|A~thr0@Q>p~Q0VY-v#_@a7z_hnr?Z#=vs zNA!WkJuA$JFF7Rjja$aV6?<^PBLjL#Pu%W~OOTt^>{hX3uzp9=y*Jei=KiiwZk9Gs zueYm;0w{t9W^crjUxU@42D#$R1_}=5SG*NfOL9!-$a14DLgObHnbhYiZ9PkepLK0C zZbL~Y_7!!>BP(HQs>YWE z&)U~y?Zf&!43|dQhvVgsWlyRSr843gxfGiM=auRwGlLtJg=YZ=6sbPwpt>Xb?J^l_ zGX+_{h;~QQxTg(dBe*F!Tu3HJ{a5tpe)TxVb%39U^2o3thC|UKwn}Ub#c5215C}+p=Ea;!cn3} zJg;h=txw4WW#Id~ns0w0rP$0JZAw7;IR5j5#QUaQsvknOU#aCFA4`boUMQkAC>+P3 zN+I_tDr7TZdDD=yRM1?lA{+zYmFF>`g|Gh|zCn8dJnoR2^))PsoK61?Z$f*F@PeV zi0~h2V@X4nO7UbzD`M(Xs76V9!Px@!ImCi|pVWXj-M1JR;2WM6n4Ds)o2V{ML`XzN zN^1~m{YI6OIhXzLr&sjf#f{nm$b#|t;DTj9f@k834?YvcCfNgYuLm-K*qILnGttTH7+Wut6CqtC`L?>nq)es#dcc{(;>!gJsMYWi9Y?z-jnfgxr9PMV(i0${9Uq z#w~1NRKxGKytn1fwm+NUBy}YuP^4$U;6|3%j0dfgDxrk_2=}k!{AGvR3J%_MwUdp) zFu{HM?(C%=FHT5lM_%(yh3MRGb2i7g!QVqDb+)|k)#$~I;u6$uH%%mR1!eE+630WS zbB_~9+6ID%gm0kI__Q0JX)+)M!Olo=s|cN<9qI(Eso1%bwyvQxQ0oYo`BW^DqZ}DE zN5)#>DAU_k4w<=Onji)Hz)aAS#i4efv7m6}-j}=t8tX5}0#&vDZf;pXPLj#x$jk6h zjlXN7z4P0#G*J3D>xvS5;qTk9g0eJS3Yfn0xJXemI+uy}TMz1Wo*8(Yt%h3VKt1B_ z(sDN2<$qqDe?;l?U&L9hi&b7W`5BT3;&CQ976#4+{7vTM9y#hH^hI11P_ebW>sep9 ze_0-Kv@Uo`hM^5&&o-gM{vq!LEOmY;6mGm>UlB}W}ZH^>*%V= z!}DrvFC5fZ6Q8>h&dGOSm9Yv!*{lxI`UJvUilhSrSgT;7-u%F)hZ|RPY`<4G2VQNSJnwf}gD~510$Zx-EsO@D-GAv}}y2 zj;6^Rfs(Z1m6QfMc@y6SA4HBoPy&=#GA5=xpQ)pQ){c(v~Y zi;6ZXl&#!o%vJk3lSGY(aM|G}$|NU}8uZu=u4|1NMv7};44zI$D;<^(tO@T{lA?oj zXOaY_+TGZ7!`aRfY9##=bozs$bG70J=xvhL>%pes!6?PAQAA1FED1pvc@#y)!RJ_d zoO?QD8>thaqN1ICN^iiC69AQdMZ9j87{b*pG^_GV7jD7zc256d9?b$Oxf=dAL|=s&ee2V^`mJoY(xyS^I#=*!IE&iUmvD%Vy+!a(dVq zUm(_!qmt@@gDlR{0LO8nFr_nc{oqMoRio10SQ*HU#VF!NO3@uQ8Cb8U3mAVAB-S<8 zIb<@vz8u$7Qap;n!7Kg&5TX5|5j6aewRf~zYl($&@>88MXC96?`J!NcWqESTnbH-^ zPIJ3Q+!hbCnt+PYRuALy@;%2LgLc&Dy|o=)sGx%!r+neWx6w0>+r3VcO&=^dc_)vr zrcE=Z{1POMDI7<%#K(?;n7h@1>KqI8%2?Hm(a8jLV$7n{Q1Hz4)K~e%dqAM7dC=3E znhpL?*J;}q)j;EoEGWuhJZeg5@=UkJ8Ywi+6uRA=Im4NoG{}pDS}zEEvGvl`@Qi9J z>1>i10Q|lrUwkI~K)nb?8uRIAaCCH@BZF@XHx`72gL-Pj5MQW!3nFQ`ckV<=&Vco& zLZ&v|YH*%Oi!>Q^;kg_L)#t7Ltc2p{Q&>}YLM?z!ktaePFcfaIV?6fqj{p#236)88 zS*-5h5T8&$pV8iu4FGOE${d&Ep#kfyh^X~+^(yGKzQa7Z_P$%)Skw89PQ6~^(qYfv zKASJ@!;{SAs#Y9*FyizMWx}w{YTt_Orx=s%oe-|#xYmw7ax4g4lRFVIN#+#zUPI#M zpg2^afZZ>0Zi`&cPz3V5W>l<7&dJZNkINIt-{Py2id4uRSQMJ0$QAo`l%KR~)JDTA z7kiiXGq*>ga2CnIS~F5eC~cVdMy*$I7M_~}G=K)I%YmuNBvX+RqcE+$Sb~M=_(2vZ zr|G_}M*U`Ne^5#EsPisi8>|6Lj2|h6Ho?3dN+|wQjpul1I<})*B(&n zCt&j8fGbopV<;r@TMJep+JND`K^>lJpXv@j-gD|9DRWoxY;3>X-aL?={+V6ne%P zS%NJ$5d#mJ4q;?*nLLz5!R%A)UIaU&uUQ5R^?IN?;etv!jC_?nJ1ef0Rn1z%)y2u} z1x#hL8^~bJd@StIcqrJJM3AFzP_2(eX6)`{h4lYD6McQpE?Wje7~%DjmvH;RA7XRL zkKoP&#-89R0Mr);8COB{bao9aDg~}YauG@pb(|8)SVUM@+Td}D<_(M0cCcSGu>YG}P(LMa9{2^0MitTPhW!YK!)x_9d*zEa)Ms6Gp z$mk=*0(RT`U1AEn{WN7M^a2knOBORSUK#Cq_A8SNn*hE`UJ4f3KHC-hEB91%J!*Y3 zs0MfLrGsXa);eXi9mANder$xt_Fx^eiI*29fw;gsxwE@2RqeBqm{eVv5TXxKdj#s* zbT#$Jae_oJk{Z_CM2h+E_Mh;2FF13vZz|5ql9lUa-}uqef*)_GQJOxwP@kKWk-Llw zK#T{f*4kc6TIi&dl~5ya(+0P-#+okCH}?Uj9n=ybI{2*Jt*UD60ef0Ekh&2)Zs5-O zR06~AH-@c;Yj-;|6 z@;KX2zt;il&D5k|9VS_@>$&U5dP81H56g=5rO>dFozK1qOb(@7VBjUj+rB`FLz=o_Ry&&0LlRFrV~(zwTB#Z4ai}@%cs;zUwv_o940@ zo$%IT(OAYHuFI&KhbG!aYY7|n^MRbTgE0A7F?!pCbv1sKfOU`a6*>~9U0Ar11JxRF zBMxo?cMl7ok%8Oezl0?AO3#3ShY;iNJX4In)nM;lqb?KAG4jomMxK!_2}HCC{9V{z<6->VIr z8Zcm-0^A&?TB6O44V?EY4%nw2Gg<;Y)=mst+7NXd^9Q}>wQQz(yi)4YyTT_@t?j6K z#bQ#W0yy`a@y8lL^w-b-Z*r-g*8oh!s8(s1$~ZC}K5|p_tayfq{IzE*Ht5 zF+V7izL<1K5Aa7ZZPCGH=7kuni$}>#U6E>ShQe|O1+qmkLb2eh5Rr$Oc4?8Pp!;IgvodpP3;Fv_r0U& zi`OO4H|DN8+DjV9vYeNU@> zrO#a9EYxEb9PQSK4rwrmXScRnk`%M16ZjN5LX}jOYCN)&89nfadB{s~Dfv!{)%s3x zrkM2%(dftLI@#Ze(n{=6ovmmT&}6(tZ~rOTaLLsoEs>I6Sy!gZ;ZndFrn`&gcBl6R zO7_W3%nq66;N*|g{r!;gau-RpR9&}NS9MgG@)sviNV?N%Tx#G{YCq^mxLY zqDEG$fGePy!Um25f6zb`lnX2I&6IeD@s*^zqr@Lme_a#PT~h(fnMJiHdVWwQ)6Wer z^R4G7ocNwp7*~&{31g7b0#Doc*K9q<+dA~z+!0aQcwcwMT=n5(^2=+ok-WdvWM1>%6XMw2};h)GlJn^az` zbI{kJWSE-%y7myUeEuD)IAK|s;8kxLAue<*T%|LqIYMG|rBkX<Atsx($tsMmd57U+4|EgnPwHld%$>!C2Z?96xk&G%c5!S44&C0Yg zwu67Zl4xo50l}A=l)MqZ*LxS@T6=*7(Q$P7N_iaVW9xzBM7@jVN5wM+)hN)Z7%$Oj zd4eS#9Ty=^Km+YoSd4;e0yLD-U(yZw!4S2oNA>uFwN?AJ|525Rv0c~?@p!d1&n=YCaNj^s$26Q_17h=!aACu zc9T6S(FPED0iKCc6hJG7Mminedp2~%nx@8w4zS^~O6S`L{dk?USY2m6LJ3)sbyp|n zbY$&9aGsFkD&;Rc>$b9QYF}jOmtnXx#8?X~>zxuzm)nWs;XjyO9>LH#sw%66sHMzY zo)lDrikALw&ip?HV9-2!9R6`K(_050*DkBA(p;;dyjZ5D$C#W1bG6W_iGFjiyHY4k z=?x|nqEhV%g`e+jEd!BuwGG)cISr#hNPx^qW@tf5AWLU(3|9-_w%4yTC z7GW~``J3z>n;Fp{DQQWY7#g#tTK^a!R=8JrS`nVenuT?4l&s9&EEWh>lXcX5w=hQ( zzds>_o2TfH$M{kt2?0Fj^&3jV)*a%RvhaGFixI?;WBQsEll)-Sq`fvf2+T=|7jPa< z=c~64Da+lesTe*arl3Sx3g{((;H9aST$7A(@xgp)s6qk@Y@oDwlp<9V&XvrB=j4ji zmkIhbP`N3axN5OJlExpe2&;e<0WAl_jXq~Pqo!acm+Wx~kVnxdCMFQ7>qh)Bm5E^{ zjkuIwi(p`|ezvtf;qrE(CHf!yYnJu+3PcFT4)^YbeXf;2`X zTDBP5WjSU3*x=^FIGRD!LO90`Yt{!IzsEW637#lz_6RzR`JVw{oiwKc6WD#9B?-2| z9HT@LH>&HJDp6Ha1}Md1yB^={Id^K8y6@o~;FN)9S+Q(d#3(C=F9&L=2#*l;5=v7> z`-Bx!Y?M{`dy$@iLp|S_NnQrAP1l@u1G?i;NT_nt*|c!~g@}SKHLND>uWJdHjCJ9= z;iW=rKmOp~=_%C~sqimR%OAuJZ|d5Y&E3jFTO8(oRq*eShlC@P-_9~u@rjwcq4$11SKzSCIg*86=E1aA zK!06(6gRrJX>c;$QfMo{OPg|kZ_C!48Bc~*xqn+)R#7MwCaC9Xn_p6+!E;7BtK6ec z9($5iA4gbfs>pR@&bY@iXl+QAx=_JxZpX;&bErRDPW=rL@`$RsP_u7Q?~t4khi5sy z>iK{T2Z!hI9V;af@1A9uu$@MddY0TY1&qvAGvF1FGsvO*IWpE(9j~`FA9HUP&k^BzmAbI7yz<>|WuheZnJT*9Q@XL`; zpzj+L5D+Pvw{ooOomlUC<+5?-?ek0(MNCXdkz(qj(^lDf%X*_7)zIX@Ao}QbxG%2Y zpHRq5v*!D&ObbH}Y!Gqk3yoQzW=9Le0arDo7}LL#Huc?O+VqXr!KkRLupD3QUAIB# z2`_qSS1Pl1ZXlS$@x90M^=&_aFJqDwFEX8HJGc}JTzB_`wod~1%13kU?vH{M`C^Mc zB0eHOg-ZqudS*X|r}OvWWkXg5zq1A3AMgyKe!@^!QC}{qmn9g)-b{?ntv7!#5RuC? zPLW|x?NAc3L-NAMfyW(=)!5`E>V>!L4=V5Ne1#4=KcT+%}lAhO1R&#knS*=MbWQ2+gAZ&=zt|I z2WKeK=kLP7aL4i|1OqEHM?iKxvDWKljjkRJIdt!g=J-3+LM4o~-c4-t# zRLZJ&7kQ_*nrn_Q4K)M*n{!TvKhbU6-h`!({< zm5_Du=US={q=?f0@<2SYbDaDT;diB^Oy`mBd)2c$GYzHoPC}p0(wqKZVrE-=AxWW$&wk zeS9|wP^#>j16O07$f`DXPr;+pl`!5sIdl%lBMsD6u1SKHn_ zvEKhCpZrs}nJIWu72&BIv2I&Uol;z}ca9t2QM=0mf}5N+sNYq3Rj8QfQeX2ZI7BFa zl}KvI9Pe{p%Am<&Mo3v2WvPBq)Y--8ZT*wY(*cp;?Id8X8uu5w=NZvWmfAk{f~`iu z8-hyE56TK!C#ves3W}L|QD?Cn@Di$nYK+lq0T$bi^ zH#72JdM6cxvXPvl56TWqte;ILv5#5rgE;g81#u4ZxqaifnzC~` zTxeuGyD&@3vaKzTOXXxH+))W}$zvs4T^1?pJC-~NuYe|YOGg?=>HRXqTA1pxFR5MV zXppq|m96f`cd#Xic9 za%Fuvol0FjQR2^rDD!)=U(J*2nsn-e{kW|eG#tDdF%K-U{77Zhb;sa(9{xZ2R%8|c zRId%}ZUtlIlh~2lcn{MiLrvPIxab9a&zerka25=rrL>Q5n`(5sFeokXv6!WdRtSV! zhlTY>@9W|H9;>}|7WOPZCo+3D?+#d0fC*9X3T15TWafBjwgv`l9zExuW%*!8VKvt; z&Eb&je$R}BkF8$r-h{JnExvxRBeyR|g5F~#ZQ41S=A_Ypu^T(;eCB06$i#^VI@E)0 z7)4Zjb3F*=d4%C)_*^8Y0S7-CULj8!2MpxGjzPX&XB3&J(G*G4ZTZ+(vq)FTxI}xvZBoUxRwI2$( zv(deTxI-tD=e?E*-x&UUVJKMiiOi~iUPaxX5ug0Nbkyczbc7Rrzf8znCgA3fa zD=bwpaDt?Ar%&=!>{hP`pku*y4cIwf)SDEhCv&gKXr|szt7|OBb;(oyz<!+%zayw z0c|`3JIpsR7pWLxc6foeshA0iRmP4}V!Tw7Wi#vBrK;p$GpN)QZ8&p&{X8Oz+nrEP zv#EC1+}|nROur{??2NC2y~iVzTxV($$Qw=rtnxCjN$pybtuC?U~yme{~A`LN{P{>|gX4Q}$6-7rC{0^P-l;%eK z)D(%oQsEqI$t1C5$dh9~0gIvj)ifsdc5zTcA~kI&!@t%uJW+3+W^K|XO4+t+>8(Vd zAJBd0qF2oQyyPF5*lFZb6x$&?{FL0xr!|A{U5G(*CgvaoB*73?ic5gq-~H1!e*b=v z)QHfi>}X)kHbx-0S%DH-ja0E-N^n>>oO$1Jf+I478_TsIO1iXng(~>>$_E~}r3la_ zJsNYP#$h{bVgCI=X4EVNRJw$J9GPSr@E8;~4Y+NKbROl(5jD6Ys(&&U2rJImQXSY+ zXj1Jh0;SlnuG-wHl(dZIE_m_v$sL8H8?UPvj zvBRd2tsvL*t%*j5G^~g@I)Wr!Bk5{-DfVFEv?rEgL|jyosSx zww1f_W(HEF+CRX`Pbr~x_cd}ozTW;Kp#+Ee{5?jY*f3|dD6ZFAejh@Puk%dJA~f4M zf`-n8%VusjDBz4|k}jZJRg9I~iR#XZUX#Kiv1A|?V`smT#P3T}Du@56$Z0)5;48o( z7Zyaw*!Vng__LE*b^IBK&`2<7Q&f}6N~}Xw8wlJ^Y^6Cws9CI3o&{pVG@(7p!Y6(t z$x3?wddhZ@qop)``BaqWX#(^oK*UoZ$DaQ4hID?RiOb@PMDo{aH-7ER{L(EMb7S|+ z87aJVwvIEM6oAFNW;DcmGM>cw1X9NByxLU$f{R%)K%ZY>n&FH{pd%=*L`xkZL`Z8S8>EamN?ZCY9Bm3!4|)mEV%>y1h9^rtMNDBd(Sxy{V_GR{ zk~ZVLMukA;ssRrYyAOgJ7xr}_Zbi38#UC8DUPzF;+zyVM^%xbhYJCP!h&1XvZwTv!0e1h{Q7&PZZR-2}{WrvMXgNm<1rr9mU?DX`vPAVKh4Kyn+~DjokaK}XH-f60 zc*20gg@p@R_oOyB>#DzfD=I`-s?HVb9&P~TJ_;r@4(qyRhRUU_Z8;VVOCw~Au!gq5 zAto&-oI{;t(?B+TPxK!#9)U!jo~2RZ9L*JZ_xZt*zMK^{ITiWnsFrpigA84I!@Vs|>NyB(%)=aE^)7?dDOAo5KJf!%PP{GT2+h6AN zX~5GwnCy6{=4!XIg`(hwe8ohUuit>xvIKq-?U1k$`Rfrh{_~;vllI!-)C&0+avZWZ z?T4N!VB8Nf-9;R5a_tPvj0?QvMyq|Md0fq;4~;2k7oY*nQ^2W}H#_Oefl6g%kMznI z!ss%zE87AJ7{TowZJiTng%&Yvvd?1f!M1}B)MVVMiZ($71DoXBgDvo13K%5W(q{UU zdk}tKmDFLVPu_s>aAkt=ofHsVcjI(Ic!}|4HNSL-|lK}DQaXco6qb%-;;RC5d zhG7{wR(jSCou`ye)SeC={N!+!Ym5I%pKDJY7o6b^1cmNe&0w>ksBPu+wPy1fzy>}{>V$=?oFMGrv8T z@vl=QI493k5|NUQOhT4eeC~bPUK+k`m)J!<4w2HeSuU9~JI-b99B=C7ZQ-=Wu0!f;V`I^Dys@?jovfmdIzJSbX_Ke~S!F3z=fb zE?^30^K2;=>yz=WBZbuX3$RPDM`52GYZp$;E)IfP5uX?*n_Ca)mLZwj)LF=pUoma0 z<<3cE{k)eeyjQBXxzuX0v@I|he8u+#q3~voh?*eJX2AFAE)GL|%g~+{5Zn$&ovoeE zPAD0^)`_ebLuL;9xU-vcn-Y@#T=#N19mVx(U#4Zx*rDGoN~LJtjC8Skzw5D5-?ZHp zpVJ4Fi;*ziqM3)TRwx=^8qy7Xv;$~aH-?K6TM5`3yCdO0`2b?Irz0e*{h;NQ6Z8!j zQD7vEaj_nCBE^U=%>{IkjUCFDbKc?%t1Je^R_rA?pM36wh}?>%Y~OpG_OP=3d%J!W zW-=HMhg2AcE?EthTrfMWmk#L59O1t6Ay~9?WrlmA%uP_p)6?^Vee8MUj-YfahnNXmKNyH6+tv| z_=lo%=b;eDV+^?}eZyb5Vl^~5%XtJ@rK~e3ygDs0u%8~6%OkZ&g30Y?86-n?HdJNl zU(1D`Jf=JB3W}VY`Jl9EyHbfWxcA8g(S!-gMptByVCu>zx_e%@Hp$Kjvn zf%-;8ta~-kDJ7L`?!@%y`~&t4*!mG5#DXIr^gxpESo5CtyZ3)xV*y|=RxB2Ifiyrn z0P{w>x`jE^HbBinA#HZU1@T`6D$Cw)Pfz6(`KF$8svf71m>t$)e08nJ7~g*V)5%kU zlnyWr8}3FEUo~iSXC!D%UkRtByQE)_F>QMMOXnaHyMOnbquMva+`|d?WXPe|i0b{t zs$?#@4T^FDmm0&fsbi=9B_UKKjYyRo9!;1mzs%N?iH#%Y{9q?4a%GTHc(voKdVNZJ z*F~m+O~<^ou09YmZ{XNAzL$ z$+sd}GMAJi@c3l}%zmQAe=Rd6M8Zutm zh2&4qeCkt9)!l|Kt@2lS1PT?H=_T1d$00`s?DPPocW(XUWt^U0-)!*mFd{yuQ=CUY zDsm+%ey`s1y>yEG?nc{+M=)86;MXkK>$%srHzsN^zr?|^223)a_&l6tSoUgDkIkv4>%x&wK%-F|RcTO*7nsu-2r|%tWZhBFOOu%OwqozlC8Z`p8 z?n&EIgpk4A&%ck6Hm*O_3Ptl=xTyD$@xSInzk6q^&~cB|NmuUT>$Dus&su5?+PSxB?s|&a(d1A0zL$ZN ze7+JEt+yrHG#0g#5&uU#XW>=io4I*Sx)^-NsS>}V>%XDO*mp}ya;L4d)YJB|KH5XE zV9f$ZZeoIGAJb_QF`>GXAubGa~c-*#HM_%~jW&b1a|0zFWvo|wV~XZ;(o zm?N(obbhVQ5BMRQvS---3a6}VJ1Xpn7VHHz4XpV+_SRl4A0kZ(ifWTz{Og+h$@MRUg_}+-y#M(w z&-dNF)NK(ei28tV{Ii97O%AsE7SmL7OmB_Xw9>~0OUa;G_{S;N|I5gD?a^Bmw#{og zcb}?X|91>coIbIj;KmHZ4yCROc338-uBqaCr-@*zBYlxVhjYSTrB%_|^GBdM&+Tc<%6=8E(YXqc;oGtd%Hs;hH z=dqr!awlmrnLrdJrq9_NH7NQsUu}fyt+Pd{H1YTH%v%d~ zl*B7a*Y%&ub<>S@etz+9joUws`(HWBh6Xi=k~N0KUvr*ueg1dL(}Zw3kZbGU#-3YI zA8!>iWlug&kpj)1O|=)@zkkj1&lga)FTd0M&$SkTT7O(!7)>C1anU+*?GCl)8QLan zrFDQ9NHPR}>dOt#b9U9uyMyjHwGcP6bG#EG)i~iJ8;4M6-AIOb1n~Rr*66xHey|39 zO{o*nUoM^(?oE4g-MI@MXbIjGY~Zm{uI>zWA81)s(QZ1(G5rm96_W( zk?xRAQE50J-K`*T=q^DzRk}e^KpGAuC0&w-?rv!$)Vo1H@%?>&_dfT#=*u8DdDh@;HN(lq?)S;#H<JEQqXa;ogR}`fvetAYs|r2 zv1skpmv!6EqXsTH6ZTV&iw!kG`WMc(66UU)tfWj*_v$TOdvKkc;*CK&Ei)C!$k+Ht zj#5*jtC@Y#XxwiLdS)?`=ibM1(TT=rgv4~lJKZ$F5AHT!D z4vmduygBAvh~U9qWIJ>ZqvHF^+ZvL&$V!mPPN}b$81gt~{~iNP_@JGgPB*QSKM-z1 zOj{U!7ZGH;(EJ;qs{Zh^i8SnEv*7N^udxgQ3a)0v?KZGZW2w{=sH%!O`JwYK02OjM zx}qO?VwrY_-8nC9y^w+_pEph-bZWK<=`*|`rt6n60_-DxjO;*H0v(3L*u8`%h@Kz9j^uC7cCd|t9GV?=5-wF(;yUDgnrfNSlZGFAb3?VC3O|@vY>lsck!x1_of@ma3v+13TPJB# zG{%^gg;4*TKX#Ab<~sLZZP#sSus7lchcRqs68Hu zMj-^FnEjR?n^NrlF_YuFF!T1}xO!LOWTC_1E(CE(V0o96IfypXvTM3;KS`R)6iL{x zQJicMF+SI`9j2j$hC3r0UlJ40m8MZaY8Lx*SasBNC-ps|Plid>MRAx3`zfQ(=EiSL-)`9Lx z8|SpwsIA(p0rQG)f+srL*Y*Jq z9Yqzm_}|O#jPI)nEju{*Ap-UCF1!*~CP|O(E4@iUXy+fEb8j@tXD4qa>pYM+dq7nL z9#yE+2q~^Bv4+M@N73=hZ5eG$^ey)jyMuQUR;Quoru0_avBzO5=ju#a%0mU;3!cY^ z#fgk3C7VxnKhfeD8T1yk<*KRNU#geiiG+Y>&Mi;An$U{x((3Me0+W+Dm}fVrz~is0kVRUcYb5HI7H&ewICFYqv1#ao zqN79oS9yzf8}JYi_fIiO&8v$BX7uQu3TJe_T`DO_H6GM{O-?$wd=D)lX(jf;xms+` zZr6OC3Xo>1^^bm@tgKswB|A0`OI;p1N^CC)3Ml}+$3REOO!Q}8riC{WkYn>Vc<#*! z7&|KzC8fWifLkQ*Iq74I+qkzPeW;@-gp%|)^fUEZnofL12&jA@jZ9^-(<6$U-re-D zsW%#2=Svt^LIn9~fS1g=q54zodzpN4pF0%MX@eB#ScL@(n^;vZwW@0qBcgAoQVz|c zj(CxGt|xIqSH90Q!E_09rQr{tURnps4`G ziCinC5zP!@$6?~ft$jRK0PmBWDyn;_QV^lFsuij6c6gSlP|!^h6Fkq%EBiUBUgiV_ z?=Q-${2{0#Yix)Zvu&t6Jgxt8Ghl5j{-bo%`TTI3+Yw9<~N z%T|CwH<>^g|45WkBc@h4v?)^s#zrAx*42kd9y;D%E52vni4IBAj41Q^Ru~sv>`@u& z$_45~x8{X-tRFATXH}IK(Txa4eHstXc~cY^Gd3~b(Lto=?a!vkb6v;4(t` ztjFJUJQQm)Dn`;W5uGqH)62DD>EM~~Q)bi(%JnMc&aheNY2P=SeRtGM(z0&*t8u8g zS|8_mxSBTqZRHgPl??|=>(Q~fZL8XYf?@tCsk^V5cd3#scP*xgCRHUjy)5kcwQf^= zdbOw~9AA(c4XfPiY{6#oQirh6cBp7|74%uF~?xA$H#`46uf#kgSGTr7eT*ttd!BlC}{NyohSp za+I-i>+ASl)eEfzqr;SXl(3%do^0yC4q4BS3MGv80(LIt(d83kKmAsXFZtN>X3OgCn zlON~u<&kn&RzpQVC@Kik)6L~e1uqA8N}f7g-N$0g*ci(9X&sNzO(_u&U=(V^xJW_~ z(KiiAfjTVBt8WDLjnoQ0LbP-5j5j%P^>Q_sWC-4gF>^=B6_{g(tcUlGxVncz87_!L zrqfRC%#IL?rndXbQ;62tZgGX}UHg?oRbx=R(Vuc9JGV%3qaPgGnl}AdxqfJ2kV5IX zOU%%s#^3Ts!%jY@SZN=c|5>Y41! zc_1ZgE|_1;!Qu6J-g%>NRswDi``ytxBJ^X5m4P|ochhtSzG-X8ZQ9nY63vN(6<3x* zyl4~V{AW192gP==a-xc?az#bG-rGg%eSKdYs1l4Ue*Z< z@;k{(YTa(rumJ&c?{H&BA->L+#0^!p2y*hM@~92VveW^_q&yyR4f);1LhHnc3cT7; zE;sY$;#X;Mmiuj>F0?Os7cl1MGSI$HP7xp6UqfnfN)xWIjql84=#seU< zwmfif@u5T$K4hn)UQ1JCLM6iox&5`~1N zSBlZ#w-rL@b)A2Fl?6R9^57(%G**l zxOKN2=KW#+r~Hnvey>7p=FwTf^8P@;JrOe664(H6g&r`oezfEcDSF{mkcA*l*h!~K3wcaKqco~&{UPPU} zJYsdF@5bjfx;yE%_`-CkK7J2@=CideRZ7aJ0_Cn#D>PiyXgAuAd9hF+_o2JfdMs(; z;?8XPux6Fa|1Zb>z{Qj2twD|R{tIVxrMMoWq z91>@PENucsRHi5k&Cn_{{cOtWn%c)tcZWSAnBR9~p;@+rlH63yy^+04-Vsssu_3J) zrZVFc7EzpUB|&QXYi2K%7ER0FhDF%alKujcrGL0q$-lakVn5$`eE*&|{q*|x{O=ug z7J^B3+2by7-a5SynTeew2y0yKK~sEF{`hhG#SiuIilyNnZ>5V*=%e)J_dk$%YjG7X zC@y(U>wmn$nc%Ei$)s1GZ@Diof@b3(NTWigAGL2juoy64R|}yn;acZ+Q?iTuMjX9j zwY&OQbJI)Z<(lm>QKEP6VHP;fvg@70#0NRdtzYt9?0;Jc&2r(3GEjWzCny?vz%)&cWwn}^>um6vh4C{* z%7K<>>PW^+8G?i0vrfaxbeJ6cs_;QcflQUA3xcAlMb0mO8zD(sHDEron!n1F-;q5U zpQ#L5aN2X(GV>!!zgNdSK;yc&9r2>IPq1WA_&%e~-K{U?aw!>ELM8grN4rGsN3O9d z#X<_}H6WX={~8?$(SRgXDcV>YxZrmg_@_Jw9m3Qx>0OB4fIWQxC2x>LSd&XmF8rjR zP?gAyT)+MEpkK_;qE+(v+uemL-Tk3F!m&<<4rqy1rr?KS!BcYkQ}7sPJe_aep0Lcy z<=e%4looIM9M(rE6e;!_m1D=}%IpON#-_n5yP(g4#VzCfyr8DaE1@1I{8hOyp&93T zJ?3dEN(aJZ7@6_q{ZHK|C6PnI=}1`@PMKj8zP77IFSW@-8`+B=xzy?AR59<)Ig)$f zlN7Auv+L!udXHVjovD!J%yDq%Xjz!tAq{Jro2`^${Q+ua<%=@3(LY_~@%A~2X!IUT zdeLg<5@zQxaF4t;tFQjxp`sJA6KEo(0VO_gHw&<+m!2e=lvns}P-@FHs-{m^kYBaA zn`bo*Q^6~zQ#37i;vtA-p{k2y(tiaXOHX3r@o>~C-p2QXRt9KpECPHf8cCwSIXT2#~X7D!s0MbGU;Mj!}Omqvor zgy@4{4SQ!!Tizj=bxY2j=nMHPRwg!hdez^fY>w#MQStE1SCZ=p^eIw1i#;E{#8@M( zcM>SPBhm84z(R{BGg0`&h4_wfgmITGo!wmFdsQb$gk#PJ;X34F#rf@{cmFwU~8)nC*G%9!z5rt8L2%+U!L;E#pWH>2eusQ@EXxQ{1I9e-0Q`8aDKmz}vw7b$ zayR$P&pDpN<5Tknvq|vJMOnwp8hwXbs%%>Wc;L1KY*nCLYF21X#4bp@Z!1Fk$~xAM zz*z0o_za?UvjpQ+52;($mIrB;k8+cCQthx{YREP|tgewqVKJ|Se>^qaQa0;L+MR_g z*3<^9UXFaxh)9?7jkPUhSAGXF8_}ek^NYN&C4DzR##dDazJ*e%Nglx|+5rZ{nN#JS z2_yCTwddS9b^g- z@Ml{ad~(4Xll4?0>4lc*$43R{a5>>|^xH>juT)BypsEK&_9*%y!UM#)!87)-AW7N8w!9$HZ{&=52P=EtUhgeYGzR-PRC-Pvf?d1R@>m1|O_T;Y z80pEFccyQO*z%49mX>p?oCx z!KfsA?=NfyJU=4t00i7wxa;WJE#4n5QB>m`~ zyV6%)<-M3TGs!)XNcFA_rCSMtS6bIv1??o7R+QG@0G%6-rA{vm@I&JsYAA>1W{#>Q z-53nC9OBVP+^#;7dNln5(i)UqBj8LgnNF_#UErl)kd&cQbLM2^4v~ZXe?my6O&kIltG>Nk~?}Sy3pH6nkbM{k z$k{JBS;wuW=@wc4n%e=^GKYs-YmkcckAok!r# z`xjAl7BZ7G7ZmUJEe8`OwZCh*7vWc{adq3csD6u|&Vm}5GAt~QfG2H*nX;_rLCXdi zCnDZ21@sM)RuZkBu<&Z>+*v9e-Ru#rQmVDzQjMOb8;k|nyb656?G1I%XlN6qD#Ymf0 zP1+ZnIa+iE(dHdW8h9$~y5XX1{wbyzXL)Ac0TmAATY{2wA?>|OP*;3wf)Z$c>U&s~ z{I_`f*5MkhP^xg(CbU!VjP~T`EztGJlg}gCQ=FOSypI_MtKy&$xPM~WToGVA&v(*DLQ>yGtU z&7z8MJp6nbj|;9d1A!mYi+u=be`Ou1o|7=DW7?x>w6qk3u zag4ptS1M?xPhlcxBum!trH9pRR@KA(g0!`sOp_PAn1wi&&z{;%J$c(_dr}t5CC?)Z zc^;#pk`j}W(=+!rFNa&P+&q&J(X!~`+-H+8bM7uAb4hBERJC6tYI)t~77Y^WIWjrr z%F!~X^{G*e3of1mzPkH47pL%(#DFoTE_EVw4eY}izToJ5hDO~Y)SifH_NQkjsUG65 zYP)RL@|*7Xb;D9vM}+2GWH%p}*}8IC-@%Hzgf&t-=tXb)Q4X`jqrTf5QxtZzWsVMP zA4(3;lq!IVs;|U-&2iXYer2VLEz{PEFfXi?-wE?5s4u@D*4DW50FuOo=M4ff0TET) z`VCiv%?m*R(9{H|Q(gCszNCTM|t5zduG?{ZO~&qGd5-3PE4v%2hWjD6P^)B zZm>XEgZ!jW*cH((O^-BKf6TaQ7O7e)7Z=+R7pUzQlEp2XEFHLNY2~*Uf*NNJtLe`d zbs7?vqEseoO68usdu>)h{X^Oc_G;QrBSI$aT%ftVCb91?EVd=e?(hs15q&yh=9AS- zDov(^VC$;9lmvy&6yP^O7eVK@XLQ*;Q*eXp&%kjO!ebDTUAy3t( z0_~0gj>!%p92G1kZgUlj?96#K$eC_hSh|VCt8a!%+;ayDd)LGtpMCVRznHly&w$+? z_n%AtCC< z#Ci5=^_b?bDtK=t){-v^vaHU^$TB+2ORk!TvJ&UQjUMs&w-__HrK8?fU{r?ADW}V4 z&ntBYjGpK@bDGv8h?*?PEB8%ib^4Y&Mh>_Y2ySTJawm<5m2Z01`*mhrXX^_=qV$c= z`%X-1ecOWXiby1$VvdBf(wsIFW_`LODI(xc47H>3Dmu~e;+;DufzcDY5*YP)Sl?mW z%5|Z)7|^yI!lvV*>EC}~EFjAJlh@C~cxoPNM=@`9&URA-f2THFmJXrfEw@`~-zV8+ zzwv`{M>9n*^B7^RWA*v^P@lD}U?*bDuYb**Gb=VPQL8|?9g(sqQ)N0F?cvS_Pv^py zSUa-Ai!iXP_Y3;26*7%`q3JHg8awW%2x|&3SiGjAuWmn`LWkvBi4slnmYJ8B1f!$3 zy~rVp@h#!EsY0E^9p__5!8;T`=^;f;w6(0Y@=M+c@#|$mQg(*Qx-(RcrZ-}bcZ!Va z13P(h$^85MnaVV9jz`zqp5~o77y_oJ(}pdSH>s{4H%^U;sXlJL{xy~vTB+*%q>HsFe4lYR~S{nMcGQ5zZQVKwKUhAmHWpv&bLR)s7u-5=_(#$b#C` z~U1nR0ZUajsLyMQ~8dmBHfNi0vRC(Re-ZT1vS(PbUu$#Twf z+4=hDdrLynnbc?EHgYC1qjc{S#`H=WKp65~@*VXJuzWr1>svG9(nSbaz)Nn4TSxRA zTvDq(rs-cn<%9)^AOi8M$i=^oYSU|bF#YH)3Gh-X{AwY)K}B`x)M>}b#by5Xu^q%> zAcRvjcc|xOYknMtd9e=!owdE_BRXp*YruOh`LDCKObOF?HWV}Fj|vKd7FF9MGf6sy zJZ#e6DOT+|P3P623&BdaBA?$IK=ugWY#o2ii36dcwt4uq!FEvzA6zc02H zF1M4|xnK^3HMPm&@>>yJBh!S75(U#eO7b0FpVDION=OKvq^^0SIY6C?vOD^XosN^~ z#5~Y(F)Z3?zx*EO?BGOI+Tq|$?s!yK>r)=-Sxni@LSD328K8hX20)V(r_X@TWcpv=ZFc9FNjb@@&3-|W zQQA8wyqe%ps~;eb%RC&yles6uo#kP*36%R=1!e{UNUQ@sZ*q$dGQhJmy|5a;EC`Ps z=$Q?j6ff#hh6AZtCF31ffq#W?@sEsJM%8R6nAD&vQxH3R^HqSC%}9iX&2p5Z}LI-XT(}3%Y5uQV`xe3UOj0peb`0^=+XGsDa~k#DvP0$Nk2istHIF^%==RT zq=P9+Sl$>?Z#_4Vu()XhhBH%=-73{ocEg)h_r{F^6$%e%OJRC|r*&DF*yJ`mY0Tt^hR zmzedTCOWxI15$E~VBDZg5XDNekKs)_0I`=b?;ateioAdEaS%CfP4#XsqyeMr`|rr> zCpxL32`&%A1Tul9j}(=-}6wg|3c(PO(f<$Ob%gu7~J(x>;(uN$?okF@o0>@=9SB3_wHcNT-Oen=cNb6 z`*UGHsOwgJ7ohPFTc}&_DQ9=%sx7@6`?8o|#)Xg2(gd*3+!bT<8Cf{X`VFmgiHYY^ zfaE&+U6e$YnrCpYr>G2~?~uN$7RkgYP;v( zjdbhHiz1_zch3Px$_r%^?kSZSWqhi0*=2Bueg|}Nl{rdlB{-rIa#WRs~`FF4$#1%!;&mq%E%Kakd@u!alWj()2VObSFyh4{Ye-? zI4ayrTN0PUsQuh}Cg)h=NpH~Gal8<}vC;JnTLAsl^E5iUJO$x=P=O;qfJ~rhHPR`* z&965e8e0p8x&H#v9ut)p9i4*)da8cDW)=$nqSm77SkN)7qoR|vEw$a+R)3@s^g>-H zQY|)ZjFvhWfbiJzvD8%q3?PbP`Bl}U$&BWh2Fg79_o#s15XT9z(dsfk0uv{@TT(>B z@HgSXvvG@0$XJ@eShDK}00^QPmrvBBINb(CC8l-(nY}6VF4Ik^7{S3d;uH~MLs^zg z0bFSxP{_$^up`!f!i+k9fbTBpe$(4(=I?YZ9$HSZnb2G^#Yg&wD?8}J9n-x`V^5b;buLk%1$qR)%3+}|eR ztreQ(eP z&*w;mL((nd1@i(D_O1ptgOAZHH3pi0)R0b(tcr$jnHgvzIBn8>1IB=2{(;Gn?k zn`c>%6iw@7h;j5*i!KzA5YfR;Es^j~$_!IWYhCH=bG^nfTv`%ee(LN0 zez3M;K9}ujzH2-p+bWj@3TB+4E}?f3?d|#F_r>M+tJIDTMIPio#`rv5r(Xyk(Rvm;;RzT;{4)b0s~Qn zXS6k6oTuQNX!WQ$k8)74CHVLVUNSV4gdA=6+BUvsK2u6qxcVthKK?jAp|ky|C|l|t zVs9Ql84JZ{xvgW7Ykk}MITAf)SiWB&X=Q45gQXMK+q+>Ukb0h>;R$;Y0`#8hXX=k{ zt=b%&8^F1E&#%H8jS|%QEL?lu8c*J8r8M?g zhS<#zpoDo~2*_lg#sv8D0W5|$|NVX-qt&X<06rX#0G!bcaoKkTHcwS?J282C{6Ojc zPe2#z8=I+l5AMti>q%{7UuuCfd$w;*XKmC+f6~zLyYF9w%1}Wl-|0#rJ$f|39p3{u z-^u!fH01LafWP1N3f<)|pBEh5lB7Ov&)#aE)z&pWC_Dyp|_Gm>683( z+?3>D{&Q3C^VG&G1Z&&Av9nYPRDD|1q_s?548%75FNU|zSba2tH+gp}CuDMXn^!S`td=NIX?!|?aN;egpFP`GsLmn1+zZ$wYQ zVF_e#law@1LZkJJwS`kJ0P0eI861eby@yz;4)DMa`tbcTbn~t!|IzOt6fj_>^X${9 z-LADUl99>#OvB%fwgLK~=4Z7gk-4yEWPImr%+*Q>U=X)iOOY4p+J8VaV6eQ}LlOQX z9N)kokE(n11i8H75}>LYmQA_&50uyfA+4_6CeZ1;420SWwr2cv3I z8#!$w@A}K%3MTVfVd920y&`$!bqj@criKwE%7+6$LfM?fCL%JWOhk7CKKT3v;;;9t zzNL822OU~dTxHnttwfgR6rfa&jw+S?lHTaExt!k&5+le;DDEZk(kDgoFn?7Qtp0!+ z!8*3{pKV70f|PWT$?KlSJfZvznvoehQbogrW|Tu)hPA{-8JGEGYK@OQD>J;AFgvZS z8IKXBZir!h**tS2LV}r4A|}N206K*Y$uNjV-|sBN!Hbr$Q;6q13!ppqTMnQ2aaV^+(&c%0yMlfecC+6e`##xYF>M zMYe@}%^>7YO?)Nmhb!k-Cw7~d_9z}n+K)K3D>j2LNd1_yEN7_MaQ|O`kh-jQ`CP5+w(8T`azGb?~njwBz z51{SQ5`R2>gxxI;klakzHwhfE`(eEy1fa}5W>J5ve2vT9;tictKub_rDdaZ{Hptgz zh>uJrrKjN^pnt!l@`vRMaMuTMX(nZmA5mO}sKk{bCz0rC&r)hIWJ+hBVbHbOB6nbT z?k!4lhR(e2{!!xH+E5BdL?Y2q$$efdgJ9)Y7x-{A~6bchxLJoNUe z3&=K~u_yno_&+#29-%D@tr|1$u;O?Q;6Sxz{s^HE6+O{X-xj~o)Fj;Nwa>o;#@)4d zEg>*@W!o?wr{?E0L*jp8(Kj72=p<#V3~$?4h>HJ@#<{e=FFhRtL|jSY`uYM0C8D zF{jHI639mc+vy_5#l&Jrccf_$)GR0Ot%;3KuLY?~ZPCj<%dZ9Yx zKQ^M!%F923`A8cVg<3^@>K!r~Sb-ht;Xz*$aM22=P59IUY=E8*ks;~?x;0?$Bh-W9 z5OWKE8({N6yYPWLZ;hA{8*Hg9eus8lb&zAko&wT3ZIFDxdBZSUz5rW&V}U_Hf)%yZ z^^LY6MIDOc@8#=FVz8g}9+I%X!oL|90JZQTs0RC2K$G(l6PKAcj3D)B4k4xtxQQa0 zbg@g+fClqlbYL(DzVk(p1*h5pP=6OfB!^HTK8W-&!}oT}J^n&H_Fu!n7f>PWv9$x4 zdhWDArOYTm;AKUrSlZKuX2GoTfe+!=UN*60|02YH6%COFDZ-aLU=V45Xo^GF;FVuN z(xxHBbGZz|3_uL*(`9EmHM9bu-FqZagSv!6xBQzysT=^rU;yul51D(jkTckA4mO$q z$G?Splxp0Yu5^0_(F+#p0R+U*8Gu#5u09;!(Fb=HUPcnQ*P#ILo<1Vnzy-lUc$~Q$ z#T5-|xNb9OK#DUkIn*__Sy8#u_R(hf1}WERPmof=t>EwJqM=&kPQ~%RMvMxrxL3F= z{U|%Ic?|#XFn~gK3H@#jx*H{V1;7Gm`Pj|;Ub6pguw7v=F6h(r?;zw%x!N831pgi; zw>?db4X#LyVfG&7ZnJIQb-wPxOuxmAEON_Q)XmA2K@ zcMvtl5Q!2c3hC>0_T6{rlH?Xkw{{Hj+r^8L0pHgwGqwYZl@jTs3M5br2Rr9dzt1_a1#)HnRa;$)0uKX)et*>h zgI{C68qPdm$rt0p-MmV(2ttai4%01gJ89b#up6jt1OB01Mmo zxmSOiYLvJu=T>zvA-Kk-Z_q`06k1U}1;myv#^g<@87o|?Okt|$HJRdZ9fx#4oE#aIb~+I>3CZ@K1`T@V%9Du|j(zYa)_3A__0Z2&1G%Q#dOBX8_+OhdpW8WWa2+>IZfsD5^?E(n;W>UA zz*f{aM*g@m_NwOp#Qp!TU!wQ_L5q8vx&y<%0JE$QN}0d$jgGzms@-t0l+hF__*0i! z_BR$IJN`kN?D;QY>gkrWcU~Rb*Y)~?a9Dp3E^4trM4NSL>BBC?Kd6fO2d89C3ZOSQ z^=kXvcBj~E^L540pb$~q#p4OfP4-2(LYu0fJJ)E;_Fp*uPksNJa{lk*qP*`V!JFED z1O0Ep$woB&p^g6rn*BH3{1u1(rxnuQl`Y11jc(}euZsTFLh0{HTho8y{c3i#rJ4l4)MW6G2|irv}pIUqZF z>Om5BVX{N;hfHtZAJ#ZrocuG&8O~g+$DI?*n-6a2`#&;@?U?FpzAe=l7QI*ZyEX>B zL4WgwzUq+&h9%jaj83rA(&zul#1d_CMOzHOo&j5L_#d1I-Q>}{yw@9$`CSjwZw4pC zoOofdbL37mKFRiEs4_n-e}4KF?{8cb`~M)aAF8l*@k!S*ib<5q5-$&^)kVHl?~yJKUv+Ad77p+@u<+=9;VvU)(QYJq z;Qz7E$g=2Xpk?kX4t@F7w)sh=cTDSm_`Z`G;b-VKqQ>tL1M#Uth}9yVo#ZJSir%e| z)Nfz!noW8}MKPq3kiXfy77cI0-JwqAH(4@@CQH}5u7iK1lD!h^_t8-bV`A7hI}6t- z?@8<~ld&&(C+7Fx&B_xrfA^xsKj&$Ki(naS%JHL0s#~Y&yaX}-&bBC9V&7LC?s zp$9TOy_QYJk|9IKE2TBOyA25Klm7Lnqi$YS+VqruPsY>F@0Ws8og)VN&#kvE?^M60 zUePgdtfsXr`ZB7{XXX_;j`MW3)27>8q>BejfZnU+qfU+N1ZhCM4-Xc4B@Y%b%7XH| z6z6I4|GQ6AUR5bO!V*Q?FwDrs_gm1n&ulFS_h_WDd9d!02KZPIB7M|E`(XG#Kkeo- zc(7c^ty?~JfO`J?mEx;w~`Di zymXe=mu*Qp@bNUzNiNvAOg=st3()k0owLWpoyNm1)YF<%K6RMBg^8bzG%{6@S4Zl7 z9sf|~746xeGBsYI!FzH>Z)M|_u^0JqqpPOlQhyPp8(`})>V1gxf`i2e>mgG2vs<_| zB2XP0t#)ltIvx632FIy#dOZMe|0SCu0q*E6mP_ebkK2Pz(Q%!;^P5OGMYHy0_2Tmf zI_g9V_XX46EKw97sypS@D=L(?qfA^EQX6{#A`c(_f9qWTM{giKvJF$o3x3ia73H3` zf<#4ibJ*lM5lZCcpig73Zy-|tN6h|dfd5~MjQ;?Fgrg}IL_mp_Wa)anvI|1mC_#M? z>K*x0=bjNQGKlRX510O>H1NISvGjD{ znLYnDxX2n-MPy&-^$TE6$&ui(#)Id0aFBf8{Vo<4J;Rf*k@14-O7pd$9lFL=@3mRVa(DEZ&%s7DHZim<0STj<%#LokQ_Wc`nN|NR3Z($@WjyPCr<+JbMB zkv^*Go$n~pcr%ii;q@LAO8gG6fzIo`bn93XTyTi}YpMM=gqx3L4O~iq_+bkt@=G$9 zjt_3A&#}gvx9yLmUQ=}b0t^dN6$=bHWPj#?W0suX)R81wxTJbi4&4*d`IH)N1Cb^FMF4RK~FsBL#>< zv@B;R41PuvcM4T$85d5;bfcm=YqGmAB~l@Ug}1sD#6>J!sYPpKFVm&VhE=A2@|3Nd z)2AEJbz|D_0?o#rNGzp`h_DYhVAm7GYUBrW7=cy`pS{RO_yL!DEFFK-E&tT0F{7lI!;ctl&Vb*PS ze@%RA!mh-EyTr^eB$PL;4$g9z`k?QqUEj?cxsi$AwRX(WT-G8*{ftf4S?|+AN1uu> z=a*yyRaXs3RLyAt;oFzsWoT&9V}-7C{7|Q2`|z+w0|lyCaSN8lTPl8q{6l$6ksMHZ zy3AD2*7xpXQ8u$X?B>NVuVgQX70c~|DwU1nLNgMTX#WxAF!S6`BRV4jnXa5%3wBdS z#_Ub&@j^MAL@Yw3N+pH_ebywboC0)4Z@w5EOoUTtyIMi7pynenM#|IYcP)nZ9o{co^+-gMQU-u7N&rDwRc`}dd!m3$CAu=!QvBOBRCnNEho0Sg|Qq-hJ z@(71DqRZ<&?(Uim_L-VD=UNuP?(I$wvA6sA@sEHu9VeH@%0@(R`i}2#7e%j)sNC%MF+aH9{i_;d$P`;{2GaNaAFgoXGjU6ab!T)i9bomUtjmD_LaLh z68c&nf3+~m3Tt0=Ws0?pp($~Xo202bwfEj}gcKa%Lx~;RrkImT3Zv-aowqF62@q_TA+Ck{sYs=aaTHU`DX@Iq6y!pwS zynmOpN;`GlO@CWXyOyq^(vl%RtmSK3w9(7168(F_IqIo%+gHwR)JCiLqC{5WYqG)!uo362&t+x7j5Tw zpp3z|ay}P;lJ8OBg(li~QMs-g1w|O>$)o>A ziHm2)TCcP)`EeF?+MRaw7SnrW#G(9V8mM|>5hRExe?7&gImCxa^)eIZZr=H}2j6(a zL3hscF7`ri=ig>L?;C~-YiZSK1Yd6n9C4fieUA%eC;38AymLmnGw`trbfny*w< z^?+p-0{(LQ!L7##ne-oDmVN<(%7PEnj@J^8lN&-0w~KF|Ap-*a8x^?hgmVQ+Kq z)$aRVd#%0Kx_`gh<5bEYM@nPy0V0FK`yfxYv_tY(b7J|tIN9eQvvPvI8HXB}Z>9l! zr26W}HMBdfQ&#zkuR4cP5qM9xrWtH?%@hcEo~XLhFgGuI%uty2gtHH&R(XX7L4vuB zixw|So6b;pMT*mo;b2mAwB$-*6~ePKUCatVx>$P7G?o-`Exs_hs_0Rg7V+{coygt8 zYP{!rGaQA&J3C($UzjUw@o9`~DrWcTf?(Xvwqrz1hk5NrLxq-8qs`XVkjxFPl~i2w zim{WUQv4ozJ4rb{X^Zu+nV2}MjD#A zfVF7bxkt($Dj|kSc>BezATj7%{m!y@%N-Fvb6j8T#AM@iCDm7y5AWUF+AJ~QXN-D&H=(lAlzM>W^haxD-Alkbcin@Nzb(l{C7y%xBhop>7~K!@o#7&{)4 zBSYG-^Re%kRc3`g8ATavhcK@j_q46?ro~Q~zpyQZMJ>uP``aUgx?iSopJ0Iz7^y8u zw=YeRR0BAXUbEzW@;Uo>0r%`#-v#8DE0-Kl}X?v(*!&Cn;_Y8 zyx}1VmaPpfO6-v=skpIHm7@YWh2Ts!LD(v~Dx4Pp3T3|-h8B7Z!>wADMOy;INzbaC zxfUJ8gChB!TiAd^oH>GyX~F#k!TM7vw9F*A$h%p{z67g&t2bYb2NBsLX4C4E9>&RA z!6~%w4ftq1_57l)KE7NGMR4hIO9&MhOofiew8|R6D(dG{G#%~7o0DI;W|Hgi>CtksM%688GNu6ZHGgF6ZvSkke9;|jY}JKP zo;2^AkQ#m4W%sQ57H4-J-UhXhqRd37)t_Oq(_!ba`z2++Kh0+$~7W!n$3u zZ8q3G<2IOwAKR3EI}O#Nl}`sEC)1f9QhUR31cF_kpu zki`C~%+UpHLWSyAe)S!hH>%4ON?!%Lci`6$$*LtoIxq8H|B{gCoaM?(ZWj6vrz=u; zef6^89@9Qc>(jaY&&U6vHww~RZ_}?EgB;U zlx&w}GZGi&$HoHK9PIJ&YS=xyJ(Cb2T{b(PFb2Bm80etR&&KZ7;?ACp~r0Y`Gf&84oa=@*R{RMjxH1_v$gX4(a5^af1prcR}Um znJhT8yOXlk`mRU@Zh$Iz&3S1!0A#QKm}^|}czI6hdNh5uEn;jop}xm5?T$Uy#WSgT0fAtB9e zYH_&^9|rZ9pTdoJ2Eh5y>8}2$J09|C$>;c>3msNbY>W{_oGX}_liI0nKN@k_;l-~< z9xk~yw#+iA<%V`$*((Osi}pJCJAj@l#>kbgY3ah$S`qP`(gY;0C}bRF<+{eGr1(f( zp!GW8aQ*}8(Bc~rlb7T+h@HznsmzKj1ga$M_eqk%YW;CK*)X+IVA+Ch=!Y&>bpK=e zeaM0nIMb>YX>5dkldgO*GrG`dY{|gQ(YE{0HFYJwG;O{%qw$9vus*NEfkaD6%#xFm zozktIwpENf>`Bc#5b)TW=AeQ2(iXGPIkCBU}jyskB7lfV7pyBwK$>iO^_4Z zjhJ#!OguHGP;(p>Fg3FAVZpOsE3HoFFf)DIW>GD{WcOl!SiFIzoAB)}Z~>6TaQS|` z9sR&Q6@DZv1c*GcB=_mx$VRNesk2vKap=%JDojx<7_l&P^^}G#?%alKbMhR$^KI?8 zNXjRn&oQk~m?@)Ek8~QIs@)t;c_rK#u%XXQG3`pPCjDJpviF2^waq@ASfz?%A9ZEp zl`_m_p<7YIZu)yk%JK^&c2SRQBuVBihRg;{!W;mSiZnUXmi)qYN(K}!F_iiIDc6;5h-m}R_f*|#y1t_9RPNdb==_7p=dQ@adI+_ zDLrzAg!eF}H=fPu2iT=YLf#)+k)xJ%KVdS`4w(2;QBzxr=NDmtMZpNrXB)?1BYbY| zN}orY`>}C;)RZg=S723&T^QN7pE2f$4Ft_pB?oN+bFrih7on@)h~T0Y)F2QP5g0s^ zJU^A)k*ZvI`@qG*w7Po_VIj9SbI7bE4Z&rII}p?u2H=6XgQP=YgQq+$6RP8 z@pS9zmb#`(^t4$^xwRlGNC>3UEQ{dkvQ6%b2r{+TNpez}S^Uyin=53UiQ3N&jT!A4 zENS>smuYN#cBlvsU4@#R6RR`%nky6(I|*m6Wa6=(!LP6>2pbEh)FLPa{FFH?s}dB8 z?WNf?T-+5(47|%yppuQLu8?@cl3krxT%+2?dL1qyBAb2YK)w<-)_VkAOlav2deki; zWHo+`@Z7!K*?*Pf}Dw%=ea49c8^4>eUBZNRQR* z?4yMF_KaCv$xugHzHW0rx(=sS^&WLHvmj26X*2NH+c0xV;$yf|d1E|L0_#rMVT6ucM_r`~xa}{dT~p%+)ID=rr#T=)UwFnY+?k)4vQ~zdI|l zooA3DpFoE9IsWwhtzR7d>-RU_U%$VlVZ@t$m&(eepg@f=hAyANjf zn7r3D_Yn)78+s?+b&PPNRfD2(*73C%LxSB#ZW!{I3^5TK21e~~SGo*lJ2c-F<&eGi zyWD@il%mKAHu9UUtlxH1SX9l}WmS^99GZpg%8HPOr>-E1GT3??NF`*Y_>`QrZdXiW z1|?|#I4Ie7D6%bC;cR4Il3jtX1m}jJM(6p_TU$>x7&>|CUJP%G2IxbX*;ZfCI}R5f zNA9RU!VTBeb+VTn-;sfNDCxs706Hfj>|Mqj#!fp%UHrmZ{Hjj89A6s;ym1-?G5?^H zv!S(O->+;Xe^97P<+9v1XBJ8-TxgMEBe<#Q*f77?BU<> z@|_1M;Es9T1HqHL2&V9JUK; z>AA}vTV|izr&}*FvIQj9AUV^#l`w5>;Ke~cO6;BT=!fKNIzs*GBsq=EeiH$QQipOYs*B8_hZ z1gQoo$$YWj6LeHM^Qb{H?EJA=lADsEtUfw>Ke7teVgrp%6ENfXi@a!1bA&(XYoYv>3+uANE8_A1#;dg%KwiP6|1tM z_|_G9J*1TipGZOv+MyOt=*31vC)~_<`Iu-C?hW$>U7E7|4!eg_IhD6j_5k1V;p2&t zpbox>#)WqduN!7#;{cEv?MJ396cH84M?*);VPP?ZS+8F>LsCYB_+Yvra7)K!N72I4ABE%Mp`U7n;m z1S~7n$O;uLk*BzlakRcr+cn^zYo()xHw7NgB*M^RbTv3F`;#QM{EF>I|A-~4F098Y zl68a09ZnZhPk3d3uInfXI@XL|;p=rE)t?{CG*6}NBd>?mt807`2Bl^|$aMv5vaoAP z2)2Rl&3xBawi-6F+yY1;MWwaYW`N1MO5kHfRDjTn_O)hnEvW1eGNea0FRw&6+y1f% znHKQuoQowOu?A`p<$Bm%HLGQ8*ah1{Pex5Sf#twO3!woykKE4+sp5YkpWao?NK37ZPe1&oC3l=_HDqk2? z#f#!(ue+6IekIY5b6iC%2H!^0Csc2>LyvbP>jThtl*}-hYoPGRaa!T=PKk0kVn{X& z{XBhntrzwwrr`4sX=?mRw?*276NPV!z0VmX)p|XG5S71;yzQ`6W`F6TrIy~jZf8Tc zXaP-3ZeWfXMz(1bz!%Y3<#*PEkg$jLm0G#FnGUPv*zwVGmQwrg3rug@@z)v+Jx`pt zOY2FJZr&Ru`5>E9mTXt6L9B2Dpc?5sXYz(1eRh>L&9lr1&e9bruH7+H;* ziMePXLHlV02JS5MpYDSiMnHTnNk(GYx z4bVj<^h-LJ?-ywO1A&G~8!ijbtq3=KX%6;? zJnBQ|)Iy7EA3HP2FgwV9*kvYQ>@cn^l<7lq*<*M5mC&mlt#ZH@l5zD|MuzT{OSqAs zTMZ`x>NS(u_y&Wi5p5yuw(^^p(l(5NPN!w_1SB1z7fIF2%);5RKlj z*mc5sczD(K7Nz20ssO~SyVtwyA=gaQs#S_`OmxS*TWRQ^8?i1;snCuUD$suEfvT_g zNLGV9rhP2B*Pi>bQUOiT5qhe3^-$L;rsimCy2n7WUM2eDW+3R3q<&k3wW>Bs*Ud$u zLsC*KiB)*6al$YND*J$U^qA^E_y9x&>%YGVh+cq~c!rj+!!O0B)>7g>Rwh^CWwv^+R`UGwYDR3Fi z8MNh#X-M-980u$QDndmYztj{q^Yl(FPTkmT#rq8R`iK&$h zEbm&B4u3wNOMxGeGD=8`O_dHHI(er=BOxQE(T#4N}tl&DUhnt^G%R~hz{163aVp|H&Bg8C{M5~ z!;TKNUSG0Ng4{hpRDUCSy4gXNG)m##Unw_IA1 z;vu8ogE`KYsdd8kmKi{$>uH)k7|b^~W))o1>&Z(ITn~F2VOk7M&$uxbFP*DSW>Vvy z{A9aQR=<*(?W-H@)&i{QxV!L*;aZCmwnO>p?s9>K*ehj}d#9}RNL3yKjuz}3(`+Wq z9$aF*t;4fuA>P3*i!6Xnbz)N4$LO-KdoOA`WSKNSi4Mcc@#A(Ilm+7JMA{&5WaK0V zH8wLTB^Q)B6_*d@xLa>TCW z#cA5o?@`G22~BMcY*Mzzd4iCF5(&&9tn7m=jQpd7wDxavv9?|ZQAOii{F`f9DIq_nEg>2E}z9Xe2W-f1?k zpO#X`r#BiY0s19Q@chCJqA{9y8a^_6xe!B+43E|&h8#r%}ihe(d#dy zkRo{Ol+h4IE|P>7oEi`~HzCqox9opLd}Xx6qAH-7M6tK%?wbgkAj|9I7wSVv`ubUn zjG<@Id<9()vF>Zjc7o89!7}S2(S9-9l>fN zGYq*OCAsN{(ELq%Hml!#|Gpq{FP{ro?eG3){ZWrTeA(&PIevVDPO}qO-*)}#KSfr6 zmzie2buzuKz!(9ntsz<0ysjZ8_OpunknshOaMQJl!9mW1r@8nWp+nr$3wPBo8i(U1 zAGMc#Ci?PQ(Wh4oP76dld^RnL4`#-l>qm-x>%VAgU-<1$vwlR$_ZOVFi}kvQdCpEv z@cifgoYP%9ubl?Z^d$aRP8G3lv~YxNYGfK$)iwB(3%H@ACriIa-k0NRe#Qhd%lOn` z4qsqZUot7D?;g=cB7HN?zMg5Ny|g^V?wzQXnVvo=X1wnp4EJ+AZw%laCZ=(_l- zXTL#{AVu;MDGMjYA4F;eO?h5jRUZU;j$O`r-JXbyuCl4f&@|OxD+x|vT%ajCI=?68dH0ZJV!1CV1UF2rTL)etFlWdwzkb zrfzgT^us!Nx-MdiJQn3~&+#E~5|gL*|N9BT*?u^b+w=jnQ3Ytj`ZsNaNBb-?gYU<> z*J}~Z<Y>}+-Y5ZvRob7DfvfJ|5?$e7X3d{f_AizDgBAhfnOW!>kp9h zAIp{jRs%X2ZyldA<;Y(CskRh9NqB#h@Br=LXu0~6MEd8J`vw4Mcyfq)lv3XQEc&I1 zS15s|Jl!Ymk%9bFj>Pvq9bq!}cG=v@H+rQ1LW^OqJy>^S05idVHq$owkEOFtFh4m_ zo@3@yKYaa@`=1+#S_SO)cL7^}tLPv5;@@8MFFRWD#~ekff0t^IdxiM=c!jE~0+Y$si>=qlMBj#e|C;2~BQn7*tG+}t8 zzPYWIilbWKxP9Lqj~uL_VY!b@)LDJWzMX(F+|gyhTN_(Sh5`%_1MwV`H#S}l`!HQD zTtfKLgJxZxt#w2KWA@L-^diOkUq^1-Kabo*L_D@itnKz@1$BmEp{y5RD6uXS=+#q? zjApZ?yp#yOs5Bw!T;9pD?H5KI#6#`n%DtSK^L`ZhGbbZM2wkyPCL(U6qNd~lx( zGVp8t!)D?e{N+uDgcH5N?x#&K|obJA$@Yl_&+z} zt9&WwpSH?n+TjBs^Uuvl|0xV6^yg+Aed(J0SDN^XRz2~gIQ+TlEY5&4xe-nbfA*MM zmubug0`jyLk5Bz#4}Vzyvj>Kk-x7L148QPeJ(3TrG|GN5v1<9oP}AVP{jUuJvi!w! z6Sw|9Q?Fd||BFuZcdLH?MEk$Hga6-QtE||yOQd>pf=P5kupkw;V|Y*oZ|hR1!SGgQ9dKMO#~BleF+@|vXII}57qi+xB#i|F0+ zjDRZ7yau4gh+bSeJ^#ru{v0HtdUWvt<4rlDe}rrKliUCB6GP?jr7J6+iOTL>Tqd$1 zdg=tk`J-MCjn-W_0)l8rz-RbBw%YH0gj#>=Kdqwe^!J{TH>W&K;WgN#CLTK1z9Abq z_nK(exkJbsQk-LHh1+I@(kUZ)LDRO&*G(r(4vj>p)I{9{9S0A^wm$7`LW<-!1P{z8%4!1TD)3GkV4m|Jwo#1aRow`QD@oMoeK2zMy z`~W>aCC$6HF>|EPF|iopcr3LIsS=5K&wT1O$H$LU|}!~`=~y9K>SMr1LkE>psQs7 zo%0V}%~qQ1d4~Gb`jAcX|8!hvrI@5t%ia(f%IVrc45@#Z;kSg;_v;EFOr4P`QJUp3T?Z6VDLP?M z83mQ~)u?O2b&o4cS$hs$ML3odHBH97f&?l>1YO7bq*)aU#N#|k4-!~fIqnE+d8Z!; z>M2B6Lu|Ad=Awq3%xxXzrn^do`FpMBcmt$|tVWYpa!d<$OcjskKogCHAsvC!&6@~rN0b{{_{}jKm7W<+l=~V!u^5XLy|(OfS@6tXL;QOYSH8` z|GlW~|2o23!Y$}o;gtcQD-UCe&8TlY?7cI8TQgudOod=0{kiwfw8w*9ZZd6GfI0Qq z=gUF+k9N_|2!5jIPseCJJl2jQ5K_}$|1!!?s6< z8~`+hloX2?FQ%AI2_c>mcH;93zu#T?iv#^~W^jA`-Oa~fZy$5l@1*ZS9|7P>|HW~p zVfp65SuFz5{Nq!+r(f^pBp2_-l&0L{azHui}5k zOzioonZHVZj5fS;3>7r^hiJoxe~32B#Q%$E!(TIGzjygN5y%fOV%P4G6FEo#$YuX@ zT>0Vjrz@{*D!YlVmwq98Ml`l`il%n4?jPpdZ%7xsE+_~7yr)(DPxrL?{BBR{nb+r$ zXYLxAt^NcAjQdZuby_D^cv(u0T>ZPD3^2r0Co6Nj*k;VMD0teX62Eui2$=*>^?6jT>`CxgB3SsYN7=M^| zw|ZWbq*%P?O`@I}4>zJG*V6)PM=l~~3Y+#oc)byk0UL0tY37ouSTP>(HVafFNC(%K z^VU+wl13Dn)~EXwLQDp4YyUXXN;cRW4;PM-Yqng$Z28yD1@{E1rqk70!H=eAwg9KfK%aTnNA*U@76*LF?G# zj_c@Urp)@UDXPVksSkOVH%_qWlU_3ePH6p_&J? z5N(*76D3TNF>hW@>uEr2lIdVx_v4i;v`4OPA7jpE#X3vd-D25FEoa{;w_K3{N~8m5 z>jIBAp3+UOQ&pdZv*LKP$3^Q>2o9q{y?&)KudVLBroLM!6$OK@+9EN7q9(xDTKp&8 zO!VLHlE6lUm(XGXh^^@Cvv0lsDKE{&yD{#N6{P zUA_^)x+(o0t;Ow|I(cT8C6}lNP2^D0PFf+Z^HD86p5(sV0opftrD|%=oSB?q4f0RX z>a$UX(QG(Zt}1xQ&AQs;lCt)J1@553l5Y3cD7hqcBj_yU%Mkga9K+2EiIS0uk1UJs z92&vtg)(gH9OIIXBljde6wj4_7IV2I)0CB91(&+t>d{wc5Sweg9~!O-pkoQXTzlj* z)G@eH)G6_NQ8TaD%kIeer~}|O9W?l^*D)T}uB&u4Iz7)Ul1qUvk%9H{aQLj?0bj-8 zbC_vcIj&z+Enro>a%5~`Sz1#0;?Q)NGEb##6+-`N|VY%u@@k(+8D3 zh!QQ4ue_30c<8*pJ@I%c;o-cV9+iFV)? zK~cNyZ>^`eA;mB>Hu)RswNINU2D%p@=C4BK9+!{l1Dlm9@{l91=yl?$Lb|Rts2owX zW|zxC)Rfo{uDqo5NcP+48^1sA3L&uvOB!^q7{gR{_>^|m5tdp>OLFRTPl-R_SJH+~ z?C}!7=JIG=mo9EiBXPqFXAjy9e%~jsnD_)GXCyQw&6cq66qAOT-;NTq;3=b=2sxY* z)9cHBPTQux&Jhz+4@_@lRM-7+ZNi2@Ul!Ev#SDO-MA0D44J~9Br4m+397~ufvzOoE zD1+cwbUQ^&s64i@59cz*&_G2w)a~U_jf&6rISrWFN zp@?t1!gwrh3+1JlbHyT~$|!l8UKK9?G%H=T=XR>8kD;*sttMO4^Z*PYDC_kg2#aXel|S<*AIggXY}^k}qNy z8MdC7r6+!Tt*Snho8Bo&C}qu=>^MNJ=kE1lAT&`8tK`+1foR{k#2Q=q$vX+~EE9)y z87C@hmi~RSos@{+fvw!QEeN5C7k6TAN>=zO?~WHA z(K6EdrJ)5Iliex?#}35W*@9B=&;ua+%YUSP@s*#^A$dqBJaN*!Qy2PClW$g5zD9ip za~m7)Xx!CmY|`FnDzc&MgHS&$}tf)=Jif9DNi+PqTx z=0{SjWpl=^`VwVgr%FWZWIK8!ZnTucb#qXBOS*@5+JC&#z?LW2nvSx$6v zk_kGmkRjf}w-lZ^GZmw>$1HLVJi8@OotooGk~WzsA{}b*V2*#oHM`K+Bxx9#v`ign z5^b6}7$1z2Ezx5aS^U4ln`7C zVX-fwxY_pV)wcPwLz|3^90+$ahp1}gBxf(sTNu(RWFg_It0h}@bmqK~2{5&)3)+<= z#%_DFg~HNCyh`GTGG!-#b-=$z>T<`nGG8bp;RQ&~M%6~;ZC~?dQbce`zWO4#v8UB| zp{=_%6IExK;AB~{Z?g&0gMEp2*f((4tMGpBEMepzWErPYXEIA`N~#U#y`s_*ftqsy zC*?>Ca*Z2yO4Z{EC+CV))JJUS5mpyRhF6^28855ntqAUZrJ4623^NJ$gwV7VityJN z(pECp=`Ywy8cIVAt!OWGNazm@({hZtGQs&|%|grk3K}a-XZ=S@y7M--BGEbhMKe_Z zDv0|DPB=ulnIiYguTZqVn`Pd=xGnPrQ7`c;0+0HiU~^OtCH*cGn8@aX>O{Lz({$9s zZ}|VzfXpD}GU1v1RI2Ave++v>D=51)Lv|_h#5~yx?}bULmGK3};R=i{@0%iV2gDrb^J3OEMk+Nk1QROT4y1}N7k{MFy&iTo`aJP zhv@b3_jduP1`aquReB;WCB+i5wxhxaAnWWF3VBj%y2TrcW$HxC7ROC;c3uJJxTw0v z!D85Kq47gK$~If2QB5iVig>jXEw_d75znz~JG=_~q7;30Qj=>!&sE1H!k+S``x?a^ z!#hlLR9WJcA=MdTf(a{uTuO$E&C`=pD%A0rW&7EgVpf%qR2yX53w=GjNT4${o&lq{ zsbyR6tdjSBA+h2%A>?-J-3$vJI@RGOvk{a7JUYczMmFhKv8~%%0ELY^96*ZLITZ`C zZI+mAq*<9-p^rieNUW9r0rdNa2nOY%$d>%50-&L-EewBHs^T=U@+k*7x?QxE7CDP=im$BrO z38oGpK}n;!#UXyXa6(1=V8y0u7^vwbs?9+5g58jwu7PoB=nXbR$9DOyZE)occ&3Df z?($K5YO+S`;D}#BISoI9^n23~_gX&0^knp;4bAXVD^Q{4Oo_vq@hd_KpO`z-1!;oi ze5Q+zdiDrSW5Z-;$u&@Q<48DpMd3JpRo zA~<>ugsm_IIWu>s<>rk^Qp};c!#R&So!mYf+eiVAB84<;TJ+Hdix@Zk_v)Em->py( zwj7iz7~-BEE2E<~lmWnjrg91qus8(7(#mgqRo1T(ZQGA4trA=eo$BP+?dwA(mSlg~dSso`tD#Bz4H4>VVLY`D(u2IQD zK*Ssu1e*M@1X9T?Rx!Gwo_P#@f{@qkM>M~i%(WG4=#*yN$ax9vYMNSC?TVdR><)gp zBnd_H==8JIZ`&t@Jw9SFjcdeA^%W6EAEl7XJH)e#cRD4F%sY=4n}_7+ne9Ci?1@RO zdvW06C_a3k2Ik&nV{QvA`bgL%Goa+{m}qm(jz@UzjrCLo!~q1e5x!ozfd-B%^)IQU zsa=yA=Oo)4Bl_)4Dtfl0xI=QuzLtpg9tntDcT2pzg@1gM5alCX+hUEd^zubFRvdzT zOmsgOY9hWUKfKMBUh59XCq;n~kbcFfGu+oEbg+nwp+45Q= zS}ied%Q|Oqv~9W4H_TTKq$+c4D!D&zt3iakgD9nYth`K1-3lZO6Y!oPUEP*$eXXBu zo_z#s>?v@L%3iC*o4PhG_0R_9Z3B~EBhJds)Y?sx<4ZN2kNNU>_peud*M}{zTXu{z zdP*J(tC?Jn4Zzi^q;Xt=1nai4;f5TgXw$40YBJe*1t?wmE8WUc&OI?+LR~Z3^~a)4 z-Tp;CyPo<}2iOmX@}chK4OAHqU_;xsO7dghi0tL6y9H&n#B`~c`t;+9dKEYK;l>J6 zU}J8-0Nt_i={j328&|G$+Qc2!bkU;FPfNIV23D2!&0ZKti;^(p>25({AfqI;d@OHg zxIsuvf{ccY?1k_ZkH{KmItRl{VJHb(gz!jGxWdZrE!Rho>yT=MajU2L1AzI*8D@FV z$imr-R1r`A?TgZH1LyzbMfQ?0qk@lv2n(C_x4!?-xCw9&N?A@s9VVEHj3{~iV9$iA z$YFL(sVPIKejP&JsD`xCrVs>f98e?X+SZ)aVifB_FF#i%h+ICPOPOm5T)W;GG-<0M zf|T?+hfluYg*+lXI7hyfYM-2udf*b4g3TUr&5R9pJ3h&|txH38_}qK>OV@E9+YX0G zO~TrC?=&IaSz}zx#CJ11)AY@6)nq9d;y-2TG$`{nxQUL(nvu4tHiZkSBkIAiVsQnfYY8VtWj@~G`1+1akm67=MzX-wxSa}azRi3kh0i7CfpjgRwfe*lw;!>3lzgjVPrXWS=o5H zv8KMxI&-yS&#h-$6|`1H`j7UiD8{x!P6GS{_KX|-X1|h^TE6MZ;m(lk&<>`S_SI%I zEixphHJ9Jz(keglc=pnm&qqKGo2hR(9kO{qM=3@_lSk$Dyy7c1ccx>|Y`dU3=qb{e zCO(dgE?O^o3fYp$OsP;V21*>~^a&m_R;^>I}tPj~0UQyL~6 zKR72vxH>tRnP5t^&Y`5>hT`REA&8(hGuW2ei-ndA1P?q|;Y8Rf0^8AYB*Gl=2&d*I zpk|~GY~YZ_0u%8f8MSaEzl*DFw+Pb8Lkk%=?QW5@WJ%owGWUYgSom<{fS*^Y1SY`+ z6cl)D>@2k~)$5h5IrA5-nD}W2>rgPNI!*WMkDQDxN^JKjQ(7KhU&;*vVAu0_v6l4T zk3KXr7wXdCYq8S-ZMfK{fqK_tO`*X{>N(;tRzo_=45}NPwh0SQ(_QTpyW^|l?>aP~ zI*Rw8ou&Sx`dvey@~b8&dgu}!>CvvTYUETCbH9=|Y}1YEpuu>dy}i&W=xCQgO!Qbe zEM+>|n9&d34mgp}VOVVgsTfAG98ytC1 zuH86`7>6v$h~U~`i_|>-BI$L&ya;%i-*1PBUwxb%%qboPNnwXB{;U5z$9eBGPJ3 zvi%W->huQ&C8fr0yW_+P+l8InJ(fDtpxcdtX;;D2s-q-@FH5wO2RV6WI*RaD-Kc@? zaTIzTwxe>rVR&t1S)44lN=buqwODvV2?kyn?)AJDH!J=;6Ot+_hUPcfC5yV4y6cjf z4n+#p+j`)(9YkW1FKA#a>tbWqAwmzgcJ7A^%Q9HhR#gTX9y0m#MHdMf`*ll}@oOmV zvE`_0I4cySZ(JuR_2!#ztSVuL8k;*I1IN8ncxIa^tr+8r{-Mi5n};sq6$#Nx_MMh; zc9u(VvxOG#v}E0x?UyJ6qLet=mR^cEuyMlb)#`1B=@u8r52>s|N|{FvLt|69aw!<^!)$@7X5@H+K%vQEY%QV@ zFu8G#P@A*R{>McniT!sbRx@i|S@vy7X)@5g!ecqh_OVY%6nj1-E&ZI`b(ud*b7C`IL9b6^gs~0sd&xdg?cK3yezKiR2ca6P;$SN- zwF}xLyZc3t0A!PADVdJNx30eaZS?u&>e9_Izjf$7!eni__#4qOl^t^D>3%c3_v?{HK^t-g@3j#B$kqIC8vjC=t|Ijc*^eEu%2(@u=tD)G74Vd++jZH*` zsHz((DhCP6!LTIrH%ge7*($#HD!L&J=jXd$iuyofNiz8pJ(qmAo@<;9j3 z2L{|isHM*f#>jz`3Ic=0ty8;Zaw{1|5*-bL+vbo4d@vhIg%%i6Aw8T>p5VyDbU{>e zLOq~1i0W-SU+g6q;$3}T8cAz}svx0*#D)+aB%jMtUmYx8IVsEb@mkdLu0%6P;z!Z4 z1{F)eL!4HqJi?dyvCxu^K_ObKE$fpsuW-FudQ=G&A7!K_!L&?zYXcHqo2D&S+j9bm z&-JwF%5F4rE_XM<)lDJ$d}*>EAqo-kZ&mZ3DV5zSr8qRHO%3_5Ud)a}%wM7y3stAx zcuN?}6rp?&O^xNpC|s}LiA1(QC-;}>3!N&OCJ|>j6H1Kf%8B^tU>j_p#eNl0C zm$nJcQ0UvRuIp8Kn$5U^6H8W|{2m%%OIaL4QC|myfbQgKFJD zJ`faLr_Fh<% zjTvFuct5&8{lx=M^N-P1QrEc2S z7Mg;=dE+V8okwKhYC`M9fsvqw-6YNyN^Lgkcrm`asTHbInU$BzWm$50(wEdxAPff< zl9-r2u4QFTa(ABvS^Rj?CTg9ERf|+NgYLtqxLxF}VnN(>9QcmoSjzo+m>wAYVES&) z$eM6^*0i0w8cR}6Q?`HNRKMA)&hq1d=Ri1p1>btfh8?V*`TYX)Mc#g5=_m6^KB~Jr zs;1z`*~{tpqzvk0{O1#mSepQ(LzR@!x*{GWj*C)=h@1tKri2CR;=G7>146xxfCx0G z)#7TP^?lJy3FWt2K8=c27FSm)xarQ=?8KWUl!!04NxW|7i-XBQE(D?8C8*h^sX~W! z)PoeA_XVdOXV7RwJW6Po&ZCVoo#H#)vM_MLVtQ|>JFHji76<-eWPdJN# z3Vq>t7WZZQdKyBVwF46iQZvHp^IXld7dvMDq3H@*%v<#pvRbi)x4+2Z@ zrP;@Zr@#&$2VLX)<5LYPfzanaEW;C>kISdJNB}r$flrM8vf_*B~hrt5zizi+fZjrdVX?C4f=|^TrK6u$jQOg&b&O%pF?%6Fl8u` z18Sb!4=-(;Pw3i4@-!qZFO@(LBwu?gAX3 z9KHF=CYqnsW_v{A?S0Ax`Ol<_|3a}OZ*}Bv*Nbop0&lHFCAWB}o03=4{D-RtQScev zRQ&4WfZjgkIMcrO5a&CNtXH%yzn>tW)N?e;T?FbxWggQ!;B^l#waR744M=H|4bQ!M z7gMLSl&qwNWYxipiLniDiVCDHCTi{|4tq0cnhko&&xW0AHFmfE&HBW&?6RA`ng{3S zwj#JB{Krkgp57nna6L&n3TaIOuCXT2`ED~Rljh~2MZBsXsF_DqL2b}(#@OD7%+@MM z3HZt#GBOy_nH}Dv5eKh_n5@e=B~ezwvm0wriW8|Bel6+!gURqKMSUx`a*wV_U*F;N zR@)CFg)DkF6Jl;OP9X4Ho$8rfJI#?taAqVKXksmeTQ_ebhJLs{lOyMo3lu9KwRoVz@WfP~ojRk@8a5H9HI_?8D|$Zs zSz!GSg35<2Qa`5nNl@GzvNds-2DBdj{VY>|Bf%%ISYp0a{gde5f`6eB^iPiBvBXTv z=jqN2bs=oG&Pb*W?d;sI*Jj*W11zWr2Q0{vRWo!b1j{v&h*)E?nqI*Q=$aL)ahxpc2np|6X}D^bI;0O_ww?Pbg8|k_BM5#%+h>Z`>ZhN-AB_Kqz`&{=zP<)g|0jS zHlu#9?&W6r3o+@vi$A>bI9td#GpOl1+Zx!V7U^prRnx`IGxDz!|BJl;kBiU7t|E<# zuf*kBTHpLtqYut+lPHFNFN-X@^(cw=8~#+K@7qIl`-{KW5{RA7iIko;9Cx7s9h22!nw zh&(0U|8G`C1hdOvMsMD!k`U zXIU}9Ky!u#u$d?UAk^;tAJwTe%=+95po}aFed2e2Qr5rq(^(h!%)_^&&AG4717^Q< zzhqU8@oC2YV(&e`n%dTN;Yl-q2qK{hM5Tj@K#)#Ag$RNODorIyFCx-Ap(rRNNKvE+ zks_i(lqxk!N2E6e>0Ja8YJeo%iEHh>+-t9W?m1`Q=icY}{}Y)w6Eeme<16p?e%~B( z&fUHhK0;*|eg4MbRR4Xjg@hrWx)J~7xTz}R*BOF3^WGi)nJ_7Lmz#BgZv3~F)i#?0 zO#a0m6mcf%stMhyn-xb_%1&>vC=48J6kHt*2#Z{IpKMVR`lp`$r@{Y7>Hoi`ang6$ zNA~SG(MjK> zV#M?vu#rmva?iU0Urv-TcmS_pM`KHmj?_25B_ z)YXny;kC-yimn5(KNLVCMEvHef9p&q$bb0Ye5)MlW*x=t zhaFgNc8#do96jzIU)9d>4 z@Yx`Cp8Xv=&qm(>0oSm>d=I)3JXKG6Xyqs0aT-0#w%(lkigj}|APST7eGl3Bd!M&Zb*BYS(Qs?uj1JlrqYxSe%zzUy+w=8ne^Md`CHw_V&W z-@RpJBYn=s%fZUV2zdtFvvRSvxpd3T+5MWTs=E3OX>Etw9yV^*q_uC~^04{s&o`vc z+c?bkS zee0CGy87?KWcEp0e0IX^u;xK+_b?#to8}Qc;SWdxJ4+zLRo+*Uy_{24B*uM5E%#NN zeGn4+i2jb*a4NObUpuSK->0+>(V^SdxVS|*{0FZ*`FUq&r}ax!b#-!bY6J>}%30a5 zb5nlyc~vU4-8V`-rfqe#D7oC1G&3V=v>x#2Me?_ik(61J)6e>#mV(+v?O3yW)MV_} zr`WH}|Gb+>3EKUZR5yNv(^7Ec_USTaBhkv?b{0#)JFmWydYHHl1ymiB=U9CknfUPB z<+jF*i;I)@v1T=5iyB2NMxux8jY&R7?Vl{`sB|6=OMFP5!l`b-m@@6(%?fWlVsk9S zHn}Njojh@3JzT{{>2-3uBXcsO?c}xp%KvsV1D+GNPal?Rj%t{kw5mz#)3cMm|5>OS zdNu4k_Ulz{S+m*8H7s0^Uzr%d*-VtABHq<%PhdU`vY0(R3+~ z*}T*A8fn@-MW|d9oeZ{}t`iVTaAkDd*x0aL@{I{AbG0?jXC1hX-Pu@7?KP5H%*_>Z zcnn@aY<55-MMu@-_KIIGoZ*$G+#Hai3F%}}4z}&2frqhTzj7L`(7v781k|d=XL_jc zZj`xGlh%t>8hF$ueOtR`5u=eo=MR2()RFan`8G{EMdz@cpzXof+}vEBM>rH-clxQC zZ(!hKS(&gZJU%s|dQ?_Y0-1s-W}E9eU*x5!nnD#E8%u^CFk0!LPsu;R0heN%2(gU` z#eRjtouKq>FR*4=N9<2CwDB=$7D?Fmi=Q`W>*YM*FnJq4nyUF(?_%!d-59x5j_Sj6 zm?o<#ewX(a2A}nomX~wfvh}hDbuYw$3&uSiRo({=NylxJWdL;-ExaR&y;0WB}S2pPTVYYE+KG)fE&3=bFRm@Iv9$WPFO@12D7u7xZc#?s5GB)9bI~wg0 z^pdxJ2twXkokgsZ>_kVnMj)zvYS~BhQ60L8*4?|#tBj~~BFWJ`2jEVLI!yLlG;Q%% zGkW-iP+RuS<4h@98b!iCKNOZDo^A&v!E0=eT{SM&ebSJ9)NlBaED^Lkzloy<2Apnp zCi`Z)#n+BfVd%wtw5Xu%R6On+=R8N(ZRQktNytwnxOM)^H`+dG*Ut2q#4XB}KRCK5 z%e#f9(f!-e|8hvt*yOSs(}qS5)*g;jyNIG&W#m+!U7Yb<<>+HjmMbj#G|P@NY-qKv z9BxEjFT9^Ll{0Nnu$K8{A)fo3B+{=*MV*3HkY!4_A@tKSLToR0zG46KZr5eG(u=Jshf|Wz?*xzJ2WU2K9dp!e;WliE zMenBjj1mMzG}VJ`w~mB?_FoYK!cu4e(6*wvZ<#5@ldf$dk$wwEnGRza;eapf1JR4A zkT2UV?L}((PGu0Y6+y8q&6sOb>%WK=;kQp%eojTHfroFirm%C6;{i z2EHW2DOS4iwj;KgWjn^1W-UhJkoYHDvh46*M;4`g|n)C|AWTzn{$>et(@k6%9Mf-zFs!>xGf*%vVfyy*4-&*#xig`bEA zVfs&ekTsR_@?6hmvi|I`qc*a&seOk!kF%zn*arf@SIfWNts3`hwOsTG2uKXSCd=)9 zpslj;4u6}Vpy0$cPcS&x)>S+G(Ce)vs1syA_rGdVbTMw~(#y_XGzXJ3M;`yfc(;@d`ro+8ky@C_H807(VrYv0 zCmGtgvseDa&t&A};C~}%GBWZqN;3a@il!ic>JN&x`(<|wIH;?wqYco|&;S>}f57e# za2BAYq1pTS{YA$>xA)pdPfy1H*$08_ZH!F&nHU+F86gnn1I*0(S-=;BiIwdD3+vwg zUMG9a_gaBJEQ}Dwy>I;2Ub`Ovc1DKNv`cg}#{gP(8aj5G-Fg59){q&%(e4fS_ZJN< z9X-Q7a7fJi!7r2?1cy&YM+**?fgaQmO(6JpfS#S<&`}x9eH@0jAje#xvLSKL8HLWg z`^ah3MG%&=bPHu-=HlkzkkUPt%xm8-@kre@|=);6|w z_70Bj9-dy_KE8fo_wI*BJa`xxpOE)`mrzmU`o<<{YkO~AGyvUi)B5|&{xmOka9*^a z4(K6!^P-{k1~)o(dWNGi`wnRuLT;M9ow4)@}aB8W%B%uhiG!I}zeY0JFSm8pJ z#ns}sMRoyJG$EyM7nt;%<3D}qXkZ$=G19o?cx zlbLpbWbmOab&_PMT_6)2$}Yh4TAHeW{O56u7$P?=LZ|_Cy8sPp3idx8{C`dcv0qKb zO?QEmTmNVVRl7jTDU$mxaIY_E7dTw75{W3hi&&k3kw6nWLhWtb1v=)@V+Q1QHY%^l zIEuo-7J(q?o1uvni1EikoV!4m^uKC;bQf^6LjT#0BmQGMhJ96pZLPAA8PJc=f6@AX z;|0I8#+S(8SGQ3lj$J@5Y!?W>LNWnwno#@pkI{lxPS!~TNOh1C*dov*{jYmIy8JS0 zM~rS4P`|Yc1mjlN7WG`n)FdkXF7SCQ_D2rkO~Nj~RX09>SU>Ue`vxQ%*nRYxUXZ{p zFs@*?3p6g&WXAqTyU1wnzz z=!_-}`@O({j|_G&lc9XnvH6>6#5uwLFicv5uLk46XVBv}NQZX;`qOywowBvP&m4-k zYIw=&ZvJHvx53+g&Q;8T&};1EeQpy(q#+Hi-KfzZ%#aXhxSwX1|(I<;>Vx zcGiv*!!L%bYDcF0Zn*e=I&9WI4Q<)}AKJq<(&eZ@U~Hj9&)h{3KB4y`=AM#OK+W9g z00T}J7?pAfMbw9}b$GJqk6nN?>|Oj1vw-}+=)f}e$D6-lbx2UYZEk%6A~ zC%G=vH1Pa`3_z>M_#1-k^yXjx$H&aUj#D{I0{eRdKcUH%SbYQG5j$Q zCK7A7?5H|_NKT9_n^D{Gk3MV#_wJbdkNg-6>VVyNY~8zz?I%Cw5B7qq-GlRAt!o$H zz3m0<8Tn;2zaml?tT4B>5IyzF1b)*j4z$4gf1u2bX`YFH(Z!x%uKp9Kq5h1C0{>`U z|A4FLy+AVgt3>`raef)sK!A7~?5nBtKgR|Tt$$-ke@OH%+xvN9yMFaE$i@o=D*D22 zCXV=>RQ+DshX6$7|{2-LEq2V0@>G3cK54&pns=c zzX)&@ZcB47H#i#4{s-e|M7rLw24^ zj&iEP_KWRH`|kV}a1ALR%`5O^-yEBhUeW8>QD-ht-}Em%aJQFYMy=bH6{ARNs2rK| z@0FR)xauljvKKxhtL%PWdwf}UpK>=Qk#)-BGI8~g-=(@~MeOV7%*03jh8ov(WpoYD z=1P!xjq)(4p|(Be7w?U%9GF+^9s7e;^lY`!L=D6w(h(2`=o;1!_$=O^`ApzTn%vxcfsV^BOLI~77&L(t08c}Dn(q)9!rfm7;%J6l$n-idlTG z*}u8zupXpHI255@-Ck<|Y!}2%=QY^$zj*hP3R%XVIFLj!%U|TCs&UVo%I*TM<*PGy zfu>A~M5NXy@dYjV`%oi!K;YUu5=dcc$)4Bv5bT>R;GpvXOF)~`i>hDNoC<>H;<_LC zU!ozuT-3-a0R))VpzIBhSaU=^04WGm%EYXBV(D@O6TR95UIGI49Rk~iTENLu4&qIY zDwk+5_-AxEu&GNvaDc8o(BX92Y=Lji#zLfAB%l#7f8i~rH+Q?+0}2dYUe+D;E;Z2A zy9BsvY`vr=MnregPQouCg$*?zj%>Q({AryuBhg)&pp@Z)TF^^?Usw9tB?tf>9Y2pW zT+hNyM=FX2)4HjNxAC^|V(H*?TDcY%wNjnAm%6>B*sA_Quesp{Fg zfKRWd$S65bhe~`oca7;j)KHH$QXKnlZ>i#+ZJ+6geS^~^zd<)eqs?3M^{uF?R@?oi zO34=bFLP6vy-svu6ila{%#)u$~uMqTeX?bG}%HM#wx;6R8VhUOu2#|MmjY2QW`7jussSivfl9vV-XCpkH5kku ze$lmoH-`?OJFkcZi2boBN0muJwg3&5p*aigoxO%-m;g>}+gb4O&-ErIzD|_w>_H36k$T z#E86r4#Wv<#=TF}ctW~BJPy=5mX@tNzWk7HSett}gsKjq)B1J(29)%jxK z2uF@<6$)g(Sig^dIFFvuNxoax6QZdeGrTVro8DsMl)Y8mFA6~c{bK~RIRLwg5uc|* zy+A9+^k&7ST+CfSp0THKZ`hYW?+xcqCt(>H1neQlA_2zc9}+6vR1d3aK6IgqC3(YP%-QWCk>_=DmxxnKPuegSTN1< zycS)^B2urDraLTjpM6$YXD97!I*=_UwN0^K*1oF+oPLrfGbeF6I^9)+srykHTTt;d zO@#aT$rTXba;G&^4HrmVA3z*)1VM*&9o*N<=QCFn$mX>ji<~`DTs~ ze-PBGQ9>@G6%KgJZ+BG!n`;fc6mcw_w|Zi=0rcrc*7N2M2wlKjCgeQR_H4Ce8s?ce zjWVnsvsP_T0(k-Mdo3c-e%CkGvV~yx0iI7pZ5p_h(q?8bO((^ECo^OOL+u4T$l~Ck z?+lC2fj~NlSz}e13DKZ|eZuq_W)MOA5-iWcQpB6oXE60(n1%}Ca|F=L02|z+V;bqG zgr#$7ZFFNe%HKVa^;7PP?P0v{m0-R+q( zuL052zUxlvbkGKW(OU5baqc-+&0~m5UF@ef4q2ORYYlp({NDTVr0oRCq+xH;@8sb{ zDF+ypo-#lUHU8~QIOA@2x6bAPz|ILzoXaq8$#?dqs&Oos!MRG=oA-C<4tL=vJB?ZJ z-`ia5@x+;8X01C~)G{6V=``LMw`@Tf?lGX6%vY6 z@i&qlSr{leiI4=&#w%sc5bYpzE;L9JJ;6wVFqdh;0)kqwNu(j@v1)4K0{&g| z8Vefx6q`!Lt@f0!hVFm@FwiXh#`wgs^taiXQXmUwz2HG`AdDxcodK+asrTlBVXi+? zP78o~XXWr<0r!zN4jDcaNqoL(4-#}kqc5)C{!Z_VZh+CeH)EL(bN}tr|6?>ycqjZx zyuo{WIu)?{*mK+c`cA*A4_or~E4nXbqzgUy`46pu?w4q&MgO2FQg4hR(UhAHj|8r- zYD}a?vtLNF8w}=vsVk816p7dM?K*&XnX9gdNG;9-d1hJCpid=&VBA5Z1mStoP)UT5UnU_@}U=OGnR718p+0eSmG;81? z;I5kAT?fN7XtLhXL2beD(Y5UhX%b4-;7wb zq#ad23b?2x=6Ai5MnjP-K2HJ}$`+@UK9Bo+Bre^tF-6_#{{qJVHRRv`sw!BnWR$dK zkZ;{z3dT&qhwE=r&KI9Xy>~)ugW8iZJ@j|l_w9|u`8S>;Vc?Uew+)AK z1m@XhHTGjvjOd!w?8OGsx<;!3eml4)HqGx6O&b6SS;K-AQAxvQXhd!aa0Kqvfz1&t z4xStdrj=O?K^o*p%)|$?7!D0as(~_Ad)df#x&Qtm(q**`U}gnnE;_*=Erc*vgz0tC zP9&strx(L&gPG6xkR{NPdRF+e8W4BQ$&~9s(DX#0dS0eM5O1yq`W>L$=@-O{^@Or! z7^VOgQ{5o1;Y`FzoF)AK0vqC7jr6LcK+(l>ULi$tF23pUa6$Y z!@tvw_`gv^kN*0%nUNB~po0Pb?q&p{;R&I@9u3~XWwM`Gf1%U0zd0F0e)wKQqedb+ zpS%^>t3Z~JT*mZWCRl1)&veV5u>8UD^i6)cx8e6QVIfP7Vn(N;(uU)|H}UAY8HQE{ zvKvLNeMMNYMX{SFr;g7?(cioywxfJ8L(jHq^LnRCmE5Z~t30z|ht1N((rf-tQzWd^ zqulrPaNpXH}Ru4Acoa6r)gLTAdw@DPeU&1rJIH=Ml;=Vy_d zqNdVG%Rdp)h3g)!Kk#{c?sZlrF}C$EBkJplV+`H^0EW@Q&X?elRC`!Uzo{> zd$p0`FKEErC+){itu~l=-Q#fH5-Os*_c}74MV`S|Cp#%s?E;l) z0jz!xRa5fraMzEBE107~oO8r0sQU?vPvWw_e$1Uu@sM(Hc4l70@bumk z7p#37q!eJ^g|=G`H&2QznKwJ`F~x&X<-KFADtw;J*s7^am~a3sMihhE@}G^lWHNQ9 z^F`H0&zlT%<=O41i1$u3k8XY&E|0I8A(stgo4DXF=i^e*V>zQmT(QKYF~OnW^c z4xfu%%ZoU6Al}r9A^U!Zv3}|Ufv2>}kNi8n3~j`r2eZbif+SP*V|CI-Ivhlb-FP`q zpOQR#P;RAg7E@lZGa+zKIX75-=vw&I&{>1`k!OZ!i*GX_LU7Uym$~C-x?G0ybiEwZ zJFdQ%U!3tX{p53fQYzkJT{*6zVyW2gM?V!gE&w$|eQhF={)P_s+_e>RGJ`pCj|b)N?l!V;dDU|Jun|F*lf-z6{|?{wFk*S@Rbk@b8VOrX6oF}-Mzv}T6& zV>0do0_UIG?-3aY9RW+H2xX_bBUiIPoWz8UJbHQCKd898IcsHJgJ!`P4rV58Yp>R= z43rXQ3nXp8yJTPZXC5i?pUY`aclZ(Bi|lMqo}?^$kk6lmC%qS zE%yoH6+*ArgExyjqC+dXKSuY5=RL@0Q4;~py82q7dNd^jJ(gSw7P83-&XWd$hhKW^ zFT!8!x%H?)6dN2jbG~lIwBu&BoM$sn$H0Ej1ExsF-}<5np8)^i=D1_QoL5-Eg%u12sFvhW{+X}gl2<3quS}x7WD;~vrkXET z+O2Ere>5|u+s}6>i?{Vn4sr4X67ov6%16WK)A;zRW9=zPk<7v`p=Du-U&hV4*LvIA?g z%mcVB=c+mTAeYP zk?N!m2!a7VYV;6XyyOJpV^Wvd^^>IZ4bw$F%`f-j9>4Vqix%u#fDz6we|^z3fvaD< z(8$+UW#Z?3FQBA2^a@M-h`Me$By9TC6x*_Fdf&ElH~!cp`p~Os)284LXJpfyKTrEh zEm$X*54KfqnNm<;s>-=3x42XUl(c2>k}(B~IYSQX6}lsK6SEDwz?ZrSyASz?cP`YY zLu*QUpySI&t;@ruHwR^h)MUTV4cTRrG_*|*&$&wJU)bfhDNa@g;+6Yg^3WDWcCxW1fq-*W9t zKb0G9Lxtul^H?yN1>Fl^-0}CWcy=u2LW>anRRPn4V5xPsjjOvr=rxki_;Sb_7ggt+ zvlD2Jk#h;xb9%T+3N2+V&+#0H9xJjFb`5C=@(OCV;8&NXU<2547Fo)+*Au1FL-gi& zsC1(EyG}$j7b%Q4?8+%qT@3$xx!KoBGZD}HGQ9f+jJc3s^hAH7WnSJ&ah9hC&TBY5 zX{dA67j1>R&tdkItuB^^jW7Z_jxIP@8p;5$%6dieAk)E9NrrGcs zS7#nvUo1&j`p1g;!Jsy#3905d&sYKF(ej}POrP7^qv~VD85;wGc)6Ox0m?}e%MAwm zNtOZ=`u;|tt!~kYCU<%93@v1-&C42{`Kr>-%^XS(ij-h7Xs=zX&F~WMI`b;_CcwEV zcxv|KlS5Cg>F)yUs~5Ueq*Di|!|Kwt*Pmal@BM6x4==Y`I5FDduzF%(dX&tG-gxE` zh2ZT7^O%3wS;Z}+b#ma-w~@GqJeZ71SfyYDIzMoJ$0h(Bv0+C^BO@n@!mG=|ehhk` zSG&KX;-x=ufVa#m499bMM3fU5J{1)waVHf{Cu3%wAn#;v3a1dr$Hu3Pt5*G5&-;TV zR1R}|e9!EZe~{E{`!gP!D;7nYIaKHxN&(mUnPLr^%q1V^HMTDU$mEZZt2LEXylbnf zV6)7HK5#(;8z;J!V@Jtn_6iHsz@@0^qA1e;pM^=p*m;Ttn;^WB448L)D zzsV7+fXFcaK(kGbC8v+*u>v$SHUw?s-Su2(QSbylvVJx6ZDYW!5HW^(Zl;DWiG18u z_HN(R*XSMZ6z~kOLGdeaUW#{mMxIHbhrX4Pt%FRuv^Xg~Xz@R%@Q|}QWf{8WXZwQ> z7N98}tZU^PSd5!Ejf#;VwKsPFnvA83cI}P?8W{xC69EsnT?!j-7H(Dp0#+pW5c!Z4 z0FlqTo*AkS7Vw(D(uyn9-w-TW%$7N-cr9qFMVJHot=^5+QvpNJl#h%c{afpyv!_UqU*SU$+Dk?6)fPS*q`Rgl>JSOY!7 zG&Yb2+G0j}FNp)~;=&k{U~HL%M4D!xZ~uj|)fzLzk=)u4&^PYp^7`XWUv}1tIle_Yc^i5Et9gT+;E0p1 zq1#q9_snSX`X`&VPi8|p@HctSatETppiv`&t}UR%1=#rVkLdS5cc3KQ z(X8Wse@v+Cn~>7vi*FmanQxU0swuVU|_G+x@3Y74T6(4 zP?0F^0R0K2XW7n9m)}IGUF|x&XU?o%&z81 zCiJzGQcMlCj=L5YyuudAd;maX=goM7BIp_bO=I{ktLH133McEmlav$d*Aa;LjPT~9 zRr$3THyC(wsBV&wJBGejrMMHYcvz>bSDM5e`aX(2r{CckOw0X%{A>c5W!KxkjuG?E(TJ5tFDy&Ygj<_a-ba^1W)5@Z}=g zr9p=$MnnwYIa+~FrK`)fg~0$BR2p=}A5Z4EP`5C_He~QI^1HwZ;q)J&a-Xg>U!fi- zrgCoYpq_vWWsqn#0jrI|_mzXX^U9oUjX&=0S2d(rua8)f-;P6lrb?U4woe*tIWz<= z8LT6+s>GhRBvZ1ES$jU+w=xdOe9cH#;iB``z_FfRSo?$* z#E)fV9Lyxe>{yc8XNJqJIg~NwG_~J#o-_q3O3hJ6$&LX+waVo~`OZg~5UGXaRH=sR z<~a$HCjIUgrV4feIHrlp#6eg>@KF0ZzZW5A#O|+EMtxb4S57sXwSW#9j z#6TBnB5Cdd`@=SJ2%j%sOJ1WeV2ZpLKiv-w6I`~EcwklIw4ciCJozxdd&kM=yUFA1 zDE$ik)0|=t`Wd@rv#9&{DW(I1py;(mLvUlbkd)ZyWug6^6JP7Sl3}ugwYsy2#q+4x zbC*%MmNM+kilXdM#k2HDq*snq2Zc>onqgh5>ZC-=0;7HzmCx(K)F8@tBQWR|`s1yd zQ#z9dgMzKKouBh>jqev>i5i@_TX^1pQgkrd>*G4E8}<-?@VGjZtkz$p^GfN$fkW*V zTHb9wJ(f@sXodjGsi5GWp)9jYfG~BnUT~eL`LYJ&oe#3IM`$9g`jrO z+{m*UA69jujn?3oj^@VZL&7eUbtkg0`eOI3!R?@LlqM4BJ@(G0%nv|WXGbu-fY(ge zXn&+iCrxiBg3TOK4F$X?;ucwIb8rtVT?r4is}oEegfaHt)L4TOtx_19u?*XrS-E~^ zzA84EgSjQe4`4IM7j@9-IEI<>@1!;C*)rVfiUmv4WW~&AYwxVw{$N&o4BZUO!k!LS zEdZXrLG!6xQl`QM69KD?#*qH75wHpu%+|CE;C^NY`Ad@J6K@WGn1EB)KDC&u-DdwIRf8XkkdrOr%}0&d$y5@NTCH~ z^c6M!4G%7xv>#=dlR?hpFXhu+R67z=)e<|-r$m+t#^r+x2{0&D5u(DP*h`;~Owo=y zWX&rAO00ZNQC{;~`r~re!?`5!sb(Oq3Q?m#-#+3R3Z@CNH zS@f(@*?|RUKD)?Lajvx5wf@TkD#nTUxPp%&_A#2z^!7#R*YUC6z(o&buxBKElnX~h z?V6$6&M-MVy(0GPSsLb3WJByt=(foccikxMJh)^jV1Krcx6Zw5^A#f5UdD4O$HXrg zjn>)e3etA*eQTOd=Dks% zY^Cn%BIjN6V_3ER( z2fL>a$6sn+O1wHCUt&_Gy>4R8>ncqaE6bYMI z85@Q#^2VsEJ02UY4LaQGd9__|>AedkGTNfKek0TZjvbuUM7qi5L@O#Xd0JXvh!HAK#x0A*d#?&&~y8bqsJ$?E>8Rv1fR$paZ7zi<{v#eeg9!r)Q#? zK6y*c_$tGtD{OwVABo{Qktw-nIrfdTR4UB-3-Ht&YQNj*DRnD5e!+=qqIxFM;~o5v zta70;zwFzOkj}`m@ebAzQe{1tvT>@j$jtM+i%W@n~l|A<>9 zMkP#NFgD7pc~8KR*>Mwh-V&c(xI!q1<*@Q`O16uGygk2>0It-7ncFQ&fMf*QA4EeI zs3AIMM4bpY1HXT0bP#QqYK%D^eBQ10mTFNhO@ip@C|Joc8Bvtl+*CElfZ zW&vNu_YaZ;gLpe?YKaG1*2 z=RbjC9QvNFM1*b&^i4TQI+UI|9zT=^#LABblUJT!L{xtivTOM{Uk`KyP$S zzz(1k5>uj$8#!D~%1wVtzL~vRyma)fAA981XEwg6r=N{J-g?J;Rq#`LM^|yemfW07 z)#0@9Q#jrS*hz-Uii≤ef6&o)6fb$eGkp`E{|+Aq(I-he$aMn#?d#C%E>9qa|zP zXSH$;ORyJ<1P%b!Yp*u_vW=fzJ27uoCMfJBd@NX;Py5R_68mb?JkhJ_5YM*pm7pV! z*q++vUH_Jve1VTf$ccK0UhHv$S;VEtNuFB?*Bjk+3ocC^IzTtA+|_mjk#9ZE*Y3)n zOI**tJ>}IvU(7Q`^OFQ16SOoFid+d8}}8TE$k4I5)h9p(m$UnmH3r(1A~%sc@%gx;l!-rKHW7bo7i zK0OwH5qQ&fwx0HovAQ|7uf*z*ln@qPrdx>KWjkzc4tlziS9p9c{D=IDFg%)VPAxLDh$f`XCqa9I7q_kLevMthtWNK2JABPv1ee;JPA7-c-i> zHiyXy#Nq9O0TkUqTI3G99C}fACla4fb)jClN()u&YqX^mREEe4P{!unrLeBdxXg-e zn?9e&4}vlKSQ+)5MZk+pT6u1_C5j1M5@Y)sFAXtD4Fr?(LZ8ijT2Pqq%a`6PD z!TnVqd9@RFxCbNau1sJUR@g?Zn)fOkd@&#qs z-QE|pymap=d5YpRQ?bED5=TY}5yci$C%0O|rW}v;%um%nnq1W-;!2w+Y2=qF zlDSKcB6?nOmbiJSf1|uqG}jLV(eC6EoZLfJR6_31dFhi@;nL|krpLs;*Qe1~EZ9AW z+uj24wT)ouBex+-c*K4$^{QD3Zz_*0uV^5cybhfTn`7|rb01|2H~_1I-LK&%Oz8>0 zPsomZI7OA?cf5~3Bu5%Ji>fbgms{}JCS_BVTF9x+u&=(_9N*vbDY{HWn|zB`2T$jP zzVre4Dz#xmC>%L-8t3X@1$2y9DW6ADh=((3@gi6GjG3`T3II*KejpJPM-i#S@tu## zN12O!(-!)UOGnB3!&roOGDd?e)`{p3YA0cw0q%r5DN}Io?de2THcy96SZ4|~n$W~T zxURAu88zva(c-WLo;;V^+N_V(ZFGh7&ErF~VG6iesesra7g`_B0N7XzOhNQa_sH*w{v;8HbxI&TCzSR~ z+~2(4ur1tgzOP8|ZD*N|b)-Z<#?Fi}5?s{lXR=y)Ip#ipZMtmDE7{9V)fw_N&ZZPF z+yB^JO8eqaIL6S`!o(Qg;%FJvf}#_mq#^8ZETnVCVYhqo&yKcm52wtxZ#@;vcCn;E z)Iu&k9vdZ?#16_)IhSjtP;?F}i+!r7Cl!)k>~F_~kM9D`u>Esq-s9d>8BAP|-bZq| z)VD6tJz&tim|a<(+|DJQW%Rjejz*p+{UeWXY<6RWG@D0uB@Rc$9%%K9Wpyy2^Sh4Z z9XhP2W~JxRD9|bx9JcmNM%k$8YR4+l$0(qq>bp)E5ANCY)RPLBQvKW4U_u;q-1ynm zPxx|u;T*A*!c`Z2Jr|M~ip=3GFMd0~pLnRw<3MSknAZD?A_B(#_k@-R-)%y^CO`aD4n+lMJh+3oQv)Ukp#kWRr#UA2Gwdc~1?wbzyv_*s z6jvoW>m$jf=Q;C(Ywc62WHyT30HJ zdX$bV%&01i4VrGO9`|s$c(N;MQ2)-TN2RC#qMb=y4Sx?===tD$%GJjO&vMPQkCl~{ zKD3PF6yUsam*GZ%-6VHI{^2pZy1>f~%H){?3c69B?_zmHEbqR3L~*Jg_38Gfh*>1mZdV`+fyvmJs85dCB{OqwaQTH!*)k| zC#Dwp51ktdL`_y8u1=_*YF&|M_Uv)<*FIfwW8FcdD+sc1gLBo6%;CM!T1m+Zf}y_n zgq}a#5X5iIEvp^EwE<~wDaFv)=)UE*rfdAc7DQ|-$nzg-Gd{sOeSAIngb0^h1;jLW z(CZKz{hh|Z*R`KlBDaE0o3dQZ60cO~xsj1mGIS@R{K-tQ3`ueF?LeY+LFIhKdQIw* zuk@nY4lRjoBc-Ukyy9K#S>kcL?80do$lL@%K01Dfl5h!H|!;dL)S@d+p|3-HhamY-gCZoi;!>55>%(1>|MM(VTT` z_sE{~;a~HGElW2GaV*DdcX037r{9TnmML!QPSox%$HtplKDl5gd!{|OSno=njT)v~ z8)=F3+a?kBc|YpTPq6B_nxCYLXCID;Ao5cr(*Yj{knJ4tOt#&Q|`#c zq7`tjL~x>%idj%kg^+sDBab|MO=1Js7A%S^ltB2Re+Cv6tWdDRNwJIjJD$hUP(4@7 zXloq8QEMx(Z6o#9s$Q+GY&(0g!HhI)vA2$3j>HXC`+7DqyN~XTlS=hnMQmy2$j1--_gOA3F=yyfGbhQb zJ9470jaYj!%3)@AsJhF&RQs{(Njn!5axdxn)DCEOdU%e@sc1Q++)XKoj5|^c+_NF!Tp&3G}?BM&BJ5SQx{G^-ELaU9wEIpO! z3h!lJmwU&}nm&(C6v`flLX zlxG!hAl%o%<`dLf>vteM`NfcyUG6*~r@D&$e1@TOjs`5UIjCl@JU}#RF3VE8b973l&7eg6IChgDAK4gk|vYrM+qLwWQ-w`*YG3 zecPz&aW`sQE?c}>Na2iqSe*PrUP|T0nZ|i9eP{PWt za(itfou#Uh;2j|(a_scf2})-N>k3OE;>UBIb@^=t0;J9__g)Z_kIBV>lLgD3ubofQ zywvxU(}yQ9&|N71^2Dm@ZOd9t`dy5INNrbxm2j4F?D^bfDJQRuii*LVCDo)zf^VZ} z!C@wDaZM-DV(;!2mx9V6E9RXIIg7V zPnDA7b~Js;>bUe4t+E|uwVbP#ZZXw0GA*4c3=Mp}F@xts+;)NHMuVAi#sj{4&NX5K zCoN;}RdMAH4La}b!)p@4V9~f39CM$DxVV_@Q2+O#t?MLdu2YJ-ipm^07iChxObSGo z_NHXa7pT!=g!$fPdVdy_o7mk3r?^YNY4f9v7h=p+mbQT z^5RLGCl1kbKgxBA)WJXHh2||shTq^`TO;_9b=$lsLHyO}JiQ7&OTurDhU9i41=H*A@`DFZS_0wQC z-$?I@(O+G(y1O1YTh$+o;2qDx@Pc4HNxczdYyz&cCv%5R_tc^fJcn$$-59N8@xBtw zMqwP7We6gU+i3L4l=?%y z-pVEGPZD^STGeWgXAvXXa5Jo`O&63Vw8Ao%dF1u|Mn};8PF=8WRrXLbB%A6D8wVZb z*zS?j*UdzQksYVH^(P5rP3pm7j z2Xu%PTLm?6QjN(+2l>kW+kVO424oAvH*ib*^h$SoCkLfgkVMSs>t7<{m&LYXzaiZ% zp6_r4$Y)G|r8<)_eP)r>L(b+>slk4XN7MuGTdb$at`;|<2ZqpubBKEhK2ejo4^(d* zxB6kh*Avuon7!rw``avmLKwYWpsJ>1ifCc|mRDPd(_fw|>2+7o3Bg{$4kShhlaTI|X5@fv-`~e`?z!jObME8!$9+85gKeyM@71s8>-qAq9pKv- z+x_Z626)A0W!3{{p}#YLYFEMnwVG1ty?lLw5Xyc z_TQ78Q#~Sj`)s!U#v=gQxkmA2X9%c+yN3P@8AjA1BjxxQ66&T+`5RHO{^@!_$E-z1 zkI$~PQEhL_GMYTh80CJYx4-LFl4qS9465RjD~~LV%XZVP=f0{w*3f9*H$zw=3zJ8? z^*g^C_gfaUZTU;W(`}g3KOdfB?**O}DUco#rFUsPSkE7CRsC{cU_VS|=(xyX{TFCV z#S%Il8{Xx4k-Di0j-B+r(#G1i;PUWte(62wdi@W!)8m~D5bJTx*u*^MYB~s#tF)3F zQ7$EWKVCO=?ECCu$O(4s{HnoH75{o=?#QIlPX8{{+ky2E-i}+$0_%g9-UH>XE<|lZ z%ZkI#Tdi84$Ufiz~|@<)`;NGmOyZHePk>}0~guO(*22`q9`kLe&5#fvbxF( z&{*M~!MiytWrG)M?YcqbhpPDGWjTJg3kimgP=GUv^9Mj7ff@puGR1qO5>04YC5-1Q zS%I_&l5Nvy!xfDTMaojvT@@6r;jAh`VMGXf;&=ii-Vmf-kP5B>&*oSovF_}#F>@Do zVMF@K3YZjNH$B?M7cTQx(ue3qbt#z~0n8TNr_c}J3{0^|nyh$LbV~DvLx2G7Qo>in zQj8^gF7m7vQN1uko}XvVN8y!rkN5Bsyq@NZNWOdkM2XyWDT| zFvWDtVFHGy5IGHf1&gLYyt?8ip=fG;XN4Z-o8Q?)VR+*@8gSuqe%*Idt96F)b5K)! zz;bHP>P^Jf9vH{N+KOgu(2s$h>_aa#z?>mOSh4XCDeTL`gLf6SUNFn{_{krnE&WeC zj;z|p$rcY8a0`c3k#DfH%Q;|`u`hRw9ehS+%zD9LV$aLK_xX++@i)T{3F=v?{XVQH zoi=9$%Yb*|1m-<7hY7WJw(2DW11~D%olYX#k9#VPcTBR~s25w5obWu3_;s7L{UDu) z4542&TUNGh+f_P;aN31^9KXoQvVg#XiG@`Rr{FG<;4wYNmCA{4x=0J~()&(Vr1k{)pcVwC{A5fWNhV zB|$M=b>=eqrs_egUzC|{>Gm-3FlUmYvD!(T@VBiNe`XJ;D0nFgaoq~DcV&)o(rIqE zGEC2}b&~w8{Je*N=qdU3=%Eg4*-F@7fRIJ@?^oN|GfTS49Xg#zo|R#K zAZibGPgfAMF45)=68z5B!+FmIpSgv}hO<|y6geH1>y6t@h%nlZfMZyIG&Z<&}&K*A~UL0YjAGONmi{bG0(+WK^vC-66C_vmS7wV}M zLMm{DcPfxfh-al!&N|!^wH(;|Qs7=&jr};eq)@e@kz-{D)G(*|y+wblWv^9p0CRM> z1R!3?!R)mXUETE?Rb4+S`o)%@@q~h(D@k_}9gA4b#J;R5JG3Jl4DWuuIFp=!zxJnR z8bbU7(-OPc`}})VEiEvvJ`1QnKh$9m2e4NZAQr?eD|hgWh(q|1>9(QoJxMA>ngOH; zwG~r!MN&J3t+F9YFT!R+?PyW|NKnOT_6c~;B-kGRD}AC|_k~u{%k42jq}cRnY0TcR z2rolumirKaHJh}wTnZ2>3;)}|=(RxE3;rx_zmxKCNJgYj!f-7QT48M0o+gfBZyNCp zECX(|#V=vE3#o}dKxb>AZXsS!S1nxU#V?T#y^XikZkWhdSZdf|y17YQ-`majdaY~$ zyLrr|)65~F#AppYRw|@rq4GwmBb|yZ7kmi&c$${}7 zGq34hY#tTr9}_;0p^UqZ1Lc=pRVqfubCi{ICFkZwJ1s8 z6KrY>>ZW)5UJ!1?tR;>yy6kIHEPMViIMe}LV~1avII|zRM{Y%U#S7gRV4cssYB71gV$iZ>dPe&{O zLkv^#+mqwGGB=yj;Et11DKeiD)FzY(6-mIpdwi~NdRYz`RNz_4A;TA3zKFHKc;MZ^ zMXe&eycg7L6WN8V$gHEJ!$mBu=y#EA7;(_u@-ORNxYuUNQd^r(jG@0{uqgbGtgHGf zT|jS1F<^Ie@tH1KFvp6ZX}oUDLT^-9WcZNzN11GOf*)a%)Bz-Z-OWw;X4S7&PNZ^! z+V0(n?99fL^As#(4)sG$zjGkob8lv}Kp&BL4q0nI&Xsx7g>h=b0VEA}LmFrCn8iGd z_OSFb-*bYhhl;S8Ss{@=9mR-Y(O)s~Mb$4G0!v4^^Bp*n!oKjXf64_BHdXxsV;=hM z0$N;K+*KN+SY>t-Yq4TH-p}YU6Wq9<8k`NwzH4jAL)P z5G)SwY?alQ`oXSNHIFnw2rg9F90yYr1U*`A0qU|YU8-X*&78rSjqwvRoLfxxpADcO zq9DMH618KNCEk}}2sV2!#2qM%X4(Us{a-y^U!T2efog2z}rK)qZ|Xuo#|+W-+g=hJG@z{xE5&8abs zR77{I3E#it=y-&f3P*CSNbbfR9vk?}O~alwHfErV(rAv%VICtXn8`AuO{rb6ub7xm z{;s#g&t+NjmZ~YcUu{jskE-FeHly93@mBX~bVlYq7V(J1bA4|z0XiwDSfYGaN#{$@cHalEMJ$?)zgRF%I()8?Dx2pa9gZ>^!3C~ znN4FGW7pa@ko*<-pvhermI}EfjbXduv>%;k7lf~T_ip*xMRf1+bso&KJ2;c_V_*EO z<10S%kYA8GmYiZOQdV;NAB~seg=#vS+Rvo%C$SO<&PWV^KjBWhnM!Fu2{JICBO!iF z6e7QR1InWAuf$c=1IE<{onHuU?kL<{)AKCN{AC&hz`|x>gRWV-GG$IPataTA9(Y|v zP`CyY&JGk~QpZbKlPW0UV02;$Zx_kDU1^+>FMMRoIlogN+}V~ND9&d@6YivRJZuPJ zUHJfE#As+tyfIg^DK}N}CnQYle?Y8%K?#ZCm$x4^&Na*rNNZf3&VYZ{gN)b&0l22g2Fz zI*o)`#PU&d?dy$oG>YiWCj03%ggKrs1eJRWv&zKYlS@D9J<-7UI(db4p<8Cz{MFmD z8|6VC2p#46Bc{56vX^_ABS)3y?XhQpJZyku*KF{ka+4;5f7%JR2Y{-W@ zdcqrW3eD7fJ^5JvQNdTf^RXbG#s@WR!%4l)Wu1@%T`Gn)sNz1gQ!sNWH{DugrBOaK z-lKQoR@hBv>9%u()_D$(L2_6Rb)b=GtTC>pmEx6Oq?5fj#U4)=*?XeqI*dYI4Ji11 zCFBf_`|K?=16{SPUzt4?bGKAmH#TkAzq(zP%pUDS$CT}6^69+F39yQ4j&~ej4MI_d zN*0rbzKQHCpJT}uuXtGFpxQQba!2H}-5yno>e+={n*+OT>|?_RrP$?9b~|z_=3vP~ z1Jz!>!3>Mb!K0erA&rw6Au|lvTzXuJ!h?lpJseus_QhXim-@w6TOo!lv&<8asK_Do zho!0*IU%M}vYCx6@d7>YoEp9M_o+?BYM3M5b&yxTIJQs*LGsb;q#3aUePa8(RF2bF z50h=34$n#G6o~qXH~1MOh%u*I)rvRVXk* zJ6S`xF!`3M^(Q0PN5%Y~(pEGIniGrs9~C@XTg|hD1Q{(tYH4?)mJX(My0q+;XTg%X zP3D%{=^*i6i_)F)G{kgD9jjbiKy0Co7JBb*3sFK6iJO*BD=qL1)fe|WZ8c%{x^kIq zjko((@Bbb%Yk+gDrA%&|oKB75(iJG@gNSjkAf9E?of08eF0z{N}pAQi|N zv>GxIR3Nmxn=Ik4u8|>Fs=?p z;MdhVdGo0gt?rgj23@yX*paY&mspHK_2h#00G1M?REWKaG5F%AqY|e#sN8txV76`; zXPt_e@#RO(P0C(bV*MI$*?7>-0(-JW`rxhlvFE{CE(JtZgj1}5*Q+T)qO?Najr|3(t&+h^c92}_ecsL$Ex9JC<&ZHtSD-Un)U!mxl;+3n%%DxWPRjb@n|bH2 zVYb-Zqp||LN7I!r1SrgPnlP+DrhL068u~{2gMEuT*T3vLi2C0mAvRCb9c@pn^js0@ zauRy){<|8I_;RG)DcD?D-z`m5Qp{?W+@KaUj|@s!Gf$x>d-zI)R@Xv5IlYRnt=$J) z?wQSj_G6ebc9r^u+n&5I-vC<+h57*QJ$-j?If0}*!o^wO+2pRjh=tnm56|Ds(JV1# zvPK295%;MGtU^=9Pw^k?57YO6(;&JIra-(Ay6KRqgoJ(eBR?OSNMp^~)7M~B;tl+? zoYVmX#94AB$j_c#q%B5)X#`==0w`E4*cRK4yK_Q-RvX-rsVVzpY z&(vf#s#ad?vULgx7$1}F6Txo8T75_mG3_a~t(vY(*tZ*i9coixxX$2LOxr9Eeg!=( zbCAg`hIihs)39cO*E#<9K`Kl?=X1i^!MEMaUCF;F*}dUcYW2wFIJK%UEoM;XX)W)- z*9#v8DNWuwcBuUPLU9lH&|HT`t0)A;LO*Jilq_##PNiPvzQO;z33M4ZT)a(O7-GIk za|z6q5hY-BpsNSds~Qvh&eqKk(rt)+%S}nK=c*B;t3M@vToUHKo!o?WfTz2Rarp|I zQ+}?B^~olc*^D3J-u2kfqBYolQ&ap{B3G^YT}9^Z=O`ypHmt_2?xNGsIJs^G=rhoJ zeb9KP`S}MIbzZ*qw6RUk{R9l#=6AcpgH9B+-}jXpDrnA2lUZ4z#mFfM^(%S~H}`Sm z9>m>9{xEAfH|x-8x$?uZGaJ3w9{DeUSMzbG(7^_&xgQ#=9!{UDHupJ!qFLRs%+!8L zK!5-{h9l<H}sh@Y%H)Mvzk6JGpE$#z#4L&K@RIOuF771&tCzPdqJc<(%ME{?r9Ip z^t6p)LXLe$M-~m7eU8D*tCkEyq6%yu-A=MT=+(#WaH^g7MuK90b?=s?VU4i#* zt(3?)th7ibbj)aW=EWG$O>FApD=0433W7H2td3%_vtHn(1_(J~nHHDt#q3CTk59{2 zN%dpdvS!+T-vDuq7$lVDGVb$lpAh;HxYwS-1SuaWT^ebi-*XPP-h7fWVi4#NgdC82 zSFWGpU?RVVy-p=M(R)?4xuo9GNzN9aB-HtfX5||JsZzt_3eYIOLHaCr8{T6r#Zo0D zr@?zwP_u$HfF?7+H(E;NR;pXQsj$P4RDb{05Z}x~n)9C-61!0kl|mQjtEUGlXVeO( zIFgWCKVCneA`dk15O%k?e)-Jp$&aQAzPHalHpe{z1`QtpNaz2cPoerOD`Oq_{1)iY zaU$hqV~l?%vywT!>r5=dlVejFxvAPkxKKYFg$%GeBfQMyr&YGP4afWiGA#zIM;Qd} z3N#DBrNvzDOtE_?_RNeb?^JreETg~Ewlu}L+>75$lfKa$`1e6v69u+0s|`H*AUw7FF_*E#ZG<_&)gd?n@?@N8jFrNFi4t-*O4j4KOrUr>Rl2SVrunORW?0dTmme z?znK@uCklT>zh^I8LklcTk==-v-Y~h-~R$pLvFrGQ%-r@obw&Y_-N2HIl$$$iM*Q4 z{ucx{+AMP0>Z>kt`PZiMxy8ykz_4i9o(|SKL`0V^RVR0>Fn>0j2rg*2n#gScE2{QY z#X;?LFzja$Xh|e(^JYZQ)4xDBtIpmG=YSU}0ZrkHs& z;S026v=GBNu%-Bz)AM^?FAcSi0kC`&#FtXFEl9pxVx8gTHfYjjdxbbM6GD_?fAwT5 z$!)UoYmAbrRt{np4)%YCz@VKJco_;REc;|Dk*^2bcey+tYQ-oybY_AYruHQjeyvl{ zHPgOP)rp$+J&X7SwmFD1RrzpIe>{}(X@5_H#%$1cMKxjEgTmH8N~&rW7WQX!TONJ2 zyZ~E)k}awP7dhTaRH1sjdZ4`X%R=Wm>v}jO3X|VuAZ+rnmc$+R%h`3tLjM$#9@viD z#WT3ymb10|O2c_IU~1MHAih<*XES%fhbNi5BHn>ATaUH+FToWo^ex7m+j~llpQvPc zyAMp`N) zQCl-TXRGnc@axoKPph*_^qARnx>*Wl4&q5A19*jYNoMxrz@_o(h~u z^>XK;1DOOHylb7&Qi6``3Rz>6n|h|282qNd;)UQIo*(Gthb4q8P+aK;X?;*UJnjCl z1fkFj`JrgTP=M)dvXSZl)#S0?r}E=}e7cC?n#58!s$-Ov0-@J2n0ckbtqTU*QZg;c z#CK~wys-^G)n*3BiLble4heCvqb)tH%n2aD$5(awTf8Zge)jq5+wNpH>=@EAacO2z z0hJ$FB^!u$;GYr2tu^W_J6$+WJ2<-*or7(JpsokuJ~G@0Xfy-k6C*d(!G5sog>@N3 z?qn8QJ{C6>uKP3K8H{_}L@o9+zt?q)EG(G79VVk~v5ozY0pj7b9nz9!gg5bic-ClTGAdxvufM*E|aFtP|@?qb~@nTCh#M`Fk4KJ^k_Td)=~3< z-^UL))p9GF0@ow9zd#`ds8RME3ke{vCd$D$(Y}4q{>$qx&>b_U6|(-K&Nnse1H{kL zedgbt2!sK1rSrG~1$oECy2f64t6m1={^oeWHAc7fL5$Sj$ODC@R$`9IfwK|1R#mRh<@pbhtt=5@N z%>kl^jt0f*1&(7rA59%D;0X%}H!uhtG(Ze2w&$wW6o0Js%XxHT##)*@Rs_tdJGEw* z6QUgg1b4a?o@d65`0wL;)@b5)9Er^{@2}~+>|W2jCwIr6lbk>S2Z#1xlZ{9W7RnEWWVr_ ztHL9t(PgFMjcxP}RVmvo-uuBS=7=6x>;fHzaapatihAc>rdI6ZJ&^|M97GcXMaJy3 zA~+&Q7F~=dRVi^aoRrADb~xbhxzqUcwn=yGef(hrdB;MAElY2^Bqj^()D5E#QolsR zh-d9NJ$J8DbAPzZa60qhT-RTYn=r+4lLDjh>9uv4t?TsDn%b1B%JkubKD6fn^&y>K zv%lk6?Lk=#HtWJ+BlvR#wA0!}2oK)6fmD-#kndHJNq*psY-^2chsd2y*B(TVAIIKX zvpNVSwyZ&Ge{d>wn0yW~hCHjCoqMvpnn7nRlGJ(KXsJFBwVMh^6CpZk7ak`g0H7Zu z=08ZJdb8;gaB+SP(X>9No8M3GxH1WbaW-7e!>U9((uG?+9`rNC7>q<3gf4~2#ta`WhMhof^zhnW zYG)L3?6n)z)~jBR+wOeae=dGZ@eaCF4JGw%lV*KUhnD!@-FTiP|7G~?C0{<3N|V8* z0Yx+8e3zoRh7~!yq!GKw(BtIWn|{({?(Hm#8Cmpp-F0zO|F zw1 zdP3}a7w9~>S3GzfOiZ7*;~g5y_p4@RVEKox@8v3ugZA@%ef1j_v^c-)?k#L?z4+G} zK^h6af{sg_ zJ_yd?vbQ|^Gfq%*C@d+>$|4hDsZP{#W^Ou2;c#_^)*@-!w8=0@^jF$-P7hfZ4|${d z5YM+umTcYqKO=4_%3riiUA7#!^3|R&`7&Bd`IQ}4(Tg_1>UqBTEwT2c*K--(_yJ+! z!T`vw!d)<6FbK?OfLJLviLu1yh{t`+afY4N54>cW!}{mk&k1bLwzAzH36O zEnF#8el@xp3#=b;KBNQF3>sOawUpG6h-mSuI+&M>1eBTAZ)V%%IJA%zRGOV)iS`05OOhM0c%*?~*lK zitBcgu7_)GT{}-m(k_Cw<#+m$9HiGccE2pH$sW0!up@YIXd%;}t3-3Q*?T)xuCMR3 z(pB$mm+TEX!q1hN<%?Tef%MlscOH*PzkL_G8l&D;Y9d}vb`6AcZ0RnVHxAx5;*b18 zkfvUqf*IBCxR5UuzH5irQXX!_e=IIimKm*T+*04Y`Mc0%QC&UnPgcqA&}cilWd@)m zx2zJi=)8Xi?ZTP*ELUd7vXL60CLIYUfG3J?ObvQ~3<|ZsQeVqRgv2 z0E`Wi1g;iANvQ%7fzi>wQDugC9Y1)r&HGDX+GIMPA{EkE_#n!8a$y`vEt`tw+QlPTVTpnoeVL31Uw zLpQnO{L;Hn({qeEH@q~T{=Db@HJSL;#zH9`ANJ~pNpn=ZW=hA5AkQAq8~aD8jU4AI zRpUO-{qJq(GsS!g|6Q*d^=*b{?vg}Ug^s%CRh@pM+V8q7&ryKb(xP}4ATPY}ce?Nw zo{W)t1|Qe%xG5HVd8_al1I+jmSz@9Nq3Yq96YO>9wDdP&Qtk8XD*g=dpu4eYt5@5| zg*G8z06T1cThA=D8WU(mUEp@S4Sx`h|NUMK+Y`j46cow#wuVg0&a#r;Q(;&a;sx-+ zoqn>EM!B7&G8jh@i>?{Ss~ zmG7~fW{7hvQU^wFs2}3o5+IP?w{E8_Qr)?uIX!uF`3q-#(`Gi-w)Dna@MY%7-JdIW zUm{IUC;+2=216rudsgVhS&5xe92V^f_auhfo#8*3<@#pVrFQ+;xvtxOy90fMrw+fE zpvxBLSCUkrq~UHGQ!75QoeI)2rJ-@8a!;Nvwr#gtz*7Q8wC@*&(u|k)?O;&;?018~ ziTR1f3(uYP<~|kNsWB9I#8Q)`{3M)(^|qf`*8-E^x8r>ljf<3d&uW6dK>l<_-S5yR zViAh0>KE!EtZpZ~fd&yq#~x1mE{mb3cUOO0zQAR5w*)AG+xYNYuh8jdVQAPMVHIHf z{JOejA{*UWl~WYh-Ug^JEZ>1P-w2#!RH8XO5k4sydr{J(%x9gNe8Ik6Zd7XOQfMNr zwm;hfl`tF0r?MnFtNchtvMI)~7$hIzqi_G(VMKJpEAU$brsqEH^K$geRe&y4(fskdai3iy z;h-d+9gBF%PSj|Ac(-o#X6yu|wAgct_>WG)uoc!EwHx^~ogJ@WaF6kl4T(Of2caH0 ze$ro>S}a`b8PoXrTy@5i@pAEuqoHCZ06gQ)KZx`GV6*=PT?fD2H<0W7>)_!?HI7cvF&MI?FB-E(UJhiRB ztX@I}ctLDfe(M~HJ_a_mWgy$ctFx%dg_Rv!X80sj=u0~ZClVXxVCoF*%O0&?RjyHW zdmR|dP z=ijLMZQDF(J25Noh&P{t3OANfAid=-;BA=`0Y3MoF|g{jx2-v z|5z5m%Q!t$M}&0DEO#Q!qH>UrY)u#XDt((JC^}sa9u8l{E8ULxk5`>}? zlLWc%>5mhJ1gjJhyl3Z5jsp!Jp4L>@ZRLNPyRN0!=ZW@Hg^klHYX)nB#;k z^F1$9U#vg!B#-`&0RJar2o25df>sODY7A(2@>D*2@F^;whl}fBK~8LPi=@8pPt!kO z`oAHBN}UB~MxPG^ym;}PSpQW>`p6B-wjLexg%7@Gfjz|e?iTlDBUJ)!+5;8O>j3B* z^sg6o!S(y+60Fi5YkDt1h-tN-J=`O>kD63DLD(F2K6$kv(Mr=_s(15w@aNBDU%>9(Zi-TD_SeZ18RD5=#LCstwKN@$BX6TCOJle*SKN$cusDsSWazn}_H`mJ;;< z)4N7PtQ2=@}6QojFupdfV4&@#@o`L|u8c+Yr+BtD7&UF*~EVW@h6#_iVAKl1p}u4+q}7%qIfeI>4aC6)p*8cSgc z`nzlj%iDLH;<)cPua@Mye#<9hw(ns6O~73UY)a7$1-N3BcnBx{JX-zF=8Pyki!*Xw z$9Qzmpdoc`m&zmFP_})7BJW;zJynSx9r2O*w-YLX(P>mjYl!8E`>?~)V6eJ&!4i{C z0ijP|Ou$2mYB6r4sT)&5Z)9(%@~>6cj$xgKF6Wf(8ii>U^~0Cc*ZkmZyvSX&P2{c5 zRD*dhf#}DYNJ24NzqH0Z=0@xu6r)g|rhMBG=<#=+Ry1Dqrt2l9jySB|bI0-J0QC~U zE=b`&_B?Rp{u1`&-zk4;#jnEh9=gd)WGoqh;e%%%<^rBeeYBAdaF#KgJDDNc5!J|7I#SG>Uef zc}Ao{Q?B}gC67Vtwk*>Z(|)!NeZ!Rz8}K7Kn)U~}BQHXzcXeMK(@{C>F}Q$MC%#Z# zu3l?&nFki6L)CjSYSw(1`6L-dQXcSR#&{mB6mwlG*PMP6V94L8Hvhw&GnhQ=NO+UD)825OwXzCATlgwj{XXK@ZP_@O4+Qo5+^l*&+y4?UnQ8~ zx3i1k#+@$KR1f#|u3aY;jq%$BdDeSk??w$n@1Ozeh-%ybRjGrr=bUVITO=fOE_E`%(&IPW{ zmvGyfC5gHkjq5`sEpa062p`5kwTUfxqTn1IJRNH+(wF-7ML((RDsOQWvLS;gOdns+ zN$2~B1bUs9ex;g4B0%IiI~L5bEJ`);m`cY5AGJ`X>`7gho;T9{DrncA7GleZIx)(a8RVH70rFx94(jHc5 zKj{JfR%iA{^#6O5h_^i-Um8;Xx_leFoxYON(8Y7KmJKcEqP*Nt@vzZlld%KK6W!P%k6Kq&J;j!Bw8krThvl;RKA~7u zCE6P+hBFb&glDS1rUm(mxo<;x)wv1$&I+{FokiB8@*X&Jdfi6S8qwh=XHNlu*Uk((WW&?MpFHYzjk~kmeSbW@tEC; zW2IttCt{A6$qr6?J?ih)5V>P2GdC#mSwC~gD&@&s!Tq&K73)V1tfNgm+k6GJe<-al z^&dX_2<#5{_jc*cMXyQ866DnxIKrzq(J5!V->f(Gq+sB^soYoT%}m`p#Moo)c!9i8 zQD>GqdtG4MGiq6NTPDVR>2wvO=esKQ)`t2>6c~g|8WQU;AcFR0D&Lm7-F9`1RM-2q zE0ssue7j~yieJVMLq|uGwA_cclMjUlSpNwG{5sL>W+TPJ3Sqcf$ZLE zDK=SSQ3eJE?s;V$Vz?pujS7y1fPJfeF>11#70qeSn_V84M0XSqdp=^x);9}JP#*yS z|LZ^ZK2??ct*>kR&rtH|%Cm;QK-+hJ^PCJqPk~KKmrk$bzXLh*ec*%rS$adDBKCG^ z1lX^%QdD;$yU6?UR)SSG9<0IcL zGezWy=+E*9)TA$sgv$FjAmHjAul-IduF)oq-bIhig(TG&;C-I2XN=`jV#Y?#UPzNK z<|rwF%s-gr3ay|fDwI~<8y)aw4t@zWp8e4MdokEuAGyNlyYr1<(>_mHyGZ^C52!2N zk#BY`tYi=sG$}^E9*klQq*bHCq;wbg2B zY;ff*Lg={2ih3gN`r2sz>*Sa`>YUzu0od_@Hiuo2n}aY&svn;!Ns#9`#C>7ZL=h+1rdV@BH*o z^7665(I}*%gceMH16|$KUkV?`{w99^X@hFSXLT0++kaK;Q>w`my>`re-~2j%KStA? zkLN;3iOZ4dNqHEQ;Z0l;lD_bDx11F~219XyY~u?)(A>;)3dRSHKIUVQmqMxAshguG zi&;%Yk@b26{{5&zc}1U&ZHE$KOaE24@gaL z{u26AIpJlc;%xj2^c<$BQ)KpEW)mox0M7am(LXQ_pcOze6=xh(64n->k^nS^Z4X%l13l|7)C$gl{Hdz38BhCLf4((`{#9)Vd&gS*s*L>bEk&r(c;u)4I zszLW}dEZ%0==EX`{h{_z`6VEpO!3kSte1To~XB&=Ih$#*5i9TH3MHOjh75< zdfQcTQ`qg)-n{ecE^;KqR?3%{fdX>ciwXYSr>pf^96jH5d0XMFu|9bPk!gc=@-ol0 zRRHFA!f-{o%}NI{3nUjY`m|sv5I{^4oKkzO$~`AI*U_|^h!3aVQkGAU=LS(}OXU&s zK5`McB|c(*2DPcDCv>lvCqbfM?yS65hQH~kA6WmfEB_WTvP&r@yKxiP7xjqz5GfYh z{#zEv$Jjl_Jdm*pe=|Yx9S7@{uyHUKRMw)&N$V~f#pkb4CtFm&W+`X`XDekgCc#>*~(M{08^%VDrI;1Cmdux zv7hfd$!8x86H#d+J&zF4L{Y2N%&VN2-vB6O1x;v2Yj_?c{&$G^FS#3yc-g7=Z8O!@ zmKU#nl?q?O6y43#E2bCw$nloj2HR{K|MA^sH4VQH89wAAIZj5;j>C>#>~kpA@$nNs zl+@>VBDT%~u2`u0YqFPrfiAaZ{aE3W*pp(O4pbqq0x!TSmxvd=r8bK_?qMbmSV`<( zk-i^bcv^)8aM(>4@C3n*#qDpiF5&X!&+PuhLV!k1+Zr43yPGrybiRJ#b((jZ_M7VE z*D@p1m0s27I&F4p9z)~ffQ@WY=Qv*Mm!&dZ8o#~?r_MkTw~2&i*`pq2u&>2>?L3PT zm@F<7I}rnIB-X4R7mbqJKYUA_oqgIP7USbU=f3y&)?+C#-N#f<2{OKic^Z8=#74Z8 z3;bmvqm{0hpg7U25m?ytSh3(?cU`@i>XX<&m}y!JPa>f7|4e&dc+La57iTxOJ@oL& zVS8N`gVJo)S|hWft2*jiOJHO_2Zeg2Em4gc*F>6{M7*$;9gl>b(h#pja$?{_>T5+| zwT}s=GjZL~HxCSm^9ls0bq!Sw{|MMgFp=xuuIvVLGilBQF>8tBP~Hc2(HKu`JE(T{ zdOnGTLH;mU|2;kWmj#Od2Z#EPO>zVVG1)Qo#nO^VtO2ElVqN$g)`_=v`q_Dfr1cSE z!JQh}JknCscRbtK(u2_~sZT1lkNnezgSYEB0Jh|RMw@?x{m+F@>jk6t{D=xo4y&N- zu_;k!^zqD>$3}@`I`d*1>!k(mTEE}w=r3Y{wXnVMFjI=W1C^k0vPVg$MM)@T8U3ii zcqwWZw(8&Z*ChI{TNR5%Pt%{eHD;Ll#QTir3ix4jHEy-0$~v-I(v7PrF>>YnZyP;tC3O&Pwg3HzS? zgW7t+1~+kJhEbU>no8z#luY0|@+)hJlV1FBJ=5l9T^L{_Kn@iYaG5Nw$G~2zR|Go8 z1^21!xpJHGeqJN5tIH^S3_+-aWXBx7r%(g&jRp&8>`C6O6^J0%Q(wvJr$^D3^mhfN zrrS66b4owdb={#0sds6LUVHS_M!dXe`|2>65@z~^0U*C)`V)I;CEL8SiKbCMFq%Q! z$2v$P?wV&VzodUnWH;}`vBt$}S|~m^?12<#HBB2(P16W}cuQKG@sX995?ci5o}8{a zU6nfMMaoNdW+yw%tRLa5^DET^ov1>4``W!=*g{d`-KlY4vZ{|f6@`h^6faqZixDQ_Gy#B==H35!6=3tgItAgzFTGt{$8NXUMYZYvyGq2iq6@k+c8t zDS+DqoHZLdg~liv%f&D)RdO(c7UVZs28yK|I9R3aGGo2#HwbAyJPGLL zbGNf`xYiH;*u^_ayR1eh)f?O(gb+C3#Aw@qE> z=iFF`>e?A6nf+OGeExjzv%^N=zx70X6vYEx6Zk7Ev*=yvgS88TKhRHN>u&8 zI{Dc3>GD>7M_fK5KrDCXT2ox{{gy)Y=3u>}0dnO$sCEBA4n3 z8t5XX8B5*xW{#v_vLp}s84Ojf}{QK{}N23-0rFV9~ zkR|$o+20c+8^qa?t-s-d?0R*KFO~brcrWRzAvRSuF&4PaJ#-P;uMJkaekC{A25@D-tFh;l;X68pbHw$~r;Bz8 zc>iMD5%-lG^mqt-kOU#YIzmo>4s|N{>ghgsg&c87`WI*bifh86DeF8TKkdTUja%sp zc;A*aJbw%7V0|zN$aLp3aZ&-sGhy^aQ|8R<9)s0W%A_#=WKqFi=BHd=X?85h{sJX| z)d13ODd-6SgsT_(;&}HS>)qWp7=JONrzb>Jc44sTl!?BJl%w~xFn)5zQ3GF_uOna^lF%h|9m3KNK|8=I>=5%_6CqW~3!9ZJVau0@2Fa?mkQNH&w z8{dj)WEnMnYs~#l9B)4Q<` zYUlRd&lXV0*$OD}10JA7=j_^zrI>iQ{KAV}90vJ`ng-A`xefr)V~hfd6??36wPy6S z^`D0|@E0gr<}c8102>NC`)u>L1GxbAb5R%Lj|=7 zm3lLILUXt+{$cs-UD>s=t+OS9pCNlrn@|kj-h5#caDqJ?iBH9U?Pa_1-GTGn`W3A^ zw|5;q#c;{De2$HlVa0_5Y(67S5K*ML=JAh4(%3W0;jvOiNR|z8;I!{c0)!}G22G5;n_xe5G-}THXrNs z=c3$aF?8O0Y-_$!FLa@|IC48k&KV6G+Uw)}$V8utM5$NZQk^@C2ztn;bo!YlD)Ci~7jfv$G_H-mGX=22IJ)mXGHWQ5{>`DOr7r-c7M-rhT^ z$!%*N4Mh<|P>OU==^!FaKuSPGn)E6l5s)q-RcZnXBB4oF1cLM;M5H4S=|$-slwJiS z^Z-e`%d_`BXYYOX{e9o~jdAZE5X|sxYrSi(XFl_pb0Ye|$wXIUGp8F^r-7XwAIrNdD@m(+30Lf7>g;Ho-HWIHKf8c#`#%nL1ikjFX)*eHb&CE7^Ss7i&JR#ankL)` zJfZm7mH1ZiDN5@he>Fe@Eq})6S8h`P)?poV0T`Xm;e}lB80uq+PapF9E@()7WCQ$L zrVNG=W~iB8$$XGoDv{v>Iu3`|;vqNGbxSeUi+^VLuYki}F~{YHjE&rvf;g{m)vRu4 z@;p}}JFB#td3U&$%6cK1ve)S)Q*|Eq{XoI&`%gA|a|D{IE+9fLu)jO)KiG9vh`#5l zlh364z>77JA57-g~qg@e`uNh(EMRPo)t) zI)g>wkrVa=zt*3S3@W@_Ti6dP1$$7Tm8;xGVQY>6WVBVR;K|`<;Ztz1U>fZ(4qB@1 zuySeqg`}O16#i$kFFL7EN&Yo9bdq7CPS*u?FA|*h*cwsW{HxHtWm;m8@U{(+>JXcG z@CjOZzTn+wdW5}C?F8Ggy4!Y=S{#c3bc*_QdltGFo&fJam8*tf957EOt`ua!%r(7E zWb00khjDr(biKWM&o4N(aYa>wU=#TsRE{;??y6RsO0_;rSrrtRB0kc9DbRkdR%LYy;7(CK{;A8>{^GD~E7zMFOZ`1oW9onZFT}WZUM% z)4W>~$8-D}*NF`3UmY4w2Vaan3pc4rJg@$Md-R0Cq*c2CtPnA|IZ4 zq>ihwm$$q9X>QoMd&jtq|9`24(y#+%5E54bc`mfIo9A5cw) zVn?xuAd+zc>^&)ZplAbvP>SxEAkcv!1!+Uw0zV63fHj`#LeF{MZCio1vG529=Gw^ma< zrIfCCv^lEsPp+z0Vl4c0$xbz9rp^az75<7R z{)Z+173clGb?mv)EQ!s@w;z7Rn$3a+h)|6IbRd5;;1!SWAej8w;}9tntnvEc3$Os|LSiq z=_}vxrj~l$#uu5WopHJU)%|PV81o_vWyk7Bs3P9*fb2?ZSiNdle6-*-vK#X|%a?+q zuOp&F6Wg6`(1?w$O+*CcEy}LqhLXm{0t+u>ll9qS3q+JBbgb0ZNi`dLWS1gm24Qg? zkw9{op1upoz`E^y+JN;v356~g4z@$ISi}k`=FC>s zOp{;lPsl^4Bi4Vu)eop+A4v+l!?5B8HE~|Enj0SGbul^v-Zq3ddC2 zIyhe@knMUTkOCzfp#Z!>x4y5jlb~mkmlD(x5oNAAYE2Ba|h5K_O>W1 z4%6~@D&WSDi>KCA8Q;t*)CN;BnSA7~exSDV?wi?zAW2kc!|A~Qg|~NGt+H3Iz7WZX ze2kPs>1(U=$Eowx+?-GQPM~>+@65YU;5uXAqJmUt+Ur(-}X~Bra z1pqLb8UDvH-?*^bI>GZqC%%8*C!%N^O&|k^>=Q3hnSe<`^l3ryG|(mgP{vs>HsHTc z@9Ie+j`w~&Ll%)!9V^oq>3;U3nx zZ5c*ZO%C_;83awRwotRE7ukv|DT5}JonYEsqsrf5HUt~F(tcG1r{%$MfJvrT{bQ1$ zvkNFP%u1%iPsqV{1W_6WYaXv+c(D78T9MN|m-wZi6P*-}ZfNgZ9*3Q=8)o#|n`MpI zxSeePuPrC8p_l_mft3~U`P`b$^Za0rFUL8{(W<%oL^%NcA8S|^pLkjvrH-zu2Gvn! zhmoPYV# zoTu$?t5)k-!mywB2XObclH1N7Q9PHo$#Xht9r)PlOzj@_7)U23i6n> zRoS1kUPa5W6B#a$Y=Ac9B|>WN7T!QE;tN~+7+YQ)Y70~|97UrHlw{g1M#|xAb{EP# zwBwsi4Z?WR%Pp=vShxbOo-bxT4EiCv+RGTQLQeykUo+ZcqqjDs@7z!)xmPbce>mun znNRwM5a5r`-_!%fzsE5oaCdcau_C`Q58}T;@su&0$Dm30FZSTC+PSa%P9-vhiI1SK z1Q^B1>~E95RRCp@{GPX6Wc(1kYCz>|eN!IJHIR(MaILB1p<%mO7!Yr>3=Uc)1`7K2 zB1T?D0+!$>WEt;p);?VTP{wA^UJU_OYJ#I5ZO%pDybfzBh2R~y6&$ka$=(lAr58el z3X0CTo?QIIU2$*I(5vIKIlCuA_NlgXtH;XiW?|llD}e=uR!X~hG+ONWHfp_xYsxHK z+JcnJ$QvH5N;H#Wh@;hy_zIcLk*AI)l?#<5q0FnTGU<-Yi+(f-p^w`mgIljMa1Ikr z;dF>9E)v9gFzbCM5DIBJ^@tmAdcX;o+yR_`8U}CzVLk)(U%1`@&$)R&hN3|pmJQvX z|BRT)Ky3rKbq=w97VHFcqjNNFk#VxbisL{4XvjdNRZ$%90`7-_6DMKL?XG#I&+tS= zj%LkF<0G5_E6_`*;6y}Vw#BlDw1k?M&$jnA2m<^mHHh2@$F2f$H(k{S_mIm{M}(Np zj*keGAH^Z)Y#i$35UzEvR}xm3n*YE_uh!06)5`?LSv8XG7zQ+ljWev zh2m0nB-qzTg509T%N=W6zHIn&Cc)z8OFQd01hrKCg~tw6OcZ=_dt^?26pcol@WPC* z&3V6_6+OpW=yY^HJn#JWVQDarrqJwriS6nVMZE;6mDx3eVhyPRxi)plk!}S8)iX{K zS^9>BMH(Wx>8r*4X9U@)G=vQRqqe^}{uvY-+T!2O!deh7VC$c!OXfe)%1_x}F%M5u z5-GdzgX{wRpuD$Kd-Rv9V?vhGOnNuu?tK(a^SOMIo5^Hs_WrWSdgAz;q{%R_ze}(v z*v{H43eOrtTqRaHo`p)KdATDc5UPd7>UzTssLjW^7O1I%yuA zzcRDd=B}}?CH?3p1bKaH{JhQ6+`_q)u5*t@9dqE*!5u*Rwa%%&JBp`cBI=-NPBOvwfH0 ziu5xmFr}c#7FE}vV9B~gs-MII3OO$iB*~Z=gp#LRd37p_FX6TYJ|hL=m|6bpiZ>E- zBGNl6xVM-Uxpc2GmZyc?daiM8X8cQ%zyQ*|1U%D ze=wz5wn??h-_grHZi{d!3+z@{1&8^e^Yi`fIKHid&)%gv72ymZXjRv^i<5IwqiWcP}eD{ME%EzD02#HEi`HdS4BHr2?$ zvOCIe(*XrMr=q8qCxS<}_V+SQu+Mny=PnOob1eOKTR9K}!%sJ3nlNvF;G_-k!KfiN+LOTRri3Fz z5P>Bc18{Da7u^zZ`bkYSiQlsn0j0b+t`@lw3qyea% z0Pf!oD8QnMn%l%j0#NV_Kv|m#fiBJRZI!!y<)^S%9CM1EdMw;4pmTQ3U7%}Zv3^&l_6OV@(I}0XNp0XkyqK_$ zu5-)n&T{m-8S#dVEpgKAiNNu@4qrnK_#<@=;oUf-@Zn~-Pcl>59I*oV;ll^b2bkjV z<7pb~4<^1Qg87*zPrRqVUT)64)lQ`P{1d{zI1fEqv;qtDs!5O3?h`y?GEwJq8v-cX zenQmlqf?!a$^i7&1cQzSkZv~tA?60fM~lJswh>1L7i=e5^bJ2izU#Q@nKby=!?0X4 zQw3Ycb8S(xT9>Z**PFSqJQlwg>AuZnYmq|e!$GlCnm9r1XBBK^6jgJcL*-{zX0l}N zB#-Z3T1piZ`C_7IG}R)ZoTYfV9E`WpAb*c0yKOp z26WcUA`Yk1;_f}@w{Y^SFCNJ%cyjF}&y{}BGPx4OH`snC;usvxk-^9Mi^!@ytaiQQq6;*nV;J{n*B92 zx})o%aPVR@S|Aqi0r!4FEG|QLk*uIp_94d*7#Mxf0wKe3t`{FZ`x64=21k53EI|sO zS8Wc*KqGg`)8J&Iv#6t8%&%Sv!uvuP4#dn$%yuB01sn|w9)ULwV_kHZ)kb^B(M+sw z2U3pL1jbn?J{%x_7%wUGitaGg9pxXGL-K0zkt*aOVu3t*iO>{~(^ zNaA&_zRZ&)_s#%f-QPlprIjO$ieg6Jja~^IA7p<*IO#UM6^~O`tziq?QDXBp6R&gH zrtg(0+ER)Q9AY%To%;1IDIyG6fuy^^P%25Eaz_to^Ire?rFaJGAdc$j^2l*XIyZGB z`Ahwojs5Iafeu*)YL}Mudu3HQ?t{?R!qNrZo~#Q~#_694vlbhq%78KbOW^1iiS(Na zZW#HyuYZSl-cXT8^EZO?4p_neQXo~*{~~DrQgP&87QZI*s`+BCU!Jk#VC4pFJvGfc z>fldVk=_KsQjU%@P&9f?ErFs0k;bntrZlrWI1sa{MivZUL>BktZpH(e=TH4TZb0T0 zFd7tntfwyQao4k~J4RXt?f@Poy&Ud?cdWCiT3yu)PM^*ptqyck<($reY)vJj5Tp1b zU9srLdCd7d0k^fZpgP4yHSrJm$Moahb2I6(u|$i-8}*VCC65c_JJomdw;A@xDjliy zI_GzPLe})sFw1M|AD>_lW{Ug1oFRRrG0LM8K^|*s(#G3jb@L5@LX!F4bA3i=Q#|-CHhjul! zs;gR4QpC2x--g{G%QE;dZa+BioeWC+&$YdA`)9! zVOArbW2~(+p=rE1pwQb+ixa*XLZ}O{2TLAI5#eGLI@PGzQwr4gXDr6dE66)2Tp9#c z@%dDPtFe&t0g(Zq-7ECOdIPY~^>8qHu!GGrf+frkxI}Svx9GajYDA;LPl&BA!U+{K zViwqPWs0-EYuahRW^p_C(5AO2U2GMlu_Y&>=we4a?QA;b4{GtM&{3C_v7aFOI=Z2X zr(fPTtRf^3A$J`IZ=tZU&N7%0`}Qvb?+>ke4{TrwwEFG1C?CrUTi3h9M+%@*LkBjC zQ!w7DH>y>iQm^eiY`k7{V7Qlza==d!)zd?_;^&g0j;{xB49lzJ`+85HfYldkxOU%6oZS3||Hx&J+G1^YyGBo@O#G3khUOP8B20>+JoY&;Y~Y?s zpxbc8DIo-%ng7L_Hg#ZdQmXHNg4zs zdMSn(y6}Yd=zxnLWWQ?ycEoKy6d@p)7*7w%aGwS{hGZ6T?kD8f29{QF1dR6IsaTI@ z=pi3=djBVcnELt<_5!o5I|tq9C0x3w!sx2@;n=pL_nTz}u+s4>6M8Ai+>ruBW<5!~ zTK$n+%2VZx@dz#vhiz6GBWmpb>ei z%01vWbRa&)Pv#)Q=DkPT`tn|e7xTB6RW0zvyuwz>WzwCPxi;A&y=T2sz+w%!ZK`ta z0`h*pc8lOh@u*rs+^3bFb2lS8btdKVN&E2JNh(nbWJ@vEIh`eo5aNctZjeBpD!s-h zp*St|Cw3!mZh9#M76hO91GoP1`F|hbr>VH??rTfyCB^!Zmitn+5R1FOeXsKpzLj16 zu?92^d*+(=DnYhA&jv?zwwg_zhQudmLGA&=$7lXD2|;qlF--|T1Nvw^lE|eY5ht^J zsFx1`xpg}+8Wt${Pe{~7`S}#eg~8Ji!}Y6%Gkylr^n(>p7KRheRW_=eV|am8qF+A| zkw(T{GpnLI#D3Z6t+aBhy_4?w$k^^Xjm#fX<-GI9BfN56F}{4JRj6jY3`D^ev2lo_ z-87w>(an->u|s{N$&D+@IcqTl+<_VvWO3 z5$gYBlHGh`tYGzz^YG!1QG4G}#JHFi85B{K8GUpJD)FO?0HEV&pml@+qwQ4naX5<} z9qKtc>@s(sO1?>LULWyoM>-xHVM*5`lABHV+Q*8#CpE|RfaNrPuF|#iRsIL2nYA*YBPi^2c_jeY1Z&{wS`cAYJAqX>*f;fk;>z%My+p>QVjr9B| z?EEVGSZew;--FQD$70`A0>LnzIfn%XC=5-3nE5^ltYXm=2d;INi`l8bDjS#AoRYH} z^uc_>Nw-%RBCcj+txcgI9CLMx?1h+&#w)Ykfso8OLR-00Z%GP=4-I+8V_cz6iWFPw zgOr28VY!l&G!D2oaTuhMw(VoXWnpBBb9kQ-aGn>P!TojvBWwUi_|B{Qj zRrF?ywoT`hkE(H8v+)+}`R>ORC2{k6-ybUrk&>_&-@mO)?$$Tjg&pya?kd%x4?-q< zH5-=Ba$GMS=3cFi;BB;fWgFJ6-X^5JGBC_n1%HQU!zE%5^l&=!1e<2F+NPBBFfZP; zzVL&LSQ@r7U+wFyM)Tnl6BQ*NkInG6>Pl;>>dR_IOR}H)@X)CWy{2I?eQ-8V#WxTE zTinYtKdn)rgVc+F7xVQlQU@~Yw+!Xz%toeIhL3Y;A^w5Sm`DFN^?|tV)A$p@U5yy6 z2Arq?G(#RhfmlgkJQpy#uTW_iER5?ghwFd|)O}{fZ=m}{aiTH!ftce6;L=9Hy+_y5 z0YK`M25$sFy}Jv&UBA56|3vHhuxlH2+#_Y*mqOg~(bedWiWk%9spHj5I9df|_y8C3s%ajssmZMBs$?u>5d77;vTEr5Owy~a6i`Rfw}E>pA>YY;UcvR@nM zWBmGKk~4D2=^VE#6z{rgNv@uy4oGwA-SU>fNAazD&b>U>?81Thsw*sELRbi49eI~_ zli+OFL48og5p~<@g5OZf0!U3VBdur1i&qCii{Gm({!iP-f2Vl;!R%&-mbTmI4J-%&>T!!F`;EY;dP2C_ywIz>RvE`-?L8QvnuNOS-rWB<8*=eyn1ZF?n#=j4Koh zD{GpQ6I_hj{a@L4}tA#%E zeM`wcJ%Io!Cz0-REstQ{(*BiTsg`Mzfc3@von8s}XL{vtn}aBA=RO0LyP&2#NjG! zGbeoSB>wu`!!psX#hWa5Z&+-MPdlrA*jCi|weKK0k3n>)21LY;Zo0yxM+@N-D9&}L zBW40>xmEJo_DSBjQ|H6dMt8%mbfY>q_Ko?t5W*SXd+^5QYQI+jMQ3h&D9_TSEa_I^ zi|O3Kt6V=!zf{lU)8*lKpskh5(kfu>D1d&jttull)+x2SjHjcFfPdrU=*8ov5vvlT zUu3)eme-Y!Z?1w8I-47`IkCC>molcI*4e5n|9J);C5>#9}RD*cB+odqrdUA zE{BrmV`W0FY{qwhADdqf&Kr92KU{RX2cxT<0zFl(V<#MqlK6GZc_Jc!@i za77|E7r5|70sP0#c*G#6N3l5}ZN8P844(0>Q|#m=gS6$Deh`(IF7>}-4*^`*S`ql1@IqmzCbB3 zrJ-Ootzml!elTDmFDD)|!lE%)HQ1pdh8p+}XXrTKYgxm+!F%`DaMUf#OapXB1Ns9X_)4k6Nmz*w@ZH&{RQO22BRsuv(r)qb|VUwGZV*z_ynj=r7}l_}6{|L8>wyitM3 zr0ZacFUr#h3S>aoxy;;SSG%tvA^OT3xK(w)-_QfuEs#WX3@uDb&@5G~F#%K)lT>hD z-`6`%OiO}Jj!M1ZFn1W@`MWabUl|VnNUnH2;babe@PLI)TPXeQ>|#~$Yf2vP;zlnf%2dNxpS04>XLMm#$d zcL9|H5fZD4Wq$0O_o15U{P$1$YpZuz;o{S5R@5dQ_LI11p8GrbA?h38WpnpKFjQ$tG9hxDc)xD zpYmBz5G08y=?(8-pE1^?rcbZ%Bf4zMd2JY)qu~mUw@Lw1^sg#H|BeX|L*;n^*<14Z z4+TSd?SFlBW~*qX@d#{Yle81^oVYFcOYmpRHA3yKdG9%Rhb6RhaN~+A`jKazn#;zV zqitf9C{-aP=*cs0i(X&cq7x2r#VOS}Tt%!Eg%&BVAaFjC!g>5(|*%k`ANB-NRRQ`YaDBFM>Ho(H#6wiQ8AhL)e zoK8!vQHXI>;em9D1@=bBq#EQ(7o_t7jq_d-Qh29Cc+Twgl9-KvR>DoNU#p8bSa{jLH7uf$UvSNyEn!7zxuwqfLik3|2( zM#SPM{=`NYdj`M3eXlU@XY$TW{ACNzFmO`-C$UNhwkqg1S{f`w4pNkQsDcfpgWag6ewo@Ix{1a-%JlV!Za9-^OpJ ztayAxnVqoe@z~84X%kadA-UfT;AK-}zY0V^_7X~OH}5&Q?w!zlDfKVcLY{Tb<;u1* z8kpMbi_;eKzmF5+4=hTrDO`WTK2)U|tJ@a=tj?={YO4LAiA%&L^a|{o-K7(#s zDDd^UoAN{u*_sgmLN%-fZRp9XAT}Hma1(eddB2VTvom{$phT=#{-Oth&Li-Nuq4;& z@e8DdA2wvN>jXNWNiZBeEe^@DyaPOX64mcjc&O;CDB<+ds59A<%g%i4nxxstKT z#L&$b7#s=Md*71lTI`G=9KPq@028GDV(>7NGhI|?UQwefjYbn+(gEDEPmzIo0R(If?!$_j*2 zBekVHY9Dl?sCm#MpVZ?vWFtSns3Cx^?%YmQyc_cTG!=@+)%jz+xhu@LH>$f#<1kvt z=ZjX&qVxD&hd9_%s+zZm4i&}c1;h2{D!&VETE;GwWj@M{dp6Xs)b~dW>VNt)R(xOm z%73KQ&bjkxv3l@J<*$K`l--JM16kaE&A0qVbCKP1t9UQ>Fny>D5XP>>;tA%ZWOcnx zPq&9GRi8!fONlU8(768?F3!FXEhIEORD7c4)(o96osWFhhL%_?P}lyus0|RKLLeKm z97X;r4aaxbOrt)VN=b!wR#xj@=PV}~cz!bJEl6Tz_LTfixx|y1mD9N=NpbZ^NPb}9 zD241*AVYV{lPupHPr0~9GWnui5q4L^1sB8Lee+&(Iu*Ru%W(BhZ)(&qJs$<5T<#*v zx{%_sJmRRp;(?*THxhmd$*$~wS2FpJvM7xj{;;qiH%O#&dv!Isy3i=A@P<{$g_U~e z>$w-e{p$Y3?)tomg}C}NdL$_LvaYIDVBDXQ5TU4Cl(ZoE|fhsik6EWA{o>(6p%s85zpuAWj& z*d~K3Lze)J)ogH1{z`^yxWMnfw*wvB1GPxLC>E@V{iy2AG3{{@9-elZizojgeeW|e zG}*CL`!?l%e$HZ)`19bDo2nWTN>s88A=XHPZV2zMC;bN|fV&Ju@CbBFI0Vjx^vLU5 zmd{7JaP^Qm@Y$=U?ul{aU2S>}*$Lw}w3 zPd{v|yvwgSn}>`;J-o|6O`fU5{+s-1bXEBo&%?l5eF{vJ);_DU3L{7BfcX`Rx!hKZ zEB5F6B+`d_Ewmr;UG^W2($trB32qwJ$fi6$^hkL(-`0R@utJ^U=&kmB=KH$^EYx?H zcfJnVa(hGYjywkRSa`xjkrzPnf?Hbw-}Asu&h7Am1Iv+=%*Vr1#rcJZXSWfxNd zNCxs_pP7lj9M#TaQ4mTTNK9BtFg^G8_xjhn{jZ;*k+=k)z#<5ccy#dBbW@8fwCC`X zO&{rRuEnSBXneYcG`^P`_uGD^<$~ZXvNc87==LkIT}zqM3WYNtY?vfAM?O7OVx3nx z#8UwkX7|(8ihhpFvnk5yA>$}EA?e6?xvI?5uOypsf*h$K_A6`Pjqp0VS8jNNrC%R; zf`Ptn`&7;+tCW*3y96?W!FX%TfLkM@Qf1Ls$hV`Cm3*qS%+O->p4fCDf(GTI)B+`=EMMibbFUC>b^v_s`04RadvOcfURWzE#X;u7weH z=^aTY%?GjR<$!VPl0(w>J+HVHP^Y)J@K~7b__pgN)#G74j#kC{rRc>O`&?l%GgMEV zJodU#&d`#(3Dh51kZ<;i;rwySKtl#H0j$2JKe(koJ}Y*GF=Fx`+?#VA7*;;v8}M?Q zEGD&ARWXUN3@_bILF^AHK2Pi{6=7uh_1D`Wsl@ZkpVw{&7q`|A+f;P)n3ewEi(8F2 z>$YipnftlErAM5W>Clf$aTnQ5$yPN+ggd@$tC7bC38|KEZycoWIjwzG$32mqZRnq37*09LheW9=F_3z~jJ@w4~mRzipH_o=& z6#c9iBB%91+JHt;Z)oIO?S{KppEb(WS|p1q=)S>{KDQi2w|-x2s5kN68kdG<%g!uK zeeKY}`3GIC4SPI~8TGT>G&8B2od6y)6Nm*r<}T_p|%1wgUEK0 z#W-0kuMR~gJbO0CqZiYDq)%cRkTvl}L)&8r1iFI261)G$%L_@AWoP|p`%a#mV!>}% zNZ>RFW5xOt&BRMNR7{F{-OX}Jvk5cEfwJM2F&ghGbTRpMirwQpielBvX;+=(AJ~^> z28$avM)0RR@JAry-MCri;)1DgU)=_BkvBf;>K7%*>yqzsp156hg!I2U;hU4+s6Crv z_CO@DJx4y(;HzDpPM`EE8{6lw8^oc{A}r zhkW23@|M1UG12quTw=I_zyAAXuamFZ;?-02V}nOP_WZB4{ZF~&k{8?-@+_aG)%g$m z`)Vp>(+m;X@kosk`mf182U$J``BkaFg%(d-W>^o=jtjXTC@{3yI>VV+#4;8=)Qt50 zFT?S>5h1xO8XKb#XhPxGQIL?tB7%gtEm*%&TV}{cRH#>>CF>z~9uU(UA@hn;4MXP} zXOK5^s&aTI`&xuNnV*oP=c%=IpZg0ja6wu!P-f6bn$)DumyKsVUFw{7{4H-HSCLxBbcn(8`Da}I~ULX>x19q$OA6h*HonND1riWE2& zBx2vesyg!Gpx5;ZzNk)dr3r^dq07$o4X|1JkH`%3=?!tUC43*Gfx~(tA`(-UzD7%^ z-9LDT+VG80%1vp4b-Lho$GT7Jijv~c^B}rNJLDP29~p#y zDHIuTZA)A!Ya)9>)pb#mgwRD0)TEw^Gf~rV3!29xZM+I-#IJgw;EpWP)H}FAvs01m zdKyY(B@Tko^E-vW#*Y7hUcW}?=ao6b%kUF&VLm_Gp=&?mWWR=CbY`gjw-aDf-sG(> zSale1SetMoKt_yv3ln`8WjIt3* zWstl_a)wcKEStC?mEk2LE`RR8N_CO$DOP&|qOdG~}tL#F>V* z-gq=xe3+DX=XXkCDgpcl6bdu7-rWE`=Ka_D?OILZO*u>@*@MpiX5% z%!7>+c8$rN>jxfkG%{jAPc5b<1okOlbZ+e_u#+-rRn-TR$jaR+-5`kFlSQ!4eV^GX zZRyu-v5I%G+yc?nWDgWqqmP+s9sB!Xixq2D^$p&t!+k}2TtAk-m8)zsJfk0PlB=Hc zo$1=z6LxK1htJ~A@xvIQ1>to-+guUFrzrwb!Fq`6$iTzW2rEpatlBb|KM1=x;#qv= z;ci6Co{988adiU1*XYINhI!aNwRhqXc+d;=9Fpo#SD4Fn@1wwa!fdVE~#&@Peyib zjXCulue}JI|2#_%p4k>M?EB zj}Ki~-J@7!zEAj<*B){eTFbz~-kZuR1T#)xo|XP^VYjs(>Vupi70d?63XPVtLMhLQg-iL zyp!lzKw1RTSM8xw;DQ1CTeOV`W{VX?zJVW}Y1%`xbFbCD%892(=9RLuu6?e4Ceq&B zOkpYEoasks=d+5nV`eS@`gO`ZXPvrb2eczj;+Ql*6}N+J#lvR5UGJJ#xheFTrvb_L z<-zmAyTR-JMi>y!YLr*xUW1mCIf+04ANiwVm@ z9%zPn-t#3T+55(u3)g+m+sG8Og`_xk%E`$Te>?U~XS#=ILmbyL>@_8nmC<^6z9I7J>o7qL5UYWy&pq}#k(8}S+2hHX=*xsZMc7G z{B5=R@YAzwyp)jb>!T|&cLq`t<@v6-MPJg>YLxPyG#8oZC$u+Ne;BVYUQapwBlVlgAdATO(poepQ;>l41P4aQ?GpPl`Cb>Z?RS?Vs%k6Z88g@;sbqmMk$0`IV?x3cnElBAG|EH_LR|gP+$cu%xb|`N7@jOIOpV=;G4W2fV$fdOHrMP_E7* zlN(6s#M)VgQiAXp!jX1NbB=%gqZQ*%NVw!n&)2E9t40PW-_m%5T4!(YkOle8{1WEe zb{+3+^|NmoBVO#aqQV&;Xjhjbmp4w`&HkFjCQrkSaXtYDSK7V{R;07UoHg36@RqooG(~SOW zVP_{7yhz@V#JtZEnoB(|dO6zO*e%4&Vrtt-^w4||me?#Y`_7I@Ea{#GU26P6;7Dq+ zXT{)>FC*g~EE+l!17oV=&HU`^Y@4^HsPV(W<&j}mV50hGE-Tm-rwOf|(1KoDU-HUP z;~twNL58B+&G{F0rB)YfM#!#e%@nqIPxb8Y$*(sHw9S~AcIk)i*H#dycJ);J>{I{1 zvyhp={!Rs7$u1+8;uHv6orSE*Nq5qm-79w4hYlb{A6iuOc6*5~C7zALP#-qG#JX1AB@JL6gxD50g`z%PmMdqt_jV2^}| zb)QU@Omp~WvG%?9 zSbyChR?Q&&j3V+rqq9~_U{j1n;q{T|D9+WLRrTq`+Aza>tqhdg^Jv7vRHhoZtPGvcDf7nE`ceYthMrDG9^O!uSigCaRY?LCq4 zBzQWa@!X*6`fxGrQA8E-sSu`>7I$emtU(|^bEHn)Z9dR?Ld$7ib2Rv}jcw$|^FlQ1 zvAt%1nk3f*p>U@W%=(q-qf_V*jMH=koc}!`yUxSqB&O&lx!G_RkE45|(X9~3Nk5ZW z8F`F&tJ`fW_A2^yGrtBS;bO^AoBef5=#?hy2T97R{Oo$>ee@@al)m(UsAklO%MFi(LbqjM3Y%Zv$uFyswn1G0(=@nB&*)NlBn zS;hUY*~7JpDF=%17zTvX5{{LjK*+E_U7%HNe=W}j@GDQhIGs_|o)dYo-{T56-+IQHH!tKvPQ6a0wyB=0 zLEr>pLOem0Bt)ZD1GB?XW$*eL;o5-g0bu~+P%8s{fqn$8^%Ad+i@-|E-VUZ{>b~*- zdDm=eab3jB(S_USUa+1j8Cr38JG!1_Ry>vIL*)1BDki-OEvExb?~TJJifOvV)W(jH z`yWDid9n+#mv+siKa3ugeuKA6h_(ju&*lt4nfNNJho=H2PbBiiT2FSwCM5DJhHSw| z;JrkyN-P@BICt+_Ke>0M8SyQ(#!1rrXbY2Z4E9bj_naZvKSBE|+o=M@yb?=F7jBH} zRQoAiS=ekROXG6NA^oh73%LKz?<~yREh#a?h@`R(gFIyS>J;sPKBmk#bYtHnsc2KO zXCj?Vu)tAts_pBKoeJXMPCx1nqR|NP@E&6SUZ1>z&FoEA$6}usUEMzYVLoqT9PT$P zrups{O=C5tCyH87U_zRqXI17p=NpD3HDC2vJe;tNR(W`m1FK8)nuTHS&Co_Ruy3Ju zH8%+~R6v6=6EZ_f=>r;~?rb^YbKf~X7!$x=b}LNTFV5?BL4<$CID1Ovq}uSd4K&uq zjPpLSL{VJ(wmF1D?SIBDVt~%bNr!#REF*eKL|@fNFGxDn9ePb_$)BUFoKB%=6l4*f zrQPtK?>#;Rq;Qhx>-{dn#gyFfu#XGfpGDsaI(-E;FFR}N@|=*&(N=VqJCK3AJ|+RH zXc{?%7&B-p@GUp1Pkrk074llPch>TW8y32+;v7z$Ogy`Dn(lDOK(<$b;9N@x%^C*> z9rcegx4njLJK+OHGAWE}L7)JHu->xbO`hZYa_v*>XqaF3FXj^|oWFfW+}yu%p%)nO zM$G|EMX zT6v?KY6sqEr0JOQ$DA-~$lzbLtm3#Ybl<&>ldk@*VRj+fQSi~=6R>CEX@#Gx@|4@=V4X)Y>16qy%i>P&7DtBGvGg<>*{}WlsM0SW8C}CJny9$osdrMGj2*g8W8D zxUeRop{ypYG2_~k?dSV~^BtzNhUh}s(kUOCitR#{*I@KMr-_t}Tjr*?D(ANrILqzM zi?w|cv%5_DIbF1mdFeC$sMeJeA`Sah?) zyPYmym&?Z@#O6f<_k$XdNB5+w5{b8KMD8?|sJ}uy+;Qj4Q`qb-8QrP+QU#{RyDEBf zU!V+WWD>1;-0B57oOg|%Y`8~w2c3Cmb`TAMhdkIPVV-G<%}t}H`O;ZczDdSzXYV$l zasolHlN^2zRVr0Ni^o_ZR@%^=z4V_Dv%EvTT%b7%@wu}lQ|DEmAKYIG=VrgG4%NAS zc%(n_ZTEJ7W~w#T0-CJf)SGDdY^idCmqS6y&MPntobV>F)TtxT_0!<^imh1vJjQ)j z{JFC>`~Uv(AQhnLOVlPfgkgZ{2}H-v86r>M+hcuaMA-;x>m&m%$9cA(?uLtD+vvWC zWV*IFd#JpLl$;dH@L11GN37HhL#uEXf#knMLnzJx8pD_Emw;xIKc`cr#sj340y zFg~?7QrbvFDe=ubhy3N~F_W{f!-5?XMQTr9{)>?S8p1b#?V84@6*{2u6B zqL!?GtPOezM$+@0rQi+-j}N+;*>4d|agY!Z;hX@cyR&WhubXU^UE_`v zOVl!WRCh5C6@Xk^NX;t_rn zxHCIH$Qp$yLTv0$Ew&{s_Ur!rjfFcqiMP9gW1f<8IjdqXrt{#bE2yuncEEc}I#MPC zm3IC)| zpEL|68~eFUjqOzwRh42ZTZYU+JC-Q+5tggSFax=(4{L8XpYmR^*gPp~vSRYC>b105ZmKX^N@$i2LpX@`C! z_C=j$4WJX3=!@E>BYvj)MOtLX>O`|6q%L!%khkGV__^2PL}{1x2F~Y^gEEiYPF~~0onz-W9WE~kLOa&7SS1T!* z<;N?jvwmN7MsNhejq7C9@-bED^-~bUpA#MmvK=AtDB>%MUoyrUjVet(n(O#gPuk{y3vc9>t>4XxrUXTO^aSh)qJ|TAplx2mgXDTw%=+EVLuGN1-*F41$59E|MbxT z{6E>zyPX_7%Jpq0e*`vN(}YBJSr)^?Tnc1e%ZJR&ynmk_X=pj1bTb(IRo#_T6suNBM z^7l=aJ|_nM?UI(*>$}q`yH9Pu7EKV$>;T<^L903aIl|SN{K(z^>ZqS+blziO$(US# zbKn&T1s9SCDkV{ZK8|e%8fI^cS{XB#@Rqi16YCvTd6Bm4QHJ}bKq!Us6V#s!nx96h!X{sqv(Nj)@%zml*boYDFc5;T$ zIEut)D{}9K!$Fca;1@9;o+-ibt7q{9o4FT+i(6V7>D7dE#rzc~INGE28Y<&MjFaWR zMRnoM4F8_)@?4k`-x3Dal134J%L3_glaD+dj7-tR9EHoY{`Fh!iuUVE1i|SLNg)b+ zCfbji_fb<5Cdu^pE1C4>pZAn*!~TgoSbx6p)teSBa37b_72LT0j(U@>%hV!dK(}wT zNxUdll`aS+tF23biFixTYVs5edH+R(DAOA5Zm$0$Ed3AgK&GV$Kmz|AxBc(mlW+V7 zoco`wJv?bn1daSvp z$P{hssJ2a8uF1IPUwJ0OcyOFY6F4Nws!X;K`Q+mda=a|$SMIjkY(8-aV{pTpCDa`$AM9mbpW zT=}ZiI`X_Q>&6D1s!p`K4PEx5Vw2E0a(v-;+mof4OcE9STI_l zde7GCIAe-?QB=Qj*n_+&yV#k`5nx#i;OxO9p#^MekP>!xy7r! zHA0l!RB6KL73Jw5ADFi4wzSxUmAznqp_#uZ(T(}s{*CM_KfrrlW}y#e!dDgid9mw0 z9~%;!73)lYrx?{#=)ethGZVbZ*}}HEEbI*P_@#1&7zHHpwws-+{BMewCamq07o^5A z(l1_-rWS=R^IEvKT7;%SRi)@i{waA=FN_6TU!T*)7kVl5CXLYu{##JWHb1K z8&6*3)jE3ion4pnDp{&r+8bK~%}{q5)L_e6f+T$gdX9j$$W)<=_D-$i3_Uyi9FJmL zlVqA%hf@ZUM%dZ*7 zzIRgcsC^N8y^WohGe(rsP1}wgw`t^2`$Np0BjvbACrG9zT?z;q+)e7uG{`O1oJehS z+&imUB(VS|tOn@`f|a1_wA{=+-AR*c(uV&#{m`}P!c=zP=Ccu{#G}ZGGB@YL8tK>F zQF2ykli`EX9P#=);nxyZM61#@q@)-%7d1WnmKNRDBoxfK?-qP5{KFuitQ1~(5qU>C z98%`_FS4qGJ)1Sij8pghCAjGuy)es*3xPy&)3?5r0kWr84eu3X9{UV8zOjMLJ@}Fn zn#a%ZwMcnCr9r%7wZvkZe}Z$3tI9-Tk9mY31W=>b$6mc5xOK)t*S^nK*^Z1!Qvg3S z8~`zsln4d*5L`sVW*C}JWPcs>geHmEW4EyR6Y+8<@<-ErRj_MQLrzIRHiO#9&S`Tr zM0{0Yg#DU2qls?VU;IVvG374sPr1fP_6$N?G8@ukt1EUn*{)Qk;dad56YGoO z_rsRxg8q3LbgOwcZ80<7Rw|^NPb|&9q*=4-n&#{PV2fV}0J)rDv8tq71%SWUF|u=4 zNdz#i4G92Y%|Jj~hl;U90jQ^rIQ#jvka++;+DY;T7__<LPM=|v(NMjW$;tC#rGJGq# zZlib;#goH`dhe}84TlthQ`}3Fg{mumA3jcbzY=!73zIT9-PrM}|NAep>eD^r)z;a$ z?i!!ou&7LyS-;kqtl*x9VYE7~ruOozy%A}6x;D5?*Lg^Q$Ay_LxG|;oO{I(AgRbB3 z-(Ga)*)e4E2854vw-v7i=UmN7OmN7HaAD{_*-=n7u6??{WO|-y`HwCyU<#pzZ4Ftg zoU9(AF-y6D7sBLp3uGQB-Mo59hT^yc9+T6-R}k8)!FZ=OX-e*u&6AFHCf>JrktD9@ zH2|RE7wGM9&VU4U`N4wO#4>#yw#E?AhIHMGHQXVSCDRGnvlr(lNQoJcb@W_(547@H zc?nIB!!cjHkvs5YtA#S&Q$^fqG;=wh=2>g~O5e&vdTehlFlC80gS@SmHoWB+^u$nR zcvS6?%Y4epj{URLQyE2jOkR=&-+P;g0!{w-v4IkEq^rVqeG-2@8-vQ#)%Kw8?0+|3$ik(3@8xWiT~7 z^vNsaFCC~i(-JS05BzLI8!@MBt;*S^9RzmYQsz%~H6WmxFH)w4#n3id9{e?1Gs;UV zHB(9Vx^oxYrhd^u?bb>e1Wu=~aiW$UW!8ueG|mu5;xRGPS3_z!?FI@gye zpPmr1uBXX=hwv^LU)usGr=^x>6M9sY5?_`%cLr4^2E(OZC=E5v&O%$`kL5BSe2BhZ z;n>vt!=U-3)=6sHuW0pvAk^A*$5buuj>z*-_r7(_7T=I>*`Tf*fsuSS=p)1n+y)wF z*nOI^-;5N_DTcP36~r9&j#7W}rRx9DAYRTo;5xN)#p|E z`VG8z@PGm%nPKX~lo5uHW(gc{dI_$OV0oWkz@w}7sT-5${|P|ww{%6YlNSm_&@veB zFBU4b8p@~cTOn8`$j@Ii3+2hS$Fv{W0uKucS=!Mt>`WUISkFwgDa)?)cV=7s0zL4zP@`$ZBwOEX)N>C${aNA~K8GdwC zQ6^vMQ{?Ds_~#I1`=ON+Jx;d7?_BjNZ5!dAS!vhqu@+Iq&Zf74{~O8Se>Bfj{tcQy zjb~~EUV<l6$)1|UJY}L;;Y8|W2Dr^tB?Z7We)F% zfS-x`*(%x@kx|{~=9LWoL^U&}HFw2thpEQh?O$Z~@!9*_da<=)`QC^J840po3G0v6 zeI`^@xJ@z9`>>$p?oRyygINe#w^_b`JC#X58{B!@j{m;|FUsP}n^U>ZgJ@?+f6p<= zSy|Wqqp&H=?OB_a5_%~tok9k1U!GlqV$zBuSoEpTFv6913dgCnK`o!Ku^;3a`CQ4-#~Qf+UsLV>!&m!1mcxEByP@xF6?wCc^RL?X zxVjwY@%wm;fVI}jD5hHhbGj_@U==wVG=F54M;1%8tNf^;EnC7lS=K|@t=Hs~v=tFv z8;Lh1cR!f`{CKLsjgkiMCy+87NV7p1vwehKbKCsOL|XK1heK++m0wb?ej`m3Lq=1` zN5Ev=S8n6Nct>c1y2&kUa~FB%dFg_Fq(H~xy@x2O*j14x?<`YpefWGB{fot`H1h3+ zhL1spy@UZ{%*1OuTK2rBX&b3}HUC~L|IMRM0Qy>{LMqn8$9}KEVo&!G->>ywnp89E z9{CUAl{t60%gt*1H@Ec50q&^oGJ;E)Zy?1?MYLQ~JU1U?lKan2E4==zF)7il+NMnC ze+P7YvC`#c*__QS{Iga@rut7?qTAtFSjg|rp#AJYZmRNAwVRTo1ln;|n9lxxbt?ah zFh%wu*&^#|QE9UKPNvCMz9$8ksF`3tJJF|lhl)if>?Usr+4sMl^HET!Yh?Xr`2k-k zcnp|7tQJYwl-b$~v?-Q|rKZ_rpm|?=5~J#iH{EHbuyb=F* z4;1w)>FR2V&oK{Wmhk zi!MWZ?1N>;vWsVk=QUVTY^5ycb+v*RL=rBle6q)Id@-c}?2$xz zRQD?C23Tc_&PAwD@z%Wwo8Ok>

?160jqxV0-esTyonfLra-dZ1d5{?&A@gTz*KV zbq6IL!V%t^V7AIm220^Ev0Hq6n_Ke*<^5;iJ#L8@@`I(6Gr^WTSX2gw;GkktdHo6x zvrKDPALr`S&c4lr<<@w9@tZ+swszygettupEzda}h|Ouni-PL~H4c?wc=j0yJQPhB zmvXubkA4&X8tWCDb9AtO_s(JLNK!8LCSX(q_e0vShb}$}?0o2>RG(#L)`#~sGb>MT z>Z74DHcBK*^E`kmN3FtW1%@N|hI0yVbt>C(P&0#?ss8=mk!6A_+DEiZE~a1v%Lg7d znbTxT9^dcZ9OC1nk`GJgzGh!b$h>&E1HD6%kG_&EU7IZaW9CNKV(rSw7dI8TIN*g$l@Oh<@-I%JeM zh;q#hb=afVkDDs%&hjebWp<|7-=0r@YVHNCnFkxDjP{Ou*e)1XV+>sE-KX6`#0Lc4 z!HV@u_v1C?i+HLa74KSn!!+BxP#y#`EU2^fL968m9Xw!a7D7;OlH&D>0neE{Sw5`q zoxfuO_)@U%4y-Ii)wDdGK66Ywsj{ixprorx|~h_Br;qEmra%6s_1cUBd}L#~#IQguI^MsZwJvJyA1}JBUlvv0zFmQ&1@%a|c@3gUk zlmlMgv)-u>TWRoJHmC{3#;=I%Ib_2;7s)DHu*u<)f0?!g7#*2x4`@BuWjT*N_lUkO zDd}ObmDSWu&7<$%=Di3lu$jU`RL1QGhcj=!|Byptcg+C2o$7y~Y37ceo#e(GDw#aE z;ybBmdY~T(9`}1-kTLv6!|P#XwRkq^p>6<3%#g^joO%%2@)YB)C@dkhUm)Jjz#0k+ z_N2h05v<1Y$^uJyjhV7q5r3q>{D+QHJN~_*|008r8%~*vV(Hs5X9Be$w+ZL5~0lG7MI4w4?Bvm_Ez?2N%GwJ zuxkMyz{4uBBfF_t#Fv^cR@H~hiN?(p+JCZm_hNiD|6JPl3T*$EK~e++kX!zCKptzL zGqDADB$l$Hb!HAiNW`&W-b`Cgb03yU&Uu?~&K+5NPrj3xaN3LZoOU3Olvx zCX60@eS^&EM|_(M$z$hbD7MwG#JtH`6JrM!H$QZ;igQqMOmf^zR$}S8@Nwq_OVPcW zx2E5(u5I*$EjY%m=^0M?-0~mFyhnUa6YOy8=k>z3$bZDCR07&j{Ao)Rm-yAErZW*{g+I_LYZ8)SdlvpM3m|48L1)s4@oS z@zovG3viYRD7Shy>zI~!aENq(%O5<@ey$#?yif~YRP!xzTpYfn$%LKcraFl2K=pT) zD3$J!`jn`#=Y%8W38KZSkpGZV3TM49+##{y8m}q@ad^iS$wHzb%Hu%oTsQy|ZVWyC zmG#YZ(RNzb3En5upL7OrX*S=i4l4S@XctInx&Db%rTewGuwOnEnH#kWx%Hm6LreeB z_H#Gz%@(WLJsYbNwHm}Owe62)Up(kCv${1ZLt=uxiz(hNgMCzRk#sVaXq9M4pv|}> zeVVTSW?A$Od)PJYziUu4Nlf;Hf4fch_QMkyn80FkA7aVMThIyZ^C4+?5`F7;mIh^d zhp>-T8r6C7D;#8ZZMBuwl;8-uy7TbGzKh+%Vv!A-#a>&7po(eMk{Fy<`^YWQ;1W9S zuQ^xLsVNp~w23}k8c3}D`CE-G$fU{StvXeFBI9TgRa!Y%9DJyL=D>|A9;+UCkD>1dS*7bUp>_EurYNgV}(~XvIj7k|`KPFd}<$bGnl9N?9y_&SGLQFaH zVX=vVv#>oLi%&F3tE|>fnSOmS*DT~ecn+I?9AGqWcFlxea%G6Q*8OAwoycMjc{V{sG58_K6zN+ zSTMK(x4CDM#={>IScFy4sY+Ha6O8u}K)bDP3rsdiV6PI~@Z}X)`mbveuTr9CY<`1p z#$OG%v6+HzjR0L!x6AV*Fr484>y-dwRX_d__#&DTl#RWb$Du9uMWykfz)qu7#JBr zy2W0W;Lpr2X@oA5N%u^M9)y`3!h8INy}IA4J|G!Hu+j1Z!^k*V5)@!^%YUMZz+*TC z)fnA7;Him!6VLc8wu(=&{vG8S6in)EVIe5v=+|0OO9^*8K-4=-d~t>t;au@vk9&~` z2|`C!Hj2JXhaxmY@$nWhWcw==QMOFw$gUx(#FP7#YlLSfN0e$q7&foVL%`BSJ3gIP zH+v8hwh@66@fOncM5Ar-Ii1)%Aaa3MFA+>E%0IJaR$XvXNj&g-pa5EhhLj?B)`oO7 zF(RO9LBUP2cA%G5OrH8_^)?%o({kH?c##PgvR7LI=RTh`b{9}dQ>9Po?{pkQv~AXx zhjg(~5pG?`5jqZ@;S|e@RxkA(+4rvBT;!EJwoG_l9nfva*rzaEPRI}9dwJ`IUWsm; zMD_bryAz+>rv0h&w}&~M`o%p)-?eDBj{2n&Qq;;*pPpj;&=rUJbjP5*#tTtf_M4>& z600amh(Ze!?&I^l<%E4(X4{Vx(^o~8*EbcW)m9)gy(_J|N7z&qoN9Mw?Y2+B*PI74 zf2a1x5+WiZyI+4?D;lN*&s~0OSKw06m*SI)ENmC?LpRi_8!zq;)F+>#B8-Z^!J@?U z#$Dt6SGA_RjvCO3#OOq_z7mShP#Yr4WfJK&Y5b+(bd&gbUS3AJ_2as+jc*6F3Ab}f z*uS9|WJgR0OZv5@nmQYt!@u&Zpjn)T=DL}qgZvZOTH+B~bKljBOBM&P$GgKHF&wDR z1zOdA7+>U_y*0z2f%cQ#{BJy+e@%al3Gi%6ooxOXr`fC!9dC=u0@;tu40MpLV?}}y9?Rk3ohu`> z*RM>i@7o))K2vm=OG^tJ@?-}nJ65ga@LK%KF{0P1z*e=>ll>19`(pzNKXdb5+2-!e zJCm&ymGh^WeGaD1kScN=MkLiX<&{TzHQ1|fdtg>Re#Ci*+V!T~+ibp^W|e}VQ+(!L zuAd9+BEKN-_>=o%QX+f5AQW@$nW$SF)_vu-9If2sd3m^u_V(h){@#Imb%16p^$6(~ zFCoj;$-kJ~$Nd`q3ctFWP1ZWGPE(@4QU|EqKbG|9rSl%CX&N6kr&M{F_$;a4`?^x9 zp%|adJE;#9e9Jm5ZR1{ga$HlZP+`b!f`>#vt2{HYYj_VVC}QuR+@=wyn!5R7`D3`{ zJBI`F$kibb-U*vuN22vr^xxiCgj9``bvySC#5li()&WT~;{asx48dx@Ofv&nNs71h zkzy7w7QWN`i{U88uRLT29R&9vWaJ?{sUmr`Qi`PgZRb)H;(VN@hKEOf;d!0sd6#jC z#lv(gkIDuF4hJ#>%o@x9AUc!bbC_Q(jRq>a)w*>ixwE0S(?NX|)Wuv94!vpjQHL2G zHQnmcL%wrb*VaDbb3TZX%=whPx3lCP2i~i#R4=g^u>NlS(Zk77W$x*mr<%~5-+hIr zd`C-};P2LV_MnDv%J$YPNSOT`>NdgY)dYeayu zSFanmRaDYXx4OPexb#KTXH0hKn{OT8Bmy$=OK*8jxd6AWj>OvO2NU=j5)6EC$AArFI^f*1<*)+a6BD{(fvYen`ipFwYJkG?qc zzFFp1qca!UbD3JR)~aEcNg7?MGA7)^nQCH!24Hg3)$cPp4zg3|Kfa6Y@j2cLG+nMs zN`wv2m?Ugz=C9_*ZK(SiHyi5h5+hvF?VaHc@Q4D#N+I%{`CFNg`9lAVk zeN!)oKgNSEf1Va4AY=-jnlm+%cUOAIIHPM@(y=J;#MjG(VZBkNRlfR07 z!I=J)k}^oq-llB|RJB;Knu@%^Dq-B%P#c*R!Td`Ya4CTU|<0w-a zDt&%%boT)5ZfW}d?D)vEYIYQJP|0MDO4D}7y%Ow^T1g|?p7W&PcoK%FRrYb}0gCUb zgB8@?HJ*TvOzNBUiAr6+&(hiRRck?sKDD7FW(4zPa>mk2Tx5C9DnRh6R_EGomw!q3 z-6AH(f|dNQ+xfJnKX*qDEkM&R;V(%M3utuN-yc_lmYDo?8(o>#C@_%9V{*wov*wfM z67KJ-xqN`pUEed4exYfRd=`3gf+}dW1p%Kqv&rp2gh=fE{uadD zG>CJ6h*fbROz`T0(nvW0%%8jEn^jo9ODg3ogqmi=GCsj?}38?);q|}AKqLACBKYEsUlW?buG`c9*Fjh@p zsotp0Co;eA+7co}6&OIixj}av@=1XiOMx$(C`a(E3{mP}J)1`5f14|=$K49nPP@Av z?JAZ=G2{qreCcBp6`Xz*8LA-fRbW;d={}%7QQvew^NG5$ZSZKbxE8g2&k(#{4=c5) z60u^E0!h*~;i;~U*OD`ySx^e8NODeqS=zoRv(<`JnU*x2EL$tqR5vXtk(wYR8(^%) z(55A_;O`DxaH!p{`P{(hE`6V4)NG~!*0But;!hJ}{-Rw?MRh2=_Wt+V$yW^LI~B

8^l5;sgWn6~c{p1)W zh*G{x0om@E;$gTs*sQD2BznSMb1yCO>%Qf&(i#uDuDQ8u1&UHSS!z!|rDb?TALZfU zACi}#z&^EHv30@YzSqz&wly>JJERSSrthK&=9U^)&@XMjtsr>+t>n*g`H$}nk5Q%m zcZoI)|0Dr?IAGbzkgurB*nD2$8}6rOac|f8OYkyTDUE{VlcpnM0_x%^LajC4aI%R9 zwI%muZ)4<6Nu?@BX7i^Imds6~CEC`H2Q+pds)HsPY-^{}N;9*rF5TY5?+fMed%;(u zv{V@tR$FdKb~FvOTl~DAV+IzPm0~!Y$zKxpN=h-A&2&myO)|;HG5np(TI1TqB-EFe zHcyqY`W!1t;4LPI(%FDtv;yR5ea^zpxkpPju)%H#7!Qi~xA^Qm{(O~u;)255DH~x! zxSi6SV+?4Z_?nDkvu>8wJFEoH-&t@ATSZz&&t^bpNC!HYlRJtYt+#f@zIiZHa%}2| z8b4o?;dI+EkIzE9Cs1Gy^w>DCr(Zk<7F@3%IXH+|3pqJ)yWYII7KmZx7x+W>vu;o~ zoqv+fSXLR68sVX4qNZjtA1}G=S47$DoMk`rn@rlcwD|T z3EQMM6ev-!7yF$nYBql-*YGp(1p$XbJR@{1KFwI}EY2MeWHat)EB4oeI<|gCy~ok- z31N}=PfuqvyMRMtDuX-VF>Ci!`eUPmr^h^YeIWA$y_M}cxjLWyMAd8Ru{{avd5msu zPJ?MVC8h_3x+7bwTZUQ1&ow7EwMsb#xCRDl1+t(s7?>Rg*Q*aZ4}BZc>X_%)BqF9=oXaFBxlE7(mN{PVjyOKDqayI5M#Apowe)u7n=|n&ZK5ng?d;MfSx-m0e zst?&NAy|%Tg{8}>`;pA@axri3jjA3-`BfT}A!IJg5gcnYUy{sk5Q?%E?H@8}UC%_? z66$IxA|9k+73C&pfZ#M}NGnCty%IYlm4a-c>2|}!hs8Dh38-(b)!i3X`>a0h2j;Y* zXOS!!-dCLu-4LU?nAjf8i=o9G)nfF%Z#?Q#N$N{Q_}4;VV;TG5Jlf`oGMnPD#VG~T zwLi!7t;|GSp+ap6nA={jM#v*l{XfAL0nS4oLH2hZ?8&qTYtvu4x6PSTNDa)-D^yA- z#EE@)@BQ88SeRQJx9 zam%QtOK(*0z+qUTIWvtejXpRvJU(4b&OW(R@pSM2TVm{?G{>5P$*-W>n$BI5;-aH+ z(M2q9?U(C2g)Sas|7CxO{KJrO6M!KAy4K(Cu;>n_*<=HPEY?i}Tib;sS1Tt7ABp5Q zFVuACc^nSh$-T3n%Hd_QqF{HSZkNG*87D~-;$nA-+m=(w65(uc&3IX;`t~;K%vlI* zo5TcUrBDGQFjJZ z`B23E!GljXNrDkBM44W?<_k`h#aL-Hsz?qBy!D`gFC< z6geBXf@~AH1^Y=99`!JsJ_&dGc%GEi{e}1W@My2%xjRbs@*4%d`(0``maukX2s3ImJm1$rdgN z1tK4c!4eUFw50RvtHb}mhL>RdQ}VZ<5ldCL`shA_<|;(qd8W$LZ)Pt#vkc&^2Yg1D zXRdBWORDW7xXK7%djXDnfw~My)|_+}y&6JtjMhBG2&=qd5Ye45R!l??0GW@XDGcKNqW3;~+>KtUz~5AO@sITrgBD?WupY@Z z5ueiag+JD|-TmOHg>$1rw~xrGfz4o#qJCX_@S89LlSLiv@MgSut<3rP4*np@u7wP7 zPu<$9&eymL94I(+5kY>Ca`v#f5g&3{bPP=N0ZusE7L#?*W#mENlUS=1*B~y-KZ$$+ zkZbbORq5|arUpgzi&Su5^4BlS?+6f&6-qN1UnEg5f=f#`88{nf?HUn@BU+jGmMRGK zR?A(&0(Mb-E?sWHGGODiLU?sJ!<}FAG7M)fX+Be+Zkm~@mDVog=ak-P68#di{b7Jw z3#L3=I*Dxlx5$wd#ZFkf;boyeo&T5;>o`rTdKaWd$nJ`}1zeX!MR&XtODNHeq6z}j$xh2@ z9Sb47bLSQutkOq{yDgm)Z71OU6Fa(p5RoMY&CL_D>Nd@D21=fNCn(>`=++N@?5njQ z2({IvhcIaaB|2=AZ@JDwO`q$W+FV9mo1*NnK)b*^(h53TqD6R|zq81K6Hex?Sb;oH zt=wn8ZK(X_a2~0U!V@)F+y*u(FD^8n)=HJv*E{9y`LeTiqOMk8;TNv<&3nE|=JxjX zvp@{RvPcw&QWEslM=Cjx#4zIJ%S9Az_b4)xT;pn6ychZ?V%_I`39=o06I8>N8e4rC zFv5X3t<>kb%vQQfWSRt_mDu1CZ|bLGPoI00sBgT4(ddM!$ydatd6j0)9sshQ;#Ek40 zXabH-3*eW><=~FXEZ~?&l9NW+Z%Wpo*=b;7ge6tX+Rp&&>#G#D>oGKs;Xg}KXeCeT7t>>@1kAwLjYxR*P3-}Z9Fb(YH4Cy4T2+22faS*&ND zX~dUT6120o7wK?pQRl$cm#X2m7jNq$2X%d4QzSK=l+QiC%<`us-f1B%VIg18kuSTx z(#(LWt%dHS-isji7H-8FPxK3{6tCK8MZ%(T|M1r7xdiHL$*b{JA3F~Joyu@fy{As2 zBW3qo_lqT$44 zF5QLzjap!a=t5XQ!Sj2jR);YLiEJ`90vp`FCuQ3?il@h|zbn2KwtfMA_=VTic0Zy1 z$8PH6mLDWz&<$pk)>8fUKz4d_(zxyr?JM-KnZ|338A-g~LlomOG-1G>MM5rIyD+3* zpzC>+x7{Z&%Z40T$-6sg7aL7Ao%nAU!B)!wRPbH_G#%`V^A!FJc_i%Pv5?tO>rYOa zI=}uMn*j*{;v9`n029-F5qnOdiwkirI8O}u`n_MMd+UU4x(p@BwC0Q_Zhs7#vUv*^ z<@RgUW;ZLV-qOJYuJIQu96zSE@l|n2mdZ#~Dh1e?SEs5Q>o3cjZjm0on)N$waGG-z_U{i;AgVpcVo9&R_IbzTJ+_YM&%qpORRO>V5JY?;mIypaAES-&Q5zo+|1d^(~R z*T1sgA^|U&kLxw4XFLaYo*U*81ul!LQDmg4+2k(yNQpO@TFrLg*&f|tvkRBB^w!QD zbLF*zyS=LiEIUl4VolmG!z!~UO45(K1j&2-?PvSMca>SXr%GH zkXL_TlF7BH8Lej8H#@RfbOPEFeU(|k-ky|@bj#V*cTK<;iZy_z5sk2271v2aeysk# zkRguy0d?#V(CVpFoCMw#YZ%}lx%UD9I64Iv9lC-P>Z>9g+DA47YQyniKb?Z)=z~a4 ziAvL`z0!Bux!bpxP2Va!vv_SY7aJvBKZMw)5$bsdv%tCLuCM4cFQ;s{6bTe5KaEEx zB{zRRSUtMU{WKjR2;(j42+GI&(fRUmjXNH8>N7j7+)CgQPV`*l$NgE|e`vRI_TG&s z_$T4>$(qz59$=Y0o?ANK2Ta-Tp_-AF(5M!6oN(rvrgS?APzZdnX+IYZaq(7&kHO4q zQC^$3`Qdl~y=s3y^u)J7H_et ztI?l8R~6K}b7l$BhB(iHeDEm5+Xb=n;8)YrH)(8cqlRGss?015_@gX^%_2h`p3t*f z54yd8ALTeTwPt~Wd?Ar7GX5jyi>=b3n0Aws#d>&;x8STp(xS_H)$P4U8FdAjIz13E za4!FFh;Ud!z28OSQDgV)R80*JXVI4^@;Y#uy&G&>HFcq~_DOZ(f$x@E?PJP*}QAR0o)!O^19D{}uoBLZc1&I9APU4Y#fuBx;;o@e+_YVZw)sof6 z#%g+*?P`dyV-NML_)r-T+ zra?Oq)R|Zz^r6#k87^RCS)^ByzS}1#Z*njH`=(Ryd|~Wq2QI?#k;gkE)%+N6Sotnp zC1Dyux>&C>z7IR!TK84^I{33if_W{f?eZDwWvDodxjge%cgx&D6~1HFNL68IO6{Vv zGs!!s-GY~Y#AqtszBnQ)XXw!DB3fknN0N{yj_0aYRb32QV=W5_eFEJJwDYjMpdmhr zI+m%sC2_Zt(r(u9Uu3LLsu0>Z3?7M7szK<30z5|cwxGjFJ+hvr3e8@3spoA_Wo}3` zbnmht(lAz~=YNan5ud0RUZl0fSu9gmimcM1tFu}Pe76EZ& zOer%U;&0nohn>>QpzuE{2{y}R>g^dKV@qBBwe1?-}-6uOliI*KPjQ4b_}gaX+~F}zi)zW64_Tp*a)-J z5Nx%f>yG$!TmQjs)@M3K`>ZlUewr7GTPA?shaF*E5i>~QtWAr}ETEjYvrGbl}QMJm2;? zGt+1kDASS>IO>PF#7EA*%VX1<3au?$Xt4E8{OSGSRm4NDcg2)CntmY{j-o%Ys_g=| zGNfcaX4$!&1|&p~`F~+r-%}FyA3mpUYT>BDMt}V<5eHFHR8m8_u%thKlwLPtfuUPp zVnW(BtFI+@|8CMO?%@cV851hA1PL|q&fEa$o=BmU!-m9;1sd+>QSmz*%}Dd9CUVC6 z0Ei5e)19Pc`!W1jk=!t!t63hy!1tP2lVf$a8RT-Y^v9)Yx)d=kOH7PNjW-|^Vm`Qx zP!hepeq)3k-(J!O1amvh3P3J%TX?!rcAnA=eodYwK& z^~+C}RrjRw5qyNlYnivqji6>`gdz?j?yp%!aDvuQjwCUy|a$G`tYgu+OOX= z)-k)7D_(#}7*V1*VbgBy&h^C$us!dS*I#y9-Zx0F5OX6ClYixw_9U>G_)lTeZwR3) zWjb?RNjO2>g{@(IVLbNctgDuyk74iVFBc=*6)~x;37Dk5EWfKunpOJLxFO^NDre$+ z_H2XsfuI3f5ZJDv+{NQb8fQw?qVSMAMnBv44d4j10!MzJVccT7MX*~9zw z#`^r6sfMoY2g@|ez)$v|Rrhk_a#9NelWP)ME-ZXij&Es+L>ab*w1v!;sNHOTx9jwV{c&87fu!d#CoQfE*a?6!K#$GOiEB>`1Iw#!JStG~D` zM(Ep=GMehvVoz4zerNYRprLm49k&Gm`#ySR5u?*guwGF#MyM6GjdCsKJUvDmZ2svR zeolsK@AkIYZN1QFZCi>uBsA*PX6lA(huMm(MMNH!mX`h=Vb$}e+uDd08*(#?WjEx(RNzOo-G*&~7K3`B~6 z{X)IE%xi)!N3$TF$t8cTPFH`ZCh+ogG_So9+CB3G6m&!5TbtZ!nE~#AE_^Q_r)ON4z^~vTN zjt zoma4}X_eHjn$UlRC4L$tRvz{il04bj`9RAnB0syTA^tCB5;5%4BpY2|ZsgrD9`W|n zz{O101QfgaX?eWr!zbBINfw*1(~;W%KmWhE@auezq4Xhhji5@B?4Nk&St2H~PeRjQ zp=80p)E>m$QBmRb>jH4ET(NT5Jmt2mLhhvW0_J=8 z!v=Z#cLF+{m~Ks9w20G%$4m_1$h_!6=8${WSrvT#pdApyUym(EJRK*B;Mm)zNJ8i_ zOQX{A&Y%oV3Np7|iinLC-$L-l3&owG!OApYIWeQJJM``tyMlF$CR;Ex<-M~`eAaPX zl_qz}k=9nm8BPF?3DF}sd91KsA(#xbGjSau^QD@;r{H``TzY&D-G<|zts zipMA?Fo0CYjL50<{H9vS9Pa%=NLEu(qkr zj&yJdIQ+Yh8ES~?`ZZeJ7?+eC@a6+c+XC7V@QW|n@9Gk?l^+N3%H;m|#Ddy^EW-H7 zyFuEf72$QuR#uB6;oHHBcm(JLlzSSIB!qY zB$7(7#b3X}3Sqw_GEG|brCwcEz`Ps$A!=Jt_bXqo`eulUy|CScPTj9x-L!`i&)@t% z?7eqXliSuW9J-)@AYF5M-Y%Ey$Fc30D|=1 zAqW^C#QWerd%x$L_kQR7>l=66G42?~C(jz>$;?`F&9>(JO~-~%8=9r0S4s#sYAAOR zo=VhOzVp?eC4#bDfIV$DHBgKd#bgjt)qGHYrcLEv#oI>vW2W^38*ESDsbPnIJ6|tb z!}eeh72r{KjaQ1WMa@$qojHX}r@y6Hy5W6m_n@GpUHJf0nsa4Q($@I7AsqQcb&=6MkE(wlNB zA4mFgX zMowhqfNw(!fmnV_g_MzftwsuKfz@C+++en5cBf84bL#QJy9m*FLQF)jxpZ^emO`GE7m+k3%-Hbv8)t?0?WRhj>BD~{6fNOMYjc|O#82qq;4TYv$; zZzAug0XVvhca7-`y#_kHs}lQ0cJ(FWDfg(Nk{ud-Yw`tDyk-o_mP~hLEE>;mTBq9U z8kx$ni{z9(t?!pUzFTkyp3y$dvx_z30E4*6Lx-{&hN`yJ?R2!J8tI&av#ih!9W*z-{mF?=?3$1k{ue(r4qwk4MzRV zj)U!@y7e3$(`r;OaG$HVC8|EjFrM-2 z@C!l%ot$W#6w+t|faA@(W6M5aNEe<$tnWp!(P2#jBY9_~mdxl?9Y};}IXNh82Ln&6 z(wE*-vV`io6wH|2{1g(fH}!{tp;NWY4)N2-o^m?TcJ7DD`qg7UgOBGk^IZ-8Sc3uC zi}P%)PMh-OI= z8PD|1&S#ER=<)YP&>vczJyfRE?#}hIU)3Mfomo82po&F=wQKii<&*I2c?6E=D1)Cq z0&gU2J8L>!R6uMWuthLUyeaqd*;7|-$8l+j_1N92v5U#4iaGF;*l`LtnZd9u?nj)o zT$Lh9tHDi-rmU?C)6K1Ft!HPc`>@p{S$qq5@7rM}cHy(-?3T#WIYRYyt3atJCeV56u%V4F87mLi@56^E~fWKn1rH*L1c1X@;>>)LG zOO|>09cR?}BhwS6B;V#lDtL%9d((aoZj<6Xz*1wX033DCn$8Yh}_{()bg#>@J?N_QWf=b6j|g^k-~~=e`>NQJ`8NVwzUea6+w*~^2_o{ z8ed@J?w>?`#7HiLM8Oter1C*!esw+8Cb5okPjudP`l*QtO)>|IE_j`yPLcD8YRHxW zH%d~)sm6p1m)*YES)6LMF~{NuW{>Xi6KLkMglcUA1B;Bkx$?8lhZymL$rDG+&Bc9M z0F3QP3);3~>8*A6;9bFXe2OV^&mqsR{_am9*JW9-+(7+-t^wLG?0I4b(_E;pse`z< ztfgs5j~Lx)^!8BIQcd&ib3?~gQryi=R!U6O!KwEkdEPuiX2x6(XINVGRc=O-K>E1s zV=G=Tb?_L_<5T)^Iab_EwR3tsY8OCx4g5NE1D_Npof(LDtEhsVHRxI_3vyzUs``0U z#^^cX?os_F+z0xxDZu`?;f$j&vP=7{j+kb?p+ZtIp)?_OCTY4k>jJ1#D2(Gh(Yi>( zLY5$Sj`LK~Au<3kw3h*xnJN$&xL_R`B-zWHKqBQ*&=z@?!9UunQXa@ znHW<&Kp9eR{h)q+y+Og$Lqk!`Fkh9@P{gR&=7rj(lxOB`2T=xYZ>J~wO=}x}jJwku z4wWu)FD~ory|m%&mQ)|g^RIP&cTab#6>}GekCws70zEKUiviJA=jug?q7nVgMS-j8 zozw3XTF)Q&5p)eMWwwY~&A!3whh3)M{-tci~(`;yW04=`wF&yi#xQh1eEE}Q~?TNiQHP>6J z?99~NfMy++;Pf6ke^h@v%c@F3nwas&z%;m_UZSM$;go>wvdb>Q$Nxs(fl;9O11eUf zb8#Y8uNjW7m9q)SyVZ@=($)J5nw^@{@Wr0mGOSQ->%sc#W(eD~fJjEP^u`*D@uu>6 z72}XgavQEUq#BonjtsKu%I0l;r*`1_YWco}N~&RMSbYu`g2hjC2LjkJyAKvBuIi6- zVZ0A?EzaF*d3`1tKMYk1Q}W&9U~z&h9_4pg9H6B$i;Nnylr*(j+QEmrp7V zzQV=#p9k>r{vp(JEI@;^Y_Z1#*?0ymXVJ|K-!~fw!hb~L+59;-#Q4k!N5%l7+;v(w zPK;7j1)UyK+&52F`?w{!#wu7LiO?vkDf}|_(_4KT>0C3sfJhDUy^92hH!jgM>P;5i zw;vtTINvS-ccMgT)2SKziJva72G$hpu6cya(&ipe0^%&t^_(56 zj8@3C9dnXp(|J)ueVzSO>uAG29dL5O5gqdfpN=HOvS5qbS{2_G3xzZnk_hd3OPSh^7#L7Bz4% z#q!!$kl49$RjHo1FaXc@4Ackgy*DA7(%zqg2j)N6MPVN=$Y?In!}j)GU|I63y|vT%ZL$?}<0KUGfIgp;=Bg(m!4*o2Kx-GOx2h{&(Feo`D+*9+d;I)~$ z&cc&eZxm#Jn)DL2&23=}9VZaJnOme6BNVTV`m7C5Rq(r{zF-<`pF_w)nj>&iq(--% zSkOTXJ5`wXmUaA`KNyuB(nd*wX;S+%x-Uv9t?1~yrq>kVusCuEO?KIwOs7(gGA{IXhxwmaDDlhF~@t7``X$uQT^Y2DGd~~vPwEcQ!4M1CV z)^#8Wety?!ah71=VyJWIwG>U`dZcygj7bfDovM#a{d%PmN4C17pUFx00b83UwXx>G zay#`?WM->Nb8E&f{rygO8V8@U8musIK;5oa1-ECPJGpVAN312o?=sQvhIHOApi$yUz;(6^FgZjk!mr*L6Q8xS226aweoL zDo~C#doCloB!c+^pP}ia`72gyB8*!Sc5f$#`E`o9DJ_fk6SogafHdTN7lfq+DBR0b z_O!#poj>j&ylQb3x!rMJt0d}GvP`)9O?NrpHIHWupFpT_V+Kt7JMjfr33cJa2fI>O zbJ1m~Qw{v;1&W5#vYwM?2M*uXMGOtD;wfH1Fp>4^c=*p7HVnk{8gxtae`w{?GtB!o zi!m#o_X}APhz=+^g}Z)ij?E?g`NoBXcRK{bGt_fWjGUnTJ-dm>PZ2J+%> zdqVJ@X5JI$i-H=>&}p;ISq!f-nxf_-#J;+vQM+Y$mjHCkz#;8FNr2W|GDo08dK+P{ zYoi0d@2Z&X$Gw)~fj!H?J3?l3t%?dYtn%47n!e8|wDUUsURz_ry>+}@b;J-jnoW7P z>}9@gy7zSBho3s1jsqI(Yc`y5U*T-Wu2a2BBCNMYlkawhH~IL$f5d_rEiU9Bq)dW{2*%9s~Efpm0A*;6FHJZDO#lfSpV&P{?vwR}6QXH;`DaD`s`OC)= zjAw>b4v;#Ma9K{Qzz9|bE#C3bzq=>A#jIkre9q)W8_4>4+X5(nne5a~h3(!bGCp43 zg|SV)bF{O#p2vdVjeAnSRE78U47WR-R5p9%?LOskOj1I^J10a@7Et_-MEwdOx z;)J6ck-jaEwpccB@58spSCOgJ3Ex+fVSGwFvTw`{&%wbXK>b52_D(TDeet4ENAL!q#vK?GNX8n5I-!d;Rq4c>IihV2-L%v zWSf$y&pP^#QOwLI%w7_#$(QXs9Eb3MI%m5wjOU_ZHx?Cx;Y?~Wf2j+U(qZda6^%0F4tp>zxerA0_qTf+QSo~+j5TROmJw|c$P6#HG5`6 zCn07RJEAdkyrpmhD)h}?yO4yw@1U<+QsEb9;BIBBM$`w~7f9_33qq{nGP#Lyb<2cH zpe~}%euxHIUj2Yr;Cmw!T{hJ{zB3vs7e5s$Q|+lu1?3&bVln6DX(+NEcE`6@Ewk0LmQQBcBTY3Q7jrBH+W za9|X&!h7!e#rr@G^o_;Hw8eXGSZ~%(at!wjkgH7SvUDkLbg|5WnEkH-bJ}BSn2oUm z9n>7eYw%>a@GFxcMpBh#6%YzC)<_d#?9|Jh%Te`Xhd{Ol9>#9UINri z2Rb^03`UH#9*nXP%hEgUE>RL-C@`3$@QI-ix6$w4K8L*KV79j7AP6UNW2;5(f=PC7 zqBRD(Qs~5ut)`9T@t$Tqjd|@^@4TCS$mBsGTgxEJ*uGd+ZtRiuBwZ&dGYhV6-r0?& zyGQkK(SpyR4$fzpSJ}AnQMRJ_q8i79bvTHOCFz1c&?Ncg(KA8N9VMAY zRvyY5xcO;W0kW$}-vMNlnbV``-b%|a?Ak#bK3M&D zqIBMujkkYxjJyeDJ|{~Bo zx6u2Hndvso0MU($d>lEJveDVIEt{+b-j$(Lm#9PO%Pi>bUi)01eYuZhHg!;fyQCCbKF;j+)Muri}i@gK* zFd;u1BLn+eFo(nvq6hp+Wu37bBrnfXxt0?yHH`n)sgt&fWNsKqI!NWxt}3zkS=tRW z#zfsaAHR=zs)dO!`b5MJdJaUSUsds0T`VhWK95(cxc*mcn@BqWjOi97@%L5>u>Pk_3ymHywG)9KJ%+sQc4_cS#xZ9|z$job(C@VRLF73APw)*;0JjVeXLM&HrYul;WPcWFZcb|U~WMb0l0 zh}blwea};rDXZC0KJhwKdVQ|+YuZq)aq$|A>y~X8%@9o*abW^aOpF$Rv0!Hr7)Cb| z|G6Y!M2YN3uUfI*+Pkw)x$KHaIFsKL> zIU}farMeN6O}m?JGnBGWRi$gLjo1&r&`3dYkdsASSx?pa9+i0})asT?t!?^9-qM@0@)R3xCC`LzxOlw@ZbrmT7 z;!&#kjS6=Afr5jk%A+ghl(I)45Vy@W$$S!-09`p=RLsd*D2Erf1NiHO;wO>J%ybYp zbGlgpPUPjYVf^ad7dliCKm(26N0ur;BALM@K2&bVTnW6RKdLKMOIFSS{P{jZQGA3> z%Il0Rnwb03DNs-x^h$eP4JgMuFG)ZhB&p%4s;I&%M(|cYLvJ?j0qROaTg6p|fN|=l zufz&vLxtqE9|8eBw+pa62YaZnKt${qJ=rd>*gv z(mb|ti%FeaSPJ|l6Rlp%FPL}PJoMjR;exTmmvq7GfL+CT^1< zQola4ly)sa^jq^-@t+uWcq@9scYC_kl{T2Qh8rloF$j#-C8tg!dtAmb`uW2R`vO}s@ax=S%0yAP zF;mzVZ}>xZU>}5C{&F_fySPrV<2B~pwcL8kBr&3P)=V?q-OM|c7}iah{`~OvW`}aFu2JBe59*J{IVT^ z2j$LNpjlzrq_IZ5&WIIhOqhS9YV@g>Q9tI^(Ncsk5065Gj6~t}V&)$}-$30R*6`Sf;b1*HB8EZD_x@yBg534A z2SMZlV;hb=W19+{az^C};PTWmTj^uQ;yG3c29fmo6JBi%`vY~cyzaZe&LH?xXcTHE z%8}ie$OO(2^$Q+b3Vtq1YD0{rT5=o}-p*t4_bSqzETpFcIn+?oo?)Bc!tvH{ zv?ia(w^!O6RFwxA*vtqza>XF)%RGKdtJl56fDc}&AWv1KM9bTmovHKWrI;p7dH-+~ zXaSY?OK>1#5l9CwYp(EG=DFH3JK(dL&Pmx}TyQ$g>itN3Y=3#Z%smiFmi9xhnx ze3Wf{#Sc#!I;up-Ls@Is8pD8M{i95j=;y3Og}mmgWXfnJfmZf(XO;dZW<3w|^xePpg>7o1 zl6n~KCPh&JQ<)GB1sm>@fdU<}dArV7L_HX)NuKe1i0fR$_C!%(JtVelwSc<7kpKu>ej+Vay zJtM<^wZV;F50fEw2+Y42JJpAB;}eBu&u86B2r6~t#=mg`Pc1=a)=$(nLwqK$O)G^T zQK;|2aN+bQ(7F8Q`TF)#Z;{_8sq!>A*25rrkpn?)0s>k-ZL7q-GL$bHO3Eo%C1Yv<`9OaSZRW zl*%rCoA+-5EGOnt$7!`_fzHNxnu2G-_Vr4i+Jh^FfEoRoN(?^Jh7N{=Ft(Q zsa_U)(9j^1An;pZKJ)Nj5bO9>9JJ(@ORlM95j1{=(*JE+Gd!px8^t0oQgeSx8z^{oktp+&58H7pkB&IXJ0q%Pl&8^4qS=UCFGAII3dq(B zr}26|oU@V_HVN6_k+{-dB1COGW zMe7smXNTm$e8JyOn9S48pJEPKm~-EoY4`7(=k}Mp4W_0?!Ve~6g{D3k*Q*5;EHxx0 zs8*EkBFse0Gy}TKDcV-`HkaOuLlalsom<{DwtNyjW!0CbwUd7mWI1Bpn_??BwHezf zdWOnM9_k-$s`{80DAF{}pYqh&MBhD`$X5vaKp#TwC$Qb=$Z|4(C-H;+BgzMGwUr4tQay7P5R=64ay~fL902= z4OE#8dHIvyxuG)esnAcc1PBCI%hmBRw$>#4+YdUS51ZK`g}$}R%T?oG)JkNEj43O{ zjVS43=_tcdu9168S6@yqzg1LV%`43&@@1n-fK*S5v-%v8oY$`(ce@P^Pv*WV-x}4m zqqv)Z&~9h^Sdm6qYfwhtx=n6a@id+6${>vnLxzICS7APlE?|a$@i_TwV2+=h?lKs7 zusY7>yFgTG9xJ?}A&8e30z~Y;bs*5vAOg{(tuyPaP^CKwnzEU5<4aPQqUeS8Oi_d3 zy)59$rX(mR2OW=khI(RKsm{hcZfI7aHD&K~F>Rx)J@&c-%3b3RCF&-BX))7{3$x~R&R8V)t(vW_Zh_P|zsOjhNL zt1LskmmN7SdO1)9x^7vXOQgV4KpqdRB6+MAZJh*Q+Y&u2W$xnfN0tC#5?cP`8?r6& z7txS~eB)oBokXX*Z``d#ff|w-6&t!(fj(#Ei?!GW1{o9@uHm${rFXu(Z7Nx$|LTj| z{?(Z9BsR@)nX#h>9y3F?vRdv&+Y~-t_ zPwreJk~Mdp{qDN<^~?6_s?%~5x>mBm$C$H4iJOFkBb+<$(^!|(?v16yX%jx*w>90w z1i330jxcC*fcWd@ha8&hGnw(3@6IM6@*ce;3isDlb@PlGE2U#MfMxb(Ud`gt&roPl zeSOmjv7(q;*$8=~eF0yu2@z*Wb*^NGu2;N5=+D{DrQ9tPwHN*cdM*7BXo42F`5NQ~ zmEtZx*>G^EX1-mKPfI(%5>v>(ZKS+V zyovJfVoYTewbCS%`qb7Aa>2$yiY^{S1*M$adEsvVu)yO}x!01IV}|kMB=hp`I~AG>rT;SRx2eV@^5;gN8v0741K%h6c;5zAs}C`s3O8EnNk*OsoRH^?S|w*Fa%{@eSTLS5=d`?$6Kb&OKko|@DM6sOPu?zj?uE9e`DBfp4 zJ0pvKFr1CY9b4!u-PV@velk?3*&y12UI3OT?Yk8uFgQ}GCMYq~YZkc{EzWw3R z%!2o>jv&P+KT-SxB59t|!#|E_x}=M37$kfBrJGxJMnQ!XvNiGbpoBkiNJ-oBE7(6X zEHGIoJnx}Y0dYx(sm=K;OKW{GT^ZFP!0wT3t6Qaf6#}ea(9%D?5g+>KTTXp9NKxts z+_+2%+p5yQ;bL3{d7S=Lspd1d5{!xy23Pb5L%GZT#eXZl*E$Znv>`&u*o>jAm*+lG zP7___GU~c%)$RuO;6L||OJA;x^T!~IStHBFp15LgJ9O~9p0$`N=l_P#Qz%=wukihNM7j1E!wlxQPPOSk0hMSl=T1U?5Vd{`1v zMl19SWGb6XT=hFCqd(wDBuX!Z()|}bT==16 z%2%#BrUdQTD~Gtc9|_wQ(#*FRcG4dugpF+&d8p7G6pyiWg&Zj6oEt%HI`( z`o2?WSNY=m*g?;F^kuKH8*38k$qLX;TK{#T3&hx3dzVqh(QlGapIR9Jpazk$T(S>d zdrl?*mHyAOfgiIn_Vk?0sax(S9JMkp5Gcs7ezn6)jN@g{2epc?juYPVi|m>ne+o{qa#EH zwdu5*C@fMdSY{~+qy0-gD&zmemb^jfEm($#)uXvgRclZ=dlQ$3@v5)TutO7h5OwgP5DQ6o=J@We+K;Z!{#&i*VuIw z&I?c0p-7ATaXL4EElphdrRm+K!O&xUAZt<}f5R{@Tr86b{FLvalKFmLWq59Iu&%vjW&$PK%wTqb zQ-O}mXG^&xG&j;gsbZMJ5EZLT?)Ig$1R@&H@?Arc3NgS-C~92MEzTi3yd|SZd-L&z z<3OClE1BQU41%VJ(mzQtUAnapq;Ly#=&7Mkkb`*L2Ke6~$08|IX?=nIQr5p&ApfvP zZcEVAOle#nCVYX}RP$-$9NxRG$JY%L0mWh0C(@dS=lw?Y#Ec*9i6m)HyzL^%)Ul#G z&L?Cgx-IEg5X$K00LFY?OI08jX#-aN8I4YHAL0c~240fx37LBMn;a%$N8aNuj!EyQ zJ>crf)fH>o55*S~da|7MjjJV$$|5IQ4xqjYDTX2i1#&{$!el(gJszIxQ#5^Xa!Y9j z;46eMN6TCJwBVO?gFL;53nwC=c*U>;@DV_~jFc{TOOPAyJFEilGm!2}Qzb&eo&W`z zt;GUI%^)9~%*K4T81M%DFd;)8Bmt?o+4~8&cMnk!Pj{vPl}{Cy?D-XG5qfe-7H{=9 zM1uUa2=(-`A0FpC+?S&o(Roecslu)W45~E6@pN1)D$6Yl6ZT_u_G$XL@#Q?V=2+n> z2F|rKyG`j)4NjI!fgEc^x(kf1g(kP^kYOqeOtBP-qbZ@BU+s%Ga!9$0e<)}GT9HQ@ zuB)I~0t^(n$kqV=Kxdaj@*rg;C7Lg5P>`V{Fx7vr6(u3wL`r^MC}&j*!AYxz}b_qkTw(LGA8!qgSb6xOme6PRvZN{O^M|er4!Vc}kU_Bqi7yMG& zq~1YId}q_Mu`~j2gry|(rDf=S-5Nr#wZwi`71R7RrYiJk5%jaEz^D>II<@pYQQIju z+1gmUy$>oO)XbfPFcp>bB~Z1XdGDu34|NA!>V%&8GlfNxYpS^qO{7w3tLQ;h{vkP% z1nfcjgGy!TG}dEnZ8^lJ!ABWDi(k-l9q#EM@R1gwHI=;bL&lsd8zq9Ef@yAm!Be%QOvWJfHtl-0@X z{ZN)8Gfg*J0~k=?$F6chzzCqMtbzZyExE7B-=P65a@GFHmceM%Y#ymg29d(+1}V!6 zR*ATXfX=`fgSRDfNQJ?SRcd*m*Wc!+#~IG}Z9YNPFSC#f|Mv2kw&yZ5o*x&XgolBs zf8<~80L{jvC)8Q?UQ*22m`U``Q)a-BDi6&A!XHMmnt|ys{(3+;m>@U4Ok^0# z1LCCHvMA7Oc(S3iZn*zgXj=~G8W}g@?hNx<=ykA5cv5dK^VzxHoA6$m=r)c|zzGFp z;IwV)!Ds{FGYW2eDexxig2dUVQU+x$NDS(8g)0s<{V&Qy2>K}WTxUd%{BTo@DToF% zh>$2K;m#qZy`^0^859~!g0S~*&CMmy%Rb6k_geK}I) z8vn~L=H@=U*hFa&hyl!VNkC*GF(7Uj^um;g9aVsD)q43S9SjnKfEA<|$6dnR2Jk6j zffePUS323#baYL162L+= z+VT${UT#p8vP6~3=%kdcQc4HZzeDK=!FS7htvtTpBQFIApM!)}xxe+&v^?XT$dr>& zaHx!MXk*MFd@6zH^{NA)-0Vo=cmxG`c#(iNXgW47;;iZAqKRv0sl6#SlBo0h9qVEf z%XaPy%N~`2TfOZ0B?W|)M34Wqsv+6JUiK(?bG{1Rp=uEq0-#JqGz$fm-FbDfnX)Cu zNtzoep8aGQNFK3So@l5_Eq?y~N7p#!StdNs&`yE!sZtf4 zv4s@K{N`cV(Q0*7XiT9`ZVQ%Q0lQH+!qhLf=ntBJ5xWY3@WbrVV-J7;47 z>JyG32TTxb@zA*i(Jzpk$S=?V&ph`1nGvp^jj$Ix6PX57qbK(QDVs&&JMRvj0HwE` zN)GvuW3Xumdh7I~PcP_*CgHj!O^DTU>xL`>N1*r%luQC-P~$>@n9+iM>*@0&I9AxV zU8Wu&C}GSUDCPeByaM1>1p^>*C~_15eQkm9-m;qiHR>*=#$f@?faqC$0`JF(jUTkK{>1!?-_+paV$jt0%iRD zvr)e%0`lX(w*LP_0vkXA6#$*e@wbdDL7XUK*dc2xHS<_bmk`Wx;H=Wr?tda9q?7Z{ z1=efDHdV zR<>5kjqB|V84l9K62pFhcqn%R=`TQIz#Nx_9FA>TV65TckRuOcKpKieeoMoDxo>g& zPpk4jlJO79{vQ?pwMzd7=As0$m=JvB7igr<0gh4nQwmi=Ayw%4BeuWfPsG2d@0v4J z93#g9kf@ZA2uO+eO93>_46hb%J5w0;l$2tfK<2`v5(&r-xO(l7X4FxOqm zpx=TEVEKO=L8ddRWIOx^UhUijG_^(8{E^2rz^n9s^6J0bx7htBUgeWbf}coYBz+lS z8W#nD5Yc5cwHd}EK*kz%=q*(I~?gR&=P6Oz0M`gaH)ZeL4qDBo58Qi%m}y9V{WVaoM-^9 z;!Q`PbJgNOe2eW{uX4NxiRbTN9+V3q?y{0sBsmlB_tnYtT<3d%L(prV2Al~6{@{~=M>%ME)fLdlYwk# zF2ZBOLmA~E_BlBscsK5etkjr<)qdy|(VG~E3v$Y?jDInGGjHd&lcR=E5#sfgESlK1 zq7#Y+#Q?4k546zpePa8N(X$lKDE0Ui z1kW6r)InJ*W^{5WrA5HI0iZZhV&PGM5xSlA3xs=XYWOwz$O20ph12Y84><+^27ZB* z1bEw)T2H9~6r$~M&5JwP>(@d)F9TC$ar+mjkYioN%b|Ich%2YWO8w2g`RQUDel{@? z`#pc}-_hUSUN40@%{^_oYauPcwbE=}K|CbD@x8%~3Qq$JV~s4Q+New4S55!u%yr4_ zGoAXYT*3Zh%6&(bFD-9NifGFV{>y>G83~Tm0dNIo7c9Rc)-zpiSwZL+s*s`m|TM0ih|~PrQF!n6a})^(5I={p?IjtqD_k`*KQd*dE9VB zI}^H&hry+edxz2uaV>=B1cu?<@4UGG6b*|BRCTwaC@b?bQA}A^tBLn@$zT>_ZFUCi z_sJ~3`IB=@Cj{nFS%5aEC{!ifq3eOn_PXGmXDA^PyKFIMn6rB3I>C$4H;Ebk4ZH;&gM%m;(Iio#lw^)$Mvgv){y{q=FW#DVjVMLU z8WEU%jE2|%1=|?ig}5{{@ku+!!CD#DyK8eE^yl3Vc_`#KncdAZ&UJ&wTWBv3EyR8v z&Wh^U^Ghx%IQ7*TEuQbQ-HCnArnnfS;|eBkFW-xrzy1PZy-)5Jr9DZABSZ-lszWr- zAJaw3$0tXt*Ru)A40`E&L3<(;^ilSMsMRDJ-$82}amA;~j7?9n1{XS7ULO95@F)?R zn*t`^mo?7K2Lf(V#9FJ z!=%Z*i>?MBDFK{n?Uu;)O0PGao-COO_42~l++<(DKG0H=)B345(=U*InK4fg^7JIw zB-6`-ucMZ-d^Den;so1tmW?Oxuh4YP@0Tcdk^3CuB+}@PCLFs$J7FMp{+esw`KutM z<6bjh%MnhaaScoSDm`24osFDK&LcHI=J@{9?w&PSd0=zp8iCuoi)3D1$UALlmhp&k zx3W{S`JgYEB;9iZ4VsOpcFfqp zyUtnPUS8k3u?3FCc@F5b%JhlZRk{tS56&b6GZQ|e$Z)}j?X)L=aD0c8ca4FZ@T+3W zR(R(zxOcclwslhm=23k#Ci7-&vVe&!cBJ8Z>;T7Of~f8iv+=dY-ToaXKS*2pJPc`D zH+)p_*r5L7%NbRc0`mKc47ccSKWrn63)&X8&nBIgq)kxz_B*RV%W0bp!%2xvX=M!g zR_F^@^v{u$n2-aA5rCd4>1fV8oIP@HHG9olTtHi_Eb|aga(%Qq&X-}?UBZ7Nh8sv( z271Bzwid?PBq}ew$3VrCw)(YKe}Tv=Turiln+Sh_q=KF1Wr0;~myixXQ%r0v1+-FN zT;^`3@jp*|`bliw*?uNhh`bQGM?x5uzIfTMz_*9(gX{+)WOO;TgiFu1(}3>}{z`@W zhaZn_F>Q9PPk9F_jyo8nZ7a&<5*3Zj zOix~+JGhm_=VLMMQ&Ypr-EeEI+x-?ZQwc?MKt&zkJWvW*<`+isUB zI=GA`u_Ejj0@AkvJk#m&^=L9s@Od z{umA&On^(>84UVnu*^xYyG4mqI&ilBG)Ptj9TIAB07L=UFa%4qnRDEeuFdL;eMMJ` zr_5fx3w(lI#cP|5S(Y~ZIy!X!g|(xl$C;MbB3K?QJ|tjh=ftb9YoE41-sjQGS+ZDl zY+I@!l)Utg^N-~5y?tJ;GR0R|$N?(?4e3eu3CnLkiPhB4a$bmeuk|#JSb2fc(-^{t zBX?@W3k>pJY^5@}Q;D!I-6>)JT&VeoEJ4tz4)ZFYAW-9?Vs{mzk-Px{3VpI5Y8Acn|T zaL+2#SBW@wY__<*TJIoX$*aKsKxA%6@l-^C{?-?FA>CXB9d$F2kH*Ns`)mHZnmy*^ zC>)z#_D_Y07pw14HK%I#+wY1iv@OI*K(wDGZ+Ez7>MiVLe>p^uKGG02u%DU?W_4;| z7~b)gQB*>edtIpAaPX9A>ZSe6;v>Z1+EG=ugZ%yhrxvmhbrAr#lhu>aevp&9=w4V0 z!$u3w$Zo~Ga_{eBHm=t^*d&eY_)c%?D@dgvvj!xfu`igqEvFHGd?nl0^wBX3DD<5F zQcYG<<^-DKW2blc2kQ#P0|lDi?H7&=?dhiAaIYE z7_9GMe>G8)fObEdf#R=k{C&NO0#4M0>aC7T79|Nb_51onEh!silZQ+eY=<##D>Z%$ zJyr&?!UHcHcyk%v0|yHKa)|%mt)%s>|7J`z3xEM+VS)R&PkO&Vql~);L)bV$`0)uG zmjok3g{<6$TzI*zYoVrL*q1=qq%sz}#q^V-TH3H4IN|8}ZR-Iv{_n0n^LVll4D7@W zy(4?;V0N_Aqil7MCc?{5D1lUw*}V;0wsj@M#WlQ@&8HXrU@^gHe&DbrzevIg2m-Or zC$hzD{eXNEe~NLgfK&U4FVWU!RiT;jLl{v6&kUGcZ&+1JDUx#k(on1qHLbnjwq~$-C;!9f(4OqiJCW|1 zM2t2k6&mV4bRATaPrJ7&Ya7q|L+a>vbQb{$bZ-oICs2H1b)uQRM2X#Ry;Ie3UE(y9 zk&*COSd6!1#e572+kx_aB>dz?6EJxtJo~#QOY=bMHApo@)`6Y;l1MV)9LR*G5OVs$AxMVJElwn3B5{i6G#P=j~ zsY>i+K?V4sLSVI%`uUWF=SbIZ#|Sbe_DZpMRP!>uUyqAcqs8i&mEH1Wv;dAcq+L9i zaZ{Ex?dTXCCr}GsutbVsu%m@hGJa=`>q3h1(0&L26c_`8wLghE4hIXkHK#*s@E7-IusIGq~U6J@o{rmd|Vfxn;*sg~4 z*kJmdCz47Zczpa?=*tK;o~W&L_V}Jt7}aIzUauBRou_BTW3+t8!RTd_%+L|yJ*7$7c*%>)7JfB9+#n_fci}#0D3rpevPe z%=wJV2Z>3pFZi5S_c`FNom3>4^(=P-^^id5{=;`<;6raT8;+FC{Vr1E-G>dSvvw!G ziccd#tv6v31Mts=-31GVliAec&hK!fqDwce+(8Yl)Wp}*h!3S})?G~vKdZG%O*VDB z*GdtlGEk}6{h=L_wuF{GU4EJ28{9*GYI;tOBUQVW&4_6Oon~|jF9u}uuH2lv2Z)u* zsMARxz|sDo)ge~=#2fRSFa3}hfLm~m%PJNc+KY#gACWMg4Eif}0ZO4LcbSb!wG1nP z){GQIUfa@e;ZI*WeV#yLmC4#vm0eHU@qvudz&koy=I~K7dB&ID|iq1WSE|3JvdZj;Ia1c+koC(LCL0lz`4x3yx zD-~0DN17kx`&r;f^AA+JxwIy0_OAyjp>5);!$(Ke`y6iK-+b%unR!-d+z}i<+3b{4uT*U5CMq-5+pN{C60n*5y?RT$(bQ%7)1pMf@H}# zN)Q1_!YCjph-6T5lpr|{FbuE3?B3_xbMJrOTW`I$XYK7U-`AnKx~jUmx~kg5(@7L0 zq^d#n6?w_+rM^_PcSbl<3kXMUMn97|FS{@SPAb_#utXfZ-xawnyFOgphnN$hn2_LN zn=@q_(|4UA99-EVnQ8>jZ3aD-2Yh^=qD}Vv3Sj0VLA7)%g!Q4sGxVKHDv8d=PfCy8 zY|9?xcwj=kH>yQO^BzdcQkSx^Qp!_ZIMo-43MWpdD)X;X* zvVupi4QFmY(>jLPAfnBHMYnRbN98xYi&M(ah4XD+rVX)b!EaT})fdms8NBt@k*VPkySG+2 zBJpar751!NG~RJ)0h%Nlsw+%e>@+Td#2nJ}&eJdB5uTOng7a@cp8Df`K1War7$R?d zxo0bg`$1=_yr)l|x-Khy{tgA>YIcDqp5G$U6h6S99wdip?5?G8%T}>@EO$JVUQTI< zLI^KuKy!|rT@gjGyt_Gq!XIlxNi6Xx9YbGk=X_I}ZX|N7?*?0n`~8R!inoihO{5BA zWN2cjCJH{`2|bOLSb_ODK?%)E3I> zyslu@Ttu-3cPgu$o+YOgYA}+&cb{9!G%6w7UfHwI%tA88N-*<<=$8Cm(gy9Ph|N8a zw8WXBb7_8Q7Q>eWf-fN?1;*6*o zz6GblTe)(p?G3D-?Al%mY&4^msL!eVcW1qtJ%F%!NKq_c1e{=m@Jt*WC~~1#G`m z&5zX`Ar}O`xMg7WPC!vC<&EbY8}-Ws12{}-tNpLHXP?#3$Yr3Hq|6b+YIN|}WA8^A zBnS03g&+(^f;?z)?K$T?NW*JN*UogZ$yIN8hB94|xV%u&0}Vw$USjQ?aLDX{1RCQCnNZkYk5&5>OnCIMR;wRC2OZu06-clx(70nZ_)Z*LHg;=D(xdb2M zB8HeRyYsIu`F>;$D(#eo+-eH<^s1{ZXRYf>;^lD+^y*Tu=_?6Iic4mX8@H4>9>XH{ z^h(X9*J@v%(JUc~JuB*D%z{4Wd)Zv3&3GHe3i1;JcraCcF3oP_vc{hLh}vFON_hV` z)kB~N7c|Z!T>9|3QOc`K7fpqj7ljI-AC8WHL0FHwBNCHMe1?)&jeu~3eHljVMVDou z?&f-l12tFD!eLhPjLxk&%E}V=bP-)6Q-@bHDG8^fZes>L3JR9ym6lb=ZEdEasoY;S z$YJw%52rY=L8&dH!McSLw!Dy2d1tWbAvXEdd+)KKABM|TE_txI`i<&LE|sJEg#Tvf^TEc>62=@f^}W}HAQ5@T zXgkt!iT36Iebcet!dvvgN8bnA;brq@f-d(V)qzc$HOrzUE!5l>(kaYb2=aIbbR|H8Os@Z>p2t#Q)t0Oec8X{b}5f*UwWz+h)m3Ci%OK?Iu{sG^HjuL@7Ssb zOImH|_KiOk+wZ?qf`Kg-cb;bBK;zE5yjO)L!+_-y^LX$;3x}c4JjEy#ebd5E0xewq zUuxkiAR}h2o5AlEz*CA4ncn;>TQZ$byEj|I)(bt5*aH3y{s-Z-@|wV)DW`kv&0ls4 z-q-*MrTdVG#bxMT18jZ7Q6Hw+4qH}G+7@3rvJV*qyKluU{xN$cbbx*G##}b$aU0wZ zF=>B)A5sMBt!KDh0PE`y%XHRHCA_clT-bO`9f&xl`;LO&zI}NQG;u{}XaR(snxFvDoHCi{!tgXNMj!B^l)N_gXoTHYQE z%j__3ycDAJ<7~g&sm^Bc&-2F1c5V|4N$eAr?4RwuL{v)iSjO|D6BX8^__l^FblEFC z_i!p+ce_rPEzLJjuNozLGg^`VMQcW9gl>Od!H2d@UsN@$2_EdR6a$+Sm*s*B&0~_a}#6FjcG{!7WLbcrV6g=@4l7o+QroYNu?MtoEna zCzIh0ik_Ni;@xq~gJsxeP)Q$J%Bk1GSR>+UCmY%Mcw1b&_P&6QTd{t)Nxa8Z@ipdn z6-D5t&bPTs>I@A6v-4BBH2Y^}e3;z=IUUDi0{BJnljr;Wa-Ho@+==3(YJQ)+f}<%W zMcN@BmwohT2h$ey2Afc8>xS!YT@A8czx1sC=+egs-DS?uewl}8ZF}^p^9_r1VMloQMo<+pYGeD{B~j;Fya~B*mI`!6{=&4)kwBKh`d}}z zGdj)BuP#v)osS$1ZOot3qeJ#e1hsr=dG?Y}*ffGRHqS||B5Sd|J5J*o+mb(gVI6r| zYj9|Qb0M>)PL99&49*Ps*=r%v(lQfjIoT{je05wOW_G3w%P4-k2*hrCYF~d}La8B$G{7)yslb#-u8w>g>pwoZRbvG^cYJyTWT* zwfhC9f~=meg9C!v{B676sQ-`M@1O6AQi1zUl>Vx>4>&ynH;#g14qNu=z#X8|1G&K5 zH;UYX0`Bu0e@Vl3up@?k-4Saq+BF^Sh*xQMRK(rV0@;T}4`SAS?6gysSu$+>?vT6X z7AU=!DUPY;b08-E-4-1-8vUMlb77g45et(9TTKSiqEC5Qbv$bN zH7tk{FL0jB`-8t*487RE)wic;csy|>ni0cAydrfGi+X~L}hxruRzDn<=1j7n?203 zdS{)l+1kw~;=i3)9(}ZBl$((h2O{lOFBq77*GCW!@AWVn4x;tZH+gs4egaXo@zZ9cgP8S8oB@(WI$YoX7 zK7>f7&u$;GwhHqg%r%5f57vJE5BsClt>1^Vz1^D;&jjmnvcqm{bBC@bnx%~j(VjS7 zgeGYNW>sMI{1fo+V5aOuGhn=17R}hDob~?#)SvBa48qXp(BXUkr$f7+)YFZ8g``T} zj(7>M>Kh-5p^x%8iW;Ft!QSYjSd+oLq<^VEY;V)n;B^<%t}W_23aQw!3?D1Ztv!nR z7`jdTqaHZ$CSY#_ME-SJ1ZmMyKarCC5F@k28+|f(w^LK?paabPB~rv_*1^Q5V@Nc? zH8wNXS2QsMwlGwncr`F1B!}$+M-C!%=r@$4y@Y?CC;M-x{4aWoN~i`^k|4fvP4H>4XDfQt|sR;Aob^X5tT~A2dS>)2$ytfng039uA8&M5c^ovhRSJ z{}>4ynqZ|?2CaNZ&W9bUf1B|K8yqs|-I&1-hJka)F)6qIkKu93yzuFt)ByW)m_O)o zh4wAxJAeLxLE7a%>E#E@xP?w49EEh)^ZrT-f1#G0MOuuH%+i$&QJGcPHwp45DSVsd zLnc2UmY*D*#IQ{}_(9{Jnd<&$rhY6BUnSxHP&V~}>vosrQxIcSqSPO^jY9UGY$|V3 zG%C7F`Oj}nENHBXc*1eqs@$hUl!;|3IGQl1BE+)hU0^z!UT)D{fdv`+4vZrLL9WTR zQ|9*9iX1cQFE+%KEHIvbRTol;c!8UBB)B`TH|V}$ob9ScO^odD!hE>c z@VVE$=^@!6Psu2qjI&w!P0XwN_ol3vs;##rK-6}wxG{?;0ZR(R0c36*D!a&Y_ZVi?`- zjV0y4y+jJ;;+O_b7H~$jy!s$K_9857-l`ic-lJ(FlnXYUjHtU$Z5~NHYJb%PF$z~@ z+)c82!%}!cL*2KbC7D>7*n0}tz4%-WO0JnwidJ}Z`eNqe(6I|6%PS*~kn6CyWE3G- zVH#)lA^ss~&@9mC)PU=tCjuj=$B<-RsK4O|%yTI^2ow(D?d(28i&tp}KNq-Kw4mE; z|E7`*TGVv{zDKwN+`I>Xj#9M(apx;VJdIV_JJJOjX24v*JTpyRCk94K?3nGOA&_hN z914__#DG@sYyvIDHWcNy)Ht$3yP<@}D+hjQ&f|Q_m_ifS`f;Uw2qbhHZ|8L!qFqr5 zeM%GX*@rypd)OhfQyB?XHclA&2yBw}3$6ulYUhV73nBhP zM9|4@WPs~WY3Duzs4s&J-{*$*;NbWXuvUlP z1r2>|yy$dV=&w@)>pjth@wG&Z0yUg>pbbrO?{F59zs&+b3V;YXlk&aMFAXf|d$*bq zGiQ@AShTBz8~6CYG{+^QsFCl%B%s^?Q7rASP=24r|KBwLbUNQKFIzk?d)eO!GXg^+ zxl)Y@{AE6+Fe_O}37xlueiE4K_^(qDgCUSxseBTO(xS|!U0*t2w%K|N0ceK-!}Uu; zV&puNCsc}*m42BO=Dpjku$c?l7(D2jSQ~~0_Iu}mPyU#t6#}5@Y4RlR96f+p27T|> z29Wr_fs`sISzxt7Achh4>z^Z$({ka` zZsaLPY4yx)&qlayrPP`mNm}02ul0!{JyhN*=g=p5Y0og)YVBFDq*W0;{E>Z9wrMK$ zCd2II<5K5EVgjuM%(31SAH=!xf)H89H@NbOgDR8|-9eQjzzB}L6^Q?KJxe(b;)3?< z`0S|)63aryUj-_n4M9Bj4f_E;Y`=pz?{Lt^&-7M*{7t?OaqFU9Sr|@mzmT4Mi6%1a zn%02hX<-774N~fJdzM#vV;Lj=h40AU`IG#Y&s1!;i?3JKaL3ptwH;z!FA@I4fY2m z#X$+Q!?5AkUrMQ63-=JC@j9u>)#Giix~&}w#-p2eX$SjQcMUO}nh1)Q-r|ok%QxY7 zUUIWr?BIsMcdN})9!6?wAE8+QeuPzP?;26pX=@B?iPoDKU{txTJN=o#1PUxe!V4rFK zsr(-x{2zq<_bBXMXXyNVALbqz=6L9~f8T1`4miVX4&R3`%#5I1YBLa@3(*81HWnOi zqTcZ6qb|J2c!hW~ggPT$%Z9*k>tE`2+#re81;@|rI>5FKOrP8@eZXRIIe8mwg~HY& z!L22_a&r5SpqgdIJyA8VYcx#Whn(u`M$Qy^{b<>%gQ7k#E_u_%3T*g-fYrPS{bmDQ zg1HM@%|O20QT>y*;{N2mqWH(?(o%$(DRP}0xqJ)pUK|;XXlKT##cb2cBI;i_LwDGd z!2#rQE`VAFEn=p!4@s+Bh63Ye4A{7mu6dLEQ~4i+{X-;wVGK8+lmz9y!~+gD{L0}M zcQ9W$Tt$D<`#fOgPlwEW{JWT-U0z63zywaeLZaF9_aVWWt*=X@S7d%=?)op=W_w2v zQ*wx~_0Yd?Bgr2O%d0Q2^f|^Z{ny3RU@!G2gM&NH|FusM)W zzc;~qC?sHOn&L-60550@ZCY#9O7S}kzlbOq%(>jc_n90%7tm*WxI%ZTZz>T-#~JPQ zoIH(_?7-es%ZtWYLCo)s8)Tr6lGPoBlSjvS48|*zgG(J)Sw@Y`EG~UGb<%!g13HhG z5Gm^SeKTm)U z{w_*Ejz;UR`p|&2;~*lf&}zDW=Qsx61RO1ojVc`ku2p^hcfQuxKixe32fo(7>Bga3 z78XUlcc_%x+SQ_{r^6($0zeMC>>Q&pkZ<DF{So5_&aHx)i z9Y|u|p-A}UijO%~_x({7UOR5tn|u&-m-brcD%Ckf!{{ZsXhEnjN&u z@`!Em5kNte2oR4+M!HsWc%><@`9v%%>+gc4XXlE&9v&$O%ZmYeqh20jmSgLZ5k`hw zX=j^okCj#gT*wPN#%G~_*?G1c_*C$FY zQk*9#rj3%+*GIgjh2Ok}Dwtp|RkN`165)GSVQi~%Y){HvXwh^Pee{}TD6el#k=0!E zCL(NZGS>1vclWaGt(S{^Web^`Rp_=z*ce$ia=LB}vnPmB#q(c!G!N{$#udba7iAwe zN(zZW@H}>64tA~;Xtm;Au2IQUYdk^%CKW2xbz*Jo$xBXWuEH0yPAeG?JDR8_ta$I0IfixjNfQfXQZosE z>@V%kq#9BfvalT=p4GMbY!KKyr$DL_eJXO$aKVh$UEhT9g@>4EC=>IMCr$Q6il~X* z^InpBiPmG4EBgMn9GuKHL5@`U%ed=Y_j8!rlNu|O@Z5OSQTN8#ZJ4E=Rdtt9y%->^ zd1*4#*6y-ZI7g1=_kd}otMK@*U5MM=yks?MPhz=C&^>7ODJyxX@(J#BJk^^%!YK7| zn18geNpEG^oQ`^J@sYt#a?aS&<;oYEtBAXa1~s$YrojcfEAX*oKiG>6eSF;u$&}mA z`G{rgR#@h=m4l$;>^;C%o`YDG7suO&e9SfjnwiE+xs`JSPhN_hpq^0Sr;e}~9xO)6 zY$v_HA+_n_8A_sxi^tfU|y|p|(?Jh~UyL|1pBpvFNIWoMX$=jAFYDBOW>uQuR1WYUAO$|xsJ8Q{MVrp(m zuL(GbZd2>&I+;!s3KP0m27YSW^%ljY5nWV>yS^hWM)P4&>1yd*b9yA=S$AV!44YCk zTYs~z#@sv3n|*2GMs0kWTW_5DY)2g+=uVr@o;b3c=+Oh?n5B1x{RI?Hn}n=Q{OTClq6`HL-Y&c5P% zbsDOVnDJWKwY7&vthmZ&2kXNelpTyj~~mV zl5RrLL}{a+(5fpLb9rs20?)ag2=?dq^NxF24b2Tv{yeE!w&1NY+=evr3gyuD6Hmf# ziAn6=tSN5L~) zR}7AHLi=X*^jCH_3syoG9^{$3=qz^)dun^d^ZSzAA$$B_I~2Q6c)iezhF2g;tys%V z;+#&-WN%_6*=KlAor!YB@Y$Es;sIT9uw)T*C=(uEStt4?N@yH*cbGX;W<@-y-x(b} z>-13fmZ(i)K7||(HD&Uc%&Q_2G~7lNLsY{zQW%8S52tFC?LD^rn&}~J9fEBmN#sBfGS@gI9|y88Wo zQJYS&g?z(wCVenL({n{>6Bkvq46j$QqMUxfWz?0b#G`GK6*76XHlKk*?bPFn|pU6W73ZjS^a$xkEqx?&U zQCjN0xr*6m3*&nDHqBQoI}?SfoJlhh<2IS*&QTrYeA7~&11aBb0mXzWH?3Uy{O@kYAhE?2#A^=Z zBw7^zYhH_6eQjmyWau+3ASc7CRbZl4U)mOhjgy6=J2t4#E+iU^#G_*cN|uv1wY>FavrwT$jE!bo>DLn;*fcRL zdh`W&nJk0zJukr(gxtNc;WF34nT)zNd;8-Jb-L(6a_nHkmun3ptK4(68*9v%`xe6_ zz-W?u9XLZj0iJ5-b;+rdvZ%J6H+1LZuSW#kbeDoPOgDaBU!koEp-dEX&Q~i!Cd8o$ zpCU(#V5_b#U>j3#baWLG#SUvKK-AF)cZdq6=__RnC}uU;yKOEMFAkW0BoC2=tQV?c z2-bjl?rsFMP7Oc@mZ9jgAag{cgau7MAMFl7U;QMxhcmLcM=L9eEmRLPwi&xfpUE6A ztWx4^Q6SI2SS$-y0P@$brlbZK65&Bsk{Kf=QLct@#<(**O{N9k4D zr{m-BH$hfzQ+*5eS+lE`+8#>}eOzyQLWssuN1!ewqaVXU^f!;v?%326KIa+|i~3n;F$Z`+WGk$I0q zHMg(}?MY-z?e@u+-X7T14EHN~(ek0mAEmHawSu|3a)#3zt&ppGOYV}@{Wz7CK~@+K zPtq~EB=#8uiUYTtFrZZFfpAnQz70Ibocq=r0`HGueRj(8SlG)&LeBudn0iSqPY11y zTiL)QmxqFDO?r#P`n?kxvY8@K0SqaxzUUp8uDpdU+I>I@Jz3LE*fYc36Zdbw!yOq) z@GLy(;k+Vb;&i^J~lc^H*H)? z%o-lw(W^o{&_A;QySEQH?NoHee2q_VN9_yGX*+7dm;Rspu59wZm)d%xsGqK$N$}Wd zjy)^C&#A4=LOoF^FLEf(RjEW~R)2wT1^8CuBTcnyIZ&E%0zRCmYMYa>$q*_;)cX)I z-qH}^#M-DeGxV9YR|1IB2#cFFM%wrFCC3T`CNu|_#f|5rJBMp@s-gW|80FYyr8(F- zg%uDQqacAG)q0z+e(6;nt8jN=E~E)pgfr_UEu1Iy$p*f#QT1(8?HGA#u}3=vL(+57 zTQ4hb52|TqsE5O@zb`q~27A3{*&L@fWu@(?$SMTW7I|TShVMNSbzLDGAI{E4)XC)b zXK31Tr1~0$^*82Au-%=yy%Ta?>SOUMS%Z35{*{uf!Dq!j z3=%IYIwYS306u{c*@`piD~?f7fe=kA)k>=%PKo{n(b9kqqqK~-gC~O5(d=n^g++YH zpW-)#m$zQW+o*JDtekt(wi!~|``k8UsC@gb;|R{eG#<97Q(^PR;36VbtP|-`-NEB~ z19}(b*4A#C*l_G@Cq&w9M-jNqety}Ukjk`V!}_992wq)Vu1kQVKu(b$Pa)@dnK7+; zz(R`C$&8`0dNs1q4_rOuOpDA>nxptgD_~*0un}_)&F^Rd4SLCtE7tUp@iD{o2k*$Y zSbSn97z${gY0g`W6W)cDmiv2MS;3x9Iv35#@-3 zOSE1THts@<)8>m_fll&qDO$J3!qJT3 zR#hm9eF&>NY?Go2q_rZ{7x(FV_p8gYBvn+(KjLw%upmHy?fV4q#WHjem2yl}?$Im*A< z{sWiHt-c^krz`CVqm>Ilt{!LTE0|Xiuu9LBt5V`+uuvVS@i^LsK7*X#i{ZJryij?f zA#}ZLqeu|7vCD?)+O(o{U$IR*cc**HJJ~u-ao1ygrEibRUcf%ddY7t%K z(VsuPwDE0>9iFkc(!cmvuE2vSZF`(rU1%*MFPUu&1cw;Tc{a3ohmti586PBv^%5ET! z$oed!=oQiHf;L;X>z7rv5X&lU)K_dKMoyuHyNvbci~Qr%G_K`1WX*Q-<%_4AebGBd zN$mD^`HS9^a7cE{bJRF;*=P#ft*vBPW}eSjaTn&})C1cMSbhhPe?0!PXXvXoUku-J zHk!CaHfAg;jXB86%ARBA(Ne#Wua?0X9u{erbIO|8l5y~PlVy>KzSm2^(L8QpCr2Le zQ-~(&P$g>MPpl63?z)D{esDYYGy-+bW2CHap4(!1ORBd^c4fr3FeAK~f-4wLIbiVJ z9huz$`ws$roXc$({FN0W<=!Oyb6;XGN0z5@%qqKWH)#3p;4RZdd~T~Go#>I1q4ICi z%)G9Wu$Yax2v(mbBL(EdK^7hlwobI^b^Je%tulZM4JqtMDt*%9>pD-;W zr#NcC+WPwD;<_%khM4fM?v(=N>k`tvU8J;8ZmtWuyVu>SZ=tpdIipLwGiP@c*Xj){ ztj>psn5Z^FmX>sZ{g2q^IJ**xr7Tj|rO2^J>oRnryqoKEMvOUUCRTH_wXw^)qGW_Q zbenUS70`a<$PQ6aPV+L~R1*Kgtto0TCKqIlNVQn}Zd>g8;*t>gL_&M{8X02{F?O82 zpmR4AXff8wr*C?@7=bqJ!@PQ4DgVY~0JPB>bY_JxPx;BG5MME zeZy_R{E4<}4LXrAFpo8KfpgHSMkBzSrgSU_sYzaa3uY&^$Ch_nTgpU&=z zqA2c>4BqW~EIXw|+xU!qql!0M*gg>iJ!-t@orN>3R<-96gg;R0j_BPTDL?})vf$dE zs^o79?Eh^FE3TkU;Fp72Jqj;ceoa!mAsnwdLS z{!IclR;tvLqfe`t12&*1+Sq5S9&9G9oezA?5W{y6o`GhGg2)oqtKt? zQuUipp;4a(OSlc27?ZNXn7J!Vn6$57!NZ}n5Nc)OCfjHune$<;Arp>H_s+SM15t1k zX`#b@@tLv9dF0HT9!r(>hM2^ba-ybr_?%1ZtM!&M_G&pfYNG|lr2}uvRjzM&F6wuB zspig{?K}N(PH^+aFxR^Y-?0hpz7F5VG+M@%ebX?wpi)V(`S9~J_lfVJdaqZGKT^;S?5A3g*x6)f zY0#JzU7~+==Qi7s>+N_3>K<_+*6^+T+4f9AUskW6M2`qm#>jhXgqPX|4#LYcyC67d ztCp>YpObz>sj|Chk%JS~eN)bE=>%*s^^#t8N*;-_DtXQ`di9OP}ifpcyJ(pB8WBa)utoyPOvv;zV83@V@ zAo0{qP(h9TZ9xr){{GtRJa?g0OrJC3E^i-Iz#CI#ZON0;gmD+;b{OQwE#EmbD;8X1N26KESN``MTz5;C$`vifdXs#&Q8-(t8BG3ziKP&DFZbwi;>cymdq`m#i;4X+fv z??t=jE0gv&bafRx?bZ|-BNWaLF3xK|*$MaPc2Zw`x^`2=J+Ts=>M{L>GVycJsd#~O z1XrT%Kw6onzqyfk-u(rYl3UhI17yU1*9GYbf9dy?ZyBG2#vcT%by#F3rZ)p>efYvHITx zwSF_7AEw#?d3e2RkADx}<6@uo*kQongUv4Uz_;){-|?5H*#Bkto+~g4jQk$Hmj;}6 zLVHtz;-(>9#_OC@cyRHJV_R;SScm=B!-SdtY{Nc)X$2|vCQ=U3*~uqQ3`(fQ>5J;|>y$d=1nm1C zHl}_}xzkte^O5%X#>m~5GL94a_zgQ-^-$t!OJThNQ$JZ76$!0@*1J!JPHCRNl>nYr z7ioxZPJP_D^j_4e!&PZXDbFhXCf~-jri-t7>olVXnp?eFoh&w#oO&OD%tE?Nr+*x$ zNLv8ECP=A@SyE{;Bplpb@j;VhupM}SNnj$oq#&$@f9Knf|8=U&Ka3^6t#E(7J6!S9sC|ZfPB7nLKr-$iQf_IsabN9f&I$amD3O=* z&d>wGJ_r9a@yd0i*uP%aal9?~wl|q>H{Wb25_eXU!DMQ1Eej-UOO7?VDyDV9PdvAJ z`chs#%}vc?$w(b8BHddV1!?m|uAeS^TBqi{uE3ocXf>G0BqSanHG&Y)cC}&jDgv?L z9m(Rqt$~rH{;3(S48ABInt37<;tto(KG98q>?*E%6=uDGS9kBtD(JE_upC^L2`RmC z%KQU3QVU+YatWYFVuG4d@zsP-3ZAl}YG1$a;N%UwRP^b+JW=mm;TAzOJq^RlF3!d4 zrllrw3nrothL3q{Ut!x}6*pS-0BePBf!DP_KFw##qWQSTU--o*>?B;I5Pzlle&EG= z#s{mWH_MyafjM*IED|c7<)p52TV_S~+txVv`Q;zDOS7lhwsbg&gMF)ip_e@E+KFXm z%(1?GNMHsW#kSP&3^7SDs)Qyg+J}(p^Oyz#Em_S0zJu#O=(G^BxDS_*k`Wh1nB2P$g4_k7PaHHrFC>y&s-Gx}* zSPF0l>;3nN;PBkH$V&nC6ON)-^YlICcgPt^T06v#9%+}=mjd+He?ofzKU$#?Q6h?; zyo>b}+zy4`D=ICC#~qeC09F4RsIH=H7Mt z5S_Kqony(v-hv?7M;8S;xQxUC+rmc(R37Z0I*5ZM8-;!65D>4E9u6Es_{4$L;Cod7 z=08>cLDN4Z@ek*GTbTY%N-%o^Q@IxEDIfWBnlqhTSj~fiWMkbSXjT}q z?j#(R%A8@fAWO+Ch;F&6$Ej#aUIzR0Z*9!L6W($;)DB4Z~q_l2B4#x$dV&__!5A(L_XC@xce4dKJu(4ZBm7Iz(7!wh1XkYs?PT;G z`XExeU}|J-X(eXcA1#g;3*Ccw0X6@QMlw1==FbOGB#3{i{f?u5Q1TCz{0|xDF4z~f zdvSy93tlK}nE==@!!1IAW)Y7vo`!uC7XdN<>`EB9v_PeRHQ4qpN(SvuL)n5j#o zQHezXlfq?M8pJ4R_CAEM<8K~GK{wLB%ZQ>4D^4IT5W&dzu(37R3B(Nc5BUNN`A6eW zhQ|)Noxmg<3K$UNt;74Z-+OyH-}{=-H=Upm zm%$}tK0$t74$v_VFZ3cWl!uq|;w52z0byQ2x^EwPaRNF~2V+xVm8;U zTe^cb4GiJVPGa=*;62^9#_i1EPH;zaxZRH~Y#q4{2ghXuw}Jk64dv##2>rF9oSl;q zA3)2&D1X!ieHk4B=jdb%{k6nl^+V+S)`*OWlasrgje(hoql}!i+K+ZXyIf`m?<@}A z9fD$JVe0f3C_q6K3o~;k#~)RH1K-WS?y!o(VVU2$Ha7ZE#m?Em`VeYkBdCeBiH(V^ zlOw3c{ablEYv%3o!~}RhtChO__M?n zXD4&GgX0ajqs75QiP1~KZJit}44s|e4u2Gtgxk3v4n^A9z)XzZ$-&v=FD0BoWp^?9 z8*m3FXEOuqKi*$8a59kueBoqbEJhE=@FM3$K~5e)wTl;p5C3C7{P&Mapn|alpqs656k@^TVYKTLscg*9S21BZ?OQiHUZNKwYD%av2`@zG%#~8IjjV8 zcCyj80TbkGBL>8Rfvttn1p^y9k%PyMUy08Q4mYzl`SH{Uyf&~fvlTnwRzUiP@`6s( z*htvP!pYj?Kze+WA6KlMzW(|uPOL2sgod!Sfh{0DH%?;{Qv+vfCwlRpgA;`wh#6~( zZ*3g@`re2r^tT=k`g3$Pv@|jL*2kgLlQ1y*y+?5;2LqemoBa-qxP!9+oq@BNvm+49 z1`bB%zZd)Z>wANTz5m+ZLH|YvoB((DWyGo`_J8z$$hQ*iihtMm_tJ-r|Jv9={PTC9d~f#oc&FiW7)Jf2`u-1b?F+ z@Lc?dFkc8XV!EFI!(p`c|!mZ&Bs&)oOCUgRP0-&f0RNBJY$;1JARZ{J$ zi4l-3P+60MWrmKIoBtwI&ejQ3gaXlI;AG)qa#-C0=n4)NM&H#BAs)VqLO;|Ey003F z3iP^x4bVn@=p~0T=Bs9+rF6(HP)!SCpuJq;`>CPqf81Y$oH|rJAjS~z!P*~yyn!4! za^&cdqj*P;;vK`o#XE+Ne+>M8oZ#Sd{KWCY&xwQ2sZ)nvCkVfO{rJYh#=#*tN<>Y3AjkJ#L5Pl>xDHXnh7duph_H?j z9ocWdN`rs_Vq+bA4u%Xq$MA9SuyKwaA;5wh$NKsbg8lUs1acG?8wYX(59=5{!ST}& ztRpzsIN10&gm@>8>H>Tn!G_=*CBi*(9*>y&3ca$yF%kv|`@3PO9i%+rooC5-C9kTe z8Tv*<7QY@_CTCQ2a7^pMXX2AGGQJm;{=9CS-~zvT2?ZrH3oDy|;3XkpX&G5Lc@0f1 zZ5?I)v?Df{ha(S8Pum{Nn; zy=c)0LP^=~`ffLaZJK!67r_@d%8|l=eH!_ZB@;L#|ecZ57Xj za*35*-FGqj$MV_7ve!83#Rst-P2(ePuVq4S>~ zZY^4H$4RylO?Dj%b@H!bAjoaX6MNZr^)}xGm7Z0a*;qCkudHc6lA@4uOl+E2(lYnL zbesTUzpF5_pJ(;0Tm$h#-7=N$0jJNXVRr9kert+nAPa@W_xK{ z{Ar?2n{u|Fi!+LWi$2m>Ec{xiT&c|m?az04K7QJ~*rZxS%I2Uu>&&R#`$Xan;|i%_W=Zg*&~IdU-l&LcNa35dy3~V88}lk_9l~L%8EZI&*y5DWj{9l*4mT6u!*Gm zf$q>kfW+C1G~ho}wlhJ)q>xF&rpjQmCHB6p;$~L2jxt%**&3%Vi7=zj!Cj`IPA2|$ zT&M!<7%IC|RTcNx&OV3sA3HMS@`$ZT$>4eYodDa=pyu)IgOBCYqnbiaq5{pQWMWOq)2OZEhKJcSP)%VXgXES)3bd7RVz8ljleUxHJDbC?t^)UWq1f9a)TqE|@0CVx$!(xZB@wBRzQmix)Z zTCL5Aw_NhNm*gROb_Heutj%K743eEs`>hjQ)Vtqzx;k<~@XdI*NQCC#GXc5&ozl&g zF4-ZL{Uy>8(LPb;a!9>mF~0oWM^u;8=At=L-;;j0A)i#1U+LG02d9#5FX4|!)#(>t zy&)2ZYj2}MBmZhGOH3{Qy{WdBRZxP2+C|Sm9BjL}e5VO2t&&C2XvBW+(o+Mz0AK$} zX69GjM~g-Chb2)48e0|o77b75g;P2tJ5RxQ=1v)nKyz)i?Bvy?{KXhrGB%IJKZzkW z$c;=h4Hd}h%zv%O`x19hqN>xQ@?i^czi~{Ik@=aPS*mhoo-Sl6=L0&%0bSuV+>|Kt zX9c>>rjq98p*(5%{v+=G)HU|GvpsdYSDzXRW?4k!H(#*us}Hy$5uRD9rs{qDg+NUy zB&6a~K~8u6Q>_qJLQb2sL=)Dl;o8l#kJj1W# zHhg&1IxnwK!vgA`x6pHzELTS(GosH>F<3rzopSxG3)O%IMV+y!t~E67ma&PjDKZ;lR7MCx`s*yXc{_^b7CX;f#?`s5LJ}?KbDLjy z!wHlS7YsO-32?_Qpqr%@`i->2A|y&mHw*$A_&U#ylQ=6Y%a-lDofI)*O}l3OjQtXu zD=iH=vsW+5ps{Q8asRpJ1x9&~Hi8woqL_=BGz3oXoxh@_p0$<{PC|~Y&&~a%VbCP2 zyO89GS{HFZ1D0y|JLeO`90_l@juTjTm;)F@SGhTBo9aAbDUe?i9 zSZq70smK`F&B)jZmbuMg<}B$|6FHm9S~+~qYm?6cdMT*Gb`VZo@1F%Y$(0L4>b;St z-x8er62K>2ey*~1_EW%eWSsqNMlB{bdH({k;EtqQR;OmPJJyMI^;g3RAA)$Wc4`Z) zcU6{k98*ZqFAJwucuieufWD?s2OTgng*vLRl$ zA+&a4Mv|)~T)~80r7I@-juw?Y(eqpyqF^!g{Lw90Vy>3>5jr+}v;&nYO#t#m&)B4hjF;evFhTO4ortV22{8%?Z<_A6E)tQ*rYG2}hQ9xAOiFcKkN zi_+)0++LkC$IAk0?<6t2;P`aSk|FwfLjQc4+T%P!>dWUCIZLUwp&6DrJn}7Pds*Eo zrBu}XCZh~VZerntyL}SAny1lqJv=ODEH4OpYC|E2as6_o;1n@iSO(?w;y_Ae`6ux> zXO0a$eYhrV$wRT zN&(L+hAwJIsBU5;zOwv)!j-zmLh=0*%MGLz-p9ftb;B#TJZckLp`_*F&*C!!VsTPs zo^ix`7&241mN>;WZ&NmQofKo4jgjpkz$!I8m)5jOl>IE;is_>&WFnBS*joIpjl`$G zqs<f%KwHkYia25&dJg?}uL0K9dmAfa%(h~OAamtR9K8{B-GeP)cE`dFx%ev7( zQvF+oiV{QeYjnu-HxkTOSXfl<;^pK#3^OdzyrR)1U@!ThV8g*s>s~usgv!#ieCb+4 zdHJ*6&Kn6>GW7cprl8#bpO5bbO|thp@o2N;U)<3<8MP*N`WTx`LQ(NG4GkR{_@4bd zjhx5r1h^18S0_#cTf}>bAqC^7s)Z&YMo}m!%NgwmmAbP5_ZwRBoYy&8&KuYW-yM(F zx<#m%mTugxuvyM7#CxH8ihoPBLhy!-G)C3NmZABC@%7kJA-}1CkshxcuI! zmpsn*f3Z1srrFp|``ssgx!1Ak_zH>FvqN8p@;&VD+V8scp+jvv0D1;$r3dW4M~?&RiDeoG-R5{dA6HXHwGYwen?KUJR(t zsR}`yX7cmK(v+Z#s(FbGvx%0G3G;O%13mQ7>P>XA6${09$_>&r{u%!lOJ4!i#`m;c zp{3B`lp-Zi65L$_g<=Vw;MNAWK+z(FwiGWE2<}i4Ah=th0u;^U#6+AcL`zpx=sI*|lXxeluG z;4*CbpE{XoC1SLQx!U|f3*YPB%He`giR4QGzp^dmo!JleOcf_K>fQbQj8tiF#@kfP zR~oQElC!$(T@XbhK>8jp<9p%Kc!CfW1b)xxbqTyRveO$R2l*n7W4RfN(%Rm7s8t%N z0_nf!#5WFKu59=dYPPA^tqi1h(N2&t6Dh03bxZbsp>c0JGfY=KUaT>KXd2YNcKAfb zor~d}pR#_b7@6eZ==l4Ki=lt1Yot9c@3{C{I>hOKbqc11Z5?`y9b1`e9{xi*d(E)O z85Q50Tl4zNBlG%0|8?8Ra?;H$LG%klv2BpCZNQ z@fsB#mSs0U8}@8!PM@!3N3zwB+Pg*r8nL7EAYMNiuVGU(5Ey3O3f1Idosr)Tye>EZ z**J0*7CJmW8kv>}sx5fdkC_!A-+7aq0mTfcs0_x13#bh0f<|PAFKhhu z1Mn*V@c=a(ZddknS{ui~CE;QE#v3)I_@wcW891RBm7Dv+Vgz3Eiz~}V@3d4#>)8Ce zL+cleuimhhmWKuG%G?g?)vKk!{vyf}zeit=SH^>2o(?BXD|9R7n6I|RlquvNb5!(d z`3bKlf(|r^{iXV-Zub`wJ~c$fr+l-@?qK3-BjaXm$mvsp+i%sNe(%f5UXWeq;_RX+ z2$$=VHbs*95^^il*>0A2#J918)hlzU67u4xA&5FKzCLce{bu5B6`;c`&IFSFP}dMf zjdIaJE(B$oJd_h5QK){w@#leikS@}CBWBFQVO?^qGVwBvtQ>u=1YUf~3sc;_r~IH} zB+lq_RCF2_4a1L1n_#dz2!cj!3v39Ma`(&9`I4iJHZ10 zZ`Mk6%O*`R5Nkw~{?6?mOWtWumtt_VfkevUVy7a?>C>i1^rqNITG6jSnbKxZ+*lXj zr9YdNH&d-1{nkS(X^#R1bdO}*=8|iz{@WF!Phv8jHsTOi3EARm9EWU=ZEc1H1?Zym z@i|)nwm*s?x75tcA+b1nr8B%On@u9bkMCx94Z4j;TTQZWcLJ@LxD!!zUr+!^q4g}a zB?sCAJidVl@`2vO-?`LD7SCgD8Jbc1I{0=J*Q##tU}u@Z7SLq8E#iAR=x(at7Zp?0 z`ktW-LfRNqq!&*;L#ew9a;FG>vC!5F$}g1HTTR!j8KC`XBj83>nsnAoSMaM3OILY3gQwD1gxsI< zBsc87m>#Gu<(ZH7oiGVeeRmgbVLVlPCREgA_ zQ^5R3eD^xi^{b`7mWtZxV8dM3YOh`wukR)jv2Hr(!_LojqPMM{LbT1%S3BGkiF{9} zvO0UUIt}b_*XJ8(>kj=URpY7O8ErHkpPx}Q;(K&^>)08f$RCL)&(|wd<}qc#2FfVg z(BwWY_rm)I(eE9~eIk~p9~iQ>9r=Qni%rnq1%k5-@4q5u6D(`K=!ono(N&+#406N} z)ruC6%NY9+Ik>z^%yPuAZ-m8#Q+e6l)e973yJXRK@%7OHXwAn%BW1GG6vS-1>T_;z zA3m>#b7W{}c%cLX5~rS@p0qhkec_81jsVRiDgS=khv}Ow^hYg>|6+f#Kv-Lu&Ay(n z*0NjerKl}C2z~ntZPH6^Jv3^4ipa>@;4v|JW?fALT{wn~DYc99S)apAI+d1xy84a} zDctX@(;eB7>0?xL^7W|qr|}4V5%10V_xv-4i2{a#a7SzmQZo9R7%kYtcVa;E?f%|P zCbbU9qw1r3M7~qYkI|n=U$tO^QBM_NZk~yE$I4<6F%^@3h_RfXhu&dO{YBW+QtFJ3 z`dX=P@y7|}jIuwcKj^%P%w8l0SkFwAh2P+*o_>Lr-YTdrI$`-m;sG{}#?c$1Ujbl zuby;XuJyy%Hxs!hRA2ZELF(>#hXzqGIi{6=pzihQOFUFchi~8(2d9C)bE=nsY8CCD zc$9KD#~PLEEg7$q)Un0E4wuT@jYnYpx4tsyCCK-uo4`Q<-~gK$RV=AbW>@8$7E$Op zi^(Rtvfpmeloel$myRfc+B@;qJw-!C^7LOP^np6&`&gH6eBq`B|Gxe9KUmmESG)aY`f>cIM6Q?gK&(TIg`KHw zQd?b=>7dFUb>J>MFpz2sE83A8$7*16;`j9wD{)Qr6zHfx6G!)A0>zUsyLWr)4S024cB zFqkp>j+*vVGbr%{KwkB?Vxf%sFX7r*u)+OqGakvYgv6IU^iAx}0{D5)7i@>;KbzQB z?L1zQW4Kj>Wq&j|Yg9&Bvky-x#7)c1R+7?Sfmo4ni^#jwS=j18e+^O2d@Sc4kJxJWSx#xhY}by= z>%JD78P2PzRF)pKmN|gDadvx_=#_TAT)Yh=f7>qmnnUhw7NFd?T1xa~?NMPRNy>|u z;%VDd(|;E+EbN-e*{1Q7Mmyjf&eg%7m$rSA6zX;y-^*e_3 zJ{`ZGYu}gnMKf7$hF#A--l@9qZKv4k1mvXUKT@bM6>1-J*l#~P*a%-RSbC%&s!H$2 z6D^|CKN1GH8F5YicnABJ9`TpnKS-56$UR!x2$Tc}nXnOf5*QNtUpTZ=2!|IQL<{W`M4b?N z-Aw#XKkNUm90i_0^gqG>DHknt_+JBoYWROtNP5I2VT^6SM+zVQYX%eATrIKNY+Cm_SFaj)PC`DC#(1RnJNar=+qrBHhhjv$5bL(rpw-j{HPbA9~^ zMj(v8B#0$&B@FnSZ0V80qyIA>;Trg#E))bSzJ1kC%DIfFw%_(ea-QrF2K|4neFT{_ z|F_%ze>!CEz~f!gqi2UyCo|FM+-tkQziokjQYK z9_4P z_7e$FYXBJg?ZJScKAqiD;qdzG5Ns^y1QxId2SBy~kD919;;d&o0g4w*(Fv1syGx)$ ziklJPm4I?547>J%Q{=>R+@z;=%>s3xTHj;8zYN))jGy&(x2*IAW_Ov(`pkZF!!%&< zY5m|bxs*ummD;feoLEV`m;!6e z=Le0NV6!Ir1lz%`Kw`@#Yz@hrCaIHb#uJU1&NmpMddccCQdj~hLjI3+P(3xom{ zO-zfST&J3qK}S{fiTI2JQp3^x6L%A1ECg%#O;2cq)%)1cTC6a0c1JpfD~5}8lwA}+ zLIFxxzSWg(E!|YN`&V`|>>q6aMs9WO2FIbi$nkmC;1n88l}RSkq{J6J?0{%uxR#a_ zI)C|A>{6YNFmEKT9IDz(UImzIJiv2qVo`M%(>y^Qm;6^DcjOjcZ2^jZHwzC(tk~P& zoM8&(@qAU{A+-8a;)d*oRWcKi`32Cnm&eQ`ok+#5o`S8= zbw@%G=_7Lc*mUAhwJ&ijLv9$TwYxUWhwIJERp*xHX1?e5YiB)r&6~f#)8Ddva`$aJ z>U1a^Q+H{kRxe>*kEuP%;P5fs^=TL6%v0k-N!6c2TRNCJJvWa;({VP5yUuM<(qHGj z8>n4r(|+BdK-}t7;4+L}^~!qLfAQikHTGJ_Lv)06$PdGLgQs)!eU{dQq0-Hae-$tm zQt;|`9S^t6WuE*s&YJma-|b>xZQt29Zg;~otVgQiA$8I;5UJp}2Zodt%<(i>4x(i( zk{oW22tfJR149j^-NvoQu{{T(CN1Omg8&jTjRAO4+55c$m4Ea&k?A-4;AF^#nP%5< zlCP6Z<~rM%=5cl4tBAv1z~r`lig;zU<5%xeDN@eLjxA^PF-@6pTmU@Ld9}r9A3HhW z4>o9tVT|=^WmEYPi5^lf|I2!v&^DKz|5D7il4t6v-fp~aLJf4cv`r*r&k6D7&!ZBo zypF%J(>_lS)#fktO0Fz?s$Dfo`8c2Cu8PbbMfvBsY@8oplh7)vbBTd)yF?9f>3b+| z@Zlt&8mRSH!y5c8rS{}-;mcn$;F+1_>1=4s6T|rdFFF5XYM^{ zAft5W$+(^Bd(JQ(M|^8hUq65ZsveX4Yz6bic#7Zfh1QbxEkC}0l#l$Ys6L~Zq(e7F zINPey=td{GR5#InMCode;DD5t6SY14K99+8Qn zb6rK3E=4-{Q$1tt5ks9Yk@rCUzhWi=;S;3X=Km#z}|0BM=| z<)FC3>sTVdDS-UVs!uLU?$~KZ05A}&mJWJ%Gq&(Z?Y-sgChuDx+xeEd70TJDv&6lA z^zn-5DYu<_Qlbl#inmL;=FjzIE8?LHEu9DXStX5=%TGl=30+}Cb{hnDie)IyOORu79Tg{O$GhN-DY6uAqsurMpK-b^R1{XiE25s(psg}mfrO^n1Iq$u~XHg~8mroRW$;Pn2!oUeiJIMN?fEp=&F znUL%QLog$d)N;8@9p11B9kffjy$75eUL3rmQF$5r_?gksB#-!btUA#=rHee}a`CXM zOKuX{tfZ(Dhp;fJSA1U7g3+$tqM&)(ZHD3f9)rjQ$BRpqdHIL9h75{kJSkLn78F|j zsO0}*udCUxzjCWjT?a9Kms<2H(HwQxs9z_slOqQbr^aJvhyJ5+G|*DX2P*-_>bum@ z8wvbD--|1JKy?0@bIcQz5hi-6f7Cy=H&@qqSI|dFppvL{!vAdyk z77&2~(_U6P=!_omR^%Ur>rH@wr%a(zmhO|m!Lau5+pa~24Al;c+!vHuNrJ8x^aFM* zH@GKGOw=7>4WxIOIaszbA`m8w>sSErecS7#3NJ<7GRG3w4J$7#H=M0 zZ9kt_IflV%G{kGOv;#`*nl%aQ-eay(Ks71eM_ONXBV#8Jqt zSX*#`>QXwp?a(ls#St($W3q5F8W!ouFrlA`eG!Qp%wt`>TyRiH4*Tejy4o(&s_k!N zMi6ta{1RRQbBgu!9>Cs^^?*Reb`)mA6o8_m$v3GUJc*2dbkl-tDQHW%wemE&GqUa* zkkJ5oMM#bYM>sCwqnGd!V-ogGcxr|-@_uWJwTgim81AgsnLZ`(xI>b8wF9fm%mJMN z)=Bh(^_n|NL@gLuspp2s7tU(%#Uh{k%AP;da5w8Xs!mLt0vieQb|jS^z=<}${IVvm zHT8k|AQL%OG|MQ0Wu<7Amnf&R@qWSIig)fL@lj*b{6nQ}f>Y>zIs$v$tYp=s<`AuM zS6XiDlW&-zqdzsvoFIlPLg&OUxnnHIT03oOg$9XM$s<$&X9S1sn&l1j76W3jX#JmKvCWkt#i;&t(%yF&dw|A!F{-6@JM)MgvnLDFQ{)^i z@AHbT7uP3x9|dUfy9hVQG`^u@Xt*n4V4{*?A-l|9Rmj)Ns8$}+2|?nSJ04ZmiOumi zBm_m{kyuO5b890dkyZT)WLR}ylw*hM0}%IZh^6HZ^ugglte5)fQfx$3jKRih-J?NC z46e>i_ifQ@F8_RgN44m)-H_%qs67M9i#GNh+u$o5*o=|^@ceW}0Me&E9_BRmYfjWH&dQRA!J2%G&TZTpK7AFAvz z8uZ|_Gv?JlsRO8NK6;jegPVFLXoCbCTtTJpGON#bKV}H??*g5DG zl;w`T!Ri_sLcO1<2^l36%e7{&$KzGOndzV>$tB)J(_+4{qI0C(eTUYfM5EW==RV z7~b#X{LQBBcQ^T@K>S#Q!f$f`fDf($S`CSEed`D(UZ7e!w2yr-=kY5YT&Gj2QNp_| zL@6Kd^gVZ;t)!>S3&OVIEav^f^T7o^gaV_r_+7Y!^G8A^Jbm#+abssbE7Z6^TXr;e z5V0v7+fxVdtc{pHnA3CIKaTA0DoY}|tY92lo^FBc$d&srleoN;`ooI1qnf6yIqOip z&Vrq3#(N}ibtc`%!RPnT-eqOrstRG}0$)J69!F!R=+c_gIfwYFS=w$E;UVs!+Pr4+ zX`1NXTItE|<`50Q)62ifS)p}epaXP~KX3A?63Nr|=XLnGc3Sr%uVYSE1Bqg5xV{!hW3Fw5Uqbl?KRz>we70Y^z~vCEHY^kjq8 z^H>&62}@n)xzulJjv92-WoREq#v>2g72=FVkAl}^bPisa>jl%l>k}E&g4}YyX*5=B zmHytkes*9z=n}A=F>s)8gF~8iOK|k8`2o`0ms=gWMV77t|M&e3NZ9X5js7?@Gq|3>%G)&k)!*gnLO^a0 z$l4b>ux!J?x$4_Z00j@?Y;w|;SbG#ir$rtmT!|4HZbqF#U%yorPMQ|lKgu522#-Dp zWBCtSBqe+ZXkw7v|Dd1n69V>Bqe`G3b0Q79{isb7u|RJTJ z8AeFp1cMz3e&x6m={QA%9StBGp!t6Q9f2hQ&0247KjTAetg{KV4{Q4R2TcnR0+vot zO%|$0&?m7v6zl{DZoCB%zN;(^PB4=^xPFXr5K*I zNh2;BwaNZ@gL@@#rnhh!g*tM!`4CVcM7J%?_qG$5pTb#-F=F+5llerpveFY+C^GHc z@SUe2kArhfLqx#pP)6+E<~0SJA=K1>aWYiu&NtHPk|Af+>kT{Ai-+BDz-F_%2{vPC zdfTU+6-lK7DXe~?75sC=AMI{&7Yn&{Q|GU1Em`{3sI~lB?y>U82v5EfvMG{%zqesN zCWTwaX)#thd+ld>jjTl*u2~wMthfnld-s`5()iHn0_5_Rp+vAQT3nBvPapFX81VwD z2QWuZgVrdOFM!?KRnc5WPdQiA5Pr8VNm>F1sVc;Q3<5l6{MRh19WbET zdct|~Lcv9+UR2v&T;T@42w!vO)nKzz;WYv#$=vOFUZKfuU}}9Q_jjsOm64vU$RXKh z#D(l7&YP+LCAtl+);f0iT*TBLX)d?8hn=PUyJMxLU{W5@n-w!&95GiPWm7%S0%`_8 z!{auAW4(wS;XmHYQJ;HwkM)DoW7JD;L1AbtK!fhrQdjR8aNgB(I*+mXt^p*iAep4e zJCW6N+83=%k@zAJl9%ve#W}1_V9Zv2K;+kpg)boUg2ItGj@X2JEm_JSuQIPf$2tb@ z+h5@j1mUgJ7b+6J9_csk`K!yXP!cRYJErR!4nRG75vjqSc)=Hq?wmc9iSetd6R&nO z5lq+6sonG*46`7CFq@czeAGUrjMk?OP+c7g^8`hgUP~AK&M`_~+RFAc^&lWFpNP4m zsvkf1uDY~Bu2Du-%!FCCJHRV52XKGEue@!%E^*d9ST6uQ?hc5dW(wbg?s^7rT z$4sTrqvIGPIvy{f^?viCsE795zuTI*m!c0MmquH0M@*%lo*hYBdhqp0?c*3n36j zI4zO;k_!-1?KDMBT!#Nr7i7~WJ>xUkJy2iExpa*u5x}Rh>ZmhG?+v87m_$p`&B0Ga z6i+H0n)EGEkGK+BwNcVQaZz~+t6SPfq_g8<(*)2d~UN0c;|WiiEUgc!rf)V0_Zd5i1-C$;((4B=Ku zg$1nM;wgWMP-EXCXY%_-R__d7)g@c1{6reuQN;aOrDNp*v^O^h~8OKjZn@a>x13#qUJLh>x_ zij!AQ!k-fF(VTMZ`*$&+9N8N0edydGXT=y8mQ$YScd+A^3Tz8e&lfzN3)2)!z<ZQLx+mtkQ}o*kPeaTzxeS66%_*t;t_3w!lEMfo2WZH0GuN7s-^qdacf(zH*o`3ar>yF6g;mhC(;dt%9?FH*==m4XB z6Sq-n8mk4jeqXuitiC7L{?ZH+0=M~k!V92}Gfmy84EI>!vCH84cAoZ5tcEkN)p*{5 zM0zKu^K9O?tA}RNagg<9pE8oYLyH8+G)IeX($l#~Y2<|qAk(e%ZpDs&1QcJMXUo`xEY5{$7*JMk+I;MT zbeq7YCF?5UqS4;(*-VAg#Y@OUG{Sr^b(#D?{%1Vf-vfFp@nm+;s0JkKvnP^IB<`%0 z3(CEfOfyn3T)M$MObEsBIFqW-!7M7uk)X?g1?|&T>;Z*owG53hUG_BeD^B0oA+e7W zzQWjSvVwx+=% zvpSW88&vbzacNG$Q|f;f{Elf(S((&o3@zfKLvsos3~5eEzr;6wc@u7~bVswQmA`At zA57B)rS+9^IK5qSsuL?O-RtMO)GwM&u17nKYvL08i*YEp(d(kuybnzPnjKx`fOgtd zQ?2nT_V6P+U3_>ziFWtL$-st|j8+;*N@8{+lp9V?ZOOryw$?qu=amgDMbB|z= z%AfR!5)-AL#l?F>4tup$SQW(-H|$F!YHcP;lPoXCc_o=HD6W1ADoJ3}1jIG%WVWnR zaPz>zGCDrR$VA*yYxucM75NBoeAIX6=)s*+hp8XL)HLO;lhaGAzb_c?_aMfIN+;Rd zNIzWeh!HBTq{rUgg%{T9r%+b~zHub_Fr=G$VwkqfDAw{|%sq*#UrT7wRkVzY1mu4A zi`()Npm_<%58P~rk5X%hzcKs%6juaOKjJuz8FM@?KXrCC)AoQz#GP)WhlC~yq&!XL z{+^nw%kAN^-ZnnOWk7`w;wv&dMP6b2h%nN=>$j0QX38jA9+0?HqlcE+Aq(% zpSvwuGwrenx3eIXzv2-fE|$ZI&QQ&I+Ik!x-^*L092o{=*lU|oF*<^#+w+uEUQqCi zMqwa#IG4fPYQb&!~*ZN%%~=ysYyGzFwbxzxEU_*csa2D>dW{^CGj zV#}L-&eLUeLLW*u*mCS4VXQuW`Wo#MAK|z;IJ!S!M%!e)!mu=<)ZLfH6F(iq?frL4 zTgb4=iZT-m#_)h%Hbgt-W9(dtT@t?6mYVT}%5S$ML;_*U&17HI)Q!86VFBWl_mGyY z@*do2;zaRBs0R&t4{?$suvkHxEGE-3^zC_EI(gl-L#&Fn%ls)JjPyEPYw}T<#&jV21k4GrzI)Ei?E;GLGagxJjdLkcF0f}nV6R9FDge0wt$WqJn9f_k?$Y6MESb4lO5~d8oi#b4BO*{zC27A@jwEThz@L0G}$U!oS zdns^Q{B?dZTDR9CEW`yu+&pAyj*L05F1tdT?}x7%JlFZrs+@*8AJS`taIZV>l}ed- zAesy)T{g0n;wUyge)$(*DW2Z24<1`c&$ri?k=9eOOFmRwFB*jfa|&Z52YJEm%zgEyV~M0rU5 ziadRCNEC6%daC8UK%}o-J5yN3KXXAp078mPO`1u)w4oMXLcOF&D&<%%e+8nJL7834 z`-YX;wU*#P#?HWmC<)a}F^qsyFauJ~qcH)|4v*_9VfgM8xRx#+&jelPz7>!-m}M(@ zbZqTcBHCRDycwZ%I44a>EbzPhL{5=)_FnJF!mo~5dfk%8+n<4V+O|LfE>PXLEt(5v zmBi##+csELcfeJsHzDZaku}S}@%~R!^Vb?y$HBrv{_^bUFISsxvE0j*SdlGo~J&Z2JqnZ>XE)UrrK9 z2TETb+#!$ZFDcSI&+yAeP?QmUZUd_69|MZD+t2lSo+R&ZxR2F;U4EWsY6;be$n*4& zvb;QbFlLl4Q908-34fB?i1pUwFT6)^fI=UWOH`K=ypR&=1b&D0r;@q{*xrGmzM;eb zkN#G81bjGm6K#>bN$+g~if zngO12A->5!506M;7755#^9$oMWTy_kKJ-)i6N*b1$_XqjWFxK*hl;LFEZ&vSO$rxu zHl`-^-(^#Qi+KSp1MVYKBcW4CdUZ!A6mmr?_KT#!sGpTcp?#y_8!wzKrpI^cq2rqF zYQARiz^k|QG0CE;u_U7Ddmbx9MaLy~;kj9=*+suITT&;$j7<(_>E0iLm=- zt5BNl&$dqX8eSPgJJR;;e9u-)y9%g=dH_F@e==H1c@(rPpvCx}^T_s{Ish5Lnrr&$ zu0B6ktnz*G}Y$S5Ym496|+ zkuw9w^clyLuWFJ{w9CSN2roc(a@mr6wx`j_02TeV$lg z{JU5f8z6m6(oLQ=g2{tG;PgGAAD);uXE}q z1h#s%3DtGQnT38&as&^m`sUf@y=6@mQfeAj#^Qt4_&%#IY*DSoyMb%Fecp-0=n3+? zgH|Dysdm;6@ie~o-ySG8vJ^l3yWRy82F`X;`s>M4Rtk=`1|3@!YYoz*N`8CNV!~O; z`=VE(alA*Qgs5@)$Tcy~`3@>OC`b=wTQriHpr6|N0;^^Pjt{SN#Z_vSncEBStm)F` ze8((xMT{)AYsS^p^jHU!mEWIxIC;33idP@sYuvIC1un)>Z6j!Lr|{IB`3N`gtt^VtgVuli;sx)e{U#W3zrpE`xH19 zd$XpYR&yZ9^OJ{<64K{L?HufM?m8FzOFgBq*@WU|6SWN}WpxLM_TBBEGzBLn|1y)N$P*29OC z3Fp@O)(T3i(&dEuF|_<70YAPOcPQT$rD!^;yJR}A(mND86?o9xQU;q@itN_$tY;w> z(u&>G`i*zMr@>KwG}Z@9Dwqo~Z@?pvW+mbzG|gFlS2y-_?8n(iRE?#q&cx|mZ9*tC z{fa~HoXFvVOnzq8rKQX;aBtA#>8@uIh_?C1KVr9^RF}-!nh7KR4R0<6wRD>DXqrh1 z%yh;%y70;3L0Xu#rAkx|pE#cRp9h)jtVhSihW6cS>iO9FR_x2ghC#9{(cDb9hZ+Ve z^=C`Q$N6zC_>9EacC8*0GJjb@mlzyVQb$*oW^@FF)}m_v zOX6!Lf&h(2s&-k~vin`lqGH=O!>^ZrJ~Qvs^mnp?$Ja9U{3$;OM_Kd4ysf8F9w$TY>h4&@*r-JWn4t_C_xu#HqLte!@T+XojN?;rUdx9<~r z-P0q;8ejs#_fwAv`Nr+-H+U=0R=il0U+?zUJfBfpcf)i3VlF{0*lFC+6O?rEZeG5O z;5;6jY`gUDkcwYkw@^f;>2CLrZyQeVS6EmAxB9^+=ey_K@gB#g@$%2d+kfunw@sl z@_9@}|2V#ZR}q!03r{ehR-@%X`W#J<)UDQMUVOnvJxkJ#Z!Z*Chy3*l@Jo)bKM>o} z-c80ot9tFRNBd_J%r93(AZ1DrKbHNKte@9m^W@|x)=i{a%)%O| z!HJCoBU2ujE2}pjI<^`X8KR~^FCazCH2j;DqlSxAYjh?-kRL?;{H0({qHE>6YB~B< z&a}Woua#7>t|!O6X2lbK=%?U@?VTg_D@w2^oE_R`W3YZVLf73<`(qh5Cl1)LhHj6R zC^LrtDZ-oD>?=`Y;-mr&-)m}=yu16NivLrI_&r|8)5@XU>r08$mqHMF zJRb>LS3I;ZzphG;mN3unEkn?dVG7kZZq=60r96FG6~?ey@5oo838gbifsHtpc6`RT zf7eHZM8)gqkHB=38zRqoyl%nw8!z(V#>?tnusFFIE%gCKN&)^{v#lZIFhHXg>qltA6FWA3RZ{rYj_XGyjyJBZr1R zF?t(!i@ssQEp0tTc0#$1aTpNa^u%3(k14m?K&piTu{9ELt6n-aEzCm6zj^fPn;*3V z0PQW8x5sbvM|e{LOQVQmzp2NdHh1LgKzbY0rA57ihKy-2ZS$c%Zq}TF zd!U&KfJGAnkqW(?DMH1wykCn@p99hQck6DSLrTVLc4fsGXnI zFCNQYGbtoo-F&xizJ4~i3nXU;72o3W2ATCa{4%qoT4wtFOsxL+OePG8X~!GN>rk|T z3Gv07iRgy+yxLr4`W@;tSo!tLZ<<9CA)UAx@Q1q6jNU&hJ-KCC>=VzMWLJ2)vVsX! z+i;G3M@_3o-P|ckQ?EZ!Dvh~ua&<%}$T;a7hSA!+{mqR%v{A*prvhUw|}XGI{LM;T1}grrKj6Ko#D6~lUURKL5!;!-OT7q zUcF+svBYhcIMAz_psYGc}c*98Vc@}Qa5>jSgC4a z&g^jT_s7)n=)&iBFbbMz`TTXdXgemm6i}JV&@|w*3q?qjE2%P1Lvu^>z{v_N45utk zaF>p&wVe2hS1v69@-QYo$>4vBlkb-Dsnk{j8H zID`P1?8^HKWk&d>WGs-;^Pf6RqZLx81O07H2up~5w^R)DkBsG4Z?pM_ar%x{hm*gjUTu1nY=_KDF{=fXgjfgniAC84kS=J=IN->!2RugSzC6k8R18aL z9(z}M4mnkeizPfs%GR9eBOiQi)I0pxB@VS1GTc^5s=a#S`N;fGnp$K?tB8A6P?vEt zQLA_5$U-s}5%9(noYnEq3cW(Yg*1kte;OQ?VpC{K9%elspVKSJe^+2t)Y0;epJ&Q^ zOd$7%4j%F>sLEkNtz}x#mrRj>N+u9*^K3&{W1og>_@G=4gHihYZbkzbML za#Yw&38mF?@adtyi1yQLu_SLOIm~Ws6015M$Qp4vuobz|5gcDj3zOl)bJE_sBu!*c zIX|$BUuw%L>Wk^I$X~c%Iy>QUwOor0C_?+8$Uhbz#FCxcH$1)kjC)Oc*}03E?@ASc zzrZPp#flj)ct{s_oIj_z@=XLc6@*?Pn{aY<**!P7a*&S#yByyfxPFvBU_b#egAL^e z?#Cg4_cUxZ^>jiInXSk{8N!Q9V|xmBIP9lvibds;{j9|H*~pd$0_T3_m@d|kymGuz zI#b^@;(G{c4{D0ujATI1r`>vgr&$8R$orf1cL^Nrr}fZrp_fUyB2EE3K-G>;^Za)d zQ)WVstovLH7kDP9CFhF%#7)NW<7mA=t`3mKbADOHXCSZ?>0V;YB{3HPwigH+DJz=dQFwV}+_vmjOV!0E)*@q5b z>i>9yXVR;0(GVEi*0V)rP(ridQMzE8Ql+xQRhFuid7~2~W}NnOjF>Pcrho);^_Xk& z^dr+`ja*$>IJwzVoiBr~PmzPQ&8UQxrv$&p+P$-Q$-hpee^>reolc#!E?l?P6{}h% zdROXOajyu6l_%#@OgrlOxWxw8XY!rB7K%odYkblX(hlzf$WWyp@-Z4t#`VlA@T|V( zM_A=>fy`Mn)eIRnB{+P_*fu>~IjL**PLw_zdMVzmF+S|{hrC`Lt88N*w~s#ZWV@hb zB84`WSCW18ieY}Vztg+(<%7^9Qe}LcJobKOBeUUMGrxSbkb&jhw@pPXhFXE$L43}6 z0gc(Su{Wdl*_nOZ-xylEQkF_8ws6iQUVJeKqGJ;}NVO>LmfkaY&6^dL6C@OkH$P6{ zF#k@NZg&EZ{j;F?<6G)rVi!c%am&V7*qa=V^gx&pw&99pJx>mkSZ5)$}gQn-O9 z#Q7@~D!_3H<(;^$YCs=@0zoNZ&m~u=G8Avdh)`RPX4)GcPlkS|NMdcPT)|JEe-(STjW zg*7nO=c#s_Wn?1Z^b{Pr4FZx)&_(aVNDEE_$n3ayG_6WCsY|7zo9-r>UI?NohF0pT zOQ@*KwDUO}X*od2m06XQKxRs`z4RJI+HmJ&1351vx{qR*in>!;QJvgycKAl?JHP(SM6HU&wNW_y;Tj^?xPO&#Ems$ZqmU5Q^ zXdzY$u?n@th_q>=PgEAUP7PN34#d>-uN^wV`(m;((~@56Qe3CJ+o=vbggOZeQbLxJ zQ<};K;HQ^Rk7?w|g7NVvt||5{dudX=Fsh(R(<{xFN*hrLNm)wCK+V){B3gMmTLoTO zMkW)7I@^g*^%Ad;%6o(61K}&%5@--5;?yH>U$=ah6saQ43zGJOX-MF17t zqqk{P;jCvXPphJDywuoR?=qw*t2vp46ey56a8qk1DM{sfM(a~7<6t~oH%fZpYv@|_ z`?6`Z9B7T9%gM@1yzHCo&7x)WfTS#jRdk>cp+d%s9Z_zOZy@q}wtf5|{~jD;YXkP5T9X67_5X$_6KU z14vbCRVjz6H2RdYDRHIT%(LF-buil{SyB>|6_5qOtQB(*bOf<*mIc_AHx%o)Q>A+j zTV=z0dQ0nKyBnfxkd@Hhn088}q)eo(cRQsZWJm!iu<2ZaGj*LKbWr5Ho}4T?tx+yv z>q@8787SxpTqRd#i!Op*LS%u$%)r&%U>xZ{q)Bn&lapuK?Z%IEa>ihOkt)#gi;jGw%r* zR26VQ01<8m_vIQ_Qi7Kz$6TKd>mAOmbtd9A>IEI7NK&w^PD+nj4m&q7opLhmG~=#sEUSIG3-EJI0>3h0%ct;OsI4-fW>Dk(R%O;^EIJYMl zn`=hU`qSZ=T5h7*2Fpfk1!@4iZt+v-BBH%+B`KYKFyBW0vVF6hLr|5MT{g8cKCif+^Hj$=H1xpT`OrH}8FJe)>dgQ0%Sq_cMz|A6gqK6qIlx|cARjr@~ z`r6m)iPj=Cs}WS5#Gg+8094w-dku1sp7Eu!C6eA{BX%@Oib7I4N;-t`C$c5ercuY` z^ifB#Jy9K=?4qRq0BPqhCfXZvQRh~KgsIO5(@+*F_uetr&mL(IojjFn?x_FKvoTc` zQ)mlIllAOJCgW&ZWj*-JuyG1eS-1(ZhPiG$P!q}(De{yL3DrzA;vDKP$%>q=JAO&m z<(8z$AOsXV)<;NAP_^npjkO0$5@UZv<7cJk403Kz@abxo?9OGT<8mwFR zyxU1oQo}1~l>xvTDm<&ot0&#(Ji)Euw^M1i(KD!nO))b@o<&MtPHjsCAxU>7hzG1H z_qPa%`Brv5)$5iYDY}P4h}Y3OP9`I%$O^+)iP~*M)R<*$vZXYa8*Dgkyqzr+eeKeH z=^`stxIU8ci;T8u*%6I}}jxQ_Glcfn9k|y0=c|K`TI7&Sf1J!uuu299KT zaZc1|IIXFfdZiw_FT6<^lOdFps1%WOESvV|V^zwPI_H2!k0?}>B;qyQJ;h(L?YB}k zT~C{%p>;Q<)TevN*W}$)%&J@;GR~vYN)@UAwTDFBE_3e--IXx;Lc@hMICBlQp1r=1 zRbWo&DN0jJqGhUzl+$A~%aU3*q@-NxcoVN=d57f`^Wa0ut5~zDCuYUecE@&&JL(zl zG_vCNI;S=Hh-$ZFmR2QCr0G;DuYgNQ zIl#C`nIIF@aIHMC8h#|&PD6V~oTa58xiuxJD+zHENgY~{ZGNl9_Zmqmn%m=Yj0Tri zai?vfoTsTm{btDk`eWE{TJ;~QXzECcN^OBP6_m`@sZSn2gtDXND~zg_li}tuR4VqY24Ce@m1N!P#@3Jf^lPj5!?B3)cy(X+HM zy%2B<1FO8Ibp9tE*|~Rl%`QLx(~Q$w!frp{Y7B?~c}XdcDyoIhn=vZ45|nJlwLCmEeJj4By=BQB zvv`L3DfXTuikhC&Vv&aN41wLQsU>UW8_7~uusCNN$>-Y<)m0B;;%=#{GGj`j;$~jy zKS)~xmwP(W$hMXwkUY^HRz|6wwFb&|!6u%;?Nr;m{W?ly+Q)puZt3-_$`l7yu@yL# zQPAHKS3;{{2c5wow7(&`4?2saEAlrn<&s zz&f0&Aa$v|3GK8)S5C8jgL${=NJt&(qhK`(O^;~ok0Bl(|I}a2y-0Kdz-?owrFQkg zUa^l+*qMEq!XokRf}Fd}bgw?*&%?WCZM0p<$<5## zM5>4<&J0znleyHF5_)lbL1oMBrRvnO*q54kyQWmQ*+N|U-4Y5 zvebOW*X)D^Q>SYhT?v}gReBW4QeMMSGHT#bme$GirDM|`T~zeX6V*Z^bxIW(v2~LyNhcJXRMs4MPB{8jwT_ncmeiGXT-+P>#14sF1gXKWyUI4R>NxoR>(MrY|o7`U$b^2+3&2fs;H~lhTR%J<}3X4V9{9 zX@EHR5(mOdaZ%w{(dwdQT|N^r9_fc=&Df|q>m+E>no7a)sl;4)BV|oU*|ci2x2Zb& zmYWRb9``(|2kVlN5#nLh(=vNYMBZ0u^sGwRW^Kk6(Y4a-w(%z2p*I%nF#~l{O9_?! zBBt#6rEsR$4v)|kFw%!v0@-}rB1KhwE5{Q@O)S)<;K~$|gw-m!-fIHI6AUHv+pDK< zOk=IRO&FwooOhJ_HL=)+;UY!Q787`(fby?k(%;7 zKmXUIs#QrkdwHd56=f`N-XWp~nF<6CBy;tzVjDUP@_4llCi4?0d0GPEm~Xy2GOf$n z+`6MzM(-Vl$(98sdFN1pD>)@)9OZM<0c#f)%aN@`t>%i=QnshqN|_|4rEIA#zcP@q zdzlb~rB~sbexejD)&{W^O=ZN{63V6?m&OQg?=7`8sdL>HCG!));k3939Qa3+J3VzK z%}K?gwyX^@qU~OYsYfgebCc?Q6FQ(15pt|gm zLXXgsEr17MQNIp4L^?W?=zXT@q(?_XVg~ysUbkw%4#%U?+?l|nq;r1@1sV!waBsl5`*Qp2!Bu4(k z_nvA-+A8!C2Y|kud)?32aA7Z111A%zEa_lc-yrquiIj5dvi9D zHSCJ6r?K~vq({Bk!fIG;4YGw^*EIKnN1q`U^+%0WwVvuZmAN@(jrBD$bD$e;gRRS7 zuivC!$sSR!Q`Ntu*_Jg20<}|MOo~&I&K@DPF)|NW3d%wI@vClnTSuu$S+5e|dL-w$ z@5!l|l_-TN*-#E{yMz>vvC=lGirSgg)@qtgJwoiF=bUVjGUh~qm1)XuI;?a6MLL;b zBPCx8NIu$(>XhPbbD1|#(~Z-^%^oKm2dx!zkI-mqU%Bs=oLhNRTxCi~H@G(mzng?l zt@QeSV@OEM-AYd=y;Z_&FJUq@@^XyV;!ian|Iw~%*qz#~n0A|0RJK41B3KNo=c-1w zIu6L^l;K9zBa3^V14fav{5Mofi=L;{WzduYGwRQT#XRY5vuwH-sS?kXq#nDf${v#$P8DmTQI%Iq zIMk{Ao=Kx5r1bo{RcnD!N(Z4=v~N}KrkU(UD|7E=ueq2*5|s&B)ay?qkKCE5bvC5l z$11=k_TUU?-Bd4S?ly$>_mVlfB^H>LkxZFW#VIOv@iqW(U*4o3<<1VauomNZtu6Gf z;&n+dt4hjAx|xRO=2}Tlg(78zHZ;>IS`}f~eAbB6^hBGwcF8%QOVH~`3Y>Jfoh;~> zY+l^@B_Na8Vc8l(q}@{_j8U+frxNobKQuZ?t*(F6oq_(`m{{Vc(dLLF~eB}_@*2$-3RHC+}*4j~%YJ1;UZ3N^YV!0}*2KTwEnPJ3U5whg}svc4tm5!A?`9YXO>S zsnfGYO_`BTNCISh>BN?T+dZoRJ+Y&}#OT*PHpE|b^?)jiobN;4|s>6c2^E`pNsuazVOn_kCKE!!E* zt6JdO69$?+n|FJIDmGtFs08=CjH9StsLIL!Bgtz=tC8Y8dieV0wQ@RE!!ouU!bu+G zO6mK>xZj!L@8Z1V9MX-)|I=Z8&G?5BVj6l(_+ht8t{0hDQ7nM607<>om<+(4uxuh~ z@X{W!-DP=G*^bBe%^`M)G1w@cRx>0VtLAJ zq~d9{3T8>U8JUo#(x6tI#$%T0DhdGTMr)^pMCqMO5Y?46m!viil@#94u$;kJedOO@}?e<+_BIflBEZm6|K zCW7}T@{SiNcD1egiZ(OxyazPuLX|pzq5&f~(4IV^Zf;zBs+H{(a6kXlbvSPgv4$B8 zvIYEQ*aD;55?><*K0R3O>bLAwraj}Z<_ z5j2}iUdFd{7k|k!_@yi~mYQaw(_wEs(v%Y4B^`(8wB8{0p@slqJp zCY_shUT=8%A8AA+A=N3((%MKW8A7ZMw;EdFEKra;8sm)Kf3V+%<#zpG2e) zQuc#h*D+-DTM2fSac`F8rYI93fElzqpAZtqJRxjTR z*X!--jr4<$VgJ==h}#tVrpczR$C*(41{OUOSw0KSGxKfa9~)yuVgweZsY~7hGPo9$ zi*wYg@I+O4PbB-i;XXv)CvvLnf+f-MlsgZ4$`ERNU71P36nDoJ{C6x z#3`j`Nll#kVay!~iJvc~m8)1Du1@ND&pSKYeD==SVnyjHl;o7IWU{p(ko~SoGnB0< zHU}xc5w95Cc}AV2Pm(={dSh+0_d?a~6;-A0Ty=?tRW20LoEKNmtf718phmGLqEu!@ z%vrICd#G1kWvLWXs&e_pSEd%rCr~)(=^CCU))5U}Ql%|HK1+k6s#=%@dhJGuJv}8h ziAwt}Qxj=5%1N_k)JZE<)>IT1atI)%$3Y%1C?}U|7+)>d>{QG-_N=30Mf%>{XfFVz z(&|M-T}4bF5>FCFeGgdVV_!tp{^EXrUdJ1upa0gGx7}$+N=i)9lCDW9bv|&S-Mu0? zo5QVa??a}Rm+qO-ce)~3=EC>uTWbC3n2y_J5gNFiRFRf)uc*|c*8tIYI8-MRc^DV%Hfz2*}I{oNWZR|{q)_bSz z>Yr1&@02N4x$tk1Zz({Hoz(QADODOy_e9dE$|>)L$s9nIno#tH$ca`RPhuiq1ImV6Id1ZwH4CB+`9k;ABM&XYKD23~M=p^1bm(i8Y2)kEFH_Vm5c9h%3~ z_fGMqYJ4>t=aP>?k|WrAy)$d%)A?#shZd)A`gbGS9^>69|JUv}i(gt6;+#-IM@=hi zE1yvxdO2ONJITj-u`gEX5QQ6Q&`9-0L>`z0HMQ6l&{B1<=o8p%BiS(SJzQc*g)hCD z4L5A%2RgOqs(m`fByA@yYZSRIq^?;R+E@gvJCtk6z!4iNXQa`y@@pN-wg8wpLFT1g zdF^XPSkENWluFLES7-+Xvdk^Ct6o46 z_+!gnN3w|PTS^qPkg1H>Yzj(+$>E^{fHO*R@k!3$54>7uM z`Lu2~RK4c1jT9!2Q&rsD3veNY9exaNt$VZ0Ozk&Kk|QH_BgOD!4_MMX)?^$0;{jr# z@=qd_54?4ZlMPcqLbc=CK);_z_D>K0(Wr3jy&ioEv#vCx3xeX5+DP)B#~jwVU89m| zlF508H*Ka`qL5Ug5`d(-FVs$iA2p*$*R31L=5Bs!Rm(o&7U$DsQ)ktojZ#eX!u@4e zN_WhljZS;(*a_zwBxIeBc3qiDdMzm?)=~&QdlZA~k0K0{maI)RB<}4erF{lO3;FG= zZjq_oe`s|XX8bF8TN+%;p#Hc=iiFP&F~;+*4+2n|^9>KYV|x+fXC>e3iO6e-a+p+S4Te(u>q9?Bz;TE~_M1bOu{> z9z;hmNOh7B^rVdXtR+&(JQm+USL+2fjqZ7#LOSZD1U68a*@Z7myYQD$~!POp^Zc`+UO~jWSX-ymJ!B-l2 zqaLHeL0yzI_QO_iHm)IdT71P9^@#G5)>kXTEFIXK4JUxTd%{Ahil-sh=;$}e#n5M1LLURMu5>Kc^rmVp$Pkx-N$x6lT ze9fybZxN(=*@o&JP0xUBE`4>#QSyrs7m}5w3t`6rJXD3I-eQ>c4P@@iRU~Db`IhZ`FP&d_ z=^jC`vF?j1*2m!($UHy))UqDg-0O!~H&t(~0{*z=*0eq9In8YPp(OI2GEWPO3k2}z z!1^N^W+*&-j#+kgT5jixcV%CDPh5KjNwT~@BEZb4S+pM3J(n@l+adXDstnWgH5mGLe(2NdbM}?k?O;FKI2i!OyY&hGerbw zr8cbIZ~;E3$u`kEh|KO5MB)i?mw+0RxO>t`ZX{J2JT1(O3^60g=WY6${v>TIk4M&j z|J6K3%&|z&mcZFWhhc1;R z2?K|OPQJL$LtEN-`C?lQk+TZ>mkVjL+Fc(SJ@hr_z9MqIs)0!iGPN{S<)f~2xBCHow4!+tf`lZwo=w)eA zkVw9%NjB0d)yS(`C#W}vi$h8DPeke=xbn3A%B0$!s?RwmEc3}>D##a=#c&D<1w&14 zbP=NDmA-^aUM&>#!6QZj#FZ8kGQ~mi(}~QIP?VB5gJJ<1YpA?uH>xHL{f1*v7{s_< zr-o&O)mEV3WE=E=Aa;;7w{Hmba(B{Cg@-Rz!^>!Kz!aB>Nf!hoh~>&X=JghA+<*Vp zXj1!olX&YPPy@B3{Ad8Nsd~5Cf$07j<&jIfKQWhr$(m@Z}k9YX{QcjJS3U~t!>xm6H`R%lQkmdV|P3#O0u2^ zHf=ToOA;>;D%CptbU|+y8C0TnuAZKm3;CYw95pP^M3rWq970flht!~z1XvP6coLqj zeUTeaVP>3sFKXY=)cBK`i#wsPJ}&T2RVBAYt7QR8>0aOti5B(nk5w{Hfy?Q^T{7o2 z;z}@LtUNSsy7E!tq)RzqIRW7K0m3!W?+JP}hmrr+>81KTd07iBtz*UCDF@V{2vRMLRFUV*L}ka2aB5R&kXXv|!6e$~c<6shZemo;8aqs47ZT4-aZa>3 zyO&PFZTI8bjcqx;<|h!V!J#hm@M#3wuE{sFdYR!Hn4wKlRdyLxU~~cJn=mhxZcl0H+m*)3lt~jZ^T;ET<R>Sa{m^ra>?hvA-Hj&qo{jOacc4THx!WwHA7h|5`*Bayws>eqb9`!Vg0 zHJ)le|Ii=iaV?S)Fxs#BCh0f$Nwg#?av0>-XA(`Gk}4BOPb8$9dBG+(jmDC0zlkbY zLX@RG2BSMcSM*vk)M4UVYSQw7P0S%ptetYOq$kb_i1Ws1o9Oh~RQpmM#vg>Lk*@<@z_@-G%znUdW zBUZ@Stjq#S53)${OJpB0F}xbd)n^!0UTZ4A4W!!U*1u;s^3-IrT~&F zSwx~s8?=LE%phN=r|`zM9^6R(*n@RuE9g~XW=a5=N#KS_`4et3j z?G6J87PXMcCN?N@HDx7jOiDa2s$G^#dUmY^KA76%v*K$8- zOp4Tt_LSVl)i$~seW!^|!vx+DW}Kq7)YEqsxQOb+X7tdBOB6|l);rU_3uf0+XWRzd^a9Zh^V8`YSV!rvDeN;qkSsaYoeZ$6yC~aQjE!#MZovYU(#|~ zHdx!w9uXRsz?0Jk%@cIk_y?X%y!wcjO1<0>=-DG1Kd7E7seRP1*yGJA-N4sJ)_?!i zo=?yhNo+YaGf)Xt?4wjR?a(ORInB-NToB!A%!_2D)chNjIo6Hz@WIf0>Jhq?v$*l4 znbS@OM9<9Xbq7Z;3Y2>D2-fY(ftK$zzCh+_>l>FRTqlL+&~N7HdL!3d>|763F|^pJ z(&|V_4@(k@YE-5br;{W{FiJ@6ERNSDub5kk% zPvB@o)X_T^c@wG#vbNV!Nh7`{bnHj$aW;u=BfX#h)(+ZBLshiz*dqS`dJ~{wlkxev z04zk=A4(;c_@iY@-Ne@Azk$gT5)N>Zo>1gWyPt(tjrHcZo@(A~Gc4Sl)YCI)2kBZ! zKD)=SUPeqBGY>g1PeN}f=HjjVYwfvk_I_qh!c!R<=HjbI_k; zN6qQT+epv<*9=<3P6N?xAbl`4FsGvq-gVr??=X!WvFgqYd7_iuA;$S7b@S7kB=QA9 zB+>3PzIK@d#&1IU(fU#i%w!oRyu`%9EQCJlug5Y{V|!;|t;Uq|YGF58#rbqV`_YLQ z*}zis@i8h!vU@F+4INmwAe5h31~9|Tf<=q(gV~qj#@&a9IoWq!;W+w7Xi5ALvNi2A z%^7F+VCUMC8ycVg&|gZbpQ6BnL8E8xXBEuHrY2`*S;utFMf{$~!`L^) z8PoIO=n?Fm!$1Gg2H0|ak(4D#9a+B|EQO@hon~^`mXqnUZjD(VQl?UMl+HTCi64AK zq-@kPZy@U~*z8r68y+5%rOkZp3GxjDdSSBNIcm3sX+L12_oECmxk#BmM79T7TUW*r zh8)K!E~MDLm3Hor$BmKWHH8VlZ{Hr4{{WYdWbzEDlT&&r zHrRDCr`{=FrQ;r%CRxg+TUnO{{+L=Y$uyg(l2MzVdn_)5HJM16`V%JR3!iQitA!l>uW4 zmo~BQMY-!6qf#$2iLyya3G$}@0E9%yh~AY$$QO0+PgX)bd5n5^cBLy1Q%Ehkk0ERD z-&pkU(5cqusz&QuWDZGAU&9`w4hzq?uNd31Has+3n^HVgDmH`3IMXwVC*F}8qejgV z{rp(i@=x2}#f&mf|I`g#V6rqL(F(znp5yCa6W~|aR-~U&Oi4)_Iq%foN_1tPGlZYx zVpM2Erm9Op={5(DllUS+HqBE|O1Vd;hm=gDod>EmFv{fK>|DpEh7Wcx$~}X_N@-|+ zRRIzsR&wlv&NekaJLQhE=#OB-|J4TEpLv6jwojD8vJ9Nb*H>^nQmk&twk35<~>cL){`L8msg zgR9jWo*)0#=bq*IbHgi&d>(n%)z6}B2t4Ycx0_OVJ<0NjZ}YqA*MJJlN0^x1a=MLQ zB}Nu|k_&e#pK&9o%Qxyd?-KL3mw6vGS)59Ta_q3UGp>tq@Cg_5=Z%*vYhjO)C$y^Z zPjllG0e0sCugPSC=(!PR50yH$5Ld}k+EkTH82vC<6s&cF7b&eWomfo~2h!}J=_V$b zA&5AS;x)>jnP19(6mF4_b7nS_SQZk92d_H4ks_qkkxGWsTyPK>N<50c-w`6DjEo#` zPmAmPQM?&x|JUU?-6bld?;UOXeQHyGTHyVV_aOOYout7~0`yy;}j^1E-EsHpEy+`27%&nT|; z{V6fKiDsYRJFKVy6u%VNeCmEP4ymllAJd|tyqepGfJh*RY^-rmqoNH ze=$y+#$95>!2!jsZ1QTLys4b0-2Eya03U%8(}TQ z-_#;qGDLbJliC)}h7OrBrg4dv0O{_M<&b`qm7zNGHnG!}z zs3C)#aGCmX>-I;GVgJwzJPWG2j&7gPQJ~m2VQB3d*FW{h5Hx=F&Yd-(pp?6qP@! z^dJjc&l;PON_b&mO(yP;Y!IB?B@U}~b)6%|dRKV68lw+3saZDy=A6Fy)SIQQv>@sf zqs>Ey4lyP%n5E7U{tW-(}l%ale*YAQw7Rg@>D z50)e}J0a{NfL!Lrq($s_a0*#qrxvYFtv>Vi4r$B#oUpx z>5XeASoIzpsl|h&O+lqcDI&%uAwO*%7=QoMq^5Q&SF8X%-IQ76ko3Zjm=OwV7L~Dw zoehxcr*ifpoIVb-ERou&k^F&)Y2{R{kGRp`vOGJPYm!Q_uP~K!DHA8w8;MsbrR?;L zbS)9xr|gQMvbtKTGgz1@!aM}3JK-+ANw-8SBxN2l_zx^gMQW{vu9rzfQK~P@p)S7S z+;Kn^DQYS{ldM^2(2~18UQK|o=6S}jVZbKlH$5>r?evdP;mdgSMAVV9Tn%DUGh--^ z3_t(Wp=EZPAm>4uS%>U&Hwc9t3m7zqeqOsc;SQNuw%X!2s9VY}8afi%jg>`>SKAz( z&#B(%K9#A(46^d7DngxD;#6&Pp*+bQE&@El!gV+{s<=Y7+IBRkZ6=`QMx^0!_ekUb zN=LmyK(Gk|L1;FpRH#7qCXh)FEBg8%WfsRHk-d1AF$JacRtivih7z*T(|D z55FF&G>5lZQW%!D^;t`roN&16_+}*7bqnwVkmVNWqBSE*oRu8P`{mGL(Ge|{00A1a z(_z7yJTU1~b-GVfddw}&k8C!lw~B$0rH0yVuuJog<`V4nB}+ZU@fNA{Yyh0}FaDFkxqzCBy3h>M-m;hSigsaXA|4lI|jW^#%_Bo7YoC(_rdH>Z`; zwfCc1u%Cog>+U4P=p=igLeSgyHD9sD{Pv9d*PPQsR$a{h)(CM1)@t-6?qz3MS+={j zQc^oEr0W0{3ah0Bu4t}%^<_(%npSt+QCf|Fx{kcG1IeUKZp3(*UR5U5IN>D3=|QV< zb6Q7AJus3o-K;srjM(ai!y_?|4?;J&&$+6jxA}uGNtB{8t4z)i301W%w2Or)L}{34 zo;{IY8y#Wwo6$wXpxI6vrD17y0mu8~sCw^5^0V)#6Y8*IEq9ra>V`q_QAf1kPPS!fs4# zk%TGLT~WEIwg*w^t6C8q4&nZBCID<;ZvGcMQ(&83ptE$MQ20G==r z*6Qgl!~nK6HSMGXRHmigk)xquOv|&G4xMZk{*9hW@ z7Sz-!Ov*OJykal#2kNatZN|8^vgJ_|{D_0~p;C5|wu(nM%*&FpP^=GH7H;tdb~&|5CGyBAib287NH zL!=F((+Hc5>!faYb?J>*-ZW;&Kf8=}J4xD8({(zdB4|jy!!1j$<*e&MmRxZ+vh833 z6bgBss2R%fT^g3s-VF+&nqxhtNo;yursj&KA9pu<%cNOut3ZT=q!5H_VW3C?097sb z%LpPXCxRw1BTKI0C8gQ)B)u&pdQD284FXaQRWGf~xxCOn6BA;~yT-!BG@_xd%*{>G z=Tjm}Dt&iS3d+*bk4UYsqhWu1QkwvE8pL$Cdd-?AJ;|FdI7z2wohmOnvO!n@M}_(G zAAUE*#JQ2vMWvIr4TpS`th*wH&=r|(XaQ360F6bJ^}|?(=A4ownN~^n6w)_n-mPWK zqdCmKeQkVxxR;z)pK>G7)0cVw(OYkv!!hFnf@cs6Adl7sf{Jt2ttxdi1DsPff;(t4dr-lr8JhXYD=U(uxlFg+&tOdceEAon}=z5S_4K9>RlGB))q?F5@>Q>NM zP&Z3t^hi-03FMd@)RtDF>1zhlaI~;9U$XwEw zEiB3pfe))Fu;u_zCjECek6*DrG4HaJD?4wKpL8Z>a!`VJGUC*$_5`o*#?JxlOx0qd zbTOkRgY#D9;9T~^7WnYVFF*g%TMiuoFgPZ1XJ!H89-|1X#;T3YNd$^)n1-TSOzLGW zn-DdKnW>hM1Ny^yHNl5GZ zKy~uRxM^1P>f(7)wQAM`w65og+*Cx?DW7yHNDD-uDk8_;r=Y72sI^xqRO+EFxGSs| zSF;2i2e~#*jM5gFR@+LzHwspNCDNgW&slVO<-<;T-inqPg^OKWXmwOyvt;1^3{qnTZ0 zSLzVE$~jF~&K9JCm{3K=;T$rWLDQf1Gr(ZU0AY*sAmx>!fT_E)_J5T0hK*T7Xz%q z?k+3Ea>H17YJ#10PU1E9%ethSv<|n{*C6_bo;2t;i92(2$+<9+;mey)2^S--*VE4) zCVFt)eNCIFiwNA+oVsORe+*8hp-p!y!$ltNehXk!zZOvD{gRtw%SdW{fuVLlvh^qo(2T4+=odoJYY})6mryKSWYs~-E zRgS%Q9uqk)EV^tX)OZ&=4eob)5Cl|e;Zm{+HbPC%^Y{G>C}@tg^>Be4ua_z{Q?2&| zc|Rq)TMR5gh*s31DRL_Bc}9Uk8*Bg)IoO+$Pcej=Q(ve@&=n}KR330%Q zboT0^4_?2F$Bmnk)+Z&Y?iC=AhQJBSsXFRKtk zE|LnXjchmeMck(+L19x>l;?TCRk;fwCr&Fi2QcIT$~|yOo<|xjCgB z1+}oZKP+r&bw(bZohfN4Z(erPTZ)u#zzu9T#>$yBbwOPkle1o=NFc)FJmem*+G*7yuFX4@X7?9HLLNOoZR>4l{^@6Rrs5!4}<2a>EM ztBAdg%AOGFc`pi%lrSof|JT&On=qy9 z1)@+yTLJW|?8AP=svC$bQ^Pb+xamP4ioCsZ1>I=bgoVhI<$yuEQiymslB zX{zcHRiH{qBIf5^IB@dD9y4>~W>J!*D7X+oB<9Kq*h_9HD^gAF z3FznmJo?N`sFEjC9Vu)^!<`v+SD%N3>pb+o9zbe%N3_s+RbeNyPUm_2Xp~M>)@7v? zsbr*wogJg2yH8*w+7EJXCpxv&zzfPepsCcjhiw**Er%u1D<;@!hQJ9({Cb#YqX|-> z3wW5$w}3ql@1h@4g;D;IN2k{&U5vrYlNYqSEYv= z4PQ}iTdRz*a7GAMch0$h~X6L#8fF`6xj!Jgr3ik znTm-MQ{MQ4Wi*9#q!f#hz!SriG;&@-sMhtdYn1Z$R;8#VOPQd`rU0(HkL$+9r|341 z4@mYfdvQ#hSJKP4eF7Wd zn=FzA^tWttGocYW<#C!*Wklu)1lV}zl0tx$ zfB)0zVLS&?+I+xfN=&qnKyhJ3NkHeBS|lFJ-?9<#xht*0;y2>*l|t9REh*j0io?y6 zOYW4lTQiDrVMP2bJc0>&8^5?3{Gqtz&i6IdCQZ`g3G%$*jp_1ryL*W0<>~D2BgeTi zp;2)yy)eTK6%6j7Yjt5Gh)NVdx#50XV%8TRhtu3u#pS9xJHtB&VCf78B#M1GpxX%T zB&l4~qHakrdk+mzfLNH0wn>1ANQ{Co@b)7QPvaP2S#7Bs%r90Qa*O-o2lAeW)Dq14`CG?toAPynd&Qi$SDGGj3C6)3NZ z${lR$6_rHxBD1ZSjBRQ)xu3vZG7OU-OnP{GOucnfRPPh`Pj|O~E7INVf`Zg8v9K&1 z64D_oAt6Y2E=wcb-3=lsp~BK3(j_X5h|2H!{`|h@`#tBL{e#1qojcDw^UU6vJ1=U0 zNNOG3^dE6m^>y3xXwg5aJYi*X3hac)`Y76+&jPi2uLWP49aL6UI>Jo$tnL>9Pj%-# zJYDHt1E`Bo0Dk%e2%7*|VpR=PP^iWf_#ZV^)w;dwlh?_->P)@it2_Vkn zZdVoZ1F>&Q#NOxPUtW#9*sk(GZi}2d_-J|761#5SJiGN&Bc}|MEY(Um?b6+h`Hbvy|@H{3Yz`{ z9IIeT|J(v~TQg#`Dw~m-4IHSmSGK$03@>ZvSLq0LX2tb@T~f{1fWK zW002LCuqD|-Mt(r^DqA{>jRGm?{MVw=T~TV{;)nq&vy4QGwyFvGh z6k)SV2DG<|^o)70WK&p8GhP0Oy)|+rwB`f4q>$W#bpHWzm)-++X!Sc822e--2?s9z zf43oa+uy?-rdK{~gse3b@{D&Y)kSk6BGM(0Pr4TM7qP8)0dGT=3)24&1w1sK zn0mMeEHwK+A^)+G)0kVPVc&;x5p@htMfxrD&^K`ml+}31{Ez~kLji`9xloNByDU3ZIK)K-=Lz*1)YV*r;>iZw+8yJ-iw{Hzm3YcH|yuzWSR-)P{j$K}v9h->^7 zBfDplP$|CIhVX z9!w1yuLT(}OU#AR_Hf~^fU{Ut2GQU`?k~Z($i@n8{FgO{Bnq^{1I8o;cQf8*;j|F) ziqc7d=Th!Akj%LX6SHzV;AxcAaX z)*`n|W}GkR<#`8|zu7|A?_5Vo8pe9-2FFml?YsGxFM%Kj_zPgh3&4`pQA~)e6)n+> z?b)Ge?Gj3@RQe!-xll%*;)U$4`%B%!E!7%t^^d>I`(aP~GBT=W-1$TH?DBpQ&3R<` zXQ6$=r`A8*-9AgMd~YH_Ht0NI z!_~==&$ay2Diqu@;5#5}7`B!NvXhQ}sO3f`qobyVqROo?uVP^Q*0{jSP_IkUeg2Tmr@^#J{z2k@J& z9ET|7iUoDT1Mn|Dr?3PxK;3qq+l|7b4QyPOvml1y&lqr!N%;fqgz8R~QxlWDTj*RW zgvMg3==}&iz+C0}*&&Zj&Ds9^wAc+e zIwnKDByFu-6tx>y=0wBOth_38B?%LBg@IYBK6t}1fJK}Bc`$H&+a?3Aiw<1_i&z9y z`bqw&+jpP+{Cm}~K=D>KCr;t&+5=Xh zd0)y7X-R(9EcZ}(;VwfVzkVMr6yIl~am8<4jL<`^0R<&5J*${M{~_*AYyoZ;+2j9x zmXJMWXH|w`J#}hZ`?-8$b~~)ed4z_TYJft<-3+`sUJgs8>NdXo~c{|VYm5IqOhL+rmDoEim6t2G>b-sxzz3ilM=c1D?Nz?IFWkAzYi zgTN1M(OoZUABVIFm)y|rF<`5-WcFw^7%(Dm2{Bp!1QgB% zFlWFigz+2EvU&B;^P8F;%=X@*6u$@_FymhO$>ln|=X%G2s8yY2<=&iQgW_$x7P=c% zRvAf`n*wQ)KNZu>yIb%&wE{X6MTbt}fo%l{{6C+sO;0zY&(wbA1CMgakv$Xz;ojXgUKtbml*!{$2J3TJP! zx%XCn&}RINSI(DdQEV66yyZV;J4cU4e>R;Y#fR!OPFi~nxD4`Va01x^;Ie?i{}yZV zKO4L@1*cIiot*sL1WcW%aW-OZGfMT=^MjJ)_)6)rhSC1KjE$RjI8vmp-hVJ(M)T`E z(TuV=KINPu+h|K0qMwhYdhn$B$^VD%cXW!1VU(yPWF1vNw9& z<>eV6QZi2`v2O7A4eA5Fl#9(wccXl$ialMR!Wq`B?&bpKXhff9g1^;*FubGC(P=nujCfG9s7R-i} zlk23jqqUCUVMm#A!jXa&Y@J8%2pd!PG4x-9c&*ClVH5qYJcVedA`gP}?jNjE-YvS` zVF}Vvh<~C~;kaEod3h3S^+~L9)Hf>P57~7!__}H1$HwnbFaBhb6-{2aZaFKd#Th3$ ztcEm~!k0O#DSCHG{<8G_(N5icsIRCLR~cW1H%@I=VlBAQ1$B0rI9*_($p~hirXUwoWtR?$nnV6_Q^>jT4fMq-O3 z3nl9FdHL&0?=juuORB_DgqW1GQoCbyMp>Wu-)}loVI8@SoK>oF!stg8Dy)MfHwyZJ zT~JMg0}JwEV(FYYsh)MH`8y0EBNq^U7VEj^z&&Ur8jXzL)2_s#q9bO|*s%H_Jh%M< z0{Kd;#fF^7Uu3-AoE(45w&?f>?TxY#ChF_4PTF`y&A%(=#bZRD4#nco^uJ{%Ic3Yp z;RGE>l{6b3K}`{78IvuE83fl7t`CTC+=+Gjj^(_lnzJe2u?=wKTX&n)|DYxlxfe5lg-O--@W*H5s$EixA_D-4}*0F5^2aLe|r9qL{4qf z3hN$`25VHWd~wgtyio45Qq6MM=!tV_<2Ft68D~mt1)@X91B!qSoKd@k)45c3K%8K1 z%xZZ@%ff~3bET%g#dCeGROH8jP-Knfv;TUr)k<}T)lC*zWgB)KcG#h-(Qals{4C+s zA00BEwoE)Z1M^GzKX!}0`mpjz!}9zb(1DDQfaDgo&-5wW)XB;H5BIwX3&R>*Ah}5p z);1JK*Y0C^>4G;O>%PoY3u9Jww`i*<+!o?%L<;ir?k=dLkzhXg&GI!muP z`$dbNMTYQOCEdjXy=Me z>DEfRSFafwQ97OLNsP2~wiwwp#p!)I@%JZdsiPGm?`~2%W)AIJpES@;$&GLc*b8L3 z|849={jqb@QmLlo@CU;Z#i>+}edA0YU-Km;LSegfy!PE>e2@6NXi|-Ro9;&@&(QPk zb=`3;UANCK1T7vJ8`!ISY=PM$*c?oi37)=DXOH}8xsvtRkTsNlIBa1RG<4F>IFv?D z;>H!V_PJ%n<%wSGRMsRCfezI*5F~_CZ@nda`s$lgnA5w1S_o#Mq$H zsCx$u3Kin8}Bsh$2^Rq$q0A`M-6i`sS%q%g2-}6pUO73W@2~D6q}t0X%N^cY>lg>IQBLO)UA7O}bENeVU)cRvW2PWP+Q;~t zUvMIoBZRiQnBO8ne3^v?&Y0x2>fj>&AyXU);+Kq=uFdDEpUjAQu*_AtE4<4`PriTR zr8V&9vul$7TBVE>c^9F00)eIuiO{4-5=`^lXFMUvuRLScYSw=hZzW`ET=|Cl-5x=B zrLxacAuc};w`cqAmB34mao4?ldYQG!ZVq>|PMVo+mt4+xvLVW>kcrmtVSIA8g*5N{ zN~W1MVUk&<%?G}mc_~?TIbl5ad@V2=n*8LQ#8WBQN^otoPznmWZ^KvW1!c)IkEaCb zChEuA4nErG&Ha<@i_0xJLwGv0b<1uyZ0NfQ{AitTxc)N_biVMqy{}MB@zHR#Pkl%^ zh`CHD$m&l)aU}aBzg2TPtwfiLV(|6TVd)HbX)YfxOo=B-udI+kNVt6U@JhJP9S1;a zz4UFi&?U28$j`}=qJpSk)k6z=gY#hs=#G`NzDB=ql=)T#p;NlAgB}1CKCYvio3DTM{Zgw+`x(W{Apt<&EtrCW17Ol8ai(adu@x z&3HaBPC~`tW*T>7YVbrO=)@3jpcJ#7_`=2fbmbX5OafV?P_NW(B~lY5pp6vr(1;nA z7Ob2f!{*z#H&Y{N;xzS4HiN6&zBHAOon{=d!pidJ=q2bV4r`6!LM zf&xc`W=7A@#$ut)o44I=_O;Mrx4di%s8EU`3 z?b+lEozV^u?ymUo=^B%2=#mg@K4FOuuLLJGaj~ZA*E8Z8O_;4XcSKZ?h0t>F;vkoZ zeMg#k>lh9W(^aYzpj^tsSr4IMJ+%|xnaaR<)u?p1t7<$E`$*uRkUM^m#6o}OeH#e4 zb7CF@)i<!=OBh_)H4uYafKLbWrH`|edz-+`>;GMQ{tg_I=>z^N9>RCzNYUX*H9k@N!g)^eezjv~wqiO`)p?;f0MzsXc*%gTQI@YY zAznzn@Km z8@%qg=eh89z*ZkKk^xsm za>cK#GsCUlW41ML^-)gGVp%ZHy*J$q)lMlE7FobPSDBx!T*$2T4jRYYR3SgzH}{zr z8ZjoVY)*l+XJQD>B20&@&EPW?$v+6+7S3b45KRl2%cpC?x#UUU*H(C;Rb71}H>M1y zec90m2jDvW3C=Q{Ma<6n=e{Pq5s3Rg#Qmk^o8?x4&y;pB4*x zZ6uzXq;cr8u;ef-h+fQ98&WH|yxP!XB*tdnNq59AaYp1!5y$s(lj2<@`Q3c`ppy za!gTtlEGKjFT#|}S7P8Pp+yQ*g(Wt5y_ZzDH0i4Hzn-ZZTIaA-Mc|-TAPk}S=XcZg zvewe63W4(@{J%8#4n${HKY+)N^loRE6?l?Q6J#Xom;zK!gRTWvlm0ZkrP;j5nd1)r z;U6(M1r7a?ht7PAKlZ252>(c6j$C2tJWjU!nXzm7#qsqY^}Ho%5$h8QxiK%IjxY76=I*p}L|C zyT(yV2R{lH#;1+B?&-VtoJQ8`nbu7lL}DK^yQzkxM~1jc#Zj3)zMFZTW$7>S-X78^ z+;zS6CWy<~qzURJd2XqHT`cLUQ%-LSYF2UN^V|WYuIWFuYcbYg`P}0L2BP0#ksY@O z@ljPgYivR#Is}O;u@5jca83hhi>=+lu3lOEyN2_!7F z^nPWTCq5z#D`v1W;jFFT>sHI)k)g2JM)TWjuC1<%>zVViQ(VLA+Ng5O;x#z&%SiZi zca-)hsh63$*gt@rt|jhf71m#+vaH~xsfCLM&1F0=f1N1CqILnyqLloWpfckok#CXA zwgQ{(83m1}b8|>PwxxW2Ryi7=)E@TObzbMKSHuyfQG8aqbM0m|h zbZ+mgi9f%M_ZOZMoU^#jvEP0XY12Z)Q2-QKtW$Hq4wZ*>tx#zTA0;AIXzMve%QEwD z?l?u^_Jl86&?qxUlDxdR&=gx|5)=YbK@^!`IRj1bbI;SUp7Tz zck=?}&e$9YmZ7FP!K4LWj7rCj3Py*0gjBL#m=Z_7>56m1rxlH~1S`ll3+?Mtrvwmx zp6)U597}_ydADWb)eW!lwa0Zp^j|&kU)1^5Mx{(c*WyA1)JjN6oaw0jjUgi%;F{p$qzCTs zk?{JovE-r!sfeb_NB0Dbv}iCNENTyx zGiI}KMU5w2=u*o|ohhkHd2JDG`y6V_cGafP%XJaUS=>qWyM=C^>I}Sf5>p;?G zA8w*PynJK-pU^--gR4mcGsNy&o5VRV_SqOD=6x5s)54YnQdE?WJ3?oEcM|7_xO7aR` zo%9G`?OT@A3#@4J+%5hv;9p^S*x7{9;{)dvU6#arMd(kx8aycx?Dm+-Z7@Ie!1_agDt3_sjC zk0QBiBRHr!sk(Omf>unOu`oX$^=_3V_RWx#D%)rN3-wT{Smf`*ta0%LH!bZB?v=@SsPM`$qOgGOa;z$s-x%e4hZUDS z>}1|sjJYju((&R@kuA=!gCYuPkx%4lB>PjH3?aqOS#}uu;>4to!8+OC%R@t%c0H;Iy$ut8aOWs_huLq>%6#9T<~ z51ptn9V!ttG9pt$9XHiL|KNbD2R4HIZXFx76B=yc+Ddv82B)b=Q4U#@x>XSEnhiG^%UAIiHx}1+3V=~e{-AM>HbFV@6V~x#Q3a|f z842V~dfz;*{6fzsSCFNLBK(2CKI)2j!27un|haBZ2H(Pxf(&{@M^PY~p60{YB>UjM%P7&KgSBqvR+oaX1b9 z2-atY{1%zqGMT$bJwL%8s40nr@-4x*%Gd0-#p~w%;x(47t+^VbwihgGAX=ge_41RI zPk6K@AsTPXA66HuMl0a!Cs!6nhL@LOu*QXir*R{P5);9v1RV22vmEvDdKw#t)>7ca zqwn7jWu|-%ogq9kMR@b0N3)&$#`pciT6tcB!91YM4jBPJfA%Mk#O4Rh!u-JMN?TK z%85o!LUt=Dk?fZ7zDhx#-~8rVqGekVa=QNct8~p;{Vx@oQ_-M6U+Q%JCb&8DTjde; zGn!~TrmTxTxNav&arLh0^9n>^RKtKd>%`($KhP4(gi~{VGb?|+HTSBF#%xNcY6&n1 z`lXN2zUYW=)`-+TS1vNYf+5P>3cwbxZ*l*a6%4T0grU(p4or2bDCs!UgotPH<{ z8){u1iN0!~eC5bjT(N3|M>uQn?NdC@EosA?i)?qikd)|Au5VCb5zrkM0%;=Qq%JRJ z9~pvp3*-HiZIi+LY~KGl_y;rgQ}q77iW5|7p{6H%xJk3B)c zgT$cY>oD+E-n#&jX0BV}rSH6DHb>yK&-^x)mX@9X31vdOjJR+75P94c<0+>q!&Bd=Y})m@7~UzSf%46_{;#sC<}$b~Lj<6gRx1x7Xu> zGEMthM{piUU}(`d-jcs(wYi-jvwrK}_eD3{0+U`Q?vc1@(*3c_m`ZncE9I5eSCD3b zn&Bn12xH;IPLoow4Fnq<*9wjQ(pzw#U`MJsA%!kvOIJqRt4uVz^Bsz1v4@rWg*gnk z^skjx_~t9Wpph9-)1dU0A~rz_`-u+C(67CeRb7Wd9Cz~)_Enu-VNYo!#buI0Uadw8s|svSZ^&q z+U9SVn6~EHCBcbgdP$GTmk{{~@0rJjdOad(W+6APkq+COJe_XCT+g&A>K9!EjHV-f ziJ3Y;h^rby1Nk>md`pp9&9h0c>zvihsnWdFjybi{Vz+Li1e{vQUeM4egnJEo@TB`7 zb7qB#%#GXD0h=5)-}p_wa#HZcj(Ls`zuibpX=qk{(%wkFv+?8)pJd54M0uJfpJ|rh z_J_Lr)mlAT&W2HYm-~pd-_`GO;55a+j~DxH6qxHrmHbGsUaXz?uCH42D7lOQQT|M` z^v=BEW@8t(%=3d(8)Dq*h22Hs&U9#x^e8i5q6rIyuJRl#++h6BEcr#gz_=jLr{SC| z-m~WWS7P^eD8eIKoy#2BuQ8MO~2|{32t~(wl zd|6~VvcG4RDI8){;lT2B>aWq6+C=SdzaL=NWlb6Bwwv6OZ*Mn`r&YVbey6Fl5;FRT zkyXc^(tplAkzQh7hitH~1J4XDn+2#VIZa9Ug$nC5p>xG4(2Qii63=1Ez;Utau_|wc zzQ3}dUdf3X*Nf!<9|EUQQ@0NBhiD;Q4L-NUv^RXx)4V8y1=|3Z7lz*t(*k()x7p;Y zFn{KAm8r{eaeg0bN3SQ^lZv{E-#9(wiNQkdQjZ@$0BS`f!Cx{d@injM2XwUI&!u{XDKp+y7s$xIy44}pbzu9k7)ycDpyDY z+TEsI7`lFU=C6AWtjJRza~8<#-aHUZhM#Vasxh4brMjml9(z8?9An9v01s`aMDBR| zaDVZq!BE6=STgA4oI^55>OrN0aQknE$)Eln)JGL#$)rUfY1KWNH2EzAy81(5d?~1( zk=dUuie!EOQ^JDImeHOU5r&!AwOr3KxI1DfY?qKZC0;xNK~g__yPUz6=G_VZi0xHZ zV;ZUHWo4tg%WgLA=JrpWptT6^?kCd6iB(7l45Fm7=^!SaWBS>%%KpvgH!EmjK5Vre zD%E$>Umb@x)*AK!c1aD9&+j7WQv3~ChV|4NzR>PaEMCTmh zS=agc&Cy0xkZ+TenBpzGR%p0+Z75X7ZjMV@PX=B~koRLydZ-9dcEsL5T|tT=aQfUY z$G%}-0vU$GUNE~ks*K(WG;oMhktm$PeHb=Bj*2#I1P^LK&r+-e;qiQME$m+i`V{!A?T&KTPr%Mw^th?c< z2*dBDhNWeD@Bny?8(XQxlR9fY23B{Kzymu==HRNW-T2}3kMmbyc}Ch=-Ata%+*#g2 zF0QwO+O_GlpOT5@k?PU4*|yaQEm96#GBMDoOFj(~EPR1t9EfyRqjZ0%DUM+nx>$5_ zwX{sSFNF0*<$1;3tSdcV*jh^sq=~qbBQ-+N%%HWs{b55|mD3BpR~-7ovj*5-yxi`I z(@}+>=}|$4dhdm-hjASdHRyJnB_je=eFF98 zyXg9&Z59x>x-0Q!VrU`<{v%47Y~NNc{>Nb5zKgAr0S~H~_q<(SPrruWJjD~fMS45D zdbq!4uu#?>hG=^Oqi7*3M2?jlJHN5a5tQ#@eBjo&olsVfbs#|{;&LP6Xt}GXj{t^8 z!${L~+G)i*?c%uPZlqCYLNh&sSg2p%`4I0k9=4Sb)JLip zqRXCg@3hIlC36DbqE^u9k_K5=TgcjF6CdVFb6;v=GN-cKQA2BHJDq%uITSEVLMngM zc=HMo?eV*43V}k;p~z7pIlDb(Df_IG=(8NL^cGr-{Kls7&PGd&7&>RgzgK>ljSU@G zxez&ILnmX3PSj4U!@7_SUi;~>{5_1K{g>{3;1h;Ugo93mD@SFVODnn+=0~&`b|6~C#5t#NY?zs*_$McVqA?Sv9M-mcjj<~kj z+AQ~XqZJhNir|+xE<-(~YZ-;Mrbs5w37h~@c)rnVOYM^e6JccmmQ{7E>C)W+PooLOA#vd?WUUcG3u-=iODR%VH^SEVHr)kO{aj)&CrsJw zvk^?1#ovkDWzzyTUW!Pey%9_%Nyq_?6jX|DOUq<%#K{8P-?8_;A)c=16`N?oHF)cl z9KvS;{5yevPAm zBw@*AX||$=RpW=tgu7|-=&CM%DbePHfyu6HnB0%ViQEo#9kl<%s}eOK;T(H_0dD5x zkcKp^s(zMqCSh*YQkf3a9XjVGdxj5CN=m#Co>U{;p*&$(>m9YgBd7ILJtcYc4;1oC z`nS4HOQ|^s&)vL>wZD%-)E!nvP5@zsEaF!_*jb+XCko-+)<$^t6&y{wlVJMW?{Z2` zHj`%3n$L)*d}6qVi_4BkKW;7}q4Eir+P)bnQA_00;VQ12(``6=-AWJ1$Cl6c!w+k@ z4#&7xl?}R~>*+xe^ly;#b-Wtj4<81)qE`Hc;uLZi#uQU{bXF&nez;gH(fm|=*5`pq zwW#~Rckj^${2M;+$|W|wW;%0@C**TwEV<`%@!+_?lNEFo(D%`7>ZlxLT(sWy+D`pn)u8epRrK&lIf9Q**Epo&2A2^QtUI&D= z1s8wF?t%hqck2bkEGxglGmsQVVZq2$e#xf-#kYfjc+baPCg102;wCKXSpS)CGt^>c z7QMmx-S+v)Wp7}KVd?#=-A10PU)zE@^XBR0npLDKCFIZKlj1#ht9(tnWS%E<@EA*s zzbYxxBk@|Sa#%b>H_0h{e6>dU4CiLOOnSXuHTi`uCs?w2}iwz}Cd8N3m) zU;{&eg)hlQT{N>%m6l-t$$$d(IA`KpuF6xM*7G=qR0D&lYUxl&<|wj-OdH=lPZ{1@ zJyF{ghFX%|*u<6H&@W27Z}@ekWOlB{H$t@W7h~d&MpB1z7lld6_O2)0b@z7V`km}Y z(mDC|=?1aonBDHvXn$8vQJRvk+Eoy(p0su1+f?95*8zFv&u4ZM#bqdzxj9hWmO!&a znk}uWNVvbH)TG*BsjrLG4Ent=pQ_WI^3K;s>`q@6hn87qd`1SfS#X_XGWg|9ObLSr z)YGP4Ohb8RKio5PC1NQxcB)YERd4ireYfax?Y^rh09N%XvNyCL_} z>f-PTj@0S)nBL)U2JK(1yGQ3f9;{RTir@fqEeYskCNPg6{q zFck##0>h|WsZ3gZh(D&StVa}+XW6Hr)1@xKaB?HjU?BgcQm=s_AjVF{t(j@my4t&k zHc|dm`bVr?b1tX(XDA5PM?1d*%$pWHH4ri3uG4>0N)=6qYC)nXB2~QK$S~t2V$D4{ z4u%==cp`L0TY{uq#_>JG7`WRu?N-!|;0g0(nfwR8zllzywC2Ot7=vHF3|Y*N5~waI zF|5z4vQVgPqn&Md_PUmYsl}%9oe$3`Ufi{#j{vP(;9M!#Or=G;&|ArkZC|fB@w>a# zJh*OK-^FyHziN4?w5qu2X!XcVc2>&ZF-(8_A;k|&iu)5&s%G8Xuhr4&lgya5TxQAN zFSVR9Fx#7?L>h3Sd44SO`+ng?$sm^T6NP{2EpMG_$jQ)5!qQ6;_O+eR;Wg1-_HtW?;&Xs29V-$AqgQg7Hj3_}u@yEe1 zqLu61Ef=1<87uCL)%Wx4iq2{EIRb^Puk^kqv`MTc;6zM-^}Z&i6P;~4^bV)FnDJ@& z@aZWToJE=`yVZrxtq5(vOT($#L%aI-e!t{j>H9PiX3`P2N9y*zMEK8kw%QSwiG0@; z(O2_yeN}!w3sRQ@n$z9B7hR0pQ_?1}jfm|Qdgs-7dr~4zvMRJx&nx39jNXsXHdOwT zb1_?5)47t?s6<$4uP5H`m1WOwLq^T?7(GVc4fAENd~!9Tzj|8r$YPD{H{wlXx>^I3 z53at}Ne01Kv65k|QUAjF&$HVtzQ;TUIv?xvqi0uiy5NC9?42vawZkL#hJ`}b9hjA5 z^qM8Yggm6a-tMu#O5b#GmS;Y_lj8*GIiGDpFI^97hf-cq8CDBj)BPD))T5YY$hxs>@DP!oWpmG_az4tm0 zcP=B@XY1NiRZ$&=jk*wn`Cy!ZBasGPpNjE0DbdSI><9c+vgf%5v67gzY-`Rcq0*(A zWTGicbv00Fw{*_z1bpp5@TVh<+v(GBkG=G{$nSdQG7Fz}d(~yRig>~Li81yh z&n;y(XnzOTN^*BwfxbuBIvK}PBMc(=-K7M$?Xqb!ygRD1G~Qmc%_$#fbK-c;b1 zoceezZKmd5ZJC93;ReE6e_dx|g%g=6p6eN$ySRhN@Xqq@OHQvGqG@-G>*ll^?uj2k zsS3l;5oIbg*xy>&4GUe$#$%0zOHV)aEA@B0HCKDVdpGMSTOQ5_$)qKdNpVDb2s49l{_gV4e<0_6HPaC)nEHs|&-WRFMV#(1w zGSwexrl}uP{d*b~i+k_>=%);)G(67}TTJWd`?!wEq9)tK`Zi-|1zwQ^{MWL&%)a!+ z!C$6y`X+fzTqi+pd&|7_tDVV0yssF>{@^-6*{`+2H!zEb{mPqHbOPeR2U^cf&p5GP z*UM}?CVRN$op{lwZfQ%T-P*=Qa|BmnqYk8^i14?01ap53wAU={s#$6jro7_EA5*X` zxN!?4?0Q%*{zoB!&a)q+^Kb-VaSrjRa)OLy=8o`svb0f5*O=0YbWqf{_DO@$B9Ez zzDgdJC@jzREU9U`p4^fyXH})>9y9WR=Wy*LLyqfi(}Z>{tYLzU2kkTaXj(tDva&+^ zzFVs~o4qcCaFOU|jAPjw>$vin!oH~RvtA|644~ECF;G>X1(0qz&1n{~jBqJnxff$K;_U6G?B55_LBP#Zo%*C0K1fg3 z@7m|0vGCF1ychKy{sdR^O0`aq-c|1M=#7vogJm^D5>d*MnYzU*5asUM8qfp--IFbw z+dZWrJ$v!+3K~P|x~DzHrp}^X-vw?bF>{m6w|wz3x@;kn$FNlk9OC2Dp6;3DQ@Mm) zwD0ny-y)VS(_e^YN~)0A?w;zLzEuHR#BcYIzxRyaM)NGR(M4iG8b7C5@5Y_P?%XXn z1Zw*8p_I4>dSjlRO}G~zpUOP+xW$Tgx-i&Ec=|L$8I4vvFoC;ENKb~&hq&2c(N@lp z#yopB6z4qOBD4vuS!nwv{HMs)L_5EWa|l!JY*XA;Sz9CE%63%y~MSS(NBI&~u|9T%$CR@)d~M8vezB)i0$K_KTv=2;Vzr)hq@6 zf*JttrPtZ#W^I)vihj1KKDCBWb`PU;BRRPZ4Ar%0UOimYb#rkdk5$H%5iDwVTl@1U zhLfkl#Y>=nr$cb%zFZE`Ar77DyY{fPVzmzelvApW_70V2F6FSP&aJq7SdfTf4q04d zC!~Y4K+xawnBldTc0g5B!iaQ$9dVi+g+SrV)XMw5cY4>wJ4;DyE{@T()NqJ4Bg@5~ z+!>G7;}IQ0-wHWBV~CHwT{CL6eA9tnx%So5SMAeJge@jAxWxKgiOyaTY8D_0U>yA` z7U@B&_BRF?#zkOE0ao<_m1#_Lrxc9A^CbVtk=w-HTELc^4EkUG*V$q#w78p4ZE5*c z*4XvXhWyXvkEIu+oj(~P8c)A*$d-ql9bH6q@Mqc^WEW43gke^{Dw{zm`o*C!JlgUb z$al?*%1f}aH+CkmX(Eczs!kcMl-^V}DVMEzn3_F1q?=l`$FWej%qQX&zA3{e;am{VxPvhg#$d`cqfk^= zb+StH8j2T}mZQ^@nP(AwQPvf+v!F&;nw4Vyo8d{?8HG=9OosckM-k~KOuFX?&Ne>S zaJE3w&78(P)tXdFVPQgx_{d=R7TXPe#H^Tdugn5uP^1xrTd`%x9lYQ(gvd z4IkZbc|8Vt$69bV?H`3F?j5|&{yZwJSx6C@5s^-}%UNn(QT@jvkDWP|kB`--m*3o>mZ$%G>8=MAHE$|%L z*mw{mB8~Nw);*a}oW#w^r1ZkVD4}LpYT=8viQ8QM*cIu;xKokca$8-^F{fWz;KR>F z?aUKfE1FOSt=@^Y0KN4plTeIp@sGg|p02mMvk#x{o8`|!ewo_y^HbV#{Q=-r22YR?Xb$ax44-^aJ@%Swa?LMfbO3||j zoxF;ruJN&Vb8bcZ@)kB5J*q5 z3Urr@^VyWi5z>o`WiQJrc&O9P@Pv&wG!Vr8M?EX<6QQI|Q%Mne#LQNoMpJ)|KQ)yf zqO-d|E4pBoju%!;hYoYc;-sjI&K0}`^{MVonqApFnoYDb?91QE;L3cg>r}Op>*&*A zW)0EwI?L>~OAjPi1Km_S;k-}W6mu$?H!OP`lyCEawK(fAu@ClG?o&p-v#mG8Q`3}L zNU@Ie+e1SkaB5+IabBc)X;XcZVSWK*uVPju{URXyv4q@@8FVz=Hk4NYx?&pDZO_R+ zrdj&uCyK2>+RimymzDpD* z^`!Obz2&I9Q19l+-W}D4=*diZC(KBQsOR*v+PoF6a%xYxC2jXz(|OLna)I(z^t;@I zK{5;a_kbx$?={G|9`Y%BYiMj>9UUivKp&zzSa&x4xpFh~nH`wBUyT}>i3UCZ>*~^R3Jf18Zj_%hT|jfkgZ$&|D))v|C)T?K1`<| z-QZ|8LZnk^*kHt9G$_dE8Xe+?ZV<*cVt~X3jFK1)ij!7K}KD&;x-!;#o<}lk$?jwV319XZ5bGDk6pd=(L@hxeBmpZLIWuPAEO&6|MmT(YG z-It(0OP8dXDG^nPJQS=}TwH$>Eq|LsqfU0Q?%IIW!(n&kL1s(hGy0NTgCRZA&a}H` zkKX9r&6-0~g>(JX_}M$rQmCV3K+Pm6<6xebc`scI9YFuR&lohv!Sp0o?gpYhqZVYG zoJ2i+eFK7ZcY7I1pk5B737{uD>@Ix;j5rLefA?mpszO7i;6DW$;h1Q#K&@)@U;ivn zeZgh6)C`Z1No|!KcL{sTnWnLEvdbbzR@}a7sw5-C07gOeDv^g>DsRv4@#VkOdUg;& z0-ck18`-Qt&tiT0icS9`p9f}K^r{+UW^azrO2$QAJD_gfK>2=d+c9kPQcG)*y!)d? zSK_KSr}E*NNQwK~Tm9d;-p{AXAApo*_nBA|i$^%*(Lhao-A0;M-Gy45H%^~MJARO_ zW-EQ~w7Vm3FaavPpAG~RttB6Nb6DN z1*#-^2rn=BN6jt?Bf4Cxu${QD*~Q&pF-bcU(*n4QEt&A2kO~>DDkJHPyd6Doai$zu zyB%W`(W-f4RXXzy2z*t^y)W$_DPS&Y%hANKn`NF@JH9!SbFF7=-&`(&w=C+soz10CvOOsHbbsB};{$_^>qb9Tj_ zn>4(Jk_194QRNJgV#BEoN!7f(yU$!59%1p8?Mo6VH_sNi7CR-rj{9WL9QA21dxX6_ z&S9%~biQL9FKHqF_`%oAw+kHz(9(EnLr2E?hed(ISMKhadAPLtu+3zoPK7-*L<R&c}mbhqq*rR0n)Y$yB;6&{KAZu*<3xP zB-ut!&E&sXcZe8Zv9G0#WDcHt-S0GYrU$GPl4{foeAkoq{H`Yy(`QlS5)qNsv5)?fI&8bxWJ7Uf_GMNs z<#BS+t40N~9h^&U?uM}{Wrkxpen!@=A^A^U){+t$_1kYhzS*=bNLs5$)nR?gCDy@3 z(%C}E5Y@`+(i4QPBsES6+psvQtSy>b%Hj(?4EpBA4+a8R1_f=tq^fDMhe5lvSlhx5?ovE*ixoJK43>*ooA+rbzV+vJDq8+jT)kMOisR#CwWz+}5Wc9V?$8;1VoPU&5=#zS{_0yjMDm9(+6uD{K>dc%FBrKTkU zvn2f5(S=iOdE;Vcim;qquy_-nl;BAoLquf>t(|JOwdfC!E)U_P*UeSG^hxGOe%gDa z1ANM*bH)bln@JDu*1tt*iTJDrmG4wzrxslP3`jF>8ZmQk*c z@on~mtGckO>p3k>yp-apM8F%Tvs~2lcaTQ{m(j(=rf$9And`81lmt5HS8Z}*=S=@wq|zIHL^p2@gi!!#`LN}6uUd`{8K%BO z%X*94Fah%|FN&bxqW%=R4*e9Y+BK=xE@1M6>SjboG@_}lA*aPD!&nc0NuQMK7#ed_ zbl(SOR9I4<{DFb;dzlTOfG4edG`-w&99y7;f3b(;WQEkc;aZo*=R6f%)J<{Hh6aV@ zE*e;jWKmFs-FAtsy-{>cY$3$zUMvMK(l9z&JTZI13N>fp*>#V+85mMkHy?R5xsJY`fcasLHOw>CSpp~8q)-=gaS#b)PM_OJy z2KO8NK-#iW$k8r5Y>fyw5ZD%rI0zCI70o%ejO$;qyvr^jHQ>&cQwz)OHMW=c;89mcq`*l*^`1z~* z67Xki?NCWy?NTzX#9~(UXC0Q+i->OySXHXpSYjKr>j$qWv6qB+za78vy)#_ZbVF}m zvimaN>l?(N(Yc>`SH*fz%C1(Hq-Qf{g7Wv`?QN510vOV_iHH}<+bTl33q6N>cXa~l z>hD=hJN;V)04ru!)-A@BQGwhvo2dFHAsjmGPq4NhQh23(z`C#VXM2fR{Y{{lw`ny_ zaqO$8Z};sC9TZ%6WBd0uCRe2U+WX`P6p8ual~nO)6a*>iuR+SVUf&L%0dUXzOQ!UtorwIR3J6_my$4X(ONsvmz`p z&FJN*QqFExb6aQVF1(9*-5z|mx7uD89`VcTm_^KMj4YAFU?}rqk#L7|+$+0i=(aJ0=avL2U;YU_Dcu?MIWdZvt@@(4 zT>OdU54(W=;U|yvd-H-n#B_W|WOLNQR>i$)+&w+@HzM4yFqr-+1ch(7eggkPHMk!4 zjuT5=VCl;9-PsktLkZE<0i2`lMMEiG*XFIWK{BlU};;93O@qdgtD zeVH95*7fw?LhQ7OuY>OZolt6M=KIkv2iGU)jevgRU3-saZ-%4Hz0tQ$4z4kA|2gKH zD31Olrd7&3;q++>%y_c+)F@uM;6Hj(>Nl-Az29!cV}Fa^Ncp!IG@!fD#p~-!=ZvWN za30S5KL%UJ(j(@z6k&nsLJ%`A-HwE;D*gGBn>Qf3$R@?bttydsat4cvf1g`klQNbR zT7OadW;>Di>bM8_?X@2|_u#~-?22O=hfV4xHiA3eb`*c#-7-yg|5NIWh~YKD z?PMxYDK71ut=%g(tWopE%c}C1E8W&<04j=^f^eD(MeMl`-pg*-GH|V5ttq+E-(av{ zhiBA^o`bs-81{{oR>sMIykT}xc6#0MYhrX*71prwRXOp^y$GpJcmR~hxtK5Mg!Wz)kut9sfJ=>L!^vY$#pwQpg-(SljS*+r4FFW!u?bKY)7ZBY6ho zGX+_vo8=|$n{`1UHF*(QmgBWy%Ix45g5Qh+M^}<}ZCM;7Mt-%h_uurISBcpEo_S@m zcI)}RbfeBf={22BUh@1L|7P}?DS?N??Rd~OU9CUVMg4{m9NUOiMAMt~iBkVV@`Y#;&v&6flBemjUFz(!2Lewz(puQ`50c&U0s$_<* zrk#>L7W^(D(QnHA{SkLQr0ZOx!oHi0-u$<^geAujKZT_^%3m8CxX%22eKn=kszZ~z zIh3X`)B*YVJvw4}k8)g3UUyjm8Fc9L>l4$fs>TiGKj>=RIIXXKar>ZK8qZeO1y2l(?#N)Q)M(T`SdiffwD*Rdwfho4ka(mLEf9c@oZ+gddMU+rgK zAl!3&w^!doQseDgA}Y0lmnVWcw|ZdbzvvFs^n5qCOJl|^`@^%=ywjH~jksV!HC7F6s7^N|Z@S3904DB4IA(ILIjmU>S zq8xk}P-%UWjCWlsrXP(`DosOC6^7h;f~DIHQ?>6Re&@pCREJe0&@FaX+TasKz2Q3+*avnQcA(E?vHjVALwKovm_{RR>MU#~)ZP zhd*&|O))iihJRqk(h9pn4T&UTi%{#=@e4^w*W2NQpZ9ZP+L_)^)`WuA(?)_d1z+`? zsVrQtoy%6w{nzYD5YC9wQKI|v9}R;!?87;ULF=^swJS29A%mGZ3&IS?{UH6m($cK3 zqj@SwMQO<J;k>A@_DR7AphU?X&%q(pJw*qH`@Kr%98 zDvES^{E^VvU&OgQt}6F2VOri|*1TnAoQVbloLKRsHm&vu2w;2oz>kab!;Z66o5=du zue!QImBuv9@#6SXG_hXN-XwPh;-XX(FC9mPqPI@s+sv?UsgV40*XEg{%{2VJpVHZE zoAurpZW_!q!_kIop-FncRfz(34V_Sq)o72{tw?;!(v{CP^g}y#z?jJ5prr*Kf!`nI zb^vYL4<@q^!rpF{Ds<;Gf?sB*ffo}6fl0f*9Cm)S7Lk6ReSEfEDE9zpdXz$)kU<2k zJwRd9hImKJ%6)e-fb`viVP=euC-q3S0f7a7`%eU zgK8B@RWa)CZUAV26f()j4>lbuLr0b)k}bEz#z8d?`UUJR5mG%MJL@XLytZ#wPHv^G ztvnwCjQzh9y@x`PV?_gbMYk1qE@_F%KhnTpu@BF`&Q;PU9e>~kjppx+G?WJ2g*dl) zl@xk09ySKtB&;;f-V6`xN4IF@AYi>L&}VA`&LMzFyJ6JVzEu#3^unxZC>r4&xPQIQ zM_C#l^x9WBzkmBGKT8d+FE_0HU&9B+tVTI$io$>2rurYROnyQCI&RVN&z&0sLmkCS+`-wT+QqOe2tTq%#CBHU zXzp8lZ~1z2C-I0PhvBD{dhZrP*=B zD0Pva@|bc<*ZUk_d3^8RVzVNgR#~ikpUH3C?<2X4Q%-(7H(!aVsBoYCLHqpVFnfdI zq>x6kxx)>pZTmPSLDLFTVveD$^S(xYX1H%2)!7wj&n}I%6rfw2EAQ0SL5n~qR-FWo zZ*@|{fx|vv=wWHG^NYKS)3a!~hV9E-^xF{5FnYechUMASoy($EdCQW%A@V?{@2t&T zKnW*%G$c@EX*)J6JJRMRsT~S?>~PdFb?1)S1{euLJ1gxwNl=h0WzA&NKH;uChkwrT zadl%>{sU5OCQb67DNdzgLnjT8vzEH1rJfAgwP0{bANzPfPneE5d2|LPWmIeWik- zTnu8TyoJ$jK)IP>pX)`l#rH4-(7<@#HnanOAD>u7I#MP1DaO;?FwNbE5RU9(pM@P9 z24Z-;;Xn798>bPZW}z+4(2ahzR7p{h(B92}#v@U3QKcdW(;KP<+D-iq=ihH?- z&WS*$u=`Ry%j_6HXrI$@F-8*hq=TzUu*^@ds8s6E znZnU3&x7l@=G3^%m4Cg};^fTfW~rcth-3H&w?O;i_GhBWAq`77#Yt4Q`H#4y)}A10rN->Hi+WMjfqS)ytX zxzh)wThck+e0~8Qxl;y^)~T0$6u6vE4W*HgD zR@EQ+Q<%kPbmtWKt89O|dL3IQXzh)N2?ixDe`7!UW2;DLdE!0ltCM9W;ny*Qi+IQF^)-i@a0kVSC5yvs%EgD#}Id?evG}7 zIuL~?k-1-@eg$&9TP#marcKiE%ux^z4;+v|lk?e;LEhW~E;)#Lll+3WGnDS><2tG& zlR!Gm(X4}a80u;UGJ>Qj>S&p%R+iQME|XT7g(>f!Vi4E>TFEk;*DfWLtuj07|CAXI zbfxawBF?^B^PR^3-j2YwpapDIt(1@ zo+_oL?lbEH!6tC;g@<=f}n}x#4A|?mNmXuGmnoqf@1Ofd7TEQk6emnV^ zW|sVR2{2LS>2n3c8{NltN1of)721pygqq~ZMx*Q+XiFcqoP)+ln>(xej;4>BJaNY+ z6iXi9u#x-3ENs@}57JeAby+hxVaVj7U;tUiTUhgts^)EoQrJ>vd2!eSOW^9}=XAqK zu$faVBj=6Q?Vk!%D3ie(ehhDmb#rm`FQj}>pKvO~2R?}T;=8`wrG4p7QjnNPAg!Tm zBRJ1lR~G)h`*1RR(@XLCr|O!PNdM28_-Amj%A-HBAx|G6D%`WX4NMAY{Tcn3hAQFw zua^6pmh^t`Ytr<|9Yu$buBu%gXuV^v2Gb|!&9JoSKTb9)O*MxOjvh-A8?SJ(`VL&E zMLDg0ka}jRsQU*UVT-ZAnS}tB=bKw1ei7CKiR<2H19DyWUG_vJovE7p16nZ}Y6LJD z^H$Ozn=EO4_1pv|2%Y-ub))95h*ki*ySeARf2+5Ap8DJ{lWN;paxB0^e;c)i1c8b- z`CWsMOTtR-0?3QbbKW-FU|Xoo0}M<`n=t63c{{v-;{{m zM1sPmPbDhv3@pdeJy#~9(;Qe91u6oftr6>eKDPqjnXE#xQJjmk=G2BGA8iDz@@ro+ zR+MR=xK!uOo|!ze5e=>xi!_ChurHYEt=L*RVhFkymp& zxP@NSVgp1uOI|?J+*YSXF6fH0cgNFoG%4(zoZu{aY2hlrVmAA{c#A!oRQ^%S%nxaq zMIb_duTZnk2pW}P{KBo_mNg{#SNBT=58)D0u5vjVX)19RcaxP>zDPdHL>%&Mz<8g_rE2NdZaq6EF*=D_{XZ)r)ON6B7OLD$#<9L3rJQ4M1=E{T}EUH8KI#b9sSC4q6fUv zI@R0nhiZyswQ9m$sgyL(@?zg?`f^n2mrY)W!+Ao7;7?HALZzi~h`NuGnQ|H%ECm<@ z%((d|j7y_%5fT!Qdn%oyBTvSzNUFj9jB~*EHP2j@pk~XCKp4;RT(>iqSubP?f+7f} zym4G>{>GdP%hQD5Tc66Xd5t(R#16=VUNe5~BJaz7$zd{n{UOp%V8|4|?{;h&%DWNf z`(|FEQxrglLz~GUKXN}>zeKPQfCsEd?(Ghvd|gd)Hz&gC4X|(0&a4>$qVzr zHB(;O`(nTm>z^d|sUBYTrLkTotoveB+1q2D3ndpP6G||&38!6?t81;P9r3MZ2Zz(I z4vcb7y-*zMZ0Ww3uktRT)Dw^BLZK@0jfdiTMlOV@N)%5O>D--n)aBkYxR*4x9#JPE zXHJA}O-Q~ouqP&?=+lA^AxiID$Ed_7E_IXpN6?^ImNbhc?>ZYrPDK|iYk{z*&9$F^ z5XG-5NQ&PV+Tx%wi4!6LpG8ai1({_btfs7iLuVPQuv@m(kdC7GYcn8QNG^nR8?W)U0+^}B=SlC>K1i58OH$dp+%zk~$ z7j=rl;R^kB_C{|N%TK=*THo|%d{TBhL$K|vj)G(iC!_Jnmmo@3X@%^M@i`N%oiUos zEdam49nj^?_H5||!u1`Kyi_kI$VgPs z*Vl}@)6+53=4qn#jC@bLuUek%i2dS0Thvsj-r3$cG|%=0%6U1%L#x`rLUM(#QrTZl z#Q3(j@$yFzk}wYVh03v_BCRFoVDH#E>yDH=2$CDU)H&XHTrUm(b^J)vg>dxA>n2ki z1l1ehBIbl`ou1zD7utmq6uKD=Uqh!1ZOu&1i>+Bk6e4%)+T3#kRxKJok@lB;;qrvp zdcF^nuY5pUdXp+y-LTC|*h!9bRQe@jdUAv<7J?yK4?b+&F52+Q4w7b>-C=4jA48p- zbn&1``!vM$G&MV{03_HvgHW|hv%OGk#rZb*GueGrQY}Mj+`ZQFwuw@@SF z%+c~Dt;^aYwaGp=vZ-J`C4S4^y|4vMj5*T*=AELh382C&?OfiVbfj|?ZGS3{>lhow znn`CCm$idld{V$uz8;Uxgb?rO-nnZRZtFAE8f;W%$9N(db=RhPS70+l_}an&_!0>W zdt1y_sxACGa5EJ2j?}UsaFZ|KF?Bbu4~$u<=MqO@t7QY0S@wzq^MP2v!dfmqoV-5vBtokol1wNzflmz>G zJME+I$zb|`O3^5UKLcf~e1t5X(V4-TcXvcy!Fr)JH+P3AOmPliG;iJkcXn-O4#G&> z>xb!YH`G_F%h66LReS-91{wcCwi?-&Iqo7zL-i_?gY*qX=wWe+JH>-kk!jAuqUUaf|J%s^-V?UE*vyj2W1F)LJ zq2PTa_NDTA-NMA=zJqDypL0|6QyjJ!7d-wRTRB5u59LZJ;e4RLQlo{&Ej6@vS3|fg zXjQs-mU4k%2W~;`<3qp9oRg@gdDTzZUHrs7gm1%&?3SlQU|W_ayd!f_i@T|37xkH+ za$H$dR%Ps*%`zL)FQsM1l%X3IN#>$z=OM)|p@RX)9*=)Z(h~I?<;Ks=2FJG4u=l5t zVf7-G0W7o`@Km|y`STNt(oaglneDwRG5SbPn5Ew>h>-c7XlMNIlZjWymW3U0PXxrD z*ygL?EtKl9uGlc|nlrtKO=-?(*cE0N$L@K5Y4SP=qqNU zl9+ElHe)^&AX=@|^Pa|;#0Dv~tnS#GJRop<)r=~KIU%!>^*pZfv%u1^4<6KUTQUep z^s2LU!ft=aHQAWP1WAY0!;Ho-<1N_r3V$*o8pfr;*Qd`d&BFBa zM~FIc13n3^*CqDbU1zmvNn67qc!+;?|nZ4YV)f= z><1rm3|$oZIq+%huNJrrSX3p>O&=(=r?k109dWa@BQ1kPK4$B-hnsg%^XdCP#?s(| zu}HP_SO>|sv68?(mO(QK7A>*yC}AIihYl7;=Zk^mbX+yKrz44Y0$6Ess=5K-{OU71 zmwTO~aYFWixy7{Vl1qyWp$bLCbu?_C|GYl$^CaMyZkRwz_c4u133UW*HCU9eAUj3sGY9y#6;xMB7?VvwwV@t3oBIgS7+H2te)E3X zKMIZLY5&jnsY}v0qTQH_5<-G?b~*!MJz&?v)brm@?_8fTb8jqYb&7@RBqfr(7n2F< z*9w?@=@J^(W9FcklN;deag;KLV>>ej;UruQog6~D%2exHs6We#M<)@5g2jQ4N9kGu zWT#S;V?@%j_csKK2{Oxn$##@LXF(@xz$UU6u&oZ(_`DOd9vB!dJh{VUgbQj=xf;Kt z(CFwsspmiTWjf%?NA7l+^xt4&BREO`uQk00o8#E+m;vswhgn8)NoHO8}g3J>^!We97=Mq4<^e5MUY@DuE6zFw3Zs#M9f+%(G( zk>Xo{vEK0vG`_#it$*TVUdfl7p)7+CDuJ+}HV~3BoiI*k;9Go7p+dc3s9}|4~wbuV|85qRD-C) zeC~ks*VzXx8!WcQ2?udn4@Q-#g$-Z{w$_+h4VG!N^fg4im*kh*)%i%Vc$nLPXkuBb z8-KQ4+$-`^evpei00#F2RmCHE#V@*CzXJPKxwz8XIp)n)q^q#2DhG_>R|{Rvy(L{= zv{y78K&mQWZsE=2aW(pnK^hhB#fe@GBE#ZiUw_QJny1IbtY0oW#VxJ}jd$7GDqrl& zfVQ5K(HkvPg$uL*uJifA$JW<<>YSY@u6D&1kZ!Zbdb#A?rDZj))4R1s!QRzk=z{qm zN_ma<27v`tdQMXBW!)7Ga>2&Y76RHT>-euQXMgt`>uqhB|3yiBCvZ+U;x!icTWV9O z5#13>hJ2ei0&Vu2NII=L3B?{)CSMvE`K-h?+v=IypGj-oI_f9a=|E4M2G&xn5=&Gx z*yo0LLPv))V27{*SYUPaZh%PdeScNj#8>+5>m+B`xT7T-D9y2{Ua4d zA^8f6z6w&YBvI||dN2PO?NFA{i&-d5{zDMCYy8>6*JSDX+Aj9auFYztRj&Gl6_qwY z@AN**vjW33@9hVwnMicExv8G*`{EmaMT(G5BUPVA2+J-0^40AJN;uQ4U@dx|;%&oB z9x~T*f#uv_j%h^v;W)8}>QzDbH=~mN_iHSsvHlC~RL)~&NC=f%x4&hJ{d4ODft-Mc zWqXmCX+CJw-F(_7`3;$+g(W4B#Gvf3ObVpzAuaXP>WiRV;PUSqaX-*TW4p?|Cc((m zk84&=DvALI+JZEf2VsicI~J=I8ME~KC6$v1CiTYY(6&doFzX`|7b z$;{a>2D%CI5e?g-vp$FIr^zx0g}xGbb^nJs~q{b-Gz7$8=jm_z!}GaC&60ixtTS| z3R@3DZNDg}VGM_szE%+~{Tex!i*m~hooQulgj0m5^oRCKIm#Y#y-?^OY)0Hqo)YTF z+>Ke6H%+_Mi5|L>;bp5p-j0lcFB9-o_8qAA5Evc)E2V(L5*cizpK$U@Kx(kwi_EG< z)O7M@bTC!E=r|=VC&j-NNlv2J3`@E;o`onK2uc-Q`P4Nz&V|1N&%pMQEb-A3C(Vwb zz0j`Rh9_>Y!C-HY$B%7?FctnuIk4h%BS46?3$aWy*y+Ptj6xeP$5bM9fhNs=4W!7A zm9=%>2)dVzt6;r+N^P@B3p_}Jl?BYU5J_2@O=&2@^ST8dDFG{+A=N3BsF#Z5sQ;{$ z9*PMS`iTOU6b!K=oAS-(X^R6a0hj3K)1jy}8_q@6=spBli_NyqyBuThg+qdSSb10F zJRKU9QCil%aBXyh2Ijj@1#5s_;EY9nm+KwNHW{s>diQ9%iCtvV7n29t2Qb4v|1b06sJ0*l*@ z5#lYe%U195ki?C_cPvGNES)PVw)So*t?(lS*ISRqUg-n1&Y7(27{^;3kdL!HQXli( z82oD^#GDVIr~GB7Nc*QOuBP^JJ>H@_>X(uylX9n1N5OZgrvR4AlXb+ZTK10K$u zA2;rf)efqS!#}(Z(3d!GZhOJ#hxC>KU&NCVBNs>fFmrFt z;gBY!Uv<#wOc*qYNxRrisqku`^W%j{Yw8oP#_sA&k*cLHZZ;{ks=WKlH*XX{H5St= z9_h3h(nkCs!^aN+Thk~@*tzPBr=|A*q}r+JY4GoJ$pqoLoMmPsrJ3i#ad%2b2A zIvA`2k2z(TxPu<-;7Fr&15np1%CE6ac3lH&s=8hJG2^5?=Tj(@?!NyXZS@1r(WFxz zKw=1zAGRD<;-D>U(&D)<`U*X6nd5}^>&xIGWL@2uLKM@}^rogs=!BFF%WRJ6()|_t zNAW5mwh`*xxH)PbH2mjBEUk2n8w|a5iu7ave92l`_M=Qn zV*xpiDM6k?=1y8ZrVmT5v)1FiQO1YK-A5b{Stn|(c}EBRabzfM?xptk+cc$t3@>%up^C2k#I z^U}zV2*XHeVNrhwx3Yrvht|9kxvDDq#T@qux%bD=f}IHT=kQbbL|sFthxRK1!vEMn z!&~O@A@rx~kV?M|Nq=J$ zZU4nYt`6?w%6VhuXoXHlpT7f5fJ(?!FoN8N3^sS?(1G^_X~^+{W@tOyv0o&kQSkik zuuT8t3~G6HQb8?gfoZ2ONMiycqi#g+A2ief8m#T;kW?X<%|I;7B_*D)9!8ucc9`+X zhG0mfSfwC(dM_69p4_&L#W~vPcHrIAW)VsjqQPGXrM7g9)x(|4!PSC@~muBMMfJs+UZma$o7D0f$-t7xFcc- zVni?!B-g@d9f)fHI!hXSXK&?Z#jMfy<~xdgI|%L&|l4%C@i~rq=fVXb`p-J%^u;AMQaH9s@x~lRP z89V%T8A{)_2o_Ol1X{I0$`=iQ1<2zdwW0j(B+SvuvRmz(Rf8kU9Vau&I+@zL0j>5E zl}M8WuvsZFEMI1y7Tx-{a+?@|-kH(+{#XK7%IN=aCPEMBoPCL^Mz95{*Z>?I83>A& zw*%G2R+XCPd%Sl-xR!+}A)ivkLCdy}1tf6Hu0K7ezOwMCoU{(yfsR8wGVHeh=ZPet z8}RspXdq1_o67r`(5y0aOnOG=3{txLMAodR@h%#EVEs9s=(q4n5{@xcqy$PFsS3C< z=ZRtbwV1j3#59<_pL{4!kggEr2<}o7@}$E2&wWrsryWsoDUqUwy-=5XpMqweCZKwHO+ZyxFb~gvZt~8Ac?<*6^{m{2K(h`j zzlyqjRvDI+2==zFcu(Xa7^`y!Gru=@ zG999%2RJ|wx_9996foTV*%6?F;i^+j%}&#)PV{uQSK**r-jAy%UaS!vN7wf)$3fB| zmn8_>a3v_(+>ZFakCG7Htyzdg@8Vg=gO0^c%4bF?zAb)oWfgChvF>=7G^~7ygZm@3 zgs_2YAi;CGfFFx#qx=!WTph@WYGCDanj+yfb6z^u<4=?icI6Me85(* z`*2&vef5s5 z2FvqUn5!9(KQHN2=mtx=Ytg?oEcC>NGk@93Cwq0K3vt-}ld81Tu7!^Li3>v=?D@-B z+DXee+ITd)gf0!JF`aQ);Zcf_5R?QXYi?4HjFnvcqcGc^A0fN*7LWy>f9zd!iSjn_ zMD&p;pAHl6GCs)1`9oR_p0Iz)E*6*+;0+cSwdEUS_Lz#OF*xv+Zi14M4Z?57p=f6l zhk7f-R_09#-=4*V>?sQ_?n}e!4&GwR4Hu8Wv^~~5c;+wG))Z+H8{ImsM3YILZ!>KP z{uRyv38k1>g|_zz1VqqE1K}GA?|K+!3BPX;sJ|)}q&i&aFAvRsK)$=p0@fpzP5iC* zmI$YEOh~(R6SR{tWV4fOXL@6EH#S9&^(=3l^EU-iCH)!{TT|>1fKZ2=RN+%*o{Ey# zYMtzBn>KMd(mw6t5yrQ5igITL1>Kefods+LqScIlfVO}5KAeH@f=^X>ISwku!yHu> zxgZPg7A@tNgP(@dVP?-s6d0YZ8*^Nr>|393 zixi$J%I_+D%e|f_zNO?&@HMSTx!Q5hz$Rhz5V&KLY!)LEERXp(~J* zX-n^Vu@d+2+lHD!l6oR-MPV#M>@89sSt%11hFZ1X^$ujq1)?%4gu1V-Hh$QEf z;McK)t_XT#Bd8J!xMxikHl*|fk_o`s&E@jR2w#>Bsi_{fCu|WUx0+J3^!giW-D}{| zvxQNHF^(*%PV*p|ws(UG#dMxKFe=PbMW8jkjM$cqs;aZma$-;TLX>;Gwqm&2v0YgK zAO{FyK>$*Qb1t6*ggpW3|F`)$^&m7|tQKOKoc?=uO)@b)g0`ypK;;3xG^9o;yx zrFR%!wLD$mWcTaKSeV9?do_ktAe+rLh-27*-|x{M7}ujgnwW(n;3M^Pc-mgWiKVNh zW|nhtWb~RuktGm~KVGm2ZOADIA=EB0eSgp?+H9C6@Sgpii__6Uz&Deh-$YU+qXU9G z{6)kOlDa=;5#JDcQfJW{9=_q0UvccOy|GF z-JqVKiY93J?~z~Ls2zHm;F3W-21T#qscL1NK8ZHtU9i($_{n#~34#YU8d?xq$+D%Cs9wkGZw znBrQ+0=H<--kkT9HF^A0hf%XGW>4xsw)v^7JQ(jfrXB5=8E99j-ILbYTyE08-94*& zlmZ(g-i8n)%@ovz!fQ1S)oSE4+$CO)r8plJ*uRWP>Z1!K!h$!)#iE?vM=WWNHN95p zVd$}85oO;bWFYP&Q1wWw;YBB`*AZV6qm3nv3I3+EBJ@uJ;p3rBRc+ekZF}fb0|;q1 zuT!`0so%Op{94iT8zJlct=v&(b;H*@zPw{kcv~5o?l-u+#J>jyxn-%Zt;E^zUKn1x zLf`-9-%_XZx{@r%(uxz&O9?L)!&OhHknxyUcSeH`%LhjEc48QA!jVK;zZ$T@v?Hnp z?8!BU*y_6{(LAo%+-2U4kK=C8=^b;#LQn~N2HAj4ae}|s?5djb z0rC>m;DQK2}-j zghL-zsw|NvlM}FLOj< z*E^m@AMejit(_&?acF5b{opG_RS5368*I2oHdH8Norm~%r2nEX0V4<2igIwPHGe&=($ zcor-1X)c33p5RMwJA5u+9M=T@u?=bHnb`UEHh9{pt~K|tgmoHfgB@`*9vLH}iD^V> z*G4A$>|Ny8825^TGAfP>IK^b|6MS>J#VpP_cb90x>_Qsp;i?KG$m_o>H98_Vx^BK| z*jn1ThH9!{Z2Y)tO(osFtIdK9wZisUYF+Xrbpaef&-kcqzZwS2(8Q}xG~l==!4o-+ zPb;w=eQ=>hYvANy+o2c4wrpotPjjN=No|;VbpW5&0do|x)K4vpqS0=%#<~W^w2Cea zqXe+YS>ll-))$M2=>!!97m@XVfqN5+oJz2SLokwcx)ereSywN}ow~`rxrfw;_(hBA zY%ri|E=6S za$u97>1a+VR&e;__)YM*1bn2DVc{VD=CBD;taT$W-!AY;lFmq(`+xB3<$GWU=72F_d&~b$l_@#DN_K%)1624m~Y> z?B>^w2$Y{#tbL3E(*RODMzgZ~*Pg}JtTaV8GHKM=jK7%`>DjvX>`vEhn=ZF&6lU2& z3qwu$taO0E?;ZC-nUm(dS_BxWdyzB{H`QUk_!7Fz2m~Z+=$U+_gRMq=ITJ*Wmy9^K z$V@pK21FT8^aFU;4eT>u6z#o8KMC9>3ytj<(t;;+wU5=G;4sv9G0Z+-mExxYezW$Qu*YLF^aV-nsJPLz# zvIzelMQ7pAU7Itn`;T|fd$P*lZEYzMtj*+jk1>H}N7!_TgY(e>Gelo~7fOW6TiryA;GN0ObE z@u>PQx1~b6k7NAr{w<8@581ldD2kBJA^m$VljR@BoWI zfMHgult)cb>LjW?CgJ-s$)e2S29eA3lGC$>{Wo*QSFtWf=ojQtwI@&s7KA*mi3-Q{tYP^waln(OZ^<5LF zuxOA;9;2 ztN4suP*!xd@0&E22QNhfN}5#2{YAGI9tXGg6V%?CwU4B`g+pKSiyVcey19&A0EQ8! zfC4uFcQY(;LmAsJ2MBQrKDgwAe93?KwCaH+O=cGZ?dT_t0duydWd0cIp#%KKpFVaB zuos~us3xaIM$j?s99P5)9RJ>=Qz9L!nuxy#hW3kXgSN8mDoZ1S)DC|WLkc^sdd3WqyY8LNdvl0UmR+5%o-JeS__}aCgz<-ke04b zSGs>(B0rmw0Z6H1 z)b{Mr^kQCNXOm-;Ke5eEpbMxjFz}Tw{a_&gckPI~K;KS7l1ls62>ykG&Q;I-zPEGC ztf&s=Vk%3~lOhfuJaf3t=Oo}kxLQW4tM&U*~eGgqI5hocFETQdv2np z)o%6l@{K^HnX%$LO_&YGqWFu5UDaPS@jjs1uyfhG8b_ztQwUct;C>yOKk@S*;PoO* zr>3BnP`Vp*?)D?yIV5S^Y-$o1XbJD-QC9`bI>np3Wr1Go~%ZUk2wvaejC9R=4MYiZQqn?-y9%NGgd8^xhL+xphdqnQ% zELuAxdLHIZeSN*nIosq1k<_D-p5MFrdlEY$glo%5H>3T>?UODsJ%WbED4yBP7t~{| z(v4lwHS+^DugH>X{B57US*S(0cftNtWxiwyqFQ!pZ3L{XBd!?Qqw&KAzYNI!=0zP^ zX9+Vxqk$xN?e02Fns|*wmjPt~J6;9cb({URMk*;u5%&(!36PCVO!0*3H^kSq(F>}> zF`GJu_QFx!MoZ+CZSmi!-|G9^b{s`t{>hJLoE5xLzFTcKK&)O-dG~KtxxQ8J*D2ej zVKF&A_chZba`cl$5O#Ltm*ymQ-VI2#Jz)C6+PI%MAJt^WFy^L=-!S z0EwUPI7-Igw?0v7rs!x4=lY#=lXC0o7t;%K(j+7u*7MF%nfOT{Y1yHh& zwI&O~4;lDk-I=DF>M%;vrogL5bt{owb~%W?%f&i>{g7KWm;Wy`)T+8o!Lrke@Qlb#7DiaKHM1jnwK%>hDEBz z=(3hQ3FFME*vZI>h32c;foV`5YDf;>jq1bwG8|)3ENQ?G>~(VXX~8u7 zY*E2na}gWX;&A0P8B0&$Zl*tL`j9L>Tqz*?Uk*2aX-s}7os6R>d774uc4Z>3+9mhk zRuN6R9V+to`)l39oL$#x zHA}OC8rx422c_!PTHEV~&x^iHn&%54wC%KzjQV<3;AuZ*x>{|9cUJaWT$!QC&ELtd zrZ8z<-SSQPt?|r_sF00yYumX%R#=N^;l`)#&!`6ES>#3HpT^fZe;8Y*)-vwo38-5& zQ?OlSvUe^zJnNUf?_@-_)jAEFGU)v37=pQcg7YzjV1p3@DN}YB`DJ2%PA6afqEOCm z0M9M6B9tlR%b?vm2y8A#yrJcJVZ=>(f34FQux-bgLF8Y#(36d*#J|E=-es9ERN1q# z-}TpDT3;)rdH!!sDmWn?Ylh9;+Gdw){qf6?AhLzg1c@$QUvs}D_rfLg-HQcb2Yc2Y z@av~|3Xa>3_Zso)-NuiqC3B8n=IGe^o#5E!Eb)iq4=!yy#gd!hNJP6VLqzzv7otwe z=t%umwDFy)L9sVAhXa#j?ctz-u{rp8a!pZj`NMd6R>*ks$`=`Bk-X`-1r5JN&ZC88 zk0dth+vX!Wn{ogsXRQl!n;iD5T~9~ifoEv0h^cG0gsZ0lA-`|N+&O96U2pNid)GS` zIt=US`2E5pYP=JAC7New%X}d@Wpp6S8L#1RKofM7&ssIwS|+P_gXE<0C;*AON((k} z@@HvLR2IFFYvT6-gz99ze5}B|A0HqF!67$HN{-g-f3pz?oL&~4A&oWVr(yFQnhJ^R zw^1gUBUZn)$GQXT14~+BT0xLn_hlZASq^!np=#esIxE`uRikQywN5AR@1?oaZddnz zyRMNtr17{=yiy(gc9L+EPxVs((W6YR)1eZR-ax9Y-E)g-{M{wsltZ|zw-%eH zma4t4&tL;h_(zsHxy~BYVOR8M|1UIB_+%ec-6_8VN=!bln|_8s9vifIgo`7?oWMaD zs-`v>yFT0p40nm=qur%CS##R8Rm2x2^)anQ;pnpI!o~D3y z@2SDPw|Q!ui{(aNY!#+Y^}ffc3QzC`tl365TSNQ8J9?aiM=IB&Y7emP^NI`41l^v> z+YEDlqLYe%+BPQ;u`ek&0{W;ZcjVci+jc=tegPMckL8jjbk_5ybCt2SH-dEbH}bv) z#6GHgv~b&YQbF}R=6BatF-Z1d&5$M$EZAEFGGU`?z3m0 z(EyE#`Wy20wI7nGfhTnSUV-DpJ#1->%A#U+wRtL_0?p0b^y=VtL;FTZhtTgjpZrY8 z^V{r)pm}7FJE+S*wwjAs<9ph63~!r$ijG^3T~lJ$ojs#((KaSkknU~6P(LRiX;vGS zY#n4t!4?WKE+tMGY8%Rr8cy88A13X}nLX@t!hW13cJGVkR->Q)o7a(6H4-P-((qTh zQ+Xry$c9fPXSiqgCQ|pMr_49Si^4B{919%oAD^sT?^b6wcjsdk3XhQ0G4~?y9EC=a zuCLH!{1koU#NmHqbDj{n6mh#*>gB=aN`J3~$MLyJh5df^aj$IPotBq;Dchm~7Fjp* zxyK}|E$cn(nphJjg9i`%t8Y0d+T;9Ov*u(T{AwV{gXxV3wh<*k>~6Sx!yX5jj4a^! zaXP=fPmN0~D>3_XfyZ}PNx^eF-PL&bFlWrXu(>P+IvfCq0;5;LUXJ~;E|pHHw(j%8 z_t{2`&%;F#9aZw|)b2h?DS+?sdPgLgO(m^ay9d9j=cS+}Juc78%uQQy9U*KG zbi#EmoEbL`(~<2R%8RDaS2@b9)h#sS4%=VS4eun^k_>>zpOrT@-stuJ_oGwU1!xdw zI8xzA>J8x+bgQiiIL^N&=1XiR51Q0Yjt3N)*bWwd^?pyn1TbfTAG@;hp49nZ>FU+8 zEJGSn2nlE3BjCgjP0hB6oHl4e$zs?hRsp&llpUAGZZXZU9G}&b_?(=T`c zU1OUkksqA{HvQw zVH=;)PKU``u5+EY$vM&3gV&t?ED%3RkDC)iKZ`3D$QuYRX}Q1N*76#1rB;}IN$chw zz_<99GaX^&As4ibFN3DmN@WR-D-hfy`t+y}_%b+qfTGeHrY1nJWq()mmN z>Td{jEFb3Pfeeo4^${cHQ{FaT>b~a=H)4k@4eVzdGrrH){af7CNxfC=Az<x#(_J*xHPlChryLTG=-hTQQPZr9Hhq8fC_zY9KpZEI*av93&9_}fCqa){W^U|LY)5B{v@I8m`=RDQ-cO19yc-&5+6jflp-avluu zbTLi!%HD?q#)lx;ey~o6wZk-qog$a6WtWQ~&VDOLf^=(JhQUzkiIXXwM)YrD zDM~}H%%V5CNOJqGIS-?=jQh{=4w8fb6;|J!ydwfGurhp~0=k(R{N{=pt3);#t{tQz#z<2#2@TNr!P=b{~#vJb4M%bGJ|wC0SuBT^XH{ZGwj* zLbv%=nN|)Y$I%sJsZboB!C`JchESfd>P!GhB)y@&N1)B(MbFW669%nZisf(-`)xQl&-PTeb=PJsJ-m`AoCW>RpvDYI_0IiuCyYg{;hc}0k8{9V>^bEv?NOHpe@+&M4T|9!$&dy+7cPHRn2mTl3jbzW63T-gmb zxa8hb&e28^XEMo79!rZs}FIw0BW378DLfHbeFT?s$S$HYw zzae8RZ2h<;-^{k(vy(l@D;usU7=j@i(qGzu;qxrf_(!x$E83BWOCahv|CpLIN7rCU~fllNOtmZ zjF$M=IH%&T$b5xf4Vt#!c2_x=&PHBT`nCbWf~-QpP8Vrmh|gEf`di=1mM#ZP+jXQ zijof)JcZH7811muW3#+7Mc65a-Kg@hhDw-L%P;r*`!f2tV2R1PyyJ(01b$6|g)Pn-xGNRXC=sc=1Bs)w z6W&|Ty+%1!Ng=A*l(w%^(|rKwGaoUVt;4)Y=r?KT|G33KT851C@VWTCa6uT-cGyAr z4M&~>Le6V}dG@mEw%#GO+Hoa$H{)LUQhe*-Apzq-^u3Q-sz^uX-R1G?l*wT6A&n^V z>Ljr}bF@{8`Ft0J`|o%Au< zub;B@g0Ik=bIlhiU~KmC`!X*;?=ExR!!-3N?&@rfrKJz;Mj6$oy3R=4;>-=g%MPju zzf;l_>&>e-10sCk8p{z9d2U$UQ3Q^7DCobbQP-AmG#0rLCIz0RBDD*QQ`++#kOSnH z>_*?9eY=t}nk6r$+w6kLr212|7r|s84?%pS-I{x5AmL09`*6eEmwO3Jy&?3v%^|}l zv>kCRU|z@N5gy>%p`?fC%Qm4|wI+ThzTod-9W_cbvAoor1)RWT>;&_nFjG?6y`tTq zF!A&#HdqP4o}badz~AYew-v}^T#c~gNw2ircjwSdF;=d+#$As`tR9$FR%H=CyV_rd z;KORZU4Qo$*!~O{U zdNgaykNs@8CgYze)1b_Jyq6{-w@R${SvRgJbTT&bxF6u7r&tO+(sCk<3M%Ts2s^ewV!XW0kQU0*)AKkRkgkuHXLQ}7U0bGgdkE4&C$QA9u+x z>Gv)kkX?;y#LJb(Gn1+l$dN*dN8Tf@$w6sV{`}0aMISDeqZug#{lwae6T(X;KVFbq zGMwt8q}$%fVT1J{&x~d+Bf)|wbRNng6I+!2ipe6Aw}z$&H`*=FVsq#|q^hp<9hbQ6 zQ!BM8NM#e;kNO}=vZRjn_pNeOIOirbC>J^ng=)ydr|@SFb8Jcw2#}b>OE2^j)8L^@ zWXHVtSsl;Ku{qV{LtAn0Nwdba9{)*-{&XiTnx`SO(rX##22H68$oiYl#!pK6%hX0x z#;dZ;-kD9dR_dD1hp>b99=Wwu!bj-uD$4Jj_RO&G7&*ef$R$JG3% zg|!?>*xDQLqLqs^?Z)W-N_5u0g&aFSsPeJ`#NwNnd9d+HGW=mdqGDB^u#zGNpVRmlVd&AdEpVQ>3tyUR|DK$~&PtcQ{)L$~i z?=6Q@{^C-n9k&FuC`zZf-Ahx`gmKJn1_k0%yUD!IYGu#aMUU;+LlH4|YdiB3upC(y z6)568<*bTNCQ#1DFdjo(U`Ui>~g$)LnoQAl#Xgpp3V?q=%Kff(zo(oGJofr+ED2@pvv@u z6~FSQq<_0p&P-{wUQDlWIEg>PWjM%R;@{#n@m;8tL+&_?dl6`eD0G#3XhQD~p?2%I zkM7;RNd;Jqtf_w`If-d_`)fp@xn<$Z+ht|lz-8qZ-Eee>SKj#@q6Pj1D3G-VFCx>P z;p3lXuxBj@hZ{pt%rAtB!92^K!IwcUYnX7eQRzI$$iS(96$BGQXVJ2KaI9w5+wz6M z(+B(gI#9XZvG;HflMv4RJ{bmK2Lte$VSs&=kD^*G@2tCZ{A<}XQ#wOU>fdVSnl$Av z1#6@8%Js;>+oOOAKgCv?v~L~Cf$Q5@-}WcYl-c(hfM3h>N!6c1rNH~xaPQWzg+X<^ zYTYvKNmyd~Ctz(YduW^D{bDB*+L2bBN0mtHDiNJ&n~iNTwka7dRcUh$P09}P>U7R> zsP9S@jQ#J-Z@ExZ8^>;-oRbxCPDx)Mw;46{xl@DELs{}fnDX_AHiRf%%_n|wp582$ zQC+2JmY&&aVIh*xN4xPHk4BZ&oOSD;RAyR6J1pNu@ko>>6Jn?J+% zNb+7^IePWMM?jtO@UiTGLNgmhM9r+u1fqk>%y#~cpy8LY(?S#*#UhMgY#x^NU`784 z?{@fSWSuj)1&KC)>eF)zd9F>J4%ppsX$zgHNGWo(_SZ971YI9p?@B8_>E@N2 z|5nAXTVZBlts7xDQtv-%`7$p`x~;+2*^Vz z0h9mkFRyT#0J@byRdV@7{3~Ur4*G1zUuTMAFj(%mb?9N^ZHSexw zq37Razqaia9laFG)tdm*!q)c%PA}lOpYfPBg5HNxSCCes^w7@g2HP}5=otY={x7J+ zpXX?uV|Rear|jkbQKw|`QWw?x+_J!YkMMIyO!4N6LS4onXwsk@OXV6p+Is;^l1G;w zfAR6r*h@^I56*qp(dP)(e+p@=Db>4tR%Q0K=Y0~D-gQ~Aam<_Le-vSyU*0G(rhD;t zEu5AHqjgT4FtFl;VHe3DQE{X>M_kp41y6ZLWd7?1FR3bov~uU& z+TgsmwfKL=u2*f7K|<-DeMvR$7U6>-N%AP6>^ooVWG>9TC}GLpR1@|tPNMiU-P&PJ z7nZb!sN>F(TJSd&?gLlF^xaL6o@1&=FPZmhQ_D-XBiGnf?|~L;z2a;`Bg@dn7} z<|+xf;V8c-F&p}bVhd%PD=z3e!Qh+DM?j#Xc?X{#_mU!yd}uOXG_oXpsB7c0a*q?Q z{s32=SY7^2y@NQ+m~&%cnn0I~=NtJEWdWH;>%yvh!yzED`D};jt=PA+K(}9iDhDiX zDlI&1N?&WbUakxRth~QD44q`3iO+4vf5%O{AWYUVe5~+LL6>zc#YmX4cqXKsP$5I> zr4SRpfH&~3*F@ZfDKw}Wf)*D0y@bYR>aCn}kOZ6jK4tO&q4r__ng*zWNA=fR(p+3XmnH4Yh4L~Y;{;Vu1;EJ(4(Z+VNQx^prSEbYIy2I0IS zL)&xDn7nOR!n@G#=Xi3=y9fa#)P1^v$2y5E%xVaD(uCzicW7pB^>=7RcDu4${)lu#E)Z`yC+LJ7Y3}h7?!`UR3>+#Y3Ry)j8;Nyiv6;v15S;moVf$ zV>;LkFn;<5XPXFt7Noml;Q)-QvRSv2~_wikyN z|JUqC5C?0>qB3CPfr&8B>{QUM&^#&2D(KRDbKF}2Z@tr*XlDMqEX9RtWF+N=N7WQM ze4A@O`Uj@@@rtU~mD?UZk0Kr75O&<$kYc*iV(Q2i{e3YMZ(+SH9K$xZqn1r|-Lujt zF8DCR%J@ovG?|RA{YEp1<12)^Jy@~bWft`PP5zMd`Slu>e{-wRP_i~H`QSjrIcP9o zOB{P!D!VALf-yfBz~!wso&Ah2CpcD5u;oD<7i)z4#-kSw{4|~13@^eChTTMcm+*>)RNi=4 zcC7|y(jA;>(v2xvK5OdI)PXAI_$TmIGZeC;JNO!2cFb#!6AWA~@re75H;O_Ayy9LvoUO+?4 z@WOhrKZ5GWrV+?uns^YiN2`ZgY)8%Rd-w+;rB*)6ITZsYQ@@5!-c}8LLf?N+66JfR z$E_hWl}oL7s%X``Hrv@G1|QP>0V2k?^5KOJ8qRL+1TLMp~o3s#{U*% zPxfy3A#6^~;@A&7wNhu{H^DUg>@tnzLT$dZ<2^>`^SqO9FK9s%(YqVb;4Q{!e#yv% z9XyNhd098SvH=qncUZGXq1jc$e9!yL%yMG#Q;xKBFc=J)GJhNLn)0#J5r;T}@?jf8 z+tN%ZtB&Y=goV+?;+d`+o#X#nbRwDK> zCB1~a6?ucJE_$#djO$al8@0b-(SVMol$gsE9{?jMtX1>ZLNYa> zjNKmH3tCvY_Bd!mm%>EH+lsHNR%+dcR=afxx}?#Rm}}rcWTww-x58iaV6J4Y~XZeD`{6Moj|3%6^%|w297vvM_T__UvEd(cKXMPQXa}q zXL644@VZCxg1iqeGexMQ);nYVqAmz;LC=))pyJllau?xIn0U%#(hs(947yA&Z@>nkL1M9c9$YC!5qb z{X^KUG#DDi#`V~_fA8JtAJ}+Lk!ZmXU->QxmECYPMzGbsM9O~$^x#{oU7SUbOdyVbMVN?zT6A*B1+xg$ zy@dtf<-)L%9uJuB{S>8rNU7Fi$|!lSHe@wPfc#C^qrMK6GU)#iYt!y zt$vS+*K~&%+bY*NNB*Pm`Q&vjk@trFit1aUHxH6hV-??7V-F!xr@Ty-vqV=zf9WnQ zMJV-+-Dbg#`I@G=w@<}!3RslNi5_&*-v4VItkm+id4NEU2+~5uhcH=MIePnj~Js0Ws5yg}`(CQ|zCcO)2-^W5-g|u$Ix-tA; zA24;R)|1QCfNE`b?hX;nHKtB(`T(9qtep_amVz3!^)h&XY(mY_i8ROe2p?ESJwDH0 z>XG!2Hv<^e-M2RZh240pO-pyd3MfMnf1%ZE3t^fc=(FAH6ON>zr4L_bXa2NQ6$Whl zC+BbGd!TO1$9`_~?LVNWmSs%mefJLBQdm<*)8C}mT5+i#v(FPHCmOc+T;*axFkE#J ztYlm)lF*gcsyeF&csgGl`OeDOF5-=HinkjEp(i`p-I<*e%f6DXyZx5#tvdGKoKABt zST2B6dix_$wyY{|>szgfYwjqE^Y~+^5dtZvBkm*x$oatBjlVw`5bNZo$U8{|&HsQI z!L!5Cs&j9Qeq6d`k_m|{QyOb{D`#O%!sj+pHI%g<4YdMPq?sJsxYb^z0QEp$F(kVb zS(4P2;TP3ccdVaaJ$*kmWFPhFBp>?Onj zk3vWc=GizC7K&wVhjHY6#_za_Sp&dA%E9G5E!ueDvEWN=D>|A-QsNqC=9sj${KG*fHU zcViFeR_Y1A!VYIVw{myCqs$VGGK-Ex3l>gXW+oTOeD7^)=(j_KS;Ol0-Gp z^@ltPb%U+;{CahL$__aQ+$VpT&Z7hF1FGztC#1}YIftS5WtBRGZJrg@6ER8|MndcY zCQyEct{L0l3xILs319oqb`zy_48=Vax2#lHNKU!@}KPSgRg*Hn`0TS2?e#v z^xCqoBYG9C~K5c658vgpPjlql03NN7aHM#^Q zzVE{ei7B`vgJ%aRiowS3aLYJZ!skBc;7zY$YV)Bo3Opw=!-HDZ}2F`!x!Jw zIk(PYVy@k7`!zf&i7AG?0TsHBC(pRDLrZNcUS;@wTTrYb{TP}9Ve&Sr%%-Zya%RyT zd>s;W?|CxeE4gkDhNfS-g5Dn*ney`sNvv`_SoAZ?U@yi|ZY+Fr{w?Dinr3a*_a(U| z?XqI-LCR}(u2GH9L#2Og0{#!T<;cV?#uCBOn-`!z1JZM z6`5t=Vh9awE^V(&KZtHUBZ_4_SdmD;H9g-~xs+{N*uoBld-gDOJZ-@X^m3Arlw4|&B|bx7XV zzlO;3sdm%iV`{Tt_Xmd~10V%Bm!wmW3UAeny2P!{$f6FO~t!bOIP|l%oeyz=&yRr^xp~!GL z0q~hTvc6sMZL+lybjg`wY9c2V(gC+NnJV607~T5wV>p8UiZJ}Xdxy_ZD*$dTEwx7H zoJ!jIDDXOXw^3fj^|l5C-mk2v)B|7VpnmBhrA~>Mbu(DC(%RDMz=)35Xnr8=s?WYD zmFT>riQ1xq8p^6UA;4D6z4D(Nu50T6!dGJCngYCv1=0c7T0=mz*7nT`1^voPR@&hB@qeCcF1SRTXe~MR%eouqf_(T&NivBJ0kWkk6$#y zJHB#rx%Pg8c zey8#t;;ogTVoWop6uOAv`_-7piU;u&1KsQojMVt6JItY$2%B`+o1Bo`v6EExc7B=G7lu zzVB%uqtZfiSn)Cy(V1y2(vCD4#r3Zdk>8d+9Uquay?dBy0h5B2epHhR#wFt@4m)d9 z4|M2iUB0F`?Ru%*mWj-Q#T@ZQfUwTXi-p2_2EDeA?H(#LpE^W)dYxZH`=B{At#B%N zfkC*$pB_l0N_{rVD$69AC6=owHv7MCoz4C^US;V#e!fJG&`R?xI@NJav$_XO)=xXA zOZF72zVduvw?PjSd}S-uw||V$qidm9qf=gCx`IWKuJskG6^xD^O@@Ru^zW^FeHclz zlpO%x3=lrgKtyKTV%Z5aeVQeTRF7GoxR2^0#oIJ?{pISyVw6l3aozWFbq2cDBHH^ zzG;=6>ZF&pHla@T+s9)c)sbD|ETxTV#==xjg?E9w%kY}DjXKuHU28YfjeYpTjj%%M z#XL-n?+MZh*S`qV3D8mNJ$c0&Z4;^GQF)%7m6v#eWgtf+D>N}joA1Pb~RX|qgaQyS?o=@sK#VH1*v zws#tL`XElw+`RWN%rbzVG2VYTDB)q_n@;6_bM`hE@N;e}zVjoF_UNIx9!8Y(aOR^l zSV{Y&2&A^Z5*)0(yBL$%dD$DsDtU84p%XJ}WeEMmWmL#4U5O)tp_X#O2|HWDwkFMm z-bKFyNv@7M^x=(7|4Hg<{p1QV&Jzwh0%9H8rMhH>ENX3m5}-xHxT+_@sVnM+6`Cqn zRs`3b%!&2VjiNPn%AU=^lPYx?0p4HFnO_btIO!A5hcZ1Bz8?RhU{%%4m-G78L_|Ux zGWmKw_sDhCfi zzeqUZ-7(_^xwb(l`87gB6N;i3=&giJ3;!cK!CODkHAl~AeX3E|jz`)$y7_~lFj|%D z3cqh;qg;@YNFA!`*2JaWTuGTOGnwtZ!4Xa72)VZMm+lEnMT=3Wn-QIO055Xf7!KLk z@7U1)P3VCE2d_UJh2;XUE7vN^PCfosy{mwaT@_$-mOcg&-wf^2Y;JQp;_P-~mT5)& z5kExqj0VM!%yY6hGW#?cO@$_s#m3cc2ikrOQ)%$>7c#{J9-?c>+LD4Tb3C@yun&gh zqxM~;I8~|EiMQ0xS!Lkz_cPy_s>4U79M%R5hlzPMQnT(!88Y7b&QmYuXx5m++Wou6 ztoH`@!>f~Sfzs&S{hPnfZgxGz#Mi({O~nTRj*>7J8_m>4ef4dNVQ!ct<4L9npt2;* z@*WPQ$3u~=YW{QNk&~Pis)V^L<1R35#iK!Z;5c!?wk?)!i!)yH%KA>xRP4fy#n_6d zApD#I8fvzh5}(nT69Z*`j6~;%dSR(eZ+7I?ni3E{wEWoYt_DSouatg4*E+hE=fcXa z`m~+R8_E}FwN`U*~voclHg|1pH1Nde>zWjhut-^ABJl2 z>(cw1Pyl?h`8%yB=1kVZ%I+jY9lnL6epdWEmUjj5yZ@7ww-W_t=+0tNgjtF2_ARZ7 zKlQh$72N={!+s}pYUBMRSh(x`2ccwd0)muA*Wu?p!npI&{dVXNKJkFO~qoO z6V{WRFk|YF8~izoNt-`dTw5W1D^2LP7wBaM!OF@(O*kP)Z#U4)4~m_|pA8`>>i5{=LGEA0S3(1xHdn(P7hWyv zDH|EWa!~>ly(iK+p-j{bR^t{9=NOgY$6VQ7M;`Fir|#Lvezx6aQu9@zM;YYfoeJoR zJ^&Q9pQ)|D)*A!3t1~vn&_9iMgQdy#`&eZqRuDr}5)JzbX^UO})y|IH6Cbk>)mGSh za2$Ju2Keu4jB(*jVb357kv{r5>x?Mn{z6J&YR{^-CW`J> zNIsgaiVa9|@$<_Ny3TVFv@XYp>yasfyYzt+W*&X!YOl`OB8XqiO?h;{FyiJ?wt0s- z`?Z|vm2kXdsG68VMtOFQ`NYdr`KJZl+%EohTjh=8)L)HiM(TfySDC?I3JM$^_xAkS zp20FKM;^#va4H=De(J}$&MQ{;s?@wPma zJzH7is;gg6xL^)b0isF8e!P($#rYfv&DVDyYby-=F6m6nq}5i~`JHwtUQ@o!B6A?C z?&qv1A_@5+^%~<({nLVL0xTJHOJ!lOQ1ejw(6q85nh@e@UK$Mh zS^c3p50hBdkjuf>l;9z4If%58#XK_jySXd`aQ{c5g4fk&Umif8m?Z(CP0|4EIKc+^ z!b$Qd?OQ0lc9hXrX4ahpafP&^x2``@zkl2H=(Q^I1Z|GJjou!8@c2^0-*(NF6H3jQ{+xvAvKhO~KLWVrQ+!PL8&=FIaOum?OUlc04S1D;A%i1W$!u zrZDhzErsZ<7%`bY= zWl*K;5Zg&dxd>y+oS48=RqEMGm&%1@Dr|eyhm8u==~x!!v(K5a33zG%MOXO038Mq( zZ?vjvw!2oS8V3Z}b`^sQQ7ZeOsgNY^R$EVh-FY?bDo?N`_z^)(>zQ>6q46*^i}fZa z!Q^rR62<#%KF=p~Z^62?=m@Ing%69mFlc<+nWjI!-rYbI5Fh2RT9#uYl#y>ez;eCN zq)MIzG6&ClPB*n+%*~S2E}7VLDLQFk6HrI%7=Z0UONdLcPbmZT?&S{G9n`%F%oE0Y z2P_Nat$=GqWHXqU;N~4mmW_$cNVeblQbSIBklL?i!k$I*8MpX3B=7?bo#sy3_))EW#xKIJut?urfYB~4aZY!Di z4lcN${$=wqI*aM3UbYF*L87{h1a`09f2D6KMyY#Xcd4Oo1FrTG4B5ssn}|A zUQ@(SpeJi4Lw&(FyTgrmQ8ATs)JpBt=&CuEup~GajMkX}0>c9}yT5yS4!IeD#|00e zTN7@=joxau&+-N61YQj4h}}j(atK+L%+1t3*8F7xPVrrn)<O0wlOQ z1eYKQ8r4DzsGhOo_M9wqR2sGB=(_w z+@G1alcOJ`v2T{0ZXng8KpUczP-0N_=<)Sgyn>^ftm*2U_Mz}>aVlcA8Y8Cn$CxCJ zc#lTgT6)qJHJk2ZJh3A&+a@u-Opcafp3zB|2NsNcvvejaTR}IZ-OuHP^o^*6Na-&^ z7U@S!3^LzPp2@6J7E5VI*bkGq_cK|_BI%)t_ME+sHUD@!i@Z!rfSbk)B7dC*zW!;{ zb4sPTD;gI5P>`v;wj!J>zDysQ^DL)B^F?Z{f=XdlEjJ|-+g!sZIlMf>eqI7LZLRm( zcBb{uvLCG@#>S({uAc*h+tm$}tcC$;(XplRUP+YXjAAAkRsz-6fe0XcT@!*inY8h9 zx118h>CKBJ1=5jRyL&kL7!YiO2|~LW`{}?8@OY7G>vhpYd-AM8P_Ij#dHC8R2y(yE z=YB<+57vEzO4<>UGUcfz(aAwBs-I%HZH(e?=k8@4KhNm2(hK=CNTvcdNu$mKJ&+at zQDm>=OP5kyVU?F=kuQN@9Pu{R@YqlLRwv zhcR}62$b<1L%HSRSwb1Qf_O{|JOtDl2sZ3!N6W9i`tLV>ir0M9$cRX0&+B3>0XZfP zb=6t^MOip=?5$_D?p-k$?b^15Nm()Y^Sc$!a|{wK#QEsweS!GBJ-WW1?fG7eTFj3P z(;m4H-H*z5K@-ngUZ`Ny=?Pv4tgV$f>+we?eU~=-B(7b)NWQv<#LRn>KBe`F$x&hU zj3J)&Vw=HuH1yYT42-W)u;Ocoj?!}_4Ftw5$#lti20pu}17L}KT(AwfCrR}@-Qem* zQ_03-Vpt%i=gB_dJ*_0DvxkrzHC~m*`rh#9td{l~1uq%~`2EDmyZMX8BJE)jtp?hn z-o7TWFaxHfhJ*c3wq3jH&qyp5%}@1$A6a7QcIA9~p{6hR>XEtK+Qd^d)Xx}=FYZ5& z5w)vy7pKnb@tm4t2`^>R(7{&wO1o1g0IZ~OAt$aN5Rk_TDP zN&{-3Og3pLKgJV^sT(SD{49k^E?3w@i?HNcHL`=z=C8YV6-nOgA49fxA7c2+mqn(e zHq^Wr&6m8EkGKaF^q;8S{#+T#IM0SAP1r;VQf6Iw>-El9m_t3lHCtK!jUVoWa5^60 zJUa6?`O=c!$tiphRhjjo(}~s{EoIee$;A|ZYlLtFe$8eCN5WUQ=3y22BW$3z?ghul zeN8-b2Ef9JX4q}%BZTRbhf0ru1wj(f6h)mEsHrokOT-tW)bqf@V(hw(0<<_iWC2zV zal8FYj3x;PUA)EiELBJ9+hL0CDxH;rVb-D5@wx*&S8~*nC7Vg*!tF{$xR^s$-?fug zvOT%RmA}ks+i?j$twdVs7^urm4i;@KnnT>h(+!q5Sj$VcCnQjEmn|0MWqfvF-+vs4 zgeYv{KyRdz1ywlqY}Th_8ZxR-gSCW*+osni6TIre3+KZtX8br@wW&>lf2c_K2(>sr zfukCa@4nmTj@rbo=0#xY{}G#0&89(4ry~2g@+8l!^~#2D*qo=3UU1Ee8F9P5Ia$vS z(A%0IYrQSy zt&&#yd@8ij4(~(~o$(W%k~&DnRhi%V(E?^i4re=tUb3~nj5?!+&(9${`zm|?Q<~dp zvmR(P%GEL|xNil2J92wg6#Ua!VvstM`@R^1HWp@WJ1nB`)NJIEM#G{-!yvRm)hAT2tfAdotiL0tww+IOFjH~FX^p?olIJ$GCR03Zn%V{(oJ{1)cYLm(COTNss=P5KYXJc1N z3}h3Xt$cs8I|x&GmcajfN}bJ)w>(Bn&b)1q%vz}kOROQ+5?l3)4t}>BnOz!EV~i*; z_BSRSn=)uuWjQfn?l)s&L>>nI=BJ#U~jVqCqRP3YG-qG`SB zWVgxUAf=^eN>G>b)p^d20$AR{Q~2r?1)HP32qq)qC_gj_EpHP!jfP+eFOpk(^+H;J>FJkU{)FWe={v3zBqG2o0Vj~}$ zo)oSD!h8jG#;+|y2?4QhY%~-&#k`V;1RS6Y&xP&eMLx#UUeB8bVILJ)&U-=jsHyI$ zKMkor*X?@*jmM>Y*fA}6z<~AecEKnvV#T>G+*I~n6~0sH573mV>pgOMK2koxM?hT= z*PeLu5mDm9c-oPNuI;m;V!}ixfk7YVJnfAr{D|rF7{I6-)U`p}48sDFw+QuO74J6U zruP9;v-39DVg1lZQGyW?H4jcD35u}SIcH(AH=+eO_uZyhQE z^B1Q%{p$A_aIKD@g)*>+HI_sGY-`RYo1#!g!c_FE*MYu$;dUu%as+;Kq@9}cpw}rw zk>$hVw+N33vop6TvZ*Chccrb&&%MfIk{vfUI@~Lc%fN$H+43=i66>YSio1jKPXSuO zl0lndFW)J@woW6n+dPwib2TU}WwBC0Q%;v4K%mJ56`f3`#0pLL`Nw_*t&J+I04FCV za?3vKK?#aM>g?yW`_z;)!>R11$>VNkv8q#xH}41eZOd0i@Uv-(aeJt#^JaSy4#}(l z-=ov;HNW=~G;%M7kvpF@T5f{Oq5VLbBCp8M<#1Y#I{UPhAS@8>9~P7JK8xBMt>t*O zZ#bq7Q)kRCzx|wEPYU*G6s}27X_TzVU^sAzUQ2snF32ukLiUc@uoS=;0LS zUU2fzFhjeYVbCdN|B^x5%MU~&>ZcG>cjds2j!>S5fTWfy;Yh(dC$eHgpo7+ozYCRl zP)f=#UXLfrb`Yd8Z=gsl=G$4@ zM4X;T=O4lYxpd-hpFjyP`eDa;dWL0rPU0nWNez)ii5@9i#S#b3fpU@Mb4gBP&2`)w zL>`3w#e^v@SsQl;onmvg`_`xl7_NMSEVX33?Q~mW*myEmWUYY3mr~e!^d^(SDOvFY z37z?bV`c27)M(jhlL9UK=3YV9ZQxROQ5^t7^;(r9m= z)j?=JVczo|iWtfLA#FnT)O{r7&3vUJ8yc)?1uvzT5iui`5avywIAzh99HwQ1Ycu#~de8|B8{)pLrs9vg}*mtj_=D*8y`tdjh^N@!cCjFtuoY^c$Cotg)ls(I5TcM*(3o7RB~~0S zmEe6&j3CTp7i3}=zjmieJf+U!<%y6TVE%$|6wvP%5Py({NE!o`hm}dhlJf&k<_MQ^ zr3aFb>`1bOqB-gd{Y7w}_z&+vK>M^7A(2OCGwV!6zT2h$CV!aaYX&8i%zI>gz20-3g(^53Z%)k#QDK$jE{^GiH2D$a^PB zJ^xb@Yay-0-=uPri`+BJGHs<*{M*v~)ZM7qZ+%mvWPv>l7swW zeBU>ab6}CTGX`q()7DuJK9!kT%DDvNVcCuI@O=0n3T0||KqVIANlv2oEg?yda2U}; zb$1#3ZkD5-EZ9D?LL>LOt-@VsmMCXrJCj99xM!D|y2v^`*XM(vO9^ZFnxr>nHjYuA zW+kJ%!=wBbbBT^!E$xfd=-00XcbhJD!9UMkHh{mVuR1IN1kD<$@n|@s4$l;SN64jT zc8Lo}b{wp_?v6{0r|tERJTxg~GA<)p(R)_Brtpb6E7i!&%5~Zk2lKQG$#O7WTSy_e zPhmQh{NAL7E45^+4Zn^=Ja+uRV$x(;io;9{duUr5Rd-reW4PSGAbeehataX*zUY$imvY!b1{LG) zt0%%>Db4MIzM{J_>bp&Bij48Bya&%50$^XraG3eS=5B_eTY?|^x?#mvG2jncIar+d z)J21)#t#iV%DZJ>WQ_M!XdOR;1#7EJ(I~K@{YWll5SCc0|u-w$Wu#kge@n zN6?+h=TZh+(jv|ADLs$2=Z5Z^-em=HlP1eu1CK5pSe+2!v>-A?#*^Dc{gb>YRAbSw z$s52+FmW{TiSexqOap&}R8R~h!OqH3R(7cskC_uHD}>!3r89YUML^ zGB7LG`$?itWdg@2vT4=;HplIf-jSW ziFLhaz;j16RG|9cfsCJ%<1Ec2_D#me)iiIt&D!mjFuGWkhqu!PyvR9Z;LF4u`ItV{ z0}M-TOTEQiiVTZKiQ5r*j)Rm%!@4oB;|2Tg(Q;(|cBqQ07!oU{vcEX94be+m-gCnk?YS?X21BS!)_~S*U(WPq`?)?t#d{o0M1~ zxkl^%;PE^3D|J_6{_)^7$0n6#WG7I{P2x=)#ODvI;w8>8_#|n@WaLb(NX!v}BIxlRHF--9x zF!pAY46~fLq+-AVH@D?J1{}yo{A_~@hCa+#BOWY19pDt1Jpb57p#a&A(BO{&C(IhP z+#5W)NE0T?#+FgBdvd#A@JjBD`SMUoMjy7;qFVqk-^I8piefdU*a?7Sa~ z9ZM{z;x~oG)GH`Q<~-J{JqRIFV*7yk9JrPoGOO>SCCuM08jj*wtuIViQd3iML9v|T z$(x>`=15I-+}9*?P}%G|o4`iRu~1fJj8K6!^;Y{u&H004xM#hYdFB{%-%-VkpV1Ax zRde-gVBty5q+P3r;8)7mnG$sL3l?~cWu41ZH3gfe8&AsCC>*a%42sTMrCc``PH%7m zyH>b25;Z?X)6&UB6PGS_DWDKyvL9&HL>knU+j>;KsaXXKMvb_m9Z}KAOLv^BU=?XP z2ar1OIf|F}Hgy(FWsa6HBgf{Ecf8dlj?hc)69z+QSl0FGiyce3iI^Du11m4<0fE(2 zydcfJJOXx~1;=^Da%CN6V~pL@{rL7E_avB!YIDm##Sl?RwFA3Wii@IflHv|9l*RdS zIYn}j!C>=@Ib-}fKHDp_5$ZfD7X38v^n$nKgXSYkEWv69FCF0`ZA;T04@4hVVdW!L;y@s3=HU8zf`x zV{d6Kt!k(Y(gx{xz+61tU>?>kmi{0ee>ZE8yoal|o4EMDOY{7@w4{fZl&haH4}=>` zd-nqcwpsww3PONiQ;?LCwY3#IAD#yPLiyo>g1o@5DM;GY#mm~o%aazu!wYEC0!e$g zy1}KvfDHT#<>$MT27XO{TR{sE{4J_#ZDkMpFJ(30=6eBpg#_;uYgv1`dV5$}d&1l6 z>g4L7?FO^7zH2-fkm3{iUA;Dh7Rm?x6Xv1ig$n%5-~}RrcRAwXAXz^zd2KJ47hHk7 zHqbCA^mjG#cMAT7c>rYscgp0o@5=N4iSW@vc!3524VKsD2f}~Tp|lXbyL6xqIiPO< z^*RtUKtJTSG!TKnjrvy%FcJK_1|aLMir<|B#Q12TJiqk<5q==@uN){4`IiO(T3!J- z7PR0s3BtSLxAi(YK<`8Th9U5byNUqIG(21_wXMC3K^ii0ARTKzFOZ@$%+^}^_d(GV zWT0;0U~LJvUd|cbIluMGIRm!;>0CKy9$E-L-(9_O&b+h`=-)8VH3EObK-UQTJ{fY( zK-UQTwnh=q2@(9=07XD2L=cWfEpgxj(sG5L6Fo?4N>N5sPF7A13>FXsgP}6O5ex?N z$O2(L;4Ad|$SVm31E&lO80vwWp86|ZS|)KeDG|z zsee_$kMQDu%(_d5%fRFCCcv8mHvt|8s^pgx2dQ~GTUdLj+raxy(aYM|Q_%$;q=o#+ zalOj{E^v^#hrO-63(V<%zbE0Xg7+M}dU$K#X2Q*Zn+BNiuigN9@Xo})Jp|8(n+rcH zfXR1q@Gw06Px-sFzfFdx!|V7Xeu2Rp+ms@+(1lFfSVV9G$8WV)xpD1Ft?x( znC~u|heyB^ez5_y-8p0%R}bgAs#IZK9`=4J_MY$y3~c;A>VWIx;uQic_*)z>^sh9n zAef);k5+wqD=)i$Wk4Z3++g@M1poZo(Zij_pWB3-y_1)<2T0BdxWZ(tEnTgwK`PcR zwqAC$0#IIvxcHwt42Hssetk!EV?~0W!B1qL^v^aQ`);KbDu}A|vftzJfl`FeL9Ijb&i&f(BuM?!?zcxn%svXxs0TG`L2a+pbaRD+jGep4Fns*Y(4hg1L128R+tL8- z4ZSS;1CB=>CU2;{2eE!SjZi)Lq0UjJ~6F7sZA9iu=t;z+dBW)??wH zzY6_)SaT^b6&u#mY|7?xq4tBf=3DhZu&r-bpjMZ2u^H!Fm%DdpMw9Oc8+}sSUGl)s zPTw<}yM(`gKY$J9J>1&Zvb+iM)p_xwSG4ym@dxREKx;@Dn;wRq=akpG#@ZWuE$5ZZ zqpbyV9qc%_d9KM8&X7@g1XW6yQWH=9EauvM{d8R4!@c)2o7>{!Svw9_Sq>egbB;5i zLkzMxM5!v8=-gP8v6(vSB{xLxjSrilJzz5tmj)$CoF^i}Le$iqViqDSEN3B0b!9wJ z&LVRDHL~R*KAWz!+Tk*tRC(74Bh|TijZTi&No)mtlpm;Y9>wF};(S?Nf7yKd>Ehvi z`L-~#%#*dv^P(qJ$D7$8#MHS&i~ zCi1ATaB!Y!?0mgCZ!6 z7m}a4H|fM|9y|39GsRexlgncG?6;8HDS{Z03v=2GQyU%3sT4>N616;ur*)krI>%q8 zk)vDZX`xV;kf_gy&Alt3w^0|={j9^H2qq*=5hR|S;-XXjnZo?Fh{LV+)IlQ-`HO)< zBFX3;-2kZQMdR!cRqVH!A!~^gHE$G~rEtU6l(5;Upj0L9-HYm(i559BYU=GQ5mBF? zh9bCG(W_jTKLQh;Vy~OG2OU4j{xw}+P*Hp%*)kF_e~qMkb2&XC5jb{RKbE^~#4WQt za6wsF+w}RqwXDS>OnIG-4C34w*_9K$mu>zpN#A(7C~dL4ibGsw=D5+6bBNx6DKD;_ zcD>LubY;(O9c${8JQqpvq|0tf{4yU@GhM8FLGSTuGCGe4Ta=r$obw%%L|JaZVy0Pi z*HeSXp25Mxs9vkNxx-fnuagJywc9usVeEEjFK!MR zBAzJXlw&JEZsa2n`G@X@yjK=itfNg?=d(80+e)&}rmTFu!(H2{$Gcw1qS-Ub<5R=1 zkcFHfmqLillOS}k?HetrgTcs(p1@eWm%h21`(!F=)uySiB`>i*Hkz=+HwO>T*e zwZx3dZyu#C7~&fp<5Ofb5garpI3&tZ*%pdue7e5EYx!x`9j$4`CpsDT)aJ5O7* zEUWDG^@}%)`*BK^+Rjd>b3@#zk`IrA8?|)M-x`!$!Pe67U$tPBEAUd|gIA!Y`nQ8ymu zkRr0!eaKx{M1|(*tVI&`e0FvFK|!4HIE1v+rtwv@DZ7f?3)GhG(=upvq19mdqDg}} zn5LOWLRx7=noEbx(2I%5Yq3KL>bpivA9~qD-V(Kk;s4d5d}TlAdXc!*`GGEfD4QdR z%8)vNWJR_G3K4{Gbb!Yvqtqg5Z|QlF9~)z1aTH!Ljqa+;oDYEpJxvBu!@iP-uqqS# zrQWp*M7MRdj6@)@>-#Fxrv-7&C;9`CLov_ir(2&%cO7_*hZ&%W#C1Jrs@nBtwyujt zK5JRlcc{_wp^TJAF)`tq-@ zP|L9z+}<_%Dy<6B6iC1_p?mDB%NreEqdU@{uZY;>?kNeop}OQx8V{rJ-JUyojyYT4 z6=&DEu)a6&1Ma90uJ0SBO^suvrmnBfItnay15tmuhak!H$I88wmS2e5h(~8Wx33~l zYC6EDUuRZhE!DT3Q{J;&eIjy7obZ#hN~`(x_$?)2VTM zZxh{I^s7KVDLK%J+qv7v053nc=Anp-#ZPN9BNrb(o@okPapYF6O}fMQ_;EMHn+IKe zyY2Z1MpW15pD{kfmU(vR?bRU45jzQCW#!mrHBBrm>gyS?b88T}No89j>~_HPePK3B zD4kf$QeRqM5XR{Lw9uU{(cOQMJ3lvn7}DL~W%$0m^(mW#&+WF&H%t*lAJ-2yxaqb_ z?+x$oHmwS{#f%l#j@HXXHH0|G9ejKzRrll4#wU0Jl_jMhcS+=QVc}<_Q)k%=iAg

any0oaDo}W97mnP`Z!B1&{>Lq^#)I789CKHWN|lIZbz1n?I&La|Rix_Q}UTdV%@qWD#i;M4R=MgGXs|v6sefc7dKluJ`%n z>b#Nm3jwxEo`?NFL;G5{U5U1UM}XlcfM%%hzyxKz2rYF*|2F<7k6|3cNa&HNSr1Kl z!*cq0!Ab_s#_f~b!&)mjuBz~q^30}A1w_3;r0#9E>E~XQ3&eFi>nRApMjhsSZUiR; zr&o*p*`E>U^;+8H-D+$tX803TNlS&gTR7GCSm~ZpsD1ggbHnvCx?o!MY@+|sR`+`c zjkIOmqK;qEmi%r0=S%xiDwbOdH04xln{E2r`!wR^QvSZtFO_r=!{45Ub0Sa-BV3_6 zJQE2*Dx>)lf<0(fw8ufjpkq^>S$obIm`#+IuRlXp43>zgH0@S@T(q%FDxW7SgmV{~Jd`{e z-kj(;6Z;`v7QXt{s3h*=^TP@+d(FOKGLk{cQj_WR8K0bdYRhNSEdl!1v0}l(x#uFL zIRV0L9;atyex#E}s}C-HiwNd^2It$LZFQ{dTs%vZk=>heL&;9iLHewl08!1JEuHm2UPReA<_<4G1MgUd*{(hQzP03c^nWa>%FJU{ril7@mznqkd@vWe5*>JYqMu`Wn;+we z>1)WNX*Xm2xoarX{JLo9=Xqky_xfT-(#1yG2FI?!HWeAD&6DTU&!EVeY+q!j62Z*( zE7{J?g04Egp>`H=Z_K*VYw@y&O!=r#N%m|waC=4S*mx@LXJt-JG^a98j-{El^6IDOE!{?3 zKN8ktuH`6QM}+2AO-7}}OS)?~5$TM|6wJiO{cKoB)|vjDPp;fc{H-Tg^(TDIM8(=M zkXFh3zUf`3WmS_svlL}u@yGD|20Cq54xytC?k|%R99;wN~BBw-=AM?Pn10yHRMkCV12VL<(T}NvW2UESu>(_Zqp`G|PfRe-_-b*Q)IyQ9GU~F?_ zb21P!=JQJt-`V6K6Z0H@-mFiZNC6U=ic;3o9~wDFL1TqKYB^t-CCGmIZk2eO!g=|6 zwD1(M`{_#pyCqY8gfKu)XX864N1LjrFGXz)HY@d>#;-QXHUHL_ag z6*@ckQR`BhIPE}ncm?Sqv0&3_6m`~DbU~tRHm~UK zwJJ;&FISu>2ZQrb2G>esT4sc@F3*+hexyB%D4%`0L6mUX%*<#NIn{*HU$JO*_#V$* zBXy5msb}6xJGy_VLE%xOg7_T0q0uw5U&IW!{R&?_Ef^WK$i1fG8nBcDMLVJ!kab=> zdUpS{#mVOKHDhTnXkh-Kvr7P?PFJuCMrH6q)XM-e5KC@tnQcXUr`DbYutl2XfTj=rQ&l8cn`T!}40nUEq+$5m)CJwiEIfF{cL zgBL;Z%tN-VLfHrr?O$w{Tt*JvvoGU9{M5#T9#Z0UUiO@LI)I|~zl3N!8~7Y@ZTKoEEj2(MmBjrwH*3b)fg^m3ZCSUwG z@7Tif4QBNC$yp0WrVceE!{%SeU*@V2#S-7Ng%cqCDkNc?=R1t|j#f3OS#;;#TKtrE zpZHl7>Oe3$0s%|O_x5(bsb6FbT?<-geFZJqG>SSpVy@h7427 z2PC+0JH=#I22=7rl_)3G=SPvRzig^!yaqoS2n3e88La3b8&QvYWf!Egio7E$YtLxT zT1{T-coI(G9!cS@UXl2wO1wx8iBM5XjGDVvyJIg-9v6*?)*|=tQit4K8fyz>>?RPF zISI=QX5pM$3pfuG(mrFzXx^Ka)QW@tVB`#=C}4txH>FSc?M>lef7Oo_mn5+RiiYpnxs?SL0bIH=<&YG zXfk}kJ_*qtk-TBOPB46X0!~ zt}UUhW_=;0ftOLxQLP~45yvxAS%hbL%S>&*BvV1lUc$9ifOsw~&@CF~_{aI@BoYgu z-5Nb#8KCky*H9ty=qv4-@SbBu}1u&>^D6c$(Hpy%vLq z;l-&>Yz{Ro7dwLwEtdyOfjwjPeU(+xldfq3QX$F!Lktd)avAC*>vcT-U;H0Jrw1eg z99`xO+vKh*aGs)nTi~aFb+^zBt5Jz-gFOnJi&H$;t4+Z;lp2DsY_~>#PO6O@Ibqs$ zRj*x%a3qQg$8-7@>I<|vb!tcS++tQr>vwF9^fX867YH0RZ(MoO8N{o+y ziFj8dLd#RrRx>2Dh4{<}$|irYmqPg^B%QDPNRz6r0Me@NRG!^aLbvox6yQTU;KZW3q^x&5W%;`^=MVF|I(oQcR!%4*ullYpZOKjok6X?YpCC-DHDOgLnI>4CoaS>BUhewPVUgFn35+%22GdV4l)^j^$;UO>$xS0?kJcJ$I+ zrB|sR|b5wr>My59+3WXm5p zmh&SYeS`*`#W4ZryMnyNJZsckjQ2Y2M_CA~!h2wDdQ`;BxOZmn?C&ju>7TcT(%R@| z^)R!b5;8ul8d%IP%`jb+sNK<}p$$oHsr_syIumJ?aQ-++tvWE27B4b?uWl-U$y#iZ z!sDoqA6uyBUhXM_AC{<#Q(Pd+!@YaaWHq>kw1k3q=AnhzV2*p)g-w_tJ`#=QAx^*! z4Ck5^fqRwvLMrvTAqh?8=Yo|Oob{Qbi^y0(C>%3U38GG+aKqvUuMuf zuk#xX&LvyG;x(%E4W{8x42a)*Lxn1tLkrQoNJ)}-?rp{BL3uHs`BT;A_2}9uR}=do zZHZTs$e}mg44E}8`w^C`SG+%!&O2K+-Z2wP8zMbcwp*uIg{Nvwa*NhoTcP2Tz{v5^#?vXa6PIa1Z9BI6V3#)p}c65vuqJ4_(g+}BM2Z*0=X6Zy$SHFbXu{n!j zGSgtyhm5-GjZ{YOY%MfEpOvZGQpP`Nyn)I2v~*DQ3DUlQ7eayIOi+i!o|aGfh4CAk zTu(ZYs`+QtR-&uuGiA@ZRHc-Rbel?NAI`#G{b+Ia5Qe$c=-HQEiS8ZfIz{}JQZrck znm@1!64;R;f|X=~3Hrs7`$k9J33QZRmCL9sB1c<_0@D`bo}4{V$rcwIVFzs#z;Xap zqr63%eohN*8T{Y;zdg`{H54$l@JR9S1iNR%#fi@C1_WeuD8%~OYvl5Lm@W2#r0u3? zVmS-k$NdrE20=?0HSfPHhA=U&rRFCqQ`ivE&f?kV>NKP>uDE=8RVp!mpc3_}x!Om} z)@t@Gn+5N;e3NGc9Dm$3#_WRxho7*xk(wT;7&&`_SZ`7k0iAoYs#Wb&&ZF@83 zxi&+aUc*fu-mxymbT3KGk98$=M7q&NFV7CJTrXYfMjR@Zh*Ku86)(X%<;jYS&)ZMa zBfS@(_VF6F?FMiCgIWYFzT{P0>eU9fWVsFp2=3g_48`;fXEe2;&pp?5J$<0yee^8q z1>X=jYjnTJlJREdE$Q6nX>V7zR-TVaIT`#8frJpMkwmoBMXFL0)tJJmr104b3 z7I+5*_(4YC_z)Tlp9}sU$wP30#-CZ?KU2WG|DOMqcT@RKW#C+t|42Aeq_u%Ld0K;% z{~Z692uN^R$RBM|uHJx!0A+}uS3t-VU}`wS>|O2{M8MRzDM;1@K2`lUemC8ImoDe+ zVhNwQhf_ajc|m`pp2oaTp*!9TKwJ^JW1;}_=>MJ&hm&CbR4nP@WiRPu5A*zE_`i8Y zfB01L9x#7^ZRF~4XWs9r{y)?8|G`c_fC^=04DeR0Y2iPn|1t^S-u!04XxqW8>|Jc{ zEav&AQE+0+-`;?;T)2371fYTd5deM^_{Z^Y2B7@^Ih%jS@&YRR%^Lc1Vugf2zX=Eb zk!S#r4NO7*y%uZFdpWISD1m7*#0)Y`IMcZq>_ ziqj=VPN>n#I z7gtYvuRoMHRhXyaKTg3No$D_y6t(ZpAV^9Tqy}egIDw=k;am@py2c-vrOwRgG3Pee+y;* z9XaiemnQX3LK>Vr2Iad$IGpJ6UqX+4Z`KzVs-XZn;NgYLz!^_q9)4{wf|MtN7&0EX zP6vE%)PTZ>0x|QzCL$nW(8i`zt`uXW#pGLF3n~WpSCdc^0B8U9q+IWDss97oc>m!^ zrKABS;BTrN0KB`t)&kg=|8KzihhLTaKLp;L6#xMcehvOF0q?K({ht8uAAa)x0`UGv z2M3T#c>p39tpJ3ZmroENZSo6ogZX%Axd0NA5JV8T4gA;s4Zta!?)b;Q2@3xIioAbQ z75^)z_unCJp&krpuJP-`k!LAJNW0WMtkpAZFg4u0JUzcGBe|q7)jd1iJ3FjHCzP(d z#k(ZY!}O9P0rQ{Oqou;x|4-Qaho`&4-tU_X9DDzZPVbJZ`v1}C@&0c*J-)wA54ex~ zhjaYrtU|zo00;EXZ3T{Ni1a^iEIL|2PTIOePu{*hCwB6uOj(Lu`uYut-3vvyGmVGE zX&wO^_85ztX;@2%Tu@G)CD$D3$#a5wnKUM07P?8ui{}hrk{|2rZ#cm^5`L?iTIE=1 z!T3)7{KI5D75ew^XiAKkXV5)&0d7wP(An%U zBuItxShe?sW64rg7{pIa&fSh~PYTEFP?9VsaB!~1X!in_+j~o+`{}{!neH9=8ksR* z#o`O+SKiZvnZ{7l+QDOk=VP*j4ohcxVXC{hk94_n-nVAm*lavLxPs=TcU-aC1|9?j z9J7F_&Kz{wHWA$WRAhz6ULDOVsz;T5Hsy&?%K3HCu=`aF=5H7LW;u>9;XYz%AJ)4b zG{PDa1O4D}_gd{6*#7CG2i8N@M^f0xWC%8)-i=L?kyOGu@2zM@aF@%~hv=3OeZAW; z7r@1~j|&^h`7t_fzcLnlxxI14I-lG26YHx;+B;5fvRXas*(FDb3#4vMo|Y%pbcik8 z_;jlUHb}`YIT_H>$a=bH)xs(n$24GD;+#e(^{jfGSs+9y6{ z1z+lVO-kjPaIPLQ-uwOI1_2VRR&>{ByS`#1(H~SU#1fKbrhWwwRG~g(1;5A*wj%l2 zOtB*JO*ddA!i6+Wg5^Lx0{>ma)0aK>zP|erJ|Pv#zEJn*%lqkT1x&$YiZsiIoFsGt z!IWqTNo(bTZ*+@&9&2*@7Ze)Eg7`x9+db+E`{}|XBcETFymN|r=p+B=@kszv%$vSm z*C)5ceB&P^E)$F1I8T1xV*A;_LXZxU)AOp_uzl8fxf54*ma)qTLrz6L$SQcVE4Q)W zJjGrq6+JCF@cpZP>MNa*>-Gx5<>WnBJeQ(tubkMG9-Gb!tth5WfvWU=afB@E>-E|0 z`<=#5q!N`(^He&~nYJE`_i~y&U`#y-RMEP6$Sy6y;AERijlV6%j`@`ywU#DqdaC9P zhyinU($_xds^Z|`CgQF*e$jWMEL8``?W(l2E=~qY&VxSn{)tH356%q+JF01#A6E^& zN&KSx$Nf9)MwaqF_)xxojISg;E$?1A01F6#q+xCf*7mk`UbIlC07%*n<^d4qSwX;C z6_(Z@FJD*CT_#8xBny%QDS#9~z(^6K4$^?XeF4%18L|OS5Wm#{BX)i`=hoH}7|h?j z6mU24;^O6p0yJM>tPX*|iNrvqz&#ImWk3$*Z13dH3Jin%?44n>YOX#ow%-}{PSya? z{?31D-KD6(oPnn<4SjWWHI6^>aB(gzYg=z87{K%e)B!wtYcET?zvEbVlK$_80c>fI zq8H4`-cr)V*6BCr-r89Y82kMmNWewmjqtE{^K$h78T{!FK0)A7@n7Rp;FkTb@#%l< z&4KlF|LMI=5=R{Rz<3eo0Z~HCk>*3SQb>b%bs@N>7uOM7b<&aYw+OOZ=hs&vt7>h6r03s$Oqjp(D%dr`wfU5<&M+KbJC#Pz%$fmoFjU% z%w6bLQG8GEU)D>r&IU~klxyzp35R#q3lQn5l|`ILm66zedUzW!R_FM-Qv~#i9`#U& zT+=zK-|D&VxX6x2at2ndRa)ZP@wMRxW~Db`SK^m1z7l;Me;oH1R!Yw?!ar;fwr9d~ zki_Iko_RHzp?~?^$|5XY&7!ga-)~ZLqoWMJw6SDmpn^PlYNB-pv0{fM81WzIjnha9 z`A_Km$LRCF?tOj%KE6MrCE#TX;C&N;f1V70>+MB2MEuLfmdVmsD!9vPtSyO)@CV)? z2#Y&|mXh+h(;GrYG;_*_J*biLZmaiHXjNY^v%QYcR$^mxR?^0JI@f?S*YD3~Ka9@A zR&WnZD{Ss#nfG7Yn& zk9dvAsHz;86$qmK`~lSfC10fFdYgatjSzj53+8H|NI>tIoq(hgw_JlE)ag(N|0<*pc zM4q7#Ar})*h&eL_Lie@43(`8Bo3;eR?%W?RF(_LN)Nc$QBCRRTFuO-ucVlxzi}9#O zb)!D=r4xj?j_4APss|;s)8e69IrVH6IAFZOdqMK)#j9>mBq~C1rY`>Vc_oyDXp=Gf zUMK}p#%C#{3;8Tssj1HVCj2M3#=n-BrnBh>%H{73(h_Jsj|knQ!6dZ6ix%up{vyLj zN6w}oOEIn>kIFe*OlD;OlP0Ny$>R)eQ^&}2UnayO34#&B`_=HHG@ojvzz9Ym^hdr4jR#h8L>jmxZLvv)Smy1y+47cdh7ncaVZUk42@JAM9FwY z=NLoAGDM+4WjHdEq0k^2G)O6w5=Db1W21-&sbq@KOmkFHDpdcqk8}3Xz1_#v^L_n) zdVarNuj`(5_TFo+y@vPNdw=%XAEL03+qG}OJRMIqj}XWd5q1(C?>uV%^zZo%krUoK z_e?f^T$Zt7a>g=|jAm+H_@l?>d7Cb@k6yQZOz?zvPgc>l+I-=8*CMEMP0DY4Td>5N ztRV+7`R}Rms3sK_H$+r;$t9Jk+N&oy=C?|FU9+vfp<%D7do}dExmMZ2_Zk+p`?WS7 zZ}3-QD%wv(%XFhOCQ_dU8B?ly335$q_rfuj%!O6%^gPwcg@%$%V!>&s`;3mkBiTuGF2i zF2erHdW&627fE8{H$BTcbDp(fqU!z?iEFJH=AQjDcJ%ed(XlPhrZ&#F z_iXW{nGctZI~{teTw=NT*<%Zo>lb_OI9J{jzqWaI`|M{YMYfHS+hlF9N1wVarHwgi zwYa^c;<9I6qYsoxEEwbIxOStvs^+!fjgwksy2o@!tW`KNa{N_`eZx0i7+JgE39lpX z-AH0%uugKJB6ZGzQMEZed@);Nn(c{tb0%yr;a`#dQgp)hMI&q71(a4RzfdxWzZqX( z+HSoqR>f4}*oPlQlq5CkCSr-$u{)x3&TJgDajWRD;G%gG_n(-4LpRnkR^Uci!-+(@ z+X}J1V{ho*a3_4cVkJ$#uK!|xse@hmj6Jc6H4UIDa4Qp?eysp}ik-Ep?{=)OSd|U2)9W7Z_a5K3@^XsZ$M)IxW@0HgK zZ#y$%NyYLH5?A7qTV{tS`nI&?ZCLeT=a-Q0Q^U4}&A!Q}ywKL|Xiu$PLS*(3W~0vy zx3zb25^no%+dX=yK+()boh3QSBky%u2d=nqmgdpvpnh*_dS2tYS@oBN$(^UmDr2Yh z__Q%W{>GtQ^>fJ|9svO@*oojGCHM*VTu4Q?$v%U3oh|dAz4`vUWY%}I52hlEc zUGr))-Av0Ulm1%u_-)GS)J2{1LvP7?94I3v^lUjPHMgVX)2>LSqwr0N@YBZ{LN(7S z;@8|?@-FF3=O@jID`v;blx|wb`DQ+Bn-sX8xiiw}m9fmx7tRg}Pxi@9cl{P@T`IWR zognqJsO8h>3trj2Rd1-PM;TviTYm9UD(Svn;rtO=mv2;dy`kC^nA1*8p*70e*h@|` zAD5th`Kp6qc)7>2xl1ejKDuod8tZ+wG_zfWsMTpPk@i5en0UdJ9`6)AS3G)>*PN=}=bv}W&g%S&T!*u2~F;p`$CpJV%K=iR9N zu`_mgR7&FOS!sN!e!D%45%$rYB2HXUkTYG!bVAopDLk z8f!4(+t{tnp%mrVnAfJVAw+8jw!_}gT~p=DZe&G0Z9XD)bz;m|#gb>sU7x?1W^`+Y@)?VB%iny; z*u1c@T%`W?zAV~G>yt#;dZ+C-XWUYhupzH?-89c>Ps^BX-}LW(I#~4f&6uq!xf2s_ z6sT>SveCbtM=to_c;)s($1TOS9y}6zWFb{dIJC$|;;Q5c{T=fTOV0QF=K0ZSm_qqf z##H81vT5M zyPJ~hbWQ4;qjcCwTl4*>C54PADx4)jgWJ<}YR6ULTws4q3Ic@9sJF^5lQuwG3 z)Gl6sEVE&|pbF{Yb-$?Zi!SaOH_2{Y)OW=ro6ebqp4dz=#pw`96l z_R|%6bF3E4pVm|EuwSNUy{3KQ@rIjgllV3@j>|jyO8r3Y=Ypmt(plAq-ygJ{d0Uub zc&>BPxW)8E5@y8$i<7EOb}egAIlX8`-08%gHA`c(GuLtEYUzMm)Hw1M}A6v!(#-mF(FvLbv(q&fxd6v!~1o*rPPGh_^|$T>tRVHREFLYhKZoc%bue_K~n;x9E?e z57vsN9Q-_{T8pA~<;p5ALXqA#BPY#182N=$8us?vuLkNx-8Iu$LDTKeJKxpQB)PU=}-E`EBt zz{P9}iSzlq_gZfie?QbXKjoftgRP9W=IAjKZ|Vmf_td{o&KI;evz+e${E;iad9^4p z)ck>y@)XjD@AK^6ObNLYb37qQxYql_iddlp)r|2KB?=bTv*|tC!g41`Mt0fNo!*%o z{O#vo42Ig zN8>^|vR(ywJ|A|pY2%b-C$>uZOgJ>@R!@-^ggAe@rUgmv>mX+&2B8hy6Se|Ca^ZlGl|Pmt1|FmpI<;`QvV#?H&5(_lK3=nz+;1eDT+Di%ta-_Bu`uhzr_P?7u@eb6G)M^Muz& z{Q0`C2n(M2QKY5Y>HZ>hPIzE*&$EU-EB18RJ#igp|LE#Fy%&yz;cG9D4m^DOSbltI z-lToTZ5GTCo~i4Igcqx-v|8_7wNz6-VjlhEmB5s7Pi*IVIKT5x6u4n8pgPa@NsnFT z!_mo=9QSmlM;__Xb$1& zt`442csWYAOZ{c65BcB$6~}@*(tD01PK+nnnJMcgDKftcE{~60WNoQXXZq!9_Sp+o zYlnRm@A2KRW>}-q6_FWVz6ff`PH<1UWqjeRuR^=!rBMqG-Lz16w3{^PQR0`>jvBe! z-*cV{UzxKv_HOK=T(4SY)-8c+Uj=JYUOWyoZJ)Wk!rHoR*Voy^Sz6X_=cfBfmb@!cemo85T*^8>W?ro)ccDbX4cM#M})%DU8pevz;3z5anK2 z-OjC3jSIEio}->pV4iVUBGjtPs(8B8CwsXm7B;tzz0?m~lm6xo58-%Bs%E1|{k@S< za!EQPbj`b?hZGD=f2G!y!Mwl0joB3&zZl(cN~6ZG|J?)Zxs7l!No8 zRa~h0K5T7T%dT62Qy9((xr#4Uc4aMRI+hH7dYwLxFmBI51=kTxOFkYRt+-@9HBMCO zx@Ug9jk0mxqqubu85L`lqRGw2_7XdnwkB`LIeoe|apx85H5YD9j0xEu6eb%s%{i!( zNK^iCVz~7bv*$;X>|R}3pQB=4TX}uC?9Q6cwe{jJZp}{8+;Umts6}D)g{;p9HcPo) zzdHSGS4ZgEO@W$gOjp0P)YV-OMtb`3&Xt8eM<2SA#z(C!b$Re6*hpv5go1^)vzOEy z*zopS!kZR~LdU}|n;)r^Cl+hVz2i?+IX3%@%IhHO{Jrv(*H;NOw~Hqn_K|tk>)UBoPXywN%B$s0gwdd!wyE4aLihs_` z-Kl!=ol`;6t(KhF${m`Yg6^+9McyGh!Aw-u;`+oAbJwK09H*HNcE|h(44bs>#?;zJ zqM_QRXP$ld!ISG8p%9W$cP;GDkMmIhEm|k@LzO0FZ4R1WxP9}rOVZDzb$RDJ*3lBW zA2(87lJ|J9W3$S8>GwSJ8MI8v6{9{gMV~6%KQ-mn&7r3wBkzRqUp;+8+|_no)Pusr zorJOl=P&YwjQ4Gm(tkU`t#r=(f(0qns>Il(rrKutj7Oyr$7o8O^+ppp!IH_=x zkHe*@#H*VG%-d2NGUXi0k6n#hDlL7QATQtY?qSFj*DYBNBDNhC4>e!(R5Cs%t$v#y z@_E0v2Wiz+^8Fq1nNzHHYM&X?8N1V+y7RGS$mMhQqKj=_t3@&dUflRG>_T;S5aG*) zkU3w&9&b35+H-2k+!_nV%QFuy9-S`SL^18WEvzB>u!?WBWvS0mAKhAuw7J?Uk4TCh zMBQvv;SSy8$grC?w`Ga`xR-G=tULGee)V=87l+)h0Y8piJn!@Nma@8TtFOoHf}XW+ zr#0s0TKc_M5mZnbGCf`M(&)yO^$#9?@Ext*ac9+}&vRaj+P^)zoDrtcddy;fOB8dn zW_r$rqJXG3vxSB!e-U)lP1~3dU6!|XokK-s%F?p>ZEH4Yy|eLbI=kWJv<1!^B+hET zUipdqBCxzHv3PXp;%T>xZ@n`(+N$LIeRKZD(W{#$_%Eru+kEQ#o2U2H3KnfxxAefA zro@cH#w#yIe;3qUZ(9^6G|JLO$ir%b#GOOKsV|?!@LJegQck$8y}rFPXG879BF9Zj ze5=<)Ejrh6=DM{1Y9)1PX6EoG@@F#wr^gSi(#-OTty-Gpbv3!v|N5&e#rOlec9!_( z_>A}((@u7FPHjxhnJc}tRXo~1C*aM7z&W-1s}r}~c$0l>Ud?B-H|x6&UD#z2KH z6LRXvrx(*b^oyHz_FOu?#3AJNDZ2^P=|!~~+dlF4ED%l(RgN%zzu?NA;ApqS%PGTm z%$OZpEO2dXoq=zRKOsP4N8p0wYNydRyPTFBu~SZZ{-$(yi}K+Y6OFH>Ik+aTH-A&} z!?wzB{1(&heT**~FHHD0(czxl(!%XB zP4`*yzRDlLl|c+R${|;#|pf6`|nd+b1i1 zGJG?(HVv(lS?HSjQFlV;=IA@rGlu!)67O!Qq$z%TIN@vbVZL+oYG!-n%+A>HkyQ6_ z_t}`K2|By(o;1dX2ZqQN~VvyKf#3QxH5$MI0f!7qOeYg{q1o|Z+&G}{eGUKz-=|Ze2zjSsrB<91+Hu1 zK1ksl$@q_t#YuE{c_jCqmc=oZ9@hvWrSEh~Ca)6SZfeq?ZL+L!rF7)?!|qaqYSS5% z8KsjybWU+@(C0gt9QBC4?!%&vI}@j@FIcU(NKnl!RqOW3cCo`{b0@`5ICNI9+h@_U zJB(7(`{@CNCx{!E`aC}lJ)PXcA9*TUTT(o%gFl}pJNb%Fn`rQ5`sWQ}_Vb9}p-!Ki zRyF&@lFOsQeY0&+r)Lz0%2YhsT3IJO_MVPqg~=(ul?P`%N)S!B?skXpmg2G5=-bT~ zmrqMQUG*YideSSu__@ncZqbg-Oq_OGHhE04>{79%GLOd88m5>v&G0xSvqJRJoW({K zK_~4a)93K>XI11UH>iE(7gm4TtSz3EP{0s*lrE(6y==jVBir_TY^AjR}>1_X} z$68odZL!Z!{P%}sSa+DQxv`%S{uieJ+1G$^PRS7euTIJQdE&rvLrmB|Y@ zjy2r6WajzwOW}u;!jB$3dg+9?MA^)%*R8JJzi(1GY`T-H`^jC2H=m6?d`K$M@sL&G z;l~n(MXvMpJqZ&>6Y2Q{gh1@$r;u>`g?$-ZzelgAeU761?$Ik&*8@0uMeXyz`M-A= zYM;liy)FY6Wx+W@b#<}|l|X{SR0MT370Q1)O~n!jpQch*`>*^2E}=qav;LzykgCWu zs;ycTIcJ#I_~*y?4PPzpdV6&^|ErS4xvsg$$A9U7(7;+@?ol+3Y{7XvR~L)ksrY95btq&gm_m~GqD*B!bB>h*u z%()ZtZzrE=YOHSlqmv^GaxpJ!>(QhWClKa|^DnwPQ}6DrLhGxy>?^B8rn`8g^#^*} zEkz#w%B+3PR08Nxdrw974|;u04gNOh^`0;M*XK=Xeen6e_Zil8lYOZGPXTWrG zHwpD;+Jsuna}M=%X1K`c>hNm?YXp1yc>^~>u(y{_fJU&k3|x`y#MFS#=xbFO0;@`( zr?!k9Dj?XKTM-O={h0)Y3Q^fvO^rxUXQ(*RT`1~QvJ!!$Mk1@KkyS}#Wi`46m8Jn_ zTG{_(bok+umcNUuhV?8Xc7H%=%eVyw`e~@Du3EK9WffV)*MGSxkpZXs)kvx&k}}j# z4hZoHbPQJZ36Sk&!r{X?#RET|S0lgd zFo5NqoS!y8b=hCZ9S~@^5>&xf?Z04T2n&h8U$S!d@(O~fxg#8w`ZdEo75|UpN66)A&EL`E~z(eZ2H1RYC!bnEXqj zp$wwwR|Y^Oz0Fu5(d(&NF3uXgH)-lP`uV}(HP)4ys(!u!fxSo7v{bn@xMM@j0^I|> zn0;6QLsppSc?JIbEvLZC9fhBUm!l6@Bv{#n>FOBd6)2;l=Y;I+3>e}Czx7$^?jIQB z=tT%*I=lJ6&BV(?2+qDf&P=~Rf@@G>F!K$fy-0jupPmV=^x++ck8;ZWD=YJ ziI&67%swuJRqk*NC+l<}0Y*m%fxC`@VQ`>|mMV%^FZZ7%?EUslo3vUD${C zz}|o1f>{5|gstS>KL4K|J;4@K1^U3D17jGVMt(hdq?dpo)-A`s(22g|@}IxudV~(w zXulSuPgSp55_NRU;a$T(7s$AFWw<^kz{Z?Z6X1}#iK=fOQ9UcAFV+U5h^?aCc zAlKis-+JzFSGhk_?zf_I2waKWZ!Ir$Jhp8|6yWZ|3<&7AVt}(d z-0a@Jp5eA(xM#RucFX-8{oLH0`>hAC1vgLs5{~-#e1NZO;3~Mgz2Axum*{5h{`jq8 zI`vzJ*8o9$o{>%HX=Hv*G`VV2%+sDu8o;8p9 z``iG{7@Xl1955aEd2Ya(L)tJ`{QPYnNOWQP{!_&E_WyHZR{wwRNegD>8V0=r%=7j2 z(&=4insQei1Oo%K8<$}9<0|Ag!~&GeQN%d2YadhuekKB`!gSNa}8_w6}~${3j;65 zfB+poe_vl$4OmOCM)CLZzqSASdk%Dhg4|s+XjDTQyjlQWB4S`fB+k;;qZyKB(dp_2 zhI$726g71Y|6jEKTOZtaDCmF@R9t|)I*H;!cU5;*rjqGQWeSr@Q>HT+6lJQjx+9t9 z=*pm}<1YF%{~K#lpMXF|m>!tUVzG7~AnQKO|HgV2(;t>CE=K;o-mHBDc*RTr6D_l~ zWjO0>yzv13k3xX8P}gw(yG&|o6h}2@22u?N|VT>y(;RNlXh*=<-mDH^aUM$60qNAMG5KGXRI<{?g}u*eOUh0s)N~a|6LOPJ=npH z+jnC1KLR_yp2z-E?$PSwFdFb0HrPM)gWoT^!VjEv?9h7uKa_L538gmJE7!0~KQXg}aP#wr3Ac_Bx(DkQ zthhD)&d1y_7!AP2J(T$`AsfOSHt;o8>A=k*DsZn2{6k^a`yID~USL4qy8WW2+h67a zz3qd1+yiy2+=H23unpDcD=t?&x;}FEVZ||u6?(}O`h9vppF$*2KXVQpgAm95_YKTJ zVXz+W4@qL1_k)!=`kQ@!zta60k-LtOb8lVpTr5hmR2Zcfu z7;B)X2!2T2I)JF&cslsA zskyBG$>u-T7~q7H+nA++0G7I0DzI~NhZj4dg|D$jpRa!*|6h2Ztv?-WV|{j87TJHR zK%_1!YfA$|8yj{@)>r+v^oMyKiArTRLR9~4misf&L>9N|rTcG(cINvuW0C*Z>esP= zwFMtoar}Q~F?Im{85ZM2#z5@FX)_>eaT*OSTS0sftkLB1&#)FZQvP3TFHRo(Up5)n z(ElSrW{i;jPYE*)Rt+S`{^u;#J9qsvg6#i~2IJa!@MSW6)`5lpU6XOlJRnRQ%m%|t zzdyrfTvZMP8UMGercGp!3C7xRQK-H)g|pfj^b0c(`ZpG4WCpv@fC3I{Wsm`+HVMup z8*9TI+WOjL+MhBP0il1xawPiiSPpAt&{+=di8R(`sQp=%qxA0L8fy#$Eg8QBmxI`H zDCUUpV%uT#_ii6Lc`j--SccIq^+9hH*`2EXm7zY}&a%HOda zR?FbC9SP++xH}! zJ5dLN{2j|-tqeBHv0{#b<|(v4W}fm}5l8v0SqfIlptPGB%5(S;@SqR4-?Ez;2TumH zlY*5p*z5*36LFA|Nc>|q!N?pV3}k}xn^4JB%V4t|3oB`8`x0(hU}u5<&7i}uH=v;7 zYGtrljN_9le zs%KzPhqW@;EC3I!_SWgz2QLU-+;^COLbT)gU)iSGb!-CcF1%j&YEZNo9?#`rQqlP1Iu(+ErZQ= zaA6@t9Z?-U>w$|<|CAXfi2WOJ2g78y8kqI4UIv}@;Obhi9&BZT_3*RHK_7ZtM;l1G zgJJ%b^{`$Bo%M)RupR`UzBZk+VjBFm!+Yfeu^kTA0Res2pCD`l|R4V`HKyo6h+0WZ}!DP-`+96qEl5Zl2pe+w_MUIv}@XlNUg$U0L* z=ghkYzwu}sGYrUhzjvkxt7XvHj&-Jpb)@Led1Ci_M~ZN;4k*`QtqeNLu}<=_4$$Hg z+Jisn@T6}bLHB#-XR%fWo8=e?E_-v`ACu}BzXO)Pndmr58EkfAr8zR|IqM&@oAO&p z4xfM>5K*_B&W@QOvY(6*epgu2nm1SFbW5E2EEa+ zqyw=UZZsgX;Z}pqZmb{mz#lks$pM2wZ#OLIKcI!RMfc~O=lRszajYS=Z?YILRkny<92A%cb=i+GJg!POE|EhY> z111RkJI{DwU%pfB&o}boim!fMO4~8kqHPvq5J)_1@>Jth1NuoE7Kb zk3B5vfUJjG4a|DD*VT|=TMf*5xY?ky9))!t4E{pwQT~`YCs)(~Sq~3zVAjLU2AlP0tb-}6 zpJXPMT}8-tB(zk(XHy3~Wd7cLiX_fTXh2biwK7Pfj>KA{ zt8;MZf7EtF66Yk@fQ(1PdKqliBht|t9o8{uril;q4|?l?*uRzVILp`pS&yri|H^v5 zdV2?civfEy|NQofU%v(6S3Fs)&>KN)e*Mx9EqMK)2E5_MCCHiS&wg*1)hr`|m%Ed{ zqkjm2NQL*fXsP~Gi~Dj0)H;~+>PK66OA~s-8i}X^FMnaR`CA#gX|JTS{_^(k-fyjE z8R_tY*cxz+F1-555eVI2KlB3HKmxppPFu!bMps7&KEa#LnU3D*ldqG95RpbAs1eX7 zEiF}Z_G=gkL>dvkwbo%Z=&eTPR@2w_4PK;7BZ9aD3X!ZrqocP}su5`Ls!EcBs*$@F zym?C12)!_77SkDC!J*1}X$f#uLtItoFnyN8%hBO{p&CtH)tvQG<3%uf0%C~%>+{(` zmGdIP01%L6S{oP@6A?Dhr5a06_)LV)bQXK~tVWhZk5NIgYs0kUW;r0|D z7@QI+fl9{=Xi$O~r~`o+(4iV;zyN~7fJC6eW2)Y6;MccQI;TB}2n44+%#*2b3Yc9D zq=C&oHUZMmFawZA9WwxF)Hw{GNw1|~G^hnf0nh+`#n#IT>eD!lL3mhL^?pw$sKfHA z_cMr2WqsDsQ8f$>G=^6=!3$TkRE?2};dfQ2mNBT9OzZ6es)6%6+b{zcse;?9ntH?g zdklL2XX=2;;Jv+p?o4Dea|19a%gex@RBhZGUEF<^!}m6Bpcg8I#oNY>2-5V97e1>2 zfeWC7+Uqw^LL#WcZ_$xBK#-xNS2iFhP|`bOAgDlK1~h^?Y~irms1wxTC(&#IQ~*DH zU=s`|;jo5o;FM@@0hmu6Bw`aFjT){6)!53haf95g&UQc`KpIE~>^4*a4X$lv6Ep&i z?O9Mw9ZGub4+I@bdJO^u0|*WSGJ&SfX%8cz!TFwEW@K<}b&dwe;M!~luyKRaKQy-0 zfuIm*ScPONflkK^KpLz<_!SnN&QT#;nn>pgz#!1sern@JA<)@=1E1A^;4p)$Ip|nU z*mj|_T@9*{33Pb=&?__;hK~D$pEuLtIXt_BMxaAgHUZLLQpDd5A!*LrV|*rO9p)A#H78YlLvZn zvlfJy8hqbd-_)B3pL=5)KBIzORUiUUy}CdYs@UsJh$0afbZ$*DP`%?sWfY)#)rKhQ zPZSNPUR|Lwb>P`MK16}&>;WPQglBsXP|!IW{}2I!u>lZKsH|77hyuab{){LPj17p0 zLW1G$Ai^2&n=@n&RE7k@g9Y2dt95Z15)2O=Jc7Z7QfLR=aWw{U&R_#8Dgwda%qqJB z0BQ!?wNV)e#*Q>Zfne-VLlg+c_IpHuVC-N)6bQz)JEB0aURXp!fPiPPp&Te=5^Prp zc}6cfqlyso3^q6-3It;ZAflih8}|_fg28ou>>)thGr*-e6bQzSNK_MP4C@v`pTWju zR0e{v!xbpR5-S=ak^z^3uvtR*Ghp+8LxEsy%t6gSFg9)@3b?Sb8c`q^{Kshrf&nKE z1%km=1cw5_*!Y0jfnaP*017d|R)&rlAUC@i2+ROD;!q$MI~|~AAQ&4<5CwvPE;u!T zCuogBfncB+4u!&&>vEuU1{;PD8;}f4!LEwh;Q@h`8EjO8iePXC8+;H&LOik9;6)HD zxJR%#gN;q7E)@#dSqYKQ2|M2)3be*fQi!4>K6q5%jzD5ZKvi)c;NlDb2e#ngstoq@ z3fMqg(%A@zD9{@lwGf45!~O&DMdyYU1QDGJ695r(_ACpv16XI{9ijl&*|RpFK%)?6 zY*8TaL1wHPP&}OrZUAL;E+PW9FaT9J4M8$+S`GykWhZRZ11OEFLI5@fz!s+_bPrL; zp}?T*i~;R{;9@BZjRDTbt_VW)rNGr-9Go%`3~+=)A;GW}0K^&W2?y!`1Y=J{5Cwv< z6B(kAUa+b`l?-;qGxY}dL9o@^0n`Bp;dD+y=>PzSQwCxJP;n>_lRYN_CSX+tfDxyR zg4l4RCV>M2$DLjvUj$?-#kuh_mMFauEy#~KOj_fu6A z7&x9uEOf*ofizHvMS||ZQ@Fi=glZTdNnk_>1#T&l5T_9mj0Ex@$0%ScXo_`)6sm@S zmjv3Ft50>p-vm=Qod2*It2M8r9t1j2$tVTl3YK{MR8$Qf}&k-%_3Vws?S zz&S3-az;E_7z&hP6QIFzeFz2yg*cKRe}EKR5@ZB1I9?7J1V(@r1u6p)iwuSXRbcBu z0*3K%NtTRU5@ZB9FlUyju{*LXfcpVUK|go^kV$~#)NvtREXziq~5%OyM??0PJzb`>V>i6 ze!!|Q0?Zg}4kO^UMKa=v5(#Vptgx4Wivx+>55f*eu24uujQ`LIC>#?21wdjcV4xrr z?iLblUtNG!pfXk*=nN`jkwFbWa!ZknT+0JC1BqpXOarXAZCO%r`bFJf;Ag=OP7-7Y zIw<4_Ool)Lk~3B^1RanZ9h1S`f#jH$3~mWQ%NaWvCKAaSEOUk|E7duxpdSuoOJAB7;v*aGoH8`%p0M zkioYo7?jB1(i991WNL_@QL55sH!7~9g zKD>@2LnfhcI{>ht;3XItu!4eT3}k>p3Qmh;$RZS+i^-5gC^+Slfdd7@4jDL5FzS$@ z76m75GVr6|nFCTa##=Hlr{I|m83d-_d`$*{DLB=WK_e8L>B*oG3QqK77&Qe$I_wPs z#Q_&G=!b$=WMnWM1*btW*p7lHB4Bk2PB3J!4h2t~$Y53qp7@c$tQ3sDWJnnlJl7$E zhfy#plEH5%80W~~Zxo!}$>47kJk=zFvr{m{lfm0582^z2Vi+bvs-R#zCqp1mFs_mz z5GWYj$q0TCz|sZlI&!56%n zf?=8rU_rqcP6n``a6u4|io%6yKq?9scma(lT#yFbf{lIlM1%~uMd3mq04Ifu&;Xni z46KMFC)Q9@V&tYkPM~1eq(DlbV2GtaMj&JSr9eVJwR_hes0}LTP#`3pA0d$tCr+6< zaN*<;)H4|aED{h6f?X3<9vDQCykwjTkgmuWvyraI7>bcT$QVhG=8$$dEU7?o^o7iZ z?7%4l!7vmf+aM?4l!0IviXnEm(1A>fe1KgM{0VsrhXPbX^IZ-JlHmytaxdhNoHCFM zrv>EO$aOhoknl-3evtA={8>m4Q~I91=;0F$X0XAaQ6wjsOx52a*Jk*jlJ5h8>iHpj+G& z?N@OF9P$Lz#actF477x13xQS{B#cWaK|(2(7;;6Q(V-2iK8%on7`2d1`;urd7{pLA z2NDa278xWAV`v`GcjRc1(MO4pGN3XZIa*}&=@u zQwoOWIwpJ%g;*271V|44pnSyP%8C@6OsHsqLBv>3MGFif274-6V4(Mt_I61{3kp-fq{;1a7tO?a-^q%y`hvNJryl6(5rDcm65y{Y0=~kYm^Gggffn$sNl^& za%@3GYYZYrWhz=@pf}91`Jy#OUlNIk6Au-F^CuE%6pI7_22DAZqk;mtJ9_{q;2wA| z5SmaGj~sY_NO0B(jAjX zM7$C}Pv?QeBBC@y#A^X6+RP&2#Q+th86uudpz{YnVy8f920i#;_seRE^@h?6dPc-4 zL^9$z0TtyL^oWX6ie$u-04mBe=!IjPQY0fzlvMB@AhEr`dw|43q1`O>n2ggF$%qp@ zYdkp5Q&FZt&-2)IQKmr;^f)Av5$AGrKm#~op-`ql&-*x)(eVr{69hh$Yf6-7U{Zst zA_;M_M(0C-#EODKZnCCA^dh%mcLF$tyoN);NfWLi0eX;MaLVB12-l2&QdF)L0XUHx zb85o*5v~mZ7^!#;h>pHcxh4cTxmlVD=tbq)6A+)uH75Xm-w^_Eqlja72p~`8+7>XL z$~7(IGAh@ykglj)!$M}Ea_tI<@uszWU zA}Tf~4H7aHLohmOM8zo%4mbhDu_iza6&nw{nu^^CFarTQyEEX2XF~ukeX1dDSa=vQ zMmX?fDxPcs3{vq_3-SZbso=vX74>!l9*hzZn*eF>Gzz?z`%sWIOTroh ze*(v);^`7(4wO9Eyg?j1Rf5GMMq1>sc-DdZ6=x^Nswl1ZwnyHIIYUlG8J=AN(r^io zhFh(#G~lS*6As{~+=CHFGLCh?Nx8MaNBh)5(r~~E9JEh0n4V#SAos-6FYwMj43H6U zKS(#6-~-oWGthy5sy0DRfgyfORU==2ZylY0-jjO#CRe8C ztNamsPxsraMfqVJk-neJPbJ<;pZ`Jf$L6Qcd@uY6=>GWNbLfw+7uv=JHKy8>HZRTB zTsm({cZRNa*rRn{yLN^>_^~N@wk`3w_Na+pM|O zjs=aOo)?yUI-WT1dPvxUqYuO<&sycF+vwJk-u~!jQ-sLarG95lmc{P&7F9p3sIou1 zU~S`-uZ}-Hep{aZqch}3i*WbS^IeaAn44@_CVqA6#Z*fNo%8$Rh!>p-E9Nvv=Uz`1 zJ-B@X6~j*-+vQ*Wb_k7Uk(N@`llf{sJR`ys^*#SKaUQdB>d5<<3S(`z z?IiP-<)}qOFl%{6^OlqCFRt-hO}TMh=x~kUwu`5?G~S8=VU^XQM+cQ8l)o&$9@4A7 zG|Ls6@^%(a8gf>>_}+mtlVr^sH;H!mn0;~E_SsPP>Q;j|L(#5mJ{O$>MngyQnivh) zcE_0+;yz)X3&l!Usbu7gj%%hvqw6AO)tq#D&?{<8`iSI^qkAstTkxHwwaaH(3{f-L z`}z!z-6D01{n^X2hxyQ3yk;49)8%N*=UiqPi`^G`OxSgGqu~mbF9k+N*RR;#S+p*q zG%0^eVj7G`M4h8Am(>>kh@iTC=}4bjNb(fl2KxI*;T6HFbAnzRnX!7?n0afL`cJpKqwKtk zU(oXAyU~*;`Oh`p?J`cXZZxrDip25L(V8_nnfvu_g(RJq@H;(zSI1vJxXT>O_tS}v$gZ$qzGq*{4|#Dtr>7+mUog^0HK!q*l@7VxH&A&VJmhM3-)qmcC@FQ|%44nfX6)L-$kQCkQ!RMuaws`yTI%c2ErMrN z-<%sQJXSGTXmV_Lr04v}Jn1{eXss{GD^SaO{C&#?^V9V^=#h&my}&WfkvEI(8F?(H z{P8m9$r2`aJNQRwTAJC7{6=o5Js={`b<;2C9K_y<(9MDkN)P45pXtmo(yw3r>eTo; z{?+Eje%{-o6GG%o$ZH+t74qbs&I=ZB7#e4_t#*zXcr?F(_+;0OjXpc8LtF_CLRWTg z?Tk1S?_c%i_Qv(^sw*~M*nV`I=^GySOYMvUu;l8?DkjRu7&e&%FQesZmKi`BTL0HuV=iTC_KnPsc~a&s!Y2 z%%XEh9Ah?RsIUESnNJRUrK3i+S+Cr@w|?T|BYBF&(L9Xnq3@lBZ}}fFZOB1#N?Y+_eeU8LM&)>g4vn4^m5iX<;p`7G8r?^o8Jyj%2GMzH*1qxPR)8}YLUHDNcIz_^PAjA_hQnA zFLjI>6|#xK5Lv!YscLf8DqG)*EBkX-)C6kBDrRnL6>QSU>ZV&uZ}9cV$dZmE#0yE7 z6kY2w%T3o+dcW_3!fGv*ok@pVv@F1t&X}mhENi^Ad3Ee zD`9jt?P#uI$2F(dMzd=_%{fW$G>%-*(UMqbG}60g{*gZ5H%Vxe{T+b*VrP9Mkal|h~tL|jCKW?$u%t&M2x8-zp2f{ZbQa$TzpZ{dIN5nj$h1=GHlK$;SW;qw?eIiYNUb@0*%+&eU_J1q5QA!E9eP;ON z?RGU)2hFa`S=YHMT6XA5v-hI=wO{R%wliK8D&_LLbR!|TJ+#~7W$7}TAV;-=1NsyB zv`d?}{*c_%psw`U(jivwL}}Yx|4RbydDUZGCe$R2u*xP11c>i`E|8!oO<%Cf**WME z|NO66YtwyQvu#V(T~tw5G9nKvHLH8K=Nk3!p@l;lT8CAw;d|d`VwkU&GQu-)CoiA7 z4v*6byNdHS!uL3Iy!F1Umv{AY!=XvR&5dD4Z-kGUnweVMV3B%D|9W8i=pc#t2?wq7 z%4jCYL%q+-Z`ViQ8T{9+@FYyiv|ql*1g-COIrRX;0+7TZe5>y%#bwDWFrWaQAI_H!iD&GAtxrIYAA>m#E^I8GFqqY!VSaWa2Q^{!a& zAqzjM=+|kbs3)9s(v8X&lP*$Bk`7#(+UBBLZ>QBGFfq+wg@Lle!b6`o@1$LnUADG+ z;g>3vC$pm`$}0P8T=H_(tgk}5nJOb1S6O9O+c}iJ-RiRDUb_E|JM+^tDl>&-&08bq ze*b!?W?b{=agjkh`}}6Vy&`?*=!g2VBoBd)Z_}>2-Wp%oqd2BTb&{gy@ChTf*Za*d z5PBi_Ow1#y^0H||3?ba(&b$pWyS8nS-}9I+tv#22e!F;{+W;0XY2~CTY4^vewbR9Fx}(+$R$e% z)AFl{SM76BOM|Cgpk?#$s-=B!Op8l+!k_=cNMh0K^2t)`-WmM}knyknuwYH&CAbgzX-%s5Ftp$#X6o+o;1pbV$l5^I>axkSfnjUbf_&ui=)xIAr@y>`1)D_YDuHr2^k9BzWok$$^mgh@S#5YlMO-cm+ zd?$A~5mGWvXmNqbzuoc34ez<+s|g zTV#psDW@C3Qs$YDrkF^G$D~YIoAgyYHacp`$_AtJ`gz+IGECI`rAbL&Yc>eoYxc~K zac$kOWTX#yzGB7eq3PGO^J7BIANyY%c6nr8rrEG_h4t(G9eEO|?eX^f2inhyQ8sJ7 zium?ckGx=geD$lKX?ts=8LgQ+MiAz?jW-N$klevPqxOYpTeIh-JwC0@OGY^c-;A7*rIK^=XmhIS;Z;-itz4^%Xt`hvS4Fg1qUE>3TUhY?#Ju%sILhCBw-6pv^ zg;Q(EdK*~0&9@alGCa{mmY{ks)=70(qik2RV{H|Ag@$+VXX)#F-#X2dZLU6$YcLc! z5?5HbW8x51gGKTu!>do-H&yQ>Ru0RU+OYSL?1!a6a>q!Yb|)%LuATD6p}u6uUBAkg zY4Qu#@}xaJ7~Q^;xipS+zEh>a_c?Xz*?S9BBbWQA#K|s*6n*ft*&&6zWq8VoO3U&_ z(U%XZL&sIrkI)v*i;q235tiuQC^YG#wl%+J1g-w;x2`XF3qA>rTqOIfbTaQ%(!=Rx z@s>|_6B45cXlthaqx-3!};@9t9ghV6POyhOe9MFtO#X>;;Z%z z%Sc(CGkDK6-zNtjJpEpa12JlWsjb;)Z?CadRTRF}BVFEp`+9SUV%gqh;sIutJ3j{IR%N=k z`rkEDTo53~w`ZE^W3TKDISW3mnV7Wd<_^<)Uys@8y)QMIP@y)uY3I7JyeAs3w9C8g zB&6CZPuXqS9xB=%Dz@CAc=hdUSGVT(%i|()Y)tPxKE7M$f(Jva+NyevaMhI)T4chC zI@L=pPo1@ehcCQ3&8>ZYWpKQ^=XA@!GxZsoeC6)pBOC*iv={GTI*G*{jcKm)-|O`8 zV?$v454$@u%*i~FOSVszF8;Kdc%xX^h8R78y7%Gf+4QfA+P_$y(2`tRp7-e7$7Q=O zr4pIr@9ci3xcbaRDPE}?yZzoW%PSI@rc>e%-|_OSu#+=l8ap$SE}!!`YA9&0D7$Tn zqVjs4pcxfB3og~~*))EAWSij8@~aA2qZqO~cg^9Gx-2Yx#?RJnn7FA_mqFqYHTyUw#Hq9gLihZSk&`8U*O2UyFgbx(_vpVyt>7oU?k zjuAI)`03@l4|Fktv+XBOeK{;Nn&vvkN00*_@rf|43q7O$J30;1(};ZOq?q>|M8<(b+t_)XN~SH8=~y1@|55cAf|KJ$|_yG zVD6=HTRP`0a}J(6L`5Uyc5FEBgG{sBkCEw`dxeq;+pZryb?I)!moMgrqgx$J|>$gW7+H>@qg2|=v2Jv@Oz7}lSn13h1%R4e5 z?s$e$xWGa`^=}K;R`BP`O;bPQJABTYh8H;Lup!CPrt_c7cBN9=sxWwyA}v#L8)i@fYXK|#Gx?dNYXXCrdI-F@xX z_3+|4zVjI?#S{XhHm@w2q*k|Nj>B}zg!s))6H;o8CeF1i4xM}GhU{I{Z)H@Ock2(% zP{}d(w7RdvHzoRAMo{rb2Y(Yg;m8elCrM7@TVc<4GJU~NdzBiO$_27>vjxRTp7wmR z)`O zKmXOf%8m;jM;wJlB~Y8j9GWJ)D1P#7iQP=qr%ZwSiPftTHdQ<|APf~-wkK|+`VoH8 zr>Bk%`%S|MhVe6f$63fvY_*kYW6C$#-wi%@L15zIMXo}Z7D*obTpV9=^K|u)smbB_ zAEjr}JIB2`Elpd0L2R?~%_puxLwp2k^x72sB#wxLbY%&SHYZeW{T}1iL`ZO7lxCCm zp0NIYZMsOqkwr3z3+bm^q)#ttazEM~D5NlLT_fEqf%;V9BJuH?rtIJZ>PqUuXKxoR zYc^c>OuA-)ftSh7=;HWiemR>br)#CYf8V7vw>l+)PivFPuCemzdhTa@uM6-g%2n`g z`EE2O=FYbDTjO5D-4D;t*}HP#&5ZQ+n!>_|o@J*Ayma2_E8FZ7Z%MRej_Pb`5t|lX zep)d6wuG3QXZPLsXI?p_54%Qwnf>|wf~CgKGBXoYtcson9vVyVIU=xs^F8+|)63?( z4QR_xD{_94dbqxBw&t0q*`9f0Cz+isj$e=(r?L2TQx-j8Y}bMo(YV+>mp3sK&aQr* zSseXr8Hj!`lE*weZGV$Q;**4Ko9whLgsL>!z9n9Z!=LaLEfp?zaJI8`8)Bi6yvzOp zubtz|m%9y*o-3cIX1z(^RlI&qx`Usc$l3EBPiGEklBRafxS#O)71WT<+f}Wfw{~hr ztWjIU<%rW8qP_S=zWpk8-sIlv-G)p%`&+kS4WsWj$$hIPNe7ju$nY8&tQ>mi?&;}M zE{%H2pMC86%;5J1{GaNcm+!VLPsvtnpr1V4b^J}Zo`6tiuFG7}@LRIis_AFnu4tNo z$RTouH`9vVTZg44p3j)DDPNo^n7h*6efzsK%8@yDMx39mX?~{i+NV`lQx4O#TIw&B z6&apfZM^*M%S~78i*Hp26jm;5QCJw)xpL!3nW*l>z=-!r_31C(TQNP;mef9qsBPAm zb*koJ^lpQFotJo@$9+CKR!v)VwpVy)d6MP*Qk##PKSUoxW?cJlDVLm^ekk3@D-@Gk5 zZs`Ph{bc2?s*3Ag;esCoqSEGe^ zPj%-UsVzt83X;XT&!tQ*WZYTMcxATX^Vo#~Y9)?>sWy}q-FM%#?@d1cF0AM2`A0h5 zVcqWCPuh$39x3!O3a=PBb&SM>jyEkGu5~%%p8nANS{E;SX~(c1-D7iSdVVpv@?B`+ z_fFB_nL-x@N{c>^pvjn;9WiTrb@EKoiA|2n?w9YL4yR8@q!EuS9CVANR5a42K7FVZ z6cG@fk@HBVRLaj?yT^~@I$70@F4=J?a*y^~dSxZU-iR+pNkK%1NiZI@`1R%!brwGnvsOyqp2TWdwnt&yJIjzyzB5!)h`5aSi*`$)7x)2O*1 zk2ZDh_a9GgUo^}Pl?)`iU8yi54HLd)NPn90tR-0Qp?LF)YHg4GXN3>z2Z)a!8$q9G zr7GC5d&)`b`1s7?EE5IYSL=(GPQ5oqF4OC!b=-P=uQd5an%w(p?vK&x9?p;Vl*7YV z1N0ODM!ht=j|+ZDZk1Tgg2$wVZ;UH=rYyh!r|ApXIc~#5>b4%eAF=qd96$4wZ+H~8 zuplH=#rJ>!k`u#f+-6&y3=6c1p}(@@{N?9g?ehEIFEAW2*diRq@So2dTf8kamqLnp zFw@hJm}I;!3eT5cE^hhhuMe9m7!e7*Ng-YIRh1eJGgX=_l|?eciKVg`I3?l|?JA*Y zc>p1(>bArx0X4EEDH2YcYOUtg!H5n^SDW!M@CUzQ$*%(M#i|0iz%DGX1sd)#huR1(4*2&> z>(2(8ma04Ym@&dK)O}E&NIUn+ED7H-?R%z&5)d2(XJ1@^QfE~Wl7JRDJI$S?r<=4fs`8u;0w^EcUA3|OxdyfB_`k$0`nWP8t&m&aCtmH& zs0Y^<-nNCEu?derxy!B+ zVaFZwgzkXs2=$bW=Rvj`R)zHOe$|>g=PL}XH2+2CR;pK^dWF97R#&1ehoN>FbN3N8 zgF5Wm5t`<7L)aH|Gs0)Mvu=Q=O0?4wx(T2u+ncwF8V;FYmvAJA0lb43`x!9X`(U0y zRmbB|`e}q2E0(gn!+Zq(31G${b3Ha;hRNV39}ly;4`yHhFEhc6gZenZT+oSyD=xAj zr=sl!G4`vmj~lnY)?J->F1Ba1zTjILnp!_T3;sL{XV=bFXW4zU2_9cA!@@f^rdzC? z91dgEfd}?tZs%5q40qPfZF{p0AZs$*AX{H&9q+d2;|=|wZkJO9Wap5vrMEMlwDcdS ziJ*G4y{TIVk4DCmGmoT+d>5Lez+_^+;lDa~%pB2-fIlZ3!K8|dRE`KPW=D>2$h?Cj zGbJvk`i&KDM~)m>^8_4eg5EjO6#d~G3ExLbgd*Zol@dAC62fXsI^l_1lk$oq)@pSV zr&vVKzXNARxXP|DUzI&*6?d>_ZYix%4Q)r+Qyn8#q8b~3d_CB{A% zy>Rn7=#XBb2tS@(@lLw{V!1fkg~>p?oiu-aD^|<=Ja)jL_uwfDHCt?e>R6Vt8?XE2 z=U?se``<76v%#jNmV`crGT~&T`=n&)n6OtS;+{Bv`Q;+ZPk+7K4)9=dFISMC!FesD zPXI7#Er!$qw%GQ4eEF+!lI%6UbsI1F1mAEUzNwU6@Rt(_(3J=&WCcpYS0M7k$`jz* z2^>}^b0;v?(gz64$3liC90<(4j43%Zfa84t59GX@>%leTQ(FEt0H^x^-YwGQ1iNdx zRuM`5sR-N!qT*Wx;yrk~K)4xRIS539H%Wsx-v{p?rI+{Q_K5iGTmK#KmOJ2;1aIhg z_%$KIApTgptE*5FZL4*o4wDl?FcKC9kSWs zrqwXv0QZ!DCjhq%TMgXLnzhp1;0}0QPBEPg-5IH$6=kEt)FWYbcMcsGf@ISS^i%Jo zlQ>&G3{~(7Nk)S+{1Ic5)R;c9<)ck}97vyu$9o&Ru69{gx05} z_-CWIn&~$Hd{**(&iF;7OfBpuk8-8H%%@`VDEgZmdR2m_|kw1?xXZ!ZzUNm#6` z1%$i2z*mGVe0!1AXS+CDR1!jV>^+)ZeS3kY!p$6+OvZuiJ>a7jUvt>b@uLYAVR0Um z!Z`{`27eo5dD`OZ%WofKyF|A-)B7JtIXFOx5qFT930qf~9D7&^U=8+_iK5$H?O8Zq z{Eoyicx2x{wEh2`f2hA$!U_MJN|aHSxafEK1yeTqHHt~x7>1hhWg`v80XGt?s=e5L@v8$={|BsMdq}YC*Q^4f zMJlcMH+<8Ak}^!=t4DDjLaVWJ{qY?3n7t}K(-H!;3142V?7W1!`WSa6LUzQD z#N1vb^(?Nr5%U$=WCyyvvYAZeOgQxxPH!vQVvwDj7!7!xjh(nNG}ooIK8=jqIE6?d zLmYrXsDanW*Pjwcqxn1f-9UlHL?y%n+KvpjkcBC56kc%HP!EmoAOQ(An4$E3@wQr) zX`dUE7qfafO%18u*X%K};mI zc82DTWJh4<>W3hd$kMP7dBy(D4q`V(pi53R7Ap#n$BB^bjMC5qz%==S$`EXrj48N! zGe**l(MObV>$;awCr@+C2n`qu(Rz>VKjTq zJP6Ixp6!U%=+cz!TvyOt(zcRlqhMu#xhBO!;1CP?uEy*?h>P(x+tW(TcBC1TDcfjK z0BcV!9^r?E1qf#Rr)=Yp!CArVq}k5wqn@G)VA3{%)NFfXz9SQF$oAg)E|UtJ)%101 z9ID)69I=P_>Aj5W{Df@g>x|cZgekaAc{-&0TV1di{)>5xy$~WYb-{pvMr`+wQx}YA z2cemJ{4MN==mT{$qIY(448za3Y|pzPcGN0(1EUavJTYu-@ihZ*D0>g*U#lcdO>^3g zZ8M@3%C`IbF=}1jTWm`NjbuFW42bn63#k=0OZoJvF$e1h zacA_wMtL{IL>SR(^zXbvKCuei;aT%LX*n2Z|(=rIRQaSCOG|5qCx%Y>;H7(55;X^>r)d6DFHz2eapQ z7#)OGHuglPO?jhZB1a+oIK61C^d5j`VPV;p#&`WD?T$NqE}$$r-3;f=7er#Al#g*x zzYvSkqL?={KqLwyoUyi!#0J>HqB!i(8IDg0hi^tXCNoNUSA1>?rwV#t_q0!=;;;jc z7BJ@J>H02ura#S{PXJt=j;p6Sfnj$tq9Fs&I*5R zw+Xm$7!-dqZofkmPRGoC<*miYq`}1f4u~X3gFG{z%F(wASSGW&I4>hJk%4X4Uep## z>^P>2^D;7x)ay zN@0-WomXr&aau)`iQ`&Ht||y8Cn`Ox%hNJqA~pQAdTvxxun`1zd0s~bZeW&yC#f5S ze7RMg*O4i`DP1cKP;*r3%_7aKifJnRx>?E^RPB7334nqDnXd#xZHM|WxGnO$&gadj zb$=&SFRb%DwSio>hLWI<#oUP37R6x)M=+I;o!cjvY;}luVFzb`I0hNUM*t|{h3DoH zR>fh5mICj`Pp~`)Wq)Z0XK-zmLt#lth=de4oVh3tJ2W{%96#~QD#g9LqvdCmYoS`r zFcMxyq^>yZKoN9aF)$8|IcK_(R>iylSr`&lF!)G2xXF=;L1j@Kc4)d8Dpf{ zM43D7s`z~Qbou%6J^#MQ{6=dg9cVz_Fe~7|bp7wYF8{p#Tb5%5fDBuqu@910l37cd zN-l~7Mzz@`imCN})ExJauRbXSHD0-Lq%Kk2R>h~~^5wX`LV3)@>dC3J+Gwu7TryQT zmf{4AhJP>!ikPpV!frXIJXc$xT2)x5vC&1+|EJsKFF#(t`{9$j{`Tqmw;!+HU%r2h zTkO?nEuvOL{uprZ>*dSU>dp4rUx+1Yce_ZIIv1jcn9gCbi36e&;PJn;tMvK^O&-3T zMuDD4t`0swMByc;(|X8BSYV}cy`j(jxB2|b4t)KQ&aF`Vec0_j8dtu-`k#ZpQND-pDO_~%I;)ceyNh@eGjiYAXv$_SoN>^gE zgN{aJ;U3;tV1T@lBB?ywOR7re+*Cmtp^S6wyX{0ecEV4X|I{6MUH%`Q%-3?Mbfha2 zl%)&H2vXlN5^;*eE2FV@-tE-EhZyit@^;fa+P^{iQRxo0l0k~~N)>uT58HaDi@QV1 z;@%Gb*P>Z8ZO@eCkMg!x)4I2vlBPF@^S#c7dDWB`XTx~n>T8)nW7_=z%US-)ZiugTV-8of_tNSqyu$?4>>n-g2B_3`5r6D%x^ITdxT z1#0hrUwSs=>wvtiu`B~{}J`qpTM`hB&;tH_r>@eQunw#Hc8mxpiqb8;q~pU0HU}n zjHgEaIv#BZfWQ8F`Es?*R7}LK;!L_m7JUo9EOD`=n8=ep>rYG6xrfT$WK;ZJu2y6# z(KFB9t-`0v&#y&JaLkBH5tFAUxLkH)p+n=1ZPx15?E!=4(a=de0*^iA(SP%? zH=XC^+v2D2d}3K8@>YHtOxVMRQWOj`;|YAsGqkniry*~{hZA=G?Eu+xi`xvDGdOe; z%f|r-CJUGE0AXD5!M;5}V6*pCZ_hK!=;C=6L=!MJw*HeBO-#Bc`+QZ|wFxIugXU8| z$o#TIKs^8U{*U*MFDWi)?c+;`VMMf0q^z1)*7>Cx)%dFZkI#`nAUhkb^Qn*aKSeQd zAYYp-2>^4|u6afdWz_^*$L3mWlt<|?A^YUpQN~of(z|Q8haB#ZemmjSr_tE?wrfn$ zwpD9O1}K1vzFg<@`RU;W>5m9Ue0Q<~=aM$%z5d0xeWN07c;B8iDy+!8PX+qi*r#mR zNm;JQ@_6zp$?q(GUC`gjYA|2j&Guv5?a<%On%DA>kJHZjFtQZWK8?J2IemffykZy` z()D)Yzn0{1v?!rnHIYIf8rQHBtbURd>HGTo0TQ@RD=mSCY2_?~&!!bJ*iGX~&)^c5 z3{LkH)Lr?!9WZ}}=VOWezi@BmUH*E2c`ZXP1l&9J|%DMT=w|j z28B4LtlumTw$g>2{FQEqKk2o*{vJ&tx6N69heAa7nKt-@LkJQq#$;{jMLgc6*SGE| z{I}DD%i%fOkry@_PwLv^Gq88>%zt#WC#TZ;XW&~x1XxD_NK#_vG7(o6zNdj?sj(@Y zz=ZU$J~Ws(IiLqh2I4wFBFomd07jCm6Cub zq%hR9i?}||c#zH2mCm~c+*~7UyEbNTgky_XS5f|^HQZk=7NYAI2MUi6_9v4ADxd8& z5rkr@P7ua3L;6AG4C5bte);Zy+?P$RB)JWQ_wN+%0$r2(m-Yh~UK&1v0o#j8c;Wj4 z{(@3wN?FyI?j8fv_NM!hR4GM@iU@vB=`Fip*=-s<0;2jQJ9@k#Exa)CYUh!J&UEJE zddEG2J(OW0jd)$ozC-TkUq_pNQ>%|uxOjApYSYrg(*uX&DMw}elA~<;@br`JILh)z z6q+@WhY|X5Kozi?nf3Q^W%WGv=E7Fp)#L3)w8+ohd-Z|hEmQAtG5~D!o|ila^up+_ z{@0Ioms(|i(@e#hx}T-Z-E}zr;OhHwQx6S3Y|G(~P50|}PkWDSM zSv&Ff!pVR6O+xtM9H~`uD`=nWIK$kyZu7_1{Ob%0C>&dfY|%=?T4T=-K$TxMy3lCZ zNh}=p8dWJhb&H=)VkPu)KN1r!zuF+AFD@cQf=pzknMISQe~2vY=N`@0?U(JI_H_^E zX`8Jdr+~)(aA*aZDhCa-o0p)VA-D$27MN6#KRKZ(GFKGsi>)tL-{_vdRIBc6S1yoU zbM(Dgn0uQxO#aQ0o*(s5S~=qT>kpPV#okQAj}PoGA6(;7JoHu3$dmf`MufnybsiAJ z*H1m7UXl37K2CO`=ENmN`+gp6pb;v&m;L#^e*|u9#P^r=YaE+8jLrA^x2BlUv-BFT zV9S;`(aPlyN56fpFhF0v18za(OlAuf^+E518;e}SY2V{uQu1^)55bj}&-458$Xegy z`^)+@E-6LZ1vDp}+Mk7(VK}UBM6=O7TGlm#Fr4l*$&9+h&CZMoV7A#_!)kx_rt&r3 zKFwOG`y;sD*DlfLN919-&&YqS_RB2X^02Kp9OnZ?qg^J?#9tO~9dM6eONia9`7)QS zpC5(GH02pv>Ima#`(f*HAA)W~dyBERxyn1+4hl)UTQx0Zw~2F@w`c`pK9jfhA!X(U znE15U=(o=}ZlmKwy+Ih(--RkbI(k^{i?;Y- zx(uf8Hs@!$ys_oCWE*X!x`ZyLrN@$+q%JNUJWlGv*fSYzPcHbxd;4KX=Bj*|i=RBN zi>5LiAMRUHZSjkhDgJk5#rM_ew<(yT=EQJYP~Ew$g< z$}laMiUD${zLQA<055y`F%~RXygDZuoJ)sralhdvdwssoi5?-4wF{aW(IK@dY4QmpZb)a^mz95$9?_)0 z>YO?gH@f3AZ&Ci>q;P5-ny{hYPxBTPC_t@9{Av)9{AG1S35HEn*Y!IEf)3M^R7J`_ zqeEdw!?4r7g}HkYf`ff;hHU!vwAb)vm}0QthI;oB%ZK9@cLpa;YI&8kDcLaTm3O%W;dtu)HO&7LJC-F}BNG(l$}WTHk4fWAG}v zWrVPqRfl*BGZVZ>B@A#-?J3jdqMyTYi);F5BBNNsSk6>* z*=$P}1bW4#ZmSJI<&wsjS=a}_4_)A9!~E0!9zFsSnI&dELX@|h7Cyq|Q#FbSqfc?U zoK}jersCgm)VXI5f&PxM@uwguGY_C^WPSjk*4hN)SSGcl|A@sPKdy6wNwiz$r` zD5XDl4Nj|P{gxH2QPOgd=kfV%OQ&nBihx9A$T&Q_bxl{3XWhwMf*4A*flMVIEfCcM z!)2>L8RTe%UtAb%!LDSpxYoVKg_lh~q&}{f&P$HE({;3kJk|K(5JnPqvuoYz**1RE9CTD)RK6_SqhGkSgv6Oz z?w3FP)qVcs-yar*=AjIAx~z_t@cGw&eSD8xT~EA!C9j(h zx8H5Szr{UnqFIfl(W_`bI45Bd%bQd!yyXm4m}=Crl%vz*vYob8YaP4Mz?5sG+P*i{ z_3rntbjaI_p4(x`HGx3Rnn#n^kt^>ZeM7Fc4Am7rkDWq|;n03*brcG1)7MC?HL? zhkcJz&Eho7v}|RLL}I<{dt9u-El|R0h#8#;{?oq4Wz)2WjK?2un*IxAYdoEv0_i9B zNUcmM&vDt1y;Pi~p!J*WccnbXWz(~W^Pa+P`vo_pxWr{=QV1i3-S(s9rZ%Xa%|_9hy5cyFf(C@LiKY2V`jJ9pnWlCAEN@G#e)6e0%^1$e^)2EB~1 zy&Nwqc*~yab-HE4bsN*gH*1cI2{K9Eh5dTUW>dnE+5Dm)*KMG6P=8tt-e5y}(;MN31X6C1#Ox z_|W86O2^Y`lMn#yc_EkMWd&fCpl^VtH0v>Ov@ZBJ&aDXC=vhip_b*#ztC2U!d{ zOx8>IL`|%%8~_w)%gb?JK+#g4SzDiJ1@K{V+!r8asT#FFK93jc((HIy0E{+GxePnw z^)-NYa@-ft8(DTJ+JNrMTe|GE1ie)xA4g8R@n&{&((4L2;v+(HBdgsy)arDlxvc2z z<;8S8uTEAWEQv2GI)iNR`N(XyO|AN8s_Tkg{<6WZ)fD}1lv2~_cv;aeAko)g!{Bu8 zyojUQLE`HQD$1P6d&MqUAED!OI84HiL}8QEIZ7!&DbF@S=E|a=2$F zkUh;z;=JS{V!KO zH5R>a$6zw9?Vlfi|F+?-6nnJS6ib76&1L5d%Ta2cN7y1Hh_eGuM~_wzb6Y0bbFaQK zlSKIs`(?5l$&m!ndw)g!0JCFXu7U=F&VA9n53K_ULD2sL^V}mdGIF8BDv?vAXuV2~^lvp00O(tZ8# z%jNTzU)|-8UoZdp%`xTnBTG+PP)PU_`D1WxV`IzBV6nJlDuwgO4vnp3P}HUmrw$LO z3tnvtnOWUBB+tny-qsq_{x739v$2Y5rr}<87j?wFwzN84#PFp&plV82^<-3z-t#8> zyWT`aAEeMV20^*?CV;roJDJ6FiZ!MTs0#D0?W1ep9>IG#pnITw+uji9aL-@1I1_mE zS}c}%U$n#fqOH}J=9WF!M4cSaj+(P(wo8d(E`B8{xh2Q9BmSD)vEQta5(T{AuwkAb zS3p=P1!nfkcvFmt*X-%P-hP$3&Yfgp`={+e+Z&k^-&eJ-yvpDA8-6(+ z=}?;bCrhB8arv}8kbcEGA#8l#%9O7?B+eTz0A+=fX*T0x-`HLfe~?0R$K)=KX$(o) zX4^kp4$JjHK!mSK3OM#HiQqShz{g~^_*_Y07cdbkQE}oauGemF6o$PS}Xyd{6a^J2pNtAAuq#!GwNST9yrWqFwnIoa%dT zQ>C9V+N=thyoz%hT}viES`np5wP7$Lr}Wy9@PEY|(QGd|maF^DnL{ULRCO>(i96gd zCt!0MbBbUj4#m$(milNdyGG^CP`y25lqoQlj@wUIA@Qm*lk_bKoskSkz{& zuHuObYi%5C#S?BpZ0TBJpO8)|B!`-N2P}Wr9eXF0K4H{&!9gu;LfPQ^*7|bDkvBkm z2T;V%3CU9Pty!HhiM3%_ew}8NC$7HvR&0MR1Jh#6H&SiKEJ4D+T%8P}k-cXPLeLrmDygZ5()tu8wp&5b)lT zjqwa|?Y`WU%HMVfXMFpo7=*vpwS+kcRV}s)d9>ItljA7WD$#jSL6VKBVA=(upbmeIH#di6iZ1NsOFxVB(2N9?1D9lGwNiLK(;O0bIOE z5-}{1slp}KIOS>;7ebD$N~j_v8VJBd=%JT=%MH1)Ee?rt%(o? zYrX~Sy)=_^WPT|{AT#3lTLjkSO<+5ZhG?0Xs2KJJcXetyR1Dw}n%|P`6)u`BYX~rF zb(_#`uK6uPw_9*{*0!dK>v2@MC8Te0%UEe#C zkIXN@j!gn++nBbY?Nl1#)PA+4Iyn6ri!?muyGG$LJ6$n=q3 zy%A^?TFNCP7Aa~2OY$UrTjnfjDip6Vwx3MRRhS%~ra&H>)aDl?WqyEhx@VU-BNW|* z0(v7KR@078>ZFon$vg#{mRR&E2(0auoj_9H#t^zL)dRJj79|(ycfth{1y+ct%<$Uh zpT5}3w?96$r#^YF$u4i@${AQ{kWByl^9%d>@wZP`Ci(6jUtYQG!m<*I zdNK`(J@G^6UjqCI0VHF!ZxFcYLgVDEy;wI%F+DIq9~-8vtpdwyG0FCpnS2R;o{hUQ zX`z6-fdV_BczH!m4yv$|j(-{O=L`ULNiFi;uw=9A@KYad=`EK|YF6gy^udaF$$43TVXi=;Ubme8+v zMfUgYCh==t?7{~a%X*Wsd{nw2rY6mDR`S3$>^()>G9AIbRxc{Oelp<2XvDMSxWu*=tzQywjA(Af$}3Wod)-3d>_ckC)6;=_A9@O{%#8kz#+!nHr{NCv!Bv( z&3atD`hN3zYCx{8meA^n?~tu>kV5m|%fWZv(0S-g84I4e?<}=<9^r=0 z1GKF5TbM`OPZ8CS@%fQJ&QkgE3bLIf*|QuaJ9t5qF1p;jy$r`ET`4Bad~ql(Op>r`vcOQ{7^`h5ZE41N|QWp#7m(&{zz8hnh{6p)-Mrh9y4$ z>U5Y}(4jaHusV4y!r(2PmaVwR+;RWfCiXr*(pA*v0Q*&d zqIDl}73HR@c;sfv)LIv}6L!s%_iHm%WinH>xVSJ?lh^V7Ib*>W>(Ly$E$iq?tBk-_ zRamksheerv>XGMjt==j618}q}bLPL7^5=tn9A&-_N3(L&YWHTXJ@$xY3LLc&wC1?& z5u+(HK~W^-7}l#X&X+#Al5tyl%>}BIuwmRu%{q|q?u_dNYG#~tlpmssw-u;+F)k|O zyfUtwF)n&nP9;$o7dqntTv#NJ|33CnW1J|ktm3P#7|$h`6Z26%V|bmai(P@8aWah) ziy>kvBNug$HGhQdUxoY5-O7C`yKG@3KlqohmD`du+a%=GGH?&B%QINvj%w*Eo*|2jERwuUkUFI@6BdM&{6-j3r{XkMXjWxV zm&Ez1iDP$(^LD!O%)4zfvFF)|T~%ewu0E23Z9OeJ0t)`)4uG$9z3XeAfBIrC-~RZd zPmK$Cz7>6qo08mX6ZxPCs*}-`RJo+jKfi#?kH3Aoj)?nO_i_aO6w;F}?t4MG-h#5n z=`2R4G?b+@7jOEjOMERPM-)`qgY7E?fc=9x0; z+)<`IO*6{D+=lW1*2^o1o@mIP@ZSx}_BND_Nn0*&>3v4r6Qg~1l+Oj@HINsavKKT`z!nd<)U2%yw`3vOARAB2_9D$#p&`kRAwi&-aI;{G$Ye zPYQ;MEzB+QhnVh^<_Tc_L1gxyNBJ=mMaHff1IaL8gZyn!Zo84fjXF?ZesJDy1`6EU zQW+@lXUcj=LIY+2T$IDSj1(4)W{|xEC6$@N#@U)@3IyUc5S=yzNCcAlKo}D&8GjTC z!54=T3;wn)Egmp1L1TM=N!Oe>qT~)oDUWf{hkWRc$DpjZ>fbKstvi$V?m#v(s<)t* zGrP-)x0tjaM_-=1%b7S&ZW+!9Lts*89>rp|W@piRal~>h0$a`gVtAN*=n5Ajzg$d$ z-S{$T=j)!4l<}e_9J&igsa)M5Dg`Nuh=IEDKv@PcFbBn_@Wa zQiSp9&iS+amsqr6UiqJ;t!e0w6=w_A4IGz+SQpUy=mMl-PKNi(e933Zk1U-|Uh@OY z1}tBZANEv!sLIgX!_BkH+Rx5&iu6&*N%v8zdL;B7ezWv&q?geJ;k#yZ@pq0c=)LSZ zxgW>A42U#Fn_G|@*bfoaCB{jw2XZ_EvellrbkVVZEE-G8()F0!-AlX* z#_1f!6myGl3;PkGy99V0kn>3*$BHPLhndJ}S-IYzcK;GD0{U}kVHAU`?@ zi;|pW40pl#fOp_Bp+$7Do8WkilxlE18abX4sk4~#VijlInUQ56Ik+(^$>&3Z<>f|* zF0a;nh0F>tDH1{cHn9g7;|~Yt4(%^K2(p$Xf(^h3Grz0M)DF!2MLVgd|Pp7lI!k%zq}BFr{(t3WkzIK zn&kz*10}{hi#UzMv{`yCc}cUp1mF_>MPBN|=x1QKTjhmQSmgyFR(T0$M4Uz!ZHsaX z{2`=R0)2yjW|TdeD7p=^Y#SV#Z^3L+TwxB5XPDzTn6vY9X3b>w7)s`)>kWSQkMUeE ze_gFi=TK%9gAK|p@Q0A@vfy=4&i|{9#G`9ZRg$CtZ99_S($bN5t-FqGEucb&iq<_C`EK#dN@H5cangD zVh+k#?FMk>hM;En<5GWXgAMvp=om7xEVFoh3n}5Ta!xWfI37V&L%;)X_wD=e%WofO zfd2j%e*HfD3@qJtrm=LUuJ24eE^m@PIGVWBc9BTYrHhPKS*e`U4$pm_a2>m*Qn*=^ zWka}-#}r$_?Kt>w!a<{ru`A=kXyEcI7{~uR#wG9bp)SI;$?M#b)1rGg&-%ss)ZAhr zj+~Dej`}Lmt3Ujmba223_U6!F+9-$W-!5n6yN(bgs1pN(tqs<~eQPlAF>kqV4f0Xb zkpUngu_nU3)rAN|v5;{|T2kS?b``4Q&ypPyWYngnWQU7*SpJgi@IO&@+)3AUf^4$G z${n~4y^zQt1SJBj&dhTzV0x>)WyzIyRcq=p=QAy=aW!?SUQ0UpW$C(Sb{)sE+qMyp zX5`wzMm)eej!AEN$2g`fY+y{5-8d$v#hgs2Eo?An289-_=?12Kmg^6le)TMg|HELW zb1-|)Et?yDA2Ro#MR^&N?KzaUXiYaUZJB$}_B|eE{5)=8UZ>t8l#ixfpqz$!P{>|D zs3=q78D)0{WppS^wM>LrGS#KQDg`R2&a)4C%&$ z(-7sJk@Y!cPk)CKlUKEH?Rpuxe!+SOCxr zL`XdmHshExcYd$>PBGQZssD7l3Db=+&c{x@lkFxErY`0;lr*vBKYCRG>%8jWgWAJPl9K!Gz97&aQEoEqC0wK?i}$P&CgC6rXf7n1~Asj1*> zu}xHEA@6qn^**8#b${A@-|nkzm*c0MyJq_;iWM-4*65~PwC%pyWO%;aw7YG)uWXZN zw@`nt-{V~f*Q*P1U5ru54#-wT7utXyt`Pj*a;pv9 zLc?Jl0IQkc5Ua(@C%21Ld6&WGx#SSX|j ze>P3|#;F?NcElw!J>n>)Qk_@_${eeT7{eQT`)l3KqM#_|IAoH{0u-|?iAxYPD4blZ z77XURv6};~Dv7EpTm%xY3#l!(j)zEb7Ddctt6<_CwhQa;uPP)7DUPSh^+1^sW?Mc; z+WtvOeqNEnB1<0qk}kyPbitv5^`775H@Lh9fCkM-3?&%3ep;4h4Gee-DP^uotiiLy zW~n=?ew9UakvT+##DWZ(l6gtLLf;I`AXy+&{UJzfZM)Q-rAz4KqG+=jgR^rr2w_>d z?zwfnQ8L=24ywp>#J63ZUXN<>hLusL+?cV2_8d(EJNFOy)v{tYl0^6Q75V{}^ZnQk zGc>(ydei%Y>4LEsO#eU3IT0x-LsCIqbD<5h@O5QmC^O@I&Vuor&^Io8OtwQNh-PZ4 z8ls3{tS2!Y_tQLk?cif==3}4fHulNu2Zo(n%MI8#Y;9iJ_f9>tnEoO6L~Jg_6Yjr-@A!~f z5c*A0C=y&fREn= zr+tP2v>*x&r(2@9&7VFhPojoBe_9QK3FgV##&gQ1IR=v_>z^v$?+96 zEU6RFT9G=3;H;1Y^2CPGp~)28v^3YBufuad#&V9+{ipYUaG`l7cJ8i(6zE}F3qx!^ zFA0s*=dlJ>KGqGCPym_sZKTb-G^c-iVM3NA0bbX^R|7B8wb0X!L6=y^>IyGAhv2Nh zafk+=1H2)b$mtC49fFGns=}2eBl!Xiz}P{*+n0|JPDChYGj|$voP~fL!#j2h0pYXz zE__l(sxb$C3dRX2Tb(x`uz|O54ox5sB0vNY#Vq-g9s6pVMK@Zhu@@&x6wu5{y+e=3 znS-n%`+?kk61IwdWx!5`g;>axE#E3#(| z5*xF(R2Q+rBWA`*R*@{Ntr>L-}-|*%b^O z&?5ErRUkCc>UfOV#S*x$9m=Pdn_WTc9x0?|t_&zi%VxFN6<`^GIX2~!i_Gpf9@R@4 z{#*&61EBThUb9O~=u6pkZ6xMBfpe)XLZIXcT}nXLLLz~hgvfNap{altI0@isBm@LG z4G34rZQ$$B6d%SO7f7Xi-~rBU@u9t4fVIF0*<9&bGM`P?>=IbE)OOv|x$~w(pKp^V ztn_Pb`-A2^k{mc{=-G!KI}-DlHw#G&GaR}bY<9_n&_oX9vwO_81U+ak zuH7csjy@jRmtdHEC3P+cOYC_J^w)+~J_JN-AX_~z=rGAEz^=l3jlhA-q5jH%;D9Sa z6oZ$HA_pZy1)x&~fmc(l7!64KK-ey=A`pC| zF~adqc_s=Ccm#?~F@d=h$&4qKZChG)E9Fo(+kBEF%b|Wb-Y7_{9NW0QM;f<7ERXk@ zeQiy?%=%}8jDiHrv-PV7q<>HA^S*S#P-p#%3ylIjh)O_b1YrR!;TMI|rfmZDPt-5s z0gx4|lvboyvK15{AqYTxF2fX_vMYe6qD+1c;(TFxAN*%e>gcK}8}xxeUW zcVScDy8wy&^nuyesZq0^KDb3VzAfu=4UXX6z zXQ#}&+S6R=llsMrRzrg6cDHM5_F!B`9OixPq9N4jgG=D7hK}AyzyR18C1cs>QKUm~ z(NH&o_%0mtie@-fk#j?E(O?3x2L=jiky}Wk_zo4YE)pngUs8b2(g21r)>(jXqh=t8 zTAPtH&@YMMzFwlyVyjYx_4BxT26+ z#UOVi#*Yag%xh z<7oOYbOw*fH3?8y$oHIIz0M}S2(xbzpkX5aKvt?2hP_s2Q`;5Rn=gz4*FZfKbaWj_ z`i{N|pAP|HE`oqYQV;~a1D(ag>O)}9phlEtU05CRjNXI~41v_EM_MlxS*`e+f()QO zOMrL4altvOqN&JE7iNLEM{}&99#N;wYolOaFv{?-2i*|+(+@i!5M27`+K)THFF<=hUr3yc9|tu3pO^28m#aPQ z%SgWL=^mt5EOHa~R>f@*e=3B_JjD5}Rn*|8HQF5>jLsIdg9&2XmJcNBDKLyx%bLGa ztXh#VYhrZ{-w~OUcHntsfk_3!<(Z+0PYw-JD)usx3eD*V4Fb?h(b&*21$0Pel{nu; zzb_wgzV+dH?`im`xH6Z;rBEi{TV)&*ky3bKa?kaBdbaNg*Bp)NWTIjAeTIWK-)B7_ z3??Q^&@S!T_yhH^Ej1G65=5?H!nWv{jB&mMa}qPfZ8I~nx_VSd0kn549|^GO`x0Nc zHJC}TNv1(?o()rYjWUQL7!e99Key*U7~AjHH?OybZIWZaU1r|ZRNaB83EoF2@^i;q zec0BB>g%a3y(bU~DcguU9Y7t}E!?2MBnd`2B&kQnY5VFh6<7)G0~}qx3}cq<|8XfH z5|f^lO+dn52L@#-D0YsImL$1Cu5C{4D(U71cq^GFuvwuf{r+cW{=WwPtNaB-lf&Oe z!hg~|tz)jWIqMTZdPTubX`cYXL(|B|tW>HIb9pPuuOq7}r+cJdY7&93H2QSe+us+Y z?`l+G&K4Nb;2O+~PD}!mo?D>)l(nA=4dX!ipcyhk0|$n*i@vES25+Nv4&eLW>u8K) zQUy+?0#AFi1&-h#^laDr`pfTr`SY(A*><@LxN@qNK^Jj{o|Irg9jDb^(Ny8;ufMKH zwSWHi<#8v^zFI%3y~tp3$!GlXJ`V%SMk zx4Gn{&&1bGUqFyzSS}CvsTxm$C(ygU=-hZ}<2kdT&(?&E&Hu5&%=Nd#>vj{3ba; z2Xf*!_>ySZC|LIO8ZQS20t?^S5`I)lQ&*zh64}g)#YU}^Wu&9x1|gQg+b;LP+l9tq zGid;sOzhMbIE`8XhiS!HJc#<@9Aqy!t#i|PhMBMjbGmm9C8sZMUF%%vJD%%m_)T&; z95EAptk!u%uh^Z)>o*BefEX9b|uBcuNG^(DDSN!!zJ_>9n ztDgBPunB8gU=!Bt$XffRo#uhHsC9wOq54u)xmQ*-U59&N>zP?^k~L`xq0Y)|&F`?<~Jy z&D?+uK`gYccZen~hGn~} zp+u!qHEhq!3v62~IC&T9Fyn;7N}Y9z$<;){uOBuv}`1x|v4}yBNCtRJ`8L z@qRWW+0RY$MHxJzvD5t!IA8X&ORCGGHGxoXBZE}r%t@B-uM%e{?%q3udy>e@gXD9R zBm$sVZ<~6*VO@KJ+a}RRGxK@nKlT~&Tk<1Fd!n=4a*kgqt)gV6TVi1a*ctqi3Rk?TU=L-V2!GTmCEW*up+1{{P?eW!E4tG zs+WKNDAn7L$=%qi!D0cMCA`8b#keGxZtQ@y0?V>h5N$;MuOBae{`2Nv{(F1*`^U>3 ze7H7g--mUG^fX|(sHya6F_fZhYY>rP7LWSzLDcC$6i-OPdwqqiX!l9T?je*U#Anid z5_TgiWLK$w%5rCd|ATHvPO68IIm4bq>0>T3Y)7H$BBQQT?>CHPZ$F>HMJDwC4&e?L zS>IxShh3yA@ZhuY6_?jcM;Yxlkqr);iS(%_Wa2AFXr97F;zm0e!5wh5-Ua|ruU%&Y zIH9!b^jpE(XfsYFN1}lo08Ah_z?>%xAAZ>E=czGAD;Z3>$h%uK((&VsgHcE9*AV2Q zZQ7VV?l_t0<9_uNpF}R3hl{q+V*DN2CVz$^V@GmjHASJ4YaT$|?yQf|8#A?D$cX4` zeblDfC$v*8H6u+@64~OZC>GC#{pE4Uz;&LdJY~0jt>mfPVVp{(tK&Q53123NpKsXh zx8&{#){G7&ZyVFin7F?GoOzYr(L9GSvAc`Tfa!We=_Vl^VSa}Ax&84&fmN4EvF6@M z`%7uv+Nq`w+nkVUi}tzk!wEv7OBxfjB%D!#^`R{8>+O0S*lEZntbT3@F6Qx82`=W* z+Px*%KR^k-qrouFPpdCC7?=K{skhu;SYL|VWZz$6wsACmBo0O@c^PT99s7A*h%o%Sanihbr-2rtH5%!EgX;law?SoPa|p zz%kS*xuZdT*{<;6hh$nuaV|LcN|p>uz(G)*_~Ad^D)j|$LrQpwyX@x22Ea;1(|MG)>2)T3^V6~&CBXw+hMM$DzPe~ z;=17KaQJo?ua@ELc^wd*!Z~rk=kn@shh!_TP%`WE3Bc;~AjFEJvZ6|w{r2#BR3Ac*H`EVtQJLylCD95AjiQRGIt|8 z4XnMv?EF8lk5pB;RCcG^vzgiM#-ahYNmr2+`S?h=({w04P;tR?Deg1{Ut`)xIq7dP z>qpVA6!D3_res}-UpHnD4vA7z=hmzbGD#~VX zQJuOfQ!-Tz*;FC>N@Y}u=Uh#dg`FvC>&7{{D`&?g3NF!0Q2WgbXN`gr&P(E?Bwxj% z;FdhxZdD0KOBQQ?@iaZICqvAos?FjHu_I&-u^b2?T@n!7=c&}@?15{;6pAB-kHcz#0#6_JpB5R+~=>8{Tynm)e>osWx+ArY$>(U z;$n>=EF+B%znyX3pZ}chP2e^W=O@xtU?C1Dy~6VQ$Y8rSgMa&JgD+VLikR&a@&9xB z;;5g*SutX=YAD2ug|5HBGbNu9ZczL9F6qL1hhQaK#K(Ks4IWw201^fP)HZ;GBYJV9 zGQ21u{xFarf?`BDa}{Ef@;$hUzKN>_VmePtB}c9rQ+<=Zer%_a&-@piray<=5|5o$ zFP)ZZSv#$+okk(tPgY|l&QIiP54s!t^-fYquYj#;5@QwR7DD?VN;nuPE1;oDNrrS5 zEHxL((z;P+Eb(NvqS?o47V1V~Zt5Z1jwbp&ly?87hS3mGT_RZqo@8ECbI%p)esm_X zJP$mIX`}ki7z(ht!_YGjO4RBN2&th|SokvUbZeX;6yFYnk~CiOp9TntPRtG=scI`U zG0?=&HWKMv4bngD2kg_|f}kxB&QHMQdJP?S)pxQnQQ%jApyyX6;v8@B57wmA^13o* z%=v|L4oWc>Lb`8d8aZViRS06F87u%O${sfZl->zS(wjg@q|k0rj4jr3K}lL!MM1)} ziuZzKTkG=^h`6yO?#ShxU?jf+j9}|WF-0lC$3BZNbw;2FT-ZH>eVgN-aiU(N>g{b<<8?hk~eF7~^L$Zn;L~vru4mVqTijBp*3kCNuq7r*70uLL^>Z>zkaW1Tv z@D8>%cbP8Y>h1+&7@J1Rt=;m6QfOyc#(hBf7yA)Oy?7&&G$8$G>MWJ?4PzK>X#0Q$ zl9n+{OI>8WJYDT};|BPn7CA%`%eu%x$bYrSm7Z~X3{~LWB4@@#hdX0ci-%>`uOmWkjO9IOehj}Z2$}iyDTwU&b%4l*UvEI9 z+zXN1ln+2#7;#8N>?v%x%;B|$xfFZC3hs9((nf{320o$7o0kK(>IF4G3m!@>*tn`& z{?DFuoK_<|G^*0;ky9f4euYMA~tH6nR>#cwFneR%kk4E_weyCR`>PM{qo6ucni1- z#yp@|o5isx_5${Sk;Q6LgvDFni=gi^&)gUR7#YwP;y0pCeP+Y^1${d}-o)A=A(5G1 z8~liMIxOe|7YlImJ1gRIkUBM8 zF1e!~9A8%HPErpAcMx3%1n)O%tCE4KysEUViq^Nzadnl(nm3x)&{YVNTMtukDCDWu z|C-bzGSrAe-LzGCOI`Ispo=dNE^c5i>Xet2(?iQ!>)Sf^l&B)ZRa={+RGUT+8!2>A30#$4V2~jWN{e&r125j!&dJ~9OO#3>pi8zz2 z&|C=f?}z3SgqbTY2J8~4qIxzH0PF#GJ3GC4K-jEAQr8e*aHr{k;{JuIb8B9h z`Yp{TTml)m(K(=}lT;uBuRuHQXTAcrC?*!%qIP#0#MP`G8wFC+blp}XaC0E>xKec| zXxKx0%56kkK1=Kd-~wYT3wQhYe?VC)uK{S021Soj3=Rx7lG57~6=`Y|EFv0ZLNh=F z^8h3&>i)*1+2!&$?KP)~vX6OCAh0amhGd8C((8*lK*9y>Ro4KH(i!a~_EY|qn8*bE~4>;qUXd2?)v!EjeacO5B zl%TP7vC>pA6FW^0a}aub7BUz)Vw5qsr6fxd>DGgo(dMn9&vXE2$Yj)V0L-++=&RT) zMWdoS7=+ohy2Hf+p`+uFrSsHl#ejN(Bhp(3Bs3S0PRhDC1OQWmRd`g)eg?tJsvAHk zvx~?!*_i-lR#|5z>n@4OCmR{hgAwfcoVpB{^!J-nNoJ|K(Kg}=mY1kyvJnHM27Mc4 zFveBn;?x%z%LuK{U*@R}K?RBcQh})N(JJ5@TuIhRO9FKjgbnmWFb-yRLAsD_v~h0Q z;Ok6G+oAY^JuMr9Buak1s5N86S#dH2CNvbF7VU2YgXPKOrehDX1f8~6-O;T_o4*CE z(w`_cUR!A0LeWVv_&hG52!2l4#!dr{s1HDxjoXMHe*H-9^Vi9K4p>H7U+e6#5YQ#v zP{J>5HWr$$O-RwhZ)ZZ6{QT#zE{wDOY#P1PB)$1rz)BT8veNniwp06fHOEgkhN$sC zDzlYh#3OljlHGp6INn$}9(OrlT)sH6ExY?1U^+{p5_Qn)V?dWqqB#d`$-$Sa{o!oG zzFO=c(~1&j9U^RU-$}-0;CQtjoNmlzU7)k&NUbE@^{{w$Cpy`Oo#lAF#Ox1`?4Sv9 zyRJW25({Uwxz%)(Hljew*(q$!zFSGorpfvqrdi0g#c+^rC$ihG7RRe)<8(di51<^P z*#`Q#cJ^Idj7!k*dMnzWTnh${3hBnt|3iGaBUi2)VK~<+xB-pvex$d`D{yjimdg`R ziM{_Se}9AIA;F{Zoyf_I&=MO!qx*kEMlHhjk_}9VYfOAOukNo`zYCl%i|FbEbRjLH zs8o5<&`4LkvOW~d_7D)F@jZh8VW^p6d~j7$>nyJ38y89jVRN%z-WVZJnWfNPj~%Wz zzN@7#Q#ZzQRVq%}g>&$U617s7S^caJJ+wVVh?kGrQ)D}8?E4OFne^HE6m0X=kwTzF zj_>-M5rbiD@G3vEUy$P3uO6>gze_N)g1kw!h=ifm45ji!L!-NnS|7@45<)jg_qYQc zT`Lv!k2|QzQb;n0QYeLDIE2V?hjh8aB+I@m;x(M`Tc)*yu-y+S)|W|`t+P_QtD>94 zo6nC+^)zR8Pn_M)@8kus#@msZ+3uD^+Tg1E)|(Ez zi?^G4e9V4=NJ|iz%;#pNurjJCozN*+deOYEuTxJl^2>%+@>&cVWiyHZH_5@G>b(8v zjD{|YNqzoxRQ6^Ho3$oFo+E>Z@jPg|l=s(a4N|vzD2Y?`5wl76*aMhUcGZl;V9Xs8 zo<~b?O~W2lF#dyDqZvM2Y%FJBQ=sSLgS-@hMA*~$W!nExZZvj4EJxb68T468d?(z- zuRX_^%4BJ>*m_UpbBU*9@qLnQ|D#kH*^oyfuO|mAU3vw!5An8&5%LdI2--}26qrPi zgsH}dY1NWYnjS1-jy)=r_iSOAwm(XR@$4!n(zoKG5NY2R%6{#0@Q;qNEEp$E0+~wh&HU?L zDF0i9s?w>!5;eJmg5S}ojrFFrYfORHOa=8owrc}1s60BTOK7rek|#=+%DLXOE_)!r zGb~$3BO99WzWG@tDMeK&*ptYF_Fp(A`?aH^9(A%jskn6HVlrNJ3bSGA)x=6*lrg2l zHC98^BV@jjGt&W(qu%EX@#6?d!6?v%Ti05 zxo~xRb7-8KH%un}hyO7wC) z2h}OF;Bo9!?HbH{Z&$-Mhjswr)G40+#SlcDM=lXmu~RY?;=Lk6=NAK&2(0&#$B|#l z?N}ZTf|KD(Yneky?=GgW(`ICqeMa$n9)YN5dAY7Rv>(48&Sl5Gm+a?@F+#VH$VldZ zXYcBFSrzGckS%#l1Rf%1e=$o_)>VrBWpn1pYhSQgn(f#a(Vfc9PxLP$Axgf(Pc{yWD*;qe(k`N0 zz2Kf>{dk1_-=y{+5evoKEtITyQ8VZ*(Bd9YufkCLq8(&(4efba4%g45J=>nxNbP=} zb(TINKL-r7A$%u4ntS_kECGv_xfEbFfYkD2Hq(&g73Ez0AkoU`$i5zxDA!6% z>f>vGY7*jCNesFb{Cs)PQ;>b6x_9?EBZCx+%qKpT*8 ziQ(B41#{#|W)ie1lLl;b{_ZG6y_8~BG=}Kek;=ZtywNH#zU8^PpPuK(*zds zSP9EC2+{wrYig@~eN|KIJApNq0_~E3$?|4CV6Yzrvdp?75`mv9<8qdw-AeJ2MqfAe zvc1t67GY(Pc3`Tn`V$FAQ!96IwZ79^kIOU^2ZO>ZJuc(bQ>C>|0!bsDwO%gM=gaKU z>gz6vws)e#LK=A`PKI3s#DdD=`mTYlifw%-;^ynnzqta|)Z=lTAU9G~G4KO6@?xa@ zGSSVK+2z{TO&x7-bc}%_>eV9MYy(0(1}P>8*~HLY0#n%AcWQ|c5bsqaXs--l>N#2xA1!d#gX=qq_<)ay0?FRJyG$401zj}i zVlY`_zvD7tx(wa!1OGa!9mxFef9`wHu<=Jww_AP2+o6f5;u(^x6u*_RS#QD{X|$}m zNLl9*@NsBS{%W^1ymmZ8%HtiPB=4U|o_c>toR-IV*7Km^X}$~z-bTTB>*i6F*L_YB z(yt?;B*Iy|Q>OjJ0wRMP>}jd|XqXg?P>;|yLZZ|dB=&VrPFSRR z_}te$5c3GMWDHXRutiahkn#jNOLJqN6-_80BR;mob$OiUQow4I<~4&{T>>?JTR{7D zph?r40xFS1@7Fz>Yc9SDn0~W>F>}jisp3v=vP3POp>2eMI>+N-IMQhII~s z>h%{0kTMvLHcKk<9LhTO((kY^06L<20}G!Er$|PFL4OFN2Euu6p)scpyKE zXK5T*7A;ljz4lhl;^p5g9?k4DcBE=~)DB_Q&&W0+MJ>YcWr=5dKx+lg;_3*5Z0ptx zYezSxGqjD6pn80z)}yDh+w;myO^3OZj;HD>T`-K`H5|+DiZ^~uhrcPF5`p4q`8}D7 z?G%u)OvM9}LcMZq;9z)~7Z-j4Gpa4yV`F9B|4QP7(2umBXJ*u7e6xM06ZjZiIDFL6a4!wgX$4MO@7WSaK#uOHWy zT`titf&)!W9*5NW^n8))mFK3&_90<@UmQw-9hshphPv==qXYFh zQ{<(5Xb#bU0E&V@hpAs#;T{+p+!iNovl}^Ezi<RL*p#5%lVA$)973}R1asbjIgmxsVa^qxS6qq_OwTZDV`{Vnx5ZU}CJ>wLljb{e ziL`K)GiOnTAJ_!qW~ewbr*bYYo~oWIPwX3>VjCFi`75?<>b7rwV>xPpU!7HqNwgNw zvlV=TA0>bjJYt8*h;e{LG%;pg7|yljAuzI{frKlUIvR%WHb&`{bN}8O`TMX9xhk^v z%?i+zR0{v8bbio_%H;2=OI zQ2+$XNJG^t%9(5ZeeU`1u_sMKb^IEsU|ET&X&ig`KpyWKikwm72MqJTskucRdemry zwvsCnO+wbAu1nMhEa2wGiy;1ogbnf+i4dWFFtUx#UH`te|FNujz_%tb2pPdy1PLzz zQn@_+X{&L*>RLmMS^-V7E`*8fgT)z}lGua&)iF>AVyB&4C z4-~c|rwzUR|2a>nBZfw@Pt*>>VRlT+e06o5croTSYbODsC={|PBO_b{oSfu9@DXRc zQc{J;$08H^6wyqwm!l42w0}?9Sho)_&%b=!}F+d=*fMbp^4j{G!{!I3Q{N#J_?&SRTH zl3ww26#?bMs65TLs@S4DPRf?C48uD9Pmy@vt{UV_j$?wLYE^#OMCh61l(9ut78@`q zp`$0ow!WJ~_Y}>W2UBauF#?cPBEdtH0GPsHa1bCLd**iQGCF73CK-zI|2prKkKJFrLoKlsR#CEa6V`;QSJZUhzn|=SeMDyxFNc7k_ zg=ECmw2RmngQiGgjg5oFh@iwtbL8e-)E;5sJdYbcC_zBL$`B~>br;cE-B|*-8frFa z0=fu`rV!j4^h9e$Be#o0h7JX}3%m+aP(gbKhv?g`;uQUN+Q42zoeMH1D+I`(l;Vvv zV&v>X>d59W9Za>ZU<~v%692~<$yj>=xe0DLL@=g0at?e@`(VFE{r6!eio{ww0XSEY zY`Tun&;9j&T4`q{Fkk|3QFY;h0a!KUR#^-vk`8g^A+32hwv3e5|J3LeOUobu(ylQ(;QMJOJ~KYfsFUy|NhOFJp-6|?b{40e(F~-$?X2(9 zdV%v;0wyT{mkCty4x{38!Cd=NeLwBl|56+@dPx-nJ$C?J3DWA8f=S(Fw6yxiK1qr$K2ws*6W@JKP#P)Z>I z=x2<5*kRX4S(}zi0z-NeK?~%ge<k=2(-YZ-5UHC-e!Sn zb0be8s^}eu@Vrbafr+fZE<&%qtZn)0B2XD?vkZqJN=;;hJ2))M!q87qT|cC#uEs^M zc>sq182u#z^XbvF5DRBj9L5+T_6DK!wEsD;q!z$g0A1R&h>vqgtKOXo>R}Es|yI+=xv51Ib*1{oEN)|2U*KJ^E)Q zj-hwgM*WkPm}*S7$>+61Tz=F--IEJ?bv}2=)H@>%FM9OOxlQkG6Y&loXS?a)UuRD} zF7AlzvFZJ=mswrD(=D*%XbuU`Y+Zg z3Y!Z}VuzzGYZ(mzI??qsx$Lg-<>#^{xkd48-qn~}@6)Px=R$MqHZ5e-FK!Iq3Q$~+ zN_+#2l63SyKX>%%owWX{NAE(|^zO2#cLbEHo+b0j$Gz|`bJ1!c)W2NgQk&0RF!e9h zyz9}w81t%k_lWuzQrz^25yN>e`~&2N&{{(HRX!vId)D}JXC*yzB<5(whnrf8r zrGp68(i#}x2CNa}F^)5Otp|q!qiF%;UUj$xxn+jV8I+`k zz<;@m%gW$ouXn*819+uDs6z%QY=rf>LRFUx=F6%@pB!>CwXVdfR}QVaXbBn2hbD-fJNC74k2D@r0r#2KPN4^(*1$5#i^G zTK&pcFRK>)ig8i8Qmk$zfQ3bi7~SW?6gD*Gfh@ajs-n^1oH1H0ENOIAMwoR<(3+Xc z!S_m7EQLc-^754cOgyk@SrC2bmya|B98^iuZ)#mB7QaAg!)i-FcFKpXB7i!R z^p$SQp{)}7&7@u~u-sQ7s~r-LawR}>U5qfD_cN0+KM{Znd(*5)^0<1W$pTcVmZT{H zc`xpKE?b%=&f8T>5c;BX1*S>DYFV|2rOR<2VP^C_8uhAR29EeXSIp{_VVV{#0p_MG zT3342uYj^FTJX!(ylVaZ5A)TsV>gaN_xCIO1Lf%b*fyro=w*;i_Ju)e5zk;I{}0Te zB-^AUC*@A3rVt<~^IEh>9v&Vp|9brAp_VTX6VSg#M}zK!`w;1Y{q@9Oc*6NL*pz6n zn@ovIwC_G|kKaBoA3nXfynK6Ee*e6De0;zxI(cAlaUXRzroOaIQEGF$@k z6}1hAu#SsvJjKR)T@%eP1U*;wFP;a`1CDNxGpMIo#zWVpW$14V( z8hG{F%}%=&Sb$3d$G8F9QYQO!zcI#h5{vWgfYseJAWqkAv|$ zO;0~VXzK|osvih6Ged>DiHhK`b{_SmC_(WdXHjvoh>Dj}VX#P?;GV{C&k@&kk-t+c z(hr@|Gvu(-B(+zCws=CCfxP#I9KjXa1Qlb4jMO^v3FJ*Y_ykflzJgEaHJ@l0NIoH7 zO6BAaCQ1Ek&ZJ+lPv*;!sI?BW?g)3gL$KdA$NAU`9YYEX zJD-2PlGTsWF3&0%|H9y}nyJZjg>|$ks2}R3AB??n>sJQnfS&2p!{zqa(p{8V>;!g? z4GuHb#TFa!d6_|~>~AxI?=k%YI=_gvr*jrKgR2Q2Dl66E|7_-Jq0bny+T|!!QTwUGlv_;4<3lrY5<~Uat811M* z0$u~oTvtD~n~h~8Y83$(TfMoGO|9_p=AnlH>XdJWSg)-Z99=qRC0RotTt zHVX@RwM#+{bq(7%s*kW>!eXCkp3j@(CBHg=tlis!g|YkO81`F6EQrj43t@j*unk2p z6P`m^i;`V2YM1h9(Dm;1`O#Z`<*wMZsL9ASOANrEP3|m-r~IX!Q_+ZA zVUcrQoBUJTUmb5^Z~P)WfQHdV{b{p$^1IE0-Y?qU;%@0crtNQhzw?N2m}}u>4kF} zMS8K5fOH~q6#UK!qynPD%yLU{tT2co@zqiaOZSQa+#70sg{2iX#{Bu;&vSa?40r`0MV~1UvJi10I!y>lNQ6@gHIBM0 z1}ww&^$0SKWI-^zL7NqlpFp!1! zweeCA4l?Cj2I=y|^rzaKBuplihn`Szl{;~Lu?_a(nr(y4k5w^Gwm~%0Ep=_s4b>QgT(B7*zf%kKitdbcEk$!>YMNG#U4Iy}H1zY+oF zJ^~PelhlE$D+pOe9b>v=N}I)(iQ_IH@p>|e31fR8lZFX3<&t<462P=^MnJ+N&k_&%g@uc){NdDW_Wknxg%$+a|v)n#dcK6Pa9aVbx} z5Q9Z^`-?nt)xbXP%nE*i!bQ-(ln(7}I_!|LO~5qfwhOyiyep@Y@ij5o6}SZxm;N&& zyb7;)+!Fw~B9{6y^v{G>3cSE(e#R^ICa<8#R%Z^ceif{iWV!06Q(4bce{!oQUG|gY zS>4!>@+?SqKS+}d=M{uxB(F@u7O9y9`IF??g3Q46ggpJ-2_banHqkK6BKNm$mt|@W z3N5(3l1eDsDEB#9 zJBuyd6{VP#t#$>d82b9CBnei_%2c(Sx3j`YG5VU|BKE@}xZ=j-n9jY?AHpl$6r;u% z=pugvhtGO@1cxs5jt56-+~-+vb({U^%2hW`IX|o1O;t&$vf)7G*^!g}stgoop-uO} zi_rRgkcBo`2U%!$70n65O;mAKr4gpz-;l1#Hd8W)&72#OIvWmzxyN=_$jBDjrfnuS z#l7){B}%knpP6lraWR|rQ^OA0XPBdBo8fDu_AH5E9$OT1v#{_b>rI#qe zHc!Kts;*FP3%#4#3lxLJ&h2e=GXE4#7$qy|25Cu(&O@m{;e(Iq19-H7w#(D~xG>dP zL!VoJU2FQ;1r&EoLs^(y)_#_Un*yziY@0UI&~UU9CL20SZnGaisn4;r8?BrDciuQD zcO~5^;`ZgLN}idd8Aaar7puPj{HEY+aD!6m>Z(?#zM&rnuS2}=h{~aArg7ewg zF}R5kID^Y~C7itPHVtW9K)ONj)Z$6VVa3LmA}VRJ0!<~G9o68s&&!8TFBo0lUY6fKFMAPiIR`JS2%dmv zdCJ>$xkUj>UKRm)Q9%{~ckzj*9PdOe3}z*o(NpL2quC6Y8NHq))z{O!oa?^G4ahYmgv#y`|ndI*Cb-g15ZU z7r6xhM<(}k%~viRqm@E?=;AD(*fuTMA^cVYG(0vdZV6?~?8mAv;zBf6###_-kO7qj zk~k!33lrRdL%&pp0*wW{bHRzvc34Z~c zKs}?8Ewhvlx$JkKKRFKdZXcunqm&x1UWP zK1%Xsm;7HwjT#!;Xp%ZTI_xyRNIv3-Y-dC;B81y|UnN6reVvan5lrQ!x|M(yG+*rw;4$vczw z27!D{rR8S_auhTXdvr6HXYQb3XrSG#aF1(xjJ9g*;Tqv6AFgHLl7nl|&eUFgLx7R& z@7)r*8D#8gOF#wPbgn+bz9jfebl6?PJ-J5Z8W*H==~|V8%`>*#Z_sD{Z1C!`WQ|tf zGD3KjwshCCqXsvX#H%E&HTo)T-|k#Xn+^5KxqR2TqYAe%iC0-#i*)b}OeTE4Yp~*L zO#aHVa?>-I$k?1UoNxTPxtgb`OH6OcHu)RUS$_unRRy8Sg3ft2PQAFdw@w^vwHz1 zM|zzx_rb(qiy6`j`^mV`CEf_C0!az}keFHG!12ct04Z|rss#2M_7Wgx{Bu?S6RrB2 z2%FRso4(98OyYJ*Mskf!yuX=fz=I>CBZ^`7!IfhL7`^bEf_8p%zuU`>M zquK@cpUK!h8Yfo04$G?m&!kRKp}plasa=~;H|nbfBl2RSeMOh#XJ4(oM{}LIy`88e zY}avEV>Kn}htgeVZf_|H8MlimxI)CrBo^NL-9zLgzUvIRy|1Ve-!2OA((8#c{5H4$ zmKm~;`(cE9!`d=5_IACktX@ye{{#0IXYTGV*~yHM#VlAX94YtBELfsDo?D(if~5q$ zfy0P}oB8eGP1$4db}_CF&jVJOgf?ofN4y6W{>t_Cvo%?JjtXvOLiU62xg5UVrT2Q4 zN&q~@z&KqgVK+ju`<#&keEJaEcRd-<9)pn+y%U2MB|gPqsPH`o202+v+}`EDI%Pcu zLt1+bd*axPYy^};?t(6Dk5T0&6GIH7vLMKDZhP{u%K(Rd?QaSEa_=W z9cpN)suy9wD31O$=JQt*K+^7p zCk~#QYcGV{t@ACstNp20|gl`OyR64A2!2%{FbAwbw`wNS9EW@Rm4eJeI;y=dGs zT0iPVgF>l6>y-jmp@zF^OM6Km0A4_$zk~IVw8t5cBMiPl4HNolfsINp6c$(<_4r^D zt=5YM2sCOjmXSdkwGbwcHUz21Z&BXHQRELve_IBnt)rSX@rmZpdI5+1a9G~vKrAM` zh{L0BYr(9(YCV`sfv#fO^|Zp8Jfunb>mvJX(6WYH%4)TMs24E%L67fksTuSlovn7% z<9o?pl^*io#8)pR#K)lp%PHxPLr7d0)ht}ar`8Lo5)<>N7Yd+|(`VF+C=;KRUNi{_ zOroG+LdN)@7ujO- zwQ!bB*b0CP?OKQ&crir@e`B&)upJM!qeM>F0<97MM8r<_BC_DWumqnxYZ?QEXgc2} zW3&i8+fCCSgo4a+xGmu6Q9_2U4z6={Uqq0qY%a)}ZDDpf@1{pl%LblOb313NWTW7< z^^o*zAVyMVhZ-J})1($K?Sd5Op~mX*K5M;*DQ=3=WA&uur)y!aVlIm3sg)>2F00V< zR_7KGa!OIQaTg`q50bl3kZV6y9?NBKOnt^QVB|B}-L-09V_JwDz%7VnfHNvWi88?Z zICl7AOwqRTGl==~AV)zdT7>o}voW-LNXi&a1fr=vnIsCQi2s!557s<@%Op2i3oOy1 ztbz36&Z@>wnw-5BA!s2_)?6c!qc!IRw$)J?w3Gdsrm&GY zMG0GYnkvmj5w^=i1VNVRsRYTzL-6)t5q;^Rm{t)@1MgxNIa!kyQILaNd_;s_?Jlx> z0#HeUK;z}HI3l&`QR+NInpshV>btoX4^)}xPe-0?vzR6~)sZF+tH%qX_ywr`cGMO;8z&h*_DBW^|(x z#pb|hjY+D!^|Tg9zwCIDO3^tjBCzDySQgei8Y2r%MIR+DBrW1#pNu)+89f+`dE$E+ z#9=7o~^Z@>QV0CMhh@3PhJSom%v}C#z{b6ov0?bjSF|b@*6OdKgfS}=JWV(|` zTt+>FqVD_GVxO}vW=0mcz2J%qJ)Jo0t2{+E`kbfB(QxL;nITURkdl!BDWAgkp+r${ z6%zC-wg3@S&;*u~cOsyt{vp*HWH!&DFWoXGtP+8)+t4f_1RoIS~MaP}u!B zw5%m(Ak5>2vjta6}CSMB4lw+16z&|i7fBE_G>8HPIp>q0JyKD60HAyk&g+z+}P5tz5c(ITk3aCgi zrV$Jom9u`~FYAZht6{Q|$HLfcb|KB0T_Kwxu?HQeV&U0^uIH|=j-yn_vxL!odUr=g z^LbGKe?QHz(nof=;{I+)X?}%F6OUFR9@MbKS>(q(8c5$iQ z%19rBN=J^aadFTy_a8oI(2~w@t_tvD5*KK*Fd;?znQKOn2}Q8D^>w4Z_Y)hggiZ>K zE`hx7-=6Tl+I(Q{>@MfA^&Fp`E`0tUErTtsFpF`uA47C+$7L51E^f^8^KiA*%h9Jm z`bU-OsNyjuUpSCE++}L9#X^Aen*j3u!upweRLsQwS@K{E)TjAlVv!j{u>^meVVLT` zUINRC0&9~7g9T9Arp#zePXhcZc;kXFGx)18expqAwaG%FTh=rfqN~GqDn?>8O9wCH zToWt_saTc&s#pi1x3!-vmg}z_LrgK^@r<&q9C4b88lE+y}TyQ!y zQFiJNyfnM5>u@SiskEd|nwbBN)0a`QvR%iGWdjvuQ$#Ssi(?_#0<$|N1OweInIwDM zXtKQk3Lc+#1#ft99klx}ZbBljW*6O(#^?=IUh+Q6T;=&E>HK|}?ccHZyZ5j_@YDWL zI?G>{8K3N;@ei#2;K48$$#-L@&;~<=*UFRc8<%b)>MorA_56IEdK3v96cpRzVqnau z1TXlNRG;jbbRr~lt7^p8a!KSr#lgnc`yMNCE8A;SSBadhwd~jG$8V1PC(`znp;DU4 zD}+eoI7X7#I?PlIIxBUmoI^jleD(e_qK%4zocS|&0H~npI%eL{V}LKbk|a$qBXnz{ zXH4KUy+P0C6?=h@V(Osrl4gifGa_*tP28>6&~6x?gf-Ora^&;=b%QK#XgG~m)E?`V zcVbCApbFo>yi?HsBIuZ=0|1Ui$AFB#xy>o>8Df%{4WAdNVO$sq`4^?>H2gfv(heBt zdZeSYXK192nq&qF;>(Xg9lQ}cdxB0nfwwW+I1>%T=K_)_0KoVzSk^Pd6hT`Fmvn_d zU9m+)N=&jv3YMJ&wgG@OmtjUW%zA-F*7Z9$rUZROY9E6dls-1JT~XFZH!&q#Oroa+ zNqAW0NSooU0T)PVV@tqSP7u;WD=88UAqEmfv!lo*sUn@4k93&!0*$mg7@4tgq0Ne& z-8XrYQdpT}=J5m~7|k0{9XicJCY=6x63Sp!@Zvc^a$LRkkUms~1NFxdN*CDifKI*m^8hIz` z5kUAnYqp%fU1n?unkTmbpjO9>reke$wh@o`TkE*C8Dfr!EE6XP{MT6|L}KFrz;M_} z+QU#oxPg%i!_LUa7|RjMfy`?fm8K{O!NpmErB?xtwx2*HJ)pWJ9~obv&AvRbh4r(S zYU4+k*c2w%9FC*kzi!aOZsbrJr~o>bnnx#@LW8G6Jl-g`LJkFHJmb9-^C5ce=gU#1 zeo(b+hm{^qTdf*tU3`6|{}a%;P-Ok*Y7{cE?{uxFQy`R*{U}KcsWZXCau}Cf4y%wu z(FR3r>D|BZSn?lytNsle(C$m6MT(hjLD5`ybjYJ{eRT_q%u9H0i*L~g5y)ghb}M_D zfHw=jLZhcW{U*|A(c90Em;h?TP4(Y*Bd|RQuOO-mq1qYAaV53mQyIY3tGu7=%i54= zofs3}naawWgs5kjXYL%1cGh{y#i%OU?rg`^f_w~0zU!x5;{u?LSke2}%}2cN)?$0o za?zU$VMH>zE3w*9WYX3Cyq_G=S_m)zc)3Ize`~PB7H+Lc!Ku34)n1NL_^A}LtN9pI z^a)Tpm(2`y`V7VjI$-uD@4H>uo(zJZ2KH7Y8s`KL0&3S;=$O~dQoWyC)>;eb26mTL z!hK1Uk%-+FnG)2+q0iBddo99Li`grE3@Xhar$GbIQ?^)1o@;hI@4E@wo?HhYs@(__ zUwW=oK^;XETzuO5$-1qjzzZCLifg)+f|Blgin1D*O1P!m&bEkCDQ5rmF^K6^y0>7J zEhQ@yJMCto-gjTMJsA){NILcr=_St;W45F4_h$XxPi}Cn1iGbkSn&E(2}*3Q)O?)f z8>pHNZWJP23$a+bk3lL8hQDO1tB)3HDEMrr-gk$!Jvkb+fTSOhIFtY&-uqeF9u_8KBa_Q-MP7<_}5a*?(Sm-%(EXM?zu*D9lPggoae=&y>F&% zdoW58d(XZpY*~}`F3X5>8mDftmG38~d85oozwF%uOVGqMOr884EM&pDc_~Ag$}qdd zVc{sFgj{b{*2r(9DGQ^{SKs%(Tfyzgk7*5w&9X{TXs%OSOn9cPsxyBnyE~lSlF%Y>r^vo7tl9K~ur{Nygz2`~~3$7qQ?K zsg!(+5=lI;OqhHgl2rh*MBKCB=TCrqx1{5=EKD_j*FvXZrTXePrSV*@Ifx4Vc9Q=? zlNUtx>D!k!Au!)ATa>2Nmg=ih%tYYSR35zIRjO(I| zMf5}jy#WAia&B7F!sLB~2k2LMTOnx!y4_C*dJ=A#VRDd#_zrEHlVq=?)E95EAeJ$D z-l5*RAS+`Ca-;y$=77gNmJrvN4%nAFl?PGz60bV6LQD`nK>IWyoJNL8)VFM;&U0vl z@r{nWdOC;&v5W(GGakapj04vId<6Eg#P;%BEj-`JxST?un(jbIn#EqBjbDzt)Xz}= zuDc3Im70PSQ8M*gL3J;>vqJn%I`A1mb#hkVT(1B-N4!fF9D%_d81@>I(+b%@=+lE+m+JBex=tEsn+6P z97iZ$dO6Kw-;49J0^vfl#0paI}n0gV3zCge!+xpVKubL1`yLMuU> zRLJT1KsH0d{tm`a&)%NFw|aJQJjW3uq;#HwJe#DRS%lY;_fccWQEE+U*8Be`FPH4f zZ5@jCJqk~tYVrRWkGk^wyKf&r@|7s9yrh*9;tPTxaIm2Rj6a+&o;kMvjTXcwhPb1s zK5=JZ22}sZatTY87mm<;r#g7v!elBESuL}}=WLfkEJUz97-4^z&7zag>&FY@VZq^sOF#q9ekn<2XpAa;Kv0g_G7CsQ!BGYOl2rL@^`HEGW|i2d9F> z@k~OxBw;0@Y+Hd<}!8J7H~4=-OWZMV5xXyPIxMBZaneilFBXgxd=uu1Nr9Cm_REdnSQ8 zixkilo&{oHS53eB84`2thdZMEc!#Gk%!F`BXXoLm1mD=MsI@)dYkz?rfu9NmC#d)v_ z$8L`1p=K9)+g6<0pJ*k+jBY?+fXH|rpv7{*%@R+CA5N9V@PG$8PHcsgW8A5CNoo_-7M_1IVX42nqSz7X7-@40AOZo652@wF6k5 z_LQalt$~S*W*zC`NuinyooC&3b9+(JM{C&X3NeglCQMsH5{alwYbbGqPbRKw+bU&0 zZklXK;4}?eT}tR)^CkUS^=Nx2)czt9WEkv-)!mr3@DDi34?1SdRYSKoSzYr$DUKf7 zjL*h66rvX@GQ&KRGQJlr-no~?)M1ktnOIzNfd2O$k7-DgpH|d}{7g^gaNgZuyt3ZQ)+(T6 z#4E2zh=N7Xk({j9$ z3OmclAAsPdb;b{1G!<36_R?YzFjJF#F%-#{hCjjUyV>YghZW#`mIJ+f&NkIYCgg-d?jOP#5VH655rY?~)>XE`Mum$K)1+ zCZ8WR+UfPXIBct0?9bknA-48`48HSugeYWDvF%0I9{oQ_8f`}?B?-% z4PvvfYy%|v-YqOFnhBYbppGqwArhsgEP=@p9nU#iKQ0yl1yWM`%_2T*?ga7rla7bX z2PvR~hU`ZecwH8)nw;; zUo93>APYBx;LBXln0(H5oS>7?%i7Nfwy*p5Z!W3l)Kz=Gxnw9&tB$~WPc$ucUQ0`k zDxm2Xh@s2kVj(Jch?VVPAgT56LG_TWK9V0nrIXx(uAVWF&AZ_Yw9p-i0jL@4fol6o zP*p%iRCN zU=F`tq@Cmx67f^|_sUV*3t9aKr1J!fb`JEBvXtvgz`Q2l4n99-DGF5=SEzD;EXvV5 zfbI$~+XHF#7n=BEL$$e=VcQlYQa-0FxV60i*qQ)wVnpux6X-nwt@q@(K%EH2j|8-E zO~9R{yeAE}vBc&*m^7vmkZp^{9gDUHDD6*F`NJvN&CG}1pF4FwqN}KG__jTH?mz6Y z*Sklp6k(|J&b!C!-EVZ}qFQuyP3AF7M04@)5WiR2+8+G1Kkx@k>GN<9znd3<+!Og7 z2Db+sJ}y1wv24~MFohvAsMnpRx&>RS@NRCd6QS_Tvwb6! zM9mhC(~lG^G-Hu^N(B0FK*|Z1kCR4Y z;TDTwAbv#L$dN{*Vc=FPw?m#z%Vmf3e6@s{A#_}fc2><+x;~32w1qIACgK07+; zkOal;7DM%FOGWLN5E%O1>BaAm=7`=<#II0|&COx4#%8(ABR_|lXL{Zt%X&}=K@89?-mJPqnm6WN_0Qz^ zDh5C0dO0!x7)1ALaqzR~Oy8bwLq7gGM%tlV#N*h=V%^#~(Q_VJ`^ASlN|OPUN| z4GnIksXeRs7XaGGZ$K9`En%3Iv%#A`e$J1l^V7rzySqYtxE)0A6rgJ}&shwpWu~(NJ<)sk=x5v|G2$dqCI8utr+Nbu#L-Q}E^}oBi+i z4=!71pH4^TX~_c`ZWN;>hG*qY(m!MQT}E$5?o)4{XCF_8W;e4#C^i0eRjD(^Y3HM<_(OoD=|3>gBWa(Z^9QBX)c}Am-STb!3K6L5{P>;|r~5#qnhc(FFkkDlt&)mc$t#4^JE(Hq}WJ>%F>=9kg_2BS^i)1)=Ai% zc2flnNNV&7`G#z33K+UNBInlJo3Kl#q$&T9G`Nl~@pe{%Ax>nq(|YYP<3)LV-d4Rr zmHR*=xk3=iWj)J*Sx+5r66@W^VaGqj9q*ggC954XAE%njTOo5RHr1oz3A&7m;`CU& zs^GEIgzeJhc&eGtn|@HSG}N3Wm3|6zI)&@3O>!M?D(vCtsLAj!)6>;ZLJjcq|GEnE`>X`5*h>oX5`n+ipdvB5~QXj5$W%yYR%sTFPlXefYgALd6 zh>*XJUSPQv-y}&zsgUC|`b2iB-n! zCwFOhys5=^+XqT`xIXT;UZBNtf3 z7c3_NU6dSmh;bTPAX&3arc^*DV69@s(Kkdm&62DEnNMQNkdet^6e^sIqLUxNh6CT$ zPF9NysNq`*F=u?H(bUi6M*^i<_gnPHE2LrQPwRDAE8fK*S4LAX<>J9>^w2UryvTvSZp`E&#klWiJAi&oo6^grYzmDqwf$LkREP`*h|x zkinceFFxtKO*!FB`op+#BE)@m|1v{5NgWGs$$C^{qH#xO9qs5Z?4&gb@dGcz?0wgtl+ks#anvMBD3~XM5gYeT>A-JO| z+bxggBZ_~EN*;wE*f|wp=uZ_=)>xp_@&*0SzjhtR36OHf;Vf*B#=%O_2`xI!KWb35 z3m_UUz=S5iU^&n%&I)}T(&uP}ya=OQ@fWPnVk$9{oA6uELykmbTxepnSldRHon*Sz;c z`drI6jA71U%V%W^>AX^fLS0 z8&(E+u{ZJuN~n{2_6)g~OHU&zlRPs_vu@co{ohwT@J1#p^D>S& zz8=u8%jdBWexMmKF+SOYC3n1qVJ`+%;WPDug`s}naU1l)T{vezo9y~sJBXInoLS`C z0OWs-=stWe)dQlwwTmoSn+CSmGP4=B{q~Qyf%w;4gB_X_RhP?Hquk!0$mOc4ER4Kz z(%)Z14#aeq9XjP%9!8SE^%EH3`=RlUUu56T|L=9y+Mm~_vIx&2l>T~svK2Zr?cZPc z_+=d}WbZ1Fid>? zHVqmwg*s`207U}q8t9ArEn^9UtN=8>-qZ$t4C>e(_A}l%jt{L`;O4-b5BUhTGJ~_G z6idbL^PC}(7(Gy+8zMk6N}xJGiA%tg@rHO5&ZhmS*pEiDbo%!r6|FL>7S9zLB3J_< zbkZQy{`8{Ffug}&=USEQe=rtUtVph6dPKGD4j~&7Wto9U-Jhbyq4fiRRS}b(G}PeG zx%PNv!@wJ4rWdxX<~V0vNSujDvQRMMz!Y9570NpH>dttF*gv6~-yjI@obK9-K#M>o zT-_-${uEx_o%0Tv11snUFNfErN;wuI!CV6-mi;Kh4wH_5*$*U?Ft8biwr2gDUu4- z^_=X6u%DQd0BO8HppIIt>cXi-UrIasq5$4+EmOi9Vht8>{$S{WEpDUCkPwm?O*27U zq2)O4f;6by5d>3!G7%8#LOZ-c`mkU!(v0x;k~9uQ#1G1$BjG`VssQI?$yY82yCK$O z5K4vAoKhC}ijn&rN!T&0nfs^$JG!R4LrfVoSozi`2;|f}k`|9uOxtp|r$8vsNla<) zkhQwv>KUof^=hX{DFi_4>~j;<*|~6cE6{ZWOVp8Pn^%M?0aQfZnGl$|%D#iw5Ck9X z8nWIhKVv~b*IdGD0T`g#(_mV-E=VPPw7GELseaH?UW(Phau>iZNwBinfvZ>%Ol;OD zkpnBZeQqco69TUYb2pl3rd^b+cZf3tnxHBo#0{fB5-nF~ah?uy@)!qd~8USp>b+sr@1!moWdJL3W;mmQ#rnN#5xT& z3pLLfixS)&h@UGtLQg6NbZqA-;~n~#C*n?=ke>AMUZrOYA^oTIrhltRt7FOeKgO#b zO_E#%`g4kRf!$9+=Dct+a*38`YEX;-Sp^=Iy1x+K~!W`GnfT;004Q#1{Vl@yBL9LzHjL7f|>@XKtpyW zU_<{f+)ifTS(a=})S_=ZMjjFRyOK05L7i2*r zz>&#eqkxa&puye~gPJK?K-u~_e8^?(LeRcDfWc=*cG`}x*zYFi4)*9CSmlIU zPo-Oo#bj+jJ%Eg{9H!0{jlG^nrcET7!;-?^nN$d_t>h>ECL3(8>uitgEUPWL?r=gj zoE}dEkgj#o*uOz1PcXlK{eVnC;;OZHh#G6uD*{b6r;u2r(q?cbNeK`rvT03_k)oc5 zLArNUq`cP%{WmL2o(#Tci%Odd!m!1SWss2S14$>u`SDbB0)=^Gn1rP#${YSveu6sZ zc;s)H&&_`Sx`2~^=qz`ALu70>JKJ*~lAqV8Cypok4&v~}$}_>@7u06)x75y-)Bt_4 zLL`}`_GU~w%BGJ1eX$zFy2@o=JEc*+p(N{#Mz2dbqChN_Z>AK>W=Z9I`B{4?$C-Bq z<<>dmy0y~|~0!%fe#(+*vcbEsQIaH+2oa#?v}xAwfeoi&KBTvjbi-Fpx|aR)GQ zcoXY)B_CrH4j3wRy)!4J# z(|T(WYOq>0KbmZBh^?1)s{Zqh6zsX+Z_Hpv`tBv#v8FjHoSjw{$K{R`%QHGB=DGwR zk64_Z;TbzUeh6{ z7RiS2OdxEs%&*jTnmyu}!GH)7$Fnd>*QDtyKCXLf618)wJ$W3miwoKv^WERQK@<-= zsy(%ZN9sL7{ohtDUxP%T!58TWZQ&lHI&$O zPRlAfy;_qvNEh3_&97jYUNt~ptguB=vO6A85M@a{KwqpTtgNaJC8_b11n7&^n6|1p zc2oQpRS}>sR)dpb#;3?!IaH6`SNb&8F18&+r5@Z-JhpuK~Ug z$AQi@ECt7m+pg3Z&2oZoyY1?^&zC`M@)6Zjhd1LZcIsqr#~!OW*l7c4P!)SS{uoB> z4W&??Thx67p>vB?ycus%dW~lM(H9AUUmtI_aBS#!o3(g5x>K&L-Y(1Y7L_@Cnz6PA zIn5|Zos~ARM)Fn=3}Uy(z943WhMkNI|Cy#dDL!Vpk&ca2uq*Vj1WdCD2Q@~%7Ak<( z>k=>?v9qBzi?RGUd$6qmfR(B#S2V?(%W)SYKx|jadWFa!ixa`tgDscAKq4A~H=qd$ zX?-KcJ?;W6qpW5?a3y;q7a+C+X!`0S1ik&+$$RgY6gS3G9>RN=e~6NG(cnbz{voiW)#&cD~0kT#S;fyXfl62*YV#%Opq~TvT zA;(1`G`9lqQ9xfwo*@coBKDU%5}^*p?;(td+ZX#~wCJltCf8_3g*7GIoINu7Ra=x( zsYkntBU;EuQOLoWBg9tH%NtZ~v!VWaLv4gIC=?|5f)H#xklj^BgfJi4Re6fRTwC@B zDrhY*=ImC_`~=NU+h3C06`vzioSS36MMb{qX~ngKP_hnr*xR0<1Y;SH4bvf5V3 z9%2Y23JG*o1$x_Nn|L14B;sne9Gm{HWKU0jE>u*9C=hZ(55Mf84~Sl zN1B>*MmwtQY(ird(&x*_`?FFybMs~ywX1nXJH>PyCVGyY-AwD{4`m_a9X<31HJ6K@ zMt^>eD0_{HChgIVY4IQLw6q=Hv13|l_hyBBB^u2X^;l~0c0Z|(c7@Aow8J=?{R(eV zXV25-pD!xn&(7!+Z^j;&y+k{z>{?8Ak@mbB+YmR1YgPMl7`!PH$$E1sB2ExxX*Ng$6AqIJLax*jdlv^>K5{`<1=QP{XRZ!1MjS~ z6mvYQ8=rrE>buWssah^OR%17=J$66Gu_c*$t_3?=X`&gk(%TxD5c4Z5d9l=nPF9SR zUpr>S771_1RZ9CaZ$CeT^CqYkY%s3U2sWIoc{mehyJZbVf?n0RtXSHg1zj>hP+B_V zhFWUp!!14EY(L%rDY?&mirSsyf(mN(@qrjv79qapRkoVJIjW&$ z0BH?%rC`WvtH!B5h$-+)@inSgb~;7JTgfWeB1VXxj6PdLK+02NV3gu{hGY;*M&89< z9{@VQXpODAfhMnWlk^dyeh2k+NJhg3*Od~`_t7xWoB6PjU78Or!e&0dV^@awGC~m0Svqyb1t;>z#Fyg@cV@kxS z*eTYJP^~r=0(M!)bhcof5l2nEzk6`pf-{N7aSP6!fEOnaLOH-tckOr&@86el zx9VSV;aCW$EstX%YU>wHr!)r~K2alzWmqA&`cQL#p$fBxkFpGF&WIDxV$H+jzQe4z zp(EsRlml|%7FJ)ksb@#pm82>h;7hL}u<&8Jb!Vzs4`EFOiq zo_c&a6z5KI_Ar)vlo@ewzh~^=XzH3fhbs*fQw+x|Yzx?tkL8p?Mu61{nyeR&G(Ht) zsn!&u%XE64<@Nh&vwcGvu{j(^#V*E!`z}MpEqpiPxOtSK9Bx8jZ&=G(F<6o&#Vl3| z$eSI>MqxT7<%nYHo;Pe5Q)er|;Z(1u>T%57NY_`<&;Mqd9>;3uc73-c%zPdmM^l>f z@`qTck$Gqh6HpM86f*!P)f&8oK9<4@1a)M+`FA1(H)sp21uFE(!*qK!&F(F6alap@ zK%W{<(UVmLI#ouGCPc#dfvIdY-Z@fBgB;l`;CuDn6s#ufyTsqIPfgh4d`T3kKCqJE zWQ4#9L{gf=M^Q+OV?`6VT0h{t)rraDS>$pI)}A^16rRv@HJT76b%*yRxE(TOD47;(xm)|21)3u0&@ZIqS^>`-#h&M0is3Gukg&kQavzuKj{t z-J2luTAao8d&penV-^;Mx>tl<$tD(>To4wcF?p9bu<4(U*expcU)<-J+Gc_h z)Br=ItE}s@RQl_5f<`C*y25sfexH8P*svQ(ybdLhB#k@hpg!r=$l5<9=>_o)kmxGo zl@vU?C>mDX4|?kK`?mI<<-2i1dmNuW#KXR2*U-i;%!@+}YQJz<$m{tuh=zyd$00sF z^ZO3tpXIxz5^;h*7CGj{eS1*j!*xJHaX2Kc&3u2iA?*wX%#t6R#DAgm-HEkY5k!gs6;85;kLYAy9}Z2fGh0 z9$P({a8IV_s=}5S{qa>PuWRr{N!Q3F-c{%nI!9+5BZ`y~3~qw;x^ zY7vOGM`doBTFRp}}jeK48xzi*?z+I!UIXsWcABj@$xfl0s9er=M{pfH= zpDv<+gY?WRd>1MoGDGh8(EaR!%16#eDmK0sJEWTu0F!9{1k2#FC_ll4|84r$YC~CV z1%a0;1ERgh<^@VW@)|lfZ(cxmc2e;UVY2{!BI4uXji$2ejbehF2zo7)54`rguS%g& zgD-)5y?W0tDLhK@zAC&oQor}bscEwZUzC#M@ApaE$UuNf?6v+i8Sd@ zo+zl%`&z*QK4dj~Tp3@|rM-jDzGW_aTt92luDN(|m78#0xT{WoHsM42(c!qMTMD>u zKD2MSgG<1nm3wIyZlG3kMjSa??stH_cvtKUGrk16A#IA~c^vi{_%-0ZWBRiqjXzBSvnImIkov4MqOy@)o)YD?jyLR9`zTM+<5)s;e}e zLA^y+8AA2)gaS%*l`)PZM^_cQDbMAd)yW2if9-VKg17}0|7 z)pb2_AYa^>=*hM81}p=q=E=KF_R-7*nmrDD3wkOM$L5;z?Q!il?xNz_Ui%U_nE}U} zxAzMNLLPNR+}JJXaTiJb**c5k_Or#J3-`r+$5Q*U>}Gv&&=RfOFzDeGJ}bQ;E#tyb z57zKpnZ!xNX*rVNQmRim(oP>uryQjQ9LpgsM_gv3&vN)h%K@CG@1YzmN43+%;R;B{ z{q#tuuH|qzs0LXV?ph;%wrxj~h|{~m1@rg+C{goV|HbgQM0?3M3_EUw@T5az>ZbNM zu)mf3#gYAW**YA{F{*teWvfQpJ6Q&&SzRn3;|@DxVid zZ(WV-k%8NrIjJKkB~Hr)ll%u6<3Ne+Rux{m40{O*Je7gy10+NBW(DZnH-9A3Z5 zm3T0j|c`bijQ|A0;; zS@)8x8bcVg(OuEJ$z*;aBR#YrPQ8zLugS9?OO@L7em#~dEfoE6uB+g-TT_>$YWq0_ zPphsML)2I7V!EL#c6ok#o$EsYc|eB0d9LRycCD`G6gwNe`#D(4=k1(g*N<})j>w(Z z#KDR@OS5(qdv&MuOOWk&^OW5q^x!Kyv)=M=kK@_No<*WS({l)T^0L6}anXS-MaNstg9>H6uPH=Y~N?VrT@ zdJg}zEUxF|-{_y~ocyaA$@{rH_O#_3{`p+?b1LtUb&ht3BW)V&;1FkBcPy4qjCaOTv2u3)6HAL~N`ug4UN8vJ_BVqwL)o#Ty`gZmt@ z2r=#FJa6dM!@>IOdqB}1?ky-bjO!5hD}=Zgea{c)FlIuBv|1D7w689oLQF~GbcLW* zA5UwY0hD)Z=+L-+$s>_<^@N&BhcP5ZvH;)4y7nR-$~g3c<-3-ca3IYewj!Izm=BjN zjb3NOf4QOcF~uE0l(l>q>mJqEHe*1w9G}utz3vd2!0*Nq|2-(=GM1!i%9c(RFr?iZ z6vOdO4=!%fn$g5#Ps3~dB`Pob+3r^c?NtFeuiTg`RFSoWKs38&R zZi_)80$gnoAN7U)j?q#_&sUYf4ygm~^irKE)D1x(l)hi6?Ao?>U#RFeG0^oTT8Yup z4-5?{8QE;o`Q+YoO1$T5@P3qpUW%2!)S?AFU_D@i|Xg&xVZ zDUt<2wy1MgTV4Z6GX>IdZK#E=E$d5N#|AW#=2!{i21z+uGEjySp^~ghs65!+6u(yq zI?cu^0A-ek8CJQk=i?2sYLnpbmq*i0sKeg3xY=O3wEM}xkhFut2V_cZwWf?$3*%)?W#O#|E=Qt9PRKh% zdTTtaDd&EBsS3mG#-OL@!VXPlTa6{nItRkF|aFH$A4nV6~8C5_A zpN}`l?xUPq-(9GaO%|w7bZ7WYqIIi8KUWMOn~dV9KA3`{H&F;wD73Nkm1;n%>1*WH zielJ#KHi`aQf6m2PP^_C6zo9~#`y~X-V5VH#~UnPgZ2QNMd5^IR%`a#egFLW_v81+ zZ-4!V|N7T|A33q2WS0u-g5!^e$oMK$#@>%yc?yLrxlS8Mi$PCc&+o@?fBOzBgMazY z`N*YIqacS926RSLtaN`>|Hf#cilrM7tA7tj9Vgk{{00RW z(QZT3V<#}rTN*djB0#Uomp3weK%)Q))WXXbuTv?;Lzk_@9U<1&T@vOc`qk$X((al& zYiik`f*oq-dOZ)Y_3MgHDpEqL(+BdNz9?_IL*ez2zQVjNWM7^#HeB~9I-D=kUAa2O z&ntaxOp`()#w`BU!2V_K#b|OlWmOj>z+(^X2jO*>wzdk30f>^ zMY0YnSs{%xCQX3)v8@iD(0kGnz2bAFmC}|pocWPaTs)*!y)TPcdF_(4z9x;E z0%A92bW9yRmnmp26$FLxTQk%wG12v#e{`8kXg4)X(`%aptw(X&-saRs!WgkdCUpfcUWOu9vLEAfIDE=P=Y zHe{qO;oRlvuuqLl-6UDu#jUWus&o*OFG+A$3fP|`SbtHx@p~X$(ZpyeF zQnsLC&8ZEE?3-psI)cBGMT?6VO!{r(XZrGdoXE%@szIZFaaoX7xXY4&p6k3S3xLK- zTwOk)Ut@zTeMiWItM}WbkG+p~bflr1-@QJdPa2aqv|b>_59vePQAs}YAjvr7rfBMw zzPO|>=tG4RhGU#B)se}9rZh^ zX>^g+5PlmeO<$gm6Pf9wrg`?_vLI6?vQ#a72!@*eHvI!^ZDOA+W(7H9QCKxw zJ*fFI|H$?`4oQ3lo;sUQOtG9xh68Ewr zKw@xSV?TReojoC=^^9}-10Ya3ZN3`+5ZXy~{tAmmVbTm=Tt1*rd1KIPtocu*x#W#S zwy>6UUi->hUhwBO(0p>bP$IZ!w?pp#(R+{fyZ9mg59rqzlDuyB09Iz!=hXwo9g<~O7q=*Zju5nZLWrpW)iF)$j1seV z01CE%5b|rhuF%VjPn%PFs*wnt7^OB@iWtBz!b zh$r0tvp3UAk(ISms2UrRxx{cKKh0 zZGjrvx`gY)VT~$;?Ku~$+r9_X>8hY6$zfRYlw>?1O^?@y(^|5bPF(D~S%adp>Ksut zU88GD-Vh>dXU1pK7SqG2X4qI;9<~?z+|fxZd6*M8iDo8 z_5y06x`0FFN^1!By4AL{cKk1E{R%3@kKRi&>NHFr?P%i@CEwj_GP=ZuWpC{&@HszM z$i^^cvOggg^4?TOJZ1utL1da@nj!LLKmOD}wFLAU41jaKM#57!z%gu|k2h%6Ky=~s zfck8Gbs^Dwt_&CIt9)3h{BWT(g#q#zBn9B(kcHXWQ-h(rWZ??^`cxACM-wL}b;NGR z8$LC0U$cE&^!*3!6x%lhneKY2T?3+pdQZpm4>EL=_4z6qF-M22jUQh1Uc<|)x?2Sl z5vXF0o0{x3ex)H1WfZ@zkcM;EnaO5C4=XbT%Y0sGNZV0kg<2q;lFZ$h$x|T~xtp0Z zpc3V|(2yP&T|1#3{mx8wtGg-Ydz{PG1uq`5$>s9@C@-5GS#BE&@B1n01$wUjf3`t_ zAj`muczJbsuK)r^vpKFL5;Lz9UanL~57-{bQ6hnXVpa!Frc0jtg!dN_i3%Y9g^K7KIbhlc~vtStkx1^7rpwPz46w>(3R2{ zR+7=XB~ke_IBhVM%=6tNkCW>#X=CNt4P!%4SnVi0#+V?TrSy{MwxZCuTAL9kt%Z}R zIfMUu5?*`O-k1zlJK0(efpQ~Si!+sq38->U!(z7gKY4+LV$?siXpf=J0m9}(Fy5fa zPjywrM{j~js7+QQOBzz8&?#h1xp7(?>-`46)`FwOM zNg_eBQC1F#4)jB^Ti#}BBa0Nnu4xA!8pE={IoT37Gvyi;pO7u5=Xy78L^<2;CDxZ7Ksa-8 z8vSH-mxH%qOwCj&)(?pajDm99D+n2Jn*fo{8HmuG$S1FlB$`+DP{E-*1$YET)-v|1 z3YlhyO_s8e`)9uR;&jXz4Fa;z-@1U?y%%Gg6r z_hU&ukkv$AT|C<>nLCM8jE8{migTr*Kq?kG1hcSww=>xk`ZQOwrCEQqfu}8C_%HBKPO|I|ZZ7c8K0MpgWTpQiij9BN2Es8=|G-H+DmR9aK8->QbCwZCmFqnU4_^_SC4 zU5zqV7+Devug*$z3Cvzm?lSWc)eVJUOJJU5GWzdG#b)`=RYkoBiarmSI?L z#nfLQ(O8emzbXESs_I ze75N-QAD5p%$%T5Oo3HKgfB7)fqqqq?3-LupYAH$21pgCcyabrfI7Wk2`uwOXHCJ6 zyD0U|oF&rB@m5%10_u^OLUom`=ghTXSdIEFvfKq)ofj?)T#PyVayg34Y4ocDH$+00 zz;2UzmdAEIb`<+RDnJPE_?!KzOAbmS9&85@;4U*uZw=QlQy)bsWOLs%Y3S zKyB$*@4}2izq8$nA+Q{VscL}ndbYv2A%_2T3}Y zn6*YZR$Z$&OcfiwpddEG_74LJesXy(n>F|%hMbfUE8NY>;(9QSH8zA}!{bfivH<}v zl%7XC-j2L%u<<0RW|DwG8VF)}3QWZTf3!<$;U@54$BTedg4#GKm%@ms3RZ$(D8rjX zaT<+J-Hhf@iqPoV>Ud^hbeR*6Ii~lPA0t!Fjza%1p4a!s+y2vMBa2DpFzr9y54`L^ zPzK&iA0O{dUv}&^FsT&hJsG+N*}=dBF4iO5kN5chcKg@%@7sTF z_bi%oyp%_=(y8vugrr#5{`h5Xblb1+S$aY&P#3?!zW@yu{O40DnJQ)+aiVJuPQ2Zj z`6$#@YqY-K!FeYTc-;Q-^Y-nh-%$ATx9x8~Z~wfFKfD3wg;G`_Zi^6Bs^jqCLi!%J z3oYD*&|Z{Y(8hIGR%7a*ya4*l@!nYAE`i*&{j;4+V|}}v{(U+H|ne>?)M>94=v{_jAY$@=4V zCi4d4MR5_Fd(kdnJ{UVT+H|JoZ{&TKAeK562Bom?V~{zYe#D99B$C6gra4+tt6@gq zJy7=9GkUg{Krs~Jo$QdrHf_ijNGJ+E1C_oOsPl+L$2$*UyIP~piUYyAz+tyo+!9XHjr{hnk~-1OsD5@bqs)cZ7;?hfU0He za{7vtAX#$`)-zzPujJfkk+RRR=J!YqJ5gVzt=L7cXQaxPA_b`o0uJI4`fLm8+e={W zFKaqP(3uX^FE#HFG4go}8vc?w5`*RyRT5l#33drIM=b>otO7Qf(~F$XU$OGSY|N@# z=okN~*3T-?KBw+dzgD2xi3~h>*%Ccnp{idBl_fp}K%dmS`=B8~ke-75cBgCWia||} zwj#(L2YW~etzPBIs@Y^mne~82@ey8#c*QZ3m!WT`hq>!W1??D~V z+q!@P_YiHsl{3l(h6r+`l|!&=swgoI4L)$FGISVh+r@_?VkDvy?uovqxY6$;l>4)Y zjn5&!mEpAGGifwzg)0A7!1|X0HuFC-F|<4aMtJH|vYW(d@WTmm1P3a^#JC6*r)5<% zR}f_jylO7uL1E2*=r^=|8c_3XGL@TIjAF0rmbuSa!>NZ?6w0%>ts zb=KRm3uJRK& zxqJg(po{$eRsOnXNKw*ml@;w0B6>hf189Wpi*hs$eX8_@MOqJ4nrJX@l_Ld0=pD_p zO?pWnl*4kfB?e^>VzJ>|vj&em!wh{rSC9wD37`}i>}!vecJp8k?4 zO03Xcs`_O8wh;YuX)3*^LOf?`Vj)q-k*W9e`*jzaXx-?kn5DSGVY%6&6y+Y#c*;%l z4AbFiae6MrkE1A6*SZog4Inh_z4Lvp8jas4+U4o^d#-S0973XxE%gTh@dd5E6cDox z4U}?@2UzOk-nHJ-@YhHYIIPSExy_@#i!OCpZnmg%5rJTITO;|Y`vE!QNZ41EDu$i* zzuls_N-88D@MsjY=4k4D;z8Kw815-!(?XB1q!?+}r`k8a)u-a2Gv>Fpjk2FOq^XUC z)kwuXWA7>XE9Za)QneCP#n-R*OYAhsF%XcaA&&ZPgN-P6$L2zz?ZEf6B^q!iB6e#Lm4i1=EX!Q6%i$a?Z zt~mO%n!II{eXbi)IdJa=eW+>vn_{>n7RlVG*VJO}eRQ`1sB z+O$a)W;eQbZYI!&Zi$ukqh&KsvXy5weI3=6ns6F-AZtK8Ok0^kUT$4 zUMlZ;SeD2hX{W4m(mvD?4KA_?I>el(U_NKT=3`@3bo?v2 z-j`TR$*}whB2Lw6p;d)JJ-V)!)uRr7<}&$%1anj_+NzJ^QY&Fa#zMB^J)pqR`#iWhF1nCXDDW^~Id`^aT(UB(G z!z?Ra?_9xda)=}mTF}<2glNs0vllhO92KCa48ZC$bp{Ay;>mQId`qf5xy@qimY2dU z2-%ltjMLyePLiT?U##^1##q@+g2tif!ZZMfpmUx{l|u7boU!RFDy5k}x(YhcZt-VE zuM2YOu0_Z*^bvxc^nZ-TFw$>w>Zs6J_G>!pj<( zG0q6J=Z1Eej3fW)mNfF`ZG{CKE-&$X&g^IbEVcSh93p#=+VnErrit00+TDsH1UblS z7!bpl;V@b2`go1PlWBcvV4~ZtuEf^`dwGfFbH#!XR3mA*&G4AE`l@BRO;Z&&*d5A@ zPX`b%Lp-%U4WlWT;U@h#o!V9o)51wUO>SZT&bELrFX1eh!RM7Oy*V6Vk*3Lq>9$Pj z+?cc(*$|Xu*27638@dg}ea}8)zEa{HrY)y3oi^2@VbkR$nv=SHfDiPDE*TLR0)?h^ z2+r;D&ku;Mbz*GP*(TcSf&T)s)|59z@GmHd?K^DNs-dPGA?k% zj_!)eippmz`

UYbEV5_N}(Er&PA<F8{u~wOaN$<5uh3Qy5#Ed*Csqz4W&I z=b!7lAAkKRZom9~@z*)^E%492f--6cBMPIGzR3D4HE-AV%a6akXQ==D+vV@;pEeG2 zYk7}}|HGEc-0Q=BZ!MR-)&y1Cd)eMWO5HH4Q3-FdOV?Z=W#nwjQ2#0+0oAM>@StsB{YSHzJdw+mTz_bSm2sCqbHz{_Wus1t6Ku^_7N-{^( zea|_cka$u9>T8*FPY4(nZ{A+axeHiO7_L$Rc1I_ z9PxC&7`~}r4EwB{TcQouFZaFKp&T;D!C{IZEU7vtKq>fWfjTz_Ms{FC*Dn&2Bc70W zV%}RQYZ>OZzX7Oo0@PhmVu2UBo0JLBtElH540t?h$Q05pE5Ul9CAjsk0vHR^6UnT;@b78%yL4~uH)AJQN)vYmWb17In9eP z58|a=dA+8%7rd9!QaHv}&gZXDEWSFQGo^&+&X#Mt$8P?ndL-!?IRV8gXRjUn?BfoZ zdcn-C{0%`yu(2**KpWM8-jZ3ATQU7q5KiFcKvDwJA}&GCLBVaTQt!!_yLt#-Rdk5` z0RyskD)m?D+3Vg0M}JYznEI@`d}B+UB6O%%zN;Q(R@WWlKI&3WKl2G$#v+)>yOqB> zg{83E-GHQnE6rJK%c4Iire6RF@jxVBAf}Xe0*5Q|HC`!! z3+UF$@FR1JGN^>;@?|`>pU};rRM#>NZ$MZ;P~~{C=B{2K6L82fhi%yK-~I=|tJkDi ziqcEvHKsZv+b*_1?{~`AzAIm_QClY^#P%Zxsy+sWg=E{OZb00rss_xuq$56aI-#3G z1rPIOCKZ`)7N-p+<_BZ$(y2m|5plFVa1Z}~)3=yH#RV2ymKPuDeRJrr?o>|IiN#{2 z!}3u(5eqqfQYbLO>VqZtF`5CYfL>F(8C3d`4@p>lKsSd>byjJOCYkCaQGW4c%3ZwX ztsvu-QK_whCX)8+C*t|*TvpMruR^f=Vnm^rlona%&Dk)gZw?$)gMxA#RH07Oj-HZ+ z&7f>;Y{Aol+unvBG9>>1zc-~=lSVzEn?q5Ne5}gD{KaYW_OkU|D?Bn+@smGPTJh`r zrBwEoX=wIWt&E7Irh;Q+|5!VH1wpg2AU(C5VGrHA5HKgBoUwf(bSiSyS4#Y4JfrOHXj~WK0P4g;a+1}%epTkrkyx1;K3ZDQ7=y`K~+n!9~OpO zPG~W!H>gy{5Y;Iu-DjCRZ4_{G$WfFm8(^ws(w9ZER1Dw*!w zaZiia1pHvk)hE|MwpD9PSLyZ@tQjY?4j$1|-SQm9j5tlp@Re?W_s{gw^6~2$^tj=L z*rdXJmgl}CJ^&@qaY3d`Q-OH64^FTs|NOi+3`5k=Pn!UftjbActDP(SWe-H`!h0dsq~^{d}8 zlgK7V52GEU7eRMIYxW|_g{&(ku9z+#k(WJQjS@Vg3eOA>nv#^^nmC%3ZRJ|)iVgsZh^fg}6iG{HXD7r< zo{hL(h$iw7l?yMhIf-=Kb2||jsamR5^n}*cyd}*SbR|eoia3)+cvbvPm1Y8JsM}e< zO&w(%#aGA;N&Ln6u=%3}*9)$ysH(aJAKg@0<{i-?HF60V_#nDy7Lp8EjUXoB0Q6lp zI}Ej3x-FW%1Grr{Q%K1da6Jhbb8eBL0DQ?B z$^*CwNb=&f;J=(#Np1u;47~dl^8q{BmwSL9=RCoOAWK1V83>=5`ahhZ~AmjSTIQMb==jBItHwuD=%QG&GYieqN4 zfe2$43>`WFr{k(GTOU>v@mRt@w$=_3j_aA5lYzz2m|jo+)Jj-S*f_h>QENF0H{`bP zMK0M!C})97TNU1YB``{RH4aTfO~HoT>WwYA21Dz4iM2{-t4pd~_E#+gX}hV@PA z2bJcF$moz#DBZwEFQt|FR2+8OQt@sfE%AG&Oh_3&Q~sthj` z&3M;j-WxTRa_SGXfZR-2K|eNK&924p9!W2EC5DIE$$ZEB!k&_rv-94-5l|SH4-yOw zhJ_d>@ zGR~0!daIpaiLpqgS`Si;LX46QU9pJB0k)kCctyxsqSoMou9kjrh>nf}NybH$2^u^* z+%#l0WoXFOl5InPjfg3@E#JYQ{mp0e>;s7leH zuzj|BO4`K?x?0cTkJ!GAYH(--Cqt2x#B+|(%BM-|S*xZ(Ls{^y+3V!AkaWwyhjEKz z1Kl7r%?Z!@it_|K0g%moi|2jM^8`Kk7FLkYd(`I%%y;c+9rJlV_j!WVA1VWEH>;qX zJ+m?9e0KU0tEi{Oye*DdhF{=SHfS8Mlr<7GtEqAvRV_ff#Mx!A2tqlA$UzHA77-?9 zC7E^3wo=#+V^*LPqKJz;^%}QudjI^q&OUt=9V>hf!};^J*<}I@s4(Tx!h7DLJ%6_y z6@ne_c|Gmr`}P3_)K+qyw`83@qwC@t_S`;ixnA-#0sjm27+Mo<2jWM7-u)Rj`)A zs+N1Y^cj>M97oyWG%M4_n_9uUY+s3VSqn&;QS)JVV>*vp&nyKPqa;uv92}CA|6`Ikq8CUgUWz=GUXhrY zqV!gZE?QC$a1fgWlq@NV^Z@xNq?jax28UPPs`b5_mwHIP=_ZD1%hhLDmno2PpPuc zkv;#KDmemLEMKv^y`;)psRF{Vqh*|diVvv@+^H@L8KMa}T44Ajn++UhmNUjpeUq`o z(2SNhzZ;~#JV?V_;mOF7`2!WWgs}1ja>QApBAkt`oqv3P`kcB;m-iPQ=Eo%oT60Ej zKGRj-N*CCSW8Hx4HQz)&&_1dDhGmmQ$K$?m!?CajW8N9ZQIX_Mtm4??T4^ar{3lzu z?-~>QITjLP+!FKaas7UcjgO;K)8M%PdL|XyA5ZcU@=9-PDo=DlFimNdjI{hzj`rDQ zB=J;^?J*o7^e~(OsP}Sg@8uUPPf(1KiBWWrRYZgtmQ5C~%S3xd>*3fDH!vo1_(YjC z$Up|eHir~LNd&6NVPQ?PZ+ct9q$77Bwc(SOc8=rw#5HhGkfD|Uu^=ls{FpU;_7F?? zmNj$aYG}h*XmQV4f3qsl$a1vH?Bc|kv)Pw%^bE{`0r1W-7y@Wcu3*hB9LnO8&9S(4 zEM=Mk2?$p~WN0HiGIN_B*Ny3g7#~)3GL+i&><)L&*h_*!Wae|A7fd z4{S+r&>101JF}w^butY}6mf6ZN~*SBd;un;j*Vn4%iRfQ>6rC#i${JcltEe4fgu8H zVvGki@kxc(833T!ft7rMapComV33?Li9|}a<;lB{XS|BIlRg;m4x5&AMT5(7T0*Bx z=_M99Nz$Z~{V_b`w^e^2gfO8fSh=VXlop~%{DHj+c@r~;C+fuxCwqqLX034Xca??$ z&@!IN0b26#%VS@{ksF{&X^X})LZp|(aA)=~0lDe8QHNnj*dv+mUxam#QVS37qKuP6 zaW&_cX)}|TV(99!s@#~STb}z8jQo(v&<}!2)#Af+BEc|iW@-u`3kyo3BTg~qC_`mq zs?-K{azI^TqZp>mOo1h+Wr`3DjEFD4@o@`h_>r<{#!VC<>WzJInCKc**0FWMR3bgm zfQVZ__2eQWD{^WcE)kZ3@ypqybq@p&2wiO07! zpoR(?mT|#=XgbM#G#7MDB<^CW!M5_~jEXSCpm12;w~)CPBuN9ba!>4M{U%ClP19y3 z)Tb0T)AVANOt@T>H~VlYM!`_W4vb}* zUd$R)C>G8NfBTIWa9*Ad$8z47j05{F({i69OHfVILTaLAhK|$pVirx{ zE}?T4FecgoNoTSw$=hN0GEgu_(|r=KpL&Iy!3R4_ClI!i>BX$(1kE&M>p?Q5vx$M0 zVu232S?$5eQjCWMUcAndAGgDOTMAm{Q79QlC4>=@nMQ(xiUaSo+WtKX&yJ=Svsw~g zp^4zR89jsRlj+4QmJnzrbO2gbvW39Ea z-^+x=olNI^jay~05_0k=ZIx(SrZKCxEK?6#M)gShNFadAvA_^th^H~W7C1bvjpT=$vXzKrw;d0D6=yA zV0}>6As)-hi`?lmOMK5=BIlWovMDV(D=kqTjNFCya(C5?>b+-Wsosn9d0D!6HgGiR z)DE4M)a0TMU#Q60J}3p|G9p`+8XbKw zPa#mmnKvImY-R%En+XJj!wp5C_EA$-!`n>b_v5VH|)q1dRwza-q|oO z4>3my2S^gPI@?wl0-q>EF8&;^QJ?}w1u}q0Xbl&&0%pun-Xn`e;2`WFb~UbBY3H=Z zS2K%8=i?12c3^HDptZ+uA!P>7aq6+EHugFA+@m8B{RC}Ppf$iH*drMEco806r>Pj_fuGCF1E$Ef#;^@@+d`@jJq1gKk%3I}%mPuzH$W-8 zDx}eE34!qCoRtV)(_wYikV?csw5rE~V;(d@iQN)6LO9ih=&* zM?!@XGX^*^HJoaJAx=jvJgDl>&Q=F}% zd=IHc1wvc}MjnHPKqJm5uMqd?3%;!h5~wm2FNM`dWewpP(nk>m6o`J0nw3~3Bnjrw z%V0+iHyz6*K@lKEeLd;RCXf1v&U{NwfOZ?6ZVKYjVn zwf@CIIEz9@WB?X?5wE2H3{Xqp+u)D7A&Nob#O}XgHzZ3EIIz>3cl;8KE&2)U+<}3o zQS)z=Nw*zVhe?@UBN29+P)4%S3N>)BWPQkz=gt>W=kZu9)N|7Nd{(!i2wgTUb5qCO z^z}-cd3}uNc_7UFL}@kjr(zD^AxXs#a}@2M=@QP&lML@PhPMNj*JR-7XU@rhSSC*r zwPcP;yMosqf;Tan&^z3ys~7-D08Eb`vY|8$lDNr>~UacuYE&hA=WQ`+6$p03eRR(>XNxAypLK0%*5=3hf3!WupHc$wJ%l zOYW)3Ihm8;agGjVu~~G!D^z_NET8rMD2F&XksH6VScu!89_!6~kCX3VUjLe_IiLsf zk3?+to0`JK>XrqZ|*jcj0;zQO08!B>M$Q$7uI^P@;|eOS2{FEh;qtzOk- zE%oRQ>zLdfZA4lNyQRc4F6WWaava~u9B!D<%^G3>@;)EI$7&E$9u^KzS9Eo+!{f0~ zI1SS6?hFenI?WM;%)=3_X0r4zYRIsfQxQynDG4V>i1j0e<3u%Qyf4>=j%XhGn9bJV ziad3)f(6w&eX*n%}x1hocT@)8!Xdg#3Pw z)Lj?oK~H;Rds!a1w%&J*uiF}#!ZV7PTK4B-ZtKM&WkkrYysoCpE{;KH<2uP6VNk+q z2}q@wEU%nVE^%tm#LcuF+Yk?{ban7W1y>XMVa;7*QkZw(*FVp=<_#pq;DOK?5PD zgZx7;>)*&fZ~Lrio=`ZJ%71#OUuX3({W>ZXK?Cz}MUhAoBrLWPcB(k_>8v$Z zJz5lLaaDeN1>PH~34L|-HP^Aj<}euLneM|{_A6{kB-1=ppYDD|EkCvG?W>a0uzz$X z!KHJ~tP~!n%UgTC5xoXGrJ2rP92p{-sVbsN9aGCWA0c^k5E0SjV|>bCGqS8~xB1OV zf_deMK`Fem4a_rCw$L)%EPEzoJQ&QW269TEL=@Ydvg*T^WJ`^s#)Df3c@lsmCGjy% z1_H1pfq?>=Kzq#fFb~G4M4BR6OT)`o+i6B<*h5FsibCGpp^OeBu*e+}lV;8beDZDf zwUsu^(QuHZ5Azgn9OY-i2FKYuba+bLtUk9=x;Bb->q({Lz>k`~KzZa%+;8Yswp#cP>XuDmUA9^kTPrD^7#3B2)+= zuA{^+>y-$Uua?bQ^!p0 z1|DapG!8=nRY9N(*Ja~9m$So%ewH2#fAB9hUCR_Yjm?cgs1Na*rt0V8GJ6__GzNBf z1O`%yyGfX5=w{LgU}e9VvuSi>2^zSW4-mkmo@1 zmp5*qJw$M#&YzE&Ul)rw5fS}@_yn7fU&X(@E;M;VrXpo9TsF&8)PbNn@4I~naQoyx zuGyQKmo4V=F9f;)-B)PkHm~vV`E-i!Bx^@@vrLECkVi#l9y=WhPg36WuS7UhRE zp07~acZZ3E)VI@jH|UP9!v;bgI{7;8KG8#e0~>O;mlYl@%#rg~ktgyeA6=bA}LT z0YD>nFqE}&pFGMOu+Kz5F0@-UDG!_KZjqQfE>bsV2F3$sV6{|l=tXy3fR8bH;m<(W981ds6XSPZ7Iuu{GmNI@93y<} zV75IxKTOVWPi%XKf07x)Mp~WQ@zS!!FD>TX%HevmWNgr>l)b;;0b}0`S)!LuZ;4sA zrT;T8TOQ}RE!_AqoY^zv&Kxxe<49ygF4CJ02h>;u{_$FFtN0gzCJ5!HfbsW-eiK3& zo{i`t3noN?iW?Vdy7Jc|3M?{u%tFosCHnDZ@%#A$4)YAo6q}kC)4;a3fZIIhc!#($ z0oiox#-J0=5I;-SV8NrVsaIhE`oS}?dF7c_S2b(YRmc`aYU{g$tNg6ITfC{3OS29i zmMH&!)2zCUW52qH(XFo172o)(uF z_)(G5u3Z^fK~WS50%HoJs#J(Mu{^08-#r=+;y0JI*BINPLq3Xd678F!`$Cr^V^(gQ z+nEayPN6l4@Rtf5L?}yzu0;4Cv%Enq0ci%LLnUca9^KQ)Q8*+IDz^Z8Le)SDB$t=K zg@nckP>n|a9^&GS)Pgqz0rMGV1Xbh5Ih1P@4VKCFa=_>H?-b6$b3hoPx{qSEuySDE zNU@PeQNfULwOmx)LgsK81?p)rm3)Vo9VmjmdqIqyEY8%A6x(_b5=IQ6ZJW6utV3qX zQI{pC0Anwfa?oB#I6*V+Soi3n#LTM#2!Qub8c@Zbhjggx4_NUIVLni-BNDj)bhn=* z!Nk;_40+W-mUPGZ!R&(~@p{VR8O3q(Yhg zE!`nR=tIv6Vb{)j2jpkOTvbBtmttrK*^?os*vj?tP)8sJ3nltOc*4-EH$HRF@66up$|Cn@!MF9jK zQ|Dsuk#)ny*VPXHDVn?=|ct;vbV+LG{V08Z%{$m}+d%j8SP*x}{%5qZ5{k^t_*~b-@dkcuglm zK(nhZ>Cl(*UK%Ngy%VoZfa>S1d2|ERu-PlMR_6cFkJyrS&p6mM?(jn(urESwQ!=9F zf-7OM{$`f!?-=JIi(8tpN-Y-&8qT*HeC}FKp?*pLYUYft!6nX)ZeiVP`LpOFAD%HGUO)e?=t`M zT8)772~N`!;9XgSp(a4|68v3A@~)J}>r;*^KTI2txz$kMU#*h;UAX!D>su`3^ymce zG=KN_@D=I`upWo`1lU8>?}~g386oOvv2sN~psL~rp0oWPECbT4(KJ5RRplyT($XPjv$drm|@1a`)EE`fi_ z)lQ;ra)xeuuy{)$Sj2|68xLfPugAb#jIOSuS8NKnguM{?S_o&>)IL>pvkCV{jDOT( z^r!@}Yg=vD=gIi!LZs$CBGDLjO33{z?-aKu^XQAguTx2oPmWu%y&8I|1wIp! z#0)3)>0XR-Erv6Jx_ZIoIVr?uP=L?NP+DwfX13Mee4Y%&8)FMvNE(R{R!dQF!J}d* z+#^VX7bg&PKs>~~0fW;*y+MutJdk%RP34OoMHA@l=e9c1&y#rrRLmCW_4$A@O$h5F zY66p5xV?s|jPB6G1EQ#4|0D>xN(0&?QNu)?*fOVcf4+KoKJQ~G?yxeOdZez!exujn zRffhILZ{_i-L@LN&y&{zgr!Ae38<@O!v-zYj!MM<;d`Ez)k9|4oR9ru>W(Yoh?SuQ zN*c#u-sWwq^ZPv6rgx5<(`ff+ljRt+pLtRz%i%%0v}@KLdU(GALjhAz;==&qq$J>} z#8XsMmPn5=U$9+YkhYB-cYVS8qq6ddm@E4msk5Dhn|BzXPXT3@2S)-r*IMw7Fvtj0 zK>CSFb4aNYXV6mrS#n{NifudcQBS5<@V(v)qlE!Ct4E4!u!VsWf=6h9Z;rR8qRH|_>0+hFgBTtAP>EJQmXob znxcSHa@JdQ&O_w(sa2!&QNP^Z|E>#wGYo==BFYD?a7YrKI_Ym6#_wh?QAzDz@d;s4 z=+rDMXITB-eM32D?ZKG&o=u9Z^O%u$Zz1<|G+~LyJhpIYLa&n8gkD^&^2>GZ_Ndw( zWYVgxy!>(sZF>@Jz7*vD7E!8Dmw`+ec)=DV3r$gkQpiyYxoTQBNNfSW@)u3u+GhJj zO8Dp0$Yu0NO^gKT*JvG-n%F09h_|P?UgSk)|ApMrst(bJEmpk2(H2nr<0wVEwuKvf zwuR@5g;Bmrc-a7i7D3?^$2U~q`D106?}%yTvxV^%qVx}}?BU0JC4z5v_kHCrqTm}P z0Ys?#fb<&eBe)g=!UQxsEH`efmq%1G$xqZf-JsBBoHk6v^=?8Z#PPMNTg2cZ7r#*f zWO69%%$re`V4(OGXoWFQGOYGaFUA^{6jiPSb{O>d4+s+g1_+$W>pMu3#Qk%;L14L7 z`WZ>MB$(5Fmg-DOtC`RCS|H0Cj4qX6BquWM3?bB*Hat$r#_WyTt)K%{4j>^`E8&8z z*{eB7We_5A8C;+|tN@I}u7YbsAM9r_?VK?hbx%jN?+ux26P(JvVpC=-HaMt}V{mG( z%@$rGuNGvMb>U$%VDuA`h{KBQAf{NkH_{!#w6kt|Bw_lHtH)VFVasWm`7mtDhI zgCvdViq)u|OoD#P7}KWq4s*}NgQAz*Ona%%$fBj1+Up7_zx5y1`ic~k{}PCbm(Qvv zv9UV{q3yY7U*8bR7*Z$l#Xu3Q8N~!r9&VOsb(wOAmNI%!9c2PdcJc|{BqiI_4pM`M z3So9{kXX(dshDvTDlI+BOrV}**=#S5Xwo3!A2MZ%pgz$xLVAUmN}zxQQS#>cNR-Ry zfD-Vg9A-8m_?+{@l<$b@K8gXkL*a*Gw}*jrF=e9%H39(+EFQ^_{vBjFV>c#((c}P= zM#p#V=7{Swif8nc@ZGV+$m^drDbb`)V?SDvy#ug}Zu5S0U$A z2S;U5SBw7oMuk86&c&`ShSo`*?MVeK0w4bab~U6Z4^mF3#aiM{`yb_HlH|ya1JQk- zLKnz1&ck_Re;0q#_h0mLFh){o)>@QR3PFOP6L2^_NV#+ed4ngvpRWy5-dw~bi!jA>-9rMNHLe13#wZr4E6cuE+pz5iAi_- zJE}f8ZRL~Ac$zHw&s|5+VYX{V{w~q%BL7g5!ttU~pZ#3Q+T7npf8S$w6o%CQGM@E zLU4w{YoG+;ydWXv*_^Y^=T)Vyxp)EL??6miPDsG;NhkYeLgGj1O`e#qE=f2EviGXd zwhy8R3vE?AVSXg7sD10R$4Rq{e1B4w3l0=BOwik!5}KZJF1?m`Xsg=WsjZ->3yA_V z(!#)^L}#>=%j>`Y?1%j*Vah8(`7RopHi(hMhlTsKVmD3ngH~WY27*cjAZLDy8g7H> zvc4lYnq3aP;zB+x_$XyxQ+21;j}%ug=CiV53Ii8f$a>9>h&|%!Obc}R!-7xBH30zs zXixZ{!X2GK`oe3pr09e`Nlv9&T)6M~vfx8^ien2N)V)F*9+6H{5ONSH0xf9#Z&}sV zd(vr9SRD=~P->_}4PKB)B~25BSIBq_1kRU4qNmZAvs6MnEeb5y5M-Ok%{eZ?_isDnZ#ZiK&$-F><~T}$XOmBLFYcIrIAkJiv;2KU?oepi!j|` z!Hx73^q@_W{`%d7D_%8&&audchDbI8c(>Ge6YH)_CQTTSaBBG& z#PdK)#--6?lBg%27R4s+u{~Ld#m^Rp(<&gJftWbt%?YG?9%Y0EuX$zTZc=QpU+`KL zxuHlN8jM*6GRG-4_)KF|qVcpL1rU%eq|>66?{Y85DC6Y=nO3TEgn4-v0TnOw|%NVcG|t!8SH20lo6H4Jog4YD3y zulymyp8p<3Yej2<(JKZ7ItiE^B~vVaco8DbO1|+#D290a-t4!yN-k8jr~|0X!l=>2 z+vCR8m%%Zxf^2ezff{wHr$rn^JV{;};owDO<8&$jsItX?bib@Nn+LU%t7x0UvYAEN zHKT`IP-6t3*375gevZTXBr$V}GPfB^QI|}4r)9Iu#|Np5j2^cWq_BBHYy3npj-p`I zP^S2FIoOJ9?V1|i9cV0>j(i_H?zNATHS1(fP^BZIUsW?Mb&rl}}DKs-&KhRzY^v zSg%o$%>odPGrg`HyqP7|0YON`s@jx>oR(4L_fT#{N^16C1dqO8J9^+RGo#%_jc)IasjwYhF)>2>VMV*5<3 zrrl|M&7oY#sTW0WjXNVbXz!l0|Ef~^j97K$S*WkW5hWQ9XUOk+wVmdw^wRKF`Eudbzr^i1!$=K1=Nye7 zXkb)ODw7}>w(h=zZ5l~6=sw5R%`9yk=EY}lQq(+BB#>Y80J_Ymn;Dv` zX7MfB{MdH~a+sS~$$sZJfT!8)D}0lRfCdFC_7?T~8TAP>PoA3Ap}M&y8d}QrFO=AO@HKpOq)qa8OzXKU=vRY(#b;%EYUH)yXt~`a?!eN zMSGUh0H~E=)80wpX$$qM!o+1EY3D;PjJUOvfEA^Yf`Z!riP8A%M4<~ta#SI~ayY|$ zb_|gFu6~`Any#FW0@lQ#Za}*DK}nHn6H4d{jc*zTdby>+k3^XZkL;DHt3hYgtcVUB zC-q={lSK7&wE02Gq;@8;q6s2>|Hx}p6Xl0V{Yq*aNR)R4rAS~Hz$^J1AN)uR*-(1X zlE%@XuEsWBrRp_%26G!nfX`^m4WzBPX6GiGvAV(Xpetu`I8|qA)C^rmX%IC2QpD{> z^FPuY8hmfh&0yZ4V8eKHAf>WI{`$p!7w{DgsbA>HIQdI`}f8uR19w4YMK0+a>{cXfd{ z0tB7LrvX^CGjv22{bds%cWL&c7D@u%RU*v|)7Vy&gh<%mrHq6DEn%;PXP9I;#78dXAwfO(wy>Z z8gvTB+>i*iX3PMJ5aDo}6SiTgHer#3!Qu(Xbd8out2PXcKhBZrNAj(;c$@6>bkTX+ z)NLwbw9G-nA4QSPfV89JwfL1d@)SNTlzzV>d7Ca_GyHqp;Z$qL? zz3DVkR}Yw>=FDr0wOrIYKqrnFE+b-F9<<_NnA0FHD9OlfnY>qP#9hh5OH=`fy#!VN zE#P6)gl;O?4$h+*A(D-P^NYM=CfbVwi z1&Te%T^U>I&Lp`UPK^#9p)Bax8*?bVvr%q;jaT;Bm+sf`>WX>PUip~AKy7}V5c(%A7Ml)T>^TO~ZAxq;`b?40Ua zd<(YuPweb7eBN)+!Ho)2ekv1;2*#Xw{=O7i{tml|lMTEFZyyPhbsVr}qmXFYMuuv4 zo~ZN#;cmNpsAHECZ>vqJZsj*xi+=<&V<$TQALUh&i*jX zK*fXXEWFAKZBrBn0Bq>x?&A1c?)119h}d)A)tS5wIL!6qEno-Ol2;!l?@YK#-kFu( zZX(K4BbI7DZ-YVx0Wgr2U2iB@R89(y{uQMK{tugOo%Bw@?8yU+xVAtB@G%nkEpvJr zpjO9qV&SEZ(Za`7Nbvx6?P1~;F(nanmR#=%iIrCZF!koZWKsWHDX)ugx{+6JHw|tW z{EVw9MR1#5*@jCnhs-6{srFl-Td6;7wq3btJ3j8C#q-Fz5CV>81D#D@IhDQX`qPO$ zYh~r`B&gr6dU5276ICT-V1Q0i07*sqOAid<;sZjqLe)aUNITEG3kk8 z#VSB2M^`vlyo@b6O>Z|1F0uTK8&AN5*Xft=xkj_+FIBZ^E@a^PGH@Xn>RbNw7(kfv zHGl5O2)ol;;8yU-UwW3mXy)yQ4hmI}88b~~GvVTqyB?((;2=_;;I_XIrZ6O~9zPMI z%{2j|Dou_2MQ(KTJWX_iIt01#&GjcjMGg)Km#B(5tl_Ycjk`=eMo5>DdEX<*V5rpMt%|-*RM$p7O2hKCN9$NQx ziG+8AlMYdI2#yeoE;2IY> z(WOz}H5}d&1dZ;@XfY~X4sZZ0u)NdsnLMT)rdpd%+6X)ya1uGv5YwGBRLX>|AByJ@ z=?9pbKOZ$32!Q==UYX)l@)13tUK+;%UMfXVuiE{1Q0LGu7l03N*I*hZa{PS(6MzUl z!*Cjd%VTJBkeWr6Z@~Bmm|jLd@(Ickctw81yo}^phF)=vH5B@2kaBtBg}*OU0hP_f zGy)`JL1*zV$i3t{dRFsg36V`IV1sZW#m~quxFRXdy@G(2SmXu!4Fv5+EBt+t4^23P zzmv(ZFC{i`2NLI7@deid3AdvbjDh5v{WDHsL>EO!SUFAvq$M5!TO{Uvq~PDZI&A14 zQUw>eAZ3laa)Jl;l2_$S2j?^^3PXaKM zyqgF=NO5PQ(8P8l{tOStxG*G=43T#aCr0ia;}}i^ign`t=N2(ypb1-_doJ0b8;~vX zy6qjpN4D2Et|Ac$tK>9v+9>7}Q+Wxz+jtTYo(bHxIC#cA<7uUg3H2hgkK%wG!R$#Z zBxQPgUBV&7a1>efJ;K{%DFX7#?n!OS%zw_h?3q6#686^~U`_)KHLpbu%t)yb)jtULd9P8wZ?iL3K9NTV==D#%EtC{e}2h2Ky-fFvcgXoahwc)KN~&sU;Z0(N(|qS+;yLk7DiAA%*I z9^jha2I>7ZgZ?~r6#O(L{WX21lw$k%vwlFq`ZR-Qg(&HH){$>FX_G^HMkNexsDK&+ z9j}WXyitvkb|4=eR-8v@2z~lZ_PT_#r*Kdd=zk^fyd=Ec6dKQKuDTgS?ym1$EiZ!qx)pG<0Q&kTOcwsd zQKnBo)e_0h!Av^_mNY)tHs~jAHD7b*&y9=jF?rZMrY{>p3i+$O9g^3dC2!g6w3VIL zzqiMq=XsHkr_D3^g?fHnHo5D%_m;&disv_-a%XqB1hVKCl%;TaLt~P+QOK{k)ALGN zUHk5&U))`Q^xsl99;S|L$%p}FLFyo>@NF}Z-kQ1mq_W`xo3K@NrVfUL2QYw_Lf#Bq zRWQtfjIzIjj%)LO^8b|_G!0sBpqR5C#NPTb)FdQ7C{pKI;74VP?mypXOFYKQvC!zi zR4es71WDI5O?v5vvXr_RViMRVHyx5Orp@w}#kjZdqY8LJuKMt!8{Xu9K@$(o>KC%c zCph@ff2utGkL9&y`!HM3M+JvxA|V_=%~P#@?GJx$J>_eI$XCV$Js!u~)FvPVcTYv%}a3(n4RB*laA&(V)6(nLVMRF4rFOU^xT zkI>MygX&oqLn|5DPixKR>Pt9h1q3dJmikR7$j0AaiaeiZvnvXm6p;H%1xWQNa(q@~ zx(IAkYtpeyVFsqf87&J)?arR0p=OEsteM0@`WvcCM)YMv4n8L49h+(=ZSXUt*^oFc z0d&k=Xgyr3YghU82p_TO5Kk!{Pv!yzgdox3FXq5EDsH)lXrj>+kI_UNUc>w>u}^Vm zV$or+!G>Fo-pf}A`Mf`csl6Y)=X+#fh*FJF3Az6Aa$)J@4- z5$Q543YADQP3+u^fT)UKBCGuvmbyx+$I{q{tpM>r2*l!9rhvuNCN}dlkqjb0j2Nx2 zkg;Udi%!49`6ZhF95Es%-3Sw|u!-zs+i7B}Krs++QMM>SouCr9graE38#@Ia36m&V zFl|2o3&d=ji8Tg-bK~>RsHm~bCcR@5LzZyl=iEMj_sxu&Mu8Z90|gk+C{+$WLMP&1 zhW{2V5m2UX)K@P>?C43it2M&5`-=jI zIVJXVO3v402A5qYx6%+Y0)tzTf%&;3)f?iy zQ1cn_Zg7!_zf$j+nlB9MZ!`tdqD}TDMHu%SBJy(Wy;L|q^^GN82EdKD#8=kUbL>tS zk9F&GUoCj)opmkj%D6r()xwQJd7)D zYBo8S6)M&>< zVnu>O3>e1>G(jjb#dd%eR+!10-_f#ebvfvyKRRS#1So?U1WFZxkU$d-&=@?RNS;H% zVk(6wYi5EDv9=*+8%d0VgVZ1Mnj$+rvyw%QLYSc&$c9pmURFdRi9%a@vU@IB;flyr zieyeeyCObdqug*e?ZE@yoS>BYJV7%-9TgA9VIRne+Ny`^I3D@Pi_Ha9)nR8X}=<88@?)Z zyOC#Y$5_@$`u5UFo)y)|>09r-trI_4i7&|Ifc)WB#_OGy5|-W_T3CrM!!@EMYg@nm zWF@cfr9C44AJZPG$zexoWnmac)~_xcfNX2Xu>k_hbNb+TC^BL4U5gq=tfx^*=%~B#(myL-B3PZ>e$K@-L!B#$5|Wg9B49fyy=+vGkp(&12%&*sVt2?vBA3sv zO{y2ec@$8!^-~zOT*!84VI`h4s3-OZ9f~0Em9DM!1hBQaE&4riiP0fiY;yBK`__Hx(d~(WX0fS6WX~z1{$HxRYg3L&h=8~-FvX9LDhS5 z@Qw{v$G9J~@dWk0Dr7h$!I?Uk-F@Z~P$6-Tzd{Zrg;q8DIfaomBE6^G2@rouJ-Vg}{8b z1nvpe?Czs)NcB#2g4GBFk3;0|4k#+K=Q5|G%#8p3QcczE*EbU)hiNpRSFm%4{73hp&zJOK#_BnkXi-7GXa#CVJ0bl+{6 z6+$3*K)9TD4bn~^pK78YsjWXj&UFV{qHtJbN;2R9)T%|lV(vg`Vi`Ch{QS?K^zGL_ z-^$MrpXsLXN6dWSh^wAJg<#O)EoPQ1^78p#n?ncw|H$ICzK7)zp)3sdbtPZ zRBq>#EH8UbcvneDbY)^ufS^c9=<=&dlAl$|dvgtyB%Yv7boCYj#8Imx{dy(!6|pVL z1_M(mJ+|B2f!$q4YfM;t@)McaezcdKZn3TJszunJnB{^q>PuJ7_(m_i;0*KPOHcK> zty`FoEl4i2CO}ULlONF8h)9fM*6_W&ERg20{Dep&D)?ho$asrweN|`Rzz!7x#iwFg zR)~Y#i=kBr{6+Y=su20vX3ED?g%nQ?Dt1{R_SFg*8h^XsxanCJ9dq3bm?GDbLVi`y z2P;V-jx_nLI@2aLNr5Ho#hZ>HZ|i%_Pk3g6|8>)=uHSDOuex4q9hPtEU*-2v1MLi# z?I6zq8Rlb@=NFQCwnp(|)x{{cD3uS^z7tVzOEzC54Ma`7m|qqSFalSOEgh3>CtqHsxi7>^|#H9(DX- zOJr*EZO!M4TuvEZQhceAo#HQQWTyD8Mk>RnY*#fB-$8p_p>L~8EZ%j&57+H*P`v*? zDIPa97ww=9;!E$j>)7}UK408^CWG&P)%-fg_f);D2^|oLDslCyO^t)>?+F@d|5Oj# znhgjAK_UpZ5=&5VfX+rhB6He>fbSWO;sy=8Qe2jwyt}(pwn&imN8^?83AT&QnlHO} zsEZ0r-%4fdywbKv+~?&A>x(Bi_0+h5J(`N5hxaM3UhfDqfl@X)kwrX+$WL0r}KO9zmR-f%#4;+SctrD8#`R59-`O*Bt^2|D;3YXEOOIleIy7 zipxy;*Ndi0+jdbP^Su_y{r*Ms;$EupU{oLx>}+AQ5ej(LhCGPiK7mHiOg0q=!@;-_ z8eIvb?*SK#p7dgicZc|MgQ^u&e)M=muLZH`PO=*y4Dn2>c+atVSN8;c3Eh5A-mX4K z2>J=5qgie1gOim&`kuXQU)gdqEi09j(dPhhCKmloU1@c&K;s^!V zb5Punt9f@%8(E+hpOc^zl&s&4w#A{*f(Q!BNr>f3+xp{^m3$v#-q9*SC+r_nLGMVl zv6xesaQCQ6xmZ+A2r~qwE0D|eAO;fVe2mcKE-t<&LAmmt)o5Fvo2&#v$$H;DxUFND ztRx1A6Q&{hdkm$hFiz034XRci%V$iuswriRmL;B_7e517C%W{<7%_fLDYQA!4mp>cM)X<1eV@9Xx zd{iAPTQgP2Du)DQz{RCjyhOZ_&E_4y8(9S~GU&=Z7RS$%o(mUOSEN{QoQT$jw@PSz zTS7Ap*`vmlEkiV8+0$mT8EOoY@p#~18eCNbA@U*dXe5F{pLkyYl+hwtH<$&gDohUe zV1p(o!oUDRN(0e%#z8#nd5-Mk`PCgNfqVYTc+-2=mltwR6V!(x`9O|IW6u$o4D}rP zA(TFVQ*ZrX5>8?M+hDoNvM&S}z^}wBok=(a6SqQFTSuHYmV0`Ao%X@_q2Le>n%>nF z943`RF%=8OS+csftY^?Zv@=mNn)5T`{9qDJk><&nyD{XNKWwuQoxMpo1(Ob*k)$gL z<3mmJsWS7c14~9+NyY>jrJecu5``{;J75Khj@?&|^vqlVhOG;r_7aI1|`spxzucy8n7O*%d z1NL?8Lt5&pML5La0ep^5p#?)K-+9JkGYO~IgrWi#Ft>%^&df ze;6nlVEHian1=H%^RGbC>janP{5T)?h0E)qo`kDO)69m+BpQ*Js;s5ZRw+D|Dcch_ z3Lh+~8GsoCt_hO*0fnD*6qYUinea@z7M}_clco6ygyQ1LMc}Y)TJh$lHBG}^CO&~4 zrI{&A)^Q%T`8yMXKp!ZY^0Ub?iw4dy8w@Rgpr&l>V;QwW_Gv?K_p+}@#4YJ(M@nfg z=0DxbKg2U87U%$1=){}>0SIwF%}_1~G+Lu5g8 zd><_*)dUF7rv9P)Di8|4s(U->5kH_O^ApQq%d1d8evKuWQ`bo`@Z~w{UiJI6UA3A6dzO6>Lnp|1pg8% z7sjU~hJQGy@#{^y_@UrW8ar+c)-$uSDTl-KT}{dl@y84>+Sz0oBxmB-eNTd4!_9n6 z%@W>dIZ5ul8_<1_%>27w@$bas^j*?+HU(E)c^-B!xSB@?5x89T>}QNW{X-!c(EWcT zp#57DmhPi!8a(^uc>3+2)5%uoIY@reYIvg6jtw-YVE~X!fnA1#dDi<=I7~h4j(3zR zNZDj^%g)}JMteVvBMXZu7YH?*~(HWHXW{3?`>;4yH+Q>?<{kq$}u> zGgeC_c4w^k7b4^`So&F|4F5~8?1?rLpBZP<}Glc$gY&eDA=?FHu7u#V*HcXj7pkCk#}!h+F1Dcc!$V{`_GAM=)KW zpTl5UPpvWy*C`(#4p_qWc!iMiv+{ual}@A9D$Z1h`M`*|+YJz#K93kFZyPXzk&)b( zH?!q*fsy8*VZ?{@p%|H>*e_!BEE#%0;KR@vIw}B@rL)j~Lj~-~Dd)vX+q;z>TYq1R zFP2qknoCqyj)$^}zvB2BD;@K}>2!j+$TW7Q4en~Oy1TKCPu?#A8*33qHmBXj)EK@4?H6voI zLc)K(XTnV+O`GQ~sk>qdLl-$3vvxMQNn}7y#lbS4`RcW3xwSaNLlGDOgtnK@+Slgb zcQHe-=t)oDI}}S~nx>nZQqWtBzfcPFv(3~(SHf9ESt`W4q&n1a7was5fj(ohTgONH zzUl;!w)s?@Fb1(-;(n|uf2ie&;vL?9v@Y)4jJ_TzzrPwbGQ2J zD>wXEkAI2Of}ill6wHTG{1P^RK!1E z06S#M29#vE>v?vY+mz`R!#|<>=yed3C3!O594w%btd<;L;bw9?c^l|nmW+5!j}7`T zxiFi2C;};ij@V#wG2rj9-1Z#wtv^}TS}=+Jfgus@_s$&oF6Kvo*bELf1q{Qog?h9V z8*D1ht$8e$O@J~dpo%uX5}4&@0~oLRa>dgrFToKv@#MCoM_v{7jTK@uG`@?k+)iPH z7UxZcHtuc~u&+C)Ra4T0}E{=aLhvYVrCst(5vVW%b$F zwXDUHjYp^$Wc~=%-4C^Y@_rH6B$4?$ZDcKR5$Z3?>a!J8bMfSq^I}>33uR>_p3OQ5 zX-Ok5aQGKx4L3t2MP!TmGY}#is>0>@Fnt#jacZ)pb7Rp>C^`kyn;`cPHkmXO0Ss=7 z%-ng)x*AmZpOn?J+#j4fOiiSjdcTWJq($FbghO*E{BDDAr|2+(rr_Kb$om-yeaE0Z zOkX`V===H$Ryhm#j~Nm4r)@t|9rraKVyHs3yXYfS4OP%?$)5WE3dXGeBRaE#v4eW7 zj!cfpH)jsxprJUvfMQ=%yvEUn;&52LWn3?i`5Lkpj$h0cNZSI~>a9}sl{!yLO$$Cw zJiO#%O4>gtbGpmRfNz@0jPat!GOrCjqkib-`gy6ccb{5i1QEs>&x2J=#+Wg2BHgHQ z$|)^19)@qJu`)-E^W7Q`INhZfWFDKl`x?!sQ1*W)lo6Ov|Y=NA2e7 z(<{Ce1Ka}3?`(N>zvU?m69<4SJCc~oDdXZMRWRc87JT>oy+YoyA~BF>KNi57k+3$(0!psc6$(&tWm(8;djQ6?U+psBZ;Ex(y79 zA;fV2EX$dc!zuV?F?DsbEkCNj3G?EyTsCIRp5Bl#gAECksqA}4#%mdKb|8{vp_6hr z2VYG-S6>BUFw~yZu4b&eY)n|al4nfZyh%SXV_r+xq^9WglbTv{IK^Hqwt`M!vn>Ww z4WPIAt}|Z-?QKqpZgE?_*68JDD+qLQW4!4mQYX;;-H|jZ$X%dYVg3k`{ZeMWzKT?t zX_FH}4KIY+ReWDZk~C}tk^S?b#=DZ*Z|YQkySyna@|m#}q8F=b@%l6^nEE%d`s@S% z7f(((FUFeg$Ex)J;6)h9;SV|bC!yvSLN%j;8pX3Hi{}*mi%_GwtDyo71V&=S5aUoW ziZPIyi5VN}hPDC=om9)Jpnc6~0hswaj1o=!oHmcWH{r!Dv0=RHNq3n|MKfNH-oSk8 zuZPJ{s=LduX@z=Oo?vx2C_kZ2S<$%Lbo#uVbjrbG-@s7M!o+>&ZoONUwy&{>yi zJpxh%YkW*8K(BdHC-Y(za|hJ)eW8(?-9KO^Vi|vPNk*_$2lNwK-&30cL;k(`|3$EM+1}Tbh`|aqxd7WAu7>|JU*$-W z}e4GkO5XOdOHT$zD!PN!{g%D=rU@GugV)upDGk zh^|YvBiGDL2DdoPn8DOVNdfW@qI#$+Y;-!zP)MUc5F6_TXkPT$%b|L2J<;KM`~e+V z`n4INzL6oLVOg|Za1r(yYehEN_ct;|_re8lO2(s5%WEF}WIB9Gd06N{LmG!SrH5(y zVDls1Yesqmq{t4@4{>9uB1Qi=poJe{r#H?0i68RCJT}`Zu*k*S68E{~suS;XOISN` zn_E)q<`#3(Bi$9aV~@)+r!7@2D6#)3albUyVH8`9T_rAAeHv@OVQkmq^IGW_oW3Z5 z-=OE+O=A^phB!Z|P)x2;(K&NKO+8vpB|xr0%A&_l5N#pUjTTS=oN@&qmmbS)AICGg zJNYz(m!MX`d-QIsH`$$K?*P)4?SX)Cwt5HT5cCLzjY?WsIF2(}xh<$z0FAZFZ6AG- zDsB{zL0-oPXCth+(oyv@UKG28@>X+@>Pa?f*G>yb$5XZYyVZmIEdB0GDBPgE9TJKm zl?IpbM%_b$Xxnhu(=!+21$Ix2q{8}A$2zd6g6EnyUh;5QhX?)C(; zkvV#HV>qu*RsNK_#Ki8;dQ_^2E;1g!y{Ukr$9&aC^`S4b<9YicB4kRLlW*XUdO-bz zl}Qy>C`>8g%h=dM%c|2$ z$IbOj2NhS6#Q)+X3HOs^GC#{s0u=42IIz)ZnU0Rxqb7;fFyCG#N%>4kYoXD!;lsxy zH5vrurlJ_5nB`at8NnNk7aL7?fUAr^Hom8%7>&r6$v?&w8=)nW7enp9hu$BdhT1fk zm##uxKP#RZmr$3JTuR!Ap*HtJ-A|BtrHG%c^v{)J4)Q1RZ%Y0lZann$_D79QX$Sim z(t0d)Y}6#C`fcnQ&$BekR0!_igQ-oG%QUgD7;cYg_+DV83ox?khS84ZjSG!N`JIhLqA##JUywO}l_BG-yeM7wUDVs0U%WRmC*sm8f z>8^Ski8o&~^f_Y%dVYPAPdCMzwFIRaA2?)-DY3C2ij7h@peI9V!%PGyZr! zA&VsOfIv9T?GUSj5dCJouh4iSL(mYxxMNk8H%_Yx6pA1B8?*d~X;pcIM+e3u68KM7 zvmGWxb3(kz!ExAt&~F;%KdW;b=x2hI1pIl6k=iu4VD~{5y)rFodBtlY zQpwaHSh#===vg7s1@XZhVF9m&gol7F0cg-JYG0|1P-P{S!K2)iMmI<-uu6D|%9>=t zetYuu97}P1PjPU6B1Sx$U)Qd6A-Z2g07&u{Q(K98pKaP5FosG8*%e82h{Oj3*!C-1<9NR zGTS_oe`vPl=AhL<46zCVM~dAJQ;-8lmy5XFV%wH&Tzqzhdg4G?=xp!R6M5!M?G`t2rc{BG;?ImA$Y4xSlgw|Fy(RcuOK!?9xJudoEBzvhP zj0BbISxV2871|;~jugPzPynaQVBzWZI#Y0mKaw-ixk6-nR=+NLYoN3T2~C;GVh>u|X($NLYnOlSklOgxb@4 z&RI7i1SgP3K20bgpqC8-7@lB@i zT*Fz=LBcB3oAL~$(sr9Q(7OX9tO67bw-Qu{sVU{abh;$EH`^3tJTUwb9-mWQ50wasAmHaQL5J9Vq`Xa9Z zXgSyWvQ?T3Rk9avqs5sj>LV55jRBOap!LiTNw{>att40LMMq~t!s;(NTd0kVSNVXJ zU5~-wp_qm1S&lH0?R_oW>uba+88$>hcDf>*$#auGkY`0SScD(P*qOOFUK;&tT0Gq^&VLYPaO z>u1GUhXY-fId3&&Q#%QPw(T?|HCSC5C!j zZ8nc~@{W<7Y{(auqUv})>>`bgHdr~*+%=9sYb<~;xC(Un4F5x$u7SougziRSoYUPn z59OQJ$cr%*GXFBCwT9}vwv@jrtJ7p@6jM5Bj6T&=r__B@`zPlM!{!hQCH;C^^rqR^w2O( z^s5a^Igp&$bkx7JZJrgd!Qq00pe@olQFt)TPfQeLnNpTc4WaFRTCmE{ zkx6$)iYX(qoHyg(v1d~73p6FyPv1;|OrFdaX(P;V zlfPfCMfKfz4K2keGZYOR>bUoJMFUL}ieb1svYJQ+8C>0AbnWuVo5MX#i~2&&YgHXL z9IR3l?pw0TWJVL~y|K>A}_hrzwDxM39sdIcc9ec&}qzkRpIWp`d5XK7;DDLc@Yl z7Hevw-P$d8tb24zTCi?6z9-TJlRp=qM$_UVu7w_*nDU2(3L<(uUKqF8W%PGEluB=U zRa2J2dG@T2Zm4|k>S0&u18kpB`&z+aL0Pjl zXw7(OgYYl40eaD0+Q7STH6tE&bYplfgX}=+i?|jdaH8TL4>dlWUlv#3CXgt;CPf8T zWP6%k)s%!Qun+?6uXYZ3xJ=!I(caMZ#mR*6IPhkm9>Uny!SW5(3eF8w`yu+A?@Yf{ zqc8{%xCx*=AjaQ|d->Ug0&q;?UT(ts+;N%Vi;q&Lr>N!~*Xmj`|9D;Ng!D%pJ`UcL zT04X9V|dd_>mc@Bep+YU!24YKRZ$nf zU#KP>>J!z3EiR6-Np1tvhBMakJl6ir`#P|(go}>;$5_8p)+yG$uFia8Wo=KkB>T-~h$Jynm} z0H)tVR0FW&b)|8CBwcAO$PT1Ozpk|Q233=L(?SpZy5A7#VW5uR>T9bMrO z%iRF(y)ofKdRL*PquAH6Cbt<^P1(ruL?&$6rrxyhVv|czqo#m+X*JBr`pwX#(ePN0 zz3gt7%g+>n2{p^&$jFd46@CF!{tqs|J+@>YX~hNcX`%Ikwa@ghZ2ZM?@=t5WceMDpcJxx* zJzg*Mi}#zj#$H{__MhIc+~W;POOJhp%tfy*B-^b(v0G?5G%ORU-E}AIn%5>7Lae_j&qn zGn3@VPB($P1&k3zz6+g8K5;JX}^Juo;&SeGW`dC-%Tm}gWh88 zU`l*LB=xD>Z*VgPyGZzAk@)W;wcjMBnd%=eh#AQw)i?Npqp13ZKWZx5lz5q1cXg)Z zvcwPOsfs&qC8gf9@DfvsI=uyeNvpQ(@8q8d*g%=zl$CTC`#RXg@-}HWg{9uxZ2|xP zrmfV^pM8egveFB>nI`-HK*^V0TQIW!h6+yuXDs4c2=kFfe_DlmdKju~flYK$;!v@^ zY|K1|Ng5yYKvmTxh8lF!=7qD6mc(mNK{7=5LD_jcr(PWmohH@v$0zDf9w`xjm)Ja5Di&wCRzBH(mWi0okTo z>Zm`H1sq4}s5hZ=P3juz+6uz+hH}OByB^mv2iI>qYywAB6E(QRT%jNhHDc^@M&baM z;}iT7;1Z%^yjb&Rr|9?a(pOb7q-)EnMNVo0_c3gv15hNa;Q z!uqT?=j2b*pt;=T?BhmJutv;NOtt?@+;`3F&jDt$#r- zcUU>dCF)_FPjX2W+>KngJ`FAD8))g&_P*5QY|5sHiAdm*QI~26&Q}A2`A{>TD^Ur^ni@#D4Juknx`kGJkblFDaG`a7n=YN6V*BI1SR)Q?WUNk$u?rJy0EYWe^0gxPyb1YSQ)542Q(Ta(}xmHAZRcGS%w33?Q!ZH2?q%05vYZSCxFts=- zh{)B2K*w6n5Y;N@y4To*98k?VS`9s#@ornc6|)$4=dI~ANtPI!A>gg+pJ)?$JlWCI zLTk}leAo4Pv%;~quYl!%vMMl}N{h82V~j+)jj)adF_qdN;2qymQp&JU3Ut) zXu}ileWcG~t7LtVbR%?!M)c^#rieKm^}$7SgI9wSGT9#_5Dv)jD=(OQ;k!!BCp9%? zP;*s2Ul5{8+5}_>y>KDUyTWl7J|l*7_@LI)*BC4Tf>j!!7F2QtQ&b&0dbKP#it6A3 z9D|o+0ca||KS-Vch4Pgb-&Md$R87u_GG|k$2K1!-8AE-5qh`p0G0*ye<1I#{Mc)Z% zp{#pj_>v?ywsRh1Qi#(R@IP5yl>m{EwFz^e5){|IS;*A3$|Y437ergo;8b6pPM@4= zDmh5`m~FuYJZ*ZTgbNknd^6Q5@iAAkMwovv;Fzyj3sDSdVOang<4@oI z^tl<%BQ+OiQ2gl}CX-a`ObBQ!`Z%`O=7}nigK7 zGEAeH^B{p#QcKE>mpr1N3u}6F5E63+nfA5b&araB2IXTl1hCC7hk3yWJ~H)L?_m~J z$mj@pSnit8?A0v-$5eVIS352jYxU;nwoVGTL z>Ne%XXhDax{r1_OoBQZ)vpPLC%J4tPjgIxRFftjU(=oynv)55DQ2c@w>J4lh2 zrTmqb)CMr8OCYrhTAP(-8oXXrYWR}X!C7k!PEwqR8Q}VJgw@sC@|Bm|RW@>b7v{gM zkjcD>#nU8Hjzl0vR*+36;St1My$R4_rGfP=`*`*tN1f54=~O_Dn+G(KOgT(R0)k|w zxO$g70s=%p(mfUIEB(}Y0XNLP-Mcai>Yz>ft~R$rRJQ|Mjs_=?FQY4)`X`!JZZ^wb z0SwkJ2p$W`alnPFO$#rOiS;Uxg~zG3ES#WNc#!siVxft;Ogd0l9P0&{{b%e>X0p{@ zFojyUjEQ<2G;T6=cQyG_Dd)VN#bgv#IK7~1Hk;K;t4__@l#neIHJd#5-<3fAVodoc z#Q1==cjcsT&krD5v==&5eHN?)e@Pe2%s2~-+WhDw(Bqm+tEE9 z@Q^*_?f>@)nI@3B`Rk#=u^EIoju5T_0?5(w4N9P@A29;3gZ zPLt0n!cqU6%2)wcaXkO!q{UWK=Lf6xB(P;O-jQm)`5)~-6=5br= zmuZ7y@Ee1F`w7-V3c;Tsi+#y*RXhWomr8Qe=7D1DwaQ9#+>EJ+ve;86-Hw8dAW45i zooi9iNo<^DNfK7Pn*#x4*_hsoi=F(2SW=Feqt}KqBZ`57XcxJ7fKkDUaGBAtV*j^Y0I=hv55K-{I{cEN2#;Cq4X>{ zaMnGDEI5^gd{5*D>Rg<`f$aP?x+#FpwX|}4+`$(byJIFahWzK=4V)bE=RP|pXfsN8)f+^ zsa|77zt~W4Jq-9K$`X`Bg5ypRN0eToDqT(QD3bqD8*eC{)&2@w4~^PZiR0g#@@1ml zOKXZ8+Q#K`iPG!S#O3NhTI3=(A(P;(xqT*5A|uVe+{(w)*?K71dEZO*BviJ_jm=eg zFE!10d;HY7Y;lbNG(>Dr188R7( z1_Ck1T#sPdpj3Wq72-^l;dZ>}+;XN33TKFtP<(bn%!4UDoBfEDsD?;LD!A(KC`p<} z@n@<0Rc?$H>|y>|Ds@|G{)zg*MR8ZSo_DYhR;mhjE#c3Af~J%fF9FV$Bbwq_<`~m2 z1*c1>E}EFwt5TJOgoNfy8x$gMPqeDn22DL!HXvy0+(QGY-x5r>X@i1kwC0;pDhT=r z{kcOyl#^%g##YCpm0;SS%2;cF3p1#<^%(gLDjjQK@urXr66pAw{SGr}78Rs>qN9xm z>Rcmr<{TV%d=pXj>QRHE2u8^<-cXz_^-rS(OQ~~>po9;$%k&N6Y=OjX!~4lVdL+N0 z?9rK`a+M83gDB_XE9r@{M?)Y6#~nLIl;yR`@Q!E!RP%g8k-6%h-9a0j3IwVyNo3Ce zqO?#gb9g@$4OQMiWRYnT-1%*|CZd>~f>K;(^|mCIO2#IaX@k-?tGaE&JIX*!N_j&u zJrF_MX;%wd5(@)=56=hcTwvt-qmc7A%c&IsOx4*>?o7$mXLF15j$C{muZ7yezN7~a+EPmxBf&i zKM>C?Uwq0eV!xe16g@!aqOzk)@Y|@V2Z{-*E3ucK2vjR2>Msz}gI-ZWvboG8;-2~% zuQMXb($jPIj;iQ;dPP}!M)=@H8$3W3t6c9nV*yPiOrs~tVnx;O95<5nfnu*x4US~P7?T8=%23i>?fXo|5qmx>2H`tV6Y%2jE3 z)Ld+SpQWf=>eH0U^!K8uW-6{XqCl5Ay5ps$#HfBE|GbvzzsZVpH&wM4YE8i0Ift&0 zjDBPfxSPha3^ka>`*@7^98XtEJAA#1YN*^-%Qc;4XR2d#do0yl*#D9 zv_Zji)apB01hkbFLBGtN&K)&i?=a0RR6000960 zq*u$11h);m?^nzZY+IzL*F8XxW8i~7U|~3i*#wFIA8-|=?vZ+W23Q1p*{LQeiYz{K zyMKIIkS#~MAG*g^9b5H`s4(LM4IRP6U=!YWi7+ZcP<(xpaqpgYs{>VG2!HJWr5j7Mw zy^|W8s3k9oV2;)LPHJ!>mF13PPEma)H8@ers)v4*?TwH#0`L2Ql8elg|wW=;S%2p-Fu5ja?(qqPra04m{Z+C4|CJp z=TzHl#DUPW5RqIt=?aM15JsvMa5NsskO`O~1;Z-lo_RzshrB|_mr@F?F!zasxKvR< zx&=!Y=kYFr?x2ecrb2GdLg0rXHIpTam^8I5(1jGp5MrIZvIyTbF3^P(po}&--H_%r zwFNpk?*%3ZJ8j_-vA6GlIK+HF7gDrU;l0|dXsn$i@1#7d@FzX4{e2zzlaxCVoVO)# zymU{|af|NAv&_A3BkX<;EklEEDZZ8g($GDeFbHezBL=}PZn;CxLiawvQqoz^8k(AC z=B1Qh7yoKLQu=+((32E>z#bBkCppv+6bM;7pl6|b@0eN2tcNAhH>NjIUJ>-26sn%s z;b<#%KtoEAHB>uT-_xG4$(0j?l?Hl3a_NUcKY7#r3XCV(M#y=zT&@-;@sl1b-DZ|Fa+koJ4 zFcP;&2l6a)A0;WXmcb`uVZ9V`qG5T;as=x8GFc}fI)IHabfl!-)>)8@+<=~i?!6*w zv02ZswmB1COVJb}ZrL-X{qez?%a_x%PVr!$T*jYwjIGs319N3E=PMBhLwz5b? z#673kmf_jwo<5KZp(y@Ro7^(vL(mrJLMme1)cJ<=s&J0X(CRzW0~gq>ge}H1ST+_> z|NSK3iHRGB#i8Lq$}dF#fI4dZ?hF)#OM1uM<=PyId$VGU-9mW zstY0q@+{+q;8S=6`umzCC#f+k8^p&fD2FLt})5PUWpGwc)g-r(*j*cVFeN=(&3aP4y(FA7g7;luZJL{Cy4(b%1bFID5NSlI3cw9kLu z2bU0QyJF#935cu!fM)@JKXX9rHe+W@0k(Ve&+ zR{DjjqT>Gd`w;x)@4w3Jk3T=gcVS2a{#;Hgci3So*1$JIx2Fw5?d$vFmw$XG#Px6g z`S|Df!`YdOy%%YY;T8>xX?~oDXBdhRn@7g;C6rzYT-z`U35gcm44omvumhzM5N{O( z6us!HD^==b485Krj8?{Qf!4zu%CMaQRm}80068V29ng?c>@*qsV{PM+X>MbIR$C6i zWz4{g1*@gLMd4p<^?+OoDFd-G?q$0oW=p6mwAvz65YEWQD9AqgRu#UJc4P=itjqHX zF=;j-2UP@Jnd2Di>Q?Or;%1BzRve1(i75VAnju=`Nf#3~{N0cVW8}uLYN5gHJZV4U zNrbB=xpSa-o?;_U%ADZH>29(@+1nEp@nqelLhJ;KaJ{PyhF)oIT=z}SE459<+6;%)*^eg)bRaDTapQzFeAqkiU7gVwEGpaBxEi=8k z_hv>U$2RkVQf9hR1!w0@73qs0Ip*cy9RppKYFextM-@Mv_SG|v7P?ZUPl6@mm|3(m zQzc@1ENAx2wnoO8)`cqArP7-4=DmHP1uD|gnLM+pk?^ETOCc=^eVCa7o{KC@!L}}P z*;I@h3=*2L1)$CCOo3c{!xS`jXNrqO@nE|lD*+61W2q%D=3t8aaQGk+HPlh}-aYw< zkUm+^A@Cbt7+L;KwF6D#XeZf6kL#?nhr6t{6s!ZgW15nObdy zR#W#rW*SGsJb6&dD@`bsYCDe^I}fAP))-kv=FF4F`k0?is|mMHhLd`mE!`jRhr=>)9g34H}c_9^IKhFa!w6f2iA;k&5;Ko2j@ z5_Dj*17RdYx6p9*`91D+daKVSpH#}F zO2x2l%YnculYzO1yMQUMigT4#`4U5}KNCh0f`h#JVCLA(UUxfkcf<&ANxSh^4(dNy zaQt1gxW%eop2oG9XFw0l{S%M4>K@-S`uv9SD0}fmaC#mw91d z+KNk{of^G>H>3kd3QoFJPU&_acRwe<1J^-J_?xZ5ZK9OVetaEt!~;O_u(8I&J; z50m+JcH@W|W~!n^csU^Z2(DrpzKWWE)>6xJ)Z7rJ08-YCDISfFsHLAp?bM$TwNnpc z$7&!1WsooMq7rmnd3Ty_rA!LK^JNT!0U&rKu z{io^jJc2lHP5^Wi()K!+D z>wr)RD|u!&bE9P3dahe(n3>C5O;`&$)gR1dBWF@LS>3W>XK!P)Mh7stbsnvWvr?AE z^B3h+lH@QB!|r)SKG0p-m-pl{2j~CS0YKXE)>D&1SC<%xqA3ypGlkRG@i7HR>L0>B zM?*IN$jqyEgb4(zLaYstY9#_?nW|jFFxa3l^dbYslWd2keL5_YwFgQB+hRQ+or!87 z@6pZB!r1dH-G+2voLb{=6A3vxqZ*KYr`pV`PoJ>WCyI+=oq`O1PpnAM%u>H$TKgH} zLNub~who=kE9EG3QJK6&e8s0c$Cu@K`by>en2W_ttO0Ok((A#{hmkGIP6kS5@~sUs z%DJeHTe7{=9L1eHFIS&(6~ANLF~_*{@*!C_lsmsn*0Ii+t79)HRRM>h6Qrs!Gb19< zu2MUe^iAQ@4Z05K^Py_!pBCqi%8#+^k{3+XI`0zb{)2aggLS5IlRG*J$z-*NcjQm* zYWOmDM+{@`4luVEKt-{pvt&&P+_h3~eO~bD2G!)JyOejv=1r+@gnkO;lR9K0{iHhM1`0Rx%V)Wt9P7v8u7#XRv@@JQy=pVOS_s|hSW_^850rX*sfA3jr{?Lc?-|o7iz!Eph zbq_5)>vdZX(D6bnnkIT~HEGvGV{#WDJ99u81!A|ufSMxh#(~a3r_dn4ry)h|K*M&s zYoMrN)SgD3h}2Hc%!LNEtDG_e5s-N3@%JCv=7Z|wsXU>-47pi9VMa|axN z*jT$iecAnoI#p)S?RqByklqOjO$i0A)%ZLo*i*iLg~i;kGiX9tTSLrb>7(YpG{i1j z%6=sTRFd1u&_KHSCqp;PaE6rHhFM^JMpPkzR?aH&1`)g_D}R}+Q^_h_K>g{T#phuW zq_x;cGw14iJuZdfH3~&06DMAC9BohbtnYebmn}?R24c`i|5MI2)XlQUB9RYa6sh_%aUEVVs<_gtkEkU| zsdC)Zys#QXWPp}zNA!YF7p<5}B<&mqTr}uyd|NSEU|dAMxmgxjGKE{gpu>q3>xi^- zR49n=2VXri!#ddbNrv{DH4Ka(g>ufT_&&~nY6!48;Vp`kO2JOPmAbi|^i zL)6$Qgcn~e7M^dSg0~k!+AJ0nhq5|x7wIBVTXBt-270J|sqFyHEqJ{Ka*!LAhsKX) zC-7P1KTa%kh-Wy4faB1b6gmOIrg=zUfYo3T0oX$oPOyCg#-LUZYO={;VMksP(Xp2pRR8EhgQ2h>#3KX~qZv-?2GL=a0ca zx*}Ii1<{@c<5;6;J5_6@n#Y?aQhGH-0720<3xftxqs2jC_@%5C3W9@$Uk-KHqfY|p z@+M0#upa`_2HMQs#v)W;(M7FUR|IsI1vjffDEg0rg1>l?GE??FLG;KgSq1PvrmjAv zWg(jpPu4B(yF-!6LJ+7kLsWNzDvS!3k+Rj%bK|N zO(u^!U?9=wE&1=e=QwUzC?mos>kGbbp7gMR4+>az1FPVDEsISlLU~Y|RAva!0mfsm z#Yl~CqZRGwv+)I0KXU_jI5dlfWOqW{hT8_oYl1)#gs_v za@Hr+;F_`aRmKh)%20Esu?#ec%9R6Rv~bcjBBs_IRu_;Z;QC7)E`iPM&Kjs*>4GkPg;K6m*8eVgKo=29;R3n@$b3K8PV`$Dbhsgdh zhSveRlBOk!x7<nnX^208Jpi_>@<(QALp6Xrra>HEK}GCCDS-t zV&$0063NL==oZOsP7dK4uHDHQ~{#gaVZ^fOgwVzeEI`gy$a znjd3CsJ!}jQR&x^3UY8?R6Xk>M28iDui1&;WrzF_IPLk@AwirzTiSmwnTk5K5}i2B za2QPZt)iTuvVJ%`9!f$^g35j?OX))6TORIla-7SJXSc1K4 zB9MWIQ#(atU0r83t(!c;oRS|?$q`bEId1iNiHF3@=jw=O7?~(UWS&CNP0MO3G9}WL z8JY~4$YX|X1{BtfYxk4+%A>ARmrPXEqhVL`ukS?$;i?STb~HyHHYq>VO*gJRA&E6T zh(dWy|6m!p$Q3{Pn5Zk9fSTk<&+oGQ;)054s=r^s|--Y9D z0)@gv%|tH{08*`+X|bwKtm=tM%hpkem<41QXdf6FN^v|}K)Hsk#Tv4>n!LqS=R6j( zS1>_~eq(!H!f`*41MmZX&3deAFmuads6d|8FCjW2abQISWIZ7vi_<2)Bz_zRaMx<` z0Fyj-ag#MYnw^d7ETiIhp)RdATGxj>AB7Kd0~os)PT}d1^BY_x-o? z5};&BmM6lysx$?XAdtw6JM?rYWnZOgF_!H-iJm^n8VN|GRzO`8(4D_F$fgfPr z^iykj+p*A%N9bl1uNC2%h6omAt~=(|PteV(u9^d(8snBzNw@>@wxla^F+^gr+Lw zB`<%Uyo1WL+#Q9eWsW6TOQfYOS?YyuDlSYLWoJQoBRjXjAX{ahEj5@l|1I#E42Q$K zvd8Pl8A;YQDZlYpfy$5$SizXRaZh0VHi2iG`1hYTGr6XR%A!bho8M$SLXvV}F)M!;OL$`( z7uia9_-EC*wHTnli)@d_+4HAYt-3PKR5CDkq+0%%KmWOqrndyHNMX!9S{{c4wr>*{ zm^k!ME+!)W`s9&kUC5e!fr%wZ9B%U}*#YX(QZg43k(?+eSLZ}7IquNYp&XB&0YqBa z0{8lOJI*VC4CDwo)igLld1M98A6wXdPN?v5ZsErYl=={hdaz87?D^|o<_|I&HrCAl zDSeP?k!u9WDXu$-$^hzU4mAINEGNS^A&nh+df?g1`U-h(KuRm_0uEchQY9;@*IJV{ zR+1h+)|&lHIbCbb4r-A?6t(!A)h~Ol#&@|Y;-5~t-~*D|2%dxr7DQ{Y_=h861UWoB zF_Qo^m820hk6Kf*O3x;L7V`8cNu?%7pfX~hxeo;hK~YGsbqry%o43L%^cijIh8zUo z4>{i8O6Bdm`bf+nqQGmFV0=?1?Sk#vAe~42JQSM2q&yO!i9OK}qRk&2U1hInGEDs! z+{vudmxziB4swWF6r<=gm#ts#jfcq4QJJnQefU4nNFjgJ2DlS%4PRE2oE53`-p7g- zdd{!+o?pKA`Jt4n^J6MiQ1h5VD(BEE463@@{~CjD>AiV`rw7h;`%Ga_qB4{g*Xrne zm_2*;Rxv;H0MbM#*M__M)GhvV)YQB(vqwV5Xg*rBFiRa<_Img(dkiL=Mz-p!(WI52 zn1?|)$%g^bmI6A?)qvc6#Ry5+LeBr;XjbPc2mm}@vHz2-XiVg+`vS=f`-XWaf(){! z_Ki$$_qb*4d_3Ln>)1$DP-;28iZSdum4^K)n+y|^fU2Do z>g4o1<^gPp)td>|0O+8Q<|kCSh0s)6_SaNzq$-gQ&e!h-nv@B48G6Q?x)e5l}Mb=5A)cCS06LRZ2V3!;Z9EmL@zJiPmRSHmDih8C#Ly^w95tQp`jnZ@e-;W}|iZ7LhF!eCZbk@+1 zN(K8CNvPO5m0OR;jXXnSA|H+$n*_tUB&`-Z#5w0H3)kc+Oy&l~8+#_B>R8~?z9R}u zvNW5^oL2jMMT0jl^oWYQ?Wnu1d+W<{cK~I?d$gTq8@|(M*?^L*;Liuv%MoXu?@(&} z6T|5eNKcBXTOXD= zF%@Zr3sF40J#qe$`!Ad=?!Pd*C=n|5tD}f?iVR0JoO;Wy8aw0*CZUfGXXQ1-Vs!q?Dcn;){`8@(CO-~$VdOgEtSyUi>NZQI&;|M92g zdR;Y|@2?rRpdNiY#WbL9Yoq`Llx>9%_v>yJha#_@Y{mQQkSJasYDQSAkxDwNb-G6^ zlPOUPRLHejZ!o}Y_X5fIZ83)R06iT-sd|p4?>~G>3(`zQjvzOp{U4fkx*X7Y7;4Ka zOfh;esK*6qHcPLC!*du=*8gP-)ACqQcS#4dfc#idFF}qwTNH*{@tylHotorWrr%tQ z3IKK5>57>i7$uuW^87W|sh*QVx)Pm{$|-|PSVp@)geE6IHl1cKBMEHhiGH3T0{Q3P z7b&2h)yPdo0=i--A!s^d?!FxcW_lisQ-~zaQD+D1{Uf{H&|*XKwiI zBlmAh{+#1aC4ZBz^F`NyD$`@Z8r}sddToff-*)?$oz(*$6wI{;?gh-sPNNOC8+J;xW84y1NNMOqUC#AV6#|-Jk_}ql$l>oTG|!ZipD37cJdC%0qTBAx=iOuzKZ) zpzbuRERzhTq9hv~LZnOhA00S-iHP&ga$dcdTDTRPtJ*ra$(w&tjs~hKL8K|n{Y-X8I0Xsn zh-s;cLtckZ(Sd3kFN82d2819u%)+Ip*4DZOjpB{#S?rc%Cg$Vu3gW(&c|2Z$6y!uJ zGq4mn8`+@h=dFc@QI=-4t(!BD*0xgY23f*IesGT?j#;xLhWQ)F4lYB^V#bI=WXx|_{It0+6sXvFrVsx{Ic`rkRBLQI-x zx>QH#_8lP#os>$mZwlZ3NYBq?L7Qga^--gET=NfFsqBc(hqSc4C?AQ(g2<}XqSD%r>sfx?If?rZ$KzrD zWXkezyhcgF&vDvAZuiS0$yw1Jr;W5>k#{z0s8{|?e_O4He32b;myeV@0 z(ScG&D)3?8wd~#T8}l0KLE&oN*JDdQUq{}C6tol!(#GP$kC<%DYNa|V;Tcn(o^^{W zw6WY*afE~yk_)kj5ojvD6Vq1@>vR@*oE|aHuKH~5LxH$Xr3wE-V}71`m%~%SYm{eV z^Ek6NVE_D74%xVX`>WimTO~#}4x0f*X%qcrlK^XFQM#nLf_O!8hw*bC@>X9{}D?938%yXC=cI8N zZF?m?a0DsKA03L`f>kk|yml>iMr8O1@|cNgnYiQ;>aER%tWs2KN^K+6`CC|97Il>u zD+PHCABK12Jd`w4Hok8=HuJg3nWtoNfm@)Vvh+!t=Hd|3r`<-tQpB?MU*=}>!MxqvorGBi5I{n&&a0M(ra?r*+6c)!@8==ORi**is zKm&$xuo1g}!sf38ZLlt-m*3*dYWjU3Wc#n(2i~<{5p-rlxNo--ZtBqJvF1ATo)DxU zU6gG1yOOzvu+glXDfHCVX%7y$ zw!tj0kXfD-ua3V_oSOse=nFn>^>4xl$dw(UIy_^u13#^G+#^S`2ZD} zcY)oQ7rc2FQ4YE3| zm<3B8K|H$YnuAx$K$#siT!*-n3$0nM%Vx)6dc*zOS%lbn95n>8eaQJ2%TFloq#npT zR4Kn$Ho&5!nrF$J(2(LXZ*ofWFpb@H`1Bld=fez;7G19qp{n6Z66&L`*P8;^)!#3L zh*kYN#j8rsoQ(TTdVX7uK^x06XD!|m_^{i?^30hTUU5wC^y6=&_Z)c3)Q!eweos`W zBhAH`9kTkE{oj(##)q0B6xZ?-rh2)Ir=g^f&B*cNWw#xV`uqlw}zNyM|h!9aal@m;yut0B;$Isc4|6x$+M3PHDCPLhUb!{w{P|H{YRoN4d zU#!_UXDe-ZKFNGyobBsGzyaHQW1PF&l6?4lK9cguSyhN|#`=psS)9o;3kO=Z?UY<{5_19#*&v zspAC7Je0O}BFzAP5(h?^l1KN#g5>IiTJ0w!GNDrH36(q{PEHQB*5~mr(x^mW-RcSo zhS>?Rn|DZbLYnglRkPlPL-rGDV5k$zwRsqwoE$IqIh#@S#_{F4oR%c`d)1=$2T z^I))ZSIP8L|M=f6ZqGm>DAWabt71aO;6+Se&^k%!N+;3~CF_pjzml8MM!AI>Cq-dB z8yqw*N)AozIf~>IPUNxkK1|$d?Vrciq|Qj-N(R*7sPyi`9w}+KChB8*BS5~!U#SHM z>UtCX6&ba_(k_LDf^bCs8;#8QOobMaZV|~jV96eU|1zCd?RssQ-{?CbId_J9$~0N% z>Y){hg)&`GJP)k&5>3Q7b2RAu`|+e|HX=@q5_MPpV2VR`%3KK(Vn_Q|Z|Ha~2CpM5 z`r(nEPa4+SLV$hAqh?qGlDeTqpL{t^>Tf0x|Lplr*xOYQf0RO{Cdqt5~?_pxLP$t?~@h|V7P=HMztW#sSZ`cxc3@=O#*$z#L*b7Pqcm7OEw1whS{wFz-8-p+)_|h& zFRx5Tvf&nnBN1~8yj>)ttq|< zpLqxAYtoZ3020f$B7IHMU|pS0&uV0>8aym5+gyQ>g59VPs|J`KgN|rgXLu52$6_CS zj%bVcKV6;an-1Q!(mS&b$sFZLQI*yiVx%qRmKouzUK0<|3+3T1NOemKm*-Tk$d~OK zQK8c)K6YCFo%m%;kM+ zt!cxrgtk5FZgXrXQ9*H6R}`130{3U3;_Bx{v!0wZA#+r5On*4rNNr1PIR6RBB5wMT zB&L3CM%GfB4PL1FYp~1{0hBBxr*oInRF}i0Yf~_fsd|nHG52i&HrORq;$qGEOJG|y zj$#xZqK28Wv?L(+_+|a-%}#(M4X!!4<21DgAPmcx33wv4k&1_`X8@X6x;3|3zHS5( zQkPneSo8!t`^1Dyb0|7EPR5z=(Y>_UYNG)*Ni-@f=2`GfsXlDql1~_VcrZjWp#6VH z5T2S#HyckO76mrKDqLk0ypuG|4@YIv&u1i%lhEn^G^ffkaj3tDc7B|Ri7XpcBZ*18 zRY%v(_$E>OBBNzR(l;{Wzj%>_Kd$!*$K?hQj?_|^^!d0tj2!IT=yf=!d}@@O)inUo zPqP(PrcyhWU?FhlKPR--ZH2~?3Aj^Ht9ExxL8ha4`$HgNY(hn3VrYcaFjQcZNf9%J zTw&KX_cHxyyJY)r>39x}>HaQuktb~_q}DF&G&^wbgxU9waEDTVg;$;583 zic3Uq`SPKB%t{!xcKm%I=@LJ^y4Hd@ksyQ0_t(k&uX$~?P$xi9Fgxs!jgNgv^J;+eG*$}kEj1|c?-t&v2lQxx|=4HX3JIJB{l#ZDsw^hwX$-dSC%!H7i;od^sN zXh5S9_pugY8-xs?TR@A{gM?8CK?dAPwO^)~V$qG}X?A27HPAS7MRRls2NB4Mk{)1x zNRWbsZ51o5*XWy=jVW}U=QNp3rj<+AzmgQ=iMkM1WY7}p4i)ofK_tl6V~GtJ%7?n8 zmHf!6f@SkHON7vPW9h`KZJB-r+Dg=uV2Gov3%IPVxtHHOMdFwOMXCg#Uf%|nna4>a zp|Y*sKlb9&T+&j7&VTu(Ebg9s&83b5T1uE5bJJ6+zi(@%JfIE>vXtKZYL^LS8a^!@ zYsp?bji*il)GO|X&2{FN5*{u9Db}n~{u(B3Hga~p0Yg0qOnkDN`3quFzB1I=h+r({S+Y%<#9-`e4 z13(@>+&DL4o(J^6%Lwh<4aajkP@Q3MPe13HMs~9RpL5hlwT*SviJ_(}xqQ34lmpqM zmV8$|@9EWgIZQdL==;!Zp|(bW0eG{|k$}%gLTvWi z_+!E)o3B<*M>GA159ScmXl(|I$V;X5*>sXd;-uljVZT!8D^Ah(OXS0pSP;{Uw@?Nj z5r!^daNMT+fSoohFST^XU7`6DgaHaJ;E0;)_%F79`XdAUJ#}YVfjMW!NB7Z$FeARaqrDXapK0g_EM z4I>|t*XkuYAdYA=Kj(UWmMeuarF$ar<8ma04LP|zGTdB100FY7h`r#U<4@xjfLy7{ z125Z}tjYZCq=%+LH84J=Toy-U+9miz-**KWn(bI)t;0;NMf#=}( z1|3m~FUj<IChc1t8WtXsu`;bFX8|A8g0(ZAn6thgKsuh=i&Y>vLc0*Z3>a@C z6iZDzz`kG?s2(O2*)L35hz%1fY!k)UUn$`*VA#5R8B32Q(wxY;saT!c)Tohr@gi~R zI^&EFw>E`dS|Fh{f1|q;pgHfX9@a!vh47pMPFAA+qyaWJ|F=G6gtq4vKDpCxG83O4 zu?4nSB;o$syL5#p*+*rlYz`Olz{I$_aoK=wX6P@(g%mmmFXPp#pAXVWkfu3-90@{N zd8vEI9Nl%imNed~QM4?aOEW_^NjJN#^aWk^y!wTxh3S>zi)njpeHPSVg!?P5pX~rW-4b;Je z05{{8E&qw9i%-646rS-xt6+ipAE4}vLuy)oEhn^W% zG_%>Df!4~ESl#u!=f8eHm$UPNplk@4b;?~L|4(H4zeM_N^W%>;3_(0)j5h6NXDjl6 z+IyI7Lh$$1f#ygm#<`%A3V-W(&-I!G9eSrgbo4rtBZfecAB;YPUdY|5!ET_gn||!H zK?W>Kb8!1*w3nK!ZA>plA6PXBI?4{?4>t+R<;+W}0lI4d%VR`%ObYKEOB_I9oq?7) z6jd>CFH?^xoNpWSrtMdD$b=f%kGF-C3WdA>k-@bD4N^5z>Urq4Q5`=>(7~vO16XqT z^xHkE|wyp6g>NLsq|4P%D!a@G>J=TaXe_sr= zk}#sZCQvEG?xvwLJ|!loY*>d%=F9fR`Vm+-;~zZeN{ExCaMo+-U01s`8-lY|Dg6-{ zOi?3o98?df(ygK4QlUsyw7UVia%~tQ{d{eWXt=!!Kn4IhOp%4Dkq;jS`|8aRx-ItU zz5mwM{?1|wP^k7I)CaXc;RPvWYQ5o%(*v7h4t*0`8hI&9cOj^p4f6CRHW8#}oBxRk zx3Q-!Gng>iNOA*o(I5cW`F)q=TOjCvGj{3SqfHlV2LAT8KvnvEY8=`LJoYOgx! zU#His_kI%WE-ZAJhDOsFW5+^ySNdj&P1LCUujmXPq@GmRz?2exFwq;%_n-VXVuuuj z;#5lQ5n3)Jt!1TNjyel!!jLEop#}uSBo~Bi7p*cU35-(0?QHv0@X4I1&MN{4sQQ7I zd;f$cwj{8R`rFDc4aynV#fLyorP;v-eon1)2M*Wqpn1G+3E0sWv30@?<{jv5Ny@Zy zuAB+1YLA=Y#hqn*&XnoQxSC0=-C{(sODJpWMb7vS zIywp0Nt_wnC59pczL(WjQFX%mfdC(hCU8xMuJY#)Ho@8FXM;B-@W>PlMtAc|9o&My zoE}st#dwo0R>-3EC4B*4E%4Q75bBM+58w!O2F%~KR!Rw-S5b8pcOwxaKH zp)D*(@`A>sQQ3&hmniS=mht>)j*PPHD+6WZ(JPKZnbJh|yfjD#WZ!((vp=;~`KRy> z9Q;oG>@B0AguZm}@71>Qt14+M##B>sD@&(a16H^{;gGITv-y|-NI_~7Ne5q2dlG4? zN%a*e&6~`hPawh+-PgciL=qwo5~UIhG(;SxvcH zquHzthx&7GH`5jX;NBj_54K$J4uZ!7v?@H2l|}F>ToY(l-$$@#jSbB)Z*yr_i?9Ys z-P#|y!7pjnI*0kzI2`OyjHg{K?_3{BMgY8cOe2pls1ygageg}wsgzs+D$MJXUZ#0+ zj|2R|_@-&y8l|cwXhBNTb0?9(jR*K_wJCi- zs)Y;m?yk*-hU=B)>(@u|=U>rQ!GI_3ise)IhDn(kz+E*?o_k((E!(G2uNN_9P^e&S zok74G3rnvR*(-yLT09g+5i5gAg-;X%XjshPP|gNW`z=dxnyQD{v7aF@lH5I)M7bbw z9A=cjLVHT+34eecoxo&$32Voo;R(cB2L9rxXBF9udw**U$n5$=B0#`6QqZjKbmYHm zdsu{%r^OL}DoNIgls;sRIG3~e@dUeRP^vU(D38mscFGsw5{a_j4_tp{CM zD)c5nRzU5eLFZ&aVKm@?X5?}Nn$bOhbEqV3g1w1!zL(=bTeHSL#6%v1tqN$gC|8X< zu_*Jkb~^cf_((Fi!)tP~K(f0S$c2^mhgtyYe^~>aM7XB#B}vsaxZ$OG;;!SF-Qw z+>v#awnGJh8CWRSK`=M0Zdo2h@`LO~dPLad*L7@)3I&$QG&2=Lsd*zPmh}~k=cGq! zu`4gmj2ELmlN=r-3{Wkp$ZyogDK7Ay2tbk!X%@jsg(2_rG!K&Ybc7W#-9t|}au}Jr zHsQT27GacwM_0IhS^(5Z@Ln3d&_u+OHl?!UdoIYd#};*tYNxN@w_y{6QA1beZijcSiJ|5J zMMMkMAXo&_qn(x>{U@}6IM&U+aCbYP)d57^Pt61(jav$xnjT0(4N0GPA-X(3*air| zZ(}w-)=>^{HkI}uh!oQE{3fD|FVULm?Z+Eei|etg_7QVcL%mX#wfQgHn>~(~_)EGI zz1-%Yxe7xcW@;tyK5LIZ3?)4cXeU4D(wYB??exqlvbOG#>o&%LB%-CTqj3MI+HM2} zhqJ-#!srxEWFlr;@asnc<|*Irl(VDz5&y!O($z~6q%>LW?Ksx{?729s<*V3a;eMG- zag{tXx-0%G_(jprGb+*OZ0XWJvRKoqYE*-B(XV!9+j^L%3*H4vrE4Eup4ntN8Ftz5 zt35BQM#0RX{51+v6a>gz9{o|g2pq~?nn}D^IfwKNVFZZJNt-;? zQTX2~zk)kaHUIS}mdf3|oAiFu%=QZkrQ6Uj%ddK^stTP~lSZWS|As(^RHIxla2E-M zun~A=|4KIcYT5_cA$PegtsV`~xGwO@qpzKN28j`dgWz`ItNX!#7j7D#cGrdwZ^?rBLUQxHS>+20Bc5E3H+IuUuTCG;UkoAM0<93`7s!h z)$epQI{ro0Fxoraij0OlKa^b3*v|aOG7jUF^6*@|UdQBmes~wPb4fLgMXR`;Ad-0Y zpqV^(j+z)*WB_nd$q2c-t8y%TE&bydPJG;L9LDi9@BP+t8q9w4D32{uDS3_d`70p0 z@Yvwwhr$)rjhkEnKEjbW<{7&7HAvvr1a>ND(8YXI?tQTJ!xs8cC{v+cHCl5C)aL6O@Unj_ct3!SMRM-~F zqUOUtzl`BUwx*b`qmGZU&mhFBL0B+H7M5Q8_s|#Mb%Yia>fvl$=0!BeIq>oIQr&E_ zDumja+z~*H<$ZZN@#)79Z9#5)%ciW0YcSjUsWex{^s{#=~{egI@Z*!X(}QyPN~a2jCB1EfATi zU`}FOzyWFsTmPdJ%Mzy$^q*sSnsL$tsW>X-Ii9SssDd8++i`GVi!F6ZL5<3b^nM0fsnCe%YXzFX zK~mXL({9Z<$FyO|e#i_gB#UBoQb-!=^W?A%`Ab+nMaRL4)jWqiDwR{Rx}_ZHK_Qw} z4irL-R-kFhpnoXVW*(&UtA5!VrDI$RKEFXIa^-#A#^a^10o^Ldq3Db(udnZQTK!%cj2V0i(Fo2>jFvM(u_kw;*(o#1f4{4Ed?${Yt~`1U~kr`uOTR_J=y;D zC&K!NAoFk)F?imdCt+^V#tj(!(oWT8eq6iWz+yYNs`c0-A{dS6TOvf5(|Qi2poyxb z{AQJ0-8K1k`n+Cy6y{rY2bD(lS2pmaTmjZFf+XOvquf6_f(u5XW#*yaFJmpo$;g!{G4S31z+SqLW z&@Kn#w6IgGS$i3)-(CpqiLA-2$IYRq7b_>hCh&7~S2MS^06Lh{jZ4qXE)@9&^R&m@ z>38@6n2>~Rji3CFoiH(J4PA9IAVT_w%J~_Wg|Wh0cA}PJ-W>>-rx6ZgDr^)uA9(Mt z+-5c)@N_D00O3-z{~l7;uU5WW8){DG!+${!`18^?lp7Wa7NYqcoMzO#O`0D zKjUvYZhps$4I53-$N`ir6{Y{TjJhGAR!OS=^Zd;~kZ*h-w#0-J^=)8wrKN7LLB`v% z5oQmA7UY*LvukVb2}EkIlNrd&+R2eQ!~NbYGzvndv?)r^!qOPN^hXq;JX2dwV)z{Z zBR(W8_=TmYFsC)zEXD-A9e5DYABZaKXPg!!VcS~({s5>7vpx!N`rw~n&NkgMw(=t3 zX9`vamYZvKUid!`Nt}Y{pnOIDZ>Pf!fQ7b9j?izbBoh9`j^byY2KycENl-%ewTHJ} z=9_rSo~2c59p;!LTD8NzSGJ%nAh5CReCL)ghB+p`MCvGMIQ8BK*M?7;W%R0PJi~9g ze<3VFzu+lXftQFeWsT9jEIOt@C+a5*$|;ae5qU(Wg4;*un8U2sZy3Z)kJ z2N^H|Fgm%s(#Yiw)Z5Yk(w4oU`N_FdY5=8MuHhGs1fT%Mp*Wz! z3dPqWih%zgwBrgZ466;a8*JlTf8RQ=9lG2Ddg~-@KyO_X(enf|8t8B!Y#H-eR~-PS zrPAg{V;hNgGif)0^g?PgRi)ZCCooh+Q3b;?vMiDrtqoTy{Yr(rh0Tf@ao| zy?Ohmc|Hwlx|es8CH}wdsO*wav=Li$raq zZ6_@_8e4y8NVwsHX!0uB1dmGRXfjEu%R^+E8EF$n*plHU+O(>^g5D#{9aHZ5md{1V zz$HzSB!3{*GKJ%NCgF(#Smx_{7Xg^$8@(yE0eRsNWQSG#nQBs`_S%9dTKWMO@(a1L zY=fXF4zjeIXC6Cxw$7UK*l=Dj-45^kKa>yRrIG(!@(?UEKeTV0C0z+R2q9sZb&GWT%t9{gZ9FnzPt$5& z2S@CvySL^`D46h}jqoDE$DV=Ju}byM!7H$JE*rcGYK7#Fg>rByXM&Dnz|TT_oHI%r z9>RAK5+LCEtrlJ(!6oHqd6A1D&0VdPs`?N1;yHQN6`Ua%kQSCSa+npty6`;yr-~t}LLl20y^@2=Y>n zV_9CPpIcU^UXX#dBLV6)^l{}2j7=OsS1YD97p(WEjQ~DL3JE8hz@%2WJjKm1Q1?rO zK6p!%pqWD3!+6uS^vCj7YSJmJ&}97o=#E~*hf3=>W(T07aKH^z35AME{UxO}!vGg7 z>R4HH<&bG=6=p}CsCSv+MFdUa>J$UXT`TjdV(S0gqqByOuof9bQdV6Y%rHBEbT!8$dT{_J=JXUgINht305~*W+7@ww)^zxewY2pRT;{8j&qH(ViQyC} z4~15m()|S&6UWg-aTf|v^a^9#sS7YbEP$euKTL<0vE?9khKo9hF-d)vyMg6sf=ex( zLOHSBBg=S2By|FA;v3p?yT*ys5g4F+#7DI0`tOY7{(tg{7cO~F9|^w` zmE9aTBhdHoK|;`HL=MmGMBsceL3`X5@>nmJ!~Www&-V^YD5Mv^6AD*|nNu##5{fC5{mEP&*N(BYDd?J~c-ddEyxxq5K7x{K>De zs+13s?UlmL1V`Pr_3{)WKHJ}<|JA!B&n*RZ);)bnNwJ`QS~=-IJ4($gBkhsxdt^v$ z#;{GS^6N=@?1j+037N?Lt|?@7>ebcKL8%8P@|xgK%5JN=K1O}toQsTW*jp+k5L=Jt zL1}*G%?lNQPhuVgCH<}yiTug8Bp?N-xWz=z=2fE(UID|=gy(Nn$2jL9d|Qbog)e7h<4>A7^lfe>Hx_21!!I^yz~LXN(i{f-b}!H~MWb5bW1+1u-eKGrRDDTHo`7RrF9EfdkX_cF&OZ*DpNN(Nz4ILRuZw=W%}%35 zy-4pGxsl+27ok0K03Q%Fev+x`OTIubu_~qd{OaGQYL4P8+$0JvJY~+HYDxY10(S=e z0E~%G$0xmrGn8A+Q(k(%_=R~GdXUoMT82hNaHuiAfQh;viQ24F6*dp(G(XwV&DBl* zh4Q_S&S^G=KG)bT9>SbJmDDjR)Kpl?Bha=GEZM02L`ML3BMh=V9)i600&g)x%B9Z> zG|N8;Z!atJ!Ti*<8LG!ll8{S9L4dE>)0xqZY++uk;=gCg3^hW=S~YOfX9UW0eU z)l--f?b-526R$8fj%Ut@r4UytsXd_gMi^@r!JeuyRfGmLO0DIYlWH|Bkq&QRc>skH z=PHyA=}~F~sfBJC ze&@XFC%samU;?sF4F#c$QQ#?6b!6B%+H_uK%s4$o+xST-4ZlpRau`SXb#Rmy`vCu) zYFe-0&KkQdy%LIXR>8RIKU=v=r7>)UVTu|UiokveZwfJ8Q*RTS7&TH`D_jSBAPzML z+49HEX3}QSLYPI6cXmP1k768QD~J%y^9Hg-h5O^5>$%+$e1JP`$@N~IkXq?Bq^jkI zTodHi6s4&r@nFb2rzl&KkRYX>qGeb76qn3kIzUxO5<^cx6o_8(5DZ$^VamarF43XR zt)g{G?HLc8ys>6~M{IKlPK}oxLM@jY7jP~b8&w8_8DXLZDYnMk>X0LaE%4_dk?~$@ z)!14|@RNVHc-R-o5RMb%Z4)wi5@A(fjl->KJ|Z4;_qjq5 zVSH!$E!Sq~5tafSlux#oT`%uo5z}dD#|@DmGO2KiXRM<_1ZR6WE}8evnXq7@>+!=s zmSaO!QA7yT-{i?ZSpw$QM4v4hM-?r-A)`gM$Qf6HM9F3{`0;rO=#Ib^+%)v$(2Dg1 z+w#J3gMN#IOV~FN%F-3gD|c_dTM8Ku^V^UnBoIgR_W`+ULbP*r{VS`7)It{;Ib$*@ zjT{JmypVFTHE0|xw0j-?j8e=P!y8&BYeo2hafB{rRZ)-^5KA>gEbfq-3ja?fd8BwD z*_#lRIC^)jTnO?I8tf5{5HepYb*in`O_ok7Y^%h|EPyB1Fet&yTw&w=%A&O#Q?4sr z7^^abNc~(&wpBvy99HtI7?xix_ggm{o3S86h6~gI-Q^?G*o!;nU8ND@;N7CSQ+5IE zQtX$$nAMq4thxI)`_taDFTDputAHX#4!R5{Y(jKkm~oI)DyTmnmz@ii*^XU zbjWzm^3}LdGTEx3yovIIAq835nXdmh%lUC*465|_y+yaF#*hb^e|f0f zIk&O_2MRedLhnmyWumFa<6tIVC$1BP@uAcLm|YakE)qdsl`(2JVoh0pCtrVtAMRG= zMpG_9TX_7pUBwMH6p2;q(3}wAsLoq$XcpsL5mnm1doy`LT+|+u23_~bKTyOZ>>uJh zQB?kHCQ4QK)D%-i2T^-YH&)x%LC|Vd{wSQxib(&(LIO2ln_vre@?k~P-rcl0&yT*& z3{;0J8G5~_;G4cNJ+7!9d}`*}9(-!!%3x& z__u_db-=!1BMM%-gU*P2LNQX`d zHO3ikqc^s)&kNWP;#1eu>?V;9>g$PEI4g>weh&6>uWVqXbwV(v8GmcuY07*Mgr?+) zL$rZDIb>|1?QyB9L5>UCud5*vOq?}I_e~5E5}b2&e|!z12t48Y{G(T-I>RsQK1+7t z#=7M_PgY6`>!i78`pKwV`VI(|NUNQ|?4qNU?KcZeu9XX;7G)p78wiBNJFO|DP{#uM zOY$dsy<97Zsnk~9qQICeif~9Z!Zpk#5^kKkc&=yUvX~KeBtLAoSz|b2sJsDJJx(h5 z()Ud0BhBrdNOFizZat`h>R^#`76_cCgyUX1dGWqqOlN7gw<_c?V#hk+hxC7DZ-4X( zZ@QjUH7=`&buX2!n*4xT*cI=+BvAQhe^A)818*k9NeZnV_cs%k5wc4ZP-l3G+yAjr z1S`mJihy*cwWR?HS#bPjg~!~SK8rT>1!ct$s%BphNgV|)Lu#p4S-_YvV5t*sA!}nr zjiyR8=Ye26E3PMtF>zh&!D@qnTBLUSLN?*C4@#s{Gn82;Mvagiyc#E1Ey$>FyWQ;j z_FV;KtG(HmrVn1RcCxK`CXQ9yVtrZ|zo3C)rs;PgUxOwP(gT+{H6_(Kk1@`Imb)3e zaX{hNc7PCCQo#(9i4u}!fb`7&*#P_ocLL%Mbh@nkNG3@KTNDIu{K>6lj={x!?HXm( zIDIY;CYq3X@3{T+RWLMM9>{}4N7k4 ziMMu7=&EDvVS8UtN{4pYxd6wx-6UlxAG$A74?((r{=>EP*#nJWa2ptK1a@>YWT%sePstoBky&4}v z_C0cRk-t-7`e+`nAeviD(L=oP+!LU!0B2Np$_Fb#&R>x9UY*)^kgD43(8Rd1KTvr% z0z9ExT)M1($Wp-MN-bdjDN{dBk#OrdAHRKT9Sy;T`Lnq0MVImXJYIcD3v~$*F~-fn zvLHLYpM44&*WEc_2pg!*Q;hM8rh&1xI+67UU_McIUfJde#~*U}ecN?Xs9H09z}Ti! zBev+0Xmw~D(0C-lDlMV}JR#v!?&6>#PI`fAu(WXLIdFVC?LWj8%i}kZNdh_qP%ySoM z2|e#tue94<(gp^{y`HQo$IInkxZ)D0T;Tt=i2+!X3$tKy}jMc33m01fpLI%J?sRE z&c$B4S=soeNSjs17mj#n!OUNTX?skz=dDFMx0_=oQn?sM)MIkdejj)4yC@m(HE##i89)I%t}K5 zyD!tbDkqVBXZ$r~{QmVen{$`%j?r*eiG6ua-|t(u&jlh&m+7_{Y_sWNx$R?Rsr!7a z)87r=lf1axO3egIHf3U>v2MKJ$4kU6%v=|DFenQW64a>M!tLbSo}0kg)URvF?5VbJ z=^(jrmM93kFMc2*P_fltxtJP&p>7@XjgtAf&=A(%W{y5#@cGRnAN_g)2%$Qs&xr4g z>|L5?qrI=sWoiVjglxuB!k=(|q+p)|_Q{JiCC}1033uG0WUQv}#pCQ?>=R1w1X;lO zu>Hfih$9c73mPV^fJBg9mXQdKj}SYR%a=BW9Pcvy<{O$=NZ;QW&1Qu#dg9{k)wPlbH4GOZz)XTh9ek-0)*>5WS^97ma6*9WXx_oXudpAt?y@7bXq8k6C5W zN{7NHF|(;}iNYDmGM{gmTIznjO-6`Ah)CI{{oHg~9hMe8Nnbm4MfqhrBDxq_@#h1K zw~M*Lxn#5$jYbbAwJ;VFC6{3^@w5Yi!P|k*Bvrm7q7N(zH7UzG71IzlM19!0cV4$# z%1K9ncrTt<#k;VL+-8X*O3tcG?&vj#&lNx}}+<0%)VC{^qN zOtmoe9Mn99rG;qVgn2fu>fQ;YIzd*l1d{6?bqN%@walVRIEQs7{l2(8W8#=z_PZdp z5b^`S(^UpfI8V2v#Z#=x)m6B{*@=4ux-^@^1J*80O-BEWGxZEEF%NLlF|;Um7AA{W{)1r&$7JE3N`wcQvEa-kw@U#m-_fraC#drY?!et(!U-38F^J%3$<;{q$ z2aB6FIIV|v8m$*Zk>M#>6zrp#G?D|n<&%+*(wr1AqsZ*^a=O$cN}oo|ll|0ty!uEg zO!yF`!&x;WhDLT6wO4k0@J&K5gsm^V{$#j9h`{w*S;^U3!46gtqMofnF=9Yt9egWh z*i{`Vx)M9;KVTnHLN+LZm$>2;Z!VA`;b zlA2Y&OH_6DAI>^O@TKhO- zFx`J$s$!ojQdStDr{4+?H zutc^cRiR2(7AhN+ahdy+X;Iqu!e132zN2_P9$Wjy@Q3d6WwQi&imhqD%C7FM{;W*- zPB6WX1S^h&tWFYqHMilg2hq2;k@0=wpzyS(<3t5IPsdDVDp1TOOpvmP6%p*_IMCgj zj7b(oIHoSM#^Yx!$&NON2c{5*Y`NHx#z*t0k89T5`Ne^aUhuMJ88uqUIiJFjqr_bI zc1QO3crq8;;s_XT671BdWTWU>lJ&pl;$Q=QX88!aGmEeA&LIxREC;=4+H??H-(+$v zP?g$2n?Q78fNRBe`X%?@@T$dMRVCgL&?*~~jg1pWXT=hPa5%XWQ`!`EL}#+k`kP8Y z|2e52jH50w3BgO6vqAJ`2CU^qM4`b{EjzobYtj#Ev*J+WN{rzCN=_Z%1=T{#V zSjcTNLhqS$KF-8knb7xU@hh71JCRzcK%&U%RQV+!({1cKHd0rZH}IP34?vG0`-kp$ zwlC*3nmbbojpp%CyV3)Pq6;VXrU zug&-%h_s&Y%t!M0CUo80%&=_c_WpXjuMhu;j-b11*=}BkiLVR*-rU(=+X}qky}cwy zMLss&SCAt8pyX(xGaOu*np{s%-qFjd_vQ2T|A#>FRkn6#Fm#AOkW=;BSFtUCJtin% z^mpzhQ#+9iNkEn2d9f^21QmFgATRc)ocXzqa&YD9{tURjip?V3G_inAw^>15A8njM zc+lt3mJO-S$4jcTNm3KWR=dQurd2p0)gp})JSX~mY*7Gzj+m0xL5Uh^Zwn*rH+x|` zcnXF5OwFJ}&4lQGe;4L8$hBAG=)?xZrj?pIDV$bEF_}`6z%jrj^JQFJ=Ue8hH|r01 z^brSQJB7P}U_P)29W$jvxL;r12By~

phnt_pZ!=}8?k1006B#P5RnoPUU#l6V=c z4A7et^w?4b@FyzvDr-j+F!?r8n&YqFc3iW-Uacoi8zHRvw5f1K)n%^!yU1!w32n1E0`0Qzq;fzI~jfQg~tP+cM$A**Qxx zgwQ_%#)GHMZjB*II+HOEA=spDs@?u0?}$8NB3AX+_}vz-AyJD579WbT-QLjvTB>h} zYpt}I$agcRq}A6A+d$~e@Tvt747heuqn!v8zxH{(CBw?!${O9|b;s;}n#=??DEd@vTR&x2(5)vta#WOVfHB zb#A&JED0S+>pSZUxTsW6Js>V8=LqU z3QR1LB&cZaF>^doYKVU^Y#)e8+HFyhjyf6FY;kSgpyxC{!RCBnEV~8Q>_`YX;-)C$ zu80M>uSp0G#p9+B3h(|nZwamC2x<8VQZu-VoVFJ@Zz{e9%)V|jX?-F6I)}`^L!R{! zaz4Tr9mWu~gU#XynreY1L}hEC`_Y-6<4P_>HUxJvq1cQ8or>Dq$MV;>3__LB^tB^3UuIUkdhEPVJe&&7?G`I) z^|o9)beZN63+rbfs`f3!1?(&5gq(6L!=sN4nmA0em7mu^z@QxwUvBUhwcnh=ew|g|=Wj-da*~A&V@PwM<~3JV%Tx zO>vE~Yto+EF+kGg`Ssyt~@hb1sCk8gRSl9gF!y77mThNy_(f+&qJ-;Ry z7WmbAqnP?u0}bAi-o@mo$@&z-C!uUFHAkf0B8==VfTtMQFhoL$#gjF6Sm~+g9k!dZ z>OqsJTYfX7MqAl<^p7{QjH>~jmkTyJ0v-K2&M(JB+Vtkn7$wfl)obbZWqOPYl(J+n zBzdl~^d!7Mc3|vUxv!4)M4iN|Ok!JrikEPm+|0@7>FHh+UI*e*+Oed?(QHkGx_{7Z^0}O8!Amt$0o@|NAYseDBhPkIP5z&@ z+x^XeKz_}kKyJ;l`hAl?o?U0I-S#Yp?GFC*%3H4#aFSO<(Gq?rAcS`;TFWb9kO5D! zR8Asvgt%P&WP4;qr4NE9P6X~oyBOBCj*Bh4eWi(15m6Ju$_|hhS+@sQ!~oYvF@UrO z=-Jlqr>6ps6?AGN^Gw82OdfL0>v63fRiEEz7X51MiAcqJf~9!muBdCPh(k(km=Zk38M)@4P8GdBpv@fJP>Q%>lY1Lf;q!l<(PYRiZD3Q#C~49Ar4~C& z@^?ayt3VL3U>I$#8@4LUE`$W~k1>_WmJNBeWFFz&A6O4;hGg1~GS_;{v)=~CZ_l8NXm=@f&F@W>X=eBv4HEJDyKY|}T`&QWukzmf z4pmYmcqwlTqnt%xPz@(F(etlo;O?trbPx>{#ze8(Dtcj5o(?nb6G1e|CyD zDX%oDvj5}g7{eofdgWDD+qP}Hz1qHFYumcowry<9``5N@+gIMZ_kP)D^vh(DOftx3 za%?4aj~m|U!|+#H+mZ)L7%7hnC(~^5Ud*%>x=_nvz?+2>!C1TrcpI|9A(w6M*6MH5JH{Ij*U1Q3OY2V4px_LGeur=cD}J{Ls9fo z#sZCl8t)O)QwZ?HH`6{ivlg#@hG$3`ogmc2waG`-Bzz=3Hw>uq%He4m3ICAzR`;zcv2&I=90Gi z$r>jEhYNoMXh>YvYm3wIVk9MZ0yCZn&)1dvhs(C@r|KsIS2&e@$f`uO@_mjk_kW_q zH!tbVyJ@3*!}M9;N=WD~W4(>yJq*2FP^R^Krm}mY(OpuEyTyfjou@8e);NXPASIhg zhFzmBsO>Q|7+^peQ^e|Gy*j+1*q3B$zohyt5z}Hq=wSvkPpMTSbW<)$Cwpmv(T9J& z9G=F&YzvGLMJ}z?hm6v z)|3SDjPVfyTlXLG)HHj^@{C3`kU(}5)w@qOm$x{PEDh(1c&`E<|I>C_6y42m^@M6} z>^P43H!dmPGK+3zne@1~{{~yGo8C`P6j!r1nN=#eUw(||v}BUMHaM~{*70PDVCxdg z*4;A_Ju$VajV^D0O=*C*d4(~o$Ac7yjutJ z-9=2dHaEa2+Aj^+x+GQ!yucW$Bd1j@Y?s%(eT_9ifudo#i4y>v3J>l;k$cVn|KfjY zYHIEX>@?>O6nzgTYAD(j_Gp6ep=1yJTWMEqUr^g2P0|4;N|v^5pR!s9-xVy_A^;9L zwNJ1uPPA)nM*uaG6`RY+bM)qCwWw#%Lcw&)9bY|ub)IeZ^vK|XMB(RaB`IoM`Sw^r z=tb1F2cgCPUWqf@~ovfNG7&Zkm^H-btJNVTPFs zYk@)ZH?X6o3tnCNStft3Qs)#aee?p7;h@L_%=d6!rg=)IC>twk(itHi2 z=GJFTB%%7S*wqE3e4G396b7y|%&_^JWxR`sn4F8s=K32>A9;UOl}1Ep=3U%ze&Q7- zXjkjUmBv3v9kM@=@JqnU{X~(dVw!SAq{iil8NJ(NW~>xu+lw?uNqhX;gAI?Kl)dVs z>Haf_sgf91;^=FugktQb>otK<_RKGGt8EUG4c+JaE}z?(WY2wP-O)*!`qz*4Mqa>7 z!mOFIl()(mK5i4v@=okV17Nc$K_1qUsrTL0o~T})CBK-V;yWha1f%PQkO6Q4mwJi# zhF;9aio^0zm^6lsB9GHI+&GcXSVM0A{w9k5_F8j_y8fEG>Ag@23!04St$pm=H(kB`aOCfiw=-DG zSsF@g^;So_`XeMrqQXXw&7nmIN!qS7YwA)3vWG#P3U{Z9yA0VvQaXtE05;6lE3_#| zv~@L_BJ7euIo5e`$r3Kx)_HRxkNOv(wib#5Rgfs zk1AIZ)BMNJ`mH^0xJ|k{=Oq{%XG*ain6eSl;};fj`@M~iuhsbE{eJT-MBZ{?1#5>~ zL}4dQX#R=F$(_V?#M7AgjLG@|)x=}z(Dl>4D@Uo*f9?F4{O_9KYCoNM%!UL9bb*bD ztOH!BEs6=_O-wp(H@=56JH)@B_booku9MN(`ZmbfQqI>^}neP%2lZllo9FIWc z_pxYqRxfG8cT@q5@vkhg*z2tpPEH;S*>oqnV=PxJg*sDJILIsglf$a&v^>g13kv}j zIGD+_gJj~5(YW4(wK)#LBW7n>ys{8TtxLOh)Typ-)E z7K;rec*|~<**djdmudbcvC%qN(nqF$3H0LL?6Z*5t)NGLxSLn)HG`}8{hT7YW_eNI zYdx?v2}g0Y&TuV!CkVZWmB*k(^F$a1x+r7Zo=5MdUaUm5S`sHNo1E%f%Qc%t!-_ge5WCg zjY*JKrt@EAYGrHoToibFTg_B(+*AtLQx@MZYL}LR*;E7{K7h@2#Bq&T;)6WDm}2vl z!ae~P4Qg$^#F&FF33gi;r_PO+=av%V5spQhc`!G2`C=U=n)P{%8vf?^Nl^x?j*!%r z*hv6KI$*EFlaL_!%{X+!zN}4G)tUvt@z;kgA{~PZ_hS^|3nw0Aj`0Sk$*xJFhks_9pdOFf!bNZG@1@*|tiGXSG_2sF{#?H}Wv*WEYns#ssV(OZ)l ze~1-X+y7YqK44eR&Ht#0c-|S2>Mi6o`x!}>X88C=lJaUcc#+Yjx>ZhIgN*$9SaLPp zl^yA4nBBPTbC!6e^iCFHP#XN4yU7NMwD*I)-pWu!~XSM?JhQr$Hvp>TBDVg;aGA+feM`uH*1v?6oDR!Q%Z3>(NuZ9 zbdUiM7Zz7E2q=p-M-1d0(+a{HCxSITqV>PEPS~8o^lt+$C!mUpy1gnIOZ$)t(udst zE0?PA33=rX!ssqDAlPU^ON3J;uwQNYf-F#Fg-Vy2e?Up$4* za=P%5KFA*QncUDavo)~ZSB%vjUK~Fz#Aa5Ow~_=ML!MH&hYR@85I%9<0!Dc~&r!Xc z&gneiVpC>#wvxmRb2{0)q`i;kXF?m>znu=*6cFH2B+X2b?vOq1LzhlVd}|)&XLny8Sxa18R%l?`e!L8&t+?>_->Z$5*F95ZpIa?HZ=1*!iC%9D1F z#t4W&#WEW?5fRmgB*=ofOcKEcEensZUoDOeL5JGLGX-&2uf$&dc!9CI!zb`I2cUlo z6GMe|45>u#5iaX~oUGtQj%7ji<7Zi{!9rBtT6{uMzhg| zw>D41LphDX<COxY^`Vlu$ zV)(Xh?~v245MG^%uXvUnC=gFcRU-l}nJfI0MjUCb~kG^f&+AS9T2w$v(nhfytB>a}*~*lxSP-FZuQe&@F# zUDsD2 zuffBm7nASapS+1W%D$nSGQrJ=Pza4ybioNL?9@*#A_bfhw3>2Ti zP&&K>*+O=X3Z_yd)8E!>kR1scjtqb0V%3Md#B*aT?g^y3w6DQFCbdc|d0!+zs4$*t z(l~`DV=LjW*n&g0_Q$4!?I|Pv5U)6O5v3EOJltJM_~3KQ?Eg}zsCMKBNqZq(7Ip}g zcdH^xpu(z_Ky~I)!Wt zl3z3b=7YD2*`ojO*|PBHLOF|gn3%#i?(p;qs3tVXp()+`paI*8$mv8r)$l0)2=4?g|w8_6q+?ERcJuJP0 zrOir1?qx`zG%oj`MidfQ$?(^QZUk!Fzof6O*PvM8W`f*Aw~yy@pKnsc0m77UM+41LfU1B&b%+%A>3u{~er z+2Tf4y)x78e!x`5qjooFjP0>*cY~E)tA!p^0159OMe{qqCOlfqM(Te3S8E2zEKTyb zu`u;jUjN_fx3=|Sic|>FOr<`~<CgYIKyx{*n+|nZVg9(;bzrR<>qi z@cm4_Ts+N-P3~sny~OCL45%TGmznjC#t;1Sk^Cg0*D+P2*+EI9iUYeRe3ND_zC2td z|C|a!o^W{5O@-6V*@1Km#5+FW%yP{K_YvTpXU>3Hm|$|b9jX!UG0Z^7+f(Le!+G5d z^WUEx)ko7?$}`ofJKERP?-=t?cj)p&d`fAr{p;e4c;}H@F2@M+(6Qr0eA-Q`9(4v< z<0&NLSx=D?{K)cu##N#T1q-)lsmFdrbzBuHd69Qe15v%9j!vF(){v9B;4>{oM7do2 zNOgwOj1YEFW|y=0xH!H#I9o&)%S5F+4UKM~gm4V_KleP91!JZyx(X2y@~yB~EuDlB z`Kiss=Vz)Rd=Leu1g=VApzO2_Qcu}rGL*zs-G~bi5m45Eg$n~djaZ13mIM9Q&AObH z<2;D(S#awOU<#>c39n4X#?(#Hhsls7cN`KnOH=KR!CVYmcQtjcDo+pUPPP9a9tGiW zya^zN#{%)!8#?3s*(??K5cSeQRe^6jnv&Pfc=sj$GP+ma#&F8_NC)gK2RaA8y}i$U zs5p$wJCWuSkhl&u%L&$YE<*Vwbt(d%77C{$>LBz+cVUloTlb0&cI%FQo6<}_(cFYm zmmOMTr6|s9Ys9dS7(B&|47g8>o*x(1uex^_rAeWYauSCGxlalTb09GXsk2N-eL7yPl2 zzc!XhGCgfom(=CHj9E&oXQrSa7M3Zb>t|7WMnaiPWJv&t26?Gco!s)jaW0Vp_T3?=tp8g zydvM^FCna@G!;M<;MU2eJBd+0hvjC&hB`xQR?ik2>hnOHQoifh?a@FSTAW6-)7~tQ zpm2BLJQV%Mr`Rm1D7>^Zsqr{y*m0Wg43)4WFyd!MJR)(mCs}dU%Ri_$XTzW?7$P6E z5vyxJjF36xrKJPoELlefA;JXBZjH2LykPMT2VzmlQ-w1VxCc2t8cA!Sb7hsD<@Rh? zs`ZnR`ZD#cnY#Kx&B&dA!Z8~ck#S@kW|jZW`YDG#(=-Hz-x<%G1K$kT*S@-NsJThW zI3K>nb zhjLvT%2zb-0IMHa^Sms*Fi)$pw{a6YEvx$b$KX0J*uPfZ4f5LCc3$un; zCMnf}DwEn))t|6!;o+EmOfV6qGH^xw z(FPCtVcz=$AH&W@9P6BaJ_h%F7CK@Dw6CN6P&x`l8d6`!*^E}TS9+ROBmcBISqk%B z%X&A@A0S0O#UAE)XQrpzF5o>?Fy%3La7q*v60PF@2F0N_xKb7LH(`{871X)5X(0j) zZOusMI{LUp|1}6Or=;D+HbP+Bc22J?J5WJ*u?O;g-6N>yOvc$sz2! zgoO21A0X}0i_WVS>8d~Ni0TDAy41IW%f(@2nn94Y+vC);6UTd8vh$u>5_YpeO$jX6 z6o2?<=E<;Xt!P!Dy93ND2grP#BE1U3206vgxOAPNa>eh?9I?FJgyHwZmc?`%*It5694;?}Hv8#bXpMb|=vpi;NO1&h^PlT|&2K zhF%{5yqb2k(btJt6r7C-&#DUp4bw5HTf)9x!>0kie5Pi4rA&;QPfMa-!3V6aSVZU2 zOYyP*$%nm#)UxKBmIs+)OU<=d)`7tK0BLkHyWA4QKR7?cp_e;J0B&}v z&u01Gm$r%=u7cHc$-qq}`{Htnw~=7+YJ@?`;4?O%O`TP9*{VVVEfG=nqy;#Lmn+&y zDo}tZ@1IRYX$;opj)!HByWTJhcL5whyO)YT&m|YfUw%b7p=a-(%cUTxD3`jyAX%mh zbnK{6Pm#17fN<5fCzMahilu~m+XXx2^8t4wwqen0p$1i%`5~hy5i2brE*?Ki!-X_mp%lJ~z91!=x2Bq kgLDHaX;PyYOIN=I>Sj<@^o;B zH-SDMbe!UA=~IF!ks6P4a9>Cja^`O8Mh3X^%qiW-CCc?m6`GN!4xSmDTCbkV%!Y9mbg6q9ATG(BQ9Q6vxME$~#%fcQ5bfa%u+|jccS+F?sLt zL+Xo5m1;`y=B)j(&rmlmRG+K~WuG9!=TNuSaNnZVaLN1O`%~87diV$a<);k#Ou%e^ zckm_r*@*c8$L{=rz^tWw|hKQ6dM1_#Tb8Fzi7z}0FD{>7%r@5FO+OX$q1G(Ef2|HN}v)dnc`<@7n-*c)YD zzbEo1K{|pp0DKvi)fstQp9|U5oMJb*2vOgNNCm4JEO+DX1{s1JZHk_$HOk5sR)OqR zw$Gu6dvNAx0Tm{Irg|soH6O#(Uj6WIVO*%nQg&6q z?^c%>c)yQ_nfSkd!?UtFrOtekddZpeHUGRP7s@P+4|~vyD^frr{B{F9Gc-cK_pVoi zeJ=wQjr8{r(*+WOFfnd$zOa;>n*auv(?^V`?ow}mp2`+%PbvULq7`$q#wJxkS?5zG z*GZsH3@)>*9W(*cLCZ1{^skeyb)adu=xW^Y;Bfb|YuDc$1SHuXVRuIHbS?d?+P6Hy z3G1QI`h~$u$QMGyFf&#i4PLw61;IzNKYHCMKQyw$zEEmpWPyosCt8}Y<;$*Ld^O5_ zKW;zUe3ZFi0)Cq~ut_K?FwKq!0~HzOk< zn_CRr>#?@fBg!s2RaniK1cf+swGMMjOQ=Bw4KAJbvY@B`vbYJDZX0#ME>4JdD=DNQ z@LI<+2wwAncqWc$m5EeB-blHRP38}Q?Q&T<3O`lFPtKcimj=0C@-l;PblTtC0zyuH zcf?B}DJb_@`*)vw-2AdHq$nZ54Y|7Xor9%G^Yu~sSA$9+tm+R&F08i0@XPZX#tm6_ zh~v*-__Q0b;;FMT-?QOe%-7>?DvMEN4$&P3BW7g3;X@;axZLGe_{n^CU-8K^hs4iO zMp5XAf>)lcV}lWwm99jGIMQFsznoL|WoEg@Q212Kz<}xX<(n#v-}hOUyLQEXztXEW zd{5%Fzu7nu1Dy_tLPuZ8yXw?;A@s;3_T5MP%|`S{1_j+lMKuEJn|5nsPicMX#n2!V-S*OezmkHUTgI_>Aul}j+| zrzvYR4iZXq<%b_Rg$`+}#MJt~kSiRZvkHO%%388sn%P6e7`=39e*k*LxffuhqB|uk zn=#JqrJgzsVY#ZrO5UFj8I0~ocDZ!}bn>rWt_L&#n!l94W`R6JGxJX#V$$ndj;rmd z7#FCdXp4SKmUrDpZeU)M2ZjPXB?qx05(v%HQ;$^_E0glpWHi>D0}a2=oLDVGbO%yEMkz=qwZ_gHOF#$rdJb?OSuV zCd2)c$jZvtb94M}1O(Lt!*t_w60%W9zoxejnvCTJ`|59M)7Y7ur0;hH6i@-!o+I}{ zqR3UC*IhSA&vZYmmwg2<#YRWP=q+Oi={L#a>5cU%hea)i;4Xe8jbB8Y$SM9IYOm_% z(fpW#TL{chceQu^&9mnKnja;}|DbJv*VcOGrP7e8kYK zcn&lT^?ApBF^I>jEQfkA4}FglgzHO2yVTyxBYO))8D;x+5r=sVM}c6)wH}6f?X$qI zBNZ!tkCZHH+}lF&0B;nnNEPb#&Ct#8=KvvXPLmn##;7g6Dvof*%^&{UHWNu>F z}D+?d7Hi zH1+okqHc?2&g_J7Dy+)!PUPw7r>vfQd0n|ND{80nA}cNhfPsPi{rmqP-*ox3Bbx6L zCoNIyB5#2dBA1oke;1H~Y{|198Fr>%C$;j0g$KPczVssFQ~rLvKZvU%19V{1eQCa2 z?}=rO#4En)SXGZsb%W)RH9rm5d-LLlT?o!ixQd+3juGtCg|0MtabCZ+nX6omV>OEz z>ldF(@sdZnDTQ?*Y80oX10^1%xTUy9sIQj-}|DzFwA33AqmrSSBlgn3k2JIviy!i%LQ@vfCv$` zZ*=Y)m=+sTX^n0NRSNeGC}$iIKf410=;}NT{C{H#^AhUYri7^sr_To|==SN&$J6-* z2KNyB)L*=KF>RHy7WB;7>j{ifqJ*nbjWaAT>56ozkPD}XqKN~XB)|1>tc=1bUEee<1>&cvcEp zg8Y-#&{R0qcEue8FQEk3OTa$viOCIu5Vd%x*;W3>Hc|E;JY6`asTj_rSlEhkTsAw@ zYqhdKE;@+{4j?g-qLPsVFsbbu#l@ofeQe*k;C#MivG<@1x2hF*k4B6mE96s*e_9jY zcp*kGy$zpkIrTY%aZT7_0%&A%>|%~O7Q!*H|N5Y519VMF>uTLE2R0B_<;SjhUQWhx z(G~26pSShJ%nv}XRR*q)zOFp6o2H6zk&!U&^=8*wjq>qhD&N@o8Jk~HfCeZByWr=y zu&K{7g z2oMVD>se5ft4UDJDwS8;S#Fc%su14Mi(JfRf)8$XAm}3OHwLn)*)i0eMIf%2_tM8^ zC+b$rxYI3)y8Qyy96=XzRHcHX0P3#37CIIeT^0oYIQ30ej5UgUnzAT%JdUB4T3t+m zqbQaxOqTnYU`(FEy%O|djH&2eJs!MekZ5#WHXQ>@Igtth0_+v)I9yNE*Iz0;Om%e? zcuqG_eI}q3BROZdh^DTzZIPQ`sVNcxURdrqYpro}KNAN7K4xO>T`rSUet5VD-u$XK zCrTEbUEe5;r1z)lXSPAk@~vcDFj{)AdRUE$anx{}?r(q4FF@GG{mLL7082zFt0LhWG_(h+Q?&`L0_GoD$VA(*Lc) zb&;a6vvYD{Tp?ex_U-3PUkcR#I9Rvg)60T1DkffAQkO_XUfQs3x=CdqCL^w->Tr$>U>b>eP>(H~rgz4@ z`qi??oElG=TE{o@J45wyoQRG%8oplY-Na`x201l;NZy90*Al#`hVww}$doj;4pb9> zk&TRr5;&dcO{fRy_?IY{-+Y4-p3u?Z8`RGOdmOMj&7$8ep z%{`%V>1_1dD3};ZRCj_!Ktx_yUgsGFjKZf#zA^NK7(TQelRVM1kzr-MhN?lX<*A~7 z$XHjJO#*95Q(c8A-A!tUt{Kg|M~#+^F?@@rBE4CnS%tQ0cDsLA?}+A(fvai+7>>Hf z8*aK&acOwWH6d}K_VL`x6p+4rRC(`1+fpZGf2zwFQ0ZGU=<>WdgS-sn5=4$gR!?SP zddEWraq3`q?okI@Pw$YJzR<%v%D05d?`iF%-M?zOu|oeUB><&mZrxZ=Ln!SH(z)1A zvofsEgQAyF^bPg&9JIa72lM>y$db4m%)CAMtr4_0EWwe~RsxUrE zchIef@;CO>@-D;eF*V^JrADs(Kea$Jlt~3bNym)UF=cq)Md~NMk-tRs0(Ru8KIdhiy`F5%iB=*!cqGS zLHdSoTPl~@?kW`DLejZ77CvHyd?;^!UN0PN)biFIA0U4Zf*_J}>{nBnGtBfaP3Cf~ z`HVzf26!3;bydI?9CeiIj^_mPPY>fwrJH9?$1akC(yjuy-7O1L2jB8`OJ&#)a_5dx z7u1KJ+UKO8Lnd3caoAh$((Id6!0&keMCnzOtI)%MGMG00fo!jDEcO2s^4R$_F7DHF z%RduQGUcf!$8T_md@bRCDnpD6G1q)|b}$d>6h+v)Y~Z)Ea4cnD?6-)Tz7EsSwJK#1 zkWHGMl+i!s;6j$92B9-v0g-s|*23<$IfQSg9$&y411)L*>0RBvvNrg7Sv2~PLNTpXiI>a)E=?xnv)8hw$W5s ziN%px0$DW@Dg%cCTp##!=W?JSvq12k4aTfqNh^Ua5l%79gy9~KmyL)n9P*~EdOze& zWnl9Pr+-GG4}xX!Jl}f@ze#4J<7hg_B*hso#BfSX<;qmAP!J_el{N>bi`j{FhkY5J z|6@Q)sM!D_`(6a7Kf?4oIS2DeMvzIV@S%DRv6h+!wTRkVfwJeS4C0Ji689do$CK%yTFokg14kl+ zI*p(x8Ie6*-qOm0I)!oJMk@t$f0Cs<+^#ES_*B8-g972JmUK1^O!3e2IHYC{OMa_R ztZ{?O=KQtj)&)|Gi0<|(CSsrZzZLA{0u9Wnlj=huy`}hs0T9lqTk(+Gj~_CkG7gL;9qp zLa@^gU5T~k7Q!iV2sbZ8tiD}mxwMB9*OYPp+-!tj45+EAv6gvzq;590+qr#y#@x}W zeGO2LsAb?{$lzbA^>3k&Fd(QFi=B~jU6iREZDKrJnoD7@WcwxL{v^NW@Iq!zdiSEK zlDL(16vkP!jGg2SPnk=1z{A7Sv zQj8)dkJU=^#`6LpTRWxrXH?awBfTlqpR^1TZeUQ_12#ETUF8jnu zA3Ut7@hWHZ@_s5zpwUcbZfo!4cc_r+46fC&Tv#G(c47Saa`l4&Q$scu4`So^-4lMJ z6!L9PSI_`rH};W5=JfkV2jTDZ0O?aq-rr_lW=<=kYm}$-`@G4@18Wf6--sxdU%TAu za@5P~Is#JzsrZP4?^CiHEHi|rz_`CP!%o>8a2Xp`E0ubIgBmA=vGCn3u~ES|_)t5V z-ogx3?yp?vA@fV~Gpg|qlUT%pJ#^!G8u9`4}(o8XUJSek~kG$`oyR)ddBcci7zbhh^ zJ^_`_0S!3&!nkrz4fLB^N{7?NCGH)&mRBs<2>Z}>+TW)D=*onzESI!8mIEf1Tw&~f zw%ne|Suyr9G_^D;p+yFm$`weU+qKf96Y(}vLI@M z|Kgx&R*Z#NxhUxV5#mhy;)sR5N9Ry#FH$GTj@Wi--VxNi0uhK9jp*Yt8phG@E5AU> zt`3M810BCdLl9=HC$F(!fd~LigUAoH%G7AdHJb|+0>l@$rQW~)M@@YJ^YKPwxUGN3 z^;p%o)wbMjM{t|8BHmW+Ax#?i_Eiqr7;KM6w(8g4%WbiF1w(k~Vsf8T zMKLv-wJ7S==vr^k?KKw{{@m-5GD*zvbs^#ex6IVQ?SHugei!q_o0{zK>|I1r<9{}e zSNtebh`E^)T%e(T;l^K5cu4+m*$@cnB;o!kN-{3r|ezdx3#CRUBE*x8ym&Y*CFVuiS_laQe1Pfp5>Li)R>hjuP3J*=A7{XA0QFRfJ5s z*<|4JZCX0i+$e?HBBcAjep(qUU6NX2g%Rzja!9d{@@>m_d$Tgcs%SPyFHZtSzE3PC zB7_)x^DM2g!?C`vd2O!Wh?F}yyr2T31 zuE^#6BGJ%3E2)Q_MDdp&p)m{4^blQs8CN(kJYl|-0-gqy=SLWWL1sbKa@jF&bsgX4 zt$)vzbJmM2X(2s#sR_xbR!>}rb>wbX)yNJO!C43S^0DLbK}N& z* zl5xt?&Gz9 z$GbNW|A2lBVHy@i&inaMI&GNnq&b~a)FEB$En~_UFx3us=WfH}!2O1g(8w)N30693 z9VByp0A>F@)`y2&(=* zD(c8^2g~E>b|))Dh_GpZ>DgXp5@!zS^W*TFoCXIr6$wrnDDWl8dQL?}oVUb!CE;jp zF{<+9aMS>UOO}wMdETL*+1}?-)ac3${vQ32ax^P=um)LoBF8Qp1&$%klP2S0{2HlN z+AxF9iq$A~bxUs}*bthse~zu+9U0*}+PYL>5ov2&Z>JgD>W+Y5K z&Dg09X~HngTpwQ-4t72iXEaz&t{Y2`BCUnBYurCf8#m5qpZcftDepmlMo$oef`@JK zu^bprTIvTf6NUw)%Y#-&uj5)NB+6(_vmlkrnxbE%R#6nkaELBA0d>Huk^PSGYg*|= zj5qmVs3@#FIJCQ7=Z84;^O;Z^SuX>EAFK2Q{Xu9MGbCd#7%JC-=Jd!HCdKe!_W-7A zN_hK##RZ}2Uxyl{2(wHcc2HPgMX_y!iN6;*YxZ)~kapVOe$^OyG8m3W$BBq=aDX#s z4W_*wsehJ9|9O!q7P>PLR+p3Vy-cEg*HMQWD`}~Rmh^aC|ChF(U#((a?+W0966?1-A>TTh6o;JSbW@gutB1EN~9%-ANd3SiXE@rD~*fIvJ@!AIf`cAZb=BnKw zBRf_EA0#tf?A@;8kHO_mi_eNdCDAlKi+$qcJNh6}>#s_! zuFVfEQ8|%VzDA*oCm4*C%`0Jh-{f>mVAHCS0i8)Lxc!U} z0GSV8N~UdPq(#v`)AwRP1C+X?tjJKC3vwX|FQZSXgUq}L@s~ZW92!!bwvkTq zlDoqC&z)#VQbI^4y?z+f=cV_1J%h$xh1ZpMhIYq12W!LX0$>;LZsLfMx9;@xdv|eJ=tT;ce+u1t)WYY<$G#3bp-~lD!S*NM0})* z(jnF`c(i7oZzY(}!inM3qYG(w0Nb3`oUyoLz2p=tHhu&Y(cX5VBrvgCDjz>k)0 z7GQPBThD`*W`IR8@Epu5q_~YQq@eh8Pd_>p0WC zC{#f9JJ?zeA&-1*z;%{c{+a)8)*!>tQP8I|QKlNZ4#zsgClD=%JytJb%AB{3=?LVj zv>weT1??k_K`F@}7PPjs>2LK?6^9|*x<8tazjNwCqX*Q0m zkAhzW7eG839K0G-HL_$e)lEUEhZH|Yf1}JSm)QOhSG;~#7$pyOX>kaB?)q$EF}nMEovo|(zl^P4$+sJs;L~N zn|6#R=B83Kv;B6NMD7eCOM>UGfy$c=1Jp%v>a(Xj=+gfadJYVQ)0H57s{096X^pNO z0ObRRrAm)u^P<3Y2{S}p4utX z4kJ&xM)z(KasRz1Pg~bB1243jR9rFLmCR}n^>}OmiIdyyoo4mlG-Q?E@{e)!wS+~DkJYD)%%}z&|lKR?0bt_Ua@Md=5SxtN=g+^uJqWDB__+1zp1%7HDVR`K0#gT zZlcpFhr7=lPRdLck~Yc*T0c){o?jwTmal=lRC=vP8+n3hHb*ub#Cvd>jnAsnmJ+&2 zqr-OnO>`c45oH!r{Y>S(KoePVCZ(s)*R<5xB$IiIwqQt&VI{J3?w@?5+B}6h7cuGH zFw|0>!3Zq<&ChPJH}!3(fmM@>Hcq{w2hk)H7{uv7qd?1JIq*;=!O$ie z4V5|<_LwGG#Y;H5LV_9@=*$J19sOMk`LkiMM{^Lq10Ay;un8kpR36MsTY`KBEPYfu|R5s{+ADe%d zrt@S?sSB6&G|Ak((8m(5G@PbR`xX>_Y(FJ|SBw2><|oY>s;Mddm@Y$|CM2!noF&$x zO)rs~!ULK!`Q-OYUEC#f@`?hDlUj=sS(SU06%9<8tJ&F5(a@YDbN&;zxAHO)UjgF8bve~@m~*tj#yq{ek!9Og z{5R)HS6|bLfA-)l4O{$GitcG}UWF3bR$m8MoYYw=5#*^@S{zj?Q$`y7Y|y}Y0UR~ zd`JkitmybInQc^!1)&*sAIQZp>ZaRieyN?LtAlq&uD3iak58OCoJOxakB4ruT5wT*P1)w)EuBU;jZ&hCe1>tQ^-N?Z`cn#KOo$;9FqW>dlGOp)h$t^( zMf=3HnraS8AT%2bI=kVz8x|O){iwF?t&yuNd%o!I zE!t@WYw4zt{+=uti~!nLxvjk)+eHvkgI>?m75lMe)UAD#qzTK&&g2#f07ovZnaxrm z3@n*>_U;XUEK*;gi03{iM3SsK@aeQrzh8}PO%UW89v{lp0&Rh8mZZ7!J0{Q5CP2jb zklpk%MIBfqnhk3)?;o@na|-p>Mip#(gOYn7jk_V35R3O4^EppI`y515`WdQS2R~;F zu9F;9oe3iy4px;gs?%s0aO@HHXN;$}Jd-lF_frj$(eJ%)z9VXXbP1pBSc~pzaDLP& zG0PB^y6WITIc^ZdSPoB)Ms<*0P)HIQ*GiLA%Cvx6s|{?vBTq{N9fQ)$tLi zX=Jn^dEr;&cpyB#m(7&8xZBP=Vj4tne*7#}L=U*$vKSjZ^9v>F?KLH3e63p-M&7#i z89Y3~6pI{_+E*IXM!bX5$P{~#j38~pTuZo(oZIQ*cpUxG;r4Q6IYP}hrc-9ZIYMfDINon*lOA?Dg zoVRsjLmE5|qDUJ2iTNGNA3AAZD^|n|2)ghKxNLA3N(@iXi3J**OzKK03ift$$Z2oE za!x%4N>C+JFR7)ONh=zdNo0xWvW9{nyMkuKyF2$kj;=90(q@Tntc`7ZV%xTD+fFvN zZQHgswr$(mWV6AY@BVye=6$-StNK)Rb@w^u4&z0vre3}lTF=J>0e++_eX_|=Q$-GR z-awy7%+W{_kEc$rbtq3%3-ayPR-oZY6DJJ+(Fc#+x+B8Z$m%`%akc^bjJwd{iSLUD z{IL*PH;1Wk`jYW4vkf9;CsV!$hiTNZE`-)pv*dycliaYyUI_|)t*m-ZSAk#B>k_Qh zE7JDBEbf%nPy5LoKr6@R$f^~xt7xIqmNF^`)bMLy)q+SeWctXzx1LJEhceR1L|=XY z>;IFo`+X;wA?5Mv_o%fzZ_f7J1b;CYPERrxTL+c{qztbA^t=nbTn z|0goj76jd*Akf{+XSrF|a%@LzacG-}GdYH=x2EIOm0_u^5X>K{~hG4z*w^B{d)c` zS*oI;fAWHZRQf{H2y`e~>N>sj9TDJQnhOf(7T4?&0WAEbb*1+je>rBd+C#d`V%a)!@s z;%3q>oojKe_}7)o@%+1d?6JeQ+{)g`eTVkhpY2kv`nmBzn{xV0Ti=UszN#-Q_lo(A z3BuLM%l|_X{ECkjaM;(i1faf3yeWXclY-7TTec7O7C`%y)s2XjQLOlmdzFD(=D5)q z*YZ=k*J@$1Nw;;um#BH8xu@~@&w)x+&P~By#7TAZT>_7c17f=brZ>bR?iH~7;8)09 zt7p+V;XC%xn2oZL@Emw)K}JZy7~a{J=!tUe#gOj04t1*5cMF(d*6#Em9B+rFffLZm zI^p!YN3X!GPJ2{HBexkQS8OPf^fa?-bA(y>Q}bCsEtmENOir`tU864=Az-&FDz?8( zwfdBMC^-BZfAT(Pjy}hZG&A#8NDxv5q2I7`+XLiSiGIMl+kEZrNBth^T$ye^Q=T1 znGE)AV$M+I)Kh>zg&7>mW<~3Im*qprh|Bd5PcSTo@LLvPIt2so2z1O^HAJ{AalO@csQSk5#@ zDExwt;YMVz9HIg65S?qQnAa#>9NPl~oo`*%!dW(sk(! zSkw;nF5m6+IY4KD$_!@*R3Nr%npTJZfj=hMPo%q`!FdX2dx7Xw;dV|bjWoOGGMowkvzta zGk^w^*yt)C=IKmm8mdBc7f?p)2riwzS7`?|%E&}+b3$=Ja74(UiR=A3P#h_AqWily zx&9PFe}^f7T+!u92vKh^2p8^wkTLo0fttC5kuTR0POFEs*62K6*+4R_3T1fA zjQ8n!HXksh=D}@@Z3k?mQux7Hd!>?7dn8xkeU zTHj#ZVwNC)L4eFyVW|sEzZx!~aAtFWIzv@I zclTMbS?|S|lc_)sSXculv{+^>h3&sp!vys2h0)m$AVcv!)yPdSQh~3o-sq2QLvza( zhUe8pc%VrIkfa!2N&*?Rfc51=EqsfUTQDPU0Y0FFU0x_LF0@eHDM|?V{3O=nF`mjx zH2)k2tO_ig`uhw>5RjQM-`xD&frf-{6Vp2>jymG$bCwf(K1hF0lQ$~acvbQIk6qEP zJ2*b6v1K@JMNCS~>7p2*w1_CQ>A+M8ml~6MR1-x>O^i1PoHxZ@Xo!rcE)biF2_eGl z#i_AF3S$?w3SLmOEtglGsBTc8V^0SX8Tl9C2g^rJTnC=f*H<94<=3>w+J<1A=YvBI zxQtixkJ3uxlb73kfmc74W}V3SfmS_TkYp{*|s0H>y;;HLkd;XtD_2B zHUfbNV*k1**ki2U)M_*!eKwv|$Z5r9xDojY$BXqox$fJF-^Ub$f@51_fJam@tood; z#Q84rrqG!Hb&>&}J%|!2#H4n`5lyL7?M0Zyh;HsUDoF`6WU~P(^&}4dT8)(CQX&o3Ft!u?gbju8rsLjbIU$&Vyq}g;nDT!5?+f7gqw- zrNnMjZj$>YHTm?vp}y#rWen$1Iai+X#6Lc*Px-1Ax{#4H0;_k@p{s zLL%chU_GGF%JUy%S#l7HC;}@morK^hZ52ud%AOR&CEhOohj+S%AzeaR9Dxwp^z|!| zjce~-PDVpH|3VkDTV>E8y+*Qg5bwx|)O?0giCQ+XKznRTMtodtx z@0ohn?g472StSVdSsA<>ZLRcMhdK7cMWc%{D{~XGtJ7P_@d!?1B zCy1V@Gwnqr_Cv%6Q+Tfu+pUnj4TY#S4+=f3bB7oX_>sg3fFDq6msg#Snano4cH+76 z^itDagQ@;FBi7V>dBa}?#ki6-wD4?7`!{K@0ZnR3tSbRLA2A@wc^>G-la76e?H%Hd zQKdj9whnuS#?_#D8G4P!&z6>v6P&52iSRjERLv>@Uz9j93R2~+??A$H#un|)e`!Wx z*)tjRFFH|OkcV;y}hj&(?JRDD5FoC8deW^=KvoEZS zrz)XLtr364)FY3W8Lp0jh>opxu{GPKxP2oZM|`f8AST9FoJ<6W$6 zFScHt5?tQ+tk(<$<%$l>vHs+qq$~J>DfN!+$>A7mk{ScBtAt{%)f^(xL6YZtnyw?i zc5d3_YQ~BT%~JmBs#bl~OtzG{!W{5Bh=C~~M60AzS+Rj8nY`cfUNg>iBe*anW*3j4 z&+i8e+qWU4iF%MDq{Rlmub^H=B+&BW(Bo^18RIdL^!8~p9*Yme*R?Kl%*aWx!_NfU zJ-)H0=MDs(5GNA@qkc<=?U%bt}A%&mOQ3-%8GC%oRT9 zko%aPZPUxqE;oUjo;A=(V&8)NAb+dl*Q{*PLT5QvuwlAq0(}%5M4P;>WTwp7Aa=Rw z#CZOF$a{dLb8yyJv*1lduzOfk&hQ~qJN$UgY1Lhj9!@X9i|0Q7_>)dVvR%FqqmY81 z_y(!<9RKmGN#Z2OQlqCP_K$%PrdD{xb-wC7!Qe%09sMghd`nKHhfo4(6@L{voO&|S zIpyk&u6cxrs3|2(+R|o{0=bcLyrbs;3^H?maFE3^sW2iS(1&(|_5`Bw!aV|lui^Q3 z25sLU_>svnS^-pAS+h;gl@`+9;z|kkIALY=Zxm*%;(6WMMq`PQiEdXyelan0_*%K@ zyv8nHYDhWw4M&d=#3BRBM>-{9WNT>05~PU^-9O?L>}a!Z!p8P7ERkoZ9~;{rJ{+zcD$rXO}YAFuh zsI=2WDCI#lIKn;sY28@f>_=e&$q?sy;y;|K)Lg;`$9Gc4%oAa1*!(OJCAZBm>h~h0 z*Ti?@;)21@t5?qKeN+T0L_$$1I7p4Gj&-!htCn3t5)nThed4^K_!{iXnMGnCU^Ss` z0DO$lHg1V1A1wKu%yaUhK2Mz_J&)%gK>Nl28|P>1++9H_gu<|Q*Oc#v3*5@pyfGM` zwHp8VCtA&U`v&JM5(vy#R1&ak^-x^};$)(er;5#CJ;vo7xn%kD(o95joR^9@TA)B{ zPIx)S>iEIc)z0cFNyND=$8azV{0s^dd4#(%Gu})A(%F_7&l5_Y^Cp_aQNglhC`~GT z`Al-ZG_harkYNnQM;qn9 z=terG4h(BcGXFQMc-%Wuc5(%kt$29|k}KCyJY~kiq94-a3UZ`Dt;B8YQAf~0e%Fu? zn}m=PxhFL9lLz+|ogM%L`-cx!VU7|}y>W3VPn|!VPvY(uLveldFtlg~1*9Xttcv~d zRJ0h515=26QBZr7!gUT^YaEpM9tEX2J!6%QD?=s@3LT$4{y7}5vy&zHGYfh?kn-Zd zyR7jX`!)U(E>^2uga4**)x^Vq3*``xLelRDAJVWKn3X~=Gzk$L4^(dW*;4?u`l-v# zGrBE}-_pz~^rH6gfb!8U)6qsWgkas2%C?>044?TjJc!)v_aLoQCmDLQE`$hB1)Xbv z4WdnAbir>)Mv{qTS_!#I!7KEm;TW5%p=OgX zNR{a}X?sHt!VQn3p|=Ke%_OdO{x@mdN2>IWPDybih$>k~4iVKUR6aGN1M_r78;PV! zLm0sAzb=@&iKjLmiwch#U537iD~RktE6yt4T4NfW1bw{vGof=<(9GleRa|iI_Bk?v zuo+dzF>?uSgDQvbnT8_hJT(!IV1w$Rt3_zH!3tnnOa_R63N_VOE)Gpgu&cP=9`p1N z+fw8U$+{gGK|uOB1|Ni0wdA-?{BS`}uue^FGPot9FQkB8@`ezyeudObtg_=$yaIhw zvK2a0Co6YdkUN5*s~LKB^JRXQ_u{LUkx=I7jw9Vox|{kU5_n#JN2SRkL4O$wF1Kxu zgyUHEWoA9%t}YQm#Lo8jN|iT_P8Nt|AVtsy57ilAnP4MAJTOKIs|fWxL&V?~QHmYS za#(?*596~+stVPYdqN$tPQhAE$Yq|Z3IFEHizUtjLlGle1JpEP;h7+S4;8J&e@RYh zl%1)bDKU=Hn(nX^of7a!1rcjzi8XvB(VcJS=YQWm7$+6U$Gh2VaV0WSKgW$XLPlFz zRr+N*Jt9!=X{ykbwHc4hF&P>AMB}-HEZz*nxV)Z!;$E3W{h|7dViX9MZo=y_{&kc= znj7qyX(S}-e(V6~GDf6Y>%Mov&gBYCMB+MymOH@Ol||!bX?Flz$xSz6p;+}gUv6?iR9ScdMSfm}?_b{K(B@+Y9=?w#A_ifE|HIspWlOvmMV42Oxa zLlpHjl~3@qUc{<&S6a{;>g~qDL$gIu39n|c$eW?kx4tylScb6)(5Wsp6B3prDMDOC zJW!Iw?%GC$8~aUH1yJf{>K5Nfsf&R-GeU?pQMYAZJG7>jlXQYSmC8$z@%m!lZT6Q$ z_$n~9A?Q>O+ad@84Yx+^g>3UQV9&pWLsfln&p&Owu{SkMiFw9wezY{`-7}-&T?!nj zH5X6GgS|eXHH#bD=WzP_kPV|Wb|3~ISvWxspL~*6<=nRH>~sk?W3Qc+ppMa}``GlK zjrfLO5H2AwE@zRY^fyJ~k1vJe3cbH#q&5DXq3=I~z=t0^I+OZ~x6Sx>`XvKzkf@p| zqG859K)ct6LU0MI4|ZOoLX<+wFP1t%HfM_6`8C2~KdSNEl@u{P?5BRd-r1oW@*vYN zK01$Ojj&Ou&pacp)QWIQwtI|5pRcgQO)oJLy2` z6NoLeNm$2^3Alceqns2EOUhe6^7_+~i27^!39GR8yZ<2GbBY6_N>1W?b?rm@Db@u7Gy zE2q~_8a+Y(dksn%obn39W_#gbjYs1_sG_PLu$luBQWf-4Y=lEH{r1ELeLIC{8^<9C zhO?LgHb62Hff(Z60N1oh3b?vns(|e}up|Js3pJ17EQ*BK>&d3tI{7@OJs=|{k^$3t zIMtxOEQpZ$_mK5radncNd^xHLiw#I1^~T{0k5M!TD8hVxw)U(rCg!uMBk6871@iyl zuuCoph>A?SD1)JZK@1KPF>CJakOYcn_G_QP41DE+2>!8rauScySzgJW`3!X$Oh62 zj>H~NWgeFj(8Gxy7Oz9>v&p$eObrSo6N~_N3dKxZsOPdrDhd7RQ>tG>UJT87!*x7z zf&FJ}%9ImVFMuE0`GA)v7yoH!9a$z^B#*viDrdBBP^fug(r=FjQ9A8nFB@)w+96_Z z5;~wX_f;&`qPo)O4#H?jMmJ&^StbzQUlQvB7s!5isyq2LvXbR1sGpPJvijs6=A_r& z(gE~NviS3R?AmGWaXH|?f=r?qSNW}zp%5jhxmzjXYUaSx6KQ`|g(*!Q2Zj@A4;HiE zFIbWa!60^=(q`%wG1wNg$k>6t* zH()*1ra=?moj&5Y$W@&?nG%N&ukl=%MfoU_7TP;B_Cgm9{rl}=M7bkAerJXaZsxx0 z7$+wCRFOFqeONfdQ=;XEmlA6f2lRVlVpOp$bT3H}!T-Ez+Vp!-cU2l;eh7-DBtf}; z8q|Rp*E~SKhiW!FJ}>EC_jaKv$c~y4t~q2S$R$iKzp5D6LmEm{gHeJk7q7e>`k<|7 z#Rh0P%PZxF6d&sXd=@PB*fa9^KgK%&fv5X_Y+43b`%VRX z-#*sH{E@0NV;DMBnuSmx5WJFcN#Juow*>fqvCSELeQ^B!IP(`k2q!D{r})5+D-|vv z=)RbDzvUEnxOuwUBkcb;!HxO)Tkh}w@$xpb_7t)yVg@JQH$1{;{2RT$b2IlaSWRs9bN*qCmk-g3|}FPku*t`RvnmFv&$luUW>NKIXK~&$jDnuBsco+< z+9(gy!s#(kR^PA{Av}F#k&?f*ZuOnnGKAUwY~;7Zbo0+0o}n4s?jvdxrXB&0jgE4} zK3A6J;0$&u8E1O!TA4d*^@dYDizb;^QFY*L?pOYy(vJN>bzxgvq`kmBmRRXl2h?{_ zU^4r8SyZl{wg39VXrGpjUK=)co{AO^-Zh1ESqV-WI`MK$7>OI2T9CmYM*+3@Qg?1B zWC0rfi-%td+${Xq{9xQ>vKEj`@T2dR(ptqV{Mx*6Q-i!1GHj*_Gw6qryXndEX9h>L ze{FkJ@@1Fjk2pi_GRG}m=VlbxeNQhk5bH@&nFDs~f5j(sp;yQ`NMcc6sqTVBLVqE^ zw)emJ^cbJuW6;xk#rr-(O^&;5Tbgd=BYOwG&u&gNpsMYXx2_Q2@pt+yc!hk3F6~GN ze7m36nufn$X^pi!P8t8~aQ#@j|CYzknYTzf*HBCMCSsb+$NT}Svdlx^X3ED7wvdbb z@|JoCO=$HSq{o8_Rk9*T4lk*4a|9jF8t>%fvD=KAUKTzMON#}s=*kt2SbeGrnq_I0aRgD8?;eT^`LyA7{^D~Hr)yt#2 z;8yX;|KmHgJk@EpQ>1L5`*`tgp>&~Fq?)r}KQP=`x~gKyzrjxGh{FMa5fnzTNS{PI zAuRXRdH(xsB+@nVPmicGH@^q8Pj~;nZyX}DXI{`GDIhM{APhuhH(FqYH5l3coNu@Y zP?V7^AOz$YfkDiz3+ZKqp@ov6)RoCTU)P6~2Bjq-_J=h%-OfzirlKL)?S}qj|xFbSg@5hJs=rUPhJDT-1?%!%cT$BhH z<7F^WCl?hGqSFj3#Ut`6Q2bgvI+opj=rL+;^~2^6c6ygMzqK1vL%K#DyFeFnSnSqi z8LttdmD>s@;vm1SXkRA~-Q!^KQQVIPt6q09lwN3XeZsn+Z8ef05G1IV{yDt^*sZw* zE@Z}YUuHhF!#{3+DWWC(ZD>UDa>+p`;nDU$^1#hOKD77E^xA@-V;nL!iLAmMw!ewc zhNS6NhdM}3z$-XD707(}Nv-xh0g%mV(4p^2BEE*?nm6X0m*{V5YryTxWSy?nVmdCt z^Pol7Tf|w~tqmZ%gziQc>s>qWp!MtpIB(S^!`ZCEpDd^j*#l*g`pv?H(^|0*(7@Hh91E;)KSO7Jx6|!8$C65= z?sV3mC{Cx9S+F!q|5)kBvq=3>nPvZrTxp_aO9R@8pKnns-Ze~7J0?bR)wownj$>m` zYIG}s9K}P+D*sHko4Uf>{`}2a94c$KzTl`OuQ)#-2}f*sVfUu(IP{vkZwG^BOLY8? z%CX!O-TQ;@;_6}2CO2U*FMG=zN05$EMX^cujW~XOsl$Zv*bv+DRTg2j5?l4qO?W2q zh-#4mdo3S4AbRevL(+Gn9^FRkF_G=ppGB^=2M-BsvVZw);PkjO9%+uQK*hshHZ4yo znFV_R&QVIP!HP8T&PCZ*f^ZTZyRvGw%rNeTNqfcKbHkWAD}#M=9pi;SgfZSS)ZFPq zrMq8z0HNq)*3?D(r~O+WcVx(6aM~Y2l!QL0ih1 zy`J#?#HbAE*l^65@mZ^x-D&+9R+F_q-DeY**1dP1F`sGDzkV{*>0B{g6b*B}>M-l2 zxVv=GEULP~)^W7BsrSakQo9QlsG)TK9H3l^RYm2d-C5m;zd6_(+yG}*9`KUuQfQ~| zPXykAe+fjFyuk5IU5xeUfdSLGq0YEse`pXc5t~j9;8b@ibI>W%()b-KWT{OIE!rjh z9HyqN{L4oqei^;T>Ag(BN+I28cECxe{(aPFXj9mUGiwkW+J1XEEna?8g%mSa@T_G` zBk+pe?~|Ilc5Wa3sGCfC7-P^6OejCL?+{f4-TxwumsC#1rtp<$OmNI-npU$#iCOm> zE2}>9bgRVF-KV~Y3({*UlfQuZ_2}78S7r!9Z{QguG<>S_J@fbKC|Eet-;k)#^+VEf z^zc^nFOq+hRY>15>06cZ#lPlzJ$nvZ|Ix58iVtn@NMfg3X_IV4mDhwF&Ye^?kmu!m z5hG)qMpaGq(+%TDw)`DC*{S{l198)rAl>&KanD2^!^GFCPt#ajvhRWYs4Ub+V z&otNL3b_`xPiB|buDSV~Yd=Hmw8Sf?tPwQMYrTgD55j(N#K&QEYp-%X!N5N{K+9Tvnm|$MI|PBBME9 zW5%OscI1c#BQOQWNw-rjxNTwH*GWZ=10V~glCgQuD4ih%de2!#Tz@!kUZrT-U)_ zRxoqpv`^W)6(jhoHbrmGMrE?yY-QE4qHEsG4qR1;@{y=0)+ePf(OX%djF3f%$Oj~V zP!-$T-VLRGO{w_A!blJ{b~k?gby5dPo6v!w_k?$ z5s^w-;l(>fxT^LvD(fl%jMfVdHwM3u)#xWjL(t2jYkJOa*oc&ucgJ;ddQ5+)j+yZrei$#{h#Zvvs_W1n1)>oZFfz9%Gjykv&TgNa0V|oVh=Pe_ ziuK#)awKsFaqPl+r8+#`c=1>~Q;v;Bp^crLrXHB{uIl1?AYqv7iRXsfSS+4LgIJ&N zA`=!?AmPZ6^MboNn8npUkASj z{)UQ>_ovbG`3xDLl9_qY>_DVx^UBv(s2Omgb;Mvh;?e3sAy8U=l-PXlYaX&q!G)vL z^MfLg=Q;S}MXZSUsxb!CO5nAyF!D8Ybxf!a zKMYeJ8nsAzcbfRAuy}B$9cu1vSB=4(@}|EJ2HM#oF(70M z$b=9hBrNjcJ=iGI(>b*i&MDgY>EfOLcvdDsFm9}x4Aen|Z=kBSpJL%~iI6z3%5tw3 zX}lgqh8k5*=OU>i|3Y92&nF0`h@$FT<29ic3XiOA;kQFRc)Gp%I=c(s}|E*6eeaMN2qK%OJJy&MEG zt+A8FRQ|b8(qQDqs?L*mqr!n!c#DDue5ZOpab`*5F!&o!Z&xg|63H0Ye8=yAGKv0; zkq6KmCL)n}K491zLH@{-v62zv>+69yOQ!dNJvTo5AyzT_c%yn2ODS^T>}fA*`Ngns zwfbWf|MaLg`43M&8IQcN+^w#H)+oVB4mYkxPhWe34my^KmllTDBNoiTW4*esf5}IUzZ6#M$Tqjz?iOIb{%LD=)3RDg9w9 z)^%8B&>wY~daL+hna5S2`AXcLy@E~E@Hb7v!Bd>i5Haq=Hd`J60a2$SUNhWS0n&Jp zo@ojZJ3Sit5gy*?+eM7;`xh=m6oK3t9KU+SMqPG{D~6cZiJFOP7??!^bA<#uhA3%F zOu+n`Ut}hu>2k=tuNkT}=^2S6RoR~edaQb%WM&g)tz*z3_Cb4uKp|c<_-oH0f}m^q zg>1t@`l`VzImRZM#ySrDJQ}%rjzCi_JgvJ}jzp^2$-?P~w)s(>-2$AxQ=Em6UYQv` zfgjqU-R+h%1(6rk>a^v0K|r|ZM7V=f?ZB7a21eHT)6^Sp0#sb+N;QYS(O#(sW8Rp; zE18mU88xg~41HP3RQ%K_b57o=VRM-oYhhr<_zRw5kuV6)}2BqqWuCv~7#>l`C6}v)vuA8;$1ioCPi0yy+D{l5Y+G^v?@Jd^df2l?Oqv6&cL2k$?$G;V9hqU%COU#2eSOs8$97~_I!Uagp86zdl!F*1 zo6vkKVdvrY)x&%Xy_bQb8&aR;m)gmLx%XcZV_Kd2&sg^bO@8(f1kGjl;(4WBEF2tJ z`8a=aUb#!;a}8sz#Y5!OzR5viGF|-M<=t0RJiuiXniEYnHEJvoM|DY8S4`mb?`WeA zS3Ls9A9Ccr>`JpoFVI-T=@EI}`l1Ip9({a-%&le~Jc*t6?|m9^V`V7_JV?N=w9ERE z^EljJOi5)@-(N$-5~m~D7d2kHv9BLq`tz=ql#SOJR@UEc(`*T6uMUbh< zyWa)m*CxRRv5ypm!Ay|E321LgNSNeMW+~A&0klp37TI~y%3ahdoh9Yh)J8m{{k-&) z=2P~ik%X<7YDi^0NPekrwcrgFfnSu+I$X{>f2~rGo%#YM)B7h-4q!EkFBmF-QZR>F znn#Tv5a7-@OZ~*SWlm{cO9qNe@cyfk8Ws)a1HqAVYGKi$PI!iIshAlQ2(aj^@^ z_uHzgFFuYb5%swS6UX(jtP%R`HyIm zaTpK=mVXojuib^2pw=xoaD3L3)>irt?$MT0;NT;qXt~65DsQ*6@pB$j%)AU3u_;vt zL>!mN@3khv@!a3mN? zKQWpf{@|iGVq>IMlP(n08$qyJ;970JnA4t4ib0|kl{(8hlj}gLzRHuzU8c_b%tVTl z;oa3;hS@P&8Jbs+5VHsHKd*@fFm{})0kevlZnU}wrW0o2hC=G@OSRA5p zEcSl&2j0k*jQGub{s0tEEIebPL1ix7drdpEa8DTs=D6E7>0nS`*Lcu|4T=EH*er^t(=846SK^9l#qqaMq)7igPW$?>%A(uNhGa;nEJhw{fJMsA1$qh4L-an7uT+4qFKy&?Qz;lvPUdxx4{ zN=p;r)(}qHB4&I0P{0tZwisw!lLUc(S}(p{P;xF`a^IF~6Q!LeUbBXEEa$bM%=_(a zwpuG#WpY?HT1hWUcf4Wnr`sk%sa>g zu?0H_)t1qOwH=j=p9~LnvWI9Z?FKBeVBrR~_Ww3l7UWT{>j0;{V)mr=XA*Yg?@1lqczXfiHmM|EOK zREt?Rb*M1B{1KjHaPDzp=0h3{&O3P27lmeW4O!@)rw|0nEM{d zy!!?}dJEikSSBuLD?c;jSz?s=;&ue#@tr&~(q^$;IR?Cc-V7_PKXMaBOL`h{<9vG? ziPHX)scOTwv%AS)w>Q?e{7t-9Ycs5d791B)Jb<>O`uMb%86f0j zPE%#KAsc`~)~t(#L!eNPOxastJ$zIW9C)o7pN+NP2f3ZnTJ@hrH_9^Q7W%JKE5}@$ zETkt7GI~`><2IUi9u5IMy?mUe4sLxzfj>(`@r+kTGrC7+uM3H^ zrM2Rd_17$WIfX#GRszOmx|TbJ4)C-2+J~5Y#MC{lZbYW_SG{F9d^#cVxC;3@vU`I~ z{w(7+Hf#JkStdoGA^N`3-2sICx++h$%ib@vXI(Jw9O&6n}$l4IzU9=pnK1OBQI2s{ID5L zmYQqEONN(h2=8TK?Y?D#l4o?tpXiw(pQ>+9k~G=HrYq&0B^tjxg4;m5bU1_KWtE1T zHM|5k|NPw(M%SkjcRXj@j8Td-cxZ@U>#dY*i#mma=uNkEua}082U)VR7iji%Jb36dm?;(O>=cv||MjMFzEd-hPjR`9>=e2M zbH<;vv}JAHM(t&uUE}H&>I?_|1t+zF4jozY@MD{N?VY+?Hn2^uTb75k`&N$9`L_>h zP$_H|<)F_C(}#Ymne&189H^@K>wA&pwA&kz^%fr2Qp zgMS5jtYB5c3`KD2^KY z{D{@z4BH{(hL2`X*D`FAl8pfHPib;PU>)VwisvYn&)qr+Th)>uY8E%E#)H8dwefyE zf=j6Xn#OLM9qB0)-NmTZUS=mq--jG6wsNjNueUm9T$-L54AiS1vBt$oQFTQ$y`oBO z9uD2H3&zutZJNj31mY{!S@c7$|5m#d}9#KpF8 zoy8_W-FAM)_61>YfiggY5esIJ)j~69sR-GIQ#}UoiN|+UL|TO+XtIjIPr)?Nbx#+3 z)m$OOq?Xelk7Zp_?}O{HUmnG?t<}CzpBa4GeYZ-6(T?7M@y(odI$@Vda2I^J;Rg1-EPB zMZ8t}`>z6U7vKNu)nHhg5itgH)(O2OnBrkf==tDpkArVSdQ+R*SYfwH8Ot={HpuM! zHgmn18Ag-LO7WjGT*bE3vRk9&6tnn|TYM_bVD(jhi^J2XNVSF<*wBV!%gsVF-bn()KrB`9)LR4dPQ%4AS^ zxHq-ILha#U*WYaGnq^pgQDtVfhR<5@Cptevay^tf44PT+qoj)1-5H}w3gbB_DqAod zA-E=44sp!e2MVgH?C9)ditPTDST#y;Qf({T$Rmu9x$*4(Mhj-RIEs~GX4-eGXcK*Z z;-p~GAke8vuYqTTuYpXD6sxE5&Y530HhEyJ=uXHfnm9bKxopgWz%&abOm>5Vj9yvg zLJ>AMIKZRsNL}5JP0`n!n@uVFC5)#0RDVt9`vc8y=2Xx9ps4nSE8UDwP_I!REpJ#n zLV{_Fy_r7dQ0U6jaok;wZyz>@?rFf!HObDMu`MR)dhF4P9VuG^{?RL%${HXwfX$}f z&VA3>6A<_A-&L*4v2+A|>I>T!(CPB5+ei)#i-!gK`~&vb&`Mi;y;FK? zQX(p~fF~7(_SJPh*?_t%oTf1I@ge7OZ>=t#ce#iim&m*t^~6k&1GB`5ky(wy4T;l} z(w@s3`_h!pB#*i22JuAMDyL0WZadn!3?995|FB z`rq_ysne$gHH}WXcvUkPyjEAJbCc-I7sh7O>~;j<vuqk_K2 znj2z^7}z*!kB4*87VSAyPgCAL=?#4?lDCbttR|-Bg37WGZWw_j8fYO(3@EEVN0WfR zCUPjd=*{io>gL6~t5g-*4v01d5IkINN6sanr)(81w_IDX;VyVBl4$aUJ85w~>@sh| z*$`9>X$Qrds$7yQe)h!d?TQb8?IGjjLhvWRLy}u96eUIb}knEkYb} zO_`GcTJ|}7_{8PRb1Up_gd$ux_t-)@$X~MCZWK+T_4ZQXt)lf7cA4ImDV1Gkdc4yE z1LUI*Zw9ZST95;-WN)@eHDHsHv+Xce#6;@40gA_7E0889NUI>Fgz3X3vP4M5+@`ps z(Y?3pD8uqp-o1^}4NpYAyho80Py3>24K+QZMnVNTf!-J~7tR-!4d$(9UY@FkXHGqX zKhv|*yXYWgXRsGKgXK)M|0Vb~!cuB^H!wpf_FIl;%r^Db&ah2CSht8xJSEX7Ba`pc zraX8S_GORPcwTpGH1AK0ru}N%CxhXD?*cT~G7#h}GxjsMOsta3ndmu563r^BS~XEi zZ;mha2mkfeyf-am?$&fvw&S2{=FH=DzxI66e4a+0i*^if>>qfO9U()0mo1*6EU}80 zJ=_*NGGX%LP%p*WNJsy5^&|GAKBOuR%a zxx3DwZKgOjGb9*)ZJK~txxtKGt08Mzz0G=DWJEvqu`k5L3eRF&!mn0`5Er@KwY*Ru zA%?p0aQHTl7!q$Rv;0P72FBuIlpnoCfi9WpsGE9W#tL#wv=7oqxq_Sn2PPC8*6uj)#KO4Y_IT1MGq&nF4`j_|*cLGN%S zFla3stB5tzT5ORv`K!DT?uOR+=5@ZXF1B;!f<#kPY~00$M!5qj^3Zk9qMvBtmPA^A z7I0CmY2(UGY@6el4)kO?YlX_3?h67>u*%V_Z-{hypt~;%3lojfRd1Tn==N5e+~+bz10P}YNP`+NAV8M?!k6-w?7 zlg2;iCmX{ZgC)+<5N>+d8WN&>g?O5fawBJ95e&Mk!1H`3cE2WdlD^=XVc15&U+)4; zz;2%LKiwdCJXvC@34n^DrbC$Ikoo$5>xU4)0Y} zjw=DGWS`T_h?7~cLtTWKrzxo(nO0koYef&?nixxd5)TKX7WG7cc(;#1lrBCe z_m)z!GK@0B<@^Gl36^CpoOPXt!zie$@q-~y6*?}!tl2_-(lw>9mvs3bdv5{`<@@%H z-(&3imSk(}OZI&m#*%#}B*|bbWjFTJC`)9?Qix=$5S6tOC3}%7!q==|g|LY!F zzTfBj`@PTqeSXLB9>;sUQ|8{T^}Md@bDp2`yk>?rz4Y*_-AT_|8kJx1?h7|ZK2+=^ zU%d1*MB>FXn|_srcGg>cUJH{T%j@%>RCwcK`VKAm>6OI?Q{^ti{5?^|l$_?C;+ z`y?l6W>)6HORW}s4Q9?nN8QzvjB7bMGE505UGyxSk4WF28O5>QTl>PAMPE)GypfdErIA^+Utq=E$^Qn;Qys*~Lr}40+F|>BbIE(?3<@CAkXM*t zilogM8%al`TnE2r=J-7eu^3T@(oihv^<8&%eN)fRwrPXxKfKK7+F>z0!#;Y9L*T@kLK zPmSs5VovZ64kEMKzU-;!ID;?E^Eso@{neVqAoy~Qf$o_1LC#Ow1^m6kQ%I4-2;N&~ zmXDj^dR&LHkoT>YY0Nber%<*PbP zvwL@6J`gsU2s$O{p0E6R-<$jI)z9~TQz|lJd$KvhO}{i!6nR<hGW7)>7qIP}3VOMZ}K1 z`muTZ>!(GJ_N)_MCdM92ocKPhIk7Uc{aYQxAM8LvPyAMs>2SVoLHIx%)(1ZGb2&;U zqbQG(M!{$5>QdU;eqo0s6lJ6(rBU)Sa*~S5C|Ox>t|%)hBYRj%&&wN+3zX9H#^Q0h zI9ES6oRof`U$8$)MnM4-VkKpQ^Yy@cq7-GMOtJVtudqWhATwMT{P)NCVJRzIkY8}1 zD=rAsx<3rBZ;c0Kf^&UqkWfJdE=@y2%HG`ND9#lR?(6x0`-*bg_rVkEU>AJ2KTb-| zFVIIrW2Z~h1_@%XWi2QTZ6W4aRFVC|KFHue^vHhdFUt?fso%Dv1U0_+-X*7&{OlO* z2&D4!$4rordOj`hKgkB}){bm+tfh2uAzrRH9q_aEQidpZtalJj%6R8!EoBpk^$qgJ z2I72O!=-HCwh?8cq48VNiaVtd#R7|C=kM_EBuf9$3YCACrtO6fvcLuE`1$zz`Qm)> zC}k-fKX1Q4Yk#aOZl`DZf!J_x3J-xsLE1Q~> zI=Xz1%n3~c?sD>Yu%BKpr7`!3Z^*`SQ_$O~+Nd{uZ#L*&JqQcz&5{DMqxsryUBmCY zAW6&4a>ZB9^(y5zshY_a9G}H@@({|0n#$uf9hQ0*tV#T18tm)lO>HCBc@fGwmnt|m zXK=RV?6FLb-~9-wSP&&IC8Ta;vjD!az7XwBB%mSj`N=KfU3I9W^NKGCiSq2yrh_)5-nH zmq5tzirI+5m%(+dC?#mwN~wn{6%B<9?ULK*zWLzWjr$x>R@pxHlx4)N;v3m24HV5O z4K8!@JdoN#Voq@+v{d?k=Hc@9mCx&kqZA=}YrCF2VpqH&uB-p5iOb7VZ)Z(+l8=0w z`M7xR%TdVjYHxNK$|!LC33SJFTt)|*$F`7x@Xu3q(`$U_9b|KamasS^DmRtNcCY4( zGn9ADHz)dQ=bPcs^(N?!Id{#%DUnCdhDrQsh7_)gCk<*xi9>nQ56Z;?WJyhVj*0a2oKQ&Rr5OwrOH#%W;E+L&`ZYPA<5Oa zkM9hl1fkoym+Fj{dGeiJ4e68kTh|^~G#{o|Cxh_G)e%~muNS^S4f@$=o=8Z*?b*l9 z?h2cm6n*>4m)3=@H$|usdF|dF1e;|I~K(D&!s zpJ0i}Atv`e@wf@k;eCk7Bc^sw_e#}Rp_!rY#Z%iI;De4A_b-IEe*RSALbBek+Zo;X+@|gY0orVGidjcD+dC>n^vkYHUt)a~8EC z2%bLG^6DWUk_CCX0OHR$wfd@^xdz2jQ^2TG+|pv}aBI}pbvVe~{Uq+`$Cu5=b)3Gv zSz3~M_YnV$Zt|}3^$NK>zoH)`llTMI?bd{^N3EGdnHDmUukJM0SeHdqo?RS^pVx#$ zI;$vNU)BDk+WJ{2LIdOV=-IxAnOVsQG$y?4#m5e^{OfH?!TM)?*6;)Y!)K8zU&cG7 z`nwSWC2lw2@>u&psJ^zHZ6NrCBLGz*nf9n*SAMU z_oDX{q+7jEdvI}FpMkuzRCnEB_wa3o{zyc*DmoIhn!Aaupdq7Xcu%iVzboRXzsq{! zcelFKSJW01evT-mYc@B71ERh%qFD=sQqU-+2fa=n$`iUbNlTyJEVow0SbK1XKlrhqj<@f637mg-w)P9Fg#7f~wVzVudDJX#pl=;8=mvZ1{aCp!LJDRb; zy|ZDMTcW=IE3^Q{6P`6_hJujznvI2b@lX2~p@mTCNTL95B1r#tYh^@SdnZ|41nPZ>W37Q2FnB?8NOZ(9UV5~XD zkw@_i|L@{|C4)K5;P>Rehis^dj(}psSPDr8u&G_G4%Up&SEYW@9AiA$M0H}FANs!U za*c*x2z4{-eTt=y4Z?WRd+y=!YHR4K2n31WME)uX3B8Cos`XFiJj^Tpq&hMx3X)2S zC`Ba&NohHG@DW}jAe2GT!a!njs8q(I$aYYBoA(2QH zYcd^UYs#@cgNH*s7Eilgj`XzjSn;Z48BfR!V;%}#-gl1Xx2{7%rq>z%i99L+YWGW` zI)I_U6vs+RADj_6oRqbcNwANXuV0WCeuovAVuOzTL5h@QewUzSXpO=L2IHi(O{L5L zvBP>x>1e?uNy^+}hi92vm;&Zut+k!b8ZHbaLu`fBHcR+LCZ$}l#H@b)+gbmtQ}%bA z|8rWW1hdlr$gEO=+x2T!$pY5&KcUfzGQ{FE!0Q*C`a50rPBryK^3v*UXS7Qa~K@qE%81N18k&N{Vm{PvGx%jY`k2~L*_6fc+5;f<{Jd|j~I zU$ej5WI(PYSthCK%pq!eE6erEeW;w~4AOT~WlIzZGA~G@*6|J+W?h$rnUbb5G$-D; zeUa}W4Huk>f2x&jou-ghV&EScFY@%rtb<1P-ajX*)??G5e^~lTfA@0y!_t>V5m&y9 z;=f(_|4~l|arXa%r-L}B!2N$SbpKgThthx4(*ZE`Z%aZ^QdUJq1*I$}BPl1R1dvuy zQb|r0rKBha9w_}gffHNyYf&gk|Bu#$oT3U5q5iF8Wi4Q&jP;g`+Hgk3uDM9+$f5a- z`N?QpbvG?FE@$mWK;B$$D}ok@&a)RF%*1^=VI9i=~gJFweM z2B|5b$ECUBv{I0l`R_Qb zl$B)v+deCKx!>PiLL!=P-k7kI5l7t)Dhk%%%A8pV8gn%GY3Su?eZ`2S1lukxY zK}ki!2tS1&p3}dc|9VEv#LU9Fi)}ai9u8hUegQ!tVG&U=8Cf}b1w|!g6;&;59o_wU z`UZwZmR8m_2W;)^4?197T-|W)9-dxD0|JBa!6Bhx;StfNPRGQ?#h*z?OiRzmJbxi8 zJLh6yQE|zYtJg})%B!ktYU}E6-?`iHu%)%Fy`!`1(c}Js!J%i*heuwFPEF6eo}GI$ z|90WS%Ie3p^-mj{pTGPVg(%@hYeJf@8MR3F{^;8|_U{}Ac8-HP$Dy6$vz_Dfo#XJ% z@&D!DmgE0z@_X?QFroaX(faRT0yvrFx6RmXXgCCiF=Q10S@=hV_5Tkz6cm2p#*P)c zV=?bUHvXmO`%e@xNLYFp4KLf)g3s1Rrl14FmHcZR|2%2-0cShE+>V4CCjLn%f7szW zVI063WPe$X_NFG=2DT{~AJxn#s#~=9ev8XT~Z{Hx*Ff<<)1~yf24&RpI zLlKkUkD>X9h=;N_wLt0k1>#UDk}?vm($X?0B^61mvYWh;f}A)?R$5k0N?J}zR!%}% zSye$%6<7>AFFp-wlzO0>yQ-D0-cD`c3eD$<$NQ^FNri@nN`}fw`UQGO$*8EPNP!N> z%1VF~5<%gt{@P0v_ ze*V9z@C}kAc23gO&qwOlV=0)W{F%|vAMYv;!~*y7S6)z;E3t7wcsHp(QxLNgh4+_2 z^l^B6IB_Bb=^N_V{3-{OE9n70^Mb=8LBytbc)8>MODjM^D>wub^egLMnjePsCuRvG zruj?NZmz$w_y-4i6I<=(DuwgL`G7c15XdI;m-PPL!GEbFI0y&dBIfgUbC&`w`Q5r- zVpFvyMgh@$Uezuf%sq#toPrZ>w+kx4hWCpac*cnFb$<8q?IIOm29M? zRf+%i5#Rro31o2d0`rDATBz;elKR&jGQeToyuEzEtT6EkasgA%6>wvemoMsHwCRAA z$@WkL?M!g5pkK0rNB(cEG4usNv0ztNR$xHP{O~9cbHibSaBe6OGb>RPG5Mc!PgTc{ zC=?wK_5*^kvLUAU+tgFl^$x^=b*2*Tddx*`zg>{8r-_o@QLMdnptYSP8tgU!OXlx+ zh@!B<`hsOI_m2s*f`V{(LtQkVjGT(BqOu}z#1PZ{nzpKTI2U4Q7@l*KEm-`);EqdolmJiKwg?z)1< zST7G>G`w2D)F74L=j#=+>ZgCAPn`0cB0IPvy^K||FW>kB4dm;|tbu)*GV zK8@dD8KCl{8z+EPDVlczr(C#RAl7kWM!p(8XPDYz-nRt*nfA6 zfUKe%*q88gi@<*&TnIq8+F`;)MnXnGMn*wN0ka`0O7KSmQ!8p3S{mYuNUiAU|4Oue z5-tRil$4r`nt_^{fq|H2=RnUwykcTvWda$Qh)3}LUtfTR{m%-3DIdZRP(CI~S~F?` zB%piya7SY@NrcJXUl6;{c)1U~F%6VN%8PPN&z#3AkuU)=Thlejo=HlfML>`!H!D<9BFFU2@(FL}A$EunrJ6R4 zV&&-Lrt^f>3y{wV4Epr>DFjBu{3H*7!4Kjgkg!9P&>9p0kwD}S8jyMtT5v%QF40t6 zXpn#bLs5Y2gM4P<%`tdNdiVw&J&7D^hMFmgi&C}iN$6$>5g;oPLNr3O6k4NdE)P>i z5MeXWa0;}WzyPL-Cq&}}siTm?jl{CiwNOMKB#i*y&H%3AN+1G)0KM9-HVoX2^!)iq z2tvb|(BLkGImREf70;k=1)-4reQ;}$J1qn^K#36O*mlM+2y#Xa6QD*YEE`$@4}Mh# zItKC}w)-^<*GoKw3;3D&XPLARQ5LNJznjT`ftn!gI>JG#-}CAXQ($1q=he{Gh>qz z5A|&vxAQk^?GU+>!uLrpD{g9yi8oR8lEIxmI+rUwb(X4`pYkr+N!(b_Z>+hsw_{KC z(*E4 z9L+C=V!a1K zyBPKIEuElia`O0zsD?whPJ;)!>oR=Q9VPSF-KbBp{;Ta7QHCSOU5;)E=x@e;1fQhu z!xrb9^l}nn{sA#gZwYh0NSeNZr>MXiPFPurJjpRD)~=a(&eU@-F-PN>{9*UbK ze%S$YJiEc$M}E|_bJ)QXg=ps?esfC?(+k?(HVSAdx~d@|ncx8NI~O>}jy0WPDHCqp z>~x8FbV(fDs=tsDf3-qU@p)^PPnhu|$CT0|GVij_A3gQtsaC<6tP zacPp${6?+}_PM=9CT6FKNXHY_Om-{A>ylV8`i7y|!L0118oF;}bqN+mJl;NIOv;Jr zy*vim7g+BX-+a8n$6)cYp0Or)%>Y%YFTy0GTql!&v$S=8IKo`lkri&`DLW9aFT`ay z6eeuEH_!1y9?!Mv+iRlAy-G$CxOH5Hf7WScF46O}-86Tu@8(i!cs5g}xW@Ega#NGe zujk`^wd55=$M`EGEs|Cu*`5cRZ$b8?a(!GR03RvBEOG7RFxK-)M{Pe8naQ?Ef`Fsu})=ohF)^da6AK$soi zMa8ltLfIuZp*KwFvq3XlXGZe;aknXlV0Wt*%f9bB>um({#fxKsE3Si*i{(<)W9sqT43TB7>Pd&FY+&>jnNHhD} z)@_AEO01rQ8UIrY!5SGTS`4h?8Bs`CYc6jqJqupG`8m6NN!Ynv(qB$l5Nr(l?0wBM z6;$5tZBKY|{!qvFKI`LVRRdgfR)DZ$NlO~6(G}^s>{6dy}EroQb)#Ph=&v6$O0sZNtxvbAW-|o3V zct_pI$s(-7H_g+&Xq_rjnD!~|d&1uPLgfj&HB*kVOSlpJGX z8W-|xajnU8SH;Q}4`^voDRP^~D1PEPltTJt_FJ}eIy1{Fhx)NV6Gi2&;RB`MLq9fk z8uOWEXHPnIuTYJ)zF}q_>`8oe-!bKzCPNLzQ@-nVLS4eTblg&am?B4H=Dp-8am(k< ztf2`*E$p=+EHZgV6;r5H7;IRly87-C#1A?5Q0Lguj(yw6lyACs-*Dmx3$5E_T@`lQ znR+gh0x{cY%?5UE_6om5I}1S(Mbjl(lXemfL)u^???o17UPaU^FYE5Ae(BW_+_Jlf zF;XmaC6wQh$|#b)S^p@);a^fo}SEg$WbV(RM4i>;=hxN*hAHAI~ONY znQAK&G5$m^@vyWQ`i_J;3oke^|QDhSn#p8NJ zSV)o+GE1#`diXA3Bd@pY(h2n_Tf3XMP$QmM-1?a9+{==peU~LHEZs(~cW@Qna5>;x z9(ad$#BNh|{juD+T0e`PM+V15+hxk!A+^$P$btb`JtZiiV z2u*S3vkUL)=h0X@Z5su;cG;`z0sA`*1u}+9_;l(pHe6zYsCQHz76k>C7Wy)+kzt*P z8f#|PI01&58r)46a)NdyCr#mv%Quyd_ntG4`!F5-L|dpVc>>RBOvrqfd$aYJ&Puyu z$IA}3sswbAv-D#-1;y!#3-2Q@)4cmyG{{E2m3BDmj4|$>;9fd4G0h_qPhBV|Uuaw2 zk`;cWx6pIK^4jFL3vZs{*5$Z7>TETY)`XK;7>u!V={+@GK2&T}Mwq=Z-gizgx!5G> zvvjE63~FFu6ScG*kB{Yr^f96-1bfn&J}MFjT7-BQOQ22+4Td7+98vEu0xk2)a0NJr zp{U=yre;BER*^Xx=upEf^`cwG1$s9Uu}K z;S-Mx9xQzN^WPa{0YC{;4in#0T;KJp{8bN{FTz z);L7Ivn|Ks3Phtn)EGiopD93q)^uWk*1QQJfVz7JL8b-DWU#7%z!&%yz$)k9Jjqih zWIaNftEP`EzY*ba6Va`1Lg7u*>`&sXOjKKd%mG>iW&(5u3;^Av8b~t+vc@$+WRt3Y z3}FEn1+`|_D1rQ7m0b&3zfIO){X^92+X@LuRQ9g*{-EnA2M7C`i5=QW16vb>9YrN# zB3NbPZUpAF@QQ}W`4-v5oZJAq`k3<~Wm+f(X0w((kIrlP8n(v1j@)J0{$0^zrE*|! zPtFzIBS&9c7FFG+RYai`6!kR5J?zFlr>^H8^2AP6rIcpM7H8>37bL#6m%A6^A9*M9 zBlnlPZVOk+XQV%Hdc6rVxuRXn$-2vK_FP4Uuo(I2-tj12l8!g5w$=uo5=K;3^=4V0 zwbN^o`=7MPe@<-Jr6Q9f@$H;1b^H_-Nx2;2Zfj9=<6N95od&AX#N}YLpa7LaastO# z&j=^wJF63wqQu$m?H+y=;66Fg(&-tUC3G`dlMPMzC}E{2(`Ha0W9W=F zVdmU9KlU8mgPsDPd8&qKRBj~izA|1B74)rRgKBk)_n2#HkWoZcntBQS{AcYU-Mdsc z_v0^HPh$d4C-hvwVaD~%2`PE3tYW8e)DEd)2X7f=R#G=fZ62fYbhIzIG!=VjuMwZ? zg)$?f0XEx`(z4f4xttKc%-`)L^!TCUlXqbZg}S_z4)xJ9 z17z_%!HnoGdTqYAUhTvolm@Oi118k2SHu$WOp1iNp1X6d|~%Tt^4?k5LN!i7PC&~sj*uQUKWi@6X@zmx4m)kWyTDRvT~-lWRCn5Gx`nPmbhH5 zj=mgS5C51Fd^~gE^{Uj)JX_ho)KE-`at{XYL*}|d9A7IDg7(ni1F>BTyaco}mxM7^+4D)%q zJr$9%h7Te;E4N&%l9N;{&gHgwdCoaJVC1vvbPG*S-cmBVz7p^hTP$BvZF(u!%3OrL zPyl%{w&*0?Lluqh`%kiTl$O7~cY)=hQ*S!gJ`m4Xn~slKr4;TWF+dI|=IyP)zn6G% zW(IvNQs2#xwWy_4i^IURSVsMZo<(+;Gp7TRz`meNDni0eZ_h~OQJ_quLxq?yFK$3h zcGM7zKO}%d{ee9&)&lJT0Mr2(%kv0CGjI!W5q(3jasOAGf|bnQZX!A&5Wq><=d27n z(4e|W0L_4(?Eu@K$pK|!2mjU}%0G*sg~GNgSp)~7>S}?=A=tKuIh+JU61?qYLl71) z7!f%84ut*~sGG7s_XDC$-PqiJJJI7fOH^5cez0+==5wZ}jOzS?*-qVtn`hpi;b9~( z-M3*NGr{;KX7Buf^9p^KmZ>y&5ZWSLo_CzTp>0zSX(nCia$E>;O^kt2U5It?Jo&8; zIZ0hi+|PqrvAQ`-V=4uEaY8h7ytHMfS`ExS_-Is0q)-pBCCrab_4X&#d5X`HN_2Y9 zlFdHE>dAs1#gZBA_8PlP_sWxGn7Hpa75w;)H~pFL`?{oAFMieMg-Q`f0;1qC{rAiW(m1 zd)8%L|J97<+({d6w5vi}fa()FhE`7-LEKPTUiIoD?tW)Q;P<><-7ndak`Oy6TU{0# z${5*}yG0t%vyf1CxE+TrRT+{{_HEAta-ZEE6ck9m%~nw~%6uYHd*QZg zXe8eO|KhlJ&NdY81jp%h%YH4TdAge=cJAFbv-nPkN1Wih$L_MrGlr9Mfwz?Rd53$1 zR~dhx?-lO246A1Nyg2AIM2Yf=hcPv2YoVmscxyT9J>^}g630Dk@;4nO??R)Oy=iy=G=MO+wOAe zIkl@=O&j$qk7-x~jrPk_p3+aXriwg!i0kB)yo!cB&bvhQnkkKKs3!RICLP&Coz-M; z>L++LbT+b2t4#2@@#~yUJVrN=Lv!$!>9VHCQL*;hy5V_kH>dTfA15B9z)kn#ZNt0B-+$??Al-oh)_`IIVVPP9N;RuMmE_(&#H)rw zY>YK=Z6ztbtA)0#A|0iV-R=;rml>U&{}D+3&~F zA#QvkiplkK>~MFQv~)e)wW&F)3!@ERDlv|i59yhonZ}(TJ4t$Ex}~Zzc9%J`Q6E`_ zTv`!kl=q{c$jHdBM_yahY}vu%h-h!s^VBALV@HwM(+C3&M@rokMP>Tys(}ThCC7Ow z#8On>T)_=7AIR}oiVmWA&HCa+daK{_x}b%F^XDQL)?eyW#T6#ZT7GoRF)5Za#27)4 zZfVOImfUj(8wh5jl#6LyZ6;5KtmYDw;yTmiy3OQFv?RqkRO`tr^rqw8W%l9fZ;T1| zKDPMQqMBV>is@DyXJwTiHHyo+wKa9XC1qUV+5Lj*a|brH^x118%AYW)cRqO@HI$5< zz140%G_7vGZuB~@Y(6cDzp<0m)15Xg7hk520bfl6Sw0>b@n{%%;fb;0+LtdV?=EsM&6FP{J7sl_Vv^KH*@;@&wtLPc z?7qruWa6#d_UdHTf%7?-SSlzN<4-rK%*KXrhHe4%$qZ{5fY@sy0EdbTz?COVOlkpM z!3tEBl;XeO6ToE$Rf+;-m;sRV_mTd@xql02uqGz$pQndQhRY>Zw4>#Ivlv7rMC5e9 zy|_*Gw!<$F2Ke;gXbyOTu@_u7L)p-WKY^GMVkd(c)!TVMQ=_*jBO2QKW6<}?sO)N& zVH?Yt!*znq1?u?w50uL{5}1#(x_hu5@G=ldZ>O|ai8xSq`QlBQgD*N0LKFtu91n@< zIqnx(I9`&oR}TElY)w9iYgOwKHszX=n9b{Z0}BQwik2Xu!cYV$XTbR+k&%`97aZ{%xf9R=#|JDP^v2oLk zRilL1uL~^8-h<{os>a788XL>Gk!IJohM4FjMP(RbJR)@Jg?Ns;2M=UUSUE%~ey*e0 zC=njFug!d?A1h1|5}toC2%31_q4r*8IcWT{YxVuUO*eskV|%JbK3Zrh=ts?lGK5AY zt-cIz%{YBm`QchH#j14OCCcM!YJpppMZJdv2KByaNAH!P-|W6K*7BA6Lcn>6cULcd z9|~>PKF)tDvF&WpG`9HU@ZJu!3U#^1Ia#*7s4pTX*%!Kar`0d?%{``==5<0{rhKxr zJ7qIoou9dEPOZYY?U-bqiG+#Iv`iF-YeR3CezN$(X|4}RV%M0cp9i&okK3m#s!Zj7 zBGal+m%gfdMuDr3@lo18e`k93d*RQ-QlL@-oKz_i2(!^)^!8-7@R6kX z38GmF;&}pFD!VG%n*%=U*FL}CcIc{@v*nPfj#r}3C!)^<(xIp3mX0<}iA*mSHhYY;zP7p01 z`|eaRiW2uqSCVdr+CUaF$cia?@-T^6A znM(bH8j_GOwikC_8|Q{nH{nf0%^p%NO|(9M%Q223$Kq+f z+Kivqm>k|Z{Ka?wG`Zu&dSRFL68~!p&K2d;kM1||DKHy+JR8tpTux*I?cZ4Y=chCb?!y))Mso0dzC96WgJvw91s%=zUn_p zlfo2mt5Lq#wX%QrijYW7M+RwbT)H>3xT)LKYRF?XF?=m_~ zh(@9>o5~AOe@>jL?}SWl=F3afbBvX7L98ph1_zJY?Bcop_5)kYfpk_+tvVSME0rNC z%a_?IG&(hL^EdCgeBk9Fbzp3MKfKb|gxF)$kt@KN!DTrVbgu8oOiqtU;~ByFr&@Qn zc%P*jT(Z@?LqqqK!|Do6h7Y!UsIAu~zMa~n+P4Ve5fYS0{8Zt$Lcxp^y=`R66;#CR zYq;s8W-E$0Hqj>cY}MxT>zWPx@X%YDl6dCgl3pp@bXobcY1KDRj&lvLhP?H%O7{@% z@~J9)QW9{ZlT&4({nU-(N2V8>qF1(f&E%=L!r#U=>UeT|f6v0L8YIR(o+O`gh%Nkk z2{&_8Fyoz$wklCk$HRwI$5rywE|1fctHv~GUuA!GbgYBRz}N-*rQ6SujApO0ZJH_} z>xPg;D5N+%!#(IB-rxJqa{t@YS0}wm#jdAy*QD9CZDq2Js)p-~tQ>mj9=`9~poyub zZ8mdt(+fSc?2ir9I(sb1HH*v(Rz(;rz>LBsinzE zWJ_-(UYCW)Zu!;PD4xCjG9M6!3kF7Hgya+AV$@0Q-pjsE&gJTs^Nz>W0TTj&Vu!>b z)|O^*3ifR`FcG?n3+O)-Y;UOm*MR%g0jkD@M)aYS|H)klEDU7-U_9V|{|r{ZGYznJ zn=cWAW=ceBATSjpluE=&BF?>=-0=|uU#$bA4u}1IZ5V-pbBD_n6C&XH`d~LMoOuiw z7~6+4FbY$6e)>S7U!aD;utp$jx6$>de}Ef}X#FwdE9iM#qg)Uhyr<*&1z^NWDnibBT)L(`a=F~FWnOY`oTBlF6t`swy<}cls_dv+OS#7Z`+VRXc$hW(`kH^ zHndHpz{a5KhM(+Q$?NLPE0s-B6~YI{`3Zw2#zwERd}<}9CsCwnt3X4S81~xDdEU)@ zUlo&luKwdh=h7?HYnUkyHaix}Dz!3GZKnfn^Rm)uu7j`4zw$bXT&8_JWxWPYQiy`83$&$^Aa%fH4QJnv=u&U-~D)wU&F{ z3n$s^KN~*~C4TaFXy@VH$a_m6xUg80d^7j)J8PN^tTnt+NTrc>W|k9+#jj7sNZ^=1 z)c7cb%YBp82$*1fL-5$IZ8^@oO0|BvodN1$>&{;oh@wo{EOKI0p;BY|7#ns z#+&~>?^8;p{_mC(jOwU3?Y?6wQ|#XocU8QJiyWD`*xE{s<8NqfrNp^5q(#F7s88JNM2?&lA>7N$ePt4gVix}?Tfk$B25${q0 z!|o5aBy0hSu!GPFeSR(QkpVDW#2{K+lP?)O&U9jNNtYvS*Q-DyHw$rTSiZK=n{P_x^qdy8!X$s<{V@D&AVhKh<*B~ zmQmp@=Mlc=dTXq!zJ{+)u!6vK>~gBeS+{Z}d*>#%FfsM~5IEb7odJy6Po6%5rBjE*}z(ysXTB zx3g;Z(cp+IR*#riG@0++qWw$E>V{2(_;*^q`k_h&7q&E}Vp1t^AC-0L$WklA2!Wqb zBaG_i_NO!WbCh_{Bo|$-t(^^jcx&SMp2C%Lo!Q@HDaGr`&)kB7;|r7A!$pqWT4s+3 zKK}V;xI=X0h)(r+Iz6SH&?_zWd-Pjd*abKTR@-MG*LW+Hu*XG7;(auC!=G^asHU5U z(OBd(34JG@{E}lg5ZvTsTUp~@KnQ7ixTlFW@L&WgPO`#ry5XXr1xc3?Mun5}OImH9 zSo@=Xo~sjrM)>u&%x9Ww$1=RA4|a_ZraJR-#cZdI?lsv)aliU z`;6#^s`B##EF<4N(!`XW83{cUT@l{U#tH7avtOktp|17#F45Mjh8UWQ_U~0O0w*5b z;@cPaI!K&1S@+e=Y1_A$GX2IA{zI;=$^9HF?m{88257U>1x&Ki1Nxa2uLs=6&U4i+ zOl|S{aOwNn+PtiEf3q4hQm$}SP$SKMSN`N%YO|O+cd^FlL*{~)R9R>eS%gqmIkb00 zbtRCx)7D;fJ&`tsyvwhDK+D!(c|GQF#C|=Fc-fqIBqY?9QFmJiWsJ_4imMl}rJnjK z-)&+J-6k*f(@vYKR7!N>PYxValPdE%8(TRc({{PTvq&HlC9)(x*0)~=R}zr?%&JKx z;emm7egbLq=T`5i{U|SX-6xA~6BQgOXQiAoT3vJHtFYC2C6_V$Ssv{1m9E3rNv}H1 zdmg8|@4tlACV%#McX`UOpatyf7@6URBRc0w$|6SFS`Mjng_mddT2t2KJc}9eCY!pm z|GrKjySi3;c#m^YPni{mDl(92{kf1nPrj?th}G0_MO;UyTDMw8*`~JOKGoQUQl3%Y zh1HU%Y^H9N1GM|~9_pyKBtE|!TzfYCgl%l;T`F(f^*o*2PIHo)?ktLi0bjDl_H`LS zS4+n173@{x7t(*BCO|r_{vjN#!I~=tM?FPt_pBOy4#){uKrqH_`}YdSob9 zE-!_<)!8pH_vE0`bB@6KItdm@ZR`nBr#Mv{xI+@ySJGD9m^ZDdhwfaF#)-_|p;)}S zyU6k@+VI1Gq_qFC-@PU46)vMwOZP6AKg@rMU*1*A#?qT>aWA!kOgz6ptT}p?(~RcD zsAzYHOW1_h(K^l|ohyocdMS(`TyrrgS}{IO3l6tXIr|`*uObVv&TL2mMlc%D`pc#R zyS@r`eBQT#F$R21F;LhUIKmCK5AOuWVS{WZgDOB`cuT@BC(zGl@D4EmrGVTb-fgD_ zdzj%&pWru63@{7ncnGsRwFrGUV#ErlElhza89^3eT%8e)ED(1!z)#>9`_J9Z#2^tl zfMnQqMILJg(QvT647dxT2@5+r%i#TXzZ;1xXoi3@U=sP`S=z1}5>Lzw$0Bp= zw7dA*AVVHk&&NWCExf4b*zyjP56Hfg94+*jJ+KuUE%U^~(V51rz`Qo+sB=U1lx)Fy@mz+{VLxtcbiYso%W4MQ4W}DlEB9H@ z*z&~99I;(i@W_H(Rs2cZt?NpQF#6Jx87AHK4^KYG@eib;K*7 zia&Wp?#2_rM+>@JHC~2$9K9YED&6-c==kz2nN3wh#a#GgxG^-~R~k?^XMW*==6wos zHjTtkDnp~Mhc$wWY}ATX-aD?5Uec9cI@o;kwpq59oRweowM;7lGGW}|u$|(q71i+0 zU4+fYQ#p@G8*IjUH>~IhB0fP`k>59GJgoNgSa#g~67|FoW-G)WF?~3ZH{L`Q8Y5Ww7Evz*?#-JdZA@uQ#@c1DgiK!Js^6&oLU7a@K zVXqfzNlPQORm?PceqU}=NQ(N1@m2rrLHma7qdiEoQi0XT; zm9%FG$(cW(J-elghAxrzTnapQMc~UU3HM6OrZ&peq2ylP##`$^PoafbMlb)VdZ&OFSxG{Y&u+HqRoIqx7L1CP`)-d>SaK2Y+?7NvK ztW!x;thTh;x^sQXj%Ej6;S7EK`IvC&M#`-R;pq#)&4=Sd>=MGNGmS_a-1R5sGMT

3+C_;%4jFv)(#WRtov=Vh>*{+0}npL!dDx z`dfW;yd9hTrq)PdNb2S5f_3FuYxT7gikQL=sAE$B+{dv`@vMHIVyr2e#H$w48M@BA zxgUQwd+wgKwdW(lJfDt_@7B$7e?VC3SV;x0=|p&xYLNPhx@t(twwDPu;%GMirGhZHurUkh1r8qj)>!xCz?c zVlG^35YIa!i_6d|)fTPPtK9)SOJBJYH25u#awsSdJY7h4y?(~Ltg}_2Z&B{dYxgys zM;e455M_Y7jyZD4C*dvbq(N%--aH8$ zf^o9%H1`VWrjVc81B3Txf?ALxPh$Y9oFbLI@D{jtTV--0wJPRLzj_+BT+m15LZ?+A z%txm$&+}S8m}?+1-Fb*Zd$pkEqV{S}NUsG~4e;g8X1|L?oO_7HxJlbv?2$k`Mhd`t zwIanKa(hS=#H6*eAqilv6G*ZTHpd|pS+nVZ%a!I84CG)})MPQiNll-mg|KaKllMVb z#9)61#r6j_wzoNN2N)^=4FHC;G;wpm2e4ZULQ`X4hGMutwr7B%+4fbC$p7@>!m)p%J^{sU$Fwm(fjozu6llaKF#kQ_onzo0gaLe_650bb z3RW5JVa_%v=H=yY);`2`KFvC%saVjT*;GR};bLM(vcT7ZZ*{qhnJI*k>sQmv+gHjt z`97YWblkvsO;ZT%3nC9Gc(00mVyMc1f(BX(n6mTjl)Rtm|9@P4byQSq-0slb-QC?O z(w#$hBi$e^0z=ABLwC2*t#pS-cZVR-0%F~b=bZ1}?=BW=F|#*&-al9`zb9Y(2q85j zf0jBS+ZKO&Cb5dUIZ-y!({#c4G&?G#_weE);8v5n^cBYX7n{->01-G^7_%Xk9r(d_ zLQ81Un8w%lOLerj{ad-&(GA_b??(?d1F$PPmldjuhXJc^`Gq_5qK|3`&0Eu2ZfcD8 zneL|qdnygoxmmD-qISCZ+?AXM0qpq>4%!N)-yZ_|Uv4d(8pddYuD57EGUT$zk-r|u zbURZ%E%5&?{nP4zCo5%`=%XEFbojv-#Y9n_gG8^f&XH6er(CA{s*U*Z2!|^F2x&{ng0+F6Z7kST#QgZC3{oFUMW2^}c zDsFD3JrfjW|3)tF+WD%RS}yDATgc2G5FUqWIV%&&2hGU7fGpmT;R9dAnrW+JvGn|5 zDw`lZS=W!6nX;oozoLt!_?A!?Yhr2?zmVbG>9$6p?r*4SK0k9}_1J=-TJ4%4NFCCWtSu<*O1Bli;AXd?OmiOaQJPyx%H_I#vd9xUE|>7`Vx1pW`cY9+|Xv3 zf5TrXWX1;yA9NExG_YQ8-V0Wo)@sZ~Zm|qpAvFcXHER`hi`ndUwMPky`X8OR&aNL# zcVwjOm3rKz9Wd1TWQe%hu&{gJ(L%h3&v(gbUgK7hA0e~FgDXj1!Z9Oa8qPQDG3BzG z_)}RezF-}`O~7~Phrc{E5MGHN>aofwDP28;QRnE7=;h;`O4I+=p(i!nyk^j%x5R6K zm3*{0Mwqvk_sDd?ffRqyIS|q`8_h+xmQF`(6Qn4Jz&&8E3N3f~I-kRC5&=eRidTH z4%zY#Ms9JtPVs?9sZFXDECpLOC&SG>S zp#{!AwM=LVWe@EXi&%}-sAYFvAK9!&@04eswVmr;NxFJ*ZT(7+>?cK6gHtUr&}fKa z^!-pdw2`%bnTJ2n#z*;r`sUei#g%(Hp?7+ui|l7*K0xwiM1bpy1_3k%sm?4zi75ss znfAXK9hj1-*9ZYE`5%V%iOP7=mqBn(vofFx-cS4S zzr1eNe=naN0PMC;v-#6x4&3s@)jm!3a8{sMBw(+F8(iuEhI{m9a1&3$HQ+=A0L0&c z{_j@%cNu?o<^M_a0YMhvBSC<<2e=5g@H!lbvHai9{&!`hz&^|h5Wu%Uhyv%&(nalS z!MKQ+0~VIP1*AsFx~-V|5ku2!?v^~&UW6Jf!e_MmH{3->Qge?PhtcDzu?=6!eDw2+ znU9!;R-ElwvrDI|TWWcA)o za#-4@yt^h{r&H0hvKICV#yIaUDGslq^2M_(W7Ay~Z>RbFvgM~5R=ikQ!Fp}+@gCJn zBg<{!tN{Z#XN<02jG!-ZxZFze?b+m0Q|k&*!3JJ$me__!Yntx)l_j`fAl%7Q*T_9M zksf6TU7L`;A%|eh;G+L&0>(l;2YCFdk$Hql?>pLo*osG@(F?ScY`=yN)m|yElV$TB z+SzT}4AHq?Zy7fy7Frd?4d#n*C<~(3YX`hQVnZ6X(I#udP-$Qe@m+-e;#FGyfjvAu+OkXMJ8m1%3Xb5MFU#Ut< z-NP7kiDa1*HH!9FGCAWp+z!d2L&m2h>ujMKRI1}Vky~Z+_!$l+xf!Try4&o|gVx@@ z4+9h=a+XOCrh^j$lk=EegEdSFtNP`w1i|U}f-Kd%2i}d`@I)b^#q;D^pH`qX^CF+9 zSFmEDmmmQJYO|UtDhj)t@#}Zl>Xw3;GuaNzx%9u$HD1$;y&F4Ek^ck2u3)yKvY&`* zIvO5ufTP9rr=>`%81jq$%IqKQuN&c~I9JwbqB<&*`w;7QAnQxDs!6`wP#c$1HZyqx zYMfD4p^|A>6RY+kD%+}-7*a_k9vbG+xCOt4F!%h9VRc^_6dllUHa)3Cs!G+Ho3u;y zg9`V|%nKencEpEG32|pK&$&~og+~;wk#GHwab$}-q2x1lJNJ{-UnKnOomv!%2JNI( z{yOIgd+%;7>zyxLX4+-y#?JUXmCI2s-H*7`rs8Fcx1eFfhp6fvbl+xH6D7!*Aa6SJ zWB$C7kZZewWWPd9`);cCYpUAQ_nIMZ2#iJ?iqtgt4Bb>`eVFvXQj7z>%O1MzHhyP9 zhE-<5)yV~AyfW)m@PuV4qr^Ch^2c&%2d|(#3=( zmYDKfVXFdM!i`^Yc20xV1DwXWW?P9zCbSS$1TPxjS}R+0!n%u+FuVL>B$cL)pbSnPZZCuawLdnk_zp^MXYURx|R(R&v*lF6Yy)iAy-E1miLD z`Z=oAiSs(Sx~?!FfP z=ZvBdOCxL6%xcMP*)JZTRvLVzeX6LFIGCnh23DPx@M_k(1K04PvW~zgyz)gi>un^;-A(YH)1hCZvc$xgrBF)GyD zrSMGT4UT3*##U*=jU(|wTRGkVTI2H%V*5JV*fWerLZy2|KP0F5z>d#%$yIf{j?mic zm<|aW^Wvd21HO>MYS+Z1H`OhjY>?uvd~Y4vMEfJCoY$#v zoc2eaQ$9}RQTZ~VXAb3Feu2H9&VtXqaoWsO_to-B;aSIX_KjF*VgzP-b37#*haKHP zRXA^awvD&_6;%&y@w^w$ZqCJb$PxJ?Z^rA`yxtslmzrb`Q3jNi31V??N9*5n0UxS9ST-IBGrrtvM3}7_ z+=H9BMqPr4S5-uWH#&PW_`~E?zGso3`;$Xc{xt8%;>oa+rSkHlFQl`tu z_c6iBx-NVDm9s_urraXG1IT56U7-SaEQZXf`hHxi8sUas;v(goWs|Hepk4iaXZ3Q0 zFU@V~hwnrST3vhs24C@F9BWXs3NoDJ9neg_mZb!nVXm9WCB)0ppwDcwBoeX@S}#?S zg7q8K>Z@qf*a(pLw*tIl1@&jr>ffCLSse z9KbESKIHA5i=y*Nz|mwPDu8qAQP%P&$E!8mUR@`4*Af016Usoy1&;ZDUk)$IBjI{s_+jG;Pl!bJHi@8fYEdnZG6oMY@}wy{r!?+M%j zyS>AObusTewYrcCu@Hn}s_e#rq*Q~Yr=+w2;gyjpw6v)p#bv;qw1-*OxIVmd6lbAH zVRk?(UQbZ_WEbzo{`XlZa0u$}+s;(tPD^}N9mP25&S!cygtm6=jd+c3IR$1?B_>54 z!uVXEGfo#!dtRN{ zeemfk(Ps&jv8>3I3*F(F`%ro@;fFVJ%198r z+OdAHdB3u8tvxDck;Pa)?9q0`p~`S-V`1Mqv$f2w_cFP_rWDI+NEbEq%FiADRX~e? z*vc)P*>EY8tl7PQ8h4v+SA%}njZF6{`hW{L+ltYFMF!DGkVU@FxMATI_hI&Jx%MJo z&2Wj}^)lV(fzg-9moqO&IwvzV6$u`dU|8?*-E3^IEtq6phQ{Fzzk)Xgdrl?c95(S2 zF_`Y#eBl00c77k!>|HuU z?8F$2!nau`Ox?z-O-I3_lr#DcrE){Eu?Y@Hpo`Fu8q`Zh#IWIe-yW35`6gg}{V^7O zK1`>=rGz}mHtPb!7Q6%!V>gUr)0op)cvT5{)z*NVqPu2nW_;t>VxWVG;x3D9+14Kr zugwJM+>uOy;+me8qi6H%wO>5^=TMdF?n;I@8629XY3N9Yu zV*hr+O|5#vjBPGaH81`#dG4}mc+9DZZ%>MT!E3J1_&^oGw$)P3qYRecUG z-@gO0nO7s`XXbu8p$6V5rj{VM=Dqd0C(Fo`)4-f$e0abS%|(2~ z^%h#lqr^C?TV!F9ZHRhnb)UNUHY$X$FnDOBGV;!);QDZ7{HkD1drk63T8@c6z7wh& zEnv1GPK>5R$FQZyjr9r6{z^bRgnY&ap?u2JqoG?pF<<~tI~7M{RkJdAa_9U-IgbBe zEAenr?SFJ-5beKSnSUaVh(I~Oe-Vs-Vb|YSM`K6%sddzu=;DR`CkC*i6lb`KSY3=05IFXA`l?j{Ka*DR~YdBz_Gsq%K)gz zN<2xL_37#pp!|Ro7&}MbcDbTHsZ0@*(WtETi&69t6s>a9yskX!kMg;~E4UjZ7RUOa$0= z`rz1qRLZ?FXJ}N(v!$}wAG#eoQm^K!!XQG1_EKiVEb+As{d(RqKh+TDtI{qEvls?k zLn4<~F_LuR(2Z@U)woMoj+Ye>yI@z1*-Pl(&0Fw2>9H!e5iBQi0?(K1)N44X&IRET zY)ZW%)r{^$Z#1TZRQq7Y#i>gfthK7WF7JZ8-t{0=OFJjTlN1~j;%}!JyaAslq@@VZ zNxhJ3-vFQ=Zj= zZV`l<2UVO-hlu{jwCseBWrH+Rhjx@ri3=O+YV(7vIuLfVv)yjyX#?{H{piDr%=^e9 znp6+?w>vy!!vQ(b#(q7#gLTP1{Bc8(2iR^(=`B%J!`~jM+WhP~>P=GE$6x2GSd>+G zaV*bs^2i7OBF)!2kJ9i+ByBPkCx9H~B2vKThCgqvdntQP9z6l>)vHTAI3ms0*16Bo zjolu@AU%h5J}+JuGm0dgKXKA^n`LJWfQR4UeyNqC>S|lV^-YO$D`nJsEM4xS&ME)L zc6*=X$zkL*NO0#XUmv-1=qU*y^`{QEWrOU@BgTl~3@Uqj#&u6w8S3O1NW3vFftmh* z_pTbOzE~5-i?Y1pc&b)SNs`Q;XpiCTvg3*3Dp-D>jrOIM7)i&v#x6C%8OM+;G-ZuT zpH?irQ#v8I78M;G!R1>o^wTJEmq6D%i5|9??$J1b{o~mD;HkH4%CY5<9M3*rf2NVhzbzgI-%+V{{#K$mqrmohTgj>B zvv6XdTc7XlMog`MB=RtjWB!~WVal_-6{;uus&HHPR%kWbD{>eR3(O>i~sb6_*hOI9m5g5!O>&l;Vx!Y zW+b7=nY`3S3}NWSnZ>p)+98i)eTiF!({+>J7)1Hqw)j(8TwbfQVxf_%tChOkY=fw60RD*v&a9Rl6BW`M8>Qm=iy|#g_;yY$_{LrY%4K%rYM?5Gq zRI$r`PU6=n#;5JBf|!awP{4NCfCh#(R0@7)$Z^!4USds~|G9T8b_gO|pRO^t9XjxY z4}+)h=OWV(*Ub3?l2SUIIU%c0F-K)w-|>z5;%bmX=-u=Ht!Q#!S5h6X0F zhxJ*uz(KaksG~L-hT1jCH5rJD-8d}%!ncC9F++4nlr5^|P^Gg~k`u<1Ojx{cgJ3%$nPDnN z!V6{*dglUwOcK0lwGO9iVJ9Q}&WQN!3*i`~O(#vJh2z#{q*SeQ-b~o}YnRBYbeX)f z1zoPx%~9~aTg`7Ik)Iyu#`2O5bxYKlb%vdk|9UBnxM$h;$)fDYe{}5jUZb;p9=8KHZZ47nTlosT`iM!FLAUK6Co*k1j zmykPatuBPfAM#!W`eQQbo9HDo$02+A8U07$cX6MhZw=)l}RtZO`9+MaEcxbHbYq7I!ji&OgW)G!P*{};qxpo}xIAiS{G^o9;}3HYubbS{lgi@G$qjN7RcjtrmBJyaolZjw*8>$~t2qP7uk3 z&N;&-)5`g?kst!$Y0&|XcY#au-)o3FqF6SKdqm3>JmHyh8dr{qmuD{D1;|>W|DXzV zbyCkIQJ=I6hGBjDxhbpD;L1r(=S_V~Qz`J0zRN|MZ|y3VUA&+&d* zo6Kg$W$W@xts4QDn=Dy{R4DJVk3S>QD8PY%$ML*02PasP9O{U&y0h?7=E5OTXBtin z*T@O$?C5VWCab^dJQ;%+cpI4?2=Y21q}sOmC|jri8DH=!fWgs{`(Lo$vjSQw@f%`7 zILAIhRL4`bbdwNjHbA+|Dnl6^Rkn?Zs{^aRpi09yWA zO@##{nJGc4Rv=U$hxM5{eD|M$57Y+-%zuA@_rKmoV08QXG`#_S>dK;j&ETuH8KA?6 zK7a~&8 z{94sQJ|2C!cUAiIsXb^NR{qwOqd6ucaR58saM1JFOQK7Y@fMt)9JiTZW0P-{n;%#yu0s zR|=`(?1^)=!FP;QJ*DyVdC{#c>IPd_!bRy^1~bZVQtZpu5OdTcwH^$07i?8_O&O+p z!;8+hl{Jay_>zdyy zmYG1Dzs+YG*C@chcPP#1c6@@jPeQL2r2H+>t3R|Px|Mx4DBvrB*KVbqS++mf2tJ6( zq-to6uA76qQr|8i3p>~68A&qW;GnkOw z*?Xj)eq3vlW&{_SA4EmMhi*KP($H4<>!)p%+6z-cLyA(hWK_f?paSoVWhyoR!fgYA zeM!BNqKQi48S?WyCvkvr68HtkmU96esc=0l?p$qMX z?!|B64YHDw*8J&|%4vd_v_|3qg0 zHxLD?d!F2jpKsGkea!C3cO0A6am!` z|H0`0ule-p>fc@T3BdpLiz9-tFG0AJMNgd+aJT?L3ZUdCvkI`rfBcJ7MNba{5H-N2 z{uMcc;H00(&Axx1^q<@b*Yeb9@s9xdS7!Y)3l*%h+Z3|K)Z&^})aNqzw)7h>$MXYZ z!dGfVAlBK>*&)yoOiiqs5!~g}DICoN=al%Had(L^^qxkR%-<~4l+7d~@4X;=-?|q% zSP5~2x@O5UvJ5TLe)=Mr2yy#PON(`1CEgVKM~}-p!7=Re^0Hs8bkZru^~LX5^`mkG zQct`~x!9?*?T!1`#Nf2QWL8|JuY8_p9{Q<$FkLY>Q8s*|R>Zx;{0RS&+KWZr#k$+( z>kRhE`E67cQep;I9r!9JzN{K+oPCJ34IYj0!tMmS)?D6)j2uc{ z)%5vJPqazP7b7h!f*LH#s<3QXuOg}=7^B_bDmzzXTRXNJuSITXhfCq$?^MQOM|X^$ z@)@onQmgMUp3I$pFVK#VJnvi=lXlb*tYu6^&TBV85ao*>lCo`t^VkO*?a)=uN_U5Na- zWnV_ffaMQHJnY-+ zn5V13kjq~gzQLuod{9hz`Ds)AV*0MKY9U;$=?e%0KgRHtgo6&0Q>M<>)5FT>Orye{a)L)z;KV>KUN@(J9wlRAhu1)yhnN@Up3O zi_Q^x|0LhF*GF0c_c6Mfq5Z@zK}l5>q~qgR%|x21tA;SP`9BU7ra%McBz8+fL(@I6 zZX^UVv|?K5o_7)LjU7k7NjU2acR=xX+LJWNRp@1)yvho2imQG*CMY5!IFTnH$oVJ;3$240e63epY8C>n< z26qKQxWWzipez^|cX7dGk?I*r6|2`1{rQ+pL4-Pd4F^xk@jSXK+tN19$ZdzxW4(Wo zTb0d4b5k)Y$TZ-q!u1MQX|?Wfk5ZN_0<3J65w|2pM)+!Jt05;Td)+2J?fFoi0eTt} zCw>~NT+P=k@xF(MhIf1Hv))7QkeO)m;DU>YqB{vk9p#Bdds*TwD>q{vgoKcJuG3zU@8mriAmuIi#*P}qv`C3g3l{a zX_$v@Q0Z4!L9DTEk|)D$-H!TVun>tsWe1U2Q~Us%6zM8ST>;}fS=1&qed@12r>Bd9 z3iWRZEd9lresX2fW|J?|h$)|0)ot+e-K9=W=^GcY4vl@Oi*-YC40i}0y%b-5v3I7cmh6^j|r(x#rA&`;C3B;Mj*Wmu^ zG^Y0Qi3yL8F{<4iU2CMg;^$(6YeZLfuH>GxK$5$A|f)?KKLa}uQ2}&{cH^tx>=%sG)gPI{_Ly1bet*F{q%el z3P1M9+jjh`Oz=WIXTJCM{L&16=%ha5RLK`H{Y6Gxd2|^iemB+(Y^iX#NpEQq{ayj8 z1@Gv&m$8_fgl`Spj5UkeE32*{dByC<1XayyX#NV<^{+Wu&RK^z zwL;zajH-`_iLSL62t~cojni(vGUdpX+NY{2_{}%Ftq4sE_zGX={(vrJf9gn)Uhh(} zi9rsi%_etMd?U)(o?WA8*TQ3cKvbeu6EC9WSTH8gvg+B>-pgm_#w9d>75XM2{Iu2? zn-OJ5;H+`Yt@hV%qXrXYMRKR+22k-}2fR^?Vrq;gsoYa3mi#PB?pZ8G0YW7B5QR(U zH3h&xDzXp`9$C7PsoXbZU-{ScP_JomAf+D!tamA=l+-guwU`LweED%xNnq7&3&lG! zkh&Sb18v}L9Y&<3(boGS$Xmwh<C%@_&Rl~7n<^g=j!}kiR{~9}ZD*D$J{a)f) z8Uf{q-=h~XqIU{^+Hr8*C=KbS#Q|pD7r{;%6OIM4KRc7Qe@@C3+;b0vE-^d5a(}rl zY?hOGlqvWJ#ED8m`st&Odf?@<3qq`Gpc`*N&$8*%GZ15z;fJ^oe2Mw|3SDMp+IQ0} z5S*K+m)j{Hy~VWr-)F*T*$vzbPc!g!Z;oP5_cOCH`(j?SF{VwTs+aBRoSZHH%;S9* zCi`s2X#6hE-Seg0w$j%IrAG&%iz=;7^lEPLRuPvLuvR=Fo!T2&OB5wpk3?^8G>)(_ z=}lEcIE?$&4W%xDldA}3GJEMmabmKJq zO93~5x#LIqSB|nhGSs-X57^IOcFvI{Ox5Nv<0{mrwZD7_L1+EoLSvBWKACPhiMvz4eBze0% zxw)kYgJHI>rHM=12nkCNUh|Xchm&CvdtykVGyzksBYeb~I3XM^(o=+|9;8jj2UK@J zA=E9NtdtGL^Q%@3h|HHjgwqJ9_W-E^3Vl<*6)CeQ=n!BjGC)P%TcZBqlT_%>9RCs* z0BeC+tx=l6Mw|2@PA|RgP#JIx_ZrEiV=D?9`~f*h&CO_W`8qRX7*vPe()fHc1yl>I zp0JN~+Fl{{XNfpy{Yz)Dx8(e6>eY)sCPdi9Q$tk5Q-iW*4#ul<)QxT#=qr8jTd7dw zFq85p6;KjCN!Mn(p{XtqbLh)HqI4a;`}L_{`rpKWuLSbeCN ze{5V}^R;k`nyO`uq_LaG$mcqPx^1`ge=ShSNJ-(&7&}_nX8i#Xa0wt=i8)hXI5OhH zyT2{F@OC3|TV;)>G#SEwpmw_lAsIB=YCJy3_wf3Vk8?3HX9syuPq8hdVMTgt`~j^K z*RZ398ncdlWgT!a#si7HxuQ3-HoN|O3`<S|QEG2k6WNTW_RvS}Hg4niEit3WV5S7%oU&S9waO$y+%)tz+;Mmr-KZy2y&WU@rkWe^5AX|4bHp%Vc zX3aHQ27P4Pylt6N-Li<2RTzK3vTo<9hq9*TM)%M?a#lE$+KY9#cs_T;>(PC&*LoJ0 zJX)4qV`LDw;v2st6&1!)C!}VVNeuUyn+I#s>!(hW*h0;hDtroxGj+t$*m`gR^+Z!rS0Cq1-gbi-3s*7CFpiedAK5BRcm2CVd*8nV=6rI^49==M% zqAkE`EJe(VgvDfEy1w}Hv1dC*qWFk-G;QJqn>M7Psk+6K zG?Lqchp7DV=HD2AFV%<5Wi*)wOZ?`iPSAXc5ssrhO?|)M3!T2&a6@}9=a$$@d=(H# zpU>?_pRgE%Dkr;#&nZjcXojY)TrHk+h&S)ix@WG%50(E(iW8fg1!C@M^Qi$31w0t z)#OMFG;d>7?lEEgq{DXl3>`OMRQi^6_e&omMjxC$2nooJz;6*IXCV4MIh+6bj{a$! z0NO7`wGq(&FU_DpgGvGi1&^{*c<6ku%$d>$1Eyg}@PQVkY|KIGx zf8OaQg#TAc|5u6sAE@8@bm4F65va7Bg;y#pw6ME_2*(^JT30zysSWkMM zl^<{m@!sV!u|Ln|%~v;oN#;E(YLsBN%zQgDfml`UR$jELOr`PF>&I?fS4i@K_MPfZ z=jmghV2{DZm~nMBXf!Fxg^JK<8uyzeee+iuJO$F+*<49*ie7>0BI- zvq{@vPXk|EskS@}cCCMAQLgcMjW3$m@bd$s(+{T?_8Ae+DSqR9B+!zcw=rq$&vv$f z4@-mj$)CYEX$l$_Q)isew;ehsx>fuNWM}=*j}eoGVvplrN()dWHlojA@LO9YL}a(2 zK8NoxjE|JwUi`tc7mtx`sF_8L#O`MG6Wqj5OOFNbUEd!x%|tuJC%h`Y(x4~h#Eg`J zoEAO)J~d6dc?Sd?je`KjeqVtlNX#^kl^b;{Sz==xd6yWdpR z3Okq|{Q)^5h0)5zbE-KiEV5q{B;u~sH8*fo(d5@-sKmLdw|r!MK^|)=>Y(pb7EVbK z)UU*OVLcVHMdsVheaz*o33dy`e#Etf5~J%m?~^B8hu;iB5X@7-Q1m4vk{v%x>& zMy1M})L31nV)=71Hl7^{ISMG06I79bafaZqI*eKwm<$O!&6%{AV9Y~~aKg_~RrT1q z`E-t)Tm_E;qgo#B`7N*7a!1Ku=)$KYlsl1i=TJS0z6QU1-hOqj8g-y~Q1Cf>%Z zV}kOSP6b;~Pto*Okz3U@9+?7kr735q)o@jPEbF|gk{w>LvqvTR%pB{t`2Ip0a+75! zhe2nwY5x09cKIQ@4>DuUU}dKcr8SK+W3c%%$GeO?9j+MuVkeTNAw~y;zAuhJ0k^dj zZ@xl-uFM1$$dT(ewBuQnlUO#b^tx0`A<}Ifx5S&DZUb*iB{wP9gHC*YJ3<~jQeWu^ zv$0C5_s!qm1=%F$njJYg(MY(U!AyQv>NZ<+#s`Gz$`J6IMHT%{LHA>l3SB1!gHe>w zO%T-bi={>S<63BrMC0AUHTsY+ zv@*&D7KU29Ykoc()#E4PG4^)ry^3>m+P7iI$@HkwSu2}uT-XCsXIncW9}pY&R#?}0 zwXT4LnLX3>D4x|#i_*EGrAY8y_O;;K+t=cb*Al{ z-Z^M(>$?ENItJ_kEaHI$Mp{g zMmMZ3rziX^PuF;Yy2e_zWg9%TulfhXybN(N{~g11M?U41aL~wM9W_gno_(L(YCMS; zp~snwys1uPE;~ve6LiW;f8e+4$45Z-|!c z3USnBTjV6R1o0fnjDb0K#LDhuoyP5YFSj*ELQxdb*M6y%cNSEE+L z_)^6Lq;+)zW%L~tift6~o>VVYV9WM z_*Ivw^Y>>^6 z0j+D_@XpIpwi*$6mgFu1O=FCbP(m=IdPv@1V#Eszt{&CRkY*;1H=j$6)-KSz$}37i+E zA(1X{J<<3{hK=U6FvP{uRWrrr1HO&Q=J85v&hI(%75>}buP>x%;?C^K!oJdUxYl7yT%+^#c%G*K>e6DjMahwI2iMyrP4-VJ1cLgcS%upwF@F!3Gu#Dtv;yL@# zuH-#J&~@)2N<1~$Qch+4a4`{aDukd)q+1f4StQg(+ zHZGtJ-2pLw@N4Fx7#~aO?;kx^9;=L7Bo|z9mpUsIdqELk@afXE$EFXj>-tc|2$k_l z3%GQfmKPIGUDA>h2 z+Pp5Sbkwdg@l;qOC$X4lLt|unXOw}g{m3?Y_E437Wnm=;Te{baab<+#mzG6}nd<*mE5#Vs^A`yJmpJcKc< z&7NUQ@U)ka)MQT=|3R);`KwFJ7mTruJ`M?N)9T*oZrM!ys1JDYZQY8qOR|Bbe4l-i zrg7f|sw;KzsV|c{y-k2rY_}C|V_YQ{`rAaL4Vk!^!HN&eFp>$=!xSa>_d{eh`byoth=S52>?o?2FksfglU`WyYUwxGwq z5^(FRFk5x{9(&#>MV6u}{X_1UYQd{doE&5Asesi=6>m-q=uC|^cxu$jdeecosU*oO z#hH{^FlD(1iIn`5<<$G!+AP1 zrBmBTo2~;mL4_Lw9R;XVg`4D?M1PhF6l>7}C#pyj0@-_9F3RQ>tDIcB^lDDQ?Lbqw*}wtz823@~NC-t~)Rbm&C6}+rPS{nuC9BiK=sr4p zy_6-Bi&QeYjWz#dKH^#8yM6RV!65U)`TTRoG?)IV&n@{w$mXeVZMlO^*up|g=RvR^ zU1?P;15^}3yh}L2@d9>L83z=GOPrza7L_}mlgeLnx=b-py@G!+cbHw;wvNRpJgEZL zHoA)NvHDwlwFrxAUOK*_QY>dHrv}ufa0nwn*0;^`-Ifqpmk3$3x-8xgxb$VjA zl{K;F;~ubCG--;5p&YVC@}b&vq2y;<6_j{WOPT4pBRu5xq!w$>`9l}5yVw4J5PUG| zB^qgln;1W!4G_-Ys8K7V^A~@cXa8VNgIKmTI7dIDX_qA7IJyhusU zu|-3-2?)gB1s4?L47sL#jw9XO2>wD^V2LTL+~%ISkriKBmAr{}{XU*%$lW1OiRo5L zYk)>)j{ndGy;d~aO649pdukxUBBv`ho$Fb%CU@|nb8~PdbgeWTF4Q))0LG5nq-C8a zI)khDD#+ee_g*P{L&04=XOh)+&M(im=3r26>Y!ob2qvpoz$+rFkSKtih>;s02hQ4y z-LpPrSjn(bQ5MM$b#;Z|5D|QLw-G!nH>HkmGTAw&RJpt=X^=}(qcOTd48iA?rp_HU zaJ^u8E~`hU#O*`f$la9cD)XFXfVM?bTXcS9^ZUU;Ix&iD?}I#Wwii^8VPo*fK4f_@ z|HX)S*0*>xPSNT_NNKIr0(bQ-@#mAH(04ty&=n)t+x={D!xKsj&mUDJjD_LQI=6gv z#TsuHf|sxY-B2OKHOjJxnQ#2r910h#prCw}=cHd_-5M1KS?dy_?s4{!(B3m&pRlFE zpQr+TxB6&{ww8%r3-58gb1%C5m46GzSYwF!3M9RKfm_A(`|>k1?lwbXY6%w%IINm@FEP1B$r>q?5Q6 z3GB_m_^8yLZ*59q%em(lMKEf}z~Z^`P$kXMbZ#ZT-aHoNT6{nBLGNY1`Sv#wq#{k^ zu(>1tm9)4S{Y~|{Dt0hbk4`*QYw$N}#~|Pxn|QNf8!VqeiG4OyneSd}PL@Zkt4@_1 zqM}+?dY};HEK2i2?1C%PmSZ#+DD0Xl{v zN;F792?Wh+o&^~JP2G7wof7KPmr*h;;0OfB3?O**FQ);J4wn!R-|T;{|3A~hKYj?n z|L`~OZS_9}v;PPY5CafF2YNmKEBE}@fA-(y|GEDk3I&e5?=NKna5cbkgsV-`k3b_9F z+}$URr9u?t&s=2EJd>$35AwugS!@ZH{7w2DTl~bN+%6E9@rN2cTIG3&ad6Kerm?3@ z$!@CI)#|>rhnAM##m+~ZKOqAh!G@%aV~=*-_Pe1XyWijgb!{B};kcOs z*zFL_vga@_>*PO1@r_CP)ganp2t@m$y^oTP9^c`JLVu>lwEq84b(UdKwSCtgN=iDE2FanM zyL$$P7&?{i?#`hZiJ`l@I|QUlq&p-PL?i_i^&PM4zMtoLKg_|f=bUr%fjRc<^_v`V_JaU!7`oc@dUT z-A-|8f3!sSjJ9)7FpQ0Ns1$P>n?c8nkhaio(yklK?`&? zo7Xds7)Ey?9-}8G&rdxAt8i_QLQDL_OE6?1f;7Q_Zf5GbL;!ugza%= zBox+qs7{nwO0T(=Q1F$!7;1^HsYOl6TCxqrc=bj|sr*j}fUkHvqB}HT#8B?8n#8;w zM7@j*NWJ&y;)?KlbB|z6mnFfxto)K;VvMa3IjtC5ZU|x9Ch^>MBkrP29_>_IROg*3 z7#x#6*v7s7PNsoik(a3%g#-NiYDk84VneKKRzT?F<6FL1I-R2!AO?sT8w&dT($1{I zBX(NX$ap3yjO62!$OSq|3rieJQuFNZyFRAfQ9}LKF7!ZlDni$L|8b*c;Jj6r#oMS$ zs~Q$->#{Ys#2Wc(XZ9x>+tMkqEjm(B1uT0%wd3UxW98%@wPuWg%`}`Ot7F9Zo@9E? zi%ndjsqK2%!7l+^lPXin@RDPa+U5;1=$2Hu8r&(bZ*fBX1d1|Hk-TXcN9n9x&Xi~9 zlhH9GE1Jp4x4Bvk7eB{Zhv;LkZgBM#+IpdKrDFqr^JvT3$u`D##m8U2s9FSfM2abY zs`CbY$C2B}9R~U?;)AUf1`<~8Q_7y^CtqoptFSEvk z?G+Y~@_Rz50?0(q`wUeQ@d=EDOO64Y3nAJiJWinju2=ZQ1s?6M~J-L>9o-QW{ZAW+RR#K^g3fRnXkBh zF!61SL+bVWTA*E8;DdeW%jY41HB|5!gkNEtK?%HA90>JOopGQ-N3a${I>=+2;{yqL zk39ws4{E>hQF%lB>jbOscjo+51aXWA>>QREN)lSG2-dyx-U+V^?rNwUjKLfPP9J?C z`oHCYh&zP$Hy+{p!RA$MxH60Sz)NF#L75CKagQ9dyK(!5;wxd6rl`k_$fUh}gaM(> zn7J#$TkO=MFHr+3i%kG3F2{`^TmyA2j3{&JV$Wzto(M+4gyzk^e+`<1WbWfd_iL?9 z7IOomO7@j5zOH*18IJWZ*v$nPB>4RpJg{|%5y$0cjU(;MGpWVy!Yk$vFG+pUIa^v8 z6UDqC27`dhHHO*21yz!Wv>!MTCYzHiyCQOsn;$gI+G_iC3*|aJl3ro?n>p?bmdD<- z$sWfMXBHgWMZ7v+9<$?9Nq6J%U~gp?=oYeeYN$_+Le~mXQQyYZB z!zuOpSjx{f@%|Mt1290(2NDd<#bBJ5NtH5|*C2VdWR#y!Eujd@*OI9%W;U`mTEK&6 z(8tP;J&vB<;|MN%{?M7KS2L~plU=nMoi;xdYd=;L+v=l)d7(i6i&U)c>3mf&uK^7N z2ol^JUAQ5Z&MEz-{5gtX4@cQ&;*Un2es_K5pz#k&N78M~RwBV~zBE|-cw{W7pYya= zze2I2O`rN5<117dC}qja{<*%Mbrc6Eoe~K>^C@)azC-0jPa7rC?Y^lFtOF{tF2#O| z?WLJNwsDN;YKcX)zm4h&6Htv63ySiE2CWuP1-~bsAE6ddWnHI}73MJMjc1&DbJs@) zyTf~gUtN-UvY8Ag$Pa$CW@bWJX0>xQ9}XpU4+(zCPysww>jCuS-~efbn<*chaS~tF zW4lCWKi?$L&11_*$yLoY1ewAfoxEV5RjcyV+>hMJ#qGnU5jPTCmRU$FZ8!YH%$6%J zdkd1l=78gY*n3}uXHcubQ0EH{mK!@DzO3=FXYQVoROnfkdTfSjhYWlx6KVEu)S`TZ zBU1^C%pfg?fGn-!YOT;%9pHX2z9Tj4GCDjij7xP2EoYq?0R{~i!;_Qna3Iw2aE@V( zJ}L-bRxg47x)(`E&+bu~HwzU7%pp<-)%f$21+)mV>CCn{l2o*fL646y)L!jPKQUGQ zv7UJ2{Sx9-W#z6DL3tP{N8|9*%jAzuK!`DZKhZ9^>|Uuy%uo%ZgEmf2 z@7v{=IJ5(5e~M*vkq@s=gITmH^73C1BXzOrvNA&c zGW2h4ToB~vHUEb%_Qg!tH(iIPrRP62Wgd*k_J!vIu;-N$f&_>0svR7vdCI?7&Nvl* zp)z?GJp37q3Kv*P$7r5(Xq18_O_?egZyMYCeeIu~L*KY?W^ek4Q>9ZN?n|1^E?(Ub z3o&Rdy3mUA06UP>7b~k=fv zN0eh%j!}${_2tvgT7LjI#Lb~Ep87Nv4`&KO3P#D*mi?F7yk~Z-s^A&o%G#>Mvle7J zGDfYPz$2TEXj^&22cqxruytXT@yh zPXDxu-C)r}Eb^ndI1TMn;E0Yz;(KnW1=O6eFJ|7V_B)ve*2D7y9j}9xE;w7fo`cuH zgD)pN_wTS2R6PQ7I^MCTT&7x?)hdwbLW*il#N#ASJ(tH1USW#?)crFmrbgS;EO~ZA zavY$H6llgdlmQ!Id<+zbiLX>bRC6&18T+6EW$5k*-?xd*eEG?X$BZolR2qFDf*w*Z zn2xi!h->^H>+_Wvyw12}-!Q}s)Erhutscgy+0=%J6x_GKUBAo6TX-d*cHwFvd~*)C z)snqb)yo-|63ob3u-xdtdIb3vc^&>w3`cP*#iroyOZnqNM78c--fo|;3uj^~ZE3wn zPKk9?1MVXP!w>Q3yNB#+JWqoQw7_vp%ns^~_X$RKUy%4dl}Y}0J#A-Kzlyp@)g8+n zCN1a1LTCxEl9OKKbi!)Z{LnLO^uoI#OI}yxuxi68VYhNo!G(5mYG>fQqTN(|z#l*d zSq)q_mrPh&PG(}Gz~vJU6I=ME3elKV%pz0 zYXYOcnL)IE&%KSD)J|oU=azdGqQ)hv-EF9)KX_8-tBV|AF_M~_C|rVxX9w)3(Jq_e zr=m&=#}_lrQ%sazc>Ju~{Wgb#heJv6)G+)ItFAb!wjEOdm>=WSqNAKi)oD_Ka?@G9 z`KuX)kI>*>a+)DZqWkuk@RnkoKw3otGmOvO~EAlJZH37c6zFPi6u_`O~OJgFtF zk4N?@Hx#fajxjq4Ca;lU9jcb@hf($)6#lj0UviEy(jQ`?;PxZe?0(IxyxRV+ZDuNy zYXeSbE(<*ih|g?Y>6T77CV55qUd}~N()P+_`22|T(^|7kyiVlEcW^cH8Hp%Hb#2)d4X_ia3Qk~ZzDBHz{7VM0=oOJMxHUE?m!-3H0I%IEHl>T0Ne zs&=>XhFbmjhiqIE2a8wePdgoZJ}{c1)Dt{_DCQ;VE zpt*}8h_Xn^>FXWZ8+lZFIV!IaW4^3oF5dMfD{@p>;)x~1#?a>7QqYJmGQ@SZ;o@HD zWAvAkGAd_Ao)~_}Va0RFh1> zE!sr`=Wxxk*}z+yRd<@w47XEnKvZhEugtx1<7yr zS)|BIgqb#sof+6vnpDW+C*LZ3J~JQBf@|Y531)dBB$OgY9`2RR<0jN9W&N}hv+LAq zpm&C{niuzu1bym^MrS9Nukf0_0>^EzRI7y5S39Gdj$aPF2uya|AQ8Zk>ka$nSD+yJ zw3!!9^PK`v24)Jo9y;Kmib^TIAFj6FPWl5NpGcKjXC3ZF2Z76&!gtymG~(JDg4B4B zyher)Qr`3#ot}t>eYmMtpG1+sF@1%jy4szllSB|hfSs#u9<*GIMn@;;qX>MYSs`}j zZE=T4hX7%Boxz2LAv-;?YvLi-D@uCEo697Q5q9r4OCu+D*6F+>X5e?T!7$BI;^clJ zdOsekGCYi!#PIn82u}3jX-&<4%JDq>$IPVrZMr|PGl8IrIe4wo#~Y~OtNj$7CkUcQ z^Yl=^=q=_lY#GJf5I|cR{3KIs*%@Pq4KV)Z84s#DxDL7|lSx~S{&G9pTp#!2~A z$~(?yEab^D^Uo;W6wM7cCnc>DUJ4Vji(D=&GPQE6hYRB}&W?l=>j~0~0u6eG@}v}j zD4)iIHdc3+6=LOme6_Y}S4Vmxi6@Ume87rdzu4`=BD~mne&hJq%+5Nf7gMeU9rP$n zbK!?FAwsZk z=Ml|9$%T|5WS! zK3(f55dkk9d0A8YBtuvFRmOL&wZEiOEmZD^q8zSovUww zd0}E+db-Xf8X77wY;P*OPobWT#gMm9ptbQK_A^=^`cq-T!ep#~z%`fTQ!QaF8L(1W zu>-WP?d@B0ul4sZtDcMNnwe44?_}Tg7EEMU$5sZ$F5my8Xk+LT`R{OId!v!BjsrMo)ND~yW^wu z>`%6_zx4H_1yXSQ`Y{FLdu$!;jog34Rj*8L)%%CtP;g=SIq4_JAHc+oRc0BPmi?Vc zs<>5Q;YTIXA~puho2R1GRmRibqbk*rjh-`AyW2X*IYgNpEqQmb*$Z2zONFJR+}f#{ zU!wk@BCg8G^_KdvB2_Eo-uB-s@}aPsm60#s42I{&tK{>aV)!O_ws$(&7;&MU!=hg8 z19-Vb7AQPh1u{w5we9d287DyVEU$l46dU0?VC~RXYa=R0O2b*T(?6E|z6bJWykzp5 zs_x*E7)nhR6Oj@_!M>PXOB~%&aj9pkchRuK*{Y)&CsTj+K33^K8LZAEDZI*uY zt%aANKjflNyM%MlYDednO-H@ZVgQNN)f}1WMK_GIeV)t9$pjf0u(`e3G6dZlj8iO0 zc2UJSmRoyNq+gw5^4exWCGev*C=jm6`&O-G7T1C=XH!&3@bcry5mf$V;dMOYnmd*f zq1q{skt`@#FixuSQ60A77?OhrHp}>S-Q(1wQ|h4?m3BR4K1#qV7K18R8rgg>>EK|d z#eFn`+Aw!BlUI6diI}TZbKl(4qpWF7HO!VWke-+FH2K}{wCRPs1g@1U+v2;u$X3x8 zgH%EriG=nvrX`Ds(?acxK=^9Wm^L}N;+$XNPRk)8zQ6nU#!0B2Y7Ca`D`Pe-vqLTJ zj^Z+DG={})V0GyWBVC50VQOwZL4X(>0tbT+IX*sc}p=pPDFUrVg~PFy}+saWb%_1tM`5c9BB~ zM(OA782rRYON3Bix;xf4D?HMw{5mp3z`a5pXgq6V13A!f*Hb2qCbK$jW?bPUej!S1 z8SR&M5b$z7fh#6?55*BZm7qtd5Ldw@W#KFZZj_7!I8N22lW<;{DNeNLV7w{jT^7K9 z`i?`UVe*cAPWaMD=62`F9MdQ)6ituk8q%wY1k$VHmP6Ev3R6Kmh{aRyJTYC#rxt8 zx)%9{CnBy zbe29IptBL7QyXdn5G`15r}+cLZKKRZQq4Eanl;h9E5B-o7lR#-4bBqjSv&LF?x%05 z@LqP)I=1@l816?qc$}}Tu`ysV1u5_0s?%h@=M!eWY$WFSX}A&x>R2w~Q0V!7i~e{} zD=&JV9G|nV$BFOx2?$kHyv4B&lR{@X*u$Bp{UoT`T+KTs*5d8(hW*VN7UQ8}X#wTA zukjhj=eK2_>>vEQ++jV1C&WdmAt+3t&p$=<#>D=lsTp^|F=?9SjW$-@)(`}({-}?I zz6(~DXk%&m18|&D$X(4TrEd$FGBJ>r$Qiu1-6A*l72NoM+T%${#Qw$m_iq#T*O{9H zWWlBRe*moJ;UHPBe!W3E~N)*qeU~tzpuW1b|2dQ9qmM?n;(X}q=s(&^J>P)Puh+XW_#AqEHXWJ=Nw)eY<|X9vCaKT zppeXLXFO^8qrZjVRz-+b^Hapgee7nb`-(o1sfD{e+fwI@SojhZAXpeK!G)S*TPt!) zrb#;H`?44s+jYI__bGa=US3yg^je42pG&Gqx9Y`kNRB;zmBD7pM#&`|kxJ^md_!rq zipoRs%WJp@JtUsh@139t&{krmG#jk5@6w_H*IE%RfuHgwYM*__86lzg-m<3q?NpoQ z)7)Ol)OMf<9wcr|zdT-sb?RrV5E_5h$l?>DcER4tZPR3p%HGB?oHI<8fL2f~-$Ba+ z*i5Bg-2g;)xHfKIMB?F?X;jxXEmD%Qqm4b6?<9lzyQws~_qvsIW#zQGMOBW>v69{O z(*aJc=)|7*hbcMCO()@JK4-WiHw|P=S>R?tv^amsu6t~YXPR5J zdY`zpN?R2~E-Bu;iygNDZ|6X|@~qZ$hVtC)KkMzw-n7@_RFY(rIYT5PthlW=+|d&p zz9c+Owt4zcy^yqM+gtYrssKU#8PFSApD!l_N+V*#9EC+wfCJA)3_k{!iZQb8_pnHh z_ZIdpj)I~vqVo6^jeT?K9-3pp#k!ZGjwcwOowFib?{~1XYt2zUN zk`CZzvhpXm*Q+Nrph@oBTDD*q$vwkZV_Nvkh^Y$F?;vG#^a2)$`NMD zP+iv@mq9rsOh8Lcr%*Kws7WK7K}afEWKr3fA75zy&0VU2b$Sn}CTX@Uxv30j z4aUKH16Wfg^+xmJfBJo={->rYq$8TNmUPYWa@x;xh@`I2%OP%5;QOa!EbaH7D9XM^eunbvRDP#hziG!jWM1%LeFP1RVyvJSye2)RE^%5&1z8af^{$aP*xZ{Lya ztmuTFh*~pouyKOU`PsN5dFFOd$t3Rr6P}%NdTwzw-;)iQ{ zjAU=9YA5a$({tz(VX~Zbqt}HF74`L!OB@CyF5%8l-$E)Fe8Tk2k`v3f>IM!pDiKr(HOC`7C419@R5GmT$$oG$2^m^ zC%5s9wfq%44p;r)E56;;gUxU?c<_OU8s%N`s7}w2f9e&`EBJ^<=25$jWz=4j%wp+i z*aP}?x610(UeOAkMOz*Pr$8KG`6Qy_wDaxwPbosjra9+UB*LY$19Y9C)Zm%!O(*N9 zOehtqn-?Q*QnJhpB&uG#B zHya!G5d!WDX?|>IX+0%b5Zm?FC&Q6E+hFzIKIo3rhHU2vRN1pM9{|Lox?>?16Xa50 z76KX{(LMj%g&@8vkGh$kwZ64|6{*rKUhwAa>|km8Vp_u4nu zF?&^(by)-p#cU(tj`73YYyV!Fi@DtV!84&tO=o%+V(rjb($)^vcS_hM)ZH))Ae$U! z1Qh$h8DHXr`XZ~w61~;H?3KCobl~(1v~g%-=wL)M&RonAc2!OD;8iZAUW0TF<&b^D zQjTJ`yXP|l$=d78X`ZsuJ$7fn{m#Bcz_(u!2rTfULEV*0SPIZS6^ONVcn--?x_}@o zC%Rf;5;msNCxfjIkt05z5%#C4a@jfg^j63={Q*6^!cnGM-8$@uKy?GQ0-^lhu(B{;YW1eo$@V> z-iE>UgySZi)>d6$C#{oXwwM@pQgr^%f1Hz|~^pUEe*sJ_lP<6>kH&1h~@EYQK)Lp=BRI>_$oV|TdJ5PZ{ z_wy40!#uNl`PWASL%UJJK(_cqlQ`YTi@pvLM~>IeLKZVt_sA9tN`?p*EJw4-d*s={ zcv~-4FW^c-KF|_o3+xYeZgqK6tbSRs9_DNwHD1S$mTBhbFNt0#Ha;boUr0xMD2nQo zTOd_a3FAv*sHIjpV}8e$oO^<8F$2{((xV~2Luc+muk)h(9wag+q;4T07(08Y@|);Y zL=$7z`pAq%x-es?XYD`@r!3mYh}r{^B*3S{X>=D9r~fj6iRaorEzOy$BOlF?u$!&(oZ-e*(Fcj^fpCI*p@NyI#v)IO&O#CeV<@*CimJ!Ne9C zLOmuX_f-*>cTrYkJa5}+U}Gr53&8aQFmQP0MemYd22WZAN-|IcJbR-dqW~U%(>1+j zNr~h;mkl0sjc2IWXbnsq5AP8>D`HiQpC^P{AP)wOeCp5AFgmw<^0qD zvyDE-U3a1R5apRYZ*ydvwPBD+&an)p%3^bYF|`YFby@>-52%UPvT7|e>}1s@*ZKss z^NCK}EzH*j<+rR)pD&M8Rrl6g-Q}?y7A8tHuVpeYiYD67bU~Li>ce9Cm>5T>0**z$ zqwMNcns@WQq{FLU4z}2qA!Y)4~DEW;&Xw_NMwx6}^`-C?IrGKnxK3AJFYT`L}-) zdH+$D{#w2+|7uQA0Cdd%N>51L3yJCZD~2J(ulc!ud}GQo|JcI*^{M?^5&L%m(&qJd z(O;46`Cs%cvRdTtQRFeC^tL&O{6YU84eq~k7IM?l7)m5P_dmrc$Zh{(#{Xycf6w}N z!@t5B`s{s#a4ru+UZ)y7+E5vv_?6)S(E8Lw!DD8}0|ll}p?`tre} z?gvRTy|NDA(ERG_2G#5{<>@m8v)}p+Jsj*dc~!Z-XI|=*H8< zvCWX?V`a)r5^JEg?38dPPg_1}82XQ>6aqHi;UKI-pv%75hW4L-sqG) zqrr{FS1|QJ?k+kIeu@-KxNI2+Z2^cNEK;V%nWZL*Bn+iaj%sPDmqL zYV7eKlm)G-I=BWCLrGq0Pa;% z%jBHx>m%~dp11^T5XKH}5!-~LYOrArF@F7PK!F@y&zaJv>L`#tgUVO^`*&(q#9K*B zRkW8Lrj&0uj19n$=wYvZ_IcK4ISy}BylH_MDqmI&^fKr3+B`408HetZC=5%qsowW& zIJ0TqOnJfUP1l?R7rof2!_OC>50czYQc5(C{t|m1Lft8Wh~A0vmiIl(IIAni)UnY~ zR--~%LnLQ)MKnL7=thPk?A9{|XCSCXLGAmZuoq8;RZc(l&q57G5WPCiI32O7MGe1% z2{ZY7G}OMo&Z|%(&#n=Q{^m4W7xfs}Jjyc%Jju`6_1$SyDSvgPr6^63K~{I1q7=xZ zd!)j(a^k2QZ=(YXc`;`=C28={SsRC5jQuMo`*-Y6p2fj6IcgY_r@hz4S4n-FVrzdx z%U1@fj!nhxOo>`74Hm~``OY#CndOMKnjch0wb@@;uzU6odA@aTKC-xTH+N>T%1Hd%hf zt?EG}JuEmW7jtq;QEl8jA24bWUnI{w{2>FC6P!WV3m01zg<1|=1d{x))(;8YTvD?+ z>|kqdv{Mv1ti)Z1P*RCx*vQSs7`2{GEpbOuIGa0&@spjA{%?{uE}sHXE=zpTna$RE z(vr~nMtWmjj#ti76-b)YF6nsahsrJ_e|^K*scvtdX+-z&Xr=tYF;Gt8NpC>HrDoM1 zKw4W$9wbenUP25pMe=jTbMV@%QsUK{qRhJQZ%RN6s#&GFMmXIlCvxGH;gS-T1?N8- zwakRa=gcpK$=&*S?59kQKm*NUc$Ds zpc`f(Lf$Erla2ILp#+?p8oZozt!nb<#XBwL&P(Qz_i#9%Zq<=b8e_y@CWg0&qx}4X zev=P%o-&`-BFl;JGoK0C7b{)&&)q?>3t`0{ml@^`L{jC^y6uAI5ganVX-7p+Aed0@3zH#i%nzW*}9BGTvha6D`kdmWxNjHW1G%e#cch-M55X2-sQK)s$D`#VOS^Zf=fZzg^BC=Ad zz6%%RD%r4B7@4-UPIZ2KX=jvs7S+|TkFOmiAv4(UWHUFwJUke87O}aHkqB)2p*50o z>LO7m%lRFIP^$*fr{pWLZ2W3S9xh&Tm3+f$wa~_0@DbX{M0a-^Wp6raIGZ`jFSv?% zZENNhhC_&R6}|*d*%t8C>=p@ePNpWVH$LxKPI@b|LuBz;N%xRdC-Q9J48yh?tOvz_ zH3$jASfbk8sB#;aL2^fE5kJwgHkXDGQJdr*>H2Fuw8>m+Ca{iF0tC}ZVguODlZb1= z*SMSw8*>4ziv5&Zb@w5M9P4f=As;giPHo}l&QRWkfJ`Q*70ph8L!J#h627Ii*J*EWQwKzJF@DPezw!Qw@tc@ z_!T2ik*nwU(LXypOmqG4Kf}6t#k95yK3bEP;FN1w?#-YFjWsW`xWA*Oa6y?6Q85NH zdCM1`@w}Du!UhjuogkKh%-u_DPVy1E$3tm^2gq!*B{L$1}g+3m-PLtkNcyD)9^YBOuBzp?ViD>1Q722o!F^ z&n;9Ge3XeYP+$DsPCeS^SP?)iJVjL@Y6qSY)j)V=Gin8=69(TNz4&dO;W)1d*l@3 zHS9!Akb;S0Ib*ArS5C$4bXv_9Fjgk_GG<^~9rq$wRcC~HTu~}a59NaX(XxKJdn9Ez z@102SmqHt^hp6y}p?3Zp&D09FoUqI&$nS`*I>r!UL)C&2ILOWYMDLnPd=NA zb1R#zKF+}OW^Byv@wtiK(Nd*o2d+1mk8`m>#)^&JjNly<0C%5$nSAX8g6WqXPC?Vo zJ*ocytlTI0Yq)S&yE0!Dg*}~Fa9%Pi}AoxZ#ish(5DHn;Iu zj--7S+}5QH&pq*9U}*7YnLh0HCG9w@ORocdjpPr!WlYJ@87*Z+udH@8B}$;rErLl; z%8r;Nmji16Ymeq~puNE$3d^@Sf#tJJZXOXH<+*nMM*x&#|o0u>=AWU<$26$lOka5sQUZ~*(LZzwq9kw^&($yop8`xVhK-w$DzKLwyrdNf5n2A{eDEz z^0~#7ORJyON0okmrs~%r!bI=c^olt+MtdGhJ2Hz`2>Yu!Yj&w>NGfOa8W~J~{otr} z?Y0E$`XYIa=VsR&dfJphFRr*1?BpS!kL+yPx zOYM+Xkffr+ea^W%E8Ysiv+2NrMjnMnq_sww#(D2#nT*9A^u9?u4)ka)9=~S1_kc|y z{qUqvrDISmJ!p?pvopKUxO#d9{2|l8z8ORv6PaiViL&j;+_*@Q3-DUalV#&1n!~6f zxtHq@@wBhs*Ka7F+SoL_rFtCkE7Yf<3-tY{EZ z>t5raa%7P&&gbgP9R3I*Jk?*a?-5C*)~eUpT_kv)xAF{19QB6Zvg{@JoKgEs{HD+P zRfb*V=X5~GNl!mvG}rUvOMzL9#`0y|eZmEmM_s%&k$z<&@AdI8g?6E`K~`NL7UqQx zYjVv!4*3yfmbziZDcJB729TyPFMk51>W7{s9(*e#})1 z?FyPyjm!Gp8*D5)lD<1C<3O?>LYSEfuX8btHH>XW|IHZ$(KUtUy58_jvL96rCYRRq z=~8<(-@Z{P@LuFUPkl+FMkyu$HpXK^F9I&p=*Y0{QG3|xK%ce$I1q6Un^NJfEjsz~ z2^)-r-O@-xO*U73HS41!1bsM8mfWsf6u)&Mn43q5j532^D9l2rBr~4Lu{A^(?cFhEV4GMzYxz?0PM~ zM6%V*05$rHP=n{3US7vuS!I>34aAnWp6PtlsYhsc-_n1jP882W{KR`qCwp4gD^S#_ zUM$>2Yjhif&g7_9)Bk>3{WsB)duw-e6$~$Xec9Ui#U8s59o3NWXL$K?!WPm6d+?g; znC~W9klvI%V3$W5?GM26KIZZf!&*JW7`N$pCfHaGBSPE!!H7zqVMoDs^m&{vGg~^b zv`9YIJTbJn(dTu&nG!7pzqmCDHCpHi(Tkk{6l^=Fm#>={R`xjl^)s&)!S1fbL&f66 zY=JkH<5g)_3oQnQ$unK3D?LdK8dYuj9qZ<#B`+MkTX|G)00A3fDPv=1y%N>wq&I|D zYj0Rs*UAF5kcKTto>sHVNUsN5*CNC`q4}_C8=+E2pDHITwDllo^%<(?`@kF^#O3EO z&b9&K`{50z5wc&PU8tKaI71dG(-`Iq9p@_~@s@mjAIz2fmPf{hM4E zCTGLWr1qf^`o_Owy!ct4w!4H`eQC>&j67)q<7RvPItqovQ@R!*R1WTGG9v1}0A}6v zjEL3tua&bGC4$ggEVMwQbDxUIpD?x+0`HM10*k&^T| zVhrTP*jaKdWGT`^ncg5v!&}hZjL|sbd05s6xyKs) z7S5^uG#)JI8PnDFq9 zPhq4gVjIRn%5>vKAP484UkpcLlL3Bz#hE6QuO9&w09101H-C*!e+8fa(3y|`q`!u$ zzaA-?CP`F)FbrV#&mm+L?f=lA|D*5x&s%T@-TuWd|0DLG4A0N~E&F~V_K!k@%oF}s z+c_xv$1jD9H}?HK0rCZuFqHqsAO97Q06PGQzop^-5tsfoS^YIy{rmVJJ zgVF!j<@J9Qrhn8Yq&S6?wf;pkNutcr{}V*~+hGo%`?Cy&TztWW)Ws=+W-uH$SF}&e zUAHMrJrs`^h!RCuLHS(SdK>muR7YCaT^o0LIdTW-aqblHo%nb}=H&vU<$)artB2-C z;zVWN=0!Lp^@J5#Pc(nl{CbFDJ|r#Ss(xF*polN_9>@%t4jAZm7oyP2`R`+m!t!N-t*RrZQ(q-IN}TXt`@#o?m&iX!HAWO#z&P$)UAl^u4*eTp>;t=WXcLac1PGZC)Fy zrta{nzO7!(1Jik1W6IaZN{J~`Dm!Vf)Mx-Goz($PvJs(xAj>!!C&dPfQZ|?LWcBUO zdgB2a|;Xi;>fiykH2vXK=-3 zzLtGvU$dPyGBxE&1y!sF?qDH%dd{A=429WC`yxUa{D6!Zv*$GRNS-34MOJ&gat|(q zE$tL)nZ&vTbqa3!^!&1b=C{4Ly!YV^NDiCU2V1x^ikH(pSlLo|&8JMjsDyOO1{q(YW{x!;=l*$qDbUeuIecx2oWXDLMoW5Dve;=L)Ra2C=?Tjh@X-8ifAE;-G-n>-3sOkK1<|g7u$Hz9<4PU&q#lp351n1IG$3YEOcjlU!?#4+bVPk4K@2&= z=K@S$+O3!^ru0RvY(7h?NZi5e3RDipk4F~!s1$W?rf2jWIC4FC0c*!o+}_+?wBk1~ z&H|O=H@uSK?}VAG(|LiWMhMcjIR7{c9i4*g2n46{#+tI8`e*fMo54rnkvDCX+Kdc5 zxrk$L&WK>{m*{1MZlGdS)j^N80^0>YZX^F8*K887!;a*V{eyCl##QzQf(hNdo)BW~ zcl^(R9@Rf5bN%(CQRy?3cSe-zCkulKufR}3;u*+ME099<=a@4mOrLQJZ%8yqH)3;!K z{i<{Og#?>vKWD87NLy^@hrwc!%HIeRe z3HdR8Aa+*S)T|f#%(VU^MnBQ&^Sd9^ORE}Hh(?P~iPLd8l@zv6B`aaRz{-hI4Fo%{ z*rB)meU8GLx)A50AU%^u_2%~s7AxtDF}1Vyaj(+-f@7@X=rB@T$4E;&hL_wPOYiKT z*Oqp3r9$@iPPm?H>40welIe)+M4osHxj{dA0myJ|a2e`;ss2Ge2wDiy6 zpKS#hz5BSpwF2ef_q;++4qj-6P$|V( za;fdOkN8brn%NU|kzc2|tGhk!n^$Hz0b;kX5!I(TI(<{J7B1$ce*ny+p+Rg%R4(SM z1~Nvc-0QFWg*TV7IFG1(FCNmr1vC5sh%o4}!~{k^?V|FlC`lm3iO-&Pv=bnrqrbrj z)-(J`#;?QJC%G8Qx@hSG4Trv3n)IGi7u^y0{zBD$nkVi;4f+zAP^PyKX%8yDL{ z)vL7zzVRGYuvD$(6@1U-T4u9vpYcW`_WTO!Z~7YTey9e-7T3v1WhPi|p-~?pocA+uJ+*Fz#K@* zK=?#LSF_;Htl9{k3$Y;c5Z2_RCju9jsRg&MYat2h-nYElX0l~E3uQ-a^%;ipjbsUA zWr(y;cyeY}gOU-P*1_Vls-xVG^3kf_HuEDx@P49?7g=s>N22x3YjlYo+F~VKyuwd7 zmS8rO({XVgn4ww8u6yYUStRFf_UwIJ_5IF*5O%6<4#mOSC!}R?dqJxs;8HIyuZ9X! zLOS>9VsOl!-|-nctn4jilCh?}@aq$cIV7ksYE!OiX+(s)QW2`JR+#m{J=u=Tv!m>U z2C9)GGS^-5`q7?mLsvlWs;wn`TI*5m1;k4XUiO7rcF0aU30%C=*Nvk0kaiW$G_=0* z&LE>VHm~oNYi!vWyb_UC8KXMHlzKQiy1rOtNvSiht-Zk9&XnwevKbuZrn#f>Hd?R5 z7}pA3%pnac?ad?dHmnK!N?vxXbE1We6{p>28Hw5|B@CY8X)V2nNWeOSrqoC7litx1 zwhJ+W$xRgZ3TQ%1)WBVo@@#jCOJSJFFLnY9I6$p@u`E+lX<2XD zCXg0~x$%bAwu1CtMz}#HGYVAR2a!jC)!Nq6{35 z(SaPerH*)SAq}i~@hQQK+Ym%zX%U0bkMZXWW6ssyLZNvPfVKQ$QuYx+_-pVfx zbE!=9<3MlV{C{k{Wmr@V zqlQaLcc*lB3@{*FGxX3cAYIbZ-8I0_Al)HdQVyLW9fEX&l!A(Q#`oR(`}R54`N^7D zi{XL`Sob{7{rL4SSz8Sa@N}f-KbYlzsOHeob{3!4FnHbH_9bYXX)9`raJ3xT^`x^x zGa&gkZI=|UpD@un9Z}CrJ`-6Xw*9O-!L-lWr14uHt2sdD>(^|(!pq*Iy7r5gg`KPN zq6u>mQ#NZS2e>Iw-c2WafpD|6P0VvG{ZkUoopw_H zE{p(9tSrZr@dl83@04rg>oNfY%!hPEyh0V{AF{bV$TL3l4AC?}zA4ybq&&)Y`gV45 zfbO}A>#*(i+}!+0Y&#ff5J_lilrKC*cy-w~xAcg-bq7i?iLiv1iHbd+)=yEvNl=N` z>6`?Xv&)udee^a}=lZ z=M56f;s5M!=J$?*s2NFs}Z*_$sp zCWXN>i=`mxs-Zy_M$Xj>yaNMAaI>LqajZ3C0fnW|na0dy&l`nO%5Bh$n9{4>LUZkf zZ!e@CcbK~Ik~LeR$a;VDwRf}8t2*Wxc_xb`(h6sB+S`rAU7z&&v=b)z5KPhbN(~+o zsuF&@Cb%Iv*P^ai&hRGoiRFr_vVU=M=r{%umQQcy(-Wm^aWJqW`CiZK7Qt$x7q>>& zN(@P`#-3@Td64fe*!MDS9FR^Y1nahcXfJjktv~s6Fl1%cYHOP-!ySCjmpDCVWHv?*$dK4#-y(Ez{msf9NALCA| z5~@&xD}%Ugu%pYpN<9+yYYQwdieAz_O1ZBj%{Ny~RQ_l{weWKkwX`w7Q480{w-#$CY+6qw#wfs?X~DVFPr zhYOy!E#_NHc@_Ua#J4e>+4PgmqU8zL#`9NEqb^?0nw-cAJ5hK#+Vr}AV#t66xKmv+ z$NLxAuD&0Nwz;(fw!ack)vS|z+l)NktWAuarEhGY{rLi$bZ*n?HeL{mOovcE9p@&Zx6qqSa_qj;B-Vd3cd7>` z<7Uu&mrq>svltp8sdSGApA6)k35T@G9xGaz;hkr7#>e*;1PAf!>mEFwOl zs;2mtDRqV+>T>@Mh#_#!rv=1S|49|4AfKto{@?oCzZXHImi|JU|It-7{O7W$h>QN0 zAsr*p{rAQF&+(+!1b;91pL5H?aJ><|x&K@V_1_oyw@LT!F(gX#zkNDHY>D8{^3Jq} zF4pqrpKF}TLISkNXZ8;Y|d>mUVbfEraeJ#j)%{9&)zGTyiY7M@1>H7BhSkB%q|6k zUlb=sR@67R?>LCEe&)E)>7p_DV7%q_c6v_x-oL`&H&p1$u1)%Q#plyxx}z_(s_mJR z&x(y~9qPZ#PWF|M9dg)L9yuS_^J0~sRXX|+yZ)~B&Gw-A{w&j|aRNyC8<(}DC;#w} zK3t9YDtz?CY~?TPAD>Bm%Z{$<+NWVa%YL>4aZ*7H1*I?;^W3VQb z`1>ee8S7F&oU1S4ZL*c!(&LwP-EDf+xkua=o;2mIGUvMElY28a@-9%n1^A~a2ejB5 ziQK(!B%XVK36nUPuvpO*IiQL~?$FOotMZoE8n>uqoW=$&RQL(`kD(BzTe6De5Wvoo zDM9`KA3W@r#tZKv^+AQ^@tj!lm}^l~Zr>H2V%6rB@ZVS4`J|+s>plv?&KkYZ{eq+3 zI+C#&65qn?KrisWU@DjBNj~VOmS|_Tovw0H=tH9;&vGd3G{*?9c8bcIWoP4`R4FFO z;e>k9S1mpmwmyB$;S>mOkB)5+b)$t*nESfjtg^)f5l1dFM0< zwVIr69@$idx{arjYk1N9OC#-3BAkM}@nD_r!-%Cyw@9TMqp3f3dL*D{?krB(t(?EQ)Sx)o4=C9np)7ID-G!%nh zcksi%PGobXOi7=%BUkLLlYxaewP)PuZ-EmvI${u|DH_bb9(S4p0(YN_R@%ZYEa*KD61oyob z)yPE*VU$IVu6U{LSQcu|`*?4*y$=j^p>XPSXXvhD3eFoZ9KyCtu>!7fUAGcB`IUj| zs8f4K+8@9as!T}QxhTdYUh7m8>6g)a!rI_jqbB_T&9_h^Cy%U)*XCGF3)b#1*!oFS$M+SqD^?xqbcLmeD|A@jtcL~Rl@D)hUhDv{-#GuZ*=&Yj*s zQvRFh(`G!p3k&5k4G+)T6B{8u-KlP^=?C~+mPZ;xO*^w_%etgJhpE*T{q#&feU=H; zfR8bZ$9;ZTV7gp_GIhkHD52W-yL;J6@uy)Tk9}7g+}cy|S(-aq@U5e1dP|8x-`vvJ zLA{qvnSMg~S&1Wulex_WOBLe){L_*O9pX0UbyA-WjyV{l!Nc8CTq=y??COI;#Kwys z!VcGSG)PhE+3clVnR8wy%qc0$`7poKmWg4ZiYoh_(}J9EHxsL*eb`J8tgYsy@go`? z)g1;ERv-t|c6$FXwuP0WTldI=0M6gJ|0Z-6$!nKdB+u7qW{^Nh!qv4|`X z-o3@xwJ*SH)h)jzkOQ;?eOKf*kx=(>lp-7>VSiF^#9xP>P&(>*ch&dW7s+H%6`+{1L@fw&k=eBApX!Xcw&@^KAMT?|SfFZ{fKb;M7y=DXLOvOG^(naT37k#lQYSbwY_@pV)>C2iN_SOY%*xUoVi`j*UNEhLcM^5 zb&8cj!T^HbC(`DZCl2)PRZ|{*u{7P4E!GSnmd5yff!Ec>HC7wW5SyoJwNl_N_qumD z)V`cCLEVTMmr47`w2|e3=kL3?hKjZ6 zq!oj_iqk3@u;(3iN0B(ur`meZ&f18b)3N@ypWD*%SG&!)@{6y(G0Ha7WNSBgL()}d z={4dUF_&~s8Uby<9Y*;v?yRm@<*41OWIEUyK~%Z7X&9vkfGskRm5lf1M?<+O#Ow>= z<~%H?LdP+M0(Y?|U34lZ1E+)C##e<}NBg~9HdyA>(+$F|IW~mrVTn5>LTTENNm8N< z(zV$OOr0d$ojp~tD~fkG3zclW%i2I-UYB>g7qnG}z9XV4L_65K3hs-nUZ|yWyiZx5 zmdL|fQ*}z`95g5p@$%)aCPlc{*$VG0)NR&9tlfgKPr{eF5Jz(`lLZcwA5AD>iqFqB z>mEoFXZbQT6%YZgILx0|!bd6&L9^Vq;`gdH*4%63rGjM5mj+JSvea|+`NgiN-wJckmx(B!OE8tC27{d}RO zYs&@dY1mx9N5q(dSh~^xVN|{vm6iCrzqK^40a4oTfj&~^@vq=!*2Zm2TS#B-WnbHS z03?SqJ5lJoIF6y^CCtB=uGi(d8jD{*Dq3h2C)AG2K3wVE=amxUrx^Q+taLEiXNV$HnM&4Qcfk9dbd9;n+3UYu3U-P(NZ zTJXM>s3RSCec{MKwoO7%eKh5YXxJY3Xta%%JG8hSk7CR3ULt=kBTiE6G~KvU!$vBhDGoFBEY>=} zbb$b5GFpTYU(fenlfMVYNJ#mb8lS$1fvww$@)BU7ivcG;Vb(7aH9*nKF`uzzHhhH=g%si zpm&N*H*G^a@G5pUOYKW$mzoogJ?y^k#L!%5I#{bs+DH1-y|Z450lUyOE1U~Rpr!(m zu&T~M?lszFW5@nsexLvvi}h1u9)gD7|O!KgMN(j4l}8E*OhnCZMq z_hebl%#!D2t{(l*r|T=wV!-gjn96X%)Vix3wPvQW~bbiXTGpi9`l%F5<4|a;Ix;NHwHJA1*DqynEU-1B&?QFM$zN!5^!Kit z=DoBBPokZ{gja8aJ|Z6h@Jg0qE}kXH2G;|}G;u!jM`Y`3^Pyyow9>uX7x^(nGGP{5 zk}~$`WVAY|A_fUe%v&xWnBk9S$56xP0tLdehFs$Hh!I25#-TGkgXieKYW%g!KlUF*WQ`F$d)9O7vdE2QIwU~<^ z!Y$Ye<7C-?Tm2s909;37?4eyF&l_?)eBN4{nk1pP}_zgg>39g#PE3wKe7U=_hP^fDyya-k7%mhibb9Dt(MI*>b~Msc%w!deet3Kh@!Iz4n86)mA$!* zDr{P!p2t{HV;gj+A{CWsokvSStI{QO=@e02S;oeB)}B&`DFnNAKCbxdJb>@v?^3QO z=#sWm9Fi68?fU$1bV#e2vK@Cz-@FxdqD*$e;P(MU^H`gWTGYi^R8M0W16D*uT3@xS zPOIcyT*h?{4Sh+|&5vs|{r!#A67v@ub;Kvg@UYZF3lt8*6I;YFA|pCm;ur+X8I(n$JOxrX93#`A&e1yjH52XpZD0Kdqx_o*I{PP!gG7TM zEaVuS(TEb(4ubk1qC4$~#}Oqj1Vceoz_$Ocs3B54s9}TN2)Q|;MfT5t8{!BMX$%ST z1d$1PL5pNlj9760JI03SpKa3%AW@`*pQ#{yD=WrDLhQT$%^v;jgZ&Nr1pEyU{X=UI z*Fik{|2**jf7~wdl4EGu7iR$r@aN_5{l|z6Ar&m$9%M!Y$oS!djD>UrN*hH5tI2hG#611>U);n zYp|}sAOAA#CnSIM+km;c;mk4Xh|!)^g5Cx4;GRz|?OtFx$75Vf`NHu?`HId;4tz;n zwWM&3YU$t;OH8BmbC^ip1CE2W;1>C?3z@(S8>lzdkjAI9?3$|=6q)KP%uTIt)oV77 zHrCA3k>OmjUlbiN;4M@8Vzj0p_D!LAadniM^iVv2OYM|8l{A^ri8J2QCSLA>!h$F3 zP|mxkO%~_*GFC4>yDqSHPt^GCKyhlkdzJ4GQclzfnKhzobhnWpY>a6A=Q?#$P=^3N z$l2^gix+|6u(mc7^<{-z2|Zzc^CfG>j(jp359QrWp+boZ;pH5IVPjC!P1DJoikY0? zxt6m!A2F4BF}T6G0RClvD1fp-^>q4rhyd$V*W!ZQ2+e&&LdHR@Z%kWr0JMJRTOjf> zOg{@z&v)}`7?kfh;F`m^BafOK;bM`xt_wA=6SaeZOemGhtKFbW?j6Bb^;*`jC#xIp>P(KC%=eQ$TNl5i7HFYYibv0kjOLf zXNw&uA+`Bh6D8j@6C4ruAv0WGZUicv)5f}>jaQnPT%~8EQln41dgZCN4FsGWfZY_H zFSu(j{RG;kikd|*ermUEkSGWn4V@JC81yJ9>$9w)b97;3j$SqVDh8}I%;&kVu5s=j zbRt^yb2#$UA@V8At2N8IQ`Qzv+eRqax(`n~s46b6n+OQ)1$qnx&RZ{E^+W^?mitJI z3oMq|#HXmgd+wN%+df^Rn(cvR@47@rW~qUt+I>SKZvlwrWLO9SW!E@NrZ4!*r|+tY zu~%-Gg4|=9t7cME(otl)INxUf^BSU{E29(ix!tv zQls|hd(=%nvo@rx=BlZ$=Z6YQ9xx~CEmY_oFs8u&hfg{lyuQ4Mx%zRh*D-ns#e%C-uMGS_s?siKx?^_P^?q<5 zdJd#6LDj)J!lzTvJG+({fx6{pODTv1{CzPpMri8sGQ1X*7(||7piD!LD%X7u8#}Ojt z%m3PN$&VfFBf)(v6p6X~+^|imz4~o0A~li|2%)JAP{C>JdVn1qdZ-Lr?t&`shaU=hcYX5&t1t4o)wcpwZ4_b_m>vv619Bhtzwkz(i#%GPB|qhAz&jP zgi(oLkZ;s=WY4y(KJIjbnny@I1^I~GGNsE!x}yZPu{Bj->FDjx#tyKP8fYCh1Ce#B zvNlv}^@t794Gh{zI~pTK%)jb5Tz2#@=Y=pOy+-K-%v99jPXhoNqj@1MUvI)+nWu>N z@A(*PvwCV7$5#~laDfdl-X_KxC^CMCt9c^Q+uzV3InnvWx&QWl^gCg@AdqUR>gpFM z#PmCigSFX{v;}r7g)A0*D(~IqlQ~Rl!>8cVmuuoe^lO+}+f?M#Xpf51Fi+K_VPJ^_ zVY_GXT!nd2u6$vs$tF0D3V*=VnX;$aV$`PuuvyVZBlIQ^Jaxn7VO-@~sb#iPWCn|! zG1Y|?IV?w<4$ri8Q?iBkF?B%RVr(7lN4ZEaNll)vd4-_Jr=C-E%XYrW)aed&FGU4Y z+JYDBd0koa*=#u$7Kxcoe~?6q<>^Jn$d!Sljq?PH3-+s3T@5lIZ_9ng0sQE*X4$tu ze)&Ab#H{1b8#Rw2Kjcb+%X*><$``kUN_|v9oqs!ls*>uB5uAtXK_9wmQDFa_<<_x z+|RR&E}^YX@xvy#Q{7}-xjrblFx3))IXf!?UOp_0C%7dqqgkRNqM7KXQSUDw7!vDh1@S&NNWjrRF? z8IDT**>sp?kBkAZj{U5{x9bPdGJ=z?%|nYjO~C1MYR<0cAc#^sO_)*xZEGyKfoGXG zHjNjD%Y8!);4E~f%^Sa6hG?lmuOI`Thvf2be#BDqXb>vYw zd)l0{cwVbImg$n7E!zq%E27x@6(K$g?f)f$PVWP%KQgz4?1*jcSCW>_0+f;*4T}vb z6DI=&yZiDXD81)^*wQ@0b?XrQ0vQpAe4$FboVV$|mFDodY7lF*BfkiRR`thnI?~F+ zBBj(keh=Jk8GboOI_fPH+Lpb{yk;~r7U}k&$;_%zl6Mny^MLX6keqji?UQxR{gWno zGD0>zy=jxTwEo5>i&GMob<+(jZsjaA&jsA^08-H0w>vxsie#151GIIoY7rxM)u-dx z3VAdnx|AUAsFqBs&I=*cI0k#s>`GoTb_$?^-0E8AEa30o*$qX;2SczI&iM)V&fWqx4J zcqU!j$$(KB6`puJwkBp)o?$Sj>MdavGYqIFMJAWcNg#!cc+11?O9A6VVaaE&*hT#c zHXWglk^QgG(r%+pt*eh_thm6C$`xkr{1Il$A=QgknDCpU*t;L3UbgvQ%}yjod}VnP zLU9nWgLiz?xd>8PJ#T#6(KO_Qr1aGFWlAkBmg0 z<08?ZO}74+{y*Ig4ZCIeF;zs++nC+_BI^eSp&{v2o8KhJ-xF)s0g7Q@5;m z^y8@)GRKs4*{)tW+Imj9ULo97WgqUu3Y;Zmu~$D6z!(z-O;_>z}L=+z%Lm5r?|w0bedc`z?KQXEux zgNQSm_nV<_V&7sMO-DT>T}C;8UYm~^<~F`$_?GLPnr2??&vP1~kij3tW;;*ZwmuZJ z^80FtURi0oyJ|qW4fV)<533ne=;Vu6trlUPcaRvI_O$9+;uzlp`_h7r2JGbRnUG0i zV+N?Is_NC22&pkwxBo#3@(|Qh%&k|hb$f+(Yw{Z;$W`xj{JN>1MhNeh_a7wxZ>KR! z)h^!BXhm>|+V4Q9$%wfy#jINpqr)EIH>x`Ugjo1l>2n2_?d?aYOR=2qv2w)K29c$y zJLO!Ec_zU{kY8oq&_!g$;ME*5QF@EQs+9+x|D)#*R;6w|8po9zK`Ts$2j~&6B`U=N zW`={%q`ZzZk_hVWN2>rA&00b)QK?f7xi4Nv#Dqgud1>U+8WU%9O@N$Aw9`6F8f-Bb zbi6C7Q0!zeo9mTP;Mfr+Y*A?xUtx$*BO5-QUD!U@ElnP$sp*naS}K;DEgp4Rxz)pY zBBmRr`vdAu*Uc7P083(y4HBNvD{a9ih^+a|lRd-%wMr1vr zV9~HjoW6c&P>C9=kFyNq5P^f!Jdgw}!>=ZtggHE}y_rqvn`S}UhvKW3dbOPC=p4wL zG|1&jESs2AlQnO~91h~wdY~?*J}MmeP8NIwB&g!qN;vT#*_1SD%?VCA zZxP03hZk_)6hXPoLdA-AHIm5PQQCDZ?{MFX4kUQ$aqngGxl~q&anWHX=sysV<#x?T zsw}4AQhc1t^Sr6In(%JrS~qb-nE)$AL0*k-oi~joS$iaHERA8)8}s6&1xqW0CMkQi ztk9DBV}+=xb27F?L3uNo-@);1+T3d@*n6*e%Py0j0Ly5v4d*zYwvc5RR4B8KPYs*f zQZQ)CQ@lS>ixf(;8ZanaC#SvLW7Z!bqqRPERMQ5hBz3r8)JDfY44sOgcE?`bHDbTy z-NqTV71rW1j!Ad8l`4})yV*#YSPMbosa&Uj52S`Fj;2tmbr$%S{n}G zW|D3VqE=lZV#tz|Cxo*X&#|b`Fz6QxV++_Itu@$_uM!*U+4+89s#!-*<@n#HlLTX| z^%wCqZ5B4uhxpk^B3zeDe==nx>}8tITS7*lAGs`0;u>c5Z$iD(hw076Cjm(s{0{cT458=j&0`vGF8?TQu! z2?Yr;WIu;|@jtN|Z-h_i`yBE=*yj^sitd^CzvmzX+X%zY`u`?q{)TC!Uj8R0^!HQ$ z1uy?LxBl{-{})O6|2z+2w*F6OND&F`FZ@A(oWFvfe?iZG5fm^0wF3<)^v~Q8_{u8x zFw=g>iRHl91C40zCw+_%*kxc|^r0#yQ%bri*6sl8{uvA0Sgahz%^NT2;1{bmw-L9b zxqWhas@IXvjrWwsKs&U9&sol{QShUmtONwI!q4PofH~<&dAHxC)R*k!CG0S!t9tNr zX7iVtYwCpJ_1r~{HqC*z2zTOLIC-j^+!*;KJYX&uIrGC$I;cGDFX9D~@#PP%)+a1m zOPpNHdeWQ;3j1F#4d_e)rgA(xRPLMslTCF&BRi5|X+?vJYZMwAIM24pI89DUo;~?p z2~+^6Ri8$HRs0YkuspUIJD=HL+T2M+uWQAwZDoC`<_Lgk$4h@yZ$tFifn699;HEyk zA&zZ0k~Rf=jE@$a3(rXjBOlKNuc`FXOg6g{db;iq>n%{vf69u~aMdhZSL2l4Zt@jPDVpS=WL?o}C7NEuJcRu3VxU!ABnG@3 zzu%s68~7af$#G@tbpm6$ugKnNwW_Q zy6x~J2@{uRRYwPzEwJ@<6VP?bLb;D^qr+bGjZohQ|6YL=q0G3-mT*t<4fY$k=-!$; zOUuu@k(Z3Dr*A6aqi*UZOkb^1F9{42Z-V|Sd-AeaSGIPZs4C|7S0r{X=M%+i4*|n*?k$ZQ45+$pOyr9Fw zpA2?3SMK=uQYY1`q3MC39Zw5Cg8fw$z0n49!gGPTF$?Adn+ENR22rUo-k4hAcZa`R z0lS_Xt}gCxv|fd;?Mbo6&`(b8Z#i?hPI4Me z`z>H?>uxTF#F)`Sol0 zTlBGma`^+@``%o$3o^^v!vTjVD;DCND8BoQa4*1XUZQmE=WNV-Fv z3HqKkh;`^^T^(1UM_Ofcn=$)>#!ih&)2{WCUo2RAI$K-c{k_eDLV)J#reaI5e5s^b3D(6HYi_PCa*rD?zrYKKR5_)*h)+e#wd zsl^ls42j*mf%edMZqr&_#$fmiC(j2*&0#$2mJlVhwfhV?+H^&M1#UR1iC)bkzIn4Akgob#mktCBi;m^r7si2~Z)aD3 z532-Aqn+0`Pkm1Z`_NNZ?%`+?@3XD%hEP`ntMX>o7u{sv&;=>m=FkJM9p8+E2rvzy-GuP#^&o%w$Fse8|Mnm@rGXmC18^(BFm7nS;el7rU}jbcwk=c46Mq-w_=Zd=D!UUk6> zTMY_(ETJ|%=9|g%Ahs^^OxWY*Up$5bvpF1pJ-V)OVU#Z>M`hA)Z3OSE8oZXP8$omi=OF9+;~$y&pwqT^Vtt;rGu(UyU-29c*7~p&t=xU zMx_1WY*vPp?}(!Bv%|Tr(Wp)v`}nFg)1tDe$}Dy9C_%vVt>Y4x2|)@R_*#E_(f)@m zBm-R39i);#66h{_U2_}{z21F%NojaQ4R2&>m z)W|8XwU~3>vM8j{q|KDPzsoZ-EhuLNG(%)H`+MNC)a~`UT2RK$$_iM2WDXR)XZ=2w z)Re{rqSIVKtwEI^DAe%IpH=LpJ7q3wCg82OoufoPL|$(BKJQBcGQ2j=d9pq6Q{4SZ88;yrJ<>V z^2N5o(o&LAsqB4nyM6RRdR@yQbT@TFB(8uxbgvnxa*%`)X)sn3+w(c}!OF zSoWSy@@~W$OAmVD5;E~5koD}b_iWqNV>;@mkqSDRe?&&1roA*E3_sG!nR4f zr5S(ns)p&nt#lm82XKOCv_nh4R~o1}up>qL+&0e2Kw zftFr)1T4(XOFO(wG$@z+vcMcYgYDr%iVqDfUpr ztIgomN+|~9P;Qnh8W5^pXM!szgUf|dF(@zz7bm9g5@TH+=vwj6?V$E%l zCC8#eS`AQGWpo>D1!ofFS-Nl*Qb+xS+C4%&YNhHiEl>BNxG7Fgw2^XQ_2b@?Q>?@ zL9%is;c5@LcQ=acqgA|+qIPLc7A}%29zfh{v*_Ri3l*aMUe8;YD;jt@6Q(+F@Q|Ze z$Q_7ndc&@Q`9_5~9K}ggQbt--wVT6z&e12}Gv zl=WE<>me0lyYll@h<cFoTi$VXY_iM#U!>U z+fIKqTYY47z*}$R_{rI*3q(YTIJpUjW1hqDS3Yxf=vAMV1&0WHFX;x-|8%3a!RvJN z-h_+lECW|Z*2=`don}<-@#7Z>cKW!lHq4={o1EMHtM007Bhb(Eq+fe zE&Qxlnr3$F-WZMvbmif5V38cY{Aw1H-RFW)E;Y_i&86CD#q`1I!1TBcdRmzX)}};> zNz(HV$D%6>s)`l%M2LN=CWTgJk)gM{&&KIQqMFooJ6ZCayxu7honWDz4+$G9iK06# z8O((~=h*$MJ+jL+SI2YIlNlUx950xRB>paExveE@k6xW91=N02Eg4jRGhT!))eKW{=<9QgQj3(~{&+13PCF zXaf)fk^f;GrxFO^G7=kV*k5xpRv4nP6oB9$e<=;R;G#Dw_CKa&LL@@W7YI@F{~rUv z{1=PR$p(=A4~*IS2ihQSA(~VFJoY#B@;6_zO^7)E-#`rV^1syOpOb-qZO^Dxh%VLO zGa$maoP>dJ+o1j5{u3ezK&&{f?oJd|AG^i zNqEo10%!C56U(|}gS5Sfh)+!p4&g4?^MH$>tz25W$sp+x0C5wl17x4|L!}b<=H9p# z{^(^CLo1u7Q%X6CvC1h~| zy;}tSTv?9%Q^i&K;W@}%Og}fq8aiT0nt8R$JY9cuz=-E&>x@pUju}ysh%*{Q%KHT7 z33vID2A%jTqbwC32e`jB!=d>HDX<3XTg6>Am5N?N?e_f;PT#mxbo zuv&l_tYQ!agz*{#Vqy7JwoDi4@mVq5S~@Yj+~HLgn>}$`k)P-QBVCsAPX_H04bxIF zb1dCkAD-a~EWJ+py#wxF86fjF$nD67N z$;d8?;vWWkpbHgeX6dGL8sVeed4O5rb{#uzRDbqMfp~8W)wAh#_$WtTa(qyKIU!TW z<>9P4+ggM28_i2Up_Xvf)3zHOoqWCx4GQr_yX5m}z7nYPzz4AKzToJj2IphTa?9%n z12jYwvyJ}vS=CY}3yvbzuIB&GnlA1e8_=Pp+s_T?4E^)Xi+ML_!eVFk& z(w!)e@DCD&R?Si;MBXZdhs|fOe0G67-3QZGW4LI{eU!?hF&V$gy0KL$bC_#NP^GfB zBC&#jl;qfj7gN`{x{8=-?~+be5#FE{9G1UXX*Y;EZSQKLSUuBUMjS!2WCt_%VZ&k7bKO|*uKp;k*YU?k+ukh<;CVkA4(vq%=SdSvtLYH8p_Otg83 z|1N6~Zq_Q@Ti0u$7s^P?W;!upgS+9cAF>}ZXHxveuY6jq%p4PcN?O~W&_hA$W((q5 zz7Z%S3J!_*COW6ux4uHH`vH&huI}3=&La<_8ulgYesBuvi-zmZL*Yv`TKi(i4rm0U zo_x7Hf4@?R6mA@{j`-=d@`n%Z-`jt4f; ziZwY{Pi&j;Pbst!Ql(yz2RrUDg?E}4wvng4ChVhumYlA`A*_IyF9fV}9=7Uxn!X>( zIJXR!W5R!P>F1b^4q6Z(H(hI!Nw0`o81}?$2BpT|he@D;sBX4=M`#?4iV+HlJp%p*f!GpMtIW>P41gQ;=;t-e_jr3Smq=GRFXOQE*?w`Jm+?!}9Ej@)N^$2YF)$N=>?YHO)P>n*AYf70gHD zUZMhT$+_h>-sr8!5O0Ul10uGuumv zc$Gh(av2{6vz_tfAGlN_8qSD0;XM3J=7?MG7QLFWxQ=LS@Vf(NxY;=*na((bep2s! zU2Q|Bo1CkLb5%-*fbqJR3JSXg+SEtDsoxSgFw{h{`T)<|4|B2RUG*z)p+-zTA;QO{ zD?XQ1JLja2LR=f@G@!lxj8?;sctJu}{F$8*>iGf7B`kkqk4{(KI{}D?*G(2RQ(=We z{?!carR0}!5Mc+75qffJsx(Rux#3Fol|`tujhH{p1D&m z*yFAO{~yNQGODfiU)K#*T#6Ql5+t}g6e$pb2PsaWxO<_67AP*k-66qUf)*%Rq!bA* z#fxhNYu}x|{jamuK6{@r&exfl`7lQyjOUv7ef^?@HJj3>X!SgFJQcMV7sZsB#)Q9c zYpZHObj4-i#zDMnX}&hxqA$S$(#wFJ0sgNam5w#kSZ{uUYSLIEA=(|6zn=Fh6utH3 zA~Go8o7h}I#`tzkQ8B6&w~&bY7!u&NS5!6Xw2fB)ohhk;WyNs8l#aYRC~j}VXXKUE z>G)?{HAi0O%y_1f!>_4q&K!J`ilAD(>r>x!QTh1luP!-hY_`x_t^R$LIBKU_ai7=9 zD^@CKL66P8*Lf>ugo$I+Gr`K<&T7i)E!8AcuF{OAC5(Dzo?_fi#n!b*0@*)ctcv7O zlDt|K&-3en+8L}kNu0tlyyhv(e82@Yn~fadcaFjAz`dW*Y-J0uatAs|EJElZwFc>~ z_r{VF=-ND#1SHBjM9|?%cEn3#XGH*!+enW~M1wxAz0ww&M;z7qZu**tAz_TJLR+&p z?^#X5TYMa^4aqC?g13xHdotTH&b!Ey=bdxrM9F4QuD%>n4vrg>HrcJ3w7QoA))MVg zU;5rYI>CvqJTQ%QM@Vj^zTV|&Z=0k99zZKSK6Sio#zKTP&Pc8?Li*~TM=`7OEf1LO zv&A}?KPVmxIu1+ZB9^7Pt0y6by}>A2Xp|o36-+lKHzKY9971Y|wIQ-YL*mly9;90k zn~XkOV9!V|aTTA77HSknr*%yQNpDnd?;^Y9C& z_yhFgvC`?eP$HaP5+RZ*bEjW$o zxB@OyhBtA{2W0B{TRR&*PTPk>vugqKMSsTD*|@%F6IXQ|;v7DR@$imP#T`UGnUC0~ zu(2ZZ+CykdMF?kz_(DW5&IuxTo$^p><{E>vH40k=-X>*N?nl?28r}3ANIlC>UJ!dI`y=$}QSv~kjX=xv<2BwFO_EtX8H1HMSUI^B z*YDnDlg&~`9QR;5cYh4j2H~AI=#eET=RB3u$Aj`hvk^GNA3c8Kox~K&NPtt)w5{A< zYKKxYGooD+@o6TA>2;;BtDZ0veXIA*O|d*tFqZRvK0v`+*=7~KGP za$-Efg&rVAR^76Yl8NYupGYm?C;b>6r<6iITwq0}4O|nMY~D^w_K1$q8yDm7nw{at z`UdZx+h{XV8+2osb#RZOOC7S+S!yd2E~HFhjZyFdd)azT4w2R@lssr`I6xRWzZV# zIVRzyBxVD4#W`UQsIUaIJrSib>tcV_xGcd(0s1!N=|Mb{t(dy5B_!A z5qULj`oy{Y!5HVNJahu8VnUvA<3&rMD1E8B8pXmMiM|{+{@u*cKY;z@PeLc(Wh%2c zIU8l%O$N~amEKn8ElcSU+OMW7Q;kbfM+T1eRGNk|$A)`VL^Q6K8rhfZz8M{%j zj^kko!s1do$;~!^vp!ye0}{^T)l~69kr#~(*Zrx(D~xxi0!?$insFPAbO&RzR#9h( zqFRl7a;u`J%=ZE3p~no97B9&zSIPHhr~0>G5g?+UWp$@n>V43t6_XG9#hrC5{e9)uTp5zIy8>l=WDK1TbR*Gp+bBaVMBol&_ zeO>hx@xKaui?ZHid=B$nsq%UTs8p-Ld-VQ87Q3Gct|bjtIrs&?1>0hym9WmJKEe~# zRL+semoXBs@)m##wP|dVP>J9w7ULhkUYd7K$M)W#^Wx4(?STP2@+YI*FfgaS*Sw9C zy=|;o=-QoTED*fdU4@>;K z`Sf5zHY!}U5|2rfl=HZpO`X7)t|B4+vD%|6h&nALRjt&jMC-k^sQ6kwK7q1t8n?UG zGozh+w~YsT($k-wHPN}M#}XZmBgd9?{3O2g6*6llFIF>{5i>eaXSY7|4i+F)V@f75 z@}zguP&X@m93)WNy*VcJ!p>?CPyb_bl54N@nIAH>Lms%?7ns$wdHs@a{bTKxWIAJ} zu!*NxlaIHygh4%1&|EWn7`dtAy^n+L-7+Z#JwNGEo!PkE;?PCUjNYeJzD507*7P>=)4&0Fa3s3%Vnm?%JFFQdW zrv4xGqrU(MeTn}>WyJrkS{m}|k1rYBrcwZ${67o)AN1vqCHW73!J0>-r|E(6e`XY6 z(yI-Ta%8!2lk#r8eLYuD> zTW&?{*nx1263TQd?W8!y^TqII&Q;u`fo)STgu2dVWrU***U5C3hILg_SN-Kb09W=W zJrrD`{xUGpD9ZC)*Pk4_1W`(dis)oK_r4zwWl9z-Zxf>&kse%g_%{CW(7r^uS$eK& zjN8)$9YHmEDPpgWT0!z_rVZ9c$BDhABUX^YDD@lyu27q8sT3FoA6qV@K6GtOt__gD){y9-i2oAR6gKeux3iMcKk5ALs zeNdkR58_(UA!5VYId20L>nrL?5!x)$= z*~qG>|3S%VsLEn6avq=$(V9|Nu^432TjN-`bSr=uYd-}M64Gk*$uo(|zva@3EyZz( ziZ{eu53m@*NQ+>4r-ji10&6GN)ap5ah>H0p$TFZlZJEB+7F0b^R{c!zsq~Hm@3;o2 zAreA@1-4@%<=rLx&{r$<;r!a+2%AI_-DHC-E3wvgaz7BY0w?0bJ?rBLOW^_4M$qy8 zM6NhIVKT%*kW*nUo|siBK65SD4qqJ-y!ypK&%I4rx!#NLg`U2ZCh$G4(HN!g#8O*+ z>&lpn0g+}`1c%iVBls63jCP3!cgANV&h#^Gnudq2-5PdUTouL-J^9L`tiBMakz6q- zRqCxWjQSf0tV^97p{F#0w;ck_4Gjh=d6bDo;bg@V7|)iM6TdJP(cRp>OC>GR&=il5 z+`5bge zoEhfDU}7vuPf0?*i6j+63pMZ>#lh_huD2r$OQ;Cn)kXd=)Oab{%E)dc<5VNg>*kdj z8+iJ{JrhOY#~a_}JC$F&PyA7yaQLGeqFDmCNdo-kEi>ZAFA5vuq@b(O5SVb&sf_C2 zlCCHUKWgB(8>nzAW`AmzE{SN`BEzFqipD1Mix7#nn%I(HPSYUJS0S!c-8fobRdUoV zEVq%8!o`fU-IWfhjv!sbQpjp~5exD&p-(pfPf-c{^o#sP2&JJkUFKFHmHHk?^2`K; zUCY_O^S0MmS!sHya!fZRU5*>!fV*Z&4wY4uilM$9A&I`%hxV@)kw>&2z6v8({6^SX z>^#^>ewqG?(Yk46gQf7LaGkt#oSIWgyF)9f|hV`@!Q zIa?_Gz~HZ`xWytsQbs&(4^}Lb`;=`Bc#WO}{I0d`DVrG;T6)Eed;~pqYN}9r3H`#= zJHhyTb?*aDRw1^5f?FpAKYd6m;=9#nzFtYwM*eqi12x&=-|o1&V(wnXWyGz1VlZoXv;sj=`T=I zqa@qWJSQYZ!fcqcAg^iwCB#TJ!9U++7ms?0iN{_`_r_X0E|d@s=lJ#2^dsM_K~4WX zWS@PzQTMa$aQ1U<=UTDPhmi=Z7-sTI_3sVuhAv6*`g^d(b#eXuOln_GXw)XZeHTYo zNIv9PEG8BD3xR5}H#xAwMUlyYX~^LH2|oig$1~hUTlj{s(j){ofoDa?#!n8u3Gh9J zO5KGqd%KyrUo#~N-yfWJX=;gbJ88!}Pp9INl<3I}Ct>sYsxMz+E_Kp?s~A9%+q7tE zW5)`;igsL4ummKA!i;r4ZE=5B%DBz(KJ83(U1~dLS<(AS0?(RtBN@is!ZFgSdzEb} zWph(Ud@@ByIN(MYCzXCW(;5>s5SMvYvI#7f4ia7*D0r0MHwEly5C_v^#<2&|eT(mN z>#WOWc)caB-Ja)v)NYM>-p5DcT|>zwvXm``)MBJAeKa&_0O%9G2IVsz4a)0ENhap{mZx9Fy5w=|r!T1pIt-z*JH zLCzptd~$y-Q#avzij4m74Jv1&HSb-8#J?Pp+RPu85t%bk^U^A>iZ#4Z+|dn zH7{8x859XzMNwvDQY6TQEQn6;%4XZHteN-M1Y-*rXFjZbO(3UfX>(4{6D7oQYZc%p zLpQ7Xt*cpGw>djn5KygTC|TW(bKe#oC-J5HjzAGg>2ZYV@BeOmi)yTb61eCK6Qu?n zv?Fc&0-t?%%m1;k$J(J9QE4(=F2N_f$zRKL=26^!os8!e3l8K;H*vY$4=U|KQ zbg5Rce!(v`c1sh~6E>VY@KRQPQ-XQRqS`$i+AGO>ni^XpI=^GJWo;ThUDt`l7A)^+ ztZQG9Qs`J%c=x=aSdo>DjkEcO90uAf*@(88lp`;&`8c=nZBnS3e2uas{6K6)pYR)< zNcU(q-As#?Ez>giT56$9{CF31E<_!K#e=E+A~Pfik)|us28>C12mP{ao%%cpo5*n* z8}VJGU3R!dI<5+6sG?ejOeLI;fo*mE(HqB1%sK0 zDV$S-5-Lg1n960XO*%LKCEN!pgMi5i=bL4^ig!@8Q(iM)>O;4X=Q ze)>+$-HwH5T9?kpf1O-V9abeA+q{JGaIr@RF}VWOiQ5~kq8vqhza5SlzKJto?j&DA zMH%HQ7>uiMr@Mlz&N?D<8Nixa&)Hi_Xn4~}DLd6R9ZyTsc+Zg(KY%>I+`)>|6z_u; z5pfwx^=@L8aACSY9@pXr8?f?ty`y+UD+yi^=_d8?s@qj)Q@%A~hsb27pSMSvYMQzc%m>sPl$VR7^6{bE>vNV_YhTXuD5|~lBfHEg2E$Q8(=b<3CEiyf?1VT%UTP!E z+R}#kAw4mZ0yoOS38bndTgUaGu4MIrAGS)}FxD3&VBSDgj<7!AB}II#UakaGh6Krj zH6yJM=_)3=2hQEy3N5phF|3WZYC4@d7JgGozVpYY)k`GrxwRzS4ea-GF?}b3tRqhn z5z6LBR9o6zI6%Gio^?k=b%-NlPcDm?W6QAl%d;#6A#!FyKDk&A8sc06h@ zBjDiSP2we8o{j+(<(`+3tL5lLjPbTIg}<;Lq`ZZDlo|_eGDHSE-fQWyfGjgAD?z%V z2TM9!i&Ab$-=+!tOjj&e`E5!Q+uyr~l&kqFTXHL-``7~{o;#l_ zBrii0?pPRu>WOx?c#@6xb=?Ih`+z06d*jL5o?%4N-1kxK6p4Uu0rwA)~Z<& z6yE#MeQZ9)9bbf_E41&GAF7zmc75<(tJsOS!(Y0o{d=Z-on8}Q2{QBhopCU04F6tg zR>aNsT@_RvauFS0qEX@!@ulJ5H#f3l#whw0);CvBL}%lZibO`RWeB%NR!W)sJXYgN zJE%LnS^@h3Lzery<=yRqzG@{&T>S%h`^d7G)OwVXqgq3=r7KWZe!AnjFTBlsL_S|N zy}vdxMT|`!^&36;{CF{Y&=m}?AQ~y6?tob^%-XsPcPr_i+54_?uDU)f&yJdxQ!{8u z0IoS5KdrCPQ&!kdM%^BeR5(#o>veM2R=8IF1S^sA8zMn8Pre<#0w*UPW5rF&sHwc?if^3y&3KY$MfpMBTKTl2AU z#W%X@t8Oyh07GOWlaZTp`K5vG6FM{}d}eC4VEQlMsR2gX%H0P17I{@yRtZ>XC_20G zhg9HWN~6br{~;e}qY0W`{EI05oxAufOFlDEUi6{$JGMKgGvf$`Bl*r;jd+i~}6*x)f zlj1KAVDY^a7HK^CX>EkI@UTo>h4CpuOM01&g>Qrs!^raaB&XAsw5pqC_-%X#x;+vg z?p-BoR#yBn>y35zuc;+a@Anrm;^G$vQYgzQ$_FtxPbq3q5pSzW0y1hz1 zf!KXa9(w(t_U-B7z)5J%aa^kK8o(K^D84x_DlX=2FH)RYKbCKl_~?|-s!wZONek`t zvlxuu1uN+mxz|N?;)A~oGt8{)JdRSso`ffoO0Pb zxw(Fm24T-3al*@~RFdMd$e(2A!Y1xT9Exqp-ae15S*5Q}gIS%m@ZhdC+SvMnPh;)p z<+AOR4c5@EK1J`ht0R6$I7KE!tmey*<=>T*XebtRI?%M#A|ymNa#R7vFI zX%+P8W|iMzY%Q*vIbH)klL)sO(yAXcu}mpDHP7&7CArQWK3KxNUQk1Rs8;W z5t}{FKxf=V@lohNR%%^KF0sqxXx=y=BRk~ zkB7={?(#-fGi@{_x2wP&tYZ%{SO}SVJR7mf)i-MGP5O>eaatuy%~VB&d>Fmw;T@$_ zk4t)GJHFXN&AM15Jc+w;MFAjXgjS@KpXb=tvTrF% z;A4m2(Oga`x4rOFy_I}-!VP)abrM4GI?*`U#Uq0Pev)tM{Yj;!5ymjZiS=*)HH~5~^@r41u#(K?jm~MkzY=c@3l*At zfe)<$xjFL#YcP{aQgpN~2VUhcper;E;k7;x4Y*5Lh!f)lNx*Z?(3u3mqg{2=sT6q0 zs8q=6L2DcAy5?&*Og0f`r2@obhn&}nR(BEmuyTU;EY_!A>1OhC!ek5fYOaLQ5MPOoFi2um(S0?+{PtA~aSzmQncWsRE zbbp0^AOhTD0-X;Nr~Fu=iDKW6m+qG?FXYrRuff`V@Fnjt+dbXG+$aJ zemZ}L_BKz~*fXo)FNtBGy=F9YyV(yf}?r_()c3=s#t(OCK9qn~!?zI_~Lr79C zANAOdl2W!lWmzdmeDXSa{OJ}oV5kq#@l8A>cmy%$!IzSyF+7D39ZIX{Co1P5h44Ag zoK$DNzJ)K7A44528$&_*d`ra5Im;=?%-$ov@I@jVeVj&vT;U_lF6-8Zg`LHRO4>!f zEqv;ObegBAE)M9$E9icWcoME3*9)$D^Qi5VNcM+Mc$VyQl|N;mhc%aeb6R~>{d2_9 z42M99f`Ot!e+@s~Ja?a3b{xnY&C|^}*a+bal+<=hPVqO=8jLe9W??3Ym54kxWQ=T= zVKc`!omwrN>4o7KACoO^H|xmscEAUP+QmNal? zKR?)x1}xv>-6mX}8R0@i=`-11-F_NY-1Cte0f)_px9W!uGk_-EPJLS+TR(E@@Z_`3 z5zu=#;z<5%%Nsm=84-gKIlpw;_dtbxyYhZR+Sm47vyqZ6KF7M(@cyBZ>q5ivVA!~w z+z#v<+X+8@R)$MA@rN4D72zZAK|Qn=6?g3cKpI;73H>0)LF;^FGTHm(h0q7(+9*42 z9XtHI93_7|<#DW;r5e_9pk&DiK|P;dDN+Dh2sZjCz?C>j-$ey?=3ac|rNPhb_f_i$ zH0FMSPl%rbm73Z_{jrHs-0=IgVl$4TS6+~1J=04DMnk?-Vmd6^B^nRaJWs649MR2;FO&T=SvzQCCKmI z+Hp4)J`Mk>TkxW;sqwb$;W)-vnQoSb(T~VAb!1*ER(bw}_+qgZt0n?c%RaOu2Ze&~ zvBj6BCx7JF_InGK%~=;I8KgY%WslXIwsxhkpM7iAuY!|PU8nHNj5s~HSQi$$Ub6Mm zcKYQw#?w0lg8vJBU-mF8!Mo*`6U;23!StDdI6ODV;4RmYWaQNiABbOsJ>2{tIOaNf zqneCLo@wUDohP4r&x7n5Yt#1;G@Ze5Q=~rzo43S50DeuI_V98y`Y1huklTpBkXd2* zgPhS8l}8d;hX1F^8nV^p<~q0M*8t&Y%ulqgB79n&AW~La##IHjT?T1?%hb#q^}R0s zWRHevooycm>F~iiiel+&Tz24-YWVmFYRz3g)OI}p290e-@`H^+X5LTMA`k%`6=LuI# z<{++5_>5DSYL;cJT8Hc^dO5|q7V3d%GP&$>0GJ`co|k-_q1~iWG1fZUWrPKOHA9S; zM1&~@1_(@zO5f>{n?$C)`xVosEyywf@{SafSc0u z%I)xJL%&DO(mJZ34o^RIXVU_&tSmF=%m!0iq(;r?UUw=dM@hc;rntv@Whs9ZIgk4R ztB6TLBDy}h$soX)F;Z}g4m{yri$1`^UZdu&nsB21VAeCaw=j)$5_Z6lr}6|eFcz4X z%L>wtR%tcu1e)F!GKP!AlCr_MeRPdJe%l#XEVCAa^r2h?IA0?d_Yqj0hLu3% zZDaGG76plHn{qjCxIE0+ljq z+#kkbI6oA8DnphXJ<3)K`lL>TkXIS-BaH~xyO5u%j+c9D^M>i+``vx*j4I)oj~YbS zta#KAGTtP4I#vHbG3x0NRnV#)pVn!*z114?uvAqd+iBNmE96AzWE4lv7UAQ02s)tJw~iqc>{n#_^)o_L!tF{T zwdl#++=YV%pRu+Ll3!R^Fo~n%w^1fvn=<5IdnMz(1 z)N%MDP}-AKOT8$rQ<{eOQ&h6n=QJltW`{2VdA%>hMqVp*+?U>EJd5(|E~Bs}pGjav zu3&&5P;vkhK=pIvCR+^jyO6BTqf5ET8;LkEI&M4h{!~JGYkXK9Rsfm;U;r>MhKc?R z4GQN12+f9=0EoZxxUeKP1ciqFHGs^p}#>fkr7gMt09ER_>y|pbgqj=@^=CYXk z)ciQ;=xADy%cjDb$SV!ZU6UYLv3c5*;vL`j1&W`rxBTvSXm!3is%{~riJ?nDCL}G@ zzu))rjF4o*J!x8tO&FD(d!nQougEe5XYA7ZTVqWpRj$Z`SIchiOY7A0AQ6~2Mmo=O zdvj7f)`(}Qp0m;F%p{Bxng;2T*Y``86zY0Y%rODM6Ff&tAfFG8<2Oq4)U2QIKkrh3 zoI4F>ojF~<{v3#72tQIqsJqshOew0JI9-Lq{qme1WL#D4w(KS}RdD@2A>xK4vCftC z$_}V26+peeaiMNp9x@u=s+n|-HQSnXcp$CICn?}0sg(vZ1ms8D9P?wnKa@!Fo|NoS zmU>4pFSGr0A&|CBPx9m+ZyPTk#!BhM`jRAD`_S6GuqT00t?{xPAXnOScJ>jsjTAS=dBTUYnf*Tc z)CyTyN~#0GHS+%9hhXU7UH(lcqop0bayktGId9(RgFaV*ZcfuqAr&C0=u5#A2Y`JaPs10wC zT~^|DL4e@{0eAG!oShP9L&sS)T}pY{WIUh5tk!|iAEHO?)$}?wk_dG&2|T+7bSpi_ zYfkbeCP+4U@+G~Iz1i-2R_->Hnk~b0D?r-f2bcB$fyR-l1tAOFut$C@&X_nSUr$F2 zN;>lb*cW#@5-xo3M(>ZbqCI{G!d73$1i(8V9p+gM8FH++J4mDEqxGy=jp)t8T|6iV z?;nfGe>h-p9{k4cqr}90vHLrCMGf@wHZpT5Kc~%E)6h`CNu8DL9^xMSI_W)^c19;Y zK8c9oVz2<9Xba5N;ilL=Grg=P+Jv5XHCR9t{^W5cao0|+)n*1g+T|o!`y(kS`?W}d z6eydW8w`Q?9SWrNGdzNiVBP(ivI}D}*sk`I0gC57+|YizMhqNkwSXD1Y}Bad(R6t<7k@ze0d982`r8qMjB*rb|C~G-a#eGL4-D<+EfIa+B7Lo-6fuD$ zbArl`i*U8tdG#j-ayNY^n00xL49_o-wQ_SipVXZ`l%(X_a8(mB>7Hd1@={l~~KYtZ}ROVJm$?>C8x0T*FfO3Q~bP#@WLlTA=L5q*M(vuCoKV{z=tZ<*6e%W0>| z_+LRMC1=MS3{pZA7K&wph`jQZqacHy!#ON1O|(HW#Qab2l$BDY(?K~AZYU|?4~{Gh zOX+8U1*b^`N*&q2eD`d3D8R_gfE2v#@4J|t&yBCI0WzN1DEv8tO|;t>%V`U9nv-o| zVL))!!;rHx)N?VEbz9#wMdkAQl@ecVTP19YDZxl*54|>$iXxoJi!i3QE~PNj z>#~gz{>iEOvh$#=BnyLyTnTA*2+MtG&OU?dOy2S3Y+tf&1`qa6Om&WRy0}EivuMr% zF+`WR3%~58B*z3@UjpyfvJM zTxPS9Q4`CbawymgdRKOsiX8w%tJFgu;3WUVO?coE_6-z5*mTyUv*zWrQX2ycm^cf6 zC${uEWz67`gMm1qt~G-2m^2_!=g}E#GJvbU?m<%0h$Nl-)|=%ra(OtPzM>Gq%R&%-Fd3137g~*{jn&2Em$q3RAtiP2RAR~tmJM1LWP%2aMjGNxdBwh z{-Jyp0m3`8nk;cwRO>Y74J=2*lcp-F;&R{Wh+>74g#_ey#L^-FVT$dS^K2SoiNlnV zSsvkuHaG%Vu8`!sHde3-ygFeXSsoe|j1bSaymYx1Elv`bf*2#?;yPzK9 zm^@hxq@s%@%0SHkiFZRkV46zvaem0v00plrA#?%6)nZ88C{kmZuw&bEN_=;_+b$=X z7%SqDTvVf%QM2?E-{Oa;f4|?3J`&O8sx`>Ru0_ree=z*?TS>-7joY?Ni&hD9=oqh4 z@m?&1gh0}Z&q7D|6Apb|m6yVAviC}K(v&rielrAMLrMiy_DrX*FdrOmoHPpv2`APF zBefAyu5K6MA!YE*QT!0RB$c_QSXA!KGNGiq_J+8nxH6ZmA8Wr(-$Q(9YG^1=#Hiub zI~U;V>4DN}@SD6XMSX2d)f;!Vip^U6+_HD}D31*V+^Y~`CspO){nJEAz^E*8mvmk# zZ~2BiMQ0PhFf#7L!emzR4`A!_MOfHi_z7*-9gOgIrJyKxzs6=#Vhx^A0f;4wiveb# z0?F2MNulPe9c4~}F-X7#^*@&$E-PU$yV*V2&*C~Qg(5;Y5f7fDnxazX-vlqx$yB%> zZUxs@KW(Y6^m=jr@kLkyH@m8L#)jr#7`6N@_1jlZ9~%q}8g6x4YZr@CZ?lf1yCz`y zk-s8-<#!%kJIzmq68vuERQvvO4pcvwJhX}8r|P?{mqJusoT_x%)}=!HMcd;O;YV)0 zLDc-=_MnlPo`a{Y{R)`3W?=tEg?b&f^gkd~+~+#Rfyd%)RODk%V=3wk;Hz17r;JKNyDV`W5?Ac*?g^Xy0S~Ov$L;* zMF>4!Dz=cg@Ejy7_-X3?<9_aFVQY9U|I75E7Em7f6@`A**o*yJ8}~OW<*N#Z1`6UW zGS2jk8F_20OCJLG&G0d2xxZ@ie5*I@E9BFPid={`@$R_CZ*Sy%^P+0Nax#fzd3Df6 zuaVWMc@4!_n)qC4(!LTjaPUG-x`;g4Gxty@Kr*4SvR^-0o(v8X2U5>1>{+9PN66zMQ@NAwcF2QKf!Bqb=r;{fh^hKy;Po`3 zyrS{Hub$ONicY?w!WiJ;%hU?TRWXRKXR)dgUEDI@J4l<;GJ#AHm&hW}-yW0S2FHCj zz2A_ntiDW2wefz+=W>i* z(e6W4a^!76e%V zj+k!NH}{)E4_M=o?6rnMrkC9{35AUfOlAGdv0!B>$_e32!(?uLo~n>0+>sj47)CsorncPdWOQ(nQ0cl=oNC)@ESQx_`f^0EvCjsXpT zGzK#1%D|8KH}@c$)1#NjiVROdp>)Y^JTtZ9J*6fc09dHO)pF37ls?FmNU_*YKRAGilQCB zT8m`(La79j*y!rVAD!vu{$Dnrgic><{&AC{GZ$0n{rm z0Smw%EP;(_^7n0jOdbDwf8;!Zg@~=_{|}PD!k9%b#PA;}$X_MMpFqYRMDf??0U#?4 zQ3E_eds(s6(5wDiANl_P6KKLCu^uKWUKvA`*Y~t$$WPXG$;u z#OV5q=bu;y+7pYu>wZb!Z@3tLCg)%|lDu>2!~JK@Zr5|oujlI0WySLP32VSu4>@>! zghh?V2gUr#&HueE6f2p!VsrO1BE%-HMUmPtidTH4scfL!;_*j6;+z zGL3YbA&5RG{Pm0~2*$B_SRt;oq}NlESMocFpWLNw;;j2aj8o9_)s!m{DM8$@w34jg z4OE-Pj%YLcXk%Z}mh5T+0YxR-2gs97x}OHOq`bfF53jrLM%JAiMxB|nBY%B7>kh(T z&)9uM$JgheE+m+$D!Qj zw!qC^9dNw+@d=+bbaQ(V@^OSe)4&_?z21%%gA*h!PxmN77DCSt&-$#JmAwUr$9~l8 z3R^RLaoHF}gT*;V+{4OdqXtXSdN^qp_~u;tHwSK?#>cI#q{@u#A-3a)SIISOs}4Vg zUQcMRnA?;a;G}Hfd}9g2i?kvXn=<`GgIZAqTCY^Ps4JrER+ti-TS39Ktk1w6UiSs zu#9zS&mlgJ4n#W3YG5MqhLjPv@I=XKD+uU_-fv!olh7Z3Lb1b&2^EgKNx$NwRfjJT z1tRZ65`g&v#P1{YzS!6pnE)jh<)0G18o>;YKkjZBtDALOJa&~AthNTTNjh~@hqHDM z9{46s61y=>!FYcIf^8#2!>d-}jPHwGxH4lzVhd1By+rHpu4K*Y4bLFurG4chP) zz}9oY;pLfZF}eGMpju(&3a?jTEA{4)+iqRll+OptH|1WdSQ4UPdUDb;sqW{&%Da`Y zn(x!E@CvYRTO=d^?0wj9C=iLLi{bxIxu@p-#06gS41ooS%y%BP=&M!mw; z9=y*Kd7^C6mx$bCbGfSy)3>aQp9nErlyou%&`avK1fj=zKMuT^erZTDRE0zu`{2qgULDyn)c>8Da%h$+^}C|$@|2aaJ!%29qAw#wEU=j^526f9t^9D zJXnf_lHLqc)?O8hhtKIC8R_1P`z!K*dMsa92YQs{j5zXYO?7EooBaG(VC`L7ky~e2 zl>8KOu8oVp-Qler*P z>BPv+LI2}Gwj4(yRO)IniR7CLF!s$+fOexP$tRI;=w#KEXbX_JB`M6~oP)A#P_o!p z&@}>-wCF_Kgm+pAI%5`c)5(r7P7B}8f}I6GnNPd{Ep6d+%Hzp%w&l}AfIh;Lbo{?o z%uw!dg7fRoJAK%Orrc8u3QD<939`k`zCH>C_14_)K*}kfnvfY3#nig(D`gF!qNzdK zFGOFtft7<9mRivteZS4z_Rl|M-*!-u<&N_d@&}7^+%jvpFa$!S8y{qD(z|vtW_!6Cmv@$W8fcGbn37-l zQ#O*I5=pW$pt%?t%)a5LZ|Hra&)8n%aIJYnl^GX%*Rsj*Q`ph_Hqso*mKLxDO*)BD zMN|nOb~}q8rXVH$*PUl|>vU>-j3sO$14IyW{do476s?-~66e6DYmSM<`J5G5u?4~% zTt>wg;#Vwv@GKeChO$o+7TTkEcc#mUd3@>&Wwx2Ff?IkL+;zrCTL6ac<-uD?sEs44 z4l=VRGvlqV$rS(+zh|rLso4gDV@2;bpu0C?bW7|C|BI@(j*9C2qece=>F)0C5QpyW zZV-^}MjE7J=Ze5?%Dq*&eG<*43i2}n#kh(P!SO2`W@U}k<#lKKnqNO; zKxoDrR^kPwMny3TDprN=Rp3~$BvT>6_5Rl^k$1BinMzVCENuzt*vtK>(u%TaNahsG zCH4mdZg@QWWNi58B+SYJVe>0iDZ2(X1!sBOCl3Rr&XMhW?>IGWy+8Rb;GDH2?}L0h z#C{6}b7yC!(iD%B$fjA#yj>2_`3verlnpH^Qr`Z~ni+_hQX%peB$pM}!(050cvZSz zn@%x>L*5dh(OFEri1jBmqekvj1%ckWO@1G!3o7GaVO^F z&zo#D1=x(^2WZYnNfU6Tbcq)Yav7hr$?pRt>kv}A!yh`xbL`4#N-PMGgXe|eZ3gJ= zIPj2@_>$acsEy`Za^uU#A>hR!t$XD59JQKrpbR5KHV#8v87F4XEX1Z*a70H{ce&3- zNR^iN)O@>uNn`7z(dg-;uLNIXDa8(Ek_P&MyDZfnYK2ZL1@*nZ4PgP*w*6B98x8b; zg=f9Q9M?B|#5c88+k+WvC?tC3HvTCe3tBN8JAf$GLT}&bXo+nV#C)_*(Q~5~P=DtnC>Da+Onm-nH{{fDy*8 zE#mYGdx%n^s6n+~X^iAeE@VTsl~I(ee5*%p%|xlR&WqH^W;@=@%x@*lHO8LBPCGobUNNVYpX^5{>gHt@wyNDFcH$G$ zezCZY;|{7wZ*K-e zmV(XDw{0M$Ddui-_5PnWr*WMu4mgg4HK|x<0%{uqemIq2yDZI?%{Q!24y7jRb=(1O z4n9N~<~1YM{%WgV3@Lfo<^Fdt*tj-|J9hH%*Vc&2nJz@$es<3J4SW#Vc^wK?^?jVj zeCmynn}jhTOLxQ!12dt!PZ|t2IoG;{LZXYr{&%oc)dM&NANMp_^NYR&qYGp16=fLDHJS*?(Q1(l`GUudT|izRTjadHb+ zj#xx-qU82E;+keVwvl~k)~HIzVqeKJSxNO)MF5>of*{pN!?AOE8v8gU|I3hYd|0?t z9o`P?_ut65o2w_Tn3p@pgV#fo4trS|+dWcg;fuqohTl2+Nv!bT+b5waXz_jG){_!g zwY8l1ZeyuesRnMpnZ=nfU82I$>MlQ3$V_!1-9*fItI{&5QZwB2mn*=6nUiA$w!eRu zxM_|}acHTW3F`}a1B~5iq_{cg%p4<2lam)o_#~=jViO`{33c6d7ZxrewIpS3s=qB@ z(7r?#>j1XE`0xpLma>Y@-Fpx+!b!9*%9TPvp{Cf6O6B)w?9l zt7;@QEx<*e2YS1YKfQm1%1h7mQRnAkr)?BgkM&LJZr1xWvpzSqpM#?T@Qpts&5X=F zWbflf3W6T48Ha#pN>xF(B5x&@$v^}M#g{vjKH@8SiVz!nbfGGeyS@SK&_g1{UgU4g#Y7vIqR2JG z%+b_3-w0Lcb?@Fv1{YqlR2l=6B?J`igwAEJ9`w|{;NerCm~ zp<>}*l|wX4703Ckeu`Tf&N+Kq+Qga%*sxy)V>{`ru!>U63!53)T=ph0SYr`y+fN+H zbbb+c;54PYEtYjq<;{WK&CUHd0JGrwS^h^eEY z8#0-K5*f8bT$L(;7k!wOLZvjJz=)){H~T;(YG0!&J_oGVNPfxNA)>quT%Cp$ioG22 zZ~R*EJpL4BT1!^X44biBp)Ol3M6fHK zt17a3ahZW+^z%-+6FPT3O=SH(lDkWG;i;Da_^R2t`bb`GAK+1Sh`Mpj*oy*1Kt=$a z00l&g62Dp^(4<9f+(3}*|9W!&VR@iP1=@#y9TE*A7ka-eMf6EwVX9f1De|B@K5p`!nnf*=Q@UI1hOl+{0i z|4s!~f&jYTaKNoGHTf3c8w6kd9RGFjv;Qf$O1zH~@LX|2Bkr+5L|gL3TOgTVwbQV6$sum6!VF*IZP!Ei}n-oSbeWMFz zHrPPPGppkZi|lg>@dbKU0LDyCQ2pvsd+LXz7mnQ*xe%X5{_~Uitn`-yB?8Y+JVSp$ z8EFHLsvDltf|o+!e3nl+>7OVElcaxJqV)d^yMw3{>bKw%3|r?pb(9 z7vEARi6e|(pA~LDdFNATGO2uD{TFl;A>9G-IhC0C3tD|B|6IItL{({yb};&RP3dV> z;`A@bgjkxKbxyShPExMipS%+N-Z-%BlHoV^o)6(R6ZGzdla~uIS!_XBk1)mDPwB2* zw*wz`Q&|m{bakFL?hMw#Q3xTm2+_WJhyC*vOO7~3gA$eBMvlpD9Qe6omF_5876Ao3Q)Qcp{*N=ZtZ;R|;hnT7Fr zn0aq&+pep&YZZ%Lg*;JMnLb$!YXR~|NT<~&%ljwg0)tIEM|-k0D- z+gzw*Q}kpi(&I$FL}%c(ltoo!AJ$_RzK{xGx5dAp7D8X{_yb7B7rCF<``T-R(J%F6 zofyoRraPJRI|3aJRBvz#=dw9q(Rv4AvBdXeUT@w7`A)g)_x6{niAw! zb+(y|jul>?Y!2a4?6^KXO>lDTdZO@Vmdr9EnfSVPR|Ik zLuQa5DiW=wYzapAn1bT>|6>8iCeusy9a3 zy_ny|=s|>)lCyy(6h+FuAhWO=gXy%ZVWjS}U1KozBHr{tF<&7?Q?yh+nRtaRqKszb z!rg#55f%YzaUKq7wlsb6?jb_!j+J?zJ6G<@dp*1CR=k-mSdyj+I!Mk3s~q0~6r?Kb zD+2|;Cki{pHKiqU2EKjs_a8iE78Z2m8iobd;85w;>=V8BM}>Vo4MOf^ z)Q7i58MyN%8_}Xt3+^pKct=Lh!yxL5fMAZnpoP##)z!TG=o;cRZK!n5;fLzYu0$Y< z;Gqf1ftW+RxOoobIr$3s5Xo(g6L{$Z{V|UWb7+GDe%pS1orHoA-*c41BAt3l<-KanSF7W+dkP^vV7q#>q^i? zyB)tl?-9LCozK}Dvw&<;Zet+2w)fq_q2o*gDPxf#eGLoc-LQ^W_>Px$BPVZ;~03i@7inn z>zjDwF@mab1An@w=IF4RZ*{aU1xqQR)t36l1`)=t#+r|7)cm$+NG`u2tz=xu%)1<{ zR7If_$FAzse-^q9B9u0)_TZ1l1*_ENwdmt`>~Cdt@GbyNleUv7sZX3_bMpA~J{%;J z-*yYt%g9PGN6yj?Q6ek}`=~h%JEY1uQi1f%6_IO!Bg1kY{H&caZ=yE~xqhF|MOtXS zx`NuMb1UL3%~MmPT(#Sigcs1j*@?B)RFm%X7lds!!-$};DJP(r?D)rOKMWFG#*u=P z>b zY2yw~jjm8#3@M@32gp0c2p>Y1^cf_U5rJaQjtWU~GOXJ8N>dL!FNe6W%K-M_CtkgG zFzrs#x6RKVI#6g&p6OCmQ428l-kg^7h~D?OlT4fElnhUmB%ki4WJ)h1%7E-k^OGLB z)4A={%iX*SMnl<~q1Fg~lkx@%_w$-a3weemrcfHNj-;Ns?5YUI?!->5(Gd`nCW|uc zvoUrKs=m2kkHd(%82`ofxslldNrd{dnTzsh4prtUx60gXeIk7fKxK}ZZ2iiCox{3BTAL^-8(jWjH`}ibi2#Ka$8s+_dx%`FgT{*P@cy z{7_5q#mJ3i|C)zwZNcz8wZ4pl+9894Ui)WWye7c@^C5XPR=}i2Jc=So6vcW_=ITow z!mOuksFzEEDh=9jV$p5l7g!{3BI$SBgm%X=Q;Yea)$EZmqqVtmbhy5Bc@K~Bqfv%F z3Q?{KXAu$>*8quiu$vrh6PLR7bw=ZoY`v(IQT(3DXSoW_%5b*|rD}{6?S+d_su*R3 zDGR#P6b42+lp(Pcli74)mt&~RG4?-6Dp7IL`eaz-=wS;V zT#-veys_#6pG{a55oLzhLif#Qi`zn}sZUB@;%)fFesVTmk?Ve8&{}X@H^FuLHC?ZN zUlZCE_SssqTR#x0G>w$KfF<&H;0^W+L={9ucaZMAKd{_>`52)gbg z@3+*tb$b-VhTv`FkSf-Za(VD@^q@VXD%?8X@8!v6WEX<14yWC25zAae$1(Cnsn7Ep*(_Xf&dq&p@0~ugbj5#L z35lzcWt8iHrm%HpGpVT5ChKjwx<(xyZPsXBE6ZfL##&&x6T%HwYd}dVlzq@W66Io| z;arJQe6T@;$wU2ak{Vi+K>f?*BMzeXvd9eQd;mzjnow-qr7YKPhv_|Qb0QaXRmf5M z5pjN#A+bS10gD~?%*Y-QPQiQ0zaXosJMk!J14uHEQ{?fJ)n!_-an%UCBU*l>*ctkg zU@`F1_*XE5p!fuNI5?y;^_jH>2&g4#`oa{AA=@#>mnZ)j7B)0{hq<|abazKa_DQ~; zOfbLHWvYy=Usrd}JT1$519LgP%C}a+C6nK3)icsHf=ruRAFg7!;G`VlKt$Ys8N82b zNtda5J&ZOe4NJUmNoe5mLv&`g^!A}gDHc^=rwQy-sU?F)_9g0bND1A9-!}^61bAJ- z?+wS-om1?EJ5lfH`l)2Z+7-*X}NT%svC2P@ZYGIk3mwcGch@U5t@ zvUnSk>QF;D6;i1w+Vbdf0=|Z@PEBPzQkhiS0=)zo1@4dIUcqD2+ z_K)$|LDoC{!&nF3cM%z`G=mw@IEiVaYuc zKtH1epDCK5 zTNU$;4s?IO!pbqzW=kYLPnh+StE^^eXHRCfvu&%NBj!x(II)d2HE^Ckjb=`3CE_i%A4eIK@0DsGF zC!TG%-sem&Z0Crv_}=KYKkQ%A)fjYd(D%)0vI4z~?!Dcq8W|gPN_1`*?hja91U^R) z(N*K>nDX%3?iH6m{wh#`a_#Td5N7(3c(vTAk0KK~QYt${E!`%4kJG+FmIubMox~<) zN2hq*@WRy!N>3FP1ZzUT++!BCTlJxlIJ3j1kOE3NR*68kA{J7vO!sv*3o*DqUK&9G`*`8qopi__IS_N9#7Y(kEt9$_g-v^V(($bYy%^Pku%9WZ2cD&I>C=xU`>d140e!J# zJ4{FCkU9m8%cSg~9|=`=x-vj`%~%iz15i7FooYi9=t?=PIp(?!WT*>93-SWH6G;*L9+@SoDwoGQ0?JpQ7ojSf5Ms+u<@Jx#YJklmJ(ghU7!lLID^(bAQHQTX1q0AL`HK zaP0DslTn&lFnjxMOkvP5U5UeLRo500S!jlqRP9-Z^;=>GY}7WGAp1Qu5?^^^a)o|R zv2YfT9bdRA)a6lkksa&YZ0kIt1O8DKZT`u=a$T9I$lehwZn)YQtY6lo$fT0BP7Wy{ z2f>L@ne|?b5Eh%Z<+6;e@Zo*a>F3rQ*229D1xir5D}f9Pgje(q{QTn*V4#%&(SaKv zERa?KVl;sUhW{}P0PY7w7q7OBS7;9>HXwo|R*fbC1web?sjn?5q9*`x0Ve{8GX7sq z;x&u&&8s>CpfFykg&olU39u1#`Ik=d zZ!aLTKw!1koBGFLT)c8D`5+JAwt+){`Y{MD%yV5) z^F8zTWxK}$;T|;P<82X%;v)YO6f~)sXR2KMI| zD7so;=5Zgvg)ulASycSM{%xHi_JRoUGW~vZ$DO@3#yjO$O*T)~!@Cu2pnv9?)+47L zJdp0^LUv=8i@v=><{I>_8xecq+cd5+P&F1%1T-aS6Zh>-SRf1i1wBU&VQp7P#XWLN zz>?g}yON$(h*Eu}QSQpFgxgIg#gLCRbqQ$rg=_mFQL$bSm^XwT9>no;KqaNzgQRGJ zx-4;+?FB&+#@myEElljsvzWqPkZWW7-Acww^(0xAQ+Q8N=X0#{pK)(asToEgS9;-0 z^1F|o8`>tq{C~!dy?E0#j?scGh^Q_VsMbPjIcbCcg4#DXaTP|7;l#(R@`f?*CHT)9 zuEABODB4BLwQ3bSamY)`4=rJ3KNwtbP+~JOSm6 z-*2#z1mm3r@~4Z}zG;N6KD%_^!!9A-onLi^3*1`$Y;I1BjI>lfVVLwc=LwNt8oD8l zBQXr%pb+fN_P}v#Vy@#J4SI1#-?()-W!f+f7#*H~b3Sdf`&fc=!kq<-_2KX{EWbZmJXX?LpCsvu;;axp5HtTVQi2$VLt17}EK^Lq znkHRkd1r)imSp%{(r4CxYACbcO*T=K!Q=791ISN2%7whN?Md*D02e#QC7ZUf@cmxOa9)* z$X9r;-44VByjgX12C(xO;w;-;e4;QE%2(X-bKa1P6SJ>ewl@qj&x?-EvQ)|67-T-~ zo9|YyTFE|hL-_d;M)FG7hg7Y#>z6UXA$`eH=6au9XT>tX>4mUJbJUOc4&f-hlx32^ zJ#K^>_uXz>U}|OP5+xeCIv>X#^rd0kdyn*fGFdBy`Xl}ngFG@QF$j~InXwngib>Tow};rG zeovIL@*Vt^^Qvn9Jp>r$guaM5nPbng!0S6(UOf_29Y zlTRJ!`5yNJcJy=Ur2=2$S?td|LTO!P`wTLy;vLIZr6uNw+tZK}UDHVK8G-pL0~6*P zeo2F@lb=EF{57>6@r<}W7r$4Bsm}gwFq*i#@pY(mLklEHK-^icoqdx!&;2JnDF>Y@ zc-hqW#zXgbZE8T? zDf~vkQINUO_*CcG6zU2_fd{*idb*u%%QRd(#_W%u2(1-b1W`)HA@sJgk&(O~&^(RV zsag<_7zIwN6FDnr`%dgpKlcG?JWb7Pdvr%Zo3lC{YDuiDrEHHBfH=>kB;!X9vp59qH%Ca9DjPu*mY*;7l#!V@5A;;v*3?!t<5J^SuPWS# z!|+Ip6O`WNBv~;e4$p$_e(*gIMMO1Xl48?rY)kshG03IKh#n_`T5s!6j}7~^-Y-gP z9vpBW$|)wLXLl2!g?;S-CPclyvAouq)m4!O9ida@a>@42dtTZR9T8r}qVjZ69Qty+ zizf4Ni#+7so_C?V1EbQRRBg93b`sn~Cf7&6QRglv2=tpB900 zTvClh_<8lwlYliGidfB%Mnq9v%U1@@kz9ed^nv4RtrftU3@r_AHJ5PSEQCVZQO&y;m$B8kf`}X@|&HpA~p68f>i2)O|!vda`FEZ+IJEzxAw>M~L@Q z=uMWEI7cIEq*#zLTS9 znp#OuTv+7kAnMEToqqs5=hqjoNNyq5P)IanR}(GC5k0dYe#O#ooVPkvnHtSAq;=j`l$dD}XmRPFLv5-ZfTcS;Muunmv5b}Jx5rX|TJNet! zk1eD$hz*)^?JwxWd{@V1%~c2?78fTEdVtE~y7|^3$)c%3s(Z1_SiP7gM@-2FT4^E{ z$sQ6U$0$tP0dGC%Dm$9?gX?AikG)yGb_hZCJq^!sywv5IZ1#+VR{y<$Hsh7XLz-Vs zWZ9b9ny?w8n@}m8nOk+_JG*#a!J>x1MT78Gn)s45m=$?hMryrrqXA{*80W8u138P4?MF0MLV?jl*i(uUH-0z2Y(X3^1AV6DRGrQF;!nIm&UYe7UA zSv(SWh_z@NPz^nYt$@9(qi~{$90-%#yy--Z)?9eAE<+0->L$j{a{y@QzX!X!nN$UE_+TOnU{B54$rnwwrwcB|2S-{A^_6>j;l@_zEl zb|68U?6TkFI)%Sgb9q<{WI6IW^#qTjK{3o8Ynqz$8_1@*!w+I35JbLLT7lZxAsMoV z!C)>kFIm$a8L8(-ksj%xLXFYlQ0-k>6;qSZ3JkKvhn3VB-DaiNpp7?QW@(PrNexc) z_gp8k%RrW~S&~wdi=@sar>0Q(sUHs;h#O{L=gtRq_f=4P$1}}WAhJ(cvTJck z_Ng&7qq7z)Lk1IF{#-CX9X4was?mz}kpNV)V1YOPNVR9%Ys7SqT1|f}I9wVNOHJ)X zt#2#}$6?Tp`WB~qLXlpWo0*lf$i+`WY$S&zfr%9N?qgXmzCEWkqRY~Fz8f^7B@^=w zA)ihsK#s9b;Swdx{toG()5mbDXxS4Rx(jv-*K2qq_hezeK%xtU&`x~{T1`)nsQ$?G z#qvJ&GNB|fl4oK;$fxy6S$(fqXD6!nTlBaycLRUi+gUR zE>RvD6uOJz*b41VaBwkWZl*$h`}E|p*a{)BWz1^si#3zW7oXz`QoQGF2WHK$6ni5+ zRB7V!UW#A9ozFd?1BSk%thPpLFwz&k60mB{uHy^~sOIHorfM2eN#Dn?SI>8%$i zd#jzJ_)z7|XS>r$ZCn+~*TLO~>NL^eTwU;}1^y?oL)@70te!k!lZP3Z8R7{0?S-Du zxFH;ERhoEeniKAw!K89wL`@+l3zPP!6iq}fq24#4Iysc3(bA*&n)5`-;bu@j^j3<$ zq%Z0b>O;PVxngeLG1k(mNisSgplXD~$_f$oUg~-Jz19Doz}QB%WX}zUrQX-g%T>6N z+@`1QC+e~p{qP1`z_I!KV&|c8A#AhilQ*uQw5}LtYaqg#<4l=GH9k)djJUxWizviU zPr7*CYdCr$YPWkabRP5Dz0tTTT;(_&annPlsIh`)vp_3KCz&-lnBrenYFch`TF&xc z_?w3t$sN=S<5ISMVpyvVrxsHhz_zc!nY3%?)n$aLu8B2t_^2I@cOHvCsGSGJ=G&r1 zBU$8*w< z@~2O1JIauaY4btzY-(Xn4+8B=k&aIq1&@t}gf-fB0T1G%c?W8wEJ|MeFx3joL_}>dOaSndP7#-Zi7)eIy*IOnr~;$QO-{^yQp2B841gV$zLcxE)Q zKq5UbTv0wkAR0V?pS>dffoLEe0eF7?n?4ahv_SOwX#UlbvH1ZoNU#7t1rRhj;N~`S~Li8hFLJ-H<1tPUi!m_aPuWNFc0sAZQE(%NWS~ zdlLy>lSBr3|C>i3bRl_B3myl?@|z{#mFEa#ChmXJ^44k(Hf&!Hk-z*sH>6&rM!LNp zk-sJv4WIrzqBk;HnqF-ft$Bbu=Th{xkbK(nC(87x- z{0WU4GQ~I>slU3795pt577`rt7&vV^4xs7rTOxUxGWGVX?(`sagAd;XZ$CO7{89?Ikx}j_FnWPtPkg9U)ATUcijzJQ9yZ{)ml!Y`=-Zs*hk3`z zyyQ-rq4|;?;**JYeu>dUw)&LSH8;^2v~^mpy)zmjgsiq>wmR+kls98LrGCwLlh(T1 zCf!yr;TL`ELhA#XkRz+e^9`8nhsL;|irv@E>AIoO>3Dc~f?UJzZPxhr->dUBfZ3D>@Z)cwBTz}mq zoA~&JG1dr{M^AX5y2rD7NPwkK??|-axWr!&nlp1Ctj2(`%py-QS+_0x%V+>vd7Yn; z^1hQ{uTBDa$mIS^z~zUROOlsSzn5UayOCq(wH~izgBW3+LhrqyXA}9QX+!^T!RwJ@ zmn7M~o9m2afk)6{U=p+EFqruP(UGx2`ne=SA!K6d2Br(#@99iU{Sy-rqw|mQ zCr_@!3;T;hs{5M4e!y6Nzj@xe3DYfM-#J!{f?6mH@qp+yD0?PXN88I1>Fdagq<18g zj3^ghimxRH51=Wrq}y7!rwC_t@Gs&m%5cThx3UZQF_9ZAY2!`e`ei6Oj(RS3%9Lva|T5 zrGtYlYHS@{ixRZ)*6hP_rTKE}Vw(HF2fR`#WU|O2yVs1#<&aU(4gqo>W51)&^MYhi z`t4laz?}ddZjVG)@0ey=G)XoikwBGoIfIa^K0ks91VSK4T)xg+E`C`p1g02yh;qef7t<`7Np!0K`v7rwc_|c(I`8(`kz{MH z59OY=S3sz!p0ieUw>)5^XJXgHNFeWqce9A1`%2->uzqY=fS;bPBV0`H4=G+`QpBee zxb9=jqZjtFtU={qw{ch-oqdU!V@E^ z9=h+h^+xX|Wne!QyR&RuDL6~9RSekXr&M@k^kE*djLnE>et$|{*-D+*FnUvhZP;FSC}b84A9MV$1odOK#4?mtw+D@*-*d}aRwP#>Hz`vS(?34JS|uDHWA?%-a%YHJ`aakw^!bCe5gf}1Us}#qaWv`XX z5;MJVeqWP&YCaa;c6I-(Hm!f5naRZ-uvENwy}N>^-o>^>B={9tcDeP(J$Ueu1N?y`%6@X9AxQ*EhWN*n4PsQw{P+{|kx^>xyyC*|kzsuKaLl5B=t=f+Zst zlh+O(WJEcbdsP~iimq9gx*TX_Awf^c%xkIaTSW;0hZUc0SEsr2!RryB(J8ZK<-mow z4+ly8N!^ovnDzJ5X-rBU9GwPDtreP zqorqX(^XziqwGzz(k(9DiM_Y9?g()uVa)VZ@%~6h=deG&|NS0<-KLolWpiK!?|bM4 zTX1n!(4Jr2o=;zd=rv(Ox`pb)@4)1|cX?|&7vUjs5R$Z%B5E3W*!7C}i{2LcGp!S= zvesO46O@&X=*6nLWz3{_7yQhbFQim;Nz|dZZ_`L-=|;TZH< zJeF4^T71U_fe3(O*DEm_2+@p^LLDc>6WcD2O>`dnZ7QWn4EsX!90`0|hf0yDZy;e_ zGCz<8Szbjjlpv~ap+xHR*g9aDG%TLT9ngHKn0)1nj;aarzg=(0-xAE-yr8!hL`NH4R+FVp^i^;GDk6%sl&>vo}|Ie5I-wJ@}9V+nO`1cYWfL?;Ouj2Rr=FII+iNxU8~;QenZ47@n6XG0yLeg>TLue-kip-uu|@W11)51>F~f2UgI zC4Z#6!c+ie5_N;@p(X**z7+^1AGlR=P#7-M2LO};k%#2K9pW{^iG0ro<6b~*mxEZX zPy@9=AWf)lE)lq>qWrg3AO?02K|ZLs8_E#`COTlrkVOJG{)C4H(4xE=>#?>87u{8&*ypb z)y5G%F|MM;hun)TphKZBxluh)Vr?NAh(@X<9?v!}z2v{3dx?GDT`*)-^{HRDg?R;x zWvlaGe_7+nqCL0}ru7Y1%!|>)J3G-WlDo3ig#frgg=lP@PejrJ6!Ouw71iuCyp%r> zNkanQm4kWDr_V5ah0Ch_8ZMPDAOe(s9`1P0ojS7bTYcsS>7EzmdqQi449DeH2}=3D zPyC{Q`-86>7_Qy?u_Id+XzI{SST|3}n>UBM6Eg;U%yrfy=a1QDONoK*oN6EMGu#5I z;O{h-5MO33l5*1MA;u5I`8QT*Hy`da7qxG*z_lI{h3!7W!?urI*P~Qx+9ngfgsG|N zzM@RgA*eXgJtujxJ)*B{;h6+1%ie&8Pidq{$b|f-9bfERS10R!;om;}=9V_`HnTY5 z>biC>duSN=!P=A7Y<6&W{f_KZk{r#QOZ$>F)ZZ#Z2o~6!^!a1taky!qWQIYHa3#(I zwYc)qq34qnrG;4o(lOuIDBZ2zn}dRozaY!-+YlwDKQXj>$}ZNne@f?`k`P`daN7<$ z%Sc`ZQ+QA&Tap8Gm;;Is?x1XAqK}|2va`4 zB!%Fh;y16`o+jr9{d3NO`xAIyfv>2xVyq@Z^Gc1V)b3wxUNAPGvgbXme?PifL7S>s zx5612#m{W*O{$HNekI|#{8pUMAs!?|Ts=ZB5*jC5kP7<7SLKEcQo%8Vs2U+p_4kaQ|AJ^RkzIcz9`^RfxgUQZ zlRB-8w(impqUxYoIV9ZKIQBUDg1~@-W?7k%hx&m%!_+a`Ke#Bt^AX~f%k3^Rs5SHX zr~ZpG&Zb`^5=CFRDedmyguU<2E-)_bk6jt%QB!Ma%ZF81wh_$7OIWNpkl z3TK808@phx#^(E=fDIHdE&ZmpEfyj{YIM#i6f|Gq8`t+yw7S$3G(y27I+J1J&>Ze! zhO1+6P)}_V+yk)Qsaz#11t+T`B=q^k|TV38+t@ zS!d3O4eB69{2PU#E#u}Z-9BeI|&)3NKG z<>gKvJ%4zr0PgXR`<|Qald8k_p9DG!<%!xM7BX(KGo%cpr_ojKTcaEh1i5d*KQ!D0 zaEA=58{$=A%yu%ER+6(!m<)yMpI8_$KCF|Z!V9Sx72;a6T0cXw>+tbqM}Oniv3B7u z^7@na(DdFW8;`0@?EZlbeIJXhJ4Zb_Iy#(noDs&UKf693wt+@7ocCk#OOE@>PQz=Z zBoRHl9Ytk!RCj%Y7j<4nMB>(dSH~ax$1%J)?*g3-3~Nn8*3gYgVry$*8gWM=L)eP4 zSxTcKg>%-eu4R^BA=AsXUb8pp{%PP~Jv|j)R=9C2I|kz0dgw&4bY~bZEa!W%-#WQK zsA*~jHt>ZkD!lAGh}b8GmS*xSOh5bXm7(<=MzVUSXc=sQ}2R0m(u&g za-Z}u)o~;CEZK7<2IJLxN$*OFMbes~IzI*-c5 zgq04nU>;w|5|J+Xv?oh%8Y!0hsxkUcN^C7(tUXRs&J}aRcCAJA>JJf6g*-V-bk-tD z;03A5;6vdTm(Wo-C7&iy{Tu;uq<5q9hFHXW_Cv!p*O|+X#0|2jx3Jyn>E9=Hm9*5{ z-9GCf0;r zV(d`gwaq(d$J7=v%EmYMF*eDs6E6}yaI~0a@7T6hAT{Go`J1=cs#{I}>=%xeoKN5Q znGuGW`3?n@&m)d>X};6PxXYa`V3(rsWS6|B#(CbiRKeNCEO2&&nrESk{h(I@V3U&f zDMtn!4dRc*3o8gx)G^c4TFL0QwcI<1qMD~q zYDptIFDa2^NsS|Vxs%nh&KC9eO%`7$TI<(lEk>s!X=x=@F_p&oA$r*4-4@IuLVWsO zpk%OgsL+t2rfJ!4h2>u@Zff7Ssj9_u_1z-bLmdXsb*d1Hj_Gj~pYkQjEAbu1G7Wi^ zvX7rX*kJ<7b7XF%_+*xBS%%;e<6<`v9GggcUa1SJnn>JqRwj;hVnY7un=7DDbq!Iq zLE-27`0PG0;%av($UC{x4C*zhZq)i_o;A3wbNDI&xAYgg&@alOk3+#JFe~Mv4KVlO z1owj%BYqnWT^yqV0!_lKdqqw&;VuR&iMPD8)5{_R^CIJ0mwJJCH_IHv+BmEf$7w@^ zxn$uwnrx~wiE?GJFM|echw<+BJ(J~qQX?}4b(Lo|icPcB@kLJs&Tb5+;28cJABqgOke1v)n}CgK6r)qC zT?IKtcL||=jo*r=LhLM%#mp+L601XsSPi)ECMHK{Dki`SxC*~JSq_5YASA>DpnMCYZX7~BaD+i1tW_w+-5@yS#OrH%hJQbRgtl8`^ zlMfTNzuNCoIL8u$Ip0Br;gV*m>YZx1f1jHqy15DkA0uI^|1R0C2)x-Iw0Job6kv7> z$9Ag;SuCo!gz6{6OteORXN#Q4{J7YI%^%gk#SosCA(pKE!Cft_)A}Hwj_cQ4E-uM6i@0!bVCZ5@| z_kMKU>t5?#Yip4wLIe;Hsp5qNtM%cN=9bYt$`Qcc`c%Z$3M1N0tek_thv zY1aF%Yj-Oh&cpsT@UaZtBJp50Cj@=f`6sTH)ylV|tB&>>Cw?xduae)|p!X-GE8UE)cfvj=+qE32+a1 zmLTT_`hdYtz>sjpD;&c6Ltu7c9V(n8a{;ZsFw6rkshxmXOsnE#@uoAR>@x#4dS`=pzIa6GPJw!Z0&ZzYK3F zhJnGGjUNWGjxbw8fb^P@KOH2FuiOG^m?1wa>=#Hwa*!LNBc0x{L!;_ur`9c)-eV2n z>-gR?U|K?vs5ccV`5Er`kfX*JpE!h99@W$F?$mu6w#}U&tIq`aGsc-Jz<-pfLId22_cPl?}?P1EECY%V&4iT4|2XeFIC1uw-$Z= zlk!iM-z>aqfW)ZKM_%xLnh2z_zgFmo+*zvO=jylDTg&*&B|Q{**CP0Q?l@szPQF@H z_<8Ifhz|ZzOWSkO_p+}*I~B`oUD6ArLZZ!?=25OYo|8YcehWXvv08e(dCo%X(pChf zqWSIJ+xO zI7Ep}X_J)BiQagd(D3?X7Oij&Yia4@rma`?F9w5OCe1OwhKWXFRdq_@+X(^qBG`PWXum@#3o~*MV_q;evTf z{C$&~vuGh1Jlb1~L!z=NLe>LmcUIc`wYcE;w792G#!%Qy!$SFCO*Y)O~?ln0$vd*6l>{z2B$ML6&_n zI*pXm_9t@6DtALAer4TJ{u(eYCSIjTA*wDKy;(J1nCW!2KSQ~*^XQt%%?DA+%fA9B z?cRzf>%T`jo`|{x_-Mwtmiy7)&(3(N(o!^Ma7u+dvdKZW)JXY>nn}9$yomYI^UAAJ zxTt+lZjq-$KjkMq=kim_pG^nrWsW5WSd2kWE#me2O&*6HXb^g=G8^n!IG-+&1YNzR zZ1pH#D$1<=adWb@-f3gvJj*m^TLxj#FC4kF;Z2_U2ltbbuO|rC-}_NawPQr}m4ebZ zGoHX9U~ct#9maL_I%u z_mbZwmX8#r^A`nc3;0ZPlFX-xlnt1h?&}B+Ui)<4K9sXb0`0T#Ffg)m|Kc}=J721n zPfaw?TN8WFOLIhR3caeb{cBQ9m#u+FsxnrkJ)!Prj^9&%4t^$)?s0n){#x|4(nq#; zu3viD#4o-Fj=S+qb-&hw@&xC!OF269w0rr2iXMOoYOOr&$~jd{R*;rAWLvV zo$L0a8eM(!HAm#$_u}#2Hy-e5vN2QHmegLclzCRd|MUyh$%54>`WRueRlBb~Iq?W5 zNPMxopHU@cA3tW^``XqReUquv)zAC7H-D&Xe3xFBH1R>rGu1JUXDK|maFl75?$e<^ zw0oQKel5?vxRZDJiddyP;UrAXFI|dXPbc3kRsV`!m$KI=QTV-9Q_DR1;y{kfmE=GYjC_@RYapCr@8r)I}@MChFXK&wCX9Qo)Bvpo(&@ zEpw|3byEb9Qo1Q4bG)* zhof*QvlgxTS5nFS_d=4sKjGMVsEmD>Pji(+U+8X<1YLmNvgX9*{=TcW3xNlc-XOfz zNP=ZsL~qpb@szf`P3TybBXOx<`!MQ_@Un5E#ZwQfUur#T|s=STgqWxx-q`u=# zRafZas7Jm6({1(IzTDP@W~=P47PB4E>-N09uj53kt{BWEm@@H!Q#Gn^_z3I+x<|zE zs3lyn2hHPznPk6}tE^Jv79{5oJrJ;DR~AjjaT`{py?(zy>$OEjfoSj-+#4T=OH50@ z4co-puush{C+_c>*V=qn;H$JZn-pXhc;R?%&br;()Df49rz7^+;;*~~50cM!KOV6x z9P3j7MHXp<%gB0~9n$Fv#PuS{jmZ5%)1gR0_Q$ock#+_fbZDpKHlMmjbfa)QvznG0 z+G0&pJ?s-6@7nnFEX!3vWd%u*v3CRnj}PL0mU(N+5RuK1a@m)z5ATYPmah$5;rp~~ zebn}m(O33>%0+)n3+?yRrDP7A_Ovh*YZ)MvoLz3_h%)^`xXKl4qito}OTuQUENRrp zzYpNFTw$>@;pFsa*?%w1&AWwc3_&OE^_38Ffo zAe+*ZVG?(_1yhHcPEi-|7*2bg-L%JUd}Q$tCHr z8h@i9{ZXmFi2O@q3k;l$cggV|MLBfsD~@?_>#|f&^cni7vs_#5lW<(ttj&gKTKCN! z4JB(H#y?}c_j$L%@d8!n$lS)Iqxo)U{%ZtQget*xH?T8*K7XYC-X=1Ejggdgdc394 zN%sEthuf$mb|Fdu35tSfelbfi3+;~7(&)KxloSp)MwrxsoPba#5FG{gd-(<-Mu4vc zbx**ZT}Q%Vcc!t8v^GQ?qds%5n@yV8Z3-D48-8UYB4{K zQI}!-;xMpKl$}(uc^A?M9FPsb+?Xy% zjupB9F}Hy3K4)$*XoUmWN`=6Dqzl42rvz@xE)bYOS7qRv)dJzpV}snrRruX`TW|(6 zb`aPWq)2#;G1^6TNsRTeg2(_? zx)YtwC+S?PK?iS%qn6Z)F>I#YZdwYpb6UbxGhQcHpla+WW46n6r28lLKTs{l6Z+2~ zw+8}-3uot2Lvah9kT-NTjJ-R}Oi~;!mR=w_nw*`K5>>wYA!+^YG{LSqElOy$U{w3%lmH*S)Q^9A7*_8lDi)9v@v|-bu{p{><9&25IcZ8YMCP z_LIhGD_VhGAz}$Q-oaZv+MknzZmXXjkerln$^I&IdtPVr@Fcl5?C#qLhc{cV2!9W& zXH4g7s(#bq`L4f5F%+nNx85MJJWx9$N0L+~eEwse;<`!(X;ODLAA#g8S}pWZy*?Rd z|J@v=drR`o&96vyii1naNMcr#)ipayGXrs&avNm`Z~;8h25tk*LEXc zRu@ozqI;A?|HRcJVM1Ad6^E-ccf_^v{4NEvd!UHK6DtEOsn>Bjk!xWAJrT#CK|>q zfWz9ovi<>`NSQ@&AYnHf+EnYQDvn9{A5 z#l$QIylxboBfIv!qah5vA170Mfmc)8!Fcld8fiDa&m$+svf9S+080BS6qd6^(^)Lo zB=3FM(Y|@7dH#F{hk|z=K8rjqb+?Nm;SKJ)rVufcrf_9=dt|s{Q8O}%Bf0Yxl^4X8 zHySRpxq0Jzu%GAsYsyRZZ11;UF?xPiTmGeDO)Sh+G(s?^EzzXlBum$V?&#G*y1E?} z7}ATeC?d1snUiUB9!HK)r$;9qzbpK5+Fo4EB(bteTr`&Gc{wg@`$L1~lPij%iS9*2 zHtGyDhW_WYP4*8tlLNS=-%F!&m~*zaqe$|ix024O$z=Zu!!OYwmyk?3*z{3bMbW#j zNE8j6=SNId`s<6lFSOeeO4Mi`T<);E&e@G36_iP~*5sq9ZZeFvsl0v3VNZcOvvM$w z-`C`zV@1mvSM47NnMGGxaVu0KIVGh~Z*XufgCb_m^Z7NU$2k&4^xn=MZxrz72i-dXHd8HDQ}9H(@?+o zm7e)-pvKHP=|n>DK_Fd4AiL2yDXb?e64p7Q$xb%3l4HMRx~(YZvP}6>hZ)6)Gz0BI zSglsq+MoBz6qE|6jg@e3@Tu0R4ZSX>S1dg2YgW&eDzJB-^eKDXcIWjC1(FDlUtSAX zQv&MJkv7&X-M2p;8Q0#CQJv}f79UK1PLET3nxx?7748nik-q*B`EU(=Y)!mgl3sBk zyCvSB6mIIque_Ig;Mj*4Gs)8BCF0v6s_EKDuJc!tBMT`P6OQUYo31+fxfeaPNrJvK>c^)&ic|O#7j1Z;egC3$$Drpf0=GTV*;Lv`UOJ}M z@XuJQ;D%`_VGk3jwZ|-&UDTx8;du~@dJ)hQFV%KGZn-+Ly+8s7#%7WB2SiE$n`x*a zD+milRDiCnfBY6CaFal>I&dgjxf7JUk-(vW-H5XY;GeqoAU6mb!U-b-33rSOg6X4g zCG%)>I2VqLodp4h3I5Bq0dK;76!`RiLTPZ1J4hIO=YR2uAXWhEXP=(^J{$q7I`gsq zZP@pxr9W`AUSuaIsjqVJ`xzM9%6t!5Dp7?VgI^G@TiRN4Bi>*2S_Az8(8*);6d13_9|;VE{Nod|_C?i-Dg5l>-VY#t!p90f7al0I2QfB?5Z?c~(hu4v0m9YtXRQ z1egB51$fxjc* zB_2fbSc*^h2yKuH?)zgYe+3taX&ACCCB63ql7AuvMJdscx{yw>IYHI$+93!#;(CvM46-?Wf> z4_qyzjV~H>94`!rhzbh-u^ezuBPcI;`S70RXKMb~tKSt7cu7~!U(8N&-8PAQ8c7Y# zLGLQJY5pcyvI0I36ZwUI{x^YQ!XEhcR@*8=a*(A?d@!HtQ8%yEB7^i2meFV(jpB>v zOSq)BW?w~1aX$%kxp$&QNEVXe*YnOOcIx~Zfs6U;_hid%@-+27t*BHoX!^BU_jmX= zjmDROOgfaB&qp^_h@)p%I6!`KvrO5RrzMI*|y&_!<~#s|hNBr~=~F6ni=tAm z)JbbTyi0YyreRc%?-G@+@#sEJV9WmIg+?9$p<3DQw%yorGie^rhs~q9wyV;btgqZs z){eW`j;A!&RXNPcX?u8rYPw0dLf7msdr?s$zq`upp*}zoo;^IgXkm3rZ6e)fmCKor z-7-lE!eYos?A-4?`3DMsT%ME+(x=8OU>8|;*wwGNyCfBIvFXNM@HC#Z8Y&dHoXP1@ zQI=egAJV#_V&Z;vgtyE+Z0bDpPX?W_8>JlDD7o?}A^wDdaj9o5T)@&*=6(^1%W<#Lm8oP!2sY*hEx zXhrP8vFbu54Urquxz$pMR6;X|ET|KU5{s2c;1(lZohGCYqo zWFn@#ZcyotCX#2#3Rek`en#c>GFfNUif5Q*9}q%0zTvn`zBCqo$l`*-A+iddX1UOX zsje<(877(dkst;`WBtTYO&Z4Jf?<+@e(eXys(5tU_^SMIF!PX(vc&7ElA_f7 zJ1Xaj)DtaA)6!G&9FZFQ)5y)xp_nd4ne%1a&jKvd{oj-vAvb5Wrmni|osShv}csy#h;+`KVr{9S1Z6t3J2%e$p!(4K66!^^bv zw)Jhz<2z2|<55W`6pL#WVmFKiw!f>j_j!TF$kfr<=!@1={bMtf9#^~l(Qgb&-wAd| zTZE`?+ci>f_Y!Yge)Y9{E&91Utz2o3nQU3v?b-W>^zkC_~24NDz%?X=lRL4sAXS~sv7SCi4L`lFL_reS;pgo!}kji3*2!N20 zI*gBE7-~g;BCS@84?zHL8N6w@OSv?#D3Jma8o^3Bi+}*QB?nLjhaJwq1YUmu=r99b z!*K`57B~X%Jun~#eEtstw}OBIK%oEVID=UNT-b)yZ2-63{S$rxTl4R*Rv^v+j|n0% z@C}xSK@0>Oq`+=Z)cYe~hy@{wKbudQyC@}an8%6)p&;P?P#}gqAUxncfH~j+zX%6n z0C#8}kK$b*!!8PM7jkQbK0)$95J;P1w1#J!562ncd+-Uu7Kcbd&J%#3ZRrYbcz->o z=_Bk!RP~QM0U!GC7H=yCq4Rqo>QS}#gAXG%P+cR+RtXWt-db;Y6EZ}*;${_SlhVu| z*37BLik;6X<^6nB8_KTYJgnh)qu%m7Y=pNYZTZ$?o1ifYlH&)h0SD`B#qz3hTW?fd zbmMZ@r6nUpG^QL&c#ztzTa8?{p+Kdi0w%C?<}u>T~V$EOpv+6W%Bu zCqTTY)X%VpFEKoCmV|3oQKnSYY4z&@_}BlSSM`c%W%>1KnT{d`b}ch+-!#V3ZWrb1 z)HEf0!^k8i8jm8iy?5${MQP-zoBGN~`^4Jzm#)2)tty>~S?BH|9k_LQ?=s6e9RC0( z{l5N4MC5U<&$m4(@17_@)cNv86MhwY@yykd{@Wp+TkP*3w^W7%yYfAqMVe-~3ssyi z>R)rg$r9aI{eq%Km#l}Q38nnRTIy17gdhlR5xDzQ=UnV@Q&?||xO+RVOqNrHC#1&2 z_}7Qr=n+&3g|RWe?;?$aQ;F6sWdgJYC8}45#b%E{V<((^Es5QP&HhEO(UdNIv03y8 zUh(2T(8IjU*&k#QdHt)qCs-yYm-SM$%X(xuoWB&Gdqills|gi;&W&;!Vy5uYyFx4e zhC{eph;93ZqM2nEd3)+C8Sk7#;(I5{x51W5*5%;5PDJL9S(Z>rub{6A=cZ-ZV zTVsz@5AB1GGGy|L_}l)0zPf17T21v1P!GkUT0*)h&y}v}H}FI$8y8j$)lRXd?Ecza z&63KpC$;O@vaKvkpIMKbB?@kv$-9xy?~-|8y)d5r3pl{t<3*IQJy&w)Ry2i4TYJLC z9*()=_L?pcf!9%&t(q=GS@q}T3?$CDYaaVka8Vpxx9o^^pwhkNsC%=fj&j4WH+;!q zvLitwF~|2uUA<7zo?J1V9bbmKta#xpTYW_8wes!Kea7}15_mG_=mSK{i|kjRBg)qa zX=z0*Pz;0gZSp7Gbb}6*R#t|Zj!DHHm5L@L7Z!%q%`*+-Nq4u6?1VU5zQlhS9asCP zwBk(qORMnYZvS;cv)_aAuRK7LoQ8Qhhq9ZLY&C>a?}+yudjefY1Eg*Z3aXcJ7y|*u zsXBdsyGi75%!@JEuQ>)E6uy2DI#DV7dY#jwCjH_~3Yp@f$;UqhKkOuoyMOkgyF>RS z@FJhTs`pp!%q+n`jj=CfF(Wm_-*VguqP{R)y*16dE;@3vZnRu0oTJ>@0Owq=yG&;~ zDV4SLwPiCOCae3mMt+{gUtCbfzj++hry(ss5mK(zimfNlh6DEDQz@-2uqJV()2LGvtcL?Beyt)#R zI)HVUNkK?(JRA(xu^=D~4+T&MfD26Qh?M?oR`C4-R-OndfcIXC7>?+}&DFqy!G-^F zPWU@u+l0Y%$UF$KyDcE#Tl^gf>jH#uYlQ&7xj?9Suw;zv1iqW=poM$*`kx&IKU5E@ zt6M>?0B;zjUWJ&EXQF2K(24`MMgx&|(8Ar#3c`US_i)_4iU|Tq1)ySqB+y`nI&`G> z5W~~C5D>e^wLrIk+G7AFW(Z*bSeVvo5TPwpeRfxNAzND+WMmF$c+h--6nRpI@T}ib z;ZtN`kKwAWw154uOx0CTu!?Vr!mqsC_ed!x2K&9KhdH^vgJ!2mIpN^`^CTHZl@LyA zUAddGnc#?7Yw;#{fSu(Jc_s4Yv1HTd^k z(Hd9x;tf{mVp_kXu+(tbjm(r-(y3xA&W%%v>#>HWRV6F-n+~+@QRGzp1GHu7!l)sE zP$nsv7uoKnS#Y7v$Ggbqi#)?M???+Kb&3dV3p^xab*C@#Qw98t4X~uB^*V^Lk1p)! zl*w%pEqb_R=V1}K?)b&;(O5&}7eAUr6SIM-Pc8c;rX|g6q3^%?RqzR2GtgIV;oVe; zS}p?T$TfH4lgf>~lOMZL0HyQq?l5~kQ5`zUmL)?v>4cD1b()Or)9LnLF|v3@j@CK3 zSzC(C7tO$<6ugkrJBW#Otf(fWoS2YmDjSKWb7{8 zJ)~S^nslYh(r!Xs$3GA~_hqNIfvy|U!yg)hJTKUjwGI2&+-R+De`-GEMMk{;+IZyy zjoqaJZB1>^l7dYj*Mdtn)Qdj2XDIM0SE1gb)=%DvbXz}WvsQnWR7uquGap{xQR7~I zi(&tlV?Vo5gf;DHiNvf;!m6%%KR@rI4Wc`8)LDd_wnke$^74W<_475NhKrb2<)kBZ zl|v_micnfiYRSnH)KT?=hy|0U)S<8HAT=-h89a-`+bSs}; zJg=Q{ta=*BrFM9MSehqM%Ilfqodtp#)qB?EIs+2)YXq*gkkRG)u?MmVkz8V_+{-nF zfg>g_!fAU=^b@Y!mAd+5jWqjPO9q*>$+wT;(-pVAODOMZOo|+!JEgZGHIuq3?701)}WkOQ0;8VYVnav+71f!E-)If z*(ZjZTAW3jz<~I%;bM7qwy^a)Q@KT-6(pTmnEytO{{$ewZqCl+{8uLTKTrd67noUm z!VaT=t=9j<-0GoQK>%tnh7e2;e@92i$5BFlEdjAQqP^tJKQ*U*`M_ z(XcTi!xJQj4e%!!{5ogoge?|_hikpPmxC;&sqnX2;a z=O*C+>+w~-Lb(7PU_1fu1Jng+Vp3Qkh@q!{)(1WZ`z8~HO$f*tylW`TpnsIvVC_WO(GZD(;-q)ZL;QfZ=JNDdTD>NW5f&PI}kH z89D@}ztMzB60f~lHrX22^P?MlmS=cP)OBgm_r;S~CCT2T;ZO&~LZyw}A zRdUVks@)2K{xZp_InacxZ4yg`=(CApQSs!Wlw2$zraEuRW~ELV-o9Ff5E=|y`s`R! zuKxI$WURFBXLcJAbCFH`u3HG9tzjgi4EZyU+>1X?D911St_~G?~|?7nWGRvufabGj$&F>$aUAPr)TgF z7ppReDI1D@*l4aK8AT%E5$S!eu0viFsd;2g+jRI=BS9`zG2z@!kGx6|clN{DghUE! zNziDUsb4joGNJVP?D4}lGHrS2L46)OifsnUo5F|0)7?KUspl8d+?LI(kAWQ0C_0bS zL{y9mm~XR)lgl~hhWzLpgd$|PA2tOn2q7aat2a|W_MyJ|`J*$auDW{<*oD99ScYvCWg!q!Rk%tybbIZnn;E9e6dcyBpNm*HC4y z(I0-+f;7Y3*Mgsi)9KJJ`jX2Wi3m7x&rxC-udGm))@dkd+Ao<}6pu~sI--eMldy)zf!%NBPyuQ3I4eZXH3*c}lJ2abM_KwqPi%y_ebiG*| zk6sDQ&3As~N68|H4@)B_w&@DeS zlQX$q>r|Z)rx86xUdW1EM<7}+0V4q6&P!2eZlj2TKp+i6bIyWFz$qrj@ERnrs32jW z6b3*C)QbW*0obuiV4K1O6~nd+un)K`5wN*1?fGMX&#(c6Xn-MqfUnXPhVk5iX#)wL zcVSB8e=fs76>RYSe(%5E@W%$zL;->T$MFDtIs>e~h8|YofFrEurQj-3xEHY!Fz2nX z^#th<%rwt9$Odf6;J!u}rlSNKVh}&V&TZw7$Rv#hmfL$_9cNeqoeif?{+`JMuZJ1V zi{MGM?nVrL_@Zp5gd`ny(VPJy?*H$6LGvRRaDYgs)gOx$yR{X9mFqMRkga@#gNy)R z0Yts`#yT!%2zIUqqE!jjp@UI9U>*b$n6v)_y*)lSRy!RVtQhbf_||~0 zqcJxYb3ixL4Q2zF8i>eZg!^Ye2NPisT4N5|zQ;r)AA}3Q$8sGPL(F0!Ieb+FfwN&M zkvb!FYH57(0Zilk>nVZoreGG4Diu;?xO1ucxK{LJkd9SgO=5 znsO=sQ8HmZ=h~&xu1@y`ZZ}jv;YE__t=`zx*TrV)Mp~65E$A9lkG)k%U;d8N&fRE5 z$*G*|i}T>nlzy)ATdtYql~?U^>*sFDMmoJwk~6yGeEdYh@^gmg(>spor1TD-f4+Uw zZPuuzE3qTDJuCZZIpw%B#4%!a*|_>uLwkP^b=@#kN$<~}O4A=)#oo8O&s3yMLqeo`$%UMrQ&#VS60@fKfTgoAM>s$K_?0D13A3f?fQ{GX%fOzBgU6@ndUW)oGAUmB^LUm|RuA4@^BELcr~ZCvawhG0+H@Ln|ogfl&)4DZuJ3U@pQ;Bo+kE zEVm0v^wpumrQEZ04RQ%fh80{2w~hdDL9imU<&3!8ou?3J3wm88!ak5s1El2ZpGEjf7`_aTl;yWpHz40ON#j9w2$ZrGV9`5GX!V z@&;)wxVY@U2@z()aROjs^$vsq5fQC$7*XjE15hAPmShq#jHM1LwE)V%NCs-UZo*9_ znAtHQIe>a};6VBjtegUwrn>3oC)xS51sV;AaQpg|MH$=snCW-Xr(G1zT>1{G~BU8DZ z`KYrZ9k->>yk& zJ;Y1p8vOm(7JVva6v*w6e-|(s=(}$D1pD2{OBq8^lOK1T?XX+&!_q2`OT)yd#xmbK z^$9#%?%VRV80RpnG55ZD^$KTYj+U3*rn-fS>Nkdjs5D;b!LUZscUDOUXbF=0^faC= zL)Ub}r_`a|9V+|6f1ryil%EzPXMse|NV**T^}|;AKy_ph!7fDhFjtC)yCivL7RkDT z0~&P>e;&eZ5xp3?9B+Nxw#aL0wCuRvqc399Ey;)X^GCuG7WomugT2sE;#&gc0$(E9 z4~-W+s&``w-ij14P)>P~(yQ%Lnk}N8&kaAdb|Xx!G@O1~`hFqH*<8Z)T7ex7)rmHW zYSE!ggsDrdu>X@#R$Z?&O`d=L_v&^0NSVhPJIPAMeETm|Eam%N=3Qrn%nFvpf3you z_f~rkky1ztJC{TRN6zswM3SAOl>gdGTj7BgOG|iJ+8<_8B)4j?Q}&^hS(CMGiRzy0 zg>a_I-2TDy9D)6mw^u@DRa&%`NhQQzMi;6+8PfaNNiwULuioK#n>|n}Afv>HTT{W1 z+=Hu&g=R=nqTqT$=;wDFx!>X%Zlu4D@jpra5}A|!>ABSXC!BJfF2yUJ+OEIq%VeJN z4)5L>@LQ|>`RJ3_j5Z74q)(}5tf>P>MnP3suA>*8ACD4d!i3FMp1_5xAifR46V4dwab^R*!BMYo_{w4P83<`js`)ijl?)~>&j6o#bMJxcLKLO{XTQCF+SgH%a99l2~ zfxQ%PtN|6{MZmZR27oJFVIE`)0mK1j5au_SQr9#5se-WK&Ol(yb?72&sbzsGK#7_d zD=chdJCBtBR;CHVntH(20w7@mEGedNASzhrm_QT4;}?Maz|0DURT$S0U{)@0AuTYc z7(xKjNq|;imzQw;!O2>=3kAXTo_>yutMOhoa66z{}^%1W}V4BAf><|3dr({5)E!H5gt_c5j>ff z0mua~Zx?fC{}YQbzXnd#RRZ$^5iZb33EXKWc~o5qfCZ3cT8Y4u5&*;!-Y0m~f6yBK zOTnt-54I2R%dmCKet_iz>V*u$wvqz;2)hMSkc^oad~3mdX#q=s;LH{L8U{mnB5+g= zb{=xEKfKe7;D~teo?KWoiA|v{l)sN_(8IJa}UPd`q1vy`816mm>g z+1GLP!=ZqP-IoihO;;*)%=Fnf(%byCT|cn;&rC+MSNMG2(vOoU)8sd#Wo*x|zY$$P z<3P*5mi&RwL&oK1oI&>`oks#1eXN|p?GId0(-OS{F%}*PY^_Dcmzw=@2HWUTIMvwG zrbp6u{3W8h@p_vs%$F3@WpqdVawDZlc{5*! z8$a{?ID@yoVo@O|8S@xFfXY@TWnMD+ZS2isP3?Ej`bLAsyVfdN8-*(Pnv8BQ|5`~c zwYc+amGAh8ysC@ej!tKLlNb9y={I`03qo<0W{G`*VU&@aoUR-6O?}3VO0&Q?J+ic$OV{4Sk2aZ(jXp5dX1dyCJzRtMl1d z?(l}tUEW3I_iK}zRYr*>pvrJ`e?+EHCheio-u2&Xa*qrw-LuY-nB0w&N>8 zMdtX2_0Fs+oVTJo@xfLpi@4vJ)5*)UI*ZhOp9-&BbZqkH>Q?T{4s*XF`(=T^&g=r` zbIy62nS*|7qdV_+QTT0?-YR>vap-~{k@sWyf3c6aEA4)Ko)lBl_9ONd(*v>S$Enu` z^eosIvQFo-=SFZI684{V@xPw1OvRqV>(o3jOJ}xLSu#AZzkbokzr<(ueTm)oAK~1C z&9YSm-7OVP3R#`qWbImB0dMUqViz57-I7;(KDP-CQ8LM^T+76A@<$)^>b;4hW#bq% zo{(gst)rGq-)i^yH0C!W%YMm%(}D=W5E@k4d%b_k$X@G`TL1O7NL*k!!`C-jZKd#b znShCtgvGRgT?p{5{}G(Q|I8=h@+8>4!88EGec)t2$PVm+z6cfwfD}Nr6b7RWcre-0 z;e@-aS&%-7LluFJ2F(_x^GFV`S10m1_B~^rAFiiVxI3n{6^fXXjKeIC~7!e$t zruf$u!4QL?BCuDDhY55|qO0XN!r<|4xqy7iAIlC7GQ&n;n$f{u0gWQU5$$J@H_*yW z0)PVMCopIUvMv}rYA6U}*ewJBB|0TRRvf@dR>D}7ZGpXWnMXjNDT5N2NhGj;XAp}q zd}o#wV-#U_fC<^*>%$&8HdxA8vpRrxwjji)2ny6RUWz*BQUj=kgO3>ffN>#sMg%7; z=4r#$El5G92z^ij2DI54Sa9Bk58h%Wge~|64&X2_w17q7?f#XmWnvTrAZFOX-%oLP7_~&q;DE>g&^Xgv{1KYLOLho@>-8XxFc>k;2n*(S05Jw3 zT3ECVNDH|277$UZ_jdqFpdPUG%=@Zni+6F_uEoYa&fIjUzQa zb8$0&QY*JihLS0>+Q@h*O)1etUH}~8x8!!+RZ0Qx=(j1}l4hbbBaQMYPJ3IB9-EE!f=f%Ps$?A{9m% zYO5P#4|?z=buaz^p})kChjO*<3uE6{-bnf6DeR9tTOUS}GH_qv7lwo?S&Lq@We2yX zy+{@+qH2iV>ssIBRG@uFy!)$gP;bSz_;OdHs^l~u!O`xVt+HIzD!koSKZGz>n$Vqlhj{v;q7M2{(h(7l?BT#64A zA2_ql>YSG-&`7=HED%uurPQ$Z8Yo}=(8Wi1@xlh~irT}6Y)moIIgbb;G7LHN9F2_! zv)JmfDyYVlZs1&0Fz3-E($AkuCwcc~V1HIo(Bw;cR%Lmws?rma*N08I$$odn4QVd4<>cDf%8UrK^`^Zgi_~- z%{rbpD{&aHIu3)=Qi& zZ;n8r=|xnwj0}8NFC7~0lBcdOQIA>#@Z0kHZuJy=^If`p{(E!EGBN-9HRGRvzUSmJuM#Mtd1NTkYH$@Qbfl*fMQ$e_;nGf1nlYvVeIm*Q%`AcON=` z*GBbl9%I|Gy9&lS zPVZ-ZT;o5zPv&w8~*^;+k!X^0-cM839tb?!U2Yb6Hp7-2M2Z#W87c{fJqc7Ven-;_iO;* z=LbNHZDGKwv4U|hmfEeA9WF@z!z_Ts1`x^m*Jxs_8wQh}pJiQOL`1Bw1AfB}EI9@( zFnJuBzsBv47yT!QGf@vhXkd<*OPQ(x76DjuYXwk4jIUge)r9S`2{_vH=x`!XM}S|& z*xxfh{I6AotB7Ft9&o@|7>3}063|@4!i`PAyFfMeH!S!UA3$M{)JswITa|YjnMJ`14OLg^J-wU;nqQLEX@TNa{x(jY6ly% zIK@B^;2JQ#Vrq^s+XIG!H|@`s!JBnPs=!4U#UP-0ptCC6PzXfF;8Q)o5^= zECitmgc*R_U~aw@9CloXgwI$axbzSFf`MDXIxvs~ya{1)6ySH@d%4}_ zbeBS#Z}UPP33uP<{fgWu%CTC#rrT?R-$P?s+o))U^=?W-MQpq$e7oc*ai_H(gLsUy zq(2m|-=$hWK|=%l+J-x^n+PJ~PA)A3M~jSVITq7Hg67A`S;fR;C)K6O`=Ho;tIe7wv9WxtsB~bizKCD{YDpU-jhI-P`VF^!nM{k% zVxCu1b?X8mn+Of1&p{3S`C7V68%68nGQla;6qFTXoc<`et}PJSQr9O6k6VpBU08wPZ4K1_LY(rx?V95-9}%cx6uA99(!mu)5a zVvo%GCoAQ|eV;feR`Q9|F})Ulled8K3_pKPSMa{Z>z(H!#IGDS^Uw2r!9{eg%OIUp z_e2}SohNPmDY{BG1D$vWTVf|W+AbseZGZZEU{5f2h@`5T6g43=_b9kzIeHA+T!&K@ z?Nms|>dPm@&U+zO?rZoQJGVDy&^SG)y2vIdS#iK$t*W^hz`oW>V$VX+(T(-_=_QT! zxRsSn3w)9wFYWnZ-lCG3wRC~ylOFohcKb=CLvB$Ua~6TGwd)xd-ij%=?`ktNp8h_K zv9LF0k0(9p{_JCw_481~DxQSKO|+56G^b5-woL6insC|sMrL+({#b4B{mq7;A1dE+ zG&o<-8xPROjhAxxUdY@3LipyLQ{m$16(5pb_V<@7tD;&`Y#k~b(p26A{E!pj*)|Oh zi!5HI6w*(`TJCnB<a(`6VdARC;_U0jl-RsOXs8^_QXFcy%tWyR`dXc67KyL?ea6&sR_Dc+{ zii&2J3+xL&ORln;uqQ_QOZl`%>AfEEla0q)@dT0I4d1&6R8R7Eb!wLY5#m!c`A&20 za`&Z_#;y*sL52tJ()R^K#2-aRF1^>Z{KcTq8;WFB@HS;~a#mbw^n2r;y6Lr37#i}U zn~_u<>n45g=!BurgN+x@+%u33;C6eQL&>bR3fs9 zIHuUNK=-)xRQyo*yBw)ktP$_Ct!KA36j;2?)>exi2)$XsI7io`BNr4gpK4EBuVJk2h zK%xum1qg}2%^s9QhOt1}`(Mt2n~U8AP=}cT*rh))n13T>c}k=}M2m5bfw9JJ0oDiq zUxC&-uvox@X8mLFfrpH(0h?7=1FX^tS8AU5`b?*;%r!qhYin; zqVmk7!l5Bdzl?v~cQ}u;J0TNBhbgATd;!3T63C?hDI6LQ4ZzK$5Vnv9z$RFK1yB*5 z5(-cQJcK&z`~RV2x&IF$BC1^Auo)OE95mE`S=bY-vu+;$$)W(tf<=Nko&~EAprl8B zarHqgIiU{Se1-fiIIIa`nV_pSsAYk`)fW)MIv8*P(J_EgjNJyfK#Bkc5Wu`keMX9i zAP~+(0RoasbCw;M09yujw~9#`h{uRp{MY~Hm>_Ndn5__87$ZmQ4YdHML$sW2Cu6q@ znb(=-Ofn3?4u~ptDHba=QU~Tg9xm`rCx_hN;Nf2^hO2typ*nay@Xo@hBgYCh3Gd7m z_%~++BN&P#9j1XF&+4TxF*Qss4pzd$c`^hO%wYd$93Wg_2w!6zZi^@bqIHO{c@5D0 z5Cr|$0d0f(|FuALAb=lvRZ5T}>)P`^yWoKSftTqsN}Orr;>=Dn!R=!2^Q)3Y?EU=j zzhCTTC<%JmNN0EXzQ#_PHUAuTuFN!kZwK(mX}fMrGYpbNe0asMd0Si;hpm3u5vzTK zcZGfL|M2w|U{!Tp+vuiCI;B%OMN*L7ba%IafV3bX(jeX49nwfihf*Rb-3o{Zh=eH5 zKiBqo-|zp59{q4-GTKS(czcGFy`+J<|LH)na^v zDtAseD5N;I&Ac?K+=|iyYf0Pg1OLz4Y%8bETmutlSWh3)7t*G8XF)^z(o)WiWK7Qs zi|-R8AeD+!ObZFms+oTotrZdaIHX%?wCJE2O4Y~InHRZ(4Zj<{5NgBUfackpTtMfu8dXo?yKC%Q|YQEk+^=b;^@B!dkL zT0Clxt3}ZDbjE0u#0R6NSM)s^b6)Z=niW+`_11Dy#73l+i73V%D)s8%cr?cdDh82W z1m7}4=BbQV9dm0-yBWVeZZEL>MX>aWoA(ZcV>U}i2 z0WZT@to@?>h{a>6yA;_hz3Ib#|LkTz;?;;5FLTE28W&4Bm?5VbYJoqmad7z}o3IM+9Z#=RsTv4J3M!64jA4hGqdmoQV$x!~{At9(`EcgLi1{fk(3m9nBzW*l{Lm)InrezxT1T<8c$Pk`eh1Es8xCp=w-7+M!Jq-7H>h0|?}OHWD24)_91I9~DJW#n+D8k8JlZ`3qNWv-!a#UALKp^U zeg%?C5d9|#;b$bEnRD1g0UaU$>cc|;+HK%t!NUbe7P=TnV~H5_f1(g@6nCc(75Gg= z+gNZhs?em3 zI=hQiC`|J1F1$^X<`klfD`M=RO|*C;Mzkyi*URr6A-EumPg6D?_#+f{k3Ft?lJreR zCT-^{xHr}e8w(k6v2?FACRsQ-#sIOYYPN1OYV*BN$E?(wft9v6g^KD{lmV*uNj3(H z#iW=Wzr~X~>kZ3KMpPA*814wBUdG6$Hg6ZhCQ9ap&97;Gure1aP{z4WC|-LT;Igi% zo%bfxs%Xs!`*=QHw0TnqD0kGtcGt@Nh*;hxBHlpI9Ud$C{m^)_(hOOckmriE4Pj6$ zNn6ljLSeiabp?Zo+<=VKDo%d2P&dOnAHE{JM*>->GH}$zmLET9RNc7NGc+^M^cO^? zat*Yr-f+{1a2yEa=1@JsRf=b}_QV$&EW3QI+iJwP$eb5U)%T^9`eO&zi7?7?lI#QQ zuYNkkOUX_Co6Z&LZ#U)|SV!1BPg`38RUVp3{Gd}Vm(Y`oU@^f`R?tO#rWq{8A_S8s zHt6Cmp(GP%;Vmu;J&v8KwBRX-{t-dkCOWaHTQSt>DQ@{}OsF^V#tN?R^=;I~uSpq~ z3b}-Bt0}l2KER?Cca(}ExI%QQ+n8piqlR2KZ3wwpzda>4nP{b%t9(8xdbh%!CK**Q z_mGCy3Ry~MYO{0Uk*|=s4x3h+LJRBM=V-V06kbh&+k2DKpL4mDw`8qS*PUK)kD;|Z zs;waia*NYo>QUU)^AIU6(;Tv8#xqub_w;IATnR_KDVHxB8;|EYZChG0X;{$Blf^M4 zA+3z_etO4=D#J0EaAwZka&t$4rbi!G(_Plv9g{8-;(GQOPtN(5-!xIB*4X;6cMID4 z*l}bVZ)AE_zY{w2V6`pvqKgjej&J+)4WE<=Sw)NHBD}qIk7lGzMk7jN{X~L(zG3CD zhe!5!q1v2&s^EInV=w#%PqQp=nJU#Tep2M$JDvSRp(7wAv>YBX`Gas5t&XT+b8+G^ z^Y2H|cpMK{SxM~grK+1Lv1&fV2>*?0Ji_ilFDl$cXHI$%l(&7DBC0*fsX@lwmg7mQ z5fd#jcWwM-j7Nm`@xyhM4z-aRd8;q`Mr5S@XCn8^1ZKF3N|_yq5|h3bZhY`vIq9Z$ z=P)m)dbMMhwsKAqHr#C`&s9-5qPDe6h2syGGc?;20jdUoFhE)d8z>Hf|MvNTg6RKH zcVZ+5*iw*Lfvgf_dmv8)^izVfD{9E_AwlJ= z5Mzb+SIq`a2b2(a1N3KD|I0OTdF}I$gVZ^YkU@pCD6n99h)4w13sT>KMS^1vV0J{z z56U9{lVbuVa2X8rKOhOl2sU8SMD_|stPw>0Ao1iYZHbETUjSwSw(sTs=D*|@MCw5q zGeCc#2Ok2}nRnU2VCr5&ug%s468?0;- z1!)=;^iTggj)>Pki*30deQc2?0fJr8KN`6wlD4&+X1Mbc%iOrgr5% zQufDXF?0tu*d!V?tXdo{HThS<215lnlz*_I83L#%pk??b5>#F)3>;V@F2plJPXuV^ zPzr%g4lkb%c)tH$Be*|^tJFqFxDgMWmK`c+y#s>d^>2nSqPFn=HTS|Iq`&Hon3LaguKKY&OEKo$Yv5UeSvK}LB= zjeWmJD6DZP?6u%15fs&XzGlHxyf-XGy!qgCAHDS8j_tcb<-zb>j<3gl%y_G zcbU^V3-jB=C|u$hhz)9Aw_S>YG}3Sm4bj8rPiT~1c0Fi_9doMZu6pE6R~GQq^HQgG zWFf?aCSvEUm(nL^BEbmw$PS@Kxw{-!ZXP`L5$b)0S0ia8YDR5GL}Dmca;r{J&DJss zwb=ws#923Os#(HE-r_{6;L|^dC=*-4Q=l>G;v4h) zte$=yz)(Y7Qa%MoOREFbK`JDPY1KmM>vse~-lY0h(q)~|sCx7ljSs9oa1BJA5`9uo z+m=D2jXNBfe@f|Blla^H8MUhX&|N%Qa&?I|;XVZGCX>uCNd}7!%R)l;1n;ACIbI8ppoR5(cRV8TnFf#=ecJuo#7n<}cImyR#(>QaWQ~rwat16I%%C|eEtSkpW}gEu}8K1$MoNAydN1a zw0_Xb^OBA{S@QUHb33$3!TF-{vq5F$kh-T?hfr&AiHTjZu9Kn_mU3VdGZF4wO@0A| zN{aQYs9`UOFz-)?yJ-z5RVN|*hdgZZ)Dq{JpvC0ajoAJ}F}VIft=2~ekMnuvcCO_I zDh{Y=oI}a3syv_O^3JHs_iHsuMZVJeq7kWz6f1Z>v7L;pR8?hSlTwCBpc!us$0{W%7XhU?5qE;Jf#qw zMyBwHe7Tp;z5DYn(RE7$Q*pf|c(EF}F*_GHv%J?7Vflw}4T+*LQC-2z4cc<4h}N7O z$wQ=L;m=(`r$i@~^S#Up<2f1(8D<*UR}KlARpjU{&8+*p5IEtHuv$43F1i(8HAU3jyp9b}lHX)#`k2XE5 z0hn=UuL|J8Aft_KQ@KwFk%N5TWGF^QMDPm;VFqwD|I$qZknN{wkN_GAa0&$CXhEV1 z3)n6Ijp`sl#b2Tjz@1>=tAMGS1|$-g015afTuT@L6o8maazKDRWRyag6i5$fDaBF< zRsuLqFaQ8OD^gIc3$zFTx1c2=Drx?%^CTej5xTgZ!`OzDOz#ZqAe?k`cOD#;`jNpbM1( zLPu}VmiX^u{!f$vq1)vX#FIZq?uTwIL_`8`_7@p@ETa@b{(hg2`k_sv1_US}WjWF& z5M@9Q5xRYd+P1$Bgn%AAX^b~O&Ik&~VD$g}D*g?m5X=G8_8AJ3zzv23_#o<{Cy%F5 zoJut&ww|Fsx+8J#2WQXB*COrZ6YmOFpDwm+|m zhyZ_n{4-12Z!FX$l|L>IgJTo!4s|r!47iQqB)t#P{zl5Uq*Ev~ms#8Nk)Gusc1wS7 zmdtdf6}P~fwrh2i%M6SC{hls~?$)d)c5|xxu*8wp@1+pU#q)UFzO!Xxu4hc9*+h+a*7CDfKIc?A zn9$+do0%TNul1A>uawt1=v7gxonWghW09gssM~2yPiuUqu)dQ&h*Ta7r0V8Lq+QJO z)L(W9;*>g04o<_JL}kz$b>xDX^LjCT?Xs^7uyoz~?voSE(68jbRZci8-h!WnX>cSA zFqY zn&zlIEp_S;aX8mkCGB|u*SaE*n_J1wQY~cu$+8K_{?VRsMZ?G(mVg z5PA@2u0Q#7;4qoKdO2?y0nhuEd5z*5ox&K>5s>)XrY56G!uQ$Bs#UfOZMy^kyBFoT z#_$I(s*}-XK;Scs?#i;uWfd;>ZQ;p*GY%C>mDa`)gKdz0qY#Qa`*x zzfmHx3w*umH);+=l%V-6$tM;Yc^1%=LhXxUPX;Z@2-$psL}FW#<5H#qOg3 z!nL^f2cN~}#sq8$?kBh6Rj;$KX<2Zkd*yqG4HXd@crQ=xt$3@2mgRhWv3zhAhBs;x z6dGnYh}q1J&wZ`ut)bV29<;W?lL3}n?{#wU=0 zjxQ;c2?mA_2?mtpz<5EV6PO>&vH%&(zYguM&;6e%!3ofrxDY6WoCyjI$^ZZg&_@t( z>%VJ5oCrG9fvlX*%V15ue?RyidyW_$xX)z>Rw6@o6Cf058UVun9jFBy{MX5W6Z;TX z_i?bIqyph6!K=TiGwT_eEj^ z&UW$DT5HPmn5J&rWL>*7y|iMY3eEVrIduZnU2o8&F~nh4;~$vUW9-@UAalR218)_P zq+3lwc6XeT-w||}w?_vm;B8J6Hd0XmP3}OV;=l)rExhaG?)6@etyOLcDUiMIrbvbz z%BL5Gzp!0hnG)YA={fY??ef{gD#n z`tsy>!sJJqQ*}wYckAij_(Kn|$L6)Q;A3{7*W%cxa{lcNW$qgI2Bc{*so7~y_K0zb zFcQ4&@kzdP9&$QMz$}@zoc_9kHNSc4bYN2b`cz-CdXEy6(;a4IzF1n60Eml{zdU6_SxFt zAG!mKSlVN2kAifPrsx3C*S4{oL&TfS>jMEyJ@md@_*P7%w2b&@;TKFapxZlICMlO3 zx2o)j6&J;Ekr)M|Vdew$2>+!!l<`;29A#1QhoVKxfe2g* zWT5{WcY!ozA@qBJ2*RYG1T7TKY=LpWF9P&Az^VX71=J<*k;fwo5xtV3qEWQ>9UO_4 zBpoLTYIBrrpHZC97_}73ar|tJK{!-vLG&SFi`MKHX}wNf-e^ihg}&LM=a}<;`gG8k zLWU#<<7a^Y1Cq}d4_1Zm6vl;o_jym#-#}G)g<01$^ld`*j^I0YOAafG5-DL^i>gzD zv|0vXn>1NRk+aXK`d!K1%vS?_^QD@!Blu)2Hf9$t#C?wPlIp$*DKis&xm23*R7n4AJ;x{{2E{mmw&}BD#v)J z?9ET6nwT`7si_GwMS45LfMa80R%dI#-B8wEVp}9u1@A+`FG?S7quPS$D|L1z*TlY0 zQxfw=8+Nq$RY+%;!1d=X+~!sLzV2h98FVenB&$t~#He@47gS<-y5eq`Nnq=rRduy5 z%s)?~6=R2LX3(wV*2!(WylmOI$8c(VcdV03dXK&a7>QxZ$B@iX3uF;kxY;Sr)fprG zh*}abf9Jzr_nv0p7GM2T%3o%z^dMS@r;b_V>W~t>kNMBdFUr5u4KZsLl7Ruk=3DfJC|7XWQPVD(kF{5v9=?{c)}b(pt*4+?|n}9E$o5yHO+f0^n;N1@&POy&()G$y&zWslmX<85-o+UQ4gi`$Mdcf(@ zX55DQHI_%|YY!q_?zi#l4RN|`dgX0v>^(+JL~(e%!KeI_Jf`t$cM1rvqK3MhKIgF7 zzDl^{kU%v&S>-DIMj#T;B2AM|;YM3Ad@jr{NzS4s#E^!DVTNK|hc0(zm~5lbeNI6Y^A9`Q6tfV`LM8_3{2&>kRjPrP)Y!1^)LGP7EHJTObI%OCJ;#@GN|eR0z<$~ z0TE0vCR8;{0kA6tusOiuLG=T`xB2>H3+}n@Z zy+Kbkt&U?J%TLFS3YDJl6bHlbFy}USGi>j1*vu2{4uP3!m*-2W!tQ6Pyu(jws7_J{ zJgL#jjO53>^3EGoa6@Xl9I6(f}S?Kz1XJps#Ii9$r)qDTPgEPy27U8GiJVGi}AAD4g-YhNN z>CWGyZVsyJA*#<54&A6&l~}l^q(14Z1s86fYTH&DND(QNKBK3gYq=M?y6t7Y`G8XI zk->c6Cvmv8So90L_-> z@GHYl_k0b1pI;BwB;*`MY+xp(n`dcShLt}hUtVE9FwnV5!Q+v*w9umcx_6E3XFE?6 zTa`aFx$#|?H)ES>LHzrfSwW?L@waQ5A+T3>MA;zQbH7ofKljh3xRO2-ltz)auU zNU&-u*Xb*PZ8by{Ou_li3VzqEnTr- zP0Fw~AjD?R(t3o1$0H;$B#D*TyL-CA%3d;8znP`^V*gz9`;+#_0e*STK>XDig&L#{wXUAa*F1RlEn`Vj9-oC zE}NUCwzn&zKPqf=u!tA9(vRzpK5$rfthqA(a)K`U9m4?IHIScPn|w-Lr*Y9@KzxV# z(z2@No#=5le*fS9x@|w#+wktwD7q!wpxD`(OwW|PJ$!jJ8UR99XG%93`9E^BeE#iL zDy)NFXih`dvR-_r6h6w+J+ibis3R@Ae!i`|JS z_G~?w>K>aKVXO{z#r@P!fBcC<8@eHPJm*iFTXO_T+5W9dVP(u^u&eW1e!TrGeU3v< zqEFt1pA>a&U<%PcB;C^5JE^M6j69t>gIil9o-UBZQ|dmKy{hul_TWp|@VsOlx`LY& zDvugnzjtQmVksj|MXEY1*;Z_w5bP!Bk(Jf0s&+Tqb|JE%q)ch#ln_0N77~(Rn2Y$d zsIf?wYh|v`$Bh~)$E6Hf1-l%! zE7@(im1FLj{Pe4Vc$#I*FD7c}yWer&nZl8>E>@^+2?>jp?Q1@$TI=2QL;dWAcN6mw zla~2dBeC1l;kf^n2k!AQg2nCK#Ny&4-Ha+1ip`v`8zx<@Fnfm|o&pKm=dYOQ&Y!hd zYaf)4@* zO|7{ytBl9GBwG#Qn67@>q!fmq`B^ySl|9#4svCHJN){28+tOb@n~1cX-!YC!-FWbh)peV87;X0mMBQ5 z#cpJUdFQB&I;gw;3lE8qdKJcth|XUFuF>SO_1xUtk;b?xZA1@)C+Z*2_EPNF1PpO& zw~9VIu*zX78&%xHD@|%;dHtedtCgt`Rqy;IG{PA0?( z%ov6S6FaOAkR<#7)uGk= z>NL2zbm2$2{wCLYR@KG<%s9!j#Pl@!USx~7Sg8;(rU7&6c-VSx6|m;gFMi55s0 z2cpo^;6n%(qXnZt!R81I3x*6yo6sQuj1ZKI5$7G`L_TZ;dj+iuAuK@TZUFHGmIu}jy+8^M-go#nxa5KXt=->V zH=3ZI4*}@w5Ddx)!L?It&3>GX1mQP=%!1?P^N)kpsef4paHkN_>!hecFV28D%g6d^vGNH2bb2fHzk3X&d=gycWIRVoQ{cG-Q%o%hf^n{5hYB=kF@gOQM%wB zb+tQv941F&{K1*1WpA`CvGdk;%0&*g!R8%rg(;(hhgxcZepESrJYF&@#(F2%tIuUj zjqz-v+2idf#wQ)slPvX#N()TvKm<@wH*c5mGp;3r_dD`*Z{3(p_A)M3^oue_Vn=rG z2%bV|B`Kvv_l8IkuqpE6lOTd8=Pe70w60VEL{?9j9t+aC%A$=W7TCK43yGRH#2-(2 zU`Uc?2s_zfcPu@eH#rpwpFMKZDmy@XWAB-o^f80`M+=!pm{rx7a&4hRVoIY-829~D zS8+|<>ibP6#u0^vuddvZuTOdyIN-nB(K2DiY-?}Q!UF^HCAlP>DabgaBI8c!5w@06R%E{TfbIaiIU6=Vj z&2{ntUC(El1cLO9%DIL%W_P;Bt%?b0A9L4HELg?xt-H-9t}aE@c|e|oKLNuI)FdMC7gL4%$BrGKnDcAh8*#`9;aZE#PxyL*^sEe^gOMWd*{tBA%^V4Q)baBaZL z?+6b7IiTHR`}Rq<3)>^U(aE_6%N%U zS&-moWc5!E%e~I|}Zw&Xm)p%-)c8-XJ{(@~>K? zDP-Rhjm?v0dhLkS^753c|2vz+eD2_~bwqQjr!)=8(AWzhSU3;MGomYfcl#R?D`n#* zwW(Gfg{>)T#VfM@aQ`vUtTCl%cT7Pkx#1k2NZ1x0d(WSsL$z?Ol7~@~rF`>b-UGwTKD3y0hV0!M4?8E-eZB zdKNki4?uscdenJg9OMRpkbcua*>Cu{v>f1CQS(#wR|(#|jfz z2sQL|=4G6If_q2A@(S)#nHk zVtZqW3E^d}3Ng@op%0tjGFC+IkO-NMgO=)^YiFEIAr)WNO?S7)XL&irW5n#WR$O5F z=zR(rQSYm=S1HbmJ|?E{#X+*0x$(Jn_gW%bcaR+kW_den~}Ve>J& zf_lnhUs9EXY54{Ci|?mJcXTE*6X-YF#=Sp1A=oo~Rn(kg?@3x)uW#2$+&Ov}YV%aY zPgmhh(sF8sYv#J#ok|*E=3DoEN39Z3Au1*Fb(ATXeHvx#A3I9|ZPNC$cx7F}xC9lC zucYd`LUQq?}n}G0-LRU)tSmtzu z;tzHBbr>&i?ra>D0;=Y#ysImd{+c)uQ+%)cR<*|NM3bwxB=fLW);%^U>YrXkDoWVc z!Wu6RsBOO5gc=Neo6X&8!%jutF%*nZTqvCg|0PNU!KLHCHFmrVxyTH-h5oKB`QR_#K zogP~0gcTcW8AUfqo4x-bMEM+U&Oc1pSf}Yk(LeFMz05-Mr6uet=!#g;?E!lFB)@4Y zGilseNXZL{Z`9V2$uGGgQ)xZ*m~qdQVW;8&Tb)EpABKNx`Z!9C!kb@HMc#w&XVc2X z)<`Px?YjRA3Nc)sJ|Jr0`k~^PC$P!kV`aaL+ehAjGDe-c+IH}1Tgg@7$ZU9iJ0@~I zXLe65(F@DCXEvi@+F8TjefC`cG_Ge*hD(a#aH8T zt^eB%PtxHV`44tYGQf03tBsgT+Us&Y=Jui5`T~A|Ue(hWVHA1&0x2G$x>&0e*N2 z#r&Xq%YTOeOVojJJ7~h>AlD_f%*$kk3YZ8szh#gSds%pjZde8X-=BUi@F0G0=Xw5Oh41h7c3jT+L%D|8K+P z|Dq9~Xam~cLNM@u;GqN<@RTjXH2t8ce48R$5ectH?ce=T5zJO zzPphLb5kwBLU=6l@OP=DQQGf371tI-RP+*OGiQToUp?wZ0YNut)HuPbmGsDX#CAo; zvIs{T&ZeVe6=O4VnO}LsS-zy5{I>h1d~`;n^cPc$V|EUO8k(~P_jCwXVe9hZh9>@i zxN#>|C*2+LsJ+J8YUR%+*_q0di9b_wOw_2U2Jfpg&fo8fahQ6?z#%y1^u0m1i<$87 zK?v_;s0{A?J&g2DJAQU?yL9I#iz6hrTx`tW@f@!P_O98H8=s(0N6h~icTwa+!|hO@cG)D#E03ABHJa41A4FHkS~{h!!MAyF+Ka?v zq9@3s$yS^$TG-f-agHjJxyvh=f31%Yl+g}kKgK=O7bvTqm>OfF$=RDA`Q6&`>_jqQ z-}BTjP)+G@fftWn_cP0~V-35C%Nv=*1gcln3;R3)g<6p+q8^8el3d%%Ke2O^f>QX# zbFbx!zR>6ddlGu29oTr6#_7GSb+)RM;W@rI5@mnz?y234!cMp3vWadh`d{sUtpXuJ}|^`&+296Ga)5x4lbf>FSh z+Ob(BpOB^QU=Z>RSk7T;&hpL@)Ye-mlr)s zxYRx*dhV5a%ShbD?zo))4qMKM=a}-ONJ@66+PgnVd?ms#Owm*8(iVm;G-P;~+@o?P z5Nm3RIw9osL(^^JM|>IW(O$E0lx4Z-1>`{ zpG)bHCi526MdelNk{1cOtyV?%66}^)wu+aZkybViBzm;` z_E5gFO3VaN$u3h7l!mi-CWr(yp{OO+wo$i~(rG_?Dc#UwS>i5>r=P`-(5kKPTaw8jEg~gqm&Pk{MB7WMjH+k`yUpFV2WH_vq6S z;qwkUGcL>6vwU7P4yLy^un?d>&Gc2=mKf-!E>Ax*P)WBA%$qz4q^J7GVFt+Q=n^Uks#NMMdJY9qGRCSGLZRWve$Z znY?&4rb$Q7^eQ&P?(&D&mEKzJ!4#RbeM~qVQTJENqaV#`Z1}{MI!|R^uz9=JRG(7? zaPAAwu8Iy9$*JluwI7=1SzO0eQ(soTmXTP>(WRv`NZnGb(Ka)V|G_ntQt_3?bd-*y z!0pl}QaNp4LW5`9^vl+lvqWdvDmsF4g+%`$I?tXv-H{6l7UbhNtqdXXXok%fs50rk z&t6FLqQ-mc+_A1MRyo#jV<&Gk&h~qL{l_T&YWjHSO5jLUV0m~QOS z1kYEH-+B@g>nB9}o!v`;10Rz!WmqY#R?Fz#Qm8{E<1O9CQVQ*zjI0k{)^!s3r*ds} z6~slaaP>I9IS3u{ND0N?oJk+Y&X-$)?i(zulm{us4~(0jKCp;43@%~TR8TU>qg}ivnnv$B*Y9iJGqk7J8(xpc!}ANbhbZpH zijQ=eom_LXT=0vW2*uvW1<9q}0h0FSgs=w&E5&MJJZX~n5k{W3&hNu{_%u4Pf3Z4a zVXsu$RhwznJx8`%!Mgqt`)otAz|$sskuts6MzNCWNP9*9YVG6&ror3XOC6^taYQq) zYHM?=!o1^|RQLsQ{YkgyhPL?eV-~YwM614&rqLqPkSoHoxBj>Q#)lH6sV^cl~}{o`dh` zkkWwN@tYUVcPHp*vVQMQA~`QTzIehKMr`O>CKG{D{bTJQ>|4V5EUWTP}DGTHy#C&@9kW@u%-}#`{`f)6c~_Jfysbt0;JXI0ee&p_QPQ zWZ#V{pROT>HxYwGo}U5^E`53|W&8n3D#+s@$&q;^*mnC2B#^+l*e(?JwT>FlP?BLK ztL?}M9^YVEM~P^(?_rvv^w_Xs1W?8!q!vrcytf|eiRtXE@Gfwa_9JF7sSZ19mY|n* zl&H4L+^Wmlo*+V{5%+2;9{bRjo8GSPhz2(D@X1N@Tx;&XW?NHXDiTlH6jRXmd}H54 zP!}Iiys$iGBAQwZqYWaMwRw+IUW0*MeyHzQ=D1C~`|!7_z(UbpL;7cb?d#WTiy6nE zRlj}W&qR1Cue_RnZ@a}k5L?A(!0qrMNzAR^4!3^59<6@Vtla!+MWE*}AmF@3g2M4L zLl@}t`fG_^FtqqtG{x4OlZVK$8Vfs)+Y(CQ>R_mk6F+m-%)Kx0`8Xq+quZHL3&n32 zsP$Qs1=U&MrT}_79_-;Lhb{F7St-ZU2s`>({px(3r~QCjykHBhtjg*4Y5yyqL!p|{4~i_>XG|PQT^~5*+v|y>J7{4?4C>@v zgs(d&n5$pqv1Zm(o>Prdisj|F=BA4sOv}hqta~ZwCMf3fOgtvzgPnq~P*d=J5EXx#({Ims z5KW||sKJu(M(~6|{~s7xYI40wa6plg0lyQ?$S(`@YCX=XxzE@}@`SXy+~>dD}b`(wDe3zSsl>PB#_TM2(UKHMS~mUr7} zw>vsRT<+{D(iO9373|H`&W5Z%wdGq+5AdxA_PVIjm6^=>wmDmU&?GGcOti*|bG}#{ zzM^e>5*a@8Ep4ei&V*6MO{FPpia|%mdkEb&$xfIpnWq;oD9rAUrt9-%!2n+5AFkJT zr+DKHeN4wWD`vAwTG9<=G{b^niZGZE3>S7n*f2O)$)Py%xBqwv@l0`R7eBGDW^mW2 zI_)@31Fi#%3e=Kd09{ncLOeAJmltdt?4pCxVvE)7-drBg78X;2y;G?aF??bJ=2>>|&{z8x$OemH~3l)MvNjh49lYuC11lp_PUto?7^-25-zWnF}GrIO`PQ1Q2^?m^E7T&M= z!jeR{DXzie)bY+WeZ%}8uFdb;Y4Mzp&iPkf9aw0tVXkUsuc2FtvuXqx4VzZAOb8uH zBEc1zG;+|NIhs0D>X=+`)bUu}cTu*R*_U{xtoYl?oX)=ImJvwBF8SlJ@+<^`(tE5V zc0Fj76E3(g#z;zd{(&Wpe2kj&bOBa zfQqWh7L1?n+OS%}I=jy;$huNu^@XhXm?hmdWzBUnX)mauwBYH4T1mKezra&c?pO`x z2BZdd^4}y327A}H{XeLJw|A+>xpjDX{o9t4(cUVdlN(I$UB_JWFmJP?mUV!Q@Y)W> zNJs)PXGDsV7M8ldQ#Pusjk1yiqy`rZa(T*FRWkC=yBL3#N&CD-m)YVzOw(qSKGYum zlW07@kQ@6qW=Nt5-NU=lUw^oSRhv06^|$11gnz%1^OHB+eymW#8D(#VW5(mS(DeOX z`=Yz;*QZlxvDA|!)=tChja=2JE3rs3dVQ(C1u_l71LdwloT{QIR4fdXveJBWh|1|; z&!2HweZc>4=&2cZoFgtFm%{NCM~gB;Y-X-ORR9LJRrgo$Vw;LLEZ<&D4NOXO_^-ecWK(U(*g-UCD0N zDWq(^f1p?vO)g8t+rFQou)8;ic(&RXeFI%0q+Zye{~l|55%+_Ynr`cJn{=5R3tS;KDII(j=x4ui`yGc<4chH+Ts<4m@QnY~~FrV?h3d z&P3(YvY*kFhfImHGYsky@5J^+BW!}M9+}l*3ErQMn^aQ3I%al)*t~WhpV7S-s=t&F z`v>nD@fVbbrZm`Odyp?3M3d0MQdJ0E%5t5Qjmn<`oMx`E@8e?=shQlv z!J0h{6nm`>`!QRvH2d^2j%!sW$rnHTyco%}6k{ z`};$8Q1Mv%sDD{eMowA~FRMD&Eh-FyP=2vK{BmqCSp4$C^~mJPpcUs=sHexz@{;v2 z_1}!UepR9aCZnjrrM9s5VoPv1lH%dgk+@!_Sl3K)hfY{F=PS~TuV>3~-2(mi)+Yg; zJlk$qhGh!0Ez%A@pul~_c-1M!@^g0B-z7)bh-CjjA#kT}1Vr<}+LqO^-Nx^xijoj) z2**Zi=iY#hc;81@S-b_+G6U=5?7VgH-g#hebIvJ9f3ciPat|Tt3N(=EDy|1 z)-et}LJKG*=jdn;i}o5j2#ThmLf>5CWLaERd)I`7!gXJ6eKNGjXoHgc!GX_q#L^Zd z^p0)iX;DBe`(0nfC3rcocYOYs?TDyI6s0TcGc0x_NAp)#z$`vHekriEBK%gq~+ zUTSovYq68+Wv$>jXfHrWg3M=~NZXNbv>Z7k7oT|{&=%~-SblMYc*SV=#k-T54~a?5 z04R0LF8^koYsjCDlckXm70-i)HNm70XkM&O3;cPd*zPIA9XtSfR+1xg=V&-5W-Kjg zwE$#bxQ_)tIXd_U@oyV(QT67r$ZT%YduL(STY&j=-0bX($dQ#tWwgTgX?w5n-Jeic zDcS1jfFndSO~l?>w`2Z1CqpS}kwpB8&YdnrWwwrm?fqOxNn&ZRep3cPC@dz1@5)uS z2Agte5KEO9pO+)zef?#vjUs4!c@> zHr|@{J_15h435ReGi^u0JW+Mt7)bo?ip_j^&^{NrUNA^dGdqK)iFpXYyKtvnv%eU* zVj!pv-0TB-toP_@2uEagZ4uuMkRHda_xkws!B+6|DyLOL;Qr|qTO{LvG;ccXERKBb)^PZO;%6X*s{rnlSmQv8UwIrJjnE53}@G$6mzq8pt zRzi4HvF*l9rEpbCizLi8g*7*@7~{^PMpEbkV$88EsI})n`%#bUUq3m`*SySs9;Tr1 zYpTz+Z1^eF*D4PW=@Z#QFUs94_jycBm)x0um{rXDmUm*tAr9Bb#kH7;e6+|tg~x_1 z-xL737pGKqO>|(+iQmRct22+`3qRwpv@B`_x)~V~x#Y>FZo1T+ozjaIZJW+Hw2=$S z2O%UR+DmoMjo2JFe()K$qMREbytlZ8dPAdA_CuAgnD5x4S^X`cnI-KXsQn(NJ9gx| zq3}B{Pu-m}))SrZNsMLv%pQbsMbV3zbJG2BEq;k9=o;t382t4=P=_i-1JW&n-`SH` zmlIHBh=jR_NNLg{{U=g&w-Ye$`M3aUrI)@ku@MQnj_N5yWay?i{y{A3Dmm_^V1Z9P zqcYmyQB3~zPSZ0X+6D#k)o{uGp)_X)`D(#M==e9>i{aF8Q)9JqJj6yLdR|pC zWri&?7TNfSFCf~rM{+gw1LPaSfGtzvxkC07qF% zs%!L84w{K~h1|Z!dAKWMN!a8A<*)H$4$Req!c()-PenS(y{Ml!np}kKZ&mO6WVtET zfnmwn-!Sd7pq6oS(M@$d3S0J8ymX_G949!A#iWY&`J8uM@woPadp@S3BQMc^R2Ks> z#@)Opaty_;8Oh%YwVY;IRgP+v^w1ynPH@?_PfW!LI`*z_VfVJdy^Bb?=-7>O7P*NC z-y5P$>{H}wB-STSvnOLt zWIWJSGhPPK&glkRg_PW<7KTbCaI%NtoC5&-uwRS?*tL!3iL6NnRUJ9yX{Zm}@^RLM zi3~U1?h)^sNkmDxbyk%-o$KpAX1%E7)<;)e2kN0Uc@JVvk+6WsBqB?n3Tnit8_+zc zw)@UBXwvm0gR)RZlj*5$^{AB9u&HocGPMUX9)w3!)6$*WADe(3JBM+(_lSn&iw4Lz z8tKK{S!k~DOt%-9K`|0#3)d%aWHU`IUE{dFs^b&ujT}~#I8md8X7Xjnp=xZ|BbKp6 z)*%8NYFF{09!WM6YPk4kQHi)!o!iyH-hPq5PbbfbSt8G7mk=XSC?9?u>hR{U1{hhQ z4hoNFI|+P6Bgg%oz#t@}W9bd+0q#C)Mzs8l0o!a}Le>fD53jvuWS9x250@vTXL@Ig z!3q31wDQe!s&q5=TeCCPY@;CZXR`wJ$aD1~Ya!3@%f9{Joqd2kRf81Qp=P2bKef;R z_Jl4YK_{QUH%`BRnSB@rV>ZpgR-l}`v>m~s=f%hPK58zu5)m$}(hxp2Z?;8oY%ENQ z=+EyU`q)@N^IkA19mG=@hy_V9(7m$3pdc>Xw~$F6Du5V{U5{di4;$F6Z~MgUR7xLLpgih&?ts^RE&D33dIq+kcfF{#&_26cTI5!2cf$48nw$uW+z>?EfOwex zTi`>E{j~{*K#m%}-rhga;jab(;rc^@agYO)5VkOGz?)Z$2n4bT$yq>8lK;2)hjdl4 zyyh-0@jpWcWxYXxT!OXxuT1fJ*Z({LkhK1P*cQxJBf#J0ZD$Btj1(f$KtQ7(FCj<& z2^koWyMn-(|ICZdq?YZE1AC@_M7fzK0<`w52RWDOB(M2!aQBUXnjfMizPOEwI{3e# zN_o-RXV`V(1;)oqKb12~mv$X4XR0VZBL&^=cfLrg#FXyH;_<{Tm9cqH+86cZoS>Pd z3z1Q^#!wtYNK@>_`Z(QiMI#evyJ3w_Rp>J!V9GX+IAVxr00r`xh;cQD9Tb4xG4dSw zARzXPl@Wz6d9k~k#+4FwSzTN@kjN`beYf1qh%#RJH^s7D)vQ#ng)oDHd%O)$y8HSo z6ZhH|nH@0h!jy;2w4}H@EFD>QPt&=ZiA29)%==iaP(oEG{iX?oOLdQ>5neT(;*jzL zg|y@akt9a#k7ZXQCRVs+#LU44J1Ro5-pEbAJ_p-aaZ+eb@b|EA$F`|j|D@lg^Uw0a z=OUcY|0dk~v)??aw2HNvW`4@S$F+3O5FiwaFA;sxt|J#8_j4@&4P1aIh+$?76jULk zKq|RvZ}myzhl%%OkF9e1ca4bY$FQa_II)el$<2!L)uTTYVt-C>D9_S}PtQp($tn{CZ#XqqQkBKHj3% zG4sws!UvJys-94n-+C>!uO8hRpsTCOhpUK3A&k0EPcdL*4U88X#hD=l7ophJ7Ek86 zCa(#%6;krMKO);JWRuAXK>Jm)K{xs81cFY|2l$G1aox-AN#hup%(v+y&v7#=i>(3W zQ2}z5CVR*WyB)AcH;-8#m9W8$L%xNz#UuVjs*PES!ByKPZ8cUR8dd->RD%R82y`9j zkI3cw44bJl!8`_h$GdC80K3A@lEmm8#bT`+;Xk=oZ!fE9*zaoTy@ZPiX(o3pTz(AJ zH+&(XXrXs!;^*%gS+Zqsa+NYlX0!*(M}k^v9(vt3j38Us^`yQsG_fT`K5fH3aPpMd zu>y`$Bk$$}G!`&3)wvN{R8@(il;=NV5X zXE+9AvrhU(Mnk8B9J~E3oUc{Gn33s9;|-e0WXCa3kLyNb=eFc1Sw66bhpaHhk7!ce90#Zog5vrC2Ez* zinMr)u_Kg1%B5^0)NSrb`D;4wy7QoMn1{k6IPz5q4d)`u>@D3RrCq*f9rPUjVRE=mSv)J z;wh39VmFa1vt$F9wbTrfk*8GM$-vJ=97~_ve6fXxTSAJmI>nMXLY2f}D1&k)Ym4;M ziaH72P&E$Ppfz%2_yr|ahI_06lND2(<4k6l2YZM^p88}QlGwQ;lj0Q8EI>@y=%KEP zFV44g-eGHzN8#Lb(>d2f9E*a}2kagGxEbQMn*FMS8O5y3BL=Q*>hxM756Zi!0<}ie z9q_9HOZlCIrhH5C)0}w8h;RZ+CAf9J#hC)GgQY3;C(}g3^)0`u_3n>Wjq-k&miorA zz)CfL)O;J7o7f&wR2@;`GSa-*<{sW8b8J3L_BphjbM0f;!fwCbbMA4S!m@1w$8=>L zn>iZa*ZH7!&>XVbwH2vybc}+hcap>pmo1 z@fqH35TF0JLtHE2C$?3%8>h{eq2AQExp-yY`ot)w;^gY13Wo1S+lF032VZ{+ccram z4m9WpU0)WN&5kx!Wff#2|AE5({eTeh`p*f$+|-0NmaXF%bXq_CX33b!Eklg-Ti)#l zVR4O#S@j1htD{>By;J55N~GutA%C@OmXyg}-sOIf`}OW&-LSo5Ay*NRS7!B2|9*$W zeYV06g&m3dYyV83Ejs_>^u!CSAqEeqll!cI|mH<%4M%B@Q z?6@P%D#`{9X2h~}jZ{~`egPcQ*Tb4q>}D2q)Dw8VqL8h9$yp;w|ACWMMM077pi}qln_NeVk;F0rMjKzzowNm>4sW>emSZtK zJlHXNJL(B~w1QS1uhf1Jn-;(zP-fxq-B);fj_BSU^LXH?LxT575;t0?VlKoa^rWBm z?7gJ;CAH|*hPs=sm|+R69x_UDp5`}4t+Axx%10gDo@C+AUV(CkU~SMG=TAwIj`KY| zbKIwiSQ~?h<7@c5r@UmsY0LN`dtSMx{+;@0J$92aF1j)ZRM|m}hCKe{NEfOrpr++A znon9I%Qg$XVnAI{nWjHdr}&|eC@bXi+r2z>OB3)TB05D`{wznG0&y3c1me3^Rzbu3 zuMkjjb`2tL-7l`ieD;7_cNywC`%bWF#zHk>u#7<*p#6R}%-bwt{ z5R_5*4KShp?vyvey}V7rCZeku#a2iPPCVImZ^(7H^;eOv>Gmh(6ew?zq9;X8f>z16 z!4vC@3NJdbV4{p~VG}O=r2_rZxDYfvH5+W9g~seluaMa<8(LYckVm%PgL_EKXcG-r zMRCjXz6>@XKU2gAVmP`=G3mk>J7EoW;pnd$Z&lqnm8ig=vOWlFBXRcaucU=jZZh4o zb=1!eF+dWgB)^J3bn9^{t$LA}Rp;o(;ks0Fz!;dUBJnU%6@uZ>K!p)F|E9IC{~Wli z{7@a^b&qnXFzv&rCjH^t4=dqsQ%`K)FGytsU@Sd@#C#F548Ru0z{bz_+M*Yv@)!H0 z7yB-|%}mS-hbMEceA#aP$KChkhtb~%Tfb;*34B4KSYC7f12wrU@&G$XfV10y{=4Or z^E=cf#ZU+#^UR$xh?oS<)E2$@HG%MHQ#QcLo)nkcX#E7W%E;V%B{Gl*q9wQ? z`zS;+lTs$z1=sWO1AKp?Q~1<~X(EqHR@C1kUkkeo7Nm!%Z-6lML6ZQLAH#2hS|;TW^61$8SAh;6EIwXgu- zGId@=j+rngM^z!2cv#5eOwuNmq2Ymt^uzB&V^eyj!_ni`6zA;pOOHjuYConvs)saTnaXBrKRD{}(TXTu zlY5oMH0)sv&bNw zK_DN5V^d$;`RR~u8JSv0*>>C}tXMgXD-ok)m>Qs^b*}pIHZ+fjD6v$A(nZax8x(3S zxfJI{sjn?2sgoQ0uHWW}7_NC!)w$;Yirn*KpFrBI2X!w_?751wEg|`04)ha8M0>mZ zuC`e>q#Z<+=BQkL#+m`?ju1wfvfA@!M9Xfc#Qjd5P2?5W3%<%haO#(Ia8)5!QiN(= zX&RW)hT2j^cEez6LabD2bY@Q7P*Y0cJ_qBiMmV1Pqka;`+n)?N5mZ-PxC`J z?eNKPt_ZBVFaXSKR6&#I5D1(qloiyiKlLl^%k$gXc#L>|?;tMMm0dt*tp4T*0uu@5 zddNEbMl0ro2CO`GGYC07Q_r5Z-<*bO+fyrc9=E_Js6~6mROx+-L7VzyJ%{@~n40k+ z7bf?TzjuUl3>fw`xmS6N)GklnC^9I?M>cw~Kv1GdMtPo&Kxs%ZD)hw5TUrUxYM&S! z*ywI>niwc|u?x!*`;Kty^!KrN1A*MYRs$ngmXsI$%LoD3orpU7jZLdKJ|eQO7NQ8r zHhkYL%mg+!)Aux+VVlMU6&L2t2J6YW#zA@N+nW!EF#(}rnHqM;@=0*i+6MAE(Dl&U zjzVup`Z2I3$98ioW7UYvTD}3;n)dfK7!;Kcai#J?D{0-2Ef*0Z2Ejc3(o1wQ3)JGPt=wP&WR|Mdg=&ph7s- ziALWW$|h3w^aVvGZ0AF@+^|+`dC_g}{b-5bzQ0S^T6D%O?;kUhM7`Ge+FNQ)5go9} z0`(3%Y%d^ws<$2*6G|*hBRsdL`7HSDhy#h32&AnDGG;^0L8zw*IFUyGk_?3`0U}0} zpxX*C#SLOd3eKa=#YRPd=nDYIq)=6s0FV($xdFJvm86o9k{@i~*^!VJp1a`FClYWy4bxglPO*G9acS0?%y#DcN; zPgWTGUpC>d@NoG$u0wtyHQ^|b>_B5Z9fk-EBv>U2ndzZk(PD6a5!$aYgMX9%zbwFC zkH^;QIj=`wGt+;yhgTip4a8*ew+J2P?=hfAHyxw`;?@3u_1ZD<&;D=-MFQ!*2o;Ui zhWnrmAN}`3d%YS&b6M&BE3W+iGhbf=3L|E_{8`wW z;TcvaLbKGj_nqUomi^gEg|j7pRv=%A0#M?gwxxqpi!d=VZ%G4i-Kanfk^+3s8FX=L zc^);Z6OuiECZrS&*n%S5A$#~OFJcJ_=W-?^AT`aRMPF$Uh1UHdJx(hh`TNT+Ha--? z8o8@Wq6{)rz1=+(@W&lJ$Z(Q-^q>@NuZ(@MHGsj(T*&7K@u`somPv>2>|YPyj;0Am z$9QumvoD`^IvGrIPex^wP3B>+*`E^i<6*SMl)(WU55Y(yX=z{{?57(iMikt#p^YBg zM(CDLaO8}^Jh@1}(ceRmHR~j^RI)$3@-yW~(y}bqk5F%<2bmkA=YFB!@tEPtRJSo# zzXN(O%LzbVb@Yc0@NE9}6<6u<$4?hgn;lurDC4HDbBMZ|>Nerr^-Lpi31QAGb;B;+ zEoNT@*reD#o{PnE2$|BD#q?R)M=rKue6sUSFt2bjF~Qf~li;OjP28GOs`R%sZ*vSM z&q=yKZz%*h+I4*{n|&rpNR=*^BWp#oKHM}xjyQs47p5+Wx5ohiAYb17zf#&hu+|?Y z&Yl9~UEWP6)j0DH>n=2RF0jG_%@bp*bMY^C@_-G&)#Zn-F!wm9@_t{+w?QX378+~cv==_+yLPJ zKoR#~ZPzo1PNbdoQ}I8(JHpN`$y9rRz*QPO{NKYK*Vx!t4Q(iCy zqMi%N=(NV2RXO~>X>iUbX1O7CpH(iblRt_pIh~=XN>e>xvf5@c&sx!pD1I^0#FlKu zh6+$tmO$s8oqM?i&Ja*Kdei@2BGi6D%QNJT&A}L(`c(Hc*5w=i&`o^QjQ*GLerP{^P*?xV ziL_>KSLBBRo^?$FDF^gBQQcKUxg_87KsCDudy}vxtoe%Nt*3p0?@Ot_26VNl-?+m* zLXre>Y}u#BHt2=xGIxM)f zs}*yZ@HmBt4%pIBg3dG-4NlU9zE8HN1b#X1kRnc5#va*Te^ar<&Z8rvmEnXbTpeq& zhHW$}SygW{ZahJ3N{-tv$hiIx;Oc_^GF4sAb*<=|XGg5lK+(M_Fodoq(QxMfpj}Dr zgNNu{`0yg5I}o>_j6#!T&t)^}ZS^QsR{8`~r=WK_L!NfAZ2oWxrU~cWe_Ufn6LjiZ z=il}bM7QB~-owrlO_gVwwZ)DuT|!c0Vl?WG*&%i{h?{L6Gs>o)ud9nl}ASsP_Z$u!WZuUQO*CzNemj%c=BrxB(?Y|z zh0^JvN)cI;OS( zFep4m77J4mqakpQLG2Ykri$PK3@w>TWm`lTmCV7k9u1|B`=uAiXr}lIs$_|K>f~~B zETJ{=O_WGu30{*^ADy5?mdqSIhR0*iJ`OOIz&5?N`hrvogi%_A-rr`HkZJh!2g;<( z-X+xvSMwcRmPM1E3gE?cTaTJ7cq@f2nyyX_$ynXk^(0zGE{P|zfN@j1;oK2zr*^n1 z0kJ1oAhUgJd6s%NO)j2U-hy6;$UWp%yOP$s*fxra>YT3|M!Bq2_HxFWiKHMCf|)V? zq}x+jxu|KBHjP))>*rW@8eFG9S9m);xJ9C{Bd!(2Du}L_d%APzXnd!nB1?EtoGw18 zcukZcpBnCuwFz$gEGcI$BvsxT=qD293-EYXZ#$Eg*X~!2IY#l(LP^UthjF1Ev|*Ov ziI1nRrJry)zfid)pdNPszcQN2Zb9=LY!kVFy5er)i7oS=kx+=5klpe^Ok* zmcD^6v1rvd+grXxKL;Dy z8I?8!lABC$3cxI!;W;BY#(2l7M5cn20)|~)kQtNi&K-3B_I0nb)UBwwH^Oom_@f~y z!<^Z|iSFi|aZq|4e$v#WJvD<;$d>g|4A1C!!%6n{lzWNd_i<(|o8 z>Jy$({4v-T8VzqPs^f>KZ_gi50??&eU-ET*(IWhK2lqsk7%TbXlG@@(o+#|kXFrK; zqmnqf$)acIg8_U#(3nzO=;|!HZ6>ng)ZCoZO~il;KoNjTP_p)gl0PqVmJX0|4-4uaEg$?H2kRWMCd3FV|=5wxS_4<{rU{}n_b?y0@AQXd@j4n9-a=m2Wv zH+gRa7tN6DJWp<1h2Hcyeh3lICG^NL%K{yn!N=n46AS} zJfg0e*BPrKbjq@~Z1crl3(UmuJob*2z4u;og0u^gPCBCVXV=!5FkzS!Z991aQ_HY;@2-4s;`2W1<= zUp1FtF*BcpR&!m1hvm@y zi7G`}F+vN~vVw78#4aU{Sy06IX<&TVJ(| zlao7D8NJ-N#WU5u(_@9}6)pr5a1aXbdDn!pyS7)i`$1u`2KVaV+qcxm#Rh#v z0A`*J%w2j%rywTt{m3hT2nCTJ$ctGCpp$tOvj* z|H+~di>m0uZyuW5ufwhmV&@&dRD`yr3Pzqy%iLy%C&e_udM>@m8gPTrfh*Kr33fhP ztm1QGgqET}PpK*e28|VCpNYwB5BM{FBw>NPu{y=)Tc^Xs^MWIix?};M7aAJ-s0dTx zafw!*@Z9^$46~2X`()j-%c=(!`z#k_kB=yW`q5ltw@=z>E+Y=2NGtRp)dvS8y$DrS zHDZPCeI9X#dysI~9x=SLZS#QlT-rzd=H{0q2_o;krhSv$c&w7<^_DMdIsVJXET1I0 zU*g1urH}KV79Rsp7N+b2=<(_o_N*1kEP4`i4bK^>ivB=BQJ`s~{i52&?Ykdk&K8%p z!ZU5am=h(q?~MzTww98cHY~+f_eOm#D%YrZBymD%g(*=i7F2Re?a|zjz(Xm$kIh*( z=3xK?AJyumko>+|*MS2F3Bf)f!qzCUnt4$Kv(iMzi{gVuUyIVX`AOux z>fDd|?l>W@5KiB6PM&KCK(dFk2_2djH9o7dt`LE|gzI8Sp1J)j3$4K9kf)VgQqZ3N zk?%;R`D&yx{|{7X?`CC_Q^qrvWClyb-EOO2Me5VL)9h#2pK~rO-eUbN2Jw-fiX`c4 znk1IjSwHps7X0B^OV`|GO=sU^5iBRyME-fj7&gFqZo4}lY;VpEseDU%d+u{Qxr1zf#Wr-KX(?fB{HT=<6l^XGZwvDL|k6fGo0n2`O^<2M_p5%7+LO zgNzX6;SvHFqyC2(cs(16|9|iBpSMpzisCMfTf7i%sXbi%H)F{4fbD3Evuk?7-l-GF1wJ<+2nHWJ>SB||f5drccC zdh#`^4J>L)Qj42hz-o$(e!LE79fqcje6DY);4~78?yEpki1R7t)hklkkUDw;6jsYd1}H16x{ z#O<4JvM2F^&xrRc2k16dj379%Nan&6H6{y8b{dD$FOPkv0t)Y=!$;0(@~UquX2w@e zadG@95vTbQPesMB=0rc`bY$g>GF9-!NExvP{{* zL`!EvVisk8428fQc4VOMhLy^ga^9*0SXRcAKJ+oG-$Da}-WOch$Oi#{=PXfURj|#W zyYac*n_~>r{wf zv8)@T@@WH&g2Nq&kkSh8HVhP$-T3sCrVfmvqtB714#OZo+;F}+N+aSo63#grKi^xTNH4)3IM zRk$!a4CN;k32)l@6cfYg*HlN*I`SI6Tte9(x?b~3m<(tObx61=~lW7XK>0`n{9G_yYG=FLc<}>x=9qPwh_8ImA6+=PB6nE; zYu{)yT7$;Q+OdBlcI{KepxoeXQ%rvstTv|&w{4t_xWQ%~MN|sSgOmCL)k&00JB9pp zvNdPB3jGRNj(~+(YZ4#(%aOB3Nd2%=^LgQT2&)HC6504(QEj1(h4xCXmu>2?pB29U zyDfV;ag5f}h(w1mhwF7C{$M{-{QL#wS@C!)&Q+KIX5RuFZ2x^9%ZE7h7v_y~?ez_N zhjIbd-WUiL7B0mWM{>boEQm3DO!KoiN#Ym8Il@D%9VXe?3O$3r8B@&!DtQ zv+%+NbD!tD6?4`|LFy~uC9b_olhde;X9j&P#g?#9W4U4XofD`Q@2(T*M4e&hPNKFJr{XRyN5i;ZK zd#}Cw=vSgC!A$FwpoA=EUXG||t_?emvN2}(_Hu9Ok@d{x7eTX4YnDx7j=iYZt=wqO z!Q?vj)QX7a2aqq!Lx*HyX(Z?dB>1AHZQmf8-n=&DPpfEgGu1ErS zBj0m6X7+G(+5{B|M{UY_S{eL8KjF#iM<6bl(G+P&;P~Pc+!R=__AKm{{M*k;_LQeW zgJrmE#zK_rT2WJ|(3XO*z9Y4Rdu${B@;FX1d8o{Qrx}Sx)}#pMO63ofIcVQ^!pnMd zTW+?2lLAd94}T@Guli|AHNjVjCnJ$BkXCK|qhy^)!MEyQ3`X$D4oY#~GGBtL{j92G z$?o*Fa;F@!AhQ#RW;APE)#l?$ck}e+)6j2vpbq^L&X6#;Hyt>(ru@&uHS%9Ac(ypI@DC z=ew2^Qe&Iu=#jR}sJzP_4eS+p*F5=BroNVxBzhHB6r)b!hS1|XOSdUeV~G+qzN%AfJsanN$i>5 z&x7T0W4gso_uiJfB|-H}NC$S~(=-%*l-3|N6Z{EbZD5bx*imO+)^zn;QI^M!-?5vt zzf&v|(o1*wC3=TwsJizliYh(<4tFp+viq27Wn!E`I*>`#TR&IFaT%2@qd8f^}}yxe^KFVhCv zR98VQKF}1ai9HEwbbz@2st=vvAMFeMD6xxnJM#+Veq35%&C05!CTFqwN^=#MU4Pgw zd_*kvr127tA{t3j8Wl<`9v)^NC->Gfl5uE$o@`zU5f6GBueg(DGM($cOQF0+>Q|j* z^MImieWtLLsih#N<7kpdn~%j-JngVsj)PPWTAC@@YWG2R?_$imlbEYSeqw3P@DmHJ z>64Y%`$3V?*ILA|kLp@*@Ds&PS}b*+H&s)~K0x)iyvyv$9`Tcq>DdD^bkJ4Vgw+Wf zDhB-Yapjdd0hzE`;!_7YOwUO+czWwZ*Jj@gZ}c5GAxh-uFa`J5 zJg4;Gj8Q;?9fE6{@#9`(xWnpYIMVyyMk%kQc}vBA%ytdkvIamkB@MjI%4aWA6hFUS zYuX`RJVOaTr&ds<@xCcdwugQuWNsjXh11<9#E&;u>t9vM8aO8~I_D6UntVS@R>5LF zSeXYB2de~lIB;y{z7eGofyW8i zby1MWO>m2Qha6p)>U=&)QKfC=!w_Z=ul*zdm2oq|qS zG5tmOJ2g+@*$Z>pe$AB;>H&_*uX0*7@ruc%!`P=8D?cOo!3LmUH`vlcB}JN$Rx+$7 zvv3$QYiRfEFK&A{h+j8nX~j+x(ct&-Lzc$XCKTGkWzBEi<4a`(VYIi|A{?OHn0lXv ze$-7Kz_BM@%3e|;($8+Zz6@berL0fakX_+Y_oTdgjU9||{zhMvj$a9TnMH_6M7Dct@ZfhUL z3W;HPUrvk7Z@EHDAkL-aBI0xjblQSbV>;EgPhW#hWgY0|0}jIZ(wu z4l)z3_6>=JC1i!e0o3;QNr?8HB6LJxvy^4_vI?qbMfCQcDbQ_DRB9%3H%Cjcnf*6L z7_O~oda-EkU3!{od>=d<4fvS0`8!SE=joqd)%QmWtAkW&0jaJzy^!8o$_zZexZB0n zgJcuOi`Z%UYYSJJozE*um8)V$4!IQ_8Wo&FX+viP7|3>7z!saU#qwz$T8)gvuRLi{ zDw$w@u(;a60dif`WNWd?+v3b_Db-VepLLY_t7qkR$GYk2dFyU7n>vv|xJ4yw*%6mrYRAVVK52+kh5dgrvpO%CGJ z<+q_3?_rI59jFkMuPWzKJ=YAJ60yx5(M;zi?a5A7osm&{i=@UespMEjN6X>DRXN8q z3&DUNdhSfd?5?u>j6$(HS5#Ewqfu%A&X&ZTBXnF8r1ZjwX`v`1zxL+h*blVhNG=_b z`vm;JZnd$W-GPA*sMODEh(8GRwe2qZb+Sg&AzvKV@FATMKk6rNYjJVL(^cAHnxS2! zt3GxI>=9<;EIoQApN?GlP0iIqOjj@TjZ=9ceC*zAOJB>#WFi(7AOm@wh%@IVp9R); z(e9vXHZ*eFkH0=20*$fpA>eU3RAkmE+JJV(%@2^_71M+q-FlA%(wDZ3f~-NpgIUJs zI%eTA8~rvs7||XOjAZNp6>AI?Dg%YK2~`c*w8Qa<#X$-?A)r7=Q^V^j|1A^>WbOYt z4F3%Z{GIh7nSp;fgV%u{eUjJ;LKb`-(n&-1(-C$4x#;@mNLAVhj(66&QW};`~}3=KS}`5Y2!Dei9B+*Yiq9|Em)Ga}Pj6AQ6z_zyEuYSMs0+DI}m!`Oh~1 zi6FpzhNKoCh6aeQg7}pq*!N0Ncuh_~GzW+l@K*?duoWPG{M9;M^$v&)LIhIr19|CJ zM*$=%A%al#KgB}gHO+ze3V(nAWFem%{L}~(RB7NmHK<4FZWW8qji?RvNQ)M z0BIAZ3c|bXYF3Y5(-Lq@S+F0rIo z>8UxnQJn4t+3n$as%{8^_rRVG>Ga)K3YSgWVY&k}L*op~@nSyu;o+{nTN!C)TjwVy z#FO7;-|e&BVi53VspTn^q8wO>n>6;UV~v<5hRCC{R;_@faVMW1q$$G2xiegqaJ#&d@H_53H<2 zdk=KfKjbvdAZdbD9R~#0G?y*d@_N_BN0H+}JG(9>6qg2rUn^0z$B&*W-%cbqD)S>2>l&R92e8-C!o9mmXMdIn3 zyrP%~spEi9Dxr%*ioqchTaJ0U^D=`6n-(jaJY*M!raYpjttkZXjT+l=dwX9`Jh!Yh zk&omSb8D7@^O3$1n&uQMY>QdzTFWqHvltihD|Afj4&2j^9Bd= zM8&PHSHqcm(R+j2hJ1OZDm7DSAJE1KcKi1zU7k3@#5A!JM%E9L=drs5;>t8M+@bZ~ za#CZ$-vhK0P__1^SJ&9o8#fo|kv(o?n#0Z&G3biP?}LNA{G~zFdo(jyyd$Y;2Jz?% zuul%?Vy-@^DYz}cFW1`eg$t~~i1pa>zQsFbJMV1cL|^s-A&WM8!w<6R>~)n6Tkt7=pa|9Gi5hO+lt`5r9$rX<6+ify0l#&{Huf%3h3Jde$P_odKO*0k z)r(^EI;>5?P(_!WAU<`Vs}uR<-y=hB;_v}mDV(KJf;3shV2hNaE#h)#v0v-7Kweik zgNuzMy1e?9A;2=8f2&Uv`1^g0M5;nx`}7J38P;MS#V50#=?d+%uR_*Q=KnGE)=^Qd z{rm9HB_JT6lpqW+Lw8C_4Lx+Xgmi;+gD`Y=mvkf2At{}LbfbWPfWUb-p7Z?P?>{qZ z&1~*_?^%nPeO;d`G}&KE8(6D%Ooy-G82r4i?AIK|u)f8kPPT^G8BW&CTkrF1^y<8B~)>EHa;n^CS2A}M@T!A z>Z9{cD-HwW2G1GcY;o_%;an|bT&+&wjp6|<_uz+p|NxQOG1u}N~ zJFG8=I4Pdn1hNL~V6|nH|EwzC(`9yG|vGWm&(*db^+^EdT zP={^JCoChk-@hoTE@!NFOjoNi=_W!K|42|_{c5)JrOoK13N*BQWfb71Nm8n6;FZTL z@pe1GVH>7td`3IxXOjP$m}R}t%SN!p6Gd@Cahzs2-?cg_Vx7=ZHV-CNPXLapT!V5n?O^_ z>sRu=K}XPN%~~7D$o5@yePuk?b$rZNKPC@S!6JSpAjwfx5Udn-j6+zdw9EsOOXqfS zDbXgMfqpUk9#WIgNzubMJ$MEw5?ndx@&V7+T<4AmS)t<5_Y!;68>A&*>$<8+#+2Pj zD6k0f&&6c5FQ@oa4b!r#8EeC5gZ;sHwfl+o&2!GaJ|h+c2XAF5yVniw6z3gkim+Js zSRy6HVF;k;Eg{XgvRs_{`cDCIT|eteKK6>7v!Mya93>ezyy=^W~oj;7ajn@fgIZS`V^Qnx?=NZJ{YJ!35 zEl>TqFrxeVq-hpM4E{jcS~4`6U>TCR2or3bT(ca4QjR55H6$SZC)<_9oME!~Ek=6w z>4bR;@_{S-$$->>79RvxxKeKnI!LhD%+!~!3@=bCMUmrA6|e(C_Fy^tr=<6%K8URH z9K0`ce?}|n*G1o@z(vHmOJ%qhz3f553?2PjHZV6jG$e<};C`VzEw(Tom_{-Uv^PE< zhlp{kMocL#xr?hsVl9(a$JvPX7(GHuOQq1^m9PnmO5=F5r}3&7DZRd%xLz@I^!kHX zIuL-EMN?V^`1ozk@Y`z2Iy`j7dA%chE}NBU23n{jffdPN zS>0`14Ax5XOcreDiu(r?MDac{s<7-?3VNoP>!y-o>M+(aN!Vg`n)4UICBB6T zI+`%2gQTTs9ZtIPb>hIw>RhKdzp2hB5iGJq>?X>^kS5#k^YrlTT1o8GL{incg*l%I zrgFZ|HS632FUG&7)3d9Rzi63LPrp~s#Effx@jlJz$ud}_DA;9Q=$W%pnA4u5c`i|- zJT2MSM||S>TX`91BQkK zS`ZuNLdsV*?nUaZq%B!)G%PX6u)MZ`N`cPiNCI^k`w7$SIJ8+4P3K@3wXkg7SI4MusY-7sb{M97KuD$KdS)HiRJB~XW>YJySf5aEUPY=)#DdlkfrCoo(kj(me zJ$r7)_X&jS)0l*9X5;fgw;WsWRmXV{Bwd%}WxX^*ATksVFbEl(O%H0pzj5t<5)vE8m z63EbaM*xx6tC*0eO7}Q)EetQkE;e&y?qXC#lacD#5B6k|+zl3>hr6rj}G z6S)ab0^a>wHEsuVeLWukAMXDTB#VJ`PXQ0Y-zWs# zNf7lTP4IUDk0a)aOd|_~Eda%0wE&QRjt8g*astGjQlc*e>^%PUA!;`x@FozQ05txx z16{jFNZpT+|1S#9`>P=MZ!@5e1!*=I6CetZ0+5giy9ucui3VL9pdpv?btBL<_8;2+ zpOWE`?s$|*P(5DRzYhTPe>@0S{`5b700>C{x&D0_pa$$fz{6u|!e7h6{-b|l`H=?s zXZk}E9+oMYUMLd6%pbV>oKM`v%~Mhi1h`+SI)^ zS+=b}VRiWBbTem5R{v`wcf-%sPpG#EG^O!TDm<2sF?d?iyR+(eJ#wNzu!wS=wG98p zjpO?oWIV8Mz5a3Q? z+C_yM`$W2uced!`uWnL*X*46F>0FDhbj&eBGQsi9$2qe?K5Qk|NR=ro+6qD@ni&RNi_Mj3><08cR^OWiJ)W2j7}0gvq}Xl>HKgt-$h63oo!(@Ok35TMLM$e_3ht-hwnxdFl^P0Z+&SA z#3s$!u#HC4UYyNbnx(QvT_eoDpgOij~afNoh?3gPW^^rG!GXgvWlKDD=#8T zjomJfWwCn&vv^~DoS4Tp2C6ht%3-(uX=$q|5M7pxp?)#PS#&##1W|A7=na?8{H{nX z|Mk#ua0ma%Chv$M!5(r`YbkFy!I}L$$GD=KkgQT+I6sw!dwRSqt*dY{Z;hl`ekh~? zfjL!e;zuE0%2?c%=4N7ZHxkWXvY3r2#}n52UgZ{0xL8EaLec|*OO-AMI$T2`jSLb( zgg#h3#A@jopA|nK4i)a&lQaHU0KyPdkA8>J$=#@QL|qUQgTw>5rgCW?5PBq5PKN{lUVOsmpn&%6Z|{Smv8b zAu(_-BfF_F%l2jRd4`f4ba%L8G+2d6TUcLd>eTWb`ntQ# z{Arx9@Xrmb6#A|*NMX(dPh5HZn^FCipz5spqM*c!|k!yXh0`(sl_gb4Z3}+;CRjZg ze;M*x(5-_(UXS6D*gDFK!i+^BWvBgOh0gZlPcYWS_aH(_o>{&CFOL?L zsuwHs=KIGK#!`GjZ){K7xsFw~D`-9>oXCtWQ_J2sDo6RME#JpFrWFy2CTMZBJH@|T zWH7d-5Rqmr7Ub}r5plUbGr5y}ctWLA7Ju;>m7j!dT%p#ep9S?`eiQYZm+0gcOu{d9 zX#sPSVuB&7SE`zDU8-igNHRw_E*Fan%_C4~c!Hx7wt?0*0H-zW-NlX5B z{H;S;i1SQ+BBnx>_`=RH7jt`q15-}ju){dE#QmL%O5Uoq-l)w22G9BRF6x8IbSQ#P zqUr~|CcTc`vT;)S=g|mHW@f)(xt0ku;`^dNf;KtP@$T zS*ZG^fpl4@{Det+;xL1&K6!AvW-_wK)3QzdOSZC9zNPyoN!WdnN^drnE5$Nbb>{tS zbb=f^E4SU5?fK(r+0o6XY^w5XNJ6XVuGbdAIZoz$`oH>bbE=oyoY>gX%Mqunkl^5C zxxIX{FtbBw2ky*GcwX}7HbGi4e5O7o*5>`we4ANF+Z=@4GtModlP$>?xcpn=o z(qKd-8s)pgztD7FYHLWHTe1{_WnwOcJ(1t;yi}_~i62x^N4ugc`u384YcS>ap_}p- zwMow^{h~rHR)JN@^-YQe#Rj_A(A!?_eD{ea$=I3m3j9t>JvXfunyo}d+{pr4vv#)f zagE8PgcBhl#!QhN*+S<|2};^gI9k3_@Xt%a?N8Vl{?<`$3gqnvPOs_dGD&Y3(qTV(UA`e#rLN$gI`TOveT@{R8Z0$(px} zoBYuOKg)+)XC!QfbZloWe(s$-pDx^WZQ5#26jGRSmw&ktk}C5$rK&PQ z?SoW@J$Fkw;@HK-AH#{33cLem3xyj9OLJJit~_I&^E&d%!$2H2ESidR9ZAl$762SDBY-flHnn)6WF^;k;N{ZhBam z2f2eDJ`>y?6BSLOh5ftIS?i zokS*5ioUgBqU{A~3L1@mRou!UmvJlMum8rGmLzShBW)njgjO2dxBiBE6;T)$&0v_% zZ}8?rl-R zSvM>NzBxr3lGtl%m|u#uhmWf+%dlj>fKKqIQ69(#ZzeiS2*{6}+@Tc>I6R$62wPQ1 zgEkvCzOB3di3xO_ZC2Rqtzf>%3OFo2hbQ_|$KUi=T3Jy(4>OV0)M!IaVEGP@FAe)6 z+1S3gVhiRAyDrI*lWg2=aNT9T3qZ7xIBB<)tVf$C;0wyq*%xEL{50nUu6-s}(BETk zj(iAUEv5_LuC+VO4RPYnD`A0Le3O?;eM0Y?Rb6cJ)^XolIx?H{IcHUxuF# z8pWS9{J_a)Ws$e5L0%ujd@c5E2wo?rgZC}VuZHt&35n+K*f)qsK#)HvBLgS7NQk7{ z)otJ}Y`O~5K40unuVA(AB`QPS{s+{xfi&n0p0yas(X2jR6b!k!y%|!XShgS->HBT; zz9PvDW#pblNmq4%9K4I&SHCEs@O3PJN_(VN!z9T~2fg2~W`bryQzV(-XN2~!3m(a& z96WM_ZKnT-@J!6cne1xnSTNoLujsZvKG8Dm1qxiYy0bAz1_;qhcMpPPZP(y)T zUMOu$)}3hZu4mf87r_VUy=^J($@PfTaE$&Noy%8st_Z|T6NzaS}zwwxpA z0U+#H4d_bQB?qZywRscSV-Nt!O@=tHT%%mbJ7?it8p9k;Srycv>cZ>3VeL^@zL}Y} zn82<F{u^RjJ4)FIocrG?AExK|WVVV&8s({OcuoH??pm&G6>4 z%6R_}Javfl5LLW{R(n#v&NjdsoK2k`7L%+%?35LS#cT}f(g(bfE@Tf2^P+B)je6YZ zrBpdiMbV2+y%bKA>Bi2bdU2Eb7zSu0cFcZKBBs<*BYip_%ook-6doXH)g483=8b$# z9t$(tRY}LS2p%d^_tHq6L?bp4H{7|-PL&YBLQ7&|Gj_#DnB3XV%B$G$Bv%a#D=zAU zq9RMJH-Y|e6L**Nj9g7zfgI~M`Lyked~N%nL$h+McePE~0|?=)`U82>l}e|5RMull zDHnc1l&n3!BbC{5-NXazX9LXrmGCN;Jqp}LUeaaXRs3?gVWNm-`C)zffZHM(+$yPu8#wo_mY8JlsByWA2;+H~+xZB>@2nlXR zBCv`ty3U+)27~65gu?8-k19kTP+sJ);AP7=Up#(xkDFNg#rf(-Hv^ z{=#??I2IJt^A)5GZ$<7+9{1J(tkDN2NBDNJ(&dQPc4IrhQu%rMnT<9 zwQ*R;r+KffP#Y$J?misQU*)_QfcJH$W&q{@=W+gx_Vh0b|98Ish`Ilz68@rR990cDR_2>gY0oDd$2Y_(HJfMQ%?B5>3N2m?JX=>2l>_PzB1IPa-761_T|A+&OXwZAl zzpo2(Kko1xs7nA~{r=M;kc`+FpkHWO2RU~mDS&WmKp^VBn^UfX?5rNe2Y*`zA4vdt zvF^Vqi2tbv{)h2_-B8L1J|dU#_i5U>{&j{^v{h zyZGZ7J~|oxBM$yP1%Lo`1E6boyc$5z@OUAQlmy_jhR^9bFVJ7WL_3s7vUjwTpu>{Bnjig70FUbhC6;Da@t@Z)|#n{%z8I z_;S5s*YlIoS!g@Own`$uL_F&)!BwDfobW(liwvVsm70aDWbAot(4v!QXkp63(lTGj z00lx#K2 z&BSAS7p@e_ie$?D+C&-3Uzf%JsP?ECc*T9g)Eq)sl=@q-qN-lEYd-+_bNAVzm~eNe z3IaUUoswDgcFvbP z6Wn1lao>A)CvC9V8J?&&=*a16G~HzQxi@;i1r#*ZTBSqhI^Z&UL(JZ^e_^%Y};m8hJKVZ8QOG_yt77z@VCE{p^(0tI7TO zoEVK@{|U`7t7&61ct^!ro-xx-v7CMcHfb-4dF1g07#XSTmNl^9`HYaE*p8QL-QjON z8M(!S5+{G;0>dHdAHNlJJR^vE0Fn1OW$Mq6Y^G0Y5>}fOH6GFnSb6c;nVd>=KYSj_ zuM38oDB|dn;0zHrmOFDPS@DeW#Z~s5L`Y_74!PD955$^&Wgy-7J9pT@E z2es0I=luJDI{_1Y%Nn4?>L?P61jHO8j6_NM0b6L3ONzqS&--q!HNoR2F@AEsAGVBs zT63>wP_}AomY0>zZ&@hHg6vzTckzoOL(RFtxxNM4(aYZzt3f(lo0a|Ue+ncFEzyR{ z7Zyeoj$&FxMrQ4RA360;Sj`N3r@k7Snk31LM}9Wq!0!$q?HA;3GR;6nv33G?MzC`G zY0*Wl~<`=hAyH)PwDb(Y&kUKO%4`=+a(=yICMhgSRkN{gv|L5=o)7!KVe3;q$z(a*R6=xweS#;9-tvHlG~#;Ea`bOknz z-aN=sFxAW+6-c|wX(kQGXV}_@Z%-Dm-43b!Lh$DP_WMZqu53&FwCQbqA1o;&G1E@4 z^*cin#k~fxzE3mzH!G*+SI|bU3Ky8g^1Bl&)|54g>1+>JAnNx$JKC&Vu4X&qCKz)H zz4h15I6UJk+veBkrP_3rE|tEaZYH;Qcu4SLA(lFpqW1iqtCALjCV3$wjp5k)j*(_fmqMr0HTf;w4}0Qw zUUn4iLNagjL!h$OjHMzS!%Cs{S*7!bz`Tp!aZA0`D{?OmxaFzmgHd5KeC?>|rIf>} z!-=eQr%klx!b-7OUz-1Bg7?iU2yr)tJ} z85xP~+7)>(t9&N^3`#V0Ik_Lx5sv!YYaE)`%Pp-xS? zp^%Q8FOzPEqxpgJhx6q6+5nA?Og_P?qU{7+z)gWKA`|Kivj7O`0c?v@wONc}L`Yo5`E<(0T(|Dl|hw zl~N(G0(bs&*_6I|i{=HE^igf@=%Scg-1c`A!OeuU4Yn$8gOa&J*ndi79V`reDuQWE zzKz>6K4Xjv8SRV=DTS}>Fv*>fxZmm$Fg;7)=HR-vso_j&6Sqq~N?(%sz(@KG{K6l1 zV{t@d%x-{;7(t-Km+~G@sdWpAJpH5MP&r~^v+07pNoXn3>6phYyw2^FHFFgn*yfKw zuRrZO$q%xr=D~fx7E>1q`_6adw3Zbf|~?7L%Ktqb794y?4h|;stie@L%RO zqT3mrTESX#`>S9PW@DjrF+yt;tSGptYj+xRI`zK5eK*YM`N_qAe zzXEb2t#(4C_(m_V$Xp+2)(4-0cMkjLKQHK~V=Y`&^8x=y@HUh|g9Y7|QiydUcsRR|=-MBTo3rwOTd%k9^^FT=u+b{z zj3u@4M=<=8#qg%G)K|sIQ~3IV|CHYlHwAVsnxnTywi=hM=RY8R|6g=NZugT`e;UNA zUvB8wZ#U_h0Li84P2bNDExt%lp@a@nQ`=CU2!`og)Gnt7PlQqGB$?nGD?b0BgkPqc zvG(e)YipILHuP*fR6DiIk<((7r6Qa?Cc&i;@ECi z@8+Zd<*xldAh30Pif*dlT<5&)){YAWl78PyxrP+Y>Mcu??2mnu$HwC40^f&6&ZUCK z1am&@68H-jk^5|@JC9$L17fFSB-pvDE|H8aTz={db#V@fDwghn1c8<>FV&a0-rrSqC&A+>s>{(h=_J%Li&C4J?Q%=;Jxb#e}gZ}6iM=2(*!R{+YpI$mn!Q*K1Lf8!Oy)4b?#O$EH=(wv0U6jLLHSZg8@xd=^MER9DWL z`Jq?4!7ZWX8!pdJO1V=?xeyN1koqv9QJMEYq041}hO7Q5GL zj%G8%DwX93eO1H;96Q!?)j)v}=paG93P9bFuq_tL`Aj2++icO(YBE8mK&W1FP{qcC z2(kyhWqW8%h3C0ZCWs+chNiTX4qp;^WS068B1}SPO7u{VQQeaY5H$!ilok;IE7W-wojvi7dXuZ{c8_k(I?EWo1MZ0b)4J zicvn>T+Cy^G)o+4700o9N$`xsz=B4hE!};Sk%Y{f7=<@km0r##-+X22m>hG+OHU8L zc8o&2MN0=e!DB9$D!4aRr!d|l&pKc+tCfK0KpQ1<^re4!FyAQni%u&wtd!$2YlA(;est=V|{XYb;mHuGb6{o-Y2QC};myZSBGy-uE~37unw&5Rg08lsY73MqfQf z61DJIlq9dTW2eLW!EX_Y5l|i_+IFKd#^UJj8qD}}g}qnJZhrOQMM^OCCGY5&R8jH0 zjcRNg$s>}0V!g7n(})`jv#A)o-trk-1Cyfq0I3u)Ixn!O=k-OHX79(Lx8|@M*WcY> zdDTw!n6G~hjb)w(@((&ZXRK31<2>MHwaSd847_&0*!W5w~y)k^r3!d)yRVi|c z!E;B*gK~wKVhHa(7kwq-b42#*n2ukow<4CrkToCNtgkh%P}yPU3lET`d#Ih}rVz#c zB^WCa96EXN*F(IxyOgrt%4vg+g`FmJV87w z5Pxf_w)un-_Ci-$y+Crn%VVjnfy3wJ_y1_1--XI3I@fQHDXjzK1K%uRR)hp z7f}ni0X81f2>z88AUy?;IpD+pca{GKrvF`M5;zjr_BpW2^S{U&!2EU~Bua&Y{e2{$ zE3q)on;#?kzodi5O#s^hU@XuD06EGdPk@_8B!-C^{J6&df%$(m3P89i-lPdAPYj`r zfdCP717(rj5UPNKll4az!hih3qc`Bc)BFqD|1R^Frg+5eN5Dr3q$B`xfyPI~ukiRl z4QM7FOCcX+5I|Stzl^~D+58E}|DRduNb461>RIKIk<%0T)Vud4R=q3Id27J;Et8rZ z7b`}D_=vZC+Lj=zbz<^n(K&g7tZeNVRm&I3JKEgvF+3@Fus${s+gSc)GB9K<_abu1 z8_6#)YYqziH8Dm1XJ+F!6^~`oj&QWU z!~8h}2iz%#;7#mmOu7jg?Fu4D3$wlYWcvd)GKPg8z7@xzB<+pIdX*=k+?o`p6Eye*lq7-=v0$fHLiE0T)(GK9w!ig@iEt85UQ zbifB9uP~r7Vn=mT%$p90exU4giP=ueXRi$OAeWZ%4#jjAC~A-NoZ*)YZiV^k51L!P zXuhHP5!<(i(ZTJ~BN3=iRVcXV47anQCP!-z{dNtZ(~p%^jvBC%c%{6u{f#CP`u+f; zUEZ8Yndv#X#&~vNMYN(2YrWD-lb!GSC0px>4oO&SXA~Zb-3vsPRzwme+V<``g2+eQ zmk^rQvT!-{Rs3lFI^AXYS?TuuA++l0XJns>BWqV!iws0zUy4!KRGzt^-}53oU10P7 zfN=i-QO}X?TyVAZcaQ>n;(q?F)^Z9<^IrD>#hq_%q0sgF2T41PUTsaQKL$K<@LO~P z8FueDq)_GrJ)xVhqzR$~?4pJf76A>3-j8wNTu8+|3#F1DS(H|7UE~%^o#Y8eT1GjK zmE_|suu?SACC9}U@7^%kZ!${2Xbu*{)uR{de}S2~DJA5DsGlks(M}6KFvvt`&?S|u zT0FPTxdx=SkoB|$sT?M&r0?qxWAfa zf#G0T_kzXKH@(O*y-mr=53J+d=UaI)airBuVSy!xY9WB#{Jw`bT zPqDhWjc_zIl&SyqYcG*M1D4|7(_W%+Z}{&0-G-s)TZZ0qUWQM2eAGd|5)xU9aF#W8 z^+l1Ah)%SVimDbIe!#bO7TH54jAympfn;8G({T>kl-H`EcrHU~f?H-BM}690j{ zZl$tga6#O80`Y-)_xW#y!+~9=3Vr5&^-^pC=2GuHX^Y@JM;^q-@+?QIJzA^<^I4qf z>P1Q!u;u;pAB}&|Q-o%{R@sa|}x_fm*-B$vacl++S(ryQzGtS;s2p>dxu*_sA@1{wPQUxXH?3M9{V;XeK zU`kqc=*e54OdJ9sNrRG^S+M@Cbia<#F&e{bw?@b(_KGJWp<`OcuGGkw3?CsQoIle0Gl-ff-su+b zu3Hc}hrU^AbdivH*zX!0A<0W0q7PfGhHgf^D}Uwf!+1z|_-$d5+>q*Y^Usqbt3*$= zCK5(ncwdmgrWoZFmd3qASRIvi!prCtN&y7N*YVO+%|zVXr_)nr+v=`2{aR5sgwGI% zPCH~a8qGQGa>+$ToY{7)`gYERze22hLv3VeoiT za}!p6^+Nu~3=wZ&Lw=HQ(w)=^MbtZc83RhRGicv9Img4-1}-$aKEj$ZP+j5dig;5%*i5Fv z@O>BDZ+%MMT|nYm?#5dwN2egbDn360rd0+%HQsjQc^6^3u`4f|!NL% zq+l^+nro_V$NtMsYJ?+^Wkl^u9DqBmK(b?tu)%-%(W?>1=#$BHnmCXTH@f_RPaY3^ zo;{6jc8-pcL`$(5RdM8O=$)F=d$=o)9QwWVJ>0}jOD!zZQ&W#P0BqIh4oCV26j!cM zuy-3*ocMKeH_3j6pGPjMYx-GqfLKatbyC88NY=LY6iiy+sUtP(nI2fnaoSEc!LM%$Z^PYlQgUH|e7o}XMGvp8!byb4 zU4+!VAIJx7b8T+HOwGUGcd5R}D@Uh+gQ`20EL?I|r{jW4naN&t(}r%{exMIBBqi=s zpB3VJG{O^7ai!&?yGh=zK-$ir%R<+wxnFoqcfPTO?jP23pjl%zb=%vOig-C-&VK)` z1@ztctHtuEmktvgYb=i-I{$P(yv)Ml8>ilx-FQ_y6Q%Yc*Xh#jD(1lh(RzcP59EX^ zzCpQ&VQI{k^Lq#FdcGOCKpknS0sFE&n>b!{sOyARq-Q6}2q`RIn&QvJE{0eSrL26m zW1Lq`Z;nfj3C`f}P_85cS*S0~ilh?8z1T6QcGXA_t2=vICM9CET{J-aGVEj_V-H$X zSuV0=qsv+G-HK2te()}ojvnCQ=AtPMIDZYlFGJhR^NCO)n4fJcjGC-)h~h7a$O=mv zy?Tgeq|23u5^W4z3RPtb*z=4N+&u&fDr;~sHXLDjYPot0oWISX*>Zp31dhG#&1ILl z7_0i&MeB5qU}h`b^%#_}iI0L@x&>rxt|&)l!9~%;HW$R;3Qn^b!o6brp%9I*l2TJY zZwbiNEzWFAPp`H2`d*W+*T&}Txuz(iyxSDE3@p1hsou8zvlyN4Qphs7^Es&m3Z>>^ zaUz3Kc6wSZ&4Ru*gi03D^fmGTcZ!}C^=_;&jtQ=s|1A)kLejClr$*63s(bP!qnfTt zGLz}TQWjK_<>7rLIqv_DT7Nn#M7hOdnrApsO<0Z%kLmbxt;ViK4=FpnNjiq~H zEDCrx@$h{@Dci}h)Ivy!CmlSac5LI4DYE3El0uTuY|sO2X;eZZlgdoeb&r%oxVZ${ zbemup8jKg`X8;f08__Y=Brv$63=V=x9|}EE6qv^z=uSJ?ZC%=qvet1ed|i0~TLQBk zbXTv_m+di)i;CS_J!A&@5%Dp>P6?Xao~Y`2PAP!C3G*}r!c2^J<0NrHt_E4Pm^yK zLk^RC@>&o{dn9r4rvo8P3%6k2;`a1`-SnUG-(s`)UZX={6 zqhrHtwGbNM`YN!!zyEqKg3;|C5Irll^L5S6Q?708j_(ylW63e^u8E+|a5XI0E0}m= z{fJZ$9KS9Hs?c@IKQEXbz2u1{}B9_V_QSlAdJ9*jIffyTjV2K|w z2T+P+(JtPPBQGs@p`s|$&uE%&Uf5iRnGD{*bu6C08gaz05s{@8Kf)V`Ir!PN&8O|v zrdi?w!BhDB9`)ni%f_AGukBsKSF_9(o5`#T`BdFlI7OzDK=(-~ZKuct&ktWXSH<`A zYcK7BKe#qOBeFl7O*HXuv}?~FP)@V{!LIF()@Ihdy~% zs*h0F_`;>+Hg@CH(O{esz=GrHdE2Mh$mrrYD*T%=D`TX;5~aqC8n6Ap|2suK?&Qq; zb?8OW$nI=GSi~^v_(^iz)okWNyj}vYVu(;-9t(nOexAO*WL}LC@tgH(OlH|N8`+1A zBFbrJY|9jf$f;_$=feHDh0ysNcaaCu@-)yqdE4(bfS@A!crTdT=2^Kc@)?6D=yM`P zc{^0&64F~h8gE`MFLZAWcca35`F!rw2W4FGRzfJ?-B&h$J zxSs}~{ExGE)BqrX04m{v#Pz}rM1rV&%rS5ZU`ILvJ*w;9SVF3R zt=FK$|39|yzq5RTVZ{T~AvQV!!~_PJ#Pdg$zzGUqu>cYaAJ5^D`T)p+6JWDPaRhLM zkC6e7PmeUkzvYdd&p}s{fLh>DR3QAwJD`KGjX_T^06zyRbZQcxLhxT&;s3A+|L28& z<|NhmXM$}Spnh+iF8M2;jE{ue$u`$TAozYu=MRH^60?_!Kbg<9$|(_h5D;Vcbf{Yq zn0cLVUKZI{Y)vE}R(qw<>??F2*ps&zKlKkNF{4De@#(#kV!7e(UkY2(>$s>+TPEdL z%gt zTE#t*U-{QkVRPf+my&^!r=f$4Tb#Z$tR?XDL30B%+VAm}>znS#;V5BtOmP6X4L&mEXJs7Z~h6@Il5`q(~`?FyI_+rG>F!i{KR z!%`R>4duMMFo18#0IT&)`rf@`3#){?*VZid4JN+-sT^o<+^@ zZ|ALWq`1(!g!#;d0m%k8!Ur40p zN&8%mD?KAH-Hs2tUJTL_!T#CN7xlo(w)EZelC=7yvCfrpLFYg1*T3!Xib=qW6@_Pd zR9_m&uD*5KzO=&;$m5A(|J1-x`~+Ndig1#+wC~ zsuL%@GL^z*da$9^+bd!@@MYSw1Vd{FJt^=aaJFbcZ9xv;XF-~_Gu^Ds{);RNtQh=U1Qk}TjoI+dDB#i|;@%+AeSQb5MK&av{NvPF1H8O zzPbB2mJv4KT%HE|>{p~q#7bpAdAD%rW^UlGmQpQhqM*S|z+2(1T81Yer})78_8(Ao zJ{z9Y72-PnPu*%_Vo$PgR@ed5NfV;So2qmAr^x$dl8n7srR)x0ud61;FOO$Sd{gCp z3sX~`CVamoKT%*k3~yGrC@LtGxl&Ea-ncvwE?JP;4}t%wW6?bBlFo0I|2fY6!N$#S zjaMhsv*rXniEFRn>g7O46RetlW+mXF?u&AmshX9?K(#5i5iQ4Yl}@kns~>XeFEoD} z(cKzxb~*}2-uQ}36*`wM9g&D^xTk)x{>;MsZJ)1s9pdHxQdYq{_w_wqWB(eoZ*G~n zz{2t%5my0?uJ{7XAXa^4!Cipays*&ApP+PnWO^=PgwdX-Wt3rJLJesP5e8A)u-4k` zT#GB8piSlE_jd3^Xs#3#>7!gYU=Y@sRj&kY(ni^fPO3$jj^ex9X*+Ro-v*<->PO=Y zC(Li1%naV;AsF{grmWyT%f)qaO^ottD}of3y5W|;dVpw)^23TJ)il|8M4l)!r&<=T zcwUE1`JXHQ2-nozsSQWmM82pd{4xz)=p@kJYUpi%jYVrcGUIU7-c&x*b|-n+N2)%!mjq&T>LRL zmtQ2zR(rt3amI@D`Xr4_+G;pdEe)F@4$I(}PJ;ldfbRyaGUJ9gb4X-j@4ouT+naTj zs(xr^UhL6&RD6OAo6sq#AbB+~USOK4iPx&;HVR>BZlo$af+Ihmu2I0Fmhzi3xBHn- zm`H{NOZKp_n+1w30;!@T#BZKE@n77(QAcRNs*H-uz;cq2XTxQp{JN^fD>6D+iW>6b z@=hK9fYwJPcRZDnJk*{oijpmqRX81&rC`^4MWjgPt@J~I?x)&xDN(NSI_aO}b=Hny zr4~uK_4=jq-?viOyaxg44y8f5r5mKA>(E`&-5@E_-Hmj2hm>?ncXx}Fw09qTzrTC`xWl22!P$GA zwUe@+UR?<8ChkX@6*N)Z4536hOtIE);e-Aqaq6w!omvKPR2Igm6`xq|N*g=W^H6y69~#9OU=bowX>w6#a)l_3qlN7i)y<6e z9@5E)$`SlUn26~PlC;9@gSCE_^^_wmGf{nR{tNy7{*M*nPPI23c9vux+;QhN1CMnT z!;FQ=l!~QB3)ryY!9NSMXzB6M-C$hM+oMon^>M4>vaRU6Ps42`8yxvp5a9Nm5Tx%B zTd{;jK9A`$)S3o~g;N5bk%>QOXyFu)arPAwi0dXKzY-mm{Nn_(em{?kF(9EDy7bKb zjSg&TvOJ!NC|zf9T>O5=h-^??%{`JK0fs{%*`lZQ&*2`~EE-F@h_pVgLQ^V@GfcTg zHW?xeiAuT`nLMXspKPRV7wZGGf{wppA=LbdGXYWCWc?lp^VM2^|b_Q(YE83&XD!Ma^59LZOx6f(%QK7}TpDGi5m?w$W5#es@5m zO4s)nw6D8~$^bSWJ;pBWLehQr?VQ9V=*M3W`&+q&8MTCQSh+SXdAanW93;LR*f~F; zSyB<3C|{d!m1L&7$SalkZO#u$z87}N@y_w;~|rZyf@8Y$VLq-Gs2ESCG*+32TQL^zkvH2JZ6StPB~Aeqv!haBrD=BE^FCmf^y7 zPRS>9G(mkTN=h-c@lS)hk%p2|qmpc|yD;UuTmlJmOhmhn5)~Z{kb#6UzAq12X>H67G`3^O3rPta%`T#Sj$1; z%K%G>0lT2;UBcZ_Wx2`x_w~)T@>U~?Mm}en9Pbj25U%1hII7M4rUF=2UO6- z6|MaUKv&y%atX)s{eBh_Ybj_AN0l)XN!CD#AS&0$4&CM1n>loOCyLVOY(}>*bYiIz z(U)e4FgWE~Kz>?fB;hYNppmd$w8fs1l~^b}Twj{0bTuML`keS7uFN|j-wnvo-G0L* zlajilxW`sCUrOkjanBpb)R+&|P-nuF@7;v!81t>gu5vECgCyYmapyUZ1f%cxB6?3F z8TNro(*87QH4Pyp9a=nLk@iA_NyOWGdmH}@Yq7+K_VNU1cd!uJj2da7Vj{qmtR{fM zk8m#@HW@R0XNL(UYcfO#Bm@Ct5q=@&kV?q^|H%C>H3epXxdC@R5PZlCg7O6F5)i2$ zLfka320pyqNc#Mb>wy%+_dw18WPl+Auwes%X#-FoK=v1V`O1Guh%b?d|D=DQkOAor zK!ZPkCW4-vq>ca~+XG$+NLk@!1pxV@h+ctEh`9e@{lAL9f7t>rmp~>G{wrp@j3TUf zDNDSR4YYtT2S}F#U^mc%E{XubqrXHayaX;dUjs%CBIte?kQVm;R)c$sjv)Ec_yM^G zFj_#O73sceP5uz}3-F`(U=PG6*Z?gdys#UPdIB&85-3qX>MoFy1u&-Z<(VNx3E)MD zN8?}p;-$cXk`2Tm0++l#hdPBE-Fx7dCE*$CPeox9)d|Do*eb@h9@2cZq@u3b&6?Kdw%}QJMlp*-QHMNTyJ~oj_~vhcc8YWI%mIXowds!cxPq%^*Zwm=nVGOjib$4nEes0 ziPLTWxcg@D9^Wy8uh(YL2D~rv1@r7LsEp{h@=?2DB#=*oZTck=JtHKx#N_-&0&P1E zDca@8Kg;aEx!BSD0w^RamwviM;KD}h%AHWr=WG|&I%A?dPPs#U^G325mbkQ#Zk-`1 zU>HN@E^Ow(8}(}*;VdqZV?4JcE+B2eVH911VYrk;noPM$nj^J%#549>zy<5ixc*Z| z?ed3qIR#gZRNazHOqtvxzMcsilGn}E0RqgW*NAZkqX?%s%JGCvYBqmVa-%P;jmr>u zw(u6WM`uF!8hgJt5g+Xl3lYExw^44?b&yu}JQdIds+$TYHT+_XyO@y(p5v|-FhqN$ zD_$OX#n(L0;JoaFBnsQVd$pT$RV3Jb7gD`;(};-?+1tOk?MbmPT1uVff0H(g~v@2sQMQx>NZ`3;w+K5{9_*q={|> zcu`#A+fvm%s8SXC^ND1+;$y9_ST;?8Z5FmC(wQfbX?;E=G6q5{Oc&`kCX{;@tyAiM zRB~$DA}A^DkZiw7{}wULUuP^rZlNGNfTEu+7W!_!9SFNvAP{Lb{9Kz|P0d<=Y z!e05qkk&ods5m!x#l~{&`9dz}+x2#ZI(g{gJVH`wJ<_Q1jD$E&eP@(7g@{|UgQ^+N zP>C03B5$h|Wqx>h1N$MFAjKQhn1b8ZCm3J&+-;^;~Nb#*EGiG6&cIOfq-Q@%w?o7U2KraL7$CDlekhITULHk{_|N%{r+#Gd3dUJ@C6X3E6U z5xjcOYLIrv*O1S}rLMxXQfcFh52qSl*y&nttu?#)+@C)Ov!;6R%qhmjSd3nU#5a3Y%Jn`(McEDlXhpB|yT2eZsUalXnls|E<{&Hg&s9|SE{HPnv>-drf{~?X(jFh;z&d>@S_O6X zK5|tZ4BoPLMxPb0_sJ|22GZgUe+O`Pw&Lbna|BoSla0|bs>gZIQ|c5Y`Q^%|VI(}l zkQFvPp)O%4oa2I3A6OKMZ6@QW0hlYG0HoLt}1%(SnM0v-F2@d%iO8%z;GTY)n3OGjo9>TWe21$ zY#eala6i#62#Un&fE7z6?SQO|Pv!ZibK`!@Hd;YHcKRh2iyPEoHt+)({&;wayCzp^ z(EiTR9MNNTlyl*X(v~9KU7toM>U=glr?xjxnfVJn)0QHr)hVOv`naA64sTqZ(9yAX z-MhtWhX8%@dZy9zz zx*SdGHj^0LJ;6}E7ho=F&$diNn`mF)3d8tuTQBS^MQg~2kY+@+>oy#!j5nibj6Ho3 zK?8NUmrUwSFe3|Jh((L6T!fUVCOo{xBn%9RfV*SeQ7W+ieK9 z1Qr)k)^Pqp*P_ufJ-h@Tzd6I5_52Ic)=-P(4f-A7*ju-2GdS9uYm1oH-VP!qiQLo@ zJ0g@~qRg%5kslh%;hbkEg%bR*hE*6yix)*%Ad?-Pdt}z9`Qb6bHA=Ie`k z5y+elh0O3UQ7xtU#$sn>?dVgaw;iGRX&Ad2r71S%&Txt*;QM#>8Vr~y!(o49++o)=Wlr92-7^*-MYAR0ITA{4Odr~AZmFG4r0X!!FRgJ+ z5mqvZ$uUqxIGm1)`C?%#N@pj@d*+9UN(sJmtfiy;A(+7G zjLvW&WDRw$QfhM@hs6w|8(wl^xIQ3nw4X^zO8u50$C`w>a}i{wr&b|DUb;fQdI4i; zO*Rv!21))+7XNuc41@2BLaE9~B@@N4@39-Ba-6B+3Oxt{QocjEV$XQq7Qf@4FDol) zD_~g3{0jA)VX}7V+zi!Gmo5U#g+`|sRrmgw zI*U?PSVJM7#L+XwsQc#*<5lHkR~O9;!LQ}YV_c)PflMMFZL?>w7qBm}t)+zg=9N*R z^LNNCaS&R+7ofxhxRAPa`h5WtD@k5862Z`rx7)eLxd>LrSAM*zx$%sgul+E$X3Fc7 zI_;x$gAY}Jz2YbGvBQlska1k&6WGLjXkURlY04E*H6d>YwP=$ljC4JhCDhTIdh*VP$sqrizrn?i# z0Y-GnC|j_p_C1jU*|4k$%kR(Xm=+&UP)h|=%Cfk%v&09tRIF#qq!Y|@HB3Z;^bGMA zuHbrmjEbeUXz?^H7%roNQi<;qK8zJLf4NEA-9|N*YflW#h|`X+(I=j^uY>(Fu{Gtp zgD>loI6Wzkb00YB7nRP%n6knerAiT;GTp}9pHYvO3)Ml-UiET66>+E6^kqP9g|0_y~fIiXIJCg}hR zeX=SuE{aME!PR7vdlGA-KZ~MspcIs7Ay+8em0urAm3F?^^?85VQEu0xiyAOao3Dly zXBjQa^?E<)Ymu_S0?=@a;2zHdc0M62fN7B_DlhvK@aa+69Gubiq>+VyROoK=)e-^v zKodLu!R$8`#&&089|OW)keD^sj|^hYoMGrKHt6#?G44h2Nj}AN+DwE_ZL7a?RQ#-I2&Lt| zwugNi+4Lm#&>1@}VWx?g9`+X$S=gnCsO5-FCgz?)htR3L1l#K+0CoQ4cFl!m8pgtd zp^Vq~t0DcI3TM0S8(K_ysjGOQLR`QsJ|elT^uS#uJa`MHgSfYM-l%EE4^vgG(q{rS zKl+qmjqp$6@)5_`$xlE%X$e1!JF-;!PL=B-W0m-+LZTMd+!;~Uv^%4nMd(0S}^hP3Q7 z>XK{+<0m7f)Y>MRB-~7ahc)^iQwt34l)aC8TmD%W4ca3 zANWF)BEgu_*Q@J!pcUmA3C{n!de;z*eezje%?0a;^zeze?b^* zIDFwVUM#FgXiTQMTx5tMX-d>NfIl$W%zOT29A?`=kcgujzeppjWq@FZX`H z__4(2$R#uc)!=zaPu{;ETSKY8AnIEYJ*vQxLZ;pC!khgnNm`OxsF?$Lt-hsOE_c0d zp*Mtc-=9!zK34hDPmAC6wE-G%IgNcJzh6^74h}`*6I6X4{_iowOeVbe^76*a@{v&W z-bjUh^ooSdvJ<#2G^Xb%=G)zJRC;pfRWcc*AH8p(8Av|hrcQ{aL^Rlhg}Nf+El zF^3;Q2l!dbglTdM+95F}E?NlY_+(wzrTgQEBp@e7yg+Mg* z+J@Jb3C1CFip-STZ`Rg02Fz%js+F+d?oT=`-E}-XcfQlw<07N z>liqV9l@o|6Bo3r$Ge}b9Jlw(Wg#VXC*dNPYd+%%y``y|I8E zdyP3Uy@jZbsprYUx(@eRS#ziR?ZK-#A6;)K2TFN!QGT%2a75oq(Z& zgpXtxzs8vpX^WGraFsEcZMh7&Sx{8JpIC)+Jdrvqk#p%?j+Dx9!>=aBk>)EHV1OX@ zHZY>4s&_RPM_8YdeW>MAtivji*Q+?^i#8rYL35j(3k_-?C-QG`!=f~?`pId!Yw4eU ziVYE*GdZm|b=Y<7>4#S(>Qt0_t2R@%0l5bG6hwhx*NwktQ#<^A=TlRj!#sw8>~MIy zgT5do%dCe|bU%tOUt;C_d5pYqm(t20`&qC{ErnmQt2A0+D4oa%O_y+l`7wu+yl0$HR)$6S zIl*kj)le{86|WVu|MeancQe@Y~{0|l>CpG0@sV$ zA8pKr*fiDa7^N<4Lum|L3AQB&j#3x*?S>5CkF+Zeyohn^PqZl`e^W=Ml7u`|BrJIX9&Xg#VPpNJ#$}VqIy*US+Nm}__9ivDlogBaN$#yJB z=-FC%MQ#_pVt(Ujo9bVLjkZJq9Ik7WhC>7;-W$eDFQJX7$sQjG!eOp#`J#e`$LzdD z+sfwJm{+j(ud*{A?SMw$SPtHJsnK;>pjni?!RL}NyRJat9_;Q{#1>!ODioP*Ccpdf z8|8#xjEtr$&$5kg2u!y)z9Tq+-Lt&zXwCK4xiI>2jpT9}Q)F;~>~fS44JPxdw6Q387*>k+tH3oo%(C7C|`k$amJ{AGnXetVLoy#$SCEy_$1h z`-u+9a66%0e1QhLqUSK+i^avely_@T@Vj%0$^FTA!gmq+HTTZcS+={}n<~b_mdx^_ zPH`*PxnW=*9d~EGI?L8XnoetMuCq&I36pcdznI8d%0%09_@R*`G z!Z4k6%4-a&J0{=Q$x@YFZYzcoJS;c$^3fliEZ5iIp_XC6VdeyP38Qc7b`vt?<|fn* zNYgtdGStIV#T4RB)*G!iN_%d>=#xVp9}SlC8DwA16u*|NbmtN9&?>G|60V|Y zxEp|{Xa<#ViMHqPGKxR55Lv?Fuu8#8&ZHM#Q<3gu#*^Wb_z)OMM`N1GCQ?EbrjyE! z$G}@%gX677F62&e7V~S$l78h9)1{a{v21As&+2P z^Rerr8^-EtRP&^^Oh-BZ-5FcewZ~)Qz6YoOQ1h`eH|Ez+0bTCI9xz0 zOy^Drco1X1?!ecDUro68hKO{APek*$63OG9{{AOY8X}(F#quUM3oeIoMUgOZxEp39HjWTt%U>VTVu2_ zPv3*M@giTcqqFodhujC71c>h+0T-7zE5Yjg{0K2F-}v%3lY*P|psM?~Jn>HjhRBQv zNKjp*Jcd$%iWtkoE&y1VFTq#h{6@U;n?V zHVx7T`?ml$A8s)NlJ(0w0z5tE_o6nxeIZI<(U+kE1}{7MUortcB$6MZpTCUqgRuI) z{(TTB?`P(Vl`vo!7R3T2ydsNp$(yDopg5AyRGM~di4%hbFv6t zPy}Z?u7?>4Ehf0Ft2+~M(_@lq?wP#ViP?DC;(ki~a}!v};wHRQG)Fm`c=HyX#KE$2 za1AfHPHWdVJY08j7G)Ip%&f8reO7or&^%H{_$TC#UM_E0ge5CXLD;A54n*WVk}qE# zI3)y5$vE5GR5b4I#rBN1hW&lvW!ux4zw;3@-4h{L>vM0APMc!vq1WAo*gWvc+_Uuc zrha5E=8VfS^Cs`Jv3N8T+?waR;%yFR9X4($u@{ZpB{!iLzIea9(ebX$DU_pcU}B%K zAH8#~$@woZSV9m1;ZGR5-azJYeSO}b<_9mkdZYmC%f&|b+MN(6Y3a7EzaVR*uiTfD zjo%pFAiQ_J0F<_IE3-G)q*suoYvQ}z#MP^%=r zZo25)MbyX-Xel)JCX=<+#5G6xqV<79RyKvi52MqTkYUYJ>!D%L9N4hc&1K9LUV8BkQPbs|vB;*x=8JYAzB-@-KRfD!FA zeXOKUYaXKuq*=jaBUvYOS9g#$Gs!S}AD%x{jO5u>jC6ZsgVIKGR%a_3TDf`SIM%ow zTms*@YZrm`x>ABzj(_}}dx8Ubs>yBwmiNq8!0LefUSHU(ov1{QGAAcBdjYN#J>gktOqQPl?~D>J6IB&!`klf) zp`)1>#h8>VSWk5de`+2!sp{F9a>x9af5$SPRbShr5dmP)z>VI73t4cNWWETbmy$v$ z5rjn`-!K_=R{?jFH{bc zLPVoHmml;;)xR@0x}llk8!0Afl+L8vyjxVkQ{U1Kn#WjWR@h@+eSV%CPd|yLIzLm@ z6(sDR@bLhXS%va!u%Lu|$MtlFO^axMT%;A+>7K_&HG1kWx8}YK%2d)0OLxj}lTu znXsA>b{q^*Dx)FoDkfU{+03&tn*Z7ad`8MAV>;q8TjDASKz3BB^`VPY0bSFVT?z?s zu%L+ZplA`)@7KDOvK1_Q>FpOuYCf7@?nE+j#(TtoPotp`4#CXKJYqT%R676&G58Fp zf!VLy9Et@_cIBLrLfdPztG8&bLlH8OQlU$Qe-Gngf4J?=lPTBYo<5oE&HW8Wpp;a& zm|Dy_$R+)TKI6-Vliaa4HYcEHQ=Of){bJ1|*i z-Bi?ZNDn7>#`{dH*lVI)GmnJNS?z86fd)U2<4=q$odCbJ5Vy;YZkmW1Ck?H0*jC6* zs+7e14fb*>SVH@&RgbO1K_7#S6Ydl@ZDV;$E4}!Xt;&>B`t1tQGkP+YQ385PmA&bg zs2!0#4VRJ_cpK?fX@#QSuW<+~2?LsGoyha}F_MzKWN72Io2L2(D4K;vLEOzwnnC^jxmx%k}eWt;8c<{?fIEP zGMH(?F7 zjg*0hT0wWja)e-&hs|i5Ae2WSFr1|X-T`yg8csePZt0lqar{gDNLHU@a2`dg_kE-^ zV`#s-+DceY90$)l6rj2%A&@M{@>Sl$PwR^99I?m=bT6w?UpQ0g;zExu5y` zZ(uWKQ4#pn-1l=sj2?XABy(n@fM$t#G)k?n9$1jN0)s@eLiOE7shwb}cf zgci$NXd$IZWp@$BD~J|~7Ar>2Qb$2v?FVcZ1r-CW>#8QStb^t*sbvCdhgN*%3ynB6w`4?)_u;+Y|w~AjS zGF00bkmZUiTxFdlYl{pw*@ZP}6_n@Dcer!u)>AEG*6CC<+<*NJaC$Q+F3XqGvaXDT z?x>f6Tr|!n0W*E}=4WUi8S{ae-17{Z({r8}~{fq$xq&K?mGZyZYxKRKtNky*+uR z+C^^KUHjdvpm2Q-4W6bUe%Z{*%3X24F_Rg!ovXgVk4Z;@yVB34XH>S?PK>-cphfsw z7r~~B5Z=^JCDxHVX-646iVXaQ?-Jygtr<}FI$zluzUxh&*)PKam9a%-Vy0_QI8TU{ zO3(#fbHUdItE8s+w?t<-RQtLHVXsE==#zbZ`?;A76W`psqW+>ICb2ns6RT>5;y_p` zQQpM62({^U{T#g%NA41bfc8h^tp%E0q2^+}A3bQ4CB2Wgtt*6TY56{P*i(DQpP^-}o^)yBx= zPjT?E^0P5Thy*&{7psK>VsVRTANAb4q8^!RFG z0h>LyDB7l$;XDETx1)2rPthq!yXYWM#>14TGQI`pH#5Ib``OtSrnbd%QyCIxh<0Tt z0_vw+Ja&n`O7d1n447y7quQNc{+jrb_0E6&a1?BRT=%4mzc^H4Mtik?ErVZZVVsjf zf$8US#NcK0KmyG(ug^8I1OBv4j&!)|`8a~S`4iqEgDY7ETtP|IeII{Gtub@{Z7hm$ z?N>|u)>Gkyb)#r*Lx0fQgYi#erbL@pAr*mbG?M6qpe}n_mKjLXJI2I+Vr&5DjX8j2 zFH8#Q1&6R5;0XsyR~TCnc|B&oh`0Y*#6SO@c*P44CZsPN7lcgiub>AV+z83Hha~1h z0q6(P9+3YA>309O;D7Dzfbb0P@PFQG2ot}MG>ABmRDcKqjQ@+HdnN1#^4kQI;Wf~U z)}B4a0*(yAb{-6H(mofgIL1zCSYHYVgttjF^~VZbwD?V z2N6LQ*&qcb;{jdukW+(rdhktJgTm{+FD-fs)iV>;{u%>_T zgYNo25uN}d&i~VxU$|Ws5Q`^U$aS51dw)S;cii`Q^VYRQdA9O4&v_ntEeB);ICY7J zM;cBmORPxTNSp^eG&l68?GAx$O%^(%8HKvB&bHd00_hX~f|6W?_R@RCQ;WA* znUL_LJbj1QqX&i0_Pw8;7E4d*(%&b%pk57rQ=jE_RbRrAp*4Cw54`=%r+IKqZ2KZWd2^JBp^`ux_I$lJ_GGW{n4|q?y zqMgFtEEq1>p~kL|!MI2%KISk7>IPPsQ#s?G7)vJMDIP^%&k1?4-_mq^EnA`@U&Lwr zf;{&6k-_e+2YlnDA9Hk*l9YO4$HVDd+!4Lt0DVsTe)`7R=fLSf{@z=j`7za7ye|K0 zh?vqEI2Pu`N!<3_wr<~{R22ffPow-&D|_bpJ2~*r<0A9*v6FVSf%1uE@@)mgSt`C> z@AO6$%HEJz=&? zhmXiR99`B5RB?(WCLVN}zA27CVPlVE3F(v&>W7!&R{NbIKg{>6x|eMUQS=Lx^(VPCUh$)KL(=VdJk3vs-)dZ5wos64RSvp=Iw zr!ziV$q@pp~xS`ld$ z_2hF)l&=|)j?4v)qvJwp3hbc`fwjs#lK_Ju+G5iRcxyejg(HL>{FQxHfV!8=qv9M= zdr8|h9to}C5Qx}a=UGoog+bD!)u<+d8ni+7%!t{KiU4c0X5=3-@&IMs#|iT2uPIDq z1cUuF`YxDuU#1m>UZn_(WonK;mQ{@+4;dP0pQ1Bf1o7kYY!P1n9FzL~DIdx+1|?LG zqU-k`o{G#C-rdL*x~GX~r0NROlYahWLmpeOgkoIPFlMtW8qK$uG8WEX9P({dloWmf z%&7djs8%?2DMzZ|>?A00j817lf*~1wu($9if2i0Xy{!R_w(hfi#VZ#SRK_kgjnKYv z0nX~)in);w>#SWJR(d^M1bP(0hdM2>g%z3d#P+U+MOgZkt?InhNOBB;lnLH(Qq=8M zHdZ2q_e`Spx*FT>N-fGJZ-#{*#IP>gM9Th!pvXXXE>kI#eq9JWBt9+JrY>*EO!OWSE&=MiWjXhxKUY@b$f+ zkd%pB$n>M|;r!agSKj{<_%H8abqy1HCwz8tRuA1KDLeU#G+NjA8#HfW3i$NSuXwu?I3kj>F<#g_2Jrdrr3-R zjTZndog$tGj5fg(9G>CSwj>mviOxSwY;S4ri^>Eld1{n!OWOp%z^#ESQg{-+JU=Ur zcap6mOY{8bwACuaP%ERHCCG>mlY|>Y36RoJ)>iR`uL@LmeUk4h8L% zBhg;gP>9^=csBlqSk<{8D+kO>QWOHhoQ?(9n0mdOgXdhHu_e6tyftfNHVcfx@KSTDPw%uo{Tv#5E~k(hiafx9nIWC$w_#4$?XPqR50ErTKE;5xeT(E!a7z5KK9L_&DB! z9X7_IjuhubQa4N{#ANm>>Nxxii7>W6Ia~EOw_i&*8mFMnS67GXym^diOONUS{_q4g zL`%(dJ=uX*ClRB{Pu|?yEM(*ddE8$RDhvB2Fxc!$Lt#S|RU#xLxo41OvxC{->7&A3 zv$QWOnN>*i5`hjA9O`BG$@0^@V91x zC4JYJzw4bc24-8pNK;{w%WKt-o6EYrhb*Jp7K?i`1&neS)lz&v470aJeiQrXesCJD zeR@8>&Hsg_I2}@H6{&oJ#H9A^;Gtg!Ei(}@r!e4DIhqYQE}4?Hi==L_^H*T8Mv&v~ zZHatI8C$|4s1tXh@#jXdT2Mfkw2NaPXZg7F7}BqyG*Yiu>6~{dyM#EhD(5?mr7D*s z7b@O~ltSM$Pby7 z?N5GEOW5{$o5Kp^s+M^u(rP?!Gfs@|%_Ea>*1!qqQ*dn!nQ>&JR*Gv9`KN{!3Oh)a znVB`kyx}J6aq&0kE;CPg-d^N&K2#$yDHVJj#`<9n(24s9niE8ova$mx6xQ)GM~WaH^QGr2_p_X=3!#yv zrSEkPe645R{78CHJKk1ok4AC8()pl1@dcv7_-L$UNd%DSwYORbo%hXkc zpGD;2xS*@bp+l9X!1x94&N3ej*$I1;k3MGSC6d7_EFF2V9};oT5-mBE#%t~b?5h=6 zzG>P8B{{_vf;a6eoY08oDtw^j+Ja)X%}{$!wktW2yDzwG2o&_0Z%z>;x0YiMrHr*d zH6|1!DJ(a6i(dQuDrb;!Hb{+0>WM@%=Y+eGCDpb4mdv~KOocPLyH3_whLGk5yHk)e z89;m_;B(QYu!)2nfxX1cUtG2-B0a-|`Rd~lILgn%)=)0PHmIWo>_$8mPzQtrqiC?l zI%hAt>T&0l+1m!Ve9YCMhm}^EX>ONJ z^4T~iZiRPYE?zb>ikK-x%M%JK8qnOJiMePlG^&sAXO3>@+*a?mg z+iDYN4Hq0Cr1A`r=AOoEaLb}TxKjmbCmWwsAgEcFs*C0z96Gr#+xv`%>FK9NYzt)n z`gy^C4AXSxCjevddn1oIIkY-VlZEzU2y14*`&I%_$|0aPj>1D_BfF51*&%{z{zqQf zfK=D?f++t-3J~=AA36Za-zG4CT#-1+59m>?2S%MaU+4K-LqtLVwp?HQydVI)-l7Hs z0!Z|~oN{P)(C;Y-7D4y~!b7hoptb?N`R5G=0cKxoC?NCf1)~1JQvZLp-IoDk0FD7K zL3oeg1MtTSyqrUlz}G-2)Kf{~iZ& zM383zY{Ec8GO!KE?|;zxzmt1;wtq(n0tC&u|M&_3&G#<{1(|jZ*&NW`3nvM>-hlo) z)mZsSH)R=VG%6^&;8<9=_z&-dqNTto#xRPoY%jK(2Js~9>$v*l`iDapNh=xa)DrsvR zBb>uNY>2BRK5qzbz;#rYmR$;L#2>*BpG7?!gMM=67zJqmj~!DcTAWX&gn$?$P(wet z<{~X#ps6-WqWcoh2GXA;_RQ>Q5-yc8vppel!aojrk5(;!@vMk8QLgP(0_01EK$Q?3 zBcOx^7qiP(*Y{XLU`78X+*^bYO-ijT(sw7fGlIN}NXIudm0K_kQ+asexduSiPG9eF zz7>|dmM097IqJ(O&+5)oxb+JT-*zHAk(In-cbQEu0L(i6AJ*OiDyppyA0E1-L!?te z8bKI3q`M?U>F$ zZ3Ff99h%aT2Qply_39+?7i98MKY5xb{{?dhnavy>^m#O`q?7tiIO4c)lDkn?APr;zNRjlJVoX0mveQ-kC_J%=mnHKHI zXPL}ex?gW%pX|u6s#!Ni>^klYpODCS2o!G5Ay_Jw0xM;Tg=AJ{)jeCAaKBYw|u(tCe4^u8QWh>vI< zz`l@|sjM@fJeK;!*U7Q7(d7ZsNo$&24& z3tlQu;4*(^V|t%0$Mu}|=gij1(mdWTvdMWYZ6R;QXB5Pz#k8Tr+1Znxo@2Yt!oBg0 zX*!dQ@6KN9%0wG$AKCm!KHmndE}js2-mZ?7H{sgX8+`Z6ae?w@)@aajaPF{sRA&3( zPiNPbqA70fA3c`sL2&1kt>xm=CMWHvOr;0!u_tl9q@KVm8E3z3^Lh&Ia#zh*IYr}{ z%0C(B;{G{K%hA;6#~4G&@cE|qH@#jV+j;XBgN_zImSv7yIt2HE%%`i#^^FUP51M>t z5z^m~$WT1pW#;2xw=lY2qv;zzsh6}m5%kg<1 zqaL4Nrs4*(o;SS^pHn6UNlR(t&I2MbpC7aDA2JBO%3mh%y0I?y=7)IrKHrrWs%Lcf zCbn40Pad#6CCK2oyC3nbQ?gAJ_c+p*t>H&g&rpud-69WVsX6r$;w#b>x2@J;Z+0{T zanOEXG7xNg_bF#4m<9No!%pmIdOC4t_F}`%)NDWb$|4U%f9&9mE4xykj&dH?@k!QV zVdXnsF~Y<5`84^0rL^y9_5M&*Z%+QJ(AAVm_Za>&%%g<(S-q0tR$wzkVNE zi}Cr=CQ!@5iO|XPnhHzs{^s#a2F0^rDM8rAUD{ z$<>=Y7pYU0R%o1$t4pMbYhT`!fQ68)bj|Cb*Y}n@c8{ zOgDvX@n8b^>E*4cqLyUt{oXC!B@3bs?6w+ zv4@skRnRQ*8hLu1`80k^Qp|3&*E9LW+GL-t;Z;f}*;w9L5pEImaO=d)^he~ln0{QN z-g42UQshN~R2Kcon!(b+GN~Qi^NrZRG$Y{6 z8`zRoEz1$!-A^)sAF;<7oQvr-W-1Txv}@I99_M8`SQ6mYTA_zbb`@Ao*=lX+C90~p z9@BnuHrI9JMV39KWoGk#@P!d=Q6#21T0G&QCYR7dPIIUEUe}pzL;M3hyJ+!ba~pr1 zIbYNFe)2emjA&o*)OFu)yphnRW{S_(=H5!KIBl+ntG0xG-^uNr%-F0KX#Szy%b=dO z`$}9&dsUF~Y_pQ5)?Sc9pNe{=G$GB1by||j1ye?W%Be#n9mGjFm94!c%OD`Cr(5^6 zbzHvX92 z&n`~sTMeK}SkMPMC zdEcq%sD3^P= zh5SgkE3)k3l|;T)zL2s;&p4%z7~*p+#ddCX94G z=t)ez{V-99k!8lLCmHe=P+|JW>eI_ofgH5otQY(O+V2JcHirqm{>_C^j1KTedBh>q z49ArYWBRw30f&crsdtPH2fB*tqLeNMaARzaHH<-ihCh_>H{k_oWdcx08p>f10OLX3 z1jQzk5dz2yVhPx7w`T!jQGo8^azL58|E98l$O4N!R161DQc(nYH`+>!tl&EY$eC*f zJQr*6cL`qVMNqc}MRh@eTODI8l=}k|@P$g`qTCgrelHYW`1>5_S%FIdt=j?)C_4_Z zJ8)B=o*CuPfPO{MXD}1+g^G@I2DA9r#i)!uQ`7@rI1~Qk*uQ)c|6bKUp?fe8%h!z} z#3bNOf4zG;QTbd@l%x(Li=+-;+=6nzVIA2y$SHyb8Y_3d#li|Jz$d_vq@cnMl9RJ< zLVYXq5Ddt_y(2E4`ei^XEMO6%nZmF8s+bQ*;tRKc2VDmxm0_X|LHgBn0L-14nAT7RNVo7mwo#B=}z>Q2#h=8%5sW638Yj1JO*ZwcuSX51YG0vv87cMD%7CZs=(#%Zp3 zCBB3_m|<~Lc+5aX9AFta(P>>kc6pEIxH+9}U+esx)Xr66%)RHrH1U`B*f}OK==N{& zaUp1(-AsAUSx@AHNkb2<$n<*cO#gyC1O?;Xf^(w`BCC&WOMWVXa05w<7blbkvo{I6 zXj;=?$pPrk_oobrR84~$?ad%M{2jTyz(EFi>p_I~E)6Wt>!21VY ze9jDaj32Ad`P`9zd^|sSi`dcWS7az-kNEC#b~B@&(_gS48r>Vbzd$;hk@)T)a1#K_ zut36+E!UfSekZIyjn$X30c#i9JAJ56$5`5Rg!>JRace+o*6$4e&b#dUBa6>x_lQUG zo(*~*r9}KnL^)>wCw3g}TKD?2-5<41IFiTsO|EN+{@C`zSMi_4pWJ1KxBH{%sE)+l z6Q5lIz8~wZIsQR-kdS5c&si?@zhEOZ9zl)U1ariLorU1A?!bRNp0{r-Z7!$`S!2X%&-;c>o!!LDSCB`{?<}yj zJ-0U##NU6FI&?5%SM2$dRga1wzPFNYxzn|a1b&QI^4X0gN2zaj%*2GvQ|zw}1QrQz zhzpc$4?fw5lySU!|L&@j$jq+Q?fZi^ONVBxUz5A+`Jcg`Ba_&VG%GXx8S`4>C&z#8 z-?vxZAqqO%JAG7LVFQ1SSks0RhmTRo40#H^-CjFN4mt}_%vWw`VK)8?mWfpUNx=C_ zTfU^5js2kNJDIR~Yz-el`z_@kbNt8RM0G^bKR5lwSsN(z%XD#mMO_9op83v3?}GKb zmO%%-Aq|_z^$G(?nnB_>c9(Y(KX)p(CFE^K#phjiGvo`M>{b1Nmt03*#4l;`(!Y^P z%)1lBh20w!l9`AKxTG)=(J+g1<;kb4Oy!?MLigE~gR%Yll}bO`%vKU>-}_*>il}Up^eYR=%vdb+2=_ymfEp z$h>#|8SpuJ)QK#ow<(LSN2umeL7B!=zL{s!HkE7vkE*XOcn)AkwkVBr(%q0yw2L9X z+$Px3=6cC)RVpTD_06T0Shkf%t*&$yq_})NvW81X-{$Z1Rz=$lEJl&1so-AoSYxya z==GB*T^)|dAsrhq=@Y}Pr0b5TttEY=%9VFtjdMfw-6(0PVP3dzF2$9&sOUMGOva`5 z!|1J3g639BakakMqR(M&rpK1abwtVHi_%*>#Ktl)E0fo5^%gCpmgA9+Fx~xn7};u- z0iu)-s4Fsg3YPuhKVbB#a5SO;22eh*=q0j6K-R6s08Rgk>d`&JOM_WzEgpNh%ka%? zXL)weYvIy8-;hz>*3bxrgahl$fs7??)Azo5NkhNTuUZWtAEf!QWF;F#&gcKYR8_dN z)`m<BZ^9DF zPA|D$BO`rt^1fknTAD$yER%0^lPBp?`ySuROYSm!=EKar#(w$TXZH2u>^=HN^P-=n zpL8xyVEu5dPs}Fm?|kCtaN5XyIW*<&^6OG$?XZ2E|7=8DmzH_=OS1#AQ7ROI{Um|06kC=L+rf8yAkT>cIdrNrixuSpE z0e7>9Z3mp_#g1l~#tW|&QI%um=mKdE!$)(hipP|;4}J9xGw@DVH#(=)d5AlolAsTs zSKW{nD5)VUB*yIa?C>SuM-wtioJr!6EJ98B?V<&a~Xg z0}T^bRPIg4-Fc0%M_&E{9arwgNjqJ7QElxMHkO*cpuH0jTNT;yjIZys2o)o`A1OZ- z^7I+yD&gK=v;Ug$*`7GKyg46tpbz+m?W8C?vR0P0d^6o@rOa7=m=H`G9W?r zf`lo{0-lBgu?^6c0HQ9aKn`P+H4an}pw=B@`Zoy?Kn-w_Pmi+my@CNNBFGr{`z#Pz zf-#1K>hVF04Dc_^Zjb*k>;cQ8`)|wN1 z7QY`8bc77}4_hR70rD(R#zwHJe@^>z7l>T~Bc{M_qvRnh;0x%dfcDqqQ~9A>|wNb?-88ek#K5U z1vtYPy)rlqmJm*}Pp?7S%?Ygvw2Wvlm6EX>o8&$!Biblsdmx8buGZ|O%{~Vm1>3K=2!I}zBmpE6fKmP zSy(`)ST5-}Bq{ye_?<5PGJ);ucY;zvcI$d>c@@_jS$7k@Y$^A!s!Ob9vM37py3MRt z7vy>w)E%$}B<6BQ=KGb$2dSBrak&s=lDDSNYa?Px=oR#{3hZg(UYB@%F~mOaea^~O zOGP<;tbAJ4h@k16{|knH+BKH+OaGJ^=Wd_-^e3~uYeMf;Io`8_inYa(6_uZ_HWcN;`XsFj(TlHdKgx=>OQSQlcP6KDsD-z{ z+b%avPE!tx+?J(eRZ!vr{rC>Xm?~`VoBZ!)#9q!W3z8`zUM|wcCFx?Ml|j!^B>$->4@#?R9_QAfw<`<_G?UW#bmJhQdCvC})pWzGYgB1z#gk z1{gg*u1Y@j*n`}@4S5Wq_AKSjrD?&hGy@Kvtc4sgip0I`cp2(LF%+h($RNeN9>wY>Yy2O?TZ#LojnOf(bROC+SOGD>!S~&=>2s1(n1=`&uAQ_x9~gq4%PHM z3`&j_xdj_qxmP(3ywigfZJ8(Ql+p?}C`-QK6y2F`J^|&FzsF1|WbJJT8!?x!W7E3| zeH9wI#B`Tiwf@`HSHH@svg%y4_a9y@eip9pX-|11HzNCOPNG7^sevF)tl$;8ZgvL4 zJKZ}G>=`5_PhYjN7Q2$|dpx+hXQTM0pVReC!UCC}XO$=3olj=EPUcfsZ4==U$@wom zj=dgWR;WzwKf-u3?C^x+P+0OVL;Y!E{|0ra8G%6VJp)W;mYxOD=B2iqaR#~x%Wcz{ zAK*@g%X0$754|U?W3UldF~U@Vn)f*LQBg650`X9L`Tcde}fb9H+FzG0zlnf2%h3l z7eI5k0FBaa>WvGB7Z^Vl6IH1Pn#qOV4QlU$x^p*9bP7xY%m9K22q>{hfZGoB0&M52I;$@C1 zVvz*cb9SHxNthl0K$&D=a~MUnbZ}Z87^va!dVe`h%Izb zD+qiTO7-}%b7-=tj}rB#fQ5uHNmy$5Y@!^UAZZj>FfegI!)7=z&;SDy8dS#^w$nb_97`;#*DcYE#2O2hv=n{HriY(`hN+*+^C|Qo|mgq!|>>1NvFejoZjs2yk z6I|RxQ$`OkQZou$nmlWtPbQ@KG7&DXy(z7K8KbM&_ON+Jm8fc(>f2kgihR@fj7Hyf z4t>hB{H*;b(lakPt;d^}wu(NA^6vkXKb@3LsJb#h5Nd#RPp!kL?emR4yN zZDUTh^wxu$a1p94>;qACwX*3vW{#>4YvXjL-_7TSw|pm5;m-98Fdqh84mzJ|>LFeY z?aSC>`$OgD#}oT>c6muLuI`CG>cY=no8FAx$D*EXqWO+kY7*4vgW-+2qJ0oC&N4SQ zA1@^w?|bYg@E+&$2Z8BQ`Qg4>EOwGNM(*8W=ZesoZe~`$w`OZ)(%{c2sCn$(SSarm$Oj?)F zPv08qT2<}s5mz^O4(DH2<;s2FbXTzZI+e;kJ&YdH-q)ucWGGlo5HC+!QN99>VYA`daVaIH2L)<7#+YEivMeFKlip9dS1$ zro_KKYgDzbDU%&jrFAGnrP1AD>up>E6ERxnHMQHPk6QW-aWINKnf38a0@A#q91kW) zukKkI@mv$}@%YIrk|7}??8(=IHE(jjHp7nL%cbb}bi_-bi+x@pB`lpTuDL@z%d2{c z`BEvRdc$8Zwu#WOb9IUQqV*lu#C8AExa4BFs!D%wXV6h z9tz;-d0x%EAF0X9A*ChF{vjsU^|Q>GIbm!rm`)8#Due6Gbct$)%T@+*UiI}w%vvdQ z_!i<8ci>*#;mKH?+z8$s(AXZel|nd!ik^VNNx=ThkJ?uMjxh%j7{F={6F~m9h(n3# z*kY)3^Q8^g(LRU|fz%1uQNzg1Wc=&>Q!MAp>z8`0E6{U*euUPPUJ9+-tJ_CF5k?K{;iASc zx|U?)(g;&AAE46$$LNt>3o!7FQPjAAfsE`%``Yb8lBbLw){I_B*U(#3i#7)0SMWgg z1dam06^FHa6-*3! zEu3d{7Ly%g_j*DK?4bTC=SiK&s;SZV?d(sY#+FNm5V`#Hu^$PYgqBB zQ&pfR79l57Ve|b+Qmgm9{y*Z5EGnoA7N^lI~+k46pg-?S@w@Ryx`_iS)Y*)!a96vk8(fnBY7vie2Avcyv=Njr~ zca**wlz+oaxcuVvgDpa}pFSkp)>CmVeUGTm<+vZ2++OL~v~ZgU{T8#G-lo~|1>bAi z)9o4;#em&|rq^s$Mz3!j`PWJ)dQRZ?DhJI+9Xm>Ge53#(EGorG>rcJJ@#@)>XHCcYMD{ zGdsapKRxJ0SAz}RwZ)G&A{*zc46xvJ-|EuTvR+i{vdtF~M!E(_qgj2*+qDk(H zo3dFuKOREoW6zPT8xs&3y9gSAz%b#;dg7MupgW12Y#CQeKIw;VIQUekLm@|+A7N7%E0rZdR+Cd9IPqgWY z3hVSCb_Lm4Fu~p!q!_e={m(Xz1#S#f&>wwtp)u+&PV|fh5`qqpbW{N2#pNiABEU~m z82S-F7if!wU59pf@C7D325GBq)F>psEp`N8ssL@E@IpNd2N?Y#)NkZ}CjziX0HqlI zj0IUZ{{bWbzW+1#|9S&ukNkf;3k-Szo4*4tp&uwPZANYJ3=r`BHT{(RD*p&`oczJN zFf}lD(Cb!R7N=2`g6;-gQ!_1_*XS5CiOJk0QaX5wxCO8y5{)qnU@;7%jlC40zeEnh z9;O3tqDQPI<0HLf{lb6+an=In)eTz%2<0^z&Qvdn>4EkXNs%I&OkeUIvB4yZ)(B*d zEG!IdOan%N3q0Xqi2+J|ht5Ih2ta|NwNN%40jSFgtuzKwS*rkic<2kz15sb#6ok_t zRS(3#9^&xe5=Ed569f=}j=8{x&ICSx^nH4K&6Q>VNoWB;ETayHVL@$hL^08|sbPdj z0u*LJ_GAoX1lptx_83&M75m^7Z0?}9nKr|ssW~VchL#4CB!^wmOX%jJ#d9N>X-;as zkwQriyL^=DXcPU6%sqm;Uo7A#U}u*u&Y&k~au~ z8k_97%5U~}p2r8;+Efh~sl{=GXmyEIP1{Z+;pUzq(Qd@(QeDqReZitzDPDXN+D*D~Q0g{UPM@}6AMrK)!k7mes%YSNDsHm$fr*H7p zzd@ro%;d~wFzEmhZscE{cLJd{u!K)V%+rRPyBS6@bCAO;6u6mJ>Y0C;I#hY{CKe}R zPRW+M{(J1#nLrkqIO?~jiu%mFK7-9}O8sjmHQy!C8U%jP1^NdMp4tcbP(Bjq=C`UA zv8wT5f9OR1DBa4S1G9+r-JJ+z34&=_j{TpGMv~5cf%|UujfZlx8##d*HXRc!M*FLc`!PQnOW~?W6in zXIlorTiHVWovpsj_wRRb^bpA?bdSP6yXFZe`nT$>3Mv@4bc0-B ze3tpAA)lM&eDunx?*bdY#IrMDCJn`}551=FG7gY@{ADsfZbPz@N!e7~SNzr3qe13d zA9`2tYe!4jE3&Fz7@@uK5{}$RU6lN>h7RQ8sZH9oB}03j~<#UZm!2lh%->-dcCNt-}wE5sDjltN?~!g?G7%?2XnfO zWKx=-Aj?V@!pYiGJo-zgrm4QzoNbw&8?{SD@kfHl^UwP+%aix;EJoLlt!ioSMLA1XF9 zvdS*O37*?hep7czFlClnZiI|v*nO&uEEO46j}RgYSx%n{fl1*+G8g%A>XpdjtGVDm znEj|ca&k|erYTD~(IiQzZS`?&IY)fBkqWmfqOO43f4A%gY|o*oxA*RH5MTZ*&JEJL zQEmhGqv*5N8>rR4ceJumP_fIu)c+j(&Ipr#2sY!JbPI2L(b>$;y*$)XRuO;K;&Y#LTpOj8Vo@Y*r@)ysJS?uIg{7Jd-HN3Xmz! zXweVe#UQb<7Rl{|iRd6Gf}-PLH<5p0GI>S$_DW^vi}GvA2bkl1U4AZ`T9BP zbbweDNSJlFHmKeO^bCN6M35Q{ZP?f_Se~rUD@zp}lp?p%)-Y84YSI4$_q&Ttdz10?oiU7bn1o_Q8ltbTE*B zy#PnmrzQco0%0F8^`TG++!DGibYm=5kk$Mf6u^kkSbyUav=+c{xb(+l2ejEg;q$-G z`afXYe*xBioe}Wo9#F78*n$6rlF*EPF9#&#{zI?*HTJYP_PM|zNil(VDf+zM==kD1 zmA8sy$4h&k=pi}@*+@{#8&j5oNQG!DIJH}9I5{7O&8wR(1;$JQWYqxCm_;lKzHso8 zjZ0>&TVRm`JZQsoO%;tVEwGTF6FLtXx)=ba$p@xr1^^f4AY6h}8Ab&HfgwwQiT*$q zrVR9y5A`N=j`GDyVW3S0!U*W$fnsPDVh=9B3RwRrx^a-;qhyu^Ucf_uIO3KTWYFTH z@59XIV9@7=^8}z=H<~xlQUkKMM8+iaP1A@qgarXQ8WS~97|_gs(dbzKW9uJ&1kg^$ z5{9&ZZIX72KGa}OP@2;XaBY|q@_Iry>93;CPd`Z`e|{r_CfPxhl*f`!K0`A+a=5hC zhMm>Rk7Tk`hMIDAPU0#0XSIzJmv5O~F^o!8ZyMB8HItsDxa7Ca6~-<Ncoq7TdE5 zh3k9ZKM%ZD2on*QZzSR*Pl%ew$QdYVo+N39ODJ+_~(D-v+FIXJlzU<+okM;6|xygk@jAzUh8HnQFta>!_MYu$Pkeq#lki@ zeUsG&x#{*fU&Hn5yYv^a*D)XK$rF%Vo9kB5C9IxBY{8w!0u@pfVwZks24_ zoX2(+q2@XrA#Y%0^0%0A^wsp03A$E+rhJK5r+{-_sREl?aX1&Zkv$#bJ*TnK047G` zdp8x{BJAep#css)huFGjbX!PuEsG)0)L4s-q8M5mFAkHO4Y%=F?#v3 zsv*|d)$|3u+Quv-dWQDL8O2#Sg=5y0^sJSR2muVA$#Y+SP!dK|->WZix6+B)T% z{Xulzwz$1pQ{Q^ojF%&x8cEFuAp|2OsRi~z2(w_{>V`%+^06)L*{#^o=rz5qiRa@)bG3x_TwAw&XPJuM7Qc1z22VJyyljAy-jZRmwL=j*=A&!H>(928tjmMYF#z=3Y+aKRfdcd}T`0+6UhhrW;J0)i`h z=&dUku_+)dg5e?{pVDu*f^1~izj4C>wZWpce0n4h1fW|ZD%%WDXV6Rm*6s6s4@8+l zRV~oEd&E3&iBLM^4n(vs_GK)1H=0&TNs$G`TV=3C6)a%HATbG7Vj!6KZ=D6Mg@Qy- zn?0cPkjw#Gz642hfm;yL(GkE<2=X5&1I~n8AlMKD0sOk~KcOJ=qVFQ4h@hchV6Fhe zP*VgR9;g&Y3BXPi3SBgTfNl)|Cy;6ouv~%#K(#|4?3HAKS^N!as2PF>`2X<6AISx| z&cNhRX?oo-Fbn88FQ$N+JW7>;y}kQiqs#m?-V#1(KAVVq)VBE=Z#cYLz-ixDcX0|? zk5o_+w|9`??54P!4bzcq1Mt+w!+C=nqZ!W)95`?rGu9Dj&GL(|3GWHRO{PZ*byEcK zz`%c4NE8sGK6l`%0wz9$F<7K-oG`?OL^mv!C<2CV0Y@M<1iK+4;U%n<@UUSR!!S@* zhWY4_yq4u80JDS)}PFWpcGHa zK-w+LF4$Z7!IdO>fb51&o`QxiEf-0am@QtX$IcZ6-C;^4E5sPLE}qJKj_aVOVy)Kr z&l2-j-cG&Lj>D0g5@J#QG};C+Bqg?oM)~8&$xXw4Pq?mgug6&~&BF>oSv&=WkME=q zY~N)VUkiH;t~#tFDXLD{UXFXj9lDX_GSBKV@V!$R5p{E{rP8fIM7N5p1}y|ZRnH*L z-k&(u{q_yFZ?AJ+KF)58%Np?u%B7X-v-h2=&^*x7hMpoejBqDU73tdZX2~0@)ct%8 zq(!`*rkNLfaZrJA)V6$355SEsQmkN2V%PAr77A~s&DjZ;x2xN-(KAqi`NXh1R?H`) z*K+iY@{c1Vj7d~cN#L-vI5LPVHQ^dVLn3w(f;qH=s-jf~EGWLuU!7x)@(=7`7b zsXWAVXMw|#&V=8;(Oj#|ai)G0|H#QMHbZl&-Cb)#Z;)A2@ck;+4Zh@x3YF1=+ulPb z){T3UjlI2_AJe=-T`9)5C*I@iJn0?#ZlL$tu#v}__Tw2|T$KTw?>3X~wEntfxV$~C zK^gn6+61y2M%h;>-cfYE`am-^ZVIobaPlZ^Kv=9RUi%*f@zTnUsYW{Q9q{6NYkO{N`$r27C{!`?e;A z2TzMa4?B`xU>#B5?(l{UH9Cz{p5CWcU!L|DETN)GTkIX+$X z@t?nIca6MnUb3EoLpNjFr6yFTtgm7!u%ux9Tt>-hJeHs0NKizRJ0RFeY+Z*?^FWHe0>Q{r?q zy)NgKv3a>%Qa~WcS5P!IV5I1|WLI3K9m%Unc;Z5ArMqGMZ2T?Z5xz|ZoLU6ApPM+$ z>65%A?<0)=kQD@aZ(3ke1j<>KMUz!aF-`g_;LK`Adh33~d7i6KN|U^aYr-O7sT`q1 zfG;&9V60;?zMpI|hba`y)bvc-D>l4Wb#XR)bj)HBm}@=e!T;ES;4KrtLd$|vKrTh0 zZl6mHA7G{O2rd%PsS3o&0Du@#m8kn*RF$m&C*QRF@qk!CbSXW`_$Kc=4 z3b3sj>s9W6YHqRwPz>&$U?X6I{r$H~FXb#tL5Rf1yo!Oc8b`0aw3l6bX%WCe0Gnlk zz3dnu8c(@yo#mHUr_0dq*8(b>Sj05Sl5QhL__$a7Dh{NVYi|z zGgZB;r=tWaamK6{-S9+ONth`JNaa(&wwRjzR$GLc0&9w*wC>(<&LoV)Q7f+ zBOJN);9zFc8XFGH-9A6I+URbVYl158RtOT6J~LBXHMltf7q-8X6?2sWXEt*1wqe3O zM|VbJ%SL&n-miF%yx~U}a_1}A^3AiU<&S;l$heauA6FNO>+l6z3T4u(^*@fLH`lxzPo-r7lEW*Z&xBm+!ilmb*6UH))$P>uZQtBS`42a@W; zjkA1_onp;yrwyTNy4Q_P2~D(X^rUyr(p!62zA7fc^W(0}l|D|IXuZ@oG@XG^Jy~l5 z1zO3=8v5^JvU6}d`yg({(XYRJ{$%2^fmq7JhfbEg&Z}}0J$*e%-jGk;QLt+n=dV68UdRwTcg_P6j0L zN++ff7N}b*^AsCy$BC$58j zmvM1Q{q<$S(wSCIs`sDn-MTT2gy%07{CKsku}tUB5&pAC$PM;$`>s*TtvQqD13oT= z)T!}A27+mh-qg(_Mgb2Mu8Z4WB@gbL-~r)Kwaz+t++Q-tf{VYzEanA2$4_QWEE|2n zHn7-bo9jZMFRp+0sW$neTKVp4L*lXT`hJw?_nr%V99~VVAm4!-GUl<5y&l9iTD_G74CsSFGdEx`c~EhcLNK7o}&jgCI}EA=ME4yiC~}kgO6yC zUk!@(7l4sY;uOhV@&L&k{{(A*LY6o{X8>mr0u)q4!7)m}V(-%-t$|oY0Y=KziB6qN+M3Q?1VR4j<7{DZh4PoNf(w%8Cu2t(`r(2e30K<+}Ll#JnD6qO7B18#!Y z8*mmh5r~Rh%m`)B{Vl4Y3H{G3|KGg<4FfF~N*#mefq`#`grIm4G%7^AAZsfmmQg1= zfSZAEod3f;|9ZEq|Jn1JI*Z-SYqu0K;TSK%?uzxRIX=X~2(_&4H@}%NJSYl}S=~D+ z-C|~7_dlf{w>uM4HXvMAtYh%>pZtn{pV#s&<1$B&P(_4qb+NcBD2v+U{y1AP5MQq`n2Od_CqtfNI zrS;il_iwXbQ8`t3@qOW^d5B_An_Y*90R!_uX{^qCS=Q?ip2X6g=SMHlLuTe4E?s|| zy~$oN>kI#^z!zEi;8Go#WJ$tU}4}NpYj#$Ce-up zcY5Pz-|l0EZ^S)qbx$_F3*|PRr)_&O^u$@(3QavS$lS@%`pmd?RpMs}--dSkKtn-l zw4f{3@^(4%;|x-Zt9Iy*Wgds81P`dBGCC4U;~EXCSshmI-f|-5K7zd%S9-ykjsI(+ zL3)*QMw_gvug>TRclnM*Tp3^Q+pTclZ&CaXc)?_X$t(v9xgJ0D5U$JHJ+5DD7wCRX z$cOZ48U%dqQ*s}w9HW!*CCKwA)P4*lb}|K{#pljp#P77JnU#*P!(lpSXsnfzJsKdl zGx}$@XXVdgvBWL;a(1q;Zg)5D%A1`$dfF>EM~T6sL9s~x=5=_c4xgUQM}|upY=6P> zAB#ONqGI0X`C`;zueG%F(C&c{B9KxoJcRF1iUBUP%Dk^hSX20slGC5FNLvi8VR%rt z)y&raF6aG)Y|ogN$%Hbk!@}Jkh>Y^~xzh+R@9VC(C$b-;?)uMvvb2@k=~Aw}&8@rX zmBPOx*;40j1>@t~e1DXDJ|VvQV9@00TzR_4nZSpbO4r-HUo}@=97cR(OzqFxiBQSV zRn5pZd{(Swsj#Tv7j@pV%lgqIs$k~2YTkk#5`n#y?nB%!IMr7qy)l~byivfWTFL$s z_f|?z9dUFq(38~n89T1w>m*e63jUX0BhjDZ`{TS8-(#@cT~O+!ukrAiWhS@l znM=ta491`2$LZu-+Fei%@QdzQv@=*HA?nw|O?>77+S>g6N4puogx_u~RtnQJ|ro($WZbFU8VWmbK|*2@smcEogh9eE>G zuQf)KMu%&TZmU8pcYVKRutrX3Nam}q%qxi%oQ_*SSUNBH_bCTo z4S3CnE2+ppF11}wOd@&J!i*}43)chLnK$5z9Wft)jT{STfIJaduGl3HHMkYI`^K&a z%UQ~P9ij3=@aFKWVR0tUP!BfyjiNbhf^2~eJ7AWWe!8+K`hfxcJwg>SW1 z`NzTMjfaZ#6EOIFZl_62hAjtMCNLCTNpSAbbs z>#~&wy`YdhKf#lXUp9!cpDSbEL0*yss0~VwH=8c1mvFeiN|wYO!qm2SwU0P8S=5*L zjalNmhevUlkwSBBZn7AI#EfX9T&*gZz8zQ2o@*NCht6J4o2-^uWw^be9X_u*mVRV) z+q%T|Z4FE76aV32n%5%}>79Frv30i^1eIE8A34Uo#!p!Qo@Yz6N9k84g#F*U zS$^euXdWR@>$i{Cl3z&9Ys*M#i7uBx)8^~uv-QY8(g$l6MW2(A-C(@OUs;9s8o`s= z`iiWD>KHqZY4w1{n7q?VUl;e)0J>=b8@2(_!2+{dV4NCUIUUy$>rE+dk51AM+;Lj} z-RQN(wT(DZg{UYl{a_7GFCPK+s>gYnhE!=}PbkzLqtkhhY%r6>_dV6zn~-`TQ=iGJ zmCg4TtaVrAvAAZ%{wBK7!|@S0SatvLq`&7B0VSg_GTx<~J@vz?i2^;dO9r1w{T){E z$q$y_q8WNlANg0l8Cf@Gqht)~`*pIGFeT68dBmAJ&O=r)6+ArAS4im=!t7gVIv6a$3P4l9$dNrp0z`UmN zs{BKvJD)`iFAu#4CTrL8BRU$H|nS37iEicQ#}*WP)AEgIm7X9VUHAd9P|OQkfQ54?Ib-K75Q zs*XwaEnl9-Jjvs&QeT{^{n+m>dWRC=qQrIunN!@Ix#Bi32PDaHQ3icYTPl5}>Wh@z(yrM8rzh=i`Ii6CF_N6Bo6QK!6 z+B6`eFdk0y9>gDZ1;UR2XZn}f21+djHly)LV8#kSrM_O!zu$To3RMF{6ov}|%YdKa zkIe_fry;u8E(A10Zeasjk;!3SWYLhITNlbB18x!vu{6`)gzZ0UMd*L~-p9u-dWE5Q zA|X-?)Cd8y17tQJ7R6e>gQTB7wZ~C@8E6iugx4{ANevv%L-Yr@M7m#qmZ5(y>(a>-TTJ7>5?vKknZjVsZDRX8)>9NT3Q-5jdYi^Af%xf z-wEvF-`~kUbIK^pv5kaMUJdupS2k(UdT!!5hnESC8F@W>)b%MzC?sQ5+_&2$hfioT zcZoJO1l%+CfvP@*Z-f{IjO%CkWzQ0_J~^RiljNklq`J+_lD@UYnf*-vi};w`QpI%E zS2Ln_jN|Jv>LP=`)pZ@2U+GoGF}szSw}p_nHvhSe1HXVfS%`^j2==WaVQ?Jd;F(OP zBro6G(R@j`>U`Q6%3@|x1`xVYla{!O>L=D+w1psJg|Y$efVZ`_w#`G{V)EB~euFoY zBH=Gheio(So0g#YshP!2?5iZ#7=nh)VUrr;J+u4P4u#*>j`FjDpDCi+I~(P^ujp1C zvVp3nBL-t|Knevo^kyhPzJqb!P3G2MF(~Qy$mdaO9%p39CVl>vh6QJNvi?SI;hJzm z;vZ1*kSkKw3ejn;%G(fr*WSLziwwETUxN=Qdl$T)f8I4@s90!%ea0&Vh}dt3#CJLG ztLGp0#E93=@KRXv91hZknpg}yAv!8nKPU4nevl~K_vq4oa;@KX7M82kmiO8sWR_js zouv!02TW z6kVLwg?rey%s8950l#qao~RMCKna%c=7x~(#yX@Qr->ri8cZg|oU^G^KY*3?AodQl zC)Dhc5pm*M<)ecSMD7NImTtXz@<|%R4OdY>Y#cXEtsNh46Tcv%P#)K+giWv;KQT`5 z9<8}d@mp4CjBgH}YxAO@8Xi=7KUoV1Wr=;xyrW(}-Sn2s1oJcwsz}rJGOm}}n8M*A#`9s}J6T{EyZx`SpW8n>Yn`#m%l3Od_J`55Gb`l1(H;5tn#Z4LdGe%=Qh+!p3EEcv@b$nN%B(o!Nz)qj3Pja8$GPNFbhRbmAl65 zG@6}TCVX;2o=(?aYZTTz(mI+prp9Du=Gr!-V+izfNBx-;TGB4{QCg+N$U*ayOY5hV zOzL>{HJPE|k6TK4Kd0B_87$og&2S{HTH)~Gu!quV6M01%sGIcN4LjlYR^4kbEr;ejL;K=sTa|X# zu$;C@%0xmsnx6+3LaCk7{dCKaE=@llLHK-*<$xMLa1=4=;IDZKTi@aY`{P~PYMuy8 zY#zA`aOZct9ACpJ4*sYQv>cS1-+8>0O=LRnjckxpGT_chz)pb{u5otY4UN{+6EwpT zGGYB7r>{0Lm9{1VKgZ)%Zt@B#?*?8K5pZ6W4?udiQ*7+i4)?0ho~%(NQg+05;*-QDtCp68+|!TTfp?~yI)Ek_r+VY|#) zK5f3GXc{PWqf}|)l-!ug;liFSt9&Cn)!dRi_OcD3XGJ#Y0%jMYEfd-&MkAFZH zLc~NLasz0Ej!rVd7IpQ?mt9RdR6Ui~n|- zyzXN$z^_n3$%E}<%loY4BH?CutJhMyUF~$8U@r{bW+dUJVlQkwO#kC%!B2fxTM69H z1V6$*rL&`-V);68GGM+C698Ff@<&CE7v?kZ=S`u$7!|JJLw=HsT-@uo`%Oz)S_f`gqzf?g;+CtXh;2qm_%PlQFLE(OXV)};peA`kQ1XV_{`)cC z{B)evJUe;6PT<#j5UDR{9c(MAiD)FSvx3%OoTT zR&7~+j0~Ii`Qb`3`swvLPij8I^qfb9pj_f#E2wK>%en9~%Dj3q+Z924Fhicxz^%>H zUOHP4x$i!J(4wvJ6y1RIO+NnPy{x|%_o|^rcy6Vri6K??G-gg??;>TaCRsjhv*=T% zGZJ_AU581PtRn3$^&Q~<#SgeTIrSSDvhIBLd^TSQ-6bj+HMbszk1U=p{?gdVNwyIV z0XaRRi}|S?K1kbN2^n@eDIXMlik3TAWz%>$=cRdohdRVIGv>dp&$gR%{7$+-Cu~pI0Qr#Jt^D081iOsp;)~6#zEFKm_9A2 z0p4L^)aGt#Dsa-4Mz`-_pU2%ve)-Ur5wzaZZ{quAI717laB5w$Kyxuk3+I~g1WOT7 zeYZ@dYZ0|xln*Z@m8+6X5PAiqm8A#Md_#0s8*0xicmLc$bkL#ID1yJK!mxk1D6=_A zsMdPmS6ac9Y)!4N@74ZwjUqg$qB-2-simC|6v5G@_H$`#g#J$6b(xJ_c)jG-wEVuGy*0=*n0I9D=~G21h>%Oj z%f1rkb>Gj(fRm$`XSIH|iuCKqPx|RKzBbS9JV^$n%XhJj#ypYAK(-`LumZG5HO9`z zPKdpV71=)^a>dCwh0|jS15oH$Po2UAWwLzh@}4WSPJk#N?qiKPm5$xL`u4&2<}?}+ z@srvLPHt~j>s9FwE8*D4k4Lf2o{AIH6dxIjBNzC}4L+TD5ch`~l)AbdeTza^8#vD& zCEccTo z`eM#-%FjYAKro~RWFIQ1fjkqU-zC9q)d1VDa0wy$`$(`1?|3Zthtxvt zHu}B*J&&Ybo+jjB0A)0WAPiW^AZ$3`G}wv%nos|`!=FugI9R);-}eO6^e+f;KoB{s zAmi^@a5cYov4H_##fZOg2H1Tj1q5&aGyuC9EYI-wp7-w-Ouy#}+h>RA<9{@F*j_bY z-U7CPuBLmDh0PH?;X>i|fu6+w-QwTX`TzakkD~wI8vd{B=l>|-zb6JOctkw-O=y5q z0BB0(4?_7CiXyWjcYR zS)PQc8-?wXsQoOvn|5vcpR{lj-<>Hl2PJZs<$l`NM{sAill{5wwak628Gxih|*2jRGn+` zT!q58`Ye4YIMdm2W{hVWTa`vh;H7ib48cgLjlWGhU!^Vvi?G&$R7nmtF80Un*ufo{ z*0+5(o@d(*XS{YG0%kROtHHr9ZJFU?LH6|_oG~A07&Xl^x)akfSu}-9wK)Svh!;OL z9WL}E`5&Gg3m`!vAaI6J_#EV*$0-J(;-z{+SKHUkqp~${&0s|>Q%R|Hy$b1zp`W-zTYs1Ml(Jd0dtEtQ>N+g%Wd%0J zKF(ooK>zzDB5<-|Ik%PBEe^eP)t?({CN`|W3gThjjuEP3ZzYxdJGsD_&+gwyrOnZ9y zrS3#H!E-^J^AVBVF8K%km3?+wu5OA{DYs54mT!9DRZ5iJ45X*qcfa&|&}emaQ-LVZ zPgs?vcxNg759#Jwt`$P1Q{$rtGvV}|%!Z0&h$9UaKfwcq+UwWdMJ^qINPPK?X}gbV zoy+PxM2A_89OE9Q7+JY`8}vXFVWi0FJyFfbHc% zEye`K71cFMRX_jIfs|kht29r&=>|t=iH+KGj>ki^m2!wHT5G~|yFdmBy&8jC@R^eJ zk8N$*)|bj^3(IA6l}q3e;;Gh>_3cubnvHUm%_m`zHVp>MjLcYt8SJ}K2Nc2hQSu%X z5Gtg`u`I$K0Uc_i@#sxwisD3#{!E8h_$Ec_BkM>-#<|xRYASMc4AA~KmcyPrQ5HOY zkkF=juQ95Z!!fNngV39BhWV_l%BzXmho!5NN281g*LkiB9&$e=#qYvqW}!RH?}BIy zhal&7QNz<7u_?o5ZrRzNrL1{_OOcPNF409?Pa_}|h|2TXs@HfJ>b;J3gx99!%%}kJ z;^*XhyG|LdI(mSjOt8@^b>O}3JEpT$p#GUg8kiXrUNsFLc z{8}23pDh(?owBMg#K1&fC1i6^zJFVZtVGL$aOkw?3BT>{86lQ>ewV8uzoXlvZX;H9 zR0Zv>1T)};Zli~eE5vaKm+oB(ofh)g?CyC5mCe>9d%mAA_!t;~zVU-nHV7|xYDSfQ zP#Z%BWg?+`<*Vld$m2ZWemudK>EwfgyX~lZX*2|D2OkYAA@_Wl@CT+3Hj*Dod6Ald zw4|zTifiT7HsjtZ1NJM&_pjb>b>1CeB97`Z5GKJ@SGp-o$S+9PBK3Fg1t2X>TRg~8 z4>74Q_pfaX>iTs&Rt@T_cPV*^em@Pw7KYS~mT(?`bF7!Q(kGht-3v0!dK48pp6k;_ z>&GLqYwf6hmoXH$=+G-+T`%!iwRCM6iut0ZXXYkwF9!|JKeFYjKSA?DyXJG-6Mg=9 ztRhsD)fI^l8iWB){NwEGF87+x5$yK8L887gGsEC#N6#Hi#H(|>o98U0Hxn^op?cHO zZ%bW;pbrzh5q0A6-I!!mTP-H9gPifzV&5|U1k<=C3V*koU|wb@*kFcK*46!*8++ek z|7Ax?Ch#%gK1Jm41WA-GcPtHqs;UJ0JS`Klb-eX$dP2O?R;KY6!Cv|c1Jy@muDu=_ z%3WvHmaG)H1^FDq%ju$-q0gDL)d|wyU+7jZH)QkB*%GT}`5P8|=FXsB!7`9qQsp>; zH4MJ39<6HAjisgg#=I@;SzvPvTeN1Fv#K`5tEp?B8jh^ExF& zxF3P;?5w(fQSOP48I&2DP!b@ zgmzHLX*C{2V%p5t7JD{N#SeT;%c;;8WO=`86eD4Du`{oIPvl0u;FCCw9qTNnN@LcplH3r ziE%^oBBZ2ftUuIge`He4UVEl9^zddhtj@^(6jkSbsHzRr?d++N^$jEJz)czr!#o9kcH^@JOeb+n)RPO-@_dW7s!Y>^yK&pSs6ki zLt4W|HBSZBN1s+x$k@>sG*uw69b**)w-OMzpFa6n#8=wwF<#@N`QDkaKky$A+>~sC zE=>oi5?BjLSUPZ&b9{*~Nq<-vFTi|M&o3|4oi|;c>n@s?-uE(g!%I(d>PEIhzJ&}+ z^s}y)llaQTxkM0dU#q3@YJ6x2n+X2I*F~(JK{y3^NLg9kev^_&#jpA+DTbOO<+^2RtbC_u^tFP$y37PjKViVPGALtR=*DqG;BH;{&ZpKIb#@qsy`v3$yD;R%GxX-~f~3hsdI&n)O(Y&h6hyg4 zzngVAJ2y%#Vxv}B??)Rp&xX>ov(YOkr?{XPw;pYv%I@#pyVHS?Fi_jNoPVjfu@aAe z$*$pNs=I!r@)2Ro?t2a*HP8>4r&v&n^Zh&3Y**c> zS@Q=mMmN*aQ$N_zv#$hQCk~Ro(G=CDlyQ;ITwcxAP_`qbGwk=p#-}Lj7nHRSfV$zi zVU=Q7zMYI0{9gH@Kh&*0Loq!+vU73hwBey_wv_ADGyeiM$-;Cg@*%Ot93KVKw_KyT z%-w4x9)r2+uSnHx`~*?oJD8vxE>i`L<=9e+VkN&wB!XUFuF4gH7n*FWwr>E3BiV9`2G8y zgk6DLl*T#1w?EosiHGiWKHD9~AS+6ZCIcyCU#y1YWjTzv@bMrtt$0@vFqIq;h_}}q z1AZZbQJLL75@3e{%+?{O|8WsW3qTprU+nu$XUqU!Y9LU+yj4Od^}i#6{^Y{_3yd%! z3gfRt^&exRg=_%zqkzK+A>?0~1u!LnQ1tf!$$l2d2>|kb05tpgTgL$e8|uIG`9I6n zzlJEBYLF{Z=+Q@WAP68~krG+>1rwj=1^|D56Z?PLjsOMdcfhI-3>E+Ssf(v55P|xB z;OStr1^2uBA8;hWlrg|w1?2g_!fPx_KmP=@_*^_e=b)*X#&pv%et@!0*qw9r7&FoofrWW8uk7k7W^~T ze^~m*wDsFm1p*?0qR#O>)MyxNb=0xHSie5V1XZ*;s28 zOZmbJj?vWlr|^c7p<0$S<8Dq6_Yi(%tb?}@A3-X|`M2GPIUN7xO+fV+C2fy|6l$q% zEmLZ$TzpEfu<GOUVU@KxJkW?I~>X>F)CXmJ;9><0d$Y_gWt$SP)OZ-Pr*qrZQWKFH1<1vcX|`8sp+$rZqin zDZ#q=LN+6H>xYFCte@vjrg!$w;p_rO$2gyTYpn{UK6vSYfoYYJn?X-}CRNb+%b=QN z4VQypZfB3dJtw?NGoZZBI2P2qBjM1kM6H=rgJSJr1TJrX5!jK)Llq0ZSf_w0j)==|Q zkuw^8-oZipVQ|@t(j>y~aczv-*gF{d#_bIB+ln)Kl$j>842`=P9EfkPOQ-GhLKehd z8@|9RU4~aP9dtZWBBF7|hJLbej7r@G&i}|B|1N>+uD!!Eo1i3#sI(Sk!<;REMvXU- zfnkpVVgJs^L!|MX0x$L{D>~4VOSYc_+`%S8 zK}a zRXJoscZlh;(rn)y!ofc#K}{y3<=nD!(+I{UREF!T<~cI_582ZmHvR#j)k|i^D{j+9 z&!qOhcTgXvEa6#}Iq7|2gq!mprscQTx`R>;g ziu?~~nQJrEu33GNi$odp^@5mye{RFO80r_C=nR?INFKJbm5sIoJwcel-a0+FuuzPbIh zKqJ6+$)*r?z{`@6l}GafdG7q~?Q3f4zG|{SEaBodZg8?2oV&VC`ZQ=;nWp4ufwz|; zpj#t8Lqzn0(9A`I4#$3)5faP0-HDRaU8fw!Zvx?MGD-Eppf0hbg7mkfCQOEP5&|mp zB7~NBy^vMSN;5kWyL~_n=ijqT6`**VoubH7jjq0ofiZip z!6IT=vdJ>RwUcaVd@11Ff15j1WuoRHbP?bcZAydB6R-cP-cGSCFC@JAL!L~TEBs|Eifv=7qZ5LcG$woYw=vhHZN&Q5@^qq)9$P)8V#c zZ8M67!}HHF{{f92*iprKe9TxyZuZ!AQ^N~D0R;|_JtnBxu0I*U9U@|xEbf#kAh`+jTmF5Yd_y*$QeCd zz=nhB6>ceQx_;k*uD$=P6vbAz()uN$;|`sgZcQ`M9(xp80QI>MK)!;j zIyrVs)6ejK(2N90OHys1f7o}g_yKV%Vi<@QfmqB0-r8S0d-O9Vx{)#cloU1)AXTWj z_oNH*w$f|ggIRhEp=ECB89}P02|Aj;DS1_M)`*|=xY6ox7aEYq74V!?DLMKJc6Hgx0d2 zlt!E4&2F>XglB`H!Hxwut^OfWcR8bb#6^i=%`kIwJVU*59j!@a#=!3S$OGE}E6zP? zgu3@kzceAr2a}sVmL#iyR^!M_Nhw|~S9*kRv8!!*BIp!kk8WV}<|fy7#^((G4ASKO ztw=hGXZ>Ybh%?ZqaPX-IY~)wfe1yv5lWAN}&-0*LOuF~m8;(7>xM<)z*e zkQ*Y=f8Sxi`VUB4qXl{?^o^By*Tr&eTA1t5pPGg}ILB9ck`kvX-3ZS-L%W30UAMIQ zT0vJC?=<&`)c~3?-4?{%xy;>f8wKx8Qsj!LP?Jj+ej(S{2zc;|s3%Voc26_|R2-sV z6n^j$B(R7WkC%2q;oryM-)7x{$&x%+`{nf!C@0zDd`4uOg}V@eD`Gyc12ar6wi87| z>~o^x&YNPp_c(8j{ORn;31!NXpDV{8nV$79IS)e=ut{|nKQW^}rorRn^EMn|gv~Li zMf#gYaBI-tzP4f2i07<_Sn5`h&RUk`%P}b@FzYIto}T~2acF9hWqflO*}$cEjav}& zQd=&kDTX7B8n4M5PB4NSb;)@xGRMGMNCL?L?nF6f8Xom_O5k?83*jDpuqjFT5 zqdBdw^Temiu29ayzuf03SL0)A>*OSTf*db*ZSu*=_NNvlCPh@l@~Bz7U=r|hyn6E$ z3g;Y1n_-z&GZGmuiwjLpve`M7_R<}%fBs$EJVg^lQDvU>tXao>hx95d#HlzlG_XxH zUl9_2PWXX1&f@kq=6O~z)FsK!{vDcnDD}~<3ctf7ZG7x0c^x8{{!3#e)Go&MKk8_j>0&WGf`%C=V+Ei=dhDcn)kV6 zuUACRCu+|;AlG}e^3lQ2xj@NHRw^L0>vIVM^T^EC=Or0DBDxLMU-((IShOIc6t@xg zV^Tkn2hc9&23pzB$**l(R3?pE6+A%S1~&QcF$pO)6$Gr`MEG!x zvD0jj;00r1zQ1&>wlH8 zAOPinQE1D7;PJnD77!Ek?=WpZB+Fv0Pq7eMsx%_tm*x48bArKkmu8VO59$6>;P5qsUpmdNCZGsue3Svd=$V` zfFI;Q(rXCnQ$W-M$n7Pp`tbL|Qzn48szE9+F%l-c{VPEJwfh0e;ctrjyAV=;$?T7- z61HysurvN&*+PH*_*3J8_Qy{c4(rZw`3=Mlg5|{iS((3+g{|MeIwQ#O_c37IfE;ij z7h|95pM_ZW77^=_yQ)<$#>*;ms&gy4+2byZWs~*FuY4pV+Zn{#{q(a}vplmS)Xwfw zT(eNm#DW$o0s49Qiq_5W7I1|TajQ)MTOt>p*F}WkVUpJO0ZbZRPLq~-hmS^!fE0F4 z@?7Akkticakb%6PFV$XfH;=ewZq4EbRed9akJZzu7-LgRUUoJW;)KWZ%b$SI`4W+W zHoKToDNm{4h02DZ$xE>o$Za7tQu9m>Vj@sFEf^DNYL+-|7}8O?!CXb66?@0Ma$E|{ z@zUeM-i%c@d?pOsN{RN<&m6 z1jS!-_dDmk0Ls~Gm+UUtV4A6VOZ>>Ej*o%;B6Ws-bzEcWE%`>3M2(HOj<&>Wq?+?1 z3;iYwXZYpBvy991yY`U&vYpDxAlY=$<;`UoPyW$InObrZ`$N%^boz?VoZkbr+AdT# z%wl}*a+k7sePe?%KPXuoiVWU%K})c+j<5#GCskzQ-DLwM2U$9EhZ+I<5q-*Ow{eWT z*1m_$jZ7zMi+}i$V_|xJT!V6*2VrFHOYEOKC%`|36hDh+6o?e&k?O2SDxqtRDB8T$ zYf4bChI(Qbg?{z@>E#Qrb$Qws+_a5DqQ2beLvmf-pKsA;$d$bEemytZPmnw-3##fi zv`cGMKT;J#r4-Gh?Xc|W;*_l%xiBsFila5nb^5@rn&iC_;};bhHSUNyPkDAB({|jY z_KPS=yS(i32`|5Zi}R?TWUOwOg$@y51ndqY&))ahZLqE-K%4|#oAkOGiIi^Ok+!-@nfsfFgn6b{N3 z`ogw{LRJ?|L=~@%D*Ad8UFf=>0!w{aEUI3832BC-aOt&RZgbc5h}f3( z%HYI9p(&l&wM3Yw#Ga`U%BILxy3l-iLN0i6#utFhkGlyTVIaju33;q;8dZ1BvQQjx=#G*^H+wK zc7ltNh8jP&^dhHt*tA+2HX)DZ8R{dy!1=9)?{S(dgy z{YfiML4XPx{~QJ8V!ksX3G-oG1C@n3VY8$SYkRZ!siItfoLB~d!`yS`CXKY0tPi{# zwv<59TtkArda>vW;cn{5Nj5@llJ>(aD81|ynW1R$Fx%0yE-|1|pP$gIh>mVq{?D;YRgA94jJIW<@xe@7(-YNBFUU%WM^HK0U`jcb&U(rBnX1JEiM} zQx(b{%J4?>XZ-4uw89Y)+S>RzyjF4zsu}{V;7>ohxC19$oP-Asl#rH2WkWx))xXHH zH)9P&iOkoSb2Ho2;qdZtSH_`X^o%IA`iAF>{__!qpCZQCERvL(BQct&)TvElESP*u zcd8bnXKuHAk%fgNi>`@d1@Ew1tgSfve|RnCu@=#aR}4_wWKuYc|;VVD(RG|ubCBrkKt?2t6B)u`{=yTETB zuWZ-Na*DF&+Z&Z)_Rl_xbR{bs`+94Syh?T(xu*+hj*-`HnRSFr(hIUEv%7z6y;hy* zd8(Grf9TyWwMj4YYq{iJcS-Cl`5-OXPKScnF11d*73cu$^|LUbw!75uQHg=9W$}c< z$4#EPh%Ys30hP*`j&)aVgPDQJ#erNqt4=)IMa}J!R+T-y@6&zX8gXX4f`dW~-styV zm>S|7X$6m`C=t7_HD}$MRNjK$%pGpO7u|t^Q(ZNRDKyR%_{oKXw{P6n=8mNH5soVn zgXSX&W+oRavIbH-`vJwU3_QbzGh59>>xh{1#!rDcBF58_PX)?u-Zd|`#8>y&wfOy; zQ`$@eDxCI#psq+Dd2&y*;=?x=<@!0kLT-%>mCn1mc~TW@0%hi&4fx>&y+a=v5$$7U zMm0E$KCMJ1msYrjiysQk-Q_GD=!CzhROD?o{5MJ4{OqLY0+bT$yQ_a}`{;P$pKKb7 z@_lnLjM9QYdz$%X=7U-5R(yvH0pS<_jQB}|YL2usftsdBgbFvCByQ%NtZMh>Oaq#* zwq@>J(h0}&*1X0>0`=MuDkjKHXn$Un7CBvAc6dT=yG;F<{-OGNC-V&V7%_Atk|AyH zG1k$Aaj29!4)C;oJ;!T)MABS16Y91M%Y39L$8scO$>G3t-9zi> zre%1yqMA?~av7LmIy^{&swCQ-B4OLB;5fWVjsjV;cuWm!+p%gwN9>g4h2u=S0M z+{dP9dL(fd8g8#CEnNu*MoU<6F=exDUttjEkGtRZfk`8V>L_KM=Wrij5KMwx6|Bu@4Nmoqv3 zkj%CxtBsY{dRdWLjnSiCKHm`vzV=PyZ2Tk<84|W=!R8V2;W*L>JXfzLK?xj7Z^|uybH(vugCFW?(Kdc3q_uO~tO% zAB(4`qJQ!pp^k2+J0#lHqc&-qS~AlJgTqa1PtiWKc7B!A1;_*z$*dkpEm}=2io!77?(3= z_?b+evQr4Z*Un=1-CgY-hy;2AR}gFbAUk@J+ORp}nO!NW{SqEsZkW=0jaCPH9^F24 z(hsuNv7)F1nasQNyg@x8Ga0-pnX!d{3Ec7A5jw(rG=G_)s$!Q3q&C%e$fan9zX?A^ zJ8;|B!Kx_ys28Q%La*nv3vo8*OW>XR2+@L4W!;3{fsj7 zI5U%G=#x~m;@{0?&PZ3A-~-F`80XDzO(~FS?zE2yL352)k>m~2!ww@$j)x^!XoH1P z-(YpEb5>F@sM0zbPiXE;s8#afE6fX_BT6Inn60;=RZ(!P+kSR z9infKonKB@O-qNPuDJQ&=K4IoShn|`$H3xXh%9Bi_`+s7 zJG>-GYFdxJm(_R`#h3$buB@$-MGL;oadzct$3XeDth7}DT*x3 z-(PtQ76At%#ah_qAWB&B63hw;gQ{=Y$Up)hkcb-fM-Bs8J^}5!L;r_MIDaa=01?j| zxIK)b022F6b$0(>>Ft?_duYPaD6+^)04;wfJQ%_r6zDP$vQHcWguCzLq1ds3US|U1 zPyk&)6xa}eLNR0^5H7_#G3s}S3ctq&XxSVn4ub*ZU#JBT7$yP&MRLFA4O=15+H@~K zofcBR;SlvV9zKQjI@y3t5%8M+#qX0p^8yU8ZNIVbFI>XfZ3Dx=rsC@ef~N*n1SSc> zYSKW8A@IFG#_kGi$-;rQ)iBR1+zD(#|B~we!AV%e6mZ>hkT3A?`*487`c907+8>73 z|4c|Hoj*f5=*5m2th_+w^0rdMbG{)CmorGoW604!}(k&P_ zb_GEK31ZM+bEE-F{q-9L2cFlg9@SE7y>w=!HC_pWj*TLl_YJ%XpN=X-$GqEwSzImK z$RNEpC0}JqMIH}>rCB7LjGH3p54M{h>GS-0I@g;^CFyed)O@xb@f-KeCl$2W5NUh8XQoaZ_E+#yC`Nx_ z5yd)#>A|DQwR()M;IonbGdr=LJpq#pfAl?G%yoILpDqzTM>FQ5iGQCOXQ@ApH#>{3 zp(}10OQO0HeUG2(yzrPNg%l*d(=&o0L+}FcAwJv0gV5ZEql5>?$5~5(=8+0@Z^NQ} zA$@4xAtwu;QAKsKgh=6_gns@G?t@WEHJt}}YOzoe2d~mdJ@-C`VW+pS*wPSg zX2qnop<(R4XXM0pu)Z_x_97^N=E!6*HZXklK{MZi!32-b#D%A}Hpo#r!p>wdCrG}O zmyAC5lS?u<;9^9qjC~&`>4|%W&%XO2v~nTC!2bl2Z4)N9^8Ay@$}4s&fu3-7mP7X+ z1sz4^fIOozIVRj z3mMtF5H9}SAAa@JJGL`Xsr&USpS0qeh^JoQyXaZ@@mj(*(RDfc*@Ytz<6P#+ZDc-e z!>G&KoN6pCh1guxNBi*e$Lpyd!)oeV_2$Ax#gWd}Cg@c3bf3~VD~DM2ee45VtH(f* zhF&F@Y*T=1k}Jsq8y*|S0DQXazQjOTLFc8;%=%EAh<-*`^F#I25m23@4ilR{JXt#U z{*|($+;_8&e)cfIH+s7|`f1?oxN4B5_Y#(3XX>diO%Qp;wOQq7Tpy9f2lGPZ(7Y<^ zjr&my)kmaf(-YX^O=_6<1vTH$T<$NX29^;v}8x)(QpA9?A+1E7vR*Yu3Nf&cus)o23E#}i1$jt zq(o6nx!)LBNzXVH)@2;6Mv0x8-jmo-O%`|!p2R9dD)Deu)z>fFb(QfYmQB-2#qO2o za9XnwJ*SmXekRx_>Rkv|@U5}c%_b)=lP-&xfGbix7CKV2Y8X{s{eoY&cvjW&Jf+S4 zK-p2Z;63z_PNvdF)QR^pytO%PjKjbzuyluUt{@r@Lxj@}&qcL+`{E3hsBw-;;mQO( z;h;Nu%XSq%e)h~{fx^(fL}vU*;{JhenB>o#6Js*AkIK*B|^M$>&JKp%&de zSwr0P(V}wf%ILPH?gj$$EleU3-Vrq@VzSuRUkblWzjbkT7JkHZA8VIv&7+Zcl2ngN z{-t4u9(iV)sk%bsfwSTKfWmjtQ8o%ZFbPSuRvv$k)n1<)fEJl6xA?ByQdnvJwSNy+ zd=5?cor%DM71ZQ)<~IR@Dt2K_p=CBWtjYHu^6}RqbI29HgDom!`fS(zN`8G=GmN?$ZlIQ>Q9U|taYWuXn5vQ%`E)fHAk#cZ`8+BzKJS~6V-AmDW$5Y zv9=U~azqe}dZggAcEzmCNjol3YpR#z$%1V_Le%MrOp;a8n z$UPGIZ9ds+RV>Q~qJ}Q`^TVunTvBPbkGV$V4@4xr_*9 znHS4`*TtfmToE#+xtQuIVhhGT5>emOL4EaR+YUSdo;TKVo@_Reg2aL^nH4({-Xi$& zH4}yQpQ&twK-DXmG0-3`=ygzx2n={dacZSJOSR&dpDR!3lEMz-XAYp6?@9GdD6sVn z-v})e_!`>O=qO*wFHGq0&x?JU3qwouyJugKn_w+=mrc20Y`>^LZ2LyE z9CJ(diDb6<3a+xNzM1{AQSeh)nYrYZl#lpVBr~XFP$uWOLyImp!<1+LfC%2FvPF$U znHB}A#d*Ty<^-J)&h>$=u{d+QXFOvywKP_A-4E{oBjy)_uXhyJ32VtZR#0w{ReESe zQWCDaH~iG{*O&6MFF#cYRLsY?s2VnLh~Fl{7hz5%(*Ag!r_;DAsB6*xK65hA2zWhY zOQX}L7YEIVK8+P>Ug9g86z+*RjSwI(uhJU@8=B{i3XB8YgM^ksqUe>K`7jbY-laXe zztp5V2F<0CiwrdJ^+q8NE)!zb3Es$hi^>nuRK>Tt%B9B(z|Zl@{fpL{S-CTOXt! zz|A48dhOt6owo^j*5r_?z8xXtyo#9OjXR=vtb?tF`f;Mlgukl8mChH}ukKjlxG zl8zw9>Wg(V&;sPo*0PcC0y8aK>k&5vhwN~nJEIlu$dUuBA#d05QADN^j3dlSEIwzY z>E%pAj}lhX52(%)g$}f-N_{GY&^ZTIl@V2 zgF!i042uUUG|k$^CUOQZEs+A$e#)>nd8&{~JA9IkJ6I5bK+t+@5;!K1r+)8@sz@F$ zZ1{=7Oo)*MDP_h#d27d4n8MD*%?yVmE!()k&v@RUrf7pj1o5Qu0a5&^VEbZmRCGht zOTKy@bK-Ia{IPWF??wKXaI_w;WRnM~gYpapC$Xp;+_O0FH9bTplS;^r(lDx}3y5z# zaYtr%hTX7S2y^g4KVfq#i;(T(PdTDB#p#IBoS^Ngq;Yfb?{f54PfKo<%Yw{wGT+9C_ZeIi33G|?!FLRr+XW@la7k@?Yt-;4z~l#%ql15ee8H+U~DQ& zWtgByXfU4Q7eaEM4~v*03`pK(3nGnY={i+5$(POrzBpmLfKO?pJmb3;Wo}Yh2`epT z>x{rVMa0{K`bklub>28ROLCd7O#z*U!>TFa2wr~rK{u&y@Kb*c@>tLCP2PK%+VC7? zhz;0{hY`VG6fBcm-nFnpDY1m3Cy?MEzcN#RSd1@$)e{)9@Gv2?bGTd5|WU&ANQ87(bLJg zj6WZ;lhW6q4B3g`LVHIoga#`WWCJJ<#(A(Lbs!`UQ9+71f*KUf2KqN%7mx&DJ(U0g z1o-1GnE)4vn*UBOfdL`{&><19Xo83m3eYX2V1xZDyaB-C3<8)1ILi*itOC;~0RjT5 z2?=1iBS5&GFEAzuEg=tRTKm6i{y+EwyXZf^C@>;Gbuiw8e-7&*hzUY~N0?%udwLSO z5A@kUsYer4C@w$*;z>jRBj!th;1r~OljL+S;_uvb7*7I;bs~Rf14w+|U_Da)a4K*N zHUZeAV2lg81dvw<&<}s0!+fx?Y5Y+d;b14g$QIV20|W~BP0O$xyg$eWas>gb_XXg| zKOX=AgnvMB@Xz0de|`W3kgzLZs{lLz7p&1Q39WLtI+}8q0 z@;5m2Ccj8l?wh^09iK?JryCkdwQ7&^)sN`mtmyngTKbY-p=FDgn_Bkv%vHWhJWUl^t%zw{%CqAjXIrON%(b_6oc@?v-X@uA?7`)CLJ`tcz(=XS3w9Ix)w5Gy>(PnVc-5cbV-NO9Yc2vNDN2}J#?vbgR~&2 zG%|E|cOxwz-O>$8H-d;t>Dl1(yze>Zw|;*JYcVtXzW3fsn9p3_>$<*Fht1d=id&r^ z+HUF8}2tV6zZ!xZqE-?2}OxrL}ymf~F;I{lH3UF-l`#F(eky2x;Z zxRA79D^JHnIhM9uDu$j)nw4cl^dO#kNP&fuF1IVoBt1LabO28GI?yI&N^E816Xy{Q zvBLBv82L0A0^-IGW*+^B_T-%1M0-R}BiY|F1cc>$MDnbuDcIj-(RC@)+*&N87M7`% zfIF_(sU%TvWuV`s9bd$_i}^hw(ycmX>b(#xuVOyDI?{^1leiPxn9PR0$Oixse zlO^WFs!mnLGRaK3deWfuq`Z|a_9A;g<1KL#;XF*OVr+Bw-L zdBmvYTM)prC|I;`Xr5lKF@$~nyn$E8w^fV%yZe#Z`)=rTip590L$}?5X|twe6Lz`d z9xYd=?KY&}K`-$O#h<^>6xsVhMa~%@7@W)C1GNotTJ6yu8B`{U*D~J2g-rh0NXzFC7yq~PTR2AAJhrKg%f4tn+|b0XXnx1&jdD}{yd~0C zvUuQK*}KD>Ss~Wh1M%MFF9ejkDZxGX9i1>_nY%((#m#u*SV0EM*UFkn@IY6C65==X z+rddbq`A?ip9%ROHnXW4j%KD}eWeCBa=fGOW-V0zf-ntJvlt9(0uSMjWlw|?uWAYZ zg!2{&y7Vazo3cVH)95y9TI_j4TCXCe*>_*zLi69}r*JPy*(Ww~obmMwwq;Gb(r!4y zbvk;K>``uMTormqih~c#Oe^`MxYqf>;`b^`Z?+>lMjTv?Y*%z?K4ocNU9-WW4Hk{}BOkPWrc)`a z@lAqFy+X!q4AwOSH&5)CF!~N5IaV?(s6Hx!KUY75{QBlfTFg@+=IBYvwh7%Oj0^-9zE0Hwm|IITnmO{thSBbD1(tY-$xjI{Og!+Oo0D-#lvTigJbu()Yn4YGS-4 z2l>b`V4`Vo4>|qh*C8HHOIGZL#3{L^`;6FvxtUOuqMiG@JjuOer?J;Z9s|KHRzIfcg-9z*{H5q1P`4V_{R10m(z(xFd<>X~56s2!hI@Z{5%vs0%zUo4| zFutHX$vq>>d43+jy7(mT6LxHGNbB28sG*Xh5_Xr11#&#r$IxHm&aaitLfT%rM;oLZ zlxsz}B(?H!H?kocwd^*%l|ha1MaFku2N8{Q|IkC%dn~*cCu?`LgiKtjL&3IDO`Rx(;*4HI$ax_dl`%pG zmv~!ZbAWeRHt~3Cv@0n;Fik_Qg;QAt6X#T?$hiZ*2*+78!Osd!Rhd&vuO_`cU)OsSG# z;#6K^IyY2}#Z@JKr_PTK>n=&&GE>#^Efb2=wzxeeCIZ7F_{bF# z6r7&9rdmoaNM(5+Co^Zv?JZ2P$#1`K6($&~extDag^7DsB!H`&qJ%qkiY2h2G@og18r!AGMfY38Vlgx?Ds#1sby$NwyCwYk4ldJ)^ zo-7vlG?$mM*&)_Pgk`J)(DGb$%dq$EYqoWL^V;`k3XcakmA!5fq{4h@i_g}&N}sLi zRv0E~E1d%&%AaUrKE06?ZQlJXvGuWlv)xrT`=~kk5xu-Mi?R@jGd|(l=VU+&6DA%S zFV@TFfI4@tbltZU!|z472Z``r&$`bd-=Y3mXQ*PKAQ!>_2|}{j2a+BC0nk0~VL#Bw z0}nk=5+;zoGWirOkXIj2-WUThc|nd}LCGO>*nrx0k21W#KjA1A!fJRn%^qunDEGD=WE7{FNfY3n!&YC+WZneK+bs{gBx{deX6 za25#2p1k)1-s^0@lONJq0FbrsMk>ffKkr6INd)RG0H5Cq0HLpd{B)fA)c8m4z%(f! zC<1`_58ME-{clhWKz;X-mH-PXNDBcIos$o&cCYmTv!}0sv~%DIz;r4~&%J)w1HyQK zOyGDL4{k-E&hwt>9u&Nn52EA!e z|4xSt_e>`Vg)l^cxfhOv;{%9a403DG0MnD7&QSkx*E> zj+}0%D)$Xez<|jWgkA1j;17tG{jwIU9ymU7CH|T_Q%FHa0H2K~sCg>=@pfQp)bC5# zvPrPdHkhAbeV~Z_rm!Wa*G9MaIKdxW7|`Al><~%O?vX`^bLo8jH!6c>|@`=NW8yubS!c* zJ2eFUi?A!%(}cb9*A4#*3cHokT=x4Dip41#&77@KvOv(D@hE;s-dQ37|`4UJ^NQga{Sr>~xI$dW%5Ip5_Rp?gG zuKRi2kOaJul(9HU&3?wF<-ybj6JSfT)%{M3_orlFlS1ujm!|toI7QcEYcOCOdCxv= zN2iZg+Z*{8#Ed@0BAVICA_Qh0&+Di>UzYhfTb7pY7KnE!R{%4N32cCVA;wn-OV}S+ z*V(o;1#%8*`Bm$#HT1V%UTwQB&UZvw(T#BM;fKq&w`Z}ur1bNJ$#HClUHsz z<1ihoJ;9n)x?dNXnzU)LXly4d>~q_lqgzY^;m1`nA%|G9>Wtt^hm2dg zv-D#(gYn|?X7mec?Mrz}Y~6P`9D=*q6oo;~)LWf6)--Ym_fCn8-fH9%4|cVWU#v4M zR*zwm5btoWPx1SVeKOH+a8yYtJRDOrYdJDf9c4$4&^GXhOwjD*uWjK%!k^jeV-*** zXL)w23L0eL)gN_ zeu$Z=1q3%FOjyIVsWn%Hn`Hh1J-pBlnj;O4oy4<&AN(LE$)3nguwRq^YRH!u8>K|_ZT>uEh&?~A7|E;uWSEt6utM+BE~4;n)m z)T-1}Gt-=2;zh#X?sukCjXh}<%o?&zq^htska$yJ3(vtz^D0j<^Ka^#r_^P^V>h4#1cQYU4imDstSRX>Pr0`&F)SI( zMXpd+eN7D~Y@voPLIf_>jDerSjiH%HlaR!QSpk~mP>`T6t}4B;$@+`VBZ}MSb!f}-6*gB%Z3d& zbP&v=!Hxq^oS+Q1|97etrjwQl3STWWM&E^;O7+nN_3 zU|Q~*Q9*SOF&MC&_T0?JK@Q^?@tn5-dS69+lHNNzCO0K9wZShYe*jyDb2+X8(sg3J zlU$PGyB2b;b1a?D17aoP=r!~Uy_xEAwKf831NxJ8%CU}w}@t)fTDxpopgs_e6@L#l^4N0bsJflt;h1!nx8Y0<9PiJ>*x-q zEsl!3nHs&i?v7Cco~zNqvWfg@)V?q(>!tjid6`BXQEQGpTw}4xBqpqfSeyG;V-%7G z_jN4K%j@GRbwoemJs64Z|0PKw%YQ72P-E{4Efo@$Zh`sc>2Jxfnk)8#lVO>9Tg3A6 zIb@q3#>I!sI|_0YBY2|;_XHYba?|94`<6efuH>H0T&(t3a`zNa>?$6kgk{7+?T91V z4<9Gn8ipoJS-;Y)PI;_&5$Qp|Un_Z>xMZ4`BeS-6pAQuWbB6PJnpv|B{h_7AaIuo2TemJOKPSy^lcFb+rM^8o> zReUZwEhaLls0?#U=neo&EA(gc*2SLnCpPRHZ z)hz0KOKoX4s0~hoqrYeA)P~nsI$M6}il>>Ia=O9aMc-%;RgAcri#W^!vd2CY$o~cP zj|w^^cdzhEYp%0joO1_+iYqh+#JE~fQFtXEdzZOem#ZVUCvli~j7TUQ`cBk=Qq1Eo zsx*{chbJp^Dyl+(0zO%&?(Xc`%ZZVirKCh$v@R)8_8|J=a@{E*bs&G@7V@pe^_pG*H+u?bs9Nb z#6#p(5TG&^LZ+b`X*ABOx6cN9#LmU#L(F_~r0K5~a1f$`%3LJFUV2G@+Rb=cD;zi*bwtD<=xHN&{k3S}XsKPZ!7 zJMDP8^f}dnCUGe)k@i-7g(X=6=A}3~QRXw#T)bz8;!l?}Qv`OOW@XiBc`W~!QB2^+ zvdaz()!sCQ4+=d~BV~2-8*YuRY2ah~&bK}}vb>sl$}KFqr8uyY)nJ^_JFCDqsD?y+ zKLOhPiU}E@y8qDLeRndDM}i4DBS4ndU7j%In%va&FpQ-(E#bR-KL$P^$RYR^YCkR# zYxwxFH4}nASVF;us|FATPcn0x5ScjlQ>Fh{3`qsh&;BWB_iO_CUpea^xsU-?I6$b| z2T-RQP~${B-vwcb%S)#!lUc%er~nv5(Fq3O*vu6-z|MHEVqGF%$E&4x*xL z1}Svun>OU{9bOzudXfhPeYhthKwcDO&IY*WD=!G1dN9+iAPq=zboc7m|G>`wkCPrs z7+&6Meh<#YCm`Sj0GQsN0|CfV8p%8mh-wiEL;{MB0R{#lVgdt^{;P+gKX4#mK?IQO zegUAX6QEIN5TFO%e*?bUlPUTGAOaY6|AU8_&<8}ke*rHbyAq%+LxAoEF5p$bK34z} zqdPw4PSE~NAdC1*G=MLGmQ!F4|CRs5Ujlo3pkCmf0ow+$Re=y000Hl}50sKUto`s1 zaQy!o82`<%-rwa1^aKswFY+(w=0Rfw@blm1?jPR=sPbOEl=?ekJ)`;Q&?~uFjN_(3 zt*S1-cv+rnAYgLJkd%l^g9xs%9SVIm!YVWU^J8RQQ_3wFv5L+FIYB+f_poP4 zod1GYg6j1>WH`j2#&o5$^D~OO1tpN0Ks$G!YIIYVr-q9z7IH{Tt);RW_rS^xD2r-!-{v~!MQ%RAb zf*uBj*(Fxz+WAO8Fe5Yo!}^ev`)Kk@O4?u*JMh_S*c}dA%*7+-4!@kz@*IzS)AA|4 zXiJ&l$Y?&;BF|E`B26I^5_+Xy(IH~Cy+9(FdXPV|-cGwQI2!w1t3Sn`edX6T%5!MS zqmwGL7A|$}H3tWBzrP2KNHq$El$rkp;at^m^Pj#aPWU~b+R>$|Jmyhr`e9|uK78+M zz?y#*b{TiY!rDhHj(x8zL!jr+r!dNH@Lq~J1%fr z#6I#6t=aV`el!jq?jzDM5jjtHhzZAiM>Y3i;|H$DmsvHfS2R!JUcK>?bm@wygSE77r4(l=Rawca5o$1nB~=%=|3acxV2PSvi~QOy7Zg zI*$NvBBRsG3514=%a>D#2w3xXfdBha4TOBZHGkD z(rCqErdEwswG%{%CX%e`6Y&SRv>af*{$d4I^%6q_d@*nSr=h-37C)Z#aDCq!Pq6%AXmVY)wpv| zUC1C)d!~!5)n5?mjxqBm#nM{&K6*KS-tQwfc@V<4M#1)mjl?I6d7L>LD8nWQTgY?^ z-x4WFtBAo!j@QzTW>>ay38U~GOcX~E*mNa4`ESP(qoNHBqH|=He)yCzUyzevw8u!Ree9%%giDK znZ3`x6Se=Mw1vU_lu+NDhnZ~xZxDV^+C7(5Y3)#wRJ1+x4DAaRMY}Wo+`H>`?oBbK zYUXM3ty&X?@p3s+={IpBZP=I;L7m*3t94tODzo%mmsKkE9 zVz_O(G*%s^mT|jnantzkL1N|B1wxWN40aw40rzsPEkClZ)yCdYhSNXq)Fc(5bG4ku zk#p%GY)h!C)+U{gU8%H87E@^HpNgyb-7rm)JK()95V}*+Y|v?1&x?-AP}TH_e6ky}F$@fBPQ2xUb$}MgXiA4*v^^Ku|$M-w>vG zRj2GO>P5P)5B>~72zu}hW%fHw2oqS-dagXq048n)3n^vo7>=ik&25(rhDs>3ES&9W zGd%`+H7f0zRVxTsCRZZAr(@o25~^aiL!!07tKDKsQ2aKOjn8S=eB<4#&#?ro#mPh4 zEKy^6#7fx?hD@g6~Cw;A2Dc?v?yu;=6)9XRvJ~dIeC6oNB`qZ-SG2 z8xf582zZ_llLCK+xalv0abU{Ou(R|e>R2kKa3_&iKrIa_`F-b$`qrB#j$8h~hceiP zRqA+~sCT{{qv`wP&`-3Tq6rE{f&^>m+W1%aju@s)1YGg|7~GY*JbXScz* z?n|j5FyePK)nr=M1VuV!nQ_91?PKy-DwaOl`p2n%L=g6!*6veub(LeM5V_0?EqwYp z<>0Xl*5nd+erB(18Hjifx7lnu4=_K}aPk-3l>Xof`dx^roM)pwV^q$G+5z7T(3!L9 z3TX;mh9=eN?OA9kyLD>f}PvCvn6%g$=rKmgVfs&FekBdX- zq8q~!#pe~zAw3vk>5*A5Dy~tyL%&~mZNKq}(Y(a{qJL&7Ig3ZmQlrPN$VOzzmqe?) zIb_0XhZ@@$dRk~lT2AXWN!*ZS#P7j_N}wdSBmujuaqEuVu47cId}njSB> zyOBJ=3KoTaMKpo-7`$yX4$PtQkL%S}UfU=ScCUe{c?iG5ej2yk z{iF$oG@vv0OD^W;Zg{*Q5^mkk@P8HF6J{LhY6IqgC$&nk#hJ7EMCvepk!~+XWqSRh z>@2jnCiPhOvA$p3(GM##qgn5@l%$2Y(E9QR7H*Y;fMBz$#{8}aUSyk^QM+zvLq)Np}{F!^(2@n!_W z|J^*vRuNV1re=p(`v=#_7LI)dBbqMEX9CTIJ7#S^LeXt_qgoC>4rs_2NHV=>%OS?D z5GUE@pA)eve!`<>X+xwM(t{CN0uNZ9tZKv0<9Oy*MsvZ|HmmNZS9^gnI4{oF=wa!t zg$G{f$<#|Oyrt*L;^)EtJUf}Iz+$5J3!#CL_O`DXD%j2}BSxX=J>fku@?fv!X~zms}0=j6RhiJcV(P=qR*%o+YHLd1U82 zS-9aM=dtB?s$3U3=jY!gq9PzdV$B7>r5K45=f3O>c>fOx1m3d)3iU`{~$n9=yntxw&)? zH4Xry;n;VB2toJ0wFmeEgsumI0{BJR{R!TraNr5e=xgK{*9e5ZtpJO5D)6!KqqlIe zO5H%e*g>Fd#)2qr+}a(DKUl#dG!O+Ha4%$l?IuI}3mx(*dW@(vMJC7dn(5~V4xJTM zvkH_3s_jS{J&GK~4s%OGH&G!Q{$T7}dLNPPgv004R) zF|!N-rYF(<`Q{!@{Q+R^0p-7t`JW#=cYtLI5>$sNEpLdu%$%1r7q7 z=>2ddXi)kAZUAZSVR-bO=zz8U8$EL$R{Bpad*If4jSUC5;J`%(zTPkO;7oidKpvDv z!3J&+(CHiqsFGqYeQ^FsbO2fbn?tbyERhc^1>mGJpar7duYAv30POAju@B%wasx&Hv$zw5Ej z0I;FBLQ~+T)Zf_}R&ZJN9R%lHUun+7d5T(8x%i{ApBbWwODWKpk4cYF&JeHPp9XtT zZ5V%iie%&6C+LpRxinK843$tO&E40C)94-fz)%L4u49*WugZtq85YFbUML>w3~5a9 zCDZp{3p`SbOQpGpkI-N6OXfNYwpA~g)!mdLI`?men=A-VIC{wCIUFr0&?^%WS7m}} zn9L|#8$L(~&G&QbU%x+JKwA{z(_!qpg&*C{XTGd5>!TNg`;KTUc4eQ%;DJ3z%jy7! zFHxOCJ;_b|cQvMH?d>+)j=|UZgMxA=L(&|Pmj@SdD#N8rG5d-P>!>`6FG5J%jHp*x z`$yv8@Y~Gz#@g{L=@k>Li~#XIZ*%1e8o0yo^DTOB5y25fFYS<~>7G0FH(DF7NhB8S zL}%C8Cx&yG8|j5xyWSZ6`0z8h!!~l>J%+esHz7%#fCSHKSXawGr~AleFBEYoJ}p{7 zWCkZxFK8-(3y@+ZW_Ekj56z5-Zjg@O;o12iAT3e4ahgtLP-vvzc9D_;jdW`?YI5l0;{q?2sK@fMJD^>$s0CzASxt-af=E;cI_v#4TV@YR=9abzHp%Y zB~zRccbHNssd2c``RxkxJY`t`cHWev|EyfAC>}4Q+$b&V@?B0yK_`lFmmm%M4RkZD z|CUUeXSN77&2^dRU9Z}fL5lOc#}~_Q7$Xva<{bH2-m)jujwsS*#hX01_|72-Boduuz zFzpPtCjR6nM2QL-^S!gq!4>0SDJIxr^J;lmWVlPKjd6+M`>n*r2TdiY6*F{I80O7ZCrQzi;cM#8qRs~~ z-}c&ljS`yG(Jpu;xz8jO$HqEawhkJtQSVp<1#V+gM2n5f&Z-_W=h%)>-p!J zA!rII+s~^Cv9GLOW>v>tF~H*UEljEe^PDT6>4BS#{PZ?nySS)cX#NFhs|W4gDKJFz z7@QiWutxF`d#zstjnWDxzV#>TdXFFR?a8&!b>^9U1z$FW_Od>{*~rLzfzyqW{;dv` zcfy~;>#)!Ty&n*P-`rJf*)Tp;Q(=_VWQU-;Buuhre@MJ!zg^)Ld131mE^CF6>$G=S z)NTr$F|n=e;3=>NtUb@C5m~jiF1zHKU@C>=`&512z$@c9D@d1EiqC;nICW?Wj(5l& z{FM|7JZ;LKo)Cw^# zZgm;=ort6@>tJDhJWXDxDOHXP`Gfae>~}|S`R^#>Bn_DDkGB>3L@DTTRi8_qliN8m)5>+eeSMEuXr#qU(2Cq!gE_?X!S4 z`+d#aU$hc0Aq}kSZ}3#(-LIG5BKwo6a5%+3f9v@3I`y%bcG3HxT>hzZR|g2jCpy{z zaiz;^>ZUe7)s)v2S|dc@AI81PWY3v=-GW}9ChZ-%X^9CuS#RfsCV*8Zj}d0hI~Aeg zMc$z$+g|B|Eg`v7f)F5oXa|R3Ys|XC4SG6pm}0K_M?iazGiSSBtX8DHTW=hO_-)^k z#JaevEn2$ub~iA2VKbtU@J#K+7mU!Z{vYC1Kd;m4B{b!(uiONG893K)VHtkpc1MWn zX_b3Te*4&mO_Z_I9JXskbu-b?>-F0;f>r=MY<0JWF}AQ-S4PWSa0K^l^s~a1>%3YO zuap;gb6x6XBTk08`b&E_)}M$+y2fy1oKL7~+9BT?w0j&{2jg?l)VRzq2%J~;Njet` zlahL1BCamm?>hD7rKYr5wmHnp=P1%^pGj6{Jl|ke{@B4?f&ZT6i#9EvHCJG|mW*PR z;8vtmf!1#CZf@$%71H>dM`NRGO>57!37jp)^kbl;Hab^S4Q;&wkA7KIu<66xX=XC7 zQT%weUT^s;Xe4I^us5W2>&ytw`2685|BfSCy*0Q!2Pm#-(l;!oIJa_M(sn{7Tm1TB zR@6$=iXNJ5E^_Tw=Lzo6YUWHa1AtJNF1X*1~A`UE(0NR>q; zEm*|94!d7xo)eQqZ0?Y`8@#SF2(UE2-F~7Lws>0TG;Cfe_H>Q3*$RK19qY=35SU#F z0q2_JPp|76S3Nt*a!6Th>dfOCzoD+vVGYqQW8`RvV9kBazyEtjBRI0b${t;c$&rJL zdlU25&SyH>Wrs5996p;ZNZRM5o-5MJXw^J_HnC|*a?jsA4hJ<6ugDWIpYCv9Q%A>y z&#%YLcJ~VeEeOZf7ez%ox;Vf0oXCvm5Z%E-;_f(uew^a~oVw`Zp6K6s3nmKqsV$}L z(^NUs+V==YkrbYpd6&_v>d_A*7m=kT+2|Wa_c&=wqXI(^-M=8gXHM0dj#6NzCKZ{6XH?uN)j`2dtpvJ zZujrszf-leUBqc1u7T$Y>3aogqx;^0}sLtku47 z85uhZ@8R)j$dC8p9HB-;^}jS&I}ZbKUj5GDLH!YY=t}io+mq^%SlH7>@)CIi&+(wc z%`kPD*~?|3ok@{{pYh%PR-ytAU zVL9ZM`zM2*A>>S0qz|Gxz2Yb`r&Kw@B%KK2{#`Hp7XbyOoFQ)R7w+zx1XeyhbNhZ zq-hT~mJ~l8wWTOi$i4gXme6a+M32woU5kN8->Y{5V~KI@A-vO=#Kek+A1bcNx^$Gr z@*4S4BJ^9G{zU!4-13%4navip$K;bwu+wRp94qWgwGIZBeT%-Fzn~9Z~hsFwIqk5aTzY%)+ z(ZKZS^ck&V?-XlyRK;tZC?^CB{bqPZM-n+$R@!n8DG{Gw*}eIMa$Q`To%d8YqG(L9 zvXhMLbZ79*p=7fZ+s@+oXr&HK5W~f^y)|GFTcTCw z(!1v1q1h$#RfvVD|IviDNQcrUNi_}JvXnbwrwTNtRy6@_$k>$?OK?Z3)APAwSfPEC z^0f1ryc+Yz`0H>7o=BCVlpjp*qR@91_7XQE&UNA{)ih1M6!{mDEB$<40E}D_*lAsh z2*DE2*XEb~rsK9@(^8lLRAz1bf-6)LW0!geej|02i0K`%tqHE}(WHSN4#qp^cPAtD zF_<$qPdyhWT#oB3KjRfS30&oIkq}=mFF68wQm05JK zP%4y?BrcVgF_}XtiAe;Dq)8<8xs7Aq?07}bvnTT}QIb#ION6FBW+6cGnO|Syx&@eBsXiLIo87r32rJ5^#DLru7z-r9>&tc z929)`ICqFy&P{U-bi+yUPFf3WbDBG8s-4PfFP6)e(CB3_jxJZ1ELPsnmR8@RmO6*6 zKwiFSs;DezOmIkH{q)mok4FMJwjGev75O^VJR93`h3}gL@2L+2_yDUw$bfGUfZqo|r-QtCeK50t09xUJXN<$tvJKYAbl!!H4j+`tCnZtjOg0jK1@ zLv!LQ0KuyFl^e@AD3kg$Z@VcKIDvH7M`WNu2N1xf()ZdV1ke+K_7KGVr0Pq+8wso` zdXL`!do>=yfCkmF1K9|XmXSfZFU6##*`9#@&V_7I&8$3DiPoki<&~OxUmdn>a`@cZ zFs1KWxw>#xGH&O%u&6d(LDdwW@&KARS(Y}SZ|C2mqs~l?I;HvHBi1}&KJ)`UM>wBv z7AKlw$C3dg@%fhOaVb3H0)w8d(wkXl+WRWxU5lb3Z6e1rSK{(9DK*n9Y1fxH`w6i| zo6fJnS&g3iT8UUeV**M_>PuRsN>V5{dE67l(Mfs-9eq_F=twRx+G?I+EllHb>f~Nv z$Cti8Dpv~qcFhd=s!vOpqPVFud2$uS$p;Q)rG{Ct*SqdhYyWz4etNsnTv1y%`Lzbw zG_rOStdrpPOjhI~dCEQO*xCO2N9aj)j*Jln-YaTM;A3Nlt`;8o4vINe*@DON9pcKRTd7gGRDS?}t@LihKhIdn zIt;fR!5+h+>=-}uVbw~4mc^;so!nr8R4B(kM z^R3lqt&XznGuv?VuxYVPCNE`3&UdGg?Z@Oi0{mW@=~^}vm#D;7m=bUHM!(WLiOTwV z2MgE9u8#F0r&TVv?#q?UX7@wg_v@3LrRc~=vCEx_q_u6va}HmAT;?gJ-m;-=#;M6Z zq|(uw@*!yqm!#Ae?tUJ6$k5C`$g;`iEEfTrDH5$WW(v*O#03Tt>aMbzC9QR#Q8NJPzgjG##6;gE~AGL3URM|zeFlF>DBhszeOyyx!<9!vQUFA^d-i)g}6);m}=H{%j zSS2C(?SUwzo@HGrDP8yi3=TgBGYKO?K1uCgZV>f}(mG680Se=iU+RT)gVOe;gjw)f42a;XAqs~=1 z@uO5O%lxLj4eh`VmkMlT^&j*^_Dqs7iH}Im)?Aa`mwG~Ms<_J+RA`5fuF<5EVWyY& zJG*X86+MFrO9G1nihjbMSNBT?)6D@MjaN=~Qc z*Mgj(_^M8byEv)E5FR2dbI6^sG7TvPhBu#i&z;^wX@iBf zya}Nag^k@px7Whh7vh`8!ph}>yPWK1g6l^3_^F}wK%wm>VCF5#QkPC6P}pb-ZTti{*aqI5jrO9 zBvpqsji4k-5NJ%gu+$k^-=kByt)kxb3{2njogJK08Fz!bYwQTw`|O~L=c;BJMia@m za8o)Io>nl?_K;*qPn#)Up~2vl#mgf5`4~Gk&zo3b!kWF;ptk3U$tD9E_DsHsjOp7H znu8LMo>F!^B|GO7_67T^HH|9QQ#Yun8x>D(sR_R{>+k~4A9t@lzg{RGf_8Fe#$u)z z)*)LR^qU*kxoe7Q8bNi6oUAxDZDmA*wjlMMOEq)aVVc)bqSTEx1KJ@QReNiWP#-!? z6svD>xpIg|C~YguLfUJQzNEx-?A$jDZ@0dZ30nbMRW4!Q(7B;!i)DoV^h28wVXnht zPqk=lt4yC%{azOLCPogECcC>5OX*my;4g?n?3H{spUYWGuy8vb2hzdtvhtrbtxStO zlM(nNUYk#1ks-*Zd_MSNf8K{a{j|f2kY6z37FnBL8aYUtzDljX72tW+gkjkIvkn;g zTVx1{HCt?W)!92)Tm^JoTg^ITG2e|2Q$KXmwVx}aUGYIvHO-2~YP z9aa`0(XUn`P+g-}(bW;WbNo+)@eokW`(AajIvcakDO#U>o_zkkRs_=qy(BkS- zc}Uv%x`>_DRpE#D6S^a|51Y%k0g*QlmhM1SbV3adCLQvwgSuU;-U zM1ll{bU+~B(rz2ZI(|t#*n62WOcV;s9v6U2x`BJWOjvew_aXRnAj0Qs@%tyuf+U%z z1hE(%k|>`)4~ToZmP!{qZilB$GM6zKb2;r7I5%cF5PwxW+j^c~9?a!Tl&Ny~KGGGI zdwB77Sf}&bGk?uB3Qx1CC42nV@J04i4`my>qIjYlxC2_S>p{p=4Xn>Kk@I+F5x*3F zx<;FL$Gr6HLk((s){M2J2ak?SYMM8g@e3+y9-X@)ZRakr*?f;uTCzR8>Zq_T(%hUe zosW?lwp|F_<>TN2TTAkAYF`zGiQL8_aUs{u_~e;9ar_+pjd{mNrU?e-N6cJ8ekQM| z{V??5?(}U`#$q955>oU%DJ<4hi#EFI;S>gpgM~!NdF_O$3z6KaU^ss(jkiL_ipkFm z+AUI781Tuh?G_G#yT*dyhN{g2uRu@?v0919@Al=&MJ%J#Jyj|CI{&e__%8Fs5mM^i z>^tW*ya8_CP-X~WlEX8O$emVrzckBF$E4i1YW>n{3aXb8ucE^E1+y;6y<6>2%VVbB zPZZe#-dMocXm@UlrSv_&feF6*((u)qhGpE((4q4;d{>lxQSrM9)2W$dA2`Ai#+@c| z(Bh@Ic!+uZS>(nV^Nx=l4TO$uN=PlXOC*tfGO9jyI69iEe`2??j`obw*S0mYVjkmU zQ^o-$++*5(B#TRKEfzY!Aplo_*2T>}%e=%p?-owe$$MnT5B5ahV4|CYsL|VNSE%KO zPO3}a1|3)Yeg4oA2M8?79|G<+jy6qu% zK%ZGVV?In-shmRJ%ue;*;aG?bRd8ETgTE|8f%7y$X#jB3zDE*9WD3UugP+lf`DbzR zDsMp;$&6u8a2>ViOE?#GEnniG8pTlvZUYvgAe1>=BSB`v#sgO%{cD&;uh1M0rBz$7 zXs`g*G#Pz%BL)aSB&6ChGw`Og-LfodEg(BHq8? z&HKg-pve7RHU#S1i3>rmp8&A-ADImxqX&fA2L>#cMM2;0MY-kw5DuvOe<}t6)lT6( zhV=cBn*#Sm0ymDjF>*zL)`(YMS^nQV^nXy;KIrUWJO3X&5C0w=|LySpTrmGR{(!BZ z1?`^zhDs!0OZtF>YT{KFWXGefQu9=!_fpzQy_b_?mm_`)>vP{dxae2t!@r z9?PB}2L-YLm+D??1Ri`3LgIZ8DgVw#L~n`(@`tp=d!hBn(29;sy>=^ytH)(>@U2>D zXdpnD9i!{lns-JD((|qfZmIcu8)!k32|cIdhiTg7e?irW-wqiO(0IY!S6k6yaqzEf zwC+24r|&dJL@zm!1*|-E7>CK>{+@hubS{FA6_Vp-mdJv(ze=^pc#_JmHjuRT7vU+6 z<-PF3D|sPNgmHmzUOgSt9-rK%1T}qPtoeVqdJCwi)<5od=#oaHySr0r=!T(NK)O2w zlo*h3q#LOrhVB-T5J_o}?nX%ok#jem^MBua?_$9k$GxBZ3~qHkeB&n!r|n0=HG8IV zq;p!rQI6vSK@8U(P{?8{w*Ck&Z!NrliMO4T6lD$P7DM=ow^e2xN>bgW;cW}8S(+Qp z?&`jo8K@nN&f3J9YMdOLX&R*)R^uc)gU6|F)z^wHixEbK?&CH;i>8BI<@Myt!fahe zZY+t7#yPkBK8g6k#rkwIRL5dJ=80Y zHB{jj>lcH0OD-&|r)*3dQz_hKU{|iRH>&3ZnO~$HVgT(TVMQ-qI8Gw9cUF{x#Iv4_Dn-w&xhc_`*Q#JjG{kLdg7I(THUH4-DeWX?J*>;#dd0&NFEk~U#1q@ zDLETDE>)18bc@S{ugN2@=SsK7llSvqgjG!seHz7dtBomodg#ZrF?S{hTqdV*P;#8IAuWGvApHn+At>~%zWSejQa2osNzqg#cR3e zFcz*i8EH%gp@L1ngM)I|2#+wLy9Qh^yIHbY^*0hfP~HG1|CC_BpbO2XVIHpOOf%Lx0|C|T%0m% z&R$jX*GYMleqT3{=6g@`9@B6dKZa~2LN+6q_c9IBv08cdzHBcNtkhJeJS zVhnO|>h>`0(Bz}3sQ(Br^DE(4W80?!{DM;!GGkV4`*76!K}Q4Qc+wkZue_ka)Bk|z?3DE<;S%|zD6c+4IWXizJ zTOqMsva@2$J<_88K@AKB%VC2~yxl5drK}~T9fGJ1 zG*qpUbnr$6ny%E=bTLNE1}U`L%t%~vGxMM6cQuYkuXCuy8b!O{;0t1sdcSX#PFy@- zPt{p*8%491eu0DeV}&}_kaaOPOxKRx>@D5Gn?`ITFGhX+@3;sKtL$8g`+oXD@MK3w zZqq0JTaoln9Xe^0K}l3~1RgT1Vn6J6l9yhQfQVoBsaRk&rnWGd=$a+>GdY7@i#@16 z`SN7-X*m#D!;9MvCpKsfmn3hj*djGxreaD6p1BfLHSI+-Qq<= zbuHE_Jnr#y=KkaLTU)Nrot1P|x0e*Yw7LESbN$1nDl6hb_M|0T%PE0%3L>QD8J&pR z8_X@Vw(6v!XBhmZbbe>ji8;@}afZ#DnvUn$6#sx!6laQOn3g*7Y0AD3O;i#!cT~-ccsRL69a&c+dLYy+U6Wa$&WXQG_jsvI@c(rif1jFjBKG?y?U{Te}(h(fn zCXCK6pOK)i<7zNtJ7~5vvixEOlmby@$HNJ};~$*)ni9Ehwr3k9b1q$re^xD{Y$v+g zCMUBRurWY85o8?P zJ2~B*MZWwZ`gYvgu7hua-DA@9`uzrag}6RDe8+CTpFY*0<*?O?eh0VJAt*O{mr7xZ zy*_JzD z4ALysZ&GUwXLh5XuDq?fo1EF5PF?ujQGODbhFQ*O>%E*DC?7c$$Y8Gs;bu z9Gob6Ig?L}JFfMrzOzuua+4Z6>XRKl!o#Xdw*9^eBb7%i$Iz?3wAOI{X)~>}X&w!Z zD;vIgq+=LiY7p*-PnuS5oA6~ymIm8#X|hh?F1CVt!p`gi+~IwLvVcoWpxZSMr%y5e zHA%vObbFL^gWFK>YyOybD-S^Fggc7$P=TQXmC8&8j+6E_FCN$V?}uVYf9Df-$@O=n z7E_4eroNBhSL;Y;s3Apb&`nD7j6#F{b=9jYrf;_0<4>Q{8yGU=Seoc@wU~fo=EO)L zJ~=e|KaLg0?vxrMHGkLz4o=i%q@;d{V{tYg)hVQ-rUTItJt6==KaUy=T7kGSFu%YN z?*lRjKOH34l+#PLsdUaXk{H85rQ2vnq{#QqW(M~cvo)T41*?2IG48?+#W&GxlB_T9 ztT{9Sbl$N%gA0PU_ywT3vtJjf=Y%)1@#=K(*q^jP-Kx&!J}dQ#t?D5=P!v=7kL!>E zT_*{298fB^}g%Y zVAScr%QBxFQ}(4H0$oNL2io_(d=qs@QedZ%33HY#INc6{9)Rh+gBOpU zYq!dhTEX9$Oa84}_E8K$Bng{5Xi(ve0zft@e2=0OkdFHoD*&r1ESwsUl0cb&jSl^E z0Ck}Mikg2>3H1MNjQO7*^S`E)$5omDngX8Qdb|^W*Y%(Oa|zf4AaOlzn(0xXqge!w z1-ARBw4oIMTm5$j{}-?R&lCRdm9-{F|AJN%uvvf~frWvnW#A*1o&HtM{%#b|0{@wh zxS|R=2|Ge-2vAP|DHk;=StxYOux7;W2_pAG5}zYIpi9EJ*3!OQDL?h2FLRqfr~)-2 zzQrwrP6;L)%b$er#MK%ivnnF=i-N!7(S>x#ON2Z`9IK6Q=?Y*^GwL~o|C$=MqzHn; z!Aa^>6CmLz2F<3A|wyA)bvJBuIQGRaI_vn*{p^ofs^q{yT8wrzW9!{hy3zT zz}fIN>c|OYvv7{m?N?aD3En&O_mW_>WY&WU)Md*svyG6ie9=|Hj8!Q~idthEz18mK z6?~DkZ`Dzi^(lYu`y0xflA@)Le1!!>@a5p*11WcO6mNm2+k{abP>cjBD2WE%1(XGPbg`O5dtkOlPc~jrY zzfZYD?VYKEAE_`4RCTsLxL%FLB!jD@30C6CIR>O_dOS7xE?kqra%c+gaS5b7?;N!@ zMLwA8vb$>qvbpLEL9}b;Vkj=adZPXP)3!%W2fDOQK@+u!6kw+SNss!vRlW@4AwiZV zSUWgfhLTL^mxDf(D`6Ku#Z*5lIAOX1lsY0(Iu$uXR8nar=OM;n;kf0vTBR|JoHkv; zp`sQ(9+L--8S$dJeEL-Z>(=CA6|5MG#zD_E3I^U|m*N1~(fPo`%(rtfvdN&ep1}OEZeRO+Je~4SsLRp2U4c-Z3$ky*2J# zRi>`mjk-gg$AqsUse&oG*UZ-$Pb0rLJZBouEyLSo#~x!8gB0-EuX*NQD6sZ-I~vAq zkM)n+h(nN_FI1$6e@5=ucKMwC0!AZBHa>N=Q=>g^F_x+6k-bTc#8SgAn>m8~@cu^N zMQ1eMHrkhCE+HpP;k{wXII&ymNA{&z2}8i&FsLcX-S$b0@>j&i=j#*sERkl%u8sXB zs=gObj<>>?Zv_@;37X#;Mc;pvH*PjtU7P^&DH?v*paZ_-&Kq`AdsM$E)XHL@wyw2; zxQ~Iwjx?Y7{c^IkDq{@$y{O2dTCP)3q^CYf0e&GH@>2&kmFid%2DuDu#u}Hm#!1?W zo7AHCZ0x?55=vWQDl*|steVhxc9?{&{k#{nWa#&BMO)-4ru#%SrdBBnN3K;y$c}w1 z$Hbw5j^A3wY$@?Z+>8^9Z?x_kGf~qeJklkGis9kq+uf)D9bi6NUOOZ-38P0H8fGt9 z7?e9RR$4Cw@gFu{k`3+u+JG^>KFIEWm)H6$0pGBUmM%B0rC*5f!S$)K>vvn?8F;hW zlH8w{#8hz7(NAkQ1OydN64eyPSg(CvLz1AzCvX~(a!)w* z(x?<}`lL`(gfkKJTL<%y%0rz@2aZL4xjV-JnPt6n!ic|O6E*VO5<;z;UL>lORO%Bst!wSH)Q4O)o@cm;a;$d-) zpbNV(9oS_wu7i6CsH&oolnrL@66IfNcx_#fl)B8GU3Om6Dly}n2?pHb=+5HH6pn#I zb1ejh8)L;4MXyP2MQNVl{-mDj{3JW$t4u+gs-;wZ!dUv=@*mKmJ4rpyre6?Nb_@wm z)i<4p@Wa?N)^iO%+Y7P1ZBn0j@1G*6Jn0uNeDR?1fzGJxHW%VmTdc7HZ)MJ_0?W#= zpWUx};wlBf*rxXI^oKMB-ti$<0V`Y8APLp2ElT=On>wAer&Mq@batv; zt)r}=MGvZRKC%a#&Xhbv)69oRtHSSRVAPxEL`g4Dv2+?O^DXp?3um46UWHUsIhxx4 zCVQ)v(9*_on#a(L88@b>$Jq@}DL92PgUv(`LbC!sY!+sB%9Ij`M|x;em^6f>3gtN| zkjAI2*@A*~p+w1FniQb?%H5f&OhfPQY z1jjq}+Ejx3+nkYpS#`K5R9KmK#(fmji3rQ~J&(c`yAu6f;EN)M^ERDvo&zypM{T`S z*imn%UJ|RY^V^c2#=Aj-QU0BlY^tkOVC~oA{C7HSeGNzDL_|V|Hh9Vk3!Eeo7VMBj zVMd=R^7=*65YZmJdo|P1|x6x~0ne3@_s%%*IJx6;KkM%>llPv{C2sAzt;oJRMah?&3kI z*>jZZzVyTu5whoQ-iBja9hG)ZuwOO3C#*8MI#E zu8&W?Q4ZATUa`FFqi>3W8zU8*zSCk>GUBYK61p=R~l@yw@#T_7k4z-mHb$Y^FFhhZY?nc$vDD5gs(Di6FHJf<}EO4K5kJci&yqQn?Wo;V8K9Md;}{%3gY7f*;auF!5}^k zlBjH+-iakXvO_UjzC!fQ#7&~{SBaZs_Bn~0l=ej%Ga|iYI_apsvV=XzNUQ~q8Mnt- zfB!-oP8fcb)O7}5qnY}Aj_0{?}$|Iw7`U+Q{X;=fOT0RR2H z$GHiA<9WdDfW1AIssQ-*f4qo~oh*PX_VcDJ*Y%lrJMP`;8sQwl zKw%h}Af~D?xp%Yi`7}>g-(All#V2~-piyZk>k)@_a~deM#>7rUGWWBoS?}WKFlEPW z={P7I8$$>?R`et;WSzWKGXjdc29-R_mcf1_c@J_Wln`U_)Oe8%&7W%; zpW9CBX6|43IOspo6qJcpHUDT>kmGa(yi~l| zf$ZQ{Cwpo&Hv@okYyR?w|%i@ zDnZFuX8CdbBt8%}Gs%H(qKrpo%8k65@2$~T-1II(R$4wB!TeM_J-h8E`AY=KU`K}5 zhn(IMX_uq>i0q?FJ_DxRdKBm$ZAK0q-dQRZDsD}3J*ugC#cgioLyS^ve_Rb3vPFj* zjT1cbWxE!R!FcOv40bIr);(D7u)kAK*9*<`qmZS4p4KotAK|UY+!@T$&*yymk5???|v8@@h`1qWDfOSfHuYF8f84nV#8Z>Sv<>w^o&z6yY3%B=> zJ7d6g^U-}x;sd_8q7E`mr!OkuNd8bofYzWjIx<=ixt`YYF64(b#q@r+A=ELy*N4Z$SfQGGn1QyEuA}GHDXh_Xv)zpI(8VF){$*(K+dY;Sz!Qib$q)yLH}^jH!kX_0xBMY zO;t7MKy;Lu+olu@YwspFE^oBM-k`cElU|zQ9XB=v-E(byJ5y%dzK=#`oW$)M>SDt- z#M+n5L#b=#2UsxIAj_>KUp{!vvy3weW#BNM#Y2g{4R?2^2QWbI;+HJzoE;Bl9U8d$ zc7JMfGgbr@+{fzDhC`1+qb31e-JbkV1!AYa6m!fgf%2i1V^y-c?mO;mKtyJC%32U_ z+xJ5fQqeyKWTwf-%(==3!V(k;O*2*B8oAt~BQws~WU>fnKhbqi#$Dquu`Zf_Q8x9Z zCa4IWz&zuSZIU5x{-czuN74L(mCR^Hph5Z^B~}Kv@WfCUel)dR=?!lg-I0qT{_z{! z`?{fWkUEIEl+!@Fwjp;Yo7dRcTuuKqRcq8SM^^8L{#muauj^?L*mb&!(fBSJ$+#I< z&Rs*35`o!%9)m|NE)nnsDA58dB_b|fq6ViS-S(OlBk(jnp}SnjvS&#z~7*7riH7`ZZI5?saF_rP+drv4`)YJ$cKxG&T1KagqeSMHWt&>UhG0IvLsc6&E zgrn7S>NpHa^Z{=Vg;~((rdSkNv`pkP%P^8tJeI8uy<;MA*B7Z3$(J%ct4t4mFbv-H z8Ox_URr+XJtW;Fq`pwO7nVU@lmW^wR5Fw4aA7}6Lc}uUFhC{<$I(Q0oa^S{FFGC2b zvsq_ZF$VzkwNV_Ic`;_#>jtwt#(S=I@b!Eb!lMKNTTRF8LG^prbqZp|4ieSS$@UKvfmE z+5Nr4{nPDwAXAmpaVcG-7{QuqI(2SLc;SpHs?$`*8!EJrNDmULQ^J`y^JTNtN_Nqi zKH7d?@IGXSK$$#03kuEZejc^g4~%NjyO<+Q!?Lz2YuHrgPM-{Wt3psA##=0B}%NM{3aeJr0|I!1)8YnWBQ3aEvmT{u|K@(be| z-<@3f7#&)~YuULCIAQ1|C*7fMOA?KrR0i|ydqt;}3wzV!pDisBDF_N!1o2b(WPfIj zn?!OQckM3gML@%#Fcnsg-IwUgjlRt@dO4Nmt>a#Rb}}WAwfOXMn9{onaSMHESD&RW zt&;~XcW1FQPrsh^=9DMoCur_>!sZu}Q?esEwkd3i=g_$uB zZ}N+Gc6)8$g0i2JSh0N{kxJsVpHYIyUb&aD>RhVx%2xB0G(i?l92JK!*|&0b`>_b& zGeV0DW>T^Z+jg#*kL($wB$RIK9k~p1$eeCNDG-$(>&u`j*M%^TEN(56Q7+kFJI1nj zw-2qT-upyav>g-P%o9mVh{)oxEl|6H*<>7(dl;=x|pp0V2G+J1a1i z>t%{-a8F-LZzF9JBB1y_JnnM3u#o~z2jqC?LrE0@51m!+4SRIRCZ}Uh>I#=xF5{T&(;0;lsJvG$J`iS zWvd1A5CSjdR5}D9OZDFbCHqB5!B)^J=gA8>zuQ4*bC*){2-c3oJ_XzrtV$Gzj9X+P zh>nyT%o{6_4<(Vdc|+;BPI6qw7(4_L1=;p<9Fz8H{sDE1O;Ag?Jr#)Tsv2H#C}6$d zpM!~$ANgo*7@$db2SF{UP*#5V);49xF?BOf(^}-L7m(qp0il_2+qX{7f?BZoz3OSjA9{Z zb?@{YKJI5W_iKBPxUJk@=CQ^XK}8P)#WK&+y>?Avz39Jr3Cgg01!iCo>>)`sE%fIw zc=IokU{q6~^q5K@z3K9*6QNYxKu*TfMOx%18Pw8wk)w<^*)V0B01>&>iKi+ickLk| zDHwF!q4Yi>tYXkG*PU|{iB=v(C~k1a7dx>xF$_c|pBkeLIdY+(nu73?aU|tPmi>DZ zLfTGp`Nbw+-@m}rk1_ou$i2i5Z65 zf(z;@pNwX%0xm$=m2D)<8D14jm54soSWR%%4k)@7Ew|XO#SK>+5AJ}wNNiIsrs0XQ zh*B8w0)>u%3LT}ut_wua8i+?WVgy^zO{fPZ0=&@Ut5#;~(FK|&pQ8b78Py^-b#SlvfpgWY&v>NhkH{?^G$+A_hXM~ug_s|w*% zmZ63=loo3JlBTd3Hw>M$k>{bvlH*{XX?0_hwFW+-jmmflb*m2Ioi+Rz^KRoC@mTQN z(+5^}`S3CA?k!F2;gXgql8m%`j-S8uJSA6^D1$C9N$O3K1E83|Sf+}1Oo8;6pEe6# znA8?L2UEO?sYqhv8i`l^ZUXi@ZDXM_;nI!{DEBqAvj98vFO6PdhB`6@5n_6GE9+}@ z-spaRmVUzEHQUm;Et_R(siwW4)80;LRr8A=O?uxj(gWXG!!lyCWR|Zbm(;7dgG67n zIn6taaOmY*C&xiy=$>81xPC<9?y#XBFp(pLdhWwqfV#j8P36drl4?~Y^1k>CUZ=CP z=^(KsINP4ROH)RjWy+Z0fUy)Y)l>jyiYDWG9*DFnn0jH{2S{;Jo?mKWJO`3Pi^d2(=jL&2mks=zh?fX4|#IO@|zr zRe&K9PpRPe3Ebbb`6*oI9H4&ee(aF3h6B}~-Ya9ZU-46EI6}q)-KYmy&d}Iv?fflf z3KKen_bfn{Sz^>4ZbFbu7Cfjn+2i>iXb zV3uZ2IJKnn1GHyn`cDcK;F%ks<=5m_vEbhsk&%drR~uFj-KKPfR4u;e$LieXvVxRk z=wOWrj*Q}I?HdgHqxTcOP7wM<%D7an!G6WJ^{xs24+zT4F2iR%e8@7+Y>i8uM|o&mRDv*L z8x^~g*AQ14=!agmeb-je>2H6eVJAU!#hn+b?tk0+vUus}KHTbc;U~pSJGI0O$h<-p zmPqGV$GGneD76aT%#yG$=)tD?8l1H%CbSusQ#2J6bqLqDP*XjW)dS)5oYl%`?*`}* zH$QQG6I5e;r-OP}dYJxci1MCpdiNjDERIXjm3aK71^tZ4vB=_kb%W*Bku;piy-Q+X zoB{Juh;rYB8)-^RBGmu;%WBRz+)4TQ#jl-@f9o(%Z z*b`Za*8>yp8-%}R1!xa#cziiEwU7}^T`0=k65-7d)wG)>p8PIu zHN?&!fw;WOtq^MzJ0jLkN;~+@bM+ZJ*^xF=D{0uu^~dH@uF)AoU6Ca`F4`crI>ren zMav{zzwlLG0cd1kxiuyh6qM5bYhRnR%-sY-P7a3#p?D3qgU{mMqp~&-am$ zR=E`U8HHmEPPef`$f3!F{28CWnEISa^rlHWYLE72R|h64Y+-93)uracbgcC|san`F zzdVhePIFE++4n(UJose_6|@B9Dn4JW5oIfU^$+N)+Tb4w*p#?~UzM%CS5cOoN(26C zsLQ=L|11fqqoAN3k>?c%+)CEY=SvJPr zGBgnEmpdOgxA>V>egsO>y;%K60Nf>*{dEU&Vx?a)E;b@CO3!X-9?mY(nx)D@Yph3% z$jkmj!D0MhEO4go$l4VJ$L;DtXM71uI(8oy=zL>JpFCQHywT(pFRM8k>vD4mqZS)& z&)z=N0Ku9iO!Qpp4yarqh8&jMBPJ+%ZYpQdgSe%#DxA7lDsy{sXE18;Hw*~sQMJJy z&vG%x7&lMo^_+-jq>BjNp!pzNd5GhlGiUcVzMSPBygynM&f3om-8V-Cisi5EJCA<( z9{NE+u&le@V7$6RiWh=9dsXVgk*}Oe&if=cP%&f36TfTv@#^LlX+qJ@a(l+h zE*qi(<|$#joSXl1Hs`xz;|d|#n>;2->=_fd)xj01iRGB@5@po%jVX+;yrusL#$8st zj7Jl=P2$2`4h?4C2`k^v$MrjnNtf`yg?@*|8kIrNQlq=L5m!(VKOB0fA;tJbY`SgO z1JtSkH#Ta)WXQ&|+4rkRea4*uPQFf_^5~#eZjgy@+fU(Hq6Sq63<&w;G0$6;bJg|G zv&vh0hiZPp+|5Rk-L$JqXwNQ}NT15@a#h_=6zX`d@a~1Kw{P^0&^!59%YHW|CUH)# z`a4R{@8YXZpP6onYE_P4`FvWVt}3AfsU_@~7%y=jL}%_Y$t?1o<$KNSg!VUcyFpw9 zX)Q**lpa{A%FWi}NOr|_>_0?MQar=flJnrhA7TF3y_KtNWazaPo9Jtg)g)_Lz1`>Mnoa0jou-elfY)@J9DV{5$#QUE|oyITz;I-jX#az5vgu;a*f`M3p?LAxqWf9B}rzqcPUwy z1YBg3k%MTUSz$r#D>nitA66E>xo81X6o^zrZm;Uvxp_6fnW^ zwdfdtQS9A7gJex^%py@Zf^Z;R=oa7S>POxa6<45v;mAdbk%BaBGm(g0=m_dnA*kn? zGp)rDbC%%6rgV@}>0;9)Cm8kq%=nT)+$LF|gnxuI(KCLKi;YjQINkqUdOv-=%BUVy zy*|-|$uJ7@Rtt%px-8i2sgjv8UZf*PjDYG1G15ejsTfiL%2JOX3gDC+2?YHz2IhPF zK2g&^*5FX^-GFK?l4NG{r7lW%(oadCGqaF*_QF?5yoyzwn%LYjF`-xvQYZ8a?*ui! zdOc}0@B|dAhA6Set=f?NKTJlK%_^e`nOj4d0GI>j zp#NXM1Skwd0N~%h>v=vp93T5fFytP)AWr~OYNR6`P!b8C8nCHHg8WZm!+g}I{$*4r zqIlyrbb{T)64LRg67r#xCSfiF-XO6}9+_639^t*W@*Ag4=$ux}1(a)#22}Qhop6on zIf~pc#e_e!s@MaU!bhlgqKikIOQC*pEG8P?RLm2Yx%bAl;BiVhhz{kSDQmOZ87CJf zyqQU%v14;?iB>c1EHkH%9cDr=a^klu_v#y9;ykZMbqzS5%qY%Fl<9{}zpE@=vp*fS zts(I{Rbs%(lh=|ah;+Y8u?>4ezIIF7ZlA7Z40$o*&Zj)~SE8ce*De=`jN;oS)J7q>xBcAlY@ zIuFkyx9IyO$sjUFiaAWIkm8CVR!V?87^0gFNwfGeOjNgX;({!v{jOgO-Y>>z`3l`y zDOT-!x^DADah`#Fh_!c+Nt@RdX0~6D8Ry^8J|^ z<-Z(@R1t&E1dZ)dmy_+uP4&(U%SKduR%ty7@-aqtI{Vm3m>G-+XA)CkdqVW8DwMAZ za`4&q-gfe8@6u5I@XTHJxrwEj7-w{TVV*Fog59=E0FU(Ar5{N0Cpv5LB>wz8+ct}; z(){O3fwcTA&EoeQp?Ej0p4(!td3oa7jj~+WW)KLkTV(6jB>&%6l7+EDb;rxYOw&eQ zyXmju{1jNVBCfG?C>=3!>4$s@2e3(bUd)%fR<#Rer6vrk58=hr6!qY%%e(vg$!fKK z9?D*u7v+I6<&mT(r<_B2n%M0N0>`Uru~`mINJ_Qbc2@rZL0X7Hg+1jqonN;(6{47L zNYht7h3ncAKnZIl%&V3VojHAH$ri8qOKS^OHt~q`J$>9{_?G)C^ebts-3-q=6=i9k z%wc>XZ78cB#KvJ}6p5;CG2%gv3GANjjmc6f8wuQUshuFQ9gE_#|8D;rxipMC9t{nv35;vI#fTA z_bmDu!SSol%0$gQhKLH4pp2*4-{nL<-r3Js&Gn5_T}Q(LvGP*BS18U95eX9d!U-hI zk21`_p$9QhU=vX&T{KNi=N&SuNE_pAzPho-n?kSlfPr!(?Tp|M_#xhXe)n zQ?L&e(Wb666hBCi7!zZH()_L2c=6J9R3P`Yki8hQU`!*kcOx{&J&oSU6KKZb9MrB5 z-_VIG-#~>7?Dqe5Ztm4bOOPlFDOY+Q+sdeEUI}&*n6@0(Y>!jQm+V>74CfFj@x*pf z(<{&M5)T)Fq~-)Ug`#?GPfz@a7xxK#>RYlRm^=&#{o%|)Dl_Ez7BU2MlN2;A5Z+}s zRv=iKIgcAh6}#S;Il+!<5_Y5SvQJKj{fcuIXH)%fKK+OsklSedDBMSW@FiShWSq&P z$oD>h*a??MV=%(77pdbKAKko;Hdnu9%wwk=7+#ClpI zg0H9PEqn?dY&NOEcrJST(nsM|GOMU;s*8oiOEe&&T1wh2%tW}Dl`?bp`LdZ+Lt&uv zAlqcH98X2B9mDTu`bDonwyhS(wdMQPU07B-EH-K-Y|*our>Y`n*!8!4L_^OSHM|sS zO8f7Zr^{J_!!+G-1xhL_HKo?MZ+f5lYFLd?kud0vurH=Iyw=aa*p9?${T^GgeAp{NT@$qnzm$EL45V-*cdI$C*l15P0ZyZH!=QgZi|-XhiC zzV*WrwdXhBPCpkwB>eFSPYpIRK8zQ)!GpIurP+gfKfVT%;?YiO^m6iSsNnuQ^7UwR zL~8-8z(HE8s8=(6)9ga@PfzccC6P6+WI_7fdH0Cxd*H1Lv6oAhb1g#B#{<9LN^Yxn zWc-Z{sn;^{x!rOSYR=d30a-P=Wea7;b@;eoC1lnI@dht7P1uJt$`}rHVHS#7c(oU( zzHGWM<<^t%vrQJPI3$GuVAiuXBWzBBMfV`)cGM?B?!WXtDp}Y1UZH=P7~L~(e-D1v zx$SPm&-TH$JO`h6!=Y9?NQcEd7vpPAQRUx2@Hg;;8t zBsxT>?F5?>B@Zp4x+;RJXOo4giE;;r&*pK}^?$wB`nfJzlcyYTDZkhEfn3e=vcl%kQbf_@qKvI#t9q=F=2+ZLwYG=M4&5Mkg>|E*o6pFSyPA@-XXpl_g+MKgw zaWZqGz|EDL`98BU?J3DSUTdJdX#?t1P%mydu!S$wEOwf)QzlpwpGMCyfr^Civa(;q z9U}Pk-2eC6+!@0yZq@#Vo3vH4Aw2;V@thaVt*P3d_!N6n17fEmV|YS;hhUz5sP9v_ z!0SrW%&lTvc0%q++G&pB*N;W6vPBrqWRT10DtDy8Hl%ov<|uU}M>jMK%`3(1%a%E< zzPtaK!AE_UOt0M_(Zb&f2`ftTo+&LE`p(k--U@SvTH>8rg_HPHBBkt1%FFix+FL+i z$@@JC!WWDP_SU$(nb_7c)Tw=1ZK6t}+8$#_di{#wdBf^gt{8ld%(2TEjvA2?)~@K9 zAnvdR9go#NHXbNni-Va~JO znsM_!KI;-G>*z@{Ra%8>8?8vJZP|zRWke=Pq;zaBn+J-h$cy-H{O{*OpP2N#K1{&4 z(|_(8my&*N2$YH%85T*UXDmPlCNnTv_nlT!lo!(ixD&v_;l0Ru!^BIClt}iR;A{f& zCIA^9^(QQXlpt(43=BN%3em6}UGxXPZlF7rUzKM4nD(jd{qfu91lN%aliDw+by52#RAtx+B$!+oO zYY~>?rUoe`A~h_YU`aTjpHc&T4)kx3w35E~QOfB=$2`gCV$$&+D+ZLYDGyB2ci~hd z?yXHigSxqxvUPwUWA_F$0wM>!LFNDnQR@)j8OOAtu1a`<;vbEMtyqms_PD*S zx~VLaeNBKaGC?g+BsQKy8ikGHh?n)(B8Ex&2E_xZXI&XD`VAoB0AdcREC5Q6I0AGs zkUxXHfiOmB*zqAjRbb!ykdquCHX5klX)$XZSgtU&1~+b_378}*_j)?epOI^?9j`Fm zxrR#Kwa3~~4hkk=!g(x|UniV=Ohm;zW}ff>Jb4Tvp*}{DJdh^n0GWmlX&(>pvH@RK z0lOOBBdKUXVY$!gBqk(fJ%JPWKq5^byhp5J0fA(ZHt2woh|>xXFVf<3&2>pxOO&$W zg1;f9MdeM*x)lef%#qffUz4EltRBO`hv?K;yn5BOqfv;?sZS zgMSYKfDMfX9cTi?27*|Br6~Yo0KM$rW$|eE{e_`k`mk;0)|6Q!#cqif(26-m z^+ciUSX0hCdP1DWc^DkQA4rnv_cfdYzs$LPfK-#}_#0^I33KD&PN1WNYp~%XQGrAs zC!_x}ZJ)V0>nw|kI5j&|Bfe)GZ7K~mi|zUcM4TShZjH||Cv^(zPFlnjV#$C}A!@~( zaB&E*-wQmLVp2$CjU$AXPa?=KaF|o^zwbWm$exSNkh0apU>&2;oww&g*_HLK zU~~^meccz#t^52xbYA^DoJ@5E3b) zb&YqzA~AZe71vIq)TL`&F3~<8Y>!tPW{8`hNLil3f*+ntny1Q6OW}&Jdgk)uX^6ISw;}Y2m7S zutDY^Ly|kgqP4WouSB#gXB6XMtkwD#nW3G45H^!f=jF0PU zs*1#Fd8^KdxrGOz8@;y*EbZU*FPBW52^`a(m+iY@4I3S@|2`@tTK#&dfLBV+^^B;2 z(U}EtqlWE9zmIYy=k7JzZxel0`0{4keHtpzIkUW4vKpJj)GLX3C`ebEO18JfMyVUg zWnyX)p6%i~Byl;i(brqo_9$N?kMTPlFF{*a*y})qhxnRcm1duizxkBFX;`D4CPr)! z#T}n>(0byIwWMi@Uek6PR;vN;Uce9zqEv~FoYU6(qgt*j%#I}VT&2}zPnoC`M!d?; zEZnysv=MGhO0sveG*irZH+ewVg}GvRJW4gFO2DKsTmIDb+%*|hGWedudQRf!dp~Ig zKT}&?d2$!X@|K~xri?{pS+0UPANeWha|h@u=M@nD710WzMvxl#h5BNsq?mf>){BwD$xx_d zM5O5{EhHPhgEvU@H@>=3*I-MDseH0Cf4qqJmfV`ZJ^%Q%D{lCcmdbNE-OksIKZ!i= z@I*DQTgn^hbh|<-U3Yy3*IS+}=!D%R{n4Oy{mVSzO?=<9K|FmOo9oL(N1 zP|$vR&>pwA_8|H9ZO^Btp`&Y|%&9^x1qF&vc$BGqwh{eNGjp5GE=(5XTJI(nMp>5j zWnpJT>seZ>*;0JB_7otQYG<_hF^biiYj23o-{ti1v@ngRu6&1#v2XnbzpP#|X^d`c zmQsC2wK`qNz<=XZMS043jGbe#kNMZGbLw=!x6Mn}9ZsW;dyqvHJ4Ju^^E_qAwleg$ z&ic=!X&I%M-mKW45aKu7hT3r)>};;g!bUzm^Mup8yrdI_kpJp_6Fuqitsy`b_&la5 z61;1x^kDwvC!^xMqlky&yP|=P&9()0n{lVfwOOiTI$!0>{P|+(bbVnGs~l&F(cZ2K zJpo3;x`&?Cx`FId!u?>aoAfH{xL{0d^&q4w{8Kus(vNbd+hhXY;e07n*pZvRrmwsIg3!?N{L=g0@&syACLZLw=STMP1(boAR*sy3!Uyrm)WPa9s$~&3(g7RkQF{Xd8uKLLIRM8%sRdbmt zhNBnHb5CWMeMVHK&Tf9fOjg90CjHfLO9q95?mht0(?$Rm9No(NIg( ztn;Azb0}q~6D!2b8B~k*As(brt=j^>eiS?u4(StLi#$;3rl_8fc@`j$#7jKPsr~cQ z5kWs&ehVBS*?rGgvFjdeM@z;;g+4NZ6i)4+HC7|JC((c?s!7WqQSMMY@1aHGWMDw?}( z+|DyT2FbWdLA0pS>kqE*JudQp@=8WbVb#l7_CPo0FzWUxTE2EMkZO86XZze~qr&R< z^b$X?a;WG|I|HFj@W~qgpBWA~1NvkiO2?=)`<+5FKim`d%9ebc--)>ttS8JDy#6ed zYsdLOOX2=6N|!fsmC?^lGE(qJ%crlp`J%2XK4nw%y!X6=L^{A2_11t*%ztF8?ux@Ywqhr5Cz!>?N*exktt?IzRmH`zN6f; z*_B*j`H4SU|tw=?HLOZ$+X$=-K?=vBg6A8c!d-+gF#js9`;msRclgT+gh6vB>L zGqF;Li#Rkz>(w{al!kMYX%&`S+&Rzack^56OX*f`@SayFHYkKU(_oqINLm#sQ$uE1 z3>h*nIEm9sJRvlkj~yS~l+V#dEwI6<4L%q08jfbEM6>+z9#H$h>KgP-;bzGAlw#cb z;6-RZ&G3|EiUNU+L3njcpLqJkUYen4vOr(|H+_|%7hbLpR}b`z%!CJlS1Qce(m#MW4|*0KN|f+Wi^2-!h~0MKOsQUXy;V1a!#5Ta3bc`vBg znZ`0*{eU(Kb6iMXT5)&tT;Hx7iPT4a8HO1%y)sWgokV~)SazVG9s_PXDC1y-gopGz03o;oz(<7g56TDh zXn|5A0(2$-J0GPRb&6JfLpX^MtZl5x-DZ)BKJH2Fu(uhAg5z}?cX7>9Zpm<}qUPuL zl*(b){KU8<c*6w$ zfgeWJV4#5p11Kt7ltI!#NVOgUcxr(b7)gotv>)WCFkBdAYlu!spT9|e^eUKPAQ$c3 zf>khFFm1K)D9FDkTJ!<o7S0gn9d}M z2D}3V-s(Ky3b3{A9#`@z%uv@@r8;Y6?f3&E1cUC}1j;0Y{GoJ7S|F6arKs9MO@1S$ zX}RL?nEy#G!+Szy!+aR`&^wa-r=vrjnU2~LSr%3d6&O2>hRH1+RD z??0j%j&7M9()wP!5zDMZF4T)_CYfUJqp?xshedzM?p2qh;>#|$U2!0eriF*x`>uOc zYq%%q-f*iWkr~EEuQo$A!(x}@IaPZcK3L+Ed+w#m?q0NqdhX8InQ7&VLvcjeE@z2& z-_1K2ko*CPJj*SfvY#O!h2?BhxV0oj-)A>ze_N4|#pT~=H19NXlJDvB?BhG#E1L0u z2x@CS;(kq*>~e-EuV?KV^OFv@h1`cgDCR!8c9ES%8YTSTp<0{VetTN+_2vO6=#LSp z)h>-5`}hk(Km=nqDR$OK=PGS|*pI;5(?P>hu>uDx9R}RU6k+dWnj<7%u;+9n>V}@O zm0(Ml+lZEQz>|(L;IFy%M(UU7O;S}mUp=GXNouX}TNl8#{)iJeca4h9$@ za~k4`0z79j zN#rrU>W~<2rCL-|s|h`5+~~@h-w+)}BW7VXSKAhf&zem+ldYbA&B(6_RJKD3~Lq1|qACTv3q-VkX zGWkcJ-IS?@wO8cXL~hVHzQb;!lN<^u_oyIBHhs)ULhfW1*WK;A2%9wGnN_Y|wq@C) zbF|kiw8=jX9TrW^p9$>~Gv?8IuIh5Jpo`6lpKnDWrSR}|W0>!-*o(SR|kwDybn)d&7N-yHnKx&+75 zx0Qi@vs5b>hrXJ@{gJ{{u4wm3>8^6Q+c~o*t-mo#3Hq|m6+iE}w>?=DZJ%zf7WyT# z*=jrozlut|_mJ?X1g)R@>kb~zMm5@Gl`lmtecu* zpDV1UQBHM(_iBOR?TFPvPL^00R;tjShAmA4PZ43QKD~wK54##C>Fgy7@?qWXhyBv3 zUe3ob>G@fa*fyb^q@((QBurB16ymByySCH&A;evX?LLVxOH3V48R7#hw`-LKKABJW zoX4;)Dg0f8ovorplxoy3vZBZr{5CH6w4$*)YC2Mjt_%_Qe}KUVeaaB0M>N`d>?u&K zcwJ?zuNus))Zz|<`iVvFWqUY3q^jxzO($V}J@tr(aK)Sgyu>S`t1q~GQ{C@V~2lXF@m&cJF0~+CshpOpuR(SZRx{$Z6X`z>_??W53?umV$;R9sI z(eK>W15+8PQ(9z}mNJ)VGZp2TqF&SyG*D?BaH zhpEs00Q7Tlx?h;G7O1RB<{k6x(j3K296X2Oi*GfzxmelRU0)1)cPi+LO&PqTSo##$ zVuJVsVC%xe_bR?A5q%m+lvUPsHv5#6^t;$Kzp>vto;sGl5j){2x>`9N14W1Ek90-_>WEHx}AQNHI4ol_R#aJ4zSMAJ?{l%Nl_Fbrud-mHdvxrOgZyoGMm4s_|sPkq?7VVk)L*HL5^ zU47I_QZ9~qr}2! zqhOD+tT4xPlc<6P&xi_4E%F8%`CupcA1sIjTbx8FF_A!DnXcHVsFkwpP#P07atVPx z^fL-OmQiZAO-j+Og{Uy13ZO$hro{wZnB%zu(d+_&Hh_u^AoQjzv}%xZ!Bt#jHEAB&EqzuW5ro8L$AM9Y1%!%#7|KE?ix~E$^Xk2N1bRWySs%n2rNh z0F^Eej&*zn2?vb~%BmQsZ+a1^{TyJhiIA-a=#Z`R^C|!nM6@6*1~*Wd^N9LoP|M*b@ZJq{z`ins9-6`ba z*x>U20O)^IQAkh@g8aX)V9Z-aQye0 ztRjE>Kbzn^LLLT4AN*?w@YjhBENU=TLEsM#{Wq+N5g>g52xZ88Cb}a)@?pHN3$5M< zDD03S0}BpJ0LuYDT6lxD2uRy-aIsMES|IBKETjM{Vum95&7q566VQp1!eIvmJO$9{ZZ>fD&&=M)$S1yeLiC_%BGFi( z38iwUnz|Qnxe|02#uGFKFt4vs)xGl6`+9i>4Ymo&+vl+^yF9b&8U)q#qR>ZDg>KSa zZf%mtJxue}NAU*d7IxdmB$S-@R412`G!2L(pUJZ;SBjdXxMZu1Hol(5+P0kZ(5a8Q z_o;%N^jWAagRHD|Nj4X%o@4mzx@JYI!W~6;QCNwqI-*J_=C??OQLsmDXpu+u^`}0qSH$nVKXo7T3^Z z?F|~gQ?w=KdAoPsx_B$lPIItUlIm|h5fH?XxHN+N{u*w^b4F1P!EqZ^p||LYpB=J{ z9e`8kzj%tdbI3IYo4n_j6emU9sgYfyrKumRv7rBP8CFEoMQ!D9#E;;dv}ev4>k98% z{{!^l})cLJiLrmypefu?aDzvBm0L5jEagsEk;3CCy zlY>wzn3ZjO^``H7aUgAD?lAkx#9T8A`@Ra=p`B`gm`nED?L-WPK_x+M#xAfTi%s`rn_o&C+=`>R!DRXi-&{=tSqD+cJo`rNUZ^RQE|5s~ zg!;q9E+v!?m_DBk)TYZRO+D@t8*>y^Q_E>J+?IKbO;6i{O{pWN-aNeQvuOUJ<@{6r z>z<6!$;}e()O0Vd&yC)5@Tq*>QSmHJj;^7EjZP_yLutzAs(m|i&k|WCNzl8a9*P*Y zQyylC3m%GPo@VPtE+xfgfu5Hc$(d8Bl7;KZqN!W&c*n!vUQ~~4d>5V6Xz)|!iCGbl z_s}&b5CUr_E3|e)NBfR>=}3M2E2#3Jn$^jDTR|O1uJccKcBJ+iQBmU6+4kB7`=+LVKHIjS0xH@B<(cZgk!XkONqos)z@#Q-_S2$okmR1W}Vjv z`|sT5TN`)h#%HHpMm6O{SPQd^p`F(8I5z*1i?l5a5#;utWZY!TY7kKD8b6*WxhBtt zz^VFQ)rv-p&zC3~X{T7~9{6;{g`<{?Hq73G!y&=(HT9hGYIa@xg72QyLB^T7C1S}# z;|M-W|6n*C!*M*Y7dhr6;Oe_qOsl-6OJe|c6mQUB61yN%xxyry?CLneM>(doE^y99 z=RmKj7x!`&=BFOKXLBA1Chd;fZ!2Us6fa6Yp`CsGMdk%D7I%YlRN97Vlhp^C=+HjX^IL`0*_AatbFb|MlRgaM)A)6?UC{84t@gsdIW2W4^K>%eO zA0o7;uhtgX<8LXlMwoV2_PO>u0-hSidcseyk!Rbj# z87o5bIa0Cc*VB9RQO&*Qnhg(v1O#-;D?a`K^5PxtwYt`5D~l^-ykjD>JYC$nH>MT$ zv!t*|k;DY<~3r0}!7)v#`!PNlTlMcIkEWbxw*!*}CUTF2NJuTQ;2_$ck=q{VL4>LiA44 zkCl%kF}*%(_#uu~Y(fAjVHs!#E1g1xdOFW(nBE!(!-pL~k9#6Zat$;lcc@+c4y0G! zNhPDqJ}XZm6Iw3y;^=qSf_}~Ys!JI42YBL%Caf=zA%J2$uT+}1Pg|JuqR6fOx0l)1 zb7_12hPKl;rW-gjN}3D%LQ4$6B>55|LLAPQx&g-4J6gp@IM3aGLF)p4tGZI;m3Z|u zu=|$bvI5>*ROGU;$LFS z+8>3}Fq)vbEGmUVo#sPn1`^JaQH0XizGC_(iv=&5$)`VcVr!#lqO7A}Fb@Y%PPi?P zdVH@HynR%kBw|`SP$uSYiqDt+>Iu3?9Dp_?-0a3tp{OKEw0W5A#l_8x&+5EAACqP@ z_jgG72&n$AEBJRd7HkOO0+cfVCAkYki841mYb(=)R<$ovT#(eVyGBmHp4#?c0o$L$ zT7A3H$n!~$yeA>L1umKuem`o==Pzk+XTwBumn0=kZ5f+Vlt2_rKmZM8+ExX$5?_G7 z$98xwSTQk4MJKXgklzS<8)zlO+ih3xjtFlf145u^L;5cQzv>=Bl-J4{mdWG0QS`C! z21NsRkT1<(ArL`^(ZVekK&J!bx+@U5cfXcaxk!pBF5j`>P z+2SF(eqtAcK~&!}5m^8>bYvkev|`{iIts0f4=$-vVJS80#1s-fbs)Q!C`#{97Vt>D zx3ZN7Xb{HV*!1gg+{p`E>PJL2dE}SymWi!*nBQ&%cg%9OajPlT_J|>)If?2SIEnI6 zKu=*L%=!mH{o5r)0x&otCy>xW%;iF9T|2 zz%D7+C&kHQE|m$~LHb95%bFmYt2Fy2~Q)q+rRB(@JJc{B2JWH z@2xD%aU(PbZj}G>TmI<}qlCxN!aTorKcxs~YorfZayQL&W^rQr)KeW(HV_qBWrN=w z%V}IK910N-`beV$N=QB@;?Uyzc3{?x-s{)P=b=_DKI=_l?1j;|iN{*?_2u)O4hb9= zMv2Qbwek@5bM#b4mF^Bdb+cA?XOs6{5Z_|u+nHZOmJR`bX6qk$Q$;M@y$xUkXD}mU zL$nHh%Fi4+^0xbzGCs_%{v{sl9I%=A@@j$jht9z#tbj(_Z+^Gk_v^lqWfn2`)CUJ} zY^)aE-P?J2V{QI*WrX4vnx={KLdIPk$L}tpUzDJg-wvm*iTPdCr8vP0k7O3IR$oqrRa}@sysE+MEqpJ(#cYyStN%zvwpG-@l1;T<+)A z%K5n}eVVZHpptL$LjO@fd))Vnm4tI)EbGQb(kIs={;Nx@H@s2-0gP&kQfku@pJEb{ z=1IA*&gq-3i302tUS9im{Q(*ul$M?gCC)WCF56D+3;qElmFVl3FMktMJ-w1{PcQRj z(^5$sLNT1zln7X2O!wuKQumkoYX14RriN1OC$F`m`ot*)F6NWaDqE?Y{foBOJ)8Zu z+;S=VZk2KTeX61d*Frq1J@m_SFaP=4jJ}oTZqRRh@1kC^tE!Hiv3++t z_O|Ht-Hz6U`p3e`h32t0=DGWxYcFYY?#hg%x6p9>2U9(He0A}5hL2~fI15b5KK%h$ zNh$*}@uZ(<4fx)u(kTg)cXM^G=017F-l>5RkoBhD=AfMS%QowcB4O1^SzJJb!37G> zK%S9rZ&v$Gq{oc_-0$w;U4hForM3MRet`s4=?&J=J8O#HxvUL7*p~yJ%Q_!)?VaK; zl@4J1K4_%BZz1-JD%wn6qOiJ6&?27PT~j8Og(EHYfnCEyY=4Ya)pQ4E-QkL4QbD_I z1fJq+ypL+*am{I$*HL?+*|LxD_0rpK`<8Tx5BFFpKd}}jT#UY<^>AS??4KxJDCAlKJ^_sbS>j9x&FrqEL(3>p& zgwkfR#RgB)gH&BpDMNsgRr*2xbnE=0T@b7Kj0dUQMHcxLrQ;6?dne7e?2;07PwysW zLwB&agi77gFh})s9lW3u5LJXzUGi=E3mxNlBeyHDi`*na{~&uE-MUaa`7_M`b5;6K z#==H~VC}vBdijy}Z88RH8cHMF)_yQ=${hAfPKzC)cv=>1Qy*a$H^-hl#(?Uwgf&S+PB}2Mt>ejSw9?Ds z&m>VDc%ZvSqAYnnY`^Opf5wNAQHQ5K281%n8ZvBS4*i@YLttsrRDS4{>WdQr9V)YE z80zev^r`dUge^t7s7h1g0_`-zF+IjZl6c;r^<@YrC#hT|0MT63M@)R*8$XV{b;SCS-73 zaCrrPx0+F|M=N_h`%3PMRu_FA6Wn;0C8U~tmW4%N^xo8)LI)F~G4ykB-MnN*!yT8> zF}lcZafqJAp6ppzq%iHf;U+ibD{K?EsaV|^$(dZMuoN6B=Q0%lOK#B4R8HiB|vc5~H_6RJx0K zG=U-PysuLJkB0oQ!aUt$_i@5&m>6#wPKSb`y!+<)^S>szDyW7hH6Yl`!_mv zW*F+QdzCxR%N1Y$>QQf=G%4A8NV45q-t^1nn;|WTyv>(K{^xj|IL*tff3$KD_*XxhY0+R-QCc!29|-t!i7-LGICs z#8iI@e$%)!=qPl;#FwWU{=?-v9b=Slsu?50Tg}hp`!`i2M7UA6LVQK7tX*}mYPFQx z2vhHFCzJHv=4Jh2T6Bh;M9}LjzB@1KBEvpqGA#UJJooVfjvZ=9F1oG48RZU5ZIXS7 zvrNPFy9Kf5b!}Yw2SS*(QR&(5#vwSrcB`^pWRlvGZcHOI$jJo;8Mgc+ zCtgrSRZ+%8i({qt#C<$+)zPt>)x)hb9l=HdW$;s@w&l9%edw|=c@IyEZFu_GD>CA) zly~|kn=5t7j9Tj4f$#D*Wp>LxwTEi-b{&}w7>i|?zrkL$wAY|b6Fcq0jU=w_uw@ABNgE4yPZJMqUY)@+3-Y*> z5z{UNm}>|TWaaNJv1AVPhHK`4Bc%X3C1|aRlFXOFNhQys6DNa`2OI-TC^G#Z^n?C| zcgS3cQDk}p*wRCG@6d`oQTt_B+%_QcSg0Ltj6}5j7386U#E2~ZG;QiJT(CrTw|I7Z zV2-Z>eQ7ew!lv+?k35EJ%#p90c)F+lDUV15DUF>#nsy=;@l+rZ7Se%&@NpxZogHvS z^gN$ku9(k=3T_j#+ZZaRfnbK|;gC5qn22!Q8Q9}{?~M94FLPI$o>Dd2}1q?1G3dA zhEZ6m1!~Sg|5)TX{sXjSzykyo_y4mc;``g@{om$)03XEafrP|J%T=&tItz*#WZZ=Q z7gG<=t|E^P*`^Id1OM2@X_bGvX>$_AD=$0Qs_f%6BTBrsN{6h{<^2UDV)SEU_|~OL zUKZ1CXLggwoxFGv?21pAuKR7ZS`f1^1yg&bFoo=%OTRP6gx`C{ff^p1mK4;e<|v%_ z1(F78jdOLCa9uWa^U$+|3fKH7t``b!4qe*vTs;$izBYGND#WK(XAN*{1)A5BQ3r0P zaR>tze2(~b!s6aP5;I1`S0_D8@lsFELzIi-3)vf9^-J>mOW+?yfEv9B#E6|+=UU!n zxYb1gtpBwT-Erqd7jq7Y#1Y;Q7rGb1TUmEKLl9D%I7_<9*xSeFpJud=6&SKYsbC0w zs7{AU_}cD4@i!Wd&Q<1|D+UFtl{U*`BHzuoNng$P3UOY;$eU;FH2gZho`&8uAAQcb ze(to~KTWs>z4YXKJ_@u>ScI~~&V!icN59|ijG=VL30t9g`dSdA9(SeEjWB7d_*SnB z5gilq!bWY^u1#Aj3~K$Q`-p$6e}!6lKy+3n+#{JUlBAiTmsU>~gr}zraq{05#s4k_ zeWf4HJ-W#J@qF9cUM6!{MS6k#tj*(_LY33-M~IlQOhage(!kx$#@g#J@TFU=-5Wqm zMQ%ydRgLf)-f-y5C}EXT`w8k1g!BF-B>pt~cbD`U{A)w;9ka#{yh*ytl(kT4d(eT= z)8wKj_40GDu5XPb`;U zILN21UyOV#w0vPx#4i7ienIuiwcFx_GyP=%|IA_3OIiAZkIK(QKFVL^2kiGt*I6x| zk$tM+-PtA>K6Rn5G;1YY8`hDI&Tl#xxVY_q)M#?oJ}{nh&^Fnwz_;+)z4XDhI^zwS zl=aufw$!Rqk~6=Ahm|Xt_fH{BN5o$a%07G#XarT?+XQ`wWqa$9$J@CZSQpmjV}F3B zD_UhQKGM`KRM{E@#5P@PFJ71&{e)V~o?d6$OYoGaNE`4LR}R^&WaLL2crE!z&GFUD zmpHPmHHiKJcDx>ose}MNmcm1gWrDqhsE74SzN0L>n(#z8Wt7NLWE)eZchTEsEqAaH0VE5ZQ zH5~Fa(Q4f$sA{cRwI8Ivr1)J5#JaJ%4|9^}J@eigA-(FCt}P0=QGHOsuX*hM%$VFM zYtN_xTBF+H7SxPv>!a5AqfelJ zM}h6@hdqQe1;!3q-*_s&`=Vq5%G_w z_rn_$!)rf~Ze-p6&GEf;(36nvL3v+xC+W!2`-C`2<=Y_sm6xfOCvjorx^i}7jmPw_ za2_9r^^=-oZpA})ebl2qdumjz*5B@Z&^60X;Lxep zg|F_gRJkMZm^tE%sNrp-yAswF^k*>Y2AVXGxMHJ=Ked%S2B(R zt`)qExn6ME{7Ry_V%TNG*gZInI7YEVLu?PcOtw&vS67&Lf?H!WuY^2&euNbc3#HUw z$eN=xApz6W$cxJDI#|q>x@)Yd#Rpimccw7Vz|POgTBYqm5L!nMnDf%57W|FmB8*8O z$@{H!#C@LU`Kn)eAANjo)e`x|9X{t+gYiVYJ-->Viv>;=ZhPPQN3NnG9cMm%FLqCS0^+%J`X!$^lp7sH7^^nz{ophfQyzYjq$?1H2T8vUe# znnHr0x+jWXW@MCl;Y#^8iQhTFXPK)j7yQ}ymt}^-!^y=QIMvE1oU}kV4GYWt@u4S) z={|&FRzD;eD}{gfM5;_#IhaJI^wVHZz>6RQwSz3Vyz$iTCDPajXc}1yE*rSwN|-f# z@#+0!G`2Nf&F=yF{thLbLFf{0H&+vM`6H|69$=82W8&qFKRIcTtj2!+3`>t-`wJaS z>Re#tohvwC;4?-!^!yLP0RX9j8Q>isV#dznt}1RmH47dw?H;CmHfEHSqMXZGg1;zx z)N(m9yDT>hx0)^E*8Ui2)XgBuv|yI4T`hX)nyaMCqxY=d zcT5O>Z#St~dYyfOW~NKv|HQMlGWxn88Fv%MT1hLjf@VgBCkLpCu3u2&Y1nsD^xvOla(xtgwt; z;VY|t7LHPm9Cc$fWJ4s?H(Z7nGY<6ZF}{&Ae5h#4@0V9sZ*^gfM~!e45jQarw=VlW zs%p1DL8To9A7k1Y@{zkxd|rs7P*}Z`Fftn*TP2kx=p<7fWR1 z8`@LwV1bDaNiRguz7hedJQnDogF^(BM7D&%!N66tF0|73ptVZi?jabI0Q3CmwhH3k zegGS(Q$Vi%zlHz3q@Xv0uWwuIxZU18T8Q-kI*l3>FNLJZMc5#oo1r0T>`}<7$%%V zU|r_m@tnXr#DeP2c(c3pz;N0iB8s1LzyPN@>}B9q+EBheU;%UQU_(nGImQUe7>D9! z01yLjfK#870Ve|@ZXcaj*a*gI)MG^#CINQAh#b)D)B=Jw{~iM)Bm;u`Fb9H*CFI6^ zY@R1!brq__aTxxclH*67cnSD=CbY1Tzclw5xTzAEK5xgq}&E`wnpSxy`%u_#EAh^uL@s2z2PU-tdalzi1Fd{Cl_cES0G@*e&j}!1F z3S?qgjfYXua3)e8CnyL`aTbr{+Nuq!VVo@UgnZ)~${vX1)mNXe=KMhZu8K45N&Kg( zo4%88R%_W!zaE2rHmMB_*8$k;19X&g)_Ve+F2KBq#L7FBo`bi^+RL@G@hs6)ecTTK z2rp?&GRCj1$Tp?p+rj3R0xdO-6p?60#bNALQsL;@1PF-+;=134pwukXGg>tZV%T~f zHi)BSN@By><^e0%NWoF2KFk9wXb`Y_+z|x1Oq=V$%MUj`ScLqpncY!0K)i=(;IW`R zHGRwxGpM6jbgs4#%le*l16tVR3&}96wbf3FjZsRhRX4yb7cS7jcnbSTO#4IG6enZU z(F-kE>Hs42d}!=ROr+a3AD?ofH+k-%Iy%?9%lq5)I-&9u$_)p#=ORvOs6}OBfZ@lt zTER+sn~Y<$!yGX)G5uZ3koF!grphSPtzG=A17(`x-DJOnQ!?y<*P=`kxzR?3X-B-Z zhsS4U#Bb1sewejBSju=XZHmuYlIfCSLS-wq+eJrk<0X2varf83?e?r>1g<{ z#0vDP8Ufe`8IHWyKS$6ISLr`898%t@C5WUZ!Tfp>HUm{R7}9wwD;|Z<7r*Rf&w)0* ziz@aF`s%>BBdr2$7=qt;>95qtAfA>+Ic%^#lZC0$<*XryZ$ z6kcZAWc)n6v);RkPCW3og?`5b!?k75{6mTpH=xn(;+)zsWyv#3>PvfxRzH|F7YA`3 zTAMK!z2Tf^Xcq2BUuKs~Pw)9)krU#U0MT#PmL-4lj4u2 zsnvFiMwKWIGZ58ZMzNg$14Fsrer)?N8aiP`IbqIeq+8h)7gsZmiWYMLx|M;VyJLuK zU_F)`2sS|V9kR3W?=vG1l@egeLo;_oW*SnC#tj<5@j>}Wag{gt6KTbWK;rl*k9K`% z<5SKTVcOv%7>^K9!r6T5M57q{1dMe$Zux~M8fy+}iX@Q+kq&)&4%%@kVc?*X82QA% z?Xf_-s6ez1Pdok1*nt(jV zs;LYaexA6D3217bC$3M{FP{T;i~dI+|3mHm|3Jlmr-3AFK}jQsB4GcIpEpS2{yWw5 zSC_gUYP8hZ<~|NaBa)1Dx_ z0pSq1miJOXdlDTVHwxI`KllT*uVFc~fO#n$!0BaaPO96lq0Nb?fMF*!7uDGlk{~`ou08Aj3 z{xi`G2l0p?WCr9o-l=n_>@TAQf=ouDbkn^g%6+z zJPcIFBD6p&56VDm^cBM5MlD1A0&WK5Vac>%$zdpQtctd={Kfd%e6$3NJlV1x2nZ&! zL8vVf2omcA>8LI^&O4UO!QCckd0T;pXenrU3jpX6f{l>_+E9Q$f}T4Lz=bz}cZ{-L z2K4!YLt&sBAv&z+DmKZDCup>d%)Kit?7&Lak|vUX@~ZGzHME+n4CrWrGkUVNijTGA zI9B1kY5EWc-5x!!Of3h!?ZGCcge9prz?ug%4g*-2n4TxIVknE~*^J!oY$;s5wMM8K z9#i|+j;PlwkCR6f2D!Lv;6wQvgw$A+v|hXOAv_F=uZP@q6N)}qL2A@iSvb*)E(Kp= zUT0UFYU#X0P%Gcp%Qp5>*1T+y5}iFE%CvizDJxT!jrEuk1v=OolmT;?gT1=yN+6kA z*&zO6eTT_ny{$An;A|V8!CF8yM`9dju*z#`uS?i1e7g6Hewv>YHkTUd%QYjVGq7AK z9r}nxy+#P$Fy{67m{x3T`jLQ|d%>zh@lX1P8$otHE{r@hIcE`GVBY&4d_A3W7|ff9 zB2>W4&LxEmWMh4Y>cF<_4nhpIiAEx zi$V-n`bheTHq*b>5KxWk(W#CJ%Mn&b&Ue9-gT)#55I^U4cw2f<34sk zIrT#a-dUrjN0-gu#ZIUoBB?YVQLI-w?h`d5*jO&=Q=t@OCUVs0_X8W$V%f6;+BWbgqqc9yrr7*#bm0Dyw#yUisNa0 zv+JHy)@mj`sm^hqs-1C*d+p+4IX*v3;zgnG>gZ{904)ATFn7{5N)fD49|8UT)B`^u z!$-T|BUP zOoP>P-Zau1&JD|!4+0Zk+_~$*zNMD`(%?+Xg|#G=fnMk>KDV zUhuz7|NnjCa?T>PQU(C^9#JKlagUjjd_B88aZ>jQ^T3qDQ;0qB=LJ`6XA>obA`=>@ z@)rk!Ab@(94<$%(yoP(~`6Do)eCoM)KG>on#p|xI5l|9VsfY2)T8aUDfTblkt-2?o zZN>c@tBoxz#8(NJQ*L8?17@yv>OWDb$I<|U>rtZG-0;29bh^z|5fdHhd3mCg`p=`4 zWHG62`X(7sV~&GlL$Tx{fdM=$LNt`|aoV~rwEQ3hxI7;yy8pif=*Xu!**=(pCpPk= zgQcU6R>q2LyarPcWr}2k6DpLY4?6kir)h^kk{z@Y&3i4#Lq(h_phQp0EMOuwpddGh zxeS#PjO{~Zv__4m1+~ziQR-hF2&o;%ltq~W!}TD5E3~k*3Ih>Ejm$ z{x>fRiu+D@Gilu4jGQYZ93-D;lA(2_Avzs-OSKFVvR!y?hnVH?^ zE5M@a+O7}X-6`GO42bm54U$R-(w!(+A|Z`*OSiNI>ZAW2ec$hYzdtYV zl51ejIc#RmUiZ4!y;cNiL9^?qT;+vnp7?sEXL6lYa%iO4C=tJlnUenNohp)v!fdUN zM@r5(UUht{#V{z?8cs9kw(iMg`l5|>Xa?o3&B_^m4>76;2|Wxsuno~S;er>(aD+pI z1UIu_qVPZ!k?FpiVv*I2R+uQ)cT%y-+nCK{0`{aK_=GCj{-N)_B*29@Yvr$I_D%BD z_3dGnrfXphkxEl|Dmv=Nf)_h#pg~ zu$u4`$DE^n9VZ2bX!2PNHsu7%ci!H_Gu~~&{3JTxQ&Y3C;0`U1m-`ZD@#8u< zY0~w(deMqI_hx@@`*PQSHI8Z5SwDT;YM!BpDdttSO5%WGDi5a(mEJ2go8%HD?JDm6 zd~I}LZca#YQ~q|};lr{~SnFO+uagncYzyMv%fY5A z9i7Q{N(9^e`h)H<3KjPy4E)%*B9q&TkGrim`W)B%>SCQMFo}6DIBhpu@Yup;YvGRM zn&-L=DK@Ve3eF*{2xZ%r-ArV{pqC)qs>$FvYRI7sk%e=-gTd^JFLWWcrM3-o2ycUo3^q3V zyg~_VwZo`2y6WIkUpnlw?8T|=fN{4)p;eBn(SthM^5dcco~|U*%!Uc>E4)!@_!8sc zwPIRXVjlkklY6GdnLD$<2hYRs!n7bDU!V(TjWSuIkwaOvyC!%&JO{tT&O`l=ZPbhbzqo2~7wW)#j|56VC(L9%a0S3I9C zJMVa`z2w8|AAL&1J}byFLt;}KCeQXA!K#g<_aiA`v_coCK&CX%LNgvFh)@B0W*hQ zq-qr;6#chyHs=sSh~9ynnvnKbGO~oP&#qLF3>6J`V(TFRTpVoG^Lj}!!qtiqv@XP( z;i#>Vu?}bqblA$io4~%JTrr}>Os~1A%JdKe+&$3&smug~9Y|9H0+iWBpL8%?-KF(MzHG9x?%T7#$z@Cm>Y?fYAN-ruZ407(4-4 zJ0eRqu$h7hv>1Q^fQYyi0vcn9B*^eN$bOQCNRX*fNON$evfiv}?RRb-93tZ<}t0%#-w4qQVm%C4iS7MS1V?ma9 ztMP7Omg(hGgL+K)fGY>-WbTYzSV9Uo=^sIda4jUh5I-aj#mi$p08@jr5VGq5#i;$! zXZ+n;Q5?C5e$O^bug{9b1&y9`mH5xudzt(ibB@7VAqiFu9{dUyx2krWjQ=6_J~KBE zG|fv0hk&?OQUK+vkYMXe?k1xe^^Ef1(iNc76`{9$6s%eVEy_o~WTYGw?L0OKP|JR@ zx-*7KZ|Qs{aZT36KC~t+A;93juGRi@I_byNna|oSyIQH$X!3-;z4DMQXZ0JBKq~sK zf+u(<)^PfZ&gb|aG9Gy^JY~lFHn;|Fe>HW~^$uTRM)7r>(stS%sq-FzgW$1Y8XX>+ zn<=$i9JCtBZhkMPFT~eW%Xwr^9`uVuRQO?%s(v$vf7jdI7OY;~+^~bS=PDRg7m%IM z_`K+QOSf8bIYV{M1@CCeXkg#^UaPTMJ(dw}>+|-UYkPC4s$zST-LhI(ZY&bU%RTj| zuBgp&tY<=bD#O`00*6rIxkpIm0~)dQ`Q4CxMZB z1DZ9;Ogg$r-oZ5^-U#a@b(S%g0S+8^BDg-$CvUe|d+-S3T%yZ;2H+-?u5q^A%yLX` zFmhA1<%k2rvdDz1NM?wL?}k|$r7|!r`1A?oy7(p?OK*j-#~xv}GSU&84ETnd6A?u6 zk<1XNiHY`EK1*>{*lIEsfUA+GI0{p$MLH8;va^7^0GzbTRY*zs?L$XNrnl9n7`xPb zT(=$yPr!Y1=H8O5N~_XGz;zf$AdE2x6}%%yAP6LI3+J2`6z2~qgEE~<#7Mu@Q@<4v z{rUFn%@E;y-uXyPk?;;fOOlvV?vwB3OMNfFd@*k6*o*kDQK?@L==HQ_bBR$NFG{=( zcUrk+h-cv@#{0FW75fu2{xT%Hk75p3U)p4?n;z;tpub=sGz52GEZuujn97nxj+(yQ zymSJBUXPT*UuXn<%Ck|NXp`h=3%8ZyROpENdGk4|Taw^;UAM{r&A72~dQmN3PhPwz zewJu}=>emK0(x+H9Wzf8XFVd$?18uc*tMO$QB1S(v!av(^$FO~9>2OFuRb%cLbC+h zM|!Q0lnJCKdT?61t<*Bg6h^36*z^8E1tw%V5bB3XT7Y^XAQ5{wo-=(=~3Va3*)+TE_1 zYQ`%b*c13!}pQ|MUPaoc*Hn?=!cUMfQ^+vt|8-Y(CbvC5?)|GR$(+w=|I|{920ZG_yT3QHa{}sg~Bc zA-6G8Xy+$xw&b{CK*yWALld2uC7D_F3N7!813ui@Os%vDj*IHU?h8#^8yK4(!?M`Z z;QTDYEg}C;fQDNk{O#T7yIa>^9`f9T?WB9}FzLBbP7_pcqm60*63U7!!+&0vsS?5X zy_+@JuC&ee**ki9%h5jLb~UOy%z@g=vxz@T^B(_Fm>$)=R0KX9uh~?G2f}rx~$s@y#0o%By~IR^?H%Pqmhx9+VV~j?AUbdEYpvZ ziAt2x#eZrYn^?gH=BlGUM60#>ZX)YfFncVI;@t}jU+a;QI%L!G5pti$|4Xl-fejuP zf%eB}iW!0b&=l&chS(q*FUh20X;HrZ*u+*BiG0PJ4Burf<|I}}JU9l_3XGQ&=FG`i z678||-#POWcM)3~fYG1nNJXTSxjV)ih&}h)bAs^2?2=+YCGd5ML3NbMQB!eNBBfnP zDK=lG4P@Wyxcq3QJd_SxYQ52LC=mp0l3)_*L=?aIvulhdz$bYB zLQ~_x@obG)4t4GZP3aCJF7;TAq!{rGo41%Rwrpt-A3>u#2gyJ}1~!Uj4b`U0NieJu zI0U?s087m@t;Eb z@(+9fKO2DDj(h)#E&qO5jMi`Z=g$F_=wJ2sXE3CMHl%jQ*h-02j}f}b)Py6MFVgvgBh3E}FoDwp+=0AM09pQ^p2L417Ei&NJmwfiJ4FwQbF$~2s4LS` z1ddz%eb8+ea7h@UTPU*wa6%LYBpzw??j`0&;--M}<>bt39PNPsy*%-KPg75RqW8D`@X|Umio>5a z@t6EF_1c$HyMRN8l`sF5-m|7PNm;)eY?GdC-@*=a{EQc21$otJl8Tj!9*On13!Lij z^Z2DoX^f8O@IMJe6kU~d_N(Q4km!8i9&n|$Ld$_klPjrBNCbvui zaI{J`J!_g)jelAtvHV>YJ!ZUr&Zcoh=kl2E{i-bQt}@|Hs5>%Y;x~{c6bRTW1bW4?5h?$TwZdG)*pC>V!qm#+YcwL z8~`KZ`0cQ82L1V$Xj%+MqN#y31c+zrF8wZ6CvOHu+ree+iOI8 z8P61}E7k_cCt5`<>0Hx8@`4l>9B!`2w)Dq*P_>18+CBT_f(l*s8dBcS_%_RtiPQAz z$okO4k+rQgiwoyG$wb?h<1``hQhnvcP**+r09gA@AkgcU?7*l%tg4^fl{n4 zzj@djCodkf(PPP^#{=PS;fgPX1$9yIs((m4-s8z>bMdfksV~ug&zg*TB0j6GQNS)0 zxfK#yv-=Y>jKOS|^KEQfoJ>QQ{vElS!^VmQm7hC3mjc^QsK1I<;m@a}RV-B6H%`~S z7Y*`vO~W=8_9Cn9T9M9f zz>upfxu5B_W&=X`i+urt?FVpPXK@qaC}I^SvrvI0_t z%`&rbr`W19{7=;qvpmxt1JnlFX75qx{hI~&ChYD85}{}O+J)aIpM2aYDm;jmfWyuk#jTWXR|V9{fJSvoH9l>6@>cw$~U*8*Y3F%qbUF{!L+q zc3E9)iY&Gc=mjM_%xCp5G-_!w%b8v5W)As0aE-n8>nA5|?fj#o z@z%*{kl>1~sCOuM_W{u!Xp22X*^NQaAR#mVZn`bEc-d0yn4S`~1*F z*G-H zrYu_VW5xFoA9XOSTr01B2~Z!r#_B3`_@RiH+8=9M?INc@yKFapne=#t;;hfX*wckREC;GW$V!_fv1w)J$4a@}g&j)!fbbCX0YOw}A5ct#FTAv!!_Q-_R2s@5&Fa z)yMV>=D(=O?78n|NLQq{>q)Hhu&3V_`AYrSo6fn@UM?x$Xl(M8p0ll$NJ4plhRBC` zvQDE+^c48Ll#C&+hrHtO+T{9!4;JTArBznuaak1%qZxjj?=FsEjwJ&X0W!YC#bT7x zUU%2-mvduFd@t`vP)2SsV{P!uldb{(LclEsYH+@McqsLnZFkcEq@zXp!wx2xq zB^e}Za}r6agiX?o5RcKrb+m6^5{&z^zEaF=di^S{;CX9bq`j&e`GRH=aYiC^T(*g2 zxJ9yEpT>5Cw}#eRQ{btu*FZ6*cDB}2$KobV z_#7tMO{@Hf42dNiHMC);r?;ppUvYN0P*1H0RGii^xf1p`FwDZ;C&aa>GBa<(2(}(M z?iGCQ%smKll2rRPzq4B;NPVi`e_QcI+{IUpr@I6%@cZ6{?p1woVso_6U1iWosqWV~ z&xxONGP*>Ye-P{U%(6D5Po~Z{`SmO(;+VBLEa@MGGp8RuPH3>;4KG%CtdvLw5tg8l zGT(%npIY8wlR1u^n+qeT2Yph$XDtRIZdnyW3tY#=;@1|YD!ACSczj7uW)i=n)#zWS z!O}58C-ZZhO?{rdpv4@~HF&~5cY|$U!af>}7ky1xHwd3$GqW%_nu2X(qYYH{Cag1( zh+^UJHDos`QjrV};cgV!jJc z2niWM^a5xlEx^!|ERZll2qmT$#Ttz!DKymaJ!ogpnxf)KtNNBsnN59d#ZpXV00I-l z*7LS=hGsFx_I$;uEa!G+MyeLys)NqJ~39>@~POEjQIRX!^T}B|h>xQjK zo`C2B@po95XvMuyFUkNGz=w_)sA7mimtN=`Nxgx-#|6^;wUHhV4Rr0lIv$Myp4lH)1^4-3u_h1}-nQ+Ign7)CgO0-ZLI6&2aTtGm`)C(ZO{4b5gJqYyz0`vSp zt%7XAfNxSmfMf%FTwe-k;5|YCgdPCOph80a`@`KKt0I8Ek(3?4>Hp^F{y=_Y)%3q1 z@c;I}AJ~f29e@j3`6~nY3!wiO*#6(1^!KoUO#Byd`JV{?59x`tqXpA+pzZ)y2|gIg z7Lpjs`qeOii)}9)TCt&u+8rFk#nn4kc8w^o-8Q3&F?evuT8dFp^2z2kYqWN`A~eoK zZjV3~dPshnJYOD@LLR*6q!1`8$khRVv0jwWBt10HIz{Gd0P*c6=+WK!J%4|4@hJVS zIgf!mQy^b?@<(pvcO-*(1aN5Q5#28Of<20QXTG=nUU}#g-rn`+$mbqS*=*KD+X8sL zdpTl5RNpdQ88?2#=T@~Mlt_HVLz-cdF3!rSW@1F1<#wSMBbZ+=380^?!j#33uSHw zhYFuNJHNkeq7%^HGii#Anwc#RK$ze4;7$C;8clYQfIZVGR&n&|*qmQHCv~&_d<(+m zQMqlXqONGZ&$+Hyj9PT+aS;)k=59F~moSUZerroFYu-co%(|E^_8E&!4JUcDmHs7e zisvsB4vLD%T-t31#vthjdmEla9c(*JZ%Wii7HJP|LKiZJMqE+zd}mVpztO$vO|dQu zON`4HRHGu%-sM>Tk=)`f7l1&?8xZ?$pDrmaF!QR}?@s%Wk%iRqp!jz(bS@pk`W}1! z?*3046eR^MHM}PMfw7jYy0Z&!@Drn@iF&Tg$gM*b%MIEM1()ptA^8#!~%6w!OwRCVl)iJ0C)1j@8V_dMA`8 z%P2MXgi*g29q6HMQga*7jNjlXFZ?O@Je9~XdzHlTTj!yn;diW(`k3N;p3ael94~{V}&d-z1_zdkXs#jepYNLq3Di?PE$7J!k!S zsn=gLRw*xX<4NJq+d zw{eNn1jUd?AB=a&$-f%$bPuF*ogc(bZmY@ zd<tLH2RGKwFpIZ0DwzIO{ApCs}nHWHJQfy*ifD6C}WDaG$)kxtQZwO5I^J^S+Q zOOi{|j5|+}UVghP1xk~e+6^_|F&xu7-YE0#g68w^X-(C#@9(B2npYJ4{qGejd+|QA zRS2uk=uynjO+;|c4T%q*Ww@|XjCBc_yN? zcbrK@b?t^T$CDV|KQ~8`XCBYnFlw%M=eAwvlAhT3Eg6nY#d3Q(*ZaaW3RlOhNe>NR z=}Y&XE#u{r)<1U*D%?8CG>4Nff8gSAA*~If8GUH9aaicqH#f`ZCYL_W`UUsp3K2OpEyip4~ ztzRkh%lYA~nl!k6uZM&(OYBN#ZQbkwHQ(1Yj-N-ugK|gPATLpcz4x;e?gsbS>R$_{ zv_BuET*9!zO_F2jf6JyyRM7v#+lfD3Q}<;p_IPGnmwUcF+WhS$S%;)RC8dFTG?Sas zDW@t&+3acV(bBmyx;fG@Z|XSZ3)IW8uTSG ziqsn(YDqI|*b_<(E2K^x3W)B zJ7kATl1`N7s{3fUdnoi5$sEj^*QY@%CB;YTkX3l?zTf=;06$m|1iU!Q}7&PhbiiDxzlKSUAlq~Qi;ErmnSplh6uktY10{ffkQqxSdMXD#|7afCTXdL(E z?(w+27vl;cndY+NDsPbqX^R*(g8R9=PTFS?QD~^bp^S(ZLh*s<>ObN<)SpXt$;BV` z=ei5R9JoluNT}FG^bj8nS4{nC9Ow*Zb%|+g{nUTy2sknrfmQ|8x?DnFLL%E>=>e5`>db}vtpHEVhFQMK>qOF7S4DQ||rSAZ)^ z%xLI&bnY|PcRY~GUJ*2rQJ%pTPmy@KuU_KDRczI+R|eWApS-K+Ca|Ms%YgK zekP+R$UG{tk1%@JFLdXjc$vjfIe%|vxUg6~@rTLm&(n7bXlW)Kv$~m2`hIa6aDKGL zeA`LOWC{RA}uF;V!T{ZKJ1GjEeu=nc6Wc2~$`lS_Qwc(WsK>Ds;%Y=8ql|%Ap03`pk-AGuR-Kk583w!Tl2Po8i1qB<;6g}#=EhEo?y9`ox95BolFoU@ZsFsr9l3dY(igiZn78)bp zt%L@cCx;`%zlk=zB5i|PR_Z#GM*-*K^WA}f>I(sZUz|Y--FNHoU&JU9P@*tF>PTi8 z5cf!`79Ct25-1{NSn^=N2df?+To}{8AuQ;gBfs%y!NGF>$8nGk{l6dhpPldCKW6|y z^#A>Y|NkMuag-ripa}%SQJ@JA))gRTq*kdGAKmj~_AOA->TB=w^SMI5Da0EYi+f+k6(&MPOe3*Mq6z?xMn2t9ASyEG%(k^c-Iy! zbF8i)|4*U&>aX5W)ZfI;B)p$!;Zij-W8aV`Uh91MiN^P4$nTC&nN9@|U{!iYYCqPA zape0++L~jYos&l*;tLDm^ghMBIoEIY1cMX$Nlt-OoY z)c&+2UL(gb1A6l`oh?FUyUqKG$vX^cdo=Xhk9gEkAHq(wLk*c+w)G<3%JXntr)g9c zuf}95`QP51XuOls!~~Z=niCo%42Ej8J;;6$+Vp>Vv8lDWx+r8ql`ipJIz#$vM~k7t z{oM{c(4(Mwoi0sUKYbpkPqLRQ`=}!Q!l& z-z(FzsX#aomJ?T#;1~BSmoaiDwaF&VrYl!_p&h3=dQbDGvCk2~ zb;4POhf%vduV&E87FKn=s~5}$uIqUN8`>hyX$q&&?VnT?F9b5`RDzf>og(2k`2 zBsJNsvaIwz)MILdosF?)n~cFCH1QYbHhhRrZ31Pk)=EK7zdu`Nn;^*9z_o2neV!eb zY?PneM+n#Ec_#8)M>buo^f+cJG9&(eFP=P>Kv_cN@Lv0pspOl$9Im6vcdRxr?sxiL zkGbE?JP~^zsLdd3BwSrV7IZh`PTxb1tYBPy3@9gOd!Wy7Ep@7p&{mFZ^(yHI`uyD3 zsG)kVYUZ@V>);*_p40X9gg*9!QW_d`rQ`C-eGoD8H*i~_J737cC zbVjt;{jyrx=lePZhO_m zJ3@}M@h$o<7FdP6Y6Fj``O&t#W0*g3CHLR$!@%a6%`y_$z~>jgJLEPt&$& zm&%jYo>6C2CGTGuBo@6M(f!YKr-xnGs9X5^aPKDZ^HZTf0eP2b$;sh-8K{KsM(r)~?= zexk=h-p|IniXGe(4)V?Y&uSMze!V*r+<8KyAfnxz(OPP?21e(!Rz)s|OmhJ~fmNgZ=9&EjfzG|4`He|nGFQAYR2>59*;*`&6)N18111ejebjo`Sl&28r!%x&L9eKS9i89O%In`Z5s zDi&(1Vx-b*)?1wIBTu5Q5Fz)C)>|bNkDWAlQDsO}(l&|f3@nC)N+_jTvu3gs7c??L z^!rPS@)q5g;na_wWViBB{CG8`6dMBq&hv1el+ZH6utQi$$r?Fjbnc%OjgoueyGf-= z+(zes>s?+ogdUNYG0m_{g<88obOiJ(K$|N?o`=^Uk&TLj$MJ53&V#s0JBE3W!H!_y(6f+c>D4P`@GO$%d9}{ znc%xs^s2YqXp@(D@1L24Fl4j*Af!mpUAW}gS4;{2(7f1K9aTnHp3VHy@`f$mo&n47 zBdKrVv3RnYw+7zQyDRX;aqMu7rWE?krFU>h zE2c}XJ?+W{7Erj-0(Jen%vu^C?M-v`5sFKWKzL5ecLH*;ebdR)1{4@kR21F(L*=!P zm5$krrW&f{Cn@Os%mh<;Mkj-&loh1qO~K#PnqDQ@RdjD_ge9F%C31JTzE;5`=>0f#lA>d=uW0Qv6k9kE21P!jOSMCR~AN2`T)F>|%er`(S zAjE+Obcvc>AMj@lXY6Q~Zc80jWm%xO3^RX@IYmUQ8g?YbO8XdM`b{blhJTJ@!1{nS z@JoL-;e;6lLMf)j-kQ1qunCZENDM3wg##a^b%217SPo2_AwB6)0FjF%5s{N%KoNk- z1c8q~2wCYlmX;@YwvZ&~z@sFpk|PGdOna;zj@UYJIeWo3n*ruLJc(%HRk6_$CD&Qg zZdg=qLu=pEst^Nf6`+*y0tqoO(JJ*(W?6u9fG8SN?piX|?}n!}_P9?6p$riN5yb_r z2(u7_#0)ZE;6;pE5~~pK%F@Sqs1+L#2aLC9A>c1CfQ7trl&L-ly%$9gWmQ%S3zeeR zv#+ABdM}53uS6ZE1-Bq_x}P!dl)i<@7>pQF$YZh#$S7I}Q^1v%kiiOo12*34OMN#f zbGFW=Lh@ijq}p^zv91@zgF)K*9*m9K2*TKeBKoR#P+@GJeNh2}3`C&4%<}&Y|AOBM z=g-ppMWiS@5F_9+!6icSfPO}UFd`w6Y5dRNa{upO6iKfFxdWJV0QyNJWh?tGymVu`fnB)oDZC|7l?9@S;%mdaOjT(7-2a+1mrKL zXn~uINunhPAc{CePK8M9l`jhU631#Y55H}8Vuj-)bS_bYT#N9H0*K$4+BAPo3V)x03+>5E41Kr+)%6lKxULXhhen5#pXfH1ou+6$DE zDe#G8fzRo!8Ktm(FKWF)@ak~Y8x5$D)!b1l=*iV{qkcE@@hQuxJO7@i_wJNQW!lGL z%V)shec`S76PvnbUnebF{9*2F#bwWUV#Rq6ofI}opQGoUT|bl@z0hj&RA#sRh$}r+ z7KHiA>mqrKI{n6cg)`N9vN5=N!YAqVn>qPK1B02>gSM|enc-^cR99Pg=Q|zYnoQE; zq^e}HPtEoQ=E6yf3V3~@el{>?*0Kq$EUaL4{hSzFIVd4{SNFZJS!0xaYFVpqJ%_SM zV{ZYgK5_W!m>EmSU?r2A`>X#OJWu+k0r7Q}*hRS(~uj%O*c(1-gEQp$90P_~u#Eil?1H=e-1)r5y#m@j)3^432bzl) zA>n{QBRl!m{fta!!_%A4t8>9m(MH+&1hmIn>pX?pi@KfB#@cNaPYZEd!*a7y5tk2| zxkw|qIe*G1|BMX=FWdkcMT$zx&y zQ|axW3r^VwAG>kWf40#3PDvEnDImLrr6ca$5&N;4Z%p%nz5M#H;xL_)S5+#d@LY<} zTy3PSJbTB&!y;@N#khK#nFUUTDQa3Rl9!s*+FDXdW3>_pF?onxnWf(} zJ_>Y7D8}VceUc1AET(Py{@ly|svepD%}1M??HX+dGo@*sC(@XQm!HE*b)YfF#P1T# z@G^-9#+hnVz`HNt#)eRJtz6G~8Nr46GM2orQ4~g8L?V!Vhk!Maz9rdk=!JIO@lsaq z*{aNo;fauPJf|ZDec1AHsWAtGlgEo~Iz{>Mu=NK)0cvAc#8KR6KN|~bI_b=^(G-3| zO!ajatpq3|4U+=O-&XC_?&=GycwDry^TOCyYcvUhbD<5-S-UHe6_{^9A-1m2i?AYM zy)-#m>P@=VaSLs;;g7WsuDzv;j<7Xj>Ll*QI3?9}f+#x4F4-p8bDzK+xS_D5zD=4d zgk|Frvo$qol8<-Bj*V5L{%Y8T9#7`V*cb+BzHqZ>e8CUjwubRlIQxu1EEU|@z3N57 zsW^VC$5<*NFL_d1jDviGXvjl9@kFegeu25`*zmmKI%v?aXBm*x_4voyuB|Ir-jUaP zsgaN`>R4pN<-2$+hd{};%E&FczS;PrFVgMNKBPOw(qF_W3w}c-{%LaNinX_s&Rltk zcRC`?MiwwSDb4Qmkm>(;7(m$`a-UQ;rDkQDy?16pv+WL-gF)PGPg$H``<2F~(@;L1 z53w#R{2Q9v#@=(GgI%ezeQ&zAB0fY>TH~wnKgJ9^D!USG2t(Aolzk58lnr~H%SfjL zAA}+9)M86NIdyaz_fqyf(rT7Ky_cU$<5v2Ci72y#k|(MzMrwLZ{^MM(WHv_@J$_A< zK#_|+&zI*q%vN z^niIeml&iW8#pT zrJ#u=sn}(DzrNdThj7qzt&rdW7=dN*yNqSU0{&*0IX zXON;;ZnS@y004oAyCb(f+}qZGwP{4p3-^NiP6j@vgz}0fwI;^*4g}`&npzml{H8WdpK5HaB9;Rr49?sQ(%at{6O z)S-tA&0LwXCw)e`R?lTo<&%0CUZ+tovh$zp6qrnCehkXh5B?73W-sXd$t3e47m z1qJvriN0Mc#Yeh=VS?L=g^$`A9Zl)WpKWVIl?Rvo2u*rV8#TNuB7G(`HZU>5a#k;S z@f!+bz9zWh_|a!MsW7NsbQ?sKAA3BPKKm?rP8%(Xt}!~7AGEz~M9aOQx#8n;KyrZD zk<1r+1rrTCHYiYYa#ZO&d&(tC`5h~fVs5L9PSXfyEP!Z3ANF&nG1_r^n~c;C)`d^n zG3cZ6BOyK_Sx@Y4ZOP$|N7lNX$Z*#AQx^3Lc-Tuh5q?4K^08U57H%fC&~MKTj1PSo z(6zU&B~xz#n7rt1qlcQEmv~VOo6tM$%cO1<%RpJFA(~zF*~q? zqXp8zG7%d-{Y;_sN_o3ztr4M6Rpnk^DFl*b^!(dy2l$W!tpvAN%GzKHKvpYvrC1!- zMV?5#c$~mPQ>vr_LMnP0YbqwG<%k9uI3NE`6~v3+dsoGefsyCYMX1VZkUH!Y5IuY{ z*o_5sbM1u&5`q?eB@CiImPhB3Ck7Cb`!B37QIv1>{Vx!Tjl}eV(4T2odFT{EYen|o z|1AIkW>Wy_;sV;1{TUDs|G}aEMvKUW20o~uYmd|k|IrvANp!HpfQ4K~32mB7`A*JS_T!|NsGF^)l+uI=wyHieXH%kx&vo`TrG&7< z4jx?hCC)WtH?N3dGP6_*J5Mo`jhqcZ;}rDP)YO|afC?4~N15f(0vs+NbSWVmq)Y-_ z8B$vUEJ%Qu;qTntCLn#i=s^}5(eEjjX3N}iZfPDvf+{PMWveeU-<>X6?RMTMp1hB0 zZ}=HwLFQ8r6ZBuh9(CI+vG&-y9%9Ga^%D)LdB-zK#H0Ui2F6vwMlw4vWJD;z!Qth= zk&m*cJ66?eg>w^@W1zOb<@D3_xln$In#Hihxe)o2tJIQP*kY_%+|)bb{`S%fu?{0M zA6*@8?h$Yi2@ib#Jo@4jTk2E#u!|dr@biT<_p3V(GVnlbErg@=c3WDrU}w4)Wy3UzoBfu3iw_|Um6;Dn{Z`06!$@) z)o(O5_-R`>gN3h@t6+=~e28tqS;wL@l`sA~d5L5sy=a3@qA6Th^nH!_9wC3x0D3w- zjLpHxK)Ne4$mGpkX`X9D{5@C_?xTCR(&~!Kj1URW#6O9jxyDQ314B+N(Ke*i z-jzP1I+Mkrt|e^~@3TDBBCY6!CpM1_59u%O2ob%uC9~NlMfXzMqa&r4?i*QLy7x~- zwoeEl%C*9_&_;U9T0OM0xXUTE4r?W`Ll*LGGE z6M@Kcp%{PBT{J3TiKfE-Zdrjb57p*oKeMg_+E+`6rI^m|Tw*mBg${r4_9DZ{j-WV_bS zQqqq~BRB^25^__#_A>s###Q)%!}eq>bt8vvVrs+Dj6A6Ih8_BKeK3AB<3pq?@u4R= zUr~3}&^-Cwbg$To@`RY_C`^FA7Txpcjc!U|jyj+Ecn!}7H76cg-_X$9IK$Yxiz7PK z;b#@~zi2~9-eLKX58U>yz+i2O||;k(^;w9{hBrNMAMz^ zmqf(tNW$*&wLwgM-HCCDT!&DDbx(UW22z|4@RP)msM;Gsl7JXl)yJ`DX+EMl<9Gz7 z?2F_Qelr5{bS2zOu4)`??_eRfb>{O73+|e*>wA!7j^l^6PL{Cdx*>vDc}x&;GxDaF zLfgs4<0^W)EJge=26NrxpVP7`)8^$$?_m_L_EYq3~+mN`kx#2|=bEo4#Qmo0|MZ|`3F*k?q#thw@A-R>x{6?54I>atm z{GUnZzW4JcZ1jtz*}tKwt@%@_p8GkgTc)D-*FFw-*DrT`f7C#5c0B8GGlchR`aXy% zaS)v?THAU@KBSb`!E|w`FQoeq9dXqub@1XD=Lgf~j1$g84Oeq;L(HrF4H*z$FUkFe zbl1GBL*Qt{U&-FRz~D?9{X`c)&$0eWZHDYT<&7xdJFS_Lyc$nC)h1H%S9@1I&cJol}Q-c2f;P9PigmwaSV%f)Y zN6RKu#eQylEWa>Jn&g^n-zW2y&)=L75^^Noi7@S{9nQ7Q)U(i_No(fYLJthjb~M}; z9&%HYm0T{^*rnu=M_1F`Gwx-v8l&^DC9Ci3>(&b1IS$aYntZZOGT=K3+p&ND6nKW!@KQtwD}GuNUO2qN*R1c<&tcRg~4;tKM#D5gou+N)b5_ z=f3qY%^>9Vl1Fc}_`R}cY+VIym;9#ryMFht67Tm>Yz>Xgsq}2e^;VYhvi?<1+83Xz16OI zspiJlgov8qgRWwyjpXxt9RAr>WK|mp^nd5L@S?zTpJ8rQ@LArFAAMP(u(+hy_hm&q zH;C`(hw`;MYiH^ZrT@_k!K{8NgZ2n4?NK_z{6o^RkPEXF%nMUJmmzt&UQc2VBoo|? zbflu6Li()zk+D)CkaOukd2k!0*BbUXkPr=ch=zbDPU^U@Ra+trt#%K!wW- zk@Vsd6vOP*L2Ed=n{Cq(gXu^DOyMnIl5)wi9daX%UZm68CX7ThJB~B+8Hk|az#f3u zGPXYIatBN)rn2x|y6bm2MlAASQ-XdjN$t|zWQX0s7HB(olsB$4w z*<}3>tbA1gX21Hkrho!=Q`sz)*nmI=FDJY#KxTz+tfslPKPWd zD#?>DB0)SsFOnQLMWR?gdRc2Jj1u|(!mjHOt}j?J57D+|M?)0@B;gr zUNDo0{G%vC=nxJ9SQsFW@n0nXnEnSk2YLvk!O26QB0>J>e~`(bKCng`G6lFCD3yBw z?<~d5m{eG74SNK#%>E=QV1mSkUI$9CYh}ejU{0)?)CZ-YWYv1^R3|F;?pHz023MC3t;7| z;Ra!W*ARrQ0^I6=7g`g_3Gx%7u|_r_zzPyu17l<8!CwtUI0nk^X}1Fx>R9ZqcKxgH z9_Ng%qG&!@_a4tQmZe?o4w_`E~EMLzACVN|2e2WN~*Wg zRG}VLw`XQ3z->YW3$5>F7GQju!%dx?yjNktn^!SMjq_th?fy1D&c)Bk<x%EMNRi^|u8JvwZr zrnv6&6i8p%92 ziDks_nVQ&ZnPrRi#gH;yEB@SHh{Na}(lE~Jqr&Hg))7{}aiTj(WmX;smK1sE8v4$K zWlr^6gjcC{H2CFSXn|$@C$vy zS!7C}wDDMaDc9Jc(({W@}Pw1LdGd!liBj$8swOau?Cr-Jh-GiDLB{#A7g1@7-)_W~s6@G1j$ zA0YaKItPv!wY8C&KO8mnN`fNoaE3|yuRSsZc7*ES+U>DtKL?(fpjl+7_bbPr3lez} z3@B|3_GhV=Wc{9-;M3gfDDOpAz8!oK0r9E2DleVZ3>eeXpBdx3DXpgZXu{dcm*44e zF!y45m&qv;iIRe{w&5q6HQ0w*-|gJsm_H}gh{wYp_<3;~$F*#O>uJfJvRmNE&U+$|P(Hd|No2aBlD>Ba|ig=0M5_i}FI zMFGvc&0AwSNAG*3jrm~dL$azbhMbgmj9)50%Gmn4%u~FK(^2+x+ByRoSM-62s>uM~ z`u^9TGs@;l?fFn*qFrs&X>_3kM@(E;GyPJVAQRlR?E35J7uKRTv=6%DX0hgph}8DX z_X(89Gc``I*J(ZG6ol*3LMt*}@OqHHq2oZ5j+Ndo|B(LpPe{iLW?vZ}be>f8;UhHx z=0rBaeSDbZBWlHH111|kKeel+;=i*O)CqnO+z(Bs7S@{>j`xl~;?j$%70p^sj6_NiBUQ)u1seIK%TQ@WOSM39~7fnly>a@}`s__;Wfz~^UasJ!l)2br^{ zQ4aZ~g0^a~_Ph4v_uW@*ggYhW);M`gqL^~^g`!fFV${h#FZE}+o|2kGBt&_1_Tn4A zAXG$b;qjap6+M%Ho=lDTg%!%lagK-0m5m`*Zy`Tq^9Ysl@yx0xN5@pSo}EjtaZ3k_ zI^{rXknxr6*$n*pucusO>()xeUq^kch$YrIWaDl#54KmzzQwCVZhZW9M13mDeEe6! zl_OELY`SWNX+U9%EcSg8BBU`*15(qsP3wpR?bq>6Uzi#zo>9$C?vvl(3p=oO^zmWB z(}$HWNY}Ja-cU@Wl#PfKKN(*n`T^2|`z1ca`i~Q?kuw27Pr6In?^(5IbG5&HlOB$p%7+=Y){aXf{VrU(~@{zmhjpK6|fmkxVD`W9GFtQ}kot*EPG zpj^+rwH1d>sWFnADvl1zbUU_EmybuhE*C$AIy+ES&#Lpo7&Q3wIBcYTnfE=9Nm}Yp z7&+#c%YtC{>K@?yiWmNp^#YIR$F!v^>2+PXWC&%ZfpVjW~@9~JwB8o6>I z2PzJ|KJl8%EFHW!kCxjixDlX??=o@wW!RR*l_M$Zx4v$re5hJA40iW^B)0IQ z+G~4;uM`bn=S+z#`%Q7f%c8e9Lh2yFHJ#9n6XZ`spWOLBvP70@sF^8Bfq z-aGns5#1}Wk{aDPrCeWkRPMfWLxwhle@msurA4Dr`>T7r_K=)oEPRhHRBt!DyBiCr z1N;GS104CuKa!OYtm|XUaM&2}1O_TXZemh>L2DQ$KMJFMM$mR+S%D3xAtC^*r&-}! zBNRA$-vYF5)H@ZfI_yiP!dOsn~c1n znz|dn>^%%*2RBFHpTcFYTaX3rzxNMBL(~*7Tr?0wSmFG$yt#t=27o7KJpq#yiTT2| z0xwKY$+0lYu>eydxCcX+jo^?)gkLD8Y;=lk1zpZR^amiCos>~G~7Fja!6JGCc4i+EsiVN)d&P0`K03f zjE^`JsdAgl4SlF{m2Hw!1+c?ILC!K9vW23sLt$^BLszpPlIrSM88TMnfMNr29_zv^ zkPOV!QRff2G=-c{LZq!AaX{!(JOx1tV(!bopgOV~O!#rg-x)Vfe|auhfn~YYIl-U_ zdF!33_{^B=8KD^w!`Frbw0~?#w@%$WXP!|_D0pp&?3?nW9JDfj`cBsQcK5)KKx1gR z+;QfMMdoZ*v%3si`bN5y`+{h`K8JYjEITvg55q~J(K3lvJR z(I1^f3csk-`)p!LC;7wR_RPNh_pP$h=E|kcjNW%Xh^$PSNZ6e?FWhDWG*@zvWb6WE zzOUrZ=Jv?EB0E9!@*}QBy)0LD68ma6Z{#Ip#F8)d&djv`LY!K{S+4X)Y3oP1E9@i>&Q=qU)w%mT?=385XzJ>B z!`1CiTvB7XK5%`wAUC?Nw#wkY-FAuIZI)n*Y%%YP4DOKDV_n}rhdnFZ1~u)1ThE@w z=td0k>sEoNdrI3f zWbE{`l!{IcnS%LA_*221;{1A&=vs{e}@E zUTuYNV+-P_)Q#ayL#8|x+PCeLnTSc|+`be`rlZv4eW!}FKq8-#r^Gz(U-ejdru_aE zD*rw_c2^80pCnSz-lMBgFP(aG;imSV9om}Tpw+m-D7H=UU5ln^ZY9?ij5AoT1d8BQ zrfweE&rfxIKwRMY@Y^E=g8MgE_9l$K6%y}rXS)CR0CII%oBI}WnzC}!-tA9RRWw8BUh$N%yC0pF>1*dP$ z%v_Gyfz~RH)D4PPSIT}L*NxT26^$-)NuKB*CmgNqTRT1zEn;e(+c&z(^3WsnQ0Gi% zF?_}|0~A3;qU;wMs)9+8R5s0(N;=ooXVEsht~C|rOUHj?@v{g9NChk zypadhW*>Qfe8$=#8p&5)=dzu%7-Z|A_9xH#K#dL+<{b59N*7e~ZNCun z5uN^!S28-Avm;Q}kVaWS>jK%=o`_IRWmDs}WgT9pO%=K}?p3x^)^l}LYHiD3ev}WMMEUdc0qjqC1>R7`h?!%Ut%$X%^11%g}?$#fs;PVQFMJ zIzpxMLX3HKDwd8dd$U8OzFUv8-;*w;sY(`L%as-DY}QiiPBNRx4!~EGi*EDj21scg zg>U5kX?#!pGf)3zSYT=IE!7O>Okpi^YXfNnqg-VBjqQ_SqJfA8_&e!|@y z5~hbb$zvrgp8IndqC~8-zODI63R7&%;lxOiLMK{2O)-shw=V>ul4nePXk$*!&wT~> z3^v;0je=Z<4>hi zW*xCF##6Kg`FDS@xCmZ-0U??@sQ&)W1ZDE&;-Bq~%x697teWq3SS;1-J=YNNI_1`K z3*nh_sqVwd2V4oS^@sCoJ0iIn4957?O^QJ0smbt8lwS=UBf=;tGuz4PSG6ev^JD)& zF-A{LcS0T-3HIU?V&!T`7@<5BL!L~F(YE2xBYtkG@JNM!abXaq?6Mi z1N`?-SdGct1ufB496UAW7066Xo+LMN0xniW0L#T1{`nZAOtIZn`Wa^*Fysk-(r4O9{#W zq}TThZ{bC6E2_DidMGN|~;;Zam=1bjaXs8qtp7(y1EYWurFcxK%7S_J^Wv&VB#0RxKaPqNA-A^F8X+ zKSsPCe}t1vy~&$dP>vQv^GrKPlS}Tz-Ph2#V6pAcSx6qN-Uxi9I(~fTr#ihl@vCT5 zi=ZlzQx@aEg|U9}ZJKPUQA=sz1+AVk=*+|qp_@jW>0XxRfnh#(8i#P%VBKY&v7`mI zXD=PF=jr(_aG!^tM{ULLOWOO_-Q4%~;-PN-x*v(Nw~R|6Xq&@0trZQgi=q;0mUYO@ zW*A0&L>jI6qFi@Mxq9+sygD5V?@2Oq&Cio3;^)0)rN^-dhPA~$Z?3vM7z{^g7UcNe zCupvuK#dihOGR9Xon6ROF^jWGtOZPN&h_^<1se&NT$RZ^HGbGpmX9S6d8(3!Bo0NM`SO;i-!xx!;SaRVRqR-8hyjCN(={31ad`#u+oFt!X zE3!#;uJDwM^=P0NCKhwM|ARBE{P&?o!=tF74 ziGN9GSg!86P?nMii7(NW9b~B0jk;y`T3;_yYR5ozGEzINs0=l3xhNCj=h=Ta;UQL& zC6{5eip0|W5J9zmr{Q3S<@3I}#<*W_L6*Lrvr)mKafeR86UpUf#xikBn2 zd}JeV0!3a!`O!ec*3d0mLS{XN|0m5h3j3sB}Hal3;m7Rr>G%jemm=`}pX z6<%)x|8g{Tz(Jdapb4Yim5V( zwNBqgChg{Mo(#ObW=;0b@e|K~e~$7n3tX@S(b_aoDvLi z!u`2)-U83cf$La(8k%DGW?N~ZH`lGs#(cvluf)t}FV+To)6xQE23we^w}2KBZkKc@ z$7ySNK-%e-7-kQ`>d&Z_6xD1p!&n3SET0SUcoiqr1lwlNdRKpB%x?2;Vn#MjMqj&Yp)}sL6PiV8 zAv}ycp0Cl?Ho5Ha&Z7qq>6*S-9HWNkSZ|XkMyK?k-aJ;dM@96X&E$I_l8+wEC@7nF zP&84ivqsHRjUssU6@91ew+xNmHp3XM(z3L%(z{s44Tmk4>^dttB0D1!ldz{^`JvC@ z{_9>^*j&86v36a%Tx1zDCDxa*5R^RJx?Ce}?rwF$eS>{|Nt{9^3Izn=9@pK7=leSX zsWY^^JLizE?yE2x?N~F>n#p|EiZHdz7kNHgP_vFPbbLZ74ClSUw)MxN*8a}}3Kc5L znrG1|Og3(=na=ViS*@vGdEMPwBkLk090E1I87yfD@bJ^L)gy!78xS{C%gm(D4EZ_{ z>*^EZRNqhL-G-NygXub?heeH1=rzkHPyat;^S7KV%XlfvZ_sZ~gl=@*{q2@p>969_ zsT2*?v=&R|Gp_q)qgbxkoW`W9R}lT&f=GA z0Ze6i=FgqkAHuMI`p)pb60@PK^~i~olzDD6()yf%XN&msM)@QXPIWiQYwwnZ{+COs zD|3Q=X*|8E3Xg(JEniN$OuFDA&Gy-#hmIS=o6Px$a&qe$yZ3+UFO{_$;I!p=xt^}A zG>>vwcW2e<*I@W znKG4@*YL;lO2 zHR0QKwFY{MU&mUW60zmo`ofkurwjI9x$aCnF zp4s6EwBdG-qP1p81t|$83}i^9nJJ-2jm*nhU0EcRSm~ZhZ-gllbT7A;v_Qb-q28ct z=rsf;1tRZgJz$hXqFI1RCx*WVjmV(O7^5rsCl{y0Is$FjEd&%mlGEbX4Vd!zux^k> zjSf93g#3S9g#Yv>z(0w}5D5fu`#(|~kn|X(IU$BN2k;r9zgCJJ3aE7;5CMcdivlUw zp;z}ezivRXI||?^T7kQchr$OS*sB{DD={@tm{99_47A3_K`kO6uAs$GfgJpx-v`WM z80-x;dEAYWz+k+PLoQfh-6vp;KmgP!Uu+a&Mh|!(P6ap#2&Ntc`(I-p1Y8AJK=|)6 z7cr-Tf%%sp9NTeMPXw^@yO_}gBS`Q5kL1T%MG($F$Q&V)v(js1Q>C?LGi718CY$LQ z@FJyHgo?eE6lJACsVhvsuYAUc$dR-MJTa`sDOa!pHCzyP79eQCfm#uYcH=7e+#tuk z2LVHk8b)*EvA4U6gVi@Z1@t~tL||sZ4N+`6WQsNbzDt-TJBrr&zhs4l~9|yYDlnZi*}*M9k}(IyL_By zAGq=N4d0DYHs7v~y0=vyDR%Z2nc~Nu{tTaPL-fvW0>f)R3ZFY45}%s~e)xIOl)p;pce^~iqTyZ08jqJi>-5A-UWt6z=ejOCy z-}~p|E=NQYMf}K9zB^982OW3fJl7=H)>0MyRQlYwm$-=7l0{c&WoanBm$^B2C&><9 zQ@yAC8s^Kix+F+3TfE}Kr+lSmtbYfuKvp=-5p|{j`Nq$1^+kGJclb}O-=S|^Gn9n?2h`qJi#AE&6{lY_;-p`{G zZ9OeT)0EUnTTqfX(m$RQv2xI@mS_i4+xytNIw`(WX#61rHOpZNMp!eg4yXRPwa<5| z`Gsw7kpjB&Mn5VjqUlxn51nxx`1{X0!hBchH|Xs@MV zJ8w$SS()nyJjsXu{#A33J)57DKWRIla5@I@1ZxNoN`H$Je@!d-7{1X3w6WwS-d; z4J1`gqkm+~G=Fa+C7Kw$H)(T~g58D3k!!#E@9W0+x04J{AS>5@ve{pSq`o^bFU+HL0*Ly13+lK=wCE8Zv~=C>weaQMOf|De<-VW#lq;RS;&A?#W0~! z#q2(hvKq@v8CwK*Oo3+iubCs>#2o7nw6OlcATwLOhtFL3&kUOto)JaUs^|~q996}Y zW#&v+`jW9fV}xzRiV9{eAANuB{>-wjQ(7I&nG9<%rufq@p1D}Np5 z+cm#Rv$C1Eb@Vwd!TR|Jlulvn_3n{VNJY6uNAQU5W){fq)-V71U5T63*nt=M75m~dK@s+fJA3;G=_#+=Scc`pn&E;Kftn2agW%SfVWDGflur>-*Qx)xS=aGq} z^9?XVlD#xOLL_*))dHXbznV=RB}Z!+b!wtEM`sv>ISUKTyNYyyGljK9hkR5T@!<*8nAN25Z9#i)S6z&~C#0tIZ^(o&|;SYuDRi11%jHVKZ3z zyNHV~?B#Io@}1;pmkeDw#&GK=IBzrE+Ac!t6g*UQoQr(QN+oH%mbIkVT_jt(D6=^# zzj$Q~+KGiGJ9LUA#IW9J9ITaKA#%2J`l0elOm9D>5V>`hM4-Ifc!7R>%#NZPVkXSN}cc79(L#_%^_|h%a$)J`Zrt_`~uohN~xasIV3bqbc}&vnPYm4 zhDhIi7(ez>Nz((Bw_#~SBCoK>a_>xKTwp`>DL?YQ5DHLAQ~A`AX|zEy!#%-uk92`4 zKcOT?;3$jR`Dmm_2T{1>$bg)4Nj^P2p;{r`iru@1yikMaFL@qYLP`HlZit~rBIK4a%pytSceVF>krAeqRTdPtesr%-R@iI0N`Kz>C?hiej=Qqf!l#<&rRXf) z-k)3M$|X}!aTZNi#0=%3r3xO=;0ZclL3q4Sc=DMnd^_2_Tft{%o_6|C>$yvnRnODneqj7DKKBAVKAbV9meO449-66>6P=F3x??~y~Y_3p@e*%G{WMG|n=9`lD} zdIierLZucWxLCVHqIGMpjS?rm-~MsFe?`F>G|;5_*gCAp#{+Iifa4H`j+%fL5{Ubu zn1^_A@IX2S6w;#yN-YpfClD)4Hz^h|2BH2>7%~J@WD9=9z|$`{6@Z_{1QQd3tTIDF zQrzC|-b&nNv*CUCghZByVtF$O^@Lrn(qMM=Js&L*f!?VMYmvrQE4@e4sKS6LC+SMoU~i3OwYSAGr4ra|o!;usa+Bfe&IGx5EOP{6 z#AFI|F}zzjWB1pb2wnP39E}K@u``K_1S9y-c| zSR^MG%32M?bzp;E|3NYgr3?>p1Q-qrwMx}j0mxB|aN6PlF2H{PLZZI;UU4)Gj`RJY%#q zqD>9i>>I1pTr0&lwQ22OM*RsEeT$QKsytacLN!~M31P!zyWI;T&~Hk0B+n%@^dQ|6 z$-vhGe%4Su7K(qW4b11u9fFS*AqA{EY7N|_)dt8AIqIIzswsp8j0)hB*h@=L#7>C9 zQNU71VFL_qj=&;j$N6N1^Y=rThHsSX#W7w0%yoh8&P&k`G9kM-UT37Y$y%uXUaZM`2>Or#^PK91PmSpo*zng4s78_3@nf|2g{zJ53;ujS%JmPYHYw<$bM+@%r zf)wA1m`tmsCg?^*u;wHe@1j5$nEYf^p6Qzsn)KL!r}HS;jMN`AL^DtH+cc^TmKzQF z;9V#bc|*2pK2oWjZci==s{aR>`Xia_%9VINVDBv7(pp39iyr<87qc2QoqeG;!sA)a z=t)z{UkLY^X0a^TEXTbZf0&OYrm`4!55-jlAJqKmbw9x+39YC``)j2Vhz=Fz43#5N8GjGFVV z*EIakG|{^*8!2};#OM(I(oH0}Y1{m0`1IW2qJ7~>W0sWq>(8bk#wVFHt+sg<=<+q! zO136K`gduxUXxEHyl+QMl!dzrmD!mTG%mtF%~xrTf7w^5miQF+K-t1*d_S6X;0>xb_*l)o*p-SBaxTr@I-ZxaW4PVLE*v7=@1i1qcShI*YaQ( z5|JVw4=cLMa7)aD*F3FQYBV=7yM^h7x#Z?4v^28=%5kBmEjcR$a)u`LD+uu3( zrm_?we`7mNrh5FHM&}x&$Ps7w;d!`vji{W+SnoawYvsa8C!K<4xuq4∈r0I0?1) zXTc@aq(Dn5|Gl0&7jl}i{i$uLPUPIMB5B#aL~Owj(DwE1?j}1wS*S-*+K-q_swk<8 zz(DANdMd3b>}}O_eI*qP)(Ugrqv!5rRdO{(9MXaaG4N=zy`sam3aj+lD=8-O$>$wV7r2V~BcwI4@+{kCHs#=yU9kLLM=fCfoJ{VS& zbk?=r^LzH{`@f}NQgrG1omPD&m{$aKo(&&}! zuWCZqmgnibhXlGv7lL@-4!DK8gU)EvZ*~`5qg-eE)-5!WdIMSV>}d9<;s=E!#Etri zf=lJ8Xrzgh&>!uS1LqELVjhd+x5aNKsA+Y0DE*@b2^8&0qaD)1O4}}xch2KDA;||J zSd|F%uld~?WE?1HFjmc$Ne}ZlY1MOnjs$j%pG4! zTZw_QHqH@6E%WwEiNYN!GK~u;t%2~l0ccJ1*>l8=X|>O-OUZcU`f3G~U?C3X5$j$< zLK(4srRSZW%!!9zYY(?Qq&i?xS9ZIkoV_g9;rgN1X2uKCFd7YgI~cX-bKvNf^e*Og z#fFA?sFn_wD?**oIR6jfYxE&kxo=*&^@%ZxmT0u_ZiY-4%O@5kLP2Y$u zYh^xi=7$dh*qteA`O&%0vy+SS&~};~Wkg&mSG!Ud;TmHuySMc+vUEk#xj4Qi1Q$8M z1VuH+iXHI^BiRpC)<1(GoS6KiI_+6BWS}O4o39&l;KZlTHYJpw>w3k}- zju5725Q%oJLq23 zy&Ig$j4>|v$vF2`DHSwkUQ#>{*I1&a@v6HgC@3EGqFyPj#5Na(SP4=RCqdG0I|a@g?(u#}MTHe@#ume~asYV_J z(zXB)1gXYAuF#CpCj4iU19%YVV?icF4hU(3031gL0@L_UO7XdF?A{;(WM!U6DJ;kB zh9{AI&NwKS*B=0Bdsw2=+#O&LvxeD_YK4N1yT}+K2tM`+RthM$jqmml@WD=X+{NSX zB%lB#Yy6lp4nh%t2O(m3YP?6;Q=70Nr(D>uHc9iqKe;c9v^7ZvdU}k|QWWG52P98n z$jPmO?H)yk_T)tpoE)o?3<`LUqLp_%Ej^Y$AS+4Q&{L+C-%+a!7z9e-e*~d~HZQdJ zr~{)S&|Cz8{@xadJFz+@#EqmI%N;K4=Z$JYL{B-{ce=)+||Am+TB*qvZ_W$G3`=9Oq z@4X-Zj&%$}eu8RtyB3K5^KK04#K?j%V2&O@&ZQw23MCZF1`6!$A20=q28w?t0gjC0 z4>H$D8X#7B7C$ltQPj^Fx z6gYh-{?4ZaJ9Z1L_vU0h{xSDPN34m;<0mosef&@j?%kW;m(Ga*w1XhV0EyTY!seQfkc;WO_(6XPW`Hki?sM3epQ>|6JqJEtxHhUGwU2os@<5=sOczAST@Z5E2Fs4&Ir+52>l^ znOJKr3bzkH$&1;aAPa*P?s+dWSU+6UZJ)_pV_}J~Ya02rNHI#`a~~bz*tLUQ)xEE( z{(b)XVF%f}ryGf3x`ky&k{z+LpGwGX`F)o9H45A#I@DKmALU=Mg$%E?e_|$qdwWIx zo(cKM>HV3(ef;ZX$=4q&0j%RbW@Kh2!j~3*A*D$#JQJ-SFS=g*PWXhLn9F|m^h3=Y z+vnG8IIKe^Eib&YUXF@Ok&V6^c?dMT5kV0_&urd-m#r=x%C+KaJJJGMb^kykh4AIj zAx^jRzS@^oes`882s34S>k*U`;uuW!@Q0-FOvsk2h^&&n`?uBa?AOy*jJoz3G9jab zjy2=eD`BhOalLHZYHd8#A6U^DV5HKg>D`k9mb{*Vc__sYT&{1tictatH>M)@@iqO?Gu z^pGWFZXPT|d;htYH#z6_GLn0xgBE05B|LP|o4n*QQ&-O=_s^S`Pl|dwHty*;)>yb; z-SBDr0mGTE#%~qYo$V(pCbqZ#Bz{Soj^J__FwnvJwMKzD|H<-w>*Io4`a#LESS*Wt z9zu5&m*bb*_n#!!Q}+`X(PRGE_=gi?g?}OUZGTsK2FbtMhn?=Ozx$+2hmhZtv}B_k zk?*2ACOPi^brqL?XdPFLhHRcYX%7r%%F9_&9{S74My)V9gk0YvFW;`NsgO#0_lGN5 zZkp)(`53Mn^H-X`**Iu3h#6p$-_W-BqU-~Qo+upLmzGr%54f$vJe`;(!!QzmpNGd)4E<^||kxT3i#=wLfVaaGa(I znK^ypxXp7u76fZl2yOm_ye&yq82mi(=;mtbDs1{@n3-8}6~itE%KJ--L3KwfII%^mQ@K!5a}D#L}j3ne0K? z&lYu!UMoneMaT1v=^SdCId}4{;Q?=LEaJ)e;?mye?`wnfmV#IfWSCl1|3%#I>{k?b zaZ{7Z?@0)ldvZeHs<;zhmw-}L2V$4=3W`<+qM=qA)h1J+#7qT6YW=W zHf@rw(6<^N8}^sam^<7lW-L5Mv$iwQ4#J-K4|v>BOjvY6euo9){w@_{0s5Vb04zbAYU5*$nN}B!bf$B>qm5jx=86^jml>0{G+EcHSdXKHY z*&Y89(MGp&XswK=Zo@RlTHV(yeGez#pVEU{X@QOH&WRjElAC%NC$vTM*KPiJ9amOo z=anvLcKs`syEQX(DrcXaW>Q}pgmkjNn39|vX9}FeVzxE6aVZ7X)jI;i-*xu}=I@Me z+>`&7S}UK1*1+n2o;UpV+mdZ9yu@k({0(C zR|yRb;F^7ucgt=&#bjBJ+>&PF@vd#7v;5qF_V;ge2}N!AH3}@`R*KPSway8?BUHzH zoB_-|4!rYXkBuXO*&9kMXEQ*=6pp4}6pxoT(vaEI{BB97n%9_BvA0oV1^q#s6QL5+*eQ&;Wi1vJaX#;Qc^q0+XE;30PkD9#l zWh{1Tt2rhe(g8!G+jiccwyBnhj9R3o5@`#fWNcDOqAn$JO5jxbkE*zPZVT>*Z)&4D zechN`e3l$1*l8&XReMhH5$u~1(R0AKeL5rU5I`0^&0QkW_SvVj%vniE;R7Gy#jUK& zczYKU>kdsCIe|sR>2Ec4$HF!?3sH&d52@dYw}xPQ@aeY?F^M&&hvu*{H}vS?g$H%h z|EDcz*t=f{SsUJBA!oqqyJ-SNK>2Z69|6F=rpJPR+D%I5&x-}9Ud(bnSq^BN#+vjE;`6{wXCeOC3##tgtna4O zFX>!4q;eyzMk$5*Q$%j>t~%(?rnc1&#fo{}+b=>L1No?_5Mf&QJTlLo5H~_}N~Cf~ z2OwGujr;(U;){i0B7>)(lJ1Q;|h zCDmXO0G=;g0$nAv+3ps!c}jmt7Dy2S5gq`a-vc`a`=cz4_(%!(TNIY))c++@V@TJ3 zyrzc+2uTHWD^@oK9UpWP!~-WH0N=!FO1-H6&^bWn|KK>rcZZ=>F)Z#s))okKV*obB zwgQGe3|{}w()Uku050l((D?r{z8E3$O%NRjqU?Y&0K_j7pip28U{@e$>h_T|1;HJd zggcDN7W1=zf?G8(4X_B(4GA3KTQ*WUlW{|V$QZ8OPKNr8b60^*l3V-x1&$dj>VMU09F6u>;?avl`3f%_yk z^EDOYa8|L89amG98?y1E%5fXjCm3@~)W=m1Yj#j_4L9@weI#(7@pN;@ZM-4KFav}! ztVkRytR4zk1#yIi1ou!w5IFDxo?s5Y3+6zQAq4?&Ktf4O8#^gS8e|AUX$4sYbB#YJ z;3jnj$^uswoWBbVKln?~URl=KT_0-K89d(I%tfW{YOnF>A2tuRrM~V;@cMDVlqV6t z<#ger{fjA=W^d0`0WLkx^vegQ-`|oZH=J8=ks>7H1Y;|EN~bdKSZ@ zg?add&YRquC1W#Zu#=h?jb>1HBT1M9{8e73cM>$OkVtFH>L3iX?*#X|v%o!a=63Tv zgtJAp1I?t39>Go0t+m(!_|-=PE&DB#i^o2hr9Rhq*K^1Ca#v{-pC<@M-RQ9qUv#zj z&$MPf&$7?s&4)YbB1>FmNb0ooB)r~QI&Z2U^k$v{Oidac=%0R`52M>Gd{!RVUi3U5 zn}(}v?z-QT;X)$070r(WG!=%EunnxgwBy>JB9vo7drwXW(B?)K9YJM0lW+JpHSTel z*gqGFWJt<3!HJv_&Q_L4fh=hSlgija9mvl$4nL=w2MM+@oWr}kX{Q1zm7Cg)70qKN z%aej$lE(2^U@JD&>Y(~!N)oY1p?5Rp>h2ql>gFs9Cw-8KI}kVDuf8xVH&HW^6Kv}B zg&uylcs@~X#NF*oDE0b)d#|fuQMOrh&@5V?klT^m)ba#MY~oLDiY#HFu_pD|ifBZK zZj^f9;8B4UArcY&<$KU=VwozGhKT->Lu?q@f>4E)2{pn}c#kp{kQP{uTX<3U(n_^( zGqnD)T6=_|ny*MelAg2mZOpUZV~UDZVXQ4+k;p}=<%T%RDdSfs(FuZJV>$!QAs^_e zSz>|J6xzSGw=MR7cm^#S-&Y`0Ml|2E{o;mr{(R34+YRxkR)0CS1}8F?Vea95tEpT4 z_7W4Rb3;CPr;O2yhKLt=e(1+mjAg9l#AGgmRbhcI@@Tych*>$R&`~AUG+Md_=V-lG z+zyxT95nNN11uCeK)*1dn+0{Fo6$q3?R0PM77yH_P8|FYA{r2=k7a?djMM!6scCuV{M$t*b0s;bJA#(0_Jm>e```kb9;lO}6pl9v9KWi-*R`%6Z8V>{!d~hKCVszKneoUPI zz=*2pYoaO9IP#TyVH6`%QU1uaW^hk_0o=qWO#gDGL+U8K)y_G?zZ^&8rM-I!bvq~XWss=nHZKpW7`Kx&R+4fqwVIk*C z_?HoSx1%R9pLCKOadMWox;=s8t@x^bWPaA&;OXe(-lBD> zKk)g76#Z1~C>0J%L~AYXzVt2ux1>h1Y*O1IO{5F8ZTlF-dfcwF@e-np#G!v)-u)U9 z3HvJZdRJ<}%@bbD($3S0r%!Mk6>FgJ(YrRlNKhpC)33Z2T;e5546J3+RI`d^Mq&8v zFCP6;XA*n}Wsv6ERwb}J)%W_4l!yA{@p84*?~$?`rD=a0e_?bejyYzU>CFMs`3v0d zoz}v64U&)7Q6=@+*{V;$MFg*aWw>6ZgI(;ncq5k2d4L+R<3?oB!CkA1D@WM-#de{B@xWdsK4>V(@p z;^SFDZhbh3LVh35Q03f+AXIGuZP~uK{9u9PBHlL3l2YMv?siaWCc(4qqyQPs+Y#Qn zQ$O7%5!)P*@GZ)i`)82DpGvPfZxqje;hM1Aw^Cy^%;!i_5x=-|Y!-G*H2#gZ7`y3x zzC*}eVOxWDH!~wtK9=Q6jvC4rv#&V0wp3Ma@C-xSSE1T7skXXORT`4m zr0l&#k`er`=j00YjHDZN;g7}Qd6RJ~`O`Q)7V=K84zBI`4oLDs;mMiyDX_>^hdm{> zp*u9Vl-n(&^hE}lS-E?xo^=|NkEqhH*Y6Opob0kLaB(HefDs?Gem9TKr3t^Zog_dY zjTcwush+vlnr(mFen&6K;fVLP#(7IYG-SQi9SbRcD7(EAhi+8g; zsdeEK0Oq$12is3{JOc1{IfGxwoC%31$bj987FyV_j?qU~=^vD=_6+zk{HT@Jd(B%nU)98YbN9jBoLrx1_qUs9@YW$6be*b3tnMigC{VZbyLv* zOyK?j5C6AKLIueE&u`T+x~cH$aUfDH0U<z+jHqvN}^zSN`?r#b*9*8Z2cY+7vA7K2|eg8^Bv^>PZ zhk)g8CRpk+ZG!W-00avlqd;%|6=Y~F`TyJKf;YJKL010?!xIP|854+6V6OnRDT;t{ z1$k{@HvehWe?JoFH*`*LH{^Dz@hoNK3GOamzf9$6k`@6I%RB@80UK!0HY%P@A1d|R znuK`V?hv%)_H@Vwg`pl$m0P%b^Ambi}heZS8GASQ_1g z-xd(4ig-mD7~tFapC$!p=mDBUK<|G61xxc+r9vBUr<1_<1+6C0sn|rBBw6esPbmD> z)7_-qiASf8jkByW_A1RN%ItETzBJ{8l9y`5&ca3U70(-1BE%{`z>C^s9V5`fcoiaw zg)#3y5ON6i`6Sd3ddy8Mm@(Am0YStxJ!Z*YKmfcM59mrSuy$|Vgy4f`8WX60Tr@$A z4WucM<`}pX7=-{)G3WzibUeh?AQI!B>FkcLVQGa zyFX?c?Q&^E?B!!~rt-4x@%#>DJ5=OaqLsU5{U$Ej#LxTc)v8u~fPe^&@b>+GAdcVn z2k`Ai(|PHCMZ{MVbg)41+lGG};^(H3b+~56Jc&lF8z14Phi;K4eu2z~D%+5u(1T>>W9g)--c=@qhDi0D0uqa3lOA!%zsB zX|VwFxi8RwlUyY;>Q9qCUU}~sD|~DoLV(XWBCirT+S!$c+`sPp^Ih6P`mH~TR(EQy z{Jz93-l0zE!8J3<=*5Cp51hN=92f=YYpE+4`ZtVz5yPK$wY>WAbS|j-hQ~|VH^zmc z>2vvFxrMiT8gJEXQkbWYe)+8UXtBp5rZ02>GAXx5V}%B5CZCHKT&F9SB%g_CM->ZK;H&{7dc>Cz5kbn?N{HPXj9qB^|tuLR5pXp1VlDS#w{j5)S zX0{7=w%!I)o!mV_$dut9iQLyUi`<%57TH7P7GknT^DtXrC~0{?3p-h4lnCrAc)pvG zOiPCFKv)P!(`5rfS|DI<#B|3PrWMB{|J=tz2o5+K(hv|;dETe+6nIk!H?Z1pHVNgm z{lLF5(zs5CeG%v@5Z!19(Iar90A@|_Hy;d;6cBtHU@#Sc;32?!T^2MgB=~oaf4|E} zd%&qHyB&s1O&H~3$eq`eK9`}swd&eR^qv|~b$LB|>7{EGm#wExMSyHu>+MRZ9tS_QKLt~~T zu3%B&4kn{ZB=^JI42Z=DNw%vS*CH9DA{~ck0|HrR$%Kd^1$-ePFJvys8gAd*I)nMf zeI;n*M=tAs@2tV{?PYEBLd1MX^rKVxR4S9661rRFHSSbAhImSqa|@?*e*(JHUEDL) zwW4-4Fg62eJ0j zpgHkrwO=3y85QLx>c?ND+F^$u8i(R^zhuo1beP=3W9K8LqGqiA)qcMC4Q(6{g~PU5gN zYPZzd5E7g=k&tqb7E+%pyHf`4G!e*W#4GYz=0m7gY9+enKBugTy_1Nj97|pX>vsdX zynH=Vbtq_xzlC%Kht>;xgNd;V3+%k1k!VG2$-`5*#urtZhHj;ef|qNjun!Z1Tz#MY zT~b58hVnhlYc3H9d+1oc;_qI@(f(48)$UNEaZKGBqT;Ra#|K&ruS#eqQ&~;q%BUFX~Rn{_O8-+i2!g`LcbnAjQq@bOCSvrkMu| zgmv>grA1P!eQ{~-+br?9%xl-G8)cnQhT*MHc8vhFL{am{W3f)KvJifN5KndyYby}Baun#a9kChCzD7w> zoJeWcVHZ2Pv)S5>+G--HNb|$3d2G)v%oo>(YG2;I8_>PV9d6e}> z5jzii>es?s6z(CRuXA60nN(EQM}Gbld$bUw4SUZ?!pqxwsS~=ie)|m-NX;<=7pYRR|OhC86#6|4Wfe0o~@z3Iq7Z}P$R=WO=?$~U$dpnn%}hIxAXwpQk) zF6m0++g_;;Bj*;bqr1^Oug;%A{S37@^WT$9FND#8xf@vgA9g1F88d*6cY(F1S^_7)lW*4K+fhXHWdw>3{ahq zlYoy1tMF3@#(OkDU`k&o2ecz74gRYiH?={$QzfLobp$EBQn{0~4QCXeuk>qMK@*;SwvwBSI`vdG&*R z9aeNn1^=ZV|0Srp0QyCq1r1&Pzq${-BSR}bv_t2Aa&2Z6B7_bq27o6fa7SJGZS62& z4X#2!ycbwC{(aoPIKaQ3i$vHyOivMF1_4V#aL^~P!CGp8JPkxEMuL(;v~Bu`uf|dY|1ScWy&y~rtN;W5O%eO|>p-s)|Jxtdp_L`H0gwcn0ubC5Kpg;5G9051 z8CF-=Q1Wm&9p?mpG15uI2Oo7r%pK8$Y70ja^A9R9_D6(*tb~96v><2f45M9$ttz}Q z0^uh^cYn>3w91bC=fDj<;Q)g1cE8*X^h_t#4A*djEIQS~D=$=yne2Vc-7QR>O~3F# zQlh)lo0s9HfsXM*WK0nP4ix85`YO!feyCw%27%~ki_*LjSAdAz35POvgePt@+|3f} zcp9uS<0nwIEif^19@E_5Y@}Z-A1jS1%KVt-M|APAok59qjGr54p)?J6RzfjUg?qam_;lkK!b+^-3fm3`b#R5tv~|w2xKZv z9WovW)}CHOq27I>oCa^z6m770gaHW+@kHlK3|6B1t@}VaM~V|<4B!jsp8{NIjL>fI z1%l;fXiVIQ;y*LKBE~d^F@#zv-;UL}cAU%~+*zJz@Fp<0-*Kxcs?+1nyIY6!8ov<< z{XPleM|sD0Q>bMu0)rjv0guCMN#N?Js9#YVV&D+Z%ajRT(Reb}e(b{}n7+k4aym2Kyk zApat@J9jmm0G@oRMMfH9{KdVf;>7&m#`Rb7ZOUpAlA2(vhm_<-yEwMBDkqY~F4|3P zS;%aygf^&@mG1W!cTQ%X&8nznwA7a<6T)T-XPtfgd#lRA8&yehX#1%Xz$Vc3&3KdERD0?c`8Tb;&9S4)L|AbDHw zpCsn*;^c6a@3tAg4vM0sI#&yQv6_`pZScA2dhlhID7_{k3Mm+w@|?0L;uWv@(@TEa zlUtmcvUT6Ar(J(q4MK8MjDd>pEhQ5T8I~FON>Y$p_l(;kLudKfhlajcmD@{lFE3=Cm@7H`v8Sfu zT7ns+RB14CR6_7_H7$&urXjb?#n(>a!c7FZtnT9uvKBXyX6l@f{2nQocU=!crHQqo zXlg2p65SAt>nDo!m-tHd#rzOV$&v*CE1`uPPrzC@DlI{liZloOb=svAE z_CU>=>cDS4EPpe%xo%d!NAbE||Hs4SC2MDGwmj|M0e?yhE{m+r_j~jU{4YebzGuE| zwmLzYT2~i5xSPFYB^}+LlYITWU#$FHtwze$330)w!NtI5D6Z$~Mrqc^T`9ll6h3V-9|fcg%HE>AQZt;(jRV%X?q7vJtYZs) zJyK=cejFz68*{Wx^0eWB-IXHk_h0(*8ybJkjwZx^`Z9R?3w#Xlj|?6UxzVqu)7qK{ z>*4zHTJ-((Ja|YwJ^mSekC2q$kL!3q-$_tj+nm4r_{g#UQ|a3Dq*nOWq$=p`mG^yv zCAM#K{Pp=7S>QW)+{e1(?O*Ope=}465OZG&VY@_6@GdvtGZ;W7Wd0EL@dVahxf^o=qRAQ`0x%kDLCOnAh6j zx+FW9m^g=dxVJ0V;5|9v*|PP6d!eY$N?Xk=DF%nobMlYG`JykFSkB1;-IgpmnOG4{ zx>2rGO|t6#?AiC@SkF*L>f#NfPWdk&`>k*lRUA9?`KVv)FO^#w%_Q(d5+a4Y4n#P%5kWEAz zEIfDuE6_@*0i&~DS zUSv*CNQkTwtCoD{$}u!m^IoH-USQJc{^cIA_K94&zP|^@_F6kLv+AAh8_YJWntwPNfZ)G!!mw;pA30O=4n!eRH#3Y z8eX${C*=AR{rYZ`!^z&2gK;*??-cI1lgO5xT&(61a;#vBOb$_XVTiXheOYe#tG%|> z{Q=S9nTBlWE?bv%Y)WAPhnVpxEb6|Q^JH5XnTA=)1_v=@329r}&f#<_av>3KFxa;? z8|O|Wjq|&P;11V-mUXTCysh)vbJljx^mhyu4}VSEm!8j^A4??@{Ightof3THZm0L6 zjePmx%v0hihR);>?6Wpy0`aWJ_x;4zY#;~SNT|P2 zi02VU#EWFg4O+&ZBjSg|X7LLz#L{%F?uoWPuhm_`vJ_Yr{qArZO-CDJ{}6WOmI)DctTQ(E;DAqnr*q7pi^_OI^#}H!kEHm=`ZA`C8OgQ<{@ovI zUwyj~zR+rzbK5X4afQf3qWRsXze^^2yv%s#bjM%}UQ4anE>2*ffmCbL$A0peY3`w5 zNSSa{76t=Hvbq+gr>DlT$y@Huy*Z!GNrJ^i_OcQblkz=fW2!SK-|W$cZ*!gzl7&L| z7tJx+pb9?yxx7#$D=n??=Wd6=)G;{|(b4BS74_4#uo zgbn!Gl(f+)fPL&FO5YT@>&MUPLqI5!wgEJw374o~MO zfRlhx6DEja=^vO-I}yVSQvmIH7q0R%E-p>{Yz% z6T$*dmol#SVrnZ!1qzNQL-)1~hD;kZp)4wvt`EU~Ax! zotdAZ}*mRoEysW553u?$uLCP|789fD>aA8FVC7&B=Y<*5Lb;1dE;p^0KGd_u;kp>mE! zudvF!IyP|$Lx@840YEOJ2#92Ev4#SzV~ zMueogII52CA?f@n)8|yF2;&~dDGMBZ(mRmuB^8Kv$%?9>n#-g1bRm%G6q=)1S-WO; zkz5+ku=9yKw8oXYrRfiKQ3z1#Rlkby(Lf-)pGi=sPApdGQ8uvh*ItEnaMG?^1^1P|{-ax` zOrg~_mgi&H60wZaR@_js=gt~&MFQ^o!+xW!j@ilnXE|zyz;_if+uQsZJO9Vb%KBOp1XvlN)jNE%+=ICf#WS=I5Aa_7jvvBWw*aq{z#y@*Gk#nM_lZ^e;sCn$RElF$r z7;}8Z$`!G^_m^)n%?eeNu+qp;=~-&m&MzET^M_6*<-ha;olXz|FN!9Af1{yjo*nHy zjred?ap0>G)T0~T?N%mUnBf>o@Me?%>wDc(QZZY6oj*mo_(pQ~Qyw(@geT+o`sihO z1+bKHfr>!A*k`7J!PbVcQo{_KQm-XW5ObbkX>Lv9pT-R`MAdSVSPa{>3I=yZ%yU2P8M8Hnm_3N5DUD>|9b!o;@-D7(O{CKr z{o!Ud%-x%c6xGtNnz3*W@q3mEdmwqvW>IDHq#PPw-(DA7%*h~?UvB&2f*{)?`>Xmj z$Ee#CRY!x;1=}_=(lsd>gDsaZ{BSBw5SjeaJ-9>G|6;20<<58w!&%b%?Fp<%7nuca z{_!uon#%5yWgI+}%a05zv5=lyq$9D(N0Mh1)25T(mHLhJqxV;l0~rm3XKrw8mkxebI^qWQaV9**fX&!?0~e(!v_BtQM!*k?krwN88=$DBLg|MumC zfMd$hAM9>TKlyH%aM-iObGH5l1|9vZ2b2gbv?wc@H@TJ<@3vI91cF!wF)?pDTp>Nfa@Lx6pD^XgA}=gP3#v#lwXpamy| z!@?ha{(HiEmJRivjOlB;NIzBCa^29Hq69gA$eyukX*_wNWMamxzwM7hIWWURTuBh`_54r5ZE|El1#L@MkvXdmoso{MUw!k4&{t&p2BBl_Rr^+<)Y% zdG?=u>b|oRj7jcm@t~@EOL<}N9ivlHi*|@-Q(6+?+JFXf`@y;N&%p0u$iNXXLAQM= z!(dhlH}bDMTu=+6*U%phe0VhF)xE~-30#Z6WU)tE4(^y}87vKrK39&5RBNfAImc4? zxMwsQA_=?VPrL|Mf#0ST5-MyRU>z*6*H$vo7yVhK%lH%}A_xG4)N1lC@zz~MYTnF} z6(>lc&(->KJjUIj3?QH(;o&`k1o~5sZJffy3K^1w)$9!So}hI6+l=sg(4jlz45FrM z3>|LkDy7T0Ct?Dk1tEyBUi`Z)3^J!qQ}OzS6oKJ2j-KD{_IY@U?PN8aOA*t6;AAk!W3A9U-a3r6V= z7@M+FlyLC%nXghIdSY$=bZxONz^hq89k;ze)F} z*yWX5`t&T`n%SvdF>bFkRsg39wV+{^USI-F(GVfo9=uIcP(C!%LET_}z;3X|f4*yT z!qXjc=oE}^_mFdRwkS7L7SF%(VW*$EP(QP{KG`oAe&b*0ZY zl!w67>;y5R+InJE`F^${jz-QEMniJ%)EbDKPnU5`56j zmHy5cF_$|~NAtEr!LG9}cuG6IiR$1t0PEv9)!sJClI_4)T$waW63Y3#uJiJ6%otTN zVe}~qsL#z5F}rg)B-&1zuv@qE4E>$7g}4xYJ<3p_NAFM;DnryV9L)lPg;`mVRHe0L zsx-97H;1=qIR-UeuU~Q^l_{gojz5t(E*-y;-NEPNE71QV8g<>`gsC*ABReox8Dy=b znJk2LmiB@z_K_UQY_NL!CVM$ZBIe6ElW);Sm2e+k(c~fiZhZt2=VVjw_aoHwV$BBy zg5=Mn(!UQiydugEr3l(rFM6Xjwqr*TzX-{aq#}u-eu!$Dw``^gDod}n0c)3t5ZWj@A~5Z`gj^(WV=iE$OtwA4yoPCk}E9EhR<5pf%X)A95J z#+S(S*0j2Tt`=4WN>8C-rl1C zc*MPgdi-KCr>F44l|?ZgWl;KjR$6gpxmGP2Y@@VuOjNZek$M@iyoW%vBb(xgMtq*x z#5?VzMfKcky| zzKPklf=QohL-A;Z?nIB<4^iOP4> z#xc6mhG+={0Jn#Qy`99t2@M3$=-(hLfWZEZnK+3e6d41UN(+_WSX#gCN<(D7=~nhx zwrsd#h`v`P1OO;ZAZkpVA9`l6hQ?YHCV-0%y1WN%kZD|%dl)`5$!Z%uvnp39B`Kq1 z+j*w%B9c)!%Mga=37SDZyxYUcT-^0%Pj?Y`X9hBg$La}+B*|V8$T(70pOr?mx$Ypc{a7sZ5TM4=&lY>BsZ;(kxf8IaF0ovs`?BgG4P1uJ>6m7Ei_&WcKn2Wzzc~1 zzz{G*fG}qv@ETxY8T$ZO5etTjofa=bctljU4=Nv(3q~4JMX=WI1D9s-neoxqNg_1u zg8z4@`TrasKnAZmiLea?nzsNG2s#Pw?;vy@azMTcQoRZl0`>o58t(rMCP2Xc`$@3z zA>!z->l+wQAlhCSWJ%cSXyO=9EQ%0CKMEFzJCig{Ng)aPDgamyboaFanid8yF)pxQ zf@ugi@?1wC=VTZQDHXIsTUENz_JmYEemN@64jcn?HEF5DF)wztdejPYBMjf2tWx&p%O@SAIhVD@?rv#{_&B z?*lUVXcMt!A--gKALe+cW8q9k?Z@opq4-RqF`Eph_y-K7BZ?Q=5KpOFkU=X5VKPLN zvxA=~^z{fomd{Q)2Gxgvsq7;US+68J-Bx zvBF9QB?c>efbW0=3_x##)aX8RB%1=%29&S#fx8VF=>}(f8!(h$;gdwIN<&8Irw_F` z8;#thh#Lp}R*b~hRCEd}6*pb`O-q?zA%}T<-5kbQ$jYrb9wQ%A7IGKd4ep@~=Gcs( zC2b%!k3d^mWS}Ulun=uoB~GoTz*Vfo!6RsaK!J;u)1XhR3|tu^;Z9hQ09-};97z@Z z(1Wc4gdPMdvxI>1m6CW2GKkYA-2xLt1sEUawCBwGJ??&!z*WA=>HRRdE#&=N<7=#% z@wjJbJ<{6EOo-T!`!wkrM`fJL4^DGG6I)^dtu&O`Lz0>S%`wXa@+!Y>wM02%8Jyu# zY>TxY@cFqL?t`T4SJqWy8E-qv5Ti1tr43K86@-5>m!^(z@(5}+AgthJP?0)4(pU9m zkLI89ce0;LMfvyNUH=9(NI7yt3U9C`$+s?W#Jn+>NaJ+Ha@(m=2-@mIkd}O-DG}Tr zPE#G6=-CKPYQxiW^e=nq&acT5#ME}@xq)rntTv64&!}MW~i}MJYHC=pM8bY0QN0WrhaDY+#c*3yo$PGUp5n_M(NE0pG*4rq=Si-HzPBjgy(S zed$ygr;kJhZq#9tKF5{S47L56N?-k)O1s8t9Bzs_Ze8n{Lo<8@36l*q4t1PwiIb;n z_xVaLDLxMhwguM{FVf)DS|yFA64$*{iGyD=++03W3C!1xseLy?$ofOB@+9b3dh|l=iSzo0>6AHfd|=UA>-$ zxA_t0i!l$`0S(;;bDXP^E1f2{dcV!Hw+bHXuxH3vTX7gT=JCOn4fH44GM!mzdKT>5 z)W>MjeBHEU#@^PC#|c(wGq|MBr;+cKXGFLD66q4pc)P0LGc{>kz8*wu$Y1p!1othk zl>UwI(ZtS7(DYhD?&43~SpPJQ$@xo#84*FMl-=66+aZxZ+b3COnIB;-#ZIMLDXG2J z$}qq_UZ9_$al@GL}!l!CT=I|m_#2`({B-Zd^s5R%3lf>+N z?BY2Kx$!>CIK_Fa1ktudKhi&>GGcfkr%oK($2MT)?K8a{ zK`30~$%}1_>8egi>KkwJb)nw*t%M-`a>L&(W_|3X7@Ohm3N+$25Q5*NRyPSp6x8u|FX&Wp zuq0v4dEni;?az_?%vK<;=&=lMtRv?;O7SPfN?iuRzTJvv6F7f_x}~ZfzbFz@sx(^Z z3`ja6{&UDlGk^DCH@1`z7cU7>>r-;he0!gi8a+K%Tawx!c-R}S#g9SJJfCf+*tY#@ zS^a+b%%%!fa6++36?Jw{8S8no0_Pb{G9HYYUn?GP=4I;hI$B7U)(!pKy-(wI`>~}Y zL;u;(~|-BnG<^=gKRlB_ow*J5eXEs1C6Lu$@PZN>*4{YlUoE#ov6?rK}@3z z3WSLyQYYq;-PHYsx{F%PU7f(YLJE=tu~LY&OmB{0;rZh1@{D4toYOyA500Bh=<|h; z);NN^ICgM$T%OKd11YIW9CGXjW^*Vq^FRGOEgQz560i zI7ZcOM3yjL>~6dDoRZ+xHor$BiZi${WH*+-ir_TGJ2SWeZ(TulKs3Kx0so#@ox1j< zEh|YEMREQ`s1$Sb$QWDONV3L*j;~5NMQsxwIt^pB^h9z$ifV0g@Fzj$49;Us&313t ztai=^V1{&#Ndx?a+}4M3zb}JHxQV zFDmpA^L2=Mk6w6?Jgb>Xr=-jLr+vjm#ov9w>3~@A{yx>NNx&G$^eDP8n=!k&ZFjdOq$?}wWoJ`lq1RXGf~0x7 zYds-kONm%~$QS=10p})tKjYRnu1>g1sFB;=2qS;4^96#i{`k!=)|sdd<7IIW#6 z1jM;+%FJB0tHw(L`sucKS9hJ=+240&_v1zBm0abW)0#x2FqJkeVC+S6mud8zM$h;J z{azht+$z7itH!yX=zl3*-P6%fclTjj!G#9S^D+w7w^NpU+oE5G{Dq~~ND$@InaO1f zT#Qo938VX(K%Z{~?=MMFe}yyq{o+30DmYnJE3GYdk6n3?F#B2Qws6@%O<2mh=UD*j zC#{0{MbEZHrrNYRN~@{u5FC{feaYWXN1ja?94rg62~|s3o%ARsdu%LB>HjXf#l3yc z3Ax2_C6*{26ff?vPK9`hq_J|hywli({}V0RjEQ z+Ak7os)$O!@%0oH;OQLoDox&d=i{9 zmtP${V?8mFGGQxod9`R{&CSkg@_=``dacTey?;iGWY^*~(|vl0d$;!-dEGcNsHDdH z8t!mk#7z-~-(Qz#;tNEv4=AT`b1g_)$wQl%&d0^!o0Eo*$Y4oGy!pjv5AJDVQ73HwGzC?Xd}g*I~@bT0~5jPHe5goq*ol z+bn5=%0P=uNSrX=c4OE8OqCkZg2z7yrW1Q~n)9$FfT9Sez+B{Y4GuQHRY2fLW*F*- za1v1S;3Es0hdzV*PG3bmfdR#?Yt^Gj{T#x;6KF#u92{}_?**RRYNi)136%oTC?S~p zsA-JA!#*Jh&LleP4+o4Zewtux;Mt@_g^-~Kh`)o&|G26DL+^o_g}{^2pHO+x0qfu2 zDi-1sFd>mzodK;4<{b3V2K*_}pW@%aj74BbD+IC~2zPK-_zUEOV4zIF*$13BX8Il$Vq^Ompg$b_0Ym{);P>}r z`rFPZ`$Wcu$O{ysdx{86lC7nYs7X3fU3Ba>cM(5ym|xOBrp0E*@fvD`#7}Xi=$vM)!Y9lignxV|}g8&ohNiza!G34I%c4>kpAN zfMVH-^bteoDKdAkgvnBh3S~hYwP+u%1ectRi*$^Biqar_PI~Y}*J_)iU&ZYunNSH^ zyy?)&Jx=WbLNag}JH+T~fN+2T(+NF_0{Y7oqy$P7HsFG@(|@NgT=Wf#3}Rc0r>qF+ zcROGMX)S{+W};HJ>}KA~L}gxsQOC{ej?<28H~^uP`U|l{??Fq-9bQTEjDc8|NOhjW zEJ74UE}fRF1Fp0H$TK(fvX9njamB}C1^t!ug@hzTeg|HaoAmG#D3-A0CKecyLf%ma zYEEzVVT7W4MSc1~fMl`_mZ%MuFdDJ~KMc0FfZ+hnqWEMH!2I*|`x~XQ7&elPo5|K_b z`{$RE!gKLLIhQwfuPonGcw``Rvt=wiG+UVx+qKPZa$m#6hx~&JCXAaIGmq+7E_U~N z5*8lJv)L@8x~j<6$v<^YYU>)E$1jMn6nN+)H9bAmrcM;aa(+`l*k6*MmDZaiBhIWv zsWHx%y}|M_W9r%bn09S2U;7pXjl{UtH+r9E(+zYeuuxnOi>bP9b)njg)xV1a+m^2K z3+{a<<;czPP(9e5T!a75;-Qn&uTHGFwIhPT;`22hF=&CSdmnLgu@<+U1Q{zcbq#f; z>9}2nQOItcQbn@r`>$?g?AvY{5zzH&G#LM+ox>La@ohCbY++i!4?3(%7R*zDcv-VZ-(b97arzd2V z*0Y0}&GGv}RkifWLhOR~QWKrCErw15PAk5)+{IVV>s6|fPOTxTOfJuI zzi;H(x`^??|GH>!HmG*1ug11?qH5%JrB>MP~1Z4g5}m|1{)}KgRQTIn7ISS50%7{!rL6UiVMD%{X_C;;VCh9%5Qk;n^XI%xy@J z4#_J_{j2(g>KW0)lv)!c_NJ?K{69Dy?-R=AzH?D%Vd;D385+Hjuj*qLnUSxQ?H`$M^)OrDmhF?h zV{tTfAEDAau^@b+TS7sB&*BO`e~mKekI^#WTmO zw$@aYsaJ7uf9|=XfT%yFcf1J*UG%9agOSiZ>L(95Vyp^_q>LzI9`Pmz7%e|Qq(eD= z@n8_H_2kkTMZ4m#3e6GC3b?+S%n7uVyDlovctZQoDv$f#ORrZ}si|$xi;<@}fsT?! z-mMFHM7w1M*p&uxDtRVrL)N=hD(Xy+s5|NlZL`z-R=QkFO5^hVW*O#Ye?&dds@#@1 z3ViYe5J>hMk<{4XC$=VcxV!wmc1vcT!m>I>NIp}J3S8`d(B$|m38B498o_M_uX=&- zBmz+8g=K|^cpo=kY(CJT`=swp-RCwAulbRF?z0U6oW<0?(na?#Q5D&41WcCtWarQ#%!z8_};@pg!JcjXc@H%B|N{HaPG`VLf7 ziQt^-s*U9fnR32w*oR%N`QVt`5?`u^z zOe?2yO?GeME1C+(W#jsbHN$FuD~r;g28hF+ZpbOS83;Tjm%cxoC@GlQs~2cKSfru< z=NvEo9>y`>IV~|P_4T?=vRcHiVKdb_=&vKg7Ymmbg^^tQJ9>H_$$cK92HxFTd8}Ew z{-N*ZF84)@hvmoVXI!1Z51Htmb?!!t-DynSziVRnT<}Lcr`+yMDqn`gH-)%zbMF-X zMxXt3c31ys{%tr)H8p*@{JmG1OfcpQCu`JHTwSuDR5Sw_*RX&`{&r@N&j;pH*FEFw z6Weo?57mxi?uL-~xBW-ysb+oD2|=W$;%z=JKmAP9@sIqismIUpsp*x#kwoO-Gn6s; zbBgniw`^-B#Zx(mUyrf8TpXk%9l_pfQs;aru*OCra*`!RjA_k` zf9v>=vv)tnXM2f*)6siFaBzy$z7+R^&!RU%^*W($i^3P5j}WIam0w_l~QPymof}zuF&s*)W52d_x!qrZ7u> zM@a392{OL6j}4W(GZPpsJ3wLagTZAy+j~Jehwz7fYGquStB)WBUTn$WYIu4_o0o~TT}6-X!7L9 zrV~?&MFjgFxK2p7!IM_J?_D*hhJ7Xc*kkMZ?alPD$#3E}>S7dUdSKNS4&FX?jY{vX^h4hLoiDo_o=m@*i%RL1x$p3gqemd;1q7=76r|az}-QJe~$@^-XZ{XKT@k379mNNc{q-Frf*7L z(&F>pF)RcOIp1BClx(7H3gKtP-BDu%C`3aCSCDt?;VIU4$A8vA@C$cFevt%WTL# zPCw$KqchNT?A(uPmCRgZ^!OCrriN7_sVgp7C zaQ^_X8cjDIrlQwy5rLvziyxZI0!|l@y%-8^S&A5KAs7sOxcw?DN22&7(F}^qBB%Y`?9MJk__+g%ToI$cMb$rrQA~4~%^9TQu0wHV$BUp(6pT8_gp6RYk}N z1o!{G0cbBV`b7bRe_|DZgi4MBhY`9`#|T0-hkiWrrf_`wMll>Xk2if-Nwo5YjJmQT z3WOIy#5he*Op=%-Vey3{5Mg1AJi-WZo+(-|Ui9^0%-YB%e4i|8REh=jD>}U%3z&nJ zL7@Euf)JuA;O{`cyuBAO4Z`OcAi&XMh%sji(nS^h-myUJL!jyqX)<(j&w~)se-=El zsx|l@n$VZ%!uEe;G|dO&E?vZ9rX-rUSWrroS6_m}ww|a`hlNIjxjFZKT4JuRQGMQ3 zo<7{83SI&jYj`E&5mEDL=oyT|Os4LKx&>{fnHocxmZc%p2WzgJo0mz}ipYlx>T);mDds;=lEeL3w1bo^^}9~GU|ipvpeCjO9owacB9$IWMh-G zY{Q zO0z*6nD*|hk#3b?k>*9~Xv`Oq{J3rTCex16?ed15G4GMt*4js%wQZ#}{rj6Ar|7&| z-}%eR@omFhi`=wmC@y-{Qdzh@RW)$iK9jfYC1`&xVs`A<7|fef)X~P^epuKN{>Yq1 z*Y!te;}^Cyv*B|wC{_EedTO@l*tXfEXX+9xLu-NNK{+zB)Okr1&o%+l7EN}Hh_*#$5 zi)V2tsvbX$<>%SEr?mzzU?l82 z*UVjvh`uNqJuK_4K(_FkC$9-!^c^~+9w>e8mMcyRcE7dIQSDeE8P%VaQ=!G5Kq*`m z!K)wv?JgPVXPhm#TePkg8_>-2QG{B?xkB*yE=egorR>jwBxyPF8LL0@!a3YMXI`^g zN8z+i56d;$1-n2e1Xp_gZn0v{?}v?;jWjkX%1>NAdT}`}eMP*&s}-c%xe=OHDgOZJ zT<5h?#2u{jDl0iPObw2{afeF3ADu5|CyXrF-Zh zq`SKX1s%GP7&=F~yA%-#QMy4w8VQ3gQQsTSInVmN%Y`f_Ze|?**w_B<>$9cRWbbxE z=3b*kz4tG@hlG7!%^X#Fu6)^{UQrJFsbIuFu zlGM(XF}#*LQn0@piFVOYP-dTGD0>`IN`U2*nNba3o@1-1P9uNPtIAj0<0`K7sy<12 zdm5f;n<<0{>_8NvCpU+7NKpaZte$Ik;?~P59C$1bm{+&7ejOyj7SJ9`J5U#4Hh1{$^5O|s9rlaGX?n_#} z;1NkxE{r&?U)e?FE?nU`=pdH8)rwzhZxW_@MCh01!Bu~-H)(eDv?hojS#m zudBACgV=9A4?;f3S!5e1TL;fp&aR47>yDIiANW&tp2b7mlrwf%gxVUapza*A&^nj# zCv$hJ3b8JO1`*&Fh^#O28xhS>E&kDpO!8t#;%l?^wuh9pv8NH5Q;@JW$*GZ_EG%rA zEpg{x3);j@thu|RFH~qte9D>l!!X)oBTG0ESLBvDpTFlAa8pT>bP29I+>qz{(os_e z<0$w-O9B*|HB}A@hdy<2U&qTudmBog4h02Ai1TS1g-gzTO{e|bH_8^B!rZeZPTg!( zPP4gIxH2QWSF!({ns-|$tM!SxT2&0+kPZ?Q& zm$;Y2VZHeA?Q~PTjN^f+_}fq%ic8}&?FmGo9rvN3L~?;~vda^M^#(kLs4M*rM#u2e z)w;0BRpP!JhBOVI#T=5PJsO-r^B08?{z7e0)3M7YWmY`)PfeCgVkVo@6|dQoJxTf) z3fa<4)6)`uszQ(FI(ZNoq0Eq+LQQvSq4hn_5f@`cTLf)$3`KRG2{}K{^`5bLm(S0J z(-yh8Z@+NfQgyu*3VD|_E_!{SN7;drj;@47 z9?9D?O!LyVmy;|49o3JKzyrE3#6v}1Sclx_&X`286B4hX`D443G)4I695F%9UnTl? z%rKbT(f8>Wzq4NLSNiJbuxUKzoP4Y0{?`X@@EE?4v^(;B&wk8+P>A7YF59JMTMND^ z!VpP1+A1KhPX2i>OZ}=&Kp2_$=coq zjLa++^MhHw-5F6xFV0N(vYR@_Swv=f&wV~@aVTX(Rx(Af@QsiE>KIkpQ~XyC0vW_S za(RTO;gKIC1lx17AR%$_N{nJgn{jVx7~;0N_173QICV06aeI%_5T96A=(VdjSp{ z{tf~df)D}&pbuT+mI)8Koda%VqzQ0@Kw?C`DCt;S4rt2TGX#Lh0pzLb5Mjh!2uyF$`kkGz#?)W!qHn?Z-}LCNo->3oZ0~Z`Rh15Z;k4 z@-r<9C6-L$bJ*aZh*3!1$q~l{KA~cYT;PZ?fgqiHMMX5{Aek`Im14~U4#)S#_i2QS z`lVUpQzv}uHJ)~6ok*+r04!PGc9G(Nc#uSPiy#66;ILUJjQ|V*-YF zV|lV|CSx1(lQ{@PYe|TKfY$AB03_pzKyAqNH2|sP+T+I{3z7v+k^t5cz)o7frQHK7 z^S~(y#)LJOwyZz%$0Q*K{XRE@NJ*~>c^0iYV~m$IYeK9+aU!thWI^F4wGJRHNuqJU zWp=!hDw@cOwPI#{FEFqKj_6PW0$g6ZR@ExpMC((4$MufH0$?1_U^6zeKEelPh9rz+ zT9Ryxqh!x4(PyTar+|1v9%T?eNWZ5%zKhQg>N{>R>pl44K zVr1|>`%dkJ#MI};1zT;`2A|r2Zu)Pr2p@A+hpevGG!vRHvXs?j4+9*j)psI)N|mvf zG2GK1nFe{Dv6Ft|=!iMe&fJeiZJuYxoM#1?t;B`bH7O_Zl+@f6E+_ZiBhXEyS`;(h zoXHOv){OEcef+Qr_exDQ>ex2(L35*%>Ch2VdaNnmXh-j&_$%{_9rmRW&W+E?v>v*Q zCGY=$$n^q45FL7MxGI;}8lvb8**43li4D|s$aRc&yckcQcqA)Y3|{w?zNb;K4?l!G z@bR~k(9t(J*z|XtdwuUPGZ}aoTDRn0*cqu@nZ`Jeau}T1%mn|ACJq#^dDXBwCE><^ zj50EO^BAF;RO!6;wtw@{jHbaQ*~sfEznMbkfqY+hLP_BP)$iRPZ$@sFC~Iv37e5pz zZb88uw-Ie}_W|vrgu;twXmlOAqJyAd`fA@lU>WYuvrTn3N72Xl0WUV?BZ|Wd?0E~& zJjKTaad6a^^H^1~uUzbHhOD|8A63^1sMF~6(>&rxp5wBm4hyU*#Bn308uDS8*}}6a zX+>;8cefRM(n7F{r}H>{DuQae9mwiRc;EjvZb{-pJ=ToFZO~Y<=0Bzf5jw58TfQ)o zPgxXx9m*^Bu#b1Mhs-V76oG851F@bTF8896L_#I|cpSgBRXMq;XUuaS-|>D0Zw2>K zmz(vAx~i>TkHqP-=P9nq5ooDs`&wcfE3eX8RD96d-PbSKxo0J*pVBmz^l-S-@VPV3 z&@HCUv_3E)~OL+~#JVd{+BJ z9%J1+TwmB$FAe^x5KbPuRwkOEOCdZ0n`=XGergImaKvMq*k?I|esC^J()5imdWl*U zFJ=Ad48vSX>_`V{IoUH*FXQEBQYBwg`sl~{)d-(<4OzVX6j+qj+SDO@BNu7evrV|i z#58h;%s`5df}km)Sx}YH4S&Kv>EKdE-@BN?E2sKGUCe4@y2APTF^{Z2hjWAA8-wY6 z)|z!TAb~YiqT0wIf%=`gr`CR!l)RC8a*5}hxWis#DCj({UzY9nJW`IN?HTu*ZoyNN z;H)U`?R|>YJ^KhA$V3qW)W~!2rdxNeGFrqYQ{BT=N&NMTl*^tKi0VOHDQ8Bv{-~hF zU5btA%c4P^?s6pp`o6T-u^iXbeYO?F=@QGqH#Oev%irJUZ0#n5m2x_RLQt=opC?fF zXx^h-7Zn&&(|{^(jXdxrtbBaUA|5`v`2;b0^Da^_jNg&EG!-|eIPQMs5= zb>ljhlZgpeTak~YoxH#QGgAE!zkQ2^o@8G{B;Lf|*q5LEOzRH_<=tb5R{Exz4ZgRO zn33NtIFRR&|z(^wNJOD8ue8`zm#{YaPSL-;zUd}aw%T@$?|g6Gd8!4 zwyvsnBR{nUL(PFTSt>zl0c+Lup`0}T@yD_(0h|d$qLoj-NC-_w+mbMJ!SPemjk|-)LsLh%y_AjKA_{@EY;8v?!Pl~k;D}wS1 zw#2_kWf156%;w`-odlvf;Ya+s}Oa>!h<+{rdy?2Kq_bKapp~jRA3F`a-U&VC)hC|iksXKU& zsTNJy3ZoDA2?&R>N?evm_4XU;YSD9?xnccxf6R_e@`}tSabM4_XhFP1JNXGvDk#2eWWD%aPNE-f0{MM=5 zU6L;)9JLQaJs$5km}F@w_ok+mnaVpEeIBtIueaax_kp+vU43Nc!Is{`yv{vcI0Njt zrI4E_dqR#e@HbFgZcJ)zS2jTwMq7E)j*S;-H&VEz-r_ZFd|LE=_wS#vi0Ni%NRc4b zijBd?R&{i5F26vF96@_bcP3*%#G2N_>xjjSe)qKCWYeBUIG>F6!5O zWYj^^y`!n(#XBI*EfPyJGB(0428r@T&!LkZq!Ro!`t*wOJzZa*yT7 z>la^e?z$MpL~{(3c4pXIT;OEV%&lNwv`A`KEQKV^li4v22x~QcVuNZGfxlOaFM75F zR8Z2K`c;Lr#nNf>OPsYe>?bC)s|Y-Kw1=bX+4ed(=`D)iW`<)d@;d`sOfOLU@|EtY z?4`*huukUUdE|Gm`3Pp%_hH&OQx%S#Dvl|7dAPSwT;NJfk@`|30DlU`&LRO+YdY-% zJWk$-Hfk8K$^dK;9Nq%Yf&MFo9*lYjj2>JxNKyc_sgoIDxA?8^u226pXH~SA$ZqvD zuoydzF$@;v1!TEZ5$4e}(&2X70SlK8Kos>*W8u1;tx-^A0RYf%AbBeo_BTdg@8Pxq z>aRv#-~EOSEITy((`1iv3){p30ns6R;5LBM>2=DzzPtOM8UJ6r2YBZH)b}aq>20irl9c^`G!$$4G;Cx=gK?X)4AC&6UcvZI{+6rM;|%Jl+u zEETt%G-ry72uZ>z4_1qbrR0s!wxvfA;?R`2Oq+?B64*h|mraj4g|CB8veeWc-WqZ4%$%!x9=8A8HnX{>LG->+xbuXH;F2_ap%K$l}Jd zfXH<)VzNNM$aB#JB3A|x5P{rSbTFFI@W9N1j5vpkw=*1w;v$k6uVSwcV-DsuZ-gXq z>w6S!^M0}M!Gn7_K%mID2j2D0t$*MiGjy^(gT}_`g72NR>~T!Ej&4HP-BPY)(PBb2zfi25%jRMzVdN$P$(T+#RVQ9@vWgP^lbBoXF>H6B$$WrUE^hct+7 zl$C8*vg;r{&{%MoRxy+=ZvwN21M?$!4E9#hJfgJ&^wJ|Z7CW}vwv z8t82&!Z_=8~k3? zbC#I_4zYXoYW`QK$oS|P=8nmxJr4~R95ABmfy+r6|$bm^m=b`_71_jtNndA~;e=A?94a>ZYb zt)D$Ln7@SUNa}6T&Ic{}SypRt(Y+F4w~dAE$Y3*_j!XHR)ctM^&GPA8?@#G{U(MAJ zCPPm@c+XJQhmldKM*im7;j(*NYSOn5`Et?O*Hyv zwSwO(n%T+(U4g~Ocx}NT!^2gl0A2UzkGDtQuH!qt)&4k6lA7WcMP= z-ydf2n=Rhql6NT|sKoK1-f`5~sH2Xi-8S9vmrmaA{k;&KLhn34G0TC?TQhC-D;k1t zIl$YIv=>s?zf%HpcFE;SZnx*)oZFC-rTALG%~Y~|FtyYt{`0LNZ^}q^?`dbN@ihj% zIr2P!;U>-Yc#gX4T79-T2PlzJTN}VjvQFVEHRaIak9_VJxH&4YzFu4`(Fftsm>d>e z|8#$}g1sOo>qk7-FPUT~)vW?LodfsdMg3yZwB>Cr)~(aV(cFt()b=mMj$-6zaHaJf z9IR2fx!K0_Yyqt6<-J3)ddf#iyIh*|9nIj`ea8oSt#kn~V75B$gAGt8&Fb78qF7(G zSd?c)W@gW{=oYH;;nm|GG&H`??>+Ns7rll|D{m6yyu`dCDT?-p0}z=^$rg2?A65fQ zLY#Lv%Py7b(Y_a7NJh3CP z15aLO*b98DRHLU}BI@AZidU#a6AQh`&#KZ`(AMBCa!wDPlA*BP%9Lw&42o^rp z$8s$&Z>K0es07>}qYs7$MV}1-6yJpmZmM&#SCa3$dXja)Y@?FLbm`Wm#+4am^ld{<;d?dW z11#!nY+SQbQG4dkn_*SupxTHa5(XuP- z&x9M~q)}uRfTMj9)dCv!P3*DZ zx(y%;a>LGZcf@A-_jyFbQ#(%k-X#x+PEN_PNFb)@Vn z-?13kIFs76dWbz1MwKdml|OPP+WF+i9eqXx#K(47Gh-=AZ>xuD5g*TCDQR~mw;-=d z=Ngi=`FKoHCKjBrOdqg|V4=@$9gRXXuN<1MVIwIO{ZW$E}Q_)XpRXtDs_8FFVhw zMtl;dZ7EnNq?NgLjjWgb&J{5m&r#J|sz+R=3hjykH4Wd#^4O{n1`eEzR6mV1AHs9F z2Jl%wGUZ+>Ostn?KB32 zYZD4eme8t?908xW>0Q^<7VnukWd}&!L%&pOD*Ngo0lQgmOES-~)Zncb_?jMDfp`r zf7m>chqxxYNbDKu`iKx~&_%*ZF0`z~s2k^>Udehlnj;kaDjglD_#z1NVR#!cxl*TL z4yB9yVPqv7hOCSCboj3Zo%p_uh(-j(%l8vU^iMIkwF@@1)DGCm`y>1%{T^Hgqldud z_Yp2pQ)K(SL3LPn-1JM`B39oo$)`5*X+4@-dJ#?45;c|YA=?SVxWP@3qGE|N{=_bj zL!n>7-(t=c65OwZ54>*;$$AhBXl^ zk_glS2nPv*DRjN>WSk>2lBG8z)_|ttxrz4gZ<*+NeCjpG_-V2DOmNE}vCUhsX@`A# zL2)B&WhixB^Q&RVfo182mYBv138$wGRREl@mWkMM$5ySEe@KhvE7aR7ZVhm!$#Q#e ziz|riK2s%U^bTq<-8O{+K?oHmz<^c(ky(L0N+e;5;9-Lyj&g#@U?-AL#^#nMgwQ9j zB%~rH!1<&a)WSvrE;gB9W@HQyfhX(%%w)hf?ZVUs$kT@)tR4)4T1FU#J{1O#QwLx~ zJ^zH`ac?n47{d>(0dMi&Ks+G6&ksR*CAgTMVbr&Y5-(aEFyp^o_y4DuZ$m5p-p~TV zIsE&tTaG*M^KWnd&)U9y4_FI;_euij<^Nxd1CM1?k&Ohd|8IQ!_E~?GH3X!5%T)s4 zNWfh{S11jh-ibR%)Quj?;99p!+{#9&I}~6%AKqp0Otw5T`;(9z$%;8T7=^4 zn@3DesLzFkjVL=DEfNZIj7$y@VpTz@$*RCn!W9M}dD|ku!A}KB69==}8bMZ-qH% z;3|YWfyk_xA-qsvZ^aKda`_CB`7>ed?7zh$nJDeCwvFf?mh^q{YW5F^_T=KO*kS#S zs~&{!zE;(&`E|A+gTZkoQT+SQ&W6BQmI%!JxlsSZ+K-W zOYXR>Ynh6D`KNn%oTX6{OWX$Ee6<7FgMG+7d!aM0nqNbPmh+khVL9276U3czbKCWs zKT0g8B#FBB=!Du-iJ;6BEE9qt+$;TxDu$v}Uo$5mS-hpj`GdgN|ep~_p% zG6(&aROR-vl3kw3CC?wJ>Z8T$&M#v%xh#v$b$!RgRkM9rWrtd}C77sTAXZ2=3mbg3Y8z~Liht+%sb%9R4}?BE%ckxVDgQRR z>vM;DGK6JEGbP;eoDf{Io#mCQZ*xw_}0U{G8e?t^OxviSM zrWk*6quoyl$(d4BDMU-9`rV|8GNM6{q~5)(^!m5#lRsGQ5qfJne@~~u z5dXQN$m6J~_vn=D=-iPN9mcr|QZvvq@H4CI6K;FtNtRx<7znN{ewFER#W*!~^O-8! zyKQ1y(~X0z8{)dy`{HX&vNS_4)x77#LHu{Gs!L_macbvBWr?Be0@KuY1Eeh!pT1LG z%5RFdX`fMSWLFElJLPt?p3f$@Q1|CaB`thQXk3`~2c(2|IA2%|^@Wi4CxA}i70}*R z_);b8nXM$-2CKe9&ej{Uz8AS?qBuC!ddrwjv%UDUYI)vv!Nflxz7`hI`p=|aHg@0b zgnjB7FnApw32pEQ;bVE@Kly}kddImsvU$o$y;e)Qg|W8)PX;Mie@8k->xBr>7*oyE zBB!xlr7^4{yUxb_C$1_YHTYm+Q=jWgWjd_RKvT0Rlfr|bgaU%)rXB+-%!B3ZcE6;5 z?nE&2M!DuF$iP8GIkk5tsojy6ZIme~odK_XHO)$XS@D^%{(i-a z!U>b;y*l+0jq!1EYky{ORNA~^(M>((B?~_UTN|#2GT@SU$nbNyH~f+lVtS&gHk#d! zsvO|f<}LY|K?gY>{Lr3*9lcG$e*Ner*{Gu79tOJ@i=e^9@DSHcF+utAdIr4d1m4wx zZd?*UIt6={1SA=iXiVv#zY(|?Zfs#YwgTN2Kr(b)zgqMv6%m;oN!mhIggXX%IVNsf zHh0B~r8?`u8YZRO=ctmSymnBnL=_-Be|$$qgp!n+%#SH*c4OU7aJNUt5seFRe?ZQr zJzpcrk1iE#!!2W~uy#p}o^d;9C|0bFLFgW|XfkToNJuLzT)iM1+A6ykwI)*=6da9A zc>h2JYg_KSllUT4gsS^K&QNR$TXRZQhZ|cPaCxuZvYOHxbnG^I*Jj4Z67*AC;Bn>y zUA0VZ$d0Owv<#?nbQGH{oy%(Y3Lg;9 z&MNK*8PG|346F9X>7kl+M>caX9}8alk%-&6k~C`l=puM`q345r)3Z9UM=)#Sr#qjK z`GtqY3M-@^d4IbE*GWfp(zp=5YAkOm$Ag%yGS%57lRB2x@u7H^TE^Mc{FNUPBQ8Sn zbnNb|_Nnu+W(4m+p+#6w&Se^SdU#oL=24vlWaT9Q{weGG}R--g#kq?6MSuWc@B*ORzBSH!} zDv3EhMIojg`bDvS{8VIoCiHS$D);I5#MsfZiQ3|Q_$O!OEiwjY3_J!9Kh19fC5DlO zcL8B}!ft}-S8|qhdVxjfdCsg$q3NHf?omeR&O3m>f@-|SV9z`UyLN$TKqi{GY(L89 zT@!~ROf5fmZ_Mox4`HGbj?Ww`r=6OuNLz}qKOA;(6u)dSOzuR52_)(Vcd-<=+=ox> ziNC}1&K>(SK5!$p}^9AtBK}=_2SJK~SuTfINP^y9;H44IW)09#~^+%T9 zRrXicprMyU33sIGHLzY&qB|m$T2G)Cl(RLQ?|C1m{)~5SAdbVQF=97by7+3n03&Cy z)^$b*+Zgd^ZCPP%yxAxz0Pqz?PqQY7=5@vRBE#H=;3(XTlE z!DozXaZzb7@$Kpu`{s_2IDeqJ`EQ-BllD$oQXaGhhNW=t;_6+=M9D{&`S-{`L1VR>s3UKuS^bRh7puF{iTmD@ky%n+lS;oMt z!vh^6F>WQW@qsKg5r$(C>{e|9h@xHbE?hq1B0|igzUW$vp1<<>|32{_eSHfJMaz;L z{wug~Zw2=4L$UBSt^T#JJwZ(LvVLO48904T5#s!8?kx^cON^>}q66qmmdpN6>H!f( zEeUAy;RkYk-oRf|D{IY_4EQ$WHmBL0;$dTZL>aY!R<_4);T(%<@#z5)5#%6j?k;Z3 ztt2EJGxRAtt{grRjMal9hi~Pe$c}*VvmS;j&mxh!v2Y}j(y%Q1yj~^}16~iJ16ZnE zm@iah8328(UpE1=*B8e(=kwoY|2*?*WF8F6eAkG0w8MZ*yh$1kCJ~yEJf%@3n zUIQE_&;lSL-O)NZV6jaUZd_3j-fdFH;C34Tc=%?KYvl(LU@0I{w~xtnP`0-MK{onG zhs8-<6fYWQ#0z3=z^Fp361n~%QFW`sog_g7AE<2TM*~b!4Mq9>7HSM;6*pk?!6E!- z?(n*ej|1q`7qZ-kf>Au+z)h-f3koPiUMm{_ta^hQ0Mx&rP+!G|G+=Sn0f)j1irfWq zAmNd+IDS$up!})2@7&X3Hyw>NdYJBJ3m#-81D|S&ffd!Z-bm z6?UwWcu7`n2EGGv}JLBA%e7rX;sA%L6Su1%K8y&BxPNmJOe%CMA1D9hK?Q=pp51Ho>v$ zUxKX#GtuRW=jt7}_jVK5+OY%B z2HsP@E7a7dxmyk@KYj8d8CG1UzvfpoouaNieHLa;pEP%9mK*vpE=@oKV};Y1;BM@% ziTy!|$!no#=!HeOa;9YT(JNGx105o*ffV#o=8-9_C|rtU(NXg|mF}1GyzP7SA+68z z1NYq_PP)1ct@laGSshP|JhO9eTJA>pz^}q2TlplS?g?lCaF3i=mVkY9V9tUSOjBj59d(TbMqlvJ$O z>buJATO1ru6*NmnrYY7{WYzB>?s(45ea^(8`Mwb>=dAtBTT)F`!KrZj4ABSYVS?k+ zTz-ZG7J9=nZMz@nsL$$zl=+k;KO2@FQ#)pHxG7a9%e7nXX z4L*KQqd(oTu9fRl+xaopKPk?>dhnqHWlkFT{eZmuOs^u1O3iTB3`!d**{i+-1_pOJ z&dYkS7=0S%SbvN$QsLyhxi%UWl<9FziTimsgm=xpp+5l_6+;k?vV}U-Gt$ zS$=LL@i>bdwX~%B^E~ep0!e=+h7lVOSwc+XyvW*bEN2pBd3s8JCUQf&Aw7YpvK;NM zC|~H>TRjw`44%K5P&;L=M8s+lJKYseNqTt3XeB=GC>-q37K!GJr+p&tEvdhBrQH=# zwRO$7{zwJ8l_AP6vN=D;2=TE|#1j>|1M<3Ckn9S;EBY(f_xeAzm26KfdVs9eVXN== z-=h3IaLK=N9_%u+x4kxt3=_G_&*HQR9kHVO6l!zWIm66Qy*)?GtSzZcHH)gWcfnOB zG`hMPl%31$9UU#|xONCHN#&zpU@pA-u}akUO?Ft=}x9A7Sk%}UBf3=EV?c< z!x2*zPv9Q_SL3q6-he+PYLSGFBe{EBaNg$~co$#_BNkvc7zk zRf|tR`^UcVGp4m~lt>~8iAM-WSKe9v(nrqCYY~s(wX^UphvuXE04>mS`OUj`=37A6HedHEV#Z_xF#E2a40oTJNT^I3BYnY z0ho2;X;WRczB+7U_9C=>y}rg@`2xBn(6{2p3DcWRpVA^2~z4H!kF?QWw-^T@iEQmYtfnvIo)&TA3zxf=5Ep%--8kPT&b;GOY==J?o98L zv1G@qhacoq36nbQsSd3C!5;_}_(?cDbW6)zemq=?9h!ps)DU`z(HszeFo+N8#JS=S z;E+?2#7sK|+;I6&t>2ncInF)$#%fx*DLHF5NexnCMj7vXL@4#9#au$&a7~GZSh$w$ zIj_S#j?*h8gyv=uQ0@agd3!n)g+O`v8doQ);c@BQyl58i*kWI6L#VB8KYrQDy@oeo zYDdz7&JE2Txw;e)JOiMjbc*|P^B|x{zJh4J>!h9m+a5(vOs=AGX2K5$zc#*^j)!^y`458u+BN%ImtxMeee)U!|Ew&rEA(sOdDRV&Ih|t&nvTTXh zt`xM3kaQ3sprC-^#+zf-5o89aCm7;L%ybneObZy$F-QwYNI=~JM8F9M zP;|PBIWFtP2YNyU2w7&pah3OEq@V^8&lnR}|CCz+aux>$VAuZ)zHi6&& z6}v$8`Ie~T_DtL@V9LY(*gLemc^l{AQ4&W!EHs-VzBpk5d*Lj z15mL$4iv`~kiZ};UL+CRytv4Qw+m#en-p5pU|XSTY68PhYw;uE6)a)NspCCtVac(R z@5kZdr*wpj2#()aQJPW0|L0d z2;gfkofBAx)P2uG7aEaIMC1n!hk$x<{C3sba~Nz=B_w54u(POhfz8tvTsbn3-yY;v z;$om={f2;e1yD^kl7{~`)jU<*YXasL>JcvK;eL4gao&PYL6Y?#Od=oTpQ+|YmnzaP zyw6e3x3aXi=?cGoS>1Kr9#A@UVCjX&MF+VDWB&n(;GPG+PW(AU-dabgHB_nOu3pec$z7Ip4-&ofw`Nj3NAg}v=8#lUd88fApvB~^ zhwYtV{|PSQlSaue+MY3u+7fRSPc+n_S`eU0gzNc}HweyI&L6|9lt}EpNk-h6JC-PtlLczc8w4~L7-e%m?rDjgS3Ez>1GF`oZiI#k;BTs2)h5{a|({^C+a zYMOU7r0YFbA4jY2gVWF8DYG=nn)NH(B_3WiikfBQ{Sdvf=iZrG;tZ64tU7IHP)j*v6Hz)11C zu3xr4@(Ot_voKZWm1L3gvW#05j^fkDe8)B~l%yW|asGMX3Er2mgNt3qf*u|(d!K|) z?FS1l62G%BZHrCsOKp_T3~+_#m6w#}sJb!!?)n3wganglt?D!JJ^e)_VAa0!ahw^o zS`p+TljrXx^6d+-sW*EmVNoN_L>{A5t}X0x7>SiQ62g2ZW$PER@8Bv`6b;ZSIt_?+-WX!vj_ zZpe+tpEEe8!2B&STNUH{me0)yTclrkQd7F$3(2PELb%b}SJ+qiom!OB96v`nD;B$t zf`LQG7k875$E(-q5qM^!^4Qsn;WVe%o@la@q5@-g)lQ^KPx^h_0{NoAtG%e^nZ% z+Ds)k^XmJaUsKki+n@>R+2eZvlq&ZJiv6I*pAETwW%eEOvCy19 zL0m#sn$N{s6y5>!hc?R1+8NR;Cn6#E3d~TSHZM2zK-Q-asQ=yW@MW|uC$?w(*@GJp zY1dU~j_v|<%ZNYMlG*pFN%5l?yezhSIeR6pFC=(dgg!gIuTrole3`mQyeuBaHe*xZ z<2e&FpHzd;_3R}n`4$QujfAlq)Y8u)YG}=_o@8JxoqCL?b`LAtlW6m>6^gzwGwISV zHCy;K;Zxo#k~VUDV!!i{mklh==?yt(rX+o;*V*DlnK5X}&WK!GamQd`>*()DgHcsl zIr}ZMpRUT=qPV||YSzvRwDJt(&pej4Q25}?XbO3dD(Y`T^QOQ6^=i|~*Q2Jkjdal@ z>C2hYOfXvAnmW)MiOgi_%FR4KBk>+li=OM#c&|Upmu6K;T;FhVDc>2p<(=hX^XkWJMLg5- z`S6$NH7tG>;xx-J^8(BMclSpe)$ckFFjU$OzwshP#!J(L1xWB-eIyW08F0#gd z$ljBg=FDG2=)|X;EmZw3RKc!d$Z_n;YlnlHMLwH~+O+1peRmRcvAOO?##jjS>z9*k zsxz#@Ug7S^;6z+3u@@m$(p*mCAKH}TTh`tT+^{}SnB#G7f}rC485GF3TNnRwj3V6HR9gRo7SMHr{S*@M6>LpPG^>MhVWVEVT&sv!Rx9Rq9?*- zQyXq@rI{y439=IQo-zXsL(8UMSZ^xSfA4rtz@arvY5fD5f^7D^nc}+Ht5z=-iTzv( zegD<63IKcykJ(2-p)pw#qty3Wz0xUC83vPofMth9% zM)`eEJDdIJRt@%SNdxw3^+-N9yw82UT^ju{L3F}P-~@owH=qL%=5&0D3p_ucr!_u(W%_gn?K9N&@e%#|r%T+tzuoitPEn0_gVJ{{aFL_TaYv zZ%a?oY7y!M0L+V^fk5T;fb>6awbO^4iOir<+)l1wtQ-7(L7s*hNqZaHz(u9{=0wR9uAR1;$gQ z3q_g`cX{oSzsD^`(ogn1H zh{p$nUjV}ZG$&A06-MN>4kV8AMR5APKt>HnVqs>AK4w|J73Gw^GSl0n2#8j{W0y9r z9)z6~x?vj)&^uVyRf&~y6TEa|#2`R)stb(BUH0E#DSK*#B zXr!|wgc?)~qhxH3@@oe?WpJVi)>w-x)gm>}N4eHe6xs1Dub9b5cL)=V!a#mwLUNx1 zn}E9rTcizdM7%7}9yT!_5sz~S^2;5hExuKbU{J#a@IGu4cD-!F5_%TNfE)qTt_xRp zSGAZK2v__Ss_#@s@~ycvBg#PHWTE&l_qML&D1N%WOr#E$1xRQMiGdG5IutoVvp4}_ zdKO8M6+jq-;pn*I16`~b>AXl{WQ8nUswb!zsAdK7GHSPBb?{%BUA{PM!I~+CXm{j*({=-LNYg&y-n4Xr+N_UdoG2UoDUbmV-u{eV^B|aomjW+ zoQh|#DbaTmIBc4@NWWe=Mpb4j(A{wnJPWWnwhEKt0}F{)>dtLL%RDJfDZcyxZS2o~+t+o-S-_9NIhu z35RQYag@n7A)oLoDMI?p)!L&~(@E%Kmt|VKz3;1=zMXue42E)=lJbi^`aCXrAU!N( ze}}!H^aM0qL_qj6;H~;1d*B0#hmX=bxTm!BJw5x|ZeEd+Fc}b%slL(j?4BYEs$K2E zZf#9GpQAWrlYGB1p5&tKZpt-*&^-%IZ%}89l_J9+9NT4M>Wg z@&CqzKQq1JJN|6nkR2gdJemg28}c>sWiVz&D|~J%3X>zd?$6F0&n`a{)(y;kRDWW> zq}Wxm^-8DQBnOfFGIzg)tJ;MgZ7GGe_@098Eo}Q*y>7>?@?z0w;)G0A>4mK46n&r? z+350*c4#KUPUK_ZozX3^E-^lR6Pt_@vC9YXsIRWyNE-#;q1>m2J+Mo5OhkRQC`83u z(f9Ar&~@ZUejrHm3K4=Jy5B<=tQNkADK0P5P`J)`i1l<>@U<}HA~pP%?hRWv=;^TN5WUQ# z#II1sLlWS=Y{|#OGsB9%d&1w528zT6`MC{SE|8C7{pgC+M^%45;V;}DWWrF7BjRaN z`xNyD)C{@swm7xQD*dQYQi}LS_L$DL8)I+)qQ6eBuDqcZ|9kwWZ8xa!iG!~~^3o?` z@VWcX&2CJ|9~#Vkek;FHs&AerFkzAgS^WWVIuF5y*>>vB(9g)nAri+vIr*h2ze@jr zY8em50(ZE)T7_*tTRnHTJdkgJ93>i9?W_I)rC9$0atgJK6Ta^$TS+La7vH@;mUA2( zlmU9NNvXD&#unu5E-DkNX9u7Atn-uf28iW3lzJUB|9Ut&!;?@uyDY-JGIui6_ECQR zDQQb>s+bTBo35eJhGyXdpE!rtraAe}D0T663x6W!)Qm6`+*D1Mv-f-^t1Pd6$GG=F zzH@BY#)c&G0wFt|YKfKJ07H*gFOxuiz#)=kRQl;ctPWNo3qf(4&9f&qfxG{YsqcWN z>i_>g*WNpuY_65e>!Ng#Jwx`)-a-m>$(Eatt?uR8*(0Qqy)(hpi!KHu;6 z|9j~1NcWz5mXq^5&)0JhX(wSyv?ZrEW|zF%;tCX*s{ESB4MP!{A+&5wY%<)+9y&V^ z=?Zb9md8i4$ko5NG?Mc%v*Nq?(9g;J;-V$amFyhv6D}GlX3`ENk^F>|j^eW!UQmT6 znZ9utd_81&DYHi_*gW&WpqpmX7i?4+RmLKqp5oY(o~Bk8zkR*0+uQAU`O5E}MJ;bL zE35Z`diB%k+^hv}paCbc z_R^Zf%4lk*K~Ip;NK1{lcr1316C+6ieJQ4=#6o|Sfvv3rNzB@A!BTD zO={V!k?U)mkZ@yF+|i9gl_)Vi3%4{P2D+Ocadlr3KCcJQ(HMEFG>js&=Df9OTNX}8 zwt^JlzG9o?BUa3xQ|W0t#Xd>9-%46vY?tP_B&azGk*BWZlf~ z=H9uajwb!ax;Q_fIczS?=`C14#bfCeT#m|Dw5*$AO-*1JnI6^&A-xoTf3!UMRfVbX zlb1+sXqk>g@*EH+uh7mYW(qOjnFAj`+X=v#$~>|R$v{k1{A`e41c76dxz$6uX(Hxi zF3`J$U246aWYWpG9N+jsJr;^qB|_!qdbO7qB`S%(DYmR9HYEfT-B;PZ-(})9An4$v z@{p!(-y~irh*#7?I{mDtUFWt`{$p>m02e)@ynp~0y;gumu!pz1?asUA5Cpb#(eI6O zuDCCg-)clx9%ERTm3Ww!9Gz%;EK&5&p~bV7gdzog3!7rjDjk~kjTgD&4S1VPxQV!7 zCPhPhLNz8<6Q6i`qq6O7$W!Wt$)kD!>uX!XY*UK1q2oj#$_7`(^NM{iiql;~%dLck z<&n!xw|A$zQEUE8BBqQW@IZ^OFSP&A`fuyiZ-2hPnmt7z`1p9X*1O}4eLgQtC9bmy? zYy|w;33K{CfIktQbj5^z9^Y1EV(0|XaNy);fznoRtY0At0RBLCt7bnmAc*ExCleLK`fPSU?kFc>CvAwx z4`NU12%))(g!zFM9*~&_f~c7oBeYF8>2g9TJj9)6L-}*%405c{_)eksfnAUKd>(}d zs&ia`b@O>Edw3$em7TBL2Z0&dX$GNksoW=g-B}7(C_uF*=anKeNr9-s|C z2dpPxt!Zza13aqbf;7sO?W)TlL;krdvOub;9(JFW59!8`M#sm>tqucxsjR3KDHorH z69p@J6{I}e2cH5WSD=cO!}fDb`#z^+@gN)qPI9*;)tSad&Ssp7<~}#EtJJC@d3p{s zt9OB$g%Uhiy-)|7J9xGLt~FVqerSjWa?`^SyHRxr?aAE-Ubs%!zZcS1=-xlm?FCBl zv)wfD)cSXSD)duZ~s8>r@e4zeAAQyYd-butxRmzPqEFZiywWK*|TmWm&G|vpD3~J z!i7FJ>*3tlzzCzC}YVJYo3-5{Wq&sH^#U!Z4V7frm;*^d7sV;nAP@;7wWRA z3fvYd`uV6fC8y?2upww_k@?#3hT0dORzf^Zv-I(fMzRMkLV`w6G{{@uBl0zWfnl(B zlD;07Zf@R_+ft%xLncdyYj5MtW7Nl&yTfe;-Lp*It3-%NEWEzr)7@cGN!|E%WVm%{ zVPH;J_yQ9;?Ir2NON`$DNDGr!UvCWvH%<2OvORqMI=8oPs@aB_iDf9_Kz6??vnA`5 zYijF)t4gOZ^%Z?I7m-E4j7+sxntSo1q0n|O6$eNp+orJUHKzM# zG7-gfehj>`%r)(%Rv%*;Hu>Rs&i=@)0D3{j$EL$U!y1W+qrnHOD0Z`QlAP)CJt!_{ zDvK=_vfe);jUK^7AKoB0-S6oPfuo`36=)7T_milT35M^G^7U)R^5sAS@k7N~a0!kY z<6_j?LHItyv1Nnw(WE&kVj`4Ajx}_1vX3bFCz#rrjKqWhuf0N|&H@_mXik zH|DJnozLQRjQXn2H(q3!#{ZsEX$|ePHV{oONu)ZTuik#63zg$$`>i%Vum0OtogIOU z3+E;;k7k7*eN$F7SiAXs>FtedQl@gn2Hl3lz3OOUY;&v}@5XFjyme*zn^tub-R6PT z@dZ;llVWVL${6>j7lr)~XRuz*Ys|q+YPX_aV_^oJM(?+%Y3<#J4y$B_9ttz#6nCVZ z+AWFp3N_NY#Kk=YTzpemS2(zK-KVM_|J=yf<@O)5$ZKRT(b0x`3F~v1QNFC*em{i3 zhV^B2L@UV+>D6#eIQi1(C-CR`3wv`cIl>zwXqn{C!|3@-LzmwKD59x`MoR5(_f+A^hRvGKzK zNI=|I=hcHLDpL*r5~1h{(^($M=SK+w!Wh;3HH-Av2>kMI?O2MHsdcKR8GhAM#xa!2 z7$0{fCD)^f598F`N4kj_IM0n=#zVuD`k5nhJs-5ZrO8^}1FdvE^OXGV;7PSKzj*dF zJ=B5;*`BCbb?B6Sq;pTK%!2`r5XI4<^w?M-iK44rDkIzcZ}b)QoqkU*3kzwxJesRP zp~+38=pQ6WYN%HD_7ck`(mxK4Yot;>gbq(%Y); z=oQ*DW2NnLWJ$a7If=piYJS7jN%bJ#3bLIc-@A-{3Av6LX(j)~h8N5G)g?h30R+Or zIs(^;&Z*x)f`UVkHA{etNOeFJjss>;1_EHK5%^w|vDn5rY;g;jr`QTmsuG&siP4>b zr{jYWDGL4cJ6Z7Puy=$40Iae`PB`ZEJK7!imFqWudFp?*kS2nMh#DXfG13dkRR zhp{3X_LLM;k_M1T#(!cM`6!)Gnohe5Nzi*P}PF>`ll+qbG-yy2IK*tLzD`)wKfhSh|1&}W|m9Ov;lnoSYXds`Z zFd+9lwIX^*(iwI?8ptZC-#DH3ywXV^WNG-209+LpJs=zig23X+Ksr!g2sl`XmJjLy zr~U7_fuU)VK(>}T8E8D=n}ja5J%gMX$K`~yp}{6FXh#zT@cf%iOr;6t?32U~dhD9Q zFzj}B$4eNcCWfMZbyv_TbI*t$t<17^gscGV@OwKrx4V4l=LwN{PJ*rMX(qqoE#3XB zn6Bty$izb6*Bj?6)KGsYcd>OJk+WA)ki6y0X~H!Q&)&g{3(R<4i{h+Xx^cR3RvC

}e54It&qe?vN2Njpdrq) zK#DPX8A%qxg|eRZ<2Q+ia}BaFDQ?r^2%cRTs=zvvWO)Ud=@aZq2!SWhwKU}o7_ zmVoVy6yR|RXbjxs1kt>ZY>6dUWhH~yUc-S{*Xi=R z>l_acwB~+ZSe*LxJSU-VcET!}w4&1N2l_z`X^Fs6sQB;k>6c}5m&*>Vj|`6vr(c;1 z!x7s*o=s> z-gWYv8xQ#$d(Z22yU^PQH@81mZb%0vuwOkFy3L6*=MJ4(4&_F(suN%Q`KB7pcAS*+ z{p-vtH*yZRTge3FgV0{$o(e&oiit|fOgY+1tjeT4@DdMQ!-8MkX_!ui&nQQ(OH5I_Wt4O6 z>~a>4KI6}g(1ZJ0AGJm*+g{hSs+so8n3}xinOQ5lDW#ZUhtF5^(@bx+ce`@s7GDgN zZwO=W0m-k(Ib5XwKTxs~hS?aX=M)7CqRzX(i$v~F9-%Qig&`7EIeINY6jI}xpHNJNG^6by~){e7? zJnyWNu%`;skG?ugHDu;q9fvDiXCY1Wwh;Y;p|Fd>amWexy4=jF`BSE4k1xp{F6Z>K zVAWeV4eq*~CB!{+^`7)D)yF3I=g;;7ygLg!+P9ab6x1%YryPfxiz00Ol;HJb8#N!5 z)a1wM5dj}Er0Oi$XY9W)u}dVeL`sR3@?`W}XkW;XuB#VAGnFk}TWrjAA`vR6IO6KA zU%ze^ye>?eKG%F}c7HhN$%9hMb4Ha7IGNm7em{BBrw3NT9w=QQu04M#^4CH-k$3-r z#5bp=Kdl~4vg|{{!C!3*Z8Pmh4!sPPCW}f)(i*2TTs^P9Dz*G^>!DdOQ5?6;Hc9nrV{XU`iCU|9e z=BvodUGKz8ynUZO5vhEtYK_QHv_3Gsa_^6p`0}f+P3*Us#qBn^D4wz%iW#%VKKDja zo_48x@@boS!(lrAoK9?$soCY;me$)138eNrF*ib${P8c^Vj%ntbd0PV==B zrZ0OR96d~Uv(+MtYcUVMKYAM!h0a+Y6|f$kdSHn2o`pAD;IRvdDEM}Pzi{o7@4P!@ zcCcmU+})ZhdbTF*>=sStZ>UI#!6Z8j3ZTqpFON7++Gd_p#%kokk-eut{-Eb<=KfnT z*b)~%B`byctPs7dZd>AA!L0qpqv z4^P^RG|j3gt_a67PrE}g+cBYEk_~=@-2D3SH??H=N$`o}ojCQPKyh6|+&FJYoWZ5F z=%ATsKgGHoBK1kRIrrm+bzUTgsxzka;*i}nnA!BkBH~N2_|kRF;;2iS-9i0jPY%*e z-imlVmkWl`6dUv`>0Khm>l7C$K30<1TQsxGTA)%A{{~Ydw-EcPGo2HJgJZO~D4z4t zjQj)13wQdC9>3bo&ktTWqHK7Wh*7qpmP@kNfM;LT^}4Z>HJKktdZ>FM)a_@5$H+}p zKsZgsx#<*|p%W204^8e9U18ne4U&WBtMq*WTwD*dQgj4t4Eeo9%}Cz}ov4|+81OHq zDxb2o8WXF9yjBSQ*$Jb3i9TwsvDl=lnxow-iVQ4nd^;JgI9JxQ;!3fSv+HxaJLalO*om4fiH)D)IE4b(VVtMS}|UWQdL(xxgaC8+)=9GN1Rt# zW{_{l){1%MV}T^MG(B^(l&FQ>J=gRwmM|aVc1~)oX@>fx=TF1EHYr&!J^Kw-x3BPv zqhib{)IQp*{Yf+J5f+)XD@xyJFs*!eQJkdEXt(7lVh?uRN=%$P-%Y0YzEYC-lx!`f z7xY0v?^{;>LoSUY{qjZ3yxG~W1F4?OmI+<6>dHhe(V?Rz;pAQ2r{3ZwqypPftDCJ; z$_gae@gXUjDxv>CF)V>gr_*B>!=_Phh6ANh3EAuP{8_<)p3t?C+aER)B>Bu_XUmy-JZmXeWY?%(fG}%m<+NIz$Qp zDKLY{|8<1@cbni-#0%=621CsUd@(Dq=+fTqS9bI1jzw-2q8Qc9D!y+NC43(9|%^22F9fP ze#zZ50cMx-OIEAnr%l1VCQ40#J0zXt=nlw@0SbJfO=@*Fh;fLTyudXx?9En=*q(ED zT9)`ol67nooQrRnp%?q38Y*5K22l$8fs%6?&oR^npajE^T9y=8y41@Jd1wHqJIIFK z%_St4$&#Raca)uw5t6K+)er$5QGj-W51e@l^o}!ZnqAu{2DqG-!PzGJtNj4l-)f+$ zwSs6`(7@ymIO!&c&I&?k6{9H_$AOT+jj@wH91_41GoWdTAXNhhB!LCyK#EonoB@`K zLXtJ~gsdwETo6LW&kck*<%IHQjrzWiGs)-#hODB`oiw&FU8$jR;TB1gM4ZFizI)ob zr2!PaL4sbAC|?T>Vm@uj1NL{bjMJUlFR4)+G&%+Qw(uoiW9YIITneH;e5Ja9%h%Sl!P+|6LH+dniG$)eK5}riVKQzIwVX-MKpEYG2XO%xdwIKR8(BU zq;cc|2pA1Wo@FQ$Pq4+%(J(IpKMc3}l(b%>$$L&^c~u z;IRvVn}-l>p;u7O>i7P6XZ?JB5|f#kTOw@FWVUygU+YC=&+YtvAgD|&OJV!XF>$L& zvvD-;%e$7DKXMm&!-n{q%cFD!uZ$t53fcU6+L1e0?V7Y}dkL!M!N$B^dJdY^s>Am1 zhUQCbeAI7BzA&!~79swD_EWcPqbZ3i?V<2rIFs6*zQyjT?=EsfuGr|w!Uso!xi~i<__enJm^~^BQv}lDlTMRAK)k*&dsZ4!tLj9zQ1 zejX{j)&LnsNyT=l#1J(ZWm4$5px|ytsXVHepeTe`xIs#zFqGb;Kvf1O?Ieu zOt9%MoU0KEN5Pb;08{dbbSSsz1WG~Lx z#be#_i;wuYYuHe4zWWQN{)oAHa+ybea?q2(SYPO@82mR;^r&xV!1Bt`X0)KHA~Psv z$}RJd9z5GR1{K$;ezlmf-j(2EH>$UxYw)>=fo!%)G`+JWcU~9iT}A}hvf+4hdxwg# zm43cWk3LDvp*f!tnH!HWRvpHbbH8gX)BLC=VzF|g<{m<6|CaGmzR_n{!?0nM8-Acv z`LYDN-}7&%Oge);+4LHWU9*u_bD0^tn^gISlgznEaLLjgP)&KbKQy}IEbLV|GmXW$ zk92#zeo{R@@%H?{dhgL!t|tOvML8LI3o%wa{My(eb@FWI^>6o3dP*SSVSUa~r zKR(pTQn(=%bmhU2S!Q#!mY&T_Za>Q{o0&GD?>!s)8s-93Cz9EW0+N2XCzVJCd)#!O zrKyPN1s)bpsVa58u}M_}qDRY_ z*{matPD+H-NVQh-xvT*0!Q?{w-l+;sIH@B2$io?>7dpGa=@yd{S9*i=RG)v@JsXZ> z=i1&e$o?K}{3iYB)p0AYEL&DeUpMhf;(XNQhvxpSO6f)ccVFJg&iU-6d8?=KnnL$z zL5P&c%QU;_+9Z*4EZO{@`OV9f7l!Wksi`fz*O6DugZHCaZ@<}8mWged2zIs{%J32S1;%LKvB!WfZ?jZzdl>j0 zZPsd%R5A57Z+VDVT#f8?f!B8jQrD%!k^Xc2ZTl^n_gQryPja1C@klYztWJ^hg0pPs zgE;e0?ndjt;%ERq=sf8XsL%&!t<{42b^N!^Tcp1h%V@~Cxq{2;ld}uB{OERfFo)L~ zezd8!fuUCarRVGn>67fCR~JkFc*{J}cK(?sJjWNK{(g8JFGR;uVqWszo%>s`A_Mc9 zztnCMxj|8lx!Oqk{I=C@=jJ3XsPdWb1)m%z%ZKv!|ST~F)xg8!vEs2zQ7R&A-qs0(cg3=1;nA_T^<1?&3sT;IFi zby?S5G3MVaPa!&<37{9dP1ES`tZ6`!MQp*$L~UHJHjw<L3Bj81tCMA zGvr?Y2oRMbdWC_9@-H^~%b~s_WRIr(%dUbce;f~iV+6?!VgEOY2Y^VhoZe<)oa8^|CP?*P*!Z82fOiv!c#ZI#E3~-o70I|V4gp;q{0G=p?YS=g*6|i{G1k!6m1Au`AaCGNlry4i0z%>Z( zp?86TH5IS$7dMGD2?fVgFmTJT+$(Wcmpj)QwQ6xgKTXe3MZ(Jn?yZC2C(Kl^gKucnG21B)drYJI zR&^7D=%y4g$~>k@TsrX!te6;1s#ryptG{Hw#V^K{PqeT%3G@;VHL-@kHN!gl@apt8 zb>Af=FmriM-tMTwk8#Qr$FI9ELDhWfzQ5(Os)O3FYgd(RmwN5N(MuPg9pYYJB6JWiyg9{M4Qwv471EuhxTe#s@Z3ovxoo%v3uTk|GQfcBSzY5liZ)pyT z^Dm@`S)5cfN`I4KqN*`<-F|GDz|C#sZ7^>Rv&!C z0&bwL-&hnhmIYJ#Gn9&x;CcC&tWtJ#OxIX3!8-SLHpG#yQM7k#VmdXAnyg9SUBA0& z!7QwscQ@DqdAw{KDKWfEdFH%VW8U{{yrfws&ETb*w9wa_tN_PEvjaNh!Om>n7bWpA zm15zF>q$$#X*VM$)9LY{#0VoZQK5V~eriAXe0`Cn z&60>84CLEX*T;1ioRheSlHyAy)p~@T-2O~-aG^_n^1E^5MP8y9$4x(`kBg-tQE5)j zOn4zv#*pDAgj3?RaX4Dj@t?(J_InQ$?7**^nLs~g*)M?nPx$3p-$Uo2++p6U zMS3kjwfQS)w!-tg5QbVBg?yc!5U*HaI+>$S1!?^_~kBzJmNF zdOhMF$Qmn%k^S{2CgVzp+y05Gte#)B`R&H) zMY=MRA`o%Ylm2N(>SFZTQ!X}hw_y1uR)!ZP+l?h7yR-3QrntRo)gnu2PEhjAH0UZC zmo}35;-l3!+eWX?*2wemzXOCrM@8U&^@UiRSX)6^_IXGDd(KX>}lL`d1CjN z9+dKMe!>H5v2}OIW*lv!HM!MJMn_-8I|KsblPEODmqSwT7%vmKbo+F(WHx9wL5H>> z_OX=q0IlEJ9gS-PMb!^AxUzbm991=p%Ec**&zAU&8e&PCMbb5V#k{Eo;bZkHS4|>a zFZX;Nvz2yqeCqNsVHNpXi=45w^3Ua4St&)%ak z_0VyQ(|dMxKubp9Fm=ZcagKd!&Q=UbDX z@hcrMcu(HUSsmk$yeyKdY&j*}X(iP_JFRo+XVP@WbbhyA8;>dOd5?MT`-20fH=S|k z6zjI$v$pAs|6~tlni?$d{*l`39_&}uGBGgDs>ro4HX+Suye222G$wqlYDkxi7niRx z{Y+BSlI6=iONv&ZCC4rm{Q4tBghf}|qT^$xQA%q~+mGfME|;$xMg=ej1_lprym-8* z&Bkr_Eh_29{XqFA6h1=j{*9jy0iltDP2S;m&$*gEc+S|{_Odt0VhzmrORr5c7%?5AZ75_;&x4gyrBUHwZt3D5w&QcD!(%z4a3RpD! z8lptqdGhM%EBM|pHBKS6zN1w3_GyVUP7)t?!Jv|gjZ_HbLC)*pD#5M%%|g7z+?-fP zG>0x*$g8&I5qBWD$CnZW}@?M8gf6c&8` zTnhYZH6?3FbSx}pN<{@m<*)oCubeqgkWo?l4~-ZMDKG0wT=7lW$K`z>rV~<}_3(!0 z1nu6aR{dHgd+qLvh2N(M(^qX3wyeanM-I}9q_s}}fqXB;Tgjg_vvT;o`C!5)QE5Ck zRlPbb-y^xCusf8Zb9Y$7XN1D^TRutY+C1>vSI6h_wcfm@IU{b-oul}i<#tl@e8>gq z*Rm8xDjM}1X=l!-@8PlwK8`Y(8BaPLqvWStnFIF+a+Rsq*&ayi}Ts=weZkw9bq2g7lD6ej@p z6VD2gpdt86Ac7AZ0R+XsM+^`VP(Kpmp*tY*RR(;4?kFdKn*QQKQUU^G1;`H2lLQKs z01(Xpl}XS65U?zPg9PGB925?qBmzoxElQ0=kqU}os7Z3@;u!m22jMHEaIi)ah!=Lcms_)4xab z@0t5c&L)|T%am)YcQq{&$EQ@IrWhv1uDS5kw^ML7u?DB&MVNXyg8L;8c!x>R%C1?k zP7IGK2x*dtqm*F**^-?tn1a7QII&K$l$fJ>5h6Y&HmMbrtD2?MREi7kOmowi6fqFC zl{BT^Br7?lfJr8oT1Qj(0|vF62)*GzO>8D#e;~E2a2WvwH`bN5gEmTajXGhOp*BXK&t4s`W?=F>+Vf;q*R z`$xBh;ogyWf1)(

J^(VbmA%+Wg{Vr;9tK-;2ZFEvxNVW@L$6KX~Z*K?;7PTtknY z+N7Rc&HJP;RO&e_N!Lafkfg?k@X2dd5E#0vbDr*6!fJ6~GuxKPL{aR-p7)D_Xum{f zZO8qtZ;sPjBL_-`>4Jh`g8RR%i9d5{OT}^h18KlqijIv@kLd?Kl12{{lo{v|xs9*Y zR`=O5zgO&I$zvM313#vtuhlqPxRqSU_2brE(}gHH4)#(qCdcd%)ZJ4HukR=f={D)P zS1LWRTOV5zG^&Bpfv9f5lVa;u=uk$@cGo#=Nz%dL>6fR+j_Rc^64obKS`fGQtnst5 zzbY5nxA5l$1fP2-^HkVutaS=6t}q6cWH|3c@?jgjtZKX(i>A?ZxpWC*eJn-7jfNvS zxyN!zx9mhszEGN8=Au4Z^)kuonF-V%sg-4Fb6aq97pAy8)7GSN-Z60z<6E3M6_Dlb zCqDVZ{QjT7IEAR#x%LhncX@-2xt7&;3-w=z!}lJhE0-@k?){`=t-C3C|3x(^eIkRZ zS9~Q>I*4LgD$g?0c&`pydtCg4$=!Utd>1V8n zZ^2@9uZPU0e7{Grk%7uE7|ZK6yDy#urc@Y2OQUDmdesqj^=6P7JI_hgswKtuP8^=HFL+Zf%Y}0G7=+z3 zDO-Vqv1^#CP_RfVBsQj05^6(2$S&^kJL3IQ2?e}Q`2gI}5i?q^Y}qx@>*M zR4{aj(LN(l|JLx{U|sjeuUd}+zriLWRCVFOo6HusNJ~ZSbd+hEH8@H6&nJCkQPpPI z{`PIpZe=x{L((;|)MwAUXLwlbbz79wl%ce!0wy3J>P zW%jsD7#+&{?j5fUjB793H_bPy6$@6uGJc7f z>54LiWWnt_w=!IgUscz)9X-#^O<2eLpixb_DJge9Dz^}op=MiWSQF25g|}+_Vc&&t zf8u8^sdy#kc?9BsPTvZ*`Xu7tblDEY~LI`GU#Z^TDQb48e#|5j2lr zmJfj>&@^th(Dd$TFzy0RyJX-tESDC+L9AlL@2K0-l#(g(4}|V;Z+*RXq4lnYvI^fj z(MLCxO>WM;i!J?0ge$84*6!FP{z+fdBJ~4R;P7|uR~2>hjv&M<-^ZMv0w$*O+tsJ? zJzMN%R*gN~dMe$=DSC@V6t$;a+x2%_NVEb8UFk}sfE0aUm7AZxs6l)5=Xgw^t`PZ_ z=D>9DLBPAu&+#E-+lj;WOxdQknsMzo*LTBkT}~A41)>+}!G1e4SXWwRlDHd{uD*z( z%iUAZtWLYS5gLQZ^{~35+48J7%a`a-sih}?TF0=!CY@paM=VKbC1u!wu9)p0%>JX6mf!)AwI~Vw(1%QB<9h(Cp}9ZP3$C5-09FKSrD&-j?ci)Hq-_ zX&L`iVrT_gkb3#i=Y4159me_!B-7NS*fZhXr0XFeqz!wwsC3Dr&JvR@&N>(V#G23F zB1V#)J+um?ZA>vM7tqd1D|*Zr!WcC*`A5yUN3qK}Y2)n}(!LHpR66)NQjB~4ATZ>4 ztQ4&x;tXD*tN?D|y9Br#W2WCB2i)Er_xB1}9@h@23FnJ!^|O33+yNLT*Hv;B)_{%S12s~i|Cb@=YM z6GU*FfFUbkHN?>UaRT%~qECRU8Xz+w;s=r;tLw1NIslUZ@cIjq2-xW}VV?UHBrl-} z01mAAUxN-|piBlbfPm?THuniJ1wXyVh6X|6T;}1JQkuMHzq(p5-@!J z%f=D-7+%7)NyHLD0n&&5Bi*C`*o+1OZk#&^7)}(1HW5IEj3lb#-5B3khIfYYGGyR- zAkJ@SqIvL9df3!^4D1nQM^Iz=5+N3UkPB{zV?{iwi$!U1NWsRbE|8*~5+Q^^paoeo zwh`CmnqW|&DMXtoaFo@{rK^RbO}=U(n4mEaU=?hdml(T@AWuRQv74|1xR>P$|93NL zo^Od^ZTz6XPtE*z))7A zdbYdRy-hP@^;y$AQm99;jHbdo5G3^aaI<*8F|dvLa7o&CH$G7WvpgC%cx9!Pg1sFU zGnUJ=w4MbUdAXj&!b3Ap+~mivh~ZH(aYg&$mzlG-h^pznpw3e+bPI zZ}EG>!ARq#zall7FZ$=VA1MwhC<8wi>o~|%rdync+vwVnBHtUl$l;%)Cv)E(WbI6w_tQe?o1YC$9^=?0M7@Cb+DW4{`yfJ97zlE{r8gCr$3 zQA_v2(K`is8QG>BvkrwiVwdG}Y!D%Cj#9R1&9VC?FC-(!>as$4Zs;_vkfbobthpR1 zWV%qwXvn9yHhH1V;vWd%@7=34zV<-#Mw-UWFBC#{$0hlUfmMcbELh9fRXS)d-ke5UF zwX93>l3e`pQw`@W^5l2tg6>w?Oq=Uo61_4BFMISh%zC{S?ST5!FI? zh0yn3?VUwxE^ZcNAFiun-CN;WhXEVNd6vhpcg0g>7pMM=q0=*;R!4bA7(65`r*=P5 zpZ=lkjj^X{k2A7`NaeH}n`z=iZhIZ#E_+Em52a74mnna>cBA%`^GAZiQ&d4=j`U-? zA6As2Ka17L^|kNpW4m3hk^R}PC0n$><{F8h=eloC0|F(|E#3}Als;g)*sdHPtm zD~k83&p?ekzGh{_c)m#*BXa3XcqL?6zL1V}xP-)wM2uhj*N|X$m#}l^v2Wt-FOm@r zli^-(ybOqx-!h!dEe$h}r?EA^V#KeuYSAmYhd;Uac933Rag_Baj^*ZHx$x>lMrUVO zw+C7hZcdaz{e-xz7J?Me#9+_`ZZZ@y5Nmuey(?dtXGN#?ptjx9Pd~1Dr2G;1m9Qaa zMzeKgdj4H<1@riAc<{0tb0BUi$kQu@#r!y)SgJxJ?}v$>nl8~sB-zoFrR1R6r6dtv zI__w=a?-A+mi5$A^xmjTlDSb`iST1;F3icB<__swA3XPqOAaaLo}R19nh^3(G)w$E zbiq?k`)YUW;S2M--a*zG;w@&eEx3lU%J;+l#|fpGVS7qEy(i|SSFOZ*udq_?g(}8R z*7qri_5B0syx-j2oME~6)A$yjS@e+VO)U)OX_3_(x~8*kja7+3A7!COp>3{C`CPnt{jRA6!3u$+ zriX;b!lLkmz8p2lI~ocwJLm{Jy2RkNi)QKzR_apTbWGc*>m%Q#a}Girp_% z*&ox3zXuVxpXm5$e8gLmuHBHuVjq{MF%%p!k%)25K$udEzrF*V@v!d^mF zv-u2HX3y4(Z^W%Kdr2F~&oyLWUs?n_)8Q8ute$eZd#5{%BbPrAXiz38{JN-oONcVY zQ(^?d$lI9t)*n4{P=EF))#PZ_3V;pxzoN3QVt^zf02l%!0v-|q?D#KK0??+DJQlD= zs{}HjuY3>rubK@ksDb~_a#@7J9}u8J;Ge+l8YHI!ig_HmMhG?s00zAFe~=b2l{yKy zn(jb^F(W`R1ja^k532xo5%3zl4H%G4jg#`C51>#G z{1PH|I???={x6b(c%1%^tPRw(yJATwc5G4TzhR36Xa=?e_ErVu-^s4q=?8&&#%RXw zQu7=gJUjd9cxNZn&yMZvr%M3Kf;|HHhOqDzu4(};-!QR7J$~FqDqi5|kq#iD6r~?T zw@MyxCpzYEivqY%R6oO?DqhmWmxa%MeC*pS)G>HvFoj1{`_5=yV zb;7!e(cID?-W;OK0HzcfSf=5t+-wrCduQX`2$q_}1!B&!8GJu}g-Z5#1sNd(MMy%fR%lwSL>nd_2^|}* zi;vX_N$Su$1lbFWTU-*1Tpsd%rOL0PuORz~2f?mRj%%*!IC-_ttXc-Hjp#Y>m@%x~w2;)4FiDoF zNCD$ic6}!l#ssy5g?0=AX`4ijvO;znI^*-Xb(Zv`xX)d+d(@3RULoc)02d4i#I8g0{;umA{LOiVZrB2a`R16p8-J3C=-!0#>?C=8K2)8IB%?W4&KjKQw=V7sfyCP!Du+3wd#9JKI-JsHk>EaEQU+W zV81K7)FE8I{Of4Zs?r9_xnMadfw2gQ9hI2JwCyRWXX`B?BrQ|K?dB<-5Wnv0v?EM( zn?bsQ5|dqMiF`oKQ0vqx@$3q=W{5MwxeCE$xf*73mz3>HGg#DWv6iOp;V!Sb=)Q8< z0O&NA;0%JvH_6v!xnK8_=27~?INgPrUPNarq9$>x>qku#9Qch2hb)pmL+amAv3U~N z*RE4i=&A+(1HGX_j5#}3xSrIUJ5Q2w_j(*9GPsbGO%%Fx$`n zhI%;kOZyr^_-TPg^80r5-5;;F>Bci&3M-2gFXmWXt}J;t!~`qDSA6*gD#_1zjTS$j z91B;(D0rwX^6Mc>gM%(NahaT5qk8v?Uz*~h-k8CZFq3f~$ zFPcx{L_|{Ick~+v`B_7~b~0S%XQUROgN(_aIurptF!LwaK^=IMiAO#Y!kE)x|iQ>1246*9N{R6Nx3XP4ir ztoX0|z5LJZUNk4gwSR7X9YnH2UiKiw4D~7~meQO7vQPc`CBEN?CV#b=_F$dI(-c#$ z=)ijPqu-S|wLn0td6^p#RM~^erzSEw`l_6mmK2JAUOjk`CwDhEb&)o|)wCUNgus6<b`Zm){u~={O zJM`b0f^V~&t9!t`BrqASJm-BqE`7JkC4i3sXp+AdmZ6>2BfYxE)-5fu~C!$85Kbyb07eP~zoX6%5R zMXM#&PEGwfY1RZufr1JaE5ZRu5#U&WWk3W52gF=O;&^QGO4yUz`nWd8Lws^pS~C_d z@Uct2)#`wovhF?zO>-4cy<=EA&nDuyh0Dsk=GMg$E7KnJBdr>3EYQ_+$yIei=vLC% zSdL5XO?fzjUgNv(bTmhcD7YErv1!f*_ex6fEO`OKm1&+d=cW5qz|15xb|W>`oNZER z$Jn#@K?bJ$JIoImJB_ZIPB~|KR&bwQt||`OraSee23yyzT-K5!J8V%VIFKSWs(Zqo zK;N%IGd)_uI${~0o1*b+T)1R_+lL|AOy=j#so(_NV2TxuD`K3koblon6-|Z)snxyd z=8g}Rc5IU+&nrZ;HqWTXrY&7NfqGXxSoAnndmg}l- z5BJaWtcl}!LZ~sQ%?K{!!9e!X=n9k4gz5wl11iRz}YbO=}gqePCSo^VRCUv;yOWEJoh7%Coi>I$h;~9@GE|fVnYg zga%oJV-wM&F&z|^Y)H_f`WPh~w{`-l5a1m?L%?3;*v#)0fCE(6w-~V969VvW29*wo zu&M$j9xMDw;f$F?j=aw#fsMVmAK;BBbN<>Vw*sjUw>a z170N@B>rY>6!0=|LN9|cNa4VOU$AB}JRn)4{H1`vwv7;-_bMd}$anG~AecIquOFWZ zSiJz32Y99bS!6H4X=*7I0r^8mWh_001$>NDIx&AV2^$Vk5w?MSx5^T*8l(eXE^Z1D z(mGq{OsBffF4zbnw`VEK%c48fq{7+|SHw)EjBkD|s3)yQ!Uw{-!YN5vEspendvGKT z*_pJ!bvY044V#zS7|AaW(JsIkH%fbw1k0?Mo% z($(gOA%@0kK~fdQG&Bz&I(CS17&gg$j!M168&l zli{wAB5)*$1YRcuIKV0!1Q>!u4BZYSg_r;#Tlzkv2?7r}HmP)g&j}3?@~DN(PeU{i z2gqu=UP258{<_lu&65^R)R z=&3j&tp?-fJ$zp4rs|IwtYLGX3tvJ5nZsGc4_xBgq{E5azGI@4O7I+;MzeK=-`EK8Eut+R} zrk76G9TIR;UKO%~0*Y#A1y#Y|sD~VQZSlGE(v}tVm|(^8)5fqWt& z%+JF22X$m%&TrQmtDTVPM12HpZTk}s;Z9ri2lW8Ri3%JNmSZw_lrCB0&(YuS&{iW} z!JFV$c3Lm)CViV5ZD~kAqDP1Nzs8;XN_h56+tPBjJ^NZ%)NRRm2@D4?k8Bj1pvI~3 z&>C4Rf)3bN_FoPa6fvT2Is_l3%1?&du^4wNY3lgDQ@-)L9Is~JQqt8#Zt3Yj3%8g? z;|ZXwYfzNCZJ!mm%o0$Vsr89lMk1dm&d<_I0(c`ul+f5d+w?~=47FkiQSf09m_r18Z{fd zjol~TS>CO?uq}wM8*lL==?w2cZnlpypOEg8gl72A4E;wM9aB`iayKl@IIChKd2Ngj zcU?-s6N;bNh|f|sogmPt2i*;Z>x3|VL_MAbNM>@8os|y6v zf>ooJ+0SbP4XbB4F9`4cSY)PuVQhH0S;V2^TQcK&_I3q|OE1*I<5nL#ZR@Jl&d})8 zYY`a2&Mx0;&Fjyp3;P-?h~)(X5O~}J=T}>ZmlOg8@C7KQ1CIST(qJEQ%(Kf4|2FVv zkNNCSP4nZY*CYGm-<H%-rt!t(?>VY1CtDxw$z_-Y^d>&AS%MY}^UWdDKqQrZx| zrq>`zkvqs|@x*WUeuhnLl)tvw8uLYu;^f?w?@>!Aqh+$0t*3?s6W%#iPF%V=hHJ@Y z!Ts%`&EI1ynNL!^KV@wC$Vj}beFj_iLVy03hB6n+$kgd*-HMh{;dG~ZUePl;_{Vo% zWxwk}s&RIU>*3i-&AuBWD5^H`II8QpDo>eux@%&U!YAZAzjYs2L|szsJd*oaOi-&% z@0zD&w)+&l>9IGyt(WZ2TFm;$+s=pE<=T@g2K-hh5LzJ)omGUHo!d#zyWcY!&!4pP z5tXly6s^_{Gj z7ExctVoCjf6d#W<#PR5Ti-Z;!YLUihyxm z986FDGA6*6;}%H32xI{EYMXnZo10*$rl>}p(9Tz6>L7uK|4<>LV5k66q2qsl377vU zYe+N%d>*V!T9uTdEI_O8D<}2!b6%#oVa_>JaqDSc|@t zkM6QzGGF@n_|1rW82wU^0ED40<#LFbqlt)POoulH7DD+l9jp}j7*K**&F9dDW;A?4 z8#A#$Z`}pY?*N)|pfj4sQp$5MaBZ_kBBl38G1C9`F4{|v%D;iQD$Vm*fTx~PK3oil zo94AOd7gm^kvYVf48nd%`gO>1lY(T~@fS-`F?Xmm`ok%(&<61KEr*a}9h6^51PJVL zAi(qx*B1ia87c5$lXDCSKL(r9vBo|7dfRm>nb^7zB2#lpgD zp-w5tn-|WDCeU?yXJc;5d5hBmAPO%4Z-Yd|F=cKmGG!Wb^b?l;5^{792YA3p!Ty=_ zB0RO3M^$`Kzb#+owTrRvN+J18Jz6FGQI(c8 zbBt43$WzX3pR;yD^s;z%hLFvo zyyPu%;esP#;Jv22U}de(8yuy}AHO3ipCc_N6~|-GEA-8tiWkKVCUd9DGkB~&Q5F#M z#bKUw{;XDd@r7Km@SSw&8|5hf->1mHYHYyjy%9$GEd9w_)B|JfvgntXA zKo%v2V$5K6Jv)yl74IVJ<`DMv<}Aahv9C(!sPum&+J?x9 zjME{w#_$hqJVSS6nze_zc+h7}iYzMdCjL6r72%%qy7l+*jb-~$#pTuuSbYPEJcw%0 zRgcXf;{hM`IyIZIZIjOY7MMrAp#I|EiDB6neN zm@pdH6Vv0?XJGWgk5Ldkf@>QRU!KY^_E6&}4p>jWNn{YUF&@5l%{;t(ja(FP^utik-?4LNAKn57PV8Y<#PSu3a};WzqL{ zzj61Y<#%7iUsEs78PTt$Y2;s)oVCeP56ZLtQPHbhpu4{*a3MoB=S5#@?>${^v1o)_ zf<&({Dm%;ja38FyF^a zUPcansIk^(zv8tp)#f#!@N*58Wkap`t1sgDdk-I{b-~(jF9mT%`Ku+t1Rj%p1iUTu z3tkRBqI5do40rG)%M>8@mRsw}wFnip5;FQ|L4qW=^Dlktig$v|-SV*<ksZ(L6faN5hq~vvIuwbxR{=nIqi}F_EGe*)icJCcG<*rOLu+q?Qxc z9ebAEL(bcwY;Lsv+qyA*_vg^li%_g(pi5Gctj`%P@glhQTO)XL4z%{N$qKIiqm7n& z9C(yP3rP3)c-epV+PLT16&JKNY1ghON3ry;2;uLOxsi?v@GWGZL!N^n^ms6ZC|_~( zsl& zr1k4M8fkf|s!;rqyEnvp6wMTMwtV8O0{REao&QoA?phDiitJ_9#2Z@<_UHIqJ+mA) zOy$q+sa~*HdrGVjbWgo3a_bNC97~sNq@PFv>!MZ8Q>RPoLpoHi#YNN=6g?%^y$U2( zEs$jmI|X=ZYqp$k0Z%TeGM`w}7eB)r=X+SX}(#`6SjKOqfZ>CTU6ju1W$yB*+7f2_gwL$?gNfr2yN(dh4JgpBE^r!Oj99 zZY;* zk6Q!{`X8`Vwt2Fn&O9Z>J78-yfK;966IvW*$!F0PH8u#}>qafM{?`jAHf z8(~|98HI7+9|dnU4TQXAazN5ju=q^i^u|M)P6Tp5UtCGw2WH-k6xvv{D zCtXA&b;QY1LA^)fPFVio<|CxFq5M^2Hs%IOdcwsvJ?w6Yn-&K@;eIan=?a39*ob=J6 z6&s!32d{TO%0B-VKfa*&lHrP&E(_&5%e=cB7aA^Y`y9mjqqXVIe7G!8`Z~-1ZZ+!9 z@SQ)u)!&&6<}R6g-CY!Q`C^gsy;AXa`ajUi&wuQTdL>`AKZYNWCv*mvGgRtId>W>I z;ezvZEcdBn5$g;vbl)p{U3o=SGRh)Nl>FXyYKkYnc#CLF#=hjidN}Uz`Ni6V-n6oB z=BFo*EQ0!#TpsArSYX?0&e-NBn#oP37l6G?%{Kyr}jML_gi-z+!i+lrvp_$|8Tsk^3uwHz-m5$%C<}?&l6Ob@THD z+p;y&sh{wlE`IS&Q@m#xQK2-BeG#cT9%E5(%z?0c*f*6AQd2N;E#+oXk8wzyb# zh-ds5`7`%v{Oz9G6z&l%O(CEAKR1)Fhc1Rdwti zY4)?ULK{~5pRCa8E=D~^h;CefpMmd!e+Pc6$-DBWpD7W=Uyw`F?cmP%TVauv)Duf)be8JjDVJUp zn4af5&E`Nb--=j2dmkHd_c5b(xclSLdy=BkoEK(8o*7e|u@vYP5csW_^x<*q$qlvB z4s`)`8cAsv46K?&$&KT^SiCzV}vP2BTg(m znOFF3eTv8yWpnAoKhWpBAx%Z)w8$~iDp9C*y<~kMME16^g`-uJ1EaFT@!yg;HDdbgt=GZWe?rPG$7sCgu zM!n3A*!sByREf{uof!49i*G1aCZY#vI`ZfNNz4g**zUoE#9fwrj1f5Gy^mMm9MfM7&%=Gt2ue#p_|bGTjY+d;u}HN0!0a z^g{+pFt7b4L|^C|b~$E5{f_d*Oawl0;+}PMdo{~Ly`I#Vy|^m&Zqc}>=cf-5*7&Nl z6Rp2ZZa@0*By!8c9e;U{a_Nop5>xbsv9EC}QtQldje_(*ZX_G0C#fpIAPJVi^MM}1 z6(Zw>2$#D#wGYxh_HsV8*QN>=rCRwP!a8AUGg2bw23-~Dk`g4vDvDoD=rwTk$sYQ6IF&BO}B)^;_+ry8kM*It^<_vPqVdxSMXWC_hp zubwkc64CDVY^U0;(2S&(wVkMVa;0E~I`N&p1rOw#k+{?57u-1~q$TJgkna5M4g&>K z5P^b84jrA$-SAj2P3~1#Z$V@M|2#}(_p!hOg0=6J4cx_9vB@)i?{s_xd{qQP1&%_; zV+qsvlp4D`kzWqRS%tFP(oQxQcmfk(zKszlCr*P;?mynt?klTB)CEN6IcEt-E;QKk z$~{;%QG$WY*2!M2tfA$J@y*Mc`+%JoNkPEvEs?7 zBmm1i!FI>5rU{!;e=T0?K_w`#!<*I`A_KSsc~0Y)!}@pkAf$=}z-|Wu*hL~FZvA^k zq(dIV09)_|c>fv+ECJ71P!NFP7qDtaHk?O!q*8S2+YCZ$Xs{<1M1^Eiw>c18;O8Bbjq? zunOd}Kn$7CQ05Yq6pTos1!)LmCqPgcmG~FeB})opB<%xbZP;tr1g`>-Or{j3x&*EY zc`uf3tb_hGh<63ga3XAp7mo2Kz`=zB@0n|C5CVN;j6m_pu?cepU2??Pj#fKuH4wck z37{G{VO{_fNw)_-V4g^~02~f+!U$W5Vh68aodCN+f1xZmn+PlnRLWRmOu9MQhy*oK zIq9#*fqee)hY#+v$0T?Q%H2p?Izgc1+aD*X`pBh6$pF-MA`&=l6=6(3!cHoU0-Q+) zy8NdbMMG5j+XE8IVH@Ljr{gHH&$fDj>}A5Lf7Etrp3Z@(E#s$x5b@w1(?coc-dm;) zGKoL1zt!&Y+P!8`>1nBxm!HdF)cLvf;6lUc!xv-GtSQ@a6I!B%)0V!jvmy_TvWpkt z8yXC_0P?Ii*?W9Z&a-$Mv#!LOxD4Noxo_%TK6h|TEeW1i;{!3?O49rlvsQ(V(qzT9 z5yRE*>OG3*drjzvYi@2@?Jt-{jbwlNO)c9qWjEv!k%UdFZu_-z%{9;0x%l#s*YXCT zs?3oa1dW%(vPY#(-u$_)(cYSxcGdj#LuH{~uicRf;-eaA&JU1k#)Rm}{4{b)7PT8f z=TX50%@5V|{p|l79j#6Mo*jJotf2P1MtQZ!(HFp>3`2-#i>eH&0BmTm1n6%2d#fYR6FOioPV7@CU0{Cg(vZil`AI=@Yy-H7 zSFJA@KA?bM=KA{KYjY=Lfbcu@Pz58s_X1aSK9nq!4^7;SP8vs*dHaqu1mOy?*)M}eQx!X^3!G6g|3Db7$*0My zr(5Z#6j;1JB%5b98Q3^o;WO2@;{OU+c8Q)S=`}bi7)@WLWDwEieuSS)52OjE^9cTgn;eD4h?kQCo)?XeaJInpvX-#~wV z*tpugWjfvO#q(+8aLU%Lkn4=@&i_E-`_FXb8a!)+jIWHzD+z4LjQs=YDpgaaYln=h zRBtWtl(B6Y%3rX!LzOsxO)sGt&2Y{*AODb{62r)$-yo<&=lM`^L8r#dNB?IN=Fv`8 zPL|afpKD_0aqP3at{}^2oL6a9!GIyR{hd-{&H}mc)d+Rhx^$lTP zxO%xTnT^F&AL(^&@Yffw=VUyYN4)5m<3hS%Lh=_1JwoanT~jSXe`p zrhU-qB#-vF3M*>!=X< z6m+fA;+mbpCOeM@D43?yWSSC6Xm#CcBdc;w5@hbP&>vk~;+t7<@a>EG;9F?J=`_m1 z@Il1c>QJ+-r@T-Zxxn1{eZg{@3CT|iDeL?9E5n9@-Yy+`p0`h*uQ?0o09kXlpzxgA@5-B3Uoo=< z#DQ3pp`z_w`Y5|vL3M$cohI2mT0G00uAFafNLGabJGtguPo{2)|_hFux&1Vo0}Hz5t$nHfY6Z!SNz-? zNnxs*-W|kAF2315U|tm*e3v7nChBc3L-wbmlGMTGCy4{Pxfj!Z4z!MU3A%ALc*cD? zbU%G%>hwIJnp{+s+E>x4HKO8DGVVy~hq}ke!V_`WDlNCNuRMCTZ$6fs1v~NSS3!@^ zJvW84vjg4&EqBJX{gWyTegzk}dgfY>nN1M&(P$IAHleu?Be8`ll$@L+JF|>|Y zz#{Z3$CXwumeZgKC0{pw8XL{`(jqB{tQl*)zrRRM%%ufD1wfT!uyhP___UANr_W&I zKZac-K=t<%28akAPYvw-$;x|;$uYf#$Iy&~;7H9(B)$s>qoe=3_DS1YqtGR7Lt}KK zw}>e7s0ysR3!--=3)_Q?0r=tt5%bERO2|RIJOOZyC z1gXs%1;7rl{7?AH#vJ3bV~__>BQ<(I)GopsuBHhrrc}WN0BRkt#ujz83582$=+SKj z{CYtfs=?`rLjpqoo!g9C!Q@D|mkl>tRz01!RU%;K06@b~Dg#SUUeNQ^A*;qf224Fk zJ?BM&pvJ{u6`#pKE`=o71ijl^9BXUO3X9ZVMF2K##teCkhTz zAdr!Cy>y`_9i()58%3DDKb>PQgDlyU>$WzXkk6cwt)BpB?qolUq6IAsp~-&Q45in3 zfjNO2KTOLua|tqmI3_bUIbs^Y)kJDT=O84OQWc^kz(HMAs6c`s-CdTCA$@Yda0)aK zN>BPkMj{cmP%SVK1)f+S>y>nAp}&kJ9q5mUVIVn`QYykaK@ZnK$6uAtaU7^EiSmo| zQ?%#DfQ&0r2O!9?|4Vejf$j;Acpy28rGsP1*cFJ|8DX%F@3t6jpvwjqrxZe%f(Cz( zBc&!#M#cdNlB&@EyxA)Gp%P?8D^cyR`zba2n}`;zIhR9_8K>24R-tLaj7tFS6tYLP zd>zS^I_JnH)4q>GxA9<3%>wgfdoE>tdv=!BAwGtUn5P*={GMRMq#5@Mi8tiCI8`8d z^rJD%bJa0t4wKcXAgz{NT)8V#)v*bGjn?k^2Wms%)m+8ipV2@2OhRs3>sRZj&Y!|2 z=|$WT=Ek~DeF=-kQ2QbEW@`X*nSQ5Ih*X@QmcPL1gGKqN4O62=`N@Hb&QH4fVh`t) zs*&%dJvm21p3#RtzcJ|Wt1(8dc9O_kVwauW@YLx~J)-Zzj9GxLjvnsbElJ8wKMk@? zw-EQ>5Y7mn5w%KT!?N)GJyBKsUhQ`_K3tyhg&FI9qPu+_Dpa-5Y) zA8KMjvp0iOMvk!D?$fOo{uhjljsG-gTwSHDBm0r^GWMFSIx;;Bstqw;E!&e?!SN6> zEgBkcEUpwLBQmR+*5*^!u8x)y&P!cGuzYI2^uSa2fuKvWwpO>;DY{CkeIi(FU~h$} zXzYozLj1(p*j{L`7YHLhmHTeheI#p`&saAycqkUOX^x%|LfDKg`aS8XHjN9J3d zZE-_dD>u>Eh7YHnYbe!34|G1cTIJTn_;p&TBG-qrM$jSd3QDxh#K|cEn|#_?-LqVe z;DJvh%dzfT2vbwBJL2QgX}w?RTGEutWKrPj&;H%*Jqz!MoEBo|gQ4Sat$7b7Os(14 z?+g}RQcxNVDD_)iM7Tik%E2pYf05YXMy(`%VXwBj{#4<1>OiJ*8J>31mtWSMQozVs zp?MN_?a{OO;MNKNQ+6I-M|yG{9Y-U@s#p6;}1#KqoYe+90@%Alww(EJEUKs8|1u= zKG>A_S;%J}nYw;r6CFfMj816vJn_zWTjzy8Y|5gYPxocEuUXlFT9h7NQsDzD;Nhfz z9=dC;AXTHyQJ(oyru}?|Ssq1G+s_QWPrsUS{tW2wzr|hP@ClK0Fq5q}Fq&jD;|?-> z^vOsYtH9yYi2NZwntt+@k+$Q^3{pX!%RNHWc}@TZq8p#wgcMT_PqxXN$Ia&D*3U} z`W`rOjG2pWOWUyVex@RgeEw2WfAvl(q-i1tR)UfVMMrvWmlcsRr2kS<;PI+KmP{dF z>A?F7QMZ~>VA*`9?zx50@M+mx-NlSRo>zN_TpnGCa%O!0MjF0x16f&-NLaltDz=_t zi$78Ed}aDKNQv=s{e8NrLezT}%1fz^eO^qP<4G^=x@u=VG`Pjb+xRKPut2TrSMhd= zJ(_>+kMwjo+j|%8mU$Vsz{KQenlqaePgEpUmuW8LolwNh2CGX}RQMv;+DmZHQcahF zsZzyo)mc5eyOT2-d7(f;L9Ckz=hj`vnaa}FgZ8s4FD(TOY7EnPd?XQxJy|^!=f!Bw z2#PRl_T4Uho5#0V$>l;_qR+jz%2<$pDc7t+l>4((okSj8dn!{s?%A>$Lr-}B0~$dq zw`b7_%RNHG%kA666%DZ0W6f%*3U&N%#!>3}FZI$kaLp?z{%!G{HoQMT61KZ^)M6%z zDT4Unp~QuF|5X>GNV7LeM{?~Y;w{Z7Z<~IWzc8Tu3NIFSyO%3!U^*ebn7iqH&Ckl9 zqDiF0jk_Gu!E37r>MHRY_B}Q)5&UYVmaLi3xeyq>o*!$%Fa5^m;0{?mR=v;Tm4?3o zz&QU2N+)3o)(%LGNRl~0=Xj67&Ht&i0mQ=s>Tn=r$A432^SFp+1JRPu12q!~8!^BE zh(MAs$g#SbNRYAwdk3fll&xsB4S`^W0(37oLJ;#rDxEis3G_K1Q(J&7>Hr)DFJLNw z;|vREizg9Lu)TkA&+$31f*?aQFmSZ}7jymPM2~qhS5V{w%2^L;533bksF^^PI)^zO zHph0{HBVxzr~-j5>lOr97jO_zts|ivumS0p8MkG-7W1xw&c+nYi5mqlSU1qe7I0+3!9 zzzBi8P?&&XT;}p1O(0q4Fl>cod0Cy=2WHUAq3L=i4fSeuz-8Cs#3~(Y{f3Mux=!{z+}hm`*0GfB2k2t zqmZpY0>PG#mk!ixVLenLQiM%c0KGsIr36Gy;_x75H4G7eGLhw&EfCO2avQq;Nin^j zCe!ocKM>7;!9P%AjuxMGT~Wi8Tpap#U%3IF3QMx*0eR+?AnJyIUpV{#Yl-N-Jm(zZ z#lWZ=mgQ31_+hBQ5T8NS$FxYk3ruDjJSVok=T6eSW6NeUYs*y6XUb@(K)@$0e*~(f z%M#UGer{j%2nw(=|5$Y2`Fw`Oi+H7i8xA)DHiI>L%+0KPJ%@|$;>3%FzD0_Jf73<^ zyp0r64DjDAYuA84$tVCx@< zTx2<}eNtSw>?^IP}@MkH!vWJCTy!q9VM=eCetq`gSa2-K;6tNW?xF;l%mhRUK3)QH&QN!>>rQFv(GA7T8U zea1U^kn6zrAz>|&odF$tgGuJMF4jcFOxLhdISpla@UTB=_&a-Mt%%=ZQcQ*Ewkh#) zRZeoidFMY;W8z!*NBvHA6=>8g4<;r8p|J24LB4j|aBS|g;>^J^k#2bCRIxNX{ds$F zd0P1g7C-uSY=kb(7xVlls_ms3UeyZe$Z00rHt5DCoKG`vQ}?oUpn&;;vaDjGC|}l% z#s)VwnimEN=wEj3wnYsFDIw2mGgy{rW>^zhDSN&>JWIW2GFWu4hgGkbGw4a8n!$Hh zQq1}C7K4KUegDk6S=j7Xn(G>(8!SUMu?|~`Vsjo_Zt7e z#c~1Haqo7D>u1#!ULGv+>uxz;DnoNQiK>Ic>(u@dz}-K|ncG?=mJyhm#x&o6S}hbm zT2gj-3|Z~;s=WryBVgzNvQv^(2su_n2>G`ji?Pi@4kV3QvHy`mC2zh#T7q{ zNvfg(!H!@j`j2JrWX%Qlw9&tg2nW$`y2dEbs(kk?HwMP~(Bj1P(m zsnW2qpWaY>TVtC>(|!@JlPzM{YWnyUGET9F{P25qGJbZ)VfmN6zE)PZoq8#ZZsw~rAf|OTP(LKCeZeXuC&+v`*j2pCbn2wL~vvL zGOUbiV`e+?Y4O8Z!F#<-={IW)1s;UdnU$GY_c<-T7F!}0>UYr`t60SGhI>-Zckkbh z$9dqU{w#A*pEM;q#jOHy3^)|J0&5)-hen!zL$**UhSY0y3_?j9$G?0G>6d_ec?*v} zE`SkhVR2vn8f}B69e}%ufGGYQ_>q(_VX)ybFL%5dF?0vWgGl>#{kORFKMDnu*#HFj zdlZSHGKl1@4Z7pO_=hGnqJz2|nE3}lwtQF`cG3cHCq4nSIl$~mL1-`zg3|(Xd(ib> zjfBgX2kI2_d9`O_I>ah?3x6wWU})9=8}>TrJ0yw$G}M%V8*lL0kBX9RRb2N%1JyGI0qYe{s~wI zXhrYR7pFT7Npk>#1Ry!UR+5!>c)xOp1`GsnCt8C1u+S$7R1x8mKqIBhE-Rb6;;sar zMDABqG@jdIN>W?HsY zUmtKUq-L;iQrHLsoiBmOPFNLK4KU1Zl6AdhO@w75jvcx{xBIbS6Ic8(vj&e9B#}fU&v-)M_|lE(nPvOMyuA-tjdD z(k61?Nz?&#KryS(3JX;}>n(_Z7wXmlxCBrw-~#1CaRlJVF8CLlu<>cr2b_j3{4?gT z_DD9R#HteC#~YA@f4p9@%82t1DUF*+ub#f*sqs`=a{2jII{xf_G=5j84(%=rC3o*8 zpYQhw-#^W+=CR!nFZNhI&6aZ9)6f0tV3nUPt#e!Dr~BMh6{o6li#e{)G|;9HpH{xf z-StC<|I9CnN_~csr?_ct@C*B7Ndn~+M*L)Hc*~q~bl~t?iS?-{SHog4;zHzUJL;jv z5~^}Qxi$v~m~Z2q>8Aw5AMMsjsU8hzFQZ;a71>*4bFk^EX=9UsM-k$gp>y`bN-du^ zEqp!}Lc4-FFF)(KYYjFrhY3c-t2T)+D*2?U{BXQWW!@|y({Y~*Tu^|5g6un zZ1d^9>VV)*so!Vq+HVl8*3CwL==#3vwcMk~TI0@i{xei4>#7<0i;l`;Dla)V@J}Lq z>C%NZOgRJjWYun3tWEU5yWE@3-se)+Mlp$xP2t+cbt&1I0>(6lQuAz)6v|951l4p6 zpXR*fPW7-(8hE*&mYtI!<2xu(;Id;u-D&aMEyT*ZRtv2J-MygA-8QD`SYta!0nC59m4W)g<3GbHdl46a6pqCE5uYl7|8 z&^Id@R|?No2trV+;4ZXn$CB7s)%<59FV$(ks>podYW`S%5WIFft;M+JU?zgu?oF3$ z?p3yjl2@|=y7xc6|4!?5*2l|%Lut4EeVSw*OQ>g5cz&bFz^!{jfxo0<)lX0F?<~`x z*v!0;`VP2=LAm;Q9hjfwo%FF5?l7~*uv((8qRut__zb$4OL&RHPPlSh>!s%ih36(q znN9;=PL`FAt}^fqpMS5?Um_HdLmmOoFwlHe$`f_LMAA&b@0^L<)D@^DSl2A)57S|{ zx(#3Xd(?wcR#vG9k*h+x)n6Avq*|6fai^Qgw3Jx9dT5b$h&PB!PBaUS%D(kEQe0;> z^KnNo#^y}6e&bW8mp0qeU!HH{V<*3Bv|I9A)VY@uV>wkn@GYRr>M~PA+a`m4sO=5v zL*N19aItG&kG;1wb*1Ia1wqUQmB6+Lk)j8B@{^Ccdv4R-?hvHyfca@-f!q;1a8v>5 zOqR%Jj3NhrtG%EF0`j&+((%GYfZ%d@RKp*x4ef&`6$)V|4zK}q$WX}Hr%aa9vMAQN z;C{~f>*zwuHYfhUTpg56N6bXOW`dtfmq9e>XH{?^9vO+W^)Vp)RL>WSv>EAFrNu2 z5~lRk)B{ThxDRDLx4O3yYU}y*r5fpNhI}90hD~&@(lXKNUaAmMKSS{R^Fuw1!TK~q z>wW*t;5~+f2J*FD^efPW^(-n`?~&*m8JWSj$4-Ew#}FBJJm(eyb+TCc@KG2!?y2nNt4ji*ko=uVUryxf3N> zyg@V87~W+IN0);pU5f+>8KDyH^puC?upio4deP~?-Nr1eM1-3lu1S1!iQ2K^fmn{O zwPWD`XO49!IctRi)du+uv23oCx|zAR;fD!qGNraLiBb2pvB!opcnK(xq+CH9;wYRySD@t_nN$7+b@d#Kgfark>~)@C=P+M`yb*UjpwRG(W*=k zD26PN8V1!gd6*yp9b-He z*@zx(99r%(K&T86Q7R8e9aA7!t>Z=~0))3c1xXypMpjtYYAW=eNU&`&0D*12BEZrT z41Wx+5Zx$5af3j{P8ze4FqiHv@=>{VOQP~zzA*HXQ;ojF*QKjE0iUo2W zo0jrO;$#-;DHoTnf6Kgb{%LHZm|)#g9rWccieHGk!NRJGY8Bb{WUqYm^cS*FP>*@C zB#?Sz7;(=-*@-42_u|#6@7AN`xh@LHX|8i`uO|8Eo;uSV5<}f1ziEX zxj!K3<@4{8895>f#y{V@d5;wIsMP#`+dD4Th*pLeAEMJB3o}2THlN)7K(VexEEZj5Aohea*LVm ze=ls_I>0!>nub(pILvPMHtA1vf3W`|UNl#IpjB{UoV6BFoxdN`KP#M=QK|129U;jt zsBrS)(Ez_LhYQA-?oA{TX?6OIvZJux7QHV@`+W1ATt2wB8GV6{K9SpXxJm@qu$w!q zPgZ_q|6@ecdBKrF-Q2Fc07s9MG=Y!e1mFAslc@UlmfwjET^rUw+#Sds^;D)gb}o7B zf^}`vp(u#O6BH4`GCab3)4CqFvhW9$!T%|0`BBCrmYIK`7{AQfUmsc>#lFx83JG+$ zpER_%)P+#yW2iBE>PYY{zMLq3Uifz{LiyWSYW-F7+iD#dskpC`)E|xn^h85Yytif3 zb#PVIQWK)-WzEcz4cJaV zlo0d1QFoA#l{}b%;k|U%i28=;XQtVK9Oo<_F`xh8Rd@Q5Yu9;HFU$o9j z1GaNtH+T&Cc&N|w3#lqGmq`fLESI^wv=`(P6wMO6gqf6S*+QL7pFLOjE_%tv;O*eH znGf;?@pAuIRP7Lv&Q`ClF@0QtkN3p3W|2{Jw6R(Is}P~VoQB#bkJ%7%7P>d=CDo#K z89bNZv!rjR#2Y;NAk||xOz^`SVjT9ZBJ4426nJ>$uj)`l<4Ez3jNoa&TnysPJLmz^ z4Ka7x;Ue;+ODv3|d>J|_i2OtR841_!D@rPP5YFv-?#I7B@uK2p#HOr;p2$#>fb<&? zQ+vj#OT;Y%%s#GM)KGjxp2eu9&n0!vc_S|auD)T2A4&pByXsTGZv01*I&Z@)sa6sv$^~&#wE2`(MF3cAz zW)8~N9>#~)RQgOl0)0&^w~N_^CmiZpBKgF9wh}noZr7j@xf$f;0isQvOa;w?#g8PO zV%Wx0i|)Sn^M(m(D}83ri%=spa1(+ow&=gg0WnB0wjlqtbj{~Oau7~-#+F9}*ep#0GUG_wJ)onGw!FPR1W zIGE6rkje3msh22;#uRUrv7l;3f)~8UxP){ne>Wmg5r8!Z5aRFoLAMmCnQ831wIODR z^55N{YOe#9!GCKHgrA~`vZdITB~Ig(<;js0#`P#C=5Kvl{LY*{r|_~RKfC1) zFZKR>KELn(k%ye|8fUzo_jOUH8K{w~Whk@N(o;`H}<70lryYrNW{+G{15Aw;%Lkxwm=8_(Ww ztB$w)d_gEa_+Bj2biFEaL~#mu)vLa}lGh;e2v@Aam!;mC`Pga@b4GxCnNX{Hw@vis zyu#E8>&$xrb;jR@<>*%zg)L*x-Bzh8&a>aiSrZ@4ZEpVuV(OV%&ca*^51L7M_;g0u z*5G<$RokUd(waSziP_h|Rdao(RE!FEs`Hmhssg+o^$Rd!Y`@=#n0qXJuKI!7Rr%8= zH%?%G51D4R+zgRt@5(Lty`E;4jjvd9#Z-6Qa6MO=<6-}FHZkXmb@|uI1Zph=Gw81q zm-PD0H6e9sGU@COgEc)=T~aA^&5)Vm-H&PbG}RjOYh)hy0-(a6*+`-22whvjAkXn% zo$kC_h(m5T&^Duxv$HtlMgG|?qtl?MC0u=@gzRz4@7eQO_~L`6W-*)T&qn5ElIhK!j(FmJn^J}?tcF*Me#$^ zOsFBd&{AH2Gmu6QFT@o=E*jK!ub<|LZJw^RIKcH`F=6RLLb!` zps%i~<3KiJnz#pqnYCmdZLPK zqLm^Ziht3{dlz_@llEll$0W6sTVGgYa`UVgV?3Xb;WRe{a0WaV%80~*YMU03ZC{Mj1^aW0mXbJyfROEgn6(`2@%2|3gJtj#MCg|6~`fj2XI zeUm9KkyT8)iFpmQrswVXofHz#Du{2u1}oTn{e@fywxx^n7EZ~hx4c0p_f+eKra z;5@mZV4->D*rdUfTk=m;XdkHmxN35h>mpyOgIQ+*Zc7y!Er`?r(R96ZuN{vY? zEc4`vdX@fnD(oUCRNkLCS3vF2@z7|Nt+H~Cc~$=$bvO_N&1X58OkMrnupP``C@&)H zNsnnuDzA>Xhphb_RK$<9z^YRr&;C5gaPQuQ6ww_Qk!dEz;Q4O0JmKz~AJ+{m8Tu=4 zloSRO*!#qZ?Na!ea~))-STh*q2UbDW0VU2QT6iYDlEg}ZsySZ?CQrxcN`cy!9{6vD zkAh1axl#;vY3<%wB3%vw{c%bBQqx{+$h{Q4`yX@CP)27s^GS?H->0iR^!B87P?AhTEV?yCWbgj4~`m01878C;+fwgarej zX$NLKq+GzB{#%mx3pqfp3>(({|L*_q9l$FkXB-W>d8Cdu0fh#A4d8=|k6Zi0@@xDT zQydX6|IxV~Nq96scm?*QUGk;|6vhKxjfA9+?E(nleqz99qcHcU znBj<2!HRY0sP0=}O_sC??k%HxtXa$Oi!jNN5VkzY5&seXb!@FA%p&!El%-b0@sX@~ zW>@Nb{KSZKfvdGp??)OIpcIAWqO1cxB;GItKvse-@BlE~se&++Jh!TlSqtC@7BnK! z3|R*QpBXleJq)R+ayY0nfHec)1z=YLDlLF$078gvh{78F;XGM^Eb93xcZA1jT*ijU?Ekc=hX8OO*Z0cq<; z4Onan@I(LvnZPv(0D^!~4meyGsNTRokk?-(1SJNa3<)dTDFl~OKzeitrYV5_A2f7` zH%FqOARoG9SoU%By#lZY1+pmuU{64u1ZRcO(mKAy{m-;nQR1#b%FYsLwNsw(av(qA z+{Otjivvc*>`+ThL+c0Xl}jly+^$Hg)+WwNpHuiBSquK8kt_DE^2j>LZ;|KJBBbl5 z`*S$Z)iNN|_vbUgSQ_Ri-Qv)z3--uhn)_RideSLWjepnL;y%rbcM6);jVGLE>8gJ6 z^F42;hua#dsNF3S`From#?Q)k<)|;qza_AJN{)DaYS1>$;11X5>8y7-VTZ!bVH>_& zXV0yn_wQF7Xmy{E4>qH#S$ZU=S`m91|AnNBZcIpU;f7 z@`GfrGZYu}^3?%gf(Ah{e| zyKY8Ip<=#csJ=6t?`3Od(?WTQkzPn96FtHBiQcwYS)~yb5Hnw3LpO3q!-Of z=Rz+U`G60XYLcX5X=T6JL2ukA<38v(HWFr8)|Sl7LM_vBzp?Sv* zH;&3jxA_}eQ@|w3PLk!actOTdTCr1=kcdd15?4#U(jem` z^9Zi=+QTAj{i=pt*6G}|2y}W_tr(T*wcnx#j28VNKdfVo#T|vOXjz6>U2V!`x1JI~ zw7t{{t)hi;Avq!?59!yhPe_}TWIl39s1BBk9#k{g1{w-5U3iocoEczM*UZ}fjcLm= z_X4l5=%wjM26SM`54sg=moH3tOz$2m<*z;%H`CdURdv6Xy6JDt9ux3HMETq-Q@D<; zmr3XFd~~|7(}}QYdM4Mwa`E*?$<_10rz{5h6xjU59^U?yTT}lWOnkUw^tAA1quKpb zL$Ad;SAuJkZqLsC&RvN_mE+?J?p3{b78AD@_#2 zoN0WZmSNp!HEvy01JAw*!=7 z6+G6#TR<(A0w~ZUDm4r&GXx}40b=1~?;SUF&9AJOYp=g7p0Vl>)HS)L483~(hP{mc z@I-Lh_N}7jHn#K%`P2Hk5nN>Zl<$m`$Vu)v>6ImwN84uGCIqA2YsfEN4o=~(qb7a+ zNPaKiZoM{#z_lS@H%lWmK$kJ3CvKU&qBTNoARiMajs z7ughM(Nnyr&U#GfiHL~JPqM>A9sAL>-0wS$gGNT!6s{0DP9{kv$)JFKHL{aDpB+_S z896)KWjh6kiJFf)=}Wz+BR62dx5&r6DYP>eY`3cR$S&2-Fwi!cDjfJ|U}+;&W1U#G zcly(di_Y8@_wsvgs|j1y*1a?i^|GgC*KJsy(1>#8()M4u$QUhXT4pJOjeod3DrfMb zAMl@7O@viPWMt`-F1v+F+;`}|Mj`xFJ2e2W`l+_T(tI`PM!<9}V`oR}-4(iU4(}Mt z;ysnQOmm|T*o6wn);Rcq2;fQF|wB-c4|iz4C!Vo6%~mb87g zd-cpW$8_7P8J`V*bX~Rr@iciEns5m8w7@p}M@U0iLom(MEp^e_5gCH=l>uSc!&SLJC9%syxZgd=P@*p z|FCKd&?U5hBf!2hf1=$H%>v{B?z!Qgz_sE6ix_39MzkDQikb?7C_>PdvgEET5(a~q z?ofbD$X(?kN8{!;sECiZukIa z$$S#wX=aa9(em$gO0pP{uG`wBY-SJLpO8N$4bTQsj)jdZY8OrH9^6Gw)63Heiyz9X zXx8#Zs#I=PaLeq~GrLkP6Ns`)Dw-}{-7LW*wOB}K56ls@80Swh(;%}QJ#v%f1x_?o zTE{y|wxkv?vVyjW6I0kwC9Q^`G9`U&l%@t<)CS_+o;lfb6owe4!FF6yk&O;cd(hNs z#Sl?egYBXm!sQK4{7?oWMrWep#&F_v{s`|*BC2dtgN>mRvd`$mP)irMRN%sbP!M_$ zOYa?z;|*2OaJ9-BKbd=9-)GG=`rf>f*GN#WgNoP3Kxc;VmqyDhUQ{@w7w}2``vrkN zH3U$TcEVr<`LcpQ=CcfesRfc60J9+C3Ggt3EMRk!4W@36L1bWKBn0>vI@+}iB$5*P z0VY?$l`HscnK2dRpyK0&+lVVx(TI{%3`bAQD@GLpV_|aoe`cJ`#*Z2LE1i@zr?h!j zVJ-i09J{3Y#wzyMt&{U-LL{;atiHF4hBb0-e||iES(Ksme9icpap#mNxz6*god|M$ zvqqy+=w9aALosAGWzT*imo>9n?^Iq8l+in0M`<{LyfaKHUu~X<4Bw8!n#*7A?>IEI)rap1YqhRk-BP z>kZpYh4<>V_{n#W824zU=bO<>7=zaCs}xdIj1o7fZZcJGpcaaY%zjS%8l#AjdYHZ= zx1l8&bUp0AY4T%L%tGOU(La#V{Y$s3rOvsgc_{t^9fZ#0$Ii&z`+hK*^OaBF4u+=l zM(6Kon0ZhYcjW+1SA zrG;nj(zEl5R!&5*fI}M*0gWG``2pJdnkfZz2{vh+cVx0PhH4R6s%?{ zY8(IR5NPgrkL340zxz1F2L39gqg?+;y)kWa5!r@<=&^vq)-_6Zg{--FE#H`qVb7qvZcGTZA`cAjZfGUY^1dPmDw0a~jo zn3euXhB5SMyBb$ca>J12tSmMWh`Z&&qo>CxlxT;;6%Ou>uD!@^r)mns*G%vm$NY4& z=AED!j_8zCbbtA|vqi`)nw>*A5o7cqqVuzK#fn<##gXx6`TIVj+(wR1lo06oI>FxV#T` zHz8^R19BP80U#L%@+}flQDhrhbYd8K95M{8m}BUp=;i>7Nv6VMh%X7OuDt{RdywVv z1OmBSD2}9K7m;L)+bE=3tMTv8d&_vh`;}Gf8t3}z)#|oqEr>l}>D(prQ(xvEh@O|D zI7ON?Q2)W?Q(h*E6zb=ay4!iR*~UJ!=}Q|%YL_mpFxf`P*2sN&B_XJc5tAzv(l}pkdgu5$4MNqNF3vd-$zAJRED#R>BaG zXtBUf6Pqw&SmG6F-)}rxS9Q^xHi_3$`%+35YxS}=F@O5EcBqrCExNGYT15TXTdI(v z#1xJw5%m?}cOTBDM<3@JuwA|EbzjBwcC&cNXcJ>0YC%@#JyR8lMq471+GxD2qS^88 z0~2G@Htkf)Y&MomD$5HBt)J$ZS=|a#?kF#g#JeJ8y)V)|lwaabP3B*WXg}R_&gu$K zPmd^v&x==%Yt1{~S{FdRdQqNY#o_8VSsSbIP^hCtI(ZjNfD6%Vo+@tKH+(+Nd(%B zq)4ud`amwN#goD^w<&^-Jc1`sW^v&u8&BR1)qDq$ErZx+=QZNz$0n!TRz!xwE$J;l z&R$^a@juRTpbi8|G`j>Q!0Ph=9FhSXKE%V1 ztoTU*3IdG?K9C5g$H0)_2&Nn-E&F@psD%ZfjZ`>@!G`<@7)AV1i~Q&5Fm(BYd4k2m z|5G+X08>183IOa70*-pbi~MWq`{&t!S^-4{AXUO4@Hhrw?QtYH0hkB@cale~Jdph*sjY#wy_SexX{$NCXuZ}fqT zgkD{#@;zbk>t;^ZV|t(~v63M#m*i_@M?MTLX026>q+<0l4Hv@iAWK2*W^ro+6*nq9 zl}|3!!^Tn%pbSYZKrBfifHDcw0y6~0P-tRRaJ`bN5@1ohJG17gk*X}AJ#g8D4*Zlo zAW#E-fk=rncX5H-Gq$(D^^S(N@Upe@3=3@6@-srx^;T_sv@x=%UJXTSmT*PK(D=vC zQK+~wDi!a}HW(+Bpis$l1K8c0=!8D4q*+sivd6SJ5Vz)M)Rb??G}*`l)?WrJv~qoJm?a@9I&h*GLJ8l zQN`mFr83F(K^Y3t>ez)WJGQ6T9m%0T%$8Cnf_+shw zl&lZ=`CF?c% zq8|tVD>Ki^3PsQUdNWC%#m8J8sZv+`-mK&DOVG5aN$EfCxQ1I=FH5nD(53LVd%hpj zZjo!F?iO%9&%UeJ@+{wPg^@yTEnaHUGyHe?-7gi_>AnjHB=pVe*ylU9wH=C{I=+j# zT5l@rm_}awoqWgR)Ej|bPio+QQLrj|eS4Q#|I1b2Tq4NF5zJP2D|c18fbX3;7(+Cz z?x5{JF7DL&l>Gt&$(GK7$*^n8_qjf2?&8nK+#b<|#5m1(Dn_3-OSil|w%1jzeCb8q z0>cf*U2ow8!E_cS@8bG8TM}0+wxDgt>Vn#buDrzvp8oEr56gNvVmIlm%j&JGg*VTX z9_F^A?IACR&lW_8I)@0+#S66)6S14#CubS8-p$e<<4-X$4wA-U-;U7K;-yqNJa774 zLK3I@?78|1XYOr3k8ML5B%3IHO^%Wk4fw!}F%FS&KQH;=hN@f=$HIHZZAv!&`sQPX z4DZaR3rn-AL<3v|m<-1$qKA{G{WC8KEMv}I&FMALy-k{VF4k2u-)eQWM_&G=N?}UD zRr7OK!i@*|I@wy2q^jB9t@b7s$}+#zJLBbOF6b;`KuXHrBjCj!>VD#8YV^5R$G%3z zs%z_~f6eT^Acgz&%|}3fUN>6}^*+`_ckxEHV@A`#htszUP6W3)e0T0^Ov#Xwpc+=7 zu6h~8T7ZeZAllV}Tt+=lq&toKII=t|BK|A1H!xg-=l0s=hvu30S{v5b9o%L)T%R;T zxs8#76dV}3iWNG6U_bW4m=5c;XX52Lc|4WSnOK|H-Id8>)LDH@UnjcAq?w}}fUD$yDX9=d zB!Vaa*jbSM6$Ad1E};w}hV`&fSRbu7AT#kv5*_lks6Cyl*s{Ge5DsSsP zPCEx5`ZHCPHZ($9nXjmt(G~pkHoxxaZR-?s=ymy3gvOjb9N=tq_7)3yU*G1%$eYEU zwJWg6?W%O*>(Ua#JR2vYB}ZLbn^TbdMb7kVdI=x#61af*r*y76Dp42m&!~v5C8hZ5 zOWJreRK=v%ioKGb<-U?0Dc>d^eCc+eL>PPY9l2g~aCVrNy}SYEIpa+C3`^!2(UuvT zy(D{z@XYiriiIoO#~rK%oAtc(B5!ONV29~a0#sS2Ht1^H?1%ELZ1hcn=j$hJuN#RCpyMSo+Lh?`<~J)0uk2W_ zw@zYqEmA(eqtI@*mG%9xOlZK6#f)sBYW7>r{+q3y0v{2tL`{>|E@JpA{H;Q&Z#_gW ze_vmtCp}olXzSW`87C^_a#asEU6A@jR`_*U^dd{KPHuO7sMK^bHb6mWh_f-O;QT@j}Sir43AFT?t#CEY&fhyxB&xTM_`=_h~NJbBA`CRqew#zAO}2D z2PMTL-HR^+&ja{_6apO}EzmL0Fd+d7M2OZuXl4tzjcjkxS!|KS!2=oL#uorr_Cbw? z1e%5IKmf#C<_aPdf zZ9(?_4+{gZ5g!Ql?eX}sc_0G}#Q~K?GblkE=`WCgEm|4Z1aVg%CFDVcH@_`|((>6& zriTAY>IHuRt*cT64peeUMdK6a&h|dz!fhmpwnXp>$=vQuoHL+Ev=ofUxT6dx z62PSZmgV?#2lT=!Yo5vdXfeamlw0)3pq3QLtnVOeM@Dhm@BJZi8HfgrqbVPRhL53< zSVxFk4zMi{%NbDhaiOUF-PnaG}z6x;;UQHA>Qhm-LQX9-4T ztC~2HIRU$eU)Ale%p_gHqu+SGy68JFsoHDy9`yCfnoQVM`~!(0?=HD;5B821%U@0i z5$W=_x7ZUGQTVzvF}~PSFSk9-#-gg*A5MdA6jvpkl?e?K zW2QcxtNXB)Tg5MyF0B45C)azjwL9WqO z2L24jnP0qMqDIr?%Vc7l!LxkCYaj9LLU|2&Jet+clWVk5LF$?2Pxp+4PK!JHEZKr@ z1B=Snc|$leZ&nd8p>JHN-OS62e9e6LSK) z@xA|MqIc6~*ok|~=Ep^IKi=JpI848-oc<5=FmsaIn@{)ivoU#sjG*uX_bZmF{0*xf zspV^IwJ*&_n~VxRsJ4rn^~7uGuhH719}|08>neD9UD>ZvEJ&=^hcv*9qp0#taA*lt zyIh`#k@*WztJO=cMwqx}T%B#1Ype$lwvr{0UbXJmQyF$JrmEQAF>`k8f`-Adsr?o`ZkCU# zY3#PvZI*=U;as{RYha=hr+Hh^srXZo3_`bGKq7R#>}%^so)WwC9}i+(MP5j`Mj7*k zAR@xBRN4rvk{n z+WYdBE6@%nvO`iWXq7+PEwi>?(dedgo}WztQWnueSk<)5yn8Kf?B4bUCY^9GZPB4f zVPi2Mui%{DlR(nUOufYORnNX~YG*MGK0aHkWLB0}syq2sK)wq30mY;{I2T7y+2ZrR z$XNKscAqnEwrN!T;T8hr(GVB==ylW%)7T=dWVK(N-=O6S$<;WAz#BuR$*^7ib8$slKC%utIC3@kKW^EO7-cRWT;pbPKi#&NAgQs7#;}nZ_xJy z+=^HsOJ~{k5DRaaQ!l4v^zAzk`$(l&tP4{Ih$IkZMPNfDXCQSXPZc=^3^jZ##=-369#B$&k-$@k)E7c6LI1KDz?0$6p9tKtJZ^ghDprFm zw&)Vz0YWg_phy~lR_i{}ryijQ7%{*A;Sc!%bgwxe#M2#Ngd;Ek%1jU+t4owV0~hF^ z0iZ_;0?i(P4*9dSF(iQor5=E2fPEP?d_uE8Dgo!!sJm1UJY)d*0*?dJwDiU4HCuRB1hJXEBqbVPSh0r|TpScbw0?E3##PYWZMKTrhO7DJ^Rhqsto7=XU~K{a5U z5qRa~-N7~~-6RPKQN|j__37q(=;jpg79(mHYBj_NR6hX<8ZxyuXksQMP}qQ-0UY%o z$?ilCsA16(fC2vUZ8Bs{J8)PYmo-9-}s z6+ul`Ac0trAKwLw&{*Pqbh+NJQ@3D6o4+8Sd|bb^;lak2SlB#`K~c-g}MhcMEcxilMi5#tq0ffph zSK_!`U^ollVyKXhw?N-#_9r2H(d2rt_;3M_ikHV7WVOaRbWt@J8jIQjvRKfM17L-8 zojG7~TY?Q!@B7$5TAx^grNF1geG`TFXZ&uJjrqOss)@j)s`LAd#gk|4@6;bK{^Ioh zvLO8RxN`}!SLThJ@Xbh@B;<^U9q{aAtvY1(8ZoL+DKGFP|D3yeMR4H4`wQ+)U_#2! zdTY=(?1%6B^KOyS2bCN=ZO@0!pDNC{5ZvM^xryl)+W_N)Z=8z|u1zveemuI`Rk$VO z?PWg@{!I7RsYG(0ZGIZj^ET?xr+*+13E6AMU-u3b9F|hycc`Q)Xbs;JZY&A#d+-}Z^KF6xzd(qnUmo}s~yc`C%ST_)R2^k z#(Yon*9yi;9cI_hp6jJpd+_pw^wkpOJZv5|+uF?XLYlTPYQ{@yIYCTf9ynH%i!McI z*_B(5-qBf_O>T(9g|I8&?dRpIHo|ry%AN>&NKty}@WDlXi4hK=GH_wOLJm)7`(*0r_{oL`klvI?abW^?oDQ_gRFAgaG zSW5Icv4IKvcH=8$bmgGjib;isd`!0Ft?Wzk_!}pm^6Dy*3o+$3(TA4~6n005t%r2c zp6>BoUCr{k!Q`W08X>~-?eN0>F?oh{$rFL@VSeq(UmvCBmeDlTi5jWZhwz|SUY?e} z@>E0s{rdLDw5UBl-t{qUvlFQ|o}8DR>Yg!CEMdiZLQw+38aEFW()}$a>sakQ>vH&; zF7<>uvHlJqb2ol0k#%DYBV*;fA9>ZB5})eTl_9<+or7UQt<}&ogUkwUay_rd;+*hDhVzu^td_K7-IZoBhYh2Et8RfWewCp8jqL>D&oookX67$ zYnVPH9|elLz%l_iLHFXGx14!mF5;w4HtA1y z?BaaOamS(y#RUw3xmjOq6-d83U>y79`MiT~TQxSOl#{C!pr6Qo3b#4_lm7Q4xoP(d)4CK7KR#&}PU>7Z7^RXeKJ@pvR_tdTYkRK6^hL1z>I7(eF-N=33 zK394juvk#Jj2TyXu;kh0mK7Xp@AGL{`NsMUPfY9Ah9l$g9T5M4E>%2y8FrkI%A_Pw zhA4I*P(T4;?oYwtC`Xs#`71jG;oAzMul1*81_lZs(jQrKfw72ict-$-j9yTdfO-JF z0JfR1VFlRJzamjCSm(;s68Ve^Z-)eiqlm4IxHSwB=u+8W4Dd&c0?aP?Z)yBJJbab_ z7yzY5BM87?BM2UP2<$@v;6M}AP;nruho|{~7K^>36W9XtWdNA~fChnv9|yWN!|5rO zfyz+>XQ`h^j=)p>M+Ex^vVd)Sz}}C9n*RqpfOcZAC-AB;%`fn>1W=y@Cj~sJw2yWe zgjk>f9tNPt15_m|^2vNidVoV0C}dLi1pn<0f+e|ssU3htfJqi|qK6vdV(bBqG;ugP zFjvteBrf|4pb$t!si?`p6;JyCvIDKeFy*N4e@cc*#p|RbfC;XY0OuV!XE{SiIdXsW z7dTvdutfIeJ=PZ&2?c>!7JvmH4iTpwAn5@_rzTEZ`3%~}(o4ft7}RU9;v#_795u3z zj2{&Yw&>&X*@f7T3aI#(@4%|k9Sn&A{n!{pPTdkLK3D(}lhL7~mQehTY+47X62-}0 zNHFk&PHR@4WG5XBO|WQM99xm(%e|KP0FW4*r6^RwGr&)r060Ka8bg?NwSKbJW$Jfw z`qzpz-zaKs%g#BRTzn9N$25yN#p8>RM2jh&NF@!l3JMjE!GoTob(Zka0$#cBIqf#Q zT;y1y3ZON@J1ODzBa%K;Pq>sL+@eELyLCJlIECc-&~e-jWy{PT3+>pYBz6)i;s9NX z=v^iN7mfsfCH28!rpoIyuXi(s0=z2U%I1%@+$=5kF=pPe9yV<%8b}S{|H!blaFS+W zPAG$waRlMaRG-;Wq-y)`Yyk?47$kBeTZglr0 zIJJ&VimrdmSm9;6a%L!Lo#PS-Z`B>c(;>?qb`n?tK;7Jv+ z*jLmxp)TnjMd*fAaMnhHo=0Nf15@isi2%w(zj7Pzixe)tqq@qkWNr)<-n?ktLSbqh z5%Q#Lhe<(U`V-!m&*U0ke5S=#Q(G;?tcf2j-e0YSc;gd6Rtx z6(c29bL~&k1HREloMC&uI+QeeU#=yO^DyZAr4K&ILlZVltf6ujQVlOSE-;?YRPOg0 zqOiDUEY2xxbJjVYDe?(*gq-V_<}sD5ri*QcmeUnYmZ-yhWeUr5x3dhbi_vO|_iv37 z<7IeiWSZ$)4Al<{Il|MZIB7a597;p)*^7u2TA-YMzEzH%|K68%)vpXGsqxW2qkSJ?G+hvvtNasHTp4#@+~Ip66_w+9l1>1pF?Inp*sr zOI(krl)hS-ZOJXDh8X+m%jA;U$?ooy;>~*MbYsWu!+Mj<&1N0#-%$HD|GU@li699+S#D+-F>0s5b}f1{?8>xQG2IK_rzPUE z;Z5BmQ4DHpw+w8*w5@H>K1jlR|3zb6nP0%%n4PVcynT3CkHfUEo-?LQISe_w$kEmJ zu4yOhZg|{?{I_#^A5(H8c-yw|zfLd?&QhH@A(cn2+3dk^`zC+;jg!?$FMFSKqmMG^6KR)0_qm)-BQJ**qqSBWjKd>|pGIWH=IlvttZwtzy$fHA(WlE$ms(YQ_dSp2 zBZccU6ZJI|>79Wt)9;LLm?}`Co`b<&Th=vm^c{KfXkR)~0%yGD*lTVN%pDp=|KsCp zqV9I)#wJF2jVT|KMD#XSXQvTU!vcLFY5v0d)fjs#8$stWg}gvvt+vDA_Zzl9gb9;e z>05H+?_G+&-jN;73*g%t$^Jo4?fdr1@ep1bLC-gyj>ZSq?@O*tJ|j0zVkn?KPhn}B zbt}%Om3-M17;QN?T5@VJ2UlAy?n6HGU<^RM+VMytrn>QT8*`r6CJ(jHwxPi5I(aZ4 z(7m@QW0l?BXvo6&I`OR4MS`#t|0w1}lzG0QokQ{B`nT}9fJUnOep-#MC_6c*=hrNz zkCV>j?#|dy_Og7U)t)JG{`?6cD%!1t5Wo5946*^a{Z02K%@>|c<$EsL7308cdIflg zgRr`V0@l>qI;fB;9nTt_ks z2S}|2JO@TBXQxC^aoNOyA|$!LIw%6r7ApaPi^YN(XaRvEJ8p{sI)=YN zWrG4{RxJo4SU?Fh77#V)uz_gE&GfP2pIFEV1Tv7td#3@~fEnbn?9zR03_aNYj^cxG zySUR8aju3f;b2_N1{jCTg6PZ|R_0a$CZ!!=%Yy9Hg7GTt|4_#%pCWjj<|GGq^p+K#zkVf6#wd z40I2ZcL%25Ru6@|x?-&tz*Ze|DZWIY@k!42*%s0Mq9sd9gV7Uoyy6qIjUQrqVtNys z15&I+W1on9(YrS;^UOwOezfDnVG@B_uB0w^r&=o|&cbXR^z}UR*s$)nqLFxg!Q$6A zsNO!l?CZB6>S{>ozo!0u<^z^HQ86=rl=9*rcVhTTTgq^kM&wuviWV%QJf&8#Gy)FZ znnjCzfpdp)EyH?5R-<+7j5vr z=;=jWyzMCi)DQ4Ddb_wBiGZ0LSNtLOB~5V`)DWl84M zJ6UvA=D#Ig^6J|T#(GM(@+V}|SxGHivD<8x#ba3?ZZzJAw{cy@Y3XPV<*f_5_Y(96 zgoVYPi5}}@1U=VSZ&6*DLNWG<~z1M*we?hq z7QpF1AmA4+}4XWhPskw|sw=V5oO4Lb!&O?>vXwJN<1o}X2&G02p1vlgK(q$5^_BubU@vLc?kFDV}- z2S?m1ypDWcK3Zo$0EhGmY+$L`gZ0l~nt&QafZdQlM>`Fx&lVAg)K9>jWc194@phv6 z-{AeYUv}HZp_+wahjS1nFeW?%uc}D$>W);Dt8Uj>V!Ehx~`s{ zX^#r3*`Q?6N4utYna_)&ZaI(SVWGNShCp+xP5HJ5u3HZifR^z+s(<=>>7tg5YNb7U z4q>w2YyV-HRQ?Uq8t+rg#PdmA{;vk& zx9Ivro`EpO!PDS#Z`tgkDY5ly;sM7HRq<_#5V8xIR&};8}Ow^DV?FtPSNoiF3E_ofKNH&#oe;4;P@@c{;q`UXW;Tl|6?gDzd&f$3Sb| zvW2$mRf_|gjOf5fR0waI0-8VKsW+>rW}ufwBPrJ2lxVn7i|lAC`1HaqOIu!*naT2f zF80o_W|(MKrJ^1f=vyg5=~bmvq^%~D_PIgIsP7Kni{WsiLk^_>l6i~#*rLK2r;{7Q zer?VX>-7sFq`3+E9Pzw9#^i|_R35iIw(?6!qnq{(e)4LO-%puw%!4v-?ma^V-MUzL zc6u>dBiJc2enqQeEP*>K+e#~N)hK z&q}xL+aT2_Nw3D4n4yQa4vFdN$CC=}Qt$DW;f^yJzIyxq>1_!bjIGBTB8%xNVM#MbXEEul=@BrBAGXd-oWbOZ+o)74r z1*MXs6Nhj}a1a1h;PCwS^#7b@4>XU^FBjJ205Ka82c8Zv0k|+<;1B>spvm^YdHlay z{4F}b?*It|x@e++trf%3Mf(@}1i`+QYOozPVu3aa1qub6^HiXeVGi^OIAD6kQV1{) z2-=|Dadd7QaZx1CouTFzxb3%a1@Y*!0i#|h@aB+CXp)@?(PDvQqK}{v4#qLV$`K$G zr3S?v;GvDIRb;@?ff+(Pz&YC(a>oHVYxs^DVtf{q@sHu5;BUO=Q z*3#)778(*15S~%^waTTf_o<#sIai{49x|<>D7=KS^Bv@fM@#GyOKl zhCiaQiCm}V#0NYX54CaZWWc9Pde+biwzKadwo=xAg7 zoqQZEPUgLfvWKkeDL)l`E6QEfF*0JlVv??mqoBemMKHP4sOIFjmOc~HPSJ8RGQN8MGkGunzo$dZck zyt{B^Nt*IpX^?|hNmH-Xq@Y)DVyRl?1DPH3D(Z4#N$t1o_NPj9>C823##0X)lPBY5 zdL=8q`chAMi(d$~z?6Y`U}s%5XmWi?!Ma&^rsd|VV_7T1_90gy{jLaaFZ@71_y=0g zzLF^Rs{hA=tWci7>-*w8pyk!~H{{RPgJxxZByelpp%#B6*ug-S}Hl{7t&L(0HzHP16#|L{mMJ`XE8J9Ls<1h=5KUQmRJ@e zd?#9&BNlpm+j9kFtK0bML@b93Z&F&{GGZRK3=^Q49c6wnkUG6fjsKbW0MFTNN05>k zmRqPFKAq0a7%a!eQyTfmAX@X|?fZE3;2rk>TK>HJvmp|)quTWjBrKW4oQQqPxxwNEpsdjqg%Mn8`;|<&X`j;mrkBUI^Ng*A_FY!I!d=MXdlxsimsz0 z`$+9`zclTWR3&fW8<9J%+xwFLK(lQnxl9o}JLZ=L@B>i}Orj3C1^Kl@7nO&{+w+r1 z=z|kChfVuaEtx{1u3*=Ev<08pdY*0+zPyuPmH0D8D^W%_cwR>+!dSsD1Xn%yO6brj z<)%edKRJ0@vzThVz(HLVMR7pE>@(9HYh%B*#EeQ#Za#qA(ax9|^}@=bZd*r(s;cQ$ z%y90!q0leG&U9zYJFQU(9lOlO!1xiQ%`ocI!jVWIdWazQ09ijZlru37lkEy{3IA`+ zeIA*TK@K7{o_Lh={t3Gvp0Qy6W~pT3@I)?n>HbfMI|^a{xdW&R!Q^_E7)N z2o8D;2*h2$w<`nA+hGr_=CftaKnbk0b--6%6$H+|Jqkc0m6>VwB^If)G=#EzXK$JvzZVwAm1KHbe;R2}ct#U~@81A^~q2{JDa62!=~Y@Xks( z1_KS=28JH6>d(VK11L>D3!9tO|3}zgz(uvS@8j?ux*MdWOF-IT03AxYLs~)_q!9&m z#GwR6IwTw#6eJ}S6-fzo1SAD%0Rd4lu+D$&LC-nQ^L>8r`|)_dJ$vu9_MWxw>%OnM zb}feGB-cU7W#&jVP48wGi2eqF91eaA&x14;NdFp-ztdpP&HN#yF*NMe#Q>5^6_<4V z41R!o_SEL$pC&6+C+)u?4gP{u__WBfUK;pltaa^){8|qVyitkI4hOsfa1r8v2%LtvtK0P9I9UD&PRJ!(1 zj8;`A55M3$G%Dh`!eu?O+;eXTAqq`-hjy*%S(Zvurr372zCL3o9iD!)p`OZ@m+FE` zjZLx6C%4#&4+Ye#qPikv;_}lXuT}MrZ7_v-hfarXKi@R$OL$bB)rVaD5u#L+YxC4z zL_pj;>*x5dPkhGO=_sjIJ=q)wx6!ImeGnQr^+SD8+&Gid_GIGQ z?O?H4EgJ8lB@WltbLRI1XN-K8T{$kCj60m<8pV^qf+TMo(zoie>$p>lX1NsIe?NYa zL)N9zC~2AB)O~KCxv$nuSN)AwhqaovEl{W1V09M|X{Z(HE?3WH9DLVD7t_nL_+U?SRfakz*xX{^dIqy`!)1P;%Z?& z_IAL@3T2JsR`@mOc$C# zQzY+{W?>~OuioLAS(!fe>Qg5b=ajo&?^FBiHo5NY@VL4|=JOlt3i}AgK6*tLEiLEI zTKfhzsfj3_{qC*B_ReGA1nMrnQ!Oj6QYBP`PJV(cHE5tT``P-tNHQO-rVh4^^|! zZxy86<2yRRhQ+ZvQ&pR|?dRK&8JMW$8$4|;X=01xYksX9_imMzNrE-ukpAT?(@5yP z|J&SBYjwTUPq;!3>1z+CaTC-5e*cA-u%pf^=?FruI z{XC&M(OWNe=i@pHZM&#t(-+}D9#Z|L#q&%b8S;`9IOPc>NQ5i$G2oNU|CpZwfTH9C z-3~ypWi|+Iess{ai2@-=2e*u}`Wwn1(AIK*1_h2$Ky<9U%?XK^brBcRD~7JkC4dnI z3lGkZLoC-q!0v%-FoUo)VEuvS*0A&jRuPOY0G&t^;Poo^Pr*m{QiRVoMo7)|;4V-L z+);uS9SkhTKnO-M1n5IW;4PcLF!?Ot%Uw{xOd!#onGf03g3tqyN+2hCbl;-G!4&{7 zk=z76V2LT$^Rm$s=i&e(6g)pLEg19Q9|!aLM4Sx70b?YnRP72T3){)yM3CioaNse}#uHx_V4{D&TH+ueN*-))7?8HF^3swZY=HwCw!A6L9N>4&+lE05@}em0 zKw*K#$F@8&3n(h%P+a^VH7%udu(|sE0Z7oK3`1U4n({;^n7+KtXMwBRBev%Z4x`?_ zK*Eh-OjlKL}ZJ7lH~yGDCnY1%N67Dg^YILs~0rqIuUw!WWGDQ3yC` zfIe!03xR{8yCjqsP~4#P<;$yQ%{m`HaTFi#w?8DV5b^RAy8uayUgYjK`$ zv)=CaB%1II=F>P0Ne_n!x=2a1t$Eb6M3ndHj2D6Q~9c=)12{fkx$T< zmj&7Q>&&f$a#@LudhCss28&nK1NJX^GgNgzyF-f6Y`Vr3ubj-!akM{5TGvC4u#bfn zKf_RB<=X)GRU`}T1>wwZ!lGi6tI?{<}V6z$YN`IA8Lcd8jnCut~99!Wv!tJ zx3RD2ZiT4lP8o7nH8mVA44-a^!lqi^{Yn;lw1cVNX^6C;f5oIHx#pEjrgbWn1nb75Nw;$}b27E`=7TF&z7_PO_X|Gp_fxbn%z0kd`ZDG%t)Si$yN$O#m*n+*2b*Om zVwZOy=X_wvUtF^K5GQ)O3ZEdOVNlW|ORfg$Whh{J9~n6+JRrY5()W&b>y6B6lf>7X zKB6rKSB$HS2wW^5s_F3z7?PN$ZSpmJS9AkB!$KI0pS2xjW%I$TdI?pVV~#?Um`w_> zc_F~H$U#~jRXlQ;G%PG^SgdvUBDNcQg}BQ9-lp*WAqKW!HZ`C!0%EZia8iJk0(vE2 zUoJp&0+4aACE#a)7=z?Ac8+{DTV-m_lxIKf>}!?H9m|4etI1~m>6qBR^5&yb!%Co# zh1bata+L__YSCj9E2%PcjHx3J1#IZ`vjVeae0^yw;|JSkg9ZGai5+jzy%Q#Ip8SYD z4dH8QHsJ@VHxeau%LZ{&?ryXJ`RNx0Ah(6Ur|c!V8d9cZ^2R!w{Irxwv+r5_{FnU! ztFr51l{fr+EK4m6?cHccm`rxiB;R}kWn-3ez5U_`l0JrIWE&W8^$Tmx& z56cHLj!@t78n?5xX35X0%M7dA38?=Zo-oGcb0I2O@q%H_eZhc{y3R7U z5w1kDHNnSaH??{!IcY4Eb)`HRI{|+ioAE?;Jp(TtIQlKkSX!ISZj9YR#GP_TC3ufgg7ZIpkibR*Uc$d^q~GB4 z-v=PTo8b6JUc68ucAy48EAgogG8aIzT|kBttvVQO0jhPwu2>jy`4)iK20P~8b0H!V zm@Sw-amcq_zkgYW5&94C;Q?`Z;l*RuPZ-jfU2p>!7GZk&?{nc2$KdHeY&bajKjuyx z81~Bohw?mhK!)N4jIH}|vhK-4f=A;{azu-8?ARP%(z}uqw5$4# z;rs0NC!Q}hua>OUWQS?5qSir=KlAjh7a|JlB))JZMhwl2`9N_o~@?J!pwSt1q!O z5+czcEy~1*i?~b`qGQC8%^=pkAfS+SLFz9kFM;i3Z*u#j>b-(T13%LiEQagd`!`c^ z(gp)E)TZmd+UZ%UY2CpNh&eYd*M`J$Wcap^3XNovUb4?vjCbU}#uh4JMDsEJ%+@6} zKEI~gxe=v=Gs0)izP+KH;>)OVD0eN{pMBp`=ZD|3z47WpOwUSYkZXxG1rqB8pW>pj z!gMp5S^Icd)`I7Y{PS{V4T6h5TW^|u|4|Yy*!ZN|jw6iiVOr%- z(icvB)TI|B?~gJvd{E#&E9jxKyI4=Qy6eOE%rnw;YRXCUIO)Z}4Q|{ajNO;Dk>~6K z9ovJ99%EcfpE=j@#m*=5Ll2iK$2|pc2D@_Rl)yW!K(#=Lv1CLLXz-*oxuCPCyBNEc zBaO*&i&&Q!ibBDo)D8$VwyyunMgeUWF@6CCTmhgV12vZq2qy$V00O!j2pJ#;1tCEC zC0Q`N>c{L{##m#`=YyHSdr}T1Rx8$Ph1{{%?N*{ku>hlj!v6ffz!uYa!e@=NAn_BMZya=tIU`dZnXwxSx z&OG%tTWUrD@(No%s}Oe-DEFJP*YbcFuMk(w{0YOSJU=H~_$*&u!z`X(GfJ02!>g-bFQ+-si5mMc|q8+prC zc%sMyq|M?RwwT5rd7nx-(6wLhd5pzq@z;mE?UNg`&VqIiO^&P>tePL{1g&&GWQ*Y1AGCtpN%5N-1KO zx<5~F1ltZ93sryfniW^PV)Sr+0pYO_gGXv8Wq2F;OLjmKvfmv8QQf`r2I$AnD}!c4 zC#9AL4X;aRy#8X6VaXC;roWy(xcKl$&YilpkD<;Mg8du?Oq&cgZ(lgG-PE37N3igx z2)!1qa@@?#I>FPIOFy2JWy{Q=A5R3n4G=clsliU4B>07DW1BVY@#P7gK!Z0E^= z5n+cXXfObVAl|_T{DAw)T!8Tt3<`dYhL6Ed29AJV;A#FIZ2ljpJedZ`rR#&#BhYS} z3J$BHf|MYT7k+?@AT$b&rzS-s{vVSClq_s;!ukRzJi`Ne9|tc8fdha+1vF3|B#0~0 zXbFcpDb3*1_%RDi#J5HTr%u7Y!t;Xp;NK-<{{_cXp!g)7-Sr?+8hjfI^Q8DxU_Nu| z^JD0eaPmG+$V4{j$SAe1fNn{Ms0E%nELYTRn-|o8-q2}?B}1>m489k zmdSTQcT$5M2&6{ll&O9)@(NOj!|0z3ip!;O;=NyTe6RDFa)%q552QaMPC|}YwJ0c-`9IOE%WwLzr5wdV(8me z>uC`IT*a~R7`G?O!K~8PwA{0e@@{41ae)-QuDl(s#(YP z>Px`=<<5uGxu0stA(Z==D{0BHW?H^Lr$%u5r|P*MWNOPI#}?^sGPQ@xg%4&crkEfp zFK6URU;Sd>z*=wRf938wR{7`Vz02C#$_cg`Uoc75ihA50jQMBrU8Nz7CoFPTYJ_{c z*Ec;L%cfxkg-dmmx@@f+M)HzWjQVlQKC9cz(}FxSHn_B@=1b*G-vuICR1&zJRt|?o zyvMbM2)=vVbj^~&qUPGjyU+oe7Nm8pprX@7mMwwy@9~3%5n@7}Sq64nS!}fkgM~!n zxo|PRa`LGR2sy*3s}bUkkA%_$6U2V~1LTC zk|E>Poud+6Qj$DvSuXLF_jNZtWkeAd_29ksp&5(HT(TLam$W90uemXlf488PAu)_ul@(y}mS7r#*bP$Ez{GlTHCo_8qph?#SMQtELAE)VOJhnGa3?npRAzW3yOaY}N!)+Q=6 zeoLAXl-}kUfaK(d*gOqE%=%+c*31wjH?Y7M>j5w}fEXXZKyD3ngJ2C0Jjd>zUH7*H zVAsRbXduQ8x{v)vShxTLQT^Q`NndBU0w-*eK*~}iTgVgUpiRKw59+B4Y;Ox@it~gm z^K&s@Yx}jla!B@X>8E?%#jsU4RXcoh5SCvFt-O8R!m^615&iI*$c4a#mAm?>^FSTaDAC^8N4_^v2N6&fpNKa^GW~jkmlZWo_>E8*dKBw6w5g$!Ip{W>Af} z6!>4}R7Jcl4mPzYGKioFqzdtIIO<-WW);1o75_PIATK9WL@LPLS5rQ8cGy?8qALK= zcKXPAOo@%LNy2T9jsVL|8>O+PF&`>}a0v++eJ+zHBACF6y%rQ9nVDT|x^LaVvi!T2 zb*Ys<^PL2LheLlC@X_YNa=Z(qP z=mSo=y}OXvkzhW?qtyAD;Vok$N;|`bI$XLvJ&#E@c6(w#cjHpSDixn_!i)I)OshN5 zP0vIP#$ykg+dOX5nSDljbwH=`Rx!5`Rpeshq$toRZVN`TdP2!W~Nz>M!i4@t0A*l zOPi0(o;_(FimDrQ%mn~QQ4uXh6t)=HN(a?R03TaUf`-{aQa(ty>cAL-<^kXW+5^P+ zwm=t%d?p!0OK8C7aasgF%chU z8zP4*sQgB7c+`KU3)=A!HQU)PV1{>_mJw)RP8D>UqlV2;dT`P2m>~EvposkW=fCek zoHrG77p2cS|J||#M$U~f0;GbS?&^XavA<`?34oX!G)l!(Gr`f$&>!j+j6x*0iNgTT zCh?(&pMqp#Sm`-gLNF8L z^EOGTnMwqhd7%ygsIwhnFow<;9m3gEv+~bb8Vfe-YwtT5jGcE9ine6w*VzBgRn*D+qyD`Yp{L zpf%9btmiBY9#ux5Zpx-1a_W$UU+>wwoJwF$YpBdTXH6f=TF_at7{th09#X{9>71ILP+(nKa3#$2 zbm6AS=;Sq~2%1yZ;%9>xJqDs1JM^#H7}uPPU)eM^>(@)W{xq+*B=e>PG!^SO*CTdn$H#p z)l`s)oVL@c&?@5*J4EyKyu6d0yG7?)ecnmx=76i83oTT2uePiY?agJ>IFn4j`Zta|rP3Gl7 zeTxzX+YoWlQ^*VluDTkVJ<&vg{r&qoef1 zGtGLp1g4cGdDSy}Mk|YxGYJ7?tPs;S>R*G4pIs0`2#< zP4YYSbDdK1550Lxit}~0h6280?$tL?aewt?5Y^&;6I#@RNb4)z!_Wwle`U?731|nt|LE++~ke#KQ z9!X{t1KcYEa3+NT(v-lZ0|MOnF%o+SG&=G+nwlSwHk}Cc3#v+ecKg7NhAtf z^dgkk?&#b*-nv1pg4(!LoX!~&B$cA_Hr41}!)%b(NCj=>1V}qQUBArh2&HX-ob-(R zi=iKONDhZ|J+>Tb@_cAL^JN`PL0EIlm6w}x^5DL`H((=VXC|-W67abl)YbyCh&X*WM4suwd5rHZ-PYbQ8UKKznguDm73GOOKy zQsG27)t9Ub4ul_``d)^;7jDVkdoDUaS|>CqKvsR)|1XFtEv?6!Bhn@eBPn%6TZ)Ec z?(*wyP(%HKT<7xG$SbJ{9wzF2?MALN%ra?g^D#3|$wPtNu@|Pt=Lg*GMJ7-Tv{6nJ z7gid5*ZNuN+?%!Pz*4-hQ=yt*5y%xqOvP7MC)h-mhgF;$ zw`ntSIp!Z|l1lyvL_B^|G05%IvmZd!^u2O!fubYkvkIXniN5u?wcf?sYLB9X*U0RH zSJbP{N;9+Vfsz$KaKFc4m|qAC5F^Jxuq8Dp!$s|?hX!Gx6F59AA6%e|D1+%2Kx!=T z=2gKf2ej+R;bQt8w0A^VZA_1i_AYxq&0LsL&V6Mc801qT_ zbsr$%pFv?_=HGVffo%z{BWeL)A~3wEfamxP?J&0sBPnsK0N@ANG$PylBnb325rh#S zr&a{miavjv)L=}2V+WY{Z!;U*4}Lue3`}MAU_i}z5)T-STf#{Ph$H-se(*~S0+mVF zU_WaE#Pl0&VSI!+Vep<|Kwkz=2NUcFu%|&eKR9#`d>0-VK#&8K8idx&AS0jak=x1f zF+voeoCz;P$SfHRM2rWJYmpcGAw66d4BKD55qU`O8 z=Jy;aGcwafVMokga>%uatZ=mrPF<3_$1?puAU}aUWcXKS_!5fMMzTZqq937TOj1O% zeEUW1t#8(6Z(r9}qG>L$9=PU<)5*8;w?8FM2q;zBshq*JX}B334zX3~c(%KndEMfi zTtZ_>2QOP*nu71MlnGpkwEiT8H_zc(L7yewzG|;Af5ss$_dc@Z{Jv6tEmL_DsUmb@ zZ6@<+QJF#vrMVDqzJi2>*^7>e;Rf!%phsAFF2Y`k$D_wM#uKR=UUR3K#<)*7s@&PR z%r=~%P?laYp#m>E~ws;`4S6OR3V;^ ziVGzXF;=TIkoHx7Tm%_#zE9A~UM5{YQsz4EJ^RaP@q1I{{X30)l7+@iIp#~|rDrR6 zST}0JdP*F&mWLmftCrlWo446J%(?OS<>DL0O8M|EN0aP~a1|B)GgDLNd+!{MKVRJI zBAjTKvwC&mESHh%c!G2Dn2uj5!caXO-&X72?n3SH@#4sJ*8Yxt!QO}u?HwtgUAf80 zTiH?JUfnJb2?}=S(2%~E0gKg*9P*JsfR0OW-$BqCinxNU_*h^rg@zgk2B5S-MAenv z2Lhh`gFQ(CFF`ag?LgAzZxtMl4+ku&FiflR6Ay+@=Klm=$eCXjr*GD%F=|zozcM-! zqVg`<6#PQiw^-Ry}(KW*6dgY29S#rE*yxfM=ZhJbv4`_YR7r#8| zK|3&FyiYa%%nA8TgZ|}OVMr5*SfR2vt(tpU`R1~|t?wQ)j_gM72ZP&BEAge)S(P(> zGSOeKy5ssK+J^nxW5t10ZI%HvfmuS|eA`c8#c4h~=@{k4m(h;>@ca zFV7fdYJGDE`8wof`9%wX0=^%|9jw!zj21P0R!d{+nyB0Gb*_B^;RY%aVMpkMjz<|`sCsJ5}$3@Dddfb-t z_`a(`OA!kmA=UorSPN1hW0dnEgVk(R%Mz`x+c}quFRHVEj-Q0KbA{6Nr=?!(;~o z(>f1`1L6R#P&y7M5hN4-*9Ct7>+d^|{3b>Z@;U$c_+J3=&p|LMGw6m2U3lM9O|>{f z36K;7dxH%Hm#BcJMFbVF*Ff|2E}~j^Fahu|U4PG-3fP^ykQ=Wz5upxf=l>Yu02o2> z7Pws&3c&S2h4H@u3t%TO-$3Zh-`p^Wg9YAPG?WMS`MMDFcf61u{E`4*p{062rUnHm ze*XOsq>1BWVE0+&YnG6^qIV56&A^ii*+elE)OAD!mW)3wzr}>~GQjekbPa-<1>^uP ztAe5Pg5>kSuzQpwQlwe#^5Y`X;RyXsN}nNSYPFN-#086NnE~ldMNtl5#|an*ug5fw zRRKjI2ci^#4oO2mYB5zJMe~MSN&gy6wnB#bQi%q#U0w5#E>9j{7FbpBEz54bmSE%Z zy6}XDlAo0Bq)nFiL&jR9fci7`qSH|gn+X`rpD$*SOCoQ^MUu2`So!m@M_<1Z2ijVl zb@S&YWe|~GJ`}2j%bRG5z?CIPg}81oqIGbVx+&@k{>F)$EWO$G$MS>5wG;I_wd(0< zwYn1@+jXKxzKAYqWm63`2q}t`OqPu8Uy(wIEu5|q$Ma-dK!mzCi&QuECwW|nLic8{ zTJ$cbOW-~#eJW6uE4gL6W0l`>Iaz4)Et7(0UGD4Gp=Si$+7o&cv4l zfq0UxaHd}2&Es=)D|?&X0ZiE<5n_jL@to~_>1Aw2R?;~XUWDdGym_-qi|ZDV-tFgL zF`zjPIxxGJR)?0q?}?I-_-PlM%2p~%8CUW^MWzvw|JEqH;&b;f{c&z8+iS=w_lcYO z7eBrVG_>Go(tNwG<-mTXZ1J>rQlVk_1NDqClKu&TW935iFB0jmr@cE1hR@i9s9zXp zId|rJsfB1mGl`20f{NqOwd+Z#XL)I)(leg-Zbt4G_&YCMu(oaU67nd885;@E+XwRJ z!^36{i2zK7d?uDEhu6d(RSw>YkQI#{S`M*T4k0GMDg=81tWpdk$Tfr)J~9 zAA6O-L}@wsW>B^SrUK%Sy?a{AFuJFo@UAQ1>`Y%6%f~wgBW1bUGKccb8!h$FdXDev z5)-T=c>=8+gO(t#gV=ta7^8t3>*(zi%BajjCeRwz%qM#7E{M z?8@4#vmtGL%5m+xR;Kp3r^?RJSfP`r4L2z!-?Ef&3mZ&7&$=UPIlBL_UL~kdRXg(B z+7Xl7*qp+(A@2D;@sbY@8(Of6muVMX`(Km@)RTL+B8-*}3Jh|iVSSRuE1vyk=#gnY z#prkZy6$*rZA2pvUyEG1N}v0gY*QnwM2&&rhYM4yKLR_$7Yr4Lbw0RUdfM*E`fO_2 zYo6y5kkOaQRn6X5gtYNGgo%{f+ltF^%nt-#V%p^L=t(dcePsR1!lNf$frgd!1t*m` ztY`yCKcI7k4@nlhE`|!028Id=L=BV}pnh)>SwdJzIS{QtJ>Ld0mKRSThXiO4=H#F^ z0|jXdc|Bw<2l8wr;A#StxHRB^3a9$r9|{hrgaUaRNC1ws{8MD`K*9o(r5}t2Osg(1 z0MPBhNMhGHLB(T`UIDNPTnkHdKCmzWn+X4dPoo9+@z$9R8aU_$Ab?@F4jMB2fusK+ z#^ERYTl9mcB0lo(10eY2e|!w4LA82iec_e{crI8a)%)9q`X6HvH9%$v;Xe>SlDIL}|0h!DKc@Kyj{p<; znusunt4lx4r3w%2{V zij&i#bRu=nZCxTen^XFH7sK?DoC9c}6+?5@j zKYwyii#6<57pe%87+PF>rn-MnGvS43w^zpZ&W@qF`&V^`hi|fxx;ycmB5boOwv9DoN9BjxT2zkO-Jiwjhs^Y_?ER;Z24wQ$*wJ7 z4zvTSFe){9dMf|8O5@c$K{GX{0FjC+N6M<`(j5IJ`OqA@Wmkeg zZMy}q?wH^`fEfSpY8%8Q2~;;NK|L+7tr5K;R{-+@%MH{86hIlcGYi;+KCtSk^V=Iv z=|crE)gPQqE{~e|3(CcwJgjGG)4G~{reaR1`Rf_6!AzXUWwVV2P_cT!5ewg6hZBJPSdlepr9N`))pPc(O?+-~T z7so3Et_I(>+Z*p5!@E0_4i@BDW^8s5pll!g!;gm8@`q4cl1QBMbZD#s6N|O7t@AIY zB`waeNjaWRs0=X&n~5H@r$Bnv>n<0LXHE zyV)h~R}V!hh6p&-GC|^FZ#s>z;SZjCjKtn$N&95zCOxd=a#8DWk7erDqHTd+1BX&TLtxcCYiU7!ZQj-+Ck7|YK89A*)z@0;oi_+_&HUUZLi&b} z$*XEoG=x*k{^H)Nn!B_zsuAzR%fm@p3AaW*@{FS}=yiNi0HfoU08*_bKHon(D~u&* z$P&%iO4Si~N$ZWohL0tW$6{QeWq0=%u1jj0F+bb~;?EdY+vwg90#p}}sqpt6zD$A= z0X5}8cnI)QU?2=h9)p~46=NVDlm>ykVmvJWi3c>zCDn|MAC~y6Wo~* zB*K6a{0K-HvkvDR5Wp1ph$hcE13wcfoJhwDJVkKe=YJu~fyn+J0{>rNbPy==eLS$%!3?CGTAT$!-I(fu*{XZTH#JVse2>&|aAPAEmhX7>U5}aEoM2b&@ z)J4`^JrV*`U_+;?>#?GQTxR7NDW(DD);KNBjiziZ35zsYWaQ)LkR2DOib-r*7$K(# zY&+N)R!N#7T8|h~Y~yuL9lyoWB`4p-08&ciXcWo^(8>#>EMPf6kIkWASLn7i)+(~bO?(SeMw`< z>-UIr2`rV^gH*%p>;oBgXNCkO+Y}NP$X3~t6U}))9iw6K4|N+C z%-iQkkTxho#ok8HXo-k8WgNL-fPy08rl#8SiVeS~elM#}QIQ=~?k?sW51HZd(=5F& zu9!>^CGE{XkM)GH^XhEmAZ>fI&yhdCcxHWLkuH7Se>WYG{TnSP+-=r>Ycjr2#16MiO(g|7*q3!dnoggkf!rd8~@K(_mKk z?|n012kntm?@^*bNEy(?{-~>JXxw?MtH|~*T$_)n%+;Bx?z)WqBzgEi=6gamm~nx?7CT)T$*c7E#u9 zmkSj3Zl4_~SuJ6RlccetxrU1Nyj%t_@D!}DUI9BO!Tw9Kx`4N zw@B%@m}uVz;TExqHJ%*$+6)eiLNyDU`eUZAgZVRML*L%#_uacI=_j@_i;j4$Z+G=H z!#KNG2Ts5F4jbEHk_@wcwvg+#)Y{p44@w;BmNd=gT4z4tO6X$jb1pc^FbJ#Zwq(_t z@Qwt%Y3pVa@DnQ+tG;_x>B-3KsUWed3Qi__$AzO9XzYCr^7q|Gnrd6-^i>X_4ajw( zW<%cay6XGUW$*_ay5=0=DuY_FOe9svIKdN+>q~udF1UFxTGgPvN%!;2PoaVM>?T?3 zBkt2o*Fi)-ko_RbTF+FD4)l3jBvhh;Wq=d~S_}ngip+8qgc^XP0nu9sFS&n~*MX`+ z)cwH{1<3Os&Jy@U5D@_K)sO&T{#YO&kqw+iS{n{h$kDJ@^Y2f7>-e3pxSsrd7$D9V zEQbGB_FvWcn2r}`-_NbAMs_u zX3PJ=7EoOdgv+awm*JzOIiMLN!nC2RB=F#p13T?tByja2(bxMwZURauBW2`VQSb|) z2i4X<)if0SG6p;Y7fTQ|sNp`t)K}&y)hQC9s9*!?k)qodC}?qfbnFl*Xzb7#ieU!6 zlw%n419bojM^pF@NRX0i*}?f~{=lrV4qq2FhnxtAEdnHH4h0Y(-CK~-E9(eekb#7} z{MXBC88NC3vpXY$ZI_#>KK&r`d^OyXY8Yqe9SgR@DGumT$V*11 zojPH`B>y0rtd5!iT3mfVZvi9XB4!<>)2`L3C9>tSc4}L8UX-3@+7)8T37-lEt#?N& z--h3$dW(3q@P$+=CaRi?+b*zjmh2Jomz(VKSnHPZFE2lvD<4lwS}|XXI5}t|{PU@k z*5bWeS+S^duMa0kEpdNo|Jmrms(j?|tHr*I1qyG8au)QrFIP^eJVMZ3Kg3_Zi5+HT z3e~vUcu`lE&Xh1wa%suiroc?r`si!dZ$D4%sJu67BbZJ61$ErN&VIvHHV04s#CTfV zjPW*i_k+*0+n1KqIetw|>PO1<-xci~Z&tX2>M5y$^7sa*XsC~omQXJ9eR*LnC|lD5IsDhpkR+UaFn>$!O=_H*jq1jZR))Uj%ph_4nF_jn!tPYaefR zcK_f!p8k#RJ@<~}#@&&SQ=`ri$DY=oNw5uEb_-)(<&}R^^^#HY`SZ;qzEw$d#U7y% zHmj2lWIxpH3UTLN8EpS?gRSDk2~GWZ#ifheTgt+JL0UnVse*bI|AKlSP3T2De@>YE zwf_oTQ6~{uAjjv>R4!$)HFRo@G&Cl@@#R&z4x`PusIk)o^RiUrJH{jG+w3b9k~HR# zCVNme5BU-0T51Ac5kt<>!2~6LrfZI)u$wX|1%Jxb9?Al8QD1v;DKcMS^o4f@?G+8p z26Ewge4Jihj>r)t;@bm_j=|$r6%F_wd8a05?dDoOi3DUmY)x3|pW;-x^%T((ZE2I< zpCC2(j?&y@b|^60cH>bu+smYTj3*Lb=8dpPgfZ;++zxMut4<2goY>6wER2cGE?;Yk z$3_VEi#(gE--XXCzbmn9KM|_LV40yz*;~}t z8kfW_6Tjx5$TDc4rMdI2Zm*rEJANv+V(3Qs?8q>llE(VO9mZgBr?P5syj*iiRCPqe zV9QwDm$T)3W>Mv7)Q9siMu$IFY1~=i*`mLfXdZha-?CbGy)ouvjeZ^pS43UXjtLFyD!s=3SMfHfB?iF?g%=7*z*_6mU<#7kUaCto1iVZBUuvEW1A~IATzRRpe1|i9c$RT^I!XJl0C5} zta5hho?o}(7a}M@#?&XBLS1ha(kilC_2cpLVvJ{3*;EDpz2L6H^@Bv`o zQfjsYFThpR4*0--y(bVbwQvZt4c;DblLu8B}n81&Hv7;OTzG2`Z#aV3Ajol`pXDD>T8DO7fqw zjJQS~XLLj6uF|pNGffpwO^>RM(yCa@KRXf!HY5s47L~&D)5*L@tW-Y?$Y4t+n9x z!pVhYW_oG`uc1mBo{V@T81PI#Z?@69{*l6c%`$PQP7#R~wHFs_aSk= zx%M)1aD3@{lvVtOor7}+wjS-W*cgVX(I<1@Qp3PD{^&EL~M0%NCD(*?? z@Zcfqw#QPMTGF-UjC@~y9ZEd6&yeI-!QoZ@yh&eu-9T7z(^6lbP*~!Sq1*S(1y%md zE^z!+TFHn3bV#fXW715?L-{#1adH>uckz+HempY0<&da(RwD{iKp9_rX7+wd$ZEa# z8uxMkCrceyitpU3+4v-Cy!tfzN@*hhd-G!tFdRHRECp{qPKAgLe`K~By`K;~ygek@ zJDk>a-bl51+V4rGM|44|=0>f!W6t~2mlf|t=Znc@;e@jo3{8gbQQTo~nxdt2Jxk&E zH8JIDjrd4}yK~$;Lq@|^BGtW^$mi`L&#>2)F95zp`BbB6& zWcgkw^ObG4OjFqi(roLN30WH(zlyYbYDRFVJj8~X$&6N_GIx0X*uk+k)%|p5>516x z!G&|u>~dC1T45wgv-2mAVe@I%q33Fvp0)@hlTMDh%bXhPZ|)~<#vhJ=a&inGZa5@7 znP+QnJet7D=3wKV7pE-u!P~k?UnJ)P&cC_BZv#wk4Zxw?ubUTv%<_I9l={F+)Vq zDEa-7uljO!-i1}NGiL+vCDoAK)rw!{S+!PYd@m;}h8}HGYURkfXH$)cl(ea9ZF_A} z@|s?rdtkJvFQ>vxDlqO)_)tp$i7B3kgyC1iM0%vunfV|V`E6bGCSEK5fSqiSEz^Q` zyneW;^Fu7_VezF4f_H~02q*i|&J9B+fw}T(-*gAeMLH=p z>a@|2!}Nt3Qm=-G5MTJIwS75E(FM0xF6{SK%O?p-KNa)zY*<9(av7x_DG`aTs?S~= zW|C=WlQAKaY-v&?W6eu5v+>{8N{c`1S|jdz_g+G?MtYy9J_Cl0hN^?G;jZ){F3J5@ z4nczIOHTGGWfy%Qls?jP+bUJ0Mnyarg%+`Txw{;3UUzy6SEL%*A>bdqy^En}YBWG% zhVSj(53P&m<#?pxJRaMcG^c9wTC2b27>TNzPF&g0h}$dVNa;<*qiNi}?@Mf>u{?aZ z)BI&oZV#T}cBl>0;zUoW7^0=1K`QWvgdM7`)1U$12AhmvDPpv6q=>G@o)V9$ z1GN$8g$s^)rsO!h21tU3k%{X6+Ntnicy+=z0he{b`sQyO1NFKWXfzJ+7bzH4Fu(Hvy_q~IP(;(-2zqyIIM_z+tEO#C zJPvy6{}l>H>G(d?%RT;+ykF+$&hd6VHuLt%`qKQYz|VG`ZldGjav=hCjT6l@AWbjl^;dNCrP0R2EBXzFa&nodd=}PDrK{Q&lVjaFbC`rNH?2S~zDIZRr z3hD2$InS@XsPWqOj6|IZa3_i@xaGTttUl^;DSMO`|b;Ak& zVQ06L^o+Usyp_{=i@cgf#yyscpT{eBM3eF2g7brKgAfy(A#b0D_!d03s>xRERjG-2 znrfIVlSO+zJ><e5mE1oE?S*hu+ z+(HZ~^Nqc;3ve?OcNC6uxjZeNE-y`b+sb=-+D(c&xZd1FlOTxlfAEgA@wQ8`wt~{z zaKkzF-e~8DX|Fki{k3if(_BfkN9Jix5gM+=i>&k*z(u6 zY;w)jT_>iWN`|Xh-o5cyJ6YMlIPpu?U1v#tkphQ9bzfMP?o)Y1Ckvtt^;Rmgjb@&h4KIHEg%zneg}!2HrlwMx-RICt%W`Y~XG&r$VM;wvg~UdL*Z8-Sx8u4efU}j0 zb>#$!49%{f9?Sq9SmD1#C8$0O>;JS4z)lAe0dyk0@EKI;Sb(LGo@wy`iUT15Oa@R2 za_j|gjQy4wu$TogYw)i7Q-1P*UF1W4dVl`dBkwPLX6%DG>L-+}DfoM&Jjc(NT7Nw4 z{Of6RnqEyxZMjb=PMi%HZS(&z_SSJxt=-%B9=fHZM`;*JS{MwPA*Cgi?k*9Gp+Nzu zp+UL?1*9Yt=@JJ-TBHR;L`00E=e+kGe9k$~`+mQl-|yo;II(B%nSI~aTGzVPwH%5L zzer7U25;hvkZrm#sQRG}x2=6NQZ8B5qdL0ed-0`SJ+(8JD|Lq2zVcRO2B6ad9!Pc# z?_9EQ<#&IpGITzM>k-ZSSAlw+2}g_Gm4?mo3pG>xOGmApXIZ0nY-5bFk}^moV^|o+ zT??rFWW$SQ4^QnRzi)YGp?Bqv0tf2Yw$%2FnF*5>@e3tc0=9;GtVWH2$l;cSo{dvg zIw_wF%yt+bDr7n5nT?l2n?ltV&(@|nxtKocQ?2?lDVI74s(i6ASojVmNC)Lbw^f+QyjZL$#RNl5!s5f7ovX5=bGp0X_mD5v&6R zMO}#UctwC71bDH4BZF|_5qOFqZGzcjq9uqn90oc7O`)K*9s&j1{og?cG5!Ie-6Eez z(e)DBcJIQVm@orr0X&2Zpq8R5f&q*yv3#}A?FaJjYuGI!YRK+!9Oz@GtG756+07;< zMzMki{@mo?bSsM#QVCQ&T@)eO0g&GfkawQ|?SS|11`ojJ10oj=us~tLo*)w?RB(Ya z%}nI@sivSUZY?@;Fh|7h_)3nyDr)dvPlhzP=o_wa0XP)q;;%5gjajt%mC zU+kvJ840;VSa)GlG8$m^As#_`#e!$PM7O3POa1fWJ4-Zg8s6An}Jk zlS&UZQ2zZhp2ZR`G4>O4!D>}q)pTiJ%9Hk!_Pi5KN%ms??2|l1QS;DwPh~`Rbb&Ml zX(U{qK5ote(pB)&fLTS|-B1)nPK8B~DIkECfU5GRWG=~C)rnVBrA74JE;IOhY`%mDT%q#?Oexj#i(cVZJLna6>n3`LIKO45xQt&(}2z)A+_bf|3%$Ljg1y zDI|tE3qKab=yB=Knb?xbXZ#r_cmHrdqpN-DvvC!%az+$R_fw#RZ}jE$;fatRHxKzW zh21oNv`nvrkR0B?t!kfzoTW z4Ns-yLRytS%20+$grp7k$eHvS&MpYQO_9G?_!o35&XM^ESC)e98Ivl?C-SD%+I{H7 z_jIJpfyOB$gVkU6taRK)YA8@VC@d;%(hC^On)eg2}`kCun3j04u;B*>Xkl%g?oo0j(2-DwE?$s*o(;= zmNeaMq+%}77PYNy3=}!yQ%%FPOz>bd3S#{};&(`Ng)MndRv4rDKa>^`ldQ}<9n=Z+ z>lM82BKcX?#hopxk1|N|KJ2}p`sj8OeN&xXXw&+>n-1@H7RI!U7FCFBow%rB{?pX% zhGA@#-|&;8@4oeuhL5Wn5a{i2&NKLUf2&3P+3K?WA6AjC)166@up=qw(v(V+T-isf zBBR%{vQ#H2yAGlpn;)Kc&?DnVg`U>T4Dj*sO~bC)qqIjP@^-vAZo95_jToE}@X{s~ zl}gexWB;y1gyx2Opb7ohU=M^dd64M?K`wz}1S+UyatvKGta$v-sy$Bc&vQYJB`_-w zZ!X7$NT5xDQ-mN2x>J&%@%nFR)$vkKBsaLg{TGxX1gs`RLLcfiJb!UAPt#C@HqW9m z$CtWlGciiGYG`T!7mRA9=gJb{7O*Z$l1OipjH`d_p%o|HIC@kRk;A8f94z=q``*hu zRYR+2A9!75bzukJP<3`+vaPFc7@2$CcD{$Ptj-{Y`=;}r_Uz{8 zFUfLRCiJr_kJf*=nERsGC)^`vg|Z9wjM2O2?Z5fN3Otsy|B1;eVBE$9)28XzJ~Q@_ z-MT1j9iMlyNvGW}W8z$6i;#g~gkAnG{h@{nnmw$@K8(g%ji)av&^YdU54|aeark4( z1@WXP18$p`6St<7`Vzf7RMleGo}*l|r2p_}Z=zD9P1?(|n)f;P%lFi0WtOo_Q9iP$ndfC&IlTo5-Sj1y4LINXs7 zK+Fyn=kS98qZY(X!VqwS1^3=@>QPd$j+r4+GIbH#yvZLLS=yIyCEv0Drwt z;M0#YRPdpoFA^~clM4Tw>Jc23z@|ZdAlcW0BM(9X4GZOok+9|-(DQBtuqA=m;=zfK z13nI%2z(F_0ui1?7D39%mfhZN%K+xt;C>L`zoYzjfJ0{t8V65VMviZvAH6_tVYC}d zt)vpA{@m5=ly+oK1mn(m?kNss6Ol_8G2uZlSLJsR0FIzmxdH1BUp_cvcmm4*BOUnH zmHb1wfS>F5%>S2XS!l?W;V&M32bg`TLZ4n-ie(c4qe_QxR~YeS<9QS>XogamJhLbo zf;jnEn3+qcsc1+`BhzTz;H~Hdu#Lq-*4<>%c0i@aip6+#vrtGPX+!DasIWBHK}bO| z6VaNCNb)NqJ4vy{W>yw-;;)Ii)^Ypnk0<+c`g7ds_zSoZf(K&u&xKs_(;e(v#F=~> zK5}h@ntV8%i?hUq6iZGn#%a3`OcNek z+N_xgRZKSDAKS&nU!PkhFJ3JB+2;IP3z(lv1K$Tg9;UTv-7Z1+Yy z{SA-0*CqA-Ky#h-^Wt{%J}jBqd64|;jM$G)-YN$Rq6-2!eZDjFa(-eTPI*!;VP%Z`d<2 zUx+cfD>L`2#9j`C`28ukY9NWzo9gU)Af}*{6TzR{5%mel)4I~@`e4dz+%|@$;@qm} z3Eup^-b-Dc)%_!t8TTQa)z0~#(`*-KzrT7o^JK6pHE7enw6VPUdv4ews?EsWju`(& zQDYDrD_HX9DaQ$~*`r-=1E+%u)W_5|U0snc=hx_Nk-vQ{6Y1i}zNR_xCd0eG{I-QE zrHTq?k%j2lc(m$t*6V}aWSPs%Yl+rzxh7+}k~^J56tBjtmIv)CpW)Zzzh3#EXi=b? z^@vPqL@;axn7%2Sns!LnrSPf&v z^o5@Oh)+)z#=j<_EWP~Wjr00#Nw3+q8!>4HwX7 zpq5z=7Azd~|9%@AUA~@rXPOV_*-1uCI%l1Dane5yXfvA7^@ZEW*Vbyz3~s}^sipCo zqxA{0@;lGRJ||pC5!tyxdiX`M7kTna>{y2g6{|`;aotNbiel~Dj6~_tK+Fw(a%s*g z;p7j^Bwn{91!;7Qw?E51X=S$6tvjEWalhprulxn|8;(f@47XLs9KsTJla!fXjc6~3a5;9Hsx|5u9l6pieEEm<@fZ4$lXld zSnv6J*Wa*|B{{6nD|;j(f&Ac~!yh!=$2n+M$CX;ARd$xU@^p5Gmz?vtdQEIi_w080 zM{i2{cT%klQA`tQ#ubK5D0cj3Dprnit19Zko%E?I16)zXPk30Za!yj_mAR@?Y%|L%cEw;HbZ=*ICX=pkG+kq zX%(}H>f?(N#i^DWyW$zO^IwTIf|`U?guXdd-`TJ;tF8BDc!9tT8hFvbH)7xD$NiK>EPYJZ+#kq5g*}TAPPVC z#;HV$*@)%ZO>3BF%kf{Km{KTlkxl>xJH@0&PN6DQvPCyj*yPBfmIg>TdX+DXk#Iy| z%p_^98M@0BRFVe8R3~-1o}YI&z^@L;e&YJlXf%m57_cfumX=%s1qk>H1SbH0Pw?O1 zI<1bcAN(5si{AX7An3n{0a%Ox?^T2^OZj&t=r`+@k~#QXxQQ|%u@zZQorwp|+(q=jebAJgXfra|5{xCcu$h>rCYBAtuts9P0PC0N zJ9=O+svhv+R*>qJrdWgUDd*IKXhi6XB!#t<|C+3eqr+xD6dTvu?N%Bzq_j*jqh=K5 zH^E7c#W}c|pn_&2YGr3v)fabljdLHo7W5nT*EDyq4W#AIi!F3Z98p$s(dJRMU_@|d zmmejICYO)h?=>i3WmhgW`Q|B{QO?8dLHe-O>}y6a`aav}OCRU^(uzk>t0fz#y|%F` z)75lbLw;K7+E>KPv{DkP>*$N3K)Lr5N_X2rA%E?oT9XS~#wpAR%BGr6cf#+~?W)l^cbf&NPIWT zVsgbmPwYXr+hu>6&c;8=P%3<{FN`<2S3b@}D4{5=YD-sxSueD9`nz~~Dy>umzobGP zZU~5v$XfD_cwiN@juVabI-RE>;NZnOq@N;c1vd-SaPBOmf8pkiMB(sa;zEjA5`9Mk(5}8tiu6~OHook>@f9n&Ul+a-JEyJVK4$>MnHv zR$Rn>)DRs~T~1+BgQiBwJv`o6nNM&(|3SH%iML|cL^|pM`olY_@S79QYr~0j+CF85 zX;;OdWH3cfCP4p zum(;jQ+)Y|m?zpNh3wEEmHEGisEBg|$tj@R{x(R1)1BkB0*(M|T>yg!Q<8+}9p0-z z&pa1e$ltOlYUzGk|3%i}%o}HAl{*y;FsfqGSRJ#KCl?c)oZRUPR+HREg2wI&`-_is zvc3@D{+iO1;@bu!{tvY*K1<2pX{SWfH=YTPv6}BWwTjnbc25wwaL`fxtw#~bq3u5S zPKa^sEXw}%$%rX_50b!?VrNllDXK+Ft|s}khxY6mtsL8*qOt>c_oyE}iErTlIaMqn zxoZ4YdLAX7$C!8cbVAUhB%SSUi$q&tj@&7oLYgNz5+|`GWz0!f&h(9@0CE?>ZQ#zn zv6Ll)*fbxR4vf4TO%(XH8p#+eh+LQVci(%Vqg^f%)FlCJRAUhOk@DnbB=>2f6=KJi zh|=T|x`~X9KdXr7w4DE-{Pdj>U2%&74z)fe+b|@GGjNixS831Nt0wU&XuUwc6_Hte zp?Z6olNQzTJ*iliT5u%{vGVDA?ek~$l+srh0k zwC}2VtzEWdH(wDefyecOu7i%HM7LeS6 z;13`tjGN>t&9HecV5s3-m{3pxeGp9$$lBrD6>0{tC(JMbt{9FP$zTM2|K1If1sG2r zO&Ht>*VX|Hz#m0kM~Y>@6N|9~Q2>W~#M=MWTMN*H04u+-7(O5Yv(DoJ~%G|#2%jku*;P^=BJMzq$BZLCIJ({E7f`o03d-= z1ds-R8Dfb+k}3Fs_K@?yhtIi*1w;Y!zda;?#RZ70f3x0XYsPo3xv3S<30oFOt0V2v z{ccJJjn9er4AiSMla{eO#mg(Kk>iFwrYy{m)1a5|SY{oUm$9Z^YHt&BD`XVkjBJn% zJqsC9xv_}}zY0-5QzmW@tzbDGkbMFZ?8Fh8Y;vH{RlGGmbTFtHp=fs6MS46*PB=NWxkr|I$|=71a$J4%o=C2G?Op0y_O9*G{8bAdMS9hfYtR%)=^~LW z7ioNK68?gEykvOh{10EdWPJ!un_sZ-zUTMo$-uB_2PAx09(53#WR#xsPV;BBEiw92eNVFJ=#Z+_Ozs~L1prmg3{P~~H zsx)SQn(j1Hc}*I|S_K$sw*|@@N1{c3gsJIEno765Vv_zjc{#+e$dD^AH!U*%&C0Vb z@1`aEQr@P-)<*}4v-UgZ>W$y6N08XCrkp%@5$f-dzJ2H*SN;n#WBs8zZu`A>`Hg*f zVT9VUYI9r`wV>?hGJ$s;o$l(7H_X*7OvwJTQ$9E7}mRR3)Dc0LDoXyo!4-LQb4Sp7^d1Mth#fHc)z3fjsEK zJF%aEDUJ_f)7PKL3vB9Um-pn`l)R*`6e=$Wei7wUREAjg4cv6ROKf|(=vO^S86baWwnyb%yo>V%mCeV2Xd1p%z`jqQ#j@w~uZontZyE z5S%-~J|Ao4xAEECBriyph9c+IJWfs4DQs5OG(I zn|ZFgo%gricKlK%IgLQqok}U)`yz(gq$u=Bxy+sg8)DA|w`=7|*Qr9>gnOCl+Inhx zeR1nXEZW53g>l|1LmdqKyw7mH?C%!JYFR66{0AeuH+Xxc0#=VMDTk#yGNwIsq;Xqs zu;~x>$iAtf$uZm6a*%Jo=~@9wT&Xe@Ffxxis=3 zv0+|Mu#ig`>8}Rr&9mXym5;VUez;SyN9K8IxwRTb!V1oJxE`X*=vQqq79$PL#NOl) ztX~bf>=^NX;wu*Ob7{IB?2ZZ*KCpU!xjb$KimG)Q_5Cd2rL2vVJ=+Ndifjc18Zr}E zH*oLhm`z>nA@lpVGB@Zp`Pf4zZ7twMTL*G4+J)pgr==PgC=uN-y0YF*|IAG_Lw(j{ zU1UbvA0@#1hTNb*Ce}LjpexQy>N;a{q2x+;J=lYZ-IjrwF7T=c6Jg-{C>Z!rkRBIk z2uN%N`X%tB$BzItwG|r95COb{;xQ;=uYiO!nvj>#5|mm%qXyTz{{e;L?2VvJC*-bn zph=1t0xLj|90n-tMD%gi* zC}22mA(oaIM`S{{|cv3DC1H0Y4FL$QRMgt#s^x4POyMEkL-l&dyINI5VmO zq#E?kNHB^sI1M*wPC7@Qt-6wKFHD(CUAovYNM}?Z`+38*}%6Bz1kMcfnyy1$PReHrXeq_9TM z3brH_rl2#F2PJjz3ZUUFQq%$?&B0L73{v3n?M8Hu0VEa>_Z8wQ(6cHD(-EBn(-k;m z0D{FO;$nL-x-W`GoIFD8i)4I^dex>7@f|EJ`AIh`Vk6xc!^|-e(;)45aFHU(coIQ0 zOSmkvAAQvZ#ADQ3p0r85c*zLq$QxBZo z-vj!6EZ4T!m6lB9rV5|2p0Kuf+nH|kJ?8ula~J&*lD^4qVb3AK<+ev8m21q4mslDy zL;Vz)R8@WMJ%4fybtp^P;UMU`NL={%HIFh)^**NUl%UL$fX;_=!S^_@P_ zTU92uBl|4I7y-J{B0nM-#8FsfnPR!N3E#*besj7*ZRV3BuNlS0n6MY_fp~k(SNwHk zm?!NY?be5ibxD8ZbLKzN6Bx-@ocvq`s#D&LrAMj={-1j1%5|N(#1j>+$`9ri%&n&K zN4&IeK1bSk(0iBsg;vMyeD#ctMSqnLsh9ia1^PUF>pI$$P=mJt)>3Kl%e+F__?GJC zz23~~4LyO1JFgr{OuUNKE`2*w9PKkV5iX!(K%1A5hx2D&(pfMq!7b*fYWl4DNVgSu zmENQ+ZQ|cOL-zQNY7KLFd!{QRv#(#pqDD8>3r}oN+dc`KzawYBLq}(=)sxyxy6Lq# zQ4+XQ)+;)sMX5Dr0fAP1G1OMS99(c}NUc8|vQg#b(&crnM)~3fjEv&9uhq4m?qMzx z7)t7ts=YMjx>T*uYMv!H)@YQS!P8KZaVDG|^CgapWk~VFfG(0 z9nK)YpWxeTFcL5;*7!j)chKtk$&KEZs!-I+%ifx^^7 z7KnA;RjJ9#I_7NIp>BQpYbBP+KxliM78t@Q0UAbckd_>WztkXp2m2UV6S>=w#mYR{ z#4E6lD(ir%1&@T>;e;Hm4ER8J(;+bAphWo(_QU0IqJ0o%!$?YNt=5M`R!@`u&?<~}91vuz7F z%3a6ab^UQU`O)V&)y{LG&7VncYj)5F+_&Y~4J^M@HMJI=&=ALvm`7&s!~5PiplFs6 z$DICfO}|9XS&h+L=yI=0w2KYn=lIL#%jF#2WHLTjq(51-aJ7g3JrMM~|9M)IKHZyf z$NxL73guKStYdt0!{U#@?kh)ed})0O`1^JEB=$g^B}aV2N{_6I0dDq}BS2eM4QS~0I{PWKw0(udEb z``CXSGI*}_!Mb>onOi2k?uooJQJgHdSmks66dFjt!$aoe>jp<0^ZMei4TTk=-XWpe z3h%*h#V}pNXht(EOxIMAsk~!^(7DY0uMUP99tkj2*Wn_|8$}K7hb}7`0qRWm{SFLJbdr^f;$-m4f_Bb|4tDP;q+Yc z?^pjPWj{`hfqDD@1OZgbLy$Rr`!Q~uh zqQ61<-^&EXWWr0>fR+wUy8oWhMhxb-kd2b&1JyWSwkiGW z5U6^?Eo(u0BemS>?u-s0If1e=Jl`Id6z<1rrG#6dh0!Kl#P&oA-D9LH+!QRJJ7t84`m{@bdQOsSUVddq{<;{li8$DCco+-9&hF7BY48G z^O|7+#ICCqOok%E=?Rb^VXO zpeQO1zW!UB8d|J_!rsWY_=c5lw$_dI4m7GQggNo ztwIvc>kcVzUu`iyeopD%oe=bWr{qL(`z;rR*#@h=_2%OzP&&e$$vUFo^7_cz_!JjD3*CqI~IEa2|1X5VUbR z(NZhw(W>aXzPCID1#VMU!>+#3YqMV$tubqU7=~<~7I7ZRjC)!jksDY{CtI7CV&1&K zJLP4TIq=KiXr5=7PLT61Gs|0R+Qxt)ana@!Ck$CiRKtxao#ImX$|K{z(&mU(Bd|?AJxV zcYYl;1}gF;wrxBtl=EL(Y{~V-$x_kL-XTC1(D+2uSjVNDS^7!Jn?C+6s>b=Z%_qd8 z=U#f}3|q2W3Ki<$nOo9+Xod1*4RX&l8JCRyH%O}nUupN@^t`BmX~!81Le z#P?y#)6$VsHnAIHZwG?@f+{!p_dk1Bs71&GR_Y5Z@YOYqZ=|KpbUjQx!{wHwNUdFw zbw*Oq5=9+6l||PoOa<}NK9rpnT(wRWJmP;JWr0_IkYc;?yoI?ZIy*54W3i(U2J-5n z^Q6FQ_B;|2KSp2x&G6==MK=MaD2E|TX-g|F!JFfMwlg>nfJ0;W9~l~`bwM~!a6Bb! zI)rVm6pR^x|G_B&;eDTykxbd`J@=(tjxd@Yu`tNdjJ6qM&6!AkwESozPCTn;K~#~xoLc;GUBq@*Yo{W+VPwRhMr1*KQZZ{M^x%2Rdbq&hl@ z>wa-jk$+@rbvg^#KHbVS;(O~8@9I|w;@KL0nY~~t*LX4mzq#qc>1|+g-(6Q+WQ}j+ zYx^Sc)40&I)^DkEyE0L>I8*^D3yA44hE}6@$Q=WNe$4YLUgQPF6N{*afQ1T&MYV*K97=wYsIkx_&iY`wNTY5!xRYiT zJ?m0f&2l=lsWQ(W%&0tnh$IiX9#5ZnE*tIqWRS7RP1QV)!P$+x6V0i<$Tc)a&a5#a znoYmm4e$=!h7dzH85%B3gCT^lHzjmxi5UVjyaA&M_Feb|0OEe%X44>_0#;(j*a!O4 z+_phsmH=9R1MB|)U4P%9zu$-zh6Q0Hk#KCe@;_nS|MQ092SDh_0>iBpaL`u?W9Am=B-TOcy2iJwba5NF~oNO{pgoB()WULKrX0O)EXU_oS(-EnA^OhIfU9pa>v%p^17BH^MS zC4&!6r4BLQ1)&0>I}^Lif+hL@u}$R-nh;xJn#5?R)QR-Y)jPHXM8!t4gxq5xVF}cZ z9~}(lnj{xgs@h;X<%%&*9f+RlkYYOOou{*ji^#b#OjM4KlX7h2oWroSj3fJ^C zm6&0(vy&z^kCzq5|T%@b$vWH_xqeZYQ@ioK|GN8*HRsvkL2RaG}BgQ#*8FwAv+Rt z9UYN5U$&h&roW(AWWoAAq@mdoJ!VkRFYQ5TBA&jNbtydi;S&|adF@1?G#ga>fXtd| zc@8>=f;Tp7uUZ>x<=s$xam(pxjZuS6Zg5gN5JP$<;40 zmpa%~g@ju7Qs$elmZMN(uU}pWw(|(9nIZWmz`e!$GHzwbHmmyTee__*p_okU;^~V0 z7sW%D42QLMJ+9qri2r%mqIs?|qP{UCe!W3{6Bo4uH%&(_7;+w{4olul;# zUsus-52zJ}&Y{DsF~VZgW+zX)v+lnznR%ytqkE#MfV$Gp+_xB?RN8*i&G&Mp|8*W2 zQJzZ)IituZTqF-Iq3VDI=LL2Tr@^2e0+&X(DY zrwvjyye%U2i&5FJ-enRi6*?>*>-I8!8dMIcC)x~12k`$$Zn#azymIEdjD z_PEpL_l5!_G%FK)$(fuLPcNz8AL>8D`cte4B+eA}+9&l|8a1BWd9kTE{HIh}YN=L; zRYnuayRI)Pb3>biIlYL4>09rO{`l|nOi6Dl=}hni#+Q;JqR+?VOPHr9G-wUB91`qf0JT zuNgk)8Xn=T6=!jqSuTub+%%|yRjXelAQx%(bY3%r9%}yi!SkEd{;r92Qmdm<%(Ot+ z)l4d@+{_$tKE-ydkmp_Z6~??qh3wvwEK+kf4XTZI>wj454D@#__ui93RgMp2E}%bq^`HL2DlmEti;i)a9 ziH$nNDV)+v%*-(U3EyAa5?#%(h4P0Cp9YY=_*ndjV^%pkGma|Dis_Z-kPmLONrhb1 zu^oOX=XQg5t=IgZk}JEXgS&Z}|-|C1(|BIPg0{-{TgD1uzx(SP$| zkU{U*-Sm`B2ETYlA|xXMOPF&(;|F&H!+ly|#EGy;8US8kxMtLg2Q3S7;I0I0G5jFF zH^7Tyi3ZgR38A8L7(5Xc?gt~>+W!e2{{zkc3-khbB%lU4`}=O@FsR7xcOe#jIZRCh z4d%b1*Z(>)LHzw+hwu5%N4J8r19>eh3?uz5X@l_)5WxV6t$s_chDidze(3}%2hHnM zOD;9MAn(eKm&?Z^T*WwQ_i`cLeG8+eNpad1G!E$^8|!qQsb;dc;#^W$4I_$O1-o4z zMQP_sraEN!x|>Q;6FhL za&FV;m|tX@c&)2)lji}l)SWR>vC2ICYy&aZ6bB96E27dGS6L3K;uzJRDyP_MKTsgb zP)>}WI7$-Ms6LT=Q@+E0isvoGygpZ`>J7E0>>GxW%b$pQ6<^{3Qi0O4b#U4bHbidLt|XYhE3g@&$YaWc9~i1C7uJY-(?Qz z34BCK8nX%iZ=E@y`z2xln9)#6lLDrJ266&luW7a}+8G|JUDl&Kp3cSM#ot4h6Ag5L z;KoKH=t)oiH8a(nFIm1%T4JcaVe2rO18pcPl{cj+pRTjJlwsFaD86}Mn^ZxERDNCk zdItS~9@F*V{Te;xpifS0?!#gME0VG_37_Cs-d%PIFJ7*Xl?vz>`Ef^TzsO*k?E8pR z5W3nY9h4y+-Ljh2%)hi;xQ8X4>FXU~k=@YJv1X`$7h;QhxA6YlCEGL4l;xDP9EsC% z_`kW&E!}1>X9^C^ao6y$MDe`SdQbOJ{DN}2+tZb<{Ef~osw;f+R7z)zLnhn~W&>;) z8@*$*y`YQ}Crqlp4HU9vnDL!Wm&tov2}YkbbLA_46g05cD%HIht^T6%HqjO2Jogf* zy+(Cp*~#^A32Ps^XCD$nOx^8X42y|1Zs%GyavGUEW`5iAt_Z2wK$pNGnp0O2A9Y?b ze}_-(vE3g#7u`;@p9@aDo*%v&?Ds$<7k5J8q0Qo(>4W(8$3e>4uT+XSLVIF2zH_80 zB-BW$w`cgs2xw@ts|Iovhi!)+c6F{*aXiK)Z5zLy3mP61&~I5t@XsP^qg%KIa6!h!=w2A&IsxBM?MUzQeo ztJWO3Mcp$MW-E}HHs_q#Terzi&c!~Zjb1DWUZPZTbjwgMtEl#lh1ws#@tCc?Hnq@O zbdX?CK%*C;cU8GAXX`qxWa_I}X>J7;mcJ7jEEzC)uQaB1TLB8(J8+o^5Lu)}XcFN1 z@IP&9pr;g%q*4#*2Hm(|vNJ;Hf5LsxKMqEFf?bTT4HNd&iQW>W)6Fj{F5G7ZurI{^ zQ>=OANeQAOo~u|&Xm@&3uiQ;1siQ`fl7!grQiijYtnej2A?7KMXP8!FZzlnP0YTc@ z&a%k67S|pHBOYdLBXf0AG+M`k>VMgrnbxtgV_!Ft4t|V3Qc|ig}ib zzNf27nk|B>P9S?XDDFWkE@H1=mj9y4_g%(Yxkqk0m$k%{?cK?Qn=5L1`g6W8I~l&t z8u9hhf38#O-SDKjcv$Ck2&YcLSN^6tUd_j6caukLm|4^IgS8bOIoyRPT9$3@3EKrx z=A5k_uP#Fw@PttKnu+4SaEJDgQdv3Ee%JkMOxjF>{CSf{OKg2D?94%hZ7i2Dn`vjS zFOP0}T5T&8DL3sT=Adh3%OJL#lU)oIQRW`_s*=~-MUax%kdxvyblo$2ySlk4;f%l} z+l1;13kl1)mV9d3(Ua}fEt$=m{vHNbwx&)n`p_t`Cn@Cb3{YqE8V3tH^~QTkuh@$i z8Dk9Fh75`#;2K(Di797lvRgE^sXR{GJYL%MIs|krNGhfeCj}1JkQ}y( zPbfb+Uq9EUq`M*NCsU01czsW!NMVragvlg63wNb9I&+G4PeS%WR4t0qWr?k));^)f zxqy`W%ns%ByMVkjZ~v;~cvnqaf=O~=ww)|aqOhby;^u0eIQJ|=P#yyn<26^obYmYg zJ2IN4R~|Yhb(4%fVqpx$k>i|gg4#92{YRP9B07s6(-R_r_G?e-w~?w>)-!u|bWUTG z4OC4{99PlFam5Tu)Qbrh)FOE|`6&@}lwkJ-MIjKL0#8j=0^BQ*7Lmb$DU5+1B0$PZ z4RSru>j0y+I2<0p<}Gk{7+gh#J%o#3N?i;Q1AGwv|D^K&YrFtJ7*Oz_Ym1uzzi{at zWSn3*fe)sDQ641J^dPJ_gk4%#;4lS#4h~h|KM}|8162Vaeg}3Z@Z&H84*s-)z-%Hy zLH-!~THq&uRSg_sgZ3=|#&9xEXjq4j4(i0f$&DV8{GH>&vBE#`37{0G*l#@bgfNaE`+eMEkvAY{~&vE310|S`lM`39U;Y;Mjb4f8EAIF|+iGd(xG7Ka& z4N;gt9OD(A@QMSN}L`mSgV>!M6 zcxxde1Il`GH4xN{Xkj*D5N=!KIx?!(=+sH)BA$xDG<4eTJIMvdYUE})5W@^k$}_$w z%?wFu;>D*|jF@maBkiaPnnD~@^cIE% zg%#vH-^N@F8zg>7VdnW!sm_V-BrGwDs=Mw3i6pAg5pHn2)m&PKb-Js?KIPRLgvNrQ z-SpYZkRIeHiAbGYhNSDFnE0Eli>#W6jjpMXPL10BwZ7NUz(B2>?%`uT? zSn9dkoObMZ&ZHf&Fm^|pVjKS*Ojp8Bg!pC$it89BuMg%FM*G{idl)C255m&CFuz)w zU*%U;<%KQ_j^X!zod3&xenr>~w{71QSBBDzRz%jG=?zN?ab_IjzbIR;W34@Lv9_EO zx^N*?o^44B6L;=5&pISlzEi~X1>7dOeF7gfE5rq4G1Z^l z{VT7E1h?wks;xXLPV^)7HmB9QGN*$?~(UjZ}i zBR{$Q%2+tmEkHL zU5?VZ)1Ne0v^`^Si%*(kXM^|3qr|F7A8{QAEBzmFB3~(Q4(eXx+l!7gK1)*I%~ag@ zEmdI5a%ERZVRUcIAcg*Om3LE&i?w%CNriETdjM?$NAzq^H1roVp>18R1H8R&&?aIA z$6VBgt|ie)H@YTXkY?`o8>rf`V`LTtZmFSQ`vN}7NGc-YCK}k5>3BsWAh5C2BY+9h zar*wxDhDGj!-$Iw>dQbu3Sp-}12^Ct0!yYX1Ze;IuL3s^6A=OJ43PX1-kmH{qIN33 zY4GLFpKHwdSN9udVmISCwcVR^q(`f@4K;%pC5*MvWrz6Lg^JV+mjsFg(-$ju@L5@g z;^(m6oNAuirQxD!N%trln!iL9PYgcN>(I{3Da>>(Z<~~9NlRl6W~FN2q~78wZv)-& zuU-q#ss@tO1`+pJAH>Gd2MxU#rCa?>+&1&;mm`)(su}fN#N$51U%z?^L*g^{H1nWS zk-RO3=b&;mV~pi7H+g`7w?baxmLd67Ms$=fn@db-t4(@ga3wNz?20koCx)aBMQ+Vh zQPF*m$gygTY3hnFm#!@81sd!M=Y|8aR8z{5_l-tV7^X+K4+UA4r+=}<@E@_5EnO26 zhRl;r-hAX8w-;SntAUxKXDyhDet;6}wH69|ccRZjbG<^Y{B@5l?waCjp^ot6V&&OL zKsFc1YIRVX_oYeHAGl;(_texa^MStV1D-05msjnizDcLNi3xK+iPJLXJY z!@NgNi~9O@lkr;)?gPj?=hsAuX**hev{dm|N^5+JTYzh;tgDexM&SJR$Lb^IqSd*; zqWZDSqrK#)P{UlVoG=I1O=l6Y6xGQxbW#T6#vKeY82{1DaF&^!Dav0?rGrjGRi8;% zekS+Lf(4$IVg$1j94Dr``0{FwcP*LckT~ zK>$qD-B34;7}4LsB%9&iP6LGS5@fgl;F=&ZYdF;fVkQN^YGdgksRdyFf`A=Vv<%=} z9_GGbr#1kopy1jIh}&)go^t z!e5FQUs^%5pmlp1My=oUI{XfBZr#w*KFG+yAz+a-(3%s;0+2?)n92e$8Nd*%043lz ztf3=R4B$Beu+;*gn7s^USiuVmoF@23IF0{?VZv7h%G-cWRv3>0!aui_dAe-6f&^=B zHAa5*h0QCB=vErqwaCbt0Z0xX=i0_vo+2`UyIZQZ*^DI!c>*S}}7UUp@j9 z8URZHh!-$?yNK97M|HD4j;EhfDJ^5FhCO3&g}BUp`7riN@|IMt$0Zfybf8Mb2PMHC zrCNh1PU$;FO~FIV8e#y&JQ+4bPwOP7=ob^+Q${?3*wX<}7Y#zlW$2C`g5fn4xX31Avh&TCT9_6-gTPiie%9P z9dqBRFXv>f9V|TKHFbT#AzSsL)xM{+k_HR>iMUuDm=Zqbgwbj%+x)>-x|yeO`{eLX zYC6u`Zz)e0Yp1tA=mM`T_q*XrnN-bqstA(1WncEu@gwUlciHE=Wv>aCBQM`hv$aG` zom9}~zkZ)0PJH-0-TTSOrK!p{*GUAp#Tx_K5c9*VF9N67bkKb7zNMatnhmqe%r^|J z=HYN5y$q2oruo)?juEyTK>1U@5}$M$8zq(KkdbJelv|JS44%EY;_dDEUCWq0sNBjr zm@;m%=?`?;?C|F7*Ut8cH9GNu*_n%mw!9TCrqa6l0$y#H(Nxc~stIU%gF^1qu9d^s zoI>NWQ@YL>xVnUBv1reXIvsC^w~c|P5w(iUXZae;{PUUOH8dturatSL*!o)qnAex< zwxtDaRBPzha#~tqx^@M%ZgwzObSSHYHeopdGhE=bRcMB_QPS7t0#5N|{sbec{C?LG32ionT>}~f8xX`hfd~E+AhHGH=m;cwH(#8}@1^^D!+^IYV5|ri z!@(gDV3wdO{l`Po{-+=Jq_hTZQ;WCxxJ5L5?Rx4ZeSTcWkaFRy(d{1TTKoYA9ZFH* zwNCm)vEE05D!OXh-U7N5W2}X}C0;5qD!UWI;;;D492rMj1*5+O+HqV$9oE2Tvo0gRc!D!Hg23Vy+wqtSW3eDy>}JkiLPaJ z?(N3@3%X?31oJ43e&@X%8KjSI;7^_q!RViTKa8=#%?W(Bb0UbD_8yD0*kos4(aiJq zG^-29xLY%yoN{=UJ!RYx#bG9$Dau@}5si&ez{Rv|>BhDFP!ZgE8mCwBl?=p&73w#~ zLs0#nvv0;)s~T8F^DH0a{-}&;_WnPVy$4iNTe~&9Lkl(Z-m8Fsp-73Sp?9Q_;h8ajw5y@{SsqzWe#ktTwGQWbkY{%Z$4?>Xv3~RxjV%$CCTU6((350Jc!_teCc~!d7s2xlhCRY=ZShXRrj^q6VZ?GEgJ)S* zZqoA;;*eZ*R({HUnX1t!6@y0rvKa)kjbYe?=m4n;qJ!X~Dn)$dFhnI;4GQPrYz2;3 z;MRYmlM?_jCSRHx%@A`W>F?D{m_Yz_Qd%6^5z!S%dLKrq$TC8bxgfPh2sIHwjtKkL zgDNekH+O|E!wDvZsRsJZl(ZYBcTn2XdpalpWC6Is-vfUs7XSk^A59E=)!;@@U56H7 z^+F(+N?H9;z_;fX72IzEg?w+wMM9-L_6{5dTzv&7aeuUUHFpdd?99v z$p?^zWdN50$v_MjNujuE6lFqQSlk#^HKlqK&SEfNi7vuQ_1oz~X9^CQUk_({bxSa` zsXA%MX%>Cz@)n#2vIJUsX%_Bo_BNUKQNc>q@i_*H=0{~%VOUBY;qN%cf9 zPDEBXi$QKlD*D#Xa>OP0JQJ^jG3gX$&ZrgY;h;Ao)B;W*9+_f^7fh=gjWH8jz+X~kooJ!nub+rw-#}RraGrBK7lB1-izfXRC zFp!h8k=o7!l<|SP8B~5jGn~pJJCZaiOl+Dh%Z~ihn;;CR0&=_r;U<3bFv4tVCBlI# z5j6u79H`4lAbwfm&-6&JRfz@IUjq!jLV)7Xbr}vtK{@b+YxNSpE|E(}9)tWjVP<#A z$=BY~7 z`N z=a|%ciW1*jGpkryUr8VOa`SrGfgAxLpDQ`1ZZd?~Nh|OOI|n;n$uRk5ELOzCUW${P z5Z4@+JA^5zT(ofsiK*9lbm7bC!5&|$$*Ef^@13?d&&t`%abmn0V}eiy*&i%}FU+N! z5;oS8M%Ru^#}w;!q-`b`+CKQY;Qt&|AFZaElYDVvja8eiY$Zn9$%du^H9eMiUf@l)W`{fO{q2eoY|UFL{%`oZ!TX-e0#c}A=cmDrNXSu69dR@C+7-Tt0j~PBXx~|fnQa{r;=-3jk%2##RFyv+ zZ8uEeKY@NBl}dw#=Oe)BmG1=AgOnHSZ?<2dGALm!LR8?Cfn^2%##xw(3C3jLU>t^3 zG}s38fQPYV6tJ-ak_t_LoqzYB|8v#>Sf&tTU~T5I1S}fOE@WhFA>m6%%lgb$wsJHs zcL9u0xA~2!$`4mO$(cxB8|#a$J{%a_KMt~9;Q|vkRSgxL#?0EN(<(Y(ls|rsr=aA} zp?#9xw7J>Q;bqty>Z?qM4VH$!vp({FjL5CEXRj)%>9l@2b^S7+hS&w$@`shCXa*T3 z^jfy!leO%V{EpAbU7Y^7d4vt|N3`Er`zKkpK@mY}&W>kXp5+EUm5QDCIOVvAS$wQ( zq+@vAi+|0I7WX11lkSg}iq|WDV#RSlLp~SRgP7yxiTjP zZSp+xTul*Fn}H^bhSSrezQ+yR$z6wf=Ij=3c?yOOc)f@YbE)ytY2*xPrbWHng2YGl z0@>?ky_R{;2j2GfJ45xAm>#(ia&CilAhcDpaU$?}2QT-KS&F<+|HCG!jF8skx<#bf zY3p(fo-uFJ;+QPmgxykr9E+@%REfG3^!38|0sZ1dq32(&h+EVE(UO8}l~c^pOpL=U z$!FQ~&`))wHX6{KY%?Dmc-920OB61S-aGIkb%XIc15T%`??lD89P6KGBNaPj#FXHE zyBn=?XfaL~OmEoxN^ToNt2Ik2%WU=qi=41*RGirL;ANq#^{^xhoroiovVxyX5yuLR zCq(-Ivho+s5|+}K8EazPrqp@JL{M-RgUVr)glno0>}mlZ^a*YasEq$g2?Kqh4<%S& zm-9D#Qc}f#K@Knw0VyaWAX!`S?3HhRv9AE+Q6{G;8PznL{_gc~5fHU68)$)!!Kyu2 z_;$*X58oZ83-6u(;DRU}UQ2&6r~@Av_H zO6hU~b#^fz7oH7AoxjAw$-+ceEi7Pef}|EaE|@!B1mC1v1VwGiuhdDR1gneK@Q;pE*SsiIZL%O0?mGU~?ErH3k#D zWZ8HUy?v6!#PNDTrt^iq#36RCw6enRy=pWF+LvMS9(AeaL&^FHop{Hu7z+vhfXkBA zb78$6iL<(8F=^SiG)cv+&*qcJX_KpHeN8P9E`YpXO2r?*uRm1?@TAeDH1p zr-oBNRt+xc0UtnuaD5!wdY;}^h}+H76~l)`^g-T?z<+F*Ib_q@8aR~=0RZ*9#SuPh zx~!%!%nbq;J4o;#k?H8q$qhGcq|Nh7ByUsm=5%bRn}G>-tH4Q0bpNwq^yl{D8fH^Z z)}Gt({Dp6>iga-h2`D|CU2$u+*fxc6-#4cV^o@UwzWd63cTU7e>0HxE8_%ao=$prj z(e2+39Xm~2Xn+6pvi_Ux0;}rw+{Jvi_~iI=RxO?N8SSQA*p9g$8cB}rjFqiR`zEOokcl2N6g|ec&li*z5#BeCoMS-v@&?Y=UZ$s&41LMpQT`=ww|Rek zj>YzoUW*64O?Pf{-&2V$IlFV&aVnZPxy&w=B`x_N)oIkP5%*kc%e33Kyu_qlOqLe1 zv~6F|yI{aFIpbCwMas)9Fdd1c?UPbCdxx=GEJZN7Wb$Omn6AjmvqY{B!sV5A_`2zf zn}?W-Hd=lh#E*~gC6{kCO?a7{e_&!I8?sO%=37FX5>|jJNdkvJKyWBQswlg>0$+!+ zlR3{K9sSg%V2nYFWi-Y%;?}ff#7Fr{u9R1?`rRKiZ4qEAfB!{q{DsOFRx`s5lQ*VUWy#B{4v&U7;`waBDFDu_Ege_d zvQ|W(uQl*;1*aaxp%t7ua2zho1i?ZiFvnzX>ubWw5+JhoNH~UtDB=q62?SOw68i5V z^{>+jME#TpV@q6O`3Z5ktXaPZe#|JknqRtd(jfP{{CDG+gN!)+dj=Rh&qTllzTv@f z{lQ0{Ceq{#^u#(a^UDBa!(^nHM#YWEMcI|}z2>2Uc5-5Gr&bchVk|$+dxTb$C0PE@ zax3p-Gng__?k&6QfbG=%F-3K5qYHZUwD{$zT2oJ(80LcW_nd8n>>vIRKX0$xemDuc z)s?+@k>vP3J}$9x^Up_*(rt5y&!S#Gd+#Fx(1dSH;}hDoEAI{-76RKnL-@P?5h`8F3bp? z(WZM~wQV@lvMkL#chSH2{G#2x8gZ7}Om)Y{O*R!bJWz?;Gw#=|^81piyJk6VH@?s{ zetm%jSYs*}j|~q`ZgDhat7pc1j`(6v%Xz+%M{i=y^wkf4Q!%M|rDQ5DsVmBgmOY)Moua-Vv{9ReWv6`&-&L{4}ZCq+$qedr`iO3 z__QdT!+uU(b!OFMuZ*@puj-Y#8reeiM1ZjboEcb3ztYqXWjGMdQD}$28W;l0(HG*Q zjQs&L0+QEDaEX@k_ZRT}jZ0vd7Vf&jJO>^!tQESq9sv{Ux9trGEa8&$FEqvAC?nM% zZKV9}UrkdO5&s+H{`&@^*#BR}_y7EP3JjycWiw%+Xo&8Ah72IW1&9CgBpd?MQE4LT zqG*v+nvtsoO;w6Y)=U+ zICP1JTwmap!56ev!r)4PA|ZGv7-3~08FD$ogn%=UhtRT%7{nYuk-BnDT!HzEo0yOW z#IFm=tJYD_L}(y9#Op)(ftSd>PV$q#h)DhH`IZkG(H6%pGM+2OOip zs{%2LK?lG9njKYa99&2ixeuzk%@BwNf`J**05l{7}jF%~}SxW78z$<&(-O>zy#LWP{vL5E~WWtmAsmegXc&d&0P(t}` zc%zq;fSJWU5@ZJ^rh<;yxDG@cu)lqS3fSV#(fi8IKboJq-;}fF2Gy?BiF6rEh$gUP zfH6l}=~QnCOdhx?yG8=M1vOjHl`h#8OhSI3zo( z-ty%xBR(Tb&A{Oj$p>koIDRdo|T?GSeOD@^Twh(V%)enIKm?y53pHDh(cinJG2i;N?En^#l70IXG2PWS<5XI&kQ zx6PXOn6F>Z&t$hfkI(qvpQrnnT%#z(xo#ScZw^UU$y_U_P(1#)@!%1J!%ygPm-x&( z0gp+U+uN;|oQ+l`bz(D4rq3nCB3!|s2<5bS53%)-fmYuh4uY7F68}$wdhRYbc)%a9 zgMS}7OW=!jpm7g+R}i3V@R0Yg5CA7o>V&IQ|F|zJ7Q^`4nOnWN^?ZcD`#A#=@hi8rc}2V}t?{gj+wF7F=^m9G0WRs&*_S))@Ko5Vk|be+ zmifAYxaEfK9`2+QAG340bc-xVV&yZzCGq*qVNTUG9bxz)pZil94Rai_b_XT5SvZK{ zuVt@)AP93DGzquk%u#1#lnU=WcI@+o0aWr4)^Tec^XJ#j-T2CAJ3Sx9U(j(@Pwz*6n{O zk4w7sn{L)~3ubcM@ElHGXm5STczCj+F5BfEpICqVG!nL<3*4y`szB+P*Wqi_`y*Bj)EVm5rhzIC zCvq@3G)0?K{iM(5jVxI#M4289+um@?p_QvB4Lk0<|Hi~$Eesgv{AssI<$4)RLI2TI z^L-q)FL+iw=2j=ln|E%zpJlJ=w>8&FFpQbog=~d^Q^5t;eTffJptK1n@RUkPOF8zY zh$&sLL%_5W=1YHooirdPN(wgzvA}d{5Xr$fN(E^B6f<;?zJeSNMj~LGu_ri2e5P5LAbw!O924VF+ZtzsOHTSWtA`d#vAk;(u10vH#EafIBKc z-2#xHwkW^X^Nkru*;;5xah+!gBump7tLgHZ%jTVFiuFfj71G3CXE;59IiFPw??{Lc5 zj+j@8BZZ?~La5_NP+T`wNDFBCwJ%ZMV1!h=u~By*#^aF43mxo5wQ$5JTs8!NdCQ(i z&5=vZgGw*%+whDujpiTHO;Y^UHNpOg5hLi;XgKpTN|K zRq}hRKQ+NK8TNPpt4v>LkQ?HsDuD!cg;)xKLm8YY1G^EjFj9>w8eHHFh~)-EBfkrU z3Q>y@5a~wH;U!EI38-z`XrAc|5;vwvJLP<&RB9!IS0TV8!#7tKuE>Kx-VucOKt1gP z2od0a!FUKKPXl+%q+vs*^8J2-tL7J%~dypgPpx7|I4l1MMJ^uj~% zr)904C?i?>c)*kP`T4kAGuIvv0H}5$S22u$CeU~xMngy()h$TxbbrU6WxJ0}y6-q# z9TPwLV1LvdgDRF$HeS|2%=_X_N5?=v#X28ZFj%+?Pxdp7-ZSCF|A zrirvt#j|&U>xQ;A)>s^O_|DkPZdftu|t^w+)r%|e9WXxjC&ZQHjvYhBS-C;@x?Hf;Uuv9-~+>wY(hZ(iV_!d zZ3$y&ON@@eg(o;v{+;vz3L@y(z|PKlRi`~%1GO+voDjjSvr#aPwhq3NE5wWh?T`PN z3I4)CXn;@r{_~<2r_$6K+5=C&06C!Ovey6;$N|+N@3-o(aQcfum$+Ta-pZ(KlZjsE zZ4xh=Ss}b6k1Q!l>R!dG4AA&ns!B^0ze*_PPrgpwsbq=!%u>R!;H0TERm8b}mDr+m zJMYmshde8!6-!x~u=%B;J2GzKkJ^0aHt9aqe_w7el51nP%QD*tXl#*vx{vta>j3{` zR{R^6duPqEG1@tCP%Uw7(r)2g{5S0LiKg5GYtlz<-VuL^_!!CIa6SCbl`32pPw2Mn zt%FIIbmJ=evnLp{*^A}m)zuk?u@XO!`0zEBG2vxB6X~2c^4@M|k13s3`=I`)Yr=Zi&(blkk-bDi9eHX~XJYsD?(zJ& z@2AD}6fM-AZ~?dskXWki64<9-ULAb(ut&{of3>moo4$|y;T4s=Rm#$g^$2Hgx+enq zpG&3i@5w&wKzW+c>+zbi7*%uik8C@s0?Z zFVE~^>oKo|IU=KqlBDNz{PwA4ogNqGm7m;k41%Tz_lzv*=Pbo8gvIAA*z}IJsXT5m zaY|Uv&L|lzFyVPKfeA^Uu?ccdk=u9RaHy)PRI3Z4#u0MHP5C;av_@MJ^0xYSLUPV% z$)=mBeVFq|uwKJEI)MOtCYPgDgA;;sVsu5~-B+HIirS4D}@=y^S@w1%dtD zrb6~p=|Smb?II_21lZgiSjrP;&$BY0QO@q5?(H>#WiFIqzh=;G6QEp7h`N3d%9i1&*=UF3R=L&@a(71MV_4{R$>^9UZTk`kX_NKb!!G zfn1PNNC-3oIb`L~kTJvzgsacEKpy*XRNh^YxDPAYNbqA|Xf>K3i~?0fjJ=SL1^yPB z>=-u!)Mg=3HKY|t9Kr07APL!oMK*zd_ddYqMzGmKz%KZJ^GgGH44q0fBn|R3L_Z%N z3OVKqbw5`J37+Q|dly&uQ}>YldP2UaM6D7rFs4A~NEO4SI^0 z+s2PnN0g-xNggyj;W;44%@yGkBoGiG=}ykTMkA(t1dLEIK;#lQMgc3yl~iV25BBhq zW>h|;KotY3*@ciceBEdvl`2P65v1z~lrpFXQ1NV_vCNkvY{X(@uBHZaK_k-3=qWf0L`{&UleGlgTD14kUZXqA zpzs(Yh*Z5^ORWantpV;SXodq)QvLGhHQ_1I>rt|=%6?9_o9Q=Jqe1;#48u}}699Px zkXi+6h{#Np$^X~kw$Wa08qsEc(RT&xCmtS#6$bT{dS6xa)lipgkP}DE$$ewx6-=_8 zHU59JU$^){qk;)AuuarpQT%55F zR-ZpTQJ_TBtjR1j3p%SqQ(o1X9?mo&Tom9Z;b6BGFW~JRig;<)()gS$sBzX1?_3&q zzq41jBeBqBTEv^U<8*RB+Q*yDC$mCYvE6v~lq88W>YROAixDgD{e4NoPP2X$o(+0+ z?9aZf+uvbm9q8x5Gv#@Cig=aCKT}u(-npCf{NK+#=@CihPfzQasZdp63}8CEZ$xir zzb<3=e78gAG3Vac0PFF6PSuZ3`dbq*~P8Sdf(ZGDh1R^*t{+Ch_G{8Tlq3t-4q<%@z`X?my z5GnXwp?&#k65CZe;vtFoS}hKfk;?~)u-Zc#{FNzh5c{3Kau&}`6%({;r5(hw1=)1o z0x7BS2QDdhjb%>K@Q^ELxw0nuFL42Xzeb1O^dUlUpKgYfLXaO$V7XT zn>L=YqAV#{f)5616zAt_B&0XQq zKY2E64)A2CRnTh2ozRJYf8GuI;c#EL%%>#ByyN6+8j~I5?9$dp*>xCQuU0QFq5b~p zwO!AztQ~QZm`?Or_I}qGiE`w(1dM{Y5itt#i^%? zEOmtB6CL3ybHk9XrMt9ZsPYY{E)b^U&U&|U}@1sdc55HMPRm}QsOmnUJ=0wqpB zn%TpmI+#83YjhRxGC*6h7@Rh5V22<|bssL&gASqCf0n*5z?VH314rL~GC|56_R9MI z%O3c@cF?bDh4VVLBH&^|1?F49Z-i?imLLrPko->=6RM}1CY+cAL?G}i1mV&NwGn7* zBG{n75(OJoU^HB&xGXWA&IhWT>I5njGu0$gEi8^!2C!0GsRi;NzN9XB0_a@;U5u^} zY8o(yVUrJy`Yw~Z(djC{O9dlNm5~oBq6plQ8-fhHYH63We44O89uaxW8&rP^0bXcA z!1g#+2-@A#UAzE+kbw#`hp~vV1U~gQ?S{OF4&Qm8QWW9ZqifdZZ!9j9pSz zaJmh}p@qu$*&qY|awJNBsyY5lPy}fjx9(C8s1hhJh`SE*StJ8)qks)jY{bV;BSnoxL^mV#gu$~dt77q? z0oBfMU2=w&oj*F^O+#vOUja{&r##?P_XEBKXbXc^5)hxkp$EU}l=K};8brXZGVnSH z!-*5rBpnDGGntn9fbp{Tj!odh4nQ&y()Uq;D+w;VFynLYD_lP=xAu4CoOVtskIbD z-m=}&tIH~8l9iv0koj_9QApRw-H7^Dfs{y94j2^=twl<9)7(FTK+$pR`;)$-Frz z?{nY}IZXP2&ZgGVj29dXpLOrLaT&+o9L#+xvFWwk`Vb|BE7__niV-hg*AtZs^`8HM z|I50Bblg)l|ArA0h2H|+5Ex^22}G(xu2BP6@F^vP{MGFb20Ij-62IeDxFqvyUsB#Y z5HP?A8>Ozu2Hs8J^7p?aVf~t8B`wdlN(#A_k1jp_!be=W8kZ+@;Ee>cxh-2oGuM?n zC+Qnv$IpLI2K2`uixnT+$VE6&;EkaZ1COq83Mt12Y` zxs)Z)i~r-Ko5K1!dF}8unX}onh`R+X*YHwwKcOUT!|dflI}KW1rQwQ0HnbCMY`SKi zDf6}+^F6}x`;MHXtH>}a7+w0{U1d|_aJWsPl4Hvl8#HSZSEYg#V-+pd%8<&56pRhp zw(lVIs%q?@(&Ki#PIy7p)$=D0YD8PS#XL`Q(d%_OCF)fCQhVjAPz|ldcVoiV`dO3v zR#`7vhfR~Tg18JuJ5K>iGd1Oz2k9&CYR|VZSzgo%VDFs#IBWGIknxzVL@!sXxJ8g+ z{c)BxnTjIw6|-Dh^E|c}{x$o;3|d-Vmvot0_KOVI_zjux(_MEXHETBHkXf(l)e*`j z%VkYwdsA#Yd2Cc^>hw?d-d#a-E9J3GPGl+VQ?VV@pFh*8JJ*%iAZ#p8}^1s|dQgQn5=ZjRcBEpxl5+l!{wO~Vw^ z_@9vI;nsN1Y8y8%zxC_9Iw(PJD78Wg^>L2P5P#`hd|`uLngJ~*P37|bL1LzQ>jtuV zlNE3L@Vg$r7VG(i{=4ijLRDTs>;t#}(c>t+H&6lxMz};E)bJ~0@&&OG+$=_HH;@kd z8)1QME&-gFYcR{?KVU*RIsQK4nSu84PV_n)jDe_X52@Cd$%?SO>@s{#?NURDG&lAt z2_W!-#TWoeQdU0tUp4sOkFZV+1fG5!PKz4MGHG_sE9Z@lE3N|VdfHevL ziVTJ}3c%zlAhc;};5LDXQXEKmRDkUM2t-GZqpr9|qU$+9a73;dDXfd%({bg~5Q3K3 zdrKNgq#3<)ct+I<@Bn)3z0Hh;AVBD`h0qvWgUgB#o>Ezg0202$Q})h%6IY#?DqE2EW;^AQB-_KG};mP|DX{IZsRApeM>*H9vD%8axhSVA|Ar>q00B>-7%_{F01$cdH#?6 zKcPce+%CsuoI)1Hx&1!N+0;7bDt0#47CPF$c0UV2&;Ftx8|4l4-q&ES8?@;-jH_kK z;Te>47JNodBpeA-*4{bJrYREYrYIGgAy1YHuK3jYf;xVY7jRBoR)@(kIH7!Nx>=TC zodHPszYXJfR};3Y?|H2@CEsF~8`54UqC(vKl{9Gv;0mm!#*n-O4p>wvh4wds^--f{gLCfU=& zbI#VR;+3+sImhKW(jK&^ubWQu2q9cc7&=UlI}yBFD4BzXa_U^~yRzzJz9(#RTstop zq8U^EtW<~Q!=zcayNR5x8;8wSu2gMqCh^#u$&~DsA1z%P9_E)${1Ciae{)zZ3d23i z+~8`+Bup70gjYO*Qd9viGt{!u3eCYw1pY$;?-|(c(8<03U>y2CHXY0;fdLGLun_qD z`n`qset^Np>TzhPtC`gclX0x{jSitd^9ooU}5H?#)&zzWSb%#s#Sb#U4qV& z9#!)PdZ)%XLJM3A;#}TwZMID6Jrzjnk|a2%7@rL}c%lP6HMMod%#4-+bMi34>d@(u zU2q^eaYhh0Cg*Qm-Y1oNyMk&Z(wO`TOYPCYOZZHvejfi(f!8S4_WFvaU-&w*hhKzy zTWm}Yh%plBjRiOZ@nX!XS*XKOT^l1G)^+dRk4Che!@ygB{ z_h~e95(5kmAJ448%v)mS(`qWDy%;-9@2DS&T}By_6Wa4`+0K{b7FM+6j72G7Xs0Wa zSs&EBKgv=Xq;*alQ=Kvth-NkmKx&$;9A^PU8`1YuU|I$Hjc2XwZ@GADT zaRpo^pf3a`J&F{B0LMBd-+<8oo_q6102I#OqqG0DO8)_8J2+*^XapcL!$$8Q=Yp3$ z5a(B*!UCr9-qrv;I)E3T!~oA9BEZ%B+8^3*S!r+kP?O7WlwAbQK6vl~3-6!byw6{I zWDDHk_s{-*h`pd38URuJ*bPwT`{%wZF@k^a9~DSCfNumq?*!_+uovC(9BBJR!}0!m zh-C@9Mj?tqP1T6oA=c@-eC2#bw8S3jO2;KSx;MQgL=4Map$4}e=8*M}rz<#5W+MgJ zLB6iAvGK+v(2uGf<0G7SDs#*`rq|@P55duou~MwQOjI5!Q{l($2nIF@aRrrBTSOPg z5`>AhL2t-q*5*b5OQ(HeNSdznYdG!d9h^|L0<_xg%7ya7Q%S0(NkUXY)0yUjv=6}93%n)Eg%xc0(7Qg zhOPN@#i%*(ked~5Imsl>kuO`aiY0;%;wmE1tvC(v39@DA;BX+J>aPbY08lVM0E31S zmk?my#dlq#IRwGpPZ?hj1E9}n?~9`SQ<%tDaSB7%R9}wdiQr}1He8kRmQKVZW|r$^ zTPW1mavFNdX!+P+j6Kl!na-w@v$C7%dDJ&rlg0bCy>2NxafJX!2H4NxS6BkxG?0!# zSl|W#87yJ^YuagN@s-pikwD;A$kiJ}B)h^#e~!0*PEYQgjuS2;IYGvPAPd7_!3a1K zn0+rvR{6>iRLhL|r&CAeSXkRM6pmO@e=99ZzIbWmh-iVe(76>_k9fWp799~Nlfpo` zc`sS@=aDkQB1d@Hj|-jgd+;zN=Xe3;O`Py>*$27`l9JkU`^@L7kSfci(z*}(lwzES z%Tmxj7ntYE`rOVwg z%_C+yQOSK&CR_W?t{<)94>I)Vz>`xA-9BMvhoh|JUz$WRG=DekAD_RFV?mb1-|B04Ai6$Ck7 zMqMhm2XCT%4quT z=Al#L`#B{&4bNKGA8~n5kR!%3QA%(;#M))?VT)s2IBC-K>s5&vdPbY{vWqM_bWh&3 z^$6+meQ&Y}Gcn=kU>^xpDl>a&HLl~lvE0z5sWyHW|Kenz4dLDo3A>R8rWV7jBNk#t z{7q&y*4HhFa`L7{`L2SrCHl`kT9z+FLSHf7D52o?=^3A_cDHvLl3)I>( z88e${%U=~`gfhl{?|*S?Y`p*z|7B%)aZBpB9a;%Y2p|bijO3_&Atop27qf~oF$lY+!yqO` zcgTlzFZ=@}OcvK)7Xb_E{QG*06j*hDUI2{KU}_MH`1iLF1RPMKB*7pD0qi0UD8RfC zSoW5So{bR;zVVMoqY{JWjZilTj4CC(_*OYdC1+g&D}GllVT=(Uk|3l_LzR(3KZ=+N zYVA{7#bh+|Q?a|R4+`L9HG?#{yjkWDc7h5aJNz8^(4)QNir;Ebc?4RBrp2AYvN_V3 zop)_&2B)=3FeKSeT`3{P!Knc9X7H+m+ABD(!SFjCsfUH<6e$Hl(1;j;+eip1>XL3? z0xw7cF9oRkQb8!1P+Um<8tzgnMIDa`c%)K>r67AOohq=DZ-zYN;>2ZYtDD1_WhWqw zIdy_+!RzK;;rJe&G5ggw86#BM~DI$k&+FKvxfr;?oQPpR`@SSx(^`^gDf4gzf(cAp8B4)CGgQL+O1RoBTSKSt>dod{BV~GvZiM{lKUVxty|GnDlHdBH#JkLW zgzH$+Ty2xz$sCnCXV1{}c_C!_1Y~Fd_1S^K6VIp1$T3=8)Y~dHdW2!-xy1m4%#Mp6>bD z8|$NMu&O!d(At|MRpJ2EVVpMpFbihY_cs1$L+{r|tf@UQvT5CDBBD?QG{xJQ@&U9wUI{lN1C3na7z)t>SFCiR-2#zV#o}$%di#4)FBsLq0cZP%EvhI#S~G7#9czZN)s!)%XyWg%jLD#l_pZoc*2&Zcjn6@-r@(&=@vZf{m>SwR`IgXbUYpjQSIqf`DYbHR4a;e7 zeXB4kH8KnDl3IT;sJ0ai>38_z*Q5Hg ztnK>>pXtTVBO&NBQ<}s8-J6Jyi6r%e+0Qo!(d>m?LfEF}2~ZZz?S# zcH>52kE*W?o4xGL{CT-!mw_w&x=PgIM+_;a*lqLihxRX~EVF@5*WdY(cUpJL2?EI# zN7dSFDw2}q(z$RfPn6bqVg!FwT->s{LI;tHJgN)fv4kzQ=Tn3uhQUO=r~ z&0{vA5~6kZu=Zh(F2Y%K?rFa_A&g;9TM&y=-^xFTh#Y5Q;LaXmz1zWm{*Q8ZbH!GjA3_ikUfDO z$}hW6U&@Z5WNlPHxCT!7aI8A6uoW9@fx5my62riHPH?(dhKnN2!gPMXoKyfcM!1Ry z|M|y`gU?L3_7D17AQ3IgMb<^Z_$4yljRobkKro&6uN?|k#lY;19v_Nmb3h0aB#xfh zJe*DnS4@RGsWd}o1B=PI>rQD!a@lx)UgE4C4_=GOT0J%rpTd$0GeTttIfb~qTi`7& z?@FynK%>OPyg*v)3gH*2s{k~SfKoXk3MC@5D@1P&QFiw_0tv%6U_v9=KJ5%`9*%Ca{%-In#jKPvuI@ zu1r>z=c1zuglO0hnPed}=IKgJvF6>OnA+Z3x8`@GA&XElxeAn0EL0j z4m*j#cM0TwJMnD7O+P0)I63G+X}Ltl2ox88t7k*E2&&~*cJ^WX-Y043v^w3s@u0$8 zUbDjg#fjbT{h{1ddHW7%Ix}2wGx3@VGPP;hr}%?q<&ext1LkvV&OR)bBk|K5&QfxW zQmgH)Ul&9X&1x8Y9S30^LHY^Q^hC!h6a)8*zqt6sBCS7{H@d#83h(9R<5+FAdRjg^ z-_NbQj#1)d@2i;u+c{@wza?0sPKT-m6uzzRYqDulNy@w7+n7Li<%~mKlCh)u#Bd8q zT_fi9@>Ir!(DQReuQYQq@BK{2bZZ0{82L)~(7#I^o2HxC`l(PxJGQ8ONRri0!0HRev`@uXh*Pm#ejj zgv>Cy%$a_TnPEisFR}akm&=?c=E`Xvw6{MMC#f;Q+_}jVcW)tE_LGBUU(vbFqJ>`D z*(4d7xD;8*TRLC*6XI5r7b@3N+~Fa$e^D*KZraPun1E}c5tdT3VEa|I0Rf^IXcEA+ zMG$-Z_m&465-eS?-(V^$Wfk*)K04~gB6R|2jYGggw-1o4R|zGxD~b=|^B;6eeQ!zq zB>Y|a8N+vduBxf*_Z^qLKT+!*2suX+kve%G{a`|cjNPLeKUuR+I>QQ#iS06rqS1J( zlDg+ct!B2x3ZrrievLUeg^KWoldrS~PSxw>n`PXKkq<7-?RIPMl17YT1$@CUVddh|5PbW zX%>3!T2y(>KC`R_btLir@^{;bza+IJYgn(L8qQRqr?N+=Ha}vAL?fmz*6KVMKtBr% z7Rr6JdQOj9=i%8b8@Zs{r3HQ3FI%LdLo#d2>{6@r{HsF5haR30AdeW{WLBnm7-c!4oz8gx%^vu0_^jWOA@OtX2R-vE<>`o*`>j1U zzDbGplb7bzd~>AjL?h&R&58#&80PvvMk^~?Pn_{%%^jrMkomNJAVl0jh7cIkzMSt? znH~|6dH-UG*h1{YS5~yErtEH~o{nwW)xqH|+RQCu8@m|PC+OC<@c7m6^ELZvYsJ>X zI9Ra;53k`gCd(rw!$iCUzvKPhsFaDXXR6QuB@Bp-!536=_<&>xIOKq8iIEjhX8}Yp zUvQx8%}P?%9Ho>8FFrO&+{Gw>6hdY5K=^M1xH|$`!wxv$%)#stXf}b~iDZJT@Dkhy zgO}>R;xqUG;2Y>L$h$zRg{bWcs*}IF!W78aTj4-0l@}OGu4j?qc#NXhNqL-R3iJRp z1=$&8KmfRZ_Q3qcEdW-n$W{U%dV_?IZwVCW;mL0>PX{Mc8z7wD3+NGb;AE|XtheiF z5uk3^j4)~>adG(zYx2pwA%QkfB%B2b)zeb{T~z!ptfO2#1hO6QyOc+`yaP4Rxe>xr z61z{YNd+=Q8J3KS@%s-Pqywtti4J9jEH$1pyEjv4lujFURW6Tp)R;~3%D>#5RmcQQ0_;(76Kec{G@l|(1qgL`5JxywK*U@YMglI1vi)TZW{8`}!dC|D);m#Bwu2%BI? zAb5l}aWh=Px+&MQ4z(#jb`Lw%gDIEpTf?N*e>Z+>NF}c83ncRqB%r!C2ZHoldmTy2 z)8b0$fls_TU)0T?QytEFt86MHU_%G7Gh%o^_XbG>x|1d5q1PqPo$<>!V32ECmt(t~ z$(n4_C~-4o6`ajQXKzC_slkjKg_w(Ooxx_)7?(%bCYDNi&Mipuvt3arfN4@qmEvkV;? zYU97`ceQw;0;!f8hEI16ZKz02xY#FrknOpT?8_m|ejdHq;)9Ik-7FY8Rnw+B?z!Dh zH4T2?>GBJmT#uO@Hbw@goo5nqAQ zC4W(@;Lz^xqv9|GdB7S@FsFErRZOX%{7uQn{ttA6kqnMGDYF?Ao)27d*c;V=ZzV&v zToBH|}xS=W@c;*L|uM^XuLyO}@8J7rl&llbOP+Y}>x`{mZ zbL!RcjBJ_>pEfhIWJ9&iw@PKWg%|y$9&-roQFbirqn~<(7imyXNB%*1ow(s&MS3UewJ$7udIC3tib6-<`$!AzFuHloS^(isre6aEnOyh%#O>w?_H+m z($n!49gl2qjZFyun{ms1+kquZIXCE>^KoG*DY8yW5h6w<3ATbB;U_N;hIy52e?sDn z4EKLLJfr)4B7Cx(SI1$$93d$rbxd5x2+Lh9wTVoR6KA%yf2yCUR2F#P^9G|ktuQT% ziCOA;NQJ6t*v=W<#`&%rH5wZ4;tR$@6P$EUI2Bph8tAvOb`^aadJpX24zY8HS_N@_ zlYEV!(@v z9fV^b=yC-s7u*8MSp*?EAi9HqZ-BAtccl?tnUG~V1tZZ!u$W=8#$GoWL*ZBa11Elo zqQH0t9HjaI%eWlZf}82H(7*$$`?4# zcPW=#2gJW1Kqr~TQ9Hp*I0`C)Gym_{@ZUE8-(=mrn`2GBVGV8(faRLQ4V9)}Lo z!ipBqB3^lN(P7({97BMYq#e?nNTS2KiBbG1=r>58z(^e$fh#hyjA2GnWeH*2Ps9}; z%yxz9A&`)1p#g4%JdQv&)5UyiAVW$RI=efNYB?a-3qciPBs!!Z(1+_Oau-cae3#U3 z6Uf0SsRjln5Qu&OuqNO%a&M^-q4EJf1eolGU;UqtI~*_JFTfNJTP7plevcCDDTsI= z3Vw2+tyS*46MD6zyz%w>SfACoKVKyW9moJ=cnMkw{jsU*1tBN0)#g<;)+-czBL0-H z$ht#hkw}r8OG%W#+MZz(2zDvP`GZ8~i=H30Ky#!C`S0I%F zI^{Qc9DXpw)e)=`-7C;J#x(7vIhO4*v_tKI6+G`a+dD=#4L-(6KUxvm7RIc!$jlW7 ziXUET@iMlyk{EWRKDixCUet^r9F{P3$d~z1Q<>db6miDNxWi#(ki8XHq!ix~>QHvD z&OiC1;DR*GGndY5Pf_|ohL7&~W*3LvaXc+nD|U*A@CZTO(5s#k)>GkaI;ii!5ws*;e@2s|3}z+fHjqNYoI%! zw@8zYf)okT1f;4H0!T-?bm`K9fS@2c6S{~ZVCZFngeoe%Ste2x5j7M6L6oY1qS))q z+_i(w`R70P-22R^kh1qq_V=xKm3O_1b4o8NcN5FKHV0Bs{=Ml~-pkXyZNCVwND8fc#8>pc|UGY2%o!$^?W+7DMpNn}yJS zJP95U>>t?i|F2%>e{AB7BcTs4$sSJ8W_I`A+;X}#tnZ>`eb)(c9vYqE_6 z@n7vs4h!X6XP?>^RZzR{fvt_kSE-O52fo`5fAAk}%;J_V-JdSrCup;I%RxgDcXMq7 z=lTk74RQIls;S2-JmnZSe=cq|x#|XgqFJ>@Wgh;_+(U$NERaF8d^naTsJj#iqsBd|p8@lUrMyPC^)t@XaD=cBM4 zyT(+gT8L^BmL84W4pqlLUCk=X6}4*`RZDu+=s&_Nzs1Z5*{~FPIL@pf3|E> zicIOQf2EMNB;m3DQpk>Gy9*_gp5^)2zxbzJJ_@%RSENa5+HkQAslK5I7w`)_*1^)_ z;$An%zEUAQU$-8YF+SVeSX$-V8fbfQd}a-IBeHWa#ey$Ov&Q=FPTRx95`)0~^%}c+ zr0l@@jq+pb8HJA|f}}hWoz1x~a;3V3A{Ek%l9fPtSIKaTEs@{7du?#+tbF6c_r3DV zS5L+^eThx2Xy2n;@YT5{n<6rnif_eU5*BJEZ&_a1#Mi`=C_j^z@4GAQUH8z?$YUe9 zYng6WDJx;WwHqju_8ODEtQ?z;Y^Eqc`C0gC;f(Hfzw#8E5TEBYz2_Z;%d zaD6p)a_Ma2n{&#FqC$xylNJs+V-1&Q9)|g7>nKWwv!(KFvJf22-}55o%T~d%D`Q)g zg!JXjO%m$gV-c^N6h0eQ;W>F2=%VOB%_fIMqrv{ zcp6{=C8uXeW6_3ZPK24LW4@G$P4s`9Fdh)**yy81Wb}Z(3jx$dl49dMDBGH^GCdgD zXU$+T`Hx0xn8_mc!)HUntr5OUa9$LZm}dV!KGT0a@ShtGibc0o)-Y0=%__;fNcb)( zzntlUQ*Y(_R%yM)6~aCS{?`CEkjDcEb`cTUGs~jv9LFYUQ*s-5WUW9>@YX|?&;k@D zjE)g5MEXprz?%>#(~#DzW~nwpAngZ&jy)9!8;~iGfkI?A;_r$0g1N@@ApsIls=~k| z1SbSeB7v~4Bl@UJ8irYK3TGfbwaBhnG;OD$frQu`%nwEePsXAqMS{xW zb)3#S?%?ZZZ3Yc!AIU6ibas==`h*~!EIV;bmh`>=z*QfAav%&*G64li5FdqTyQg-J z0gkfRCvUs5c{N_N_3J@g9$Bk7&$Wb)5@QgO&|4gAnww-%Bw=V_ z%*9vLmdkeU_Ssjq>#f>-nIm=T`a6sC^Er{S@K}a%Eh*z`rtO{Xt$FhJ_?VGfPXluK zS`w(ACqsCQ!>t%0(Rsx$8&*q{pKDYX<9MQTbK8^<+)_Z2EeUCoxa~2OqG{%HN8D3q zbfv(dxoYW9=qElsFsZl-?TrKZzZ4$XNeSD@=AtX-cUZJ^`}zfT??XXq_PpAV z?~hc0jSr-WpSzFQx4`soAol_8C%Tk=S_7sJH%)*wi8>hn;>Z8zp84lC{{$ffd@TDs(R z4_#E%Y^YKuiP}H;IC0R`isi)Rbb?)BeE7Rl&6WkRCont5SUmJyoqzSJDT(BmI#HhQ za74h50|vm_-=hwkzARrDo9zL%FD zqgWIiQD$Ttd|sQIqwOvn)rl$-czJ`-dz#2-xM*oxFU`sLUU5`@u-a+E0^(ffl1Lb1uDq zm!*Tv+%&(EalB!u+}p!8z>!t)+cD=GE8i>lQa7daHAaOFM0cJq{46lBFgGs;6K#de zH2HsX{)G~%5q%K*yKK2)&P}FE1eOXG*b9OJNP#ndrqTb!R^@?oF#?Q&f90otBGErq z8)~WsO!sM+4pk$DR3&J`pg^-><~vaCIYjAnurUz-kArgz>$tKON=nBeI)gVtRMQ$W z2P{JP1qGb{$`kyr*agi2!Q^@n^MDus1B~e9poa!pBP(nt5SbcHhwun(cm8q3Kyrsr z2OM=o_gb;zBSt07Uyyilg!w#Ls|^kwIAw z(u&BYVg@F|5+)Q~Lx5F(3J!_vqQZ~pEP+#}0J_&T&{%E*=Hn245P^og90Ie3_~K^S zuL&a{-RMu?FP6NplL9|h8x-|=S)>Bn26L0lk_xo_15&}fcbw$c zibiU2MTuDecuSaUHH23b1hQeE5x0LWFLzerDLT6rhHk=v^%f>eeM}cr+*9P1a zgg+Z%Eg59|8pr;>C%R5$n?S6t0u!=;1%%!^M2_qaX;lH1c7o#X=34`t7*!_(&0e3* zQdnDck9-kTami1c*4b+!TqSFJ`73LA{%Xuq+98@}pP6mi3#X5zAx6G*mq(IYQg!$I zc0xx_B=K~PMwOQKNdAQptdn%3yN6u2qkrJZg#_hk&Skb+t>a2IDwgu?3f1}+Tq8FF zq`$NK?cZ;{CdFTP!ED;B<(hM0Iwh&VFzZZ->Wx%oyiD0{*{De?J+YuGj=k^JEXEuM zBitReFMBxB#4l#=XF`wN*ZJ`EUwN|ED>j`!O})|c?)lue%VqhV7ca`|ye`WxLlp)AzY1 z^#}#;$N#CNwM$FkWJBxj`Mkr4wv|Mg+zQ=*3+F>{vWKJJ>NQ)X$EfgOPaj`JwtbQi z3r)N2$ZnHB+Ec*U?qhRpSLS7*T-l{(_zO$?i7-(N@(Nr&(sB?)C2nNv{|9OSg<3&j zeS_bQR+yMhBf6#0TL>%cXRYdIJp6Mf{&WFTn9FrzgCo3(o~dSq!%1WlE5r$B3Zxq%Umr&uog)s@*`{ zU0GZA<@jeKyNR29-=tXiUl>f_vKqSEUZpJ+U%J#x7`r^d8q3kM?#kUw!a3OEpJ`8R z&i}}1^ZKwXG&NzYDlZ>xTqbZ>h`D z$W6IRkuDkcJ|&fFcYONR`nwswMvum_$@WQI3<=id-kR@I#)D(2FZ`Tt2DM!A~ZO4!N^TxjDS7sMzx&!2VnPciwG;)Qh_|x9H`M8{t|n zoSzr`1*`6V@~fHOC&}E&Ujy4nTcKlPm#e;dq7`K_gBFR3LonBx2-pn>P*~1xAM3*qvIDoA@ybSblD4(MhrT=ioz|Gfy zU(vDyg7t4lt4k2ypg`u$LWKtUOHx3k-fa>y3sSzIP>dFBf7-SmM?uN*|9~iid9;t~ zKhuue(BvIV8mNSc8XLlD@G}{*f~YJOoa+jcaRC_011Ugu9@uXh2-@$AY}wgc0|HsV z0VK~F(qYgRG*(}qZN#o~!x#kuggfsMX?B3ClQpvK>3+-8R*f^86t@}DqFP5*RK!X>Xcn#&4V?Y## zouxX4&Ta*BhtMJKJB1LjJFO^GB_miLAh0ke9z@ZQ0Lbeh5UFS(tlJQtd>CPfaHt@{ zEAVpi+^mnD6d^_omjLbW&aO$oOVd@2S&Ycm1E zizSe;0z3qCI3F7fyt8L$6e6mxrCC65F+n>Lc@VrTChfdXYphLC=OJRFZ)QCj)aV?G z-Ki?|p(8kcXSxtZB-QmiqcS}OVVXrfI_K<`ED%tku3<+1W^|nw!OeO)Ws|O z7qxp?cF8h4I!6Z0hp^pAhl2wawtUy5TyP)wM0|KyU8!>}{=|Tr?R(D){2Ej!D#gH( zkmp48p5O-*iNNRlxotsupIsPZy}`1A%m-m3y}{ghoQNu#G)MVBKSQexKNL~?uWbrG zGrPcEV&zc4=eKhsebZ7imr>=va{WGXSKVQE{XT{*QL=^c|=y$Y}<+~o0HzJ z%T>*Z#LQnNpSE?b3URQj>J<38`s6QfJ6E1~u0{PKnNK6^k;gqf-38h6EZe=TN8G{; z-v&Y;MhfQXCe^L(F-mPYWoj|srMoIP$`#)_boZH2pylAT%ZZVK7X?qqxFlxoHnobN zHd-3lMn+hO;&nwj?EKI95RZ3PXs)WvS@(>)6PBq$MTE?)9;aSwXa_#C*WF*@GoxO? zJycHPvtT(Ag=N=LXO!j#el2m!9vRE)QcGh{TNQgXlWyuf)v&P5Q5IbJAWk`6`hez1 z8n-y0S|gmI!w|7_i0$6ZQMXNAUURZ6%CWvAO8>}R)&51D*9wFwdSdNc-M8rv?e0ns z3Fg`I-@yw7#~+gqP0XFm>13BOj`mNJvK6&FuYA5#r!g;fhr9XE{<=S2r3;Pdd=mYv zzNsyF*~Yy56P`jV8!X$iw8JabUU7@R87}CGf?|(kR6j>9&L=PIM)AS0xL%j+ZUMdW z4>^kMZA3+f`J3O2WTqpilPkgdDqHcvd7lo2n&(;OlI^OeKKVAatS9v`#b>AnsR{3|v? z>FPgYtp7kJNKWY?bYTDr7^;pjgJ&QZ`;UYEE0@p%eHth!!W9E(vPRyY|N>z=(F&Ff)TN$GB^nwWKQraL!w-peUtNH zHhJ$6S#7nO57?v|i3=1=%WYipP?jA#Zi<_S??G#H*5uw%HnyVaBET^n#)pNZhDXM4 z1`Wa$Ui1X7Pz+?KEsv*f8u=W$7OA4)galYZ#_#}!@ra6WL$2-&F!?aEJ}fdCh%Q+L z{TRUGh9n_Q2I)aqUm&b#F9PuME#TXLER3H97u?hVfEaY32m6=Pa*HbjxMqSKrG_5-mD^&B9I0!9wifRkU^=n~-7aJQOK zdcz^}fV(#j#T0d6_5E54Mf#5Rt!SuTG_wuS5C~q*mO*fhn6vh`Scz-d7m9aNw}yP; zsLJ_mM)&~+ zRW$t2%^jA)&+MqNW3C7LLTHN0lhrF+S-aLn99pkb2Y5w0R4Gn*yFW6&xu6TD~8Sn}$U`sMDa^~dA+h8)2+Gn_I~ z9j!ZCUfl;tb=uMajrb~ePtp}vCzAoEvGsFr72Qr#a(1|RI~(jz*z-y??3i=CdDf|` zBBgordjrO<`eYjwhA6HY$(eds(Mr~$4SG`cq)PLREckha;Kc`DVMOI!lcRX7L(O!G z+&q&!c6j&&bkB2I+LF&x5))>&O>B=g@D?ddOTJ_NC+>0cSxS?(@bOIkOWl*J;jye! z&xB>No%+PPoOU000xe!;xPx0$+fo?Q(z|)TRtGq=ed{+ViOc5oh&*?=NJxFBo2YqG zTo0X@B*bYna-oA6VP`YT%m1~zp)QJ!p;R;gca&L}+DNzn4x&iN%qOCgqkp{X2Ri;c z@6T~&+X)E8`adQ|wwUv54Gj53fpaLqxB&32D|@O&ZF@Nn*BJQ%ifj^EVy4$z9`_}e zJydO^T@o3JF59I$(Ia%xyuRsW?`Kj`5xe1|9t+kFpT9gcelGB2z8_EHp~w@JoHMKm zZ}l;>>hJx*`yHOp;z_|)21$;gmW8e{Z8?W)gT`lFJ@(H@wX`0l)syBlXQrdJQ*IQE zo>X6mDBm|ct-o(6A_MOlCmL9+wjIx-TBCuVOb&Z|yr)gd{IUJBcADC((z(PpTOtuk zY;@g4&4&KNgYEB52k>~QRVulV5?M)ItUa%C23vl2>CGr!dLU~n8}fRKd-Jocv1ZY~ zD=oV26gBIA{jex}?{xfQ;+K328?uhfi`s3BkHrE(d2%?5dBIi6-AhHzRr;BU1W&IW z*oi^D)D8i>&Z(DyGasv;#ugnKD>&_`zyE4QlN@y~xT)E_!cqo(&3d?#j?TtA)wUK4 z+z588doDk1;F6s{i`lkf;Cbp~gy!w~76*k9aXTeW;%WNwb^Fi1b*8i=-%ffqnz3XR z-!RWd;e5gPD(0TwBOzIOVqW8-g+mFkJpS#&L9-Z4v}O0og?-u6B4^!pvGY^(IAu~1 zwmUqcA{}Qm7u8a?Y|aTKeG;*co?dp?*Qdvq$T1phnk;R3KBJ({(x9PAOT}Q)O=5F( zAJ$+;LOIQQYvxS+8H@1StA!0Ob!@+wgy|h>R(dDdvpvTM#_lp#5t?&Dy(}RDJrbIV zQECFXU0IFbjAQ&ECSoEB6r29R0VZb$t=@wm8Myu!e#CVng8(b~Cpf_BL_IOoLqmPI zpHBd?MW2JJxePa~{0&)|{{w4)`VOq-O;AabqQgsm92otF$IO-mE`b@Ip&^zT0hPA~ zm20d&8Mqw!K1`A#z}o-DGL!@Y-k%QoiJ`v=`u#YQ;C zBq#m&f>yG2nrq8D;LgX*F)UgmS9yvt!5`yhsW+o~D|!~vjUKQ82;3xKoKT}5V0lT3 z#dnjtfLZt>t4~>W7qzPWhHttA3h}cQ88f7D(pgC4OC%8YBN_{MW`?D!84=hM=m0jD zdx$t_P=TP5kAY+`$}|t7qbWU3L=v6e1|gFc>R906i-!nmfd`tiAgQP!-Pi}bj9?sM z&0+r%71Tu%cB9t<|6@E645%KY4j_G=S;O?M*-G;BR$)xb6Kk?A48&Oqsj#buV%a9hNfuR7h3gTnVl+k* z8?2-X>@$FCM6N|Ha9VTlT6)IHXyEOdFxZ9GNDU1;Y$YOr>#YslccCIUxX&cUh7B~T zfar(D#;9w>&dJn7PfuU*4v|#87GWs1V9bGSVX_u4zn!Ka z?)A3TI^=mSUa!N+Bl2z`J@V-$Lp$28wN0!E2Jxy_eKy5BS=@0oQYGh)tTz_ti$eIa ztLyD2b5DjpXfDdoPlI~T#qJ9URpO%+*I#AFas->np1Ae4#HlFIw_3z2aQB^k@2c-> z3tS+c9k65R&XdHubd9se%9VyZu)Uuz5zhXIc%k4;%BpJ z8dON9!tJd;y5&C`$&Q}EmAC;L%gJC9%X4XKE5VlYH-;9QZSS6t^tfQ8C<6SVygy9$K8Ab9~539tu9Bf1IQ z;f8O-dH-V}ATV2i!0aP-MRt3j%Jyd_L3=6&(6CGnx_vVVHSKd&7bE5fWx^?sy>ETw zW_C~hCa5qDvOT&Qyr#^-h)i`Thz*r6!xZISX z)c^S+iSJs)q^b7w%H1&&+Njl70!^vz1X~5+!Xh>K8rdzbef_D_{vzrTlPV7k{ zo*glo%(;GvTQ7F|^OHp#<=z>VM?8jZ+wwj9jo(m)CM)8dz;ia&{Kk!RW2~W>`X-;% zGm}TF$9hS>=%wT>*$mv7*?&EXDvjJ&zuK)A8x$ZFB3oA@wS!e^7U438=UgJs%pX5< zX@^pnLAh@CfdES8w0-9v`vn@zQ^F%`Q`)!Z{~FRSZfY?0$|ZlKSUmM~xI?44cubd$ z&U%LHN4fn`;<}2jgv#@e$KYkZ94dCdbmF4@aOiaRvCiopg>8mXueR=wRyZ)!a%OX< zaFSM#Xk+6quY*^GWIZfN8Sx!~Z}Uf%cT=f^Mw=wIuOB485K}Vu3g5`EXe*#lID}mf z??f*71T`P-YMk`E&A(H>|4~k6RgFXe``SGb#^uytq&72#4>SxW<71`o?9a5E`B!Sq1*AqaXsFXii4pe_(EcdnrvUU z$oZn})>ZyJ3#K77bIW1rm%C${KJfiDaP|=29bvbwGDKa3)o~oM-l*0X3PnsHk^(Zk z(nePx6YF-PId0H!#~Y9U3)mgm4Ot2_>_Y^Ad&m-I z_TQ0R9Qq>Exr4-+44U85L(B-0Aa1k_HLw4><%=0P4o@RT6PdF`8)17u=h%N-#{U%u zG9bx;#%E0G;YQvOAPiMY0unh(EwrMAz|;;D`k;5|2lk;Lh`tE@w9FWF*+*7o708Iv z0=Ht6hay)so(zvtPtCSUahg{uLpznFDk9bn%~W)b#A}hfKx0U3jV9|cmFHsy3uLuL z!WAZ$xLY)i>K*M(m*LUmkTDE`1mrRRT>$QhK0&fb8bAfXiAqs5Q_Ylk6Yc3ZUXE}e zU!XXrjYx^1L=0U(6$F|(6;L(?_B>z;;FcX1r!#^|TJUZL_WTbL2iy`+k0-B{DD27JefPL>)O=Qmy8N&m0FaoNjpK6B?JCTnGKy_T2MZQoGEds_W8}SZ6 zaM0ET#E{nr`!fRa9LOCozq%OZipWeM0HOT#2%MT#8Auv|$H>?`LL}Y^<9ir!Wpg1j zBQ@bpcQZ*1QCTO&p}+&F_PyfH6;85^#5JkP_5^KV5#Pus!YNvwJ=v44Xpf*QKNs~X zArkV!5U=&H)Jmd(=Wl&Z@s zyR2EAg;BRAls{0WMr!Ozmh*N6CS^xpI-6P*@0W79coeW!$*^_Sa9^rZ*42HpWefOu zM3>8pcVD&SSy*1ZS2Dfx8{x~>_gSTzGL-kyX_iVn!YZ|2uxvLDxvmOs_o5E9_MDd7 zuOA_*aD9~8{)BxdCUtUJx&ftmd(FZu^#mu~?BNii3=5P^rU%6$e_GYM|ny{k1yd1~OqUno}(U`+4w{h2QOr zzWcgFCPWIqZq@9`t`aFVi>aL?ZjDwk$^JG=r48~|Mi)47y~!*G3`;I3 zyeM$gXpgiR>Pf<;2AxS1bI`7nfA;o&Zz?I2SH+-$5Ds%sp;}OADV&*EM14gBi&nuQ zwIacEf?Jv0$7r$zwJ~V<8p{MR{{#Z>SS!!;i;{`2^IBUNOYhV_?+uKcYkykvaHg=B zSYqKZ5VXion{=m>-kjEdtGY0BOrv4W{r*+bm8_gi+qapRmc>3CQIv4E|6sfMkPFFT z+ZWSz>_pcKz8I0S&&4A?S?FwA+5X!ZZKZuKwKfkH)s>!EWjKZ^ei6~`KB30NK7CfM z-bOm~_Bl?*-$?GrQdaa6Zv7sLHtQ?Om)H+klgTyuI%~I_g2t!JR9GJ#rM_&j{bn2@ zI6$)9eYrwO{M_Z?hh0xR&K%{rRNQha)`IKf4Uap4hcv7#n~hj}!Xro%G<>~Yhdga$ zvsL&ur!xbh#Qoh@9vUA0LXQl3-a!tgUSc+aM-ZHlJqH!Q1Y{a2@Nsww*w0dMMkQgL* zkfbD2)munD!PO=5*mzvKKaDeQlg8V?o+-yLha$@l+#;P5wkuOp0@vqmw(r>NBv$Oz zvDMz!*sCSb&hTmV^k*{@>6Os^Bkxz@+fNI(Zx_&>dh05cLd#a;lt1Xv6ECgzqSUyp zgXTcAtE<_{`ZsdcT>iZTzZq>Cu|Tdet8O4K&zR)KTX1D&ax;$-W|kE7g0IPZ=4M;S z3Dc70Pa>NY&1Ge3Gza(e$Jog^lGLRuRL?!!^~5qeji{Nogh!AFwHN`pt$R+5ZVB}r z8r(z)?Tj#|-5Xj?1eij@62OvwheQi|kYaSTGFgA{FIabBIyA{Z2o%1_9VRv!`W$EK zIenluLbNlEHVmVQ$oJ48--sO^qko`=qei|F`Voh3A-56L3Id!*-kS%3bRc+N5Jpu} zStH>`C}lBohkzNNCJ5^u5>d?N4(89$Gz_7KFe?T^L{tQ5LmB8Ncrah`pJ?*`@c`I3 zbi0B6XId+Aj+u%C>;VwMC4&?rQv;t0nnCDGU>~7~`(ndk1hphqZt?x4X|k)cl~wj0EdnML&ODZ5y*2=wSe-Dg{&eQ z0k{*wfNOeAAYO>D(lL;v#6G?&ZN60a<;@fi_rYtzBEr|%FlVmDtx53=C6SR%#K0Ls zJ})TV5o(u!u`$c8A+@viw*BaqxHZhnPf6rGb20*9t+6t@D2qyb&RxMPcXws3*9+AO z4;h)oijRDl+a7*j6vLQ{L>xMiTL*%1ZmG6YEcx;3?uJG|F<0Z}rdcl|ja89Sja?Ak z(M6<`ft$k8F0sy*Sd28z*@03ws-=%`+(QsFX9)*!me%*>rt)w)W9VHd_|7^2Z*vEL zo#5kCd4(1)t81#V?L#I#DT#3_bVz!`>OuVNvr09}{A&sPRH*8ha3HN1g209-3wpcD z$(#NjyV|)%W;Fv|2smDioE6fI+B2qeA*X^FjzJ*q7~Y&o^bpRu8tlJacJhd9LFjXy z^D)(571S^Pjfl*rXC_>Dnzm{>c**OFBI9vp;FpOphhF~~j_8HcO@mYH^*Za)er-Dx z+hb^pL5fa2+h<76u?_RZ;*O&l`&UbXZLVCe;B}C`=BC{@ireLvSfH#Uj$yHn$ba*K z3v)UzDwgANHi1a7v;ByDdPW7eKpAh6OBF&kC+ANzDLG%}c=P1VSYJzGa^vnly&4y< z){}U5fAbyD3LKa-XDr*=spEEDlva^EwKpjwIs#d>>%dYH>XnCxr_a|;L|wieEL>}R zw(Lu|uH|J}bE~j@Cr6}RIc7I^(D05Dhqhc-?5@YZ|1C_=g2YpF+-JM~0aYW__L2_< z_ycm?20il%rBl6`Wi4uY1sQm=J)C%)=W_I)WxKgJ;*7C`xfQ1Y_D91QBuV?#Q~Pzf zS>J&(192L52U_%;jD}Y1IufzNQ8(Xy$!>nPIZ2&!`z2|!e|%namX1Eb3N|r4fl7M{KrnZ0#EI12 zqAgb~3_Pl|g}P2AuB-9Ydr6ZNy8t+GMdEZ@w;r z-PE9%>UOK%!E1-reg)ZkwssMu73l1X8T*a@7b834P!b=HC*G2E<)gOTZ+i2GLhrj# zv>b$v+>N)rSJxIj#$|3X-HmCxH34ct1V0JqW1=H7RofB_)hm>a`r43hcwK#Y78mdy z=czm+yBuJD%rk9?$0>qQ`^xu~!$Ha>g=)zFb$t;_wku(LpXAHb>dP_gv!!C?}2 z6PJu|^2l@;C(C))(x8w)9@_&Rm=h0JNZ-HD^`)Hk@=jL2Zyq0}uBt5CFNsxs;d}jK zM&x<%T%njDKAl0U>cF-N9TEGszjT^1EFOu!6v;95e9@vz@|7*nOjSCQZdFpAd|ygZ zL|gGW|KEtBg@W7dxb8d|&EuaMsI4WR%%NxA`C+F?O^sO1z59PUHm^pBt4LZ7`_Rr; zI1eW7FVAkRC0&)S-y?W{_s&U)(XRabcX(x8FAAwp@vGwOvUXx+e)Q`5_|TNDLo!;T zoslnm=MF#RjB2T4JdEN~8`b#!l5Rv)c>B9Fu&w^wHM+!gM)fqM*3IWJen(0`vIDmV zk3z?mxMQdDYT}a2C8v7LC7N`0cZS{=`##;@pDr?bipBb(s7;2$39c8d=C?Y;3jcKY zjqtSQ^;umA?H+ZNnU|YlK}!nFL_&N8Bg6ig2Zk=tO@ydQDAA!29e8{wwxKI>8;U0= zw}hFjKo=yi41c_2qqc?OEc)&rVbKRDtpRoh&th6*kZn9H{Ti-YT17aTLBjs7RO4=w zqx26z;$Y6ErLsZ@wLwb(?-63cABO=c0H*4OK<^o}mIn=G8)y2Dv!K`b&+E~vLLXp< z;uDI1=qH>tH0vO*ticCGem)Jahce-Rzm3^KhJ+C?oolB|gOSi+7u#Y9O>};Km-Ved$`x<1eXr;*&r>SGLTUgmsX& zVXe~bm+PV2dj^v2?0m+ed(O5`w3tIV@yV{Sv<__`sbuP0#b7#rt&_o)w=%9p;@qI@S z5mRQVCe+Sy@Q`^kyei3(MQmuWC+if0@U$Y5CBaLWh7P$J@!AfOv|y;}-JWHupf251 zIkLBKsDOD0gxY*cpgyBoevE5v~)5rSBlC$a->MH=Efa zo8x9N7)IA6>B>azg;u^4tMqOlUO1qE46&^{hI2@azK{Wju=1>da=z}2gtkrFT ztS))ho||a2lY!1R-dHaP$aJA@A0$X0UcE|(Dkd}J5J1G73Y`;EI?x_>hP0-!Ik!ZwI-GM+>+0G??DB;pF{NCiC-L^rZ3*o;(M4qqpHPeZk5N?;o%#=yHa4; za8aO9K3sSG^op`#%^~U7MoJYyUTqa)AwukbOUryw!T7Sqm$`W|2`=76$}(ej02C3W1NnRWw*C0vu?&77pO{4IZ7W5im!0Yi)y4*?Uzwi{*%OaX|w^) z<=4yYC%PW?VB{c)HKXoQtbVTZkY(aK%d~|k+|K$YX}iLp0_PH|fv6CNca`~=han=J zd;M;)AEC~-?f*SKEz^|GT8C)!!NTiRBk81O*>_*_kaL3a9;D{{+`-3p{YyQk#@pzr z493IxsUtBNL5~TY1@11Hp3*pnJu2ob72}{Xe>bnhWVFXu)YU<RJcKzJaOf!Z40u~LZX3)~_%=aL>^N8I3 zkWW_Hw>YQE@BOKD>h3q=iVCRVsf%3SDXUT<=oFMaCsXDjiJZVZHr=M$udr3LW@^ex zR+(rn?>-?-nEp#F$i7vtNb$KM?>F(1hgCG;_cBjw{}SLjS2^N{vuI!Fz~e1+-iWL` z^Cw3w^*GJBxkaXpG*^W-)NkE`%eiSBa@tF%dZlwoc~M|w>bq)f7Pn#UY0^j5?r>V? z@N}4xr`X(0I?}wgJXdx^ceF@O0JPZT97kp^-Y&cq@DH+~1q?whA!HRDEKhZP{i-A*8cW z%_vs9YDhQQX==bRzEwuBv@3!=x%QeWSNPND5<{C>E6t8Cm+`4p>Yk~p`S-qk`gY7< znkaXPt7*iDI9mQOx(Cu9yuyn2hOBH43EheIG}m0}!}qzmow)qjf+MOBdxC_sOSVjE zf0n&|$bj*}hnB7V`ry*s9H;pU|75&U#!7(|!E1M83x&;lLgK@gy^&wfHWe8d&lu}h zmAwC@^x*pA9Or_fiHt?Zp9q6SQ*E=%WCYrYf{FsKpxI6<&_eoQG9acx5po07`p~o_ zE8rWN@??T1EVWh?Nzh+@u0?beqR_bU=ZEMJ>clYthe-u?N3m2StC|Uh+lCp??F|3L z{F^2WL`O8`3S-S`P~@v*fQ$%S<$so{p|s|Xp8P$+$^QfKFjKo@QL$ehCjKEH?g31a zpSuKbaaIPoDVpVqmAEEyG&%Z=h_GnBPvf3k9z^q|PlAdFvXn%ZYP!qKE5wumv6CUh z82A{FI{2CY?jy)04JGoI7@9R3`4ZA*8!Kf@E7PqLp~S|Nsci;*5O+P{1o;@H zkLK8OtOQ{xMLpp_qB@4*0;2O5hCz60iA9=wXWd0Y2G565l}<5aqc zGY!PDi=zx&TA6mZ&6Pt_B7bB|#`lYgWJXA3#k^O$eyFNgDKFPjj8suaRIU5GYO%-f zvdQ~+rw?P0&e#L`7hNsgBbDi4QMFyEvZ|%wHuj{=qRK)z zk4IHoqBs$^`|i<7wNH&3v9~@+^kzoYG+w2*=|sK8f6QKp4)ayhn?LV+?|P;wVc9|D z(gzNjTH2$Ej5jZgM%DLsl4NMLuFv+6{dRQuXif4^4iJ%va$4Dt9bUMAwr4;n_sin2tAZlfQ5VWKtE3 zI=J%^>g0J6t`A2&zua`JCtI_uv)e>O!XOeqj$nm`C7h8Kq7WDVl5s(PnttVKyoxKM{=AJGE?)5WQY4tM4{K^`t zvvTq~HM8;zX)(w%r+ksWB8OIGQj(cd%TYVBaJjKq<{CN$!kLQZESSa z+z+T$KR!}wljOvS!6Qc_={>D7F9PZCK!oNwCSDBof$BbMz{>d7vVY9AyUY}zE| zAlT2RT(w5C(vN=TAsMcse&sv=yo8?>2fka`m304wdL5%??~BT7TzkwY>V*Z3Uw!e3 z2jaL=svI@RG`;gP4xU@yp4>Nk7I$mQsi8cH!YBLumw$h@igyS~?3AE96J=SFUU?^| z?o}wrdza;v!K&T=dM z7gmU(1RwlsDKg_bcEF~eZZdE;(DyMm_>b(aXf2JYX3M1d{~PyyylJCv?FRrd)hW>9 z1;gykRLl!^pp*_s7)6;)f#wa-t$1;LYj4>DJL50T-qZ%6n$04l!b_Ff;T9gKf*lJzyZJ=M_3h66x_JZu-huU0|E7dlU0&Bqw1Vv2Gm2w z8U?bJijnk`P*E!0Z+OO+I^n@zC5vOn_RqPeECWqr>Qq*5{ z%J7hODko^&XK&N@MUihri{{SXFMgiOZ@64gMUoH+9cZ(J7(IS8&uRvPqxF3VG1_oF zyfWZghzrq>&0%C-7c|z~?W4a>0n#Aj9tX0j70*ULR+`Honb}G#b%J;@2s=;d`y@*v zvpvC^j0jR<*xo0AD^TQHOXq=6lRk^lNl+53Y~Q5Gt$(O1+s^G(_|c>X96r>>_@+S~ z-YrQJwwc9>K32%7<&eb7D*`9+Z>t#WNjR6ymqKyW;7VPiX+Bza0UId)~S?7OZjU~}ijv=*nso;s7pY;75y*T3;y!EyQ@=r7&-P3&}${IEjJ zQn}TmtkXjg9-~Bz?D5Zs1!bFm+qSzSfKodr+PI|Xa#n`#9WKfOnVR|>5%XSxev=QY z;NA;Ussa_>YtE;hB3bEJ$VICMg~4y5<>~HO!+dJf7J~@Ii%7u`s?21nv@-|8Xo6|nlsw?1K{^RelV;hFbQz9d9?b1f!e_ah|-}sAF2m(WK7C~>_z>Yh1QhD z!Wyfm9@e}5IuUsC!pD8-NzY8C+G4v+#*ZON?r$&Jw2o*!h+gBKa(XLOr}-{GB!AzN z?9oZrXNr_GVXI>|u9m#!&1}gIy)@GM%0@+JW}4`9IDAk(><`y@_Q>)Y*|6s_sn7R* zmPsb5ZK6av=jBZu6Zxg@g!w~(bk1C#nUF3n{bTas5hpIZNVSsk?7m@o^w^~pg_&)| zb@38MR+Ma=WL0bIe@&Iaw6#lwZMJ!JXZd7k%tYXlK!K*GW5%<%w0j>uOz~%XooZm0 zsxj0aeO(YvOFfp+_GfRj?lOs{T59MT(PikNI&@LJ<&e8Dg~tPr?@lzx@rl@LKhe~C z_DtQg@UFYk-_Dw)e$eRT@*P{94#6bIieNv9tfy0T<<7siz9AQn;}9OUI%=8zWc%gx z>hfZfR*n9cHSW-2x{$JE-jN(1k8ZXPV=oq34HzSbw&NUK9xs=?s>o)KzI3XIef-5- zoRf*UnKRz1^g??t*Zqa_ma&GOtk2k=vRrYER*4{fOBK2|P*tT=cT}pa_T-;$U-*%5 zrmwb{M@o`DSYDfMZ}!>|=ACM0%p(!hE`M^R*h<+4`?963&~A@M;L*rUZr75{m-G9so=w@I$7U|;e{FNc)5|lXn|Pb%sw5lF zoqH}Cr@y(&mSQWHxS_kj^pt+)3DJZAWcXk*G#b7sak36CL)#i_`MyIM;ifTDu15we=Y%Hi5w|lQ#MjbY-Q$>#BimLu4}361OACd zy$6!+4>wM0r1jU9iIiX^!hcnoyvr%V$vmPvvTGcQAsRhd?AG!t*)nF>M5Uzr3{yqJ zLwvEE_H<3Uu$Ur3edN<5aOLUrDxRmY`f4srMH98 zhuIR#A#Rd_>K<|#e&A(rvuFcSMPeYgsplj=3uBkduP@XXLut^*Ai&aBMW8+ZHJ6Cw zc@Tf>pXKIy2_p*z^5L@{vIK2qiXuy^Z~RqyVSbj@rKR*y@!*H4oG^AS8GI2sIvNvo zOwa^3eCe_(?mCWqnVRkhI&r3@b!#5{`n$(0vI!Y2tAY(Kz3k`^HCfZrS8zf9tLE>P(k=pLTuWLE3Hi{kQu|A6h1yM@^pNwnS@t;$F zO|8ZhH9YKf?1_`injcebl>2nnuPk3F@_^;}E1g55JXY6kyfvS2tmPPzj!pBZ2wpqT z=>CGsQFG+u!w%kCQPH%r2wc0NhY_i=zzoN(Ue}Z|6+}StR7A^kySnrVZ**6<&BPv! zNPB)Dx|w%VMpN3=Uwek#80ViC9MXH6qkra2)KNki@%z`}5sJVDV*)->S$p&|ibC}Wkb_`KEF;?HlJw@f&s_#mi z-EYdmLlo<5a4f4I{6l%#bS0xeVQhqO!@1q)nbJ#2^@M^8M?~Yign!ce?t?t+<7L9tLG{>I=DP{fVTYMfh&b=9rGFH6Q$*r^yBy zHXS{s@&;JjEM#csNk!=b|CkTB8E+tzV@OdOA;|*tw*7?YWHZ*(jcx7&ehCBFiMp^q z-tmJ74a}>|+c>g=2{4}ZaE=%dtO4@?t+z%S6FxaNKny&Up6vtCQn$3u4JDW)bG?cG zCGpIa)_C=d3y_OE`m0S>b6&$4+NaC0mN!SozwL{=Dk8iuceJ63Q-tI8LR@^FsMb$Z{><8m-ec1J+@hmqVP zs;nQ(M;qK0?w7_~FJ3e*-(Ekgu5m*l@D4Z0=(-1~dW5#5Jora!KybKOd5)KYb)Gb% z;>eb3isgZ6cPNMRDcx1LulW&9` zxE&&}iH`$y_9hr-|G97RNaXcBE2}$jR^{JzsL6cpOitKpUo}Ux(8X(pX|8pTaG#!f zkSC|p-X#&g5*Ht#@ljvT-eGdEyx+I#60Q4jug})bd9t0{Yc@IK7u@v%K_8TfZYlL{ zDM7*7&19|{F=4)AxyQ{gnf(t-59epo^5kik+RnOgioEvdHk&uCII3&>&O*P4qp$GV z&4GryL#v$SW{_QA0Y%3DhO7+$0pkP7hFQf8KmwmkLy9WH4xQoY{{t{TS23E_1iSQe zO+%^^midNZ0&@?rfcfVS>X!kSG2Z}CH!p*<|9mfYqb=v(cnli~O^55!b+!iR-i-Gs?p!r*R?Mm)fb3ve^z( z?;C6}$AZwk^?d?3Tjia_i6peAjgR^9*e%G*kt8VyfTXdX$jdq?G!qb^U{pYaB@Pkv zfu^_^pe;uCqGG7Fi5k6BO&Ty{HCzfO~F5ht5-nB!pTwh~j=3w3x@5LONh zs968VmctEavKBC?Xfk|}Xq(m6zlX0zp`RXvbf8@iZNR`1pv}UL?H-@CC--y`yc-!Bt|Cg&9R^zZZ7j9o5rC^><&wVl2|ckr>u8(HZ( zf1%W2jAQ28jbdZRnbXFX(%oux6&KFlcbnk;&GuqDCHY9(DV^`Wyke(rjldY;9VClb zBTi!UBh!P;Y+sY9FSyOvql2y+riKL%_Wo}7B=AzOz3~BqJWRy@L)e>uL%Hy8z|R=_ zIvBFd$i9VaStdGT-^ExGDoaF`>?w85kUeDIqDJ;mwuDqd2uVl?St44sFQ;?P_j^X? zocDeI-*+9XhYVdW}SL-X0km99zB_o+$=R|$VP zjo{o;!`Ji7pNA_{`ZTo$^L#t(&PQIVW62InSE-;e#jafWQ!61^&~HDjz*k9ECVqGR zlRfieK@(lsrP|W06x`iwyfZ1gh8%*IFDS8;M$}hOE!yoxve~Y+wJHUr)_zhvu!i56 z$7FTr)pItvcT;?QWp^(<-hY}q(ZZ_Dg~B>S34dlYaAD(x>Dc^Ou{0NEpVbAE?Q3^$ zvw!=Myx;cg*+~N=*}h*8BL~BDl-ElAACUV9Y$GrVC(^T3A;t^PH+~In^BA<(g5KgF z5QN_6P-E*19 zk09ZUUw#`I+l*0{cr0JHrW}8?vNQW42R2-|?O>VJ$CEXy)N4mSbhS>u5V+kPk?7Xs zchGvUC_X`UF~R)}*Tl-7-+QsunyNoKtK@KvgdoL8kA>mJNtcMmmn^FM*HR?|ly;Ev zb(gpa)vrZGBWHI<;H54LMR{{d@Ljo;khWx#tN2Ey{4LW)2-7R>*;zu^&AtjPJ;}PO zJd@QM?Ak#|7gpP@MpS)ivRL0)nOKnY{{7zek==aG*R34@=F$s_ z_DTvIPLQc`8GSWlIUV9>AY<7U{>%B;~~Mae;^%y^o3C`@lDpgCa1`F|S+~!#gIHNXS^0 zX{^6&ReLWp_s^{Jq^Gat47^wBb+oFBAbB(Gf( zd#!s{I3{GIw^OoL;;}gpd;vizYZM+VK?+=!O4b03r;GJ55232{;CinWaS~OcE@klSel|9%SJHm zabWWr>F`bhLpEd+B;7S+ZuHnbER=-t7&U{)11*$c0upaV?x|S7CQ23}oQ*_IMnnu7 z>r{_;$ah7J+DYJ;gpmx;$wxK`JOKXanMFX{PNiXi25vxooe0AEK)fh`YI+e}lzBJC z2;;eOBr_AUgb0IF{khBd_?8Qm2Z^GM80soC6I*7=Tf=&Cpm=L#0b3|ZZ0uDelM_Lv zP`E=ocpp*o>1F5(!PfUCysu4FXqloKkrW0JW<2d-f5g0T=~A`CWP1FND}T+K9MwG7 zLDlnFY@{XBnFY%4RODdS6PD#**Roe8G`U(Yoj2ni)4O5DkmlTqFfEce5mxkrJBV;y zKv3IG7Tt%@uEM@F)5aUTrsHno{9fzhk;2wGg_Bu{BypSvDK-OT?1MlHZ*N(5e5$E& zxBQ3%i}j#tqJk(g0F7s)ESg*7C~ol#vAhjq>0OOs(DjJ%TW5kj9dM}W$xJ*+l2!^? zbQ-YlB}A;_eqJ8H(1K%VGnqSmNxVNKFAa<6;!SFcG-Vo{PcilP&qqBu#A<|32NRgwwjR>}`Mf7~ z@mb;FZHc<%QNXPu~(MEwqT7q_#E9`E#Ti6{sN8 zUs|;&@3`^6#lXdEc8B&hi`}Ag+vS(}Mo-J^@=v*@=$|+o@Vj}Wii}x}qHXO&z>^^& zuD`z}Vg61_xPWk^rW=P*MuwMVvh9kBmqA-GM`5HI=j$noJ3qsL6P4S-uSRIye3M6f z6)CwD%LTmc=){~nE#Wtm+ovDuIPGs0^JBrM#kB|G+-hI^D+CT=v{@?4Kh{$iBuHZpP~&#;AQr((=w z;@jOP-m(V1Fcb7w3~Vo{&R;Rkd&QEh8tb>n@1r$#t>n!`il%mkgrRd;(u@XcWIXkn z=I<&s=LKpFBt*{#b2V^KX5+_3M;^*-OizUuZumTx7Ag$FFd6umvxW!+=J}d@8tZF& z68AN0{D;w!hT6xzPNP`~3x-wlQSLKU*OPlc>im$g5ADcnSK(WdOMTk@4tGS{Av`(y8WDhi}8SRo71bE6;Bl%iYoI&lY%vT?3&|R*+@cpjJLei z10!|ZWG{~t*VZw4NSwfHzWMak@N$MrUQYNrXY&ipU8|9>sk6V|&k9`+nutjbW%Hgl z|9n*Fyj$=GnM{===aOQ1YydH0@=(1#G4b##8}kviWm!9m4#8jQmUsTXXeM<1(j)zB z|8W(*@B9U{&R{mN8-Lj!`LKO{7$a>y&M{0d1LTUfyr!ic7R`JG@|v-NY$6d zzYV%lGziz3NH08Yk60P5HP#ll44z=Lx~=k!N1RGqIm*ab7jUq*OD|1{{K?ZeY}I^r z*!hB}zu=FZlDAc>c>R)(pkqGhW4NMZ(zY&y4Gll6aQSXE+5ZkaKhXufs!`sKANPe; z1SWCF0PH8n(yw-Gb;A~A0=!UYI%9s^cFeG6LZFvvLWnf71%q_t0xa9Y*_DcaA{!lh z(PN`KDevId5FrYzZ=&6_t@{dNjv^U=^Gg)r=%YhGQw-WJ{YhZ;gAOC)n()&9+<)i| ziD`?6CHJwz-3r1F+3-i0b(Dp(Ym5l$Sa5>wLI{TYCrF->X_-VG;P*jny-ej)msWdY3~rg4SX{5MSR$mxk;@fOY`ISqoW^*$?>)3d88$ zA&!7mrSkaV5X!R%rH3buCrKt&+^2XB;ZA-5d9kf(j=rQyKzcCZ-H1PejvzOGW+3PR zLAnceO`-OcM4<8o+qIgZM6lJiAS#@QF;X#lm@;W(_r$x()-kO6i{fsN=xfnRoR&v- zdw8#s!_sPku~kD3eq?Y8z!*o3K1{GVxZA_i!8xOZEgxYuM(BA&GB})*Lb@vqb9hbp z=F8i{&ZLWDu?=~KIc3WGX%#+6%*AYULp4->dQqFYu3IKK7UDtjVaAOnG3$(;m)DMG z*Fw;GmmwDV=^vgSc)&)&lx)aGm|zWkBnPE&js2z@ z=YG?54tSGW@Bc%R)~q|pELJ(CsFW!nUPNtV>&!05&Xbp_O4x^;5>PBtBV3Wb*P>x| zSwp;PrcizOnSvslYx9ir?U#t@1+_u_QOk8PQ7^^Fpd!cN#7raQq8J}G1XFq=ogpr^ zUG#hRScICl5~ytCS`Nvm;A@YLRwS&+IdT0l8aJCmH1u<~Sl*EH=XOk9l~ABKp7H#Y ze=TPv{JP5lHoufXt2|f7UcnoS3abjFTAyGU3F#L$SN7O_osedhvF^k_(pNs3AXUgz zAAG)^_wmTr?*50P%fZYAwPSOo6}LVp`rACW3a-(r>KP|kn72zl7Q-z^Xt&?I>k=_J zACy_CHH)}V^k3bduHdofyf-Fw+vw`0%XO`d5q3c*pGhAl44qu1n0jb+B)2K15EDyA ziE=*?XZP)_Lxm3M-WGf}&k%Jm;Be%(UW`T(R2EQzjIz`JtFMGAr9yIzFp`m< zj3O<1-v@2gNOOQeFf?@-&bcBQ>I>m)!3lTwPa1g`Iq%6TlGKr(w)AAN?hr>Raj0mJ zD+g92i@hbWJiRBr)xTD?PPAOe1if-sQG59mo1PrpLuyYvcm?)@#Uo7gMehwB->$A6 zRaO0mjFrDs$jZ^}kDOK%Ub8uv=A3aho7*pbIZkFxSW4>jt6N7!vh}=w@#ztmX7<#0 z-9GfH>#~BYEzKPpuwCk1qHGfHd`TwT9a&+cM_*G-qckk+0jc;yoPOOM|%7EAmvnrDha}%>Kc)@tkPJ zJQER>mAuWVW>4ls^LTf;feciI0Wm{IaV5U-@ zjDgMBQZ~^utuj*0-j#;NRlMW^n>UqTlDBm}>X7T%?#8>Y6!1Z5?;lpR?2HQo15*S; zMyGv@gO6tAL)x>Txk=lIIXL#rSS#S6eAu+6{E&P@029KuyW=_uQ~fqcrLXCl4MuGI z;{+Ai7gNfR{OQNiGx0}#x%=w;RxR>$X7Bdc#SFTvFPqJ5s=gQTy2xtRBkh_SYNDZ> zowPHs;%W7vlAVQ5B0NhRSGf|}yHX2+=2Dz)H7b4bisPt^5**`L0j5?XPbd<^TDjV@veut(2N4CL`?4Z&PngyoV7sI>ONU3V|9C+yEv+{`kyt69MxF}%u(PrGAB1ONq1Nhs>@pjjEg zX-7|J0U41(?u0IcX%Q+wvfb5+8q=LH_?oG3IBS;QQ@61} zZWq&YgNij8$HRHKU6>KrXk0TesQE>mefN>Gu&7es677l`2?Z%?kiLKzGJt5gb#sEG zE*I)z#%{8R?St5WrVBs~j^3(-nc*9N?*PsdNQ(>DTG62EenB_HEYqtdq61yEv)J(I z&kTiVo3L{V>qJ;ECs#08WM`BeV`5>z(q=&x3Is^Ok6M*b&So7o$|xV#JusXx&9rJp z=FCKdcOqh|caF$&yJO5c?8j)8I3|%R!)pl&c1fbTFY_gd6p_&KLlU?$aS+OZru5R- zM(}2qzvz8ciMG2HzDmh9skE{}B|a^?N$?3DPv(BO48^E@tYvEiwyn{d8pwDMV@mD| z8?~d{FK@%+uK6*fv73}vbIG}NsVG^Q?ecHcQysBmWd`elj8b;v2+Xy=FI7e)nj8X& z7=Y)$NQz#3TSYp{Uz43(V~xmV5>>)6QXCLo9PtJPvoZKmId|p2w!4J3-+ru1Us!|h z5U-@gFPGiL{|vpb{H0*9eQADY;mD)fU#vRkIz^SUm)*#ul8V`tN%y+}a^*3?U1<-( z%ua>bJueE9#=b*>*n;m$IeYUI*O&KQexvB*Z+Xs&ws9=u-DGGALH6a|DyJK1AHvoP zb1X#UB{0{=a@r0n>o%X~6QD`rmt{!0k;T~T9GOq@wNDgZ%-$Og%f?8~auDxil&3|u z?{~_->hN%!Yh&ibruld+>xsS4bp<0FV*?-bU_t%Zt zr==?m>17;pscVYiiV{@Of_=)t3MccV-8wUOZLHR7s5z?mxj6CpySls`y6j^sXxo+0 zxu;S3tq)&adbUk}mcX04Jijv5O4i(QJ3gEz!t2G_X|DaU;y{f4{EuXUVOgYz-}@ax zsx3)S+N1G<)&{IjanJ{Zs*VA8#s3SWTX#Ajsp?i(fIa|B3Q=l9`~sp;cD{#@P;>tE zwS3Xw0lsn{wL8AX$yOvEu$hOoD*_33c7WV(f*y+RA<=q?_A;bZqMR8VzQv6Z0duPS zgliDDtop-Ldvu)_d<>I+#BUIcC!= zs#vY2UhAp+U9QM~oHXOD_0ITFpu5TR@}mFbkmH(Y@OlWoz4Z;jFd^lsMUJNcKzu)wI}$jCgY2d1KZuZceFPn zbJQFLQvZcKxjoNrSh5biq+RZRJXy;1S#qqJ%;#+I<=5sT9ZNCCHi$ZRuds)P+t%}X zWQBRx7$;pZtir!YJouRs&L1-?X6;#qJ3zA~gO|2{R9DSm_k4}FusuavRM_PH{F{nT)8~7ZwWYRk*6iq+>@dZjp5l!> zG5h&?RnwEUkT;#fk>5hz3EG7of2V7cc&l?jx8zx*>NSg9%$2M2(w*Ba!v3IyvpOC~ z_H(it@0+_3G~GF|H=CB{LvhT@&fc@xG;KJ3+n(#(6@sm)vmW7>%(EA^WgRGd%i3xz zK1Ta@eN*RePtw23E`XV1sD1lZAmO10TYA%vcnv)?hF(al|9#X?G+2&7Gfy-u ziW9k^^O*<{I1zj}&qTuy(7>!Bs+fu3D~?!YJ~2uu>TMbl@IBlSZ9{BPb!0IBW zieSYR3lueII&Tv7qvb&d23gCngIZX^3}z(o`9kkdGX&-{uxr`PLPJ2AIST|$&?z6} z3(08O&Df2^f?N)KPB5R`iJ1)2I%{Mz{oe7&ET8=7oHWcs3HbC@MZQts)d6o17E7>X zlwn2xsL%+6RG`{tIRqHnp@kck<`dVAD|}5gl&XQ9KA70@#UoylBvUow`a` z-IYzk2U*=Hh+ZK@Iry-W5qm@^R~&27_mV^BexxiZWNk!TC`{?7`C4Iw$46L{VK0e{?%}$U!U9mdej-`*@t0EfPjhv$s6#`V*$!!yeexs z*WqU>Oea3q_HkTVE|ML06g^qo+HQYoV2aAVH(B=k$5a)?-9NGdVjtJGfM$L5t&Y5g z0V{d?k)@Gvx5^*4b!vRl)7FT!J9!(c-`Bld2tAS9Y{0m2`U;Cd^s_t;+q-XD70>Mr z_Vjw;nolLwY7M`e+(0->)l%H$#}!)2G$aS0AL>_%YGW%7+h3LQs4-kLkWGJQL;Uf=#F~|*+JTa*wtIopPewDW}#icivLx&sWSd|f`S-92^2O`X%`L!$ii&SjmhzMw%QE$>K!k*t zgqa)jne7RX@}c_ftr3fiWM*}75-u6(ZZ&hz3CJ~!9}}dmGaf{C5scAh|7BwxEj~!s z5y8Z;_b`M^C0;pv-!Qo?viUuB-KplA>As9e>HFJQ8`O6%Q|2*XXSyoGdMuy2hz}9r z>MGy!MMW}FdhOS=3yx3C*d3k+81Z>GiLpC=mut>Vz*UBgUf7WQ@=L$4V1KDof#S{v z^^L%`yjq#4&V<(6)Z1xcH6d#a)$7CRqXKK8&)W0q|2XS%_UlP<#LQ*KJoT=6-$7Oj zh1uspGz^!$j{uW$-qX&yLnFVgQ*`bt?K-5Hk|dp*ooz1fYMRQ@_swvf{B?rwyJLYP zZ~o`eGYvobRHW2N(Kon$ci8`a#!oo0U^0MqeRR8U%Xk87_UAkqOZFj0zTH!8y$^=) znfZQ04n8mMS_TbJ=f$V}rxrgY3HAt;)Z58yl#}wg57;#P`6X#W)N`&pY}nF*-Ku*o zQgG^dkC?fCQ+IBKjI%y#2XT+xd*MLKeTTEz$s_7DxnDWfJs5RA`b*okRozW>PCI)$ zR&ZNFvbPQO9YbCA)wacTTdCL2Y7Bxb1VnVP zlMaL!6uejwoH$&WPtX8KUxGn@7Ya3&f6)+mi~PKHQOY}dWkZeepF^I1uoPX0fS8+w zDwUxGS0VH#>`1%>Sr!a3=COgV?wfVppdwGi>OJFKSNm>?BasKX~Ux zJqQPqK*IEE-~`;MP~r|0u|3LuAmibEQ}t&GQpIUL!#y>ov<_N%aa;~NzXyHjfkczR z!vN5gUJ(BDd&2-+q3aw!IsPEn+{F_3X^{lOLFRYe5TYMvlt2qf92P$gTY4uM41-6J z9|IMA8$#T|d>Uq=_{>v@ATv{#s!VLsWGb(Qd;q=&Eh;u%z)b0dvkx#1CwG#Wvc-Xm zVHhXgIL^-RO$elz&X+ayj$xYTr0tt?2>7&nj+`5fIjpEeb%+N{EA4b?$ksX1QI3H> z8tE@b^1WoS)MV~NDE-k57!*}>yj3eAB*sYqfUwVsOI~M`r>-&$V}`gHS^QKXYA|Dz zU@&+ld1=f8aX>_0>-r(1m1Gu$H}9wze;nrFu^X&d30aUci$)$(f<4LJKws=$vu-pU zd*(8kHB1TO;hj}mr7j9m5&5o&^@Hw$$g{ZaetTf|1B7$IhXWmS9DLuKaP6TjH+q^R z_;;zt4PJDeHf2lVbbcSjV~gqs4QIl`A*@Iq*I_q~v*IlNo#J&~T7oAnv@VhfuIEOV zHM-m{ACi2YGndjRZY~Hqg*&OGK>hJd|kfK~D%*!2e zkx|yc$SAlKrHGEsJr194UyQtdCUqoDY%a7&0dg-uGQvaas z(wJk(g|KVKDVa-qAH|=G&J47eeKKHI#Ldi+ZCtSH?ys5c*Y_<~;$oh@q6QnM2itVk zDNr;=vce=ry$Ol88sr}dNV-PdO}KpL<#DToedaFP6!y6heCL~ZYQtpi1(KoZ1DAcSd3>A zo_rJ^Hrnc?kl<3R#!J)zf!i5qPoQlC24xJCOlf7!Xgvro38&14b``tr&w$$m-HFB_!{l zE{kHDU;)goA*E3=FMd*FD8>6LZB_i2-&SFrXEC)MT+Gv2zyo zCio3QW(ZY4;mGI0}6%uiSe{Hv#!>28P#7*_s;5b$uSy??Au$?Fxksz z!*?k$b#9C~amcxoKVaHKPQ|C0pyXr~=IW!=QWWH(z=*j?{iR=0f8dge|AQ;%6c-;U zwjX#8`PaNQ``a@4*I%~DP z?#qE|*KWHF zyibspG%AxL9gw%o6%5b3aW-PCw>Di<&rz#GA#@M>_FT8k!7D?@<6Uug5=wwY4g))w zK%wvk$dLpiH&8C?{@MTh$u5PeiH?Y9Nw?K`qhk>rZ0L0xa382(S@$sllYy|9)AvcS z=z#Ad!i~l+bd(3woNC}XK$ng_3@1mxKpnz4Jp!YTp~d3=_OMWT;i4)N?A(vB(L6|u z413Ao+YPZ7Wyk|Gf_EyYT9<<#9rObKMLXD~G^2r49h9ah?9z+A1&q1q08oTbEhSKO zMkk2C%Z4@1^0w`|yh8$>mRFewlY+n@fFV=Z1K*6;m#FK&Klvy6UiCE5_uoxl&e)0W zrTkMRU4;_`Jx~r%#bGfVuss8AC*9Dk1XBG*?^Fh+l=VJapleEVzNbinKhIFBNL-p# zFsZ0NJ)E1B1D&R}jU`UE9%&5;;k-^=v~?E@qprdR3%9!<{;<)$_%=4t_I2E$HltN_u>+7yowKp3e&<6EVrj2# z`BCz?+KU5n6Kaz~RDahyZdWRi-6xWVh5= z9f+b~5kBB8^g};<286L&<{}u|z4!di>uE_V&u8{q-w!DUKjI=x)AbAo(QNRHI4C@* z%YYAkWc!~ELk&$v|FjQq)#t{At~rjBd5Hp|+sc=J<4LlefX#FSN~ z1R2IT@lV+9Xx8>c@5*Mu<6f(h?Wv z4q_9;;J~jQfx68K^}s@f*R2s|b8cof7)Ed1gfKk+LbcCg=IfrOI|3s^AaVE@y&LHP zORa_+(Oog%08?m4)4(@`Q4*W$P1%VQt18#LE*TF{Xg4)$npPexn|%>98zjKbSyL8x zTV-|PX7=L99?9i}(DN$_*LPmBS~n{ZA_;v0IE;n9UQp9!+Q`}V(&M5B zQk$8gv#yRxHBI`d+43JQ&ANH#Te6AEjWX;mnICmkGy4wj_R2OheH8uyyH`k;9p`wm z!}?(^BfjFmwbPeaOd_P-C)ky}E2GYy?K?QA__e~&E?@hD&Z%*qJk@K27j7?xPpj9& zoj)h~bjj}k^{mgS{QTCqyju1llJE6HE_OMG@Xl2HMqhI-VcoLZCT?HA!N=p9uLQnx z-As{_+YwWgg><&$=1TTxxHR6uMgW#03So!(=bZUSF1P>M}*ZE8^v^ ziTL=Y2KUS`$oUl})UNfB3KNwbB=VSC16lVNNB8Bb-t|$ae^otVH0V=&O;~g9e9Bqo ziO9Tzv&iv`647_&I&sO%K7)ZIyolnopV{7#$P60GY^i)ub6sxRtYzmMk`q4l7m^k> zN=%wPT|ra83^QDKQ|xBsXW!dmTI4?WL^mrpL5rnu+mAA-4_owvt;!AdSzwJB zR$8{yWq*2cqoD-_i2thiwjO}Gup3rT=>HFXY+Y&aw||?JW008(p|yf5yvCLkG_11d zuz;5w{1VtLjDa*4y)N1kiGhRsSBn&VK6(P>D6rDYL3$5#>t$IXFmIjLR+lvfd{D;_ zX)rxP2R?{Yl0j<(4#&=wuX}{Y6-8{|qrn@dzvTd+4@3k0{@ok{1g5{6e~VRClv;ou z2+CRb2Sr-Au`uHZM>OinGlp5gObU`Bcu^#SYG<#|YV5iaXNq+Q#dMjU6`wxI8W<|9 z-W}1s-WthvWY?W~y~O=6OTc$`F9i4noi%k?Ebl>>fsqbNCme>haXAE1dT!xjIXEjg zbu(u#B8jkU3;h}HGtuC-Ku~8QM-1heF$qH$e@^9L5yy&$>5>mWU_+Mdh%MsKg1wI* zAPOyu&G+tN*h@wL%&6eeN5ZHQ*nu{;3FkW@Qsx27LWmIHP~e zTvkN)=q9G7!_O&s+#|}({6*FPf62;z&u9H2yDUAOrBMqiI#hvlcK6S(7yUH1vK$sL zv@7RhK8Jqse4ptHMf6V`@hmx$De+jyex%RjfM~%H?N?t?(ryd(~ zMUj_ZoEXZzy3?VVjY3^Vkl%W7%lB;fSW>=Td8Hc9r=jvk$73eLaw68(ro)eR)APKgVZW zPI}rXtrfRd%_>5o+vzg}$Mv=h_sn@pb2@P#`oQdhc(AjHC+8)H{P@e?+~xNltayRn z*7RXBK_O6XT;*^Q)^L6@9MAO3bNC}mq~M9`}c)s~J>WlN{K znJW?Byb>q5sSSr4njC&{roQPd)12_0B`0@5aKekDIrDzxo2Yha|*VOjnoWXXq5K$QTl zlI{=&acmEQcHlvk8g3+xZn(wh3u7=HSnQT3StCa*;xT!$h`MhEq6;y>Hv=3(!0fUc z11n9|EY`rak9_z-JPO>&yM(P{t(;q0bH$-YSn$8w2A%|>XcbG3-;i7gYmxKZZ+NMODuK# zsPpnz*{Iu~ZY(x*>Q7i3O)dN0`v`0m{ojzzo;a!;%Id~;) z+b*=J$#SM^hU>%{_}ne(Q##^rb7kiAn@yI3`AI^#N;^2#q_@kv#CGL`9pLvbpx~-= zXXh*(cV05z_IU3OGy8s}YB9&p5v!JLHdH}my8$hQ*PDx&s?_A`)YzyYBhI^M=8`35 zw6myA*Vy_SC4Xb6$?MD{_l1ik5li>XS_UQ5u~r8x%tes$>xmb5pXl^e8b-MmsHPmp z8BVoUiZPi5d0@OHcD*((^BXd=T9`_x_6`!AOr-RE*d7_|!o$U;_NayLi|LhZ6`b1c zH4`7XI&b?2-Efg7DXpF}3jIwdOs{`+Fe}=V(5kF`%L(DhYd!lb{_2P#zu;gT2myWG zr2VY2$Si1F{=3zK#w`SGg0Zf{kRG)%_)mQLZ(Z1*sIi42|M_clSouE>FrX`2;(!rA zP(BGZ-|^6~L}iDzFc3_@>1P6!6E&G$ywOW2G#iIeA!ZDvh|&K-!1kI$i|zutEr~va z`Fli7|NmGTmpJ4Aa7VC0n-UMzo6vs04S_P6V+=5UQPr6zwqdGvcMO7|bjuF#n>`HcZOXOSSkUO~_z#V%5l|mta$!qp14XfiW zj!ozWV;|Ixhe?sjutvo&BP`%T2O`vv*uwdfp=2zt*+_oLj#MFPISAuVDN%aA<|PdE zs91pEe1x455wJrJvm&$R@r^tL9iOAvnptLy0a{){J*Kb?Rxd%&+5^k*5DGvp@A(7( zPVgyWM)a!QB7`sdnMsBD_0MjNnx9nZm*J<3HFfIelMtU)7MKfS^Et3H9tcN>3)4L& zDx;Y#e1G)yBa~DAu%jkZ6a6-E=-I-*EHp#{AWHlk|BjA#E$^>?;Z@36uSnpDoz>8D zKk9s7^R0KhYI5lnE3HVceMLHEFL$=j9{Z#G80*ze*^~wG;nQk5?+@rtiU$T7<_7Z= zjvd79=0CSXQ}Ka{>#$GvZNVxU+}4}dbwrz|rD->A0 z9y5o0w&@~Q-kNb-c6F#ZZRMIUsif;K+btDzh4raR=$k=)u`!0{KAA7i9Yd0}*&Zu}Rz*X!Z@t%rBxXsnWSLMI{ z)+>17{!H^u-mxeVn{o$klK`z8Zi0F;at{%^2~;N7y+ZF7-e{!Hlk7>^Nz{3Gx$QN3 zQ(Ky@cbhDAm?=S+a&|z8VhZNw<`rq{8EU?vY#t!#)?LPd<;Ai6{ECes*F!4k1j`%* zQ;cpq(?w)SL|JTANR1U%(K-YR*E484Y!X18;N&I|vMq0WD(BI0JXPi`ol}e$9zz&G zFyPUHD-(<2!A`Z0!nr z+!Vi`Fku|_OD*z`c$EKK^@xm=s%WMr%iek30bGT*u+^lH&nRVb!A+uDb93@gnMnE_ zT>knCLl-NJ6x}+C(J|@Rh&kWAh6cCaWQ1=UG`Sf&d41ofd_gUn*2hNS0YAi>oR#Ir z>+Fx(I}4K;&vohp8{>!@zr#iUYFWOjKT0b&E)D3~k#JGh)09loXax>$TQk+yPHRsX zoj&(2fk?PT+0Jfxjp6ersu73O9={w`R*R-a*;)6}vcXppZ%8e-57O{ikvyZ)oXmZr zSDZL?#)H%DSzZ5Kvj6$>0K-11b9?KgCAjyLjD~YqP$(+7b#6KBwsFt<$13_-BZ#ML zl$a;x&A)V=miX9TjMqGlZK!uARD1#y<1-UG?azHZbiuVb*(kFjk>{*V>?~pAe30VZ zaIQG*xvZHram1Mwqic)oh75I^Fgqpzco5Tb#i&Z(G+EX0aJzy zsDfJX`~;V+X#aP?^M8=(|Nnu%u@bGdQ29b&5XZv62pq%du8n>GNNB%}8|#O#F2Ohk zmD574#n+d{0DK?W`uOye zA7P0`AlD~#!)rs63Czz3kve=GTuN%uW`5wN`)~L=H zOF&?Fcoj1Vjx|x;pkY!t+5W=NZP$nrnHgdCK)PoU4Vlm(d{GH3WJUq$;4^F$(wzXX zOs=T0kDvVOcohTChpa*M|HWX0;2T@YooC3z!cJY6u)}1c9s>vi`0SKZV>DR;b=+C3 z@3|v~IY9II0XX`Aw$~Ve5sJ+GO~gYSStMg%O*1H(`wY0*nLu47NL`}#j22FMAc=53 z*uGhW0p@me?HZU!7Re%<9x$6?BqNoom=efdsf!W*n8_o|7*i{-^NB{V^?)YP-IyR~ zwjjGE&kmro_E~(0%xi>&hZlhIJ|c4LdZA$szjWyP>E0e`u(DT(wQJv9(@7o4v*P_l`h}2&P_f*qf}AC*~nHYz6M9O6E>gii&OHPCW&TMrua|jtl%v5TJq1D2bAXW zermZokI4I(DX>ci?^?H(a<%`OSUPZy@#gF7Jr4>Le3mCv;v!vb;*yeLS&X6^vVZ>| zCN0YoqDMGTUn!r5{gM#-!`S`zUut=DI*t9y2Cw*r0%8HUd_ZqLGD`}Y0%8$H=d4L) zDR!*zHt0YXax>CJ9CWCh_tg63M>wTnu~_vop4#VKEo9EkM8%RJ5xGuJey9wP2$EQ? zf(rC3XuTrBj0|TITy@5TG4a$84;^SFBtjm9@^^rvKn{^CuUR*@1F%Fg5oQFs>>_FO zeOIY-eu=u{X&1_-9^A9f|9sBy_cM}WVtZT4`ZKjo9JPD*cr#Tve=y3QqCAARZdKp# z;mB5As#m>Bm?@I5IB3d1xifObg*Z3l>~$(dx<{xr^j5C_Knr8`(i?nrC+o)fvg_uH zmv?6ev)@)@-OVJW{W7EA{p`DmM3T~z@LmOrps9i(dpU<(4p3%3!{c zcwfo9Y4M(KtU0njd)bOwa#`3>CGc1fd5VKw$f9V)rSBZ$^#?iMC!bRon!#F$RwK&m z?WGhHBLr=I$6Y#;H*GTY*XC64=Q^(Z*?FS3NhHAYfW!A|iYG3a=}(<^O7G!6|7GEE z(vSXA8S@^$^9Q@cEXjXUGQ7|uxcnu%#584ps}hTh^DS?Wh1ZuC&z3fny-RZb{j+ck z_Z0yPOLxYnb_VZTT{kNTJx!7-yqH9EFCU^atPYjaI1xc~n9oW_t}XP6?uI_wR=W-2 z(@B)$23;~1=n#~pcw~26#d0k1cq+#RQkjJ3y_Qd@j9?MvgQ3_fPxVH_38E7|Jz~dq#F>mga8O7 zBv>!Nx&E`_Nk4xwWPL)2f+{At5Gcn?i_pH%V_HOhCu3-&GprjEik>Vs@rq;l2}M0i z;@kA1s49NofAeq%oM@ID!+O@Ji`!6}WZ>*~W8&dHBPi+`W}bRCgoi2#rbo1cXw?&a z8R3ZOhR+RM)Yw>*q7o(fB3aln*ttcioMr9EyN9=?>*jbcN&VBC`mD36wN)5YvJfNNe zvHs|Frk^Sj&;y0JH?^CYjAAqfhXF%|?t6X~-5y8}w(Ji0yMhD4eNo+A+_HaIU$MYEmFC6Yz%q!^%rwKq%L)eGV`g#35vJmvH+nRX<|wc zc@dzbpr$D}#-`Swogf=p?vfnhr(g|N4|qFmV*Z-wXwTF{uOoJ2xX$Q>F{018N{Dsq zI)2Jx`RJwb`V76ID1&RSbd|HOitC+pH$9U2TXNUZ)Bp#Ugyy6T>Hbubb0U?6^2D6U z^v}a@1;!7r)0&-zVg_hIiEbkU=EXFYdSYuq!_4D-y(Hse;SY@b`?7 zSMnd*s3&B^x?gG&O(!%yVUDhKNu9om08&S7ZF8si1YyZgk@#vEQ`#Y;k z-%gsQ4XYpp9d(RfX11|s zCd5l}R1V#`CQo})DOzei;j*5%KT#bupPpUoH}52OQ5gG(i;VS2WC}nYhdLa%YRBVDFS$`!7+l`#Tj6v5IDkpgPjPkN$fNJO@l_3W+ z4AzLfyui{nTpCHgSt;g#f2OQ282iELHmXJ0vF(R2$BszdRL*HmALYxQt+%+|=0#1O z>a%~8Uyz`bt5q zCWg<(u|y#{z7q_C`53bE&NK1Wev~sB*BPtWou^D^_1v?T{K`e|ddW#(4pEGtKYTojzx3DC{ZzWMpT+yxD=1J=r>; zArbe2{bzLZh{8OaccmE*xz&mjy5H;)Y*mbJQ>-2`q~>=3n7b1LEv}_}9DmoXPWhVc z>p0G^zquzaeD~9RJD)a+xVyQWT=(yD(oOb}*gbRcQ&PJHrQ?Bby8CkB|<;#9uXG~ zOZ)D^dGF?r2+`gvMklSquBi7FQ+(NNa;qk1V}rayy_@vKbthM@rOs!S_}W<59?!N4 zmVM?@k$1?=-E}rHK`Na+RmECgB|iVrkZrZRw0m~2MS=vM=&TH@`Co|cgvNyMlAl!CkuRh zo@eaTGxo8meKa;w%i_xc?5mILb3#$OxvWB0dM)maU<0JjS(#jg%}B*~cS$TW3AUH% z`wDIw z?_b1%RGA((GZ0lGYJ>;IrAZLD>4H3ezdZVk{{wDl8329BEhaToQ1CRgjDnM;uSlXl zHqqT9`U?6MGC~fBq5?qg7L5MqFOwn3`)^3w!a6vWC3wxB__=i=AfO18X588Ct@i^R z#@J{?AD)jF13gALql4faiq;?W_zoY95=t`%@NC^;chk?Z3mY3RQ37Kv`%G=H6Xys) z4Cyj_G}xfWl96-|EQudzV_MnCibfIltW?hW~&lvtHGm+H)v zIE#Yd1UYM|8@c|NF{t}uy3yVlfFF*4>X;CrCz!*RzEZ>GBWg(PvqtcRNWV3z?T)VO zVHQ1r^eu^~Coi%9SQmo=7Y3XQR5h?{I`mE}lw-x%G7$N=inxe(N1&c|2vUehOhHMe zGs3|;8S=PQ9u{wyf)K*J+y%kJnJZ^tfJ%E(Y{(=Wi)yg?%j+Dfbk?Q)O!B^(c{;ovhDox_XQ$oFU$e%Dj_37iNW8`fr=B0JSZflK=G)Z@r?H%p*ZeUx({>+@()#fW zL+mHPA0EdtV_VC2t63G6=MAvrST=Sed$am3{W%<*#G_kT*0i{aB|(Ot!0KrW6{G4#=yVK(eg^1o5Yrxm9ir( z-GY#IH3B6CWuq*e(*#>1(DsglXNWtMCmAJ>1-TY?dkByPafRGMA7FmGNILnMirgob z=cA6f+u-%QC@a-U12J?P0;#i5;?j;UKcSea;P&6$iFV) zt1)M0#+F@0J00&-F=-n_tiWq_=p{<`LxXTfYgGJ9a!2&Ki~AU0;NlmltA1~Owv^N$h_dyJPyTM0R)B=pzR;r|6lPYe{VD zxe5E*2Ha^JPXbGucA??^ z@T+?+Wjn86n8fGSuWo<(Ebry`}ay`8%{Zev^|RXa`LJ1MVBbs&xU;E)%JbAm|JUB<|P&fu^HmbAJl3&KVImq z2o*o##`w#K`sKiu`y54VR`+Xw92&HI-4Iu zt>MZ$*4&Uh%h8fVRN1Zdq?VnV?U>&)u17_;-kSzfJ%e~Zx7c;B|Z_Bvdp`bdqetwxzEV`B!WXRe?fbBU~SVE zW5rkU$LEWRN+PG+2z|b9B|ppGn!1%B*IS{Nm!>i3>F2zUH#3@#dp=@T+JsZr9{Yl4oqUm%|7#8 zoBcuiRpPPS(lk=roc|lWX#Y`PFH;I7&SCM?9^RmyObzxj!FB4L1UfDG|6%M+;Gx?4 z`0+Ewz7w)%XJjX9ijiy)W67R<-6r8coomm>e@u%G8HezuJsN5R_J;1{tPYRK<4H7OwivlA z9VB$fDK8zwzzhY}UmXGDWBv0@$Q#g7L{vElz?%&7Xfo{=G(+uD4}$okG>(j1+uPAY z!->t1&{nQb==lNmq1r;In*ex+p7X}`iIe>Z^pX`|FY>PBO96o1j&4G5jD$iiI$#P% zq*z8rX$nFhCKvS(;Hc9WLvAA|Hc{=MK@(H{q==8j8m?uDMj=XD2c_T5%KQD9GBpu1cXN;&pbQ$u~G_%4|;lJJ#l66kjuz?FG3MW1ypt#bQ_8( zoH?6G;BCd8%jk3 z#gE4&9~xo|G54QC@2u|fUY&{18=YAtEj#p0yDsRNNr)8SYfN;HfiNye#P1J=UY+~=s^A9@VGn==h=Y(C~k@xtZ38Lokr$|NAUWan&p5Oq0N!=7ME zKg-s7<;>fCCa=Z2J@t}s7P`$Prs>hwRgak9FU{an)fYpIK?F3(!=yqwP+WYFD5upT zd6c17#^n69a@or2paP1v2#3?-foG`I#ou#yCi?jcGjrw0r>opmdQUq%$EBuU!#O#f z>dF;zP?B$O{JOI2uuAisQJ%vE+}`HlEsh+PhC79cp1!pUZDE@6I~s0qulO?dcT}$6 zw)&L~jguWGxtiiy?>tpCZpf$>OJ1Y%4?2C~%r!d6nDpjn1RHuhACG19lssV{rR@p* ztGDwOzp_Q8>1A{B{y25v1onymJKPlT6D31JydhD#7okRn{UD4GP=~b;h*c0UpQ@Mezuxz&=Tfzmis1#~7A21)Xj# zx&}I6P{{Jn=&Ye)b$H?&R4usxx=w50YliZm4`--4YzMw(pFio?{b9^VumH4utA~K| zxR7Mh7_ofG_^klDyGdB>8j*aaMM2)pTMp~^?g5FQa+!cpDukviS(z7 zzkJ}Uxx!2;rKjoW>t~kvr`B$#+6J=^s1N*wED5^V zeVQJ`r$%;0ZTFrhTF?*vF#Ddc&+u5?`_#d~ zdp3;~7!8Vv0A>01jI->nB|U1b-fczYB_4;wym3Mvrmvf@3!!WDE}hoi_GeW(ZtAe+ zFjTv0vgJKoIu~9ZDVlQdk9di?1-)@&-@5cGwsyP4MWda&0^9ZS-1OrbyFTKM_=O9b z4c1cWcb7ZmNFIETAj^D=-G0oa8V1Z-JLvECXZtD>E-2qTt1gr2q*HG{_Eu^34pT#_ z?%jofA91#G*7Z9gX&jC1EMF@vzgNBYbz)iQ=-r^)&G?=@@71Sj@7u=53E>j-O8i63 zs3;XVS0lYN4AR0pAVB1 zleVxcuohPCrc30w;#a_%r)xp4YaD4LK78(a!!A8 zB+BKK_^1x$U;@hhE6ATq&*%%2D@1&QrR>}7DI%L zZ0D!9{vf`OPtwem2qMmuSD10AYuXv9VJDx7R+;dxMJQXkKK1TwGb_(L7%$!WSkg`2 zokjK&cQo@EHjx2}B}&QDAI4qs(I`r;5m980H9=Y z3J=km&R;&j-?(l6`&wXkH19>eKrWQc!VA#E2AQa%Pr|{;ZU8)kItx%YzkTRmFb|<$ z;EWIghN}hGZ45ygLtvm8D5K={4QSfaWUE8 zJ|w}XH}64;0KN=`C;*@e2%!p*gAz<@G%yy)qf1+eRO zZiTx)jc5W{7;J77HzXv1oT3q5P%~%V$&Y-6Nieq%ED+#1gc2Ib9Z~ZMrKC^DISsHC7CjM9@f);m zsomGvWd=C;IRrQ1OHjxVfQImvsMRcMpLhwOP78s0$-gGszND+{j6(Z~;XWYWBj6Ox z3mQ%waP0ch$Cg%!jmjp5MXX(G3DP<>|{&qgJHmqPP z@6s!e*pgs}Zkv75KH0~xcxO|Mk$CUWu2FxkI!TAD;!U=}+a0lH7K{y;qmiVrnCMKS zk=ZDQxg8+x8}OlhWvn@!b>A>?pn~b6+8jrk@>M-j=HTVLD%0n?ky5APf|OU9HLC$S zTr?(r!7LKWqIaB5jjpgR-N6cn_Baa7C=lcehR(SMr%)V{>Z+<7@OJ2D2%zE$D;yAW zelj)pd3@}18h^l%B-Q2WEQXQOHkPh!Hs{`@(XQjBaxG<%CY1uO1VAF&?3eca@_z?L$br$B1E{vWqLWjP<%CmQK~-u>vs3=7eb z`7Fp}fVXK0pFLW|q>rwod7ll)tw4u{4i|>FzV`r)4Ad=e648Vn+5crA!Fq1_H*0_` zriB<5tUk117S<#}0c$0g--QoS?!Lr(_?%1EQjT$G-a|4G>6c6HyjO@Mg6bCS3DZ{uE;W!=p zrBk098P3Mj2#=MG#ae#w7&QtUxUihbbYaH%K#k_~CmIKwYQru6^Ygi3xUIpGQoka( z6>raMCtsJJS?LRU)q|f6te*EgiPwI}P@~oDwVSZDm3mEPz3>vjct*l*q=7|hZrZox z?nvMQ{rJ(--HQJ5dsn3775Y4Pn6~AIJv=_PvqZy&KBBeVN#ia#wpH+AH&rlpKPfFI!wra4}%CHI?N>T9)$W1EpAp|=@| z{y;hzY}=DCv98`M!5C52$Dh<9IVELc^EGVZE|27@6IDAh@xpuGS`iD*~X)jz^;%6ld9d0>#236KpJBE0V+eFg|@j zgt8jO5yYhx8Q6&+M*!ZSfefZYKslS@1VYuT^Dw7Vr~eAF_XuW&VJL0HmS?_L`?7k7 zNS;8k0?xcxk<%HfIRzj+dJ9b-f#d_?MMNGUg7CwD@>nbl$ReO(b^>)ziy4^EP_DB& z20AmKI28ThP^yhkpp4@0A!-=%1T`v&5e#IjI?Dj+j&RcBd8%$R80x0ri3+M|nEc&w zqvO5|aSR6|uD`o)<1x(7pndt>crz3Q+Uomby6oIw)Ha5-L=u|iR?#FR`R0->Mnmj~ z&q7!K?8$D&?iBq~Zl9d0pZN8A>Ub0q@)pa*8&?duW(y7;-v4fYQt5*qyXO^D98Ju> zS;XU7#wBL*2-$I44mw7U@(*@LF?}54uF#v5-*n!ecWe0GY~8+xonwoW5f2xQu#)RD zPG`(#%dX{5ypF1hh!`3!F%!0bIkYBrtwTQIHFfh>Jo9b5oBe`egtvv=+n5sE$kmjH z`Dbq5M6;9`OD|WHdJ0`}_T*?Sn?u$OMMskP*jNq(8AvB}AF!D@rvE8-Xre6Ufl3|4 zc{Tj`yEie-_o%rR4Ep%9zlx{l zBHUQd5fe+7&C&TXM>p_(!OO}%ci~=~d|ZfX^Gn4V{~UhuIBE@pbXJIVB&07K4lWstLlvG3l$kQ>IV#yXMWcj7S>w{3qc z^wKb&j>F-?-e`P0#hcG#lqJ{jp^LESnn?A!G{?&vVW$^Ar;n%>^U!JO zpz6`BzxyfC(<(0MGPBUJ!tDLKpjZGY^*k6TBJ$0<9u#J zGoeK~pk07HfGPQ4K$nvtv*)X^dn+l^YJy<4F+z=ETe}Gt%fmJ9{5z6f(exQcU>hS;_3x0gV$2LYx7LSX~f0BBQ6p$R0;W zoN)87H7HJSACiGPNp=IFF)kwpK=9ULVrZdnnZ9me#(?6!Trcw!;dR7v{E9t21HERm@ zdgJtxf|d}Qns80$Ds8BVAFqEjm!m*eU!~HE*GT!py-w4UF3D=4pKDup^7e|ob&vgN zQ`nsRHvUh71A!v)UL>3QSwyALVD(|4_uz-G8r98qJ9f|pn&_#~F%T?^rB$206?AgF zwClcHB^zw4*+@O{p5C4~)<2Mu{i-(m=3PqRBE7D2nIEcsnVYkVOV{h$9+p)#PusGd zdXd2CikDx=hvtWmU!r+r*!SJ! zTKDLtlVSfk@f_>RXFT2dc`UOdaU(Y-dIB5X#5+sm`(}$XPgNhU7d5AG_<}bpsVos+ zkN8nGT$R~`YheqYqn8+Ho_x0%Z#SuI;;@&->F^rG`s(<53O8d{?Bz;l&Ao$V_@YQ7 zitf`lx|=&ZZd|tddBFN-_p>ej*L)WpZVXg>v!7$XVLWj^WLdg_C_-Ar+>L2Gn9VPs zbikv$Ce-0d&@I(!TxVj%mAs!JGsGL0G7IO5##Git>m$NUT(6gnI27fa^h%W)&93tB z&DrBM)+>A5_7tDgj=VWT5&oQytkq!x8mHXNDu&u*^12>WA9oB9VoX(vt_~2qPUGr- z;=c7C-EuwD>GyA%)SD4znUqx|2o-|g%!x*CnbKw=`{C}&45RB3C$GHP7&zRVXT#fW#Z~hBO|ozFZ177K zy~xAGNdXUPHQMO*Bt0Is;x%@{Up~;unL$4g{j&W=a)C&%!mAf_&o)~6RuifYsW>y! zOh?+?EUfTa7kzHyaqbVpNLp`8N@Hb>ePdo1CU%B>jtZxC!J8Z(>sK9leX4}8BxXIj zR9NlP^of~PW6pcc{X!0pY-?X#m&Y9kKSD@d2x4` z?$!+IVosQLUWmB+FD&kZRkLPF#|9O|087O8WFlN6uA~^(58${80BFP3hqb@Kek&3LHQ`Slp&z812Gy{ zD&#s?@}HRPXz6cCNrqAsMA23D3v@;Y5z%5sgsBWgS4IF@fF6N53V>K42zzc%JVPU> zXpPeEnjJLnxD9sXP2^M~kWuu!e+71YmWc|sC~m`e>skR6%vQ;hJps2H!$=>2Z^n{7 z!a!??=uTnb$$7zeIB_y811qefW*{?YI2$qwQkB(UVo3~e;-iBo^lz&|r-Aw=900ZA zj3L|YC;*%;CpBCcx94hazZgYR6d+LvGV~hQNMv4(29W`YfTXRB2x&t9`?d|DgyzL4 z=1NKmBGkwLpY}m0gs|*cQ0k{&0wRr-7-3pC2$o5-7%C{bDs?u>vX6DWKM%#PyA%YN zB@TrV`|=w^FPlBhSI!ugjO5Y2sR1)VH$r@wbh{^b^~{6)(tNe5SbWbJ`e|>l4KV4R z`y6}D+~otuar2N599-O5P=~Q%zznq@FmD?Z3%nTo4b*vpFgM5C{o8C+h z(*M}>=qPvp%F0iPEcU0Tn53ypITv$;I4Y=LYR49+O}_{^HYw7eZ}Hl0=;Y~9xhPi|icIu=;z8Pm6Kh`Oe4!(9#_xayDMllk^5N1mBE z*e=tzPRs_kl!v^q3R)NlHydiS<8fSxUejC>%JJKK0H;_@)f;xBTDbqX>|l7IG3Q%Q zl?hP!qxM7mHHTE|y!DFl4JiUVQ)VwL(}%m@LEL{$;*c{Bqkz)6R27a_o8X&n&Os{h;4(ecLfguYWzdKDWyKy1KpFQP#tUm8IYJ zRrQ-FOg|0CO=lCQ!Yq9W`N1leJI%vs zc9e#52D?Uo>07J5i^)01`r6^RI;B{CyuJUEB66+C<8`W6aez7wSuDizW1Gmsc1`Wd-rUHZNNpKnu;_|6 z(>6L#quv=Kgj1uQm(?VmqHC(9b4lbi_6(0X=9KH;sx$r7h`0P&SNB`@WoF55OxlSo znBwN9@|5O>O0TZnY5Ld_cX&Y~BRtJ;XY!Y=-Mre+hAVUfXiyX)j`K(}JVb#I$R;_lh?W)U0GdKFkvLCAI0$!cyQ3f= z@vCGOAt468QSrZcnqZ3UwOl}|0lDvjj@$-lOo3(gcc%sn=LAG7u0sb}qpX&UOuymz zw;4xcN3VL(t(*VO9AVgwPrsmeLX^R= z($QK%aXi%Rwt)J33yeV|(X@qv1wB-ckn(Ni45qYB}fs4Q$pS2G*YLLP8Bnh zMs;PS*UXl`kK$3dP;uP}*fva*5e&e%gbOiX^I>S%JUZ%)D_RlsCpwO$*}a-p$J_^` z-a}l4P&Ep$5Y2^%8fF;5T)`4wLIM-9)tG14>)43#5|`V&zQar8Mz5J&>OqWzGQAF^ z)G8NDraBOUp(QfLD5M|ssMK&fxAm644x2|sBqST?bc3P;qqpH|dR^JIzsA}{$zx&2 zK|awG76VjXPKT!8b7IW_Ku4PvwiS78_0iAPnqON|v-eB&d#?PHnQ(QGk7c{{__3(W zUx?UKxn`qrtL)u+ucBN|tv|HRQMHS775|X-@lz`jfApPTNCHQ|V5_;FY>n`NW#jj@ zthHw-K96+j%v}n)aR|rQXM9L_Fk74jGmJmIEG*IgN7|jQ_)MpR4r)H8Nxk+bP326g z{RtX!Q|dX*T5IieMo8dID6-&tBlRVHK!2a-6V{4^%xSr~^CLSqkSF)Z*~Xf6(KFxDuG>6O$iFkoT70elj?(S<8?TmJ%Tit)9^Y|T15;l& zMjbMK$>))<>Fy12ol^%wn3x5!6eb#CPn@6)wE2EQ*ElvYgW@^&p(D@xmXh`-6f8H( zx3#6xAXPOFA86O|7M{A$bCMsez;l50DSn0Q$IUCiortDaxXu602X6;LVBP$Ug5-D- z1X&M|X@19caK#5aWT?>+0#gA_Fq(CN+ZvWS*|$20(8$1UWVHnM6@#D=Ih^c(xWxU# z&79xG3VQZWpBk;4KbcXT6fU|q@On1W#$(*O4=FF?%-c?eug1x~d(LxMR`mLYM`~bO zqtIK$^O>D2E?iS?fv$(uZ!0Vwd2U1)9^Sb7_6z2;aR1dT z*DFD5e;&G{=X=3#nEo8Yt?KpIKRn*d zjia})X&Ee;sgYXdFZ9&)x+C@~bC2X@Ic9fvr8cVF=BC-~1^s}ov9`-*UOH%iR##UH6F%X*$e*KDcRt_K!z=Va*&Eymt}$9BS+&sPe?)ek zI=≷Ia2X1l3}H(o?GnruOV+jtUvkYzH2EX4%a@5jCUc3?=sQLte(iDO9oE-sN5b z_~lu*1FY*4Q#d=UBHfT&nd@ntooNppewgX=RzJ8=rOB)3f0|xLNVPN(!M+Yq`9Zl` zpMQcf)!aZ*yF=$9a&1;3;@exSj4Z5Q8E~4Tc9Uo#zn1qO+FKeaC~IX&%V=#zz)T#(+Ef>P$JOzh7zXVfklX^ zg3h=gI%WFgCY4|Z#^4s1ZW0G(a(nhz$R-;JlJyu^M!zr*%(-R+OdW>t&NPR?IFYqa zq3Ir>orhQpIwBMjlVpMfSb|Q?hIfMiBsBh$u?2t-nyLQbFM@u9mJ4MVi5ng;U^_wX z1eA(^Mv`BMrXGK#J^9hah_Y9Js))7Kd1$SIS!95~z+T}T5iI)FXqRuqDqB|~Ik$=e z9{F@XKiXN7__DnYo7;@iX+-gANE z0z(Brx`M29y$aqm_{F)X9YBrB2MAN5J~3ho57BN?&~DA57{R*egpr^i2__(*XM=&c zPEbvox&5O~)1ZU=uCm4CVwgL;!HCK{ebZjX*b4<@A!(#f0; ztt(}&QfUH8lsdfkjpxe_h#ZD@81>pckJSSs%4= z-eDEEN-QJh4V^z_{ngHFl5m zw21qkv-W-b@ji!QKZXbQvu14ZY$h+K+J|J#G^c(lY06pbqGs2DbJg;RkN0LNElpPt z3eT(3z0DfojO3+VPVzROso+kW###0s9?Oh5I54W*aAQ=ioI#9T#l|7KiZxImTeVU3 z+Q{UBH(gejN~ z-;n$m!+UOQE<`ot?HwyO{KCZ=>vkWN_nP=fy0X~nENfi8_Lz*!1!GQ8m8-Ci@s4d6NXeit7;PxXsh_yZtUDnbF!U93Y#LgVf<@AeDCG`0?$@N{fUt{wN6 z?#1Z{O8;RvQ&emag;m3Z(mZ7CG zcCGj&$%2BxKafwRzypo}q)*#n(D8 z&m?+7n^y#)&l`^Q)G*464Hft@-BBoBOmL|Xu9M*iFx*K!7u~sV@6R+7S9dLabuoI^ z1}A%Lnr0sRqClVyj^6YpvUT@|%StHoQJQ6^>_{`?y8NVynOyp0G5;KChGvK4x!%wY z2?O3;0oI)r=2crYty?*o-JOnBoe{VdO^Von0CpIR{Uzd@&7ww{nMxO}>HaLWy?nmq zDQ{Zip6S!6iZPs=ij42}t-rkxot&TTyZf!DDuIJ`sIb^;Mz6l5Q>@#~J??v|HH*BJ zSF=tr-pX>sdHM_fYwDKf!@g_TO1Qm4tCWrmoNWHHYwu!8RF7XNFp3ORPq{BV(Hc`? zB*x+OD#vD2PbZ?|_}4$>trLLvrm47Dm-fLlKF@MSHS%JF0IBz21;_ zIu82*xzhUL}g1WZnq0iU1r~1SlL@b@1;704=WlokPU20_<%&7Gz)rbtZIgz!doCf0xgK zfBZWSL;dTE!9u@^E$pzJfdH=F2@kG1cvY zwlpIL2@cO6{ParW&%4i<6Lv@P-16P)fhIEVHGBu;Dr%Cauxm^`nu!(CtWi(+TZED% zuQTPAKRea%LXL5PvP_c;&oq!0W7B5VRU@Zx=Vq+9=GOv_BsGCZ&H*~hSD7X$_quLM z$u@FQ)k-l86zjAZij{WHM44_JzWH*Omfn}av<8j7&-_T?Gv*f~R|V^-+68wyHa5%| z^fMfEAO_K&J@W7yxBhuGPe0w#%W_!w!< zb=TM)B@{SojA-1h6{~!7x`CdnfcXz@N@XwWhKeOVCin9^nL*_f*T<$Gd-F?*=!g~g zoFWPY3+ynkq@Xet&NF)KA5nDX;kn?1ImM|nixP&j`}%#QDChb`{zCZ9kAxUs?W-A* z8uC-z+U-FJGVAbtp&1GaA$8Qx;wQ&OFeD*ZaSG&nj~4j|l3?WaV?=O!6CmKf`I;ys z{$Dm=8JCx|E?(+-cb62W#1eb4ZwL2Zi0{3Fc`=SXs#(u{)y8_(MD<#1A1W>L-Nbzg z7%HLLt#_S}ZA#*rO1oyeT*UWnSv{{}F4U7w$JjK9QmV*$g;6Y&SvyEq*63v}EdvAQ z_+j%P{oXmV-X3hMv>&0&dT1%@mBFNHb_JzGpG8A|>vz#>N7V`58Uh+|E0@@dp7f3C zKYJWF{ApM~UFg+C^`Q?Fvjs^flwQZ6YNJJEBK;=4Set!u@z&yru$W|KDX1J&(DU6L&LiwrPHRZJcsLMfa&)N zH8Y2cP9-n1Ebn!yjLu}xd$v(g56lHm7yv$~1il&`zO*8;R& z`{1aKNFm2{>V>4HC{&Z!q623=%iIonuD|ZCvJf{luDDXUZbKAo-ub-zcsiGf?WZ%l zMhbHDj$8@ftyDtWp8dvLe?r!U`MQPBOkhNUU-wkm4QV&~3m=A^oqP%6*%c)W#uqN^ zxRh=*Qzg+e7gFBB=3#Q({bZU_Uemt+F#hO zj(Aa9;7_>opqjl!ooZ!h`-dTCq zwfhf@W#fYiyEc;wwPusE!w&eMH#wua7^swS#euh;_%Hjm9WC1i1{f3rGy;GPMTy^# zhJ{7&yT@MVABOR7a|y;4sKKv+HXO`=01%-QLIJ}C;&a<2E5|N6V-r(oY{B=3ygE>| z?QrL(O{h#oF-}19?- znr??k&{JSOhmL8H0(}Npz_4`5@C)+^0D%E<;j$pY0y#mHK+?ilY&Vaf?~0;!6f?AL zpty!Xp%2a!bRMuMqM?9Qy!|0GqC2X&aPuRmi3X#x7sHC7}kk$eO)HzBS5T#x-g*rMo z4K{=aA+9TlIkQVmo26&?3@}ohTOmu)QzOddbF9=lX!-88;zC*_4XE4!SfPSX;IN}1 zERb#xLS83Vo$TH_+iyE?<^g9+V*T!MHEH9^S3@upbmu}h@4nb0e)~(_$n-s$uprMA zJ&BpEev{N(^7ONc^anuq>Kb z!Wn50N|`#9?YoNaHqMC}+sM3CcF3>kSO2k8T3)1g0YgPv@kkAiMMl1z2}ueF6+LKJ zi@mh}V4d8-mQArBmX}OVC)K0O?&UOpRzVUR=q>JjzL)z&uReXERQUtHhE{w~-ZS}X zGg*=`A(l5}1us*?Y>L>d^KH<%q%ZfGi3hf?XS2o$g>xOl2VcJ{Y?Ru_^YnvR`4Dw- zfCA^B{jGerC(?thrtuFxYIUaZC{U@-IlX>@pE(lYNA1rVJn~^5t8S1)Kz3_j!<4fXMZj78y5VHebs(xGW4-zspoV|*w_;g0>6LKwP=xBaPOBv|HX zLg0U_Z1CUy+YP(DOc6bv6U>V%2ltK9?>>}eG}5|mxvBQY0t#s1N2z_k2p-ZK?vuD& zvvEU-t2l6>vTQ|undfPMgF(pFM2n=2%{h-awt~}YBBKNK$MuZ5xn|GURgOne-PqH+ zP#&tuZ(zFKF|$LLxr#b-+I%rc>lL3&BrhLZQ+LR+Kt6rPFn4ul?4otC?Z{Pzva>13 z$oX%FzU$rE8&(s)PzDD_HpLz-glCtvqW$rT!L^2m&9b;e(OP=24 z_=iR1!)B&KWdR9IK{TK`y&YKY^Sbw0vli@ZEoR!~Vq0`|1nzIHf@%`}ia2Lt7Q zylw2zGi$CN42>3|WDC36$h6@;CU9w5@>KKgywZWB>ZJScneZ~cXw;`P71hbLaO`kFw1u)Z$)n)P|tQJ3P1b9qX{x(U6<73b^OI}Xg2 z|0qm;t6EA5F|L-a5~lZhA#!n=w(VQjS-t|j>PVg}{sAWK;D+3Z0glfRvGFlOv}(&c zqR%u~PxvxFU@}VM3iMrDF7W95{FLX8c zg*m&~JGSKCbj#-AkU`8`ZpCl>aa78XC4tN4NLC5vh~}4>qhH*dnLPpu6LE^gy?r;+ z{hb9^InIN9D@X8gjlY%3{`3Cbw!r{F&nAk9E}m_c@ZbYmW<5ag-OfzTBP+OgKi1Y4p|IDsHwN5lqz2{*vZH0<@t z9w`n+%&~^d*eK>vfE;I}Yz8!uX>|XOM*csn{y#UMRTuVXhd4CdkuRw67jmNc1Pr_* zxfKJQ1BdOz5~oq<1Tg$BiyV^ds1e`hjPS{j!+-yRX9)Lfe~{Y#(CdMs8;XgTY3dPy zVp+so6-8!_lYpHdk5r54fk+VvtWGC<9A&w%-PT++_JI)IRTb4|3Pfof`FzR$!r_>H z!Qg*!rUBu}b6**0d?5dKAY$#60dqbevRT1 zXm6ljE+PUdWUhvWY@;f)V@R{nbF7h1%BIsOUoh zp1a+qW;M%J_u`tH@8=r1+|cKU$^Ciolf>vq*`4!a&nS-Oxc*oO807fSFhM7|bT&>d zVf=QjJ;A}(C{&lumOwS!Bt)cn!%C~B?kW2^b4c|~ke7}{$@k{BryApR4)kjsGEOGV z^$$dsRf~pyFZ~|>Q$E8XFTG+K9YPaEvALQ~3ko6Ifp7F)hdclR;grPlL{={F+y3D+ z{vCv*=0JlgG~4$uL|XK>AN>#7hPqs6>;S5o(-2EwXxhp7JGBn(T5)dd zY|<$v1IlJM&K*>hRyk8uQl5gP%EP&RZwx1RD?D?g`Csx8654kxyz;-_$6H_9Etw~i zljE02VR5=;npHE-lWHUhGUwmJ+R?JurJ%^v09j@2YImgqGc}Tp{fpAl);<2awtpCAHRE^JCdP%Dv`uqdGCU;Ip5OK~cVc93W$s;mp`*L=ram_3v5m_3 z;n?3U_}VO2SeeStM{T)=Myp2>4!z};g7J1Tg z?Au!wQ=31()1IGrd;@pv2H{g3$NFTG(o%avb0RxFcxe>dt}Q&#jF%4=6c6R-eTEm5 zS0N71-Sf{(+Z2$YYso3GV1JNG-Ix|WHm-D7_GxZrE??krI{b)?j@Z+q0U5;~($0J2 zkiM+m>weV8;(y7_P5%MRu#iQ<9(-)bbDh(+lBXY^2&|`5Hp!_PlKngxbpPzrNv*cr zSJNtWCzr&ee4Co%OBmA|d2+AV5!m{T1&q_#b&Y8;IOLqa6gCu+ZOry-XN?j$vyrmd zP)W-Wxtx;%vdnAs1tqdp!PyIgSKi32(>*7}d@qp|(5o=bp%0|1F$&AjjPXgrXECBVS|BBIJggyFZI<`$E*mg3Pn*T#lOhsim9o2i2TSkm`e^AeXul z#RSFjEAsM5`kc{P`CNt~D^FTmdG+L_`E6g%c2A|I;N+?kACi_2TeH$NeG6xC0bcLzD*m$BGzZ;k5~ zvW?msF|Ay${wUPT?oFG--4d6%X_TGFG2f7V41Y!|YiveO&MH!PS4>fMmrQkbNsxL# z1;-oe{*g}p8f)sF$2K$m(w8h8h|!udLD!6Hs6({kj%p9b$Cq$=>sLh9?~(Vo@yuT4 z4^GUjp-$)dW_3AnrT&L4>5Y`Sylo+ zAcUMPLJQgch1I`T@NeS-vpLAs+vswHya{;}G7!*TX>BNNfuZ%NJwn4gXm%dWl7nYW z?^@WASRXF(*2l*P|ewVm0VOCb`gO2uS)=Pz#j33E1wN?liQpG#j@V#=Uz}L7& zX^VZ-{W@#9@2ULb{-p|sJyO#(G1shv-7pm5-Z|n_1N#d^T~lYT9_>4RU5T;bDUOO> z%t_+2z`?t^@6I=ys8x7f`?K8_?=I88HO(7PBKex)-ltDuKZFCX^BF#{uv+>sF>~D^ z$kXI>FCUjJB8HrK6yNi`H$cjC(T@VR-f_d2X&*aY|DiR@iGA9qI!Z#_4lLy|7Gz%E zV-dEswRq{8B->ThBnus_f{fC}os%P5IoDr}c-Fq=(cC>%wEGiPT(r-St@%#6zmUwh zWGaU}jZGVL?O*A4)d=fdEooDbCL|pwTS#PYZ0AUSg`>TDzg5gmuVS2GRrJ!-q70kx zc||7IY5%^gqKZ9I*OX%&@*VQzs$CC=<3#$#zI`q|BHlU>ogs3Z`j9bQ!b^Mo!lCza zjdfvs-`fSZID_ukZ+^RcD$bYT&^4a6BP(MGx#PHjMXP&Tx67|d>A&^JivH3$!>(a# zR`)<$uF_rE(vrh1fs3`G<{oW;$YcY%{`a1)+J#WQ^!KjP(s@$rT})Q=m$P#(y+ z+l1AV772GVEzZdivvE(X?yR!g+;$Is&g?toZQkx1Fiv3SH+G8DVK;p*67{C=eM6SPtPChHB9TJc|vpb z79J7aTU;N0`or_u4mTT?MehE-2udHtu-#sadxic5UYIaQ3lRzo0+un2#~%LQRsa4M zNTM`ryYd62SVWYb!V+R2ZMWT{fy{rsCji{P!w?2A{yz|yya{GSZ_ESuku@dI@GqGl zp|A!CP87*u3qmyy=0`LIF{`*_~dYdQz4|tCyqcB>rLLM;- z)btlX{|ZdOb;8IT^w%VD-Jlk+Sg4^OLRUZ8*8oEiwJ;7b>@p(SbqQ%oX2|ZPVK&N& zPj1Ig!N<|*2)!LsOIHU4t&kP{Kl(Q4CBu;wz#jSQ0BeXrKsy8So&p@a>Je!65+bs! z!ZK@x40wIW`(SO6zDvyclp*WNw9JX{Z7>=W86ggUO+mALs3HjjA<*Em9LykjJ;Hzc zzByGs!9DR%F)2bpk)#_#R)J4|OJ-z5Jm}NRc_>PR_*BqHc?ZqmzeehwrZ_6J>2d0d z2e&uT1sMl8?{aO(;iGw68{c`vJS-PS+_|PAN zmbZm!SElKtEzC?RnAe`sC?p^Cu6lJ6%;3$BPg+(EK8mb=+;!=gQ~#R8OL_A%7IJ%s zmZpqXSl^gKnL0v25hK#i$K94ZRus8{kIpYdV>Dc%i{(gPfc*wf{BC_q`A0iB8rI|ULn;g-3uC0I=ciXbjlH9hWKrFC z|9neaPsQdr%h22YPggqGnMJ=orNyUN^w}cRcy=1ys_{HqU<#?8#G z6yw3ZOuR%9VYcZ$&SE!qB-xSsoCf>i-ZAdW_Du>uGL@ZjYSs8yiE@^=Os2ke+g%hT z+?9DIUf!BXK_6>l8h_#L_^Mg@=(pVt_C@}ou(a{8R5}Uc>bEz)*U{5 zJ3L?VC2T}KzaISMxz9pR*sF16j!)({gJ%5NF=>@VQ^ndp$2>1 zQxjunkMej<>Hel$O&vmY?#c4%Ne_}jignHDZRWl9?NhkH=NB*Y;T-#buk2iR*3Fl4 zpiruzXA|mmt-Hch~;V6TpRrPHJY_ zPU)CUDOhlAkLz-53whx;(5PM-l zUPn&DlE7l2<$vg2|FD1%lV(|5(Kj0lsP)evaFj2FNG+=lQCLS@6+L~x{dD=d$-JMs z;31EY_kDfwIULmz--`6hv_+l?G_QzP-)51mSX000_K^oaQdrLN|B?0kw`?;S>3zTctZe5Y7Pj2fF^f@1z;34*Ec=m>%GZa+nikf>9 z$Hh(jm+e~FBPn&VvnVAzig=rb_wp1K@pLM6UpQ%VX16iiZMsofB=zhV*{C;`MyXQ1vCxQWGxo zsCey{45+Q37+(yg>UaN`AYKidXu~sYm5%7w^Lx|M$eXPUa>_b7d?h!3+P8_h z7~DsigoKfJ1rr{)fQF;C0fC7mFQ4R=X}2n*X8Yj#5F_5040CpSe+XcQA!5xXVieT4 z)h;)k9gNsC*z7Z=zRb-XdQ@H6zCO=L09WPZB)Gc(DJ;j`ZBCq)ZT86TU>747YIXno zqnEQk*A>~rL(HH_t;fr-HI^Ri$8g8DhQ(b2m1Tph-W&KOz;nP6206&O!@@GsDDOA9AIGVwA0xN z2YEM~yoL}nRND{`zyAGQ|1TTR!jL}^?jmkGf#(4wtwS$vLCHUs6Y4Pnm6xF)XoFyj z3g6o(!u4WV4pyKjFK{`QKXDR;^9lYMD+tAaMh3wV>;axK)aP70lqi4>b^-Ipf>dYU z`k=L=S(ti^1bHVZ>apDGN&sS4KH&t9oqlE3-pT@JTv;}fHb(Ekx@H= z?Skk90R$}M|Ia+DtU8!Eqz=>-jfYC?|va6t%E(Ulju$BKCE1*-w)@Y?Z3kn4_g3+Nb18TYf`XLDvM*0i5 zK-5(Mm>~l_yD(7y;Zlrdcqyx5WgY_`c~C#XB!**#RXTJD)lHb03nI$%9%X{Z;l2Ks zauN@?1@sjH`=7};d{B^aDcUGc#(^-NkQ8`xmaZ=1fj(NNz|eLKG+j$6sonK?VV{oHyzWNBQ1C0h5SPl(>svUF#2cG$Dn zRQ#mQtmk8q@#dmgP`ubDujM-!)H+eotsM*Im7XU2HSVx_wNPkPiP!RosQh zF0W5j4hv<6v*DWGsMMXy&L~3`&wFPP*jK5KAT|}xTc@iTu&bVHLo(z-Vb-T{i&IC*7oaCj(iUd$0u7Wt*;Dm{LX?1XJmrKvp6))|2nKsyj$#`ryu5wG!+(jpvSKrGpYaizQ!#Ap+;%LNCWxuR}U075smWJM8+WaI-$>{0u z$Cx=UgT)-t7$D+&jwh?GFV(Ak8JF7Bg9UF+4~AH%n&@uN`Q910AfEntRz8Dxr9%bL z!3HyTdUbHckofT<7Z!%aypNMZ-0Cv4xwvs}*LUq-gi)Q1RLo)XykGnhb>HynN<+w3 zIv(x%FRwG?%6xc*Di9w$G{1&Ycckqwebj$T5aAW)%{7FPG2ICbdMpXC*u~4{?o)23 zwnKWPMp^pWWH^Vd*JlLm5DQR$<`%o>9lPX$T*D*p?PHvmB)zmb$XNdTvi5@UV*}L> z6d`L=x_XTf98#3&=3+`OpMJP}^)%_%QJI1qk@-O6eZw`2pVUp#su>8!at2MaC9Pqn z$SwVx;+X|lWwkhEmKdr3U3idcq#Uz=kL2ip=V1PX)Yaf>UXw`E8AtPyvW$=wkEW69 zr5?P{(DS?p1M+OJ)$O=XPqvtQC=r^?yCzJhWzo4=a8g!I1BwU|sniDQ9Gx+WRm^Py z?&~2DgF9QE{I}SwCcfKVi?E_va=B?qpI1?AX*xXd*@2IT58lJgZ=IOuxp?FRzoTQe zbo{jMkS?HRc(qV$;HT$mz(NAN2Y^ z#|7=#<+R1x%*U&|p}H001=pnx>l7H6bZIz}_D-98~nWppq`|;y=+KD#9_zUvfYtbQpq^ zBm@O&a2~AFzH|2ut3H!uP^Efx7&3Po z%TqI~S@w=(RJ04Dt|9mQm5-jS6jd*PkzYerdgCKITciVXTDxqL49wE+L7_-smfgCf zRE#x((px+!+}V?|!~9S!$5#Gn(KUo&u&~MPtL+Rg60=-*EV);k+Vk%v5VfWn34Gqy z4zKhKn5DPy|K*+>#TBS#rIV}DirrR~jC{?mtjUmEqhXmXHDO>N#v?ZDUj{m}5e-m? zQQBmUU`opLyLE-1@}`yy<%hR?--A-E!J5s!9tQ2Sew7ot_8cKkb3bx^vfCusbK>cn zA+0iPo_x1qxjZBo_9#WhOb_W?6JG5YuRK;z&uF& zRUPX|h$@^A`N=>g%Xw8O_qNcgcKZ(FL{jb0bWjpRW?v&pZ<534I>CfU!^F|RP|L#B zgUZVGCM4ZtW-k#3!@?|s$|GS9bNR@n3Pg~Q5o;TzSDLvweAQ6WF~W3`Bj7Q$nStG| zLk46$y#oPW7+@{tO$tZX&7!Fb zR1bi^u-aeu{{OuJrRhT@NiVn`47d}(Y{w{|21 zBrkQWFtb3O*KFk2y7v$tasWJ&QRuS}NC8k-_d+v(Itn!kO37V|hj7V2&}CeJAG!d- zz^4_p3woRYnq8n#lwAD3BjbDt-_S;CD&WZ>s}4Lq3TNU?#{hgoEfpE-79p=&t})@I z;DlHtn0C*@aYCqp>=3;4=fW=h^}%3Re{V%=^Tq%@1h6o;2x#nw#>J@7q0nX?R<8)e zq89WmK)Ei9|6_Erit4)Ke-0mXp{9q>gVx{g2_f_O;=ZqmLIfoIR~IiahJ}rU`h|c- zC+ktJ*N!m8SRkPN=?zRpz;B^*P7pqb2%n6*fDfZQQ=Ys(52T$6qoJQifbm#=QGNuN zzNfK(o+=qQI8h|8)m@qGJ;S=A*rQyfELVVU7Wfq4nmoT!iuv~UL_oQmT#uAO?6t@e zMkCl0PN78JeO2wLR^r%3z-LL#OAwmNgeBp}?SFHUzN>HcVn3#CV7JDG_vxLF!CFMx zhJ0@|u5oikzIO=O>zG-LOQ6`LR^;`OWZKI;dHtRVc}Is)v^UPcs{6~?rtXlz#Oa+` zgKT$XM1GnlZyMu}ii^>c*UdIA3`;izYU3OX-+keDEg|Qxn-jaayH|d5bU2vds*t5h z5|P11f{+-p6GC{;;^2ulhpM9$AMG^9$?ZhD*eFlm-Kf?SU0WP2ns**tmh-_i!@()d zCDbX%TO&{n!j4cg{K~H-5;cXllN0Z(AbqBa z_Etu}eEvLq$iO2dh?}SOWx?A=J)f`rihcQG@zt1JbZ+>MqxHGc%G=R*MEf}I7V5FQ z(U~Hu4qs;Tl_sOo#Mjx!S-%%XNSK&4y5AH(;9qPNYFGii?pbyo-azbxKf<|mJMe=G zN9GcOqiwT8h}QcfiDUEc2@E z@UzOTEVp``4$k>i70L6Kl~o*l=Tc``ClGk^hBZRiyD)%Ng&pL7D7B)zSj$86C zO_e~ADUVK-r}E^4G}%7{sgw8l6>Wq^XqO?7{ORx##%;oc$})}vA8s9=mMEDYk>{k@ zWjv=9`{w%0tpYbBmajkh5yjRTe8O)R$H%X)Se)ujoKxGF3(nSrS% z?qRti{LYl?c31%W7NbP0xp>{ z=0U0?4_zvL$aVY}cD2CT^|7yAi^jDUk7%Bn)TCHXMIf*8Y$A5tJs~N}!GUVNrkk?U zZ$Ace#QKBizxf+N?8waJK^{*sX_@OGof|M8>A*1A{ylQAMdFY&;Kp6hfwy60<ZHhoPMW<)w22-rP^;=N{TH!K3IC#mqBl_eoxXZ8Tu*6oPl4IWJw`1Z*{ab zVASnKIqP3NGO=ARG#Vq0cV)9gR6}1{k;%~2HLQZHcXAP@Pdr$TR zv$Hd=8FfY<0d&GglNsCU>VxSNr5{Aq7!NqKuhmWm>Lu)_c1yb*lyypB6XH;(l@Mf0vA~%6{%Bm1@oE>)u9}^aBWXQ zi|%UieZ{_f#ek*WW@*dcX8I%eHt|gY{-z>7FC(;eDO( zXgW4%VUe5|TFbDy3K6lU_$&4SE{9Mx4+QUjhN}M^8KC`;17|M+8B-z9JP@IXQrj)H z!?7XaCIQ`E=PR;(lE6ivWF_!PJbt>Hd!hN%mg8wva*)#EOt>) z*$(lqf>K4^`KU$b4Ynhkgd#F;mc*cYF8*IcLc29!#)~ndNhvKF8k)@|$o0H?3XNLr z#mnPegLkg=MN2k!6w73E$J{in7#Yf+dgOeE4D_|9o}(}NIgLTM<+1N2nuT8}&C@*u zbGX8X!!!1dZH3>XBc!WfTT8_ugx=zNvTM7e7EHG}Z|HKt*l$RSXUYG~rPNtK(H%IExj=-1)+1hbUKO=-3JIDh zcEKKT-(9amo3dVwDh=m4zDanMi!4iAb-hkyz4)!38$}1?^E2J$z9qUtXXzPy=>a8- z8r*Dn+fxxItO_5e$l#>;k=%E`Ja?X^bC@Tt-@WYJ7>k2sLE=2%uX|zi@=5+MJ@Zyc zX0ET!P7`OE2`3++9--clvWDtt^RiO)*sh%*QR|&Wv$0)9uXJ)`C_al%$MG87oxAtB z3T8ZU24?#{j&r4ul$!^fCQ*kbHc15fsUk2wcC2^y1jMrrb&H>6@WqbitGad+XT!Pm zlC9Gq+wuycOAmYN20gDBv^$GlHo&~XfTGbbfJOi~0sI$`i~(eRpa@T_(=%ikqQAx> zt%w29BV&}i0cbrUh#;Wztk4EGnB!yrA~OGaPX6$m{}Vf}V4!L_QN<^y2WSOVK94qr z1K<{jaa=Ll-7(?;JPbkGxm`f;zux>8T>S6A92^dnv;fKnAn%dBqbNEobvaM*NF9eg zF?!=cVv0w_!s+ZfMxSq&r}GN7yFRFLVWL!2*YC7Z43xTn$5J4hi>{Obo&_M$iN=~P z{fftbFLwXu8U5R^Kn~P%bbL=;0Am;@C(pBAfQPZxM1Q{)n8&Svs|*Tf9R3AgA#lJm z3PR`>)toen+>lwy>O60Ua4GLN^|c1|yKd4Cr8V;PIEzxlnQA9&cp78i z%jf}!s}@jD7>o|B@c?ql9z}2ho&V+H|JzW(5f1gM@>U=4sy5UZ0s z@<;9PaR{QEmnRmnKu9Ep$BytF$*5txe5XMja&p83d>1hMNiZ@Yka9=^ouT(;c>H+x zSYfCpx=*e@Nhpv$p?n#D)`Seqn1HF>+3Sahh(N3XL5_ygc)uqbk;BdBNlloHimW6Y zn`TN&IK=R^WbbGAl}?71#Kodr*R?gJSw)7gVe5+Rw;?-I4H?`iGgvUgin4gjSvjzR zdVQVS?>|4MrnM~={UNpb&LBc6;D^*tdH;AL1QJ#yl@VZF`#sh0MeAb^{^tP`O-}NQ zR^$55WC!`*c?ycI>lUV@gpA{GMW9qA`W;V|`7raszdG+}8or{q8t+m6My{2kCiw6Gh+~?Y9cfN1H z>~o*n85pF)V~UHr2n1=UaH5ZRLS+1719zzXH*YYOk0SA6TEf!wFB2MQQN~>!!9hw7 zY_ddD<`or%7bR3Y!HCL*vVOY}vNoKpRypoaB6@$#BsC*5=|)ks7N>!eyVqHF;vupq z#3&of3ob}jk}C8gnK@pD!;!O~pt7f}%Dkmu{&~XUdXep7!B1AaxVm9lF-r|U5%cZl zkc0&BQSX_4?LrTNcu7%RGu4NrAFik27?22*o8CY+V%QgjT*LkvBl&W4wo&q0iH(OZ zU)>X&DElo=Iw)*!;w>+ZSr`MP)FKO0acPctwZ*HU(!i)BBcZU^*6g6=GcoY=gTe9= z-+jh%@tKiU3@;|{dfXLRnnE$@MY-P*ac87GKimsmcB`GxXSs-EFTb7$merJoX^U%VQO6eseNlVtDF(Qwm9;Yf;^#z7M4D@_39d3+* zAs1FP>4I^WrOfCZzce5dlEnF#kJf^1G_<5YC*vALF+sk1@ptP9JCP7B@RvUGZ@lNF zYct_P%{grn>*7IDGycHt-pLhBU&1W5pKD>%I!%XWzadOtBC{Xf9y#XuKC1BHNe(`ggDg-2wFdnd^E7Y zGP`$@$a#J87rkc%k*a7+Oq8aU&NYd(XwN<{gxxjWXTpPt@7w0{ z7wpumLgk7bC@ik4jdCyArxqMvFGz777!l zaew+ScI)^iJ$vYbX?9DbEHu@pt4@5eJS){onSl`St~0QFTZGWrJ(mUX``5|Z7S0hF zwYQbs#`!1G3oI!;Z?c~G;fyuzKfvw(K$E^%ip+M-(dzEDrUd1vkTJ%;5@!&c^$=kH z1DbuHx_)6ou!%bVLzjf^I0C{F>h~W@0SpXC;TXmWYur+lhZozjGm9f7&ur|#w>ir1 zg>(nJhH0IX$6AgejpdK-eMU~d^H-ojo+vjh!{K{W6oTW6Rl^OOqHo|D+OzzrFoU4H ztS4Vy9ZpdAFlMvu7GFufPmx`Pxn9oc5D>4IkQ*v7M*ISwd3z@e2@ABcF3_LYt;$fm zlt(J&O%|#yll+7+Bh9HJVfVGd=sDac3xP<$Q#pMa&bv>=d^h`-{VS=k`oc5>{;OUq z=EP2kMHBuTBW*VPu7b7i;VE#{^DDGF-Ldjq2R1s;w{ud{OU^U+8j`byPabPL&pqC% z?sB3&&YnUHl~atgd@4?gw1o3R4N~fnoW2q`w>X#!WO9J!Q&wWnWJ*syS7(MXE87ea zNryWtaafrXL(>$q<8R1bvEiv3o<8?`y6VmkXIss-v=UxX*mhx3XX~WB|NC}xMJU+U+J=c^?jba2~-Af2I%@eH; zK18lnsYB6iRYc~mf;Ke{D`uEBdc2v>Mct}6h2NNETbDKRZgBIMnJcV~U4s(Lx_psr zCzvD~A1H;sG)y7%H7!9Heo{Gf;B(m{(awtvUzlx9_`#_HQzMW*v3X%Q?3rBV>43vZ zt!BJvmQrn-pRjD6JUPMDn`j^3EbLqei*ySr?183sGybH&R{{lEc79QA1f}&@_8{R7t z@l2pR2^ch&prnHC5Ya_6$VIswAFSsAEgzcw1xlJRlv6PZvZ2I$W?+L_5E(Q%J0Z76a1HH-tAjMOPV2}ErVucly5bpxi0n+-S4Z?+?B#=2Q$UALj zw4r6Zwe~eK=GRU zHmbz$uPpz6U|FzV)+N3^DIX?|tS)u^+Dk0k!7EZ!MYNEf;uT=#@n+SSm|n|qtg&xF z1kn{fhOLen!W%!QM`tYs1Rz*W5HK15lmFHc{KqH!=Z0`dAbK?qh~{f~U{>3eXOdM1 zJUKYGzlZ=7qmG*F#=A?Zn1G#yOdwdepspyyt^|k?fQuREYz7*6YXV^bhP7kJ3XUES z7Lcmzp}xeO&LY%^Fi~O$a9;pa4+ByOTAleba=eG5Mbn1ry=)+%nLBaVFQ}eb4$8c-|#H=u2~S zul2DD>A=m9D{0PCNF{4QRz)6$2#A{yN!}Nk?u1n;Kjb#&N5PY8W?hDniUf%W3~5*F zHrshB<5)lMp#sBaI28G|+9s;{Od~^wv`D$^@+1VzRW%l$t@nPHApG(7552($Cs6`h zh5UvAygH_74h?>!9*rfpbl%C3Hv8OuFZ*8VU3Np3d}P^YmGq4UevjguOuM}C{oWQwCQp#JKkdzU`q-&V_k%Q!9keuQ>1&$eq z;pdo4C~?L(4|@xFEiV(5U=e4IwD_Qx;C1mBq@zL2XXNN>?bIo$tkb_EAqyO8)R7jEIjwXaHG)^>Zd#rz2hR>~Yg?%LNT^(Tx;_3g@dvBb!G_;^ zxo!bTfrTX~r8g^d?yh1xf2Y%j_>3!M{yN!8M(4q^#ff6;aHMwrq86gi@KS^%oo>O< z`(GkYN!D+RzGcv2+S(C29piC^U%uD$?8kw6wnWS2#lxe|vPVx}EwfY2&?c3#BhCpI zxHbv(dF5ALs`WTR=63u887X2rmS0Av(JmCG{M>V&4mlTtby7VoQ|s;AVF*5^*`ppB zAaU&eA=5oc*I>XA?`CZ@r`Fz!Q+*zcgcPpbkgkfB7=Pp}$g3;KDHKtYk)i3#%ePg; zI-GEAG=ZX~9fC`-0jwB)k(YGfn=2_E5}zDy%-(K$_cMnLSDW|C_YJK`<2a(%jVDXg zjgl=NUnt)kfsiJUV_HxI6I8^xlx0Zi=4RzuZ6sH3gb;iSVO3abBebwPbd+*aT=G05 zKL2*~xi3~=A3iG-XJiQ0(|2I~x$Os2>)2j#VmdO~Zh z(Q^{iF%dRPLg%WV&L@xfu!%P)1z#BBS)lkT!%}O}CZ^LWnZ3nhMr7u|$Q|<~io9p`Um~ginCLRe7D2LZEy70O=!|rJzw4W#NNGM4g zyHX)?p!do?$tpKyH#BCOiS#VcrNeTZmG|(u-ZT?8p z9oWT;FJcMF(+jk4_Lv}|I3vcIb}qm15rGKe;m&Owv1oce|I+|@P&aeD8)PokwU#Y? z-6Y98La33^jFHf$mjc7eD9`@8v?lM%9wCzSsMd)*8{Rl^1g=&^ic{X-D$pQ09Hb)A|yNuMx%RSY^|{ z^*&v!O2o=li_{L*wpk3*$z)eN%zHjI7oEt|M|-X{DsKQ!qln-n0N<(Jkzd4A@|KW# z#Ojntk1Ww?)UcD6m_X6elD%;!kN+=`H3mm0JBh^VRvDD#XJJs_75wewSCPxMu8szy zjVt<^Ep#}eXD>MR?_C;zF`LQr5@x3PNf3q!nPY}V)d2HNE|8&L<+Z^P0Obcl5A9A#Kk2+T{vJD1Dr}BY%=a(Fd<-| zbk<-T*rR&VcFj~l0@S`C!#LS_%J*<00Qw`82RID{*Z?fd!4secZ}1%*leSCs1gB-X zAP?Sw%|%3rJKmkw`8TNf@59IH*Fe#GV>F<85|m>`=_b2`*Euaf^D*N>I^D0WVD*7a zI>Z(xj4_Fs6~P|Kw&cBHQHv4LqnwZ$hf5{#H;4J>(@=_7F!=zAR1pxERiM}$_2ED% zx^N*{fGmt*9ITf((XQyx#N%Kw5z2$}0_LP+CV8Mq$c4r1SYZ^{@gMgTB=Dk~L`wz` zyeJrIS4yfJk778%so3WY~_XOz~M=_ zoFT7$-A$3oCv6X&$UGb{RLz`wKMBiZuo{qcJzg zLTw5ZXJj*FB+g>4{u=dGpWycV(?Rjqa-OH!QJxUB&_^vUUS9uUkYP$cFS6$ru9Tyk#yC8IR5 zE_*OSx3W}*xocux)--`Aa?08dz9A?(2QObTtokT2TvhQNikqvqxi9X?_f~6?Q$D|w zV%XQTc5f_1k|RfMgv#C6eL2?@VR-PeXp675DXC(UusJ-`T3eR9HAyXf#u)M7SpNsx zgKKpp+INP!#JL0-pWMC5ZDN&39~WOJt6S3B^h@n>-d287cU5@v!?L+%6-OYU2*x;U&O2~$z^||KLSKqFz5{wC(;gmlTuHZ8!kR_s} zmc_ejqshiN#%>y&%rp^ym%#rJK_9|J%pLQINJ>@RMbNtM{B=dW@{qia9G!~pyynNS1`xPz(Vb1=tH z2}hum0e_;pFcX3TYdLEff0XCt4$5c?qUene5g~&}TVr+JxQ}9F*!>tYKWGn?ewRvy}om6{W~+PAfLz5)X}f4Hpkz2@jcdmXEd5;aqq)f7cH`7QB&^m zs2?qKF%4QDrlxn+TtphcV%7KS3unI5t*O%e0r97ITsg>$A)nsQo`L=m=^@n%wid+1 z)9xgFi%${wFg&7W=gC9X8)Zl>95JIZ`rWJ?@0|yk%Cqcow+xFpc1kJnO&s`}+K@`7 z?P5!@XX-pqsi_Q!-D{G&a86Ems3T=&?>l_O<>mCx*=A&>GRaJwn~N1ss$$TR1$Te=d5DhHhEfutEm*_*^OhVupx%b8^aL_ zij51^vETM>dRtQE)2&(}@|xI?3JVCN#N_M_(5h&%>EztwM;Z zX7l9H3O}#Q47?oQ%#|e~Vt&41RF5PUfkrNwjTwiF5l-hc@q|GQi9aRC4$993xJvr^ z@cZCMOG<5&BVuBF7nKo;Fe+C;YhM;OwXdIIG!ru=cHaas9MvF_8rfx@LDjtDI*u7C z1P5zpHBzJF)-`4=Qd1FEuez8I+H)unRvxy^Ims~OG{;~GG7V`}WMq8c2}>ipx{Yf$ zmKB`8-Y!UdwN+>{_E9MZzFu<8BfYYXR$Ij8SkV*0n2B}U%g+;M=+cX1=6v2;j1$-F zj_n#GJTdTI3ehd-*Mc+lzultPkbg|y_mtdJgiYfen0OoUFv&q03n0yZScv>-YzUlG zK|}@)Kk-|teYbk3F{c(ZUgcR7+9Dou-UoiBQVg%mdpoK{uPGQI;&(4oC z|H2BjsC5M3HV%O8(#Zi6A?~q>9+~MRAgDyp92ID-0%9?$DJ5WeK;Q=YLjjC-G*N{5 zLU+2sAFE?5SYrt&Mdby@1(L*h;QWC=v-6Ki5q$Z1@=Q|bivngo2y-aL_8RIALT>}N z(FN9uXS)7-rk>A=n>L{)b!Z}d=?+_GVheqax=EFt^L!cKt8aZ4{xx4|HOGfCs73NM z#zmMUIdNZMF=3{@dO>i*p_^ASZ7-=CANralyll2wL4q6}>Z+E-I_pSpXXNUmoRZEs zW06HSRu9!lC=e1}!}z8$8Q*35RVcaMyW_4!!_aiUrP&PJrL;alvpH>o-#=WdZ_req z+IjsK>(SXvDKf(bv&nteNKgZD$g8y(LV;Vn^_6DF=?&HE8 z%vp9G7Bg%+#GsFnfN%VgT5~#}S}+fj*l1vr*hs?duA7;MO@BJ#G|D*2lvgQ$>nt^- zh;L`2b32)2*s)bU+>1$0S|c^jAU!Dwr@0;vW?X3F2!=;ayoI1WbT zJ3DE z);%(nJS6zBOU5kclg_kWy7<66b#d_QAPL0 za(r;)<_vz)H~!w##7vV=S5ZK)uA|OTr1wipJw!INQYt*__IS+WB*rk=w;%11i>H3ZT}zos_AT!%R!L+XHbqRxLt3b+OySK-9nVCNbc~ZFHj+jh z%0A*9`3aiPQb7qz?+Tt;deb)hLM!?o>x2?W~j+bfs=KYW2UNG?Wdi~^je z=<2T@(rrI!_W76Cm}r|HR!+X+`VE;1efW|Zq#{+nGkwJmtGuP~aKm{y`Qfhm!{sQ+ zhXvAy*nfa>|f+>;2;ES0}7mKew-Tyi)znc>faFckBM8tm0v*Pmh<(0}zF+t>4tk-07?| zR6F2wBgYeSNK9c3MKDDHGqX7a&r2?uw1!{r>X3d&!ut(`F@xgamTYZfwhxlQSLnL^y43~S-cV(m+cU0ce87#R% zp2Zh`I1VMa<8bC!L|?0S?|$)m*~<{wvw*Hq0<)#U_!p5G@aHh2JCEYaaO4+@;$CE( zFpF?_zF8R-uOBqGK}duZTup&cKwqv;oOj~((bZgyn>d4o!lLyFnq!(03h$B09Fgcn z)rMs!rSK;Q7x_ zM``m>z+VKV>Ichb5bQ%y>tNtF0kR35A^4DER1yK5&H}H~LLM_AJ>>6ZA1FNI=)Rkn z?OklsMW9#Pg1JESrCpMB?r9Y99?1*`g{8BOy)?yTmjsy|Olc0`&; z65x!siP^wXW`KsVuvoEWlZiA}3h(g|1e-tP(p?L_c-qGYOj0hqeh~zss9ZG|BknO{ z;cQsfQ!65A;FOOkvxHQCbj5hZ{VyG&|a7f>WU2N zt`N`$^;%&bgnTk&K?*eXM5P6>ArF7g){QXm4Hdh|u?ByZJ|T=uocje8m8(Hobpel5^Ou4fr2;Bp`!zySg1$ zo~#uNV<>wK3&`E{5qy!Oa|jjZUXx>$z~$TIyr!vZq7Svirwgr*62Y(z_QrGC_4bTx zV?G`mgbrWhE9p`>5N{vdf@Z-&cv(!apAt7kttR^gM{bh8%|U2Aevt%&A@Zr^7rB-4 zenZ08W2HZfRXkIs*iB8Nl}=bAPR$W;4UBb@kZ7b)lriKRDxrljVJ#%(rI;{QU|R~6 zbn>{QZanhv5A36togn@+YEZ`Q)p`=qb0cozDyGp$)VXpVsUkctLUk;L;BlbQ7jwF& z9)erHn!V28pW|PR;XTD2 zjk`dU={spNrLv7(WefK&xA(uuM)l_?d%K^RL=I|9!fY_(93j~FknPFj<+ERUeO4+7 zba&yM>?bL|Jf708{f5N+xV`24@slh~w6WYHD?lsyAB66`w)Rio#({k=|8gB6B@%(+@)T6HG8t zWxP*KHbVf-8db&AP=aP>CuiarA?mte*zPN$ofmmwh)AEC%C~^TmY8>G@T7rTpJf$g^RX6kL15~MEZ+P+3!i->XQ8UkPs|*J4*V08B?JK=Zl4v>& ze@D3GS7DI!*v!Hm*;r|DyH}z`g1iqOzB^657hi5VoG0;f(S(Muw&S+odf0B*(5I4N zE!Ri)cgM{7zAFvj(Ys}TqE8hYMKIc#|e z?Ll}1oWHx3z_hQZzXzP3#W261EdC7f3bB zuvAQ!mEFlK*B)lG+`&e)CaQLp`E1u~90i-!R|>!DNI2h*%{a%T1OVK_hjI2E$H1(~@YU`R$fraEYyh4I8 zh4NCd12MG)H7kM9f;+=cjy0V2Kpw*ctXGEHcg7*dmu-5`jnOrDC=s@85RUMt~yrOTf{-+;;m0GfA2H7Qf5Z-uKy=$P(9Ifid=ZtnM<)Y7SV3uaQD&#;V1gnwuzFDW ze!zBsu4@;810A=~e+3_ldIbbl6k_;8PN04P;Q{K+=>5@$!UfS24JrVV0E9K@PvZ*2 zBKQIz!YTm)3C5qoMhNg&ZHIt=hwKmp8QXCu%WD@JXk6Wd2CG=@GHA-|%l7N6iZMoi z^nKX>#O|&$#6B2Fw&(a2`XZW=fc1ndzxMcotTB`61mi#%*ZgJdfC;*AccG{nRA9eY z*I%3^b~I|_fFS@U0iq^~#J_+i-~`ZO6)+|+c5uyk@OKvQ{Ly`@04>0R&YkRa;z|L| z{$nTZF$4hpPS6nt^Rg3UfH7Wwk%aN01t_)smX(xm_ni>P8wl;tdZXtEp`o{CTskW4 zV+{&4`Ys3w$_pysk3juo1vF8^*h5o4VD|YVG698v_wbIVJ_XZR6SP(4l?nxbVxNPbk8A zRmLFQ>Y1RxZc=NMaqD2x+~MbEGlOF$oOA~F7>?+w+3vc{@)_Q?iATtKJ5Jn` zc|1=^hP2T%9V@vOBhe~ru8%Jh2**@5&qO9oIunjdN@%`3=*W7;-|wV3bB7Pc1buYS z>cjE;{hQ#RRQbIxVWq3NnO*!kA3QiyFx{fmV5B)U?R?>N*P|`8UnKGjO>n)34!f`& z_~DNTw@SzmxnL^U#i|t)8)7eub<*hXeVS8ARDs=5Dj`gAMS&S{GQ;R%(^2pn64kV!Gg`$l_pVk> zHgAb?eTMPT@|c^8t(t+!0RE?2N3o1Ic;nW{$bPi^hERV!7j=CB>OpvCsNEMGB%n`s zD?Y^+#>M>**Qdz4ay)tEbE{tRqrSen$;fk@^}LbGx2Aao_M*Q|EKFs63r}Lz%r3Zg z^X=@^W39=n+GVXVLoTsUGXgz6? zJS$*kC?Pv9oF@dn)2^Dx#rDp5hTe7r8-=kMDB`JSShKSudaT`vO_x+STBDM}OSL=R zB?g%ivAF3rFC*6ngG*xUa+j}IzTv`iGD)N=DhfOX>>i`_5pYV4hDnh-zcAW<$m1#3 zGm!L+`Z^b`C)5H&VxiO+0raX^?7ZNO|+f=R)nKf$Cuc^BJpK-gNS!atO;Rw@~$W8@Im zli6KL1pD%xA4@NPY%%{hG$OiESR8ngG;v@m4cmE?{rost>9+|80|H(Sjx7zcA_>-# z$MfZ^-%F{ujSa=#@v-gVl{GiFfI{}7@-XD#n(S*OKe)Li-{CWIk9?50G$_m6gv7xvQiP-HSev`A4MLMA*j`d|Ea)!l*6nV(JtT`u~qdotG z=d_M%pA6>VBm$fPVkssYUlhn$WmGOr__L=uyziQUsdgUAeEB(Mk|}1haP^){+G7iY z{9aC_CbN09Ur`#)hu(hMZ(GWi$~l^;62dC(G&K=6XEN8#d7Z_iv3}E=0ZN1U+(r$0 zLIWm9tF;UcTF(jYHdHi0twdMJjtb4_Yx4gQ_LX5(bz8Wb?(Xgm>6Y&9M!LIEL6Gj;G)i}fGzf@v zONo@EAl(h(T^szqbI!d#?(^)2z4lyl<($m%j&~F!)dwKP06*0<&;S58fRcA0AYSWl zMAv^kFai+MB>m7YBo0q-?;j}g4-EKs;DKf9zp&in2>)}P z$G(qm>+k#t{4-gn{7fYMCpYa9f${x1=}l6>ShQAVY1V}pm@f>aJWPK;f1L*xpfqqY zO2VsDSgjWWH22!H(>0-(Xe^+n2*^U~C@smqG`yh|JK$}rR(0-51kcY-fQyWSz^AF^ z){qe?YAtL(19dc3xH#x&T!#m4~5|{UuO?MKPP-)oRGQaj03|xDZ8< z6wNX$ns;j(xXZf}s3XzOYn6kb{qr-eW|*kuzt37RdD=7Zv&&kVd`K;(VGQpRrlEM5JZ51bt2_7TOHKi?vVeDV0wfmY9-&%dy`Akg~q?FYHM zPm+EeiXYRwP)|oR(84gh`*kjn=IuXrhGN-iy)XV;mR0ykEQ)@|o_0D-wpdYVn`xMz zMk(c|lVubo4|bC~w~DHg05ZwwF5XqLm!`_)?_N1UCzulYRCerD+I)FXF3K*(A;+iu zih2u0D^CAK1{2;kT>fi9P4BA-C0%F5k<9e5$U10zjD*+M{^s^Zn3p^&8J7g5#kw#~ z)%F=uAr`4udV$cmVwmQ$d_LDI3b)Vcu4-U=`pmFug(&^=-F>L7it|5Yyi*y3CCrUV z{24CfQbv>mScbxZbF# zbyFkzfMTEJS}N%>`0n$Z)T-$Zl6nkY>Y!#)BsdA`9rc-eYGZ+xk%OeoZXWyZ3YUQU z`vLpx?C&Hdy?x2laQT%of4&O8oA-mgxSoLu^LIZJ$t=vK9Hlh)|2DN5Wcr_X2P)HOD(YC&JBE~nFXCxG%fXzV zHjV@xV|~%Kv3|a4UX>F@72L(8R3zUrQqHK6ouQA6FQ{E7an8B<=6kXykG>#s-A~(W zy2AO5G^X$|GVHH5@j1`4K&S!VUQrB_M`mK1!UYc3Xg$c6Jnxy$J#Yi!i3krFu5){J z5U21~2gDKod(DEZvj4-<{==FYKCS17|L9}P@%n(9=F9Zdxgwpy1g%|c*r zCwwK4<*1rh^XF*(hye;5N@ugeTttcx_)yukFq=|zDzCPqvMi?zS9tIM%F{ley z)%o~jG!dvvpMP%bzJwE`0My*ZWCik5IT^HzGt5fCQOPN*$ShYSTxi!BK)Warno=!L znW>fzWn{#3@js6*;p!)#t-6UwPYau>6jZqQ2 zmBaGJngPN&lZr1-IU3xvopg$hN8X(#rV=0?;t9ylK$$nzIB%lMOf02FDKltGogIc7 zDJG7%q(9H6(4W#-mRJ3*_`xf;9-~ivDJ;qzBft1L#~qzLG4&1a9EpGa&wgU${r%Cb zYO9u6kE$J=Ppz^Q3Nw{TIN!U;wCwEr$CwCu;;S9lam(9?0$2vPM=kP6Y;*%f zdjNtOP}ToKJ3u7jU%CJ&t@w=&b($mcKF|qDVt{2LJ>#JgM^k>a!5_{@>Q8xMrXb5m1v5c|Amd zSp$mFI2Q_Pio(6LaV7#yEPJS!8%JppN=E!;r8DS+9;S%sfW@>|U`ke>`Q`oeVR6&E zy@MpaP74z96-b!H^Lr73oLneboKmS*7i9w|2GLayAAHSfu9DL4MP0F{Ie__Sn<5R!iV#mnzlA^kkB(uN8qz;$eVO34mSxit_(L zevg0#z$%c+_K=A20bpGV!WschE@-z1pY+bKwu)o-~b7ygMUmJK?oox$h9GZZwTUCIR0noAXo!f1fU>r1`G0s?6KEh zQ1l3G{_P7O9H1X$q5${v2vQ)++utz;V9bXn@&aPo06xGZOM)~YK6Zy33js`z&kY%T zNPr7u5AeVXz|%dRc=?H`g0Ne_13r>c0DA&l>T#AL{F(Y#x93qdI3gXy0BwI2x+aT2{xh|()k*zQ zI8phCjg6~V09?uhXMmT^!Ql1o3$Zk5?ZkEpl7r+}lWB&!Gdpb1Gw`A-i7P5P+2)`} zmZUb6A{b#HK-woXi={ME52ZR~cAKG1Ej^-J0KUa{AtWx@Qy`Uoc42*iyq4ZQ4mZ2J zi>GuG_r0Yul{q^lCaJ;^6N6iXrpmC31pHML#>uBcDrSm#!RD!HCA+s)`79DJ9bPc5 zG>A>16Nb>*#Y_XKLw0xujhMm%0saUPu|5p6Ow$_9w!3Mm(0L1y>NK45qMb%PP27?= zBo?w7BBK@BrNpc)GZW5mFBJ@R!BuaUU|(!q5!<7mV?QV4JXFdf$Z}8b=uJhPm#I!a zg8B^hp{A9$M-XIjGg6LH7v;wni;Tib#abZZF*9RzCUt)#~`S2aIg-^UgbZ202lWwCMKHZp$-py9S=HFL!tzJCx~i_`OVmTSS{CoT)$NO%~zu& z!teP8@x$5PbhFrz$G&e@uFHyPdijuvBe_~JRhu_eu{Bt;eq1>v^Xww-?GS+$(~)4~ zz$d?bzt{kyovGG8pyFK&)KAY|tUQy-r_t(9j`t)_DM$ll(H7WPaw_p}vgpb~Z4@}E zYIUrA>-*vnaLb-6rn=#=_VeaL^XUb_ULX6K4~ZvECb4+{l93V)GV4;wuDz;I_(LN@ z9xRhk0^-Mk6b;i9GQw>UxxDq#&<@c`DxTZ7O!k?fYz|GA@-vIoO%cmW{X8+TY0KDi zBp%hCI(81W>OsU3T+<=)|j8d1+G51-vJT+0Zr z(aqm-sl~>Yd&N!VZ%I((aEqXmH2fweAT7`AN$f+Pb1Q@HSr(QsD>GpREIxubu_+m} zfqhSOkLVac_e216&j|%U_muig(d)rK8an~!F^I1X!VfjQ)V52e5`h0^&egSZ5v-J)==S^52hevgguKB*w}$`~k)Mbhsv$mUv_D z`h0k><|63)d4QOgMq2knE*I@ovXjhU%N)S|eUzN6Yi0mKU^7z0*%{0lTi5|#7HxYw zK~e$F`oXf%Q4&l8Lq(bXVh|qGMn3*|{PXz22-aKdX50{qUCCrM6Q5I>viP_0dYH^U z4R*WCTaE1WAz9Xgs*)m-;b}`0jJ|Sf-+oCMHh-Wp6)7GYQ4T0DQb(%&8W6s?j2%B& z|F(2YC2T}3{tSUdsS%82KCRs4WZqA=&+48kQlr8Q%QQ2WZ|aBUd@r&QM;bZ3dh1^P ziDzM|Mk~Q?4Il8Py~A2_|2QQyQ8NC3QQd6#i+lKGdNFQgiG9JGSJA>YKb78+-@Umi z?_x_#eHmhf602x!B76lC{`Y)hd+4PN9G)HBfDbu)BaVWSD3L-ScCx@Hc~LT}1*CCxwDaiI_>!BGS*0ivo`Y`yMT~}b71emoA67z_uMyf} z$rbT}n? zen*c&iN02pAwJwpRWpI8pvpiO$xAs_`1Q#39T(qv-|BMsFE2XbNmWA?^mj+K)ko`c zH5I3LG-WS^??udio5XWl|9P@m9$lxEO?zo9DN9`T6m=K&|9 zCm9GSrL_hjSe{%8{}t5#NI;4<@c+u>e=hrIG69lsKN1a4Pyas<$tLxhgrJy2QDxYaJ|(JsQ{`ZC;H!^LDPp6KM_FU^uP6MeN7h*3eR zo~tHOK40Dk*SQ8iR)=(!mlpg2kF z!qWA!I{GPvmh6@OnD|9w=Bkwl=eia|5E+}i%zbH)=o>RIi! z{=AjfrmkQ{3C?Sle!2GnJjlx__6V&D~hX>0P_SBclLSCs>fEUJptT04o5NHIk z-#`ZGG1<=3=D(u>fvmtv^Eg}p_5uJ51Rend5sEk?inteQEvX0&)O7FD>hm}-PoP`37k05{G&MYX4}CuOU8ckfjVTd0_%cb)HIt0)75_pj{!r3|Ihx z8-NCqzhgq+)&DR{j{y5=X#`eBz>c;CnKwWyM3|g)=S#d$?w3vLNSY3h@54Idp*42vc zTT7ba_*C++3wMr99nwrxY?1RfyxMO2ZN>7>l=HjTL2v^|D9E4H;Z4lP<>1(!;V6wy z|ISA=)J~;qHXQck+hq;rn{i$yHmY*pr`%_e93VhrXHG-rg9;5#BO%56}K zS{9-dg(+$nopumEq$jMDF(W4M||7J)5BNrKiEY%iTc|gXfuZI zLu-)N#tDG z5$-TC=}u}02JWmvA@qk{MX|evDQT-rdWuKoO}&n!>989w0(>^dF7{@8L{w``U2l;8 zfQ~*eal~74)$h6GtA^fjrCb#KL_E^BQS_F$a-O}Fr0Z$C2;^^`^uVnTxbb`_`F{GX zSilHdtBZbu+5d)WM#k}LB)ayM*N3>3gjh#vV+fIwLz)!mmm%K&;(>O?m!J@FL)!*#le649(HrF^X>P(Xa5V+iT$-4@k7e8kJOudE+*;5hDtRa z-7rox+^^tpY|#$ibvH+Rbi17L)jKy%Kjck+&SLxr zR7g&i@u^ckGh1LPZRv5l3*qsnEoH{`C}USpsxfH@N-9`l7uh~csL~KVN@Y@=_~{|& z{jn4`tWwQWtK(v&*Gmiwd%BKW+ly9b1#{^wR_0K=V#56x)E|(bGZEuPYhdwh!njxX z!QsS3>Bq4^w9@$`I>l6@{W2b^%Yj+uOl1#P$Y&u_1Q|7;9{q#Kg)d5n}9@20x1L3yv0DVL#|6nU9`;vZ)UGibroz{ldTFQS;d;{>O_ul0j6#<@tHU#5-MrgXCi zS^5i-xFk3m8ZOymABw-7R=py>b9ghf8#&mfhSjyYp|!JlTB&QY-)$F6lWvR<&tcrp@%2w$aNPC26M*EpHjwP9-{(B1%uaf|4#_gLxbp+0fMTs_I+7PAiD1y&99lxC$GApc58*3UbOQPk6NUx+;-)#u25_Yb ze_Q;|ogH+8aa)%+WzC6mn@oy&os}`P=%u~ahJv=}qSOJI@U3)uM$sB0>tLe?LPI&h zsOZpaWFwS-)6rJvURKy-WBNYoE(%|*8_9LLY!9z*DqxQGuT9<(i$bpD{8y^;A3Bfo zS+%rnnKIm&a4L~}eh=B~yT}&YNJLB#eZumKA)j$%v7Tx9nXTF)smNcu?RsO6LC;^L zq4{y-0JeNM*hKLQ)2}9PP~z(${l-WdJ2&V2+5C-?r4csK(5A(LvG!D3XWywsV}G+L z%2l1?*WhMV$5Vw#%O5oEc^wJz`tcTqHo^3XMaAEW`6*2Yy5hhh=o9K`V_9(gi}V>v z`7cx1Tq~&%_^cgQW!faaizP;3jN?ER=d1jpdOoG=l0Omi2h>sUf}xdw@^^namJWx7 z`p`BYcL7`lio}Eq1IQylvRyt&NmOVFK$NXLBAZ8H{wTpw#NmSsLx+>z9I;}G9J+!? zE+3VMMZGcN7cMd_~<+R7_Lf*kJ2B1HCzDd!IC> zEl4;o*DkTHl`*zu^&UAr{THpr7g{uLt&oEjf3N0Hw7Cj4xwnK+Jj8}JB=SnrW;UKm z`JbFpIw!(t;%OqjR1vVq`@C||3FR0`uojmmyU(t=DO=fuFU(SHR14G8xtaMo&WGQm z7>!(=%D=SO|HHD0KC~k+W=7=syC{$Hum*IihGa1P;ty*v#}R0hvBahCa^HXt1XQ9Ul8;ktn%N;=y6p3Z2&-8kS4&O z0bJE1+&^F>)!+ag4r8HyaOl@mQC<0B#hV!ebM zow2LaP1Ggff9@QUGYsSCviEu;kZXN}Ipmm5(^4F)Q*=rt3$7|qR}-&%A+#pPt6!Iu z%4%nhhNA4$l6R7p_f3~yMb!30f})dh^XCKXzVReJhyT=qc`8(f$E5i$XN+#n%$v_q z6$67BW8?HHaB5|6tSRLmMa5m-V4+tf#wnmm>T99mvY~kj=ZmA^m7iVgkrozoIwo-y zRbP%oD}7;`TVw+KCRX)<;GXaDYh5fjD%x`y_B-HVPhxi{2Tje|#u!_b^TRlV+#+uz zTj;b6^wE)~^hLyUdql~XZ(UfD6OkAO9SW@0LKy1`hAah3;jNe0Ia3Mwc(S9N}S8rr+z77?R1|9d8Xnn@s;x$3SgLWNW7*~ zkgs(L1(M_iP+kAN#hM!{H<$@f`-LnWg0r_tTlpG@ujAJA_v`tFDs`XgVlVq)Op7jF zW0+LYGwJ;uh`&McO0d!Lg^&>jG(i?MMqUkXmcX}Y)p*uE4mJr(nK&>H%_f=v2Gc}L ze+F-?+K z`c<4w**JBkte+-k&+JZaLBG*Qn%mQyLI_@Zc^fZExIz1##-5$8sGNCT!B9J8TQ;2Z z>J`>{{$%OwB!3zI=NuF?(wD4m97nHQj2{4EjHl;#pryC8c1xSSBbEwAMqo{?%Q(X@ zayl_C|696}BQrL-w}66JrTN`jWZP}D1?A_|zEVdv(;UUvaI5&7;4`7n>oUZR#N_r( zfde)n25_r2%bcxl1c`lD^IbwB-Vmj)N_gH55YA`9Cj9I3uAbGpqXUVdaJ7Z8^^4xq zqx=T#O=B}f0r3oH+hh=vf;#0--8QT>Vp4y}v>BbRbje5IJ3RZe(~cAQ$0B^1?cUMP zT;H&o^61}*dX3+?+9a^%FlAk&lO< z#lWw{>KPseD9$ue*TtglWs-5ycQmCWfd1)>f`3J#il2g)Rr1c#yiSr^7t9VMM9a!(b`AT8+g`#zjH}@ z?_5j=DmSibW@!!*i_kZeBbqDHN|L3vW*mKoo0xqNpjMNZ-a6S`{r%_eHhuuBfJbus z;LOV~^3Fu0{M;`sAD5h&fAbaWIcsBXj5wI|{q#&;h&Ix9ngb_t+YrDyVhr=PZLW;E za2<{6YciN7x}!b!g+hW;Ab{UkQE7&;Y>wp-aM3R94vEq<(y2#Dal;8XYMFlRj4Y`t zeMw`Sr4A*jp4V8c^4@wXn|^(j%!iy~7t@`taz#n0rO}4XLopJ*H>mTX9nUe+qfCjE zfY?HY>kLVp3j2VH|2NgxVdyyvKaAE!l}LD?r!R>n-F!;=WnIIE4BhEW7pWjq<_Sdj zjZgV2cHT~Wd^v((N6gwNZz^UdDn({fwJHrhGKJ0`R9`U6$22#8Z6?~+G-Y~Zqn0B} zR=ee;Iy}pV_2OJ0CR65(MkCJY-a2EFA)thM{bGpLju(Fx&(c}{eWiI+tQ1G{=Dasp z0Gx;jM`fbRwoyFYl&CSnWgaWcx4&S$BG1kknMy$cR~kRc$iH&&Q9M62{Qou|t!aO8+~X-90ojus>+w1Zf9+rZ z0C*C*k3t!M3~1FLILZ2$gnkglV;Pu#K*Qhk)2qDk$kL`6Yj>owAC$En6wn*lYqaZa zE&(h3SheTGi_7R8>k>mb@?MmKz%E5yRHH^d5+<#;f*|_&nQHXA1Vm$x=Gv%@0+(a7 zD~CB31NNfe@F3WWDFRDvRt^%SqCxm5qTpFIfMhKvwM)ox+@P6`{|zUXrhUFqFzifG z0K{oJZ_;9eujv=M8x6)7DBv$&WLI*L_G$Gya(>;fW&lqG>U{zyimbz4SBpe(tQ}?C zqr;j$#LTz!z&h2XBv7&r*1lYtI12*)+sxUpz71(Y&GkY zer1cVwmMWVTODuFbz2_9np(OJ|HC&1Pnfc0lHL!^fa|U1)otBwuzzqPMXYeVHb1Rm zj3FHwImC4y|B29lvL-_KH(&%Fje(C$*3+*?Htv6I$-pQ>rNNZ`3xgoz0=4)&4JPe1 zE0mda(7}5opp=TH8Ormt3Ap#btlMu2+Jt;VNK%*}phHL+sD2)@9|Qv&u^DvmHW^e4 zK)bpwAeaOl1_G*JO6wqIOF+YTJPN>}vq9^C&wq#=I+SCV&zHyi0Z%7^X#%cmTi1pE z_$3Z}fzb7#yGEdplE1xy+e z{&CRGe)A*ZJt6W9f)2*eIKw1GOP_+gI2dpjphF>RLpAo@KZ6=U140=_KyaGDzLfrE zg0{(d9g$*$&|k3;G|qxpzk4{B$jmg{_acxcjk;nF*Ib!YPaFo&G%)nahRk(g}1f0#$`x!`R3a_;=k9S&$`bI|N1!;#Da|22Rb9N#K z-X-ynXwKd_Afr|Hp>FHV8q-Sdb`RZkzo6ppH8gT9HuEUi<-_e&M_>nbb*7xyILT{Sbv}-!KoZ(HM7=E_db^AI0Zd=%ckS zCk|9i8uQjW$N2~nF# zYFHm`B$bO3hBJW<6BnmgCv5Q3!R(iKIZ?8(;WE${GXH1=ZV$ z=}<1`b(c+r3(+m{V)56vmGUy>M-=UQXt9HUA6cm5dJ4Y4b=$+Ud~|(bw5le7O1E69 z-sE`2hGJ_RM)fx)a(yh$ikcETqly^uA35p7)_gb)MTWj~S81_DFQvXRFz>~~alfO- zd?$p&7E#hlyO+XsNJrbW!clE#@8rRv7cTYMkdM|40$tefH(@^p{mE+lG(IJyCQK=lRFXQsGfWm9%6; zCcd*JKP>XseQqATSG=TRn5Bc7Vfa_k3k>rO(@6_>Wh;_rF@8H_8bUw4w>t`~Yn9@( zn9V5D@kdk{+LIEYp)cCBUGo~_H{{R1T5mcaiAIi`Xq6}+n_?C*SLI(Wkv7JJd7Yoc zg>o6_ZRFea3}vWVVdk%+DjFq}&!-W{Ik6Qs;6ni+xP~x6SP;qQ<4DvlozrU;@^Mu64_h=K+L){Az)V+FOR*MC*8oE$`6OE!bi52^>|5rqJZy5ugx z0)+tMRs*6tL)lFiaUz^OncS$f|A>Vw5etnRZl+72t`y5+a-o|yiIXMP0o+Sb+4|5_ zxh7pBO4%@T{Vo)A7&^VirQ-Ak1KYxdSyGb)$ zJEw*b4N>Kmf{jXkV@XjslC{TUj3>p4HPuLyT_@mDKK@;P+XszIBNfp~*d?3B58!?0 zwVF<7SZI3ZOlA2qMe|Li8LOQ3`dtDe$3GzWVw5wwG#*W;79jZmkpTP7@7vg6W>Z{w zTju(j5ng`w5$mbE^!dhY)pzU5g_7RzcZ3dMIY{Z&nsW|2_P^LYa9*d9=pW_B7n}74 zJTI0PT4V{X+I~5_h#ZUz(xB<3C5JNX9iLFA`6bq7tMBk>- zkRp*uB%BINV$p4!tEF>(FW;pAZ&uM3L;4#TWvWR0v2gZ8@tBdHT@ zp0Rk;@q)JujQaz+C^cx~GHiNcH0TP4yhbRb2nsr)23hv*4C&lFr}#fk1$v@17wLa1 z=oaQxg@l>pvev+VH;!S3{ zn3I3Par}JhaYackiRTkgl{#LTcUBLb1lbs6dh7g0Y)iD0o@=nil~29;o(QVrv#q!`T6t<b&-Oq< z&R_cVqS0M9G6oho_ZY_G;c7(&Vonl8ym{RLg_pg!#1r)1A1_03i6_^D7CI+_LkvZ1 zNhs_jB&wkf#(uBC!8c$u@dKyy1=@`$oFwFU3r)Ozus(&HJYd>eywHy0js9+J@)iW2^VW+IS~hwS8g=2ufpy6N9IpQ-N6COnr3 z%t9iQzkhW8vWsvMBL2FY>ksJJW>l@>&^4s{RVd!5P34sl1;sVcc>tZ$vCzkLJ8+R~ zf?Rmt%#*zM-Ms1Ay=4~6GL&m1YwpWZgpunndAs98Oa6mo{oew`fWv$TcsD-|85}j1 zg57&}M=4v%2jybvPIjPsAFL+N9k59-)s94L}f>XRo#TP`7XS8#ZT`cM} zl`NbrU&pB;Ziv#Q7ysr5EZSV8OVM1zbiHx)o0?Tx0cdge`JYy7cLhs7bD2!A>{}37 zsf@62tD?ljP{azoiycxQb6X}L4ajTq{Z?xhWZ6ZngUI`nmXIPMZa*OwGcOdG?D&Tk`FL+ zFOtZ)phmU35xiM6jzMqE$R<4dWfM-!XZD6-}$VR6=qh z+7_>B!+*~(y-54LC7kywI*!f)4y}0Uru4TR4??s(ckI03DHDpqHO1hUykD_#-#-eg z?1$y1pM*%P;C7F*IFD>O+r!l40vB1&2ux$^a9ebs^_zQh4IFIgO3W8xYh>u(7kR%r zLC(}!rN^G{1;?`HI*tZ9EfhOVd+}YcgAG31w@(%(hHhZq?H-u+5?}E^oc?83^)OqM z6Fq$r=$xq?;g-k1JHbQn#aH5D_w>&L+GPveQ`pJ3TP|jSyN(SJj9Gwb3&S~n;IPBM z{q9JRjAY~kGY&jC@whv&rm4_L5lH})5&mLQUzwG@J;&jf# zj=+R34TWIj>1Fv1E!yoh+h`V`a52PWs`Of63KRYhGli1mSQEpIe`!R zgd+6h$FcSLzrnGiMOFR?M4)7DLlh)t*x~^qmpdQ7C zsBB!)$#erA6;=r=b|S(Ey|kXz*BPUIN2#B@bdIiH2(KX-OXL8BsGLf=PIO&=kRE?= zhYuaV{1#ZLCGEFqdep#ViN#Ji=}E2o`6;tdIwG- zVeE`Qpaou5MhuO>aqN>AgZ*W~gWO|Bgi(wQgmB+wtgl(UhpHHrZv1QcVgkEiNH3lG z)cW?4TQc2I$Pi&EV$tzYcs+$s`rocy@G*=MZoPf+{8XS`f59p^5i@1OGH@I(Pib^? z#z~5oJtfD}#RW;|R(!*pw3oc-s5r15ufP4CT1eW- zTt13XnWlLErFqNDO}wr)5d5tu_XbMkvt3{{=~USDhmURjwB%ZFKCLSW&7EO>QQ1$zpBILScjlZEwn8dlfXszP;zdlQFl!%JR+Zc5w&9u zKRXd0w=IEm(ZT{^wXfF${yd%oPC^2y>Za$;_X)rif!zE(?`gFoCrdt4Y#@Y&4A@F$ z_6klYWTcHI;Mza9hqhbH`j8#cs^F0(?;!1D>|GOzaCaV$mA|1J{jg##2JY>F>vLnnc|dMuy;|y5`={V;~;2za);gyeWD|?7C%k+_Ow! zX=gbf+kEMjD-+lxxQ5V9I&d8&d`T#N!G9mi(k*ZuZed9=6ZI`T@`C27>x3pI(pDzc zRy|9nRk`S8a-hFwkNi>Wd?kM`7IkfAdSasQFe*8r-^Ez;)<^$O)o>g&&X+r99r@&h zyW?#xj+F!=3EN`B6#c?$IVa=({T$h1h0aLiHbB<8_-k8o9|s148BLdxET&Vw-^YID z8}+rEp1UeHl!1mgd3y1l#=X3ld3nUcUP#}86%?2SLeL!=Vw2owV*P@}C?^IfH&O!c zCcbwc+e@r}rXfi!Z|>igKauCZH=7FSbvkvdN1bC5zvqn?h=?4|?~QDVK6;sOIlvQr zqH5pkT6U$Ku%Ej@HpS3u1D>VLlnv{}kj{Q^|Av!5BcN0^D&+ZEDi_8ad5XXKitEm4 zIN?6DO_Xzt!Mol{n;tznV8m~E!XC}FMQ7cXseAXO^vgZ?7~%EFl1?g&vO6~rOA3y6;PRLON_%4TLGoE? z$cLI4%}-@sRS}Z^?G1Q%B9{}yPow_<*$voj6)JdLDYU+P(;By0m=(L{KIFWW_FUVn zu&sR*-u$X#zW!JvesWCZ0=eV|`Q5M>4%7&g@%cmCrauy&8+E6mmiiCU*02~# z%bcD*4wPkvK!zX*A7nbdQP&BecwMZt<+c;^w|d&!U9NKX`8Kcb^`cXl#hyfllJ8u_ z#p@J}B|DFY(MH7x&jWOOR8|H(%N$bziipHRSa)AmSJOy&y7|YKY$#X2Vj@N!0KxjL zUA-+?9>Mcj$*J5?ik-D|y?LSfKcqPL8{0pS1<%|}4hdo6#TqWtgSnMy+lmtdGKv*6 zp=G`pM%F5r#QmN&W0#1~_WC>{Gj}>&-ksLNbx2ZPGG(l>yL&gxP<%${pyn>W)GMID zJG5)H4sOax(h6n6N2aoGk_xQz6~ZYJCfd<$H?z<>9Fk`N z;4)BRsuxjM+$HRypQiVy)Y86Imev{L%SBcMkjwhKHhR#TQ{VV})|B(vDzyZ!2P|gB z`2JUB@H2TrOs1I;n5Vqt@-LYs8jf2RMAeqAeF z0yPFGL!T5U2`S37N;s1NM{lmB7qs*BjfQ-y#PA1kxn7cxZOaNniAsSPVmQ7eKKkC~ zdgU!TEv`)kWCo9>2;X&B4B@?9Pw|_fudiPzCf~)=SV+F5AVEoxvWq-Z`gDtY{N2jD zP?or(BDqH>Yi!kzPh*p$L|k2T=*jEQ_rn3 z`acmDr2R}BOy}mGL?O6g3Cv;8E6x1DK!9a->%(P_eW75pl_^fw&->awYkJ8-9z6qQd3l(_mJAbJIlkFBiML+sSfl^(@IJ!5 zIWFZZl6zWu0l$SJ*^0&=1lOKS&NChc#(D)h z*#|YfFO$$|QNu{3x;!tUZia4jbvULf6L>j7p|zbt;Uy3x6J49W&%7ni{o)Fneyx$T z-sHM2sMM3N9_2I1|Fw{B+L|q|1)T5j^))RtE-O3QA*(B~vPNCJRtd{C;qa%ffg+F1 zj6#8h)-$@*%Bo~>&A4uPvYCbXbCTYc3ZY`70za*mpgtdy)^dZU5%wY`1}-1bP7>HNA?ro7i6#lX8lj~<*+@80 zxwf#A<`7qHJh$nMB;Lm{k3&a6ZV?~N2aN@s^7l$-zYYXXL(FEn(|5_)18qPvU1K60 zH@S>3TBrdnfuT3z_@gr1rEjcANSkaG-U*p}1tWNKFSUO8_BAQ!p#BR^z{^}3GT1R6 z8)J=g(#%NicgI7OHH^_k480sTwmY-%Q$gRHF1nT~~?qgX~$*G6iQ);X38{!sZWmd#M^Kr&ed- za!{kAsg`FT;a3HML3ImO^ksJAI^9$0Le=W;)^D46k`-n!UA#IU@Mm#|c53ZbD)n?& zyz1ti!O0-`jv(TfaUxV7dxOeHm4^ixz%Z;Ej_fsEbBA%SHTS*-(!i)d= zSU-zsiP-sm-1Y z$5Q1*?-ZCID{;`sD3)zg2>k0CyA{$1kW_}zgTq-roo!pstvfGbi{jE(u{a$Zo|a0R zzcu#VtmYV*_-*YDY^vuLX&*gbSKY-oY9D2)Qmuez?~q5|T--GY-AESF1Y;LUWEO^# z20Y(73j=2tn-zh}uzuwqhn3pGg1_l4{y=sv=2)CMATSuk#a|`XKV;`h*}S>6j1l#!#?-3;&74_sj3fjJt|ux)&V~&U%z|X5|O21nlZOIbs|!X z?9RrwCwnujIt}R4mmYo`Va_?I?_eU#wQ&wiAd_)LfXZ6pY>zJ6C?G3L~6k2P;mT#7yJ>D{n z#6FZ)2GUS!8x&O6Q%s)80Ta2f!1wvN)%R;&ad@?Yt-avym}$q1^Qk_MpHN035`YU49P0;WLNg@FA7Z?%vF$Ln{Y>bO;Fto8h)$VGRhWt zO}ud*MxgiTD89&M>JW3hmQyvDWKo2haiR&b&%BYzY480djM9bg!gNA8`QT*2U=8yJ zgo@y#P|#`=22&i4?+|!iu=9S_p3Kt-K&Y(HNn$Ak9J|F&8As-(# z<5|LzB4?KLs~y^#Tkl3i-Bmo_bq;GmusqYK4`*N*bdPWx9KUCyS8?_%W~(_h6oHpp zLq{-=HRVA*Xsg7Gn-_O4WARd&1g>7BTGc(w_=i+kW1dja`1;=AZ!pOp&}T4x*sjfp zKv3yO_y0V1)m}(pQJI@qAwgD8&jCr$BJGqCtzdxCM7BPKsM`cX!v|?oM%c zin|sm?$$S-@B8~_pC_}kv$H#QXD0XDdrr;^)+m1=+AS`9#>aPXW?CfQ_IdB6sK$}$ zaZBb(jh9`B=6b@8BT*H0#e=UpPYn zH{+w4z`?nU!TV^$bTVoFN-=;C`wF_GwtgpDoGBOHp@$@*l^IHFX;`PbB^egnhFSGu zwNu1XC_rgMp-fd1O1DGhpHR>?AdR+0`X!=&#^-AJ zQPq^KgTeI)M8kmE6(<|_!=UF>;%9luKvJnY6XHQS->mZtb-ZFRY{WmL-M&wv4{Yf7 z*Z($jg6)fxw>gUoa!AV^Ej&>Bf}-&^z~XOco)!z=>F$kZ!_x*9%K#8E9}yQl0IqnMnEA|_GRsAy@GjyBt3ozBpE-4Lhe-9eUDNykUtnV<9&Sq# zBAU=Fl7;^iuk3r@qwzH6jc*G~*p%*&hC2G+_(|5l=!hx=0AFriuqM6cD z?0BEk67EG1?nR*_T10qtBuX+VNrMi>`PDwzu{j^y&2bM&rQw_t--LT{at$J*BzeQg z{chEfrvCwu&jPYJB+=b!6)Jf3YdU)+1DQl}uxdrYL-fx1*jwL>x;1xvn^Qrg0}eOK zj#G9eYw_hb(Y#v2`&H(&8o0`4v|`gi*S7g1N(2uPqIv$K6?Qa5P~7~&N)$Se3Na^) zieOu)Db2hiGt+cWuAoYk^5E?3AtOh^?D2no4=c{OT1QOGDiP^R)XpupN#;Q{<1ka4 z@5MW{K8d7+)t`tW`u`pySPEaoVonNdhh27^D$co2@fPFfs#L}!Q^FqLBy0f0;8hzU zxky2|SqT#|>gV%sluptIH;_Ljyidrcn9(OM#)W0BN#?#I@v7>>n4x>%z6j&Wb9H| zZm@!Bz9tui4Dswy=;IJyPA8Vy!$)YSJGBLpw$U4GTO1Egr=$rLy=QVN?N2I#WT2nr zCR~Bo*FPMFw`Zu{&Yhr+&acwwe}XMl7I-@aKO7R%Fx?@6uR9HXk3B^JdRh2(3EZ^x z&^?2@pqRl6OLX&uKBs-A&s-e-kW2%`NFs5qUr(%h2wsK-=}}>luaWooUof8y?d!`_ zU3GHk)Igh6MkupPnx<;g^+sbz^P+{MvTS@B5aPfWWHw8I9cqiJs@|9mxBzk9EApdE zYljB7XEAg-ZXk+{JRLK$?#HYT8liDV=`Ur2-vtw%nqDs~%snNH68h`PK~7MrAvV8V z!+I(f^#TPqJf88`fOuRXDsN_q#Y~59mTQA8a zt%rA#Zh7{PA%)9|bo2DyyCidaO#RoOwK0yZ_P>E%I}LBJ2$3MGYXO9%416`w3^!dL z!h?V=7H2N?7k@<;=Y+#l%uV3M^3*5ypP56&rmOr4+_oz)ms;K(Qk*M%j!qJ4a}&r* zRhX9sX=%>^I)7Hxv2<^Ro{Qnv5A%-74DGS(Uq5BrVy#+b_^isg_FeJqJO(>7HCo?< z3peHLzKdGApND*AgAU@6*^5kBU9evJ{bPFw{9n0(v#TSkZ=)K~9h~W(7 z^;3|3S{xCst6rnfM?0n3AaEofY|!9la(qUGx#5`)JF5Nx#EICUK)Rb_sY?c>*J(HA zFWau1a=YoAD5w&%Swf!_astuNPBBCEChTJ@>%}JG74yh4U3<+1oyI3Ls24s@(hI#? z!P%}INFr7+eq>O-jqw+ve#815b%%Xbb>QC;BBLKJTRcwT(<`veF2sL*gM0vrS9+?s z_y^zs(Dd-nILE`AT9E5w@-@V#7ZWigx@(U6IQ34!DGn|P`5XHLI`9&QA1CQOcv*Ws(aj0~!|A?S^I_k*WC5;Y1+UROx2F60 z^(F-i%ZIZt8O!ikQgh7PSgb8L(QQ7kHtkW!dV9FwB?&6B$cciHxNZQw_@IG~G9hD* zoS01axk(!er1gcnTTlooR?8)DxYTMBZnoCI zx_9D)Wt$r9M)|s>Lfb;SI-V5qpgkRh`?~wqEsbur4xWe^YK{jo|S5Jd%L#8Kclmdpao$&3$=HUdHUl*dbYJkcE_D=yN#jalIe^c;U~)zMlj} z-c)Cntzm25mmMbpw%4N{yd?!S)+jFt9p5Ci=)RJzQ1$Vfgw-1mzr9h4u>l#YA<4b zFD$@mH1f)X{(3xRPbj(93FaCFKQ_S*$d*&x`TgAlWS}4&qat$oO`ijoh(SzaOC3%a z0S4;~aE_a3n7%IfcTqh^!T@Fr!9y&wOlie>Vywzc*pdeGmwQH)ePgwyNnV+OoT64< z!t-vinDVpkSUR6%sb7nQoCW?d?vSwH>t~P_w%VP*;v;3PpW(DD1 ztb>A-gWn-jB{}Vt0<7r&^&h|q2BoQgw_2#p>{wx*T@bdw0%}eQmWDpc$&^`L=k**` zFv&-i&djCn^bgN8f^u}MA4F;cCT(Qx^|ZVjKx(_Gm@uSk^5Kxuk)WugVv^yV8=_bu zz4(~fH^$i!zEq2NVcpeBzkcqjoU~T@RA6wE%K)Ams@i0z?=iKgrf{@;pERt=1n%=iX$W)xW^TAdhU9ca;*;_w24x_ zCTefx0W1ZtafcgR!Ng8BJsR<2zevmv@5P~rZL6D`n;McW(i|1;LD}j)EaccFMC+UVi;R5eTFHsrOa|ah?i<+ux8W`zj>&U;%QAi&X0?Z4SNd?+JWk*CZ(w4D3OEy7P#SJJZ`RBn&Jm!URZL^n3H705}IT8U<6xF^xPxzI{$fR&_3EOy*9n%E)F=lDES zE}D{f#{7xNkp}E!`1ou2*WSO^P;$#Lq1)iG?noS$xcL%;S#^{)5rS!dE+GjwaSOuH zc`N1-cnkbfct=pSG5$0W4K*T-;aM(Mn7r=idP0RlK{btEDcW5t;piRG zO7N7Lw`lt{UlR+wM1+)X(UE^ps-^TDxt3p@h>=KCGl=#x*p%eCPp4o@HeH(35Acag zZy(d%a%w1y`liFDCo@U~$B&TYr*iZthR=^Fb+Cn!&f`@~HQ_x)R;b0(fRU%mPXpew z-JBQ{H1Bd^re^s^`@dm3wfQH5+$LvqZ=WlUyyuR6i3TQMDcWd_XwP|0?KBFGslHb}S3!WJbg1g?^h6hFe;LaOUh0Z3)Hq{Z>uf1QfZLp@GjCbpZ3Y;yi|3E7n z-wP8EO%BI~%~ECyVW{H#a4C7iGKHWpGwiq;^g_6chR>Q7R~U9L{&wWS-^*Vr7KExv6}FS(LFim6AEjDLXi?$hX#2c(e854UjO zP;detryUA`9WbQORe6XEM0Jrd=Uio&nw|=gZc;+85~9RknupvPhb@DHlE+Vf-_02e z&WsW0+w9D-mB-JWP4Mt>X7^yw9*sJEQcD?v?uLLLGE&3M@+gb?+pBnSJ@yK*vl?e{ zgAdJJ|187e9;qVUhTlG-3{Ld*$Xq;V@8k=*ZPOvLfi9BaPnFa%}6%S)E6<*(6_=@LE0`476lHeroKV=(hin)o6#5T< zG#<0m$UIBHoaTL%?sB5MumIfl5|mKlxTEb4rus19sFo_rwI!;&dBWWSRIzun3i;Xw z{6?K+?^~A$BMk$4&xM_19k3vmVSHokpBrTv1I7EUVA-{kj3{->Mj0Z6QOVw!!^a0_ z7>LDHcA7LHq=_T@tPnbxiJu5lvb-(nYR(7Rtc!WlkG-l(aEUXjjV9Kh_YU@(5N+P!nUS=$0k&O)piRog^a4!5RzyEFcF@oal>cg38Ff(^d8S3*4g!9sewyUGfF=(vB|2!&u0*YpIFhKWhV%2mEZ}H88mG@mBle zI!2TSS!)Dsnq`}ZqYc-ubnSH;M{Hk_b|VQbld~MOh$9S&qF`IH36v+@n`7{5^f=PG z^w@1EG6h1XwO@+J=UvP`m*Bk;QShZe{by6r!To%tNP@pMfQ zbRw)g3&J9&QnRwXj=_tpxk+gF^GVha4*z)mr(SnpfpHwy1ZBowYr9P*W_q+g4cTW# z5QPPGm;`g}U}em^@pi?DMy^EPo!HENIFn-iW~8CKkQAr%_M6k1ycSVQeCXDC@Y<}!+g=E4${eTBa=D(g2NwTQwUvfYF4A_{0_9%@DI{Q!BuBp*sv@ZN~ z_y=f$wdT^XlvH9QQ=fpsJWu@Gj+`PJ~ zFV>U~jw{;UgeBL{;kmo>g$+84{{cTDDWSAB73&UqCnvQ;zZQ5}L0QinoF9 zB7bLN$WAuYjGsQ~gQaA~M?lxBg-8}Wm=BihL8jt3Y79dQpEp_Iov#_9kvNT^eMmr2 z>_(Xg>#qGv+iQ~$`EXavtRx6ar)o*%++Dywz^U(fDbUUwNiVkY_ow($#ayJ=Vws$_ zWYvtd%uY~XL6h{65OLj{D8{5>rTTCE=}IHXFA}umTY{b9Z=%I?>D0tImKx)hsA7cG zeI(r07;K;9){Z-5vd5(_=f&o*XD0e}1+z+c6Fv(*SpTK2HVBSe7t{3|;L3h)rACg@ z`m5Z^y}&1tD9G|56LkYEJsHib_0hi<8_GaqSmMhnGIt#fi?o~w#Q^-Ken^qLOSAo9 zl)PbINI)XOG@6gm6Uj#?akE+N7m|K_(10X0wcTd9H3gl*1CzCOnVpgSlDCk^dbS_ z39xCpbTKo%mt6kz*R~g3k}D#l#@OBTgSos!Wc zK+1Wo_lF5xu)WVHUdgwBD&8;D?_(xl*aHpHMS#{i5}T2Tu>O~ zgxC8Xa3(*2@NDuR>5LR|VAbHy%i;nM)EDa>)|bCe==p(3weKAJ}l$hdvI*C;H#mcN+yMaLd-UdR{F$kGlU z6!|N$l9bBJ4M<`pl$maw4ye1QLKj$EH3W~mhecS@T0^42NQ>bK4 z_lN4$_csBWZr(<^+r(!OB_~gxW#9rSS*qECG+Wl;y6}QQ1yc(clgC}#UgT9WJXwji5r8gaGOAdAl=%innHQUOB-=D|8IvUq*(30kCNQE7irUPclG_ItUSlK<*-Y{UO;$V zgbMZbr9$Nz7t#Oq%e0GlN`HUe#}f83j2A$xe;(A$BqC2l5q>3L?Nww%O;24i7A~Nr zTRG2}iT4!a@;h=7Ty?1L1@8|s*l;HPz)%3&`&Cd_sPQ&I$<59k2_WzgYv+z{GZI-Y zvhcTgMB>W1*S}KFk|~A*O2WS6@=~AU&Za;O_9q(RV^>3t6ESnC$pm@@ zg<$zy5FUTGIlQsanc}tN6zFJ)#cDW>%W+w(w^> z<_JuM+5yyM635P^=H$dD?!?@T5_H9|6Vy2|l8PZY_@XCm{8muw5oWJI+`%2L${K^} zO89H8zbDEYmVMNWay+R2W(YCU#EP5zNk}7VWA6hoCf&(Y&+V} zi~G}Z9vbMzaT-O}Vy$cI?iBMi0Cgcy5PXWqi(kr&;-aTc9B1;pwGi#*p!e?P6~jHo zIjF>Y1nDw}Hn4?z`hZo&USNz@2;pH!VvZ}aV(HD#haN+Ptu3r6xRUQR0YG$u`B}}Z z+wa}#MYLbzWCrqR_Lb*s`5SwWB+I@W8!Nc|0br7ANr$B%L!8Ku8LjeSSdb$650G3R zl_efXhD-PtIPXYH7dg@nJ;`ojE5k7yQ(shUF&*OmQ!$8&#+Gkpx^Irrnt3}efrOqk zcUbg#nDpARpH<+DoxoMN-nzebhMoTowvU(;sQQ%Ptk{CLc%la6(>Kbm{nprl|R!A&y!y_ApZ7^652xx&a6>IY_(g=<~1{BV*Nd?}DuKD|cJ|IHb zK8KMyxJYKIR5%mgA-a6j+r6R5Yi1kz>S@@On~S*(@X8;C=$Wb1N=xgI8uEm!wSE0d_A}}+#%aDB1?F(EeB-y!P?%u*GTSX8 zM;lbsOWDa^>6JArD293It5!c&sVH}^)R(i&K8l7hKJk^GC293nZcpvRWPr2e@;WMM z7;H4m9Cek6f+Q`z6~u#qeEunywEQ$dE`JDEd6D9xGvPi5#mw@1$=Sh3YZ#EYN17v% z6hdaB{PIN~L|i6yCrq0KIvNpn0L_O$sZZ5RLdo(&!@VUt{7BePs&y&hdKfLFi2{x7 zlSCmVNsW?LDJM8Sm9M_SdsNPu1g;DwEzD`{I2|vH07Ni<1TP6NzVVBSKq3|Te9dJ3 z0qTS!X?<}*p)-|hqy>t-sDKG$7t&?-j=G#pM8phXxjJX^)nQRl!w=#Np3O=cr>Xlu zc0L`WU7I~jHX~J)fDXC$?RvXmJZ#*i1_Z1 z7xoE?iaAH35+JtJt5NkKEZ?G^D`%iuVwuZU?a-(WQ@FC&dItmY}=nivzbN zv$RyIA2%vs7O>P3g&mY55VMO~ko;rVcmQNm!*W=C9<4k-fNJ00(9)t{vX_B5$R}wt z;}hEZy5P<4LrBj}@)%7C6UMGY}z9Xx5UYknV(i@8p$O7&9fc6Sl~N%e2eFK>Z#%e~=zTu5&=aPgp4yt`oiV zQ(cECaa#Y_fjVZAck4L<{4F9Y?_$>wfl|pcgRH+NFSwwhi*ar|w3L$`4OL&FxD8)1 z57az}Q=D5V_7#}>eW9Z)-VWhj=JT5qDXdLz*KpCp`D0!C+B7_Gq7nVTS?vb8zFHY4p1BTPmqv~h@Hs;waqw(B zr}z5(&BsbyM;($8eP-oMsYB`9>aqYS9$|rAr{DtjE~f1p3+f)B_x~Yxu?vw^_Tcm< z+~lK@T9|@aV4QbBX9ts1l(_BJfv6d?)+rFFwL!TZBDyyysAXv*Z`C|JkuT4-AlB<+ z3~W)g&@Yfs-ar13rH8n%=7U?Yde2>^Yi&GJr>ocr6(5=<} z_GgPoHV)ce+)xq&Kk|k(efawBRom;7e@9J9u0Gv0dG{+S(k}>5Sut%w-r*%G`61_T zlRVhyPQNh>;wstOpW#j@C^Y0LduVRNWyLK@(F5|w=-i{viE%*9<1zm?4WYGfDDS&D zebE(p8P~V|#%E-mTXA|Dy01Ste>T{ut3du!k;G5WD?Kj#g#gRF>EaM+G zysQ3N)A6wvdS_sM^ycV?%NP)Y-E0c=E1K+9mXi@fSwhnLA}!g3dKDD#ezpvntQd1$ zBRRE4vA9Xmj7Gmb3ae=}1}fOI6}5}rxYd=dzt2IWo3%*`@ui0WMP(v3mwUqJbEY|O zu;P)bg^!QT-!09%sE#gj)V9QY`lFt+aD?6AG-VWO*8TL62%U1hwtdb ze~=WKDSTgf+IWK0UWT9KJ)wueK{8nOc{?^Jmn*F!Y=n{JmsdV=9y{MHXG%@5GjlNe zzyA)j`Dx+9`!};7*sba}NN*%%KNCjvmK^_gMP?q+AFK{XeTpjP7orYY(R=>EwXc)W zA)Hvcixj6@(U9i+9(OIWM$x@#jq*ghfjX8sHZQkz_M#)|t7Y`-Qs{X*N!p1_VyTIU z#5WI2;49sXR$P_CgU?WHEw{2IWuGZaCkhk&F8aC3)Kty(`e=<$C|(a z`S4@v19Lo3&@iPD3cU<-F$sW9{*?a(g0&wcYD3Co>bZN&VwTjeeREUCiK^S1#fkYY z_^N`6(Yv|T5CsMB*Ma4OJyxU%jPxJJ^_U&fPV0(#SuQA2MC&{$D?@;RE0{!%d!|r8 ze&V=(LCd}-iCily)6Ej0t1=%=O1Yaw8;lG^P|FbW9iFY@NZ2V2!q7tKq4`E_c;{hz z3Auc2jcMw8!JY0+_Vq186dy^bc80u#3?Pnc(lq7tkXMhq5VYnG2-nZ_t{^Xe_9 z7f`G4>6XfOwd-;K!AddUB-buVT8}x3F?iCaDa`L$$ta07O~(Xj7&J0d>8l&}!o;D9 zo#-C<#@@1|YL*gpCkz=V03=*lYornidh*r06AZ~1>+F93#cA2C;D3PdvhvIKKjcf{ zTffEI?5_C7ms=+mjUr4g22Mq(U^;wv?6-zfhFOs^9DX z2$Bs{I`S5u>D49X4$ZJ!S^qMs+mYWFpLRgvJag|WRp&1s9MN*|vAlTd&$pBh?btht zSe+7fymL^8A${!^LD5=a1)JrA>Erkd~gw)C`D zEEkg9_b&UXl>~e$B=-_i*Vs@jsr1R~VA-1II^c zi@q<^6^$7=I7&$~Fi@>gDdA#t{&nuGM70Dzg{>VMO8RAsUq_ejjm2Z70#Fz8Lm3*c z{2;8Xo`yDmQDxTE^IJ!X#=?GP7b40gBsz?M7?juGtnZsUb5~OAxwyGx+WH&ikH~A2 zHR6FXC<;#1s{UVLIvX3)uNv$uOJm#ProutTii*!-%51x$5@;WHGAJmh0pE->3@*du zwI4oIhOx`+)^kp@@+Z&EuiE5c=KY4tPb!O#=VTmQlmZ&@14MtHoEaCg9GNze%IHod z!XqdEaB-Ix76CzSkG%`MMEE4AJt3I#a;<_5ZQ%iyL}*ZvfYh=@d;tSlck%eF-%doz z9QOQ1(ZtMiG;5IHOo)|&&k?b*{Bmn&+dlOl2?v2p-_~e1+ocEeTyPZ?^TCw2$R3Za79T2L zM#a{0GzO5XaE5WgaWX|uYn@x_+A-fZRNVS9^E6Z;G!d*205pxbTHt@(L4VfMX>}OGKezJRRiEsZp-sk|{S&V<3Eks9eZh4f1A5ow0 zK_-nGBY8JY$PC{tL`a~8LeMx;(|QCzjNy zC7waK?*vKb4bjm4(jw%dBy0oV!?tQuKdS6t!~*MQKNF~p3zQrkk-Qspecw`OOw@BU z{vAdF3)gduBk{}W%Iq2~O2P>fCG-yx4lROT>jewDu}tVt6!h9|zm6v0+aP1g)6p!d6^*p!Eq zFEg2yFYGn>k)R>11R{yvlrCYX8ZikmmPqFXO<)-{Rv!`lX%lt< zTIW`Zk#?}(ijhvtn6M+V2a#rF-EgntnJQo*>7Hs*5(xBgcf&hYtv%{9aj zVg&qm?#q7%K{E*e60ACaE%hT%vNNC0T=XuK8Ph{D6Cdy_fsfRgD{6?@fPmDUjek&lM3_P`8xC~Ao8DQYf?8M>eKW$Gh<;&K;2dKg2v zrRi~#_!?*i4HlfG`mrGmh^NW1b!IJk)v{Z{s|efJI|mHDCVIc zvv?Q)mPtW}iqN+`h*j<+Ca%30USRX>Vq4{KFv`)~#EJ!-p$|4*OI6Yx35}eJ5Tc^3?09X|FLi9Cy5`cEne%}Z)>zmM&87O!wso}hSb)n~Ip zr|Ycw2WW{t;VZ-u@WD(Z>XS0C><$^0bPo3A>+2DwcwaLOpC!{Qqxeg-;=tFJ`yS^C zYuzaKDt_h}3t?pLVBaEjEuDs#M50MIGa3~rK|B4Uq^HQmgsIYZl6&Z? zF!Fh*WA8VFprhiquNg0fmkMt5y$2tm?fFn0Vczp_$6tC;isv2@!dJALFqbOfd1T)& zJ%6SUCk-x+(8ruzr10m=3k{R;i=EJ+cKWziQy)TDyq+N562XJ5MB0o)nDBxIECs&0 z#f_;ZJ9R4=n0^oSmeqW{fc6XRdjBOI%2YT-@lStw?{3+^Dn;0q{FSN7ur*Q9J#g2lPV9Ba;BpK9QJLH0p=hTNSlR2Gfa zbW6DMt%3B4^q}4U(2S4jOrb6AAl_#-U_*TEWdccnVYs!rnGcqGF$KG&JKveU*%&Zg zSrI>_q$S~C^W~Pr^Xm=4S<>PkcfFi4GP9-~FCrMZ<8IZE*YZ6F&o5MeXYNIBbj)3n z%SDr}(`Q)x$OgYx?RsUW4`}Ez+HI`HqyDVl=FluWaD-Yt#iWHLW*38%!sX+G#@ZY( znGSHSCf2=A@N$cKA45^x(*=v~g@0z9EVqg!yNdK7JnwiUx#wA9J8cvy+~-!deWVqR zbleb(?!p|O(=gSJtf6U($M-}t^nL*E5Ex+wcuhKHr840Ny`22C;fPr)(deKMI-){- zX4lZj%`k*(cJir2ijICRjFdSo)pl|%Ubz|m&kTAoo#Ol@>ncqd`3}+%21kUChP<{( z?xl(A^-{`xVEYXpWvW;DFWX3MQiIv!jnkP$Mmg~?hKUVI*Y)p~<#oTEeXc;mq@PsY zI$SqC3gLfiIjz>0eicA{p!O+7>L9<@`m}o5YGAAMOz>6>8^?a}_3!4^^)A%OJa@r( zuP}40B)Ja_X&WB<2cX^8*M~w3p1MyYzwA())v+nKxL0!slt2bZ^Q7?~5P(`c_7}6? zpu+VB)TZv?L^sO#FS}iW;_HPIZ87F@vS4-NT@*5B3gHtmuN^wC1u^HziI)7k`tLts zY%T^dSVDhU2hE;&jBVSN-s%*el-w>cU1BY>0md#MOEjUc!h-_417V(ADdJq!2(`uu zrd)9+DGxonk}Yo7rzRftP4sExC3K&C8OV+#1ue4f-Cg)cwu0#r71WokHcYAC>;z{J z`^IWVGqw~MQiwc1JHyN*_yC3qjxaWhl z=|t0l7P^;E(WYKa^PdS8tdU`|4ys;=KLp_iITaDpO+=ZeV%*-}B+Xo-e?8*~FC^x9}D{*2j~S*(39UW@*#-1Y{g zr{1;;hqGP#VZ`1Xeo-xsQEj`JIVv#Wmq%=synU!~h+N7dLM z#A(Sx68A-W>tL_0ydm_W(kjF+UsIg{r|9ResfUp{s-y@8>*m_l7_}T3Bzzn>?5Tvf z{{W+s`odS5$&T+p^=tWx#m{!tI1?xr-6Q74lJIQPZ6%x$8rg1&5pQ6;t$%>{Ne8y_ z5xY$cd0YeQtb%M-9?*BY=pLm=KVNC}6f5srT8`Si ztd7!cs@T$P8?wCb=Dy*rg1xd)vB3MuDqf zI|#2GOjad`ZopsI zYg>q}Z(bwh@`fLIt5-Qs{2u^cuX~Fsn_(04EY-1RQ2EX*q_BSIUQ*DY9TRQ$&v?{D zP#|nJ<$D9iT%;k+453gta*|X(8Kpv0e87!plXC|za?_~RXU(usk~fAm{ho;X+CFMABo!eYdFotfip7VecGZEeF>TTJ1V7v1Xa5u zZRRhm>s?1$uQL;pTrVFITI7$^uW8Qgj)}zPy}UL@-}Odwb$#+A-mt9xrl5UZeH zazrV8UF0a(DIz8N(_{2)me-w|BYQXOMoCjRX}2xfl6TIHVF54BMfnxH{c;mTYoDsU zU0&bDurQs2NTcC5j4e>N#_ph`g(HV~!XO;9jiJt1@^2=a(8++<(uETzs#*~VSY`kWdX zLlR`4PDv^^J4!4wudM`Xp_8D`V)4pHVqd{h*fG^O(1jGf>VVE~l)ngXx}8J;6=30m z$EHiptlyEWhyrAFftqd1BU1wUiiIFua7Z<|j;`3ngEtL)U6fz(Ic zG}No|Wrj=`GYGE>|eHkNzT>K@kob6M^J<@#8Jy3+_K zo3HSB;icPjBg>iJqSEX};hGGIXvoPHfS%j^=hLQT{4t|6w&Q!idm8LmBoTE-Vkg@B z>&C6uZl%}BTcK1({4_0@y1)bBQtJa^;=)w07%?>zMRX7>+A=#-94P1aDRMyM)e6Sx z?sG_}=Jhf(19d}$bK64s@bg(t3XeZGF$Aj=bWR-T>nT$KIJTh}t{&eD?O7VkGsrZq zN`ER=ZRi-HT1CD7PN7w2e&nIQZY=pRzU=R`HQw!+T%!cMjNk_((f==(V+c6%-Nkh? zCCD;=+Dw${Et87Lc+ljf!W>;-d#TZ}B&rngMRF6$$DGn^7-}={k{QpO#Duc|-)PJ2 z#0DmnL6yKsMh@=B1TQR@>yh;dl6`f~asppJHzfrhYB>`ie05aM^)|y!#egsQpmtP+ z;u#e;DLr;}EPwu^d2xXsfnoVGf{e_TB_1zKK#kJq2O=a*q1E0RvS*~Sw$<57Xr-_5 zvFmRvG+#`Ur>F$cYHkeLk&nCoNYNikFu=b-k zoxbS03}E!@PB$wzo$K#6ld=zyy6oG%#0f5@4GJidsENnw_;XD232X9$A}&Y@v5Q#o z8@JZgAjO{O*i$1(JL&=}hh~A)=BH26uBj?Ny`BRzysMG}zj1hx4Tk(>?Q87C5ZY!X z1-05MGbAZ9L7;6b0bgahR9&CL5MVIZHqV5xD9aEOM;Oy2O-_q^{*~|QrhIu69}gzm z@DXAH=?R9?0i)@cR-{}K`|voF=ATgG+ew?0K(!aw9sE0sqWlVl=eQOQFL=jn3ZFA2{alj;Eqi|XzjNzG&V{>6LvU4idHXVsca83y}VHeYI7z~`qfXT5 z-fYh%(jREPDO4-CF?yu2IbvupF{()OOq0pF9}p6ccqvcn4?`)DVz)8iU;C>L4bND_(rBoS?523Q~n5TBlDTK}JIA`9L zm3X3Gj2Jh5o2IkTfnnXPY znMY&>PPi`^vYQY{XJZ86CC&E-`_>=%bI!C``}}^&j$bls7_`9|w5t(?IEzZg61-7z zK|-WqID!@7?2b{1?rNN=#gd^R!@r>G| zwj$*T^b+wql{cEqeC(B5Fxbv zNM8m%Lp#)_v+|VJ_|P59=Jb9-lNjZ8OY7Eu}-Hu^nLLT-M$;LN)mX)1#|4%2_? zv9wIu3>ebW7wWOnK|rM6aEx`Zug>S$#YsxVR#DXr3-h#8QJrQN$=$?CsVYRaR`Q`{ zg_<%3&h>0Xo3a7yBIE(-3vdkT&9`hPx{oOM*h^)`#6g^9{2n7H zbrj zj*POlDQb=Ao?$TM78g-6-v%Vbv6qkz**6RX)}BrqGHHZq zLRhA|3}hUK(*0u-8#YDt+-op zw^E$o5Zv9}p+Ji}6n7`MyOiQ?MN(XfJEasT((>JT|GTnQCK-**WagZ`pFRDab={*< zHi2*^IJOH?=`wPKA}-^Le3HW|NPSX^AzBRb!Ft_Ru)~!aGVO3#n{`)(wYMcwg-x84YykJ#{(cf{3 zryCExHcBs}zWQNjl%myI9i!{)v7}D619+V}3{}2{J^Z6j=!}_$2N{GGOTCIX7jM+j zJQb9CI7I~_B|{H4BasE_HeU5_9;I+^J|{N5OZNy3jQHLG2CzAaP9 z$%`V(68g89v%IDmaeN%HVR6A5zk?&Z^|D!6ey#v%Ef5Xo{1Ja7yiYxA{9bHiYeh4a z2QP{ksX|E#M3HXg9?UhT`)Dum|@+0xeTqY@6^ zQ8EQ?<3;1;(=s`nK7bphZt*r#+LJzFtJ4=NW~szOL6&~b8wOFYAA&qq-Jjr z(CK&^3D`QfF3*cCE6;Z75d5IAN%g=T#=v&iIjO|JhWvTQqqS|{GsQa%F#B;T#T9*N zWvjy@pzmgtfO}Liph589Gw9h)niI=96LYLX!uZ5g-z|s>mcT>BQ@g=#fn5rX7+|g>@C^R@mb<0Nh3-W z+x-#)$k$dT{bp)=hmRZ=QD{0A!N{sE1WYS`LVeq;pGLBnqpVHnN>-s%!9v6S(%NxK zx3ugxgl*4ldh zz0AlEgag}n24l^YuBH7(^|K7ZV8i7q<>k4B3I;Bf5bvjE7||)M)3GyQb9SvP$So)t z`OKz!G`;&UL5NcSy_%;6Tr^tVl%0DUqcd*CpUq<}-31PZW$0wfFt)8&8KVsZpVFxlGijT_fSffaCyiC zkx`C^ss+L+@qnH}Pbl!P=opMrNv`279ii!nog-aSxP<1l;Eavh)9eh)0r(F}{_rh0 zVS{^C{_`*N?07h1gJL9ptawX(bp5eHj*CjWLJr2=z_u)*ap)r-k)qtZkI>qt{T+Oe z7oqgyk~{)pX8Qx~520KWq+B8svw-_6Bj%p~uLjL;+X7Cm8g4z0EnR~1sQ{SM+~IeG zfddvZ?&kwwhM^MgAx3 zFV6!JV0}K#e;o!K724QnxaAe|m+hab0k}QjJx5x$9T?;XiuTKZZ6L?N++pI*r0H*4 z+y9NBh0mW!j|rKI^DVrV0qzT}ZPqopa>#n;D>}_ErnrJj4UG+MXtLqPy8;#m4pz!z z!fI9=OCBc-gc}1*SzGC9R&2tB;K={lLwD~`C;#j3U`U@z%81tsAhvrOIAEsuA|BGN z_)A%U{{L8NP3r$fkYihOMLcN#OGRnR0~0h9Hy2-i2AmZOlq#j~ZQrlc0Je!>e$(k7 zu9rF5=MtK2)L3dVY2~c{fe=<703XRO#1Yeo%7S4($ClIoJ^~4;n}tu-uJ0{rfJJff zBzUm$mABCVZz%pQ-bplq<0Z?p(EmWq?<2iOak1#n2pXLX9g3-qK1EV9;G+BSA<-hwt4F3=X%PGVE1awmv< z9PHP+Zx~w*3mVoo6R`S!2A9{iptmV&-8PF-Y?!on%H?ZC!1(9nM^uAHnx_p4PC}#(j5DO z(K_2b!YVf5Ud*rh_!Do%WxdTy)U18-g16eHGG*h9Wn#BvNjhDSu3(V1EjY+$ z)s^l`iD%nKuK`|dR9gWfR00*McY>TON5@ZrE z29iB=r6Q_aQ=1vHwuizE^qZH3Vl6??JY)<7(bujhE-sTrJgL^wR;c;7M%}11LiL*|I28Y{D7Y9W_>ugy^Kqr2bt?9&R*xp~vENbU@@_1rJ4 zR4J4)JUOS*cB5F@^^nOys8@$eU=zZMFtwahxtq2@G3T-_-{elFLX1NUcx6SNrYL^Sx@gGM8kZ%qI?_I^{9J7! zqjWcs5lEhF<4i^U(P1~5O7IuEZ$Yd`iG#ZkCq81?kZ^GYdKo*XFil6*`5r#lG!aM# z2K#5VBOk*&nqdEDsu?cZmlDsM?n0!($)JnpM*@FBQ}~*EMwmtxSQD5z$5c@=g1E zqoc1eJ7%`e#9nf2XisI^DU+sssm=C}CU6F{K#r}}>x`}O>2!jD{Iyzl(#pe8f&xe4T^tXtIkY2B2n34f4h`IPS3D<=1WLuHNYaW{=7$8*bljkh1KH-2LL;x4?>?egw*4*9A9ebhFE{c{$)jfx&G zi=CEcGsJwvw;&M2AcafsGc7*9UpqJV<1iQ@OX?u1!>9ZcB1}{nm8@Ag|38qm?}hCp z8c&>>mtMbV*QH25jduGOP8*-rhv@=!JLNWQBefwV4A7ZXg@4!!qU_f_*slNb%hxfn ztJhQI{Vn16eDsfs1Z+`sSre>KL+_lvy|;Aw?CK$DDLCdqI->=mS%QyUn;n5ZzZs4u z>aupl#dI#^cx-KJ<^3A}ZXF!H@%h5>#x;0Q*+?acCCe0|)UAb~mqprcFeZAPH8a~d z#n^f6GmuU_|95M4cE2*~e3&V7T7^B^CV_|m)H~F#Pukra#gP;od(9S|JNRkJzJ_mJ z?4mkj_C(N{501d;iyu_zAD8p{)Uj3Imy;T?iQ3EubyIrPHW&%4$boqc7fF8r*akIv6~@RLi%b*rW;Iy_o{r^jLifd6EKTS*!+$J`86 zDi*Pl9R0%NYGOl~!-LH7ClL|$kS?q_t}I4AMD!HJ3~~?h!{dJwCb6A|!>dePK{>@Hu`p0K&u@TzE!Cw(WsJyJ44;fr zZr_tq_Llsir1htsKye-E{*Ii{ih_?5#w06Tbw#}!Bc;hziVFWk zLM~JPPeII;zF5ONHM|+ha#aI4awvYen+Bsnlv9p72xpYaHN)SOxs zGL8KmQ}iy9jY{;d)L|JyE*R6zvM1R}?fb0K*3O^5F_C_6Z$)O?=Q+qPt_3C5WtfLk zepe{6$A9-|PUA=;w%%^%9%+>QQ2(hP)_zXJxQ?P!q&_0@t}c$yT2*}{y}_(+Et zQdY5*S@o))Wp+wtN%C#$Iohf**q!$TGZIh-%W}|f5-JDw48v5!PH{vCG&pJx*+)h< zHf380;^^cH-HPdTnrw3eGg#x&S~EEjCi+(8u{*Xl82arMi>#`TsYY7UwPR7{L^czz z^7)qPOk8c!e4;mY;Tl4c-3YZk*`jK_M5~;bYGb!im=%oo%@<$0Vs5&8WWG_=2Rb=T zXP95dZg@oVClb0zBAH~kDIokiXlK!sxkKe(`+%4iff|!YYvBKK!#N?JctA;P*UQMXvEDgxFUK6^B*yofErV*S zhFS_uMFu{L1t%3bYq@47)bUjw-}x#;9M72FUz6plcua?|N!cP+0-3ecVbMzMsQ~{3 z5T_;Aa8WjP_65wGmx=&u*wjw0>VFYMmyXBNZbgsEIFgJS|%cxQaK)C>ncgsta!`dj$z=W;MbnDkb?C6 z%F9y=C_q5S{xp9Vx)6 z(!BD^xvifvtLlrUo1tTl1+q}1bM&-&xlEbxZ8QskDx-gZ|H!lC+f=I$p5X`Im@o8s zr3jEak-(J6d+b!vj~Y@4!%B=FH-O**B}n21pWtvUR%;uxd~>ij>+9pWjIlyTP}E&~ z8*;@ojAe`+3i*vh<`un3l%to)DQlh0wV^4|C3LQ#jZq#K&sTj8CXHOj)^RGXzp(!s zMrF@1mymgePGU7jRVsuMB(3No0_aP5bbzWmcoRb(JcB3!wr>Ln#z0apF&c8qSlIaiw!x%pR>Uf@4+VPH_Wo}KV zk?bLpWh5uYt&-5@C?PhaE4FD&LdP0M57vAHh0X34yf;!tfG(b9+6pl~<)b;ppv&t0 zz>4N}rMKj}?kEM(Z@396M~X#1#Z*36j=lqw z%~w8x!?p;wXP%7biE^Uj1jD{?O?#4NOVs$h@LiXPCa`JtAgb=~gp*qPyi0yy9GS0T z%W|cT2ZVP{_==J$ElendIp{tdG<|@&uw&lcGA`aI10@nrV$lG5jsU-2_inIP$(3l4MY0@Z9+Q*=~5vMd4QPwLa}Ubgu{~!+#NarBsEX1 z^)#`J3v148gwmYUn;D;EO((=niIS2PJ7T=#6i4EHvQ^!0&F$oJkI@3(iqWo6+Ju+L zT`8CR4MXAA*1hV^LP*bpYeu55>t?e8WmjY>FP_}?Vgmq$Yv<*h#+~(Rx~)s0*B-Hu z7KmM`bYSsxVAU&`DpV{WB2PTFz`g@GV}ewLq_QJFxVBnypv{wa|tk~a(U_y zkx*;|1|N7m8ZH4y^%Dv9Wl+Ax{Q`^0g*DUtL6>)M?n#gc+R(Zg!(ptdE zCK)GiigYGeH@&GadD%T8fJ-SFmuZ1e4jy0oX~a&79Cu1g>^UHq_1Fy5ydD>N6;7gP z0Gc$VN9-glun@IWi3g@}u_KnIwfggb{I=&PG5PAvHC@5W1mVwQr(~J48U{FT+)j2# zAEkV5jK+^e!1G=LJXBzb`AQJBHyqe{?}WiA8Q;60T?h`UjEUi&5=1sF4THUfxe9gP zb`V%LbphRWH{b`zn{|!-)kq2yy&^W~!z1(8x&(aeqrV4wLqMcZIgVIKAG6r zzqfb*d-|>cXzB_F8wrF^sSiRTdSC46uT` zi@7F}-x&1?>s>N9cAkSO5@f5ov$B0-jf>cwp! z3IvBi)Ql(1P^{p478t5bt>aL&H17=PEZ?*#Yr){nNJR*3Gv*be8$%ZA|CUw#&YR{f zRd_>YOTxKaE51RJhOCkw(jUt8}c`(Wqq^GgIPrPt-#7p zc+S^KBbgTM1D)tIjv5dF;KULSk!YmvQOKUnPWw=COD@eIZmK#Avt_9y&wOiqk>RKw zov+o486|nzEHt1p;zl2=ytZd48abz-QUl%(-$&DqP%-gcdHY!LXg-)3buB7^4~6MV zyqvf4W%|dGK(}-o_SIi`3l9D$`Eov5X?HEgFN|8b`a2cpnf=eelh!;;7YdIoQGHYTq3uQJ8zSawC(w_|& znE1Cdm21`JIpg+|vr81je{*J%Rz~gp5Q>IzBPR0(?hE79=u%VfoW`iI-Bpnu{S)U= z#rLE)edplX(RE1K;EEiI9 zm_%DE_eU1)c78E11_r;^%4yLbzvks1x!W83O~}t?a>4X*cF~`mLJ7lkJZn~p{G#5U zh`Wi=OEvz^<-Pen3xQ!i0nRjp?{X#~pKqRyyIn*0ZGvWNoNiiDgR6v<;vYGZKb%@N zTf{K@Qe>%*k5P1|E>0Z@hbDpJfmgrD8N`&AJwqC~J+WIBNu|>qV~TTS^87518dxz5 z=r~P^evpb?HxXhhP|9nczGVME+2MYGgjFmf%Dz0PS z?P)yQ^N&>Ox@A(UHT;Gk3-}Il{{xZt&-!snucj8sW#)h)?^`6u3vJ$-_sqqUG|$KMX=ax+7@$q-r0H%Wt9dVBgxXPypOH{IXw z87}%|dt*$;aHp8sbG^C}lDuQi_)79CH^V|g7nzJ2Z>S^e?d3u+)_+oI(Ca#>R7ry%9g{AXHoeVS86E z@!BtkY~SNkc|x_tSry8;MxCn}1c&+$N+Tsc1;s-jb8Rl%`kHEWTBjJ(`18{^{PeY8 z!h3?77cU8`zn-c5whDy0+7gV*3k7JLVVHy={R2G{se%7+lHO#S=ec$zD5)PQ&4SRy zOwxS5mU<5V{P1M3qx!|D1$~T?{BYYab8fo-H}kd7K6b9_LP^QK={835Jv`KEgpyK! z{P|MXCNDTPE;is#LaKHx1TszUn5(ao(Q9nlP>S}pAKJu;rE+7f)HNHk->PUiE7hk& z$H@NHcT8aLLkPrB^O(a#g*KvE=}*i$2*Djo#XXDe$>hwf(uIR=%^%e0E1eO;)3;Mv@_87R365K$SZ>ERq_ztPjh@cNub zsqw6U|1-_BzkGN7=Jzx4=H}>#RaY!FaVO*HDW6Y0}9j_Hprek((x38i4L9jn+j#}{^@>lIyqFlqWThmewxn_Pb2e@oeb1gF+*32pn7@CM zxh9CDlM2UqFgs(BamP7K&OH3ng6{{>JwR^0-E!qSJL&W$uIt@*|G3}DGR=Txykk-tFol%9mTEYt!ZXnXoeS!|>5`B;DAskHB}PlXGvTk5k+>iC;|&L=}1s z+&)E#tNmi1RAQlM_JbdMtNhJp3!xM!zyy>wTymrPh7u-nHdT zC}>^|RhAT^Je1!@pz<9(@Vr67ez|{)3UesFcOli+*dlw3u|Zat%s7(b4U?N|V9@i5*5+R30`cV6&FBhE$o z=ZwI_aZ$oH8ha|v8Vm|5EKzHPO%g3hJStIN-%3}wO4$)w>(*-1y2j6TpMy)Ew6wh* zmSvd7X?ew4X6Jv)PcmeekcQ#&DzPdfh;l1>NCjx3vjGtc!xnzlH`(ESan+G)62DHUMD273d{U_}MXr*q z1Q;n!f5bV8i?yycSiV;2L?;TqKv8YT(Zl#k+i$#>(G=$NRF)WC1 z37f@aR0Ee6HqM-dqt266%x>=4VfO}F1|BGE!pLA%^)l%E5I}nglnR}B^1?L|f!8L% zBE9ho2nEXI&95gSAuJ;B4-X#+GIMJNGFe~rELR~%7;qvr^BN#l70U_CQ17j@ZTT^S z3Y>g~i#Of-nZsN*0H_w85~&ea31uZOI3b>ak`D4@4WzYD9j;SWTsoi_%f>+dtRc43 zHIq73hL@|W*sT#MtE1?uJ6_Il>g4n!%Q())-9|x9T15;|MR6mN4J~4=j<*Tn9@eyu zvBlVyqivAdESxEmNio$iHya9#GGRpUr>)SR!>>rCUn0vVQxzVn%B}ulHma<2lsLq0 zK>w0Sxg9LHLvE2MOuGSW8h*Ov+%IAnJG1h|P*6eVPf-ptfJjAU9?cx@M8w#?*9 zf0DevLY$<=hr=EcpY=>s1$xsqy8=f$mBEN#cQ86)_RxMI2iOZ1!J#H|>-ccij)hx`^)z|z4 zF?SApE@4z$M;k{2qttwpLGIsWgieP2I&l}+ezwE7FJn#gYw z)xKONZ=uRy%kNW6^HFW@lTrsOo6hTO3sMn5NK ztJo*!TOg!5O=uI5^9XFCc`q>JLJ?;@lbgxEc>{yk68=Y&j>Vmf^}^305FU{!?)%Q7 zREX;2S{i~Rt!T_&>B{Jz#viE2s#lKg&mLx00#v`%q6%`A)s|A-(e@RMC2Fe#z!@w{ z;;`f9xmkqzssPq=`%FGEEmQ;c;ZtI2p_IlrGUfmkElv|1)1#AdCIV(`YaswGjmP6>BD_iK+P8(G$b^#Nj4 z(X#@G@SM8=P+Rjc4CMMS>;Uz9vqV9j^h4}}Qn8b0R4BE$6xy4v!DSwn$swurhHo>- z$T`F!-o_P;4DH@poy^LDovA~5uD>}_Dlp9uJ5dMPJ+P`*5K9YWpgy#NDD?Xlh`1d> z9R>twJ3yQ!p6G0!2gimjd}CC~mtRy_w}nOonOqz9MP$|&aafFbw*H$v=;%G*=8sc3 zrbrk>S%ULLgak9hXuQeCbg>Y(8`ce(9H>W?GEJ>{k^+_dmZk>@sIEJ#4SIc}`&%`9 zgItKxn(A4P5Q?)k0s56Y>lJ%y;Bl_-YY;P+T}W9TsGJcw$@yGGt4=GNz))SrqfT|} zQE}D6 z6wu^Ki@4r~Ip`y##w8qzV9a#`5`I(!jhnJBG8&IgNX=)(QhW{zMc@qN05J}Ny3@kE zL7;`X{SaEjH=-J!vkgGR-Qerk9~A6rr7Wr{9!+v+IFUbDR1%&CQH)su%!9<@HyElc z6P@uOieMP9)Zh*XYr{KV3dN@?`)dgZ77Myj0`ddFCN8vFXCMR$RBI5bGJ#Mi!nuTn zSRkZ3S(92pVZ6%V0C8T0IDZ$ixBNf2#>3E{;5DPZ<8PffQhRczf~+hUQ7DOt7Mp17 zszcK7abjTWa?%9byV%*E_Vq3qnIWjW7Vn1zpX~b#UPgm5KO%j>ctyJLCxW*4QoFfj z@^W)?i^NcQ+P;BC?i~K<4Kx`M6^ZSbO-(>5dm{MMA&kfzupAe8PUEJhmS^oM%yTpi z*pvn3%GraS5rIFKsC`K;dS2P50DorQ$Do#b$*j$JU8kvB1JtzHI(1~$NY+s0dNBKR z>L&urqcQo!eiDe=i=+oXsimr+QVqPO&Q9IT_O0jefg-z$FD*xL3h&f$g2}LmO)=fy zD}F7hCLqlmvriATdr@EA0#oKQ>Z`smu zEw)4IBkQ!TBly9XPq(HsrDR?8?uRRz3jyD3Hwc3T&^bpC{WZU7-HbU-t`qSjOygHc zb?@m_tJgcv%=l7s9#n22jGsM|TEoQh4|7dnWh6b4nxH0C1?}iJGlkr+uc*3q-k+~u zMm&kNgT6cwGE8~|v}nmXX3wH4$Tvv2c>&e7#?|QZ?h|@$&0qYKYH}r6*J95-Zo&=g zbP8uZAofACgK#-i_B~~3eJv_P~lb`C`Q!S-$pAV zy6%Ph?*%GQspIJmTI0sf3tUOLk5x!&Y{wKvA@_o|%r8U*bGv_Ge|?ifUI!QUE$h@^ zeeRh`F6Ocs98@m;ElZTi0E4O;9)~HfCwKG?4ewI|2fDx%>B^!sGch{I`j zoPX6(MMIHoK~{mAY70E0|dt~Ny+dZ z`HY*vkpUd`xON(XlX9qcpbeyZXn^&35uNSI_2kCw;-ODzj@(SrhAE{Pp%{`=Pov}Y zq3fH2IT}y2x^Fr8zEq%dRkwzcl=rrU?7OKy^!fFl%IAsndMU=h4SQmWgQxz$4P0%! zDa8(zAna=2_exes$tb;@Yb>TSWUBsX-?+=iqv1x8=Vs*Q@q92$o#bEj)#>~mh@L9xORrxrXS}f zscA2;%+HqFT1{WS1|@#i$LNCc6A<+Ez{I&Ozf3{29bKzv_)#tfR)4rbLA6HE&d*5Aa_l5ZQHJhMtKBotukoe!#x3G?6)NqUsc~`SM_YQV#?t9W@jugnqo9?K_n#{ypc4pEf zU0MF(MKAjh*O1V?3>j=|(7sqMld=3>!RAiqFXK|Szkp#pQ}xw(SGF`t7O9na>F5TZ zBQ?q#DnG5ungeMyQZNEd<9cCWd zpr1xZ%O#h^7CVTujI24z?3Urusc=*K8(jK<^}5`gg!dgJQ|F$iPNF>4xIt(`$Hdi$ z0K3 zK_D{Qn0NVzQss`2?U;Y`r)Zq6Hil;|2F9`DTz7lcluM1JJsW&8cw^0oV}}gd z_=&GkJ48Xe&5vqS!gw^@8wXCT?o`3m1G9DH7P<(-K1P?Bi;Bo**~2;1QtquIPx{R@ zgKRNn!o~{EcR)=G-3cqIiUl@@1T=x?0NE}rRj9HA1ZwrBM%gF#rHk?vDgj#WihDk^jH z-(CA2e=5hfH9uBOBvwBAK0C!VD}Oy9$+$D}>H2zr>1~)@eDTbyl`#6cvs?Q&hCo40 z&{1a|T14pOhS`3)kldq_Ud=FJO?<0!merh=*7B`F8(;8kK@h}1t>8~kd}l9y^*Lv0 zq;uoG(Ic8}ht6>NC9t#i%mb3EG6Jqlqld54#Fa09=@le4+@f!-w2hOAwd3Gh{9Lt3 zN@Fv;eC>1&N7*DZFp305Q%9kG3l4_vUlNVw@R&3e^4%)raYFa;iG^f z_CD(?|Bq$b^y4qax3R7tZN?_8ZGx5Y4@WHK^(?#_u7alr$^>K2oo2X%SD-251#nwlvkds<=$g@OYRoj+Tbx~Tau z4c+4+O(??R^a%w5`Xqwyh0RZgLnCwkDuVii!*_$pjAJinMOrI`(Q~8wHi>t z$nwM=9?#9a4Zc(IbnP>0B{6Fqi!;=xN?UjWNKPMyt6C`-V{p&uixqU@sjh`C3M#Ym z4bi-g=L1f;(tOEdlSGZh4tiL-O~u}F3Y7|ErV(4tOoL|Cjqlku{#j|@e#f818zT)P!W!y@*w}!@*mWIxOm(}e;a&;@ZOqGe6m1UBeTn}Q@LF0Fq=dRo(^_0EG2nT!U z_Ew8adUR=!o;-_B27ng;Qrni-`!{lW;85_hO7R{gN%CDMW7RZ^Xn{j0cgcIeRZjJJ z)VjHdp~Bili>F3^;YPK@B@GQZa5`Q}s3$s|#&hjcVtenJmdaIV(3eZ;D1)7JZ1v=x zb=%IZ4cnDciyzZv5-vE|XCG6yrC~o7czQj8%)YV0*gCeIed>v8MtZcgSj;(*eEE}j zRcF)Zjo&6w+|8%H9OQ+`M>ndnXENSyPb1)!xs*sZ|B4h6DdX9~(3!J~o>{s|%j~}m z?f#=v?s|o;YElNVt6qL9)r%%cN;6KW>Mko{&~hG4mBBTw)aZCCqq%0JU30GE1M-c~ zbP(hjG`_@ZKgz{;^+?#Nm@!GXR1700!^>jR=6d#5ZaBke%W&`BKgu-<6`uScV@xUM zwC7SgR7Vu<{;s0qh5jaTehSx{Lk$1A?$FXtSOL0u;VO?Vdg-;zym}TOh?1T+dN*Xl zWgFG{#Xn7LP!g2%b4k3KQhknDdK{t9gW5W;m~J7Mwz<4@BsY0M$QS!FO_5BsH`ti2 zgC?mxwvAb8X!yxCo-sM^R{II<5W&G~jNMjcJ{zR=b++WR zGc6+hE?5Epo+Sz86X;k(Sam9FD5ULTTAN=jC z6t-4kBS-?BcMvH8gxuPRs)2U4u&%=p*3DGK`7wp662!yo)-?+POuRT$^qR{CA01UZGZ_o^C#94q zhao#Jm|Ho(8?5Wzc?j9_UL#M-%9MPG3vq_(r66e6TpuwOYr~(UCxMgjCv(e#k!}Th zT(vpL%ZoOp95yzYB?5}BsIESt?Re#=QfV{%Qo2al~kz@bq?{BZ|wjWrH7W1Z(U|8-u7l@}<_dp}3r1q`=S)MgweGL_Z~E z7b+h~t#M!e299R8G;UApQ%jBySdkLGm%4Iet;>Y)I}&^3m7sHgl^Nk{U_Jqponhbl zvPY3M>NFHm%q~#Qe&OW}=174?i7irF{ps)b=PjHW^A>yzu&K`RWqV*I)A_0p4P%0^ zF|p&gaX!#j*j^e*NZN>xzsqLxnc{ZM(yk58zg5A6w5+UREbXL9QU(R_Aw4q9eY9qZ zc@g_&{T!NQIl_v7k)f9m<{o<&=bohGPbZ0=EdDP3oatUgT+?NpPU*SMj#^Pzy}9@b zdGp+RYge4q%QWG9S*@admX=Noli}BQ&8Cpc{&J0|>-ko3ERC7Ui+ttaCyW1qsxX4> zQ$G9sW*8t2pyhF7b1NIUu27Q61^NQWa@goh%&UFulzNRZG`O(h0FCHmXbk~;bV{Xf z(FVEC6zZlUzCGwmLuEy=&$&)#L6O@(Dp2z$J{PN#=#!#vez12e^uTapgds2_%4R7% zG%Nj6JH}5ykHXOZI3LtX2+*Ro{$_dFeBt-G15rte9`rxHQ2w#8v2T76kslG*T0@hX zv#n6>=y>_{E%+9BBzDVwy(}pCx~y_*DBFfnXi3z+m#{>yLh`=J*%3!EL8Tu-?A$fZTYa*f;+JVQ`>EO9*D|1&3C(?~|ld5Wu=p@*md)R|CDPzy#!G4u zl?%@{3aRs)rPP-`F4IwtAN%pZuv`A0?Wl;TS@})F6$4?O9%=-oIh5Ika*cq zG1^h&oDFV;Leb#&p;!%K1mPJllZzAZ^1FAb0!nXL+2Dg{-$ODbWrnA2LPc{Zb2WDZ z&PKGRnth;dVi({Uu?Fq+>=tN*quAEg1TvGNdeMbjT9$(Os#yBT5hYQvwb~i1BbQZ^ z{anuHC~v8avMmGF-9ZK7(V7wZm?G=M>e*LI%?xBldqo+-T?a#z3AkMWfAR9OF6XIM z>2IKbFE~4RR-GKztfTiV11&>-z@rkf&sQxEY?qJuY_PYI?9DAwzC(gIFUCC5Aw(st z^tD9X?w?uETO|nK?Am9D!*E&1s(E8YP(mazS5h9Y<1Q|+D6G-|dvvlW)pKmL9AoS) zdRB-s{^+?V%CbcAE7DJnOyyC|kuXmA{TW#%2r26l2+n4fxc8A3kIku{GH&EH36*Qc5Y#13~PPQ79)k@5(&0-S{94GW;Z0EBj z%1uG8H_3~0IzDDKT#lpN`(8-`{rjSdzJ|?5I!%7D8lgJgkOpZQpP8|3Hy`VURU>R~#mYW(xyEjS5a6?U<_xI&0DK*%vam&gz53 z5QxDPk;#9GUcO!}J0Q$uUEmPCtllF4TcRLn{340`Kak>0c=fp-v7zm%uL)X`*N1^BjF42Et>gOrN^5Ngw#5*XMbk{MzseadepvH-h$%cmrT z{P9o24-B!%EKUZ#ChrAT2Ne=~gx6yjtXuj0S4}UpqU2;vDg|!`3Z*P(53YFG?{!hn2 zn4*?ERzdutDMNS?DYJ1^Xl7ksW9mXLE>FogG}Xhu&jTx&6UkI8&>g(Y>MBOl0eVA; z=BejNTil8sdbVIW+Po+Xirw23!6rH9GN@~q#9x${tL=#1B*SS#epey6)EHFmfJ56_ z!YRaf(sS1Z!6`&Y%UD5+0~bDOSS@yiPQ)VhvusH3GVpb1Ewe3StBKfjm7T( z7z){(Rjw{K=pYNTD{dlLUg!zF<5&Xd+nRVZMfNZqvsAj3i|#twI0i|1M%Ug+x_ms~ z3Oz2;Sy?9KT?O>C3=y#E!<{Cgz_(*sIc zbj#g6bdH=3iEn84iOb;tQI>2J*a8UjfC8{NX8Wke4x3AsQqFAwfDL?^iGTxw8y0{J z19r9Z$SVV97$}1oe6;GR~u8CYG62P zw828YvBG?#rbjFtXr1*HiaM7{N+;HpG!T>gkoo8YeK1LFB$jjW} z;CjFY!ck$U_{R>J(cc;f4%x1(vRdhwz!yNvthfr4U^wC zh;4SwucQYoGpYb;MW8xhVdN2HfC2hibqJ^$-9Aq;(Jhkt+@!?(hJ4 zu%}aP%m+*o&HFg-8y^S&&u(Du+Wv9I0hZAN&JqXz)tR$Y++4vSi5eLk$3Q<=p5jsp z6m;E6x^2(^W6wXdVfL5r=xn?e`oB|dRASYXp;Y=`mD>i=={bUat90yDqPm3Z z3755D=kye~W+>!v?klA{W?!A9dny8y=5`fiHX6BBZ3V-Z-$K`W-i1fnaD2Z?5iT8( zCl_PNpA~A$r&F-SI}oXsT5-w$0ApKn`IM8Jmimb1G)=im`#>tgOU3p)$t2sWT#;8e zTjW2?aVBGjAq`K}u3)(J5 z+?uD78w-+`<&&aCh$h|^w@(I! zxSW}XmzMd;KtHxcuL)-mY4wR$iwW13+euOL2^YVXvD*_ytmMKetn;RnmgUszZ3K&e zr7YPY&k=oq>S5?dP}H3qiY6;nE@oBPqb`OE>y{%aX-uhYsDSEJa-f5kygtgj;$AiP z@*?EicqJ=nc5T+su;Lq2Z7C@^th~2S)57BZu<~{EBek*7t;)GR;w4%olqo7%QW7tj zDgfpuVW=a{@TNA0KL|8{&~C)HU@zpIHHRQIG3=l=TM0^y@|$18c>JPdIiZ$9nx|-! z!~8=xhw)-k#GKsf(@d(iGRxaV7GH5{0WLNO3Mm8vY(O23}zsrER0ziln$l=%2pU?RfvBaLiGq`PQn4vhC z`F`@0%+k-bdLh)HC1=1dDf5Z3;?%k9IS5yo6RH?uN`mN?sLD-9%>Mv^nryVA=A7Q} z@F}>77Wz~85>}Az;h7w#A_(v{gzICz8Z2M2?-A3CX-?sZ#HZS6spc_j2OO7C)S~9) zNH)EI8AuS;NcAF4li%P;7v)^0s0H_suXVxhpVdAJ9a9WMi#1024dK)2nh3NltduwDQ8- z1m;z&PU6~Fkrw_JFEXD{_He42yi-L)!;+6B6OSQkWkpLlP)I%Ft&W5UPKxynLdzM` zQ4M5>Kq^3Ehr7{hzZ3&bWHsWqT&2k7oXVyEX z^E#NJnZwJMYH6`78(_>dLP9Kzi7CuT*m=h^{(`JtVJbwl-BB+~rI3aiH!TF)GR~JN z>tTP4a#7q`W{xC7!b#B5tW`Ae@zW_koI#uX*&-|QBStu;*0F<&6Pcyya!8jbT&`uj zr7d5j<(s4wr{7Toqj3#6(!Rr*EJ1d6ugcJ8XC@eznoNTsN=oWzNLtplWiGaKO_r@m z_lO(9Gd?<5PZ_Mf99yZkzF5l2>w=8C6o^fmXUN_l?bnww za*Z7R4Pr_9b|aQWLZK}(TyaTxPP+16O~Q&&mfW%u0;~W48$u;bT`_!#5lP~Mb&O$9 zr!)zclb6i<;@qSx>t!zX2HibjJ{>FXVwCoxH6w|Vc*3ZeB?smlb$MHtAE81*$SZM8 zsNE$xjKipbV`*RJKBk+ZK-O_2h8>i8RfV$3gDwWzYbaInn-G!L*LYlHb;izh4-|@o zvqYKXrKa0Mt6kebAqlxBL2Y$AL;C(dpp72^MmWtu!!m1eGX`<_0;io~Pzq>meSLlXk7*uQgR;kNOyGD>^PDNoM6owEgl1 zZt2uSIq@qV?eEKOUouR1cRiBZpY#;8tOqcpFsa$+UQE2p(+x|p{MuDWc$7=Drjy=K zKqW~8+WP7&BBLi5<;iTgm2qw-olKo^PEyw1RXF$(;T^?Z z!@FPw;^zmnTd3vuTIY3p-!zKcycKT`N6VdTAS7{J7HVWmOiVq6YidI-avpZ{g_n`c zNT|%M1wGlai0vX{56skN88fPRDwvg1XmKsAVZ^ev1c0W6vgKXD1c-Yd8kCcN z$YUo8+H_;#e*xzBLgb6`v+~m>Nr{P6rQHIWcP*Um?C8jlu7x)iiC*z-y|-j<2CJUL zyKfw~Pi0G(X;y6kPP!9j^i9;DRc!^gJt5Vb$V0?e!`SnNIKH^4iCHr{ReAF0Q*4(U zTZuQ$n;mUy-)jrSgOiMH>~=6s(&kN<>WtLnkgaoqd#W3QxL5n{8NMevlG~#+STQ)g z`k^5#9Hl%aB}gXLQWdh()ea87s!ya=#%?ax-;@0d2Nfkx@8BWV+4~I6Oubo?mVGF6 z0Q`dv@>)Ze)y_+HvX4`H9qksL^xSQ4UaR>K7A-EG*Vm)|W_56j3$TJ$OnpZ7w>iR3 zpT0DP{q{?s;>CSImEe9AUH<^$gc17Ax%m}BqsPy(5iT8fE8CCUO~BH*WGM7$nsriI zXr=caWVDo_Hw0L%MOlrAxEgn_8jc%OmAc(@DDzTuj$RbTQuR<0Lu4puY?71t#e!5r zvS)TYVG_c&MpUFsu%oa8>aI_ajQ;?&7VF?z@LZqA_7j|coJwmCt%8ROj3I5PSxHrZ zwxe|GeIq{ie|?K}$VAQwcQDJ6gywWUl_KM+6pmpB$g58%LUhiZTE!wq5jtII)d__t z6JvX27P@RM4%ddYG$|vT<{Fc!)H$^zHeL*rJIopqKSuIF-6UNuU#xLSrLo;6<|MbaBt&nydeqq7AN17T$Ho3O3I*T8sx1aT~TH^g-T!WZ{tWT{d$m5S0bQGy* z%ujmRb6WPlLVO}bP}4iyO{=?xl`a`ln<j=}tJ znxiet@?k}pmIKx=^Ez}yUzb#PBna+7i z08+Ij77Eh$(mNcE8&H`?SMnRmmk;R}K)6vdfB3I zDvn@X=;pV88KCuTfee0b~x7c~<3BAxzr@|7es6GXjlVS=~2m>yo{rqE+V1?Eb zq`6teEJ{1|a;#-8I1^%k=r<)>0qdZSY?s7KAM9I+1nVfJs3$a<$~lO>R~a7QH{7RC zdTXZez_K{eDQ;4xmsM*nM9l_32T^TEBYO~Z@w7W9YKF;+!`b<7VViPH=6#n-ifzye zKvC~^IuxBX*cguX6Cv!uHRmRjkn)flIaY->ke0|-***>=-757SFzzXCL(LtB;}9b_ zMZWB9_%>oV)FGS&Iz{R;%+?LZM(Fn{-6OUX4<_(fPzGEWEGY0`L19O^Fj!Clm@Fta zDmZqGf?PNWxCC_SeItix*HEzlfPF>aItrOfyP*fwA_Jzn>8t^(4EplZf65Yc*psC* zxM8pPrk~*nV&Zihrm-{KQ!QKe1T@FuNBk{CmzTvA1-8pb2xX!&pbbs+&~N9wHo1;I zLeZ=TOnGZ6lb2eSvZWO^4awA

#5MVEGBTfi9UTT#bvkc|%VGk3SzM?Hm=U!c^po z2{~{F__Y532q@{W))|m!{{YA<1JShq00CiUg9&4V9!DD=5B)O<^%RA;y`(%~cYy&X`JEHz5uLf$3pzJfTz|MWctWP0cL~ zRO$(7umY^`BR7EVordwsIw;!Vqp04eK7ZvX{{U7yq%7!3@bYc4a@A*m>Gi+tj#VAz zY2q##O;%)PCD&J<2vP`AlI@7Ufwk`(Xi^yt1@PHac~|8G^wvpPwWNUI9Nmr9K)F9C zO<1<Mg#<=tCKdG#+vgKVwkHc%cW1-OT>xT9hGMA*vo>npcY%mn`c zm1tEQG$yE3Y(dOz=h<9K;vgD(viV+`2rB!@&jXT>W-cp!KHM zk(FstAXsRt5v(OE1_eKdHL|kvldS5H0zy;}E!86X`RfkGEM`o~o)Og2bBWP&uiLSO z=woK%ygRFlWtnVS!A|S=$8@kXCosi!T`58pEbY#vPCk+cj)z$8mU8|A`TPLH<9wC4 z@KTU-WO+bsuJ?{H#E7TCyat5S>P?BMw$m);M3g&Xp}p2^-Xi)!V#g;NC4z90vW%1S zx{vUH{^*kuB#bG*@7Ug@Ij`%d{aA2rtmnIe=b8jJQ-5Bo%A@&5P?o&T1|!0ll3Glf zZAC6jq>BfVY@yfPvA=|LC|KcY6+)hQlaq^llmMp48A7_0_22N0oJd%5f{X_OyD6Al z5$OOlU<_V5CWDz+EbSQi8DI(rmIMbVI#8QxAUa}GHrfE7?aOnB7X!?j2m-7JrIOmR zgL`!wd>{sb`zSjI0)Q-m08j;#_`nnpvRGm;lP!PXTac#A zIzq?@I}4wXivA;!d%(ME;zg=Q7bFRkmb1mngxEH1dv!h$j?D|)^b9Vx9l5M+BF}ln zln>TP0xRN)(mB;0BvK`t3vzXYB%1=Ifv<+998qIZXC9-8sf_^Y=2&bUl%=INzkxB- ztY$|kSkjwoiRpWI^OO8x%3~&39w^gfSFJ)+r~XT)_`~r`k0ysITNubp0Hn^aLH__8 zpW_M}qC57A#PnIZ9Lg6pD!0K&Z8^|Yn)Vj!{2|u=3|4{b)-}QZ*Bfsi->CC4c6+ zKa6urJ7%3nA4*D=)WqbogsmY%o{bWHm4|B6D#bkXHf?+ z_d(a=0n;CHSmz!a2mk`um`-IaARn{#zEA;>1hZ>i!^QwKYDltz?E*N>X_mRRQL#O3 z05m8inz}CF>81KWD8OZs@FSR#e2f4mkuF*$!$|0pW?AJnq7X6f$30{CDaX5 zx>P?eIN+0@z$-~}I8C<%>+*n6s^f}S&}rgE@zaL=E?+x&)!kNW0(PRe0(mEGMB6>~L*=`U(AlMuH;5g2dpqi6%heOJ|x=6?1zLac-B69Y!Qp-j+~8T9*R$1ft(F z1qQExrI@Jz(B~@dlcQ~p?YbRc6=GHP=BKk1BFRX(Cg1@8kwrt0b;)GB&_PioU0eJk zj9g8{NzFIkP(VK${Gd8&2Hg%9GhBh*Hn6vc@PGqKP~DnAa>mEqK+t-s1Bn`wG6q>$ zN|K@mxq5kC1GHvlP!^Q5sHM%4FJgau00fkasa|!YsQ9b*UO06lB>b6v>HzE305Hu< zxkhX_R+D{^xz-M6IRHJXS+MB{2{zGM@8Tdkxskc~sihC*;Uy;dl9C6+m?$mwFjSm* z$h30?xdm(^yiQZImFST-aznU1N`7OLJC9`KA`8SyINk z56t*S0a&JzX~{Gx#TJ}WweOpl;J!y1ZlvmkmfLnaWe4z%(Z?fdNVveUNwu`LrZ~={ zQPnu;H%~6xSa-g0(}H;pxh(izMG~Hh1e5C>5O?R6gbr=el%KMrV}BtW6xpiNqav&b zxa%DR%|~8#Oy$vS_>DmL#|~W?rK)cOW;2WQ1m*t#WO9z`>~-6zEso$;Wu5J*zwnMw zwIE-ec3-*{r7c|s!U{WPc^5s7!A)l;bC&VObvirBEhJ__GN|+d-#AFKgxsr7x(d>u zp|Lw($~q(k)R<-LuOyzABlpK>=A>=ZUQD`>w4@Xcht4>Twi0EQfetfl#B}Ka(+s2K zIn=FGov#2Ub>-HnpjL#ZP0hw{;~W&3m8mf_-OHC*-8qJlz&Ubq$1;+v!6513^NxZr ziH9YZ^>=dK0ICC=jIT?$>deB%QU-~>zbFoeLy4SmHq=_?`#>DePRSLUwi2IBFY6pS z%ubgZKti&BHX#21zs3WG{G{TU867RD2TO$m0ILVM%1Hv`?Qh*^0M?LvrDaM=j+zT! zUpN69WkQ}XZZ?nxH#fa*BTPNijFTr7eCfGo_!=d+<9!>zaRfDD@Q}5KwA2(Kd!gXGjY0yl_>U?9a0^VictM?Hr@F7JcCA zlaWHh-XOpYnU+$Z5|w5ruSnt0!Q~`a+TK9Gbn<4CFoKYye+{5HVc2y@(RL~PU^;0! zrdm3cC)8>9KyVZ#r#r}6SK=>t0K~VPnA0%`>Jy{@ZYt8v-K6FxZx4(BVVpvWLW^l9 zsYtlLoCi(j(wWA<2W`?1?tl#`$+0X#Y%TcyFaeRNq|GG#TC(*df%1S2W>gq9Kv47R z9AIqBAyS>}#lU)Iy1r4vrb#)2IzFr|2dG%EjsQuSa7~;D&*GD;01JdB$WcfK?<&v$ zS0x0wE-{qYYCnVkYD&1N({{+s;9vt~bLwZh;#Qy8{m>n=RfZjLdBVG%4)5>+1BXTT z(yaoLpIsmn*@>qEV&tV)>$rg7v(Ie;=dV$;2W-OI$bETIfUP%xEbvmLiApmI`I0^m z95b1R4|QrO^9NWC*^y4%1eInd%UA^)2|%^30Uj^`uH>_$P?Q_>fDixHwMUsSe`~0*KE+2n?eTLbYx|*gg+ehl# z_m+0QfE_%5*hIe-rC0G|S`nxuS_&#HpshrL>NAVQ@jcfc3aOu#rg`?BttDntWZdzUs#5Z~(0U z))3upDy-|$C0e9D(IkSkY6_I2W1zmUhU{6nCtqh2R9!PEDPml>l>&OpDI{twp(Yho z_t0+p3OB3r^Nu*ToC#9NHwjw3J6Jp< zmzE_33rmPC6_*k__DLY-BtSopOO|$2aEt2$QkvapKhK8Be@roLTs+0r=h*Uz7aCdVI$R1*t$fkUN<#=x?+; z0jZ9@7IMjCbWli)_sZBBiqzS%at zkub7UoAe6I2aH)miBjj!=lUT_R5^0_enfVl@P~+8Gp)(inWv@KWR~NACFW8bZL#%; zJ>#O1NKM7bIs!yZj+rXD{zP2Ue-hrX-Ca25RTFF^OS=1MThi{Fz+7LJqhYFVY{{_^ z6+?Z7Cn{T-l?en$FCrF|9c~5tzZ1N5sv1nj6C5~XN@KKe$(9NWG9?y{iDJ_TwjNvQ zAQ8$RnTc3PTtOIQX-cHw>}uP&d(*BsGLS}9%eQT|Hr#F^%J1k^G5-MJl}u8wvlBrI zQdntD6c2ep0GkW-AZZ z(ts9}T|iu29{4uB`f4JtBr5LtmJpTlBVA_&w^K_9o2e~Q&AFNBMrB?JeXvOlmoo(? zOI(i+2!|J^&*aH(f3!HVsKV^aIVUeibxgVq!kTeJ5-o70l626GdP8!)!-;u{UIgJ+ z>9o{SoHJ8MmQui-n99?ZQNJu85^RxRE=~8mM#{B2s`?9Gg>(H!GNr=i>JAqc;97_P zm9`16+g&#C-WX~3`W;gk6!5;Ch${683$jWwi*2Xem`lrP4!q$~N=s=V_icOL-7OER z+1}_Jgzaa64e)ZF?3D->=BCLg$n$A+Wj)}Kr_@Hm_So$XJyUz{=qe2^TMgY;5Z5sa zb5g>j?2!#23T0I5yoFd_E3N%ni8mytKn=Zi>YigG%j+s17UfB6hnG+%tDC2h0fv?9tuyF=D99MUlHH+ z>R_Jj359}?!;@~brweIPmcyWwybFs~i9d9qR`+^GR|Pll@3&pwUy;Yf#e92x5!9*i zmj+@c)Q4tLw%!LaRVw<0-A5>E%doR#>(Cp65@UvV-SX?#wS5r8vPMdu-%+Qb;Mz6~ zTk|+S6pAKQIHgO3^QF?3(3Zkf)As`F8P>64ti%Ynj}+hWt9|)DqAOk%({CdLE?3ZSn=0CL`R-Z-%~<= ziE^}nnQ2Z;vh0$SkX=%cbO%6fevxGvY2~-nfhB%tD;VJk&LyRpX~j6H2OE6MqgImQ zN-PtYSwh6-(|cIMiM6;Y8CnNt3>U(g$$FhJw5Dyfgr$Dc>aqob3W^k>6ad^?&J4Uv zrm4HKUK}be=#fd0l~;MG)`26udLM=2sp3niY_nfRYP~Ne#;#8@n{N-u$2<$_j`;P^ z%}lXWk%QDiusFKyG{d_*o7TwSKDZdsI-HT4!QRHQ3fu<8qg-$HI}`oqi0Ih6>; z+0RVFEw~y^X9(~~(il|7$Q|3K1V~FJO12qsQ%|eeooOwsmw*>St}YU!>^i6)DAId7 zBmN#;cPe1O-oBnIN+Xjko(276{Wj!)DjMt%5QzgtWoiNYRylT7JNPp z19!#x0w`5>n(LC@-dJnv^QxYk9+#+Ustg2yR<3 zXz5|ehiWSdW8MpKwnkD&?*OaxwZPsHB}Y)>rG#R^nbwCoT&psIy~2}~U$mQzwGh+T zQrJsWF8&_fDjb7?8gYn*B})T6JmUwCj!%>rJ6RtoKMz zJ<)Fyv^e5%F)3QBrc|kF7E06JzP9m)qZ=EOp))T>Zx_0iEoIF11e@qKAA~;Tpl?p0 zDKm$gka(d=%Ggqqn2YRfu!myp4LH%>qfljpyYD?Pw%kTfXKg9CcIvW;KV$)}yTI5e znw3en5Dw6CR?23YrkJkAeJu%Lu*6sHn0_&E>U#q zG&z!Ww#E@9OzLA>LjHTqK-n`XJ9PtCRJQaui9vz+RQJ^=kd#bJO-usni69|KvQul= z=CK||#urcN^c(iI|j?0cM-@jlT!T z#qokgO(-h~M;s^U6u_V561Nl=2$P+-!MG$I4E0A*fK1qTeO3p+tfxgB7$ zlw&NYY+$gX7a)@bg&B~+5y4bxOkKla91_j>aI_ByOB_c^S*4uHBwEHAlOKv195pPX zT&lU?+dzB-Ho1#@h1!(4RP#UFp9paby^V@wld|BQ*0Y&jrWPeCJA9XpwjVeSnv+Rd z3KD(gn+V_;aa_8QOn3pVLvNHa$tevF1|`m5jGW-9DV%S~*8Ts5r&R(h38qH7?^)D?l2Xd~RW; zJhnp*!d8@#QMlfD+x`*Aosi>UEHc&>4z((rt-9fI-UV8n{Pl&THrbZ4`|h}zHVvG2 z-&fpksr5SuR*@~8;K`IoZLwse03e{V5;@n@Ko%AD-I`h&BFVmGd^Qorg(fq7q$Jlf zMP8QyNhEm#5b_f-irfaHGe}`UzFua>a2xdTj>P1JRX$n8u#_o1;5CUcBD0{>qwJ39 zHt;a25EV;(KV%<_0cJAdl66L%P2f9cQk0b~4n9Y`4ZQ%;8j$`z44>)QD#(mHT8faw9y{m?cs!=cjBUK$82?O0JNl3=jX zY=(jbtsJpcMisV$set7msc9S9@!JYOsUYcS;of1rj^k)XvCjzdq*CCv#tmnD8!SMkjcqlq( z?Vax(Q#kP?bL!OOOE%(@pyfD!$uQz$E;J`NND(TMWl6(>N}*z^l<648jfi& zDw-pS>9$dwAxfx{1@-Tt_1+>Y7}`K}jSOk}e3}NUx$_GpF>7m2bM*+Hj3@0y>jIWkD+qGRrxZ z+7)6nDFi~$!#IL!Ms*yb+a}}P%0Gm44YVbO3zC;r+NZLwI}hIy6J&OD*~7^q-o(p( zc1eXH4UA6|_(@HuE?Q=!5T+9_2PFu|6r~Gyl#&gEJsG%i8!1J|)4Qgm z-29=%xPeCKmva9ARKOl-NAHe_Vs4tbNxFh%gA89OIg*t8t|C@4E<#N3fq=^An@F%r zwgbaK7aTY0QE`8u={-+UdhZtKp^`b~oDrq%cyh*cnP&*d5CFP-Bd8gyxfDE+YlV&c z;Iourm!ua-9Y;v*oTFIDl$#h1QI*Pik)i7VQGilbt&N9_bSN>UfNT~3@jAd1Vwj{U zt&V?4EGW}zRa>OlL&^h(K?UUMs}*^O4w@58tyU`3UwG-j44a7WB*!caKE*ROt!{iw z0BoW`4C!w7i~&Ysg=Hwx$E~%1>9;9L_9hDN-#uUhS&|!8XD;RZ4WI;SPBfXPGc}@Y zG&|lp0ShY{FG%15O506|C(EP&b6%Jz*jmxkhfSQ*&78w+jBx3eTb>dd2SKoa4jkro zluEm*9x>C0X_uayW4zyRZoAt500`iu6}MKaBp{G9zH0#h8dEu@78_|i#qN9usW1Vo zrzRLx$OS`9Ewl#(2%mYzwN70%5DKwAADLRNlgdEoonSb18FZj#&PhFYfa%(oeb-wk zSOpipZI8-0EY+Hxn5Z17QOcbTFQYIAs8E>I9{;Vg{x< z7iTRq3T5=N6`0>x?FqhzUUIPIJy}{!lz!R$!UL_Gq|S!y-~n%IxZC$Ya?NUmMd_aN zs00rW_CZG*I+UuwX`q!PTK@nj&^Fw0X}91j;3n4Q(WmPbz~rWfDO-&j1(tTn5G|o zbx2VbX&UXh{NMv^%E}w}QFR`t#tJ*AKG$g)8jK|+(WX}SVfm*o-^Z+n}67!J{fpH39M z@<)3A04M<}He8=|;y^-|ZR~9vJ7RL9Iu=u8!Ozt~s(Tym0E>R%KkO0HBkYX$noYUx*L|90>|?Qc4z72t5h>uN^p%xcxscDPgA+v-Zi# z2f&?UheA`ivM4gkXH^n&m44_BEsle(J1puNMqNkU5DGV^8ZD;iH$8NK>l2EVGfM7& zlhsFf1e@rSM2N6ZTD&Yz;{c$^t4y#!00j7D5Kvjwc4@~FGBv-2h2bI3VDLqkHZA1L5+4$@_$)sQ48 zbReBz12PpaDoWZ@qp>JnQn4T0>GECVL$O=uB;w`LjEY@7g<`Zzg>g9keGjmR|o1okAfDGJ~ zJ~OGS_^2x1gaB~dTBZ$wDoE%>t@D84nv|y`%G9*p`v71Acj*@us#dH0&_8{kJ7%kM zGb>TeY`zD7oB?J)9|Yt|RG%|w1tY2wP>jS`UPj;_-vFZ*v=!>1Z;tQ+XaCo>1wU{1 z`F#HX81Q!^&?o@y_S60U0C)Q!QaeVv-Xs100N-yOklUZ%-`W*Hx#SIZ{{ViTCvZL{ z6|3*>^7)*gTbvE;g$7T%?f}c-FYy-wwYKo<_1eL}7H~L7NPM8?sh~AfuR~ftVk4K&0m}Wq%JY1e|&|*pQy?6l_=YLb2@3~r<^j$2uoEl3p3BD zKI*_)oI%prMaqCX0(bE-$6}C_!gE5P+sm*hGacVlfwU%j3R{Z$Qh5`obzl^g5wAje z{{XfcY*iR5)O6D&W@Z5(&CIQ2UqT9!K3aTZx|{hNN`%{gNp2YZ= zkd+iwRtPpW1tK>X5|Sx$I%bCmu&lhUE5pU6n`|n1!DOTh{YuFu+v{jY8HqSG@H>WW zGF@X%1}7C&q*XZkjkh5t_)^($wy@;G!AT)|izIn(ZA4;JTq5JQnR%~Mv12jA*=aQg z)iVAVZ(m&>(`(wI5b(&AXAMK9W$`@D_Yo|K;URiMRZ*ZM$bD$keNW|&}x(j7lR-lw9*jVHsT<@*oWM_L2B_5-hgYjiGsw}7uG`VFmZ)FUnAXuah zr=`9T$2!>Jjg5~U=3l1acBSNHu9E8kww5iB1!qQUYz2TLduhCO61{=M_X)U!sM1jQ3BArihsdS~L^5}$skO4ga&<{v< zEGUFsr6m$*Qlx=#I^Ml?NgKtt47Vd>bVWIO&02ttRD|=WKvrOdtwjL&SlmU6!kHOm zXmW6;8u5KOU^y`^@bGafQ25B9LK^o{I==2$DWs&Se4v#F)a7Dze;{?V=|Q6@06*u0BlPj-zXjj`%e0`Eo^PB$T5Wu&u^N$W^oHfbr?BjEGGO8AfW^`bPbZwf zm~1bXpHy6Jr&!8y96pxSzmqNT<+aIr23-|H{zfJbs_*-vz2NhHq{W-bdKmtQT6TT! znEnutck_RLAznX{F?|c|2E}=Z`^iGT(Scy|^{?1GUn8345L(nqxe6bw!U_KXHV*;$ zdLdpi^Yt1GZ-6FhbE)<=Dc4VPGty{L7DzS=15M3@I}Cbu{#^rFV%CAfb=o`YH$vA3Vj7igg$5+1KAb#KbxjY#u{V}&kb63jadQe~u6N*O{_l#Nn=4Y~~kKBAD$rp?FQ z6Acv&Mp8%06u~i%udzldLZ)TqlHpQ8F1FYt9qpS~W#VtA(3rDVU#Zrn;hI-3`J*y! zBU5yt2G{fv&jZPN9ruR%zf*@dhgfCgHnhs!cOe0W^OS?$wfs7sknAuoFGM#kA@_c) zLY^&BT5@JX=t<@mFZwy9O0*bolVN3*T#N6Z(k6SdqBp#|6jWO3XQV{KsST}8lqZtP zN{)cq(Fcj)(p~-wa#s(;@B6)s?i5VhGN(`cpc;M=Oz|$#{{U3DS)Z4v%<+?r5_}eE zfE7@fpPS4jW&5c?DYjy=ZIl7A0GO4Fhu77r@3-hCS?i*I4aYx)9CMK3RW+&kV=xk{ zrN-7!U1`LdDGmgaWe>zy^@_eNz8+ND_^RB09c5Oib-$F-vjC+<(hh_WA}5Zdzq~lH zHQ0dMYppI;x>;{B*;1AkR&Jqofk_9Yx?U#YifgE+&_~oL&()<;yRVoO3f9o?=mxg& z@$rSHOz4u8t-B`b(1(_CjKeCFg#~7|RSm&A`M}T))gpJ0)U@J8Q1frDU=?giyW02- z&EcsbNMiVi$MZP^OAcf0RaAnl!h+M8uv9k|I(`uTKDXFRzf(^bR~f<5s7#3~c`fBw zX-4k4>WNxx2su-?-U1N__>XaNmXsuBDlbuGQ8emVY4VK0v=T}ZPGii!Q`B_?!<3t) zZ3XRYa;khpnyog})PVMR)ijBgWt1%1oEs`wUgZlHuo{IDH4xr}p8T(x3)tM^G=!cq zp`yOR6Da$Rr89E*GAU1ipb6hiRbq5Ehhz9z!X{!0d$Uil+QBVcl^&Yy65#5_WQFRc z8N(_G<$uUOEpHQ{ImgvB(A`cf>PEpJ#}r(?Vw<52iKWb}(u0Z09kReZ3biBD9X(=1 zISt6<&ORyGQn75hTd4RLQrt_}+j3mZtqB6^Re%FsPm~r0DXCW|nSe+NBplY)L-;{< zajGPa0>V=KO_FeGCRkZj(`?}dBT>02NwHsm))0_d=(1_%ff!*Q06gc8$W>HTz=~DUYc^&IEpj5DtZ+^nowXXwws7b4i>-9`*qd>#V zJta(G1dvi&dSC-(IPHyS)FcfV>-H=hzYzIKSXvT>ctVY)x@&%Ev2D)-&B%|=02Cd zmWCMS4eUvr3qY9qF^ROyIn8BCLf3r3*2&#q``#e=-W-Q?K+4t8AOyjhmu*JbwFcTo z&w!SsjDH-doL7(xXyRt%jbJSc8$FaOcmObL2mm%qz;rfHG=ShyZjb;Lfa#G?09>Lt zbS_N9m>UWT;)5Xg+Bs)UNk%@>qm7)5POo(792__ErdgG^q5?p>^Ci>HPhE838aVF>I4k--EBA7UbEToWq z2s^`;H%99z<{KF0ild&w1Mex`iSDQOnB!*>Is8bRRHZ4<*t*n}Ti}vRMU<$Rqhmwa z_1US+Jjb;J=Q)%LZU$TFd-b;Pm@!k2VbY?l6(yzdss+L>I^M+p00@@{WGNw5q?DV( zqG-T|!Fc}9?}VM8i$I!~4fH^|y?RF*1g)K#v&oZ|TZ=YIMa(eSCWu$V?kuq`m9oQS zQxjEHw2+}><=twyJpex&LvflFENv1O7Go4(gtXyh*URsvl%=HSP%7AwaiHpYM5IQL zt)|HP9%mfY*G^@h4+M`P4h@}@x-D%Zr)GgRd%D?IgP z9t3~B@WdYDvW~=ulueamtWJpnXzTz@ARdq$G7Cozg;?+cI&|=|dPe~F zbaWpm>C_d!tTswPgttSmj-n@Vf*i!AF}>FhUCX@IVp2xQ)W~9Z2|tAE8c$W zY5OzogUfdCl6&-Y_tbw?pnoMn?>}~T`!nvpkSDiW0P9PeK3t3c0HqxFpNFZ>?9aOX zMhU*$1xQ!3(Ps+sk}oWvpHpQMZx}u6&*~4^e|7waXNFy_u>L!CR-UJjiTQvARaprO zwyC<6zd$!JCK>F3n}O1{CC{-bCfY>!%%q+cga;F`bw2<|I{ivzxqQv7E$2`dQAx0| zBL0FTsSzGFH~pP4oj()N*p-)^Vs34g$2c^gY)^>Xd_a!QRwfvlL+;`-!)I!YYDM4! z7b`phXcp!9eh1b%6-SiOFa-dl7dC(a_F^|M1qSwDuA&397|RZXM*@K?jSb_WK!kxD z07SZ1;3J_>|t?0H7AgPVfa7y__#wz!VB(lWSFxUH90F6^C2#}J^Dl%kq9O^O#J zW%4OOrojm&;Q$@HVMz@(Ma&O@DYd$1x6PqSS#jdE=ObrS1WIEKis?QS(dJSd4Jcn? z98?Q&EtoL}2C0~WSyHPnAr}X_=>#ZjM*7ENu$Q>AqEhMjag;E$C29%El$51TD%xLb zpEC$zk;}!LC`LS$TP13dWx@$9D7jw0nS9)CXI-b^tw#rWokx5TSB3|{5o1V z#TxSuGN#m=$qEACUt7R|npH~cjI^0_evx(p-3P)7IN7HqJlhBf%HUu4!M~&cncbI} zLKU6F*r(=Tqo*P2lSO4qN`dr%<(oXzl!XvRZLT$d>CX-~IPX$XxH||Ab2miCEn!)8 zzM4TtZ0G$rNmAQVfJyIb*U}0NM#}1cOC)_}qkU{`;RR4#ob*+Y^3yJxlY4Xn;{_bl zZ%$MbM;QT1oL5Aff$IWRb;^!gl5MO7Ekr2my`!RN-Fem+d9dutTt&4hRmyz5U^`}N zl}2F*%cQBtZs)TsTEdVFAL;*r*#sZ1ivQ_L(K+d_#VIYOJG3v)@!oH*JQ*5_C# zEZ2Uv=5!>u3RG>~G1?7A%-Yt3=<8`71oxwe>t?z!12Ra+TrMwjUs>0St{NWTYQO$O7OF(R>7Zs@kpzw~-%Q)W9sa2>FtB-Vf z`NwEY(4eQ)&;ZUrU!LELC80`2H>VW)fhY}x5&>1gQNMs4Jz%4)n;gW*zEYPhw@@$Z z09ntUbgg7$KDOQfv%OASvuN&xmD^nbv5qlGnk-@kA^uyZyRD$0)NRx%3uPt5tbx%Z zXeb*vGSxYGq646z&%LHtDCODKdZdtpmC$?uR1|i^#I) zRFa0>$zUyT2|jwkM_i5ioa$OY2t%U%HvFTA>t>X-LFsFhB&=HM2U`!_048^2F*{ET zj%nnhZ^k)7l#J`B%9E(>oyv89?VFAJJ&9cql9Zh)nqiY1EVxVz2g?4r)48Ct7Vi*AAKtq?`Pp6xc@G4m1J-iZ<0m z5dp(mn_6)T$cwMUZ(;L*>SpBJ$`r7$lbm!1OZmV6HHj3GLV^kXt3VcO8id2@D``l- z+$Ud@0cTmay{gMrOzF^+o7>7bbjH<1ZTFVZ<=)p21)WzbLoJZPiSbYtfbE=_j6mF& zvVc<0M#b&wU<(f~QcC;Il%Y1hx)>Mk^Nen3qNZb>tj#14({{SdVrj51|qq$b! zgcNsCl47ee(n8kTY6oQt+6oIXJzGm1*Rv$}qzecrEZAbOCeTU-akZ_y6c%bVQBG`& zKxtkDHou|k1s$^j>gr+DAt(y86c%*-z0Ov1U~PMAaU45gDK&&ncL2K2L%*mV5CUfC zm`sh!xrNS_5yPgzs-z2rU-e3LfGpI0rdmdPx3=QffDUUIg(|YHGZVJZ1)cZbRN4VZ zC(CH%9XP_P>`Tg8H|nIOc+w(6x(P{{X({ z&#ZVGN1+D^C*l780PcPQI+x$y-(WH1`R)GW_ifbc9IwB>%jVA5QjF)zf1c;Z_p5E7 ztNZ)?-@rcp{`Lh7<<{TrKEJ=F!aAe(_x8CXjfr`Lq|UgNB`ULMBIyUmYmGf3!wTEb zM2v1yWZgGZytzIlme1yxlc}K;a~{KV)f<^PTj{T}wbN1ddUWtH$011#HyG&>GPJa~ z+`BETP0NhPZ7EfWI$aay-TkcMG|Rl+xDgjY~A|Eb`Q#Nk|GeAc8Iqhg(3M z3mZw~xk7d2xC-UZHI`gjvn?x9Zj>oT>rz#wrr|2`F~;?Ji{v=GJi`r|3v&$+w@F*- z2EeN0ybs;Ahy%-LXCrNjhQbd8Vg00qZhvO-O@Hn=xBMAYl$`LY|_Utvl@ z8EF6;sVPz&zuGz|6Zq}p55W=U#+q)r^wme1%vh9?W4w`da}_rBR***i;tGYYZ8nDz z+wYZ$B*Qf%N>8H28M#>&Y%>yUq^9=1*EWTzQ~3-vXn1h?GE8Ran#W%)5Bnm|gAJf22lVQjr_39exszFEe9o?CwFt{{Ro5W9C|9 z_8gY3Qz{Oq6uh>V^@&jm1qeAv*Gq0K*I3C)D{{^<8|kbMF8&pyg@w5Ac1dMwaaok5 zEN9Gbs3P|U;PnvGNh|x@elm74pWOoCO@A9oQl>D_Np_gIhm^=tP*e(10YFgzkz=O% z=@KE5Fm(Af`iqKk8d2- zlY2BW-ys{Dj6+-d7{{OMB@Z3VQVZif&Sg#+RZ(;1A8Sl?B- za|)6g3XcW7gmZAzSexfo%vCfg>1z(3Jk&9%C znFJ*jIcq7WZf%)uwvwigh*q9)Ix*L}^yL2lnHj1iES+Ljw!&s*91gO*lszvA%Mh%$)_ zcsnHQ)h)F&ryN7mjwuapge5CpY=YJa+Wj@sJC)lL6g_>Tc&9B!T%{{1S#{29$^hB6 z*+E*Abnk6z1ASp|-HDPb&$F&GRSOx&&s5xS%SzFvz0y`nN=n*l$-T)w>JFgWK^6;S z#*22vn4!6ZC6uLE-9u)?5tI-YW8!tO9SkBTXo~%&E->?M+q%^A1xKI;<6n$haL;ls zRj~^uaRjOkt|WY7-%$dLQrO~BK$i=tQV@lyLjM4DB>p=>Wh6TYoa{fxnH+eKiAr?D zo2)bz`-+$kHt4;HN-~1k1cRl;xABG)?0v-UFA~#g8muM7d8hZ<7iT#gDO_r3_FSCA z%&|_zsfST->gKh)tq7D;=DvcH9GpAa!nH?OmYAJYL5IL(wBur-RXGjvrNSIY%7UPxvXiaV)E#<9Z6mbU@XpINHdznji6QVZ(3)c*v1E+lBfw@hjK38B023}Tayu(<^%jcKO_*Gn zO9@idvOy*aJ7%sNo->Sdow7>qN07dsgegXX?8@zST#^fkNFF9Q;w>CnULcg6dT!33 zr7t7{e!R57Uwks3@DJxuvxh9s~N1BJ)V**RIwqw_}p-FJ}`|O!YO;?7NL2#vMo_Fj3J!5Dkw@i03cA zF_uRDE%vab@OuzHPN__x32Ks;kl8|%T$@veD@903vXYH^)*8ixIBjat7Fj6K;m2sE z_?nDBicH&csFY=w$w1QD!FDQ`10nJHN&6sIN%IgTmE5|Bb$B|3l&)Oz%Wyd}SyM9AgXT5x-_yq^nZUvYJ* ziG@rhJjP73Y__GRK<9GcuG$r7Rn(ZHGldCb?@3tSAyqj#9Ef3n1zVxe$pe zbaifaWiX?QrOP)otg2;~IjvhUTFuR_HcwJ@2WU*5`wBt{>_7CE*D~r9^su0+lFD3BsT9Q_Mz&9h$q;*Q)%8rd*B3HIe zI<}C%k_~|>I*_Ask)`5%v8-@Qt0Kl)r28YI z#A$>VayTrZWdqb-TS9Rm$+0&$wBi(^W!Dtrxoq}if$r##2(|PA>}=MmT8c5$wP zqlUEEj3rM^J=M6T61Ia*7c-F97703&V4zd}$aXWoR7A?Vb|kGmqQt6FwPq<&h3)c< zhqKiqA;)t$j=q@FMHz`RRJxH18?)Thm;%C=lhnsT&wEln^Z{V=)8hbG9@d_Q0I=NP zdcXlwFgCmaW(k^$GC(QU5`ayCCfdgvp-AC5jpSKE%WpR0i6jJP3A(&4bOX*1*tCpN zbxvXjK5AU7o0}*AFS0=EZLii5XK3twCoa&xwK4s#_D3vIM!2uZgJU+${E7Y%%R51F zE-9x;NV+Cwn@dGKAui83sE!E*$p<79Tnl{);XwBh}&_|^iyb46E3Kr zG}_8lax8NBZw$SL1=ARPUPD94wi=H zCOV=*egk3E;(0d~mlDyHsXq86yu_Q7jczPFVT9;ZqhzM1%Fj>cTAysBD($P1H|nbs z@`;eie8_Xf*i*75)A~oyzee)@_!W~Psb7T z!c|vfq!?yiNy9E1MoTFmZO{{V&!=wz}S@zA4{4=j?j zlzNbF@`tQvNxq!K+VE-(Cn{K(`G*}o<90)T4|vBc>WQhuS@$KWj|P%fwFBJ*17J1Y zB4uRUXofwPYVS%hIH`G3>z>fE;3NUzBe zSe0HR*&2Xa@<4DQn6}UXfK4d{!5jKT1L?S}TRC@3r^wkcaD@s82mL4B!e z`!G?v=kO*ONDzt(bOF% zQ>SYIsXhV_-48+zOobe8?FBbem~#)|M^cB8-J72_%P)R_D0h~61e0ydRdHNe#I2g| zX8SScV=0CBRYRa9PfXNI)a$1+&nXHjQjX-66%!de{A0n7{{Z0Rng0MgE|K3EgW=b2s}B7ZZcO)QnsL%VPxE&DIYuUxHQwl2UK6up7kaOIMcP5~Cy)ci*PO55@hSaTMcobvYJE zos_6J%+#YLJlSQ~IENCnsAe7Q3O2Rk(-w5LeYup`@VRcf^eiIH{44sn*098a`16u+%**0CorxZHJt zQj&KjIB?6%AZ}x)Y$6@C^)MVvASza*$3V)mr3+p-D8vxEd&WCwD8dl3Y!qO#fRz>ImJ}2)r0h@3$80FrXegb`a8fsB+Ad2x3DY5nS@{_VfY zBx1MSk!6{_Ls3KRQHij1L8+&w-gya73JO-1CtWOIQ{dwzvY`uzY3^QE2KdD(#mNTL zvXbJ^4f-ohdJSTRc-$Q_&NJ1z5d2-Lrv}f+G@w-6%i#@?_Eo;VBTGX|9gEg=v5e`d zFw#()kn$I6^&KG7M=WS$IHNO&-c+=$IVyX-shAe-n-jD5>#7YU86UAYA zD5)fTp~N!H6uRQ_q?pB`=S8c!DqI)fZ$gpoCwU5-rDidG5aFE(uptu zj5PVxDk1}cWteypl#(y+8^Cnhlx0qZ48#y@2aEuMBbw5(l3)X6XjQa;4l}8C`jUKv zbW1jr3n>athr&2?1jAp!K`#F=X*kaFbT7}D?A;_N~}^rBhol6GX&jp>l9fAD?VP4=IZJj`Ji%h2rM4r_{gKNGIqXrLoJn;GvWEI=^SpM>DA-n6Q)FgOcpLi1 zP8yT5j!mrC-AC+!v~U|ePoTRz;##;1R>1!FEb3M&C9wLi^2k_9-9GPt{O=sQ7NexV ziX6j>Dk=)=eXZ#QhL+6-ntE*5txE%NRCW080m?g%(V0^NkP??|s(1WMa>eO5?bEp_ zJme%O^w9n>(J397M+Gj!FL7EQE5dn;TOB8)T74mH5)Y-LmMW~&YMxVa1=St1lxsIn zQUbeyJxmsIj%$sj7FF`!$5>F4Iw>lcyPg8#IcId(VJxY^YXYwWyc~k8BB@KKT}w(q zBHA0lb`?P;nF|T!EUUx0zhk9OiW2VpX=#OUhClJ17Hhn2t6n zBZk`#u9c&G5Jl2Y zc$;hC2^5$UQ_i%sp<%L;Y@Xs2N61GG+3LuCLDW0Qg4^@(Go5a>Zcs!5|ci zYvXb^fZ$Om7Ro~@?_Ylr0n=qHHm}k$+ll}J7p=WIKn4Y{QUF2+kQT6j4Gi;gE?G|Q zMUnv0@CCFk-JRtQPI8wPEC#y#w2lk0H8F=2(zA!M5x;cU`q;p7joExY5T0YM5)V|8 z2jFi2QOuugQr${WoXI-ry}eD$bPnl6yN!bCOJ|`szsy=VbS*gz$*(IRSqM3`z0ZsQ zjBQFK$I^$2%2ae2)ByMc02{ATl7${poIv}zi3jFjI%?D8QBW#El%!?*w!8pg_I9P! zXA)dbLZw>XW;h2y*&ay+EVf5Qq=f!Z9W-W=g)6w=D(VUS@Ei`~%8~#&NVcg?gg|!A zeQH8tV$K9+3fDpe2N}CfkeTIxg$Bv{Bn$lDI*$7iNo!Zz3M1{6X4liC0*(@-T5)P| z#j8_$BH;YNfZ??%Q0I3WNWVg*8~j0zQPj>`)WWE z2Iuj-B<&ox7W;=OTHH^V$VbF)9XVl|lN9vx9V<#n@h9hK;oe5-X$@2cX4EqJ8~)<~ z(__37mzYXZ`oHdAI&UH5zR4}8Ew>`$^MC~FRX3;4x}|~SQvg}tOp`7*o%T`>huZm# zU;#NXD3{g}gsCVy1svD-7y#Utqb5w}7R}&+lk&6yN2d_YRPx_ZN$?~0h~OQTB?Tf~ zK?_o^waGU0xh6UX3R#8CBO(gWp|XeYjscC_?RQ;KRliv4@PG~339oD=uxtR)0F>N% zh!|O`D<=Il)h{V+rDb1*?ligYAvtP~a*$p+s_TpAItfc_D~rbpdY zKu9YCrq=mD04{1yb*#PAE5P0WHRKsgf^xRo z8?(2#nZp%EopyDDe9fpKW1t{rNdv@%0uR~)${J(DeZ;fA-J(vR)hgEeHnsKigbs?F z2K)3hxJW=?xS+P((=%!Sf}3hWfjaDbVX2Bp)S+N`8Vyc3E{Q5}{7T1#V@8G79XZCB&S{=u|*WjmKDN4uum5Vrp7vD9n{PdvqlPg?v9a z>U43dJGFc_Hva&AS#2j<65&6P5V)bIAxrcsY0`|e(iZp#P+m|?)=s{IQ*R*-j5c&| zE*qFktFun#WVlL8Zw#tdQ*8F=HVycvQ>;sjb|Ow&j(rBG?Iuatxx9_Emz*~j?>2;h z4UbhF5(fHs#F&1hS@RP-FQp~_0BE0lUCEh_dRrpgthYmLsB}|l_lH7Z*ZBxy%LL%j zBU4<=!^(B{R<~Du28SzVzzYzQZwOM|h@04xv^k8gYBVHT<6Shp_986!XZVOY7R5yI zCB%$ji`!AP=bIzW$WQT&*AK{}$Z?eT6NK>q-i_YcX1$2hOy41CLdrz0&cbbh11 z=9tOLsbvv7PHF`#^v^5#!!P(($a*~eLE`m7T3J%UW%eb~val5Mp`_evqKO*$2#25X zy^9_n@Ql4*6=C`s!!uPDGuto;bSqC0nNZXsyZRDaeZ58|Z?ttDqf$jKg;YWu@AH)D zY_v_R5}-*VUm@!fd>0ja(;?3;r$bYTIQNS1OuWmiRw$353v-s%ML6rpzi}b75RgvV z5vN#GaY4GL=h$LdX1jV4;!?XOhh^FoImu?HjJr-g$SVaaS_0G(o00~-&|;bJ={Hrk z#JGl5(!2T{tUr(BYOJ{FapqY4+b-rz%Vk9;mQ$fhlVT102#GPB5nekN94@8GrkcxaODsf3FlDZo7T7e28z60wOw zwiEb*Nt&H5VW-fSTPkdnC|nyV`ozdixe=uiv2KeYD30Wuxbn$=%);JgA!8$NYWgcK zVX|76X)EV9st^GeAZ|6*_JsJB_Z@@|J{;lvl_pt+>8-NeNI2U}gsE3U&j5t2S0}r# zcqkA@LlC3IH15g%0%NNG00VK2IS&bX+^W=>Mx19nvm-LXfSF3qCqR*M(uSnlHKC{N z$gZ6)pH4%|*{%A}m*OrG#dt6}DU}4zIA-MAXewEP1hmp@mt6>I=~7&{T8D5qt*;K^ z_S7Wl?Xq|A<9wbPxvjF;B&NYBbap z(ocTP{7Kk-p6y>&*Ub`cog~c_&t+xHH7`HQDa=pROt*BV_tb)Jl64&kiV1O!Qs4Y_ z@@TPKJuSb(e>BC050n!L4LVB5L+q&B>ZX_7KecYVn0pRgTX{9;#&cuSzrp&U8;xkJ z;t4Y-@g#FtD@s&Spfio^K_9*(Mt`8zkJQ-0w8JR3()tE)y9X_z(mm5{fdfNe1;i~o z2B^bSrAvV7=DBHPs4Yra2?@(<9LCn$#?Y=}*27Or;xkn@=GepXh@XAO)P1E^Oo}q0 zIf|YJ>dW?$fNj)>?3aIt;$KfuuyYd4<9f9{r`!|t^EirqR#nCfyHc|=2~y?O%2Soa z<;!LBl(dwn5Do4-6r{KEYvy&_d3pSH8flIXA-PuZ1gyekYZ8>Hr-a11tlN`PwGL4( zG_x!PYUv2j1f`i=;jo{+4|)1~T4spOWd zErq6+GWuoP3-+%5d3P4Wi3M$pgHx8m@gu=f-Y>4}uW!kb^;XSv+w&S6P1bMVy~eSt;5N5#uMC zlwBf_*qoXy6|J|jkEATiz}aD4@=BCOw$dK(m*@2vY_mB^putp}lkZER*<`Z7a1L84 zSh7$Ol5PPu09=@exB3iBrv4$zGhM}1X^Hk4Th32B6>P--Bqb>#=dGhfjx?1OQ+tn} z0dS*O9=|I%z(Y+=)2Gtn5LIg>DOyPft>HO21X$o;UeL1GXZ|XfdS!>0Qz$D`s@B7t z-9c?=2Wx;y00R+Zn&dwn$uUXd<07PFrd)By8|DIppd7^_{oQV1mzSXCfuG_eYsVAzpGMEIbz-h;OY(a+R&XxG>(@RsxHc5Y(U}^Qnbq?g$)S0k`BI?hts3c$gf4aB417cCSMM3;M8+|7e`Zw!Hn#Uo z#=jV;$&W>)+_c9nNk1c(E~cyUvtiN9NU#I-R6rw7F0mJrBy$pcIt?aWQtAqEwi`*x zpe&5*P)Y)Yk4uZ(*zXFKJ8-N%;~>Z6$ot26UlX0i0U-EHaXIC*ur7 z4p@s-E!<&HlEgHUgt*b=%}Xg%Xs8s_G|fzvO3TxhN{1*L0a;pl=ZpOPma*+ogG52AK}A5 zkWBp3PBWcpWVWGf>IZvnH1Il}k<5RI()fhk8<;}}Iap@Rg2dQPV7ET1T?{A?yRO-a z#(;r+?Ywo!4M{9FA%JRa87bdtDoO*+CBn9opLF-Sj=mjX*-6P${D#t@xniR=hU@j3 zd#s_Q=Ju3?ro*}1^0+A>Lc+xB5@i(Q7xEj6-LII4#4^jATIMEHGb>Vd`9sj#k;x+( z-bEphy_?$o3Aad9S<9hefN?b56{Ag0$}FKvc&{k2Bpm=F)*G7DB!W9DI&?Xw-j;G@ z^x4%RWk7-r?R|_UNm#YII5G~YGMUnl5{F%NKeSV0@P$5N4&047wY5%42rpUJRDWp% z*!o)VhWVVLKydpJIEun*(^|7PEiT*IBw1+E;0pji0bYg}o7%fDp+P{KakPRK z%W)@z=}ys7i5Y|~4z#5@&of0S4l3$OZKAT@P0nI_Lc1%{9nAddkBhLDDy zgSZe_X+ecOzX&WeqgHN-FF2fzww0#f*z2h49Bk@TYkwvrkThYx?7{_`Qq)Ogof>R< zBu5yebp<`0f)nx(k!E(O^5FiBKOr0xkXpQ>N|kVwCc!75gbom^4$-Q7Q)*#is#roM z6xv%6K|lYkA)ABn{ah@Qx9vN|iNNn{IT3j$4ftq}YA*=r865u$K_AT)ZPM zx7K_dSMh{60+5+w2g^*%Eh*;ZMuhWM?|5$r(PFh56FfMSe1f9xpW~POVDQCi8lF0E zj+s}W%pvY^4W~MOxqk54_a^>^@XVt_&|qL3F6CyOD(st0u#(b1L#uS2=mO&^fU({h zQL)Cy7JCHG)esWtlv+Us$DBpR$KHkLY)zY}!!=FRwGn8Oa#VSWn<#otW?Z(LgsC}*1ZYP6Hr6?$;irx%_4%q) z!)#1T2ZKt;vV)<7w9eTaI0)q49ip_rT3wh@oK(V6%A6r(X7?i~0PZw~TNKF)EnTS0 zH-BbQb+x^m-%h^%(DYjwk~)n{%`9rt@BaWY{{ZvUIc!A-exmy+Ah7Y%U*_V+{HQI3 z2`U8a)g`>8Gp+!lQVg;H3BS55cKm$fiGZ+cFt)WS`}7Oz7@+$=qdjI2!f0HUwAAuqp+z2c&q0fu{uCRkRCDHIixA4 zv`(bo)(bnO8y?7=fiPL!CbH>CR=Jh)g3f6KQErO-3N&o;n&XC-)Q70A$G8yp)iWA&T&m&1vrD+PhvqakUZUub?1C)`QDw07vq?_DCh&Rc75fd{{s`KA^8mc80Mqv)g*C!n3IZHFN zDS-OQ8!eKqR=)D|0E;V2i;WCVi@nnFe->6`+1Ea+;D;VUT1uf*`es3Hvi)X)iOFtL zivd%Tx<1{ma}@#Z_lVbMcG_BdG82k!`~F{SbO#M-RQhXG$+QWT&ZVU|)XLF(%eC#I zR8%j}-^L$~R`y*86U33BP^4h`9cj8sX#sAQi>^4GP>rk&*VoKL`lQv_4@$ZoS&R`u znr$jtC7N!+$vm)s5@9POf#X7Pnob^~&NVMgbTvNuf>5Sb*s$tNuhVTI>~el&e6UnY ztUrK-43(;GW?^bbA6&4YJpf977{0>j%yAIZC`CCbU|lm11d;@!%2_X79g z`9%|s=FTr~kz1X&t2G2na!}fYk#%8C0iut1&_2Q zAItnKjgOiyHnj5+Oot|&LoEW5R<#7C{RPZtB(rvn6$jYFn<%xRif8DJ4V=K~?v(N}Au$iyi)?o5fhpnu?7rNttB*V~Nqk zpM5qRdYC9duOmL&N||uD-HXb~a|?cOAY>fvmyZ@`lGM2c^OB{l*@D-63mr2Q-rpFs z;Npn6+bVcgT~u7@MRucsT$?T?${LtMR4FpRJ0Woa+$PISOs|wuuv^S6apA4E8%0MK z3*4Q8R9S}`D|DPh)jDZYE%RmOTX8>FkTv(OuYuYrlk88f=W@R{D#}|S#B!FgWo8*j zBcZ$@i$ga#g{fRNak=Rkj#vd<*BwbfzPqbkd@l>PAsmLa?kTQ%pxTSF{El*NGp766 z`{)MoA~2#not6i|$%$&MLZixcw@1|zkzrQu4ehjA;pS3t8=>`bLA7im$ugP5(p@nJ z?83DOa7HCk&^j3Ip*jpor3>EC-A6P6X^B>aKb#taL9g^06m%bngHg{6$@D4)q#uMD z&iG&&B1r27vz{1LQHxq$`gD%#4-CYrb+#6RQOyP=(o2Ie>D0${oX`qr$VyK^2B6Sqc9x|iB`m7rse;2v&lq;g%;Rb#?r#R8nhn>f03@XitKqa3cS)ee z7%A_#*-;xOTYP%J;aK}GIg&#=np*jJO!vTxuN|ZWY@yj}(Y`;h@oT&vMYy=i} zNz-QyXHR^T`fvEhELMX~VwNO(ty~okdvzb-@Pf`b(aU0pmmCOK^Vjo^*p(BnHAl{% zfCxw%jU$#V#3YR&w!u=9r%x09$Sf33J1k}`-6Gp*1%+4-NC~$Bi0`Cj7Vv`3)t+My z`!dU`8}$A#Y6SqY^dOgRn~cN#^?|U`9m*ddl)9x5b{95|Y7GXInacW>Po&)SZFmGk#*kftOwx*f=5A#60$-p5IyCqsq&6l+A=0tC*KNC zJ6PHaJ4Od7t%KZd#C%}0no*cjOS_bd^e|c4F(O4W1SJUold8467iTJs+3H}ZD>hI7 z8VD1kt~PU=Wycd>kPtd;e@N-dFcdB249QUgsSq3m=A3kv!gD9WOoOXWho&@1w`KF@L9?>CZ!jVC?5w=Bn5R#QSxt9F#Up>l z@Bn$5TdbukY};P&>jBy|meE1bT=;mvaNAltq_~ikf!ztYKaJyuO`2rfX z`Pw)Za!pzHMrPNW$eVr^fGphlQek%HB_quwg8*5uDoB@BbrMMEMyJvPwrWpKE^LQN zKq=KA4PZEGyHs*|#$l%sZLFWp06KE6C?_!&Pndw|q{C}{+o44Rz-xb)FdRD*s3eTX zU9%0~I&;*-#I4IY6ns>je+b|ja;-QW=RAzA4Li39^^Tl3=gOwhktxl8c7J+eGNHY z&=kqk2O5~H1fGsfG=&12ro|2@DI{BBJmK%`$J^?L{p{~jc=t=E1KpgMC+#~kF16dj z<;&YxOZHQ{R~+D)NE5(eyF6&%jS8<04W7pTH2_SuZ!A zwg$Ps}=HzerepvBquP=FQta(T_I>` zjs_X2wq0&bUi0aBX;(l}uq~&J;$A0ve19??Rn$yj3_~#doc%RTmlsc*JQY z>8|1ROiQ|RXPbFxSnzNKf%uW|^M^0*|o_@%-uPhZ7&j((dZ&X$^}5QUdpN9d4*nAZwIO9$h4iu9YZ*CZPpNG9Sx2Cns$(`NOa@yl_6?k(4VyQ~?0|Bab7EK5v&` z$BNraYTS%3&e2+Flp=to%sRD8OCTy)MN?aN($87BwT`SNRHy-*sP}-QwXMD^ zRa`N?BKpF^gYeKcZ&2sJ`W7O;A%dcak?;RzW zVcDl?Q;ADbrgeE1+P|A$M^coVs2vFj1w*J2*vYqF4y&oj;jQg<S!bouO_*4aEUINi z)DG9%E#X3XyP|_pM_IjG9~RSJeu9DwDhC%V*GSxPiroryiPWVu?R_G^I0B zP0k^*%BDaKEd&FZ1b;}2p*={4p}$?%K`#J#t%IZ|BwNEzOqx{Cmvlc_Nqi~m zDJm;k4rbI;GA{XTrNxb<`06!nCHAXt%#QedT$T3ouZX+s{{Y7+Tz@AwPp&W}>Jp1_ zso8P~afPItB;`oXEo`ez!SRWWxV_%p85_e=TXS5{zpvrpOP6ACgs<6NO~GE`{^{`m zj)!P-SqgZxy@>0_$pcWJx{;~pGjHt(YIC7@;bsmNPs!GwkS0OTYDGz@XQ!?8VfMbW zBCL1H1(j^KBU{C8X5&=(wfUBKmEV$NtHnxYeSEaOwzIQRXej{Z7D*(eby7D->UNBr zr*l=x@_ad$@mgZ<{Dw9BGLd2G6uiP4nrOd9Y@cayOMP60oQ^F-k`$nGTc9B}($I|3 zZuxH>oVI+`bn+j90Lwr$zpC<`a_)yVwK(p1ml!&SBqjyUmL|$0&covg$(7q{yc+zD zLmFvcX`n;qpE7`>a4K%JJdpc$%jt8d+B>gHUQ>Tm8Z|HU6ZxhmCFRvO%VB64T$P=Y zS?QUTW^VTBU~S>!48~2;?xi0`u;ikZwb902yE9z8xt82^)^Yl5wBDM1Y^s1J{v>JR zXj{p%f8?k0k5KT^b=qxwq;zL%PtxXnp|zm8mKy+{3B4eR~5`>2ng&QgW5qnYvut^3sY# z&1yxNMo=2MrWk0-K9b%{$^a0r);A;(4>T*CzB}2VVpQ7 z8~6f6hl#&PjX82$tw~>!Bt`Y}gZ%+{6Ae36puVP_Z7V?&l4e!lLV-!R zH&G)}0O$yjj#T!1>HMqpp{d0+%aWJUL{q5n+O2}=%$Yy<&XFx8P?(;lPyJ(SRFvUi ze#o`vT&s#~rAaK5lx5QQi%eNmx$Ntj^4P4&jmOP)`0jfK%1KtMGO|?J<;c#nJ1Xn6 zYLNQ*ep=G!)lRFqFak&+DbwqDYBJi<$$Gt54>-# z`yVK!mPSvEQ6I5x8hV*fT+5kLG*-6|w0BgH6>Y)u7wBP!D<4rX_Mok`MU}&~nWjxi zZL<0dhd8m#%#^7vmlJXd6p>&-N{)sl&>W?!5XClh(s2wfsC|Kb`(J*IUAqZc8ic%f)4P%Al6+ zlq&bw9-eoFN>wfTP?W6;iCV1v8bPLCM=E0~m5|vsOE)kbfMfU*xu9ni)gkQ{1!D9-8xT2)upL07!*HkkPaTe}`lc-71 z+itejBqd1Tx8QXaT4qjd=ZaLNywg4kLu8+*gU*M_A9%c%@d7c)Huk8>}d!s*3{rS)HQ zlofg93BO+$dJ+6C`|L8^NmrPM#I)zwNG~9yxKa`?dxCVahoaC)87ioloR?*lw35mk zQgek`%h-ht&r5WHQaH|z37qz6H6h{yYH*C522=cDGh3a5*jd&cpOTqvgjsF9bgJPx zTweFy#6lvIUja-istBe^B2c6#mASCnH;M3qt=Y??e*#FU#j0(0TXO8E1dZ=&Wgd3F z!V@>pN*$gaEfqAp%UM>GsSYHa(g3x9KLBDrL@0kIu$z=3XC+ge4+>v3%c(12Ru{3b2qi@sPQvE)u+|M!bVgR`%EQg1I7*5o=7L7n zQk0N3zTG^dso$zN$%jRqcMDKjnl7nrOv_3(mX)ed>g*Pn4M}qlw|=I4 zD@&O~^ve@&E!8mhF`%>GZM6YqHmlz!MJD7C(@5p-_v#{iz9hkr%&BWC;De?0Hua5% z0QNE5YB=u*)Wpk3)>Jq&%tXKe!=XJd@qhyt34j8X7y$NihycnRya#MKdH_6=n{ymz zO=*duodj^{mAAC;jvcUqX+*(CY|h-up)68n3{N@i@=l$ALXY7Mj}ddTtm`!ze9>t^ zO7^Ephk?Gv2%M6lOtR^1Z7*PZr{lCNZp`(Xkfk!WPubhdodEgAQm}HMlx7TzU@KP@ z-cj>0$~c+2Ce-7F84ggJ=eV{0?YHxeG%ZMNc+lu>g)&c21VhM)a5HemWG0m;wCt3p z@)5`@M`Y-8*09pbM#oVSR1m|MWjq=MMCbu0;T_P9DY6ss!P&&s=v5h2j&sv1X$V!c zLeg%nd;q+4^|=NlMkIGDIt`2I3!y4Tl3nM%Q}$3b^Cmf@?x6KW1vXLu z?`Q;Z#O|Y2>2%6UFT^yheh}1^55d_Vdp@=rVr64buUF>`K?`n)BI@!id5egZ1Ti*j zHttnhp%C>AS+bVWuL$S{QwTaJB#%2l2Rd$*Ejj>kw$uT*?u`$Kj+{2wZ3z~(kQ_$A zX$NaS6b@F?y`T+(6f}CK1C)ZT4fulq1?4s)p+Spn#{*!BOMiRtfGHTlP@hN+q;au+ zET(Y&NmUAysbz%qAd;id00AVQAq`4&PRD~$0yvAs8LWEX`a_z{J!b4v8#z?!Iy(B3 zVgcydzA>HR_}-Cwo4;p!DMp--h?B$Nd>R#H4|x24QAF64+WGfG1MuAGo(rQVodiCDM6Aj2+q%VG3| z^*Vse(6Eu19{pe2s#nrpo%{m~fAgTys^4r`;ZTRH-3%rDmHRC2K$C zsyKIlAu~IODXs-3Rrir^vQ*$#%~8gfrRHJ5G#PAKO{? ztbR_H^xN|(WVP(MHs5|a&iYzH(Z=S_v7 z^wasre~SKuSuf9Tfjg^I%3WGjzipCA+D(cs0@4ZUm~S4#IT+7lJ`_+KbWc4l>o@N> zQOqT29S&7oM7YhZh%Od#(Okf*PC~+zMxEwgSLP$M&hBsFdVU$1sLHuZluBOb3pvPI zECugnCgzsAhIRADCZH5JScd!%$oQlBUe1j%lY0qYM4=mTIn zM*s_7qyQEG4IKauumA?o0pbUQbPQ!-9V3Sfh)`EZ4w>ey?C$=-h}lan7>BOSB968y zFA$k|XI)c@JrWXs-$<&_X0=Ye3WDt!+ELyi&pRnjmrA5i>XZuXO4of=szDx`M7&sZ z5VL01HT*H1sZP}-W*00PX%j6B;X>CY*0d`k+586az0rMDscBicWC_Hyrc@D_Isr}k zZ>8fuBH|)%5mzwZ4`t0tXv(mZp-D@KXkNr>21NCOD^sL$ZkFUu;g1^deA^4BKE%4S zKDFmkNDC@aAw*@+fNlQ(3`@}0G9IM)5^*%_CoHzdDn%|RB}f@X_0$n@@_a#JffENZg*0a*E@VTwzR*PJ|negd#^#XkC|hs@^-0X_@(Hb-5_CBsf`a z>H|$|fv=voihd>Or=K-D010$gp3FncKx! zT9ZtcVWqa&Wezlipy~zm09$WZY+811Rj>sTbsVSV*-{7CU5NQA6&-}V#^$rayeT5m z+%j@uNd$r27d-}%CM=I6KAaAclcr708CIKXJ1pi1NEhzudv9T&@{2qVa+`@;5;zbd z#HL{uyKNmfc}@Ymbm4__A+Cgo4g>8eR=IB-024TbokgGv4ef|K3&0j&H8k}E2o70< z)KI;FfGjweN`|q(u&SC#78<}7V_e#|KPUpsqNdqJh`NtR=vksBEOw6A8%mt&L~smV z-QgVrOw^Rwxd2B*wjH{%QgaIxM?%jxTvJ!M-|&FupjoOVI^TY<1%{ccE?-pGgSL!$~#~xxV+hc)9#q<9J8dl#!C`T zzhp-R*`@T(xs<%N*&xSgPNM=V!NvEKesEA~H;qvW*gD8+sN8D2DHYxEqkDk>S(MDFASp>rj^1zqnKcZ% zAbj9EW)##pv#akEbp}>5`YIzumU#u-p+4p=^Q&}K54)O?Q6$QGijA2=7*110UAuDO{|m+#0L?w z>tV#}bgRw-rps&xMTpRKjvX}Bkz|XLZieDIB*e3p$wzc`w(tR!!VZAx;Q$3WPeA|} zopmiIyJ2YP8GXH_q*x6`x<@E1#se3*I{2H|M?+xFFcNhMAoZ}00f;n&s^F&HLebNP z)Vs|UTS8-pQKQRLx`{~A@BnvNZSYoAW8gP{46Mp9QY^25-UFs5BwCp{e%C_*z^a!r zqQ>5^0gaAQ0p@B><^!O~w##?8u;@ka02|9?l%trX6%LoYaOs(;RxNX>I)SKw3@poJ zxgaGs_fEP%bi*prIpC!>7u&`IhQ&pORKER!eIPmjQ%mlkf|vj&A*SvEQanHwfB@yP z$khYZ*MQ;35=|v}+W>!8U&cCc?4u(3`in;e0I5dWRqP3X4cJRg~cwCzx;GMZ|Co#@bHcTK*6Lt{hFs zSt+ytfB)0A3Y5WaS=FT2gxnF(#t)5_n6|njSHr7md5pdhsp4s>fcCkzjF}1uKuQY9 zKIu`&En&C@(Ug}G+Em^Azhd54qaL4_{k<(TET2;O^V`V~zYj&Y z)A2)!EpWzAA)79s@hO*ULQN^dDYB(5bd;R|aGP{U$L?brj?|txxpK(`O zmf8tY)^$60n9`L4k4NCuI=wVlb#g8~+hNBUOIriBVg>DgOWHHsPqfrkFVwTe!(Qx@ zGT3E`B{}&vl9Y#AQB{dZ+uu878UTPS1)`6|c`v(PZ}unEe2Ce_J|a7dm-K9k&(W-e zht`vrJmrRgT7rT0j+Zg6;j!tC{YreZx3I<6Y3wPXWFRY_E|ib}_t%u|4e^nvIv(L< z+>xZy-rSbdq^Y8;zy}kRX3EQ`*TUn-h{Qv2yW`6s2m$W4-w(jA=K-u)|KxW`W~GhY`|f0HvROHM5ZRV0m6 zNfs6sva}W;!$@^ILe7^@Rc2iQYf^IysQ_4#btB8nLed$Nqq8eT_I0%Eusr75P-!CO z{qUs^GHv+7(L)n`#_EMrYMqK}wDt%rKT(x%Hs5$9YhWq$DC?HQ1ghrAQ3As8bDB38 zm00CXlCKle)YUR(`Aymj2?y+;gwNzD2^ZLQ zP$3RB0aehOUwueBh<*$58IvALUDbQvPZ+R+8bcL~roE1!>q*cXui~Su4<2EFrY7zMvY>no?+hj*iN~@Yj3lID z8As^T*CNe5Cc+q$yY}DV-Fc42Db}68!+j;zFUj=kH}y6XBJAR)5~nVv zUa6{BD)Ump-pN*yww(66qHLzk*eH}8F57muf77F1sJO1%bF1k3#rbwR6J-5=wWuY; zxYP6NmIQ*MZ)2;;gQh{<6Q9xOzUG>x^55rQM!!?3a<0uQ`oaE&u#+k-reuZ`iL|{q zrh&^TQ6O?E(z%Vjf#LdKtG9A&k=}*s@85rqNAMDtZT8ywuCagRE}cz^l{}yV@e*#e zHXU`u4&^?mq1>pWF+cHq&$_U?qrIX*y_Tf@`}g<*f_%5zZ#eaj`N;J-^&mH%)c07L zSvR&?Wl>>3ymJ%(02a>N<&V2rP}`hT0OtcMzox%qm~fQ^AOX{ z`!_JA)T)b@E=xRBd&o}T>a*rod;}EtZPzyU<@!I_oYKBKZ(rVzb^cQ8M%5+a$Y4u> zB;!uFiFV#838z#S`bvDo!9K+|yBV&&@W`RvvTt?McV17k@@E=Pp8G4VvHt)P^Id4f z#iiYrT$V|98&j-Eht;H{>b01pP3ivtAkU8Uwrja^GN=rq6&GB;qwEb|J^43XS4l55 z)b%a1CaFY3%_vM2S&4;z$Xz0Pf2v-lR`*yova}cL{+IPfTIYURtE%ZG=iKNp zvV$m@9_a~rieI!9St|bkk*ZAht&g&w(r7!{YSMhG%`et3^ai=#la+lYzf*wAVIo~L z=G3(NJIvFXn9NG$f&P6)o7etA6RM>@q_7uVfxGGc%k@VZ=Y7+4-=vq9euqMi8d6#k z=v(csNlnNXQQn!Sr}XrBoqyytoq0C1nhUJ=@7Zt5`mU%dx$VCGQt2h+`t%t7DRAy` zw)-{AF!2@Hd33Hp<6-oTJ+WgV;%rj7gsrkEAO$I~GZLYAwc)s}KZ0AX{Yu^=hPSC~ z`8Ct}KAvOmz>d`pJ;P0xfik=od95UFps;V4g3tE0T8NFe5rmY(r?SVeTO9JH`&4Zn^X)*GUgvkdtd5v_+7r4KQ+10r{c!z5^Jl3J1*1g zNK}GfPc6g`bzH=fLNpnUwz0kAnIhvUE~`u1eonujsBd5CNA(sQ@1vbU+d116Fm9U> z%bIUPeyO^JkLLt-e+mBp!;sx-UTz;)vrbKGY)i_!YphR6T za^Bki03u(x$*4U1)jZ@WQ>&#VU;*7ON~{tGUn_o4w6$~V6?Ohg3QAuIzeyn@#q3^b zld|*erD`(_QVo2K2c#DDR1URd2eA&!saBgl~vgR&gV^1U21A&LzcIL za{*{^NFC7N&1Dp%1rD1-`0(1VC;N;~Ej#mHl?uoBV>OAY^(m?LWTsb2D{4`BTtd{` z(@nUrqLKyfo%aV~E@D%Is`VICTR%fX4dLllWvdkz(CQ~@sbz13uFa%N5z7NNyP|BP zt?$wq$gV#QUba66Pw%yUqPaNwmn_81R^QE6HuLLPSWri_HW_!kf>HuV8rUvdQM7d4`^43YB5tiH6Bfu`8V}=s$4SrTpF_Euoc;zKhe4 z`H2uLk3={D5sL+@^cRYursbzzDq}5^||`= z#bFG)Jm_&~Lm&i%q#+;!nCOrJ*Hd#A5#noN1h{6zl@ABd*;X{<`=?ExL_j10Hk_hRjSDA{{Hk+@3X7Hx0RL*verEu!J z))&NT4M|QghiTO}R0OiYxKl1ZN_bh9%a$o1dyc*<+vxM{bDq@Dber5>`s)qJZgm|z4TvVVo~g=A+K^{uvpFp4MU%^PSS5e2p$Y(K z2r=2kB%10aGl@4xo1A6(bHQw-)bhgK7D_e?N{+)#P)_|}38e3^;neL1!zm^y@?t_| zl+3!)SpjZ~tTvlo{({%>(j3PschF1SP}ktxKQT;7P~yQQv?Q{Pf*Lu^&gExaw6rF2 z>@GVSRk=BQaU$!qq%B58L2e}Ktg0m3fqQ{-ug(<|;`avZhO-oBRHC9(6qOw{9b&;U zJq!Fk({pP{aD8HSzQ@;}Y_UOK1pF+`uyxq#K3zt}o$XVj-rlc64%ZB{FJ_IWsf@pGjd83MfG~ zO3t}}8fotxhVabyTLIU`oKkxMy_BhKoavjU%_Sj7QVyz@boB?kk#6>&l|tc;fcf3x5+Qs(= znZ+gKX86onn=xSCASWE9a{&oqq^P%*XDgx9s>(`|O^1l;V`IbR)QpyVbj7oY%5{mz zgwcmADBwccx(E(XRNtt844Oa(l>iN0fuplnI|rlB?|jViP0d)=qQB?h**(7O>|V|7WwxZ zyKVXX;~f&WJF|{*)2CSApeZukhU|AHIK@Pb9j2yRm2ObEuyrTn5HgcsKQu{%%*sox z2I(!P-w_YQW=!cxj#A2c6L^q_?CDItnM5hYXc8|SIC5w$D7IFwdBqhUj^BiJoJP}0 zGj0_hbvh4N<2sBOh3{pNeP^R)7?~ym9l!vW=}s@IomoD&FvdPZvmbJ-?WISikuD@z zGa{FfDNymWC_%iF9XJid02Nk%0)+tp21~F2Cn}%-mP$H60A@;H1I56o04P#ppcFNo zR!F%q%NC0TJp+OEQpBz9!Z9l)B1?}> z%q_(msnQdvK4mdXnRH1}N@0sdJ~aI)GDtq!gys9wza{T}8OQlyBhb z46Yn?$(fpy#%=9fS`rSua@__RoV9f1I|x^p=hCVYQjYW6pPO61c($95PT&z8l2UJ= zs&cj;8I@C=Nbo3Z5Bb*#)F(%hIqR<|cV%jqQTzOof6NiVNvL!jHZnXom7>(-mZ$xcz3mSU z`qP@(^spyuZ4ws45+#=nm~Fbm(pv#366{zFz0($WIrGoCg7VWeD2v1&0#>Lu;OvfCHJ7v!cE*0hm6~ z7wG}hAGIZ0Kn5qCN)>1T*=cBSTqF-T03u&)qGO<9apbsk1~>*aJeBBrLe3eQd9?kI zU^)YnNZT*r0n0U=ais2(9TF5e*7;TPfHnlahc*Y}0l=tn191V+94!5t{9rh11*Ljr z-)IgQUCSbD>uR^^>i}{ws%}wwf=8&dc7oBBKF>4O_SjwnyBe;kfO05&0D$JkqUo&W zxliXEu{4e1#IloQi>f#)V;?27=tKY;==KysZmoKB5Li+$%*eAXWTxsqTR~ve8C#J{ znvzlngccNgBWpQQrQgob9SHoAS8FXo-ERej1uW*aXB465XabG2(o->Hp~YPEu!7F% zG@q4ln1Wqm3GrN7x66nbfuyl-)FuRg@_t`Nuh(IjfT{TsiMv;NCiNjiMfA-S+(qaPHvCI=0n(t)DVg z`;2rEnde_#*+}x!XU;|k)uMl-kzpVfRmS#|QGN^UF@xa{9w_ar# zmZaS52TxcI-5X8jm~AebpO{%f5X(zhQnXHhk#c}4a)bK^J5ryCFa-kJ zN^an6U;|EWTxL#ktMtlasN*xcCwmoN%fSKpYN-Akx2>hS`c|oI?s2lXW2Ms4Ba;PK_E_S?h;CJQRZDF@E zgztY50non05JFovPh0KqfDbNQr6(`L!{-6RT1rW2H#SJ>e}n*ak1}sCY?2eX-Z@8X z)Mdo0M-{J>bOJjj>PRh+LGkGT8_vn8;4_d9lyK>d>30=tD)#Y!4AadSHuDP-2f{dX z)}}C-rqbh!In*y;Km*}u>BYI}#_|uXxJdVUM-H1ZXee&WK~g$jNDiYCN>T2l+xCnA zXGFWMowBFHtN>(kWo(;T!T_^WEkMn=+|N6cnK`BeL+qBBjp@AbJa1(QSY3+2mt)!v~uXx zao0WMC=XG14q1WcUYP)?LrscwfGpjXeQHgVNk8wr2U9$$r4j~WFX31w#aOlm}oJtBp0V8v`AHF$9T#jIM za~<+if7LgRoUpFWzShG29bgMP3`tBpo?%)E@CL+uBZ7@4C*NsgEGQ2XYe7L~xu~{> zO_$$S*-oVVBeWKGRWSJ=DGK$2z5`jI7#FX%*x z?jB>x+{@F`bin-6g{*|m%Yc-xcF+_Q0!HfBPZDEYhct20kKf{mjcLeX z$0!NzElPP_-7KI`($jSWgoCKPfF!G>p?P@vQr$1Y>u1yN<|Z5}wa=e&aA4UfG}IlK zWuzf)vNNbA#DS;>(&jKLE0gst@wBo!z^55cHe*H)RV(-vW%_${Y1@iZqA}rY&KToQ!eupqDch= zp(LJ#TOGQ_anmo6p-HX3Ft*zWO5bf^!row@5Tu;RTK(SXu|XR7LsE(zM*9>VbA?jP zq`7r-EUi?tsk+tgE6bpUtY0If^n~qEUdSc6N_`4p8CIL!VD%dk1+I3EB}Xj_*|5{n zbkrc^&f7t-1;;X3N4QAzAfFK(5Cwj>D>hLw5|ulVAwZ3d`f1bhFpx;aL!ad=I7VwK z;P?~!p>bkng`A|{(TG&iZDvrl{D$5-n++mfG(*V7kF&dS)%sh`^0_mQyz9$&SgqA9 zef8Xrbt>+qB=4=7Ghsyltj2GT*TXr%CdzU1!nh&J7|zq()&Vr zqm{U~oslw@Z91f(H$H;H=L%>-c5YHCN_}qGVJcNCRyY9LBB=7xGta0pB=8mO8ml)GkI9QlvNkjRMA!HJcVH&XL z7R<||LM{MRjo``A_vQX~Z-Xl_I!!*?uP*D&5utJpHmN}-?<9$r(@id0iBm$7R<1o37m^yw_8HQdqdTQzY10mdou)H2Bfx(oeL} zX6|fMjZCYi$w&gpP#X1C-hXWby5B~dYw0!mqkchRd6u~h`&t~9aT3ivY}0Ha{Q6YM zQT;r=rH2(^VWLi?tMB<8dtL3iy6E~zc|NG-%cU~`wJ?ED4@sy?rOcq!WYB)HN@F(D za(lGm_qK@M+>?JF*Sh%}etT2j{F!%NQtEW&d36K?qK*_qy-#5R+BYck-9`f6ab}MyQ}sGG-i9!c419&K8LVZk#R3tjpLO zlg$4BN;~UTT@s$`CSQLJ;*#ZCZqo9XSU)Gzp^fU2Cxq)0>r;gdFzoW#%#!?p)>gGE zY}sa!pqNO`vQl(TkeSA}=<5C(elL%4De|qib$$B5`F1i^reE5&-XhXmFAWA>j(NB35V4tX8pe^6x-~%P%I>X%ZmR1 zkZR1By0W2qdrM<7ubS!>H&x%?)a+L(?CSdWgZ&N4g(sG$xxh>E=8){ejHC}?nqTOu zlA539^BM_;Q*(7IGX3aJh}S-x{{TsR4k+DL_MKl<)-TO;V_U@x2Pur?<|OK95&^li zsrQ*mNu^FN^i>IaYwS~o-1d>GR&y6F3{2s8nPGliS5N53xwv(iD(6=h)z?q+m(DylH6C~ui@onyjflrl(&uS z{(>_cF#dVP0$OpGsgpqOn<9c#jW!2Se_bsUQiV!Q{{WKylv!b>qvoc+Q__6tDba55 zVz}aNz4>!3eV;R{qNB6|xbnI|qL-(s&ONLzuh+j9URPOR9HkO|Que*NNFloZgM$^NlHPsQ)`oCq-zV|@wwf9 zcUAl^`JKw^pH&9FEBXy~D5g$3Ly=u#X{k5UBI-(%l{m^Dm3dhTvM8H!$pu3|M*Sk& zhLmkrE?$m^JVaZ*_kO64)czCVw;FB9dd#Y&-9lEX8OM_Q`VGnwe}Bx9RIV{$ z_us0!FF5OhbxrchWTr?$lE_BCSFWP{G>+;@{{U|znqJ?!?jfe=Gc~+4wpf^ax>+c8 zX%Y_}@b`#lsSDS@d@l_uuKxfb>v#Of!Aiov^LZOH2#oOLvk<}NbR%unJD2vhiQ^&WC&zJ(&E-ji)KXJ2LP=}u7MQ2l@*LfNwF zVZB(NPTT2PgByjW?Ym&I92PJhK6OdL7CB3)Ly|~WSDJBBa%3AAFx zO1U#8{HmCdp)Cx!C9WnE8_cUbk_w4E@HI#xISw&3%KZ2JPD_K8{{S>(IBt@$D^ylA zsyez`a`OmuQjT>>ysW7XC?u)WFWomJAQPQ2*T%(dTfZ-_F+SxluXXzlwO<`GGf|l` zlQp;2`-+o8O-ReOB_AL-kd-=td#6+_WlbBAn4KZGPWig{*It6*`GWH8aER-4w%7VqR8a zZ3zf?xh_4XU1wa2%#^7>9Rh{Yt!zX$mC74(40Qa&wlLtX72%AwYK10?%1FxFi=_pE zZJ;DLq6s^j2&0~Sv3&lI{{WIMao~j3%j&;kGE}*A*5yR247AJ5a~oxpWNox4nPF=Z%%Z`bOfRttfzM;%F zxFA?)2Z;Db8`SnVkfg&)Zw$87%(Dt*Va(QDmZy-tR6^1Qplf0}S{r+vI-Fo(EK^#X zTAp%U+d8!%jNu@WnAmrK(48-6?l`suYkt;Hl zmR5o}?M*Z+kd)Y{A9AAda4K!={BULDwcOr55$di;T%SeV_=r_=xL!2}p9=Ly{8fY4o9OsU#^{ zkz?XF)1m1M^J2|;iKMdJv&mQ}YEZFYe8>=f=LwJ5*Nn7zL@HV3C);KiZd{>a$srfe zD1r!3I*Z!y%Y%r9>_yDgQ!e!Ms@QGXdn*cIr<)5mQf{OqE8PIzzyakAzKtEL9to-T zlFYp#ReZ!qwA<=zCn;n)oXOnSq>Zhpw(yBr)J1G*Ec@=Z<4FZAmdey@2+rUF*VKdM zcyb(s$a(O2Zc4Pee3LD@nT8#5Z7y824&uqu%R1dxHn`JBW?QR&AzX=Nfn`-J!g93c zX?1DNbU3smScIWLBIvQx$|AN63eGO~jIV%SQdX zV9BNYQD2)5wEUUJ#QZP}Qdo9SIdm;B01`ofgc8XQ{U!l@PN>J|d{{ZHS zb!$0ADnWPi^LFtx{zTr|^%jlJAVGWCnP}lKi zijQEPNtCBeC_JR0#}aHCE6`{+I`oRky~{W&7rZ;gGn82bN=znY*?<+51-sl5NbeJ1 zHS4r6oeqmBIi+Q~<=;w`s*{uu4~6d%6#R(p29+Iz(s_yG%w5Hm6=Vl}hWieXr8+sF z>9~Z=3n{0_{e+M7px0rdh6fR2c`AM(YLze@6H7o-A!6!UeLy4e2g($svCRUrv^7-y z3Z`ruT9OiwvM#^b0Phi;$vSLX@bW~tN|wuGm9*bc;5^|_ogp&EV)9N!Q;m>|6x@Py z4gPU1GuVwN37Rb-bt#u;9JhDsnimH_?<;)?KZGr0XFMVlcFk$D&(Ru~Lb(QQu;YVa zbD+4s=Fq)%DlwvaVY8lDw78t1C{9&e5TS3t`9n@@T7nbYPN^|Uq)fWv!cdS(mCy)} zES<*`I}Gn<=_E5sQjw@r%TPWbsF4leo!Di7`m)$J1jOi0h*HO9g;spX%aowq)vK0| zRcU{K))(TT4;j5mkWD?5w3F_QPf~iA?}~H6qh*kp^&1dEO^>V|Db=GTNLqZaC8pAy077l@hvOlc#Ln}4i!S>eVf7)06CHiC zI$D-b+fXX~lZr?7KGEdww8gjBs zV?!g^_KWmwEyaZ>=Y2$ibQ<)AvAY*EKTS&zg&_4e9~hew9FdVS{NyRS^w7e@QNGhA z!^Xn!9iaT8AUQ{iH-POJgC0;EpbHj& z$YMnaK+yr5#FA_U!iK(fiupZEwuDmdA?r11%ylY+&HF66a|HyTcfAdl_-_ckEO$t> z!U&uxOG$d1!zs}rNGJS|B)H!ClM>a#Mm z*BV20X{M6$QjoF`j$?TfcU7p(_Ikv>3B#Jc$@MB$SCwyE{XTsKz9EyR;Mqq@0V{t8 z)g|T-w1Nw=Gg)(`WDEPMR%;t5rsX=p1mF60gyg4QOVGSF1-b>)hDl2znXFM`$At&E&l+Y=5lchxK|F$Pf{u`JufO}8LZK!8Etv) z`g19yfRmLOhN8(TNw$V2;ft33RLb1%PTxP7ATc&Is?Jf+xdssXu9lJl?u3LXLgvQD zHMO@x;}ao)GOl?V9+hHN0O&v$zne-z+jB5VLCSQv8rw+Yg$<`;7sU=f)A)B$r%KH- zyt9f>Qu7?mq-=78o7}?Vfy?A^Em$cfN8Sg@!*SybHAI-JD;Ko) z1{&ejLAt#;)d_jW3Xqg{U1iu8n(JLNH*zB=&B!_1X+Y-rPszxQUc1siK%z26? z!7irCAz!Rby&_a{IQ$4XxIYt@GRbaGgt$G$fI;#*MV>sCWpnWE4|B*~eT+#?$TE!^ zp?OB|p(Y~bpg0*WKmom^jUWI^#6SiWK16f@4*5U^A7~?_2M-yOZJ;_Gw}OSn!^!|L zndG1oYvly|pbI#x;^``^qoub6`D!-SFFW<8n1q790MQalfi@c9{?Y)g+nl+_7BnKzic+e*ykt?ypi0j|12 zWVU|+QG1r~rqb-YL0~BbC?pYZcHBm8Ma)G^vuK=0El5diLd7I#LGp&|Q$rJn@NFhh z`KFnYmPteF3Q2D1H`v=j5_L93(?RN-9i&%kQmT4UlxU@WQ)xxYMu6CD;|q-6A-5i* z(#{o<${I557Sry9BoI9WDGinR+gg~H>9pq3JH_WhK=V2Q7d#hI2NFd}Zw70;DV6$4 zd6YFQ{e`)WsaHCV>QqS6$}OT-iJWc0isurflToI$9+qg7kQRWe?oL%G8+;>@M{LE} zzK(F6MqXN=IS;C1GE%OfbkgH^gT$+eCkv)rpBXTXE^e3Y4@xrW2tvEb8=C@l(D}x4 zPfOUij{MB^P8>*1(pZs8K`bRrIuL*oGbH944;}nrtwWS)V|gi742u&jrNln!kW!&> ze1w8WU89H&N-%vgRb9y$WPnDYr1bbhso2DkAUI;QuB|e!78(2ji*6sE$rSujq(3=Q z=J9BXNf^|_NYuiH%tl$KPP)fV2UR(sG&T{?qgYdzKWLZ^QJ7NNzK{hTG7O_aq4IzY zZdAKxMSO&C42za&!R6y<=mOk}L!kLU247%k^aIKRv|@5WtNFkb2eG$n8^8djQM8Kz z08j!=Fa-c*5WT?pKybk84Wmm7z;MUx2f{mHMit1W_a-`VpuvQmvCyLvvZ+i5C?aXe zweD}>08zE{Xtlt+0Y(>W$GngL>i`%XS2*va2Lq;AvtU3!2oBMVNjI&47V?1Q1QO$* zA1DHk6le2*;8KCLpa8zggQ-xzLDm4HI}%7gYRZ7^1b$nS=KwTiZdW+)fbAUFs#prR zBp#$2L1!FKOVZNytg;W8ycP;3#Ki>w>f@L4AP6k(lg!Zr7Voa-YpM$kCe+Oi>B<}^ zC#V3J4$-8|F}XwDQkH*PZu3R>;z8@)x13U6!M);e&;mP4DU z-T*p{FqRTY?;e6Ubi%gF-ti;IKn4`ZDL&%K^?>CD4NN1(-mo1rHp9+~=OQ=)ZoN-V zCX{wcXsFA%qQE3x$I29QnY&DrazT_Z%ZlY70FmT2jse0(h3U*LYvi40A_h_jW2Pz-T(o{EHh}K<{$v9jBdOoJ#=Y zKuPgBz;Mk>aFi0IsH*)=gU~?Eqir)KdKGKu919BctD!mbgX9gZ037D#9dHyb*-xBy zj#-*#ni@-EB0$?HvX7~}2TUbTPACVG0tKyObL#+Eu~43RQ6t&5*k(KVz>(JI=dk?b z=sF`mfHu4oa@#tR$*8tF!6VgLesGV*2lz zIYO+_Ov$GyC0A2w-^D&+1D8U8Of@dwH49aa#3xUTBwd=rEk(qvD)u8}*c*Dl9K{>e zNn{l^5p`Qq6L{g<5s%f{lU`0z$BOM?{gDcxHf^(0X~o?p$os$_$~i}D-}*vTfJ#YH zyupC&nUI7`qnOKSJ~tq1=^O(Zoa84lup{9C(_Wb{in&nlC1drj55@zFa2;W-K`JD8 zuJO<_dpi{LrNkiteF*o5#yE5erYBp;vW83PaIHQu+BvA{I^$BZ$q93qR5y-LtD{*j z%AvcctSi9n^RyIl&Uexh&w`aKC%}m99JInP5>Aggq2OH8@{R?YNo!)HlHK>b0A_li z)Su|CPmRbQC=T5k%uJc2l_{{Gc2KZa!1aLT*aovKk=|XcxG6V|&}v3zYV6G?W##+d z>@ZMj3hh>2U)^lG;%o)Ja8PPCUUeY}aAip%`AGuN!?qS)aVr)e-^js0q<{a_wXnRp zpCfAzs{Sfn9sWg6j@#{Idg9k?349+f?6_%2uGZ$1jGo4V{FJ&>Y#Rz} zg%>TL2I^9c&4!T?@NRbI)O`7RC(q(O^RMpj_tuF)!O2Rr(`cHkvedN8tli0G)TI`# zZW7@jS$6l5HacE1d9kR;r0so4lF6z*VuOpkUvGt8#m!;InwfEFc(#(RLnuwu^6W-b z0#cHrpu9-O7m-q~P1jbrY%z}-mp@-IX1a`?EtP6wRn$0@0JfAA2vG8|vGnnQcKpX7 z7YDe~aaA74O+uVWAI_!82lkDx;&s=ci3xsamcK? z>l5+rHi-Ac&h<$C!TjNjrnlMO!h|Sp(G1WUbHln}sSd;^4z!t@^9}y^L`JxdpE1py zWIPBugQ0~rWqi)g5_vUQXKB+zG62bKi9z=b_qf{rAVL=Z0EPStywP!LOPU%ydxnsc zGO31_GKZT&Y7HXcbCRuojpi&t6H>;-ML9u8)Ey!$mizDD%`eq;AA`EBx7*53qyGRU z^cws|+DfJb$W-baZI@>hz!|C%O`qoT@`W}Y*CulNKt+&J2`N>?Ii~)9b}c?tw(hT_ zx~Js&8&z4b`du@s_LP+}{PWWGyvriq%UP4Qnb@*K*dJ6ZZiA)O&!69!$n90PG_RxU z2l426*{)LGa&cLSb*HLJm&;`v4`r^&>26r=iLdCiS948z-}C*>M{2IkM*gsWq0*mF zlrEX4Ln-GW>DL*{X=#K103h{=YlHmR-4ijI?Tve*y>^?veg6QXUPn^CTkPukuCRV< zr&E^H;g{wavLy;8QsqOGMp+rfeuAkjm>=eIKhtN-jZKm}&`a;h_xLbgTkT5v$E;tP z=qcX|N=SWTO>ImEA1GFm6$O5ZWxIp?!e{O0x_jCIt&<-<`}s@1!H2_pTYr@vtNi3} zQnevyaquLZVr=tlO{uk41(M=#y*6xn+4BzY%arWn+spKSvEF`rf2|e&0JkHdDi)H> zfRk~Fm8AhiR;N{52IyEj)246S&vV`xa@{#oCtkji{g{@o&e!_T@BVTU{>1e)Qszhr zB{4ASWeb5tH0rB_^QERQfB3d){{U1~bpoX2DY|T^OY`)7z5vzT@3!^UJsST2DRr;d z?a`c2LmteJWi2@Ka)@{<{x7H~A83=Bxj)S2Kjd7h>hC8h9oq_*>HB;IHFta3S6|+b zM!(8kOfu5BJ(W@onMI&F%{)v4X;&0)HB6kjKT`hkq}_Uqsv2BQwqAcH+x9y5yWf*_ z)pU~cT}-rR(`j#FMdOY>Xuya!^P2Aeb+UTXX&c9f{k4~Wa-;uHb)=gYe;xp^ea6oB(T)6r)L0Eve6GNm?mx(QjayogS>T-V(V&K8=NU*fN% z*OTkeV=y~-kAM?NRSD0eu*%T4B^Yq#s5GYk08J(m5(4HL?-J1@sR<`>7B4h7nt#J5 z*Q5S@(OR&}4W~{kr&|5HGJSCW0EzT&In#^M&bC(iG8KXW1RLd0xhYys={kdWiNx^g zcNr>^ReoI2%yQ9EhUq?COxVVyErgzM&X=1@kIOh54HY-_U<>9O4Lij9qgbfTg~Clc z=N6r9vMeym#7U~zNmcK-fnGYNNg$RM;+{<7lSxB~N08{O*+n|1 zI522&X>?8Y-9OlO!EX6)T(A4RehdY13QY-1Mp9|URMMo>w3f*TMyYt&U!&+&J;i9G zh~kZ^f8nlce?PumPP{Van!Q@NKSP!=EgpGuFHA_z1f&$!9+i*K@ zys8_tue6{p+N>0iA?#CYm2Io5r+ofjlNz1{O*Y-vMQXWx{{S%({bHoV!e!{QB8u9w zgeAhK8VWZmVZ^K}l;JwFm$>RZ)6y?EZYxheqkmu1xmUz+nz?WCUcbL#RNTc)Qo(aL zhG4yQ1qo?pR+3Tg1f^}}B|m6xH?&Ik`1!wI+=uQB_Vu7;pBXuh;u?vyjl{IFMUKbx zcFInHTVF^YA0E%^` zNBpl(r#^l{mjyo2^=Br36-d#3yW8t?h*9J%q%|z0X)Wr~c5y>i^~@~|Pm5C7 zYWY{|dk^E_|qE2nn({eJfDC}rvlViYMs(6puI$zE_dZlh(XX|`Xwhefj< z>!~`zB-{FbTl}A>IO*xp`hD|WhjmCYs^%8f2wRKP1e>U3P#5lnukIVN?%*X*YJO{X z`+EH!#BIes+?U_O>W&3MRSmX=18KU#SqUQHO_gRX!ciE(=*eu>?Ra~M*K^XK==uhEIM<;(Bo^+z6Z zO+W&hrATdP03_xCNA!6QybkMSUF7@CC}|9}`u%!S`maIc{{TI+n7p@R}!sKq$wuE5w4f{MLg4sr(Ye*C^a>;{5IIuu3^e{ zISCa8kupHGa0*->va}SRo#E*54O6@Me#275S6hBxQ8P>7e3llLep**L+L)L_&NDo& z<G&Canu-{mOj>E~aW2i($NNE3eJyRCHeV!YSBElTMaUD zo7tp1z3x;mmt8@)2IAHbmIN=Yy-cK37P($y(rv5@proAExy#W_g;7HnLnHkw>) zb};Ide8Prf6Jn{A7NndD)@N&OFSxc!t)i6@YDgz-X%v#w52~#+Lk!l(rv|pvI)E1an|^S_x$Fp!HEb&{NvJe^oC$ZGvJZN}UKhUNB*smz zF_x*43cH6KoR`fa>XZv9S#4?sYFbZwCYLTJOQaug9U>xP+1kW&YNfQraXhyc?7MP6 zpq^sVedMV+1C?EU;0>T(i({OQ!_@EP44X~8E|*dQbR?xsD2wI<5Nrt8-o_hFg|sfX zY_Wx=-l#aslL&1*hk0V_ONPn|BTnhs`$KZ%6=UCm=Vfa_OOfX`l{tP>q+2StEn4?Y z_ZK$QLo!D`CjS6v>V_bvO35P*w(FA$%omXXX-aefOC%d46MKz!iFlH=e5vvyrFUKW zjgJ=a#x&*9kxHwoUBs|cQ00cK>w?5B30q3HP;FthkvE6p))w}=<-hYA%fk4}u-X3r zBsheEo?alEN&<;iW~FbwmimqDz4kFZ`%!;~@6?LDm*@BBI*wrK+|3Slp*dctA^Bu2 z#@!}e8F_8yAxTRi1tmkTde+oO7qpz7%kR`B?A0BFr)0j+(par(q~aFLt|VGgwYs}D znbZ+Vo!flx;NC$8?i+J%48?H~UGN&&BvUJ^aC%UA$g6;Ry<@@~N(;pI~iY(j< zi!{ut(Ys1Mktf9=`>Q~5oIlYhLE?#gGY2V8yqiLl>~2_`K+TdBVl>bQS$O(K0O+Oi zG_-JChElFJF~g>^h(Wfu^?=}I0IP2S(V)jzLQb^xo(n(C-B|&}4O6ku^f6zS39@cE zQKg1BYcD+|FEF>}!q(U-%JH_)(!@Ee-+zU&uDso*CkWK4@2jLKVfcx2qpvf=c^ZC2 z=6ztBSx&5vjp&$+(@Wn& zyblsc7G2Udc-_OgM7u4`DnYr2<B!EFjLU7Xv>(BP_KsD$yV< zNJ^e5H~S=$e_L4J${JYjvDYMTDuB61Qoxpw1!uaP(*U166%ykTGZhk8O>)NG&mx=a z?>+m~4k(->cO9@)v%bwGJo{}4+4*&)C?_c8+=PtA_9u8;RSL2~((oJYH=;hYS#9dT`%P$uiM}9h_Zu3h`SHNW}m?l;z`#j_b1#_ ziZ&y0a7V)W+8d3ntptV2tCJax*Gow0-g^H4=R~z9*hpM?!;^To45?nOz+qIl1Hoo#UrB4a-r0DEBEw1DZmX$bcxvkgKEtRv@^I z#Ogl?B^5hanL{Go#&ai}>FAcwNGd15LL7-$@HRnejwY}6ljb{Dc~q=2N##g1oRgCX z8*`LGic)+Kq@7})iS~kq(dXRPaDK_Ua$hb+%ahDXvYJ&koi>RU01ctBkverM&6uB4 z8GM;s&AuE9A7Q(4yGb)X%)@~cRWPgmdQa^$dN^Rr5sT(8s>63bU zW)Z6S{-cV!zoEvScud_hk~(z__lLt!VYcX#73L+B)*NMB_Dr*#3x#c5`5g9+ZaKJ+ ztUET=lGBAr=-Sj4f;=t;Yk7kmUjS(5$zm3&D{e+-o>5lc=>z9tFh`+7l8Q_CLeu9c*qY@wn>qmJI~@3jey zExIP%ujlnT*gj2IsL|%;m;s92I%0`dO~}gpwq&$b_f>SQBV5MdTK0uBqq2Q=`}7j` zzUzON-Grgxxy(B$OsHZ7%E|jIr0p7~?G6^q%!)}&y4xCES_K24Ad>{8snlR>y@)%Q=j5{u=xyB^~kG9Q@;^oqAk&y}kWOPviskdkM)py6=8p zxY%$@7tV2i5lwwHFjqRMJhF;TR?^*+2}@~6umEkLF>wq^3XxBpzNLb30|FW5>DgYJ zE0%ey><@2wXF`^W;jO2&KB_I9w&|Es6U-Evi*Ir2wBX7XfxVY<1XyFtpC|GtxUL5IubM5l4dQB6HIzjCCUJ?GcL1`G;#IGKvC#OA zk!g!Ra~;I+E%fC0)N00vkN0=avOz;=yAX#v9`R+GE{ z3f6!&j)8|dRUH7slF%wzf9`qAImfuu#83q4@E^YNrAxopM28`4qTPm1?E7dL?=fhm=jl zJ!N)mULU|l;T|L^wDhYpjg&fv+95!9Pk3*04o(A5k$O(Q&X7Wos}!=81N~dZW@x*K zqerbwPRpT9IvZM(e{>LjV8ba6F$E~jAfB01f~4Mr*{^4AKZHGwj;ABr_+@5!Fhc5 zKqU!57B<-+4~$&!T}T{B2PqgbtBoAW)WSjm(>XeR1};==t#YHCkMN~qhRlZ*HkBnt z#57Kxw*%n`oLUIV#V=;OCH?iPKukQey3+IW0oS@O*5V*>6Vi!zV{ExzGYXCzqRECP zGbLq)*O>@6N|ZlWc+ItMe#OjRZsNlo)v6dWlH}C8$x&sr5ER%qy@k3&b-3}#s^NL8 zUWsSloN+2{&NdR$UDYW&>XQl8LX0yQa&-eJs!Rjm8e{jiVdy&;p2L&EdB+o3n`vg@ zGR$jhYu<})8=uIe;`w~ZF51F|@ob7Y7+rIl-2_6$&1r`UGz35fBuke?_l}&P3KWBA z0NY%;+0a;+;2P^n){~g)&gV_ea9e0in)$MBEJB0FH?Y z+{EZRW%UpS=ce6woXZM6U`J8MW`bs>5Pqx?`$>+8wi(&kgbdj;d58kpt}1g%(Me6b zfq><)NGFTP1s86^TkCV_9HDk6<|ka3(O@dubPx$_+f~xuVl^B1M^2l5(&Vanh&Iz* zAUkwoerZSmsNASuK^!>PL`*5LK(N149XV!2P9-R?>9x9_69L;e>8d!=x_qOwBF>5$ zLc7_;t$X#qq;ORjTbL;aF$2pj$@st)ZZlRgS5ObH_3f&ENuW; zf?}u4Qr1DSIsi4a2Q1C>n3yS28|8uPbL*@JZ0o&KO45}eW>-<+92aLj=hW~jUh&h1 zCSG+-D>`)7uCN@lwyCnd_jI2~1sL6^xKcuFpBMtnDSfwq<^WHDQ6IiIa4U&!;V5k= zJ~@f}%m8-gDqlw^DJciW`}`n6naV|Fbp;T+4)7z;M@}Ye&Ei0#l>iVroj)kxSTglI z>luIvvDN@Jp0A+_H%-RCKo({dhW1i2tH*c(&1b3#T1t`!sn9`3Ol~b{2s@~Yn{5HZ zyoqO=ATG!xToa~|!9so6-cr<+T#=x+Q~V>MO_4IBBfM-+POu#}QuBFb&iI#BZH?Z;3;T$>x4x!70 zB&)=qbbMd~RmrxRHVPjNL;z?tCev3^TvCZQwZ*?E>B=?&25##0>NJ22_K>$wN)LG^ z*0gZxynqs>ycX`P_WtqG;Jmu1x>}LAICH-xv;^ zviNDRm1PSX<=QxO)*;D_t#2DZ2RYY_iL#KDcq>@x#^}oA^4n}FD9od&HY5*}0cR!C zF+MY@=}79Kl`x?@vu07gRf3e2sPsee9TINK(%3EE zO#M!7zmx}3GfA?r4T@Bgpt=4L#sODFc#9B9e<&>N8m5h{i)CLs!C^;LicdKiP!^Pr zv;Oyv3Zv6<3s?yVu(i7D=K;zIDMfJ!BQ385g$Mc+*rc|*z!YrDOD%>}!jM7_QZ4wv zbks83##yE7qnF8vLVpY%%kOdw_9ZFO;Bg;`7 z3NTdZ#cm-D-0FT114nv7lI)r?44@NxsQyvLDI4z7OKHsFl0fr>iZol3b>c!)Qi19G zBc}`#)T1zfO3H^qZEwN=XyP?RR%>M>j)L*q6Gv0%lQM4VR8K%Vzc}EdYGRhy0Vo+) z_dzF5JHT|(ou;Uu2R^YrAZk8P95!U>ZBLu8C_n&MTz*ghf1n$XDggs3hKExD+Bwp+ zu`Ef;n0TuH0E8BDj7?LSMr5cgsa~0F=hixK<-1H~M38`>d;u}jhIZxMW4^+be+6rQ zgm4YT13Ho%ZLm6kH9t5Gnx4WWY_`Y=A7=W94sts#^6QNNyQM(fZUl3Y-eHq5>@2CJ zIF}NkYg*^vbdH6bx_vpfK@KfR$}Wo=2QrNV2}USwY;SC@gFXp z8hnSDj|#8X@9$)K3F78Y!1e3b$M>Hh1=rK>@0r@O1Jc~@c%Gue%UfG-+&bLClWX~X z{{TTPSsnP}z$f_n<19~AT$QFvsS8A-4PQEri*e(4cP!ODktoXuMw!EC<|$x%>sUxCbnlyF#eRM&Szhh^{=Y;! z9BK>i@An<*e2OWkC;H1#+@CYnAn6*EwK1s2^qG8TD=@^+S1H6LE6S{@%a|!GgKeB3 zXB!mgVGde%>Z|kFeEOCcvGn`%eKHB91s=Q*XFSyDotbxa@=k*3kz zB;MqD2)xHA@jU5Ew?|1|rSmx}$KJd3UB96r>Uj2*#hg3zjVfTi$$5gLD)(%KT#G0I zKO+fvo;SVSt(&^$ax%W$p6Fm{SY@|dpKVu3d?m%5&Shp79{?kl$X_9KKzS{%$7 zN>tFfP0|I8$hftlR%k};JKuEB#2mR*3R>nFMPjC@rsk%lQuK?Ca-|&Qg*ei}LY1Mp z2~YrATUeOvCsF0+{DjFG*e?c6;hKu(Cg**)Db@;}Sjtl@+7?&h#+Zj6=4s` zYFi~#?2o0cWR{w1*{0C?fyE=2Z zu!h5Ej=W3%0F|Hh59blGn(t?S2#(2Uh+m_dP&rUxsgFSzIC`<|lS%PIW)T!O#ByI2 zJ5M7>dWz<8MEB6niI1`dS3hK({Ze&?CWa*)N`*!slQT$aVJi)VEEGL!@*db5XiIMU zt|v|Jcy4R2E&29;v+6;{>9yH%?!R@=VP+|&P_~wWWXn@Z43lLFeB!<7MOxXU=E1d- zl_|}tj+Scc%k+J|442Q(Z}p?!{OE~#b0ME+Q)m)gx7}@&FDXqvZGWYtyalt#Ozznk zP=ZFMNMGN>%jR*b=f26m@}vGW=DkhIWhL5rW&N43iz(#EG~$5`Izi`ACJxJ$UZsWi zTSb$itS;M^FO7Wv0K)zt`rnn;Zj)YXuTy4KlFzb+TDe*tYDo{NHdChM>KxXVQ$SqH ztl0^$uvNRp{X6Y_`o;c%C(itvucX(XbB|9-lkDi0N3>^cVHR zGR`W<8AXz-cZE)?<>&rO6yH1BmDf(wUmm929&EeFZcG`(E?v~f7uBsnloRbV*{hG! zO6$mRc1?h?4UPL3et)l*#RFA$w(9Gn=_Ta)py7{fEUHkM-fW|YmP@3Mq@S@!<`HJzu{nZ!Qa*YmWhRi|8Wv=C?H1-Vnr zYI4p?Y0USQthyyP7EHGD@8-MwQN^`Z+qAr;)<5RHhX$_5VRL3^8IYzLc6hXmrgBtU zkyn=0StjN54-Wd*mf$D59ZmJ$m(6rx9+kH3E9m;c`97TvgzM&5yz__JiDjo}3n>Wp zxotUBnSXmM%Ob(ljO$iiGWTIuck%V}I~B^d-KBjWSU)Gzp}$yRGiiK0qOi0y^Xp`# zB~1^}R;72y`Zj$7GSzOHU8gNKe;4ro02l6pJuA&C@752?v*dFgm@F=7GfL$x9H(a% z!Ae39e?eT702?WO?8|A)vM+J~*ROA-*G|%3sFbd&&adkS`Z0#ZJTa{B{;KvO!;Z5m z@}5fS)a9bKjY_&=dq_;(pzK2qrW zu504Hq_N?b9_2WWW+)ZbJ(j5^LMEk_bFHFBb!c+MF1DaSO3`pqb%o}~r7c^<@_kU= zE!%P0OPqQcF@FYy83EZ_y2tcn1n89;maKGBM{>%$iX*yEt3^(H4hwD5^7?-+UjpBU z;ucMw&2#<#0GQhrO58}WP;i^7#D$@;@7v!cy^?}N!#kx;AX+N){qx)N+tqoNt8c#l z0KcO#r7o9`g1x2o@VW*5(t>ezktRZ}nd^FZcWYo{aCaK7?jU znhLpXhZ#~+WT{&6b?&5f8?x!u1qy{VTQ$y=ZC?+)pGp&_^>_OH?z-8}H1RT{lIjau zfX#BH28X<@l%+MYQc7QJ3!!UHk=X6<-{ZIK+nVmsa{KT5_vHGdXiQ1DE`+$A>E)#6 z3(AzZqhzY!St@sBOeAv6^1RjVVQ^R1r{Ax2w{#*)^ZWGe=+1++CaQ0=CQw^arV}m} zq~%Yv0BR-8ewiwNU>mHj`Lr4VH#y&L&=``^8tS!r~>oXy==Q-~zy z4kc;6WgC#9wCp|CQa;nE-< zW%PzoWTcXml%Z=q){1UY8(!pU!-VKsRCZDPyuCj5enQs!{rrAERpx3 zVxXMqQEX}yf^(@T`z(?lYu;(aq*@yK@A-b+7d6qbOZ5Bo@5%K@M8Aa5GcH_9izs?k z)Vp_$oua$33;_|3-K$rE8p+y)2arq*YEmu=+2#M9nbK_MN`h% z`59osCgt9`+*i65medJLZiM&q*=$VeQOjAdk%kK_w7ssYwf6pepF%GYEfLhZTlshU z-5jh{#_5Sk`3i+DNYwD#tS#kDCBR+Gvy}uO*=SotTfUO9askV{>|W1K)SWc;U#<6D z3XGh0Ej*gt{*~Lfv8MKikWEgWm9qGz&M`0?arG>?%k7X-G6dMRp>dcE71ke*v(oDJ z==USbj&G7*6|kP-&k!*6c5a_E?60=d+*;+P*)BYuNl4~0`diT|*Dxn3P&TrMSF!Ng zE}dE$mk`}v^e8Lberi$aZ=vLypQpbnw4BOPUQ6t#2J<+xVv-JuDa?{R?vWZ?5~sfV zbKHJBTff_3X@;?M-Xv&0J0vOY5Vd4W+|yzGASnY=)kq~t`$CB zPd_I$fu)koGFdZ}^tiI@i8)+pC%jCWluA$$t)++|L)=)}B*t3X)z|a#?eG|Jt=7-K z@89Bg=oLvy{F`+;W9ylbbexU?P*R|5P~sGv$x=>)5G;B_IdQyy)a){A+3fpOixD)L zqXAwR>-`tC#CD^rBL{P4_NDRN5JNl6)j zNdz9cUgJX(V(ej@Dx89vdAEYDmjNIk*;la8_ygkwoIQwST{30VT}}iqFzS@&N=d!^ z4$ws5(5_^hsW#IA9@6v4L(MvpzpDuc+8S1YBqcT}Hz_{0j;>5kAz{V&k%g(L3@<#) z%)=#VS4IHMvuVh}l9U0IC#GUNed7;V z#Hdp*7NyoDYI5j8%({b0V52AqP$5jHbq3^k6JrTbr%dRs#R)CQEtZzGQzy}OoL6~C zxUg+!s7bg@z#`T#a$vV0{yzw+&c5g)GMptg8i1Q51Ah=N78v$JGBnXP)k2!7IhKl? zO779z5PjsR9}UuaZ3?P(j&nyZ2uZghmstlOL&ababZuY@`PhS?))y_#K~dPOO#wKj z$wHe&iXKJmq>;6bx*tzSSMve(hDswGFDB`k;`p740o74h3*!86@}(l$eR+SCv#|KYK13b zr8`q*vX-S-bg4jPAOeCDrV#0;U;F!I!et0`$F`aF_BDNyQ0=VP=s*4B=ixc!yP)dM$D8J3j~p(!>bV#3P%$x?~kC4J$P>{~arhNE~(=5>-s7P;(_tiGn* zakLT4OIFR3sUz(HxdT{v!qOVX_hfNAOQYkdvYJfEeKLwt9|~<~EvZ{1<^ua^Xfk4W z>iY60VRwDb)34`Fh8b*qBbkbEjV})2(u%apGSc%;sihZ^rKMu`QZlD|f!9kzxZ>xu zdEewBe}&uVh?~WVb`9eST6R{oBOy5~Z!a{%Yi-03Mp1nZPzHbzW44iL!^aR*Vob5gx%!LfMNh#jNS`?ccx?b>y?I#{-eNL}u#r>mRf!dn2!S_)kj%Cp? zPf;Pd%(cnT+v}Me#SaUMTfoHZTxW^=K80p(0Y{&yIO(iLiQm- z;>T^eZ{-s)@oGgzZUMkiH7u!c0pF}oSy5Fi4IHJ^9204m$=p+ALCf_A-M8a-bvq-< zG<2R?(wxU_geXX9IaT||uZ(cwHo{HGfKb`u$&@uSGLow)5-PCuH~rBPe92KdG+L+8 zRJkWDbf`9hHnwiCh>K@!6HOvuGFSEL8NzIRz-_+Yj7vy~CU4HG+EtKvU*!v-w#;4f z0O=j0md5`86w9pEX(Pj&PxfKC@)sUx+2XQ!(vxae*+LRNFVKWT{Sv}8&Uq@<(}ZK;W|g^^`CJG5!pdX$?pEwtWO8%q7r)L+6J@Wl9_ zmYSPhji%qSKZJ9_4-(DN%WRtlfgV6dd^5fw(`s3}TOvR^=pha?IHhDY;Fhqc1AyQJw(_qqnIC?Ph8f;IwhAC!i*-VpR zL|hPr*p9t4v_0Xj!&;8))(E9Y5T9ji<`*5&{3E^^>>7=RxOq&l{%qJJUcn>yM?5qZ zWls(%VB9bP^3(E;cxdg6$7oIz)2g&fWKtA|P_z`Qsz~1Zj~Hfg)5v}dRB*=)wN+%=zM03 zi@}dLphZq}d1p`Xj)imZM+*^?|w-7}*Z7uWK_>nKaA|CYrp^IUbvFWw~i{=2R2RBYPoV7>AcShc;Yr z+zX#2^BE_w3sm{jTgG$D&QyuaggtjzYxP-V6$B4ElNs(KjgjiJ{gwh<+AS-x}>GbmE+T@%2w+m0e+B;Mz!zqV-mwd#95|eP1cal=FyCp<-ecOn!a;@4) zHT7T2u9EQ{l+9jjE-5yn++vJNg0aKVQYon z#^xB5wNgu^d_+NB{nqG@n4`6ft{Yt3wiuQ6mZm1xH_w{CEvJ`k%3-XiDHj=q&GQm( ztUV4A{{V}>EuZuq=jmI0?nHcHifWuge9Tp5-I!4~2~y5P`6UF91X*K(hc8~DTtuqr z;X4R@F{wn?p;jNj)hTMEujwV$2~F*pH}52o5}>T7;&x=OsP>7*e082wt{0OGv!X${ zDjq6Q%8-!{)pIGPJ2)Tvo_|h0nwBxCJv91=TBVU}xA0QbSD1QR)+5h~)3O>^tg);Y zgK2y|mQ1BCQJHpKT@wZ0~y_QEa!uqe5G-ua$7-^si8N1O=kHI z>aM{nPk~QJvc<%i9y8f)8}#l!22{17i%4a&F_VUIJ<9?lCuBz&1DAMEnhos21GEn= z`al$UQi&dL1psN`UIGJ}Oe&^<_MkbW@@VRs^n>fG7hkdlxx79n#Pzgin%sP^xq5L9W56p$d zaz$=ov;jRUnAjJa1pfe7MTEH(vF2XIKLor|(}JTgwpQ9~&5{$8i(38>oXNR!7el)( zgXN^#NJEY%C;)A5m7*Sz?N&z`j}Ii!^u*JZN%q{#wGi1kg^tOvI(Q32sK|>Xc4-_U zZm`;1O;W6t6y{2tbX_;sRFvp^uMVeU4`IQ;n0}=wmyrEU$N6p)p+x}QHv2%G zBexw4;hJqde8sz(Va-=->#elXE_fx(ui{w1aK{%)VOeFV)`O0^22!GIk=H;qC&v3l z`y(5#|1U6znvF%+{O4`}kO1K{pXsY5PaV&7k znREPikabvgNQW!~(&bkdHq1K4eoDOyXuB1>K&G0t1=h;!m8GGY*RaeY8YG}*aMasP zgra%G45Gm;r$KE1B*R>V*nypppQX&O(VTJ4aX$JHu-|BUF2<&b3BwF36;+y9S=L>k zbnw4lj9g&Zl$=VmKdHkZJ1u`Wv{ETvGeLMzlcS4;*xP_%g-9ALXW}5Uo*9i8RrYm5 zi}WN%Z03dnFvP=#>TyHjAhVhom3U?K9Udd$ujd7ZgGtOMG_9UKzwThOni-iGZe@+% zB>9i_!DnJ-w2y`^K(Kkbf%8tmcerb#9BtJDGe;5nt6NukUi=}*L8_s0(DGn!n=1+!fE+x@Tx zmSc8OZrMWZ=6~UioTh0RS;QXV)0@XH`(Qat%gCO0-g!6ugZ{JuxMZSlP`8Dxr*P}# zymU7?&9gAGYnbSb&BV#gH_#NH_wj)90VQ27AB1}vt??7Zz$=* z8(WmUl_M)i|X$8lIvHJEYZgWjD$R^VZMjw8(j1PI&eB< zi8c|#v>Dkq5Ht{2QGvN9fd@~Q`(vPy({G%m6g1dX_sz6$QGrs+kX~03kbJce9I6Ub zzX9@&oiZ}YT~(Gh8WGUP0Mtyit`?Ad;IN~m?CeP+m<8NABzeae9g2I3jB^nS@>ji}#T``2CGPm)LSW%K(wBX8=W&j33 z`Mw?}taJjoP7_ucQ~>kSTm*i)nL5AyFgn0y+i*EX=9OJMJBU{xBRe8hpf{Amta*_SaoeUo z@@yPg@fWawKq+4X(gUEn$U<^AnO6I@NcAM{U;_fA5<#+#Z#`fN zG~1~=ES^~wAlxVz?FqBXOYfg}oAj_S9W$>zI9W^I$^hgYZ>nLvP0vpV4xHCoc}D6W z9)t@=M1wAs)589+s4Q7m5Cu`ONsxAVN0R11Hv-Ydb#8a3=`Sb-$SO$GsHkh?AvP+F zsmHP<1wFu#s%>(7pgM7zhhk=Byn(Qk=3ju09kWtZ zlGdmq<8+u98;?|+Z9_Umx|FEgd@me3X2XoM;)0oUsP0Jy-h>zc*Yb7!1#N#0qyllQ`n{!!2mD>RknN|dmE%7Gxq4j4X{a4dkO5C^@O-aAKZ%_%ZY zrEV0SicweL8~|qOX&mP0EkX(_$csDh1ERD)kb;8D zX{$EyE;!mkM!=9y$^f%UV-PhwLr6hr6RNa2c>o}wu+>5TPS+RXy&R2 zoJiczyJ0^8Yey(G9OX`evbBO!ZjstKW>Hv^RjjKU>vWO_%Xla)853D)%*iSlM#@T5 zKMmlZuvw}}q<)a|dTF8gh$t-Dec8ES3yr0;orwV6I4aNo*R}OJ2HR=3`}Fw^w~q{O z^gRZQJ#07E;qmkF-0TD=@9*#6bnsa>@YAQ^@bK7mG0Xe={JlWUD=uC(0_s)%K6mi* z_yG%yZ}0DKKS2_7YT~?0DZ^QDH8huZ{Q;- zyljxhGYwOv*qmwCiMO;%EtJ_J=IT)N{Gs`KJ11cn@~FMVHENvgAcQ!im7A21cTpYZ zO~!#EKs6CvpNE$Y>DBaWyXP(YBG(2*lXdpHe8k;KQJS=}>Q&2ax%P_Z^JJ>Nd++}1`4K}Fa8(#Cr2Zh0Uo8%$Vr`#wDGwIWEYoNm&|5$` z)NG@Bo0z&>Tg@FUZnyYfPflb{3q$z+olZ2(RZqw%{}nH`i4T?fhXe zTZ$L>eqvs|N|swn3R`F>Qhw4Ee)1GL7);U5rquGlNm8$#!%t7&XlPwgeeVxSx%V1o!Y0;-l ztH8?-!is*2`WoJv)dX*p4C`^pI# zd}2$L-``RqRYz?sdm}?#QULjB4pj}xUe=GJ*9P3xN+^+h4dN_@F{n6X-b1NzkfD`8 z=nq>H5M_nKnkCON$hIYH#?itfI5SNL0R(742hhSKgdI!^QbN+@DsIY3(o&F3vnJXP zmY$*-U7u1969%elni5s|F=1*;$@YR6Q%|?Cos(kYK=zbEt z*4x_u0486wgu^t&R3A%9Q**r8aEEh{lvN~eWGoO4S&3WOK_Hb4)-RzK^K`teU*?5N zW!r!CWz~EnbEddB!;-3#m70EDRmKr6<4NykOG_$3vnb|D$KD4uy2H^`{XEXOef&%n z3NXVmqDgZKn_(=d&9Pu6OF?Pn&a_3;rOPVWhMAIXRd4}nYoFD5bZg*sZq;o1K9|)$ ziKAC&PBk(n)?B-6xj5qlUDT%D&smkqEL4jDFxqT^V|6OR{9N7nU!Q3&)dF0rZfZBv zydUVzYOyUDrA;}NR$=MKSl24XlJ%KT018616D^FWPPZzyylK9FZ=+wS*sfLPmHlA< z07i7@792Bv)JsYWVd)7?UQ*Ue*ca_{r<^Z0i;70S2fmGxa< z{MSyVr1NH3Q-08S2cFB*fvc!W&6{#+lGnC*S2X9Rx`g+%R<}cZ@4C9^`bl{{r(@E$ z*`<9~SU)w;&+R5na|@V0&z5Pm%!FM@lAl+(P-|@RPmj`HDiCkoJ?kw$&wnT1;Lat= zx7nqAW7aSHrPHaNdY&0uxj>c6HkY#iR3s`Z+Hp6wc^QwiO^}jLb5m}~-<3Z{-{1>> zKg0gCf5YV@aisH7mZaq}Xl`(+B!Zz!sIK|mHzPehZs#i1WTdLWA9XU{$*0e=@9<#v z^R@o8dw-mc!}7_OQh7x(YG!DeWhpll$;U6u=3MurrtWerS`6aJ+Q@?WZ@2j`uf{K+ zSAFg~{{WRAFY=dDmXw-tNMH(jQ8ce-&H)se)oSV zy!rkuxBmbtJuCdE^)tybTMc_L5(T-H2}HUQevFw{>7?Je)>>~~O4YV;l^*Oi-!7ZF z<+JSkpF@)K-(_|E==75FT|+ki04-AHTqaPq`-qhfWwevZ{WU6P_xh=wOAadMyfUD7 zW03OOcS-c`7v%aJeQ$e8>-)>3*P7~%g(>SPl(&_%rNL_D$Db(_ap#V|cT{!NfmedYt)^t4fu(OPX<7q@?CmCS+_J zLAjS%&ZVcjU^lYiIIjt5d&jrw@m)KR_>Lc2)V7l5*CxNk@O^s=4jcA~p5dg#ts51D z6iy_indA^9U3EG*!pf44Ov(<6Xy2g*#wEroNy;0pv3$tcHfl53^pfOB+WrD#5+PHx z(i9byPBU|LWz{w!sw4{?2Pw%Gv{J$sExLtETelc z^4u3lI)Fh^54x*Hi-zG;Rm*hMQtAA=6gl{fPw=j{^Zomel$QkLX3$qNUw&n`5`?>S zvW{SEcP^xA3VIN8dBo3lkJ=)8%-2Qh{D*3rf^hSVftfEWKQOpnvWmdVpSqv{wuags zpxzR=IQDO^I{bt_D<{LJBY^h^=oM!Y#EYDlSPHO0`I!>ER5d5Mcgl1JQDX>~1f{aI z^%l74$9GTYa;jWBrAsW8RhdhQT2!#2o2VdI0#cw-vC+Zaw{+$ZhwSVA_g>$(=5{{O zf8qN5`U%%C3a49Gmzk)Er6N=|`Z@2RKa%8+* zd|TZ$b?5i-=7y41Q4-1}DJ_*Hq*~VnDcQ9GZWNg!%$20sYf_d{75YGtV5E>POMh+Dq&ktKttma|?3VVs@Au{3pLE3Z`}^Ow zF3dEm?y+r(aw^8j2v%dMJE1wX2uZsS9a5&3q%R)dzuw=Y@?s{h@9+0sWqEOb4N$3g zg~>@7QpjAY=3PfI=G4=PNF}n_Af%njRhua`1wzI)d^DvfCjS60+{SScN=+|5q_d?` zXte~>1G3CZOHBm{eq-)^N)iD8sGU@$T#VbDFAwRmHPDip?6oRp-_DtbUoVo_N>*BN zqCw4@Fw3DJSP^l(p*Hz`hfwe1o(|ze-{0RRbwt2np{Pz&+WTd>-@pUV6PLk5Xzq{8 z@9&ppCsyKGa)`M}mnw9HH!V_kD0rw6#L@<#x6$@V=<-rsPlCiqgx@E~ZfP~Y%lUoL z+rrrTQok}}9#Ey#60E+%Ft7vNbILkx?G2uaNi_yx2WQpe7_*#oJs<_y$5yM^zZ^Z;aC3vv~$G2=tNF7$hk|d zEyZfv?X(B&H+}EqVtjcFU5z^3tW#qST_6ETeJDQb6foNjC%Whn%cUQG#B+ z-9ZdJFtW1Z65P^qgn|^U6qDkc>$cm+bkWqsz82zZGIVN{B48V|>a2^8diK!hY`q9Q z4dbpaZ!?LJ4xuW!hm`RIW+eXr!4o5}+ea>1ZE`QED@QT3+T&4}dX0=N?j<@4K&F~p z%*5)ZLfTL$VWsHhm8rP!PS@7(xk}Pizg8wOrrrDwy*iZK%C7np;3~dUsHEGjq7!21 zT30J#QcX13OQJwM&k0tmDk;h{D}4rhElYk5K2ipg%8=>YD97J3kgJ&Qsz}Ei`i|g**72nMeWwze1vj9hX)H3 z(a?t4l`gzjbvRdK5q$yh(?VgX?saT;-<|p{p;fCPysWdzum?=b79bv@eS9G`X)lPL zLeftInFr+_mBhxW*6}lrC8?C4y4e?1hEu0@=X>;m zFGN>1eN55()d zLZ26sJ$};Mb#U>0KHE7{ycWaN7Q-_X_HuyIM|DEk8dp$3um@k`4K6n%diMORTj8Mk zcl_vJaQ*?r-InH@o5M;q3JSAJ`$bdSazKPUQd2h|@JeP{?_8zkLWuy8?+pxcSmlZS-=Kw& zO>gz-@ffkdn*RU;ryQNZueIzBuRPr%V q?9;P;@MHyWdrv_{Cr}T)92s!I_$8%f7_; zVeWM5(~}akI(mxPDN$oYsNCI2)jDfy>OUAqis)O!hgd3gg{LrOX}+g2f`C39-F+f_ za*!vC>)fH#gZ7e4JK~{_3_DJ#B|%_i+$*3SanBV7h9xlr1?r_fVI?YQv^$+iAc1kD zH9X0njCVq35^)-tG@~zczFcuPKp=|)ZES9B6kJCXp2dU^q>|$0CZ#;}B30BErQ1O^ zDYmiw))EdWB zXJ)0;mlE?TD9CeYMZnXnO^#a{(PL+grI~tq)&{!#OoxrzHNRCS_32_w^&Lc@G zRZh!1EYmkaR8kVGqoKJl!{SghG<;6&B_l!?0VCyBM~nxnS<) zM>oI_2jvxWf0;Tck`josW6(sXjY%AKBoDQ7j@e28>%Q?Yh>$f_OyZCdKSrQQ{n6S6 zcHWRu>{4w73abq*F6FGPVGL4CZMe@WrP8u_pTZ#ICqWt<8f5(p(fh=a^MqpLb0Qpx z_A<0d(%Tag;6cc0R_cDj!c>&!amytL@h7S91F46G>?InJGSdLMu_RchTPI>jJ;mtBbSItWPOjg{}mUfPM_<#n2E6@*WvjNaLIQiKwAN>&2wq2Z)Q zmQvRj2Ykf_746|cuPc{PrqpTfTIEHwy3fJHsD2%M-qu|m~E}(pFF9-1N z)N@ZnnCM}wF)zdR2eHkmw4{5@%4aI{D_lpEt?o&TdRNrctnpyh$d+Pl`9zHuF!};Y z{RXK>^SlplKbW|~$l=S<=3P)+wLud$*X%C;03!`IM# z-;5w~DRdi}rGA|Di)m?d!N3#v-U?&L;Vx!!SvlnvG9R!&T2IGu@Pp!X>`^KU#6-0- zCgVAGbs(vwd`L+L;A66ij_Kd#aXUKH+3Y!istNYmud+PR4m86k4!B(!q?8kVKJAWe zw1=@`l-1L&^h3{?M{TY2ZnpUnCyG>RKM*M?dlpV0W@nuvG?Hc1%I*|}77CJ7=ES7t z8;>|%DM>#znp=1BAxj!cqP9|2o9A9*4~+X$Q>EtLo5QjS6$y!UrKTs}J=YM(IS6aM zlc^@=$DzHVd~i3YH91QbZ}{O<6FwU;WRhw zL6_TTPa~$sFe(t(;tE;>g>@Z9@P`{6Q=u7-cx_4IV;q{Sx?cOP0#da3f|4Lj$B{1{ zcOTe<_}j7#Qh*fw5@|DR4Mek`rO-SQp_@0A?Gjc*`TYse;uO5TJiSQ0HtfzGnM!9H zenN4h+)}}9K=`Fb*Zhn>A1%oaTDkuKB3$t2wl!M_BPDUA)mRC#U1XsSq<*pjLRIUS z7@3bYl8=k_a>=}QWrN@@Ak%o8CW+c>&A62$6(B7oXg_se54 zD%gS|Y-MFUpyC?jLaaauB*#EDVweENuv~!SHGwELfIxK&x}Bgp87M=Wrtk_u=Vs-o zGR{8vLv5udgm2zey?Vq6)lE#A|qipK_PBP#SFUu`M2C8ej! zU=_JAgP3>$r~4vK2+}t(=*M3@lc7(uUnVJEyBs3M6AS>LSc-I zpkxV3&}=&9il-YVDObpN>G)Qt^s*dHOteaFQdwmtDWT<%VuAGahG{Q)>Wy_$h+g`v}ABlzOLvBKc3gAb0PflE# z>qtz)?kT|QjiWJI&CQafYp$?pwi<{n+j56cm8Qr$Jy0{DQwj+Bl(ZA3<0&`4oLX?( zSqm`&lZ%<7*$y(d2TpxQBE7h z3Jx!n3#n-;Bi&Mk!LhaNp@>;|GEO(SZ@r;tHA(zGAh~(ew#$63ecA^(+c5C)%eS0R zHNPU+F>^OUniM6ls)`;Zq@5W^Ad4P~J8ncna3ralv$$fnDJqryFmo&blkAO<2^wEr zqn;M$d_lgbV2n{TQsV0kD5-&AMO0 zCt~OFD|7NBR$S3wim3%4h;VGg=5wHcOAN{soy-ReZ_BCOm16uB%a$5z z02+l$QQ8190<`pi0Cc#ocHbE413P8FJJ!5#3~B{Bzy>6sD|^Rm4QY}a&~F_=S&a=X zLiQp$B_kkf#sjovLVPsyfbANt$*+6fJ7*}?M4In=+5t3dE?BElU=>H2mmOfRNGr0d zT1mgc&>U#REhWrN?ht$}0mO}uWmd&k5DKH6?Di)6z#@*54CPLyI4vVp$wtRhe+x%! zO$I{<0_8~%1p@7+1&XdbpgYV4B-%=I0!PLGNYjj;oo?9b8uatD* zto1!abRq+k3gm-;1JVGX41!w%0HZ9tgL|D%tOsZrsRcf6lnV#}qdb(7nAX4^g7L$t z9)6e4H#^5{DAHXaN!H{hIC77B2XLK9=p&&GMd80eG7oTcR}Cf-5-Ha@XhTt^OvdO^T5DCNJD0Y;IOTOQ-6D)2kUY!4-u zRxaZH0Br%o8q!#`&F*7>WH)7+ znj4qQa+MyY_JYEU>kl$RPTJe1+du}Z>3OAumeNw8?*$tVT{nOMmX&2^z3+6jxx3&RnntSVW#Gk{{Xm^ zB|fpkwrDppv!X)%b&k=?HlL@u)>S&YX6fPTU<0DMbCPMyT|&jS8o+eWTMMZw=@-l3 zG>)9+8FMcnfn_6Iblx}?DN{y8Ng+!`m2LI6%Sh$WsCnuWC{{R6UptDtp$6H2a zFs!3o+kQ5V9I*5{qcd+fr&pCB9o)ok@PVLGvofdF>QC7n2UF(-9kWuKP*aN`eecz_ zr_;^~1a*qmlyeZ;kffaf-`3H?r=FT_s*YlTLdJ@?-_AS8F3v!#urAjv)%X;rOZ?-s zCs1`vDdgoSaNo$l7G-H>T{g0l`$;jwq1md2i5E(*)ImpVJFhBe6R?f}*J+QU8w)(L zrH{Npv>eXzG!~}j4rDZxud0HH{NsRNZcS1u%t}E$5Bp=FZB3Ori>(=lkhkRk8Vy&R zrvQXm0Bi{UFi>ivVpeR`+_63KFK|DE6+w0xslzIwQZAvPAbxSfwqY{Jnfl)9M}n2P z^nl^YFEoXWsJXtDHxbYjDx2hzg`}my?)26Ly=t-GRrPGlO z3-u_>pgnILIC2Fw`4SZXPZ-Fc!bcIcHip za@2%NCo(l!vN%tvdWP*FQb(kj&!aRZqRA$m`ItlCgMpV2aBV7kHfiRseXUW{=x%{ z(%#QNnYxKmR@o$dw>gQs7qBv04+gI0CNRzp&;55%;VVY zGbWX-K-gN=(|i6=)P%NiF&ai33ZFnKOA0}KBXu&Pk!l~TkgNHDZDGjAaV?5zG5Rut-b;-pTy-&G~}bm%Ax|6g(w5AQTM-8{xQ|D#_Y>fk!qoxPu*<= zDLNZ1765{i(Lm~x(jG%B;d^xM8=Y=uZC=w&dB)oggpm7dQh;nco8?*w(>iqrQZ1}W zjaB)KOR)a{H!zo5D^UO>5~6x#+?aJc7-Al3qD<$uI)x@yX^_g-;6eJe5qpo_evn=7 z+~p3A9hfxMvMI3RMa+ia5)Ob9ex8u@9eRyRapuFap2!rC4TY>vSf2$$V->|(6s{za zs7p?=+w2vU7TicuZjuN#Jz=TI#@aNz92E4Y)`;W%?y%~$`XZfw`IKw@Sc&7yyY*&` zaIx&Y5u-c9stK}wil^)0D%bk3hnijAs~(RH9^a83xEChHD~Oe8c}CF8yLU=kZ6OFw ziM^6E8u&!auHhT=E8wZiFVnn5CSxqUamdQ$*aU_wU%1*z=Bh64% zjt(klO|prEuauQ3IbIvFF|a;7w>{S_dxNfq@Ww^gm+3Fr^&nx{xbvmUynl7jX;mQC zJ1eDf%_eCYHb7j2>9H*~MeQvzIws(icddOI>DzR+==*#bF(=b~y8i%rJ^ujCLz$NM z^*@|R8yl=~EoUX47GcD>mRfWla$!cumV67S%S;a9!0zU??V*O{f6vdi!HSP=dv3hD zuQVj&*i!_1IOHW0DsEja5=5-({{T%*d;md_cXqN}0FiYKAu{y+`+Nm+=f2kKta?p< zl)Cjc%(7Yy2~Oghm~ojjyh#X|P(12f&4rArzo50-9p3hW=)cczk7woBJKt+{{vMNF zefpXdWG+*X+_5=1?lT}J2_!mmdrc;DO<5ZIF&AuEJ?#bC)phY{Uw*NEUAi2XTkM>x zw@I%){Y~irR+fE?2MAlz(kYoFmGA8|$-}ji-u7jFk3{#pc%auWg1@X^=yqLivU0Da z*Xz{fQ$C@|WJ&#SSb3Uvv|iIJ5BUkE&R_agh*z?eSr!7yI^EdD_g@A3Fqd6ha&oSZ zq?eQGZBm^MiE%19?YJCfL_d4KE}Q#BI&%L2)3$RNVtbkn@z&^-zDapsRn{-huuE&b zxj9!y(o4zp4^Anl@_8Ulq2}CSj%XoMl4$)jl+abJIL^F+s~~~C@x>lhzTJAqs(x#s z$F<(urt74iDKGM0Q(BhloKq|zDVkfYEJ~M?{{Sl*bAJ4z*MPHxm zAO1-lZ{<(@SwH=@MtNRUU+Ufha7{CuEF~l98AkSaUd1&DZ7x@on|E)~#SfjW{Ohm9 z1KY}<`m%jL%w`cQm=_id;Zr%^<>dx`Q9q-dZub6vFJYXkD$R~id$Hd>ef-ydiaX28 zdSB$rtY7&rp_eeIprzuc(&GWw9cX~5nPmQor!G#SZIfW|IaY0=PLPzpE&SK`mzwGi zZd+5NpGNt?{{WKubQ2ik14;1;p7fnv9M)ZFF3c^ArCAgDDzufxkL)IegNhgKoi8hg z%Pdk&KAZMy{7d8gwBJ8&zd2e^JG!B={q`97#?Y82O~&n8-B0S^+ekdc`R zwxO^I)w^n0Sr$6BqqI`aI$eGIJ|13${3fQYa{J%o=jw40I9uP_sW z1bu^Udw+FlhP8fQetUYZ%z3ZBzW$8Zm?7@sfXHm3G_h@36Q$AL*?Y9H?}pB>H}~ZK z0Dni;j#uBG^7UOTXM0T0YWS*z+tLm++q9)A zw7oOs$!*Ka@8sE^_J<9&sB`A`=lA_a$AMVUymKm+X>;#AKHEWWQ>LyIRd1~1x$czx z&`tbp8u??Qf*A*^169s8erah++Lw`G&UzFI70-0j1t1bizVJ{7Q4Z+xB1%@T%w+NRYMR`IMe1yu60CC7qJmZ42G%+s zJ$l6GaOst^%+sP`_8iCaID%%T?OoQ?<0^Tz2#CJSJ+ZlqBu?c(egKTDBr zfm8vbAffD&XgPz;EkRxDceA8lT%ZVDP|9SrYJ|G|4or!+lp0~sCK)OV762eDftcH_ zkkdkw8a!2kCRvw|GgD5tPz^0jld9dx-dd8fla*Gs_Ris*_obl zkg#5JIZcu~qr0H-8(&zi&%!LO`x7y7ZxW%#R}NT0vuAUzfQ`>xw;c}tu^an7K4ah7 z4D&cXS=SW8v)L(1uW_g(f}2{_Hn|%Z>fmF@OXH=?+m+#*n_lYOz0cad`wd3J?2oh3 z7QLSzF%OTIkc`B%X%)WIoAS&}2Hj67*PBY+X-3ymOWg|dO}ye%I5ilx(U7OcHtcz( zFqEXMy1_|V$g8PmGLD@|)){;RS3ygSlj?NoR9RUxAR)Al>Us|dZd^2B(FZHz4X2BHBxA%PA;nyCDlvAdd^1 zc-zVlB{7+-PCGF3uO$UdEyj>iY@De=0Lf(#FMPwmpIB826Vg=YlFFE6Hd6VmxRYxo zvgULfgWxQFP^$ryq~Y{el!?8~KRD+>LRMOg z^Al*FY0{T0qM~lAtD;mlDLWql4rw6xoIXTLE+X8a9WYho~1v%Y60THCSd5)oN zfDn;TN*uWQhXR2eK)%}_C~GGnNG>CqT-z=HkZrgdF53mCWe%eHh~!bmII@_Fp46G8#zYrYAzhL#EK(rx`*5hl`RQlCStV! zl;1v<7rE4J7C7>FZ9jd3$%HMnsIJ~G>6t5vJ`~|3Q(=P-ujZCcdhn| zb)Lt3Go6WeLnlN9FFu)f8635xY^+_zkTZ08jH_cXN>+}0Cf0ep_BXbRN~}S>g`+LT@NXXLld{tm zbuWsc@vq`)RHK}?=Gtjp?&^ZU=nqc~BB{eyCc5-wl-lV2fVYULbAwsQVm15TK7LW( z3HM%%OP`ba3`RTQB?fwRHM&hzbc&-yl}t%@dBCU=my(p-#M?}#c)7vEI4v@%FP`55 zuQmlIYS*U!03PDfhuT3{W?4rVOLEd3Eweu=*(}T?d#WuJmy)$^MpBZd^dQ5yCgAqJQH-(Fw;Apl*XQRd zW|N2NQ!{e(w(RMstd@#yLO{!B6h*8F8UYtjO>f`OsL5QvsD3MU)}5x#%hG64@>3It z(rIoswKP?>R=denyh@_NGi7A3raHV5?GIDO6F)}PWEyI0T!-bF3zxU+U1do>F$2mr z@T5qJt~!^bzL{6%rJH$o%7V&)Rkya9{2?AEna>PtxP?eK{!LOY&mp!PH&#Ygg?a^L zKO2Z)$ahK7!}LZda!pC4{{U!VkTr2AQAkd=y7Jp^gf`jQ9C|JwV-ch~DCl{xcSj_R zJo7?cR=(HnC&M^j-#(c2O>zPB8HSUp6cUqj&=X{zfryWcuA^@d&*N^=ZDH!OY_!T= zkV;gEm4K2`qic6_48Uu90}ZY&QshUJD2SYE;;Qi5Ox3AX1h^fTGU<>;aFT~MAZSvt zw)uPn7_L^Yzj3W2Q2zjEN3fMCQd0EgqGvLLPrQJorAKkh3e0V(9b>B&uByJG(-TyV zHc89BBP%E#4@)+ure;#rre1kw>+f6=(AWiQVYD%m6G^{4x7d0tleO%4zAMvZ=HwEY z$K=%CI-2#u9R*e@2_z*;@XTxsRV=R*zZ0e0n6c_x6Pt#3ji8^ZlzvqSYwK7Iq$L&? z&?Q7%YBas#(+9MayX?2yVYkCk4!ccpetp?C5}7B}Ea7!ovLPWz2FB?wX3%PMiM~IJ z)QLQLNI^oW%wej6RWDI}+Dm9ls&Qdm-7coo+O#BX-MAyHDek<;@F<%m?m>s@!^QuCK(X^nr=k`z)6`8omr%jhQJ)0?RkqT@4b&{W% zmC4RiX_+f^PBgRxpq(rgxgG-gUMr=aS5m=n4K75LbB}aI7MW^s9sZ;d>AXva5JH~@ z`wqmlZ4(MYo4T7<+qRdBh-9*scv=+_(gl#BbW6h3geRc&@$-oYW`!#?125gs2d3CkRP<4X=$p7dk$eRr>4htZe({-$UkK(Do=R)K!`c`g#$ss@NQeOz3CJ3lI|K= zmG;_|&SoW&9(7AUY3J8w#m?t3v{uPCz0&T>=(M)0eURWWzzkK1k!qhNl~3JLwD(eG zoE{D=l8;*(L|O5WhbwQpR~kIKAxVe;Nh+lO}jcOGb?1bYo&#_QrZveBm;BfsfOJ4q4=%uam|{< zEYnm{nVLdYpRkrxNIt3nUKwbUAD^ktsLkRk;&U|gqm1-ULu+|uIzuh4q?pAnLN0y! zlOQ5$MU^r=^-JYazp~*;{NWV4kE541nk3k?wrO|#foXU301Luxj-DX?UHiW$; zGOMd(wtIy6qSu5;wajuV`3}p}r|{&bwAGg_BPa%oUTo?gs@iiBePCGI`Hj4bruFyC zjI;b*p&=X1eziZ0 zpEET%mnK{$<2uTcpCqK{k?9iS1s-3_OICA=lF0A^91+Oe!qhqbAUCJ_mvwrr)mvBr+ra)5V) zv~<;STf!T098xf9jo}n7%z;3`M|Dx1Dz>r4g~mcx7GOGFJZQ60m1*!sic%6*Jkp{r z3~@ISY%glDoSzL=?S=NeFrd8pZ z!0Y%#c^WPk9V;Q97p9!SDVI;vQqG_x6t>e!3sJtB1lXSfPLar~Ce6{s?IB*5n4z{@ zb2G1UR0_T0Wb1qCJ}{()X7(e`XHFVR;~9fLGR(`&%eXs|>S-q9P){(9z7XYD!Y9oB zD4DLhvCpi?OSS+*X+l;Fv_9gLA-xFWn-Ue=YxF~DNvzfy3Q|y#<3%aDjesUOrFIjk zjxAMHejdoJ=BtWyq$ODkE?rr+vWilky-YUJ3pi-v#wC-nH5RTwASza1@8*$cMFpF* ztXuTuL6_?jj4p9q#!^{)CsU?WsRU-e=Hfb#Sk`vwF0o0cDaDmuVMg5s<3SSe3}h<) zb@2MH6Nu&+X~N6RuGh%4s@_1}03=oyLp)H$$axA=Z77ETIuKF-*KyJ#<#dI?TP~Lx z;TeTs)XNvS%RIcQR)^je1o=fxUgZ5mf5){ar)!dwDsq(3ETQ?wMr#xxYLsQ%sEa6( zuF=m89o8suZY-<1l7vh=gbfjumx&%7EgaH=P~1^5U2aBc3Yw~|GT_}o$ye2=-!DZEJ51cAO#~E z)gX^_4~!HJX4I_uoE_jTd3GBr9A?t*_PDD9qdb2Y9v@Qxj@ z&P}FVgcIKIj?v9j5@e-*@hKi#zzi!WVWivzA6-lVuyxHajV@7tC<4)mwIw`lQ`HI_n*v)E-)S z*|TyoqsHbq!8d9-O>Zrm z$qKfYzW)FL1sv3nn38ka9WLlcQ`1=MLQ}Cq?8015T`g^Oj!>&K+o>^47R(Z^gTgyU zEhEoP%uJ{dMo$o}V57EUZfGS}TE7@5Eb`tN^9-b3_P+kGQO3h2XP!=Q+I+yV_(4Ht z@3pivDOt9~7C)H~QQI;l`FZP?LedA`Nd3gX7IEq|B&A^tASolpI*^wmETv_}v`SK& z^Z-FeQw8dq<$1CKp8^DOj@SmaW)=s1HXY%6U(&`3IjAFxTgxkWTkeg(^Ywt~)22~n zswVD{et-)fi6Q`_)hs*gD@vuwAx6psivi;Wg&wKRqFn?A_7}QrBa{u%&XcGI5)@RC zRif@+JGfS{{Vm=z5r%rw8YW1)=%n)17oWs!xBjD-u`1)=q-f& z%;zQBsN8z+6WtEYz7SQAkqI)%tfqB*%H2ZjQ90$eC!&D0~1JL~!U7$!107-2pc? zO@`inupKsMYI3L-B&eSQ09nM7ZK;J7DA^~auK~ll^ny~&&{LP8wUq(Wo*Ys|ijJLN z0K#dBkQ)I?S?aId02;1g)G(l}uLYc-?n|`5)RLbe96D}uq@74A3sQ!Fr~(I&j_!A0 z^Aggs<1*5;d5Z|(8a(+a#aU`u@Xh}K1avkx-jryf;ZCVN5|SVTfi{6St1ST`JqD`y zov#3sdY+kTcu~6BE7Iz*BHkHq0p3Q`q=QYB9Qo39?${rV?ReqS3)G1dbzSc;2)D`r z*w&@cnl5u&3Mue5-a5e{QuRGAgPE+?-uX%V;R1y6sXUvfnBZ@6lC3QY6F^GNlbI5# zC0$BX|(bZ5)^NHlWSYjI)Rxbl8MV@d9t&midB33par;T$~u`LF07o}B?N+C z3N>6zt7ym&wEAB0(}1(fd=T31pf**({6(Xbbl8xsrGTUaU3(jiKZJIIz-C-N4rKs3 zj)UPG0A;1xX+gPnR2Ho)qhy~=AOk=0acfa743^x2HG;y8bW69KwuQL00dg(}=VL5CC0J}g$zbVdpPK~IQ1E{gr(Av?)aP2bZvEM+Gdk~@4I4J+ouoFvdp5A$-3EB%w`)tW95h{6KiG1 zxeZ>(S9wHT+ktar?cje1&v72kmR=LPUiP;4k59}* zC+z7*r^BBo&*nb3r276tZ^emOiHbXjae&@u8bLQvvNM7$a5eG#%ry8{i*~D$>&u|@ zGpRbh?2E0`mb9?LdJKqCk5vJsz7~kINEOPM54f}qa_eE|r{N8-HRUA3GeN?1NH!KX zxiQoXTOmqV4h!T80a|IV@P!STSwODLyLA;Zws~cuJEGSmSN(0RQuLA90%(4>^u3yZ{zP*d4+`Vr?XJC3b#pva)VI)WZT z*c_xKV5v*YGNmOX-9vi|?Hx;D7r3u>P`pDswp0tAU<}sym|b-98?z-|pv=UJinvpJ zr3G7EcFW{$cHS3z2oxAWmCedBw@uW52D*E@l00GPs~eWYji)a<0rC-L7BYqhi41dP zXU1ZmtlWC0B4*h?iK_O0IQ&0xie)^VE>4@6uQjWYr#SW0k~~Bqj>QpQfeOvU8rr|c ztbS2xm-r%5$DF=JkSJX~kqAkuv3L#|?#qdUl%0--5h&WA5p&#DP7za-soHG($`si8 z<{1t&w2^I2WR$242>9M2wMnO6xYV#Y$w@k)p8ozUQmQiOG8IKUqKRcVxnLS~g)8dA zr#Z^Dj>`a&H#)*0j@8=Rn%dgw^Iga19rV{d_T-;k`#!|2ZL6do9b!U`#CC+udYGq@ zwWXIHZA_`R*-yIiH_55G77uv~PQ46A$rsT#wKdVM-cQU@Yr0$7eV>0d;RLi^;v?NTnJ;1$tjq`utPu573j-3Us|D zr$X67FJ1Jf+FMWP%B()E*19;Kd#oo*eL7R+y6NzKXEjA~bxzjYpI?f7j$FkOptqh5 zNf(QaHi?2}5|qv*IyOlI>Yr=;B6U@T{FC9g&wJ;|TIuj>x;v^p9dEYJXV>DNV>I3v zs7|>506I~(Q83eJnY`FRe6_1CcTx3kHMVs7_7{cdo9DjN_gnUSwrlEfPAaL@H(Om_ zHP3YZhV5>JIXu+Jeo3d&>KiVBHV|K0Es@b=eN(O5-bwG@NewD(Lp7_^R6E z`8r^xqg%bMzYWrS*FDqv7-w+2^+m~^WW1J1g|g#^+f4;_ABc<`JA@ReN229*?I!LF$-xcBWnnVnJNT*>P%A>XDtstWz=qTKcy|tWuup z{?UQKySm?>;_A6RT)|E;s@1Z8-RSyr(}qhH0cui@$2p6K0~qs};`9I^+QFqer;%7IIX8a|QB z?z#7pJA`k0!11?x$9A9bb??hyQeWk4tN40$=4lEX>xfBOX{|f$Dwt7jWoIk4uz4R= zGOb_ICqx~0ymjM$)(;pCH_|`<!4(3cZndL0#2`B>BIwM@9ixs4GUXL<#vVe-|HTimfFH~BmUthm3$(*I7 z$pwu?v#r8(8l3{k0?4+(zza_7;!tj3N>%su{(PTNRezWA{#@5f20`;C@m7T;w1qT4 z0?In~RdAB#+?9P<_nLD0LNVmf(_22>eII_@x~3*@)~Wsf08ae-qPh6nf|0rpa~dnLDOwbBWmV2n0Tz!>_IDJxn0c;$eatTvh2W7fW;p34tTNo| zr3smwPc~pSv@J>`WKL|h0ObPq0xY!I7gZ4(vYseq>covT(5+QFdy6EY%jG^|(JnFE zubbFqc>e${nH*a-rU)oXl#o(xG`7YjqP~2|aoKi|EAqAEsY*dx^5m%@MM(-mR8Me) z3tLhzZR|#oRqYw*h4U;p2;7qMCIrqLmRzr}xVxona#1kate}uA9_o~j)=p;Bee8tC zn_WBm{+~~QyjIuWr{4bn6ODo}q}B{|Nm|gdw53aYH{W$hBn2%5=%pl_&4NH3_SUPE z0#4nnzE}DE_7%;2{r&D%pKVSVF@tMDW?gQS&Lf$TX(a&O#5U$3@buHHL-L2zotv-sip*A|k>)h9nJKzRx{Zdh9!PR5(`_v>053Ig z0QbjFj6lgHeAlTr84LK=I)R8~y`EvWP~wAcp$ZBqBzH4f_SXKlifsP?#QsI+5Bwt| zEmBT5OzTr^1(RP#bPta`KYxNHXa>#@%-|U`F>h zB=}g1Z+IT;E`_AMLE225${TfRc@pJXBr3^hTPPRYq-cIHlqrmM8)R2%Z5gK&?6`d? zEh|Lo+MEL5>uY-Shj{}NOP-eE6u?_5ag>MoEU6~SAvfR0QF|N0w73P>%rb``d1!Gh ztz}m#UWyv-Ep2>Z?uQQcDwuX+nJ*~tPy%7VRCEp{BIqFb0#ZZ~=U~Rq5{Zg@>uHm9 zOtjN&<~ef(sao3S-SUUyRk(>+$;3^}*BG941;^7alohLdfk#3>`y<^a(iIJ;Or3_n zvT|&=%e5ssi9CVF7SckO%Ni&o6(nE8-$AS@U#OL`9duSGd`O*sLk`NWRSmVwVqMp{ zikr%-ElrgYQs@UZM3n-Yo{*`($>b$1zS%)3QA>kVsP#(C`-j7DVYWDhe5>J^ zT&S@DyrSBY0lmF{IBBiL8g$mhKBXfuEaQa_smrCrWK(KD8G#p2BV7)c9RzjmntcTI z7j*gYKDn@asBLK}1Y1IqN%S`OLoHPbv15kmDZ}%!H93o|sgS&>Z&f7-LbC!k&2lUu zE!qQqQoSa^S1~NN9AOUR_dzKt8n!?uL(=;lAr3E*+cg-MM1$kmS|PQ#6tiQMAPbb8 z>`Bm$ke9zRqs@n_Zc}P=2Hd2wJ*g@hj#G&VS`EjD8BdfkCAFi3tCDrfm}4u5S`-vX z7QTQRE5ShOJfW_CQ5Qz{95I~k0j5h%$*r)ox&qMexZ)1zCd8-2C;~@>SVdiY#__9c ziOI$ION)~kXHex9eZm5kHimbsEnlBtsk>!>0r27k%*_odnwfdo()7xMs#5`=wt(fO zLoS{4jRl3W?oG@^X5y^gq*V|Mu{E{X<_?UvGRsvjlH`4@+3T}ub`m97>-7;gsq%}^eG_z zQQa;)#vGH~4Xsy+@|Yuvw3O9b4%4ROQ7)3@vM}=1+<0ctSwkwd8Y{}tZHpefZS_rh zQA?U`GfThjSickS;ZxFeMy-}zVGjY-r!>EXf!EWlMvRi?DZAK?^bF{Y66lD7&4%1!P-)Y==cqC57B!tLS;Vq2f9CYdFg@1aRf zXVdpVDoTfs0D>&R+vOCY~!9DPlz zPpR5XlP;u%EySCpYa;3(T-aZvT=00BUyIOzmv%?th+M>}%!cwd!33;acg}$N{9?i| z)AJfP@kbJB6(umKx7>Mc3pD7kDYn-DYDbB=vA-`XaRKQmbl@x@<4u4Lpkr{0{AX z-!bJKT*O};g0$OBK<`6*Q*n)@w^T{St(LdOO2txYg-@qQJu^0isB(_|+&>Ye?)F#DZ;@=USl!_6&X|sEu{BkxI>f#I06@!S$JRX#P>-3k zTt|&fT1=5163I1&u;lI^lU$V@iHS*dt23){Mc17+wbh)QnsiBsS@^lj_)DG}hJ-oL znUItE5!HsB$m#d*b*TD-nkpM*>KBxpH9uePmGavE00`Q zhv>LL&)Bla<-e1H%yoZeqsw}{E(}{ zbw40+USflXw0U}lb=4*0*>xwlxmQ(X4-?%*y*2fMF2-_3jBIQ}1bqM)fh?26AecX!J`?cN=L&8c; zncD2d?uO~j^F{pD76A3y6!KR$LgT|(cNB)40ds80;VMWo9uhDwg*LAB;r#OflOC$uF0 z0EJhbS)s+kF0TG`N;(z{lEV_BMpd~+r9k}lXdT5D`LwwFy(TS-wvZ>?)px+Nhx zlhQe-$$dv*etw8#>r_e3H_5h{W=$2K=4Gwmq%F`k3Ayf%KE4qAX0bkx=dsCSc^5b7 zxTTPx(KveA65^z0<`6RGRM}GgAdNNkglli-<~yU~w~&#=yiS~XJefwMklER-5C?QKZjw;k7ggoO@=j^3P<-2bzfmiuL5>oQ|iql6va=et-q zr@|Aap3cWn=}az)>e8xf=u^ECpRD*4?jUx#id&A$I3VF!aWjZ!`mQR@JnjT zsrbiyJzT$-j~2ZCi_~pvoup+b2~#*)Lz3ap&c9-{d8NB34~h6h_;9`5eP8kzl<%JY zOJ)1AFIVd`*veqdRNqv?r0%T%^a8>sLJAy)+p|e)O8}^l0P1uQ;Fjp`;Jh7H;!EM0 zM4Ph!n-{W_u%Fs?#C)z`e}|v*BTq7kGw>H;nP~+kV-(CLaeJmlTQEXT>ns#0Umzi= zX0Bh%t)6{<&t?3{$v~i{gD#m`do9Szq**9Px~=F&o}`lu?)<+p6!I>+{Scz3(HfCa za0{&NqHa&mZ-g!|qApC$>~F4QBuJfKc-cM>x*F7MF(#I@0u+@TvwgX8 zsO<%WoS9;nF7t>-?GOwlqlwwU{#i&~+{^k1NUA$Blk)Ws(YTZ4ad_ngo32Zd29vgG zEx1F7r6W~r!dyjaF`J?hR4T)z$PTAQaOP-3i6S{p1}DN&INDuOwFXfz%7uzmq4*K3 z3Am5OWF5ynj%KLJRL&cjNN-c@Z)W)+&hhjFMA&f`{9dDp_S^CzW4}o7&VSkziJCP@ zCr9!S+WkVTg^y7a@yoNZtguu5CG+S^JPF&HdW3{Eh$Rf_GzM}|r!~A(&Qy@=zLFPJxiQv(nZTz)67qjk$Z#d6Qh#M{%#TD92L47-$;7O_NXs8 zE7*wWlUm_DU=n3|pv@hX%{-u#G?Jro2GE&0CE$jpS5_|JO9>qUC$sXm``YXi$PJ zVR{8(UUS*pH3=8pHg3$^E63g-e6Il0B+nB&DOH}KiKWlGGc?gl+@+^Z?z;}Z2ul%T zUtZ$wA*{$EpEEACOQg0-e3F~;^++Tp`|k`29?S`j@lGxU56QbM5|PVVTDb7lB_hBL zw}#%wXe%{bL5gbMM!PV!rdR}_#mOTeN$QoGA6p3M3|ASeG%2}+(s5(c6RMR_QWVM( z+D>im5}~O5@h=js#wN~g6u~?rsx(%%9zuZG$5ape?TLwzTNE@77;u{sJQzz(q^#LD zae9-`S=i~zp|iw1F~ArF^}5XK=w5S?3>@VtzJQfEzmD+C$0EmuwZ^tF1qHf1rAfp9 zv;?^8NX?e|-&+y}u@YGNk`%_N>>X3XIJHvr`lQ6msg`YMTTP`(Dssmm7a%98JqEUh zrMedqO5#o$V@ZOC9jncSWf$d3B|sZ(rLS)rLoJS^A?p}p70WhI?P{fziyKG{emSF- zc7*m2k*i_3fa6BCK6mK_SX~}^u7|&)xAmjCPP~Q`&ya2fhpcvl>jq|M%?suL4Tn-=iBLIN zfKL%&YsYk))NBcobx=0(5K-MmWzMCDup>(IAW+$ZUIn*=^E5;rmR=5C4T}T zIz{X9HWN__7v-rQN+R%SJFm#ZnzG5t5Sn5HO`}YU_=q%zh>^a!m$Z!! z!a1geJeFx0^fjSQvE3&%&@9iT&9*RUIjr%UEFXJA(hW8msLs^rQSTcjIiyywjnooO znhz5l(s5)ua>`WF@}yi^8_*jfuo8|1ytuDS&%F`raPv?T?b;Wm(&oXSe?4u$28H^ zI|6Hzm4rH;`nDTb2oeU&Z?e?8N^>TO9wrJn-5i8WH!=Vq+s~vbgzB@&`m`3(E|P9U zc7)hwRME0*ru^-s6n4&o63jKKR7$!MKidgn(UdlsWoAl>R7R?>*ug<&ytNTXS2Z?J z9Y>FxbmCNUrX_uaML_qIZlXkVPa}2N5aL0&u{YCW0u;@;VeHM8&=ant+h3e=j@=rb z$X0GhxHlamqE3^6$F#=F-F2W_lO zbt^dC9QK^fNe!1ek`4a=80ecd+o;RUuOd=Hf$suF-X1VeT4vkzK*Ou$g=JN=Nfxjk z5K-M``xuB3kxif4xV&+|>d10bguQaFwY}k7gmXM;L9_v`L$CzFVMgL6T5TM)pp@Fy z2Vb0Wg(-9iO>K!~UABTr@g&*?aWsszHc;+jvO)2^phskJX_Bv!KzTvGJ0FxO>>*p~ zcP6MTp|GcBR^raN5-bO)zwVA$rj1H$su@ts=_x*14^tdr9ge$|Bs$?kKqDeZ}W~F zZ{z4E9aPPM4-}1tb&l);puQ&k^)CrE8Tr zVp6w@MD964{{W0}#T`?ZSM)I|edkFW)sxie*UC9Zbs6Q<;1*KSuL5ig4C-On#IDo9 zN?mOt{RPSR!K6G&Fq-*&L1bpvU2S+Yo$(FPHuS(!n{6Z{W+^9Id1)M@x~#%6QJWmL zQYDm;s8I(urjTe468wzP^#a>uy1dR2rGT*Yjx=>h+oV^56jGFj)_McC$_EpwXF(0W zS#+zGLQ-`}B`HbuA~{ql>`&IJE0b1BrAocKmLuoZI*^%8j_kbp9%Scia|qE_u)n6! z$`qt)JRFyAne7Y$KEbg+I4I+OXwywyGfGQ;rBSdvv2plEbez_AoSAD4FDva3wF{(! zf55_O#knLLVumIxRdS#XqQd_G3&%8uv~t&8erPEywos0w>znX}X%nu@()Hy`B`I8} z88sd9HTi1>kW=zBrmKRat2^~X9THRf^n*D~eSv z64-2{4vr@$#;71>q}8fxsvHU0L%CoG>KUdpha1?8x7e@18lZ}g=!P;R1k*< zOKJ-O_F9yi`3($rNzG?8R$r(bicUauAx;uLJ=pG=5w68toYd7ZzDFUl&iuf=2|aUL zcufmUpsR5XruqZqu&5|ihhnMhYf6eze_N=6j%qY26KbAxEVz&f(BE%eBdHv2&Xd&_ zDXYsbFcy*lxB%<%yd+i7pQvI-i3)MgboBrTR*?>8X}mg|~ zCZRYf&nW?DSl;P6Ytz;{LR_fcdS%JnhmfVCF2LUY8jYHFX~cBF_(l;%~~bx66thOxm&;?*aV=_@Tblz6Qq51!G~ zgtlrlR_ZQ;py|D!1Gi7COv@wy*>wr=PvxPGG<7p!SfXaCu`I$03ck*R_d!Q>SY){~ zOL0hiDMw2XBZqk(|I)BpWl^cu6v|4or$P!yv9-p#N6rrmT+dlq6E{|LK886JZ{`is zIkFRyT!~fA7x|NODq*fwtP~Pebzfm%br;v9ZDZ`{HFWp*6pxCMb^DuDi8RvOnPDWU zEu`41eW1(1!yd_U>LxryrSlwV7cxt;{{SSB`9|Y~$8lc-XSj*ee-?Rf5!Nic5(CO{ zu?)dXi^lr|{{WttJP|%I2fIQs#H>Szsw=`ZHyV|bGR%o2I$PCDCB-aW$keN;2JrgA ztB}La>`Gvkc&SUAK*pSEKz+3(&MM^jyTc8DOs6PP^2L@N|ZO#ZwM?)N2RAeh&OT8 z&|eM>yGWacazxZ<=oNIleiO`-Q1*lOrm zqE)(ke$Lgx8&OTp>QV10N| zadQg@DdoA#1I;5?b{mYzQNzZvLYXdRz{=L|1ochFc%*M*YxTA59cW4&JS6%ojGDHj z*+Bi1rLF6ytVqVjralzQB_IpfMEH#&KXE<&RIL91{FMXdQxS7=e-l~k<-9%v2$yeo zuQlk@R-}4}LmWhB;FElgAl8%qHAnJ`OrOCYnModU`4%V6wc;4v2Oanjhp~~d9XK9k zu)mZ?oNRt9WwApD`a)4Q7B6k)0U{WTNqrx{kPIg6qxM8jOJ(pYA2;z4xSm&>^JvVV z3Jvn8j=oUT@#;FINZ_iHhK^j$k~#$_#CL+WIpX{e2?VEqX!)!7!Qgo@9xuS$m!+li zq8>h^{_`F1FQXFj*JGxd0tvO04}m5Z?#Mh+J9eLPt%vCns-wB=>skLT*Y> zLw8Y2iUAAIiydq=iCjJir}&oC{YcrTEwuMugoc!)XKA%ewvh6Yoas-x7Dk|7rS^!= z0z>{I45|=LqFKY~m-xqh*7|-!em|MyQf>bLB8&Khe;7U2%kmE&&+|50q&9R@AwHo! zeIWOB)qX;}SKsp(Zqia!2}(l=q^)w!J3B6gywVDmkX3YxB!iVo0W0a0o9PlUVT>KL zp3m|doTVkR+>kPqJk6t?+kD)q&y;s_TfJ{9!%K%AS*cB6Q*??&wy|Y>Dgi{pWpBN`S&MR-|76hb~*KAA)-RA z1;R>(P*NARy8^zaR$Lk@DURRY-+x9aZ}<1h)f|?o=zTzJpt6uGEtqN<0RI3-)UvV& zJ?4~jg?_ty`+qM(t=Hez{XnEAMt#Tns0Vk+ZHs5<_ zW709tQH;wCBKL;eW|`sAW!YS;v#OSLOJ-?Jth$t}5K)*AOM3gHSQ27iA{$n0P%vdz zjWtJ?EE_>rG4~yCI2vuV0iMYTE-a)Q0h7n9%`b)Gfpm@XHv`PL1oOX_f{@BDkLGdT^glVGS80c$`yNNRC;gE%jN6n`kFN@ zx9#`wOVtVNOUDWp6;p1y`+T*wpt)qURP$=Rlgmi%fCxO+l&ueWwH~rDaPEAU({H~o zK@-WPZvOuHKT^K?NcNAG;-x3(d3iMe+{16TGWbDxBPk0)R1{5=t81Yt04Q7o8vY9h zgp9`*lUpN?26)9<;gr)d^2JMRF6d|yQsGh6B{_g9I}bRtqNSp6QhRHwoY&IS#7on8 z%3@)}qcV_Agb|#Sl$~`N*!70x6R8$ug{X3Pib)e8OupOUKFyQ?-L=xBn_L@iM#dma zbq&uDa+GZ9=Ai{m=WE0@fGKh(k?Ct(j#ZdNOvAHQbz`~?fkm!UrrXoh@hr!j%5 z?=dExTWD!7+OB}teHQo+5nSxvlbK>5SAaLrh0OQlGXPyB>V zEjr)3%n1YVj;?Ry2QGeXhh?Tx?tJQPCA_UfMMCIuZYFam6yW}(9<%@?xAvWq4X`#NkMFqn~RJ5ExdPC{6%sb zj2FX+N^p}?^Nyl&U18>n3nJ|W=t9D7GYvXuVodWlbhc!8;!3=S&x#XA8cw}FbA4)t zKz9g00U+uqVevLND6ENK7Ob`#<`)CZ!YEap$Lgq3 z(gs}C3d#nAcAj3ZdjlOV7B;C@gKiY(ZA)x{do3W@3bxtp zp*s<1R5^`hY+B~M8b zfs~y|Wh%-C?B4znF+b``$CY&>t_tFHX8|eMCfDsU+NH{ENh@1GY*Lh~RQxWVD1Yx^ z#;jJhaLs;k57B04Fuh^G5~*g~49ZL>3nV3NrD(7u*g2PdggTq9;u2T5qsQC@T|uSE zE}-KRZU(tByv)tJ%TIKLm8q};;Sah=s;0R?JWuoy4W@#V zwdL^`ZR37jOP}H25-5G7sRh|=ue70&=3Pk6+O4Wom0#zmJ~34|IJ$ht6p~iCGB0AT z%JTRD^D!!FC6`_9vncyXDF=Hcz>#6#3_l!=?9%v*I_UoZVWY;pBSliDPpGn|{iP54 zA|8*qb<-x?{Z64-Ov0Y}xp^tXmfJ?-o6SA% z1C)^od|zd^z*534W}ThEa;Bj;x%9Hy%5%)9Ezxss>RDMf>k%C7><$!gIFE_w*d>P3 zFjZTtyo<1h(qBVpR=Ki}0&G961-Wv6G8~-=miYZuVxuV|hw1Ky$;{?<(9#Ws)B(aOTy9%R7Je#M!tpDCkK(Ofdsx;< zSz0)A3{){|g^Ftndo8nA=$q&-bEIfosEp%d&5N)E*9j1+HA%9>%G*Q7V|?Q2H&0K> z0S+{A@FbLtMnO5q`bC+ZT7t;PTVJ@Vk!vL0=Jx}nah;;Vrh70KaOh1PLF%$q%`+@M z*loe&0j;m& z6|WR^JLr`)I2S{}^$3Ifv6%rB<9{OzHIVaNUD)70eOLJ4D94-L3|Sb0lK?P6(VKnaB* zN#-b7A!<-bHZ~XN0Pu~54714|$$W}@kx^t{d$UDv4@%6|<{C>9g+w74!j?+SlA8{i z>SD?{QzA4+*=##B(w!-_*;2WgRx}CT+UsvC#HS>1lKdi+JWh2|5)81+s6tG{i2k}Q!FH?qiMT`+7mQymfl9VJNw_OAq4b&_J&g8~1 z%TvETSFxzY9VkU{ClJoz_mumE>2_9-d6KgT$=&fn_C7Wm#m@}&FFwhVHvXta(zu;j zsxj>nQ%pL*(P8vBhY0bzC1Y)kwTmAJTFF8JV~7-qM~df}T4r_n*=3bnj-C9f9~fou z*U9WkTw6k>hmT}2m((>-s5Z2V^4-i+lz0~N2z_DFF)a3Ur`eWeCAXe&_SK<6+I_%B zm?^P|F+^!GG|c`Tr>B%;my~^!(~e(-(Gt>sY>3X4HnoNtS>;ov8d9_?ZcR;}jew5R z`)3Zy=BUGQFr<0QET6?O$`o@_YWBBpcW7G92Eb6lp zJNrlqx8PzcM7Zo~JBX>0MIke_WQ~9YKz=a8$MN+f#(qoCUec;G$&`yu&*rtrBop`p z47_c39$9_^FO4d!R~%f3tf?}u{aTU{XNB}2EQ=2dnCgz5`w}B7H0TuC4+&fLSr;Wa zpJ`68U2u`MWu#jF02qstBb&EHhAdRMKU1c0U4F2zrV&bgjeuTcE6@#Li%*~AiGCW7 zbS7)`$+`5OYN5!GPkC(w6?%)1e|&dcbsSN?tU)ouYE0_;uDL4r_%tgZzkv!CFr}Tb zehnS;aO!$M{{S~EK9AQWD*4+l~>$QXaXgLzr2PekpoZN?k)s6)p9C$`hCa>m69EM~J#_ z`3&t}v_y^<3TFvOHr8zyIWpMiE6pJ!Th#ob!W=v6`>~fR=jgUy%#D@G#O5n_%v2^F znRK6d#g$vg1F-TDGB8o(C7jn585xvp2U80;_7wON0akdb;cAB{xtkjoR6}g1_LibA z=$n`y;pRu55TdM_+&b)KBSUcy;+dapn!VE{E^f!7f|GS0QUo(By%yh@T|Obtm#gGX zdR8Ar9g!_4%ThAQ8aC2Wm0S9wD2A!OFU+o%RQc}yhh3>gBkqf7>0PBA*pF-G_K<%vDNZ$(fea61JL2aHU632{uUi$76-a9O#bHow=~{&ZP>G zoI_;Tt0E1)0dV8s-;kdf5~~AoB8kKYmoHD4DVl28*;-WFiNBEp@VrBwHxc;C$L5<| za-KsodZg%;@AHP!7US4fI)FvQIYUXBiV?~cVGCf#G}u{%Y(s7XibgDjFx?BV$y_C? z9E_;gOOT48^*cBilM6`V){7I;%*?h$id;feN1-D~>}1y=YE(e}E%ruT4YkxT!q!4f z+>>!*E?&I72gsX6mL4Ydm#N3UEuYYYveg4ln<+xxr&JJiQz|UEaps)}^@~*KVsTR0 zlTU@cvg;Tu32a2y(h_MF6D*6&0pj9Tuodc^Vni~PIsKlV=$||_<0c;B^L)xg(p*sY zno>#}N$@F92lsiz$jvi7mxYubSjj z2bVWfs31%!MC8q5{!keFw#@EcPIURR4SE;Q7bD+C}b!oD9jw4KPZuI*ilv zEZNlEO`%=Xjm4}w2vl7WvPRJ7$l_@#+p1<+GIkNesPw>dAq00xzs3X%;<}>9y^JhuGcWUnf=|i-vl`U2=o1|PgPKOd z1BUZ2xKbJ*WdxFAlyw~GspPV9zd1JbYuPEYWUp!U@cxJnsOT z1%m^d5K=WCtG?z za?BL$Ua2LMn)=*=2?jeyRD}ch;hEKDDFeqUO}#?~WhT%KuF$GVZ%)c8S1 zH5T=azLX~js$DDSKY7E_QzM_WQ z2_$ND8hXJ&sOmLRmIz8xqPGC=sH?kwF0h&unT*!adnLd;fF=q%sKE7IXiyQ*;NNO-US1lVTEd%wePx&Sa4Mywum2-#) zX*Ng}Dp1t=YXt_YIgC!s%dhI5BK;1~9JY0;Rk^v=gHEBFkG7CPkH+!AO|yqA@sjS9 zl`UHfn+WKYvAZod9+QQbi%YA?)Os>uVO($G*_G09?gr4mru^Z62O z_{V7Cnbk!?VMx1$ARX*0>b5WgBW_HS01P>ixstdCipAt&fOZjO91<|EaOG!{5CpwRNPM)wMjO)tN7?=qP z<$-IGkaG_s=Kvfz^a(;&s7?E#6okElEs$FYaOF~k^csQuV~0;NQ6z$tmlS+dZXo6y zjSh2}#!WBPTMI&j+1o_)x-6fqal^kXY52luU89#$cRIssOR4IVs9WN7j-f4?J)ky= zYj`Lu(jL_`3xy8yhJ|9*AB=X6S<#Y1rvA=Di0YO8aG!{!5onH3{5!fqs$3fk_=fUit|t5~a0;e}zTVJuS2qVzpNxJnd!a&0H$< zzjS&C?vWbXGA@1Un_(_EJ)Ig0jl7fB_d!&4?A{YbX}rlc57NP&RMLx+?jS zhFn`|7hX$d1IJVNM=FIUW(qY?QZ6Z(7h3~UXOWdj^g3(vfve^bm28fMMthZiYJJ5h zjS$k!kFQHd5<2DGoQf>ut=ujGTq4bmgUsF((1^2b+NU8Y2`N>#NidoeD^bjhFknB`O0b zw~DQ-CWkdPYt$0DbDXs=nn<`IS)e%G9QF{yjsr368GIVb2|YC?I&pl>#m<&SRJgYi ze#-BiKOLi#D$K7?6*3W-$FAkF48HaJBbIiJ$-F$eD$?7jP}1QFR)^NwL19#3n8FiP zcXRUELbS>fa@-FKXnrtQG-@EZAm~zn4m5qkxwk>n=3on>r#2lzeV`$1I92YFFY9!Z zym0GggH_4CU{lLo_6p1o;ROb!DFoY1C!B{fIrfmWZ|FvZd}EX<&NS?!?5R1k5a7%b z2?_WEVI4SV)22kL%1F(p*&|;)Hi4W@joGTVJzr9#CfkK3;QTKfp-x?am77r{XGk`= z0VglZSQ-S)iCjaGVJm5+wl`1(EA{Y#j_VYSKQB-t*(C$l(B~;OK7@!%7M=7G6=@l% zCy3;!pf^pDQav)5P==YcPN_94udbF$sXLvNJuYnkCU-uWVbD^;4-XuQ0FRM`(7i%_ zp**HQEz76@?-xILzP||V32wR@(sI+UvK?us6555uh{}E!faStzK5;FTf&bFLaQf{2SwkA18RIJuwoljn6rB60Sqz4iK@&LefBo8HO)GORh?7QwmCwNmwXSGU>MW zzPoK340BpizcQk6cG=dhPPb5capu$%+QG_3$4G04l5FfFR4?WGth4_BB$4?>*M;Q1 z2+wgG-^G|4noH_hQ@dm(UPO!jMlBL6Se?etmT8j&Z}ns5w8D_o-op=z9Bp-~!c{mW z37ePJ$~nK8wWoLY!>Emun7`sv37MCtH_f>+=m9$SfH%+KrH1}flGNt<03#k(XV*lO@O(A z4^H66&1|zvZ45H7!)>4?03@p9bOU`nVQggLv}M-nlIjL>6s5VCfiCV@%^X zvAhN15q= zIC1hD6I?%`D-W%ONrf3lh;8PSvZB(GE{9T0)s+5?N!Vzs=?jAsB2>_x<|Ko-(EJQe z#_VW~{9u|5%Tzplp#%KbYbRfct@d*MAM-{|QOx65uA^Fl%qy2;<{>OxNY%k*XW|WI zLu~5((PfkPBl9UE{8ITA2vzySS`uxvs~7|`X(l)%*drJl?#rdEO=Z>Qg_)E+*GOy;>LG?U7>LY5Gt=pRK&L}G?!;v?uvB z{NHk1$*$qA`5@or8OdVP=!^Ku{aM>e@`ym;&3(_TYyL{67Yurz%x-d}@*@Wsc==zz zwc4bdw9sx*g-M}+8f`@dVC@GRMwvj zdpj=YaD|ntGSW(Y(WctyB0|8C9m{L@{$#agpt_R{zUj>4vhq$W+SgLs%%fqZr20h< z5r^?Vk#ED~{43^l*j8OcL1>(hKIW0iv%H39jhKRNgNBmql*5v*IZ~EqoYk|0xamr* za7LrbE;vXkD>%2m%k~)-acy{DY)I*zntFOxriLY7U4y|Rm)!s)4yw4cS$J{n*sXGX zJkFnF%x6-?NUt|PIP~IW+@}VMq!Nx|N|ptH>-j`pCJ9Gn_hgU*|*1>L3@4H{{W-9dv~I~Z z7fW_XxGL4lAzy3n%PUel&Bs#h_wxNc1>N)c{+s?%^*JpBOemqdH11LY4c3J)le&7k z%8rUD`q@+OSO_B?ui@Ws)qPMmUvd-?Tlx3frvCtxzD#OKew@8_{NwXR{N$5qNu5-;HQepG;($wTDeC|x0!Yf+ z$xe!B{Z!D^B&dtoE;dox`E}*<@_tWe(5-wdU)}B7&3W^WQ;R1_q|g5V$SX~yA=eOu zlpLVEKb$2fZ~~rgx#ZVpTUULpEghd3KJ@L2%92_(TRnz_DP{QKXReov@)Yp28I`rmGApv-Yk zg--DvRhdaSlTS-8^Be(^Le%b#t0I(=%E+-2$~>2kd6g9r6ZlN)6S*t;ZvOx;hbPd9 zp9_-N*Vk{?2;Nwnv|3+)GbZR6`X)wrH1o!4bG0TKz)&QWm0Tn`aaQw zwy)3c<;<&m9GBnUuOmCXjixJ%J2I+>6Csp187-k9$8TpF4s!w$oi5bJ=v*fvidG1R z;q7QgZ@<4jL~NeVl(+l)^5$TY>_lfB{%u=SyREv}L2_3rk`A_U1;D0XO1;!B$#`ng z)ef&~#dN>FhxO=3e$A8n`~F=_IA^g%W{WoSvvcjZg(=YL6v+I$X>zMCmC&g>sJHAXK!no}Ae}0U2@y&8ZRrwmsnwxpKhjmkH3PO~SZbFlA zcIgROwFvO5Zo{F6s;aKgCnnqpVJ|J!j%d0vXgl{BAwxwIY@n0UBIcgYdL73N(xHPC z-(#3=c3Ce=%{Irg7Lx6h5TSPE6r*$!l6kU|Hp=k&tDD6em3{BTAiDsIsfmLm#IESW4QxC0yshLU|0YS!1kufX>FaTWxDTBnfe;WJz(a#AkTYdh$ z7?{8^5>y$XQ=M{cfR_-KrP38L(?P?Pxu0oo^pehkEaHYn)pRXELL6Cd^RcO7{l5Ik zcZBi9DY>WGRQ$I!D-0*ssteoQHC;3Y@ zC3bNnSd6V?-1v17-e^#jlx6nXmRpEQni8sYZXjvg*sH+wJqaE#yFhAFrW#izr(R2K zqFcFpSxO~D8;!L)9~&6!{Z1NHHb3Xyl5r~wD1G!S0d84Q3JE?p+#QT9b2x-GMpV3m zZjiLjGn2ynNd610`%_?&rkrSjy_S+R(CQ73!X2LIWi7;C5`wAp)zVV(xl2)X(nonp zB&a9M3*Sh41N=%uS(el&sCYfBKO-S9^NU2wQt8N#C0#@xBYwMdj!Pz{`!*^tq`Z;U zo5gO=y2xpVaY_z4VNJHr;Q-J0o{nYu}YxUANowKJL zl(^~^tq=z<%e`^=+5k6c%_c&bK9?7jOP6%{=1QzB>#>BsXc;efK7>rDoMWNGv>|gTBO!botFnPn4U&*Z=nbJ5`H0KNeX+da zB_)|zmM`4e$#Ezs^SL7T+AZVLVzrG{9^uMqQ>&jra!1-ieW90TdC6EC5Q3wTL&X;J zhVo5Sa`>_MKcC3U##wwg?IG!k?rDiRRF&t-yv=!~Xc_+iG2;ovlHDfX-*N6sbwz1# z?}u~zd6ISNH?ut=m)6Ql?qyN7*BTqxf#OVErKRu8XT(w-8C+3b?CDElLlV=`GQ&z+ zQWGt{fk69}33;6AZ*L(u${LnpU8&@iAj(a>$qozm6x`8BWRa*S zSxHsJkBmv;>(aU_BttUg*W*LIP3=mGqIolmW}7yolkD?oD7f)$O98i&`puOC6`2&5 zE!TCw-^`U6#rO3YTw{)vOP_AHO{hz=P;)RsS(idnVnDl!Rhv>&dYkJ6H|P5d&S`Dm z%$C?jomR&5$$6U1KshsIT%n}21JAp+loM9KJFKd89=A*aOH;VsR+^vy}f-er{$E66Q2 zNKRyqW?e7PjUr4XvN+J-;ao3Ougft!%<>s+=8~|`vw(nx9ZF_|fGl10jNJ?}%Wlq-bBl(+dI8D!{*_yY-2 z@k4IRRVNVC%P$4XHoJ~t-sNJ!AZcvcMeL^I%dr9OZ(F#phbE!($2>N{ zSmuza68aknN&3+0?o>LG6ffztTJVxkcDa%zY^>@|1ghc8Q7a)$swv4QLWH}iN)`!7 z)dx~;I)ZO*k)mxiy4;SfK4h$@aQ^@pVQGffDAI2JP~y@?RjaMgyva@e0vb_WM{M5W zCkAC*%Rag^<8z?^I=N-{TvfF>QmYSu5U5`xjR@L)24ILn2m?dBC>W9lLIiFX=OY;|c|bg$xSn?hN<)b$&>?b>x>!@Q7$YIW}1ZM-(& zLem=Dd&Ue=F=iiihe^j-$l0X8)izJMr_BvR4W!@=M)%2YjZKVN|l(BrnsTRv`z``c9zT%+o$n^&RD+jWsDb%T!8Y?Td zV69H)ys~;iB zd^;^T%PY!~7m;~@8uyl>r0WkY`G|f-r8@*vaCDl&=}A~aYIW!4o^2s30_NFsD_)%< zE>&*ZqJ9TlgJ6!*X{So2UC_jZfl?Y;1E^Kbw{fsaJr)5GS(g(}ZP&oQ!qk`IRQ@Mz z{C`fy$y2Y>+ju1E{G-9p3F>)0^!!s0r57J7`4&*$lRGq7rAyn`YfQJ{D&b4E9tS;^ z3?lr#W0Z6%c%o#ET=a@wYpaZqyZPh;IQU)!uc)dMGU!EFcA`Bn!}}J{g|5fVw+5cN zLy1>4VBMYh_XZL`Rw$~mE&#tM1ee#~IY=arTSM@}tCIajo=WrjA&13%sFfxcErsQT zk`RQdoiLpvMBb>~R zzTA>-wFHk6Z5^O)hXVz0lM`_*N%|_D@nKucx;ae&;tQE`{{U9;#?m8X;uJ~8!#>8e zY7&z5c3@Rz&_N8K6t;zUWkSwtezu-a!_9n(+?m|Jcd;^Br97t7F4d(aP%Ij348(X} z?88*q3FJ$DZ@)viBS~tIn>LWxJCbfssXD{4g>oWf%H_-xFcqRZ-f-%P8O+LwB|EC& z<%-5$LwPKvv0)FW(8HC0Qyn@8jvNlyDlyPCF)eKvW=Y9~Xh5=kPSCWD5IeND8>YBv zOHDeChhD7Dps7Ws)Z&_K?yR8-7d4!Uv`lgO3??GwcxhUg1O6(Xz0~Q`w=Uw6NIoyR4$;(*qm$xJllvURqefsQfz%9 zqbxMCd?jd*m@cSi+gl6w+BWmINbENgGrur0819iaVh~VRU|^sIz``6wCSg-ohMWgf zj7237+f*$xA|1BynjKR&SbHRNb5a_vCU81~#kR_7662fpT}dfWJ~|N+apiF2al0$$ zh`o<71_3I5inCFc8uILvxRK$iiC4o|vWF0*&tVl@h_yEN(UU1NO}imJ+3u)?Hnfr9 za00&(5|ivANlTeBcvss}zk&i7tDsfoG#umiUU&v<_r$o)#&L&;BdNMG*EA|z(f zb393+vnqX;9&)^Cjk?>aC@Z*FK-14PuWthu__At7cRvrM`5a75*=DUncFnT2BpuM= zRrxCMEh{VJsC4AGHsuPMl({W1^uZU;mCom-t_(S(WwW)w`n7KYR@;_nx|GZUjH+xM z^tcKdk$d^WQbI>}iDMGcrZT#v&m=3ml0h~j#MlrbBiwNA%u38VB2>jPVrpSX7QCXF zN)$%7&|cnJ7-UhUgBxy@B-x*tsI@R|T?vs{LJ2w~5H+`mgh)~ytRE>zt2nhaGdVW( zyNO(@s7O~$008ZCI4~U0cLulz+n+YLz*so~%9 zpvrJBqyS@5Ios_4%Ck{YnN8!iCrETl1^t`BXLN=VNe4vQ3k@NSJUOMHu+m~(B#xkb zAhVhSeHKT&tNb9;8ca^pnGfB``_yHYE9BkE;q$G~=0ri2%;(?iX zZeC+hkWZ06#tlb&I}FVYq=EtyVFsYkX{!#)xNZ?|iGxwi0nQYaa9L;y`Nwsg@XV}X zR%MV<+5$qiPVvoQ;hK)%c~?J3*jJUv{qfyrJS1wlfTY#4AwM(wV(rxNV{qSoK3$f1_3AYb>{r>xgWke ztQI4=PT|{B!ljicD=m_nUib67CC!mLh~WS613(Yk>?5NZVz3+&7y$x=$K<_G5j2WG^&-B)(j1Ez)psM>M0k={x9 z6C64at;SJ&q>oKt1IckovcrAj^MDQ3pU9x1k`$dstOrdxx|dTLpny%)ZOnCSaqelE zc7hVqEUhafT}Ji;tailFxSCl;_ZH}5mUl_coT9ktxKV{E32{7(I_eS>zUV!7{21D5{)5KJ0_MRNjboB;Z! zIYV$W=lR|X2OlGdx-{&e%!7ONNwE>zLUgoj%2Ov^T1%I3^a@z~%nhTeEIjQJc3~<= zZp7$FT3}5Bi!sX5YI0JFluPOiEm@S^fdu~6{{Sd8AkylMNjx<$vP$0!WgXL$s^`N^ zqpm`9Gh$X+a%2%Oo8|Xc_l$DV6q9DNwAt5m3|M%mgpZkpS~;cmF+D|oQrF6Sk#&AB zYB{9Fx@*rQjE({O2VYn$G_#`idZTC#G8;=t$`X)nt9td0aurr{*>y-#P|GVoBxX{s zO|Pzz(LV#dh-Sz+W!TJ-x~xV12T>eCq;VxCrX_ib@=HarTn#0IzuFzPjW{p;NnCQtT%RsQvWkc6k5y$W~>T}KkcH3>i z;j#HZkT!NO)kH~I;>&AFg_MO{51evBqGznkOHC%laDRn2 zB>4kq0XsF9OPE0`4dw&xs3?zuNiZCvM9n2ycS5~&_=pZ!ftCGgbB^Fp&24m!f!M4~ zu;Z$6AcPa4C{lkNqk`Kv=_Sdw)DbFO2UM&$LHOTGLRryAy&$Nd~{8l0--B2-Ak&MJre3v zQ}Y@?cVmpV0-j4usTNXzQ>g~p`6>gJb>=CokXvmbN(%iZb9H<#Xa!NtZ7edNm&rBldMUz;zq+=sDjGWoekKB6nUX)dqSn6aakQ7B=hr2@c> zq5L_Ud$;N}lNv+Dw(=pd`icCb*SKy=;J+gepY>u=Ma-{F{{YEwK24@A3f7HWR727( zBN% z2@QY}k(DCe0>e%8j!=`aCdy@`P?gwaMT&^=Q8)30^c#H6%M*xn0#%%>pkJW1!9G{( z=L=8t63}OG%4)%U)nsjGT2{2G$_P?OQ3U7+8iHZS#A;FzoHWG=#uScgL=-an@?q4c zDjf_QiFFCw1q)vG?*c%|L`umGK7$dJig|qR)q_miDx`^j$w^XD+4zj(t@4e!kzbL= z`id+?JghugLM>$|W>SGSJrFDnijIJt0KTxkLu+vJH7D%3px#L~+fwYm(k)^JeR<%o2LFEOA+@bne%O5oH-OB^7)CHvO?smpqm3rdjA0PNl|CQe-rp3yNg!^ z@faS?SYa|1mnK_%myqTkbpRl%GF5cm;XrBU7qFK8r9Mo5ni)>dxPEgE;|friY@rIK zR7+~mr9ie0gddpR6E|^xeFSN#FTSX;>0y_YKjqz@^J6`gen`8=`m?ZAVG&6uB58JU zq2lU4d`ZSJKEDD6_Mso~^=O`or>o=}jV3-t1it-D9k-hHiqzW1?a>gU@e3cmB)(%c zx2ZcQ?iEQ(9~nA%{{WmKDEN+VS#-TJrwCA3j~pdHPF|%@Ovz=P%;)-{9J0;KqxpY!Uye|I$FSqgY=iLLB-|6u3<=KX6lHx*?Qm~Lx0+6i& zf5HHtb!z)%0HuFz0u{@b-`|(b9Mr!5059wEXKs-oxyKZ#fE;ebD(M$ec1koQD;;cm zsXC;j!;#-_zrVCKHkaSj)RV%K63SDoJ_Ud&OQ*h7eNy4mFi8Cx@0~klBS?864r{N| z@6{RVR5doziwSHx0aJRQg00krYizC`czdckr~|BVMTyqF@9$%uDN957U4M{=R@e_E zYDpschJm@v(oVd!l2CPRaA|*km&3{Yna3o*Pv7I_zGfH0tXbBk8B=YKtjz7rj-0}v zLXKUMy&MBWm`8NKxAp#f&T3Ekeg4NjdYw+FoX$-$%j}>QoMqId_5swbwWJ)G{?)sS z2fU48>`mkHPw&)?l_?yLY{KggGVMXM8ITjmZDA7O-|+1rDJf<3eWjq~QPiYfEupHu z1uW9CP4L-rRk~VarQcGN%1dfPg(?fvRJm)VV2$n2{2?;@U1|LUKfvy``izXA`rb+# zTA4$Om253t@{x5eP5Yf4Mysc~F5X6A zB_7gKFR4jU{{WHMGplR8oMXC`D`=9XT)fxIs`#&}Bfs0>f3x~CH6_Z08g6EBiPxR> zwixF&rxdwHTslk5veDHN(;nmLP1f6*l!2^sU8J_#s`KRjACT6K{{T;iHSzq%l7+-s zyo&a@G`iwaqy`%)=NYDxnaN?DLA=Ba%_}fM)AoVVIacfL`whwq@3(P?;@&2a#eun} z<=tr$Z8GBlXi0UqQguqQl>ni!u^)&|!gZwiXoOJl)6t$!tCm=mhBu(@@@ zZ<8{v*w=BeAOdaa2wR|pHKjxWMv;gd1(zk z`-`$0Mep^Fd^Q&+YeUVXF}Y!t9t}v*Fszj_Nv55hZfqIH5|p~7tfbvbSpccMigvKI zwbB@qzo@9}{zD^;a5|_|He?nQBxa`_Q*#7^Y@*8m4L}CvCfbiN2u$2)7D@VMADC)k<%Sw=WwfQn+-O@kCgc;Lw?Yl0iG2no zFSa+Gwc1?X4s{@@3rbY9lqjTyCdw8gUBp}P&+#vrTa%L?Oc1osQRJU+W^q!C5~XUQ zOKIGlZ{rpDmh6!RAiF_SrfGOqefbmzCXm(IY_=Q=P$RlfbWkGTgSdt8)Z~Rt(9rf- zsZUm@OPHUevq*hYM6D9?##xsV0!Viy&50T)ivmW`c{)#Le1;(GY`D8h#2j;}6-%mJ znnb$qDjpfRro}3Br(ZBOxaklxaqx=j*(Mm9Vmf28tMlm1G`ecCf=#7=f?})tNiJ5t zWYvSY#+>Z;Sb2rXI^>MhiTwgzZN>6DOBWfLC#Xrvd?8-{03Lg%)I1g=@h4`gv$V9y zOU*LyY!smx)E1PLX0lYEI_wV6xN*_D?lU|NsOw=I6^yB}e7EQ4Gb6f&(y&MasU+Bs zLkY>n!uI_{M-+vB3);sCGfhn@UFmm_rqrpd=P#N-RsR4BM>6p+t-Azq%c+Wu!n)=d zZOK_>(^SKyMNOBbxH+>Sb5U7R1~EkUwa^Q@D_yT;xWy2 zw6+Lgluq_J!quEg;^m&0WwIBQ4l={RWhwVclrL`!YosR>;{|KCRw`KJ%{m+S_YKO4 zX;;*?n!Z&pH~@UXx56f@@IpK(4*m$l_{zN?{H(&Iom=V%3Rf_MBT(jw+>xLbBhEQK zE(!IZ_jxgguJ#9&=M}goPccPAwzi6Hb=ZMul^<-n>9@p={hMbI{{ZfHO99LZnnHhB zZIkj!Oe_0s`3e5ZJU_YnBpNRB=K)V!q<^D$AGW2+m()M9?3O$m!_}S=Qd*`-8CPW) zD=1s-xLi4oVhI2b!XV}2l;q!6=uC$Q;;W(){8y#oUN})s1Uz3rq&Z>m=R03)qX z>G8^h-YB58N5X2CbuO(O(&LC|w1kcO#Uzy->Dk`fKFm30>&n|K3wRA8CMB0I`s{8=WZ(#<5lm82=)w@?*(U0Fd`_-kTe zaf0q~$X!Zf`Tj9e-ey5l6t8DO`T3FpvnTAKNm7Nr5VZ<9s>mxXO07?pDU;!}J5X`K zF8it=I+Wh!!ZRKAxEInLaq2f@i|qBl>c0+WOH&TWyvA(VLyOK2P%fJgdWdf(;^DBh z;@1u9h?iT8DoHFMN^qR(=Hx$Q8*St_hElF$jo95$xH~yRnWqx>*3B(TaI~c)a)NJ` z_T2fx8?i|edDiCS+2uDcmmnkz;YvP+;9es&L)^mPnxnNOtz{XARftuAMw@T>LKviC z$F*vr<(Ax&d6jDfhXOwnppI3Yx;5~2D5^#H56_9STy2+q@24eB+KMQyW}A zk1Nwv2aM|5YE@`gEdfe4SkMA?1IE|Z29UBw(dR0yxYJf_p=bq5&UDkDwy-3_Vj|-V zdx}w8nPr7Aq_m`h*m2Y-i(cbgr}OfM6jg6$E%Y2*PlxL>IB8BTls5b6%-{}{D}Ana z{Gtw5Ujo;MR>;9A!<;XOQd*jE*=hCPK7pkb9mZgig%62}Y37_CbZMc1Npd)Nmw{DD zS&n@v#2^OJgmMX&Rgs*?BZ3| zE3B0&-URC$*B90N7xNrYlJg(TGs9}}PdY+%iIgbaEiFrNDe}!=pgmyo}J&+ zYdG)5+P4oTlSY#)OHKxoW}RSNK}zVC0S4CB#6_14!)o31B4o(AZ+*yTH!}TU!!b7M z-gR23ZYZrs;;Wdpj8t|*E!nQ@^KwG#AP8C8q4D9b0Wm)o5|?Sx$!1kn{&O;{h_{MT zF136UZ#ZS-NM?D|Ny)=b%@|(+Oefol>or7xRE4E3GTOgYDo9FwR7r@^%-`}M&T^Lg zmv%~dsx;MY0$Vq+%Zq(nvC6A`(xIRpAu!rakfoJJes8-LRH_R&eUOIImXJ3i-acgR zOg|V=114=;%&t^H(S+Rin0Y{pEQS0j?h_=8W`#l#ABo?Xtj&qJA7pWti^>H6lb8i+Kvu@v!^3tod^_W| zE3CSu%;GuJvd9Z5RLaJCA9M|FJa*C$_Byv7{?)Z?ML&u%$<^j%B-JS{;zA}INFhno zr6|(m>#Q{-x~mq4Z?aU()jDcn56;X^1+tZ?Z>+4`D#FC;XsqHFl@l>C#qg4YH8KXv zY~SG#q0D+*hZcBT7qlsOM zE0`#*W`O9NmKQvy9J0Xh8YD#6aVhf@mtq-KUtFWbiPo1dGJ|3iETDXpKa5FE$EaCR zc(YccG#Fa_p^>*SN-G1x;Op^@IN0QJG&r0$#i*@Tnst9xOKV2|0C;pUD*~b)67?f< zjI}55L-OI7mq$IzD>BLM{vBe{B@SL=g61r%VJS3B7u#{A6o3{~PkUf;!}LUKNn)-u z)Ub_4NpsZp%EO6UYG?&0`CO=P;iMu+O^^L&w8PYuguh9gON-Pbp$9|g;fnVGdmUf26A52a;KIgOY0!@i7X1(pxEO1bKD2nrv>X$OK z*O|;!cNF2&`4C_@BCv)v#gsa;^oQl?NSIOstd!>nQZH))HayD_EJOsrKpAmx5DsoU1mUwP;eI5*1uF#1&ji zMMT?lsdna6q6d8`Xn=j;u3$U`w}eS2F992FTgNdVOZG zh}AhaPp2gzNz7${3P*T%yVm*d5|@z@MZimpji&zqbVYl-Y&a|i(Zis7I0ia$gN8(K0TRhk0Y33P zW1&IR$1IecU^_;lq(C=GK9E?QCMC0$0HaydD*fM-bmK-zL@1oLx10cxh1OhUM2ir7 zAURZd47h#J2doDu=%ub$)&X>2FZe(dU|h)rb%5cNx>vGI{4|aMu0p=hvG9c^C8Ikj z$|H;rMQOj`0opM0f!G`Q!C-AA-db&7RC?P%1%(==2}!!YDD9k}f#f=?n}9sGg22p& zK{m=Q=^U{}XCG~Q+#f?7umz_ZIt~29aOr|#Tqya+QxfB5r?M$0QKWZJohIATiAe>! z*m%KWv=|;#3InaJ1%`mmdozD~;x&$iBx*c~X@RJ}!V6+rOfxj* zhj}f8j~ffX#je;Br(zyD6wFgD*g)=)wwC$AT!$14 zQq&iUyXqG5FgcxA*^0426HZy6qBPZ74~OoKsnD5YzD5~rHsqh$xIHg;HKq#_M$^>g zvH%%~+}_ssS~;jR8>Wz_n+hl?9SDO^tpas4>8WKC&ALz7v4v_wT3R{?r_4B>?eiVH zJ~xhPLbNs&*%^s{t2uo7{!k`?#iL)?otH=pQc6L%0G&Q@+q0TlHyul_pc{8i-|$B) zRW@rkN_|?S1dlWPAk>a%W@aVdVE4jEw?awzL1^kt7$%#3a={GR-E08$-aBa=X}*Ej zmRz79GzyOD>+p_PQ(Xfpp1Ogzb+c{Na1Z-qw?{PDsq{nT-cNLd>PXw;2B6US8|sw} zn<*E!UXjZcMz7G~eD^Lb;6VK2x~S%hG@qj?TSa$|s6Ui2pV|DP9$u~P=-RKJdCHzjJ|@=%Q~V1?Mq9x11~8n2UiYk zw)hK}0*x0M4%ms;6rUiprv4TnM^1dqGt@?#1#0*APEu}s;Iob=4pnW-sGQ3}{YWR` zKYS=k6;4Z;hQ?$k#1(G{95$$Bnrocb5>~P9fC0D9K?4P`r&)d4+n1PgV|1XBK>gQ% zIhzm900Ek9E*+4eu@S?!-00FOrc^1(V1|LwKofKDFfmBSJxxt;hr(NJXK;~gk=MXM zbQ)|;vI9r-a}R&@MK0lJ6+zzdt6gRFZt2T6Pvz$m_ zLoLRfPcJvi!}9A(ld4)K9za&DHqx#$4;2ys8XIeCMPD6~qE6vqY{Oasrcsn#MK%fa z5s%HtzQ#xSI-e%5IZvp)%2H5=<&d;xPa@ZGNIGXJQ19w&n;QWPOCHJex?{?F(C4z_ zHT8Q`qsV(JVZ677D|5XE0NM6V!p1O?A9W!z7;MY>L8gf>GK)o21M(h8CCHm}#J^o=Wn7 zr1VlnvXYzGL%apVNN-TjA#+QnoI728_f$D^vdy;Fn~i3=e2tC9*V+|zx5P`_afI5Y zY~`$S`P#$JYr?EUM++1wPs*qy=(Vy5{ZisWgms)3m~r&UmlUCJ9Pe9Fl;3*|NF96z zu;g8OjmvS&!jCsN*mb2PNO4OcNjC}?BH)ObhksT!_9BlLRwq?b4Unr&HiKh(DLF0; zwj;tMP9K@3_I5@1f6ZbMsV5Q8{GuDe%_Mk)jY;-ajJ?u3$?4`Jk;6x2p2(xw-gG^T zYntoMcko$@9N6|>0oRojTJlxUN7bWp8fG$Ea4jp2ia@`ce2G1Nz#QZv@1 ztQ`ohY(xn5ydDz>Ok4fRTFYPTf((6^ksCS8w3I3{CBz`fW#!*Pt?UgjytkqC&o9HB@ zdZi^t@G$#!#(I32Gcff`CZ8xuNgqek)p2f(0r{Ax&bRa|a6OmI?atPw8Avknywzv2 zlBZIO0CK2z-zgK z`o)q~S2owwTJ}-Jvp9reN9IM=?BtWaAEj)n!%e%f7l@6=@3|v}m*VyOiC&80^52o; z_WTBK4+y7}XuFEPzmdQ6!9XOU*1um1e;9(`Oh`deaeUQ2vSpi9nRTZWp<$ze+@V9# z`*n!^9-h7b05g+{n%#2!jyD*1*EPeDE}8iRO-igNyD`s8O73fR&_&dsJH-Iz(!%hE z!}#k=w|}3fA|sl?_@dffx!12Tn8dxUsBJK(CFWTnX)?_FHG45O&ICL%9o zAf%Q6&?=iON^BSAk3O7!c8YS$YJ|Y`Fe>OXB?~a>WXDwT*S+cq5fR562e^1pX!3h zNf$`&+MAaqg^0a5WH+UpV*vf`gN z=l5eD+S0GT*k~!3#}HRSxs=wIEQi%}nbJ~+5%zAKd%Z#5tUUdn4wruq<~9ANK7W6a z&#lSTC*_pFC8UB1a%2v;RuEO3j$u{re!GF7(iI*GF=Ah|r23ua_@|0mP|Ze?aYH4Q z%^H*^C|9ktK0EIXKW9PpeuJOdlKX$iM@(@pp*HJmRjBlU#IjV|Xk7D6DZ8B7ocZs4 zd)F}heV-JzZ_sJ`N=^R&GqT4L>S|G2RT><&b9JW7J#*$tk4-et!u`e_Q+}c!v?tvo zkuk*@?J4plYqXTD#3?0A$x7cM^im3q^zw-j;bHz4>d5or=K7r3z9v^?SZSAWB#IEi z5|+{=rFKrK%s|wO3lpq3ut%g{s~UOa`M;p%U>+y{p+H{0V+>Ht%e4CJgU=PD2AGqV z3sb5V2Ex_{Vr_4XMa{#)JmUQKWB9YqT$wm3*gmI4Vp&t`GqnXv4s-bu(q;k>!?|#1?zZKPW7Y-shIX+ug=Dr=DLR9d|L2bzu zH6q%b3UDZMlD37_n5Cr)jEhy=3E2fjI$8{PpKIsWWy@vd)MGY9eCy@7wx3ly6r~dL zh!T^FP;njL97~OCw2^Gq+Wkg{NS5QTr9S>^sS!!zdplpb%$(r_lAS~T(4>~$TZkHE z4ZNJQ3|jUryYE>0iq#f|-Wufk-!E10e?e=AZ>QSi{zo1|gKbN+7*$1Xqm|0cLV1=# z^Gho@H_pbXO7~h#mv~2l-(H=)JwBqmdg=Gq)MEJ4Kt&pKhZW8*r7HWkb4#deVVI28 z78krF#-H*e!d8aS`MLVy9cE#LG{IzY&9eYTnh-n0j)MC_bc?YOF*z%b*~=w7(%ePD z(%Qno$aGOf?g~h;09Fjy^YLZoXxjn2|3g=|fHjzO4@5MFO7c^8un& z?(Gg^b$gta6h+F5}2KyU6n$-UQ(lSd!h1paWUuD3BCEz>iE!-#tX?-mVUVZrh z)vju0poF&N+;khEcGmv@tOw>{&Ok4mkmX4sQw0t42`DN)?~TuaBTK_}EJWc7Sg?5_AL1=?xAnT8Bu`-8Rj*J0Bu6A{5=6ilIrw zE*DK=$_by5o*c<{U2bYXskAI49^p?%VU8$WyFMqHj^s3 zd3i}-W*=R`-dpEC-AKKysI}p8mAhkbi%N~o7*{8xC)DLN$69@+ii*+R3bDSa zHv|s1(i1(9xb8jJn~ZD4)RrmJOd&2X@|{D;UQiUHb$wl}slJ!CxXu(_sOExy`vKHlkhA7qeEbfnu<>!dX&TLKBg zigd+c>4h-LpOpMG>!8=d42Mv*uS*IvnqCSDY1vge%93sr%C;Bll<04+ zn!{Y!s~?;>D8?anT??^&ndH8uU)@V=fRa<-Z(w|4J=e@1=u12!j9kpMDY0VG3wAdp zBpVN13@01Y=ts#5^&2kMt0M^J0FqC2BT{Zffbl15MXwFbe8@REkLDDRnVP4{1k0%e zvfg6p%a^(|%egTgc$}Wg=EX*7b7pFr^Eh^GhVAVMT2!T^B_l-r(W$uJ-C=OX@xK26 zDiY?U%@kRC++WCs9di;dDNm*Kwr6g;SM1BGxJh#pL2`UF> zQxeI$?!J@jr{@WIS97`_V~;-EomJ96N|uWo+sDoi6R>Fj&nBN@*Z_40uf`CvQQbCl zC8wEpyh3%<>v$GW&~6hb=A|UIZa@G62`2pqQ_>vg=q1u$ zGtwMDqqy6Asrf>ORgtono3hvUQg3A|$XxkD+9bB$ZhH;ui#v_B&SG@UePNd&)Q?ny zb8QyYYZyeb3Q-Z5VaW!cT3IOzNwM!=Uyjg+KI582^XnVmSnFbF=gs|K(h$z06K--u z3DMdPs*+Ta2^NJp+07$kUM(VNg_MOQXCl+lNmk&+mkB;zOpTfrpTKYE90B3hCYu!5 zie#GP-gv35T-$-xo+8RZid+k^wt(o9(mfZ4&#UHR^YHq44Hst~9#i;H#5%PBXmz)c zmxQQrp7f&q+iGv2_pftn?-SnTa*Z-w)Vn!hXX)~k^~$T+>GKMjl^o|Thm@?!UToJ@ z&qZ8$Lp5B5=^1|8IMSPj-KPnO2B#*SlqIz|qB5i#YzDf-e6VapofRF$8uL|$rJ9p1 z_r_%gnNvlz9SeHuyM67CNJLhiV@$}jXhA*)%r*K5a5bAR^ z{6i?Vq$&N@8z@se)eTCD#gvo-t<(tcib+l5jYaP+dwmN$c+{P~oQHc0*6NtignJEU zMpc4)tjnpnmx>434lLLoJhu@Y!AET_{xn*}TCrf$a-2G3)GG5!VOi9oxwn#{-~;Rd zw~$DU2eYv`?vo>Dl8DG)jv`aBT*BUykoJJ3DO~A!!Od04?-mIP2H$4UsPG(iEBsp# zRXHhns)Y25>Yhxa%p|rZWt>kX-1i9zDHpwg8Hk58QW2|iQ*lEcP2g%;+n1G0z?GG0 z!7os^z=paF4q2}*^+l1e}~8(8V<4|rB1#GwU6 z1ZcEAl0H_55?#q^hT?;ZDinFSml}{$?K(lt%}NFQ@75Eh z#cDRO4lu;4H)fE?Pl~5n8hl_;M;kCxu}yAgC|wn`3yjJW%^ME8L7?uVbBHr(s_BGiX+g;ky_os%xUDO1Pud@p6a4O)9hU(=MF@X}NfwfHsWRzTF~E55r3<{3`tS zuUD}jFA*3m_VWAOiJV#EsHu5vRJ0t3ou`=!BPQGSUwRke$r8-$8&w|zF{ z{L1XSLzdjWJpTZZ8BoY&cUdLHowZVwPnM*U7O7DkGDh(Cvi>RJNlLw)ROuyZW~M+% zw~AU(O3$gVhTc@X{`-lZWfE)f@3a0C;b{*v((9F0{{W-`MFC!*mQnH6B1Dbw-BUHgeh)Bq7!S zJP~;99I$fQ6ma#RI24EgGDHA3yji9$c9>jj6)Ba4*lKJeqLEe|sqhs7QmoZ#s>I@@ z=bAtcOPe4#1&UNn>`$Gd%M;j*kqG=1Rl*o64`No@lBh0Ka?<8$ryU6^Pcq2Juno03 z@1#f=WKEXhj}03+Q-&whzK7{GgMUt4p?XA;v$R(iu1cGY7XV(e&mkHZ>I5*y^z zr4q7q4vT_3?vf!;$ly4oMSgK7u%ljbhdA`MbP ze+0e}QkHs6^eaH(NEaRowTxK7-soo|?k0G=%A>7k#K4C>ic*?hr5yIfyul!8_(O8W zIT?@LOBdDD+E(2)DpB1Y(11tA*7-zjBkDpohIGliFvQWBV4>NGryj^wl~^jF_$kdQR#ZyiGboZn&fsSQ{j2 zN$8Pou$mQOV}}@`qa{c~4AU1ek#1b2_R;|=CoZR@?Hp>3U74{r6X$4Bi*f2C!k$RD zZ4RYcc$Fsh^o2$uWg!8>M;xT1|hZvd0Q<*V#|FdVRj z=LgtN&H%GA9k}lRAOLdTXbv3r8gaE=;?MwTYs`{#HtPTzZ1>;;5SU61y1)iwGM5II z5CMsMc|ZYKoHodm=>S=cb72O=+5iO1mFzD78%!)6O2U0@03$|dhK*pNK4!sB=jf|kpxNVZ*dCrIc}dH(>Z-02(!b6KBC&4K(Qrwodl4(O5i zKn52O`UUJV#{!sU8V>Jkfq3cKGAvtY0Lw2f9@RtwIv?X4v#D9nbYyT4ES|B^G;|WA z54I1$kIp!DfD9qd@)zr9?S&W}Svy|dFafMwbwnYxWa?CGeh?fwlG5%hi>xU4+z-k) zbt7T=O4~Q*AwGF;`{TBENsYRC85YgVCv&&RM;kh$KpIYa+qgb=j_Ns}<}N|T4q~5- zcEo9*^X2D22Iuz(5!Q_D%91k=jB?KD3Z~TP%#oVV9HSEtO(5m9(0X5JRf$Q0^G?fm zlAC$QEK^M!{%phFq)wgy?jb@qI!>W2kE?99p98Ps39(g1f~o6$8OlyW*I^3PLUdWG zhE-x3Ad%3R?VQut@)G;X2`JQ?ToGaCeW0+W&d1SZExCB>U9u!PHz$X7o4C|=g| z+BspTZb2JcP1qJxm3XT0(A%(MFs#Z_G*K43Z~>QmGo#i~R^A_k2Ugs}%uBX}jHn@A zHza(Zv#ua2oi3CGIG$p+u)T-M4M#L10+tGZN=Uar40Hf#Eln(?cJt_Cmq3-Co1leg zgxw=s_&}r&8NTGyqT9>L@7N1>kK?p+bGsTGryp;S23Co_Q>pxQj@ivN5~oUUxS|eV zJER*C9a0HE2?-QZ`|h+50}V53JmZcQOsi^>F_aHiHCu%yJb=5JFeh<#yX z^HM*fzEktwINb_Su(NF~kXu_wAd*GYE+DXKgF2;qAwg}cCr}OUuPgL|!i`E3GWBf6 zVWhNDJEaOF{EQ9J$g4Zg%A~iES(MnmRb)0F5&PjbIMK+b10teZb2u85a>@K{aRXvf zqpHl(98q;HDWsoyBodN;Xzc)`W~olfRFRfvlt3NTa}o@3Yz~>hLK=`68+9Yf_x#~p z#MJ14pKMeSV9t1+h;G0jlM=XVyMR10Y@-Of#_qPjLVfm5=&?a z9eUg69J8$%grhG?=Sf*}?&MX7@ys-W&Q`*5eG8dVON5-8D%y`I?TKjZFGSX!bb$%R)CPCsri*>QbovYABBWqPUMwj*_gIoj5Tu04s>ttxPu3lE2G+D|5~Nc%Y+?9q+4^@7NKa1I=2w16 zZdtTCb2Jg&1SpGzTS0D+<6?OMh`0>Q^&U-h$@!NYQB%qGrRUQ@kyaN8Hrw%zYCA)p z*`~cz!(P!%o|!^q*h7l?wvJ}jMeYiZx-LzK-rCw3$&o~IFw}3;_-{qR)3X&hS=yZC zMPVh?O_s__ZkvUisS2^TaNjMo5k<#wOC)Q}bS!v$4le%yQGGm*YiV{>`E8r!S9o7v zP)|srmgR!jYUf&>mYYHzVVRUAwFc%MPG_4+{p9L3N&8l{;g|M@4O}OMoMNC$R$-i$ z`kNp)`R`^311*5=_?wZm4chY#M_JZYEm3_B%;#|ohmf@!6l6A1ZLm(g?_EqK@(Uh0 zml0J%N@+n!T2P?0YTAZfa;RJ#W37IJXy{2xwJhRPq!lcS4FNVExI)sSjhU(;LBprI zs{lMLcu;|};!~py%1YFV<{K=}vu79yQiE?@3PQrIc2r2ro9~qFB32cDenS&up;DJb z@+B7b#aT(}3yA?LPncD<);jm09E8ht*Qiw_Nlo(*+o0ul`U0?Rmgj5r8{QWbC5oJ4 zpJ9^C*PPCtT-3s!->88>fGUD zAxS{@QWkR%pDUF_tO~a5A(fBDjwVX*#}VQ=XQmG>W@U+%@(`lapd~J(i;SkgD1Ih1 zc;KeFa%_7JM~u}?h~ubWD<})C%HN=H{sIV+dU_I0Onp;-vOg%19z|^Vzlhs$9%(Z3a#sYEH!uaf znyI=yjW^mFOC(0|An{x#eV%k5sQ#ZGw89o9@%+aw;Dc74eO)g|#q0J|p0DUbSp6Q8C zb@E?SSt6Xu+A^S!C050ga&tVjjUwWYN2%qc56&H2#_w;FCQcKdQP-h8bf@ffIvq7?-{*c2OC^7PMuHNrzcT~VPZX=%x7Kym)=po@-{A~6 zefkn3KhyOY3XNe@+(9T+Fw1Evnkvq#1pw+uNY~%7xDdmNb}7sB{D+T?IBmRHN|*Yy zyUTShSb(nX$Hz+@V8pj8IES+#4Q8=St~%u+nk#6+J0_Zac0*=4*VDpxSx zD4cm<9Nec6;+5hwLAgF=74F_bec;bCMy6tFD_Dw~Gg6pbwChc$+A<3zO9^nOB{$3Q z@VJCL2_0FOwZ%Bm6s-zCNKnpFE~KL3{D69}cb4v{f zv565~1i74UFk-q*2DddwmBYAgNs@P#3(W*NvQiE5qyTs664WSZ%ETo5(h}hlLY0Ra zS_)hYqE*b-w#QHi_0Z^HPaT}rF3~k9#ry>^i5`%Wlbn*7AqbV0Z4IdbX>6syK`I0) z`->1Q2$U#Nke=bq7M+A@IDHDt!}VFIfy`kDO3{!Mw|y;_HpGLhM4mlKk|C2z99izu z_4#_F#Ub-6FsVmW(pKwAyMtkzrCY110@v_}Z-a~P^d&AWn0R$kW{CTel6Yd8CexkA zZh{YZ+?>j}vA&*AnQ+cr+kX*jiBaXZz<#CsVh$QCNL47xYhpc=q@aV~6jQH5=N*p- zmthj(HE+4f$Ni?T<~TzxyGyGvGLxBy+HJJBH5r0coRX8WhMy|kB=~D(XksMzXC6!F zONM*v^$-}oT0(WV4Kd?1%21WIw5?7As^>OhNgx0=zL8m$8egGfj(UVXAjI<+c9lAr za;3P`fp8||<#EJW0RwxINwDZN))57|_==m`)I@Msh0>Mk1u|ua5iKz+%X2H4Xap_5 z7J12WcDk-Ek`>piKbCJ)zfqiVsG$j3t<~ic-EK|kb|t1}oNiuK{N)J=_Z|Qn0(I{s z*bb0JG35PG*55zOko+>l(-@MSIW0WcT=FG@Zt_lMf?T;u@{^e$ro~!qZ6Z99Piv++ zpK%X{AO2IxPEAuKpLB|OVqho)p)WRa=0WNR7x9HS*FTBXEAkXwY zDbyZfjjW;vP(0v!b>=A?>SbDWhYM4Pm0B{Kjx-8f1oTkY{$do;>1P%790{!T8eFW> zTS63xg$B~)iCbB0qOt3Iogo~B4b^^6n4WQLr6=vS2Aw;=Xd%d*Voj=QT46@OmF4e! zq}ctF(*1lyIbvu}&dBplT&DeWhZ7LcRmnKZ3Uph#Q*`~S9=7luW407>6D$(4=@(hl z-}l3U8L-reuPH5;3L3wD#@cywymd;1wPV$WE3~X9D&l2Z64T0MZJ}nwIJ+FTH@>&A z1FfMB*~+1Zn3G*nPF2teaWgH4{8O%^{;AsjIz!3Re*w3@sVysOm7i`>T2f3*iH1}| z=}63iiv^V)mO24r(jxL4Y;Nh4&T{iIg@R3rdaB(lH`_r3nbJXUR~6Clg*BF3m_(sU zUUGF06rpo2y0V6l-fL$X#)=6CyKh@>7T8s!R!!4l3agK5^qS0t zI#o-0nDQLwx&_wJy_>S{V4j+SbkZeh+nX6U&G80Phxmf9^-0y_ltTr!)V#}BT1c~D zM^!0WSX$;7mdtT0M)P$g(kb;UM&!C0n|YTeIYl{2P}&J?wcA|Q9sPacZ5h5JBgraF zd3G%E#YG&4D#^zZGLx%LMNG=F=}76FHzVUHL-1lQZ%lH+bKcO8hS;0WVC{% zXiH0ZRw-;;*k9!wTb&C|u8EfrmW9iJ8~6?Nj@W58eXvZZfKGh+W4jQAaNX-0c%nXO5m;^sk9{p+RkN= zEL2K`$vtCX&n9p4CHfRk_+jy1scsG?>TyS+qXySMiKmYx@DbIjvxq{H&Z{7S3^@;| zjqVP^4#~C)inFR&TFv#jJ}|7AH493IEwbxwB{`LDx|nHfbWrn@p1OI*Y)u>)y0B8R z1%5DCr4t&$fZjTAO5#Ze8&tAMIo@+33Vq~~EC}-(^@~0kG)Ks+M=K0JNU60UiR9ly z$#p7_#8lR7g#_x9)JPr2Iu+&0uMr#kd84B4sU*|y-{58Cj!soq%y+T(3@4^B^&b~X zrKhRrr#mS$>t^m}Co^kRg_MgMX1&wlXtRcN*M3`~vUnZ#@*WxIxrtYyhb(Evipl=y zrBQSmz8srQQUsHUQcqEzT|PQ^7$^9Zc@d_DXM!9za)UoDSe=q$Y|RxJWVoQAE&;e( zs5S#O={JgAD>bT5motz=+^SY^r77=ds|IFfn>R{Ume$)u?i(5pj`2fMS68_yBT}hU zRwN`n%GT({4(*`7?RK87b7I4qoE=d%)|~HheA^<6nhQ zQI{i^G7{ISjPQb{Wn5gul;UilrW^}u-3U-AHvQ3Lqhv=a7xKJZ#By_Ko)rZcbb5zh%Tz9S^syFu15!*dDCO$wN4ronOGl_!=#y^4l&CZ^Hk9V*E=h#ELE;=d zEyv&F)bOR%*=Yz?ttDwf*+@Efd&DI%$A~;Z-l=1ZGdG;FsTN;xHY)+3K49L^--gFE zq6_gZYFcWf@}HcP1zpxTN=lQId!&(~Z`AL8ktHFP&5R*Usy#C(syoub=GGONPKzjw z$8_H*>N>(?mr+q~p=OgjSEb3wp*51yW>SzG$g~uN^|obS=d4xB1@tFJEp-_AE+wj^ zSmetghv|xFDIuj@dD5=%R=Gm0w~RIJ{-XS0)2ZW%bi%T#i#p;?=azy$&yIKj;~RAR zTZif1{G-y>=(5^B(~fu=x(e}YsGY^Ql7mqowmo)1V9Y zvhE1jkDOC3$K~hQO z+pYGrbBEwD{{R%_vgqkD!!NWZo|vwEP`TjeWT)^dSBWuGPSvXbW|xvr*C8uD>2o?o z)DHGG5axa}SKx=?kCxZ*u7YskcdAa`o8|Dnrp+_5J}=^RS?TJbW=#($Eo&-KDM{H4 zf|3SNrl!IjhFHZ^Z*KbpvQxI#$ei3T?AM04UIUCX^n~dD0Fj5n9a2w`$^u8Gu-vk_ ze=bCMWpB x9d|dl9H6Va0}q%rZ(_KeyESZ4J1&4fv`Yy;p<*Mc0T#HE z!-*=Cv(#$4d88&TS$4qkly)IRSvK;CFmxhYm7$FICs^TRrDmG@F4QEdQq8w5Fv3fg zM~WkiGJq&VebN$)ej%AaW(=+n-*44WelgK`a=?x3rfo-reSt4qYcvO=}P9xLI6MoEhKo@XarZySuz_B z{u;wg;VDGRqg8I=x~WHUOgB_3Rhup+IgU_R9JnYf5Z$1lu%$7|J7EJsa=~B=t3NOgDLZs0L@aD^lF?TB|*MW3MW%?EtW6wQ$1JxbSX(!?Wr1X` zym!97kkg6FB+m}`$1zHzFwm5B*HVofO54hOFLm5osDwCK%~WfDDyp@_gqdcF@0jzQ zN?RmrWm!j0F0suta_m&m@r8Y*+4*W$FTtsdr|~w1UON}Ag_TDgRi+XPQWC02>+M7L z7;C{D@lDDuKAB~rW@+I|9U6Hm{MC3v#3^MG^VPP*%d_aFOeIc)g`i}y%l3%}e;b%j zg=c(Inf>>r-320+;85$Gw2$-QUIE3NVX=1+DwU^){8=D|(zGZ#rxVT@4aQaG(iE`J zmzv2vhxRyXmaSYaB`fp< zF2Wb!Bqio-lpHa|OksL6GXBLh97rW#WL4I8Az8J*j6{|#$Cgt@V~Wo_wcdp~qNJ3C zWl6t=xwMXWR4c`?g{ARMw@<1yEUG}2ms{xOkdc{52X!3VjqlRXy(4Z#z)@;!R#`)m z?j^*8fJ#&ikAbz~N+3+zcpJmWiz5oVvC$wTq>W9L02o%2)9{6fIqopC_Lgtw0Gc)u z+S%D;k3C=mapnS24r6lwGn(sRftaYDC=MAA;$3S}1&M$RGUZ73R#ZN496AE$cn+G$ z`umo)8`x<824-a~+*qjje)s_Mvq5_x4zseF0cWhw_I@nAZR*3 z2WC$*DFp|8!7;<2PdK$5NgiSVW{_FR5>Kg)oCbbeFtd=|BG3V_f|;iKim~hBBY+)} z(_<}^Rn)3F0nkc;CVf<+_{R8(3lRL#@Xej z>fShX=CA9IdqkZ(yT=X$dWp;LHlu$y>Dn?=n^d_u$uYo2%+!iqaV}f|;7kWvGoU73 z`AJbd2CyCE5X|#NTNL=;cn%s)xV2ff#!xjRe&`Mx3^bLF^3{H~v;b;6*(Uok|dYwG|})m*Y1_n;L)45MdaMZ7Hm z$~+n;rN^8HOj8nE@nK;AG-|g?P&NR1^nm3X#+pdBfcXdoQKYI|z_$$sv${eGDnYr_c}FZXn)M2LR6BqVgmp8HCKjl6O_Z~* zL8NxhX)r%bRHc%O8=H8T>BfzRX!%9Wui+d!Mu?C|H%YRGfsUM`ZEd(nKJ~n#f{e3L zs+l)P%kZ=TK({T)9`Psji~wg+Rz|iXz(5B+ZIDn1&|gsj#*M_5lA9=td0GGk<+POd z3Q{0Ca`Iz~W@!!$Qud>%g;<>-re&7V32}EPV{69_(THK!X3k)wWb+m=+c}`wEuuu&1r-jY zY3d_~YK?cw=79~Mm3W;5bmdvZRO00ZRe&wMjl^_EBckldM=c`PU%QuB;HGA7qPC7g zvcDvBK5zw^SroMe*pd#>+c`nqaSKhXZh8?M1|Cp}bl%{OfItZaO4Ry}LJ9H_&@xMx zCka7uIt!bPAOMDFCqbE3`=Hu50GHae){;*_9XMzSWzRTrqyPoYyd$?lYRs%NV|1rq zG5g@NsRfwK4xoPM0M#Y55H6y!Yyw~dsAbnGpp&A!OeV!u7^WHp%d95n?PZSH#*N2i zl`Na3X;?iV3N;^;=BHF!z^8E?Od2qWWm6NKL1zB|YS;K{1=-4@%8+_>8I+q1(|g_v zqq=O}61>LJk_U8tG0QtfqiS2pQ$--SebZ5o#VE1Nw{QJHr{pQ zAZ(-WX&kXyZ099JUnom}Z`~vhj?vSG;-uF;l&Pe&i**9m^|W%rtlLzAl#c6xJ~k%T zg3i&$NqUT>1Xz{z7dIYp-e)-*s6&&Q0FiOtDi#m{gkf}>uawody3=v+(hWy6fb^RL#?o2yAKI1QY2T6mw^(%XJ`2lp$B# z?E+^S>;uxTxPXV2l&7g|Sf5g3wiRbuQ9+~ziim7ds?%wVwZU=yX15{}&C00wS1IUB<$80G7*R|YP z!Itat##Jvbm7FX#bg>5h_3z|w8Ql0amRR%Y6F8=V^6K=4xhj`tRhgp9#e&k?>q1*f z4!>z7L=&c-F{BIEWipaDq#TX7P?l+qD#&DJaP6o_)b$b8s8Uuw+y}yLQfAdY^MOQhX9_0sJG8 zVkCOEH}q0V>H7@@gTC3WeDs90ac*Fnt0Ijq+vq@X%&9G;cS_X14+3v}bPyosbeD$a z6zgxiv@k7xPyno*{o%g5jf@H>H4WW+4^42j)lSn~DW^=WB4vvO1{UIg_Lj2~rOlSm zupr!R5_NcrpFWIgw;qaxMJ~9KlWc>!e0)ju@QCe-M`5X@O{gWc6)f&;XmK$O3|p?v z@s52`4HYVbF8KDDmDmTJVL+A|NC9>V7B2gy#0%ahMmjfdchks>-Si(~>fWlhk)*t{ zS%L<^#at%+bWWf`EayWtUO{yfdo!&S%e;~^f;)>O*xP$YXh`0*Q&n=CEL>4i8<{9{ z>`x%8DAVs0rsP8T9AlY*^ zLz?X+3@C+wkfmi;UR%92>X!z`U}C}yOpx2vWd4jOdA|Azh$%XEhrZeM8iNyKxej|0 zewAD`+&3*)DNvZ9Otyv}KhjGrK=Kvl**8jvB#k0Ujf^?bY1mG_iqlO#jZpFuvHf9q z&GCFaUy-Ze_=~SGR@A8aK`!+Y%TL2NF`t?*qW1ZrMJ}sEX(3{X4dVnDb5^rxpOUj?AZ2qEuD3G}ovgZCH7sdK*exo}i?G{8%p{AVcCbnHGsWznYT^Utu$3&}-^D;sBSUxRqARUs0!SvDool%=MF zA$+tX0F;Fl+}I0T>S2eLFZz$h4Sz#f?iAw3&R?hHfw49csr%ox2=Qa~$8^i>90}eQ z<0%r*X0I(Vo%Yb@)FB+E%CjlabsX7#=7irv2Z zl1K#$P)fb=xYy$kLx_w`w$H}v<~W(-##|HIq#7h z_jlOfRk$R#WmbtQ<1#l>YH&-)AvuagfIaJwE^P>WWLWHYX?de6cttqexxOcGl&7Sk zb+GV=Pb_}yuu+$9$TbIo4pwD?=5Y+lO0Eid2tfk>06k%sm3a>+OU?QTM!PLDNT~^x zVkg%k6qi)OnL@L;l>=f;&QdqFu++GfRkip2M^+hK@9;8l%AGe{!)?o<^)o3aKgykH z8Y$Uj9TT5$n-F`tk=70xbp3yFFB=`Ny$I(KErTVTrpUC0WRou9k`u7Fu)Xd{H{6@W zwl`*PBBP(gX%^(@l&b87nxA&5BP6HOuQF7(l(wX*>9(7I51d=#MSR%9J;Q4IY~bpR z45<=jiB(Kwa3;=sTZ&SY3GZDd-EA4CB!dI9m_9S9mGYWTcydIz%Ritb3ZL zG=XAlHUc37+mG-i-2vG7j(j?-J;u|ZowPkqG@ttMRd+D4c ze_=6e7+Aw*EG3EsZd|_kDp5cwQ9A^J3V$di3Ixelz%+Y*3M$Ax>6=}T{HAQgY^sMM z#fJ>!T&?1qG8We_k@SVZAl(DqSpA}{2I3-6<(YBk2;0KdTCGvlDKi-sQi3#Bd=#xD z8*FSuCWBD>OUN-K=DMRs89hWUk1t~-=umfN=0nA3kY)0`NV{+s^=Uo2m zN=?qMg_Qb>LSa8e)bpxQd2FWKQj^b4T~%Rw*yv7z7M`}LZn^w~{{Rm&m5eymN5uGk zN?Epub+=h*EflN|t0_ov3(5fpP^6tj;Y$-wRX^BM(;U)3Wl5ntozsZ4ig~ zU^IrC1QghXZ@94#hq_6+rDs;n{6}$h=WvYtjDwFBq-Uw?LukqhQ2RiYpq6LPPQWqcu*UPvS|<$%;3N>oU>8v_Z9Z((j#%w=&UCZkRZ zc42^yQmj-IJKBM9ZkE>Y^jZczSZ@g<5z-euF0s!U5L01w>O#7U9gdsBY*mRiY7b#& zd4UO0NKzeXRw;1`7E(#p*BcS2I>%P$UgL6?8K@wsf(kQxx79lBuBOoMAWX$SE$r{1 z$0ma^uFI)yg4s}Uc;n1ToUVCryiFt!R!USK6|DqJfn5aJE&;>FN{FJcsW^f23y4oyc5&T!47 zds0H)6ATcduvL|A1X!S7FH#hDhT6CC3pkugsnaAKT)gQQb;aaKK`Ay=9hY2_+kDpJrtWGLv9<6>=dzVXI|q3C1UXb&*XQO$izO@f7%Y%?DV zUfStsVXHfKNz5lvZlGIwQ9*Lf6U=V*QxBs;Mg8D)1Z~y?tM8D+zWmVcYTvYUZY5p zkx_{-%t&#~!(2x`f7aDnK75U_)Cf8Q$)Srn`I!)4BacU(;zI7cUDI(6hl*eTO8kwpnk&)iFQk2Pni67t-dMKvWXt#>PZ<$a(CNk~e15N~+D_b&yjd#&31w=3nJ zQgzkRf0*XZ_JF7wLMsw9)J>qe<1b5@l(gdxA!Qa)l#&hYewGKUNQOsiRVC}VJ`r6j zzs%jB_JU1DNV`8vdQB@i94)wsgr@tOx3Ay~KOP}P^7-HBa$e7J>wZsTa#M-;a-y=! zbtHva;5gHWAKEDbEThLq?_v!7nKjeVr}~ip0JhHrYki>?NS(syW}w8Bv#h=mFwztj zr2;agYDrd}5j!6h7QH;mPA7zvT~P_~R}1kU0VI(8>r;z(wnCeAjLkAmfk|6sVMKY@ zc|;jWWtDPYnHA!2Rx>mz1okL-6SFRdNnT|IEFoGSx=L;Gg=EO1X?(hzP<+WC=@5SIlm47rDAUpJc2Q-8UNFtW(RXOQ+P3k=Wwf*dK`)*_k$JZB4%EPqfc2b?IcS zLct*x&=KM{iFh7NSldpO@}%$AkclNJQ8e)1Vw?+(n=5)zX(%~QF0AvmBgEzwF)I#f zc`urOq1j?aj~eiGLxc46GfKrxF(}2B)RgX54pi)vyWVrly?DFfH|D(tXR%$JW8)iG zyf;vqTMoX7V#B4EjnuMk788_sY&4A~DA59JWo0nsKBqq`KT$5GQ8J{bJ8K-pi7)P^x@8)&0$Y?qN$M86pT+>O*1?!x4oXckEQvN=a6W`S6sHMFR6K4q^AML4wsf&H zwI2`G=H(GaZfS%ct4dblN^Uf{7r6C=P^%Rb)!|7DI=ZaoEu#BV0jC-Yb7HGr_uLQ4 zI?yH{v5hwh)*2I(s#+bryNO$Z-vV^=f`Z0t4r00+(<;wNZtZTAyx`l+8^F=q9UK?L z3^`bubq0pglG9~s%=4!}bvm1$NN!P~N<_qxm*M{avoiYR+G$RtC?prYBfAmW7h_F} zXRvbSQq-KHvgW&&RLB`^vTl5Jfkf?%^!6db)Ooh~bcDRf2bdml`>6h@J6rLGDCLd5 zDB{i@lAA3qg)YlPT|M^{N3OBm2Xzhy54fX)=49MWR+}h?IfIpuID4KNczBrOfTbf# ziE{K#AQ0b`E@Pv@Y=V0y7VRX7{Zj!EJ{ks%T#7(XrZ*^ zk_yU@k)_;uIaYiMFL<6C z-t3U3b5V*ITcw!>jKhH0M0Zl3RVZ8K3XhVol)Jh|X>^6v##hd8cS3YX^&?XgA%(tv zgh_D;a@)-Aieps9$25c>Y@VNlPL38ppAd5#sIF_dE}V(`=X3BeC17M%n#_{4#GvL` z%&$0lI1=VI^4Z)@RF5cAU#D080RZwq4ZnXe z2ZkOXPp4Pag?z*w7-IjxBGg!ptT#5Sj8 z*{if!c_BzvgcxxuINgkV*9qq6ua{|a2a-mz>HwzX?h1|kq1cVLW|*SY5U%u#YFFOO zm{6NXaX3P&Spg3^nO3@l1gS)LU!*2NkmX^_IVXf!<;y0-`^zMiDEN|Z4Cx)zY)?*x z#o;Rzop~tYeJ+vqOe?_?;+_?tKciH4!a3p@KA0bIPNc!BqR* z80L{$#UHV^QBG#gu$1WQ5_pdQ$ztYJD^g_-G@)+r{o_#*apiD!n8c!_LA+y%E63@)BFu|8?l91Z{q2+UKJJv`# zSn00t-3k=a93#M!tl5hxYX;w3@Hg`BM`%s4v#a)gVYI1K_ueSiGi7GrdX;MpjvUS$ z@GlQj=3R2C(OW^XK~mfoUHlTO-V~6Q!pd-82;y3pE*3t{q!2oYR+|%S zHXz_`52ObiWoUKA#ltsrW;fd~HXj&PlbWnUVk#v%a$G7#fZ7m)-*eg=SNSSX`G{_X z*|gpy!qiDteY%#E4T%#o7bI_B4Zcv@h@~OH!&K}Ak0x05SDauQhZ*KSt+l<>dU^_+lqXNfR?TMob7LT8_WQ!pQ>Q?*JV-a!{+1AOl)xhgG4<2Uq~p6N+JZ3Aj5OKo)joftb`A_&{|7Fw&3- zRkY~a;TqJ-ufCIYWXlZNtzy|E3%SZ$*W6A@jSLSo3_rHVz zXDkJ%fD>`oSPmQ6kffBTX>G3n9LYw}?_SFN-VxJ>oMPmg-T*L$)}vuzf5reeQsP@S zQhqQUIMoW5vZSd*1dY#tj+{D_Dyk>Sa}ZN)2wU5I802lz@mX&xa z?r4xc%y8`(4D;=)RRt#dTF@P{csyQ7Avshx*6;u`Zsur^03eH606CL0PPbx}4SYt? z(}n{+=mdM~J6mA^!%1)IsAebL?lKM?`jG^$go zlCtk~`t^X}*r&R=q@_gV1YdaIq-AwWLV^J|I)Qi&n(ofOE^_86KR6DV+NwN#sju_6RLK_ zyug910GLxc>*NHk#PqZWY$MZ7Nt?K!pn7R|0?xB_2GoF1q3PB+M{L16P-UbNrxT{> zBUtIi#Okpd3~G>(>-;Sp6R7M-&7x#?$Rz3j9V3TqG}O3sgn^KB^MC`XlEQ6!Ejoh% z+By=ix>1?X5`AtDpOhwr8q-rNc?C_Bn;pN~9Y+mTT6yp^0{ua}bPbu;N|u&}$^Fm+ zF{LS)IW#?WfDH**&Qs;L6r73c`=B^>g!4`X7Kp!;2Tf^ql$7%noZekyhiK7WXIw5R z7Z=#TBnKv&X?tbz7cc>_F*Mxzb>HKx0AOXNSs(2>Ky@QK%WeMpwF5x_8CgEiJB{2A z)__toO|taBvVu|voy>6qR&(X4;paZE-8MTOvD-PO%!#6g301SB!uBv&Xb9d`ol4W) zPNLiBV6dt)rbTH1Z0Mz4{{Ze_u+nO#MYD9NWh(SK!KmhtT4glgMT)_K>?(~nUqVPJ zZvH9p_{T(wCAQ*G-ADk9p*A?t$9h1rLeg*dp;jTrjYUc=YOpp$cFt)xC6bAq5W=oB z&3!)@;3a(kZb?#3b1&Yu-cVW98UZE6D(#%0?|U1V4jo5iU71Eztt4+?1^#i%7o^~Z zy_rQoB`F5iBKL(@ilAJpwzHMHW<5Z+=KxvEsJNtCIl51lvC%BWCh?M3BwaVy>39xu z6eyK$Z02btvUed@9}re5 z^Q{C~E$OFv@xe(PMIlTmoPo=4V{3mH=$bT|=T4FtB_#cWuj3sPR$_g*x?+KGBp)3J z{3E9+qhW8l>T`lTNYXe4!e<^sVR@9C-ssSX0Mbj3IdwRstzUBBEAY}3aMfJ$oA;Vh zZ~DXcKycirJmGjPOYYlD_BQm63P)akVdboZAx<8IWeJWQIo##2w271jAm~yRx5PjP zQf@+CTxMxt54uh5^MLIbl`-uoJfvI!Wdy)*;LS+;N)vGAVWq95yfK_uSD zd1!5hf?QikX+p`DnO3h#JK-xZJIrl$5PTsV{xbf=Nx}3>}xoQNV zMK?+rd;%65LWXHc-v^o|?B90p*L5d-{@*9&x_J#``~BCG>S;eqOvOc20zpr+hE$Ke z-wGu9TEo^Ky{Lp{VnGv)gs$NQ)wBQtz!FrDM%L*K)tzpH&1!mDl{lF~>Jqdq1#5Le z=t;Is$QCC;HX}{rwLx}jNK_{usXISWLO+|#rd+s%lE_NZGG)vzl$8<8*F{^x7S~}Z zk41S*;#PS}C_@ec910*1b}1jNeZB@bCy>z8F$ARz*>o-N+UFfWKwrG(O&6f(ZE|+k z&IrNFe$?5<=u%_a)3R)$n@kB68j)PIvXy*|q^9poFE4l{q-;mqDIH=)7~cI5%-G<` z(iGgAQnKq)GVGxZG#l=chLRI;;h5cCVhg>*au0*0jJ%;MNlS&rm1e$Ut${bxn{_a_ zoRPa#q_H%Co!8masAN@zz`4JO>u6Ymg2Qt1GVPU=u`Zv`wy~9JCsMU1s+4sAYh!b~ zbqN&oQJ!tNq>G{31ryO*f<8SuLyNeEKh%;Ro74=+XdCs^#JqdUzz0xH z#w=p&ZLyHWm|}klIHso>d7^u&4kbw|NcUG_2Yo$Hgjhpz1oj-x8)6q~SZc9CKniej z=5ihKAwuppI@oBvHrJ$0inK&>Cl6=bZWS!Vx|Mu|DH`sD3y!@t5gUuesb7&}z~<8E zoMmCR*&SBXzvS4)A3Q7SZSc<5p}n6e5e1@B6w-3(m}4;)xj%$PXmLJ+8IGyQZmCaF zbSZIa{{SF}>{Slk-^h|OiTZ~B0AW9rDG*!T{6t-AGN*C{ttsWC*(xJjp9n;`h}o_%mj7|l!jlvVVf|q&8^3QzT?URhc6RSm|{WB;%owJEugZ6tUo9v$XpiU zv2qQplaV(&oTBIB4r&pk0V09+6Y`GgVW2oX_fzr^SeAn#S+@2G9|0Y)CS-s-AV&aG30~krTcK$L z_9pxU8knsp%!WXYTRT9xDwnqqmMLs;=V^_gT%>jB+%M*1&C00XnlVJ*CWwMf$ zTU@Q`Mf#0T;|}7JRbP7$_=K8w_qheBk`s8No`xk{eo9?WGnu7 zS2X5OjfzTaZ<_r#v^N;Bc1P~rc#XVHsxrCBEG}IOO2Gv;Qb17$!r~?35Xi-krrKLn z)S+o!RvJkuP*6>lNx2(DmLV2-!a4S(xL-Td<=uQar$B+G?hi<5U-&>QG~bVQsKp5oJ_Je`*~xhKRaibL+Hw%?{S z`zkj8tqzc&tCDYG2v*j(@rYB$rH&~QuMlwotYKbNI#H(P7)n&9o;FfZVeX4uT<&kQ zF+kYK$Ybehjx=(V`b%n=lR}wR#>i5;q?57HLc@3h#r8YlPtzG4Vb!6=*O&_e3V^qG zTI6{6!Ud)y_|w)irs=NK6WnDmyMuj~!J`o=)qE;nlmluQ5tEQG0kw#Nb zGL(f8r--~}_^y8=L&I`^5tHH?n5;>&F-B!i)e|z@()rd3`m_2pW$2(t1E}kGiw2Y5 zlO;_$5S&`6JH(oNw=PNPK}~s;y3^^(r7hP|l9T~_$+gb5(^zvK;C$BU@*A4f>V;nw zxOFSbW>Qt=8B24L?j^UK%gZH0m{D==t3pSJCL6~(zk?Mh+WCmC8KhzSNmr!KsVQ|{ z)cm5#vVygzPztTCfTrFTh2{KFO?Id95e=JPG2g^;()hm(I@@JVOjA&m=5EScZ?ce5 zwA$phy;7xVcxDa7{70p@(qjsQ#b$+;Y&MkE5SLlypLZc7jECJK-7Y-g$SpG4pqYLp z@ilmbB~ZgOx+K%9&f{cDuQG||u<`+PD^SWY9&cnRSBJyLt(3h zsimhgL;y9nMQfqkq(|oWB#UfsSCAE^=8-C*%GpBQVU&-3ZJUsr+S-Dl9p)u+Bee=f zQeu4#gp?uI4rM06L?3th-Z0~Cj-$`lmT7Ym3k|Ibnk6bJ1xYQEl2T8*duwgsNpJE; z8NtJ@Dz%zOevv_ZpnlSTxC6%UscpC>CuS+GO)`}}g)$V3z}m!(j)%a4J`m;5nl~_% zscogKC@H%Ueum$L;c^m;*lt`Jr?a5?)25p(x*Su% z3l_Mx;{NdPA_lgzmMUeZ-IZ)S;zFgJaIg|i=Gln0;2(J>p%)N}u(P#M{(?biAwQHwuzC%||hb8GrinOZ4(3kd(bBYQ= zfk;Y^bSnDXctl6fVdGMnhJBf(KQ`lOWwMoBvvmV~{4L@jVPpM<=sVVlLx2YFsQ7)lW*V}-?B9C6hQ$rl#Y z-9amDSyTn}%Bve2Y+}y~s`!v6&*V0k9|y?rI+rz0rAy4IA=cl{^798&ZJR2Mg@799 zHH#d{&*(&k#taQvmaeko+`9RV%s%UZd*8ilA3`ngj2EdQ8<4Y`SS_yI1XARC z77#}sh>Yb+S-Hz-h_@t5VIsLsP}6&uK=NXSlP2z5*@m4j9kDHn24{)@79SA;k;*kD z>dIwWfp17G5&;#ZD@>_B2vvm`RaHqgQ)xd44$xsz8zl)IfI^YOMdvnANU$K@(K5!U zQdDS;(Ir%0cbvn{6}Oyso6W93e(2~T%RdhBM%`20cifMUBAlsnLKI8NldDaiI}62D z#NEx8<7*Ei(&r4tlJV-u_U9iLrX9;9|<4;KnDz##=QX^-WAciC0`` zF*PAapKUv;c@4Os=4?0WOh|_k;2lW!Q6gFWo`L>$~6 zpW(kjABMO;IaztxIjVgsc33v0mypR0Y4&wa{y@d%E+Hkee*&8(2YZn|yTd#*n!B{Q z=4a^-ll2a^kQrF`gV#+W^B)x@9a}!-eDJ30k<*v#&09l+Q7ioP1l%-cNM4_0w`+O` zlMiV|zY>2gLo(qXLnMa;>vN0AQ>C>xV`U#^%HjUHZLgV$-uDjZkKjwNwf^&1ezeMH z(-Tv2P9TzrS6^=`RCPH8i5`RqUyiEIcu$eA$7JR(;(o1D@1$x2MJrdp6o_x$quf`3 z&ZR%IVN;2nVp^`-qfnv{hb}y9KRDy!qum`?A7iNR0c+EcRTL#>?Ygn)Q3vt(CqVX z5O#GSU(U&d`{X;JUhOWzW{=o%ZfR>R`)$VRO27vGd3A+*?IU7CvOPx#Jf%vv zQEkNxr9h^{czdzQad7SnhnHd9!`v{g(Ez)3H4**|D6}&8m_DNX8Fm7t!aALG-gM$? zgbggEHUJ(1`v^Vi3#rcnU5#q*X1b+mn@c@9g!D_UB}d_5q;+v{?swhfG*kVE>UDAh z?>T=JEhG0rz4jf$-Q;wC-?q6RG5e>dR3#j7ZWJ+GnmC5cJQH43W zSZ<<++(g9Smdx{sI-sFu*^&l>!rMg$8^-H@h3w0o7lzWm5!l1hlRS8OWX#pqCrEAb z)9k6vRMYB5yp#4rM`AZ4NTrrf51n64%SzSL(GzP8P~_+mEy~f`ZMjq@Dmg#|*lDI+ z3_@>HwmVb{I8n-znV(YJw#iXB2g9$%6$t7PIZ@ZFRw+C`Ydu0`mH-+dOG-)fNg^%r zV=FRF#%1o+lzFEM5^prxZ*F4Lk@B*l!ZEId89O=>yhWx?9%82(bw{ajC-=mdt0Tzn zH^eCrG?-@Jwx8n;q%_&GjDIM-pJ@6mKgJzMOEQdiDu1SL`(yaR)d<`Zk0nO$H~q2v zW4j#O!~O7OFZyQx0JcAjcVG|vzLr1Iqx(bnzyZIPQp*0BzwHm>9XJB9)TrI$e`tRg z0M-8ZGI#wmf7&0$3knDO<4Gs_bbn}n80~?DTuYD}%rre#k^A7Ylw@y-5)0a8uY%M3 zV6(Jl{$ENT>D&I${xRD*Mn>`6ss5F}?GNJs84nQTkZfK-K1v7o$4&z05oHiA97*!b zKa6zYjB!3ytyZv+;#3Fkj({hL(rks1r(--o>Sbs=?{bBrI1K-PeME?LvkL?fR90N0W##!B*PxgoL zjtVm?7)zsf5&fb3U;vHd8Df7**#5BoFaf-rRW7Z0sQ%FYFafVOjisfNtBF6>AI1Qq zn8y$#-an;4{<43JaOtqDUn=jq^MBhP#yBX<&L@^9^sWB@XnzxD*v~HBWf-hUWywBO+U;5wzyY z2jV}BM|j6|23>IyYHmcu7EJ+zVHus?W+ z?0p@KHQHL8HDt^@%F=YYRGh=q6+jd}REqqLBS>;d^e@RO1pI-4J37@Gc!v$i;wH;e z((Sy1xLN|gFkx}Z;mG5Hkp}qT*gl<(TT}E!iD`|)YOqE8vY?R`c)g)pNQIMx>_uAl z2WI$hCekak^{Gt)3+ykJk}siB)&y8biH!MuNK)b4M=qCwC~~sxJ1)%o>2b8FK+GT| z1n!&MUKX>b)M{90!BgS=0W7&PVac@g{2PM8lE-0hZYHm$bs_fM1%PRWiDM6;MwUS8G zd|`e(UnY)tPq2=_m_m)jH&o3Tb!Wmo<)!2V4^wFDv&KByLRJ?c^lP&tty?vcAxjz5|Hy$N-J1!aa6cb!Xpvs>7^GQBx5d3(A`jO?s zS3`$T<1QYT0DE&p9=V6{iForSLdk`pdrO;cuE=?lnY9k-wXYMCvbm}#Dp0ZwmH_a84ARM3FLfbbiGb;> z2N;IzW zvma4t1nh1&fiOFXAb8tI4xHDUZ$4KE+o7}qOe&~`yR4+2Ff{qVa?Bpkr@#wt%JCb2 z7y#cyz_H9$N&RDJ1sdP|+}grx1l6hku-K?HXyO%Oy7C zqd%au2M(JosRP}zdI7K=PzpvVs&_Djf=Y*v?ttwXT9t4n>$ZE`TYts?Mx|0o`hg1? zsUp`&v4HJZb}8KE!d0BC9aN)#gaJl3q*E-QwJ4A}Cx1u|QJvTQy+AFOIcXYLSlso1 z>vn6n;6chlg|^M1vDiEJ0^orF3Hpsmwj3x@N$|7+TQmzs;eFsY zw@B!bLoZN$%`SjHbZ}Z`N_%bvm1&mO9d7~DYs_S6d6%M;eoz5~OLECxa(oN`V&?>1 zL|;wdIB!!>iO^P*5(kL101FeSlTwnDDFpdx0n~U@K^@?w0(uMW0oyjD+f$dwN)WD# z{oW7)HRmb*%0fxHNZn8!YK^uQ(_l2(^PeIOqkseQB3Nh4Qhbf0plK>hO<1z^m)A12 zFdQD^nahKsioRfaW0n5FMkJFHc;nnTbl0IujkUl}7vXZQoEmEu?Tz zK`x1%8ctm`QbmLS0F_+0B}!U==$Pe&8tguxtEHC*n!o}&2W9unwTf(S@Qw;JlF@XP zC?sFNg8{=UGYz&f6@W*Hv?bQ8jfg2S7gx0%#{#E);dQ{(ZEYDRTrEP5QC-mCKbqTtn3PEpCL;q zBzZ?HUXwK3x>@feSdFYBfkvycOPokaQdCdc7tndZVODI)(%Wq1)POqp$80p2otE}R zWX8Sb486kSRd*6SA78*>cl5MLJfCaVFSS;-c zo^qxZrKagk_aC}CHg*_kGYQNJ^!wd?AhAJPm`l2HiRo|wOa~3YCY1Nu?yJM0j##QT zT%1;2ln;m(5Fj}3l~^ju1FiNjp)BV=ksv6Pm7S6XzX2T(!p&1wY^4B<-436G7IDPa zMFmH@X7Z8XZ}~@T=7R$md8vDakX3!kps>?M)Q%VjFiO&IuXqD*j20SArdj$hsVQtY zM&$!<_Qwvbjdz`C`v+3Aply{PF8+6pg9W@chk~3dIeyK8N%-7BXEdBu$UjO2Y`nV@ zs7;5=2rT7M)KvL>2?1+T{?R%l`alLMl)IBl8Je&n*}7ZI$51qK4GwLy^)9C`fl<;s zVsx|r(YU8wsHk@zPsIW z;{FGyh|xjtF7!dqL8Da7BV zauQEdZ8V84KY@HkFMp9GA9*C$5oG!P7KFBNGit~zEPCq-PL4B)TAvKPD3Ul%SKf)$p{wMPMhULrDtUfXDeOy7r6=z$Taiy83QV;;j zNik>JrKv`EzvK z3oQg$ZKx4zC|qk2*2GrHoq?*X&}*`u%55P&5iu%0>Q-)B*IS`sNV&E5h2&PgL)ayz zNVX-o6zrRxJjDM1Z6EB6PZa}q!q2C`>CElv6zvwNi%KH1NhJBJ^N6w)*W`vj966q? zBA*iP;F#hhE>Gl0xdmonqy8;Fly!0-%Vz#3Dt8OHQ-9hUaHQo4woKc3-W>3CZ~72& zaVi^E)XLTtnFht-{{S?P@r5oO_xcf^7Q1~;sxa%Vd(Vs5n{w@NH|rdD8te2G9wk1X zQ4NYvCw+~T{*B3$<{mjgP#-Z2GJG9hz+c-_3pfZ62{Hp{S0Mo23j^1VoH01NKyd2F zQ3Xi}P*Sd;djaPX@!-^o+`LAYMs?u~yOsVB@4Ae8;8kI9E-s?4!}!M^4PDNzF8dsZ zq+BQJl2o4(K>hI@;w8s1ljwQ8xw&G;^^*zkpJ9GF@ANP^B{3#5IN3@^TZ8#WC60y1 zDv&L%@XOeJJ2a~cvwuIx!!s6!D~mW`+JvNwlFB^xTT{)X8)nLY6rYMoh2Wl_njvv2 z)AC|#h7=kl5{j2gsg{~;3w7t(x=IpF)RHzf+WVNi#U&#*l~En=_9em`UXhxT#ICAl zQbKv8Ffmc!^v2 z8V(*bzGG)n!sui$(w3FWy)f8I$?mAKtAm+8Wk|ieO|KA?zanEppNXhnNy@z}`hB8J zrw}F97nMuOkW$)>@88%fbix#?kR)tKE}v0t54_P*1Afsc;)%V=Y-QXYDNwd!xfg?x z!H>i|7&yA7DwS24Ni;B=_C5DiZAF2)LQh_>^m6D`*2GF0nC)=$4a?LeQYee|R~TBu zOGjl>m(pX#Q zE(D|?tPqkl>8P=S-!8`)8`!6zh62<9E-h+OPlAa*j5%VBX{3=9vmqU&y$vjau`;H`7xKyH^nU%f1Ch^n)I*>q@Os^~^V*`=BShjJ{+8 zczyG+q;Mw?r&5;_aOQO7BXpbhRp(=9ekf{8np0Fp`2PTe7_2ZuRSIxgW(N0DdM#j^ z3z4ZvxIH6|Iz%abNO4P>6Hc(TlXR=Q@ivEa>?2VpWU3OXeU5Sw?Gno>VQ1{CVlwTo zQxIv7Y%aJ(U6!fTTxOu4+v{;|C=}czsGO?PMI@gOLLoUJUk>1;b~u(L=~ZPaQeh}* z#?YChgm-zTM#u-OW4146lCjbT0x@UFuj-KA~!lJoelF0A`oO(C{np zB1W^{LjM3-GjDRy80c+s!+#f)4PS7iUsLEdYQwjss@Q)S+x8ULpq? zIHhM2VQ76>Z{9ju(3QBfWkoGb=oO?XAk|^bEk+a;bEMXzIP9rLh)ZND`uDGWB1|#g z%xY7jE91^I&0xCR%O2Pg!zu|fidM^d+_)8jXZr5`?n}}*${)6R2 z?F&C$mP3rlsp((=N|Ll2fz%|VEAYHecok5T`kOL*Y(^-UZb(SXCC62iW^XD%^HE3w zAaOhlXA)j4jx6c%6Nz*l5HuXB%_R%_EeokiJqL6fdhHqfUd@!bE26?&LPRR!Cu(~B zD{V-iqF!EK$@bRkiSoL8pNSD~huN@?@!RsMOZOR;cKKJS5a*_)t1qeQ#Uf=TTB-C* zEz{<0q4`C+i;Aepd@6|UN>A}c`i}<>upJ_#w5ow#T)WoT`AILo zfc`YO#lOFaCGcJap2v8iQkgvS6Ec#SXCExI8`UPrN{BZ%I_PcX5aiTW+}__I`AMaH z7v@gvUot9BPxi>2K>`CEaqCDDfvau~tq)Jxh9+P}9 z+ixJDSyZJFeTX`04x?>EM~hMHy-9Y{z1@5e(d$7Ire`;hchK7R&Y4V zC0TKjK~Py&m54S5(aWv7i&nYWfw|wJ9y17?VG2?*5F5Hk@F@3BuJDxl1CFIs{Y|PQ z^t)kMr{$S$=D{@V+wZ9HhdJ|qL7Bs}TmJw`j*Vu!PQnO8+Nv^XXj~UpAfPOI3j^^R z#NHihe}&)3t>QU;B-i>w_d=XzN?n<@6q3cf>VW@ zOvHqvt^$Q6MK3G5NVURLtzl~*XtJtgyBODT&LDbjV6IkGZk6XG6@g~-iLi$36tud#uha!;6_1N;x7?bzbhaLfg*re4kkrG305bK)5kSQG(3i6 zWalT}NEy=0>uCw`x|D2Bkh~%iNK=dZqg|=#g=NV{pGg+DGe}p?>V(?w`HH9Zg^hMv zW~hd;NX##)(j7}=Y3|`V-IFb^XkbA{DokqIYbb@oZrMAHsQ+{K?!OkH2BW}p1q@F-` z>Qtu62?tYajjw&-65Gh@+<)D!wv?V_OqAPDKiDBj`HZ#XMm%N1`~!=o3g=3e@h39W zsf|hVy}nvSo-FdlwtEnAVb{$GW_vVn_Gi2ZP5%I0@AaYO#>>CZW$>%8pqK2offhTC z{6mia0Idr5*?0PXAs+0zeN7qO%Gf|#B;wF6G|uT3{?sjT@46H2zDG@6ld!7O^>d0J z@|EB9;cJicUV?qs$iR-tSa}EjL!7sVG2iv0pV}V)_d^8NWt=n~Lt=Hrq=HH2I(6th z=vVfG@)Pc-0<+n2iBC}E&A8w{<6TesP=9EAKK?=OrsTh6S}fB!*FNhiBT>z9R{sDh z5A6r!9_nw&c1ocXi`89MpD|9My)1&vtef{};{EmCF^Ec%?GvOI|fW*w=(&CeJpgi%o@y(jw z2wLO52v545H#;WbLc5}U#E%YZhy6HTzWJk`?c~i0{{UrNJ1Wk0s&63XNX!=Et#jd; z4}SOp;f#|#kf>8hAMvZ!w^tSZv>yKe=7Zh5gruKjiUOZoVyOD^k)~${8hl;w8rGDi?AGAIKz0}wL0FyhXgP7Hy z%0F3O>qkGdJ_mi&91q#LhSDAO%A@lN&T@dIx0N^3Wom8X1NMdTqn_(WN$$&(SIHu! zF=MdiD^D+bSV#7Q@)z!?P5%JNvQn9vN)29MqS~V8^UZkg_Jgj0?x%bj!l5He>}@K9Hdj@B zN?JiBB-kFmY6tBe$QKB8WxE~9I-`=R{ejoLZ_QADXuilj(C)k0Dw81DQtA^q`YV`! zEYZ*H7vy){QNJbGm6=;ETC+0Oo@@SQ1?>mbAooz1zkm(BFQsm4op2JOa{y0>2Hz7L z{?L7q-*pqxy_RPXl$7EZlYRS%SNc%D?FHF-ocB?Dj?8i{qz7u#OE%Qz%YT4WBj5f9 zec0F?k|;A{>nCPc>hg!=xIOm!9rtmP#+{6C?P2xG%T!%%VF?N;Qk+(YZA$G7OO9#u zq1D4$IQV<8g%(M&W~vUY&Y4Pp1N(5?y`cIeIJiO4!<~^Sw2L__QJiUGRH-XaApZbr z8cLl@K$u*~VO1akNXP{wWS6D{TQeh`y>htbGR2JBQ+; zzl)h4FAm=!SN-QD7WpG_GUQOwh2O4YzkdvynCriUJ&#Bn8hPD$NNuF|UQTF6(PD!muIZ0qF z3vXgZm+_8AKK=Z;9e6ye%xrj5g{j!KhJ;lnW+ooF4u=BBHa*e?g55`iIh%;k_S@_qcxIJcNTemHhF+MKQToNM*->qYNf$o|;>kyJdr76Tg7i?jK>yn1xaqTBT8CBM<^~S2_FlBPr@!DiWy4IgB(DwQ%Y4g zPg9K*1gS_;K~4JQwahF3QV6|{;sCJCB)D?)I>2z$UDil|;gh<7V0M5E z3!6$T6hQb#Le7dTl;1LLb}_&?uFNTB$#i@Z02{K%Eh93{VtV;N2508b5(b0F2oBkx zR)ILlp8m+aMcZpKHH-HVPsUtRlbN~bgS~c2I zO|;vj2MvO<@X9T3NC4DJfwAt~`o};wwUq3TF9FLoi>hZ^+BhiHGw8Q`k3#^PHBCXi zg@EzD?v90R+oSg)tGI!laj!Q;Io4*AuRDHI)EAxb726Q3|o?z zSZxHX_0-r$PHX~YT5m8dgJoz*@Y*!cVoWy`Wa2+|1R2x!&Z(r4bOJ*mC9_T1njo~z?8#|0*9Ow$|0?#HxsY%VbC#(TRyYC|Qa49~2@IY|ME)#NsZ`2qLncG`a2O<^~ zZNTXO8Jv^*q+S3xt;*+ct@~XY9+vUbtaM4Z^5viR78I`yV~1|eYbZ*!R%752KYRxf zw3IclQ4zOJ&{7z{GbwL6x5O70on#%Jd%jbr`>?z zpz5x$RpYb(Y`rLDt;$j5opO&KUEm5gn^0*PUD0RfXbzmtTZg7#HoO33k!#q=TD4lX zJpk|!9R{T^Nbg-r8x5d1+0Bw^V(wUH`!|3M_I;^(l0ISpFp0-gbgi_hT@Cj5Ko%Zd z$D28dQULoz{^;X6Z0B74h*E4k1apuZp3tCqYRhje;1qISdDavYl!V{jjvPBO(@SpI ztfBHE0Z89k&;`VBP*z+DO_c%A>Y5FU0UQA7b4#e}1syRzE}5j+TEGTopwbHp1L))pfQ}u~8`v8=q(B->>18cw1)vp2ibMbur6+g}0J(I!EI_mX)tU{- zdpgMkl%KQV9TP@$tsvW5#|{`Km`kJ_#UywL04keO(`@%11uz^8nN%zUs`ouck=qJ6 zkJH?g{Tj0m4Wp>#2a{z}7b+P@+5@LemwBSZjKidG=qYftN@beG>x$Mep_f>Fu5oiF;wJjadYuizKKn4kC7Q2FTA2KXIj0XceN`^y| z=KvftB=I&#PnF}MDBG8(Jit1DuMUtMqX3X_D5#?6$HF>tgNcIQys$j7m`T&lNVzj- z60wteTX^l9qZ5>-CzqIAE`95f1%+9%%?sGhaJ#R?TE}cOgiFpLR&hZ>-(+=w;m@5y zXY_dlfwKM5BcfjB^4k*N5~6g|yP^1q4xH&Xo~NxrD^^7tfKz=>hgj*wvADDqE1fgm zNZ1i?z(59CgzGach1wvhV^wszc3WGdSCl5{^9>&1M-SU*Ok zrjp1=4J9EdLUc$-*a6|?2zdH*JE-R;3&||pvY1DM9>Vp$=KB;`X;0C%k?;_giamua zjdeP$_cqcRmL9{=%iL}_uP)!w=}O7an$wkh#W>OD)#1y*fQJsGB-}t z6)5Y0V=G|yPS+>H#_?MvMD)#>n$VY(Y_yW6R8Mq%K5@VU3DDnZ*C(dCsmMvbgbu$8 zX&p%9q_TDE8zb?Cf@(ep;a86H@DK*4=FiLx>=y zV&3p0aC~8zDrZ+AQ2zk)bT&?fNx2<&j@=14Q&PaR>&`Zp%21^x7R{KX5(lrOE+Sd0 zBU$==l$me?9JFL0>6ndEeRM{-x`Sa3a~l=dL^U=-H37G7kZoe5>6+ez`Pw97N&1b* zcCfQb69vP2Eu@QirE1sYVrCV;%k>+4zWWt~-Y|Cx@j|ysnLo^`b1t~bj?KP?#q}fr z6b8L+1ZuE7zHEyqy7?h9hj`ld4x~9um6KbO;WI2IVQWBWCB-W$lC0rY7x2<7A~fM+ zPlLJij0-=9r&TJs#k(~$+f6zgTZvFXUD6K2DTz=Sk{Y^yW2Rf36E5>!k#b!x^4ae= zjLFUJ<SXKPgGLiVkQ;UUK^ER9mtzVGjO=t{f8ZXlpIDc6N{{XG|n25)Ek^6`a zmMe7NHYMTyL?v<_B;_+%W`E?Ge<OxN%^YH9)P*G9Cg=aN}f{GN|vkcvUMlcCcJB6tHpiCZ7B`St+BA? zfIJ37#9Yy@sbRxSzo+IhRocUILR6yv098;!M&jMJ3=@%r5CRXa#%vF@3-wW2|Hq`1wN6M9xaY>H%4dp_bJVI8KrKCD+g*r{O*b9ChF;SZvU(C40oj>Gh zRwa)x%Yqa#pRCLRb8JSw5nVoY^(IDEujnW71|D5q5*(N1+j3FFsY+V+MpBg}HopFP zS`w$Hs`VL~yV>vLGh9gFY|bUBQ{G~3nB6_4IA>*6f8-%5PEea=DNyU)_fDf&wBh)L z6}?|aWhQ((_4FD{G1(?t4Ofv?m70)Dp$aa_Equh^T%`jb11OFO(zev4xU!_?a_75a)N8j(L|n3Lb`c~iZ%EVD=?}Aa z7Nw|jQG1^&!ve&nGRKmPN_#7F3=60geQE))>F+|Ijx<2I40^^6#4>f2%rY2}acNQ% zv6)=Zph^HXHU~p+FBdrWM0Tu=Rhs<1Bdg6$Da5*`omzpoB!YA%CRmy~b2uqDi8<2r zq`F47dE_BP`3+#zL8i|1)+(t}#ITZ|r$~uaXFzIWDwMJI)dd>Gu+kjNqNQc9Ndmx~4gBGz_B$9d<8l5I zoW)HohGgav6q1D;nR~a>E&MuOBDP74OH#Y~RdWrg*6ZLY#>mxGLv(6_rD|ct%1i>} zgy?xnXsCOLc}wn(y5Jprq13Hf=hY3}I%CG(HGd6MCl@OzG?Yvs3kF@H2wD(1szE)? zZJ`>QUJ#Y_7szBW9x|22X?9(<91b`MT*Tt@JgffzgCN)u=h7Zgad-I*w|fo`4lzwO zVvOw`zS7pRgtFR@l&IJe60w-*MZg3OkV|K160~bQG^{?@ro3HT+bV0JFC% zDCK5~>eLQidKQu3f!!K(CsTMXm<=K;PV<~RmlPD@kl9GOG&Ta;=001*jUp`UP!!EQ z4@y=M?CE_)#@t#;RFxeFUT?AKs4>^R@#rVwH`RC1!^a(F>Rx|wE3$za5T?nu&Lzco zglRnk$=OdBKSQb-LyvOhsteDRNw_Pq3Pz*^=D60x=@J^UJ&9~fgI&S3hw0Y=Y&u+F zM07t`fT3#<)4+%tJ7TzE6yutDDhWzknM~Rg`)C#cSIVLiFJO21!#Z@j@)dT4V^zw6 zT~p1=ORa_`me9(R?F&ME`yGl+`X6`=A-@fJuaVtMQ~Ntrxi{t0%~BtjVfNHT-b2V$ zi*Mghk_jm~>Nkd8;eR1~$r7erl68S`$$WBMNx!@jpa|*EL@E|Md^DI3Fc5PUsWwtb z?kJ+;PcjCF#tBLk>|` zGSuZHh8ige%A1?_Q=qxmNWk&?&EG#g%iKzm{RI@9>vZ;BapPv$ZB8ioB><9sLMmY! zBuUZM!&6OH8){-)g);kTaSHKDg~9npbZ^uPMG$;C$nn7}tu8 zpKD5UXh}`B7v4LehmMh?-CRu^nHQkBB|YDqapQjzvCf~6ag3-6>=@mZQpzMCOh6r`fLE!eGSmX&ZBxjN*QB zhsfrs)yHO^<|Ty^ZBoA5M}B2VH%i%>QBWhrNgrp-8;EN967Qq0ia3)~RWz&@*{6a= zT*)g@w}HP;C`}|OCEc2c-X7L>g)$#7hu z422*c6x?a+2~0!2%hcmhF*M7Lt%jX`VpTTC^GL}s+3>%*M?y4*9>OILhr#j?_@;$U z#q)`rtfIL#nQ$z^olmo?DYz`N>X=ng$#nluE70SFvB+rl)4OV~S}r6nEW}6SIsp zFxzU%+S1~HQ79T_J~2NG6q8S)wcL%8Z8X<%bMZdEKZL1jen27DlD5-lZ)+()6Wy`B zqQ6a(V$P$?O(+GYASy^UB->Ha8F6FDp*E>{n=2~H($ahhymFYUMrxGo%PcJNZo6nR z4gFx;HaI*um3omTO3;)#wW&)3UC)T#J5+W~#br@72b1*y1f8>}f%r#hu{Mq+HcGO} z?z1m%49dUaBfFe*DV?cJ$`FSGWUFqlQO%4`Dcg6#b?6`fB$Sy!X3~`U3rA?>jq4O? z*=eb#@*%+cnTLN+0I(ZETx?#XDkS}}y;RygGyedx6HF}zer{#JKx`-D32B{2FgY;7 zeZ*QDX`yP2(oW4OU!g_3ZXuZ=YL2V2&&&%HCdY7L6vgaEs$D8&tW8j-JuKR!otJI) z`?m>L?wbo(U&~i3!_?cpCM2d_I(cEfp3f!2NC%yT)D`m0Jnk!CehkwN=#Bl%sKx6G~=nD+)%sh zjiWMH)AmLFP^NIwm!!%}-NMR6_Rs?zOydmYCRxqf)4~foM=oOx%DzS08~H(Cb{nP2 zHk_f9d{QAwR3)R0RFr9u0woK#`-x7TvCFfmP@YB#m7Q~({I*kJV4y!MTJUa;*rIC= zN=qk3fCI=6-5o~+{Js#BsXkp=0SV9z?E*R~T*IQukaar79C0->W{{WP6?sWuB7E!&W)AA5lQKdbHAH%7UXw#jE8cMqsHhJRAr32`r0905c&cJfMKV&2tScZ-Fak&&NF%Ip60;T*;wgP*miqTd@RyH}&y^?k3U~ zjWD(VNI*y%3tBjn63!KNp)n_rC7kIh0YnSfM|VLgz#f`y&tTsm{4Pp75JDBp?%%u`m1&Q_2u+Csm%BsmisL45;Qh8^>toqhW=*^70n~5(UbL{5@lbY!@b#Vicq(1ECrd09mb^ zTomd-zmx|o*md_Njg$Z$N`URzl`>5>JF2-h+=FNWg3QXfAOS`|JV3elm;lC^*Vd90 zl#|fvK5@{tYB%i;s?MYobhYjv1!s0^mJpW1N?Eq5PUF@%DA8PrNEQmetOqE-+E$@^ zk*&9Y;yQ0gOQ?+HNA`ArS0gmU%34L4Zpj;yqyc7|%PUTz&;^7mZJ<@9x{ny>S)NvD zGbqZ^kcDnQu(0??DC%}`rK&B>6&n+j+T*E?iA>vLzO2bsUs&K7-k4LwWh5wRan=L2 z8EvV(9eAYu+}1xR0K{BEbPlOrS+4+DwIq}%l_U~;cQ73|uF9pSIg9698;g<$r=$lg z={hE5{HwO^gQ_mYF1_t#97R zPKog_0y=Vzs(n^cz)0~nFdegB+11TbnOW@)6WDN;f85z0Gg&oZ`B zGbw2vcMu)3K{Y0xIa2C=8pkL#8C;qTkJ2aNV4$$fIH$&B`@S*CI*dNv5)G71x^?(R zXe`er;-zy~U3rrf#jxPX0Qv?o!Oijz<5w4aO= z7H*Q2>_^T6rkdG8&R%Vm;1zGeI&jF$fJeM@A2WF2(>i5>O~t+t0igVlm^R5^cU6V{ zaHEDaOD0aq8iV7!0A+qusDgm2j}4#$Aq!aVC-8s*83epL$w$Cz08z?noYnNqgXOdW zXxve{Y6F94HjU6l=14d6P1 zl4X)j$@4G)sgs*!6)X+=x?VaY%(-5Ad!=UG6mJEA%4S#EiAn(lKiMR7Frg;;Z!x2b z315L0`9KFf$!8LxGkkXzfZ^mJ+4LK_KpI?)K5!f}N>OE{JIQfsbE<-_Ob1dkPRt;- zTRH4>x`Y8|8di_&BrUSNdM9WOQQloGwVci*B}8ke2jc*<|I@o1s5%&>*ibx{em+s! zM=Z$VLPncF&>Cu*N;Fg;>4Tozp6|vHu%n)-ptEf)5!slp z3PW+lW=d&^P4E2Woqi@Dacl7W(Km+Y@?#1@M9LDr`5-F9eUL(bGZf7hiJG-{T983n z$VJp_dYf(qyni_5P_ANPjY+IOCOy7&WWMMDkd%a>jMuRvQc6a;f-eh_IGFZQY6z$= zDnKb^f>e?;%#~d~hsrx0{XbE;ZR&Cw&h)|^2fv!?JxK5;!V;F}Z(%3KTqL|rN(U8I?H5Ls_1@8wOc za&8sl4GLld15KvXv+u2d&|2_Y%czF@Z~4X+pcf-9g-i4NuM=hTfx6+`Iyil)baY4kA7T$>&(nhuy?*Y0=i`*`~Stc>KuYnC7!n};(-42LR zDp3tMeZ`%7&AYY!!8*kCkZ-~g%*oB+`Ls>b)}~%6QWBf&;2&8mvU)6Pl^qDuB*!5h zSibzpGRJCal?$=4 z@VL`cyjJm$y~}-~v6N?oN{KjPE*M`DP1I{ZlO#$GW_@b;+VY_ZOl6lbOvYXv1~Pzg6FI(ck- zBSC@*qZ7tU@qEW;g*9G%BM-jm?>#G+lj5Khb|1ne)fGdaiL^~mEVe-xbYILNF$*{D zT5!Lx#bQcoWRosadoH5WgnqKF56&oNseH|bDO>*lM0pacm`WDGCi_B?u?^6+rQ!K{ zyD4?26fdFcWeo_i@G)nP1Z1qG$;8SojILmpZ`_y`@GbuU0}gw)pU`jLA8)Cs?i8DB zXj@d1%xp>D${aGF9$*v8Yo(<4bn4M zo7(YZ;v%aiF*xEJd1*snCGC>6kTe9F0(a{Gk!>q9inB>! z^=Ci;0e^Pe5p9U*cZivBsV&Fxsj`zxLq+#lbwDknmgOj3Qt&6 zQah76l^j7@#KA1oaE&rykZ+N52vv=@8Jf_;swzCcFXkfbX=W+np6jyc;pH7t>La_( zXH^cjEndgNq&=&xh|}a5`rNk<>C+R>;0j|>Y-L-yA8AD)L?o)kqHU9jX2m()^%J2l=9*VzFS z`N~|IAYCjbiz1|h_K3`#&sc3w<_-sY3SgS;HH@y!ODPrW3XQmJ4>;YnS zQ-Jexw{zQOiV3obm|58MC3h#M;T)k>c58i~W#5!iQ7&fIf)$I*3C} z3Q`s?@JkMsrPSnvut;wxN}5Wu6RFL8$niSFJhr-$@wCQYiI`emij>O8G=@;ajIFlN z0#ci(DA)@DeRhoYcT)T6UEtjtbt?N+sRtQVrQLX?E(6|4ZAZRPq4$8XwxS`~CXIPI zawsi?ODu#oS^>6h)d%&evvssdEZEJ6P#}u0Qood0S(;vXp zx89g_Zp$f6y)KkEr705XP1b~|N+&>apS^3sr1iBzQlXfbW|@kol_`hTiGWqiM>H1H zl$6~_?|a!z&)zR(xh_PzfY|{=lBHj3*kwD%9D00C#o66zxh;e7DuXSNFEt>Q zG&2%2kPiFUkz>#pD&u~CpkDMTC=_8qm2tNaIqu0i+odDjQts+Ph|rw~^A?7zU+y#b zZlx^DoAPghq`d2HAyy;{B&31{+vs7*3P?1>=%YzEM#?;}pezVUHty^{bO~D&#;&(q zmXMW}bhc&R4wUoKvu6#)TcCTYPv0BFs71+)%2X&Tn7JD3i+O1hp%%J~N!X5VoZBu1GPNb<&C_dw zJPKA0ht4Junc0_~dTL>F4!E}+A8BeUReK;(q$YyAa$@Ne->U28k z9cs=Gs-%@ooJ^`_1FklOI2-GCQ+&x+Tj)qS-WXzs&W9k~NI3*6fK#0l)jkoHn)%}&T5x`c;GQh?shAP}GrkpV#U1|v1O(a*rC_GwvUq<5B_ z+n(}>%tpHteF*9yvy5J2s%))lhVv7s=F6_x!jqd!*UVA&vhGv4w~TUA(;u4r`HIIK zQ~417n?`#Ks%3!tp2YKMD3qO9s7lK!_HE|*`POBh(JBcb%N@nFhVyYRC2o~XAo0n-IskcGH=Ve-#MEq!AT&Tpx)pe zqPjdZvF^97zsOYPoi0zX)=_xZh4_4F^ieyRZ8qG!)`cYKkdc^W-2M?VJRGuqKUc9^ zmnx6p3opf51_Ymaj3)x-rd?aPR+5_?3Q$dshoQdEzjSg<^ed;ENXpcB<2ffbziF3S zFS|5ZX|`S@^3Vol9V|$_z#5%|NL(6gXVTxqfb+W-KG!`~siohgl+7J7;3d4ddG4!Q zsb{{Q0z6?J98_s7@1Fd=0=!20>`1vOcAb}LZN1(J0l*b-PmRo0&xXDFml(L3LaJ8{ zrhPX;+yw2Y))crQ{{VV1OyLtM3YJ_~h`M1>;C??qmlQLV_YkSlcFGa~Cdw8aEn+?q zvfweOMI$%GX4NYVH8Q%Ze5agK&2??-JdfIAH$tYorC#b1 z>1lfSExQnW#jOfyrLi*>eO%5&-(!q8$`*{5_J~KJ=q~ z6UaN1{9bUv)YsgkHsklEA(c5S;#AwEwIyJsNhN9o9S9)Y5JX9f_jfzP7~@0Mu*NETok)~P>*|p@9NIQ7l;z`EhV&1 z)JPuh^GuuhlZI+YE*QV58hLA~_)#UKjKg%PcO{ui&n2W3v{n!l zK-)P44_igf7+OYSJnB#4AzkAtsS_wQ+H>+rNFY22eH!npV30h>ixr7Vd@I+^)L6jBHYPI0}!)+J%a_kAd0a^$?rB;u9kDNdvxc}?5QpVc+BdP}+jMDYgPJ&wo zz}n}=JEo3Vo7*!-PFaYoZUDcJSSaP5O0TpOcEc$F-*{d-rp{djVNI_FjWjCk_c$p%)SpNWfp-!tmdW^m29_3c*8Iz7RtX+T7lT7P zsN0n)d|aTX$iSj;$k|-FfYLkRvzpBbC)E0ia+IGN?;TJFBc!=?E5yRw7?m&_V>@Lw zAiL8RrGIl%OVX*sCZ zc;*{N98TG-o5~YMY|0Omc8*z@F4_$ts2*f?d08XJ}5#`>hY{rWK)y z)Qx&X+RM&aySbXm)C(UCG=eDWVx8w+T1rbG+*?(McS{=7Cn(fuiWCSm5X2C+l z^ximd%H*>z4(avM01VWlEHj$l)S`=E~q0Ns^&#H#LJDCkTFQwvae$-}t` z8vtN9*~V17!jw5_7VDVa{{T4XlVJ0thO+2z-+QM>4w%%JX1mz}Puwfs**3Ef&lmrrt!6QqR6##tAaWgo^@{ z3zM~k6n5J&B5|3+l%-$|?R`(I6c=X8F9w0KQqUt#r23c+rg}ky%cO+cQ+tTxI*iTA z=S`No8}DcWjiR4oP1388_N^Qh$k3SPOq|QHC#~bOCGG+wTnDGl1GH>SO)iRyrFkxO z()z~{-bSO#a(kAgEUcR-CIgmtkF`{Lhu1EETh=%$n4O(Tmr+8JtBuBDKPXU^V0pJ& zMcTL~+GZp1fgCrb%kMOlsUTafZQy52sh4#+*na5Y(+l!$IB#os+e^R(^Yf}m{Sav* z%o1QbW}9`1X-mI0y8-T|#M{qE?FEVU@vN(>x*RLk_9##un?XW#9cf%ZiG`f02)}^P z`oTi18JenQUGAu%Kw7{MK5$XXHl^yzmL!E=$m<0LppDdm$trLst%5=Q(aJlh-Itn7 z(7Im$^t)mMsozjTiE8D?GanczE{#dLk}FEGm1HAi4b*&0bmiDo%*)D=WF;fRLQE7E zcPA>XO*BeUn~P~{K}T%h`)ciAmeLP^);mWm*KNdt28Ug|W0VI6+HI{bRIoJ2_9i&vc;;0-^6H5qRKP*h*4_i`X5=@bZA^r#p8N3QfV>TldFN z#$#J9Bw4EuH~`*}nwVuIJag<4FMIh~IYN`8eqD!xuJdIHJ{CWeaO!3W$#t--$+1cC zAGpAAn4WRg5=kk@dK3ugSbAe>DJ3o`2pj373=ynqDx6V57F|1Pm?$+ESeE3dlI@hA zuo1cS5F9%);Z+mhWSme>uBNB=;BseQ`t)>QV=!N@8=y7 z*~Ue9x{}J5a5`JV&d^cII?`1_(B+e2c1lri#0_8+nXNN7$t10!ufY8GfaRNI&u9ro zTcqn^tk(5_?TUE{VQHl*TqegwXaUoE7)as@*hxS_(iA-Z05}eu=iT;Y@}<|6Cw!_T zU()bV%j_$pBvjjD>h7yFfhrBB z?B94O6E^A-b1oz;EfgU2xWD@&iYHv#F-fg*fT=*KCva9lj?gJlnYUV>Ne#4=_}tz( zM{dqU%aam|OGpU0>97OF@!AsEwAE5(NqJw$1+=xlI4J6s8^1`jSDfTh{Kyf?6{y*A zVQzx1=fOac1s$lBu3Oi>5 z5l+8K%Ceg^vXq@|>Nk$0CQgjB$!FdLN^;U1)RFgUFl>8P*ZDw zQJUvp10AD{h7~VrNaiH!Hva&E3JW*csRs^L(pI27-K;(_$~$3=RmRCl$`6Ick=hG5 zE3CMc6o(SnJE$l4M`%r+Zf(SprKv8a+AIBr05+$ea!Itioj{T9goD3G4l`K~yE@og ztL~4o03SPAIsi7eRFdm@1o#^m4j3D)H!-4#%&!xDUn0Ki&7=a3q!Et6EL6~ z1!G?FPJ`A98F4i8@`)QkVrUO&*FX=Pa?a7L!A+04+^^_=m(RUo=bM_J1Zr+*dO9wWTR0-p<18 zE<2)WA$Rhz*UBqYe^1P@zrT>;Ny+^tg;W&MR1oe)2~E@jjg+x{fjbenjwn{)tD)QW zF*h*VYSAewzlVf(O|dsd%*>&uvZom(E}_t%K)#6`;Cza2an=nK8m#EbRE<%R;*#1= zLX@c_{0u9fZ^-8%A&VU}i5I5;DO+e(OvHd!l;r?0Hz65+!nx;aK zw57M(QAS03fU90w{AJ!6u&uL1g|Mz-GNVOHgD66koD_sB-%v-q%Krf6;l0>BQ)qQa zZb(JW%JP$S=2}z&l%)I4Av-+Z`1a0^4_J9ImZ)wq6p$q6DYC3or2C;q-F+XZt(@>N zCM=6INuC8_CvXhBok7KBmUY)8=Lo;msd~1h8-bBSRFn3EIVGta$1NKq5l9l#WO8Bk)w-h<<;qjsF-u{X;4Ry^ZkiSATr9c z{{SS@`A1O?CtrxeaZ;V_6?ZK#^L)x9$x<70Dt+x0YkR`x#xJlvzD6&LR{mp)faK7M zP9H*o_XBC59>dUT^wbIMCcGD@CR?hd61+R+O!XTuE-5hqbg zkVMMDidmXrL?mWbi|9I^D5i10Q&9<1`7zFt#EjJ#l}ka!(=g?aF$D_T>Ot2oop;g~ z7~iPGr&j!h79gTKKtX%-h)$;39sEBic389w$B5VQ8@w2r_7ks9Ot=|xhcr^+5*<9| z))E4UY=Dq1Ec{P__l9c+^#xhgTz4k|4EfDg}ORrK!D9R&c zi70Ydnw(_)ptPr!6LgHO=4Dydg!Rk)c%`FW~nW>t36#j{2&@%)$Z`@4AQOP?wr-+VFrpHCu z_V}Sja&nT=TB*wCN~M$nRF_-PY&a8gFJcqtW3+cgh}A=9hB0z@p0*ePXj4coF6PQ_ zQk6951dyOX1t(1*w~J7}6G-qgM3rh`xA{meG?IibD7ry6Ha#I;3S9=?R?a3osJkH4 z%)=ll#@M<-fgqlj199UHD2z%&1BF#rt517XNm7clSsD`QSSh)=&7Y;T(m3HmdaQU0 zEzF@oX&Jf`39Ab+Nzf(qaRa3K9HgROS-2`7>j|M&C3wk) z(>;ajOsJ3*BI?Du7RGV#xYx=Sk=r|XGEJOmN2k;q7U#*Z=Ay?|)4uRHicC?<(?vD6 zNz|xVd1-AUsx)vsy|SQqBnVI&Dp*NKCt?f$B=Hv|$CC58a-wkn68wi51n#H+uUnOU6Vs%1L~2ImSB_X?4W%Mxttozi4xSRiVj7vo#}; zN+4>ol&f>_h7@eY#RLZFm;Lcw$f+bBtGDj~80u5z94@{G3{lAEt1 zLBigXJ{+Y1FdTgd%&e(W5-!@*LAroD5;s=;V!Fx9btbUvt7JUl+$mdWVJS)XlbY!Y z7S&1UdI;c~Jvk(*Zz+TqQXeaA3nuDH$hu0e(?UHXlmjs%Pky3iBwZ|`VCPGc>&%w& zs@Y#-TbtU-J~~6ZfrvV*H0eoZshpX|Whv<&&Ke;oDk>={1zIfJkP6)@5WZNLc)sDKI-cL44Tbv;`Mst8D8R+hD5_%}+gn(Ek7-@Va#RtuZR3l_d{2p_Of?M5gCe9=;LP zElQ5*Fw0T>vZQHGIx&TAe(=;z4aG9YE-9p!h?O+n;WS zCFFJSwK83a2}c;ZT~gJ}MY7w#SZQHkN2!kDdx@G7Gx)_)Swa@83oI?6 zkSAZXtutHR-W!voDI!w4MVdL0Pc5@BP{2<#6(->~T1Xq+Lto<+P4Bq)r=v3LqwX2Z zxtUgXS!8z#mWz_uR=sr|5Ysw5STW?(nrYS)?s@qZ!gJ53Qrqbk)AF>5g+$zZRHB;M?z!&Q&+>eqQYKy%P22i%^!(RBsKvNb6Jn&yNmQjID^iSi<$SP7b4*duFtqhjcsYq&mYS!r zF1H#jlacau9Mme;SQ?8B;VN-o!*|#D4Y)p{O1i~jkh0}EUSLWaDWou!1h$n6uVc4| zggK6-&zOp2!{HYbDa=zE63)ExLNE2I&f*pac&vl9;n$CGQJo>Wo#Qj8n@jU^(##Y( zvKuZQ`g#Wi`gFHgnU4ZwY3FAag~aD^RZf0I-b}(?a6cycQ)a*k?=_i6Qa7;q#g;f% zA|$7L%-E}nRIDVxan}fb;XIU-sY@i=xG#Hp#jGJ@S26D41}|!|`kG3Cy_7u<$ER3# z!yLty_9ZKA2QQ>UoJ(j(DV9lw97oj6h9$Bd?uW_~q*|DO;*_5~66jgFTv1A|uT2iV z2T>7nK(ND*uWlty)!C>sD?a^mn7S{B7R?d zn4hdysud)VTf~Z2ibG9Y`H)G7tA}6Y{$!bPCszQ`*^_yx+)G%Vr%1T}04hk-Zd&G|cOLuHz-dfpG9ZGEGICZq;c9||LE)g!f-Z>ryFQfW?$0f%; z>+j}mxmm2psG@rlQ)S#9^J-gdtv*F6Hy;>#+#}eJ@AB{W>R_9|_>UH!Xl}mx*-!u$ z6az{Fs%!`&%x?=^1b@PF`$ev&LRW?LW)gk6zdqY39rYLTBo8x`S_iAuo(?uhf-@nPUvfHp-?OZ;*hT%W*du zM_ZlzZwz=h81j(XC5y5%0kL4~ zjk;E#HY%|K@Mug@l^NAS#_o~z(kSu_yZg*>N61rWb*f%5mPgh*BEME0{{UJz;&n*n zKS{<@E}_8ul2D!7OAgsyy1iM6Ex{{WH>f2|0kwvJT9o+v)*RA5(ly3h37&I=-H3&M!8sZo> z57NNt+;o2U?wIy}LzV{Q-9ObDO_dvDnr;d>)R9tk^p^Ys& zvcY(3i!nV&IrNn^h6u1tmatW)TZm=Hu)7?&nX0q??5w@NS=E2527{WB&uV6_(Xypj z_&Brvj2Z(`w>-L=t(2x+ti*lwTjQj4z!Z)}5?-rMLW9!s`kUDVf zPFbkULZpoqD$xG`l!y31q%Ol6wE7ORs6LA^-63WsaTN3GEr~EKxl*)+Bqg(@?KK0m zyCeGQ{t?{=H5i+ChAk~j_k4z_0RB*X$?S$s-^z`W-02l%dIUUP3x!;)A+}9g`8|NSec|Cwz&zbUgNrx z{*-q>HY!FZoOed#W&r(cqxZq2<()Qa(<=9+oCo^9#tjE`5!QJ)k&24agj3pWYPwS6 zi!RvpP)?Whfn!{SIgZsg4_8)@r&lO{XPIbe;$r+%byr8LBkfB3d7r`!4R$%LKH*hE ztE_0bU{8|cnjewfYs^m5uw`6{x920L(x$zd_5AeIQutusn(PIxbN$3U+o! z;+J7sPHJ9Z4HppG^s+?yIR!J8yv<`w#HiVFC*bUMj#~3DnM_cPLgYWN>=YJ*7I8bn z^wJ4GufoJqM1 zOs!gWn}0OB{9$PvZ5+v}RxVOIuTw$&hi&=7=tZGJ!rIklg;Yvv$d+?B%F?BR?|!+n zoxLJXEtwZK=$u3yBJKqqLzys_7J32etV%=)Sck_YZBr*gt(3B>8|w>0GCI@=wHX*Wa)jB5#K zl2ifm-Z~7$%`Y6iJYYuymP#(7bnx+o0m&{u_C7=y4jR)9x(25zuhKej%F|9YWhv50 z*(F>2BZp8|WoBDBR_kfMLZbj~ZYrc?!cww_R61{XDDBWQlCDfz-~x98VFCtVdQAH` zY^U7o#CbJGtb z^GjmeWd`4j0+4s6Tw1c(BhCZ1YfehMuoBr#&g&}M(gTe0P$W__I25l9%m;Y@;9SYG zZd&?fQnWt^;2kwO@)`^;AW+)S9Xa04S{>uI8z*UmdYXDL%(q{=*W(gX(cQ;f2c-bc(wXyBiyw$$RYG_(|ft%$q;_X{o& zm+JE8>z{AJ05@jpjLW9#DJI(|ta5_RD>E|liMs9RO{1qRGdYlHK&TXuIwahDU?f%#fnx@TNBH51P!^!{%nOB}ydzKT@*Nz=KGIDKG z&oOpVx&deom}-xu@y&E2F*Zsqbr|3?Otz`SfZ)oMYybeqP8!^#=SuEWQg3A)?HvQ7 zEYz&~g-cS|Sk~78C(<}{<|dArhgPc+o9SrinmV%heWekRMJn?)ACz!a8C#*{cb4L; zpS(_o(hCYX)9!LqT4;iix#<82l)UI!31xbHpfo=t9T8_rS?5%s6xbP!f|dvu^)L!d z=&zjO`D=Q}0{K{0Wqf0Ye)csHJnLYfF!G1qa1Y}ES+M;|$Vy&qX}^t#{Nt1sawdaJ zl&d59oigq57t$0Y=q6*3=C?}xRCW1?;oCY4PjbS7%77z4j=sJk3KeHES=Ccq4kaf2 z0X-l&$lGdZiS_0oNY?5H%lAhP-HJ6&duobhl%Yu^`wiG_yID;_Qxb*yta0ATO zS#a|jUbe7JzuwRVoQEXlXO)=c2|D+UpgL_XR%L@`)RIMwl5RdWfa%b2z~X+fzFUW` zz@Oh76lkttsW&q@okN=5bafDT1Ueogd{kn#$Jv`^wZ40KCq;mb-tER3zaIHVmx zUCy3H+ec1%o7CEJ>I)xSq6XsEQFP`iwzp8rc;K!_CYLm~+;!(0TH6)_DA(Z~ID%BC+(70_XFwm(tQ~zV90tH{ zW@fO+Ex4o+@9K2&^7z7zb1_q99Z@Z*!m@_-T9O-@=_YA-1%S3s=2%VmopCGUx@OKf@eBzjWs!S7h6aM{lEbpTEHfb z%&h$5iR6@(8(1g{{7v9HXFat{N<4{qk*fA^5@_fKAEDK=cMUDKnQfI9$3)T~NNc6LAF`axo$4Nq`dT4x4SAu#o^-H=b=y08q$m z4Z1*d*U{=y`EZ< zl0u0msMY~OR5Hm?uu4>;bg60o0DT}5chf~u84FsN%ry&2O^gR<+~>-zw57#nBXS0p z@_-Nj)ne(2T`cDaQ>abK5|#4Sg?;2WJIV6{c+MAtv4gu#;>--@VKn>9<_D7cgPIKj za}Y@LJ!7M836o2QJ-KOkk;O4yl`<+K?YNSsa}O|t2nL=aQ_{GPhj9{++?_#}9C10) zfKFncP5v9gTN-%95DX}kp{UN#I)Q7Rkn9x?JlB#(RIHGL9VZ>@X zg+W3Mdv)Q16bN;n&s=4TiH+VoG}{BI!<3lH%k7oyOfGz6&(?8YBavz_z(}vEDfF+Yb_gOv%hupGpuKQYD?tmo9t9Da&Ae-N%e2;Bq_S zBy?#QnU#UG(n=!&e|#MLX3MR1^@x607Q^Uqp_+rWlqt%7;{u zvo(iI!jcf8GlbgR2KpF06PnI_R|%?6slzg%axS6VHlU?zHkA3uuKnhY+MVpf+EMU1)6J)njuHMGeYA zE`F}T-NBVakl;y43pxjqEv9XpK<=+|a}K07P=g*d4 zk0I7c+HodLkNG5z$~c)CYV2bTB5GFk6UZwRx; z#3ZQC=iwZk{@lll=$9Wt5^4=42pz;GRT)v_kaixCF=g{B9}ngAI+Qvok(m#f(*2O6 zhQnbA?+xspx<@7Wj>TybIGTYwQkF+8g{=Z*r7VH4O0IO={30KM{-uY!CC&64XUo$P zffFr|<7*`jTkKy;_!yZCTW&#~ZT1)Rw4)i*S1$QEtXo=v)F^6|f-SDcPNE#1J5>6N z!zPz#i*-{qFES8IsF-?dD@QTN%}tc(*%z^5b-U<(sSD|t#(Hh1+1-33zebC=rShx) z07d?&PbRYBIS)u7?8Q&c$S}1Md5v6DDNYq%OJ-X|UD5Uif*MnN*TsCliX*x@KP2DB z_+|T;<#7WIxZ2rU(^BGD$=N`nqGstYn@vj_>&%o<%#7b!Kmj(^2P*UZW7T|)=)QY9 zr{y)t{LC}1%eLc!W#?R%LkzVz;3~VaPaD(fXtuoBby>BP{bhyLYy>A>+w$uCx=Z9Q zPi}Xz{{Sg}6n+fYT-$}`T9|dlW|K73yYFT>W$H;t_DR$MplWplA=IPl!6Yu^m`%P< zpI6#lAJ3>#=DAg+-aS{#q0SCFFzW_VSxn6bW)~vSR*X)xFFi?FIu<5U3fn6BpigvM z2wWukb$c&0&3wd8E3ajKY4VrF2+Tu;h9gX(X%0CjJt&h?!!zo+ai&tS?bMZ}L=`2m zm?bU}G7u7*CNDTVm*$@@za~=gP_BH|&-8yZOZw+&dL|wmsf8_5p`K`$ZMCUtBxp2A z3CwgC&|Wmy_-4%BO!UQ%3b>5#66D0x#FFW=Lsd$x)ViR8PEu5m2DaMQ5M;rmOf%WR z<3%gF2Lwl`ReG+vrdrrTKCK+feVQ441W{44_#8mP&s z*$JhEB60GRsj8D>MyELj!I#vK3c(jAd&e~2A;%<%M}_e8y$#o0X$ecNlBZS@0+zCF zRI7C)li(rc8W?i1P~-Up6Hr7nJ*$n zSx)kkp-~$P>uq;7IzZ!MP|t9Ok8`|7MJjpr(=M8qF(yqxCm=~SS{IZlK!JTghTLdb zE|A(>B~}9d00HtELuX9|w562*G!e==Wuq{b^Vn)ta$uoBDsrvYQsj$*=$L87lsrPx zQb*$g6fymis&Bo7CFSN#-={q_AiJB9?9QnP1oF2+Q6I8>Edv+5vHkWj67@ zjE&;laU)%)ORiz57LwB;N+DALvO-p}MbmrS-sem8g|0-U3ZvDE)ZRLpey3Ln_Nli) zQgpC3%9IOlU;u`jB*ru==rVJBKdZ{L+^Ko@5T`wv4uoB@ldFdIK(@Cwv?EoZoJDf6 z#I0JNF<2B?L^9K%tnNFRPPuy&ww%5D9-~h<=^H`MsN#x@gVNHeq)0VVf4tm~X`;SW zugrCMav)oxh&^Ms=rZDH&0?9_#KWsh%(R@8o&BPD66oc$=E1hIfVHanT^)R*w`VGk zVV)>drofu5%c89;vO@^T%bh4mw>dK{B)Zrg1B$WQI@p~9-ACbE_ZX#Jn8I}#skc%} zT@!^(rcV9rh;XPS<&BN5Evd1FC7VO1*iy%9Vcp=*WCyB`BBPBPamjgO+?8?g_qIL$ z5oNX6Ehk{fxK`@ZLtVsi$|~3M_%Gal9tPbGrx#|$3lhso%eIzSdRapvER-N14&qP- zPzdNO1*18Y>bCs0FK{Y~>T)EVZc${0`NGIK0v90G2TOoS2f__N(9Tk@G{sqJT}jnUdppjS zQi~yKZA$LuaU?4ypyVdW@P}Nhk;5xoFZw9~x%!HllU&Gg3}q`k!>}&gn_pjDcZI3n z#7M;P%M~)(l}warNL%h8Jc6}2lqtJ{v}V1EhMFF}Q6mg5ceM>o^fqwbDrL49lA8)c zZIfq0GiXJuQ*NCMA;+ks#iLTFs#F%rryOoX%b~_y2uqpWMygI#4GpyeOIpG>xp|#B z6EpANO2Qjf;AfIW3|`-#fq53v^VD3ms2vzaiPp5AXupT zs1_g-@PaCt+Ynqwkd}6pEi$mCoRLz{0Xe~GX%YMmN;N91AkGR{&s$Q_f zvN={-bbm6lrNeurKphjNgbgk))*gEtTbWHA*|*)7kwb1}%v%exP@px-t$;g$du;-J z!HvZ_RdX{ZI#${etyoivSW1D^3!T3xlVd~gN#Zn%Qm;v3NhHimfTc^kKufJ(WTj~t ztT!6@5f0<>8kx?gO(vH|sx4fn6w?feM|mhp$2gD&&Mqq`Yq#toBhRhohs zcI-DJB%XFtWrK3DZNMbl`avi9oJdUL%0a6<+i7Rn<|LGY+hW#r3LvW1umN812K!nS z30KVIm5baFSX+}1t;Hp^Ht<_z#*iIhMCoyByxBd~1A7f&oQkMaNij#SH;pN2OX*89 z%sQr=3FxtP1!-%A4_gas5N4=x9PBFUmKc3trQd9Eml2q#StwP3xi`|#i6n&*O9xRt zjRmx%p(pDK0X@ZTNV(7-yRbTlj&ZTo#jOvbpCFJFkaJr902_GzaK>f$82y=@61I-=Jr=iBf1IjMI>8nTSLDM)eDz5xfi0SBT_*|F+9#cn`4$5OAaPrume z-?!i2#BO+ph-L7KB_=8fRi@?}mkuSupcF@OYDhOA9Ra^Fzp$`0iP*8Z^7!}V_wwjN z%QX*L<=^l330t8`RT7j{W#y*YE^|U=981X#CqSzZuK5~=Kn@Yzb2M@}UOrB)`u^Xa zsmF#h>C2bl{r>wH(}iTJj+Z1Ro~ElRirSQ!ciGDS0Hb@^kJN=D?I0vJyXu&J97fdA ze}4iVP7_*tTR$gQ{ude=uZ1^^o z^!`88K)Zn*T+*bTqt@wi%4*1%l&UUqw3}*6YFbrq)jRk^ylpjmbLFS?qOT_omeupW z<}(=HQfCHJW|*K?(Cbo??mD!tp1DblEDK617Fvz>xiMpjMp9O}`IR{_xTcpv4pVr8 zG}OB0CKjh1D;XBMEMM&c2tHAJ;4XzzJ94~fs=QE?%({fOZj>U(1IEQ8LVRIs3PWxp zcOBz-oI^7%B@nx`P24LauKqXI^NBIoZ9<9l*>@g4L8!=kK~hVEwCW1;TKc5*{2}VJ zHyxR1d>*eeSgKc$+TKxWaUn@?uPSbVZdg`cRj;MQaOj_>&=H5k%m1T`NQ+z_laQ9L)83P(%}NsG zl;iFxVPK}<48U0R^N6{Y#GG$(dSiSmORptqoRUP!98nGsqJ{e1Boh>p*tLllFvkfc zFg`AnYLPKG#H;<}v>sZUAbZFmYC1wCEkn^%So^p!ZX2Q7r>Y8X`{5b|Y9dD%IOm7> zP~uyf(d_wF5{0Cv#FZs5LK?XWa-ftxGf*+JNtl+ZID~<)abn)L5WOu0+0$!?bhNo+ zT2@~S`uy!2uZi0>syNn_GJ+Fac_YOx8~#vwoiteDB_dHFA56HTpv+u1KDt6_ow0Bc z?E>O{VE+JK5YB`ME&l+>+v@dPBv3`IXx?SQKW;d5=D9N1(9FAk+f;B3nQEI`8MUYS z#__|nbWpahbkDv205uQqj#yAdj(7b8AGea#32)5r$j(f(qh-fuW-_E*N-wMcJm9bz ziSE%@VutcsT~*Z*ZTd$RJ~|jzhTm~IlI(OU9i}j&Db}Jv@>_@ZLE*R2hP1m4Rd2P1 z6mH>D%TV$9&(AC#44*@*A{ab9+QyYLiraCjgRMw%6xVpHr#V%^ifyl~IpDOp2=NnT zi{Sif#wYJeR2y(*2R2lnz`|o-#WJfTsG)P{xbSTP91v+f=DCGV-_%4JSXq(Dm)lLn zNhi#-+;W1zY1yaKe{BlB#4?LV8hy^$owp`g_op*|$|Q*81%^b#!B8rh3r|tYNc=<; zcEhe=ZIYn%yarvPlon$Z8G!TO9GwwcxdJzB{$)C-rScIJi+ZM04_z376*{RaA zkt+dv-+1L64wvRW_&?PV+6x4`Fn-#9vLFL}4>@aGU(iPmhDkk0jvX|rAiR|}2mwhT zp9|?6V2*7*RrwSpvhY|)0CzypLMU0fw;UZo^^VcNp4hRyzEDsbt)rYe50otkXF1x8 zs|Lz_utwq)M+38oq?p=ayTA5>fCCEq3sr;2B4!U~bpm}MG<3)m_eBBlfDB5jzKfwMNLPtX#B||}HA%tm za@FW99o!AZDh`A7*%RStQb!v)Xr4&>Y5Bs0iRbH!lyOO0sZb=8+o13ZB#y zm{X0bmfDwVfv~=&J4Y<6UJ>z$tY3*ID)qVI$SW<&v{a&$qr?RFek4QlhLn=^5gA)2 z0yyDBkr_o%1bj#ChBPt9BNDjnMVnY{H73f50BT03;T(9_DWTbrom|2Lf%O*1xVE5! z=L|8!I^I(Daekul#&sN}PLQh?-4^x!5z7@u(r0sQ`u+g_00=DQ8gEQFn@N{#`zQE8 zU>q&OyvyWxTHm@AXDAmYGN6R1WmfBd;Q`7vsq1}US!?sWbmJPFZN?fl6PPm93FNfu zcSm@iQ($cm#tn_RP??qE)*PJC6*2Nq{{Ti6p^4OuI_GFCJ4+}>(ibWq5;L2A8b?$c zIOIs~3r|zA#L_0E9ZbR-NjZTg#Q5GH!l{gA%>4C`? z@1y4489|PP9z`Z$T8V-^5C`voG@R+oD2cJ7xm^3jH^0IX5;IElzQc{fa6Asl)1Sc_dhVcqS4Vb(XTx+ z<72(d^+_?%Y$FnCeLTcI`6<^axcF-wICkeLGgHb)OZiFMgac^d(J@t^%u~*13f{KF z58MnW<3f&?M-$C+UQ&|2iBP%xOeLL4&rDGk##dT(DPMs=RgaM{9isxik~h18-?E*4 zPzAGMp1Fp?l`?FRpc-rEqzo6CytfNT3q89!e*tI^T?twG+m0Kh z79KzDAygw#*-bz#puB}zYnI=PBvpy^Vg|~HT1fRt{Oui~I)zN+oVyK&646;A`d-n& zbaAOOjZQscEPM#D{9vIe+1x~%ZLgXDxcnd&Ksz?rI|88`3o$CDor*$IcfP;60JEUf ztiD^PTaAW-1G^mg>U&L;@>8kRRy}+_+X2RNr_}QT%{H#^*Ss%(j42^4oK|Kg69LwIr(M z>eL%R(ZtM7)5D~pwnDAe_Kt%wNYYEGQ5hPyp(pZy;y28@3|S#%kwZw4hJ5n^J*7BVq>>y<}zNe|)@R3O5 z%+iu)5{43_w4tCR+W!C(9SRi{2__^P+cTE6?sW9&96HVx87Z83N+`~x`^rCLc@NmmqevK2#_J)e=e#kms;{Y3V8MRXwN>tiXwHqa51M6}A_kiPc z1l;4Yh(m}{Y(=}ETh`D6VN{1yP+oAQ3fAF0Jp^>=)S5~VtD*9w5voYqICSHmWFG3S zuDX$bga&;`ZNu+wqj(v` zvD2taf~=*(me)5sd?SZiI8MrP^7|-5>pchnk4wUY{0vM}=I0baA+isDWn0KV0je_X zC%T5h)CJ0|ss0ckW;E008ga6`h-8m)z?0{iI0pRGvx`@BAfuv6b@{+_&~{x+f>MMZ z7y#!nHsrF1PjgL@Z5=shNvc_%?>xMz@i#HXbjT?zvI#=cZPwO~9XKYnCKjNlxsE4H zfU3awX&nnYR8&7KOvA}2LaY#*`0a2%d~i}nMxtMxa9=7?KG`6Fo{ z0;ChFwibZp9ct|*wt`Dy$7^`Nb)Y95aLcDNWdS0=L1S+VZ>$F>=1S9CT0?-Rz0hy- zj)fdmNUiytq=f6CAZhV{O$#APYDqZ?{<%YYUr#QAI4*+wI(cL`8zgK%0Q_JII4iEZ zB`%b-&^J}A4pl4G1C}b=lzMq7S!a~1T&FlX_yhak7giwg6wKtkjXs|0mz(QC+z12@ z0u^F>;c@d2*O45iyH?Wh{cWl(LQB}5a1Qx!tQC`BoXJT@KBgU^2@Z^}8KgLmRdSIm zhgo`AAh_b2DnhSo06@2e__ z>3Und)VAw{C0EL{k^%Sw1)QTwtx82Xc}uzxa;p$W$m;>dj-?u#a+mq*%9FZ=r^t1H zQbr1-lB$lVr6S7edI$on*aCJT_E;P)^=JUIT{JT56{#;L6fNeF7J6$9MyC zI%*Hj1pP(a8(mqCz@4LkX3NbwfC`xnEbd84uL0AV({EN(u-RADjY3tH0X)pq=A2cK z>XfUS09LQc1E*GEqU^ehZXAI>WE*MfAPYIj2vydDuZ8s=#79mUUY%QM4XI};h3#uw z$^f%|Mzp4p$!O+R+0cBWhf_G~oLkDY!^^ln=>&`XAPYN_RmFgmB_-3RfCd3tjPq~u z3PY$$QlWFEp!jL~pgM5pgAW@emo9nKaANx00+y(1_DttWiQBjurhE{=rFc3mkU z2+XdRPLLh5mp>w^wTcoNHrU%y<#-M=hfb>*2YDu7fIZ|b1dmWP{3E9>j{DWt+&M#u zDH{;k0Q@Z+J7@paXAvr;B$SJQFLA7A3&T`9akwD$fDEoF52XoGLb6*a)D+vmkKX~q zB$_?3E+jgpLugvkQ|}e0yq@;r=cxQ+pg!0iweBgwp$J>dRArmW6deICgd|%iQgVWP z)CrF18gNXR+&=ANgt&x4XMv|obrUKLAxHHUoTUB`hXJPsi3MH6RD3T@Rb!sgq>`J3 zHlVWMKI$7etfdp60K#+#qA-rs(`t6j(;a2CT%eY-n{>_I-rI)7F@ z(y5t2D$|L3+25COkXD~_>k;0#=rdTI!G}^$nZdoJ@lK;jWGZ4+Vq9)g;3)M4;1zET zW3L)#H49328RaJ0%-posqR1R&f5mTb`6> z{(Z^mBrP^mZzZ%Tzf_kmZw|3tmmNOjm`cayPK7%@fLv#kKnVb>Uc=Jx%EbQI=A$(B z1Ae+kw5b^Yw&bhI)&N4h9bC?9qrXVNGIVq$4TX1n^uMK|L~tRuk&4NAM9QA#fZI-y zE-}-{Zq1ikM8L|lr9;4gVe2@Z4YGJUM3$Ozeo|Euv#$H^vI172;BR#6)PN713DBpJ zkYA420}4_mRHi6(8m)1_=t^60<)JE2%bHN9O{zX;*UNpp$l zj>%3bfHEP+Tx_Htb+V=3PN_PJ?qRu2u0yLOoF?deHN|u7NVg#W0JKajAsMcbn%#T% z8V?AIJd=*;zo7IIW^8@gvkl6ywUJ=ry3@d-C~e|vZftBCY2q6 z*`3JuM7E?k%#&dM0E$QD4K@|O%t=o$K9pGlQo=RsYn>yB(-AnPzGpgfh?JZ=R$`4j zhy9{u1#K-h4d^aXR8Ic@4x%k^M^dtrh+0o^j&_>u8ezmtPRbc9vth$mz#Z_TaKkFErwQAWehYQS~C28I{aTLd^`NVBSFGs{_kFK z`1M~hI8Qvab6TI6Exz2tDVu!&0NmD|!BuEl!Iwpwm?!GWt^zlTR{7t3{yikTpHkW@ zl`f8#m-nFj*FiHhx1CZ#9`-quPcN2j+>xySa|LDx`IP!e%9Y;gSjm);VmBU%bAJhb z%v(wM?7ndQ(a@HiT-q9#lSvj63Sw1hx`7|^v!uE;Q7i8|ESu*94)9DPWx8D*FU~)) z*1P#z{{V*1^k$s5vGVyr$0nsrl8XsCu5OI8^^9Cv^Kwfhrq)tY26ZTt1K)bum(D%D zC^z^!-^zU-!bZ&E8fCY=zGc@@mRY&UmU7+6a!1kiX2<{qux#AIfaTaK=r$1Ir_aj% z9VPPQ#5?KdN%#Kretglq)*f>bE#{`x%jM05&$0$pH&H+Zx#>l28kk3UL03YJ?2+CP zqV{Uve~Vs!%%J18TXx&w+vFzZq-QDh7uG6o2b2;NqSF^B`yifJ+gRRWR*XJZOkMEb z98O_+%)2XeO$pLkQk0aXLnzEGlq7HBAz2`r_zlK%$q~fdH8EI|JjM4y^A?ltd0$JP zov+d<=L;?|PKL^q5h~`s^|$@dnjW!FF8OTc2YBj@oN_WwOcI}1?wUDg2Dev55|udf zx;BKROILzH7bnPWVJ#d?jQm66Or>$OVY&?4GZhM?!*b3kl_lOxu^FCp*pL84z)=Kd zI>JKE1#^WHoE57l7EpurX<1|zCgk26$%ISkb;J@mAJT$NgYg;lq_>4i0P@S z)16Dwj-aUu1QHKaD#yCCofMtH(im_TWMgzb&v=W8$|nSo%VB5>^z3F0+HCT6SIehTNN;pI6l(WS5tJx02c? zs5Z5(c7!S4$bU@=*YLEogxZ^SX|zd6q#5_yP$0W+`309z7F*p28$vbO^L)Q?R4m3G znsH)oT1353X$e%kx>BXf(xuhzzdoU;bdLB6BwFes!V{@4CHedTujF)`;e}ChB5Aof z*@|5I!MVw{(Rr$iL zoQ)8qwv}>eO{Us16bNzU17xY}!!S~|0wKOS9J(P&ZOB01MHw|PeX8F4QlJU z>bWl@DN9em^y>WC54%Fr7d2RtnrJO5Y%0nlTa@T*bhq)2Idk)(b}nDAgqEF5#Ith* z+nlEJ4qCB4G{>WiPn31>cxZZD4u>rOb64Y$bmPBCy$M)up7m z=4RA4E_C00Hv&4gIb%#~tYAmmLnSFGaCcIoRI+qZfG1Sje>hrAgJau?9hR%JEL=!i zDq6~u(A^@(L;LhFS;R9~)`Zm>WK7YL1oJCPOJ&iW6A5)3&R8brHc@mP2v(OM!_n-< z*oj4MTOZ1*Zd|u5HzNCPDTSam;sDXW>UAXeTf1#{ha7Zs-o&Sou?lvXoC7j&2JB8NB zHwUeax*J1|*5S;HQc_0_C7{k=bGVgXT@pp2TXrFAE9zA_6+XuK7mJ}@bZqMhG%JSRG3_{8hP}n9S8vlx!ot;@`qt6 z8j=)v4T;G~S&24~gF2AGWiAZK&XA&zM^yo+7B?{Dq^|l6(b$)y&b>;hG~&>g0(sL5 zNU&B#45?0oC?x6t8(I^sSUBu2tN12Ly!*4IKUmW(xI)}gQX2^eyO+R{R6OCI8OLE- z5WJtH2Uux_W!Ot#ASp@;E+Xdq#OrcAZ+K-)R+E*3>F(0!oM^9{1I#6AEtI$~n!wu0 zQY?F_wfsqeyE#JIR!LJeWy^%@;vGS~fm#6v{FCv9?v9daY`syFd2-GvFXYM+yJS*9 z)1~chyTe0#n5x88cIeo7=cWN#T5Gi)>RW9JHup zJhxU9i+VW&J%LuE(F;4lCKDq_!vifUzozJNl*L1X?NqMk=Se<4xC%Kj~&PL`-_vh;$& z9BIWNC0QI7DI_M>N!!bN!;!}o&i;ck%KBHH>}pu7@m6j0ypvC901KeBs~-|hTZ{Fv zhxB8w?|lfbEd0KwY173iw2)_H5ELz=X5-T7+(&f5beE`yIX7s-0Di8s}e#~k*=V}|ccQBfjho|g+@YMAdKN=fdK-^@VQ zeRYexJR@m6w<)vcR?6MPm8qOzIH%o9ZHHD@%V{}KoZHw%)Kwyxp<{+I8{9paVsc$A ztfh8R7LdHiIw%l)M^R!tVPh^jhZ~4BT6$*}GfqfDFQG0aDYj;mvED~eEN|naDQq(o z#D@s61JV=iggBx@s89!8Lbr~OG<`Af-g(LTdk(m6wKgtoZjoD=lkp*W5y=Mhu(^Qh z5*$lNQ!NA6H{}jM7==IFnGe`>>JMI*Bu9KpnPOuV}bNOW46?#;G;<(Xy^ z26kv~@Z0uEJ`sI~kwca4MV>p&gGj29cBsE^jJVPy{=+}G?eIFI?O1x7f9;Gc{G6dSyzf%p`^739=hb zT@nY0-tiYE$&)ee%W{~Xn3G!6$w^-{SqG6LYJzxwp?u`3rR|ax)^47>|AC;CNRAR z1Wl@&J4h;VH&bsk%9fWAeKo(lHX_!DPS-M0SIFqr6^A7dNTNQiKjoQ!#uKRSkt0FF z7=MTfaSqUCm~0Pxu%ul04)HKaxc>kx!A8b9SAzH=lJwm^yD0N+W>btzo1r|ld#M|0 zHa7(M!^P}1H|?zZ=TkcS%NJ_+Ez51n1} zrAq7k?L_|op9=9B>-h=OBZFj{lx3in&@@J6D%aO_5>Lh*jw{`bJcEkfAC^z_Nr${NBU?Oh z?4j3^pT-Xf2DW7S0#tuQm^?Mu=C%l-%Ma+22Zn=N1kq*x0Kuo_9q`a=W~0<56hB5G z4-yupMm{v~R+WmJW@>s>Qw_EX2o5-sl$~w@Q~}q<7-_?FI-a4LM`v6NqpYwVMqz*J zLVQ=;?vr&rop3W+`y+qzU4QGxd{^A&lWBYo!6{9In|A*IlFI)8UK8Rz=X8r+9q=xL zFEAgFkqxCL`O4No^tmEBu4gWZM9vnJXaULx=MSt%Z(B3}04L=-w4cU1;iHbu-m2PIJX?^4_}(2Fxj4OI?6{iNVx?= zbtH`nPU0B49jhcQ4tASdKv)P@$8TF0ks4z%v@DsUNh@a4^FPKP(1vw0d{L!H{TPL4 zL8+LRM3x`Xh%_M7#AYqP(zudQ*;S*s>PkooP(K0<$HEzwG04b;5_|*0QsGTcQ=Si@ zMI@#7a;n=XU3bj_YJb;vWR5jn&mTP)x&& zJ_bS_aVbKE;Mjlx>E{f~@a@ogF3fE3a|?lfTc7iC@A~kI6}Tsacs=oz#=^Xe%fIW# zby3P}EXN42S{o=WHWEdMGY)P2xbD9&rUo40?h~V^ihQd_p(!d~=1e8Z&gr3DJB8@4 zHl#fyl_5gJ22P{lta8GQY(2uN4N+kd)aKF>LCm()0QsF^Nw#sSB>aSnbjHJNfB+WS z9#EmHvuwX_50rOF%P=Wm^dBhY9k98;=sr+TS>o{?5Kve{GJL*JP+5=K50}b0L16Pa znjNFG7DudkfTbFq_P3={`)-R9lQNQ_w%XXlc`6-F&I=fFj^4jUtNv&zIbx{hRp^u% zTNkOTIl3lYO8ld#oTHUUO*aoe%%sUr%D(4z?KI*7uh8D&-gbv!Ey(#+#JJ)8GH!(| zU8p>_Uv%EfQC30GBSG==i>wR^D^$G(97_MCxLSLZlLnRLW27esGqD6utna zY4?r!lD7S`cqr}s4w`3+YVSJMUnNHRN#EFaeXA$v*p_dE59vcVkW3th})nE)sUVqqHYg85cIGg$0Y74Lo3=y9~82Fd-@` zR@dooNa4`$zVJ{=l9Hai2>3u2XXQJW>d-w&v;cZdhtRyrN^~1u;sdDaw^Dvx2Ebd$ zM=0%_XX>mecW|~B=AaCAj%qba0QZq^fsULsOuLFIxWUk8D`*!t1M`m2+c@@If>W64__GI12a)nvE``;F2Idopwx7X`Vo-=>RR>!-;8pFYCOx!oF$gib!(!0 zprg8jPN`I8g65nSy|Mx`e0Gjioo>0BD#Y@#>AF&*ewNqsj_DKPBbITLtlEP`r_xkx z4qFe2zR}$xd{q027U!F$?BOJf3zDmPLTbk~QMBDwS<4oSs8W9NbTCofNY$5G5aQLC z5THerov+|v3l7t)Q=1K;Hvm{0-1_eY2Bc}Al_uzUX}-BmTYe%63o@|sSO+?Si3A-$ zHa=q3fbEUM=L%&=TkkzKW)^PC%5W`Br|zIFBp*@@t-h z=i6+dXw(3-1mz@nfDfE1j%pT|1A7|-l!;WK3>$6S$@uRaXKslbP?eig zcJ_dl`lKZy{<>Zp6kwOAE?fi^q^Hb?C@jjSNpjao7Trd}<{&#}q^&K=cv_et)vI)+ zKJzR^*ZdP>_`q{>p&?Y5uC$~}gf_H}^L8MC>AV$3byy5`K{q}(j-(~Cze}ic(5BUyDz=s#d<=1+Nu0S#Tg!7i&P1o6Qi@bZ#yZX< zDHSeF&UA#@z$AljiG&L@*kNe}CE^l($tfR@ymaBAKPE*l!O|DeD#je>S$NkI#wgPgAF8Xd# zZRB7~UQv#}H9=vdJG68x0F~#rimzzt$}_P@$Tt@9G1L@AuF&0|8pYD$a#7UF zJI-vpR1#29O^Ldaq6oe8u)I8(%As|D_#pNGl}i$ju;yJ-;*y}F*5ssseQgMnu{sAv zT8BF{i&PZb&H`*vaFCxvt>L>DUCp25(pc5ICgQ{rNI$+gVWiQQpejSUz)Dhg2~i*) z8yng>a;VCx9I03Hkf#=P&20zD&>f_89F}D*goT3IMu|K8I>!#t!$ldX=K_k<6K{6* zRsJ#C6GurHbrR~j6y^NLKe{<$w3>4=Ez0-S)0%yx>2Fx+#*PbA_0$|zQnG{Yli}-V z=!3gYm2R2#TuS_M#{~zNl~l>hm6a>?g`hZV231Zx?5bOx2)VbVqoK$Ol*;EDPGX>= zxhWtf{WgH%qajZel&F<=ltCI_@PI0VOx735Ev-4pIw&UA`9N{AnAGbzNtw*0{gN-g zoChq?m2FHCw1k3o%niQ?4gkw8ERy=rR8E<1Z^TDH-CI{uZ+ywMt^Ua2)1ndVK&Wa? z_SHrMp-{eSX;RxxZwsq2^#gB&0Bj<%sS|!u0Q1d%@}N6r_{A-(YK0{9Ac*1HG-eiF zKy#Rap{N!o<{$$El;qsq&(z&JcNMRuum!WQCf=u@smm8t;+p_IFagSPP}d4n`E6NE z!AS3VA1}rL=5(pjN@Cyug!H*kya0dy*Jb9hY_yF54&z`DqGiS(1EW zGsi>fc5oKL<%8E2Av*kHiBa1cVQcjV#6pBNETx)wu$2~2`#X1rx^H9C=344$2a*X{cSZ$i4b#dWevQg%%RS@|coMwbUho-_Rr@1BC^}+~|@(%14c^ zPfekhmWLDv_FIlEzMSC+T7L3Zq(^fe(kH*<9i|d3DOmw(3Hh2w6$eeP)?~>1fLG>&;aB>8^5KP=Y}sS{6m+YNm5js zCw))v5WjdipioNUR;G=Dh3$K53R%Rs9h6TYU18OcF%1olE@ED4VL?o#M1ggV>dF1F z;nMIqh@q>-{5$?tNhK0*vefHJDq+fmzqU4;`^YIunpKX$SMKj)9Mrmti=mChoF$#4 zyv0Idl)~1~X=|I22`T2L`HEV^d;e=mt)ifBhvaXh_inAlNJMU)1whtmH5K-6CexC(4r=3tX2W0vIP!qo)3OJ!b1^D!Dswu@ZItHue=ZE}<3 zxr6@zILQ6*<~OquCv6h)kmzbrf#A|VArTyj6mVx>{{W0Lc(j4}!jy*Ow)v4CjTn)q z@k^2pAoEQ&(#ruv^Bhf%TMZ7{f)0^+!mq=Af1yFd%H>~t$ELebqf>Ci{MA${VIIz@ zR}zOZtmX+#lA;x5lhlK4$cvm(D6>V5Y>bq(I+rgoAkb8^Og5DygqIo#KmaI!GimmK z1FfRc6S9_g=u1muSsB-mfKXJW0k*oEctgz$rDRLN{h_OKGPtQKo_h4z_F0!IaZ2U3 zwXG@xT?K}n0f>1exj!5dEslv*e-P1-rivFe$Ur>7nJQjDd&1)3W6!PQJ;c39rO(W^ z#FSdTUR{XYi4dT|C*@m9;S9JHEZ`S@RVVq(n$P%2aygRfBErQXCije;u6;DRUz}h0 zy$u{!N4D#J&!oP5n3Ajp>P;?VI;JF?mS{|^DIs$bD*XiVZ>XG#@#la-d#v;d)O!{dD|3eYp+3QAHN zpF_<$gt*e~l_5YWDjozK2!@LY$D?7c#to>cWQ3#853$$mtok}ti|6JifhrQx=Y z*qv&rjCeHrX?X&-O(X?OH}z8p2T!bNOHgoll-e6;T4G9ayx#z72D2`OoF`a(3WEzm zk}0!G{*|;_^ll$~1f6xw344k}&TerTL1=>7k`$FEVv;Th^$^2Dpwgw@<*jd6CgkQ( z00HM56o}o#-qu)ahdJ6|(@>m2v1O2;kVlJ!B|j_2330^P0jm9`s(7-v{vwcVG^gB@ z5{~kTQCnc$Dp~H`W9+Kh4v>~igiwmDOi$tl8mLsCnw?C_$|d>EDSXx345&#bsT$hQ z)$T~4Z#jTlk|IdFnRjK-AF93*IZ`cJ;jwShI(D*2*Q7VAub{d+v}!Y0rRf(MkS_%s zw0dTo+42svQ;QOwRz!FbV*HwhUV%TI3-Y| z=1jdgA$k&$Gdq}s?UwpP9K2*9*OTAl=ilHfORMk5k~}@^mqx(pQ&VVesN&MJOEmLo zR?rAZ}A zmsu&BnR3g1b!xaNaaILl-Q8{iJEKUh;yBr6>r0bstL(gmsOfjtnq9p9BZ}Kz%aOLi z5y?nOTL1>7(glTpuqp#VYg@u2Jd$so>(W2FJNo*+mEL5qJ4TtS1z>w0M?i6jz5;(h}%*Mln??`;y%G2R?zW13cW23b*`(YMf}8H zqwCd}9C;0;O3reU0dRhi!}n9wBj=p$)c1d+XDNXh!+L3>hDK3L+ zeZ;*IWvP}}Lk>RjpQx3TJfn7$2YI9tof4jdW8)le^E+RV6?`QxNGCIGzU!(bwJoqn z@c^Bzxfj+8qrA*?YT9QCn{lKt83|iD=WRguZ?FJf!q>jLM@}&}iC=n6Uf;?}OtkAo zYC46bO%$be7B)@n1@;i+M3JKtVgps0T-q4+S0)ve>9iz(S=-!5zN2!i*NIV8*6XL3 z(;du1Jt*Xiob;;F`zV%Fvr9Kh^XEYqK^IO;q~Abcw4WhpbvS`ZOyt6=63bf?QZ2HD zgYG($YaJ{`r>(*8gHgr%m?@l3UMZ_FD^qDGmR*_VB;6`nhHm>r8|k1}BPr|BJEve1 z`2PTeio)(q&&amnZRI6TwQ-q{l76u^_mZ$KY%Y_%QZp3;M@6&tLJ zDGFA$KE5ME5)d$xtf}O59n~sp1)3BDQB!Nk z^Jexr7pPG2NgBs25x<4xT#%?;@>c4dN>HVYrDzBxIfqgXmxAm|Q-)RWa@&@IJEa!TZ{i63(bXH}_J$nmncJvg;3?$= zH(J6%(yLgT-_kpyZ@%Ff+Z%81a7fZw1K@~HhRJ>^2zY+thKwYSET6_X;WNG>Gsxga zrA~}n`#;7yu`|9ZIn|mR(o~=tQAtS#);o)Mz~IoeG{aKpPrD~B3rftEl9eXff+5I7 z*T`!umA{BrXpXi068=!_5t}ilnzU}(zp`Vg9J8fPX-ztUP(TDL28VwR@!mETv4~7{t?<6qqRR-VeaxB01l**PnE3#K|`a!YHN6cq{+Ctod9&X zzJOj4l6ny2F>7bi-UgNWK1G)P>Hz#AqFJ>Tk;9}~B*J_{z8TP!FnEW2F$cvtj#F%p zHGWX!CUN5$DJRkf@cNn>aAZa8;Uzm%!&1!CTuLTP+DN;pZs`d*yUQSaFA||7H=&CD z8skY!K-D3JrdoPtPMWsn(1n6fwFHfN5pZ=E5eFl#eq`uI{)6c?F`AhokM;#v;ch{RvXXK@~A)W_;vb z{0uz_@A4R&HXF=8I1t(i*Z~?WQlw{c#@QEmjf1fUD{iAtVo3&8YHd%qG`W-lGbbnL z_qDnb4gOIhSlW$`pA2Yg!PJRbd&)|kmqt}7I}^T;DG6~i@fwFOjA`%FW>&V@n{2kV zwl1J94uUx;QP{+3IBnThg@k4$W+kR4+%k?ASxS_Ywv~}$ZI`cGSeUNOn`$TG$JCfp zivT5EO2Iz2ik4WR!fK#bQ>Q1PaewAQ7cs%+d0q2pctDrOjZDr{9z?6&&gsennR8{= z!s7n`IOMqsk1{a3HH##i4XL_((t0{jP*12XAHo`;csVP6_808(b zc3r5}(m&)HPv(D&a+%vguZI;0%9@<^w%cr_Rsp@fJHxO-B*(A_cx=@~(jAygqE?@1 zT1wL1VVI>mn|KJ|8!9Cx*3?3%;o!JhLO~`93jnGL0~(E^lm@$<=tDx28BBE5VH2&I zbCQW{qrJ~*OIB@X~hKxE39M$9|Dteua8eSbK$t#9>(RGXy!#3l%FnN`mnlvgx{IA0qaX( zd{O?aD!hc>n5Mx&uWKPPjWDpAl_VzizlZ`C4q{|Gk5yWd_s9`CBv~A)jwwlH&t_UV z*-tMwyPKu<)5aaxY1y8giNR$a(oi1CGvvNp*4Exot&VPO98WGj(2i_(aDSAnAG9FY z=H?}0d361u1q$58aXSj?AuLijmHNms&aI?{s3Alo>~x58Bt&DW)9=otDO98qdWEC+ zh==kde9p#4&eXQPE+hR|>Cc&fqGWGNWBzI*{a8Lneq-l_+x}{WWC$dCqShW!Hxk&5 zHh0wyv>;*lvBh)4zFHA1?8AJE{{WC`8_Mvz$WP}T)$k1h zW?r?9_@wgX-)*`im=|05!>-$|TP+|TG7KfjFF&Ex7AUYz1Eyiu%IPdBu|5r)s7??< z4_g%grCY%Sdc<6lawNtz%q}hA%lPtb`D(<|(*X%d475v3AS+^&U0RP4Poze2X^$kD z5|qvz*LYBp5-5#34i4K!|HymKjuW>nmZ%BR&+`dWLp z2`8>o-ANu`nC_a~cp zrAFT*#GRPMQ7|yRA#W8*w=~W9ZVRUADL*0shS;ONq~1A4Mo$;dOv=xcH6odY@}!mL zN=^L?L!UB4ekOpZ&RhOfY5xG4jsE}$Z+^nI?s(K@#`MJh0L@na0EBmb$39}G2)^vY z$D1scEG{)lukwd6^ARD%a-fDi;sj2Pn87|Ngkmw-``2GAW6`1)blNfkQD0ccW4CsD4N?W8r3Tse)I zezTA%GZM!C0OFT#`PmGPY$vB4#IGm@=48@3{Y!`bj)>|K(aByltnlh#sp`9oOjFXJ zmsHvmg*TYkEP|!oBd7xKp!YM6GXcYK=@*nN996up90q6_O5FFB<-A4XrzqA<1qnJW!hFeq+r*#tzyKPjvb>5boqs9NVl!e z=N&mmJ?e6uJKy8}*y+kO*GzGbwdesq#yW7>lX>|;l}Hxx3O9}gn+lvReYK={69LmZ zQUYvUGcI~vL-)rl67xGnE};oPe2k+)FMm>Rya!Iao+Fx-8B2kF7a#48P^&h-l#?Lr z+48aeG0F=xC#v&0DQq&KjCAMB+mWZWFMQL9 zbpHUqnT{PXJ%{EeR8-W;?a&2UIcI9j^4NZUUsCGH^H4BYB+N53*?_OEabS5JKL`Nj z%u?D(%#fEYxLS4jz;MVaE0smUTS)NK{`l<$(Uw-IUN=#)dX(=40+pEE=FIAqkUZ>Q z1D!WbpGt0(_YYL0ej@tEM6}I`30aw7d5dZ93!@<)B5wtqNbH7QBKcB1AOo6Irx%lD z9fWk@r!g+`3b_{^Ai!|xwJ5V^5TC39z}^FCxim`6Ww&7MJdci?-bEc{Yo;iya za1cQ%&2kT0ji95NjoOsV-1m4fEL26WmfyYvfwub^(oD^=F5_&1JimdCoK_5}RP)2y z&=A^gLYmZ*&=7VI9Z$KuDpSxc$&Z6=^aYWIZ?+(Heq&1mM$;u?P2nTX%XTB{HTy0rIu4_{gQtn29VZ{ zqxiX+$QQX%ecdhlqnbr)u?6iT`Am?J-ZDb|dcwK|?m9@Q@|F^o7F2e%p$!VvL29+q z(vsWEED`nr8vLO;PU|&fW+ms=q_~370^uqbzn0P31tfJR*kVlyL&+)3FJZ2pItWb) zY~ahGmWeDrv|mG%k)(7&erKASM56MCm9G8bHS>TP)C z3)GOE6Vh#h8+~pl^-&~~@{Z7rM_Nv*%jgU~o2#MT{{RDcDUHmPC7`eXxv{t5 z0mG0Ctu%t{!rDnTxZmYufI@QTUc$;a1v6RpM}lily%5bw@VUk0P0he>J?x<1VTp=p!HQXFZGRIJ+-#q zC=fl4X~WJ*wwc5|aI0t$ef>-a4q=~K9pygrh)Eh0i+&f5(al1!GqUXa8L zCeVh5qc9UXxq@%0@QzTcvw4}sx}9IjMwtq2uZ8ag9o6PwN~UK!jV(zx-uik#7S61t zI&odqxUfgsxFh9w;H72<=3SOiY_Bm->i+-*!U2EUA)`HVR@ z;<>9Wt&%xw$(JjMIga;8`$MRO$C<~v99lfvijZZ?tc-&(N~}hoj3tUYO;;L70WaTA zw31K6=?J5`jW_EB)o62%1f0K}8w8Ybopt+YOQ>BkjGXPn~U0f-5TJ7*Zo!~iV zZbEoIa-Lexh)D7#8v{9J4gmBU?7igq!s6j?g(6-l(p1Ih#;Un_AFO%Q%uXX}MIC z-u70+Ur!@=4p^XWvF*2Q#Hz=B^@rsF+b}K08u!{?mwNCV0iueBbstm*Q>lOq6A#D- z0#p=8`*{f;lmK9x#I*S(1f4-PzD0gIM`%lu6dcJ=-!KI7{6N3%ym0BJ%B1E^+Ex6* zN&V0ToSF5YuPbU$^CXY>AOPv2>7CHwAAJr3Z#!=QQPOThD}BW(VF&M<{s&kE3Ab>s zwqGb(K;Fv(^MK_YDn1Z2yG$X+Z*Or*3P~Pf(ZNX@wOPeflgUBlUv;EvJs<|ma(H~H zKU+BZ{{U#_SEP+;=3;h(KZ}HVmlN_IZI25b+t6&QdBRo(?U8BdJz!ZD3GOPzi{t@ zxF-+OB?Ur|+MZmyE;#a>b!BUD2~vr>mboWj0Pqo0JiC$-eHrX+i|`)Q!uu9G1$RXZ%}E-0uiYutivEtysxU|2-I z0*KCI*EQQ43eKoFCP}(VN={1xcPxime>d7Aj`={e|C7vn&DTQT$_?Ld??qdBd~FET(E)0xVB4 zBTt-h#O;|V)0i@#uIsE4HBt7DAM4s0Xzh+)vSG^Ge74+Ym1}75*YUJADBv#$VW|&&>_Cl|3!Z>uvJB4MYnjDAZ932ws`+#|6hME?bjTkavw+FM&QRLJ1l+v>= z(#{np@PyaEUayF?k;KCa*)vs2L#XP$a$0lbJE!CzrgG4tmE!&zJ=ux*AUsnt-{W;h zbg;9DSL0>|q!3qFk_)x$Uui?|RB_{dpP}7H5}DdZ0M?%}&DA9m<&B)@BF5j={4EK1 z+TEw*-~cKU4)7f}|y!e=m{ApoB*oeZG4NZiUVb;{5Lsr&yGbq}AA$ zUSjOj)R|$X(vh$(ZlZJ=5ejLcG>JOq9$H3(A1mt)>Y=R`a@~{U=u>0o9CHN|8!{_s z=4nAH^0$|cIhVMgO~Fa)4&%nI8(e@XN_v$x%{48pLOZ$uEmz z%Zq*AE7>o*?sBELkQS*&UZ=G!F6~LmZ0|M2^CTY`gG!he0WCa2d26`1S`XTTz<=cW zuzX$r0Ez8;CAv8caaHM7(J@k|O0pzss;Aab^@Yh6)}ke*#m=(J?x{|y$q7})#?QwS zk5$V0{{H|HEVFo=uYO#&0Xe zD3vN(DMOjoMxg3IA}=^x$-2H}KNSX&XvsguS+{AkvocJ|J5$4x=yIzp+c}Ko9m8}? zN{f|de}}|?+E0+e_)DkBhQc_td^>H)Pia$)Qi2pzfR!1l zGvoQZ+hmUWlGn=O(_~pH&6`MrlOwk!es$G8tKd#pl#*4?mGqkE{Fn}7xr$O>ZlN%x zs!3rrH8hkYy(Ka~n^l;w(-shNj@|DbyQ}Zk zFVDAApN2Ssa8jO`o@B7%X3;H(G7PP@@_g}g$;mPJx(U8fT!`x6O7(}l&%f5^Pp%H5Fa zc6A!Gu84`g3@`AludJPrUTIeR{u>DT{{RT_gD%M~Voj;wifi&y+==H~<~pku=GY1V zq1`*dUEc)7hA2f^s^4wMSu#HV075@v3{{IT%H^M^VM>CScAxZhQz3EGs3kzPG{{1; zHtJ5RC%Unvq4$CfG%~Wg`H$4K5<1!^A5T~{U1x3W&BROY?yF81gux$v-wu^E&5 z^Ch=u9y?5_fMzZysl+op&45#qq~%h=cg)$cub|7Ryi9|=ioEcx%LA%XTb+~vDhf|^ z#+DBM0BI^6A@o+ghYtx&m9V9&a-)BQMaZ`wgV^e+@U=vCJdaEzF4%R3q5RxT|^SZ-la0pV0!h8kD9Xug{ z^i;1J>KMNcPQ6UUFS@&_PM|Y%%fFkeCn`$33QxNUWrjMTJt>0S2xe8jTT_lFoiIte zQgZgtzOB;f+$8C@j4-Ngt+sdy8>FVJp)2hGmj5=IMFuzn@{n zzsK|?cM5wfNmQg7e-N_jWlOyII#QINwW#aQpCZd!6|KZWpukHW_3kVGcGKwp#$7ul6FEi3Dor@n4-_ePa;vZ$=m3> zmv%p)bEo9LRxTGhiAK^sta5=PTcHQ4+*bEJ6Zl0=s!46PE~$C9`62x_`tR%TM%6X( zIL>^oB@UBtMV)x~fzck8(jAY^pZd~&u!(H`9*g;%M$)$wEJ8A9rH^$3?l*nc;!WXc zH|1MjMdZB3+xqnH=KPGSMnTC!NmcV9v(xq6J`vijm&GsELT|6D{Slv630YOevaQ={ zv-cVsTk-RS^WOZM@8pDX+tGfkG9~$$5TuPYZIEo|A6;R;c@O?)HU&564GU+itE z+^SNuWwwq!ZEx9cr}2L#q$b!%Njp|!A;7f2aXa-A)Gchq0TI)upyO3d`8DGWC^%vn>Rq~swfR&(51 zx`HibTjd>2&hj|bT61Z`^Jq{F^4wBp5Tb5!8zm_xPzbRb6XObv{OslKCMs)fx@eSa zFO>RPSSvSC17YymI-ciF6;b1ci*FDSESEsgW-3l#3T}4P^|p|;xx*h4@Vw?KmY7nO zlo@x6AteDJOuSMvB|vJia6B~ehal8MHGeY)5*VAPPKqSDf*NTo=Sdy+GJuqoEAES2 z+R@nUxN{Q9WydNd$ypa|E=x*r@KA>eMVFhsURrt~3eQ#tIcKqc;4zOiZFtK`Q~_XC>54j>LlA-u2JMAJozjMoc$?WoD`j(;p2f zv=yFWNdz_lQP%do_R>1$`GrxJ2uM7sgpN*jT3hOAZXAdKNg$l(eFebSr~%dn{{SO` zzlRuYRLUz0N)+!lVabAkPWQ4%HrxSl4u%nycFsjo9IQWxn|Xya8w*-nc$=qGlDp;> zI*Vwbt)e?rEOv309FW5-Gd_heGb@n`1;t%SS=Q;uKm*rN9Jk2ek#`b(G~!wd31N9` z<5p5ex3Ezpg$?zN1q-I>%+TsCDW$mbB+}D?Yd2Dhm$*GG;6V(z<8#5O-N>GO{B9h^J`7O<|TGg6yH)!?{8RA zbT>7BLFL7@2h~q=+1NzOmuxoD)KZm|D#I}w0lD;tp6kBoW-6a+B*T>N|UCs$HHH2{NL<%-fO?27PVeA$hRjijUJ#>RZpuS zGL06dzN{%q$b~7e;7e**?xkSdkVDcS*Xmhf!wCoBpSF-XsN#Ye0HB+l9n~BpW zOA3~#GKaxTv&i?{3Fh+(k}Onn6a<{vVaVX*zI@;2A?4ck^f&(imrStb7MPh_R?PJ0 z*GjylOOravMs>F7Q7wxm#Dpad0b`q6$9yfD{eK|Wy>02s;wYT$2TgHRI+JpEoidc7 zSg1=SrgF--1pZp<|(vy!QC$YVs-7)ZzD>Z#VJX-YDJ~-0d}tbX({!} z$rVfh3d3%9N)dDdMUs`2jKNTeL8SM4d9Q}Tl{UF1e~!<3mCzE$!| zjLJDn0%af#7O-;NyY&EHYu*;}IK@5r_7mZ&>FPFb_NR83ysu)4aa%4FOt!jtNJ&bp zq}(hNuR=TBdPI-J*2(U+`=Ppu{dX12_M~d7QcS$1ep8n;0%V(1i7Ro#U_05sT1vF; z0pYxH>Pq`_*y@a5^*R-9E7dA*ic7PyPSzyBc6L-#o+Y-o<^*#B(h5i*n}d6ZLz_zJ z)4JGkLO1-;hI5JnS1jsh=>m}Y3T3AiF78D>H*ISUWE$SU9Njk%Yka>(bwNMsgoS>! zINOqvv#w#pO}w(|n3!f}>SX@_NiKr2r4lzb%L!Q?@APB37cKo!%bu$&xct=?X9&3> z%2FMeUpWeBlVTk$uPR0K7b5#_9oN!Ve-GT^U5$q^^+mZ>`BfYmx61TNrr$$FuN0EJ z#X#;h^SpIRpOt*VQQNQRDJuAuZfR&lwL=Fjg{IDxPP*HPUsR+A4ab2tJ|Yz##J^z< zlk4<4675W3X*C%a=u?vp1cghgpi|>;FNfc4 z#9d2GS=NFTZt_*R^do-(4&!Naew+TIQ{R>R*8c#Ik#2%qZN)B+C=`_xM$OJLY9+L92jOPH1KXp8Qw%EkwtaX=Z0cpfHc7LNPc4|Qhr!D|h= z%&gT$oy~lZ+7U96N%Pv?UNH+MRV~R-#L_xdntPO_j$k6>5U;Xz+$&=d+^lg$p;JtG zFVyMENdyJ2Z!|!iv?;BJ@lM@G)*lMl7t&11lZrs1cJ`9&P=A~I&yer?|kE+DljPIseNv%!;wN5 z@3!PAfY9U49?4hgOjJ}9+}i;vL#WYO9X0Us+gM_9q3EjF4Wm`g`&YKx8|5X+1GSz*hMGiyOYtaEA4%p#&10X&e_ zW1+rl>93?J8!b{Lu7gOOdj+*R;&Wm- zwIcl+Z&Bn!ViV(EPs~<uXF$S^9GUtnHBpt++a5*3)$rDJ{z|I&<74Wj#Vg)I>>!7cr?%NdWPGX@OvErd{A~s$D$CuQ0 z97(G?NPw;kkm^Kx!rVW_taDjzsOlxzbxpP% z3@K#^*xgMN=?ha`gt(J8hMX@*l5N_X%AI=ov#BUZ^s{L|u=I!FzT;BZe8VBI0!4t> zL!)7NcY==C+2a7IX_OQY3X`q;qCDfcFIMYY1o1$UdoPXW{G+drBi zJ~KPvnzcR}y31tCVpWB7&ZbEJ0G)6w{{RoDJbw{4OX1A)%D{u$6q*Z zdy9xNHwhN-hNxN4=Gp)O!d)A|Kq6d`aVk3Xj!>%vx|v;EaVZBunLu3l3%~=Lfi-2@ z{rGkRautrlf=nAhKmm?W1R@e}#zX)VhyW=N9YN9{0XdFZOSI<_zjTy?^M>X*9%EHa zafxJQ%s?JG!y~NUm#9fitxcumslM~D23j#ppE zwpwoysg+7;s_gxQ8K0!}r;frAfD)AchfONWHBRqm?s>iihXYpLOdwqc8+ZEbQ>X(M~rmiIn1=Ma~AS1r~6@6CXCL_ zOd`Qn*KDB20hlJ`+?E$r)qe<8oM_bcg3$3#P-CYKk(@$6uuiZ5A>z`rEhx94jvX-! zK-pGQv`PJ&{`l#`c3z_|Gw&fOK4Ra#IM}MNP~4ttp$NaP`(u`Njl$b!-AY08g3jqY zi7?>r1RsoY!jC&dVbNtagMTv}vzkq0VTpFfb+nI({xRJ_q~=UeLwe;0;~cY^O;JXc zcwNTD{ZH|Z*ib8=%RDTO>Gd(o4JhWEE>LcgZQ==z>N%j(dW2GR3RjKQtanhICeBpL z+dYs6iT&^$Hr{$tWg5DIzJVt3!CM?B>8;N9c2AAf7TAHT2W&HS2V{lAk1P+>AHq0v);Qhe8+~CO1+jm^J4Y zK1vEdDD9l1arTsz8b94pB3vReIV0 zIf$b;rDiUSm-k7x;~lXy3v@Q+*UT;`8{ApLVfevkbe*TF((Rt}&8O8u@xfMbW~O8x zRm{mJ)g*pV)R>0Xa6>Fk4&?G%0BmxD_=xGxnaN+#%RIGC7Z#DoX#fKQ%N(G z8ta+eeF^=PNd>lb>Mzt%+8S?=@Efl=3i);MS@l3 zybT;u?$F~>U240V*_@Z|>+kDmZR|ds@}a$$s)^ULp(+YNJ>jj$@Q%=nv$0FXWrqTk zhmxbADQ@H9AfZY|{X-Ns(K%XIkyB(};R&HmR3@Lt4zg?|^C!oaK>5dXh}I}u#9q>n zOHJxJsQ&;RBa|yq)s~r6HPooELbBeOWQ9%%vM$MgxX%ES4P!B`GJaZtunb zLEM>4ww%N&-4dZ3qqj#vy4r#Ek&xUZcoDDT9icjmGj%aK z*COP!e#uS#M|db3vyi|{s0cvYYm$FB>BM%WREOMc3L`1^iO_uEG$}hf?7GaM(d4C| zu9nPCh0c(g9o0uVy5ldam_k*t1f6vB(mIftG-$I}_JsiY?0^njr8mDwG={$Bu$)xu zp&`J8edQAdnmMk;1zCw%bc>we3za02e+W$uHjYfKR$bOqCD7skASf&lRpu}Iqq;=v zHKruJxCMnJByDn_ep^Rq<(+y&x*Iv>GcUkj{s>D$k&)4!c3rnJ4DFj=-6VX);WRGL zMrKw>OA`t61QLE4esH9NP||VLOGY1`Dp@Ka8trlv4#F1|xR%Ew2~Vks339MVEvCgg z>^FqC+0{BbL`j`h$>=LPf8=&f@_y$pG1EK(dkvKQp8xUo#IaZIYJV zLuvc25wWw-%HecT|w8pDX_W80pKSdSz}E zTSO>}z^J4oW@D3;M-1bb#g1ZlvpI=Al$E*ry6hHEEfgIP*484l0{Ggfy{h=+fJ9Xgxr= zu#P!cw2w1^DR}*s*rC-F?7>nHxe4?ZpKKKjz&vuc-~##p3F)j?WmRmM2^T|(sI3OM zDFGoULQ(+GWB?0zTGouVUS+Hpm#nat7!5jvxRNYVpa}e7F=ts4IHSRwIa|#(WEe}W zq^O`Yj#}-|r!MEj7@dl35oZy*W3m<&#Lcxf{IfEtbs(fPgYzI?SeCLfJ3@|Y`<>WU zpw-%W^s3rqR#1Lm+8xw3H!~mH>!pQdOw99OZdB?>_*-~Gn-*f4{^t!P^w~8j@UH-* z{_z~v6l9YA=6x$DQPk>W@>XU@(h*#7{daMR1=y#*v;fBT=*X>*x%+Trz>ZvOy2TqWl6UWaJxNcI-P>K6K9 zzOVWnNFVd6IpcXRL$q#=!Ps6@W_EVC;5~i356P(KjQcM{c8*m;vEL5qb~7^-Klw{I zRrxa<@y_WpV9v@|A?dZeihHvXX#g}|nNbd#>a3wDAtPaZ^*cg5b}K?8TU;T+6kMek zN{ijMeRAku#FCSLjB)0d+kd&;3H_t7EY%)}=uJNiQ3Huh$!<-S%0c~XgMSOdGRWn& z-wpo&RxM*oduMKAkFDWw6YNYf;nS9ul#RR;l;uA-j^xJ_MMWQuQ_{}!aIhtzTI{yF|=ZMbf1o2*VPPUhrXtd(OZ>iAr-$+M@&gd1>ue~hi zEG0@#;aBPB=Lv3vqf_Yz+CJjegSqNF{QV=A1~)2mDg6s7bM~$ePZ>{-Um^zJBVCl;_Y+z3U2z1)ibm8 z28)*-Tq{lX4A^H`3US!!rF|m zOv9kmTbgMyHKve&+NNc}voq-mQT}-^re$}E!0v?DSsasZ>D%B+hFj&eZoWOf14~q_ zngqn*s5ptK`aHL?*5y{&wN{9`a;MY@H<)1sM1#y#!->kA$+Ojby6w;J?uC69HRUef z59V~4m~Mm}mVMu(Tc^k+WlKp{(zt#5S;sfcF)8*=q~$hjXVIy}E$hqW_sDiHSCzZ? zO@55Z^_gn5+T=W0|A4?k?9pOMYwb)8sdi zDXM!W{{YpO?Ed+X-n6Oi&ls9su|{xJq$R1%ts#0Eodw+qb6)!8f#j$Z=E{^SmH;9( zn5W_|G|c4VM7!aAMqZUL&L5>Xm+6yI?p5%d!t^R_MEg}OVA{>3l7N%T`m#HxE#i~f zJT@x7cCns#8iDO-Y-H>Py$s%^%SN zWRBqoR#SZRd2P`;_;p5s^}eksKF|BIUmm8sqlro-CMl&ep%SjWOb#dhL+Ps4YMTA` zT)ypRu-J0Vm3}Y7Roibh)g7z5+jON}CDKdcbLsATFDa^dZgD7;a%PUF6aN4!8d9!i zsgK|7OW*3VSPLf2oT|FlmF%r=&$>9>-R-(k@|Q_3k5e48vh^b_Wfk;;E>qo9l3Ypu z0F7xR+G0uk-|{giP1#cV3kLn;0!}=;ZGBg7mvCzN?fAFymqxswQ?0|PQQWD1T||e{Y*OWlb0*+`q}-6Ji^cXH6Y!_sw#6n~+qK)iQMo0Px=s4Fd%ZNakvTiuq{$sFi3@;V_Uc++zr42(`B2tGatA}&GAbgpKAF*O zXkHp|9Zbxn=hhlx&8b;H=of}$hZ7k}_8ybsl+^PzX?9$er)ET|)Qsy6t)fbSAfD~U zP&$k1c7c{uSz>j_gP2c&mA92EM|zy|YMDIXhe*#ql#9DG=p;8T*s%;N>lN;eO~gs( zOXFX3SjU&ln*RXuXcY3|CLXCxE%f&$T|hz`LtSO%5n^T1ecPo=R$GE@ZYn43D!Syk zzrJjd7{6XbrKZwlXw5SvD$r(GqyWUK5)z9Kw4gM%TN@kdb&5=xT;;v*x{vC|Ql-<) z{)j)cm)$EXxlkzz2{*m{*8Duq(GAVX-SgV(=!bODs`~zBl8JT3(16$t-!;?SLGj;J z!+hFXZRN6ms~5`o@Advhc4@4-j!ICKrAy70!tM}nnZvLb=?aV!*>Ati`M=miq}Kel z^!OX=ZF0TmkV4d~pru1@fwA^Sjp4?ed9H4)Kceh5nwKu$c6FO+N$&E%QbodU3J^Z= z@l-yOodddEXQ-4mK7xOky zu(6pXAfrQZ+-uNvSDZMV@~ynKkMj`!06$h@lpMCzo7`FM5pd(bzBoGc=auasi^FMiBk<|~UPwvO}VXN<}GqTl^Rx^;lxAxb654xCfEw6q0 z^?$Mw-_y~4;DmxgPEt{+M#yi?UwFaRwzbpytM_60`mn9cA=If!Uv!%nKH86hN7)`5 z#}t#df9Z98OR@m>KnTATUSBSsGB$CZK{GW;B`ahpU2mvt+v5qBKfc7=FK@o$4Yji{ zwwYRoH4Uf>4RVq}Nm1x;w~nxsJZsO;7@3z~O1v*B_cgSOs1*d|$fNu<1{ZV!3l`K~ zqWcQwRm>A}O7@_TZD5O~Cf7Diwef|;T4xO$NjU8)poVFT8K&JVy(W%eN%U9 zT$>Gg!q&oW`3lTyP;O3~W?V&^W%nI%2FB@QzmZyN(_2Rpy}PrVy$JC!iB2@hh+X=Z zot1DYlqEoi0`1DV*6B@^pJUP;md&nvgm*z-YEu)*iMctYzWOYe?6qLBY zOKQ;d*Dt~xay7RQYJV2US7y^pX->K{Q;jD^(3Fd>EykdG$pfaE!gMsO=B|SG4`68m;~vb@t&pI# zlsnwg`=Y=rp|?+{yoX|wPnedNnf8Lx+jKM<$bynWE=pFCr5^*(TSx>jX;P`E zPbPJt+*GrRDz=I#%#nWr4%gH{`y79$_)0RAHWt$A%Jt)(n+LGkUgl6#>QbxDaNM5b0>++$h**`zl z$mrE7UPpvJ%3aRTsN|PYk?vZnX2M5IqeSgt;T>(?>HdiFin{XW^Cd1n!VO|vVTYX# zIMdQH^RE>&yoyo?Z2`5LT}>%Q>PEzXVU1ti?!P8-J0|@905QK+0!g_ne6_iinWtV3 z*x4yil0sB=waUHY*g~breE$G3 zHOuAs2&Ap1u$K=Exn57CX<;W^#1>o!=lMf@U;1B}A#;BP`3{~BrpvL!JXVmUlQB-F zt?Q2JNkgb0c-lnfy<{8e(vx}C$#5}~ECO)P8Up|J3V-zENc{@R9@C-D79 z#UqB;V};nBNiQs>omZ$Wr)}O!*qjd_+sNo`YwK%X9n{>eyKVBJdR49a{&q+_RfnbL zarP9eB&ba;ojivMMT3oo+gfv*T-iz_0(!$rZmZzIL!0eu)M9Y|01j!bF~sR5Fw@QR z-gOCew5do_l4a|K5ughEE)lozugm$8CY?r?k>Z@|$!K#YC=3@?Y;Vh$ zQ+^lKBn4k^1R>4W&zHzTkKw;R++oiT>9u|t*XazUXqTtdXVl43K~h%4&ov+m4K>N7 zyReAlYj^jx54a~JyRYUuc<%wVGmCI#aV;dR4a~|of{;=WKoGs*Tyt#VW z#~m?W<#YUo?z_X9B<2djGjGbY6(donAu9~FOQ}=5r6tbo%3RTENxyqjctkSErq^4s z?Fmh;%WsN9p!@u^cC&nCHa76RE?QeQyJWVoQLsymwk3@gWyq`7V| zp>cBSX;{OtzhEt^A`L;;Z_|*YXssMDJDd`^T?KZSuG_jyoaTf<4(BUtX6_As5b`3Q5{nJEmH63 z_Zvyu-<9v`b*O!wF!bg(#FV!s8&sstI#u?OkOL^=#l$Sj9g%X7v6KrdO`!2zFE8XJ z$MD_rdyMlu4Wi9(+ES&;T4(9gcYa`8J2sZ4%PutWy~RVINRIw+;hOW zDBnTxtMD@qQ}~5UN72nLLZM2TE0aZ{EoazgMW*kO9~ary zk5a?9+D1*6zLBF(OfF7qH`auuq`uoDZ>s|`NYdiOY9ZyDb$x605iE37?TpLT)YB8lL*4AoOP7%2Yao;>GDtco6x(7hRI}24U%ec7_xtT;#MNgT_G!d* zY&}YsRwbcRrCOd+XVez+a*hLgET|GtLX+J|BqsSIw;8MC{u>EW>@6_vYlW9oMpX150xz!cBZk!-bvY8E;w6`u+~mwP_>&z0 zK&ph>+AX%g@+8MVTVORUT*WK^LVy56kP#u`Z^k;#p%sg2D3N`<=EIkAd;mARLCoor z@kY@b>wH(P@iuTwVYyj%sq%|b66?+o9CbPs1YIY)(2>5-oolJr2hetSJ&tQwjLk_` zrBKY=s*+OcX6SXb>_(*ASc9*^CF01X$cvI1N3a->Fb(ej0cZdsga=0F9!eRPC9I+> zRewDqE@gB*jfwQhEPbM4Hj&#jUu2_m2xw5%&dWTy+`Elfkkf-HHU!*S1Pz_(X}nO> z`qY_8HA|2Jd*mzBoBj~$UZNYZeJxV0l>p?lvO(~0pWhA%HEI<)(+ln~DpTTCtNerq z2QP+?Ow2s9G?vo5yEaJ{`1OTE@RLmhsPy|@s@Z||iid7CDQm5N-ml{e?wUR@H zG%>+L*@wmC+WnCd;mD6CxzQs3ZgfpbA%0#ObFb*l|r$T3WlQQm-((>g(HP zC#A-NNZ4?g6czO-^W}155ak(^k92&5SZPFS6}&yf(_A^7Ozk;*w-fIpUR$Z^+ldwm zO12=wc`+=Cn5fOfw4MaxhN;u?$dpemkzQ$UFvZSUIo5wp!(%`jSGg?i za~yz~vGInea4N!p-U>Nl#{rAH=C?KwsDQe}w8mfwbrFPf&? zEAi!~4Pm4-t`d`#aGqKTw&5UtLJdKra&RRsT2#EYn?ed}l#xg1u7?|Eo z@7OUQWeiAUJdjI^PJ`W5p}HKiWtk?`sd2;Vul7MfW*O`_)kk;c5#)z5kID)72UQ`vC~-YnLYl5cM~-}l}yA^h?b{4Jdn^^l8lL@2Ex~E z##E4>D~`S}2#@Q+>~lfmWN@l^!~|g|I0dv?w^5Zc$V{;SH_ zHHq=!&^uiTC5y3nqqQ#WK2hn;YQR`RfXJSt-q*K=@o5}^tFWYy#1#4DX6EwGRIcEI z;i!kx6q;g36LB7253LMIp>vNdNzNMv&7hrDqiY*@19KfaYoNH2Y*Z7><~fm8%ibdQ z^63Sgt2$pn1m7Z*R7RIn8jk2V&(da8Y+VThdlUR)wkDadoGiBm%+jsuOm@RhnWHg< z(2=aumhutQ&Qa#6%t?!L%B|v<>B=*%n9WF8PAHEMq9ccBG?opQlO;_)>PZ$hS=4w( z8x^G6{!B2P6ry~|j%quk#<~(EJ-`em&gr8Y(vOt=SWU*){{V&npk(G|-$BmPX>fa^ zHvX~GsMk{!3tWbQ^(XQ$9HwcpN~tYbvo;5jSMiS7%`8!~M^jCeJ#{;Oz1_5Nv04sm z)Mw{EM`VxMymrLtXHV#77hp}Txfa$76`<)iE@g#^lkp$zgxIR149g^p$w(*5NCBgi zx?|3ZnReIYq7UZ^u{vL4ZbFjL0G1m<`i!YI_=w|YR8HWQZ35X4J_0#n=+k|s`k@~o z0mhCr)Pqj_kPk};?TB$To5PD&y0jlHe~c?ood;E_W9;c>kI(qWEL9xm=?`YQIafYW z+Y?3=Q0Eo1%>&_={ju9QOwd&dqz%l{Qal2G+XbM~&9-Rs2-QwBv*VNl`N3y&vpm%* za%fp92pvtY`{1-1S;$@yc}D7dsQ&=TG@suFqnZrN;faQR+6et-LHv~lqnbYG)|#Xn z*+HfHF>myYD#YpgqYD%SGIJr275bni3k?7%=VeX3ncq;P$4*y~g>!Q&7Hy{!=4^i` z>CMeIqMT(X)~TK57X+x;tW8@-eeamO_oCfE_G>1)QbW)qYA%ex=29{PvXC-ewyJ^&Bl39#fNR+BKI zN&-iQkXVX0nP|)mfCvuJqcKK$NyM$?xRf1$BE~ys9B4I4gDp}>E0}QsJumy9QlN29 zsljfD+LRF6t5Cj%`kz=!WQ4y`{6{{RT(iqdwbSyaM86zgfQuqCTo z}gJbC(vArO*K!0HBviKc-16VBXkpBQd zu1UnY87opv!MNYj@K|XxO;O&QyM?oJsj(0PLw8@7Vw^{`FyL21VQ<3lv^OO}zLP68 zQfw)MrG~0EADD!TM^I2_ozdmX5&F&k{Lomc_#H=BdR-QBWfn-XQjlyv6C66k!<7d| zcQY#UQ)Hi>Xzd8UhoOyt=3&erC&VBT^1J|d*6VDh{In1{^2OmI?8!GRCo-feQE7Ca zc|5Y4A4Bqh<2Mq^4|i6>ck)e-?||qtG=>PULeu*zv;jt|bik3Oa6A-m_{UBdrY$LC zWGla0zzp<+qNc$~SxPQWUB&$%1JePjVYyNkk-mrWfH@pzD^yv+JIX@5n^nKfj?)vV zGpy9TC2f*a;+4>+Fdr*N1yVFxkz#P=Y1fnGn2*dr6m(^9;$@Z=x27CV-R1y4DB;w; zCt3NWHcu@*-hi8t@zOa$tTT1RvYf4@CExLYl==&89MW}8j3W}%r4D6DHh)|uM;-fa;0P?BR~*I`Pv)OD_N^j#IlSummQb|3Kti- zBgm%L5K+f3Gmgc1>5x?;J1>)q?XHC;>1x{Y)oUL`K|yBo(~~mJURlPAb{e|cv-yn4HvA)$DYKfnnc0^?P+?X+ z@luue9+BD$I#cxZR0p{%g?OVfOmI2&H4#pIw1hjAXd78uM@|~bq&4^IaWwpb zN?X)=f=AC-J!g2w*CDVU>w-T#*SU_{s-Js8{eAXvheNBV)PN;>b`5S6HV4zR9N1S=mP>FRd9WyB) z$0+Uj8Z*-~Y$Gc&{H1v~HT)yA4YRR^>+>=IA?r2>xhhCrzXAz_xQdMHnbxXS(>R=~ z<*am2NeA;Vog&=RIZREe;Y_6I)ji+NJETso$3l92%A#^O!bj_77anj?-BxQ!lu=kC)-{GD%QBM-r9OXJ@JZI%rjk& zFjaBHu4+bM#iU#*Q?HT&b>A@B5cszK{{WEWVMcZ_n{(<&1e64Tl@oh`p!FaDbK?}v z*=Dvj>r?#Hf#-$CaK5G&D5aUkbAzyL~1gd+CuT#rEsI&DhHnUZg>jB%X_IIzl! zRFjbO{qUA`8Br#c>Xis=S;w6%Op?Jl%Jfo(-hlYSY*H|N7+G~LHgh8|3r|t!{`Q2? z)2CLbwNKEY#n|kG6@F3IupunwB4Kt4m6}pX*ZH|2BgEgr6Jn_2&OXO5nOTGYp?e`Y zmOQc!zP5(gq-rR&Q3!3>r;yrI3ef5TLcr<0(;Vg~Q%%&V@<>~&aRhEoU;wt=egZhr z)F2qebqQp>I*Dgqk^~0X%a!W^s?w4UU{69p>LCKe%!d%=aWdR8v|5XcQSTv1 z%@DG4G~m#r-!6qVv@t9@QnkJJ{K;|RTf5%Y{XZe6n&3re3(Gty53p4uIH}qmU_zKn zn#@SKaG<7L1!+R=qMXCHGKhCZ>u;Z*z;W>kT>7eiqav3b@cX!0N=jZ{MtmY>q3v{b z<=M|OPMCBbZIW6PY~ya`QriTObx2467`5Q?TfSRwdwhr)qPp+!{K&&4h~%*4Rd`m9 zJm)G_Wfe*qpKLPZl|YZKlYI&$NzY>0Nh$!8kekJ>MXoJAO;HXHOY=nk0G!9v>`_Ex z5f_n9L(?d5I^eja))CxTm^&qx{{Tj;+5&Hu>WqF)5?ZNmz5FD){28Ig#KyPel{@Pm z-xMg6nJG6P4b*9}XqZxG*g>0UnF^{uNJYrb!}ru^6La-_?Hc!aK9zg-sV~uvd(3*f zt)HA9>V!>BuTP?)ZTWhwIjL6)YBG$qFw?Ko>Y)8^DFI(x!{m}vahEcziyap%5|Uqq zuD=F>aS`u--F|WX(1?@btrDp06?AVfxTgq^k@uFdjuhL2My!2|9(XFj1i9%gh3E zAyx^wAs4l!;Nd48i@#su^yEX!#l}nN@sCfMD(ke?A!=_M&ebVAy#2?l&SHnViS~pi zGC|Fn>b0&l8b-H<#^V&3pU;s=+8uk*lDvs$!cm#Kg6fo{f<5JC zB=mzw+mN-Z@nVfYOGbKescw6G*3#)p3X!$!Pr&#`C{ko_ zV(H8hE`!}8$b$%yCF01+X{}NMCKeeZFSIx%)^g)1o?QdDey zQ6g^2bs9W`sYdY_aNTLO6C7fZ+i9`{Mv(G4Ue?_?DO0LSK~P8}+Uh$2ey5;@q=lio z;L}T~N=-}?l({_PrAMF&(4T;ctiQ==bN{{CgqW^ILsB9m1d~vJ{Y_qH-4!n}9y*2ZxHG8d~3eb!l|$mv1w+ zpKkSkpX?T8mHKl1+1T&T^9Z-HrAciD*SfEvaQUCIJs~ah zOXJf20Asb){{TZ`QA?I7anMw<2pMj254t>kdcx!QcYD7sh)k92w*5@A^A)zwR|JddA2KEe*XZmkWDs{ zr6FN%>XkT~DCxRVk>T);>PxQu{{TdRMZbq{+>7=4TT+o#^egi}j@y~LcO1&VQf%&8`9sTbcagMOf^XgUr)eT9b}TG!q@#T(mUrv4BkjBIgc2x73%41$(Y`bt4jNC8^8kzm}7 zZU;lA(Bx%DPOTdUeHC}nGVIe#l&!W%3n?kzDH^DerH{%xb|%fq%Ec}8Ay2TUB-b%u z+JSA^cUB1?gJM#3DOK*BMXd{?o1AG5D#=OalWB7^X#lESr;re&Bz>g0a;2wD2?y2` z*P+TYF^iXoRW&l}83B}TVGB3NrLO5IBH2x{i`&Oh9AV30g~k}RypB~$VqwQ5(4{mK zhS1k7XHpPsLepVun|MR0*}V zcN=3BxWJp5a$V_Q5VqEYrPnNOk}jYuHq1BPI-PvZ97^&WnW{`wS(teaf`p{-% zY^$4GfqgG=u8^eq1sXCF&dQ}WK@Jh`Cs3eARGy|f&Y-MfciMTGY``|9D018%RzCIm zr%wyVXi3v*nN6!sB3qWGWz^z%*I8RiLNEF?8z^7E+R$4^1oN1NUX4*ivMLn%`3N=O=n>8F$?O}*dS5{>aJsuwO|oC}RD z#@lVBUotLot2X-)eSZi-M@8LP#7ay(FxgIYC?wwc1E~01{^;n1xYyHLULIAZ6tuQh zq`aUBZ7R=o5Oy8i!L)EuFxp|ML^XV_%e=}^77uh~_f7l_?eP%p5jl?a230Lew1nu8 zMTPINi7;Dy$n$%Vy_ZfKn8%e>w4#8N6rH(&sR3}3bg(3g_{63ls{jXNdt6AaPB zo)*Crk{bcps&a}+KhU(Pj_*=INd5XkWc7W2G3dH)$qqgfQc=VVMKG%bw@s!buKNMb zS-*vWzoxO*Exmt1tv`i%zuas%i9q%&3nM2eP`_!bNv*uvCeKfE`d;G1`tK3(&eCts z@?^^VZn`hnd8QbCZ-_F=2kIE2J8|H*W>P;8pTZSt{Qm$#Jyai?8=5^?6Sz{i`>g=n z-BNj=l@LJ-d@u<*ToNz%LsFOFWQ{j9kQ?>z zg}1u+5!dj`;x=u#;}Y2Y&R27 zQGeA6i|7o0lYtMPy;c~ zG)>ju1+@6W?{A+!krt{i@2MZ?ROG+I++xvpnx|^DV6`O{vXt-^1Lb(@oiyu}ew&YJ zwwIUgN=ky!DOtm*DjAHc=}Lal0hDX#Ew8LamozRv!!L^b#H}iyEl``rskl!#A-9+R z076-H{g8a2$VsOBxe3V|QS<%ALlhy&P8s1q(#S1M(DefM33Vgk;}2@K@6YmKr%c*k zYhm@8E{-R%QkC+}0bxWA=ptlV=b_%itR=m?@AMk4!}r{51xV+5jVYY8FO7KM9BP$1>Zq{=AeSFeP2?uMhbzlZ85@QVml ze-NZ8M660?zT)f=-SY7Byed53$V~qLhCe^diuLJtSmCu9B}!77s#EMrY(Pxyg~yQ6 z@!T@C@_&;g$$zqZzeGs7>ee`cOSigdGncsE>svMl$Eos$`MVj9`&;;-ufgxRFNg86 z-CCBPq$=4$P%Z~33s`Rsy}pNJw~xUId{~F&sT@19$8vr^C}q(905n)1D0M!62l=5D zQh$BN%8=sE5$XxQbLd$!Yjx+l4gLN?f4TD*bj{Td4C=hTY9^CEG}}P50??0duMQQ)SkJQ}QNPLKYSZ z(tt(wDbVkshLq%z?%h9t`(KV<2l)$j61i?CJd(RLF^AhFvXDagb1F`Urd-;Nw}~m$ ze1Ae6Ts~v~#+{lZs(e1Hs7fUjniW=bF*4CNTLNP_Kuy3Y<*vXe5(;!NDjCv#m*^72 z_DibRQ{kQ#<8A@h>6Bb8SWEJiITt3<)cQgi&el@n7YTIcAwZ;})&$&GUL1~CzbCNX zm%otV(K~3-aTD_tY)d0CM4w^hOH4ipc2zGV+R9nUmgHOlH4wUMb@%cU_x8oze-2cp z8%*sv>1wQ>M`cx*q#wMLW*)l7RP5u03E66+sqT!0V|0>19-`NW6S20a=({xg=pZRA ztn5d6-!LIoBwldw=Ufhlib|5C>XBe{@P)uchp8&=$5^B>oJdmUDoAMip2GURI}gq) zIG^JA7JNGVKQWx_pHEDl8)$*5o^+q>n2DL&`|L=@wj}lvyVJ8o^g;lMTq~)3h`dVM z<}Y%^!BTqGfB=91BJco)#=Xu#{bD}|V=5ej63Z%1$4F|2EaXkPNH^9H;wr|$sg(-c zvA=gCg5G)HU8;J5}URsL#NeKuR9ybt;BCHoF(>MJHK6=5VEHI_bC|j1H^NwgcsNqdvl>?bb zDf91t819prg{KPIRINxP6Jmv4ybIekto0V>2W@*Hi3d^d>mcl?8b~@(Q!X@FT?lF^c8el%o z2%cr;9SK&6w}{npVK%bl2YE6 z*2^R3XmNW*N1&f}vkM#tn5*V(7|xWtB}yPlH?S8c-sm8H(6heoXj3pvUk6H=+HNPO zRGOoybNBr^bn|=khjK;shV@;JLEQw%aO?QA{8;&$3krBP_VLXtVHHXv1-Hh5Hv~n zgZv>H1!^|L-A}4X_$&B9pyr^acA!4WzDM{$r0$_RJ?-jNeNcRCe}s09Sm*GDdG{WD zx0RTX4ef6zdl=N%?BZYf1AF!iJj5ZGYFoH8=?zf3F^2NM0qhDFee$2m01)_oQ8L;p z#a(aX2twGkX({Lcg@_keBUatF-~G_!4oFrm6eQO$02aIe0T2LEAqN7KzyS!n039L# z6FB^oQr;;SJ=+f*c7)52IE{IU1Htt zW7$po0LZ_c{t)C)%$RAcV^*z7)FkQ@!79*`aFz3O?b9wq@8fvnqez97+GGjg6-q+0 zTBV|{`khM&C~dGa1eFpS3)E#uzWSJjnlznleN5!gljE)&ukhTtoz|PC`%x`3e*3_y zHe~m1P&5SI-6NQkW!~$U%8DM!1^}gET3oEe{L9iav*B)~_KP30h}V#q*1-B;e{qI#aOD^h|@E@1X14iTH7VKp%Q zBq{#@WNb>Pq-H~|yg<&Sl`6-sU2K@Io0I3)ai$sS%)bM%RMgbFMQuGOmy%glWb+ht zAgfHe>um>wFC5(_p6Toie7hs|mKC3DVskU8X-~M9w8|}Y5TZ05N331&{7#RD zfhn*@7ATy1k>(&b%xz$;vZRudleUKaI>n|wCc^J#EGc|Xpgij3Sbel9w3RI&r$7yf zCjKzB#i!TuI-#1f&ep783fh6g1LFSB{>r zp$9(?WAxQ?Cz7%gu^;VH`S zD!n-}oaG5&Nk-ScmoeT!R?f>*7MLL1sE;x~d~(jHogP;-Stm}S`o{%OE0tQjBUuF9pyckA2DbGj#SKyxnDCfujFs?7mkQ&0?Os{Y8)i>BmJ-j$4&NFmlq(2 z0iNgrt`xcuX(9J6v-WvZ>p0?}>4&_rSZ zJi)QmXzhI=HWRBzPotOr07OBt+h;utKRt5cDLoFBj@=2S%~|Sn^tc737d);9?tw`h zacCA7GO=eFP(Dfq1G|{jB=J@EA9SkFYB{BW>=QEzvUw==T8aFi)OSl~T@ur53l%r( zt-mNup;W8e)jj2~7E?m2H-UiMjWn8Omp7UrY#6f3h z$PxvzpnMDgMrUTrKoqjIe#*6lqmSS*n2xIB7`8!Z1qxKE!jf%!co=bV8+^yLRd>gF z$x!e*e&|8n%_*!z`&uqod~g1&a2 ziqdc#qWem(?CpF>{t?|mbom>tVKf32m9!rsVAOZRMrC1!dXf1502t<=(2NS8$+h}I z+4Zo3&gn)LLZqSNOz?ap>9e^@yt)*Xe{k{9Jl3M zYwRC_Oe(}tpo!BiZ0Wa=Nguj8Ce4-2p+hyrj1&e&kcU#GDQQ6Hbb`W;3(IW-y)slh z07(3dC`pEj{EFPlg^)?_DPO-+0|?NhT`rk0NNvQGbuF&PXFem0?mU5q9leFrK=(cnt%wGQhD?w*kW`#19Q)PEiY4L58 z6radPTR4*roF6-!xZ=>Xsi6O~lBcRT$zp!Am8d$Dj6Anw3+-X4J1#Zs-S>tyC#UsWY1_ZaO7a`IMgs^JMH+IkP(AfVJXyl0ngdk#)r0Vg0Q&=7h*`0Eu@`2Nia4E3Td1@ zH#B>*c~6HdS`sdwb81$Orlr(}9WG2<<#jeT9WH~UaP1rvVJe<(^!Ur-T1p4b<~wIJ zzUMxtgr;f<<*sRD4y~wb_(xMX(U%F~89E7YO(|}zb_i0{mnV&^Y)`BWf>bJ5l2t#v z!-QN|s=$xVIn3=)oy0hG#?Ey-gPUB*MxPyYj;1D26LjieDkL+{BkczY0Qp=(tU^N3 z6`6;c_H{6vm)kfe`&NXG8lmT<_ia4Cx}}1DC;-+IN^qQwB}3t-;Q(2kw9FK*p2E&y z^=eA3m(JE1paVid>B?aWP<2B3jH1WnZX=>qg?!IcmZF!|grDf`x5s!6?#|6QW|*`o z(4~NGp}qca0iL;EQ<}4MCilsqF~GBooJ{Q9nr#5Mq5w*QK_}B#?FE}v6wOkKMB7cE zt8c8zNdCp6hk0`eCiBX0oQ=52wp+LgljEoY@B%wdOf#31w1b%1_tRe=0p}c{R$-{& zW@+jtkbz~;Pn0mI4aJhnVFb6G*T=aD)* zhppq37I3PyNz6in>~kK@9m<^cD$0$@kO2cZ+UH@?IY&$syf5?vMT)e}TLxmvAhfaxDZYg(zV_C{LK+l~4iv}kRwkxpCz6?G85$$JLX&;- z+Sl^jLK+m9}O@Q{gC47EncrPodCX(i>{UBUVos)1(ulsz4^? zDz>NLLj6d@{DZK?W;lWaBviwGH#GLv)G*3Evm zzL6eGbrT`#TH3Z(RFh$F6Mmke1tF>d4mj3?A03@vp6els3{&fzlST zd=6^(eQV48%#|5p8Il6ljw&x)W%Alm?0NF!gFR>j6)IfH~ zpT>U27(0x!UfVKp_>BP)(6EgPm=y;A~VvQdFQ8EJPxC-pwuhuHVR7N%J-MF~iy&K4NPN z*Xb1Zs+7Qh+}fp3Ozfc+W?@B1Q0CZWbY>?o&0r0oTJLlsTM``bI}5&&hUroasYAN7 zO0*P{;s{K2yBkuX8S!TdJHkoTVlgbl;iop+Q?joxg{As-YXPf)Vz1wFt$ zG9*JU^(Eu|3T<)Lmoq-wqxrht%QS)SGz!luZLbxe=&%7LJ{O3RW{(QkP2w6`E(b)y z)0izS%;dNHqMT>-j+xV{ylv4IJktID0CHgPTeb~DhSH*yTx?Cs%ao3KR7$x@_Z+u+ z;P?$e(8G%<4<`tnwal`d3ymo}NR~v^G4!~Fi-BSfrHC5CiP>8$PCUiHrxYEa8>67a zmABFm(ar|O ziz63wo-N|#`#TQSmdlE7+NO%%Qj*-Ewp`X&E;+g7B1c-W$FS;?9obwph-8~?)!CITMF~+`C{QXoXf7@I!!H7T2Nr5O)qF*W@DY^` z&#?0fc&24KA&|1xX24ffEiJmkdF;AW;Z4=EiH!znAYGt)* zl{B2mSA6|mVVfa0Ab|~H;j}j7uWhf-Vd-VtZHGp4jWt{@W))ARCaEPZ!jRc+YTp~jHf&vuF$>pEBssKW_8t({~1t`0HyK?vnSyS83 zzcF)3?H_~c?QL(xf6qDL3XcfCrJzPln0X6364**_N1oo=eT3DFrI#An2ieem3y5 za31C<7u=akb4Xf{q?2^+hfuA;)2G1hAyGKdnxQhx<1)5wc@)vJXG<)u#Mt!~(Df1D zzp2D=7fP6=A;n5_0-QPotGW+}@FLKp7Ig7VCA>>8%(9lWmE~HFYb60ARS|D^Y6Xq; zg&`zE;$9ZgS3%{b|0g}B&Pc!sPtCqj}*1tU;>VaGdE2^$nT?8R=J8fXHAHscCU zx~88&DoG!zpln5jtPT1{8l$GZHnn}0=#L4xxLM=3yZDLni}Tk z*rrmDr=?ch%)5)1Q;BedC2eb>03;HfceeJtIMu(1BcV4Yj7uho#f+i%5R|&&b1uVG zl-k81BK8}Y=kT58Xkx4^Fxn~}!7%BUN?LV?997oh@{ph}VmrQC0cdeMp(8+yN9-<2 zwx>uh5R#*FUut=_ig)`X@E z(M*7*O4HqK*FvVHoOyRu!b%sDDpPL_ePDe=qdpo;+{^9DEOVx2T+1&nVVDD=mbGjU z0lrgfp0U|0TY8+bbFQl=z{(r))b^J%J1&wEo>>9ul?~KwvPm9R9`=ym@jb+hpAM+* zVEGd^CEpr@PFIPfT_?37}upMny z0Oo9{Yh%{l@v!T?;jTj1wwqevT1rUnkS&yHw~^>=4lmqhT>S^)gq*FQ zbm%XAyy8wWEXeDL@ggPgwkN77w7P|^aRE27R+J<#0ln>WaC~F1TCdHIa+FtOzjL!c zPD^zxB__5~OAS8d^vc<4RVdJS-F5_R@q{$(0_7+7%)vxx$<5;l^#lyc2}!-l49S7s z@E0dfSX!2=U9AIKNAIZ8Vk~hnA%(D7T9;|p=jUn24X))W0kthkPNP(Ta8BNF#fsHm z@bBrj>N@39etUZV073Dg)l*f+H6*21`aYE^+R_2hPq^c{o~J5Bt*|=l3QMTOwt`*d z{Dw0OQk3Toi#+>G| z{JsOOi45FK_JNnXK}rsqo6RVXlsl_x^Zf|5_$+L2G@}e)n)9k~p)(aan~p0j!c=C8 zbRHeie^Ozbt<(4~$r7XdaUFbTP)xQZ!psFDJBXgr-QtwXq}(2Y_PCDez57ty9@6{j zB4{%usoZo@;#|l=vgIQw_AhjvqfU{??*9N$bJ;|1CFY#PTrk5gSRrNlIkGnHype5u zK-L#DpxS*KTl~)BdZ&Hke?&;-tScTRDGr4SGK!92${@@Dk(Sra2qyQnjjh%ieEvg! z^KbnkI?BB?_YJWTQ>sM3nW^{6ZlFZLww+D7`NE+~;qmxb^w;B$!49_(CKoF^f|N)l zQ^5+%H1A2S=gC@W>kCT$U&v)Y;$Bbn78nv~3dOjQq^OdVNGU+{DrH-FXf*M>b#oIx z;E&8?Cx^B0_DC00pei!gQBJA}p4g6_zEI3Ii7)U-2-ya`1TYSeQ&L0FMv81VT zm4L=_RGO54&6j`X&I6}Q!r?8xDgJ2VUy5E|%y(%lTZnV+T$|Bl1-gEn-N&JIyQ9VzlY~#(^tkNf>i1d!F49$%My109}KqI z`rZ@1_sX_9`A6gWi2neptl^v-r%J$F?LA4$zF?IoUf}7bzEIm$UlIHKbNDf0C3A5^ zxKyGB9!LqlbY5)VPM7>*RqgZr2!Gu9jTHpG-U!8OEtlL?PN+gk>|7k+EL45l4F`~h zB~5nj$$#I7>tiZv-o+R}#?q0>YIilw?2|6oDH~kg);nnh@vN4>#FeDTF~kWqPGLFbszD>X+lVc? zgVZSsC^z^BQkdI;*5Qk@yvN&~Ym)LxZkrH1G`;@-IC~tdYa}R;EH2{Ew#1}0d_)LD z`)BPLH-uI34}Xzqfo=06?`7(;8N*2@`Zu0W#4S-9H}MiN?uiM)N|LIRGizUfx24QK z!}EUvKN6`S=vpG?B|N#B_Jz^I2^NlkQm9G60gp~(F>mmehO!HYk#HtiCB>+O`JFxj z8Wmz~(e1Wy6{LOJ=zQTPY(g~G{B16L1Gf1>KFARs@q$Ae7rxIHh{rSb0N& zSmwE+w~m}R3`(~_PDylt6tbn0sVY|Fo~AiRY<9S8Kb^R*@niFcA|}U*tN#EX&i=uN z8aPIQPHm=V9!RsE&gs3*gdo_D1J_Qlg%owN396dSB6>=g@~SVnHinnZH78JR=(+BM zkO1kf(B%zTx5NA=EyQY#Mo>&uWs@QlQd3fKS@PdP3PrZ*c;oqc9ZYOw_=HkskQ%EL z$^MmMuDbzzp#G1q#ti|ieK2J;+I}O$&$T-~wkk5yEgJB;iGvbPwEJj9zzm3>V=6gCwKsCxVDg3YX1OwIL8rQ9ir*qNTQ~m zf}JFP=PKdE=;KyIE*-SGHXW|I*|Nv84LXeagXDUSvDrHil@lAYrA|)}VY;iVG=>~o zUtHP+fLInb(_?Fm;fb->qAT!~DE9Z2l_xBW?%-|{zpQp)6PLlIDsoD+K(JLNXb(FG zCD0;RKMo20PEytX04~!10O-Vda~+9b?0$_OvOg%0hCngeI2|$28qOer&tm=xh}n6L zz(zXy7#;Ni>S3W^B4LSv-B>UHz2Wk5KHwj8Lf~Rh|3N&s<_k;L5UQm%*25S0qD0nu@bbs4wh+IqUTC6cu-{xV4Jx9=-fzBb+z*T70+ zr-dzwsS}lHYL#iRCvaLbsU>81E0w3n!dmzWOmAtJ_1cuGri|5aHid@Nevw9sBH&w+ z40W%8%dz$0ten)QB1E$1=cc7*X=#}a%{|P>wJ41U2?uTM9BR?qqGRypOiD~RI+T9+ zOjQbOaxowLfxY_%6vU=5qMqBJEUC>!^jQPt4AAYI$?0{1o?6tAe)Z0zctTjDZSxYL zWfN~$>A^JZQeIWUoZu1T39viz^_Gx~>re^tg;~lRo*m9NHq+d*ah~_}hae(CB07=LJC5#}Ys3qYmrsl)e1%7t!in0Hvcg%DLya4E z%b_OTIbo!Qu$ZJ`35F7yQ*0s2+?SM82apL;b@RL}F5_|-8e90nP1*EU+hNHkCEN;e z1cf(Yrcs$%9=C-`sDn25vMY9aovPB?pO~i8>Pt@k?EG1JjyvJBTM|CYBH_S*%hGI1& z+tMLU;*#vXqbzGBIJGHWolPQ&!*a4RDk^Tm>V5KZg}Gpmq5&jnr;H;eClzm-{Ejqr zc!4J_!!xq#oiEI(4K|sLLvqPlwMvDJk5QFd4Z6g5K3h`l+)5YtTYwX|FAs#_hs4X% z_DsvmP(pG72~q{c!Pwl~h;Cd;oWB;yT~{&6)MtAE9t>5JRhN0xCFGxImP)y3Q-F7h zGTd0}p$6VD)y7I{x~@;H31|!*h-C4#N$Ck`=ViI=Im>J#yi|24Dk8*n=ns*O%5s9g z)aHY)j4~c%9oKr0O$|a9S+C9L)iGc=GxnCr*t9I;ExuZrp-;h z%+t%4Xf1P+vn5JYyMPrGp;~51*l2C0u_G57JWXok#Oba?=HbT{U00zfik=Al7a)G$-WWSKN?}QE- zjj@qMS(EZG0h#nRzkMlHyhY#!aU2rU_9-dTO8{;1fKJTmOS0UszCmvx9XrUv^x_@< zjaqp}4p^I;su_coQqHL$=x#rJC_`s;sta={3JDLiaG0POH2Sxv~d5)?cXF8~HXC|A_VwR6_MKp!CU zRXMp4nM@+y0b)2P#?5-6Iy;i-ZvOyjN(b;3fbFw&vp%9TxQlfO1RsISN8uc_8=H;F z%xZI`UIAME_$(=$3WM{bWJ;)xhUxwAp)UN43{|GlWWOgWP=4z5{6qorLWMHS%%?IX zng_t!_(v{f0OcwB)NI9+n z@c{n-7&QlmW0;^k{)u@hPeGL5=b8;iG#C|xo!q};`nUcu-C^PRn&S*igZ}^_7an0( z`R0RJ&kgrCouo~;fP_9$pmkM=xb(bpP^~Yyor*inpryw-it)Bz!sZP@q~K3U&C4IF z8IOU}@w_cDw-$2TlbdwrC{gho!5y(0S>r(Vk>4*ie{RF@gHhclQcn+}KwY=pC&NAe z060#eS}UkkN+E)7;`1L9c9ANXB=6pAereO(#yJ# zKGKR+{%xQ+x;qK0a{&bfJb)1PlV69-W`^8k_!1~ zvJT$p>(Ua%Ga9k1>erF!ack}sdwk&(b5O3Q&$~C2Bp?I1R>Sdt5wkru{Hvi21T1w` z$R7yd)0sJ2_C;C3kWW;lM11v*iEPOyh?!Z@!d2i>q4~i5hQQaXyKe_{k23wLM{qj6>{{R6UICNTeNuO~5pVk-rTgWRhRE6O1I1y;o3E1X-v&J8)3ks)2Gh%faMsgRL3Z;>JmX6Kv4N!0OV_}>WM|U z11Z@^x8<5T8-mjn0z0p%kJZVW<8ZMY1!w=%yVAU#^3!iJ1XQd{Z^S_ynwABAe<2;xnadS;e~%ce6{#}oYn0I` zLVm3_@Y3k$Argv5QyoeEC(K}Gn{5jY%qdxvr6dah_l2#mO(BMd6B1SaHqB1C?OxWk zymvxbO4GK04F#{(6Gv>~)A)^Am^t$%T_)$c4rB98zEQ@J)OCghfsO|cJ+j|bkJ`TE|So0LUGeD?ruz(QRWri*2)1^ z{yih7M3m+q#BWSVPE`crgL8-hDMlFHP&)HJ#2U#JJeVi8x3h@>> zd`x!qzD=FxIs%5+M3R+@h20#NFw!OFY97*p+QVxHdjc== zjy#vyhLf33TXd2`O`$j6-ann=k)3ur)q^^gr+e?VjKg9D{{RgkPFKw3QOqq&Bos@& zwwos81_$O<0+U>u^gCa6bmg3zl&}*Zi)d7Y-{TG`waNVi(l^_loJH*RapRB}TFWKZ z=yH*;Uz>Dl;P|vZj494f`UNkxVr8k|NfQFz9H2jpb5mV@fw8jN?O14IRT=M9sOa<|D0z;rQkoaXJjV%Y<1)1NDZVIGG&w zGT?IYZWmQ(wJ^v-t3Xm5K{`6h##N)PwmNC@hZb4{h)cpnPxec#KS8Os^6<>#s&-0r zHm*#XmPswV;TB3y-cqa-JQbzB4C-E0->DNUI~#PK(fCeYc6GH*Hsfxsz@;Twxq47ymSs4`p4qE;+( z1q)vG+e=4K&5GXHH0nJ`no=qgYL{^>=WHRqVw92Z5;G>l^|iDjOY;{8`3|QOl-eh# zY8t25T+8M%rqLcm%zvR(v}uWU=A1*6*=e=7xu+#vTaF~SQcp5i1dOHOx>9u@i$n>U zoDXI2J8aL(x|aQpogmo#4D7X=^&))NF!oA;Vw2N%KWI) z<|QhXN3Ni@s!fIo7Yza~vH=8Y3BANt%zZL%VH`a*GbWbPIC)@ccF>}3Z`5t&u!`5r zn;t~b%GiOpes=7t3>8v{iq)VNZufpCL zPgSuKRLX$l6s#z|l_?>_-r%-$*Yb&3B~i2{4|3a8zTDP~4?qb{_*CV@hN?*3oW z_m!%wY);3*Dqc!|$efj%vivQdq(AL)n6KIAlGCjx+GW{vB@Zh*iBn{NNmqLNgSMJS zRM(I+blIn3Dgc!q%4#y6mO{c^a#1K!^9uzjA$H6LfkR&y6r<_q{Dic`n)p9goMZ(~ zP$!!*Qw%K&3t&9#!iiMEoI+MopbmjI3bwW;@x>^w>UNv{hXSYB!ODu}TbFK>*n1BB z7}#oKK3SlvnTsi~N_M)Bd_$4TUcJ%B3;u^A6Lve9#p#!I;UXTCpr)S6Q#9Zn*o)!d+sq|bd2n$tIJ)inAPax7|4;&dRU{op~d2lI|3 z7e`J?P)(roEUT|7t+n*MzH!uXu*|aEO$thLB%y0)6Ym0oMaH_0qVTFYbZX1VszCvi zo4Qk(d3;Xh-h03t#C>W-*Ia4jWM3&qJ1zs2)T~&5p>mVdTyF|OhW8W%8Ra3gnRd*& z64PtF(f~PtuvNe(Q-28Q)NNq8ukto^Q*}Fr3IiqZE*(+TBy1I7y0^CbLb>ud#YYgh zblxtO_R2cBz=b+g+Oq?YTqS7)OfoD|Y%-}ptIiyI960iLrTjvfFJwovEe$Pst`voSgm_&7!dkIKXJy341R$Rsm8+01=hZjU4vdTC+faNfoE1rF|{UJ86x7J0}jQXXmO}?*VU^U!B z4S<`d@d29MYIc3p+EPIrmRnNtb6g+=twd}9&|dc6NaHw=)70mlu1y(s^K$0gLJE+Q zLnzC21rROX*(T$7;{1+|ET$M;Ds2-|ue#i#5ZVK6vYP~?>Xj^$adUEa7qoKD8#q$8 zF;tmdHA_mHZN;TSE~y6Ux>dc(d!!wSz2mjeOYS*!l{q;xH6Y5vYEv@kmkZGu^-%+T zK+x`faJIU92A13WMV=g`rjZ<6o*L@)0@zHHRO^hc=p zqZ!pn`iCW?l8m~X%*w245S!K)>5>v2GcEI&Fh3el=&-5eL z;J-1fl|m&jb|9K}l7TZlJnM$%AiLogQ6q2?3DbCt-Nllt@x^va@*LbrC?>HE8(LgR z4Kp~PEpo7?P>@0BHT*<6-s|8qAK{n8PT|&`m#pI_lAuyVzE1DDw8`oZjk~|XJ8Iw5 z>tBW+eMAEdJwJpngCSu&$=Ydf#*|vIX@;oOw-bFx~2ls zRrE?wQTB(|k`?HG3qsVluPgls@BOd+A~VyTeH=5dlq(~GZm0panM~S;Ul2~e7*k1o zKO{T-_4nL*@dTSk5@BU1pg7#D;7?L+%V6a`9ZWZ?kVS1TkLqY)sq{Be##bo?9JMIe zZR~m#e4~)&{KZd{KKhL#^S?&$;|ye21#?t%q@-_mQb+^R@T$IRzdxAb{{U=%20#A* zOf6hNGI@_IQ3HWC7R+XBP4_wrc}HA&{D|xQul*sVk*d2lg7GtqxJ<)ywGd7~N>rCR zr($hrW-DiFnI>PyAA%h`Xi+mag;KI}`&Te&p(&MJ&H5c~JYmgMUwwukzmMVinQ&yX zSjKpXXytGK+V$)ZXx?1-G9+n_}DEHgzWJ({nUj5b9P-lQVKW|L5*qkBujje_%Fy-WBNFs#h4~xWCt2< zcWp_$vMw#rJ#XWrElXy?82$%RP%wegxk;kwOE133sa%bv^1S;IyJ*$UJH?acayLf9y zOXpuwQ-6*=U!e5jCHqbx!YjHHc4rl;wKtYWbv`@a&__E7kMPg$s2EC2F1w4|C*Kmt zBHa@zuDy5KJ7G2WVfWNxs+cvmxK~49DP>ZR(_dvtY?Wt3$hDDw1rgUxW4@ z^-t(kbl(Ikd^n?3F;zCEr`JHMJ0jyDqJ@T=aVSg3c`8vh%#yUNHUjXzWM(EC{1p5#Z=ZC zopP`$Eled1a(P9f*(CM8Y~DRB3!yeEoTto_tH~q7CBJ+Wa>TM{mh*~fcDfgqq23*ApN9~4xA%<$mOv*+33UR{{SSyQN}~5x&rDoxC326+hLWdBUGfHkd9DUB`~DQ zW+WI=bsV(o65+^Yo#J6^;fXuI18>EY-G;wt!dSSFi;B+E<&{u1PH2@?GFLHV0=*qw ztO*@R>k0xo;OTrJJx-sXG{+@`(s# zgB>^>A^;kGA|71CxjR`xBW3100luh8reWrmZQTTG=M4@WWH8c(iBH1O(}ME>X)x#P z56%}8jBqRLnVCmYH_A*n#0+g!cB9PO!5^KWE0C_GZE(+r6$*7~r86*urKcsPf=+Et zU`VjEDZPYH>TnX0;&7#5r4I2c{Gl=wwi((U9DL!)*FYcg7=;abWwZ?8DXh1fVPr@{2pw{Z!z180%Wiwo zz_U&E&_Mz?&WL88XgE?+n1j8vK9S2hDq5RMNw95J@=3II#Ey3j5oF9*SQUf#L$Di| z<1H}YiwF^#ICjJ%yg`#;YC%h+q>yZp(@z)z%+2HZC4Gm#vHsZU%LUwjB!Q}3{>S@Z z3p5WBsiShS>Yw(<4%oP1Nti-hPr9H8^fA-69Vym0bWh`^oN}1>X2s0C%k7(`{I496 z1Vh^1B*j>EP1(npriPeCb=~&{gQd$hzkupvl$p`u!h)xWBpaA?vdqCqRgg;3E-p1v zQ`3Dn@s3f!35@9YlCvW`$x{jnmvJZ{5ToVpo|m_rcC3k$kytM=NOoD7I@F}aGG&&E zIqe+b;0dypg((CZ-^TE&u0?Q_&Nna}T**R$lB05M zr%(sND&>}^7iy^>O2y}99wW>*hTJa6O}yPdx`$HUWL$UX7MGN5-oNjHg2GGJ<=N0?NFRG|nT}8?BViS(QlN9B zj=4xbz6v|2$vZyG%5x$0Cf{@e`{SV5hEo?bz_wY1fx3%!9=pM$=D&&6ZxFRU2BjeM zR)#r3l&r-v+cK#xXK{W>RnNdjM6-)AQ(?q}sJoW_Hb0zn<7Q)1VcP=C!u&0#&mN57bUTfsrA$m|E)Q2h$8=V1ZcIg@i!jSs4qN%K>d{E}m*Et#C0Y@+VANw%pP z>)V~#` z4)artX38brN{8M~-;5@X{F%@XH0{A{YxL>zF~LD4*+U-d3jq0F^D)LLd^H!do0m$VTFBA<{6ZN+(szQPC(mE9HB{dFD|aSgg~K<4r1LhNVK@RkTAuEmrgf z@WbK|>cV%ac+r~CS1w)TWi~m}l!NGDanE8NBe30ZmsQGARuq2nbos=X&c-DgICZw2 zbzHWRgeR)a$@ByF-XBDHBT`+*X#M3YJAG~dx1>0R>V`)d)CA@)q$p^WHm}IS`U+3< zB=eN?Zlo!9@IUPk(_-|RbpP7^fLdv3PUPh({qUi-Wnoi{kEv2Z ze(IYb{NMwzD9uu6+U*@LsZjp_MmTjD((Oi?ZsTn!H@9`tPspHta2@1zCMypuAhN+% z-pq1==xlEQSd*w?>A5d@RmBhSR$t}>c8+Ric9U3K<6*_H@(+U00Ush`lqoZ)-9fiM zNISk3jvcegoo4;ek?Krv?U{LPIx{ORykmz!X||X8G$me&Fdatk(e1oD?I-bq&e5#> z0fX)(C_Xx$-vyk~k19&m&f;tZv=)FU!!ac+@Un@&h$r~RQO1$QRXJ4d`eqVQ_g8WF z>SLm6j3~r%ZL2Gj2nWC}{{X@Y4NJM-O#GwCxP3PBA`?QbcQzO;Ob+70hltiWLb-=| zUdO3PQcpzcU;_hlNM5KyllxEsq^wljn#vtRqT47U=|2!-v~y9f{HRRg?3Ab@#ET!4 zc7(YFeYW3LWK5KPt&)E;3KG|u(q>_l3n_X27KDmaZm@>E8vteFYt^1?8j%YcrQ676h(v#@rzjP@`PLI1AZYp5Fx*Yn5aS9Ua`$U7J zI~fV^&F%M|18TMvhy3*TOk3dvEbagY1EJmuAQE_>c%Sb*v)qYt7cTy3dn-e&8tu?5bX&>^B zH{wJZkZEQWVL8{VTw5zp8-PXr7PNNGX<~wvBR5V33kY$wd&nTz{B3dYgtjdvXiZQY zB!n>8NjC*WNh$Ic8+yTEq}Y+8E>*y{m}$fSdz{4$d~a@^5ysA_`5mcRy5(j4nR0>j zT;IQK3EJ6C&HxFDyHq%e+ccIpd@hPQl9FR zeN=4)g&m1jIadimUx^nm9Y6ooaaYDXV)Ke+*;T333#m8T!*?QD#)?+i#-GNR;<7nx zONNTAVpJ3O=QfU{k;4+*#gZTEw`Ir)_X1Cr!oog$|!s>Hh#m6Yoo~ zuMFtO_5@1OQ$1dvS-*Fd>VUVNU}2ZWuHQjx5#5yR6HI4CR_kNQ6Ci$Rgg!U2UV@e* z9KZKGu)|Mt)ljc?wxFzf;7A!#zsl{K!4~$$BHc z5v2bBU_2aEb<9>2Nx3F%8v2}(&wYP%9ucyh!*~)*chgc>{b`_o(S-Zke`xQ9a^37h z!?mAsqwtsm{Rlnn{n6hH*=w+m4;u~=7$x-;+h~whqyZr@dMrnS=conh#09x$6n`b$RAKHeW z8I$e*05M(~6m*Wv_%{yBvo|e<Pggh!h#2PeRuPPi8L0V;;wCYZqA!xamEN4Qj~bx zQwr44$_8exrcHrGj@Jeh@=?k;hH74F!PT7&`=HyG*}2S#E8Rtjo?#vfSFQ~1YD0ulke&*k~YXyusJw7f;i({BU*;uLT(tTjvT zCC9Dh{2|D??r_Y$Aj{66u=`4VwP>U*u%Mylm1uqLCDfwyHVhxcrOHcWCl7iVj zecfXBAG8za^dQRx41OZPwSLZWl9M%r&L(}P+>~2OM>br_xCpauvQ!93?*Otae#}mX z5gBqKWW>jRiS$@h;)Z$lBy4u&ehd-oGSaD)(YFu0wQ7=;A zh9s%;xpd?^q3&I{FWBwSpluk*xIV=E43RYzV zj|;4PA=L-efjo)snKiJ#YBnl$DH#Px%`oiT!Wp}*fPhtUMqsny=M2eEg)19wDe*Ry zf-2QXX_8B;n$MLY{{UbQoL0^j*&;F|PXhRW-YBLaZRW7Lef~pmQk04GXe9)~2VPoN1Sp znS$z83PA(`_Epl*lY%>jv(MG0CsR+z(u~61S{8+5C|MwlH3~MrsfBBN9xw z8btYUls&VkSXn;s1lrnLYiS&lp-7W;To*FByu9LHLZw<{p=bo%O9Mp^MT|#rq4gnF zsVPG;;wI%;%9J5t)gdIP9W~RThFoi);+2Vfd4MEw8rzsd45*7H`4V*L(i5a!sxwpP zX|$CJbjxUMz&nE=vXgJKVe=g!x3IMAW0Ay)L)g|%n<5fQ8kj=LQDNQ*%#w5jjR=J( zK4*1wAIu+D6O|c>NsOvxpxw086<+%MBa!BHy@xsKJh^FVU=XDG0ch-z)X1%koN>CN z>TKCzXamrs4I-mA@jr=ai;^{JQ>vF(=J$$8HuFxg9CaKH9ZzIas8=;kDaAZW&{CfE z;2yT=x2++7u%+zJd zEH$w=0{g?w>PHeaT@F^z^t|NExKfH6N4^xc^A#)`17%zRt%3YuN!I5E{$Xwe(~EB$ zjLavR(6|b1q?IAX3s{mg@wo7ZmtTN}fWi;Ei7K-b675V)Gs$rdDS!gf@_cMjnKI5#VK@#pXg|t)MQXK-p3IJH3=x^bDV4=IALgTE~ z<*drvy}2Ye`Xwj}xDo!|q7_1U35l6$YFn%(WPt1MgfO%KmlRT*)^S69tWRAaNG##v ziu2C6ge3^~!c}|cZQJNjp?&;M$4KRZLxX@TQ*+hnk7`KI%VoC#*2+SCNY|~mFzRDc zTN2raQ!gr~E-Z%DZ_rpB;zW60lOjuZ^CQM8rn63kS{o|Ad+S{*x1b2TDSsc5LvL(<84M;Do0h2X z{l^($1&P{=p(%4v;C6hB=k~qe4@+JVIJFvYdnB*+&xC(L<-`(Za~jdpl{qD;^R5Ga z_GPK2zyre9)*Nf`A&Bh>KJ5t^3W*eqTR7)%DsFkSs2wcZNoWvnp}zibg!Ys39cy?m zBy}e#zeTfzsj0BY>tv^)49hC|_}qd#V~_i*%;I~^`F^Ks43$n}ddthnmR>?dlvo_V zD7fmg9gd`0(Bl3tkkps^8uM&IGKOooDf?t~naQ^YxK{MUlV9wM z$$o>WTPS-IQst45DTzs!N^EbGlr{oQt!wo1hh+Z%5?)M?58#vT(2u~ibxto8KBAwi zoqYnyHnURb0{$mWW4x?fzqr2noH|tNhJ}R&X7jr-EJ(?rPbq3SM?wb2q&C$gyD{JI zPvFJ$jM87m^9|{ls#6!ZH}AZ&q1cT+aPRlNLl6D0{U%4%P6zm9Qz|0MesKiY>J>Ut zeD*uS9mQ?;$bIjTd>7<97_iDp;;b&xoXGF9&jwLqbAZct*4kKWt*^8zf0t3Hy`}L9 zNp@0T;^&)MPu4BB&O>yTkkBy7saO*e zJck_SIW<#rK3gv_b1lI54}>=dseL^eCSUE5_%FzEu{u^~@Q5o}SaD>er@Eo+r!tA? zq0n`?j&>W5DgE^nm@$%!VP027OViHXayU2Z4yU-zPvDQmjI;9TkiaaVmlcpyTN#v{ zNHf}tbnv`29pX#>0Gpra{)69%SwY40WvOH+NzVkMDInjMbDG)_=e#YtXp0}OV5t;68IFx5I4r_*qYEoUiWYEX3dM7qV* z{?4(>*0K5**6x_-T>=uAyCV=37j;X&=rbMTC+GQ^w5N=$#xQYUskEy#v^TVpa|=f!&4jr_@2JyERLhu8 z1H7c%IX_JVUqBYx!1-wl)3tW}#}oW=_zuHFD~ZQI2*b(Osl41d)93mTAMkv}6|7YJ zhYax)+K}1NB!$@yWFC&qAPw%O%g6a-EU&f6n*)97qMxT07S2yv}7faUc~O^BNzTItYKoy1M&fR9aWv{(>V2amOF<^9xDWu?sS_dIaOfTq12sdGsh1BwXIY*5b1{{iAI*!0LJ+3Hvi|^BgAnp! zeE$HNCBrY@CONp14`R+A%X6fpq#RnxZu8C;C6tYIPcOa|x4ZzfJ%uQ}`3z^4wYTgf zC2QE`bveD84eQf0(Q6tiq>Q{f#&ujxIa8+AC1jYHkmV3%GZZK|FMFt-o{+XTMS)45 zsBiWY`9g%AG1HO-|`jUE!Z3;&Pv)-_yf?di3 z3vjqr;88a=wXgDyQQI8O9<|DwHYALlVQ~TR5b44))!pU&AUqkEKjawThR6{!iB{Eq zktpK~EG?NLhZKTbNGZ9>tLd+lEg`EMegjm;@{X?ALQxM)AsojNvzZGa%U;0gexemZY+YdLz@4pO7X_@QXGWWCw!V?d6q#XMIZj!Z zuenYC02pX_4%?bv(7-Opp;3{Uao0;O1ZHtZP;b0OXmvA&s$}{OvjCq0ogp;N*hdNT!=kmuWj8w1Iy}mkvWLQmDet1VPpS8{R6P=FJoL zqk@qDdrC3{q{-@Otp5Pc=mC*00!;}@6>m{;iDEVITnym+c2{stQfr9@{{U1^;SJ1O zNa?}Kt8!Iv7N7u@oJsXkNDrWFx-X2pAv@cBlbt-522=Ij(}kR4Sx{Z4mi#F189$wb_0I=yK@4{*W(O}Fsfa) z6J%U`U^*j)I6aN5-=s z$|>n9Czgp>thyWbQ-2s$P@5OMoN5Z6!u4gVe*XaEBa8_0&M;Lk3(mQg>27t9N0O7T zSnit(B>w;mYKp4jDr2el9H9@v!yKTpYw*~2=7;Mi@`NF5aH|9PySLjSzbNU#G&3=k zutwf79FS@|R6yNH9~elZpD~DKC57H~2?xaQ9J8j26Aex{7S5>XK;O~?a8S^zuFb7& zs$KTblVq)7Ialdr6K_xvA~zvs zDq>~O>%lq7P=pnm4f;dSh>0OciSHvsHR3|SBHbcIuhJgPIS zFw1TfKK@tlnWP(p8(-d4hQ~|7c^wtCIUG#ZWHM!1mIJz$inD+PfVr@=a0uIq@kS|| zMC^kuB`+~7US3tM`A)za>U=~g5OT7qYqL`m4K99ibt`6NZv=7#|U}OPOG% zpoyd1wUQ1=?Lt{;bxdx>Ul7YtS!p5ZnP+{W(47-;kPklf&Z5^5 zlz7{QuFk$=hYyK3l~@LzFm?-*Gc)OLGs*}FZ5Q2YSttcZTLE(m#FkIRkL2k$|bC zxg^XkyEAs&DhD77I)?I_-2S!oi^=ek$oJYP<3sb0cvmZ0ptFc5a_`H`%BcHeMPN9j zfHNsStUSo{h}fjl()Z|ah&T?bSK}@w=eXO`i9B&D= z%5g|#GOevb;V-D>abWH&Gz18KGQYa zR?1Vb*FZes{CV8GlW)|Qj!Thc%U3PF>DUVx(8D&w)e~g7l!4=WMD>vX%0M;09Prpx z%c1XmDOacl9n?1AXDN7kN%B;wW=SVfP@mxn@dS7)uvc*8o1(>(e1vsn67Vj@5rw4F zvtUPjQ=aaEs|w2!3PO@cP-DI*m&2kual3;UgBw&Svs7v1Gc79WS1`+tEgZlN?c4+q zMwT{*7Evz&Ad!bxU{qTw7U*<7M|eC@9s?R&QG%U*w<|DI$#0b4bt+c6TPey$u(gzG zSRI+M{HkB4yd~QKZIqnByI#r{v9vBT8lF9bjyx|pF3hVg23(nOAxk$F7QW-<3Q`d$ z99|b;WMPR%W!E^jGQQ!=y-6h8jkX6t9dbCLJW_QcEQB}+8f~N|#ZkL5%)%5D8$mYT zHNOkTY~xJep+4BWj<%lhwZ6&uKqTLOlTV~yIvY=oh5rB{1=-q2;hL2(2fE=%@ybB_ zp<9WxY_T&fRzllqZCOaM$(S2_pbwd=At_4^@_nIBx-`n7cktQ`!BC}E5R^dG#~LSM zmk9g}a>Z#mGgvJS_e<}rd8ioeoYQAoLkzi10Zq)V!=jaV<=9mlj?X-!VDd+*Nsdw5 zHD8^XYQr;Yzk)UVqp_K>YQN={ld0zcG#_=uH`klJ6&bgkIkxcteQv9gX1QOL(nfUPaW)q1%Klcjlik z1@ioLi1{58p^fztvlwPhVr?pZWezymC1uX~)=xz!jfaF*%#xA1)SV`R@O_0a(!tG{ z11TrYz-bZM6g@~1wS*O=!V>aFc_zvS#269AVqB;4Zcw{2r96heq)5AgJ}TR8q(z1| zL`lRXxMrk~>ne4?t5}kfpUx(DgkJ{57@(m^)RX0*gT)u_s%cn;isDc+65@P1 z9|&?ec4A%vOTScRNhvN|0yNzIP}|Cd_zcl|5lT!XqnYmuY6$$`Sy9J@iMo~}Mj8o9 z8(WE2+6Mmsz8_Mu9OI-JOk9^!olLLOOa5`uCROnfse6?&@<8ik{^dtR+0CZ$8dkEU za$0dkI+C&!5cwY6l8$QS$s6dI0F@sy3l!AgJRk^T|gB6XuNoTXL9Z9PIr zKa_WL7MX-GN=dR^QctP=5N>m0s?r;1S-F#MF?0Aw1$@kY%G&i*((mL*{n68(GeEM+ zRb|YTc_;$`!!xc^nif;xC(h&dKpPsK&f3OiX3`VWco3E|ioJ$};k^eP#auZo&%+H&oGVcM@* z*3QSeBoVX=-DM7h2mt*FU~FV4@ag zMTa}8cqh?c?0_gL@YThde1Lop?}Ecgfs8Wzupuwz@^b2q>J1@NM0I}hnD}Y?ptG7z zZA${GrDEqTU~CGFzE-q%P?wI)ae;E$=m`U=6=V5FbsX@_b2KG1lAP*U8zs@0eo$%+ zCYtcm;Te>c)2G=;5!*SWPqf-8<vRrlAtcMj|+oqL1%Qn z#t)?Zl`27D^`E>O(0XeC8Y!z6lCQ3LwU2QIT-cv89XWq=bZGPQ`kBJmZAm<}B_wyh zTX^6h9Z|(oG?kyPX-XS}u<=jKe(3E9Zoi{Cw46gNiCjxO#B-JQN?k&4`$|as;N*2X z`(naszcYe>Vf2JHPMRrc_z`&LF#){qp=&DGgV#WRv@6$IRpr;ncGdcgR|{j#xe?CB@6BeQNQVs5I+o;D$9mR^K- zq`jB$hGoYti|Q?K-eT&L*|E7SrP{p9hjnFbv;*n61E%oHngHg&f*5m6?0$D_Om4Wz2E%rM{Nr_YT+sZsi z1~>^F4`XQ~OF?3&)>VdyP2n!inlDNf9YwF=L?OkCO#o>Ju9xvJcx>*ZYCkAsNCc%m zMQI5qm-SnT|3Rqh>=8P{1X%$)7meQ}fNd7Rd1+VBQS+C8f09Vdt z!%}mk0e>F!cft*3YL!|-jg>PmFy4Q6I?#*yT#Ni6UK2U2$<2_qk1`4UWd8sd?}cHk z)M5Equ&~V2Czd<;R+E#~$4`uNz+vJXhiY;%*?F}|WaqwHt+ATh+UnNbW1jCW{{TSo z5vXy#9hP*k07gIHyT zKuTsshk{f5VDNnYhcz2bP$h}~0Fadv>LaTf?sHL*+BB;>yr@>1IcFKxWz?*JOJAW( z6oSLID$Jq2SMU3F5Vf~)4DZWKwCX@5%N~mF56Fm@44)C1L_p7QGYQmRRMWByre(`! zbpc3GBV*mNZ|7*X#l^VoWDJ-!bUBqS1f-18b51M)qf1(VK0#?#pD4D+#aRMaI}Ke= z204cgY1(wyY;NKoapVs&TPDNQ2$ZrX)N4asKBj68CZMdSFeS>bWqo+fe+69JA0w5H6xVB z7mN7D_Ytv`DRiED((-R6X~OeLZ6PVuebSI^Z8Hn`2!S~gB8Ee>4-sk=ik(EtNG%Q2 zCf4^cXjb0pa^^@QL3`+35)G4}1cY4M#KUb^;zqX- zyIECunzp^Er)AL9h;1mka}9HQqvf;;Cq->(FHSevjt*s5@jixO!<|wtM>#U{b)CeS4_<}SsO36Xz zoLX}rAe*IK;p1&1heQ_#@e6OJereQ%Cm;$ZOBCE|=cFkEDie#GZ(S1+w)H7}$yf7& zp0?9nI_tgniTLqa+-c5<@qoKeNMZ&O^UomX7h4XimPPlmq22&oAD-U` zl)0g@biK}> z?jj2&Ba4Hl(Nddl*;Za<1it%$M5V*t{tg|%G4i!3#Y6^5pjD($_EPpK(U zH_D}|=?8TS+*_n_J&s9U=O_t5~bu2Y5FYjdtXml%AM%B%!I|1Jddj`oZ?l zt&|i7sTQ$;%V49M!NjhmCi5b3w%ALmNK2`@rShnxw`JPtCse5DHt7q=)8Hiz%+3>Y z1Txv7N{P9yVJ^BINU~L_?p%Tuur{)HgZPf!^DuFWNdif?oEautY!C{;SPD=oY=Q42 zAGAfTG%$s*sInqr2eAZ`(={n)6)fYACnACnpy)`;ms_PONVjzNh&Q&8DlKwIJj{ z-w0vK_ZQS!V)^%JRPj%g1qz;+X_dGQ%33?5Uwez}K>`+pbKkI{qqR)HwC3d6Xe9;Z zEe)kAHc&Q6zP2ZFN!Is*@0g0QEmNCJ!>l^=x~83$37A7@a?UoDlXawhpe<`^PeB}u zI&~R$+UL_U5?g9vLBth}65tyj50CDE=RsSAeKPjgPD9C7?t<;-IL0NCrhBkD+hhLsmr?$l@I6ac-7W+(Ebcz{NSXfBr9 za{UPl@nl!geuMACD#KKKL4~Ch;6QoVpoa33nMjw?%IRQE``^krD7Q^?{(~@kOU(8T zu7_*5rE6bySjwjPZImWhuG@F5a&NBoj@35%{(&#ykKa+XnZ*gG;H*CC-AYkAJ5Oy{ zkZ$04?7<)ba88E$Z4In%N{?^S$F+Vo{Ga46=WFeMd{!h<<<^=jjxDT*x)m^xm1ecI zu@=6T^M@QazdFCD%w55+I~(pFl7syaiH$$uD%w8MlB`fRtj6s&-Xj@D&d*M z)wBn5Hzy$^3UdC9YUa3ZZE{Glwy?cBx7~h2ZTeWh(E zW-m^QjFz~$?vI|3-iDP{{fG5068wkD5!2=8ajgug&>xql&#ks{o2e@0Ag?yS4XwGq zlsRvgPX40_)L+DFFl}~Oxg2)+e$6#KJIr?>?i9+PD@$DE+e_X$)A}m6eaV$6rl#r*mw9IC%Kl8bK)JCwZ*4}f z#Bn-tt=oHiNiIuVUu1_j7E}_N))!zYUGp%on`lBMt(cyc&9_^}B)48)u!wS>-&3uI z>kIx=*Be^NX^Cki07tq?Tq?2L-oV3&Q@_22=ll`)v8$Y}$W*W#guJsR5Bx$d3@2#({(cEy;UUdCf?B#M_3iLzET%AH{xFu*RDRmE} zBHM*Yg#x3~LGv)payu7Fe|=7_6_=Pen-!&MCS6QPa?z%WGV9DoQ++i$bdIX|^$C9r zem|)kag5vaJ{C}FEVfo@({$I?kU${~%w$p4{{VZSKZGw5)wgv203pndvOm7Wn5fWR zUl3#}T)>tM7GaQ!>a~~9y|4C0x3^eMzLn2={RV%y{G>9}=l!=2@eWBz0Srylf_2n~ zB~szP#F%!fzF(M1SEu0r059e!C@(gOZUB2Sa%E{Cf)9CeBmg{h7B<=%$+P*t%y$yn zf99di!&0TZd0BL=B`c;=#y~Y0R`#dX`bQJD_vAMv{>Hz~WOm2Y1|;}NIMkzo! z=s?U8qjcN7ms`Y`WpP`15t_SidTxkCPL|>qW=Wdbs54H?Qz&zsnUWBN=4nGPbxbQc z2+BrvCu`pJiE2@k?BDbnX{B$F`QdKZcv~FuT*Y*`ibK;P=&7=oiw_Z@SZp={9yxP? z3s7tIuh>ML{r;o5!+Zd0m71kmg+C`*k)3Ih+NIuXI+B567S3$xKA?I-ihTy0NvA6^ zW!gd=1q(_*AwYr%9&qxQ%ZZDA;p1giPuh^NFPo^r;@VADlH} zj7qFCG!HFlSE0Oc29mB4?P5h|WG!drn-9hVj9$|ya?)6X+K^P29FR_4P#R7rTi!a53!Wb?^Q2$wLZSoclMbCDO+l`6v&r#lV1JNcLsB7O z#WM7ojT%wOHr;k+UR)vd5*CdJ&<*Wx#ukQ{qu{}(l|bXmmK}IesLUl*I6Xk#{kutmd*(A1V<sscp&fm^spg<_-&9 z$4xz9EgeHC!|pNCRZ`{3;pUL)koA@(2_z*Xt3oZUplI!xutykWv6R&0qG=6DEy)SK zTc~p~tQ$HI02U%R(aR)H4CV^(eJHD>qd%C0NOC2C$seg~{-FG!;j=L}fCD7JaA~-S zti-?Usu;`6b^KkNjs(|el zZ_yv;h~nfakeWs5W^1#G`Y$_)4<%D&<)kQOB&ROJFw;x;!kB?^z^Tb;ngwV}v&cwW zoy^5n1YdKkCPI-PBo{9;hUzS?MI;B=?v*dTR1KWybO74g7*LW!@MTCfnnpx~kD*oo z7dEq`b&efG6umea!I>r4qY^gR-Aj64>V~v5G=5v7Y z5adKiS|~?E8JZjVM?i_3MQBVao`Nn{Hu^2<%HmW8WI~P&@YPPV)n^ou zmnk}5Sb6R>$nW-q!F3AVess#qI`CI3R3_kB_k)qq-{Ewkn8dZDs95r)wDf5()cFoa znLp&tW*hy1`9x9RLTwxahm8l5BFJH%+a5O^<|AN*a@EWV-pBOmgv* z<`Ln|X*D{fJ+xGuL3FqlrwT~-Zjo>lqqdibvDcO^E0yxJD`YgYxZq)@(}^ll=2~)~ z>JrSFkJbq^l1j+6(pFAvqywgqJ{iyOCuwfqOQVgCclZ00$JKODXp;>~y0#08c}d+? zx>*51Cghz>^oZ|;mN?r~u8^y~LlcGYlz5kEGUq|HI4Axe77LKI0B?xca4N5MMvh@3_RjqT`hY-hkU7q~FF>eWI)$q8zb z)yq;4ryO8rxNN6WWqslWj5C_%l24c4Q-iC+&d~BxvWaoYWreXec{z%*mcIIzmdWrp zh_l0?*FL9Hp%sHTAtjA#GgVfm(K9{m9@N_nC=?+IRmv2wt6YnXYtUY(dNMvSn!m(&o;af`v_8&u5o)XF!xF+~@|8-C^Nb&XHxR%%dt=65>>Zoj@aP;Y%Rf!QAJg2vbvQ z%cDgbYIpg<)=`JUuEyeUl!A6)BK{ZtFz&WB;I79KYlgJR*9z2y-@rJqK39c!qJ7;5 zm*M1`s;-V;7WZ?gi~R2gh;!Z0mcd*tet?(#zHw7(b>*!GCQOJYx{VID9boYT-O#&M z7i}rCX5OOrj;x^ge#a@iEabQaTx2bp;;CtD~g`ax%O zg56{!L*BX<`3f?u{ut5Qh_U3MUco^@7}tAx5E0zQ#j*h z3Z5U4ZcR>1%OwSsAUAz(Nfy*?@q*6j+mND_!@z(*8Ev4_IjB;`&6gz8Eu!06@8M|W zozTu?)dh*o7Rt(e@A-orQU{O8oSEz;ChJ)g$tVWkU0NSo$5eyDzJpteF`gB`C?=^s z#J*jcFJ@Wt2}vqHBOP<0*l^B$85ekm+uBl1lOu*C9h-4|#5m?;q?4esR*cH@5X7<~ z-xmtk-H;EA^7w;=;+=^m=G_%3r&hP+gDFB7NIler3xykRptjbC(VCklJWeQ+IBx{K z##(wSGV{($zV53nBq=3U-o%R-mkcUJeBPFD=DR#sA5qO&dfsf0;}3hX8u10K3k+jC z2`(6tuYE{22~@LcvGOW6_(O8xBiQD)ESHQi^*&kG9mEO9P(px^Wa;Gyd^$qn+a3HV zQmpXyMp9vONtkJE0Gu`xE6>nev&VY% zXCe_S+e#wVGYu1eKp^+0wb)FDLDTC9q`3PPs%f1ky5n`Ev6qrd{T?3Id25_j84VIF1r=k{hs;{wgc@2 zh4HMwVW)(w{{Y*OnJSlf9;24%N{^~R9&u|7sznZ79mk;b)mJi<=5ASsT0ZgTr8bEv zq63RvKBpy`lTtt-a;1QF@8?PMA{Hm)b^;5@`h+$QRS{_Ag)^TuKz?X)S;Iuu8sPG9lH{vU5?|FXTH!1K2HcNReji0(3wHZvJyt)nm>7t zSXbShS$bk#?>6E}MwiT!Z;j)YDvdg;Xj@wRUJ6d!;ogS9VwZ4At~q^0H0g!9oXjQWQXSOYp&bnNH83> z#LYE|n3y5fl-oM*WfS3`jpY=cETx`=d&zv`G?$sVP|T(mEyVC#I(<(+SG+jNi>* zenvVcW1KLBB?}HpIv(m$he}BNNP@zVv@nt;NK(Shwn~+M#275)8xxpa$6Q0nmIY|{ zRm`#cV6(Jj4L*bQ%%oezNiYSSiIBq3G)4M>lt2dxZjjwjWN82&5aAz@j)|j|a5|Bz zPAob903}L?$nPApw0GHRY2cJhG=&t4X9OhJcz`vI3Jl9_%d5NHS6vVAfa(+}aZ>Gv z6s*Z7%Krc@;UeyVZlNtPpd&ZJ@zjFQlg9~5)VaiHL1ALw2yqD!d;yr1RR&PH;7(N7 z3y}(+FjPGc)tKEAO(b|5AI=z|+w(Lg@symH0m-KC;s@{$nmef5k*rEo6PYt8P(G2s zOzQ`mY-->m(7<%(KQkop?=2+xI79$xJufEU?yX54N?deK$2wklI4I~Qerdnx1-zI3$PR`C z&1$)QesCN;bTzUTn|`W@fB{6?DOPJNpV?RNfDM_7(wI-xBmMm#KoU~4xwCAi;(|Xo z=pBU3xHQY~%LReuzQ4E+$^)i?)zqfZ(}t=Ruyjcy$^(E;p)&STTM8$ANc^L=aidYS zEqbXo9vZ*_A1t%|2|j^;x;tW8^8C(moRUuMC?DB(_(yj+x80f(H41ji(*FQ^n1S<9 z0t1_U*hF)I3X)1RHy3yM%75iBSLX$Wm)q)p|JSX$;(8CVN{{Vn*`yx2d30zsjhOrwZ67v%h z4%@oyvXYVynpBk~L)1q!u40s^g?N@jiJT^NZ@BYyT6#$cb)*F>C0Y(^B%yhR_ir*m zhiN}A$m$zRHN`s4Dpi}P%qWFfNlns0y@;_L+j+v21hy+HII^cnWlDabG@BN%82+*4bZ6I0a}l9vEeD3)0OC>~*T`)Tcq+CLtn4)@UPYF=tkO_) zy50l#LE#3m9aZ9m3kbZ4XX=w{dc{jqZ#Y1<_g2K;!tmsHX2d+n2+T#rxjae8c-JQK zA=Q_H9dR~j3n2(jTd8M4qIA4F9vQBJUS-@Gza6P{3UZ{8S*bSS6kKKXCCuqq9n`5n zYTt@&ef5W9!c*iS@fXxgV-7X16Va^ANlUAMn<+u;woaujoS^1c>sVOY@VIb^J=Ve{ zpKZCFS$-_jDm0g+YRj9Go_z^P31_T z%;qT*4d%E*$z6i2;4N;332^E3M;2j8SmIq4N7wu3}p zU;ri$c1cms9f{0Ok17(i2Nx_9TYYO=OuC{%8@+%bDzLEH#?Yn1MV#^4H|ShPsnlHd zaVpK$lgv!A*3*hYP1H%xV{Zd^J=GoY*uI{r(DOKbQmSb(stHz1#O5H2jLH`8 z-s8#zgP?e$XM{MVRKiR+(j?_3(v>Th?JehV2|En;1dk&QJ{>VDGe;*1IWLW#T=prb zJ1Hs@pxbioEk`%qZ7E8FX-`sj>3BRHJdxiP$7_Q8IiO>D%hJ+y+KcN$B}ERjmUFjo z1&g=7Q)_|;h=k7&xX#6Y6=*UXFPv$qdGPokms(lO>v?s|lG;K5>0)zVU||alig{>^ zi{d=I%de=Hxr!$uQUORC4bF%6!>fl7@`?6n&Ci}<)nc=%mPy}oNC#+@pl48`qe)F+ zCAuZ1T}y8urN&UJw&D~vBi%n8L~-Ilt(tRnWy+{tT#FpJkzy~uj{g9JcR*?uvK&K| zr8HFg(=JRTk;(T!@E5*NFX7S}mKzqb3{E-XokqBYHtT_=2Iy}vy}t3kd-8<5NefvR z+EMWuYSRohw2n)_q}*$9)En;&yn72%CdUKu)k1=VG!}%jk;jqD%u|;k87vNgL<6AE z>lJzMDU-2eXq6ZfwLJW|YGq1NSYgo2;|fVBNOwk@LbGZ!3n(3IK>{nE45P@HvT7#1 zH;+faUE(NFQ;OFeUbLvBXA9f_!~m@63ywUB&eID z0ppYt4Y-Lo>7lma`n8Mspnm}g(!S6hRv!(UtO9>kHvFTG0cIsr*jIP(H-u?HXQimJ z%qvu&e^mZ))f95hkI+m#WdcRK5AhJC6mrbzr6VnxHuKUPNJ|OyBGvCKpIBNF&DN=0 zos^;J55jad<7ZK@P%@HKJmPdS3_L?cjkphm@!i!uPL~d-f?sI?r>;8l5CK0M#Hi=< z8+gd)SL`1^xm>PyfmUpjE)%~%pr6cqVq`Pe%f=#VU6iOeXb)NQ? zl$WKLQu2Z`Hj}v5aTHH0MT&{QM+_;~`pG#`FVU2L2s~zYNvnzYJ%>q3mrs`<4vipx zqX&%6={fRz7{j#&^0!Wx0Yh-w2kwK$VW8&Wj?9>I4bG}`%As2*1*HTagL{FN2br^~ z6gn?rN=uFalm5ZmDX3uXXTv<7t7Ca3O+*U1Lj08-XbSM z9{e*$UuN>DX?0A_&w`F>xwmYRp883;Zjf{UjrH0R{{R`w(n^di+74Q&CG6D+Ik`0f zY{>}(T>X=r!+sSC)_3MOl}wVROi9YSHskN93PQ?8a8j_KGh7aq@YW4JL8xHrxPueO z&&n<#Ns6Wl$8%O;#SL+Qm%A4ZZtkx zf)7}%CmM7LifHN*^6aIgI91+CMpJF>Mx)Td%d4i4~RO5>o|r&Wv5GJ z0mS=Ya#c?+Y|Q3X{x=(rrW^i4zsw4SP&TH+O(UF~#I0Al7B6cL1HYJrilHg(@>ofv zQdUs8x7%^)f)GQFXE~OnD1ejRJ=Cb&SbD>*-u;B5N`UQ03D22&T<%)Z=z<;a(SsnfVEprFm$cVY$kT z)|UFc5iZHOP|R$n0T#+MF!xR0$Zfi0hsN!_R{@y?yxXLwypv?5I}ioNqa4?a3MqYRm|kGA>V}z- zb9}=3rC$h?_p~C%f>OI7PMS3$$_ah70*2cy^BYmHaVfWP>x(!QV6D<&jp~KaxufGL zX91XSDGffZOKq(sWF!z&7DenYYkiwSTxjVcDbwLI1Wh44wH8*=$O=hF7R-atgK%^N zL4TmjM=ceHYLgQZqaa&kXGpnEDL|As(c4p@2T^UKv>c4I*;GJF z=|BU+eSCC*ZRm0CcNmdO+}ahBE_}oy`T}k<0n+~fgmob;>?|;)Ic!a)V>xlpaY@)5 zqfPf98w24BiW`$3n*6I1l$qA%0*fnQVbBMECSLIKRkRk~9O(W79aqGLb*??&j9Fg8 z6U|OKp(5}IO=hrqNM z%u!E%amFWR+*=b4nODk7oQ_Hw3rlCbH3?@z<}igQ~o+{VKec7wo@ zv}`|2a$<46LUR8AO7HV^xy@=VzTAg< z3~~Pe2+w0$l~K8=obJ-4TUwPW@>^lFDQmlcqcA5rNL7k$rQr=pE%{&0`7?4OW`x(ke)4&*u`ToacubB{oxQM!=MibRb72?|NJ9<=gp>$MC;` z`I2U{#N0QGs<>XdA8~T!sn;a_p~7=5w4kj?%1Uy8N2%%|nMucPoqk6n8&0{tUjvs+ z;&lxbD*U2m)F$fXUdFylp$_upgLxZpqbin@d#3mByd_@mr%qy;{uSGwsMu7vk%ut` z2cfNrmz-vaSEaEqlFHKZUzb=5K|+!Wh}B)&+-z^8NU0}XTKY8Di%qxFe^GkR8*r4K zJbtR|;(&IaEg;+Fmw5?vytS5=qKme&a@#$V=XgSHOUsy=sMlZ6Z7Q{@H8%v~Dhm^8 z_Q`3P>6xb1+LELuVesM#d!Z^qlWe3DtS&B1r(F4boeOn;1;3!S#{6``l?CA{@~Sqc zO1kpNz8Bwassk7{}G|8EH zXEM2~t~}8RP|2AW3AcPFT_Kehy>d%%{_Q?(jYPK=FjXQ$8c^mcp{dE)s)LT^LiG-` zl&6-gg(@HmTKB(09jP>(Z(oPbxeBzJ^5%0f$7*a3Sfk;l*s5JL%8fnAlop*!h;4?{ zlA@AZdC5C|Ygr_CF zZ+yOlhf>h2ntO;s70Q{j-&B^Gt0pa;9RNYDTcwckiXi|Na$$V!u4 zUm;;J#H=@iu`P9}$>g&*?5whsmk9~T8c;|)SaLIb+TNY7lNBX%d(!XdNqVc&^BDe? z;vGp^sMA?fm{_GxHbGB`I_=OxdWcW(KZuaS^odEvG0eLPOLH$xO>>lz1AwYgAu2s= z2HzM`Z?8^Y3t=k!HQVYY=vZCZTswfJ+)`HLyYg#N%B+)?S$DBJlYIwMq;hk&Yin=w z7X?mBvL9SH=Pw#nng};kgp;LL8jQ{+z-~6y{xF!w@jrqQIe)RQiy_J;(TO-gS#d2X zNnG^z)fED!{{WwxW;Y|d?_0xYm0BJAH~AqhTBY*+$y1FQb(}|p*4s%_cAP_w+;;(% zPEa-1F%}!`4A&#EdrR-B#^I(EdX0(kobu9}O}i>uNg$<3ZdSyQH67wXzesh;_U(UH zV{KATy?(<7h99U%aH5X6R4^vQ{IN06Kz1P>5?mUxH^P)o5 zpPn2}r#8?Y%k&h|rVpRAAR^x$f;+W&-_o}jx2MX+iP|*uwh+g`4Usc5Jyk4#kOIP+ zN)S>n)O9x3SmK;++u2qAqmC`O_ujuj$(x}~wL5{*N`mE^bUu(pw2}!oJ#4FO4O-jJ zm(X!?pWji#!?g7O04XcZpd9W?$sqU=8gjsV;VIi_$SzV-i481hsmZkfP3{*Uf;ImDdqSMKc~|DnwfsJ5{)amV$~rK& z4mc!=W>@1?GHm|-|lO987Y{Gy9ZvYMV6V;Yozf<`~4x+!iO1Ax3 zmSrW|TdqGQMpTQNCB*Bz07py*!^*Ujm0>HAd>M&m(%2~)sVcb}z|Ic0W(+?&Ntdmq z#vDV6m+qxP#FC#_Opc*|;SCyYUar%NmwQCbU%72dY5)RsB*$0^o(ypQsY#rAa&3hn z3YD8mNhz=erC3_`zu_Eb32DNd&fvOPKl04j`6xqk9EoC*Ix^qv56T@vOvXBJ@=O3U zd`grPPP1}Ff~{j{kCb)-Arg59ysw-yLxCSxDJN3^4j&9u6#D-FU_+1-A>f+TrT)qM zq2xBm<2K#s^NIaHf6Ii&k=9q93BpsgJVR1(b0`fdx4=(4W*PKJDcD$e>O3LAvFYF@ z7+ofdT4hcl!c?#nm0S=9jf5gf#U?XUj0-r`B6X!a$y<)LwEb?$LP#K=kDk{QcSeT)0MkNQ)J={Xd-FrB#32h8)qnX1bM_DA0nveJ#vA~or20c6=B&#S z@0+bDQ1cgrGp9Loaxw&@WJUJ?TJg<}(`E+hOsLth-SQR?S;{*?VJS&j2SLzl3OFt} zUp^{mdCZGPde&F~>DJoldP3kgG0a$nhyW}gd<+0X{wGiS6vZW71x3sM0L>M|%xcCa zK^_+4Y0920V=M0Rmo&RI%vM~tI%Ou%{S4Tq?K@wZreaB;%kH&i(0h(4Kam%X9UuM@ zy0`HaRca*Wlaf`=eZFjy!^H+T#YBxX@l>Xv zVWwDHZGuu%;RJ!G7PkE%vBQ&uvGr>fux4fCnJFbnNiTtAB-q^~-$NY|B`KKa5N3U; z#LI@lUJA0wa0HEVjdX;`5hg;)2u>iIt5xToeVSTWOKW`Sr6~#pEu}h@0(1h~ctu`c z!%^n!&d->q$2clmwB(UsGcf+=}c7|-`aSs;Z znOQdGF#S?}hug@6N`#anxBwbiAtOz7_(x%mR@9Z>S6{iotfDS%ms*s?Q+Za5#bD;R zQ3GHvajxLQttTA_EcOfS5~-|HJwHCcs0SN48Oj!rQ*s5CbV_>LUkFtADvC>O_p`Uu z;7a3ara8nqaVB(s6lAz?+dHiP;!px)$-02*JwLgj%%I#*u4XEg~&vCNCriK_dv zhDx9&3yjO5rP|lgB&R?vxCR#RJt`Gyxwq8mK5KaS?mc0}h9!iYyX8L9Ju_isAa|6~ zK~l*(4I;8QJQ;7zb~|=J9yeo|Il6ScHbkXN$t#wZ1AMi<2itHB3Fryd+r`ffh26fQ zM(cyTRhYn&!f~`rIF^#4rkGJp&5eq+9nrZlBZ%SDmv1%=5{^TU^4xEb_FDR?Y$=5) zS>=Xi>~`h?R869T#;*a&UiYE*d>H8j+~9 zsh3VrR>R`|0M=VT4~d1ixT|7U;@Fln%A~Djp!Bkk>ttOjNERc?5~pIGI_3dNCS1y< zd#SRLq7$j|gHhiOjCFYystlIRJ%BHr4)R!J2!ADHqrsM

+ZP#PdIfc)c~1d_l$4 z8FeuIW`8S*veH&H2XSy=UMVBoz8->lONrRO3a(tq)~6I&S`vodSyMJ9)>=|;lzB&1 zR5d;dyvvW^{{R!EIE77Z<RE!ht_p zRW9wvuP`5h5gp~erKG)|CH>unlU=6i*rk%>l-&9pZ8_A7HVQ|9N{9+QED6_WZ^o{y zJ;nb3g%X2<`1V_fw3eqOpH#p%3R;tuR|jPQpd(`vVVj{<#Bll^>W4X5tZX&ueWGk9 zWn`5eMq)eGC(0f}W(Q>(cv(n62YaMKl#Xdk(rSq*Def}bZ>EV5Yhrvg*ve?~zh8p!ZX`R_(WjrJl@OnF+Ss zhX%fSM^HKJj9bI5v`KQUBTNmI_ur#J`IX$1N2tT8DzPJ~h$VHO2a9K(uIKn?}Vn_>tR z0A&YLsEh>orIuXl*Y-8IxNi-AL%l)4@}aWp?1I`GE6Sw;TOeOspbL*8b%^lGsFLx~ zUvoX7s&sc|5laot=Xvttm3<0!+f$ZOn(MN{~svfq`LvADS7I z()(kv!%jHi+RF^nsdaR|q$C1o6t>+bYuvMx-_{9ZkjIFaqT*%*!<;})YK)rKFwWD` z?ljxUJ}7vAt9V4N9&Kz_aS%^&tl{=2#e6z{+2p3>>lEAfSe}@?=pG1kS+aaH{Nn04 z8YpLpNS8P}v~C&2Z;EXBdY@AU-pw$Ks=w-~Ih#=MDN(#T;*5K}j$Gb2rO71anz8$; zLa*})v?b?4mk7eO#QZ!4vkxgiYur`5{>&cmh5L|+J)*E{#^PnuZ}AQv^dWvZ$H93C zS36c zp$AS7sJOi!LRua`pUTi!Q#vW6szijT)=K=*sr(~{R>x(jYm2yskD5dzS*1NFZFW$C zu7Hgo6GkRIx#8YI5PEBP>D|l=etfuFaVaUcyar?W$4*-lwHZo_YDtwLl>>XI5D%_j z$~qz0k>%G%ef~m`)V3A)>juHOl@fE60F?m2Q5OYCH-PH4blIg;nov^2vd2+k3HZWA zr2K^hiJUporc#6-cPZ3I1@0#6IC5rnL1}RzW9+B}B>vDk{ET%m4FqD2=uMn%P^-zG z;~le=@bokt!}D^at&~dx<|g8mt_`4JsBa*;}!o>*~N6rTi?+wg+UP_>k4`C)ECKdF=-&Nwc-jYnpjkXB(P zwJXE~pY((Q@-r(FWgYovN031NFi>g%nZ|15r7gUTKGJghjB}8#X1KzsSb}4eGLyax6 zg(UhAH1ijZc!IQ9*O+Eahl5YP(@R#N1wbg@z!*GG@Q%V6mS|bBm7g*ro+@GCQG_#N z-bz#HXzsLgLo*51nKrRe@D}~>DWK593aKXChk)@pE%++`0E8(?9Ma8&Oe=Aieh{OE zqw_91-BQ$n;w)o_4Pe5Mbb9ykPwFyYmP)8W55#02*t&5_1uMO`3pWM>rsYMKofmD!&~5IKaUBLHWu>YU zHwbx~j}$BTz$DG|Z1V{j-3oLPNln5?=m;hNI%s`u{*(*(5&U2}Zxs~|>zRHa{`dem z&XMnf>H&Zad57~1str0k6bJ8)oHd(&ld}yc_EJA|2LV*l*Y1Rm>YG4x>9IDZhj~f7 z2T%XdyyBr5W=sb)p(g_KJfoI$1iPDYXyt_kQi=CWC9|fPn0M}oMS+|=p}3CO(>{B_ zX8;%8_KpC=aWjEbt|9XuS{El!QVLN#!69k5wbXz@Ry>qGA{PnM+!g&xEp>7RqNEYt-`uReV zIM|k+<}JlN%vJB)1H*5|97sW(w;i8&Jv6mBYj3GJMS#D+4@huJX2_}gV#;O#Y3A!ZyL``B7_sl_e3 zw6!QGI)&U3pvsa-^V3lU9kEEc1}pO_o+)!OSDCbD$d<~!=r$??!1RvM%QH_^Tmvdq zl&0VS1@+%p=o)g!Or*OhSPBVp>ICi%rtlp&m8qFYnUdoLutKhu(Q}k|XilCtf`ZOX zc2ViJo?0IbIO!_LgbcUvzew#JOl~l2$&^Bxa@@sTDoHxp{{Zi-0*8kUt#u~^x_MX3 zmeQA9OGzqGu*~YnLJ~JBQMXR9+6KqJi##Mp2c?^xs8{LNS~HnhU|m=i*eNO?>!xb} zcaEi~<8((EUMW#(ZWApzI7)~)J&x%l?k*L7E5h`gvn^6Wkyvr+imMLG6(;4MV=L7n z*>9MBAVOL?hBlKXIEtBs2cBz|KBSgPlIn_p2vHX0>2gW97PnYw#>Z}l`dffaJs~kO zMs&16?Fh7HbOj`CbU1c031XhUsKr0iMn7aYjq6DZ8Wl7zCtQ0ho3 z&e%$V$gsZ3y@k$((O;hvTaz(Nm9(B4%1WwoNu!#dQItuSd>f-WR7yZq^*dN!rHoX| zW?03H)pHh3PPb2GVI@*h&LJ6yPIZ&+pNO$B8i(vqOiT7_;Cos^}<&crVF_``Gto6`)iKy?{2c$4|UHaKWL zrkg)h_)nL-BcCt|nu^h6sd=+)WPlHpcFs^%E6t-tth7#{k_WwiIFT7wQMQ9BZM}+zq$|W-!%5`4 zfz}*ZJkDt{38bg5;dqxE=wZQ#n%)$o;w2S4*be>l5`_=!*dK_AFyi#}7?uq~Wme%V z%Ly(>zL|m1wE&awUF?1!MT9uS$W!6kp9okE!* zKg|}<$}Bo4n~TA!g(P?AwYKpYUD8tXJ;{cYl?3 zT=PnPRmHsNbC&Cb6PVmtO0XByThb)MiD+tA#`<@#FVY1Ws#7kc45=z4*&z2o@AMG= z0K6f;4AI8jiYoFhNVQ3*Oa_#q+{smsEdX6A8I`W0*7Jod=;ndXXR>}Mlb7~+JXY^a z$W*I+29`PR{9swvR4YK1o$SrTIYopuT~gC+RJIU53z$pd66h{C+a3%ZNUGqeBuG`? z6BDecsJs#rnJPC*j3MP4tXyvK0Q@&maLp>r_OvnNZBcq9-GmNt$>)4#vE24I=SFU!a`IY*UL)a=xv z5R@cV-hh8S+cwvUF^7Jl9^)}yt_*)7qLSj*%x%YJRC8T+?xhLQ zBXTS{>1)82m$aygwTX=7m7pa;*@ejJH1N2GV>^5N1hq(eQ;cRG zm64j3eKV{~lG>X>5}PM4bp+bs#MtYhQ5M%oYPY5fam&K0Y)UB(29GuMl$EHZMLGn5 zZFkU(;V2n~g<5iEiBv)m8GcR20#lnmER=$f6n7nA$`JXXeMpg*s4{0;X%0B1S`M~! z&T`(#BW-We&{c?Twlz~lVX%i7XCvlivip3(=28%&Vo4)Q?kxozzsOip99zycFzZE^ z)!kZ7w#$21>_Oh*6o%Nc!xZ()O$mf3EI2M1BqzL+l|(4`gS0LvZcKlsW_Feu`zi zoX$2R!o;vk&e@=|bp-dcz4e7W(tUo16&sVipQtq^TbFpwskUC{ww`Of*M9i#UhsvH zuCI02Q{SZv@nzlm2Hrrq8nbl;5rkp zoC_meeE9{g#)tQYkxHf4?Xv}PlFOA~si3TkELlzK?*sbRK5^HX_v_dxcKV#UPiFdM zC8-wLn{fRaTrz4?UFNyI_y?*@{ncDR^EZ3*@)D9=KB9I2RwU%=t7Vy4(LBKR zWGf`VB<2L`Yn@U_Pn0jmcYahFS8u7iin~8d<8EM|tR>Lv?My5An`pDl`-@InWw%f? zS5RRKJ3^^;`iUCfWFcH)r!Km%4b|O4(}USjbvT3FQcdoUL|7PhJWEx}VJ->$&DytS z7i%wbr>ZPWDAT@<8KsbmGiw4esCUQS-_8;54SLw674#DG9gW#jO(WYGbxcVvO|D~L zgtnkSHqEMmHwxbUU|dUIH({Y1N_S!jNk3%f85e}SlhV#z1Q*ueIbBf>Xry0DYJ6c* z;@iJBe9kOO>DWrryB0Y_o25Qjr_41@ZPYs7Fr(U(vZ9qbbDI?3OKt_Ba^qW1&boy2UQG zs+;n243JE*DYjF`T+4CAAfkeZz zaPWda=?-}Da&DI`z9M`%B)956f8LWC$q`VKs#V0)iqM)#b%Z(m-9&Q|=>`ziSmxm@RvobHt%`;F%*=1}tg!5JaT8c;|8AZSeuvX>~;zCrO z-TCg0=xcqvyp2STBvj>PWZrUX+GJVJEkEqY8DCHUwoomYBzJSF=_8~i$`^e)E&l*9 z$fr$peBQ?ffmGt_6*m_gBr?O}<~l$kca@7`9T1X;S7| zdSXqPcVwp0$w@=4k!A~JB`YaS)6CNT1j1#dwRCe3iEhxCqO(MLh{YCO zW>TlmRI9$$hE*&JgF`~}NjgiS>NPa()zdgb4a`xdXl^*F zTH8`xOwvnlg7-B5WkDpHfN~Xq*3hp7G^2d~07I`M)a73QFg#5(( zw7bteE$uC!$|2N*tmjY(TI@Z`1z73~2Nh%lBBX~pnHq+iumsPjaRcg|@MSAXW=^S~(m3nR%r$2_~ z-7Oo_m|8OnGJ@Kc+K!4Ne5Ov9$`;QsbG$CAtV(x3CweBlc3N-;gX$l-)>D;Gm?(i&u@dXQ-{5`FozP7MRkX8 zVuC|eA0$1UEWZFI{5hgr@ouVOB03<;`H@r}9`Jz?esN)1dE<0i+;Lm5DYy~*gIokqk zE?iGo;nFr>?l{%!l2sR+C<0NomzPo%omp*tE%?CE%Ouxj?j*m7<*J3`pmNX(NWJZs zQFE*%qoiP#?FBhIid(0$lzTHOa9e!JN=eL3ucwC4X%nb?C|K>8w_5}@7d0<6kR*~w z4JzkdtqG&HFE}+YAHj6d;VwS~M1#NPq^bh^Zy%bI=7| zBjp`{$knClGj0U4FqTo68-~J(9vYZsj*3euNy?>WJ~p%#aB%os$!claoA(4c0Wuz$ zp?25%D*U13Hb!~*?_{J;tZs%>N5ID-45=z+62|iLZ%@n9+E|&)prts16qW3Ew$S#& zM2+DG^2ZHRs*F7&F52I3Ggoy2>$n7Ia5TQA!V=NcG%{4obOPBF$z>%(-|Jib#yd#n z3QIzEu8{f_*!4ag!O9%1prYf?^O$m(3c_9f((v@7F8)@eb(AcQ$2gYiZBDpfl z^kxA75?paBBoV#s_y`bL-r;8zE6KzUsk%9J$%=fc)XE-DbqPh1yyRNS8s*$=(i@uC zTv;(%uCHNFr}>kEhtk;R-(sT!uyROZ^%Lr_*#RCS*$%!otI~l66ZM~ z#FYers#BoXZR4#fAxwcBR>i5uA^Bz;T)etw9B?s|kX3to+IVf!A*^~Glvy6+{=pPk zei>m2dCA$u$*y4vaU~Ybszrf8zH9hfNTkUJl3RI^ScBo;Y1})Ao)VMn%IL6w`4%?4 zuCxKaQ@DpE!O9+IZiwN;&K6atWGZuX^)$LfwA+MCHsTG^v#L@8uVHwz!8Nt>4bT_#%V=Q|92VUddIJx(!!lhAsH7=rp$a5-r$_g4bG$z}V zYjnIe@z~hfaT|xP)vB&dHU?L+DFHp=r4Tj)T}%*kg~mjZ?HN+V95us~$EMtE47$i< zOJq)F!bjRV+?~$W+9Kh@9FpJUbrq3S#cs|LR&GwGXu42Q7WN))0M#p!)5rNbm9Ba8 z7P6r!Q7x<9zF~|S&ap`DE#^sOaup@ho zyllgh^kiYFDK)*^*HDq{&Dz%5CgRHEcf&<}_M=<8EqSVaE@kN{M~PaH+V)lM za+7rdcAun;10W7pN6q1>^x6 zbR|cIgt;~O4G$DC)p}K=Q|pepSwTvW97;&;?0Jbuy}IiU;>xGjaB~ZAYbPImVm~1dS}@fs#4wm0F2l`Q>?arvBp#OvfomX;0Ytr z9EAElMn{j2;$)k^eW2a;MyBaCl%ivno@AThHYx*D=2#Xtgj5-g~~prWt?>?T5@Lr zM{+bI1J)*Dlan!i-NK<2CExQLna zJmF4Mcf$zqB|??GSq`}mkfB!cf&aJe%92gobYFy*a}UOJJ!v9rzo^9#A}%JFj%l-kFs-9sgM;3L`^w- zj2%>M;(B~-3h_xxh4LESHukrl;Q&);rOZvZMvot8*=b`qS4WwGxmS|auzc<&3AMHO%DkH-z{m43vR;#p#tCFzVmF1c9* z29S<7T&&FL zy_M|M6fHh?P(_pRG28AnD32Sw8O3;kDJ)Z_J_@vu-)5 zZrh^Dwbc6y_}C*zR-q?wc4x(}G>HVtGMCNNxtAVkNm2&s<%EkLFksYn#00NrI-U`z zB;r{o8>X_ZVR3|)Q1XH9poZ?G0(B&d03n>YDQrl@t&&z*67@H|s${r_2^kg{nnpwq zaT)-U0Mho?a}*Qj{F!wJ_h{4N&kY#kREU(Cm?e}b5Tu7r-3Zh8!G}A-?S4$`@u{kR zppn2`iLk>=D6LAFwwf)}Wg~mpSNX%!_MHCL@;M$7EBgNcGZrxHe@L54ZPM1M6{MbG zieG;}fU!0f@f*W1_REX>O4q^u!_R@fUz+{K;-T1m)u+2v8vg*xqo2J{{{Z&lU)_IS z*hjcG*XqA<`QV3Vx@QLzCJ^%8oLIAt1%s zEcjb}9X?L>`i)5@>ea4lxB3-o#sxIwt>J!3iB;6eQbo_+1~gY>RH*6DR^-2Rza1mANAt586u>J922q^L?=aI{pl4gl6;=yf6O1dZ= zzBh+PP25*fRdQTPPOTFypm#!oa|?adj_^Mi<()(2h3Oc>2UAlqO`LkACy*bb6w;e@ zBHD(gl!I~xz}y{#MU>Yf!Z7L}8K}95UgV~)IZB$bE=koUeUU?5n_H+tTpnpB(hW^? zvCS#@92%Y%YE5VpD`6z-%vDj+93CJbScCeyM^x-vjRmYo;n}v7iHR9E#fY$;opW)x z8B92s+l`5i8sbbt+4PCLIW{L`3hw0{XmltK@lLwk!SWg(2$c-9K+VIc7IVVB)l?oP zDKa8s=<2Zmxg#`{H1Jim2}_AaapsGTu`)BVo_HKd7AdYe(Nl^J6=(uL`I|$wL~-sT zMHER7uW3a;cr8Qlyg6eUYnhG8Q<7(yF4Mi?-A;0DJavv(P*zx&2`ZXxK$G{benLBE zE4iKU^J&h97K9DTQj&f~00@eMlO-*-`=x5zGeBwMw$M;tpU~^c(q|=B99+uQk@iDr zAMJ$Lsyfp(3B(J96o5Y9zp1=*>uljYTB$sXww`s(vfU{@vE77QW=U6PQSY{-6ZS%r z0B&t6sWmU|%PB|1s6Z;tjHJ}u!gH#~x7fD7I7p>tH*0RF<@ZNZ1qP#aspi{3zPH?s z;GnaKGRrUAtxgp90z`C3Sr*u25`y4O^|>eWfDMN$bmQ-4Hu5(4$7toFqTV`Y`A8si zxzp!p}WeQRG4;#+D4@-P$JgU5+PFNbbMy6h)}6oi6HnDW}kqM~#RumW6UU=@qdXBCJh`H)mFd!tI&MJ!2R&8Lv&_tiu;5uS3!+uguCLD(09TdD4^qRCmN@G$UE5>6xzbCt0_d zNgp(rJVTxt(-M^j1;pY2@k&Ab|j# zU>^rT{qfs5K(11RtyY%r`$~@3QI#p8x-zz;C-zoP?}E-ySE&@YKcnU!8=ubc+Y?CD zZjU1%u%_hP*L5LBPljz^ut@9F<|Sm(2P$d6f5Eomt?Q(8@2Hqhu)C_n;yjegzv{pz z)c?`E<)buZ+9uJ5Asa(<035@la13j@Md2(BV=zaAH((qrtHwBV^@!+T1I|H65c-)<@VRA1F0YQ5E>b*=~Ww#TkXAQWXxfa)Ag_hx~9U zA^~KpJePs!&R5k+Uhd7#z$llC>7byw@ z-WptVhZMxPiMk&FXX|rKH!kWX%Zk$}AS7>f-8v5#dNQ#M3T`Lx7O{XBZf<3S`#Cuj zwv<+so|(u<%YBkg=SY1G3{yK4UXddW1?A!%nv&(6yn)@*jx;X*U(#A z$3Wp#C>05k9a~Nk-~%8^^LIvorrsL}0311nr{0`pvncpk&C5w?X)C^#)C;5&d-Q+@ zWvmZS!}9?%axXjyN>gVPgoP8-jmNIg0J3|7xQ4$l0;Skt1<(m?L^hVwrivq5^;Wmk zz$%24&JdEFc72)Y#7RucevJ=4me_SV`=j1b)285v>A_do#}v%cW@lxotI3bj`fnXb==tK#E~b}MW|$-}*ERbK%%v=ZsEeHIQObZeB%Sn**Tm}i z3~njoZX88V==SK?etK_GjnOfAH2C64di8?}nk?*~P@NFM6B~H%R z8|6sKdhM;eJWLH7IGicR7;_ZA?3EiT+RTU_LT`_hmxf@Nh2^q!8Zp@E=R7SE2x)ee}*(y zD-(&9oNmc&3VmRX@U+y^xkRr;1!Y)4O@Yh>uYR_Ux3D4WpmDbmaFwFs9)0v8tuZEL zoKlpa%PghPcOCK-uS*S~sbf#eVOCAP3ii0C@l8Cr)_E_BkP1M$b}9g<+zpgQ-C>Er z$DaQH1GRjKDMz2A;kliLE->FjzAQUMh)P7OMsNumgNoeJm zafPF(IuYp!zk%90vr{x#HFFhWqqf9)LR&~THe_nj3Lu3tj<#AtZ}EXO<>(a7imTM@ z$1{ysebxS2!mW7;rfAGor2)H6D)v8YT>4(nme<=AKyzG_NqZ~GK-axvzffa|{6JJl zVgUY`N_5#t-{Yu>F~~OJWqPQ`f&#jd6Z~PtF)k-CVpe5zxKE~0`{8RX2ynBc<|<`L z%536D)C()-FA`T0HQ^1~_-}@BG~cwMn#&VpSj-|_v?%`3vAOd)`M~pQ?h73WOk=^9 z8%}vCDLKHC?x>}gZRBz(B>LJDxT+%#B6^=qbhS{z6@(-k7X-Yr(Qg#1HIL30r_A7w zou}Y=mzZv5jaZgU!>DBsu2CpuD_OF0Eh-@(oi81xx`86_9t5XgB+NBSF7nHX%oeh8 zkTy?%^oAttQbOxGoI0q&KuWQX*p+!rxQ9v*qLn%kbR>@xeLZ8KH5l&@;u`$#vrwF6 z2^on~;bpa??U11K>m6QTICx@3`3i8DsyNVn2_@$ct27FCDJs+_*H}wOPW-#>I@3=w ztmu1N-r~nlN0p%hk<-K2;$4@^E*!epl0~jQF&23dCJ&yu0OM#u}LZGA?miWimCCv;G;Y zgU}S%>+ms4#4X>*yW!vA5X+*uP-$s-KchW%@fIg&g2|R~6;FCnbrWfEwJj|;*#}>E zf-UGquymum$1a;p3I)=Oy~{w)Z+I%ii}kVmBZ6BtC$RvlT^xlKrO;GcP#xrGH|hJM zjs4gqLJGT9`Z@5@k?ica!>T$D(j5~OqSJoKt2gtX>l1hbH+SccYBnITuui+px5z(T&AO=f+SxP@8#rX9v<|{gSOeIH^@iBFg1F5V!mR8?VTlL%8L&cR1Gn0Ca0eRsR5$ z!E8uN%t^4yuaGobT*?$Xq_6D~tyDA_b?XCF=5$|E>+)PUrLxr14>e_X(UmH7=eO>V zbp)FX)*xvL<|mlTOxEgLQC&`0rD9aFpoZB=DMP@FwpO=rY`+bJI=>A*p+Rf7SrkWo zm2a~o{Z>X@D|O`*Wm9@8=Gr)V6LAVnzchr>M=Aav8COvx)Wnpc22A7H6a%?+Lz<)l zPWgt1NH428Eb5d;rrDT~T=Ek#IbofPa}BtYm(}a+@v_DB_H} zb1keXAcTiS_cj(z`HzQKa#H+`B}3(ds!U=j6-_={47Bk|R@M1oZJh`v`W->>gjF1G zu;9`#rc_Kgq@bbIEy5dJ!pQ?EbMIQ)bQ(u${{X1lkh3zA4aiI~!-a(pXDD?yuu8Ng zK3j`)h4Nm5ZSU$PFr`(=Y1y_*YgsEG_8blLEUWCG&af7IiNg4B4}yxv~xk<5D`Qu)D!cLcxQY-p337JDP!VcI$Ara zFwLRWpVBYpU{~FRq-_}|f5NPPSi-cv;&pi$kxzU4JD=JxY4Z(UNXl7#AJZuOW4re` zYp?;=+xukt$9L{>!Y-)#dXJPEnme#_j9rmM)Rd~wYG-ULw-5~I)sjA6#yaE%`&hIe z=!_O~P%mR9nAJ@mkb_a%2#j|o=IA5T590=)volztQCfh%O9(71*cG`4v{P3H?>3Vi zuro0+OKe>%w4X-OKXh`=)9!F<6$vMFM7*gN?-x*;Tg$}49G^w%IThW%kJeOD!^o~9o}b}q&vrcT!7smf?MFs7VR zv$6^-o`pnv-UGrGk-@^5r^)3b+1Ufhw2$2iIB?fYmLkb*0C)t5CMnlIjCO!& zaeRWPxX%f+BvB;TFZWxvQlgW6t@G;$Vv#;Lelk=RKUH6xM3E)~*yJE|j&*sI%DS?x z268?y%M>T4t8FDEyQwNr(A)RIYz=m5sB^nzX6i`N1EiJ0%jQWke^f-MauRmTEDt0{ z0B<;|ys}9iDul2_b9SGUn6H^ye5eK2q*evZfB{J)li?h?Iz`+q!y5e-PI_CE%EaOu zNl;n1$gINJeB+KtYF5VL3V0C^AbDZ$9GX^eHv~g^(|;_VDtBu>y|;yH!Jlw`tCX)RkXbpLl6w{`PPG(AF=0(2qHV4yKH3pLtb8ftD+5$o7tqQR@G=z;KfE4UIQ)*;X!rx`yU}E5#gK{#2-^v^i8;%?oZ-})e)R!`*65?`% zWY)lS(8n&0njAMs!nnd>Q@pU2H-!UqK?$Mxy9)Fr7!wcESR&|lz8D$X=Tnx_*nr9NtB+ay{` zDrM}&v@F=>JmK8f*H#iMGW>N zW*g#MrZS~eC~D`vnJ0*meO>aF^IFSQ$N-IsK=6oC!KJBp7?#9SV+PG*96&&=w@>Zl@p~^_V#x7#5Uy!sCy^H5DUo9@J#kDS+tstnBp*z_ry@$da zP@t+LH)g6`R~}SywBY4S6u9c#S-JuZ#$EM02#3Ta6edV~yJ&H~PZv`g!tAoACfZml zdBoXCBU6;#_C7X<+%`6zu7Z&e_$%3JcZ{ieY%LPh`BenFGWEh#uejODK~U;CL)=#y zux-tbRg!lLc3Y}&@}%Q(6Hc;L*$ueRP;qT2YNV?u09$e*n=iChMNL?SDEOnn3Qq^x zmBf^{l{=KJFA2k$LC~J^t^m{>Krzf*L(BMH*V$3Vi0vnj>2;Y_2PqFZmgHkfNyxi|iOw zX$$Xd6EcmKrV`Nz7YbQG&DT*89EplF`F$+fqT@=8lYY)r=}0;{%K5;0g&W#CsrP4P ziZ6O!HAWmmh-xzX3T;RF!r~r=O6E54E|>ClhQ@mhVd{cOpPARvO?XB1%z%cckZoc5%fJph*@WsHbm~cC62FF;Z-U_^-1CUxKxdrDd3M zuSQbVwW3u#=Tn#+(Ud0I^oOrfu21M@^5AjhxQWB_tk-7UZipx4o=vXX=u>3`n^+X= zd_n09O*r$fkrPc1U0WYK?5EJB^r$e})bbFbpjT~k5_cXJ(jm!pHXrXlYa_nf4Xrw& z7TQJnLk#qUb!1=flN<&s@>8FddAf|kW!iKErDoR6>VM&hygGNWk@otyCFVyAcT|;T zsU;;OC8yBODFF%ZB4Jm)Rpqfa&>fFRyT=`^m>9vfS!*4k>O4P_Vo=cOtf43amW70+ zC#VTF+7R<1`wz3+mhGIC_QrH7%A?4S9`k?eLVRz!C4Xjl{YcN+7ql)O;$ui|evtgE z;!o91N`{i8k>IH3eCXFf4W&eBN4UeplKAWY0<4JiX{R(B(& z-Vq*q4dacG*NwfUKfVmosF)6(m7C>U;9zOy7TGo)aHaTF$=8=s-wqv4lDG6n2ZueF z-IiasR;QkroKU)h6D12myondmA!OrkXswIve$Ugqo4=h8O-;(C7H_*)t0GwjbK!0DIT!`Z2<=1JUaQZ}slZSr-b*~P zPu>YYH}Hp^R+ZHe9u4VJeXh$Z!Z=1ol`7gPttMHb1%pURPpPop8(AER%#qX2py^ZP zOp-Dc71-#dZ*L34xXOqU+}^*GD^bcc8*O1qTC$P}$ziBYniB}t&gns?8btaFZlNne zg^E-z55U0kS=6YGxRZcV`PDN@aJ2o6n|tdRH|dhvd0S|OIA1TRV~dFB{)B$1qIU^4 zTc}Dt9JvI`$|I6|3RG5`{9?XdpCnttrOBuB6dW9yDE6eGx0^!Ll?1wglX5k%O4X!7 z;w0DK^CUqIrC>XkxPzO?rJu=BTRZLk=3lul9euU?374kk2+F3EuUTcE%}~y!`aktw z?mbJt`=$E?Vdb`ep~U>3r}G-G zHS7F{-^V^B;tC@|k4%)9nwDE<`&lzES8kjbF3zxkq=h=|xs)Ml!UweQd7@ zxoXSmEj=wV$_C+WI*>mx7m>t4mQ$5AT%W^iw$!Z4%6aA3BRNu1ov&@gIqdyYovAFjGX6c}osx>r^yc{`xc83UVRwJC? z#PwOy+9xV+FLF|>-!o`ciDw0T7N|>22}MrMp-MIhD^O9tOIvs~9HB*7?BQC&N(*vo zbA1DaRyOg_M;wl%OB^5CE`JC~wNI=|sR?ZvQ8Loq2suaefGXgh5u`%Nj`#81$QMyl|h!X&?Ku^D$#`gV77{yJ0K^uxVF;&26xzdyr?WX*rqzJ~QuR5u zrCU+hhMXzyYqr;k@on~N$c*U@syJy~n@CGs?8vp$D? z6R9AzI;x&$+aqf^%ghJHCP9#LAAL1Y9!d9R*h^1K=;C>Rr9b_g)t&gmCRSZi3J8=C)%G{eSI*{2= z?u4B}e9RU{aiFs_R$oy8_Y`~*y#y;z(}}V|%%+-!p$-{_)NWR_ zXCun~9#8<27)d0T5Vx5pQJL(c;5;E#H>d8*Q#6c;`p4Gs=o2xl78UnrN|8o-SgXA- zfJWKEuk+eC*rdK86NO$ZAHFX)JEs0%*Re{3$Dz|l2p{e zPmmc$#sKv>DtdIjl7zUHuc#ZJU4JM9?kr2L$+lGBvsTwlL~vQmet49C*h-Rm<-g?} zqn2|VdC6iFTh5-TDL;e<1wAr!Or=X&n`r}NWI4YbBZAX7Q+S4DdA)&`9?Esf1^sL~ zdBAe}8@NXiy-`^c3COExhcq|!IzZ4SD)AJ`pr(#+9igPO?V{Y*|zE_0MwI8XrkKJ2?4)1kHDw*$I{TY~&QlAWZXYm{Mb z6)Y`EZ8!IiTV4?Hoz{B^@S>YjRMLYBY_~A9g3^j?1SU`gAyYfT#K=pyxmntSOG-%u zK2F}C!aOs&geL|iYdEq|ZoOBVLc^{kXTCy|sH9lyeYJ$jBbGT6RGe2P@AG(+7lDBx|)@8+>-qPzv3ghj%hm7*3`ljiHQcu zBSj&!l0H9_cTwFwLN=>R$SkH7uU3iw05%q;HsEEUGb1dkzS@ytpbd~O`q_rj-Dfl- zWfP21mF*2a*mM(iRI9e6`W=tu9q}4Dp&4hVlT*CI4ZIWfz*WWn08+hGX7hOLUD6vDZKD#RvUVv&I=OS`JTLPZ;Gy31n4f1Gz?hG9Iyc3AvjTL$5CFm=BE zupl)Q%NNX&LWaZx9ZrIX@x>m_5_tK~Zl+ACjaSZ8x#k-Vb3xoX%E&_RZTB8AI}Z}! zv*a->Nsx<+930~R01oo1g-~j|!orm4YF1f?TO(o0aY`$=*68%KTVvv3GAyw)Ks-;! z4j|B`Or=HFWoA>UW!Y3P;Pc9+(tQZi&MaWl-4SIT;#zC8HZ+#GRNIMA(1kXOe3Y9+ zgzRC(Au`Ws%wp2XZhh1!>2$V_&n!GMK+W;n8P1ElRGGJ4>TUT#gtLU_7%?l!$SMvh z`dcbLgmmC`ai%7o7hOhSBW>YAShA!|VksPxsHx2br@WPCwT{{w@B5>t4At%?;(6sH zOjPDqU_wc9`d?c|PMjvNt|O`_yX@1ipq*VvSrCLcP*!G`qOY!dZcZ!j-+>(j-%iizAR2>&J+%+aYO`x@gRIRh0)P%#H=?* z;VVqbvoIf;SS7%aY@Y#po5F(ZMM%=Wz9DHVS9EAE)7NNPjf2=%@hc6{_3MlMJgY91gM7a3TPo+!Uhs(^Oy9$NNy7NG>8enfN3%?Yg?3yq>DktNEM*WB|$kuX(|Ot zCdDKTFRz)jA)&~#x7i1^Y_|_4evPe5^W>fZw77+2agqtK1P=HFoeA_YSH$4exjz<4 z*q!`WO*UGaH1#U5n=OF)B_B$qpHa90ZSyjhbQT#wxfj+dQKs49M8 zkWG^=w*eWJfCxb;%dhPLd-c{Nd#9Msj!%vazeuQ45iumRfa26v6r-D%bx>A)N{8jP zkq%JM>5>%n49xxr_MA%8(nf5}5EJ61sY)LRi1`u`r-$Z~NT#~<>q>AnTYS3UAxZ_= zZcc;AS#Dtx-(gE*nS*JL*C=UomanB#KQ!|vF6w0O88S$;=&<$3)BGmp z&20zOt8Y6W&J90w!p)ZHOv)s;?Fv9U5QS)cZhl4N2QeR%F4N|6 znU#vwH3=DAO}4gue~fnH_QILxajiMKvbPdO%1X8P5JW4)NamI^6^;&Iyj=ePw4sqL zG!&I{S#id}QdOBbn+gr6X4b?)qmeF098QeR1DT;E#W3?zA=PHpNoiNLw7IeTAv%sw zlcouYrxx786veOKQch8(_Z`#oj;3*;y{!opwB(|(1cPO1Af;+)3K_cDO9#-y$}Rr@ zK^8VRZwWa}&cvN=p89tdnPjLB9TrHAw80%g!e^?*67I}O%rd2nv|=7k`8% zn*OIr5hS0ZQ|!w|Le;yz0@_;Jh;51^^AieYeQe}ffml!>B!V+|foQ16xA~TM-olo@ zEU#;Gn03r;e*?5dmoh@+A?gwaUF6ImMJ^y4C~2YGL8^hol$$mNrtH0Or2>Scr`-M5VFXnZmregUMBzw#QSqi8qF*UZF!T zRzt7lK{;jFS3*0(t-cyTXDCI`Wj7l#>FW@$QLKBz-t{+u4h=IZw@xf zgKa#3=yA0;utWUD_ET2u?ZeJ z8}E2hVkk=Cj6Cf*1chBwPV=UwmY{Q~T~OW1ZEFPEPOzrz>AgY56L?O2j6UKL5c=j2 zmr-PtWl30Yix8r3dlTohI+ds7B0?t`;#x%w^|e=1)0HV^vga)NRQi6zSee9*Bc_@nuoqAdo2`Jt6`h=HZV~nO6 zp-no&Kwekb)Y1SJ9o(xRt6`f(8`yP((bR6YBK+*QO-@L>fZ_{jO7bHq*$c4)x^=$B z1+l}mOq_D3E{3J0m~E6a{{TIQkBl9i$>bjEsL-w5(1 z8qzAxqFXW4ju{JiVN`O=3NY@G7GupFqm~Y6C^ZEp3JVJb9Sv*3T03DfUK?=~n0as< zPoW_Ch!jq?ZJB$)pcIW~WXReQ@txLcC=|e=4TQC!T141W9iXr;XypJo?Hr@F2w9G4 zJ7&rWFquT^k+YPDVu!5oS&pD)BusN$Q+wqApNw*V%a+hkS&e22Ibi3scS+4gB|9C` zcTiBf$25h4q-PMVCp8H=u5uWr6UtmjM|i#=7YM8XVdj!_&5(7q>7T2WvIWGOn|Q>sLFkcNkhQkOFuFOYeq<#%4S;npy&`o9j8gcfhE`37G+f&HTU|AVWf~uYvr1zY zQ&yh)$hVqE{KQ8jP@j;Src^GgF>9SpQ4XY-hT1v!p|w-l4#_l^5qnuG0YBOo0xh^m zRh9fi>_#&_^P|4nQ+@l_{n2WXUf9ax%CTy(OKRHtP}kK49z#uzS+0qy%$r4rl29G9 zr5{#7MxZJbfN`c>P3&*-h1tV_Rjjo~Y`CVKa1Fy~Dn7OVnBWV38c!m2aSLoHA!sCK zNlEyE0UsDtK#}Mg!-q(dQm(T}t4_4?ic5)bBFR#&N-b{aJz;TlG}V#+0EfI^o56IZ zWM*i!Af^=H%q83*K&aV5$m%*oh`JeS&ZNg_cb2TbL{tht=2`3QZ}4!vLMZ4r+EE$> zQz{^fY3$E) zeb`3FMZD|ynf3uyIzu@cr<-6tHiVrT+(>b3%&YS4(QZEck$;z$Y>zS_c-0fU9u zQf~`k$$D(sKz3a!Lac5zRr*0GS=6YpDl#(4GC#$q@`(}THqFRUzyts_{6l=Srikz` z#zDx99L6A;WZ4WQUS)Ru(8FWEeLpnnd+jAB$yfc*SPn-C^LtCGSg|M{oH+p!A31|` zFZNI64vmo>vr%qdk5VMxD=ypsN#CFvpM-KC$f1IJL&-BwVoBLa@2YPt(=O>ZzPmRL z(2F-`J4DD~#pVc~%&{nISxUq<7n1cnR5X~z6U zVx=y`!X;BraV5uDTVp-0Mbwe$=L6&ju)Y$^36~}mJO}1tJ=pN?)f4p&e#!i!hfy9x z;(~4k&x9~Y4vLeB`!HBhwrVR-+6y^CVZ=D|gpDBwO}5p^QbLNZqhJCGweuhlJxzpl z0O{Z+iWdF<09G7`)P?JsLWGgGj`;pV0GfOA&T`u`N$*&lfjZb7JmJVI5hg-TG4axe zQu;mld4S>>s3qqtm3LAJH?~`muSlB(L}?8s1>)p|4zRj}#Z8sA>&se(M*@-*tAH+@ zK=?zV2{&BrqfM7|rb+2{5}VmeQBD2@8bWL+WN`Os3RLbmnw@>bH7_wDhKsq0Ms%j+ zUc;#);R%-^Q6<$2j<|afPSYgi=NfhXVp5bQ>OSe*f!+A}L|Mhq{8=}Hg4c-S#)cvP z0FXC-WXBoQMlc+ao>F;|lmV^p z<>q0z?oi2$QtH!~I<+}E)DJ$J0!pCC?aZ*&qp67atK*SR5CVht7mSIGc zOxR^4-%zc!+jt!aY2z0|FT${Npds^pG246kT@ z466!N{{WeD98}>`sAWh}SCw7skgay;Y+_CfwzudJkk3hA`IOUDJj#NWl_)yZtftaF z(Z2rx4Wdhy;wjQU`sMvChkcm_>rO!V4d1-Cc>fs@FB|}gwZKjc# z%GBGGx!%jTwz>|#9V-)9TMD;TlbH%jEpnSZ+bKgpv|myV_S8g99y;cei(HKqY%P5T!YpycV9M7|+)pwh_FI#Ylbmtdtgo~-!c}xFMF9%6 zuB&fvx?;~W6DCRQ3B*di8=s!4(k4XeC1n&Gl~tP!vtkfiQiYTe;59aeG^$s(n3P3c z3Dzm~+S{`=w59b-KX8Sppj~9$WQ%*d*yv&W$;EBZQzlh)`AS|Rs?{nItC?XE=x&}+ zlD5cf4U~)9)aZO-JCdqL23xc3DLBs+BM{fvyHk&?nFiN%q?8YMTGt5B07Z%Pj&TxD zj+Fi*i(&bqV3ETr-9ouenpDzKRMV`b7d+RGc_UMDkVzU^DYE8sii1^Ln7Fzo2M>6m zErqFWu0$$nH`685TOe$-fJ#mG1PH3pPqAmi@jepnNUjv)C1aX1RVkEmMUG;v2X}L* z8bpmX^6FdT;DY&;H!;}O%|p2pAF++Vz_Ph=vRnJZu=Zz-?_h+9Oa z-b%DC%gXz+R$25mY#43R_uF_SU)UxVg+Gtb%~Y$Rp3!<{V9GL{uK-effhSYsE=)TJ zIdTyxDD$J0hv?N_CB6|ymR!8Q+NikMMaN!SOR@g4z7cJMhWWn5R}sai^ZsPe;lBzg z{5eTl5?z^It~|0zl&+-QpWznq!$xm667qZn-2C8CB$#zYmD6@3CMhU!McHL4UGx1S z59X8IKPVnClZjBFeJ+fZNo39+`DttF+#aY-=g|BiiDSPrj~bB=aX(~|W}ls)RRZ34 zEGklE0V_GTNK(`fp|mw6dw(Lwfseb&{HwVWu?7;vTrpoNt4^3@17}i_<79r?0UwMt zEJ>Pd99!kg=Thk$m3gMoGSMnh2uSY>YZkMTY5WUY;IkcJFd>WIX zo5OBO;MS8ZAtbf~b_zlsO3#@o)kZ6_P0yL4#fd>u{EocdHF=j*p;BZvy*-*?kii~V z)&>1<3^lhRRARb=O_OS%l{nym}sECg*!cKxx{)bt-9ZQ-{Wl6Gss}1mJU^yLJeQ@V(#xw*M=>f;BQ}@4;eIrp&Fn{? z2MF$#jn$iDi79 z$qdO$&+187vGsyqG02j~7@A=r#vV-5cD8mD%btxyaTZt?m-@H*k|CA%`q$_sgpy^|ph}JH`V^!5<-!ya?f$KPquQ_fxB3feMrM=( z@@wJB{{Tfq#H+yux8W`3^#5*rP?Jd6e7tD={RGmPaT+H^f3yB$M&f)zEvTH6UilqDve2z8YUpyt_WHz52r zhBCoT67ghlWs2grev4tbmQV__3)!)29=VpVpOK1PHT^%CZx?^mOIA?V6q*#;gt8oM z(U&ugG;-W-JNLhZp~y+a?Ed{iaZPT%{R-;AxIVYStVd9h!wHvl=2Q}?XV%+7VW4iD zt94o{!zm^&VUto#l{1AshlyB{N~t=Q@g-uXf~H*1%gjsrOsb9bTXUI1VJBb-u)LBN#Pv;6!65#qB z8A%t=-d9x9w-zKfZ^{b|FYOvA!_V5;l2hT5-@X;7M~2PyQsw~h{;2$n8iiWf$?#$2A@B%xa=O zlbN-q-2oT08jg5uBb4Xduy?#h)=h`!2BVr7WYQhnBwx-ALE*D`i9+jYL%@serNkB~ zN4cf+d$QxWq}%py_(7=VhL0jyQyaVzN9z9QEHs!HrYUzgc8){&iUwaLSi??7R2Y=4;`V8d7LhLF zg(lYyr+-3k3Dhe{n{yhlr2?rng>=lX_D6Lb&@~kNZnkl{(6xp`(y2LaNH#i)+65u? z4Zddg8&x4otJ5ko4xzSEvKH>SMqqchoOV*9ssqm{kLeXwvb8-d;z9^W3m4QutsHO| zYzfAkF@>ewrqtc#xYMdD<|V`@azRS+u^GpDOyI-QEjSjWf}1Mc3GpAC zbHf&=V~2vU(%h!7lH$^W+H5j~X>U82ZdipZhH8fmDf8f>X6^&HET7yVrvX~T%bW0B>4=H~bd~@YtmzmyTp{HVct*ahj(vHdEYsSshQ_7yO`57pMt3t}9z8c@Hq~QbMiB z$_>YiG~&?eXJ%U%;;D5fJsmR%>ZaZZKjkJlq%7;X#EQ#0J3*Ttu(Yr85z3>f*|PT( z*^x?BJtI3V4TaY%wE#~`gd6-II%ZcCF#WFUoTK2jTtWO&AhVQ?X~x)6uX4GjMZ8wF z{{TBjQ#qv@lH(3P-ez^6KUQn_ss`E(2>;XU%5XAzh3!*R$6c00tlPn$oWa$$P=z1@ z0L+kc1oSbBd2gAdQKC+8*R*X{1w7P+c_G9thMo>2D>72$>>LVEvW2y_k;uL8bTDC5x>dLkXh3-k1Z*RV9ROEO zL85M9GT070(<@%20TE>uIGLsvSsIku8{{a&xdDrKaQb1O0MG1Me% zxR=5T4;L6R^_dptZY+t8T6yjHw(YYd`Wtyf+U3=u{lF|Re46$ znQ{|~9?+y%+&1D60*&?uDf1>SF!9OrAmriu5YLD>rQ9y0)19PB(^9JyGW?${)RdEB zoqgkeq-bK-9Mrd4mGg}aE3Qh-t2=4stlviLP_G*#-XshPIVz}=Lb=lN02A*x%0iFg zAy#lt)v-jBs&n#X$^jQGBEwy5Nha2gpfO5uGM>vp3`;I%VJa#K%bk>tmq^r+*QMb| zO&m&EKa@2&d77Iu0!%-iVL(Qy^@Lu606p`NC5_JIhLed7#hB(A*aN+SQ zDy)i8Qk0aN0157mEwGNX3vm}Kf#x`+KH7j%l&~#(k#8H==?*ArJ9IdlL&DPh6GJSm z)T(J|%%megg!H}aZeeX{IJXdMrKgD~XCchAtlV5{aiz)q@K&(?5$VA^E~Rk!e%)1> zmQGaN3?;fhSF zWx)F?cJ~X;E<7!z!G`Et99jGvoNm#WMA~_>ggBcn>o)2Jro!6C8nc&2D!Gm7*m9j& zsmhRL=g^sFTqNBt9SKPUcgjJz*Fz1-4k8Ou^D_Dhe(?O^wk)v9j~iwir?*F&mSSy| z(vsA}jg`zW2)gw?9c zGR=gt^MOsa1+o%GfjtglPLW{+u^LQR@kp68+ie2Gk_~oD+Ls^R;T+t9mHC$EDb)a=kuCvsw$Kt1 z`8NQC5_50jA&+-VRI^90tCq#8muxn+*-*8zjfnIn z98;s3L?`#V!kE%&*Jf#wXqs3VoKr25a*GQU0xUcwW_s@m@WjNznUr%CJfs8_Ju2IeB|OB1q-W@C zZbh_?uf2{OinboZ)P}%vt&BT^RIRsx^szv+CQ0^Re=%u~_Y6Iw=y`Qa7uU@N#{H#P zpA3`re8NDot*yFk8GbKmGeN`u014hq>lDYii$avQ6qFT<9H8t^T)uH#Wd3H{*t*Kl zq?B|ww!RmHv#8gn$Oop}ONmfJ?dGu1g4q{Oq2JC5J7yeSXJvV8)0BqRMquKSbx1Z+ zPF+bCy`b511Qubpn{2-|%UYUf6%q(RH}4yILLTCbbG4S=rY#9)*^ufEMWlB@RnK@{ z_b2f%SXSp_2;f>h0hSx(sR6cv-AEv3TJ<@_h0XOoP^mlSA#KRrnURp4TaEiD3uFad zNf}5d?4A8#G%DC?nUJEPq8VkQFrt8~Wf{osq#qN~70lp+#grD8Fw<*sX;YHxmIy(z z?Cq|gd`FMr9Zrt(IBsE9aD=F)GUU^oyL&vu!7FUIE}|5q0hIuN1%`)6RHdok^f?{A z_cyThbr{BRho&XVGr0;5WRQ^Z0ZwMg)S+oR?rp3ouP~}XYaY(sRcLaXFt=8Q(&Ne~ zN*(3gqbWKn*Xz)ELi%(0S;{ftepL!-(Ja|BCo|5r`M3@ZMoVfgod-j0BbRg(C9AxQ zeJeiw+aZ}8$yx|DTZ%Vr#cypr)2KSbiD@{_%|ixM@KriN=blW{DCD}Z7NspIQ13Q= z`(PgF+*`ssAt{HKmTHc|>Qsip-AnxCw3{oM%7#~30Y3Jf<~ilkxOiYs5h||v4>ViO)jHuJ$nx3C1cui{bJK_gdl_N z5!FA5j!5Db_*I7lvr2Q8w}Nb=eG~z(BKqdFzbJMiQXcwr;9Rk`+_h+T1Py)>A}o(2 zN9E%er3uL{h57SSe~~&v$^%WC%ww01ye=iC{{ZHR z{xF>fbsLg6j$W=xQkM|0FO|e)BzZz*8Wfqnq{D3;u(@NDcF$zIb4Xe4R2o9VhOHga z7G*||X|S<3If`bb)I&1C)Q-8Veo@a29n@(504|?z^pXyb*(pE167gRlTEz7`jMU>e zA|#sNs}H0Lqj#leu6pzvxh5Er<=|)t0JyE;ZXuZX3Al} zBb{oL+K?gF3DOIoXG0_Gwg=+JIGB1?vb*O$8j@X(oD+N{CH&^`ZKf*bvG>Nrg zI{BXtB>>B02`DQkyf5AY&}uoPS+5Sy$R|6=vU=NJ-5hchk=Eg(N_uf_*yTz{C(ptG zNPN`*vN6@FMKf=qDY;9BtT4`;rz$fe`V96EF6D|r+Wq!3N*tZ)e{foA=( zoXYKMr)ZN7LRhCJ76+1G3nRa1EJ0VKFxSzNUeqsjYHklpByR|iq%l-pA>w)Vh!mB! zwEgzgW9efIHY;OQJW|C{u4Q_Vpr5>!oLAwRIL@I5Ighb@E@-}qX4Kl1?iL>kx6F&e zHWWE7adNrK%(*<|4N!(1D)inFXJ|sqarUx{kD#XQ;#gSy<{WF_aMw>7rdT|eDRU#3 zZd8_+kQ3rft!}V^MTPMGy1YS6W#<}GDkvS*Z?sB-v^61KOgJP60BSgra+ZBh)?DK0o&nvoLxailtfu%XA{ zH9bhjc{Wo zD?~`9MADQ+l;<;=k!?w~gx_wKh3#Hv2bPXz+IZEgZx^4b!E5&Ct4Za)T!Nd+eiOfGwlI1TdR$5Au==;gA+rwz= zvVwrE{{WL-rMh!DBTpyEf&Q!`#AkFPu}AFTOQXy;Fx0H0OKCw#TWy4>5#Vyi9PH|i z5)ln#u<(Y*4jwV6id{No^$UiYQpoYjFK@y)brBna?bLC@pUN7DZ6;v^OR|8kt7`qw zZ+%Z&X&jc!T6RA*Srth%w%=M&oL=DATjTh^42X%8d5PJg6c&ahpHNUY(2D_a=3-P) zU686QSBrspsaYi}o8B)FY%WQ#7CZRf7NAi{9r+#^%+@6ws7x)yve^k5`^#5NM&2;X zbVqU|&Ofgw2Vi+w9%p!vpptvaw}AC9!rh2lkT2rQTL4eSB}M8wo&1KIhqz929MoE*)6!Qk^MNAQIaAd}z}NxS9?3NYY>`%7 zeHNWW;1v{5<)7x&Tt%F45VfU5YHlo~C!jWret9{!C;W#iNm~OSmlxjm%5TuyM8O<;ImK?y zG5g?`5_xrI=oEF9D4gr_98HwF=n;Q*$I>I^#YjRr7-fh3zSsGt!i-=}ia+RdLdi)MOi5-e?4Ht;>a@349 zQshi9GEA~vv2nZim2_V2Yi)ERNQknyt81StT~5&)xWxMK&Nq{#(U#(+sbL5}NF^zA zLah^~{_)V5k&P#gPF;GP%T#Urq>a^O@OC`gl+rFbsx7Se=`RXk@ zwMgn3wlMVPXUC;prO&RTH!$M;u2Bmvf`RsnX#o1(9`P3u{7FS6v*arDlNXDfp&X}S z7LiVuEltfdpow6dg#ZJ7=pc=5eIhO_I+|BY=sff6M$8{Wo33E?lZ(!ICngdZnPa^3 z2(`&t*KiYk4XO|t$;##jwJ4}l$)K*LCua( zcP_shEx2!J%L`gMG0Lw}sI09GsT0!3)9WpnqC9V?{t?V>{{Wunr0{%u%Nw}Aj?89w zgIuLZP9{cz+Nx73O{{ZTVkn3>MvupK5qN$0N zAA3UFwxx!=GB&Zl>m6e67Z37ZQlmc`+jrlgFJ;(jme^^Or3e}TkO$=!amJS-ig{eQ zoaw2{Z4y)nvY3~B?B`hR2sHh#AcVAZ+n1=9Av#4P(^5>-{{TvWqtRBfhoRgBn5bYEDy#r6OQMmVRaNI)m(8x8qzpJTu%MFLm-n^* z0DD95*nyvRhpm00+O5;oOr1()=JZKZhawb5RFxe;i8kn_@RVg^IZ&n{PO5ALsl^-f z7;q4MK!%@UR9WQI6+WDbQ!5)~n`-|6i4fCO{D9YR-MuMP;WL#}5d#BWG5v93d zi3^HE;8T0Vc2A1f!8JF`I!6aIoQGTX)gcP^ONa;1n@3RIMX>BLOOFAxKGm7rkxrz!^&&qLc=IE}KwE5y%8AhpAcds_?Vid8{z4_<;oeR8 zF62zPRDWSF!-^GVrueSbrVu9`1hm77QbQ;@fRvwfpAQH#&OgH*oY?OViT?l;y7XNK z;Zr5C-er3IsdbzDiHi15OYMm|k}30~rfeZz37%yq z?5gN#vul<=1cR4fO<~wcujZ_0BokkDEBIS2i_@T zwab3%kxMLe`MT}b=ud1dha9dg6$$3jo?qxu%Lx9tO}Fsyh2y~GyV-W+Ldls&W%D+w zp2)eu?P1ABR4m-fN(pI0pm9WZRrqkRE2}* zdjevrSQ`6GogAtCv_+a#0b3L{hbNJQ&DdB zv{&&QRJBr*TWz>bA$G{2P=_u;mghAp12U4*KsV`S-~F*`kJ)hSm&^GPJ?>HF+bTP> z^o!LR29$-GOl|M2W6Zr+`=jisbwv#2?8U{Sj^b}09ILUQe`c)r6>S((*9dS zRwUn~JpDoCq^zZBY^e$c+aDgV*raZnwEIBk$Wk{`hQNBAp#p@JMn=0+c{38(UIX1M zt2SRN4TN;*(Qk-#nI}+*j!n>@qB%*-2=f~lLl%h@C&Xo99!jOzmz#WO5a0x)^&|s- zj5R~3W&1%jQe`bwr;{cN4mPAR!PzJ`Igox=9dwRWi%yFHr=^TvMU|Kg6=rP<<*B3_ z0s#PmZTQ7LNK>!T7Z~UFVsc`*hiWp^rkE_vy>%eBD%r?{?zNDkl|2FKbcT}h`XWb8 ze^ziA;GG)`R~)N9Qc0LvN?dJiAR_0lxo}6UOIbFnUW|<6Zt41pdAcSU#~;n+YEzg0xDMvvY1$X$-#M*V*OL+dJ+8lB0hf^}GOwyiuPI$d()< za-YIUHzePyQ{72cX4HiMMa{?{SbADJ;(3ir9rR=2{qX34pzpUzl#mXNCi?ka@UIaK zcrUP=sbV}cQ+PV`#G`~J!Cb(88XHG^R43iU9XWdwW_phP;d zSkvMBjaBhS2+E6$MNUdj{J*eA`O)7L=er5SakB}|s?66~Ubee$rAfb;1c>9zcioQU zj}U2-DOpWsT}T>SENSX|VDWs!_#Q_$`{L2$LX>d>JAJjJf%!q=-%$5@?rdNlE6CUR zp~}rI?54>}PWSEiloUa?ptqcH=B{k&;l;&67s<)CT}k-WY{SxIc_>!=?9Lxhr7PPWjL`*bz~xW zrC401_xWoa@z-;{?)w{W@oJMKoa>oVQ{%0Nt>d0L?swhaW77O@p*U^r&Hf+84;^ zBF@h?0n+<^FnH^@uXcTdF~y8B1%&e}^-@WWd&2HKn;MbhcuIXIcQ>Ux9kDQzXGlqp$Gx{WpTyg4lPC2;gV z4%Q?Ta-wcrxO53GqU88*2=Rq@0~uAq%ES{yI)IR+-!fiof#+~4lIW}AUL;MovTo0gDDS^kW!Q&sGA$= z1Sw=W;hk&?h-)p#ON6y7q03E@Lein8$IcPr9q@%n$5V|t%63(yg!j$Ypqe2HB;;(O$ZRXlZLS`8jaUJ2_8*2+r#4*Q|tS#$j zRJun{b0q%&2PzDC(6D5TvHxj6E4O=7{serQ}ZPEp}TFHXWB(T1dW;Dl$?a&JHJH(6O@-Nxt{; zhS&zMTqF%wB*UB9(A$CAG))~hz2UzIR-lTer9B}p9Uasc==6_t5PV~r0?h5o+oqA# z6P9FhNeUk5x$7NqIc5fF{Irb4Il7U1elTe}W+hYXZWXVj6mavbfGn-X#sCrc%LP;M z{IQd(O1C>KtqN8wK=M$sho~YY;>_SNI4KpE+8?lV?Bd#+!{}V}ux&_Gwr1IKT`44| zDJoAmSleFx#mP5|%sgeS%IussVhqdh@va+^nyYzc5^mdbAf-cJx%RzIk!KvLT!?bU z>qAFvD!5Ih9`O5|npsU;q}s=MO0j>7zCZ;M=?~VRhN#?1@Tj(h9Dn6S2^n z0luT8Jq^Uk9UOPWDefgxT$XNZx))(cwlEX6KxTh3y zjRxD_UqcI6=;NP3c~R|1>X>>>rxlTDQZMV^N^khVM^YjaG&xrmU3t=_DMdtto03i8 zT1N)}r9fK0VLVr#ZJ@&`Ds3Pn6JTsK9X}XVoS~en(^Xl0a}Vm`&B;AHp$!W{*9zl$ zjtXr|$jz1zt-?~0eq<91QlpIt>h)LoM*5~_UN1bad1~Cp8@^{!qmXK{QbR{I@Bqgy zj@6ub++f>d>ck<)QbGb|d2{P4QN7^S5aUhvK~Rjq%KfIt%57@V3(o298U%s1XqMUu3SG!vWUcswrKhPpKB z*p#ojK?@2>R1So9wT@7mC5|Gh%43PPn=W$9wLK3rVY7_bkZo=3W33$IaV4wEqsS;s zq?X>FVsW)!cGfbuJh~W9Bd13Z@Y!zEX6h6-47A*Yz)Nle?*$CVN`W@lYmi5bGdL*@ z!g@&&!VcUrc^Sjlv4bNt)6S{M2v%m){HkWx@G*qujslM7gwmyrz8Pc5m*L4Y#qeA2=F1nbwtBl#tts&f96o+DP|Na&q6oBZ)j?G zl!d9$J@9XCBv&RqlDN`ZY3#`^pm&-ZrsO8d7SiIzAy0;Nw&SZRB&HR_*moRDwJ{+y zUrWV#0c~YKpxH!&YgqLdjUALpth#d6w7q z-9SG$ij}fMWWI6nlmWC{#H(jLrIk4_RBn*QgP=AyF*g|=LkEQ?TU^`hxiG15?Fq_4 zN`i@DuIjC@^M|NGC#!QxlbB%ujH+Q*y@sOJI>Iuq$X+q0$L*hON$6QXKDNAOc)#NL z8Xg;$%x0>#VatJK5Os>SSRp`)dvj7PB|`krq_5W6K!W!TN1OJkcAZzgfTWYQADINmacyBT1g(3x5hZ)DLO|>45ga2ISwT^ z302+J_HicKgX5tV(h8t%m~2HdWQ%Qs`gaNzE#eJ_#OoXcBrr8@VyK{o)se}3t%7wI zIe`ZI?XBRdI?nDktI5?`6xrsGw;Xk}y4qaW6?YxeYaMd+5VYFe2}mv=#i@{-TT7R4 z7SWltq=f|{*-}&Hd^ZpRLSGBGwpOl7ixSOGAw?tu$9z&JDJrlC@+=1URA-qD}qSaYp$Zdmb2BnuRj9%{|*O zJOk|nfNZN>MJImufwoi999bRj(!PRRM8!TrTARp~o#=AIXrPb{6=t|vrY3~Exw{blQ0_1^hcD!{7lcD{d!&38>nQbcOWLlGz zMI}jEa;oENk>W23LpCC(<{GC+WNiIIY)iI_l1NWHBmz#lY;UZ0pQ8N4_4&WZSIcCb znJ$HQc{xElTsVINwc*SA`HjE7LxC?>M8wOI*|Tz#d1Ju)su$~Sht30{!cP>-VF`%| zC)#mhZO4O71d@PKFJeG8J{Ps^4@7EPl7dkI)(XXxLRDp2+l``bIN1trh^30So~|7& zDXp4o9Nfj6%2>{kxwt_W@r!8SZ?OU7NZ7)hVMZ;Slb4m0ly+8k+ER(OohnLQmq<}U zkWdwEOLUw zhT&9l!B~#a3Cu%AV-QQOT46cbb43pk;T=aCI5^s3UjTaqjFl8r9GObOP?>w)GA?iZprkIvQ&75>CD{X2h1u8+d;DfE>j~AEJH67eNN^Y2!0uhq#E4y-R z0kyS=l0)f=SVbK@XecZ&5KsmXPzJPifGLEuC}=pV#d+=*Qs!pm0$f`GIS`-%Nm78+ z*qtwbIGKYUrbnEp$U8zggwhdPc0fPNN|e|RB#giv!c-5!C3r(x&i#LhwaQ`>HS}dW z*qzJDb#rSOf`!G>8YD*^5LpJFANG-{;K?*jnkq&82r~?89bt9(^BNdfD zHn~!Z1fVD```=4iIcHARTSrbA0xun)3ZZD@Iwf&T`XuF+jzn!< z;_VJhUCFe8)RZ^?_~nI0HaK)x;yos;kXW5)f^@b20CW-p1&d;+4%rbg z6z{TBCPz+X&&C*h#UN2XVX2NCI2CC_I_pm%;Dn;!x03nq`q%FMF~B8P4~AM>K1qo% zz&#jG(y++W9A#oZ>8e0roBaZ{&nMN9DRh=g!lIHHa z{i6svCMy_R&L`@p9c^6+?+=lLIEqXeY%GMQzclW9YN4caNNP3S!EL>%oSFXBpwf3y z#h9QmDobW%=M+b}qD}7{suZ1*2Mx3A(v2giK>VU)c?>hNcu)r302J!6y>bV{^>j@Xs2&!i^FAgEugc7o2G4D%RD zx{r75PBUq9-uud|t;}#8N@BgrpcK4x>&bF~Bzx<<61Y1GLf76eWv{ z3_H(!A#od!xNt{A7)I~`uuY*r6qo=dqkwqF0K&Ce1E>HXIwi5(f~pj$#*i+hu;NlY zNl5|@M^OVf8#{|In<;Ww$^z9(qL8xnDj-UeobYRK>bW zUszmS)=t9vTF~y2nn;(F95`xp>30`0QzZEgl;sA>8Xb4iAWLRKlNws{smE1?HWpVY zBmx>It-esCw4q#(q+)7PexSu93(Ip7sh#XXP0B}6dsvWRwy9W#x{sF?9Bp%QvyzPl z6ze&H6Yk_}*(2rG=L|u25zMa+Bx47w6&Z=8t5u$xSZQdv!--KUF+1D`;?&;@rk$xt zkRDn~eLd5@;KO`Q4SNga$gu7QW4zKY)ZCh8QFD%v?bH^$plC9io&6&>#b9aD6nhT3^anGy?QX5Iv zeJ_9G6Z1z_$m3+0z$&a_2`_4B6jLSU+U87>ke1h*!`?b|0D%>mqZmE;(ZMO(YPUPa zj7=v?l9pL4vWAko-JhtQfDRl(N8sxa8nY2EH%1JHI;{>mor4znX zrs^I##8$pvQ>A@it}-4FS0-t+EY%sQxucaOpx?ZG+{+5KrsU`ZT0AakNxDgVKwohW z7*uf$Ms4g(O%&8hNV-akfk|;{8BhU00GsV=`NAA3w7YHcsyH^hH{z{JA7PK={G5X3 zmQbdp)Z2kJwyG-x0jG&N?GNPP^v>J!6y?xkcvXpJI6x<))X5WTSVE3$s&6UHri2@i zJ|3|56OY~+ZS0Qfu0@F9PA|KT(8U6{mzzw~u$bpEd#YsgUQh~r^#&`J1&{G3vSp7A z#mWtCPaYre+Kt0WHj^OQLP)q#z0aPc#l{HU{NHm>xTiJDR8?^gC=!(B^1Y(s5EAl; z)#4YX5>7yydEO*Y)~hsRr>3Tj)THG*0G)ntqoPX?c<*8rTwvOLBv$-P}zQ({{XZ$g=A8KRGTZp$^sJ3 z)g3wZOQ<;%Qmbg8(86d@!I!B{NoeweqsJ%*@P^tJnaZr=w9`mJ(yOm)0)KQR#>J*7 zFyma&&PtTqhwUd%nApO6G%v(#Xt?p&(VjIVKJ&pdji${ylmwLe@w`LgICU-JtGRo@`$5BLJM2Df_Is^K zf?JqrUahD7Xn^>3Td!$Hvm4jA6I`rLdo;q^Z6seZfU)%NZyk;%hO+T-mi8>BxN5!< z)8-wiFx5g`ZItFJv1r>%Bob9~&}$1&Yp2wUEXyXzwesdP+$!wtJ&bKttf3V8axSoq zGc7xUqLl)lP2x_UKbaNfr^|kbO4qS0#Y(nWpuVXZG`Y&-%5R>B)|1}K7Be7p(?ht3 zvy39STYR_rld?_snmd!?xF@|dH{Q)@rjtQx%1>zaXezjvgS=$N+g{rv>^?q z$Q{w)7WnZcwHds*Tivr1T<&8@f6JT z{jQ{;VQho};D%36Eo~1+hK%F#{`u&d{YQ6Qacv*h`Tp&0QF} zpkz6zZRLj43RF#i0@~}P?QXE28>Joahu)imrZDrK)QYFJy0DTLJ1pCWC>j8uk*CfX zd7B(q%(Gbg5=guY=%$Gj>Zg#>NwNSNa+T7#Er;y&^oJn1Mc)<; znyI|ec2((@0uH*Q5bRg=Jn8w)~c@soHIzwtu=t9t}$tP~Gx03$=sGSCE9>ld(#Vu?(EbC-~mCrcu`6MUi zF9~@?XcYAsV?Ng{$(e?oLWn>~T9Bml)g%$|jx2%UnnGql7ho=BGl@;|^PeF`-3o?L zxF-13Lq2ZnL2*>=BCc+qq8+#o}@msGM8pS(Jc3pQhJcP zSwcCjhJ?erk7nt>wCgUm`i5jMTvgZoe543hh|YLuDzU`FH)?UInI{x9DSRxCJyDeU zUOKW@e^Z_vjdgnt4kNI+TBOq5XsDLM%1!f+byja8fWG!Rh*Wa4>?Ms2j|TBS@@}B+ z7pY4oU2LfG(2UDYQg6)6qN}A_+WKD6CQUVC30B0js!>rS5*kryD;5epFEqT zhY}4!3!)6p)H(P5jYw$a_{TL@P;os|*r98>w7(rl-PGgEe5R;MuPfB_3cvn-GYjg)U3auku+Zl1b&k|k%`nLtSn zGd9Xe9$`TzG}*$a(i@n#GSueR(d5gmMLuCU06#GYiT6REOG;tnRWh?O>sL~; zq^_Ezf==5wH-f^A+HVNhm76OvGE)yX?qx*8u}SeOOSapktqSpPVLl&IwOGN^GUZLF zY|AK%rKGhvFi;NGUoy&pWJ{mw8Xw&emmJAgYAZD7q~BDUTuQyNS;aE70pi-06rW3& zmkA}hBhC%;9o!wmDmqx_srvkxMUQr2*A4oSl|~fvP%Kt(9OIj{4D^{=mLi;&mR?fQ zP?Wff6O^gK&~W@!tUcl}m5nAWXxO(AVd=%st#wxEWs&vkeFfA3sVhQ&xI0)3!+1`! zx(@80X{nd)+GeV6rzNG7BWR)JW)}cQfe+$Dhhc*{{W(Cp<}ry$(2C#Hqs-!>{o(?O>Y%e11g=BsZJE8 z!Pgs0DlLwRTV=4NC&VXPM;2yr;W||QFV7}aOwOg^!bQydszc4FedSBrn2#_5tq;eD z@9IUL4cN&)i)Jz1EfbWf94_#ZYuc&L zviLv?0oK*17Tqhi$`fZ)PMg%%WyIzMH=e+l#ov?Km?FZmxEEwCqiF}kKy2vHn$XmVRg%`ABag1c!zWyy7v{ODirC2 zTz8sK7bQB|%m`PAj%XXM&zQU-h{{ter)`)UEh5%Y*2i68PIPg^|J9a~`1sOi=GUXr zi&_e-b6922px)Yn@r-1#nk6AuAf{cZO)B(8nU{HmKxA+dGKF7pZ6IfE#C2PRGC19bT$5}x;!l2EU~+XA1p>sR+u;I}JMkl9 z*t);LM}elT#Hj=j%gRt~#Dl0sh`s*LNSBQ%d3*+^>Q4Rw_RFU6HNR({22yn$)wbo3 zZ{jYZNb`r>oO$|@UM*a`38^bI-1-BJC@lw2K?Hsg+p;r_8C!3c*Q_K-l*a(am_Pxp z2Kqn&d#9-R!e{^~1~}2soS_Mzvq8yqC3%8~O})@M`obDI5%xK!a~wJYa_Mh)=oy?= zP&r{ci{{WR#>N$4LR%K$N@g~fRIOr7iP?1v6g<*g7V+-`Z&9>JhY;d7 zENPW{#=gb#+%0L!&H;7VmQr&)OLaxXfKU92WJo$++)>+O(l0oEF+OArxH}MYj`$|3 zsx2Yf*R{${&pSFNC7lHUkjjzC2|*W0S_+h`#a9C2z!GmCH2Je+r_$s1!ffT9YEq+68IE8M#a9=O3fvKgCl;#` zLG!=xfb9yIE*-e*W!Z(4C#B7=>2U=Lp&M1h{H1`|%nx1REzqqtE^syiYHjdlKrQ7Y z=G*ZQhat#7b1=>Vr(&v-WEo)!D+C~>z?G5`kWQl4H$80#)JTjI*q0R!%v1_=^HOcg zg4$BwImHlFomahvT>uFr-=(2eN$`>&)+@k^t756TRug5}`F7s3CA1eTkOpF`ht^4=NJW2c@gE8FkYTn>{Tfl4hdfiMJuLQc^YCl5&rfEp9OO8X6a5 zyhkTCnZ}=Q4zT-*_5oCwQxB|elwBy*Kx$5a^byqu%?WZ(VNs80bo!*&!s} zA{uIir(&xJ;x=kakf%(H;Sz2ochp@Zts`F{96CApaW5jBQ<*EyXJy0f*pgGrB{n{G z0^7rE>N`^y9Ag&c=O$YYHSEn5DQN_i6pMhO4#(vUN;Wv9Lc;}0IZI6IQb}>Qmb9gW zvPwZ~lv3hWlzYe~#H8p>u*9IBG&rWv++ga3D~L=kSu6(TWjn66-~~=tkX##^lfQ9irj#VHTI22DR2(B;H}(5KmX<*xQGp=+{;a@YE!_D@rNj7FSjeKVB2IQ-Jy zS+i(qCB=&ykO&%dwaho9U78A_A*S1O5>cMU{#*WVP+6_SS!HIHQE{E1#5 z_*468&}z&}{VtNiCRDVv`*|0amaL@AB&zL`xEkrKF)kVM98*Mw!|9R6NCurhEdFHX zNNvDLPmP7mykZl^(CwY+oGzw?mh8At8iK7oY(yc$;B-n(;ntV>XBZ;-6p?Sr5aaL* zGD*qGQHnrk+Aeh{P0~Gffh2(My(=X+pai-SzJ&OB5vYYx!?eW?L8TWGpoNVtS8M6g z1c2BGNOUR3SPhM=tEitl=^Z$8>Nx2V6Czx;7STy6aW=5mLA}Y2YM`T-iG@6M|pv?>r<{Msd>^5LQ`n%GlwnbXC&N7uu^aKd_E8(qRE^>wKr!_6jS=Q zQS%q;3)Ci!*;%=F(xkYzR+21G@JSyL;T(JS`JEZ5jugw!&U-^446Q4>V)tm=ZWC_m zhmo{5;i1nFitprv#Ii13XpnWxN`6{H%VCxzCm%9KWINnG&Y`Kb$OmKB$|d8F#E}-T z79?t7eqq3*skFa!DI^dFA(Wj)o;&pfMAn8$k%=6asy{27lFuaFNwKjuweO@im3~6; zh(0D-QShO#ZLgNmnBz8oBxpEY(9}-Iu4Q3cqWY22D%va)IS!%uX~d;2Aj|8S1X;js zp-CEB#__>NZhfUnFnLMS%cq^AjRH0$R9TZ+?R7SSq2@-h#B@q!IGHZa)1ECmGSU{8 z39!uHbfH`69enpY$R-HGGZb!X?!2Y*TRGYQSg3cj%b`644c^CF7FC*T#YL%krxD8y z5be}0lv`uz))FNgx`dkCbu#i&`MfGv2rqVK)QZn`A>`q9kHjV z<7Oo1{*IcKn3bJ%uq#T5N@LNjX8-fut#Z;P?6owbte(rDY32 zwX2)TTWSSL_GBvMUPn+9cq8Tw8@P_HiaRP2YH0{^UGOfOJ)GaXR4sdS9vZ-(-&2%z zDb#sp(Z+n-9* zflAO*nG2Rd%$wNjZ45b+aS>&PXAY92?4=St35@*tvdTP-l!#<-%#>a`KmkM)0V9V( zD8L6Eam=4F`NHCavzNsyqNhnv=*-vosf!dxVuqelskvm7i|SIVYqq+=n31N(v>@Ix zl${6!23CceYpsa6`~~1jfwQZCT?@wUEALRz_)RPLz}CQ+;B4cT{{RTD&MM|hiJ36a z;gSG6AOPtXfB{gn0AO0IBa8-@j8tJk(G5uoOkk%a($v(m z4grxhT6rMt-wGCntC+OOfnEugoN=`5Eoi6B8fAt#Y-yudj6P<70|9sd$!Gu)EgYaR zodhK5uP&p_*K0yoGpAVV3pf@y0NU^X8o&Wo*l=Z4h&>~e0a}#|d%6MBq;ihgvAh5k z2naWVs0{aj1MDCJ1kL$G^%}tW9Y-d9Z4S$a6V+)4*6@}oBTBDIYO^OXF5*R&(!tPp zLy=&}i;t`CV5$_Wj3K)&>3wQICny`=$JQ-zDtH-K%$UUVn{Ib3G{kO}WT&vh&Hq`h>b2|sKC`dDHqlgLagM?CnUo`D$@F<@xUc+1V8a>K8N#(FytYM zRTx;CJd+)uu`7)%SVi{F13_aCh^sRgN{v5KmO>qRT_sJnhb8d%T1iTPoGGyzgL4OfzR}MV%UA6qSE4q{&d5^SVabN2)VXPb=|Y?~ z7XxTZz$?Th$z&x!+i(mqLhN{{{{W&-poO7k)OOC;aRJL3z9aXP!1Gc3A&i5O8&IC~ zGB|40)*DE-Q)uHjINU6j$njbGq(hJr*!ZZ!!($c1x~ZW1RN|4H66`75zk49PpsNPx zj8y*6H7S-`bkb#-4xuYbT$@8`%As_UlAuM#q8Fe>qhY=;S88OLT01Z0_qkJHd3|z| zZ;ToPQP@`%@f&E&szj;>>rL7@p$4-i5#uF7ty*G_KTm2~+8J@y-f7-qNI|gx_}_Tr zfz={q;Jn_*3cm8K>3D4po$7$QEB%#zP&28KT2fU_pa497ID|?!P|Ca@12|-kk;A6K zG&bu2!?xDZ)Fq3o5AQqSq%I;PE*GhV2r*k&0LvW!iZRd&9I!pS76!YU#}1iLm=0O5 zSw-a?{euaYAyMWapXA#m)t%8_6j9d#t>a zStKtYSCW7SG(C;e8k)34ToJ+vjugyH2PTV-DoSHAHT%6zn(MS!r)6xTMN=k-{a{Qu z-?|-L{PpP)3WmoU0OE>+(ukuiE~%8bRGVJOBx`fEzkD@3Yna5>QQncmjNzc8%}G+O zNCXpjjMa=cX5A)F+MHEMSrCR%Y|8HD*K7Fn5SJaO5(@rLpNFF0$$%5E2? zCcRd94nFp>vcW-CNII?5kS+SQF<+K#?1?hpC&*NFuwIIq!NFNg+zP#&QoJyyiX|>CHF%pShRXUeNwKukkzJ)saL9a8YVbdqkoNQ7Gey4Lqcc3IcN#E6x~%o(FAn z@60TV9iOYyRC;AY48FH%rRTY7o&cpNcTgF5XWT-(h0IIO8)|EN>Ev+hc9y|U;Yu|% zH3u18OsJ*DT2U%nDE%6Wk9do9+rl}+wB+lMAwk)Pj4e`|n>8tqsbWpka?YxBs=#Hr z)Ws@Qf?g)WKezG9SuRJYIyGYf@V-1@w0@0w-TKQdATG<)cU7*?jbrZhFKKlj z>Zka?<{lBXhbIv@TuBL+0>mVYp!nDgFA3BRCsonHhyTH87nBQp)?970IN^ z7Syxdy|wd(-Z9waI?hYW5`{Pbu?05(i~M0P7`2s^@5elCSH?BlxCn zk;)Zj`*Z%v($;nfC-8!X=ei>o3OG2EQhup6Sk7EhnM}pP08!s-=I|it6Z3I9D6ZR- znD|<5Pq^dO){Yj=2Ue1%CdmrqItb0Z(obI^Vmxmq-Gxage8WyxrRr`5nM~rHP`X)u zUpV{?t>?6JPhF1c9h?{0<;+&J%vDf^huC6W83`UPXko}jzF*9Tn}|^R*qBuO4=08g zOET<)lz=l3FYwYV@o@Ff&t~G>-t2Rlm~L8KDNTi<${327>$ju?Nb>Pe?;Uv6Tp(9abEsOqpgD zqbrz%HnLQZI%Egk_-PT=q zPqVnRBwa5d0Hf3^Yk7z)=8>v%642jq$$E)1Xj|OE!vmVJZH7^C@G;ReIkkQuKTwn@ zqtjZEZ8k`Hpqz^Ueb$gq!uE~}p^~d$(_Tn^vsQKFlkR&!VqAFyC~7`1SWuCtzb8+d zcArO;aWf6uB;31gu3u4mxV^~nvAlHR74%LX{WUl3^))T|uo5iY(ACC?vVPLP*$9-V zdJxp;u$%=!mf;+S(sfdVO}L9P(Xi#Cpb0i1M|F|BLY(V&@+@Hs{43_hFBMd0u?360Wm;q>*X})JD{oV8)Bga^+Z&u}kNgC4>8l;5MNoA)b@^@BHv^QLfS?q_%reU78!2j5XYeFp-J zr=*aU9U=5u+|=eebj_H2;Z`Ds6Bu9ya9ieLRZ4Ah&XTWZLs!fPTci*N$6aB?JLk|& zkwrCvYV#5S{{U!hbIko@uzV#>k<~ZLm|SQwz@~A;Kqrb+S+Ir}m=Y5%x}?m=&N7tC zt<97L^sRLf+fva}_H zk$&n@fKPY8+gM&mR{aD*i1crbnT}mH)DNXe|^^T`N&UF%- zIXI=eSeAL0(4_L#!t%7TEp;5p&0=~TZ39ViIGF8KWn}Ra8S(=92XwZe>W`?<>EuBk zG0tJgOjDkp!|D2?Eb2AP+l^UP^Et`CgccMd=c!a$)8WS{%S-2S$Vh7Uy~=mDjCDvT zQql0+L6Wwl<^7=wRkJjlrrQI4@VM(70XIjTtTy9}u^}*<+!ozfTLWL{?5mF}TS)B( zGhsC^p+RnCg-p!McX>$Vt!29$0IqCQfNm;Zw)y^S#_DO zsBm}Ka={=Tr~_l`yeJG3_!WkqT;(K{OkG87xNg#~(<)P;`@KA1J7PV_YOQ8rCAUj6 z2sh-ql9pF((QLQ*7~(oBr0L98d4gg?EA86e&Tn)2!~jGGIT}+HVJ_JsQ4-<37MX_J z&-+?0yr0$(9ia3#B;I{4KgjQ!Hnyyir5%zBia#N&a>9oZYL}~XC7qgW4BI2JujD~c zBgBn<2Y4*y2w7P<{5*t7Ft2MvWb$SUyugHXZE8seyRv+vt%{^}>39}T8U-2G6x-=K zt)+Kw=2TV*@dRxN)OL(t$Xd1>A-P8y=A}oL_+${a&qdoWd&G?h=?-cWM0f22!nwX6 z%Py}Z)67<+fae6IO(JQe?gm0ut6Rir5^&|MpHZBc`x-be4oPu(p2My?OKPg$f9UCF zRWOA%k*~Bc<R+uA@t733753Ne)&G#nO1&nJ+ZL`K3it56`ltHlu9cNfC5Ig zhM1}rbXl2+>2WZXq}KK+xS{9B9o-qSVVWQ|wGP zzFe}+`G*sj-^W z&L*NN&&$fyRs}D!*ie5JW#5mgs5X z80kJZ(j9eXUUH48I)>eC??PKpi6nOcTPMfL1iEs~R31vk#$ER^k3hTr_*IC|DJWcd zq0T>wVyoX<@j$3@z|G$|JKu% z;(Dp*a)nqeQK~N#@@i;kIVU!uaDuiHGRu_%YmV->J46}qTi;H^sPQC&z3L~d z)S#7lmc+7`nJaB-cIs(OtvV?y2_#tD5n~kjxNSee@5rBzHm+jj>i+<+%|0gk@)?v( zh1Al)%c?-{rCW>prXV=kB{9Ll__CW*Y1PUvGhude=qV!N!unp;_(OFnzhRrtiI{{E@l9OYk+)V z)sv&-CXN>gdq-CIQ97D^K~6s`SCcCATSoS_#HdGQw(&UQt7ciZ4|v^6$LJiVLS5>E za6$Ni9FA+|F+2@&9uI$8>C(m>vMWIH;M69JDwgJZ#_`Jv0SqCp2<4!l<>aP0sUV|V z&H=Ewggk<@nNczw+vDXOQ?RNvr)SFztxcypi3Ft@49B3k{Ns*P2>~rWR@zjwN!WVi|wQq6lyMB%DZW|rjRBSB{60L zrel`FRcSV+01C>bq-Q}|N)%AB-a?8=7fA-jB;(BD#$^jDPqimtAvGx{GlFGMqbkUk zc1amfn|`4@`DpUm zLdsi0bN~+sR-=?XxKgt(^m|WCp#{O1D5wkfO}rr1cSxA4VJg=bT{9H>cbR=b zF7jMCknlo?Bf65XH#W85OC^g@qS2_`o3Q;lQEk67IW)IL-Iz1ZG*$?;?1c*gKLcyS zwkuHuc=Lu8!C6UxfP!TaH!K6$S9y}!6tL-SYdOgvckm`he$G1TmIh#?lcIqqyS}!EBPt_GHa#3|;ymvY@kKoo56e{PQm(d_ zImNaaaU^9@jjW`rF3u;slVuA-i_4JR2+k<*(+Tit=N+iX3dEI1JG9r^sW^ujR>oav zX=>(WCo&#T8HR^g<4JQmpJG06vyIZqPx5~jvZ?Ai$xBLf9&D}lQ%lNMVbvgjVJcnD z(a+;21}C^E`*j&74BZ}N6Dv54JBk({iLA<&=oAD0{iW*Q`2}%kRc6EYDP(ei6m3YOU)Nnfql-7BhJddPYXk0-(y!2(A&hb zRNDNLoYbvtlCgA<5}*_aCrfG$n#T^OTN`+gzadhXd9(c7N|l8DlBAMIx0tv(K+YqZ zB}G8w&d^-?K4tWUw5Ie!go~EcfC0DkZ>HDo5qqbp_c|7LMTciboJV_cGb+Lqs&^w;rcx`c2P=`o0WOikub>!Q1wMk zQca#p5aNQ3^>iet+go4K8eYCDIe9@OVTx(v%${NuV&+X0!TsUV{=+$W}03w%xCJcF5?MpB}XA4`ZL zkZ~*#X3pQt!nvL^^W`w z8cVlS^=osLXH6QQ&S+2O1vzsz7V7&*F?11v~{$&k-l^xWAPXGLy6Fu8hk_9Qh|;p z-<@ntQyrN`NsnQfT)R#Y_SC{iMq|{0-rU^8{CV5vGbjw!HSA@IC73CsV#%47+CdCS z&9#wVv+Yf+DESqnfeuS5IT(tD+OM@B!&rh@EmYf=2z9i)heE;)vxTR+Ng9#8^xiVu zckz6S{uB6qXI_meg*0YRqIroI)Y`*K<=gkgbrV}PCS{W1)TE>b762;p@$&PuA&N}n zQ|HA&_odrkb+lzB+UFy2928`u^JSS^POmb91qCAB`M3)B_-zS7na$zTVpc=hmVk%l zhDD~}@2&1M);ico(5)tO0kR%!DrY;kOF>CM8IAN&zJTe{3g5BYv0X{TuhyGWby-DA zoTVxH)VLHBH3TP5oDI>+>?0}7IVCXMjDw46T0w=X`l|fP1aI8{-;i@ zPMKni>oSSj;151jKfkc z%O%N%rVU9lf49cx7IM_?z z5JDUZvK`ZVn3*UO+P`GeP3QaJV;tT`;2xv^|0r9==q z(;jf$Yd|VKB&S&GIAg`m0a_q|U;xlSFTdEnk<=xLJPuNfZY|b_`ArxfBdBncEaRWH zug)qaO^KZ_(BOTb07L+7HkeX4V{#I7)N@fBI3aj~d3aK|d>TKRV&8-y<{=(0;-a{J z!~rcl1x~h}mOU$>tG5)4fVC}=LsA*^?4_nM|N%GD1)F0Am662>^YodW#W>a z!<1z(r?W7njNHT_K`AQKi-Q*UNO>6y`yMR@qgqQu6mtnl8UizDK#AEA5fh^+M_+_S zp<`K#o?N`_nHw2|gYgCdELO9KYgGBxW#(zAQ*IIwFw^NN(_K(|!}!9eEOcio6OE@Z zlUmP!aU=7NojCH-uhcKims=i6QcvXqIL8MAEGDGL9t!-SaOQE6IK+V>Ll+}DJz98w zkYRBU%8`}AwX8`(rLLU!EvDOfE{;-MD*EMH-XhvxXi(Vb@G0cdu|Sk4S{yRYX3U(o z8fqae3ORT(r7u#b&CvpqMSM(=^o#!hw-KexbptE{lVUF%M?x-|&oDcYIl!=0wGrAmWP!m4 zEj_X8`NQyA2x5$?9HW2(9RVedPxEAXI3s{FILS#Ea;ck88@c|_hjH^8nO7Lsg;i;~ ztlYyg4!FyXW^HK##8_>tOd^jjWeg=fhpW>b*Dm7)QmV_GTKn~mFic@F4h5(xqc*c9 z>VlqdgOd7Q02FfAdTNtEUp=KXO=du(C|HrT?Ff<7TZF*Mpg&PRlvc809Xev}%6$ZN z3$uI}>C+&922+cyOgyP?W^gv3qnN2T1a%gMav^aW^m7yMD*l2Q6=saXZa(5vUHY`{ zjH6T2y#)o1-wh@|oMin%VaOa~)^&%D4G$P)QuQ);5xkq<=9pSTa%ENVD+8jmxfj;^ zZDyxRfE1M**#K^saAbJHzSfRUZEnvBDmEOpmW;|Y9)BGV}?24&C&g3!eere&TN zWq-1NDB~2F7-j3Spjl1;K_G$-{{Sd~WV37OnPann{NS^cW)+Ea3zdL93>F7HHI}B8 zc7ag)*0<*gu}6AU!l4}!#}fmp>U4TTkr5$ss91ocM*tX57~FvAjuLRmv~&zg5x_De zKnA6CIpp2|*pwZ7Au{ADJjjJNgsZbptT$V6w)81NWt+JEw^(aZ9}yVeg}9!ogqd37 z#YopFX|$CeTY(Panq0=RE95u$Uk~CLpKWHRGRu<<%e<1ZgoPv#_KFU-8(*whM6H=t zl63}XW!8YXF0TIoG9pb`OCxS`h%C|?AtK5nOKGpbM>JT~S<1on8O(b!nOSXKS+YWu z5()6RupbypjR}&{YjHZeT*C!2RRpb;+t4?l2h8R7y>*2`DV%~#WgX%qz!pM{yf1&w zBzR)>5i|8A)ZH$*s*E_59I}7*YNxd?PI^LiS+#p(4v?iGC3=qSm2ALYpdu?XOL8_x zxTBy@rI#R|ZPCVVgrMH)9W>YgI>ctgHZXV&y*GtbFo{HgnbJwhlc3mKgQPhv$0V$A zmBa_J3l7T7I1->cozMbRee98I!!km2(BN=;5YEvYO*)9_`bKTUW`8h1?wjQ~^vmP4 zLd}Uy+_^4;mMi;TaWZN~a#l`k2Oko{n%;cK3bn411&G{>L`)n%HZPdsaDfifXfl<# z#JejmPi&EuN(*=@=VXvVFKzF89U-Y=w*1an6QnWvCvgz1xh{!@3+gLjU@0p?t`rTy z=ycOan6T-M1&%i#u+gJ1+n9c7Pf;dvxMg()U26V}l^n!)bQ?j9Ci!l3ULN6DHyo(NH-+d@in?j(N`SB_LV*Lo5x2rF z(LOBgVN5*E6_It?Oqv2xN`pMW-en!ne@ptqIb9ZbH+zk3YXnU3HK6TAN%xjr3YS`E z(16;LsK}HMlVi9b-rB_sxVIO~(Z`32Uk&*&ZC9wvQJ6w;M42tOWC`}HR*}=0?ET?w ziQB9-4DF7*DgOWur}Y$4_##ZpiOPFk*C`uzZTF74W!;xVXhFx{>FB#70d` zy-j~4%W7?Yf5&K_9F|6K71YW6`raQ-#@eA5#fg_yB#_A=e8gCfB?4ojMaxqHpqX&L z6dzLvkn9K>#z&>wtj#iVm$L(vLvVb|ROMTmULF1vH^1KXQz%hXp~$UCOQelDiz?&c z5gh25r7_yz^DS3r5hi9{c?`C-CAS`Rc?w5B;*Ot$MagZJ7@CA#bK1naOa@(X1Kmp0 zK19T3i@3A0TeyVKt2tGnc8{;DngtpQeWk5FjX;8bK2tX8x`|twKWtH&wzc`#kL5(#-?iOUOuA9vRMJNbxZPGH;P59d#VaHY1|d-Yp@tvoN1| zr8nOA8(Blr@l`a_C8Wkfk5sG!iCA2%Vq#ueX({fnmbAK)(2SrH^R!9frte{#__q8@ z=dlhboG3EwhL=#9pQnvlv+gw6LDY8wukbs?x|vNpbSWfGYgZ}5QFs@-?Y zqvzHab}-{c1~{V4aU~SFWmcX_idLsVVWcE|yz3TLy*kHvb2!&wD?#CWXzo0iYYeeZW05GxVUej)Q)G`DgRj6s9LJ-M$y>v&9XE#M z&1QL^a*WI}diX5rKqsIhNMdu^$(ZreuD_7eCd*Ipm8m*;2w4w8*k$auQ4a76?sXtB+X2%Gp(PinQ~Y* z6c6-j3DA!McIg~oE|ofH4F{ZAaU|VKL*xy51ciP!jwknLIsX7dZmzjJT_%~CS3Aw> zm0XgAA6>!g($Uj`Zh)!GSm;}*QeT%yZN(+aTwK{ef-irJbnDnHe+pBVo?dwkxR64? zb%5w3>ze-nWZ$m+W2v>&MOdQ2_4HPpeWr<=$dH8;lHVxw0Y>3kZ*8DD&ORf-67mW! zPPEgmXhPP2vXqmd@IHNDwiRXx+5_~~gUungkW+qGmuV`ukUDMCcrBdRP4KlymYSFn zic?H%^*O<0sYi9AIUyctMu&KDu`N)J?FGS^Y58GXpr|)dls7!G5VfFg+KtAeqO3@V zvE;3u=xR~*3EAU}u4A+&Tmp%v^l1sEUjCBv2*51lrI1r>6+a_j_)p@;yFPXl%$*3Zb`C= zPM;V78x(1&Nur}mnrdxJK~o{JP~cYN6sX?ad^$&Jj#;AY-9kha%#>Vep~^+b8{DBJ z-|>W=&GZXH!B(%PTr#!M&8+Y5>*!DAXy-GuaO?O%+4oZW?Ibwa%!iV$_MJfj z_wt1tv9xa!(&Vas%TS+Ceb57KKQ5vQlx#A)lGpJ`K6iy_wPzfu(Xly(XQn2WiF$)b z2~~q)U8NCk1(E*%1R9b#M|@&xy#Ohh#F>VGv6x;)@}D4pN~5=DC}nt$fM(~M7>0uD zW~(eSxEXUQ<{BHNNj3#Z9c)P&L-^;>@*13aq1V9p`8-9CO#L0dXq#;*GtwZR$odTJSJaLh6Dn!JL+fFv_M>#+VrU?5*w!r2O7*~V63D?x?VookG zFCdwx-I{V(9L2*eXF?8_TWTQb)LQU}<8pdzR;pGmD6-P{l3BOukBNk>Ik{?Ul%NQ> zBm<|$6D)0PbxzJS^xVv(vy%>~QtV5pCG4rrTS?i&Yn3O)*SA zpgZYpNeaHiZ)2j(M;P^P24^?GEtD1$KTDYDvidAqy+07-Fg3r8q92Cc8?<)u>+X)?~9 zThhTOPE+<)+LAO-I^8xW#sjo+>L{C>@6#t*Q>gcZ!b;1C8zkP@R5s2#-Z8|&j)bZc zh(Zg}k5g(1Hd>{p94)*DPyqwrMaIylw;)C-hUzl!^H`^)mjUlQhm@e|NBCA$GN_UE zz2V~tIxgv$nqGcbxWJe~P@&FcFE8rJ>H+Us{RZ9;SW(!M#tb$T(`a(wT{)4=&warv z8HdIVM>LTGio7DM(p2qt1-hvh$;~$;(`}@z4OFB!p<{hcQM^yZl{HL>I9BN9VfyW3 zhzzqkDUeIPqLsYr<=c6e28uR9Lxo8?gK>D|sRVaAEnpl()XVg`oVsc)tLvGlWS2p4 z8(7&%QFHaKSLXzuRCNxX1i)=nWz{ak+x+$c&n)nD(3|a|oytM-y`iS>`U^^g-6H_v zN$H@}%#@=EN{MaTBQXitNeW$o>#nd$x&jrI94@6)6EE$CpI9inb4YbLUMc9}60)0* z6S(n)_Y^CrPrWdP(_LF~^C`@iUqYL7ETrh>T!$`g$OM52l$C-VJ;GaL+@*AEkQ0SPbDf+%2T{Pt?HA-WNacJ>VvW?|Z zhg~z6pMyQ~{K&a6e8~BN`zTCtT_wyji{z>e0hpl4sShDHu+H0#B|zz8rtv+_x)Ah^ z?h))GiD)zO(^D0eR)!r*ib5rFDOpYI70oukj?virKw)d+E`nzB?`CI zgp<<1D$xn!r+!3*J&lYr#_GooLL@ONRWnakP|ZyVD|IO(WityT1tQ;Xe^{-}!KrSx ze?n$F^~{6>E#@dBqVCMLPHu#H|?#J z2NIQ`!ESS8>MWu^2ugG;iyFTA67%EuAY`Qc_j5?sUIP z?;KeO&jUio>5{bo008Vs(mCRZ@QvlE)eSNqTbOd+kjqHdP<7GXupUCthTA(-V!E2z z4nSg3-8$S`zzF5Dv}n096L3^7;no|}c7v_O4|KHv{_E|PTz%tPxVLUfgX$G`4&y;xf3FvQ?cAgRV5Rh=inwYJy? z(OUkrTj1ksXTRn~o*N)U&kbt*p5{Zdim1sxlikgo0bXcXuu$|SC&xOMA(xJX{ujqG zEKAPJRV1Zn6bX3=QzX2#tnJK7g_|0c1J_XwJc4uz3Emw)Sdv{yiZg9W&LcHFDg?Z9 zoS|8?K|)UFrPFw8-YM0KSg)YmO>mZ{i5!%t%TZsKo=z+FQ){zx-7Tnhke$J}+R-^NmP7h2WOBre5T1@Ko8>wHJWO%PAv$bYR69e;u{is5N<|%NZ$Bb+`9S2#noqcOQBH7> z03kY92v)SjXredPDoU(Pndzk|*@u_STFtIhP4*fAMq=lHyXMRF-w+wh$EADr=W>+*vy2*KMo> zakH96`fnCWVTY4X%p9jY6xMWDwt~L{e51$5tRb;#HgtGpFq|Zb>UmfwA#TeObj_B; z4_ywBCK5-ewFjxv^!De;TkbmSvhH&nswAMB?lrfkqz5S7ew-66EXYu8QZvamy|g5E zejuA{AOTq@fr;C4QP&+pADK+M;R?#Egs3)p-626b9X>XW0vk>bR)!p`J1aFV{M9Z| z)s^#6o0pRI5B;2(t#Jur&bw5~rX;Ai^sKDAa(Rlc-UtC&_Xs2;53^$lXzF6Rxrm>@ zt}`n>8+C^UnG{w+PP!>p7uNRij#1N!aXh)9498no!YK+$i9VyoX<8{has8WcK|>^vKJrW_=xU=)HZNFw@QuZKg@7@^A%xPnBs z>&%!HVzj1dj<$iyM=iSxDBE85iSvZ%6=yzqhbhIxr7A?)9!Y7$ zk`0G-NeUX=8xe0fO&zgMh%42sHWbQdW)d9AwX8U_=1>6NFd*D*ee{GlC((KfQe&sX zF5B3f1~!>$lSrw`gKlHF*6>aC&zn#N*9Oqc@F@#ZEH8!Kqwt3mok|fh?LGXU3l}EH26};WI$h|#Bln4%(ZRu~(IJX7<-ms&F-96V7 z;VKzO8;I&S&WM?r+$a&&-92G;&K&n#dT^ht1Hj%nVMf%1tHB2|#{DdB?~SAxl)CPmA5C(Ay-mu>~4r6ancpp{s6R)rg1_J>$Y*l})grx*fc>Pl3!^DM1KPVzw>2KtW(L*^|V zdX*oL_qNMxm{@_a9ts1)&uCPRC(zQDX)|tzkZ+iaB zVuE~?wYnJUIn>}%s%ooBnVhPZC{boynd&2EYt5PFE`BZFgy_=6)tVfTW4sri=yRI3?FmTVN2a>)kP8IJac5@92+ zFN!6n+G>7XPPU1KhJ!CBAwfyiR`bvUs4>YZ*bc2OiA-*3Y?oW+KItr}wPks=Tk8^o zZGqKE7q#_;t^W5A+ZB^k*CgeGIk~Q(88ef0C=CL^JF40!^^UY6!^%r3^*GG1mgY3B z{{S&JQ5qcDblelt6okK-$-#0G&rj4OXOf3d?prsM1dF2iTL(ZjxIJ$Qh?#P+XG4~1 zm3cxI11j$qPk4kT=}=eNNcTwHCrjNu58f7quh;Yt$C{5ew*d;&gpru;MY{R;#OyC}9#ladIZf4R^Dix#qswYt zr&~&p6_l;Og(m(MHy(T5G*~6EPnB+E;lgI+@qD9BK3tb(VqpnMNFC)$p?Qu_0XmU? z2!6)NE=}Hd{z@zJikzIuusRLH1Exp-HSHWaf+`Yp#$Y;dYFm7v$cST6+IFu{pstlO zA<88U%ySa$@+k@pq>Vc3`NgzIa$<3eM~Nj0SIVcKVwr7(B_-f4;zfuXWdMyKR3gBw zV;n^NP_*MT^5L3Hp;g`YiZg|N&AvD31qGQnJyWSvanV&l3^)G(6D=)<6r}fkXa)SY4YN5tO?lNzCBR8b*-$`N zckGDk}381lgCyS~q&B`$~CR9qlPSN_b>8FX8+nv;)Mt(REpJDJS7?&N>Go zVxXW-ml4phMSz_y)mhU^EAoX$m=bK5dX5OZY_gU~8}i+^_7x69ZbeE;(;BPLXrgXr zW?o;FGFFxsmpKm|!O))wP=QOpWm5(&ZJJ@5B@)i(_KRNRk93V~>j`H>{uQsu;Tok> zy0v?1X3C3tXH#I`xpE4(*U}qm#V11F9pa|AfH2J5x)z4hT*=?CR&1K>anb~+?b&HK zZ2tf^w}Omy3P)-RI!AiLC{*kDfG0WL7-(?QSV+)Y;ROMq%jYiSPx!>Zb&Pf~ndIThs+FkZAIw9L8j)96--wlj z)n<~J>86`Yr6@{XT2hbzumbi1CJ~40vVJtE*DH^+F*y9f6D(AexZzj_T|g&z7z`FF z;vH?N`Ie1FaUn0b0(t8e8I6D!+5i=jSc-D3Ky_1ZyD(8!r{ylJtbuZD2|7X~DHgFf z>C8`x6K|AOvRLj?6ZHuFkpen&W2a1sFda;3c%$!2e$u}vZer6L0=;bwQP7J)J3&A= zJTuaC{{YD|`NE(B^h7#zXt>0zk`taD!uRB1#5E$XaqVB&ML#V~%6o=FRB7%gWCvSo zyf`vG9h#c6d*LDx8ld_Bn!$hmDT$#wih<#Lv#U>q)MvRb1BxER}$fnC?Kd zbqQnr!XNmiv4@ybiG4_uo^P6ibgs^)ybpvWibbWdswO6NRvT|p03MK&r#`n_lb~`8!jg`2sX|G$u65S^ zI$zETI4h?eN|%u%Pbdx@8Dn4tpaFe>mP@Y=mP{@qa~wq&a7CER0b%mqIu;R0fGjCR zpgIm%03w8OfFd{sg?w5~-`Rvuk=XMYW}6x-sSy;ABqne~o+6x7?8B1@al0is9Vtpc z+q<>=Ogk9}XpFKry9&$Hs*K6GJekfz$Xb@Pmfp&p{K&S4c(#IRBCjJ`l{qnn9(}2a z!0Tyg3R1hof}&Jxl$(3rQ8hA^v9+bpRf#7NEzAfj>Z5O#`oi0xGIU9adNigGLRymp zGd<-xZJA58t#NHU1V_6f-lMCF+k1+Xu3P0P@7Z6mMbsY8397mseLcEvB3lE^FDNXIJnQh}7ir6By7#AyV z%+wabQGDqpI_e#t%qx3QOa=p4$&#DILcjqb!f2XWg#SuR4w7s7;I}(V-tqy zvof=x>kx#fAtc_!llZ{Zjx%S9l-DrcBA52Y$(M1oUiym;pq&IXw_6>LB5L-6;@g-@ z3`k1Jpgi3B1uAjw^^ygE79(z+1{ueW-u(d(w}iOC{v1v>ID`c>pit^oE|n!)k6#FS zSoIxa^GK_;jA|22N+gD!N{bnVid05}OM$M|g)Dkj<84t0-le?7V4?inEA)5$W?){6ZmF??2{ye zI__lvZFD1{+d_VJhi8LSt@IYjiP?LLbzCU)w6x$`vJVv?v@UsRvAXO?NJ!lI3&aj5 zhfj2IJ;WCYvEZj;$@l5(I`pE{^0{ocooj5Uf) zweW~C!J<_9v~?;vy@@+WO3yH4XBCmerprzDx7!z0{bBjR;Fa`aka}5Tl@<{?fa@mc zShzk$E%9ZvS!0llO97|aDi=s`Ikf3`GP_0R4)+`WE^#hjhT+?pSUZN#H#EAO;BHCBl0xMr3Xsad>hceDOY^XavB28gfj%L0-_8Dm zkn^gOeS+%^E?o&zOIlJ&!U)qa+TK5uM$5ys($GUHcfCG*z>@Y^rqb$A(wk+)Fy?~A zh3)Vc8|l1LWR9Bhbp8ySq~6=^t$b0e%S=*6MKa&>cYU4B0Q!eL!hE$G>ERHqL!U=a z;Q10M&#T>9_@hurH%?Mk@V{QKP2?L)iP#Xw7BD{NHQfV>X(L= z@wiQ*>Kt7VCBwda{{S<7vxO%rvfC*9`e5u?R5pHA;hvZb1)+8`0FE(uJeQqW6a7OPMY*eLpf%c50_j%)dQUeZUhY zj#9&y4icbrw~v{K*%3PqPLHeGC7vLAdX+V-TpzW!rR#Qx9H7=E7g+Gl2hT0v0?SWq_CTc>Cj4PVgf z_M4w?ki~FQhII}zujvWYzP3<8CCtK>q+}m&Dy~0f+FA+ly(8C{+T+xBeua!sIB_q5 zB6XcMG^H0ikpgfX$wk@2sz9rF;u@b_Y#w^LWsAdc8=JokZDxrP|kI)B0$WubsKdj zse*#eiX9|t9H6jyf)hflHgN?7h6eh_8aie|gd|as$2+Fbnipp#i0Tvw>IsJ09J6Yx zOKPl}ECNQUSK3MON!%YuW?1zPMtVdxBc~>(E~!eqqg6RDKcqlhz#piip(Eg89)|`= zZB2fi2GXa2gK{NUIWo^ECdN(mWp%!vqZ`}9NRbaR9!U27L}Q!a`K&%1#1j*Q`5&D$EI|7pE)6tNRb^|iDbn#6a?X&Z(7b^w zD#b`z(vW{z+Yd9O0(TVLs*_BsCnjp1r3E&o)URpD>z696`9LE6`Utw$2IksA>JoKH z=M=v38#9Hq4y6Lf(DVS@UL4o(8~gGSui>TE>FZmQwP!E-X&2pSzKo}PDL3>Zq;lCyAwBT%^@Wr##*DrzAj{XU@!YA z0De%ZPQ)nCpv0I{`{A|i60NRIYW>B_ujxuh(dHNh&Av+YW&)a`-LF|HV?Rx zGj0jVsPctsuEIsTbd}O%+LDxUGU{ViN=nil&Axj9e_tMu-!Vw)Q;fuc+z%aNry3c~EpWnep7OCS9s0TE zhH0s0^ChW<{`fk_feJ((I&tq_RDTAoTm zRO3Y=P=|WjcnrNx9#-i zpBZwOl1O>7G|HoEf;K??=7?>rtACHP#t1SCZws1N;SCZ$oANGhK!dS z!*8`ux7Exv&_Yytf~1m*-v0n<_lsOOtx}>MN8Cs={nI*qacV^E5$70Inl#&n$4x?< z7t$m?8Tkz?iFXuKel2kRqR-M260Ol3amy8{ElCxqYIPS1^8lUUjGQBXA=u@iFCmCN zji|1An_Z%=RpNP)>z=*A-pRN~SD4evBfc4>$aQ5*+s8GQX{c^hG&f!oX$7gNX4(ve zbUfsNVbu7hA<7lcVf8M@5~GMK*mX^bhh!z3NKY-K^IAgF>z2g%j%)n+YMO*+TD^u4NQ~e@GeBDc!}>GAZ^6 z#$A2ID#YeVC%~W*k*7|v!?biHD@BDGeL<3ytY?>X#00pZ(K(6LW2#2uQ5*oXn0ivQ z;O6C0l5Ccdk+qV1>_|SAF~hbZvEL9_eJ#@xQVgU@Z~ zA1xz^(*`xwtRpc+o@$)y&dkXW7Kh$&zMx64%bU10(2)+QbrC{yh`17O3rw!Fhr-#M z2}qxn4T99t2lS1h2FiD-x`8{0av3#j#^nm#8@P8HRCtk3Ou9^~(z6}TT-z=-TTsy5 zNLsQe9gg?b2lzp5cBD8&aG~T>8Bt;6_a-V7v z3$p~58|5(6)>V6FHD^XFyPqyv!Y(|Z(*D>#y^OQZikr)*;k@#5H$Kr%eJX926>H{g zr0N~(10}bhT9f}A;YsYx79f=!;Gk+%3)zEX=H4o+0?JZgLQhs zZ0Mn;ORE^E4mzGn!a!J;b0c>L-Uuno4~ROAL~_HCp^CU2NyP-XfRxmmx{)xPsCNGV z@=*y32hV>vb!BU)+luTL17n)E4kZ>JB>xUHVQ!er(0uhz>WwNO^LeR(o zebs0ZlbX=b;T0z8vi+Wx&niq$Qxw#*p4Tk3Gc_)^0*Vv~DpQTB#0HOY!q$c}VDS|X zxBhfI0}M&A{!qPGtOiM*EVA zTB`d=mv(J}hbAQ6T1Zx4m4w}BBntqf_mWMm?!^vBSJbkMtY1-QrLj*fGK&^UL0d#w zY0y|}?+&*R#({T6OiL*1GU{=lIfysD*}7#uu!r~^7V8j$!8L@ zC|p~@8jOZz3OmNn3lR?|V^v0q>A^as1z*=9Iiv2*S*)Pq4Y^7K)G8BCuvw_4oWHnj z;zS~u(`77Y9WM$&Q&EVSTO7v{7By39Q)?fxw2+{D!3GM| z_Rw7$lJw%r6X(_zqH@ftVr5K%;P}R4Pm5+tNAo+_C4#y*ink)B<{{YSk7;X7J-4V; zT6;wXWGUB{+r=QOGSsiEO2)TIAm+?0L@yT+PxD*7{`(!4AD?2c>exnW3M!#bttC?R z4ocl>b%pa2GS+~y@={JvuXrt1KV*UoT|uU{AW2c%!WBF}!4!w5pJs3uGb&ry+gNca zA67%FLdpp`kPf22gAONWISwq(YWxjU0pH}Dkb3#Kz_ycr*-Ikd3mA1KgmW9J?-8gx zNmK09s#9&z+Ho&2N0UO*mlUC81w5iMlz;{8Vm1OK#$!$+0gozm8FFbfiFwLyAAL90e?=L9w`IX)#V=8696MF%B{mLP%ET-hZ5P#5k9Cm9dn7ZQKUuTZ`CeU~=5%orDf9lAXhju;VLI znnl1_7AN&o4_j${j_~r8jJVLM!MMU+rtW#f5GCDhz`K$XLC}%sv^to}h`g&ylp4K2 ztSN_(9bhF|g`kUEbT&T`9b!?^pw^7*((fSUb>2o{;HCGFuTY_Q;85-1$%=kzn#Gdc zc3tGDB_}E-TkeoOS9|O=2Wa8Zv+UlP+C<9e)qq61-R4xK4FhVr({OYJH#>`Tfq~ek zOH8*nGgYawSB2S|RJ&Ct5p*`1kv`_^gjrEQlA_o^MwE3E%oTW~`ILHaJ zk0og-BkZR+B&2k`p~QqXO@7MtR`E2`PfZZz*js4ME&`G>YENA(FSIi_i%eNH+E$T_ zs$RnUf|oGKvVO22q&2WXN&(ZLzR=6Y#p)8=LB!IviIq$=*C1sJaFu2`b|%1W=hVV< zov|HAuQfMQZlfwQOR$8YZUOex2n!&NnjJhNjx=>K&#BS!a@@?4l@yZT*C|)p@%d{B zp-4?)IdJ>)lBiLBU$|ItM)_==ZGRKIAX*zL1fZN8l;1v85q&Nbsk9_fxQYpwxn|)> z)PbP{bsl5NJ4Y;4D~=eW3`#bMD#b;ITFMfhVw8eOIgfaeptXje$2>LI?xJ4d{@*M~ zigQ!a^KL7Wmg);L9_xUF^P93Ru%X{lG_g5G(Gq+m@*G(S`ANsLj9l|lvNOnPdmve1 z_SBWQm5j+y3IG5`)`%|+4yg!U? zVe--$ZiUgRyhk>W18%KoS4@e&rSu{bXK3!GYHTDPOQ}bqPvmbMrf}Dpm;@zFmqNbM zGLiAPfa#>oadM|R+go58T)EfNaqApRDCjkcidCJb5>@tqS5L^tbsV8>C5h7N0<109 zx($z*wc%<)Xx?iO%et(ibI>IJ00`q^;xfEsp7vR$tPgn^esNR8^Z6E-IS5)is&ZUq z8H!08^t?nwuoT*XHx@S15Om@^Q0=c}WLI8_8pj0*<4oks6qQ}&DNZTR6_cmJ-Ox6) zC82k@$VF|r30Gz_IcD$7Y$)3>HX_l)tm)9E)f!sc$O#7OxF3P=jvZ*#uF}!WX=_dM z9_kcHPHXiSu|8x+9>-HXOrsin)WVd$`-mqZKmi=FrLFPxj-0aw6X(^Oa&CMML1YHi zU;who>8<+5PQAGbYCT0bxrwHk%9K9ai9)xzK*|=cKAP)jQWDh(X&0TL%W}w2X)P*U z)>J{|KG*~(EAFUkVWzRh&hz`|acgpuIKFL}M5vx(6sJ^?-3^~~3lY?4LBCk)?i_~z zVY#|GEV+fK1X&=Y5N+abdyf+dXe>xl@RXJsn{oG0fa9-}CCt6#^F{LCe58wMrm(jw z*x)m?#A2F*Ev2xwSW<(s>mAn0e%cl-Z9wiDgL{o&Oyk&4VCq2jcGi`%Ht3jj#+*IS z+Ldsi**e$_2-w2Y5g;)Xy(aQfQijEmrPPa^6b_g3g`_9QRY|;OLr*4D z^VZ&CP;#lVM|mdJ%ntT99#PQ@@uSRC+?JSOSsPo4bx)?mlp!ifVM9ZEk*S462y9i; z>WZl?$JE|c7TXp!HwsxvJ{{|83QqkO<~G%ROq9y9{h`LnGBn%DXefQ7loX#I5$YjI zU!4hPacRj$wl@#439EgTCov4CUBP(?T{{T0Cz4vX(x%h7u@gT@dH&~ZpYh_P|R=R|l z3bnJ6*s-wE=FqVQdhpF!%$}8oZ~p)^V~0&%4NQsLVAFtudTi=RAFDgGa$JQ(kn>u+ z@9nB7a&s&o88Fb{miK@I2mtYPG(aQ*tp~4!a=_O!!qw=wf zZV-i-iq#nv*C~Y!s?I99%F}W7xj@_F78XKiUf}tp$V=g*KA;puL9h>11RXy(;o1^% zbEyr{(f|OzA#FGQcCq`RAF!lO%vx_e@4_i_{{RtXkCDi4NQg*A#%o6oh6}U+WD9@{ znVb9F#{`jEIaq@1A29Q^>Y!4TM<8fUm%jFgrZQQx%^P1j{V$|P zp;j||MyC6E5TI;Bt&{yz2xmoma`h>x<_k|tiANRzZB3qF(_1R`Ci;y8Ci!}NMn z6Ap5&iL9&TrNN`>7P5f@ZQ(;>tH3IZrBf6k)}9YJ?CT0Vv><_TZ*U981r1I%#q|1J zQf*3<%`)7>mY7aJt@H-zIe_q0;WP(HoLr1WAw_gFmXy{bVJ9d`LW$(@v<&OD2~f=xKR#t+bUY!*g`%VqqM6`!MkZ zoKISLA4f_`IGJ5C-sw9-clKX(VvI3Q5ZhNo+u~Ehn z*tUY_DxS=Oo2kfV4I72sM#Shggh=Wv-k?R(Zmpy8isnm0!%9C;kJ%B#DBC6%KpZO2 zPz`?*Y@siIysyd|n7EA_z%Kfc=?x1LvlJ)hZ)x{i9Wta}=3|r=IXoDnJxHBjHf`CU zq}&$(1wKOFK5(>flV^BXSkLjDL+JUT{{SwIeo*8_?8uKhk*cmzDtYe+W%X$k=O zTpK_J`d(?1U3+XXKWJfDWR2q|=+i`;9kUXg8$?25drnO0?lz06_q zqS9Vnk(hz+9c&_bMA@@i!C4taQcXD!(}--?>zIu#b9m;igF5%3N$^fVq}3cnRkS+K zu{iUIa0LxD1b80;HHKs{HZxe)5j~CPlS^S@Qc+4bvU{mdL0|zseM~KEDmyD1JZD00 z1Wl?so=v)*q&MfDekG@-pHJN3oXW+fD|ROnc`j{g9{5l1L+Yxq{5Qc zDU9(JMq&DcC~@|{4J__2xEkpVwWpECu!G_SNBKi8#W<+A)RF>QzuED(#vR8Fy~iRY zYLwYDQBuOrS-|*OY!A3bpq;n3oI0bq-lC_4bt3?UKzhGQnAHFw2`(wi`>8;_(aFS2 zhCSMwScbUl`4&RmC*gRKvCM?;9!CuHUGN#;v#D6XtR#(ZjN* z5le=FA=C{md;SnOP)lP2SeB)P)sVX8T~qH7q0o=qW4;oXFr>!=g}g$VqgUFRr>~Uo zX+V$#hy!H{SdUm@SQF-UsA;N|RbnZ*xu+CV^Ny&K;z^G9dQ}TVyT{M3gSY}hn83?5 zRCK=j(x7gUpa$0)bi71(6s2#VqBu^@Kf?O8I(nYyN*)cYr~m-X?;eSi9HdnW|DlYV!d#VPsq?dF-2{^mqF>EVaW_4 zjIwN{1pCX~Yd$Jjx{38MHy;k8$q;h!E_~VA6D3h2!$fZpg)bhF-w6h`XiQOCn@ZAy z%PtEjr$B9}B|94)yTyMI!Nz?m$+&o#M!M0;uQ@j=w;fcsH7?6?))KG++)uc@ec#>V z8J;77Y4YZ&m$);gmi(Qs)M=!6 z4#q84r#_v*#lN2G_>`+3}{$}v}Y;>A++wMrPRuuKdh#TPtH1`-}D~w8vds*i}I{+>PZaYd36L;9Brkm zGLA)pbv(Tx3TZ=4bSzbA5aIcN`Qv+vdg>4dLTLn9nGn>&XNZtvtNf^w4_R8gjAO9WQM)7t+JcOi8(zXJioL zCtrALmtQM<;9>=(VpvV2unHC}WhF@i@V1bVCoY?brYR{yZDr-7xuOBd_+HS92CP?0 zVrQk?3Q`++pl+n3Wj>?R!>n{o3o3<5oZ%~Zq$1;2ZDm^96TEat!{Tb26a}fuRLT?3IMx-UJ=Dy`f22#^_SY z;)X<{Y&gsP(k2>;AlCzaoJrY3#5Io?!IaFf6 zn1EEAdP&rwE6PofgrejQp&$Z!b&efqNL1-F_yLKj>37Rbr|UhJASnH92qVuy3QobB ztYWt@TP&VR7PTQR1+=o+7xA)x4U7%Ynm2xss$tg}o@j)$gO*{J0#uTN_R^~oE!8$4 z!lJ~rV*|x%eD@6IQ;Dc5Dv&2U%(H4dwyt$?w3B3oeV~+!9b#rSr?dGoJiiX)j=)&L zQywyjh5{OybqQ05x=A5I;Y5u;s$r={oeNIQ=_;@D@gp+mX?GSNg;fg%UhVU}pIGz}O)Vf$+~Y`IhF~dDa^Mx6fH1eyz@@)ZCa$ z-0vaHq|8!i_bsd=DZkYPn{?=%W0rxYbL%|XgXw;n>KRJ1l_aG@n2>wM*H3%)wSvIy z$k!RH&8A5?Q0W&)al4g)xdskrISiI6$ByCor&BXID<-6sArGoj={ZiRx^8ypVR2S* zx*c2@SeV3833hG5P^A%e^h1f2jXED z_qYjMK}>ZHnbss_W+n!MPFjjjijImtyTa27Ihb;QaT1ng*=|~H*_P50LX&O4B!r)a z@!JM;rl^l00&yfPC0QK`YyvN#1m5Hwh_#Fy8xldtt7V?NplL)-V0G_ z$6org?u82iq2_ilo_M1Q(T#7KPahmDaIFNBqc)Qs;q2x zPSKO%<5Fz8!tGF@tYMoO0RGCow|$9%QtKk{hrouq~f3a;$vB7IfRhGAWoTN>GybFGQ_d-#`kr zxat+W05-hpg#u-|T~ckSg5r6y&A8FJKtAeb5(={Q6}k9-C!{0y%f7xpFQBezCm9vsmj9CrBY^4 zxe4is8FvUvl8&fNGh^YMM2{@CBcyj#oS}J6rB($=z_OQQhUs$4LdWW6C2909kg-XL zk{W0zWN5dec0pJlt8Ax3_(u*SgIlaKSCK<NNaBFGIaq^kQ4=uW*4NLpy)LkGm% z8&be(`dW_3YH0vDKO&5Q69^iYQG2Be8=RvwKL>j;sVdzI?gr!8PBXB+e8X-uKn10R zA=b~@Nht}`bWpK^P|^xkWXBi>*xt&z%4R7ItSQME);*J-e( zVUr;$1e3D~X-NiNbt+ScSm@iWgPXty4}YvQIrl=xE*Sv9pK|hvK)wc_B%WX4q*Kh^4851ohz^x#qU$S#2rNkOR>~O0T)Z)fd zUt={nYE_*f9N@5%Z>&lMmwt;QI(%VvA)$N2r#_s1Ww{x*jKWX}Y)w0n8HR_Fr3(XZ zv#5?!IbxF!;wky}T&B*g=_;EiK1IG=LyhbT7Nct`$mU7Vh~$+WOk2s-7eFpMH7xi+ z7g~~2bPMXRP@+|B^cur;M@(|{)k@44kv7!CyTAtB2}n|JvQ`1j@jD&kjOn9VRXy4C zOIA>nxiAyTaaZL(m+UMgl{f7S zAOtA@D1z%?+*qEmp=!C6CvOpAl~FKV4JvuElUtQ4C{Q8B*n65RuPoPA*6V9TY2r`N zdNZ$4PVP2Lyu*vk7NpPO6(uB#hW(d1b~_&(q9n1`(2%4oxSb;{STamVvIO+iHeK-Q z)nMOB5?;4D#a5P==@oab?5oY3t-6!mNyxnS3f9)R zHZjKw6s1D50P+5#geE4bIDt&b%ueW;{HhWzx!2l)kJOcoGqMt$bx&BR;y4vQ;q)is z;wzahxMuX0FmN=b2BsU!W=h6ubaj;j^^Bjew2}zlSkG}BG_h>?7I^b14rK2TTBHXW zsgk*L0+l^&QPS%oz@T{ON1Q=Q-4X=m7?NVIDD<47Qifb@$CUF+y0g8W?k6^DEb4p! zBEmbkF$uvIoiurNijOT1Ps1A@WXw)Io znYHEUl@P0u)EE|8*yf(2UyJMYp3kY0s3(}IV{|?&b2R86kek^hCqkRIu zRN70;C@BgWANT75b`?fen?iRWA2{kb&4eL4<_F>-)PyrJ7up;+0JZNOI2Uko<#E)CIQ7 zY%uE$%1mbVWg*n%P+36c1JqdCHl!Ge@m}fg=1h)i=DiBvnc>$I8=p=Nr#AGJE=lD~ zCUx?&DxxgAnUx^sY#RpKu+(>k@jo7#xpV9`+izos+RuWRwpK-o#PhW0T9{!iPR&T% zD5$6$?xQY3gr4s)0BdZ*CSu5!&&>@=Es>)RU}fQSB0(~fH55&SEmEadQ>aGkY$ZBn zzNA{v)ZFU{S=H|( zDdX&h!wT>!N~2PiZjj5SpwhXMZBICtP}s@}No}x&1qEE?Uw2?`E+NOnX;%JJA!4#- z7AV!)?6o4M=hBY0%ekFekcN;BQazkY^4rK2nF<6cK|;dN%=5UdT`Y1qttVk1oDj9a!|6BN5@L>cqYy!cP$Y{fAw@Z@VX1~@d!^Ks*v6Gg;>4SD@}}e_WR_-T6Ex$f3VAI6 zZk1n`m{>0;NF-j-SBg@^@1rNqDr87g^4vPAyE#v6vbWV_J9JD-H<){&YPiZy#aC9{ zV)h%QWlZ*Gt5|Ywxap|Y-xpZ@2y}B@Jroj=WTU7%M1?9CYQ&Ec<)kPw36-ZbZ!(mv z*H*PDVIb&~jS>a=kV)~hI~QY3P@BV5$$FX?l15KyEw7m4sv#Fh?lzkncZQwesC0D9;v=UhU)O3sNm1t+mCes~Z`xQ1)S=LFya!tn5}-AJ zNU+2F>|suqeOXzmp~mI%xIz)mb;KnuIenT?)kkaJOKBZATK8+tA_^W1T^|v*C}-YF zKUXYsOB|LfB`V6apj$#LZ)*_=NLyt$e|QRhJZTfsp}ARik^l@ir6npGk{l}_oyZEy z;b?s!hRlhi)A$Y(CMN@~KCIcv7EYG8LGiZcIMKw$!n1*&pwBf~V3ifR9YId1I_;p= z;tD%tg2wY{dbvrdN~9`9$#k&z=uqh>aX++@d~OUPg2oBVBUr#LRi|mLp)%Ch@;u9z zC2g$ta*J!{sPPfTtnH3Z4Y<6{Bbty)mn9Zj zaisu+vhq-qu~^QaPnpxbZ3ILg8;QDjlt5|pk`hYTbP_D9X|I9UgS-tLMi**%8dT9u zma8WAAQfAo+t$#dhY9(lPs)KX2pN)AvtWR4pubP}W3&RnzR9?&h*V_aN;JDul=*=2 zkcJ)1`cl%AlbNi$oTn&CijJCV3P=P-Ba^6NR~UM6$%mX_mYYKI*-fDW!9CQC6SdB_ z+};$TCdU&8_JhQ@0I=0IqPJQ@nTsyvak5jPN`V=yM&je)4NC-MDP(Axm^-)Jy-DU6 zsmP*P3Q$Y#vPnQEs#2vLI@p~B;toy?^d62>PX_SaKM|!4$;`5_=nEXD6LL4xad@ki z0$P!|JBJLDWaKJRM(S}%SI7_#!WnR{>UPHRuO&M%-jQleN0+0M4!$zGeJ&Auqz{ZY zUwexC=x4%Hv#d$Wrn0$b>IqNtgC>QUbt^H|u;tbTvfnY@{UL3MNK-!Ob;1)SwKvg8 z1Rs^)1Gy(iZNds#Qbo2=AjeV*6iiYk8c->)9tZupz{MgvcAlv@h2=hwLwwb+-eQ6F zk`H>`U|f$#uFDIOMTQwtXD13NE=x4vzE!k^j~ggo_rw~aVVnkVvq(1ZqASS~)oEb}Ztigv8%A zVNH@|nMiplHdcFGDggBxD0LoiHDZ&YAyRT_s+v-U(uQo&3Ku10SRX6fOG0T2OmI;s z{Zf6Da>8YZE}X->hY)N9_Oh-Ij)nxRP0-p_-F3>VK&ef*rx(cx9rKX)#-M}aZEho} z3$tcccj+2)f~wM!Ft^-jrMrx+sa8s?O|xnZ$lmalmp~O5W?}3s1hm;hfhbXJ)__UM zGzoD!3oC1Zymg#=jh_k_o2|*s&aLE*bmPi>wQL+|WFRD+kW*km)Wf+KWa_atK#26PPQnz3_$e zVm!{y2Er1UQe8+zl!bj`I>6SW0H z=_+KfKtEe2Iub3d%W1S+!H{H#%YmJhVrE$ny02(V^BkGI4Ju)SCLA@62(op=Q2*GZd!9~I2Ci`dLFkB zjE<1Ft;vXH1j>})3QlzsWeX915zxgRN4a4GDox?0#hC@fBn%JEHz-n-p7PC-JYc#y zk*hl-#aN&^0=Y{|h!?R6PRh{VPn2=)DIEsXPtE|K@8}^`C84t%3`Hv3w9>qNogrI+i*YG7m6tru2yq98UFyq z_^P1B*Jjb#i7bW3N`XBgfEeB*)x!=oEt<<(+tbLatRjV2=Y4Y%w4jS}%g*zBbVqjI z7*Wd|I)vVGbS1x_A&|k| z7}4<~%9(zRi384AOCh8In2l^Nw}eR4HA3$I;puJ`&MIo1N3W@CMnWBBwI;`|;NRmM zayds5rNQc5S?4AkrQ$HBR;8#0TD8<}ZRG~Ap(~1TTXY(7r72X}$Wya&uDGeTQWBK1 ztC9+J*uo_tNfs3`JM@AXb)#^ml0HHpvO*k;8Hv$01gpd)&^x!&F!J+`p+fmW(6DEO zc8(375s(+izlyE$hUSIEjbn(kF+$8~mrA!0+6x>m95fo8)9x5jL1XStu&}X_;@2{9 znYLR6PAXMtLPq68Xa}q*4YC4D;J0QuQ!`X5if5408&j?F)|(($WlMm8^1M4@C|Tfi zPhh#3nWm{#H(Z)PLiwSgUV_SvP}`TM&a)#=6Df7sq@*kBtVg+}g}2fY+07wPC*)!{`Veu@x z@{S!Ngo)<0Z!`JCVnMJOwvd_wZ8FU)Syn!#R1#BYIVr5;L#h zAftnkgBO|S2kL_kL_~)RBq%|!%5@RbggoslMryZ7d54powMTC zkpSnablP=&bg@ULdpmPsjKwbJ$(q3alGnFi7?g%Aayvy+>3k@ClvC+a3PRZ~C_0A} zcD{rxK(`ANJPx7C{{SoHW~C*YmP^z`JnL;{$(_Tkf{Kq%7)1FCiD=ZcWR`3WiHL*d z+;9yF_{}Ew?3hIP3ya)i*rx>nVqzgAP|C^%Myj`|(iDy{uf@3LohswfYeP=E$#kh{ za9K7%I_tlbSmNCk*_{*=+`=n0R~r6=OessY`Ez*1rzB_Ruj8Vt61`IRUolo{647iUBg<(^k_2 z5TRkdu39xr9h- zAerJVP0Uv~w~=Ipt!hZ{DmT}7>N^dFf3C}*I?%2)zolIWKq+k`Efu47Y6%kzs2NrsVjjohWx@ zA1La>T?1d3bjI<(cNN>xf82?u@D+b+{*eV%r8J z(HktZu~L~P+$AX><=)2j^@+<8A?r98=5=%lR-I$s=Qb=rH@UT}LHsp`R1y%~oX*fI zpO?dndPF(xNV=2DPGtgZ(#95$+bY`=aTdQxsHF)CC>*S)EiFlOC=A)xx=rt(un_3Q zvVUMKJ59uL&OPkyDaAKs5TfOlMxYW%)9{AuTOgknMNm7%^u6mvK~`J>2&FTA_t5N;b%03mRdqoY(hr< zkkcGCUwC+@<|C(0LzMuHE+e!Cw>+;{T1O8TR5yZv6gwTDJ;( zV@uY9NLjXrvj|Iwq|69GP3~_EP`eJxruxEKI+@L;)d;Ulu%d*ZOEjQKwzoQ5=?pQ{ z&D>d!X;^v0%gs%+hZKF#pmO=E?vFDFXi}XT7|N!ZT4%IMxZ28HWm+g3q^tv{p@!tP z7a8t%E3yG(KFZX~paPc=MgAb&BzX{Fxkkq$Bbiae6O|biN>-)4x=CQAMqNGpr>c>r zzG;XvgI<3ER4b;>%wll&0_d&0sj4IEcFVslxs``n>I04IYjwDY(ry0$O~+L)FUWE6 z9v5=5j%g(m^8V_<0Ief*s9M>)G!VrGs`v?(C8~3aY%MB%l2TH=)}I@I2hI~#a?%}i zU}driPD?9rNd(6zMxhV>plD6M{Qs|mxa|k3Uj%HUb zH|`r4?w8C>o!Y%VW^f5~w9>-PsdOLX`9Ofvr11JqisI6csYUzBNGFs}hzrecg@h{X z<7VAE4bN28r`UA5fpmo3B`6^K!~}(W&8-3lMjDm_MP;njIRq$X{W}U;P<$1bC|LO3 z_As>iiN7%o#LBDeN;4%REd1kXAuCFcFa!-XP&tV68tJ@tJDg^B_(t^Hnhcb?Kv*pq zTyP{G1!Xq}$~Y?M>EJ4QX;Uo+rQJiQzctdeEs{o=GZk4U)DKwWK-lj&gQVwPOzeR| z9n5opyw<(-NEaK}kqJ3s9)3#{p|_-_+LoPR%Y?7IgOvIW$HYflM^X~JCBe9snx|NG zsdFxZd1b^9;&t~yO@fjJ*BA4S&8C44Eanw%sHMrxvimbD1f}GHlzhS4_d;UpkTJQX zaLguU=1|kT=F&k^jwwi9VQm36P$SE4IFz>-V;_w;MO@$!O;U{4I+{*-xg;YpkfLr> z+OlUU>t!g~CI0{x&(x30knvOIDLho9BBaxaeC7d7DRy-W@Bt?O0KOy2I!B``JMZ9@ ztMYBLG?&LMJ=CSlqW*b~WAoY&C_vzT6&b0iiD}d+w!pl*ic+;#-BtUxzQk*2>KRE>DkoB+t<&lu*k3`p zD;FFa!tCODN@N*QnMAs*+JU(V=q_)24K;=`N{1s6#i{VxvqK3ixQW(5?>3{AcJWC7 z4}peOL3&Y^Wu?(jIsX7ui&%TAvG6_94yR*uA!jM?NhnWK$`<-nWoBB2Kz`OxHBXON zS~$ly3`$ljH<%(-Mc^~7tm;C*+TlZg9ie_`PQs3V4=)ZiZe5vl zDKsWZ$`|cxh1x}3+fvm{bt+Ytb>(B{xyM#k_jOg^`4Wt`4lQQ_PZ>NGeJ}!u~N-sFZ0c zUL&K-(;gD-G?yF$l;w~TETT?TSPP|AAe#XhjxtnQ;8t{=p-Z9i6o3}zc|Pz89wN#K zKM2pt%T#f(E)<($;!;JqfncPoJC@r~V67BBP?aH6A+Wtjt=C$gmVKxH0KlmvFT*or z``~Shcw>|Mnn4ybp9voi4UR+=9)6qs$XLSyKb z)i$~`(lba;3n?WkDFh8un@e1Ky50oBhW`K=a3J9{dpkmFmQ+2N!~p9_AnDC30co{` zh$a-Jd$1LM%lW)IC8VotvIB|9?F^E0D`A_WNrfe18=-kmqdLnOnGP%q+nAx4j{rhN z$A$HTqz#-QR&c(Q1~09SWm{hWe0(n*Kqokk^Ye=n4XxQVBn=*B=>&BJAm8V2C~*m7 zeyQ*&`G(xDVb_oo;eYR|1R%rL1H0EG#8g*50R?WB?rM$qa=ZHPR5!3uUFk@`lN zEZL|_jMjP5rxFr$UDzPoO$oRiMWM*Pm$zO*8W4C!XBXmkl8M%28A7d*$;7;bDEOsG zAvuWn80_N|axIdCCbLbHQ&V#?4m8>dnnPv6tiWgi&6tl62{zgywL_y{hO3n7+TKL* zrc1iCjzq+)!qTkw)HobjvD5F0)jhLMgQdTBu4Y!76RCZEcFwg@7&h zfVdQ+NL?B0cs{EuAktZum3iO= zgQdi<^L=cfbGGkLFO}oNnW0%Nb2EGE-s9O~@O=ZC1=$@*g=oc-=x)hVs&tpP=f?Qj$fLX+);OO+C+nF%D3t z^CU)A7Z6ojlwtX{+DnR*qS2Qs$sh*Q@mfJaw{+aMMHqqF)>eN$LTCDl(`2S&Zctv%aoW_ zXAm_D<)r1-#1Rm4;8|5NPCSkTkH`3#`pz8ZiIC+QZrr-MTd_`abxTdKft@N&+}l}J zzL$y@!)bdiT{#wOEuvNMYKo~@MXj=z8d4cb9YF;yBbEUmj~#r$igvBCUF>JTl(aky zix~@&Q!aCx9n~N$MQL5OR$z6t&G*(DQEXduZKjsw!;YjpQkN8@loaTabWM%!6}Hv~ zXljL6ki=B^OjSe;RV4kPEvan0$?pAP4YQ>A?k(eMz?)m6tyvARM`p>|9IU~^Z>`x$ zu$3-Ak(shJ3rf_k@g5o~(JncYtLfBb!np7-R0&Wk&p{#QgV<* z`=_s6p{e54yn73bt7#TvgS$pZ)fU{fK|zOH0Jh+{Lc!RA6K!G*vDb^SC8cWFk_kDI zc2Mw#A)mjg5_o$ZWWCN8MzJkRS0XD_%+WIrERY7HrR^NEfMs!eq+7z^$9DrpVaBOV z-BxL^ZJ@9O`3N4zIhzfXzAjFt6t_5KOpa|v-Z0{bmdu{WrpPHU;zCU7Wk;+iNK`iB zBcN=znO^V^pfbP#lBn%~RW=t1XziTo*)cxSnSBX$rHd&F7X)|_)IwVMjz(3>VmxCG z0yjS*^)it#)P$SC#RgX{nWUk|4b_vJrDSZI9$IXKpL7Uq^S{4ROmc0%KK4f567Yhb z!5L}PM|iaSlzX-v4OHL}_@xz4nP!3a@Ny0WU{HpcNc2ejp-CY|lQ+I#gw65*0|n)r2J zGO%a(jfHT;>y>uuiFUPMwuAInROoW{IaI94LWZ_dQ`30W;*{F$9{QK=RZU0d@MD?8 zECYymiB3&getG(3Aaf)GVwJ|h_b*02Oj`H)A9%)+1Da@l_G`Rv79Ike{oN!2z*h`8OUPGe} z(x#o4N_+E2KF@UQq7*_@4X%5;pEyg4T;IyYCu0MTsk9t4wyV>%DT&48ami_ErVlk5 zSs9&G)U=?GQ(#2himblY}=(8`;aBVfJXkn7Jr(S6<%{bx>xwm;LEt_17q$poYL~OX_ zDwEw<_BkcDS|Sxsi*+jO{LM|rTzyD%vg@uZGma$trNt3-8)yl=$9HI$v9Hu&&#^YJ zcLcEK9I5D>!u2NQY6@rh?JenIwp?{0TR)8|zCd7p&L~*82>Mu>XM5#%o zxwJgfYIVYeIV_Cb;FPQMsUtvca`Yk`NNuyX#42S!h1n{I!4mjBsP*BrzqJiH{Z_*Sb>dMznGMm`+z0!3ATgnt7hbM~I_H!OCQlC_rDof0^!!N4pDo7SVQQVR& zE`3ZWNSMM^Ii44x%44n))@!6J=#n%x-$M&q4Ygxc#SA|+i``7)YAzrP9|7qdI6OQO zsVvC}InMt8C1kW!t%bEn^6DT*8Nt9JcCgh>l;&*mGbj_G7q+*CWs9)vW=c*DH7k#) zggDA3U17CL%rlrFX>l5|@>Ff2$8}cNi<`uGLWfkWX{YEe%}Aw;*GQOf5^Yc!^iQslEi!~$=avPmRuxVW*06hyXmIB&&jmj|UKCMi`pmStwr zOO2&!<+iKkJ;F#9Ix4^ed-R1Iu^lf|spCrP%VKf)S!r+@Y_?6@UH8jze99!7+!3TH zAuWr3HcUTEQxy=yOulZ*fu_)m$x1>>ln??+%Cj8SxxI-Z6+%-RYEiE=hup zT-s5TEEI(d?TeHs17pzIIi`hOj};3W*665Vid6E`E~RH}XjaNsT;A{=SFrGi)590d z562@OX0p}?=d@N!1v;Wqm5-FYI$m*~X{J2W$XK`_CtkN6aT&v~t2xfk z&r>X=B~CZjEv`S{hV7%YY&VMx?{POt`^rtfbQ+G(r;(|=NDe6hHur(Q;T&vI8Ll@W z6@FVI)kx-XMCdP(qtU*+SM*zy|Lq9HB~8 zfJh41D@`v67KKhAr>3ttPipIF$H7YPr*S%{Tf`Be^YDQjPOL5(p&TxXjH_wqFu9l4 zlxdVH0O`HRR=RHrl(ifQMwXT|#pP?5Ip18`fw59ke8T=V2E%1SKK_E6+}l8F5>ol- zan@3#rASJ_E=#ZMEe7C?tzlqBheHagIcHLVSZ;ZjRWgK@y`8g~+C6eb%59;zAc*2P z{{T~iRhdmrRnU~Q0uhmAY1IIZ?aju39_fJ~96BX6Q&i?w09*29vdJVQxDqu@&ezmy zczG)tlc(_;Ioxeel$&uWlYUNZHcFe$qS~8rU@c)Ix!q9&*j!%zFt-sa)a>yah3?lA zCh>XMRLQ!R!;Fnqm8Q-ox z{5nEnCQR98rYVwdXc`H9!fZ4FBfFsSG2ULMD*XgaRf578ZN)6O`U{SgD3BZbwmNII z;SCByxrF6IZQq=vt8V? zD;6UvmUM@Fdl8_O+!>a|6mc}xB795|w3&5)f!!m#ES-1ph}jx^hYjLgLQqTP-N*<8VoY`0+cS+~Ec(#atN1D44A+Re5)1mn<9wEv2Bc z6`3hOAtNyFSPSn6o<$|G)fz0Phgju&K$m)9#<@#F>PAp=3ji!{VHEil6Cybh$^^qg z&Wnl-jbH&EUrOD1kl($oz5~V^khFHCnrSYF0J_3*=GSivZ5=>$!eM7j>S#Ea4iQs{ z^7xv&DORP+WipekDTH0L=1NpGAy?M>bRs5Vo|j~K#>f#)?A4FxZ6y-*srFiL+(>xY zBW(vWNU-;m$o>;LQv4C(N)iKjhI{}?0IuK@xz%TX#yRgX4+)%Ra4!+*H3?Uzs#6op z%1pHPA<_aI<)|nELF?yxct>7%uvqA^z8Y~drH!j|CVD|qZM@n_5*_BG6liq-TK9^) zsXfVX*pTaD(G+;VQD^`NNEsVV1=Cn|o= z@q}{}b=Z_P)ZD_T4Uc8XycBTROuAPE0j~VGVJcP5g7L~abLlgwo&fYQ#Ow~clHhJ_ z9iTa@T0*jea|i<)jVWDiXyqL^%vBQ7vnx~`2^~D)DT<@2>kI+S&OkjxDv*&Z?L(ea zSy>

%1n#(9iMB%BxiAzEBS#EMFlODoGvVeY?BctXXi}_hfv$iv7X$dTWxZOvOJU zG8C;!dofyw(5Ft}2T^ZGzbje8?AcCCo;;ceJ;loAA1Lg(2rMi!m=S*%U*urw1?r}qbqOvrl}h)3UGn^T!h+2? ziF<8$4xPLN+L2RWoj@dh5UBGw$x!LBhk#90XwvnC0{S!9X{jHS2Mt+lD^Hg?FoWxJ z`I89)JM>8lYQuK)gtMk3VY+I^{DU|0jv%8>YY9`;sAVJ45609qF7f6gN^N!JJp-Z*ga zluMm21qGR<>CMPoB_Ll@9H6s#F1C#dfG_~9!dV@4Wh4?3FKFr##j>}B2{su{q63VJ z{h%4OE!7SEx=jB7&Q!y&5Xe`FsaQ!kiNfR4B7fS!QUX_#nV1`2Yeb=;$n8+p9Yn;j zt1e(Hv1EpVt(L;%+B@(Pnb6>Wvb~7fGMTvohb$V+?`6)gFXsrCA!xAraJ0LAkqD5C z_=st`A)M-kW> zd_17JS$~$dQ7Xwok1=;3fC;sRy4u1L*hz_n;z@c_gf!X^?zxrjH|0-6Vi^+e^fG`3=cglBHXfsm=$`;zP>OS#(YObO3tz$0?mkj-?)o z%HLD76A8E%Pg|dyaj+K{-gnyQ^N)mwT;v8)wE%LYo02cLfIo~F*5_h~l`@www4xB& ztuo*Wx7{5H>8x4fhNehL&8k)?o_UpfYV$UMa-{*Fhn@w{Q-T^w#w>cLFjUDXY#jhL zznn;pG=(KYt%m9dsy2~(sC(CjTqsLaC-H|6Qz4pCPRZ!Cjn9_X0v8-$qBK6-?Aon! zcy_2z;o-Stwv{Q-m=R(R=M6}0niDu!Og(lMLKJleTMt{p8xv#sgmB@+szoZEi$0)o zCic#u>Oi^kFvDbK#AYp^OOA!Z1ng8@j7~GCw>dbav@8f0^|rAh z1IuDSc5Z7AG-qZj=tH+>mnwy&NOO5 zXJ}GzE4D>{8Oo-dk@(7s3z(f*eA*rG4Z0@C`tL-P|A(|vvu$HZ{A2AKII~I8>%L$>w zeW`+&ZN|q`sOc%j=h2bmg{Q$n@ZOQ#Lv4w8QpET#NRCt86pra0x`3hNb&hC4wXvgb z7S3S#ktxqkjVm(i(-&{G9xrE08ZzDbp1YPEwSB zf#-bSe60y?g(fzu;?%-Tjtq5PWlaA72xm~OEb2=3iE|Dh35+i>BPEy@T|q*E1^w); zrsv@t)P*QEcQJ<@cxQ{y+UgH9;YyORnqB0ZjX+n`i`&58Sn80i29&=X_-Q`0s5>fD zi)AX8UB$MsD7d#s?VQjr702usH?={MeEEa(5!*QNv=nhy2fwJEmj2SCwkJf6?4C2j zl?2_n)(G-&h*h2N*|OzYll=`v4WIca6h1`4j%YH=RTPojo0FOFxd=ajG2MpR_?~vM zxnY^_WNkh?@L^jC)A2PwmP`+I=_P;4Ye0_pe-mm`6#XG^+9j85^313AfeP5CBFc0NcEjKz$myEM6)N?xZ`T3wSc(6Dyj;SwyBr1&ft zX~0{MxSGS`jq*OjQbOtV_K|e0rxt+qzS>J=2_W@Jy`n3{T#oDXBbFw_vr^5PRasBU zPD&^SotNhOpjztEUmXvQonVZ7>l zPK8M+QNLWo!fQxfos3yF&Lxm)S?R?s#$HOo`ERtV0b(;CgH*}gb?E-Yl3`X?aici)8l_kc`l$wzH6O{z2UXD^c4OdQ7?sXbdD8e z<;qsn{H?B3voNKgfvF1%y}ISw$`w8T0H8;2>T7Vvj+4`~&(hhS`bJ#?y87BvDnL71 zFuH&}OmikJtm=@gk;c`$FF4?4b(!?2l?GNyR-Yi~7q^AQp&C?$S-n;5KS#upuSitf za-BD;d6K2AO{;6A#?lSPj*zI~Y1-UFkikyQ%;A9Jjp7&Q=$v%ZdwH($U!=BzIIVa<=>4aF*|x)T@y0@X-|qsas#)w zptneBZC@eC?sO=4jqC*La`hU+^RGHG@>CpJR6JANJfr%+i$W#%xh;^msuq-wwpn^l$V@+3j?7GPGCHV@`dLS zmVHPEscmW*kbIJD5+%dQ4J@gRZFh@n;XCSg3%I(1T>z9R)ujkk`^0l@ZQ=gN;=|&9 z7QpgpyABNb%Z^4{b4JIl~oFP7uyvS4kb`9w56J<`(tQ9vR`3kN*+!rIfj}INQFF2 zzvL%h-Hl!Y?H5hMlT(VDs=vrt0#;aOQd=EvLIL#GXqPS((xvqoS&`n5?MXzd`XLb6?lBe zIi8{@Va^C*^r#|Jkei(?G}yoSacSZr9+A+(95buYDormF%@*XCP;qEW%W$bkHwjNH zk`4Ay+jwg%?Fxb>9xv?`Ld5c-n7Wk9GU{07Dq&L-L?nH{>U1}@x4cp1#VHfvG>%K% zpfL41NfHiLpPEZY>fH!=w^B5=MI||tZwruiF%n!XuIP~*$XU?)b5L-*X=J}MFh2W; zB|v%oSii?uj`%4*+hN}w4WASHP|`T418r56Ag0z7)9GPc!ET=D8lClraq!ZIHGYC8 zl|D{|&K&JED=|l0hto}_sDYK4?n!ev8x^#)<+<34`H1AOwE1oE1vJbOy`WV$OI(FU zxh#r_3d=erfkC;@7BT=VG`K!++r@8Xw_$2@jvg4}X+Nuc$1Q%;)1?*AsNcN@SDmPMZ+pfs~XV01}HIQwm%&>T%{>KQW|twN^aG zs1m4aBV|MD5~e`_dZy6g;n0Vbi@FyTr%_IJRu| zqVWa}3X-VdaE6MJ&Y@OsUXv+a&63uspLN^EWFq16cn9rzUN;k zLd3eipr@0tvcx^0=de7Sv0{&Unn+B{m5XRbp7U=E&8;V3oy0fp`}5o3{Kq^|X-Dld zN8&u9rKaWEld2^pP0GxIkfn6U`ce`vkQ$5_7N>Gt`RNO477w;e_Ejo>D2)a8)3`dORN~P*ld9R}8>1>r2W>x&; ztg6dpw5%N6({S6m8y{HYmGcyst*X-Ju>#tjp*f~(wC?K+@nRzNpuG9LdYXpao z2})O>14}a`Ee#y^5~b&!ot07^l6&a-Y?39W)61A9PHigHCw}4FZ(?jAodcSQNsV4j zGN}72bs@!J+Wf*Scjms8B##r6lc%oH9ijBitOJN77?zlpon;v$FyxHsT7W58a$hF5 z)De{+ZE|(#4aji_TpK3#9FV6yPjtvt=Bb5lrQnrHKFCsnTbgM=lbJfDXaQkAYQiDT z8i_HL8w}SbxOXh`_&sgYD(tvlouE#e%gyEq3RHnn<|zl?KuW>X`3Q|J9Z#RA?}*nS zu*Dp4sW*ycDox1D(yA{uhG%K>Xe||ys$7>UKUm%NH_gz3A|$vqO?=Su%*oNiUL;Io zDqAx(X409bP&uV3DFeeeI;YphGrUAJNw2A4joKXAszdTBY$y<(m&{XbMf&O@FzCtC zXbY05t#U|OoLW++wK*I>&?O&rY4?+BU#-L(_BtDhyc4DIjhj|mN|e|kFQBcdgoCzg zcS-e01{Dmh4$;RIEr_o(!J5t$l}$Z`E}>18T8yf~Z!p?dsRSehts81DV+7`=?~{D{ z3WRj396Slfd`H3+1|~B-CV~RnTYdBc;thz>Bj`_-%zf|7vOXShmYI&y%9vS0uOKK5 zE#Ym?Q3;OEv-%P8W81nPK;_5^1e4ahbMIa0JH zB`=XS1l)j4uN+WF9FBu>NN?T0&K8iC!}8BUN6Hq2p330r3@G4xEj>XI&@$)E9ZU>d z%ilw%e@?Ez}CY zQz%-M^$Kk&ERvL|C^_?HT5O@VYen}9#V9u^+kRZAfs+o}W4FYJoJX$GI43VJEX^^8 zE0YWZFoQWUF)q>$o$<{8m64brgJEmNi-vEA-v0m!dv_~x{{XS=)Mn*7KvwIn^PYZX zDwaS@yArK783j6q@&x;~+?>YIY2liOGRdTk@_teIqhhZnmsP4M3i)ElSN#LM#mGY&ZFTQbuU?O&GL zZY38?*OI%g?3Du!X`wo-ugbivg>?-*D2_-eZ$%3vJ(P1BQ8yyS=X-!gkRzftxk#SE z6RKOQml=pE2v}QWd%#?NVBC1eKvdAN3w76KIhj_MO5Gtn90N9;Y;9u&ouRD5QZ8dz z~Z3V?7+$m~EDz&^eK6i(k7)WmTLyzXLYu?W?lBqXzP*Qb4J18AK zFeY)U9DXa}=kWTa7fsPgUolDvxKY_7!q)uZOiETP1%KFGlCCrY8=VD*5_&1blsJ>& zW45;!5!w)XRSh!LI54b+pHOo!CuF^r;QEZ-8b@dh)kMB0YP3Y8`#TS%=CnE$eOl~# zf(R$V&`>6Esd5dR zKI+IBlt|EJ7aGHEBGWr~R=n;rW`1CmF-@mGGU`CESt=h@eAl@)wz_XQ9(^*uare^J}w6VCofKpAt@w{?{2Bu+_B&oBqp-FYO(&FXpZ)7`V0uO;BLNBev zbsQ7C0jbm}6*)D`p#4n4NJ^BFGbE@4@1Y4cG1PI6-XW>XW6?7#@JO4HoN`_8of4#} zWTDa4#>&ie7uZKmasv_911>V;vfFVJjwt|w7M!R680!Rb@z({_hF)@FMrjh3r#m@f zuc~q8?0HGJHd4|~P&ZJpwc#!zl!jJ?i=S9CwN&!aFwRC6Qc{(ar~;&uU~RD?_Arei zwGRFdsxw`fms7_)iy53dcho)9k~&`38eSWeYml_Z(Oh4557DZ!at)bfOt{n1!Lp;t zaSHmtl2ve(CvbCXrjZ%oO{*R82j7C7yk>BXK2n`fOK!H>vU3mV1Anb`3!ChE^@zDR zPw@H<$1U?GHW=*%gt4sOvk8Eig(}HOaV07wUrQ*GdRi*wiLPmq)4oIbOH`#@YaX6n`hy^NUzZEU86G zwd@nGPbiC~*oSgEFMmYromX?+MV!A=YCev*)!jce_Co;AmZb|*|+6y=px%o=Ff%T!~t%ra@+Obk{ z_zs};-toam<4xkE;i)%4ZNi1R4Z;<6(xY-z4xkShN{*wpVxZ!6*I1oe5~Ybbq}Tzf z+HoVM~)GM?5cKJW@&R16H<(}^5v7BSiI88kc-~=RGTGv zNGG8YFB~71!xE6A;qDrm#j{fnK9@q+64O$RytTF#(uIq85=N;YfqR{^6A70szJ8#d z`;uCXC+uueBpq>c67HeWRQO4BW?3jsbbx!l@0c3i5m#S*PV&DY+;*U+8p!3vfXGsv zQY~$LeBcmj$;ct(NHv*BNe+-wY)Zh;`T9o^g|-QtA*Pb=)x29s&u;3hGzz~$HX_|& za1k^+)QwYZ@{%q#iI~w6V;P7PTvP4+=Hg~5)XIV>de613c3c;E>-gU+`&w78U(vW&MH->er$K$cXs zJSjn>g_ExO-{S_Lp!NFvjRBQ9>Hy2R>2vXgU7Q;HHHezV(~c>&!ewRqtL}@q>FIrR zNZ!O7onwyBEyq_5C7`wP&=GY2t97(DVuXynN%tyqXi~e4s062_tqs_*XybWOm7cv| zpfdY9uH38*PzmM?k{tusVp~8V|LR3d}B>8;>hT z07LNpqLx)Y!T{wm;yFWm1*9u;zNR~<Iyn?vdE{WD`Ld%dYDy( z8QyXd+0$KWDc5-Af#jq(AOn{%FsVSS$tQadZD>y;r#ehLl-*^;AJrrHLAlWxH8WpB z?iNd-i}x;;&4s#xoBlD|U^h5Xc)u1*ELI+tZb`C0_H>?N)qMrjn^+C})Lm~@l!T} z*itr^jH*&#q2QGpXj0mNzpl_&QMD(F9(|I_s~Ma@1X%Y;A3Ywzvwtuc195QI4nE;?BK=<^iowNi?aNth$n=pc0nF!0=AC)ND*8Y{Bj= zaZP>7+>^5G$?u~^q>^dRN-AwGtf`5n8B&#F zs*t-{#2eb+>DDw@vMigTuOu{y4$2s6qfo^Yb4y1c%gO@c9{RTkR)8f3QhNGB^4wss zq@0O{4w3JT1y7|6UhS6{SHvtpa9({CJgS7G*EzpqOQP)*ocXLp!nQt|X&pE^70GGI zpgoCgHlVOnT}eYEKk{CYxwG|CnL2QJ#$`}ui52WtkPih~EHXzW0eu9$cZdxiip z=70`l+lCupXO~^Xbphwsc<3AQXS*FhZsvsn8gWw6x{K=SmjFK~k0rR`6UvrOVzYfs z^)Qp55QOUi!btG_(B(Ml3_gx#o#zK@|1Sw07-2s^-bUd zTM=SPFAo|oR9s=828ixwK0zkN@Bta8J6*9brMDqSTFzn{D`*VEp|DlW{Dc5^F^Cy4Nu5giUls##AbVVNO+AgDzhvBRj~>2L`RfNh}=QQIFJ zK9XdazuW>Ik0B=h#uNh+$0rI|mbU!g$`LcDYS^i*T5k*svvD&@SBwX2UhukMN~rg? z<)6+vj#(q!au-2oF~wZMXbdi^NaH$Vab4Kq)4eRd;EoDMHnQ$U@8%95uh~D82T0jSAuNq_1zVpp5t$&{1qD~kZ|kIR4aCa_g|izU18Cq`sO0>f9!6Zm z>+YuOStrD5W1Nn2JF@SyG?1%qI*S+p>0oM`e@QRY*p{{WD=LM}kr?o_ku5QJ>MAZ96J0CmuiQI*_P)t;YA8vB~7d;B&EfU z>FW(kkm4+Amf~JvIY>4Z(jhVQ&4M8!&Q2pG5-*XsK_U@8LZi%L>PB*6RX)m;dqR>l zSs^L7)aVH|=pqv&iOK~Qt0K@$%9wFt{oteisD#rx+BROS&Ed8mE=v~&Da&$+Rmlg& zC1B@7e7ujIj6+v`a<4Xorpo6mn~k-;v8PDQNp5hT#%{UwM36!7j_5;L5W2!u8nzBv zD^lr~aR@m|9zbvqd{Uv;#B1jaPM*V3r?D<%dr4LMoQA2PvIUY@8eh=FHxZMiTF3Z; zsIXs`ri3V6Dnz(aeg+zJ&T2BX+7eouE|%ux(5bX{Noj^lBm=&^;BCL3lyg9|bmw^a zMV4D`N=T*hs}~UbyKRBvV%otbIiZRhnR46DO-sAQsgN?o%tL(=MgaT z^qKEvr5P`&H*=h|45+8VW?4C@w> z&6P^2)b5gW>u6<&W-1chtz1i`OK@wIBINoGu-x_$Er$yT;uk0t79IgizS`1kv6S!N zdPHe%hGeZ0%eLBFa+O3UHdlh&1dY_8b7Q&aI@%*}?{+5^&*WDNm?8C~zWRe`KJE7> zz-bfwS|7V4776Uhh-*y9yD!Nt&s?P;MNTw;Y*z9@Pb_#|D|7MCi)*SDi&NlV1?apM z4w+IWtDK-naYE_`t7$elZ`2Nvlh4Gm=wOT&{QBg@6J78-2oW~|k1iDz4vam1zPt{ZHTnN}Az8=G~5NTnld z7~yG}SMZm|0#ESy3uJ*c3@R*!A)F!X$?x$<;C4Q66z#%Ltgz1P`KDvVE(lpd+sW-dR2v37bN=9!W zvQL~irDHBF3l1FdnxBqt(n{s#(W8>DfZNGEdxYNJamgW3m5;2n?W{+LA2SS&i@DAa z&}t}g4oEP0x~W-pB=x!L4=GU*$+MAK?E8i>4Lj($ntMu?w?UOa_=O~ccy&x~a=-Ya z*al*POx7J!bF%3rN|Bpd?ni+-ppp=X4 z^_MChX7}-dyA-x0ZW`iMdlfVvTGFCzbtTe^`Q<9N%Sf)vI%Ve#i&Rd`-AcPSL1j!6 z)VVWnz$(zkh`QgQFTk!<^E-2VF`wdnImRdEWm|a)3YSV26`58y2G=(5wzrOZ!jExl zhI0NyBKkE{d4O zN?W4)4r#gc7rBnu+>#_`2fIIGE+!(>WXwp(>3NyOy3=HTiy28@!%sNpi==~=C6(}Z zv5S~F2kCm$^yqMXWUyLN$tSP5%mezu8kZ4d7Kwd9!Zh3(*ltE$2nqYQB>G&EeM~U& zSb)zw-XnC#J{&+&a}WklM}}`7AskY(oQ3?mXqQN7J0Tzef(I}0{;LQOGK#TPngeQyh8l&X@iPVQRXFVt*Xt zTE!BPGGB4D)L3x{TEYQGds~E&;o|~|Y#f?If$ZF*;`tV4XWMVQY_gD2R(e|I-e%Dk zG*V;ODw*h1)iky@#wv~gK0RC48^Mpo1*;m-AlS$znUi9}TSe#*GEi)+vrGwyA zuD&8IV%*mBLz2?=I+B=ve;%@`q9)l(%FGa_Nd*LW04->7MJby9_MY)u- zIMmumdDISS3P*~Cicgk;Ig+d3b{xqa#175WEN3ugB&tqH%f2%iVC}$J)P#iv5$Sy) zg_64uXm7a3Rd7`ogU%vVtU$I_6f&~MDNiXx?xc`^8$#{NdcRY&keS7*#Pv5+nTKYV zD&YFJIVnbD^a?0I7x4hXBc$$@cCZcya!vNqxyKn%-o#$^&y29$OGddqxb+k5#Wi7F-vs?@9wW0MZRj|~dMy3v*MC8=h(Nkz{c4(+N z+n}MU$zqr1!jt%6}cR6 zr(zcHZAF%4DNivfu(YaS!JME0bepKFE&SmX)Kfc)!L&{_y1Hch(+`}PhG5!8x3Nh= zLbU1l$6(ss1d$anzXB&XHlrsuI_Rc2v&wKMI!Az6$}*q8#OTjk<+&ZIT*!UIs)D6h zeGRxAZKK^FSSVjZXtKu}Ax=i!3x_|-ibTBpgq!ZnsF322g{>MMgaQHa9+0OIDUwTq zoHq6#{{YkUS?Pe_0ixSZ0)cH!?wx*d9&y}yEJWklO#K1H%OaIN+e#;t;#qNaPfOna z02u6H)a0Z`=_z`>c72+AFNLY)gn^Jxgnuk@ahB z8Uyx%m23I~9Ezi@*~zHYoy83`EI{@~Ez2oD4gyDd>fDbbdqa_khRwWVJoX%2ERmjG zQF+CH%%Dxp&c@qX98nV4$;P}(nZ~OQG{TF!DQ@M}BVl9#YeTS&2$ZZwnxxG{6eXt8 zq>k`yDmL>Z+{1`$Mptp=R+7;}FRU+Q+-5iO1VXuqM2N@)yiX&G7^;;24$9{%OP_O1g7dyBoYz6fNNqRI*9F&OOCFlu}?E; zloIPhtpj9~-se-f(ia%eHZ3GD+UnG&UlQ`}w!#t?l{eq9`#`40PNbObkkmIARdm`! z_;E>QRRy&sr9Y`8?!jwM&5HvJN)P&tqdV^Q6 za&?kZusJ~afd+<-YDX&#)##|GwudE*%&5_2tLF!zk}qR#0yc+~A5o_?NE&t|!Z=y= zKE#~l%JPws#)(M3P!d!4$6QV(aBT-f@;C{kl% zOL5FSDjxXq=y!e~)0D>bzuWe+3hl~PuehY znQ_IqshsE~YCu^QMTh}FZKaGU^Eijk7~u*)c~#O+bJ3h7=PTWz+dEXILJ2_s?^ zo8xhf?I5l8>7u z$#*u+N7)3EZ^k%uj?$ zn3zehLpl_+%D_kmF$9&|2-B5k69-{sP-)Y0lR*nqlj(WjwS<-w<90ly18}gSjZklY zND=`dk7-ZT*DhTS%(XDugEK40sfA@1T1%u3en6pMuorCt?jwx=qNP7IN0X4HHiS;| z2o(3wvn?`}Ep{eaVCu;VvR2B)^IYl-C8MIAy@}+pyt=7%`9o2Cob9(lMaAhUd1mT$S!CR%N|MuP zR?L^vV5a`*$f7JP3Em*GVmCO;!iioe;TIfhFsRbpTP->?bcV)Y3iLK9+gn3oh-+S~ z)p%zqFHFR&ClEd8+~r zMUGy-sy)-@E)Rqup=q4FPkj469Pc_+ z<)KI*rr)Dbz4ixB8$#CmF-UZ>rbm=iwxWIT z^Nm!VA+#4P@D6>Z)o@452wIhMBF_s$u8N~8(>S?@RM8p1fb~&{eH5#F3=U}=(Al6d zG@1UCe2jC&k8se;jMt^+O`C8i_(9^J(9L=5O2mi1e}FKTognbp%X=HkGDzU6}qgv!msZIu4eFwCQHX{vE@l~PkpEw|R#1!z(dGoff1OKv!# zl61AA{{Vr>qC3i!@?E>qD|5$F<+)n&PEX)UlfK>T;cU!hn3fho!;9}(YDqV}@~b9- z{!yxolid|<9PBZ~c?l&?JyoZ^{{TH?G`6Nf1i2@?Kqy&RNZ1k*c01l35+r!7!pZD7 z^C>GUmVKt(lzd$#ZI_ME=PZ&z`wB+sP}f2ssN_%O%yq$%cZl31pW==jrb@`InYx7% zVG=Hd-d#y%aRuhscbq`X%YjX$NhJyj7PMExjErSZW&4lI3mGaO320MNsb*e%QuQ?g zAC!7rg!9``9JH+_#1b?oLFW>lX1A+d#x^v0SchY7nw z)woS8qL9`i!^;UvobaNyK-nuoij9YoN_;I2ER;0yj-_|9jSICbqN=zaeKHTad9PDe zn=l?DT)yE&_PvxLdW2OF1onKXO-)Qv>WE@WrzbF(bxOM6ZLg#6X8ibB~+2c47#3J zeF%N9kJ09LE@Y0Gn*~~4+Kb*J%Ps6kjy|V5k32S(!WF6dojpP7Vfxf9Do#_)R*3_9 zgXMU07F*axOm(>$C9%qzm>Jqa*$3StTX`QCo|ytjbL;g=SF$bU5(Bvj3FvRPNP5u4 z9G(_pbYiqQNS#Ph@)b)sbx=}u%dPab+gdvll2kh{&`_!q47j6}6MW{>Jhf1VD`BB6 zS(bKMYNo5%ml`VQ8E=d6g+uGzq?r1lalB>D>6hm{H84 z)!)JtYG7;huFrj9j`Q-saVljgj?LK635XON=Q`70YXiW z)*xM0($};$EJUhpcuImq+oidgCoL?boW<7M)HJWvNxAX_i$@NzQ8QVXkfg}sWHto2 zaS3r3unS7=Y&Yp~r<4|Qg{Ktp12{UPR(3df{m!%t1lcatE?(&cAcq$mdST<@*4 z=pX?pP^n8|$tqNXsamN{sSX4-6U}MFf|ruQmIzLL)-9Dv0O~|=>7UqT-^2~k@bla z!jg14k<>z5MJ6}2xfbf~%r~k^S}I81%FGSC^t?31p}^s68 z>S+o<1RSITrcie}_OHebj>B!4qhMV&y z*WbfXY#`IHtwwA~LY2ccDQToNY?*_O9dfost>OjE&9A7ARUJ;w+cYya{JLglCOw(< zi6OUal;u`bk)Z?;VnioTbGJg=@X@+seA#J*l&p}P;>R`jxa+2d(5(kGjczBw^-KoD z-1F`#WiF?gmD8Ch%cenNe57sQd}F$AXX+Y_E*fLHRW?$3pz6}f)>65I6KfEgTmmiz zgT@!(zFfq)4C_2ismRRBR;kqR?IqPXoXcKSzJ(GKsjxuIE}Y3acwQV>QrYtm@?Rje znL6JQ+m|i2WMv+i&rvCPCDH-5RM>!8wXOgp-^vK33+ve9ZP4q?Q7N=^a;2JKIhR!^*VC2rCE{LCv8BCieq-UKggun+-jN6#Ge3o56m} z=3tv-$b13Ux^JkCICkiDOTSZ-Om)w0OICNT67a=O zUgar20STZ8^*cAZkWauz8af#ge1z)CRDA>hVof2p(oZcRU$P^WVP`&em?c}ff_fRYrYZ*9%s zNbQI$HIC)0la5lQr)HBd!)aM;sQZf8f~45=*qcMiG_P=C7qm?o5^0jCO;l&465D~I z<0mpeR^@GkoY(Od{n0;$$m6#%Hdt!hg7`_fEJ?(&lTV=Hcrsm2?xH|NQk~w38&DIJ#Vp|%m3zfQ*07=YA*a5jQ$^sNi zah89Il@-!3suG!Ij#-+LfjN2*+6h4?z}&|Uh~6RaE?Wam%h&M*S@)3I)BM@Q^8=UD zMBQ5a52SJIbXLmo8G^2L5`fW27ZWo8Uc;@jf*}q^QZ(qiSH~EnrO8yuHq*siq~%r0 zQf+_I56Tf@%?gJdF?JJqQu9ldQqpw^O4Yyh%y8+7YqWh%VFeXRD-*KhcZf+!t?00z zV6%com&2?x#%hBPVd>S zo0vK!%Vx5?^asKKCl(l*ZfZ%qgb{5B>LKWyI!n?N15L!HQ7~mfz$2Kg2-9N?%H@ByCykD zY~@wXbX&|v8Pq9dJEE>j; zg|BPwZ2`tP;93+U#WaHI6p(FjMZ|RBR@`UdQ}Qw|Oe(EVc|Ov@xh^^i0aM_3U%P(q zhLI`^VURw%!@9e;jl?N)Wt7fkOT}cXE_-IZ_v;VZp}HJ?)Z8(t$<N<@r5akw`6~(4FbetP0gV_%@wZF|mRc9!zA{#CGg$yE!xUsmh}&OC&Oo2nPB9 zdjptNw{kZzo6E(Y5hn?P}oT_+Dq$x5zKLo$!_fD7jS5X+F; zV`EW~a)RZYPj>nqk=wCXX8k6pw{Cg?-6K~3CE{V#OTeyygMz#DyuJ6FYFSIHiWd=Z_IIOvO3P zHY<^95>;s|DkdbQT$GZZK?`LFXGJG)+lKn)*qf()qcJ_RIudnC6f%!H5=2Rc7agU%WGd{GbP9zZkF?e%s`9NpH!3ocpa>p0f`Q+y zj1XRWlDiJx$)W)Lx&>?VVZ>y;grm> zq$*w6lsqmDLc5gS#OOfZXhTDhWZ9d0Qep!|j9H|KfT-q?c5NZTVGRyMIZ~~DgL4fI z8_g|1T*GaPMsVf&+7oAJYjM{GDVY3+mK7^Fol!Y0X5JpE0_q+h?+R0)w*ylQQEQk| z^7G3~<4GVjFp-gJPwRrE48z1&9|%O4q^NYOouFm#Rhp^GJj#WDHd4ZejnI{RW1b}q z_&3R%m3FS9BsR4LCASDjT7trEdJ<8m#yYZ{_hu?(yF*eYSIbJ%o5@G>%V=849_q#? zir9k$@qtUGR-{`mELo@W0O%(`QsF_j&JP@NJR|NyEK%8_PlSs~Dn-Ys?pQH22)4T+ z#EX!teW7HZ0TsMPchJ&sJUnEpopd!NcvFPtEJ_I;If(ty0r67qUPpqD_)zU&{6B|q zvF1p!g*ezM1owz37q}#84fyhxF<$DS$x&Ol=MfxLRGXa0lyeSf-_&puc}@TnNk$DAC_w()P*I-KvmLgd%M~-N_J-F3OmZe zvMEj6tVy8xHtNse4p_rOrNGW6(l}*0<4UAS;ujV5f@wgZ#!?2UNO=oL0@uEW&J#6g zW?aiA!dLG4N7CQ^=Np&IA8;{)`)_20_73q;KLjK9HK3)b5bai60I-SaVj4M&ajPZ2d z(5*t00tu|D%6EfMuMBIkT_&B2)Tuev3r`z_IuU#L5U?~JM$p`ve8=Mkw?sj$c4(~N z*Ey8Z-1`KR-?MHe=c==6J`o!xG1$p56^Z9DKMa`*6xPtv^i%0~m=b)_k_<#~?m1n7 zl;TY5C0P*C#zd*rsUG)F9=!&z&4!T_#tLGgQ59kJ3L{31i+PUf142BY*U;vX1;q?0 zJu+q`oNUZ{YLc|L-G#D?TGuw|>k5meajPFb5aHT|3PxH%^p@H#BCH#lshCM}9e}eNEa$&Y) z>eF%xMZjfc#Gv>Kl_{g}v@zm$Tlx?99iQqdq(yrQS;@&cS+t|wbxZ=I;CYO!`s#xX zwx5u#5AXSr?-d3s)hFklk(!k*YNsV1W#+*G*D~vEE?o8RULA|uW}m3cvA%5!{seJL z4PfV9mz}Bvxc79n{Ik-;cv$z5n0SIAypeBu`q|huRs4si1yi1$b=kRE%e59#Tr$a0 zg45pjO2zJNu-f7nl>Df7LT7oZkZttM)ai(ldc`Z5VX$)_5}Oh{^@KV3omhq4Qx83j z+G!MOlYoFpKtV!Hx+_$Wem@9u4SYtY7QBcl#VmPS!1IPeVp+`Kn~?gfyL#XAiLio^ z5^{0qJRO&DW0Mu8%j~LMZ?djXQ<=djI-RZtyBOq_ldJI}WlUg+iPoo)U2sk{Gu}!F z0S)CE1OioK*8AQQ8Bxhb%6IK4f||n!dD?g;S>EVQmqNkYru*#|m?eD5?6IRlkBD&w z1i?#~r_W8vxhpZ=ZI^PlmB1BsCG^@)iQnA6gGdt=I5VYJV!(47Huyicj?4tPjT zq5a^8X*^rUYP)hZDvQiA5~52T)op#v$Ket3!$`QhHL%50VcM~%r6I@Le5bqyq^`wB zP5S!8VZvSUSf><9u#enc%Ffjg&UtFARn>oWrDlha!xtD~#Li+DS-1{3 z*VT(?NFMKiydqqMA>_hXKCf7vM5raLd%&#sQ}80-c|$fiLg$GbIz=vxGiTL4hMY$< zSQ3n+6RpqXq;W`7LKlZPxw!^kLpOPugcj5kEn-Igc88J>F?fRy-eu-`w#%-j;2(5c zY2gnfC6NkCjul!Hq_!9~xU!lAe2hNusST;LDyaNws$#jenV1X&xS*4fpq)Ie2zV4u z_>Gd@ohvgyooS$z2Ud_%kbtdrDLyd?q01dg#vqyr(qO0oYpEF*exU2GuUKM-6BQU= z2`h=zb;_ovGAc@aDNMS)v84bzwmM`0T$6irhNUedv091EL8eJl<(k7)L^7YLPDH6G zT32CZTSAa;(Ch0AY97)=jxpjI78P5Rx-7Gk6AXeD>WNEiTfsR+{sz#btm9_457$hg z$tI^&mX~>@HWarCY@{C`0)hELgq@1N5UJJHmW({hN_oIQAvqL;^&r?^@Px?fIvgyU zoT4(h8icuLK7Lx%E&z)_biWo92`MC8U#KT>q#?0XM(iz$DfGz@+~Yy=+s}PbN`VP0 zBoJ&y(bkUHJh(Ad!`w}$Dq5P)Eg%-$X-Uu$JkkM%Woe6BkeiC!GJgWrOuLefqD|KT zZNL)c@8FPrLM7v#q(_`-irhcLX-qjdCTbyVOER43Q)~dWn`v=-fIc^eY;B#68_uye zUKKeBu<}@Kc26y74U@1pwexkgpt?BGmxxnSleGoUI60}^KpR`cf%!n0!Vz&oWBxfq zqun+m;}1k_lIIB2h9Q$`QH80A@RX#isFf+D9`cf{HU~uB_J&#=M3%-lT3(?=W{_XZ zw(J|du1${i(|AfcR`wU7nk`aoGYuJr<)&$s0IS{fpJtgtLUM(mtSKM>qhOMCF{SVciBiP8s$<ZDWMU)Hwy z_l&cv(N@Yx(iobd*pjb@l{RtpDysC*KUF6nmCHJwTkSn4RL~B$xX_@3vW~G^HAMId zM9d;uZRQ_QElpRX*;)#>NiCwlbkRoe(;OSzCxdC2k(rt;VYl0xqs=ae7jPRa-PdK7 ztLuD(B%J|PT{YDbbSf&u?lIshaLcSDFOvMN9&494g()QuO07i$HM+Dcq^JX>uQGHxS*H zW#-GQO`>1gy{V&O9BrpYMR!OkB`3O}U`UF0j=p5;vE{`S3U)20H1ZJl)#Y&wbBk-e zv`%1bs{?QeAle#Ratk*l+EaNFqFqP>Q()-$rpaBp?0sP$eqxSBFp*YgT~b2NEjd$S zK`6Ng<9kBr6C<5#h3dqwDrmB0=F+q(T`N#aYCr%u2nOT>Wn3GJ!|Bk5VZ;(MoE_v( z%Cds`4nU6aLz;_T`kgPRwy>yg%;cSj+7BFYe+Z`@m{wW&N0-ccS!v8rwQ6}pWl#e4 zwc+HHw&XJ<)UkdJ_JE-Aot%=+dpzJ4T(hbOa2~l*R7r*>9Y1>rp~kG!ACO8^(gL!p zyp<1mC(ofD3&c5EI+4Pam_+-?Pbn>^D3Ucwg|)rB4Y!7qv$aQU`q#9m4|Tz0l&eJ% zeZcGM3)g=U8bt|g=2A|e>u(TYLQZ&Ta!5HlsVXBb_Z}(#0DDI{1sN8Q<5@-X-sb&0 zEgb_<5{8Vf2_~eeCDZq8jPP|`MJ5~UV9V6m zucjpGim20UmR^@z3q;9TxKd?{VQOe!yi~0ED%(SOJ*wiHNxEE;xBH8a3ZFKY#E}@D zPYlb`Ww6C+tYzGhmu0?Lb-8kEd!;3Ll#y{|+g!atv5IeaoTaHJ^G?5CnQ0tJD%;d~ zaQ-Nyvm%z{y_RZ0v;yO-%pv3WV);S>V|UQQ(WngpNY6P z1n}v!QEK$MvvVBwmS(1ulIogRDR{KDmX^YiWGN|9RGmmMt;L>m-s-v(vc#94n84xu zUf*WQu&d!(l4j|XN)q$3Pa(BTxhx1-O3+eKVRMmbDY~>G(PN7%lHFJ2M4mLc3=Lx* z$w^{)ij50Al!BaDDK^zAB-<$}NWWC-2S|NM(AJbYydvY|?7aF>N1c|ZOsV4Qf#Q@( zI;5u8QixL1a4nP&o9qFOxlkzCXP8g54G)fTi=g7^CM73H$fQoR5XzQQV5F%^O2M(X z)Ef{)C&dpAxe#lP{gGYap?;%>C8p~1bs#B+m<81|e%f9LPOXAFt4_A}k63fWvx*{D z3-GpM5@Fey=_RGsStzZT`!^*xb$|gy6rdBfBd)+!)t@eiojW3~Iz%R7=h;CsPT0u8I5erO1RxRmxrRgd( z;|uStYg3F7s2trF{6sBFVYd^LGmUw2)Y9?qkQ;mUQgVy<8(IxPr0G8{-1%vi)o*2* zDoTHEU)>$ElrHeiZdVyo?E2f45^5#e=l}}2P`M=L{NuW;c9PHuIh0hCfv~@XF*y&yCr28#CZ(y< zN||a&>2Q@gw{%jJkN~o6sj$~!3~C}*)f`)e2bPaxRzaAI$?qiF zb8~Bsh7mlPH+;ULqmNfFzTBT0&m{%w(#2G zV%VpJp&?SDrx;=C1hakhsqo9CChE%B%7AyV0O@fOl!(n5cyg}p3q?y0u&!xXL2*{O z3QC9w1ajWS|aSLLT% zAnt6HW=JE?Usw*9F!aqnrCN1{*lux1N}Wujs#-JLW?CClN=n1X)lF;f0dPiE_?jZ1{K>m|ekl!XrJf=$k#f(QqG zhj?woaWi70FCkbj%ktJ_kP@&GN>!0tsB5a5R{M)VRLl!I$nfB?J-H~kLlp%&BA63wkoIEP$IcSDUEU109CYzZFl+WT4>(m7&+sXD=t zPki&9LQ-2rl&kB|7P@w$wr#MOfid>k7odGcxl94@-_)%_Jd7+q!H)Ha&F^ z>|Wjh-pOvz66*MM9e?Hr7&6 z%FIGlvQ(l7IeMMNge@k&k;_8jLT0kt1*TId`c07Rx{|DyN^G8479k{QuUILGw0cIn zJ44LG)jn0Vr6i#UDmq&=&B!(a_k>k+6>0T0X{npUYH2guT=92H#wpP=;v)^q%_dx_5JW26{=gx_;qhooi$gd}#CaFS99&2NZ@{01|q<2x?&j*hmZSOId92A+FEGK*ZrCU`gq(8FTD${`?S z5CCi106d~?qyP{v#sCeP@BzZBwp0zj2o9r{BQoY(#F8`u@x*lRJir19IBN3k2|8`c zBp~0zSn4<>X)>djwF~!@Nrup-1GMokGA32tN$#I5U|@~8SCJtyw#n|B6nY)woP{A= zH5Y}Q2vr;d8~_f`0i!y8seiJ6DB}US;j%=#vq>8e(fkZ@Aje%tG$`Out3m)0U<1Iw z1}D*R0n}}>Y>^#67%Uhp0C9RjU|=RVa4q0E7&&MF#HHRi&VrT4Ea|d`NPrEbI7|R+ zq4JpRfsjmI3j>`!D2eNDakO!(17=l>qQ*Lq9acNLZ3;jnv9y{UmRfg7Pk4C~tZ|`H z8qOhAaQ^@bsj8lwLukr^6W+4aNcU593zOj;j4xxlgl7vX=*4(qT4|kmjw#Wby=$oV zReS4gEe=+fU5+m z&b-o;07beI596#$Aq-CuxvOm|Q5P<@G#{)W0n|9bQmbN3a_=ZO>Iz;;L2WAiV|$Mc zy28>D*yaBKDcP3M*4{p8Md8X5sOHV$*+BuUlCfj}RcCw#1b;iBj~JgrlgNn{W~OHiD9Y;8dG_H;z%;JKRd)jvnGmNPccv zdCze!B$POd`CiB340R)oj{g8=Tny(A=m?Wqin6-tNje;*M=kvAVqwH^cQJM#RvnXi zWeu&;(hB)#7gDS?NYhy870A9Y&32ue6a_rpGDRlyfyJe{mj(1~AeCDG0Bb;e;VfDt zEcX!b_hTGUScNg`9u|sA3_^10k1qWi$@Nf=~Z_}qyp16A63w=**}zYERJ+ZG|RF8(3LGm;-e9$ za>Gr6$%9dTiRm(D$bG9jDuWTq&n?6^*Eqg zFEL?lZ_givq4luK7A;9tNm83!v2QxS3vAxORvM2ku$Bj5`V{=mW1WiB=J$IN`BvL(ay~0FdHNJDI@JuC1AMJdR4iDH)1X zMwx}jcf|CI9v&7%%PKy7W-7|7)aIsL_uO@4+txH`Q9&^&U#bFfr(wKygd{i^EKq8; zGw65#pLv3kpss~US+-vrSi=*vGdm>|jXMI)G{PCJ)LU^v&jm8pR1@K$)7J43*xeiQ zd@aJsDp9Y@9ecl2oxJ;yn*(aIhj7g|EU2$OwI~Z@ZL*a9(8>&ODCRN2>SGpl%ta)W ztm&ALv40R!E$871p>!^q?9$~?r`(XP(xwpF2`XI0x_E)0^V%Fy7NPJfTM=-EcMVOt zA97jrrAF&z(6pU?&x~5d*y1_uONm_vNP3Q$l~i@3-7(XL9;s1O&9j@rS;J<9h)pK> z0J68ZgtccHvE9S-P0RqYZj-5q>|vbzS(3O^%%T>gpLXM~lqCY#CJDgKHlk+1Z3)~R z6nut}$w(z5e-PnUB$b_#OMC0RzEItXPQ_OYF?0AXaWAw|Q|`Eh08*r$glQ3TW7dSq zHc5WeyhoGbb{Up_MK+w5B@dhIg={TzrTW?;VS|g@($q3Nt~#)qLh90uyj1Ee=Zl*1~cpP+=aEi+B|(x_>`kr|$qe)>al zi1cK2=IS!^Id>-K97|H|B&lmr2^JkLbi77!vQDZiZ?q2-YrIXTIX6#m$kN+&DV9!K zIP!(gb>BB|+q+^fyf>u?c^H!6k818AGf7m(vB}hBrPYyc6gV9LBU_~k0N4%f4az9$ z%E{@$9yBkC6ol7mDV33@6|J>7&F?m(=u4qS&8GcSZ*5{8N2QY>^)Eief^t>KG^Nm_ zI>Ue#-E8JUf!KmH*ULz4%7-G;8(B%^yNT4oluJfUD#>$e<|6j}@QW8)e8-ikuV?Na zON|j?g}HJ)I*8@{*q0mc=rtT#;YAx5$SiwdkyC@*Q=l}Z4Qx`Nf61|j6Y9RAp%&dW zerXloM5@uSv+9(nOf(*4WjZJVpbm-`BSX>=CuO8zr(w*gSLk?ww4^vz2FJT$@dhJH zAubpN#Ui^UQj}FXa%C^cIE;lVT5gfhgMA2yGnsFTA6}$>oWbr;-Ev(HCFT&W;?kh3 z$lPiM;Amnyc3VO0ESjyPH4CJylXQ%R;V(xFaqCER#s9E^-k&Aq;2?k{uS^sd_<~Ed5O9$0%sRZw<99n zd52D#Xpz-wBV>W8I|!DDGHDMsJfqBDT59PO2|2lhx{zu$G|RZQ-XmO$xD%8#4(b3C z<7n$dWZZ@C1FH;FDDBF+2Q`9Hv?yvkE)JqIoN{rU_clJvsluN@#eW0SW*5y%T(>^^ zYf=y3Z4f+0i+>3|gM~t<*C=^Jg+bsFZj?Ggl24f_D!0ZL84&VtP?tdqG1`|HmsAw< z1f-Obl19hUEh4R6nL*BVU9k z#t#5U;Ob1=rBw1=gCY2d*g?*$I8(eq;wfrHJ&gl_L z##0lL>L_i};2q|za!=}xvDC#pV-dytYfi&*oVw$zmAanft2R{FJqIrOA6T))7WomU zOJ+u17f4mHone>hX*9}vPA52V(k7fiJ7l>U`e}XQdy-3i-3awQ>GH_Ln5=Lx%H<&AS4?0JMnDv)uM0nAc6swoPw^dN)r1|&6NbfQ1t?#y&5 z&E_7KahZf@R1~I_oM=swK(X9gq#-8O;GmY~<2){?;r8E5wNi80nO(z5<+zmk^BYkk zbd z6%^ZbA*8;5d_gu{zA)B{*jB1XCZC2dCOkn;wld0yw=LHTOZcJEq4LrZqEQP|^BdWY z#}w+Kl{H9Gu9Y0FHsXP}>voUsj=a+4&*V0+N1rd98xxf5d4N)uEoODV;Qo=MPAaG&_&ZK1jnX!!BxkYhY`mI)NL>(AEVAsqIKG|zcI9w z%d+YAb+og&C^<NLyjad?PG>t zr_o$(a_s=Mwo>T|&wSoK@8)9HhReR>9Qd}_jMP~`a9wOnSx1`K1RXDzp^Lc56;3S` zNXm*c0BvO$nnowTU{!~4Luyvx3jB;k&N%_XugiNaPIX5>nWwBg^AqxjBjnkC5TsFL zA6pH&%Z-bZe8^Xh_Ox*A4UZRSGETcDw$qS5E=XDpj$mwU(!_2*D03Kz5u&Aqmnxzq zpG%}2GMz#5u-+t*+9VGIIDCM*qW0kOMSFU z%QWiSDefpKLi${Hj+cZZt(8eE*_5ij-L)1GDG|;i^GcGgrzVRY;qW%Njxa^V_GYdt zh%!i?bONSOq!f@ls~Rs|?0N!XuQSr%xioYD}xGPc-YSsq>x2Mq-ixwz_GoPl*`kJX2MvO_T%w03eTq zkJSh^htS(9&Zv%C?hgeY&L*LeLxwKQ%L*Iw6K|X%Kw4K3CZEI4Q!28#RI?=7vZ!2X zq0%c}E8329kw zl5_xreL4t%DN`h<*q`9F72JDDa%!lgD(<)lN&;+QrjXZ&*ye#@#*9NZKz5jvyq;lx?q>j}E>cbOxC6v$JYr@U z5%NTgIO7{pr6x=3byaES!OF`D3vIh}Icz`!#^%vrh-^0jXQVO1b0$(@nJMR=)q*YD zPJt-QR7p0uJKj3>61O?i7@gLtF3L@^^W~=$gUUcy3B9gBu^%fyfP~$l=s!l*TV;Sr z&WjHsVdycbB4yR^jZji$3RpmGhMQh=s?G}w-9V0?lr}ho+Hqw@dDQz;?IvBkss$l8 zSCLWF9~)XYbVT7Y%< z1qrNvs+D#65@-{P_KJ$swwmWyq2(nAm@8GlOKv!oIc52hPVl#}$~Ezy6r?J+ZjjXL zT)KlU&C59ZX8Ja=R8)|j@G4ju9jUq;6RtDwW5}w zNa=p4Q_1<)p`q1II?Q5A+?nPWa=D7BW(vbz9Kuo6JkNje>2p~1$P z#&QX6zck20kDOH^97!6fFMB!&Cfen)t!WNDcNAOdfgD(NG5dCoFb%xgnK z`-JK8+(&7)>a#7;EAFK&(4vf|~qNZJ+YGv03 zP_(Heh1m)NF+mpZXa%=0;sc|IWaaV1s}qY36fmZh$Wh8q-v=fiav)mi>%x$p> zv4tsget|=WN9~DK;YyJyie&@xVAxKfN-E2+Do=kmp2T^_d>wqf7}T~VMiR$V4lqmm zO)_Z<1dxR!6syxv3_{6{x$Fsw*@_C;N=iX-N$NJ)LTg>^Ht50Wd!-xVZf5%bJPq+KRGh&imA0K zP;r&YG^QLw1-@I&u-H=2Qh))v!7C&i4PmU=Q&CHuYQBvJnLbZZ`5+4mX`HhSb_p^~fk8 zMG8&9vECe)89SzuR+ip-h+H~q*Jf|=OZ%J@oHsix$g8D<@*R2COsGLAY~1%-QN4gA zL|od|5bU_`4plCz&zID0JU@u7bbN@H+DnTGuGL$0@FpdgZK+f`+7!wIZ6P5l0ePHL z#8|CsIgWzB3q<@YSjJDlP96+#Y3>7IFQnya&Q_+TnnSX5g|_G{wn<9M%278$KnBSO z&C>V0HnQ8>YIOSwc=p{1E)>*cdt1p)QmQrSnk`A!l;ctoO$mB>2|B4#=n3a7Uui|e zs`}WG5>uu#Uwufe#9j*H-pqBT(=x)RQ#7>+IfRh=b181;yo}2!B|7rl*4ths#=7iB zZHjgFyO@@g9?2muB{uU(3oMd`P~cs|%`}?^+$qs^I`!~}QyFI$h&)Nf)2fx2m7Wu+ zoNU;$cE(}vrPkD~$5o!`@i63acM#$?so;fEi850abq{L{IvJQuqMOdkgbcmaE4-aR zB?B(L_J#+Zjx1IwX}z82u=6akw^Pn_eemkrN@d$myr*oVsJ-kC+X!WGi_ml3#AgsV zdxhm#OH$QE%+xa+`501I-|VQ1pHXoNj}qn6>T%&nWGEG3hUyA41h~?URgt<%bV`Qz z^zex)V=g1{ggZUrJ|N2>bm;|&S)9mA&M6F`!aK&r#U}nY+8dV<71Ub9*x(|8Lg6f; zfK_;q%H*&u7FtT2h1zDV zHbc&imo6waR)1Bbe;9+rPB{0Qci9s0LCg48%uvm6BM;$8^scb{-F9^bStlq&i@jS|L#H6(<%T9F|P5|A>eq-Igf z6>Z^<5xx1}%wB|r2WN++!>_JEO*2jjCCRrFnfc@uWmw9qWMq(1oZ(w$v4z+Y^M}b?DT`B#X6NsOeqOU&bLBKB^C!z2Zr%87IuiaF(yNW@ZF9NR%%Lh)y_$~ zBB}XFwTms(s97aLUh-9NbQ6I;Ii8+S{Fegw#P3|st z7T(=q!M5mF&%A2YiR?Qp*b?QgY`2J80{ZMb=_cmGTR?RT1p^OF((4UP%4S;AGA`zA zQs6qJTHoWb5yPXSDZ-=0Tyn&VN0ik@U<51yl^W(+vfNxGW>vJkp%RrLNf)Vxq@?&Y zO-&kvo=XY+EXf0(GQEqAtsq>VvMt?BfYKm5mOZ9~^va#69PUg$pnt|F2rS`&%1WIU zXsJZ?DkS{Lg&ZS48h9x7J>?gc@)E_!LKX$d`$Y9N(h|_5=wT`N75*I|)GfbkmU}Jp zjIXp)vYB{h%12OBWep(>3sSLHhr3f$_F<56*_zlT8#z8yDX ziz`QMuGO-brfOPMGHM_+~4| zJC(jH(<`%b<;jLn8qJud>AIG6HnyMcVZU~3khPr&S*&)M>B*{dYs|J%IYBP>Ru59G zx6lj1mk(Qqj3{_}RjT1<%ggR1U@ieFU%q3 zYj!T86@6`>Ab#i<4&Om9GCO!lX;YbiBxnbBM4tn)` z3u{V%Dnin1q2bmCft>M#jHWtbUPanrc@72!Wu&E7N))S(Qi-*Zpa5Kt2?>m7J6nZ=lLrLlX}DPqdk$j&Ylmolg*YM#ALgm^=K z?2x}2$DGdJauG*On*bxAG?I9Zr#|bUF0$KA ztfUp9+FwhOurCWyu{J0r=O>&tFUp@xzw5x^L1$^dYd_L4e^mbftqG&HWPV0*&C6%d z5A~pE>7?Ye+@fv+Rv)YU6$xpevmGY1sq`p15*CFK-MxtEz2Ij}%pXLR&j2S|2N3 zJ3(hzx{SJR1IQ!xgm#XZ4MBnZDnGO!IvEovaOkuj>j>pDhUjFTsriUi1)7u0~u)f-Z);pzzh7)N$W13i4 za`-w8ZyckhRFx6522r=~Q&#vf87l1XeaKDpF?GA5yy?3k$~>sEnz?5*X5&!;`YqE*4OKVlo z*aFr-=nm!=LR%F0CBW5ETlW6|bQB4awslq}6fVwbQ8CI3J#*t67IU5is6%W~&}^GW zQUJpDfDNX}hY}Lmw3WiB<&nb}$)(DS!B*u${{Sd$fS#16u_B_Rixas3YwM(Pj+(MG z6*DsP=56;-=>;q-g4=fcngR!wuuu{ghgB3*>G|6?0c%h8O`&N8ibv(Wrr_GgLJxt3 z(Zaj?Kz3Xb6HVed1R+i`=q|QCsV*b+ibz$*Qa2qTwy1G4T1$?SELpecvMO`{3C)`N zX{wS>;|&Wsv)o*embWsEOhF>{Q3U*g3^c_c8RJzb?@Oj%!6;Yf%7mRU%<-Z`=$br& zhwWSQYB+Qj_^&9Tb3&(q;#NQU9B=}TEK`(hsx2%ZHG}^EMxdj%YSeg_At2hOmqDjE z%4`X3NjCYm356sju_AccL7i4s@a(GB;oJl9ZWl)f@xBT<#)f2OsxqmPm0;&?Sq}3O zw4H*$vU2{dzEI?2VjPKqNvEQU+8Jp94YrV!r62$R@B>JChOBFN(N!`H%C9I_){&H( zU%Fu~BDD;T6vmTPv@KI~@hnoJ5tZb*nLm3#E$IlMRw`Fj1Rm|6qn2-QT2WG!m6R!E z3rSLfjmBbn4uS-MGFv|35UnDt(Nn~9gy|J#GT}WVjRlydR86f2qqcOV)@&gS3qhY% z;SA~6m0pmfj+x$3C|9BUqqGE4!L-v!ZPT5{*6YqL>s9gsqhu$+Bf=vw| zazsl6-7`GYoXY#WyJjAzO(7I?Q8dC*ebNjh4wHl?!CFTJS-8l&bmJB{Oj-30)cx_) za9*oO=m}hBTR3__`J^X0nr%u6y{s;AnqAJ4tA!jVoRz6Rh-+_iDh{-SA*QvLLIBYtyrQx?>X1)JW>e^g6i0`In6jr_ zo}Ox>C?$~EfRWfmqscN!Dq@9ESM4lw^Vp6F+Ge(vqlO*ekaNGhw(I5~n)ZbmA+lPfKAmx>mK=k6I zre-wLn6ZC}i^Np4A}42g>$i+_Nblg9G7`XbBI;Ga^0YCKVr+8hl=h{OkPDNkBx?~^ z(>d72t2;^MwJ5a&tv%v52gAw)g+*D@!gy^Akn_tbbyg&--2CH*8Pno4o3#NhiF26y zqzcylmIAJDjDle?x zrOo1KvmI9>1caNyz)d{x5COA8qN@-)mibfnj-W$wl?iTzm-02bNhN1E=xw3+Lr!8G zj@>!-7yuyJ-66IlQ?34JO3;v;gb{5aCn(K|=anSWa}6x1#}rDF&v>p z7{Rih#OhjkrpsnYBE?RTmotXltvC5b}Jawlm&`hx~66Yz-$guGk6sdVe1Ykjz(*t z-lbLDnq{?2vSr>I31Yklc0eNA2#(bpvEA&~PG)9-P(b@GyK(9?hGuawqv4+rrTaW$XC>-V;%^Vu z2PyVds#KIjGEzjA#g$Qnq}MVUW%m+0t%RioN5e9WhpCQO}#v~560ummwO@gD+pKk-B(^No~E#db0uEP*vQkC z=nzy@uH@|u=FFh9u57TuiO!_?d5*;8YY)l38=j-hN?+epv*RjHlSRAR;$pQoC9^H- zPxSqViiw5rz9UVj)im?S?z1?`+g1ECC?zH$&et+-DYesX>-Oe1Sho*WIBKA0+FBS_ zxbhYpZA1E`+v5pMOP8S~WldT%rLj{}?JFw5B_s{T;uTcRx#~iVo+|$Udb(3I=b4pl zZ^;K*4zrmvE(H)!=}Fhb6>cKq5_9Fs%&uuDbLMw2=W4nULQz!1a%`%=7bVo%lj;&% zxb(U8iOvtBzo7?Ln9gx`kFr?FCQ6+rFDoZ~Rh1mo*y(iyf|2AtaO@Rx4M>h=i8WnG zc2$=gLI}E&l0de*`bT9nxsOIJT#FFLc!@H&dYp~-$*0%4$CLKBn~+}%U~1^oOX9#t-*@oBAx@rsP0J;ftXb{^|xs^kcn{#vspYvQ~vF~aJ?rMTRbtds{a6U z3eqmX{#QCipP7S6%QfD`PQEOEGYU$M8V3=UedOl#FtNExj1S`hlz@;vFrk-`2pX;^ zbwJzmFr=)5DOmP)e59J&i&Ks$5|VNyX$RKI(4So*4;MWvVNg~}Ch4 zUoj0h*FV3=U0-j=a&X0RUDsDGUS?&J?xlA_fk*7+UA}S1vy#WwsE<5Ft>Y|2w`Alb z8KFuA6#HGn&#ZW%O^^|PjiOSNVY}bUm(*v%b9;L8`VH0v;3G73s$yk_r>9P)bj&jQ zx8L1yH&39ygmzp@mo8n9{CHT$pFcD>Qqpp=^#*(L!f6V)OOk70``d0}4n_Q-amXp* z^7^JYSc-hh)umLe3Xq?j;>I(*$oe+E@43lX?93K z+q?L5h|d!o*YzDbUK_8_8B^|5(=?DSeW{SNqz(2^guG1Vq-)h&n#J^`tkUW8s!_8_ zWkIl{^-wNnvGUp;jymW^ZFd``VRx|&Jjwk4xoL)uX5Vf0kl{UUv;ntGp%VNe;8glxkS=XuSzwE0r z2|H~J_|0~I5=Xl)HT4ULshEQbOQE-CCtqbtNJ~@bMM0a5fLauiJxICni4e}ZuT8&l z9Qa%Q7xeyy%~nj}`fHTc$w)exfH|T`(@%Jjv9rlq2^&P5d}>b9_1uq>fpxhIv1el% zWS(bSn5k0{VnKO?O``r8<%s#^i#U5tzKQ(`se3z5Rw(-{@M(A}5zEd>Rb?h+(7P{H zGP0X%+;YVDS`6H7rOKbgZX6qrpU8GNqrtlC^{JVeSw|Nx>&jYG+R## z6T;Kjb}F(p%0)I&4AYeJOg00pEP!Fm=g&(*06LXS5>dpIKX&h zsgwB0rx-y_R<7t-O^H%P!Y_Yx{I3EFBPAYrQ zl=e!rx=AV%GLs1;_>?LoCNj}jRoOh#uOw_7SLYKG7&;V%gw9K(4Fie%!);3QAOUu+D5fBBD--DI2mhxr_-g;@DveWgXRv*$M-5zW#8;w;hV2aq!a^ zQ|pxEvfF{8kTW)+sJ^;v52%WKv1yiYc8t)DjK6;>IgtB$&@$zsN~%}#8cD&Ew&Z*#-&MBfcP7HVdOH- zJtlLLGE%~tnW;MA<}KwXDCiUpg8fdnF~)ThTL9pbg(Oz&^UXfDl#*`dx$2F;zaU*>akO(AIk?!~lzw zp1K44W0oq0Q?%@(aJLtE*w4@8;khp1Xys-awcLW@LrazV>vASIRo1p zal*9O0kd?GWh9WJaBXl-`$dyuk3$+e&eTq+2mb3QpD`O4{8FCDGJB{6yjPMyo(ep2EuuLXxLd z%1Trd)P**y5#k6sYYnGD>c($_m}U7ns*__PgS4ruDGCG;l!585LlPpyv{RNLXtOxr zJr;jBxkNL`bDFR}SNDkMlmFL?C&rt6o=cGr_ME%!Fv_=XVYLMYly(GM zgQ`_{&|{vyUos@2q}Q9INa7@-YYmmro^cN_xjE$zX9evPnOW5nn&1(U#Gz>yvW?71 zihlvNBbunQh3c$-DVTC*W$BiioR%Q4<7_rURh3B=v#H2X;zxNYz3y&#eyrf{RQRbW z!k4BflCG)GqTZTjMxwz=khZ3Eve2SM!d6mLl_=aEy25@ZXm_P()0C=8sq%paOeLI; zH{VLK0)4G^xk~=AVMrv6uB{<2W1{I^%STu*w&c;Dph;#zKn*u2kWk~!D*3bK${R{k z)Ewd?y~h$b^yg~WO_e`BrspM*B3+c4LdUc)$+}A_x^he@y#m^Jf|Ig@Ga=N6cY<_f zw%m&;m_kukmYG>DG*Zb)aRoWjqi{(!3Q4dA+So)XyCp?Yv&DQ*DK|w_rA@V}R!XwW zl&sKE&nEE#&a|WYc2KW*3n1mwz(YdV(n|2MslzHv=7TBy_#9>*p2uG0`#-I=E7p(=>=#6@U&#oHJfQyb74r%#|Q6AFBi3cITcB$S(l3lMGP5w%e3 zLUq0tQvkz2JijrD-jXbnPhC9?Adqr{EV2SY2Kk80pl^6@Rf9ur-XE;++F8nE;!|Cq zEPY(6)LWQjTK@o4=2aCDrIMv5rlK2@OcJ4jpx|jNBRcH;3@yed785Zpw3JOsC|yYt z43eM_ZD8_ElyoDka({_a1+ye1rZ!aCCFi8ok>HRsq=f~bjTD}W17!}87ex+Oqr{l8 zs*J6sWy5ntXaZrSXm!^zGyvPKwlJ3p1kDa1ArCuDS2U>xPH>fIO00zLFKhbk3ax~v z`HKn@1&3djamD6wD41 zqi02;B!ZUFQqZMYNdqxS9!FSDE=LY+R-hKFq!N>$<=Ze-_UW&bam(!jM)MM~+`!_3 zlJbSYSh3pLfNcv@C7otc8c|9>NE)i=QaYayJobkWgI;CyTofCE0nil>TZrwPGSyek zV>s)fAvewC;tX}WIYN1=I-F7hkVFpyOpoeWFoumoBy* zuvb8{xXRgIxZ8k{(_h~S(7eYrjL#JK7b(Q*L)58q?Ky8b&F8e*ZJg+=?UEAUP`DuM zbsEAJ6&H2M-;nfkzWpdmVZIJ4hqQJnbCXU_i8kLTnOg}#47fYUNkXiW2Egxa;=7B5 z%K3AAw%?xiSYXY6MbC08aZ4PxQhHX2OO$`uSWZ+oH&0XYiVh=|pr@Eqk0ZEBlDvw{ zrCQ?G3B!#)#d|JF)vHzC@1ZJkYi_Tu^mb~!oG|YXrJtWebF$KGwA-(+#LUuJxzS2V zacWtGIviwtI7-QNtK3<Kp+Dnquu*1*4EzWsp zs5vsjN^LC`TSivWq>J1sM1n4xYZI}}V09{Qmfr>Y5vLb5YS+bik-rM!OjAa~&&W$s zDl_%xDosvI&&o0FD@kBkGLtQ>AyVo=zNiN2J#Q9GLo2AY81{F3zI}HhT(NH}Z+>4A zQDIyIh`T~REahSL>C!Dr%evT;ciLQS$CODzl(eLw?&wRcs_976U81?p7#dM}m96>n zdu?o&_?m61eL8aa3JPatd?|q@msgWhwFOAH_1TvuZP|xN$V!+}%Xynxvm0rcSlZT( zPue*h#`ff?Z`;v&9b7bNI;Pd`_8<>xo*&{F+(0WVp<-amHJ)Xb97&sT0>y4NfKbD! zPE-CVR4nNUZXFBu_w~inIl$9(<^mBxsuQrl8m?Ya=M1#RwYK@cc`L|55Tm|yBoyCNm}}njY=w9l zxtU+=JBKAD2h=jjQ!b%MRQ$@46r>P^rAkUcQWa(8BPk;((^zfsugll@3iousr}H?x zIqXYGt-8wUiD=J>WVJKwQ%^9=(NA6>*`}Et)RdbL6>9)(ad=YVx7%g$IIws8gg*f>CIpb5aa7zm zsd>c$wHF;*?hu{whY1>QVQa#&Woysob{NzCgowu7moU#CA5BW8yDX&pLvl1% zCRF6i#M^}iqVm;py!w>OCe}d*>q2d0i3w6Gf`nB=0?W;+%}c38CqjmavHhSy5y!dI zbL8+e#E4p@UVV_G^?@aNsC3-x_`+ybqa{9{TBEG4PN?&D+$;w{_$+?-?HtrE=@_#T zNnAX(CQsg5JfeOn3I;fK&6?gjtUk+(^4OMnNKiwdl@zMlD=Lv=W39T!Ldg9}q+_`? zW_r0NINHcL9*}2lpcJ4HeT*s7IdnW~G7qv@c8Mgc+Al1^kO}LjF5(c-r6Iho;0j~y zIA!qExp<_8)Mp)10=g9dk)ZrwN{+c$fTwW%atKLt4b#@@MU=G7zMRL$E=vzcRS492 zp@!Z7gyH!Vg$ocTp3VMlkSL>$Mkx*&&B$e(lA)owhRxEX)E_oJV<7~1g9;O4hlgY< zQ%O>5w8mywCh0>HYi&tBX$eSInI`a3IcE!qxEfu_cD{n7Ny<%gGdu0mx+%MA5(<^6 zJDn^#!qQCTjZ1h-5KIL(DJ4Zy;A$9|Q;Kf-1r&?hUlC~QiVG(94>&Z2DRS*k(ahZ7 zPuDzD;7XQtBoGFk8VG}tD<#2>O#_895^vqAG_1P=bt-A>-d)~Zt?`B$PoVO3)O{&f z3HC>IY%-D!!)Ply_$gNT!hAdBLbV*q7XYbriNQYOlT#0YWS1XvC>#5sK_}FLVO|pI z9wQ!9Q(13h{K-GQ9gZ|MUBCg^&jPD;Qe5|<_tl?#nU!8(YOhiCWLM46#E*_#G1`^>RIW9pnz0aV1!w(Fyi z)8b`qd5cdVJShmt9t2^U%1e^eaFhio z4AmLHbT+<j};tz1%u@9E;FYJV{Xc^KSr8y>2*vx`ZwksrO zY7g5!8A^(+ls8aiMBi%y1@F>3;iuH*wsfbek5cR=FtpQ3wZJoMB$46)P`r1;UH25NWP->F$z$oNK&#x;R$bMQ=s)qe+$B5af+9$Awon=MrrlWp_bS#Fh!hj zE8J1ryKP5~qTU7`iN-WTw0;^y)Xb3+-04SD%h@E{aRF)E1tT!|+enhIIuWSpQ+q;T z8k3x*P8Ls6`z|z*ZxW$l@q@r0SKKf*br41%QUf1xMP{{XT%r0LX=f7=GB zC^y*08Ut}jv~&X|IB}VZ@(aR|!_^sNRM=Za$1)TT#6T#Htx@WfdK=ABOvkjzI0AXC z3%<}dP+)g~xHdsLk~OvAD0Q=&kFe>yC>KgtVc8a5M z5@B+Hu2J-?r3rs3L!cX7wO_pkkkm+}NtEl;#tkQR81m(XBqgx^*Waqe_NPc9ZYZofEZN;jqe%i z%~I$yDs%0mr6Z|PjyRo8inznPIb#;3Gi!B*%8tvKDP70-vG{ny4kM|ObA*^iPYXKi z+}c*)P{`Oy2_Oy0xf}E*8Il}B?fj&q4W;Hj4G;C98bw%>sZLX>3M4Twd_Jzy$6=qXY8GH*@{qe?v#fmEweajAfS^ofRa)QXy+Fn*pp-n@wC{jwEZMA}orpi#( z*E)H^;*K*(JUOJ$WmXwyGrYU!&Q7-1Kw;Gpw<3FCiKgc1^3F7FlG1JRhhl^_baQJ8 z5;B}^mNTqNq;Je8@POlDPC|VFw4k5@01$^0szyf~Y0KOIBdG<3}~}^Bf)_ z8agND=cv3f2}H!nF07JsDNecSMacp<1C>dsGgoD~nRRDr#Dyg7q4GON09)aS*3&o| zC%(4Ifbs^$6o7EtFfcij@(tA+TQ4UwYe`Cyb|C0Pa0Im@hIE=E2$q$X4Kjdopea@t zH`3(wj@imK*MVgZx}2xR=lI7gG?DKQ_IG9K)k-7g&E|yf5 z8wEVW-PgJ-LVP+HxW&kUGL36eZd9h8Lut^u;rXb=$}3s9ErNuCZlV;k>!b{6vC-k; z5lC@KcwGt>^gb}gL@|?bY~=;%*OXd9xm^`w5!xFH&L43~<+j??M)pZJgisqaY6+@M zJekE7TWy7|=PoP3oy;);|`N_7Pk#D?2919e+-3^!wK*ru4HrfykDaOF@JNrZ_T8e=IdBG*thxQ+@I zD4#M&DYo&$hb6X+K~^R@bk8c!(N0Hb?HtTdWZ(MPwo27&1p-IqXzdF~L*Nz=Dk*nn zl5eksDTd;VeO=jIr%vb%88iDVIpFZ2$z@;5GQi4x~01d1`(8 zD|i^DO#TMprA@r0G|DDsZjgr8e4vxLwate6MQ0Hz5<8r2;+u3@EY=^Fae-0POl3`q zyc=mbbp-V`_{CC-yXY+scV+LSFxCuZ*AN#sHsXtHxJ!N1?{k!&5-dETEb{4=-NjM0 z#cG8{rA`T&<+h-(vf3A|uVjSi3XRS79~ha#=W=_E$qGtd4s24}m0YuqB`ZsuwW&x_ z+(Eb{M^Ub}+T9~ph1x@FVNroG1m!_bvpXha)P;Rm&7CVxh*nhV)B%yDe5Za?;wUlW-W z`eEeAW&uemNn5(w>H_5>%H|+Sc2A5bvCJcfnluR(9YR)xG?XbS7a2&_5O#|3k-?Pa zCu@$&G#g7(e5O(fvQh=k=Ue&1Ol^tI5M#-V2F(1r+bT@Tjk;T1_SZ;mO3qy!ek5U( zVzzlMja1fgzLpt;HOTFc{{RDV<|=SfBiRJf)Vh#yQ%tFs%AV#DIgOEY_l>TU?Qzpsua0*fd#=TU z#Gfx(I@FwNi@0knnH)n-dlu4WoBF5akP$Y@0Pi;AX--v<{{STc(|CG0qm#?y`94yg?-#VB}OX0e6jn@XQ;nC2}h->T>R z2TzGJ^-KdWl)oo4FO&p_SWhvl4Yvum$}1di`IorzCbr!idVVZ_6=g)gVreH}=hZLp zP45wMY)p@kvcp_HPBD2>((Jm;wR1ALjUhdCAd*Pf8$&8}$a-0PHEsUnk)+ThC*{Qo zpD&(Gq~&q&Zh*e20_N)R8d?~)dwP)NmBaDP@6tX(f{VgBdqX1|o8DN9KyBT=Z|^V;GW$Cq5U{YxlCt+)Bt=vC~- zKAx#lSf;+p9c6^sv&<<_9$+W)CMT$GV*EzcF|(biPRQ!ol!Pbjg`K`ox=d-wqQ<){ zaFo^L*{#&n6o;-`ms_qQxv*Iya(4r3b&5VWiBOi6UbXr%R3y^9@8N%#`pouS;rr8W zIrMW$ean^Pop}enxd1Oq`C1aatth0eQvU!ce#LyaXE$!`{{WNx&IG4rtPzH15bTW| zhY8TB%8Q2~zTpbY6n$+9m$qd!yZW!u4Xz5m{g?ZXB6u%OlWF$koo-n(NeOo%g~%HV z-%EInVV{2UU+W{DACvTF0)@gU3OtO}B`FU}zN2-nWRs}Y$v3vWFA0~lE#BU!d%@+; z(UI>3_9>LXm4@pQbqSVTY0|u@2q8)8pL3dgFroAio1%jQY`ToP-#4ZBS zIGr+=s|-v{wv>Pw&Ra%rzuZ{4ghSeXA0+;Ro)z_9QL4lpf$&vSB+E%XE_(OeSU)#^ zD4M;iF3-^kSp3)D$mil7z_>nQMQln+zb`aX+CO+VFqfe}5yc54!ps_kX$Pie^oXN<}Bl zx4+bf7qy|;jJP+{)NlKp*qz+K)hYK)?lL|vZ$4agdtV=C_wpO?nSx*YpV*2_2iG-A zagnO8FzNvwWVCGu_P#&1hWrV3B{mi8p5-22lJiuFhMWTBQx2hD1*Ip`&v>k#v?C{a zz8j&>4X%&S*jETE*befvTT8a9k;$7(!$bOyG!Mf602ppuRA;+s`hMc0jrR3SMoI8j z5Kc{VDl$~+fw?@+dZixt@=`_r00>LsVbRx?&-FW^Uv|GiPgBAek%Sg$>7J4(IyRux z^t!yWxs_mi3^n3Mtv{U(X>Z8m4iVO-P+y**vg653{iaf7a?YE7iwMY1mF*nyW6{5w zU$`Xt*US1Gi8k>YOXRfOM5As*+=?DZ^5-F0t>gn?g ztOI3AK2>0M`j?TH@q{falN9CNzWoi4Z?Dx>RXHNL#O=$QkyN9D#?MRVxjr_I%26DS z+?{;?0CQ;=qH0*Bw`jFlW|FN#Ku))&#U;*LgWxGZK7I`hJa$O+wKO+fX)g?zuwXvi?I?^BY1I)8>NRSk2-+ty3`0N7YQWg zxZGTAcyS@QZat=~hmml!k>Uu2=^L@N!8oE&*J>#f4H8t>cRFqkU9ElLG!?5!^~XhlEGoh35~ zm<{w3Qb}8O{{WKB8{5v&5wd!U>0c>V(TKc6+=V@Dp_H(fO7!+xf{>y|P}6`9h2yaX z+voLPu&0@wo1O`7Xw8{&2mFLcHtIb&t*Z9(jwa4&USBCt6LjfX6uXZ|auD)RqB%2b zLcgrTqTc{aE;6x+tLOD!suNgo$=cgL@v}~r*J4uqh;f2HPIEEUNBzK*Zs<@83mYmCLZ*PQ3jz-GNk*E8w*^PG;`%zEuV5U}$S(={0>_WgI;^8;E07hOU)KNvPO$I=*N=d(o-q5tfv}AgM>8-NVvJWga z($%>gxVAz*9pWeDTly)<6+1466o-k_YNM$Zx@~>I^Nln&Dr7a>MIw)j zrKwUOgd@GmQ_k|*PcZ~{oFP^k`P|qrbi4g;i+{g%YEAlcn|huI~_`ex}@otqL%TVSmmKz_HLxQl@69k2H^BC!yQJJ8pX0yW~Jrn!AloP0#|-& zHMk^dY(63*&Ns|{GNM{d;(Bf+q-CkNT2M(zAa8D<-9IRWqMpQ^L~g_La_!d~a$Z%r z*>xc;g{8|Wy>(DWQQ{ATOiN*gM!qrd>1|b}7M8N5N+l@(*(0DicDULfiy4w0&KP1G zIOMdg5j3Y;nkLJ2-ttzn?<^|%4*_8emyNzBrS+$db-^RW0sYI=7aruGv&I^kEf32Lnt zunBCSzb@iZLWuW(H`wcIi0hU7eGb(Rj~XzI10G89@dBmLzvxsPAf($}K~4VvbUlh~ zI~km8i(|5-9-A>LkJx!*^Ew9qD%EGX$0<9Z<}p;8vB5d@l{5e8y^5i;TZhRJ83fS*f|1N6_2S zi&KhOP_|H%BqcwIK^m;k>UFC7Pg1Iw{p=zO_{6j#l1U#%#t4Z%m^ppduy3+P-5gQ0d~l zF^0H*UaH7XEl$f!JXn`fo4brlzJ#q)1tbrxZs|%g-(183EeUVA+8ewnLak9H)iX?* znM2_-1rov11FT9S^N*CS!zQDa-@K!nx?8}S0O-r`-{DvW5+-D0)c{y_h7c?hZ zGa%UM^c?`*s_$`jfY!mc7|Ms5(kDH zSD2IjOD?R-lJe<8#WM;|)wtZlDMD;+bqf|yHq%{VETTOYO8y?=2BzgHc0JdoXIe?| zQaOkH6KJlKT4bx|@-ogJTO~tOAQDB`ZJ!T@sU}x3=-gFTX)4k=KZvFqeL6TBj>?o_irHNz2S>#{ei^ z#b^THrCM!h4m2~9_+c11qM3rKON-HmQdIRVVMKszfTyL_dg+qzsI5X-9xgEnq%Eq_qJcEG>{5s2%KMfn`n^`9*z^S0YGJw+b~3zp$1hhWv5LLJDuq=HN-A2^?DI1Zq$w*8I`R6ufNf-?U02xJ*M>D$#CuJg^l<|a z@cvnxEiU7)lH-2I&H$~nAcdhJ%=!R9NfsGU00&q@ik|H1{3NHqJ+r9Q>7S!3&90eH zNeNQ2{Ysa$!qQb>PS^RvQo*(ULTjNenWRh4HkGt_iC29tB!Ul}{{VbN&<2`Wd8fH= zoXH}{Kab8i%b12_s8USH2FthwAxTgM#OzJ>v?_#yOr&x_Y$?P9j_#lvA5AocMI2{I zwp_n0!*q{zU&hd+aP1`uc@_#c8XJBP>fCLd(frX_mQ;Fcv?V$^Y^rGkV`J$G)Q(Z8 z^vj7+Pj!`T}1~!8Scch8DLtV-jd)uP0Nf_vSfj-R5$O>9-V35%0%UlZN6+Fjbp_)5B`(?+ zmuk5$-)?DTXwFf40H&N$bEJ(`Yn$J@75MQLd%L&qZa`LY;CJ>`i z9(h%1d34H7Hj*7>U?-HN=v8gD&@3B-_hO;td(-99a>hy3KD~R5Sgs=;zQYnT-$zZR zW#c_JBGas;Xi99H%TT)9DzOV#I%x^Vk;a>=r^`}ZH|O8Dxnrx^*Jn+V&jWD&Lj=iv z6-`psrvY)-*05bsQMqua0d-uPSZNlDJ|oc$+>&kGQvLfC6U#5-mniI&5sww&6>!c{ zp-H2msTt{q3({{X@PMV4662ZOQMf|%%#?sh%mBWzBOebuld0a+tu=JK{uT2bpAj84 zy57xoGvHNI@hs%)xPi$h>c~TjT%5XGa#mf30#M>qvOch?*E*4XK#O?c@Y{XcYwZ>D z$*m>Z)N(j`!weUM)S22;oP@l}h0yqDDa7CIscFm%PFY*)`u=1`6o!L|oJqnnb8bsi zs#Ql2RGyB1K^CE6w6+%|2O3lx|wjDbHkiZnmV9+g#x)1Pkew-msquAzJoiT*TO` z5Ah-z zszpKPW>qSH;$2tPJ1zj#N^@kS^-c91A~MA%)0-dh66?s}@g8b{jwPk149lvb$jX_S z`K6?#Z?;wSEE|l=K{v83VhGmJGl#_Cw^Al-nz#IjMO)%*?-GO4bjcRiPL@j7ESF_D z>1_x(bGVYMfTs2tQlNohZQ}D59Ul^|bJRn+_6!x8f?cWe66>y~n1ax0B^Lo)pb`;r zai`%HD1yv*?w>p=u2SWKB^Y3YA*MT_NgF7U?C|Vvo@6}lELm%B zFT4(;y=#Hj&uCvU1fZVarYYj+rzS>;I*M~-IN#NTmjbMFT}lbnAXw=Lc~p6`stu24 z7x)8?F*@X1rch^_ET}0u%8tpz8fSLWzNpH$AeYrx$2E9F;AJ4aSkj#!pc+#T05w4t5Pg% z4X+ivUR5aUpQrOB;DtVd>x&-W>~nJxiY9Yn z!?DWOQMU^-(-G|!T3;(o#f|%>$6pH{!X`sIBTEu9RAspjxTLD+U)eh+_HC#>JA)ED zVW)`G_GQ#Aw$_w{1cRK}Aw$4#>kCARvZJ0GLPrbn7FxFRsOGwcQpqK6Hn5bbM#&{06=er?TEoU1l=O*E zY*VX*)fxF`CMKMhc1>tG`EDqZox+e)vD(`hM~ZjD2+G`QOWIi_#ODdPx{wewAy)4P z2bi((j`)If3bv{Vr2y_!r!oh0fnrBcJjVWU-w`0uVqY0GPR1>z6OydBl$({UzVI86 zjJH?rF~^+>SeX9sBZatnh=Es@m6l0;ARxAcf>55TxV`Vt`tJ=-iLuCGB}ej#U6GV1 zY12Xe$d2?A3Y*zmODA*ZEB_Tuvld-?0 zD`iF*PmwXg}O~}xlu4A4xhKe={!0Q~; z0(z%~q^khuZ6QZ>BFR_GLK;jH7;Y_a9qeIBG8Ff~KGiERXa4}iI+qGUk~)E5alcsN z{4Zf#!qlk~RA*m)YFX5wYf`hLD~YlFl2!Ob32g44-@um^j&Ba?jMN1~l5U*ZXhHWp z4U9L9^Bj^J%q>!CnB=ZlPlA*TGzUTS6q|@m91SRQZyf`9A^$n$`iI* zY4P!n#2EzfwiTyh*&I~N@|;4Ot;;Qf*ack0GLdT@gkJtpJ}*r*+xHkIMh)SuI-cDz ziFXcZK--p9t~dzLmD=P2bR8kOu(RE#xJJhjXX)uHaSvQ3=vhcD-s=hjeIQRy%mn`c z60j7e9H-UQET;vj52Ux8mc^1a3Gp`GIi{K0vu}Z_3Xq^5`EmaMKtmZh{MhVAu8%M| zsspI}j75m!6iS7NvqnL@vnoG%N&Ga2;3bfizAp|2(5v+Z*h{aP{NqTt1O*V13iSkl zHny>1*C0y9M}!=3uHzczA-UICeo~<_QsYWtHYp&RceS@oZwQ*%`4S@p$#dG(Y;ew= zX6e-WZ*?H44#_mMk=IKNVl*c1i7yhXAngki{{VbiO?8?2WhDw?mL}z$mXbqGAz{D) z3L1h3gh@`BA5E5tgj$z&MxQd4n-04y$>szAvv$Sqt>V67Sl|TO7&;sxIY1aSXebVC zZ6VoL+v=v5ZFU{2?rB^X7;cdX%oz+;6-*JACGYU<+>>^@9 zp-+*+^DfE^VTwzPtw>efLWR@5=++y2Ojl2*^CicEoRzM=V~2w{aaZCTp`N7T`mtpS zQV+BtvU4YWGKJX4h3{d{3?bS03|zuE2X8DeJYG$o~Z0@S8n z)C4GQoS?fD%RCxGiM~v#C-s0T1dHk8;2}s$AKGPkHMw-mB@Q4dAb_;x zHuTmdEyfwjdU;E|g`r6ZY&{0DnQDVA8eXd{0L1H=pW+;{q}+xN$OGn#|9fGg)`pSPRw-w7Pl%<~*Csnn6nn=5e_ z2Fi31ai}{%;T&=~jnEsRt!>)M2|0!D3Q?i9$q~XS!tD}X{{XH($}qhmH4X@R4JT}A zxTiLj)hHFRoLBj6HTQ@ye$c%wrvT9-q_#a9H6tafvK{rRYclbPdk=V%*rza zj)3oP5gh^OsNtRAyjl=@n>pGHHTc~IXD!%+bd{N&HOYLfbCd>saCNM z7=~JKG`dm!B-^UVFr@X!5>=FXi^EcOITb>S4^ioSI+JypGcL?cEhITMQWWx(MTrYJ zPsGG#$I%)oSe@=4&8z7pJuFhIw?8fpZBM&2-s?!(=>&lYdx}Kd!hN7btg}k14r?)BE%oGRAd z_EYkNT?!Z35Re041oQw{e50Uuu&Pt-VMGks2nVkB-UI`X>~(>N2;dpeAOkLNbhHOV z1`)2BrBk$49igBg)*60Zie!diKkJS1gE%9 z-M`-J;pY*aM4b|r7S^G1^Lb24gCWfr?PzdhIc!8Iig72aGIVWR zaON8&Ad~zd4O!g|LOyGY6*;wX<(^w@4S*yc&IJL*i69%tHKu#*Ot=@~34=mAp%PcJ z#{%(pAEqWJQsM-HLfUodhYgga4N`zJ5_Y*GEG5L}hkS;=jvOYdaK5N1)nu9`+xzY zMv&V(D6BTn?t^%2O&U`Zue_3XNzwzfawQPmIVHykNIgt(ouN;KB-_W6Xp)pSTDqME z@x!_q)5QEiYlo(CfQcD%GL@7Wr6)6hgZ53uzERO@6A^N4E~1;2T~>vmHAgz7E$t00 zrRr^@Eek_KL#eKs;blg^sykK#=Rumfl9dtx>NkY6C69(mc%)1=+W@$x^>M%o?{TO$ z)8PQw9&r6Fx26=aaD)wQz2OXTlDmOe?Yt1N# zWy-@COBv3J##uLCDF78D3-!8zPN&ZMMqf0fw!fDl)QxKXF_M*hH!7xGT&ru!%RuBo zR)AW-dfFiFD2WG!#~x0KgY#35I@^J7%e1nTr6AtT0yG0n2?xR~F=o?Cr+%We*!l4f ziU@91Yo`a$W!nV^bt=rIr|%Tr;PvYo{u*O?EsZMsTuM$#5cWo9vRLJ5Ywvh~oBkw4 zn#hqO-Pn~Ks$6bVA*p8{cnfo$Y@rJC$`n-xj5xSpX;K*1jE=U2zPfaihgVw)Wft%k zC1m^nie4|;(8Rf>`y%It_H3onz9a2K?4?AZwCgpQS(?8*W%k1GamL9Tr7Ox(e8y1 ziz$mRO*t zQo^LaR4K4ixW@s=%E{H+XBA00r8M@WPqMN0Lgo~P+)kQiAm6My^TQ{Xub_pFP~_>Z z)RSG$U?(U%N~k|4hvy8O(+eT`bwQwshE@)t76m0gu(gP9E*7`w`8LTo_~l=TTU_*y zJzEcsAITbbwW3u^NpfanCBovhv9gkrVbfheh!eQFb@d;|m&W{5-$b^r%*%r(sW?@H zskbG-G%Vr_TBHqaHBhOVsoSXw@2e97=9joevh) z2+*XU1%u&hgBH9ro%wqHWlmfv^IP}X5&r;)9C_j-w6apPQDn=2EH5nC%%3kWU1H8I zFTc=XVbi*=nB(B?EO7#ASQo_&<=A(SW`NXba6z$zIWCv;99%ko#q<``UMJ&KK9p2s zDNoBOKoKtMsc>BG1EVQET0&&gM?KyvlW1_bmxSJ}(x#H8R^KtDSqkN-17l%ilm7i; zGsP(G(_WvWCSlJO=`{U+R8cId#XPOItQ6XmlYb)?T**m`Y!Sk`pBi2=^tO;tpVB(A z5|pR&C&I!Q%b8;5=nrz<_<4lqFeM&ZoZ{5;j5ZOUmXa(q01J%=PO*~Dk>qWp)%hp- zjwct_>euLT8O8`=s^pX4mn@vNmA?Ke1pfdCircOK0O6>8$8Epi!rAr;`^ast>q{Tq z4L_Iqrx(xtV{$>_K@K*@{Lom0r`<>WRw7aC<^Hl0OskgTnUgDg$3VlP-nwdiArq2c z;r{?uL)HFw`pDO2pn$RpB|qky!~GjUt$&m0CHe|*f8~0|_cteI*a^N_T;3OPKaHSy z7x_Q#zhNKPu7JNzSyFT>T3X!!aeK`k_iq=WTVKjYW?#5kpWzt&?- zSAX?TV`QilsN3~si2UHcH}aT$?-Qt?r$=|5eI`@kk0GubyE^6aQ{U&H-IF<&3`j%U-Tbdi=_C-tS= z7yKa)C;7kXv#T9{i~VF}n43hryN+d*QA$Yzl;9c;x)bscolE?W^=11Vrr-CyP?N&= zv+0R`W1hm4+>D_w4ZL%teo@CYb@+aIzhQENU*h@;8F|@Rv6LcK`#UUVWG#`cG%L*CF9vr7XiD$}NMs${3+S;uepNuFv z4s{Zq%mrUbe z3zW)DH0whD0OHoH*7CG5Uubd5;QlG0jN-CWH#sPUs#R)3iZ-2=TSrlAEyl*aL}_un zFB|8~OqJK~euJ${qpne;xY?X!01xvSv^vlH({Vvxge4rD*O$$2>TBZ+NR>#u>eDSW z(@m1UYnD?_fI6jMSf5B-VBhp2CAfWs8h!nHpFxksFu83H$*teXS}j5-zqDH6AAV#hfy!@*>I( zJjlhyCA7Mu?y{n!C;*aoHu39tkcJs2aK;6zVq~U%Un?@mLwTK2fGf(8qCmMmcd&@L zGbr;Pgc~f{SP5!NEFDVPNhj248LX_j#)O~p!M7Cbqf1w{GT(VSX_vdNQ3MwzDom=p zNk_z0IoY@AarTc{5y3bv-;TwkxsH8|R&Q%!C$xLq^2?!3ga&lNbk=3B~AfQs1g!rYYs*00pH>9h|=78I}NQ) zQJx}9DpF3Sme7(_lm%qD+->;_dB;+qZp<7w;na+UO~uYsRJSG4R?1je1=S>6B=6~HFK%3oOL1(KxXwSg%*+qygoj_`+oy*y?1O!ffJ-)YCH)Z%V37U!+SZQdWbw3JUyfc&f{#CYLg7F2_t_ zhHy;uY^=J2>MUZtrcGOmye%y&SW*((3^Ln`0`mRc`svryLRh3U zTmZa4L%)6CJxTe)KO;I8+bH)RaHS2{eVYqw*7v+g#WfX7W@^N52DslXAvBtGMNGIt zNK#dD5PVxv(=Xmn$`;it>0&wU)R(x*y(v3~#M+ujN*qWb2>_5yfk&v?8r7&$jWRsr z=?oc!Wmhp!mYq^pmp*3Fti@Y&*VM(Q50g`^_911BE`&Ma#YYXzND0g`x#?xLu!mV# z$kM^sfCs!f`9-8i5;Sm*Jrn$gT4gL$8Aeo0vf7*G+hFNViaJ=6ym5ji)XpQ5;}#G+ z!b|CQmgqk67q?sKeY~ND^p3?@T{76FyTeM;NOnj}B27w5Zzne}C0#;-hP_6b7+aCl ziKQXhjz*;^%AJ0og_~zft~vaY~zKW|Iw8EDyzy)Rx1cYNDkB4WQ&1d<83&}HvMD-@6*=tLl;WR zRz!?P!+KX2@ezFsN+wZGnwa)+bfv{K6qYhAD!5QsB#o?*zR_ccGscM1hNCYOurjLj znlspva%Wm=P0Y_U$`(*&EVhfF}qd1!Aim}n_SKuzritMwIBJ={#<#HSG?*sIiO#pZ;&9@gxl%7ZQ~L@*vUN=u0dIon-` zBwFy(V$vmF1S->YiWMc>DD&S_jjF&m%;%i^zz209H`HFlTG3mP?o5K%)8dz~RB%k; zkw8jJ^9?$T*9u#6g(_G*QoH5{!Wg~B2kKgbGlgfZD6U#tH)V&{WP*1R^HwES{{RB& zKphN6c?VQZJ}IfUJx`pInP|&RmLES_j$6t}LAgS2mBjVTlk$Y?6{JFN6(33AihP5v zrP)XgY(HX*!D?PNP`j zg+GzUEA=c5j6{j)hf+1>)6n-#iqsT87>3n9m+CL4&-4j)x^wEk)k=q3P3$fT z6iL_5%tL&=KVg5kN=+%WN~x03C{)7Owtt*me9))yUwNROD~f{)PVUrhz% zGTVVGn38n`$!D{7iLoTNrt5CR7?T+cwPabu96O^v>yEcC^c`Wa3R5&x?33jyxD3n^ zELCi|R*jEc;p-ZssXttIg%fSFR*_V-JhrYwji|jSL&YmsDrkg*sQnoODbPbw#e1Pj zR6BTU70Y6G!}R&ImlKsu%Q%n$K^a$N0!_6iFa!(O_{3>r)6iO#ii*7xJqWFYWvEG_ zX_tLqey7QXNoxwrt>SX@Ih zdyXS8r@2gVme{BwT4boHQd!clt%{OK7YbJPw~&T;4x?tTL``+|sT{9tP2O$7vJ#5~ zrAgYr5x6(;=?(K0$Z0XZ3KKZX;7jG1a#7HQElMc5woS;f0O}2mx<^ye{s7gD?+*Bz zh&wf|QMJ0csyJFxH7*boS_j`KQ3Tv?Yk~8Jnptn78fuB}!!FbKe~YsYOCf5PS{$<> z{HW%n9_o;DYERwVdBkbrapoq86*nj)`_1Wp4MF}N2x+PiYBKtjnI$$z8{YTy{t%Oa z{k>1>gKb9soncyzQJz|?B^)ieV5I;-*ccS(RHZi-1l)`IS`ncOQZu5SiCY8>M^6#!;|)AWb!1{g z7I3bcjLKIq-IOxig%Oz`-y*;w>Atq{h#7b&&vmozzaoAfHdyxNG)_IMkVOQ(jH$Oe0*+X3nDbS~?cATQ|4xH@TB`4+O)hlVqlr)64g%NCl(yIcq zrNxv6wubx)7P1XzXu8~o6{ylv@>LmsYLJ&uRFakoc}oMh$p96s0pBD7d~}C#$4SXM zBL)QGbJ#Y1S;}i+gu2((rPPI?YCz0LDheZ@1ORWOE?D&~!ZV@I$9!w5S0@otTWROW z^3Fs!gU@Bo>YHo?jdGF*0H_nS#5D{FbLuWxdvqr!1UQXX#7{TuIBI@EOrWLLXOgzt zOGy_Y8Ihf9`?doywaAF?hSBHs731nU97N+t;cae8ob5rcqo>l6r-BojTpcXpNwEiT zNd~}zI>#Zy+Su%~cSJl6G*~DXwa~WGw5Tg^6f8VqR59&C zFCo#xxRJbI^xhVinO`coPjobw)`v{H?IgaHhZCyMOL1Mfo<;+aEsZMQ3Mq-4G z1?>w^t@?>_y^ZeB98{ddGE%gM9APqwP?^Ze(onR7gtiKXw?alho`&amPCRNmij?ec zu+J1)!IWv4dO&nfKI?wVYx5XTxp1b$hZ3=5l#%CXcDEa_xPP>kC&o<8NYvX!RfoU} zW!8ptEwp7rs8SLXg&+ZP2+eCM@auFYg!Km$mSzyC){)$~N|dsK02Z-P7q^+YxQ?bF zp~>Lq2kG2(#SFk+rk|H?T3!5`#sF zsR}&%YFD*R`%^g-3KGf^f=IW#l1viKXI3$?RveXK!tB0jS%eIzc}}RM9vOyHboAEZ z(1pc6zvwT(M(rkwr)CiI-p*Y@d(#q+C?RQ2*?FK6n|az5?=~mF6Vi0IiFfZ5l(ejiq$;y4ndP#~VD>%8s`v(;@rAOG6JW^BmDf zMYpQb%_V6|b0;t*NWJoP1tQ|`l{30Vn;Ld?XN<1ZX5D?MCgznb?CQQ{CC1Q0xtqF1 zW8E9v^|VXJ#yD4y#IV@=;VId?FC{N0&U$b#!$@!zxoT3H00pGn>!zai^N8;?yIh|^ z#R@u-_}*(0&3C2d8O{`v^3s$iO-Lm>pIGGbb+AyO!k3tvk-JDj))b3}1A{3COKL5D zC_>1?ND{BTMj>vgYPtKvFg^fje}o<*U(_6IRn)6fZny0WJKRNyy@?>3TW>vKPb+G~ zXh_7~C7wo(0&nMU!qA@@NbZDhvx!v63R`6dTamFoK3-xum=nC8rwp8 z!lT49j~UeA%TF{Pn00PGmtJv5Id%tR>CkKsSeL>#yLR_|26HZhnKe8T0Oh!=_#*!R zJw#h;@_vLmG}%xmMxIZqKp*Epe-o5$8Ra8poIbW6z7W`?gEKzkpV1NOp&Zxc^*cs6 zx-`8^UFL<(ZoA*?1t9ck_MRFZezGDqL zg{l;6S44gJSJN*mOrB}y%WCB%YjG+_E86NCUe~dS5Oo^!{l;ax9AQvO7nvj!XV%_g z8(?&ss|5`;F~B;KtL6*!fDOFyzz($YMqLB|BRGbOO3H)L{{Y<%#7u~%feedv%Hk)b z%)(u*u!g`S1g%p0sE(Gn>**4u$$j-29ZX49rp;C*mnkNurer2sl~Tj1wngh;or*>J z*uoeg!|e}Jnx^|S)RGkJ%NB4npLuD$lm>^!J5~b&#LQHx?>WGgBu&s~i9tH0NdnJCdtt5HEeBoIZ34_5YpUcu+!>d zVJT^kXD#OLkz}hnwbJ_h;fcMu6JWO|w`-asIEIq89hhoZ7Vpe<`936V>k(o6M45jH zU;H=138Tu^vQ#Pae99xuhUJ|raAa0sqLPu_@i*SlF}r^<31wInpZKDdd?gtF0G(nX z&zl)zjv;|YP#^%|Rxkmwv@iM6LT~kbz;y6Bbn=HIGP5Q+WOw5Hy+Is8!wN-~=h4$)^;*Ly zSj=|QTU&2fmltq<75b4RxAi7A0w2wt{{WK8h@#k|dIN?C5E)Ql18Ex{Na@is))AAe z5+-F&)h_8$i6Ec6opglI;%7#C2gw$S(uJi!5)Nex9~)j37@TaYTnC7%bNJwjjLWVi zDVk|kN^^43Zjc3lBnw-tUt^6Trz6~cu{4eso+#l8LviM-(hutQ1k>VA5_bWo!Z`)g&lKyeDuNL8#v6m(*7hXEL` zyeFwEGV=*N+Y_A!$lQge$wB}dj8DQDi8Z%1Q<7?R#`k?qt)r(?%OHGUIb^8emuJdp zZHlDJL!7al2uj^4PloE(;v=GYovckGntkJah!*%lk`maQEd(fnO`xDWlp(`(s`~2% z9I^Jm1D7PP+fjuibqbzkj4F;;%Jz|Smxo+mRGmIhBzDF_fQ<*Ka*dO!m{;$G>9e*} zmN4RuBc;_Q<)!LRp|+oKDH*R|6m7gujuk{nWp~Wu{{VgLRITcBA2IwPUJ~qs#C^=a z-&Yem?^Py#WB5mW71-y9`7$D zAI=Q9{{Rs%Pu_F<;~k@ej+ZWDv~tE*jTJP~M62#4YDyHf5QOGd*3fl?$sI#D<|_`R zxtVq!aR*g3%d*JuvDm^W?TX1m1T6P~l(+v{dJkgoO(wMBG{v zLX#VAC-!Kj$T)0D)wPe5a9SFK`jkR45j;do`Sbtj{Zl0pybBUmg3 z?w`Sbp{prHM2Utb)TFk^N}Fw^6LDqVGQ2g8*}}p&eZg9P4wAQ}l2YM89{R`tjjW{+ z_(y2%jg}9WX^C9R12J*kPwkjtjv-K9mmO0HI&CvF(|c(N6o9O`Ht}gvZ6(l1&Pwv- zPly>#W96r;B<+i7bSQN0_`r}@jK)~@V~0}`PYD+$WuJWvxbsTYoaWhbaCdz(UKB+=Cdh~noMo2K&8v-Mji&FC~N_!)XDQ>c)0-%ykyLoDF7Vw&iR>)F= zY^Tgxq&ZfcaXnvh-`X*E7qMK{;zE9~?5A?}ymrGvXB;KTy?2g^qp3@l5`>jllN>oh z%9~#HD}ijP1Q2Zsv9_$e{>AfBlNb_76!ie4W)I~zA={Fxi=E;uvQs52c8oowq-b{Qf^Jff^^>S+?AZG z7E`n=Cna5I%_^lYKvQQiLQv$+a1FF82?Jm={~!{8am=dI>sMF`XY93{XCfe0D)KKUY-2W zvn7Y|+{zeJxQV1Tw3JLNjoKhy)mZ!2@N_EJ#b67Z&p;ht`t*>bBjR$m^`Pj9IZFRcqxAY)?YK$?9 zYVz$?s?`Y@_F6o&rG~?E4IxJ3n%Yn;`r42VmocUGXAuYZRi@WgnMucBlDE-$G7_aF zNxF`nv7;#&%b1#4PFB*To`E2r$`mxmGX!u`6Y&*5N=Q49{k5S*Aw`~RG-i9 z^Cd@bFQ4AQCns5^AiXm%-zioOm07ZF?yFN^;(CBZ#3P@b{raJ4c3i%HXh~u|7t?W^ z(%z{s#L6a^OK!RoWvwIhZnokGAg21*>Am6QmQZ!~@%_#ut8Kpde#2XaFt#<|vkyN? zs zexEe*WN{3M!;=e7aL%Y1SCV(+%vmW_zS2lZ5T}n<@Y7w!)yMd)zTbSuo}t5v2N>kg zm(?jhE`ek&Sz%!#?3AswXh!2$nTHgi*U*iVi1L3i2a7msUZyt0qB(V{So*ax^0_lD zC+w*%B`W4yViZ9;-Xyqu#pBNx{!8oF=-@sZs+8ND^gSdBj#Q~3zz0AVeRS~x8Pit{cOvxFH;qVY+w*C|Sh zR4@3&HxIxPfv ziJSiDTAX{Y^~5+oKlKDX9;}I}$%a((N5A!8PNb^eum#8C3cKH@PsO*dQEgKH0PRIf zvoFb@fEeU$#?LT}0c0I1L}kNcoZgAIVBwAK28+llY0VbN<1v2F@M^0 zf1?FQvihC;ORMyWmR??6Bf1#)KI(sT8dL55w2{W&pZciiORibH706Hh4Xl1?g{2kS z{dP4g^Zx)b*>2_N`k%Zgx{{U4ptuHV2nZlfEWz}2j#lPjv1b>|z z-_QL-IGXbR09~CKKv_kfO4sJ8KtBYSFYiMA#J%}f`sR&Fm?nm1nnn5r%P4+Oe81c@ zbxOIv_edn8sgNlX31tBE$8Xv~}K0yp=D%r3bo?f7a19CD)s(^XO2GpZ zAMnQ-=*;3bMA?3kIOA=$rYFKu)zB<5znfnU@)H)3mZfWu#4Oq8BP z&D4idLYq)1u(HQ=?a;#PQ&xlUlNE{FKEg@LY_t=hu}X-)?~b7_b8`nh^ksCVP8Sqq zm)M z=vhi;P}IX&P%qt4H&E&L!;!i!1NXUOx_vKb zTEdYEd~ zG|;OYSy@v!gcGeD(!iL8ZQI$6|q6c{f$4lH=AIFzS+@WN0;?HMUP9YHcHkFzik`z$8ZF?T? zs0Jou<8*V}k3Jtzso?rkL`(EK;0aP}rW|cX%1IU>AmzQf?*?p&e~EP$jv97ksK>Q= zObtf%x9;O;LK47i_uMwH02>SV>SDRaTP7!@~9v(=l$;@WBC5IC|j^y8Q ztcAe$F|sYF1QBnHPmbt{$WO*>G~EKXI?H1!Qu^!#^cOKZ8l*8NxY<#ZQ!?5~x=Mw` z{NYlFl*_5(z8pno0@2@OSg^<-Ywm%l{qa!ADUj0v@ZP5|pQWYL^C*`gO}dmQ*+X00 z>0#rqq&Fu*(j`{{sB$w?iUm|krc%R*1KlCSEm?=C(h*d4&VC`owD~`0nU;`!f|pXI6*cnL98M$r`%F`QeWsFNqT)Oge zP~ZuXNcvP_8M!AO18>dAUE7_TE#}_>*5ZP$3TaBhj>PJ1YwEt z;0c|YoJ*yv_mJ2k=Er?5bP*FItdov3Ex5}=7-iNcnPPYN{SZJybGsd zgmb4Bhn-46AxJHqMf53Fqov4*k273}QO20MlEPFv6KP6i+GkBdi6`+f5#+vXl%RkA z(vWyMl(}q6h)kW2J+^K(D(AGWQ5p}lHNL~nGqHb%|8VyMFL1 zTaKiSFL0u*6}7jA-0zUx4}TRJZh5(8UTr3tsY4_hI*YcXkZrZ>NC$l(c;+Rcp5a~t zW=fLO%(KfVeo-rOQe^Wa%G3}7@>=LucoMV_pfA4BDRB)6@Wj=Ao{Tey5i}C)l~$K5 zLfd6Y5Au|dd8#SyP0ImtjHjFuNLx`pIkh3JCXP7aZ8M21$WBUBjW)XDZM!a9DrQn+ zCXKC!5Q17>QW6s8OJ7R}ayh6REZJ2)UxD(9!*lF7scH9*(hRtif@Ws`LI_y83MH%@ zLdIcoY)R4;uTW{BX~RwWCnl_5i55QnjTg?y->$Sadz%>j|L%R2Xfxir%%- zU2P-|_bVw$2gbx{`A2`43|AKTQpHMxP-WB?6t`z*^j zF`|^>noe`2g3num1?>^o@*ByCDYUZqbtyvEbvm?YoS9|&kzv86g2VJ%#^ z(v#k4)0n2?QrSN3yf%*6${Px{4^zP?mzU?IP5o$6l9Xly_q+c9Xp3KPe4~P_kNC?0 zOH*aSL+w*$SSxjcGb=e&@84+(+hpF>J43Oa{lvKT9WD`ehQ*vZla=~iv`@)6g(zlG zGXV)UxKfr9ZQyKe1e9CbZ^&y+^CwRW_}z!NxtP%DT5vzqo8if&LJS%`=p96LNfi2(4{?*Y?I+0?DTgK!E@d%*ty z7;VT>*cGj^kOPV&5$bj7Av+zjAeZFkS_;wEDIlldHMANlx;v`IZl>Jb2Hi!W*ko{f9IGp59e;DtSQerxcnRjF_007;pyExfsN^^hl#&m+ z9U|IyqUIbzp3IEnM+Ut`t;)$%SBvSdv>ut4nVXboC2M+7w)t6`QWoM0kgy7nRdNl& zVf{+^i8vUFohRBhl%^%75k{6_zEqtyU6<(r(S$>dXNURF8lTUH+7M=M+P%XI1Q zZ3%LqH!%kW6@{FXt>M|1s(#Hh!sjI1Vbr?P%a?6UA;cst2G%-~4X6sQkK-B-lI3Tl5^|>JV{yIM%N|?F-z zVM~sR67bmJ@Gr5pDBxXsQo6HE6!}oRivCtPKOpvgUqWct<(^r2tH!*IysZvX~v4Q;&%cu zjt8hJr6BW&e)+kLx}-0Ci3AcnwTmoy;WeeNp%zeab}Vo=Zc6S4K$OJNiI@l@>q-ih zaj_(?apMiof>Qn$>UCzWWPzjh^TXB9Ijy*p`iUd+FvH+vE5}3Kg}Xyxyh1axG^8G> zT2v3^4ZappJL4ufuVM)r@&cN54vU2gZ=@$fT+ZrD^-{Fl>wLaoXp#w5_p#fqhhwA~ zXe>uh;idsn(2};D?zn^~0*v2n7qHOkMel3a7$_`WQx`8N(i>4qmXw5zbs%}b2IF&V zo1hNq+-5rZ^neU)$WrC=T3xiMdZ?Xs`DqEGwr$h!wJv7sSIva8)T<=G1s2gm{EcyCeK5!4C;GP4dmg*>eP0MV&J z*XnzqCg;S*T<>6`vnNSSHf_0yL~_yu-JHc!qkS@&~A|R5b~J|agss0 z``hk6-&pH*B<`}qtsvwU7uf7Q2T1BTYB`5puc#$=C<+ScdyfOsI+4pA#<1d8Xrm~) zvfts-Ik~{D;Uvy#;;ejAyf;TcX9hITBQlf~z0Lmsba3c|#+a^)fK z`m*H)WrgMONC)OOj%o@wWNPV}BPqX)!3H{{aig@XucW0w6rI5rA1HF{MGd|r;hcqL z>Imd0?xt*leMPKcEuBM0P~kO3n4)D=+s*x)$|+g=Eq|0FQPW+bO?;Uu!hEq zgepx&v56J{RjSMs?0wc#aw1fg%kQYz?P6Rgq*fC*E`nQ_TMKks-CJt5Z;0Q0p)x>+ zFCV2Qeo^HDQX5!Rh5CpX4F3QSsB+H9ROW+eCAw_qDS2#C6xqxMnq2SW99+QQa7+26 zB7o@k5h~twbO57s2*|Dc*re!tq?M8IQ>Zz=IA$>v*ri;~a6~Ib9MxtFIE6O)g8CHO z(jJF1jDVb4#BO2AHYh`A&z`)r6RF4+$_{NlUl^4*-4A1R=tDjSR1%CsMrk)I6V08C z_C8RF@?^+8(PLlT2A!Lipr2$(QkD>nKUlJ@N2zQ@eAets90K6HM>}*FIRKjjJOO5< zO|Y~TlcG|8C{hA0@x{AS=&D}gy&!&Tv`xd!{29hI97uYxD_N*HO{l!lOY8cTEUBxH z1pSbD+A5~^Y4>K66n_f%4<}^4Ax`5AKU0{W)@7HUN{^02Ty^+*LZ<~6w^Y9&KgPZv zxya$?Y+6M^NuZWgmlBd49J|>`(A?hLE<9mR8-W&4*7iHtnzY^}#+Z6-uXWly@`sn! zHf;~X_yr$LXIa<;n%95~&A3`AUi}sTV(i9-<|zWH&Ph z7bIjTw5etrD3fKf+E__BLX-%&?t^lCdY-Y@5h;sINsp7=1Ot5NZbIhenlY1 zbhDa;%^lX-nPTc6rA@vjI0UJx6D-o)8-$WRP*A4I<9b47ZP#9H+`Pr9L|s5!pD0^G zQ!}t9*wBJ}(&nFzu#sm@SWG2BZnRcNl6=q;aFRG&rJBVy7}i>`Fi% z2wFlL+~PY=aO;%*AI23&1pCsfmnSZU`$s59{{Zmf>XKdhIAK&N3MV_J7A1_|Xx7Z$ z9CQy7PryQGU5pQBdB16rkR$v9fc`N2R>v=Lp7F9TS)Ts@nWulwF=GxyNpm@Ou!krC zNrHeO(h4|prxkePIGC{D0)jDQh5rD;L@a~QE=L+a>=k+E)Al7spVf#hSt9oz?h2AH z^r=_8K_}vG9H6ntZFe?~(aR8c{!`jrlu@;krQZ4rWw%&ER(8%>X$T`QE!*~lCrR5d zJ4*y+3Prqg23eaW!aQv47`Po z_*ve@_Vwuola@{NK9`uy(4zkUgeVBJg_})6R>?Y{$4B{O!z~L;?uuekKsLX^IY(?z zF(Q_Sx<3f!kkm5#bK=C;52aGgE?ILEuLGATPFBF(M(R$!0A2+Uayobev=pscoR_Ms zOiE240OMt_tjEO}RI87ScTEPN^OwX@vy$cHB~F5j;i3Riw73>o3BQHN*Q_Z-EL-3# zXfa%>9d(B#UA>gcxpSt+sX~;K;s_=O3LcBGf}$Zc97|Pg-tunP0O|&vJR&@qV~#eE z{IP`?N(NK_ZN0UK`iHzRbt;3)NLHi^LbZ`4j)un()TQVNsZ7kgiFWcJa}=vu!(Fxc zLs?y>If^vV1o))7Zyb>+R>SSQy0o0i5X&h5bDJLVu_DQ}$SNuGimb0^9_YEnvro4F z00KkMF~p7lqPrnGFlDESSW``?bK6q(vDG0$``nLMro}goEpK-Db1gGqd_>fi@uj=u zI9Nj-)3Ajlrst}D*76f|xV2|-M4RetFKgT36LE1WD|c__`jE45lF2{A8eb|p^`0!y zpOs(p=6lHm0!{rbXm(swTG{XLV-VnHd&lw-^E_L_w8o2{NFe1G$TMr@?!#}1^WWw^ zxCuA>Kau9RKCu)O{>nTyQdEa) z6+lvKGPhty{L$0n0`~0tFGu^Fe!=XY&P(LZj|mke?=Ys+{w6QO;=(7b1F@W#<`DQ2$6$`l)n>yQWky{LFr$R<#E%swFSvh zN2NH4r=GIkE+Fz7X4hXcHM0;lNV&XU;KNIWDO$7I_6Ek*K6=92)C(BW$W$C~U8|K^_J-QA zP9>jqOyL;9be6H@aI)&$3KaQ8fa7EmP^CJ8J>#xh9XEd^4sD5j!r+uT8d4XH>!z z?=@oCi={b|Z|)mgOGMcFMaoa(&!Q_O?8hi3mdmGC=kY09k9;AY;Du@GMEXV3-(|pV z9BD_otLd$`78X4tRfjUltr={Xo;Uds?!Mq@yB*>}BS=Kcq?2^+A#7m}W*5XteqBi_ zvxrIgLQc?uTdJE`JKVe^ihfFO{jmpv~^|^6<1$RXzS)%~lR6 zM{b=)^ATfgNrff7qGDP}EH74^PcbMuxqc+q|V*kKGJa_xVulrmKBFTQ_lC3ZGq-dPbzVHKpVfIhCSa*Y-h9Vbi7J%Z5@? zO;xW_yNH@=d#{efX~8|2FqR5;oS6rzE6s83#j?mAO(cJv8%Si7xtUCjEr(h|gE(=S zlQ`WrT?v4ocX{(eWr4^K`K(L!#3m!TUMd7&Ol9jG#Uaf|&4)Ml;z^Y?3=ca0N z4W%V==53WY=|MUGw2K6dfK`p5=ZaZdYQBhTTwuSe^%RsWcSM}2HHoF>=jB84_FS1s z_E(aBq*GQoRyEWRd_*RkR+{VE>F^f+02i9B;>rFy;M`PFht$NtKqav3u~<#TjkBQG z5uvw8aYj)a=hS5$r{Ih#2t#H|jmj17tHW@7tq#j7O8N{g9o;652N2qG8Wz&!5>k3WO{}@i z<(HC1$w*gpDEfi6q9S|6Znh^!1#I1w!BpU$7RQqrDDKSB=G;=!nL3I?Xj0N_q_(sr zXg2a!q)3+*;m>tk*WczLaGJVNIQS*Qil+-`jZ>#Xisf8|F!~F5Nxi^O1bO+!caE2d zElSe(qQi%%s@t~dj%$vhd1wVsk1*?Byx-*&AH~*Qu`EA_x1&0fG({fr7c+6-w$1)= z$ziYYdc@>%_tWVilKxN3RV!~7*qIC^q-0)6WnDm<-%@YzggE{lzf1jz8kd*UbVQov zhESK3KV7EP`4J3h)8FS5b5-{FHg%<*2uHhOIu2X>`3MR0PPM;^--{%@>l>3)hy@k5Yv@^hy7Rj2vGR{ z0IY=DwWX)@X_6`EOEUvcf@6w*4@nPb{{TDIB88gNti_R-HLO zYy4mCe{*3oNS7II-d`tNAG!^3?!8&fE%)?C8FMn|UBc6U5iqg&h(eNo%1m`9_Y@uZ zf$xVDq2MNn{OlvQ=KlcJIG30ElX9H2&l6?8e*rd=`{7An_`lZ^ExUiJ&8K9Zm%5O- zk~}@7v;K4`#s2`6{<0FJpKtY9uF5&u6-?$m1I!=a9Mk77Sc-4_-$@%EL`*ZPRX9h1 zEFa$r(AW6C-2RMCwEqCZ{^;9ng-lp26CSEBjA@556AF`jx9c4 zLGQx*`i%A@qtN(=QFc{N^Y55+LD!!#nrD{@d;+^~=RB|bD65Ee7I#?c}<|3>0Lobaw=(P=CZ4hN=>si zt1Uiv79KD;S=Q{B*h*3Q%^h<32iDGsCu87ZCPjXOv6h#9WG@XnCZ|m653pKMLyuFY zgK9|!?Y829J~{#o^oV*8^UBeS`A|yoOC(fVBS&YY(VYkOg_N&bL8M|?7}QnfT$;r+ z*2%h)B=v^21gMQKv_BP5`H*r+x480*AX`u_8~kCa6R1n^LY|pA6wm88!hUNIsB;k} zEoLzKT5T&)1$k3%OAA9RT4#2QjE!0l2OhML;Q*N64uv&EhT1?;xk%GqzL47-M{1)^ zc1S>C!u-?xHGj&RKLC{JhI;8@_>*q~s+>#EV7e4)&tEFEJx8#BZQ6Jq;No+!%(X$CwBd7t=VZr`UiwJTUksst7<-V185&6Q{lKoqz zv5PR33Ql28C8ye2R9he{42Ns!{>Y}uu__~Lh4^tfL}gM+op8%$A(Vxv5|hzswqKT! z8M_@yhlZ6$95|)Crjpz1Y$?!}5)_>V#0wsqh-vP{k;Tq1(dzTUca*6q#}Sc1K)EQq z!rk;-sCZmlc|+P78`f#m@VzSx3Av*-!!J#;q=r~Ziz~jiDX}Tm#^*r?FtHgcJBQ}! zEHgID!!yh&SD0kBq%9=eTquQlctWY1v2jSnRN96d_E6?&v^?dKMxhG5i6>8y(8Dr~ z3yZT)3-e@zztu37RO@ZHw5eIunA+-1?d5w!OsedD4vBAE!V>Miq%_2{ZKRK^EZpsV za*O^ERW#9I7JCR{%0(`u-8K28t=BuPwgUZ}pSxl$eg>8mL2X-}?p%a;5J)h$mQgvOF~Q+I zVp^n!rPz6?w6sQPX_iVBlq*YS123hnA*pOB8XS1x4JJa0^QkerPq{?gJ&1EAQ)V=X5dv2BI8 zMN*KW)0uHdOG=ZMQ_c~hELu=auX0pTlz3lQOtU2R7Z?r~8@N#~jihF#9%ww|)YOY| z+T>G7K>Ed{K!fg+akZh$dG!7H9B{HS*5{kX&%Gl&wwYHekt-uGQi*z;yG|)AxWvIA zF#1Pyq?63BF=>iUh8h&OHxRQ@FX4)BB(1m1FgP<2?ngZ!kkd!1A({};Bkm!^%k0y5!VY#QJoO!g< z5icmIWcRt~K~b8TQ-1PLl&K3Q#>Cq3#)8R}!)_@qVqQpB+f1a{Z3>jA57D~Pi3w7Y zk(6I8fL@-4E3)I?Vq7I?cV?tqOYWqX8ZR)A;*{TYT+5Y|lcmOrNKT5qghX7)9Rx>a z`6SKZYHhScxtVC2cc&5f093zvH z$-wxwVdmWlL*bPbXrK~8fl*GRSdpOs*uuITB;78u+o<-|RF-phU2!&XwE|6pt^Jg! zeY*=@*N$1nhDV6}IZT|J^OTITYCv1YQA*D!^3`Caw)r+;L=)XMP3@!<7APeu&Q|dS z71lvgB-d7#nkm#Yr&(=iO32$av?oGFhB;d`<|CM@dlIILAyu51H%yIAVPgLPWjyw; zw?LJhHPFIbZ4feQ8Et83`DzvGZD7)HOHpYw>_Ulm zWQbvM&2kpn(rl)bd4OwRGazOiY+y_%XR+rApT}*?viltAIY!m&j*wENvg!?jR0t%p zMwhud80vI!t09jKUIK(jq9 zGKU#MNDZk3C>!4}BpnUxb@Ym-7anA^>`>C`3$2y4HsZOcvV*w^LxAh3N4iGGad<~F zypEK@TB=Ja0c^PY302aCC2AS8O01J{*Fqqx4nl20UBZ?a0H~y0r4oagIx5Omgq;Wj zNKG9vJy4mdp)vwtQlaaiO*t%=dx-bKR*|V1Xly{%6@PRTBJt)MD3(hTY5^g9xp|P0 zqEwuvc?Q-5_fJ?#*zYnu;(igzQD)_*r5u<_B@oy{jH|ygQbLx5l_*;>a{xucbo7Uo zR_#8cZUe`|j?~lmdTMDEIy}Ot{MQ_9YD$*uvu9);=~K4S>e3NB5qzrqe=#=MK6rD* z%ss`X3aK+la=-<)LXx3=g)0Dq({7qXY2(qbit0JfNTy|?*dSOZDcGa~;n&s?LTte; zBFa{!1dyZeDQ83FZx2XP*y9S`8fuf?mKIP|>C;F?pSz(}b`>IBzH%%<)A$%uRwU%2naa4h@YI+_kydOfLA3#5Q?0I>pUyi$W~Ek! z(LzZoE53&*H~DSr4bCEzj0`c$UnR`O;^N?e@IEk~AxCApYeL0GQNEkPw4pX~=4lcy ztx8H%96PBcL-5)V;Sou*TA4{qlDnl&Se)69i1Yo>B|z9}rW$UroVhtRzb$ATqT*lZPnaG{yO-UJQq zi)nwtIP=T-{{SPZ2-2FGZfUhOG}8| zLhAO{kD>W3N%^9Pz7{WVt3sZGsU)gd`;`W4wE zAKH#AoAQU&=6 z=5Ra$K>q+jIp9R+h{Zl1?Y})JujeT$Pg|&8{K!MW7Alf_+-T_%yeDttwo(3=bH;4X3<*z0A(>9 z@Po@S%3p3NN_xjB%*h@Zfd2p~1jjwe2aYdkUAid~=>BlFtZYhDZK(6gB0Tsm!_nde zBVD?1%9D}ei*)+Je-JLz0#Wzr`@?v;|)Fyp-Va!)Q;GA zVy=LNmh-ePI&~Y{YdY*$%l@G zE*Adi9HnN$UY|1ShoTU({{TkeGT|I~*QlkI#{ze?&3bXLxhy?Ua{F1A6@N=L4STwM zSE#*p+$|@GoLR;C$zjDXf-V;{>r4;qxn+J3zju#+L?^`iv3Wq?*AnrwN*IF>Gf!>B zT}(;Kw&RIMR0n|oe$csv_;Fm9tNjq2etwF-GC**PvtA$I^Q)YcX>ZgX{VeP5Eyq{= zr4W(in?$IsT=%X@sSLN<_asVH7D1{#4H}EApTIV z6$x-)y@}-*ITY#;uLT<)#s`@k(9F!%8=Sa7N~|w?+(&#%4K!hx#8UEh4iEwBt)rUI zX*K31BryUqxslY58|m?c_=z3TBd2h6A-k^pwC!-ESRXTZDi_mj;!KsKAr6&Wh}bB-EiKG$VrFIL*+N@!%~Z2( z(rhETJb>GlZw=BU88wFz(~4W=w5|1}N=jTKL6{R^VR%Z4XKanQhlw&(YOKW~N?VsM z^)8~YvoNKo^4TOSDJH<$z#mvr$6NWFv#%k7n#6b#P0nknTXf9n4XA)rmhJ%n>jnNV znZfwrvjU$-rZ!YgX>qAH)PQ%_#u=A0ruP}^lX!BAIWZ=zlLMwO%ePzUEnG+)GWVEvRa%SSV+(u^?&d5pu*p5m5v}(Fen_>fCfvCSo&uJ z(sRi(&zP8TEH<3LSxeITgL`;HtPoOriIbs_;v#2LhUm$hX~a0qZkd>`Ezi~ux=*A@ zf~NiqEKKA2Ye}tCT>3=IDN`%V+N9R)w%JLzx5_Fet@@f=QhHawdiyl7Ek>o(C6Mub zQx426E99-b{m%DwLrZNOeEwgc<6C|AE1~Wf$w)18H2S(_=0RQ2?9V72Pt~hJlWns^ zwUYLd?bM4rb-Y~?(*aMZs<>}9zJk{Jlvs@>19O9=xhY0H8%u>}N+dBf3&#F&ApaU%ud3a7Vcn67KY39!>-MsW8E_DvG=v=>YR)Z(d7d+2w}wS7X|dwDceFp)gy^AHWBr8qy(^6A zvn@-yUo1DPg|)Z1HUudm=hE@b2Xzr^8Dd$U9?)kiGOeY@rIOu}zjWqSxA;T89h{7) zhmzmj39Av`rpv3+!~GavyNg*)!(ZJ8sFD8wDwaRDZ}cO+?j9km{{Z(vYG-Ow1N!&> z07g0P=X^txGyTw-sz#K_aDQw5d4xV3JW@(_c;i&}8s#RZCfI4DvPMAPUmKeUZNo@v zvSHw!B(a3Bz zFseG47rQkq895aAHb>6zxN;ooRG$#QZo5z&J*nUGj94No=5P~Z))!|Cprt)vI%86i z;{nEwG~$PhC7ei7@HNoZDyN>D*oQIbmlMQw8EMLko-#^Tz$PINGEZ>nXqTbMWcN!c zSHz3Ls>C-&$hY~C}&)AFo^)!0c&5)=z-7bzCLTU=klIY22e zpA=}=bzxFD#}tOXC)l~Z_Z8s00lw?9EsN3 zpg2<10%6o#3!^DsR7WazFio)J%k{l+Z$#bq{vsAwUD-bP%L; ztE#6FIEP7_T*8w31h`g|Eg)`g2fJ^CE{QSNkvtCLEn->ex!gk~IEA{Dskho>tSG0U zN)vJ8e}qNL8{|*JD&|ZaH`=C#B@;B{@)czSxXD7&<7W0bfkpJ(=@s%#GQmezB1YA? zktZi0Cgj|1ZEhnoC~09qcNZPua0i*v8FNT!Vr}*yE(*aD+)c#O)7X|>3bIj=yWI%~ zPzF)~APZjCgicAX%yJOYDk}UgsqpU=uCs>oFo~%}0z+wWq&SOr7L^<2SkmdS2UuoP zb?_WeQs>v0;?<~999c_fot8tjN16$nc_>mtIeysK9c(T5#Xe}hYv;EwGT(;D;VS64 zE9c}TW_TMS=;ggA*;qks=F&~p-oj~;54<;1V&|k)JkpNcR{sDm@h<*owOLc^v*i0f z@V?$m-=gq}LP@65B^i0tB)4y~Ho^Xp1fJum8>C#^TdXv*$?|vC{N>$tenO=_?w9;E z_I^*ec@7^*P?pnD@{K9Rg8i7QM9sEA&dReJA>?$vrq=^|CFhgteOI5ClS7=-w@a^h z_I`0@YJLTfr6nj~rrSasE0%S{{*A(W(yxQCJ0)uI(_PZ@x7VLmy7qs#HTiCrRsJac zsU1(`U7Gbe zMwXQ&VdjznA#+Ti0;bkI*|vz)Xf_0;Hv`~fk0alon(DvGUDuGEx;Hd!Oq6RGsyx0>zb#p>>>zgHLjFE#WuS*9}BX~}o8 z7F1Cx;`HT{?@2xm*V!swx{Gc7OlRD`{Dr!9q8Tg_(;u;yek z*d_TXl6}me6)mR;(5Pep+-Yk&jkz_`;_0TkZ_ORktDgRSB_94vX?R~+ty1a}l`6!l zRW7N5sfkhtK3NV6`#?Y$l-biZP(ak_tZ6mElDl+KOB}h?E}ztNIHke*WkDitQiCm5 zVq^y{m&-~zTv%Vd@cBfjaWcnAI$a9+U|BBt^%=P?6jEFWQNJFee9%Mr}c%$oN_+VZPui|HYxB5wzu*^ZxZ3Emlh;fBR7T&w2-r* zmfcH4`KHz?J~p|D5%!*rQn&CE?lF?xef)&Pl{m{t{TCsIrco^DEnET#J0GlHT_M%& zHuuzn+)~<@y5O$?SHg8WHq|m&!7!2nCYN;~TZZ%8r9Kxnxrn*FvgOV7=g@K<&V+e> z;|;~^Rf};2TuZKy^qW$BvNeOxk)Q;_d8>2QOl&;|!)Kn*n>zJ5PX%eVwKQjL6Gb9k-j$>h_u@aQF`jcTU zqt!~2uVS{`!qur$?DI@#Q7Z(rg$odsqyd;6H@Jkw>EvDEdbx@&9dH{A@Nim~&_j&^ zTqPw=8*krmm3%}wl5Z>B{R<3h!&@P6F*`W9q|Hf7GM1O_I&6>#H0dLY;V`B zXY%5=x-H?CPbP8dI3Eo!^pf)b0NU5^F%|IsL*6^?Cx;HO%E1lFwr{+R16B4eeWyP*!I^kF9WOQf_+FH>PbKm)vP{V)4 zzn3GiFUE%IX>FWINai+$g@>C-bs=K(^;h^VNHS% z^Cc$;rP&brmr!Fsl?b z{{S`I5ennkf2_x;uCM)6V0q~TD#{ECf6Lm3;dn!((SNSREnVOGh|t3bZBESc(t?FM zbmX4RrMwC5`a}N!5BPYAdH(>z4t_kZ{{SWF^D`xq18t~+XOb>$umqh?K@Vbwh|>Q6 z+pqEvQPTQB_Xdl25BVg62B~+K`lv>g*?O~)KB8*W~Hh|zLgiA4pWEZeX1 zhlZa!L7{!hU%AU~zxt?DQfJu-Ds3%mrTws<&K-{2lK%k1kM$$XUw`!trO&qRmk0J| z6Z`E8Qoeui^u%fV(9Fr2xv~m^ygjM2`It3!zxCpByZ->gSaxS-oK{tHGWhdZSK$iO z{QY8a#V+2A$uaF2eywkV;u6}STlxJN#a>@j7Fw>ihE+K5BkxMv_eXU;@BLJBLhQfR zHK(ZVOxb1Cr6W^mE8KhmguHG40Q&-#M7w{ka->?6tQC7ZiB?l(e>8M!;jAI>{{Rp5 zAMP*3e{x4jibGWNyn_CP zC{ap9maBj*(#9ikJVc_>d;HQn3~BP)<4ixsS>Z6t4hh_$E+MCaCQ^LmUFEp4Htq#^LaF}%K4?p8 zzsr%WB-J*8=O|WE)14)%EIA^(_ys-^lj;c&r3S`jAs1D^m1nUN6)9k%08GcfwfyV1k6cG879pCJLkw#QO|(1j6uAI=?si5wO% ztffJ(tZM%N5)aHnwl-!MU6#gFl2i9pxVP(X9k4jqmkP~dHpeaCryB>B95>2+e~e7Q zlS|xZByABntQB0Q;;JXK$hZ`lurmuOwSu5Zg2lkoTODIVizHg+R?aMnouwQS*rKEl z{It3Laf=LY(H=t)Coq!WHxTHOSgDsW^eOmTUZ=Yx)VH)P z=fXx{LV~k(7CPI^X%VD{qQ+~A)ip`fRHmjJOG*JNX(}lrp|)?z9E5B{-3;|YNu#8@ z?mP&&N}3?2%KIC5!<063BxW0zWl4V{i7B!{J>lVNYaDSqW{9FN<4JWzAd-8xAc5j~ zM*!NbF(ANX$*6NeM=`YBK%X0(y&($vignOXrb=dUmga(-MpbuGlmZ4@5J}n_rO0x} zN^i7nZxA-^IkYC}N_mbc#@n|*N|XX_d@m7S3c9i7oJY}cjb-;+eFj+w=AlJ?*u#Vy z-u=~^9?Y>T>W1P&#q2bHXTybr6ou~E{prgzN#Ox zPFU;Q1U4|k*w(jLb-!S8YC>UM_K;>6zvsR=Cf)d^*}JWB9kS9JVAUWyk1G2WDx^&B-Myv6wDA39!DR*%Sw% zhVtK0a3mHd$Jmad)4xX697|fHhb5YDgzcCp08fvMGM{nHE6ACoqtzw5n<{@^b^;LYR3@w~&xZd&wyTSmid-@oOBK zW%466Xl*f0KNvz%md$aulQLu&nP#AyE#1_j+f(S6&9Q1(N=?*B2QW%A1Jsn* zYZ3IOKgiPTwNh1Q4J}NBl8Th*$fL4DssnEe!g3>!W7=jyP^OwsIl!x_>ssy)=+IBu z$_Up&bcRQW)l_0p>`eT`(>&>SWy@i^WnGry6qit=ptZ>H1QBgveFV_+VZI-xL30A1 zFzd~&E!mZjA3#A-wzflw*P$eV=?P(d&AexbRMj4N*HYIhxhGQMQj(BVk#JPm*;|4} z@x-hi!&Hh3OR3LPsZ%pF>E@Kuohm%Z2lKRr0`o|_i8eMW0NZ$QMIFp{T}h-)Q!5Q7 zoiSH!&RpUTGDYcygymRq8J3HbCopj-JN1H&3hMm^X>~by%(=sq8ic!xNd+9jmX@0y zxs(o5*4-g27wV254>3CxHmcbT`36|t#9K8s-Fy^-2yy%Q3j6w!D+gj$s?zk(paLeP z8d@$jQRJn?1Lc&GZ@Gj$gP6tOnbv95S+<*H0$CFZW!0-HQi00~Y*_A8qib00($Iyl zr?`RQ4+s?M{+Yv$8f{#qJjT=9mv=BL33Mb`NKgbD+;lKm${0B+wK}&vnMsrkJ&5j5 zsdT2)snve65t}JjMR#|+5{0hk6BYE#Nk1b{RWhjG(W@b}wlkcrq%Z3WYq?62It$#5 z#6Zb|Pc6w2osN&!($wWfU8YumOJ&CF7F!CsQmY+&b=o6WLBVrBLm0KDoL~ecXE@A4 zRu-SQM_mp4K!mh$Ix}JnJv%U3T%*ZCoWD1`LXzfPIcfvCS8Ebqlv>!TG?J!Tc!f)wSR9%g1F_hT z2oPN!n5`^GA-5^*w)=^BiI&1rZ0=l{Qc1P74kqU*1AFNW%WtTptYNV(5UucRmuL$} zX>Mn8A<9(ZK)6sAxEkfP#g6dir2hbjO?D-x0XsoV@i*DzW@n`Sl2dt|mkm6XCn-75 zRH2lt01tGLtTU1hJh^$H8dqXjSFs7hNajB*>&;vY%%m+s`U|4qpE55T`Fac}>gpPk ziKQ!wamG1|8B!L4*-1$|Tq@fBQOM0p`W%!Td7Y_8#JaOx)n@mChTazN^M_Ne<82tH zX1%R^tmO(jBwplr-qwM;*y2=as;ssO8fjrm1cepe$K@RHD`oW!BC$Qea&CIWs~Zfm z6f__h8N_M1oTykQFWS)G;nEPr1Y3cX5|sc?*&{;D_bWpIodW>oiDD3tT!uuUjb`lr%V2B(iu|LwWT)9=A~BZNYe1A?fk^B(;+BU zWRMg_p!I>BMto_C=Ll|vEzZo!(KOaY0#LA1 zb8m!ovxgRLohvwnF))?)(h^h%@Y2L;Ez%Ow>U7$Ep4}yY7;*Os0Llu10^T>Z{QAP3 zE>;V3lT?zHrlifOE@X1q(%9KYWq>wULPqe3B)9wcid%_lVrOLCQElm!%PAuvaR8K^ z$<2G)rlJy?^Yl8`z*^GPJnBK1DQp6xa;(ZD`nw2mU*GZ&&a)NvCK%>`T?jc&R2zak zm1A#9!j$YN59I{B;6X#FZ#LP|K|eb|uEMC>k*0DKR$Otyc1^{Pr$|x5B-4(|5TrJx z3+j?U)8}a8*cRd)%u6O!N2Z~ zWZilS#;K6c8F5jHLyL8@{N1D_=a*uBuG;`LI$Z74b%vB1`I2sh-UG%m70PlSlXsZg zqcRTKDBnKBWb_=mvGTNtES{zM?QbqR)7X%Pvyud@(6YMDjSRras6@NWaeQq~` zfarT-R?|pNKneKthmhMh(Kv39t%=efOlh3FMLyD3%34tCN>6zUPGEW+3`mQinJXEJ z*9K(yp3_KiQg5iAs!1G`C~NKk{36F5dLqjmoZ3|E{QAtS=xL{#QWByrkgWI0NEf&^ z+;y~BLnfjWqe89T8zFu5w&R1TLx~pavaNV_#^^-Xu#E-AxsJ4w4gUa0+hm)00eDN2 zLXr|_;LaYZwx^R$OQ=Z9q8dhn#@TNO)+&UGdoR&3D$DfhQeOZJ&6KvAUt%w4Pl$Cy z*d2?hl|=^4Ahh8Z$`-)>Fo%?LNx`djAj5JGC5eU~Vb%M$<&>X_LAS=xmy(X8CfV#$ zhNk(sTbfFl7g)PzL$Ma$;R$&tR+C<5u+=fWbGp(GMZSQqkV>H*D7_~NW3YUaUfxA!_5n;E(81JOLhg&*=Q z4L%@WhIVB?xxSEcm*xkTJs-KV4L%`@SkbFL{m$gmTm#xBm6%@0eI(oa0vmi+kfn;w ztv|37wAdrsCbZltU;;nq95?T8$X|jf<-fV}BPNXNecf+hr->irqB!`cjobZsNoa_}ymmo_tg&zl3ulXX;&v=k{XxXQB5~p78%1R`7 zk#qQi9ruYG@X)E1>_b78P|YnYe`U0v%`kZK4-FgN@@n!jDj}MDl7O~STS|U*NxXB% zZ@JY3KA0Yma3KhCk4b9!h0DvNSwqI-Fek)m=?vt{@cE(0!Fi5+*B4D8NpFKyfS`ucaeEMM zJ#~(FvJD8*bBUD{=%Ua*0_6S%JL5@p4-FekaTclxLV`6H2Ff?Tm@w+%B)W<4k;7LK zDpRipl8Jyxws4%S`jS<9d?7wOpH_FnUP7)<9Z$)$q$uZI?R9Ho)*R zGd(D=P#K+;8He6VNj`)V4k>wk{Dd{;E|4Xg8FHioHp|oH5){zYGXRm59y)Y8M^j#B zH#Oy{-psYB3k3?)Cfgt3N1}d2Y&5ad zsm&>9a-xK|wINEdS-NkK{J$s^t8V8S8`>{rG~m*@t5rFbylHdGO~@dlmZX#$rr;av zXkUqY9I7;>o~pfvq~v91l`SlA`I;dkTcDJbg$=WHFqW0ynZix*Ax|p}QIxfnEP|ZG z^viog6X)|_DtO~GvxlldHs&T=k$r&#So}AR?zb91Vgx)Kp%P`w-H&AA6z+AU=v~u!;s3h1cT_N8HTFF33 z@JAofXQigyoS2wHFR)8Wn*=E!f>HvkHqZ?rJ{OR`6kT?P!T6sUibK?iC)iw%J;jAQ z$RR~Uf-<;4(EPN7tW+sw8XP?KEy6C&PU0DNjFM^7O(}m?yoJGyvAnJ{pv#F?-fa@d z4Si?>Hc?_h1cE+Riry+3SoS$tC1L>aiNgR9L$yt9RB0Inp|v`{q!`NDZFMU80dfbY zoKN9nV^ee_c*(_CdiEQYeKPYcf5%b@A;hFvZ8{2*aHHX&+Wlf=aS7BhnEwEeNWu7q ztlN_9y3*!Kn^UbgR4go{>C^r15U0XlBHtGmN}ohMJ(zgqO~k93VM$sYX%jCDjV~re zBwul*x(G+QxQ@$C!#L(ZRPcn- zN`qd(Q9{bV1vgT4QQE@V+VJdgH5R=80CKx5?pB4?62qS4AkteY2E?SC z);9BwN-s+Ij9%p5kkN#CL=n_w5y3`eM?mYh+(AA@Is`MPW0^X7mnAwLLyW%d)_@2h zN+b>Mx0D(zcFZ`}h)q@5azdXd?9)y%v@J_1Km|j)Y|0lP@1#k^8XB7`!-Mp6;mksX zy<~eZbh@Eqlq3^_D zsRt*UIZJCoz*rsuD9!%+LagNu)*Yiai6`oHrsUYY9To zruPU*`y^jbbUh=d9>eGT^(ixMsgxjd1@to4A3ItNA*k+2SKFPs8f8chB!Y4!2{#@9 z$5cYb1B76Hn8`SQhcrsq6P>aCAdC< zp8o)nDul7fksq^Mx|b~^;L#~c$@pH-s6B@(a;5l|=lp+A^O! zVlS9A9ncWGdPg-K&}d9NNY)bMcf%F@5Oe;1c>;gJ!wrU-E{lqd^IWK?bdXU003stW zq4(kQg}gr?PyDkZ@`c1pLSGhQNqj#p?Bv?=GRku-*quEDJ#-^Qk#mLod%=|jOr~)y z7ae_WrA{)HoT}(a1pFa3n5_*CookF(DvX@|$(a_pT4d4^2aU==jy;a0Vrj0?{6Bd= zqi7#FcK-l`BvyuOPH~$B%CL!*Q;OMg`5Y2xDOI|sii0?-iT2G4PoIla;ccUy)UIz*+rz=BBhkG>zgt8S{9~v!xoHU zd1`|K6i6@-+M1V8Cdol;T=@VZCP`UmiZqDj!x{vhHpCT* zqinX^tB&%KE)Y3qCW=u(1YD67`D9tf6iVuT8J4D{Aq}AkPJt;%01p5Fh=Z;oKCw=# z$<99YHF9We?7yW$gtzV1yIo6|c@aLK+*)ZH4D# z9Zh0~VLH#g!B$r05%!RvEpu;lk_F?MELN?lip()rr*WD|6$*OXmztGw%SXDl9Ul8@ zPPam~Py~eyZxuXW1i8m%xqbG1Nf>yyjnubKo&EDddUfV!kn@u3TS8giuWSMrEcZpA zb!B^~3)~y{#(N}o)V52S>lez`lP_^gbe{IMeI*{x&2%^u4x(W$`$<|-2yyV)?=a`s znPBVPSK77Dmhl}s=ku!756&SNL1!8GnWO0d8SsOfT9L>t!sJ{*HEBZqv87*Pwf)Rv(SH zugTvo&31lgJKCyy*Eq|%{{SV2lPLkGWmcd9i*l~Jd!=7$QfID9=!3A+y|wv$Q|n2- z{{Z2CpqJH2bh#zlq~qt@$t?Q}g;@?YF5ACYk#1~+!RniTK(ExyEPOUponG|5v460d zZn-wr-KQV^NqL=DhEn2RX4yb;X}0a%`;$`Nn*QIF_dY$YNq@ta>LGNe)}r6mGW`u{ ziIzZGS1-dvO(=7&c023_aE8X66q>JbLTD_ z0*T`HaO?Ee611yWp+ca$@mqd9E~)F=EbqPDl+Y}oh@5}aLmT_@AL ze^hsAEAy*;`%Cm@`a)dfskLS=UntcrJ>p0BH~n(l_`;U;U4BXa(h{{Y5IE8Q(0 zw2S8Q=?=xV>wZ^B?!4pW-3{F+tsunjb+B=xhT}xXppZBE!H#`(MOPADisW4Ec%kuG`AWmISE_I zRj;5o8{2zn7AYoIyEvG`7GnGzAoWISN}I`H1!@U#!lD4ZfHoKPA{|f}kf`CFJy#K^ z(zQi48dSnF6enT%!_kEhXFC*bOaM$TNgq+jn4QhmJD^UnA&4iwrDLIn=K@91c2Z~%IXD>3*8YIxG;^c1GY*M~JX@YLJ% zs`H4LbObn=grnWgHA%h50PPgn_;}BuJ~^6OF){88o?EpoA zRkqk4D5S~2IPcAT5od>tg!Xoy$6*a6Rh+3l(!G*RQqxGg4ymFEaC^NMUf zydQ?|ZMG~Nl23VU%~_ib;!|Dc%gRVfH9sisN!fQmPEtkEv?(_WN`|2C=wf6zZCxYi zN1XKk0D4>Uc5*nT-1Lnh*OyPFIH05qjuV!}LtBw+_z0Dcg-~}%d8N3^%X?g(#OqL` zXIqy+O%_SM=r(C+3BQ$$IW870+e>k^nXm6NYHFiUk_qNg*a=dCN7i3c@q~Mfdm#6R z-HQik)112r1_>kVyOjPh&v9Lm&v|{>%9q2_4JYd)p3VBRAdkgD8-CCGv3~dP^fMZ3 z%_m72k#3@47ykf05A6Q{kEnas!_dUkgUd-OVssw^GK>BSguiF`zx9s$*ZIHdm=PnT z+-|6Y;2uK1(~dp^&R^>a_pkGP4Hd1Kb$3lz9=fGN@g@@Z3hOVMJMUgm^g4|#s;$Bv zpBB*FDH{AlCR`KmFQ6_ax<~3D>bTaGM10FRJvx_Ctg25TO0hjI5J%$)_ZGUbYlyyx zSjkuE%Sk|-c%Hf0xgX?0R|@;TK`%Fw_5Noq7>1Q9tiINz8~*^yFt^6Yj=l}|`XKTA zzOVNeGBpV&1^JAT;$?_Glr3=8+vgFPWN*Lv!KP|b4i4+GxAS2C00T2owF55oIE(9kX#9*P-J1UZ57b|c z{&&#s&C*yyeAT8@gpEjAzYQS^5Ba{Y_7mfOo#=@7iukuqtQAt_W}lRrLb8M*#h|F3 zfkYIkJ#;Z)i-oQFd|4WKxBf(hr6Ow%N;ZaOnkh?ZD&~yN6K#9iU&{K#_+X;Gd38O+ zeQOoW%QmUWm(saVd!?s2D;+GLzUlS6H9iYpSMqiG598u=ZA<2?W$_njN(K$es^P5D zP`}W;q=%Vwc%{j5==dus@`4`Ba^&0c)%(#S-%{F_p&hv8S()t={JO9%BawAYw{tBp z;^mwtp$b|O2|YozqR)oI;M$sR&~GMPU&82$%wT>f;A-PlT8$gqCK^UmI+EMzQg#F= zI&MeVH@Jzk{)FEHu?;Lc#~P7 zVkau;r#RwPoQX=TJAm{V#~R{x4PgiRNiC($h#=&C>t|;DkI> zJP5e7KBw^dh<5(~#q<+ALg8K=$L};|QA}=SB&iOyotcB^v;d+a+ZPciu50T=3E@)a zrS!3xtnjZDVU_zlqm=APOsV?z-AuN2pY}a9DZT81UCaw#7ynqf_xpa?$Ei^C$comZqH3^;}9dhGmJJ z)GcXzGJZv0&Q$tOf{0Rn1YAOVGrETV02=mvq*bQcIUTaq^{GR}2|aI;*-0luu!XFS z8zY)*keFTf%^}HZdn#oTYUQn^9{O7YOAu^)>|wdBhY*0FQQMeNaU|wD+{7`^m8oRN z8^RgXb>y8y<6yU`wy+$bGhV~Ws%6SR0N+?tXGa>dh^kw%qb<{DTAiGriIZ?>t6Dp# zPLUp6T|L_*n-kU^OhZRPa7)w{-#OQsaS94Tn^lTc;xBt2NRbSb#^oC$_YiwFQZXFL z=MO)9=FO;V%r}brBMo4FLAPaveq1yZB9KcI>A6Bl&O`CJT@^UagFsu zPYnt@NyM5RVu>S$=k>p z!6#oB=8)7TC%I^3t1aBM(xlr@Q5~Tstj$;2*g}>&z*$!Oz^S6h*yvj!HIlN{)^);v|hupX`!Up(YEV#VxF$D!_qzD4wv74!0Ms#!idG z*^DN&rM8)xZCj#c0n2{Mt`w8#VY%T`7aW>NAHc3YDoUV~&9p?alsmU8D8EG9`@Tl@ zioPd>T5WSg+&TB$ni%%EO2@Kik{x1lO<9|pZ2>Apjn8-+kbDO5Q5}iLdXcTO6}}+x2Zu96yxww; zdzP|7hnUVTJ`pEGWH+gy%;En4ZmM%r%s*V0a#mrGQ_MqV);om^#M`cs6E6*XhoPE_ z6ydjM+%v>YDf7*(#eIccC*+_amp=FJV8j4ZM6oTn5HGwOAFa34OpGB+WU2g*&$8*$D=D1_-c^rFG))}OODGh zr;tU-In+>-ZxEkb7-V#9_!CKU4prs>PM=KFnK`s2Dk*h3A5}z*lHGhLZZX-5&NyLO zb~I&8Of;1VV=x*b_d{!8LEWw01f*;BwudohaC?2BGKH1TK`vk!DVk+a393_7#7oSu zo26(RwJbc#$?rCxEUgZtSngv+rDbzQ98HNU+##qviz#!-#1uK1Ln!3HLK0hSq@@f^ zv;k5G2Pkz(0Y~j-(jB`JN*)$csT@?p^u$rz`Zjt=i#H(qrENc*Ha2y6Kw5>ob{a%! zB2*Zu#_4klGcfrIm#fs9mug~J#1N)LxbKuK=(Iebf)tH6u{y&nb#5}8BAuJzY~^8X ztV>EYG~&?0$1u2wu$Nj0I+Y8RBoTbaO~s&+v#{8cbewS|j45V!oGH^RXXdi2gpk?U zML+};s^IkpNMYll__G`IwAS$uOPb5gw=7VgZiOKMN_3?|OB?HMrZ~_Fdxe> zz&+lU5DBloM1R8Ak-RGXLSA_)lb)VtUzIHQEr%4-F0@J(Bu5a zs{!Jfx&*EhZg~YRCB(}-2+B}BiPVdLIs~TvJHlKp&RrO|X^5%SoI6~fa?UcD^}6Qd zf|;zKn`?A}E#(oX2DbPPrb}v_rz#>u+ma-lQh*xw6_6Y6ZDF=`5ofe-1m!rNOH-{h z6r{9ED@n4F>Jgc;lW}md-L}`)cvK~&oRn;1Wu+@rDq~W!^yJqlPD{%3WJ${FYvlmr ztvD{QtAlh6&d{Wh#+Z-8G*)N<(}k)pOw-D_p284)wwmH~%%&Xr$;P)z(2 zb#vx%ZOCzO{{R)GF_Ud%bqvhPx-8hbgKi~PDo7w4tJDxjcKJvIL>X}IKLO=C9+v6` zRR}H>xS$H0cR`rnOC)`uoiEqI@eW9EJ}|2cIMk%etr^5AS~x~ka@@JhoVO{@z~!(aR_3OkyVMB#Fw;AN|w~3fQ6N$606++ z?PFp^j`xmBa7vD4W6F%<2-&GM5Pqysm%RyO#g~e95)Jw^0rK^AvS(+{DA|Arlh~%sNR4aW+9e z)$xZS?Bf=qnyi_WtEBF;k4w3EzIvVm}`T&CZ%d&70#@6b_AlpzO|{I`y3Ozj&)qR;wfY2m?nOEE44<;gxqt2=FtgfvH zP_ar<6>l(i5WDjdCFSs#aAbaIQw)!FE+BVLh$6-lruzK_S)nV#gwhUaIky`G-!1Mw z0YunGG*>1XtjqLOT2QGdo9M-1F#h%aRt5lv~3< zqYFv({SG#|8W?L2s)~^8^vQ9+RcojvIc`WA8y=C!tvuh<>vza;4P}HUFB(IGoI6(&sk#g!-kn<%IKu$r^BY$`~U=5Ji4${)TQ zLK&v~@3SZq?&+tTJrTBXF^g)MY`lY%gqxAkTaU^gLrmad3aG>q&CI1?V&_q9_B(u` z>Y)N-ixg(&!xM!{Y_g!0tY7qMBQj08b-v=)hhaTCcN?5+N#WcrGc{91z-mc1D4FLM z60%if=1EqT8-u5eI`R$ZH~5D_VqR#wBEM-^DNCiWawTU>+mHvQkSx8~&kR<{x`yWj zvs11%Lum?H3RH7j-M7z8#5VG=N&}T8Kyq1R`&MMBAQx5KR-2@!L-DjCS!`0rM*+Sc z35OI>K1mvq0kFS9VDW>)I&%0O#H;G2L&RG#DY&@vydE{3@Xo@pTdylp5K2hT;eR4^ z9#D@E?t`aA!tJ)8MD%Iyr^Y(teQ4r!&^vUu7#SRSPm{iD0dGhsEC=O&j0p)zDe}~T z<8HR_jx|Sa&oqR-EW3Fd+7bq&>Kt{q8%5L-6bbMELL@029vZ0mDpGC_p%6GH z(B`I&%MyreS-mv2r}&s!R3)>OGc_?TZOOO??+swKzp2ngc|j#+UBr}|SPa+m7TiLV zyoAxFy5cGd05afG4aQ-Y{O`sR<@fzXBy=X_((-xDS*HNj;^6xDdcvB$`5aD;Jc~1v zJ>@N=uf$neeh`$K>~+wyMB3$(u3Pm!F)lN48EVc_-EM7VF0wM4+}IK6ZQ;d~=8?3h zaGIYnFwD%EGOo0xlaT}^VZcG|lawDZyhx7{*YptajixN&1luyMw;?u_pJSMnZMT{! z0WShBRtde1x`=ulS8=&x7*+OU#8i5GqYR>2cp{hV3(EH-w-zp9W4?c5}&A# z4V~T};rgBtq)F2zWM){HlX&JxL3m`b0EM;`l>$2cP>E$v)aHseIEgsaCIQWme(B5^72u zK9zY#Q(bL9{{YHTV!|kD%P?YrBZ=9kxiHEcQ^Cy2BV7}CQpS$!5%_wV#TIrzOEQ+x zFvQ_=D7DIT7x+SS3e+W}cpZhSEy^j%dqs0BI^vby8lvR&>v$G3uOk^wBH>9qH&(;4 zQY{AAO)jOC0F&<``;tk7I3yaZ<=}cF3}U%%Luo>lK$cOk`&o_8uA0O=oW5ewVib2m z<&o$jrIO-wF9{T7Z&>IG88r=+v~&vR#|j_H8I+Kupex?UqLO?r1+<5w$Wg_`nB}}M z!;PR2wKSsJgm+YS%9FLm3N=?RtDb^&WL}-hRVF^lRG?HnQ7Q=vrs9$vr$C!mC6n8MU39HXlDl~a2n%hjX ziggIkTrA%ACcvJs{20X0{n5A!S@ukm6{nk-zKTvo0pvhdzOem_(Z!kU<6U2T*IiLh z>L>WYXDHFC@P4fz-c?qn2tEy@{`gu)E{CUpTt2DN-BPBiFHE(vT2fM!`4eq!K2W5N za})eVr9h#tg&e2fL)T5fgg0kW zqQW~FoY+>bk-k+C>I_4f)JnRJ7?`Qy%4Jej(!}hWS(|tyFCbmQ&O@Qo#6lAWhSkm& z*D*r5?$%JHxv3^eyPsHfIuO;JwQ$E2$+j9|uEtO-FCy3H3b8E>g?ENETqdCPM!h90 zr!G;RRiT>O+sEMrfT-b&jwr?oaT0Y@`x9o!nD!RZmwxd;Pztc|*uosBQdh{Dv^*>@ z^GRFIg*u_$b#_K;Zf$TrP{Ye)nBq0Dejt&l)8=W3oR%|Bv{Hl@kS?R37rlY_!(KXF zNh^hvx($B|s7>&xhUDtAGVHqA4rKEIASh@_1c4m)sE;lRMQCv&v)sjQc6N3`dRAq{ zy0;T9**TO7x+vKsfvvBvNOkei>OT)=PojQG-+{{U$}#uM-O`=Q_LyuaaL z6~Np`Kjckc^HIO`p+DL<{{X~=FJxtZ-Dcu@KjLKz`xv+UmS}&c9RAVA{v;pS8Nb5* zh8Md$VrNE@iTFOz{{T)n{h^QiLcg+ee~0RY4-L38Si%)~T8!!%M7vG`vL9(g57|n} zkDwQZ-?TBlOc$~8^@d`D+2CZI>?ghCS^ae#@6sEhrtNFs&+@ z#GcC%{KuK??y^-`*b-zN-pM@2O!!^AL{~BmNAZLgzSjOMxG*HNFARYUN+`>KK zF>8UBW-->Wt;?hTtHLvyKp7{^7cl$nmUZ!>SQN}j8l1fL3d9U^3 zp7{Y^+4J)CIF&BQ7`A03`#VH$ZhJTX06q~eE-X^^bo`59;Wjg*V7xmmPO7+Dm}w)J z(Mq%+0lln#8bk@_R!oNhF2gxL#wuPP#BJ6oD_pqBTbMydFglChx=*@q5#JC?Ue05} zj@YskM${zOP)gKRqDa+B+}%U{ks5hyk&l6B<4ShuX6KyJQ{mr7@P-_R*9S*gUA0?V zWzxb6e|wmleDcB^#rv0;r7PQtn&2VETRs+bC-Afy&U>N4ob7c&;tItor6iXm-&#|n zsvUGTNCex$@P{p|QsFPDBjtE+f}E8}mz8xaX=SwIwgmJ&?&1#q9pye)7mz^DSm{7?5(-g`8j@~XNeeQ zUk1}3nZk6yx|@wCHl$meJ@cGm~1pfeq_3ZnIOhq7Mh<;sZLJ+c+)@}6*KJ>G|{e_=(O3@^bD9mJn zhU=BJ{%ijL3pCg=YWyy{4e}VtY4qRE0a@9xUOJK!;5ayETn)ZSRU-lBx#)^-a;;;x7~$zwRX2(;$7FD z)I};)vQO~8@XP!!%j2*tI;WJ|%sz)+2`H7BHVK<+?MgZ}Ly6cGckivY5!L0s+dk{F z^Z1EtnrfBYqy88ECEa}uCnnx)hRn3UZ7sNcnbiS#XHUH*_&ViRx)!TjPbf@wO1g6H zpJ)8V(rw!3&3}o1iGL#;qD;aR;@vXgD-JCgd-VB}x`^FuuU&sfV|&|SD)?Wc{eixf zds5%{qx-K@a;ZgTt{qIul$5O@Q%s{=iw5YOWT#S|rzV~|7*hVL{{U`Z$V_JA%l#Jr z0O7CC;%p*M*$RS(Ji6EuET>e?vH${MqBe0ORV5wc@-fx7PJGvO-FcxBmai&%Kk&cs zzbD*l_?yG_v9oMBD>uujG6|*6?3aRdGOq$cLdCNEXL#>xgA@3EA>(xSi}`Ka$*-vs zHa8_}X1T7Llzkmt+!97b^0__ zI4Ha2=h^FXEl!Z8)}~x!lG@5{sba0#bw6#D^mE-C-$;usysMX&lkT5>M98n5^X)G+ z*{;E4+)UeL4kc{_o?&G@<;t)8J0xoBM{*N%fv1RsrmCyXlin}7?uAJ-@2@L-q`$)Z zFpSTxS;B{s9OwJ!NddXQKc;0vL^?N9K;|~n#uTMo>FVaXOU-tEK;eA0)5-OZlU-Ms zpqO*o6U=R4&_+PDcT)0yz&a1;+#3Zd#F$%`UVSa?Yy2;>^BIb*ny$6k{{V@1UP4te ziw>Z)Rc5=WT8DmC`>^^>t7%_l!=UlCj5fC9`FgJ><>pDg{e30oyFVkVHtK2Y1qR$l zDCa0e*11(5=}lfX3h}zxm)4i{xmuK2T0oqR)CA=*3@)X-@ zFH5b&SS_iPrPPq)OW7*Yn zktX129XNF;$t`!%V}e+&k(f(2SvJ0r!7R^;uv#i|zSPUvoCEZEZ*k%c$F14j^fhnIUZ$-(D9_IgUOYcJd`MwoKUi?e$G>=7ufG;$>qZ1%@-JvA!R3I zIGsodopqMoK(I@MS!8{!ZD@;HS$~6V#ziv>D6??<5PET#bN|4QVdhH>JYtsUoD^GT-Durd{x7L{7*!FQIZss54yq8U6Jj#GRY_^he#|0KvPLJkkDyi(thPGDY2&iW6QV%j zcN05e4!`V(4m4TC*#S7iOJbu$Z49X@nU;EBI)U$HQ-wg0{2?t43aPFU)p&`5DDxDl zWlbtsE+xj%?^vq(Uw=WYC8L9x*u#O9yen6Fp;MH0O}x2Mms6Ch#P9zA3`WfzNOlg1 z(TikM#Zk3@a+ZL&@dhZkj8w}UGT6ybL$4$1!M~(Jco#%V@dU#-cA)aJkgIut4Xz!E z@dbl(N~gA_-LTA(H6U-+I{0yGApv;)(+I6L>-b`)Swb2XdR;GaO~ta^4X6^EYC-E3 zTs$pvqBcp;t>IrC-Qb%}H%Z~;YFF9@cNQCc#VqtBmQJ2R!^$QscDbS~r+m=7ob5P_ zbe5j2;H*Gq7*dOCZc<}Fe9+Q7ajCu=xQSL8lW?a{%BE8;;7IU8g6cj)bEGwo@rs(#GE*J2XsVl0nvq*B zxB^yIN>oxkQ(^~{Kj1b;@u+(+M{B$-E)o$_VYbw4SbbS6PlD7x*$MY|(F4k#GF3`R z)3KDA-KRQ*q3^9pLV|!^;X=mWEh4Ws0~se0R%#x|8%F>90?cWw`ODJL-7V-a+??Ee5F$`ZA;HSww=*AS$r70D#ZCT4vF$(F(b zr5__YRdRut4);JWcp+QAfyE#posQnns^4C0srQ}PkwYFVI*6o$pFV7)WqD&!sk)#!2OdQSkcXF+f>}b1=BS%e-28Ia;Js zpEAGlA6Qp3C~BldsJ&%?LFLsT@k< zKpuJuPUkJZF$ac&TN+w^B58-FmYJqf;-<>Q)IGoe>*)zt#kt?0t5!Z}-!#mn{Zkz9 zPHQzkm2DtqF3Veci$UQa)cnr8hY(2sH!&ulIu#^-H-p1RZu^P_V%MgVY?9ugX;dRZ zLy3G&dQ|l3B~37-^&vnDdBbu;tL8WK%B~!*u4TNR&L!2AW?U*^0QAwj*!8iByp+7Y zq?(fcdoiq}SCvJZS3a#M`$bl1smV7aGM^0YB`80>8D59q;$NJqmjw9z~~r%ywoltmLAyqLLjz*=6B#=Wd>nX0Z7c{vz&2 z>}O1@iS}e1psr?3#}cqo;z(^k-@H5q``GOgVTDz_pJSdS4}8}TMAWO2=%*_qsj}Kp z1+{6h1nJ>)*!70IF35f}U0Gk;TI@RGC|vatRVknXuMU% z7**9RRf>eF6l_G)i*wA7H22#{x2S`~PnAENeqtrVbmj8>hat{1KU+dra$bpC+^W+; zobta^A9{+4z4MLUFeXcXNK7PTbQ%Y|Of`(>aMdX&t7Qhd#Uh0h%Fe7dFk zY(&)fV7Ri|)5J*sxP%M2uU zxzf$tf#5C)K9MsQ3x0nhJo6>f>Q^@s_}_@TL)IFnV8$0PiB}S%HinRqoF9EoDIg$z zu5R~%i#%K^hd!hk=W^su`i?op+&ZN+nz?CC2GUnhZH{9|S5&&v24s)%gS+EsW#Zg% zNi&hd++m2Z?CZYRZ*G;39CC&8Jwm{iP+jKs*h zts$qDm3pBnQd95=ygae$8kCazLrBGA1+t~Q-BOpGM5@YZMV8(P|L3s~qwkn!LY&-+rJoprfFQ#Za+z_SBU) z4wk%hNRnmrPJ*QFAUcglUEFn!ql`t>S`8e;M2NArjs(qNKn8}nj5wHvg$q>m7IP4N zW4ew|-(m@8A7Rvkbtwu+znn_NDq}NNb@*?=tSy72+g>$E_NkQSYy##`fvt&Z>Akfi z^oxk()yRV3Lr=smB;aWl+@;Ya7N)s^?y2`&MTUeW3j_=Jf(%NGMkL7TJM?=iKE#D` z&Z6My<*Yu2S<9K3SRqIP{RZL`B;Ec~Od*2OrQ7cdX9HN}1)PVOQraMa=^ST7dy-DFc#7wX63ObA2QVbn!`9!kkVUeb8@K`E;XE`1F2GzbMY~oadLa}^exk& zzvG7#)n1a7lBLSN=$OhB%L)b6vG%!TK#P&_hj1w zs`E08GU9-jl~QsP4-)Cin*Il9Op(hRNzTT&7a9F+J=U&vEj~{DZkG&3mRAvK37Rt9 zkuh!;yL22!GQ$V@H8hv3I#`vH_z17b#K-&5Pv%ID8FX}i|JHTtJUtj=7D%c|F1W#z zovY0Y-6&MbnrLJI0j5%Q*4OVC&%faqx_S~Gy$xk7aZ z)i)M|W?Qj%$uEE^uTqSqMtb+i0(9K@Y9Bq)k$fodM!hk z?4$YEljf998Dfy*OP02d5Dk{u(@hA0yB3uadjN6#VyQ*av80oZw=ZUuJeG)lS!Zr( zaOQ8+i(V4P5vH64JAf+_6}0m!^k-XX$u&xUI4rG%5WtyeY}!e=D7ge)&!n_bzO-*w~>!^p4f@6J(#@hZ1SrL70ACU6jksyy_P-EcggYeaQeo=&`P1fcm603$>3UP+T!N@@GvNW+t z1v~VD&d|(pMfFNb&p##YGA+7c8D%N8 zH*lK(<4H=5hr9;F!>e(pu^#vhj2Nk5tXm-@yOPBF=t{Iu%Hef47rtu&eKa75B@1Xu zdwj{iM8@vbF*O!zP}NFTBsbkrmWF}d!1+4Z^`4Qcr?2yNGmXZwWWrAgplJk7RmrcMN*6wmV%8$6Q(CcC%6!538 z@|z^K62@%t3X?4~(@SYqO&F~8xO_UmBHLimc%s1!;Q4n z-sH>_45&+}HVY#5%BupE4!gryG3fM6R9%i!re0wV%T6gvY1Xr^AqOT>0v3zxEpwZw zhPetkvUOJK^6ouLTBfDiQd^i(k`!G*(N?yK7SOB6#~#N~*JhP3ifJpA%m`LwH0AUO z3hn@{>!+ zN=?+K5+`5L0pv1!t`!gH)nuz%+?}ru}7E0V4#u`cx07{p=y#D~-Xm7*vUol#RV@;V> zxlAfuBKOqTSe@)4)T@;Z-^2;2Qus)8B;5B(b-%~L2CVIx&QlwcWp3zl>YnZOJ~rG! zbkYm6kkhp!po_`@(D&`}1~{+F>UVE5x+W#wYnJL;Qk7t?m7biqz@YnVkH&U{=QN6rqEKbm6Q`< zaiWvgDe>`!@4bukIyfuYTXkq*>80pyAGt>T3F{q$UVku`$XU#+Q^`VEy~b;%*FHnf z${c$L=5i)67b{L%!^CpQ5Zj-}&|Z-{RWj3#Hu9!RYHWj$9HjXyZbw*dO+KQPqnBQh zVzi`8Aain@q_k|W9`OTTE5arCx99K_wl~|QHCky$G|LJ~6cUoV5J>lc*7lC1pMOxg z>|w&#UFjB(skzr3QbxV|18)&+pp1O}p(ZM)7);1WOP%DKf|XeQ5VyFLacU0z9cNw( za9j(7<~H#*5QgixrMRMyRJ}zZO{(ZS5Pt&?EyO*JxRq*5jLXVS*CSY6P?J(-VqLZ6 zSXb=}S~+O#8o3IMlCY7`kVu4`G0xCT@IuRpQAxNZJ9>5Xj_JSX7HuOBA^SPqQnb|| z4Lpn~L^T=}d?@VMQ9{5d-s3iycDB}2(lk{xN>szvn)U%8kQ`0X8*JqHx5b1F7J=O)g=uSB%fbLPnW?2q zQ(4MasQ_qfI*$?K96Du7s#BR)-X$j@hR4^>!Vtw8ZBMj8F5M#fSRV~<2|9F;%2(Y* z?5lT=?v6ATC#uyZk99UF?}EK8bPZv-3r8~z)=^ezE;OL*y6h6G+-ub*q#+7s^-^8Q zYpgg!XauPlZ+m>9PA4qhlyq{^w1kYw1RGl5!jd@HEmaf(jgUf3j^tj^(}AU)NeZ(8 zr6}eqNbaxW;{Y0!3FOM7Vaz*dFYDtRZh;&&>E6~etT+kxkgy6>uU@1>dTd>p=K-^>xfPAt$LB*l6sDUIY(^h%T$<{?x3M+15lC;j40uw zKB?5HDwjeCvAR^EHTVso6e$F5dZ_kb@>*pfKJrdu@*)NYHmM^qJj<*p^aU-x;?>+B zo}%BoSZq=hR2pKa@`71PQq&vDR-#1_n+SG4w3d?7Ile(JiR8Y zYxJ>$PhhZ(QRWJPQ_Hu7w1ud@KS4T?+-^ZA)k`PSNOeR@X3*sw(hr#sw2+fRU?{51 zB_{iY9X|*|@)VA9(kN@*Aq4a~rvAD@94PIWy_v>zB_R0|l>GGuI+H5k}gM)xQSTvxVssaJ0OlS z{^mrCxl{OVp*bsil{GOia*xUMKEF{KOD*gbORUr77OIr8+hIA2DpE+kZvd~tD)`AJ`H$m?HtCXe z2|0&d<~5aPM5{KQ7wHvEl2R1j-8g%zEag2?Re#0{J4IIZ+@aUyIZmYrm|(gbL2NHF z3VI%v^U^N3IVvJ#L>`~wCNIV^B9f-BDu+<;Knm`-gK(j#0Ql*wSSLd?Oe`8-MtXzwJjg`j0g00r&^)wFX{3KK8()t1F|+GRp=N%ke_^3yC4lf15SNC)1v zhh3p9odbg1rkZaTqH1|W%dT75f`HKp2I;UTKsx+%h}ofW7ZzO>6saP1OgMvdZk2eA z!4X3yO-NDGs%%b;97db>hMv9!Qk$hKMx?6RfJL?G4=Ga`aI`-2 zEd;o1G`vVmj?u7(%1O}L6=GT=jwr>BF*Nf5iHCV=Df*-p3v|{TQ=u9gBv)tor)MRb zTg@$^RIclZDOInf!G&tDQK75ivO+N4BK@WR0G)VxFLZG)%%oXqo=bU&+{4=Fc|y&G zswr_KUsx7I!QyD-OwHaJl&o?vqmAvCHiTF>mWkN5MNCjC%`4uq1bXWX&5gLxIG6@o z1&eMZ)o)&q)$SFs!=$NFa_rn$MYNOh5WRG9Ld6WVM>!Y0qpKi1LUR=fN}7tc`(d%%drX7;b*Yo(gr8-vofA-89Y0W&9GT$Noa6HUIAA85U~ zXt@O?W2qXErK7XrE}DBkGJY&v(;eO{aHkMrS=SpgbkwcqxypP@*&(5#T08CG)&-vV z{%DsBJ8k(fAvwURoh<<^RcWpaw^2;iT&JkpQ5<-<5C>tGJRvf>uaf zzSBpqm@yK0Zp&>jD{9uR6dpyO02;-z(^2};i5)_J~px|n09DNPbg+33QAJ7ez-^{ zH{%Yukz*GZxdAa8_9wwp&QmI{ydOt-3rgI|w0P=4_>CeQ`ylxWfAPA1?!urG0C9mj-n#b`T>)o0YTt#b~QEC5boHt@E_IOHi~LX6^i zli&k6GhhG!I-#KPvHW2=n6(Ai=rN1xO&~TWCUU0s`o&*g6MaN;QPquh0qjLLG(NIr z^KdJivZXT(xJr~V_mg{zoytW6*%WLrSY zf|RHbLD&L3PU$`eXyu*KTCZnrAs!)7$1zu$V$He|k<3s|#l&2PP=4^%F+S6Sg#Q3- z{a01>MaK_Ke*XZY=*Q*RUSPPm({!tECKi7d*QZFP<^6X507d?cn7;P^0EaKt9NBqr zm64DHs92;6G&*;YyDp!+p6P_bO?KPU=D)iyK0@TJec!KD^(lvpw14DAC7SkhmX9!~ zSy$hCk)ap($ENUEJX~qL%+`2lldX=u7Z7p#QI%%26s9Hlz?{gD2f`w`bv~q^n$1R!86wNMvnu4~JtISJ_*=g!hkzt>}_1YPp zF;=9hk3o7v8_6oIPi#y!>Mb=Y042aTx(D>B>3wvxP;tB^T%xc1QSQHW(6HfnmYRf} zSMbZT?R}WqRU{jwkhTz~lD3a1s9&Dg-G@9~PuT}uBQq#zs@*}?J1xqQE3UYoT3b^ibkM{b>6 zl1prm9ByBjd23j+lX%gMUkbewzt0Gy3U>`yCA zL#lFBXqPVk06$>~vy#qiiN;g*TUWfN2km&mlD>Od-Ff#ybUmrtU&8yZ@V@6orkrrC z;?f>?r|X&;w?8ksUu*A7BwFh6)4~(+?Yi!}{7zcs$zIQ_W!e7#lEnzjR)?j+9$K5T zOIN!z$J&>B#q?{Gf3`TfH1D@&yFW3O?$g_S>zrl&CH_k?Ni>v}gC`?K;!)M^($Bpq zG2nu9N`4!G1X|jiZ}?m2{{X_yNxko%_mb+r#UDQBS;p>+r5upjyQbD$quxGJ>+$eE zCE822{{T3@{zZ+azk6RPFaAjh8Tm6fwWY>VmX-eiA?znY(*DHcpy&zJOZe^#4W)PG zYySXlLi7d&hwO5vW}0w?6}ZaVHY-=W*gw(Ced%-dRj~1h4g9)W=DeSE*^{Fe zukyQ^&JuT-Id^^N?D)x21qxklb#F!z) zDYJDYee%O+LPzw{2cv^^Bi0eGr_Pt>A2H<`-{o)emzQQJ=+!hmdnqm#Q(>D%raYtp?}m-(l3d>#5r{{Xfb zZZXiM-oiDxXM=68m(C0lIaz@Rn<;%l6}^VayjpOLsi%Ec?YEH5f5f}0d-eD~F{-Io z@um-!rzU{w2$Y#+u!i0%zI>o*m&Vt$T4RiN)Zadwh?yIFlwEVxVuKDjj4@G|r(+3G zHBFjnNLRBJ=Rvi?tmkyw#O=IT;c6Wlhzy<96DO;)?Tr}Ea^JYm`YHPN%DXW{WQ(XG^UgG zvGFXt-wbGBW6;sOjwMX$>~#pcV`D2JuYtx$fJ)J<($D=vyS$c=Ja7F2blIJE72< zXaW;4ET1yk!6_a#=?+6YvAedu4$#Jkh$gkN_ zOMjv`n7@Shn-7k2KFd&G>XRt4wI4+F_!yaw+IZ)+*T#sF;3T>cvbBv2zGfy+wjCN2 zIFf}Af}+h$OLf1)ayNsd<4~~>LdK%dISwciM+sMp=u>E3MJ**EUv!ac#5u;x2y8-b zBeOZf-g4$pr4%gl6agV=J17%tgVymGswAPc!yTq(aL;z1IXf(m@Mv*KYzvPD7C2U5{0`R9fujXq?kz%<`!`Pq;^ z<0+y403_KU{{Wp0cya7JpwXIJv?H@a>nfF7exg7>=RzD8VM-?%>WIg)2x3BZzcoED ztc^9!wq+knkde9Y5Nx_C_z9F*Y`7bO)eIp=mXcj&u7}HZQj5uPDR7T>yn;eO&}$T# za{epbd2&Z%UQWGEl`DsJ#a%8}s;B@IT=Mi^P0((iI7D;bb-CF>J(D)@*9tKtk^-hN zJw;0w4x=L_Bfz5V-rZtS&$m_Ic1CfH@=vjc3Gn{_5K)x3Dj0^NFr=+TOrZ@W1+sgp zNXeUR>}|e~%=nwxTCUvdxa!8P={xV-Ww_D93|l2C^xhe+PrUMex7i;fzTWB#skDMr zIwa_JhOy*}d#|5S>0e6y1x)8>$v!C1rJJjB7dOia6Kk=UN{G1yWjE01N5Us?)9gjg zhF-7O7FMQ|rBz4Omu%^6R`l*(F5-%*GBj}`vNVqmCS~P)t+|Ki9SySIC>86vhyYn5 zsTYONluh0QaMH2CCXABi!}5OfRw~Zgj_KCGqrh$=9%z#B62e}%#dx6;=t^BdyKevm zkC8fpdh{_d<_6_gO2c`hp1vM6^}fu_bMaG4w(J=f{`k+_JdD_?K+ASOHDP9oww z!K>l=obye-wR7d%dC#eNCe9@p0R_Ck0sevx3w52^)XHC9hIjTNqDft+u@D~`;=})vs z^2O}qs&OLTdT9$zK4K~P4Ru={@ot9V*g?0HBc$ac_vAG$mEg`B?`xSJ~33ZuxZ0o8|pj3%Ss z@;h=hsXd`_^N#Yy9F$tGvSpmV=L3v;i;I_G?4t3*6w)$H;tE`aI!F_lE|Q1VKgG6n zQS#H)A>?t6#f}_qV->_M(=~oIO{$lM8%&c#5VwgfcXlS}QMvd-87d0p=!uZV<+OcY zA@1yXg642zl?h451J7qd*6LJMn=)^F$5Rwsc4aziZMhHlP78haC0eAMt`dc%4zv!T zX$t(o5mKhk$|(y+FpP~pN!QwC3@r#bR?y|B8*U11tWCo0q7Fg>sr*Y(b;Zl#DvB9O z)C+2ybD3a%$Q?W*c?6nDkwYa+;!a`t>F0x!7>>Fe{aMwBkfOUGx-nN@n!pJYb2y@^ z(+L+TdVOVU@VR5lN=vF{dZQ_vAMvdWx_Yivkh^(;Y@y@gW0CTH ztR?1+3Uf4uKCWJ=Ql_Z?07Ee9kl&#~t}W#bTYVGwB0EWU_5H^ZUWHMrl(dHE)pVb9 zKEhVAI-JNII-6KS*qw5<@MJvkzIF2({AXFhJU3~@h8HJR1g9lBWVXUc@hKpa|5s!{+#{{U3?Om-++DymJYhY{=ZGV{uLneyV! zS&YGHwa5wv=gUnZVvk}YcJ~vQlCI?fVG`2_Nm*V?6zFXWLu}(3xo=#fewOo&GpOrUTbG}lnI}+|87Q}ntqD4FD0ps8 zqL&k0`Bo*lMfa(kpnc!^oS5a$xXJ3L=t|F0h_RLFOf1;RkR*(%!K}ncK3` z8zYx4nOCutjJ%GGOJ)HeiwwZ%EwJz%As0*H$5OUTTv(@M@Z7}13+2AsDpFQJRfxT= z2-HIuowe~L&1_d29Dl2|hs|PopF^B&sg*F{OKvdovZP%`$_XTo_$?ZRhAGmtQ#rF= zh_o&nVjrW8W{o=_?NNrFM8t?_p&Zj-9L=roy@AtP!mdi|dJ##QxSRW!G~z?_`isez zPy{J?Nf+@cKoMClXxBtY_e(KQzq$1N6y9GDPBMSRxKa5CZTm~f0^vN#r@~Ge)VN~O znSQG=Q3@Nr=5-|Bp|G&>H;SGoh}P{Sz69(zw5|6)|JSij97`t=PfJvoA##ePF(%>I zhf?WMkWy@+q2AU$F`sI-Er?@`@ak#RU#dOk=U-s?t+{7HK=ZL4u&C_5LL_l`lRdDLZ+4jY|z&-we$#Z ztycH}tTUNgW4QSep9HvP==7V6;i;~3py_6p-$C=yNg~l(F5Q_iKgee!OvV>RD3VyZ zq_GP#Nz-DhF5;p zIQe=GK02ZzW=3LRDgm}B${+!`Uw9}UmbLuv1a^NQd-{w-%;Ph-Ms9J0g5yjjjP}3O zDbS|?9YunVpGdLB_xgQE(nLhVoGnKdQ%iQAGMPE~`L)dsSnsndB+n@&Hz0!IiU0E_*k_lHAha*mC*8k}AMr_ibM4Dy#eWDuEvLXh(dW8&3Co~cI}`fJx0r>*OA?Z_R;MXa4Y=LP<&nz^(JRgp zO3=NoEte^=*5W$B9f{gB%_gu-2q|o-hL)LCETwHNAz6YJvU&iZ4bpapBF5yqksg7E zC3vxlr;yW#r_~;pbQcOwCZLm|lH+#)hXP4SDctK4IuWXv_F)WP{p;#-H0)n2xku#N za$Z7Yt22D35|k8XY!s|nDX~|0LlcdUMV!7YGVKzPTwVK##I&il7CqHA^QKO2MQ z400=TljZl^eDP&RJ{PJ^Aw>%lZ6Pa3)Hdtwp+I_pYwjVX5ytrrULnO#QD@{Sk2aSj zAGE66*q2h@FxYMYNWX`j;S_alCOD(R`7BpVdW|-asb^)@+6fmaSt`guz4X(qw2moI zHK>JLEa3pebU8^SElx~RDyx()TKT2aGbEJXK$0!i@!3zWaS?&i;yo(8!{-rCW@&7P zlJ-YYl!c`LCs1!|1rezR7^T!(My3eI2B{(RJyeEg+ixolrol4_K<)vQWkZ6(;G3vK zT(I9#7YEUj7LJLGIQk?ULOBk~0urO&OX@}3$aTOQw4_G4W9GpBi*?q<{m(up%fN2zsjnW z0n|3b;N7I0e=_{^ELR(!a(z0ZsDV15i)B9mhR8K1}4Je21TgU8?F>0&SX3Bpm5?R+i=GtP^shV3nmQ zHa=wAtaV1!$EP$kI493Mk~g zD}2$%LY)&*&V-dLGT|1mHz4?J3r#=jaPsJG%%~_lNGC&WAk%$9#P%pau1XuQ2wY?WFi^EG-;;RzFk$MYJHNuZ%4_^Z6WTL^)rU zsf9^S6njm9N>WyXeZ`7^N%XuSwD$gAn5v@@#S<7=tnRe6xJpti<0WSL0umL|d-aaR zOSAawanl~GJ6T%WyNh!6y_A8m{g`n{^}j(5CndaI)+2p#?2OJJ*+^bwcTR;#xEY6} z8t?9o>7hN0aa|*a=n0&dZdnN#!0+FE#jg+J$E)p#awF~{?b}1csL3cDs5nVV3Q}81 zS48GgEf*NLM){Ftl_Qxy+a|9uAgPupYeC9LCS{dr`!)ygi5}y9P}h$|Z*hyYhA-kf zZ%Ha)$r(pRMYIsn1a$<2g?=I?;^89?HZ?5mk(yGiR>GEayqWgTyxFo82Z&a>j|i14 z3PVdR4jvohi#0>+u3ZZxSt`(i2AwQ@VkGz~-48A!xbA;^byC?0P_ltGH{SkMh@R_g zf5xFtgXU$cjV04y<4af~$8%+Th}3+coRM+ZaxTRjs@z3L%}FUqB`R&iWbUrSDIlw1 z<<=2fQ##({nWphERiyHrM=E6_J-4_6-UinAM1Kfgv$IUba`m>s8ZARqZF_YWAA}DZ zM-dSbT(Z2!Vl`b?VhcmV3k63X+|yrTfX( z%meYXJw8ZjGE}!t`c7cVJXF)grp{YycGd__fl2WY%?q)>uG1Z;%}hI#6oAH12nS76 zetKFu<6;w_XQmY7!^|AI5WAhiPPu(=*UmW6)Wy8xNmGa<3#B6V8tvl)M^iMNndLZ{ zVx3*Ok528kgtT_e_Z4k)?j+ccO{0`{%nZ&dc{fF~3tV*(!=_ZY^G*)w<*7QK1zrj| zbQyc=03*Gsn>|S$@E`BAah)6dOHws8E<#<^u;WTXxv3Y(v)@Pn=%Jvv*n?>1kg-no zdYY5$^9gNW-D49=5&UstWKwh`!_3p|m4S9n^Ft8<%{0DFW>TkdRJ;U_pgZ%Q;L_y^p$w z6rgXSt=FfFBT3sliFL~oLC~F`aiFtl45u(%u1{Fy9kUe0Zd|^ZM;u6bV4RoKjd?TS}5^&X-S1GyVw2^Bol7~Wvs5&1b9MeLz3mFQ;5uX-76p4ZX#uM^U-T zn^VE3lv`C@-c?S0HwA>HvukQS?T+RV)tr|kJdDjIbX}J( z#{QA&q*z}SySW}6pgCfi}5%T>}k zYE6t3k<+SLvIUNSX{2=Fpu^)hH`?RE6K755TrOBN;7YHxt`C%U?BSt4=d*(2z=8#? zo1elG_7sjvYqA7tptJib2lCPptsT4Nz67 z+h|OsT;I@AU6IpiN~eId5T@;OU0~~EZ5J}?vX1ohv!=)E?LoS_9O5y*OeU7A*X3< z&m_12BzZ!$G$MuG9<;jyOL;?(V{%6F6sHxg(c80!L9__!1464J-1}v>P?eF?wU*ih#Tk0B7-FJp`xuIgpe-Zf@HNNL`h{}%vY11zuZL-!(-&hrx zoWH6VH?*eCHZ8L`m~j4(@;Pv_GU zL_IBcQsNo__eRAa*+a;KcuIeCDE0|uo*+we&=Qe*5Txjq3^58)dLnfIUv6c|^P!Gzgq^4aXC^ zJ28c5vlAwY+hv3W^BJ9Vk`hJ5l&fkw#JqW})s0FU5&r;(xTbrBp3RCVlvkzNK{?+u zX?YH!)>2f3+@x<~Yl9XlRke|{*z8m|^j~1rCTY&IFErtBz24=OEb2kaZ`}^5jl4`| zrSVe|)z)zbG&+{jKxA$~{cBiT(glz_A%9QpGexIVRXpT_fzpmzmKLMk^a;1d6tmMg z?$$1m+UE|rs+x3vZ~aJDy(6CLDQTUmaNN>v8&&)>tM{f7__T*3!T~wjs}D9it&o3d zU+TcPlq=m@H|U+MXiQm3ZDQJuN&f&w6u7jGJ`u6C;ujg{xW0)~kd<(U=Mmfr1Ps}) zskMfkOg$bwC%BJsWp^{d7YlawwiVYXyea!lb{$*?nXgUYn&w?7arW9s-9+BQ&>dm7 z?KHPYQsBJBL!F*w2)i{#+&^d*%0T&@VISIc&{w!F;U)V!xtuA9sYh~fMU7rnjRW1jXS+|EKfSJ0+Vlr0WsNCM$X7q|5wTw*%-Gi{#JR0~~cc#i_% z{{T`I?`TiCvqGWTXA3x!d1b8s0Lew4^kFZHLYD?02Wr{{IcJq3wBJn@uil7eTuqKg zhN8;&Rm52yAXAvAQ`QvTP!yeRl>w+X0zA)&n}nV0?V7wvG^?@IqG5JtYLima2<|P! z%*wgFvkN$jbr;+ohd~jep1EvGEAzGI4PU@6OT5cjCBy2nk~A%^TOCfv$5_yC8T?C6 zogJFlHPP-gQ~=VFg`;%~f4|b zLZUSvs-f5Rqk_!Lt!VCx*lGaW4-w<(96D~GsEu_B)g)}MG2nbbfa$8P{{VQ6b|=Tk zkKX_q&P(3fd%J6@e~6CQ8crZ4;C0v6%tFMojZ;8%wV^;LD{yu`z6Z`7gQhc*I+Za2 zhAPsup*v5TndGJ9qm{$bAMZD5@O1Hi*YNBFdUB;G1K(Qfl?9d2r|wjkWl6Q{RqC>9V3!s_@v^tBTp7M zMO5It!ET~ClBE4y;y?*kfLansN&RiSVmmFd<-TKThk}idQGbW;^$>z$HUS@mAn0_w zG=S)2tQ{kaaTwP4MaPEyZTw+2bmvV}(JSv8e-9|-oU@+od5(*}!2bXURUB;M&Q+Ow zWzBGUA0D2bvDzE5XYjYPJiOy_^%|;_>XeRR)N>&%bKNi-_3jmecCVQ z$=jy?07vl=)7_BiGexCKIPysz;9dEEZloznwftLEk4WP7)cI21mo8pkw=qwHkEh4$ z`-=__@Ko@WzLuX;(yuGH7u-&Mi6-T2x#oL@D>(i&aY;I=+nZbVzHwx(9|wbee?7lc zNIr9|D5+$n(4Va&0;HqvxPjeuKjRVJ8^vRjx8JVaJl9`}BvNb3r%n8yPlEzlYbx6* z7QT%jD)t>z+lNID@oUs+ok~9)DfGHPhmX?(MCG{hn%GrqFDmcWp%= zrA0$hR+H|l&{)Rn*m;zqw5vHHld_Wl~5k1gQ?R;NM)ivigAvs~K%FdGI^5)hmoZ zOS*lUq6dAYUsK`^P$4fF3SLB=T8yc*CrH+#US;tzn{OPTv6-53dxh0j>QvO{W%Z>K zOk4nk~JM|8NM@wyK9sF zCFlMn@cNcKHx;3z`LE%AU6|U=(Nar^c!!j>?=;ZROtv%=2qWEEdZjv>dPNkW&#zX$ z#J|M5KO*uuxmMKw01N*B3;zHM?!3g)RP2uqQp4`4t+WDqR0DR^(GIuJ`^MgI%~vh| z09D(`j>{#j_TT+kck@j1bkv_^b(gNtB{DN=7qU;iCi+i9YXz@S>$;m;S1ynAVth_^ zxBm2h_T~Ek&KQ=Jm*u6!GbkUsR@HR*qJGJ}+-*ubYLE@K*wxpkFY{mOguJf%y7@{! zqdHUAeJD)Fw50Og%k9jhk>2|=Y^Z7pwaOE(#uDdOYnJj~`*IMn-B(ZHfBS3w#GAA< z)2CLK9_Fn~j%!5aMD)K!jcnV^`B_RM&qQ}z@9MvC?-x={ZT|qaztsyxOnWNWS{(~< zEvwlbUV-Mm+_R%(sB~JjCtnzIQ(vR*yD~RBwYB~vx;~O$uy#z8*R#0Gg|vkd!9Mh} zpKYZB@3yVA?v9-xy5+ZTC)?n0x4oGS6>{mjuT|OkoLNjl&L5~QW>_WPX^ak1~3AO$a zDid|T@@Q&t)T_4feOHmOUB+~J1oIL}o8^wc@hpOZR{Q`@J4f`vAQk24}pWlEE;HKlIjO5CGdz7Yyex%B#ZuIR9a z`}4iLrR4iRGnZJWrl6HJQ_SW7>1_uuH!ZC)!oI_a-A(D6!W+Ne&)U)<{VR*9kb5NCfD~7P(pg!W*!n@-HFr6I&Fo{svG-OJ09iCbWzObzT6JZB(ISS^-H)4dCE!UGJhgsN zD;F}mFC*q(jO2>U-d&5!Ka6@FAK_mE5uf;<#BC|v^J5Q@7`BvHNdY5x;}SWvS#+CU zQ4Gn66_n{yQ*)Ne3Y2yO_`_0`o??=*>ce>1t{uqC(yA@tj#7$Vq^srDJfA2 z13~X@Z>j0DP-o+ypLC0iJQSMvjh76270py;-g^>HDp9nogk?xsdf#g@Rox!3UBr7* z5&j?4xZ(H-K7XM&@c#e+C>RyKQfZ2*A;1)0QPg+~DP9`sXsOG`Iq$#Ak!z2IQQL2r z@_Q8Iy9pGDhT3hg0GC=p)9&Uvr^BtHuf)~8mO4~+Yvy219ZoM$a$;TCIpq7UwyS_g zT*)CS9!d};Vx0UnvrTq7&jC(s%hqOP-DM-ZrGS-@)4HC%VhJvesBKF3f_L}aZx_T` zW*-V}KupcDKFCo@2ar{+o}|nT971LFbQ>k5}*W1 zgNk-FJ@)7E8dR)6At0WEDr_QOjK23GXe9O-?CRm`ETY z)P`LH^obbDgp&2*`kTAr2K<;e_Y1)#V&%Lr|pI#3>`FQZ5MmqW(Ngax06!pfn>dpcsog|$vcQ<*Uy_$xqQ5eL6lMza9dD4;&fJEEz`y; zxSaHw?a%iZ%NG`s>(}%r-gL?>OL4_0rLoKw(P-$f2E=vCuZ&VTX>GTAZ|1xI071I7 zvaR;=eU6NUO}7-5xtW)fIMd&6$HL?158}$3tKP5Th9?T%y81IXpCM^zE4-nZvuzfU zx_pTF!^&@$&3UfFZY!U!lkQ=8Mq@5TamfZVq@a|<( zfy5FIFI#PVi~ZpIqpj`R^kG!{{-{m|d2XqDAgCes{^HNN;5|X|(jCK@L)U+ZP8yfx z@Gw+aRHDii{{RT_jW#)2D&(kZvF#ZXthY3)W|nm;2Hgp<^oNj|7WH;Av78M65gRum zP9ZoH5&_(G5l@h_#x^+nA5UQ_oh_LonU~x==7=5S0pdZo!XoJ;tn>w#3?5p zWT?GE#JaaMW=jfCI}k)iavssULGGMOuQ}h#R=e zslTpKVtoOKG4f=&D;)mIl^F?1%7Q8ATXM-lR9je9WGcrn*HiG*!Xt5tO)Xsa-}(@; zRc+jucuHtYCC6LUwJSqwU*{E?NZB0<>_GTkCHrZWB$4oo9vM?a46LopEos+tD1xOZ zkURl9f3`Q6(Md72g|zz)jQUR_HM&Nn*S#21o>t`}~(93Z6n0T88@wkAe4 zw>Gf0IeQP!)K^hq*>t%5no`nippjs1kbfBB%#gQ-S0SP803~r`)jj%rnkH*5I#DdJ z=O~>vQjL>u+KHI5Sr;xU_>mv9XJ$-K!|8VGl{RJ9FP$O6!t)kM+c@eD*GM+=XhcSa(wdArqZv?HX6aBRAoPb5 z8)(lXRB0LlpifMvU&0m4fPP$k0I2QmL z&9F2d*N$pCV_S+S6IeQ6%2cJ-Ei|3mU5~^mH%a&y>SspR7Si6S)GpFWi3$9nEO8QV zhcq`SlA>)$x>9oLZFLTwF;~SqCt*}bOcTVGY7NXuzS8B?;tDemRGoT)2ELI|lO1kY zLD_?Ycudf75(=J7!CLck0L!J0gdL(bM`)Fe6Q79-_Dn50ukj9T@rd|&uaD|W$=Bdg zD8;h#_!f17@(jW%S-EP_Syqb!Z-i`g)QTI}R&la;O0$HPebG;qCda{WnDqtvmnBiC zC0KKqo~@*h!Z7(>%+Ns%y)L3wk#o`_SnG(gk$*MMlyS3^fB(>YxM9VF$+*YEA~+e@-)9Key@ z3Dlh1W)PU5v0aF8%&rcqRRC`^x^TKCSS#-ozb?0>+;m@MlsRP)z2Ql0aAUY|m!>fE zie=kd&bftMN?JfAZWNaSQjj$#zzA-9{$r8kKb$efiLa^IHiM0-PF7ihRo%?|th;J; zAYS$dxS&8c9U`|pX}8>&jf*+@Gt)J!X*usoOj6{5PNaKBEUZ{B&u1*VM?wm8%*&Fh%#&@>ZMN6eBxIc`?_+U9<;R#l zQiV%G!h>y^ftyiT83343Q{h?w8_K0#`)Emsu%7<_G3xw^+H(@saFJY*Q>Aoo?>y^Xa1S}o!ABeS=~EIgbKCry57Y|8s%NI+VNOJUI6&ow|lPXoTvd(Nu)t-4LOhKG@-k1CRApw2%q z(wS(=%x08W7cZ8SoQSr8=>VO41TG^}Aw~viyc>noIVyu*hoq-rP%Z71%hHS!bo zZE$)+Ezs=|+l{<2n!~t$cu>pJ6u?@2>T9bib&|`ea4t&2DL^Aso|{6V#^$y<7+IC^ zF9W{aDc)h8EKDH^RgQE#g}m7U_EJb*oix7ia$vWi^Wt>bO-hoXsQP3NP`O1U!xTBw z<@$*{IQsAu&3!YIE;}NG$vV>BSz4H8WhzpVRDQ}8dw3_t8)DLbn7P0V%iu?nm87h* zDufPFO1X<#3#wO3-oq(Akr~RL-^6mQeE$HDpnK}%U1DXVti0+&CB*8W{{VSr-7<@l zZHR=o(Cra>j$9C#q*LdrR3$d^4>Dg|vc_bqmYn3EByXYAYA$sUM|OlsQV|U|J2NLM zTA;TxQIc&9KIEH#y*S8qy#%_4=_S*-ZAUP+=Fr=Mm7|)gbGw2u^**;S;Y*43mxv2# zR!fOeZlwjbq7;>G2t6Vc@wNMosU|CNgvCn~rBq1=6x6$pa@=^597B0R$ZU_YQgkOx zArYmy)~r7baNQ>nEogD%t@K&6F!hRy4BZVWK>Oy`Awx}cjx^5l97phzvXjk}Hd5jW zl!Yt4$N*UK)$cZ)FZ?M&V_CX-R+%GO%| zB`%VdpYv?yDpkg#NO{^;tK$CvQXH|X{Ru5d#%)v#!X{8yRI0*OwP@Ob7Yaho>GSAx zgsJnrtI%oVu3OpB4>eUuT$`;pdf7oh`sM53VKscH=PqJ)ZkXjYwYs-L5;Y+gDlpT7 ziWPQk(I%UET&p^>6LhIyf_*P*$6|4yU!LZXaN>adLL-h}A3#Xhc1h`^lFES=xYXL? z{q+&rzDF*NiMmXpEj2gG3jhT;t5{#4C#B&{E^dw|(Hx1XIcmCAnO6Z?Zb17a`FQwg z4YZ#jY1c6cF;J+|mfJxoQ(;#*m#UI{G~db@w!f&lOk2xRQCIrR>ag86+tfpx_P%%`@{ebmxOhs7HUpm>00Y|eJSREKy|P)r^3qILR=J))ab=S zrK)w6vpPatZB|3N9KdX&ar2HwH_RKZM+wPVwiBIH(i>`aUC@*`mecj4pjSY2-tbe4 zzGrr8u5$d@iSz+IDY-cY4qzz-O8v^I#vi8y&o#PfdBIY^g8!fLxO-wk+2`SM{9Ig*Lj=mO-*O%^c#z}phrQVy8sG6;D zg|ecwwr0wZqBY9uRF!YFffpJ>iPEn9*6P0_jL^qDpD?yRm~raT-J6(s9JIJzQClE& zXaGZM>w9WHV&tDwo^9>-M-H7cWqs)?UqkNE+rAufdup)Mf_?*Z-=4G!is z7&57UBD*ALgpW|C@ciSF?l(@An?=&>jMHjt5)Vw@dvvKL#8`;E#|tYbIv+Z<7K1NJ zOYcicy*82qjkEQj0xm*AZmZu-bTKwK(;~c-LaLPI0<8SPQ79!)E)ivARs6=IL(oT3 zM_YXe>xksdIns+Z`#)t?xgLk4GSw0zD-&qM3+AHED5VFwl_;BZ)4~x#>~y5DtBp3a z=E`;oN!$&y*zP=GmxVFKk&n*`xQ@Ca&_cq}ZJjDr!9P8Gy2Kp(Hm%Vk9%?0JBZ%zJ zs%5mGeM60wuezCV4BFpPm0Vb86A&eWks)NUUgbVp5-<$9vZW*}qfH1mzMVQBlr>Z; z%+w5E^t-Mwpca%2x?G?rdEZW&M;+E$=4yixpr5C zCBvv{8r%m!2Dwyivv8NQT>bN95r33+P_R;>N=;79(OXlps7tN{W^FDfHbZ{;6R`m3 zKpVnRIM}K7_diIyx$K?>h!rDq7$T6qg|QhFxy3x2NtvgYukStM<_KNIu&Vis7jwfX=)@b z1P}#{w7-bfJ5&}XaY907CDdPWge}s7TUbcVxM} zijG|`<7@BIIYFpya69v-zdGp?E&IrEv6!B@6}cWBQO1s@I~1%y)Y4JSA*H(ELK01i zlr_+G&|lIypjM+K)Nd2E9$OY|wWJHIkTh1J z*E@drG@R6GIW;Rf>Ls3Ev}Xx&>mg01%E|~m6?@v=5NQiHE7bCaQm5T4go1z?a^2hA zDg^zjZ+nYJDC=TEr&=pB4YK;y+`3y+h|OhXQf_jndR!feg=rJ0+^13~^YY1A044Ux z4v+)3P~SM$H=m4k#1jjGu(cb9N_F(UwXMrt$DGcx0JXCl6XYY6XLTNPh|-g@E;7Wz zTQcD*bq*&&mj`s6e6)i{P}F3k;@Lb(;9#V(R@1FCvYRD&tZv$lw;mhy);ObKbQ-qD zHRe*47aU;$E`@5Wwzh9wj<&pU!0M62#5naeXT*bS-7Ye;xKF%;rd-3pT8}v9leT1D z8D^6-iNNBSWw~TDropo#F}P6xSSTO0;iPq{`W#GBN#m4L)McNSe7KY?z(5Pmlneb? zz14B<%XxuyAqp3#LKBjJ?6@;+5WFjgbFpu{>N^|6$K{6Djx$9 zP{E$advFQ#g>24pG-st+a9E`T_$nKkUP7YSo^{8Y1uZrbpfoonC(BJ?hCFlTB%Y{% zRm^X2pcVL}#~QPzI$oHm2g3QzkS}zv-PglNPa~&w>Wi%#6lWa>O~=j#&QXcEgq0|% zkdk`%$1Lp$S=x)#^{6>=&rm(^JV!zymf9Rj&aFN9X_RKnN`F=qnZ|Y4m~GQ$)OOiI z#@-~e;p05PS|ZU~N?ITA=>hOXj5 z8&b8f00MfOXdpT)mXU2COzIkpLrM#;rTbk;l?WadD!KfG4fGb4!m6n&EQ))L&9;|P zy)vi*4f+sw5!CB*yvBZ0hjbRDy@hge-p=V4Mnu@%K%0wL!@e`_E5k&CcMi`_yX;OP zOXysjzh^C#DM+<|vF-uoYec^pg2ITcQtW?(kvj19QZp=^sURc+(IYN{$`bg7Enq_} z#qP}Xip_JEE|+D{+YP5HHb@`~4U@i_#5|mAqq3q@I7HQ)274M)W=5_}pH<)e7=rz! zCH)DDfQvluVTwz}_kZF?`mxXLIeno|fQhp&*h-F_)aUlV{{Tig{iP?^@3=(RPhtup zH0HcN@=OofGW!6lKvci}rym4`GJ7FV znieW}e_Vg741Z}!4L%hknKRh?554axc>~LC*}9^4*?oz>@h(f zZNc$R`mx{bNu2NyZ}~DDK97BFE8?H^V~^Ui@;mP6*hgb5GS=yE{8Rp{F#V~JTH%qj zj>!04U-}gv?Ee6(48Lk+?l`z;_BmBf%Q#@9fi6d%cl}sqUe?OGj;v7?GHq@>u zmQ^3jYs^H9Z}$+7H?w06R}d_Evj?aY5+HNK5ZSG zYsEW(93D2%;+)?pxE}6_K5d_}uMy)M6m*i}lc_fZYENI=AA8ONp*{T#?ml+?;s6WE zxc>lu@_&RV4M&*F4&NQVJ_b63vzqHf+#4TJugA;I7KAaa#~1;;P~Jj2z+DE{Q1mu8 zPnPjB4s9i06T^6-LkQ!{UBTuRDNcJc1y>gI4OBN|wLWPfo?jfed zEx8r7$3Dk1cyO+xhJLnO-Aa@Zw$-Yvzn{)=kfDi zXmN1qeeL|1>?^`uz8!z6^Fo%L zCe1yOERYg}Xn<3cHacfW)wOsyp6Q6rTDkLk@3LPW&&>;}<@EhKuOk%O-piXsD#H4w zGMDD!MvkMw#CL==-`n2)J=dDtaw`7o)3fq>7?_+);R<1DRfYSj3UK(Ph3x7+^Goj! zSX!0x{O$aoRpib!TF`gd!JhV@pp}(sojHh5 zQD5pdv!jXeY0mK41pfN`6Y9L4=XC!7Pt~rU6l%RYWSph6l$+~xw2wpYOS|jbCKG>s z7wZ@F6{q9+ztT(UXD&A|7pjnQ+=7wJKdkF}I6NFiu&D3%zs+^{qnoemx5@PQF@xZ-&>o7pqbHE*A%ujtC&E*mxZe&4ZHa;{wj|5i(@_^Y1DlmIV6CW9VGXWGh>-rY6^7+${ry;WcTdP+Evaa51?v| zxQeR)q>z$AvgmF~iPNb&LvAB-AG%I49La=-P^7Z%LURHyZyVY=p<_~&3rSo|%}@ld zEy3InL?&3oYqQviJ$C4^^& zOav*l-A%7mB&gW>jjsrBVedwe;T1i-63DliFm4|5D%ioTHh_bBBv=cb2b3qnIQW)f zpTRPd=?Hn0I04f#L9zIVPKpJ@GkQ-1NJ^j}Fx|W|iw{9)TE-#q4B0qJQ==_^V1Eej zh92<4{{SSUmu&1bt9YR&^AO}=LSAf3B6CgDZ2sDD^k_k4Vz{Fv!l*n5Y})T@}=GcJZ&43w=QBH%V|TR(nPU0eIf=sHCl zyMJGde7l-B_uJ>m`Ag5UG?6F`(7PP{@2fUK&qpQC*?fJZ^)ScY-<~qK=NB;oZ9b0|wz8&IfQrh-qDYtCvWMoT^>!X+N)@PDA0tNve{e^hU%H7Y_#alTQq7Oh@m$(Ay{9wq^rOp+7t1vE#(INrdP{-=7Pt1#<{(1sWOY)!??ug%E$rN!&|LaQR;Iv9{`q$Xk6l?0`3I5kQL(%0CNeWHVl&g#1KEVz7kxicH#tcMI+L$Xv9RpsxQ z$5xi+93cMygVQOuf$15%x#cIjYu3JohXxqeL1~8G!T82$xv4f;r&Jo*msxFx5_}6} zYwA96U7IAD=Ii5Vw8f1_p&(vyZzLvZl(;_2jP5-3)O;en$-Shn&2uHiSMa*>e1cUL zC~e(yOrfr#WQ*I^PsZ`aoOwT#w|_v4l%DC|b;xQfJYS(x)tXvi*PI)-DngTgF?$GZ zYP+w7%j!vmzIF5FG&6mor)Qj68j@wD1KnGQQCJ>!HoxH=Z{g{<;)Qi}+V&E2_?oSV zLW`5L12@=8${Qa6uj3853$-4I$%42D<}X>Co_HaPkTM&%vNyR7lZiOdqv+^Ad=;cFNplTN_IjOGog zU^$fXrd@5dUm!x%Sy1pOP$~EblO83dw!%C$K4#?Q8cMd3Y82^ptA2EvLo*(>Iuqz( zelKax9Nmmdgk3(ojx9rjICB`uJs~$Vu$OJhGipjE8dpmd3lZsfv&Zc>CwniT%(!al z>A4Jef!S{m@WgXNCVop>Jt`F83FxH&kz?nyT| zi%RY}N(IEAYNQKYN&|adB)p0%niE#V46pMCQio-xl%*9QBulK9Qa7-+t|!D_Xh%M) z)Lx{H+=Xh(Z2KhI*PoV@s##~+8#}b5f!=TrcGrY8=Dkk%pC3YB_FdxK?HYIaKI&&> zqyvZ8ADdxq+Qd9HQVBIPkp=jKK}p%Wv3XcB(z-xN+h-ovmpJ$;pyQP zoF@>ItLMx1BWA?=efJr@DO8)o^of;BDJ_K9D5!*iVmh0ABSNKQ8WjSdnfhQ_2vSto zAcMWcHIeK+j84gS*h0G6De`kHpfnibNX_C3Ss!H&EASB0?c%>?7n1WfC7i$GA2`N4W1y>PY!4M~~#C6E$UXR^RA~R^vlmz&2Pv6AWyhQOCOJVBikX z7?r8i$Wr7JcrFxv8i_mmWL9x>TRYft1ME9Qq4-q7d{a;D~7rW1Uso@UGUh_ z=-0=XYBvsM>CLHh^Gus;o0DLt75!xI74yk_?Gxh~H0rJv5E!b_-6#g(a_t2qA0C8y z?qRjvKT%&JR+=Q`)%@12H72jJ!_Qvl- zj_CC%7uL+{DoJTuxSg%*4`bn_5?(PQ3lET$HF_BdScpXd`UQQsYzP0#AvfJxO^oP=Otxa zNCLsj1gJJGFh6XrOKkeM&r`OsU&`~ltEgLpocMI)cVm6 zK6MVO*K@B(>`EtG_S|V#3svvz^3LRCK0qxuv|PeU3Y9O+&CYKlz2D?N)T;In;e3;= zP^C=5CDZk(lW8s+kH5;XDn5FcdFHR?Hn2)VQCH$-Ag{}%`W+9F>+a-7x1_dE5A?1f zB&jX=@8uky83;OUe3+%ewuA*+gj`9-X?9wpTBplP5pbzaa#XACk(g+aN2Kc&Oq%t2zGw4$I5>lksqI zk3Ie(rn%Vz3RYY$F(hPG3T(MW22O*ef%u;oioK_j_uu2c=0EPRUv>E$r0^3GVFd$3 zug@06%2}Lvyw{Mmw&-El`$tzbUk$%dSQmd?%rmcI+FQ+<%_5mpV>(i$%C?~B1dFc9 zw%t#ZOUK5g$@J^|gTTMP-0F6PuhHpf_8N-oh+)QTQy}fx2~f3`l@dIyv5PJnjc)6I zi`b7WKZlavt#9-gdg8{{W&`4L1PDPqdYV zI^Zc8d8aax2ZhDNPQ^7fXrap&2TakZaEw&lX~j>^1hTBjWiP9ge3XOl4=dUvSsZvJ zLYhcPwu0IVeh|2^wvCf}Xf^yH)FALG>ON57fC(&O#X@C_k_^heqHMHGl?0LHlq+9Y zMDe%EpTu_?OP#NQ6l**(t5cpcbFwtX%lVG`A5^V=-M#JX9P3OyFJ5J!gF#0Q0?d;HZB6uj52=H#soW|*rYUQy?W zxNQqcoKW!z8kpyX*Fe;m=~1wCLU;vCw=XV}_D-w$TF~Z~&Alh&tz2HzTKj4DGhVO|SD57yKgDX^(ZN?lH z3kgVDYC9<^Am#OkqdE#IGqe|B`o9X6sp=;(p-xV@24&1PJrIxx9wX%v6s%f9ErGbi z#vPGVjN>jjmBOKv<#8(5g@gEYh*@E%vBaqzs&^lx>Fy~(va+B;QuB!x^tlmVE*-LD zSo(Hi$F1XxM)Jd4oQZDfxFchzH!%x|$Dtx-7j{{TNn(0XGV)Ti8-kK9H;Ro!_YsrD zJ)JPlD+&)vH+5e3ZL|5NB}0syIW{pY3S9`z#9qR(7^E}o@2R6KkcKj^C_+KFPF$pA zzlEY?J*OqjEyg9mr`-~V7qsRY!v&?B%VDG?L~KZ~yi~u%^JLVhZt(2SJ+%3O5u~VH zjukolmk`X3#Q)K2I7eG*yGW(X6Pb-TGT1G}@ zmoC<80u{-Zc(yJ^ip&A9we4+0HrC%UNrpJ>+)&)Z)ntijr!bXDS-iw$nOYrEv$j*9 zBny-sL?J{~n?0SUQAM7@45-;JVb;n=iptba=LyXozGCsQcY(Nkwu)-YuyxA4MazTl zF)`gpI_?yo2&v0EUqXB%Op*9tGV}FB9Se?12Lb!2U<>+b_(Vqk08hwybou^bBOEx( zSh1P(I)yV-!;{i%0oBQSysdmPpDm)x7VGb^5_>Wc_ExP40qGYJD#e<1X@5e=nryo^Svs4r;#Pz>2)N2~Soj^{$}`ov>M>MI zoJ%;~H^Nm}qSI>j2M~oJR#IMJuHwg#QWPz1K^F$*ISjjMMb6ECd69$#JJ_LItLp9@g`@3RQ~{_`RYb@KwO{UN zaQ>}Erb{_o&FxavIi%zSDNZhOX>K9Vq;xIiNJ!ZDLaahWjo_CN=jroP_+Gv<%rJzg zCBg_pZKpezQbwbea|3d2EH#Fl2ctVSFn<{^{xwxev^&dnq)a8WEU8Fw2}uZfH%PHk zK+x-L^^SOSD_xvyGl&%{BSfaPFqT%iPiRfinGP=^a<`kNbbqlq zl_<8Afqw7=WnI7{VGlL1#qLZD8#n9|Gtw$#%(FJbN=t4mC3!+g1u8d7hUVhL7>^=C zJN3E?RSZ2k*EMe_wzRs+flAV&?v(6$4YYv>WJ2J*4qmTEm;V5aoTk*7otth>bCz6X zMNR^yUQUPwX37OtJ_a6daiob2FNocw&r4IWoUoOBx6<^C^J^-Xm~kmm0XZ~mkfYsM zv@qg0or>&Rg^gjV^q^1*n4_?Ot;N!ZfIg7YRK>mhS;K0)<{F^OO*V45%EQ@>uXMVm z*>G#(E-wtY+kT^qWWH#As?%)ARwX5zCgpP}Yz?f!1Dg4OqCDa)SJZWGy*{TZs8-C& zQcbs=wzU5dIQwBxfYzb-bfS?lBF&0u6U{X{q zW8(r{M95?D7AK@*WtRAXPWB3fx|GW`*!z_zrc6u}p=!?Bn^@f_ zNlla#JU57q4%x%u-xH23H7U1l%`#IvP0W&9Qrx*powb3;1%<7oDtPo)b|E_)OgAdF z7%HR836x|}xGCNGh25Q+ET^-}C!Cd;*_JY?L-hrfo9y-VJs~Gf z-7cPtLh6=@K0#&7t-MGfc~flG-zmMkL>$gt4Wcl!G~7bMo=USJwYus`%77$f7T0TZ z9x=tpTVg7{mT0(!QmKd5hNmT*agy7KzjfBl$x5}bBc{3n4zT1Wq;65w%xkbWX_}V{ z>r-viUJlDmIO?2uwn$5vP1KYGl2WCBiwzTd>>=d~R<5PBHw<8H=N=yPk7_nu(^ zEc29`_ez3&HQE}KU2?HWoElk~3Q{KI`3<<6D072>Kn<)m^$^D{YOl`4S7ve8!87zp zv^`9l36ilYm0B|uU+%b7blcG0I=18&e9qjXUdpA)oak{$Qk9#$kV*HFeEd2`F1GlG zm}<1FR3av`O|7P9K$vw4zN7+M`{LFY9vj1N@oe|~ zh4SQYQ`GXN6v|xYw3B{XtcNUm1$DQaDSG`G!NZ-Ja%rH;ZIY4-RF#X{O)ul>B1Ws& zZm4eOuoLxUGV_cA^J_LjUMML}+A8)}q1p{M)9QA`l|G3ywDR3;zz0P-l@B9vufi7? zzTZ?Kv6{bsRY|PSDxOW>m5qEeQYlJgs=0Y&(zBmpri!4l>uUUi?hbx!{P2sB^XJF1RNW}an;%bXk76xN+@g6iQ<99hO*7AcPw!D$vs}X+%3w$H1hjQDW$VsYg8HSXpnm%V+-Ax@7kL@c_49gXABtt#(85e~|3tT+foAV;$@VqlrNxK~U8^#IR z4n-5pNazRz4z|$W(iom4A;`_4*O~2FFdR32goDJH`HAop!!v52pPPnhqGMApKb zQKnK+OlzdRQ+2NFVyVD5nD=@J$8 zlB2DUyK6#dEJ$$Lse5)E(%f!If=K3f#b0{ z=<3MwCzxEy(j?HE6rig)C_d_l79gv`ao1Q*i#w=EVg-t%vL&V74bQle^q4vl<2GHj z(%lXE9+^sp45O zp*quQQ0AgvMX83CqsmIv_Pe7~xH=IXmNbD)fr=qTxk}YC+DcLiloiS% z;2g=`*UO>a60x1uZYqeYE>)_7jm#kD0cgx@b|U81J9$EUIygHQXJr+PA zU%G!^ELy zSxXPH=OCmW@>SDNHZY9>wH%2#X%{7$LyeY_(nokG*&Rq7R0+QDcxN?@OwD#esXxi3 zo0f`H;LWKQ)oBadZU`ToJh3z(%zWu8m1#xvl;$b1HusN0e8$nw4DO*NiTI~2Np@X_ z5{Fc$(vpIoben)uZMY)(LYEDwMMR{7F%SOr_7pr^6OiH#35?3vgNWCEw@W)5gsAsF*{Yn zbNJ?2xyozGl?ioiIL1UcPkgqQGbmgO?gq9$7>_t;9*nGZE2#Pwo|HLvLrDR7jf&KC zx$CL;2!oMPDlW}F4$aTaRA-MVDRoV<7L4G8gp~k68}x{hL!_Z$si%QU%%ypK)dD{d zV~ID?{RZ1dI%aXiC^Y1f^55P{#jWF~ES;DhQR4OpaUP$|lmQl42!a`qW^PnPHB)(A#|OmM?2Nu;}$#agI^s=-p{2GJMKNyfvvmV~|vfHMyz^!UN5xj(;& z$~vPFsUQ~_P*+ejx5Q{+UMF;ONy@2XI(rT6P=>n-vwmK0JBHTG2YDw#E$7w+AZX~! zRR~G%fv6C)g&Jn(FrqFuQcu8`emO?m2Hv-YXYl$8&R5ce-DLy?BzTnG zUWpL-&r^!)>>q17n*Vumm}H=m1p!9NLp} zP6P>Xg#xdwO8TPPC(ZymbSct=nPup<_P^abe71o;heS>>nVo92E+rNa9hNzXNKx(` zH;%XY4o8vEs(W&z+;(ZisI-#eQV<35_@0m?*rd`ST!(6!t#|Y?EFxV_mV533Laclc z4@i{br?1djRyzCiiIYlp`Ui(vBnZBtEzw@_X}E-sU(_@)_@A6|pY6dy!ur-@J0 zauz1ku4;->t!rYBPUrV+*2mmWv z6q|!$Hi>Q)yHN^DUe9~^7Hh+vF4Op^&6@g|#E-0DSGYY$BmjO93QCHuBLm0gyNYSx zSvtab6*D;NnY1RxY%jIi3kwI^Bf5i7B61BusMmIHG$qJVXFYRJ+hd8G=ceJeA=Jdx zMsDI5ZpV<8k$0Cc6d|!}b6c7Yy4t(}ydmtE*u0aU<-;da7WCStmO7;9LD-0XGp&bi z$aBYD%Yvj;SHt5gsk+xL4!7#06)N7TwTx)EUOJUamwv>k-qB;h!3uvXM5obN*Au7>h{39#c{Yz)k6mc^$7no+cRuroR+bUf@bxHn-e}OOo zwn!l5R#G%2LggQ-vG#|8hOyLeDL`JsD!{pJ_bDHJ3fXBtbm}9bS)y7@zyR5KwF36d z=zhtCAq?itNjESFS-tcwTF3SlpDv3K;$tmXkF4Pq>SHp2&fck7baB504SVCuczzig zB4om+`;y0jJ*s9fVwt02g>xkqLS^nbBtGBrCT z4mO~+mH|S>#2D?-4WXgprvYg^QYo8LEs4Y%f}l!V9a5kOwfsh-cxr9*9>+S_@;TIu zCn>Fh;i|r!`EU9gjn0>fR1&19 z-7VPMfH%sc?~n0o*TN`Vo&6Wv=kR5YpXc|};*4pS8B(->LRFOnT_CTmiPf|Es_vL; zS6f6@Oy?!<<+gHE*4T0<;BiUfPtff{9-%9taszht^OYlzZJMuZoXe1)8N9rEVmSw z5ptyqH)09N*D8;7!TO7`heI53nB-&lEdT=u?QKVO#OwbI*{ z(*FQ8`3kHqhn$v5=3fs@AxcXxpak8%pQ^1lZO->dCA+n^Z->XP!R|KSO53XQ{XQr= zvdNc8%A}>FuH;yRDbF9jF2C{*q%!GzFVCOnAINz-_}9+ADKDw8w@Mc37H(FI&nqA* z3FsVbcU&Li8}AL{l~>=ZuAXbJ#cmbL%a;EDlj-nc6A(?zNG*`U7WkP8X@n(1>cI!R zhgG7-__wS^(B>#=eY++n|$sr@qm) z*1KljaPC~Oo7%R1eE$G7@#J!=v8l$OSIx(8BrPN^3sU}E<_6YlAGm9fX- zTkJg;2ZhxR3#xiH0yo)}ZrE zx}~-VAg>_-Bn$XL=a(dDO6iQp9A(L&xvA3H!B|;K!xIe4)GLZ{$0i)VG2~{kLqS&w z-)#=DKNk?(s$7>pkpn&j{oj$v!2BJ>d;@7lYFySSv#kY9ONF7A5~T~>E4q!xm9G~N z$fwAq$p;a=;tv%+l1-=RiUic0(O16o-!VCS0!X*S#MK)hN>nR&WyYLSS6W!9%C_8_ z_CZi_1w!On$w;~N=?I=Qb~zbxDsS27=Pu!-k@Aec8ovwp7I%Rg?e#}BqY~sMNAzFi z2t&s%-&A*6?rb$om^+{k>j+xKF5gp{(U{WS>Icpj;Yd!jYpRy{`@c9mCM#MF-7)^9 zF#IsFE@oQsGV(4Er68pTyn&fQ-9YQ<6EbZNmri2v?=|u2N5srsN$!Pnd*LZIOQe5F z+4~C}TQ*l*ZBVz@(!|CMvuQOg~l^p-*8ab< zBuCP|b^E4aL&$XfXL&06r72>;ehfT5%7@u>Z{q@gw*7pc?s2N+@!O~QOTWO}b)?C6 zwNE5v<|t-U0RI3+>VKtZ^j@}yIefiWlkU94E&hEuC+539BS~eZic^rZrVlVA9L0cl zb))?&O8ZUgVbUE=xoy_D*P8CUgwuX^wer6w+4+sH8u%M6kEy1t%Ke#gi$m$kyzISY z0!mSvxKE~p#*=}{;G3B|Y}s1e^C)a4&9_ zv{g^>b1m_@9ZFAVI#xPLWpQ;qIgfPBwp2m$C_+M$@Q5V zh0~omRdTkk)E&e))owR-IasEwDKZZ!+YHIdk<^n2-Gb&t2j@9yyhukI82&Bc=4<$R zes#im($2NZ7t+Lw>F4{R``NCfRB@Z3C&xOSU5SPfF*xHgKFG@DLJ}>a284}Czf&4K zWjiOw0O}KX?+6d16jt(@S~DnEkOqY9tXFYx)oFGoaL%dui3&DmWxzX)K2eRIGfxrc z;jL-6TXI=M1*KVlJwb@mi?K|{#HqBnwi!tUK$RaLbP>p-uoCH%&YSgzG}x;(5RYkB zBoK3HVlF;L9FE+MF$k<;aHN~h$~dNwiLOGM2Ej_q0SUdpz4Wk)99omxsu`V2nJ}>R zHkmOkB4wEv9j-)+WYlYQBF`rfy2_`B0&%;Q30k2~yfDxR*nT zJCENfy9TWCRtT$^22=>Gs>G;+AUk8f0S6G@YGwIX4)FzQ`NUQ3=^zh&eR(OdWp zj5g=q*Lvvtj%s~3+ix}4?bdMPZ?^ItyRz=4(@h_>rMamiP@!#d`tJnOT=!qzU#N_E zEv}FIukAD<^d~+JGhK;0hC5DBYv>_UA-57c&ANpp zL(5dy{4WYplzHw}WcF*ljtzIUWgP`G^>>J5;aPI1PlE2i~bXcZ)eSYS8@(qeOD*+X4V42 zB1V-hCfLeQ*hon|K()0oKD8mPM;-aEpcGh`Ly1tn$to807l;`lxiS+Os_r8XVu=Ql z+p0&ix%GjyWePh2ZJ{TGp z%A|myw$SZgBfcdFN)HQ~l|#VO94^Yal`RR?*rg)qJ>zR14PqO|eLkeG8oKT95i{Me z+@w@mqs&rOCpfnf+Hgu~ zjfD>ANKz72w*5Mog`GHc=3DSFjz?{B?8svF9i`(ru{gS_o1FwLJl6fye#-2V`FKSh zOs+Pl)xrtW^c=@1)w)VEILx(GpA_X~M0^Ps{NlRP?!Kh4x5O^eY9tBjJJj$FuQs(f zf9D;(X5trZa(DOU72ogBJsn)TCXHQDM@HRjD%a>kfGhXHWc$a^BD*oikf&8DDJZB) z$<8p8lDB!OV#ytHn}U3S^M=)Q*yNvby7BsCtJNum$uJpUEQBBupe>=)?{gYX9XQ2V zLBv#~aHMe4D*FKZ$K?`ijinvYEV^S(Ho;mFw3Mi3Bv|jEfHcsOW{e#vYF!Fbi#bw} zxh55;Mw{eMz6fwuv4P}QFw64dVf%As%22WZ*cAm_dJl|J@p)EP}5eb$AYaRVw-;hEP5c=-ZM5|@Oosd?@+@VuYLFTarCJ3C*mJ_D0TmSZjX zNN6c!_>~i6f%wE}ad)-b?c^bF@P_Gp+c*^79!pA0y*To{t=E%doU7fntdx_LBgEPw zOO9=R8vRG~-rR*97KJNBY_}xJ7;fg_7s?cOu=`3rI|zq9B3XIApJ)31LX>pBzqEFy z7P(7%_O{w9Q{&=%wuH9h-}BrT;_dkuzOuOCWu%f*Y`}qJ`IFT6Bz$3MJg%3|%kQzr zC5c-CxcX=*<+w^SkdR6V7d>>pz-S}6W8tpf75C^ErQ&Y4`I-z%u*Y#$xFY$la(4vy zc_eKR>2>=3{RvJ|f6MRc9k=g9lHDb{!sej z=hnWA5{mEjMrOE0UcxC)&~?}3kUi#HN@h?8k#Li*me50rui{>eRN)+*FXUoW{x$?I zY{^wn+HMkuJ(X%#l9SfnJ=j;gLS0|4?MFNX9g?q??reY^xR1}ArT7eci>3e()#Bs-0GmB!pqAWP5=tIpt-k)69)>d6 z9X6Be*uKXbt5@)5m1>mzO+oqjC8(!qsab-rk1P@S7=tDDnQe`wvVSInQCCl{l}k>( zDh(S9jKEN0|@fW1_ng!uVGGKf$O%Dc-5ci%zoFMIz0zR?}*DvXaLx&z7glkX1^))8Sw zT!4LIJ=KkUd}Ee%BZoq%ikMqYpbV-h%npa)(gh)UXzX%UQ_H{BBUGOe;R@6#A}Dd+ zvPBDx%_?oQi7K6}CQu32!D!5ss9&!BaH}N2(Mr5*;0>5Y*BvrraJq z(n?Q~pe9Fg?(7Fe2B|!>oe&zewy_2(_|<6>Fl}X&P_YQBw4*NQ3T+2aZ!?@DbSK)N#s4vGK^dDOSA-GWd%cHHv9fcFMC&GKw1J8v{gzGK+u?paqf*_9S(MX>0Gu;+6gRlD@mltyAAj zu?cZ+u_{WmB?|~kfjw?P>G?!P=y@X_5jb!Jl=39oORh|*hIwuPQW!>5IE0I63ISET zb%ZRG{$rYN&~CdoQl+P*XDIKC&AL|0!CHkar51^?@d!aaFz!h^_^pn`Y%BP@sXFY^ zrQd9X%?D%7E2=_;{0D?Nif-@kvB^hozlmSzYpFj{rTQIpx+Z3{j38&Oi5 z3Lub3Pgr(_+wLk;Ia|cYVpdjL+3`g^4l=K3Y_~BpEj5{^ROW8;iEBP`Mu|<;uF#|@ zv%?MH*VOGUlBR;_WwkRf;6YtY^$>}M0>|kaQ6Ex~ZDCXhOK{VO@>ot~G@7S1A&FN* z89T{KDwuPY972w&WTYi3Pr923uDxoZiZ)|qmBQ1`LBbvBhHWh)5-R4Ufxl-S|5O#q9>CFN&ldN)qza-gLVw zG&0UKLT*ypw^rbb>QX_DP>1)}hn=7CJJ?2^xnnEsGV_%gp!BnV2g1sb5}sPf3LqZ( zP0vxJJt3%~Q?u;FKF=WYXiUarid{r~Lc&dz%V_tL>WinXp_(20*l$zqcv5A=(NeTL zgr0pCaaT*t0p9vGL*GuPxOC}Z9nuYrw-k7%DU4;NX;joLmrXiR*5!(FJj>FvAo5h$ zH%h=4N)U6zto(eqE|}{eNM`{{Clk4Nf9}Yt?aed}fT_hHeKy?R zz~5NqP=@ST)F~ADq_c9WVGc1mg}8fwpxHM$x@JEc+6IJ`{{W1516tvGkJRv#(wI?n ztJs3iB4S*m8#u@rR6!&g>0%?QUHy8TaqMehI)gk{W@bW|w9qjV%oICIo4Zmkl?_~! zK)TXN*SoiYgi8|V(CU%h;Pm|02<4_ISei~|Swrf?-z=_B1&--2X=L1JNEYj?GnW;+ zU(8e)#KDttIPPWnx@(4?J0~(34oj&h69E>^rKL9tN{JRdL^Cwtx8BgTxip)^ZcL>t zOcXNsASL@*rKiDO3-UT%A=s)nXQW?BM>$5~F1m4@DRv6O|Rq@*}6bp6nFI>Lle7*oSZ8f$Wr zPrPO(WYqGUQ?@+D-OQp=ZK@JgYxK6di0hwTSJ)IzWp9Uc`dp%>S!vIyORgYGSuQC^ z2>>M9P)XCz)(FkLyZ1WP4o468?TC12>k_jFa&}SH!--3ox#>lP!h(nylY1Ce-8TG$ zN(x-bUoYD44Ls{o+|?>=<)ySsHUo~8pR<)JI*rw1-5Q-BR@KwkVdC>c=KVr$Z7Jlk zK~VFh+(GyXd_Rg_Oc6m2^5J<MH?^>2$VlvuYtnTOA>1 z0#fl3EAAp%`IOlxaa$025)QhKzA)l?sT`_1p%apzp#cG~laXps3I_WdbcqpzLrzHN z%ePgONm3n3oGb4oz)CXsq>X-X>ct^0XjG|%zMk^305vB-d~FhAfw8BOjwzgzq__*S zEQ|Ec0=`{DKOPaWx18kGc+Enjm88Cx7TQXdmh80zjmZfl*mXT3WOzpU3_R&|8o&8D z{4R-iCgoiZ1l;99!jwq;T-S$T?Du?z<;5=JK{ML?$>lRNX_PSG%*?{&^ERM$1T88e zC-b~ zycFt8%GRZ_p|SwMKt8_}astNoR*>r9V!C|>-x9BKJ#P(2G=1& zt-*yjoKmrht6=Jl8F{AW<))IAYT933V{amnr;VW+S{JD^kugZCPqbX4%!Yf`8R%g^nzvZ;iM?O<-j%J1+jCyZ{#-I$j%=G&>xvk@j~8zbcgrw=jWwWj*2NZ{ZBM zk`$~q3deO`7R(pv&n>*x<~B-zP#p*aU*iqR3S7k|Y?(QR|vO^v{V!m&Oj4OTJZ-4a+Ori$m*)2Vf~@`Gif_Rc}n3*Oe;0}5Ce zJc4oF){Y?qolHZTg!inalB1{Ez5F3dhetd?>gYSVF@>yg>w5tgKl5;jkVzg!pH58qe`N4oS+i*U}8SmI2Ai zSW}lEjR5Q3Hnz}sXLSf^e$W)xn{k(0oLNo7F7mU553*fJJN@f!Jma1j-A2P*r5Rzs zms_)B41tMd5`qPd!mWGxLE#er+UjbZ zJQ!6ja4@5y9ARPIPuRJz9$LqIBbtn9?Gn}(=NZ;&$Pc(y*>+eUf^^Caz(1TR<4on6 zvm9TL#;ht?<||ILr6om8rLeJXnS!nodW%O?Xd5~!;-v|hcBNRO%{YbuOKN#33U5<< zss~Hllj2~~7I2fsgNK!xpCK@$-u5noxY(s64LWs&X*eaP_`O-g6AjFYMALzXlJZiP z%79vY^&l(l3+udhN((vMLgS52zbvL_DKm_rM3Iq8LUV2j3b;1j#sw4>Yhf-mRw)w8 z4aqd}lmJ`rtSQW+WUPZ?2Ta$r4k2e7$mhMdy2id)d zhT0a6<|yNKFrI6gnMP$&yX7ibLBCsFSJ1;Q2wGg4KYDzlFTtxS>_X|ODono59BPg8%jtXJifWd8sPqC{@DC4(smO^LK}C__1O z(yDzRGWy#f+z@ULk?|4A^E>h~y!+DV1d!ny<=pw&2G}Hx1kSeUx`564=mB4ha_{-0 zv~?uhK?J2K_y8fqC735`e#h@NvJX^?+txbdaYW{(tj91ZY09f;vYQ`F-?|&rh0(T| zSyzc6rpY^;qgd@Oz-!F7!(GKBqe@bEB}br_^FIFofHNxqvOpPVHfU~{Dwd)$={ znhpJS_(0n73TCsCa?%a0K}|N=E~Vz#Jx%-tp$#S2Rkm>{HOf6z)goSQQO8hhpxdY< z8(&~fwl{*8k=JJZT7=zI1%20+*$PHe-qTPo9C5!t%oM2LxisXkO3baVeB@=g^ilEa zcxwEG9QkZ@FGqAVP(s~00;F8qdsype69%kynwt}?=0;TlG{5hMlfFY$M={~cy4RH| zw#g%3oHZ?nP>wbBpUj;rc%*F&h}yv5WSQbG=(C|_UU9p9jxjw`6C$|XS!OS$)Nn0^}m z5Pl`t?$5c(ma5d)a0jHBDK@g&B~~ZI5D4>ytL%TtFI}+6!X`2UI!t6d3yRg{u(T@Y_>)eRVcvLo zAx)@QvaX}j2#TVor{$+9vdK#=Io_z1p&1kuq>@g6+oVm}_v|fN^(2ADf}2ZBl#H`- ztTsV?1;4Fm{rh+w%J;Noc!{|-x%OuJg20kb$V62*PV~z^OUpYaGPPK(hK>2{oz6>Y z;N2?g)*!AU`>yu-KiIg?uGjK8QWU0;0SZqg!g&uU0g-)KeA`3N2pj2NAKY~zMi81( z0zz3VC*BzWQ!77e+Xl~w>kZxSxVoc$UaXa@PY2C4gwDCwHoSlk$IMJ>6BbZ+4+LnVSLt}`Jp-?6xpkSyQX)_%dY ztkw1dXyvx9w-VN^n3v)v1(>F&*6HY$dHmeTsYXTHaVa+rvXC#$19N`#D;`BJ!uGyQ zW@}FC>-Wq=R%YdK(M3*};+dOK2FdQMI6dGp+}wSjcIyr+$M|G7CZx6`PYSq;Sj7un zDx)f;PBPe7Qb7w^HVP?Gx%C3k$vWk_`kAgThST_$@)wg;LoVrM)TyUN=vd0HTOOWp zi?Wr*gQ9#YI)==i*$Sh88MqFb>YB7Aqo~q)Y7o%kXEE8hYDjr8JwGvcVWITI^t9L3 zh)oNz%BRd`Qcr*}*BjVHj@1hds=q2G8+i?!#UMGNNgi>A2 zE9|er`bSP2HqfaRsHxRB+K!p@Qaqg2Mt zezsXexb(I6Q)1w9$B#i0)b)IRkNK4uuqg87^l%vkV7Z_*%jZCZ~Qg)B1d`@e^E z_(Ju6y70 zUQE`O#8PiL$wTa|;b2<}Le{(NrJ*P5QQ+b%p}cq9WzM$vUB5p602R1A>+f$)-v_bE z#8}!-4NR?v-a=hr8QyO=E|mS&3DM9#(<|?Rv_7~QKZoAe)p;=siC(^2d|zkgjP&ev zPMT6fb1WAK%mv6oQhv*7IhZ8k&3)BaI0QTH5_`YreV)|U)bG76>(;$HKcKp<-b`D9`~6qyjvZeS((96E+Qg%h zjuMq6(2&Z1Z7S83pS&)E4n|Xp{5<@x^5&n=Zctr$dGGw1`jM(ff;fK%)Sju*Y7R*; zGQ*6z${lDf&V8n>V5a;?HzF>-v}ZW!lDd5Bf96(ulw$35^!`F$3_mNvDM@Jx>%xAY zAy7=kI&x9K;?c~$W?c%~T}nU$z{SKfz9L_RQ)}@qT#B5SdMwgK0RHIF#%6j^ zGEsO0 z*k9urCd(#;d8{&jrbqUKENtPU7)ZM6nM~74bsDJwV5uX_UgP5mc-q|Nq;E4^VtHJ) zoiC6LLqeA&6Rp{CNF)?C( zV|u;@xZ*UR7v)U+PzUB=)rI+q*YGyz_|2N@p`4{t=G@xDY4z&Hn&6groP#e<>LX!$1L=$<;XyWv2aDKW(49gQy)LYj5Sd`FCB= zn!o4E=h^mPGfNH&45bP=fI+fB`_iiW4t?YuFA^ZH&*A?7w!V+L5h;DY{kyvC$lKbR z8?T4hed!k2&bot%33;Vu$P;2qt=ts2dX$2d9ZYFGnS)ci<-ezwe&t^omY2%CeEW79 z%rDwTdW6GF%ptd#Z3zKJ`RoUdYhEtA4#YPyLU8{8w2ZDhFG{l~H1oWdES6f&u2Z40 zAYWm7YZ5WzaUkZVw)&KfRgiW@w=kK;T$fpWWVZ4O76O%^DLTf!Gq~;8!{&`QeaZb; z?Ab1=19cjEsY3ZB)g;(n!sJ{hUnoP&K@}Z|=9eUi=E{PU3Qf1anEo)vSGm#b?Nd=L zVb@8}tw{sn5Tz?5V?=rEvXlIquHWrT%zjZ9KR=OSgwd-@q*CaFf6EW#qZM*3VkM-n z?XtG(Fwps`8|XNRQ^o!q)7L>%)9G*8oX)1Kkd@^c9YDGByg`F;Yt53|)V>0*3IwK~ zC@rd4LQlX&PJiNMmM%iPttn4-BeF_4uS}&qb%ao>I1^L3v=H=QA;{vC=Q{7wBqTRx z!--S7sYl3?e>gNC)Oj-DL|;)IQ3lQ?CBSUrHWu1}N*0n7t%bbF7Sb*FMWR+g&-j%Q z^B7er_%WonP_NBRa`Zz9b+?KvEC31?PlRbV#Oq!a|z5+ zTat2WeYYC_0FaWtU|hCQe9F@6PJ|y=VaB)nujDoSY4Tsc^CeM0UQ!8FlXUeCB<_>q zd?D7qExgxar*8hw1+SM#w3ItLmI_l>(%lu5JN7HjO_E!N)8VuYK;4GCW3Cjn?&D$BThD{mv}O zu6Cy*D5j9Klr+OPS9I#G_4~tdZx0w_iNLXKSMuECCgsVr{NBX6o+12>GElt3>d7}t zi2F^e#b0!I#cbCmx9#S;KQM<>?RWBh*OAXtt+bG|sR&5FCB>Tt&)Q|v(LDf;N6X~j zPx4>vIbHr~b@N0;#XMBQTy3A9z|WWDX4^qiGbAOnH87G2RW9&RAQNIV8HLAKw8EYw zr?p=%zJpU&_<6eD;roo&4KW@js?E*eYK>Lt3`I*8VMzTH+CIa#UDU8euV4gRYr2x; z{{S+%#n%LUrUnG3Tj={Huy^p759#*K;~+zUfyuj@h4-kofA@z z+FOUS2^`1J!^8sPZ?ao)B=49Jr{xt-7m+hteMbUQiTE;iDQ(tN7h;kTp$DitS`)Gt zrhja7sCYt$HlJycW?swJn8-*Z`IPnb*6}hiOp7Ts%fBq<1aKm`lf9eTygQB@{t6f#Qwt-bW_i0eW}LxwVr%FQgvPBkX+ zN=`?t8*|Io%S|Ge+7a84d+fM3n|VZaebf4qsOwYFFh!}gcINyWnQ<;F<7+GULsIiq@D`5Z zX>-$m^0K7MOsDU%JKqfBuj3rFxi%GjhP#VcQxCNur7BK(QT?0D5QLQ&Qvs?Y{XLy zt@MkjGUY8an{ELhF5WjH@mVRTz2Bh!0FNpE00Q~Q?_oYAQ03I*o)?sD;>u2UkP=hf z8Upq8S3oXdtdr5bSDO^^ODFNk{1-1nkx4kGhz_`_zG`%ml0!&gXPytL$m%&r` z{{S&@+WGw6-+n`{Po*^~fQFl8umSxVLPz|g19Re|5FDKOzrQcs>viAnxxOYuxbEfv zCd0jOf7VndUY=dM-}PrS-#^Rlk>Ki<2(|1r&9MIfl848^A~~x60H5po1%0p6_chk1 z9V+jnBqsJE$K!32<-MUTx7VlNE`pLvr{C@-u?1>+O#rsbFC-CkrNY{ZI@pjv9=5zW z7pc^$yq$fZ(_F9Sta0cV_F8IGmL;5JXgNb9BU9oER6$RQjiTy2R3NG)6x_4zf zxH-;OC%1k708s%wD)u6Dzcl;mQWf1x3n^@QAbqa|D8wARL!W<_=vv~$u_{S?*8c!A zye3cvR+6g&VPFlAB;rac_VxSNB@QfP6SSd(CPI9iH zBzJG(H?&8|k51Pgk|yGloNlG_H&Hh(@{)$;7$@Bz9fyJk-al)sHMe#5*mrf&{rBRRgin{v1LvrhAB!w+4>H8sDdc@uy5}Vqqx?2$V zjIqSGyX@Znf|ZIqh8!WmFD|*X`>RVxvwlc6%sl#-((w3N=j+qtXLyYI`E0v&`IuKS zO8NZWhNN$J|gtLAxVevz7)hQKP@2Sv#65= z4>pXd<%A7FfF{-huY^XNBKmy^QFC2>qB?^ug}9Q+rf8Er(4vyLRfOeG=yL7xirkzc z>1eaZ#ZElwuRX@TkBlV6P3Z~LJ35JfbeyYEw)wAOZO}mu3w`(U9L>bEtx~bWe~Ali z!do)vW1=1^ZNNS~-;`Zq;poif%VNfXjw$tXmC_ntj&u?5AefurQD5R%t*PQ4qX6VO zRGVJ;t|7?4OOS}D@qM~TCFja*`os9cjwdw@Z9}z;yH0YXkuy5(*;q$2=0UKA*t9s< za~onzQI*n}c?J%r+7@}X@OdKO5W{1t0z$iwCf!1W zt7t{~kZA#KQ{~Ew~c2 zka`fUBf5u@AO{PmbW9N0dTS1!S23U#FvIM7+-h`I_f*X`rKMOhCWG%%>2ZiKM>;@Ji>&XPM2FiAEHdid3FP$ zNkYLsBKL^ZehhKVtoTLnPtJUTtY&U z9yiTk6mDUjLiv^d0FLPMRGQ6IxrUb8f%)+A3Qu&pr764G;=~X^+8qoUmJKDe=_ixX^`M?GPuAO5ezn z8Ci>n+#qR+mJX%Ny7SVZx|5EOwIvFfmmbj9cJ>xfPy_CQFJlsL?wcCP%x613)m&<7 zi#8L?dR9`dv?FZA58WxhOP;Xgm*_T_>fp>uy45|3G~u%qiX`1d!T$g+e8(=4YXFr5 zkfES9+gN6J^zMfgtV1`4CKX!5EDWh#LX}IJXlY^tjMy7&3ApKD(i@Z6KfT38ZcOeU zRaah?rOmpGi+XkCl%-cfxoA>zj}dfTB)6X=A4shP0`A3zbzfV*4}v(nnUEN>-a61DNgch0e~QiQ*k% za~;mi$}@J^rprt`=|S$H?26^29WJ4AtBd!whjFbUWw?UjW)W5;mwykmwUy1&n|(aa z@=)T|!^(3p*Em>Gt$lBJl=4%tojVRcXlXg=X_@(nNs^CXT&(+fJFXD3v%yZmKmcv~&ElT3;CZ;h(HKARlPfIXn7$LWZw67y>7a9o#NH@8;Dz)?`CdO1p zYR-jc965p|n`;oT^Ma}bT4kihWeIk~QDOd3Pz({UU=BMXsE(2>w zqHbYM1uR)aWwH}(ZbgORLJ=gW7?JK8y6mejDHP;0F+U=cY?Jbe7nV)b3Xr4~a@G~! zIYq{?)wtssTr83Vr(q2Ft2H5VZaJ3 z6p|DfA>x%e#ss!>r69IV&tF zOupKPx={Bb%U=Hgq$gd-g$ZHmxK63UAjJEQIbOr{BLem0bX>3~NBR#z~eyGP4b+w(}}Y zh0y9qS9g0}-#9M01z$2b)oVEBi8J&w)dWqJ0?SW4%Pu!K+EP>*nL>dnRgyq(l5Y#y zh^B;Q6RKg%Sv<{3oRs1GK-#lCO;J*%CxG{og^(I(uG$aYbvww(FU~0uWVr6r4Xm(lCcBQ!}ZUQNyEttE+X>}UPhiV*8HXC|R4!Hb_h&hz0#=?)^unD*$T{PA#7qfe^FTNos#7@|icX@Ku zc~{s7N(m|g_qM3I(``1*t>RuUXV*SNdGVLXLeuz{jrfi24>>%Uc~srBH_vUp^{;%v zAl!U4@{0&?F<-8*R#ecrkZ zt|I!KP8-Qp1ksnCsA+4%u*5Yy-G?P|b5wP|HuQ|8 zN}iP1%rPd@WG`?XMoi-4a+`q;XraFn{{W!aV%e-ih2_&dEh6NsgPr6hmx_>pP4CNI zVW_yZlcun(Clr$vl!`SwiIS#uA^9>0S1|}TOP2SnfRzN2H%-%hZ3@zu+nYvdX}Rh% ztv4~6pn#mb*BL2WBU=o|^r=1<8|`>jlbVk6vQ+xDoo&gvA`ViPU2r1yxzQ>E;761c zb5aYKJXFGFst*LDl?5g10ponab%BaZ z^RhGZ3Qx5$RFZMMgKzV~hmzE!s1BCDSV_@Ki1>?1!ze)#QyJ6%AI=>~DU4t1(hg7In6Jk*3~p(I&n>m&3D7eRGo14kV89TQfn#k+xeML?Mnxenfwo!Z=!@ z>WL``O|3SGXB$fIz1sszAAy9@W2#LJh9vCyMdA#|m!wrW^93ZOvo5yw+yyGh`H>9D zHa#4aCM0_-Nnv*irt3+PnL*Pk7P385+K3*88_`1iOFMI1FvKl|%+u>geSzIe>6b@% zkFstv1Lkz|j%hir&ejUy#yy!pbrlpk8c``r<*w?Lxk*{j`fapwj@jz}00uFes$AG@ zg}ZC0vSqCG@jr5N#*TU-;>kSGt>s^;5oNz6a zKQMmH)=AUJ#eVoT1r63A?7=eI%bS`$$tqL|i9$|W>;fBbpOCaA$WXuj^B7wZ)7xnk z33lh$8Cz1AQ08lJ918BAQ?|wi&ZCh=;f;2Rm6oOHGpSG5EJ|j#kpdHEMKqQVMO~#P zdk;336@1xDvJr0-kd&1C3=d#9vYnn&G)t{Yun-Q7l}jj(B1P{FIncEm6^(XJmaZWy zc3GAeu?Q(9-_$7=hF)a4i&)ziQrsV?;FilQQ~j=4JE2Hyl_$f$bAJJNL&%>|Y79-v z@FH@s^N!On)2}SqSybXB0x!@ks9gC7=Zcp$DM5?*ZUo|NPRAl|4y~6PvJmL0FqNc@ zi76nge$~nGggo(GMJ#M_D1D5v444RU)_Hm=&L}uiuC`V4SpCvSh94BW3-C_s-HYol zU;Z{*UL2xP@X=xt_{6$>MR+0D>>n{O;vAc*snn!yqWYEy>JL8ODC6TizNdTjsY}jF6ppik=Q9rw70g2Pq2EUO49 zMK$SU1s`RUM7T;vyOaZR zKWH0>OXE}IE5NQ|x?i%p^-!{FE=(j*q;Pd(K{DY@YpL{#Oi?uFk)rab-stX<@APU#_Ty9BHoSJ z3kOSmWYn6b-OZdTW?}b@_t{Pq`hpGm#4MiBZ<8cPhoVVSDbmzbp_yPBZq`Z=0#X3j z04xW>DyNrUQc{H+X}oVH!^MOZIOx!&C{~>{Hnc*PWz%v(gD|s;q>`c*IciC_diR1k zP&hF_)n%#V-LsockoujCxY46Ys!L8KT(zpm)k*IHpB)b04I{CdVIW}@87e^Rw1 zot6e~z`~r4QORN7q_U*AbBx{cfvvnon}|<8=y#B!lW7?MOMsFtEG>9>2xeyx9o1z( zfo&8(j+`_VC!GY6s{?B)$^?2x8vEvU%<}Sqp_fFMqW~t4UhSC|m&cBVJE|9Kg0X6nRjyC&t2_527nJPis zFtNBJ*3j0z;`E$qUk<2jyX|sv60I$2&&_S5i>Qlc?t!?_`DqGj{{T**Z423CDpeU8 zTWBL<5Of}f6t?AFf?nq168e&&l?85)JEzXZJ4Xa%M*~x)7tal)E*pTMuqR7_us#ME zlu)$Ul9M2bG^K*_*OyGj=|6?94W&Yv+*GNuo#+QUIi2Gy!SutI=2Pp+`93vc9v>)dQzz;o=+a}3L#$gH4C zINNVFk~b+)y3>CRgfQ{HuWKDsUwaDo@Y8HKm8pi7;62r&>d(k&33%(Ge?U{eyEj`i zGO7mILXN3X2mGihpxK3~8P`*tyQC)f2~fHD#~uB%s*SlNCBz{`@>jUc*T~yXoGLr@ z63*8=Hg2s6{{VgA;Rb_qtxc(EZE7TFv8{#ucKAS@g&8H3%Q`r$%G%@^d6}1K1SVy*G^69U%xMlO ziPChKp9&WnLyAIZ-b~0{wS`zw!NqAGN>graoen2^Uc&Z;zJk{yy^gBMr_&}}N>EgW zi5evS=yd^3xZ@mDXIvc&e8Ws|UbwRCx+Yq1JUPt| zW^5*8Zd48Im5uDHDEP-06$e{$TWP+vPfph;+)N zW?sdY5>3;~HoC3azMa=|SzVthOoRna0NXlDr`gb@%Y(9# zFZGE#_j*Tt?kPK5x%qs${DE-^^8WYm_J6bZnBVN@KQI?6CsL;rd5t&7MoET6yXaN> ziyw6Nf!aIoQN6jfw*1$7{TQEkRd14YFDKcr)Xt91c3Rw3L0pIIiFuwvL2b}%S$!9| zxzH@wM?LZ_UrVd={R72&s{BiOzwY->ufTF}{{RQvpuDG7IWfs?oRcz|6*9B4?W`NE z2krnxp^0Wqa@}+8zjQS$_sjd=!umfiC-FMiXM!~P1j8k>d8HLN7Bp&kCsTCaD^3kH zO^LPjj?X-&x1;FSZz4Ri(r&ipCDt$XLV~BlIT_~-Qc`AWQgsI+CQ{Zn(2Kxmh5<&CY94Z`dknl@kA<|N`D5XH=141lE!Y)0ZiC+8uF24d75kB3A zR{>8yIfU6C4YQ_Y-^%wc$V3j<` z2}dw`6y$w$0F0>a*A z5b&`}DmnG6KP!n@T(t8o%(B0Ew-OYS@I8DE;v&xlb0uTX*kW;S2*ni*w@YJT^ zJQ9SPcm*cJ4{RLw=cqW*%tPhn_l(~tPA;BT6`m`8xZ)fBcwQAD6HJV z^2*bdMNc?Nli+*Wh!hxy#b0kjlVN}X_K8?!DD``c=4wlF zUs2@RqM-~lgrNe~Nmq6YTQ+&HZh<@3o~Vfh!WVDIi%(X>KLKp{{V(x z0?P+9M*b;G8g3j!z&0pxwOo4Gf5Fx=(T1kH%RAkPHu!6ZrR0$|<$lRpQf!$9t~2Z} zo6mUBW8q@b*sYdRhehmtH;3mPsW*scJ*Cv1V#`QX!Piiw5$UFpVJtSPmfl2FFgr8j zd8|b=xmoP4zbyR2CS)ZkQ-QJoDoQ{DevzN{j}D={c{RwLf_KcDj-tjglPnOM#xo*D zn)APLIlfT-6=Ebd^j->5u}qRDW>q?;97c7N&&?oQi<>1bgn{4y07lb>g~b(_WlS?Y zn(*|%xo&Mj*VcY){{YeGv+zD1h>PM8pR*sdQ!6vl3VG$ru~3+8q&ni9%7oZ}3W+^@ zVm@qYmdJVxvRRUuM!AGsBwpT;2gBHwrEZAhi*e+;GV7k4l`@GM8!MVzPel-bbn;L( zias-ic{hw{_1~Z0nW5n4qh~AnP{mJia)!4;kf+LmZJ7)@ZV%bMT}SGhr^+cmv!?vI zb6>ymFBcPA8jf)?kkD+a+JQGIDVKB+Qtead1`MG(_Kd0^d&C=F;z>4FUmI0w8*JpLT+OqS_!?= z+yLhAfh&6rWaYTycFDkB-zrj15J@09Sjw51pwMY+x~<`Z;$`IW=Tb@(prsNCN!a;Ce3@YZ zxd|wml(zoV&-u`fjBuHJb~cr#HR8;`KRArO{YR7M@-tCa?DDM-1OfO(Mp)Y|amtV{ zRn#;CNKb+};vCh?l^tQl8WVP4RriiGD$LSo4y+48qPIBNsfzJDjt*?QKQM+-zPhOT z0do^!!%Hiup{J1|GvW@`60F_2Os_dz9&nI7LJDH*53+0cpXx=I5qyRN6LE66i*6>T zoI_{&G#rVyg^_5uhYcKjkrq>IWM_&Bvk{o}QjO2!5=L3KK;g9C5GIi;Oi#2-FWqf6 z7V{*K0P`@3Ju29k{w}DlQ7$T@ILIx&5=XEY3mv8CnPhv zdwKKv7I>7gt6rSGr+T5pY$Z@|v09az!j&RybaDA`uN=*cmcNJs8TT9BElGX%+;MSr zw7LEDTMArz!+NeG!4FH}*@RYdOov-?U1>s!H&Du@4MFMG!Y6RB@ZB|A{(~GwO={O~ z)UAFRVq8OoF?}tHuzplGI@nTN8Fe~Xn`?X8F69){D&Z+wET6P4JT$uNiQER$e)Yc? zqsfI?af>F%jEv&u>T~Q6l!B*%N=CN|+?$Pj;fIcp?z?2b!c{56Ov_=hK4jT-YI>gG zPH(J8?@DI9(v$BCoTL()X$)z!Do(enCpQi2(^E_qCz&$qLW&AX^W<80%6g$&r^5D# zk)1l}`7%EdhSsIKuT}e)IF-fqMV}M-4@sK<@6m6(3Ms2zL=3-r#Fb@Yy*>MLK=Cq zuq#SIP$%yofu_POI7?Eb((1YtS=@3hRM(d=McIWkn#~E-VR`T#QO+4!Npe|N&C6O` zvXnl~YgmJE5;%;F^X5j3Quq&6AL6L`RTN5$isfb;N|$twVm9RcrS; z(uH(yt=&J^Tk!{i%fzZ~r9)a}YjR+!pFO#G8>&t4Pk9I3%)90HhQ=4eWzgyFpWmt& z;v=bFCb|9gWIf{kA4eACRf*}Xa%%MQSgl9_Wj5k8Ub+QZ*9u4>Nz@q8;hv43C%R=k z<78r!tz=7Xw`CGVfzw`>ix$Yq9Qsv3#?w=EX*|!Q8O#uDNdyuSdLDrI!!3(j7e7U! zQ!6r!zU;aj<~D@5qQJVNET!?c7FjwoYRT zP$piZQ(KyvmqprW6d? z{S{V70Yb#I@f}JshVFiTajJxL@+sx`iBVeZ0XPs+!;*mXb1?bkA}o~=90t`qT*VdD z`!uZlv31LY1h$2cdK{v}+txVJLgNv$;x`-^tV*j7<9b)KR+2xO&NXE={#~3#QFIgb zn^887LEG3{gIvnCdlZ^|LT#5)TTU(V2>B*NiO z6gXQf(k1aUl+q>wKwRP-edd;W5QeO#{J;j*-YfHBb0%TU;qI#b1cjNbaB_X3npPv3 zkaX;{zdk_qZO~9hm7=FF1fNf$WyTL_O+NltLv>ig^$9`^Dz`0Llvuh7*g^>hp(DM2 zhP`7q#9~<8SI=`>!)AG7e^2NlCgc>#uT!Ap@p@gvD2r}JT&nZ@A|qAF`jb?w?olTw zUM``s-@8BiBzv?kqnyFRd%}d!S%}mw#3Mg!)zFJPc@wf<2 z#NOM*h6pTb-p%~~03y3KZBCaZ_tbhYw`43~UjWn-EktMUIN~N8w~j{DYxxrr{6!zS zE8cYZeK#K3FJ?Ryf_wG)tJOuMT%@UT&5M4kO1-^ICGiWO*W;H;_`4iBJ~P5tK3L6R znj;Pb=!aUC3R;!W2V6l>K6m)TQ_SwUd_^ox^Ka$1d0}gPVH1rWro0+LhJdzzREQC0dxDDngZ61Q=DzkBp zU&6X=-_(@72O5<@ki%>?+^Y<0obT;rhq$5W|+=Z-3O~Z};|s08R4(6bF9h_Vqn~WN8Wed;Wd?2<`s>FTd0W z97$G7o25F7TI0l#?vK?Q#~bO{ef&NLQtRjU@%Wg)DkCk2-LSD&?2oWNTX;v>?*1K@ zncu&@{{RDZNDhps?xb!(zP&&Pb$+?p9joQC{eM^HA#Km^`FR*7989=31t8n?wevfu z`soRiQTxB@#YJD;e?t@KTj@Fk18mm;Rvs!ne3CQ}JAPkZUjG0Cs+XVN-sX(^&B!5X z1+*+Y0`_dwX5u+&|DUVpIssrFlTn0z%uj~V z)m+^#AcSHPqCmFcMp<0PoSSH(pe~F3)RS)*otuk`O^UuZhNLboj`b~W2EcJ;WPPFq z&&nGdIrMB7OQ62=%%qzPJu$1wZ2>&bHGnLyjCRFY+n`~I3^tXfMp>C)yvk5%2|y;> zkdOuZ2~$lIeG z6SYUu2m+%@c?A2y*{$+Lj89n7DrY+!ISxEw0+J@fjg!zxyO?}XkIEfG432oGwE`&b zEfm-1Qp!|voQ|j|H`BW6R1>F_;bI5#hcw#GIF?M+MN+d(IFPpU%jHoAU{s8^J~t55 z*yK?pFwH%h3wBL0q^qfAcE7-+L|G5SP#i}kDyuxp%%3*YvGYhGBFL2yT_HCsP)*oz zD)O;O`5Qw`4x@a_0ulcHu#5z2$)%$rLWj0w=T3S7v$mr30JAqLTKt@ zO^zy7Fe9A0^EsKlgW4?$^SVJ&elQBsnC?+{lT5B4Im)wV?IA@&YjVA!j&SI%q=IM?tpi|6kEGdlHQDR9U zBXNCy7?G(_8%q+ky7nf(j=ap&)j~}rYAI%ACT)_EbQX7*owS0J2WXSL3B?Z7D7@ED z$`-empOVs9K_g7r5CTCxYz5*LRZMyg$8pNAUWHJ=;T*9$4AHS0^KD!isboTTS5-R4oWDDYo|rs`8G?$duBRBQYm2ER>Qyz0&FB0c4OaR^Ll$ zXyw?dI6NR~UA$$6-j;AKU5PpLC1C6jg(zRaKq|y(Vj-8vaSk_TiX7Gf#Z>wf(i>Aw z%~vLnwWOCjfwF}qM%D_Ib3#9u)BKCmdWL$jcsC;8(zm-MP%)5@Fv6e9xMw?nWN3oWmL*rm1arw6q9wL zVIx$Yp6$+U$tD_GzfsgeA2|Nm;x1T`56A(kw;Pi+8Q4 z*6{1ue8dSJ(DPLm3-2(6IEUMH$)eU}6PCf2)RDSKP{<`Ln7m%RW*~(JZhoq^s>RyW092L(tFM z?6H_C)AU-D{EVI{Vq*_fCfc2C3zZ3GQ7c5(Frn6$aJF10nmklgd<;m8ua_adLW>jd zo7tK}wKcM-M#y=Zl$G6*aip8L!p^0q7N2lmCVsIZ0QVvFT7IREYO{$`T$;?Po^oB) zFC?pU!j4&BCsG0~g|<;-j`=5On4?5tZ-hHhOj9PL>6P|YHmibXC>Ns%7WROX@vLN<*mgfEf8;%Bp{?GP?UkJHzW}rOfu8{%Q6^JXJjwU zW>R34IWB-cwWKR{oNZp<8Ubi+j`9-trKx;jPAX+jPRcyO(o&THRc#9zp*{$9Wn99Rr=i9Cr2)oSK$wy)46O zOPuEJaCGg9_VE^M7gI@{l=HdmQ} zi8(!&RXc+!^$IlmT%=0O^X1fnRKaQI0+q>L%0^;HwXJ&{VT`K6BaPXrsI)U%W!>4u zb4eH9>l78O{bD9%%Djc+>+>9p1B)N4F0(F>lgX^jOEfL^18Gyfp% z;8n@BfGan?n#Wh|`ikfEBkvu!3n`8#9j7)7vgN}omwi?ZmCO~SG!9*^k=-3g>S63} zNZgj957Fxwi-FY>EQefXVG6e>scMyc18b!>7uQ2=LFp3QBav_X#x2B`*mJbZrX)#i z=ESVxkm+{77M8ralpB===r4Gz%fYp{>}EQ0SdLE=vfQNJQ!=)iR#goR+XNAPYgoBw)lcR|jAXw>@KL~G4oqL?7pICi!a!GmFRT8vZ z9P9z7Da8GOn@>XtXz8^g5k`@gkepS}rJ*mVD%__XDk)QE?2t{3_f3R!1$GX@e?_r8 z#MV;kjoDfElu|ATCtTWVZ^{!#8yj3POk$ixPFV_>T;q+j?y#cHE!C&W9^> z!+lv>l2kN2f3MbPi%wKky_rKS%9~PxG7;}Iw2aAgUrfU;mN8|AhfAlaU6UgteJ_Xn z#lEQ;vn{at8&f8FVaDf>@iw!m*r1D?!r+@lq%khvLJab^)a=&rBe-I5ZOlwb%uTY| z8-0MTWQ*-vTNQVinKtWWD3ElCQO3J{2(KgVbKjAW!7M*E!xK))OoXp8+Y540Rv@(c zkLa}^pzO2_3_hbn4pu8>8luQ46X6P|Omf;&vXbwGDM}z_P+>my{pDZI9YZadS>h^d z4+d!x?aPI|mH8Tw$b>G$l^}&(yV}=1NQI#fVK$6!H-_fjaj8aSURY8Vm90vaa9g^g zYl5JC)pZ1jUoj71V}RM>l&y zQ*q`aheQorHxRu?Ud|vFj%C7GkE%|ETye-NSTv$ zJicU$s%h4MHv~4N1h%fAi-UhS<%J`mIaQzGOv+xEovFOUz`IU!IfyNtLLEYdv!_s? z4X?Ct?bx1Y5wiUHoInW+S#%HzTC%{tofZ10KyR!#Ha)LmWXdwk!|9nrBowJ^IHW9t zrgV}@bUro)6Gu%M*;%&SZhBU7YN;fp7SzBc$(EF%dpL`yAp={3<|BfRRYQm9n_-n1 z>Z;P{Qc4QSh&t%B5K2!$=^Z#Ub=(T915iZF+TUF*X$|F0ttG%gN}q1P0uJO^KKnPx?K>3Z}Y~t8W(4^N)YP)4!K6m$~Q^NVS~kg0bvg{7rkX&T*1MelNY>j`I2Mr-JG_ZV8;2mo>#ePsk2 zYnij9{0P0oAX(C)SElKc8JU=uNk}7<6P+Y@sC8GE);Prr8LEv&pgE4cFzB#SQz$?J z;^ZkFUl>DTk`h&l>(qsVGTm)R$(%bTKuxc+$y!E5j-vLqu-v3Q6d*9|YGSHgQ!=W^ z>#GI1go5!F7I2YZM~|E*QQ8+%I9{PomqC?!T`E1`(h9+~^#MUSZVydFb5JOoayY85 zMNmWXGL9(;wn~Jd?+wmHj_L9?hTMk|I8E_7ZbhYrCFJGi5Tz_K;t<{2Cge7|gPQ*6 z*p9G=F~tK;Ux{@&;%263HA%SzkW~9pOII&p+;DC$zf0;2HRH#+^&IeDVb-E!%C;#j zNnxrrK`UL-r{|?q+f9yytp5N55$D9hJGQ=Ck4FoAJx2;#v&J}Eh?sVvAkvj!;N>{A z0pKhW2punB5GCyxqC(+V`_nrz&AR(}|T{i&t&9$YPm$_HZF zEjpy+?9-|_)y)&K()0e|k$ri&&m6u9w?(&i^@U(N^JjHkh z@@XYX#54TB!=eLF<@pZwo|ePQR$)jsE~aWj8#Ua+^Z# zw78Nq?`k^#0Ja=_MRWbctafx%>KJGpZahY&`dIkF{CZm)@a>spnQC1n2|_|HZkr22 z)>=8B)|Z!+oF^bcfHoi-k4p_8S#@&!!NQF>x-(TJAzZN8X+VNIs<(y5***}5H!qjS zQi?}`az(E~!|{%%_Q9j3w%nKrus~J8 z_edIfjf^jtknPAJZl%BrY6nm>O1($#g`^}j?DFK!Or>C*hM$}b(bTLws=0$PZ!M0Y zR=vEf0yt-OV%jG}pDiG4DAsyask4pnzIk$OhhV#?GWCrD(!H zxU%!kAw#@}P19}k(?U8!dVW7Kc5O@|QlVn2h1%T2kQ4{!ZzxNr{DX8Su>Jx#e3eT~ zETZaCd)?D>dnf^8;prTXJv^D$I~NLZN=S5T_pPZOo+2FPB*Nmtjnp#u6q^GHXHlr@ zp|Vm5&UVdfE7Qgh#UoB)U)vfXNl-S>qoMTi^oH88T#adIRUx~T0-!bKr@ixp*V{s@ z>&nO_)P=YJBkuIShwp_XCe7z*%SNrNk!_Fev<@}M;*o_;I7mvff%lX77~^mH3N-36 zW#rjPDjv2Y%pVwPaj{9!#ALX_!)`p4A!9_mb@(42oHmtzF;DJ|lu~CYiXP7QF_Lu) zB&>NQT}OrEz8jAw8k6R8YO)4a>vg2K(bU67_=sA5Vpzj1f&9+pxF4|ctV~1>?y{K zj!#ca4r4OK79=eT1ZX;-i|^oLslLHWx!d|dwixDsQm`&ibR)*%6{#UKbrVo+U?pp5 zDj*vJz4nD__z9yk4ymE4ff3sZITKU9(U>Hl+w7x z3;Y2DL#lV*^c!@(xYP14XIcGN7~Adg=db~EYy1h|YpXz90UD5n?OeWW4f2ObTm zp$W0ntO5W%FKCyA>;7jdhS}z2sx2jKKHJE#`oyg&1Y4;F(IF~1WHYQ__JZczZT?rY z%rVP!I!bQ01=J5ro02vnB&l-SxEDg&+)5Zjj-ltdN##sl?aYj#=~?QdxcSGOagFMH zucPTD+4-7&ANYFLRn{-MHLMCjK~fTxcS-lyU)*1VXYz{5Rob7S`mZPCE$@48{pj>- z{894_%n9Z;v=9cbGM{+|qtgEXtJIi0t8S@tU*$*0=VqV6Ppba_47|*!T9mMoP_?Z+ z)gRGJqrqM-h*v(_uauYWan*H6KlGyfzsWUJfi4qeDJTlFPM>{+e}jAcQP_DxYQ77T z>Yr!iF7EkXRnkkmf66snP5FpZM%%wEk*GZ%mHf&5@!yxleyCD>o&NxvC;tEqk)4;E zE+B^idoR>Je?>5l@J}AD4-XxDM0GdaUq{kQv-1$rr?%I;dd2sTk;%mrDJ*3m&wh`jm;V4HN4zzT>YNLxB86YP z{SIqMX|>(X>Gx8lsDzz54SXWjGEUdN{JP!Hq6n7 z5))<>%^2f}+cX?}!)_weIa4m)8fbMfD>XA^0uNZ?h~s0ug{Qfc=N#+K2>$>k@R>rH z#Vb2JPnCY9!|ArAS#|ddwVDO;^G z^-5QY2s)2AwOl@>&{NM{#%i_OcCNG$Erus=(7Mvd9{^*%?7N`%huMp61mh{j>2(_0 zQV*H*Fr^74Hl(Re6P58{*3lYR>DSc~{7p$e%*p=%CvT1$Y^4}U%iDD{@9~Fx zCEw^Xsr|GwHO@9;jBPN6YM6YtC!Xr%u;z4+BBO6RK=DSldy0hReqRyR#<-6a;QCcD ztS>Jr?qoViJqa;MU`H z(H1p>aWu9dXeozK;z-b?K##zfS|DVOleJKn6ADH8IFtCp@K!~U-{gQzv^v=J5j8-B zVD58 z_aiAS{b10WZ{y(-;q3Uy?w6p;;KjV?T0Ied|vo=*Gx*wOI@g8dz*mfY;f zcrf#bH%?HbAgEn7)M*oA!&uAWtDx8LdlXM&%quHUpICAC9B8P4VQk+RMt&Vdw7a3~ zIosdJl`kBwpm>oE#x(w85|yuzt3LEzBAuB;C`g{Kx0+G^0N61@$FIXLgDh}!L{#I6 z%Y)qV$@z%Q;pZQZ=vlsOcP4(afYJR%58@+PhmtAh%ypeb+dr}UqQ#;jE7P+hJgVgX z0F_2?f0|=A?LXmP0>=kZz+VxE$XY}~@jP0GIdAYv{GwM5B4U$<=l&sJpYQ|x*xYcR z!itRC#RVYeZvOzQ`=aF#iv8ePxmc>IpZSTuZ;De8IG%*OWrN~b(IF!9irEdQpFkoK z+?O4hL=_$^O>s*Vsz#qVJ1CbH8%|Y}qbNF%HP$9PIwNkGA~`iWTNVjR-~-alB@3<9 zO@Q}b0DJ~bBR7{Lx3csu;F3pmo(CZ!%d1sXJmyFGu*1pl^c`DtM`}-kl=g>yW_iQ< z^9nzda_sAuk~1CzVa2OEl8AL@bvTr%N7Rvcab;_(^&5Nk^g2>}7{k)0>5*iA$~1qg z3R$K0#Iz_EfoQbQl?fKj$Q{;_ZGNXs2b?M9eqwZ)Yg{~$smi*;Ev1JRf)L|iB}g{V zf(C>`*s{Ar8Dq03a;L;u*{P}eHC}D!rX^;1Z52356cXSD;GIo}KqFmOO?5^$F3y=~ zl;{5do3sA_B+>q8h^>{3&K2!8O0^z(!W#jy?Hczwh|+p<)A<-`Y@dN!BVP@;kyhcG zhu9nnWk%{@%ak850TwY9QnJ<&p~1&^^?Xg7Zgp&OR+fWmNZ62XajDWGNzp1JeKS18 z5^h;@3rYfALiHeA1q<5y#}?>Q*p=K|sV1)^+}S8o4WOB4TUEk?q+KfgVdW9`Y<+Sz zC7jI42kMW?A+$|QD%v}UOGB1v%)Z>3OOLpQP(IU&2_G{Aak+9G2Z8qO^Sw>)zf|Gmn2S|@Bh)YD3;NNVCEH^M^F*OodrIVA|>GH`!g^j!E zDhEToy7Z3E2BJ5Mq?)x1MK_Nngw6)5)8^C#%(Tf4EOobV=Sk_Ph!2HJnq#YpvI%id zw01tg?y6d|OqF3er#q61Q!5@yQnHZ`LxYD;)Al&{nSI$B80`gAq_}3J+owsqPGY%v zaM2|Br9i}og?aqWEX-d~yIip2PyC*f+Dt4 zggLwTZcUCkOOmgS#z(k8U&l!mNE z_-u4!FqI<%HkPVXGWi?LA-`$Anv|~a@!BFRvTp9abXdGfOZOfL7Ae(?i>FQdF-Y#V z($b55(?ov=jQ4kAiD}udp{ZELRXj3Jw6Z5y+Uz9rZRUj=AAy2Di>ciae75+AnQT6e zB`-Xh+?8=g_G>c_r>A)%f5bzu{12l!l6n^WyS_x1qsuRa@}@aGh9UuVWz{!j#0DWN%Bm}@fX3|#BZO3Fix_$+kZ zEg++pmd~@~Q)OCqe7m7RkGQ9Y_`Oa9S zS{as2N!Hid(Gl>)GY)WGu$qMp{97?N+J;hPQdxK%(6MBxNj*Wfy2Q!c)oe$LOV8>} z{4d%`iXvP!icMNdPGMZpF!Z4fHlj5uP*LTMw?8<7uyb2K-^hM*x_)0zFfpwB!Y=%<^|qnJl_q- zF>NO{0LrZ`t%jvH>W{q9>){dMKc~~-{z&Yj_uu2@L{2$&J*M$eWfQW65|1d|;@U-z z_{M-v_xJC=tY2`R(s&g;*RQ9M2QLn?d3`-dfmrMjh?spzZmQ91H`SDt=2ARB$zn%T zjiTv$Y8{yi+*s*wm$D^ehEwd-xvEnw_gU+sL`dtMUQcFmxp5{ZV^GQs8y&Tua&-b`rc+##maPM^wcwru5v?!y`;O z5>^VgC#biGzOc2!?j`YVx)Zyy-xfy}C@i%}Lk%iLrrMa5SuHIt0b;8n;H6f&N!;G? z3y6fV_OFXXXOb`RJKxDa%zx8{14~-wWDB{@;atmKdj;%0A`^aJsmGT2OZ5DW1mS80 z5wee>`Aw|Zf6bCoZ}+SX$E+dd?|z3=ANqzp`xtpENCibub!r4gu zqxMnx$6LR;_3VySef`@x?=aE0&Vr=@dng0s8}Ltw-WzdVPt)ny4yivsPtVLFa$-!W zL2e#~$|_Inwhrp?JtL`U>*(L2?!n7fZ%@z2(3W%CUQ);@4Q-frQ+}%PbMl18@jLDJ z>N@`b3a*mBx z8^Lt^B>c?>guHdpGiFwqH&=U= zD(i|_AgHK!5T7$|c=$v3@k=A9+x(Im$(A^k%D+~}PF7KjGCRuWzv65{PvQJyO~UXx zcjo)PUn4QZ@sB5x?75t|xz{I^nZtiBgVHZ!jYO+*vjc5j9!NuGds-AEAuzBpm0CIh zbJ_!^v%m%iS8)xoNX;m#CK_X?-feNir)EV${{RCEh^i~|jNB`#RVL=$lT_5BuZHrv zg*w_nO02sr0DuZ@zgU-!X%TY9#xk|p=D9B=&Xlj!UwJ3KhNsGaw%`HY2gt;QnGj`& z&BMME*Q#r1%~tDZmm|Cs@`3r3$6jQFtZj(yEpWQAhG)dOF&#k(T2{0vPpESkBi2F+BBVs_PF< zOuE_>>t!o>N*%?dUsJt|Gbs;7CVW$d>Uid}>~!jrlFBm4dn=P`Z3Q7}Lb8EeU$)iCUbp#LeuNTSAL&_!J$<@etJ5>`6yN!_y!IElOcK zok&^ue;8q*-AGeT;v-0UUR*nH@lej;%%DKOPZ(H@nX6f^`wFbJtczbT{t!{r(3Ezl zj7}9U;FXwRLd6pVYCJNi5geggd6Achos}w53ihlp8cR+qGm?vN^3qS*Ya(>>1_rN~ zi(h*PT5kpMb4MfcvWM061O99@=?^H`!p0q*>eDZ_`?8Oz&RIwEXIol8&3^WDgMSYw zP0`&JfB)5&)VfM>W*~dp5){mYwK3*9pcJh|dC5?+h&CE1kSr_&Lb@L-+YPZbjH@&* zS-6|UH3vXayP*imwG`iN5>17!ePT-e1Tr-6uDdZ!#Y$m^RNp>gakP}Eq@?C|DFk>B zG}!I5Jk_I!v_2kVi9R=BT11^u^rEjahkcz(PL4S$tg0D+2}vhWwwD6pAx&2zL|ut2 z1H(t~&OVgRkcl^1n@f!hquJkeoTO-d)!Q-%?%v~gZtV-L%v>?XOT_h@HfLWds54Zl zFw=klw-J#&)#U&L}^Vy`E`+R!HQ` zp*+9=`z2Pkn?$JMwXoBjJ8K>M<`TJEs3d)P$v0O`nj2YV3Xo*VObRki?UvE z7X~voLdGih-Eye=)<0ovgaKoJy06C38eGR>b+Fzj67qOsE1}7G*_Pg9fI-a5OKrrf zO@T^nf87wL4rG`}l=Q4nXDXD^5;=2IRR+Pnp-5<`A3_pu@Q87b(UM#Ikx{jY4s^X~ zC*Dky;7^hIRkZ&2uw6bY@*^_HIB=&b6$XeI{j!rRA5Na)QlG$7cTkG9^%{h^N-D@nNur z<|)Z>T4n`GPcgy?+k0GF!X1CGk$EL6H8oMEOgNIJCzs4v&;*7Gi&?s;5S-a`0Dwp) z(8^-kG z2k`n+hc%_tq!y%$vWFT~&6;}7GPJ0YYzb3kKOF>eS)2729BB>?KEM;L%+%+dZ8Ho^ zO|-c-itJJYH(5cy)vDt#BE*qyu%|wYxFz`!XN@?87?m$e%w?HoR#l1l7oARbnlCMu z(tzrQdnH-H%t#>Eivbp#J0j#p))%e6MVDOO9hy>Q+ZLXuyq;qt#SXH&qbj;Q(rhoN zi(G7vBs3gdpf`@1U3&+p%1<`YO;U=5T&1luy)5F03uu5dvfh^aJBXPX5#*SMa}3cd z>=0{m0BDiEprP-KtNEqzR=vLQXJ04xXyO2YW~*JQlTh^Wt#vX7Wu16 z&^$7@N>7FMwV{lWp~$-={tUx26$*f!rLbFJY^@XQmu`aUf=g;ZQQb)=F#}wn9Y~1G zcj9(2%=JE}Oq+61q{~cG%B7kp?x>cssR~H|6q{c`t-8We6owM3ie#%~QR)+o%FU#> z68o~b*?XFl-M4~3P0x4hfy@uR3kD~oFwJ*|l~)>AZI-GmC6glX56ew9gcP=xpBD%g zJ$GUSuSdW(iO^fVPASLQb9R zBK+1crPY&$3fQVVgeelsb4F%cS`@aDT<)MKB3xF%Dqv2X9R;qTTEZII8rkywWX%VLj`VXgHQb6K2C2G|J zO`AwsCmD4)4_-meHt^p1S{R|l->}@^)yh{W&Q4D}9+z?Hd5L$NC%TlBlnb4Eiv$bn zc;sz;1xuf(km4T+r7@hd>Sj?Y4zW2iEb_EdQz1b?09+_$*82exp*s4E%0Ho7{6ye9 z<{5oe3T)!oOD=tKRBl>xB34qZP3{kd(K*d^A~-SYdZ}8$NHqzGMNh~}yOpQfQd0b; zRHr*dI+t2EHU{~37Kj-!De~BLNyp4^aK{ko{6k76B;4l9pxZIHQWtyKNFXUbq+8A_ zCyB$D^k${VT*%fPm779Yy~|g41ERCIEC|_J1Fu`d4GTLHl=-}F`jV#FmX}L|oKOOa z){+#AyIAN4my9JNypFYR5X;RmQF~OmDAJXgB;6`;1tP$B4SM|JsT>i!7Mha7w0S93 ze?;p@c`gHSoy99v6W+Sb?xWXuCvEO=F2k8QPLtvwnSHc{yDs{IHBuCnpbYJ11RSJ~ z*}kAc7^Se>;ruZ@J(t>oCTZ@aN_ZOuq@`9ybm^R+i-jFcp(2=!#QZUstj@9@mP#a) z+S1a)mP$eiR$_s!WfO7h4#Ij+i7iBO#}qH`e&e$=Wv*U!Pm=4aZs}SS@=j*+gWpKX z72&CiZW?XX_2gG)hdMUsU8nI=VM?5z=QNZhN)EDzQI!4UsCBijHoRYBopUKNLdW-n z_yVEY6%N%D{W4v`ptLZyIqo!|JGMzuLrFR;BwZxxMdEZPXn{CsVpog3lrhYsZ#dlh zQ|OpdT$pXSHYJo+k8qNcb%E1gQ4-?pi!F%PgXU`ZFuW?WGfq@c@_Dq`fK@Fz&>)0q zbfl-KRlpI*8Il2UEk9tQgSc#vl=K#dP{VtR z`K$p%#mz2mSz&J=Aul^H-gSkYGAI%hPwN}s#ul~^H&o6QHqd@@Q`y{@mnEm0aH+O~ zim^k9%uY=$-6<)*Snng3XB!pZ*V}C`&eWTeaaJYCL~{>&M4`frsU&Iw$g;t)+7xkY zC|<&63@HuFRUCS0)?9H<}|hZrC=Y z+-aqgs?vq{?O*`w9XUd}jm0TCt1XE}m~r;=q4rlUhVDMe2PJ_UcW>hbSaLa7f|pWm zP?=^?CoTvLxiqw?9sP2Yk`212_eX3J5mL=!%oy6Ln$sBN0ivO_i2oma?958d$S`un}vgOxGTSUOME0 zn69GYW@+sy6(qARrjIR_kW$gg4yz?0I-3AOu1{OS9Fi8JVk*5ski;_{*2v}{0+q6v zzEX76D+MY|x`GpH!gW}rnm8=Xw=}UV=d#Q;ka9M%ms~&>Cd*c3ojgtSgz7@{u|0_A z=(5N|j4EDHO`EMvl@hGmW=-#J+1l{Sn(jWJ*r95W#IhMWmd1M3=lynH&O+sQ*n zLz?a>V||WJAFE?I2u)OSfTx0<4W}U*ps8mrz9#3uL`=L&$IO!q4rAknJ161{ zROn4b)~L;`I;El}U%1o+xD=G2_>`SSky)GCiESQinU90+J5;{P4h6E@-XfiwluC*{ zpOl74JKLCpogk5^8}%_?{i@$8-Pa;lxuIQI?5|F)qUNDgM=d7J`&)|3Zh)wh46ka+ zxvjjH>@VEVxWOC{!`L+iB0;B*FTUi;eWBHq>vH3{)IVepp8*y5eWNKpeF;$EQXR=M zoS9`Zrdrwriv-wvxiq)JE8iI3C$szHN$?WpV5NtwtEVz`%CG>j2i>sz;f2IbUk>A* z6j6eqiBl-FA!<`@A9mp6U+Ujrd@l@7ife99=*J_3-D43Zu7?ndhnv1+lc-rJB*r=$vmBj=ktf3$)QbwTsd?D!Mce|x^%x%YSmt!pK z(xudSc6j^QFJhk(3F+kvl=Qu~>s?phW08&d97!BZ&H_Q<20IA#5W$(2%U@N$(`?l1Ky} z#yPD`?fG;&rNs)FT9mSG5oEY7NM^CC?u2} zG*{tnkgB7XVI}LWPA`_;q+0jse_zfzrDq&y>MDILX=8nQ7;{n+LV9Yf%%g=XN>J&! z7yDp&`2H}RLbRQxXAIIp+DKYe9qv!jfdp<`5g-);;d@$}@ z>h}VPPTmT&zkD*}Eh99xBWhzhP@uK7`b4L%jl6B;yc&Z^r!iD`yOo9%>NHSZaFBeg zb@hbmzDH;}>u*V=PEJem+DP|;g2)Hyf);Y zQB)|UCtPS0x&ndOU=PGYiHM_NwKnk1v?L9RfbjBzW2QtPOAM`nl~=I`{r*sL0XZ#_ zMbeb>EIstyT7Iwu*p8ME-yvMi`;$#7&1w{{bdhjjVon>2GX#RkT2gf=U5N9_Y)8Tx zd-VE_8>)4gqy(W$0FS&OugcD#1i-Gvyd z7>-8^a#b~zD0aarvC&rQKtGM3a#1*wXJxwk6U}oaoJzd@VRR(=>>NdL%1*r~d4pOqR5>2gpM8(Hx{x8bE zBq3wIM6eXsD6(t^rB=&HN)Y_0UVmp;77nzrxEA{szV_ZRJX|+zrj_oyKk+Z*X!vZF zwtLpky6pb|nVpxNT8cDW$W79837c!cje>^S>I_zH{NK_`_a^MVA6UQG^D|An65bf=Ec3_kt0ZCd45`%YJ2Ub)-3~QfH|HqylK%h_ z?EVJmPrik}k~ZICC^)r? zwBZ9J$~v~R>=ri6b?XXF{M+RENp^l`9WIoYHP$b>^70B4hY}ZcAqY7_^)5=U?jEZ_ z^X}Wq2UUF**VZq$nmbjt&AscSmwzT1K|^w3w=oMB?J7B zA8F6PM^^~Cu<=5x1xu)Rl(YR}AbccFtjtZ-@I0F>IN}QPB_%);rh*us4x+6NM=NJP z1kGlpx|7ympOQpD$sVML$nLksWN?`wPfj9Tr#0m`oWWf#00jJFxS=U+6O)o$$6dUA zFJF{bB29*Ut0LC>At~ltRFwdfll^T(M9-1dmOBXbKuNu8MIJ;>h^Cd9h?F>X+Iujx zI*tlisbBAjB&tNj%hIz}KFK!Iib{dD$0--|Q6R?O*uK)=!=FFyzWzmL6NCH9=8Ck& zH4Ih58mp9w#MIGw1eV8<2n>MVj z=9+lqC&Xsk&uHzP(7PJbHJQiC&=RFOgmW_Uoh3-$GH$JO*4z0)H4E_kjVXDVnV{N} ze6s@VtD3y4KX=~IUP`nMNqo7ASnub^X;A)=;0MYjM;(wdPK12q@36Yb@O1#fmManBP{VdM z$E-f>PM8K)*`0jv?>0L zO~LbxHXJl(^JKC-cA2j+S;6%(%jkJYN;4Fy_PVsaqQWquCaWE64EmRcsf9-BEernu zW-|WLjaS8*4hh}-4us*lPpJIjibbk5ahDxvd_AZpn?E>~W>%D_Af-gu?Q#JE{;{&* z@ak4&bI!IK3fCQ|c+PHOmn${Rn@pU_^5jq!4X7I^fIk?pc<6$pCVMo^2QW0D9SdLQ zMSl>tea1PA>VD|4WK>tDW{`fI zsb8f|Yw-z;*R=ltg?tMf1pa?`!_2jaiQ-dy$}Hgj02HsvB=GK-iI})|Fty?7dms51 zALhpQgIgk(H!*KPaYj|M)SzGG7RZP|-Uqf z;%MfG!=^;8ItFB}0WBGlsOmXJz+5c}HyG6X3_XvS&R#_k@k@vFH}PcJ8);&3Q#sT^ z)DklgO09byx<<1U-j(n%oJyw2<4<`jZ7sHLlqD%20cb-i4!omfTS6G5HQk^SYE-a2 zW;OoFh9}6e;ko>XjM{l>h^3&pp%CdlQ5PX50+x1%En7z}Wu!WunTDg#?miIGlaC?B ztm;rDX6TaYr=>}lkXaU&c_Br=HrzK*^o2QJ#Og<95phbDfzfICq@l!(8AvNvrNAJ3 zV22AVpTdXyRT4B}e%4cSg-y~Wg8;%nJ-=z#JmCr_&nZoWTjKUwU&QaoY3FZ|9_#qJ zuZ&lkp*ZWH{fxvUdL=dyZ;uRd{{RX|Z&Q5EOss-h_fzqQ&K-v3^9@7-jfSL3b{CET zg|<~b>R3QL<(nl5+@6uf>wd>ly@~n5j>R+bY&BD!<;_3cS|rqRAv%L)Eh^OfEDUF} zdr@+V`IcDtKJ0WmNcMnhgi?!Pie%ip+l}Qz{KLu$BFZ_1%I(lA);qy}v%9~Q?lHwL z1#kI%(NlEJDk9{*3yV^TD?8kqo{_1Fqb)gD=wQn5oqyUXlTJ!a4Rf;Mnpi%mDZDt< zj9n6%iQ01%(2^yq%}e4scotI=ZL}P>lcfqI`ra6pBt03}_VCt`!u~Ezhbb&e(<=%| z3a3rBr89wi)UN95DU?erl43pOUPt)h1?UX73l)6{&EjDGCbp&=`-C9H+f)*ry3>gSY<|kE@QnMi;V8??>V|%)j_~b8f6gV>EjCV;D`8jv0FsEZPsGA$ z^!*7*Np;)Q<``0)XWL|-DH)}mm~q6Q9R^1VidKWr zeVwfuP6b-!`e%(F7IIss5tho_ubG*#H>y~Uc`+RFX8^sOS~ zrFnlLXiI_xBXWbpx}9=u4NcT0o@Gi2aSlAPf|6`PlY0@bgf}Qs{KRw=ONDv=LNXy>3jV%VK4w(xoS; z<^&RdtPDCPg#|x|94F%7S)Y`54NkbdRLb6Uf^Xp12~YM#qq3BjFWlma``ER78qAFC zHecxZ(>}^uN(9MYG0Op9R!*x2VikDB@w_{7zWr;L?!1e>A1x~Tf3rGMROQQPQc|Rg zfSthm?Vk@8_VS8Z;&Jk8w{Gjpyh|8lQu+7%pYC&7nRZ;H4)`MJ%cgPFX#1)kX}ydv zq~qt>w)w8lx*l;)_5GiJiPBg;OMOhj#c^Jqw;;9ncu%P=jObI_ldkBq;YaxD5*3Srqlvn zwVXk|t*GutOvlzNcy2OSH;dcPzi0c5&l;A^e7{xu5z?{PUkyzq)MuD&3b)!S<$8jy z`cK~J7N6TPk2TAmm-6!?J`qcoUO)~QSGzJwpP&@wdkvIYqlad)s?8sL=~o;p>8WWV z$HMV*!h20-dS&=uf9d&^97hGCc<#RY{zPfx9Zv^hRIxjQTw8MCqK9PGhf~QQ-pS_d z0k|nnfbAFYle%SNib}?gUCS_a*(dUc1QKfn_M)Eb(Jdz_KShz9lYU(jP3_hqWQA|Z z6Y%c#w*3etKR}kmt}XWi>7H7%Bm^b4QFHF4Ccq?g5eiuxdr@y3N?q)-ukL+Np2KsM zb{|MfgfLBrAn1CFgB1K$MJlermm7-Txnh{!r8h>AT*Rt}F&fy5f;xz=+=#2G7O5Sx zsWU1pDq>aFQf##6Q)CgL1Sz{;;}7^!T+oeCeMdH*$La-i0^?1nc#MvILh#Fl^IwtO zO>%GQI#^a>iHlhFi6)yZ+=4<12t9fO2=F7>9r5SgiWN{LMyXS%BW$j?KMdA`-PfP1 z{lnfR<>R+s<&s=WW6Aj3wM-sk*)jDhG2`(0uzj?Lk@FLgq-WqBTt$b4* zjHb7%`JmGD$$7v~+{zYIFR$jHP1Wdh@`T5SQspG?@8|Ot_=dM}YQFwQrZ7LW_tb>C zbl%rd8yw$c54xD^;G5}woBaAOBz1Agb+2ExYEMuemr1%wP!z~k4mA-ek_aD4-EO-5*xIMr^Xbp_7FcrzJcSvl$K6c1u|q1cC-sRM-1r@$*D z8OqG*YzSQm4YYI&OI4r)T~0#4*ITjBFqdEeInl~HVHEA-jS5C-cXFl~XmuONcJP`M zk-FRYU>0mDaJVc?78EAvoHV7mH8C=VT0@T%m5W#@LjCIlYxwD`CQ=)5NXIe4)ycjd zly&Cq_7dq^fAdXhDIWkKI>c#1dBi>u%i}ZwG^Q5nb7d=OC?hg#Y*3`zPOzxWpm0y2 zsIDJN(`hbA7SNCxAT1AR-AJ&qkCyi^wUM0gkpi$!AF!Vb=H6ae_ojKS7cAY;oROO< zg~1n2glQ60jcG)L;q_Kpv5G0PEfhG!)g@&hl&ILgqm@H&Y<4i4*ff&za{y8tz2w^0 zeGlb$OOe$PzQoiiOe`sE$ux!;Oz|PK3nUdJ-ows0VyJxGT29f%6kr<10LiofCRL6p zs3j_VbqBh?^<$QHj53VNV&+1E$x|*HIN2yZM@t>LLu_$65u8h=)@7MOsk4gC6p|Wu zyqAAhF+JZ?cuGfXMd7|GF;<>tMz1gI6&Z7#E#B!^wTViSGMoIwKNt-;P~}$f162hZ z5K6Qkx)k7XOf=mYbk_2`*hwPeWohGacvgz$3U|oV`bKvSwwEPlmfA_NLV$4}*;VrY z09Me{pv1QK^O$8*b23eoOH`@<07oTC7v;@LOt{kSZ(y?0vjMMk zgJ_MUcFj)D)RtbPQYTWJ(-IZu10)?nTx_Lc-EKdO4ph$7kcWso9jI{nZd$g}iFL1Q zE0}E|LFq*);%xh545=XKzjXM+>S^qANZ?{gZ1_5arq8=GS4v1fc4FXyJ`mWk=TH`V7a1J8%OB%7P^zIltDf>hNl%nv17r(ULD9kisZB;20qUV_6&ZN8rYL}~3C!p7^EiAGsqIJ&`QOD6W`i;LKMp+nXr z;*||eSkd-(sEjaXW?Wfma?=P|aUc?qg_J2k9SySrLFssUYR2QSYIKRoEJGnzW#ZSh zPD;Nt7Si)e&N#M$RO<>PoWLPG#>cp!dsxI59mnj7{4&cOBMoNe$FY){iC&bMZe8wrRWTu3KvG&*C80Qlw$NA_fNTg zQPl#=3{5uw09=f=>X71(l5-~h9b>ZR_uTAxefA_}J#IHsXPT7qevEzQ5-t=H00!e= zPQ#_G5mNkzTl~#l0#sSWQw`2Fa?|pqB`Vz|FT0rw8i1j(5Y*$RZ@!|g_Z8e$!!OnA zGP2T&4SP}%%~$F%nAm7V$;t!}{RMLQ8hlU1scMlbsl{^JX(8uVZ~)~Kn^UnFY&^}n z!?@O}p)c^+4yCBb#I)CyQ|BehkFqwB+D9^0S#LQs(v*@mxI#_A-q$)9w1o70h^=Zn z&hYWdJ~gJ&sbKOIEQ#SVE?iR~DlY{p*>b5?MXg{I1;L3i%Sy&t=x})P!zx3w(&(hl zCPK2QyR-uA$eBt5ibB<87SyDhCf(9)nIm|ShcA9YWfQGEPp0Czq_c`Zma5CT1hryM zDpu3Uu>x%$qEbP&Vi9|9Ys2d`3V5txJ3&ZQ_$q{ZB(hj)c6Ajwx|0en$<0nRbuyV{ z5o9(lrvpmwb5x;nfRH8Qma;U~kx#^KF4aWl8pL>fHoBcwUVKhUrL>mRw5=uNa>l6( z2_N0MEOa`h zVuqz!DN?9433a8hB3YW6C@Ie{+od7)&FoTuQdV>}Crb!n#)nqta}PN#CYM2HC=yOI zw%wQjrAM5F%LCp0geR;?oQqt0l=~sYo z@Ajjvn1yK8!uW<$8PnwGQi*a#rB0|y%sWq?A*qntZk4!DpXmp95y4w4>q8Wn=^9a>FYfj_TXcjT}0~;aoRuz(wTbYse#T9A!!X3wfAQb|I=Et}pEGD~zWet5M6;x{_RVIZ4Z9wz86KWdfDxY@l>E z7Q7=?-=jF;V^d7xl}mav5)ZtmSBxj_Q+s0LGI`Jg7@h%q%QLl7s+yo6pqnTc<{)Zx{ zdnj|0I5xXIE|lh%nOa;%U~H_(7P7SOX|}#_#D^$%8K^ft-Pl5qJN(2E-m-zRmDa&R z*Z4wM8qGe#lM?a|YNRJKWSa$`@9_uo5Sjs|$8>2bNHr&v;g`NuHh@00L>9sv3Kt3i zM)o4ZB5xHBY|eYAQ9dN-6L>zi5U2mvrloE@ckOtvEB&w#H8cF>=kzx zOsJ>2w%y9xN>I>-)Zr>0va1mm*tn}Ia&WcCela!+II3w6${~;to2C5OlufkS;@=C! zj53v(F*_M&aK%pzE%s)n-$MZ*$!8vI4~FJRAxc8SX|il=60F<#M3~7wL|H|yf4<`* ziMV@C#`WK$@eneV35jg-^Kx&LA@JU*F1D~!zPCz8UkF|HIIpONqtxp-EUkae9u1{P znrdONd5t!8RHK0)Ib_*I4r^^ehb(S|tChzwi%VRLw7)IcOE8mkrQ^&Q*P&S=9DA9kq;T^G z*kzOu`(Z`*kV--dc2ZPTdxCDQEK}0a)WlGuz*Sag%W%wzdDYm0`*#Xe?U%lS5w4dC zN=?KKiWC#I`4lBnPD;$p1T9U3GIK41Yb%-(ZW2#W4w}L>P^~sMc%o)nxCG0rEwU3<8`F>I+()Oj#LMbs#==&^D_d_iNw~9(GW)M|@&kQ1anh=sMMY$g})PW?2*RxkD%!Ow+|d z3AM7_q@_fU)+*DiLd(Z4guHw!N2&h++~bun;nFLz`$A3EKIEuy%iucerm-}^N+p?>bPS;jZ8;PMpm>q#sECh? zZFYU1QU3q}yu;HPl$J%(!e!Q=Go>jB7aeXocoWhXmlb|qLe?5EPtH3m+Di`RD^fs6 z%6C3vq(zo_E>H3wjy2fDR-q~KryX}K$RTQr*;6={SunJ+ftb6G(-bx%>IxAcbRk=Hx)6&S1JW|w>wskTbe zQrb?}BzTSPM^WJ%Pkp;1t#=buS*fXK6E2JM7NSy>1qRPkm1(gb*1e1~E4uyb)qbMV zT+QiK%uma$$F)F8u7?2%x=pqFBzcQpcoS_l`BUf5_BiPr*+*AW%+oA57%2kRxz}Hgv&X^h`wNw*Ysr)iSNb)hn{pr3W*kTR6)R7QbbWLUzSQhWNLDZ1Ox z=u%dsI#5?)Z_PorR};}~5C=`|r<5)Y-FmM6XiS#he^X{ow1uFBB|v6MTRCn#0Vlv6 z{3EJe`>F>Y=4sCH4qk%iB5fvJMPvmmS+#kE6K#55tUKaX%~#|n!oM@6T*XY$mfGE3 zRviPD;I>feHj8DHpbc`uO@oZg;!-eMKnNz|Wz#6V8_? zQCiTIkaRXW6ZuDH6!%?Pzf+NYADNjiyCh3)a+^wtD6+DWJi*ZU+6!x)FP(m2N%sz? z5ipXZ%VB07hAFFCY!-N4tKv zzesX&)6cQUE9Km5U&R#ZG`7m>5{$broajp4LQu5>d!pw4pnRe{V``UceTUxN2PQ^+ z6+47F%Y>s)+JcV0g!~LiR{sEy!`S6gug#FFqHc{;S*ija3{8N>E|N=1zMm z;3Zcg{wY=e0D*)hUw^o_xw8EQl&lakYnw7fwe#tC8aSD>mIcUDh*FcbwpXDWdRhuN zVSZWAgr&9G{T3N8rKO}F_NOGiv$ z$4Lp$p*PNy>Y%SLBj9z80lOtsLx|0m#wM-B}ECiA!z{mq>T^8629zHIJJs%(||1`0H1Z#sD**xpaDyd?7Z@(Y=OhGfm}gVJJh2O~y-wwl+8+1!e-t0c~zP4zML>UdLuhPBC_$0^nRIY(YDE!-+H{?qO}g zEKRR&gUIwSo=16{iK)iaw7BCd?(C#o*m;i#OZXi%r&5~ARLKpv+JPI9zeBi#e<0*x zqtWHCQ&wV4NC7rHzV@FJ9dWJbF8YTPYh9MY9YbnXz-~N9I*%)Sp}KF9VuQI=nUD&~ zlIm}&74KWi&&oTw&5ZKlxzJrgoJy6k7SqUsai>^PjrR*OiKk@_RfQD|E{)Hfj)&nK z-E;Z}GkS8M^C$!^z}nfs8g&Ov3^64q*Vp^$`!=p0p)pNJ=i2U01xyzrj7wp#73=Nb7xKrKY*st&@Dy?EH&J%Tn8W z=9ebBuQ1^tAxJHoAz7YbH_Vg%6^^And_18#Uv6C2UyMcS-tU^FE}sb)CR;8nxY7`sfNb1r3Yw51ra@BRE>lgbS-*vUM{*0IZ044A@ zh%RSHN)+Rr=Nbp<<`ehXJLmKuUKhLg^<5h7yvFXUoi0zTUuWbQGaxMvh1oX9%ja|+ ztxOHA&>j5m9a7})$xHN*Y1yjtlzaaGl@rUCOGqflc_~(Bm>15{@1v~s$$d@kEwJee zs$90c*HrtjAX07J?_Y*p8tnYWyNEnCa}d6ol!M}4w%UK1&7gqX%VSHpT`Sudke0q8OJNyXwP^X%6uS&cUOAGqsv~B_E zFu~lkt@Y4&M8xeTy7D@^8k4m2RDzPQm94>Z_a8vmr2hbf9#(-m2`d{4{uH{Km|^c>zd@tGwi3@MO;B^=!&^Zbva^?plqD!7VjhzbAKB} zjwEL|nA7a~ufBty+7FA9m=HRedpX|?g}0p~hY2>bKpy&sQPM6kqK3Eo+kq^aejJ=rGH-qt%^AoK&%Z|LY zgsmkcrDouOZE@$cH$;mqKBGMQgE9+wd`f_XG&rO;(-_Ap%Vp+*#m-#f`gvX&aUN0{ z$?iYX#YNDYukDmy`g2I-8N#@YX0e-V4Mpcs?sh zCh%4=m&TJ4>y77k!R2f9eH1l&e(VbLY=FWya2e*&zy_rRKcdl1gdoJUNNQr=Np zT-7PSqHc2}B!I6G8r(1NqdS>fX0<+cjlw)BQl%oO%}!!3|=4r&RhVY+Ln+aMny7|&_`tkiG|@)UDR89pQPiWbXch+EpD2+=E8oimg2RjIX! zc9MOGl&z8mpk~nK@fWmi_$gd@u79DB;-OEF)TW^)Pn=akkB6}e=F=wRstc@+UR9)| zW*VI@p$Fh%!e15YLQ!v{AD+!pwM;97%%xgg*=4rtVJUS57X^3H_KJ=!YVCOzygVP~ zPS&P5jx+_v*rz~C#Hi84F(2HLE?gi;7!xDJIim@!r)KO{VN8 z(7PtbCwr%niH<`GBxvlVUvCoC=jNG8!%ojW;xnfzvZxCZJnb3ZY3&v8C*Ukq@feAs z(jsda%llO_WgS%7hs;B`_OFPU5XOz#kNFcSnp&u}XO}LXTAXfMGixJDrCEj2dKmN$ z8)&W9sY#c1&cwHDuVQB^F#Th?G#<;RkiK}I;(4!8jU#Q@j}^?~3jFlUO%`U&#F%e49EiKCV;9Ae}qP{=IH~wIUa{mAd`|3@^ z_kVo}S2Cl}6X-7$86jngl^laIN7!@w1{v@euN4_veMNb*X0yu9=D|6rv*vELKI3`gu&OD}DONmO<5|w+#!r?=2OBmp|s}p>EnG;kwH`27Yl|7p> zc0Jyo!XwF9KMv32aJYTJ2~HzYS(!}BtWK>ZTY}jch#F-iZ4jpPmayDzYB*MNhm*^Y zpUPYoDOwM8NjnjHA6+6m_asAMS1W4+a3VV%M;@ugnnw>@aZ_#*@*B*C(wmYYM8Gpl1w62Quf`K@T%@rum;)6@Jb)R&8e)z9ckZW(YA zSA=OIN==EhFHXXjhFvO^aq4Wr`zj+M zkD6DRC;GNASfr!3BExpKsV^_&aq$ei{avqOt+6jZB>4@MFccgCT4pFc-8Uo=6ES3` zXn~pur(1bGL;>Rm_dg$}xa7qMhg;P0NhM>gtP+1X+VI}cwNf#BMh*5LO<#pIJTo>J znPtg$LV&u$kOsTlfv22ZMdg&H~Af5 zDpq!emk#1ee-rN0nGo>zQl(`l_D%12;~a}7cL%t$itzqgN+%p#pdkP{+E%8owUkqP zdfp&r!nu|>a<=K4d`;}_Bad2~efJ$zK!WAK0CNDnt!};ptVe`gNm81T9_M&$I9W!g z%~YloRWcMp0XA#{rLzD;CU~5l!l9W*pF!c^j}j`?Dzh>YH2`ItNwOcxq+E14hHH8o z#YY#yMMb)%S@675a;EKeCLSxskI~kNdFeLi7+2{XlSx`r>Xm=CGcO-@zDAZ4PnEBU z$fsaBMNEmRMAx#s4q|}duvhD{=3qVmLsr)^Mz_@(Q`M@qHD#KMLT+5?%$7+e+jo$y zKeO_L(tL*!T?hXFg}gSF!Dw=Mrcvz58S?WNoEvN1CnzVv;v~U8;*~VK_bIr}BU|v( zYF`CMEy=2`Fqt_SK&PWODW}w+;uZci7P&&lxS*m$a`k+k$@E@lQdqt%Zr5Ld)SQxT zuF{H|4Xr3FxRu(8(B^YR*b+&MbXPbElXu!7mm zb*Y4_ZNU!7tM4xBK-ogjrAwdM{fD(*&+7jGNgH^2lZc%{NtuvL#JWyG+FUDXA7oiX zhh^2(O3Xmmf+9p|J-T|=?dnIImtMY?`Z6GP)t8yXG^te0G?pLDXF@X;ivIIOM3RHJ z@Y>O(;F?^!8O}9dsFmUW01lt0;l}5bJGnc)C#Cj_O+`%&b!C##P#Rx&P?0f&no~1? zezI;nfxHsrbrxG)tKui*8AU1fXKBYEo26G69LAa?0_zU4lr2nws9K817S<}InlZHR z%kQ_qvW^!m)qVb>5yURcI9Cx&mMC*(iB)wx#---myo|`)s#($$r6 zSNs0rr^5F7eyD)hmw*_jgz9zbg*o@6R-%2bU9~+fb@zjb7P06}qShIsK1_h|xbr!< zGP^N`UlUY$#mhVm!9uNL=96*r5!tKeaxRJUf_rb{3J7hwn=*AqQbEp?mgYVg3Q$k= zL{?HR!JH()SfLu+>m{lq$Gc6h?7lx_TTcCXW5cs)BazY{f#p?xig#+5(ZLKE~I%n zI=A4ls2yRwZac4r{MX02?D>vqQrqY8_<8vmzL723*BJ)GRU{v@kG|3CdypZ1C49bZ zd^^PEi~0ILk7jSk%?l+UTn_eBo8R@>JxAV2y`oMzbnU$_&OfRfoPVqQrTQ|o`(EK0 z3^P+Rl1-rtoJmvaZA68vTU8@uFUHmf!Z+T_%;y?z(&T2i>`FV;Hbtp*^B7l}PvsY- zK`g0!7^HTLrqYxAp^}lEVofaj8^tMfsC5Zh3Q+S!#iNXEIu^KFvF<0}b51TwVp-0Vt==ufE2c^@^J#`Rs(W<2_W;REItwlAp>mQfuIA zQXa0%lQJ*W=FF21OI?I!ZO{SGpLWEHLvH>he;mIG_>&_RAQ=}gOpD3u9 zot;@_E6rSeD^WmKa46_av=@ndQ>MNMXBjLw{{VsHr<`_M*_aK97hXXPgsBc9#3?FG zmFfv2$|9$wisnd81h|*zY$-ikK|ZA-8cTDmbe&GH<3a#!oW>0{buuM(uB?B1$zP`1 zLe{BNg((PiO_H9rv9-qfh*mxuRI9l6jin6D3$<-UxjAWxi3)>8VJTBhw(O$Tw5Zu7 zC~&1}zmSKez*E{^eu5VheAnNo>Hh%9%G4#09Ck*nEPZ*CgWWp zj|MX6hZborrwyDRPL}-=6yHwj)IWSS_(=ACta)*A?!6J2cx@#?O-(-DQDBgyk?KN{ zZyfh(mNq{0C7C! zCa}_l(IWI0 zB}y3^Ndy!pW0YG$e(|}4JP~}K(~=&K6F#c?zcwovm6M@mECo8?)hb!I7whX6JSPJc zy1lxxvxwtoJ)JA)gFiUr@yxSx8hm(^c@&bJn9zVCLPK_E8b?l8W26F&cNb^?(s9^b z0jRfa3ZOMs^eTYG&Ab!=OR!KF`LW6sX7fk53^Oic$k}OjhS=&h%eI7yqg=n|03A6x z(UeVqNgu3`VJMi?qy4Zb zq;ToFdF=8Qmek#?mm+O%ly;5@#bDZN`l?Zb{Xq&j$O#+)NvF&rX_-cweIDx42qON5 z7KA;;_q1k!O&adB98y)Xl5Ue=ZSw>`6e(M-%_wT5+S=VC_(5WHp%+ib5>wMklv&8~ zY_)pCW0rSFxpqqFBzS27$|99tv?8bz53uySx|c3VQ%HCR)PeSrg@6v4@9~8s zaiU66DoCoZ+vo%(#3euw0RW5G+pILsqn(S^6DpN;OQ^TR!Wg7CoL%9hw-V&TYWlgB zyVCCs3K!?S!RjH{&q#?YA^igm{{SXmOtvAZPD#Amh|1|p9>(UkNK1-9SSH$oubfEL ze1>X?yrPB5C?&w+LUScRf;~a-j*1%DtYa@xXf_-{%B^y!9Y;+J4m%FT(-U&jjVhwb zlAwLz^AOCSNQ}_nR$6NH$86<3t^f)+EO@{zCMV3yFAM zLx^tu9^*-E*_j!Mmgdj~f2mS_sbG%#YD%s`j^pIiU2ZthUD$68Ok)f!hbhvD3z?Xn ztv1pL3CzA~NEbE&_T1?bwNTneW3$tL$h>b$l$}bOn_^mV4@<2i7Trd5AYWw#00>e| zyyKIVp-B$!4Dfwwn_6p~nU&2hu;6{AWo^}{huTV!n44Uam0bz32Uuye*P!Pi)Zpd~ zqw(O>lnR-wbJ})dM=&La*iriVR}?+fA9)0*jjz@hbRdDfqj*IB001gYHru64R8s2g zY^Ld5loXJ9pMkVkLvk#R$7IY`J3omVqA7XgoMvUxHshJ;VVr$;~S< zODJA@D7!T&Fcz2AI=E7zLdd#KfW>p3rSm4JQ4la#HA!qh`tC|8lcxUwt@MLx{lX+a z*lvaWE}tnzO?b3|mku4I$`q)Nu6lVvXi!zO$_=b;O}7??=d$_V5`}mVa z@+M|n64NPVOiUq3QDNnmF4O(p8&b|@+`aCg6>+pl&%^Jq)-2YyEdKx*;~9B2DK(eS zP+WBlr6TIFc}Y#K1<3e%#0?ZmPVA0cSHr5tH5Ag{Q=Z7n&aG$%y68il)=2xL_m{q4 z0MZ@DEgZbW&1(7$P9%Nfi6*ivqmxBx>koG92HZ}APZW;;VoHC6YpFQ+dxX_inWxp} zN>ckW56X~%qT79GaReKZEC$+(o{)tmw&}PuL5?lXH!ob2TA4>SPP08M;Rm|#_7yF+ z4^X=h6{*!X7TPQ^Izuvc#J2}<^SGT7bji1at=1)`X9CJ^FwDfhORtzud^?-Il?_67 zzOeI^9gEyoR%WK~12Ym8HX5tp*_SykFthb-xSh)vD)x6q;Mjt71{VyKR4#D7V=csN z4(AT0DAig!%9)_L>#|JFs9E`C&9deot5*AY+x2xPwx23TDG9QP7Djz8km*!{}0&&gC|+xkJdNse6m zNdP{;Zs#&P$_lvEIf%H>bca^tX-2(HGnZ+DG?1w_8!VYOnObr_`=udkQ)w3(6RL>R zYYQ6tWQfFch0rG&CShqq&6T2Yp5vgR*AC^nTuHdK!0>^ME&l*vwc-^zmBhB1a<}}| z#G6W229c1ETqv6Zp%#JWUEpQ&~p*^jUg)*?e|}~*D6cn`l4Y@R**3ZQe`Po znwP7sN+-Moqs{V%m`-&B{oauUL!0eu>Pd3x@cg$ot2O@sXUxw!-(Ngy4DmV~AE^E${^QsB*Fgp&?cu#@U` zU3Nag;mVQ?^hpXxN`;M$z7VF=)l1i?+k=lULCWBVXamJr;~_TDmZ+tdn;}ZNjjU~& z!!?NU@rE+s)4wyZosP3q#a7%)i&155uOpr)QcrZJsU)5H2(OZ%@x)s~nBpIuS24Df zY^0>zToH0LJD!l+LCok$RYcQ)Y&evMW!(Wt7bQp`S3O9!b=)V9`0*hwO-nt55hVL7$>BYh$NLGKF*6sQpSaCxSd7L$_CaB4Z6Uc14Cnm zWIlZvbPi)-H?orMfq8aPNV!e5(m1y|_8N-)R&KtVPD{45%mTL5go{g* ztGbds>*N7JK>OVx)cT<{+-k9>2iluN#YwW`>2W6OT7I!B1Q4_Kg1=j=NXNvzmzd1( zu3~S899+bh8Oe9~j!sD>%&Tc{EMCB*CCe+~G>dp~S{)UcI9+9)@Z*WpPAoCVb=0#k z0ZXhUYq(L+j_?<;>LS+<6s5W;^KgzkGed}dn`zjw$$6l;mAx+6X$fv%w4jo1Y_gN5 zm%=P#oUWD%Yf{tc4}FfIm9VNrG}K$sshk%Qnam0Qih*&9|B-`XzIse zZjf<4D0NfPN|2^4yXIkqt24Q^?_JLM@UZI*yuHQvYoOuENn$xw37U&jO-!Mzt(H^F zmYPNGq`HQ|QWQbmd4aaj!{V25)x)!$hU%5~YRxf5r_M|vS%dPzA2(A2AW-$I4uo{CHG{9r`Sd6`$@dstmSY2grO#clB<#{sa#T@uW% znwu>OKqEkV#=wF!F%n!u^sgcHgy@=roEHlULRDqyVgTOb_(N|y@36Iv9O}(6GiREI zoNG0QaQ9Dz#4|U2Sma`BR%y;%rx2{pwr&Q+Ng5mY!#NxI{(|6kssBDDX z9=12yBgysrwjMzwUvc1&GZd(19NQ>cuGS#pG95rkEhG{xU}7OGdjc0K3EGv*(vX~w3Qp54RrL@ zI_~RlgWNh;ns*O6!^ulUqR_c+I|k`hdNkk8&N}LJC1xf$ ze$e1fTbrb$=4=fOjm`cL;%=|>;nVByN*6O~r)4R7h|52*J;P4)(*Dv1^xbuA^wGM?xFTzqsU-#F}|qMM~> zBP~w43Hm&$OKqtp$+5~#z<67x{WS83_~ZPCuMk;GD5UIAcLUzM`gPCstD}FbiNN|uow?0vK`TtkhEM2 zfQ;Vg>upGeJU#jK<@*ln{Dp&*!7ifWl1eiG5&*Jv_pSJ84!m`}bsN=ZK@3YvvZW~; zrboS{g1tmLrB?eP7Vo%@s7y<^qL5a${MDM?X*M>9@*YB-kY%KbSqj%cldx5{`1pgq z@a{CZd_MmGajDxoE=TP^m` z>tp0$o%($R?fp(3^?5KLcKNq-N#wveoN`9U=0zR%23mqt2*b;L5;nbNI5U4b?>>8_*18~VcaI!^xpKiqFl z^d}a?%<@!PnF~_EP|V%J4~M;^CwIx;USG^tE}v76IL$&>sI;U^si2akht#Ym^;`s` z`GO;fKabJ+hTgw1LF_ZLvg>UPw(G47?IHg4@AeCTfDcRCPN2k?MZLRs-|96cmj3{k z>?ZJjKAEJrntfWFs&nhPY^7n=Tqkgqq*xy%Wj;{sUXLLz8n;fz0+(Essi7_YQV2HrYGaef1DwXgN6W zB`M`3ooo-Kuc}Xu@F?3l-3MJ3U~>u_3D53}T_A&d+Wkg`JK-~$(dMNLv%Kd5PzrnC z9_{@){&CF}x!qk4PBAR2AOV<4n_>oyzR0@?=pwurnasYhk6lVHz)&r$Jh) znVMc*bF8Q>V5}V!loXIUf(bFz3;u^SQP88xt-wMaD^h;SkZgSk*!)P2#~t$gj!IM- zVvLk1%w1?UAw%9tzJ}?y{4v*uuIS>QLq)_ehIw`?8Vh7r-9@d_py>_iRbQhQXGz>L z)6$xbV?Ye8<(EBJ=drOZPMAm_vgTvBD@pi+q$yyRXX=hT zi@(su?iN$34ke--PudDfN%bRtSaaQ5>GeoQio2TCJS#m>P*^G&Whhd?Ngg^_gW!J% zU%JWk`lFsIM@~x*&Y>OaC3|W@{Wa3?t`NhY&Suh3CggA6zCL_mqX$W;eP2Z z%hczJf=S`2ntN(PK>b~bH+ze%q$9itwAdqfj$`bhrAk-xG~wyrgC@?jYp??IQ^dA_r9OZ>f&ps)CFLb zxCm6jh$6?k{7Hp>XLjG>yaUQN?lTE^r0bC;hTsmOC>8| z!*w_A7T5j}qo_){k<|D_R)1m6KfzK@r|`7lcQHwyrn>2N zTp55ekVxguv_AJlx;hnJ{)b9TyfpB?#F~CL>hv1S$&P{3AM zd6GNqJF#KWzC*S27Sq7QT3c_m?E0tK`4Y7~`oHf-qhI1)X2ioC*V3j&;LXYd?)XeF zcE8#nT%RKYT>QU^Kl^e7`EUMgzxLT1GU_fkhZ|B>>f8F4Pq{YO8llnAY1-uZ+i@LS z*88=y=_T3uoP3&lB==on`>!JzLn&o8yK>22zCTGO?fu_2$6Nq~rUW4;M&GZYlwl_UI3^@6|^}6WSb><~j+q%EQF0p^% zenweo)Gv~xx!hKg(+BMz@DC0Au5I&zGUdPdvi%rJFMYXx6o2;UfayyqT2zZA3e4*u z_odJHR!`mQU@zy=2g$1B_gz!&g)Q25&227{U8UwnPBP=!EGmRl6zUT&r3AL7&vtFD zrNj&O(a}fu+9mMOmPY>oKI^;lCPFJ3r^~bEpJe+QoF$@RUOLVihc#Z<22v8DkgIee z!0F&({{V*1EL9h^?!3xQKMIs}E&KOE4~f`%bA;2zUU4K!xTEaT8>K+&l~%oo+gn~V zm~wcF&#E#xVW)M-Of_2OoeV!jYc?ILWkS5tN6bPc9ge0Uu#CsE&}J2X`5y@f$fhbY z!r3|!p?`v>^GzUhC~zO_#YSk-CBdDkDchUHe4{JhjQhYquEUfPgGppC)t5cFhrjQHmPNpbE~5|e87TCBLdq~a0^kLs%Wl%15D zi^k{KzS8l(1pfew^ZsNR!QlK+{vNBb0P6B{m=YqWH>icd&I*x{eMP3Mzd2YOUNNe zac{SlUDXRUK7qSWr|i6)f|Paegg?vZbl#xQCTqz`CEIjMFz85_QTobziaN5tw6=VJ z0^MP}xfVU&@?w_z63+v09Ta4&%}XK2TsfVVDoIU&xSEr2eu-aeCZ_sa9b%V=<0U6i zT)gSH_e^QzOOvJEw$<69Mo9kvGRj*hS#=>TOer=K78d194fBnH&WFRKLXJwNo!=+X z`9D80Jl3mD)pLq_$NZ@Ic@YD&9|RFJpQkAaEIPqH(9i?wPgJN2XJqwA^#(0CJ}djL zmsI*czC?&iR?nS&8Gng>KB(-8k1y14ezxWgLRgp-h08wGMn&~YP0Fvh{fJUjKcRdJ6`<@0BEwx`W*pBS zz^~#sb(MB~{{Ti$+yjneJ5tizqt!u?t;vv8%U9MkvF^Oe$gxVduqRC~8cb77S}}R? zxHg#3af=Gps_1TuFqYe_GIL5yqR11?ByJUc zjFZF=;B!(kE3bP~Z$7tz9LU*7`NkZ1ElzEs9nEB89|c z$}8EPrZjTO37qX^vXiy4k$m414LJ3&-`I}_j<|D-l{TsJwDhw!(}hmm2@1-K=1PuH zq1$r}-E|&O@);aY+CvG^UU4na8gVTtNm9;H?wcRz{{SdMW9bTM4k%%~b1q$CjVSYN zr#S>CyVGKbgT%dwyfWN+DCutv%_(v%A(S98w6u=uMr3LQw%#&aM5G|s#4N&f$)l+BP+}5SYg1in)5S!)Rg$d2Lf7DANff* zjh5Yp*_*%Pc(9KVDD0omjV>B8=Dwx}@nu5VI@*6_yMFlV;->oj4lWWMzN1TyYtxg7 zZ7;sHBsznaVWNiO60*5-W6KO<$r5UjG97u3RK>G~xXw@D$@qE=b7hhMcD6Yj=*Gs78ND>&@q3sF;+ z`n;(KO}^*=S|VrTUR6Vo#iVjvdhu5&kECLnX*C8^%E`*HV{QHrxMZO+h>2r{l1z&S zA3xXs0Ax>GY>>mmjj!){AhBXxBh7#8h5PG&)K7$FlfX3kOR0UPtm1vu9Z38kON)PO zJTb!#a~M8oF@M8LR8X4SfE*7t#dZGx+i(2XvY+s;zN7Hw{`wORpHftWr0eJat)!JC z5pi&vi}^w^M#DEk1n^h3g>#A6!HhLEFDTP%E@x9|UV9)LTIwJZ*Lb;n8eK}icrw&` zaaH9pTexWy`E0Gst)6yu=E|S6Q?>lB4a7!K*3(^g zjYJ>eMlXxz$pweDjwfe7xpq>Tv;L>Ay3m1YdZqnzvtk%P2ZRD~!|2tJI|?9=9>c zHWsT33#eS!YotYyCI=>yFa*r12)I+tf)1d9ZDJvj@=kG6f|zp?$V}8_P}eb$mBa?p zQJ82&tOz0;jGE-?naZ-YYJHk%b)~6jaco~vlm!9lv9wsn+7evSVtf?D>wTIk)HIi= zli|c56%?qAhmlY}3q+`UMlYIc>UY9xlO&xNvoT(D#K6|r7tP- zPr@AcxW4|Ql-KkZ(%q@?#u9Zh$)F{I!h&99wp3Dll3O`brpLVuH3$9w0EW~rSCH*H z+rpCLDOEyU*-50Ft|39dP_epmWU+`6!zn$f`KCP_%0II@6rS9)x}t(hZN98J`@0k@sK^=|r&2;6nn-Vu9&Uo$nCiYI9l zZZy+bdVW!-1MP(c|u=cqWp@&m#0*Y*~ zPoYnwM$f}6iPQNG;m+~9H@J)11R0h;lanfKmedrs<|R~0kKIy%PGt1k&M6R4OIaQu1Q|c4qQf+FdI*a58 zC2c&DveXist4+5~iceD=lC^bT4cE`O-Yjn#rTD%(Ka=PK?^EZO&Ss|UtH~Krk!4L0 z(1hCRLHoD5VYOcmsvX^JSNZ<{Uo)hMq*7K*MaL5I6PqvvVNC(LhzC1L`-<-*{NPHt z{`-EYOZ;59dT;tOUSXMMS~C*rbRZ1*z$HyIdZZuHOP{pX;6lFs3-pue2>yXx2((n8E`T3D=wC!qU zwTBZr^s$!ax|Os;nc8#_@3e#7XdbPrP?F-Hl)|FMmvXYCj9Id@# z#q%nJJ~`pE$^mv=0ch)D0*Aow3R0t-#uAR_(KDe+8jT1)j4AGpCRyGVmz{n>U4=0F z8fHj+!0XMlb>>UFG+QU_OQ;i+=tO6Dh4{Yy{zdN&_WSz&jNFu`OjDf=me_S{lJhO8 zu&^3F^U`Hk$dmmfvAVah9U@n6kMsUS%TMz8_J6s#AzhjiVd)w9X=WZt6BOBoOY&}` zqs${aWu+7PM#)#D^)oQ!(z$#)dJ%Htx4*AnQXz3uhuBWNJXpmIH-=|lB*|2%t!I#$ zNjep@fTbZ{c`8zUV&fFsR-Ki35>AFg6Lw$57!fL+rzNW0B|4^VQPgJ3;#n&z9%9BM zDJcxJ(ATkCl&vAwW|PaBMXZIOrAJ*s1VrY07blz}qh`Hidrq88qzJNws+&mN;1Yh>2@ zTKSgzJ8gIRKanGzWFulmUC+Fv1JM5fglPD5iYBY&^K18ynkk(WS6RkVJ=`^Y!EJB`=o ztMgr-baG4f-|~I_BpU6HgeU8BEKNzUmzq*Cm9#RbtDtcgz3e^f0AtX-lJtXRXzJ!+YP>PqD3P_o8fLYpz#__tP75*sFHD%hADM)H<944vXZ>2 zEjl*Om?3tt0K;>1B}Z~tVQv>Y%=nHAw}76 z&$)=6apJcn)hrSnTScN)6?~-!Q(>*`Xm7(+=0)Q&TCXyE;^hAT#qRn;&{R;!sO$^G z1n{byxugT0a}!KUn+uGpT0y>^abuSjy8i$+$nkVePA}C|nXu792zH+NQ6s!EqV`GX z4_K^{r}7+Jj_+o9rMX7ssOXHLH}EM2IFZ&!1?pq8aLmB8E++_++kJ#Rg(@XoC00kQ zS>RuZ4diC1E?P~6SS_@ZWZu?Nl71rgiLs3~MASV!vnsfg3{WWZ zG|9R7cUxp8WJ|iSe(t=?r@TQL6L^gXtKYDzG4@8qvly~sPGX>WlWs|&PB^3h;)ro+ zIgNoKtlNt^7gQ)I0kbW1uI`BuMVd8g4 zRpJiRSdWJd2P+h*h7f=`jxCO09;#)<0qbGoXzJmwuh4DeU5R14YN-X&f}1e$e7aEWlN4s$M`QR0FDAHE4fg``P3z9f>v zQf6vt;iokScO0FSR zBf~Q_Q_a>367iiDr*mi{wlw2L+9n9l$3!@WT}74wD{(2drse~b&r|BG)e+2L#JG!* znI_`nq<4^tI;e8S6=GU9P`kh+={VVShXQ@ZHY*AU`}0dna{2gyhH!fM45 z&jnY+>Ujz|ySG8y+rk$VH6~Z>YX>onas0ziIHr)9MO>f^$2G;Z7Kb_sdlTml1WGX5 zEvqtHN>T~mL2Y6@kfiL?#!i1TKk`w(^P#BNq81cQ{4G$T-9*8c!Qh>=cHY8Z~MFEr~Z znU4<0X9bQUF(VkhUnu6t(W1TIw zg^Mr6Hd=C%t-9(VO&qch&+!hSfUykiQk3T|YEEaGGzRUHWn0F_aCEdygl!?2I%M19 zT_R_;h8RX6lt>ktTWBSQ{m0pGX67XzDOvLZl>l;rE#VJFT1J|(3-)?0%hcy)4rbkI zlTt|*vXY?IQV2T{c*4Pd!;n$Bud(j3Kv-C;6`Qjkd< z2HM;K;SARA;rxd=Q0n7KLa?;+hFK^KHvG)u0Q)L(S;J%HpD`W)#dCZ5{zTNa`7g{~ z&?@ae^b!_F)yW~ncns;VC(8GWJUzuwU&~0ZZ%EguXn=PJP-9BwfWk=moUt}z$ULe@{iwhm&tyj&kPx3=m zR>N&maRowLW>VavDYC2Iyjp2$_+Iw-L#gfe-rG)8B0tV$v0{ZE?HBxdAHEpwo1!w(+U)_KJI-lw@u>4 z4{w4aOPGPe97k`4bC_;(km@F-8e22L#>#WaK9<53jK;+yF(G2!q(iOUh1C*ov=uIE zhqKakx+)uXTB9fIlTt2SZA=MrRsjRN6_G@tXi!j6b-HwhanEWUn%>CSi1Bp-vrJu5 zT2c2Ur5~1NenI7^5SQ){wwBt3){K{BWQ7Y^K~ZgjL|l@wLoLGB7@ThzU@6yX$w3az zQ>IiGQ^-gwPDa2Eivl_;%*6D_+=U}FN>2jkCaYBUSe&WV9$(PS6=z*ORJ2`p+8Q>< z@VRIuK|lnXSdwFmQeDKhKETdlM`V}cE%58E;I-6fes?Cc@X@+({(?7+yhC=2fay#G+G<*>Ad{Ir(i>24 zb-#u7hE^ZR{zB(J)AJ;E9V{!W@S+8ji}hR z<0=Y5l0X~gAl#e5OYg`T80R=4EsLdQr5XvBsI@XGGHzzd^C9&sFgg-IT1|q18rtwi zOiO|q9ACuxwg9WNoKVYemQaA1nRJw|CTr$eZV*W$Q(>;qhl^h>VS0Iza|>gMoJzyh z2Ii$^WY+FxIZ5xdg#l*V)c1kDYwPfe{E*YI;@szAY7EsC*6Y+|a@|UjCgs(tR+4@8 z!3N43+TbW$5Mc?br}FrnA0A)w)s|BGAr7HeDOYv1>AHH@{0KWkEIAu860gWKsdg3z zEGR9Pg~&l0G_k4i8Hv8pz+`-L4zKDG;ZO=~qc*0^vK5`c=uLpvt>G{B92}Egqt&w_ zWV8YlmXl@K#_ys-mR5w@POvp+7RNIaP-m$MLo~Niu;NnbvXZ41&@|i-LcPPLx@rt? zIgv8F(rT!fnnD(dR$hHs5RY~Hq>!L5-q$I)umeu9DlWF~`3*@}kD+0;;?>k#nRN}W zSzOdD+oc?|j`7Z$D>lJ4HYCKCJvBo*ZpFV3`)Jp2nQ6D2OvIZ+B(|giuz+?7xKTFP zl1y4-;w2rKU6Y24i#nlkE|S=G%v{FH(hIH2R|%`y5xx{?y0 zk$uRuuhJ0sl!be{e{4+PzRNSXG&;=nMJSL_QkycYG#n|-nJIE%#+0iI{g4mqL_FMT zkMGca95DJ}zRy@zU0n1_HtU3CE-65r?`yf^nuf5JP>RFbxZ+yO*)b6VrX5;yQR);r=~Q<^B@)SrB|l_e;37s|1F zk#lRLjY@oPsD@_SUH<<7A=spF9BOM0FI0ugsadX%c_fP*y*g~G-WzGeUolTksLVLB zg=AAiT?!YuxYA_E-;0jbUS4}Oa z!^RV*bGNWc!vdU=v}OY1+!=@+K}qTPLwO^lR9%{l*Alk^+sw3D%E~TKK>I^+4D0MK zNvAhZOv~J~-73gbtt^rV(Cg>CH7Q#hjA$0B3uQT6CA_xp5Hj1>XimE4vE4Rq$hM+N zCKi>sn3j&$PUC9=M_WRc`#yaHy}5kERwcw@l(4tdg_5j_LI_H%M^K_JG~alQDQ~@Y zb^OPp9kx1jWji{@I$yqm3Q9@uq;vs8@;CL4#Wt;cE2v77-}xA&tL3K_(L&pD_gPv& zMeVxEbxHB*Ht=8~YC=IhelAdZpL;`;qTrjA>wiP4)gfdBF3Ok}%ILTj8wCxu8W07es}uS3eKziMSEpk|b0$QDFivA) z8C8L{$^)*Of;w*v-kx5Am3;k8mT5ekf?OP^QBsnnY7|AjN6$|PBagR7->Jtg{Y*tK zvIMeF2no&J*LCjq?!KEe zEzY(SlJse2%Z?;{YL9tHS@*Wu_6FT8XmMj)`uRShT$mD+24(||zStpl@1&7(Ha6(5 zF{COOljgbh{kw#u`U+-}Qijl*q$5Lqwiw(6zN2xyC@(k4`Y4bAaZT6H< z(}ii}uHR=qY^MJJWb96wMDKEyYE<0}c#Dv*#{H|@p{+%UR87h)rsf!R2QbOAfnXnb zwRctrx=6n8zjbo$%;J(lY2MpNsnLt_^2N#UysB*=C;)a)?_8&$Jq$YdM)q_iNplfW zeYs|5fRuik9CWAzC@U&K8k>;4?XVqToSY`zHs#L8BPDxTF)-g6Xj3lEl zFxJ7DrZV6ez$qR#)8ibLBnnK*!*byvD9AwQ3<@iu%U~Ky4gv}WyXt?8bHj`18kwZV z9+j3SmfCNz)St|l;=-3hu58_IlGa?RZ3Q>*g{(`m5a!L4Q(9zq5RveOcuS%=shpR? zs!~E4NCfIie>iEy_WBD=9d>Su1C)6Pb}^w1n@O}hq9V+LSaU(k04B#+;(%F@A2?ot zHWcX{c*9VbdDmwq3o1bkfD{Q%{vzUY9vv;vhmo^jAP8|{ zLNxPN39*u8jo7h-2rEagFtEv2$G>zbI~T~1Q(WXwu!j()APJW zuQAIuP*$B4ub)@|@?Q#3O^%x1q4b3bvpwPE5f*wEKzchz170}Jn4M)Wf|Uz{yfHYb zY{w%ejb`M7I~8qf6L@K3NON783p~MP0AWrVl`z#@gq=eHNK{LuO#oj`S8|dwjl08d zj{b2~o7ot$w(6Va)93mVvHL?LD|@b1HuWwRzbce_E5xc?A7)y$aUZCyEVjmq{7a+r=d&7>N-2c6ml!DT=bV*DAzA+b<)T}z z`jNMl_s(R6T4}EF`hFRI?X2h}_Z(hew$|&Zvo9ae%(wmt+h`r%-M8i; z2|tT#XVI?D%<5{qlihWT?!1gmKHDip^P*X!-6!S;ro6w(_yaz{`o!cy+<0bvfP0fDAJQ?`mgT3_0hoFhamoe*uQ(CfP67`ktCy=(XQlVcRGYJA*! zH{E#+Ru8sN*+o{ROGS(kuxsk?uX@wuv2|?1QF1ih?(ySH>URWuYgV6Znypy z{oCz*7~9*V2TsL9NtR=P*?T9ZH~UTp*2Ze_3we9LZIN=Z782zMV7wwZ38>-zM6 zLcU6#q?)ayy06|pQQ1x?ntqmK@l2{`B}fg-mXNH?E2@?*2uDz{s2aokKN{ftmwsr2 z#BdSG{5v=2vm(zGI1=^-XjQQC)lj1-W+-g)USuAlD6*R#B$W=auHpE&<>$}8@7T)c z;hr~D%b>$25++c*1TT{qzuR7Zb-^iyT?h)%QA> zTMZ0e^Rh}xR;B%O^2k+$%2Tg8MPK2qx^I^H5fNu66>H`D5_aqSiQU8OBPmMc%`{Y2 zS}id&v6V%;eu8-d$>sx~HU~}bzFRg|DLv_1r_ZXzR**zW~X&`~u&INu>`K8KBy6rEa#T}F7r<3a!+5Z5Nb_#+N7n*68XBZ( z$PLt`l9fz0gOzQ#1;gxXn#n%!KIyn3FJYZebY-(}?;EB`4jRf&D-W|VIPzY3jNG!6 zpR7pGDD}*sHX2?X@sS2tNHK`rp2aRsGc$)O%W3s3A;d~MvFmHweMDNrGF?$oE*ZXr zbe!z>RB5H9npJH?jWbi!1;*DmygBa??!83&v+Vr^mltUGix17y>eBS-klN%}VQ5<_ z<|S>55K=websFvA3`dHN^w%;^x;N4C6*By9pP8S2ZT4o^wH(T{jzX?p(AWzQb=deq zd}R8sQRTxm(fToq;GGJyhwI|9{W7HBTW+C23?A`XNJ;NlSQDNPeJlS!xvgM7;ax=AG7);5lN#CxG$?JMLaFz;rpWrF6@HBOg(301<7piR=P z$GZ`-aS)c)Nrw+8??r>rt5r&HTh)nQVrVwXIqoPW1fe->Z=fXY;~AX$@-%!p)6DFz zid5-wV?82$Umv){FAbI&k)rP!X)JG0kq7=tgZtyY6Z^Bem)#tfc=bt6^*Is!fBEVV z@V~Uj7D)ZHawfY&Q5hZjq_V%{o>Td%4*|Y{{8;_7i05gHJkImv`XLAXC>96U=ZzmP zQ;|8^vk#>wEX(RYs?tAKiW^-B3H9Fa^f*W4GcGM6aBwS) zGF(k+S=lF2wIN9kHcE4*!*T)qV%rQVyo!wSyYnWL#v*OAsUL(~Mv5s!=Pwtsj-%#3 zj4NRpO{VJY)tGTjs2=Kpu?E_CMK2n*e+Ev%hPQ`Kml*!CzcU_Xne4tL{SH;(i#U5U z7Iutf!XX-tGyzrNHgG#;I*v1PSy{wA2V-&o+($Vb1;b$v!R{fWep6O2`l^jz1-uZ% zxsW4*4g-qoygAJLkwrb3YGy}_vPl|; z9CaTwnAFvyKHWAcs)sKYXTrKox<|oL8!zyV!COMQgS0=7ogDSzYhn#hlY(#dBm@q5$E-H zgiM(pWQn2C*IB}C$}we3KTA>?MqmomR1JmqirkK$-*U-|w){ z(cjz9Lri`my)+hTiMxrp^|UhP(DFikSRKk~DwKWZNjL7VPmu-}7#M1S&Q)D zDwn7!V03W_KQaK|itaKeDXfRn1#rEX4- zGMy9QvDOmux6wbph_xE(#LXjxb*UPRwEVSIKT_^wDb$?F%6A|mTaJ+2v&Nchn&>TK zeC(DSNbP-zX^gg+DPqfQ1f}V>SSV>q16-v>);%u<3@TjT$vwnn$k+1~d=~8uC&h(K z8mz>!W=mYPpp>>0j=yZ?-0Cf14$BLP4bM>U$Z>ZJ;h>6qwL(n+7D^irpn>Ibqxixl zhEm>vNg>mv<1|0sO3U!ol~~o06~C za0`EG(QAv0Q~TVDJQ_xc6^iv4p(1<4e1! zQWT~xvHDq6d)7bFHltzC2t&r#-{tzCd6WC!;Qs(dIFphS?Mvh$Sh$sv08)ZeeU{zL z_4`Ryo)DjRe5-cD^f+)FPm>$eh`NyDIvsjk9DjkO=3btGP4b_lrSD`UC=hVlAv_kXpbyvT*(oe zTZo#+95GXkB)v|gEwnF~0z}9uSKiUVZ$6$d&$~m+d1sO|X1KjPm6J0-q^WBud0M^- zi5e(c|TM#Du9t4}=kdkJ~ur<Z5}TwKL0afVbJM@40CAa`b2ac#Vh zJEVYp6bOZ^jdEgK24e;ALCh%Ybt-j2VKQYv@|{W*araep@8CfYndQ`}qp`D%*sv-34&-cD5LELE5kp6ZW_XQKR2bUqQtzs~mM z^6dPDwf6b^{Jh5VikwTQ@VY_Ssg)x-`^awM>R&=ra8j=uX%<{B4D!m7=I{Bw%uAIk zeLntZqP{2bLaW3Yi_^u|F0-N%ZJ^j`9*M)^SmQ=>JoURXQ1N0`+8S7#ZfRCX3c68p zZG6P&JWoiKs*2e{*>B41{{TzJcvec6UzkMH<1J|OE6Vd(wHCF5sZPYG6JdDIW#jb9 z;@88-u*bsMrk}^}ki*h=ja}@TMjpjX8qN=xx>|X(mAKjze#@Q9*lMIG<{PC#ABI@x zTYT5-H#~0>z14Dmxc>lDa6M-TO8)>TxOZB9c8vN1f>64du#XVgS{9-P%0ic!CrEdf z-{vu^S3ZA0(tW68FkMDQXBRN0l{mmlRR+^$(7(3a!gCCS9c}@zi2eee{Qm$kPI^^x zChV1Ri;m>Wl9Q}WN~~(*4<*EaM^zx3d|^HWP~N75BB=sZ}8XS6=2oR@ZD zP4-mjH!8^cZYd`F*+L{$u8-IB6Q{kQ7hY=@V$N%H`n4vgrqZVQ!c?y+TpsT-T|ofb z^bE=0Se4-=Ha(%SEK5Scef&@jT#`l`EvKO-XU|g`BG? zI;zJmn`$=R6QVTVTR590S7-YwgD-EmpUNY#On8ow)F9zvpZNzLwG(iSF(S#hixf6& zUeKU0t;;|LgU>?JI&)lh7LXbay9!7w=eYf$X&gE3O+%D)z$OZ#v~cXERhQ+R_O%2s zq!6_d00YRKBdHEW6$`{3Dp7bPS6RXy(CpGm!ExoKY^O2TDidMU+V`{~a-x1bTDkHg zRw?2ISBOrj`h%I)uM2^1L8L*Htg?u#J=+%#xV}|Fob0>A+RRO~Kt7KxBz$37>wasSfmDN>ytY9L5`31^Sh=rD^6Piz0jOb>WiRZ&qkt*QM76AR%92|9e-l)X|)b=Tf5Gz9BzlAGTx z$-j-jxPj#Ru^KnJb?|3jg1kST!L-FoE?r3_=MV zAq8jRNQn?h5po3VuTh+=E1J29hgxM>2$+*xs_sR>veE*FnCl&qp_{Zx>|=!GlQb&| zaJHsUQb%+nDcqjz{x{MP3G_JFdZrtg1Suu8jll$Y8^R`a7%?_7W@XoDs%_*r18Yl) zN7Xnp4{>1Fk<=R)i7rHlin)h@173m{Y*Ge8>lQs=j^H>AxIhst2nU=}VL&0cfy3Dj zBT6b-b(Ff3(A*GwK^lYLL^&DIQ5G0mTo!e5ZcSyEPz8}NLRKxha}WZ6(#L-odhB;i zqyN!V@kz#4RCaP>^k!y}Echq78fhkDH>p*HyaCeZO4P}eIaK=a#Bw;wUZIr^8j288 zZ4$sj8EJif$qGKZ2;)ak%i+8-tS==;Vshef%u3X|tG>A;nsH2}Ctm7{g+yF~eJvdU zzTh;-YY^c!wg{iCtoUfP{{RSIf05Eb*Lb$p7NTM{Q)qEe+0 zMuY*hG~;wFNOgE!g4n@zmMV?Baz8^`e3cCYjUl_bk~9iZM}JF_FMg55Gp!WO#EMkr z9;{3vX|*)Dgt(vy9p=_aNdyuIA}t`(L|JnsUkqx~_yUVco|2kSeVm~s!K^Ns3;w8WhZ0sh*{U>OT_6K+%V%L z&Ifv}MsW$4OoPi?Y`9I^3wdJgtY0rp2E@cU!;>W^c8219T3%9zURGk4-lV+ZP<6Rf z<1Q}h19Xde!?2d(Wg0}p;d)cV8fFywHN=;w%WYGPtQ4M0tt|^uGg~#Tk}~GM!Xr+5 zwfD?*N2rqRi1hXhk!ui1td3G1mvypEMQ83MN&t)4EndEm)+D6q_5B6S(y_z9^KDe= z%uJ-HshK7jRlyc0Ikdk1qezV|Z||u3UsEdCdkIh=UQJnrq#Ic-r3*mw2+)D~ zL)e{t_Zi5q>GUfP3pec8PZG*y%)!wAAvgEo)@vx=5B+nT1rkW;5zr0>0ehFcVs{YFMcW?Ki3f)h}PrZtv7eaQ^@gnWv=XowLS4rkIp%S1pH2CFQuF zbhyoQoh@ze333+E!pE2tPt)qtk4`%_>weEoZe>IsN~RnJV9SGY*#SvLgyy!S?G8sJ z2-AK;gTy`xO4Q`mx}z%g8hpHy3{8xj#jxWcr`53|ltNYot(xQy1gz~nyn$oCsOE6H z38xm*DT=B(7OXz}$1s7JFJx&=B}Vtqrpq8+AVi9Y|VKg(oR}gP41%%#ot6YsHQ{*UVy3qoYU0G8}8DvfSa7r(%YZk7k+3M5R$h zBywiar!D0Rr7vd!_XQ_tk#-}HmZxH>rw&_`!gV=SNv@q)RO<}7yy{DDHm20rQf!4b zo2f`zbl6%EA;=19X9a+!GQ~B;KU^~Fsi}aVfSF>gSOD7Y<@(^O>+a>eL7cZI!BY8; z$M@Z-Oi<|c39`)4nsI7Eaw!YW!-bIEY|6}Bz3-G|Rqt^SWev%ZclX?OX*JnAOE*q> zMPBrT&<&jyke149cD;?pokq~kn)?1io7wzV<|(8emz17#(->0e!A&zcU;zJtr$~uI#_t*K2j~eG2!sw>1NlrO0oy8tn zhIFz}Lb83}fJq4&>88;y8X0Ug2C+MglPgb^M73H{VW(Ex%e!iEELbfLA@Q3dy;()`B?>)-fhhrd;(Ie?F9>z{qd>Z(7ClPexq76@*I}CKvVHt zvvQLGQZsJ6&~=qup(shrTte&tPfWV1AkT+umg9)kz(_(-ps~$zJ{@7}mzU-uktOl27tV`Sd; z8jl-aTWbxc)%WdVjy)G+ZKfsXKSZDbH_Mk}~=IfZfpCh5|tTa!3ASXq4VR!dKbO8<33RH!H zP^*J(okVrVP;wBptW__ArWs7zjv=R(P?b2Y=u!7mw_cY%Q5KwEUcATDbuNchnTaXq zxk-IR?et!x9c|%n2o^NoUr@JQ4QlOrpMgT=Cmc%&AOf`!-t({*ymP~+uzwO7s$U+k zt|FN%wLZ~!C04jl3h@M#fep(8TeLWt+o)sO6-|aqlYs%%rM#(L%D#ZuY;9}p5#@_g zT-Sdg*xF*@6UmY-tgQqr_fWDf2_Ioz9#;6nYS#SxpHG80KaSlrtiP2x0u`!m8{{WG{F1GNzfm3bwTS-wu2Hr!<_dvhc;dRjCj=5Ew zYSZ$P>k@JB&bD6%LL}|( zJJ>rNQ8C=ICS=@c)aAIixlfSH0TzeWG`4GhJ;qv>K_iKA)UOWmR9u_pO1SSW*3@oM zn`I)x=Eres+tL|^Hx{dYc88zhRMmNo9v$KpD;2lRm6>hCs@q&0dJuKIN+Y~&4Q?cD z_hzSCoPDWg)WS@Z%2(e?h4T_FNGUcq7R-`Gq71O_ziplU(K0gIZ<-<fFnwV4GZDdlE?6C*$DtQ@XLK%`JjU_T8)1fecgS!hp~%`(N;hKI7-~ z8Sxima}0LjpQXM&9A!AAF0eS%qQmg6Z$?HP?^mL>!3zSEjza4D-DPgR>k?}UR9;;^;e z))>A)d0oiSHXwpllYO-cjxG*9VdFEF=W85ISCeIEm=>5)(ww={q01Lh)luJbitZjW zHR!#faWcqPw<|TSl&wp#J_P2{JMOVN<3A&wzBFQ5eA??^}Hh;y=0h{RMcb^fdUj+J;jc($>VRf~4k4 zh+1B0;)0ug$_4z#SWI|CozfTL*H$&WHsV*b$gXO)Se#_I>x{P2O4r>$7gf`9eRn!} z7+kQWvPTw2)N8RuIv8o?uAf|}IW4+W;7~X4>3>@YbHP&PkwWojzWk#k}`8(+pdp+1K-v@K{nVonR5m8i8MrzU09 zn5JpodkR&z2+9gdPN^W=9bu=6_S?`}pWT)_!LBaLc8t3(O4EfsDN^TT!ZN)rGn+GW z2vUej(6g>|Co^l+N32%n;q>(9eqS<7GFbFaPf#V)?7dQ?)9B7Kvh!$Ch#R)z@~AkU zA~&(TLRjhU-rl~W?|y?ffDwZDL0@@vy6n`eE*##(rRR}YSh=zS08U%{MNh!Ne6%c|zIlH7NXhcd}GG2cXuNHaokgUKZ2EeFnZGGWxHYVs`@hr<2?w}c! zbsogh(3$DkCW{#m4T?~O6U;wr?OV?9ilJ$k@tq2v!Z+ksCp;>2`Ikc43Q0rl+w$x=&7QqXes0D&-2HkYLae>En zP`2Pw65pMLj55*FVM%qNcGL+y7BBF)BHxT0fYg_n=PxUWEjmv_aBb#4d~t8&ah+~{ zMdb&ku;qyk?9VME*pdyb1?FoppFhCL7 z3pv$ln{;N2u3sqL-W^ZE5hp^DvvIYFl!c((DgcAzb}*&5lf|DsVRR(eg`7N0bPq>P z9@;twqo8^KJpdjjEEWLXJ79RKIblY;%)(_-R;$==VR&aGs9IKX(^yQ#tl49(;?WV$ zuXK3!BLBI&u^@r0E!|EZ$AryM%9I+sUUOQ(3mjD;Iv~jbi zEY=aNfjLcx@QChXv~Nqzrf6M1h_op?3O1oua0pqzsz}_&DDBar?K!8FoS`LFwqlS? zy?2PS;iD&QCi~K{_~vVCexf3KhLriH*3wX0ZD%$_SS2doIt9C`zPBA>lP|F`WV*Pg z(N$k`t7ckb_MGA8U0*s8mA)BGp*-0)TU^3Zm+MpAc|URR4|~8XOK)SeROR*z*71^m z6;``F_xP3=y{i|rlS|3+eb(Czg!Lu*I#P+2)YQ9YGOTXwlKLs7jTFh-C>I0ENX}-& z@YEDuEB1$_wr{lV_6oN zZ?(otn_sxnRyZ$5QN2U3?ASU;qea_5(Sw2~B+ZKOY+i-grHzU0h*hnrQ~nK-F#RutJUN~4&d z0`*8szpUZ`AS`|4lYQ+O>FRHnK76VCSAR4qtZVz+xpTGTpKl{7)mBQAW=YHLthk)x z^;C9RJctL*8e023y4t^m^+$i$`}65ezCKLDF-M=7M=UagB%Hw^z&T6%%#o{S#CL=( zW0PE~;Of2|zM_^$CwF~0b6$PUq_m|>k`{8#EU z&o;x!X<3;rS!!>~GQH&a5H#x!#u8sHPVKKN>Vw5f>i6c7 zr2Oln2=5N*PqO5?<)niyo2?v_<<0k!H%h$0F(FP%ujlrLyiX_V_h%ae@V-+4GP!wY z*$pjaYELM4@6pX{yKEI?nC!ASJ91u+_d6_?{nzV4*-~t#?*2O;7-z?m>h~o3v{yuMXFEsJSasHwIQpDruw7Kk7t?sdj#&O~<*+{{WNt!?M~oO}v|5`jEX6?e#)6$G_0g zbNir_;z((Sob*ce@%JOTW%kZ$kJ>pC{l1j&{%cKr#dHKL1LO8!)7`I7)!9EmCyaYY zRye~-dYo|c?lmxygseCQRSk`lo`?Pz=iyKImcrw2qxulGSAn>NXIg9I-rA`@>qEXY zd!b7c>^L;O&KR0yCe(Ehn_Q_)-(Tx%4a+=NU!xsZpW8d%@@qJ;!(`FYJj&bu09q06 zG4J$ed?)00Y#y2=}GY zGrAJ%^gAf*8;O@-rzL>Cry_0#{M6Ud4|($Xp)|Yw4useDJgU=aIppY?1K`lcl7izW1`>#q9+iX?l@og+8y)cU9SA5Rql# znY#_OAL~P(+R^_2C)AJbx7^TsvV8Vmuf=o1`kNbT^Dw3DSiav;FNJHkx#72EdF&YC zrls*MMdqAJv$myOwG;NOeZ)rMc+VA5uZpv{@#uT{5(5F!+oLiWZR0SMlXnVol5efV zVfd=)-{4vy!6qTtsxjt-S}937T1s7QV;ntaX;ZhvF6EHAlX}U;BHtp^~z(o z9Wgoi6ffD?zh~nuIc|`UCR|A*ivyKfU)D8A>}RFTk^_kR7Q}Mc_HwkugQ}HW(yZVp zu}MDlvtHi_jh0HNawxY7MEYl_EU6~`>}9ye_+P}m;lGJ|4r690nRboDm=V@>B}KvX zKa@$u%#D|kM!Zs{dp8l#gpv~bz2FV6pzw`WFW@npS2jy2*JtTS4oOSs96{Kn$<8kt&>smn6&HtJt*x};l!2&+)L9wH8_m(@r+^c5 z)&=*wt*Cxc-7mM*9Mrp<9Am+m8tj{ySe9;MEzm(miuHlTuj+M7XJ{NLT@Ca*GN~1W zo0Kg=$NZ>e#r?7G5iz9gWy2}nD6rg(I&PUSEHzq7xh{ObHa@)~&x2ZBzo7?+mFz@5 z5Oyk)q)#~JBb-FUu0xSD`h#pNF8eDo9L$n5u*yO4i&z7vWUfbCOtQ za-`N%oK935CeMX#`w-n{t8M zsE8SGsPA^kc;?>Rj{Y;_{uaa2Xp@^ul&3Oh1U9!2;5%7KKpI0H>nw`b=VR+KhR=VI z(xdi*!fx8tVxWKJ-QV?LKIn>(6*H*A9*|4-|aA*lGJiPgqV1Hiq%{h zESV;yX*PL8*|yX(m2a5{UQ$n<`$S3LjNP%==5aH>+CLHm8F_Z48dGB`Qijwrf%ZTv z79LweYlDxU)AkqdQV`Gan-$^#mD$y_MeGoqxqU88p~eVuu!C_FR}t>s`N8+7QsR&NWH)rj!zugJJH7YC_^`D+sD) zT@xrIqcP2(($LWA4KT=COHx|S*iF@KG=z&e_?nKzT2@`u-3ke^Pf$DzCdHiNfqs>f zX<_GDLuyy()KCfiYi}IYM{31a4Y0_V54|!kl;v;u!eqsxZxT@pjJkx3*^)qnrYeqh zDOsW6wvwNGI@)dV);hNV=EAzt?r+JnDKy(Ww-TgGC+f|+t56r)qPpKmTrsIte|c@T&HmzLl1aN?!uQ{L{ZUU{ zs3az4>uYMOFt*zYC`mU`5`M@cM9-CpZ^B%)|A$pJsHI7fqN*c2)L{q_mW&zEgt! z_|1N)A}zi3%eDS!fcR+jy5#(ypzq?I9pOGFJf`ZhGVbL!x*)&CEw$?(D627`v{!ve;knvgF zm7Ghk^jRKJqld%^v`9#Em+qlJn{Q~Fh;5Y#+by{%rlvl-*_l+aRg{l;!h5O8Evmlv zhNdpCmH9c5vbTe=4;g8)Z_z2aki?S=so8ZQ1w{$5Dg{AAo~GNxnxZw61B`E0upI)3 z{F>@g?zbwG&NkDk7O)zq5TTeG`i&wRNwz91XQkIU#0jcJL7LRe%O%ULO8TdoDNqGH z3WfAGxEI@4VogOf*XlgCF3yCddow{qsN@=*&XH3hWKPONaCqBfS~>`Ac+~#@vr`;j zgHC*{3tYt_tZ`ks}Yex$i%5l($W zIVlYcjJ5ad7j9wcV}6!~?!Ny3Vb>I|pYs#%Gdv${4N&Bk;VURoRuEEoPhd93bO>f)574LmPskqpiprTL8H#HGzI zpx#O0`YpjUDvLxCo1xHq+h{-<4=8=*m-vv!gulc0>T_D)y%MQ5(VO~p47+q83Mf*P z?%^R>2}(fm2lj+L?~+Qt2_5iCTif}wl&%Gq2$omkztO zEAamS74fwZ_E5$uOv@#_%2Vza0#Eog1*jDsmlhDe9@i)8Bi$+V^xTv5ell?czRDX_ z4rzy3E_0qh79;E{BjD!fG!e-0O1J0o{e;hg?aSx;iB2_kw8k7WmzOh?%51kh6*l`0 zmr%UE@F)wqd_~pqF=K*iWp-?SA9wM8$sFDVcB{u6c$`BL@=`)kDgoEXbOJi%Nq2w3 zELO!t%R!c-CS52|B)OnE>2uc5nG7SXiD*2ANO6?RvY}<5kTgCZ+z|*mhC_*bSi@Wa zkZN|TD5hncRzwsaF2~Uz*g>aItD~F2-qCnRv=X016_q%tY`MdT$?t7!$%H&r&{B}~ zO;XuduxKO7;Qk;(PZDDF9F{5a@=LnjDLx#se-L3S4GPs~Y02qXWZb`hM%4;XIBBzA zl$%~g+$CNaNc`ivPMu_`5-3Juj2|P5vZi)jm%vYH^eh0YuAb3@O9nLT-_AM_XPHn70zX_z>Hej;lgJ zK`Ad+8Wtw&4z%Krq3>Href9YWp;YvouhG&ooRA(}C4l3El1iCVtmfB1av>w(;|(?~ z68DGr*v-|j{F|u(hiOG*oyy)B0#A_%KCsK%)Nu%o&>S98(z85oOhd178_n1!;*x~Hbq<)h#Qb=3Y8}9%u**Mo(D}cyh^9Hl!iO5ZPt*fO$nFMWt#+$~ztW;x1Q2m?6OI<%cAvY7$ka9BrBIO#4pB zBi(sC;Kx0is^Hzbsjw|=LEiDQOQ7^o7HGJRlS;+7j!J#NnVH%3A&1mJY_{5o4cw7p zNx0u@M<$y}h2wPHj%{-fAu`oQ+y>&Ami`G`+_FjeLvUlWM?(o?xsDwXOP*=zxmhJ% zPGVdEGc1yHvUCo&;uNoehGeyFI=0w-xS>=}9x!sHdFXKuPRh&sQd4Zj#n_d%rbUZc zNd$}Q4Mn&=hwLrIOVCov)h1_VCu!2R=Q!kyte8?onQSqcZYTk&Q(~ig+}Sq*7?WP3 ziGHU>PL)!u*Hee)9%)l_mC96Fo5_>fC7sU9!b@V|DsEKIHpk0(`HeN{hLChG!aIGF?@^l&w{8{W*{mPhw5k#HerW2xj9k zwt+XgY<0e)NNb}z$&a=>s|vuO)Q*L!gJ^JW0C6QGlh6ZVJz8c6qO~`(i1h!d8WxFD{-af7Ew1+v~i^cC0UF<4Sa@b3=JCS}FU2j$Z6 zC;_#1icyt1+T**gSbp_Ch*#!B%1BNq#Z!UuT#+f4pifK-AU^EciFJ1x4p;yi5OWTZ zZwrcD-sA~1+a2{_MsXOeV){zeFI1A6Tas?3>dM0;GNdWHQPeUW)`I~@)>Ok=1VMug((X_IUTx)Ha4_KmP_Oig>x4aj39AQ zH7qYs6VnaZ^iw937^=%CBv`j>!f7A@Y}rDRJmNf+l3_hO&byM5ctyoxCf`Gy<(UdA zgraUvr!)X{Pqc1OhKO6KHXwx#=l~dHtNq8((vs%Trm0nVGN+|h`;Scwfhw1nGS73F z2T)M|0O=8XSnMG&jqEOO@5qpN3lz!ma!E7vS)@v-{Hc9~sVle%2JWKwLa(UH32>pE zU3rd)ntDtr64L3GTREm3vhE&nw1JsAUd1D*0_N810E!fEJRM-Dwa%A$u47?6;-s%q zf}OOziMbZ=jvYio#kdkqnJqZdB%NHk7R${_HsKFTI;{EKl~MPV-3kn-hSn}LiFoB> zGl?W0WAzw zce9&p%gjB3rWtyg^J`4y5#^|%VOpsua_e=64ZX_&exeZ0Er|PyxSZB2W=@?p%aqya zTI`Fi%ghX%v?WD3u53zEpv*uPv4qg3?2}cugY`Tp>q-ho@``;$NjD!@h1h~L)Ezux zD_cLlqwkvg=sG-I##0pB6Yqo5w|EjY=wiMww@<(7N}Q=*m*`|> zQcn$GsTtDR98{i4iV}mWCERm5lnK+il@W8`b%yyrzT>NZ%jZW60O5b-V&rSN)X1uP zSapkOm3fw&*XojxZ(vR1zs&3XhEo@CY-8DHWfp`Yd9bHZbeyg;%~DW68+SnOC$5GN zooS`s(M1tvo39<@*T>cKwHFxG(oaPiU)i2f#Or%z9U++kG*G# z(v2aB>Wct1&%K#Ar*1SXvY_ zp~RbI1l$XQxI2Tfh>cLRcP23`yOPO7@%E)$BFNC3%Cb~QwY2xGai!yp*eLcH+;79m zTa3PDC6hRWB|L@m6?}?N`l5uJT{k2hZyZw7$W>}RO_y>`n(`TM+L0!umRJhpts$GG zMGFB}P*zo0S`Y{}g!6ly`~5zZ`{dZL6mD)DW$rWsL z8F;LvDLJo~pe1>(o1J<`IS!#Wj_~smb8~G=xRgx1^D@jSqORzcm$H^g)4sh5MZhUK z!j!2l%J1gRrPsKM!(F4X2Mv(OedknM(Y)XQGMgO=bsZzV?5E3PuQs3J+?sexw`}y) zJ!N#)CSGkfQkhUT2TPRYy}d3W&jH76OMd$hB%wN;OK-0vF5fZ!<*2{6f5utO1xTgLHbhRr`OU+y@ zw?oK4x%(~yn?bd}zmzj93R~3+S!j7Nw`n%37tmb9u^+3=0Z_izfv&rPW~Lmd%~I#ogh{EXmI+cDbqYyRld4KHUpX2aqklL=;cIbG zl^WQujM##9V6JLqX>c3rkS+KKYu%yPbH!5yga1{QoOR%yqzxkx}ec-S7EFqgu| zwH@)F#IQOK_d{izX_ZdNIx@C-&Nj3wGPJdlLO>om`Us5pSKSNO7Iy0Wpty6z*%gX` zEI5U88cLQ4OPbk9MsSjRQm*NUzUQI06w~gv`aOr%X1b=l_7FJVv{nnkvg%DLL))ew z4QDIL5t*cvp;{?cHYeS%H`ejUa4uUrUEA^rXRf}4SjRk8nBuZjim(D&-%`^=H^^{m zmlKpHI+A)TNVLU+!sXBOA1QTfMaQ)=(NbL>WT^lQit)9R zP~uc2u|-auGILVys>(}5sbcynz@2?eIFN>F)tp?C7;!6Tl&0!HSj}Y;t-OiS6p))b zP1cuFWhQOlrW`8nx_hZ2;@N=E>wA1-v~tCDDs6|7nMPe@*Ot;)$W%$os)u(eKOe?B zM;j3smkGazS(IA{&chEnqT_d3Ea1xGRBhc*K00}bDD8=6Dom)U2vAkExYoisM{Mj& zOf;7oVSuOIQWB*lq?M9My{wzfAblXUXH$P%!El-oj+ zb!t3Lw}mLt%~mlyW31BgW2r+-wy7>=e9Lc^sg!D*?6{lQ1!xABBYQ%Y!bV3D&}sN$ z$)Ye49o3uLyW8?4mK1(DN+zkh*w^sBlV%~gv_e&ZcB@_DsOsU}4neb~{7Nr#@Kg((SRnA#gsigSfngsSQ( zP|-the4#5d(V=^!;>3$qdsVm*kiTjE}=A;DdwG&bz2vJK)K5wa~-JLk$B2CT6MbOfTzR8G0umhFbF$b(tbr0RdU9*GO8} zOWfTA5qNb84q-V=M>X|ewRY$iLMW^O=jUBTTt`9i9W8||n#E}dcI#0JWt3$unmVODaET4?R1;`qLD zEOjoKi>t>F^GV%AC!c$0_nwf4eo%UV^LwWo9}Y@jYaTOEvNIL~6^%C`J2?$>`( z--h;-@jm`fu-Z*<-k~UY>02*6p^{`+p%WFi}%9oPrWx}k(*$G^!`>u3bU#?BY#C3{^;g&SDDJpw5 zxqj%dhFIi#G~4E{X@1PZ?ZFQ@EaCxEh|J>y-F$zAmseE{$_2f8!yWeL&2)Zg{)5%B zcgvIQ!*WrTArEiF4@x0A?(> zrNg=>YDx=}H8z(`pJlRH(w*NT z683uRJBm0vTAX;hPIWIyIGJ^G+zEIr5!@lOs0QSDjcu%5@gC8JRFdbvOVM=!c>r(Tg(v%#zT`Sv6{5>CGUM+>wk1~D}? z619NH0*=UK?`B%uaHJ&VeJRMFss_bG?XC2Ouw{<%eP~8ZZBs_K4fwl1#GEK5DhE5# z)10jOY6^7F0sHR}xZDa3mo8(NCue>_s1^iLWQ`UP6l_&8b%>4@KAj4R5+B3`!783& zn)j2}UkGYg=zcEFqjRrFD=Y1-r4PQ6K39mDB8j-goi?tO?-4(QnHbpOwTh-tfRsC6 z1%`qjTtupq9q=OeXyH{c+qAUierYX_6%?oQhw8QE9hbOGt5dD9)o`2@YsaPZ*bvhu3tT%EqUb zQR@|deT8l`mSTl4+GW8@ZZ;L~6Zw-7WfdMnkduEf;E9X|et> zlAp#QaU2W5*8T*XJWq?{VB)Q1GIYn6eSq@Rn?wwIx-1i+eTDFfX;P9?NS%3!mXa0< zMt1J4a+DKmSpGMK$1a`L-yykvD@`VarY)f1%y#FsO{gMyZStLYyN+vpQnX&gcoHr; z7@O~Qxzp~K?m$>vHe0UD=TP_$g(wMbX{OhFr3hG3@0Vhqdv7hHlHxkH>G>Srl1ST_ z;D!vFZ7sPW%t91YkaO4*xgF@|zNOYe9Ax?<(p(wA)bdMouyb#4qql|CqzjH;<$e6Y z<8QFBlfd|PR9(7a2lYqsfpH77^$_CwqrERprb+76IkcNwU^I^V*ZDtD8eemIT};UU z8Ix%MZLj?E9rvgH73=(iN1OCFQ(b+n5X))wKl98Z-lVxD_wo-3KCkcQYr9;YR@oE% zTmI;6@wq&`1*}o?FnupkSM;eL)Da!=Ss(Ylh*yUW-%}c<>JIMz0Qn>MM?8Fw``<)& zOjkqKoL282kdEt{>cZpL0*BAM>Wp>DPpdg=v5(l4=Ic@Tm~Tb*JFM}grCJpe@i3Q< z?!#C_(2>6X061^MJK~$I(Hrm(wU5Y4$ZJ*UNJ9#+5i1mT8Jz51;RITmf%=O5@pp}W zA5yw+aRq}>%0<6fUzv>O6S73)F3Jgrnr!Wa$!O+~vl#@(DTRQm!9rLlQ93}8!>cCP zPWnWwc-k41jBkLGxcSE=jh#|87UF*J`G{N~)8uinNln&YPXiks0e`WtnG$bu3Gj{5 ztY2MEhcEJrY@fo35avpXY|~O}bUY465tQ5HViL@w%zAj7mcuajXN&-~mlsV*SypV> zoCh`UdxhTjiObqPWEa70=pTARpQRJ6fB*7>ca<6n+76k>R%ZIfb`GHMe|%Qu&p;;aglWT(YSI@k`T5Xz=F z82_o)I@B(%N#PXw`2vKVzNb=I&zB3w&24ob|d$PX*hO|DvJG9WyyvZ7jcY%u-k*| zsX==Fu9rR##kTaNyBMBICWj7qg@^c-giO<=n^Qof1*O1L511du6tO#|hCE*~O#c8O zq?%VbEhm^o%B`$S@JC~i2I=gv-VFM_sG0M*+TQ6s0EA;el@V-;6j!*a=( zE&vMBn-Dbw^z(y56rGWWwcQnox?5Atp=n!|32`M!DZf)=`NO#3rP!A%R8~x@6}dH8 z6K=ZQ`lRjS65T$7HpP_6+;Yirx1DT(n1DgQUa)|(uO}x(kZh4GtjB!!C-GEv*a=$2 zKAAM2Tb5eyzFXXUE^i%8oM$eRg;Lze2ih57Ta+{wukwfj7UUv{F@QLoTfvPklP@@# ziDUw%Q2Qv%g!mJww}$ZB+)`qiOSC>JrhVEKg4IqP_EuI-g(JE?Ft*Mnbm|ld=F@a#%iwfB zI~eLm9MRo+eui63=<^AD0d@OAiVC`$?{9=UklmaX*?w(GZLwr4P@U{NFS&&wvBtqP z+59lW?X(iPd5_YeX*&844WU*CF9xwqsMVQNvthNg_GbuitK9n`C(o{yhaxuEPB!8h zY(p}shM8Qu&G$;qigWtAdU(RbhvDTB=}B_z^213XPOVNGWM~WBWZK?dCObzPHK>@a zc*bQ@EHlZaf*N2i^p7g~yS9ltBm!V(2QI!OC6Z9X1rC(hl`8kYge2-2*}xkoOTa8j z%{(uro>9R=?ZU-N%}J@X0nE>-J`mK!A@HQTCXc9Ai_D*z9$?8*G0-UIm($OuNNPTY1!x_DJ}h;cIZ@ST_go=$fRWZ)Pv~lb$8&tU?P6e^3JK7M%p-(A?K9OloB!gqBdXI!5v1tvj6saj{p4vy)bt<>U z7MPZY7qhc3*J>}OS^iTEG8&m-NDD*ZY0Q&*-6c07<5PG>NLu^kDN4Tjk_lWOo|SEc z%hUoFD)C&Z%Xy1vSG>u&@1Tu4*CXK(7Y#(OdQRnIMmGS#EZk(l`l4xHczyq?0?0P;+&~GY)vXAH;8#pqYrApM;9pQ45msBIf zTkPqfP_7zGu*Af(Gg9p^w*%6t7e31M?o`=2l#{MQ-5QOeE5-2cIpgk~K2-eIna*#9 z^(SWEaoL$i<)>N8IW1y<8MVI!>n;*zT5e;uR2v$wDNzUyDfoh^1jCD zeqD1i#J20k{{YS$C1@y~C>0Ex6RXtTqtuHbr+) zT&4ZwgO}?PbcQ~|^S##oX5}XY)~Pcy4u#68sf49!Y~~qefU$iF0_n|d zTOHVbINxRK*SO5`r{8bOu^hWe@PbmiGb1%R;_3BA?Ax<)j3xHnzJNG~7T5=X2OO)n$Cs}=^4#R` zxIMm~e1-M~?L$b#&p9mIz@^k0ATFC&36gXlx`zo^UzNZo!aDFu8>(yXsEuk|)BE!M zj`tM%NK0VZGSyy2YFOX8w-Nl=%|6V)x(a;s(j?(cvOZWS?`2&}@ola<<1Ce0TXhp|5ZS>U$R+K+=XSC7@K3&Q+a1tBqvdoa`=m2y@> zqd3z`N|ICU1<_(Q`oxu6(Lx26$m5NYAA?wB+!;!4Mbs22pcAgStUd3KUkF9mG14ON zv^LH*Cr|TJ>LP9tsSWdL(kzhJC034ssOy3NI8#$z5b8Q7rsnMqAxQ~Ix{26Bh*pqg zf?GnLeQ9Zw>ZcY$Qa&e0UC>pK?~UEIWU$CpHh_7rd#ZgUD!Khp-h_CRO~-@3p$a7M z4mab>zJNeX zs{`c_ef|%>)AuBJO?|)E!!OwP8l>40OepvwZ3;gQ>~-;Qeg2=gX|K2Y9Lc`Q`0`jE z_?lrwAn1~nABDG$d(2;dLyBJyR5<;fI3J5}=MKqa9t+K|{P_m)*-Vg}kB zV!Mybr5aD;NSnhoy|lh)m-vqe)FoS63!o})S*Lk`G^J;K#crity#VmNqdJ@0pQA38 zNb}UWcSA)!%#A6s%=Qq&(u?Jxi}Wzcdk=cVAD> zW@yOOaNx|;xu2(!_|AtLST`oYv|Yn*1Jw9H;{H1dQaUfy<*CI@vsqN5q1!#ox{FBv z00t7Vs*ha6TH0O&yt;XVXHuPt(88p)8FZ#z&N!UJ?&60m=sH}Hcr|=ZKR5Xa z>8U4Zpr&UE7s+*5mWhj%sOnTM*g1YcM3_74)2)ol?__#na+J#}_Pj3qyG*=*q?M-c zEm|cgIu&@?F#LI~{-ay;e+|B;24k?&IHNc8yWmpf9kPUhQr5Mf8~1V#)fe@R4+}rT zMqiDTb#u4Zv142=;iWr5rEuyH;&D$Iod(qJ+K5C~jwPjnGk>Oz+ z(sdylj<5wAiSnXKwIiTjDIoqZq^Ru(+zG&}F~Zq}O;G90$vm{>TH9NP zGIy~GQiLh11gLfuHPRcXt|WfXy}rs)upHEYLjVTzQ97AK->j`mj3`K zW?K%S&vB;{_7(Do;*DI(8>L?;;nV-qb6VjtD-zSyS*c_)q#}3}r@fshVaC~7lu7TL zyuv`->>{31t&wXOSf$}>5>!bnLYd6Gw@YYFk7YNzV!x(mE zohd6bGN4w~60X^?zq;y_6>+#JDYPNwT!%b9zG#R&j8bZq+7d0@VN>rD=HMua8E2=} z4MrNiq@TpRCU5y5N>ET`jLf?PkW{8j$stN2+V_+I=pq`=y^?$$hW0X~HHMWdP?rQd zPvlCZY@D*|3pOBVNKwB_X$bMP0>wvriZuf{i7T?{PE^Za^#GuK?`d^Q0^KdQTlqwo zzrwyF6}bg?ZNmrg>zHy~Y`*I)QeR0!E+wU@!lxDzl`7y8o12h9wT|&BS!utZg^tki zaPtbz;5tSnX*YGJY0o&q{nhg%ogBnCi`^?gBIjjpogzG@r}ySMp{MW2eYhRM=4q>= zJ?#P6X{svNL#Vh|n^Ki9wIu76K}ykE+-_ls%H4Od_$pW0hB`|JQh3cXH8EC~LS~Yr zGPfB4l*~8*vW>#IQ#<`_@;FAR1`#ZdJcoQV#qD2)Q}{xYJ7KCjg^BT)!8~fP{&KQr^tx+fzZ**(dcvwH{>0VS9G{L`#$Sm5nq~ zDD_Z!IWQ6ZS+pp`#n0rwL8*SEkgCm3V0Ptkct<)(6c#1hXs*dKPdt|W-E}B8Dz?BR zm=o#O?Feh{>M5{P^u*ONYEE+e*-5u^C0djgoI=nqx4NNXIz(ygJhx(Uv4mcl$HJ#C zqjFUVnc0;Sr!5jKAp+VGRJ8%u%tQVqU(e}GkD}}E$W%Yfph{GySs=QJd3k$_-37u_ z;?L^>;Ue7t)*(msCDqr(nE2<3+2Q>!4A}D7xf|!74f^ zsUU!QX1j*xs5-0O+IrjX6sUj3Roaz%QnyjPa^*Hl$8PDyd|m~PS(Po7+0n+1hkztqFa`1PD{M= zsPDHiE6a7JrkGH_bn^ywj%O2K4w}NF5R~uoBg^;_cMD=SsW?^nr)F7c3uBb9g*@72 zkn+~QbtN_=fOWN!E@DodT*!^rB58JO;_vtTr_3`{m`t@=PTaRyx)$WR&_c7M-#wHF zP`^-YH;DOh*CEVvvRY9keU@42WH?KVElh=^=#>Q7T6DO|t8H@;YKa$P5yVPz=4WMT z&$_l-nr>H`^J>bZw2pF?pmnjxEq!h04`bWtCSSkkMl4kP#}62os7TGI%}LEN(-V!Z z%bAyTAx#(Z`{77ZZk6@E*V0;Kc|>&HsY^|`+|^B#QCyf(lFde0vScS5PKpx}sqZBC zxD-4>tqM}H4m376n*vQ?8pCs>Dw_Pt94%y8S1B^(hD9aB_X}@*ww%hKe$+UmB7`MV ziIrJtpJ7NuqS`~Ry&&RLfVH%Mr6ms~K_xD#;Q(BufqR1v4Yo+SKNn<4ly-4X(CTib zDocbFpiWo?OilXFtjH_X%M4XL$+5Kk>+5Ui>?ouiL)zji%% zs&zP%1!8Vm^R+i7^X;m~QiTlq9gdpBO*H=dk|(}XVLW_N|_n+C+;R3H#~g=GEF z9mnzg_Z&~~{Qm&<(Z$ELN2wGFeL_jjN+gjY6xw^d(LTx;CgRyjONGE}ZlFD3n&0oJ z>fh&oMmy3}-{j*Ga_%EM+Z6W^-nMn}%0-H`{jXDaZGMdF-u@_qd~)H8)cdsQhb0j< zW~3&N>q-Fqc?I_EbMILs1LR^}84P8K6R^f0tnlfV9*}J{DF6#|G-{YHHquVFVM-fh95Lc9n!7aAS*iV4R_H4dBfX5_$IY3}H3dg;H; z8))Ja)p~n18AVGVnQ<~4WUajv3e|U2r`ywiJL>{;6bO}-!E&<9NlLclm~Bn1k^oxL zYzfRqz7KlDca8eT8#<7Vn3tHtGwjb(RwkI3M=g@|#n6&UnL3LRvUBZgctS<<=5f8Y zlU{mmY4(B_J1E+ml$dNdf}|@WZnWiwQapFiZ5+B4PwFsO+lH^vrDW=I>RXbjnL>(| zq0DW?DN+D=(g^YT*Z76FrQE2~ozI7PGgk@$yn zA}BMJOf-`*ChLhF=?OcH>_zn-gip|=%!1{laGT>x({%ZXM_N)Hdzan`P!~Zuk!{F6 zJAobdN_IEn-ojrFu_Ii0P0mk=SBSbxjjd@_#)C3-7xUUBMh)^K%4rW~7sFJHD>E-W zQ=dyKmvm)iEE3zn8!J8bSBV-zmMakQ4CW}s6j{of?aRH&3wdR>R)gHkZ$m=Y`lI2X< zWwfs~vZPofj+Wo?h3<0A$`=x5rCmc(gxPCF*g1=9QccrzUsHQ)cv$H&EMe&Q8O&VL%|2JSkUp>ivvbnd7WK3& zO^)9TaBI%zkgPW})VWE@q${`;(ZwdpHwSA0Ywr!o3QTwC7&fnmq>}BBhtjnz39t%r zAQYuV#CJ(4(B>M0tTia#F=|4C5%9X5i3=}GC7B17gqPNYT_I{02`!**ch7JR*1QKS zXmJk*5hkP|wU<`vh-h-kO6}Do{`)|6G0&%Pp1SjG)92=#_IDa_X><^!wCVs;Ne&ei z0#4Sj7PKaXSl8A#ONb>upUt6}msm+yW!BOZ@d+vOoXi4F1E6Q#zvQ!BT=1dSh`N&ftz4NDlYq+V{-hBLXkSeonBMe zIm=2A;>FN&8yl%N0^8W{4(aSQsCKbN3!cH`vnTX@K&%m!M#>(G3d#uRbTQ2*H5|$| z0;$xCYn+*ure7jTTXUG<%ds|Hi9JEy3JVsDE}2Z2T!l`5B-&H;iESq#x$d6*#mLse z`EP5&97XCnmAo}7#HTh)`%p>mAfz0~J{H*Z{m_~_s7GNA948XA^y}@*N-)y0q?Gs8 zzKID+g06Jd))1--IGACk=W0TluV=$gq4mPJ z&Vxy1h8%6e)Zo0sk6ptq`zXqO#%)O;TVdl1Q5)1DWofh$wR=0QhZeH3TSAIXx?QrJ zj>@-Pc7lprdna18S z6vWOY1-9NijGX(z6* zQNvRm;uT@)Xq$G9#G^}66qnNDYg#}cfKr6tQMfych)o^35)`gA(q5kaZtHSQxQ0@d zHpxj!zoa>WZ@stDJEZN8U2>B%NS1POgd$~>sUFpsUFO1*bh;OQ^J^N|4Gx6D8WfII z3ZAON>zZa=#~G7AT9BcTJleEcK~{poX1r+&>Npi zLa0TI=MY(vtxdHjAe2weB_Uktd0{N2Tz^PS(x5zag&YOW8P%|}PR`1&mRmwp@);#7 zNmvAeq?;bP+gn?BRCGge z!o5aIf=$4u8bhcLDW9uQAX!Bn)g&Ie3tj|{wrkgC$IhzjdNVWc zsDZII2v+(+(2>Ez989V=Fl3){U2;t}9bDle`Gixl1IrT0DGh`66riG91E8?BvDAT$ zrV7DLq)bUu>O`gI0WJa%wSk}(Sp*~vMz=5>INw1G9XN%*F4X&MKb1>cB}r9{$}MxR ziPT;I6_tv$GaJpwH6>&Q)i$RS%gPvRkhG*Eix8800jH3>aOk+C@W5kfV^@`8Qc<;s z5c=F`7Sz~IlP#bWskPqs7a);;DC1(15Rx;JI32+?O+#~`66RU;fLlbtRr4umP$ZBn z3D~P%kcP!1FqIru-7ZdkNXr(}GNzP;1>7JZV3Zv@z~4iqt=16M;?pL-4rSHEDYa4^ znR!WNZiPz+6qNGRF4-2a1Ramzq*diwU&Nb@+8Mz$ig*KCamiIXI+PW(nR$m)P_~@+ zR1RxqO0@C#7)okOvD$0Qdgf>q?jzHkeyK}ox%7hUqS{gcy6y`~1f7AtU_emZTtrz_ z>`9N9`eBSEJB4ZAL%#Z^C1x1P;d528vNX%DeY^X%)g*3jq&dAzlO2Xan_ho~HGWlH zo=BKTY`T+n-bg*iQ)}5@c`DRE;cH<^LxaRzBQJ~@OU&g`+bK{`0_Mi#9=eETGSWEr z66^}!51&)?nWq$u`7S7wdV9m>AXE8#0mjFRhyAplRhg?xWIBxCsDqb7(DjLnG@<4} zmkSyB6B`F{hL?>S%+smARGa?rB2+lE_InVr@N$nW$3>MP&=iAkd^U-(r@A0XHO$YK zG&w>JG|6>^rEQ}y2E<;+*TUb79F7}|Roi(*vvjO7!8&BY=bf=LG;6 z2Y`hkA+p{Ujsv`O;e||Q>SL4!t5axEQZL>?u^)(poiq1XFo^xybpo5PdH4S9ZJj|(=7dnT6}aihMTd|8`9G*4ASqW-U~)?@F7W# z)9B7@bdbhxd<@-6bcZyEY}g{urhzk6S8-WvK)1XPUkHyOXgXWT_KEe@5kP9K4+3%& zTcyGNFdaClu1rdsOiL7N?y5aV%S8l&f(}(*q5Z}Z<>m<; zNt{h9B(T%V$g(a0Ng$6R1)*;uT+V5;7xJ=1f_cMD^gqHm;x6H(oheE5&!jD)mm5E5 zX>U+rN!iMv%*`p`n<*AHApUTq2FhFtfZ?S#HsdQmLuF`DvXl+7_#1VOfsw_y2(Zxa z;v=UFtt>3s`i`2zkrHi)keHBf3QPbx$86{XS{stHsNh#B67-~JdBWJ-5DEMMF#|Rv zy0l4z-^4=BV-o5=n=|ccRe&S92Lj?KGo zeY4S8Td#~Z@jP{^?z%rU*@>J%MxABFO-Lav%ppk=QmYxIrWsa> zPymf`+>OXO5Mo4OP3=y%OP9ytUQ+B#OshmVg%~SKzjL>RT4XFye?8){w%MQ$UjH{NrGxAFJkfE5_#H8gRM^XZ^*pUmm zYPqGin(QUTJM8(c&$$SAg~2I~56Vm?iqfX36$!+?*hsUo&TDoG2fUxUpc7y$LEa~1 z&*M|_ufH+`aOku)QuNB;0E$fEN!Wye`Iv(!r`3H&;@@w`SSJW#RUj!edA)w}n;+>! zc9(yn{fE+hzNmF@HVVb`8f{8tnGa{3akQC0h?X;^``LE6J%20=>63QoucQF&~YDV&09{`Ba%BhL)|R&-|3yF}K54 zDeafso@KVJaB>xkdgc*JD5cG>%(#wAbdzt;^04rBU!IDyVWN^k(87*`!@glUSAU}( z*6y^wR5Enl35-&|q^ni7=BbL$X2h$_t3zN4lvA?HqdYZX!XPTC;PO_PlK9s#Of-|*nld5*> zZ^kA2!%o)Lt8JB6!R|Eh+N+Pw*r&%h)ov+I)oBxQ^u|ySxrW|CoMd!aLT;ix2b@Py z)b@M!{%m@*E@|_8h`Yr;&y&1VlM}c~s)~%V0+te`mfi-}2|1JjJ{kiS+$Lz^lZ=-A zdVN1)r;3ZnlV5)`la2VBQ{lXY7D2P@&KXbV8QbrNZ?cKd{yW9y2&vt4WjHU7j*>i%QgsmlOfA zKsNBPK2WJ)aY?Ox<{gVvR|xXiP)$p{vBzl5d^RMZr;9e`=``64Vove%f);-%Rg*}QW@ zl4(yZa{;6zsY~`}tP%yu_it!(`zkC)zB9XoF$FUn$fBc4cb_VBJPLsBC>q)Z;_(Qms;$-#|ctC|nCf*DD%vxgQ>O-F~ zi+Z$*8qv*rlF=>_a*|DtOKs*%M2;0MWAc;eHqQ2=!DvxRu>wI!AdIf=G(Tc4VeDqr z*U=Cq#nGcV+P?-%psBjjp0?o)x=;C#@AfyB(Fpgmdk6NB!?^Nw6xw{u%d<`-sR%8& zi==Ksl#ngw))~v}zX@t<@;e?YQ=(4c^r=$dEU1u9sy9Cq8NB#ulVdZZJt(J}C_yPw zw7PU7(heVoO`M)eL|&}%UEDb^>uRUWx`x~>hgCSz0?5-uoptbyP96m{Y^vE@YFM zPO(Xlvx&`9SB3@AkCS-dQMlSI9SSob!dRqigJ==Zs82CghjH^mIXNQCeJfDn&MvfAEX^p^Th~n0bt?GFE1!RGDU$ z>XI%(MeILxR!&KCEYzs(VN5?)u2d5w)S8Qgg()gfNeSBbI}e;QDJr`;EV@M>XeqY4 zK86~cX_>P1mgKU@EfcbHBwQ?u?qOUmCz;jO+|dIs6R`XC8pNz(@jp1!yK<>h+A`PZ z)0HFL8dx6=k!G;CY~AcbQ`B2)6N#B=Do({B4K!In*~;eRxV7OnOElFYUEF{?EgaKl zZ0FaoklXSn4`geJS>W0JZ!^ z(bgnU2ighIp>G4MBn*_)Nlq&(vQ4Yb{{ZZQ&I$>d9HU73mQc|0Nc`ix#96ySqBOPU zbY?*5;|CzS5S3XbY50lfla(wPRG}mFkC*SXIndywpyD|yD=wyGDRE0#DJSfv-6NG@ zXD{h#1+Oz}LbcfR`G{2sY*#xx^!p1$idtOSkV6Sl22$bob6&#UI*(ZFPBW)e!pfJH zX{q(HX97OCOrRkdyfWQZw%hBxJ5(a9M}=?j=Bz4@uI(te ztf+A+1gl#R4gO*sOhY=V_H0QqCSGWSga<+ z%iS!W@ndxh8=DANlUi1qW!gdr<%aE*BESo6VbU8GbtmTx@_|)~fU!O?!=gT}17vNf z1LpvwZr1ooQDrH0#Bx$>by8Kn+5>oRP`VbFI)Iu~qSloX;5HpL>j;yvLz^QuxhXHC zrO<^q%JoWygq<#JW27YL$YMSxu3}>|$(M1|8~%*wekAH`qS{EP|EG&)_GDTa?zooxN2G^_srQY7Quk@Gr4+fj*r0wMUU z(5NxZKp(6id^ot~Bc3D1vs7uLQaq2h|2 zb%$S-GA}mCA;lJ*Zp3e)Q81T*9r1oA4tI!kBmk5qo~ITSktdo8ic(c?Edhhw(Z`?S zZ*Vh+Zt+T*#YyH7Eb7#trqHbE79?m$1|0Wfn9I(|2D6qV`?@3e%+^zeI=FNmJ2f6z zAj19KBc3xO_iA|;UzL(^l$9wDFr#hloC1Fsn}#$tZ3dZALnpd9XbfuXq(RX=6I zT-)b;2~p$a9-SzhycXj_JZYvoH8R;^eS{jlrregNR+Cqyyprk?Goe1t5&)7T%XIMBTs;I_vO#J`Sn9%g>iokaa+n~6Hya|Y9Z3lQz=&=PJ?5W z_F4f3{{VW!%*CRdxy9P6`%iMGCK}nUzkBi|W+Lo&MyOM{Qq_u*WTq{2`#^n{0=nh3 zzBhsKt~~40_89k7E?<75K7YA+N|NtL)TUcI_i~TOh;?y|^g~aFNMP}g_dlyrH5C<9 zCLd|0i;~4-FjI*-Hm?2958oH`f$^$5)f`+iWR=79>}h})M6r^Wo7i_A zChHzL0}y2>OOqtV4GQ@V({t3opQNc168V##x}fcw>aOMX>MegLN{W1)j@1gu9@n^W z%Lir_%9U)PZ8`}DsP1j&9dKv|Zi~kXMQZ$swpU^S?^{!_)*EOlh3go>4|}8^LkOmJ zj*4+2Rk-|PrzqZLwA%W@(1wnSQ|-C2hhjF-tB6z_l~ue%PQ}b=jhJvIEJln@JOlu8 zpLaIV)O6rYIcQp9(h>EFq`fVrOienLT2AX%`|4pzR6L^JB0l0i(6m|-R<;7>RFS3b zgdb8Qbucm6ka1ZE=hF zx;t*OjqzKPh^xM-87VYoS!v?qYgrdVZKbu?l58#kv{z3w6;pC=qb9;K?3Zfh$(g`r zB=MdVXWAPRb4;m8eYXM5N)$)DKqWwHsW;jx^Sv^4&i;g#CYrsIT>Sn9THPj)*~{!f zl(ww=#+2h{mu(#Gn~)BRPrN&a88Wo?D7ai^{mV>tOp zQiaoX18l13t-N)G`0PuA@@xFmZnH|46DpfxVxSh2laiU&aw%vX&a;<wT9vd%DT1cD@vCBUPobyB)Zyhv4%lgYD%6`USO1yvJ!HO zdJCB4`HK7GCMK}_n0e$oN}Oak5aRi3LW@m}Y=WC)Cfevp9V4np4+$w^AAWh&qV^>6#EZ6EYO(Yjm%P2_OGJsJ4pABLxmoif1g){hv6esj_ z#@rqvXeaX#8i#3jFebB!-qg~C{{ZH7KkCA0RWAPkL;uv8N~pAoQKOQtYnx`Ip`AH$ zhS9CYZj+Wm~K@^DwGOxb1XaA5|rk+xX=!; zjE|R+7X`Utlb9{p#$}}0$O5TTa*0BTNGn=WMaTqzK(RWJy`sBcs8aIZ zPL}*Nf>P1-1h3Hz?9{9Dx8{j|p4~!CQY#Bc3JlYjcEl)eb-0n^WSgB~_+)QksY9rV z?2U-faUCj}uz8k-Ai!L57?Bi3xsWuEAK*#^t8| zjY6gp(il{;PN*Tq%Y{fX#a32(WxHxtsssWAHun}IaZVm$t17zGhD51N^C#sJNmFiK z%gmFjZl~>_fRzsLJ}G07b+D?TVaZDF5}B8t%j`yQhsu?d1TB<{=F-+SAlz#Ww$|&T z{ROpqKCAUMxGRC5!4zt}JWUy-J1p-lSprEdr9mnR1m7}LpNPL$MCGpfS~!-P@?y(_ z+((qIDT&6{&T%rxX-zspX64&9Qmilatr9b4xFBn;(ajDl?46<%$kJb_N>7%QpJznF z<2ONeiIT zmHr9#)<3GzKe{DiV=|41j>!#%tF}r)N6<3LRfW6GIHeQnZw^cKVi)WwIE>=)4HlBf z3QszAVo_x}8!ZYKxYt`-$9Q8OFNOYuiF1D=XN>$QZv)_|^~+gJDH0imxq@4nLY7G+ z^xM)O#V!6n%wlT(Omr|XG%Q0n^til>vJ6ZqCq*G)0V3PqGIS!~0+4mQF*)tFVT07{htl066K3&Sd6H1#5$IC+_>-AQ@!tyMZWBKj>UZ%}-4 zt5}-kCJ1-v($33IPCn~pwna>rkdNs3ji%0K7Ph1x2t&*Hjwo%nVT9rb3>uxSIwh2f zby=l{gUbX-&$hAMTZ3j+M|DLBQc2z{G3D7__A=qs9LLnD`XuERsVGE~DoW8V;<7GL z=T(s}$~r}yX=Lh!6t+`)5Mo?i49O;qY%9dMz6mgjX0hw^jn!Af- z#eyAE=m|kU01Tk!RpL@3U7WexONaPjh?&N;rXLh}_No$-QmRdyl%92r%K)iF6ez4M zI;Tw578ZrIV|>2+#a9t>ba~_K3CukuhgX}WG=V=bSwx6XG6=qQdYFl>& zZK){)sUpc1Cr#n>#w8JVJ;JI#7vwo~mwA$A&P&KloUgP;+Lm`Ri>c^Pqi&ZF>c}+V z+&&nRs_?wbKK!a{at=y2B>gy}lQzV=Dp5t6%B=qSwIp8t{Bg)mlcB==REnd5lS4?I zk#)J3MJ{Oa-IHO3gof0k%vf=GyNFhnNg;NIS{_Xg4J9mBB_EJ!j(my%MAa5(<$aUX zw!5ibXat0-LKGngaj)t}Tunu&@XA%;OqZCL!xJq|O1RokrOe4GIUO+5$6}G{`ro__Qc6@ub^tNS4yn#G{WokLek3x6Elu0`^I<1RDTHSeB(jNm&oLyV;^%Sq!^0pv%rA zIMmuR1Os5J<^&Hrh&3H>OllX1tGqi|`e6^ep& z`Fb5vapp{%KgU4iiw@5t+GNU7kv}APtRQb^(`1$xbE;K)c*RusZr+S_O2q~f;tZ8) zer8f#NmZ7ahTRHEki5ytthVW(KRAgzZYtQ~b}un1lFNx}p4$kOZ@ypdB)H;&+kGn5 z==YFz7xMxdXzYJ6J{qIr2OVl&X{XARg*_-9064UNNQETk@%KQzu3%}QRwL?jDRy3Z zN^m7*4klHCoAVYy&n^HK?;%~@p+|k=mDpPTW}YONl*N)%_Z;S>3Uf5US}YlvZ2_jz z@V${`0!{pOF~q9=`cd1jznKlYNMU7S37Kh$5``@?#>mZksV)?#BogjsNrw8%U} z=#1D`h<`xNH!o9aX_nHl&Imx}W$IEDXuF3FRL?l=PH`+$DlQrNX((hoIbpSr zwBozqfvx;}q5l8~W5hIT95A2mRH_qF&df}V`4F^)H*a^jrG}atccH}!8*{Q}PgUt& z#MMd3WK^b1yKN}}z)O6wWhqUAasclFH}r!*okTUM;5WE|P%{rW)U=QnLQ;gK#~TLS z)b~L?CjS5!RZ+_q*uIw_RZF2^lxBU&l9wJ*E`oxd{ms->loOj^ld+CzJE-Ua7BpFi)eaBQaNLPAwNc`IGU05{z6DW#VX=?C6G%fE_6?R!IXD#pci zS<0KPb1JT|?ak1plrpRCl-k?r9ix^f5sRyGP9@c?*9&IpSF@A*prf{RWH_Nrq0Kir zJwaODD=sBOxZ7)R?x33xb?7v|NamBaNWLE9mnB_xyEjNnY$@cWg0(2BSwv_|m9a2vhZKF~BOnBQ>zhYm0Gx&bUyXIi6~Bk7 zRQZX?r$J@L)Vs8>q1{j!2_JbXNe0m)Ngq(8rPZo*w$jq*Y7Dd#l7?59>uZt-xmKNZ zgtT=tUk>4sjSSj@Zp)>Vg%aaMDr}Roz&n1o#?Xc-F=IDKe-z6mR(@VidR+thR~AX!o-sFejJCQhn~n@CA> zA^=hrtvjhwg~2;%tagsrp=OBu)7D{^CR%NdYsPU3mQq4ZmCf$2D8AWl4~!HRCD)7U z5>F;hPMG^{Jm5<&OE{<4UH-|;kTn-K0QyI0;NtNE0vBW*MOv8ZTv`H`I@%Oa97xee zE>e-u^gG)@01?*&V2KX+OoAL!s38k_Wx|4QxJ|5W)B}Gw8Pqu#9SFkH>ZPDby3@&0 z(3h8yrd+kkIfW#g*09iA*d29*ojQ0+3(~PIQ4;kjSLIoGWg)cYEh)~4B&c_Ki+rFu zE-@^&738W^OH8zcDQzvp%I84|?xh zDiq3)s+6cH(Jrn*Lbq*cB!wsSt#}SITZbHVa|J4C;Z2uvR7_=bAXt;oi=^1wpddqw zVJ~uJaK{$NVp&4ul<<}=IJXOPK_OhDu0$vj7L;6!!o&^sj-f1!7`|Gc!%Rrj!!yXA zrp;$BFcqJWO0`lHNzIh&Z4I=5=$qm<5glD@GQ^j)NK9BX%d9E0t*jEDoYz+3#Q8@~ zn4h8IoFZJDmkOuKy=5ttC2k=jVRflDNdmx~{9z)61tz%aiYDp^WDtVFX3$nH6|I%r z%1P;cPmCpsG4V5tHCdWNw5D7x%c)31ZzZ4`4O?ztPNZx{mhr=*B|m{@YK+RT-9Y;m zzfsBoVBfryC?5E~RS{re7AYg7_YOrz4$e4MnMF&uzCv9}fPa*(`V!&LxB$3L=KF|k zy~U(U{tvS&g|TFu^s~sCm95GpZDdg9Fuekj>Mm_%0s+3G(jevCd>Jbq-!wc}wYIUe z?N*xab>$F zNl5J;?S1o4#FA>0k(s(uw@^&JWA2jS2~rP3zl?TRf5Pv}sl}JNuQ9}|;JM052e3>O z7Lt`Tq#XBb>Mea1n`~kht@kC-mX*ZHg%ufUlEQr!{WBH|x0(O|{0-xdDqObsowkLo zF1tp=C?Sl9%uUdu0)ac+6LIGaN-YXZ$n^obV~RQ?DJLS*NYs0$eW4ADM#c~0h9cqZ z!|jR5GOHm?5LS`*R0?`{-X+5&e+#cBN1i1lVt1;Z93xYf^9gNfDalx)T=^e9%V4!25bLVNzPm4H^ZwYG7nB^pWhy=EKz6W2% z6I20Sqq8#SHN@s#n%wl;OWFpGoeZHDR^Bn&ICwZ6PKMVSLR^I;AXmeQNvVM{?|H%0 z48M`L;SsbZJ*ZUC@cg|GHy{z4d#In!Xpt0=Q>`jxhg^_a7V8A&MZvwd8eZNY#5vB_;pjZ0T*Sa-X6u1P>I5Ylk=%)SyoN_Vo1@% z_Frtjv#A<;$WXX9^A{uK2-AFy-5liA4Jl$>ZGe8lNznemBVQp1Pfo(QojIzUyB1TZ zup;*&*7fj(HiXfJPNyc7U5Ah}ZjeC+I=q33LowaVJKm7;5Mq~~L+U8meg|_MK+X7C z5EP5YK*Y7Jv2ZhaM{Ev!&1Dj8^A?rb_9EJkUoSX3N;^iQ^#raB*#%WcjE3I2Hl26)7v^G6_A~Te`?bvr=V@szsOKddJHUysXijB{iyiUhS zY&9*;ouS4h1fyq=lEJQHzCOD?hJb*Ticu5Ac6Y?mTNkYIAx{eXVdF?f<2f3gYO0Y;s=Fq+RHfBPh8tO$ zLDfoaOVvbsssm$h7=w|xYT372etUN&Vy2byz2E5j8?(~0wPj0Zt3F$B-KPRuZ3WT& z3yK4}v$j)xZ`4{VT%|6zYiG-T+j3;+sK)9kS2eqJ-FHVeyM^1ujj7k>r&%mHX_k`y zRWL@&DF9su-U`qZ>u!+TWZ<=K``fzuZiPO2X>P7Bqw@Iq8koz464=3nNh)RF?v6G5 z;aMh-H6a8M-nOQ|+V|QV$0v>LS5~id*OuJQc)MHWbm>!1&&c9AR2V(hnS1K!@8xNk zgWvX7(kxq>=6jisy1d6-2p0s#@U^S+)6x9IO|73t*Qy*E6%om#Czm9K5Oq>itwHnx(JvMWWaS@L z{{UhJZXz(}Hs6w8x!pzzeQ8)zOb~V%m9MU!mEyua&YwDutNn;?kB@nJFWhZ0(koPE zkjr$ny(+7v#Ywyr>H!wGLeP?JzKRAUE)I0t+PiOmLEL;)8|SvR#Sp6Xv1cIUsm8?gMA1Cr$zS%NUN$P1e)}7a%z`-*l@@5)+ z$=QQWdBB7zNF2!-)aX+%M(r+$$(ISjj`soMM!^Zx(~ z^E=YmA>%ZqHtQ~#Z%ax7~0Qj-Pc?onOG_}zcFaggsm^AO2A5zFr`Fcd@ zLo(??Kmc4=0kGaUvBCBSmnWa0vmrsDQ!mO)vw4lpl#z4db%`qsCCv@Ixjg+2${eJ( zvy$WfQYZMs%Z7(!GUq=(Loln-+Wwwcf67FE7J#VyReQ9DN^g+?q~ayc?`%_hn*kK!S@b&6XU0%9hS{YRFI zi0+e`jO*^SG#?NT=NJ4OYKrX4(56i-bB?lYl`^Gi8AgiNU86+^^&mD@F9R{9V-n&@ zguLAA&M?TB328?`aG*VO+VLh(NeQxFc0+6@1fUkRyLlCb>c zN(E!h~mGAoJuw@qVT%1-9e|N*`AeJRHr3f=Cw41 zd&tUdl~(EohsGXpY_5?bc!ApnTZ@$GihQ)IvcMxdk2*W3Y#mfZw&{M5+_6!_$jinm z%XpTXNkpTqKBDu0DV66<$QB1ngXCf?@!BLpdPm=f93rDq9+r8!pj_30resv=QD6sq zyoD00ZUu*|XEVJ@pMQtcdRfP#0dXQquR8NZiAENMDJD&pRdZRHPXT5N=*X{kUXPMY{evxTg1SI?iB23dNN`}>`4 z{TVSoD$7P4A>K2K^pUn%jBOgT078Ff)SIUjjcVnMh>iLQ09~02klJIB}e` zG|ba?S-3ipv?&P$PZ~3bex7+tM@3mdUPK$|3P?+5QT{UlG##3zG~xn4R#gJBdXe29 zE5no`#~OviIz~3n%aCEF+DTQW9SB;DuVkbHe+|TPj@Zb~@g`}qRw=TLfTNHe@dEmN zfeO-bvzt-kwOXptX-jR8t@1XIZRBln4=9Z}4UEK>v;va6p;c6_RDX%#2C;?#& z+>i!g=5@Z%9U(^(@G|9UifmaSU=U8kbRr##5+r5ta^=-*!1TN-&Y}6h6vr^~6qc22 z-uHosd0momj*P7>%92Xar;q$G8my6HRZ^F6m(<IF9{ZNCulBCJeNoygRurVXGgz*j|QvLjh({` zAM!|vSb33i@+I}+(j{XB(R7bkc;X@V5+%_qSTCu<*-2HbjQ7+Xt|2Z1szZ~)bg?}l zQClu0XmM^EfomOzBKw1T$21*s83`;e?NidPDrpCjwT@O>DCRjxLcB^! zl59j(@i6J!la6%BGa*@Ou`JxovJ%X)o;=3Xezuu8_Jf1`5|!0N3lMVH>4xKYPY;(S z?LN=;Harg%;%xb)Ro#B)aSpnIwK&>RGXpfpB$nL2a%rsv+d36{qSrdu#XP$GSD*No zk#v>SKl5L8)-TNB;;L%#M62>sQj+rtcm6_{Qk9YR$g*Y`Avd`DR<*oLb!BjNxvkxG z^G9AN$y4O^SJD3fh5m$Hqi_=u@I4Ps;OWFmya{mAuBWBu*c#aibSQ^MP>?@rEhEM2 zbuQf3-sNsi5ijB8bkn_`>G2o!uGH0BEU8wp1wHCenMf$8$&o!OrCU_3DoaXikF)_% zPlP*4d&Tnm<^0I58a9&q`2PSQ>fz2gtm0YJJpiddR=+P&rBx}4NgU}{LY+xFXK5+! z`Q2JWbGWZDy)l*aABvqsQyNsn!;PgW8-b}k00zL5&_i0EKgdRe_Et4G1BmS7De0LB z=6P?lPDb5qHl?<9QV93c;zq_5tLhTPT!ke{iH2X8_IJ?Q9zqIol@VmCru!ID$b@K+ zk(=z(hHJ}V)C8YrN|J$apc1ZxU*t{5hohDBeEtJc+nO8Y_A94JsRl}E)~ux$Z0n<# z54s5pHYw?0sL;cUGwV;}BV(Gb&bYpbky2ICPHQhZ5a)BIP^4%_T}}L9#gTUOVt)A; zoTc#x52UF{mzp7YEE-ZqUXEr$R8N|6i*zOyrx)MzJ4UTTjTnOmu;j%?j=oz@D_?P;rPQ-$hk6h9B%Djro=J9+$x@sou^7yFkJ8t&81D$rQLOC zZ@qMvn*){*p0^_D9byJqeiq{EZcP)h%H>YB^X2g@c8kH8d=)h{Jt@gy$)lQOYHKEI z54;VMExoKd##1!qHM`k&*tW+wN0Rh*b|xqc*Ak+UCooD2X? z9Pb9_r)4Hts7=VebBUzM-2fl%)df?o9y<$XTYSX7xzdw%Sc~Z+*FJpj&*9(b$5)cuwcg(ztLlQaOO|*k z9@{R2+cQCASsA_bf=$$gYnckMLE8El;(~ow_5D1$3VB-o>+`QK*Uzc6noBZk<~21e ztiUBnE{iDucT%H&v-TYKzRI-LJK_1SU%!(%;x{{S)NlDqm|-M$ai4fTJB^d{X+KBZHXlc*q@K2{r3 zZY)?VwyP&!>04KGz@6f591@oGero>!Z&Wip${(|9)1RX{SXZ-5t|n=7Z#_?*FMyK# zvWaN7d-p;~LP^w|zc`)YOQm}M03s9PqPk1wznE-C*{YtEmeDsYCdyC{*bc2LMY^A? z0Y}yw(AQz;@p_l=$^3@wc6XkWIcd0>UFV1)4K2){8>LRDk>O}|lkMwYxO>C@01Uk^ z_8NIAtzwBaF;1z}#FOmiOG`_MTT>2w^r=mz!97KZhT2@?zt52=KK(`B8m(1nPv7}R zEaPiWdoyhPW2Zn8cR6&u_40=H?O!o%c?*g>#b*&zlPgWB%FI5b130uYm7!YMDHgs` zk?##J98hiic?q231#MDZWY5DmML1w{o>E<%QWBLol;ubOXcC){BKL>9Q@2lH+}$ z;%v5Ej?xm8%EZKdet9kI2={6v<)lakEOA;#sVd#RkT_IBLp+o~jFD*FWJPMgBiY(rw*O9Iw6 z2VyoNIFZW(ooMcZnuhxeP61V_sYxdy+R$oL0s^%2@`zGfvUGVNsqHt!NqkF5Vc9ob zm*l>}idKS!Uz(5zP(3yx69}fqs)gShDvrNQkykS*Dg{Tx9(t*o*%Cc6{!A;Z&DIkJ2ibnP>Qrzv~+&3wUF@&{R zQIxcX*6fRocR(+)gsl#w0b_9D(n&YC8VHAx)M%59Z)E1GRehSTECC#}I8vj~X9YL- zTHdi!C%X9lWrABjf!vvulB%IKWLoV7I2=f^S`rBFX>|?kI&_4_M_TActW7G`8IqNl zWb;0)63sfH-Uys?Gm0Bp_W*efZwrn6`ki~4eVb|tkfu#aEP*Q{HiRHsP+Urqt+%>> zIt}h)xnEc1`y7hx*zIEe7rP|#6x#l-R!XHZ@H_o_bV#tV)Dh$aFCI>hpD{9x^6rrm zcmqDpAH-|KMGiVCvQH((k!$jh!(}-Ew|J7Fy}crTiKSP}jPdG!LCwUobxIx>eWqF| z4b|o*)bf-vnRgyc$^rmZVoqQPAPo4ebkHhhkK!k4UNV!N2oF*lKk`RDXPOj#)A|dsUX= zjvS{;N<15SS?Om1H?qB*z@?*0*pYPD+kXgRZLNgX_wgLQFi0uZrDod)GZP>m*m)%i z_*|sJZ}t4bAE)F+Od*MxqEzbd8+~D6rp2xl>PpDHyoj;#gyiHs6>O2>XEf{5iU6hd zW=6YvgDCmj!XwYr<6C?viI|?g_B7$`1=)u=vl*7tsypUww?}xL&QJ+GVr^-Abg`ta z{ODHpSf_I9POtu8vH*W%nB#w&{SG+RMu;>ndjC zmnmy#0kV_|0&nOwzfED8x*dYGeqds^Q(0z7)yuaw!{e6X7LcF{Q=c#gOOlbP^n@vO z64@gWc^67jPT6GGMiqfRRWa6tfNn`ph0ylxaLxjv-T2fq@?JR zu90`c<=0Jm5VI=z{=-p$IL}nV%r!v9vMH;`Eu@s9Z6W8wWDKj8d1@#i19a33Iq@=?j8meP__cGe2BDH;VBdW3!X4Mj7L zk1DvlM)Nt9BDKlCNp(3}VoZSFv!$X)3IHWXT#8V>)`YYJa=6{pZ>o^n zfU3ne2O#OwNNP~A)snfA`kyCT!p}<0Gbqa4RLGx9+DJ=EMAK+OW!z1}mlp}r=^7{- zUeVbhZ|D~rQBf&2tU?2llMhczIVUQD3v2#{Y&w(z2_z^E@XVDGZVYiq?w{xS3Y-yu zPqLaq)&Rp*c%@3(mQqvHL<~87G^0Gx{X0| z4$4iUU6Q#pE14+b+fixk?Ow}8!6{H7K{mgHEKMB@QN!fdhte2*mZheu2vbv()F?M2 zI)$W#s$W1En%3i+l`1_0g*b@2j9ex%yNPbkgO=2n}Gs%_g#I0n0+L?1qY zL$X?Z1SX}oXZ=ST1mV}*l5Y-I<=S}?vdT(bzc4rupb~r6DOObrf;}{Zxo&q&EBoX& zSdRvKD{|6u4YxGMvnl5ocFI_2_fP>K4Hcm9NQ7$qhb!|UeRqa+9uQCcD?)RTDDYXC zl6SnyhF#XmY?l%hq5D8<4a!NXV^14TVL3~imzk-hG~_0aiE|{Xp5e<*ngn0@qSJm- z)D6O2DM7yC5jZI=_g_&8RQ$&m5b@4lVzVSFEx9i{DgzU;Z=&F|NeULalCS~HEJ(Nn zMSH;4opm47xpK3yjO5$G@(P?{S%f;5iY4Y7PDKQSg(1YLHa92U8xTmeMUL)=nBriZ zcPw0&o2W_$J*mLsDs3T4ZPj;9iX!PGW)`_gy`zpaz;gJTOhZzxDG5kz@&myj1gY%l zI*z1(e0u8$h!uO<0;?y4s_aND*BfbsD3qsFkmB=@EvH>JjSmF|(|&)EQN>GfgRQ0f zS3VSm)Yx%JM7mx!IY_#5ld)FkrL+-u1w}lajtrh7n#J=%pGplBvfbWr4pTXSu_znl zzLz5BeWSWW*}sS|WkC*!S80WFOF<}Dm<0zgS-zj-q4XEN>?8k@+Rg7E?uWyK}@W;0@g^kFp>6@1&Q&FQQIHd zmN%?$ksP_V8ceq>Er!`>doq&X?yVYvNg9<{8}A4dakw_ya;liBPs}BnWRrxTuF3(! zsY(Tj1H`0jwd03IlZiZFqPbg|oTkkzwEeHkVOF^v;zEEIzM(?qJEY}`92JVFbeC51 zwTYR6@<`-3(u+Ox*n$+Bq>mIG4~%k-i3*=Ki!jns`)*51D?GX$ZA(g$PGATiTYGKi z9Y_Vee-g-IM&6p6sm)5TqL8T>bd(ira}sXatZV_eHUI$#suf~S8{p~*#Xi8f~Y^!xi01$$r5>}KB=uu7fympQf zsf;s&u}jWW!_yhc)@GS1Ev*g#s!9kJ)OeBLOeLHfslF>p;a1&hlG$-C6{T)Cg0Q@! z+*0(-VPUE8gix|O)A5A$W`8HC6 z32<4|Sf{#9mj=OG-W-UAICbh>Qi9r5O`nx@m8c~t4U{ZrHobrVYvI-$8yBO5LDMp- zq{`eGnm~O^%CM9S%2HL(g&yVZMWIx3#(m6G<`AmCDvFHFN?pbZ6dqYx!WD3&orana zbrHj-PFEB&P@0r=ho&VZWzy+#&XHvV5QR38ptoOG4xCBuC9_&mlQ&nJQV7VTAxp}% z>~jr``uMA_!G#ZOX}-72Rxu-uZ#Q|Rxyhce|UO2O}-eUrV6aOtImxTeh( zWoT*FX62l-gp?e?G)L zIB()SStCHEsnklzOfcGeg~FBP9Y0^wO(Ta$q}LgKotjI_m0%rKrJ#MJ>IhIL zTj-?jBa|w|txJrzNmF$B27`?9&n+uK12*QwS$F$GTOHt_J811QUy@c<5{258ie$$*bc%R!S}9F15~Ho{dyijODBz)~c8#Q0R`XKQ!dhL@ zR<^k*IoE6V$yQREjYYiRqqH(qPC3--b8gg{qe;vb^>xI{-$d+H-rNqOQ5~a)IbES^ z6{Tcsp@fojN(lG59bllbM~67aSi;1@)2Bjz2h1Usl`}7GGdAD}AcYOVO~#{p+VBC^sv7n$qDwl0l{rpv zX>%d7p~m%XMDN~7?v$GYu94dTal`aXag{C1PfoZbTP3I2&Qj}&79lRA_Z5Ds8-caq zFJq{6_?Jhf;8YsBYW8(DfCQ#cwq`O8>Qu-E${iLgL^hbVge4b?a@gVKrDYhGRIw;C z3{0|8>tOGez@b2H4aVLuRR=MO;!~=u`%L8~U2RCnK9>22P!>{;c$AZJgKaYH))3I5 zO7Jo1d`E+){**&+Hp}x4Iu?*ZJDG~DsTUpVjc*Y$wz&_%C(Pq;qX|iHw!R#7)Rq+{ z)YOX9N|KhJHURfUh$l^jmA&r~GfB1il3@}+P9dq9n{}p;NStNKM^mPnl>=`w4UNu* zAURnnMCIVwd5XRnS1mxzDU~4{!*g^gMUYk3OAGl3M=^Yk&I`jboKB}o)g~pH6Zr#A zXF$(p$qE3QkV1jWb7)NV28Lu}TuIr+eT6M$=~o>~S#v0>y|wiKgRmoGyiLbb<+DrVM98b2 z>A#s|)P6ov=cucxzOGtZ8C*h=K?>@dM2K-4S6;*^@U2U3UCyr#ILk%GO(k-UAQQL= zv@afXwtF$Wyffyv9_C#{z`9SwMW#95BDQd@W@3#zVnTK@;%O8TuIRs%IELA`&M6(_ zABDe+EeQ`RHr&AOe646v!(*5fZP&oS27=`jm0bjZ>!->SM?zHR{)uS3yOgKiu(|kJ z681WT<{HLK;#~Zzs3B!1G73oY*LZJGsyA!ZLq|Y-Xq><(9jtvehUDvUX;_`9*Jfts zQi&&;Ny~E6iBKovG$X>$hb{ILk=~K3PqeVy%K+vE&Ne|!{J|jp5bAAnM;bO2H0lw{ zd4)KY8|jwbmL~Dr?v7EJ6OxaB+R>KU1gRT-VmRdZ-gHrn7DdP1lVILaLbDo7yi z2m~1A1&EWw$t1X^8!Kq2-zo?R2gqAUZ$cHQS4+x!I&$VF-Z9z>HRtI_pG}R@u8K*r zhoORk&r2cMM1-j41MMGsI!v>J}kKHS~yePfPcMo{2%ZFp)^6-Kj?O*}%1 zMaIV3!%f(sGK?UJWvRy8bSYciXXOp)7pUBnVcKywQkIkAZ*NF)HxrL@tjnubsW%=5 zA5vl&x*rEaygR5#;QCe84M+g?lmlz)2BdTYG0{4hOOTTs!7g_|wf8;{i7OPH2??Az zG~0@GhZAydV{v2ZA}hmNq4k%!k#sjFm!4)`U1zF*)coU*74t~y$y}Q~P{A@)5nz=v zuM}A)^0X#gG-c!}JVc}BA#0o_GvTGB!R->O=1V>9xRcciP#U(amY$+3IGzGi{uaEt zZdqXClsT?@HPCEvW*bf!<~chq=djMLKGfS|IAQZ(nU=EZl-|W;0-$WGZyCJYG_ijg zr1|w%-BH`l8F0OXLKB6`!3wOrTuW&Z%kvtP4cX}Ya`O?0`^4PKl} zGmOlIXUv0a!9bhd+MRXRXwb)n@c#gX++OIVla62FRM$H0OIA4jEhIu}63;W@;sRVp z;H=+-O<0I>#n^K&=Mbrwul_*hP~rQ!rC%igVQU*1aiLoM3SOgSJkk`To1~P2LGcHn zj=mXBnnG504o!(F)fSa2&0EWD33WeQlWdFqWea=5qPK|IJ)aq0OXj*i=19lJNmrLA z)qf$Tny5-81<6U-XQo)ulCnW{uB|+6-W%oU4UddfOWE>VskO_yU7zS!$BSH=X+C~W zx;;*u851zcPtk4*q?_|)CNFHZ*frC;au4d5t;vhS=d$|7U$HVdJWn}w?I`}{^Rsh1 zI?H^-i_bEhLfh#32dNvI_pPO_1>0|(uAhl_U*cbOITX4+zk&9D;eJOEZ%s@jHVX@V z%li|`xoT;R%P;lMmg2-(`i`O-T{qvO=+|fFJ+iyH{`7jrUDuG;V@?@U@r;zroWo7E zNgxX)2@lief%_uGJcGY>`=7FI7mFjuElTS5?w{-_{wj;z^z9}80Lcw4SA^BhAIgWY zQZr^E_-vXjdxwp)=kyN;IF@D+sX1d zSeG5Lx=gKS60)?)%>X^Jl&NwypX~iw4Nbm%tB*mO_=>8>N1Tm)3nzM*z@Jji0i8m#Q&?!j^LG)S_ zq4Ts^W6v4#uR=7jGswhJ)gTn!Q-27NsSN07)~(Bzm~lu^7D+lAK_EqpURgDU)@&k8BC9cgstla&7el4<;+YD7{P@mXA)Z-&2F$&vUN zkClEFNyp5YQ)#lJAH=Q8yia2YO`;k@_IW}&k;?{Sy2&wn!Y)J{ryh_(s!Q{eKbegb z5doEtz-koTD;LyNFw2d$_p}z)q}eI}9gIkrl4kZuPD~pw{{SUl{{Wq;iZ5vOCSV`( zi^fh!wM;2c5Yt16oQlED%Do{_RL)7AJ{%j0b^52F770wS-8{sujdnPk*+cE7A+&bZIwG&p%3d6zO24-;rt3a(!xnRyU< z9pP$rIjk;emCUMgn&DH3LXr?JE-nbU_;0LkICRv0MIJ}EwC$5gMQ;nCwIOaVl9H4m zK`J(}I*?**Q5`Xa;r&`y5Y;fG#Hvl~Vl%iP7x`ywzV{64$hROQ$iN$d)jMnpQ zeBoXT5#uADF~%AMx4k&j9t-RqD(-O}~xZX#xO_-joDL;)XE!14d$|h27tC64s zE`aD`X@WHc@G$&e@i9M#TcuR-g!XdUr3;NIqnEf7ZEOh8Tcw0aE9J>UQfJhe?{u)C}Z89oIaO$JNX$Bu?Nzf8D z(8D<*cTpWM1xFNP%E6GNrRS$%YlV5>jlCc;B;ybAgGJ zn4O(*%FNQ#n+opT#5Bjd&3>SA!^9bryn%{KZ; z8J4el%I=anYBltS@Z;6^pU5$*-SQbu81VwD!l~I5(&rvwb1ycTl%;1XvpH_?1Oh-i zo5bp}TwOEjD+W#~T2+)46}W5(JD(C_vo6fhVB{?7FR7A+6<7soJapP4vS60S7=`*B zG3ln$cL1^nnfSx_)v*%TW%yae3Zmu|nu|p(n_B7%-@?T05?n^p9iAxHCGiCUY|F1U zP*S0>N$@b#$0AoqeKV>?eL_=jj7A(4*mdO6*-+BuSA?`C$61_jc?TOs%ZeFw+Q)vd zX*pvI;=P?mcyK^xCJKhJ)FFw7mZ@jR`@=|jD#SKyA+s#3$+gEr3P?+IY}BVr@g7j6 z8aU*06w+NH+k*>24lQleN?gLyIM|$}(;mc1yN-rf``VQsAOJs&p?XB>J9At;qewcJ zUUF$!btD6C!7iY?o+LH#IWzbMgw9S{`sII-QaSL8kiN8q0||y}1tK$+;_?mCOn)s4+s( zZ5Al7x*Vsh=dw~ou6Bl)>N|7qC2BV5)I(#YP7pR(#P2KoB&%P6Sc$lKq84?x%$W*a zP2$=mQ!%c24mK2%a8B^`39=1w{{RyTZBr-{X|TR_WYsW(euSjxM}?uptnJX0;Qs&@ zX}mv^oR@RyM@-7ruzrqw1QqIRE#nJuv9}?PrsG+eO0zSwPtLn6!|HdE-8NwgP_Y3w zPy=JF^p0seWV!5@GUIe6lJje6!u!g|;!0MKrxc-Zdf13VTZ3e}c~GdK4A3SWLO@z> zg?bnTk*A9MKmJ-&BpyTRVcAB)#egA0HHbGK4~!{g(mJu~A>U|X)i)JXGY~UVk$d=z z!X{#sqBP@0HqBL3%)+vhYoE>^)J3Axdjw+=!ev;^YdpWiMRye;{CMoLt|QY|foH}e zkYqnD^F;2Wo0fmXGxxG|H@jpKFc=DNlHhPwp(MQwkb~{&aDTU zu_(3N7Tq5FtKC9Q$s1c^q(u8&*L3`e`dV(+PsF>fl3r%LDzMH*(3hMHt@R~^o9C9A z1mS&LDxcIag}e%`T0NDjXZ7bv!%D3e{@CsS-}|!4PCm_gY%SE<(vtrCYn;% z0biq;Lw3rhlz&K*nA-i_BHs@X+-g+cxglAbA9Z#1oRO90EHZ#m(i8(4eD*yi7Q_4+Ay(Kp&rO%s9nIB36YdB`Hx_Zl0k=+8;>kT12;G zp68V8U`#=Yz=^O@;!?Do!hj(B3^^Gv5SaT8Qzs>_H773cHcxq^tGnT-+skO1ih52Z zV_h$WXsEVYe6X;v`jlx1ttw3|71@d7%s@!GO51%wtez)_?t{Xa%Uj(zUZ_5Fp;9qk!|IDiPE)Fmcf2Udy; zOFo?BARnAV&4O5!wd%ipiwrqDO|Q}Z+m3}1seDk7pv;z+&Xw}ivEWB6sB7yHBDHjn z&adfYna{)PFO}ES!(GC(RuHFVo0dXSE>9_2e^n+4LJOUGKiF~^vOZd$&3@!u;tbvd zq-AM!4`y}$0C7x9Oszwu#zu{gh2ma37OgbW@?@VAB6Q;S{{SjKqh~J=@XrF`o=f#X zP^vn^B^t>%7O}Xxxk*xp`#Fx0FBIH=g};SY=0nYjQ@v4&^VFZ}M~bZG0KmUnAvudE zEroZBNpvx<-fqMnF0o-8a>=&N{ulZc&VC;JtI7VhavH(Yd}(!G$vjOVSnJA~b@@rZ zLLNd=qv&mZu#a@o>94<^?mE4o+S$7D{$H`8-vIIF4PI_;a!AYf?alUpwIFp;RMM0- z+g*Byi<+XUNv_)ycwD|C{4GA}-|9K_D(zCX^AnSjQm#1ATTH8&kz^g+DOQ>6HCFrS z73#Ss)1hZg3(OTqsAKtt*C|PtY_JrT+**NbDOr%fZO7qVh9WKdTpx7XlK z4i<3wPlod4sc;uE;VOP$fthPN>tJH@hQgPbmE*XnWqp@KITKSUWL-uy7@>TO=1I}V za&tKDg&#zipBzkx@+5I)CKQ9-3Lc=t^+z=tqM(l$G=`&LGl@N6Ees);2nR%)QqA7MepmXM^WI)ViNCdRwtP(Eo zF2Jpng5pO@TI|ezBaw=6tmMrOkx-_-b4>G?n0O#4A;99&oarLN>oSg;#8r(heZNve zpE~dQ3LY78vAk7>XM>0mwFxp6Vlx+39bJ73;tt=!t5xAD2kg%8D^?eQ#y4C zDobAg0n^V|XDh$IA#il-$qqgtsfv1{bMH3#hYOY+l;gv=wa@QkB=3(p7#! z*MRkrDqL*Z@4Dlu1pC2CHY4C6oTJ#uO^Br>=5Pe#YF0z`W?UP%ckG zE)I~|f0@}{uk=R8v(FJ{ab+%Qtv1S$IHh|W?C&nj%poZyhZX?J*|M^!U;vYB%CUvz zj+eI~80D*(99zTlICGfQMVBSg+WAUxNxNxX$q7=&bvcqkkfK6V4Z$(iF30l*%cgyq z%bwwOTI6e|CoTSB8<3=NrlsdNYdC6hY34TZ0%edwQ8Wh1N{z!$BXPEUjCS=ZVrreD zUSX~zF~uq*`%F9S4oftZm1QV%?*zDl0ZPS)KYG^?%Z+pCxz4J(x+4t|fQ&X~srmVe zMNXW`S8Hbam8_dw{%}ii*uTk=6*#I}3FN8HXEKucQuEnWlItP7p+Fr$Rn5HoA~NPJ zt5ims^%2Y`Lloy5Q%GXA{JTX!jP3H=$h6;ZQm`%w2HV~w-v0o7gsuHQQOm-Zi99%- zs?4&{bCV+~!VsOsn_ZRHMCG~i>l{oRZ4aIu3sxSImT5P3b(W?-uHre1-}SoaHHfn8 zDQ@q!#7*rPgi%7F(3+KPL9sb7m0XqOb;F#3qEAq5(@i1#AEW&QWasmVB_3r}Duohk zgUfoHtjhgj+BEgHu^vzILy_dynUSVvD9uXH<&kitJIr+3xZgJ@KBOCOePO%%`OvEC z@cf6WtxtI~(j1n8rH~v;%ghHXB|lf8)ZFQ&-D8p?#q7q1iFkf)aS}7q$t_MvRMp7} z8amsF<*fvr0$okg3B8FBLnf8;ufIX`t=IV@fre-0#GsjdCACQxQUSSBcNVd?m9^Wf zCN#JI01f`ZG~Uat5$7IPX_QGh#%fL^IX_LAOKVwDLV;~ggoEy$@CM-AD?_|l@J^rK z#E-49qT~+I8h3?NnqGHORIJ4!o3|mVj?)l9-z{WwDfp71#7;GI-PLtS6N# zUsFcTwl&V^i*O+r4l~NGb1NDm7&Q(%jhWzY1DU4 zs?1QMoNRQoG(Mi@g-Zyvfn=ueYc91pJ5y3zcR51|W@1famK%9$<+zs{Dk%X#f=YEd zLPb>_Rq;a*;JiC8F*^SMIoY|HxmKB45d)SW+C9btOo71b09wxKejYg^r{|c|y4oBRgC6W3?fSQ%I7M zOtMt$w8EDA>rL{eTQbp^S`tAAL7^rasub3*znH6#tuGAA@?Brj0fyA3-eCnn)~$AP z1ZK!d?q6U<&7-`8Rf)Q06KRol~$vC+&H8k+w&Zq8lpO>L7#etE6=^jaQ$M7^~bflf%=b0CGdlbK2>PGj~|His0>XcQPr2vz7o64c;oRQJ;IlP2g(FQJx}1+x?0 zPznV*D^D2Xb}cFtRr*Ya5E@H$1g>mLoQ%vM7OFJmr^O>G-pSRqf=KA7Zs=Bo*Jt$p zM>7d=Qg?*YDNTLE&C`m4CF`vs%&l7lOtz4HmEo}tWxt#fikBh1RkQp1^dx;d5K4b2 zB&Qo%7435F0I;A!thnKJMc>Mwxq{->eK0 zF;C&9F+rG{oc5Lk!^LPqKm|xquqr0n<`%b%BE=+X9ui8TQROt^k}Yr+`U0~Jlm=_* z@-UmTr#BMFO-#4^_L|}{p&-nloQqC?D!^D0JmZH)URH-o;e@e%tduTex|SG0vyLLb z+^An7MeTA1yUBCt1sQ7;+Qm{$6ecn~ARWA!T7X+&f6)t^$^hsIzmy`*m~qjZ z;oPjF4_Q+U=43UHC%6DMDNr{zCh8+!7~)m~byeb1^;M(V*+Xa}Aaj-gPljs&>3CW} zVdmSIXm`EaXO4ow!9Prd5$V`6$vL)vNuV%01Xs8 zAOg1Dace0;32^ugH;yx?$AmFGLUE~yq&lY1?8=tdusRD^>O6+A#t3zAP~G^t3V}$ zoT526!>mjN2G%c_bR%T~I*43YmT+(%5vw?LDP_baaRB8;VuUF=>8Tq0VezqPitG4? z7dRVwRI*9S%yHx>Bl?4Q06et`yeTfWnY)t?YU{^$4ZJnV2S6j2XK3w8;R(jWb1W@3 zDBP_GDK^w84iS58W4sm=aWRal5iZq3*_%j8kj%=^pff2%+1_6109Y!+E&9NYie4Ym z+Qe_DI<+QI2)1M+KX{!jXye!g{wu>6azJ<6Q_Y|N>#pZ$0Q#9eOJNGNy(uBB))K+LY6GCm^`g?|(m7?HoDCbU39OW+PHW2o0$v zqM_Wqm74zm25RawT)eM=rx>oU_){{Ti!b0*f(opQunHf|GZTF1m%(7hsT<(x;1 zW&4s+YiSD8E?}YY1`0uJSWqgss+r78*EORsl!r1P48c1M2jVPaly=P-Y&ke*OYTWb zyD!ZPT2Pe&QZ3YMbl;?Mj*5&!#|%R%;Z;78xpdmx(`VL4s)5!xpm$K-;!Y{feHkQ~ zHYORU%O&<)aI&ko!`mne6ooAgE4&qa!AQz= zH`W`LI~Jrb&M&27nOUY}6#Tl2B_%dd2I(LLZJ`=m#CDo!c{?5M2=U_%V<%+=dT|nS za?%K=I?Kt*+o(o?L3#j4ww(yQ;vRf5>C2fT7DP@gF(Hys)G?LDkmojCNI8;QP$?Er zxFm16-YT3)+Jpugp3hI5lTvb-cUIbba^Eog^gUq>4jgPB#X0OQ%AJ}>eYCu!mi^VB zZWa^=coEabt>F?@Eg|2K;>8ydC2q9gVq^eRq7JV(&8F%7KGL|;q;y~moC&K zQ!vT7C^z?p`)ZT&jz(@gwg(k1WGI{9M7|e#WfE0&%Qc)TRAtZ0O29m_6r-QwFX0lN zeO%S|8CYwR6fAHap@6CX0Llpm+?lL4>yA3$77wy5c2?OXHc$iw0d$z-&#lw`AIr?* z#iw=8^B$Rs{G~yed6q_ICK*eKvDG&nCYMmH?v?BQ-%*CpRZsd*$RHysp{r<5%^<_vH#6>a=UBB?s7S+W3InM!UD z>P^yAkUOH{#`;*^5}gGJWzi{k+CK>+;nw3r?Yaghh@%A~NL4>EV=lqq2e`Vv!ZVBa-QJ)*MW2#L5x0DG3Uu zGaci)PFa`_jCPLMtcf%>NlHK_65w{hT(ElKLg0%L;|TEVR-=mU9dEmk1caM`YunSp z8+Zk4J1NY{cD*tzL#j>v z)e)NCJw9-~8bsZi^r=~l1IJ>H?{Wi>+*!RVuUiV(*R{^WyaDrNmir#TEi_0 zvjVVu!&#kbb;O{s89tb;&zTz9kaCa4?2)aQldIu-y$JfoDS5&ny^|{pN4CEL@6;R zRJxZn-WY4byM zRpElBjKUJ|GSeyVvQc6k=<*g0irCuLxV%&3_ET3*)8?A3``Kxa+AC{R*C)?z!$~_t zuTc!N+nHBTmAg{_B{^ym!v5*^TXjD0PO2v98W^w1idfyXPm=1I`1ksjFv$#wr2ha5 z-~8A695);a4oiuYrk6CJx^&PMG81F^7eUumT&J0oT$YH`LotGMmn*dUKHt=nt@Hl! zRVDr?_g~1VE>E!M6 zDznE+O@9p&_lMj`r}1u-CnVI8yrZ1W?xxk?Muy%7)`#kbtWQ>Hw*-Nxy^h3uMzH)5 z8fQZXV!T6CXw#XgxWZOakfPdLDGE?cz*UZ(u`(!wCK=ohMyghkMVhYEou6Brqh>>C zD+1=k3jy)?#I!?gosKDR?+tKq*4UnMr!ZF8Sz0DmkO0u!Cia9h*DuiQU7Ri*Q|GW2 zF{{%lf!d6MSYg8`^Mg5M=I*eCs^v>hLAtdY#aFa3DZ<*euhX$%!cL`EOY&rnY3X2z zQp3tDHsSUOr3HUBb7e|QgQ{=tg6)m$J>W0r`4x5L{4cZY&2$~zt=jxi?!Uypk;|D9 zjV1P-Wx*!np>wjJD7hmse8OoK@2Qn4$1*#E-rF#QSACZ@x~JTEUd=t$(U(a_{4cZm zhnk#q`K7HXNvZORLP<|1u_y-3tMqAb0(1neCvlNL$5y76>iKm1OY}IYD*o-?oF)0! z(9@?l)VH&;fa6kVx};|mlbW3V%9NN%?*yHKoU%>w-uX-q<6G?eKFo2qZq>K^QU3rE z{{RyHLFxzzZeTl2&(B%X}5J+hjttk*O{@cNEd+v2ks0XqSgPbiG?O z*Y{tjoQb(6si(`O`KRB=Zt-;*i6b(JTBMA|9G;j3Y)s23bJDM;s*)SJK<(nv?29s0gW3n9&;J0<)kPm43%`Lc6zGs>oJx*c>N-YGE+-w! zXiYFyt3*-rN~&_Qv-+kN4q{o+;lKQ=$naX?bUAvBNMW%nT*;Xu)iV#L=7mF07bE8@ zjz=ybs3h(t9Q@}HkH7IpWr6okCLQ-s#(8Pv@5z50@s-22!IBs%DrAr4{oKo3ZR+5#HjM^+D*qw+L zJt8!^kHoTU2;g!+TcVZun1Wfrf>>32t|U~G(8{)d6A|XFKQ>t7bpA+wF=q#j^ z5`rdD!%90PYfvZPR|9Qz1k>ns=v|udTk9rKmR?&nDg!YC!sj$L+wM6U>@TriE}-yM zURe`ua+-a>+hGle$z(=b7i=E}J8XWmOlQ%O>?X4y&r z6K|9-@ve*NKM6_o`W>3pH5B(zligQO2yaG~D_*2gJ~4GO81}T%fc+>V@Qr^AzXCD5 zZ}C5gqk@`lSBO5w<%>=fg#)qEZ^k6FKzxU99dPzj24W*B$ohq(IDv8sb02p1zL1(3 zVq3KYs;IO%H(4Zd!qP!EJ>$N&Fxwj-KMS$U#t*8uQ9)LA*L4(|8yyXZ+enL&8r2L* zYDC|euTSF1aXURzMC~aG<{ZT-a1uS#lVzKGr!B?ey~Qn(rb3r$++j{HZxp5C8O-8T z18M^5DJH-Y0KJ8}T*RouNcNf=oJS_Eb6J^FFSfKVypocj4Z*Ru&LkpEHhnU1nyxCc zG7pR8a$T}7 znB0|-B8yfMGXaM|4mO~bq$H9EI_LrQiB>eCJQ(fiCg_vC#uQfLWo|5?NeVXoVZV@u zBWqz>nL|ojjilTx4f@!4-q6_UWI;7q_oUG-r<7&Sy48S4 zvA>1PIHGmP->27HmhLQV))k~hidlJ+QCf17cqlB%il>`ss##&g9#V)}kf4PdY!q}R z1rV_-+J6GGfiUGBewMYg`{=vtN|oOvToMT&TWbqL@K$t(IC7y=t+s-xmyTr+MfS0W zw4iLXz7jHtjvT4Acb4qINhec${ZF8X8Bpv+J{#e~a+Yph_E$wJ!{$sxdygR#$Lu8a zB3@0`3IRmQa-=CIMGUa?DA>NMhxyf#bXl9ZX&DR!l0W z{(VAP)6^JhNOlZ)an#^lI&d#Ua#R#S**|OWf(vnSdk`OsnCgo58l_26mQ1sAFN6gu z>K3;BcRQWp(lBI4A?>GPHl4)O1Oh&;kO4Q^`s?AeHIaT6E)Q~0J1iEiYDLg>xYqvw zD9_}HZ;nQK?JbO9DrFo-c9-2+E=9rf79t|m6BDsVF^3q#(rH2fLK{d(*FXTU7bY5^ z({F|H$$q+rk+GEkpG7Jp;pRlo{68{O%qS-J@G)@$qC;?HXC~x=B_2x-<~`*jK9}0p z8u`S52LlaJr)DN*S$c6~w50cf6Ru?6XziS0;aGk9TiX^q@+LYY(pDRL{#zVB)l78Y zNqjtI))uGKyL2f6J4Xc)oV+O?#DLPqIMWn2(<5fO2@Ahu+$bcE||s=g1f+D-OT!xK+UC5a&Wj5s_Rdl&-OYvFNc&|D*D=yU^OLEZ7x%$ z30`SQ_Jx%yvUgcfHVd|6blB+)<>M!jZpS0RLmwr{@9^$ON@p3?(j+FT4Oyg@BO8w_{{T3%uT{j(DcRX`Dv6nehTZ`x090hh^o>|snAqGP z<|Gdh5hcU7=Y0Iv-(pNMMOO5eFY;gQ@f1nMl4Z}UKwA|#aqMp!gu44++F8qv>!6DQ zt1EH1j(fY`&3*htYvsQ2d#@+d2_82}%%)yx=`|sVf~h&xkfLQKkU~<+>C1a6{neW% zV|y5TzMH8qNI`0od zhUMh8+v&_i@~eJ+eMRk4iR(nEZc*0eW+cL2GQQ5H)iWf0IMdD@Sl_3S z9k}neKRev@8mULC*_nAvi+LW?O?4>%O(1ua(@qUDr(%*q{IrBl5=(!z*hF1BUq3H1 zB%HjBs%}Z&ahGnDB|}FUQ8p=cA7m&3u8_l3_xHH#rm5`y_xKKu6%zD^Lk{Lc zVOg1Q-ziP*Qb*ZRPKN%lxRtr1Yj2u0_>qdK_)d5&_e)500+j~Vq$=lL@Lk?N0$Ja(LGn=_z8g_TTLG$5jed>wr^tY> z&K*Jo&Ngmswh)q}xC*>7k#4?mDhP4|dcqz~_Ov{c9y8RdQg~$r$>)&Wh4PcB9-D#Y zbb?Y*=19ebX$Q z=J|~sX`0AV=48~mlP{?y)|3D*r8_B4w{X}$;K8`+A~a^7@onZyl4*V)LvUBAn4({k zUzA-sYQSCg$wE?}b+(*HOKHE~Qi1ENBAkDP-^2DBwI%qKe1CIdy^7u8(`cD)m-M9( zuJVv4O3>Q6D>_1o>^1LZLVCm4pt5t>{0MwTM~zzb@)j6Rk9<1fiWG{aIp$X2NLrS+ zUJ16rE;a^GJhH;&!%rVC&-W|6=}T++64M6I@O#WOX$q8>VS#qiXNG3_>W3GcA2n+g z^Tj8(jV(x0a>LQ(Y?ei<2$pzlH98dPHx;xgp(AeBaR398AMh zhEmQ-V<|?-E;ir;zz`t(f8l>$*yYE+=qBd);e%;PQ;2q)lWjm!f7OL}IVJtq^=DRC zF29mEvbXLpeq;gEnR$!!@c2dF3Z=?XwdhsnnwIt;@V+kMfP5S;Uix{oD(M6J~Gf(nffC$VIY+@(lX!3C=;TU9(I zEQHLt{NY^d-!au`AqiR(o$QNW${c(wmnL;_Df8HtxI2Tgw8>=DFfJ#Zr^>8dw6>q5 zWv|sLL&bKs#9R^O6uEOaH>rIZ{EH~#Svh`d^%a$=tX$NgMAWT26r_xfA#5&`{jaG> zA#JPrxndK^43B-jPx%ugj#&Qyg|+^YYwKdW0%FOG2O^0#aGdonTIBx#G@5Rp1@$C^ z9%lalWCDDlNk-aUx6O!}ocD4~_G+kH(|F&7=kAo%nU{EITAoVeRu$kx%3Bxoyjx-0 zsZo|Ms(&rS{vhI_@byMbOwF*FXHw@ez_y)ikFY|)Add?jV*daHifq`$(zv>6EfFs> zF8aRca5sPJ3xO8#MMRwqo)xd6zg?M>Q?pX@DQr2DnwL_bI-rYY)2HDNP|l&xZo4S@ zf8}D!pj;F@&O!*>6$=nx(kV~O;~I>#!+{OAETtZ;&mlj8&*2Ku_d=BG`kRw-jLKzG z)2vHoHVJjsjr@X=yHG#X~`;aU|JlE8#v@Z9?)H@n!yWPtvRV_pz;b`3R;M<(MehgN=QB+#FnUMnG^dp zV(eRtC*7xE%ABPtO-n0r4!tjCfj2ysrW71d9tgM{Z4mOxhv18K!x*Ybl_rqwYEGj( zgbra2vWFHx)m*eH-`TuXw`BOCvg3~$xMx>sie4e8x`nc!tjsOdBrPZH27v@zUdHg4 zzQWs})#>gV@xZq*)qYI4(`i9*6M|X7fGh&SoNVdfMZtx}O&rztXaCoc*dDH|6)jVj zn`AA<=3aj)bwFgK&@3znYON3d2Ow;YaF*FHysamXlqsOEk=j*)?1maC6t4m6y>^4 zOsiP6y!1DR)3^SM`jK2}Kj|W|v3q8lhi8<80^_weoEmCxnF9WU@DVl=)YAA0oOF+i zoE<=-)81NBD&um@do<%CxNeYg%>XmppSF>0bs`ZgmCPcyrRa5;k(i-i`pRm^0c=e? z;UI;lE3J1{k}usi7TD{ob-R0aUsMg#_^0$|6SLht+FuVU^7Cosy5zI3WE+Om&Qz1& zuI=s9NP16pGhf5#Ab1w#Ub#p@pEA?!$~vieq)c6FdQT_Smw~u(Nmq5Xk#r3Xk<5;_ zLy%n%zpR!G}qWwVx9;qWy9BPFMPS0*i;R=2tn|aGHw-C}6ZcWsM1PulHk1Ioub@HL6 zw_h6>z8uz{$FmQu3P77~r!MN-B!W`I1(LCS4b-8aH|uC>e}m9mUZQ$&BZutN@T}z` z;RD$Xm2I3)d?@MnhNpOm7op!_N$P(VFny%mRMi@SwR^?p3cYz+!r<@I^cNLZ@f)g} z(}3bfBw6-}mSyE~wXb+9Gi%TgO_H*p2KI%jT=q!sVo*uq_F0^6nJ$7wF_tBsSO6t2 z6eqZoeQZ7A1+~zai<6nyM{kR7~|&Dnc?mcl{4TO$ysobu6(L-%&pk?0H6)JX${Yx$^K_x?fm}$LBmA<03vcuoRS=W zDi<)}8std6{{XD5ZRHL1Inl9YD~Vfm*|warOtB>Spa5=n)N6k&pl_Jgj$UUc6U{Y< zsP4?ktuCc0OUGTO80p$p9@8(J7{u_M=)s4iKDa7)!8OyYqT%^S8$Wks+g^LEPM|cE<**5Zv91f%L zdwy(H0ZNm70mcz?s0nRg1pSkxqHl?&h_4-?uHipt zguOjon{{Sca?iUbDKNsaI+p^%i@CtPz{;I`Ri?3IxYUwd`;nd}ci(Xl#OyaMI8iH& z8fr#)PI9E{EFmUdVL*38+D2yrh}~I0zgU?Jy7xmaG$Ez%wjkkKYNFyPQ&Yne13OPL z@?0#0>K&C*)HzO#z{&!KkoDLt%^X9*CGiTHj)ud%XQd~umQkFKq^M;p{I0scS zR8K%-s8xr4u|Gv!I}sYMD%Af-04PhQZgzrLni3)%*Wg=!CB zTDy)gw!_=1>A2JjZ{rQi74CK!Yhq|hRh5TWLg|P?n^<|!^Jz(K z#1#EgT3JHMB!EC3dc=7~htt*c8+Q z9{&JFDyt%5u%%KSmq2;6r87%-1*?G~Q|alKX>{t$ znrEe1Q>b$>3!0Tu4yu)TL>^9;N^TYhj?kTL3UJlB{$Dd==Oh4ke-yHN^w51?NbYKPHJLd2~wq2P}_kFAFUdD z#b9W@_d+09FXk!Z)AC=b*u;2I`b@);4x(Afr%`n<>Te}cXr10}+B_|y>e&RQ+o(j??m(Jx z>-!0w8SzN)ma#ue#ggvG)M{_E`-&+^L0Sc~B}ghtlC8-Eo9aY%QM4u!r{+nl4Tuvl zQ^iPaS(4>WLF6cGLYqMc;si00Hop6hW9RqS>~LzJv{dndBOR;v94 zMNQ46_ohMuY?6f`I)kyy6iB;x*Zb4V^3|1Wb4dYc2fUQ3`dEW_g`0;{cgc@KCXvEt9kY+H z?7MPBO8P!zq3~0cNo`8Zf~4O2ToNuX6_Ud7z5K~h$fd|*J453Ku?8VSEQKw$rQ2z| znkh=qX>%4FEHuXZvb%`g(XGSmdnGFJ*r>1^T7InOP0ALNt@i}WKDx^4sm6D}cWhTiRU)T3SXy}|x0;8EvFcOYo z1!y+NNU;Yk^jC?Fv~=dx>I$EzuAx?a3Ysd-sn8IcBqVEKIu4LDcE_)T4Sy}C1Hgq! z)0xiV!hku{Y>QuWfB0dkMuny)`13RTq^rwR7655d;OIdal5DMs*K5H93~r~Tq^9KF z3Mf_6dmj|<_Xax>TTih=>;6KxrgWybMxiOgN3OkP^G9Q`P^68 zLM)Ya)RF)LtZ?YwRF=ZT+bdZOyj748PF*ZE2HgpcfTW~V8Jwp#&QWbyLr>^HNdnn| zh_<%A;Yy+yoj}S=4%kQJl)DDOZY;q^S;fQc|Rwf-a$J zLKqJo4V#|BlamvZk}7Svl>KvQQ&tMxtPWu#4Y(^f4yJM|tgQR|JFR;Co&s8UVt zkZzN)*2Eo+w-9)33f7Kj;=U22IKOHL3O!PkpTG!QaktP*nnHGev=#(mRT%tu5NR;{{S{Qq%6RAQBtc5{WD8y{ZQkV{8JsOIy94b zYNsJSf_E25Qz=OTTD3D#Qk7-2km3>()RiqM z2gnP;l6`@S96iKZMFG5x%hV;+mc_;5um@!!S1L$c5Br5+lXqbEBcgQq7V{3K*xRBCp>0x zSH)`a(5VUYN^E{{-*$=58H$AG zhxhBn164W~=BuCI2fIW(W^6ad>`d0mPrx7J9QR~*#$jFK<|tA9F+u%XkKYHoqrNi) z@$(d@Sk1ZfSMi1Wx)bBGmp8`jOzKKZ^VU$Y0c#(=60jsI#be9BJW)T38=RM!b!#nz zEd;3CT-bnbv^SR$=7nR)+?)Ic!T$it3HRH0l_9pXo12|3K^MPK5NC{)8I{MzMF#2$ ze=1VxT8SwZ3bKx*4KLFDV~riLzh@jw$rUZLlQ0>ra1Ff-CF4v|n>enz?k0Na%9RoJ zZZ_)%nhUa2aA%Ad%Y@lmmYFWfIzwTn*0rO(r*vEZVjf-|GyX(~W^pE_2JJG5(%`7e zWL{z%TLR#ycSur7uldDvxE8s6Ns;20QT4)-lDPQuC6pH`>J~E%3S1ik4xsvvj8@MJ zgQkhm$fULqA4H`~3=x&k;AGpby?$4SgrV`md_{VnmQHh33nxCMD+54PbMGF$CL6A& zY)J8c0kr5vR#4=!(ame@kTz09w6|DPWO1R~q|5}-(y*W%x{6YuY^2{1$D&*IrU%45#jo&oIB{v?^F>I3R z3{44@UoKJ#OKRK#g@9A=xbuc(g~iiD(aM^%bU1a58>viB%DT`?Y;xUc#0<(PQbv1_ zO~^N}^6`%3#ib|QOjL`aHWr^@4tkbG+W@%0x z5}g`LgY6^%ouzrE=`qzdj_I?$j9oiQZK(o1p;yWT$9+fk93Gv1FpgsAM^59KPBCI? znN*c2lrC8-<)v8^G`SZxP(Nr5L^_j&G$E}+fkMF4dOVVhlWmZ+*)F62ubqJg8kF3* zib}Z~oI8@MP%0^Hnb%yEa^z=OQjnqN_k5vlcjWwp=aE}vZF_S8GQtMhh_V!i$uczY|82H^wmi>yXyc>hxmvMO^ zQ})DWC@Atazu-(x#l&k@R6@yvPnps~fqNL48Ky;)8Zutc;Dfk%F;wpUQQN*Q%h5{6BK|SH%MXe0VEsIRgOQlq$NlS&b zwb4mY3Lc>8@{Xu94T~RTBUpDxiw-4oj*w{!Iq&3Z_c?Of_x#~3>50lqGvqI24MNeO zKBuUT)ts|_R!!M$0*cf6$59JPjx(c?T@8#VM0Av$DZU}k!+mypq|~ zNm5XxsDbuLNVHk1mp)@Ib<2?W)3~Wh#^?)?cf3WMWx!D5YU-6GKpi}F5WN&7&c%lg z(v;Maf#To%>;@l)GA>R>TCqr{$Ya@Qqc{Y?od7Y*R;5TH*{yB0-q9$A#RqMLu z-YaaaPWJxny2bW>Mj3Y063fY&N|dGKkepaQTG`%Ccd0vs+yQ%Qn|R%;{TBN9 zGDGUC{OGQa{82geDM@xyGKDF`$uOX&5Sx2NE&ao+AMgiq5t_pKWh4PtZIj(~i~WTr z?Q*uZeI~m7ok$R-F#Q- zg6^7rP@jMDWz@*b>elROiog&<<7Qi_d>Fz+AfhY{KX=?)ZHei8&GkzwasWGk9;kX z<!8i~%j=1T}FN^2~a#hxOQ!lE^QZ7Qku>~q4PckA`i>@w+PZpNE$wS3%FHYe~ zYt!;Fq3&B@X;PhUDF)i*3(iN5mx`%=CQDJHr@#(2CyUahN*|3U2*C*DyXx z0xNi&dKo7k>dyBXD^+?thdPdcj=Q465_7?3bsuL!h*;$*PFcK6GorxEXHxG#_DRWFc6OJf;td|iy)2EQ?N?MbATm+SS$^dC@ zv403`Rm&r?y*Mtan|QhDqTIq8bj>L)1Skzqqt{@3;nt4165Fx{Jf9eOXmPo>C5z8w zQyDZ+SHtCxRzTHE~6~Eh?8)I1UWd`6pXr*mh&kpN08Rq zMGi!?wYQ;V2|FxamhqWowX0I3B%e|vF(pr8;xAw;1L~FO9fI5&I{ZGeWYj-hQ8oe? z%}+=sr81I99EaRc^&pSm5#cY)T$kim{w)6I8Zm`RVtx9T{DeBEECr2}Z}$vr_T-5E!g-cbjN<5o!0>N}4Mi?VFc{{TdPXvPGB{4@Il{698Kk3W(ojus!z9RC24U%n#5 zb1xzv%1IeaMuh#9%_YPiE1Qp>NSy)%*^jnd-?7ce8<3+m#fa)Ui})U+V-IQP@EB4g ze+yee-kRkaBN~d(JgLrsx_%J zfRKc^QL08zLP*-z+u;#sl`ce><6XaTKR2=qo zxS52d=J{ha(S82_jBL1Brvzg-*u6}Qn9{8~g>f1yD@h411ziWc0(7;m2qUQRiG_3I zNLnT){#iPS;_~0jedUr=HQT+Yw}#MxmJezgsF|lrG)=;gtvunjGi7|xq?=()iOlI> zxSnZj0_QIM;*e|#t+n)qn3hl6X~k?4Jx`OT(Ilo+#It1soRlD}t5T;5cUPv73Rv4@ zH;ui>#V1on4RP7PkXr<)2p+xL!}VkOb!=>5ylio;Ni(x4Gb9j&A+p))Uw!hTB&(O&#AO4#Ah@doNFkGg(7jQ3xq3S2{SnCW5U=7lcro9gGE7a)U0n7)n&)P^APbVnFNZymf4K5Ej4098ZpB=3Q!K z;E?jtpxUye5zuB;?GNn|Ld50BOwjQh^?tD}L;6mmEjsh5K~mNV1^T3>=jRTk)M9H% zB{8L0`5N-5@4BbeDK34ebf5$A4+RtkC*-{7NY zbqTYHL43P5OMvA9?O`O$2^A_VwJ%(9!UZXH(9YPco z$`Djit9{}u2=Ts;m5Z=_9LPFWgyu;KNeW3ugeyy5(@1hLp~WjAhX?Bn zq?Em2Gw5v&FlCl-CEuj5Y|~Af@+Ov{{j0=0u@@N$H*s6iOIetCTlYXw01qGxLzG9< zga$muPGSVG*iwobbt=@8bAK}(NGw>+V)mXkK{vIIony2IM-A1Kw42<8UwGls#o^sv zTAw&ejW`PQ%-I*em^+Wg5aVLwDm&at#WJ+1DVFA&e6Z>Y7N$}bw53~{5;p$;aSmgK z_9{{;=MYiw+>Gl9rkTmAcJCqe2Hr}E?_{vZG}xWa@oKjrj=efu0O!XU~qeF@mz5}$+B zK&m=srzXqq%QmG<@{QGWT&P%$cGJtOQ|8BSV$&1YV`>e?j-Z-sJP(o*q^nnr)T2%_v|anblc(pEzn9#&dEcl-lfK-xngH zXDvVjpaLHo60`;7sLy)0{%my}Vy$k+QNse9j)^f9UKWIy3hfF)OhtE&f#%-jonaGJ zhal;QULi^`QON3CQ!^++(VZyFl_5gK4htN~>IaNaaWL**@Y!o_Xk(^*{D>{(93r-t%n(#(|MP84(Wt-v_`*ZXA+}f7G(-J637@aBQ%$bJ1sQprv?;*WA zjh?6*_`%`)Js3VB`gEtcj%Nf-Po{OVGTK_5aW51hf)dNg{*{eBt-?jhwKvu~;kVn- zocDyQXSbhEGj3x6PSiQU*`&CMmN_#BQwb@0!okM@9p^_y?|4$e#QW4&PEWty!DP5| zIV`qRspnLt7&7_F5~Z!9_8laBU>yRlXzzmG^f>sq^jzKZ>SC4Q2eBeiDX7jT*p{Ws z5JqP6Zh)+}<@Cw!+e<^92i*vKXFZnu%#(Z{MDq)mH3`JFx5UMgQk;&1eC_vstlv|X z+n*B(SS$Jnd}os7Mk($N`(d8VKQvQOLQ^!J=2esn2Q8Mt-2mo$#@oV{FQ<@?dh+GV znaq2FD|T#7{VPAt_HSibQjk*XHn2;;r|T`#HSG%UtJH1r3$T-|a4|S?nA*iocnWe< zSaAzTd9*7Ewk2oG5g}ZI%zqBP638}_}z*FhCxNU1f51B~R`a<4HEwJ!% zmhWZtBDOM=pW-HZg)X2b5~SU2KA^U&KKfJM0PGT++HM3_&noJ_a{d_URB3)k4nneM z=u$BqDNC{qotF)|(h=a6)U3@X(Ioj^(H~B);eNcwH8st8atVZ~@))2k`YhwJP9;Ml za_T *I=Ch19PVkb&nMl$>^wv#BX^H*2p}=&iZ*%&e^Bx=(%92u^PSFoy`w`z@2M zo)DF#{{RbV{q_>=E$RLCW23-41BWr>r1X^2DsU|K(tfKg$9X7gOo-P(t;VFp{7JcQ z(~(KWPfT{?&K4>D=RO^qO3fOnQ;<@P@)r`OujmjJ_{N7EubN(lPb8>g8SLGNyFO^9 zW$S60c_?Yn=?Y0ZB|*S~oA`oL5*{U!$Yo~ICu%?3^5Qlum~w19%%g8CtTbn@%L+FM zvOR}(nRt`(ZqTm=x*YNR$6AT~%{rv5Iq6!} zYFP}aNm*M-TGTTBy3hz7AZTO00$b2{_pqwLKisULfF@U7omy35+U1H<>#C4`7KM0T zM?7KG!JUOLv_(v1<|cRM`f9dYtiAb<>@6`wN~y2~TvNJBX^{ICVeb z_3Byh{6mi~x^?YgA$snvm4ma4Lwy()l`)|wSIw$xIj9mcovykz)}3Q*s6ysK}> z)nMY3wy3X<+Z>q&*r=;2BxjM&qs+?F~_KmnA0c5`76PWdQ+@?YByTN$+@UBS(g9 zbKK46#=0G>897qIwaHnDFRy-F+0JX0PDLA8Yf%6X4Rnd>Nusr?W7&`UDB@lsRF_a< za#Ecv_js}U;oJ_?fKjt?rh~HJKnww~DdT~q1?iDz^={*P{`uW53aDQ-z7^;{yLRt456OzuU zXaVb&d!7oo>9yghVp1Q5R}uZCapsLRNtvp#ooHo4oYkzfDCuK;52!H_z?m6Yz{EJR zLmyJ!nci5-t;Ft?B!O^28xiFTN`k6bGRa%h*=~i+%}F#?pppUs%%G(pSZjL=!;aa)4B#2X!|9kRgQ)?fDWlZA;8Q34OZ`(j_Sl zv|4;P>yt<%TsGMW2?uWatTO|!JH!n9+w&%3TYQlz=ro32n{rj*eq^pkQF|K&_jcD~ zzm!K^yuVRXdtaaEF_<@p&)}SF^viCk`9~Ri9QF%kYRbH(=IctVN>(%$A|LS+Rn;~n ztKYpI!`R9COtk#Fpphih#P=wRW(28C5^dJRk1fO^3hTAs%vMV0@)SH8k`-JPMVLtM zyDXOp@G7|j;j}9>bh_-{&~FsAZ{&qktyNSym$W*9zH(7dXoG7c2OUz6jjRQ{_l9F8 zpVRXllr4X{A*Ll3!^P9Ord9{QxKHLHY(Ha@=1z%OHV?o#D&P zp~7XSB}fFTRILWW$4eBE>*KsTIBMM-gtn$w1hcg6ERSfEN@VISDJYp_lAw_0sahAJ zNKpeVzjQ`%A5MnT8_E3^vr(E!lb>P4hr+?Lsc}KHzJfcd+y??~6b;RkF9$H>EqF;v zMC}Hz&H-$qtkRqtrAP zHjnIdx-%*{ix0Gw5wR(3f_({xW4EX1DjVO#F9I~h)zSA`mi%)VT)8iw<|ij3i^9rW z%e3mnS#2yhy1Va$kVi3;n*y8e2BzR^Yea0#N~^LTTRMG(ClDQb5J|MmyNMFhGwhf4 zH%ii+mOU)3O||I^>gVzO1;tbNFV&AmF2nx-%9mM@Dj~Mk+lxL->H+mtzERmbe|-iZ z^sD>a+G{{S!6j#RB0 zUT#8etc3?(o|Ju44{TI93key1$QB>~2B7tapxbKx_7jm+ufAhVz`0jwX=UV_8HzPB zVLz?PP;E*0f-ZVQjI#Pa)M_xl%jixS>O8g*k*GY+cbvDToFtR=tFb3umjc6RLTy|4 zv5(?ud=UrurzG|unx!szlD>6A^a~x;4pM>=HUubNUZnX&w+%L|XDm@2Xf=794&?41 znY6|qdUd&WT5)`{D!0aDmfY1uw|{i$VXcH)!g`SlPLPz`G`Tiq=jjtlLzMfl#Z8gl zX~tAiQ83n`$A0)IAd4y=Qae^DDl_ujZ<%Rz70XevQz}RkF6$vzNEv(9%G|r&2i`Zf zqd@J9?wQ9%1ewG5jjDZSSyY#*5|2qCZYVh}r73N#wYK=O7LpR7VnUK^6>Er4tFeRQ z1tM0i1k9^Ra&_EAS3}Pt>UC)eXtLf>dxDB-1dKCX$TF zS|4OBCBzY~M-ntz4U{eop%RUcMpR9T&M=|kTGdLcDK>@EU6hwI>9Gwshn(ag#VFXJ zO`QoAzRI?SAWkfojii@zu`=yZ*)O77IngeIo#hn&06AeQ9?YEEfSlP%fj0wKjUr4^ z=lA9jieSal2&2!Hp|_fS+4~X{T9*k6Kq;}hmb8nfTMaLGW$ZiCZz}nT`~^Z7SsckZ zqPeL=WlN2a3yj?Imf{WfMUqmXa8i22XFJ@IqqROlm3W4ijNe-mR;Sg77jy+FnScgv z@>67>^(1$Zz3m0xGpRUo-FE7~b2c)mKTvI!sx0SmEUhi~?aTp5QdG;y?zo@@)0CBT zQgw+Cb~NIbF8=^~bQxS)hiY{?Jlho>Q{1V5nu8%BN-4@vhY)lMwevQu$Rr4`iCs0g zyu`S%IKD*D@#QpBsjByCvZ*G-Y^5^D<}{(XQcholJfuf(BP}-yS2zhUSxUz*)oN6!rri}M>*9xTs`O&+My%5KkuuAv zyNRK)^JngD$clDeX%}W)xHtoh_OiQ8Ux>1`> z>aCS}+*?s&9LDstD=N6Zz3Al5$}x_xdsHexGE)vr%%)kag(@veJZ1_K6=RXc%0g9p zWmr1IrINhf{{Xoi<7xIuFW5`t%n;2*irm``^4z9R`$F@ilr56d7QDVdrAZ`TP+`X_ zITcj9q9#_jA6vn0ivAo?Tghps9Bd#Q%|4vu6sVA-o`TmMAuZm_?uy+E+^!=|KE*A) zKQhi8ca@Ml`$~1BzMCWk1C%$PTNPO;+WSJ|j+JvGw{NkZ5_V~+VQgFUQ`I(4wzS;C z6OFJOL&fWajDch%TpsoE*k5B0sZzef4-=CkuNWsQd?TyBNqN+-lB)+fNk(zFHrChm zF=K)&BC@|K(CFz(gET6PuQ&8?Zhi z>eJI`OT^Bm1jLGFe@ingJbtym+^FY-&gwOb5^RE(DiYuxfyCSJFnBEHv@PqrU2>r) z+=}Xw;#H(232iD!(K}p$bMf9g93DbmLAPTPNV?~CqRVRg*_EfrM|>C9=ZL$C_bcdS zAgaGELGV!|dW%Dz>?g%X9axG>xNfSrCYrNGda z#Gq`px9m%V~)PUBRY!adAV&WHDa-KFL+?8+%~ zZKXjLGR~BsC@5$fRgx~1?R9Kz5c6=_HzecBs8ROBeaw3=B_l&Yc__@Oq$FFG?d(#k zfpRn&X$K7sp_PzoM}ZiQV2etWpW8+M0M5KwtWA*|(i{m617ddvePzE@gZ`8r?sLUE z&30w4&yMuo{Wt#rN)LDPIpP@^?15BK?@ZYK#lJN|ycTm=+>`8QJompcqx&qWUy(82 z0kfVUs+H_g@%N_P_)Dn%`0s#o#5YG{1S8*@djA0PF2CakfF3E)Yq1z}-I{oh`5>YB zsyOh6h;}7A5QhEfhyMWPn!nbD-VsYF(NAL8cF%qHi1?56TKgoSvF-jU!A3X(ru^s>EX$L?}Ev7pq&q`w6) z5=HaMA4#wI?iHaN)XlNNTn5B549tyX|d@viMqvIk!$?ZMMB3w-h-RCU~8}3T7~?yD?FHuV`3DF(ve)DG389 zPH;w${x~5rke~kmlU>3IPu5MggXHdS$;g(mp@$>Pc5cCJYwbaQ*0<*5FT-DKPNSfn z3}DGE3J||C`bYg7h4@HIn=yZTj2kY0Lo9t}?f#rNppe^a^02N6Y-Ljt!_sd50O>-s zp)Ih?VSE&&Ncz07{9}rPaYZYOFifcKeI7iEsy~gRw1Un50Pl-~+0+Vn z^l+c_V5Amv=6JV)!5PG;BdSS1x(f3@euITlUXp@Qv3 zb!TA7AAvDdl@nrBCmdz(HF49LK2E9`lH7egh~HU!xRj3o1R;t-zk{<<@>P}*KXAry z95yDv=x=Rp2xE+%7>^IuC?7>izOeNfQ(;nzMY3M~;rD^D`$yAgM0YsIdsxOZ_#+X| zIVMh2%r7!Xx=1HuaBUM56p+TMCD#f2NmGN!TaFrR&X-UnNKy0B-#Cw(gx0%{W8yTE zj-QN}#>QS`7G8a~60++`A6Nm~DAN9##&3w=+#l*(;o?(AR;255D{)Me^K5c5uIh=t zz^cHJ)5a@a7Ky7OHt3b#?}tS!D(uf8Do-VS)e?iy8v;$NK)tty=a0i;<2^`yI8P>= zL5Blxj{9Xv*Kks7KM0SLXR!Q6*0UnhuZedxDj_%9e@G4y4~;#Y8mp~tC8ZYy{{Wmc zlX2je8w6$^3mW>xh8*rHh?y}d4Ic)$RP8zMWiv}+XlE`s$vKb+?v)`%*7+E7K2+88 z8^w-?(X2T)hMpB9XP8v64bPZN&G9O@SdM;3+$#+k1<|877|Or0nO>rlqU%sV!M6%bX!cVs}l>m%fnQ4heik zL2gagSW|qk>XfyPxsLb!){fcJnLww^QIJ&1(n5430H;7$zYtQi{g9#dRnq3yv<-qB z94U>_LVr8WlA95w&5uK12_KXvO^O?CEb!%yFS6x9IafBy!jqAG{#g4u5Js0ejp6J$ z9yjF1GGkIYm?m1O!X{gGRpl;CZD{!cMWA&lSk$RE`&*~3k=ajMzD(+cD&~hxzA|D= zE|jgbB4sO3w|yWi9ebw7Q_>ZVZ9a4&c$B&iHVW-aC0KPbl}UGG=5!%0C14wMN`gXF z@Fpk6h^23J-7*BYTjWXl9}%gQOL{m#3pg#qoA6j3QCj~k`OMd8`y7iZjiqf3D9%Z zilkdmL4B~L06;1LkbEy4S&_$#?6We7k(mT2c!PL-O2%5FJ>f?TYrVAIICM?aaRR9$ zGpw&K-cFjBdrvm|W=0nC|s=`-DLm^_FE5yr) z5`JR)k1-vKM;YH~^gHgTA43it4pamHU^6N42jd*DF)8%)-U|RwwVl5x0K`{^- z8>28DnTPQZ%Yf>cfX}+vxItHyqlr+fLQ55J&WFT{w^XOL@US6eB`Uw|Cn|yX#E6L2 zXfQe*=AL)`X(k2%ZYHSsvOF_hf!!)lxCu1 zi8|Ieoq9mARB6g|oVjf(x+WBqWp%VJ*3G?+*A~21@xSeF;#hFM#7atSI!(DLc4fJZ zNK34lM^qKgr9Y_UJe7CLWRfoDbOHhHDQ|Y0s!ycXZzdQ@O{Gej zOHDm9GMtlA=~8(WRzS)hX@28x1oyHhynWNq$9cbxPLf}_&8oR1_I+UcHPw0YHxd-+ zLfU^Imbj6hQhUud)nvxQSbg#U+9i-rV66n zmwI28iI1$P(!z;a92%x}O~IxpTpw6Rov>8Q%{!BpO^S$+vXBka{)-0 zRKqUK0m*7~*fCLH6a3a-d#t`T1y)vT+p1%?*UFRV{F&NZsny$$SikWu>*2APHN_mm0X<4=LMc*Ps^88(x)pc6&9zVbGhd_nooQLO5=n6= zTayCQGRY&AJevXSGR}LUcGR?ko1xakskQ6Pck@rbk;?P_AK{l+{{WKLZ#Ht~=ziW2 zGSuy+<%*FnP+LOjZAV!-rjNQUWb+mQKKA>nGt<{@kMwKxXCK3#IN$rIztIuZ{>+V< z*V8n~iKf4vwQgEd6H^)QOH4XimM$H#l_uq<2Tmw$*%pPGo0=yHfS7 z{XbMGC2(CDtv=FSq)yN$SE6&W`B%3E_)_tTihiu3vo#|bz|Il{TA zg7nn1+b-Q`ah8J$%%gP$pebJhAvv-sRd()0jDIml#reg{(P!3$6f8@*Wevf~VO%@5 zHf>G!$Llq_Z`NU%$N&}=M7@#=StmI~?I&1Myp%FRiMtdmbAZGCqy zDiEB>OLq!6M?!Y;yl64RshpXg7kgWiAWJ?&B@XjI0>LI++vcrJwuff66BoG$I4Lxy zczTe_g}03C=xsq+PI0il-#sFyh(zpc^9!f7H%x6)9NDul@3gvHB%I9mQG4aKZ2%hl z<3EvX{so*m7Ue`p63qVq$u#~^mXh4MiH^2@tolbI%u_nNJUQi8{{STw5}+ZCe3K#P z<}cCZ#U^~O9_za%#wuQd(q3I9HXQC)P zquGw){v=F@fl_2M#HpM8sUi3*#qaliVwXRWG4R6w0Gzr103?ht5m|W&9LT5IuMF1YD|C!Q zLzjK`C6bLnZQz%yY6%SZ7P|H>;@ifIR7|XQEDgoC)Iw_Sl z6LGd`5jp?E`Vw^atJj&QAOPsT7r%-(e-{B0VCrGWwm^z<^M55%UQ7|8uZEI;H z6}0Myd9nc~eUHKrrDq&YWp9UdSxH8mepS|4ngq0`l3EJ`a-8QA?R@Pd!%-_ zN5lDw49c8BOUokR4Wy72((2pyLm9KAyBC}vv*nUoEBStp|WhR{9WU!npDtN)9WhR@0tVWv4>51So4AM0r83hL#};laQQB zwJJ#<`C1=<&P~x(w45-!N?LkNwY;?z0uTuWK}1-cgifNlvRP6%KRD!?6ELJQ;2!0{ zBi6<{q-nFOgm_msOqg4bC=`S$$4eW7wTy8_!rzS zAqk2p?bGqy4djaxGS+C3!*XOUIaB!(8;uxEoIi?QtWG%M7;yl18!EBz(&tcjww8-* zc-uy2CQ3VWo+x4IRx-0MFycn!C1dkV;&gG*0#g$e&d_u@Q_EtW>)tt(q+8~gUXePE z)(*vz_@Eb2DrJ(8R7#dqEC#yRM-HY%%xR6KnBls^C~4Iqs<2S4ZFLobKi<&gi%3QA zgBiA*eqT@kzSBo9OP0mJhO#|{qIAjPG@R1Pmn#ZVtVQ~h#Y%+i@R8{gO9#Ijh!s4_}O1gwF+SU{`%93n+$QnZQ ziPUtc?M}E`ONq*qs4C}sh*cc3zl&*1zb`j7;!BPe*0otS1ly?{OfHTlAYH?9+-0Ch zu3;#Ym6r-_sdn`@2IWdoAnJYsIw?96Dd6rF!>Ib%rKNpRmot7!H;xV|wn@$h<4Qjd zDbrFc%oiAZ<{8^wWSu(LgAC-2ij1q6x1r$*9y=?W3?=(3Dwb5Sub?Ani73$eklyjK zk1K{L;d0F-v5X^-^i119Rw#y-A7(RRZTT)xkwt@TSpvD zrYSJRT%bKRcUmf9TP^Y-f;|>N%))UTkv|OI@hJ<;L z2#FD5G>FROK8M0t1({j4(K5>%TO=O@m||O&Sn$)fGVNn2m92Ql@JyEjv)QDhP| zonl4F$#Cg9CES37Z@k|1C1fgxIXM(=*3s`Vi z4MtdjlW*?Vuj+BT^ZW8F6-ivk4maOH*-0Tl{6t8@mtqb~dzxxiT@IeHF=ay!3lTI* zlPRcF6kI?`3t>d401jTa+8k3%L&n!byxt^{eOXa5(vN^pG1WEPUVQ6imS!%Q`2xbzf=or>+BaBisTWBwF47exEcU2igqBt%OoC?jcJRiFqi%q9I-gj}$KOcqe>Nr5EWO@Q|+%D%#2k zw$OM-JVT!<_?tpjI`~3-BfcP<$B9qTGl5zTO1Fi0M?6tcL~MHt1Z~PsC30S>>DJuuz zeGEpP8)B9~ym7$znzdDCW=>s)nr*NKWu+%I`@_5lAoRZ8u*{)Aq%>S8ltjiWomEan z49p}YwYHDh&2*I8a0a7zjhpyray-d*R*+%081^;0E?p`CJjIKUFYd1Y02r*6+=;OZ zRux4wfQqW+QniF;TMfCdP!*+#=xqp6Bt{nbSr>Snfw7Vn@=;uuc0ptU)1jo2lhCLT zvws1vK@NDat=H7G;qW_6Z2M^%`S+^SG$v70)V#;^u1YK+#UP6i5WA6o6r9Il5Y&_F zUlT)33CD1T55!KTZ9KYU`T!$8HeKLGz#(M`U+rrO@h1;8@?sn#FDK|I=PC8ucW8#W>0C ztISJHF8)L1*`I?I*rMZ|$CYkO6e{M? ze~8KD<~Mvzl`|=qQ2P(IuabmWVj)P?;njKPv7Js;#|dpMv|B+s0HAMS>lQeMByqc0 zyjW&HgJ36E{8bW!vDD)X%9_HjsV7q`f6b18)a>qgm~K-28c+G607F~Cr-Ct^Tob=5 z@-PW8@k0|!%3~^KXA&}@%iQcVj-!m{cCF%6wN`@kyq0-~93desA#NS_IZ|!$j@51) z#SaO%hOtMN`iIck8ct^%X=npWeYArL8ffKlBecag12vu5#I~)$)9?gq9CU?74T-!T z{m{HOSs|&HrOK~hqN3gW?h;ZyF$*p<%N#a|1y;p4UyHJ>t>@cq#COYc~wT|3PrP)(uE&TlcD%UbhuQ>emh+ssI!!%%}Wt< zrDLf|hvf>74MJXI%Krf3_7<+I70u3xdV?$_4W?3Mme#c9z1BuRphns&!Y4x-imx&x z=c~|UF}@?4#<+cGuDBeYZmNc5-F1|+Fd6&8$wH5v_Szqdu0$Ea$rCZa7O9wWa$ZVd zMRO9lid2wFmE&@6{{Re3g!d~a0fFHz6_vxZ^36rGzUzbQ5?oNoMu92Htu5ueTjOmI zWW~=P_338!HSkd7QB%zOOrQ7PNSyYu@WhYy0)*#A7gb@2sCEKWB$E4*ebhhT* zY@o=@%pzID9hKj7gzfOx#v)HPovD)H3nTh_KjUdB2PNq=#^>doQdYId&q~hbP`#Cv zmlnM)Z>5J=jV>Z9sUc!)N6hfs5%Be}?P7~iPN4GFDDqG|3Y-Yab?JR#Jo81ZnCvmW z!=r%spEEei!lFwK1t*i8JglG#1f&q1BCjPbMEq&KVw$7GwN{p&Y;h~Fw>3F)0n*_< z_vZ~*?NQT|TBehkpRaGCn(zMrX(H-L@=y?##Zmv!nblb!{dov`y3OiAO4tm`YR2bI zv5DpC{{S;z`yrOY60>+pl_cRvA&S)US^K4Du5`K=3_uh1fe2WrVx;v73ueVeVr zDRrcs6DoifR0oQbci7t9Ay{SjhVm_h1p6{m^T?N-QrZqZF4JoSB(=?_%OwwYzRqwH zn03>5a$EiR2#VNhmx=0lT+C4_?Ioqt>N4)s9&H4BV@SJ_%Gcgf$Vpiu%CNSurn;`H zk;uON2_@Of9ZO=CWf_`ys%`ma%G_~7H`P9+6x{2W0!i=!Am+!v-^7`YdlH77SVJ>w zsw9lFQps_&sQr+FMZB&7Ht~oy{-2>EO{(+#Ma@Ez%;9dNY=;oavmJp#kaRvaCgS^R z;~n$+M3`+~eLs=RoWA>*yDj2} zTEb0AJTnOiNf%M$mFDhK^A{U$2Nlh~F*qZ#_)z}i8fwe*;L39kYIW6H?4Yo#li}fi z9U?MYuZ#SLliB&=J zp0Uak?Gl$lRCcj88rWvAg(+9ch^h_Wn*5oIjuqu%x;*O=;DorwM#0>vYf4ErC&XIN z+$T={`HPM^`|=ai-W^QgED2Dr~j^&HZ2 zI8BR<6Nh+@+E$jQ1jN@W=Gm4Kl&2-l$-doh4!Y&ui2L3AMBfGYfj5TK#DbH}OVbYb zlut2g=CqAI_V?QQL~OCXL+~9=&^YpMhj_hHj3|_eS$5RXxkB?ep=BoEAIwK|DQt2w zq>MP{i*j5o#->|!3Mf$=vD3M!I+L_U@br?R{`!la&(#DwimT5ogeA{sLNBGt za|;hRCh0Ga>NPcM@3A4cV@7tLO7=OX$`qHTkW!(#ORLJEeu_y1c^HVlR(B+~za&L! zgwb-N^fIo7<)@J0wZSM$LB#(6mH0w*()g0D_wprlg?XjETuOqui9rVb@<=KrK063S zjJR#;YkM*zYmC%gaVSjd36^OGMHds9cJS0*z-ys}$C~r~gg@bHv$7ucj9;^2M-8-G zq6hg#B}7~~A>iOMS*p{&tt&71pu%52ker{x^A)pI)|jC>`zj0eDYRzGt%_C>r25#K zh>O$ahimbCQxht~&eNspj4;xKvy$^_O2@d;LrNhj@VQYrM#ETkJpE2iO1JV5bXoa1 zhj82Sqa>WgHMTU;$mAtf(@TXS{{T2#xEYY82p8Jn2r2ftC`50-- zZ<{#?ek<}sN1Dd-SgBHqokFFTEr?|sX}1AFf;kFKfkyTu1zc&~2drD+RrlmV$@~6f zT*cJsnabk`f4?p%z3geU+yi(C%3F>47@`4A<$`Tm6V;r${;l}v7Jw$RHf zn3yHCp&BnQc3ksG-lf-SZP3;D0g?#IbBZKBlvy9s=o=A?E^POFOUR*RGSiA9 zzRR7*8zZ_?q(;e)R^*&>t)Ix276GyLgmbq)dS6AC0H`C|CU`kW`-$fPA?orRQQ zvUup6rGKBH#lrGGL(5A_@^eqApc|ZDxce@wn>?|y!hyB!ETL`8LS*IFx7N}Wvl0?) zNVQ3Er6#PE8IduN6t^@$PxCFVSS*zzWMeJx6_x)xv7SxImTu}ZKE+x zHgTld?lcsTN|--kX(y+IDiW`O+>pKc{qq>!CSbX|45nozo0X{3st>8jXP+kJNkKfN zsTp#-Nw_KZg~0&cEpf`xRW-TC!WE;0W?Yu0%zIpvyqKA(%D$y3a_d0;a3z*|q$Nl6 zYu4Ri;e@|2RYs-ENzHvBM{W8gO>KvStI5kLIMTHWTWI&qkAE$ci{DWQY+jo<6`T!C z#xufpl(B`eP_>dsW|us^pcIR){VipJbp{h+Tr}>!{wIEi#8;^^3#8SUT&;d$bUfs; z##B1!LK{Nm$v1JOl-(-c_Z!4{N-1@-nz_09mg;$anUCchQ1TMz=41L2b$`&l zf2hCV9nkxI4r}u_<*+qUd-QUX3iNG9_eXR-!ZivxJ`C5V{n-hRi)tUb2L_I*SfOLH z?jUpiMHD@B{KR*|Vl3(-vyFMr=#W3IBfb+0I+DGaYfk&cgnrWP`=LtRVl()y0L;kFD-OlSV zE3(=T{Ix657XJW75b)5oA#=js5u6QNkO>c`p7=-Bro&G4#)2yNsD2W58E!m1qIjb* z!n{vXr%1}nDZY0w6`+!mv?P!$Km)GZm`4v9iWQPujEtvg%IvW`rliq*?9cmRVwDk| z=J))Z<|K1b?8E+1f3_8<J2CjHmO2IkU8J9OKR=bn7}k3O~jTVWh^c zG~$QFlRoNyWojRhj%o@uSHw(BG<)?4v*@=!j23X;ZxvTv9qHPE^jne922+UZh$7Qf z5-+cP-Jm*mrKj->=eoM0$C92ulyZX2@1d*jYNqPS{{Wi*0KySRZ5v6!HM#!)`4y=v z)whf$h1xSGgY~(Atc>~fZO`5zsYxzli5OSFy1MtLP5%JRCI0{jY05pvbhFHGF0iv< zPo4DTtPjc(PAtCmk_73B~2w|BoGdS z3waUH=@N1B8j#R4!<<<)pp&0J)N}Yl`;Ce@ehgx_2YN<-*COMZy#A+jokqJl;>v*T z%1w{j3m>`%kuJYb@Y^<b*ou8(j``zh$$MNxrw5 zMZ`*2+v-MgqpW)`)LY(qM0(CPBfb}yonVg4Q^!+Lr;qv`ZVeu1bp<_`Cf0xDWls3c zqxeT2Fw}0#_ELF%^-h*OXHovF9vEsj)7d%1?N+3Z`W;XDvDJ*`qa&S{pOqICYBBYk zPx`Q>0Mv3G;3U8yA4pObNwCW_2_*jjRu$oi)JNQPgQoa5XPDm*=Sr>X-MI`x<SQiQ{PuO^|oZFr9k+W&Z$tMwc=|BV&#?nDY~vB_wH~2cd*BsO#W4 z`FdNgDqv3QkE;Sx~EQaBF+Qi zb1QhSp9G&GbU2oYCxN)5Ej*+@Ap28DDoV1I0`ds!YuppEw+1P=jssUcn(NT9#l=xA zum&~yI%USgYecls&y_>nbFNdc2YVfF8TsLF;)`XK2r8EnsI!$fBz>VR%_U?4uIg?& zT=gDMJQ7OiQp}#hre1onFF1rDa?eVx$G(*;sXc6lNkAvzA#> zs6%r>Hb`}~r!q+v)TE07NU+mbQ{`O_F5`1p`a=&_Tb!2!p#e<15(=Afl?=$w(4^`C zIsz>S*(w*!is?s~4Z7n=3}&*E%kFMuZCW`ky1=903_4BP`>5$yu<8f{c$#xN_&$?D*Ss zm{kRwms2x_T=u8Zqb_@^aj;2f^je2R{o~Wp1gsmQs{GlmuQZwExB$%a9nwO!QMQT% z^g0+4u4gXJE)m6b8X0wol($fmQqEy5bvV)MnWY}(`i)Y0L(+n4ZN4LFPpGA(V#ycT zT|L(W3Q6Wk^N%fJ#^DDyKy(>?&XC)KTZ+_&;!2qJBVwLv^5yF z0nAY*(^aOp>oYAYF#$v&U~UK=J$zxv<*lFdIN@Z4!ab?jc2xp#2b=|#0&l3_?S648 z98{yT+=o5}GTm%FIB$$}Tv(*!bphRgQAk$3Eqla;#VK<{De!WSAy-quvX%LU=E+(d zN7`*!bC0^a4)F3Y^=jYpB3_-D+LfdtkIh>^ubFieoprXu%hn%F$INe-%1uy>N_jN| zqN67AP+M`PNaQ%1+!Y|)5;g=|Lug8s?@~uxYqJ*EUjxZcE1u^u)ui`Q@<1sY*b8mp z;S(`IKjufs*y=MXi9waSBn^PtCas99+ilei{{RSHrW9;uymMG-IkRpq*054~f-WJs zNs35C962dE08=3aDkV8hfG4VaA*xJOotBwYow;r=PKq}WwXl=y#W{SFewEX*HS4qR)fX|Afs)!3!5AHM?|pZ zT&u=AKwxt0@2HLe$d~aeQ3|cwKpLRuA7IUQRe%J7X z+1fUmoSQ&W!9tQXwxHYcycWPbo+oO4>9I?LbSPO~pmiRQY6D_nNS{GUk`$BnRyB?{ zU?e_*c2wDyGYjaKd)a)Fp{NjnLFQ^Ek7Z0Yw#Qdm)dTjt2do;XDD5V2Ra?3`q2fF-IPrR1xaW8!*4k5&vy601 z*czr}4FbR^KAJ`^iQ$|c$?msxaeo>$Tt5*Rs%>-IdTIGskeb9VytFo%T8dDW6*9g` zy{=8m>eyGhxns6aZ%1Nuo3x*kt^NNs%gd?djIJn^a^Fw*_U&b^+GiFprG@r? zzsI3V*dGv01Y}DMDWi5BE-bpwicq^>mUhUii$Ji;?eh2?_l$oV=eE!J zn=RlP*;|EakmbBSwUSlHTK@pT^8U-6N|Hvp!n_vw*8MMUK`)7d{{R-;pI?RcGstk( zvWs)4rHYfFdoqjJf59n7MYq!`!O|7(&${*B;3e^J=%2#2`20-laJF%RwEJ|pWke9j zxI<)prbg|P*C_+a74H2mKYy3VPrfeCO)>nV zoyg0a#2nX9J{gK`Q~IY!T9RECFEN=){?LG+VGrel^OCYyvTAANU!L1Q_8wYW6wDSe%tNET;1zNFkY7lW?TvJNX}+63CZT>I)Z< zx5If#rWC`;p-oUL6M0^Jz_z7Ul>Kl6?F-ym_qP5q2Q;Gp0KC0N;Ro1W;AiVi%(EoC zAv7fr=4RY-SxI#YBE@QPUDAB?iX7=XdY7qTjXkz4evx*ino5BR2uL9A4Yo0pl(#O@ zG1X3FA4udmoo82vE6T&8_0Q!KU?GjI1{gN<4gU|n3d1uOw2In^R_cPiWFL+RccEj3e6MJk|QM8S0{%-BkZJ_lT< z=V-NtO_t?Up=>7`usrVrd8sEP z*=?kyo?^nvfEG6+sEY0)eY+EI#8QZ%FOYl37zwKC$!%8a3`|iYX^2D8=xl^3NlI=M z0qGLdyA&B#<3Yq;3{W_b+L@?R*-<0(fuv?0im@>KIGIDK26$A6voZb8TqiKn!&7fC z>W-gUiz8ivN+M$RgYqLj6$zb7_>xLbcDZD$I ze)1A|Zl7hCm}{Q+7TrZ@2tvPStXF0Bgs0{4EwFnoDQ~;-8a~n7A7+zNW@>5YW|~@T zme%HEwm=sMNfttUhLB_8rOWDQI6r4&lGN8OkC4_=m}XN(6o%3|Xg?@Sn|#d-BBQcN zd=(t}&3!C3poF&S?V!J3fxLA_&bP3Z!WdxjCULo0$C{OD!&%9NoxkP5G2b{B{5 zMtMSM{(-Ep_4mhC!q3z?W(fT5G!zMG%+$0dQvizsnw zDum4+f;frl?3C)ICRW=MC~&R7tid4bdy8ojV~U7bGpTnc7Z}wmF*>A8gsGC!E(rs? z2cKB8!ck}DFfCMY-8ke@R!8b7Hu=Q5B5Wlw1%C?3B~B@<$My1Q>TeupEJ5&QoaQyG zO__Oxw?<{97ji7+y1`AYsL&gqNUGyAyeii|gV0t;%rV&xfh6A`&A8)JNh+2@g(_)l zx4Z^hDEWS-g0Hv0BI=-R(!jJ*aKiT@QYl0 zd~+_<+)XrCbe|HbI3{XI6)9p=`ys-#w{X*!u}hcPK=eC9FwU}FK1Xa>abt><+;c>k zmZz+(K?}@uuo+BCgsf9#UEns}nQba+kL@3v%+&GaN+(trZPeBo9bo zl9CmaoF?^NWvMn1nfKHZgn@elx`+bc2#qZSE~A3{8mI7@i|iiI`^cHI zuD3LlmV=fViW(^gDLVJ>b7L4DFWL_zuIuPr;^Fk|SM#%SufR+>i3--bWie&Nh4Wiw zEj&+OtUwkXAa4=j$K_n5YvTU^pt*4HeA7?hgjnq0_8bLNdi8dj^_jU%&KDTSe#31k zCidxlqQV~3Yn)f7?9mQ<5|=0U^G5WAQ;AqLrMA@N9<0h2l_H>r+nESEDQ+Ujzm~B+ zKG4Sb+Vp>!8e9~=rr(jFM&eCXrk;AcgN`{#V$SDWP@b`_;SId9MZ^3VNC?)uZ zEn8?iND`GBf^thvGNp@nq^J?)3t7_Vx5PxSebLpywTgx$ZBIQ-o02JBP?v0T0rr7G zBGCMEC&-U1HO_}g$%2400zE`n$0}uO!qJFKg>{D%#@rdQkXH-lHV8$dw04BvDz1Mg z*j&Q1a@uWfFCeK2YoXkE5w7`|l^G_=&F=A1T5P0Ob>#{U3sKsxwC z+7Q*9oJrbgI9aD(nvtp{wm>e~EfRo87g9r)0_198IuM&=iNRQuV!33@pscpy613;{ zfIcvq2E{s!p+Zh=PGwTesY&;M)8h+-ZGj7TjoUth!a9?*s;H=!+RJq`hSb^2E-XsY ze+YZR3l{G7mz8a{R=FCY6EcLYfZ|#~bt>4P7dzL#NJGSg_=j_boJaooQtnF0Dq=~= zNs^aP^GQqF+@$JkI(kHTMuT0CFA$|oT9-J7PGDu67WiHeD$KYc)h?4Mn3Hx8Ps#&{ zh~75I%+;{fNtsnW?F(dv`6WTz-2w`G*S~}%i-}fPYqo|q;iS8AH5mz)13k`Skmy>1 zbUCvS3cO-8mGWch4^9~V>8z9g09R6!eZLZ>f`I=3E*X?qq>+yYcEqA$OhoMSiD50Q zr7fGK1wbapmO{)l6J)rE@l9Kw zCoy1<(~0D^4fkZ;#FL;|Hv$`RYjwZCy2jK$3ftm&oB@gHOqrTTK6+PGWtj$Ls}H*C zc2T!Y>|?EJ=ACy)b>vaoQoha86V)79Co%#t4K2pq#;B6 zFXS!Cxv$v4C4-XCRL&c#xTf!`9Ps-iuju{e)6&-l(aB{0022At9E?{-`lDscWjjY< zNUhLXeq7$p$xD@h2ih&W-X5m@u$2Wb;dSxY9GrRY@Z3*P=@h&`qccLPDpl1DWgC1Y z3GfP*P$xe^l=oq6$~#GX>-7=%Ug`XY=d&|2>8Vb8aY0x}*c7M&Hc~Z8d~7~D#Jm*V z-HL8I_;>C~*PSe^+B8_X863RCRyUgVhT8*hw3G7@V~mF(2Y{a_;sp3VYF&~)7_h`J z&ZldZ^GM4p!f}uD#7sCjoL!ki7(vpq0QO_4Hv2FfI9w0KE0Ds{!IT#qETklKy}F)| z0Nrrk2u{jYXC|j6nln?13N6d1sI-)e0HSu&@qp>X<1Cdw3{~Y6C5+uo?&Au1z#0ej zwlUL#kvoZ7W<@gfDH@cMCtG^$D@w?w@F~Ql6nJZ6h+rmXXhW??-*p;$(A$?r_b(lw$e%WYdYe4b-L(Sy4@| zn2e_>>1}Niap&OX*P{ zXKWIC!0HG$5!+*05bM8KT$}iQUFE4P%(kZ9BXixlZ|HZtNW~(%GzfQ&D~|Ao5KPmi z@=Qo6WyCC4tqEDbby^D#2)4(RtCliMQ?Rv5ig;bhejJ;WeW{hGgg)Y|jWr4=2Px_S z5jAB?chL-}K12ZGUu8}s;KEXxPqve?q)Oi!`DF_HAoq*xKcNjqBfwaKdk#q9`Ra7@ zH4#y9T!$sxLW&fTY@m%nH`i!HrMBa+j{6Uv2YWSADy-F-snzx={T`Vrp{92+*+5J>4h+d99as=HE=53Z);v5=Dul@an~cA z+Pbqu;mv5v(HTsX%S#EE_Fx$q4YuVJ9M;#)A;uc6{-nKWB}4m#_+dL*{(nxYR#}is zBGTq}n(V`bTrZa3T0#Z(+}bldM-!seZ{^Iq#eqtn^!}$RM*`QUS`DnzD&-|cWK=1+ z!#)8HHWIAE?Izc`h%bzfXZfOkx#{NBbl-L~@_ZK+-fC+2enF%Md%nW!veOGi{{TqZ zTuPE!``Z+bnnRM~Qspk3na^{+pQ`?$>3yDX)ALWUCe|gDTRB49l6i@ST+Od_zyLPt zHwQ>@aqTXT;ZOBLbKqaY<8l2N|I(X$NW@81Jr2tdRW&g0CBQR%L#j$v;U8rwvAH(Z z-cg7CX3D=LF*q|4J6ypu=Uz?H#bRb%Yae9}EnpMzUB7%ik`(EA{zF*Z@8rIWkXW)s zshSQT54DvoNVzNCKcoq0tl01FfGxZ+7Vpqo>FRIS@IE{zCD^J-#NMHNcWMf|)xq_EgMNWm-zzQTKg~3dz??D3hhHdmF(V zukXojDdS7!`m(<EM~>B(DKC8>q-RS?lW}Rihv-(4 zFXgShAz0PFjebWa>3aTR(}GwH{{ZCWK53Jc6M{ug_?dPY32i=^$tt$L2yZ_(eg6KZ zF+a$ZsGAdtX=8HC!fogX{m~u{+WCu`r2a806AH~O>T~&(cHHE+6Z*$R$Kk`yNCQm)%h_kBrD`w%k-B({Ek$YWRVzS4iFnyAvI8mGF#PFEXg<>$51 zl_Vk5U*%|yoxi^(KK}r3)g8{yIE~IQ(U&t*O_ws1DA<&o%q?w)Q)_Qzoix6h!}%kk zO>_PhM%A)w&3ujCC~)blV=L?x+EyQ#n8**=T96794aJC7vE5WLkyqbB6Yw{Pjnk@hrZEZj zcWEu(DjZy>j`B{4inOGwedRpjRD6OIpWba9Yhg-Tl79~3V}YtuQzfwMv-1w7 zVY8tr3m_Do!A|;b5N5S)@g~MQdJ}UC;?^n+A!u|xF1rSw9w%np8>K^Qs@L_1%V%Fv ziNg2wU#S}L78{vPDyU4UvYB@bvRiuKg63SSMYp&Dfn}VzD-#329;SNf4gDA-uoC z^E$XY4=z=T&GM>Ab1tbUvCbBi9(DE9TU6~4d8hZuj!IP5f882Y>{ittQlzlvW}Buu zUkMil#UwV?*ReUebl+%RH^0mI9Go>J{&wG+8%ib|V*^v@(m@J7%!wCLZdIE*YUY%k zdaEtGc7%KO*UathP={SLBAoItC+EQ_`S0%pn|qqtH*J8N(>{2`jL#`G_p3j8TV zR}*KZ=jv@G#wBHwD=d*>3zp9FsVTOkgaP4e2$u|-5c0=IsRt_jJ+4x*0{JqEnUs^O zGgxwKI#XtzYm^eCUf_b0b$M(e-Z_(v-t(zo1Ja|?(A)A z8^pXELyO;)5#BpqY0!_N@dihVA!@{oqDG}7C|-J|*}6kHlG>K@AOH}ew4F01#GL>( zpB%lpKBRXYJpBZ=Gwj`nI3+ZkRe;|saY#z$Wm!s8m$M70)`FCzsVW-sz&IjJ#?8~6D&@8nm<<(Wj)cUNHgR~9F)_jyXR1!h zOi1ENqkhiPfC`jHGyyd^EijN@IeHqikO0`evo0L52U7Qt7YJoASEv`D8tXAGP}QFUP>au z_Yj>T)VmKx1>?BI)WphF989|0WVV^SnVVBs=_wrR|O$|GSk20KtG?~VOvTWuT zOUnH-InDM^D*;xvplJ&D2)pOCI)4s~Ny@FcS+{6aCcc%Cnm~AzoUSCK_tXLn!;LEG zDM<=88W@p{(9T%v@-%T53l(0Id74Dos!6Z9rV^yHIWC@{+=V;fP_PtyOiI*5s@d)N z3HgkDSDcn+iBr1$o%V9oQj*Kk%_QYmepfDJoSod~xUKJdK;)PxHTBr-Q?Sg%LX^6f za;;04Q>JoQWzN7#$mSy{Do`l_MFPqm@^5%a*7u{4H$rZ8{5rOr_PI%VlWLH5`J9(; zGDD1&ZsTU--|x1dBdLwb3H)pHG1r`XhIpQ0xl)%~l+b1xm#8qVYbi^sy4!n~o0Oy~ z`mVzF7ZKeyHs#;49d0D!=^QgdYZ0*UenwSN=u+AtL?y@4b7_0!zNy^DV~)hRrN7@H zf$Y`9nJVuPs?&1siImhDo^dJ{1U3swK_G!+-6Jl9L$4p|N3{Nf--zoC(wf0iY9JSC z>MFUlfJ()Wu5l4O9livKPMh;p`ilNIVh1qwHg>Slw8b*2!kM|y=g891q0|&DL#?;o z5V70&{(|*VUUB_LExZRKQ*LH%ZJ<;H`V*Sqa^E3JKN|}lk&Z{N%v7HwzsW1J3dr&* zm}Rwl$!$a8CuRrlhu0_a8j`2$`3;|KS#E89uA6G9Gxi!&U1-{e64&zMS6 z5Y^EwHrP@W!jzleMFiX*!)U+7i5bU{vP)O0avV2&H#p*DP<`7YF;MaX<|IvN5T+OV z@nN@zdUj^sOzHVVcO)$~%_q3Cgi5*UR!W@{QL-t~jnyq50ceRJgN|tWm zP#J-WsBT%LXHnTbPQF*tIZ1R2eZ}8q zek)XQp_-7ZD>TAcW^P?Z*HaGNDi#0(l|y~?+A4V1(z3^gm6CyKDvZpTa*>Ya6Jn^w z0HZ)$zpzg5Y6>zm(LO+GPfv_J4aVd{{x^>w2 zQaNG{a&4KpcU%o5rASs%6KfJQ)Oc?WbP`1_)00Z6;)fQ$cnM^D5`+N|r_6M)+j|ZEVYE8ycKniTF;1rN|BGx@^evp*6266CwlcyV38Dinr zWnJZwzGWv%d}4kyLdeM{z;4k3c7;15RPNQOX;x;`Y^Ol(f(5*7dtb&RHDqzl?90W5 z__nvC=Msd^%c!B&_Xk}R1%R>Gj)o%f4??m0Yf!r4=VV$Z5zwV_gEItZ;%~pEU?LB_ zvQLCo7C!82h_ExtcAJ_0S-8jmP#q7vZxZ8~OiPU$SPQidBH=@clCMj+^C=(@;&Lbf z;BxEphH`L`$-g1kXK^Gy9^`3Vpm5x-C!#&esIc*F+Jl)Q=}N9r0UZ=Yj3W;Xq0{Px zPd=n@I0@SYtTvR>aVraD#+9Sm=&gy$6S3Ubn1P?!I=6?TCSv33X%pIkTc+dI=4y0D znw(qtONc{*I0+U2r1yaJ5k;4Uo-g7|v&Y0ne3=or|wk34F3)5-0>#C|hy`~402KNqm$FH5;fsVU``05UExv@JmHkXAk6xC47wZxQ9g z$~_4Y%%(VawLd{LCwXMcz20tO$016#Dz@GR_Oae0X}3g##$LT!Zjm5|CK*)9-Cf$3 zYgbg-byJ85x`-Z@v^xmf?dBp=qmM`J7fPZwv^fjqwKxYZajRU$HPhXe>5TIkJ@J{vBW>`oi60s zC=&&%gv-ygr!z8*l%*xHb=d2a?jhBSM%KOqekQJ;F*C!4sr7oB^q16``LSnNQ>k&K zypf`s2y-g40jfy3J{m!lG_7s$2sL!~9IBN%tHT$B#UW0888hwyuOWBuHmuh-2k%-K zZDd>XUs3d&UfhRI0rA42OmQ;R27R%o4|Pc?ONqYXz;}n^5$BCEL}WWHvqG#mqa^ca zm|41+a_zVY>6Lac#H@8O0g5Id^+5!%dHHGR^sG?@Vs`8S-A9)?czKj zXzCHw2}WKjTbDr^D2tn0VxTo1yF__zIF4I&Buj-POf>6h7a*tt1U0I<*u6G*VprwX z3m`g$3#B_)c`Ic=vosnL6;im7e1iJWq@_OcY)Xf~3!j8KvkkZ$dF~>~OJq~UX+rf5 z1Sv?j?IaQNg)GUO@Yt)SR%L343SrbZleSd@4=E?eZK?|DT}#1fbcU^B-GK!7gSdbV zyy&%+t>6TX8}cl>d$^>Z9}kYu-63XHB?OouPpZo5QZ4h^3a+4Ha*~7#qF{s5x(svX zbUO%nujx{u;8F+U90P3=3qk!FesS9aeqpgb(QMf&B0J0mx}AgG!_KMMCoP!w*-+75 zS0_(V4Aly|90_bx+DJ^wOuD~X_P^~~*7Jv>F*GUKbu$Ap6ci6oZa!ipAs{#v(iA0{ zt3tYJeo@1QMwCwXxQ>CYCx}r>g{{}d3jm^^6g>P6kOy); z9inN#+Sq-&>6u729;VQEr*w+<-faTQBFDt<9CAk}<4iECW|vtze2zGiN)4BAdti3zvO zh@_6q@`!TI8Wjg_+J}@o2e_7wj}8@`mw)7^?upPFV{eDYDsp$t^Z7=1itF(w!}J_h zjf7Sq#%Bt!yeiHbh+lde6l@sikVJIhkqWda90;N#fO#qc9Eg@FsD{A$h}Qcn_+P|@ zo0$XW2xEz2`>Ii2f}>AggXSS~`4Xv4u1#faoT|026{3-beW5t(o zUKD#8&Q<1@{UP}XOUozJQpFX}C$_xcvX)5jgzImpr38Wl2^;}Sgfpn%)Ko2R5(nc9 z&7EVBRHQy|8dIu}G@!A)(JLx8zXeGTCQ=;CFQU7;3;OA8V#5Y4ud6Nb$w4GAQwnNe zSU47*o^c^2huo7LxlSfiY4mYSZjPR4MU^sENh>?9*0|SDFJZKDSnNWTb@>dvGEMrk zys2-jaYUSSg3g0|>-u-^eEr;?|hXgWelf=!x5z|ay%`NfPlX3Xwy zXhl7Qw+LpPr()Kn=L1E=B}qaUaVtY>R+cMG!iXE|q3|(cxMdzje=i#HZ21-o!%Rz0 z#^v?N0;0)U99g~dr$V0a8y^h}cf+C+$=G4)%sXA5QW`>>T284*xf=EG9%dWR8iyoc z+JvmXIg*f)EJ?M}d^I}4lo}G{WKqE!GDa=NlXWTgS1&J22vXJ-KvRhq7f?_Z8=iz| zv`mVjs~w8Y6|BF^nv$&-nk7m~b0YRS=t77-LLG__*p@SunJGsecCN9JC0R-nrMe!v z?GLD-iA|BJLmI0S%sbCo+*(h(tDE1$OGK!uB2RH)BS?OHb3#uqs;!{)g^dY}e?~LX zMV64GokKALr;YZ6%;Z_i!JVdQJU5n2GEsu+SAx~DYC>sR#6ydlJTF2yOtQnXogDb)~!HjO~i z*+%NvesE}PQe$~r?G+(LNmQc+#al(Kc@uw3w^ze>JR(dXWK+hRNT_4S`Om1VjS;3) zpm+gce^^$HC5|+gAr2^On>m->FoIPbX<7i6)F8qe7NRI6>FVjA^AO7(M@>v}06BA# zYzK+x2U2|@wmOSS?4Q7Sz8*B?R;QJ@sl*_lr6Fo*z4B)Sq!XpU8M;Oz+PrGX_+r{i ztzX~fTk!bw^H$$WqF*V;?h!+X`6n-|0tfbSV{a4#8l23Z{W>o(GJh4-0 zD%cdL9`EFme6C}^#nbQdK>q*_U%%AEx0;tBD(1C*>H<)u1LtrFKN~=+&3vER4c}+q zbYVqZr$8+})1^89vH>a^-uB7yhvP3h`}!Pl?wa_0?s{fxmg&seoC*O&EplTFKz=B@OLAnj_B|mfNqBV`)e1y2c(^ z`X;AUr56^Wa%O!cJqAS*Qa@RC^@}L+y1$8iKVl2v^zwfz{p{+{Df~gfNi9oaIa-Th z;)dns`TpZigOlCw*O%-#GJIXG%7r4kg_cs46#GPs+8-`> zDH7lZ2g$@ObK6^L_L*1O04P~QIcy^1#_=jSP{YOCiTo+-<%W2BiREjQJX;|& z&{~vbTvKUUf`_^n&Cu()P5hzfm}%fUoJH*EiXG{ zbR9S8;Rx{)>NhM>T?vuG2TeYeF4M_VP6kjEg@Tm>Z9xjL2g*98n9Q-Y&~leF3_O_C z9ICs)Oe^8}!}$4u^Zx+b@MOi)AF|)%B2m;xUO!TOshkxz?M$$-B`u?h%1x9t8e7ZO z8<7q@Ns-y2Qf)Pw^N*on2B4tY%50SlJ=3xHULj4Y6%tlfYqFJwC*+xRDw%1g5Vp2h zQBB5&aC#A;hIJ0=J%Sb&OqWH*cA7$5O~ulnH3W1%P*|jIRcpV=hF3UQT)<>zQ%D4< zL#={AB#rC=CJ`n%9%3!7)mScPxj6T-uVRP7&_VDa#H5I;%A4iCz_5UMi7p&*ktuAd zLTf-01+xGR?Q{@g3zLs^@*hgZqP^IUg_y!%v>Rcml#_PbnsKG8O|q%YN9@Aa5iXDK z<{lT9-^lG@z5~g2Zz1Xx38&?bj=Sv&Q}#b<>nganL|FR7T)8DZ<@e}M!-^}Dr|=lQ zCRQm3SF})MsZi#$X^)9jGlG*R_{f?yqQxMc0Xx6EX zOvn`GT13Mvm8#koQcc&c*$!Ll3~5Vse~~N2>2>GKa;sGdP9IWd>h#)je72FVY&CSPCELWPK~&n%_+0Kr6d(=_pfM=88z4F zIg>l)lJy9&DnC|kqA8I~LS+xZ=b9`ALxZmahpc0a?C zRNtt?G+BvEzw$8JRWQ;0aJEI#JiH-L$0htP^8HB}GexcW3vSIbG`e+3)+ux8nq;&U zlRe6OZrZN2+iiD=xT7oG6#QOADD3)@#(I1(<(1Yn7?#FcE8OAN5}AYo2q2O9#P|^8 zHaKBit|Cm^tfOc1i!38d>UO`H<tjazEJLqx?=?o*{04k?gId8z{7 z6(?H{4zbgMeEtq%Ap{T8)>AcD8Ia= zT&-H`ui*jO91b&ZkvvG9m77G_mom3E2nxB=TaqnnKom8&w~TVs#}z`NOf@-KQ%WG0 z5`?6nY6^%gq@I^H1`_6wr3T1g<`bn%&n?VXf$*;#}DbV z2?<=XR0g8=KfhS7cvo-Cl(?yP{DaA1i7GP6*_Um#9WDi-k00^Q0*}(zcGcVN??hXc~nY+ z3_mom98971w$)*}PEiM{0E~`C7XJkku$RHCSl2h zGQ6%J9{y_*ln%BRv~m;Qx!jSpbw=(L;!L*{rdn!M*>{|gMcHk)f?NjHD>nkk@jBY^ zCNgmNudjd@p5amELkm( zAz%VU!S_*PW8ilkA(?VR=!-pwP=i{18OjJzu^ap9{Pu?AtbXWj`&1>F>|0xD;t&+3 z3RXqP7fMv5j;sOX47S5dFL2WTf~cHN-cD!^?|SKV&>x8z8* zChJS=l$9?#>+msq0&C?>xQ=K+1rmvDjz~RLq3_!hoxlLZOe-c$Yry1_>Hykh;!!25LH7H z#Ozh{e7KQHRHs}Gvo4eFt#fJ#(#Gd1LX^8~HP#GKxA)X~ZkOLdgRk(>%EcQxM9b#f; zL?bGY*Sw{&*f-_8pJ%ivP2>*unLRFVM;d(dUDtMt0hVN4v`lh@h^;rvT}b2 zm92xON6}5&sB_IU;K>EW~r_=UBv7WC{tl>POFoU$|2GCn+ zQm!K@7Aeemhzi=r_n0*{?el0{^4f5>$t97~vra$QcP)H^1@GWmkJWeQSBT0YKj zp=~?Bc|)t8$$dYl!~O;2-_))ujXe?+97dH`2P&*39;tBXBEk~CMf#3PH2(aB)dPex zl{sc>vJ1~J<76$B+!X{80$Q-v!=X34H097=COo~G>&vIHSxVAS`zq%0mI_optozA2 z+TzAIKm%C+{Cp`UVTeSk#r?$T0lt5G+lvG2-E|lJsgUa zd_IG7g;>i_-jlA^{*9=%>YI@hGU|1uWpUYNRb~p0SDQLtM5tR!-W`+DtZpjZ9r44L zxP6K#(<*b?DX*xs%*gvIQqrWh{(vFfEpDf19JNR0j>a`FlOK2F6F$?b01@poAobUp zts)GU>-m%7{{SWV8k{qJVwGEwmTA`nyVC$Itj8&^Csggy8>{*YmnZOJhsE9^H7$wR zp=Mi7`)egl<6=Bdm4f=KRR`<+A?(G;k#F+`=W8rm~RK+`^w(QiiQE z9a6K9H3w0XrehJl{-dr-pG97@B=Jn7+_$vhDJ+VaVnvDiakYt=mv=b7?b|Ad7r8o! zehRmIyDu%q+?2l;n@`~O5L|7gx+kcT^MM@j+`l*{-R5V^urJUXfqsG)k6~%*SLVgW z6~(6r)FvhpjOuvHvImA>=XmNi%Lsh^7p;kuZCA(i9}W@c`ZUZ<6qHmI?Fky(bJ7CR zZ>6()yXbY+8RgIJ`Hf}W?bGxU3gN4Al$zX%ikz5zwW(_ALI!ribkG0*w~gblb+>QR zami13zL)vzGn5M9tl@k;I;CApY1TQ1VB(T4o?Nx%SUa%087ht#DVuzqm&clZQ;l- z)Qg?(=r)MM?^Y*qJ8auKva+nSox8|wN(0K}LLAjg;J=y9v3_B(2M?v1m||w!hvivA z=*eWIY9JxxELz7kf#`DpZw<>M`X)UEeyt8uQWDNQ-Ev^3EUc5w0;_j3D(X7;q-Fd% z!;qh)KT)a2qU$6=JZZzpYKv|^AnH=O?GAcDO#QVy(oDlSQU;1VqJ@o3?O_&NE=LrX zZ@ElsneXAt@_Mo(kUaGX{G24P?eJI8TVvcsv|2jAb32rvsI8^Jy!Z zm*^dmab#U1acw}_En@9j7-&*ga4hc!kkxX7Fe-F3I+vy9+q8$vsS)h2GJ61pN`V|`}mLl01ojajZ&9Rrd1huGTMs$ zsTzASi@^#*%Dvi3NwSW@;25f$cP$gG*KS_~I@Hv&F(lID^C`u=rn$`gy zBrO^heWh6Si0U=>)N)S$0B-8JdW}8}r&cJn*B_h#%;I;I zc?T;Md31!UFWF4x^s(676f0ezauK4rdVa?dI4XYtI^yNliEn9bNe-}2(XSoYb5f*^$Mvl z^V3q;dTlJXJx(i1U#ComK?*`ON*e~mUf`!uaS~$4&23-MjtK1SUf=}7c()8b)pnMU zw54)+o^&*;f?aI@1t#A9L!lc(+{RYNcNp=CQ;AaeZRuqt6LOU-j~+3h3i_e!#r3(Gnhpe*+s&W2=MsvnA~x(68RjsuK8uOF6JpF5lpj7x=mSjMwZc zyG=;{04Zxy;Wx?bidgt8h*oIZ`3YN!>;>7HgmndE|5lI zG~OY&k|Vn2Vw3FgfaR1+*rPD;ZAic3m}$j*v?{#K>8u6ADp1O*rCs}P%1cBanqe&p zO?jMV@ZSnrH_2aF@ygHegi`ynyLp@LN^r_qKUYkyKl@2<_d>S&LPN>aa3XuGVTy~V zp;$~QS7+#R@0g>OZj&%?C4}XYpZRz?{A^*x8|m~yTRLmZ#*JYrGSBQONArQf{nzXY zNP9RNMx|rr&q~#>?LJCwP&TxoxqP8bFHGJ0lc?Nj6+BaLVzK zMWRkDjrC(wibQ0r@gX>k(uxf#QK?~|nV6SIEAv23WNVXQ++RLhA` z6AQXfkc21dm9PMQF&8@gBlzCpSF~fy(Xq7qin@Z5!i|7B6am&Ga7*xwXM2gpu!bGt zazYA3w8z+(WF@y!u7y?_j~=mUEDB5ZAgqoocX%bm+OG_&E#UlC=Q)?VwEBXHIj^D; zTv-{Cb`}>0NY3%xBTCV0!)CpS-nI)wrCWm;87eN*v&co^Cr*^R7lj}qS8R&f7AW)~ zV!4^NoN+&@6{W||q-i)DeM){RLobVPwCz%T{{Uj|2HjAyNelEA-ZUBtjYgIh#B^C_ zy`Flbk>rw!t7j(4PK!1+>jK!)X&Ko5%%H3<0Z5WxVW|l6^Vu(Pq64Ph^jofO+&s8Vd z!x9dutj%+(4ptU(eqR$nLup@c|5cMU=Wns zZ_mW*7BEC+#`?1=s%3VvQj$=K{`IxB&<*`RD6rwt8zI)>D{oW*5p+e|TQR2+n50 z;LEI8RD~*-C^~`+MI>3CW_2_ju@4bt{!UPE04;QM&YR8MLBYlttaVH`$L@B%!M+A-*N(i!LU%; z*Em0SRYeK&&EYW>T&7^Fk6KnKOrW%S6P!)liWh%%F*urV*OtfKV55 zG}gsG0~yAwv`j@}%t0kav(t~X!fjw&T2p^5NW4zL7RcEh5yKIq1#y*L#Pjk_y1fFz znhOWWo0zo5oJf*(N8DM2{{ZCJTbGe-KG7*NGV`Ge)DRGyr8de50G;n+6JV5vTW3N^ zyc5L^n^9*s=1ykk(8J zYMQ@@>@zs>I(T!o6<>$Xi5z83S!gFB-AhL@x)lPo1gH_ejAyg^FZ@4J+ZP*r$5RI4 z>UAD#>3lCTC+L$pP14dr-<2vp`%>vTHGg~y*b+oiX5pMwHBY~PiD{2D^&B>Ejvl7Y zGW#q`uAe&SRJ_7ajPlb!=H;nC45(4i1KtYLtWwV#U(~dO)A*15K24TnC#dsCO4BT& z>JqRBGVYwffO;oXn+pqCB5ALdvU!5LJ2(6RwJNf}k@A>281JM|jLk5U8Er9VmgBoCeM6M$6gB#n(h7hdbyovx!!gL= zeOJ(OP*NQX6+JUenwq26UTyWyAur0fpV7LsjH?JL(7Rw3pq)wYb%y6nS{EI;np1dL z3VFs*+EFmwmW2zYMI(PwI*V-#Ss+)`u(#6;1<$ga;WtC=i!6^2t6$l5o>IJkxpz>sp9KT?7_o+RK1{8i7Y=CZKRzXnsZkyvTtkj^+-X9=a(yin zjH)@dAvYf%2wt%oP4a-Kc81MIRF;j@J~oasfSI&! z-erDEAwMl)4C#f2-l^^4Whm~TUr%?Z$_oQdQRL1NQj(H4PTzzi z>8__7msu-N$Tc<~5$X=nz&cG;rQAK&kQ6sbPzT~K9k8QtzuwDnea5g@7#o=mDO!M} z=%92yzMcjP144dzD6n+}Xgez|U_DPr0O2si#W}+4i3?#~^J!M2_CV6{)wduDEA?7y zx!g!xx#*xngZ&fuLX_GDh3yLw3d(PlNb*p%{K43WeiN~_s8I7nIwUIEL%Z5I2DzrT zd}EY$!g~f^bw|+ZAq^d~UCKCFxH(UhCXRvZuQlMW&Hy}|_xDPFC`r>{4>kvS-y1`2 zLZ}Iq%grYu@{!&UX?FRZ)3l|!C?FWh)OiWagrCRCu7~;qj zblX7OS|378rC@IgumhM6SmlACHB6VN3pm;p=V5=GA;m~ilR`pwhpjB#hZck2O~>U3 z@K-^_m5G_mF+EM!D0Mz4xj!gv;-PCLoFAk)M=HTeya=)UVICO0X5uFTpwJqPp!hM( zCv3`>M0ZKcGV>syvoaSQps;GEJfoxaV!w!6GEOJD8(CG@Msp!$6LCtohDC`glEXTL zsYk&g<{Fk3)uX!TOeD-rue!sw^Gq}D^L&#P;-%FK*>LVrc9cD0TzF}A7IN%Nyo1A-keEdHK=c z`TT@YaciH%n+7?Jqc8$0=yJ@nKUbiINgPbjM)1koHv*%fVODG*NeMP-lxdoXD?kA~ zGhbhnJq!}b%j!2QsvORH$y~b2ZUU7J#5bkI(^SP>f|5anqk^u0zGzpHhvgcdWk16H zKcNpX18Zvk0I8bSl%oFt&Jn9$z&5{&dX_PE!iG|K3!L)@gk z%c*rLP-?&_v(wC49*w3%bV6>`9j&Sy52>{!BQGy7g}0em%CjWju2l^qN5k-oB6dTT zO(lKdY+;IfSXU=pOS24yTS?{0y0kQ#t3;cXZ{xX!_?$4|qscpcQ8$O1$m;5gP@>IM zFwCPRi^UX3j$K_& zc$!L1RHrwZ2A??QfyI#`QE<!be{Z2$7G5)y%5my`|y0 zi1}gcVTG__%%v%&W+w8escA|}Cgq0fu=jjbfG<8nJ4KkYD2BkAHjTYvL2g9X=H=>1WI@MXX zr&;A7kQ8hMKcprBKAo(!}(%qr#N_s+b5;lGwe8Sxv%6jrv4qnO$`aCMwyVyHyLVNJf54Hry+$I#@5rw zeU!SKi{8Or=@+;otSV5{IEhWbe$UP0`b_0zikp(N@~Aw9Sh|;->zU9JR2e&6H?iI- z_>9_iYSG?iJ{s}Q6JYsy`YP7YdBK&3mZFYQuijD?NB|Mg4dI-;JRM0PHfP{B7wXtb zv}Ed)Lgcf>NpVVaxX>!SiBV8Cy|o)}9M6U=Tx0YLB=#fV#xi=ERVz?ULZ0%b|c;=;{@edA*H%jlz;*S@(T+M zFR6#LA!*RpJ6D;guQHTL>2h@R@Pepv$1aJ8Q$=Sq%ZYJBXn-z$H;D6vld)yf%gkLo+3nerPx=>W2!XB_uOpwECKuCJflRo=8HNnR%KJF?6HbuD($D^`Zr-1tPi7#>GWv7EUQwvyYQ@;m$-fBAUXZn;QYg+a81C=iv) zFE{uX1^dJ8C00;6>LT|a0gbwL_W2Z(EpG03~IDIednSdV-Ka_0w2)+~T=K5#JXlzNhMEXAaAtgY4}E4Tx?8FTO7;xX?`Df7!$F|CMk3OTNNE$*IaK#H5+_5I)M zU03w|kguk2^>rrsF1IZ)E~Q;aeVpl6TacmNSDA^NJCgn#y-{7nWshH@46e*rZT8&; zO)~DfZ_SlFl_2<|AOR=N(Qyot>Ql=ie7>U-i~A*1&WNuCln4FLRFq=Zt_Uh=rC8{F(H3x(t02l6 zT@Sx#G)dJdSUJaLP{Nz1u%x9)Bq#*}br-R}j*!Hsc0q)Bk~fFEadQOYiMkZfadLC7 zB~su5pp~g9)gt;Noo)x5RLXi)`ihJ;Ii0b1{Jt2~(waj}2VMaaF6qosPQYbQHWxRz z*WnDQ>)i@a?nn?#X z4rbJ!saWOj&5%ZRUvaaqb;1-qQ>TUXhSn&j_e7PE`EvP< zH)aZStv?mG^qO2@m9b#M<15J^>zkn-2Kx9!+G>;BftQxWh}D`i%eP3GjZ!J{J7$e} zlkCYtG$4<_#K;lY)luIvoJAo207)d@;TBj{!%XgW%T4HMP~9&!f65UoK&-7%)jfig zmr2Uw7SnrWf`Bh&S3}rgloM>Aq<>V}IY&mvihK|Ys5xI^rmArXyUQvGPMt=bd+lx-u%oqEu3`;E%))C$8`M~@YizgLYr8iwkb*B&) zIHYopao)(VGboOSTSZ1*BApgc!L^MHw;1tf2B+Vr%1--Z67CeCx!lg#0O$gNNg6_w zweB;M7MDVTquPpti@UhP3`t!fKN8-f+2c8Ic6OODU8a@;_Wnly@q zeG)Ha{J49@oGDH@`hIl+*wK;jpW9c?N)lX@( zq>sIOk@AQ1j5)MPx<_WL5yqqKv`j}d^I(3CnLNT0*tW$DAgMpr))4j*=YC%?$ak^5 z9)3*{6SX?bq4GH@YTUP9YWReFn`OKT4-=ob##>Q-#lCB!^1Owv^C7J6an zb1o+or=_OcNzfG)grV{V%NuE|Dp^zHIUW`D5nY_H-YUZr?p39cEQwZ-r8rzGc@HQY z*$`U2oa!%OtR`6j;Wzl>#rh{5Ch4uAm!&3`GL~kEm&)J^RffB$1GqbHXlYD5CW)_v zsr9;I+mjATO0z6EWCFJ)o(b7#Y*+-H4b^DO@j2tYbM4KSJT3;(Z?C7#iPt*&EsRdLWJYpugIM&N%lJ_?K&jVlT)NrWztkqTyk48LffmD zl@Jr=Z4NKR*^T?JXJ0XYBgPCpKGArs45Y5bM$O$;@#<|2ym5Ui;j!0>YpwiuKmXK~ zc!LMHTB}VybbhHk5O?k=q_!{UQy7N#Ro$C3w)r7h!8(&QIxQr)MVh6l#q_g_bcG-C ze;7_qe<%5zk1vZ~kkt0dY1TM%9+`!h`1i;=9cenzC9uQvbSC1{Dxqw ze$qo3+NnbezTH+y!qrZbJ1(H+TivId$>>GVs380zP6u|o{>W!4**@R6pYqFpT$x{%5)3D^W2%2DfUbrBCD zxA)kY2l;-azoa}VjLN9$IjpAkx9Jg<_VtJn+5FenVb{IC2IWNiU5 zi(9iTq};6zzDk}1n~<9eq+Edyth$!{znAC=H1_UJs?^iJN=TuSEQYf?`wABQ+FQaC zH~5#pV;cM~;v>_D6NzLeo^`>>Q{r8>^EE(srzm$uUDr)mTq-)`6+ZL<_mPT zR#KG>{zF)p@>*XXtNw!-F}SMdOX#-!NY#waN<~E{{^A5*{%S5HNAw++HSqn3ufuw} zaQ+ULeNA(YY^iGbbE(HdQZs#>?|&$bCriIQzGHJ&KHGkSq?{TI`;RCECHYmbw{}qn zRD}!cYnv_)~Uyqi$mabEsNd+`=8 zRV9fjkkFZ=IQm$6WRR6Gg?p_&-Loj6%(irEZEt99D*pb0-rpa+{{WH0qRtw_lWLP_ zCVE*!&Pao+?OfT^6QW&jTZI0UTf|2y(B~tm!=y1$#5A{RT`?Ar2DH#vRp%m^(_*DelVyzmG{4NoG4pyeA~o~^40YGg+@AO@^|VyTqC8vnq2Ct zNGW;JqEJhUJ&0;o_vEoe35; zKkSDfoVj_8%_k>+Y;!PdsvW3Q<`JlMOp$LUz=Av9-$A^aBqg}RL4Ll|4NI#c)T8bHru+VU$e9+Vm&enQ zpAc}(jA@3{{RDSsD)V)jDQu-BQhA$cRth&6ZdGHc=rs{0S!wU*>Bwdfzo!0t&ek@; zPVoJ7>9-~nnU|%O;GStYGO43{rM;A#gc~be3^g2GxC29%1E zR|-cpu;XqPk!1s73V^sBL{7!TxV`!j<%aos5z45>BkZp>ioHG2HB5fNQwa$y%(i~R zt@nx*Z8O^c0F+(h%BQ*@&OHXF6Ibwr(x&Q-)1GcxYI;E~OQF(}BQoKuQ zWKap#!qyP$Viw%T0lW=AhNaFTk(o6q0H)Mx&5W-~xZSy2>17hTAb<%-DYfsUM43Mm zt%o1`<}o|2}8)r0#&FNH;A)=Hx$>&J-%ObbLsBZ zxLq*CQKHY}7=~eFf)NUJ6ZkwQs*xztrEm-C1_;nnd3&ho8yiC|yOHDT3 zX4AR~%7J{K+glYNk*$TT)*I7Qc3pk~gNF^dS(WFs@>`o>F09KbAcx!LD4Q(%q;I9p zu$F~Q@A2!{aHOeC<0_h(0Es|$zk1?Zl%>oA-OPmO6MZ|Rok;M8uXB&^ugK!z#@JC7EIHK+)ZIFyr2E<(3=VX2LddU^{F$f3EGH=B#TKm~vZ`}+26GK= z!CAGn?`0&~#CK1W5orxOdp>DDnCfG?si{fN)9Vd^F1~Sa7941NWWpRP&NR;fme<7`T>RJEif*AzqCvZJ6)h#;K-Rk}rt86Hpd z7#cjiONMna{X8oUPde&Dtr8|B+zTWixP@IID^MuTjZ$?s1|*_3n?l!#JUyrJZe_Jq zWz&YSdejWG;z@c^d1%!jl#tpKqt$j;@mA2Q5vRBG{l=E9jO(*+F9c%tOr-3?jVUg7 zR+Z&gQXD}*%Al(dEOfr25YXb5u4MVZG=`+!+IaMo|ZlD z7>ki}B}1Ac#v_*!RqQl`Xc1MPKpqJbBTtk!AHPvE-_!IO?$cEA-Ylq-_N3GYph-84 zpRu-s__HVNE^FXcUkGK?E7bH2)We^VjRq~6_!)*eJ)$O)MV*sh-lwS}*O+e$%J&kV zK|QbM%$gyVN@QJv!>x4^pLrEHP&^18-$NV$tOSd!+O2uc(& z9D1E@dVZgUg0G(Qlf%U*{S#-%p7F8u5qH91z1dmBWjS?LMIn$IPOH%|YbeqnMcWya zRoiN$(_zqGX}PCX5xOkGfH&La6`6S!5L=B$XlaVYTM@f4N@Z^3ZI+av0R*A6f(`fA zcwY;XOm+;gwlz3giNZpCGId5hjq+?)t+RBxK(O@@dxt-Lyvn?g=!qf4=2yfD5MjM) z5(GTS85~5dggvNm_C1l5W_EQlm0;6om}TTGH+3S!h2;n! z+WYBv!10^|PSK{}_>|Q$QTr%PRV0NaKqx6B5JA|2G%-x^(O{)#a-PZ&bu8Hl1xh{u zYGK@P+(e{QO!~D2%w5Y(5CYZNi3;S>r$2aME8KPUR`Z%W3b~B z6D}TvCuIuiYwb_a=Co4N&q_|=U!#~$!9XbM*GRO4$P;bt72nxRz_X5MVFwRHmd znRr{OO^%1AuupVy8!}FC1Beq-f!r}#Kk>yeAO)L$I+oeDlVO)@1q+kZ##fKw>FQle z?iVepWR11rr%jd?M2ty}aWwsMr72IHVp>v7ZOW*p_+vgy5W+oM{d^=x>$=Q|^R=YXAn;i)9K#Emk$0TgS5a&lytWWe#b1Hxz{{ zr!b`Lpg)`^O$tmzVhnt6MlY*M&LZ;D6A3DCZrXwX3a|$-@ewBksB0{2esI-#N>W+C z;)9ZowBngvjffzOwzchl7`lSARmsr6);Lp1ou*Ar$V-Oj7-+hMB}&mqAy)$S*cfLn z6-;v;R#;yT>p#nSEQLn*FR+5I+W-Z4bp|rIaMNY{GTIwX(KYX4k(Qt^f1Op`N)`ID z$RSQB`r6xr4{-Q*8qJeqmxY*5wk~jsGbYON`r9f;$~4eaiZ<+qeWuV3A47{aa$;$2 z0pb9(b11xGzkpqkDR}q0F~_0e4@T9aP$WcQH?tpAww-nhfoBa>~f2-E^SZ{p;=V+9FSxDl1{O zeo-z`<{y6Pm}%^(7QMoNARd5PL$dtCYi)_N{S{Bmdw1ot8Jkx&H_@T+r3~^NVUn=OBhU0nHVs|Q8Z2?&CNOPwJXd& z)o$@;fUnFc@pV3F+En@{QI$_6GieteqL>79@HX?jS#v}KTe8h`PhxiR9`m&3(7)S4 zN`G*OxudNQ?-V(J)FQC&Q?DQY}3!?l|>^r`^pq!lGeK12~6(?V3o zi-x=&lj0PE_;RTGvoh>I%%{9=9AK%SN1MV0fX}ZxLZdmD5P6 z%j#}2wBkpaRK0!>ynJM3&ttN{(HLbhO?!nCJf_}uRpcF6aXNpL2tNq0jI561M76=) zrYTs~TvPEpvRew!ye_0D`K2kkeMBuG4VbYfWC<$B6SxHh!+*w6e9~feI zRJo4FD_n+a7IB9gaM2D^aSMLYF0o^rAZE9^pyOiULcoK2=@hwrl?S@p>RMvspHcbY zcWzlJ*4RZ^Jh`Tk%1h?z3T*C`1g6^f{9`}Fdm>SH9oOF6%Y0mNmd|2k@KYT~vcegc z7nOb0DW`|KbsL0{YmZZC&1S;mv)Q8S9#t&PKVJ~rrjL`28#h|yAE zl%;Jr-nqF>0HQSnXh+D1;&d;Vn4gtlnfXMvGs`QUmD=DHAPWob4emVQY3$At3l8v( zLmkVlOHM?9Icfxz1$gc@{A01P6PA)W;+_U6mTFQJN5Ga-h<;LNX~}s2j$lYP3P}Sn z*+A_N$0bu=2j(JC)HC!RAuVpApIDe>s>2{Dr-H(pnn2MiIYw5LM(HQcJ3M#zqPF~k zGp(O7`Bo~OkdaF$05_=#IY>$0MGM@1aUV${#uBMln#GALVP(f1N`L@m00U)drqJ?= zk1-c~g|-vni)_g`KEo+o(=8OL+7*FiEjK?gr$|GUy6AO9BMhvo^2qkeWcMKbrqnf0 z>XfTOJj8O+*`ZAx>RvynHqe=xX%4XB`FzBXm0xRtZA2x-0HdrkO~g!OE6D1-&_M(q zqo9Pvw9d3Mior8-Pa>YQ=6M%W4uS>S-^Rw<5KKPixs9ZE=?vl?8z@dw-L_kmHf&O` zI%|7JRMR-(K3F5STILcA{JCujITWz0z$?QC5~0Rc%!iYL>^}09Hs;09pkmG$RJj$C!sE=`U7Qv$?Tt{6tl`-gK`xSluDO&i z@-Wj#?HF+N4K$P~D15xxH%M0L^1kQe0zz4*B_}q+>v;?2w6Cyi3VcQS`od0~HH~*}sje-=y4xvQ0kI)O zD=&?qGFEj87AY+d7T#c?W4S+pfZ^2StQ^2xT03BBy+~$vZ53;4uAT%P2#y^&i^0sL zIRX+cH5Rx(J)@Kd1-uIFJwVGTO%Ap>l7FhAZSaDqEbRRn?8pgxq}yeIWAcuGrID3P zvO;gKi2e|?a3k)uDBx0&bz9#9_(uTTeeCEeMVF_#bid93IC821Hf3d@d*o7X0qd+O zI_hzuRMnIP&aov(ZJ>^%BTIvRk;cxX6*)jA@U&e5)^)D4Lv#A^w1M`*(2%B~7V zWc48J@PklMu=PO86!l8F^%2cMM!{J&@H-eA1DP`}B(CC9a81;k?+r^~T*PHl5H#(Q z+bcd}{jnX$bt8{8?GuR2F41kyiYN0<(1s}O(#*uFL6}ItT&MB3?uDi$ojI9NK9F0r z#^8_lw0D`#Mx>9lQal0p18hFlsQQnQsWQcK$yOG1vCCIOC6 z8;!jH2dTelXFp~uxRv->FB9Djw7Zd-nk>^dinNC4?VPNo<&X`Hv^&_H0k>GO!3|pw z^2&@&aN?vLZI^2ArEVmtAT-#x8|*ZVMlK%qDd(Dq+sBMqQoyw7^CLYm?NY5J#5%57 zNxPW{$Ww35CC7wIp6Fx8Y>^x|sykVuNX*PDJI=C&Em{kxjZKD;MaAP$x-4+Y#qMa% z7N!T?(h(!5;!VF~A4463+$4_I3m26W1N>n8qT3fyi3mzawMu*bN`v@CKN7cp5==QE z(hKD`o5CUE#jj(Mog7)Zs`?-wh>M(l%e~tm%Zf0jVZt*h=27HIe~e0A$4~G1jr-d? z-BBx6RKC)c;0Pz=AuribT>k)2TvKOuT$hn^6?wR2j!hz5GHO;=_iYAiG+M15dXYZl zm<}Nhr7IvWz6iL~c#XYc%YcL*iejoZ6VzNB9PMuYomZCK;6d zD$<_|n?-AdleJOHRdPiezJc+C_+jEB5w6Ie>CqhU&iJU-dbuQletIFfVq%t5%t)PX zXl89eNj*V^92y@|vqGY$RDu{#O71lx;@xzFP^&oARglVw)P&#V4NV1#d`nBJ*4Ijz zr=sZvDtTuuvRiF+9;3nSgeUHxY&H?I$BkoDin&WuB(Gz>1k~JVoI>KuRQcJ0-H~ND zq@a;<06li6*y`z^Z{FN%y;;+1(Te~`>z?!$8x38hpqT~piLTC;LmZA~F2_xF;!pMU~1 zvB6s{zNJLCub&^R?o_JUWR}lZkYMH*2IdyvgyOhm_SjnT9z;3qjDh< ziP*C>T5TM{>bE*t8&R=$LL$G7pQa16(8@Q~B5 z8x-39u=Fs|$CAjqNyYQC3smc~MU^;jwex-vAt481e;Ba9GY+V_zLwJG>56TRIBCoClozCtR8tAhMJ#MI`WT&(kSi6nyHZfGUNB{sdlBpYvc&Bn2x?T3GNN2niPj{KBb_k7MyVp+vD2o^o+f6Pf|p#d zI%qE(p-2X?Op-xTU$OH^{t?kuCujJKv|TN!OCGi#loWErWd1RonFTG7+D`TY{{TB) z0I@5|TjuK|pA#KAZnGuh0O8Y186hH&qom?Q(Na>|C@MRw>VF%EPa(x4nwM8ucs9dj zZmjoEfpSUk07FuADQ-(X9CkUX;w!mVbJ!eHMagMySb67cJGqjTfZ9p5%Yh2Nwe^bJykcL&>P|_^pP?^t zytO`i+2rZ87%7JoSK)j`;LqMgaB@FoG)lk%UB_3SI9}|4dZX$7( zPa0B|(~OtcT1hVq?PV6-Ab_*KyZ{C!VBz#i$n(saA!LUK>6HV`rPk-9Ruq*3cUF+0 zs6O_#J6<$UY4c0ark(U;#G$ptr83)XVy0e|$TCbCe5r7!rebv`%-LYdi0Yl0r!ewa0~$ZhV9;D_0^?!>4&{M>EO?*ba zbpC=WrN=pGb!KW=6*)zco@$mGSt>Tjl&K|79)`dOQpVRXb5i8!PvRfokWPq7T)N&PKva~3olW5JbnjnUI-#p? z(#KO4PGbs?T)k3SlZsgi4f33A5{|l)_J)AB{^mHig)Xgqe`YD*X>$7i090YB@n)aH zWlPIe@T|oqS%yP-n3zn{O{Dv|N>X<4z2lGZa(`O<$nPH8u6=9v8=93<3*x$hs(5o0 z%gfcBL2U+dLB`x^Bzw152)9huznlq5J3ZH@WF8UF6yV$QD&Q#S=c1~Kf)Au4} ziRMC8eRE~b6qDcxv`&oDTW$3rJS=xAxMHI7l;vZGRY{`D7Uk00Ib2a%J=H9r<{*)- zP(bvEZnx9Be~|29PjXgGc6-6~DYoZKtMxV}MsqOB?zT{^Etv^e7Ct~&^olpc&Kobu ze#OQ<5;Iozes(?hTMdjj?3{+*EEx6M1x)hy32~o_Q$Gn))Rh0Be2Y8`go|_e*RLtW|glEWrmm9tE z8zcfe6h*{#j?tZt(U_wcxMdd6KsQNJ9Z27;^890(P^3cMEKpa%j9Se5RS#`(%&tBP zN><(XO0S}ans2Ik;htzm<%$Br>gme5w{uAe-t4xFgOUiW-plaA|T}K$4$g zWtNr7ea5oo-6=Nm+(PK!$8e{Fl=>}xr6#E~DJgjhmn4!&(V@+0d~;C_>C#fqT8BXCo#AAA|$MIR?Z}& zrDN(=FPG0O@IG4q00@&95m?$xIF`7E!oTIwBj*#bEs)Ha+3k?-Y6(3#t^Q&rHArsF z-WE7SUC#6&sdR9Iuc(-ktkp7?2t8)fQsdZS2N z!s$fRlaD0-09(7Kq*7(#EAGpjTqNbmU(UZWb9R5>rFQ^MA+%NHYc!5tQnVwK<5m_$ zkV=iMq1Gv9H7EFfd;aC3j+p)=)99N0R>gSn`w>gw>`6SQloFiZj9YN;@S?MdkK(cn z@dt@tO_jGUqs#pN00^5!Ot&vjuzcUQVaY^}lBgf$Dj;Qhk}=0(Zo4$)Jq0TvOxsi| zZ=T{AOp&CIm~#}5%_3c4$!i?VE9@vKLn^^KSRE~_J*e)TxAG!xDD5>= z!t-uXv2_uOl2S@A9+PYf;_i7Lvoc8G2?HW zugr=V@`W$NTtzQRo2pMssX<=Qgh`yOEjoaNqTSv52)30b@~lPqsv=3an%x$m?~+O@}IkqFD{-Vcz42Ypt$CW z{`&N6|J9zAnxhj`s)7yCFo82P^J*f%lxGWQ^<_kN74RnUiHvvo{rrubxqQCqap9btIYKfc2`IeqsYJ`PTzpHsw*Tpz5H_f&y2v;sBMkdf+4 zEvBEz{{X{-n)LjJH;r_+YOgsutfWmgv}N3Y*jdb>(LLahd~}I8nB36TVCtmRDpH)e zT#iglOR^G!a*#^7WI6_+19f>r&2BY&9o#*R6GoM&CRqV;jm;M)n#xwDXC;F2gzKXV zT1HZ?@b^uPq2`*ekj1C+vEt!Gs}*S~3Rdb%?$cCCO|^AsL(ZQZi2IaN1r^x|a}v+$W(SN+Zq{C%gE4 zYxMZK#V7J2);UMF%GDT2v0fl&tJJ|D3zH2P z5{Y8m!iQ3nJ_-CGha3Cz5dQ#=>GUMUQm%(rC^B@ld z@MAR0P-?RF64fb}l&Nwork!a8w^iZGQpMBO=U8#h(odl+!%CHPrf6fC0QMuOx^@rS z51zVNEh-S1Rj(5TvYyt-Gsb5TT-Xx0E7KrMErB zscNU>hu04_&kOLR!<5A=FvFr{wA>PuEkSE-Hn1t&BzPNM8kNuEXiY6k;KyqVP1E>@ z?4@#D(xo=S(1ayJAr56EkT2g&t-p5UK$iRS7?s5}(a^$niDLEYGP?UiY5ACX3-lew z{63>+*;2RdxQcZf1);(5ZNifTm3>8JcD)5XTAcPN$5m;D)V$Q`BoNrWmV&UArrtS0 zQa0~H8CT(dAIg!~Jt{tbo3=RA9AJtvR_mmt3?gY|LwmZvtGBL%dc;^i*XqY-3){VY z5wAp|%~SBz29Y_W%9}?t6Ma;obtk9_)CO$n$u2Ev5NyN~>S_C{usNBw+jWXL5fN`|L&POEUQ0 zt5B7jo|%xEr#mjwGi=NjNo~{umfTS`Hdr}+TEw)ptEBI`v5(?)*qd}Jtx{VIKB?z~ z)ZIR5Xlh{Gmr#tQ3sSz(vWQZJuV}5!zb^j(p)(q(FEn&Gk&ET%wBM#&SrW)YGfrhT z3rcPZMUJ;N0A9xM+*YQmtqw23o%Fxlha3~YbJZ88F%4O@3XN?qrd^c-nVC=tHwqb& zR5GC=g2 zPJsAa2wqw4*TCi|?ec#@XYr;{IPVOowvxA7pJ@$%lYaBTr6i3_id1tCF9?eX*FCp? zU4^Am_^-=zV~TAQ)SINd$@)H`!opoav2FH}ECJajz!X~M;KHKse>0Hf=D#95$j{a= z&LW+ru%?}DRCLUlSHUvV3U5WJNa*8;zGVUWO-`4Kd{g{3hEg!o5L?#!+rxnyDD=wv{=bd<|*;kX@2uF9>RE2kv0z0`5%GMiX zxKmw!R5zSJr_W(|LG&9hF)Hm@iMm4aoXK15DYeU?NzmCyC|hH6lwKTLk>|H-9gY_9 zo<|T)`xQxnAyt=fsn%Qp4f9ZJ<7foj5&`a;YGIt1>v7m*y@&pziJqyjrdRZQ>ejrgSNwp@>tLCL^;y{LuL5JM@36z=-BS3kfRb)jp)Dm< zr^-rlXUjqHF73k(Jc5u6yPs*L0hC_KNwC@`;&kYbJ=Oj482lZ@cB*qN$X2Bjk%cxM zrcX0z#tIZll*(3qv9o)EFL4$GRrtJ^{ou?9akV9Lvhyv?&A#i)n30-Rc~zjeLJ(Q8 zEtH@nHb%#Lh~PI*e^Nf<>@bF;TzQvPsabcJQ&O`k&htUiMbEMeU%{5hIKAV)>-1X0?X{j&q2s z)j@Li&1r>L{_liGhbQ;cb1vSWpp@-Q!;;v#ab$f_rzt@H0LnF9HeSd62k|nV(ftam z;O#^HJ(O`r^m5LT@JwiNZr8xewk-QqsLV~$LUvS{KiY9d4E)B)35QhmCkJ8qhM00; z*5zjq8*E)h^A;EVQPlK<8>HXB?AI@!=4#-@)iDi8fm4=44Jl~}Xe5F`=&SG29E+2? z*lDHEX6EtMF2;2?scZ>?8d}gAmd=!blW%n~UpYJ9Vq7A+ZY(AE3yUg;zb5G_>gIFv zxQMdKmpAn#M-zPobeCitPdloZmq(~k{{TiKd(=CRE*?V4OR)WI`*R(ZMgIU)f%u|2 zxTpua$YC%x8+!v|Mk(`lZN{dRF6FzaRnkIyE|qC(jdY2SmsCWQNuc{FlX1y+EE1%t zC#9|oPUb`8B;TliCEuXd$r&W(jHJT42Hw#mp8$MKhlEz~nDr)4;b%<~wxcVQkTvl1 z=^0l7{{T@JF^?E)IDWG`Pn1&#Vp(VjQ9_HBS^~EU1AE1{55h)j$T_pPx+C(W=BH}v zo(0K?xsnU6tdec_M}PxBBHlRk@+;i$nTw9Nx@w6i%&SYwGcvwXE=bCbr^H;4FW?}} zvJ70scF7AoA3xB>oC6M0V6 z34#7>S8AeSLw(w}h4lP=g=c48Z7G|ON?mE>r6G1C0+Op-jec=+!0`=!7s-|UP8B6( zYH)*zDGf`B*Fsk)=1`?7#Yj61P0han8oW6+r_iCCN$*+1Qh44)*2_#S<+8Q3vV@XI zPGC}OPoWXqs?gjXm0{3!CKzR4k!`jZw`@(;;`I}9vqt-Zr1!+a|hE= zhv|2AvsJTcZ5pYzj^#loFu#q6wc%Vh4ZX9Ov(lk}!JI#5g!K05VM$#4$qr4qa7kC) z2EgSWePd6CG>Sa3u{YX39t7SrYN6)ba9 z%0r_rrN$1cLCbroI_Z5iiz_SWMO7(F$C8q>l;?vrX*)eln!U3P%)6==Q9`}ak=7ZU zFJaiqi95lrEz9v%So2ZrwK-FgdQo;t+gRN}B$aZ`=~3wv)8VwT$~m;*woSN|b=nB=?2vOjqW~TNAND$p?x!b1lU=%u6by zq)o8$AC`9A;GoDQ1lXLa0>losFpODrvCNqDA}Mh5i?XdDnk7v^tcAq1>b=sJ54xgG z$v#>}rw&AC^22gUVQiQ>eW3DlO3Vczz%@;dhs!AkPKG4OS{RF<+yUbpmkOS&Vd}G) zC8^H3{G!xAD{Sk_PGT-qag-!$6&Wz%w;<vm}I zLrOYpdLY>%j9$=oyeCjmnpNUlN9`x`haoM{nJtQ%tIQQ~Dt*3+58vZ)8;pHE2+ias zOoKz{Db~l?mT>%%Vp<~=uiBED8n4V7Y0H;C^N9u!z?k@%SHKfC+mR}N%86Y)M#!PT zG0eoWgYPuI#?cOZhvCe(ZU!~Veeyc~;$oXAVG^IQplU-C&8BQwmCQPo6ZTTGY~KwJ zq(qzCl^#Zf?3=h9QX(w>B9^#XK4WXN{(oAB`3^R=xk*(4Z zEZqF8svj(>$qw>WlP*hLODRZExf;U?bm@+1u|G4+Rw=D2Wi6%E$xArrEC7J*kWODy ze^U>@VrMeHM*|&BAa1&4{ZA-GrXsr|9Qypryj8==d;rBloP{v@HA+_6MeL!eu}zel z>6k@_A`OuL0J07`m%=!#Ds5R(tmth-jG=nv1d=QX(ghn0L-$0%lbFvGH#bmGSbeq5 ztP)7eoP;LE`U`3K!>S`rL%YO2BT8WAil!Ho4FCjO`2a|V8lekvDa>}1lyU0@oG9_k z0=^pB6R2?_W_EtZ-^v*=Gb1+SvxuL{)2@(Hbv1mCfP2jwSb<})-YU4KY_Pzo7JGy7 zGO;wVTgVMfGP2amK-?w3FLWKtYXm8>btxhVBRMm*BT$(@!pE@eY;Q-YLwT}pOAw%?~Z)WVx>;5n4?k^+&;u;w(Y5pph{D@NOf z$>K#bKb|^Rz)SxCC^$m-GP4Q|gQL>UsdDT7vU{h{*u{-m0_cBmmu*I8iKpV37N#1t ziqP05$EgcdkHQ*pL(!O}#66pEXB^oxcxG`D^C}nQ=WROpDG3C_GL7@~M2O0{5q(&9 z8g^Hk=C)k+eA=lT#mlPScy~bf#ZMK%M>70M{Q8zyIF}AY_w3`^`frP~YNpOhp)aMf zu;MS2+hMASj5oABm+tFSUf)wo!ttIa%yoFnMRKVus>G4@X~s}_?Kz`!4I~mmfcKOK zx^JXWs_XpARM?ThG=p4_kacUyz-hNKq}ZuMl^n;YhMvuir(>U3$BM&2Ey-Le#>8v^ z)a-sxAfc+C#Y@JN>6wYLS0>cKVrjKls2f}0&l(1=O&>3&Jx~YnOjA9guvhoXW>V zHU)s`*5hb<#8Un=w&d4Qy$(Oa=)qqTzrE5}dC3}#tyP0(+FMtZaU}P$n}rLFQ*oj4 zgTdEy(@)QE@pSV~^d~P2vCOV0r!IDy==#)`f=L$y=%AnugdGovirkQJZ9as^O-Wh7 z#*&`jDDG)c+v!er-azgu-tt0*x3M-JP=&J{4N7elNjiL}NY#0eJW5m4bsmw&%ms~Z zL8oOFDlH)_+$1^&x=FCPJ8KD#k=8UbRQK?t%RgSFqFrHV&Z3|Ytq8w?8+3Ms zz`~9jQx%l9fUMddv^5_X4jR&RLo;-*Du;@7`5uwm1E5_&8B_rW$9U)kZIa0DD3tgs zTY4Di7@JX6r8$R|@xV38d0pgQ-B6+VM*!v$^s0)bofanLr*|K-HHUoYPZws6~aO|+2j=-lcMbUvf3DV#LfeG?11 z9Bp1UHc*7vqoC{jq-QBEByIq@hr&B&D9YQdgpEp4t+Q!k;p-htEmceAx7&p7Uo#y=(g=}r0b{q?;S@O zy(n3kNGTyhqJ%6-uQ4v;M=}%*x*o8a3$W-wc{zyng>wVJr8aJo2=o3TI&j`%YdF{E z(i}|Tnqkn$1ds*yCeXe|46e)uKvwBJN9XAe2{sAqxblS~loU7>v5wiwGH9V~!H$C) zs-F$z=9XM(YiyHp1+DV5H!Nd|Ad{ZJ)6zP&Q0jcIf0dz^28R@rIAMvYV`mv~TlGvf z#}G<{_w#oWtAmv2bo}BLZcpGp4q^^P>wy`}g_I7#b4Xxz%vApS$IyOpZ^0{Ne-QRM zjaF4Th@`}N8)$amTxCB|yWS6K&-_8kZJ#HlUDqR01w@B2m@rYrtk z(f(+Rryi-Y?}uZc7a4|IBT8ZG2x3E#ITL!eqvT8w=5|MKg->%5{l4;lD7nUnvJo`b zEmfW$;}iKsPZ7=hNipPyU3OChdO|pEYvMDPkj8Nr0#mUA=zeBh4k;+GCi`CY(l^{H zq-V28-g}1hU!ho<*q=m zznmv5ZY**V+_4EOWz%TEaVzn&L5b`^zTG30FHc`k`+w&|jtlso`K;znUovCi$2qbx zr^S?hQJ&4rnG>q3CL@lcwTCxY^AV)>NB6!&T*L{)lR{gG%zm`1gZ!Zy_^XJ;)A! z0J4RSnr-<~?bb#iE%^;F|n+0f`?yq zPPr!19$&oUXi8RnNEeRP2yAO{2WN?iP*+NvQ1ETznLmPW17`+?qd~-Y7?&rd%k2I3 z617{*j|djwVhW*Cm#Wq2^(NhKn#ocWoWnJU+S}>WbdFHF9`|cNU10C5b4Y3vPE=Js zZVr&GG;>v)D)m@0)q=H!Mj>P|;+*`P+vP5lSX)zT1JuLkVj#vSqROD5Lzv(i6oizI zTagLaP~FwBRH9A76K!di8budGko3j5lft);CEv~_GVl{waC zQjpU@D<1J3U^v;UDK_+h%n2jo9IFLrQn^_6-AJ~U(i(9Vj#SLj8WxUG*66~D+p4o| zjNSkX{G*N|ddxEOvy!i&=7QRFBowJPNe9ToEhn+Y+a|Ub?N3{A4YyTlUUlYEW?h5kP>Q%vtx$tpsYe2^rhn=cw+%lR;d8M$+z?3$$tV`ur+HEQ$C_X9D7motHpUmQH zZm~8XO=4-urCTeDQthR?#`;~f=e zLAFrj3oQqG_|E<`5+*jdPFRq z(#HbB5I3 z8A~at85w4jfD)9+sVz+`9WJ+3m1K!292#tkG^-(Otqao5GL@9Qn{I2T>t0CRL9i3>fx8M9%cZq3EKw&mgjqR$ zw;)PZMww8XA+2{(uI0AWM-kB-iYd?1X|BxF8;S18&E<4^?JCHOHCLHz~ zYhjI`%FWZHl;N^bFj7^a%#aPh^7D&y$PG~c0PwL7Pj@pbCHA?tu`3xCW3yM43hwgI z3N|2WuiEp82@JL{Tvn(*Ol&yYh(jP*X)4NZ;+}>UqhOsKPRls%OBS^~AnWBa(#sAd zZm0z6JKB?LUiOAFM0yOBouByCMz2+Bl=dc)c?Gc8Qj=wXp7N1nuDTtfkBW_N+^~n@ zR6kgki9(Lr-AF)f0NqMZxwlXOx6FvDcFA$Vx{$JOjnnv&q0bJ6(VC{CJK-V&1QeVfsnIySi%kCAMG%6x)zE5}%l)e;lG+%FTmHcw)?btNuHR8g1^x7!JP zplg@fQj!pM774YX%vmeH#SLZ0f3X5FRtu(4+-;{NXQ$H-a$H+)_@9C)E^k0h%FK7W{mw&vn@ca z8cX)Er`K0z75cKz078?{C0cY3j%Q_|V8FD_tnz+qtXrQjQj$z`IrKhJs%$zey$h*TX zCCkv?A4n#~uz=blQWoNNYzk2r;@i7@PYDE|Jx8NO94OCp5Oo?ikty+FnC32$uGo?9G<_)!r zJQGwz%?luO_7icg_)4+k^{P{7gNJ ziaT2UcGQ6D(%M5R`1 z3X;S%>9%HCDGuc+c3)j?!nC-txVQ$<3oNyM#hwgqJp@)I?68Vc4OK9Wa$2~6LW>Ch z0Fbm4_pi!GHv%a#@hUq#th&R3Qs1|sCa_0rIod3{Qn;Fi^NK=pmys^JuG#`aheP+R zq-L{V)b280HeceKirqEvLbDY1zM#%g-gc6GmUIvUCe5s0ssdC#C&m#D5>b}?yonw% zYrn*Ymoc%I~pW?53f3O>U+@>{5&{mxQFmV5|0h@4c*nP=UK=F9j>QD9|QZ6Mrh zapMp&^Cn^?D(Wjcn|eb;#Ds-=5;sh3PB`LHl#8iLPzfHSm~t$6BD*-V+JbWz%^DsP zW@d51pqZJ8R?CV)39^f23a~cVs>1N8OG>uVUSiU>OL5!b*9vg{4+YdFc3!2EGUw(< zGi6E_DGrOE3+Pk6k(SNvM>kxT-f3c(*7zRF_VMh7RK8Cx%mEXB2St>TJ$ynuLUad9LF zoblW1_1Jl3XecaO@UOyU=!dw+L#t5cUQzsPVv(XNCH(-mp1#W3i(<);WM<(wFiju7^$vw zmpSIIY{_ic`d-)gM?4{EGym3dq_G6lwN?5ntIsIhg+wK4{UQ6dd3#yhv=`VCF=^BwF_TYHD~ zJV^YbNm_%FNh#O>=|FLI8=Go+ldMF^3)|vJ$0{W*F_-#&t4v{%QkE9t94S?aSZJxF zovxF6o|=@lIn*4{n z;DzG)HBj#B?S@-c#kTGiu!GR`Bv_LTDe1TO-0Zof_t;1A3xeYfv?>&IhD$7=rWprE z0b?=Lp6auv_dB0hb~!b3>tB_PewX>t3OI))Gk~!a4d7T?CU=8EO`9^>_fCgkaDO3u<$rdXGmk$zt>D=2N*B#u(bwaT(XWlGTK zOhU-1yYKoE@$SA~sPo8G-;CGFweck<{{Rg% zJ3aAPy2~_~8E2K;_P3_eP^Hh_~bdT*OMD(-z{rmU@phD&sdf z6kkf#mk8T3R?)VqfxWz-9j;su8=o?#jiVfm##UY(f|Hw~Y{ z`=MRhj-fjRH=upd)q}bnBOe0qQA(8BtE=1FzQ=MY~ zOs&NgCGhH+N&5`~Qk353!v0scNQ~8bkKf|>A}C?LA=G#><5P0VQ<4r49%D6tRfl;S z<4I`Rp>QtS1oKDLWw6k7Y z=>CvR<{o_037h-*3COB16?NMcUASa3E2tM+20SZb9Zn_sB7Hy$w(_kS;`9&Y0w zpU`INRAkX7rsZ8oESn_&jS4w#DI?*h$U`bL>+Y$Ol(i)O`J;Ca)D?^B6vXE$5>k2H zJ}#vh06t)-pHX;M?fM9D(x05aQU0jD?NN!Dc~vLcIRGO21*{tr9lN#Uh?JvE^0(-S z`^2dPPT(ap2v;kXl1JWY;1%*9!?<3{@2w9@dB2C~RmLltDx1Y@6cSABB$b2iB)Fvd z`Dx=8&|5E=0lnYIwH_DBB3B2rmG_Vw8S{6poWL92_tSgDE^bfaSi|_2`KN1)vJAUU zW=*6teW@v7hSZQ-DhD|3?O+peeJ^Nhsuzjf-$!CU1=1%c=OpIbR#d#$LwT%2Yi&cC z)w-2gO1*&T(jAN4dH!~GZ6w!je-4CN;H3oBX%+Cu$|Y^eu=iX<%kCg2z>K2NGcSK6 zF^TeCY_RMRSz@OnFEC0=b0M{%M0?J!y=z-V0yl_Ke^>Phuczd2IJ-$sE@_%t6kC{4 zRKgxfAx!dtvc;{cm1NrcUiT5$N}32NxAG$d-v%g~hw-|ivm zSS{WiI$mw}jEgR$8HAGD#G8uuQ07ygPqOlEg^d-wN`%zMxhi79R)lff*h6nOEs4@O zlJiMOOBII3xn4qS+i!uPaNSDZSafO2PW?Xq{D%Jk6LA8mGSwoRJ1&`NYHf9&Xa#q5 zrCpL;25Mmx^C%G#O z+S}piO8P}Ee*jLqHmRjfm6VsWqy;UccL-4zx`6KmZgm>oAU&Ber8w6v-yURY zCn8_nXdyvpSUXzBO&^BCa$LVbp?40yPLyrzM91=moSy0??i;B{q;*WgXP)Rt*C|$O z4!cD4J0bXVYtjt&2vVBuK6Q0WJ27&KqiM?YvAvR+mPOX!PRdzL{`l)1Z0vh8V;|xf zY(a$InU--bOe48Ew2LUrE@2KON;VfIBoM81u)dMOQvIlwFX6Ocs$bJ|i8ejC!7lvr zk8x8Cv^&7BqOGVsNY>^VlN^TbyV~_4<|GZ%@dXo?3s!2Tvn+8?1*+zUb;#4-tRT?%QyM~`sEgBLaM zGK1yXuAY-sr&%B+GN!-_00PW8m2M}hB%coEIaqRv6QL3_D*n{T{t?`3^Iwt4zF!CV znsrK{m#WijcT;6w2O)C(#=>wFVnc{?N!U2^!rq1|c&Aa9$g$y<;$Je(W*qN&Mkh8$ zW}h532$!wY#C>C$OuXW)$uZTDhJ;o(ZOjt9Ia!pi%6A0f6LpO;%rZd-eaNx-#+QT7 ztyf~3iN#OiY-3zVoJUKh;&us33Q%r&17wvPj$C!fy>14_O(Oa-*r}9kOjPeoT+K3a z>yeyqQGa!0UAIx-L9x=%jOsJ*bee-dtY75 zQRd;azlm#$KBe#&D#{a6#MO1FAw*0iwBPkm1>(ns#ie|Rxuen7OB_Hmpg{(O1;!2B_wJsx13dH z&8MHCVTT=-O^h2tXXyl_Ee2&wC?2SFr6m49##V0GeHBPg@bw|IPax_APGDctEuo=f zw>d z6}ToV4_?Ju@=CqQc5QKefl@%Qj>jI8j&^Y6s)vTOr}1tj7oMBHu}Y}iq#aO!Yk}gT zK=X%gxrnPGcMNbHW3-iZN^q%5d3okuHnUCN+!~FBfCz<~DuT95#gA6S<6&GWDS@O} zrpX{S!w3mT19CSf%$-Rwj?IzecFhhr=~Q=7yhdZkRle|!0EXh13#9nJM}CnykaLX8 zxJAoOk9A2m1RME?m4hS3#xlcFE31LLRGQ$OP3$R&N%nNOTgQ?000Z1}s0P6A zylJ5I6myLaHAb8L>Z-y;)moQ6vbuZ2-D%ZoSkmMJ?;%8iu2^{ty@KP65dI*~JxX~} zHN>{0bK5z6r36^C?TAUf!D_h%7bqN3I@}DzQk5ENWZ6NNn~+Z?YE?$+LdU$TpLi(i zaeeoMRf`!e)Rl>MX6STV1-K><;*)FYwQaYAH$8`O?#U0vxpcKq!>oaoCSgdjbhX+b z+S`00f?UhEauK{Ze4`WM6{loPAs-YV0|Z{@S|cZHZUNHdX+pP4mlE!xW9z~R%k`Rq z0X9yz&rHoJp`kbSJ&0yA9&%Guq0R z9mlH#@R(!i-{mcKRSdP2B2q~AiAsIP9#|l(_yvQ|Y$2|DisU`Diqy6gmU^i>V8a7M z{q=o@(g%*(4FqyWP{87xeCG|QFXAeKzvFtYVJd^WXd=Lk2muMuXf=dM(iatM!`Od= zN_|VkbwuZN+}_KdQ?I<{`<|B&KD&Ef#@+LPJou%+Ic{U|x9dn;ao*(k&`TqbW zCVu2nzPna{E0Z7dFD!rO5@9SEC|`4(!}-kG+FgV2&LU&w@*5*h0+0?Xr;ddL7=@FQ z_zy#wZafT4-kAsNgZY@G%vivu-aSgq8pT3-S*~MJkDqAJ5D??o3Nz zkVYa)x0SW5xLXPPDN?n_54t)H1SPG76JHN;B;lHsMs}5&c1X11+?R2a zW{T0@BQ^4XtBnPSv9vL!$82VJaf*&2cB&l9kz|P-##|XcMxUCSpfHt7)EeZ?ON%5SL*02d>uaQd1WCu1 z*8K>RhWikEh5Qh1s+rZO0_v3NT2|Rsl^nJ=(1JIKSmk3G6%%reAiO_5pzr~5^qFRr zZidB5*VZH=J1d=3N|$K-O6;2s5W`A0B3@tvmR}H(p`?;rC9XIo z*-F$@r`lT&U+pQ2DW#tk1m;EeBG)FuD|n1{udy=}i4Q#}>xyknuP-fkT6!%6SdWH; zMO%q7%GTrVD}N4R>ZH3y?Yzvo%1ww0$~(XiMf9=p1~%T${sd>ZzGA8F9?-FTl3q&z zg7aZSv{Zp|HM$dIt6vcp@kK18LhdE@VwjRqnwC$rG4_-!+S^FoRw}Z<8ryh{kx?QN zu^Ys0&-k~qtDg2RjbF%8op%)p@l@%oV>E{rZUc~(Z>jHMYnKH_f#4M(vEVPt| zR1=v#YEDC*-g?I+G1$a#yF03c-XxoeU`)i zLCDO>9ti~ZKdWKo5M_j!9KFchi*YSa0k{~b$Z}=Wtg4z$SCf$Ls{m98@IN?dV)Ngy z?zVX7iN%vF+og=Dl)$|oZK%IQ`wz|h#0rz%Aj9Dt|oZ5b^X)3kIxg9|k)Nct+fQ-{}#+>J}&N^=0 z+im40;lu;o3Lj-dYn}IpdGY~COr_6Z#0Onh^A&0qn<*oq1v;NQ5okl)4yt4u4;SQ! zY`EDW=8jZ22KPX)zo@)&`T&@ao37L51pCT$O(2_us4238(6@bkZFo~^sU4wJOvJc) zzcAwk+cPy_^s>^hkVqh%cD?#_5!!2h!g=gz(fAz36_k00fSJr44XHx^09J35YEHJc zyT@md$=@T9f=Fffafh)656&sI1+grpl{PJyr&|=*okyL-6mk zrXav|Hz~E{ds9WA@*Nf(!=dhgNw-nc(j8gaN>P1jrZX%GPMY{KZD0=2w0vTq!)^pQ zZ4yBrE2KosTxwfAh#7bn&2B%8zKM_&n;$r}hD9z#T%o6#n6Q=W522S3!GN7%#Dp|u z&}j;xA)|l+AzF2gFg0db&Yd(c)T3gPG)s=METrZhH~rAlv@GML#muaN&`9X8t;d+& z8x&|vVh1Utg36o;JEV=hH-rJSYZA34!h%A9`z1Pq=tOYoxWuz_!p)>44Z#|GAxbuI z$2TS=&ZOl&18?I60hPH0$hJrcc{_oWB-`?i)d98iQ&T8P(m87&8>dg08Xt@+O`NkE z^d{d}aX{YIBId`=*Wc1Pq%7nk3{1+bsi}o!y}}eOE#Y!t&=z;xNs(--!@4i)9cq9| zKRoM?eO9fI4T!zGwbmMJQL?uZv3C#w9~eo~5~dnbf^B2-7xd`>3YHr=biUidk-;-3 zU1qAc7*}=Hm1T~p@IGMqLTv3DFQvL=)>#g9%#Z?%aqJ6oN}Y-%r<^I4SxeT{wOnTM z?{$Q!r^r)_G^#T~shghDs7;1pasjdE0o-|O32ys}N{-Bw_?DN=F0W}#_bSS;JPq|W z^VSxhZT|onydXGt8ab2{Hnb@mF*!yd%*`mFCsLikKAk=gx&xq=mOH8e zL%_p}VJ7b_AX>u1Vc`xOF}TKIWRjmq0Op!WD$UGLK3~IV?Sa*8ynq64=MEt(GLlR# zju;&)Nz-U;p-F&}rEg+9#3qi}tu;)SoECMoC?6Dq4N3}J#i_I-DjYJ9nz?Bum3W|^ z%Jz!voCIadVoZ3Jyu=MlhO^RFEGaLK17si0(OWJ8QRTnTl(>}qgi~xiM|cUA)YEw0+e!wEx^nHaeDAvo)mmz3Is zt5oTf>@DX+QO>LSL!26?2qq!i1~{3$0wD< z=_~!FTpx&ygg=Cg`TU8uhb)=wqpNEC#33OW9>PB#OnWSw$MxGE<%pFS*-bgoCry(} zY=N>94mgb|Zbg?66^vOw^5*CH!XwDAi`eE(Ok|jNe~ee>6w_Op3~yv%as43_IbtUh zRK1avDD(yqByqAra7sy7eo-iTpkEG*?X;v=wv)0#x`D8UB*=L;=s6R(MKg2W)Z&8D zQIxc_1t-_NdqcSAq=_YEXZG^pm@XoHs(KleZM9~ZVGV_I2^J0n*+o8P;6>*Rn)>_* z^MHW<=W$%C7>a43Ww7L$kgIqFW&rt(REKM1(rIwUJkd&P{V0*S3XaF%} zq*l$60~ROw6HQ?V-vDbbuR0+z#Do*Z+VEC6ivD9lIU=Ok-@RC9+2d6DRMZ-{{X}u z08z1N6D=^AX{4OVb)l4l<6uBP7?BwX)H1UiA+AYgOD{Jx6S7J}YW(dIQV`|XW~!BG ztSGX?^J`&#dXJd6hcsB7LvLEfXd}M7pctqCK_J1CsySvLka z)gi{;<~XXGD>Wj~ZHA96A<0ycWLZc;R8UTa=R>KA+}DeA&RugKidSU(I=6qGNpgX8 zd0R}%)PT@E!lRrKakv_Yhwr&N{zp*R9p@loTs?9OvzU*wB1QgQ>ZE`xgHU9 z!0~d)v+2}ZAr=IuO?@uhmpRtTuXQDA2Tuzay@T9sx+e=52M|gm1}d+VeaBPHN%$>9 zMC~uRAH-dT!yU@aVX~1{rpitwV34%5hE{F9r~uwL_UE|tT6~z-OVzN2MMbw-n2=fO zm91ev1EKlCZ83Jx;$W;FM5k0(oI~>U$y6wn$Ua<@E&?2+5oR}wx zxK9Zw4ou-zD1Z}b##D*mJT3}UyLp(+@i`?WN>}tOvC`;Cyf??nJ|t-fr`6?LB`OI+ z((X&D>D@VkQju>hL}&6jE`NT7jAVxqxtg1bLYBcpYDiLM8hsNfw?YuU{k;q@+xy@1 zBq2d*c|x^JRUC2CYat=V6MqAjOZw>uZ_o2XtA3xThp1AWt>{2fK{~jW<^dfnutS30 zTEh~J{iZz^Uvw<+O)-GK=dvLwNF$x9#r++*P5iDQxjx@d<~v`1(CXt{IV)RbD3Fs% z)p3|D7DAKO%1yGL0w9dOAdt^f@MN_$SCy6aa0vvq8kiS8@gc#U{KG>PCBnlqNjC}xT{6nC+UfwLkAy45uArm$c5*Qk^YWPz#EX*ZZ6&Z!@ORMMT~-#g zu8|JK*p`H)5=qL+6)QJ0F8iujQ%$!h5}-%DnLnZ@_0@F`I9{&DV-rt~w92LurZoF> z@?{X}N|w2T=3+*d&wRT5kOF@QlYv{`Zrx72eF*Z`7^EsvPRq_VsVStOmd;Y*6reO6 z(P8;TykbF~F?GStExSyUD|SdN4U$zb77=|s2>b+2$FT=AC|XuKK~gFb%9(A>QmlRA zO^=##-X+Bl+)C-Gw_YsY+9Aqsb@&-ccdab!=NN1UPLwgX!5>nngh_qnMQhCRJ-%hqzSV*QgD?wMk9-MsJA8 zt@bSOEhtu2CO(T%`gy7OR9JmzTAXPlZFUu4cn!&dB=Giv0XXD2^OT=d2}}FE+r)|zCb7*Jicl>*YIgR zLO7Az8Dv$OH3Tk7by5<`P|^0Ba3ewWO`&&~x9b9gbcG}(v!h&9MxQ)^EiCm?QDkO$ zl_py1JxgfOR^RK1zh1B zgJXe2rdKP)ho==KJl(9NhJ>q$z5U111I}sS5)2|zLZXhQ8sU7J<{XuEa};F;^Emnx zrE?Mwx~AJXRGWRL6iFM1Y0tmqe~|5c-2;h57Hx**ueM$_8au%z!4Z=;$ zz&=qXF{Z}u(I;db3o7!7*rGQ!ZJC&wv7wDjYq-6P-oW&?Dl81kVMtb6+T!|)*zO~* z8Wf}|@J|+`c!MB^A4S5`s8BZ-_(Um3Nb=lgIEliFePzP5mR^-3R$OlOJ}D z+P-68&IrUP!wLZrBxz}oKxW{0=1xov)}_Ld42;6jk2Z$qqF!!n;DzF3@j zj#ml$Pu6%=99wy33xEYE*$#_!D#~;Gb@PWCV_Fd^Xg$B%sjx!XLgs+c3vo?c_!E-f z7>AKNBtom1C^$!tu^$)Md8&;a5|WEfT*7ZZF(-Xe5~TSMZxp;&7Z_~^eb*w>hrr(Q z+qYA%iFk90FhW%A25Z~o)IPS4I8y6s9YS1qs2@d(`NMd)``TN1uh?>YJ@3!y^%#sV zhj@97Dz>OnTA|h3(b-2*wv0vDsp6H<~&Ibz6IcZB;!(Fc0mGkvtX`sz$o<4xUE3iD>#laI6sNK{$%KI(w^#z z2<+v-7Wf*%oU1giY)8c#^qi8c-mffy1VrHW9VJ^rW9dJH+C1cM=`qP7z|6 z0IBy|GYu!b?F~GKEpENl6%UY!x{*;V66|01VvJhtUkOURP$6sOfVG4KsPqL{K+Hzh zI-aH>W#&H&V*84`Olt!$r)Ar6am6Shwwg&Ktc!%Iz~%9}tRa=VCPp???-Mak5IEac zRTa5s`J2P8ae}t_562vy$$ZNQ;GYU9+&Gp+K2`L~PV)Y_C`oLs z&$Oo;Rm{!#gOySIF zINCpv=#{Lztc^@a&3ikAN3SuIG_!3<1lWk{h{e%kjPRbBT$5?prkqoYY-dq@?AN#6 z&wIlpgch5@sx>_dXiIYtqjDW_ZvOzDqHX0Jp~Qt0mklWDM4Bt1vG^XcOu}} z!jcw+0_YUU6l6@SxJViR(kwp+?Fvf9Gl)H<=sY7*C7*FAS9;fja2eSALrax)NsrYrbfk|@|&8a?UD>+m=h}0gV zSX3id@cn{r+WCH?y<5U=V_Zv!q>$)kB+0GCl1J4xP^S~1KJo&GhPuQYtM&ZJc-R*e2RvrjZt0 zw(EYhEvtVGBCj1hnzkH6vg=B} ziy=5NyDK=fOgN9S(p@Ma7xEz~1*7H9dP;%|klKQ}n#B5}YeG$tKRLKK;W z1YHffkSw;#NltY2C!{p|`tCU&){fr@c*fLdsqR zHmKN}S|iULZ_tpZdv*R|KZO!Wry-hnSSogEQK0h*x-w=ZNek0OC3#5L*o~nxT9~*x z`jeA~Qx9U~)KucTp4Blf!Ul^`IN;~2M)}# z^8N+K3H;)8SK&hB>R%*SUJAqOpQYhCiwVu_&Lf(kxM{>KH@|>Yuj>pqO?-b)lf6s2 z7L!s(4GE>Vkf$0-m)-kUR$;$Wc!K``56kzlpd^c$K)oV{Jyg%stOrXp=QG`dvf zmJ~dQCdW(b2PD_TUDbKfC1)$mNm7LCspd7wY^^p1;aNf7PPZ_pDp%x)afQmf*$q2R z(nk*Fq^eTg2vgV~sx!|lvVAx@TALYztg zQi4^v0B>#2lsfs)>|VzroynW5(&js>L$ghTu@_2IN5mhIfprNEmu-v{Pp?f&O^^)S zn=QIie(I6VNXW6c3e0tfBP}oFLs8VX@3GdD<9#KpH8o3dsi`E&IGIb$pf(b>LWoM2 ze6|2#Eyu$Kq%`(v?t-`_!stW(QumK{jGfR2Yv2=NDSdcsjBnaJT}uh6xrc`<%k z=9+MNjiJ}L)7d|O<=`sPuyV}Okm8vSOeOAD=@NxHNLzobk^$F3FAYvQg_aM4vBNd_ zbUn;%*4!Q0hRDi%1Df|&;x@cRdp-R~bI04$_9MS)$%WBZPI;qZ^veldw75#jP3^cL zcGti{p&NfM%leDOExv!5&B8SQ0OYM&V9OlHoN1u?N!1Q6U1~`HYz|FttTOkd<@u(` zFLm?$n*GJM5AiaZskXsA=be^gDJJLBd zEAmbyLB{85D^2zzo^&3XABZs_HTUQyYw;)kN?$?);y+|@+-l0gy{#?MCfiW8iW2e? zpnVjue|%a)lKK8+T=s9|S=R`IZea$)#>gtNiRcP|{qawillYb^_?N@w#_O1pl2#%qSuMKL=^X~Z`4ts+Hq>DQ8=w$m{(6zL&ESfv^zN;V-%+ALOI ztNq3tHv0Ne5@gocmYtJrTB{b)ln(vgOMo9gb}S((Un0Is@qGUPVntzkpuqE$*{Y+3 z#}iy>haOJZoNq;&+Q}MUz(OWSgZuOs+)PW~OJ+GJ-pFOA=*;l}tg>lLl~tpeazOIhabsNaJCwQAP3f+pEF&#khUK=; zmw(((@dC9`;!KpSE^<+B*Lkc8eCkn^Zz-jBrKgI!#c3B(2;YAgbupH!mo9!n=N@rY z+;oO1?aDh!t04qdiAN#lmXrpqq0Hk-NGCG%u@;WWiiZCHp}@wer13U|Cor_~>-0CJ z6ELL!l}tznl7%TpRXCI&i<4lDdKhiJh3VhsZSgmVRje(Fr{pAFFE>w_ZMkNNQk3Fm z0B|+{J@N_4k!$6KUNngi%H*$ZOY%GXR>U%VPoh#uPbZmCmu=>>N}Eu1JjB~vr6%_W zXl*SlCHRpc@iWwZ98ApBWNFGpWiQS#F6)T;x14n6TZ$sZTM(1)Te>tc&*nE;tFR=rcCVAiCV zm(JUb$V;wy%MM$G#&e{)p}Y6*TgK5P63XU0;8!wTYfg!6e(6QX$_OM4Aq^c) zx9ml3C05| zwCx>kB|w4*aezgL(2Yi;NZETSR6b@$+7I$8TY-|r{6SAh+_dN)*fD>PnljIq$dLV~ z*i_X@nfmgo9}u$+W#%IP03qeTY7AlOP0oUtN5ssz{3E#k0AJ8VzfaUn;>Sd+!U1;hUQ-;@A*&#Ya z$U588@3|Inz0PJEov2|NlXLX@BBLy9TXNwKBzw%b1&Igjj~hgZ;!;Bq$l@q44l8dH z&#Gs= zuf-EFborB8gR&{1VVY|w09sL{8w+Z*g?{+VaWb~e1{l&pUy5@XoTQ{2wyH`S-qx`s z{!vWH=_^L9rIOi;fvRsIJb@P5dtG?_b6UZl~P2dmwK^=X_A6%Md|r;qdHJYE~8~8 z$5kyOan{#~v0D*a+*0DKHT<ntP|CIQGC8}gqZT}kMl1E$cI3Ob#PmuG$( z&f_p9sYpEju_~ml!;M4jAf{D0%oS@ zX@(pp)h(3_joC>-N>6pR!h(~ObpXT+*)*&4CSiuATTHtR zQkp{&=m>4Jgrosr0N7YYQ#`HNe~L7XMXbaYNk$;Sbiyjm+0jKM$AypyFue_&)NrfS zsaztCbmYqn<*~BdNID+^Von|&Qezo1sG_kdc%oXp#aADcSaF9+tg*2L8jtiW60r<_(~=1+*u*QuY$hNWFhw7ZfsOXMlnnasA`u+uh)%5U5| zix5VU#Ptf~F_pPhVa|N)yu`qqX?Al^kP@!y(BK{IcCqe}>kmh9x3D-h@1yE6N!YGz4b~0FMiRMf$_>8IdJY(3IkXDd-U0zCt7-GvryOBXJbDcincu4YZ|_e1tNN zG75Hmcb_Kv$^>3<+gw=KsF<|GK*}z7uZWTDHB>ZywaRNnyKZvbDz{T^w&@d59g&lR zSXq1?#+1bc6-(76(sk&vE8jx%W>wRL&N|w))BWluFPYN+=_=!rDs5sbZ*HdQ@ zHAq@XO0w>9++1He@d*R79vMD4K zn7dOSP3F~ObahY5s(WK$w zsSMW}yBy)JB(%Av*%bM``O?WlX;D2~NKKXIbTJkje51EATfmtKI8WJ^5%4b*vpP#t zGD~V6E`dfht z@8TKvq}r&<%N3=EQm~SO6uh4DTQ|{UUnfN#>CnKVxye0;gAdo_am1=BGD}O19d0em zY@OSABKcO6p$AbMo;Me{$j?&P-)VF|9IjL^iiDI92&zN8k*$tpnrCB~gkzS%#DLA(l19KVsr8#k~%AgSRN zl7`(={Hu(Mx{{<{VmxiJ8$l^1&ZS6FClJa?IOEwC+YYEWQd9aRAA4<+cxkH^DQi^5 zYfeeeORcvQ!BDzLRnW24-2onv#Ol$*a%%ue)H$Y5a@83My9wsEmxe7DpA(7~$C zt&WZw<5fe4;5O$m)QuFAaz(x(9E99CIuVl$XU!5b0rsY*VrMxo9!s7JvQOfux5dY} z{{RtHmw-?BNhwUl616}JPN6{lu>LV|i;0Z+GNUIADD)I5a4baCDGPrCVB*?o{U3n`%daG0FpxKTJx^oCQs* zOZ6VTJq#jI7MO>v;m0LNN>o&lU^5W=vHTf))SZ@_$b@(F~FfpmWdj}lqA4b6iQM-SKT|oKy&6D z5`bxt{p)G*gtbRbWkVDSNeP$*AzG!>3!wU*hC6f>W@f96)rFdL1#}?jW4C7mio5cs zD~Sp}t9V+IKxJ-qZyToRC!(|v0m*i)P?L7tuv;M5o8JDTOMWn0K|+e3QgUIe?jp(? zg#PQpk&(uY`5KE=B<5*hKpPt!LGUA?iBXk^YK_}Mjs+s{mH+{0Wr{%B5_B%THI4vR zT1(?9(iA)h1VWLS-!JtdXJoB2;HXE;dJ6mtp!`h*5Eu zrxJI}@mi0lQgx0`GYG(4(&^~I@~ucUEcCk!jHpV}U;y*lGn{O-ZdzbeZz6FnY(b3F z%UGUq(Rhx>6ERG>3u^t7`9k2gLRpuCPGv;GPe%vi7jXTE%t}ZrEp~iL7D*d;wodKU_;&1N-ed_)5T zHB>CTlC0_s(xFCQUgG^+@NICpS@^>frlkJ%6SzC?V)2;ze!JW8ghb#33wM$#X{=tSyFj5@1T zQ{Y=%C36#-kk;`oWnqV#-tRa606PJT7%hzcW=wWIvXYP3Ogz@ZQG1bMXEeSql>~dz zuYa5(wo7u}9E60^r`jL?0FtZx;+|aDe~*&*9xq-HI3?@SXrDlBM=Dgb1rx9ZKobqf z37*Clmz0)eQnztTr66TcIfqz_A`Y(N#!h6<_ls+8-4-lkidHqqW;o2G(>YTP%%u{^ z&FvEI09$z(NVSfa^)`iS{)CKM{^McUvVMz*X|wK9O97Rwz_!`Q0u(f{N_IM5UH68h z?gr;JMXrMJMP%?;nghWVlgAb?U?6?pn^M zAgO9mxJq+ak}q!|8A;@Kw=<~@y$=^q zy@m0o(sL`7QY;9#Cx6Z~95)%Q(<90t&EiG_%57lxO|BzN2V_QaD-!Hh+bK|OLQb4)a> zgYTQ%KR)$hd$_n?Vi@F5Xk6%m)QEcLTLWmrT+MTu`;t zg(Rb2POvm_O3fxs61kNVWHzETS9K&GUZN0m-mBpH6pIJw$=BC9ZIKBHQVG7Gl=r^~ z<3|%YoH>}6ov1ED5hiU+ge$tj5??DG=mEy~8JgQ;tdbb(vU4rTw@{=h_M34T zgtYTzr%s<{$tXWD72Yt7R3La&fNA(DY*euAI-*8)xb}sEtHth`2&}C+k zl_3*_M9nr+Vggi^YBaZaZJ~x?!mU^I1$>M=MeP*q<`$EsOr;Y()DpKJQbLx|Nzo0e z{oRIZ>#d>u7&OYzr1}w$0#qfQ#WHTGX$_q-5&*rn^^4puajEhx5e{;VhSt(7=&u_- z(DJByN}8*C!O?$040Ku}lCZNAK{?QsTn~95{$dlPd1Pkq3V0hY#GFklPiYOd+T1zZ z%VdP0U0Q^Zex9*O$MGHnWc;=)Fn%g7F9qmK509Tn+55A7Z|X(y5+s)oxb(Nu z;wf0M=2B1+hAQjk0sAVswV@N?ljgk#W0ty)l{bwzhLdTjnF=*kO=T_3Q(P^-ard>d zwCF9YLZ1s4-4DlzXi-(WY0~P?a_UH}(+SEyoHBeG~rxNN-j1X?!`AJ;%=4l};ul*(OkiB-CtDpl_kl{o*2YcuhRV)?}4O z)$<|EDspn5@K{=$K{|wzN5BY`riNUMTusCiICTj6m9`gryvvK*dnV!>#)!G4L~L@m zJ&2u4NDErrASJfJDp5NCk#b4s1>#>K4H9#QeTgx*5WsbG*@-EAGd(ubjcMYP6cwxB zA|_5QF#bZLiL!HW&$6`_gR2t`x|iz-)wb#h46;v)NFX?);7J~lRhx@>Hd_*7i%6`W zGiaMG)u`mQpnkeRpr8}f*yRBA&E7YN&YvghIE9rN_Ugzer&Xq<9a2DPnbJyZHVG>k z_4`34*V-Cmh~m_!Gw%Xt>GBm;v!yP32qDm=Yj;ujf=KZ&d;-l`%7qIF=T|PNN?H^$ zqcTG(Ju)psqh7lJqd;80$6ByXj?BF_YZkJXr5%xfn6d+*e_VlXuPhxt_bE5N(2Ai} zCF*!}D|NPNDw~vjtl3jCsz5-$tOOS*U6FjxhamXLYZR{K-(MZCG(ky30Gdla~oeOLp+#aojduoi8ERb0HCNtv=# zEN2`@S_m69quxpAa-A-u=NIDeuQZ*_7^Awx)RfgI^P^&mD z;wGP$Q*zTzoW!S-Sa5~`8kCFWNKomRsMu{Bt^WXFNKHFILyjR+G^%w_gbOZHzPs<0 zDqp^vea^RzU2ScAc?w(f9&9zjCE{eY>`m3^53F4YPGn1}-3m@__sZ~{bobxnIilBZ znIn~hXnZl2RMse&VrgL`y)qgrHXQ*2czP+f`Ypy}`+BlI_Ho3L6X~cLU4){hT`ijISh=4A63u8liFV@FZ^ zydy}pAxxeh%Tnp~co#xNlvSuF&iYyp4I{eP%hM?)oK*b^aq4rxlgUE=0Gl{}#xw4y z9=5UbhNX_jV~|$MabXO$Kb3U!HoM!}Rh!deqBQ8m}Mwh6XdL*kbI(xDxN>za?cxt`oD(290N(Iwo_7(l6b3h31<0! zif{9Z&l*YW*)8LX>FO$+#Wegp+GUxw(f~xW2@7(=U>ioZA0Z9hictQ%kl9LcN>;Hv zWG76;9sJg9x%T~;PmYC!EaYFHIfsNvmk%Vb^5^p!S)+Bc_;MH6y9H6P6u4%qF5Joh z?ybO*;&0UpI)mv3IlO$EUop9@WN@Cq_09}`##l~bW_p`)U#B`${-3JWfnaz76>W)) z4-3XQbKB4NDl_oO4YoeS(wu*k`Zi8`=o+oA?6btRCh7a6>gz}KR5IQ)nE0lb>Qz1+ zC--G{;{Fa*xM?(6tTMJrkJY+C_IF2%PTMMh@dg}utd$6z{1?Ki&k1z#v2%x#NjknL8XDohtd3rGn@ZR4E2!XOr}6jJK4fgeiv9b}G()NP2}UO>b>u z&bY22<(szrx&5$DHH+r8j5$)Y-j&~Cnx`s55X~+3AIRd= zR7Pt9bLaR*-YZH=vMHr4PQ?NwpIUAkOQ{_{+a0sC2ewn0?twJa#=*2CW-9$#Zw>F| zUEd?NmvY6p3&OP1sm#n^kf&!9!&c0ET<9MezRBD%}=2_x`g5LM- z%#;mT>wO_7%y19VHaUs(8LXk`BC%KZlYVP)&DZcsyq?8(cFW>2D(h;IBDH~Vm9{}f zQ?{U+kBE&=vhdgAYvItY;-$8pub%cW+&h_H3Z1!_15B=IYyG6^ z3}5Q9ufnc>LAj_Rn^Z)?*k*1`@{*>~f)vT>Lbg(Tt#Jym4n3@RI4RmPufw_(&!4Vq=LlXLp2-<2-dZ@~G1fN;K+$nwcwEE4S?5GRC$YA|DaO zLkj#{`Yxl;!18q4yDUo#V8`(Li87T03#C5M&Q3+R;N5C&!33YYY^cU(;@)1VF5JH| z?l4eW#lFpNx5RTDO+{(D%*xHAUn+&~_}pvd5Z%6somy8XD4eFmtw5zKZTS}sfh8rd zE%ypZ9}@&p_*_Ndv>GzlT^-`EpSDOPUSy34F|+nUsV=)c`I&w>+Luov zs910*r1+82Hb~1G93ZKu`DsOMDj9^>>-we=`3$q@-bvu5LOSIHL_$hAs+kSyO{1v~ zh`dF_8EiJ%oq5!@+Cj{6KJ%ku*ZYL z=AP&O&~w0)En5|YZlN>{+ROcu(iPbBaB~w8cwzpDJPS*qt4x}CT zhTLg3EjwtidRocEn6*Q6vzPvHMNVzLznNu=^+zus;dEe%ULKi|R#zn?l!U12R0Czy z=Dzk;*Sto%d;Rq!rO)I1g}pBcH(8&iqHDaWah7qip5W#=ETW@f=CW>rj*REG3$2 zD=aGHH1aK~3AeqJD@~zVDZjp=T(3{Z^dNU_q4d1e;~@#nnoaP(wRf8rNbpFpCflgo z>u9sXv0s;!ee))lW(I{pbI3|TT8(407_r8IW4lARfuu5T?z+L4dYLnuVTuuOw~IF$j?-nX>B3GW*dH$$<4naeQ=faoC8lSD5ZYL&_afU61xIC;vRR;@2IS6b@$MDF&!{FC{jRE zs#_^qj_UVse}MFcX1_ET<-f^{b`6(XwOaJnPpDJA&JRT`w2a^9+u7+^Au(Z( zoqT^nBzZrI{LU|BYCDxVM`e)enOI@Gt^gHcFS<^O9w|B)Zd}PuT4J9wZyoTxs(j?M z*g|DrVr4GLbRuzZFoQ|wK-$#MBs z`EFdK<+w$z2)NCZ*z9b4;oVgI1|htDY)0@y3953HSfJO?iMPEmXe@B z2EhYzZ*va0UDm>78m_mu>N0p^4YQ0X%l1bWl_k=a5UZ?9WgnnY)N?JBk(siqmT#1I zL@B%GI<^s5Mdc?I$;-NqRKjK%O4~bvldq8np&AhiOY;do$&R)T0&x$30Re8L`tw%^ zV(d+`SgG*VY1b*PvCT=oRjwhhVP1MkjtWr5aWa#R_ zEhH=U!fZ{4j4;&=M`9T>1!QC;JF_6yBbPHf~ATxq95gNVPh0 zNfWZ_(%i|UB)p#zL2ohJQ?Q46{q?WdLVTB0>(c)Ka=B*Zn|^y2xUu!CqEm{0WK6Z6 z%W#;r#`a$q`VcZl@jsX9Sl$lG<_LAX!6js&2KMi%VJHL4s=!4)UQgm!NBGyke5j?# z`fQ@+2iK%DrT*ACRr~J|`K9q+n1{5V%x0vqG}SqZ)pwSaIV8&Eki6FCa@DS$ zR{XVogU!SGdSw}@%CbpAZ%rrIUgTK(YYy0O{gkA#Fd0Lt}^3Ng7TVan!byNgTlIBdD;+D<8=d#m@ZDBV7Ivbl<8)`0L?0i#=C)s^a+r*^b z#r|VUKf`*otuC&bi>aP9M}*sNr6C8}7)ZKuCr^ST4ZD^vTu;2l&>l9x=bOmVwR=1HTjFYAHzvb z&oZ?twkau`oLupCMdjVc3T0dRg=PgsDpyBksUihP&uh$vnH-g ztklGnU4$n@sJP-AnrwI}DmjjV_r0Kw{QDfq%WjYF=uLhjROI-;2Kqp8l#jnDbT4prjMrVZ6>6Q}`(x#ZTFrnXBZ#1ioEhK5~rD;0dJ9xs^>?W)0 z`->{2GG7@s)lPj4xT&`g({h6067!5YRWP)#ODRch1v!A~0XdD_5#`(R=r^2Y&dmrs z+LVVHpM7akNe1R{cyu6}gQ0~l+)Mue{{R?sBiwF<<_v5cFHTw4Ej-))Zr+aK{eM9dE6l2oTqp9$sdq9DvCTju`Tk zM^2fLvW;V?iJNdAq{aDq=o z8^Wg!t7DLtLNzysE8U~9t2FwXN@X(YKy{mfmRWAs15t2oxZd$qows+;pMhIN%0DED zMv~KM32g}pN{eC#GAdlI>Vsa;R}mIU`($ zl5dC9UM0wT6zT-D<2OrFNlDC*HbT-Zm<@&Y=?`Saq&Epr?{Jrla~+D=aAsLcklI@BrJbqbbB; zapqrP$fP;xU81Rz%!pOYC5kthH-P}2#@s`saK>2^m6@c?C0@m`D`6bnX0>Wu-1)Skfl0yu^r$?h==Zm zs>uHUz&NJC2uQM4 zG`J*_8NB%P?u-00wYajuw1(-}(-I}s{Z@7#T8Oq(t)!`6FUA{D7pQ5f756x=QdL>o zi6%;sPh|V3X(q+nY2ID0ax(#?<4eKf(yXN7a%yxc=)TTSqY$)<%LbPQcWx|~~g!MKi`@$lxcgPzbx=tCB#F8#Z z&$5@K9ln(8I|gcD9A8)L)`ZB-N~Whk2kIsp2yMoae#(MDQmx{x zeBz@%Ek%YLnn^c;c+H2nqTphgHT>%-QI}d2mDq1$paHj*v76#BHMw_(Dr1C{>u9ZL zn`Yef+@=?mT>U}Bvn<%UmU{UBH6|ou!sW zZzwED+cX=DEY zI8zGfagt$!&A@YL8;M3fWpOv4(HHO%Oui3L$?+9@ER;qkqRTk?+cL6FI_%W5ttDx3 zD7gwrP`VTqVR5aDH7%IpD;J1(y;#PhI{RZFnQ=jBPKhZB?g9V+k!|-jiO`KAES;R} zIQpgMWr~f;USh|<1rZO#YDCP&jQbA~q#RD1*>;Kf2$4i<*sv};6+K8xXgN~*tTy4> z>cGsfPk{;65e2xJkz&yN66dy# z7jChK+ zoKxhEiBUQ)QXus|iGqb&sL|YPa!kzQjgWHXP;im}15Y0awSwjFBFM46&sBtByd=4o z$jc_Fl`G()us;zTmMdZwN<=-ywG~fHvR?PmPMw;VC&ln`-{)wV6{KOi5WGI@X)DEy zAt6zxyXbT{{Xr9SfT|zNO=_$4MSulmq7AS zU60`pLyJ$Cmx-Z;!`w#3dTsqwWOu7%Bx})*DQsv;> zUgeHHCd6HDgAY@t3X_&%S$7L*NeEhR_L95n<}|+h#3zNXGFr@;-l)npier*&q#&dx zltzUMPN0$N*JBM(yCO-Glc-NTs&vw@^<`hCKm~HsN2-+GjRhU=YsAi*txM`K*86P5 zZZg6ck?JvKpI=XijpX=|p}yh~Xip7GnE8NyGl=Mw|7Tf*eMQkr$t&fJV*zJm1P9$yCxpNKO!Jt;4i*?!%&e4uyPF`+bnBG$8)x=uF zsC}S(ZNH2FBV^Wr9#&!I}@-v!*YdM z6&GW}P{WL3l`AR(Qvh9Abp#)@IuKz9Ssn5J01Rt%!X2j}m)4zBl?0(gc!Pc7Mkz(} z8pxkP87+-*4hwQzzT=Y2OgYKtA$ii1=^ae zfajG)#6?allBsEpEb2EYvQj`&e9w4lB4jv;DC>#+`aBPUH)W=hH*YDy(VX>D%= zty>E!{{SqpDn8JzXo){(_9P8263f+_ORcKtSOq7<7_i60#$|R+8Nly_0}`x@M>3$w zh`L3`Q3+=#=P@YF?vs&SM!@=wp{hD{0OXAi$__^YzJlnu-UFu<^{QMI4}5+whp-xI zpH$EVKM05%UWx|9d_|#L&KVUZwuWEQBVv_!b@h&c<+jYBN-G`>b1qK9AIfRK3WF)+7V|> z)~YCcY)6z92Ea-!u(AAL0}GNUcn~y>IM`hr$0d|(6r0;i*jR`~3b2i_$RLCe2Z7V& z1yEVE2`1^%6mU99#`^vd&lRVbXG+aFTTLzvZkdCmGiIF|um8$}QqoUB1sn+Mx?WCG@bZFy)J|Dq zQ*D1ZMeZVtn_7M_^}3RWyJU5~7o(z}wa&c!DVLsi1UM z$~mkkGc%}~zbxGK8xim@-PzMB0Vm%0M-G_gC5`hZ;sLkg1p(rx5vbI79mmExjs{HL zV`2y}t2sv4FdQ|eq}rPnaS2fHQbGLToRCuHITu0(r^6a$O6o&=wSDHvPv8g26=Nq0Ii&)n?_>?(txieOu z!0K6NlH}D%#{S}`rgHp)fJEi(1>F(f4q=nv#V-iYvp*vy>gH436AOLE3KDnyBGrFL zkDHHAYeTT%$s=4xM~7d3pUrXuXmB?~xlfLI?3yWVOVKWxAoy-5W@M z3n8v#z@R9al1S)<+8aW$@+0m);FdDQbI!dlTSTn7mQ;q5EZVY;fRd|{JWNi8T_~)c z6(%a_oHgPEte}=wDY`(mvP@pyxvvZHg!l;9!F)2rICiRvm0qrjiW_Z6N)*d&6oqa= zl1=v5#9Wh1l?-hhnTPW{>be!E{xMA5vhFI7LhNyh6V=y;DD^i7O!$hYBvT0^>*_{jdG^xd4Mw2CscuLumKIZzaV~3qp?#M<)kt`bp~suiZGoUsNYvX) z+g`DrStTlpr+m76hWL%GmFG;ub${ghl@{LRj9BUX?;vO@<(2l zt8b}F%K*aFsa`5j*3$~*spi1c9__kx+iSzzA06OJew_y84MRbXaQyEG<|);t-E}gl zbTK-Fl3Q^L?xkfnBSJ=?U(PnXKOVC38F11&*n+yW8A%9At)={aItX_s z6R%|Y2xx}WoFTucZqarSuMFxZ7KvL*(x9tu(%eB zHIjz(3??yvd}lPG8`GK7s10<08NO|FyOgij#;IO!p;YA(ey920Bl zT2sE?O(x4%EFn!FG?fxT@)|^YvRr51)Q3`LciB{1l}c0o5QN|1eST5FkBTanFa>q1_I(>16Sy5WM);3PRoODA+8ebAFMG9}Yrq!tnKvupWk#X>jS=}cN zVz@}km03Ojn|z~|c8wWHl(^su0D}oRVxC&4sxzsWVB~SLbP>@*V;yH&vsOnQ&$mz& zGU-&}SDh}X1sjdDP$2w7B1*(jFR)i_iiHhrHB`+rD`FmH)$>yA`i$vOZ2rZElt9VD z-ytqED|q+CX$~)8c^aI%vf=4Dr8c<)Tqz9bq~75h&VB@>JD0%jFyy|m_47d9XaNv7b5#i zf(UlNfz%K|iFmk(&C+VcN;FP9D~X&#NM>b3ttkUB+}LbmLlU-e3CD_}T&7a&bp`(b zmB59`P?!z8m7Zk^@`MW|Ujz8+#|R`|Zgk4NP@*LmLkaeRPT_7P8-B8hHjE#(cy~OO zn_F*tqUVO4M{$|2afwpcwoB zGDkg%9N<0}pPZ(&sa3k^n3YjL3$oRsRBS@Uw6d-&c82kPvdtzur9~|9gCC=a)is_up+?{T}3DSX71G?_Si3`z>VD)woD zrx*+sa@3+ze860$_K2KBRSrf?7W;_!6Gg8TAhB)7yrMs{qC`}@c1n&$h&{(%9Z)zA zFojLilQk^p2b$3=INARIlz#W&3ywK=9oB?K1)QgG1=TTxt91!!_W@XwQrGzlkrPrIPtEQH~}tZ8l5j%s}a0b)>U6nPjG6y>+z1BrFSPLa%WNjwq*T z3VB~~#ltuk5Mi??J4u)ob^!Y3W=JOIUgF-&N5e?9!G$f?ziaZsAEBttzRJ^j4H0w#u;d%5RAs4Y%)~PxV1l;*U zZRr}-e9JE3p8{$9o*8O>a-M1rs3l@?wFDF|aF&70;85HxIc{PGY>q>)CH)h$lP@HL zS9PMR1fp(LMQz`wFpDd~>M>J1ZppBk8m=VOYZ&CV=w*t;n`;Htl{ORymB7oU%1!MA zRe2q3=AyNS+Cmsw>U6oJ-3UtEeZ-@!lB=l;Pg`2VK+`ywrlDaP?j=)ZR(@WgEoB0? zS!o48>zuD^np7%H&v+= zV^6K7&!O_l2Q*EBr%-G)0sEyF{{R$=->u`kfLP(oF@~_rueH@A<|eJ)4zjt1hHGj< zkf8Co@c}yMBbLt5%cNs@8uafzi&XkNT%bwKv}P2e&?RmR;CKb7*q9owfSsLbVhUkcK2O~|kO3CmB%D3ebaq#ae+kZF79COpp@UN>YCy#xyu}(8^ zdlRlxWdgg1X<#hdVpNcm@QZ9*3}gITzeGcxchhgH5Ez!DP{op{a-lgfG_^L8Ij$*o zxbr3@#|n=nLo&$a&669j0|!0D_-$gFlGte$PfFbhgk zY9mD?+Q;%g7>7f`A>4ad!q!aBDrK^494QD_p#U9x_NgPs@N zdNOplnCDd{*VPVFwMst}SQ52)CZAFb%M&dnWeOcrnLGF?1Q>b}Z(q03d!a3@tHvLOp6DFPZe|?9VsY0G-xawP*2TYD2B%kXG{{RTfWW^-= znmk$H)u&!*-_T97OOvLBCFvzdleuh?Jwltcy+w>MD5UpPN>h}%OIOGFocW9mPQ`61 zS?QEbvaNYj2@cx+1%2V`dx(>ZoyG1WCRVw})AoLOnL9Ga7$+?DI6TSK@ia!EhG zn5P&0ix5)VU^9@F0u^u$n{WIf1BQOgyfkBoH8sjlvo>VfDkW0MxF-4~Y6KLdj;Xnb z++KeMH`nTO7Cm3h(k;gXVJa>SN?D>i?1{CDO1UaNB)f7=_p#P7d9ysu?|(AKONyr( zUSG&w%+qGa{Dd^r(sVblLHTMw7>_8vsY~c`IU~`y`ml^j%DTISJuK-v1uG@}2XOoZ zacS=3XIql(CGx-ASII~?Q}vEFFrU^)5jqg=)A8 z`Rr7b0ptdPG~UeF-BLt+{5zC+?)#NdRpCZ2EU9$9RNFSuOs%l1e#(wv8mQ$=&*b2x zA2G4v1rn`7#*}o_S#_2Bb6)=dneh;(D?}d&u7}f{#bq>wGKJidfHd=n>Dc^n+9E$5 zJ5EUO#VTbA=gtsvvXXT3QOZZcAA=;v8C-14;~vw~b^>KmdB$>{<1HfklkS6I;c{X= zeDTDszmYEU7B`#oYa zhcMPEVs*4kw=F8$p$FYxc!8)O>u_|mGdSBNMpQja*QGGF7;a{o{{XZ}wN$4ST!lF< zp>AU@5n*9*%U0wY6L@D%GURD(*Y^}uoLto;OU`#v+|5gt=~4Fr5SD-j z`W-y?gm_<=uM+(T@yE)`bND`^AcO|Qm0o&Hq=HUlGD5-Bl1^1?55o_J(9E*yOm#RV zG{zdERa{l_noBOIb=51_e^$^ueEiqyb!6pz85*iMWN}{@&A&1)Dru5)2|+d{(%I6T zI%Wi`Un|6~;Z#I!*)cmcP9lvVAfSYWDoZlS+^Gm|$IH5GeIf>aex%G?y$1KRT>56K zil0UKZc~!o#>EZKF_+?QPWxI2?!Nv4`9Hsj8?bYTr%p_V61Nldl+4PTNwLbN)paE3 zLWQn1wvpNHzCz%re6h|wsnXl_36O$j1iSA{TE+P`?&P_)!CCBw)Q|umYh!p}K|6iY z9=dDEv2Dj!C3t~XpiaoC4@|Q(mYm3|Z{8C08wYb zz8fZLp*LTBS>~romYjy+wo*?mwF_x+skWr`v_#30>2x1a)42UoW>C#xk+SDxlpMF- zYzr&POOJqtW6$Fd$iEBnklFDcg0A8Q-IR6bCuGdHyAIenWT@)e(3Ftqz0gjI_f>HV zjI?s;`W)1!&ueDoGLXC-ftZq!cRQ`24NEw%JIm(X8Gsx8;0HsbH#urn`u_GV3a4F{ z=qQ@5&DAk1%!8#|mL;W~AOH{?Sh4fD)Qju{4O{#22&#{$f#7B=PBmU2ODYSL`b56L z*yVUBD!-Oy$q?p9?eYF+FLm&*N;Bh{0_(0Oij*yAsLe_^r6gS~rI$I5DQBR{oTEeD zAVWCaKZyH#U-(lQKGOL898SWF&84L>S*&sjPf**SB}2q0TV1bl(kJ4(SLe&&u@Z36 zYy98OaevtO=Um0U%Say^suKB*X8saK;A%9rN|L5rPcf%nbxTT#J@UJ+UB`GGw%Q^` zb@4ftPBOLG5tp_@a@9{`mvoe=rAsKA*kp0wk}vSQPR9QLArMx+e~`K0)Xd#o%EQwH zDY~)3{Zk#cN@^zG5k< zw>W;je=)h5T1)+IP0{gtJ0Gauj{`b{OyhS1b@J*WqFnw@^DQCzevFuPsiEzy$dhC~ zm0S%Dxq-3q*XALKbFaRncyAl*Bk*1YmZwO~&{DNKD*J27wHv5~=0VJ%Yp4(}rtt13 zZLa?S(B@~#U03xXr(?!np;hMPA0WDloaDQ<*qplj%0Y>_Uh(r)^nb9z{uz94>Pox| zAm$aU)a2e4ORMLwu8K;nnIijS0h$UGP&CIyYX=FC@jjsAOb-7U3 z-|X+Mkj?e-V~d@2v^qb@Novg z)&x?@xI)u?-|J)v;v&<-xokgFVI^pw)hZIoNH?-(8gbcW`V}aE zO|NSUn7+Y1Y4@VPJT$fEPxKv(6~tC((-Rm&5;i6&PBAH+E}OWAW+l?&w^1P2tx7iC zJuME#O)Cbq8n~TP-I`hwiyuv33Et>Q`qw1_x^t73$RA-vM#n?0u_7|mHkO|%^*lFvTHx)K8IDKH(97uvU6r?Qm$lV=VUa1qy>wM<{*w`_8@HtvGvd7{{TRoU}-L4sfB&X zx6l0*AczFN+ww9}u$@N@W9BAUVQx|@vPew&@~F0glvonIlC0?gBL4ttJIrpH-Ff<< zx8qdVc1hIbC{qtjwxpfLS@vvxDIkO3VKDv0iA4x?aNk7x6UkvFGx%2sk$6F~9pOlnA6CgR6W zgxqkL#PdHxS3(m|DJEWF3CP^QPU#?>9JaPd7mU9Z!{{^|K7C;E##IJIwJY5dj3oLv zN)P80GKp-Nt=aNoPYqG#UU6Avh)ODh&F$WGOF-=yXSi$no zs#-0e!Vd!S*{RZU%U{EQvn&T>%rcO6FfCb821xdcy(w(pJhqYLZG$64J2^=z+mBuu5 z0W%`@T7xOqn8Nfc2yNlt}(KiNH63A$E`CL^h)clKq*=Nueg(QP(>tk!` zHX<=Ou(&!j*z)Q}UA4m+2X&oB7L+ART7poJN|a5219D6*IGYnJlvgGvsyEtK5OpRlQwArd-Stfm_zT$3HiKgxX#{L6CrHK}YBe<8a zxT#cC#Ck(@wh|FiU@0%4X=j`LA_{e~Rt99>U39cG#iI@^o@TQ*g(^*Z&N#H+s7XQ0 zljujnDYC1w*Bhgs#`@W%Rxt}w>iXJ}dZ#r3F)PeNOzduBE4$0 zYK0pTKHd~d>uR30xY$Zdr720&s=$oDx*NXT0GwPW?Eyl^%2ZzL0DC>M2B!jm;qee3zM+Z1)zXR2Gq#8w25fmxRB>E0G)Pcxcl=s7g2g02O-DQM2*3C zcALSXY4~NdOw^D9X6jD;V<=ZtHDh9-;6|Nc+8S)?RWOLeuKQI@$0nWo?kd9mNlsLO z@Qxfh%_3h9rAm3mm}x)&Tu?yM!u!J1gwWREo+n5k%}ToP1<>nhP!~$G0u!&En!>f& z%>-iY4R>lPSNyw65BbCg?uYsfvQyKNCGbSqJz16?G7L`X@);sl6`3f+RHNYW{m~02 z=*OYVx$YOQEc3&}*!lycP-ZP4RyPr5omMES$gtv@Oxu7xlnbf0?xHmZt&hShnkOTz zUzw?3Y##fK&1p8Y%esev<|HX0Ni8S=p&s~E^sx}yT9~)8D~e*Kx*C)%_JAPu7m1`{ zZmH2HSC^MUY}<;KR=S-H^gkF}L`a-mK}r5!(bxB-kUmi^h@A;T+NynXlvX5IHhyu? zgn0y@<~}`bczX^l#xhT0A!0l-WvR$irI9~RZ7(vk{q}8h<_^1!V$DE;iZxvhV@tSiD1 z;v!(<>`!0Cl=1Y+CEAvfVb>2RpR98sN>6*BzQBlQE+mzXCY$|(EaDJS+-6pP<`D&hV=}CnpMLCwHiD>lz+*qEwSi`&= z+t@~RNJ3F7v)F~jVP;LFikg|9U9~_$5(`sZHhkuh;VwEk`60H+|6%5DoiVWOG;$^NpTM$>Y z77PAM@d@zXaTVzfV@mLvXk1wS(gvFEv{>-@HAIP)6vxZ6ZY@mhPGPHrrl};v;#0Bq zhCZTUKBCDaYhmFKxZGOOeTf`A^onlOJVK~&{!t-@6EPz-Ec;U+1I=ub5*<%WsS59d zdktc`96Dsjm`!2yt(ls0vfwF@%F#T>!42~qZ146qGdmIwVNgDoS@}U0_Gc^;zN-i^LCG< zRyIpVI=6U@LDtf=xRjM81way&jH(0=yh!ng`8YVs$bLE69zNZ8qGt&zkyxaEf zH2~O)MRVcw+g%^>C9K!6uSs(T(&|Q;Fs@Un_d~AbxI0-{hHGuKFz`vORcL)>S6xTK ztAZTC7OG+3mzi2pCK$PK45){{SiQ>b;tx&@Ie1 zv2={uDY=%r-&Ucbj)Z%_$8}P!pL?9IQK;dY68KJK$rmM`rwOCYRK9G?6$AQdHK>&o zkG7Ij0(G=Eow+OLU3!bfv#wu|_SSG!Kt7q-2T-S5_f$=Z8}tMaN6sQe60BI$c%8|b zYFe``mR-;irDd^gdj%75+&f&}+Cntyv0S+Y#8_R2vpFh#(r(^v`0yjd9+2LVYC<+r zQTA2e(LQ3tLRh1;xir28Z4^D#4O1LCbDN~L%i-r6O7iNJr+Xa~lW!5U76W%h;nc+< za&BH#V3bV&VadwG#Zatg7|hWCZPuJ=#0xfd%%1^$74U><9I);2 zDz9!~YcdA5T1eB>M`;{6$BDG;UhlHbwq<#?O4Pdq5(p{Q~>I15v}eCxZ|A1muZGo+<63r>9Hc#K6*pTHEg+d z8+g;)EnkcHmxZWQx*cuS){;Re)6V(}A4qo;ua@1$@<+NHt_Sw?YH+4Xw`QCj+~fqL z^xUc}JUCIf$Y0Xf54YLoNa7_a zE~y0}Lt}5<02;5;kb+AK<+w(d_et{yr=%sufJsuZ^NmayImvaU@OMH^Re6GUgr;_d z#VWlmT?dk|RFh>U{os7ZNO4mV&H1K~q4k3@MzPihrKTEucS!WS37|IClWjMJ9174< zeeHc90FIymdtcHx&22UTb&8xijk@^9P6GVNmq=DpuMju+LaZpjXBwCmRmYLg$1Dyr(&e-D zOFoBKLC_kXC{S(Pj>K*8j#wMQS+xxgzD7GhWepT+JHzpUju~G{CPr27Z6lx_QG+X> zH&2I$r&x9>gtLAf5Dw4*<@ZJP_(ug8%jpRUCqoIdrn#I6>XJQdVK#KgnZ&QGcTiD+ zVM%cpSj>+t#BqRW7LdrhX5jhWI}m2oiVlES!j2xgT+qjC;AJwE=s++X0ZgSr#AyWp zEwmaI8$mz{qoPi`B&JtLrTo|6)a=AavO1NeAD5`_*a8BF?Zn0JSf))~+) z&rHj+Qbt!$7K6};(_zJ#jV)V& z(=_?lr=*-qoa+^(X3FmEYYRmu7r@F^<4r$OW~3?hhW# zHSt8PN?eR7sv%keBd$rDqhYzwd?SuPk-CYy#CI{(6KSV)fk-Hg9kQGbVMhV#t3}TO z?r4jdQexM$-9%5}dV0zJi6i797aFQ>;yH_u@4YmXh=4q2!_z_4tPd#Adn25_2#uSe z26(VSxQ$Fc2zU2J)*r&ii<%_`L9S`GzN1KqHcg7LEd3x8d$0Ry{xKP`#sa}wlCCY^5Qc7k{%5|lbB}pm( zU%Ch;7?|Fr+>`S4%4JDT&N8Nw+L}mO+Hp4_BS5`(=p!Y?&B{;oWG5q;!`J3@NP=10~?IhW@6kvTC+a!toj;Zt)BlqfWSodHt!1dUQt zt)ck0jcQMRYPpQ-wmp57cq9Gi%}tx+Zf0OO(?xldlmrCsKqlt?KCwQ0bIn)HD(z&9 za-r14^ck9kCUQnyD9&6^1$WDpT9S0u*D+S*w%r)4lC(FNQkhSXWi-}Mhk{ef3QCQL z0>ld&Y3UJW+jq>ZXkn`Jbe;=VooVE{*>$p}-3mDquehQ}N^kZ_8{b%wa>%cPgpK_q26RP}y2vTNIe3tI`*an4T2gU7eTZwxpAk zn{I7?!XC%QI7{Qx;Bry28&WDbn}u^S<-{d^$c3N~36?0(k($@dr`p%y7INa_J89Qz z=0?#*>%3s8*Q-+QxU@@_7L^%Bl9Qda4*H1IM2*FW5Yw7by1y_`AFNf0=@{mwsX6sM zFqNbsJeNvr4YdhL2Qcb&^oAkDOCRD-m)|Bi;it@py{@q3T8S*f@{X>fOle7LCStWD z1MaM~m0M^@HwHD{#`dyp#!V*qH?sbtc{qNjH-wl@lZjqn;ryafbs?(79(B@PZ6J4? zY#X_4E`{dPtWVADdE&J{^klg)9ttIY0eD?a!j;!kNOPG>o0nT{Iu;bRoJl#GQMRhr zOWeY^Uu`+bDRX}$HIoSO()e(iah#^kyz}f#wx-tGgjfq36q^Hmcf4zseOsb5G0{go zr#Nj@;SE8#$z=yA$|bfY8wE%?Nf{hA${ZUgc|@4xQYENTBQnz7AiT?I37H1#Y+lRr zNYvlNZ3`91OwTR3g{es#yPZ-t2g>omaYr3;>UU$OoN!x0+X!%;w~g19mrt9VH?`Pd z#}W^kl9C6`6oy<$IX~Dt9Z;lEQC%_D5TSD0K}&TyU%Y^uhz@C@IAR<-KZjOXn_egkMjbF_Cr`9m@pl@rvbf|S%hSZeZn-Y|!@jrN8IqH)aR3B`UrzRIJmWKy+m88d^?y?K z9><6&8z3V$+0Spa)fa1G84VVQ{uMaoT3-=0L(HQ{y6B}+*Q zZEhq4sQ_p#a~fU`it%Qzop0Do)gr3ooHD99Z5mg(66lO*hC8T(KivXaU65w`l>XxqajG0_uTIA^Uc-%~4~kYl$uO*n(3I%<1R)Qb zC|r5#5YiQ9h9Yqk;@SWJE9I zpwM--=0M#62*~&&#cHwZp@@==b3^JzqJNmFFV?B4X|~%V+9Z~?N&(dXtxHQwByU~0-u%hEnwoB+cSxH5RH`83bBfOEyJA5GQ-!F-uFTWu( zAhh>`h+3O$>#{6$^j>WtTg%K;io8blX1#u*@=g@|*Z*rMV*4BVqg zn5NXZiAV|}U=-=$-XD}S;2O!R+0znXpI~`3sd=W^=A6OBf~?z{8=WFN<73fd;On$` zr4!1S&HG7?Mhsnv`M1)-d!T{Pb&1hKOl3HoG`HyW6#eOS06gJyRD~g_?At_cc7(@2 zIuzbysHA|PZ=fMU$MA~mvZg-;u_5a7zeP4K^I1ljR&qK0lc&lfA<;KkeYvJWj;K+w zHa7X~3rI^IiWI^oWN&arOrzxrp*Ba%Lr5tlKw9b`_!xCSPO(LUl)5HVpbWR`1BHgM zJ;jMSjb30av?X%kBES=x=Y1^(fYdNjvu;!8%(4_xK}a5^I^uIs;ZP97#Lu>6%Qo7r z&1FRni*+Cn6g@$Rxg%s(qoPxSv$5LObD&wuf?y#xJFi7TaodC+-&4 z{$j|4OAv(6g5u{CC**yZGEFIv;)qh7X6e&gT>kBC6}j+t&6+ zhE}bn8V8VnXsK60_0!HGcqw!wWKa98{21|7BZ zPlxk=L$TvuW%9q=Z|l4>lwk$rwgQ0EwU{sAV-;EWN>|RiU6!0bv>cs3tx%nkmvT=i zZgkrIr-B!J=vT!a!KjND3sd#m!_?TUssEw=fVDT3)TxM>bZQ70N@ ztEEj!J!>NA1dOByeDzX?lx6Z{mR_r$Qe%pWPEmesebB2`9e!=4uB6K^s3e7QNmgOt zGi-c?y9Hy@P%*oB<|@UrtHd|?Tt)vv!nSvCIv zc`1B9l?vs*QC5=gOTLTjp{>19*WnMRE{#9GA}WkJsVDc`OXAw&IDT1kb8RV?5S3+d zAgKXX(4K&JW{0t3*3xm`=t#z!*-16l_GJ=rD-g`%YLm~n_I%4WI|47E5xc_`2&Lpg z$n`UeNi(!E6vEVl<*)9C8%#w|?b0}@Tg=*K9t%TiO3+q;aHN~0gKfkmh;UDu9&RA^ zsjuQWM6k|AySZFjNd;@t+Fsxjjcm(Zf;HMTwNN1)O!{hz|QekrBpSNfFv zXAqa+i+?)(4V+ty{)Sj(iz&gX`rFIaHE_peDgV-s_)i8*(dhW1No1v5iBqbsawXw$ zaC^eXLwhJkI|{MWz__+ggOYR9+Pgwxoc(#WCtGng4ob{R*|$obakx~;&oETf5srS%%27_y{C|x zwlSY!!K0zokJ=e^^@dWfQU2cnS;5?RrucPIoU16zOUl&cSWhr#$dv#BtU=AoDhdN} zlmJ8~aK1-lI_4?(n~K?@(ItZin2}d`!MH0!Wh*3HX>qQ;Fo;0xrZOBw#ed2vdef52 zE=tYSS)7$mKqn=JU@ztXJ6wzD4$#$-W}Pf()VkAdC?K~$VUkI(&K`9(_14-$YnRMh z<}_HJ6dn}MQmZ8e#^&f@mstlXyDbzQY;_k0VW1)uqpQ?Il?y-R(M**(R+zGanhKnm zP`JvRpID)_*JLRmjYaM{LLNI7rfbj5PGgzoq-M!(QMmZq^j?r{O(kjU+N;I8Fr72QtR2hpOVbGWRg;quRg=2_VXurO{GiCepERnsxRQ# zBF$ZdW|=CpVL3Bc@60K+y>x_XT>QUU7|{87{+2gb{VdVGj+12|XPyfUfpL@)rJHmE zHT=3lXBwsEJ&E1FBLlCsK%Zu5Da_?gaki9CM58g+;h-8oxu^b8{KY;^c8mOoU)f@5 z${r_jSSu{7%#A~uj+v#Wp2)xIq?GB<#f0hnzxf*?zDfP_qHN%K#NxK4YRv!;gua{K z-a)uRhTGU1bi6=<-9FYz%Iep8Aiou+c{nCf=a51KCGjVEppP6F?6_{wH~8*eiE(2 zPSy9wUT`N2PT)K>KP6CfKQ`3V%2x0eE)1#2qBXH8wZ+YhIVq`bw%lr(YWLWQI1+g- z$*|xdNy-PI1cE(5jRX4E$-%AgXfjg*mabrw*C$}J74Uq4Za$Fd2)6H^jW z?x|Aq5@unRT)9(8%u=K!#ay@&MXpX@2)MLzwQeao*qIzr`Z-9X$+s-%5NcRWX%#o=UKJfU(a+f>q$6hW~&Xc2BuSHW> zc4l4Ix$1G33f@S{6jn(j0k-;jLy(S@->v+_>bdsv`4tf8=FL_5l;LnMg8n{3EVO+;xg}_n+&bKgt$~j#Wu{7`9+3R zX?cF+Y+Rl4f4A;T9w~zHm*kR}hi8(8mNy6qJkN$uZVW)lyT38~J1>^zE+NZ@Q6oug zRZZx)n z;`fK6jn9{u#9B$;kgt};G8nPRDW;rHc|jmwsRV!zTl9puu}Nu73;Ohur{!L0Iw@_e zCjK_l@qw!m2Td|NV7f~(Qtj1c%7czMmE@90LYw;l9fC+u79C-!KEHj*{N9(?)Sat_ z=H_MRm`uwPE12Z-EN{tG%V3a58C97+dqa`(?*9NVYi00XR7TmhnN@O`AmeB>N#_?g zKGVJ6hU7w=N`XD=q}eu3s!7XY2@z$1(rv%J$eHc(Tb(Q?fT>-fYV%c^njK;G<`#m4 zl_00Sl}jyQB{#EVAObW8UkH-&xcndLF`;^XhXS#T=lEM)s9|}OqGmrzlD9 zWCJO;bVQi!H8$SgH2aMA6l?R`P_0#-an!iFG}2#}S1laW%JUMJ6U+c9XlYp%lq)r^ zZDE=oLRaiyt{RsW6N@nuz$K-y+_Q=VSUllLLQ}Qu5HDe2ajYywE?!@eDELLfWz=yM z0~Jg(muafP?7F2a1tGbHSxY50C+?iXOJ49jhE>UY()D&dcxmQnsYJB8%FD$$l%S;$ zT+I80;B+xrY$TWYV6h zxb+T9$hwx)yB>Oy6qbI(^d3sJt*wM?J)X41{C`6w z#=G=nF6_kTwPJZ=;V%CG`H^vn?q=H9lHH_ES;}9JE%Wns@b+GReS{&?!)+t^F^Ahf z(@4)I-YO5O-;6I0UyA&OvUK<{jK;1mK+3kX{{YA_Q2x=q;pr;%8AHANgQsy?Wi?sJ z=h%5|Hrld+q1_ho1OuVA(A@Ce{{XEHMrQp}fLMzLC+RFTQ&iehu0#;h>_1yJzJzNP zS+MH;nPHD53ceh6%BoV`_A28hW!Cg@E3@ zy^!L^LNkXPCzs)MT~xeZDQ7ATgf}py6UkcjLefx3xj$;)r1(QHuZ@p1(Ix0rNy=l> z6gr}dl^FzQY2$0n$@D7enFB*|R7a#ej$Ig;$Eev>D{E?{CsN2$FC#LCrUHHN*wZ-b zK>I*$A~toa(U0PKU(A&pew#Hqe2A1#Q&W>{DGm*?*sTiqkT>*J}}w#B>= zVn*WqBS($j$fKH}z~WXUGI)NiG*nWjmfW^&tc5GR^8(Q;CdiEeo8w0wCF+!Ud^Ls^ zR_xa;m6TmJZ2$n+xY(-X>LIDlxer1XSSM$W4K=|GI>d=eeXZ~vn_Yn_T8FxIHv?}7 z&*$PT?Z~*rijbP(hh?lW#P%jHPGPC{8gr8SX~;vix=9Hs2VDp-oP1lo`5m7Qn&eh* zX1c;SdtQ2vIDMa<6v4j1)Sm6_e!6dMV?%~tQlBgdqgZ9iGwVa30=uQg)Gmdj?v)Ke zN&GhvVOo(3_*j+0b9K%Qyr=N#Gjyj3Ta>pJ2OypKOI_|fEpJGv&%vp5{mJ-vhY{eD z?V~`K?$p|TN#HxkQWmX!LTwci;H#7R7AuLdnc~kLYaC@#DKu2MBTjn3$FqH7$vrko zk`IOAULF%q#A7EBV~>UDjbQ3~bjcKiCcrF?r>Q+jJDpOs`&1`Z=r6_*VnusbgCrcVyj>J%!A zoVJkooR?81z@tYH03Ah+`;DU86sW9{vP$p=h}8UbQmM5iq`b)s2(hqrJCSfb;lD`h zY3_j|7BUS`E3`^eV1zR?B4`9#O}WGV0YV12b4$UN0D1DVj~XLmr9^iE3T@}OeSUWzNJnQlxyTP z8bZ_9Lq`7qV4NJpog!wrFxXto`^y1p7d)h!W%MTG?Rcoqn@-;{%LXgle|U@8dkgU! zGs0OCvnO6_K&M|DB&0-T#Wm(gd^%(%!qPJxoN;2PRX3Em8T169)n6)-uhF?{s>(w2 z+#UKDvd5EF=QJjeGEOutT>ZEU8`G^3myi5d`k5TWp~iOE?K=!|`#DD@snT~vK4ZWY%Fw$(}473NNODtM~4#V!#HVa6AMCBQ>ma?VI+Qy z1nLUBQmq7YO&!!NsdV{D8!F3{i6#b_^87&*jz-NE~QrEO3QQv2`W+* zWmH^BRHrTe4W-zRBNh2GC=(%zQ2Eh#8$_gps&NabOpV={QkSoYLX=XUfQs4iP5Be! z!=x+Ig=tcz=#!Qf+v<`0A)k1X>O0_~vin|3q+)5*p&=;@vOogE^kZNnO~X5dl$q5? zc^Xqc zAeC4Z*Z=`l$d0H{$15YwC2bQ-sHoY&x0r_n4lJC5bEv1zDE(_@T?fqOx8-PhC~8E} z;&SDsU~mSmy%PUezMhT{Gx6Z`H?aZ+Fyw2O?|0M z*@K0|Ej!(*4tYwuOx`s^iWes!Y-x4BRwR^?^3kCvSu?nQT3U?oRH+QYJ$W%CxP^ zDkOT4N9P$HF@7(Rqrmna4%O7u&f#LDD=h0%EITBA(S0ixN_;LZ2|8Lk!G9Q@Blt)e zjV7nKe?EgOpxCRSGSgQ3F0R*DI@vwjf;-m$W`tnvrw>wDRWEQ@C0(B#?R#L`Q}?7UyIwk>b*5jNx-nna?LPQClt_ z@i!>tC=q_>RfYA?804{z#zI1)RIPSLt$QT-T;3d;aYdp}bpb}@NFDVdNxrET3W~gt zQ@-f2gtU`7PGVN3*hwMz8P={o>y0dY!5faCj)p5LiIy+8b5?R?ha@JJS2ZBMON%?W z*%_I1{?aXd&R}kD5HrI|zT~WOvBhlUIz(~OE8_~=+&{)?m}updoRmZFHa1>G^4%nO zfKsr0Q>NxDvAd6*k!8%4({gB>K|;WBwGEU31RoG|`NvkmN~-PM!5TIhkd~`cWt)|K z*VKoS(8`5@Vh&Jpf)7vy`o)e3x3d_UGWOAv58)g>>FCHGM{JJa|BTDKUaB zJ=q7f{;EVrP)^sM>Nw;;F4{C#sJMv_F_D;HM3e*t5mNsdGE{-7HpjB8 zhh>)7Qk-w?Wpgi0bQXq*85cJU{NaoP1NyH2(3pScysSh-DB&Tu@QEha*Hz?4w&0He$RD?`5FtUVmO4@Lo zz$DvCYqy*aaYD6gmT@4Jp(;BqKI5Kb4H97#7BrZ{8=`{q3sL2|!iq}LtEI-5w%b_r zFu29Nfy##j&M}E){;?@_2T*n?C#XAv>1c0sFPNvL{{T5@O|}PdH%dqb`F9%lhz>ET ze+AO&F22mz_H-=gmw2SD0{WJep9}k{`#VFbRB@w?Q8jKFhSM)P;w9I7h*9RYZLN|? zB_R17BfrJa<(MTnwO5w<_hmWE1KwL|7apm#tezJhXIZe644?o!Eu=_9W`a8=+rR}R8*KwtaMcu+!n0cErS&7w?;O$xDrXJ0 z)_0{+mY+K219CO7@w_F(4s62aUqXwynkH#BdbY!K{;%uS`%kOMS9bihp z)B0W7TY)b3*iisF4ay1GDo*5nx6V7NxrJD=)WgC<184x&o6uenAT{NdpscDl1ZZIg zOi#!*y-IyZgtT-N$*GGFqCoN13Ikqo*Bb>*=tkqAjsc!ZcbwQ-zA@Cm1k_kjvVb0< z3qWr+8eXZfymSp2ifUa}skrETBbq|OC8X@1cyvF;I058TwO=|42=llx)CM`0%G?Ip z9gpsUfatKvY-(ZXp$y2em}$IqoJNCF_c>H7M)Au#L1*dTNT=%ETT1ApllYB{aigZC zGM6zWbiDUDCu^hv55f~iOw-h|=BQR*5JkcH#~M0mOVQnDXEgA&$KxDP3lxku%T80Q zI*^l+{HyH}St;K3upbWt38r+-GM9ou3MoE79eg9M&KokSQ^^HHdRp4TkTYe)DYTN2 zn2m+)c5>lm!)wg&=|yk~$DZzN1KK_ocMuc|E+_46Owg)f5IN%zC zBp$Gj2=1d3tfkRq0HNST;ym!*HDc7nol5~zs+THZAxG^axPQsCR^;|}IrOiF-;p9Y z4 zES5#Q8&#`dlGF9IyDqjYtnHyCvG;?BM!Nm(yV@mW#~C_`=iH5B{l*EJJmYQECbJB2ti>gUrDzSyOE9e-c%UiP$=mAIFXw%P zFB}xz%H4AF0zz<;6?+`34N6S6H_HS}D#fy*I)qzG`Dqcd#l`YEjXYm1EniF1@+EUJ zD_BhYk`|`c(FVoDoejrOkS;Zj_I$ek03aCLMcIB*YGJC58J~5T(7$oisa8qf>lCXJ z2Sr}{M7VLAX_oiWtMUy3uLJN!oFzDFt-JJ`<3OcZ)KHe(`&K|U2hdmzp^0a5T6U}G zDMWtogu^v7sg=qy!Ev>y00Pohlf8(s_{2Foz&d$viPiTe|oW zv@0Q(88NMAixlT*=w-TX4WhRldFIgS+*mi!Avw@f1U=@#(IrQgt>9CnJgtKqta z6?_qNC~AcQ2qVNDz6LH~l~0i#cwBjiN6X1kE4U=<4vC@P;CB%uxMNsqrBS9!RwdAt z1xZbQjYV54RHy|fblez8$}UTX-`zgKly<`mVT9A$)4ML~VLv3YnCCvH8lm=A_fT+r zhE%RvVF5z@4xa?VwBJz;(AaSowvP!omeKlJj+wP|Qkel`(P>Cf`NPRI*XTCrr<&Ih zA6snai$rCLy!bH$nJn~7pPRYtN7V+H24vnYjNOY>W3Vw$w6G$?}hSGU#1{y#3M+S~``U`cJyBLXCpA zw@r*_u;-5uu0Eb-TZrMMfz-ZCdAl=lPI{9$H6rw@wKis1B4GhUC^nI)%mE;Q)DWTL z5%{QVoz)T29BwvYdFo{XRTSo@o2R<)aURh!x4A=J>QLc1cg=BY^@;w=my42}HkU;~ zky1E|{^zvbCzC|=4zDjfr&1JKS~)5Ni;zl}YmJW4w2m(O5SiBOxxVETLt?`EE0VTIPG00uaLDOQ>p^xL=2^!<04YVi3vYQqOE#?IJk}V5S zq0MAG;iqHT=L>NprAwIG@{K6wT1rxKoiA*}z|d>5)1@Y}kbNPa3|65p#VVRi$-tgJME zfTeCg78izG2NaEdBqei{IoygVSY(u`B!Ul!BE&}&MU>xxc;{T6#VpV!T}#M$;M!eN zXyzath*(ZyN1C;VJSEIVqDNr9FFC}D;lk61va>plYr!)}`n&%CM)Fl_+oFY{B=Oeb z)P?3O>~hr5E;A=Cr;qfqsxqqn%2k))q(-(phBmjuJX3$)edja<;wA9yM&!mt8|8HY6!PIxA`vsdfhixL-!I=o{`@POOp+BI2dz_ zxHYz(c{B5riMJ4&p|)OWw4b^gYwFxTti4X=@R?y~QplL(;oM7B#nR#FXXR?L+abJKLM=7U#=l++etu+Nx@GwM)@Z7;JY!!57y-U{Wm?c(^{Y^dr2A zJhy$>4r{deyhy%vMb*6OwYt<*^48xdx5tSku>&Sn-us($x@sfvRwhgyH{GkmTvPAYi#&b_g%(F7mn`y;`Ht$T^ zY&?3yYBo5ePij>~*KQOw2Y7Ng&g&0VsHh8G9)u1#jiT!5KFIhYSEq8e^PuVFLB8To|Lh(jd}r9$>wD@Y!R0FO}?xFc_J4oOhT z;CxuRdrFsHpqr-WPlt!3O_VHRISu?zI$V`-gWk}HLWsK)bUak1eyzm%9~c}?>J@b? zS1uc~s|c|7wJ@GXd66wO)K#lFWC5CdxSJsY+76{=$q?HVh1MV8T}r1q>nN&9u{x~F zZGmN|>wKkm0C+=8S{HZ@a%TfMGb>z5nx4yaB}U|Sz}ENH6Qt#jRutoXUj&@)y5&Yn)>Nd{t|WEKGN7fA`m4Bz z)4>^eG04fIa=*b|9`>wlOQiCt6~Z%SZIar;y5~UUwD|EOSYc|%&vXtdMSk(0fS9+l z#%F3$;$oT=l{3sKIZuXm!7E3^Th1n9l93j1aT<(0#Yw7ll_xg)2lX6KA0T1<7B#3{ z&31#Y$~GTWLTTX13&`WDQcb*-ari=Ig-KHv9F8v0KR89k%1<9;0F)|}skV{LWoTO2 zc=;%#Atd>26gl{JjJd;~Sm)7kQ_5l4G%PZ(3IJL|oQ3Ul-*o=2-9$x1i7O$G5xAR< zxLZ0UpPVhE49(ahBdPnzDHZ_uZX)X(BQ>%qvN=WWI=mI)jw|CMu1d3r+NMq>+=iWK zEI;BBv)xG^2KVV4mKevN+M8sEdHyM2MhmrB+ce3)ILWaz(~13VK@OwWEyO{dC|@dG zr0jC(vwnsgHQHXGiWXX(p*1|pJ?WVl#?-AknOBnAsq_~;BCjt48TtH+JbYZS_g_)k zpz+5D)ZY@URGpHWAP;7kY4((ocJ8{Ihv01xr@=g3TKU@jNs;27PH|H7PxKyjF*NI8 zZ7r#`)#Q)}@w#q47KSuQc7IREbxsZSkIlc#;yFZ=bt?9$B(<91N(oAV9(hInaNCpW zn)?1j%b($C`EvZu7qYnHh)jg)TtZE`ZzDEPJTqBdU%n%AcBOwG=eZ?1PgHB*{{Ul& zKZX5*w3&e@ht%^xI-s%&a_OBZRnj~N9pj`oIKE9^TK#tw44R>{s%LF92{|V-GW+st zR_V;OB>IICpUNAgy0j(aljfAY4)m=qVoe7snVLb?*%FKTl1^CMk|>lzlu5<2Zk$^rshgDo%8!5o<`SKRm2)MB12_dn#j>WSUX_?-u&(1NQqtO! z(2{}{Ply7;#wmE8Xn1X;_U@6_jkU5?`ZicD8%3gZ!5V)QtRBS z;&`P6_*=fhw-w?f;pTETZfb>+JO_+zabxsGb-NkaS!GNTlBFW{S*Er6`DH8gh)%asN4!OaqOG#Y5$g|NS*%6Fx!N>>xoV!SOcW%I z7N$t$H*yI8n`$+^wYA}G)BEfpZb|;mlsP~md)AvQelhfbtN+j2)P~*?Opr?avd%^$>x!%Gn|fG{DNCZ z+^xxlB_mDld~}B5w>u}Xt;9yr#9G6Wml@=0FH@4CVvbz&yNT)clCa62J=3TWR2;7j%jJ%r;w@6So@rui~{x9^R z$~`_`soCMu<)^uhHQkk`7G|Z8EJj7kt3pl512&dASZf0OtMX!{`P%xBuODI|h^oy^ zOWtmAs??;+!wsVO8&d_O=rtncAzc9@TbP@UJ8#u~#B7g!x(S+h94V5{tW!DSLS^+T zdPPYEOumORb0y8mu_Ep^Nw%dRM{;0tRQb`&d9=IeO5QK=b;-Hucj%5KQf{%C_mUE{ z^A^&aX&JQvNh!J5+}a{MO5OPqAty`bCuDe$Rm3&9j6CbjnI>i0dBrIMI=PGqi(NJX z%D%SSd%`l}QH`s&f4I10xA6XihNp1?pNnUcJu0qpc|4>ngOoS#D4>lAQnXRI&<{9= zG}9e~X;+!Y#`5c@F({WD4k@YiIpz@Jz(PnK0Fmcy;S2R+i?6{AFAX?&smWTULP#V$ zziyJ1&QEnNOuFOO-%_0c*I0T|e}8?3(n+tsy~#g@P|Y5i{W+^84M`zL7uhRqLtlu5 z##et2%?ZgJ)AMW5kw>-zpm6@2d=oA68E+E!fA0K0L7cze`2MDs45dwP4$q;yr72*# zZ?QreSUYv_hT67EPLdya8AjJFN}o}>oTo8;edU(L)~_IxeBp^~{$GEQ$h)=X{{Ev+ ziz{ZAj;T%R8!|5~UTI2F<-dGOg8V*%5|>W*^dv70aU)zzr%cY%jzrCt-)uNFOP=bI zu#$AT1?)|)2y2>tPw&v=q?JF4`}G)JAaLDIy8TX&(Q0@rJwlvs^}r2YmrkcK=s^ik z(2UUJXL~=tw0FI*I#GGpF3}kdX7`u-$JWZys%}P+I)({g_c>^cwQnG8itn=+1jGs|Vn^6rqF%F1j} za&^AeI*r6MqhG51j_G!#zoYq+cR9Dr;DLMUx?Gf7=x|;A6p#AuWyggMez3xJx<4U355kI zv`7oOtLj$e&@XEflpQ(`D4Q2c)QOXI@uBURqbj#GE~20kz*B@SCoM z%TFrGZAGO6VwEWXYC#+Hh!c*ME?cYf8_YR7I-2!XoQ8>z4GEn2PE@{^GL(gFbtg5` zzL(M>xUDa}{zS(4dU}a&CCkiVdUMJP3oD&%=58*gm6$f5KWJ;M_k}?VyYw3FCDPO- z_{5k!tM8b^`QN~Iu&U-6s+oogL)8g636}9 zIek1hs7;5`wJ-sllv85vx6C$q3BHN}XE8#v466AmGO_snCG>wHE6ZZXFv@1}9u`nT zjXcsSvNj7rLyipY2K7=jxmKVhT8j-L;}@9B{I~o3%}IJht~RXAR50%*pNZOA$(yCj zs?xO zN|;lr4k>9-Qq({PDBCWg7LMviD*^H1txMtlA*JRas%(U$qiv}GDYs^vbq`$Vt%b6m zbo7qU(|vlc*s-h*em9&zk0l;lKS3m zyD=$u^@xs>~^l>J28JwdnwHNNevVhs3oJ)fy5X3|QoHu0iQA5$r`%37|9 zpl)Jp0tsn`&C6=BIZ0TyyMeqjgM`xU{Do!WEo>&Ry(PM{j=eH+GK|kStJ^DR9w$M! zShtqNYP02ih~FsH zL$8I$q&>suw_O3v=#)G+yim9BiGrQ)@fB@dvGqLhQ6BE$m}JXTFRE=;)L;d_&^eq)+$Vv15N zB941+1d-(lu~b4%)E$!A;+mIQqL9s0cbq{{2y~5c$XxNrjFE+u-QtM?71dqC_r22G?95VI#l#|EMl}^tW3o}wn%_T5|t)&|rxBDt1 zOO215O^eh+lG1KgFd}$`D!D1efZEDQDbZspvkMXrQP%oHbApnlE)r<=FI1ld=`&Ty zwHI7ULsE%WnVnFz@{G4iKnhxZli0ZLdRdqI}DmaQL>zSOm-fnaNaY;!kU5~t@t&%)|h_cDG55gA9e88Ad zJU6FGQkWlCF4##vD*HzMv7XC4Zp)l;(x`N$6s2tqp=ws zrQMTxYRE6Tn3{!Z&n4;#Ss04hM0Gt{}7YHC0J!wJ14lsYE3+2u6V$>frk} z12kX4MJwD<;tJxiyH8=sW>GL-P%agNl3OXUaY{+LR5}kG!H&+J$0M-i(J<7O1(Q=r zSZZ06^Co6pRjx+rBe>ghFJbV`*XZ=1B@k*n@C<$T?!q}97**8_uN_{(I&>ylYuD}X~|hPUlL7Cq0Fx>ea74gJhdpQ z_H9bARqvs=jsVC@xQ}Tp&E>V0($%;dq%A&%#{L~4NZ_MC&E#YjleEZ6ye^ZthoUzk zZSgqf#8_=!AzzK6$u328^ByiP)_E10i`UXtRi?+6aHx-&iI9yVES<8Tnyk&!r_or* zqMmw`7niznol||bhg0e{$zQ?TML&-#6HBKRu(`(@%2GSPBGw&x?lv&$mAe{fe{mKN zpRPGjYM_GL`{_OGr72s97YYE4m2QK6kf*v4)Mey&(Oj;m%C{=oy^VqbZR*5_{ERfFrX)_sx$fz$ z`@;JhgJ{qtMMK7S@&=s5tAawu{)ZTQ+k#EHbO^kGrk4ie5f#MvFcc zHp??wvs{SB$k9aQ;#@YyH>XU}=7rgtWo)aZvkL?8HZdoM%b}sHu+*7O_(Pk7!?gOM zGdn?;T{?ZTEL^5cs>xlnHbRIw`=BI^<6({J<HK z(&`CI3cuPszUqhryps}K65qKQOXybZXNQxN(&bW7rK+1NT3S|66s}PO5Kfi}vEKb6 z7Fv$P{5zK~QNtAeDpEd;sw0~(Fw#lZ%1W)G(niD`d^|yntg_QDR0w0jI&|+2s+0H* zqN}Q08M;fSK(_C7BoYQ-Mz#Rh=GRDE)}^cN&PD0ied^ep;IPgjC|a9o0#=}eCo+p9 zl{B!Q6fWSKjTP1ymM;-dd>aWu1Y(oUiIcSX>&C=uojwourO!HUO;#nUD! zrbiwoEjWi5H!L=mrM#7q)0wWZWrG&qG9>4?g~hyn#299t(;+M}-?ONt?4?UkZ8{qh zU{1#4tV>)v8SzekZF!|)ObsPG1&MJhSCLu){NZ?`rG%wo2eoTToxl_)Peh;}i(tax z%;O!517;2fUq#DJAb(*d8cUzVQ)F%Jqf9MUDYG{2nS`XDJn=h+EESu$ci&?Nwbw=b~#v)2K_9aGD%;VB{WW|1Q zYjsO))PyaE+f|5G;X^`|4}k}0jcpH#stqI1_dfPLSnUnDzr5Rsc&xt$v2eC?l7*w9nKsRGH%hKNAx=xN$~PzYQ9n?pvpXW`ZlIE`YY!i*SO?uB zE@Z0P5O;+}X*ztnoRWOdvcc8*jUhbAGUSxwBG1absulX}-sGV8gQO!?o?fWyTDgwm z`&m`+IzsBwD^nwPSw>`m;%=c~6Y+5}dnUeReqI(l$xFjNJjihxS-F;OguCu%vU3s8 zYDN5_!W?Gw`IWQbI-%&1t0HufYY`J+nM{W~PA5dRRAdOI?xbh=dL&sc>*m_+_*He^*f}K0!-y%1Trf}<-g(%pA3$upN zQOjeuoN=5my84>6vZ+6eC7lU5IJO8s#rf_la%;$j+`}~r}C5(cIrp(f`IKYps+U{Fyc6C zK9s&}bUkB_a5EMP6J#Gt$8>>>m8jh-8jq2I05a2Qe3XsG;uM6lXrw9>B*V$SU4P$r z|@PtsH7W1tOwyTb)U+yDV;2k8p&ra4S$7oOnX(hc33uA_0@Kkod zD$;im&GP;_#pj1OUxMAuTN1 zHoJ@5M=0UBXix(RpaMHUdIOdWa)QrV6XBssOesh@Lvq9|NJ&+&G=*g5ajP%yB$S`S zNT$#1yjgc@pLFPz4kA(NFkE2Z49+uRdLYOVg&*UMuXWacko1P#7E-v%DstX>uoj6IRv|DEL!>jVVEn-l414uMw_u&h&ZJ`!Zw(v z;n`ZN?Q-rtv5=sV&;kZ;nL0yn8kXXgM-de7Xr3XyE}D1){zxwW0F)u&L!L7^zu&8g z6^`JL9;#treo%>FiWeNraWID!s`B#dO=&7K0bSI~%PC0-w#1Qp-u_Vvaqab@L}vPn zY&XRUq~g{kX-~WlRW_!_%$Q}wZzQZ);_1qS?jET>R$-YYIW|w$9M|dPv4w%w&w`3itsj7>Ta?8l$J;r&b+%^YX zz8Z8e<~3H9*Xu+qjOOrr790;jtGK0>=N~s@kUQaC@lI_CAHp8Z9db*_A%y5-IFj0M z^)(gzEV+igndBmQw^g4qmM$Df)D3T%*+B4%JTccN9EonWt%ToUQ-pY{Im9LtQ>pV< zR#3|3iO9q0NVhCr=_=@S2Uue#3*ows{cEZm)ntmsJWrEO9%`8AOOLU2Gzq#wQZpc| z0uGk+Iz&kD&AVOq`Ht! zvc=)cOX<(xDLW%p1FY8Y-5JbJTa&1}IOBl>kk&$mz&+(Az!B!4Vs3nKob*AYx;M+0 za73o;&Br=^H_uL)mU)+uqNH<>61y*3=yoTqtq?QtuNzNhpKj!=bLcBE?-q>)pEAug zvoh?tKUN4*fhXQ5NzIUMde~?TGlz$BYWDc@E!PVvD@9*Zl`n{~9Q58cotAz_khaqD z7DFVsG)qRwveV#o1V+NNLMsw?cGosj<%K=RAAp55D8lM0({2A4KeTxm&C zz2RUpI1{>c0PYBh`FQm=8%;IO;zwA9kBpT1-WZx(g;r(BiIkk{NJ>)KD%ZPYq?6-* zv3$kc(OX@#uneXL zuF9%HUAb9VsWzNTZDz_evG<8L@zmZV#cW2OFnBB3o{z=`uGLAOX|>F|i{-ifQDc9E zJEaV?K2CpgLUw7<$apq_FYl>G;oO8cp$Kkxh1g*jE>dCS)}>W7E`sBds!=XwPWmM} z9{_FZ5#;Dv8vY4(U!CGy!4j^>tydQ2yr86~a-_DAb!p>q6x?qbu&%!%W(-=TMdIR| z8&I2|F-w%Hu}g8LkcF+JHY|jT5R|x;1mDKj^N%f*?pmajmur8azJ|(`r{7_m!2B?x zVXABBtyQ0@w&_w6G!%rTs|zV1ZG~EpXxmfjxnbz^KE{FN3XwJ z;QZvo?HXZ}Qy2q~vGt;0Z}o%{0{Rj%i^aA$Lp>=csq^VYbK>WX{ui?8%#h9Yr={X* zJ1VGDC02>n%P-3zKs?HpEJ~A_;UJ%S<|EI6oLy6OlC+g^sk=J83y@bbaWX8ICZj}^M!yAnEbVwl5;pPy{zWE6*7 z%8-z)&GggE?GV#XxgFq}+AcpUY+<MW^6?9F> z1~k6K_LAZ9r#S5`t$v%)O~?BiN_u&(J4JO-aRlWtYZ8yHT}i(&2HGfY2q4&l9@if( z#wSJdBnJWeL)Ip0t<$FFd9v;+EtHh{Tpb9AIpCzMO!4Vfiw>yIsiWf*@>E9?PvRz< z2b?TAn`sQ{I%!Da>R50g6K%BN`zlyX{Q``3z;o%90)h!4L&O;BRw+t`W3*i%ymF~I zWvy+czpP5zASftkH6V||CP7ihD*zVMi&&ZPeUfLGxSsL>%Z zg)rRGDLhQ4ICW39G@UJk-L_9mj$MH2f za&mrBMd^7G+GaDfrq}g^fKppfPL|f-Lgj+F2w6o`uK;LVTBkKxr%6n*m+n&JtA$}I zN$Na57>6d}KB<~=SYsD(m1=gCJei+zRy)ncoHfLUWZY&(HAgcLP zJO;XWT*aOYDm;d#lUFg}Zw*M*CDko5*jp|R@<}50@v#Ohk|MSt9-~WPamkfVM#0b( zDPM|-F*g#}i;>ZY)QfstL%J+yRU8VG{{S!(ePL=8AG#!#`-JVB!<0DIag{@3c1J8j00|Xo;st%CHfYVT5KIYDM8%PU;-& zD^T`#9A)hY0HsH${xRJrREd$SjU^8_`$wH zhKGRb*ool7^D;E`kVt9AF8zk~MUK8kD|2z!@vCodDkj5+l(`}3!`+aju`6m_Qfg^x zI$c&megi1dDJSie{{V%2-}NUh4^KV*1IL4SDTTOJizOuL8hdpl5;Jf>VlS`vXYV%kfYRG1K|$vp4q*p^5n(m z_H};`%#T&R)D>YMyep67Uzd24hUSvjEon$PtG+-xd&vYwlOAP}T50?WY?z!jdk-Za z220|kIQ|x>)8?I1NJ>Q7&p99sGUPc)@wgy(L+f#eu-;H`blwk}%ZOyFxiXy2N`x)7 z9~6?GcguL=IEONuf#h))Fj3g3wt_;`ndZV0SNEG+edMpw!WxkDM`mLm;+zR8mSy-;G zD1*?ptA4CVjGE`U7EnyDt~2nz6mUp8AzYDlkg=6B0SYWQJW$~PAJ57jO);G`Sr=v( z=jeDMmi``=mYTX;Gl+3(4s&ztoTl4u4%$RKu~K`IvB{x(jH?VtP0CfL5~^b7lgo84 zoT)>|Ht!uk1Z;YP71P4{77)spGjEL)No;S0UC#3ky(SCNt8K)pI-$544tx=s+8&1LJ!{H#GWwgoOv+_Biu=O2qiRAyt}I z8^#Scd#;T7jNs^Q)^sc@#9L1&OUA#i@*IvwALab)aQJt}oHHTLOr18hNS$T7u1a~8 zDHbNzKz&XhE2M#Lkkqj0`@hU}W^((d^b@Q*A;h`EJ43xXtd|lL;-*}bZN%&Dl=B)Y z@XU;)=wZJFF2nvae|9-@IIA4t1CdIca0LF6enGjJZvaHhf?8dU_gYD|u@fc~`hLWW za!*Wl~ z5?i%iX^%%MmeG=aO&jQ!9JL|0i3-xrTIs*QADM-y?MeEa)xEXLu>rWr*oE9;`lqSW z2vf==lsw{yKeC{bN2bwx!*Mm?=oPEskS${i2;c zBFS+PmtRp!$((5{ABpCchEqyg)!w(Jg57qG_>p}@Hqklw5!u147>}fDbnuz= zlaWbUo#dzXbV^9^Ax0?p&N01}*TZv>Yok}xmFZy;X*{XoO}nAog#7Y_TgXL4*6Log z7T-AfU+#1;?GgIRp(a_hH@cosP+2`nQg84i{334&!pn$hRW7aF{cMfI@e2~WciU9wJ1Jw|NS z;x+)At6_?T7C;G!rt9425)>2lf?G3)Nj3)7vPH>O!sZ-{3nKpjWy)%*nCgu#32jT7 zQVH2eITds2KQRlQ=u}-2lYm{UQHJVsw5(3z+-*ykmQ3x`Tmv~rcv)K8P<{~yHxJbl zac1brWm=eThg3-kcHM1LKT16`%F;Wt68xg-UI2Ty2}n{&xK-jCg_4x$K=8whvphM$ zRGGG!4!88I@t8u5v$XJ2#H9U_lC3wrw$>FW+YqHgU&dokq);%#oi=4t4YyQU^DQ|X zN|y3mDO!3Fp4ZtxTtNl9_#JGNloCy^M7(S zaHEV2;TblOG%oDrUS)=v7qKE?{$je?$*|XRVGqj{J-So;@ADhiYkxn#puWPGu;bc< z{H&o`6EQ_oXetFIFH5+z^|#*|jXdEIg(~v=hbH+y@~_lqyI9UBaQc*&KS_CP{{Xd_ zAzzK+Rt{_6$l10};)UO4Dsn3<&r_62TX~0BxZNpIN_6R^^oCzQlOLO?{2C;MCW_qD zk|`|r+NZK5oS7g6tCrqUl#Yar&Y)b{@fuRq`mp{T`@NAHxY0{YhA5^^CjHuc+h^C= z&4-T3`NX_V)qFo8sV=>*^AsJ7rDkyDH4;-`C2DLq1@GN^>rwHw^p50}zlsp!_9ip4JTu;N3wE~IBYm`dOF3BDve!c=H z;%RN%VOhgBFR=;A1i`4-@-W_bk0kamO;ieQdNg#DiiW- zso9qrWl93d`t%Y@YXFok=^0MI+V_Z+*iw6m{siC#u)Z){%3NH-6V!xFNx1cksU)_S z5>HhG<+`jc40DbWwX?6?o_hNzc|kjT`kJg20E&Oja#zna;yA;o%nJKA7n=Cr4sqq6-<<=u- z=Dg6Et6v65?iR~VNYlAf&2n6BVqqvv?{ZRuz7T@dTZa)=6@O8gohOPR28Qk`TP-`+Q4Me7Dd#7V& z*h12=<_I5*c21a;_?O3jR!nLn@OZc!%2d!v3bwfxoYwi?2*1BBWDJq**YhJs6Y*mL zUSh8@gx;PWEhSo|#V8~tDi+&KykT&;J-+!8lyvRzBTgg1QxyD5T$rRXpJuAj8gij7 z2taH-m+PC@6(HYB501 zH+Lh}0VQEaQK+$r@nm^yZA)>wrSxrLW_D0YV!9lX6lw?sF22)mAQVj7Rh#{+)=(!w zczA8P{f?gy=yJH8dZi|$wI}?f!;-aEi)gY0SD5@_!yK1LE|WnEY#DGs!t6KyZw2Qo<5i*E~TW-+&Gx+1p| z+f_M~%4RFhn(Jk1_lZv>cRpvVIfs~x?{81kg4E1(j6;C^jY+eza&z*#XiywWh*z1h zAo+;Z@Jf?1{9Cj}zR2s#iJ8Cn7ykgvF>8aFpOGp%Lp95sr(2^AelA1#p5t*uy6oG5 zsd%#mQCB}M+{YN1o(NoD5~lViRKg zGe5#zJwbsv(Zhf zTOUp0!NopgH0V)r6BNITXi22hS`({5N@QpAWqB$j433p%zMXE6Vl42geq){`(52zd z0!|raEhv{}LQ~8p*B03$^+#V5tSUJ4B!szJI$fhN^L!?v8d_KU`k;`hixLZLeUt(^ zudcgvh#93y$#~=Z#Xn%a60Vyh_9vW8o}9aE0ta=VZb&=#kEYR><8p0YrT+j4j<+lk zcRNKJEevijnu|_LI(v^cw$aMIa5A7NDqwPn!0(j54y0RAy+(1BZwCmUquFzm%GgQ8!Nna$!s zRqg4Z(CHMMXX1YX(}vj-%YkxU!6h`xfk+P_O^y47w2*x@jO?A3)FPgIHH&dIJ;7(5 zGE?k+yF8HDx1k^Gi=GXYd`c6KQWG+j$-JD*xTjL+Hun~So9m{RxbPw_rMmeQi)L&8 z0CTo^NW+yGOOlytiqf0-6#oFSGTdIp{{RiTCk(@xj8n478U@Uz5{`o0&P_xp;U9ZJ z_IQ)yjG1+mrK+1LCAEa4b4T1+HuxLq7W^+2r)S84p9ZbbS(rD7)t&=PIZU2pJuHO~ zre6hVNxrrK=zJ8PlwU(Nd7`3tY=7muU{Ps^<|aTFE$){TQ-2F`!MDa9dC(Yrr7A5V z=P0$#nx8nJ&Bn==*!X0JqE5J(WCSE7DH{MR2f#&a=ct(&(b#6N9foXiBYhL8Usxj+y!7IOh<9myI zV*W1CQz-67YR3~3#te5)5@R%kl*?!f*2Jd$4Y$y3?RGE8>6AG5+Ei^VADhl^iIDIj1ul%M%wLjF!BF8=_yR&^PU z6w9W65lI969%X#WVg^UI$dd)RYkV|h%hhL8cJEu|6nS|TQ7WS!{{Y8rVm1;kuWV_> zc_0O*{{S)~GbAE4$kly~a%-7FT|;0rv^Xx3o7nya`fPQM9T7ZEq&GmT%uCCtser4p ztKR5VsnlBjx?jRNnZtEe(Dgb>P$tS|WT>m}1zO)L5f4OaMC;8+i71pOLJ7DkX2!DOb%L3 zC1bh4E)vOb*B7@fE}r3)TYxAFg{4+I2x?QbDMXaGnvWyJ2}zgaicI8_i$b!2eC_L% zM@{^ENo6D^$qOQR_#_ulu8^6tY5;0M^}V-?Btd%<60uc(gVWApN>W48&mcKJC7UW7 zZ|zJnMu~YNQ*f?gbl+I3;^E>dC-Cyp$>l+;HC~l!ZIVkbHiuA1vC6cC3yy}yFQ_W-LGg3aN`k4Vx=PV%DZNpR!y|;3n9V=>b9VeY*D;xxD1+= z6dY7&Xz;!;RXu5+bn~XDHP)#wnwZ3*xzSOem14^Z8bGqk-SM~2O% zLsrtk{{SKxirjU*hQqWg!lAkSgLD5QcAlYI`cW{6CXTs7@`FvxA1 zyDiMMpyvyP`k#9L0D*)vq>-p&+!>D<2%L4REPJmsR0aIXbc8f1F{i}6j%oOXqd7yI zQ$bp!B&BSt%Gz2Plm}Gkh#0elRsI$_T$*8MZ*ORqP_gw&Nii09@1EoF$y|lz4dax| zgqozDZ4(meN|2}1aOg?s>J7u7bl8s=s>{GBJ6ke#J}s@8BzR?y6-|?9wBVkSXZmzp zI?x9B9BEzh2EdJmkxRsI&hDv}m~*PDvulc6QJ_#?D{^6NO)a3HIcvz`72Z#HC(q8? z7>(}Imm*5ekji2X&=ksLDNj>LRPJGLpiW;Cn51S0YiS*i2;1M0$#E*SJ3XJfKs}Ee zdRnf-d2eju_EH=+N>(+}`XygrkWPjw4LW-ptpr7y_L1-J)( zSw_SWxECP$5r0S=XyTQQZDO3>F+fwP<-cuiH@8Ez;kB@%jMg7qxj<9S$-abywE9iZ zqBcr^*2m9CEa|+?IjG5nH9o=>m-=?M)2RTPk4r$&)E-kB$kq;5+)5@J@kz`9+RC?i zC&CirM{HclvoBbe<(#gtyMT8C#Wp=WjB}8exPiiWDr1H-r|ACx=M?9b7O6K)gG#@? z%B})!;cNNCmzP@Knj@@Qd2$?FZQ3vU-^^u_mvP0b>~l_AkA{ci4`QDCZSxwQEw|s~ zcd*xOxmKCYRb^77TIE4%A267(hZ7|0nGSp;Ui^u1f;h2F$4Cp6c`76WV1L;YvGFQp zeohs`am)$|iDWi|5JuX^P8zOBB}U`APs%x@;6j%Xph#EY9HWM-bI6!cX+p~zgZqxq z0h!8j9@vzhC`*akFuN+GqQ|{%zs3^L(;22A&<)7)JA6bYjvI_q#J9O*`2nZOJ3tso zC1j|LW0V$o*&s)B*m8$p z=|MeXpc5*S;D0y((hnhp8;q(u{{X@vI;bkl$(u^Hg(=y}GM3U*7qR^PW1wfe2TpX& zH7~0$Bp(itmVi1|nPJ}U>uBd7H@Ag>uDNu%zMhfF10!v6#ja1RbsS;9hft8#hbT$w zM<@V}QP2*MhI9fi2|8fED2+(J$~v6^v^9s55&+ObfD@zu6sG>L95P-yaP^^fbO-?T zuN^qSfB?L5z#GRKIuR}f-rYBb-seD5iB9mtLX!%#2S&Cd&sb(rzGI1r8qNZz*Fg?4 zkfZjH0#)+@E3$h#9!{0!wjYlXDD@c5B6e?HDy2=+Wha!J>zBRNS1;>0O1t`~t^ zJGAfOzfp7IHSCoxjK07c@Su6qo818Yc@Id` zBvmw&DqStOf)*2ELWm>aA)LI2U??jy0l9~=fGpy+0CkEs%V_dCcnYMagyB&(NkAT2 zUJ%&MQGo4lGdEhKN=nPQm8WJBml1mf_l1G+zk$*ja!K3sA*MketfbrkWGbMpHcZe7<{*s1Xkp<63tT49m3)Hqsg{2Ai2%VI&*aU%PRC z55^U|KZaGeC1{70cS2rA08^`FiAGZMazw2qNl;cr9jr*XNbuZv!3NvknO`(Rek-B+ z6xu24m|N_y;X_x@DLJ*c2Y9~WQfa!~kY*}y);^V{Q)*Ik5?skQ*#X3dKrJX}mjEd@ z1E>Sz3-Fz%dx+FCH2g%xHl7%9^$9{slF_+BR1S&>8U=ZQc$?wdzM`yc=dt5SeQz;P zb;Y`sA;#1e0ZN6fuTLnJv2>(JOq~2M?BOCPa#PgzoR_bqDVPps1-Al@g7yIxAFcVt z7Zb!=Y4YqE?9s-wULl&gX%Y)FGb#yqJko<tRjdw#Ugy#);~Z4nz7@~(6qx>S zXw@m9QuxTbD>mYk+d16M!@eTPDg)G*q~fC+{{Um@dgRxdP5g%%u0t_T<2EJWi>|SYX`#AQ>WR7?=Ov{p-U8XI zI@;QJ#HitpRaoBrQ`_c_t&WB%u3_vgG5o5fz7(ZOk{V?z%u+TbAZf0K<4yF2VX9S+ z-fFAjL~C5LLLuRk)ET%G1KJ0!N011SWS-AeTf-oz1ca~J;V+R&FR)9zpJJWl#$ zDvRseu_x;No^aO}5-UO^k@TzGN322&aDZ2;rT_#|QlydA!LEI6b@raou=lGl5yRYUzRE4E&%p=;d zNnxe?Jyu@M5QH14yZ3=okO3bXgRDOeD<=!O>(RSU`I7Kdn3Ur`W{FBHngunGf`OS2 zm1pLkw1*R?O+nv56S!Y#$};?J)AKDMk6*-%Rld$OYGWyyTL^wsfV}J}Dj_{U*8Zt6 zd5_vLmzULj2mAszPN!ei>XYTPT=4C;xf6*>G1zSQMOqEwYI~`* z%b_OTac-R%>26=WLY|5GL%MF={{RSaIwDn-pWE*a8kI8-RFHxH03hpWO48({gKr-g zpNZKUBuE{B%aSjl=|`5t!U!o^6jDJRV$kz+G?8JHzTFkPF(veUN>M!0fP~H=!jgJi ziz>&&gRhh(#5{e3txJN~*Nla?nQ?}tCak5chZ3yFS65Zc%&$dT(jw%Q0!HOChZt{y z(`x5cstKBw?x9UKwv?v;)lI7@89~qky|=VyIJELANfNQkOA&JXcBfLR&O262{Ybu* zB?0M`Ae-n31tkXF78=D|xF;n_m&mY(7Sp!hsL5mOXv$e~T7bHYyAG(S=~rg?jFog! zQk0^{d*1Oc4-W3;lWVPRCV9WY-@?Y*3RSA~(k7H%n2|!jm}8t$3VNqpz+a)tKs_Q} zOc9qvpL!dPR*VyPPC~N#j!Mi4R4VF1UDZjxxk{1%KDGnMLX&A%F>!WxD4b)M#j=w4 zUbw9C4ZGZRC+iZeK<^yg+xQKlEVxY#&K&!6EwJ(W(#MfpUe|8_08&WsBZaDvsW{y> zx+DlrcAA(dKe&&mWhr7SP-Crla>`7)jNY&)(()9dA zD8Q0+N|tnjry6jPl-Qif^+~?*K`sI+E>Uf@y)ynex2BT5tGI(-7%F|6YqRwFephK> zVaa(}=M)G+h14b9_fpvCf|U;g5`EoqF^rzilW|{~{Ydh9TU`3?>*G&H76#Pcv#D*!6Ox%pR9GI7|Qh8|s*7nRrfeRiW z>kv3kYTT-CXV-DrW9&q{M=6M@j)YMjb(x(KWL-*@ldryoW&u86+EChB1+p*-Y@~#nug}lU zNzAn{TY6ubQiSFwDM$lb>}*c4ZyqU4(&W{lIvC<`;}NwZD2aC54kZd!RbN#F8-hoS zNmEQthC9;OrI(ZvO^J@#-7HlzP)kEHlmNEpXl_H1MisqM$1={!QP3PNq_(Gx`Dh1o zsZL|y0f?CHw#f$ z>Re*>eyVQw_zPNpVr)5wUT+XnovSxjL;Tx1;v7oUqI0E54W~nW^F@F5oTRC*p!4=} zi`n1IeP`+u6h{)&<7K6gEq#xeBH|}Pdbtp1i%H**sAq|>Rz`aW{yP1B7n}J0QDKQu z7b7Y63AO(KKDH1!lW3kteNy_l1 zPll4gQZ6JVN*U6X4M`X80Cf3p6C(-}uFTTTF08amrPVZDP){*Cr1@V+nFx(eLT3<2 zu9WJSan(GeD%r|xuZ@WZ*H1{BjS#Xi5mc`+P8V@mK#5U_8d4FHc(BicnRbXz_(dB7 z=$iuz(jm-dF%?dA$GL4huh~wJ)REN9d@qV7D0MU;OS00SGhW%Rx>e#1#2w+f6=lMz zWi< (qk`6yD_+R3)*+is&+G@Y>nHH(yuvV-Dpv_A}DB{2t9#bGxpR%IVsMEFEu zv8=?E&u^BPZvOi#O@Z+mL$i*@BKIS=1*^)V$UMuo?#vwypxkSuQ!-*72^=ah!h&RJ z?>O;kQkqyDzqI#aegePxdFn+1WWYUW38G9?ny^ z0!2uiuFUdP@5?Ys5Yn%50nDSm8ovdQ2zkaY1I5I ztkRMVspGru)I zX=Ud9Hbls9@x{q{?#)*iOCv#VIAyX*MkceiE)D$ev?p5?NRJ(*czsCXT^Ri;&E9R+ z(9`G%4y3JC(M2lL#BCQI&*P_xTY7Y4E+c}DUA|;J$6bNzSOKI|@MTJ2_fi6kx{6zJ z*1n1hLRaZvOl&xBYpJ@DuQg_8H?#EeW|t3pZ`Js4`e``UK|v|*msAu_sX@(uRG7Yo zWj)sAM4;o%Q9P55y~KSfuzvi3n=Q&%~S@h?%j7q;Yy)q=_`OBFvIy+fy%c zN`hWWg|n>&<3CcNzl15oMxj5!3_nh);zlJZAgW2=v@a_8YDxPlN`>s8NF&Y}&n*#e zvD{JA=(0>fz^ax7WmC9HdS-dnHf_c7=R!v5Zfs;q({Je9LV~uuXV)DZj-K9X%YSv0 z7k`M$Vccnkv87sCZl^4&ZC*vtx8~`?*e33ibM12Z3TB7iQ$;FJzL8<#G^?6@d66D9 zetnr{)d?zoH>Db^v+PaF^m^e(7+Ii&h2 zd5>K-UCH*d%e>UXByKEke-f2j@PsH!$^HC9OEhnE)BEx`GgxtncR7Y#Z8>|F8dg*O zPNaE6Nvh_W^GuZ-wzg^cG-r@$)=$++5)KJ93xFujmt}&ObE&0I9X~ zGqbKIn=0F*Z0RWkYtuE)$iuL}=GDbNgI}o2%%HZDUmG1s8Afo#xg?yaxg?wX2bY9x zcs?0njUzdqE6pnz`n^reQ1)eL*!NS?F5swXsyCQmG9l|Dv~jD{Ib1*xCR3Xw^4Qyb z_BmXBvAFqb}z*wT9+!UkjN_=IIMUKmMo)Q?HT|27w}h?b zV((%uHIJriv(&0g&6b&2xpLc<0eKX(cL@UO1Euao{2|v0RwYQY9uwm^c|2{3X_H4F znVy=LWki6Rs^lP()cv0mq(q!KQ0kE!IK_mQf$)V2VWyQX<5KHo#3>~zORIaD3WBu< zGD*s9sewk=HcXBQVp&Pa+O1Y?z?V@kEXql>#)-@T9xB_$@fL9&OpKg=lyYALRv33E znMNQ|o@^VG^B0+`j+v2V4-jBW@e93&--A`@sdFQxoGQ3EVG zmKf!=9qJ_u`8i3e^5%#S*6Jy2gp07Z8&FD8FR3dDAZck*|bRktm^gqX&^KdBNX z@F9_{Fou|X7iv`3T6xygobIm8I*iKeeNDdzmln z%ZN?NN>-(Z*sE`W(|AUL zc_XB96S8gaOusKtr=n#Asre~HNj}PKT9{>OD@@Bu)4G)s6asss+cm8e`TV(AV-3?B zt}J4|r|EO)LM&t|DPeu>LK-csxO@huPXT+w6w}|o&~_E;60|WTb($g@sV%iE%hXzO*YHO<)K-M5b6@@8(FaL_eoH( z@+K>JKVQnpZWldj^9a{u>8(#ZwFHFC zD7bt|z0f>K@QBcS0GmK$zy2b!!M45xcjKB(PNzZ2u+g5Ja$OD^9Hqt_Adqx72G;6K zNyN1#{`vm^F*15-4lWu`(DgO8k*Gs$pzJfTm;wD{iwI^<@8CODzWR&2N5okKRcW-` zs#L_n!q7#JFGXB0TY^9$70#OS7>pcKv7qCr=2vB#+nFho`){B`tZ(!ekNAFnp$_<0 zLXyQ*K}eqp$u%=Pq$xKADr)5_(2cw{F){7A#LZqcaC)P|c_Kmf%6?&zVW3EDH`%}e z0DiUoK!OuZoRXqNcA&!(_`3ts*`{}%Lz3?V4b~e2MA#ibB>G+qQc3UTF_JCv^8CiX z2XTGbJa+vBm2(7)p)$xS1M8*b(3e_mRwU-O$L^D8UxBratld8Onp|Y!yLj@YPJQMV zBpzYr(Bp>fDbS(Z&!7h4z#U1_(8h+-qGV>Fvl6(8ha{brl$mWzOd?^W6f9*WKY2Iz zllsF*PMRLprO56`)7Yy^)L&P<>~FEY;YrR9`7y|nB{8nJ4@h zS_xz+?OXx!OOyw*TZfgo%wJfSk@_tY`+ep@e-6!hA|wED!;3Ud7FM54lU)o3aT zBhM+;I=Ot1ha3L@S&7_HftlhfO-N1630X;Z+IiIJd4~^wEy)&07EYV%q<0*&{r43w zzmS@hsGL!Vu^hy%P==|E%aon+g)33#pwRR?#e`+I#{U3emm05$S#??z{OadxbeGh` z?31rJ%2T_6wFRjoreR`0vAu|ks6I%qnxEGI=Wz>;yK)Mc~#DvDzFD}A6i@07(iqh#-7HOs?Y4q7?HB+Y45aQC7`K<$X9 zMAB1oJMGLU8;?){5aU)xQgQYC(5T~8buzNk4%+Jz7>OwTpr%v#LzuaV%=YyCNb|-F z1ji4gnWQv~s$&kR$4S3=*HO$`ytPpu2-I*c;{Ghm@rZ&Qlu}iRrNHXj!~BC5*g2F8 zmA#_o0w(GHOuPPkKcAS06Em`0$^JsqJVBa2^PO>%;~(Q?_X@uXB@I4$=?48TZwRT8 zH49l8j(R~!1bE&afZT*H5vsU$p(gB|Y58Kpl0wq8f%x1T`bLX{gt?^3yzO#jJYy_0 z)*Nx?sfu=Dh8_(v`r9eUR4x(}O0%{$3nu-(ry+7?Wc@0lOl?3k3tsqAmt8i{y5?$ z=Ic)sOFH;l?veIE)F# zXp8|SDB*YpJ;5+cnTa40PiT%cZpvH-#rh1fDnHjUS200;a-TT1ArJ zB`O~jk$;Rz$C<;B%<-uVGW!_eqUF>Uq=S2ASNhQ*@vLjz(IoI*5~pzbSJ^4dhMVhR zNhidUc!!fKo3=k3YA04_>otgTBt+0uz4nG$95c(Hx7ImFZ0ff0OmyIb;NF_7d0}x}^6maDoVSq?Wi%C#F9E3yA z;nVXPmU<%h5b&lk<9%VbE0XUefn?bTAt)Xrx|o>^b+ts5nuquc6tC zD>g;Aq@zEHN>pxQRA7-A%Ezi!oWsivGRhloz-W|#xhKGNF!j*gSk%=i6>dMZIZDGy zOBC5-mHDNDQ#j~8;uMgpAb5kR+(az7(j`L+Vhai{9dKS>=*MZ|a#5uywv{z-o1Jp6 zmPrT9!%HfCexr{YMr!{6YYMIwEv9Ce)UaBG&RZxXC+X~Biu~AA_a zq?C9&7)fyfl{+dH+pViB@~;4w*jIyyxgZ{j*u`A2QztBiaQ4VKaWwjTCEFkKjx;=a z>i`kXb)_@{oCj?$jjk`JmEriYsUk=5 zWEE5}n}leh)sKzs{36;s*Tk%liQ{Xv{{6I*V& z7Qct8qF$25Taz%}MBB%fqx+(QeEwykE6K-8Ve7G%nfDjV?{cQ4Trj5vIn=hEq zFp!>7&~qd<1@ov7HM&KkSHWP@xkbd}y@;QPW?0~gsUF$hm_c%#IFX`XlyGQu*o)k0 zaj4A~trba=&$1ko7($sjLP5KdQ!843U5ESZtaT#SNjqjq7crRjlqy%<7rYy^A-hZB zN!%+>* zt(b=cWY~Dx<|bo}F`2tGI7NV@cxi@Z9+X0Tx9Z$ey4>a$wzty#A=d0_h4&Wl;;}6< zWHhc*?Y!HJtZGoV0$*&8MTHNK!W9`)6C^<{)f_^r=Au>d2It#krE^FZL&Yacq@)C> zY@}*62KvOjO2#L!x36L^?}taC)ln|#l$w}J)dI>3rL{4-NEWar>KdeLXzaE)iJ{s_ z>3l(eCf}7>TwzT%w$_tyK^D^ABj9w1(dIqSiX22qtZ^BhlvZF4Vics54RsktUl`+w)W(k+ z@D~waM0;$anyypErRfX0q>mN05=wmaHt~k2U7SuE@m_NSz0Rb~7F18xus~4r3T;=h z`9~<}J}_Tunr@C$G*iA}>UfwE3PzU1?=L^}AAu;^mEp?7E6Nf5| zrSy=cwzYRu*&3a!MbAj9%fnXdVtg}q7|tqC>3BMRVw~Ki)XK_I=vsldntH(w8MK{> zd6!}4;V)*{Y$9Yk1G+#ii|k0^<%%OLm7V6jf!bRN#5-Ed->Yz@R}RQK;CD z4;YBa2#&R!66PpFvoh5wd54A6SO6vK_3ndmeh}*T17KkcM6ob{`jFeI9JfNwOv)Mn zpmtZL@QEQwj->V>MJY!!YHM&-eb8;K$+e*sXKskm#O!+JF=440B^jyGOAbDSg4k(9 z6qOP7hTD8%UN}>?vP5~x_D5D%1W7!fVyLjBKHY$IMNKFhXhG9ss5=o2xxQ=AUX;$2 zJBOHpkua35sAeS*a+aM&S3vtDDL2eK`p0EBwaS=?#i!2Kz;MLfNtC57D?4O?n{Y3% zR+>WugRO}xKgbz3r(Uu$BI)k}6i?Z?^MONF!d$40_*aeidx&dFC&RSqq@Lrd0?1$9 zNxDLkdZgP(nLZv^`EI8YuYamoDCs)Nj3#aNEh(mc%L3A$M}^HWx`(ZWV4r?MA|}Hh$t z+UGVFv|iZ)Zb$DBm$B0vjd$q*ohe#8mYYW`4zIN-L;{oQHiaXG@?N;s6mZC!bcFy_ zyj$o<@_-F@XEKYVT=;DWas!ygAw#MtAf-cb{{103&e68){f5Cq$~fc{VPbWs&c!AL zB*Kl*g#)1lCLB0pGNrra+ra+-7%1uFsbj#8BLTx@L^_fPzmx!KqbmZy6pt-!90Ora z6bt*q$~pkEIEQrD_!#PE4B(J_q3DQaOT)Hs_2ZTSEok5xlaqo>0#a4!tTQJ<(lwf^ zw&>YI$cRRvRBRW6>Dw?njfnM*-JGDV$p_oY2_72iAyyO`R4qN%HBkFq2>vnMM<~dq zls(fN)OL+Yw%;c+Yq#p#^6`YZGqiFfYU-GMOeuZj^eMN?#t^bLcSxsRWQ{d3AxLeY z8FxOGv4>+JCdI7^H~}%+166Mjb}-A3q-D?4YX+b^k`=A39I!BkNIoJGbT1&I-8y(j z0N6&6!A4Bc!>5Yv((qUaJWIn`HZ)Qkos?#6hflORkkEFt$8`)nOqt5tlG4t$mfAwlkV~po_tyG! zx!OCzN5qn}((Lvk@f#v0;chX`;7VeWjIXKDk+YR4N>n#ev^#Y^F>4$erMBJrl+qy{ zDaX@wspU;fs5s&Y2~hw5FVG7MMvoT@7{-xbC%A@QIiHw$ArIM0SV(LkHX!u9wfRJ^ z0x5D3J~cL+>v_>4+VJF^bIkpMM`PeY3WtuQdAOE zU~UqfPIQsiLLppE2Il1zv+KCH%$amdV@l&yHeyC(w>Hp03MnG#J_<;&N%Aof!Qm8n^+@GT|%~FuN`&60*=EG;INlJ>cjgxfvUMIsM&HPTEfA0MId_~7$ zyyM))5Ncjlr%S`>s7_C2$k=gd2qWJvB{#7_(Mcmip&~3eR^;4uX-m%i3HY6nnpd^8 zXNF2@kh*lVn=PA$kbt6)qjQ%!bw3+<#j5svb0*ZUMY=q)E1b0n@@MbMWpm(=DsEHzlpl4HQ)FdQkJk2v8>0oR{_l07_ z+ph2GT;a-}$U-%U*u_-jRH@Fg!Y31V78X*Xr2ha$TN#D#p->=?2%Q{m4X4dA&kkLF zYoT7Xxp$nMf0y;HDN7DE5t(Fbe(&2&x{YnpHdviSdiSX%=3R3&*dvPk9kNc-9o71Dxlb~e$@ zz}R?kri(L0pJkI$lWe@&*0p9z2JNJv0#|zw6@Lh2!lh_s%7}qq;H6g$&8k_o1uY;f zgk5DRJ7>#$q;|G9y7vmK}4=o~~%4cPTyP5?L zG^{57062@6hEnCTEx3PZOBeBeCEKXz@ej0HSni+nQxBPW0#d(aQb)d>K~dC$(%{8z zJ`v-0*Wzer?FeO$%c?A|gVT6#hNRzlu!fx7yI*TEn!-g*5E5YaF_RS5&KrHaE-%aE*_=0qYFQ**6VQ{{UB$BTL#b z)lE9@%@YR-@#70)m5F927;<5HB`ACqAK4kN@)2Jy72{uyEqU%L6V(3z1e5ZlY4JaR zl6+xlwI*!|pO#i>ca)G+pA;x1Lg_wwjl^AhH;g#yY89~79d&+Tbui>S2M%*bZWKN|8Dw1_&Cptm8(3K@?Aou}q2&A5AN~HeLOOiTW4991#(u>3ny&+v~DGWHY zxbRSENO5XCERY5C0G)gxS+S^7R@2=P(D#aO7v7*>?nl$XUUJ2Ldg z)tA_0@`}&dQ3P83FB5UjP(>Qpb8FFM!<)0iTBeXE&r zZ_$3l$oo1En~$p+&Moi_>H<>!52VdD>qyMwD|oFgq;8aFD<#hWEq@rX;XSU~{{Uq9 zY`>8oi1vDl{4Ft+Bs@B(2FX^UYdGE{{X$JyS3dEZygq2 z*}8f831_M9o3$>hGzb8MokzmQNUh>{g+4^Q5uwQ979U*GN}Q9*iPpv2QMd}X*j2Bg z+V(bzT+r5E@Yyu%`4Qs=c8i{`R1ry>pi~*0O2Ss@NL0E3*=4{1%iwbSA-UjiS84ua zh^-SebsNM z+jzahl`@|$Iyqcksk>FfGc8KAhFc~VVVpvVEH=e8)61DduPC;y2~EJdZ>h20z*xj=k+E@P@nU;e zYe4RyuI(K(k%cF(_XWLTPAF3sWJcpvE>3|>ma5A&%bRnM9dRmGe=|Vpo8`ZqqI@DD z$d44R&<){*rBAfug|z|-K()rBSbaoq#5olXDoNv+mnIyWb)4!XqasHAGX;L=lLnC< zPf(tJiS#TyyEt5Q^~+@+nK18&hFTM~J~gKhFO^D?a=>g=nMyw+@)6Gx&QR0Uv7KpT zp$s`Lo9kxn^CVsxl$q0z^6HfoW-Yko_f}KCz(Z||rc7=PW1L>58euf*jKW(sY4&B7 zthVTTnMn0FguLoII`tinCe@Pb`7d0?=u4kQJuN$P%u4%-clF8+s8@&pr1*$#e0Drb z@kx52=y0;h$qCF$+3y?sDyEpHhkMrLA!nIyya7N2d|?aQcw_zVMf}Hqv*!DHjJv&` zc!M~Fx~W#Al9T;Axm0|@LJi`(i2ne3tQh|Qy?+Y*$+*3ZIrRL;n}J=Mah4sN6JF6K zg*mEX_XwLDU?@3!}SrE4rEQqrNeTfrHh@&1ls;E-{wlnsnDo# zDM0TJge9boEzb#z`)vlRJES7q%e-;O>PEQ$?X)0R)NzfVDM=Rhrls`sa2S)r?EX*k z6t{mN=*&V>Z7c`n18jgzdoy1v1NY-VOH!PuSs?kaFN|R*+=we0=HdtNu8Oy>) zBBH))-`x6`p-n2KgDXDCFp^Z;52Z;Xu2A4o^M6@7#=nO4Z94Xpc;W&Q#7JJhfPTr1x72@w!waPlr5mt4{v_GMaeaK5OvZ)ewGt>SkEDZFl!GS%5eRzgoD^r>9tRnbXWLJ7BlBp6o@ z#Lo+~{{Uam=58Jt6@M?(ty}Naf2CBrBn3&6JrocDL?WTN0<{yT7L3V$wBkb{9+zX9ZUJI*p-io)4uEA z{{V5jqIQbFbA-vvwN=9JsMw}?vX(*XbiTDCUA7Sld?Sx9qq1~3&0Oo|tLlZ$AK?uX z6}#;;YMm;iwHu{OzNsfi-LaKhi6_+p@fqRo_1K!Yy}H+xNqt3x)him{(uB1)I#?Sv zsYa>|0pMOwDd0THN%e+hkIDXMab$$MU&l*3lKg6@$k~b6DLJldv2Rw6>HTFM-I4~N}QY$!cL)1ns`_uafP&%+g{@HDGELoH!&xL;g%O^ za~R?rvMt(m*j-}Dwbd8PzE+XF_9xaavCfFG$E0s3v86VIGIM#(^l5?3Sw0z4c#-0c zd%J(T*iA1MS8J(Jkfkk#$Mp3FJ(&P_|yG3xJu^Pr=n^7HA^ivTt;JUZmu*dCF(n5H#wm1E|ob>v#^Mg@EVPQFj4NI5L&XRo%Bi zoH|9mdPhZ~K2vxZC5tfR%~8jlmz@=dq|osJQs&JiO}6Owk(k^EFO(Cgv@cx+4=)So z574Q&K1z8diHTfF@*GLmDuR2vTpQ_PE;R-lleYc?h(sqLlU1>^Id&5iK(1o)cDzcp*wlPGa6bM=-rQ1;I6czy=F%o&9vPyBw5ZN)!~5H3|n*o`w*is8*^U+;zm3J3#RIYG4q#=~YYLC^uQnlrG0m zqjD53d)n+_J{=v^V|T-hM)n$~Vkxq$&o(}-3b_eWDnd|ge0u>00#a5;ydPzv20bOMj6Z zIPt@&tVLLQb+Y2r;%ZWCF`-J-<6tEyA7x5TRb1$xI$9;-$y*V!Lih3;i3|-+ugTWf zl9^xCwN9LE(`?9n5|(w7qI3i)vuhjp!>)8Tkt*ty$$ToRJxQ6RwBqHP4wR^=QmF|@ zF6H}dm6Y=kEJew`gbxo-CFR~ccpX6f{IQ1gqKq|{qxtds7!?J5%iYEHy9=q-7xSYED937oNw=I7WuD-=qqXzws2k`ZeS!?$!VpRZQdwp z0YM5QQ*N(-eWAFjL)_)? zLv_Vj_ZN=vRXC+4Q<*h1K^FzYBb3?j?u|!KP2$T6sJGp(Oa4V}S8wG1059f0^?HA^ z&XuGL!f`~OE?S8E;smyTH~BJb9k29%QLhr7-mMjfK)m$n_TyCnw=`_sDHO!(`E)mTt8%Jx^hTsSP%cV@m+C z{&97rB#R|UxbJEXZK4b3u&rAr`t=zuI^x$jdxPYv>^F4DRAtb%jlnFb($bO-LIth3 z(`!WT7Ct9GGB*)D4f&)%YFz>R3&g}!=2};?H#VfY@F0Mh_S6|!PO7!eRULI2+ASik zG(eNy&K@t~Bb+bpou@k`Iw~kf&^Uthk=@ZUB*P>a`IcOC;*PU4H#W@<#~QI9)$e zrBy94BJ6|j$j+w0E`%W8GD4MQSzT?W+Cx%`=DGGB#WvkOTMCNCBKBD|zT156OIh4# z8x?7UU?U=a3O+(gRaF&{31Vxss4VHFIJSk`q|#b&#GOfoB-zy%B28rn~*LC#KUu6 zr{pUezpv&cFn<%J=u^`8Zmn{v>ZWDh3LWO02nk6#5TvXq4*)@fDl*&QWNA(;a}Z47$~4$gklq}hn{nkRm8mZyCSOFMI&MypHgKr6y#D}JMvhO# zUE2K#b;W8CYFSfq{q*H(VUzler6i}vEry=45^I02(0>&Ad{gxqxtfg3wPKqxd+VN< zRG~VIjpP{ubvp#@vANnfqj%-}koD60^BwLd(-@{ax|Hg?ef^KP8QO>l$EX1W)e|2!e-pabXZbOYm50@8+5#1>g4)S2lpPF7S$t(_-1Nl zlqIREbcEEg2}l=8o62vX>)r%-+9t$lk*|)Zn527L`wgvaGUXZ9RFh<-T!!qG9)&?9 z1FT9&W?Le`DV%hcqEnSxlS!PTI;5s$NVr_1sz~m*(bSIxq-9q6LoNgQj)g*HifoD} z%E6a%qSV4%0NA1DTCpQ=b+HFnWue6X04n-1CBhCA&G1u+Q%VR5rq?B=3l3ZiibBKc zKu9NRoxsyk3QUV7cK!rt;zO=iW#r42N~S9qnYDrL=;{YwAr9kP{DjTlsybb+rN`4V zR@pds5Bb6)Pr!2ZGrVC|{gU0uiY0$x@A=kZ+Xp|9Ldi4QHSoi<_Z9aZ2m5#Z@gs=l zBN`^pWQ!aVO!D@T@_m2CGF)HrviFAm6iGzMuU=WzK!foXiq@=`bU`lAoI|S6aT=*q z*|#N_Vnw2~w4yUOqHa_H9pVql(Wdrq1stpK6#Qop;PxXz61msXsr9=wrJVzg6$}2! zxQ$jkN(Bt(sFRfJ2R~4edO>+pCo+VBmo*8sh*AZ{RSzEsc2qQz8yN~!K7_X@^&o|^ zr6@BsVb5rbSwM^37t=0;Z+k~j+0m*sC&Y?+u%&%TW@cEEPoA~H{1C13f-QdV2g)O4 zhP|0064S^;$>EAD>V*!eDfE2nBFN;Z0I~iNwPh(GTjeJ(@r2T!;i@{VZ_MjU@WuQt zulTaQ`$`_`ZlQlH$xt5{W?UE=!WL+ZzhjREFmi0z>#O#oH^8aY0I0$3usQ{jm$mb zF&a?w%rDwj757De8vzVRaU8csu)yhw@2VQdXyL_M!UT?*!f#z6R0c%N6RdRLD4r@k zW3+P3mgesbu|`gJj5i@@Ize8*m`;zhkHA!(|;UxT_ zYa2PN&-6Q^Qj2^?@r7tPsA71zC-jWvE=;$~yUKCEMuD`Xf=|U-dB;*aWO}D@f`Nl4 zCuM3Ae5Zu-$1X)G$x#_eAQ*Zv5ZNGIa3ObWg(k^TR5l=sf<6%H8f9koxPEG{i&>Vc zI;2wwX-)1@8X#uw-1WWmyjtOQh#5&>!_466DSxAqpJq}AElq$Dp>6x4e_dkQG*-w> zOk#=3imWr(_!A1D2HR7T^dKFm%q52WR&Hgn_%xoSR%o2lxR ztvy?1B&2|LC%u12fuD$^O~r=UF)%GEPlu8snIM!mF4zIQqRKjVl;IjFMCwkFM=Y*I ztYJrBVkEQrKol?bh2gIfhcpo_(pqUwvT`XPB_&8-+PNSb9-HfUnTIuV zBjm??i1x-3$DN&}gy=|`l4uTNDp*odkJ$?*-hkRB_=)UA(L|czKNYE*P-ojEZ7(v5 zbJ-W}9)ueUr1bFE#~IW+HM(CkD-u%jrlBH}&q8~sn`nE@zBDC3cbi!z$DxLF-ppN) z!?i>7{8w0ZeU%$OBFn%7(6)3sZZ=3H8ABi_|9f~6HJxNqddawl@Xy?=uOV&^MD3svdB}YlXPV{h&~|g zZ`}YAx|vU@aVH1P%ZG^+rJy$~Kq)Ptg5r~XQlKnNjflRG{1D8T`0-wgnT!t>B$P-%(rx%;gNtiu8n{_AqaVlKCWO$RG9`MCnNx)`Rk@cck4l`?hk+EJzu5C`(j)k##7UZ^8lgk2ptDeuDSB5i%vRcL6p*b)bc>Be z(st50Hg*WKj?cJ(Sf>opA6Xf~nIvDKNe6zBL6z_GEnv1G<|~q24!t}ktPHhPw~e(N zyx`n_RNm2hhF26;{B#}mvI`IR%TUGD{WpkPVm-u$W}CSyF+1imyYEWM=#r{ zdGjYiB}!!y!48-x3mO-G{ERK4yN|K)$bUE z#9-F1sw85|r(ycyJ|}MnQ77k}SZp;c?oxH{l#r2bw12brAw|}%4%fO(qo^6q z;5H*pI>XY){*|=yT~AcF(aJ%;rQ@$-govTihA*6}$R%2~nLLNV#@i;^`0RX)ak>OV zTzPdpWe%4SA`{XzDA|LtI}V&W{FCX*sab~*w5z71 z5Ju4aos6YM{v^fn&tZ&DN0C@|QdgGiR=t~3g!39m&}0e(rrHabZnqt=H8S9w;M}nr zAhtgeAw5NOJA49~MOO#WLbOz^Y+L%lL*cwO_H0@@UA9}zMnLP&TutG5vNmES_NGbZ zVaJBWiE;Q?#gPb-yyeqz42DtNc3mk@=t7$o)6_vOK$z=&8pBQ%vCXHx4z5b8mKFPG z11g7zA{b++Z884<4Cy$$=c`B{4b@YoB{K5}{b!l7`MxBk#P~-Lp_8xnX{gCdiOe}P ziu8uMi!m~fB_V3>5##~#fr+sdfw-wy;p62J6Aqzmn>i@yP#SI&ft zahkamnQq`1^Fy&i`++!rNNTAsSf(M9n5c7_NJvm4P@n)m0~ONT zn-@i1cFLP`2;zCP*r2Vzwv={IAZUNvXu069DaUdie7ac9;4aW}SWVEdg4wvbno&qT zsn+pp?opDaL-)55(6~F>MpqKFnQ6{c#l?tTV85Dy1}M0{V)cn-gN{sl{{WF#SBPu= zX6oc0QO%LQ>Iw5fPDA)cPd~GqJd4bHYkp#1iySak8A2zOERwd$N47C$$p=7Ik*}`4 zaZfyQhdxD)JgR)X1_u-2%I7ISQ{`sVp{m_BQSeYuP$6D@Au&|qa1w7%P0?4#N>mn|6)x(t z7LQI_gG{REMaMz}cC0K(Phy&dVG8z1DU{3$3nfWYE`W6oCrw910uABS6uGn^$(npZ z;SGO^6twd>l4)pXRH#x{pTvb{>Cq&7Va!<;Cw% zwG}p;z@&Yvq?`J}B`a^@Ek?E*ZYywhn3?psNOj6&%PSnYnRAdSD*G!)14Fg1Xd{D?{gAMT}QOW0(nN6zJ3)2K?FF8h_IoQXX8NdZKZu0M&{3xRqACS1vQkZ~bhZ6q z4O!6XlUg?felVJ#HMs<;`+0OeVhTES7-yQB6AmR}O_VgLaB`BbBMVyrkpVBJ_P61z zbm5RSmI?!jGUUP+YapQRZDKziVFyl=O{uSR-a3)M@35ECsQ8Tt^fA^3vO|)j1K&s9 z`$_fj5!<7cX4f|RYYI~eGNr(D>k8I#fjY+=tSIqESmQclUZX$>=?OYuL&-_HhEjC( zjwS}~YmFgbYPmR;4VR=Q=mRCxuVV#(4y3q}lX2ig3=U!`#kFU!QpZv?`R@qPM{M6| z^{CjU#vOxVS-L!8SkPer8jhEeuINgW@;{t$+0gB*xwyBKCzt}ZLj1hpI!@Rvw~$)o z`oW|u$Wxj*L1qLrw$AqunmQd$2KVa-XHk%-0e+BJpuE8xunZ%hV{nx19J&e&f>bP^ zBeueXeP4&Py3)C>OEj0QZfX#exo-@>UeU+6sLF;L682_9;Zu@x&Y?$Kj)1ZA8BgaC zC4;dxJV$gf6@C?0Fg|rU$1#iCxY-1Hl-!t$JZ>YeB9PbO96-|KU6&;0bx27X+ybGP zi}eB_%X5s8_&S3|q%hJc*n)Kmu(Dlvta=ov3wmBN`KigfuaNXs+=O>%J|4^CsU`(R zxRo}_^Q06Ex7y?aZ*Kty3nvH8{x(J8A*phrsC)DMeSg*7dI=?iD zYE**Wlx;k< zadOuB^eCj+WSEZ<8JZp)azUPTEue%wGnqkbzo0q-6`K1h#6>dUs_$pNPJ4~`gtX!I z7^qR16L_iVL?w1h4inQwryEdHSeG#U-ptgi4fHRGRYj9 zY$UM8ESHo*>CQ|in9(Rvu>{*o+WQ^%iLsdyc=xl|TLsS4eWBbxQ*vH(K69tuZPZv^ z&8bOFaqA7wDu|?o1u~zF9-jf)+8m{)MJ!7epDX_W22U|TrC;q7sU|A(@sUy5@1woH zEs0q1JKnw({Kb`OkvPk00;x93snt^lDwNIk<~MJwN9!PuIIPFUNj?5*{{2xdSQM7Y zZ};|y?c@i3KhSLghST)0~8>HNrJ z#I7pV^A*mnZbGu_YDDWUXv_I-0YFWYYiLEvy4=NtQhc{XJl6Z{$l)Q{Dy>XqQqrx< zOCac?%UKk!5~T%ZH|wlUTsk2%BCxj<>R2*=+a=y4x}Y6G$x<8y>J~4k^@sEcqv&@H zVERW8X%gaopCtImk^x}=rr;e7jiI?9fx)cyTf()3WcC)=J}7Cw+>r?#Lph3j0pYsH z%78sB ztxmUI;6#Y0%}TVF8zef+!)b6RAG8h5hsco?SvW}MmiE35i)e9=992`U=WmCY_EP~; zChP6FBx@6n9Fj&*-dJBp7;qluYwRv95qORry~d+XkxRsIUL5K?pC|nbJRDxQ+kX|!eN7%De{>P7 zILmEP54FBf3#CP9N(uWU+Qj(S+8)8cN&f&7X%zfkcrW2eh%9TwnF{4TpNcBYJx!@i zkEr$qgt)W?TbNXkprQJzvbsZyhn2WSn)6#3E+Oh---dKN9aQEerD&{o_K3N)^;M_0A{`DM5~tSqHss&Z6$A+eQF&Flna*l8IaULgPEn=oHQP-g zxxzE8Dck0CY$JF}#~N-an_&;A$j+*2=~`2C%-uu;sX-uvu9=C6uYqvoxHl(FMeUN#VN%JI+D2n3O@jpa2 zmQhL4`u_kTzv}fjc*Q!y^=4#c>I@YnGakrXS{1ND+|S+~A9TZ>E61{JuZzLT?t(g_gKp z=x?dDwV@%v6LJT7+Why2dxq=waDDxEu@A?sTjlXP_2y+~i zh5NfiaK^ZjrNqi}w7I!QYs+NBgjbpwqkSsdnh-DV6)BCpw}vxuFB-j<-^6zp58^V_>3k2P;Yxdo zew9i_RG3#!Zk@U^U%hT8a#w%Xc6jR=zij{^M3)^U+#qwk*ZUFSWONX z7T5;kcuR<+&1%ICOA|H7smn1q+0!HKCBbj&18ARvik2>~)sZrA@t;DcyHNIh!(1?$ zT~`iO+@(~9d`PyHWhcS68_UZds;iGk^gm~D&op=5x|x0_gYez0tcLXNJk_a{$$HIL z8iTASAu3))sTQ`YvaUxPhe!XCs>!|i;&dPPIjFKVl8r$3E`^mvt&uwy-HAb+J$5 z3abkfRQzRA!LuS=w^2OPdbKT4Nqq=D3^|xBli)#6{a9lrJ!*x;*5mnxc;_dGvdT|| z(C3zH+8p}%cMs}3grzCJg6v}{#rrYF+*xb!!HVDYEfvNZ9xh_3J&JIhSv+fmi{rIP)%AX9NKinem~=KY81(t zDaK!6PoP_wF6wMX+LYQC7|_(^Vf#Pvjz& zj(-{ZB4BJ4F;7UGsnf+#yv(gdxw&*WMqt{T<)O=XC@WzTBYg<1lIQ!JvoA~GS&4G; z-Afe*+igWkwp7~LK|RoS%hK?S&_NlpZsH6hOU0=z)TCu+5O)u-+rQ_e#3qN-$j6HN z58&$ah4}{NsIT7P%3I#eWBUOmKMf<5et#XuW0t&)T5kgJ*A0?YK*frvBzv;ed38EZ zmpKn2-no7d+r*!j!(v2p{Qf(PuM_yoi0~0*&LQC$H{}ZQCZQ<$6hS>e`o|J_fK(w% zg;L~6hZ5uE`FaQ=+8+j`<{zckYcfe`V7V_aR{Kj&>ZNGz9+w8z=?=$*ly;%$@iA`Q ze3cSLk=iQ_<6^I7ed?o#3Ci0@bqQ7aINFnBD0Md}JBw`%yi$iUPCSZyn)B*8RGdLt zolo;BY@IC!WvL;@J#2!DA5vkonB=7e&9~*y2RM5%h*zGeP@9<@S_|c~>5yLI)R=lP z6YnX13QOg<-0_nfO7IOb$dRQ>%=5+7ba#gS0N-uQO~;Q>8eBts+du!;RJz{U`!q`9@roUPsm`g@un7n=TUMO^0~AsLQy6AJMg*AGR#kvyt!#Yw@kqa3R8vWGq%{hfUy~s z)PM%YA>@{k=#B0=!&4Oe8}ziw$2q5wMOq4Mr7B8kYHh>ilF7BNrS4&;&WDjFXmuvA z9xI}>l&w;-Y_j!|Gc1KmIJYc1lBE&__tGHcjoC94sFK_h#EGp^tB<~d+9xOGW@TDg z?-ZdyvMu+5(Wn=-#8qX6oxG7{32NWsh<}TjsA2Xf*okhX#82YZrfh-TLR)JqDOtC@ zqO{uJ?-F47{6Cn)*6ZR(>_tvQ)-uElPNhw?F(Q?r%Xe;otJz0O*+ARFSYl6aQON$o zk%e%i#bXyC^eZhsNsGME*EGv%$il}|kd>>9<6>H}FMoPEj}ImB4QY^v z<`+EkOOvqy#@-yZR+0g-#mchU#2a4mC1q2k*k#90%w+gMF*S^E{c>2i(q^R?TQXUP zeJN!^ZD?1BRfYB}J2FSkLwHWDM)eVhgg0%2ZUX zTK964*n~h%2X}Z6Byg| z7Ux9zIL?>Es&J%J7tQ3zO3d>GvW{`cgpdiczR?>EwTj%Bnp955J@2^FU<_p|gl1;x zsR~e;sY_=2JeMD7N^lY27TNIkw$jkdvAM57^)(-;tm01@WvlplwDSmCZb>Xk_p+X0 zbR?lj@>nDRz2Pehe?Q3Lnvcln;2Bw;qSGfoVz(tdqaocZzk1;7)g!L|l+FrwVlvo%bLzNvMFkm66xAnHCAiFg;`r||lbGVLq)zo9d*#xs`1j!I0p zavGeJwBtcU4)WT{pnfNDq(;dN-^=o$*h}#IEqt!dFA-@fqG4K$vi|_3GQmK7#~f`7 zA1jN;Fe>_e{Rf-XB>w=;{YJwW$}-Jvj?Ar$vo0YGSmpt=I=r?z+zVRqFAqPT>cq+Z z7x&Q-1F`l#RR=vu3-kA#H%R+fXG- z(3K=8f-PWe6*GpHzoBah>Rx+pHaO+M!f8=fOM-SyASsEITPuy`0Zco(Qt}c=wxvK{ zLwMwI>S->ck1Z#C2-%4x8^d(T>b@CTUXmoZwgR(dY2SGy0;^>v;OU{ zIcbf=ksMCP5|W%9LJ)-)DlR7|8>1qSPE=9KEl_xIvc5A_h(!8T`Z^{9K|Y0`51p6@f^RyUB7XG!tWR8H7R5E zDYDNK`za&$LYVqu=YlUx$u~BsS2-@cnFJxsp;ztIl|XH>1J zdbIsSmmQO<)EaHVebg1CI0nNl_1A8Z8!S{^`F?!FsX1-m^yGGXP2gdVDNW3!Wm58v zA8KTOO4uUe<4{t2-eTevj#aE=y z>%2*e{63$k)qXFZ>^wMfW%{-dq0|<<%1oLP=(Y1DU^cHy2#=Ll*YlywPTTXZ%FaF+ zZJOmtnG#1jLUk@JJ#;}SAZ|3)Bl7hmH?#N}+(T*F-DTNX=B&adC7739W0l2CIu)R> z?&UE%-3qJOcCSB9eL?wY z*>#}2+DJiC(R8Umj_KCcy|wEaTun_8Ief>Hinz7T9jDG!C8}agRkFTZst{DdTUyGJ!-Su8NwEtFx=0qdjx&lC zXFG@3qNRsr+?B+mn!{>gmA7D&7P-weF0h~hvI)(YSgO_}!!lRMb#2VDD#jtEVkNN3 zTy1q4d(67iVQDK#J;JP@-zt(+4aK3YBWr8y(O6tpNTf*8l&t}+VpWsi6yS*%*8cz@ ziERF8%iAt!Nlni@PV^?g^ev!%_|b4Kkw?Yv^(zyyLQ=d=$X5J^%6)PexZ(NyjP!@g zwG`fD(@6VV@4-SJ;<_BfSPx_Gt-&D1GYgu2WX;aZD5_!WSYN;a;pii4 ziwcJ$H95H+n!(c*mfUqW31tPspbe5!sMo~W)`w<>(A{AiZ;UwOFlltP6OldgY!Z}> zE~Nw$6&X0TmGUM-hu6z;VQ{0ccPa5biRQ%HwmDdDI#QBHRRWSo^on_L``X{)PmcrK zOYt*=k6|f@q`d)fR!i>w?{%&mOaQoAn>@j8De_tb1= zWldSHVxCDWV??&+b!i?c*pbu_V#1V&yQ37dleDj^YH4X~XcDBQcKEAUR+EBD7Svx_ zn^_^}nk2SLKmd`wg~!4h$T^I_nT6u&dZns}1xU<8q*}t)2S7H6(puF>l?{mz*e+tA z+GpjL%rYS%NKsF8tSdqfi5JrGkK)Y-4o?Zz(>4n$0HH%$?WVfLTPC6tV{X-0XnSQU zSU&6TCB_SvMoh}OZWEZ2FX^NwLES^oNaKYof)4U3W!`kd3_PaWNK!y8q$Gusl23P0 zVQsbE8qs2`^w)2kD$zEVn^nBpAL+x37@bEU&fmCYe(aRl{Y$1FnA|*iJGVPLn#Q+s#>q+@jto`1T~3o z`gj8lpQ@$*0G3bgj`&FCwsEKb0J;dK{{TlIl%G&f;vn#m-E8K!{m?3-;PRwRhfsh= z&nzAi4PYa;RwSF%nI&cM41zv+An=fDIg_2Uv5Nc2m3b-ZM7SUi>_=8Kb5l4e?W>CC zmK$nda}LN2qcQXuAzBg5MvZHxA+E`4r z`^ZQJ#H(0M9n^9$rxdW~5LisTPK#4~H-1|ADoWFvdlaZ?a6I5JykOI+@0Hu-_B0U3Ju?NTtL$ETp`SNU_j@a+s5jTa3tz$A;q#Vo8^N zlcv)Y7NVwu<-m}=OM463V|x)6k==J8vD>TT_weItZbqw3eJ(aoupY4?Ln#(e{rkd{ zFPb>yMjS^#nr4)1Gcz*gQ;7^Ko0kq)-vT|(J^ zTNct!ygv4t+f7BHL>(c9tXS}prA6VzS#wf#?5Zg#SaMMTD;+I&O^E5VN1D_<9f$s- z+a0yy*pnQHiue-;DRmi{T8rMvGD;>|O4|$P z1zAHS)PPNm#jXj`D_SL^uUl+NJo=V}J(a{{e59Z_kZiGGnIN4G`V`t56h#gwNb=`7 z%_u0`gJW_O4(HZ7aG1T7CgaeVnt<;ic~$rHX56Sro=V(aWhTlXDDHRb4&&ojDG8Sk)eRqIoDV&Kv6Re=(o{fbWOFGA zQZ)%6k?=ln?o8^fF%iV?a$I(q;SDbuQm;MrPYd!M0F?z>L6i}i`&uAAI*AL0vzOUh z0nE@ON0N+s&!2${>zOB z({Qr5BBv~Ai$241%fa;H?Ne6NW%5Se&Z-`-zBj4LbmoX!7 zW7aJpj>`GYhIVD_Q;+9mDOLI8%}6qNfTg6j%~O8wGbkGQT#Li&hEd#Q=dl&q$%%@r z?Jo{fls%?%B2EVG8)*r7Z)7cF+i|er^+j#6`$XMS5;BvB{{WJSPC|ZYN%%)6_=Uq_Om>c%T%^Sd z5;~H(ISItBaHL$J6AdLi(k*O>KJg@2Mp|6jFJZ{q#FcTu%JZ0wfT@ZNVGOQe$#KjK zJdtF~n_MZSC%WMTWw16d++D9R#)!?2DAgVU)*QwdWTJl#)D_NsrVezrqpFlv0>Dkp z^ITf?AVaCxhNzu=o`bH_ewTeoQ`I+2%8GRXDgz=x()Jo?1Ti7Rgx3}3WGM61S=UmP zEHf+{v9V0SB`6?+y~xw>f-D%xaaV@;uM9ad^#q4yYiVdqAql$Kc|j>#hq`;GazPfp z(EKv4qf&v|#9f=E_+^D>o?&-+RQ^=h?^(r#=L;7m#2bqXTpuVFT}(7k%uo_$_%u>C zLeKdtR6Ep7Y$p3NRElt_m3>*PNxB8~vXoFyr=HQta}^Qk?Woamib&}CkIY^raJ<;Y zZbV+=`-!R2aI^j?YUSKBQhD`@)eU!D!@mU&b{|D~jdm zlg&KB))tkv@(XIP7X*Sk+h}1jNvlHBt(dXxYg4CUOi1K}*gydTRgg97W4^Je_C!;T z{aIDUy5vJFLD}J_ezuzUKszLYq@U|t#+Tg_rWD(28A@F# zDE{7tGdyRpbtdEJUU2@=-*RHgAnEapHhvaZ?MXH2X)$L~ ziMeda*_9Lji$5`gKRnX;cW|kqtEv*@taHx$et;ff} z{t%SKh&dVAj6ST3QrXULn%71AP@Z@Lo2_8P?%G?ztwO_y2K3T>4f<+Gu6y%U@Z z_miOmP-Bh9r|fYj_qdwkZx1SyX!<#c@Z6HEkww1pP<2LSZ(uaOyGLU+7rHwn6r=d7VoW;t$_mI+9b;|$W#3vzux-zEci5yGT-<4_GYC0sg}Km+uCVSATB=fP z{UJ=4InN;GT0(`+mLWjzxbT5S&gvR!%lJEp30EymA@u6D-Mec~j%zCE^*RW3YKL*X zqzxXEP~nq_nWD~U047<(az^$9<|H16uZ$U z$}>{rL2ziwqy_H_5NobTFL+XjlUPw1K_w!^TbNgdCc}wk%WbHRI5ZYyP!8&(!*nP) z%ze{w;9)EcNoka+MLz0>j>ZvZOz8mxi(38>zz&Iwrzze8rU`@=PIT;d{xCEEv|UoK zbg3u9LO+ZM;kFQ@o7@!mctU{3%m^fiE`otep!dgOx*KIzk#ca~@&El!b0OjgRnzv!>!)b(3NV9yWz7fZpZ@4z~xPh24n- z)F|qm2{h$+7uDqXUhd6aqJi5se6J zHe1JZoU_0Y9Y_NhbsT4eDIqp`(b_nBEEIOnS~;XF^{okL>Swlwg&tHPfu}Jq&k)mA zEi;^!9+yzctvn9jIA?S$7lQ0^-307yad_i8WR-FB0iMeA(iEFGXPOImT^bP`dx5OP z^4cLTCf;$yF5q=SucugbZg4md^2R4vYe#$_)-!nj0D$x^Bc%ImxXyms6r`K~091&B zlZH>0%zilyYJUh?qBfS8ZdqtR%8;}vCf;ObiVU90ljP$5DX+@Oi-=xiEbSH9-mN`lNV4*+fB zv`e}fP;w;aX5PxR9z94*&wVi=AgO1T$d`R3ZsthUOBYWq2KGts6Jl&FuUcKlJQmfV z3rMTt-UH6eQ|WaNXG<@ww?kk$!iYMpA!#}t?f@{>OmUYnry2skizfJt^NiHzRXE~8 zR1Ja<6ittHHj4F&M(J17hb^}nd3;!`IP20AD9H0Ze6__oPEPC(Hjc@(u%$Y$HpnLaIur! z?arMge;X|DCn4LXaMHMB5hqfp)92EXdD8O9&vws1NC!=`SQvquhtlpJB%QL-96X;g zGvMi2o)BXs(bqB>kebZ7cHCZ68|jlWwahQDI>W7akh&f+)S|S!gYOiTD3GD0fEHJjXg!t0N&X7Bt*qx0jaBt4R-Z7$lCJVf(`|vV z`SguRPa?*a55{6&lKKY>5VSq6bxRhc0` z1!;f1d*1N_EcKk#pm*jlEYnk7)P>pLoT?!~S<&}alVC@I+<3)yTuuB(apy~Jf+oKz zB{L=IVasgYC@-NIRDRP=6$9$ptRf1-CDWIm>-rOXc=!AGexrefFsl;`q1MYm3e*DV zCg*>4;{G{JqTh$b*Yzs%=D$CX)%Ka-e6JHIFUm~0BFPEN+{DZ3Z49Vv;aWxeyV&S< zBnY|T)|d9m%-@L>A0_?Ivr{LRjd04ci>Qg4*m#>5ypB}+m9H6&tJo4klB9{8d4~|9 zK?9k4*!eCTQn9xhElYxYBzFZ!hJTcDbFC;Op-rOUI%*Pg8>I9m3DX-&x{@kNhR^^i zq}q>LHZA$Yc88I*KSq@Rt#jcv8k~v!<~c&huf>Tb>iJVCiIXLk`PJ;LI0!pxTmX8( zr0Up;)m$L=51N~OtV2?K%`{SGK8s4(IfkVUCB+XdG>$YYQ3-HA0Vwt9+|!j3`j)a( z6K2$_pR@|DpFQmjxDNQNxIP7Nl3Ru{s!cXU01=qFxs1esG}$VM(tz}G6+PN-7f$gm zwwLN|Aq^!<67!%j3zjI5d+kuh61(n!-2NfOV=i_1?flBSj} zec+%DZ#_q(S7yc6xj!Efr=KCi;;&vfnK#0R60_T=~OT^+V<> zE?7^a+ssL0FYb5Azb2OHP9=qMDUd~V>iQ-m$0sfi~8 zjjG~lu40;4^diVTbcs+!PDRvc@aGb$bp!1F&fC*Or;#wDk;aq`<0u*Z6?j*GzFml< z@58>yhGkeqcB?N^pPg|DT#DUD9pl|eC|7e+skQu~3*oo8s-e{aZ&PX%t{fpP*6>@w zmaMj>Bsr6b(@<tz>pK5-4<#=pD%>6G3K zy!{C=!Au4?cRc!jmQ_r;l#`jXprYDb6sX?*2G+DE91?p9j2a&tX!?w-z)0O1Mcx>b zak^+{Y1K3`$V;nAY&E$8Cb-clGADMA;9W0`e5cr*OqA;j3rng2NF;PU@JCI7+h~D2 zx?alrj!zb~+PO2UgRu|e_Sli(secl&Uhir8 ztm|R9d0E-D{{Vz-f)G!Uu+kXR`nvd?@FUR;{YMmIOj1;&Q&yBKZfm6q_<(~Bt|~C* z_xM<)!#Bx&f04ze@b?-%NiRyvB=2&!2>G@(f?n2w?)?WBv*!8I^#*UV#YYe<8QRK- z`$=kFUqDKQzEIqM-i1e$UHpHLP-u_WCAMZgqMw(i`#c3+^ zB4qYFV()gBN^kWfl&@m^B~4GhgpUBCuf(eGukCz~oY%=O*o?Rsbc6b#KZ^Jl!>kIy za-fEnp&%1w8+cv8cxn4jB%ac5;E?oq1^yJiHgd3aM-I|tTW*;~OtX^*G8XE|S1c;Q zVJ7?Z2SegwHxb3kOLxC}CgI?eUrOymp5&WlH*pP-LI4clFxs_zGA_kSs58hQU}^Q5$O%zZ&9bd@6h5* z1f^M&wY;Eil%uE1_rou4t^5fQdu)>Uf)ez_^LSrizxQbIQDXC9&DxXEg z_t3-m>Yu@ij_v#haZ9`^$kb{n%jh$M{t0q@e9C?^hu6PURAo|vxpk?Rkfz;9vXHct zs2?<&5gTmC^~gc^+twV6$n(TbjvH}<3vrE*nmp*G&GnR-C^tRN5D90Z;CZG$|5`gd91Pr_<)&nH<*U5s)QhkVUPr(0n0@;?zAE z(7;HlvBM|U)e>hUky++QzK(Rd_2^Y~wSN>F4+xEyg;^Cf%zimqb}MQfrD?RwOI9hf z^y}Kw5@bxvgX5U;mY>-vI(WqfUu4%OMT9u^xvL&79`SaUT?g4~)ak7+mBpo*gpUO> zcl8!NQ4w%iF~8QD9+wpiogd3}`-#pgPT~G6gh5 zoHLY28Q_?goo5u&SPjcori`c-3_imzkU9XRq?7R^#h$w>9x5BEk(zl{nr=!qVR!E%$1g)(n^=t98M9dhOarJ?vO?Q-zlGw@8r-jv6d&BgIqU8Ld=Yz*=an6xMVv?DJ-9Qr;UIJxjjLG%= z&zU5){Z&78#?8N~VxNq~)3GlGUCTfM@m1iH)?;~rXmU8{Ux{Qj?T1o+lBow+aJHo( zNhEk)_WT4(f;o17|IpzY(>0o_%V>)|DOYKB1O>Dcot)k~6%P$G5akf;>hR7*{C!-L zmYzzQVwlr>vJ`%?ZYgfENYoo9`F6LIaiK|=nS3)>l%JY$DK&>{FE){TCzzg65>JUK z^8>~?Lem+VZY?z0C(%tdqN$3qr^Bed)9h0%f&d!ol_=@1k=hkxp2is2d|Ix`nqWS` zDAeMT;=ydX>1AO=B3(BYjx|f?O0^aZrg&U0y zy?Vou<|vCjk@&Auz&N5#UPa3{KI#~GrIi-c6m4>lY;EUwdX6_mg7IGpF~kZK#N`wR zWL#RN++_RG&n0$sZ3}9`jl+o5#45_RU14iujEC3)gk`B1skE<^&1OblJ@!M6m637K zC)1?Sp?McA2lVfyu5`cR9q}$Fbv;P1QA{>a_$J9JHe>UU6 zK}Qu$9dslI6p(#1-^w`^zsOr+<#klCh$v;iRJSQX-!&A=xnb*|5gu?PLPLc>;>4E@ z==26EC|W8rD|UI-Qi4M)PQJGi98u5$HciTnu11juE;l!8p)(#u6;G%fOO_SPEmEgQ zx1GrP%Kf+a3~aX8Yqn|rQxh!hU{}E;;I~;(G$6=)R{*XrsgM?B8QTV4pcU; zXiB%;Dhca-p}jYM1a>l|^J3$NwV9PqVtTS1O4&~}EQFl`nNTUy#~=wlghP22-zF(O zL!pKwrTCdEJv7qFSeaC#=ujGkw4hXi4}y|XuPuxws{ThMDzBLYP7;yBRf@8uikX{S z-!a^B)3@JY zyv6nEmk%*4)a>hF$tBCNH!>1#qO$UtZPqmdGE}ssVOBYB4MQHN`PlsDPs)c%sYzW4 z4q@7RE1jHaZB(90$ja&&mQN@tM2r1muaxeT+V_U^ef)=Y{rtxxfHhN+l&+wuf~qWVUiBTSJk=1lvLhy}HLMRj%|2 z*8XFm#GG8saz>SXWvXv5)5B#1xn-dF9OByFbL$O975s&%(8KZb97*v1020eeGh}j= zAW(~UQkPy>U9J09{xM;Phi`Su?TpWeNmJ&?nZQb070g3WeT5V~OLC_$(vzja(sCWI zp#SDQ)(sIdtYt&|NKHh6za0Z(Lc5Urj6Y5mj(5C!NDJ9O@EM z^HT`9%%quQ6_nogDN;qP*G)u5&52}IJ&P-b#MCr;ZyTtSH4HAaI?U5$Q#99fV>un= zCA)oFqoTpMR`*V^55jO{&lyP-G|dLDgli6A$yZj_v}ZyB)>0JRi70Z~5-d}(2TNRQ z77Zu6AzO~cfXvZRKY=jv$}>v5iHR3S-F5PUfN%| zgv+}$>ujhf=Sge;PL|8>f-R}BHrnP-#Hj8+!pq~qlj+0QR!(Yl(|=`c*Pc--QkJ_C zr5#Bmold4Rx#8R5T4Q$pgDKjt5D6?h^ovcdW?97sSIQvVO*G`XRjB}^EyNWA(_3i? z!H(tI`Y@cU@68BK*{ODc!rnvL%uA+GwGpnU2?t+ zaCV^X7Q*bv*TSXh_=aYE*4j|-b5t{svMv%%Ta8ZOUK+~{T(?6}l|A;V7MKecoJT12 zHQ{kF&S^?N;Q}pjzJ|i*#KRGf)OvmUenJLrmS-^SB4Nc@GOf?cuKq4Ewv+x)1LF?1 zA+7xdk7oHv*<2i{daG)0+2)>Y2wvf|5qoNGFPhfV!V{98uk{eQ{J)@&?9oqtxm>E& z-@ZwyhdrEsi)*=>+S^-!wB^7*lU-T4xIskY_{f)o@`tg8U*d<-@;a;x+Y+Ewjzmdh$B3drkD1S;K9N^I%)_bNJC@X*U9}_BRyvjOV+5>QbuGD5s-<&J&Afp(Fr%2uw)r8XAe$)&N{T|QeNFa-DA^uQNenR$648oTm6x1Ja#4n- zr%R0wt!;DeEwUU1UF0Q6Myb>lYjF?bg%R>f#P1(*=kosm46$5NiA(fE$}LBKX_i`A za2@qILV@ZP7knnkl>AHBgPoaYJ%bZSESm)vQhqI}EpWZjLm}SnMLt%VaY^@7{{X_| zM4m6F%x@VzyEJhgUjSekIf;}knQ2M6uyWlBv&AVvH_=5zY1Cg>sg^xVvd5C5Lx~2Es15d8jHyW>u@1y(Ns)hYDN)AvY>2(Yyzq@IdFv9gCkA>3R;gSD{K@hK{0e(?_os)G0YTK@pj(m?kQf7=^R zfLfB2s1BN#)$sn()VEvx4E}BpOWE!9G_c9K$Ca-opMtyDPR-@8~2ui zN69dI!VLoUk=P=ePC!cL9SQ1`tO4=}ggzkehA$=i8&IWC5P6EXQm^^u6XS~T%;@Zk zLT^FL1NQX%pz+RVIMY3guAr`Qu2WL4IuFtX*|zn%sC|IG^N73+^aCTJ|x?CJVqKrVony}EG;bM zMtP>&WdiGQXh|pJl1Yc*EkatN3^UrNhN7^E6jPlnEnyziSwXUiuu(?&Z{c%pkhyGe z603_c4Pn|8)6z*pYHTF7P>`KhWQ%|XgdVX7bgNF*oMN1F6(U|nVa8iykkJjPNCc!O zHNYSfd))PhW5`1-mkC#?H3T!xuyswLSrmb(AZm26zgT9@vE^!l(<7d?rM;aaF>@+( zNb9sNBW!^jXzg&;XKDCeS(B8ME@^E6sL=BD2jWC%IDQ({ze2YzTGAjn5@jsOnHSoqLc6{f#JS^u7}qI@#_;|EmYK_=~k;t zje<|91YE>SycV)VIE^H$z&)U(IF$2r^~tj>9vLs4(rqMz2mWqXB(li;%8{e2Mr`0 zeYu}%ohc!P(3KR0k)csJbQ|dw7kBmn}Lu@ zRFkf;DkOOFIdcsu6=gIw3$?m!1#WWp9Cgytr2w7GJmPmyrJzr_RF~(z;>wwHHrs_n zsTpOk2=omLBX8>F83rJ=)dB1h%FKb)mSaN zQRV7FiOq4c&GhuV07;(A{7QC#RHxEV!$pVYi=5n_T$N=hQUdS#Gu1lk0f{)C;~5Qk z$zN`#;XpNOLK9DzmP%PjO0FzJCpTqKAyfTm9K*f@FZIRHkt2YBOyq znp6DJnnyC?!A~7^8xRKCLsO9KVk|JL$(X7+E;J6U3m&04N%hb|Au4nd zL}l%9Nf=tMBVK#CEi%}WnQ(oF+9b512DVa31naf5jW@Hi(rJ}EPCMjm_E)HXD{+g{ zQn^?K<(Pcl==+j-1adN1W?h{3-1u9M3l_eybB$1#=`zzDH?HaBZGRUnIoJK7q zji}Wb!A-wXc>!sbZB8coi-D#6PlQ`Z>{dl?N507zdVh~tx$Ij%bxX>X2Cj6@bO9jW zM2|?M;iPHZ7J4LY(772-(4q^9}w54sCR!fLj3QCXybA=@6MqAuQM>jX|FR-nL z1*|bB#Dh{TwAhsmB?xQ;^70X)LUy&fLkZCJ5p6gjt`*dkAdpTTt_LMvmL}+ynsF-S zt)zRXLz<;x$Gw!=(JC_3z5^{$*6ihork%jbW<({~+EU(^N*p`#mTV1<`F7h_?3U*f z8|vjUXB5l0%<)=NIHW1p0Xfj1b0DVs6rFnQ3A#EXJ9Ss{a511}Sb5MSgI(A4qVLdA_YF(0&eowk>4okrEHt zmR3yg_34LDkm4rNjMmhU@>H9h^dwplJF!q4UfF5Qht{tLN8%!H3(Sj~krMdRFU!Ih zW&Z&1YESv%ErMBGK~@kgFHi@ z;&h`E6*UJPL$1s7EORQ!%#gB4B|q#%7n8mP;EM8nZ3PIBA<@tz6AalkZX9d ztib3sK7)9sWr`tQ3^SZr#m!dV$eC6iaj9SuGbtkJz4bjhn3oypRorRBW&3q-a($|> zt+3LSEb45vq~647s2YgV`zwfF!1?qlc+5@ih)qJqbqq9niq79uD3U%`(8j(QTuk)g zW7UVakxImtW@Tns4-p|Zbk?k#`mzz|$!A?ban-Ad# zo*2)T#}-D2^;+Rv{U0_^myn;jY^!=3U*UL%EG-fvnKN4maSpA4oXt;}b+VJ*X-ZZ@ z&y@EF#V&9kt>T>JX(N*3FcYria~7-V-H4(>f^ObI%}|mlWW> z#aI2%onoj<&Tzg}hXSQvQw{q(<)YXQE~Q)lX10(PLR0ead*q|5iEA7Jp&6&Vd_)# zEJovVbf*%gnwd9ILABDA6$_0lQf;9SH;&-D?bYGhBrJZPWc9MsJ+PGHSQv_~L5 zO46qKr$Q}mnhhdr#jPjFzH~)X((9jNdlq9!JV7#=;zuHuFJ9L0GfQENq1xZjf{YU%P09nl22J z32G(J0BIt6mRNiab4yZO{h)Q%&v>uQ>Fi05BfG?&b`X?XvYC0`V*6jE?PzKa*yBV` zrgp@xVW*WVH7-Mm+j5dGx=3H=W91f*PCLcyLy}VFiGjh+*wnmq;$-GZnVC9eQckDH z+{J`Arw`)g+<}vXQvMQV$W~dO7j0J&Ws8c8`4xFEI2~lDD`=jjWLBs&EJy`6fZ?d) z7udrx#wyNZvdc!GUL&|PD$Qin5)M^eD)1xy#5O4DrJ*n^Poe%00knXmXmt_OhZ1p_ zmKIjUl#jcy9*~E91s_xQvpi{7DG}B9UR&3crTWx>bL~)=wGdP7* zkUgoT57s~gesRrJ%Wj9p$;c(E$n=u4kE1bwT7HUSZhI~ED#{l76=xDNLWW34hs}$YY)xk04Pi?PKrTM7(8LYhci!%0J{<{%X)IN1t0t*FcopI95UW6;N= zVyrP$PG+4kF;8J&I$m)JT9k5)O@;btU@sDAugML@E|{9u5}IEDi#YH=n8e) zc#Al0navb&xD$${aJ?#ZpJ~ZFw^&0=6sV=dDL^RR*+Ca4Qa&*kh{vg}+m9&jeGk*A za^jlP32gxx5_07kZ*L8vslh&I)Zm3tz@^tDXl{_yo<~n~tpOtc02|)Wmx**mqQu`) zGUBFcSgL7nPEw@irJHzrIv&gIV_$irbC<+irYSO3J66+weK#(n!YL*Bn%LI~VE!j9 z#_=4K%Tto=CAF<%F>MD_*~I5fwedc1-VP#IHchMZvzdLB;;U5e=2sF;{O1W zm04Hi)-IN2+*5B4Ag)kChk>~BjeiO4MUj3kYqGD*%<*2xo-SWsvBu(` z52*B-dbtu(PR(jiCK?J#kLzU@x2Cb*9*41F*YGQ69`;VHZ@fOZgt`wrE%hY#0C)>U;e!Tb0XHz>a=2bi&+OPF06evbxijh=ShS9J6Zq*X z!8t~%Q?g3>ISUQ1+1t5oD%n|cCrkKk;R?eK5!S>^&p@o<*A+0&8Pq2z(`bFQAOe$_ z3rf5SQ~|s`_tJ#8!#g+qeEoE^elr0V^I-eVF5;0@&`B2>QYvxvT zf@WP?2t{8Fy0TK+u9u5Rz0N=sl{T$+0HpPa+7$XL_z~RN9)243;ljL74@lRZXv)ne zDV3RFNp-SCl#+YQtsV*r3h_vRV$sM;$!5IYWnL3vWXy_O^YTuq7hf&plp!Z$VuCW? z&Lt_xX{1&^5PK$7aJ1uzlAn~BlnT2uDSr9W(B%U#Q0gsUdYGGyYa&h1v*D){vF8g4 zWtc2aGLvA1m9OM;B#3#&#w?f=4&A83&bHPfrcBAYNCj;GruFM(FEzeq8gLy`CC3rF zL1EfmGujN&R32;;B|50)8(X2*tR+BO$cmqHj4g3evok9`USgie8IsAef&sBMB!WhU z-m%t>CQp9P3Z}I9&1fGG`kW-iogev>;)sJ7~-WtdPwN=mczNF=L&m7$s99E{Cw z%v=hh<77Wqs^pxVRKm)cBQRiv9^!(N?{zk~@G)PTVpJx{`zuF92xOF%$dE1EKpK24 z6_P}yGp#2$uyUvrp9N_IVk=qN`e;jwDaO-p6^MGMO^tpt#MC*V%c;92>tAUOq__z1 zBPoR-(_%7SM}*bfsdkr6E)9!PV18&2k7`+U01{PAIyRwRslGg4BDq zQAi-)P;aHL32ylcj3|;4>-M(Nq}(M*1Sh}|v`3<1jflY_!*8iPrtf>-B6|EHTnAKW zLUAh_$zdtUbWXS%Lfbhnww8xl9>+BvV;#h9I$>&i8D`%OgYLG5%ZgW`Y+;$k(C3Pg z2C>&@hTKW|28#OZbalou4~KXdi{RfjklgdWiJ3SV+A|lmQYvzmwV`OsWY`@x_nf!S zqz?>Z$&Ery^F-gSaStEYB^KPggp&ot=(ncPbozv>o5I#;$D1BW^h8Bp1@Yx|<*ItA zEW%W)klXI8Soj2jA$dKejy)SBV&UgLsd|zt0r1+L!#NjbYeiKofUUb_0VJT^TMvwLP-z@0g*ur@ zmru5GlDAMU>c|TQ+GQtEXwl-}^+%QR+|6a<9A(e1E`xHKEAq}16%%8j3fvt*_=sY7 z9zB^i9(9pg8Gbm+Ogl9rAt&r*#}c)^sg}cmwv(!sI)l?olctdF2&mh4%j!3kxpMAv z@CFjZb-A@p6iZAcNK0wX&O{+7_ew0FLGiG+loM*G;<$5tNk=WisfD%-^4M)eY0At8 z%~y(36dJ zf~Jzol?hhdBa($69EsAvjREuVw0Fa8bEV`*oYZCA-&18x8|6Y&vOdu^A2YAY6Q=oZ z_vUj~eT^B4OONX7fC2Urys7y0G2aRK3R#ln>qfFBT4)rZ#*=Tdo2dT)k|CzF^-Ift z&~}^X-LLNVQ(7~f5H_UGnXa$36^Yd=Kf1@4U6RI(re_+PbD)( z#R$F1l$}5T5B9?S-KEa`M=|Ge&ZRS$7rCJqRE>bi%3L#%0VT}$u z3VRzHz3N)#{mZDa8e<~V8^ob;V$F#_gNS#)Xk zR0h#`EEcPoQ5mG~k;9sn4J5d=WlxF!0DHv_d^#C>i!QU3WlUR;07>0z9Y0im8$=qu zUaXgO&(RwVQIgkqlC^#1>PM%9E5j4wU-AVcsE`HE;Rsuu8h$8K*FQB#N>ySe^AXV4 z8~*^ZCSrP1^Ixb(sP9!OEK!^0Ot=t>fpg+^hS=0ommnqFZf?s%iCE|op>L0j2_0^Y zg^O>0gme*hcwq@N{=;9ZBtE=Hz)p38&h}I~H_}<9TGzR; zE6Psy1{$H;BWD$=OXrrc5n$sFYp1>s2Oeh5)ps53&TI;*z)-D**2+Ua$L zIu2lTI$KXrVJ(Y7;{+{I^P*Ez{K9dxU&oeCy>Dwm7^H0AP8`ejfZ=sMpD>%vQ}c#K zVl!VdfEL+G7YMjL;cbb8-j+Gcubv%n?q`QM=7fg{ah1=t%UMZ6fl92Vok8~BA-=6sZ6;fs#0l}uC|nOD(O~ortf3AZJ>rPGv?Cm1z@nP4vp&SrE|PNoiLk5ZwT@wM0kO_CBpZlI#iiNZ zc0AN&vo($Iiw9q;OCu+7JazWNx6wISrqzRLKK`G%$4nEJyzHA-lcrMY2BD)X{Z1-@|~G(R!eNRToZ zTyaYmJ6fA64M@I)OQ30)#S*b{H%e2J#^=j;?`82FzoE+EGprmbiIXe}TMyL2MfC&g z2j>nr@4t|TA(-q_+IciOEA7?Wc(7fUWyzETl(w~9C~?81lAr=qM^SqcOgo!~-q&7& zA)CKJ+~UR#6PSvAZ7WU0f?RDrJj|fDpAa$xpCtnwg4j%?MUE`-3T5|Q66?!3P<57z zssmG$U9brE8%Xac4M_sgCNLV*Dsc3s9OHxZsRja?mu77*&PyqF=etn2d^W4*yGlwE zVfIP3TWX11M8K&V5J(w;7dExWhLD_ST-ceWacXZ1S8DU}!O3Zd zn5DSTc_4DzTH8yBSXRQyI{0g(b;n>*+?t#}!cSFdvRIW0C5IoGLunc$%a)cogQiy< z@1yl{oAip=%C;w^`3;6HuS^Nt8sb51*6XvatZ!tV>V~7LRcPh~_+Q^tCqF+=$&xRR z%*$3~lAz*4sbY3jWGE7zYb9t&7vC}g0PArJ#TRI1bEL>sT;fxeTr-6yj$!RfmT7u{ zmDzW}&Ec(-2HVA&;nlQ4@z|5?Svl=oMP&;2NT=!O_%SaOY9x71*o*AhSZ;yDiMo3A zmz;8XRl)kIQit!~cvRuB)jh=;DF&TDuF~8}o=lD@WekN}C<5Kp=id#B-uvDV_OF1X z>`7NC$--@vEa!FUc9Ar91;-TJ)0Xl|6cf{8bcXK5B4YNC;#`g&kf7NFt<|>r3P`e3 zCbT#K{i`WA8+pegx!a;V_OsxfLTeFDR%KF`W#`bB5)Hs!U4u6{lG<1fwy~8-SYBHxCs20Zq$+G8Ebz>$YvR1?i2xN+=Td!nKf(pb zI*>M%j;j5f@gsB8wG<`wU2PHFUb>F(JMIV(BTAYYa?;7;RK&O!wUn?k>iRCH%1~`; zPz#rTLKct~kn3dXP^(*{F(|kWC#ZPcq&vf|9@MB6AlaIyOSbzDwxXtA9MqIdGE@>y zQ|}9RPK1#RUgOAvd^pAJVk$)K60(F$y2SGfWy^#T+`@uMNllH@VXnFxK`oBQa>=Rn zwWo(Q88%!lE|?x+r!-a2mF8%IE)9mAc8E?XvRZY>gM1b3V!C9)C8k~yi+d<}O9^sS zPd!8km~kUu5+uCDjE?Y$UdN~ z{`juXk5AN@3E$A-cEGQ$y^SbT_O7gmlqgD0x#nLXL)3(eM={4|@EV+{{Mg{|ml?M+ zF!KbIszvvE>auQxD20MLDK@gccZlyDQ1hLcFrGDLuZ3zT4kbx>*HbH~Ih5j(uoL2K zbEV-f8g}wKt5Zytd}XexmnAJC-|42-mQXw{olU%78S$HP|hflL+y|YgsQmC394#RFH0@AWA8qR-S_~7CRfo(azrzz%bqqm};)=L|wUcsG$tz%m!2=>l;_v zX~Lx}ebaCu41cG~_alSz(iOJmB;`QP%?)kM5G{9_n{CgD0P1|TL7v*@( zft)NbS1mI(X;m3)z_{6%S1pNz*j$Fz61=_4!s7Zv@gT`w-PYc_krRr%6K{pHjZ4$k zU0Y05B%CA=T|g)(I+6iNS@rRU;O&v;8cF#gDq$`j)wqJp?h0*9Hj?0)yzI5oeEfz9l@>58oU(Z&tx- zMDx!xIV&+R>n*pJyxB&!Cfz~beIj01v@sStoD#$MhmRO?Zivgw$j2dF2?EwCc9GaC#^!@1hCeENj%u{JeAR_fd-9%W@WF=Y*iQrz6( zt}>_Lq^?S#Npi5$YWj+Vq6)!D*DBMtVSRNb8p&*28bk8W7I1wjuHL#aYi2E48J~%>n{Y0skD^y5&K94k?XWpWP^_~bR?PDpJ@QyHuSVb zA0XFl+L))%BpDtLoVmR7UN5llJ|u6* zfjs(IVpt1_)ZQ*g`)xILAOhnmAgvyt6Q_ZQdH7jjbjP8QNWnif?D^E|fwtR8TaFt5 zlnqHF>FE(@cFHyFciOdlTd103fl_I*>L^IKImpnck*>S$V#^#fp_w}y&dfXzUllP6 z2PyVRRVC?#5ORQ%aGQ>#_>mmQsRAy4i!P;98Nq9e%vcS7q(~85JW{I{9l6tWbdCzZIuw_%d8D=?zXy z1|40&?hiX#Z4S{dg;y_t#$AyQS)OW+jH>}DPueEJ-ZwF?gsBv=RwS!@VrG$K%P>|* z(Q7tI^GMd?&K2VJ8fuOUJZP$`zNuiQ`q{lL>JuIDn32W8++U_*HKtx^qbTBt0nEWo z-}SFzk@JTmnLc7#78t7uu3J=_5JKB=JqXn+N&f(FVN=EtnK<|>+IF9eX=;_k529Y7 zPe@ALT9O0k8U-X>J>k@TF`di6H2(k(BGVrfn%|ls&upI16kK^HEl#93N#_XpoeF zt?U5#!|iF<;&x-e_(E@uRVL|j2~lNA9QX2)grI7zK=Aa4IdUkW=togteW)d+@b?eI zteQ$$W#$lz@7+pxBE(l6o$k<`Bx9KNEWeqD6gg4)HDl0gvTR4qFe{3n)6^f|2QD@vw$ zwgX_&tgD`Yq>+Ax(VF7k<-ZTea=5j_b3=6>K?Qpx*AtfpX`WttWpi-bVIzXL+*mpZW;xJ~Z)Mrqa6vXhF zmw0Ge=3Or|s||BmDi=CiNSBM58z8fBfZB1Q2i!^j0Gy&M$PAizeUQ!o!}Y=mMKw8Q z0Mz?5z~#8FL@O%I?Vvh{LuXOIe-X-Hejrh5eB?4GSX{i*ick%>0JCb$O@;fq>C;_e zE?8?#5+N-tvJ6jIlcPvKIX`18!V1-UYo>uGO-{qcDgE8cVt0#MmAyve?B*D(Bik0l ztumygDqOgWB3Z;61UldsvW1CRxk>0ouw?drmA5fa;;oVm5)L^zGPhe2?oTZ)q2jF4 z&XSM;W&M?!z=2^DSs>!+>{&)?T!aQG$Liq)N|fyEvitL8hp%+m3MtC88(CI8G`_Li zSe(8{Cn_JFCAA}p5jQD5*mgzLkg#+~u)c(BLGU1mb~13}Hr1IsK43~$3S=i6kYu*d z0%U@sN`i-XQcjvdJkDFbh!iW4uUJUMlLh&uEiWX6GPJ72qxN#zz}v0#I~aoHsoNwa zT!zE62M*@=+e1w%bs_2Lb@OEE4W_^yl!w|D$(UQboZ{m45p%)u-V5J;%uyUA+{LbRk)8q>mpB<6ZBOYnrb66rSr(k#+r^FpP!-p|eYoDK1L@ znS|`1;TI%=NwMg5BWTR$;(TdYZI2d&DR|*fmZo7^vy-4HgC^=0l5Kp#z+cwZhd5T; zk<7aykL4U)PF7AyNwbVdG}?OKnDJUot)_?1#x%uJE{cGZ%t$evAfap_D?!+dnN$y~ zW4Mi^{w9MLA_aDqp{IqC%u3RqnR;q*#3n*lF;}yMEGVful`CMB+#3i^Kg9k5YU$=x==?$SuT3i~)+rWqd}r<%yc4ViK%}EsHY_YJlaz z9ny5M@1$*gA^u}rhnAg%@hugjJ?*KfECniVoVL<{@(!geEg-2YA7of&Hq=5+i=GD7 zS*cD=Dp5)@(@irll&o28xRR#U+k)oHPEeH#=trDG%!v?V{{V|+eY%%A*WQ+Nf0AK{ za~8_o?DCUPz!-v1ZigQrdMFsSo7{+vUe0oX{v6g2O@mWK#QLE~SMH9@?hzh7)r|Xo z6n$MsDStFxCGf9uHf}^k;zGqohx8{t>x6uk3|kNh4N&jl=F|TGF!{v%iG?vJe|s!X z`(6-`zu85<7|ii`Dn-@^+8^1uRw~Kl%%Ltev6VqW`W*~IhIbZ;631w%%rk~l!#ai{ zq$5N~R2qG;;L^zefOW767cr)U^{Xjo9VEf*?OYPoDd{t(JqdLld2}}U-XU?Zw3#D@ zbjPb4V_6z(twEH{GA7uTbe4IE=A`5#cL~3kihl|9EL6sCf$e=B#XU*t+iLizWMIE6MUw0*$DQH^Tvf|*ZakOFY&c`YI;RO|#LYRvk`H~Q z0c8&Y2sVn`xK>qCC*#cVyG4v)uGScHiGdRJ`9(`i4FlPL0QiLhgZaj5i}oU(>-m>_ zKeX#^M3%x>Qw=hO6+#h`urk}d_1Gk`W8{jq;=~wrq+3=vC~^>2#BsEg(DRLcrX-` zpvrA{N@rRdsj4G$4+R^A$ikB<$S~? zM+JOVvcpg6Q=lfp;9+S1&0{=9@~Qz+x}zvjN!dpFWi~b=@rRm90(6 z%^^)rva2ZzN=J3UeNt_q0^4s7LG9)@CAh4uc5uU3)>R92fWx662b)r|sB}>806~Xg zno;UCENVgqQ-(DD629ELpjw?%nRB?CWdvwZ-c|MM@Pc_BPG@5U9zs79Pny6r`DV*i zIXunJw4eDHZL?zH2SuabwT5I~=SW&#-F%-R54z}2E(lHJX}RVWm!;<03e1lXE(z!f z7apQ2vn}YG4bk4>#eIi@QsRP81<52s5R0+pu>*0G{Ix=$hh>xkZUMcl4YWOUiEvbe zGoIBon*7SzLwuRmY_zBgX12FT@cbcdxUV5JnWm#H#VE0K|uH$#oRL~@+#+r#M{1Tdd6rAM-BvWu)V}JDA=Qx;{^vZWO;~=;n-D} z*7DsN5|TPXS_6SOUwVyq9BjJK_liB_`IOslFkzP}7L|%Q3X3(C!_25CbUjCij@_JU zjX8SjYJF1b1uIXEfccLo6AC-dG?zt`0SBRl(ZM$5Hc7WGTFRhrdlB&(!Wu_yolm2g ze#+59=lH^uEaiuorMEDUEo*E?NbZA{0wvWYsML8!H0cWnr&_53lfSKqfx9|4t?>2A zbisaFWyFGRP)*0e_k?MoRyb|T`$7U%Zr~pF$MA<1;zCQyOt7x=foSLoKqKNIbj};E zO9zNn%NrQz1#vePJ$_Nf2OYW4h2>Sj9x&aVqpF$UO{{%k)gdh#sBkVM#f`Hq;lU@b z0n-bKCs1;jO90K>jYvLXI+zBB6B5ujhXjLo02{yuj2&1-m zX&j@r7#Qswuw%3btsS5S(b_l+bpTRhpay6F_ITxhAi`Lr8W3~>BY*|%9AeWF70e4y zuazn0KygVaE+mwy-UNa#@rES?$5hz?@t^lK=rz~en39@ySxzZRDImC#Pwgt>UpRMI z+s2t5alc{ez5|s~Wo404NHU(xfW%8iQ$Nw5`Q3-?TQ`2))aQ0@fSe)`>USr{!cf z!>7@%&bBvd9B;$8`TqcDVxr4QT6>~lVYK;#sGAewIzm<1GC1@_FUZrt_yOmq#Y$GT z+pUKR(!zOeHc)=ZP&XsM?+(2EDIqTx#F+Bc=bF$of#y2?5G>7hAxnl&t2ouVv8=r< zB{a)!OU$^WI)XGQw%bJ98C;nYHx8noz+y3H_df8Ib+?(2=F?F7sdapXtdO+*(xvD; zL|;N>B%(Io^z6!WV1}#pH28OkxA}1Y0Ei<=BzOneKAFJ@SD949)d`2!nR5>*S1BIq zLQ0g72D@*2m{zM2(ZS;X0AXw!#wC~L;LB98g7DhKiMNIzY2l7$=bfnbCnLs7A%BIeRmq8Msy z0mQ_U-JUQlVXk9N$Tn?%`3WIkBDmnY8j1eO5)P}|s8v>E-5`URXs9u5x@T-Z{{uIu+Q&Ubd;*?b3d7B~2?vkRDl<#dUV~yBRX+4$uVd1_Z)Z3?t zWk^&e9L`13TXn!S%5DfJptM(Jk5Txd!MKBg=4+23`fT&EOSme_Wg%XvRm4|G5@O8< zaK%;T3sX~U&0Jf)$W8t!gwqz7(adlXmp-+wcACIa?{^xQbRBx-HXn>Chcyktdm@i% z6EZV=q@?!}q=x|bo8RLK6{uM`*{Y*5k`+-%SKdoWAC{5YJFHFC`yy4b31^vFSq!Z% zAQn(SQg%98JIFbbR}W6AQLxLT6}Q|`8xox_@rHDkT24c=Ii{3+;rJb*GWM0J(mkqD zUb@o{NW9vDgXK+tp|MNI)e6@^v57nM8I^T4ct68@6H8Y0r zDoT`_ld-jdKfV)K6^x&4dpK7x(*?{wGW9)nxNJIRT35l*aqx()cl=8JpOET}e+#d_F_~wyb~)kTnr42U zW|b&HR`3dFYq79wkIFmlnCDGxeLmUGd7O58jqU^f=v`3H25~zno2Qj~t+t%)`P;dk z-eeemH?re3OY6EL;`W4~_xctmf;&Xu%uvaCN`9X%5}e9zVO*DuhQSI^1oY8STQ6m} z^j{>|Kl?{lSL%qzPVIO7^=j|X+qEe#tR|a2Qj&t}YSAmbg`C?$t9Tf*$LzR8Cim~q zgFk4=x>ieiT`Hf(nK3h6kWwl%;$@~Ab230FI=J7u6xzMys>4HQv5pl5u~$6KOjosB zlfcVKa5Sk!ASESY;Td!Z%r*3gxp;Ly=B$&8h;i!Iz-?=McEggDl(xi^PfsbUDh_*tm^W&}@(Kdc9b%2$U#PiB*YQ&MA;MIqBdjOt_)WZuj}J zWHH7ZqL7N1;1(3Ff+|v+=fW?|b>~9G^}b}SIZgFR(%S-Kk>ckbPM2XBu&liIH>lL= z=L}pxrqq!?A(Z5js18>xBcdmghZlZ;Jc5({5<4ug&HPJC?!Rq_z6`Pd01LI-sO91Q zIaBK{`yENQ=+kTNp%Z~ECDY?9^~-Oh^eHz#b`vfY)vec%i04;NXXZQ(Q&CPqbw>6V zQmu6x3*6chjtw20>_OD4L`pv~C1;eDl(w?!6hOVS>(blB(%i1C%t^1aF5Ild>GpRf z5(o|*5^b?2*?a~4B9o4Wx3O=+Hj@=fb+>dt&U{jApY4AO#VfCiELHpiFw3hySV0{C z*nb%6i+s+umm^`^tPOQPbZTKuP?fmTV~3P$6n6GXoOqGwk!W%YXZO^0JecgxIwjJ1 zfD|5v+WZdio6<6tp_t+i1Y~ivvXvsWQ>RF~Qw@XNS3;)q07r~S#gjv~y6T_a$0sRC zRs6;hgTsy};YS01P177{J=D1IT2NEdH`FKt>QAg#IpCA!DE!rWwm__@beGBBqC&wq zgNnFeC37^HYLj-%7bx;qar&c_jMv`Zj63e|Yw)-8ihq-19`jt%{{ULQG=${WYP?H_ z5qg#ltBWedX_r|C`zb#-d2mU;;*ZZ`p7^^<4MvYtky3`7=2Vb<3W9G3 zxWDe{e+gKn#xAzLF*`J_+E^y8;4aLrUBRYTvH(BJ{m_YUSr_+P_$wWc85gys@pL?x ze~y@67FfzuSy{cUm~ZF_h?y}xIn352oEJ>X3clU+{{R?kSDF`I zOxtRCr+d7{log>!T2v3hI~iB?5hSJ4=tM3%b{oUoVp*G%A4XITrRI=U+Ruuc3rHTR zv5Wo}+LFVw-4yw_DCF{FQJvwx6MG~ePRc%t#WAzqLkUurl=!J7vZRj_bpaY)AKGxr z>zBuusZp1Mlsx|cF;|ECPvH(W0*bpvmsGY@IJKp_pDj|A`X~bzQJt0ihkWqN_|XsP^6y)5B9>eiPR=IqlVRs=~EJNGObNaID!(xr?}_po$cy1^oJm+ zjbwI;)0)L~&Iz{cr_h!BKGK4c;-%86jEjS<+M7s9Qg*r)EH=DPPRhw_OaB1wanzfg z!&4yy8&14P0@k{&E}ygM(izM)xt1Ia;u9YRH~^%_P!azCwQ@_CPGa2@e=vD(G3{G@?U1O>P( zZ@s*tULj}y((ZAqi7evGJS$D*TW>j0mzGdXk1sk9-NDxO)cN#@Wnc3+RH>%%9yg@D zY{+g|wXXK=sc0E@>Pkt{8+?aQ({_}hPEKL!bn6Y-xkS#FQ*ac7s%1bB2H8zFi3dCR z&`@kGVnNevqf-e??;}gH?O7ONp!OS5&Q&q>1oeJVN-G*@3Xr>vH3HGeZYnH8aVC%S z?EVX{%rb^5b5)Ye+FAiEsZ6a&%u}y^$pEV6@ccG8Wo>aKf{LT-=$BnZ{KJYi`9!oK zlasQRBb26K%ED^sTlA-IW2>X>Cu- zI9il(*@nx68+}vlBrhnxypTXPxE%yVmJ!8}btx{>Q063|QxcZRk#2h`Qg5rgZ+4Yc5J%cV(iIe_n~%1)xn1ZZM>p=}Y=iTT7Tgw*aL zq!tEXygurtQ+oh{)@$l@vVgGE!#ZeIq9A)RF+Ft-yUcoO?6)S!1D1rigsn;d{j+i} zrjWWhVj6`yju+PD-gPPssaeodZ0)>~(}}jC)>Y82)g}`qXk2AQh*R)!!jy@m)p90X zRhgO0$W{4BnsAmJ+q$$Ur0IO8tV5J+lNnJRX?3LW%~KRdE_ZH>qn1DZ0Oy?$? z>#Lgj#}wN6yD2D2NzI_LZQ^y-F0sKxsGQq77?pAe!mLtOLo+N*%*@E3Ccq+H)H$I5 z+UZ#UX?W^X#NCbWX^OLI;!KY*R?eDn7wd8r3xe64Y;Cx5wNf~wrq}PHr8bjoe$jzTss?) zVPT|lIW(PW$tlAc#J>@6-7(3eCFb6eZMRaPam;7xmG56rQ=#9eF&=MA7ZqYwx7qCs zO&RGWhM#S)Qt8*4kbTLtr8jXS?5#cY+sYRV{l)1a4-e{3y~QeseLS}sr_{od4Zta2 zjSo?=2f{3uB0o`v;`SeV6|qE}<>d+Hvc0ZW-&5moK@m0#k2E#&I0@;5Eo^(~1l$`D zZvzXEn3kW}qL(kn>?JD2aJ;7w+p>kktm>5vpe!8M7XbQzVy0_LCq?X678Ss!3sfgF zyUpY&4z+V)>LuPGj51?{EA*N)0oDk_VV;g1g7lED*deP~)L4W;J7e#=I|0aqUN zx9NC^CQFXx2JvGD%<%5G{G)@o7N9l0mp&19hFXzVmO5CgrSWc|DMy*3DfbmAFo2TU zlvI@1gPpkVmBHni2 z^NM~ZHmtG4=#^4)6!y4>Eg?{rORm%;8G22{wv~iAAg4;KqpB7&1tgD{Hi&91#`{pI z$tPWR8=P@~-NG1|)UYhYSx!9A1OOe&%bG_(E|nqB4&*CRbcIKC@DnYFzuDPqs6M!2Q@9nA|)Uwnq~PMv-8ETTT2 zbkgy2VmcNZ!bH5fdYpL$D0+5n`8Jg1Wi=`kl%p=D$hc8TLD4E24WSHL>+&NVKAyvK zQ(>IBg)Vh3xliIW{R(~cp}99-nr>F)w)=^? zQ=K}bge7HZxE582Fy)Y2t6zJL?;V{?-DOwlJyb`@3>beH#$HR{zfqCkO%%@J%G}z! zs%n=gqMLPnNl_s5uom<&X@_#3F2pRQNG4YpETmf1WFMR2F7fk49zs`kfN?VtEHuBf zQkXvii^Yaz%ixHxf14ei!MSf;2i@n&AMG-rVw;F`$=J8Qke!>Ee~0z?#&%m%1!+mx zp?Z%E2!%pcH#I`f7E~8lX*D`+)>%+m+CK7a?~8Rw7t;E~gfSv1;w~Ids&zHI67g%= z6?Y|q%Y3(YQc?x1FSfRZr3)R5=#ssc_~l>6^V8Hy;!vlgn+G_$oC^xdK~`c2{qae~ zVXe_^!{*hoF%*)??_7GtZBaJFml3i1*gb~iDc~xtJP4NrcUo+F?=0L{BzwI{=@PKv z)z6U|E?p#eTi88ovsc7vaa@eo7D!=k zxZ7wK?r2H#z4VJO0U{rYK6na-Fg%k|a?PkE1H5hTDDF+8o*E5oLUA$b{x4b>mTWsL z(afgJyXRsQ6l_Jd5Zl9Choh6Z94UB$V}iKSn!0c-8N!szO5B8u%F3Xmq=9X22D>f~htIMM@OGO;Z%?UiVB8&UvuhF4Ko7{XN;qu1pVF>vz9$qhX%xEYiK&h z0?l(KTqD*b;)7x(Dk)pG9t1cu8cjavJc;DDG7gt1S9N3HLDDxI68sC$qvAG@ZVuzA zz715vjIBy(l>)R}knFm(Hvo%}lW~2bW_}%Ii;MX&oOv`dX7<;t&%c6RoS`jTw+bDY zDJ3d0t4Z`E1rc%hMo+`i>#=XD%01xM1}gkspG>@iMOl^KaYo5VJCaZPVa{TiecU?X zZ7Z`~3^enIXE4n%FuP`2tYp@;1DW zBETy9Ue~>}h!TwtU6o(j9!dEOeEOynk#9|*+YN1;gKx$&vOiKi`(#D{n7Y9&# zpb$rah%#e{YVo%UC2^e!c9@b;F7t_TyV!;vA9PzpD*D)O20XeQoRlwOvGE6I>{Bl` zi5%i(D_BEBJ8*BH(Ae$bG>ho*N_|TAg`wia90q5z)Woxxp|#A)Ov$XF_H5@SYQ&`l zDzL~6uWd*-1}!l05q!7!kf(*NV?QazsVZZ?R>50#u}Y9Kk?DVwPg$sp)tY#cXAfi1 z%#ggC>Hdvr32A4*6oX^on#0ZsIM0^P=pb`AMZ{#yHYn9a9&2Q#UBzqa($#aP+~^Nm zL%4EuV{(sC6O8aGrY9UIQOTIxB-q=+2}5x=W0jAh!5F5O-e7ilVF#dzom`iOM|IRF|?z(pBH9NS*H);VJrB~zC)RgD2`1n zb7>vi_ENs-KJDS@hB zUU2+}=NUgzrctR=h-)LX)P|8`-sU%Ttt4r7-E6Aq>QiIqReO`DVrw*t)k0~y!>N{; zmsGQ>mAN6FTbijYr$UDYqy=Reuc?7aEsiug94W%G&(s#=oU&2vZnrSY>N>Jzlg)Lc z+ib(u`(7mBp5qx-$1-KROyeYURJd3CPM5l!etgMn9p61)6)aNiIOY7v+(VV51ZnYtzKyjSP*fydIU;$*E<1_6J z68Gr;05b1{&(o?C981RZ%1qNZe-kjLm|NCjYQb(a>uLozQPf*Qa0#}Nn}#;8$hmT| zJn>#{7;rwfIasGR^qw7?aJuBW)Ladf09FHKNz1LsDY&s6VpL-ps^rF-Xnwdy+G`K- zh@qJm{f=!-2A!026kgjUCsdKRu_L5J&BM6*4?`kj?=?qqNSx^-&wt7*r3xe|S;(HK zy-jhYpr|Bf3Lx$}f4PRWGdRAaf z$v9eg3l$9l)6pv*Xb-b}L~%*3M{34%wH6_&PvDB89(5-oP@+?CRGh#NZg$i~-?MT# zPMHUZf=Gch8T7v+Cs9DM(!)VY9eG_3p!_3cWhEBlgK90*Wf0>E%`WS0I??dXp78P+ zfzmOYQ~XcjU*Y67_@YWin~N#c3Yv2^{IQjjSx#iNG?kT`iyXPoY?Tczk_j3^aNTS= z&QECSm$xv*5N0k6Ey z%t`YyU1aOdY><}$3AnKri4-$r#|c|AC2SqSN_E@>+`~*-5O_(3FkUZO5Hc}ZmQ$>c zvL;wRT!03N%#s)8Zf|&FDz)$&gQiKUi$&>olj6&x{DTo;%z8y>c2Po+pG1+rR5cTo>KG%fYJB2eWerU8x;lGGu zFCrCU*RR7mYQE&s)A)$CD~Vc(Q8Pnn9Ynm!5A~bP3Xqg9yB*B?MiO9s#VtQ25gBeh zREypf+9e&Y6-43#@rsOT+(31u1f{y|D4_=1y3p(Abd62pOTtT3ehjAK6*HB?%JQ(q zc0uLbB(IR?^~PO(AVlnu)QFID#b+2eAkPu;Em2B&)*eD7)`hmLw@TZw3eewZgD6rZ z##VHn#SQSN(InkpdFhtfy^g3#N^kKth^rNnb&h{)3>uteE(EH=Czx%wrQ8Q9+I2d% zpsQR3SftuJjysLXjxPZ?syM?yVr|iB)(;|W7WZCnLPn>3?|!i#K0N~AEkn}Vw$dXe zIMG?Xw(vZ>opMfoQtV94OWjLu$;_tCUiF81;@7`~ZoQA2R9bxu*R(O#&%Y)o zCS_9ewxGW+VnG{+5KdrxNCZZvEYGnoNuw(Y1;@{xH;V3&Ysvon=7k(v+Z++plN z-D?J?*=oSe%G%krQ;8lRl|>I1{`2t7ygv*2enqYyYRVtQy84p`40f2qnBZBt$%%E3 z0Fyv$zj-P}kKu6{J|ozXT(eS|7R)bUXsx3TaaFZKh^P(nwQ@ z1?HAc!BzmE_-+h2c5r)`;Dt3KG7>zJs}MajhTPfFv*L$m-=tX+GDr>0HG3401BvRD z5I$GZ7YvoN64jAjUxqb`dinB8<+u*$aG_xM9ljzYc!)-d7VfI8$`4oRtxT}qhGn3Y zxRLt6s^`wY$1QYzpp!cEylXK|WH(PO&QnE#n^-A%kaq|tD7Sz+7&TWjx@>ah8fO|x zqGDCEFd8;D${uZCXcQDcKA`IyyX11KnH{RF95Ymzs4bK9c~}#T*k*4yw=*YH-r;t> zh8<5@uDu52wC~V(J1@4pD=|MoF9n8G&y{Sd_m+5OLXmq53);fjcC;fuX&gDk5knQR3R6{c53?or`kaC$=J6+hwY&_<^oWUHo3O44WLsxpfTmwv<% zu?jZw>!d=Ge23QLtem2vbpga36fPnij!_0XLSebAH9sj+WRTH3r?Q(VH$By+);9<6 z=@wi()RRx-F_ARWLdOMh#<_$+WoqZ-7Xd{@N>1Q|n#bb~LnDXqvy#TA%#nOI?Wsk@ zD@?S?)WpT|sVhMm?Y+p0m~oPa@pA5pneb{~!b~c5CYGuIrkn}~QSpiR__)uLE2qOa z^Fo0x1w_qOL~*0RvAv_Ta4BdQ|n!|A3p(5y;G7TkFChmsH(ZG~k6wA zVH#*QEH?0tD9~B5gX0RLjhPGwEapv9lJU$1mEtsnI9RmI2yON@vWJ(7`|*NF&lYKzVYgf8IzwcGu?}aj*(y(9rOLs0r9d(CQ2{q%EVQ zS7>=ogi(o82}ZpkYbc!tM64@lc}+15QIhf9K|pNc z+1Vjhw!Q0@&2wggJZ?OlY1d!Sj}La3so`a*6{=UU1Of^Uwzq*wh$F($X&gNhPvu{j zDr(*R8N#G-(L7|Dagj6Z5)FV$OyApP3FwfV!6-Xi*!n_q!^4i`o*GI|ZQq|Si1kY* zc1Pf$xW%E+olW&sdUBaIK0L0f<{0PX2fb+?b_D2%h zQdFjxQZj`P`D%2iUi*NY-e&N^-O}mNeyn-ywO>E)Nj_iXqa$lGiCc|0g{*fH-O6NH zBVs|ZTEAxZFyi0O{u;ebOYrlx=g%YbDgGVP=cX_I9RC2BtyOioY@uOns$)Xo0dtODY^65{PwiUJtFNDZ zDtdY?puKsR+9;;4*%YNUog{lRY6^YOM)M9H@8h7-J8nB}yq7nJUX|OHNZ{Cf6=XktoYZ63v75o>Ik$1AMo+*3kSj$vvLwa$7H(8I~xt-swN@ zOLu-qWQS+kYSB@hkei*SzNK>#SX zsJ69qd&}dt$WT+T?lr^CGO9gtT53&9g%#App-XUX8%t>lC^}f3M_76sPC0JvcIotF zN$}H)s=n)+^;-)@IJb)M`z^3s=0jqFwi zpzKFc4y=PN0_P9#Uk*vjAp%8>2Ud~(tS?(Rq#EZ3Xvmdy$!Q5yJcN>jt)%29rR)K; zB3USZ9z8@a{{WMSp>XlTEr@W$)QZBg`&5%GyvmL22nAta9|A8CCy~BS>RHDMk2Ulj zN;ej;4-%b3pqiC42(b*h(xqS5V6I{U6@MZ`S4%X}Ibe(Uj{Q@F^eT+LQzq9f!Kihl zI@*V-0*B5TTvK0vvDd<{zve_bUt%c?6^kV?B`^d_w6diz+JQiD=n7Mm5C-;#edAIh zJ{`rDe^PD0(p2590MP9WjUz}QPNWqJA1Dr*vlO=H1(pdB(Mg+^lTI;}xA@gfo6*tL-4&teHWSPFJwln>Te5#I~Qax-j-U8gaGyZyH;EoFv?Z0zi@0w@zW?Y(vB6Ff>HCEz>VRChY=`n#s-tCJ0)J3 zVTNZ_E|j_&K;?pW0^qACJ47tl^%8O9)AzXXRHnuqY|J{ALnHb@YkuPuPYaJkPgzv@ zv4X93rJ~R#6vV^9#4A)TS*0mxKdcU(gdb54W8q~!mFLNco=C^P!S056uHVSR^)k%F zqq9`M@a>|{r_7;hNVk^eEpgy!ZdYZJe31TAE0{C1pYz&e`kk3=B=QzkiysBDus&%z zbTJ!03aii0bWGv6$>ZCnmowCvN;HG3loIT>GT*G+25z-!mieHM``|dcJ+xiVY4afDFq$!D{$~#f#2E#3>Y@x>Q?>4tILzcgB zWho?EF0f^Uc5&qWMKGe}8m1 zpWi`TCKzo2u#~MX45&hrboqg{UqNH~h8ws2e*XIi(|<3&zs%;=C^FcVTiE7gn3$Cv z(9FUTu$6eXeG*3LQ01&1h8K$~#_liW=k#Bb8p(-I_`O%(?nmrbA&B@hCb^6~QZus6 zf?bfSxK`_9?#sX2(0!D>(?Fva*f@xB4JNd{TP~$WY!bz~cD&e(;fHKYJC2GZ6`Gk? zK`G?8kR{w#Uh)co*TYj58F*P^R=IavzGOUnLYt@c=kg|;jt^ApNtm4}n{i{vv-HDS7@z$ZRm2#MpS46l-w18Vqi?AFt97$ONQ1wG+`LHovS$irK$~4nfjm#?**# z=2v+`Vy$iI;SI(%GUrAoW*avMyNeoWus&z_UO3w2&7Dd75zYc(VL{fC>Q03zBG&LJ zU4iq0oBRF6y6<0pLVlfx+M&${C8sAO%ZWCVOW#mE8&FbEe`JB>53J29-Fyb;6+Ur{ zyxQN_sHKpu&2yD0?dn71T`kQt2_yAZp5lk0yg3}sTWY7-rTMLh*)YN@R*PNY{{Tn0 zX^KuFsI``1iZtzxnb6=C_=StayPryb8~q59@GqW7`Wz~!4diBAN~Z9=GGjOC7KUY% zMxWzSl3{){*MF0L$ZNyLFYkY?AL=&~U7xUMnmKU$(rQ@!G`d@D2|h)a3X-odAuo%Z zmioR8r};K5V6E1Vs(+FY)jrQyJ>)HRdUcPgEtR>T*-ERpYGS?2cl>JdD(ALXeGEAnX%v6|(_*QW zb#QB$BU1@>n@%%RQt4Opj<}4i_>z*WrrM1)iEOMx%h|&XJvB~6VcYY4k#h=Co3Khy zLQ+t6H?^&}7a|**6%s@>DAq5-%5qjzO}v?>griDPY`BM1Rg|8AX)5=x(j&>!9$TU| zQCpS3)COfFn_2@HidjjPbQG~Go(iHc9Berxf<~TT?5GJQOqNbd$ zqEQ-L4nh_Z00UrEZMC)U1s$`WRiL*b)mEo3c4w*6Q%>`I4q}uG9_Y~P;v=XH7o}!o z@b3?d<;2jRapyA-RtwEI>I#QKQ)K{kvAjBtjXwrBT%IvetEpO&R@?2klqiIU3a%}j zk&#!iO13AuMT|cw(ZsCgaQg(khp?6*rp+v{xk`kihd9fsNy?RjsJXE9w@7YI*rZ6@ zc7|*6_@#Anq_nB}W2;hkXf9a@E~O)Ux7)3)9D&x#{o^+X>U<-8k8R5QjM8(+&$nXC z!aRye30MSXNjDKCO2kzX8;$dd`espKc?v0#AS=N_T^2t$LPM5I9?yNSWu(|eFA}UY zln@)4KIk{l_fw~sC(6?RLEtN?W@ZN#TKMxYy;2xUiV?8P=$9U7=5Fs)Ui{UYVH>3(AL_3LPnLM*eq zPdD^#D4~T8?A-v$kK0=pK=_>^DB#O*2MJ8q%%uK_o|G-Nv=9opK}u_zxc4n%p}05c zco+z(%T3e`K5eEF_abA)vOfMBDklMfhT#m`dyjd%vuCYSB% zxKR>v2}7$Y8w~4GTDbEf`iN~nUa|n!v5h|vIajI4{aPvpnEFsNXue~CX}yNUHy5xy zB0_+jM1tUF8(-oR%+cL{`P*`>Ju3Eqm%^8sqHF*v0A(cF`dHo~Wx-0xSo2#J)GC5r z$4$S9of1Vg?^UFKARj)_Xb&Ca(`Cu>759Y&X4V)fg%(~#U!-u_%vCZ9{~ zxXG59m0$}1>Y8NFrWs#c+@KstvHMvz*HN@L$OKmz z@DapyX?o1`s-31iPm)^`&1PDqW*BS{%tAZdrID3NP{^C+Bw7&}bR40ku3)+B3B?&% z$%K_k)Mt6@Oaa_iG+jx!xXhAmZ7;p89dlBN)f!~kX13&?6Wf<*8PfedmK-|wJEg#V ze2ug*21?>cT*oeXy}}H5J1|t;W}#T8KIwQhQd{jP?Z}=$bOe!bqy+^8s1gplTF{ocF=_K4 zL$chSE!7f%Y}D$Y)6JDdoIiyT<;?5hS_Ib>Y4VAaW1d@i*`nA|Qm$D@X*LGe*quI5 z{=FwE#y)kG;Ht8vXB$&UTJ=J~N|ST0hhL7y9M@<@nq`Z2M39!klnJMtIarr=VdW4B zHbbi-z-mbV00!j6W=U>LirB2`y=tE@+v=DI%Jj_I(v^~z8_eM$MI*eDHXz$w3@L&w zuZ5gMVt)g+wmFkD=GY81G}~%giDf}63T+81vPeDa5vKiOG_R8-#`KXYkydoHTY1>UhI`CsWFHJGI5eiveh=_ z9NZKH^8>ko=vhx+vTh7lN<>l708O%+RJDu+J zl&ru*9vzNf>FO%c#oBqsw221LQYv)0huU#hNh(splANS!R1l+mI(Wm;;q@!~-}($Z zmABsC)P_B%-!nML_B>^;@&v`EC{p>1xnH2dV484e3dk)t3UMG_y_tH8|@`Ois3yD74u@DN~t2 zvI>GyRbU0dCeU4ak!w}2ExgDh$8`xh+LD{w>58rI`qIoR<$b)OW-eqryqCd#qf^}gFT7geDl(A?3KF=q;S*`LMKn7W5FQRM1B zouyP+66haleeb~{EOYW-A|yHbk56JLfYX)aj*F7{@|79xHhO5Z;iGm)?lN$VJWXK} za*7R9*iDe5sC66i)u;o=?jpY*5vA|Qlamgj8BnTIR4KP4stmg)I=}@=+!T{wt87ws zxV&HEnv&acnAX^7ZkwJJ4uqWVj)T>6J;Uof>%veql-^ z0+f{kZUM}C?`v-nrH=l7M2O_Ck;|`fw~72Jcr!4CEhK;mOKVBYY(C1j=@F&E{{WMJ z0rkZBl3j}Qcp$2PYg?n zrDVw@FKT$-u@Yf5tx0u-OwHUwY9bcoHg>5s)&;lJ9S7tR991ZP%(No^$jf+44p zhgLE|c3bS#S;h5{i!nHJG87iraXD1A4|hOCfb`ZV_`V@>Teezo_?qTf%|r!W{bGfd zsIQ;ygS3HzlJEmMYAlQOw=H&w82N~i-R!3<#Jv)gRcr*h^Nz6Lx$lG_DoOCT)Mzyu z?Hr#ou`E`3z=E5dGp7ERh9WJWJpHUDrz&{XuJuqYJhzw23I#t_pV8aMqzfNA#><0> zQCHZh&i5PX3_V(?QsrjUfU>kKu*#fDT;&6z(uEL8Nhe{giHmrtIIjJ<5Zm0e{=%FT zbBEFn)aI6j%}oMaC|Xnn_CYC9fFpCU@{Hdd8r!L1gq`m!Atg#7DM-0dAOJi`I|!xG zWVMoFc;?sw~;;y%3Y?H9PlRHPuaC$)l z5lr4*apTKn&g#&cTbX+j5>9{{UvUm);dQHfF)+zRy3%V>n3i1=vQ8z|92W!~ypNn` za^ukGof%oaPC*S&s~~4-{x?nV=NZw2ql7gogqP8N>eA`5(xGG1*3oyvaK0kHk|AWv zq?CMd;{2}*@Z+^+R14Dy2$D_pQrs5=Xm6Ao>MawoaJK3E#%G$5Tv&3CJ=#wOy(aNf zwaP5Ru1l3_ruo%#bm&R7v#UjEeSwJl#|lj1-)IWQ8D|u?-CK%rR!S3V3+w;@LS*c5 zBEdK*!2!blA5|yk(UN|k%2GyoKsuWObtg-8iu{ruNQs@M=+jhebi}0Ug5PAY zg)9(4fJ$+w5WTjzP?s50z$;Z);Xr&)>bB-NGiW}`j}`~ z+2N_y>Xm6Z)Fh>zb7Wt8Ekq0Tg~n7SNSRosh{bJ{%S^VHT3@_{>JRYvM7T|-Xpbdh zT}j}^9;Oq^kYzXXC-X5nJXE`kJZP`p+*}sJ96Xk0dPn)SMqyVH=p?0S>Y@obe5^H# zt{!@p<#!PTxe@1r`~!0rG-qerRI(I5nbtLu^;l&$=sQ&tSBt0v z;0$T-l#&>HFz#GZoBsgIL!X(1$M}xfJ8*?56Oy$gx-&GSr34>6Z}5kv#?htNpBYMF zI{iXQV1zXKN<*qP2~r6bJv+l&k}YV*@y3saCU+Dtgw0fiTQt1ZOs=BJ_IH~fRPZB3 zB#}iBx7{OX0{vZq>by?u3UY&1uOeGOlT9?6-^V{ zvGbwaA52i(HlgxbqNj>~h?|9MCpeSC3bzWYFXJpO6*Any`IS0g0`4Z=_ZuXWm};!4 z7d;`~7dm?}yx89~Fii0>Qev@F#EHncRLF!W!Eu}{l_4q?_tT;dm$=th)??&Q&zT)D zR|~5c%0ZJE(Q<+S2Q%s$R6pUy*gWmPpaYlol=UCf^vYmL`b`MvJoH zi}Z#nhXgJ%q$e9vr|Dpf^HR<>kVo3J)8IF^T_SG@KMrb7qZrK{N{V>GxVbo1QeuZb zhZ~)jQ;ngrlXVkxgy=Lkw(+-)Wkn;#%Z}hK6PUqxc0x*P^v$rG!^1Huw&!ccPl}qH zn?=qj(mU14gtUcvNfU|*&n}|DP&s*lXEwV7me#)gA*i9&BIV>2SFTT1-3KU2Wn}>y zG?R6#e%ic7!+S-RJ&_W8#z&8wI8|DKGQ&gbnwSqt8)_8c_eQ-07#$a0oFCj^_!OBS@+iT|>)3~ifisE9ESf#aBk?*-6>opl=CtIa9 z=A?Nkr7Op4+VK;Uq2g20XIrc=9&Cj+>m^Aes#c4S&LSmDeZ7j`?5fCh{9M55T(`w4 ziz#&Y5x;Yd*z%kvsCbzQ+VdzQ{!!e1Fsz){z~cQ!n~BZ)b_z<4=0aItA`=pLcld^L zEr>&0XWF<}*&DSyyZqwhtR;3DaMUClNZRCl7c7$?w?y{h-=8{?e098Q*s2?$XVmzTkv5^V5 z&5We+#x$hK$*elmySk|-Ou*d!Fvgl6PRHN1E;xSxVro0d7h-NqFyJ}`i`;8ts6U(- zR;BX^x*DDi@l6~d#qYN=OLUsSO`TA(5dPLtv98bWwLB5v9Aj$n8kk9 z-Q=n%)J(N~PwOJ#C*>ToiI69WczUmf-&@mZ_Ni>$>88N2^IB7Uza1hR=1qi6gkj46 z01H;lR#`7emr#|q_(o=(K^GnEP(g$#u8ea>azx<{*hS{VrX`aOHmwZ9XYnaYe}pMy z`5bZijs(vOaGxC!nws+yN+aD$@;smF6(vXEcpFmYbz0;#+*9o1E5rF(e7w>*sdJi? zDBUYa&2*&MMBHn|6!BCFZmQz$M|-LW6htbe3TKQ0pa36B!jF^H~UI<^pS zI`p%xDF*3rDa@Tb#l^j19Pr6=M7U>9lRCIdixb!qq}@`Sd2b|w;suIV_kjc(1L18V zuZZBGo;qZ<=vZRnrH$%eGRSyc+sdC+cp|2eD7DxZH7WRjk)&cc&-b336~lke^E7-v zwIeO1u`eVzlTO9zNo{SZD^M*sg@q-{bOdanzEi2_BQuwWmOg2x*to})OOqeTsevOc z?J7T3l;$ewVHJ)qnI%XxjaxDTkaQp)D;VIRuHqdfijoxSP!RA0<_CLpA_VACBdo1P zZbb@FN`oo{6%9uEgW>97&5oSa(&dT-(v!$=5;=g}TKo7Ad^$q41sG_qKSrJaiy`1r z9znVsPUCNNNjli;@P%|a%ygP*7|Eom!VytyDF*vIorpUQ@cBn>#8rFw4yDqGn}fLbMa8Y5O-!}kwwbJcL<1I>_~iC`6?r%oxo$kNwHBuZ z(4e8@Zx%7irO2nSG;WAls*3$_*fNOW8mt ztR{|`P_X27fHII5yemjqi88@Dr${s$vm%-c+(NWiSPE#Jj2;+R3sG!n3G{`u zcwVtOLI*SIokx@!!$^DScg{fGYGHo5OprK(~810;(*MJXR zI*uN^C;`2rwg7`20AK(h0HjA49s&@>AW6#!ItA|>I(VDM046~RIvgg@APs0)!`6a; z0+{BMD^NnvFr5O_&K+|M%HlT5Q*9yC5n>b}oR}2(kK^JTIWduy?A=DgD|PBKD3X2a zha5^ultJ7DD3YIskz2%YPD}8~uP3={gW5V@;#c$=`j-YLsVYE`3uT706_%Bq*U1`% zDN4FQ^f8~G1vr0p{tnF!KWW1!H@ok$LJ|5!LXg6nnrTiTuQL?%rzM;&TeO+=jx-Ye?Exd7U<$pHL$tiQ*x-FuHTDOc0%?T}kwTi6*< z475C7nDckqeVM>%P2K%#$>{VB6DlJ@XE>!f)T3sm{< zU3nzNoh$zB^!_Q!_B{PSyy<*su#lgm-$+AA2XwI7t(^E+8~B)7?|4YAMwwU932hRy4$9_MV><9EdGdElQtJg)J|F-(L&?_bZ$IQV*018H{z~M&GC}Ip zlvQQsrRJqjrsk1lG`{@I*IO$ud9ZpNGDDHdk}cy&3@ZIt0GT>jaq$nZ}9Epx``Ps8)BR` z${xd*oJ|7xOOlf;Bb38;*;6VvQj@i`D(Ms9$3?BxKD6KKu>&syB-*{YTHXAXc;`qh$Bgq4!gB>k^~HsVh(A{K#*Hr%hMiVa%s?lc310 zhU$r!r9Ak%NSv2>jN|oG;u4j73`~Y!wYe5pe)%1YLys7rmU(o*+{#_d0*k3a6iC=9 zRs{TE_;GRM*&8PbF2ZAl(iI688dS?mM{tE3g#q9$l1IiRM>>3&26!J~*{fz!NCF-4 zNbd=rkvOKB30C3{7LKeocMU-D9sQFH48Hnelq%y3dYx1lw=MKjr znGYr%8zIu+?>>_-B#PGK3PB?|xk(;pSd$4A`7vJO(y3(Iar1|@5&R>GTAW28l{zf7 z0o_14li>+-p>e@t6A$B=x`95^PI;8y-UKXq>8v5;9b7GS91~EM3C_EudFgLhL(Y)m z;ali5IMa{xJPHew4wW$9>D*`+c_8Q%;t&*|pVqa9SmbjlIz;$z5=pnUcNm&?5pd2j zeQ(h#^yie}Cz7|4(!o6}wIu!!rrPGeLQEu@{hEJ~-b{sQ#hHfXTbV)Ka__e1;10hC zav3)hIK?h?@l6pww3aaw6S6ewfS8k%e!^+hGPH!Y54&=ZH6x+88pW15YTT;N8rWm_ z-NXzP!-fqf47AMD(}>FC*mX_>1rM`)$tv>)NRbxE5=2UqoRpqQd6rtN0l3;8OlpO` z8JTknEo!Dty(}H~!)hQa)LziF8v$oAGg5q|YJOqzedLv>ABD6qttjcusnO<2Gb}hS z_wW1Tr*}G-eQe1}xRLH^aOR#o8Q30 z&n1kgP?h3AZxqaDR*K4>f`l$I8fOq%WxYi_uP+k zq}m^hEfL(QjTdUH5%m2sUU#Xa0Cm51Fc<>);98rLl+jT~hU6gA^^AtgjCrMupLj>KP95TN z0f{Nr z)O>XFF;eYp{V2Amz1IF`4ylDHIHfr%O$^5U;!1uYNw>>yDB^X@aZXYG5wNRZDwYLr zokv<~(oKRyg46@32XfQ*Qmy_iVM*`;29){w_VoMm7P8+;e@1p_HQ9;QQOT5EM*-%` zy=18h`?uH9>A35ZL?)|lYwz#$B~|YBW*PiSs#A!TbxCb%1UAudb1%>~edQ70oa6OC zhT{hLE?<8i&)_Yk>T;|6Jg4yjSqiGOCWA)mB}zs`196!tP|Bg@zf?r5Io?0v`TpKt zdkkg9r?dHe{rpZW-wkNh2{lO1NXk?tmanZzZ76j*SX`i_m0Mzh+n=gTNXN#`F8ufD zUwNC1LDe(HLkLA)!MF*f9Dyz|o?*8ZtKdqSc-yd#>M<*=lZ=eda# z782T$w2X??MMrbuNio$Bc^Sldl9Y~2s63^6#b+`HqE~W$5T7OdzN4DDzJ6T(f+A*t zHHBa1w<;SSUq`HG|hLI)7N2^|>DJehVgkQ}s$Z*}7nQ0BUiqjz%*P7E-Rr+4( zv5u)f@u%@oB505O8-FJwd7q_{tMlaM5JrF}DfRBC!oL&cPw&V>(b`Mz%;q~#sHL^0 zW{#JI?e#CAL16XDpa}TKTWkBb@M8Y}4@{NuOybXB+I4A^xjRL984dEIyriEI%1|fa z0!#cXab}!$Srfm$rziOjhAC4in@e-j&mD;N(4Us6^@kFVE&U{e$I8`y7yhBvoSJTF z)iWtwd8vgYmYPx$r2}m&ml6uSI>YdNn_~}__}81i*iUh)W~zz{GG*^*s6!%iU=)ejoSv%@R zo?yo{i*Oi@3gG9lElH+oV=`3cb)f0C$*{JO+ZdL`p$TM3r7gAsQjh=xpb^3=31|)( zlL$JDunG*F;6O0lsuzg_^w|u z>|D!UaaJZN%UFfaXa^DO_kdCV)WyUe7$=Bw-P9$=8?h)R*?=JBC&0v_uxWTX$7+@f zdUFj=%Y;8UJuHUXH!ZZoj%8X=-qAKAC>IypLK?AXm>dPgO|Gn}B6L+b)S=K$iY?|D z)6(4z#{D6w!>G8iC&g-vra5YjIV#y@RSJQa%0LP}%9j$Nt6X11+T@*JjA-j)ET?6- zZiE#5b0~S5mDj5I&or{>2Th2&O|O2istX_bOq{MWsA4)p1UMG_wBoe7RMAK)Xq#wF z!M5A$cuUw?+>9JX#Dc3|YGPf$rhk-aZKjiOhS4u0%1BC2x-D^GVWd9SIqeG3`oe zAzjxULVwB@j+`w^wEW4UVhJi~DGI9LX(`&ND8*WS*#Aa_(V3pG2u3< zG zHJ3&un8Ub%MLyD`O;IP*GnDgEml{i?-|EzKBH9u}N72}GQPJW?6P)36_@17ZM7*=K z$=Q^lq71*a1+rW%0CWT(D#u>&)QA@68N|XhNla*os#LlXD<0Y;S!9FCc1~$&Q)=s% zl#od}0D2q3=tYkQ7Ur6%q_sV(-gZ^=DGjYizw}E0 z+$QQujqQ}_$WFyL(UO9q<~^>Ir!TRxUv^;H&9;ebtfeP=l@%!T0U{h~(h*}B!>nq# zDj38rGJ^jA^XZ8+<*-{6=1Xn!EvYJ7jwwd^lYJplg|n(d>%;sxCtBdl%|=Y9JuxFR z97X%7aStus1+-AmX1>8O#~PJ_mqIDw4s`Rx{!s3`zyAo4LPN$H$K4xH>i>bAa zVDvTwkq)@ngvYP@n3Wm2q_tvg_Z)elJi{z4YAUi27OaW6xJb`%Gy^mzBIGU-8p@>q z0JHISWZy>^s389U%_YQ$$MA`A+;@8%)@89yB%6^*DV9Ys3u#T=3Kw&yfdrA@VZ7>) z?m1f|e`t=)-`@sFYF(7;Lo*YI06u~?4{3Fy$1c86UGE+n@+Ej`LN~KICMcM0u}-Ns znrczCt!Qk8a}q+GNkP83>}(B>Lul?6E?{q zDJm%Ct<c2&g9p@Se1hX^OIXP9=#ur*$ zGpXL^B5s>Ii5Qrp)?0MA+_c(VVc~adhVvmxwq&e@YL%kmJAH*#!(+kP8YuGe?>2RM ziCRO6@a49f3wr8&;ceKIsNm8l=&nl2=nu5ETPZsdl#Sz@h4T=&1B(+pD42SWS!dhm zMdc+-I610dgYPmFY%SnE5!pjl{YGw!X5c3gBq}np^7QH7q-oA5AR*GFOfna60nP_- zd!!rKY)nFM-*MLLuN(tMUk>=aQei-b+A|43=s-f0fv4)*PY7Js;SnBWsHeJHX11kS z1&P+29WDICq@P~)u?BJ5@3AdEznFk~iizS)Ah9ZkW#r}xS~DwbrL`#mEw;f}Cn`;j z<1TEsAVNGh2lv=gntP#J$A;I2@um{4NHiR2s&vv=Xz7_!=qlx%t=&F5h?R$UweTWO zpQy_Am#Mc=#mrP1xMpscA4T*zRNcTM#9q-Z5u_zb{-bk&?fj0Wtn^IZ$dErcQyhV6 zIIxEJZ!ku}h_At@j}Cu*$uIT&3g>oMJ0|OC-MU5{aQ^^OZr|xefYevyiy*<&=5X>{ zQB#W!&OESGph^pgWp+>MUixohdcs;H^!YE<5epAfo?>#S;?b3f*$T3nR-Nx>C~eP8 zM_tCSly$xSXqG%U<3yh(sZW?!F{)&*Jh+spd6>z21pCTTPjrAa($|inG~>Dz_Q*I0Qg5+88u?G4Obp%ArWGt_5zU*y#HRDQd9z>*z?kC%-53P}8 z_mHB>OF_l`)#WKgiL$q_i#$$>yrfB}FlI5yY;J1If6l~+yN5JTWa>#i({ecy%co?| zxPP>gKXh2<mKM4*lOe=bKAV-1&QP4dlBB6OHrr4lN*Ss#@eZ>miYn-- z=De(eiV%;o^Xd0{r*xxoO|{x2#v>DuiK*hoL!Q@CQj0+5C>JYm{n5C$jrI`#03v#)$|;^dF7ko34Y6nPghUyi`I-ec;l?($fl3Q*RCJ z3{AJq(j;S6N)F6jjix@4HEQD^OSF59xS*vvzt$EvNb~CyyjK{p?6+mF55r#UvFbMk z@bx9o@+4Rb8+}?VKgo(2@sg6F);JO!SLahMfP?^)fucaLh;JbwKt<0@<~qU@tX`TR z&u=MlIe}ka+@F^t`zufHiI};J%t`iRs;~JYM@c=@)TRtVFVgE;sJO zFy<|lUH#EqPb)`Eg9wsgbJI+h7c!&*yopglQ<~tNy52PW4qY*QO6=&X>_Jqo&d4`V zd?>Kmxd?SCH%3(4H@|f@)Br8KS>?$m6v$Cqlm7twn>hZjF;JY4c}_VZ>p=I4h)aOz zMa_Y>`fC*YLvmY^@$5{_*|@f5i-r{?BQeUTO|I>>lAyO5XcFK_PQz>5fJU0cOi|o+ zPhyR@WrV62ilF0;zT~1BN|y8FoXH*lZlX?>i;PineCy1KCq|ts57c<2Sw%Wk$7VjT zASr6sE%fppkcmmlt=Cp5Bk2DCgg7bQ98wvOae15oDPWs~n*m|)8u`X+h?<qA3nttr8d<5I?K0?~3j+dTA4ID;_Q_c5TC4V9dGM zaMa4breq~5D)CXuZxv57eD@{jLo9@`Pr-C~C)@~TQmlq12-CSLrKv=Yx+ER7FiG14 zhylhvA7dWVc!lbV5~>oetNFh%VJS;L(dbldblBU*8{{n#f3wG8IeY;6Diz{~rcq@f zl#sLo=XCz~jgozbqO6%*WerW?ijztKC@r+wK-0WjPFs9!5J%ZpJ+ma!Na75*nHF(s zkyc=CIc287&}(~({^;uDHpv}}G2)dnjx@-v^8;~L^LXJ%vh0jet z?X~shSnncTD$ED%k_h#&i0z6)%Y$i2#5EK&+Coy=+f|dG8FdgX*fL;LWlPE=M5M+U z!7?k%0!L92AR&~y+AkERjTrrMp+!=1YUSGI*;*az197RpO>Y`*8y!+*HhEaRuJH;_ z1+mR=laK)0X&xH@Isx#Dsbo<_cAFax8sZsVDAfeYl$6wqjuOF6RJz)RoV98S!PKQh zU!}}3460(K9V4HK=?&ByTTUk6+z@vM_Yn@vOh<=-ouURB<2BbZP5=K zlcvDh!^S8$t{uyD&#`BNEo{mCFbjwaM|}zarAapgc!JE zGYzle0>!W@(u#FKO6s6KAVae`5;t%zT50O1GEg?+{*lV_OWjB}0^TXq<{n_iON@NY z7YtbLJH<1do|;QZQJdztm9-}2){xqUT&-6Dppwd6%CMLxV&Rc^ISDGxZ} z8&gOnDr#s8sS9mZITSMjK`A~xA!}qMk}`V$%hl>FOuU7*%W{Cd$;y`8T5PbKy$V;} z*23Fs4`O3E1}c7BoMVU)_vw%S0GJGEQrQ&^?#WBoil(XDBP@gc3y&ar1>g6@KN}jC z0FXd$zsQ?`>`c1Fc3%p~zfhc3NojV}_>&Y~;I2`J@%v@uxohj?oo z{{S_`atV;0Sh6NigaEVR9Y|Qe?O4Q! zME6jk@dwHzIYxiPzG!NieevJ{11ZFdLAfe>`K^B%hy+J^?{c%Kr>)#e!<&=sfwIUG`T3Rugk zyzi_&v&t(-pA9|9!8<6Kbr1(Z^0tu~vE((?Sw`wp^J;k@iDWXAlWyoKD^VBQeSIQc zCHf6Wja+=<{FVTcpOiznX3UZn(m*2o)08PBX>q@Z-Yqf4$a7~G24cy&-VBsABYCj7 zJgYYr;z3zkl$Y(0v`;JAD6M+*dZkn2Nq?cq}dQErN z^hAUk`Jkl!;SI_?M{I>%layp@xV5Ep3pW1LOP3|^8U4i1V+zWqQ;H=M?kO%fJV7W> zG2Dxnz~cQ$9f_FwM+2cfevNDVlX!oJ+CzD{5Hdy6H^VB54!o)3Z;j&Ys${X@MW-q9 z{{XKqCco`V<-g$r+z!WMXL&MJX;Zs32S?+7-xV{FPu%#eIV$5@-fslgq0QInjDgxzqHB~$vu6-+9b9Qj+YUw z$GRvoY{?7232{oURIW{?P=`_vhEkOeg1SPd5iw+G;I9cE#+cG(po*$_3!*s9B9~M^xszHBZnif55RMjh=vHX#M+a3ekLfNxizzB^n1XsN z3xYfdA}?0uYuL9=6i$lu7Di8Q2#i|=MF3BNM4jC!^qJ!^|8;GQ6Qmr!In%Vd3PBfoDO5(lWXX`!3y zP-MkqoT2d&myG0HnWerRA+vN4QnZuell!j=mO-fEV@rx9{hFBmZtzsQgoCJ8bnZIE zc1Bo17AwMBGb4zwjXF+shTmt|TNxZkP_|LE!Hm9MDdUlO3_6h&_@~%0ikVyZdGOg) z&mrU79!V)h!1;)ihuW)@y+)_OUm^nHZV}hGH#eGLx1^p)x?W*@(`|@S59esN$Hd1c z@Ujf>IP)GpHDbE9DZ$h^>9>@(lwAS+Lc6BcCif?Odc=%bw`gj3_Od(Sjx1Fub`B{s z4Ry>;Z=LP)i+E*m^B_+hkDWJ+bgJkLOlE0H(52L7LHLZ(F=b4Q;L(Q>@D`Je+cOfN zFyYiKoS_HRHoPKuBQGz2xMq|{t&VsjRl&(quQZpX$Mmfm+xCWpe4++U8OO|<4k1gJ ziNiSZt%DQ{l*;*GL0q*hSwR~RE-Xhwyj5o5A)EM;^epl5GRMi5QNs@33{O&>rB~9X z+*?XQ9!g4vVl*o66K@?O9mW3uyz^h}d#^r!k$=PcRX^g{lKX)?Yo>7yNvU+Y6FA5T zQclYQVw0`>uVdl_W4PaEPlkVqZQQ@X#YZaGd2zgZcI!mOiGhw5|Xr}osE(SPpz#EMO)b8bZOHm4=t3L7f|)= z<7rtX3mzyv56HpSbGB|XiKT%o&Lzo7jNeq|=qJFaT%_N|z=-V}JF`4McMjxweUjrT z_nvCXHt|rtu(+!d(22&p0FvUG1$PfjQvpW%9}xf>5UUeFS_=vWJE$lu8iIfe@`J<;A@2&*6bLYD3Or16QOZ4d z<6@{S$%I+ZEeNxwG74e4I%Nj%y8zdPCUEhES->wHu%p+4!hy{lv!QcdIbx4q@P;TU zMd7xECUfU0txkfMP=$k~l#qWokCPN<%_s3lei>XjHoj*PV+qMTfZrj!sW(W-n*-tn zq7?X8HB`K|CC7`JcW-|-M{2eMtjNr|zEck+O1pC)=5Yx7jiGi3Q0PXHp3A|`9((g# z>*vVQ;p6eiC2dmW(Z21jV_!E*mBWfHa^_@NT%f)yn>Q&FXskM>WnU!=P5BI)%q)YcedAy+vW4N59-aCwe>OhlrCaIM z{{Ra3BY4Y~lq8idmD^Ry$`qxf^}NH1$`(9G}t7d4w?%HTj6IOchAX)hZ_khRb3YA*SNQ&VCGidW)|x$tGr%X{{Wmi4z|v3 zl|E44gx8nm#^uG|I(}97SIfD>mX?~7mv}tda_1$PW)zg?9XZYw4As1{A1kk4QWSZue+LGe?0hI8lEJE8u|r=YJHbbmeX)X!0*uD(j7M9OCz zY=HBCp_WJ;-dkxqgSEjHi7IH?lLd6g6)>w-CF zOz29kQsLa&<#@7opW(gxvJ%Mzx_prQ&roUDVof-DMTQEJfqr^GZ6m6#K+Jz;`omL} z?RD#CF}E+o`E;&iVa3&)F~OEZqN`KiNhp$r*l|yHj>#wqwm^Ck4Z6dSQkLuXA8z@j zPrA4C7n~rdV=P4|sj9;=Y_J8|TbYuzr=paQRhLf_e<)r~A;vYS97ya3z~Vg#jpi)gA3^q^}?!ZnWQIP>-J zbSj0$V{^x6Qw2^3((oH+{n0ZPPGxp{T)qN=uP*RpnO9KE!nA2?Hck9A)al_5JoH6e zI&XXPp^U9Ap@p7pHCnXF)bX-flx;+kdIb?+JxoN&#dKW@JUl9&D6gFf%u$N|i>bFs zM1^X4dFI27B~G`>%X?;0`H4y`)DwRwOforj^?UsVylN}^wcRh=Y%w-I;xlurq|)h( zwaZR*K3&e!P1{nXhc2ZLx{y_UfrY~)A31X9xsA^gRMNEix=Yia(B@XK1xtvO`Df&D zOyUcxKG^cg+Ly2$^vfWnE@vGx0t`o7bYS;M{C!D}gp=}nQdO(=LaPpNp;#(e#-*Pt zp-i?!%hd!2=VqK&M)HAX)wWd)JfV!7dY|ImcCCl8@UAaIdZez^y7{-T)?@z8G;C8d zDKSu^{TPykHq5mgwu!e5`>#8ga_l;c*@gPVtbWv#c5dx?zs!k0W+|rQ(eC*r<+4Lw zt^#6y8X*$2JViR)cRE(766>LaOQ@SIPNZbIKn1~acd$A{+3ETfdIOUW5QmUZQ=3J&<7GqubO|a3EF+o{-8Q~E{zX*r zN<7y-ROoN3{6WBcL#4G=#TY(zl*_JUO#LagT0+(}Q12@C^#{nr%y}hs87Jj$^&#cN zlD4bjm*^(Zg1ASE*(spn3F>s(hjA4qikrWJmeWSV;}TYB!}yoq$Y;V*<@f7HL7v5! z)%kvP4rYy5LWRMXnkikq9!q2K2g)6f8y;JXybW{xNYli8C6Bl~ulVLpYDqm8aJK#n zZEH{C6JeE4lNoSmOi*z|<|ApxCLdbdO@c{TKfWFibnuT5RYrf4Itr703D@_-a#k)f zqG8bSTQyXr)ukn)rO++#w~Rn|iEAjD#WD+gZc@T# z*eh2o4q_9hsRH0%!XwLvy`RW>IqPxgtz(%!C`th+pzOj&=+*UZeAT7Lk=7!3E*!_! zRW3tyNPYR0nFJx@HWidItc4|B0a@%mHWrS&T~2s{^}fw`+Nw&?O>H0YQf0dv_+?U$ z&I(9v&)_YoJ(00I?998>2Psngq>vN?t~dgt}FUd)wRmkMf=*h>^iyoM&8RK%mKj&d6+Cos&CY=gM& zf(`EzW3e5p9$wL{$VgI4379Sw5x32X2e_&dJ*_XVuZFUdqYtr zDcGiD%eazU%B7@il^%ynU$0o?&ctnIKY!$`I{tQZG*_ahsUAYw{ty2w;33-r4Um&}Pug$^3FEw8RRy^{@$&#l9 zc83Ki|utGN5Uwxdopm{Zi`G@a+c21AG)wb2fWiy z3ylf_Y%k^r)93MuS>n^(7P#_j>Y2!5w$({S?Q-5Dx~!opCvN?_svi)1p@}=^^xM~? zBq+7X?c1NHVFQdfWX?QI>MgYDt}-n*Lfa$lH0G*pe}V9hLnDKsHA=M4}RZffhz}_wo?cY;tiA z51Pd?t74?oy!4)1C7Fi9t)knhyNt~&bW>#qZsCbI_=#fPF2673^!O0+aM8>BOYiUc zj7)|X#C$G5e+SglQ>T(rs%>HQIgwpaDKMP8yKIy_lfziIS@Gwkk~&-JlBf6bWn8dN z1?YCWHvazrF}RoQ*C|eXvssp?NX@jOms{nvFu)+#?BZ9ah`+`quVh-Z(@*cP*Y=HU z)qVU$eJ{0M8OF6%C(%C36AZSdP>0!lw$v0sy~0&v;c^5=pR#8d*2I{5N<6nFB^MXF zh|rfMWz#a+hv_9|8DGdPNmt<&llFXx5#uA@)j!ZmVoZBR!A}EHGm@?=PGhXCKzgYG zU=P9~E&@{J)8I~AR^2J~H)MFzho^;@o@r|zd@Ud6BwyhJ;bk6y;#j|vQ+1?=8+k4R zu7|tu1|oQE^BnOs^g89Rz!w>hK%IZt3avcE>eOOVO2yO)d_rM7&hj`ld@w3MT_*dI zvlg~??Pd4}5-etzchmNXE$D}92zwY`q{D^)n zTG#%vf3rCYqcE9;47EvY!*o0Ke+-LVkHXQ<34fO#gZ-No;x@mzFN)vlk*QCgVo5Ht zimcXV$+?+AlvD97i-GZlYD@di=AY~mi+ku_=(YQu8Ei>1>nSYMWFIHpQ;8|RPKp}* zA=N28(~DkzXldh(?-?(HI&DwPs;Mt7^rW+jQ)R;QX5|2B_O;aQtXN`;ZC!WRi;|RE zP4lXM$Z;qfKT0PTQl25%m3xWZ4UT~zi{He?vxSRGb32-MvgA4?%SDEwEe#$y;%js; zSeGGl1RS8;51dEIp0+Ho@Rz$GZyWfUrX<@_?o2Z|oh6o~mKGdWOzArh9Yy1qvRgZ! z8eEPS4QFu`UZpEDHpHyCS9KvEhY32}!jey0R=4?^|CB!iYvRo4^Kf z4V^*3yaz+0c{>~!osA!XYhMoTapRRa+%eegF z2NTQYJByiYud2#1PFly2gt=%36Fr*n3P1nV%Z8<=@C3`08ktgFVA@sX4IOCvslL~? z#^jh@JgXwKL&=TDn2O_u6L%3bnb}l?)FlX9yNMvHG7fBnZK)R*)Dh3wla(U z02`flhfoX;53wZTaQf(yt@9IGc5Mqt7h0WVC~{mUOW!a$3ue8cO&zjfac_zW;_WV4 zog~YM_I1lUHFJNh<{^|eG#{+5!rfto9U|_{ekRk!B8!a)Ag$V*xhB><=F&j;Si`XB zagjQYU3!Z&#Ppi^a}1QNrHyPr)DUzbLqZQomNZO!ZG&mNexOKAHj(tTNi%Z-TQSb+ z7;qr+R7gp2qH`q!R}*n#YrR+ThKQfFn52^mU~r&0mRbxG(_bxF7} z+X^PHYU*S7+lUor+03WqREFh~eYs49WgfQE%)>XZ;WRiekK`y=Zw>onrN3xtQsrt% zvL0lsn3pa)wmK4YzPGeg<;L4=l?fd>A3CTpx|G_2Q!tiN<-rc*WoimZ8-RtN1Fx(q z5vGnwl}A}#Y!sAqHAVgjOj}VB$!jkuEl#Ue-j;YGVVYc&!Mr_-rCH^3!ASfetva!TBr;S*lG= zB+JRp%(~kuN(o975SOLgO^%?Fw#t1;+R-Z>O+!+R91LN>NxnTTmxbCC>^g+B=^z6( z!-`92xhd4z)<1Y32zdw>oFU?>IJZKO!T6jICMBv3bJi@mcjd`KhyVgeK?+c~8W9GX zJE)G6Gc{fW;#E}ag(2jv5|gO1rQbr@+ zsmIzn8$B%YUPxDgS_;4iee7WpM^PfXB4fsCbs;Av>H`RJVa`RtP;O-*)|8&MO0%}F z18dtzui_!pla52RhjAp$QxHwlRHUj=9F#Nw7Y`(7cIxYJpe^=o=Melokp8X6l%-Es zE4Y%l%K1{0GL;qrMTvQ-c1lXhPN5lq0d^hj0XH!@Mv@q_R|GaGGxT~pXdJOhP)1@% zP@QenI*<<5AvQPDZ3K2m6CO^)%lcCQRVa#BE(IxQWbeyb3u;jD8Ixn+d@l{;<}NIZ zSnr09P2p8lSPKeN)T=5_P^MZk?ps^+9XIiXMecE-=z4l@vK1=~(eTJz$f-`hP@Opf zmg5bfwYuGiU6Pbsm4XNfye=tD?B^ktugo<)#hHg#Ax&hRS_n4<3t>u0^dQ6W*$9)| zQ+5h;w~8jy)KWkn^I96>m*E`4%$^)Gt4=$Q>r*a1RV=V1xfy$?63w#XYYOpKIbe$m z?{gG9LrE>U-v0ms%M!n#BjoU{I}E)wIWF2-RKkO^3%Rl7rq?$%01K0A2#*OqM2RAo zxNF1*IBi&%sI*MQJ#&)`HpamSnsb=98@N95TNX*S_ZExK*oDY)S34tIpR7vLTtkh` zQRnZIL7Ar6Sp*$Ih3t0L9*P@sD>Jiy8Xw?oU5bE7ag>!M#9rOicT`4)TSWQc)`-x_ zrI+mXEu`_rLPma4aSgZ$H2R8lGVj|~9ZrCS4GLVaBW+@;QE=F>jI3jE=ME<*Q;$`X zPIZ@zg+ZCH$SyGI-DD*%BG=2B*C_)?Ll{f1aF7`|0pn`wuP41EX;MnB5%EQp$aUk?h>9Y*0p1t?z!fz3;8! zw_f%>*2PyfifXuz4o%8QC3BUG7g|zS0Xf`uMq`;QZh$oc_EGOD!uneAaRisaufM4U zws5;&$vK3o6vQ|z<5Wi4Q1DnnLWf=f6U>kNXtpfwc^GoN94Foey1Nl^+}V0BxPxo)+d8W<_R_Zv z?YE36A}rmy^D4_8`we2XDw<%lqm}8`nieBP$~5BiR-?RCr%swg*di7}KJadg)m$x? zf=Kb;3M?N5q?IV#6I3*#>OC?HJ)x1ODF({{YV6{9^J8a)Tr1_tcX; zrX~c;x)46h=?B-mV#hxv@*+c@sov~Qs_XXKne`D%_IVY1*396oNhG5)bJOw7-BhjW+_D-=Rmv zHOr}9n4YlBB7L@*Xv`^~6E4C@C2pR&T%C12BH_s*wIO+dE3z^(N|u^fn60`#xuP4ZL$Uw3&tpO^Q~V2NFfDE-i3Qgl()-am#OkYr;RNV=0>UjnF4$JQ4#A}qFw(hnnEks2e6V7R@& zT3;TiX_uZ(NtP~UrUmmhPNY~66c2&x78o+PGB!xq#MiJD6SMU$olKf*+hl4psg|2s z$v{b1(aQ|PkZq;Lonm^*=0$3WFGj(1UJgmTuN{hKNH%9ixAJhmoQ zLejL4wwv4SZLNsf99&aJ9y=ON$$gZ+y!6D)LZXmnO2}(l_kQrQh}WQovvC%wb>=P@ z=$#q!D3cXrlM9n2ftfpqTotp7tRCGGDWO%_sjIrg^tzi;j={hHAfAU~(@5EH4xmx- zTQP~^yvuSA%9j?9RZNpxX8!fj)5mDJWCU41W}H5}H-+W%B!$csI!96o?#6G7mCN8; z;8cZ%BjP0^3CsyvjO$E3Ku|)B$OP$oZSjizEt0H;Tu-8-5X?x>T3TFgcDnS=WDr87 z)Y=wQEPd0cy~kK`x`?u9zLseyTHIP?-nVu+1 zp=Rkyq|!YCQKUH@OlgzSN{=rgIWszjz$(kuz}Q%MX{pVxo!W@yrCHomr+IF`&I`|nSoOxuO zGJ$iOe=B@r7stz?rr}X3`&`R8iEz}tPF+RJjv;NV5u<7$K}oju>%P%Z7rA7}`Gh8! z!Zj33Fovr+m{XN}rG*a`hu%}&((y*1s^Kb1 zM~1gBVc@(cXEJdT0qKP9wm$-*seo=zP5*2N^1fFNapi(wVEqMsl+HD2^Sk*%P=bc-y|( z+RNyr0AVq9$7pnLQwCa@BA*FXNBIIHNOcZd2+Wv{JdLK>%>WI~B$yI)He_l64pXW~ zEi;@8CTRexmwnGQ7b)7s1PhZ7N614G6MP_>!l0^v_brffdmEkP6@H@BN|ApJQ{@ZQ zXDDR&p~EU47-fu>CzDk=dtOw+vso(fOR2MJAF8A9g~ua_#|t4vKZd+V?5{B4qGqen z)_$=Kr3(sAn|E4DyY*g3CpDBX-FH31p$Cp-DFc8yk(H1l1BEMl3%k{E^4C zsU)1O)EZ`eq2g_o%Y1kIp;C5`A^73T;+=`=QfEOhiD|~ii772PZ;DfY$~jvKWIgQK z&P;8J<^J<))8erbTG0PgSd=*;Na<+2+c`aJ93i>Lc)gNgB^~{S`a`W{13`Dc-@pUR9xR?>YEK= zDLJLA2AX2)QP3wQiod0zx_BIz^2tbxyg9`m-!lpj%ivDJ3O0>!HxYxpR1EY8bV#lH+$|diMgR zK9HwpoRAu+*3)GnKdz9a9Xxi1_QT(x2?<`=cMns+oVoavr9Q%vKW&wF)~mmWy);O4}n)t)gxjIPxRS zSi?`@yeEbOR4Jsi+_dwK22!<>+Mf56fJq@LH@Zc|_5v;xeI8zV6v z7|>wjapmOK!IgP9X+x!r1q!`8g`DP7rVDCG)dx}NLbi)I$*x2RM3FdKkA=_?QedE+ z6ykfyJ|uu5TxWd9tx>;-I8%qXoRajLsAgb`hg&6AJ_>Izx5^Wf3YfTMaU)JB;7w-^ z=K6y)$o`S5D^E0nNQg4wn&r7RJVJcNo|`i_gysX1jxJr~9j#-3Ll83IQ`$=WnL7?w z9pcH)!yesLItxNZxYxBy=re*6pg*dMn8)#-?>PzYjp_2{zdel?5AA0k;`RGP$G|*z z!#KXml$~j}6>GBUvM3)c*1y6rd{?q^@ciQ1?zdksUT`Db<_h8$o8&v9v!4n2{FyF z+w&2mRpWJG?k-A}>kOd|kN|fv8te{XU=M}NDid*g4ay0lQ-svnP9M4?>a#_skP?|^ zmI*`br`%c=2}vVBq?4FiUEx#wTbx^LNql)mcM{2l(uB-3pcI7*9YMGtkDNwIh1rh{ z)u!pv>1jzQQb7tzhMzMHv^XZ}ILbxYqbD-rTXoPzQb@i04%dY&Z<)&y6-*^FBG_EJ z$e2n^(g{jcZwudF2we(N6G*1EwHr22rRt`XH$6&KvG_+QEJ$M73B%1dH%gjBq`^_l zg}9KF4w@|6AOP;3%G-@9-lvxRQCcl+dW6TP24!>H~ZYOaK(Y42Lb-aaDV zJt8g9Aq-|U?E5c>*PSOL!)FEWZ!vpBjC@0g%M;W_UUH}R{>-vVdJ7qPQ^JcOo@{eUo==I0^_A48?u$PFo2>3 z(oKlJh#(lT#q9;kTQaXN0M_eq<(HmBz`96KJ_aqJnM;!^C5gwHHo}3435+;~j)R zraQw-P*oJG!{-e%pl2Q<=Lu&*^N^pkK4KAKj7pekTd6-W3AA(qwr#0T%tvhD?Yctg&S-wl`*T}lmz{9!LS-wXqYT0ii?6j(fr148qNH%nZmWQ1aj99P!%^ z49)bTi}H><%rqKqPq^_ZKJe)cyp5evqeZ%diWf?u3nLYz%$lmm)c*ho?~2Z7GC5OJ zxVgM5#c1Z6IjY4cE@XnC<*&=eIpd1(!IH)8%&4a|y?=PNk=2~%hHtK@Pq=P(wfBX1 zy^d%CR=C{9U3!kA;R4JK21L|K6hJo}BdaY2lW*x#pcD>=L*#tnUNOxk7HcKKQf@sp z{G*;R-6rQbcFco&ZaiTwRtUz5p;@(urR@#s95)L{oK2RHLFiy{Qs#9{$CDfC?+R)4 zb{5M?P zS@YJ%!Xaef+DTRX9eoQ(`${u+{4cxQP2vex>J;U-USZTFlp9L6(()?XSxt?7Ay}}} zS9@|*NKQ^Bt;O@}cFN7-pJ?n&fv8I~hhCI)KBnC6T}ficFTR79z^GX1Zn3Syf+_rr z{#^28XY9+yY+q2ta`PyhePPv-uoGUsZu)e54> zHA!ag_7vI)9!I*$7On)$C* zIF8|YdDZ50DPq>kn1uT1MzK0PI(*3QGhB|0odQ-x0k+!#Alw6WYvXfs5@Uif>H3X4 zvVB0UVaZHJ(PC|+JlcT;Djg2`?miH?V^ZdhLo0^q(G)RXV~SHuC0Jo;qR%w%If;Zf z&M9-QVCslkPQ@zFbhI}-SMcmk$HukKuThD`d>_SiIT?pBwN2^vm}M65~EP|Jj(mYKPI5IXY^;z{Zc zQErgNwGZ~a`^vBBxjFJytF%-7d5`4vVwfb`rr?PuC)U?>Gi|!I<(lc4Q!ZV#+wO%d zovjdFG~Kt|l6a(_x^Uk>pB z$p>9TyK>VEsYIg7GV24PN?ii}qj+KD)7$bLcr|mi_56i2<|>`6gx+1AKo`!X6$aPf zpc9!tx9)kv6U(h{TYdfX6$}a;UHV_w`I_RXS#Y)#tcg|ghT02K2SuQ4@_c!BQ1FIi z{QVc*{D)Lvul057+vX-J6SbyWF3HV>zMGCyiAa~3*WKpWdpnl<3$ee9A~R2$+rLl0 zC%E&Bf5YeIzFk+EH7OiGs2MWNUWYL&E|PhvX<_0mt<;9D;Ys_#;KP!}m*Gt{=pk

;m#gmfNO#0dS17OUuf-{Rdl|%( z#XZEiEa=Lll+Dh%kP5WZmJYY*0(3WoRa;K4n`a!9)k$)Hh6(<4`kY5!W|+gR7MCR@ ze)G!J>AUU_liwHXYo7@3Etbo#cj`M%Zrjx^iGK`!HL=2;!4zrMT9lb=%1V+~FCfyE z+pl=3!h#k7zNuD#Zw{=kJHL|a>M-Kv%ke(4{_65eslr|Wok9L>Kh9+~H0nZ9hh^oI z1+zHeB&|F5R&>6bM8A2olIPE7f5?sCt8Mb@Cacj5&1nB4^K4gUayEukrn zb`31gz6`9&0u(QNzz|1FsvyT`ELGw!3o4z zk%~<4b1c9)TnZ^rHqh^^M9Q?LKL>1(b6uD5&KY@2qGCsx3HK7F>~z>)F&{A%zBFGn zNpP1(^gGyZj68AS8-P?8YY@pK*tD-_ON4nXw1)@8D&7$4lqco&Bgztw-47GJrt$VY zvvhnMWLy^J8JX0SU#)>kG=)YHM;l|Cf@<7Vs5+F*qL(Pa)mcDsW5`>tp3x#T&}xR0 zwbadGjV&yyn}TR1V5!8RErET33BKMiy*56!BbN)O+r>3mQUFd>i<77Z#3Y@%+B>3- zYO!|SE|=m(b(}p|rvmd2DJg%NK}KD30FVy45DBn@MG3K}<0k{EczUGt%OP_zs#VhR z0Z;(+Rf!;twS-j)yBmsi9mW9WtI!h+NOcODdJMaOk#wE)hS;PoQv9{7pfw3$Qj6{L>G$_XHFQmUIeuaWt;A*})`wDsyDk!}(@dUkDD+ChVM-U@P(ay85ae+; z&uU+L{rm*EP^QE9fYn(KH8h8kFPNmIAYW|OxJrff2Se2&5Z0f+zrKfENY|&~8bu-1 zyxUEo=Zci!?^$a-bR{{DREyv4L&|N{^k08}L8hPI-`{dLai6oc7RD^C^{sT8!pR}# z(Bp`CT{E(x5CQ5?Qb*m=(SN~lvc{{L`}_S0ZYzaTc8c`HdXL^y~~lULZFo+(F~8;U(nUPZ$3S;{p^n^8%>h0_?qf{nbDj+6Qw3)ot&O6|~{ zOj65+l%MkbS#2IEFE5yrrqbqXA$1CNFp)!+NlR`^rKIKXT2{2!+d@Fz6QVHMOY2*b zd|63spQZl*G2G$B6BX2I3@U1)AyA~*Mq&9?pkyi8Bm$yu;s~@ZJUnLVpPu)y#!e%{ zPWkk>wZF{UtZ|B$hpOJh`jW((#HER%qNcfk*-fohvK4zl+;JJCJylU99Hxl1D2`!qhkL+1^@vBb$`;GoQ;fs`se`%!R z7qIiGH&fXV>nlI3%f~PFEPSHJgG&?LTKTWYg~ZL~Rr)9Sj9v!g4me_P$URUDpCjM%=`@m26U^i+nGBkml`u zvD|4x;xZ4`>o}63?9?||oGuRZ$`WkF&)W+bbAG5dh}tZl;ws$iIoaKbBJ1-`E@H3& zP<=`$@7qC?D=1G-3q^(;Y^%?iK0*#>iF4RmMs8B2Pn(f{AuOzd<3+)?SDQ+bFVL&4 zgj&W0ESSn+ZqwXM;pEq`)LK;hvW4Z-IKo+3N!2OlB>?TE)u7y%b-^+-EL*du9@^vW zF>`8_5;JT%rk<7N^9U)~K;=oX^wQBDQPKp2+jwMB4FIDm40Qm|_K*PKNx**Ti@qD0 z334d5lf&x%CIM0u>4}Ebve2ICx0%u|rISflqRBnk8-;be3yGhbs>-TWrOSW<){MlJ zY25^>+HY%l#eR9(9LE}EnNH2H)1|ekVOO#GwOiLUt#3V|ys(Id#W>LzPEGmOr6yF& zx=NH%E(je(u5IVgKsb(u48)(y%4;MKvLKaH2^%joM;s4f_`11(0#HslvKnZlQ zokVD|jHH4Mi56B+4~eu<@Z3j+{v^EkwUNqlp1F6Pl6ZpiM#>**-4vm?J}1UBu$H8s za*k2b=!2Yjpwu{TG{pR@zIhU|w-l6;oW$IREC3hjuCVfAD3_ctt38b8F!Rza1j^J` zP|l&ESUkinRwCdpA~Fl=Qf;&$ojP5mW&Z$?SeA^o5|t=E4yj+LhW03#U8T2Ov&r!KXmizp!rQj(i) zFOaB%;vuH&TG&?5@cX=5PA-!OLflPAWo(iX=$9%PNz~?2O|CxGx<^#B&{dFM6yaAe zRl-AtRZ3qZxGd{RKsnfaSOmJA?e>vn4I*4+sA;MdTv^1km>UaVx%zvGW@1uaY1Fuq zLAvGz#lZ&NU2hy)wkhm9l)7CrwWE?1`6MD!6jNT8dUjA{LMK>h#Hnj(BQlirh4mmS zP<4cV55QkA{kLk#!+6<>r7&4jQVE!F4KpYewxwyZf>W*axHp8ybSa!ndyM8NJU*e; zS!|_dt1#J4p}E0vwldw-BJD=SzVGkv2|C>6&}j`kYD&8c*F$}Trqod}B#E}4n5xN%X@G}rwhA3nuLOYS3<^7t*;Hs z@Y5H}*y9E!osq;ia+K7v->6aKrjX(r1wvuBqy}XtsRc<|Hq?u5Z4Tn(*ohJOmK~$< z4M=q=Ly4xXDoTM0O1+m*LDUhk9U@$L4YAGaHnd9Od6!&JLujLBTGVWmq&i7aCqMwy zldy)km2n)z_aw}gG#EpQi;@l?)3FUbnVEM2fkNgG*a2;-`Fr6xbiQH-gjQt5t~b>` zqb0_4{v+wySBSsJY&PRTVH1@lqC#8~WfJkq;()j|N-uIRYmFhCIBnSUve8+%j+)(K zfhARyWb@clDOwvA=OjGq1Gqi+MnvU1?w)q&J%ewdOgGE`sp*W5>kTT0@egPts;tP)d|@IMb;hIMali1mz{%xunZLeiIrA6DTa%{j8Y(r>Ie2_0;TSc4n5 zD$Y$j!;;RRwzt@IITnRxNG8|Vol<(F-th2?CEsVO;$K?}njY!h312KnXfd2rv zS)u+^E3eFTavxg1Xh~cjg4v;#)TxEgWQtX5qVrC2G81vAPk;Eq9Cq)_ds<8Hu^8*C zEMdxPNd-hsG;9UQ4a%gO4!Q`DLe|t+B{IKB;thJCJtHwMGRowov!K|iE=v?CDk=M; zGJsa;Rm3IkISrCtf1RAl%0myzGxwK?2g8wg5;))f+xd})4R(yI)xEO|q2kQM)Y>KK z4}z;S`f>u(x|7IS3baTkQ>CHh0yL+;suz4^k!p>JXtM2uB~8yh(!u}<&LkTL!*Va< z4Aww%|-8{@n)MY zu;1YL{tJeDyiSqaXvc$1W#X(}pO~FHV>bnp{qSuAt zoVVy#=ggz=D?=G^1kFx7w-mXV)womll%@D2UiojLKUh`dD21l>ME*yQ87EsubGq3N7yWHa?_)BNdXRy zysN0FsC}fJL}j?%7e?!JU-0?05)x&!jiQyJ$qD+Zb2eeNEeJXJ#XK_KK@LS7WL52K zo8YRA{`9}hIsVw2i0>r~+)DbR(og)1{7Gih5H43Aadg19BjrY?^^XBAe{% z$lSz)(^Dr@XIr^e*ziymI&?8(g>@oiH+xxQ`Dte4Xj2ZUxp&KR6%`{@31ku6wf@?) zvW1K|qts23a*WecEHwPBxeH~!P)M*1vu+96VRTX zFv#jUh`J#MKq}3k>l_p%alSUC@ZwQZm1%@9-HA#Hk`}vt)RHfFm4g$T8l32--qHMC zs`i6I8<&w&RAe|*)10LhlAh^OlnQ_rjgJq9L}_*EQ0JbvuSHu&p&baDdOYS8}B|wa-BGxA2-W?&fb(R6x@`*oEnWWCtlvm7=oOV+& zB|#}zZ(ICw+oUe`6V!COTh^*L<*|ft?bkFD&!19MLQ(+kG^HfyuDMh-Fw@v^ZdZ2* zdnw`^NmywUEUH`3YhjEl=gB`TwYY&H?X#Z_`~st+jdi*YYb}t z02Xn==__$UQdNAAo1GGY-qPe;>UNDU35Kb6=2dYMv(**L(4~EzRS9Xdiwgh=^CWI# zK+;N)Ts9PWs*Wg`5_HC#ed2B0Nl+iOMePu!l7|w$MWc3Y;Dp}`sg4=kzST0k?hSMu z0k{S;oJSR@?a3B+@X{YVNg}zX(vSj$iWY({6qDuG!&rslk7z5Wj$Mhqn+{a);zLi1 zsmVj4PhYADPKU}Qn^X(HY!M?ir-v%IzsaqP4M6N|cbKkzzV3 z$H&SRm5tdNxSK2NvWRU*GC^N0TVHK;{9&o8Le}H;*;s$Xb0e>`U;L3B#mE^Lu#$|v zC%OACIDa@o<^=Gf%qgm2AAQ2F#?a)>BX_dAxt^VGi zSQpi`oQgVl8y`rO1^SUB{{TUET%c5VkoqMiUqrP9ke4P_7Eq^1*CNU8uIHD7l!b=f)yZs=WDvch~xX9;3lF8tE6gtGLE%GIDs z%8O$$C!qrO+rlDoYg}4Ho*mOxTYu=yqZ=+}i3~4lb&-Q=C#Tf^0M69MAJ{Yy(WUJVO>%Dx%+5=X=QPI|s4zz1QqBda4!WZ_ zHnqXE?Rb%lZbQpUs5e+)xrWFnc?oeObxOcc{0t(6AS#r3dedd8hS2H`=~_aE;{Xgy z?+xd$q`{b^JXFfP`A3vggpcu79pBkE9+AtTT*$Y@F3*%MFU%7((rNX6iU~_-d(Uf? z4-pE6XA_PVA^TnM>ZytFgrtmu9h`EM=0`v!$CTbc0_+9Vu>|ST7lvs)&Q3dQNlwpc zRK66Yr9h==mO@A(#8_-^sJDbOH@h5)9mjIM6x*o|Hngb=N`=Cbp=AO(+(IKa9mP1= zUsz)f%kWCEQNypfk%`5JsmpNLD`jB!0X79lBPmKpgj~XU)s@nYmTd6H5if<t>q)wYzSSq`BZ1QTnoO+mbJO3~EEi;b;}EsF5vSZEzD$hv$&hGgIUr{N68 zbkMiVUsNCdPvY7n-}G}xn3GxQeI0K903&b87ZtI_MxM{e z7KBS;s@o^tQkDSz(1hgZb#)}HthYM~B|q}-IN!-i{t&!wq>g0jL9Plb+HjsEm+CC2 zzD%i-GGK`%RH&3mhmS3fWm_%0ts5?-)qPr(vQ$ACLHD6?Vj3h39*rf9WL>1y+RTKT z0zl?6PRc=5?4QCDGqGc1!CXZ>*}D=PCslJjCVf|vc|_zw)$SB2SyB?MlmPdw6#Qll zYWkwfhs&jwC5WrY!Lkz*?jWo%o8%jlds|qg$BxSxOpo%oiF`tsYNI>BBU-6$yD1(Ef7xCh5OKl%4%Xk$uAOn_DY0XRVOR z@ZStQ#5zqzmr|N_#}zP#C1zH#R>R=|NLmzbQQpy3=@v4_L`9Ox!`at}GZ^-X%cyBo zr?{y})SdZ_=oey2thCucn_l;dZYCNTV}@FXu4#l#q@l!xB=k_Y{9?UL$8<~5nO&W( zJ1kP_QVOk7n?#)BOBu^xA+@DichZ#j^^JG3y`?EVGAVf85mlnEDl{sN69CSzu2$UC zq?Z0Cq4kZlWoBAw$Cwf`<&qthaJI3iDOJBHkTJ}Duy-4rk_m38*;+=N=7)RLK${;p z=A)?&#aoB84lcFLX)?=kLiw2~OQ89S6L>_TrOb8`apXq4U)hFokW^%s%t-!?+lBlH zO^iXG4P1%v;yaPDw}qy#>xC~i?7M?vK|%N(BDW+O=1<2o`3@cc?GcE$YVvYSDfUL~ zyrnH9czeP#d{?tE=H{vQREwNEY~j}aCA#1)(Gra&Np&X6Eze7#^eaMu6`>a@?%4Fy z9W{(LUuMb;*7VIJIJGW&5*5r7M#k#)*?v=sP#024b9r9TSu9jcj!_R#!-%0f%R+SU zh?0#Gl&tDW$g@#lO}d1w144y>N5mLO(YeGtDv}MTH<>LuHATTnPwIWoc7R?{ENhs zotxQhD*pg&1cP8LV|YyJT!DF#K35RRPmHq&N)>HRmi{o)k8{5Q1@XIzICF>2^WRsr z%(k@_klt0B^a|GcctiNHN_z%OiUodRPBh~FEj*)3L(8 zyfv2-j{MW=hcV<*+p6ftcZs|mM-rvE%`1~qmN})S5u$~+LWl&G&s4)$zsBD74~wB;^O>BeBbT&e5@i zcHaZjxY(7?f|1aY$5K@Tm8Vdn`$P8_c05{qhNZ$a%j zkbjo017Z>ng}>Vz@mOg*<~ikyt0?vV0EQFe29T#1I;&V*A1LRH#c4H_j1~=wvg>Vh z*TZ;6jKfKlc%kOL*UmWeGOlXLiv7hmzkZ=jS*aZ`=KO!@sNp&7qy}l5KHjdI~3F_q3_j*(gVhx>PcMBuM7T@Cuc^l>E zcTEPT&nBi+vz!!y9BEoOoBg0XJPadM{qA&Z?nwDO%&mXZ25Mydn#j4Q-^zNa*r ze%kULwob`C<6{8m|YA%5xX@|xPrrtErcOX0tpFDxAE?q#F)!S znL8uW`!GykDr}UkB2q{BoYEXw4B1aMo8LJ~ZdYTz*AdxH&O~&c5+Qb(kZA|?*#P{^ zRZ6>k2~ob`>NsMLiRH|?k;+N`00)!+d~ISs2x^H5vM_NwgE*TBF)ulSUu}trRVhx1 zbt$JNP<6`cP%=26dJr#oe+;Sb>baes=;mOr?v2f0w-X_cDKiqUf)mbVg*LAY%Wc(* z`k;~J77$mLI~~sB>=}vw*+` zqp1WO*0)>j@q{thjV3GM}WAJohH>j^6Bt8 zxZ1v|8O2PfntGp~eZSXFi=U z>nW|5Q;`m!B3*`@_g3Q7Wfb(jmO4W;-tNgO99!FxSI=`we;#70m0VINa}qOUrUR3c z8i{69e!yC9d-z)7;`&0P1eWdms6*3NUcAQQTeSuxqRA?Lp-)<5nR}D%T!jX6Ue`j3 zhJ@^)q<6qgs%IODyH(%su<&7i({xNmg(hn&6C?tp5R~&SH0B{j>he4I7>knwTh~6R zT7Mqnk@9~g>92=j*2DPjm53AdGhDTO#jGJ|@@Yi-zpATOy~{{dAkd{v?{K`F}6iYVdR`+qf+gIPn?ov30#X_drX$q>g zl3TQ`voN8kRLf;qE%#Op{{U7a_*J~Gmdlm=xeASZ<%s=!8O1u6kqS{{R%9>?YZn%g0lcxD6P5H8;i-MLWl54L0d$D(p<(Q&Q zJff1IwB~gvKwe}oLM9qIJ1#n(c>?_*IV9lrbx!u@zkciT7~$8A1%D0sZQ1mHn9k1N z8XZbp$fiXyo2j=c`B;2kUS&FAyrpRysiSf{3@;xWILS%9SJU{v)xK-Vipjz$MwZ<> zSNY4M^IHiDMj6EPI(wAanaK=Bj%ie|t{}d{tsR*!+cPs`VwD1urL7jr+L3Zkl53~% z-)?(9BC3ARYCB!8Uym){$w@yuYva`v%Y}2jny;1oIx(=X_B_PYc|}c9jFoawT(|%AMH%xmwGU8dfwlAh8X<5Ql zpptG#7TV{hlts_{EPEQm?fa}lq?6$!L*c+)x*IV3a!t?xyi zCuMF}(;Nu`8xd!WghjsA49e7G(JwWk9!^Z!Xie;O@H)iIYQgd#9|35NVZ==-)MryO zjiit+d1==&bkude)`zHXk;{<8&7L8dmc7-u;)VP&!Zd-u#2!7=@I`&8saq|F8$8)% z-AyeZ+T|CvYjuXEs8S#Q0OkH3;w>rH=~A-aNG-Aqnv&9A3L{e5Z*>8Q8|}MZxjD(9+y-rZ?DzdaH$<U-_qdC*f#kCK%-AzH4SV8MyKv{59Jf69q5n3Ozn{ zTqf?SS+^2x)kf+mNj@h?tjX-mZfkGWX zzV;z^1H(vy{gUDQFK>_XCVyya=DwfI>P%yd4a8Rj#GO`NnKVwIxQRu%eZ$B-)q3hY zL`HlBo1L-i6?jzd`~MtdKn*XKKgtmI3HAhb3J zRrLd6cN*@>`g(UnNwq)bMgA^! zC&M_JrYkdZsiexSDKiqy2BpH3H&9Mop-TH!0_R(67x*~oMO9zNnM0cbZvOzG(4_Hq z0Pr;^k-}7l=c)i$I^4T%yrpe&wAoQ6=QVF-{!tyIzmcO~r12-T83oWOl1kaNmr}f^ z#UkV2Vk?{>{!{u6r6=Y2j>ivsFHpEV*S6MOGt(sA?-Z#Z_#p)&_{C=t#5|r}T#48* zY4h_P%u|XfauV%1D^Hf0Lzc~%4Sv-Hrbw*!RmK(xHXKGZ&rRb9hc;rpQ&{Lt3G+I)m9V|wPR@z2q zjo{Sfb-%#5;kcI-OzYP;Z#yLVU7KcVsQ%$kBbhGW{F7*C4~62pz)rjN z9Dr&_Bxw%950IxmrsoN9B^`A+ifuO{S1ps85QL->t!|rp!=>U(Ff>QWn#C?YnG&@} zQ-1>!qaBEDRxli2=VLh+X_D23&>KQ1fPRt>u!MiOjKp`WpRO~!VTeOPy$BVI_5h{3_ z6u#8+>X@{;EVl}jpfeo-BGJ(bt|J|*BJLQj zHIAgqtsoSt?aVT*awvQ4s2f~(D0I|C(ONMS9Coe)PQ1sksS-$4!e*^y}To*2KNiPs+Kc*5Imt~swtF} zM}s#|TE({oTj_D*4UVQOIO~AjoWc#V+kpEGMs3t2iM~Gfz- zUK+aSXa{VpXMFO_{fnH_X0m{{SSI>*NU1?F}TnQAw}W8bTW~Qwx)sPWH2)!s)`+L z)X6GXX9@PX#7~IQ=BRcR@TDO*(F(K8g+*=qSpyZl6&D>oua)?i7igJm1daAqW9!l(-J!wXsZ6ekho$75AI@2rc}_0+xTPg2 zZPU`~4y2LdAst1HpA-0JGs8?fPi9Hpds4H{dtPLOg{E;J2P{dkYy_nsZ@z{X8C{&J z8$R27K!1cd+J{z`0ciR>F#AVDy2;UPt3zNx+-eS@Bw~i7(3v_rxB*mLVMoM5fL6l_ zriD2svbAy_N{W)8rF+){ap9~vrk>(k5gdQT4^*)2KDNxqA;T!r)&g#)9KR%_9*4T4 zds|BgdMbw4$aZfkVyQxYY^lUl=PF8?MaV9tGWH24&tDDi4n9Ij5yIMyH?<3styN`% zWd|)KNl^w-Cd{_TDa)HGl7#}Ux9NC8bSZ9P>|u}ZQkCH!yFhSmuY;;JwFddJv&>7(HtK9Ma$Grp7bFl($kRi$gb|g4Lrqn2GZT{p zyrikx)g48WO_s}yXyuRHT1dFpU37;8n*0!;uL(_8Dh>XqxBzmcve*49aEzr!loGt`3iI(c2YA9{$0ubucx?5DzQsTY|B*Bm(I@Rn7&M(3= z{{UuDn5bdeyu~4$q^F$1-YaMmahJM6l10ezi1OL|N0G#(;OVNnu1{Ac*FQHTax$ea zGFvH90SK|N%C)5=>zIS7gg4k)7hRiL4@=RTaAxJzS{n2qO)B5o*VZ`24{i*q$<%6i zu1=byDVezzXWIzbP7w67${q&cDI-mFw^$H1QO+g9GZ=nx$yt;Z-nmjzc2W+ZNjngH zqWc__kzXyCgK-?PL5BnuIoZyNyg|c?jH^m1T*XJ0l?@2LD31=HL@cV=CmSD*&b_0~ zEp<3=5~wDvDwieLb7oz?GquA#UE+@4?3zm#ZF#PPo_jA zNeEZg${?s08Xz0G&90;>#G=-O#fxm_b|AhlqFs%OxVl#Y4C*4Z&R^$ zHJp2;xV%|iroM!Sr>ZQ8P_YtZWVI=I}aT$iTvQFZ}>u9E& zD4Q2#YQb`IOz}#r!;EBRQcdTQ{q7u0`r1+jx)hWsX?xn{(LOP#t@^SncKrzT{m@hg zDs2z>b0_kPEF%&*QXo&^*?AmuRh3O9nJDv_9-XGqot92g zd7jSesCZmx3UpSxjiK0`>G$L>xO0h9gl91P)W{yl%+nn8osyZkXW1$u#MouO&uD!i z=E-?X#dv!Z%p#>lb&#)SsWmbZ2vU&CNdZITI+ z?a6ANR(+*-m)N?6t@^jQ@w6>RVl1am)9B8;hX7ifn4<9tMs)~ffh99BD5m?aI1rW; zpy5|_MJn4Zt_NLV#D-<~pQzIDo_$9a%c*L)YZbiGe2}RIh##MvIYenYJDs2E0;5Qj z7rNMe=H2ORt^&~T(JDHRj+O_;CPk%bV5F^T9=UXhc=#B{ zp5$rqQkN};nG>$hEFqMY0&b&yRId_DPEjJcS-pU;e4Y$-`Qk(Kr!t&#GBvgC_Qcr@?aia4@mIC~V;<)zL>mol+y{{V(SQob39 zF=vA#Yve)61fR@SaJvPjogjf#Ky@k1k~GrlCim3o;Sy4$M|{Skjoc+)2&P%Y^aYV7 z<~8o0Um+j+w-nse6v=Qz;HK>PgI@YpptO zZEd7I;p#&!bXg7=#FChzQK|VC1G2LS3vFWhgVM)PM#LCv!f5WYx_eMAPInr$E~gw* z?xH{~Ch2XKn^AE@D`Hh^n|rqFc(KC@UZiZ2+~)Af>Yo+yG}UrZ#(kP%XOQw15~Ybm z1CRupSSv5R?*j_cu$v~o6ZoSe!Py4gc_rDG&PhpR-!rP)a1DovIz&GP*#7{DL?@o@ zb%^j>+Fq*5u;jCgv6V{EodEbLDI}2{o&*udO>Q0WQklis13gSxvK5i$l#-P+yI(1| z7xfxNZb&$?WF=yjVtLtY%4Ip+4Y*rLHVRr$N(KDX0Pu#A7Rs!^pFweEp!HWB)Ereo zQwnVo0jEB!17Y57!*gIQ(($3dtC3xkeqzTP_G`pEE~&LYhTQ?Cj&!yF%IMr*GKkeZ z(kh(o0AdO2`3H?f?N6SRj$Dh&M3$jg4Ir1A+J{ z%rij~b0akUK}Kq6XWlAzRD-UXZEJc&T^$9J*_q`Fr=D9#@C_v?{C9}bL1dg|K!B0q z4V)pbY<|*XgVJJ;P487EP%|iQ+E=g_Nf$pjwc&85yCUYvr(&$IW(b;)eN}3r{=Iir zQ>uwqQbGJ9Ns9}Q;(mopr()8RLZ0H4QJOtGUFVN^T3NR5s*UVDHIC)UrEYRD)ae%= z!hR1^I4w^^oRR@{-(2>&maeB#ZSahr6U02P%c3puV^CWQ6gkd71nLw)`NeILMD*=X z*)yA8ASX`&y}yJe&e5eWSN5c##Oj3rq>;UjuqFZ{irgWi@q$%MRT&CZzOCVKv>t?5 zi~1Oui!*@SprldX7dUA#z`E;{;P*3^l}K?t(o(HJBIjFg8Z1-PtraXAS+TKEm@TPr|l`0P9DJS~MymoBlMZaOTl3uDTs>)lg1dkD) zf5I^S(B^8mPD6u>snhuSsXI-UQbf3%&dSt~OD?9_&bG{z3xWx@x9JqxlH9YaJN#MU zOB4z+CghWpNvXv+$R{n*QtotIn+(aZNWFru(mM%X%;cg)32CpUu`HX)`o>wF%`Wy~ zo0l@Qxyn*EvQ$Y5J|t}xn3WK+9h_*_vhhg@`|DWwgBt!HlK2_EBbnap+ffwBda4RS z(7C4>aR+4~VOJL#gQdZVas5cI^dsZAhQHbdd{ODGs7totLR$o7KuOD)MB6da`k0HC zEpGNioOsKe?9;#*P6NoH8ZLF>lKYz6pAE>jq*7$#HGB(5aQa9~#Eu_H;>;~GE)oRO zRcYQ+fa;Z(m22zPz*zdkwJY=((?quHxx~eBHw#L=FmE|4c}bDiJ3Y`&fNGl^K5;|E zxNPsWP^ruDm23Rb4M=czY3cf*4GsY? zo?wnp8Jd!AsM6)$7j5JzwU5L6p{O*k~^*P{o`h{7gcv(#p zC|drc-WQQmzULyx^=iuviZs?rj5fsxd}D{@@e3+qWdUhWJM=vWBT#)KiCNU>gVLD( zqfO!n!$H7g-IGJ9Bm$%;AOo)C9nH*1@KmFHY(~0dnsl5qbk5m^^MHqL3KmzW^GQB& z7Ex$&#V!6vB!yNslrs`CQ#QJ!>Qb(J3W87h(Iz~GnHTsP?oKV&fa=qq=fs7` zY(;iNMX}XbcrAa5%qJ&9vFc0QJb^VpDE)cl{{WPzA+twjKz`4%<#ITgkMU~!FBf)J zG)RudGIH3f1S*|6*mhY@KHH6+psU1c2{CHeqGf9SZs~ zWna=Dd(w_?-bnXWtyDbW$Y<6!ELu%oEnw!jvrBT5Y_qL2xw>PWb2qDvZZ#YCkD!jQ zLbr!pTTd78Lv6qR04oGI+@#ui=WP4OKs&)V)2;Q0j}5Xy$U6922dcpEfy(JlvKo<8FkA0--?Z+5Tj;?QCdB*=h0fK$#W*Xxybl?Rce&qIA&+ais-VBZ)2t23D$a<;IVh z7q?!Zj*+$DC#nm}V>!e|nJBmoR}^ebHzcEERApP4Y>4@l&#A&g0p<0VWX8dus-rlub>)5PZ`7bk=vPN!)4Ol17bu;2jO z$yU4#ib#kMOp#I8= zwDgKx@a$RQmvG#C!_zd3D?pk^AQ=R*d{VTle~eQ{7M9s!@>-%faJ#fcZ-&ndj;U>f z?wbugY+*TgNM_lgaN=c;kzias?Xx9{-b+)!A=L|JRmIOhNKLizjL#M9Nk@1)^801Z zA89FVEr$xR#TIdN;iZepIW&bK4&LJAbm@N$Kru}}XUYl7w=&8+QhORw6uRC8NT=1@ zQl+i~bEpZ`Ju@U+k3XD3$rX3Y$disw;$`9<1;kV)1oakSGo=<-WP~J<*2+8FbhYD< zORuTP$@KIa=6I;?Etg9xl$@nhSypx)XmgT>Y(W_;0ZO(Y+zt9ez8;6oHRvN&uOXhN za9bYYNrld;qP7(1Ie|(w2c@%H@P}S_MOK^njrdZ1euLw~%ok9=62?xcE{V31yur-C z>aTj~)PoT+%}v_d$dis5RWe4>o|LDga+yPDSGH~S3{XnTX77MIcMt{R;3r}584OBLaa+fbK=hnB>2coyNB58EFNV( zc_8XWytM#Acj~BWqx1SJzYq4D-r+(}5k ztUo>*SK@~2>V{#TPvM@==*cBLi>R34)Tx(JiIo9#kVbp;1b`31Aj%}zvr=aanRfv~ z`Az|%t^xTItTM+_2&_Ll&Ty3Fnq=9_5oLldl~@~UHMsPSJ&vXJ^f~nz${KsRq!HvAuf-gs6p!EhfbHj)oS(#I&XpZeDP$zPpI;i1`H#7ijk;DN{_! z%RIJH;zEvFY6yw=A67=my4YiB)Y`@!Qf6f;E~UY(l$59+nTcL1eFl6sx{s9)wdNqe zN=ct!JjnN)LXtG|PEvkQ{y9F6X_Q@n6KK zhb|ib0EO8sq+ge*c3ewv`8v|-(q|K#8R#;H7l6sF= z7iDI1l={+;uAR7 zBnzSR8xVa5{1Ml`Gn|a5WkorhR&w8UO0|?DfN4w7RYyM1+oZBdR#GkjJJ{|%Izd&r z+p$FbNi@Ow1NCrSt`~qhzcbi}(?^g8Q7KO0iCMT_M>bR^IAt9`Z+0FTbYn zmmb2C?rGBG#a$uJZ#5*@E&-KEJ_LA=I80UV%owLzPe_!9yTK%7banC|ZR-y55O=FI zmg-}e4T&8(m{V4BkehCg&PV~=#C??u5%Gl4+ZJ@kJ(WLLd&0u~Y&HkR-Z0{HA)csL z0|MbU9ZYq|5)*ZLnU@KDw{l$A8(k_s1bvg|333#THC6tWDND&h(0bm*C-?jyyADQ@ z>MhB;%1g?ZUxJcWlN`G8`hc;bR+Q>XPL!+-mV z(=ATm`Q=DWk)4TU6`PPR+<30(^i{-3j~81@aj9XxM1$<3jd+D2D?25O9?rQ}64bbH z4QI*|s=2Lu;OSy@(|D6CiT?lz9b@iF7qLYAzyWWOZLE+F&d`laQi?b;wTB&1EGjQDbGnaPB

!P$`raK;q4YM+zey4i1#L3#tF^aVOk#1Z#1tL``%&C=&2HbHVeONn$s8|h2h%PC#uc!4T zV_I&x_1}67j73?a&dZ{HT?)jtX4DY2$aC0IJ=BzYmbco{$9uvh9(DKf`=Q9R;*2k-sR{}OBQdxICny_78gZw}#jnS0?_8pvmvfwW zX+x_^F)+qi963nMk!`I?dT6NX4V9fJSr!R5@en+%+kDuS9Tb;7-4YX(OgCPpOB#rs zTMa4jx)mMPkui1LWz3_fK^OP^+uwL`N-nQ&sGTm|Z?^p_Zsv|8r&cL-M;BP7OIGm> zW?PqJx*HM=*rXt)*%T~qp5a&0@avLxuB(0bcko1L%7 zlrFT~&ogZRN_mO$xCDq{;Cs`$`F>-|Bwsa6^jFX1I8;8-5-bN~U1gMq)~iS#{f9p?P&<6n^4PB7X28~8RR>DX>gs?@`@ z_tNad!BbOnt13xJ2E-)>z#HsSYj~LAil3i%%l00gX+fnl(p$z0d-6V>gZm1XENH$(kY{(@yBpZ?<$A*HHMRn!zBW3(8+tk|pU6Li%B$^n)mnTw{Xg{4O zajP$uv6uoBg`U5vMU}CI=Zlg~uDt2r#H8VC6y+A{?x002#;=xmdWJ8YL z;SQi{F6ij$JBl$_((B2+_N3pRXXdsp*OxT5>eBLm-d<00dSMSc&CKRigxTe-0YxbP z00jGEM^HwA_WQ$lOMLwsuAQ3dywSy5eHHcYpGV})X=-}@t0`I>Z6wQttSxM}_LSQ8 zm}vEBedLWJiPbMHy3+2y#Jstkl{@77?N<9g@V_)N&+rQi8kwyzDqEbJCf>_3^tg4w zyUY}KC6&+F@lCa}>iO4`U03-?hP|vM>dhgU znd$L}sf{U2wKC&Km7SDP*O2;B0+()!P|Bm!7}{`LTym|pb?5r>GrUI&EI-7y`|7!o z)3bGESvbO&mX>eMAf-Tpl2UZ=KB6V(pW${y#|wKG^d^ZWGHylkjTkB_E~8lN7)c6h zN9bEWsv_$TBvWQvu|(6kVsu>*XocOjD@mtFOOu$XN&z7$QjeaA1jPJOuxgc+n6bC)Uy0r!Fl6lG?UvR4d=MZxHQOla! z&DZEzWA;qfIVk)U{YOY~f~fMH_Ii3Gn$#DGO4JlK3qn(x$D*}QoI;--(%MOPR7{Vu z;Huk`^k10SaSmE@5i*9WwD~+oPb$tzmStX+N!*N?xv3pW2sYe9n0=t3z3*4|LUM31 z$+G-ERrTaUjv{ti!jm&CE}K#~a$;w^#FX1>nUs6Omp7Wpzui&Ho}w=JUugJ?b-!=s zmgO%Iz&u>HOPl^rkjL>Svz{{Htg@!(X}rl43yHZ`TYa*hy<{k?4!VsZ(mCTTip?Vf zL&qsu%bVfX@`)NmSh;T#p~0bq=?fhE4UG8>xh7Vmu=p8*Rcn!ZU&nKy(h}l!&B}!- zy#hv_G2J3;O1my)9UQe~R-l3cfl1sDZX>jE#2o(s4%Z~=W~ooER%n~$LW%;9icRf* zC?yR_fl7sZmuZe5V3hkSl@-h|JEgapX?l1PP*39!a&WPh)kK(QXq3Dl?X5o`3l&)u zJ1l?|++JLO>2YL}YxL9)3q@v6XC=$g{^ZEb}uZk`g{*Bg2AG-cFZpqmtsA*>3xsOeff$zr?fc__lp*g`CP^0Xlesw5WapC3xC4 zf~DP&U*hKMnD`R`VNMOOnOa~%T_-3a>r$2GNmjnG11#M4Y<4TK7^jTpN?g4rrk&-e zp~-dKm8--hMJB{}TF1s1A5r_}G}QU3=MYJ9Moh|}`?E7DO3DGs@ZSH|@_$W-3y~R?tAy1SI7jBNH*=zlU!Coj_v0GB!;87S=+Hb4vdG zRql2jl3c>luoRYtMyxa$oK{qU*Gry}u;C)HMxMnN5p!h3;lE=xh)l*LbUaO!?2X+G zpzmcZD!TqQ9#JM)*Fq}BO`1g-Qw=bgX-1ICC>BamEC7fTm6Br-GgZd&@@wTccU&8U z^oq=xQsi0V;algi8*#T2CTbITY3?^Lw#}C;6d8PYkR3=1^aoy%1=@zT*_jts8I(C*8-l*FY1Gm+S0V$kYf`M9?UI_vN)aqybgB>rR5!JIFGa73!5aM@uJ?z&V* zv^cx0?`~lvdJ71LE+$iZoqR5ygW|dxSAJUc=s(+ddO2AdSP{pWr%Xy7@(CUzU&^IW@!Vwr8F1k zle_t888X~(v23WCEOjB&k>-=32grkBA@u3|#+tGK_JQFGyeX?1{S^x=JO2P7a>xeD zPgNl)0B0MEopp=;ABfkp=2d3Hr*tK8W+juvbS1j$iCm(P2`b7)LJjx5ln$2Ybc;J6 z707s`Fq>$X=D7ML=2Ps+%t#F^D>z6ex^6|luqG7FBEz@?!uINkTfil3N=TvGC3(W8 z-a?iR)=JO`&IOI~gL^|0bU6`qz?pN1aNR;eqjf2Bs!ElzhcNe6o9udn;}NntW6-3wa_yjzSNtIt*6nOeCr5+YHg z^g`VOHkUe_skzYHfoS4EVpeLG{p>M=H3?*Z%3ERJfz%X*x;kn?kC8jV`G+GCYcJwV z0gGo|Do}R0FqYJzY|W&k4_g8O@X$wBG!KxSugJ2xMhIc#A=cC$OO3bzLW0(jWe*5` zFPMfj*z1M!JUW@?%e3NHVdR;KRouHQprCW3L7GutVa|s`W4hGrMdpJmW#yhO3@}R8R z*&yyV5ybSpg|%p_jDN$5h8?6cIPw%)SP6V(P*k(&Hd9ZekE>DL7x#gSILgS9LYLS@ zM+MW{=(?QQC-z!QC`o4A7UGpZh}7mJ=7=pzyDqe)!ZXUuvNEAt{(*YgTY{nvhADWQ zdSAqwj#h8>j+90mnN3yT05rMQ4%(?XOLjd^dr!h4#dIEQZn5O-)72*B4|SxsBI?eg zG7AAe5zHe00J1uWR+E++i&%o9tRnpDk2YIO^t1C#6@6oJB%!9lQ+*A8t_j8BvF(Ast>JVg@Rb zxN2Terp&wY1@$K=Huh5HbOh{FR7fE8@G;1oVrK0Ak<>~YdBI08#D*oC zn?kv6S4~lr%MSTr4R;DO+^J_c8)Z=j7}az+LUxD7N#r)=K7GdC=hE7ql9p4sU=`2q+IL?xwWh> z3}lUtMUh9e)+=@9-(}QtstBEyp1MKhtqq_d#Wt<nDkJasn=I0DD1U8f+b{WGD=GFcU(gg33hE@jStqSBRA@s>kT$K zi4Vj2dZp%N=EF%uik_FAWl2r0gs|{%SZQ#f@y)4(Y86Cm>@!hvi(U-A3JlYA22vIF zkg|!U0KY;~vNs1?bui@jLQy2RzrqPA#+`Y|Q#D9^MN=#x0aFrAAL->Z?xOwYQ|h2E zc zeu{LdK1u<*LLTf=bTK?arpw~G{KJ;WRVb%PMua$pfte?vz4e9Zu^NdZ!oJrv?i{X0 zn^H)9v^Wsl@yu4HcICWEfIfXK5c6>Ti5T;DCIvHxk~mhd<~PDkr7b*^rm;yvMba|` z^Q9X=7P`C2Nj6o<8tD}eBWk-7;~F8SZ){4{PZrT9B-Ry{R$b=QlerTM@ai@raCC*k zbS7IePw?xAvY5`bF)Y(6W@V|lSKJmET;`w>;w(+Y!MWe5h|^TQBhg}ej66(xhTK9a z4Wa2-x_e&G!-DBpM_XJB!|a}s$m7=^nb#^~yM{Q@nGmU|4s}ADKTRq~a(Z9>NdSB8 z4yirhH5Y|Lhoh36kyEyIEt1ER@{^SJ1G4T(tsz#~Kx&dYC><0!9U^`hQ65iYmxU&| zn0l0p>Z%YQDYXdX*5iv}&Rq49!sGrX2)}hZzK^ZJjTE=qS_xNxX6o zan~C|9ZP&p(pQ}s(3&kiab0ZN6KieVKVjWYzyos=(mAMuc$y1?{ zl_aQ2@)`pux?NJ16R*CII*91!@A{2Ax>0Ku-9t&{6cTN%lHy1Ng@Q~ep{B^gi*Z762&K=5 z3(7@yO)7Cj6{x0BOcJs_+2st~Z}Nv!cNm<9JF`t;l`#D{f|;banXIP3DW$rkW=PzC zQQqmOiws46LcgmED#Ui_^qBtu+K^(=6td8_8?Fb- z6=BRu-&IXghvOCLej-EU{zAq{c!Hw)^8Wx;F57Mtp>|c&FSsZD?|6Th%M~nO`Fcu& zm09++*S_$-z!+UuF&xeM{{S5@jslia8zO1YGzcguC&5QBBtYh(DMhjl;;eayJ3`GS zN}kG^l+9!^%2t;5-zrJWuQL$mlKhbTG4?GVvY%vWUJ^2jl~D1^idCSe`ShRJE*@>dH30wc!Ek60&@Xtfs~k=4l%~7 zp&ED-7;63-t8gZDrYbIbRU%oR*-KIzimingU|u^)PfIThPLRaPR;4mjLPE*tZf|~? z2%_ULYggE|;j&Yr#^%~nM4>{;PU17oQE;7!8Pr&q4w2uqvUA|d&^rbiBiEXkm5Z3v z`4G2(RS#jo6Pc7QYn1YleS4%_f$C@dCmQ6 z1y|Ev@;y~4xe|L3>wvhS-UZi%25n0E7ObvhlZrjoU%iWDn+R>F(S#!XV?)gIF8aXKvlY^95J`>OlMx!d+lZ-M% z%D@3`rLseJQMJ^rfcWVgk~)Z|RK#;QxKy!iL>&1!QcWBEUUO#JKsU0D?yRSHMN!+b zLGUYr61+cklwXX;ELEwen+ z2`!{r&NpyXU;xxxT}}6hQ+7#;p-k<0)GFFq8&MZyE5z;vN%1;mnw+!dpHpb}pJ;>^ z2STC&B}1W$4j(3+h}k1z1=n%EXX$6>+?;BwM_~m|A?2-VLOeh=7t~u(8V(yGm)_-W zNH~#GjeJsLj7&*Y+2!*k*Og79a1V&NK3=hQnrSuMfW>cS8vArSK_co_Ia95>DEPk1 zCp$$$p}vCu00@J}LsT!ZCx>*&O^NZ%Yk^8q<{NUWL@PFU=3Lyh&Z%`;0)es=dRQ3F zR-(_4$#$1rGl_C^>}N+%akd?9UZ9OLrL`-#rxKg#x^AOwggp(0<+WZRLIxh(>`p$Q-nY?rYK)F$?Za>G``kaSG;TXhYmoRF6aQdX4e0*LPceQkZO z6m3yw79n`pLpVBlL~0hv9-(5;Adyd;Ql_8phVw&T=Sf)k0}@E3)L?o;cy3j>R_|g1 zs=nn*7e9{#&8rG3dsKU?OnxqEFHxz5>Sk*dq3O0nJ>6mlxADYd5E6@T1eEa`y**%N)z56DMA z2}+osLYmhyT+4qDc0alui?C>?j@gU$%wsl<@|My02-9%i!it_DZb&DZB3Xo6WFUW% zBSMO1GkvIK`E;sT>-C@KM0}#)E4w%@_;E!40ETn&f)8PAiFgc!ViSM7@9&0JF-wtR zwdVO!lF2<9ZWS&^Bh2J>P|~i#1EsEXyXN5AydG7rwBJ4athmb(xe}6s6sxa4nL!~o*81AQEwJ)L42B*p1h>TL zLY)D051ec8e+u{+yxiHn*}g}gH&$gsxSE2qc?&C8k#&C(JzWxSu=Jx;>NM^|q$pJ8 zfK`R*}^!(5YPcUrwEyB4T6$vd;qvU9U<;2Hyaa$ z(?)SnF_w)Xd@PVw3KwRiZz$5v8#D9yw0xEe(zyQH}w! z(!(jbhy%o%ZxS)a#7WT-c;SeT1FLP~RvRuiRA5QWFpbwV*0PS}7P%mnmaSEnC;}{@ zhgzaLl@gkjP*q-4m)t>ZZZ?%E2Xv@`bo>sHU6MLU5q2FXSc*7utBK`hS4BeNfUX*q zHBx+9k(ego`f`BsDenH^77$;D=0}$^vD(uW%sp3>kV+J`B-u;KM(I`W=3mmpK*xsjxT;h zqmr&G7`rg37DE*YR@-^$Wd4En7qg84u3$j~=r5s+pBKVBCEgs$V#f*MrYoJmd2gfM zX?6?pAaw_!ilS>mW3;P0{4%v4u{9{alcFVId!jthtgg4urOkK`XK;U2NH_c<#w1c0 za2@V{7OU#;W#99nQsgu>{gkSTXNZ%k2fC%W6g)%k&^m0TJx8Sec*kE}MD-7k!G+=jtcvw&3N~KwZt%*5@0pu%7JVn+5MxE7Mc#l|J2~0n2jwVlV^-|LE zPN}raG7{)XAn9^8A~_LFk*k0ha-mDB$yKJ>aj9yDGFT}*4enY7x%Rq zb+lXFuahe(hgY&62p1w>#~6&+4F#4%o0TMxRo)xiTSLB)LG2vWn(NfJ;PKnCLCNt6 zIIV5grWMSUm{1HLYn3HMHUi{k>OhY@&u#8&F>JOaW*edN6dYLYje&@fW3nSBZpZH8O!`Qo%X8+}Hzs^y%Rj6hN_}qtR!$(}b$Cg(SNu%Pt{W+^Lh_Dc@Tg zpPV+;p-B&p4xg3d1{$ZPq}pC_2`wo~0I4R~a{_Kb^YIbI5q3?E$Mxxowj4yH+SKFH zF1sz6M3odavJ-N3xE3D>$?^C!&ij}AHd~12c7UHvCk@W6M%Qeo=cFTphvP!COYpLa z_|H^(2g)$q(n$?Ek#ViitwNJ~dU}Z5%5;p=MT_ufi?UdzpC;t1sClB$L#YY{#?&+g zNd(wqUenTY>!3L1L@zRuk#vPx{ukO68BkFPyC!ggoy0oy6I2SS^cLL_t>58O>!Xi zA(E=#$1+qUW+j|S(Mm#*uZmP{5*BqW)3Lt>xsQ(wJ6uiCK$5A0IVXwXYOIeZWeZ;8#C7u!rn`vbCo!H0k>XT|rs8R2JP~lr+i3;F_+3i` zkAy#uJH+iahO%K(TaogY*p8h(eVSgX{{VCzQ)TNE_yml$(|ZV+?~YHQ6Wvr-Q2~fJ zH;?EJF-Dzr$?9Vd2O4}A6!HN3B}8rIv^w(R{wk+jx(%#zy1QNamK{>SNyl`C7;bgR zTCAc+v&@C%b8GV4HoDQ`lNGR%z3G#rnHj72lN(?O#vZIn35jWC9%HhoaEDt~gsdGi z0jN7(7V$z`CewYyDamuDyobh{FxDedUy*neI*{WeD%pYX^BX91A|OgGI}>9o-0!(F zGd`rUwOM;y+!N~wLWSiI1^X(4jw*M@kHqq9sV5+O?%8JC8wL?6O`OSwrU%lOf6iYI1}e z+fP_krZb_Vf~qM&+Q;yYX%c5lrzc;S=^SX`!G4;|#$>oMgVbpZxTY;Lnz|$GfP}l9 z18biBy zn@rw^V+gL|uEW(DnMzc)$1o3hCgj`oNc^LXFiZxf48js`kl1Bj$v>*I;|+@r!>F85 zWyBDrY2HoHeN1xBfa9M-vQnnhw$t}}_8wkPo5SfoE%YM^m5_Gqk4MP%0oO>W4;({@3n>92520l=T-Q;gw7wBxfz$ zuP=&v6XFe_JdUl-lX!>ebmo;^lt+D)_gwy}e0+RkmwbY#=S$XBgKlDwZ)~g3U%;os z(i5od3JE05GVd|OrEREKmhMHo$K?uE2SIMGStLrRTx-i%+#SWgC_V=Sywsa39LDpp zf6^g3vQO;v{2>irm*gtIkW9rK1t%=bvFO>l)94RRE|8d}yw1JFfT%G%n+FcM6f1Fm z6qs=_CoZ9edV)fH5__lBC-*{JPU<^!IRr~M8h2EzcU9njj4milnaag9CDNu7G|q(R z;2SMH2^~~A7)+r~!ZNgR)mNL9P*4eRqIDJ_L-$7$VyNuQPnU0zCf2|4fZ@%Tc`P^< z>J*fpw{OhsL~_oZmS4=_2~biLJwPzK5^PhY$WpZ#4uvOg_+zLIwaJN8_rNIo*1nz# z@g8uhqm}`}a+7KABG>AjK2hBk8jf1a$cAn>LaPGD{b*#7A4SXq`vQQ0RAu0h{6w;o6M$5Nw=-S#xJ z?=>I=TE@e8>BAhtU2K&!tAnkMpg_REBR=AsD0Mkc*&{%Fy=hlUkI4+a!sDAiVW^u;O!z)<6 zQ}Bmk-$4x-(>85&r{XsF!qoemqidR#4fOGa>PINom`ceCLaawlht>-?Y&7bQ;yRcH zepwS~%Hl$jcM2CDjCHH#bvh9hjvPrFm<0J2o{1I+AS_97h)5+-sM9Ma~`@Qcmr@Rrj(tB{*+}X6o+ZIkKnarOFwm(iBpu ziH88PR`W{LNhiDr-*~R^+KWr8-TweW!SMGbeCy@?dkVU(FB)*Q$q%FE)iYG6zUEqc zxu0TDrD`vGIE0`Z6MG9-M0n_XJ*jhC@8&L6)2-F6e7yM!_fuJFW@?QnnRQJ%j%7ly z(uggKU2O9YxU1YCT!5QjSc#=2%$%g1Hl1`|tqEK)i72?9Lz0#zsrYhH!kMM5u#+_U zed6<}x*S4|%Int9NlGnsw7G8o0F(TVt__q0czd$BY8jDjJh=0nkK;jj42PuaE7x z%x6jTu1V~+^>y4)%S<;ym!6!HteHlE3a80b31(sB5iEx9o*2CV_HBuKuyrafoCrgsBc1^m1L?Pl*y6Nlm>K-cUzB_Dn zUhO38gRawSQcO79qk%7{C6a{$rhf59rR{SKz86ybkSQp;O{d<+Hj~GiJjB}O^S;~8 zG!oiWL6!h)Qk1J-U3?*r0mpv7Me-EY#YbwpzOUvg8^x_wB#|p4IZdck6jTbTB`QKt zv))NUd*oQ<7U{e@iY^Q6|m zYMp;ymw5SeER@q%v%cKEeWm7MO%pLGQk0e6w0EWNLEKB2@4NT%( zqNS>GZmmFDn%GLFQVz?Pbc4@ebxFE_=@uL|d0}?1^M5b#N9u^#aVe^`^VxjY_hs}e zJ?_mlt`cJkRL3aIQ%uk;&ajm&pp{%CEm=n`L#kDvJ4UPC?kl-wvJ@97Uk4apsRB{(V)3^+QY^3pDF@_U zGdxmeuD9i#r_MJb##JTv+ytb3(P7s8VlNSyW8Js%EjUbC(@9(GSEm@$#MDSl&Cb6l z{XK;g^4od9^R1}cnA1x4l5P#h$}3~U4LBPJQgYF{Mp`jZp09}s`OeGL>E z%MVlP@{J`;hfrF1P5p;ap6XIg#DQb9RPiuLwXHB?Ap^Y_bm3)7%=5@Ku$R34cSt&@=j-&z8 zs*7Zg6hjw(lKcHvpt`@mzptsQF*@_WmJ?tGRD|ntbR=cmezSI3dZfc`{{Slc-{QCO z6q4)r_vf*mMo-v=a7us{Hz7q!@jC^mbR#34Mmv3bet)a`p5m0%DS=BBjYwzp9SR?>lP9AzL{;Z^R@L~svtjRrn=wB{U7Ma zNr^i!;e1fz!i_Ui!*h(Q>shU!dkDVVxrUOU5Pr&(Y(WvFhqMx_Y2TmU)fAH8rMsu{ z{(rc}<9^FH+X6Nw+LaYqO~lP5N}Fhn^LGWn>$F%$h>ZNcBo_w0_xg#hA90zAEXN|O zhZfMfR*jxP9!ok9cLpCwX^uMaRWlJx16fkwNMLCay|d&LWm^}G1;Cnxav33c##tB#kNaLZEVmTsn`QI*wee)`mt zuk7{f3ywDX3h`3z#}cF{ye(rnKy~D&SLO;-qi(8NtYO&TzDPu~cVts%waqeiw$!up z$tWr*DQJ#LZ=lR`f3hWeqvl3@Lgb4K!qSngZc)=6#B$YI00WyKd}kc>d3wsace6H!ADv3q%QX5FBn#{QGmZ`>|`ob3<||(}LJE z*C>@_IXc9Nn3zJ?c~dEANK=VMSqdRZA!K*7J71`dolI%4 zSNu&|uONWpT$*Xng=&$^K_r3WrLPiSBul$U|Iwed%K9k|$~5M_+E&^>Z8u-a!2F{o zTaJsS?Zwk@ z4!`h3#K^$#D~fd<94=1?Jkn76wWjkpEpo!aQo$A@Q(z751;E-Hnz3;g95cl((eX_} zgyvMXYE9TE0C@v3Ngj&a-u5um;cCYtE$HlG`s>)rPzAN#Rdv<~PrO=`Qr$<)06sU4 zC{V3dGp^0c)vA+CF{>5XCZ9+*`nTIy&JUfCpmrC9P*^-yo=zxX6**&&B9h~lBUKc; z?8JFm;Q9}Y2~ak3xR&F%LSADIN}E#?Kup_+I+ab#xzAgdI^Vl%UchvPAZ$-!7RZ&t zqoR3s{<7QtFtdcPtZ?m)C)Y7NtkTwk+N8am#NRV3RIo~j)LbZNq@53}F{?^nG1{^| zc89}53*u@*lC0`o9oF3zuv(awd9*97i5d|OLD|M87{y=7z86+LhF>aAnN69ONYpl` zY#v8?jhYPXXw`q9?CRs{OB12gxB%C&GqbvXgtB{m7p=`)l?*(al zL(%*%$V=R3@n;X@u(b|ORz*cptEtT`v@8&|bFwbN?rv1tl2dc<3m&m5JCWtF9wevd zusubos(s70SW+}0XaJR=K;J@}`SlvYGD7w{8BsMcRx^K%_y$$PH)j)6Zds63bC8SJ zoh|^-6R87TVz&3%SYd&Z0$KdP4BZ6N%CF&|FDmNV_X#y_HC31(bM z=2aqx5RvwqlW_`APoh(Qk60?GP{#J^sl8p4!^?5RzO*7`gu0LbaSf>fvtg&YK=ZZY zL{$iEcDo-=dnCtds046{;!5Dt6 zBVyMwbq+0Ru`Ml3l&-?Y`LbH~u-+A-#Mp`8t}B}2OUtJ?;4+G0s9Q-1&6;Jf(6WdG z+<-tP-E@S?G<7>9<}2bIN>>$9gyIRKAyj7AUQh#0sido!a4xLsQrl42SVVM_LxVBe z-S1=KoXdn9jWFHF1lX=#!|{ojxqQS(=XL~`Kgz3LdTZz8;Dm7;j^pM^d>@1cDB^A< zn_7rWw5zP9-4!;3wxj1{>Mz&AAmo)rd6Hna7Cd6%#GVSx)1Va%gLqpa=k}>I5ChLcG3l%iL8F`yQp9 z5Y%PnSWvwhp(ckC2lQOUljE~wk-mn|xb7xf6U&G=seC`ARjRVhhu0-6x7u#@3pW{c z*Fp{bA(b0+b-jqE+7k@6?hc)<(n5ZYsmV1o^syI89dIRK_R6(Nh00Wr06z7BiTGyj zn8epnitM9P_I?}H6g5+oP>+~yEn@c~j3zExDD~ClJ;!98$?BzpZ-IxGKakTE@1-?4 zTOWHUBh(FH#x$8={f?@PV}~c{vjCGW8F96xMI}E}k#I%2{5+#M#$(ejiFL!|w0n%4 z4yNO(>wMn*YL=AGG!h8**<8mvWgvth#F2j$?gp_9O~rgk4JjQy$(%R>t5ukp%BRG% zuPN030E1fGP}2GvcSt&mLT4*m3QCxS?P0_BDp<*hhW8ZJ z8;Nk^7{X2ZWZH8vG=(;y;hSU7+#3<;78oa`rbEjeN{B_n3`XTN2`Squa-8Dio+Jyc zv?!%F($*>U^^Kkvtr^^lOB&uk@RnV$E{75!x$+?Q084Y2B7d7}BC#Rfwxcl@`Pf9)%#K^15b&q>!NSv0O#cALLQt2b zmG@>DvfDj3BHHO=4`ZH|N1SYgRkl;b>I=-EWSMcZJ164Y;{)s3>8Z+h(@g|kz?mTjL4VaO}E>lBS`h zOda#gC|RT%>T)Bzbs&;2tRjW8fraQO#}%1rNpX5b4Oy0}==A9q2^X74rfS{ zjawy!Mqz3<0_G{?SR;?gnx8gp1pGh))Wc74#535}i1d6CytN90EjTnSq$y;4QV59{ z@i}rrT!fVij@WLv=P4C5q@A-ius(K)D+^r)^&x@nZQ3G}FHd6($vy1}n3!dAt|H(T zQlN4sT7x&eB_=`oZ7T@{bnF}sH zsEODxA4+~Y$#hq$99 z#0tF%zLxTCaC$g+zNTyT;0%q2R6 z?h9w&4dF36CREi~u{_#r+UEj1bO2k!z{I4f5t(aMm!3@XK?^N}tqxoOLXbfU zY=gD@cNU0%EuVNLNpOt@vA`(jw2mK`;N~`%nP?tU&U-@#qS|*=4!&tO*GSNCxoVo| zR%eFhx-n$Ed13aCo?fHMFBU~UL=7}r2W9$;Z{g>pnm2M%Y0Hn)cn2F-#2b2u&wEBS zEAERf9qd1ivU1p_#xrcOGL{NeeWQm$xSaZ!0K%4Y-4?h|BHpk8f$0|Tbhw$DT3KPU za{fmtAly zZOmWdVU^5RLdLPfyo8|xqEbE-POzK;i7I|w^#XdO_0NOJ$FA=MaxMBRQMNR3YhNc^uF3C(MT&V#%5DmH;g?M?x zu$GY$RzQmGFp!$7u2BmT%6TYp$;6<6Gcdx3B$m(U!61W@z^L5m7g$kUm782?WU<65 zTgP`FZvOx=8vGx^jOKN_6uq6?4OOuNeiMo#=3+;Gh{F8`v#~9GnTcARIGaA)^UoxB zp+qG4Xl>`LWj(DO?7ZL}#N^6jG+fw);>8>3oHtQw_EH)TpxX9Z3Jwc=t?`RK3R+}D z;uWF+aALaM6Ns|&3;i8pNlmt|y6P;fzIU-2+jzd>BXKLSI%MYU4NLl42~|)&!wX-? z7@(5evx^lx1;6rEm3_pkf9Aw|gYh5PF8VJFQ0XA2l9|uNivDbs4vG+{oGb4Vz7@p^GkVjtn%ewBzoQlzHk zeU@Yni)mK}slAjAgX0>HXGo^v(GjOOp7uI*QuNs%v;c09uJHtPxEjU!cgU%G69<9Z zO=*v!s_D^kBumWSb;`U$ZUqZyT3$u$Nf(N~H-_<3^q+>D987OnOhEAbLcbd%0D3_mb1ptL+{%o=oFLbKuHX9Lhq*-B3Dwzu- zy~l$BN(n0T#JIW7vXNhGnVQ_9q!oQ#0+Pr1;p} zd`0ckXt5#^eyLVd+%uX3-bE+#IZW%?heEtS3 zv24hhISmH}IFjBT#uJk58!&&_x%taXG6kcvvfz2+j8IsW@V<5e_2N3_z11bmqYX?wHaH)j6p9?yGVylkFs)@Wj=u~#Ut`B3Bq@efaUP(~> zMCyMiYl6d4v3c@ZqO<#4$fepOx=6az_Ei4>51d~E- ze+WiCCRq6~*NI50F3`W+`fa{tPYbIe({(CT>J7E-txM7`IDcvC+Fqm#oGo%2&O31a zr&7XHX{P0unpw38fRHQa0B2=m0!B3=&S9Oe{oa$Hgf(MclU`4B;i zoOv8d%#gBHVNO4_EaF4x<)wR+l2U#a)6;02vZu_5@iaMA95F`XT6ygyCEl(g=|2?c zA#N%{RGdil#6AK{Q&3-*9Oi!2g_NI#?tT!&v34XwFLFQA+n&Mi2c;IK+)3Pi@L`EV zQm4q18R^{;ivjk`s^MgYXHH}bYhiDYOi=M2#mAF%x8KCI#qAkKp5))aeWob*-3e2G zA!puFNk1E91~PnKvNB3lXkO{cq2q0gDl7)Na|_H<70r_wU(({*F5iGX3^=56fu`|c zr4>olWz@^zCg?XglhsKeTj9JrqqgX8=yz$=8ENvFRk@j^U2=0k5Tq!7MxnX4iQYJO z%zW_9FncIsqCT-5-f+|?bR{5l@s4U6aO^FrSbe(7CDv@E0da1>!aC5D=;2TvnrMc| z&dRh>6a~kK@zN7?Eu_X7bOd3VoW&jFls2aoGbG@?fz4K%54wC$TY&~eW07K!GBXC* zm7Pg9&8D#39kJe_Pl@)${o$gAff33&Lk`gmp`1k6aA;AaOM=;n>^GG+5QeVN)LPe$ zp+P9v-Eu>bFq;puulNKGCoEn{)EJ)C3Irc0ZiO2yggCO_RSi7hGy;CJhUF%bQu`rS z>){GhXiI`)J5a&17Ms);0S>2`)h6JNnnXxhtN4`=<-`8~hjK^B&&yRn zQ!57XB~Hjv$3|(2UT9j7%%E^4DJw|ZF!?~ns*WSF89EVYPLq~oWsX?96c%rV1q(+` z8q;a!cUGIEjSrZFNm!(ECS+Ff`SQ*do&W-ON`UB6bolQKxL)g+;+1nalX$P_OR9C8 zs8)_GI;4*@fpO{~hWnw^ZAr~0V_8+DV2h&qTzG2;6m^@#X<>O?Y@v2J(0Y!f8(8{5 zXG6I~l$rr()w8Njw@LCl{0tRgXFdEjwIN9c=uok~w;!Au0?n}|w^`&mGoXM82T^T| z6mY?YoS3D!rk1SXBzM15?QtAOSZrB_B&&`z`oU@D)!kZ2(EKzY_!#4f)ab@=vy%?z zO48sXD~KZ39S^9EX$vu{4lbDJQ%h4?`@4cZf9;NGpt}^WNGhU`mko*cRn&jKoGPr~ zo0oQGnEH`0o00a#tm02w4Udc`lNHS0oR?`?Uq-3FdfE|x&I;-lVyR&E>XvYK$r>Ax zf5tfDV42UBOVmE=YEVjj0d1)nIROh;PvcBp4#vM#U99iar zsR=vuF#Qc76FW|JS$x(2QvTXB0b}7Ww}G zxP_!8vqo-Z$`hQ_0=8B9M0H8=AMAxKgP5q2s5L&3$yfDGhw+CKzCt+~Ghx|vToQ}# zrevSt9QpySijOG$U>52}``$ZeMF?pV>B_Jak~D?$5OWhIx?09dsjj1{e~cAJd7Z|T zT-e+~gqak{R-o9&Xyt-c`sVmQ@`Oy((+fdJ!EvVH^RS8A64DvW=_({Nj@w7H7Mrxfjx(hZ|e!t7~tOy@S?_T$I+UFEdxfvn}$arK}l5 znisBHjG)^0BJXu`y95 z6p{~kTx)GaL({g--SXs5PfJbg+W7qrME*3FtR_OGRFigEfP<2mB$1n)FaV7}a=(x= z7cva#1n8W=r%RIya61jHC-|LPeT59<#H{@1wM-VLu?yg^#IZRWk!?c6DCm`C2XkVh zv^S}>zbpA!)e3aBOLqCTao@tTG7c_B<(MXtV_ zf=#ul?7A*&<)WKEUYB-SQP%$elCnUky83y3(BcNE?%BeXD_ft$M^#tP&{KM3oBk%b zE#K^Q={Tv{t8#U!?J-Qtb2${+dR7;aLqO;V0IVx}sCPsnYM$G#K!SAAbuMl5{(`ol zTBp&fi*X?@;BfpOjL)owxdllf$u0L7`!} zm8Pbpm#3;pQ7D%S)kBuDTUKs~NziMgIHkR{biN9{M;zN)p39=EZJKiQ$=do~rZqN| zVVOV`H8!@w3(g>Sn-;Rl6rplQptyv^D(BZ@vUMcd{7rJZG-q*es>?H5u1GFkfg-Sp zNmM8)D{yFs2uKboBeo5=+(IyGKU zuKC);Ay)8?EQ!5OQI{mSb84OZM9NET`S;qs3!dYHOq;D>2`WSKQ%IkgsjHUEyAA;27rm95 z>HVvOfz}y#)bFR%bH%Niy61Zf8kcD5$;U900 zn)CDX9E~8!*ji`#UuREz+E*ZPckNNA zB(45*`uFlW7^fXOMM?HLJlxXdP*%?=Xh^lTN{Kojx^6t6jwLGTT)e$H9jd!&-!~lK z%Xe0AXmXgl8`m~x2R7kSxfNBt{dfF%BLlQ@4g!ferP@VFUekSp8kC9Qt ze-O2Kd11yfkl9vhiCp_3i3QKT4qVx?w%1(5tGYj-f(1`YQYTYs~N8-`$;4Cc_}E`3q<|^-6m9 z=1-B#JS_z;MfdSus71e5_xG{HRN1frH*K`sI1R0Rt~DtK?+nfOfgD?Wm*0B&p>_59 z`{ctWQEb~YhhnURSX}i<7Z&lhWFDyyEx$jy{%gn{{{Vk~xH9MHY^5r*Xh~9&xYu$9 zq$k8DGCWctadg*~{{Vl=*N}-VUq8RTOlzcgYec71S5&4-DpqmSl{);q!>p$TxlL4(eE~!qy?B)3IE+P17*y zg*J7w_FGcf?znmf1(I#8qW=I7wBuL0mv6u3P~`S=ZkEfZU(AgauE#WtUoi7HaZ~gf zvnVV2E_J0$%dg23*|J#lB&*Udaq+iTy_FN-+WCF*IB4KCCxl5$xbCo}xP2noiI*IByuwIP7AaUa7O(?QHibM$Z&_izm$)lL;bk?NtlCSJDWnChXEpWK zz+8X^-7giHRgS3+R}_0hNZ_W4anwr-X@2^TqChbdz_H&FhbM;oK$ORlY|hF$mz!7@ zT6}uk5C}d-I#lgVO16IFrzvz>kHZ6&4Z5m-QNnJR6L-Yc#0|0WUj3DDKL- zu$4BWxNU39u#>n7Dg$V7J-o+MlXfQN_(J^hmpO%_gNv8584gUa~Eq&r`p~|bPUlL+OF=`^^%KEZLNvBa3P{dcuAs?|+ z@Rz8*pVkpMK!)UEVsxq$q9L=W-02Xl2Q28z&xIQZG#yOQ;$>V>WF;n)oZ%0)l024j z-{E`2sKiZ>=LO=n<@ke9OD(BNLnr~X>Qquq?SIM^ogL;zzT54dDq>dHq$O_5ttf1= zP_!#Lg@Sv)3;EvOaJfxJHs2x0LA{aC>~q=Q7Vy^)Dr%`JxptXB3rdudKvj+Vsyb;D zd|wwCM@n|f9v_F2cFTQktm;p_r=(Dpx)H^k!jy{QRGFzZSD)S?IZ5-lv4tq=J9IG^ z>$8;_qJzkGW?31tWkaqJe-U+l8%2&Sh%OdF)!jr?IqaR~XUhtbvf#U&|Fc3xdttti_#-CM))dlF;F|I(XJ(T*sc zqOVYiC!bq~ridV4*ED4!%W=i0)d8qCHt7Idpm`-m+WrtHxx)@3tGQd6l?^B*mL@LY zDzGWFf=7ubTSBhH)d_AaaMc*Xh_+l%RLFTwrDswUrCcOwdl6tnNyC-ncjiaQk6IyJ zFWRsS!*W#tl3Hl1lbZKoz;ta&HW?H>+iY}=E*Yt-MK(z3W_*8#TAFd0;xf)j9PPM0 z>v$8so2SAgrDH9T&y0ALiTXP;s#?`j%Qlrh74_MIl3Ok=`LdLi1YdoI(b_p;_l0lN zY0|99q0eYdJ%*|etgT9Q-)cfLx*QLLD9Wqi8eJ}ZDO8lCnpB+0BbceTma;X`K_r3Uq;Z``ON*2TD(+(1 zx||7Wo|b8>v_9%v&>tWUn(xv&g)@m&2~4IH3pN>(bNZ=$8vKMP;NWn(v{Gg@7^;V|wB^v5S#1)y%t6l^#Wgs|+%vCc|HN zsGT>sj-{mq*&p!!9XNY}le0@J=FU``XrWgb11@c2s3ek1KDmXE^9y2`tRFCm$tM)k z?IN;K4pXB8nhQh=QD^KJ46IHUlqz^he#qBn?8o~tA{(H(nK z;3-}h&tRGqp;FnEe1N6fGK%I>Nj3m^4K@)k6tycElA!!K$1?mWpTzU8wp>a6Zj=Bm znQl5Y)Mx-Zc|(#`Au>whxp6InCTQrorl~xqnYODk&se2m+USMZRsau3W2ml!F(*(I zZ{(FZ3R;mlIX6D@i#IA-Zpuacfa`x)a7n_e*3pMBz8R}aBRb`tsy4C(?J%bt2ns$R zsVV~ZwxR$w@Ug(h;Op zh(0LIJ2Qq|oWoA7IDVq&b=h{6Wl7B_q%Eg{G)qK*%D&rP6pk9acbIaQB{1M~`Hfa- ziCpRTkYrQJmYbXtF6bZHAVo5>3P8Lhft+h!hnVNj7ZW$MX0DB{i=gRekijcIB zi*0kPMVyCHI@q!KK}M8vZNP=IHn|i6Y?Uc4huH)kp*czqO>Lowx7c=t=V<;5J3Clb zA!1@+$jymyR+DeMrL=?u=Vc)~fnuOZ+Tt9BdfU(*J0gE%+z|H-xQXlvPlPR1}gGU<%XjtPgcU(B@2Dd*h3p8| zq%$RPLy6Nl7?+8)4k$5DapsWP8p|n9OLq#jLBypz&`J8?HM17%$q8Q!b`U^GN6t znKb9U^xb(3t#e=w+joN}7I>`s8O@TN4bNt~9Vxq58lb z(0V9nVQxYaCof>uR@Nk{l%D4)y**GZ`9)_Jy%TUc8_v-jZ*K*0B4T<`MZ~cyF3OaH z?z{r@xFgE_Z=^u*wJP%_snhun=V!jr(slXwCS{pRGj4z?4VwVyPq?Iaz3Y_$n@w%j zBV@+lNXI2H)8h^xk;K*MRWRaIqbl+UxXhDu+!44wFq~u0ks3JBg+#?2Zd>bFK?IJW zT5I@4pARZzJnGQ{@YJ6yX11wQZ7GkP zKAy#f_Ikz)SMXDm({xQYOqg0wtvRi&D0#A9J{$;&TJEZ z(lm0My?x;ka>l-8gdX31M&==8iiDDqH2QgiptXUfx;E+Q4X@DdPM>{B&f$+8SHX-~ zGV{rFGV2SMa5H@CORRw1g}^IH@~N}aTSUaHfj3QyZZcuXtU89w`cf(;Vvg+MfU#T7 zOFX41cd;uV4CLxnc#+hNA!Wj;nQTo^t6`bRb*&RKhM-&k6a=v4!d$+pX$-3yFETB0A=A`#QQmlQ_5b(Dpp2860O(W2)PJ{{RJED!8}!er1OY zxA_)uiS-e4@r<@fvi1=USK@SttbFN9D0CtcbliC*Rs@Iu=esUaE+9K*w4E_ac?WZG z6EQnvX`-dEwR}rsy0Tg~ZO4kV+e;?@05Kab6KY;YcZlA{KZ%&77%vA;y)kZeMFL%v z9o3t11;MZy++HN{59l+8^Bm5?%&uDtI)z*S`6B*lAHp(RcQx=d94{hLPWMgXq_G(u zJ2ECPm2@7mD?iyOF(Vf-xs}zyrd^f66=IRx`cj*J8}1@xxr`#;4mcb=rpiuDHnmAQ z0Da^P+=4*LwT(WnaHV~n4$;U6nH?(>lwn*z;FDSvCswreIp)+0e$;{W%%wxS^@F?; zo0VMNG<+SaBO`qk zN&51osd6f{Myg$#nS9^*yH2R7ZmC05guA$qTa^+ej}3UCKf(%w#v`fHqdk|k*;Lf zL)T(_qcbA$2rOHUP8yV|iGrm$G8Wny0{2?MN=>hOt3WNev@0666Ldh1C{vrGRjEpw zmv!LHHIHv;1H8aV$((crB&7GW&7@vnf0+FQ&`@PM%?B~PpJkqyg%@-nVrwf z>UMZ#Q#hKq$u_jo)~`XDB`&`bH(^ED_N?av@#M`Od;uv|QTBJ0wq+Z(QlnvIdy2LD z))7bTEL!96EjT&pWuZO`R~uxuH+CdRBhvqSqr;JO>q0=d~ zW{sw4brwptd(jmVGx3o-^_W+i2;NANmFZ>7~?w*TWl#$ zFp@5p(W06IHkUr=CiWsY_-*L|%dqKCu}ro*r^?kNm6~2{lsehc;4EIo#EXNW*FqsH z9*u=+vabICx_2VEZ=q+D4<#+Q(v$~-fkaEh1| zBsjrHc9Bp?<*bFFX|`t8Hd1a6q0>>MKZlBVU7@++Q&dylBjN1lVyrGWC*uhUaVYGzcfRq&+%qNWv-F$z`eq~%r4_qr z&wo5#LoG7v%ma47K}bmmIu5&U6}(0T6|pNGYc%i`a|hwvQ2j!eHin#>PbJi?NJ}eF zIw_@n>z?vS^wulojitz#q?p6-6NNP_BaPgdnUr~?b07M`gOH?~f)#5JcS-6ZE?Fjt z5k%jYl@#igLB5KfX~F$=hwy|!+1Zdcg3AlWHFm$kOTIo?qWN+wBs{%>Sj!_+#7z8|D<4AUSCt`2aUn=hDN;zdDLN2G zq*NwYQAxaP!IQiU#R5sCDRj5iW+d)O2)VgP*&^EzJfi0wO-V8g;Y8zR&lfS zPdvlP9tCPaAber>{77YTBh7D;<{&~j*-f=QK$kG{yI6%6_1d_!x^dD`f z%{nFuM|n-D%cVxb=P9_kIs*_EN`8l8rT&Mb#cmIP=*luoIQ{{XUb>sm~= z9}PQCICa-L^+q!0kg zIz}Tm67oAVc=0HzBR6l%3n-=0s{FL2;WQgtfglnMt#fPd;$r97xg4!Ngf1=>x!Ua0 zTxSVlIhH0C5+0F4!6XZoRG_WxeGFY?#i@MCxXzA7JghGq)*q|BNS0v=4c}mqx#};b zmWN@BLZQDCQ44s_UvG#tIwd+-=1P_np>NjeHR%mzdKc7x64c9WWrS1MYFSANN*YR3 zk}eLK+((?{;@!4t;e}CGy{|Y6DTU_bu|+YU+X7_`&9;<)lqp8(SP1|Cbp(^Wqe1Mx zKgIkq=DB`60AyQnuT*v-U{uS7sHZTz zV6&q~iJWB1XNa^uGQ3pdJr{*!B6;h&b>$+;UB71F#Jo71w;G(%8%`GSdWkh;2Qo?2 z9(7WxbOfL{4}F!~*e?2@eV}4gpwP~%92|YwzYTFEr6zJoptTJhZ3s%m`h^7F^NwTU z<%^R!EGlJpaXYXjMu(YHNsnk?T&1^3E)O75fFkn;wPP)%vn%p&ZE_){YYSoy8b4{K zAD3EAivejGcpW0^9%Vn_WC`MN=7(Da_M4oe0L?`yeXWYM=3C;c7?&KK$j=!eq!EWW zyw%v{mk9SeiFkSqZxR(qMKm#7N9^Y1JqmVG?l-S>L+carO`$IrVM`$pDi~&W4m+8m zw$=|zr2gn_!iN-xhlib^>KIXJYIib{HgIOlJju)=r;7G`GxJo-92{h^`IA!)_LBNl zBJVBDtU~jA``7u#M~e0Xj`8{Z(V@fbB`#!#!5m9_5}r$LpsbGSR(1U2EyZv$!1qqO z^e%Am3TRcD^!$t2Cnc4T?Bhu!d~X%J zls(lH-{yZfaS0F;&C{w4kkK;FgWqX(PNVH2+mAm8P#P4>bgCkQ6GbaW*mWlQcq?5G z;R~TGb10leEhs8mGQ5+i^8^E|bC8CPl-C$WCqj`X!43nJPN!t3ZY~YNhlDKU5NC|s zaIDTc)h?=)$-L6ZMAKnOQpZBug<6jh_(c3zQ{7YYB4o*1aym5bG}ZWASvBGGjV1dQ zY7*f}TW7)2q5@Bdgggr;@a)$|`U1+~&zE)jlRt;};#(ay-294)o4!>jizQ>!5(Lq7)JtifNac`ix=+3T00ajP zOYFHSZkvw_Kyc|Zh!ojLStpmV>l~o5#gN5})X|k@#@%;@oM>8SRl09HWd1Bo{Y*G+By$Qlbdighm}ChF~OitLci)-nhxb1~r7ezA zw-(rwsPr)663$~PEV>Zk)ND@2(8ms)TBM35P*S9Yq>TX=v4NmWNGazjfFzX`j-Bmo z@$m45YK3z*Sd@1#Qz{2dm8kqSFeDaf%}*+Z=5;i*rC#wsx_wCf@!mjoW#(F%vaXf3 ztuK3zf${MWw9XmTNo|$nASnviox$=jsuO19wK3T>jE<6?sb0Eye&|wEak~vzq9S_A zM{(5qsv3L`i188DjwWGYg)*GT7Et$*u=N5sk<$Z}XC<8pT5f}Fd?TVwsmBXS?&)!* zyknpYto!M(br%QiBz|xy14jJX!>PGWYj|!UPji7KREeK(i}*(pur;bO<*}bCvks{m z#~Kuwg`|m;-9X>VLO*8T}f5$97j;EeLw7k{eLs3S-h(mZS&q1aMGIPGO^4S zzRp|lCOE+w^OFjbvyH4Ny@|cR^?|xNm6_31D%~T`{g9<2noZ?PrNrlK>G^tyU0)#q zrQ9nU>LE#-U`)IbWfNm~8w8AVNLu^NsDspb_=p<>jmmuMgk^XP!>HJg;||7s#IzkV z%4x+mMwYr&(2wFHs%;#jb*Yf}^BcnT*c!@pOsgukI~ZxY7L5v(GFq^nT*GK_Kdg{` zBJkAWrObaGS!3kJClGdMpw?f0ak+L=H89z2Z)8DpDHhRLNghTa%ZJ*N+qW{)7qnXD zzG#b8j>a`?JmXE#>l3JvP|G&Uk14|AcfM3vAPedZ`a=?nS8-3ZBFY?eWlrk5^7@G! zX@)TsA;rA>qb^dZ*7h2DlH!Z17WdGQ5_;u5I>Z+gtD1dpv26_6u9|JGY3_HV@yyKu za`V+WMLArkjFOT~j%Tr_re^PU(c+=GhMqfat8QIB{E0D=lCDXA6YujmY);bII0eF6fmEokTB+w~pV@1k2M_1N5zz_j|iZPO`*QuIkHm)}CH z?CQ5DNf%44ljHD?JeJ#ke|-Tr1$|#7(S7wfwV7(h8L+MulHF|@iGMjB)@I!zcsTZ)#-ALX# z?lj*m`Tg?lI;vZ~OZZ~8_+Ocz{sWQ3?IMptbV<@AiCpzbE@W}rd&xtI?x-KNm|7fD z-L|=RUw=RDEp&x(m0Z9t>0h2 zQ?5-q+f!TDK|e8%CfZ!JcDW)Qn3z1OT!Io;$|peZmsYmwRt?fDEep}kn%Q;b{RGlW zO1^u(zNcz`6SIXLb)bh%BbgU^W^EVtb`I-oi>VC&bm%(5H>=$WQB&=ua!aqo%P+&) zY}A@)R0o+*d0x>_s-bDjI;gbbKGC@v+ytF>j=Y=iy?5pP1axwCx+t!HGoG9#yh7`Y z(;jkH49T}?rA%tu>p<0QCq$A@yiSM03snAs+i|O>C((1?^f?H{b5k;Cui`024KhW1 zs(gbX){F_>m6jwvv4L^j?3=L;N87AFxDLLUf0Qe`u7pxt8bF}zvbBKv%^W59JE|LIWU!|E9t7MjuMBE zp=SYd$1;*G5>@W)0?n!0^jk0JCF9c_`|W$n`i;#-fc`3yc2-r2al_On3ye-J23>Q7 z7Q02!bgZ31l$!+`L)yCD@8!&G!k+84-1&Zng>woaI* zp6i^o5piv923s8rNLZAeR^9yQk1Wk|``odP7PP!?M@3RjefptWX)a1mx*lwe$Up+& zeiy%iiixLnTds_ktt#Y`{__1!Aiy*{M)E4`vbJZMb0c2e+-;%_l-nx;$X9}HFVsgP zk*~s@&(Ck_Dp20qPM0;i{)6jSY|6F_%0d%i-d4xaTSUBax46eXLu*=)mwC06JfKQV zlbY#1R{jxbjABEV!zYZTDqJqXBQQS$(k?MAihSzW+IE5CUc9WcZkSMU1b*%x*Y6!n)(DO@6Oln`v`MQ_oW6-Mb2Gj^GWb5_`L;I^Sa%A8K)M zca1JxdY7CgCl;jle3E~{nE6S|O{JIIn?BD;NxZWt1rsi5s$2s_0)5+SZR0IlE$MdT z{)U25T9RLieP1}QJ^31ywbSaJ#bH=>Z8*Ml(oeTkb*&dacywyTgV0O+p+Yh^xN(tHe8S8u<_wN}j_+|1H00#lS( zJD&Gj5pS5vvD6qull1)lpQAfzef|EZ+mxqG_A>-`yPQ5sr{B=tZitF+ ze5?e4dn(+*qv8dwd=84fmoWN`eeZvNF^7{@-_ScX>2zx@*;HBR=G~iek1t6%Bm2@#xmh65p7_1f9c2f|_3e|1- ziH8X)aVl3ZCda8D=ywDgS{r#g1A$4dW#;P@H&ogb>Ky<1oLoe%TAm~lLT{n5 z+oVW_AxdOlq}Hi&l224pk`&9Ow@lF)(6Xxx>Nm1UBFeppi3=E~CI$$d#8nJL<8$rH z{T|W+nQ~aENjbVWNzqo;*0)%FN07sN61rKUk}fUqiAfRLA-@o6JetexpCc0&A%+@{ zQRb{6H&Twt8mr_rfJuXhJW-V4xD7hfk4~*OO9=x{+qoG;3N|IWB0V<~)wr99B$H8e zw!u==nPwEEwla&1+V_u-NOq`2*(|$9V-?}NKPQq^*`VW%5*o2kAlzt8_YmR~nFjbh zi4joZ3y)8<^pd7f3J~bZut_9YSJ3rIhO)YgAH=Pe+bJtqr#;PPe7??G2H#EoB}f31 z=NSySAAeIvjuEb2hJ@D<$a|jUZM6@s%yR?-Hht*nN_t2O3|j-(m@}DNQ|gugptVNg zI@k$U&f3H9$wz3ft~hY&c7<1MWu(kYs$U>*waiXrt3W{n1z4YeF)>cXazFpmp4dvH zmpN%pp3qj7&w8x*NTT{?>!YYCSjNOySMfl-F%shce?IW&?jU=*YwC-F`GHt7tZ)0xMd zQz=h!QQ0AqYEoggl%SlqZ7(9}8f=qs@zN5Is}tDPY)oOyV(CAntE3--E&HKJ?UBO^ zPfXTPg(Y5bN=n-qZ>~_ehZBDju+ycX#w2iLFskTu#mWGcKPyOwhuv|sM$ zUBKu`JxnIW3oH~lRcd)`fbdNFYPa1gwfzl`$`a0@Q&x~?jodw(VwGevneywZ2(WI$ z>lct^xXdnXt&Q!ZDLOmQsLVq~n!(e{k)1|IQ)6p_l_dMBNf!kqY79zD;XL~i@j6?D zO-xKa;bYqB49g|`N?R&us3mCt=0eYPKY59)@8j{)$r*aDNEI`Hb!&nngXVR`Spm zJ+UmMJ_>o)TS|uh={NE75c?V=<{-zC_;Vfv9LtxNr!^@)-`QIENd+Wqa)K}Eyfx5O zn-jb{LK>q?Bj2P}pOYSJzDkfc*l2q1yaxs{LEmlRB8UvxKCq;hJtUZn-Zk1G0=) zrHr0?l(OveVX1|HbtozURyqO((A$*?O3C5Cj0m0_A#J`=gvyZ8&4N>%N(f7KxxQQI zt&~>~Cp|=k3L#e&aDpbWB-D)Hamh(m=3i90R6yMT8J^j)WvER-i%|AitiJ2}5F-XNy6{!UVWm`njT$HiM zl{^MzwXKi|P1J;doA zYkc>#SU6f=0ye5SyfDP{><=MD`dMVS{e8vG6<;=H+X01jyJ!k-*3+aeSg)5rQ=!|z zyj_~A@rg330W3-_bi@Efl*`R6-1}};gsZPjZ4FBuL|UD(dD?LzpIln9+uEsf2)OI@ z3pYMsv;;K-IU=$6;*`tLXQ^`23t=jDoiLdMwp851jxe0>g>2H1dmC6d4Uf7aLK$VC z@iBDTJ^`xX*+-DMnnfO2xt2g6wieLJPL}T*lVWUlf(v^T-o<@(UUe;S{$;gp<#B+Y zP~HCkbWe#HkB(RdhZ@!PCqhhgjxW>D(h594N%<+-id>6s75O(;sso*nsPHBd8;x8i;Q^b{)kkWP`^z9gIncot2|c8Ei=+ zgv?5XgOYWJhG8z~Q3wkbuz1}|7R{)LiD~D_l3UfwnjL1A<~O6cFj!V_*lwdFq4kok zqeUnZ2QdVXvwsjwDLpS^uYP5ARB5QDPfxPKvo?vDRV0rBg@3^pkan!BlBOux#V*if zT5UEm@5-SrB#xZth_;s&@`1*|IwhZHTxm|k@~l#3KBjI_w}gzs2}xUP3R0!lYg}r5 z;!>f~;uNv<6sAPH86x4Cqf52`Qu(OOax8|X9C2d6*+7JlQf@XQQ4**k=$m{s#7J<+ z)X;||nw)JyX$8eN-H_VcXr(}AY!$do#jLL=V=OuovB-F8vuS#Dw2j-U$gg|oxUB?OLfhurriJq;#^Fe{Y;Q1VfqJ?EOn>Vyj)Ax7H=n!17JXwD_NlOU6Z+TJ@Cs zJ!wb6q5l9!1W*0SnG)N!E6Fkg%6-4ZCM9tkm&j&3%?`|s39K=T06K-pljstthach` zmnZTax_sDGS;o)2Czc15lA9QJr^sio%!j-=~_d`-C%aLYk(cpDqic#6-oQs$8IEtyFmrAg{;4T<F38w(JUM(GM7#M@Yc;L#y5UCVLA1ti-2A)#ims6Q;=LXcDyvVq&yIl0k8PA)tM zShOxG#LHnP#f~5~!dg4^CrIZMluDzjomPpqhi&zXZV!iZWDX-LiYsddVcB}j+fKZI zxt9W#>!;pPu~7%enA%1uZf4~s*%;WIu6Bm2w8QEyhMX+0!az%CDK;b|StCtJ>*Elz zJKgd`oM^kgA8_Ta7Ezd{w_>m^>VUP@cj{v$#N^b?4jAb{YDXkNM6rtFn#-78wg%rv zx_`<{NyW_#Os@V9)(S9HT^GIT6tizd9e;F7pD~nO&KHw!5l{mzAuB;>0+j$#K}a?r z=to0%M0tdfU)){6vs@r(s$V;l2i6wCGaS^}zp(2HB&;U;q*){!q*^qb8?u`^p`XM& zW%jx19ZBScKGJ5T-$?GIOL4NC;=;oWUC45dyc;3;KVDZ(#vb#>M% zauoH6u+TZVnr5U0>uQCQgK4!gx)b zA0U~-ZgEgMYEXLLr=X1%3@a3GsSZ=r#?u*MY1*+0R$(p=bvN$%pFdcKo=#r@adajm zmWi}1k*-q_;;dVCaOsj<*9C>uzraEx9Y-9fow!?Px*bUC z7O{$|A<2@mzlECPKM5P2ntPc)PFYePP$fxICnj6zx^1q#I>kO^Z{$jcA$8d5W@2{> zlQ0gB5`ub-i60ow@jJ557a~AoR8++(bLe#?H6Bq^u~15ebn9y?yQl;U>2ncd%yp5f zsa%!qE5ph8l{67KB0}F|a?9;|{zK%E2lj|{{ReOX?j=$q!oCP z77&U=X)(-ARz{dCY^D9sKY)kqWZ>1)Gl+lW9hU+==my3cl#&$~*v)Y}4o=Y7m2zdJ zwueiB1w-D-Y<^J0-HWOucLtm)!m1t|{{YCt*!c)#Y~ZUN*SVjRxCMDoX= zIZ<^T5|t0~Vaf6l5u@SuBuCIx<{TMP)lV|q7wHe(s1vQbJ!AA zN_&v;DfW(H@~jP1l_udN_!Ri~MpjCT=&_yc1yPm3b#^LQkcOFQX?&<%B(A{+EsfNb zSb_z|h==g4TL{SLhB%{*vRKNXxmt2tb#oH@m)vmxlG-e?l;%h}s9$)t!;P+F43bO^ z(vxAlTSi#vFxq}f0yUU6NYCcou^WbXjIJ4C%Cy3mTaxZfsV^-z`mjmwSOb4gluB-| zRlCuf{FQ!c{R72rZh9~;^ZA05dr zFv~rxri@$7Zw{5L>p1HfM~Tc;e^}PEQYKt&9-L;W2yK6AnzSq8(Gi=>>A#6@jckMP z05vs&DduD)Y@%6Qz_FPn2)I?jy~T#mh!04tXD8`Y%9U1Dj_Z%$)lD-wJtW#xoTUt0h?lfFk2axKZ28hS^~qn>f=&;&h|*%0#!ZrkWe&v0@X+UBD^2MSxYo9~g<3 z4G+R*ZrR)}V~IE-dAC63$|s(}$ki%OyauB}G%+iN{4TqVW!#E=kYv+8S)k0VS5jy$ zr8hg}cqLxCe4=)4LlAqCn~hkdJRHSzD)Wi{XHg2I&Zu-b!sXVj@0RKVO^MbjoOKdY zqBvvDE5BH-8G4$}I}YNel%DOC>{B4NodDD&Ru|NeK{`OOhN1WD!&Er3Qn6QADt2zE zF?AA6(1H+vJc31r(HkTwk|8S@-Xy6~TtmYy{e`DdkBWu>JZ#S z;jJf&5(=l)rO^9Zpr3gPwX-Ec#2-VfO5wPPVs?fzVpCg`=fzA1J=tcYDQkIeQD;@o zr@VimeFph$br5acR>45t+D7k#;#O6ECT2K{E(WeC!pY)oYFS*xGSu{;aX~jAyxMY; zYk_m!xr>DYu2Sk@;2sGWE~zk9yujxwBwHv*^*d`3@?+4SnEpBHWb@zzuk!w-RIRoz zCfvHDhq3zjj+ z%(8yW*yduTg&CWlbx*0hs7lsup?d%dj-+2rZ)nW>M*@Vu4%UmF8zYk3U*gx^mUro1 zQqaTvlInLYEwEB=ZAh^OxDa)-)I+4&r)< zHd7NWsk8d(04JgAXhh>|>U1mkJ;NhRlvP%2mufShy7Q{lc2Lch_d0r770HPi&N1LU#7bzAN zvw$nqpBP<Wu@PZ((Gj9KPvPdK@s&NbevSEQmKEn(yVG~moLZ(#9Q*OWh5)R>b%0{W%MOlncS%%8!} zOD7p_+D0YB(OH6OZK_jCef0!1fpsYC1UZTp=tSj6j2)u5n}zWJkU($04F+OYH53 zmBdVNmw>#yif`mCw}fT=sh30~`>HSaC~A@|lA$z9suATfo3mvY>>zlZha1LNcB3ey zg@v%C0Dkg2z>hJ|#gDV{=$d|HZXy<_s$Le=<{N!$LWzBp2b@YAeb$A?r`%P79Xd_Sj8 z(_g2|vXwC8!rV$nbhfJ}yxAJ1KY^EsXv11V%h_H1(79h7jD$K$UM-UIl?+VAn z%NHgR!l%s@gWBJ+42~X^`eKX=2+x(q#mZ7uvDI50w$e5p&-RCpw7HbLPYa`TR~(D8 z_)XBHsco$XMI~1F+(wQriisjnV1Cr|wA6-bs1vO0RI3Gn`$0E97?lj2#w8KzkVY8e z0RCpA2Z+^`B!v$`ZTLil)P{FMSC9KF%(9a7nghw)qd=fMiB_=O@pc@H$ZuGn&tVry zXsxv*>H#Sr_z`_#ETcq-$aHWA9v-8VqJ1hh+F`Y2T0F=|?|fprHwhe^*UO<{i;8jm z$@9a`Jx|S`Evb~$CAx(G76+Ij@s{I#jTtY)_+P3oxPCeH+>sb(jg+dx!d3K%XOuge zl&ag<RdOe;Q7GRq|Ylk8CIl) z6knx@Ao~0vH{9f-9kP2_qbcpLFhp_9%scvh~xNk3qB$pUY851OC z)Ah{+tJD~EO2!^Au2Yf*QZAnZ)6x{T8*!tI{W(&%Ek`Iptt(km1f}3W@!mKFNx4R! z?^tWGv?akYN>nB1rFmnzlG?`KX)68^9#O9^sOoliB+xPa}U56Zu$y0ev57Okg!nc`5%bV6{gNvih4$Fo0ZmFDFE4NI;4*~>G6&< z(bVkGepM5WrAtcKcx>ZpAQ9nVr@+T3=(dxkH8zaErE2l_Nj`S#3ZsUCXd%}M5|EWz z;3xy~Flh@m+j&&Ok=-=Y_=o`9lf{iGMYl9i>*73ij_Nr^X@ZBwao$Mq>E+20Qr0+94y=~&^TXM^7 z!QEd%dXFRc7*b(JL8sYmMS_%|lXBS_A23H>#yXB0Zp+Lwmo3y1ZUH)h;eNjuT^tl? zwAcwJD#oMuL!88NG^f=wB6B0YpSpjHao8=)G}@|aB!vuwZag4P&b3E**+8V+fV9Hs zMVeD9ZQCUK*3vl6ocTGI8&N?wOmQ=<9WQK43K@m3vWM@5Segm!s4iwtboB#IjBx4M zO71(_h*`r;>1?Mm4g9~`2x#b=nys|Mp{F~mBdE2L8>C0TSNAd1UqO-^0TFW1Nng=ArCF zX9c_LcS-qv_+F|JR(1dm3ym+-Y+=q~OinOXl9hl`ddC#MqWTln^h?Z=ha1~qxq-mItqie!x zH{`3&Z{|pg)qmk!-!1+^dD+_C3bbhS#v7Wb&Y=c=pq1UpGDmn_%Y`R=sY-@l2q6U1 z-*w4z`0g%Q6G^rBck*6abq1k`sM1Jwku2h*B~q-FdWmgrt;ML>O{vfcvX1M`U=6f^ zUfG_NAC%fpmFY0!`k~F&Od1ahUKMqrp3d1Wr$;0~PBrKrp5_4Rb=ZVd}ecdnF)_OYiD%>oRW2N;_Jsy5m&fpqecu&#&)`1gTfmK~~WV1S0wvb7qoTbKjrm z&?4HEE#LQ=+wGbYxW27}-;|rE$hSF&DhVl-mrBx1i)!~&l-Q!fOOENkUE{h{x_ehQ z`yBoyOJtt)*S_G+Vt|EA(jcsN=ejJ-=ECj zQH>uEC3N~E+b>T}tg59{Afd!7bs-5>Qk9DkGL(^P$7I^8_^bYZZ0|dhRF=vse=X=M z_$p%>yd@~}GZg$kDhQ}espYHN0)6E2)~w0Cz2UB>cyk=1O}+2qOU}PRthSoIcd|)e z!v6qM3(0Yb7w29>Kgqcj-kmD)atV?SiBb>+?tRs*DkG>d#FMS}-|uhCTe!Nf#MbrG z*YXm$qaL+Menzp2sf+e!?kTc>rPigK2e?+lV3iU(!C7?MLl0wvcctFX%WuC@E=fiy zC(hOFZvOobVhWxdsfn3@WvaNEXmXb1^E{-=AwtOkmy?$&LGIXG?{NxKl1rU^KK}qA z4;qtuB}?Mi(C{A>yVCjowc>Lhx5M{I@09nkTI%m z4ea+tn_~JCb0^vwN()mK=QO|2Ob+N*?!1Pk znTINPUCD;qsVT~EPzjWsXgry9n^}ieqNf5)?1z(d4zT|KkA79pO%WyH?*O zoo(HB_&vtw5MqjVwyK#p;ls6L*rAt6nU#DUl!pg(Ao&q!xyGx0ok)_OPIt>{V=dYf zi&(3JRQ8$@E&%X3XBt{uU<>Y?p+e_=^`g^;$g*v9M7w;RAI{MT}*q=IKWh zB}fHLys?q8yM1uabX~o|6fAsXlTE@M?|bct{(Q!hv)(?Y@NTB&5ql9!)#pBZ9gX9HY|6-gNWA2 z?{{sWv5Ty)#EO!R&-kAu@uNTCxVpNMe}?MowfEbj<38TMtzaNSh8F^ZWby4N219 zVOG}&@g6Sk)G9wk%U@O{P?b2L=J`33{av~kvB!%}?G<@==q;kPKSV7l7#|H`Rfj_f zotAdk;<+X0MQ$KqUKG?+wiu#I z%})|SQ6h&W)tk-6vY>0@q*!6kKJVs7$-^#ug*Oa1QCq^2j~OhK`2y0(k$FaJEL%XO zIHhDitc!YS774aiO(aPyEjApKrKo5MZEuFq^5{lpmk(J6tyVwdQ~qd$#cpun@se;z zPEr(2hqc@0lLUbepAX;mwp?*&30E;m^B^5H@G%x+g8iVDtP%hNU^Woa0V`hm#~im* ze(0Hu>03CuqWvvcp)IRK%dn)OKrI@O4bZEk->#l}#Kex-=~~@hPZF~)hXZZ8SeI1W zZaA(}=qcPJ+#yLC0-a2CAuZpjV5+Q6wBP)LElbO=bvbYGhf*3M-YCPXm7QHn5X>~h zxfVkWr!&r5QFjn-JplN`rN1GWY;aiOr46=J)iveP-yn{9rOd$x%|vGTZ3@uDSkP8@ zS5?JIRP>zuy;V!LcMAC{^s|TXg^la&cKSV&WYHj7EjpS+8YoEC7H zcv zI*TXp@!VK19%B3;tg{r-^C%#58GW^d4dQs-|u`5lo zpO(I&8>$^q-ozWzMpk87p7%?{h^rntZB`3<-W^d8#%GDWo@tzJ&be1ijZ)dUfEOEc zrIy)HPsD2yamt7}<76vZF~4MKn=p^II2FV4oWWdBgW*eB<*cuLrw- z((xuqY*5IjJfISp=8BwQ)g3#*2+Y<009xtuf{1c~JLIX&PqH3mXAhC)!lS^6<6x-QUJ>?}m)qc`8zljhDGZ}?S0iMAJWv5i1RQ;If0GvZA(6fsO z*JFErR)tsxT-$SM$cGDe^3g-e`UvfTo?=af4qCtf8-Ss4@V(($fdAB<_QBd`qtFOQ5MW=F%0tLW@Q~n2~s9nbzUG4rKovdZ%F4Oq=%v~+^oaSr%<~Q@Fib8 zVM}2qY+U+-3kmy7IrFhG(}>aGoUgFRNHP_#A*HBaL39F7r|*SBp~(nN(L6RhMy85| zDM2&x_i=@%Wo6wYq!LngAZ{YthT=3oCRgXfYv4edZAM=jG02&0p~b6~`y^RRJUZCw zoqNbVL}+ZLqn&|Da7{%NvWL}Ka&-@xmpjeOGt5aUE74uV1Dg5`b%ZfvosKI57*gp~ zggB=Xs`T0$B;V?nF^~b|1*|r-AW<9mtv@@C@hjBnL=`b4w;gn+!73)i?Y_3^U_!@3 zi?gjihjAd6K~8D8M+$5&nQhpc3+iou9biC2-W1lplbOP(DJfH5R4?|jO*n2oan|-a zPh4MyWgMu_(`C@$b=ih$nSmAyd1*?J02i?>g=^HEVTB=W2s}AWQ#BbnkOJwGOAjZi zR%I4N$3vJK-&?}0;os~TChiZHo}^4IDpJtY@@;!%d}@<>Uci8Kw)(;{I~{RAd+MWbr$ut1Iv&hd+c) zT!x9e*|W8y_##$N)KaN{!jj2R?{g&~bPDTfprl$>oY9J2G8-9&8Kg^FX6 z#C1r`+Rqa!65`Axho#(=eWzJV%`90t{h>E4s^>drbT6odoTMeIILi@A z%{GUa6KhhNT0)XbQwmy5j+X=i4?_vbvN;i|o0B-71fU{{SW%gVt>v7K}Omq$VJ2+ z$b&9pna8=>U3G~(E(E$-GOAMDx-pFH~AU>zlr6qfCoZIz&@2|IhPs11Cg8jnHy5SV(CB#tFZP0J2-GOHlLXsiV` zLYON;Hp_b?_eJ#v4u=S{KRCAQ*wSb|wJv;CB_3s3q%|yrIME011p)xrBt*FK8)65u z+SHs1)?T=PU*RsIB0?J_S7(HMC5)xqPR3ogPxVmpe|#~W{uV9^as0*84vs0)TrM74 za`Mt?YwRhx#-<#5FzRmFZPQI}q*TgP5>i&jN}s@)JU@w~>(u2LbW8h4c2H=|-ft;e zNCL=FAQfy6tVdi!s$qU(ZWnuR4Zh=AyAYMo~#pNe1Wy4Mn`6Sn*n;u64OFJ2dg&ai&2is5~Vql9^J?KpPC?k;<7Q zlgd?q*Fs3t7=@P)hDyhiU+gJ3ufcEchPUTrS#D1fN&)S1fMsHB8;4r}6(}qEHS||> z!A%dCDzenK$kf z)Z!3t)Mts<#z_amMhnvtCoW|JI)rI+nNGem^ES4gkox2}hhK*Ck5Z*+NKthXlN8Xm z9F(}2X~x!C&fyILyJ%rCzCEx*|$Mu zn|xwBjUm?|SJ|H$Ql^_u38^^K>{RLLd6w3ss0A%Heq4fdCfvj%0&Gd?9FiMkLhU0> zZw(@5n#1o*Gftn8l|tWEcS2iJr6^LgxJX@*`k7)(NSQef{{RUU^gb-B%4P#Pd5UZw z6rhD$;&t(f7|4?=I~h%ph#yGlP`~`-5ivdfWn9U3+aZo!B}5%nQD^2+bNHB>#D5C= z>M)k?;$ZBQ$zB`9C zDif|mn&Dq=H)#B+EK4HH!)Q>m{JT7xAHGyCZS{)WyfT+9iO|nn%X;DFJEieDQ4^Gx z(CcJfNX!d}{iK3oqIet`VH}D=^_H`ow$zwuLd9w#o;vM;MZyzqQ|axlZgmPR{hn4~ zrr}p2{bJjO;2gJmeqB01;Gb++V1Qja|U3x-`lPxlNDNNxr@&HCT9c1xTUE zmC2j9hZMEKnF-pPf!cIxwSwsk*bs?<|rD z8x@=BaT)GAEk?SxWzPqXdn}%;^QFxKOIdY4Yd7$W%;mXv6gTyy6o^6=G(1k0Qn3AH z3kJrUF~5#m#GHK4+=|KIJh+&`^+uJ}dYSSoF*bb05qh#!*=`J`sPy@9`?L zZSd+sPSD&o{`YK;W>}b!dDiA6CQx%BZS8E}0hnkM1ZX3=D;lBPsN(v4YY@_BX4aEW zq*DF5V^NoyhQJ8a+U0f@HaF`W$ql}2Tps@bAwR?3GD+a6!HzK}HQI$)PAX1aBz;7h zRh2hN&C(b4Y)BwpBPd#~M2O0_Af_X&n*7x4@`(+p;-qHk7D|WV6I1#Ow`23degfBc zwI;f()9uL9TN*twOKBhvvQ!Ff4?K-?`5;lgM)cnaB+#6)wYfzrYdTbx&#JQ8(7zB! z$8igVRXjMfqG6_)Wx;g3&^)I{iWh98M0u{lmze!_T;ZgxUXh6^Apylp$(9;bfhkg~ zR7RQ`4aZBtjp^mp{)cN)enSk7B&QBa8A6P}=1Dz8^wVCNLZ1<#P}Z9y1`x*+G=3Yo zO=AB5&*yBi3AjK5FdFsizJefT{RgqViF?C7(%5SbOG{H7mwrvA+e2Z+1QzeHDmNRR zwu%h++jdz(R7^>ErYa30YFWfO!mLu`Y6?jnqpy@fq4F+ZOgJ!K5HSreAQJU?12UA_ z$yQ zm_}5r4uGhFN_?VT9wFoXhH_(4DvOPMoGUyPXXykwnVNoZj%o^ukWRsU&;|Tr^A8ZR za^_cL#Np;{U>c&U6sFeVvneG>*Ika$Z;jk{Ay1hv`z3KAR|LO5BU4ajPH8HdVZ~S{ zJ0i{?5UjMn=tn-F3aekEdG zp#D5gWu@TG3t`?KFqYYtZE6Eo9ZFQSd6QujIXJ0Ln=B)RN1(P_@@#0!Xh9 z9MD(a_d{Pxlqza$FYQke<)9H~!OHB3#I1<=!CNB=te&C&0P{><@Xk;S58VK1AZhOA}AN@Z2=vC($M!n%m?z6GMj>Hd)*WJnN$Fq1M*I(_?iD zTwd3;jm^9-84e}XjV2C7kYQTLz>G-LCQx!YPp}rb4kaDY)86UUGn0j~<}%oWSep{e z@iBOsR&3f~GKqR!r2+s$M>4VlbC`9v#wNl#Xl73AulxkyO?E}ZXcqHHBgX0%i+Cag ziIv)6cE&X3`U%nU<_NvV$|X$svP$-FVTZ9+DVBW+aiyuO$WR0knDjbBTt-ba&f9*M00UDkXGurebt&l)W1GYtaME}CDbKZoF%@GC zAy<=}N-A{goeCTSI8MVrMZ!kuI>T9UYe-xtq(XL<;k`#0VoAqjrdHbxhMRq$rDR=@ zl~|-{wubRLhs4xK`7&D=3{gXx#u&PphvmYH42Bk@0q$DGYBsp()I*te6OVG~5XhF7 zQU<|=r~HE%Im+Fau~a2{E|kn*ifC90N|5SQ4xoayf)A+D3#KobUwm-kdmJsqF13aV zn4OlAGp!^a(=ARFDqUGXDoUG5f)Uh!HH(~6)QD14$)VXNjg)>o$trDz8F$tht7_*W!hQ-&=XDq8? zHFjmh5722;spT6@P-@(#(bUP#tCp~Ol!9{$*&^LcJ(3%5*k&`_w4T-6G*=byg+@Vu zOw&#KT$xY3&SSoin*wg22o~2};*$3#5niu^q%n-WI~+cy`L${=l6jQ?Qta_&%^MJY zuqgxrNmg(ztU7?}b{698Hxkg5hXa1iRi@m$+N?RlH+jGb%vE#WxX{FGvFbktC-~Pk zC9yUbS=}{hq+iOw{`jq2pWjkfQpIJaj!j~^$LQN>{P3tVl0|2KbRxC7ou1z_yg8jf_mJ8a zJ_;YgDLti+lkzOMN%ST^2ij9?UJilX=7q~ zS~-h|)ajj`Dnl0gv)EnZQ>F&pQ-C!+D6&Fd3DFL=2lUqNl^=LmM4^O7J`izwTZEXl zw%pTYiD{cS7~3m=?Wq7ANIsB>W7att=_FTZY*!)0Y&R`dr;(nlqs1IG!*={RP6$21CPpm~*O zB5wzQ%1XP8XUdX)0;*{^IgsKPkOeC!CcpqsU8B?SV^Q42teNh05&a zQ@y<*?AszVNgcqXO-|wCD%m2bP32F>sNU+Z&6FQ_rC=$t1+RNvD)_isr`KY`hn0Mb zT)|kKo*+|c^=WU>%$C+iRFaYugKOBOR|Iq-FnM@)2VI$^hE*l<8(z_zQkSO`QQBB5 zUao*f-UnU0ZX)y9yepg4(Ga+->MFaHp-yqUFP%!TC@Kg}mpYqRX&cBHX%Xv-JaCvR zLT#DHZrQ!_Bn>j}@(~k=%chd*NW%`LoOUSTA>s7{+vgE!s)g1`8h}T1Y61M?&;7NX zHln#N%-3)jsb6vCsvM51$j6@Kdzwh{2M??`r6F3SS4kd97BH+5rgJK^RGT!>fU#uL z2Sm$Foj=96Nb=KL9+Bx-r>-gYNX$)BWxRG!t9t~T)*f)(QY#M25`F1c`{*ObDa?am zVPGMQ_-)v%c_?Q4R$&=>#ZF}}wibtFPzWGgDI|cTn`ohZ3`*f}ZSfn+lEe-H#>`=? zBI~ZKDcX7zg#tk&?1FW_&e3HoT6Q8S*%2Dz#b*~`m#VVLSbmvP3rmR2q86P2vA$F8 zooq&s#Gr>1iH(HuYaD&UYEb|>>qg*i+{0q&QgXO)sLQE1csGfTHK57O zxNhlbDRajdPq$njJMJg8uF18{p z_!anwxyUt+do##Yr4dz-DoakKDpD*6PHz-}?u+ZL(YxXE*38Z2$JCB^!?QA_5)|q~ zA!E5R$R=OQncccCMFbO;3mO7Ih?~8@BsbDL!dfv^i8VNNyJPr>fx8 zrJ1rO*c~0Zln3glsA~=>oYG4vEPI4_=+J5K+fxKvE4;M1e*~zLe~db$n3|!I#=VXf z>Xhvz)U78_+Wqf_RKqgFnCxW8xmMxbTZZr5)}LWXKKep}f3yIIIU!pzW;fV}V|{-(tj&cqPli@Q++)R>?i`+WSu-w%(6SPhEqV*>yh8Ul zK8w(lvrD-l`#ko|n88npYMAE9I&9(%%0>55LX~8z@G%RC_F9^_^B={=IPA+X!8l(C z;}!dTDNO}DbA>jvC3@>)m#8t2&xTm`ck?dsWKVTN?TRQWn`Naal_{VAQQU#|j8)1c z$jIBnvqr@WI*-N}V}Mo|MCwa!BoIdS)Omvp$&REUa58xlZptj{?V?=eLgVmaJ8qE@EU(Co6`>&!lrr z1%^VHnz1D}@zOd7$n7*B=12-pUa*t2Hkj`NB26iukx6M+)yDg(O1#QO(EdD^vlyH@ zql+)a++T+R9BI`)+hiLOvZ6k4{9_*UF)QquE_i9%;j|XmtG2cjYzc8TP5o53bxKh4 z`jMrIGV&*;660+n7NII_=EzXcg(Q!_n0`D$eD)&Gg=@@p+vQFS&8aE}z=IOhtbp;+ z&YPvB!Kj4|N)&KCg;Kf!q;`hDLpM5zC=DsPXE9|-&?swd2tF{0K<%26iE)J#sD&rM zjbSMrv#QEkeJV*AZN0R&oOeoLVbIsJ>e{mpTZ8Kea672hdY~F14i4(Pecwn+*ityt zRMibz0mjbgS9v!5UjyL{ICd7KZMPNNx4bzw@*V2xb;Gl2u<{XUFD%{Ic zNn&h*p{f)vFXgXaDB@>D<##OdLP<`(>FNwE?r=e>PcMS4x=*}4JVZA~K`bO3%&ASQ zs&8+Q@PdHsQ|D$SG*Bu@@;8p4I}%k!n^8(uQ{t8EJv<|}2T{p{utLYUt;iQ280o-` zOUus^1(3fK5CQX!P#C7@>Zu`2%ml3AEk}I;`mjxU+pz;7^E-T^;6j z=I7G-ZDVo0v{3U9t2su@wMo#O6>>KU>OYT+37lxoDkzvxyJRoK5BJhLXDIBn_p^=d z3%U|(Ot6XZp#bhIc0M8pxN-W^W0uxZ6}a$He7s|p0-|A; z9!6#qoWr5m`DqIhbE*zL^8wbbmyz!$#@=0gqm1ekM-j|25?)Vndnp9yeD4iv7e_*F zYnVB1)QpM_Z30`Nvn8!yQ$$ zQ5!FmxsV-sdXPMA;R953Pa_twG%`4}EwiyE%O5_m#XAZ&kvdpTX=hUFWZ6x)Z*NO& z9ZtC%p+_X6%glk6+U4o#3qo1ar_Tw!TUbyY@(I*KidH3~b-6^6NZ9U^x5^ZiiDpJ= z$(L4SY30%vq)TRJo=aLUKz2TUaHEDKqc8Cg96dJCeHvJ(czK{i*X?EjS>B~I1cIHKh3h@L39B@(>9F9DM zHE)KpHF8!F%5;J`joB)(-@FCl7ET5;^7w37;r5jA?A@-TgOhQNy!or^yzlEAy%U0E{O0V>pJ zVLE$#dHwensYzV6isZRp-$PBDK_r&kr81exN?f^7sno&==PVm4^9j0nXYCWMw6KKJ z+Pe1L{W^9Wf8uoAei*%#d>>P(F@>=1FJXrgsaaeNc)BbCkc;M$GmbeyZ=&GsX6$vV_v9a_YLS1(NEUAfzj*vgkVN9BnmS{ePgi zy)R5!Z~M}Gz8Cok+Puyuz-5Y@;}X?c?8z-PEZA974IL8V5_CZy(py4yh0<@GD(k!D z_d|B28eEgzt&`ummR_dj5_WEw%TK?E=36gKO`$yC(_~#qO434*w2Oqct9PyA2x-^z z`SkjZ?KYd*E0X2EFF`jZXc+oI6k1%%a`bSZ?Lv9%t-Sl*@oX%M7jJywUE#2Yu2FXR z^iSd2@*C*o&9>4}<a0`3U*PE0op^c5TEu8*?QRn>N~(G=)X znoD$-I_2y6iF`pnA%_grFu2<5^MQXz&dwkxFxJGR>O(^P%lAOk$5VSZ%KDt8C($If zOP|bUv5x?$)d@*T77$FEuQE*R#bxIaa#9b~q2~3;eb7aKvAj!<6!kYd?OeY;g=F|| z!*Q;Ab^N-MN3*vO#}x4JVMQNVp-RQhX3t+OV!tju4!&#Q=jGgYRn)#t zx!;$VqIQz0M>%9T3s+K5lbT@w`^lCkNtq+|**)ZqJRyx$wQ}vd`FD?zB|g3WOXvO> zd7MeyG{tGA(6pgQWktqT#gtoDRLPZsG98|ja@rCSZ5@VbLzCOf^!-!$1fzStet)m& zCG!!p+&-yEsJ%dVQ>O^OB^kbjniuy}&532>vXE>uY)ntb#I920`mf)k@?>e^z1L2U zpYvUs2`Nmd;d$ognQc_}<}wL}q`(r+^eTQ;b|FJsIMRu?NMYo(*P?v=2fQ@={NL_A zh^JTO7V|AjN;xL-F5JYLiY9@#y6A9ax#*yN5gWn$D!KV>x6Enhi+3jW=`LR?5wf*; z94RDa<|%bq247iB+v}ApbxJ?dIP+y)-`CuEMH>D_J4zLr1ZxxGqJlV8HFlKB}! z^y;(BNYZM|OG}{zOSHfk8YRZTNl`~rU=?lR&xXw`Ek7<_AB}8Q@mQ8b)wxT*Mf}e9Wezd_0DO5D zu$_N6s?+<4=c6O9GCxG_M+s3SHqWK668MfESNXE#Thr`S!z+W-zlu9crLN<@Jf+c{ zRI7nSS+uqLsU9Hek>}n;{3AH=IJTdEKiB!ALm8>9OYiUG%yj4G7F1G7GhW1KQlG}& zTcG(vk&Ef~_vj*Rb^H7E6gXiIJOV0;OU;ESC1E|{leTbfE<8oX#9Ago3BCCcvd>EV zJ3pbPRj<*h4w-QJ9dMh5+FD#$9RWbO^u5LUhA3YuC9P>_+JHWm>!5asb8PIrF-MNc#nF6u_bwGYB9 z(ktv^Fq53A3TKnbPvT+4&`UyN58}C;If!aZiB}wD(i9)J)uljts!=2N!jqvjXFG_P zYGa9^o@?1u!|l3`UWfrFP)P@I;R)0$Ng?nBTsp&yDOW8lqkEqb5vD4I_0+LoxNRMy zfb7O+*4noT{n0lcBeX#bV}qA5KUsERN^U}GKqXF~T%}E_=HTgYHT1kpOzjE$Gc<~B zGf8b}aVnRPN>(;fRF!HyZFpB9HD!U#P2^SlLp!B2_UbR ze!f8X#K=n4!et5|RS&eLAfc4B;#qV9reL72o?#Aa8hFzrwF`>#_@YJCJ4{=I02S=I zxvx~%oBnr%xeREbX~O>0&fq88RLH9{Dub0~VYTwdO;vobhcqk0WsZL=CAhuxG~9#e zc`KR?j_Y^i4*xVliA|ua3(ZDJvxNQAD5~8q@LJ-2)aReLOs^LI^Vbc4An^x#ZXZQ{euA(z8sNK0`on;w-4+LK?Ed_(R)XkBwYJjv+{+)Xj%D zkcl@>>N=$puianHIYSbGH5pemDRl};lCgBU(ahS%LT#b-5Dd}dAcuYAC%wIe+gGT7 z4>w6mASDAJA7ggN^ywWqXGDtF{SwFr?5j{cJR_ig|J9hdW~gx#s+ex>BiLGdn|%~k zn-OmtiE?WLC8eIni9QW7uwBQmts1Eij!J(;s(p;5|wvWq}) zP~t+6*j2xwRmb&6jr_Lgt%XUZs3?Vvc-AYCO0E7wGq1KL%4<=i6g))(JHtV1# zphAt(JvD{nkc^0lymR3!yoAc@RM3{*Z030>7E8%S=~lMPH$v@yv$2cb6NjYN0N!Y^&WuzSCz=GOOKERdo49sa_!JIF0Iryo*%nbW794NwriZ zv{9FwQqoT@{_ATg1aiPmq(MT5r-pnvZhD~m%9m-wGdnq*;%wt(D^@{k_mWZ#hQPub zI)rrQ9eHc6Nz%wv&_tC%4Y&f*rLsy^$qTr$fUv&T+7qgUt;Q=F(52hNI8LohmlE<* zDrrTe3ndFvgt|I?vOyLQUdKsMNyW_3adm5+*>JTZE>XAiX)01~M|a-6{Gq419J*t9 zOs=&}!;=#zXsOzS%)+IYeOnE(wWRr+q$GO6#EDK4;+OCiFJ@YN2G*vfWTsFpWb<3@ z?Qz{!UA|%oD?*~^l9bwL3(amjH3QG8jUVx}fLK>JtxB>TEl8wiH!no&emT zLqKv``;&2augbR{h~V)50D|oHaKsg%N#5TjB0qt5Kxg)ntEtT&Pz7OHAQ6zFC^s(I@zpxVIh3oAf5yULoe>hhjYV7Y9mIczH7=EXZiS ziM6S7MUcm^Vs#R& zT${LFUp2=UbE<&^>*KzW9y8T%$abh(cIC&zhlruhCgxqK(%ZmwZB3LY>~#R#TU{Zn zP}O6yl?kbwPdCHbx@Oyb<1FfBlpGEyv{2$xbgiOD7rnxO2IdtUcDV_1qkD+WBAt(_ z6w{*^j+|1P>IC9tiAJ6Z2v2|oA|yd=@EUAm_=k#G6k3&Bu+paODJI$Fq^%${l_g41 z7w@Qyx79gp3`j_B#;$jTQ!mlokpT0#tuhUQidvCp+9sXK4b|UuBPi5?rN)6lVvh>d zpWt-GHkn+ST-_#pCHYrVbS_ZmDQae2LhEf}!9^)4xbCPJk2QRUpy;2xeZW&(aYZsx zdFD$DFo&6&NV2BhR)y3Ql$O+l0KB)=X5(mw8EGGC%G=`J1gqeO>oafE9bHmVp)98! zPjOGEwxyx_r0Ah*+;zUUi%egLi9L>mZ;X>Pd@VPJXC6?g)*g_UT*60nQmSj1>x!`V z^Z|cqXI*uP8aMb2YB_R~675l{GBVSGc8exGtwc0iOOubb8f_&i?-GG?t<#w1we^mr zM=VWNa2Tb~sMvwGN}QRTb%KlP5`-nRTV1X^2C={&Oix<+PI5uXbeCtRDc?pooBonv zw-m!>=WB)B^wWN@#D|dM_KrnE2)%@Gb7e0gN<{{IvG{DupUlph;KYK^i}dlcQq8rzlHl-?y%yxAFwn%Oes49&~a)`r`C z2Xc(XNm6V*>+8H}uquj0W=Cv|{1~szROhO+L3bq;nrc~_UzYk_KuVkYw+bOvvQJo& zHanl)43`STlFpsgB-r^xtSD||H{tdxpTN^bYMkapAJR5#TX{WD;!V;)^9ILQlPpUj zrXo2U9>u@#CybI@WJ@y*KDla?nsO<%DN9>v>fUkzb&_=nR&0mev{Gik@q7yiWY%xg zIA2tts&Z;4G@v#$#<)bzb6PO`$QGIG-MxxguTDOj==R0z1~VosL0v?51Y4!dPf zNY*MfmB}Qf#_Cj-rh!RM^MrH3I_PeIgK?qt5cEiy4hIcpT|7*y2UJP+G82Cbqc6y4 zB4#24`H){3vRcHh1F@e^`Qjw?`H&<`j@b#cidp{vm*$oIr2hc2CvhLbzC#Iabh{$c zmp4nsQj8?6#W2B2M&y>2v_RCOC4JE$M^bgzjo8bv2OE$Ryqv^QUM0=0NOQ6V#~SDQ&KtogPG2|kd_u_+EmBSa*oVoXulDy-Vub;K~D z6r8ICw^4qc@VAkOxiMDHbV!C?#pZB7v^_hFbYoX#K@Lkcqc+~X!V*q>hKAh+@fKVy zKaV0*bKl6Tjve8YVk+w9)H|-UW4=35cqr@i#^l7z z^EMgQPEevR?&Tvx;!WY{~9 z_!X=7MClA7@8?=>w}y)f)ebO_d@eN?@f%!hMu$jasIs_f0E0k$zZ9z1XXH6rqOe|} zK1iw2*JU!B=%-r>&19>=2^n_UE_iosA_i17*vp6%3~xztpGbX4m6$x)c^6WpdmH0Y zhMZQR3-B3IG}1NLw_bd&xlKPJBGi{TjHe_hQtD80d2O)pNw#DK>~^^7MfyW|<#fCA z_#sh4!P~%z)a7Ew5I zza|X)xm?2`!ojTz~?Ofa<^vg}w}Ey~TwC%gb6!^S%g#1CQ7;tnd3 z73?L7B%BM9nM1O!J}-4P;O?P7>)pML#q^6DFtpJgZ<8R03%GcA--#w^fq(I1Q*O;n zs{O#)O|C&BeY|2!sV)1BM|MkIBk{&jk}!S>VJlcd+gqqjkc5Ps_DYjtNCajlNQWq{ zq>JoUhi77{jyaKW&a)?fAY!t8M-g{5dXiaM+a2W+4X?HKF;yY+A(nn&D9CILf%5T& z#TpV7X=f&PO zZDaW;zYv$t`7xoz$f}nzI&fN$D|I(nHvvs6QND)o)-`Q|*t9uHqg9MMCW*8Z zzh?Pn`lpsPI&L}`pqDb*BrC1q*{&egYp=2L;34GWtVr1VL9_ByLgRmh58&p>y^ipbakU<9Ob@PGC2St4eXjdT8*6cwri6o~ z;+Gus%E_{gqOzRE2LsK}@d61+r%trP$6{n>bxIG4TURl=Sf1$ES~Ss(uZdGRQ6Vu$ z6seLgR4Q|BjJEJR1-&~`6 z4Y~o+DE*_COnxl0;URAO7C$!qn{)n2x&CR4-lE=wPh^>oX~6XF)lY>R!!5Un6 z;QDbJGnL5|WUD4sgv*n#c3JLYX5`of1u3<3DOY;pBxB864N4YqyFBoEmxN~>sY=Rw z1wjrv)YDD4N)#T-?o|MC9HjS18e2;P78vKKWvVN8wG~x0UM4;s)d+Aj2S7*(1~j}n zq>7x+c6az^M`n)oQJIX%GpKzM$Ly6!+2SqZrNKT2cvfZkjlq{mhN{S}$jZ&MLXhhX ztt#;fNHLMgvo52$E920c=^lb0G(L{&65%N;CdmTi_yG=L$81F9ML_Wr6-sd{iLXB_ zzH3ra>1`)lXBrYOX!IXv;&|0QbY%F7suZkJOSjqWf5@np0MLJ~v0E}_9WKxB- z?*fo~dd0QawGK-JQMLWlI zPuE3v;mQfAaUI4U)P*@>b+P4}AA!~`?B?_GYQ&Q+eQT1>ZQuVYA4-NnoW?R3GfE-21JxT{h#=h?hH}G zv+RX(8V*Z5+Cb*Z{rsSN!|f*dkAzckJhc`$S3+C2QIN*+t~7gt(OYMKaMT$dNhEiv4K!>}_-^hHo;Y|+DcXH{QP!I(7Uj*e-bR-? zg#lx5EU0R3hax^*gC`!8s8r-95>YhL^1PGxfXYvXq+jC^^5o<@7!6Np3JX;RD{_jr zF_j0==naVxVHw<0@*_$+vR`&G#L2|iIz@T2Ewpmi>Vi{mm7T#bZTJNNdwbI+fZW}I{A>7ckRv!g%YO!qv4Zb;#NT|z9w5@ZtG|H># zVx2nLHQ4tv`8Fm000lVPFT;=d_iL`HEH*RJ=NEF9rB117L<42D?sv`905M;mfYj|T zi2gnqH1^QSLK4-IkTd{V){iXX-S6gY zIAT5G3$%0eRAw@k*v&dR?4m>>3{=qodr#p%ps|Y+R>?0~mM!M!A5MV!<_SFpvFIMl z%dQpJ&T&xE$G3%?OkD-KRv}p^RGX%mR!4#qtf6YtT#K@WfzX|88aU(BsHl|aeE7#a z-YTt3u-U#zbdY^UVf2@-W_e0V<0dhkq*bRRrCxEirUFvyNl^(|8(eLB^@nn7 z#KD%o*vEjZHHF@isI&^Ia^-FzLi^t$x7>8th^Eb!p2e0tdkmLnDr>wyu2iUQ5)jL! zNF6t^(_O?OUyF08Q1fsbjnf=3sZ3I8tgRHMrxuxct2QEOft%ntCY2s#P|@N zv8~3pDJIRFJvf=UT%-jwMY50xBf`XO6Oj~-yjkG{t{_1)^$BN2rL4J{U-b#fgXRQE z$DOU7<5I_bh%Jk-I`F~e)T9*2CdqlVT`Iqj)8}ZFsXjwmXiRZ0fpz{GwA}vyDZ?t_ zLfd%+0s$8n0Fn$ftv*a%iZ^&q+Sa*%UP2}wRNSyOD0JL`;1oe36tdSdiUp+LzBS=a zG0TSL(9&K|)u&T`lJbCKu3CpuqnC<%D@d~QHM#;*Ei*2#=t56%U~V;5QE`5e6~f1p zA=ec+B_+hQDrGXMmzgByTUv!1>!rr94mH05Y0+g(Ul-L<^57g_DMkO{A0g5@DWDWoueqe%~O<{BlN9VN6shUc7~>g&Q_en&>v-fAMJ-ijXBvDB(4>5pBU;AClsQU zZ*d(sE$H)VN_6Q6I(426O$4jmCq;U|2Ql`!2VcSfHS*@x_kiK9iM2{ALv+HqoH}1f zhlaNY#B_p=fYYdQ>2){oSCjw}ZjR$B=1Z)UAF~1g@|dmK5{Ebvo}j?vVRSpRYLu2F zWcxbOQn6*Wp|S9>{Nbk>6?SMlgatg@SfKQR&Y=~ExO*j81q*2g{wcrv`oiOp#7wcN z4NI6FqlDFZY|E?wbjq`Dkv9Ax^^r@OBfM@rhocGhn8kc908|2|<;V1?QbK_9NCxn@ zJN_45Lowg>60V}fXv#y`Va3L7)*1f>GL}HcUrm%=c%1UNKzxX90|&D zlimYZ>xhGrwv^e-H|jiL6b8hzO|Mk<50~(cC1*lSw{c~oIPo8xa!3<7srrud3M38C zf7=Y#VRmeNB7y>xkfik+5#}I!owK7j%XJ3AkfWVDC|nyy8nH>xmQ;(<3of)$vafjr z1n2cTU&7<#4QXgq*q@r0Y59byD9Gs`5Ji+cvuvU34Yjzt97&1`E+7X5)HO=}(od27 z(6iPQ}HW~8ahVi_($o~Oc8usU_=`9h8frzn$BYs|yy z$@dmBTjEXQl)}v^j6md~`E#uWH+ypvsZXkHe~5(NbF_6+N>jOAX<3ueSH7Ma>k6Zm z3S}oL$}4D=uy631L8bB5yum$ zi5jH_W>j6Jb5J%yt#CXu9mlLR;Kvk%{GK3P9_f9hw4d##@Y~WGx;s`VsMGTG%~&=m zH@3F;1GmB!w>b6{%{$BrLDx-EdWcnt5)R>{I7-=VD^2xA#CjM_3b2#7VJ)XK1h%8n z--L5X%R3CI>0~6OIg~d}*@u)bbAZT8Gd86-*(f)$8xVXUOK~jhHrw*b_p=Wku;SQB z*!H1qbTHy#C>Iooq!GAmr=*=W*3&rqk|m7HFUzO||H(t4pG<&lv6-G<`CL^<$s zPSrHJaxJlYRxMPOA(X0M9Am?0M694eK9ly2WZiBBcwXt~V!7i`PgSnp z)V5q)a&4 z`OEnonMw@R9V?!7PyH=X2k7d16ABH=pzN__7Qi0zfdM4xXzP+xtJ7!n{Dmf@+P}iT ziM7wm`Ist|d_#h!C8?~%VIdw8}SM zg+BC}_#KtWu5Hy{aHN#U z75a*OmX^p3%2L@`w8Dqz%h?ZkciT86H`K>e(p;AQzkX+Ty)kXethymPUZvt(E*q*U zZ=F|pU{h&svfJUNiTxRQUg@{=hQwQ2!->VUdwKJJQ7d&N9oJWSRs4cEimO;gf7r}} zbC{BOwDTsKcr8+)M%h%AjGzt1RRsA!l6Sp)cVSwRf8AWyCGqb;q)j!?ZKScxW}?-_ zc6sKD&m{^S;FS=hsS4Zb)IvepIdY9(%kt^=&Qg|>hY&KkzjtkJ0j5|nvw zu5xXnq`foINkIiJ6su(mk>vy88k28#zcqh4{DxjCj{SK>I!oq+=V!_jxLXuVzac8B zW*&FA%Wpha%vuGChH_R4{p%~xL)mgErEcZ=b|EZI7OQX9xg{|d7pSy3zD+?3mJPXf z7UOP~)PD1BAu8n_nq|M3hM~i`t6e&B{+}a~$)jfZueSd0ID1JirC?=9#>~p7ek`Wx|Nj+yD%F`vC(!>upTK=elaQ> z8t?hBnemBpuS8@tJ|^Pu+F$kxay87ZTW_w%%b_2tKrt$qf9}0#jMhB+_PdMw1F_bO92|0Gm zurn2Yw)fs4&xe$HzI`?qj%y?2lWVW&HWWATw-hFvd5@#2P7P2J!Wwa(5*@N!^|8EH z%N*d{?|myz)U}N1DsDB++n3XGzOE8ekuS-SRNS(ZtCGaq%S&V*c>(pUDf0;c9f*WB zoo#J)<@FS@$~SFSnpgBSp5fhP6HH7>)g|WKXGNxNO*zz)_gzV{6g)y~dWc*gt;qoy%MlD>6v8P$G8^ zZE2O$ef1HtWQzPrt(PXN>Lgd&MJ+ooA&clUbh+|FeE$G_DpAtmK>z?x>wIDS+#bG7 zI_t^$F^n0!H`OQ8n!k!9W*@IF5;)rFQjSc^uXV5L08dggfN$t8=3=MAr?UMENljJB z*VOLf%ml3Mu3@Q%CBlYeqHwm9k1&#wuf+Mo@lG8+qikGBHIZ$yYDOx_I zuzc3BVm&Vo#~*P`S3SO_gIEg^<6<12sVYr{YwYsL0NcR22vPMGi4exR49_w{rG~gG zM#GBcrd=+-)#q;Og!txgsb7prSjaQYCOEClGcLYLGJ-zHwu90gN{Fv>sWyQ0yMX=J zS`kDh;x7{AxOX>BlyM6r&J~=gCdp8-Ccx-A!_i+&#JCT2V~Z?QS}jV0^@A>Paz*#D zK!x~%dI5OoSB5wEK3;1HPEQ$)5jOt-HG_MkjG$WjfOOc}BhM$)kg#9K zdn7C2NjD@EjZ@d*hC%%VR(I@R#>^u0sdbCe=ovu0A8 z1_4TLGm>;Vl%Iq*KWHw)kl_5ug2OWoAuCcsh_Fx#03R@S9)uWSao%51=fbZ4070nY z*9qtxK|uadl_{LzNo`XOB?C)k%7p}x=U}1Z9e&f%%kStdaB5p~7`cANJS>yW`ed1T zm$W>|reK;)9=)4>G)#@;72A+Y)p=(%{o*!!q zOv}@f)ztgbC`e0SYOJJl6=AJ{N};(=O6Hw>MMnyg-L(2_pXK_I{$~=@afMvT({Qwv zLplSE&6&{KOKkPKfNC~Uec`>W3dfZ-{7U;(k7UIxeABM(za?x^;_N?D!;I#m)9G(k zGzz9R$ayMF_5N_+<)DrFUe>%T2Nf4BH}ed*C8t$7^Ll@o54%J0D;x0DGU%yO5GJ}QY)o&Km2pim~zJ){TRzIpx0r(g+p_ZB^e7_a&hZWcoll-R=vHBT?$pHSU zigZ3;-V>xq!*M^cax0B0YYWUJ#9HD()14>&NxI_6PmtO zx3Imu%w^<@G{hAlgI<`L(2(+-XpzyebX<6Kv~j9BnIbUYG9HceXJ}{me^{8s5>slJB{M8JFxktZN>i$IH~Tie+Q8A#_rvok zl9uM9OR$f?T$t+EOIC2r0eHq;sa56-Jlo~coejwuENpCdKgJ%zJuNY;k<_S%d|Sbf z@Ud;qB}Fptx*D1%VCk?!<3JJ?23I;})Bze!A3urArOk^$AGnEzrfF`fwM$A~aSBS` zWZg+#LzyeGbv8CTkCaSAQFFkaG@^>>db08qxoJ}{+L2+OI3Z1L0a#hnuB2WQAxVyw z8kPDZ6ILf2aUq{)DJZ{v7RvBdt?rz}1Jr^ciSiwYyu|ogLldzlAf+L>#@t-QqHkqp zW!tQQ)iza>HPGLrGMht$OUD!5(%vzeVPQ|1hULHpnJo@PE z&|8LFmSZDww-1@?h zGo{)7Wt7a~N}KPJiuCi6^yRt&6*5?tTHIIw0oK5$LT)S}eY}Mtzc8DA(S$1_?$qTE z{Ns8i*wFs~V&2X2*n*2ro~E{CXXd1uaSAFv%`~8Z6yBiZnIv5)7E1bS2ze+{Mtn0? zc7wtR$r*-JCR14Ca?}V@OHm5B8W2WZKPZVO_=lGwY<5=SB6y8UnWt8UX64e{q953! zn37YN-oOGZ72-fQhFYdLnOD4a?Cn|M)l#C*A#XJqVYLulQ z9`Alt1nKISmld$fWsu`s5XL*=Eig=}X-vGloZ13Svni!Gn;y2lTie3jVWqMZM@bAE zah&AAdSS4~DK9%H6=z+UmUZUY8BVzoZ0Z8Us@*h)M#la}7CS-4tyQy|Cy=baWC@El zyN;J5Uq~7{hnI_3MXo2)Fq?DDIK;rLs-H4|GLVM}by-2Vu}BI*=nO~YW5R-89yh|H zJB8|LThw-^Ttb>jyR5RX7cToMxK)Bplu00zn`?Ws;p*KE>!Yj0ydp7v7@w;LMEGr_ zEt%9?y(-Pqk?g(Fv6}Y)5_eZM`){cW7YZpMr-zN4Y!3@7T_G}$AWYQ@m1BiuwdVf-l9KL=f0Gl22_e8a_e+?W z=E+K#rMiTXxb8Sf9}B}d7`U9bFiLU07^zb!4lZHrAyQ23JcF6XWG0fATu910%1V+{ z2mookH6>5tDKYf_0F%Y3Vi|EED9A(eEv2;1DH;H@*-j(_VxSF%g&|vrYCJkjQ_3+^ zcG;Jh!cwajW%_kVr&502XPgSZsTcK$t6`J5+24dua9@ZZIIe88)SJ@iSl1)2wj4@S zNCLzH2IlsKIa&mU%eVT=wfT02=$A;h!tpnUc80PL0#197yB>xt5gD=0!&A=4bLw(0 zDT(>X);E#+Fijt;vI^44^&V8v-i_n%T#7j?t62#g-4RbAWm4zsb zst3L;exlZjZ2UHz(PN7?u49+QZV00hOf!h72nm^CK+no0S4z>TF3XKcP4(Ohbi5os zTG@(}Y+|@|BJFLa(JrH%>P1Dia%#V6aRKxs0j_0o$VeKJ2#Kg(obXvdzxe(mtx1jtZe8j^Tc3%x*MkSdGE;!(QMMFT8 z)7%yWb-C19JFeH?aFl3^RGR%;2IDC&Wo=H1oV2`(+BfgDH7eR{2-Iv;k~UI$>kAp= z$CtGp7o5W~Zz86)ou5?oDN_$L2o7s7meh0|?1@NLfLs`PK3{!?CWOWmPcMp-=<%m0 z{DWur#JpvE`H)+Pb9~H3us`Lvf1V;&Uzq|#x9yzry@f04nU=@kZTZCRBlu9t<~U#6 z{g@27h#tSzXOd6DmZP+1xY_6|_*Hg3{6Or#gDWggRA#Bbxyy0osV*%yR_5L756UW+ z6v>YQWMijx6s6)x1XZXLGgSANbvE0p2E*)<3Q4it8|op&#p&nt8+<+T6Dr0S%d`9F zV-!mn>SwwqCEHOcAFQh+e`tJSc0MOj5_l+-)I3d1$5MgD7Kw>RlVf5oFVR*yC`9D% zbVO>oj2{y?debt?rq7_iNO+Yrujv_AidUct9tPl!kuEV)Tal$LBp%_039ey`K{G?8 zOb=(9LYaNk_mE}RsU+J%0N)9>moQ?-3b*@7vozh6T#gZZ?hP0P3Y3ArjK z%Znw=?Hkax;E#1V08jp7DrX}8%EFs)9Dlff7Ym%`a^ zWTmtl7VjvVsa~YUQ;E*!%+TV;r;*xrXzEFdrpeTCpMRNnY*?FddCBm+I)t&m;t$r+ zDu_E8e9is{F(Ly}D#L-#pQ7d^zRR^45&f2)R9Hxki@U=M=1`KK@kt*c5nnOhfhZCJ zX(cNGNKy(^ld(w}gXI=HKQc7RQ|)nsu>SxLt4jI>;!BrP?F9uk+V>$U-{BhUPw?C3 zRAh=zVW;3<7HQl(tuh!`+swyhB>D3Z4V{+p!`>ocPSZ>! zqL$S(!7D=!sU+O{#k(l0)NK{>lZNP<8j%J2UG`jF8<<@EJqq?WyU9{>5Yo=+U51G8 zJt6FQRz<%tnd73f*2}bq3LR|b9w6BHg9&3?iw^7~z}k&^uGS@-3Svr7m7z+y0*D*x zEK)k_9G1v(D#=Sh;w29oVw#;!sITS#CRL3AN`ejZD1)`d?|4L$OJG~E{^B1E=osw` zzc{u7XhSxI@K^kXOovz0H#DWI{&oQcGn)*Y=MeC| z6sl9Fu;o$COH)ZNO3bY%B30chY=TXI(LkN7b%Zq8)K4~Qj#gA=q+D)pSeTfWsM+K5t{ zQh`d6NdST`pz1a07g%L#{zMt7*lBw#$y7LmxvET@(q&OKkj*UURM0-^O^&xPrz%Gy z9m{^h922B)T1$~mZ1WZfdF7nTSt&Qyp!5PN=PM?m7kTV%DRzKcx9PoD!Cv5k-|R7=ytw_FSvWJha$5&Rx-RS$4+9< ziAk>e>B^LwYNYH5^BqiGV#%wSUpUaL;!PQuN062i-nEaJhi0g14#lSp@m)`aM9foM zK~sPS*>NFAa1Zi<9STT@`7tT2$K#R5ks_7bLSjL%9i^zOZa`5@{JZf@lYz2)IFZuf zPiXmWF3u`QOY$CVqT;WixHhl_N2ak=pNH_txU%aW>4YWZlAA z)C!Yy*~if>Ft*a`MbZ+5f=IAYI;%}n;S`G#d!loaMRN9yrpVB~n3H8mm}I$;C~aX@ zZfQbcm0W*=dzh2tpq+YY@GFl00DTI4yFHEv7BC1!6AaN7qJ_UOl&JL_%MyPWmy={M z9m_@GPYdKYMMr9%Bo5h@qHa{8H6}4!W?vE6qrnX*S51qdU$DRPOji=b7h}>tkuqR( zb@BfIIaLqKn1nsJ#+vH200KJo&@8y;`!;m zdO0&~wJeFo2(fNqqNbOo_EmzCPU#@UrUgWKl)c9Z=c_zSoMpX8o+|hS7}a6qz6hnt z_hp7*`4=bZ2$FHOmrq2p-DzpRF}aMYL)SOiNl_kF=?dZ=!ZDM3gWS3<7m+G9X^CXq zo{2!*`VCBE^S{K)tV?7y-K6QMnQD`Yr48PrPc@l9-7A!tP;Jn61PsYgIsh-MM^hi7 zLrU`1B$YG(ZvESB@QBVs=@r4+wWP5(Mp)nJtDnLX4!u*!G1pF#OVY8|pR_RZpx z{5!)*Vo6zM=iTI^Kuw6&!+*{%J)4VEud!Rj0%n^B#P?PcsU7X2gW4GNEA6pw!pgSpO;=dXpa)z2 zQ9_YpWfN2-fTQBpPVLVq{0fY1vA@E;AE8M;Z{kS~!jlPS3OuC|l(Mv|j0uRN4z{PRli!(1mJIG{G4bi|cd%q@6@raJig1kn>|w zBb>EvrNY3a&Y=}bE2=9GNrfp=&K*=0u|Pj{cd_t`xN#O&OBDk{#%yt#y-Q+}hl3Ii zDrwgo0^r*yPL~?_+tw48GEv;_JZ|E>Ec6P-$0l%sVUj=BM++eUvU8?3g651|!bRBa}siY1vAXV`6V@E@67CVsPqN z2L~~Xj~p<%SeyZ9TVh^uuxzxcKI@6Gx=1!4`1FWb{{R;v!wcAScxlFY%6sa;*o|RR zEvEGO+XSLzl<1VHS_0@AD=Kv&FkaW;X*P{V1)BMeeO0oy@++iaC&Sr`Z+?I`=cDQFC%e(dl?MGI@3#4g*a-+}%P(eMM7pnOoO&G6q)G zJVsj!+SiLnZirlnvqiuX_?L=}%1k4e(p0Auo1JVfKNzgzC!sgwPT`}eqVurys%bSw znQU3JDv$@FkMWF8j@#VP_tdbS@S|s82vtPxy)=mjNL;=U0ma#ty!BXXwGRih~SS@1S zBxM9e-YzZ~c`^jBN&$FT+9tVyL6k$+Yu!_Brr-mi-pUa(P|Xb6oPVrgdV|Ylz)+_O zvZ)}04y=r2#FyMS?IVY{s?ucZs1ox-M7oj^oBUP#qGU3u5vK|^IE&e)pNOqC%2PDS z8a%@8vFn$*VN=GX%tU75M67AqlA%jUdPDicL+se|2ay3W5_~&ci80H3$jvs)));%f zml$;?Wdf29#w+IzjF|~`CEo_SYgVv9M7-LQH7uJ86pY|`5JYEqzhgr-@!9(xw*fFkm}*y zHD^{;Erel~En3(0gbp35ZCp4@FN=|}@g7D1M>3~EN={~v!1WMW#(-|}c|aO<5x_FB zG!(Mg_es;%06K3-7c>VdzX$-v)RUxHU}o`7#sD=vmmxWZz8zzz;G~eGwKNThN`|0# zhydeF6D+KX7Z>RrKxUSh3D6xQvEVCJocEV;Q%SM{{XCQBkJZ-kz$e2 zdW$R2L9au&`VGqh$^2aVi=HL+i^COJ`FCbjXBkl~xRvBmN&dBn@*>csH$CV|#o_IK zq=3MEq^ULBjUr_W2EZK1C-5;R9}wfSA?4w3b@U``ol%OaLYi7te*z-T8587IPZM0h zeq0`q@^(gWql)z`E4+hcei6qJ29B*8C=h=L;y45Ht<8&{cx*%tDS~u!O)Pt-P=L$}_oTH~9JPONewf91YQT#+G;BzqSv!v+bCvZLFpW*8r18SpB zYN&ug7bCh=`5S-316FZtC*;_B52)xuPUGHBqT^}-=JyFYD0LP)7;l)aMy#$Qa+2{bTqN67 z4&uj>x+q61=)0e+B4S*+n<*B)nxD=VAm>qMkySwe`=?J4>k3<(dmWZ(`J4_UfZ!Im z*pC7~+{1|pu+=&L0HYKOiTbsDvGz~vd3nN_!!Nhx8Gz1{;jDJf7}{}{j)6#5jCC9} z(aw}}ODPIE+xLj?AZL6`1n5SP;Dc$jAnKibqo)I`g>E1?YrjrP#nZfZN!vXx;I>B% zh}!xX>H~D7qM2VhQx`v)26=x47pws=^>m9SE z$<%0Lpchpnr2OEpG?`1Sj`fM?K>Xu@W(Mj?ZDkIo-UMt%@qwXAM@#DFM&N_e5aVLh z=s;qg6w7HDzhYlbWqsaXoWrs65o^Vi!5Hyo<2_gBO{9YJqel7Rc|EB+X%}h z9w(O0npp?~)ZX`s`S6p6Cu{G>xx?*9wNGyK{Mj2`;O$R_EidTiopP@}<=mTDP?wgu zB}KH01dHD&u}SL?^B&96O%PmOu)C2C_(n(*4 zN|F|KHa3C9B&(lQ%YT@yO-|qOKjFRWf7n^Jtwe?6M z;BMm_fDN5-*m*ug}YaLVOrRL;$GcuHUB@t1YY-UTVCgn+dlXj0%EUuOj z%`P=vdu}PKcInIesqCxa+{*V3={#dY2n7kCQ<5enW#x%W&JnI|X5<};QlKxqE;-&d z`|sxK=hTgw8!O$mx8%0v$b9J(hIoxG+eu)xNNA-3-`82rbx}IPuX)7H|Wdsnf0eq*zD>LJg<;%A+ z`-IG!sd|iF3B;7j5A%5%oko~ae?;=qq#AU@gT7$$Ho)gVJij4fM#SFR=Ei{#*n8tr~w}*8hAoo(CxV80x zc8%Yt?nuT zf~7RgmavhzDF;A0lVBm-Slph%=JvKSR8BC|-kYbfNvBQ`Y%!>QFzOTC2H=^;kjznQfMVD%(X2pUu8i*YUNpwuZ@p{JEi$Ah;-lR zFXX#!(x)DBo+(wcGpbCule@?xa8eX@^AXBxs`W=SC;b@9;?CGK*&3LYa)Ve!LCp}- zCG7L5BTuPOQNQefVJZ$>n)Uuet*G>VhjP8z={!28p~<{0UXyLY0v9zdQiUk%V64Gl z_yh8UJZ=8~dOo6*mpXqXXG;$DqOW5%UY?V}v!yK~Ffd;$DnsmD(_ zFO#vz)9C(aPT?Na*v}VTnsyDHQ#T;3$#)xQA2qE&4^awu>-*99ZgX1dn)uQYd_(O` z#AzwyNXyVe6FuEqWltmpZJEoIqv0R7T_ielf=^Z*5Nh0MQboFYx|p~r_LI!At+-=ecy7T_)|N=hkG_<}}wog70bvQzzav;iJq!ae5= z)jI0a99S~>C($)m`LmP5{v6_5MJOJxVpkBb;6mkPT1rcI(#mz_@&kQ{x=%w9vhi4> z{3`x8`_VHW3zlESx5+Qk&ZLiKJV=M1_UusWtX!65P{{UFhlAw$9Qa}Kk z5gd=SoL?pBZ_!g7e$Ur+ChN1M>g*aPWLz0X3UQ+_?9*BUSDF9?dCIg9R1ZLGbryu> z_MGOnsQgl2P1s`gYJ*N!FY|6+S4-$-cd@1wl&UIzYMO;hI)HLNH1x9#zBlE!m?=%G za0-bBrJ)PjS(2vGUE0(6^cC(Hr^?&DOYuLZ)-5p)1Tc>gB<0air5;qFDQPH4l$K9R zDeS?=5OhBAJw>6Me0E4~o43}IUarX*eV++B*{_Ro^o=2HfpFR3q=S+;e5Iy`=$n;j zIKyO{*~ynjG^F+Kl@5drA*aO7d$!-hm#ZCI9yro!lK%h`r}BzA6q%`tOvsolFsEK5 zI;vYqedHT%C%qm?dQ^+>I!O2}(7 z^T|;+QCMBsZ6^ARxpjmrnqB_)`XT=S3tH1wn(~Z3U0K~)XC0kH;+<{8Eh6pBlKj>0 zaJJfGDid+33IupqM3Z z<(lQWYi|zt{Fu81bb400%1m>c5kdv~#i4jb?6H$xJ&|M2ypj=9VXr+Y;qA zwb}t3@O()sP0UQ;@Y#VWL!mCYIIsa5u}Dz5`p7Ru*+hHy)!`Q8%Fa?@jDnR#-H z9SzQgELK?Zwdz$$53}?&=olzsDTdpaa7!}bw>?Nwk`GJe8+nVtEUG?dBac^+(weAM zcxN!F`IdXQs|LTKgBU}|k*@8OBrIk{zw#!yWq zZy@+3Cd<>M&HUlE&NMi@JMFQFcu4bf*@UWkQL+%JN1MB-9u2KFUHk&`2t|#!CRxV` z`%>XfDa)57Cy`HmAElI?TTM8F0Czx$zp)`IQMkUB2Hrvv-3_=O|JPh_8f9|_oED`x z)6*z>J<78s#e`~gJ=Fj=uo0ceiSZrI4ofDYW`R1(y0oZxlCy7wH6%EPV-3%joMFdo z2z}Pp2G&rphJ~BdrbMd`zJ2atLPzR@Yy5i04v97?slzi>7TY8jN}VI1x@>Lojy7~y z(q;>k_UwMFwx0Kq8V|-ebX(INT{GCjWPnh$C|^Pal9BT;;&nnAv#Z2R0V~8ARmjYt zDrv-Pa1VO-N!P+B;>hv4B4mc7SIDJ3fvOHs=70+~EGa_a)D6;i7fA6sj+#b}6H-=E z&Kg}2?})e^ydq|%8f!eX<2evTzM5@&9?q!1CSx5t!voa0;Gh3Z@Jf}TtiTtr>MDyq>74^ zmcE&5G3j=bkYC2h)6xn%W3z{GxALB9S(jK76BSG`E|nYINKhrAYv11ky?+Qmvxkc? zx@dpM`6pDi43wQg`y}KleG5tkZ%}pWcD=}^@s$6cZX-{OA)M0p)PC-BYcZXd)gK0}F> zQxyq!@{7zFU~_Xv_(GoQ*QR4-Tck4?+d}B&@Ik3MJC#Wqa?0ha6s1o}Ek^1~tf1y> z8x5{?AtV&T^d&Jt+3$-@cAln+T}-8nK}}9pX04mr5$@!8E8jx>)r{6YMms3z-0F5k z%w5^7cq+?%W-3Dx@mZA z#O;%Ninw*TTvV!}5Cp;>r#7_#t)?4bl^TNkCysk;YHX zE8?SrG430g9_+-hW!-JvQ@01;Ps$le(-cOmFF|=2y0YGNbEKzVQv$^1Knr}f03+Vi z0k*faIeQ2&*SLK#EZtJ0I5NJ}yo2dwBlKum`M@998XG}pXq&t?pOvajzaub!^ZwrK z)RNXS6sa=o`?uJHxI##=wZui59g7)GA~39Ji&ZrzE``fWrKu+$SphQ-wxwoBN~}~; zNo;OAq~6fxIMN9*nc%k-<)!JhtP47|OQxXv^6Woiq_P}39HUDGfSUp|Q9U9}bsJ0u zcu79G-A@fq4ovc?a>djP8&3yimp%5}Ne#Fu@L=}2b{%*;B{TAwus zS)3$UK(YoS3^1$cDJ^1FC95*eCE013T*4SqNEy_H2SH8sHvshM z4`6#x+|b%~cEuvKi?G5N%br@DKQPjE&il=}QrSOrkUcer+OY^%<0^~I$V^m%iYFZp zms-q1S1^?@rx`ch0nE!CE&;qISkR>-PqP%mxc0S)otZ}{)#*r@C`q^h)sJ-l03B}; z@~TK&Sh&HIwaD<#5=p#nsdwj+3GlK=Fx;QwUm;783;P{5kw};$ zNRr)#R^48;KGVqxZfQZar0NufHuhwn5Jr(7G^q|j8=O6!M+@<%5G9&yH7_kke6-Ne z1hO)=1-e;7UkFT{q!c!|c2ZJmR!o9Y6uMlbzeOoI!I*Gqp;Ge>mq;7Kwl-~5ZowPiXZSDjt z9X$7h3qn)0rwiJz*X9LSnN&^ZcFlq{@nC-Aa= z0#sEeJl7%h8@H5#+o}7=AdoNMP2%qsMK!SsaiP7HopzX|p;u01DGDAS^oIlv?h2+q zJwTbAmRUpcbp|pK*E>qk>NM`yk2r1aDLO3MvOgM+5CpI*@1<%)!x@fdl$0rb(tYMu z5};A8Q`RdoW75kQWV9vULU7Vt#JE*vc84(PCQeb3W|-<$qLP&8R?sC$QbI-0N^UoW z-R#E^B=CkUlA=j4j%sIWm1$YIluc##8d1*rP;HqhDhc|sZY^zX4ak)fkBw&LsI}=u z77(dW-0Ok=0JqI*oTQeIf=B^F&Jv_5Tl#*Y`j6SVnZ-&K8oC^MR;wo?B(`2?fSl|h zD{QScx~-~BlnzsCz_RW&p*kafZOWsSB~^0-j!i;>+HLynKHE19#{Drj@@6KVIrlvl#aOlAG0(6`|_mJ3)xm}wHK8It(Ow4I7b??!5J zqSYZ$>?W5gvdekPZT(wGAvY-<)Q*G0z(+L&9I2XnRi*<|jG@NeK+e;EEjsQ9HyU`v zh)JQTD3(AEBJ5EtZW#sNu$ps+`8rtCej9zg0Y^u!zpt+e&DAC+Q zB=X-$Nd#GJJe?FQK(dl_^BYC<5mhEbP8(B43@US!`S4RT=qY96u5_OQA}JrBk*d6hFkjOAv{yhR^0UUVY%-q6^j zCR=Gtm4a`W+<8OMLRgo^Er)57;QhH7pnv9)qD&CnnOR+zX(_Esxtm;*$Y1=@msua2 zPmvuL0fZ($m;`jx7>fCe8}2P)$FRK_X_irK#oQ@ikV1NZM~qr3=v|$J|Sm6-`?088zP_!{dR;j zg+*A`O>s)USZypSc3`xDWTTk8sU84czgF)MiYmfy0HBE z#I*A&lWz7((p0p8=A5^%@;gKR=X{vojDztfwz8X_G>j<9XI;Kf_jnbXYElRm5hE7? zzTk|IxWznY>_P*(YWfVbbTVqC~k3q&Pj6v1HC2qDns~ z*?7zIU3sg36xdajd+BQ*J9rq#abLt}Fme^Mld~Akp;e-{AeLAz8MI3+X(nArAxcYU zL=>o8fSYJ^yjQYfG`mw&6N%*8eqEpuCgLO+aXR;sl(>}xVV3tPw%T6$!ttDu4)}w_ ziiR_Frt0~5(rq^^l=T6vfj2iM`q;$GYKA22l)a#4IWt&RWG5*0IW-Rr#+UMojDM*E zC+J9S&FS`@B-V!6*uVKe$8*C{p%~o?4lUwpXA?05#H(rNO36#1huk8;E^`f(fN=^D*AlUTqJ4Ck&V^%#_gBvO8LlxOj7b+QM zd6lO_kfas1zN8cr-T-Pf5GZsxsN`Xp30Zt@{OpkhnzbrgX;u~mNN}Jmc$FlJ++N}= zaH>NRWk_Lq8Zj>tYjcm0l3s3L?R%x7r60;P*tvQX**TLZf|z~kY`tQnTrSG1Ke6WA z8H*5&P5tFLn)S=8aV5bz=2XK1eb=E^UBJMR(S zG2~b8Yc>ILkl{V=rowII-PRQjzcY-m`f@Wgi+$1gLK3sB(N^8BF|&BD98xGi=0us! z;QeARw%!q`_G~o9`?8aamZotrZY-3gO23`d371=Owi?uxEzaN?4L9p(&`NqrXvWER z#SRLbX~T3=kPo)grQ4a6Rfb^e3Aq6D%q|Uxihp^z7CsKdIN<$CYP&~ncAS5n$jtjx zq6xNFl0LpwM&s(-?*Xvy4eb&q6+f7W%Smf|D&i!k73tFTNi*GZM;q5OPNzk-pg=cC zxZ7R!ifM4#T@&M$%6P3xW_udSj*gZ5lw(H)viN?5WS;DCyA?6?mJ6R?k`Ef#V=7jx8Xbv`lZoIXoNKQ=04eB;JEn4nHH)RU`0 zNm5+OqAz}i+u9w?I(rDi4&=-1Ey2mjnU!KHiVALwtc6&UeM+|`Gd|Pew5>f~GWUeR z)U|fj3W836>GRSvODS&PQtz<;04DL4A(NRPI;Pw}N&87DCgb5_8%`cdX+I=qb4N>J z_kxulZ>P~v2C79$UjG2{gxLNYM9cj@GBpjh6rh?_Vu-@^2wcb~^@hKcNaQw$+q12%Ho!j_0qr1s!b2H&GM+8 zrA?bDKK7BOioMEq=tg#5svaV7E^2uq>1`^p@+z?3$}|4apW$V<2DdKZmU)xSC}^OC zCh>usshVi5h+*4nvsAAXDUa4r3pE*b`}smjTnQVVx3^oxzXQZ?rS&2482XWmv$YLs z!H+P5-z~eB_L2^tgkDiuWxMcJw2J;8lAFGZVFdYUtWxB`O_mVLv0q)OG17R2US^KL z%-piMj*)v@d!olr&MbIb8W+T4E=w5>(N!Ph-WW2&-Pj3)Q1BxA#EddyQ$$(gH)E;>I#Hcr36q*h3e3_F z65$5|A+kcJL1g(Ss>JgX-n9PzlCSR0SE-W;eUnTHAn?X5~F zKBD%CamwOHa7>;2FYSp)#f2mzgpgR;PTKBpYg_hg(W&tY?=4xjMlMNgu3$RIiL>IIm|s zd#^(G4;ZDh56eYSzI3v~iB8H+{)8Pz#wnb1^DGmv7f@U1NEQkZniO=MT3m4~q9!h>O9|BfN5inat^FNh%glI(d&+D$a_T;EIDbAQX|b4IQz*IBh95xg({{ z(B6SsjIDz!c9xTni(dDH>7cWkB<3VFWx}L*D_@52-iEmg)n^)Ywk9;0Ym|QSHucbH z4Ya!pMnvqw2cfD7IZ|b>PTA- z1>5fnADzeIAZYEG8LK!BSK291`&<4ZIeo%`sL+#CQe8nFVD%nR#&l0qC=(KPQ!7@V zX8L@O`ysaxNu9b?XPNbGq$NjBC3=pA1i_gq6!pA}sk4c_@~d&^d_1ikaXDu;S!tKD zUb+H()o*VjXiC`Y6)v&u2@bHkEDgq~SCWJ-gxSs&4r)kJLR=f5?SC&1C;;op&MD+~ zMt>A2>OMVTNaHfINS3G)q>|bDNw$~sPwx<_IcFMq_0g0YDb9|X^neXNq+C(@udGK@ zD?*=3{{Xf)0=}0xmyiI^^#^edAuQ?^!69F27eY=Wsd7=`LAz@gDLoIAGSxA~xuPVP zOT}EUlCh$Nh0liC7;T|eYClawR|IBlM^va@-eLzD4OSjjkjVw45{vzju^wF@(i)B; zX==ld658$+p-Iq>1K?wdG!59Kr_>hPnH|#mX$~WTj;&16sVM$7~KG^f0|pN>7oF*idAxY#S_+Ja1zF8#9Y>v}bC{ zw?a4kL?xlb&Lb68>K(_M0bNG_04Qn0S2Q~unt3yqQNT3X<4Z!CPDe$S001ky! z&HTnS3t~m*sySPo#8pAa_FxNa%crJm+Uif&?10{{WH| zTqve#G^(7`#dX7;Y4-?mrdw9wK-j9oM4o0~Ksv`YE4uk7T|Qu>r54?3>1%(#BdI4f zFeYXx6q4HM?V(Dk)a+VXT?4$3tNma-Yza=;j5gw{pUS!&Zv(EUPbYhH?k;ad?zKMap!d*NRy9(jW#z<-jJmQr zlPE4_*$FAI%6`^|!X|LMGtT_F{>3*J#4Z(EdZhVZPchqZ=H)EIDFG-JuoeT#H+(+~ zlKhc?&%`$T-!^ibe5U3tqY}BYDATy0<}AhSF(f&XY=;|pvWT#?_Pyd# z#*rD$$2x_?3Zs=2g-ddqK|I1#LYpID)Ho07+R(2J4eMh^Kg5Pp#D>{(y0>K%gdKM( z&2RU#H7HQ@Wn}5YH7{ymX<6?Do#F(^DBM~SgL}gb4<>CT#3)+v5=fZ|(FpkC!J2(p z<QX<$OeMtpw}$kMODubjI%znnn$_QsVsRg6Az=sCD$0S5_;1XL z@<+W5l=lzmoNQ@w)0EKC5aw_17dPvD z;!H8o8z&IvbMOWqLNM!0%OjR0NiyR1utCrR&=I6gjxsFrZ}B)BP_Iwne_^Q0I*~6j z<5KUX)Rm>O>9QR_%#suoa-SQGtr8S$X-I7GeAB9V3S7*=ep0C@(O);X;vK$Z7VThz z_ilY*NgYxgUL*wc-?-ms%%Ak-?|&lMmBeA4$qRL7a0(5|)&NllsoGoQw4_ zUz!eFpQED76Zk)l%;zoP=#0-i{tN3#KiBOb!rTPA1 zUlHMfR4ZJ>pbjF%6HJ7m^xN$sV3O)oJW>JQ#v;6uUF*wltK63u#n&%`{g%dhPbQ~! zgUg&YPu0GK%#^5Xtj^d2;z08jghFqlZvHa-#pK4Kw@EK1qxo5eebVV{)R`qu=%7H~NalDbu6y#*zY6;E5rz4Gr2haL`Bx!!%PdqHWm1cJSh9I}Wzc1U zdSzR#=FA5|n|VYfB)4Bhr|QYAINE76_xw*){G&&84mjIOWxSJ1ztyC+r(7qfQ|_Ff z8vr~YjJhq~!MFai*h7u9-Nkj?MSrTdITQ0TtxX0e8CiX8cR{?){{UcwWkPMZzMV$U zC*Pl+;(rc`R{DzqKN#lY`FE1g=OVUI2=Ng;APvkqoveOjo^RfdN+SW zIjuXTyXzHC{bqX!(zo$+~dK|@DQ~X_S zc`sZ0~^=PS9Utck2^*Jde2{-pn zfOYYL+ULJ(cl6|rK`GXUUEEcFx_g-GGc2XXl{^fiZzn1fGU4T@+T;mVY)Ksols1Ju zx&3*1BbfPqAH>)AR{sF&NXEpYsbD)S>fM!XL=wA7O4x3a&^*Nv(&yk~zYboD)0x)y zsU)QPemQ#bN0O)O+{8=E2W3hQbxQ=wvaW>=Dd1MI<}@%{mnCb<@UO2hX=DB;zxh`; z@k%t2%a@&}vW6EZ`lZ}Y)p8{pQ&%L|A=!s+oeqg2!^1)$e-3??-&QHYTk2N1+?s3U z6}i%vF4Ek2vRD%;H)RQE%}#@Fb#oWU2Z6B5=Lavlexe%JPj?iz-$Xt-d9#O8pA^Z7 zb=0L$%j>#JvjkKoQQ>4GE>xYm+o*-5T>iVWscTO|w7NxjarJj*-7;0$Lr#>;%&>r> zw%nbV%!FM307oX95Q}Vrt7{JHYo68J{(~|~T@!EoG2i`WZHXDzR;4<^CMhqX%M%I` z^0(`jSG-o0Zb8=mH;24dx4(tDUW8YQAH&zlYL~51r9XzLIIc)DF-&CBnR3J;S-ELc zSlKE7q`0B`HifPtTLJmuXTs!03qG{BL6p+e+F4N={ zEiig(F#1&5hlm&Qiv`4F#`pC5Y^&}vbE^;5$^hq3!wLN&-bB)# zPu^NGr6FE~Tf!&e;^g_!SCa%+Cw~pUGhYdIN#W-XCPTqGX>GD$Oo>9~RB+)X}CTp;&K8c1K3W$sU$CXQ(%XBhhwPU4!1r|EMN<+pWHe6+Ms zbm|lWhg;Yiz?})ufB(>Uj?D%=QLh|=QV9KdhWSkE*~J2*;ZyfZN}xnm3^bweP*H_3C~}&dL+>F9z4>K+LoKg(ke#unsBL)9!s%`!$SHQS?EvJvi8dia zQEmSKe}>UN25k??kn>{HiuaPJrxweDv9>6a~*)h;bnTKCtz-p|x%Zrput4?y(w6+!iYT*TAIZ*{<+j|@72zv^#BB|xhQddk$LK3OUrlarK zC`w0yY`uEJY;b<3FlgbfCN4IFr4rJV^h%qXa$8zjc{e+&G0pLYUg&p|J4>TW;%s+R zMB;hP$jCUkbdqwR)u3|@o1W?ojlj^@UtYn|LZ33Xu=3E}5vZhZ^w_!mQ!MZA1}2S? z6I!bB$=bQu5_I`R(Wl$BH<}@qML0E20^mB6st5p`4fP@*WQKwG%TUO6#Nirnq|n5a&{Zi>R%cX_RDj?aSJJ^( z7b5;TM4U3chUSXw!%_)eC#N_CuQuJssfT1Bo;{@aqx_KKY=t?uLZs$XB;4~t#D%uy z+drzLf8wEN8hb^dED2-r*y=B&G~FFa#a1n* zKfub>6;m#AC1)IZn)As3b0sE{5K^>|09q8Vq>-hq=?%teUm<#EXE>8bp2OH6%TKf# za#F6D6j>!X(I(4{g`4h3I;dD14FowCVp=tLk4Ol|6bF(?Ow$y{EP52n6j*t8Zyj8Y zlNXOvSqlC!!xD4DnJnuCm4v8*7POVMbtHl=QV8+zA{bnlrZs$YTJSC)nW#4EW#1`g za!qQrl<*cPH}|iVLoZvw7ii;KiY!x$Q&`2db|3!$kXhP$5)P~m>LyILI0AMSIuLam zS~`#knM&E~vbpau33R=F(mu0!G`G=5)5ymi>!nU_*Q z2qsPv#pjL{7AO@p7UpHCl26G_qq??V39wN*f|XnX2q2h`k!jq14)!E`j}v9E78tEa z;zq+YrMOd(v6N1@<6N}NFbNrwK>Eu8l#QakYTm@e_86%g4I#w*4~J1Or65bmO-oC^ zdo;x3ZyxLCWTk2DB%R3{L-CVO;xyxEfjlUzPT+h;AuE zWy(~^L+itj%O&!Vaz8BUUszBegJ7iraBh+DitNOQGkXN$d5lkiv5KZpl+2_RIEMYw zwK9-afxcDPDL$~wl{767ce5g* z_zyL>(p0c4^zBMwps5#&blRhB%d{IIPX`^!g|v`0X|$^`R@N8k5>`Z#+-1aXIDx_Q zGchGhmvAgKR&r%){YRbTpkCj5t+s{6XB^1DKhPpl6rTM zq&s^FEpG-@8OOAV7iLnIS)G(;nu0r}Su(6!rHCWMMRes%mlbG?9C_^inoNU?vcr`M z9;-5-sZ&y`=(%Nqa*@>wD${7N;dq_*Bjv)uGrr z8vG%~I=2GnY1Il_g}lwWhk;01RvVdd2I*Ft5IRFrRzDe0W-}OenZ)U!{Si&mF+(7& za^+-6O%(uC8%Zi!RH1CiPF$+-5X`PW0%UjH58SROHHMx<;tacnMt#TFaAk3qQ7oq1 z3LAuyQc$gwlX$M1+?=;wpP2pN>Kx@u1R7;I;LQ4D1iNe8Hu4%s0O)kMvC{T8hSayQ zGE_i*(#$IoQ|4xtjE_uI@cNxV=(I|>76$qPPr@y*zsZ%kP}T7MeQM&-VJ653r~~@e z$ZhiiEO9@`uF1@SxXN%UxcbiNsVMxOiT?n)E96f;*YBn3S_#-pxBgHDEVF+P-*P(U zW9$~|O;qs{X&vIkn!)nAfge3%E$t%Pgz8w_t0HOO;rk-OGcqkushgZ?nJ(nR>kYEf zO59qFf>M!kNrc5&#^{feU7#79P&Dd%%*#ZJI$Q3l`zbb7qtC)EF>t$EAOG|1iaIT)Fhh~wxg7#Nxi`a-XO(C6T;sz&j%7&o;&Reg*bfL zotm9(^w=q+u(YX4N`=x5)CK%)6<*@{qQ~A>a=kGxZtO#dW|na5m~K%d<@%0di1AX1 zQ2AIx@Zgtb#^uD1PiJn`zu#7TQLAls5wlVQ)xM~O`!{J*X}sllb_1OTKj7cF|=H6 z8Dz^#EeECT5t!)Kak~wfK5g^CCL9bh++wS%@o+dqCB( z+s;fWElaxni|T0^OR7k)T7}34+vNZq?GL4;QX@I)8K0w{t0<`5YCGEI3Iv6n4}|Yj zNK%uOc&g*~M|?XS)kDKc;PWj3nC3nRx&6?!i6IV6j-?ZV=4bSBvkLPGHvFTv6mpon zl;9YDM_A?gtx5(G=7UQHbF##ZP*}Mxm2|tRAG#QnljtcXCgwXLGlvH~Yhg(QdybNI z^$^^2v#!zDPYl13trx_&LJ~hnvOf#{5c-nnHpe@IH6}1;KCLzsR{M!aN^N|A5HvQ3 zTuk;J!iR=qv{fOxZ1kklE+$FVUJ4{xS5UT4a{+R8^NNW{GHOL%c3Ph=V+lgLl(b#T zeuJb&Y*~7BdWtA1E*-CLki0{C3oE0v?+#@v>P{^Z+{8MrMEVq0^-c>0-$(|*DgXsv zPXTzJ!bx&ue9NgA>pU8#P0NRaB`8qty4s0Pm5!jr`oj{v%Eo~h273z337UMyRkm)0 zY@zsCIA;QEfm0tT;AHZqK|WoZ~d|67W(f zQtAqMb|adkn}h{ef;??#iNtXp67wC$hhM;XxTn~c58?;b^sstO)e=cYS`Igs#O?_G9uVY&MNss1f5ra* zKutA3byt&pD_uOO>eH#!$#pBJBfQwvTZ`H%c#KJIiySk(hBy16=}>lXHagN3^uX1U#3BIm26ZnX7bJ!F~ zJJ~e-4^N$wbP%=EoGqS&xHTTTX&G)WnRkPb;4^?;;{>xaD4Lg*oRpSAW;u&3y4uo< zB}5QLQUXG=XifGpT-_3o&^b?jeu-L{skosvDp+tKl90oy4gi-Fk~)A&N-~4gL#X2+ zekXNqR#f5FGs#`NZ)0ee5tdJ$J7L-9Fpe9j{*{SfS}O-OOSzdTBxnHlbvL-QSYnq# zE<`x|BgIYO{99kBm4uN=al~phP)ckC^d{$MocDf&E?-eu!nzox(mffR-XN;A&z_ql&{R%TAx7u{Iu8TZAo09g zj>vn5!F!ef&80?AJH8%KL*uf~!YTtBQHN(Nbo7WNxjs7@gEMH11N3Qf(=d6vl^IICRIKcQXtWB$54!v5=X3i%+$ zjsA$LT*-U=&qhPi6$cO6n{fUyN$p2f^C$3|k~_8aE!u_@eQdP1RM7;b2`W%XHzvcN z>lC~`N|Lg}Bz7tBt`a@RnMUU+&!jyn3q=Y#6$5ZZfja5GSkpmjDyHa?{2}c(Tyldo zgl5p8S(Z>?wUk(fc3Du~=^Gro8^h7zRNahAh;dYR=@?`?0>*H3@YoD=@yn|8I*mr0HSV^l5!Dm z9lFMK$EQN!OQ^8y{m1$r7-XA7v&m|4v;?^<>XMfNk}PtJ#F6;NXMw~@osuo-a)S&w z(4@>DLQaNF(r!17t&SC|+at3S-Ck&7+%}a7^pEFFAgHN&TRIW}*4ij(;~Jl5`$CqP zKZ7awt`_%1RqWBgI)@bNsG6%V>vGbH3s`X~L0b9^Q>gKaE+dUmjo#!;Ts6K$=u;#b zqcE0QNJ>&H0E~7_+TF79IP~mfY?Z8f!%&s6a#V^r?O>_AZH}CBn`F$gfSZrB6Qzx> zf8iT`7ign9pLWNyhjg{zrZD>}Hd<%gLeHCwtSiIDEpCVuCiuxT{t}gPr6@m~Q)csx zE;6{1m0Wlc@-XbBO2kGs6Z@U?+NLC|&eo<7u2ad%94R0u=Dvp3KLZs!UT?#{Hp?y_ z9{Uyx+M|N9oM*$6Qm>-(678+oWr9IU(l2c{2VyN1n0ShQOq-JxqOf>4^UvUy60@1= zY{FeY>NzV4Q2AagGVZI&h>+Qqnr9ot5{%5Gg(cRIphr-k4dczYoOIfK4L%thhT9ET zMRHV3yCXLm`1Mu6wGW~w;k2walH;pMQh`?17q;FaG`t51t!jRSUlEqJ8Y(6ko5eYv zsJy9%T<Mbuq7 z?!Kj4M8NE6!m3^atyPfPmF-I@b)=~8F0XW>smiOReg@jcZ`%0u#XgVoE;t!)MTsz+ zvu&Rv7)-p)EDfASZ(aUQsM#b2gUSV`rj)aM?C>N;K{WqMWiBx6=yW*4L;k0i?g zXok{12*&5)9hdm=>@fYN_%kELj6XQk!y#`p(wt>_g(Ybh1QGdcVeT7=-i~F(u?qVx zWvStm$~&_vTPpGdl&UTy$WcVa?6Fu>%@tJFkJr;*a#=&JR4cfAbx8*H7m6M`9Xsw= zaPsI$iHUoNs?tocC5mxNSQ4J}`@ZXGBwwlN;S%_KPHvFSNzyAb81|LKwZ#{kQW}<0 zhFc@N0X7<&i^hsPI*D5HwmelyIjR*+H5zM)W~^F48UFx9G>ZimoK3pxkx8^PR94)K%wowQs`mA^+) z<=xbTDP*SpR|NhsD<8EhX$;GSPmx(z=dtD`z$;Rc!k=j*_nJzTU_5)VagT_GPEC4| zC56YJgu@uxx5KwXlFqHAr1TdWbRdYZgJ_2&Oe_c6iOk7ny2@9u=Ai*M_3r@>rZmZy zPIC!y%2*cG(u#(yt!W2e3lj=^986&NkJwsLeYH7BTA6cGk!mFe(B&ubv`3T^9*mkR z^BnLa5b)t@Q}WI!w4c&8g()`iCoYj4!iQ9>3hh= zT*(p2;!J!c#yla#V3kywRX%*_?F=s>FXjr!`GO*oiS}G)x-D?=?Q<0sZWC1Y zwN);*JHV%LXo)36n7cDA@y#o^K9C&-r#6|8FJo<>M;XqRmPEiIdqRYqnaWa_UvpI3 ze*+6g4OZ$3k##xrJ|}2Z96R-7w(3KJLPm$A2n3SKvX;ouiys0ZVog^`03hgeAo+u# z5zr*_vutrTikDyi0FZ`LWvFOUuq+i}(De|{Bcyp{E=m&Gh3s{-Is%n0HDQ%Ho&8~| z6l+Y=i6Gm3V6Zg)l6sh{q>y~Zh6=E{JIrIo+)h`}tNrBd@zyz@?xQ1BR%XS*wT@K< zoil^{A#@ri}sr`Oj!>W=^$CgW88;>uj{$NhrwOl5@XROPuB|2w9JHEQ8X%8gU@peaPOJ=B= z{4edDN5;wxIPwC{!9^)o%QQZ-wakq^89qe9q*o3f|5~GnwfhEtoUbIL`1FnezRT#C8W5m-bRx2|o6>8pm{;vqo{rig?fOr}ah1^$>=d6=s8Vw64ld zhW+boe}ROZ6inur1So|hjX&E9NK0lE(h)eD>Xier=ttuQiw#t5za+AelEjVm{{Vl+ z2LRM^UP%BIi(J^>_rfSuoRmu@Rm|Psg=ul2N%QGwPMSMrNyoCN6?d(nJ|p1+11r*L zmpsN4TT#~IRG(091yEVPO0J2Q18-#x>=u*VSC_ApEp8>9m*$Wcm1G4CucRmqwbPoI z7Y4>VM*^mn3F;4&c8*!nPG-hcYiQ}fvutzIcF%ZpJz#3V9Oj!30+oYf(C9&gRh_e; zE>hqvIjA~c$`ppefpQJJ z;YnG`J1kiM0}Db}nytyqFtGH#RS&k4)OmTrWfQ5GrQBw5H(O*Lpy)w_^AvH_O$|A8 zcap6?*khCycBD(RgOyh;9j~ptulYi*j&n0rCQ&E@;1Y{nR@`~V8?C`BHkqlnTW0Jn zE4b5N;doM(u16Z9pG&B|+W8YHDOcH5v{3c&jwx3#Yp|?C-aA9dh&iJfn>O zX?8+UWN09uH5nOIWhTd>ld+Bg(o;d?M`#XAyJ~2Yazt`~*yn7*9Yj^+ z!6>cMwdh*oAk+~nvG(-MN^w@kuxOJt7}Jj_H&dWBXo?zMG>}!6^n)Oc|TMm zHxUdw-THGM*$IXytfEd*$wCFMd;06+8$J((P)SzE#BqE}$lGsrY@ybg8;_i5;)*uT z9Q}G)St`t-u^Whzu?@KuTiOnvP2oLen}{gOB5+S3*GDrjwd|l%eFA|y{4EP(C5XLH z82Vkhy%341SJU4^WG!sF_K=`2ZF&P*~gi8S=9EVVjmU~Hh!1LmU)IH%Bk zH{8~H7uF|L{N7ewhWZzC75tN=N0v7G4yna+Z0a*JRj7+C{Gakkw1M+bFw?@>)sicx zsM7I{jWb52xi*=(g6aq$l@FDIK(r}v{l%>Pk~uw_R%fIhdCv2zd1XpFlYQaUi6M-c z8z0H1*1^4oUZma>p=5njY5gMG;XxXZ4b8?;an!>6Dh*<1hLwp%rG%Ou0G2>$ze>w0 zDN^(ZQm#qLdVzaHn8t?W?A7DFJ&K(zET|<&Q;m`@y_`wDpEy$lMs6!g{SYTzZvOyR zQKh(V)Mma? zj(zS*{QCaiK}@PF<7p_FZ7u~14`)b7w@_5(Wsf40@-WiI(x>#>^R_;-Medz{obUb{ zNMW#jJ*I2(L7AC}MYdAXkWwAKfk6eykh?2erzNk_;sy9sa_G9hSzhG1yN%L)dZqs6 zg5$mz;>v|ha}w3%w;*hzE|%L=&QZEh3q_)QE+RslVz*kK$A6_FBxkCt@UHZ$)!P*k z^m$~I%S=tpxbmCR+uTc8ywcMMLP;G*<{}PCpO^X0zKF2LDMxxw{Kc!)$VAjQ`9j0b zeH`soE;`Z3sdn2+Qm-$o`pmXg*O zQse~%A%eneH3Yit*Ku#N4Azyt)!9<@cE?(2s%gJBZ_+fqPCa&AhvcRM69Hyn0OS@` z$oqW9bxpp}MuU4oQ?A>;z2*83LAzF}y1l+tAJo{SQ(u>53w60?ZEU5rJ2v?p6ahTD z`Rxi&N$t)2Wd8sLaq> z`SbK&soZjFetka*weysY%*)er>@tEcE-sf-H)%%HIus?FDEWnS=>wB|`G1x8SJH;! zlv`_``8PR#y4XxO`$kpd&C1L&%(C-+N&^z44V+8H?yWZ8P-rqNG(G5raj^khIDqlHBEoyFZai>u=EL74{r?sq0 zw6u$;WJ0;w6nK3LLY&UWQl&aD-2r5<9 zr44LB3b$D5Umy5tIXm)n@2us21xUj$FFi_^b&5Nvm{4-zNJvXLN!1R`Sg4RTAYaB5 zucy+>%L~SUphdu9YP>=s@w>I~Cjg&*Fbu z8=RY0e4qFK00Q`=sj@mf##tN@S~Qw05{-?3UWIS`Dr)4)=sS8~1(Q z{{Tnhw(Ee^xjp1INNuDl+odfQ^z|ku@c5*j*L1` z^0h=wIJXt|f{3@JwEQA|JSqf9dF6&2g6@7}jdSVTs;j-l$5m`x253@>*Y0VDB5UGTy0;U`{Nl4RFf|5ZWIJ-=$Xo^_z zsoot`C1u}nPe~-ShFm1umX&7+BIoZLY&Q_)h@#>+e(fT9oYU)A3#mHPxq{cw4Ng*_wwD&XBTWm{V~Zm5wCrP6acQzVy5yDHiWpK z(v-Cp^BkpMs09@5m;yjM*pU-NmNdo^`bw>b>FP;LwQ~x9jc9A;%mAx_ia8ipfG8X`HGl7q!ifqog3^k{f`S3SS3Lu{zq7dc6gF z#G4V!Yy}cJi;J5bJP$}xXHzOkOqQxMQfo;{(({ENixPz>kVX1Mj0T5ag4nuqhxmq3 z63(f#O}g7^0QYkh3o6@RePfv-n5eof3xeE5r(YZ0D#9R@P zchcVKw>B{nQPa8|PWB*w5cnfI!3=*-rA`dZnU>v_drLgYBn1l-Vh)6E4@g>`q;pLJ z+V=v~Q;g>E45LNV$WAa;j~?Pyl6Ad}tqrb6THIQ81eaZEZle2(QEpKHw%Uid?8&mo zzQ)M6n25RF!_Y*j?PGHJ4zgg0-gk@Os( zupG&<;kS<@l6^@!n16@rH;`etf(kJn5p;XTMnL>|F4`YlnA;r=6Hwou#L8x%>$8o> zQR($I-Em#^))98n3BH}>C(S+()Skk}6OQdS|lD=$+Lb4?u*Rh$&w<69q4 zL4-u>8!R%X-+vfUoknSv>n+X&om3m=1QUM%g(lWF%W<}lyAs5cDq zt;Ly=my65RdjzTE0x;+s*IByLiVJJXx zq#|H8GNUBgRW9b&x$mJ$Cv*5$Gx!wGkkxtU~Hzyiuj6k8zL!C44M z0FZJJI$j}8eMizGwO<6zVbnQ9#K+m&a&3iE>kN+LZy+c(m9`3$geaRSB&2I_p$@61 zy7W1u((Gi+<`&13)QX!ysl=BYPzLEX3hyS@8Aw&erotP|El6Ay5-+u06_?@$BcapY zuu2=wqHV7^&RP&J)kG8Jm(n6d(rk5-?rw1y8kDJr7E~nVjg+%>EVi7fzfwuCBtuCG zA(j|n%B4o2`mR$X?IK?P0I$zWuAf_<$E-|SBr^A7MI%F1KZ&*1Tph`!Ewr64e3m|T z)Oy65v^7Kf*<%x`W{T}G;ytFDFtP_;ORH8>@K8|Gm7sQehG;_nwHFeWg=a+(@t zK@PDrgMD0mVGSmp8Tm*)Lm%3j< zKp9-qDu~rU#rFr9%Vt2&3f&Mhfi4-`Gl+t<)=fj;vOj!Uq7b?4Ur`KV>QuSiH5YCD zc9tP8kmOBTG^HYwgyyGejB}GPnw34JX_=Qy=~!_$Ng+bXvC~3D^^PUCsOaxux)kk7 zeu+^iak)2C!zi3>b}lUqAueaPcqk~0t0Qjdy@8I(HoilVl`>!8JbO;<5N5FTS${@i zIbiInW||%6+rCm9BzMxF26PpA5fr(xID88Xd2jY5_Yc!GMVx-0K0TIVX{@Q`o3^zf z89D78a*`}c6mtSEa}d`t`EIr=^NbR&(i)bhOemKTU#Chuv#D8bNkcjDB%IxKJH@sq z`4#y{?Zfv}&lnm>-EUNnz^DC@XOEFtK4c-r>nznL+&dzq=s)vRn6O`}E96fe*K58X zOMv^&GOzMPS@9pk_uP#hX2173gOl|d{MD||W>KPV_OmE~Z$M)y$Gf8Ah3Z=s9+}NL zf4GVXM6uLHem!HA;@LTjKSM#7apIQdUI!u@Ku{}9&4P&n#>9&rv17w2(~Mb=nE#+kJ$rZSp0L4?8hpP6bj`KQ8*G z9`~jsRbYaPYEW}nEjxp)_OvmNi;d9axM?M3?Co}w#EAtrGK8%sWT`#$E2tM8(jvk; zkYwma;Ys?A10{(m*9!{wQ1#pi@*0an$`m2YYWU^CY3?;DU3~UXw$!4dwewqGqo<|J zGn)>-Djdg?NtX=vDwAL)Vzp6q;E+3-5n<3=t4L3~uDgrz2gT}!9>8)dr_*KHN|b_( z;Ry=VTIE?ru(uSBsWwOY76MK+tkNXp?uq$XlQ!hzc1qJOk`w~YLxya z&~ep+=~JfVi~1WM${bu=yNP&^m&7;)o?4X39bJXe)?|#wz!EGzFzVwP5b&WJi?|A! z;!(+*bZS1W#O6i*1wMen*BsYGA@J#lE+cT#V~29((vEzhTe@BYDNC03R-2pk%AsMj zN0$?*abltl)<5Gqn=NNu-;9_Nc79N=wZlgC6K!w;EHY&Wo}{Ws%NB0D)vWihZ`IB6l{_QL11G;!)LvjUzZ(n zB9(I(A)AC;`B>g8oT!W+21-j~H`Z!%Uc)Sbd!@B4#}C~|8UyBZhNU)jDcpm{v8951sHqu3a3@l#W zh#T%=f_Yq>vU-ACgoSUmMjVt%xkcBM0kU$aX7#!ury+DRoI>M{6XO*(==zMj%V^G* z5~jc<3LE7myJ|E(A{>O8+~k#!w;%B92UqE9c7~a`X~}RD6uhMl3-^M?M36u?1RsQ0 z;hTKOnIM-VYlLX6as;VEGi?n4Q|U^QJT9ZR!Ywh$(F$-KYUTy2$}N}CF()qL4x(YK zuZ1luM!#f@#)jL7ZgSKvF`+rf7ivAD9bpfyPF1N~#W^l@RkLO!+i`KVp@=Obviw77 zF~Hic6s5Z3Ge~|&f|m*`K=J!`)6yitwl>ubz60U>yt>>}-1;R`ZtA&Z%-ZeUI%%%3 z>=1^iTFzk#9O{zUsW|#I&t~$EA_9ShIM`Vy`zuSiQp69i+S2QCXiCM?qpd2*%0=u5 z>(KZ{caDt~ygRaERI1cw>$NxikRdWsd7TNcM9Xh?P=%*2yp@jW*L|X1 zlW(&(5fNT$xq@nF56Z3Oxht5H%U*j~Alv|SP_?XYuCV+DBs$zC;dUJ2r z*4>nul|AJ$@K7MO<$x$TZ};noFaNgmXY`z1?4O7fDV>PR=W&7qm`I(Z9@8|Fue zx-u~2pq8koJiN2dQ0hSLlm+IKnCspb02>gHdPRg~sVCfu)eYLGr@JCly{eMuw8~T^ z)P(bN2yqGqm_Le;&y~`V}xbw$w*3Z zEk15$SC;JEB+NFmaHghZkFrfS=9d6U)DK;5sF0>Nq)~r#vk_D%m|{%Iqt(V;U zNKsAD0lmOb%nyyN792eHBjrRJ!(13%D8Y1=(38wt)hAL$P*n3$;lwv{_kvV>>}{-C zYv@DLT~B8=%;b93-I*maGOJ8VCXU2Zn%^# z+Y6;66Aj0&%v1{p zyY_Dr;kta8U&Z0ntgmhh@p@|>$+smqEjc3QN0oD#VIY82e!5udW6?NysV_4ho-QVr z4KQGmp;l{*xtzM}SE?t2j!fD)_r)4<9f^$Roh{ z#Sa#_7Thz~dV41@X|3WG^IQj#LG@(>L`82fJ{tDZGCEr43gYv>$Mt>8C-5{xx-JB1p6vlQOrO#3sKB9J{AN-rH@jw zJDqGeI5QVbNY9)#U&<#6Z!0t}mSqR;4Q#(ttTlA${DtYXITd=sxO0r~^zG~&9>(F@ zG93hKZS0^35kc)NYH(%G1uZfxCmmu}aQbB4Qc}4GUJ~;_i>Vyl8+9i81$R`N8-uvC zVVr2xMcG!oMc^$KcM;652G&f4Z4MO~1zioTd!AE+AVtsFB*nHXYMR@*7JF_kaL;T! zQ^8kJOvd!mP!2&en3WrK&YbB~FDC^V@)I1*78S#OD$#hZzkQU(4|*Eac_QApTzWSDBj z1!Y+lljjaYn3-}a5vq9{MXI6E-)Ty<{RtnOZuocjSHR8Z<}7i%*k$@FH?q}IQiq^y z#f^|sH0iE?dpv{9^-Svc89*g3}dSBxsyN_<*gW#<&h zJ#*i?ZAFStlxbA;r2LA99W0i-2*f5tJB8-gnr1{5N-ad)`9&V-@XU{Ji|hfg5tR0i z4Zfwx^DVf1y%_#GOe+^o_lg&RmMbX$aa^i#RxGG3I`Z6YvHet7{xP!PG3bItHxWHd zP2#>d()ezd8bY~~ZRSTV!~k}=HrM_2jXnt#IT2r&Vrb)xMVaRm+U836P6Kk6edhlF z5o5OTYX@wsmoj%@9xBb@=Vb8nHDLA);bO6kN$f*1o1wB$#lSzbt#$H@-yfSo zqUVOkZp(^s88i`#o3lX_YARhbK~1b(D+MHZ5oqKkPQ^)DDxZav<#6K_*D%AL=~|{` z@6{^a*3-cBja(k2nNcN7dN@g5{z_u^B~_zUW;3V5p2u}#)kw0n>NhaQ6^~qg1DNHd zljkQeTgE69Y_M#sj?}zxQ*Ek+FwtcuWhm!@N>rT&gimod+LA9Bn zvi&%;ND4}BgP;VBMzMV0ip3^5_}>{xV+6~YH*Gm6gysWs5(c-hhI}d&;vMb_WA$N- zMwV5itz`tMH#S7uLsACcSe;eoH!)qs@Yfq%2{?0aMD%^ooq9%AZi|SF#X&>cRbh1A z?MJO!t!vbQOLEIjggg^a1?I8Len3t2;dINtj=i+N+eLp{af zQFcJQZNYikLq5>s3QI)TELlmvhMJFzUaiW;G*pV^O9MTgS=F|r>Hty7eLykM1m581 zZ#kM8lPgz9alNjkDMWf5ZRs47OzdP><`m*p2a3|*va~BW)wL%u^wbECB}3`i95~6? zZjX-h%+r))rWJFQ2v03X%_84{hMKWym79(GH)1{(x~^*~TR{Gi1Xzz71sH2X7pO+i z_@P|kJmzh#`NLqqVs02iOkWyQr=uO9wH@i3XppoKbRWz(wD#NLLB`9@i&ENA1 z3e@=N8ICuBrK&v(o*#>EW={-B*w$8J^LTb~$z>6KLV#Nb(Kks?z}w0*Q;*N{E+LYL zgN?BLXNImQRpk`ZVAwv{<~FZ8ChAY3zHu8x@+Pc;R$mdKeL0&@DLq6b#)lNF>Ppo! z8(siA$emC&yeQ$RJj!QNVg{XKs2PS)gwCX}r5js9Iv*%e!6P)6=;|RyIziCF#Bw&; zsy8+)MzPSbTY_;H(2H>wJg3l7w3D&uNAHBmS=7!|X=SD63L^dy)C}CEKka0A^$>=R zrY~jKE{uu<4u`@UVua07Prh4N7dsyqQaHqHt3J%(Z1|lFEaB2!AeClDiB~}gv$SML znx^UrBiH?~Y{1!P5Ty#UhR5R^(iSQtYv2nc-6UGqj!+wkWw*`7#u9W+;%o-SAa9^> z4(fm!`51B;97IkUh61O;M@`&iYnPZoxKa-OV%9&5OIiE!BD@{89iA3;jl|q1vvU`l zWjY+oR%;HR+~3mBrn;?$`SUDihW)l_c%`)S7L+-%lB~dk;i!jJcO96-xMeNTD{$u% z>DZJ4+kg}6{32X4DG+DFxQu;8FlK2KOH*LOWujZey05!o??e>(~&Kewf8Wyo;ossnhU=+-y~y zxds;`fC4 z8IpEakE|n*u4c+xW@EjSq<&ur?Isp(eHNL4bSqKex5^D6Vrl7iv*l7#m>&x$dKgU| zu|YJ)Js~E_AZSki066U&JtFXxITvy3`=g+AXH@jPmePSwn7{9Z962>COzk~M=e6}` z`b3-C;knMJ{YT0bs*Y8Pc5xym z5t#!x>NX?bVQOM%D^IsR32$+_NVTJ!!l>m;QdCvUX-Yzdwg*p?CXS|Oa-%SmWpSY5 zdXb^|7#ll6U8?byB`NQts#m&w4~N1U)H$Zk6Zm~{q|VaaQ%c=TZrMIS5pRSx)oz7f zMt5-c5z{t9Gwp`f4vQC1C*^St$0u>O4#SzwLaekZ=~w&SA53PBhch6uwuda>Ov(Ev zSOC{)IhD7<1P4ffMWNafbJ+T&l%BAZj+xz&OSh}{79-)SoXUM==0b(m(gmAQ@lrzUeRuPSPl~>So(Z43#zqcCSqlu6tw9=PpI*T5_U?8FiUWvoTc+0 zYn;El>E;vttHX9XL!C#%@|3_5%MBn7i9jEafF8n#SbLxkgmmGB$5IGNh|G2o$~biy zB2_n1fDlpCGd-XyY^H+vN`i?XY2ssz4#Y)vRCn5`PM`6r{Ns)%CAlW19z_A7ZM*RJz=`dm`z}VNE#BWECNIxL#+sMjpZYn8T83=OeW`RU^R4r9)H0mibi5j+RlmVo`nO*~ zMXOI|eO)i2-|BZHgzDC|gUr8~H*7wYJhUkIhSZkw_-F|6FvMN<`Ti&L*nWCe^wo3I z_*3<^M66Qh5LkI%N}`)7P7APcND~T3Cc`65xts&wbm(-6vsmJl-S*p?`7t=BDNFEG zci;C!gu^tsuVT$BI^x1Dn$4z7gq`(hl{i7_0*3k+hSTY3b=@WW$u4O+noa!YFWDTa zjv-T&n<{QZxSOTVXHb`QC;m%2pD^^XzgRRr-kU#Hc6BOkZ~l|iy%h(gy-vgop;Gf< z521JZlBu_eKV?pzsorc$fOHV$ox8LZH>?Nwy8gHFNZ~nBl0qR=oDs$N9W)y@FvNH);X2IL)mGzDw z*xX-Tbp{sI^5nequR$tWKZz@U>B;=o$(^?Z)aF4Xj&eTOlOD!|pAzetipPzyoO3!B^fw!9rU;Ac7A1K^DBP{b%YmH*2jf-|TVu z^RXe0Cns>dJ^6|GG)~O5bu!!U2NtxCbhOGvkbhL%^t?&M3za>ut9SGoo&tRSD)>2#IZ1hT zS!uU9ssrC!?hM5v%X@f2Ieqzx9vNAoQdVFM+&NG-APoio065{%n!&Rb7qP`n@ZfSm z=_axzHaSac>aie0V8$r_g6?eY~z%;v#*Jw3|(0KcJOFH1-y0@-;S} zm~T?!VEtCNzKOX~u0??zAZQSZ;$|CiR;^rktqwHItL}xPP_p%<##>xw?;xvP0KWV1 z>NvFuQn4-}X<02JC=n{B6l@mzsI!Sd`$`0xi`-iJM-Go8c*Pisvf~8_O692Y32i{% zGb)uH_v;0q-+NqZ2;?}oDe|L6nxJ!8uRzQW42@8i5da^0cihQ(BM&?a7!m>jp*Q|-8+axA5WK^L}) z3%<6}1nfl|z6x;?WjOX$LT=v5+=R5gLUai&md%ZU?`Ajkv<=d+Xj^uH;4vJDN!J1t zg_P231Q3Q(_GIUFNKe^q@>X^PM{(x|0t{0F@>qsKN_mw_PfJg*hni5fxwKkuYo%MH z+Qb{hmc44ms)fI38oc%t;#E>=n!K|DVZu^%4g{qnpo<;Gn`sG(v~`v{!Co<8?%DK) zaP?G)D*TUrocoGSW}HQ`<*`XvxUoqDDLpPC9HXOjKAn-{wI35^_-%`6k54wXvmt?4 zmbQ+WcM3Bkr~{En?;%4i#kz>%-2)XI3gQf>5$h8(k|;wf;929qEvZ_vTw%>JD&cYC^jt2sDEVzs1aQml1Evz=-rdBOV z(5L?BQ)yKioLeBE%%~)Ta8glVK^y4`z^Sn_8V(@1B=HUqaYE@tr7JM;8CH@Z)yaq+ z#_;lcBGT~%QmC(LOPSX_Z)op88i@>T z^z^)xw8M6)RVwY&gJVuxNm5(ebDJqU00)c!IiitL#k@mgRZ?4KN`7JX5>unS)wtU8 z3tq{!x79c@C{W~2yJ`V)5Ytp`h_Ue?wI_c%6u9^#9X3Ji@a8Oy3~4pv)N zCBxk^%RS8deBS&LtC$Md9P?r|DO1zt?1xGjYq#v$HQQ29L zZj0P#dc=I{*T8!jKPprvaV1E}O`tm{`%7*1kGipI5N)XIwTLlP<)@J`DDK2e0o=mzx=c)sPCL*404lhROs1_$P-VbMQmqo(ND4WC`|cfYup9J; zps5WuC>d1N3&RtYbR4hLtBeq$FJ^tA3=IyR=vKaWz2m7_+oP?9*dJyR$D06QY~C3784${0xEo+gu z@fXr4vvB%81)e;*gby5WbjB!krH5H}+N<*K%S^JY&5+!vZ@xx}a494y8tZL!(d=7% zklgnoHW8t&UyRP`2$L@b9}?ioPt0B{vAv4vt;+Y}HAS~-6;y+%sJx-+%rRi!=2u9t zZr0L?dkD)og?q)Dd=i+m&-^}v32r4nxul1ht5(^~^-7juN>4(d;j#D&{NpplLd!lK z)s~0Ey0fgZicG4xZa$3j4v*;B+Qapiu-i+U#3*6v$FfhLz*n(^j}EEsJ(DD?umITV zr5%92>Llyp#G+g{l_yXxqBaMm;tp;j!`X8r;=!wSTjc`_HA6^C2}%$JfJ$v>r^%VinPD7M zE~KT1>vITM0l9_`>xcf8CaTFCDx7dx_T)mT&nW5j9hS>c8#UKnO($in)gM0 z&Q#{`bFMX3L1&Zisc9&%y{>LFAB1S})E8ucR*N}g3hO)mj--Qz#4k9O-4!!SYnw;Ft5rn4Fj(%uJ}*ugcdUDIEZ`XS3&dS#ygTfrA@P zN;54o)^^b1<=;v>!&PKDT%G&}Sd53tvFwY0r*SXR^AgPkINIfu)^bplmYgbD0<1;I z+d~VJI9SFP;zv62(~=VsuONV|%1KA4UB$&dwtHUD4$hQYGHf;1IMBeJ-e%6i0Fz`tKfarD5eh?J{6Gt=5&LH@}UP1Xx2Z zp1(pnjr0+7+<3xtp7EDjRlS{Z)RCPs_JbVd`Fn2 z6L~$nFugTFO-WphiEtAQyvg+yMx9Ihq}1`FGK#nDCK;Aq!qAYJ{^-QA^%5kX9K-lS zE@P-dVju2?zckrItgk6Y?OiAH1{jlUQfA)@`%Bh%mR)F6<)t4+scvBivd8KxOP>_m z;}ItohZL-mau|1rHIN=+p(3Ww+YN#~VHSo39Gqo|F%J)AdG#zwN@(1G+7N}fZM~8$ z>E#`;8_WmAV~?fO?A9)BNzk&A%9&_fUqvL}P)5EYIs&^B@TQ6EDymQ7q|7GTWpDzb z2EZkI`9WYOFG?X! zzbuvHK~=#}xJbRNdtbsh0`m*-Uk^$oyrxiuApvVr)It(1eMvnb*qmf&;?HX;4h&MM zv`H~K>TaH8k;?>q)Qs2o#l{#uq&$+MFsqN4nsApdhN|6Bwl}Yfu%sQBs zh9k8eFQf3Me85;(c-}0yXg2SnBIT7LtMENOVs%Dj+#sH} z)-B-{Kx}#1!hc9O(`*7>eZ)3^E_=#0zr%Q3)dDPEjJzh2;f4jCM6v>0C}TRcB&ctx zCv&VpgsqZfsSrPe)6kjIG z*;og}9pkuhso055g=%p7QcAi7j?n7DkZT>D%@x=1y=rcKkXBfJS*0L-w%uPXN$}S< z!ZTjbj`Un`uVQRb6Hdof)}-mL*vmMyR2xwjm|>?2?S`&NQA2>B<+bmrwvk5F7739j zjab#bAx=1@OJ#7S)F1|bulI+X`Eavg-OU_ zMK($vm#i|j)-)+4N=YN&dg%|rZZ#%3RBk@cQfBG0)dZ?}Zk+OOrz#y~#FCXKYb`1o zSx4kyc`^1A36@)c`$^KPP8oUhu10YKzT4n7PlBvY$HZJ87^QNe!mLAaPYuXbYcm;C zhpG6AR0R~O;7rRV$^?U=l-UYRj_Eo@#|4_zb|7&W>we{bW4sGnm#EVvUs0W>u=SAO zN%vB9OP~t{r6VcS+yG+f+oH8r z2wF_C;U&itrU-w-QuXWiu_<5<=NfH?ZkqZ{RhF{5fz*>&!HiOvvvp}UnW)MI z4|&A>V`L4~m8UaG(2J5RV%uFZ8%Hk$<0+09ROMTeaHfdsrl!Ld7WPTi2IkngzkXHn z93uYWjmm9f9!pTP=#fn>SB5C4GLjo=PF85Qu7NHrx{F-?xdYEgi==kOsSTrzlt~G5 zDD;estlYH17X5*lS}sF*Z{5zXbyq$aOm(2Kec4`?iArrsX~m$=PEI`R(?M5TDk>o@ zxSi6Zqyeyq`4J)vV>r`LEWa%)(fmTtSD->vKM@eSl6w{rPDw%%p}4Uh2rihmz7fOvDnhe^QrF+twP4 z>H$i%`VvX)^^T*-ufs?&S?*JG#=dF=d8Qfr}G#Z6HG=Bdf6(Ilu+tNO{b7bYAX z2?T_mpp&@MNZ-L3c@c+(cpkl0ROKdFw;ghs%yDca9N8`bC>FUp8$u%V?Agf2S3ymQ zYV~Y=FD{;1*6kcAYIG#?5Q3lpT0qkw8k5s_Or`mb#uhj@zl&~hK+xqD(e|lnmI~ZS zzJB<+vVby+Z|4;JT$76}IC!+tc38$w+VJ$kNVMqs*^rQIF0h+}ZHYR> z#|zwzu8!Unl*4>NofB9Nqx3xg0KS@h>wq@mzUxotS;CdbA&`QDN+djF% z=Tl6^wAqB)x|h_D-Nx5RDN0s62s*`PZV5|~E*YztKX4Bc==@J$KTMcImlrMOPcc44 zAd?h1cy|tD_~fx@<5_eu1*#vjNoa)8(_Lx209KD`DM7+)Z%@SPN%jhpX<}tSXopeV zx{1(SSdB);HJk?#sx{c8;&D?O=jyEEjCV$olyNUJD5C1tf)t&6$CmetUmB4I!Zo<( zPIrTAsLG<@Qj1%RoknSSi>V4t_sXJDcNgmuW0^`ehI}e?D?hn>^V4lq-&OKD_&2tM z+g)OZ+A_GWnQOwTWxNr1%xW#@tZ(jz@Ge7nXS({rumZ#DA86azmWrYf8Kl{D;BZO?GM?0M~4_~ij^!{ zW}7i}s>i&8Wm{5qI^4yF3C8%ZOX#f;IF1`iv^BV5aUylWYqcrWAZQ~Q|P8lbC%@+rn)pjKJY0fOU zhgn4)o`0RqXjCk6Anr)kDtLSr?UV9l*oMo&4ay-?>+dZoNO4DU29c}7vZ9YB<4;(u z%;Pqn6iX;ewx>I%F;-2|EDepiM8@e6lD0;U8R1&zXxgBVZ7NGiRi1H4Hb4hapx@;c zxpQe&$=I>qBj|&K{4|!~T`8J;xBxbQ4*H&_QyAVaH;By!7-<(TD_EzKCq%-XT%Yt5TBx}o7fkf;Ey>06nE(Us)b}O^SortVYP-_!so20CJeKKVe zETgGXMtq}trPLAuu@^f@Qp77zY0ZH5zK-7V#lvhJ(8Nm{{Tdtw>}V|jO@OfkZeX_zsyF?4$S=7tHmD4w48Q@KTT3)CQi2RDGENB zw7-yrvAZj)7j|x&rp^f&qM27ztf+O%h8B8#VYRR3Ar3Y!>_FA|@f+gifA(dN_vq;R#;=wCOIZcU3)DdH1Z3wZ{iwnS< zSfKH7fT<~l%81pasX4tgCJQ*w+VN|$MH`6CsYQ^(>ITlEHLvIh1`{pLr$ta>4$L*4 z30Gy^T1?EkT+D?bD!P-@07m{-h%b+eo+C%$Mz>Im-~?49(HoXyf+190-(VAY#~9*dADLdN-*6ofc$4;K-G0BB`z

UV9ym1ET>STu{&IoKAjBRZm)rC1Sd$MFz}CWR+wHmN4n8f>{L;9Dm5Pf_{8qqsAg z>#3V1D%kA{I3sE@A4jh3n~TDR+BPL$ErNP)@qiJ!X1RjLXb#wENuesBrqz`~07BwZ z9JMWzjsV%!@Sw|PFJ!_GQ@B(ZX6 z=a+aXJ{oBXqk*R8CejVUTpduMYx)rdFb_(rviPw{X+w0Y_a3ppJ1izzp?suVcpDM; z$25hSbM#jp7R($SFQFe1ym7|PrX~e&(ih5nDIjPHhj-wp4)YZ0oJ-cXU7jgQiklOuu^M&j9XV$=`8h2$eF{&JKgJT#)Wpi^&(hp2sD+~dfIxr0 zbgyIRNBdzkD#a9@chFElNgE!K)FkGWnGduNDX*M^G@;S`P-DX~> zMaL<@(Pq{@uv%v-g)F0{SqfPfwxo?g9z;UZqlWa2O$$F(pht!Fj;1DsDqRjH`@(=m z&c4jj?BiugH}3(cJ_g^MH7&)VI`rJNIY*Sdiya8KBfx@Tm$2tE6uFSBo@z=E=sJwr z+zEgg6emg`fgs)JuN&BhJv`k;*fNQ2msWJz;le46B$Z=zU|ha4>ig zuF=~AGE;3q(mO(I$W@jVV2o;X4fc-MP&N*E!OY-Xg+6i6GIHaz1_$KB`kmvg0f`bt z8yMvPbuy&tHxK|l*_}>`5Lg+|kewr-1Fi;jJ4a3+T6He$Zyi!N%yVrv@@(h@K5)Ml zj#Y_S%pFahNgT9`^$Pz0Y$eXl(2H}13X(ac9ZkFx59h2WQ#(e4LW(5m$VwCkg37|J53T&ho9m{+@TV4rnKwH#V}`5L zI()NiJOE%NF6FytAh*5H`D?63n%rffdBwR0(zypv+SZoll2%fZLQ+8mN5FWP;u1uT zK4Pg#9ZqFF(9`bD`x+aTVDny2Ezq?s#HZawwmRIyiCM(S*o;ctq^m9zIHain-3iTa zTWt)S8|kW}RcDmzM(HPGp&p~8HqhcWfDQ{CK^7tkI&HLa3k{&7wr-;8R$8GVtuw#Ua9O zLu9rCFqcb0ub7<8GNbYDp)jdsvGsOYd>z zk}t?hR5-sueblbGO{h|yY?LK$G^90Ud*52xf=YbV4Nrtp^YUM4or{ZF0t-tXIZA<2$mxB@sED2phx%;4nPna+N&Y4AcK-mOy@#mFnQ57~ z;nXa%h1d3OV41?0Duh8S?(()rVG>qD~5R<&(>wu<^#$WyyKVCHAlSz)G^P%o7f zOgOg!R8FIi6=WOxz8(f8ONx_@l-I+b<@=5JH7!*4T-WaQ`Vt^fpIBV1&Q(jPCo4$H zF4+Woq#$!N@rG%=pDx#@`GTBQ@!9v@Z|kua>Db2+QfF5v)d`s?WGQX6JvBDDc2tYm zDduw2r4@afiQj^-9Jd}2!d3h~MSoYwR=CUf)BgZT=wBqciMoWt6$cRN(ApnLa;fKB6E7h3L2Bqq zJVov!t$9C>@juXd6VbKp*?tAyrTZg12? zh(}jGo!{xW%(CcvE^GUVzxPgvy^Qex01`1KARj?Zu$ftFa%R+lF56*V@(5FEQh@L| zffkJh40zmC{>FbkSw*^}pLcA3!$}?^nwu`(b{Fu1SQMQl z^w~d&AqM9$>6pCB)?i(B37%*wbENu--Fi^d3r* zQcjj2+9u+Kk>+n!s!h`y_KCOKmS}2L>cW0N?-Q29Vjpocwxu@-rE=6()ipD>Je1@I z#18f2l9ED{EUrvr#F_peOsa08;@)va;CrDyLcl|M>~$(X|I@3f$t2HDdd6E5wX{B&tqYWss#)-ccmDp0ew`##?*3fDcHl;xTm{gozbPoK+fRG_LAWwIxYC zHv}I|#8pWW6CBfCL-dzcPjX#rE5F$Y2VX^85$g;%?mK3)XjN`mhMi8TN=ZrAMS!D! zK@GGm4t(s=YSig>kTWZmd3GAy5&^l}Yr+_@!oiQ1!*8!ltsz$ZVY~X z=1;A4Yf_hCa-8ZZ7v94$u=9mP8LPz{YMKiP*!wU{%ZWD^Z3{|I`PcIzIU}g;u~Y%n z$@|SZUCMt{r7KVQ(be1HaM8yYIjn0=dP?~gq=B3PaG)%c=d?=0Jr2nEA*oRTDHv*{ z!{?Praa_iftEDR)=3U(Kh*i038h|!EV^xZ3YSBTGE-r)O8e`O=xuiBh(74{oUAH84 zHqiKpkeI_l0O9&|4Qh5?VZ~GH4m8uOuH>`r0ahtd-6?ShQgpB&gMG(B$76>WB{-PS zn_=X=E|(@ICJK|P-e&1pApNdlj=Ja)b+jd&LuY`b<>|P&i8syP4bDlvf<5FCu35gv zGF5A9U?Hh&IRZR(so*^Q8TOSV{{XeL#G1=(FGrIs+KPzGO`PRk)&MIdv^IhnYBE1?dDkk7MW&raC)wP%_cK}BTU*}O^63h@IEx|To*|WP ziif7<(KRJB^s7&ydj_Ty5T^yf?;wz&rS2jud5@KY+Q$KZdYnUt{qT{qK!~eS;VYMsoH$XK+iJLRgrDFNY=!C z;jefN#8zICPck_6F5x1un;%+WHFMAk~;o2M5L;1(2|0oGg0q0|f8V{7(wetd?Q(`T11%TP`>jolvuxj~%bu)7G zifR-t0vNYF`)_{g{_dx9*OHYZsS+;;)YFVH)BL{kGBWcQbNnR3i$iJx`v#B_*gEd3 z8yJg`{vV4Ug4}+1dyHjqpl)hdoXx&id9&{{w5aHG7rm|s(1R7TgNHIob}IO%hUKet zS@ssva=4Q7nLq_)3xuhOk}IDM*QwQMr&5QLV~SrAWB7 z+*qmB7KN`vbs!UQptT|$j?kENJttAal5IA*IXWz}66}PhGG<(RGiy%PUQ}M`wZ*|Y z!?6-H6=^w!lDTQsthGy|wNjUCD#0_7D@41g>H<}ig@LIg8^fYSM9p$zg!Q#z)MS{X z&(zv}Y4oJ?B_0J_*;Rl_iX00mD*z={NicKR?Te1hIO3tlxx8Y!g30DJD&q~_;jr4= zErfzitOc~T@R>%1CPyqa#iuw6joXo(S^6o-rsrA;xeU0!c(w)dhb~gE2D_N#vFkvk zME>lbiRLTP6Z7-V6_nH_-9nT~h;7t|a)NcsuXJ?0RdG@)->hIE})wY4TbHY)50Rk4jVDuN<=!4;$mtXL8?tnwtkFerio(yZ8?&R ztJ&H&1oG72Qj`XPWhUa<+QSyh)P*UGy>f1UhqLmS)^$Q-+mfYBl26q8Q7S-5xi)XO zk#3jTA8@gyA|eKz0z{J>6l5(u7sqd5N&aDuCUsLA$p0U$E#y( zF2vzY%1o=|Z|*zGUHq&~;xu++?1el;mTAc+=8$^HIE8`k*_E|%;6ZHL&L4{!WNO3Q zIhe%w-hnwWkqu6UXWVrN%8=ZUUp;CUJ?po1pR`qQB14wLX%nxETur5Mdxy0ul_lP5 z37JzWB_$*{gWy0mAcX_e7?FY%Bqt=T6~V!0c@!GzJXn=i$=gM;Au?Ka2cpYj2dWB~ zKr5A~F#AjUNLV(yPU8C;ZZwGbU42P7)r>Q(xj%>9Wt)|~S;bQMN7~OR%**CGm$#HX zAN{mT{X+2Z!$_jjYA!7$xvE^VE)`zDq5Q3+f!@(6Cpgp4h?|9MpTK5pUE+Ea!to7Z zN>E!yOri*(2M*!vt`SYGOidQd7;c)2&P)Sr%SFN`rZU z2kQmVzQ!YE$GToav7I6rQFz0MI2Sb|O_*0Vnx_=&FA}!P>B{0wvk(+Qz|1uoZ>Wg! z$N3Jai~3F>MOze3V@4L1&Uth$Sm~I|ps7bS^vZV9IeK;y_uQ<0G0|qQjedSwWLbXD zwSo=73RYl27Zx{(QI(>*DyB;gK5>#y65;6@eLdkY=2nY<1q_5CH{1jw&2go@ zjA=GI4e?=~64qyCYO3W+%rM#&a7p)#h_%j18k)#y0sr`uF=esb+F_kxbI8$!l+24613`Ew7X!Gr3oa2 zpG1NF*rUlSEaHWe{AkA&Id>hEZdf>!6{WC++<-5+b4@&=3y~s(h7av2iK?k4r#_iK z)M`=JRDBc`VE_vkc%NLwMYbumIi)(M09%V;ZGfL7lc~Q_pae_7yBN#JL-D?eHBFFl z{6jd@;|fYsm=q<|8{a3}R=y+==D4bdxsCXGg!m|xn?>H-JHl$*u0 zV|_2^R=tM;M-<{d9JGCsk?ic-zwEDu*KabLpTNS}eUK+zMW<)(BuViWyoq_r%}Pbm zy(MNJan{zdZIq}b7Eh7+#UB?NTXg7KaL$=N@i%41s`DyvSE?+a*m9d)l00p4OlIXW z<}oX?wKV(vpYc6Dk1v{fT4jbDE1Xi6qNTW`EP@ErOIirK2eBZywS#I>^mI#MHq$9F z&TVBZS)Zy~X6Hhj!!^eDg~naPNP{&F2V>=^t?7qBR^-3`07)W6p@t^^0OZ(lWkly& z#Ez$#f5({%)F9TG?5|w837Z+l<3IfO3e+ad4t8S2GXOFsRIpCLSN{M`4Mz^Y{Ft61 zn*mO~HT1vYxKffiLV{cSpEY+EoYNKDMGNLIg`pn#^7-b1LkwqgMX#1jLWI*_$v`(+ek^$RZF~8EhxXT zWtg|9K)fZKJE(Ws5ti4ug#i>hUgIh36^9VSqRJ6C@{rQwPKy=n_u35ccq)-pN?EN- zqT<)fGTL`gzJXwBbvcJi#%GM-G;X;TSaWLIsU_wc6z~-3OKI^^f^>?d5>=3owBKpt zf?aN(K$t?5QFmQPR$xy+bhVhvrg(f%t;a~xCZlrYOp2KnrJ857)ke5sd5ygsCp8hZ=#Y8 zv6SQ2;`x_+HzTMJ;g#Xtu1)D5xZ!sl9|t#zn|2XwtzS%SnH^Hp_$H=lf!8 zBfsBbETyp7Wi3@O>dwLUQ}NGua(zBxV#`S4CK037BwBu_m4#U;M9N4@i6>-*SdtIj zIz}x9sGkp!kKXBoVFQE*0u^NN_tw;`XrR4xJ*v0!_dd}17l z2x&NDCslV8vx%eu_DT7P$r{TEBsSa36$YOOxHnh{zKXK1t&Wjq$uLH*9VOK5Qk{!f+vIn4sV$QMw_Q|0pnTfEqaiUV{oOV&dG|YqEP0r@mBHjix zJQKA=PY|h^+zG}Az*xd|i1EoUT1cIgI@msumFB=2bPCqj^M^RhTH}3$V4X6-ciu8g zy-Xu0$V3p?gt-;HTSv3;W~hGjvmfS&-}^b-47VBlL~+4#rHoaH&_Cso-`^L%$fh=S0rju4jf+jyB6}(#6d`Y}FQTy!R5{WEAPW;3Z@ny3W{a3`D+^wuEpes0q&Z0(V z^R#G}>{7{(w*&h`&+u8gY>c$1ot1V-I`ctAE+naHInZ?k*lI0vZQ>Ub!z{^nqDCz5 zAHbM({@xVDN)*!No_={i1Tv(pJ>%k{kTms*RqW?<%Lm3PA&xP^HH=oo)+w*7^OJ0h zUg>QL*dpatK0YyjgA&H5uE~+hay{TYer2&U3@rB@MohOhN&6%Z9)!f~a@>nDVuYuJ z97d$n+V0C%5$x}cl2ox^O}Dau+(R5pzYF{1KZR76nPak?D56QsOiec?z;bL^@*78d z5n>LS->u^npN^Dz{$`gS4w%+pZp!$70n{Czmt-w#QBo4(QlQ=SvU|D#(kpX&LRl3u zWH@yZ>cwCpmpGn*lc%8(2};Q|MS5`)1JQdp%hqu`#5Q- zoHKIUv00jy<#%x2jIJb0wDgKwRMUugrAjz1%*)IGzFMwDl;cM_R7talI^5V^N0t2w z#>P6Q!xvUwsNv3Xy^%cGxnrZ!WGcq$8FQs4WguuRdqZxz0wli)yJ@_Zo1gB7_rWi8PvIV+hyu=RdN8p|ebobq2~ zLg7jM;Oi9=#Nta*vw3ahhG=kXIJ3g}9xc+IrO%@~YXqfM8IZBEkVrOA=wa+xo+oH- zaMVJ+1NM1ugLBVJ%sbD2K1SA31&|Jha&sQOaWZ^%t(L7sMkZSq1=3P#wGCTM@O?y0j2l}NfHexxV*|zmOuoOdfFrL98=0W zj~0SRZxAeyaxoPtn#`N>^C=5u*3^ZhfI&$XBF9L37DpFoMB`|nx(y5dO}8CP(Pjxu zl<~Z~hd@HLZ0T|Or)wVw)8omlSy4FF#OGdAwo8O^(h8M*g|~?$auadCkMfmC70~Gy zTk}gxYF?vD>;;G7VYbIoEkm=02S*PuQEB z6rM^4zMG#=BE#7^FCwx(7azh^eiLx}B@$=tDVOEd=8&V8 zV-`D33>mugOxiHzhsG`3Ts>UgadVEJuNu#XLW%E{y5RCqK-Yk|$(4yUYQwA8k8sMzPG8 zFLR3}4c8D~O=?!JG)2G)Qh%yqRv74^sl7!~RcgxOjbW9^AxW8Kf~2D3Qpn6mI%{BT zB1H0~xXQ=Swr&Yhc5W}2F?HY;{bttBdL7Yk!VrPLitK+{llihpWh zQ;)!#!epjdZ0#|+nt5)d6#0#eVxB!)GWAY~A=-rfI_fCxD=UpFG8g1WSke0{4xh#H zD|oz@u@tbjIG4b6CgiJRO1eeRy;PM0wesHAjZ`)$=B%4C6;-l?xQjT##nQB!f<6%N zz}@k3U5rI28hHs`W2ME$2*RlhM2_k1k-5ix3ev7OC`VwMssr7Rdm@T^yp%z-xcmzECnv&JTHnn zJ5S_&FG{$R-637oTfm`KiIJL?=weZ>WVqo6_d=>ze4<{g(qC&pN|dvwk63e6jp;0R z4{;9;c88NdmT?H1ZAo>cs9dFK*4HT=)3F{A$__&A`7%DPyETVqeUhxg!YlCVBb5(t#Er@8ty@ zY~NwvpLkpt;nTSzFxVO>+-YJV4IMf!%>kj?p@h-Xo~5jw=+@8y*`duhTS;ZxCB*D{ z=^T3icj@US$3+975R<1}ID%=kgyt#$ZcG#b8^mCouO{AbQNuI*sg#u`tZ)R&?E!xX zSR2O;H#WuAkV1yU3lZ^wN`$!B!&W#zr954yKIE&n_ggtZ^syF+@!~tHAxj5g!@@jV z#ylPgQj}+<(rlo$C@mm)<~R96k(6Zib@>g-EiKiPM~8jBJd(=2c*j8OOHU$TcT5y;@knUjYsVTo7Gb8RQ7$l)B`XMg^4%F% z(D=t_0@NuecoL8$Lep&N@f!Jv?Hse787WtBc}eJY`G`#cxhpd4 zyO~~1x?lIlYJlmim%FO5@VNc(ssnIR%W1eIb&hE}W~$^{tPG9;n%a57TCh%zD^xFH zyDCvFtL&>=dP90gEb|Snn4r^%&e=WEb@+J?C{H82%vDAb(}~KWfUl4+H9(k+tu--C zUEM}z&dvdw=WSuBS{AoERH}%T2z`YWB#!%Jn;#t^QDRyK03(fA z+d0p0{zj^Eq?Xszr%U?B91vvra0u2 z_qbCQLBGP+gtR*ujdgE_xZ4Rbv==2S()#^O^F8uBIlRIz=2HyG5+d)BAF4B$c4;O{ z5>em7?tS(THJkXQOrq%>b%a$rM1^d0seC(Q5>eAnp-zd(Y{0iM&mqRe^%f*5-2mwg zJ)N=DLY|q~l(i_9CfO5#3sTUxmX}sDZUU99yaz~We78Fd)#y`c%)*$=5XCDoET|{!uCt z8K0a#X-8A$8pc(H@DL&!3+m|BxDE~Par!k$ZRoU2GF%n+h34YVXc z*uzA$>_0Z;PK_nZWXpb#7Q=-}C#uu;LEhaWK3-&55`&1dt;+y~P0dSLR#lKzl@C7Y z7W0Ns*n*|tDqV7U6`3;Fc?m74#5Ruj7SVS|Hyt*P>JmNjA=bc6+OX-${t6Hr5w(?} ziIpU@f}$J=0`jsUMcG(eIcn~9F9{I?Jb(B3s1I(n>(Szg{1ryq%+}I$&iKr0LUp+xX=@D5;7?GL}^p__GN@J$u8*2fbh;C!nF3+Ayh>{rGTJ` z){4|Y)C9bj0ZIL&m~LrHdaLvvSr;dJb-m8y?me2KsbaH3Q&Q?p-I-xXeJ0&OlBCF!_= ztyGsnnI-n$m1*RJDe0&3G2kr2Aa}ew*Yky}ceeikJ-�$BI_kb=h0>m66eW8^X9+ zb#;1`Mt-uT6)95LREcXVzyMTo{gasbMa(ATlwy*uwO>+`B%QfC-=lY5BtCQwAj;PQ z8lh2GLrkS9FS?LRY1j}H0XFFpFz|P~rSM;=A1@ZtrzZTakk(1x= z#Tq>&CAn#rC0hXZWohmo~(|T;-59dwhYq=s6Q;)%7WcSWs40( zu9I&;^NINQn8%wN$-}XLYP(vZw(9V{8JwJRWxnc4PzdT9AtwI-7_x^I71#41PYYbv z+QURh8=5)VYBYXJNpe0&%8zcDKVe3#@S>D`dHgE;Rcx&*?O zZ=%-H2A`~@f%xkUe`sUx^kcs7CH+wOU~a{=>N_fOyM=0#vr173X_@IZ8A3M-z1&ij z)1U$&XXDdD7_-$=FWLj0+@ zR3*X&fyPvoB$MU^q92&>{?X^qvg7I=@CZ+rbSL*jR)>8YX6i;~tE=j-P3ct|c!10opx~(Fn`Yxwkrzw;H zsa2L%Kpk`)AdBDcxzWwxadQ?oFHvzTWt7UaSYcwz8IYFqEB1nJ2D(}m*YDtSpzO<` zY(Duu;aYP3$Qs|{cv|WqjF)Mg81-8Z^Q2XhciN?!ZNN239dRgCx@ZZv?u$MbE|{-b6s-W-!s!P%`$^YLZyFd$OOZ`Dv@Avvr*j@wi^Z6A;th13uaOYh-n|FPsz#X{#O9h?&5H)89 z^A)nq10BmH+`-wmWZZ35?w;r_T$7>H5o_OFqCQ2i^j_nwSEjedT62qF8EL6$m;I5$ z-sQb6;+qOPT`L00Nw~7Dt)dhBER??x(PBA5yctiWlo?lMN{~_k9G+U7T8)i}N=Uu* zus4Bo1}7`nnx$8tM5N2P(IrcjONamfsi~~2pp$Eb5K6M0he+)On%qy}%);>ewMJ3! z`wmteQ%OL-CS5DZV6DxTg(+PJjCDQ0PVobck4|vc-1Pxk%i?ob2LM zOrF+wp;Y`r%4F8Irl~T^c@8GmC2n(jqrfEVz4g)~MOqz`CGQFNuB=yw6^VHX=e|U= z@JSzB;s8P(Ndm(|s%!_GBSmZ)il@U!_L;e|wAo6SeO5bwR!myqL`;KcjVVZGc3&=; z-8sG%{xF%Nu_xzfcLP|qh|sX*%Tq?C!)4o3;%p+lt(hr4M9-+ypT$)iJz0=xWwb78 zLZZn})=LKv7k6!ZxmMU3+WC@itW)02GFn3;+KUVarerFcA;e6{OnHu4o@o3ER0i9^ zu*;yCp_k#W5QNSQd1=12DI!9xn6)o1w-S&%l-hn`B)IN2nK`&&!zpSFGLJCxVALeo zCqB1JlRsGKBK9WhwxZ+8AkJ50h@qz7-5H7&Im9eUYb?TAy^dg)Uw4?|FRr%-P2ifi zppP;b;SM!VVGK`Em6de0Jk;x`VR=H3^IXgF97*b&#YkAppe~)QX)g+tQ}Pn0Otjt| zaiLs8o^pXxkzBm*vpTZs4tZyr7DBS9gefZTYMi=w#5r*Kcj!2$WJjRjS!#20s!CE{ zLe#^`9{1IrLXMwhZ7sEQvYS!rOh02xLe_CJG^)Kv5v}zhnrrB4Z-y-qlYUB z)~YySyHt4+u1;Z@%S^!UR6yc)csgaOu3DcN$%)K-qG3NQsxoJ(PLaY z;dTP{3b7??B}oKdDceYcJ|5&f9JGjihv;rUCW>ss z4>>f#(>FMy-9n$9R&+FgHB*Wz17T#PWCLiGriL{gCvfZ4>@hVdI^rBtGh#(lZlI_Cu2qd@@O9i(63G$;e>ef%v1$(Kwz=_!QM0p*F`apje%RZM|B4N`m zrjTxndn$6cj~3OKgr1;vj?0sd*RPt_bl_^RXZ$oVb)qM|;YejWAy;J_KHfLRbg5Uu zRNIBnprLSV(yR~0#vsk?JdtAD65#C~u|`;Rq^f#SY4#>T)k#uTZKdz1+Tdvn$?kO{ zpTzzPO5=$iqof`7X{mLWSmrV5Iz30ndT<2YqkOzv6 zkhc_ZGBojGpo~{klxm(s^DGhJx zME7nr1qvW$*QW6%F39pa^0kh9ssJ`6locO4SjTKdnk`E(!$tQN6O}hnCfi4K386!P zsnZzQ#;WZSnR#U?DQ!TdOISYjhL$65ouLw)Y$-&OAxNJ{Q5Gj~d|`_pqm28CmAY-y zLNB|c+C|d!DS@c{S*&T`{TB7L}R`jQ}NS5xyHhjkI}dZ3P+&?TzME=WkOm9 z4&nDO^C*<(t>%%UbLv3wzUJO=HWYU!u)}kC+)1+3fRp3h)O?Tdgz7s)X5xI6Qw_Xl ztnAF9fzFnZb+({4wY5)M-s8Z)bqTBwi>jEltH?;a>QB1j`-u3PAHwjFLj4>as@I%L z)k)^sLP$J@Q=4OZ6{{)yAPXg43ZhBjL|L?Eb!Oz==U<#IA_(8wTece=}zbycZj$E19&rF zao?aqb|w2oQk6GHL!@Yz657GPy65m9L>)Fr9K21AX*@2W$vsnEoP?zaNg38a*1(aV z@rB15pCgV`Ftje%)EcbwQp#!RX4as9>WWAgHU!*_Javct)uA3D9ga3|nH*!Jze`KV zOv6h|#H)n&6`3|8PKq6MgyMP_OLDSixE+lr-c2#YtRcSQR6>FRM%skxBH3s2B0P3B zyiVZk*9xi)$WFe67aL1~)PfP-7b53-ZGRYY6I0|jC{f0zVRt3e9F?75xHcKAPv>}( z7`An*x!shSeJ$DQf2=Dnoe9G0F)H((@ji0EOfRSQ?c0W@7divOJx;W ztjJV@ZmB-ZkaH<*s@>uUu+vRUQ}H}khqqFG96I;tSyS`Kl5G;wsSPsHLQ;{iNa-2b zWVTtTk>j+}#&ZSLZ}xd)AB;@lC2|iHggDxs0 ze}Mz$W1Kf%fJjx$uIo%m5;{Gfs*^Zt={c4dTZ@=V+GX^ls4}aJ%Lv3&}VKvQZa)(TDU3R@f_eiEuraC)%A(t%CRw6wd)aW)Plqf~dV zbU1_DRfsqE#D%znvDxzzvtHr^#On-+W~K|SA%LvGuyx1@we1qIkn$1=i%aKL@yw@E z&~$o*1w`0C)AAz7Vyka*+@UY-R4jk4QenyT_=$+`_S?jBwb`i}M80C$CBxZLFLSQC z3+Zo2VdEZCA6~@WrcG{{^kqSIo02I&Dk&M;Iw!+Xx9^JV_tuKTlBi5>arA0&$}?uLbD{H%VjtCYCK`NvB;s;k>$MELx3qHScptcv_XzF_C0=L zd02-D%_>58kE{p^R&P|?gYt`985dF>NRbDLJY?b?7N@;LttB&3?HhW$x=Z909Yh~4aKzaiS8s@C$9(i#VN(t zgVzkrr7SZuE=ajb9Ofy+btpEm&}BX%AZ3P+6p)pGZf+DtZk8t2ipgcN zbYejc(JEat6H(<-dymx{bdT0bEeu87k3NNn%DH5x(0)-FIvk=gcF)3&;!GgyXK%v}q`(y~`fpW<6IGF#MHOXf3?+d0s*LF1AV*G`CPl+A>^L4Kii+43>vpdDiJ| z7oJc;M^zgQe9T6UCu7o{#DC&$2b08(%VLR4qGgM)@{(`NY^V!d8(kz^8(*Yr{he{! zxk1J6xmy@f9eFdMjo3&}vVAnJ{EA9W^q|&de#Mf|3q(kTtf~+Wt|;8WN;L zt~&9x73NgS7etal3B9iBw$JI{E^oXc)JYNCjF9^ou!yvu=yywdlFzhOA`_TylUZ*^C7)%~o}$Dn_d^*as{F|?RYkX8j6~Kirb|z- zptj#-wSovf@?Sn&i z8`Pdu)7F-el9q7|odHt7xa$kw~eIYBC9J=K!{*_H08{y1Iml>O+ zB4Wkdh;_87Kr9h(NCW~mBf=v|uB3>jT%5-nU!uq=g^sEJ08BK7m|7nIHn1IRs3d>~ zdqpH1*Cbji^xq;)i9R35(cFAgxOG}ZG3^TJ)5;vTJc7!cDLpnK6D5DdDLUj!S_f*6 zqTWP?E|7YcFiup>n;Az>id`WIv4}Z1OWiT}=I%;a3Dzr32jyKu%_vZ!i9+4i0Q0-wF^Hteot)~*aqbjnHY@wkB+YomLXj(Z!!L`~H z2IFeHahy3As%XngcXv{fpPVyvDvJ2+U%-Fw(@hDN%8HzkE0}HB1 z?bfS`4!$g;HbRC|=cxRmr-|d#e++r|CgS1mc3JgGWFTcmfM_E#lObsch|GUNa~)x+ z*;I?XQ0h_Eqky^uz zrCCab$0^Z6;k-tW{6;5>M>?3MED@-!Ap(p^ zR#SeW6&FsvmRji(6{jRDu=b#3+h}LuPUOzCRx`xjJ%YbyXuli zBKNQa4RPvix@a8A@#GWNE zgkCaU5pS%k+*MZke-%zV;rgj^K|iuJjYkKMOi@vucE~;2;*2qlDU_$mEdfu4+d`Ck zfl30|h`oloo{>64WP~*~xs5wA%$a$XrWtJ})>CCntPZJKlVS`J$aUi+1p~FcHypgo zwDU$)^$;nk5buMUOgBBs5C>U8>}R^=jbwPqTNIo;oDL`?qxi9dlW z7R+ykbIt+hi@N$=3KoH)+Nnm0AzKl!P02D1aliM-!rE zaJ#nMLV(&DonmycBYIGGsWH5_Vu7));>ml&6|yoIhdJBz`xFO#aJ% z5`I1{61I!)_r%P_Ou6ws@R* zlOdA%5C@1IiI+=!xre6&x_1)prAtBmm6B9H7)AHobxXFyXU14=y~Dx(02$MrEsft` zDaQRzbtN&xljQwJb-(B#rE4fpg()U<8FaU*4T$JrB86*pq|dYh zg_Jb)j!?Tfrf1oesJJ`FPFcsOwwBXyd!*^*3rs^eGSh38SA1tdIw)=-Z4IYF_35_V zWf@KMzoGDkXnyS5rzAP=Y(yoBL8eQRY6T|t0HHu$zv&!0cd59M3b0aaL?NIHQwW$) zeVewhcj$d%hfK(;7XaoC^|c}j3p(;@=7X#yoej)tXk}7%jx&b7M9G2?r;&gHPDu%w zaPvykXtW*uM~IHt4osj4rGl}ySWi=fXvE@MU5>UodPAoLTAgZj1ogJD(}PEdFuPAE zsjvY%h>;wWF)Vf?{{WDSV(&`6rXCuL5-<4M@P}4z=xO5YJzOB|Q&-_U!ewgZPs?5+~{$)rPpry7A`vKI(*}+J6y&k!zajhsJNO( z7PK5?X*cjtKaq)1%$W-&29DxnflaS}IDc6i!#GnkWhFsPn;!^uNMXW^>Po_FcYxul z8B@bUV*ngUnzQtkchj9dDc|L2OICKp6t!IwNeUk>vCSuS2652gxQ?7OTuLu{S_%Vo zF9i&w*xN$@7y}DWy=4!Sa)9&FdDCsYJfSWpZ05_#t()fW3-p9gt2;Svj_<54jtTc< z5k5<;_gAvKej*a#XKXyQnwb`GTy!>pMviJXlGn7SDfoF9?O0tJ%uO`fxo+s80Wlc2(cbU8*yk| zoa%)+Q{;3VL4>&2Cqkx5m|IA)t)`;a{Nt${u_0Q*;VR50%= zR+K_|r+>~lq%|CGr9Oor4kVPT-BA39=wpo?JJjq%nU$88-B{H(Iw*N<9ixX%U?stS z!T>pJNHpt&WeHZ`_`yMDcPPAzsW$N<3Ii82+55v`xP>Q24I@x#!)xW&KyBDkLpqZrkjSM{;mLbI0m}8l*SnH4^BdRY<$g8>DPl5h0)0GRL^xE5@Lpy4> zTWkCyv6;q&k{?Qi!H3j_!zJLj?brrNf(^W5wsD#73K9eWc|!0VFysfMCXSg9n@3JC z@bUxE&^-VFcm*5^#u=2ZprQ7{f`z_thXltXk;I6Yhq083CS0DQJY*)E1QnnYzv`%z z{H+bRH}E7wI$Z>Ucx}Xf9(Sbbj8C+m=$~UDAau@zsEBS*U00y=b6;OmlR4U+v4dC3 z#8gSP(mm&8k|tU{XEGa7e;94zzE9M3WJ{-@=wMFL7)yvs4Y4;Y+s95z#SO0h8A%2s zPZXoi@*j>w`9G+y#QYn>*x&0WB^z}|Wi<1RpHN#;VU?A~koP`ha>o6ODb>W0OPijj zyKM<3WxM{eU0JyFA|zwu{Wdt7b zRFvNSH@%LRF>eWYs@BDJMB%XTc1!IQM8onj%o$m>T1IO)Y~ny9>Y^=RJZ%KwWNB_$ zWfvDyvFm)=blVQ6z&MhAK$vGu4KpmwJ#xB~{6N$2gtTx8RqGr;hW`K(sQYriWJegZ zYuPWSD#gXY_>GKk>9mso8|}eO87j<(k=`qqby9tpx>}C{^Hbv1(K&@zmooG|7d` zjLq`a4ww5T7|D*wSm#4&!XIF+(q)${{{SuU+Cs9qt?ktW+wh9~m>PTY@+Pd_gQ(QC zNrd{+^B7@DE;RwV)j7oFRl|fSARiFxL=o|XFT(G1 zKN+>j*~xc=3Yh@YDzhxg5#4Pn=A<7b6MrihOmTK3$Bom?D>rzN!l7KlW|p^<;=m+4 z;knJd&w##`=?`MZrK;{RJ||VaUb5yY8f$i=g-o0gGh| zdyplTxe_jBl{ZV43ZpQ`F(_74I;8?dz0jPh2L87ZI~-_?<$TJ^pwue~$Id-9F~~1V z1~C6VhzgWZssLlX&KDCU)3TlAjBxbb-ww{WexM0HQY{ z{Ph~8IwVru!re+#EzDX?!V>1~ukPPMbhw4eeOBWURkJKh08O!p!%s-k>J29j?<~OHf6=NcHb8JE6Rk0 z_@Im1SgMvw>+2Qz6QPPPl5fd9$mW^GxMfqGb#pRRDsA>4ZQagv2_A@rl#hlkw~1ll&m(_Hc>7gajDbYGNhjFYq&FM52dMEe-t#*QfbHQ zzo+DIX*iP}%hjgo?#!`ItSi4OF8Tqd)RG7MicVz;=7H}w$|PuSYuRls@Adt@9me%3 zFX83!`t@FYjaB3PeOh74jWyR5Qjs}obSIcgQ_Y|qT$L73nQ2;Z+|aAe<5!*fDtfluv78BACbHWoa+f!8-C^el23_SH zP!r4q=reWd$B$>dbxr=ieqvTh?v!_4Td$Yi+>VTbv9>Bt(XLioqgN!wrse7lq)W^o zXeOkdN^avs*bq=MlVWzdJSZo${Ljr46RKmXOQi6#R>yfh*u3N&YFNqHwt zBaHw~9q|@#fwg&hl)6c6B&KBmn>^Buh$7$;2C2VTkCqyh3Qmh>qR&a(wL*|)X$WEC za)g@#FPi6D-`3uS1Onzk-c0Ci0422`0Fk0VZrMNsO(AQU$H-92OovoS*rhZ7Ld zwOf*EuPoHNnxsuItA4_>C-D%w+vbE<(ib@|X6EHwT9C1!?i-VP6W3o6 z7JMfYrPJy`;xO9Sg}g7Hmw0m>Z6aqVL&(cups}GB-6|e2qfDiH4c0f|5yO*?JtCx` ziG-;vrFXD#%?nopyS>qV?e{RMIbyqs+(UO9OjG7Ld1hoKnQC+t6u8Xd0?@3dsuYxi zm=Z5-dO~RJju#Jc>7>$|l3_|}WbnxyPN7eEdA^0K%(DKPh97Z73LYZP6Q_pIhPM`o zgFV5?>G{bVD&az3aLY_7MOqdcd2bRGW8N*?fo)EjL(yjpym#Wud~c*m)VX}OB&v_G zmo2`i5LqWvbyytMHoQNLX%i=6n}!p?TxFbJ-jymJ8FrwT@QPf=bBkO&kmJamo29f9 zQKQd>ln4n+<*=2NgKvKKP01OpuZ%Sb>F3FgHDgo9IV4KsIcdqRSVNTLyOGaz%OjMu z9meNd>80WLJ415jcd#}(YlT=Yt1BX&Ycg)LGRR+g=yAk{5=gb|p<(51Om|JOHgqZ+ zE~Rm&Mh~>=7 zy0p5B-zu{t3mriOY6#pz@^`qDsFZ!WT~#)`fPzx7PLU}f*n)saAoMWIH$$zDKV|;X zM;WONsNSv+lugSW5j@%jgQz6i+R{3#fUqsSqO*wMtC1%jOC?VkX>$1U2+vK(tC-qb z_J&kNl$EwhRFwiQl>k%}H1&vh<4kr>Vzg=XcBHU;vl97I@nTIu09dWXDaKZM0(7#D z{{RS`Ll#V`M<1J?s!CI(-%;k*RO5=&Au>sq2E|89DPdVhf^I<4BTEfi`?19_Z@}sb zXc)H>v|dB1oN`K{(M|PX{N*Q5HY5T(#3oA87M|roaei6qekH2RO07*i-AU5g(ri*e z+!3r?V#oMbz==6-Sf^p0DOLE7Sz0RUZO3G#TuK~BIo2E~xmt-ik92-96N<;B4&#-Z zxMD`AaW#5Gq?s25Nosg2R+NOOfns$EB^v{8D1p#;Vz}9aYCKt=N(#|0LYGXW!-;H! zsm08;l@}C^a}uIb6h@mwh`Jj!=}$Yuism4xNvD#zTsng;H145A43lBkDN!4DtYK}O zA1=$4cB^!z=@WyP%G`RI=~lU0m_oTKAm07%?d)>sZD?*=3PVM~?i$q$omn*}KblgX z_8^6;GEC1fC%iQ!2}ugRnvrdcb<64$b-1%YR|{k(%#u=uCz#6XBi%?^LRXg7*=Yqk z#H>!nr?DP5MD*SPtWswKh6D3iI$XTc zomp{p8btU>H%eSvs+CYkwwaJFuB4=EVQ6k+ksm(IblI9_BE}ewU<6V#I>KDN)VC#E zTHGNcTO<-M)aW86LPSOnv;9rk99qpnpp>=rtj0!&)eB+vSIb6(_ey{TD)&}3gw0wM znKnB|%`+)Vn5JY2U1_xC@9uXjhwEdg zQ(xzZjhK^!P0%Uw=$)2&WED#{i~Xdebu7s~@D|%rk#X0=Zx7ex68%jc4%DXQ@N~UG zRo3OvGgNiyxq_0ghLgWG8IK+W#;E( zrB^E11*9cRrC~_7*}c+(wpd&J7=i~ghi5ob#L8t!2ppM;kbQ+6Ql#^g+Q9Yc?C2~oc;QdvJX$v=!Zxw1UTsZ5yv0G}w^Wl7+r+k*Bk}CF6p8$3G144;t}3rrt_jQ!ap@UVh23 z@klWPKNg|Qf}j!0T>vzmzhO*2Kpgu{IgP66h7wrPZ(W zEb_ySsGqxWWREgHiFmQM$d8gl7MkO28x3M6sI_S&$xA$x7M()E$PQbURbo?@TPoU* zIFl@0Q5{I05x7|oK_`}i0<;ZQi8vHrhe+W;^1`O)Llx!5Xm6rbi z3!lOqcp1%Tln4#H(jRGI#+(;Ji8o38{{T3RDA2Qz?|c*+6rBhn_k^7>(`4DEpf*tB2Eq-m&9s$HyC4sT$_=YaA;-Q=7nEg=^8|}fzuk4?6xiu)mJ}4 zr_L3X^Ca2@M3QcsgA_ScGGcaxyY&^!k##5wi`p4FGn`JrbZmNBVz81H-i^GJ_p+0G zrCCkKmq>OQ92v%}XfY3Bnl)XZx;*QMc|;`vS|q6K4|4wiD6z+$#wCn|yi36~t`JmB zDzFk?NRwe$DCw{_+oV|H^CL;_D<&4~i;ho7 z5|BlnN=>dl^}5@vIW4zCVw(xzj7P*}{{Y2|7q$0_tO4^R!&7vuT21mF2Kz7L!|W|C)Tw|vXFBjv=Nmm1OP34hJq@IqhD9! zBc9CUoV#H>@T40PWoFXkUc~KVymvv%I9yEPjMYk`OsGt-(m4{$HiV~jA&&3XYjRGz zovm#laY9=Sz-i`Fj+$JlA%|R1KspeW>tpGAd?G|PBjhI@8pg3D8EzIDRc1D?R6}%<+ZrN_Tj7vY&i4mtfkbr*-DZ~AcN5Fv_@E(d!kB} zp-0(^i*xPZxf!{9j}^U@#+IT2z`rpFxd1quW*4$ZRj+u9mmNAJLRL;33B;)kXp)&_ zDGwv`j5sp5gVYhR^+_YnB2^FFj=YUSmTh=;6QQ|A&K@t}wKE>HQ!vs3kJ`$c6Xpmv zi(EWQfeLu6ggi^^V8iJvmtm_PxI!=K-O&2!7nr!!E@gD^G*`AY;B9k))5)w+!s|@s^mwQV(RDX|$#3R{=|iP!=FxMGNdf zI!1qpjTU&BDx4>jyY2*2NU@1qe0pWNwk)Hn=a|h&0^Ka66Z@et>NrnHeG)w)8|F9~ zdReNIE=$ZLEti{9ZlsHaA!5W>>9L7eXQ9~6Sn5SNV7e6F1F=m04w+VIbf`|#mwWw6 z&ck3XofIrP!Zx^P;w$cFGDl0Ie|9r-Ee>K(pZNu-O`!P<Lub=h>`dn#;@^wCsb52W<*35>lY2?JcYR1 zDknhWM1+MMbR$C-s#=wm%~1S*bLWba66{Q23Z>IGPAbTgbM<%F8)2>dWS8n>drdv$_6hhj6{lO%%D>j=n2(dC3MY91Tc?4S@jw z{H$YN!L5ouA?`AKUzc}>_=68(OO&$vQp?TvN&rH%7Cj=@m*iHqKh^w6Bf#p^`x8mc zAyUaxl>iGq!{DZ2gR*X%%gU2rM^mNv*rYeLJb6mR7%H=cW*jqe)XcMVNxK~ALf2r! znYBuja+@RskSrBzL}{udK$BnG=D?53Vdq|*Xk>O|xYl3^&{&WT#wmE5o9tO)j>Cc4 z!j_imGNU4SRXG`nT-s?dEP3+k1EC${=GVGyq#Qru44V`=CyHk24!9XvZNxaD2qY1% z*9I;$CP3FkpLTBIbw`P>)2Ov4Q8gz!Eb`Rc+C$0C*~?^w6Jgg)Z?r?phfg8stZSH;?nQ@D#pJaK(J0P+5P!r#1_yr8VtrgiZr~F=|xX-YzmF*(S3T3=oBK0xy zq=NcV9F|_a6ooBG^2`UELVP9i-}59ay~we~9xv7VGvis8Y0KtQCxRwW(Im9AxR7%t zAfyZU^@|)_G-n!o#$}bolb?c}u<-u?7Xlbk%(U?W?X4svpVc=b=3+K)XE^S+9fuI4 zOUBLYp{OxWC^+*ar)GvBYue>hI;4dURGY+UDnip39C18apKVS1t|2NT&#Xn1+8j}_ z3t8d)Hxa&>r={9d!VS{tLUV)A=C$wV3Xc^is=b7~NsbjgWfzav(z27?D!GYVG^vQ1*rQ(5RC!7cK2NZYUop_70iX&ykzg$zzrnkNeg-p% zRVGQa;()p8ZA@P|rA?vSqg>38PMvnY;}dcsBu@7Pam#qQ`NXxULQ0Z+b0nCBCu8v$ z{Ao-T96cbldyY=zU!v9lhH^33BI4#aM^46gVKi6UNo7ocgOqnotO(HC;3AFjH0-lj zZ4{q9F<9(zh#Zic3UZqA^+s&Kq@5OlZ~}*}#{an*iEwZ(w zWiLxVp+d;jMJB`oY&_x~XzEQ8aqP<_W$$TiD;+>Fj>#P^i>NzBGK<3$J7IY@g(Ma> zJZ#~UTvfyKw5I^f>twQ{ZtI|3CgdAj=wkbUmWDy%6{3$gOOB_wdr|&)6cEdXQhhp* zaw{SnBKoXoGj$QOfk7fxabl#d9-8R02gJ{ruH$Isad|o|Btv()7R%q=!*Xbq7T|o0fu1EPKM$1m6 z@iVQ{E!LyNSxR0TMNq4{wgQpnRGp%&aIL!YBs{dNtVxFql4hqAZn@_>x8BOOYsK6# z>DaH7tcv(@RPir}GRWO5tSevDHXGg}<(8D+WIc^rMepJa1x>~hX_uduY4n7EbD=8f z(=aiRmm1U9zgQ7ZeYJZNOJLbUi16x5ZM3jv7z6~QbW#9Fw!4e^MW+kK_}e~Y9Q;0w z(b&LqZsVK|w3C_k84jSG^D;uMbL0$KNs!`;Zs9F?7>p4 zc836nt7Ox`ywTJGM;q|Eo5VR)%G4#Ac?tw~(3M#HLHWhE51L7lGC?wixUq!hdp=@S zwM=>0bf(H|p=29<)0WpBN2F|cS?X3%=8l$1z7zJ^c3mlAzRxiN!=B1XQ1ehKx%gf! zpvW&`TM4Wo$LV5$$e9ZpEwC0Z`$^s%5<{LN{{VC0w$!)q`{ku-LoO%;dRQhCr2z`D zuL^6NFIoCdSxuxJ9YG66tmyUW1t0Zkze{iTomuiS|yf;rfa7t-+Q(EN;M zGw>3}(6`6LCMhdaRMaG03T+NqCg@s02ggGd&xd`9Ybq*pi`*Hdy6WfT(78ndO8uOK zd_c92m@uUuwkuHDVZI+#D_z+YF+7fmDlI?$U64=484e4#W4 zZ4>OywP33&!V^?<*31roYXBXlQj(D34T&0vNz-9~9VCtV#||0hWt5@P4nS)m9G1^R z)O3!3ub!P$q>5Tr#9Ts74U>{8Sj>Z|FyNXp%S^i_NLV%kItEnDiH*c8OFB~W?aT`s zM@|V0MTMH5Colwcy`jj?hNT-3Gij?~c~vnXFtIMPa**P!e<7d{;%U9c+G~)Y;g24% zFAfO+DdsmRDUdsd16u?oG;rN zkyd>zIOUR~U`hzzZDH8u?lUeQu`KEJ`AX6P+gLe;#7d0QAj=gU0Voh|A=@M9In@ei zf24IWE+-vSlqg$NpAj7!IjfU>qhn$`L4fJg~tQY3ImMG%58b=YyL0*r9|3Y79&F)09i=s90N*z znwia1EP5zg@w_HV#U^oPnRT|gYPm@FRD)#?PGF;pJF@jKjTHkxXZlsWm8gP%B3(l& z3Q4+7kR%4g+_qp;j_SVy>L6$iH9oYtGE(U7lcJNbF~B;{&-1j_-Xc15;Lf(<1;$sK z+=UMC^MrxdW?hQ2Loza{BSi~bdL84SV0uaBPzY9RyX(4ti~uHFoqm*{R7#sZ>W-v; zv+;yIg>ySj;zwnW3dph9TaV%+mK1Or#Tl1p04ecK-;8rn+7t_=nUsf60@3)}%otFR zDYI#1SwYjPPU-&uWD#J+Ycn3tq0~dFR3zH^snKwLS{Po;;ot*Z+mDY}Nz;_=G`xHW z`9c^QN|#i)191g`&6;G$ubQ89?+I+_)J*tL?(5|pOehBD+M7TpYuiz=@GxD48w|@O z2Vn|F8L+8zt5Li>gq*Z2rG8KWzFkTP3ex*Pq$Z8@t292CfNufA*{ubgJ!k;JS}0Y) z^$;EAW?lM1n>b@-!lAD5)gUuMtPe+Q?VgUE20C!@fa$`kVVOGGN?&CP2YaM`@d%U? z7a6of{C(J?4dT_8*_T5PUg2$}Evo)E35H%axiUm^C(R5UOM%$)h00l@)D<%<0m$3# zl`MDwO_Oh1L_C=9n)D|_H)rZ}a93(7&JJ2+@pV1MRkySgI~tpCQIV^dD_)FQc`wZmR8EWr5TDs#q*^X3Ih5Y*n`q6a6!RS?lGELgiipl z9akUHY11_INJ%u(Pc~gFsUhUt+$f9m+h3ecATlLmh1K|9U73`TnSNDaOXC#@%4^NcHsAzhP`$o7Lo&uH=;utzxgttdl9D`Owy5cW zFKHYDd8c3jF~y~OMjf9>+{(NDY;a@~uok;YPk_*LzlRpCR3;Bh&iWa}|3A<|0r0KD^^oHIf!DOL*fOwrJ#6%Rd3S0;a zEvOOQR>xa{H0Vf(?*$9-1^lBZl@>x$l;2y+Ps8dlueN3Q|lc>K-^oh_KyAoK2sq|Y5dns5zB|#?2%hZG7H-}NwSJh7%&}o>( zv`SNFDwE2WDN;(B0UG8?(p02{r%)6Xu-jO6w&$?4_wyyTAC<>=*=Sqd$w-&D1roOk zaVMjil#_1=fjO$${{SRSO)h(pMagr z%;{F!4e71>mUBm@OHvs^8Eq&TMu8xHQCldsbxh~tyelP+WsIcbVQ3^NCc^1Z*n&Z^ zjx0=f9}(fZL?WSmF~j<;NtwB+33@j=%^8_xI!P(HP1_kj{h%-6VVug6OJ~<>Uy*T- z{gR&VYe_nPRwirQWT)^7bv21voV3K8!h&ZcSZVtmb#bHwh*2DeyV9nxD70%486rF z2Af|CwdA_5)eBO$sdMDjZ2l|qW@*Z`Ul7lI7c*%rZ%ay-Oq(6n>XN9`A;$qB#H?GG z+KO_l<^T<2zI`@Nz5Viic?eBKI{q1Sd!^>PdG;_%<2m`YFBIYV6(XfBpvEVmTPAed zyz*KkCC5Pb912%49p3TM3Rly~^!}auFqLUhmDT^IWO?JN{??*021B zc$O&26>%H`6-5GWTiK1WXU+w_)w1ut-8POe9G=U(N?rx2FAq*Q8valqXQria~AW)On~n6sQ6}J$wj?hq)k9aN4u{)^+6z zmfl`KH&7Wut?`K27UR%j?nY%OpJ7CRn}r`Q8<=2lTFp+kO-kGz>0Wbfbhre^PKh^a z6LR%gS%(v8VARU22=}sr+D}{99Y1^kFEFJ+`hyKV<7KB*gs7mKjD8!?Vm>_ zM4J>SEnb%yzYSxzM=H(w&0R9tPMX1 zRf(d%xY@#a+7phyPiU`_&oz=dpz2swx3YC8S^b#5;W(RHvZIK@Ph*jUu}e7Sp3>9; zg41Jt(&BeYhL%!K@r$^-Dx|1vsA+ncH#Z>QQs(ESX4p%LHs%zgGbtT2ZaiwZXlbFu$GZ;C zvqyUx)gNueNlr`3A+!&9QxhplklIG1tG(g0GbB2h)Zr!&sZS=KimDDNb21>b>qP-1 zODUD)PnwaKYDLKOj$Jwx=0lo_UN}jvV@pG6nO`l!2up+7A0(vPT)Q1iONiSYjuSR! zIK2M={u7d~`Xy>PKjCAM=1SfPOt&vJiDff?IBupKQ+Cug>T@Ar^$Nb0@bie1RF}Yc zJ0fRp`im7hjW$a#%_%D3ddJ-kC@ROpOMK!^1xRZn5#5<^wC*IJ*NU#W6iGcU9Q!I> zWUT;rkTvu%C}zg@v(FV3!b!}tWc?F519K;SLcy{gwTU2g8Ui9+9hCUQhErYYK6&CN@wq1MzCl_zjUw}F$9IrCB!Y!@HaY;x!>3xl% z0BvKsOqC8z%0DqEEf*#q`^t3;1|`|H_bTQsR?q`=XhDDpA4A0K;65eO*EG9JPht9N z2~u@IQ;A9tNf)|vCfC>!A*8N9G25nBj~J1Y5!H})`a%2pf+Euw@S-%ilJonXfTp=n zKjLlqL{2e&5!^h-_X$@yxZ=A=T5>H&o?1yh^KLQ#Aawwb9pa)~ktmCF%6qk@%QKjk=0FGrQHGcf2|HJQ1o#}#a$ zq&R>Ex7Q|I#a9J^ts~mygKTqM2Prw!d;QVwtsx+eo5j2l z5<^MEei*NWj#H{M%gjhV>m;aa$#qH&AqQ1mDoGg?vbDAK5hXF29S#<}ymN^0TT4Qv z-<+0PL8mlQU0Lp+-rCbq@%K)z*N z1f<@=`ouhvt;gc5TX9x`)*YG0C~>lu0w~jR$*}-ua0{cv1zdPu`a^MdOj}e&>{DKL zkxZi{l2jKk(q9(X$;_ysJ85#U`D+fdh__4yhN;sSW?ouZS>);sOg!?gK`NYD%h&1( zRHB<{Y`r47e90)O%8n44!W2o#XVjrLg=+{xR&*+tQ<>Ubx(lcfd)g@L4|9JMBFVwp zpA|`BN*t4ESQFE1rlTYWRk4vv2|E=Fp6=vdNJL{y>vnB%Qe`vTFH^&3C7V~wll$Ul z4g5nnITdk%Cz_X}RT){b+>(@1eC;t~7eq1E?7fR-aAi9YOv&G#Uy*GV7dCP9g;-eJ z<-NS&sViuI8x^>G`(-v+Lv><=4R^D&>5UJbuZjt-^bqHcV` zQ*8hm`9!>GnHqeE&Blrnn#6DB-BL1Z{{Wmfg{5tg=1eA1TEO~sqO1>tDv59SM$rYk z6dqnSrWI@vFn&y`DKq~72|o`q@8#!mo8BnpGRZ`4xU0hHE+|rGrHd&ui*` z&5Z5Z#9vf_W4+jn~Ko6LOQ3{wG+Q7KqNqvmfI+HC9p7&Qse|!hu2nSqdvUYzIxv^os~U zhdhh16zQ~id^<1fQmIQwaeT+S)=pw>0V+P~ePT=?p~#NpCKAe}Sb!W*7iX?GlqZ8z9;@x3z(@a9QnEVk_7PJp^zdBR5IT|ofvds;Z; zp}Q25k*U~sv$GiPW%`{_r4}We3uqhV&Z0?8!5OlPd21QID~j-yE~V!UhgR&kw@PG^ z8fXNeBESu;8ElzcnROV^qt7bR5g8q5sg5vDCx~2HM3mUf!&3-kBL4towA^@ZL})Na zVy`rXZZyEoVXCCnQbYt)X(cnP6pJb5lCjJ|7q_@hwkJ&lJDLipW)s|$6>M)TnVME0 zl~zVqEWGO6DWZ;PNxwmIFKgU{89H3G)U>UMacym4Gkmp#&NK=~&?PCaVwVixLfszS^yz=(LcM zPr$`)ULN*)GE_5BV|X96juOZ3ay_Xst|-|&%jG{C3w&a(d?SfAIa4H)(!7uqk`#pt zr9j*edV)6*3C4#+#MW@G?xqrS*QHk4tQPb_=%XOdln;wcz(KKTr+AV)hgr>U;xk$lvOfFy_2EKGBrX}eD#Fb2!1+oLZ86; z0_rM5Vr_ldRCUkyz_Ist+SiK?9vc1wStX>Yz82t-#FyqV4k1#Mmz1K=CdEoSuS;k; z3tBZiK0Dp~ihPnd*t-ffLVa0Q6wS_6`F!G2R5i@eqpfsxDGJpt3$}L(9!FybARfK| z_JE(@wBv=w)b%;VeR>Ay9SH#?Kn{u?h9l&Lv@R2HWvJooeHkMAaj;SJ(tT#f2KeeGUSSn)LW_bZ#n%XYC zpB?^0E+yP2RBZi6Tvk zGM?qkCS2K0D520Tbs%eN{x%wz&T+M6uMfyn;0zd<>^R)%VP#HKP}e^xDMA|xDi`-b zQ6La~VwID|0~_JdBQ~TmER&Vg{;q9p@P(io%uP7`Rphxaa}=N*eUpoG7yg<_AC6HDNAww&FPOn`XAiDd>1iCcQ$^qh?5miM z!Y4OteUz7P_mTkPc~0d>seMl zHi=l{scttXOoK9=qbj^VkwqR$xELxyP_Z}6d_jT5AdH(hRh(~$_^nQw4x!13bcWRF zNCzc}2~kKFvAv1(hkib{*lr_u#@4^h$_YW!ai8%DR$5n|CdV8Av)FgxKEE zp5k_u`4;%O9p)tQHwdT2Hm=L{IR?ox)d_U{e67CKn+j6E(3aPs0wOw)_ab9pZa*!V zbiFw0C*%io)TPF#KXzhWAgz@Sr9cQ}#BnlWV60s!ix^9?kGAt`7edgWpnR@6`5jI4Fl446NlKCh{y)AY$B1ZU;<6ZGF2l6>nyPA&OH`}DS&Et@ z8-siM{{Xtt*Th-Xj)}d8B_?UI31V&H`=~}z=>a7`Y)DR*@$rh;GGt2e;wrhA&P@v3 zRN7GelES}ujxM5^VTo@+=prjarYA%$9K=ko-qdtd$zwb{QaUB+XXQz@nUYG9FXC^s zYki$7R8aA2aizpPpd0MG6p# zbwdkbq3q*7^rj`BT7`&^aS8{aN(euUMw7PwUzs8wzvM{|?tOP$srX&*$i-I~%jQqv zzd_sV!qutxlfce8NA^TOmo!aWnOqdPP@29X1X%kM{{Wba*gk&(pC><=EqEs+nQBy% zw(glW5PoVWSbaU0-$94XjaLe|Cr!t^NvX-ynl7}4xs98VW#-VE5qpk?DEPi1@6|Gl}9}M{Lt##YooT1fr^R<>eP!N)8W(@fJA;Wdf)f zmK-?5Q?!SHZJF1M-92YSIn33@l6KCMe(5(o1Z;R5`r}=S9wQ!>aItkwz8m8@CMam+ zM8lrRIyU#ampkqVJ9OS1;vuOta}253ZcV%BLkKiT^e{w&=YKhN=%Oy9UtVF z<~6vcQHN=|JCqvDLa@u3Ut{R}sjwiS<~KL+DYnMiB1%sLN(`mB zd3MI?P)b1cCMpuPPr56&wg(?D{YsNAnq=!!6-gQ9-)Xd6M5Ka;Q+r!foqG61w+o5E z+ac!2n%JflU^>1kn04t%CzO{Kr4H%P6MJhHF-?`Sl3ho?1j^$)3c7oY)1J*vamBK% zg85vwWE~C0(#1sqDZh>MiuZ3K9P{kEz8&~h>P2wg-ql8F8t>%^HNrE3LEA7Lvf@@;PY=od9m8E9?|5c-NSP3 zNuOvEt+6=TQa$k51;+hA2hRN>(W@gTMWgWd8_MG8MxB;cX54AFTTs4LA!6dj);2c; zZV0ggGMrW?7Fyz+p?+csBurzxNW2|STvBR>d7>aoPtc`v~GnKn6?_@hTrj)AHGHO{mscftd zTScb`>O@TZie%xfWKmd{l9=v0F7v2TPJ~%Ri1bWxwPsHvrYmV!s%sgi*lt9N3MSfG z_qn!%tV~d?`jH&0=(>Ye6B9d1N;04iLTzpRePOn!?byY3AfYP~;+eXIi9>424^0eE zaoH*l%(UTSY`o3Jk%N;o$VOw@0&!g;c1c4pb(M>G*u<$*J#fBPZp+` zX~JZ!iGNO+_V&W!Ar`W?8TvFsQ^EA-^2^Mmb1XrqQh9`h~bP4UfET zH9l91z8?i{$XO@YYEi-(e`-oo4pg4x*IH`ISUvKPNDIgcQc`^_=N9;~JbZ`~j;>@x z;tyjiQNzWR%C@QI2D#e-Dg*X&5`GbNhl-53?8q4~waamV3Y@~z7kRg3UrGB(QV+<1 z775=XD^yD^8g{p;VO*_FkvT3bGOH?72aH z3R{5N;f!rj!4HK>y0%235hTne%keF^DvZo3$)m$RQ@TzIwIgcx^-qXt%*<|q~v ztc%oJeeN&wh;!iWa@=-2O+O;n==i2mw=Ra~n?&5Ik}a45LP+R9xs2XSEp6MOZw#nw zc#GL`i-?(2<{5bs(-ygA=PLZHrC1*^5Z$hSQe$Xh+35hYR1)cwlQ$ zQB$`$R)Uip0H}4D;Bu%EI&5R0awn;%og0kF+W!E?IY3~Requ*LlWzd7KvBO9!T7** z=%%cNXtb2y$8Vem4!bI8?{t8AM^2lKo=3f)jsRu2Ksim)dO}&#oRzq>Uv&6d5_ITu zTWL9!pc|dzrwx`{Zgh846qDd~j?h`CA+(RzbvAroGNJjgRQ*|@R~bkX)D!a6skDSFYi&Ho@e#l@ zfqAtOl-yrq)&Lc<2@a$ZoTsSpg{5Z>x@6Gq_VtC)%Q+s(x^j+9LD$j|RCLaYnq34d zy0N|CEa-H%FEoPLwo`kH`1nFvIyckUG1+3E!>1v?bwc2e3z%ucu&qZ0yfEc7_s~K} zu_IA`7*2{6s>N0xsX0jcwd#(C!WBYUgA^n!NttIwUqUtb5#V58g&c)gRGSykz@0~5 zlr1|F(V*MumUAQeC0^?M{{Y{l2WafRlHv+Uxwmxqi0e2e7_7f4r62_xY(T!AV$hov zLXJlfDr>rZ?z&j~qqcI6p`GR@DHlJS2PjL0`#Zn|1e3M&zn6qJ$XS+so?Dr(WV$k} zbiYF#V2-^yW%*`+SA3^K<~n>~QIkSiI&#&f-!?iJb!4-SCrmbnH5$UM#F`Ur-V)dv z%+wjaUSJFGIv>Y)69$f=T{8$d2){^sU7;FHButfeTp3h9-te7AXxwSSb|AvjIMK8h z^M@==7?Uxa+pKd@+5~8HjvO;)g;-EfuNXB29?uF=0~7N}mKm08AzIFdW@QiRl>$7W zYE}k&!hrSTfB_k_FaV#Z;aN(kvyFocOA=$tD?=NK`!P|m7;uKd6zWP8Q~4`Fu%-(-WyO4|b94@m8%*qM+2O)S#r5Wfvp^>(U>L zgf(Nc!-`9knro7dpoJ`4g$sAR4)8VvdEwpykjAyT)THZ3Q%RWaB||}U-osI7Qxb+8 z;2PHo=G>a1JnXHOyK?))LdaNP@)x_igjt266^3%CYwhuDgCXqF~H4){X z!BZ`gSs}sD5&`}YwUCbDCMKz~5+9~%X!u-w#*pr-5v0>Y!ChfVoTG84Z3?kRKZw6w zLYf19TE8ezvLxW=eXgTOSVe=hwIuuuDuln(d2uYUl#r&hi~j(~a+9vRwyzlCR3Jz2 z5}v6FgK1H{sptUuIOKPrGFx0C_XLk2bMlDvD$J6T?E~-I_JL34AxP+m#_p3i3U#^x z(jADjB#}4CbH1F(AcZ99aCZ>2bgZ0M)SnCZl_xdGQsvzW2?sM|5_)fZz8e^RwMC$E zrd;hhWiu_d>V4G!N1=+%1KP;xgeRSq#&ve=11=#YMCd`*#CpQC?ek-ke}xhtt13W* z(7~2gVJT2bjg(J!&&$>nk-?;p!t!|S%AB0yb2gc@sA@%&5(qk4{)b3rP`mh+c=J4N zEp{8cQHg8#LUmOBWj>uxN>Y|4W|;~@g4W6uk(T~SAeezDwaxuMk!u|}74Ihbq~GpE znnaCLvpn?HC8bp5D-u(a0dv$@IdvlGS+bpA{bzYMxk^Gph2d^-$dcswTYpDrC5i88 zsPp(f>#xhG_kSp936gfBLO`lvN|MWUT4EBSxi=m6-N-?C8lS9aB{@%gTX=~mxIOl3 zf4BKRktPy(QorI~!z$*!ADS^gg=S=P;hNA(lu2-zsx?{Jlru9alwG7HDj{zvue?-B zlVq$L!*3^UeOH%%JMGYNHG0=RO)b-XpKpn@G32cJun5V#GQUQG`UhzuheUr;soyxo^_X4q)pPCR%RtrQ(!7x&cCHP zr9i81bm?mtaxqD4uYO$7CUIGv+?0~7S{iM6^gsXCfq|Z2(Cf5Hu|_3RoR+aF-_AGz z4YwvZ0#_7B`&%JR_gzYYg2Ax_8-fo@eBm-ybh3^Y@kPEVQo<%22Bjq05ja3Lb-MtE z#qLSy;X2=?qK}Bhq2EGGC1c5i2&OdZLV|&P*8v+8I6)p7j6Yjz8QE1|+SwOsi4l*L=$=SyxM` zynuX2FrXJx)mNz^Z3yTYbv{WhB@Pdfg6jT9D#et=IhpLrT0)YxvJge~RgdQnCr|IV z+?AC%k8sMkLp?P+EN@QsqTItk>eGi*IE3gjk)o}w#A-NP`nG(^E+Y+YjbNnl1xfZ- zxpOT5^t0)@NONJX{;_6?@s}*SN2)tC_+Pd$BRGl1$rl-$Augpv*-23&VpV(T0|bc; z!im|cjQqr$z1)~>sTUY+N;wjx%Av5UYyxgnqB;*4LliT7TES-kIWag7G1+RwxOK%2 z^QdxNIj(dhT#^TwhFI)bGjOK{W%0fbny0k-{jO=#GtLUJOv^wiloM;^NXnm0j7O8E zJsr^A(YUPKs%GWan-QjS8-^qwye{^}XTv^Ah1$cK{j%&BoQ?{z6k$!TdSP3%Dd!J+UF#Al_BwP>mLDH9YYoROSH zNtP9r#O^fe4^VnU>#>r{I|xm+Nsz2e%qSs-)RMIwf^B1eoJPycaw7*VJiL1^O{h4q zr)YIh)7LtxS!9NluH`n%rL3E25u_~=UxuBY7~;gL>(zz2hw4)=OfVZz8Ckgv+z@qD zuWfX+MxI?RhhqyG+&5ZYGe#AtrM`3Wl@-wDPgI1ynTcij*#T+r09XMFTVKE#8#uvD zcD0M^2xO%>CuZJN?_!p$r2%fFZPG0jJ_XWnSvE8-EFrN2=@cmmvAU` z8O4v0>k2qL+-Yr$68n{g63~8Dg*2W?NU=(0nJp5LZth}J)5-|2WMQQ~m11sepLvRl z46G0cA;uj}bd8OIh#hV^!-7dqiLv|B7+vaW6r(veRhgwStLw_2^-0S#nxw1eCj|%vEa?tvV}P zT;A7)9ISCFEDwXV>4)(Y+`PyNYI&4BPjDOE2nkEgpS#{rSQfFlF&8c;4|YhKY$I#3W&U9mq-*xR)l`nf`E(b*s&+6qN&Xn~(*8wc(!& zQ?bodM2^uI#%YJ<>8ciXpxnE2OB$C`CKQyoqt$8wC1l>@4WVlvQ7%KJiD}Emd_KaJ zmhNWh>^!he>O*TG4Qyy$fG#}v_lnufdDF?|eC=bHW<_)BBe2UJ( zk{;I~Hov(}mtV?ge;B(W4_9QW9M&vqxho=&xuEom%^^m?N@e6Mq?4eyzftQ9%VF$j zaHus&dJ-p|ngfwf#4gOJ5r5IsW`Zm{bLFD$WXnA)*gp1zcIEt)fzFw)E3!fSbJpyE};I6*MZb%chL17aG5S& zKhQ|xa83H|8m==xB-cKc?Bwjc>H@4$nrXt9LP-GS>$$eT!dkPWGwln9=5UP{5Yc9W zO6ju_i)~5SY`r}5t*rjFo*?;%L*xVTz^Vky))#Rmjd!>qL*P%BPLVesGBo)S z(~L8#7@nw=5=$vzfqsE9=ov?r@Z=vdG|630niDu2eytJX^KC*UKjHNJhS%sp9>xpJ zjVYhrfAI;lK|M4M!jd=!NfH$1lG7;Y00f^CU@m;)Da1|9+b{9Pk(OZG-Yc0P;^G`dCxPT% zs#F(}T3tETck}>wlM--4TcNCy(uz>Qc(P-OyhKhWLkez5>FXg|3!CK@xi=$I8Z1$w zqb%&O%wWq+)gFCAyr~zEuP{=r2MR&yn!Bp{^Bg1rZ`nKi zA{nWIX;*^ViF=332A{y|Eiip6tp*7i-!}eOVP`Me-sv78^ zHZat`F;Qjs(=pq4nwG^{l#gkZnNDB{30is(K_gIfKf)+7!%L#tF2xNdbyLly#iXG} zbe@qMaUGL55vA?D@2~@N0#+7OCudaa$d84LmL*L4$?R zx81V0E_-x{SN-dsaY4z~!C5y@xl#1F5o6#!tcR?5WNPfwl8JV-DF6hd6Zu5wy4ew= zcT-v;MI64MkIo#iB1aNXQN%XD1tHeYbw_)3Njm8aPCg*yUXd{02oMqy)5>OQ_Cks7 zX6Ok5;{GE@N4xFjcf>4bu|FFo@f&kEQnIBP=@3@QQ7R<~Hd-?hcF>K5qJxXUr+-q< z23=bdR41GXv{g|o(L~!+uV{W`*_IGqaQG!4lleoChNf}4DAS7AzHg40jp_BM@>a9U z1e+nSY>{G3w2cldb+HC=u@iwP%c0_Q${oU%pHNeHl?c?RV0-H?AYxiIw{7GD>7E^* zG;s;4r5E`%U93tg-)?b3U%ROh%zL&dN^ul>ES##=0=Z8uN*ni0qq(+A$(%+kPe*P} zL7Lq(a-WrXwP#0m>0YQ-n%pQ`alCUjH7M98Me5)TV2&kFsnv${Gm^+toj$Q6E1%^9 z;~8Aow7M-LD^@9H7+j-eM!;KANCWYPd^Re|d+o)Ni)B zw~eCrhQpyG`M=14ntGjfI19z-WrpQh?y|~qfCaYeq+cmf1;mhi7wp!)GE%21l~t{o zcNtP-LRF|g;S?;dmxbaUZY4)y%y_kL=s?%snc>vylxnfNXjR#HB&xuk>XLWmtEjcX z=?TZ4wtTuUmNC(gc`m6WDJ{(bp+BN|C!)M>=V+cXC~&?YI7W3dG|7i4vw-)TLWpH& zsIqjot)Z#njP__$Wu@9CeHXR$QbQ^#(u_Wyt~3Z)^Y1FrQJ2|?{{Rd1C&P-aW_pip zj5#RgSEc3~B>mBEz?iOn&XVj%_o#_ZI`J{CCScmc)UxwQqH;~SeJnsN60m&pUhz8z z4dFkNBjwAjGBsd@+XOg~wl`eM?Rsp@JL`fLhw6&)>WZEuWI@l)E@a>o+f zliivyl%^C-S*d1_(i1$e0zd;PN>$U;#(z7uTVgqKxS~%JVjv`)ORcpwT74s6OJ};E zcONkj+M-yW;=g8RrQdR`g&z_Vq}}Oj<&>E6akQq!{ci%FMs|p&hB&oW;MHBm>n)~^ zw>C>?Qsh>@9IdHE8NToyq8xF)M-!sM_<7nIOBE@mCJ!cM(R3Z!cg?keN5NTD8p zg_PTg_mY2c*obxTl7rlBj!;DqfA6-bDYG=Um$;!XorNm$RG8HOiM;iYC z4WhieO3~%`f|^3vvV*P_Hb&*QKvj>BRrK|ZbH`~fGdAVF$XsLmLXH&4OHk=(=2V_a zLQ)3BTd0w3d?8bv9E@yyI6v5z>6rsJiJo~=(-u-n9XD$GSlHP0>u9Q<9-!%O=E?Ek z+?M-%1}6z{ncfNGioH2*^N^VbokN7(MG8r_eE`klZ&;HY>T1`Q<~86rI{V}}pWOU= z>gtYodqMmRL*m`9nJ0&hdJY$6OiYS^-c0uksqGJ+a5j^rabM*P1OyU#vW*Jsh5x#_rgMC2} zuv65mq|-&M@Mje@jpz~;78RKf%eJfegn*!Y!2}q`@zB#U{{V)S#Bi!^mStvqJ)P1& zvSJiDl9^GRq$FCZ)Tia#0`5?0@25@F%D45g-+0vUTcVqa=11Nxf5zBw%t$$TbxBDj z^d#695S60pPgNv~U-w1rY*e?oy1Fc%6R>24A(SWSDi~p@^k@|02vA#Yc&{pM2D$-j zLo(c4SuguQcA{1VdXAYAwMomWS?RT+;H)~{X3_5pf}Kbr-6FT$uJ5Tc#;!vP#GWEz ze$uWLCB;b6FWf>Fq$x@1a0-Mwi-gn5)MqCX+{J{rFG#~F3vsaX!&0XJSI1F!v5qPr zOEY8t079xu(_08(mcjj2!1-wpP|cW)X;mq~Didc^oaq+a1Jle$IRe~P-Ps}ai8lDe zc`@X0>+~vCEn!X1%QWI_PGW(WTc{*l5#tcDB5pZQkK!|IVX&E6g3QqjHq&AA&Cb{W zq$rVdU~O{@MG{*ht{?iebXqN_@kEyWwPeb(9rRNX&eV3IoN6S2m|oT%nv zZqgE%)>VaKifEgsI;93@08h3hDK;QDR87X35n^Iijkf+mb(#n&#VV zXIz`E7AFyHNGY-#aDK|Jd?C5)s!R43yP?m)9k?qPDgOXt#L}u-5^}8MJk*iDysH?X z;&=$pb+h^w7`TSHlh20yVWRO}A=*^Hb58S01uGu|q4*OSJ|lvbE_{o8d6dU(=^kj( zD_ks+n0a5R?wD(kv#`UV0F$ge2SQm*-KVg8#|beb)d1RDk*J}0LbXEDtx8R;WhCw4 zp%;%(_Fo*bV@s-3(VF70wJYu_{{Xq>>gOwyZ=fDlT!Q|GNaq{GB$ahyabvOl#FHZo zV=2@+Y>AY#`)9{DbdN1WF^h=T6SBojMq$@wxNF45RN@f13fo~LGC|1h=urElC|dj2 z!gD)9ptmj+l?0_AbOJJYUggvl!h0G}Mk%IE$tYi*!q5kuw2t7OnFQ6Mru!>a6(VP- zlOLv#ePAT&Iciqkoh=$=xm(D6xL=Hs!5Z4I-9cGt)2mzbhmN5+&D@qz`ynbfK(H1& z#6Bkmz0mF~lvq@fJ*go>SkL>rvdhFHuWJlQ#S0HQ!qsOVAt)Vhc(dU!Jwq8XB#6C_ zDeU09BP~!uQ_qzNST-Htq25XH2gAo$)nkQhRLVmVzSnfw+GC9{%98ty<*`nQSBSBT z7|&uOL?q!}B%7mR1=j9M32-86#OQ|&fwlFq{9&maMY-VYPMi^5Vska5YQYlk5wd1L zy9*=r({vSUr~^o#_J$2{zQvyplS?EX5|VIYs)CezrM7G@(#A2W4%vF=vK&4qaWX@M z@++L2SQZ`B+V?&d5pTg@c_py}h{&S1DW{3(%~^h=%0p~V1ih6y08|0nrQ^{!cxj48 zQ#7rd+$B|VN!~~$EX=7W&G#Hui9SH=PP)W~M;(6AmF750g-nBF38}3Ox`E~`)*@w< zD;86xTa?E$4eeQ8e>%997j&95=6CC zq{+;92a&5vBgBiKlXy=Pi^Pp~3{%p}SCU~a0Hj+f)-n>sY`u*3ArEO@KhJQ{^~yBQ zHMOMo)9)kCRVMycyjk%4DtnQ#=BNxcw67u1rsr5HN|2#qr1Uq~k+$#%vOeP!OiGeLHy&|YnQlzR_8v|f_O+YB(&?0* z3Q|x23r)!Ye_ASX@Nt{6Y&eGZsdQ)9hGJ3B~Rh`wM(g5h8`rde*t9O zBjXUCnJq|&II9j-cy#{&Cbuh;1Nv6TaR3A$7+mGn^3@zf;CFE;z6B%I*stP}#f7fBg*nRy4gw1A=D zM}#IU>o~Mpl4YC-RlqQ&gxKP|%3V&jwV^0e5@ocfTWP3=2H2i)v>@2q%Scd@jXh3G z(FHd6Lemh@$()lZu-wAa5Y75VAo?jlIHHl#_kp0XXz-K7X|k1KdWcHc7?z#kG`&C) zg=^vszjQjXv^4RiHFZ2A^edc+*1=CjjqTzLJf~w$6nAj1wqP07XX%eB?Wid?Q3K2y zTS7EGA{DGlg%VGR*jkUrRIxotCQhcTqG5y{SW3?7O@Rd@>MT#4qpKwdaIpzH!@eSL zfkN)B)|wo^l{}-}8r*AWcT`_JglT^gX7F3LJe^)hOVn4$oM*b?6q9R?pxo*4j_Pn4 z@YIR7!+tc=_=MRkxC?`E)Az%X%$Xi|Tt{uEQ8F$q4=Gt1QKMP;BstJR>}|wL&0)mn z<|9MbrQ@O~=1fRB*23fQf`o=b54uF-EYMtYNYYLhP%HnN*0il2m8EG`Iq8m{f+-tX&q!b5n zsfQ8oYaIhCj%P_J+Uu$7)LQyX~@Z$6%?w)G0ij7ZR+|R)-Ow z=ttyyj15uITPoXChLTi}LVzTAU#Nqb!8#Dk$A2e7?PH=?LU2nX^KkEzD*) zN>-gpbsk4p5HqJ&pO<$;WeV!6SpNVR8N<|~*I;)^0{{WJ&p2iMfV`~&Dny}k}NmqilKM@^L zqnbs$yyJBwW=@dqs}Rtet>NKO7fH&ovVpO@a1N#)4={q4t(m5=CjE~)i0qA3|W^m~M3^~k5B;*m^KoJfl&7+45 zraE-O@Jhy23xgc6M)H*)76#N)D*j$T!CPA-q7Z=sf`XP;av4IKRJxaAwa1%JC3lmAZ1o#d^Pk_&mqJS zX9&tgjjy~vV=WJZTqvi!rX_(<=d^;GTiz+vD$*0E?F{U%52k5B`H2~)rJt9Z3=qqO zyWdctQ*FA!TNIIGSXInTMv_dWL`v3WG7F+{C2Klr302a5A}jKF6Jh3P;O-~kR%R6{ znP;dINha-bQYF-H(6gNu^|V3DjlIb*mqE&YsWm~TPEGq-W~7qKi$k*R5bAU`1ZWSI zf+IX5+R(4zcN8Wbq|3VYWS&|Iku(o8QMgh{fd|i6lyO{{S#83Ztk<;@Wh;rA;B$%5Ku_;d>Z%DC~&k!nt8K?JC3cQZFEzbqlmOkks}Z z{6L@Pk|ge$f`1T12x#GOzFUz}W6n)u`!1>qI!J}9EHK5H9x+U$p39jbXiC~p2XrVZ-wT7~4YQOg(N^R#r`<<& zv6$saBmvhh{{Sn%aF6^E;;lOxRI2Edcqx9>n<)h+DFGn&fY6X(bA>I%c$c?gL1MZr zt|F9jR-lBfvM+48$UO>lI>bzovPK-v4$#ozwnq-BVxY|WnqiEgWo!l6yV&MRP!xU| z#0Q35-uo7i;^QYxcYOZdYM|;OL%tn?eC%->Y z_-9nFlI6V{E^rArsiwtdW@c?|t1=Mk(pp9L2^J&|F9=j|HNPQGk5T>L+qd09N8|(x7tDu~igV_{$JioYh>|Okbw#plP_)}ZHod{p99V-F72!KXO`5|j zO3kjA_7u7o$8I|W_K+@7{O^p5^7CF}c_F_M&Zc#~H7E$iri|In@s9Vq50 zmQ?J`L8(Ub5Zh%L)}S{w79e;Nyhs)*6-K8OfNH8EsZ6)=Rp0|=gFu$VNqSYOfQhbh zLk>9OZKX}x#^Gv6z3g|tNC4tjsISo`W@H{x6!QuQCAFo*5;wBYN>9L>9XAocIhZ#e zP4MD>+fj75(k$JQ4sCnLUY_ccaBq8PVVscGsO()9g~QxaDPN|dsVaY(PAsXT{s}|$ zjT`H9D&t#RSnOjzmm7W#$%=(N==jw{((j4eh~?e1)MDcIZgq zJ||6Jnt7IxaHZF0(D7FJ5UEtVu>=sIbomi@OO1-uBY1a(oUTvJ%03ERH0p$lg87DY zkuZV?@e13gjB)HK7_rweJUOKohkcrYn{(7>NrkRwdJTsQC@j@DwCtnl%*@2QjjUgE zt(1edyD=m8 zL%uTbB5w`Ny*DVzkn=>UYFQwXfzn~UNn0!2l-xFSF)toe#5mB*%Tta{F%iw*kw;QD(Ot5#W8EJY`V4^QrJ-(WprMgK0D4%E z2JzgS&O~SM{{Rh~q~kB-vrbu>k!31b8if1mP#5=z3LEu^)0Hb6in84ueqNm7WMtHU zsZL5cAcCgbBqaq&+yVxK@8cB{CPfj?vy~E04p*@(gqniog!?mW-6Rw(N^!RkFZWcH z0Is8Geag}iR6v@&Ak;CPY$RNhRzD_h8Vp~;iuv;w-IX!_0Qa(;s8tltJSEvyiZf;I zzO1TM?0wYTKy@O}jv_jd*g7A63gaYVnYxZQe3T|#*~uxeHO_@TlPs`0Wl6Gt8jVT3 zQe=&6O^X};Ha_W^oRg*mxSF*=OcZ#fFDi#+<&p_fre{*8-6JR_=H3S?M?nuo2xARdqp=}Cof7j1sn+oe zsC`XKq?Iz$Xf7-%DZjc+kGr+vR9Mp(>al8EJ|xatQn{AmXNl+kb zuHIWm98M-poH1FD!TzVNKua@5K8?h1t>T`CvYnV@y}Ma_|kCH>B|mTUE9 z&W9sL-`5bvMm>n-adMg|l#F13{T%2}^;2#n{$?I;@)XCjg|hMr!dMym+cc#7i`g~R z?Ael}?o<_(R^IkI7*;>nZbw%YEwxEHgypjnl$D&Iq<)#eqhqRWZc2I`HisWinAyPL zCuwA1Oh;V7#RzU`DxG#s#Vi2qz*^r7n~MUpl9ZBn@g^CuT!^*BJbyXHDt08QyvmTm z>5L_ZN=ie?mz_b)uo;n`A-9G4!6b6YOTn71Oe;++8>y8k4*}5FEjRTCNSTkH$r0zs zjGS{*M;29-gyk#tcN9F-!fy+K8zCd<11<&%9cZrq0Gg?bP-7`OtRK%)Ui!745X@hZH55*&L=naLA-W6Jf+Doxn)bJ z%406nEy%Q6pv$TCodnB(p|tsgtv&CAU2yyap6_C>Hx`#78dO-C#dC&wpz5Y3mUVGL z)*p2#8Ug4p8Yn|aO*!g2Z7{O6Nl7@C-UudcXxk*47VjxU_e#_>3Aj*)oTzO?PVgU% zw7flBnWiw|RWe|dvoN50s!fJvXih~Qsx}+mBFie4!_miEl1qp(s;0^)9Tj_D*HC}k z98>r4I1;D&jI+L^QUI4k>C@b;!AhI!P8+KW@xk^+umg!{8R&ov4wJ8<$x^ zKn`tiGboQy7W^g}AaNNsI`u3+Ekkn-(q#}38=2-P54ziZMT+>DYlGt#&|rzrmbd50vW<{4K+sV*snpnBvA-{BEb+>?6|wt-kO zxH@GThZ0?BUaHskMC@x}iLr>FU`DYH5SytXKhC7*5K4yprKZFkZEM)Wnl3lyFr~c~ zIsMM;Q0-cWJx^JuphI|!?I*)vfH zyG!k^ZUyHJ=3Y4VO{L^w0Xj7Au3JGlhTyRT#E={QRX{1i-vSuQp%W`l|qoAV{4DdgAK=t zlzB045@l2Ii-L1p2B?Xa0-vP5zpHZJqgVJP8#h)}pM1G=iRn8RR`AYe0tswy~q#I{RPDSfuuE%bX zTf`+dPpT#3dUq{P0QRcFIQJ@3Jc(zQ{TtU!iRqYtK5M8F zt8pI8s#~Bq2q-4R3n*M0-r7R(VsUHYc2d};juOaArhzv*G2J1+ge>?13Af`H*p}8n zvxmbnYt`rK${$k5QO(liWk|n?ghTN=6e_T5E5`VVbEyQ&NtBYYwrhl>Urp3Uj5U)Y zT*o6DA3oH)K6?*hwyF)L%vPnEQ)@aT%%LLf-u4AVSYFzZ3E^^T`5ns|e-ba%RrJzSE36#>@>Q-NE9+2K2rZr7Svq)hr5#yzgoMk7Sw%KT*L`Urp z*`}MtI${`=$tyi3g?l3IY*IBXs_Fv7>`lmq@$n5k#W-112x@ZxOe&FEWpeH#-76Yf zp-CDkC!qw0((u{(K1E(wP_%OoDyWR@tT>*8SpN93t0OU8Mwb-1Hw)zENI6n^k~H~m z3rk=l{wQ&EXA;9esYL8NVje|dWXF||RWF8hMpy49sKQUdsN|zh&zW^7KW9!U52zPivUrRL#jUy*9>4pQWpjZ_x zqnjwdQjl$~yKfoZJ^m^!cy+Mc@jr+Y7@?(1vo2Vb4)XISV0Aearn?d|YrIsG5t>?Z zR~sp$JcOm$*;0n{8xDI%x&hF4{n33cW2XqgUt!5PvIdl3<*z z&AQuu8IOA{{7$y=0n2KI2l@=IzkB&H=MhBu*W+e@#W?xGPBXXyLLQh>l zy}V+zW7NrtbXV5~7Uu{t^ODa3iD}T6KvuzN(3|Vyd-xdUd_RW!597lc6g1J`$@|!I?EeFA9Hc(6jHwPJYA1p( z+5-ok5wH0hAo68cT^4 zDcnmquSgT}ZN>*l z;zd;>tsTMt066a&ZV~SePgMgHgQjn?@ zo4GS5Ecx-w5=Z(sis?Pq#Fn`g*~oc}Lsvt0R(Uy)K=8HC@r(FB$f(GPL)mK^j7dzD zl6657l4W z$HlZ<@Q-rSS#y{#(lHs8Gf#_iGSW$itbAoS(T0shwq_Hef=W+_vAR#d!?>h3G(yZp zDJ?x%tW)N|_G*$@Tf?U@#(*mp{bc6S(Y4^7tZU|H^Qw`Lu)ZUE1WnZNRPwvht{I6- z{if7xtiB^Y8rmBK?2=O zbHqnhF_*->vuE(Kl8Ff+EZWi(*j0%sJ17++Tf$VVcSQ~D7qkW_;yn82+n5c%Cf_g; z6QW58HtvDpq!ilNTw<9$6GP&)HMG2iH8h1JD0f=11YC46SCfd0Ns++VYDH5V)Dt${ zYK%*1m32u{6o5$sP%@3k)Ogy_4qQ_1NL)KZNyQmlSIks}c^I98E5*oWaZ=_pyer_1KY??Fi38kq?8F?HO2dR;3{>!M;@kEd@236h9-~1Tju$4i@GA1h zOR>?$GE}}iP?PNLrN$fq>1R@PVf6Gmf-mlnZR2RPjBJSHA#kS~@uv*sgp;fppKfBUcG+!LOEwlynIhLP^f+}MLM4{PKWZFs zDfo4&T2u?KCH1)28m0XkF0Hl(g?Hz_+5o{t@^o|b+f^mf@$}L2cJkeCE zr0AyHX#G>R7TAQSbUrYQvDhNXhr&!wx%rjPOp%?rRJAg6(dJ1?iSW!Uq0+~!XY%lE zOX66^h}ePLV#ZH#gAp9dyp+1~p(A3Tcj>fhJ)gpOO6aEI_>FrEuNG?Rl$Lv!-u6%d z1E40+aP})~Uhqbm#}H|R-}H$fo~cmS^wbe}Lwg-tj870S#v$UKHe!oVX=P26X0m&w zv1=?^!ph%$FKDRZa#z6vpGMz6d+H4y_LG=UU9(~5-w`QYlxLF^Y!C z=?ZB#2|)6P6F5O`-S|kZPDc?io4F$DO33?{vA@H}#=F_Mbt)-1xK`wErc=?0W#;JZ zC<5YBIUv6U`|XkaZt1zUx`?|gOF8W2kB<;&vhxek^rx3F-&8!`b!kwrvABvX_%yP| z9!o?p?PA9^vPG_voqh-Xu`7pEhO)abc6wj5)0Hpwm~lzBmgDn@5{(S%vGAr*oTuGm z+$ukw(Hcl`94t>%RtBuou@ViNT7-oE0ER`Iu;RD(Ro%U|R;D6O8xO&gakfv9ArBz?COu z-Aj!!m8d1~f~4qnQbox1jpjM2t44Dqbh;K27$UVIz?_zBP08Bj>2)R4f%@r5DnaoI z0Em#88L?f2IJr^5tIa0rm|gW66rWU(M0Kk;of6jxcFUKUPcF2Phn{N_2+a zG0zZnGmMI?AfG=cqVDNs%RaT6y88FJW>4k504lN*IxZIQ)JA*Ngin7AovX4(8w2>@Tf zb?F(tFM@D(T=4utmcpxxbrj&K^iRzpPEy}(Jj-s?j;gk#<-VfYh^X*&ZQQb1DI8g@ z&)9p44EucwWeIg-Fm;t*`$)}im=K>0@)ojnBc?Cl)+@nFBammBAJR4wmD~0%Z}5g* zD(A5wW%-SoaS~;f%9+f=qe6#LTUGx6tOPLezJu!`6>_yjCd4QyJqU){9I;tWtlVW+ z#t_h>d2b?M6su7H0Mwgm7Q6sqsZ)89%0TaB)g!D3<2V>*q$J%++!salJ|3{CAu(d_ z8&q4E32h`49a3QsM_7xNkmfhPczdQCIYO3Frt1ylUcPb43o#+W4g6!G4sB9cO{YU* zAxY4dYO^95YnU`p_q-uia*ia_&5e&paUlk0Da}=z=>^aUvq*NFtDyQquEf#ZmBcd= zBp#v@M@6)@E0e@c@@CSIPmb5|>1a(fa7R5rOp~NbtGI8Mu8`u8jV7uo^Ab*>`E?fF zLAq8tA5Dnzg=!O^oRogkOx7p{pIB_7c?c*%tVme4;Dp-W8;Dk|glOEaYW@bJ;%VM{ z?x9*$O(4bKvLj`ss6rFcDD4Zk(*5)Xu>GpGe6t#m3zyLG;vaGA?k zMif~kbBHw#6Fk*KJele{!@lY*nY-+w24Yj=ZMTNh+&Mcq@u}?gWP-x{XQSfAlIt@K zkfFF$;#@d{`H<(sHOOAeS7j%EM)D7p;!?<&7Fb$3YGar#H6BpnV=e}hlBGLCsf@VM z%$i`VM_L;>NX&(5BZp4ps=?60S~`vjrW}@df~%vZn?g>Vm8GfVcZQ>5)JG1Q?XZ^i zvGtAtuTW}Up={%p;Mqd|0PsOTZ%HtuAOfuF@$rsp1Vvu3YO3jnM@Q@;V+r}con{bP*+VVR>i+5^(AW*t(0j2c4DgH>15 zGPvE9<9#E5bLW!wZt89EggX|EGGCUmpJejS+8sRf+v5p3D%hW8NgeK*0zZ6k0H`Uc zw(=aR9S58T4ka#Qm9i9$hjJltIL?&Y%5-VGEJ?FRnOmaE(PKmWVMyV;ef@MI6maV% z&WLddI1|)ts^&MpgmJ{_liLnUE2oSmz}{wMFC#K^BXJHUC8K?(!|A*&J2=sSQh=L- z9TFI_uNXp#&cY?yvzhG-k@JAxj_~5TJDs?w|(o+W@O>b&d#WkwvCMv+K>-*IV?fY-rfX6c1TFWGMQ(VRuYg-=YPTzLx_!>UZlw2 zdVK9xS+$~MBFI}RP_oo*nMqC3E&9UHC1R{q@K(Ku@ihSxPrR3(O6(HzX-;Ow!!m92 zv?Z!wh1}m3>QuyrY817GK^Nt#oQn>7dBTDvHaEPRy*35S6)h z)3_)pI+LZW6e0LwLvoc3RG(`6OM~*NqfUJYRjgiR$#8uN+W^Af4-pF^9x6v{szrIA znv}cp=X~wDqxhvT+u`VOOk7aAKw%`xOf5BaEowrn+sYuPL)`%AePJFQ4mnueaD%jV z8ADC7!c=z=+oiE z(=$~T6w1=HhGr9?+v{&{#yG^#{J)_w8IBobm5|;Q6Qga#YKtGWq>JUGJ|-}{qlz~nxm76j*(9IFD)MuG5!ju{cBGoGzsn0$ z^RmcLN|Zxt13_+p_``3QwD$RkzA0mgz8^~(l7}F$r1Kd7I0{aL+=J>Zv>I&V6;5#~ zp(Q5V^QEUH-$rW{hLi!*ON$@;U+DYa-&poazVz~RMVWd$`rIG?>4ozk`ZIA z)!jGVJ1FdO$!AV%fR`n7X+rsPg`|%Zt8o$8-e*)#2KMM7;b{wbY7?N1H0yZniqdvoq$MC`LP;HMtOsb; zLqb^HDYmd2G0n?~w4C4{&Nu_{*~^G1z;nY6Pq?3=YHAB%#hoRl?Q3QvB?(^2uq2yB ze-n#RvB)|n%{8^W?NymnB?=|QFcva^u#lA8cwApdsFEb3YMV@4yXExs93J2PPn>!(r?~NDMC+$%87)o zLWI5xPtkQY(PE`0o=80bTDLz7M;GWHxziYRyiGFDc#x#Y%%?E-vWHTkz4s#CmyWId z7+rdgJpyer6KGYmb(EVQH-^sfza~b_i&7yz2gU}rT9c}Rse}{A zbz8WmP0K4$*P4b<$iHy%{jSt>IRAoD^F;2>ER z+*pGMV$hbWP0ZrH8?`Q5SGEee8_R7}wE}KB_qPxyxUm7kDYdo5=EI3n7M6-sl?xE0 zvXF1_5!pIIqD__?X180!G(y5Xi3*pSQ3F#lwOo_Z&{q`QP_6cm>%k^P}?ZKyE%ouREeoxU66ocMy9I;56^iEdrQoieFK=2SP^I7k=k zZm^j>j>T?F{AY*Q#x1dx#+j=nP9{l9AajaSnaOtss#{7=ypgu?78xjg#>$W5?gEy> z&wFf=OuAlD(CnhD7cTlgNZwEdn?CbLs$%CBO-PF<(A4(ADrXld_K8aUhMMA34TwI@ zix5OP9!D7^_+Q$&s%*108jt*kG=xjepo_OZD6Z))0vo z7*k~BD`J%AHiKA`Tk`5b1hTxOskIc0s8UD;BV8gar26z8NP@TqwKv2`mTTqG-Bz76 z%V9|*W=mtbNYtFcBr8$8B1chR{7jpATNFvwDQik6-jQk4OD$PjooPMi7*HPbfE>*0 zqJ%|pwL__g?Cm7v?P|SJ0Jg*PECyL{Wqk=NTg&F7p$c%O`)Top^wL7E$RRZOIL@|! zbw5h~0M3K_BSVk)QC~h`_y;way2R2O4~aJ9=gT&~F%qjwjw0PjKv3}UHoPY*2oi6A z@-l94>ZMXzgALW{lP@7IDJTIv^yET%Y&u+DXs6AyCPd&*$;+8qMDwKkdlS#01QBI6 zl__U1+}pd9j}zkzi#0LM8CDyuaRu>k-1Q1pb(IeXCK@Kj!({`t?c;b-XARENSh7Nf zuowRTA+vH4YXn$o>ut8;ly7{>N{K!o7*aUJPth&mO03o*9Jf7|mV`>nIr<|sCdT76qq#FE z((ZOJvOHss228g|nZz`C`Y5N)ow#Tge|-b1NXhULXp6#;b%J>*3n;)3aMd<_Ed>^hR-k|4k#!z@`hAcY8uwWX}m5kP?j@oR46#R z5TdH{3vPi(mUf`@v!NQLE@okiYJ!zKyEcPv?Z7c9Y=++CDXvY;(^pcaOv|}1J23hR z8&JxoQl~k@5xDNy3u$jCm#W4Z9$p0SP0UR^+_N(Zk)B~;VJo^6>n=8;7J+N16#xm_ zDz6BfsO(WKq_AM)4je>-sw_@R&7y8iz-^Jqrisw%LQBk%rn!#yirG43l!a8xob5w~ zRpxT7`GYRJUyRW_%JK-R$KKZ%aTr6hH&h*Itlq+zNpR&GXV*B0!nX()L~%nvs9 zu+$N4L|7?|=^mf%YgLV35L8@N=2?J#3rN4=2$ZaL3WM>ssmw+*mLo$`E$QHvU0?2r zscgOi8zlZH;aha6c^btL=EXI)BqkRta9KsuE|oaINU|2Y_x0~}hhzKxqf#3#D^!La zpPZ06f+rgx1n1Q+s{pWqFx=}-(n=rKWHjQrDICdcgzTuDLzGnm{uW-goL92 za4H9l8S*{}P>GNDMo|KL64e=_V)=QOuaTKK#T#lz)es2z#e89}Z-DN-EquwHS>laa zc47GmnfK6IdBlB6vSvzDKsVpkCqssZWJJltN%a!z!=h0d zys&B$NI8`Ir}{LlCh7q02#A@obR=WPWclpR*&as#Qq=Wfq`Nsd)buA&o_c=J8nDm2Fcz$haRLp=$Vbvb<@~Zt3?sZa=?ks_8ffKQ2)xUqt ziIX0kyA4F%4?If4bviYGcI~*{ZjK}!xA%tLF!Yw8r1Xp?8=2w{0VP{Q34L;`4HBMW zk_GRuumU4X6{=}5_~ou!6N`bJwP~C{ZBq5TvQvzqN>YuGl?02c-cdLG@d5CO^7JMy zC%F|U71#S!cL4#ZzTM}$eDHHx|1NQ^N|o~k-POARk4n~E7wk>*L;cxNc)A-17lO6&L@ zY|SYSAyRFrgjqq>!kjLt3%J{Ik>?P6M42;2#BHL}W#*~Xc|}+yPlYx#`<6EN?-ux# zkml%bcq1%i*s0;?_MT~BqITvDQNN9?weJ!!LuzDsz0TKS-X)F`;-%AP&nb!G7;`^# zA=HzRM&tl5p(n;G=ZjX|Q8yk$7`VPxA^5j8=xI0&?vF)>Nr8)HpaY`#U@**cL9oFPe5PfjtgAFj$vvyWQfPH$z z+<%2o+uWCZkGOEnLFv3zHI>JC%a@i${IZMO*o_I-P-8#s4EyQt%&_6H^(;PFYGt6e zEEchKTWiG|l@rndiJ0P%+7f(3!K`r(lQT_p3%ZN8q6cx*>e{w8?^^cO*N5=sc;#qs zBsHojqZi_7o*T_7R$bzWN6;3zWfNu{Iy%uwuuYZ;1MZO;%vrS}mU#4yB;c2?xEA74 zwD@R7u%}WELhYUjNaCgn7_U4HwtxHkP3GR z*xW<2*=b)fQQXN=sv`u_lTMU5re8Ku80(KMs8JB zwbYa)dB7lmbpVnzjNcK&T(;<0gS0Mi)Tpd3G;qRli#w8eDV3;fl30F~K)j^y9;0bt)xG)hZ<1l6NHT zPl<&igN25s1K661q>EX(aq$4&6og2goJ9q`C)4fHNjCXj6gEl@)3QsdVMmHjd6l;5 z{hNS)0}kN+A*`H;6@+V2)oOCXfhUrpp|#Sa>Xj$L`+3FOCupsdX`4NeY4Ti7ZofyI zB`&_CO){};=u!%RQVF>Pb+=6+nNGb$MPH#L_zi>H!8Iz<>Ml01F2WjdVD}1CoYyx4 z?4IyFVVsiH$Z`sfHwtQEN`+i{hO(BJn+~yiYTfLlkevwML8j3fYT6!7ktC`U3aeA) zR_>{GdQrtB>Mj^@Lw^DUB|#&)zcfYuELNF&9#Q4M)wY+Lv(n0HD(xFM!iDFZ=_YMv*!jDX} zlBa3&4NWH~y19A>ZD3B?owmGPdpjh&D;8BR4y{; zNgG?GO}s$RufF4&#=ke2DW@z~jQ% z!R$&>*jiHj^4e|HTqemX0F!H26Q;UBl3RRT34*VX`MC7w1gBfX^mHl4nnP^WWe^Y7 zGLQgy2u-fy2IWWHicT^sB5C}KejVv{i!s9(u1g~3VG&M_-^B~{Awqp7nJ_Stw z08^L4ht(`(-eF~@(AdhP8z>O7_z|HUL^~csGCDkSsZ}s$BbLQ-w@yOc){FO40KRKl z$yVFyE+PhaU%;7$RLfrB-)bhYRJ?@J87r5XWS3S2!%m=pv?zrTldZryk*r}j%vu{Y zcqge6rL1XAd7$?>AQ60|fT8Ly6cUkUkil_B7QKqHF(Ps$D(@>%aph=p48&waK*mqy z#K@H=y)z`)N&R-oABc^&vgP;;=NPvT*m`+%P9;)a)eC)vvhV9y5HIUsb&32;bw&IJ zFuG-}R2{UO$v^VW@A-x@6lf7s+*6j9sbb0k;w1Hvqh?CDqemJbRP8@babvDnhwpM8_jFS?X-ovv zwIW%@&=T!FetJR63mYNQw!zb2l~`WhLeYQ2%fwbe%MBv|!S$Isi<0AcnKzK1H6=OH zK4K;)*Pz6CpGkZd#OTIYdY?RtS;==|pSct0<#QJs_Y1eeP070SW+2apiYSi^&a$ncBOv;;{NAF?JiX z4rDFVr4!w5VWsF+5R{9!FLQIPuegn;viQwUOukH^;_z1Jt3E7AB8Z0APxv$w>QV`f zT17PWH#-v;0@t3TLv=Udn8LSi{Hd+m~AdIH9Grlpo^tRIuT=jkwwIQ z63ZUta&cNtvDo7myDvA zYmoHtH@6#AhXp4UHe}}#a`P6Pn*P3ZTzsOdKeO+6lJW5!%LkxNwLYXjF5(<*Lq(xM zK!fHYqFCHHlGLnB@giPkn>Nisl$EqVOP~TuN=?Ct@>RI>ci495H0CiBqSE>j<1+{$ zXix+xDjI?f#61Z(yF+bRT^O&hJFntIPfJV_B8O1o8(N970lrUjOKd!?7mJSD%!cr9 zWuMVx1u|U?53-OVqH@&9aa44Yt3zpu8*VUgzDtZWhpCf^9psYQ>@J1$AdqeFiw+lv z@Yx?OJxHf+3)1Rb4#g9AMyN_!c$Lc)Tp>#6QJTWa9s_vS;hL7{rO6s4Rcei8lWTaz ztT_s4T-k*p5i>EZhV#;hJfHd2rW2eMhFJS@({{VC%u&P};oa!`jr`uXjP(rU4 zUe3v>zkvgZjUqqcs`6dL=~50v)g{pPfad{Y^E>WiK#@+^yRBCzux#~IGFBR!mt|^5 zy^`VXD2=VKzvBvyBN|?Dcoj2qy3@KxsMG*8h%M|$i8kvPkvKkjTM+U&tCc}wc>y4}sd996 z9ZK6i^~mntD!8nAlcIJRQztze5XxfdHm77=L(=Y~DGNyiSo&OEFg#Qod75kzu&NnM zQ?kJ`w@r59(5M|^SBjW98198TAhDY}N-6889)>OW9GWCT;v=aP-Gr+T&}A5#Rm;?Q zlPffxZ^%-+sy%ExO@NKH8OBbI6XRC6TZqzDpqgcH1*KQA5jK&i+$3`oVmBo~!+A05 zUTExRq(5j1Pt%j0)SXjhesGLf=v=2{d*L?~DR>60KS-Z=OT6QG*;|TATT-(7w#0r=qMNz}?z91CJ{VqvzNCgBdDS4wV8tfZYSt>QjRW3iDX@%0fkiah+P z{?jT_PlD0jN{5&rYrI9%W16UWcrA#(mJ}H&qpHhE%zVJH@#_>kPCYEM#VbRu6KI7) z=G3mH#va7?5hAlYOkvijRbZv07M@uON%7npZR;DKX5`eU&v9|B#J&W>(h{n)qt8k> zzO5)F3O)-?${t2E1v@!hMZqnwu5Cs{lpUt&t%5yXY>hn1V~PE*pDT8kfwvyG2{@?}(LL z0O2(0mk@xfl^Z2B-{3En1?)X zuhW?-6J0-$#)`w#M>$i?IV|P(aV02M?5OBsGsoDFvUe1$*9EQ!Q1aL34QUXn<-6+F^OMbD@2jw7r{Q|C*LWKgxutqL1VR#a*3Hk92tn;ToFq;U(Q z6D%rWqFW>p(8o>~skOu;mS%xUx-4u@tagOivds8VEt7u((mO{27TvKv5D7OZGfA3p zQts#$E%E6JXDn}V1B$1-rq#H(`9sm%ZR{GGJf08A3ee`s@xv8iq8v-9c^(Hn{{T1;GF@<|w_8OailSD- zgF;p;pP5uUu2J(CmL)QI;0`oW@%k?=^J+dyN&Jb4P|lw+4onU_hj6x+1;vPoN<=pU zi8oHMx?#mD7?ddHl&yoRPpH~E%tcYmonX3iAnVje8U(_!RLO*$FibpKRmR2&IcCCA zmxqiL7Ifv)%NiIc?VE2lnZacXpB}IQhFz7)?5xS~JBR?@6DW7Mtqc?gHP(c($Qvp- zM@^Q7WSw=ia1JV~Dv?%KHt~)D-jkkgY+VF-+B$UQPoOxvq?`Ch4jrj?R@!bif{vK| zu)psCap3?QY0NOqWno|hxSfO`4Usw*d zZKVNPh$!KmK{nRb^ML9#Qz(XYPjnv*j3Y>^FqTlQ2>A7c={jpvCDS;Y4(f)-XiJTq zOy|hWu2o!@#nN;H?eT_|+c8YgouwH?8w<8g!5twEG%C(q%^me5xh{75I^W?5)7UK9 zq*s!$mE`1D(OOy+7h+l!=$1qJro=l~^BJmLbZw2}VEQ#ga6+Y#pq zIBxR*5W53TVT4QqEx3d=U?bX7l=mz(9tWuYFxuEqu4cu&$=V)5Oeu9&u!RURs&P$w z!T096}kXi*QXl9LSbj0kx#&Y3A&g8&KIvP}F(a zB}8efBdYNxG{R_dMrny`MN2`qE^#V#{J*NdbenB)4h^`B%;q1!{6~1QhbOSbKo`B{UB!%!mjoq#d0nCO*PtOPFU&-OI~6;MUYZ{aLZ$eVljsVu@yZgWfVEi zQZ!nn*((Vna&qbfBJ5opEEzG2lG#-yin^L@U??)v%Su)?0Z9PZ`s)dFEh1I$tB?54 z15dEJmLHpbR1%k*MLG1o5U+Vc)=5y`QK-B}nq3<89MOEsXQfx=u|&FNr4^kD0FkoO zaeFB{r1=LkSwNkTKqkZk6Cs{49(WwNZS*UL6!v|@5;Bst z7hMx6oFyT&7gaLbgLa;2ND4yy2B7W?OIhRHdZIhw<<6g@IF2`oFl@5rrp)M)P$*L~ zC~&pt66ng64=WK0)}JTn#$GnJY5E^Tcqn~8h2@!HNV}5E6cT&A)THh&;b^Uv_91L$ zpO{rY7RjpP>m-U+JkmjqRh>_7n2GIEG>Mu-;(-KZM_+_0JjAoPiY3~e!g6;hA66_$ z1E3&Z)Iv^K9XmK<>ALc#nt8Oe4Eu{oLcQzz$xylYc!*Th4X0&>E8hOfpb9X_*X8Doi7hMc zIx;Kq-{Bmyx)`Qt8+k`XME}x(GSpQ_d+AbtX$naBkq%iYDmzxot>6@3e1#yBzerKW zC!cha0Mj*)yY3^W4pu9r3Fb1LxAZH}Hi@Vo=Py>B=Q0 z)YBJDuFy(vZ@e#aeS9ws*Wkk;F_dYQ!P0(;)m!Z z+GL%xDEEjSg4ctQ)4zt+rfaUKT(#^dT6`?GY;7G!80W~LxqoDJwdTm_w~!>HkCFT# zOKLcEc#~LSizhJq>j`K!K|KJsc}K_%Oevg3n@Vn}DAU1LNkU3g4ulX0AoT=(5CNl& z7!}G)w76D9%(|A6uMJ5D;cLR8>V(NzUfg!!l*SVePA!F@x0DRhk`L8PHLEjdweAke z3DU>Cv|VtyuVS-4D%{+_d_+P%<ni0JLV!0)g4rdo;z+Ru*;Fm*uCUyl4@C@<95kQ7JV>KXPPxug z4ko}TZb1r!x!N6yq2<7s#Z-(ziyfIw@qaAB=9!$5NCwX(^`W;C6g0R=CtiT*5umEan9=_L zbSjM7p20H8Z0o6YPAGk@NFZO}Z4>xM%ws79`&mo-Rwi@xY1HBJmPA;TINE7r6(@BB^Q~sui8OWhQXswFShew*0d#q%3`v zp#WSTA|dPw*qORF_$AsQoP6ZEryg!g5z7FU-dO>;*7Une(I`n!&=aUTM5V*mK0{t0 z#z_UuW2&Zfvd$eu-r(@8Sq?M zRNv9)Qk-c<>Ss$Zh5^vN*0bLb&a!F zN?#MwF#Pp-vS!6LW@>3mx=JM_S~Bcr0@ln;{`Jr_*6^znM}L8IXLzT9s&mz+15NuP z7?ycL#R69EA=6?mb7UI(+g#ogIZ@Pyo3U)F>9|H&>4D3BVqxc3pSo1Cyr9_l+Q1F% zq(tH+awKD05)w{;&J&ViQdu@blZsN3b-JEYi%>Vc?oaNBy4!y-?LU!Jd_~~IwpZ)y zoQN-?Qf&ZtQi-b=2|!(TcEQ6N;JVHpsEbUpm1PRuDwn;8 z+poZb))d&95uKa6OaB0RmOg~7Bu`jk1JSyyx9s}c84m3 zk!z}EP;y?d)4gOQ*a3UkT*Hx-9B6(!H(=#r{6|h(iYqiA>*$!vqms`O5Xy#`NLgL4 zb8CxOLvx*c&ZwHW_GQi$vs{&BwYfUX!ewNeMZqQ6gw4t<4Q>V0kTuPyzetYv97Kcc zzld1GQuSjm-EL`YPNk!}Yk4IT4Ul!Z9zub=w;By1ClRpzEzQo+U7x6&L6vQ_gv!pm z!ntz*kdmOF0#+^)VorqYVVrzRgWr(!vDpwi1n|bC!aQ46r&O9#Y7*d~M0Zw{xHSh* zZP!?{j#T$Vbq0=hE|YH&)vHNuNm3`P=w&+SRP>z6QZMGB2Te?0Lz4dhG>I;MF8`j`;H%FnoZ<Cq5%X3@bC`!;$EpSG38V(81=0VD!Uaq|249b{>@CSxLF+uF(E2e0R@?`16)MqSYoJqvT~_fOBFZtkWGOnd9jbOAooogqoOGxQD@1}1Tb&`+(i=&$A~0d2Ais(# zY{@VM%(G=KI+DHo<& zOSxWuA>}-kGU9SyOs)V<`-s$Hl9IBEBw815<5c0m9D3*-MTrD@0CYYvBCKNQjGd=A zO-aNOX|7Y0mXz{Fe5XZ)b+IE+)ByzGnbjkM*_qm$%>rV9CdVnhaSqgzY=M<(t^MWw zkO98FP|SG_awL;@eYteCAtH-1(rtesx`{qJl1wG+a;@xY(XfIz@l}_nN?mjcQ-SHZ zgx{AlGB#}|LQ;*1Ng%~X6Pk-W7_4+^_>OT2tjVDxDjR4^gJ1|&bnbMrZTw=LWo3(k zD{B#8X}kvNFy6h4vFN!ec!;k-4OT|T0*v!%lv3@InuW{1~W=t=uG z>%Q^KSgUp_Q|N~#es+5lOo=*kE=^3U-EFW*^)?m*))kUe5q3x%71)-yU&`%bW7$x3 zEr1CgR|*Cx^KmL3e~~*LCoW|F0O98hWO!9gYC=Gg(0waXi6=76!j7cc@t)0<3chq$a||nSRbovljsJp9XiyylNB~Y((X3%OZQxD zVQDr!6p}mo9##ZcGVsAf_*soZ)(xB~t=kc?t;#3QD4E>`9^xn5o^Qx%)qWLP0J~yOEl{W7WWo_GWpo`FsQxGG2+EoR!1L8DxXkk zFEZwtP5%G_EJ5^(EE92i5$3HF%i0GEQ}{z#6k1H@wy@$!a#W3FmCy$XR&P$57}jFQ zs<_{4?GXg(ybu5I$0441k`P3|L;mgg+8-pzfjsTi4- zs8g-AN}X&3H>nN0cDAVjB>A0UkBWuvy$c*UFK$HBnw(KlO3jtjMr$OC7^9Tw1JWZg z#B&{g?(YdY0-v|6019T5uuyDJq5(-48u>z_CYVuBShb{Jo+-SEGzObo$!MT$XAzY{ zTkm_u$Ap!&=88<}y-o)bWsH>iP&5U!tK>-i(QiIv6g>EjbLp%JSx6n$YEq7m`AE%= z9{FT2KozLGh9;L`Igw8!i$fURAOnrZ;*26sYxa2mVwm{ zAb{Xd-sw_v3juWMG>YO#nc-z?`8iXZo0)O8QuRM6E*|REGOH*f?JCzzy6LQR1Qsln zrMpR$smu_mxr&6}F)1WCmU5>h#>5qB4ZK8j;iG_QNf@q%kaHo_G^CO(p(@ki;|qw~ znL6>J(>29OB%P5aFXdr)b4bNo4yE~55q(m$-9BDKc|xNdEJJpR zv%|PS`buA6z(SdIY`&e8l_2bVE;R?QNV9C;j~k?u zbz4KwZUiE3!aEOs9>Xtj4V+_5Wp|i$)pEAE$^l5V#)j6voFT44kq>wikDlRsa};W; zE;d&0ETw59n1vfH7q@hz*+BJ#CEQcovl$twdYu`Y8xu6hWE+A?T3U1-oAieg{DfcT zMQ#^WDbqYyoR_HpM8j*9ms*JdFBDu4>uQmHu@i_^n(`*#=2&kB=S@C(dXC}mw~@qy zzS&9qBOj6$Xkj7P#kGk{A1b-Y=a9=t1eGY-{zJwZju$PKwXzr^jTw8&aecazzf;|b-UXcx| zbUvN#ap-lW*V5#LU9_fsk;<8AcC(;pms6kxD<5|DI&T0G;}Q07RuZ22Zw1T=8PuH4 zN-w<2-YL6^vTwH0DmiavG~+@yiu_#q0hvmraz*(mhGttz*ik1VgZf6?wpSY|zSje7 z?F)`ObcDHAGHu`vBgkU8H6e!*_)~e3fvIr>T}jKiHn<)=A?R8ep5z_koi$t-LTZ#? zDj0poa-bzyU6OHT<%Oi(!Y_LT07tvw8=eE&J|d^h8J;VH((M|!Q;2dD)*h)n+(`ho zk_cLf*|05gqI9*d7d|p*tniu_PIgnD;}#RB)aRQhu1%>k5{;b;X=>#Rj_^*Y+>kYj z?3`L|uVQ3)YFE^2yE^fi`L(YP)xmC~ER{Ahizz`PE=4B8yq&ewh)ztFFB~Ya-p7H1 zgXPk}Ny_u-aU*oQ%vN-$Zj}SL(kU}WZ7YWF5Zh|IE!)a;s7ThP@N{y3|M3Iz*TYC|44bFW9!ZoqR!db@uziUYAYn=Mf{iWTHpm4lB|z1lzQRCfagxRS9sR zD!Q^Bw(1geBwpHH8H^hi-4*-V*9QkCF&w)>=$d9yu`E-lQAgCw4|l`T)J{{SW@r6;;D@)WN$-@HCoi$+)7GWRXfR$-0c{TY~s@^T}>wkD@4m%<*=jR59JvK%c>*y3>McAC7lmkEiNpjVA!QeQ2|43 ze-4m^8`yGAhUc|TBXg5;eFlT@jr3N=Un@J@DyXW9KQAz!dR+^5`y%j}3Xa73?C*_dI5{wkM!e2p zy2F`g&A;RYzqsrtP#sVb8Er1MR-%ZTqK zPHYeexFmuKd_mIjT^39eTtEKjjb|3fw>L2FAxjs?PzfGKzBPnA$qQJ{wC@OUj{%UU zu#EERDwVjXNVb&om{#Fjr4=b?P_YU^NE+)3O-LP~vv0I56O2I8vD~Vq=2A*qs30jX zOP|+iDNivzAzH($9dZ!ej~5M-i+Bw0x8aGDVmc7jW>ld|2VDo?0NM^a6pytz``Trs{yx%Oe~w<*C{erumuHsBf7K_37!5gDF0jMuU) zu;J26skbe(XWWYjqPYJ6x+8|3sNwl}_Q5U7JdpK;?2>L2e7Z)1*;zND2N@l#i}-3n zUl2P*o0V}YQ%QBT0B&qRQcv)WoO_ws5*G|&Rxxc}c3IS9d8Qp<_LZr)P$^d1DLRgW zYu*(0`VDg;l}=;X7W*S++**D{(Pa_~GR)5!b{Ly@Xcj;R&%zZqOXMayjkRZjQ@Bop zO~#a*=Pp%Dqzm$#2I+F-p6a$D))7|cdlOVEa&ypeRJRl9Y}O?TN|ulwKsP9K3n?UN zZG5!`8C#Aq7r;DP{{RayAf}}M0L67ewI#E&PmNR(P0qX9K@?un;Z);&i!Kv3mRWPi z>lg{fjXYg|!@Q+l8$*m&Q>FrstWLt{Vrt5V4je+6S}gFn(t_0YKP$L zkz5$yO-gqMPs`1+xoO!~y{1^GcY@PnrlR2Oa}i}EKBCDFP2)oAR8}1=a~^e~+rTIS z76w(^TYo50!(trhVEAv1F+T$qxruVODXDN3FtD3tQoyiLxd&KhHxI3DFCJYb$zi(3 z@`_QZqMW?Mg=M|%e>lnIhKEJWC1_Afr@SE$TZ@w`pSHa@%7Nyyd$Qt6t0BTW}&ERi#4RW+@#;zTtgh(Y6wHB75Ikv!M4yuZ*+HdKYSzc7*l z$B~YwT!4?b*1KK7AUB94(}*bv(J!LSJlcNs+XY6$#_*Ra&uXs}tx&9B;#lpAVnUGcNqAi8?5PK1v!GWywB6$}}kO-)LIy z7YR$N_QnUO~PZ*u7^ zis|C7U}}Vf9Qn4eRS zAI2ou)f%+7+Hv5v94)AwY)Byb7#Y+`Tshh^5Md_7yulOl$j~KuQmc6=B%ho^pA4ns zNRDQSCxf`Jg!rp3?33z5v#w~SAGjAi0>}XRgAixKQ7#$mZgIb2*4-v&56yB?qjZ3C zqtF#Bh>0vsd6FZMKO#0_4jW=_9xn5;ZamU=d7u@ii9&8itVNbTktI*&XT#X}qHUV? z_mXr_^#oobOB+O(Yc z;T@qiY9;1sH`m}{T!fq{s$-H$%+<<#JRxa`XzI!0bhMsY_Yi40sK#sTr9ppaX?RwV zHYG76_^Pj&e)KsNLL0F=DL$!lV+uGcC1=v&G%$flom8Q@)RYo6*ur@M#zV81eOZt> zhzD;k#yia5wvohA^Qj6TrCm~Q@q{!g%v0_&G45N)_(GAvIW;chyL29qqlZFA5X{J= zC09^_jtYq!QryT0bGWZKn_NSw32aDI8VWh>e-jEr zY)jHHH0}VL6SU_`O9tv15U)^g4pyPNqSE*o+j3H@+8C*+EI(@;=en;jte|`$Dsq5{ zVpAqOhaPD45)vP8UZG&bi18LimkQA8Q!1=g(iY0nw4VbK<21-p#^cQBJ4{2m+gN!> zj^SpE#D-C{IGv43G;$YDymEvZ%crTmprA2x+-pSwN2GA+k*T{F0O<*|jTAyj@q&)o z%&57^DN)jbRmZ7QrpLIvvN)ck!D6~nbuW$JKy4xPy>JM)=^aNIf^JnaNwTAo zje=&Jnv}rEy+G>?(5pQx!lhJB=_l}n)g7?43PTg8I>x>+*AtdtMI1>C%$r-JCW6e1 zpG3lPF4?++1=vx|X$oNEBfEVyjvW*Y1ccdJLeP*@Qb%;hK-LQ>It#}D$1>0dGz<=l zWM#KQ3r8sQvJ>%+prdnmQOY^)NTetbH{KG^qZG=$j9%9ehNuHdPoc!>Z3(lqXXZBc zmj?YHI&o*HOw1dR37|T15&}S28;+3VRS9PDT?^B!Iv_kK04CAP0}nknwcylr%p;(I zS_1cu9W@mso|-^()eNgtojl+;X*Dx2$*~!L@zOe(%QqEMQ)23EUkzincFdC1rY5ut z0QCn$@-VAAX6wzOaXC~1l4G_4cAUm*A4>BQf zmGU~#j*VBtJWNWGw^(&b(QW4k%WVks(8pb&9L=fz&W+G*J%(mnkbmzmqO_k@)S{E} zhTN=DHL%r35L5FR>2y|57Nn{6NS1xI4Ha~a6i0!#mhju$T0?2YDrCW!ZlOi3w@0i4 zkt&>JQvBA>^ez`H%E;)wPtG~B+3)lh_uS-7@c#gc#R!|3#Zt{M;RBr1s$FaowbYBG z4w;RU=Mg6;N1R`)B|2?;op6WR(%HpnU5^#KMn+Z3%*$E^I{h~C996E!S@n6b@vbL7WzII6-#9gN8e0rldDp;3IdQ~|lr30yL zP6X-CZ3HA`S5%-7gQ2jrS-f=leM&d+78sui;)-rAVt!7XUzaVY7S#Iy1m9e$Cifl& z#Q4G%KP}Gd*pf5S^AqXH^&dJ^24G!m{PlxNeFpE$%9;ZlyDE@EZK`vm>Er?YqnbQ} zSD46AFkGEFVfn^r4qb_Zl}R>P2lY4W;9(kkgXTVeMln>g-$uNZD1D`6Bh@*E(A&r4 zElRqK9x&oN*dA=ly@w~CZuUd+&A9qhJVb=`H4@gZkmJsT}R!3#ZT}sEAL2ou;)i7`N$5#ruH^0IDLxR55m@ULv zW!n*|R@3A2ZaZ(c)NkCS-FgkaAnkdCuOt^1s zwjMFlhH8W1<}&rX0B})^r+9xkCsvVONtrd~K^L-x`^Z&@x>PO*>LI+5)TrgrV)Fc1 zr?(|5im5FWu{ki5&#;?Wr70vhGNjoyPzp|Cs4+_{R_n`RLXh*;B~^+PmY95{3kg_I zI%{S8?Z1d7AibFS+ZrqkybSKe$K4K#=!4p@meHTricn_?7>2##p`FVqX zEfRHsBcs2Elv4b~{q)n=%jOj6UA_=k<@%ic$4*fJ1R~Z-TS|fHcv1m3#)@N=tT8@X z1#dYj;!+2RNe16NVR2^-E)>lt5#hRVxlQGe*|vu=6OfOXf$j%q7sv%Q$w+1zgCuz$FE7{1ru^=l&Lfgf|7?xNgYj%h*%aIYYf#7U68h=Htkmq;#Oqx znc2#+(DkpFFf%9-ZESK_ZZ{D1a`*_aYFM&TkAvh|Wutn7zS4^UWC;?{DOR`G9k1|? zR_AYF!tHrP7?!vOBcp@o`D^jxK0UY8C*|pGAcY}JPLQBM2Tp`&ei0*u>LVczc&SR4 z#Mu3rNsy&5^EBq&N)41#?5Ma&*Hf_bizsYHV{OFFAGyPXhvihMiZsfPv&>rRX;;;W zivW~7or+=mt&Sv2KEMtlYEGvtZIwz{RrbqZP5iuKw}>TU9G(?W7~=j5Vu;M+OyU|f zYIb6Zg}4*WLrV)&N!>*%1waH?X3Ns?3GDotB?yk%*rl9nMWsGaT9^w`A7NuFtt}*l zC28Diwf7b=JBC|~W#m>|^GlXMbtI&q+$d;49tJH^A~Hhua-DX$h+1*=smC0ZpDS94 zQj|=x^(5Sr=3x>?P@?|k#P2H?DYAX`58xFQyjSqQi6aj`ku~d_I&TzlVTzYENPb0$ zN79WlEtIn2SLc{3ExKC$Vv}7)iQ0D(9CgCW!<9;*m2Bm$Qu8;IXeJtUJism0KqW_V zP05Z%R*tnorw&(M#WaUxLUX#tA46pc1gkrfts4=pwoUEf9prHBak5?N+{HppQL^KX zrbd#(NYIovgEcgi_!DxKSX*n3vBbfnQxWs{b;H?qrW^KEPtT=qG_L4jtEtqocD9W+ zjHg0L9uVEz7gU7?C3Mm_YbN_kQ$>`?yj(%DlWBsrF8)B3A1H3FLzhU9xGx!;WYm&e zDKkt>H_yxNta8+*-bSR9I4nUuZaPFsMxV@)79eqd3MCt(S7Z{UEj0l${f)bXBq<3_ znq^XMJz`ukyIw;wfg5-gRcb=FPt35PQ<4apu@)|r^3;7zl2v=0*F9p!$c+dYUdo8T z*lMRUP;9+FF*4&a4Gl;E#bqHSAd*rqVSevObxOny=VtyRj2nlYm9I9bs#~>lPMw!@ zXG3i|&Sut>tl0}n!OEl3;>3ts5-9lXf~R;@B}rySGt5&aW}l``Ch9?D*Bg1Jl(AvV z3QEC9uqh(PQvzp6BZIp~P$-xVtBR%CM6FU~$K{I+V7<}-PTfVWshDdN=01cjuykdU=n+`u$fjjs;ln$zcD zCAnIdlCJ&`GtMC0$y`k$=)LSp65_0Ux<=;|ZY$u5OpkZ*Bu)gztxFXiUw)!2*Wz5n^wgaea$to#p)g-lM3k1?1xX7% zY^4Bi_JHamub<3F=~L)6YRvF@lFC-8N~ba95<$qeSj>$#2UD(@fH2Dxjc(GE>FOPB zx?TZtRa!*c#Jc;}Lgl1X(%Mz~y5Beg{xHWRI>_(X{b-YuoqoyY2I<}VcY;)#5q<6D zwc=hLe|?Cv4h0TAMxRd?gL9gaj$7VI< z#FHQRO`ks|Nr?EiXhfCYz_Ln~9&-`YM=w+C?KphFKvkl~GNeS5ZIFIfix|40R$U65 z>&`kB;!=$3&?J*<1JG%1z7Y}SY4q5AK{5QpeUEWx6CF#n*^g&rp7L`nD&2kLono_z z<5K4Au*1T##dtZ{=7Yh+4`X2~m;=1>(v>KmBa|4<=Hp!ak!_EMQ6IPFd8Q!Bc1cQ& zRW9(0J4Vd6)^|@>a~O$@uM_Yt9x_hP*4t^enn^tCB@To7iX!*;#)pNRxgx8Gg6dS} z8{_n*ES;OCa-VXX(vK!+jOt|o*cX-w885lEf-hs1-`y0?9>U^V15_S@5|u@*-x2t(jREsZ`z(Vi)MMGd|fY(e66hf|im`xal?o zr(03!&!JL60nA30hVsiu zs4EqnnLAWV@P>I!RHT|)ZzyJ%$T{d9OHziOQCX6D)jf%r{{Rl<)KRfqo;s6E{Wavg z%F}RCph(kWVs-HmLBuL8G460`+~(;EQca(2O}I7PNmw>MM^Iv^lF@@4%8Wu=>O+m&{uQahqu&_{woLQVZ|VE_m$IU!HrT#T(K7u3w$^4eiQ1!P;q ztsz?kplxw~NKwJkr%Np>B#m=g!>RIzAU4Ru+K05vp97`WD)INLb)LNC=jT; z;qmQnkpnF2WK|U#2~{|mFuKK6)!o8W3d)L&{4-xqj9lZ!<-058B1>=|8%SaHosy_1 zCze)In$}Pv))(s&u}LLFc}B?dRuZpbT5{(T{{R+DOd%^l+m>9)LFsS|K;j)c_>!?M zkI1+B9Dty*^*JF8p|`ngr8Wa1bWMk!;$tJ7+b`g#X?Vp|UKf>aa@P$^G)O&2L#YG& zsD(qL)4-V#Q9>v4XHl1JH@)lt7e|l>r%3KJagMe)#R`wzUwH ztMyiV4^KFpm5j)5Bxp;h%%v+qO46d+tteSZUe+V>@`O+)W_~7MR@g1SBujHmrspZO z%6u#@m~@6S;?>KTxXOzF?19=KaZXfF>aGD*mQ9&)X2tf$*(FLUQ-ku1uNT8t;$Je~ z23=bd0%R$IP-2nnO-8B)kdvVgdH^znlASmG@ze!H@xk!N6O^&mZK8d0rtz-ezq(X$ zCl`v3^QYQZQq8_fR9?@SS~)bgx%d+i4+*&w{{T4E4fXkc!sW}*MB&-2_$;Tvmq7R~ z6(8aG97Js4(7Uf6)E}Hj#yUEb<>hoAG5N#n;w2vqLoK3lQoxz{iifhVP(G-Dys0Pe zfKqRvHWrNU6}v34av~oRv2di-A8EE$$VO(;+k-0G?;Occ2Y!TjMRO$~Ek=3D%MVPu zs!);uKAk+rNDi8q%5hW1Rh52?me7w2DO!?#d&f>O*TPiyDEP*SD77JLVJ#$-8;+_1 z{vaJ;$nzSJFe_>Hjw&Q|`aM?lFWdR^pmBwd&*T0l9{Z(>v4 z1J)dmnB2A`T#hZ0$2gv_?26LltlLbyf}2}5L7Mi{HsM`w60z(@$+;xBxh|Y(!-|6{ zAg)ceTxj(RYRAvO_(3R%jD|ypyiHyes7hC*oc?WAmT5{P_kE?LhTmn)Knf%Ur8g&A zz_$;9uiECMl%_(lEi441j|IBw5<9ERGbLnfue)=ogk;!UHzu@&IjXFMHRexnrB0&9 zON$HXMZOdQJIz^6;arw+FwWP1(|W8}+Y3^gLMr8h9pvR`a~;z;RzZahJSWRBt@_8hJ( z;GtQRo2S%@WYaX_9b%%wZ7yp^ z2g%^hCsHa5ATjOjUE%;r7T_cUpa7`YUiT#0FL-ReBz^^UY!Yq~2 z>sIQCkI2EFlK7m*`Vt?p>E%*tiyz?+`7NYGS*_6gc@^!6SdyNtPtB#(3HHp|9BA6b zr8jgf9dtJezlgM4M`!XNQDnV`z&JWq;1F|Ye962~ahWvAypdyv9ihGAMh=wWEqTdw zAR>i`QnVBx0Ev0vopOy5fZ*>9$ymG?c#U5aB6z5Qyl#4SadOqRNfl}%sA6?VzGWo` z>LzsW6fHJN)<_wyBePnz7Y9Y8aEBf<#Y$YYS&I&80CgkmI-L|O3Ac#8wv1;L!n|^> zhKCkqC1Qt+Tw#>q1vEUg^Jbm8S!h_5D%+88ZQ?{Lh2b7oT?FROp%rV3U8!*huAxyv zlQQkpizI}W@3Jp)N_zN4;};IGsz!Esb-l&!0B2@+n~z$Ub5zsiP}+#St`Y~Hr*pQk z8;h2hvHTIXTdhD{w{QLl&+|-W7c%&v4&P2LP|y|*qMXr5{go=wXTtu(P9yghc)u5a zeR_1BENBa}Ak30Q?xf8tGFEM^hyvqV*+AMfSh;La<$H=A7GU+z%M7qGyD+4MuVNFr zlufj-xh5q&krwTpz76pPT2~a}x?LsJ`!d+}wwy^86B5I`v6S1t)PZx>DRZkW@a%^& zvBpVGH@Su8m>|65@#dfqN*2>(C=dxE1iF znKx}jrASb?(%OJ@y`s+?6Bv^oeg^T5V;@biDO6cpvR;^yE-aEz#YrV8LX@IFLLCVy z8v;(|EwL`7Svw)_Ji`vr9GH}OB`!<4<0}Me6onDt@re(S8KQJ{TH>NG!_<2DRheE| zEnr_nC>zPlFIxnW+$&k=KoLjn9v{Ysz_j6V>1Ei2bHay;PvstUENyIQl!jA*baYYW z-6V{;+$8h^IVKa17RBU|R~@o=(%v?%xFwbqFCvoK2sZ_1bD<;UX!Jj3aIYM9>Sp-7 z*8T-#&N!*Z?yX9dc+pWp-LdDw)VCEYP@7KD^1&qexS%1o)OP5#-UrG^wS^_6XA*~L z)9iBI2Fgv8E!Rtp#r7icQN*puIOKMCX-OD`xvm)E73Z0gDV(6rtoNL0Co@G3D^j-2 zlB|jME;>a%MERn|64-rsDcV|{H!U$vt1S{$DHl}C%PuJ>@1&8L0ZO?^weDT zF`6sGv{w@9QaHsmOfxl+=UcEXIC8s?+amIw@weGGiMXS%%--W)#cXFn(t5wT&ys+)rX|Ht!(@EnpAjp)o@>tdu>Dj?0Yi4Y~15o`E| zfl8OJNVci@CtE@)Og0qfeInk_+EZXN0pBF*Y+|lFGM_SI%R}qI-qToni>U%uVGT@u zrW{gIuzG+q6AXNCFT}x;s5~z^)?AQ#qSTt(xyVmg3jk=F3L#Z1FlZZtD7>g04B#M9v4V3o+pjg zsU63MNjTQ+v>QbnrcR7bYs)7R61yFq1O6?7MujM$YVOR zQLkkg*W0hIn(B(0mRj=Mov)|E!Z+BNn97OLD1wE=G(Mdho{_twp()bm{meQ?BF-vr zl{YzUjKkmO7`KNcR?C^5sMwysb1EM5Zls^Y7&3DCFo)_`$7bq0o-@G`@=v8MOUz3I zELaiVO|PxR!Te(-pEija99Z=tu4=E;yC33NifqtY=~D~8TND%BaTm&*!>mikl}~g; z$&X0u)GG*5C915Dw&iCTd^nxCZXBxAdfe-6A$b<1@)Hf2Zj{-C)McA>CgErVe51}d zoO)YEuLP|g%VQPPOtYyZveJY4x_$&FqoXrP|N)=gzNGNjfdlhR6P z1Wu%TslU4E3DUsmR8Lra#A!;1>4EVd_sQZ@GilW*TJ6@uVdE7%T(qWH@XJwY>`rH{ z&Qgd8L$afnrG?GoIkCXhEoB11aXVkRWpunMa7o@(?)i!6mo?VSArZ?!`w?{9?t4nn6SGpsUY9=bvJ@YN*(Sg;U;Qy z;tD}1AwY{ zxql*Ta`z#=Dd5H<;fmC>B+bhwt9gr-^soocA<7-qenhCtuz+I{CZ@hygtqTgI5I2b zVV4RXQ?Wp*Yls&j_v#_BMzdL^m94}q4$5cL2JzZCXD)O!_0?b%_(IUz6OK#V>9jf^ z!(TR8;Y<+*(2D6$3tiv@*IlFT&0yeVMXjaEJA3h59%d2qKWioYAw^=61a_T=aR3T0^ zx*Bx$Wx4SCwH+rIw1pw&^D5U#QbN92p>X0F<}p4QK17M6;%Qpg`n9B=3yV#iLB(kaM9-#RSeq(1cFoC0ivXl*40eLeAe6eRjSLhPVw$Iylb2u2M>K_) z84gQ#M$yVUX7f|0Wu*Fu;2G5DQ4pXu9!g#rOmGDM04+Sr8((Yq`oaYVRDziIZ~LI2 z6Xs~V@MUQh^BTthP)wti-Ocp2qkBLCag>tqb)^Gis5%q;V~0lxr^BfSp@jewGGW1) zAYZ~da3e;*gYu35+r2sLvxCgq8tOPNSKRNXLU$j$LV)Jf99*io?5KqgcyuGi&{!R+ zW+qJEb-`tR1{GpjHfIx@=54~0;e9?LIL@O4y=B>5A4XyKk*N5C2yTv>Vz$i4Au1Q} zy^qQhU>y^QN^-2&D`Vjt1C3FqbGyKTN1m{jDCMb#n?Nn7l@AhQfM#a2;Tc>_k3$84 zqfDzfm-%bZF8NQNgb9GXZRGpPAbR-2s7aD-XeqVCb+9<>ytE9LxaeUPbmpdY>1Rkk z4eVo=KyND)cTI=!iR4`%2iiCNVf~vxTyE2vvdg z79fu!4KzHmcO!l}?72DB)H(;jku~ zI^9l9KhaDV5i?=nQZkcoO=0b7M^g|SG3^U8h3Ydj{7)$Cn0ex+URy;87wEMUWBWsR z8tg8~55+tsPU1x=#@3deLeZJG07}L81t!PvgbPf8le8>F!p4|gCT?K~b$JZ9ach^& z;HK4}Nsc}Fj;CCWtXIb=TEmK@@dFPrFhX)Ba#f2un{2jRaOOgW=_w+|q&K0*_+5Dm z)vK7~;fytfILg9llXLCVQil0#OwTP0S7p=oGQDd%ko&6M-Z2__qV*;5AB>Y!+cicQ zTa)R+xb2yu>nOD+6v`F0;@e5PLFtpHv?Hh>q}xs7lBg|ex8}b33WS`$4{g)?>UE?m z@|;Sjy@D}3{KY#GO9cBJUP0q4?d>O4TqQ>CJO}BKl%$;5PlG-hkNYA?r_R;y=lU`A zmHz+**HzQg^+t{}ovCBqehaF;=F=;3E`4)7=7}lax-3Xn+DXws#nfef zWll(+Kz)?EVM%t1ZdIv}nR>e@P?%(pkfjg?X2DTWN$Y(ILJU-G=cGN`%NN9B5uV3bB@y<1>D&y5IYxxKnd|O-MM2zJj zsf5z8Y?EOw%eW7-J_ge=fZfG5y|ax{bRyyza961}U9aw+<~tdze9~$4>Ytx@kdF%X zrLR+JA41jXauZc#J;`lqmdh|6y^^xK`=su$0m}=V6IU0vc0U-ar+3*szNLfVY-KaV zDK})>mXxOAIds|i8RkbVN*g@JUi*wF`>Pin4U9#S?AMz8yD_y0<9eo~;nBtJyqSWG z)Q&g`k*Uf^NY&*{=2@ARX-v2_=S$}ql!A24()K#SExt~^Jin*fi8>uFcit3<#@!N(&0+S~AO~GgLNhBWN{)#I zT`qLF(f~Nvs+}>1st;4h2{oNj5yOm1RHS{SB|QvqOB~M6oLNT-YpqDt zl9kct*%GrN+9fL|mg%r3G70HpZn{KF@YKEn;OMl8QV-tT7ebTW21Y;Ht_z!>P7+SR3BqgymMf zAu?1cGEL#>giKVX&_K$WCP+S@i+n8z{f>&NG{Jo+4sL{tj}dza5!1U-TFjK=NY!I8 zK-;`P)8`5jH`oS-?FySCDBGOU)1^-=0FZMjN?nJBV_|NBIcG0PN<@&(+Y0+LJGkm#8~PGK2g-pG&k5~m$3~VNi`n(u9st+x|0vHXR^GS5_-wOXF~6se1nCgk1vr7R>} zDN;cSAYEI>YR)%8LyGg$lDLjyYDv_JbM8z_NvXS8DVK37ShnX?ldkt7@TD6#-4E^` z;^!`YuT^obQ*_EZvdJY^=D9Ag60Nkl)&;eNB&6BWNH&AAybtG zSy4N$G8dg*nb)U~(|8;~F`{B^U&(o?bpTT*QJD>%pgPN!1Is}OYjMQ(9;yXZy6zvr zGt~!jASu~Zxng^Pc~A|!Y?PDI_l6%fI(0CX9cu{7;|hXvb7}Ik?Z}+R>Y8vXI7m7I zR0z4&!@@atLb(hDVwpQe!W61>>VnlO+s?9}ZaEW@>6k)&QgZ`+eFRU!?TpB7aU=KQ zQ-7-Lihr{#+)0liuB7PWbq-F0SW9wEdqb6$UR3QU=!wSI12c(m=+ns;DI(eOk=7%4 zgZf5Ovn3`+1XL=rbjQo`Q&MlcE>x125JGIWoJy{sq#Z776g3wRiOTtlilQu3B&M+9 zXcc)isRdKB7FgXY4T->twE%d z;M@0YSMt4~yk}%EoHxa7;aQse$^a^p_Efq503^e$1&jXxSy1a%BFC$Q?xz*vmlb@% zLAi;SN!!|LE?J~>)hr-wefk^2c@-gX++KE}P-s72MO>ntE8l_aW)Sp6vL^&1sfxU>U*nfsbi?n4NGL3 zZlVpL?D)Eg$1=(&^@&Ve+MkqlF0#DnDi_l@Ac75uF$qGMApkStHRNtp%98j92 z&K6&9?5HK;jQXDGwoL#rV|$SrAFeTCs?H>?(-@UU^A^;X+aRP8;+aadzPCtOP`-yz zygd{$$oq(8n8fqdnka9S{M@s1$!hl=*CO~*)SbUbg0cZNPNQ8R)NoPobBgkmxjLOI z5oUgqGh1Cf8MF+Awx=@!k(%LFwTR2(36eUQAGp!kx%?edGKg>kF?Gnie?>T(8zlFL zZNLq#uX+V5J4DNrtC>z0(dx~&%$cCHrd?@Q8jSMqwy!SoRk64N-Y|vCQz3N^j5C}z zVYZ85<6iP&aHz8Pb|#Ofn8ZeJzGL#;a1?~%kPwxryFeLy$! zh;AAQ3RY8J9T4R)j6k&vt7^M0NIeK;-{BklPNKifU!g&hoA{DjfS5(sMM_)e?BkB=ZqSno$b2V7BHMBIP;~ zKJfR3u+*J;{)`Q(FCOXK3~p`7!FOk!byDM7XKGc9p;iY)D#HCYh95y_XLzT^rSWoZ zWlUMhaH3B-(}6bSKJ7Q_rOB|lN`W^$HqsiB`}vEp3)sq%T9BW0M&ZU}la}9g0E76% ztV*BXVl;#&AD#AmWl#rj)R_MOoB|(*H}~9&ke0X&1Ynj=g(htN3lSxM51`Wh8CE@- zQ_9584;p;<`LLl8G4n!av2D0gSg}$^h?Z#|EZa}q6->UQ zs2#aSH^}W3oJ91dO~D&zxVI+#p+t?kMng2Mng}BhH;Chhm85V0%>W&0U`j5vn;{7* zQSbv&Vn!(28k;GXwSN}sJ)x^i;rc;5hg~f&k!@0wWx8$#o~LNjVaKIcSIni&JwpDM z!`ARSZD4#nLSK0Sb$Q!drM{`MiPY>eo5bk4Av8)_RS}FYF3lpEfZIqG^YdDX)RVrZ zAB*ZV`w>Hpd|98yeEdCz5~a&9a?Z>q*Ku7?GXOx`T_zT-@;S(goGrvNJ)H5Rtjo7c zE-AFUllJB2EDindbnD}B(jw-^%@VOoseX*7A`Vk}B=B_ybd!a}28XcW54jKZ5pCdFX}#Pl}lrtvd}=10g=uMPmk zRnp|q%v4-)SL$_*cMbTYXR~eUKSqM(GVe*K3vS*0;pKgz)}KNNlvHGE(r=J~?MO~l zAl~WCrThr<5H_Tap|Fv_viPoDY%JuMPK>**hwi9e);nD75ao$YS5f%ONUZGR$65Z) z^|2>Em`SO?iI$DKpqpm|1syljc%{#d_I%N0igaEjRSB+3HvFT3a_^-pN`}fw)E|^k z{i(`qtH35vQC_;qhyG@)*lKD5UHghUWN>Ji66R>q^|s zb$z3MD`-6OF z$7VOuIJ&D&nNKzM1BfAF=Ua_I{35d?FPSzIWxMefb*xi|=+929Hi@Z;MLfG)49UL3 z#OdXD&q_4u7HQcg_$5I_0ZU71$kf?Vl8%6b(|z~p34%Jv8{6BofG$0R>7zueEW-R$ zHyWp*@G*J8$4}zx(1V^`2s6X1I=W=Lt}J(!k*9!*{1DQL*|I_KZj1c4s?(_B+C+=5_8F*QCZ+50rAS+D zT&P;;P(9Urb~;21xIYcQnEY~6*tp&balMW>Q5v05%TSjgsiY38wu{&cD#YorjF%US zL)f~*J!p3`<`#BWg0K}{O^B42xR=#7KL0C=)#AEz)f&Ty{Vj6t@`yo%0`3+tfohiagPk?-WA_%|2 zDuz>ss>-MT0Azk}#xcRhrahg|Jjdq_f*wo>f$A>QS6plpCoewIofrEmSV>*4b8CaP z(VgOdiI#Zz9j?`L6xqyAKB>7e%~)*#L1j5yMYAZ|LzsUUfJhnVA1ZDL)LXI+0y?|vnagFHB$vmf9ai$z` zDg-H~ifr>{`kO2g4#gx|9gfUuPSGd>L0n&DD%nz?A3}(bzd}3xNYBSC6;8o!PD@QT z3#on7wW$OGb0p|?u@N?v5yr=}4Oi&;;FnpjeI+B-JB)5*)Z=C=IBO27jDz*HNu=Bl zvf3;U%=v>3%?&_8c6P%p(yKH0Dz1?9g!4Yq#U7c+zhj@wN^zE9xidPe*|pRubA$F)a;W+OKiLYcg7+oYYo0Mu@Ld9CPGRJipOpcW zBocXqT_-?Ah&^_O;e)9B^ChtkJ15|2Of!a@uDXz^r(GT6_CfyuXOviBjeN@dlD)@$ ze7tIji8sZXn`LY)ox9%Q)4;>|7Q-->;d?FPcWcx+oF`HlYM6O$Hh_0jvWW>g3wKVN zl0gPB9?`*jnw}FcLdCd!Q2I`lEVI5qlj<~zH3H93PnGT`)@%Gmo|;K4%+oWr(^mu> zhQ+g`h;RZfZ)@MAU*O@En(kL*%D{mId;hN|+aTAC|{{ZG;r8eSD-9S5TBSnvU_!Tn|{91E26RJbTl<)b1B;(n7 zeq&7Fe{=En)hAPAk(p_jAb5ZXKbVAP^d6qa%@#1#QAcq%G@p{K3{Uuw^m!F~ zQgo{o)X)68Jbw#Cy65sC7R%U~&PEKCQP^fD=3_1GCsX+%fLoInxLJQu~FeZE&2ftXQS589+6qwya{i_g$owday1t)oVYcu`UEp+ zBu+MI96`o&4J*9OGF=UMa~5+S4*}y6xLzMYA3kkIR~}MXMJ?5=WirQ_+3+A)L;Ax= zvyvf2jR*HWCYgR>r11bP*@XnF(_tAOX-kssX!tmmi8j|c3LQ!oK4~$Y*ST$^rmoUl zDSwS`(5ceP$oQm8ExU{6Q!bH{aclVWi+&bc5V(XS=^Q$Hh7_tz3S~KFR=1}nQ+w;8 z8|p@a=R@#|{8A|Lqo>7;M>R#0OqDeyQ`1d3qIV3TB)Mzpas|A6B2=Z&iwN}^Zp#lz zaI$`P5zV{=gN!K+>6uCnCsY*ba|L%zz`d`rirK`pgo!iR8?&2JRSA4fhYDLEZYh$J zWVlpvkaKlUKs1P1Gih{7#|t@M-6z3P6!+z-O*9cQ_&n8ud)BqCHou%p;iY17#)zZX zp9rzUiR$G6YY2XNn6oLp{h^fy8zWFI28YO~^_ zxs8fN1lW{*l;o4`IHZt=Mr0m@Y=037YKD4}a|KC}LuHFyby|`V2a9cQ@Fd%$F*l`H z>Q>3{oC3bi^9ZKQD60!r)Dte@-bQg^;k9a3q%7>CWQd@aRX>R_LX2EVqEsKICFyIX zyM|vAQi>M3*-5*I`=k`>u5U1~1Oa}jTG z!EJ}Q+gqXV;m6pTUTJytGSch`2rY$MP_8RIM=kw|wf5V;SYymaB>U;w1YEL9kk zs6eD^IjjPPl@+jN0!ds`;RWNiet<RgLB3fdjn zaV>0bc&~|G!E~k0u&k?1$Rq+Z8xVYAXAg&48p)GM4_WOqS;eyalOz&WELWTq*!g7< zuHpDy4Kj~5eM2!s;6oCqm|G3x4;8J{18{TiYn=y>+BA`c6tb0x{tM!tqh=;B?Ddoo zRFs4En>rNf<>v~j6K8+3PYTh)%zr&7@w!&hUX)S$O_S48du(s6k)QU8sQk;G4en0L z{Xj@#W*bobEU+m*vVYqd8Enh-$U%1E;7qp=X$q<~kS1l)Nl^Pq8-u7H7{1`M>HIH| zSH$DJ#z(R}2~(5=u(RD>cE_OwF=aUr6iNHp?rgn9X_aWU3Yt*!Y?PnMC^(4jT4H+| zy`b^JaAhUjrp~&YsU3CGz{5DP+a8pN^THfDsc8(({*l9(UZ+^T;r1&tGADNIl4hdR ztg47gvhU%nUE$^PEAlHLl#dGQSRIz;9hY;Gq=li>+ub`I2{9#XGo*U(ziYYvABN?s zB+W?^msdu#2zQkn~zflNm;zBR5)BO58!+lWl z@9FCS^HPGbD=<5}}l0P$BOg zyDZXix)n3X3N}6Dl9i{-5TSoV7Ff91VVm8MuNK(zsd*74jiHsH)+TWC-~}#S^cxUv2qVbv68VhsCw~fiVpOo8 zLltEET&S?mqEwOaP0TjpIHXv{1mjH)hz+F5%%m+t^h*REnF1JUhXn>P;hj4hFs7$j zONdb4f5aH#bR5d|;$LE!x+zr79D3*%CRt+R&?!o|hm^!P5Q7&cV-36PwW(#wJPm9~z)m#a6C zO4FPP{8AHWgOi5sxhgrwM-_0wjl@RzjU}m>X9dDd!jgPaphAWGIz?3YeJq_E)AxI{Abu>r)#rRHTykPg-bcG3hyNPDLO+wA7SN_ zxsqn8+lUq-IHGmP&`a6UP2pk;(vO6y#uNth%^*9d(m7yxxg{kT4xk&P_!#2@(-kR% zBq7T!18p@BP#h;7KslT4_=r)%q=$KC={|5=L-*FA1Zff%nAf0#51tM01hT zkjgm<@EsvX4#1W6;g%C;PK1ntsetQrk@AAh8;Y!^OT2zDz&b8Tvs!E|Bx|vbrf}n{ z4VfD$2H@`svy^VPP~?y|0t1IZPccwVR}vJSzBl!N1ncy_U{%{WkaqHpfu{7Ze_KId zG+4@liG!F8cZcA{W{yP$Sfy#or67%zHxQ{o5Vg2pXjQpHAP$%kRZA*U0X?GY+B16W;+xEe0VDUV3)2&11k>ypCZIfq?s zXbu`kJkgw_>AY|cGg4*4l?xfXHb0DT4dlI;?|A46X=HN*DFK~KC0oHjcuJvAP#P0d zl)I?V^e~+#Y~{Yf+k`YIPR_P>8;C*Ep)WY1i{D`Y9M5k=;)gLgRyHxir&(?&3vU6# zirZ*ftdo^M?E%xQhgOTE4gUZ*>BDMDxD#|bEo}?{8lg4-x=!!_m_;=c>ddQx4Z(zI z6=!|-RLU)Ia_t?Xwj-)fE&l*@MJK4}VGQap(_K;&3WdUaJRv7VeKM}w$11Jld_*V? zjLNbQq#J{{j#wPono=s7FZZGN@={j0Dq8HwF>{>SA#Zx852nsPTo_!6N1-Vp+~pin6xU z7){aBzfP;N;({)9>u6Ph+IhRC`;@@Y9EasmFtFk@Sl`S-4x9?jDK_Q-sD!hroOvnr zAwtFwn6`zrK4iP1wTBb2v#9#iz_`}kBc~0jbjoK_sId^GxzjuHhjFijDvliqb!SbE z@akerEGsgN_l_fs*m1kf{) zHS;njKaY>Du-v0!lQpGqDjT)X0P=*Wg^TG)A7e-e*bSldhTArZ_0~EhI$gAK&e7#R zXe{bRqp#%}7(7Xdhupp=UK1eu_vp>j|T}jjXC{Xmx-r)^2GooUSIu zI+&q5U%(XnN&0req14W)(2h?ABw%RyWM-3AcG9r0 z(YBU1(L~?p9UqQF#&Z|a%gyrVSS`Dt8HL7#Uc_kw+;t2uXbZ`k;w|3(gFB6|i#&6g zRuIKyxqN9V&FNKSi#JqdH?b&AR?xCEQWi-EQ4%2Z{wVV5zW)F*iFSPYe*XZ-gws@s zoCxg5akW$N1tGK$Qg4|}tN@|*NFe!x5|i{J$zH|H_Ac$4C)yfFQ|HKLw=9sCTR+lU zOzG~WI`|EuMylD6Tsoq9t_g@qMKiJLs6_}X9tSY+WPc=vo$z!+SL`RJz>eK=f7d8#{4Fc z<9$hiH2I=qT6LY4o@qS9K7=0Y$wkuIl25$ZIgxS>kc?S0-TeDM*^A8$3si1Uy}CH} zUT9R}ni6=thUpcBeI1Kr6U>vGXqz~oEzfGiCnEmSDkm-MM_7*;bK9Rj&35wmlC*d$ zTpp})=iV>%APzb0KUSc;swOg#Vt#H(Wg%`JQoJ()(m)|YUG4FQebr^%a_#p-h-UYG zTVHNXcizwc)q`ej0O`MM3y8$)tBi!T6zKz+aL$HeD& zr9)O9bzs#gp(VWMS7ojeZK+a}k4pr_PZ5fpq4-E~skn*8>GRqD07*}oQ)(&H6y_b_ z@ICFKBZ%T-ufqAJ=Tenur1PCtn%pTlkIL~DYKJ1n!w=0g-0bpDpmNAELBD}nKbVGp zVb9!INk5%Z>u*$8h57;r{9~vMU*#d6k$z>fy4)Um3y1*CgcaSEMf6K0XUvgd`Ir&W z-KozeZ49LDthye#M!I-u3leR~G8~xDY0F-oqB;hEX)ZsLVA@+Lw}qeqwBv0OTMu{$Nx`48X))bJ7F*wtB&Z5k-qS9!ao0-ZqQ;7|S%WK>aNGfRVW>&C^>%W=TV@k2riVYH-#R0_{mjxTi{iA<2cLms5R-O1r>X;8?>5 zb&fw3>y0&r6+bSNtkz|v&TVK)j<&j2Y{cI{bi6Z-ZaDc7*NU7vsqoU7Ce2CY zJYH!iXe6kVA(=dd2QU`0iM6k!Sm1W{8JeO!;z5&%Nx%HGN&f)tD{&=q8tPdsW`@;M zAIL3gLSJSq<(}0rVRIsJu^z!yRmQ+8Uw5 zdCWD7LiSK3TLVpX zHf9XG%*uC2ec(r-ORJc0IO{|>CXOxLj%`5FD#wm1YWX)DU-UrUR zU;bOSkxN;UeZ(XJR7O;-HX7W-ml3NwSOXqAgsG^gtSg&4S*Ok$-!Ww>TVRbr%6-f2 zxP;0UbxMhAL7}6KxMr(Nsy-T=ov76287Wnk-?ObL%-!yCBpim{WZSGqanmJ3soFGt znwG?TE?~;5GiF6{*V6f=nsF)y-f6hKKP7F)}HYONjA9 z?i47EwHgtq9yf~#;<7wvMS^gL9?|%bUv8yC=S!@pH$1@sExH!kiWX9mL0VLsW;(=K z<8kIZrD6*LvSw>IqLiXJQ>JYVC&BiR98Q~ER@12>IoRcn1`EWKHKy90WyGXY*kv=V zJ#gCF%2bydP(P+fx>cJ?SZxo`)s^i~;so|5uT-&YsUB?+B+9#9>fyjDp{^!)Xt$LGfoOrv&2{=Er%T!@y%eH-&+l$WKhdu zid&7fP8e0OB|)%{XmK*(^jPIuL&<5uxHnMLo}}J6lM%)#BH1-E(WuQ>H zt!*qa*|1pVK837UAF_~dYw7C{*AH@{UyHSn!?m*+9>u92_WG9~db0JSO9l8>`K4^0 z?09%{Q%?@x2y_tas%6nIq#Z&9HNIjVPK2Q=QZ0XV!QwA5bXno zXxt_f6e?RQX%q4@lju@Fq zrZ4EW%v5npW=_G)7PO|rS_sMH=3l_an$Xa&x6K>_7&kVK9V2&Z&L%5|xMa&Ptg|&Y zIS3%whR43G2sY_`L|t%L`j9w@5UaCgEjVUEp^PRGcOAT~IV5+oCqks(@2jd#y2bPr z{q!m3$x*{RFsv;mr(f?+PAi=-v#N7 zF`cS#lhv9`g-TroPRprmxKb{1DCa@YUe_cKly@@fcN6F=`y}?rs#0n)bXw~9k}jz%TNU=LbUG;!0QvZcwfkkmUL7P4sh({PJI&%ptP41 ztfYbmd+zvw8Y~cP*+-UJ6E7U#c}xjFGsu}PP7)E65K;<-yp6@;#!iS!azrn(8#SyU zB>gz@>g+Sk=8ZX}&hbLXP1K%%L_Z#xC1KlcWC@XR%52+>KG|krwPk&hEK;u!4!KW5 z5)`_K<}0zr25X4YRz-yKDZ2~Pz6bPbHYEP1fzlJ3ABeogLRv{1*aM8uPNHWCR1|Zv zl{+dHPGsaiSlGF~n}7#H8J;H}UsB@)`W80&GmDP9#bZR&b02ALwx;#pLkOWp`gt^l z7c(%R+bkfs;>oZHNV(MM4#EyXBBPbSz`TTbgJJ7Uk{nN zd`@M@x4^G15@O~kO+Mp}B`OvG5<9>fkz#cbq{AeN=^+KgdP_LRJwi<>4>Yo}+CUkQ zcL@UfZUjc+A+1{Ghq22@?@)NNDUNVcG+Bk^s7X!BA+(*{Ynk05Hj`3fOH0}xEwyG*|CT+=lvaJF$6%lONZViWsghK|m@E0taQAIR4d7NWB^-gN) zQ;Sl{m2-6{->u^B3@!W$=}38Gu_JUgvbY7Wt?d>{bVq2GJ&7qMxrwGKX>CYhnPQZc zB!EiDxdzth(kgiD)TwnOaPYTfh+;}ZIL*15eA)t~rkh(X0s*j4uu#3l!Lc4<@kX;W z$@(m&88#*`TeGxTtNTQYu1l`>?;sxPwXruABTlic;j(LqPm(m~?_rAbE0A(dV#*24 zWU9m|CvmJzi`t0hmkjYbJ2T@pLfi|cO(iK>!S1SE`xGqd24>0Ee54T+999e4(6Pai ziwwjaqOg@Q;)Tu?6q{YLiyw|?pvl3>GSOvB;xDx>4q$)CON#infAgWgb7y>1Y)kf; z!&5SEJj&)vE!`@6Do8?zxEZrp9-wauTqJ|VMMUve8#BZ#TK!5-m{@W2lofy!K(Hj( zk<-R6@W)F?tjjALTt{~c3P0eF`O$SE2&bjaEBPUakT&K>f2JV}OA%OYL}5aozFvgK z_(y1HxOv_$`UqwNg5E$D-6z1p!4@6C8mrQ@tcNEepqFy3Lg{ZJ!dyzvKtTmIzPF6; z62B8H@$wlS+qBtvX|&a4-)-jRLud&~fpH6IAqO{+01$3(tU)9U9~kRW_`a1!sWQ(h zWXmaun*b8xnNa~^*E*)a->C48fZkxNM!8AZB)?$V3Y$ZOSxF9Ua(?Q&$?(<`jt&BN zi%{YYHjBbtXPfBI^2hp+FOD+K(XiWsU=sAAAEixrg|e`w95?7d1QYkP8pW86o4!_bB-9gXeti@XZr zSLJlcgTaZ!R_RNX7RrZ~QRJ5Zbs&0YBHmHVklajUR~;`7&S7j(Uv8e^ZhBE(+b-E8 zCDd-?Y6DdQHn&@A29UDEI77uLUMN#ro0d?_QbUbgW^KSVNf#u3uZW15IBH|j&16Ka z@y2U`RVB=}r9UA&q|6}-B$VbPJcNsYGN>C4hjBWD_hveJWZ*hQTBPPFoEwBTI$#De@1$5#LQi ziSz401uLVeX(M8lHV7lg?jl?s-+jg(Kfc0Ou#|{)MyfVi1j0gw;^yYZ;2}BQ%i?z* z=tv&NZwD~#U9x-0o0=qgsu-W~A?R`{*0$(l71clHS@9O@pU8$;-(^afZv)FTgWe@T z+j|8V$9rN`FOn~K6|nNLOLf7W12BxiYDR83&}J}v?7k|JZCMny->CsRb!h)5uoCQ=rpq>XHagJ3KL`o^J0 zkwqze30*?NPvDF-P^rzViP@IidDjW=a~3qz*y++HI8hx=$OnPdi}>*JWY{k_+LdDJ zxrGA9Q+-52o=q!vu{IF5v1m9$v-#j`gKSHz^PEU=OYwAA?h-nUx75Z9+8jrTFD{0w zg~z25n+M`l;<;v~0J4+{T~FOu(L>8!uhJ@1?4IL9HF1`lM98|<$QCeOQorw zWX4ox%4McAOo$F5B5T@Y65w1 zPX(tGV%l{z12nxNSpmW|9MyM~(2dQy7_0V#v`64fz^#`Bi*RI)I;KogY6uIJnrybA zrPKFTn}Pz8Y^0uqMlob**>9ruAP*1m6x|YG`VCN(R%i>z95=k&m)Kdqd41gpuuNRz zcC3XpL~r9WZD6&`(HYKw9~D{*!)DyHzyAOsGQ^8nHy27#pitE75)u+gj5Wi#o<3n& z8vK*Z8uYs*m-A}e%V3+cG>{6G2-3>iLkiL<2)+ezNbowSnjKk*iAia*P#(o5F_YJi5N^g|PRFZjZmd2zL-4+nrvBJ2!An{t8gR9jX zGgMG>4%c%sd6vqDH4V6P9El_w6gdPq}+ zD>$ct3zw=>-f=SSuF0~NTPhp2uq-dor20gOfay}ye0Ju4bn#L3n?w zCqS#q;@M{BBwS0ZxB`--5THTyzP>Symki?Tv40%NjK6Cdt5j?)FdW@zAP%=W2({p_ zHzh<&`4U6|?CFjhsY@!IIO0<=E_=Du26oQYxw)~8z8rc?=2=-R9>mgEO|tv$wv?oG zP}j?Nl+eLX`0E-jV-z`1rxHs}6@Z<}0oOo$HH0_0)L1ogsOCANNn#37{{W2X_I;af zpr6vPthZ50z$GcTx}v*?#HN}j;hvqzlY_AxJB@O*%KWvt$Qq3^Ci*S2Yn!D*P)?DE z&xyg)=xDKIwecPvBQ@>xdA3f!QmsA^<`+!~$hIK|WR%{CVY^cfkCKdDvaEY#c$mit zsIN9FvVzueXM&LQ!)KAVs4z;Se+_d+oTUmXqUbw$?2#Vgo|2vOL0Y)oQayIutymBp(8NKiL_7Ye$nU z_$Sbq*qMIFP~iK~j?1xs4aqS;n<{AvzUc?>g++;C*efz`)2vBDL@ncQ7HIr6oI^__ zy5aX*%1!+)A=qMb+#Kj`G4>`H_LLUTTV)6;P4rOfuBTXfFw!N+*5C(dXQdu)g^03{ z?vj&7+;jX|)U%@e0Ny6Nb;w~#`I3Via7PdE0R=OXjI5}8#k3MV2}vRv@tj9ASzcUH z>=iLdDwxBs=1!!r>WNLf5>ktgj7f(WpE0Rm>_a-%9jkEV(u$0$(&Z=gnG_qplI#Vd zWMrktVa3FCa2IJx#tIpN9?^4Bc0}SsiTlKB@wtdH!Pu7^y~plH6HvI4*D2(-tlAVf5O44|h?2!z z$uXZ|KXD_mq?KSQVuI^j14k=mPMMcItq})PiRf;(YqUtk3S<`IHrNLqaqkwT{ z>4D3rLagD)OuD6xhVTK{mYvD_0j)@I1i54^@$7l>lo91c`x7q`gbY3OFbek#wHf5f1 z&2_lkbbtkwDKgaq-WgTYX=n}!%yETmfa6-)`*?Xm;^<3OGKiPuFTlg11&qv~on&Sk zLut_ESc*;#ML~H~0KUo^5PfY5bD;`0D{$>{zrv;GlYL5O?&eV+Ei7RcrWE2mw2s=9 zia7#dyMf`G_o^I8p{Gorou4~ZvBVa_TyQ1f?>0`qBBEi%nZ#mP6p67TilyfT(y_0J zAI2p^J&@&sj?+`^Olg>W#7Kq(^Wy6;2K93PK!2-9rwdVCKp%=>tLz zK%}Zv-6Z-#KvKz07DbFG4&o+I_>O_8GRWNuAzr#dK;$)BEw7g9NIeubG0OwCnUp>S z$c}-_sZxZCI?|3K$GZ)NDi*ZfY`<)M_C%0>_%n;Lw8#O2nMG`ggRpP&XQje&`%R z#8Rm?&{fS{AS=;+2_tU_@kP4~VxRh5d%Y>bjpUA?P8Khnh zC~}q*JTI&y=rt+NW>uWbFR{0F1E&G{a-0RmyTg9&wuanJ*|kQj2G@~&)p_WD80=Zb zE)!5o_d>KjJq#>K$Z6Hf5>b6O5yPi)Qn}9-A{L}@++w7ZD{*e4taV7?k?D|y+-ZHF zYy&wsp{UjkK}O374Vs*XjJ~74WF8)N4#wo3}Pi>l{ zl%^x402GqrWY4rl%W2JngK(jhK#k$J%7wI;&v6U+9mjfPw41Y&a#QG6C7GG z?mX_LZH~9s&K!lo_Y*(HN9rHqKlV~#Xe_+dKj7ZbNDKJ>Dz+UhdNc&#GgE;hGp zRFXRQlM+@fd#|5S=aEO@(XEgF)`D-;u=}RcwHF;-je?~dM!p-LoGQuTS~+Q@!GV5|VYW8xKh63RkKRQTd2SR7Agx7NM}WQTJfTMn>#8lZDM>0&MYE`0 z$<4LTOTvcESJF#(o2Z{C4gefWo9hZVaqFyvU9tw7>Ea;=2J(Z7r+8abVzW(AL-Omn z0N5=bX$ssFsAz5sH8^TQRH(J8MNXB9D8{=>vSg~NQJ6-m5gJ`fetno|vCNM+fi-0DW43;e$rkC9lU$4`V+!Cb@>l7!s_hQK1E+ePNl# zkmOk)@a1GS)1tr@d8s}CAwTSfM+A-tcvNYbe#6eVeipQHj*B^L(rz}}V&y0er_Wg7 z(a@ebCYxFJTR{MSR>Z>D!DmBIQnUD=h*CIl>TU@lw};tell@rZb?9_Lsf0R$`^mc3 zD5Tu~0E4~lZMP)fct!q4NbAJz3^&DEYMo@{nP~vF=sK08WzB1g5CGS%(LaUad_B4m zb79rLQX%lW7CBNcQz|Lt)a2KZYvcBTYa~l$Ivsv{z|Nvva2Ep8xPygI zw^U5R+Dxj7f&Ol(b%kY0NdoFANl_NeED1J<@?)_g&N!cW>8wEXs!Cjzt4KZ%T-?N@ zdg?zIVUHqP@xK#GKUK^P+>xj;okMK%O{ofR)Lkk)B0hobM0}FO>6zi{DVa!GQ8_T! zCwARo(Bnlv^Oa}roNPvqBuXLZS{QR(tmtN;g>Nv8C}?G6ek|z$ywzi zmK~dyK}GNSCX(6K!+f{+#NLBMm9B9%cNtdj{v!jF{XVrZOqxm#>^eiNUcg)_yvf+y zi<5YRk{r<@GAu_KRT!Z&^rDmuyDYfs7tuvR&4K1g0xP2uQ;|+wPOK%FdVK9UN|%}T zx#blD{{SN_WeZq73+gu9YZkFYM#UEr+IFRdu*bBgDxYF)%OBTyL}}1#pogK%ZI8cU zp3`$2DxEYMi;7gCH$q9%FNo0UKNxa&>?0~Ck817&({UpbxaN?{e%nr3CR|zuUTY)X zCd6zv(3^D97=-I)E=#HN`-?D~_5rEAD^hEexq_$KHwsGIbd@DZBH)dEe1up+R!3@% z0@LidigzPIG$}iU1JHP15;HvRNxtik1e6&UaZ#Nk~$za_M_o zDf8nzZs;HYPmjVI$hP^NixIpP z#4Ss3_I8q@M9i!6vnolwxlSS0wCSRgVm#s2zY<`c#9QIgP|g^{rCOU)QU~okq5GnH z=7td>dkHW;l${@R%b$>NLmW>b%tQ5puzOQHOP@heN*c7!EMCiTNeKkl^aSs{?GRrf z;yL4*#X(F>;rcU56E#`aTT6*mgKaRSHs$Zq*?Nr*ktrdj%_`>)q_}ZOm!z@+)*qKI zle?>KZLH+npS@^#Er#rD@Qyf8#SGT!D_KjmDXDiHDkV*%k;^w5hWaOK3uy_G7MVP| zd|+nlbShd$$6!~lbmlQH3FCy9mttU27 zqE&dAk8zn1(}|d3WO!Oxv@@Aq@{}mJi;`{QcE{z!>E26~b64oem| zw2(Tyqw{Vmc%}GXz?*}g%(S4TD4Y1kQ!Gp9Fv`%w6gglb;tC54+h=%OVP_nusLtM4 zq3lhIWhgSlsZFJsX3`FcaoZKE*HAxvXz)WqUS&pU+a-HgJ(_p0Qky^$boP=00Pd;8 zfprn%dzC7#J^6%gBtMHqIgT%|Q&+w(HBXh6^;zJtsF zd8s*x(^IruaG7;4kzK@NrfcDugjHz)6G;n6bxBYn2f1vpH@9J zCO(8x7LMRTa-a>8JOo^)MQhyR*Q#s9Qf|wIl`p!ai}gx@{GiD@LR3q`z|t;K=<;kk z?}i%-*Y!kZ@@KcPbsThvUE4>1seW7eQ%GzHmIw2+AX}KTwJ`6ow1*=+R5x|P=51>)8a(!L}YD`dp%je^;&RpzSiAS_8XhS?-u&Man9hn=i8 ziq1bKm0ihvJZ;}%!>Wk7TT*l*Re8k$XF^9A(_6(dDv@~!TN48-s8G04Z+m%ogSar{ zXIqJJD?hZ)XNevjwIx-hwpo``#$IV4k^-0dHR?^Z?${4A7knmf5z`=M$D?vSqL}3+ zR!Jbm#ZeSb%3-w2)#RUPHVT_(ItGB8*ZfRH$pkotbSZak(MOmq2#?~DBmJUhS*53vuO#?c#tk*GdzvEWulE3-J2=8y7cvi z^$Mb|du7mmg~ft;TxIs@He7HHt|slMpEF_W8gFOGxcmyPCN#+Z08hj7)0SH;sHFTN z^(!mctBSB}#w%^MU%DM&6d^}a6MN;g_PNp;%ZtSLp~y;vY3%n?bG+lJ1H_Pj(ult3 z`;T~r(;c52KK#-Lt-scT-8{p@9V|CPI9iQRp*Z_$Vs&jfp4zsy?l07vq>*cgJ=G_6 zcg5O-B_D^h{5vw0t@OBy6Pm|E;cLR-fkD`bWU)_+Dsr=dv`g!d5qOa%Hf~|0^YE4> zKXuA~=D2Bz{z7V#X7HnVcO2q=c7cBg@)@olcT3;Zi0~X2z~m%|SgIc>9D6xM!`{M$ z0NOc=3LBQ4wsiRvsUU;Cz7avh^JR`MM17&M_YtO9Vr}K}oP7yEB&ZC^0NY=W!Yj!% zNZujfsT>0(Cm}mz%}PAui)!SB%R1=@0YH&)YxOoZJ3?&e-*Ib%>cG-ytDz!hlQfc+ zloSxA9wRbA1eK@_{0Pz%ot$W7xN|-xE7Zph{Nx266MfF6$~j z@FCG)4~9}jw1viY=tQHj&Eqy0I9|KSMS=wC-E4H_&bAyD^jZ`TpM*UbYDjIWv5>-a z65kOdU0=BRi>SZe0Ni{ChUBVWA;j$x`;MKKPY|&?Ri<14rvqwr1YYY+hu-Qf(krKx zawbLu_Q2FO<)-9Y1O7podoQU81|X?fDu|)SqfW&5s-=aA0d-jfIzb)LIM6v1I%ZM; z1l(T2_l*w+ylMIR6zU?qNN>Fs+65V(zT?5q7xBbNZ9GFhS8pn6J?{rMQL$ohNzcKPYO3+(q>Zhk^8L7B(0#GbO>G2HMkxEG+1Zi zEAlI69WIGG*prBh#}tpQQ8P>g%T1)}L(KOscK4D2{pK2;Dr2ynmE+n|9?j120aFPo zEy*53n(W$%N{6PqYZGz9O%bO%CD&z1$C{a+m0F2P6xxx01tU+w6`CS(v6SOOg8=b5 zLU8w3ooKS}f`YD+4*oFQV`p2VnARVh;5H>wk}eS@mfL;i$GYn(bRy(j*+~kxAYQ`J zDMwlua?&FBpGjvB%eOeQnU*Ru%m8-fty$CZB>drP8OM-qyD{VXmkBEDvg4}yGHvxs ztr@$hb95*Tck;0Fh}kgeTaUvomRSdBda|lmKA?piLJ~prJH%W#6lLm2$(GR@xId4V zP^D9(=MsnIW>kbNw~`jwD(;Y^s1QN6`Ve&nCioj!8^+vlaSjqi7OnK{460>JFzkfY zJ;wWdsOH+hIZb2Fp7rD>Cn)O}S@OQlVpF35K|dY`!CymgAM# z$(Lx9O8d4cywmx5XsZxJH7;m=D`r(Avx}%=8jG9%05^Oe!Y-os`49^->_0NPt{x32 z+#zlR{NpF>XzG&q7hEK%603^NJ%;ELE0=i7KA?m$>UT=ipaCDi=thx8iw>zJMCs(E zWK62|lb%f)c87>5Jjs_?Q$l63Ic^c|JC!N!kf0T7=wn^Na9$lWXZVgMR?Kc@)W#>P zVcNUt3rxctwG|8Z+UR~4jRrW=^(pc@UV_uMR}$N%Ng{c|h zR>_gsSA{Kb-w#SOw$dgF0@kYx*_El+Ur5D!Lx|Mray1+-Ehv7my(Cs7)nVU2%#+j+ z8C<)Uc=jWP5SVih)Ka#;xRKv%n_s(a1+A`;po}P{ zmgJS}%U(P`!1WA3q~~$PJur0C-DGNYyh6yeIwe6;8ve{Ztl#41BAupG&CB<4O&kYI;Fq-ptxTaiC3xR}plOZV!QlV$Y$8lq{ttPHUM1iVN#6_PjQcvlL^#_N=F5r2yvz+RXp&! zGHENZ*tzyc&(;?n{f-lxhd8ohvsD^H6il=oa;-GCCX%2t7B&DX$|BdyECu$89yk4x z*WH#l7M;hS_WGy2ikXxk8XVG4+Fk&KG_`xK5tA_=Wl1)+@t>CqO8S-yAmMhe!pp;I zlg9E0yu~$0ZhR+CXpwN(m3V|+<3enFpC!Eha6w2SEsu z6qxNx@O`;wCCkmNC~?L?P|-jwK{=9dxF+HvG1OWi?F~P`JSMqm_srbuGZPYR%$*9* z&9W6}t!$xtlj{sDdY;3Y>26YI7cq@<5!F7Jo^inXmK<$l`={Pbt+zIF&M7p){BVOZ4D}Z0a_2Y!`D@kH) z-0jHJQ)I0#Zpl$^-%5zeN{*SXPLR`&MmVL|a(H>#{{Rzkf#+y=fhK*abr#mt!Ag{n z4TuUUQ6Tz}5oduiOfxb-QZbhf_^|3#Af@5zvzmwHi--Y#tlDz6uZW85kZ~tMRy>1> z*z2>#S1Q2PsJdEpvYUkXsjw8Wq*l)qWJ-+MCHD#YMq%zTv=t)yQt=wJtiXfu0xI(G zt|Yi+vGQAS1;mh5VK3y}Cp+ln%sVm7&}tM-z|-Xsa&a%C9*#9*gU0L+{qXSm zl7xj!u%2^1Cd0grn~%mVcn&winrwle2BgtId~2LxODs#O;9MwbEN!v$F|(d+UlNUD z(q0c^xmRUyoRey4d-37C86q#F| zrPT{`=zNINXw~~WHl;;37YaEPY;P;X`eeOMRFAFE#C^qq-$}R^`B;e1!*Y&$4u22p zNyEzmpERm^zocLSxpxnUZ1-Cyu1f>q4CLX|x?i7BP|Vj+8QMP)P2<$FPkG$Q7AnhN zl6MK7C|D^S2yX$gvxB`r;)SgOP+4r#9XgP|M1p66(ooFByp2v5w?6tAia&eBQK zD!O%svMU~gq2J(@W!wRZ-KH?2DYXl}(|={RZ{Nx~U#J!yQJ&+teOs2CK3dqedW|77 zQlzYRRDu=gL{df+?6H)s6v08_1m_0pHJS{+d7}RSIf6dOS=0><{;_=psH>BrKwxYy zGm9Tg^^^lI`N^sWQC}STrVuAR1%PZq$NW3M_h(}pNrk3Qzt4D3Ls@# zkPnI49??QntcX37FjJgO#V=K+24>n;gzKr-${5c*5g*4LOuRN5677VIEF&S4C9>)f zqe5y`Gl^4b7fRAnej?C}d0bezLeWw<8lG?lG^){++(WDOhLh7%V{eRXu;kQ?{#a8v z*v6mz>G8~!VI9dzpyWSogTrEX-_Q%hE;kmqvPTa+ESWf_Ow?EbCtKVY!Q_qnjVv7x zwGH7ZDAzEA=#<>}o{`j!HZEJ8a9%p zzrq!%3DPxGy2|C9<%KPm)Ake!P5%Jj!U;s`bU&C^jWhH@5im=r7ToGQ?`?iD7Fd%X zSqT?J;x#K7CzAd}l?xO&o&F?5X+fd&I}ljovi$=U-T798qsLI=H%`831OxF9!-rwj zA{t|!0b)E3O4?7i%Z+m)m0@z!9%1Wx)zn4H!!(UbW|qJ={XY=$0_GgZ#eCo zqmw+9KfH7qtth7v-CuZg@_-K77nnj0f`UOXq;T3yvvc|pVk4&xbj*t7{nBnA1A3D* zO2Qm40JuXOi+RTYAq59IJ~oc9I*v}RVHrs_@bH9yj-Q~R#TM;ni!T9)OG1q#;U3Ap7&7` z@#a$@PZNpQ$`ul9k4CGqX>+71#5kO(if&y*bZx3R%VkY!4$vGhCT{0btN>+OA*{sZ?zsaV<2335$ANjbbkc7WV^ zVYUcxjHU*H#Kn5A?BOo8Wv2F0e}pBYse~#;S-Xpa2Aer%DJfFL^D6!ZIi&5Hu1X1| z7T!u!IubXICEP5?%`v%41Sc=1(akh=%yk(PI05P*Em_lrIUu@apGKY}bcWiaws)DS zCc3~5YDVOE_{V7J$P#ZzD>F;XJiDe6<6Mr}+LCp;g@fryUqV2?&JJLAUX?buj+`*d zIHa##|o^Egdz|vYp{J26W8Y7N&BI#5r*fDOiwJ*mFqe z8iHRTj#wFkw%!sdz)?fG5Da$3*~g#4(p6AHtf5!&NPt?KM0VnDWb8l0Bqy0H*jf}6 zl_V6XYkdk-40D$u<(s%Od=#9eN(O23D{CThrstR}HUuq3{=36k2{F!@T>N{(vm8A` z3!h~rNvO2(bq$QFNd+zfl-vvHak8%+$9Db$l53ePcy@_&)0-@>nAs&rLW+n&PRUMf zQ*M^EydtYBwpw8pm8>&M;zJ(GQ)MoVkfryQ+3`yBSHkd!$)Z}Ky76xWE1Wi*dV3Ab zxl*UJ>X9=b=?YV4d$!|>Djy?l|(b)9Q)AhU;8I!qiq?Vdkf1vW&F(m9~cn@Jz`B5;n5O#wBpv zPKi@{75VT+Tcx=du_yOTtM~?Obo$*P={dH|l-ibq@*%4zd4fc0@yRu_vXV(hnxjd- z?z9x>WL+oCNFVfS9ke50vi|_xC_Gtxx;vD`mR?uZgsCcbmNijq7RA&CsmemGG}a;K z#~CMNz8^Bg?OpsyS6s$4DXAGIF$=Ct(`H>lBq~d7$$6<+gZeZqqy?p8qqj&qDC@2& z{{Rz7Uq6cS^EA-9*B7Pri{3Bx5?oZL;i+XcCB*3@&oanAN7gbeE<8H2>Sg=sT0yN3OH-X$vGp#1)Lj%CXYpVh2mdM$X$3q-tZQ z4X^`eQ42V6Y6|BqN5&9vMNG;fXsNZETpJ%dX&f779ux6`XN2<;GA`y_E}+_)nrBiH zqAZu21cZg8*xd9H4=z1oqbe=egHvozVd*-CWT?J{1uSe=WTxlL+UEM+De^{{E-cvL ztgq2^8TrI$rdC+L>YJKDFZk-mGIoNfm#(dQhqRp$m&9A`P);9mMpG9kO%64{9!k@$n6{~ z6opfymCOn`kfx9aLZPqc9E+o`az6Hi?D%m*ZC2^oTBxz6WQ@GTfHYl&&#m+^d%q7t%(QK69I{Ss$~lM1ojOO9$Rlt!5r)HIKx^X)2YH6SO$Jpq}>H z9vE<&l}fJX&)HHB;vskz?Cjpit_~Lz$zs_r1kRwuwjiC@TLYQ~A;mN&oCPdXr7AM+ zeb*UrPPDB?;Va0Z2HFE?hc|nVEshM+&obxp$KF)CB@YRF=aiK?p~}jGpxsLH($Lrq zv-~TU#ncB_eMP6G>eW|Se)h;3N>-q5J=Gfnwxnwduoj)Hr`w&7!z*kAg~_Er3ji(! z_VbBY`HiwF*C}e92zp$W=9nREtY~!B*BZpuh7&D+u_tLy2vBKPE)2;a+V%)*-*-lb-Qjm zyV^Mk(-h-nP~xmBJ%DGPrPSLk%&@Gc-~gOJW50l*(P$(Kr0xt@YSf7JMECyY(|IPU z{{VL2-^c(=SMeL7Ml%lt_=LLlD6dljxs10bT2!isM7ZKfPWuyLn{9LB5hWTOOebbu zAHT$AX|y@O<8rjr%)LC2N=?f0A*E^dh`opx0vOFb3dP1YNd7F)Wji;sAzY?hG>WXC zakbclB;PuaMT&DK;a4^yBjU*NY&j@t7`n|FSYB%vNF@ME$TK#!9RU4fGwTx!>#+b6 zYjp96@ZN@A#7)6W6;P|{`x&W8C#C(NNAiiX=7te0dk@L-s}&$W!LUcbE*Ro@4q_j? zH&#stiIZz{XICcO&)sn(6Z5n{e2D~cuGXs<9=TnZr<9aP&wYDK1f;bxed`MmWhYZ{ zp&P`6_8JsZv^kp8+tnI_E0=XjkaY|w8y2Rf+PSgT*G;X``raLj5YZX&S`mfYZe+9+ z*V5BZgps0=&Qo^uhXj_{Q{lbhj#!f_cEiwCz1~^g6PTfa^9aC2AtV;G1dTsk)Y@GVQIbM%^Ms(qAvo<3p!_q$M#$dbrx0ZD~dzaG?&Qa^5X4mev?q{+uXi zoA;6F3yYv&@vVm{l&Lvp(EFvCo_pNHS=QS_$!$gZeV|m3RkE}0qr@pl@Tw->iF)pQjiG4jrA3s7MW9}|X@Yjipsi{21%#=$0=q)Ye-I*6jJ}F5b=foGnrc3vM3swH;3yhn$B9J`O{{TJ1KInz}!!a}c z(C~!!<&Y2TkM-le>Vw`HqWAYk(JpfdRI0}I3I70|;Y)^ym&7tKa8nv9i&*{2^x_Fq zUe`HcvQ=v!YkOMyYrVCJQH{DH%6&^jr7PP=Sw8iyeRYQ=u*%#(@CuTgZHTJ)q2%UE zZhI7s^$9~-ElIuYbJZtZVwZ}aLem6#lI`bn8^vvtNQuWz&+{1mqN=?vZ<98pwuQF8 zaE8-lkOE2d)+gZNv}{Gohfu^|Iwe+%RhYvVhah#<6E`U1Ab{pw97;-tsoh$$X(O+b`1xrNJYH83E+QCYaMZpI`2t6TDXBsKF%o@BMU#QWN zESY(wa#Q{(->gNn+Q&->*l^O+tf0*uF1*I)jXW(g(@nnm$`33i$?5YD_Douxh=j&5 z{vS)QKrXF*wuas$F3znp4a>;gBIPG=b-XQONamxzD@l=;IfE_V$0&~INHq_J2YBMz zY~-V&{>(#-C=EhR>A&I!tZ}g@nEi}gO6YT+d)piY^)|2{lxKMUWv>m(=1Vu6Di(@{ zSQ>zHbTE_#y>AW4;)yq@^TZTl>36UEGa8k z@J-T2u$g7hbwg2c7*h?&U`Z56NH!Z~v0wlK{${{y6qzLE?USRi&YcUnHqszT4;<#5 z6C&MXlmsE|$uyc6rcQ){wY2jh<6@O1SN!8i?CDZve-yb8rjd>(CS@|BVZ;>smRSSy zi}=a3Ry1Z}uQyO1T+1j*o0W0jwfMktk2^+j?K5A}<{Oe0 zjaP6)!->Bw)ej^n{^&&=plR3|e)nchX=n9VaQ^_K97ia2zmOByHwITGW?ON#=FFJ^ z#?;!9v^bzrLV)N&1YAOI^*Ysk26qTQ&%@bHp*-9A6C8{DBgqW@40Dw8sU2oSfSjnwO=8K_xrkLa&RD#wwkl+TN`qvpQNDnA=^Pb9i`sfhT6%!O zC7l`RlPQ*YoZ8vO(xk5^nFh+!!aEa^L@dD)4$>>qExMAG2ihadD#Q`+iE$#yQ8#fN zd8|3bG(P%*6Ut>bCc@>UfxJ4MGCNj_1fpOW8Tp!w%VBuY%g7$B9-8MYEudpA|be3yU>Hc#|S{zk| zs$eK*NwB%g?+rj2!ti9LUBqOKq6G1hob;E*pA zSVB{`bn>SWVc~nIUt&oyFEY51u{veUsrg)OCoeSKRWmT!974s30civfb@7Z37qc~3 zH$+&)G80%`*AXlNiXBSBYS@r_$o-Y1oWHFUoS9%WeV``R{ZgAe(iDWQOra`JvCP`S z(uE(q0Xjyr*^}0qDY&@M+i)Wlx5FMKDX^fLej;kg*2zrJvVb~-f=*=hJ>laQz8PJv znakqEF_cf^R+NO5H!{N8Spzak@|y#=7wHmX9lrYv&F(#2nq5S#Zf%l#&dIRieDZ>Y ze2)IHABc}pcv&BRx+1c|sk4oXIEQQq-s7d=h-^7M$qmEFiC#Bh)@ld6G?^!5T^epc zI*m>A1bN;kK~WY?$V)h-v4kCIM3uEum`Nvpb4cxd{KVhi$Z)u!!8DvDBUh#%iIx!4 zuY~U6ZVqE%a-^M)h2lQDbUmkQAI>#Cj;9~{KsVW^dhecQ_Z8& zJbkH;^WtK-%u8LD<`^4=r+f*kjO6Wfop6*G<0b|k2YGYqnn%{uBpJgfIeUQ%+}_C5!!KMon= z-|`!lRK}x#d}Tzw8%`0%GEba6GQZ~2;j#?6%C41%7u*R-x`A*B5UJsO(A;t^MdWbq zUAjd!Rk?Q(^C)Qn4kbZJT0j6OC}=?uQ8&3Q5HpOtCzZq1d7L{nW~jJ{W@eW0uuPRv zBI-a<0WGE8fgq_yF8D4YzAN$}=Eha$5vUVbK7CSkCd+e7uOpy>0>IEMH?bh~F{V>f z+^lMa*Jv7iwJo|PP!hFMn=TzY#^)*ZwTHqK-{y6Z)<#+EO82wMB$4))Z4x}ljxEOS z`4SI<94$OquS(FR0Wvbn4o$iShT4!w1Rsco^5t0KIS6WX*nRtbab}TKk(8j*lCZfY z6cc2GWg1ujZ@BORDCGX7iYpqML7cClLQ$6KLQ05A1=On!fND=ctVd(V(8p$M zY%$*tS$?Dgt+yt&UJKVc5()@a$-aY2#cbnJ9J@q0?A48ajhULDx)iy2b*qq->QyN9 z`=;i^0CdvPd5D2BE6DIAylGUeNwYAPoRU#gyJ}Dcz+APq=#z78y&>H;a_D^l+6;Rj_pTQ&LV#W+niK}t$i_FHBhZ zy*QisWk4|}0vgC5_+7%Y#QGfd8Sm4XA83;*>bZ3)*+~TIo2Nmqj9R5?hz;&GJ(;B@ zv4o`l9c@`=m|wNYl1Ni?4RlXYn%PtUxzZ61R3(#B9aQBzR$*y$tLkggX;K%kT3u?^ zH}5P0MUKYsxA>ReFk1|OqbIb@0oi$k^093d3PSEOxiZ^&YkbZvKn-?={{V?^%z129 zl>EcAnU3|s(5~<|2H@&EV!BAMj_1&aWx6EAXAQFagyY4h(g;J26(uB#TH4qH?+BsE zvn(UXV{u*?rZHZ6n~2&p`J|AhYEmIATq|PvIvsQi1Hc$^8?BB#hl>pHV-|2hS6Z+bGbN_Z*qb_R+`;61`#YOenOPmCf5x6K~Q+Ef$Wc^shyWD>XL^NdV-wS1}bxK zt|Z81OnKc-P<=FrOpuw#mzWdDydY4I#_~y))tX!Rk2{& zLPx-SBA+fzZpo32Bd;`^(HL||;*2#bjpQGuPNXe~geeLH17byi7X(~H-WNBAA&k(} ziXXyM>8{P#+Gh;Z3WSu)mT5-$d|Oy2DAZ_35xe2?Dev6OaS+l@%ElTh*j$djF>?r& za$|2RBGpD{wx^pEdYk|g6+Tn7oe zCeWzt%T7Bij(05uLn3umx79J3&+R8|BJ&pts3&cH97|R3s+?h@2V}eLl%!obbr+7hxp@dJN|J!1W`s)<*_TU0Cbrxm_+i~6SV z3yN13NW%9gw;#B_^aQA;NgUHICn?LWUlMF@6p+Du%L!#7rWe9;PCO@_X)2q_5>}uI zHt{50E#VHOY~(KMIFUGU9Ngh59wy(EJEu^MR3z}$FaG;0aW@~$)n%lp+!5C=$4Ks! zxgAZhi0v1RdF8qchj~g+O2Rd{@X-A9hNZCVNnhCmg>_CFrPNNL9G9%(6r9%tjY6&m z!qJ`Mb18g_Y!IS(x@{S@%S3A45-6>H+B8FgD|D<-(6R%8r^x%N(B9Vd)W)NM$*MmB zqltwuylAGeji~a{&s&o=>RRV%^-EfA%c)kmNLU*95<11Sm7=|DcRMuVdAwgwG}?$F zp-*(nKYQGiXceu_qg$IsUyR{2yIo6+8SN4;j!cSP8k-By7LL1Z;Sq4)sV|8lc{U(r z540tFgp{?*)!TM@n(J1Vn?_~0l&EMNQ6O9h(fhjQRrtf(ViCLB0C=hf?)T49Z zpoxiI<5xtl`dN57t4_oX=#?olbEIsfEd5&5YhNn1BAV#u$7wnrXmsz)?6YSixSY@@uF?%DkHA2tdA$$RrXg;hmVw4aMIk3ky;jMf8MA7^N~w(75YQr~sMv!c>0KR=30xc#AAdc}&5MxO<2Ai!L1v zvietXn<`3^=xuOfJAl1pE5+TFX6fZmQJ+x*UQ@)8=m<Rn~^Z zc@9tQLrw##W`ho))13+m2hQ+@g`rzVom9H64WSHjEN~gCrePqR7B}!P-40pjXSv{l zbnuP^nhRmIf(&#IF(N{2&9rBQ&QIl$-cR7y%I3g3@#_Zh@QHVoBDsj65%={P8KZqUBue&3XrB)Q;suk>J(L{rl49mD5eqHnCZ}a zWz}%(#&=Mni|UX`BmAi5hIZ2@#|HanQ}MEr%Z`LPe#?Xd@VbmY9L_w(CxJ_mHmTUw zT6rMnNWYl3=My2sCRfXcXjC%#W>a*KN0doZvMYsiHQr<@7Nuh{jS1YRjA$&;1+RObLh34 zz>Dr}q&Afbu}Z|qm=^{XjvTtP)=jlJw2m+mk2BpMrofG12ThteEhoqb>H|V*ZPwOu zt1^5HBn_cG%K=MC`9}_inW-XlSRFn_1_lO{<7Vkmx14f-QZnd$1S}17G0+mt$*zSm zRNb;2!G`LES=)6&W4wWH5d{UD=Vf`iTK9y}&>CCJ9_omXn?TGfB#&3*SSiv4JDDDIIf=E+KbEDD!iu zbA2PatmPX?DclhN9LdS!FRp|_T&U_t9%Uk9zMGE_A-A}-v5BRWcalxVNJ-PDFI3KQ ztXT9tA!IxeMKhX5)9pC)d6@>%Q6|@nCPuWL`|h} z(Mm@iyM`q(Gkm#*(y_jvAIuozRy`TGjg@AZwArP5vMVjNs8{4C+KQ;k&rjjbEs#^fuIsuV!&8Q=JBdy(~?wd&ASy zO1X@cJF)HJkQdWc&4F=<1SmH+<#+wx3 z8b25*OI=N$Z;_a9F=@b+xWd4;X>|}wXM5Q16R~HMIS}$eOPIqB5u#d4`8$ZD#d8d} zkeM0qg#9T_(!e~W0cO%H61KrT6p|vsTy3l5$V&$FBWgHGQ-$bb4r6pTRKqVUB9UH5 z9@S4#(GASZkd(HYST?k2abi3XE+OSt9&4KJyu10KQO2P6<>&g2vrfCf#=eNfa}CyT zeMLcudAX0Qeq5|~1le7hQz{xIl{Hn*`*>v zeo|_`hTQK{9c{BUH!e=Rhe;tNkdk>TO~^>fdP5FMU6bp3FTUiM<8A&I>Cf-6|In{r zqGvMm5ZaWV5e_s>G|YtX0Y#OBor%zVF8~KLxyJx1MUr$Hh~NtxJA3tgigenUVP(eBl$()jD30=cz&&9@Y|lP}BC^|p%Sak{TwHzz0W9IWG87HX zjfwed3bTg2G3slCJ3Tnuyto(6Zlw}>1Sh@fU>cODZEF~cnq613zsyDSUPUJ3#>ZGm z%Mw+Y83)pr-G5SV%R&xo4!1fB^oH5eUv^gG?6nq~H$|I!l+#lT%*mGtQRRmKb)jLo z1QGGlD|n20w?p{kSl$Xmy=65g{%(^YLrbxGGMiW2<0 ziqs2*B)8K-4f;Zo*iDg-9@S*USRv(~ zpw!n-c3zwnAhsEhoieF%`NL^bSxW9RX=V4Xu9oWz%798`u)oDO9y;`g6WmDRV@w9lKf(0**KQL}4oW)U zxhyA{+?tjl4{e8mT69y6+h>)1lKX^MQ(mSviF-3tL^ za<(~C4yawhN!l364x_P#nhilwwY5}K@o#!1;zFOa-Ux3V zVLACX78`X6ZN?O>xyimn?mhiceTDA~V3wHUAUQ7+t}*@FP+1Fr z_lXhaHp=(J)b&l$T5a2{LFv+)^}NzTZT(<=H;HIuwB85t0jgaW3d({M-Az*x*~uWK z*4i#5J9Sb@Iz?W5dYfdZN|4BQ!NoJ2Op=_ErRgP1ZEvZ;U|o5VGnA8M0M@o3*+%x- z9^qrBe&RB_ApR=EF7YOXL!OydXUg7f^_|vOVR=-ou5yqG+}l!O+7TkQEI4`EEfR^A zqShO7W|uckW>Tjv;UOrpiW_wUEy98_s_C&d8r(qDf?}4HL7CxRJ5-$MD{a;#Q7-WU z&$NdU5TFJ13CnPG1V>{lLaLc2>g^#MM48M6U*&Z*BI8Wn%;6s!kbPlre~0}RDf1bA z%~a=W5)VtvXxo^b^7@ylB}Anu2i`-3?BYm0FAw9{dX30+ct9Irdd|rKM^T4kuG&nPBQc*KzY9Tf(BQ{txOCWF+9N27aAeqD@O( zC2c4W2(yy;@;nu;fgWY(HSVgPEJ^do3`||T z*&1(uk{Zfa0jYT2p*K;eg}m&{!qx#%7D+mFhV&$JU5>PuX51+xJItv0XJ7izhXvSD zo9=D9z>FN&)>AjC*Zg4c{E^=f*K30KF|Yaup!$^0jx7rnE>c*Gr0BaV(I(%NHIf6E z@@XRGhN3pqILA+%ZP{AGYNgb&6uB<6 zsZFV1ZiS>}0QhVo-At}<5%v5~nidmHI#yjz&eX`5E+Fbsr4-~>O#(%UBYmTZ?hR}p zcz@aB660kj+HFmiRkJ8%TZ$e;C=~oH9eJqY$7P1_%Y&4z6-)ADT1a(6>s~sz;p$YP zN%&qX^5t_SLJA|Er6N;6FQGpui6vvpV-wS4bg;A{hYovn49*6?-%G;MILf}`9xQ5y z#A(;by8&!A;T;s(1^)mz)bM*n6nsLtF^a}`j&Bsy9J=!$D5WOi*1m=(H*AiT9S`IT zra-5s+CqrbZ*P%>Y;fl}gCx`LPUiiVlwjE5$a4wJ3TF-1qlDDp|8LD1`hG`_T?Zf`aoB z_=ZQWGWL_HakUIJI>JIFl(jdM1fKY@zEq3t5^>^K`3+>rub9X)T$q;@OJoR=q{cQk zn#I$sYJ?m4i~i_5MuTIbjw002{TdIeNI&Sud}bO>oR=1>GH2@2k^cZF8~*@O6XP?w zMLd@q@j_446YycN{)8SZm{Jtuv`#l@WeQmT0F-Ty^kF)mW4e6IPVw^}1eJ&1LPoa% zBk}?gM6wykGn^M6b=r+1Vls3Fk zaZcG`i;#nNhznwz-6c{jl%dw$L&_&o+QNcVn^=nsr#9nQt|g1P?jlP!UsW!4$YNy@ z&azIaZA!6HK(?0#!0Bs3Xj(*j0%5y6O)TWDTZ+p z>($u@owj7S(lqcvu+k*OQ4&tcCEGg&&PY~Ut2C8zUSXmfPuWrhj>i56q&PJbceB@Q zS-cqHB&#b^(%J;NP1KK)Ng_JXiA1ohA4ip+uOkssol4}U*>gG*vRze_Q~}#Pu0@5F zuUKY62_sx}y7C00=?j;bLYs9bQI%sUzs?&@w+btqVW%WzW~nnnGxWFDF1zcQm1@$x z3QwF~<9d-_HKdQcKjLiPW=h#%qE%XR7|Jjrd? z(;2x^!fZ&)sHy5}??|{#q;i$@e>4$o_TDi*(8c(+H5@GVAD$;+&!m|X%nz<*KUhD) zHaEYTcL#o*V>KjOA~W$mn!H1Y-sGn|#IW{;e0#p|9;v)sdpj>>St*(7Gk3xhsM9O57iwh-*Ch_$SwO*J%T~nW69d`*gAbAZT zdNyoNiK(JO@Jgl;iX>DIy(H>S!9dy~=8d98C%B#MzGZ6^w768BYZD>H)44kLhsyr| zC}$o%*10B;x%)}EyOq9 zakR}Uob&C5*REy(3rGgqTQLJt zbP-jS8fAUUOmeh07?*|g4k5EP_7a&4)B{UGl=XnrubO~w8%QK>~f zLVL5DOTt_|ooFW{)YVAJ9*P%GN`dqM{{R@6qjFyhAj#}K7_Ac6I$0Ahs5aAKDNdV_ z&{`$Ikmicu#yFOs?jWeUPI=BrcO^1|Bffh@+E3LaLWcrAk?7 zySn#~GT&WxBf{2&IW%!3Wtfzi;iSDk5K@4boTg1VCp=I9@1xJ$$ausr#f zs3)ICp8=WKb!w88Xch&D3PJBAix5Wo#)68r>6WG0u5d{%a{yEv=UImrO?_YTF;AIE z?tjWMLV!}UXh5`8=EqLSFqcA;{8JnSEukrMfJZf z$Z*LA6_~bKR;Wp_IZAc0HUwxjicT{RR9SHOEVB+P@Xkw(bZ4nk2P>n$Eb#p#yXn;q zB!UPa`G7=MVv~ciY}TY!J~_h(<6SCZk6l7p#q@P@TzfBiVX!`}?8&l7Py*uW*I2&8 zn@;@-*~0cBhiFPN=CJl3o|x{;wA$rg9w}*MDJS8l?}^KZ)G;h#8dkdAAPmqjq_Ioy zWlN9!vwaos4Lxsokv=I!exf6Zy^(gknfpG<@B)wu(iJ}Pb3EZ4;%$9R)fsI3e~SEz ze0)BHP@ibI^F3dkH@N36-`X)Q60|iXM5yc|g;75|)9DCtYhr5cEDJ9sl2dc{f~<7g zU1C0YQWp|#;QTo=fH-wpWyVaYN3@hQ6?};+HUN#ly@Bc?E0(4?R70tZZzY5AojHP( zwih6V7Q0(A)PSTFSZm%O1JD?`#Uc#R8U_u-IO=A4wN1@-+;cuvgpvU_8;jo2B_{V9 zCHG)HDoW7TT14O;)FjsPE~uQtAUV)<`0La|6Wn$rnXXkODirEf0+})b>n<(V9Y8l) zLJG~shrF#0qTUf1uA|A3s#6}f!8%}UD78^)VMb-OUn|WLZE`Lyg#c1_)Y>_s!sumq zt%}i!uq!htCo`26);?8weu#%sGcYD4l)kEMKqw_b+S=z` zck+t}J483kk5$>Tz)mMjJ1TN8iK3+>ZOU4;9d-r~)jx^EN}O3YCBO_=Y7Zo)fruGV z4x;DTo>=dw0d)~`n!_&l8%HJhe)@}Bk=KI?tKyt;%*2w^;={Hx4SIZfWrJ(>mpOr2XooR($S;s#}$w}EO%2jV7Z5B@zkkrYofVj_sIPCFUH;ZqaL*sWu*aE9TjGlQJl|&u1cf;CvuTguTwh^8tnV7+8~Og)R)0m-S01z9u&jNp!)Pz^$QEG&St5QXl zqz#SkHu#v;dozjX{@F{#;l4yHz&))TlaOtit9-{=NJl#Qs@iG-ca4-YCCtyu3w(%+ zjrfN@R<1ogPg{vY%Dz++uZEtGmzB4$rH+Yp*$0Aiyh*R7uTpICSRq$lw^z(XXB)+M zar0#E9|f}a11XhlDM+vY0T@~2Z*xN!R>K#^s$%N+dU*-g>XoO!#P4V3{A$K{jC&N- zF)EtQ323O@$yKZa)GfC(9}r{EIioPvzp6-vvhJ9u>`Y8Kg_Vld zx%rYwQC3oQCdS?|UbY-;OyUN9f|r_;FUkOtV(QZY`IlP#Sr(9J$>o^Gzfx^ZI)#&EfpsVwD|6Gv*6@m+Cq9)$h8SMu$>1zkD~V;($*@vD1vaq+bl65u zJGNaxP_lelA+ka=#32eAo;YyPjx5k-sjj3IsRd0EE<(W4+KslV`Q+rrTs78+yI$!LgNC}|k02`XA;33KX* z?*Mvv#l$hEMRevnycnTN;M!UkWg)ZxPEoMAy}H93MiqM@%sD%pG-9b*6l>aou(`S$t+($Rk?Rr>El=QFK6P=)b}VyehA0!qcuvoy@9!AF3LVMQ%W`$@*}!_5WSe5Lz96x>sr97vL9O7=#s4m%pE+TE(x7eqF>-n+7#NV zguPKbrJXbCN5llfP7Mwzrb&6ZN?#FWbGDXdT2Q@|kf2AzLTFWyrxf;Drd7h6r7cnq zpSVhqe>4>Y!jlrw74dHmEBrZ8Gt$M`akR@s5pNQJNfF(I4u%E9kDM(#J0|b*iC1%^ z+oqZ*C~QYUA*o}wEll6x=WHr9a0z;|DQVH6aU}2P6AFAgLKalXGMY6Xh|BfFw zT%_q}>BC)fL9t=90Cg#?3W9SEn}|y~ZV6{46?TapPyvE(G|Dq8MRkE3IyAbnCfY2x zd&6tTXyMPBr~5vKQPLC!f}~rR7aCd%IMCD8=;%ZK?b1vL^|87D*udlcYPU zSjHYW%{-C{QIJ z2vFNcIm&u1bc-J-=z%>_rWccIka`eEFafDfb@?HcYAPKs03Aa*M$iGM<7t0VAOISZ zZR>%!jscCzf3x?JZ3O{^ObMTRSSSojWpd-XVKj8WYHOGG#-1_D03Mx0=t`5g>-(dC zZpzImZIqz*lhQhlnv(B#k1$&OV}}mwYgD&eh)^9iXAiumX4s(ZKMwF zf;mTQ7a6jNKIwvj&ZM;=sf6802JzYhn(YNL8HhJd_977DLX#8p=2&skQ)LV6b+jPp zqnl+204XBJO{1p`CTR?y+@wb+4U`FeLUOC&w03~zPv&hvqQyN^x5n_6bmrA26FSwh z8Or4 zov}FL46(84)*7l6b_BfnNw_;l6FWk%%?YN#8u>z-IE-mdbd7BQ85xpaMHudovkb#d zHY}}2oN=S5#VEUJv~e9~WXdZw!MK8g&97&+;yFi5Yf6WRfa5l$r(8&~jr`$uB8{V0 zLc5F76r^&Fw6YRY3pi>#_b8JEfN5#8&WjC9DKIdtI^{3{fwXcBfz$Gias#4?tBVs3 zDIB0uLiCQ=!+o~F7KadnN@ha(i0Q*Xu%>l8M*!)x6a~a6?SkC+Cdv>BQZ`t9gAvO2=pmXhTa9xemrC9 zG&H^dRWO-&H9YI=xI3tL=gXyylvGqf@H#^i#>p|y7AY{k2b#lDt;(SZ?h79BMaetZ zn2$_#%`>*FF+QWCNw@8$5YrT;9^yv7!==`xoRON8W%*}CmcxY#Z2F+xKZHhelpfoB z$#GGaKgdr}cw0A5mo&E}8l0r5ISiD_lJXLt1Q#wAvJ5|X?5uBZRe zgc9{Nv@DW91|BAzRpKd!#g?+6YXD8)15DHv)a?Kp?@g8^Q2BWWGuaCx^qF#!RzFmG zy7e*30k_3?h3Xuu^K$D5SSbV$2~renM!kCJ=N%cFp(^hdnx8q=l_aPP+HOF%j?h@v zpz@Vxu_71APG-RG5IxX*Pn>j3*xk(`mR55MkYE}+)Y>ysX$r6xjtfGe{2(zM(|@eU za%;Ir(LaTRG~EkG(!ks+p5jB3RN7mTa_E;sZp=M0;cKn3XCT;vazF!Z;fc#h)U2>> z#?@Bp*iL1Z-@M&AZDnN&zGl>`W&^4eHY5$YMQ;%u?2`sOoGHW4E&7#F+vRa(q!aeC zsFf?y=GsJQA=El}LTJ;ZpHhv8m3c}&C2Amk=#J3kh*??plIw4wHf_~RDa-CiZ4I_Z z&*L4SBqbRuYF1ill-=gsQ(zxJHHKK~92!0=dQxstxsZ?_Q-BoTOrrYV(EOlG=;J$A z6Xt0lH&cbOpH0Q#S7#___=QjmGgD#KlIu#AmL(@JB@Vh9cwHnL1nY6PT_LyE<@t+U zK4!3;la!cDgK1t?m}y{M$x2poAtUATjxZkTB3D6a$Bxf(;v z;~J#<52HFwLAFwMBb6+ZU`I=pM3~P`;}eCE>xuXVV}W&Ly)J^fbjq&cHBd^A+Zqi# zb&V$ppI<&@ClQNJBTl_VrEv{`Av%!cq{2Z-2Fh%a-BL*KKB6somBe12!*wnaw^VU1 z66~Wg$wPx&!7qij=D=mjoTT{a);hp>Dp+7Nx##I^^Au|?nW=r&wZ0NsTXxpSDmNPo z-o_Gib1_{lt_nEX=ayb!nnGD{wsR>?w&A)B>qIdRA{n(&<;)0s+0$$TrIw5`9O<%j${iOgQ2#u5*CjlQB-6KxxMa$`q0YMP|&K zEj>u}-Xmwi>d^K)of!WBa94pT?CpxCO)g+f+#Z(Exq_E7K>kPOE1TfRLDN#CH1EII9CQqm$S9Wflaf~Hc!!D>T zbm@7YW_2IZOTL1n8;#U2xE(}9%Nuq(7f5L;ykV+QaKqG^%6aPuW%^X$LCXICB|_5g z5nx>!fs|c9YHta6e-*Eot$Pm79;pt{_;V_UQ^h$`*YI0>`MdDB&;oaadmv>vOnY6S|W8v6P*Wnodwym_u#m2~n^pT0qQ_2s)h( zu^p=25@PR}(CyQPt6VOapRd!o_?yQ*nM`GFvvp;)DA zj?Od_fEeCmkFyR<%7!JBnzX$9(*WiEY!B8b4)$Oa3As8IZ)lqrOXWikaaqJ_k}+Co zOKsF4mu4M(An096=PVGN?rq*ah9uYN`3(L2NP*g86V@<=T8BSLTF~#c)Dqf~E|T}P z<+j!)*={^749e40<@p^Po-x#`_47M1Rzh3O-1;WlNI6wMCo0=Ybr%;1TWd|Np&*+L zB0^NYUrom3W$fxbrgmZF>+E!e7DwIYyh5$(VG>}iuaMVIkrTU6p>+IFS08!CSN*wm z%r@0G@fw>a-w3A_N#UyxAOfUPW|RTg_g4?DUV>LIkz0L|!l&`IEvCiR>vK(k;#Vx- z1LqKvrgNPZGe&v0rDfTwQmX2lmSrq0P0JF4%g_{_qtC2NQtU@@7S!6rgo12o)r0}# zEUh5t*h`A@Hs*14Jp$rJuz%=Q@NeWAL}b=1k(gKft7~L`%)Ox1@DrdT7?xF|+@sb{ znwbOhFr7zqotb=E(;B9YR3!c6p(Fh0IfV)N>{Q(2{I8*%Ly8yr=R!2`zH36Lf7t#^i{3;X^(iB&f4s8YnxslaBU2!B*$iBwr&#x zxZ{Jl^EOYv4oO)%5a|>xBk2#@T~8Oj(qoR{3xALTs;P@{{XKX_cz?{ zjD&qdx5WVh$Zcx!B|o`vE(^?8j*bFa20Q4Uu~k(6HruFSVtFD(6J_!y4kCZ&J zFEN)EF6Db;O~{|-)QJ>$T3nyaW;^11PFKKCG23Sq0re6xz#X#6>j}Rv%C-O`sr`Q0yKt#VbICB+lBGmo&9{8r; z=*Kim$X=vq3PwGd_nuh4j-Tkld?|Sf*Y~lE@cS7~p8U;^?H~1FUJLR&;uw{{j73m6 zo|`~EYCr17JQgci&||XX+~4Wv0rVvQ0HX(j8pl(I927?mTz++hxbw}+yO~2&p(O_7 z=q-J&bc8%~ITl2DOeUJp=dDU0-umsVFF++?ww-|KBE{t&KK-Hi!5ncGQdn0E%KPE6 zKUu^4L^-A+XzHeO3sTQ@Et_~KpUqL*NDZXp%r_`>X$l^8{{UJz#;s=HP(FZwAZx z!wN7>@tUVnNki*Ol%Z_FARi8zMST*`vA{TU`A0I(KfbFceuDZBNaH0!8i!jG)>^{O zbDh}>>mevP_!2Ae~HDbAz>A=p>6s|Hbo?6n>;zxaz z6oY>hjKq-*X%O~3$C@wDuQiEUNm2q+EmKGr%`Q)I+jK3c+?#=vo8Bj2m25@Itc*DG zhtjx-r84LaFyI9$N!%S$q>=a?j9TeZ=2t1Wk^cY)c66vz>H?e3KSwLRqDj#p?e5z& zB|)va3v*K6sbCmW3R7@2ocyIdITG}kvzNe5tc7u7ekdS3+Y3i+7+DO8_gCUB0OH&v9Gp^F65 z-+jQ62r9jbeRSF-LG0INMQfrrD8@7GYJVv|6bcKn=J5p4*Z9LN~khw{Gt*Ip-_eZ<| z1bO^oE=VV^{AS`yzS6u&mc)22US>^UNT@9t0I~BULU!2i5uuAqe*#43X?cv+4wN#o z(hZHo+@gQVzwU{(NQ=#n9t&)-#Jaju)wHT2-{grapUsdHwM3_};;E$hh)nl?A=nf5 z`E z73fBCvD)E2GOSgnYPfmKucDDSDi_OV7L?t$Jj|oR{07^;LbJ4mN^gi& zI(;IZ3ymoVDN;qyr7uz5P4D@Gc;(U5hkLR&18W>R#1qJ?%Y8%4Hk2#^P@;l#xdU5k z5i{`$wqw}vyWJA6w59}MnoP9(x&mC4nHMAOxH6mkZ5`n_tCcs+4DmQ=UuHo(Lq5(P znq1_B0!btjhdh*H>5unS6bARNZzcmcFz zc-{lTT9KvUxUG8P1{B0WF zW%6ZT7(kHMHtAN!NWUuDvSx6H8%@`#ZM!b7`1cH`Ov#&S^ril}qMg@asL)tnSZ^#X z1ZDIi&uHva#yG_Dm05I@H8`Zbl-l5}Af2u^ygr9|~7!3U3b`tg%X9%*;Og!ld0#c>$%W_Z{n>6QQ(8azhl(7h|eLLSr9DRj0N3 zMY)#{;Mqz=!qc!BhU5-}7^}}0*QsHJnp{uqTZr&RJbIxd?Uu`mXtS3x9BnEfp-Jm- zI#`Z`L??-IB>0S+98SbCJV&U|aV&~LS5T*{tlwVku9ISQNx0vnA}Y29?2p~6aH?w9 zW}i5l*=+*9CFVN(VaU#eRg#;spJr(;6jKFBupFOtw5&R!NEv`O0>hz-o-;e-PQe69 z^->64+^YuGn2EaGyjRRBtgN=UG= z)(q3t6OdHPXW|AEPA;WS(_7QprCvg9_tb(@yu*h;37k~^v@DLH_>i6Y}~ z7;++HFpn~o@aj?9>WZU*L&&8jBrZgDKi!jRGI(}<6B7yzvoAK`TDl-O0#HwaZbq>) z8rY8~xP{{_IfB z9qM)hpw-@8c1^S?Q?^^Kg=n${Tb*nTg^jHh6WpH_Mm$Z$iY@_Y37NK=2o?jFoBC>D zm5IoET@|0&qqN-<94=8(3scKrI)?&4H%i5YtWRC`i#!;d2)QyQRI4~%cA)CZQtqoV zi5OzpDmefH?g@`(QyyK3U%c5U!H@1CmgG)@cQHK>I zt0ie$d#BWqubeSBA!=Z#y%!q+B(JBmmDl}P) z2Q1U8QLdf@p!J5hk7?@UFCPn} zoiyA#D~A!wmTVzDQA?XUnKl^on+kB93_{dDMx5n26^0#^bKQ9gLHLN1!_Q2FWR0We z2ecHeM})JL3L374eW6aFBx!Th5&=4VBhew7RBd%LIWg0r`|Q|Xi&`C zs5e4^7qXJ8XnhDVU&J~mV%%&nmlm3%IJ!0_36iL^r6n^89Jy(vgQC!-5HlUr00R9Z zH=T7ZF%EN63d4`LQj%I!*&{wu6qP5$5vSu6Svi()WWAE9CaA(5LAq9ueqtiMhfr(6 z1qRL3Ly>j3mWs0N1xh>$#S{GaT(q|2}QF10ELyZ@F)@ps7U)W zgEAazAs!&6G7*&*&Nhly69ar zp)(@R3y(Nhk+-jKnntL3^2JiqN!7PoHX!+pK^`{|)No_*1~jY7XQx->S*bFO3bH9H zDe+2@Q~v-AIbtYGwb{m>#Tsy_;YVC#n}y2ED>g-q6paFu2tFjjyiGjBX|fh${uNa4 zRKZ02yNoCu9Lla)^idG}W|-THM`wo|RI705(79)dKs#6zpMm|*N;V2qPV67r&69HzQPHr9c*O*yLRkl*T(~Ei0%XGXJS&k*jOOz(h}k=NN``o=4}G! zXlp?3qfSbypx{zYk=BIRXyX)&%v=I>Fq5ZcDi;LD4vE^!3v}jei-_tt#QGjz+7^z{ z%M`eFd)eN~b}*KXrYv2Wco;yVD4v&_K~K8B!aK+WWb-AZT@a&(Mo_Kf_xeXb z?#jxBK|KhBHUc)OOb)x5J41>>S~FAA?8*aS31?8Xeul+nSwN2d*jJ#;aNn*2umHg6WNdsVe!|@T;(*&9w{5#rn65$&Mf*nBW5<&dLbuPyr znJ74C+tOZj)UiBEBwq;--?e+)9Fm=};r^F(y1g27EmZ zV@{%EU9|!{j7nK7i7Ye`#(ZJbD;Sg-G#!%;LWCS=`?;!`QoI&jKK8W`Xh46+^2!ADM0w0=$U9SkAF?U)#(FE!J=a)8P+q~vgFI=}~J zUDPW@Zyf`oDX4s3@df}nGc;G*H$sAw=fC9~paNEJ*wvNMm(1-Q1HPA1?_0nI?7ii* z8$bt4s7$8D0Z2ql;S@ISIjf}J`WS7*>A6`-md)*`gn^2eGGz=HrA@@+SAQ@n5viBhDE(k_#!9blujYZY4rv`YY!sx6h*bg0 zdQlTQ8yMvQ(vfhq0#4ASvBqvCCpC<996BvXrunU`E{-0Zk>>Y?ghyHgaOYcEMZmlv zoiK$dNVpbI=wJhKNy6v6EMakH8QyFIq&|k(o0kiqFuO0z7LHIF%-xe{=ouZC3pWq} zw9v{dU;`4}C_YdH(YBuOhY(l_P4|M1rf@2lVp^;$>M!xMN1g>DL^y{Lud48Qw+S-O zyvgZh>G*>Xr^5CuA;tG2rXk?{Zk;r@oq5^D2pL9l+S6|W+ENYw09q>ZVR7mCmsmKc zzFT@6nR!-d?xEI|JjBCfDLIs*Vmc73r9+|ein(R4C-5w5Qm0K1L;OLJ#0?-$Fts?H z$W4X(yVtZh_?0i>R{W6;95crM01Ml*KmXE!><|eD)*dGrua*O#tzh{N2;(_N3Vv`) zdcr_uvGnTZ(~y&w!UV|KL`O_h1)nuwe7GlqlJ<7 zckFFT;?)J3w8cX_%h$}pK?ReTq$NZs5>2mr00D-jIvtEGb|-rY%1|8*^Br`7e3{mO zK=TSP%(FB+v7ytT_F%&@jW+Ajk2dm8c_H@+x_W{aZFhzqM$YI&MD2Uol~^^E;yNi) zGDgB>qToT)*eG3KuIF$8Jz;Q_jmc3CI7h}Az7J0|G{%2qSW|ON1z9gNy%Y$s)jsk~ zt`5=J!&0M>bY89ysIf6fY1u`GCEiChwSl72;J#~gH{5S~#Y~kFQ#gp2OKdoviwHuK z`l96iFv1)W*b=a2>1acu?n=!T+y_!ZTuC1>Zx|$wqEjNwa-73q)O=v&^Z`*;!GFpL zndOyPx22H6G`+VaUyjknj;1&Ga)#YS`GvZoOCHZIqCMr7^C)_1ZwX8E6vw)#!;B}# zGE;w1Ykm->B#Qhwm1?hwC)>b9DnU)Hxx6&T5TM{j zB$dI^)fsluS1zQ^)0NCsGlty>OrjAk`-rf(Q%UAI-U8$krHMOf3yf)5#>8(G7*y1}wIxJ_E?iB3 zIxMoMjr_^A?+Ql;FSE5^CZ#z}2U+R$+ zEsLM4cf844WNMWH+DIUaDKXATFWsv*qS;(+ zzRQhLMjbjFz-q+K;W8rGy-IsKltOF)bA!>B7cPfW!Gn|b)e zrOaiWsxl_)m?oiDmHNku$8!8;2JLWGO1AYcluR+7RQb+G)S?9I=Ggx+Fh zWnLF~N15Ld$7xWIp544y0<9ShFP~QQTjDeY7@* z7HVk*f++E}y3QkQ3T?35!!oj{oJdWq>uwa?L;w|GYb#rWyh=g`V+l)3P;s>MyYnjM z395Tcyr5K8Tx?wg+}J1*0Xho^P1+n>$8QyOs5m1VR~xK0Ca80DFQcZUUb5OPu*y&l zQk4L7Cg20E`d&JqoL7G1nzsqWei4oawfv>Q?x}ckaVyH>R|}I%zoeFW>gGDbn*|+O zJ>h7666pDeoO=!o?1K|j3QXWYNtR1$XkRtHy80`wop(KTiJyN$DCKacgp{5se6-0jR4ON=MvJPSC@@6Kfbn1$gJU|9zE*9HC zSRc|Q1tCf$MOL{nB0K!+^%|cqg^l-T%A<0D*WEc%#Uz)= zrtBMxr?4$Sij_IlGdC`7+lkbqkWy`McLa!q7r5UdL_ON)6uvw2(^v9YAG#!K^7;wq z*XnSe?L&&Du8}=9LFt`G_eVTWFQAsZ{-(0H*^6cqaXB~#lGh4Se`sx^QI06$_f@3i z@&3Am39&65kLA`enEwEgiR1qODNpf*RJ#Ib$nAR?O^<$a{%ZdKwmVWsb~OHq#&u(I zCY9>%@l+gHGG|uC>ETW`Y-pFQ{{SV&`p}IGaY*E= zgt*nyU>qK=kM*Gs42Kp|Gh744bpvH6i}<=f)`s2*4lJir{!KFz&i;|~-_2nE0Hq1= z7;8E*y@@dl=(jx?ye^Y}^5dQjbvvrU*SJ{j0mI^%T0le0)XIv1xl3zl8iEPmdwEAx zX?(!t()eM8=1>ae&Cg4#_{7-aT}Bz(PYdvCBfm7FeOLTp&kiC?Nx@hlgWqu5#I4WW z2Zs>VM#-Y^{##3hdY5Cq97O9frkR3V{{WD765;i8_s4WZ9D__uVCoHn@+e6n;^9iu z#yHeb&Dd7BiGw9Q$tM2*=AHilF&x(sG;IF>e!MX&`Y9&#@M%B2G2amhqZ_@XX!7FC zQ<8tOKhT8usO=g`?MW`*xlaTBQh(1e&lMfgYPs6U^nQ*_1J!r`07eq?1pv=#N`*w* zl-qt50RI4^9gOVbbZQPg*Cy0J$(QyMr};3gXA`j>h&an%N&2_cFZWQ9Z;*zkk@Oyl z5{HX;neX`-c>D+OhV{r@8OA%sbK|=E_VOTq2Z2{9~F<&}868SN6xt{jg{QIyidbzS#MHwmGB? zpYL>}?!UwRvCSuF1Yi&d%(H9nZ}!I;J4Zlp#S1z*a`@Z*u$mP{Q^Q6X-NLVhzkC`% z>oJ1q^5eXm$JGA-7&M?~L5w?0PKAUYoOX~M6yXYN)smTHTErGJ4lwNyinQ( zh8lYdLEW88I#>Wa1*4j%?OD~rlXTgMhgvSapq?TIOm8TuC!g!5fVZ@OoOyLWhANHu&3Et;fWECHKskEIWPl zE5eUn7)ugSDy`ii6*pxZ1FI9M4j>cY6r-o*6LUjSYshaC(#u>-_p(iflzWa}A^l;k zzFNjYaJFAYLq*z8i|2&cYHD?pX_fs;J~`E;#)oL1z~I*}Bu3(LX+>D!o*v9e%A#q- zDRmcbF*fN}dd_MaI@sx{^R#*%2x&$`H1#vFhS;2_Vg{+SVw6o!wCZ_=*6snAo9;lp zwGf>7mM&tkVtF|e&-lMC_DH?uQCZFC2*w{y+ozWPAv>hhTJG# zpuChRMd-%G$MCkB!Xm8;mojZ&mQwuHHIt}R>qq+_ksQg$Aq1Y8bE!YlN~KW( z{{SLwZ}TA6Y&k&QD|q;%80@-y1;m)2+}gzQwBY?c?H`$a)iQi?GBYRQ4gL|$J6R$R zpvCb7dp{DS?bd95aQykNfgkrDj>=MEp~QSZgQq!%8$T6W_r!ereFZ>mG5pmsue@5EMmJ*Tn z0aES&*my+G4#pN*VtSv#bHh6BAFETzKxT0g^B^1O?Z$0M(OVESxW8Dc<6@jkJ`!7& z{lp2ABSN2hs%2a^{;Xqbb5fa8oOpVhSf$YD_142uv$6^HdD~pe%wI#@)k#&xVQ>cV zqV{gqLE^V6uN&bRz8zE@rcVnz$Ezqgq9y|U(R;22Cw%dU- z2fdwoiXu{T%* zroae+lX284dmr)qIrIe!ywy@dqNb3s?!P54m2+EIwX`85Ugu&hXo$rjS45%xFNkJv z{PRhEkx&&6WPj4>;vB52Yc({LCC2{%WY`;OJcKbg>a_Y;^c_&Zac2zw z03|r8${a|_YKS&a1Q4~{TpNN7`o(@lM8wGjSgk#S=4rCC5~fW}&(wgI`zS+;3QAFJ zGT!#Kn#5)-Tyc>5b^~VP^m$11E}!EF0j%L4XpBe09B(U1uQ

>P@uTTTul83rGw) zkO2uJViRlMy%6}EdZPQHUKvv@lDjJ@RS9wXB+09omj%L+VS9osY)0c^G>QcqEbfLw z5Mb;r#rdXcid!$Z&>0?0(zKKuz=Lo_wbCqbCmo2{DUe6DO?pPPHA==5C&8MRbjZ%7 zAcf{=_X_W8f-V8E8*3H`QrwEmMd5ZSUL~eUPOA4?XgBx>q{!)(5mtx+#Ed|m%DCm{ zTtGBxs*^a=WjAasM$aG%D#}WZWU9i~(kDWGBz(~xOG_;84PxppJ(p{f%33DbB`G6E z5pM9Y79d}|3~@R*(EvMGc2A(v~Fd8TUwwh@Z@nmmiF({G? zhIqZM(wG6&OtzIxu2tE2rj##fmQ$}lH6ScoO?QW1;9@zH;`J?P!d1l!mfDBQt6i1cR6j zbhJ)`t%&kQE;l99M#J^B5?xA47Q5<8PHC^Cb1x+O4aM^%$}vo?F0HvwtSoYBv{rVX1mRhN@`;w28=tF1*${Jg}wua)- zTPzmrn;f)=zl8fn;{zZt-96V3Sz3^#B#hb{bsBsOG4AQ~9PyeToDbQ8a~71%VrlnP zoP(8XD&MAyv?=1!C&jW}(mOI?IumJ1WKgsBjqZOF5v+E_#XE%*IVELkS(eX25D9|7 z(xzbKw(E>eFw(+F<*$~DDLpnCM*!5t91@~p##GbtOsEmn0{;L4EJSk7mBWa8DXN<~ z^60Y;N*0_T1gP00ZT6xhrbvuQCBPmiVr)A)tTll#mG`-+1ZL zA>@L4qFfyh?1njS8&Vxi%(^O+R|=Bi(g!wJ?55pn*_V{uXHKMR4XEiCc31u>?DPzGD?!hp&M@-28x#1jjP2v=~W@+yw)F=aCdyk!>rzQsyTxVx->2jEbC{X&5szFRP zDAbq%X;Mza5gY+OfF+!k3g&y)AokOjcf@UfH#i9bTuf5>U9yd;%VT7fXubhgzf-BFBcf)QTUbf zjj{(~>Rn5U6{p253UTRFsnmc#ARyl2_SegJamvQ@lWTyu(OA!uP?b`ec`68~%U?j? z7Uo#k493U0G%;Po%VKsEN!&|=>AXTpAJBRiC}#z%?{9)E;& zXQ+spb?F&~L$d9-qOM(yl$7QwHrublDzd95!Imq6(556BN$4WFWTYtMs%=gcHV=I} zr0@RN;%80c-GBx&j{Gl|;_Vh*J8hj$Eg)pL#@wL zX-bxuD*AT|JR!e zOT-(&^TG3b_SN8tS%2~nh7nQ6A)Z75eZ)+t(TmgH;J-UqB>J*~vF>2kU?d=@Qzl7SiI4$wxqaJntEgX>iIfRDBC> z8!ha~RN^^zC!}YbOGP1p#5F&pXAZXsiyTqXh9>MR)Y2*PkG!pt+P^5Vff7Yh&^YB( z!8K=9Ci1q>W;SSPL73R`rN?Tr;fg2xCn;2!rhZKj( ziHRj~8aa}VCB*fy+7c*k_<)qly4&Of(OP-JWOW_>2n0|k=a^^&w&Kv>NYGtL?+`rB z@gFRy4#qY}EJKH6F;iuk)*5{WaI^#Yh=#K`@?*~(kk5&|i)q!6r>M*JM>RaV6(i)O zSbQxLG4Zv`VthYh0AsEd*LYs-=VeJ?e@xi~ThJ0jS;HcqA{3zFXyNQo{IL(pI;(@a zR8pb&5ejH-$+N(&HO^u~IVDhaPI6_#sVdc3LGNk?w%^7RLYp3mP8;FQE49vcU5TdF zG+7rvj-n*MVna8M`vp?xL0u(AReOY{+`_!v>ZRdjA{BcN_et~dgTmx7b5AP@+aL!#$R zU^-))ry(8W?*)Y#NUAEFLFv{zR&Y|b^EGzKX!osfBb7%)RNMjA_tBquMXkt#AG&L?As+)l6X&EO^G98)*dwJPJ`d)wh0l1xh5nLD_D+m+f= zs6_SBgJ4c#ZT?I)oTJE7gk)HD2<;I}#tkKCaVIxXf8i1##P=dkhU`7EHAZTQ3T;5% zC&w+7^TS5TId_Nkk(?;P^rLT$L@vZooqCeCP10^7wsMSIwKwG*5@%{`r+5yXHrz}5 zz;M->mdb7n0A)m?mM%4b12vhRkN_?%6B;OM96A@+5a7_-IY47VT$4N8K|pRIsh2|q z0hz_KIxMgZ0CJ}#lP)ZeccrwBP#Tg|RiRl`ay;NcXIf^gsbuCrzmx}T%TKSFlip3f zF~ho!oYKHi?CsFvqTtdy&Nr{BzaUkEUcTJqJ zF)>3@Z;%5BaTQ{D_GYQ-x>J9MgjEHKihW=_0#==4p=WV2Y)|w7UOO0Gkg$rU`#+p< z#*W#iJ0d3luon=CM$V^3xI)q0I{q--F;;4&v@1X%v1c7@rq7aRjvfSuq2$SDU%=o?O;k#W2z;7Ll4GeULng{hoq z>ZQP8%MuvbQP2cw03KPi0Bheg2Mw0=5aKv_T0(%xAOpoWj?vpNt$@AZw~ogaMug2* z2T9e%on;F1wy_T{2O0B7n~RK;IWe}K;IyNM>brx$58rsGpR!j%-ygK!Q~%R~O?SjR zPckb&d|&}#g5Le z;^tkL2yi3~MTsdS+q#^$x!w?Vh#QZ-hMlNBnmL$NI1nY(G7=t80A?x(?%1mNdgZnC zj-ou(hy-Dz&AF8T$40ag-l@U-H%6n<>a5AQ>r;&u-*?&;Ia7`M?T|a5C|O7cQZ67D zp&Tp~SAT|+NSvlEOuT{)hT%Ycl>=}=`T4?HvBer6+OKSEQ9E#6LPhpVX+P&)8}QNA z=u0oP-XfH`^CfFY((NODk;jP%)Wp=}(ZY4%aa6POl8PM1F8W}80bz^1rJyE6@&IK#x+!N7AiJH+2{ zv_Q{}_gv8ABuvCM+~bM~NdZY&P`A3EK(X*U=@oTkfh5F(bQ+_qq-JgQIqDufwFIdA zh(8GAmco-9>Rn-IX~xom;+=KHpbytN4~Fo>qCA+RpQ?mTGcK=vRP{QW?R6+NZ}Zw4 zYikxfw8ZiqEwrF{c0#t-D7Q!eR#9uKc3G7vB`b9+7Vs%i1~_zTFm&tAxlwsYC{NQU zN=XC)l=p5gxbZt)2l}JGu^?ZlvsagS#tAuW60V0`Nbw$U93t-xWtyecXQ~S!A^F9r zP7`6vWi|)E3zKsl)nL&nB&$qSSS>WP1oxzILiKS%ycIb|{ zs=X^ajS$PvHXBULl{wVr8N+QS+FiFml{t|MJJ?%G!?A@S4qJ>wl+*S6QB|FtXr)yb z5Zt@gBf3^lQjUZWbUNyoTa6(p*(x|()9qp$MO5Q&sF#;89y*X$Wmwi*wyjvGmqC zlc1zE94eDg;~hl)yum)1B5XMf$Vt|))jJn1U8;&-GVRmz^B5Of3g;AuigqYQ?g9;y zbGVB)A{__{wJLLm^UX`nlrJy~m7Hr?X}0<)rRWN+?<8ztZz05q)7eULQ8cRL%;M7A zyKSVprCTTk=SICX&1kCP{{Rz2%sU#q1+UZb))k(nSDZo>Pn%SXgxah*VrV#o0(QzR zxf&$;L@bJ#B0G{pvX&c|!PsEaCliupRr%K4LBHN5Di_qHL%fsrhOn0Hoht-OgqIIe z{J=j46fGJ|EAXPLBi!NQ%yB&-Pi}yP=8s9gt7WP{u|2k41`Z#Lx3zn|OVf8BfipVitZxtY>?)HxuS)xcWh3O#bP_TT# zAo$uJZiGC?G zZ`x^-66l+B9M_ead9VOd#jTxSWJx6I01$^d6r*K^;ocj|)3EX|=^0r1JjyFwMs~_n zZ{wJgf5IxInYVsq#gA$tmkE13BB@Q6ReE0}>6M(O%%t5s){uUw%Xr-(Nl>-Ydc>J= zuIX|RuxwYZD&cdqR^6z`^A{xWM8vX}s)FPk0oGJNu~JiVEvZPkwTxb4$e9twjlMcz zDJ)x!r)1|{afwOV%LPuR#Yj}#niP|+md>CL>ffwN#;tw!63Mf`d}ld!XEI5Xcd5%km z6?YQ5U%H!;E^eJcBwF2uTG{g(lrMBRJ(i}Nn3t;4rQPH`GW7E0-T)kq2MR)fHwMPU zixFr{r=%2YhkScAdfg>eTF^o&FG$v9rkg?v5*?Rugy%|5$y!hq@wfmOor+iJzfv|; zx2W9k&Y#R~O@aRaBNSJDX?z&A#)TegFr#R?r)5XcK)c*kVNJomk=6HX z>Lwz4iQG~A}&2<;tAQPQugV~8>v0Ixe^JPyIa9F(fJo~NDGnwn8=hOeKL}W(xhTq=8tDp08PY_S zebxuY6mpELQ=6DsZ=9UN%xeG{9K+;m%uT#W5SA2ZOiCt4-g!Fs5gdC0Mw^O2HZEnj z(*1oQHgsE1I7wK=tg2#EeM&v$tQ4dV8{2O^p^0TkR+cFyI2}}{L!mpC?yGu>X#&caIGmck52{jF_La*$$@{^z8+z%aD_UnL zLZZ5ap7p`=5#2`<96UEyWehsQXLG zz-#FZw_}Ntd$NDASDl!ZomjX|WFbn*4~?}N_0kxbI|Ck0CekUGcqvGIA+VEhRtW@j z9x=$fADc*lIQJDjjV2HU{hgf~ADK4lVq7*WGD*nnY1wDUZ6`1wDSIJSJ<@iu>j|cWvJiHG>^g<>C-Cqsya`g6Qi%#X_dBHD z%J8+h$FU!{Z`uxT2BlbA7)z>Rl)tN6YerXE{bZ<=n+^56I;J+^WZ&T@X2~pYuV<5~ zsrn+U>n)|kmlOApNKNfyVlI9Vna@HM2x?`TV0;@TfTUWd$Rn37*vbay)RWdT*(T=g zme7usM$Q?nvxwMI(W(@;T39|QQ9^-+;Vax!qeV_}noQDY)7-z(NKK*Cc>e%5cEjW? z8lGzWihf0wU~E+>j^&uBG_<(e>`Toyq^J-SQn6y5n3ogKl8@gRn=aBQSBWyqcNx@_J>)MUM~P9=H2gE=@F}yc*zWN^f;A2u$TLzy zsVzE@&O(la4LpA+v2yG}(_GF+8Y!Pk)9~FEMO??0*-$AthkWX8JntQs>-q?N z1SS=vP2i=~um&-OJ7m27ykfz$0HgR z-IDW!Ql_V0r!qC==XG8{00D+`I!tpKwuOCGbJ#el*&1^tvY&y73zx{7*XBfC*{yQ% zL08^sCKmZ2OJULMA1t9=l5|@tCtX1uZsf7I`LMLEBI5Tr+;C6PJVTUoYfdBl=yq## zH-DKSyDT8caYC|@{t0UT04x}Z#B99>AjD9Bv0a+Zx-ZUqO|dns5S%gLFFY1`{=f( zGC|XAQ|B6P5^WS2;Fyr%eP(60OH&C_CV8uE_Q=pWoqN4yZt6nYXpc>lOT5>LrH>4awog=Z!ZCRTb1rD17vclHHnAR(EQg zKFsSFVv#kf6(N;HCe|uQ%0cO47yi!XK;l^k@oo`&6-&(F>9q$c^kgk`*GBUas5fId{kFH zWaWjhIK{?4?^9K;NFlW%d2?a;1r&l3nUnzXh0ln(bR$@>;peI;kn+Zz5e{2}4Pu&v z-f55;_BQ6w@KCmQa)3#-tQJmh2(j?3{D@9eK0G($(^v(mYF%-hl?h6-Dw`l>FEkOA zx07-%MwhSwLdUEzDZWpiFXlZJ*or)R;}q6A#Lm@JpjON2Q)&PY(WqtHzyT0)bD~UH zY+a|UZT%<%rfJ^r*mdP&ezlsVigazCo$`&pW)TdzLpSA_RXOv;U0Txw3Zmc zlPR)h8goPIb|Nn=+C~=tvjXh;eSW63GRF@ueGzQ>kjE%ajaG zfue~GH86Zz3o1*gK9{z}JEnrp2Nw7zOUEy!UlcGU=FW^%86^z4;FT#_C4Z_%p@$(V z6D48^eVs8!1|@!!!V{)zm8-I=vedMVLYm5+_n5ptwE2nt9z&VIPws)Peeq4iEUBr4 zoQeej3kPdhs2ltuK28xm(ByM>ELRP23YCq8r5{3 zi6DI923$m#NKElPnThF|U0{oQG}>5r{{V`AKu?8~2D)z$vSFl1jO~_Nhu8*P2_JNR zQAd(HmN9112r$?NH^LXS^Xmahx2}aj5c(JP3=Cm6zKy0ZnkydS4vTQFWm5 z=bN!oR@(Gc(`}SACgR6f*l?K}UjskH!nY&$2snu+Oq+6y_)@U_Tr1i0+U=F}|+JuIzKQcbfdJ1WCSRAowzG)3kp$i@6i zd2-$6+tEO4t@hIK8;HrG-;pPWhNez_EMevQ8lfE%U$KnnGl;X7|`efpBC1_SddlahL5Mt|t%;4;<&kHE? z0C3e<9}-T|p7)u$oAU|1j>7S>gtaT~Q8i4lF3R<$rRwt%;D8=&E&=+Sno0yB>lve8VBlE_m@E-T(qygs8sT!!b3_^0_jLVCu^a>@DW z5^Ru*>hXwvbewY6?k0(R&h`fwx$4)VU4s645av!&tVI-9e2~ z;t=4sp1yG&L-9G-3U}G(+g<+vO4eVBbrBCX=#!6TN(8=EFBGko6k}BJVA%D9>!8wQ zRI?Rylsb^4od_`OGPTG=p<@Y+dm&-mWU~86T(rUaZLFtXO-JDtnE2MVWEt@2kC;QV z)mMZVg=%>FO+IQ})0J`9+RCAx(LaC56O*3gUfVgjL7WN_!$wvPuX9 z5p&SRlog^B-sORCpSLqLbfucpK`YP|qy+qRRg6DFMAyUE(vOZ17bh^&mmcX_b9}D| zVvyf)AG4hkh&}n1EbX*$3Mp62Xnru8pyoo3Aoenyq=LFzywr_yJA3*9l<(^TkWmin zSYo4s9w?b**>xoDw2+hNqAd!ugUiFd(bc>X5`;J%U~byd6{nHV{xH6wO{(Df+91ygWSHe>idg5d zl%_?$Nh@MtT!0ixPnC!<4p^F75@V4v8dd0ZtRm@VW?gG3HYF)Pz(iLS@Fb}}iI!5n zm5>$`()y)iDg0r#5ydfQPOcV+AcF{T6=LZX_NUv*truuUniXd!mF-}r`u-51B0bjE zNPI5c(rkPoe8h4V<*snf1U5KpJ1(Sj(gX)N_IlbnaharBL*7Jg3~`-DVJ)eRwuFi@ zl#&bw4kF)EYL0=`Vr!B$+5kIJRTSRW(i1>*-JD1f!>1BraG?1|QaEOPB54|H0s%V2 zyV9%7f>R3;Dy8R3-uTzV#}1u#XV8&iM!qlri^Noh<~zxS#f`OMLSGMsD{F{TXDIbw zhwRi*nEO;Qo_pSQ>GT$hQo331Q=GN`H9fiA@Je%YphMfwT7xF4>ms1 zQLVi75#2xGVjld_Wn3lgi%Q4HN*#45cdArUm3*^9vEm$gk>|rF$d%OmRVh9Kn{^}~ zG5lg=GbTcw1}NKoF6xpDOH#5Ug$8w?=++lwZZ>llC?R$=Mg_E6+B$GDW-p?kICUi^ z0yMmI4C{3((f~A{lg+4(0nU4wEG~AA0f+%X=VM9>~XziT@sEwni3|~korCCq_X~{H9i`oDQB;T`X(f~U^A@O4i<_5Z&4I5rM za1e690o+nu8tEN4YfB@&ZlXAjv$>Mu7I00}DXJ$jeo&TkHJx(VdCa9-xR)m{GKuoW{l+QW72%2J$r!JZ~?a@$hwy_I2m3w7}64;Cp{n>M)}AUGniLvxcOD@jRDoFRaLMjd&* zTpFG2Xi3UDQnVnWwTGN`gwU*&r#CDKPWFzSqD1gh5K7O>%wdYR{Hy9EIb7XR^8-fS zY!E;660K600at=%Kn**Fp#*Ua$bL!W<=<$27<4GHx@P zUBZ_kaeqbfnCUH#*ots78~1Mv{bEF8+|MCn!(jN`rKE6s-!5 zgVg^32uz09-(hoE#H~LwOlfa5N@&bFGk01GIXR&uj`heOr%`L{A&Celmt=0yE^#7a zVxLqa+Ib1eZf@p5VxxQaj_UC`#co`BcSMN0B(5o;y@($}vd$JOkN5P3t6{<5 zk)909^H6)MQuF){{{R?lQVox|kuSq0rB^ZnuP}rJi-MH6pcJEP-*ISCje)O4#iD>LG?Vj*;d zR9kV0gruRtWw)k>a7UQvV?dph?NJtSo)?q;FuQ*c%ILa|o1eP^ik8pM_O+s?{eMtI8+o2SVzOOfU3_B=Z!~E)CLB zP?Qi!8t<@9ky?&UCB+WCNs^lgYl+MhXD^ zFx!&vTTgmbwS(|ddica9wk9rPaP}Q$e-F=1ll=OfF~|ru(~`FwP4vCg6h?;D5yZlV z>V=A5?4e7dOv|MYD-hHbJvwroCDITBNwv;_Wkj3UjkSj>P;xTxyOhrvXPs88g)L;- z_iUp*?dG14`s5+=6&;^ZFH*&J56;KdUr6~z*5OeSfQ zEiW+Czy&r*sFt+lwi% z*o)|N=?yn*Um{iZdHPyaxo0QdT9rFWZAn7an7mueGiJH(D>(E}}&}-N{INz zmkGbsxRv)7J$=*UcZ&Hftd$YStlmm;UfO_MKE2Ushjc$yM@}*D+E)zW7ZoVbDUzC0 z>1^7{L(U&*M^5UH;)RDm1&yN5gwFLVV;M2+u~^-(si75YK;)&<$epG*$xekS_B{wY ziv)r?i$>cDym#hP?le|h; z_V}TlM?!(dN}p!x+srWEwbI{G1M;gUm-VQWp?F#98IJ7pvUxY7m84ILVvbD z)`LWX{{GOQrFMR=yneCNH~9Ymr3zS|bDD)j$7Ood`fu$CBgrHEcuQVlsKp`K3Vk5+ zCkk)TD8KqpjTO{TqNDaCnVeQ(IPfD-LIAhO z+`duWLRvDePM0C8uaG@1KPcv-hE}SyRHf%0suM~E^JX5+3H055QDzIObQ+L>?i+&KF6jp#|ev+A&Ov_S1 z#?~&A%s{=3wmR-3o+^DqL+mj%e05l+P6f8Yk&tC5xg&k_wy?~z)7Wuiu~K-QTd5-G zry*DCoA+EtUlrU^#LX1X)TbGBb8_L8kU4fB>wRypgeB+HEn}g+nH4wH-nLu#+fSS| zuEnU(zQQYNfim3FnbtBb4z^C=LfzAE!&p+ur;x26;l3VHUshu4gzuL@Z@|M(J3^K; zYvQZ`<15Q1@`85&rsrOl7TOfJrPLli#wjcVKKcN0YZm)KKkbD+DF=qm(>xxSa9m72 zyYJjOLOtv5&Uk)jPFu6I)1#T~4iANo;$bU^@(&NpH~gE`P2=2K>K-|h`^AYoOEi8s-k_Ki;Cid!;5CQbw5aU8jTy*TSO5;lfzy!SL z7emNOZcl==7athv+$gV{FuMN$W_8an^X{=XFUoRC%U3Pn9J7Fgl0DOMl0o%@Pe;h= zEd#R;Y^feMf5p`#qDrm+%8*sde%q9iER*7rP5MPnei_Gg$e)iT?8$$JsO?c!rW+Yb zoKvb#n$6Tlsn#LG9S_PydT~<=ny1obWBH@?38`mPH%4n%+sK>7yN8CPm-#56%Q|o3 z$Zx|AC)fKURK%R>OwBoF+@-AKQ)K(i5J*Y3wzmBt=fkJZ)Mgpnc@MS*#jWw@6V|K1 z9!i@_ECqd(TWxg*#@a%o4Id+t$*h;Xkg&>YbJMti!Q2Y=Nny}7(Xxo@Gb;Dm7|WWr z7aU|{?JHAf3se+TLK~8;F!g}hvO!U>`0Wf%T9?Rw8q&*Ns654TlP@&Vg3wAFX=7rN zoyVw(R;aR0${yl`n(+2KCFI$;$D45^`7iiI=MOtc6}h9iBs*|dUNqWuI$uv}cP@t8 z4LqWHo$c}>$}~ov%ML1bttl%~1iLKjjmxP<`A<|E-%hEutZ%*H=smaSG1Pv$Vqmr5 zDuk{gk{Q<9SteSr8JM{l@3|@3+UXrnuVa%#JAx&p@gP&_Ahnk|eGiX>NKVE{FWE|z zoJUrjsH603q%zU{ok{qg$}0G*oe9_=BlxR&KND%r59u3FKb%I4?GkkEM;_aV2*eWV z`^=BZ9$bKMdksJAl@vI36)8deww+8p9#7^eb2PhNOMMrO<(4|lBmChGN%9(dSs}YQ z*^Vnz)AyxG{8C~M80tQRoGRHRyIEo9=+a2UvPsV6KJ864uyR$^3##K>%__=9`<)`U zhs|!gl5#_9D$=8j>Rc1V>|+XIxsAR+c_fgR0<20GV{?7MI~{sO##}0EeoTcNnjNC; z=p1&W;~XwA3l>ukG((M>oQt)Vg$rwA<*15J?DnOkuzXU}Wo*h}s&t~?#5EA0wotX9 z3EeG&-AEu4YjhiUMbhE?GNM^^jaC5d5i4Aseon5_l9bukLRpmHSsm=BF!%#v zMc|xUR)oQ;+_f$Oa85&p0aXXzGjmfmKGx@WsXu1QHy{zMiHxrqnag8C!(yRr+IeeE z5}iX@sr53-eEEw5Pn=c3?pT%8$B9+qEMUzvsQ&=P(h}eg*0s&NBKL&LqjJAAY;CB# zJAa83I;JG2i&iN07iOi%x7IX(1FWd%N>q?dui`9k7SZA?g7KC4#|$$oO`T?~O&Me= zjR~fauxV-}JjmNbED$srS|`GGN1SVOgMw>HmzY$!Q4P(srd8^D$UdP!5#bzTkuRfw zSm^N=49LzX-QdV+?a2-`+)&rj{{R@kak22`(W1ijA|7__;mVzzq~cWQ&SvGNm0@J} zyQ)`GEPVEhFJ*BFy)WWJ<1uw31f~V9VVZ>95lQ;#iC3Fu$`)DzxrxeeY`sTF)kVKl zQMA1dhaB(%s#3UWd0pCzsBTVqHn|H*hbc=xX+_^_mtDP}Hh@RlZAi|N4#XWJn6cX&l(s7$v)e(* zdX^hP!*5g&qb}yfGYl^_Pb=F+Tv{*jW37=>Io{$=5P!vW37UmPpoy|j)8Ox(*;Kz( zTIBh|*)gtfp28tIrsh3l#98LTVhSs7Z3)tY~aV0FMpr9fWj?ld+1xlOILk$(PpNWTK-i>Pgt-3d}wuNRozGYTcrx+Qi&9 zldaPRRmv%ehLoKYkZd$ogj)8~poeivn8ekhJL4`e%JIgZEl8hjD1LfHN@>)Rudi)3 zvXVxHMK-C$HgHoXW(`JR$;KI5 zi9(KwQbp`_>+2Dh5St`;Z56S^>?XW9FCjdFtdne#p?#b}idFeVlm?iI!|xYn87enV zF$F;EMa98~ni7k0;df`;If?$8qR+6Bxp$eEmv|*17cn5R0NiwAPHih@D$DHlCNI~|7P z8bXUNKTbmxRW4>xvNKFrrh1y-+_bZGDYTu^2BT0!D(K}3ZX;J}k~HS<<$3Vzv*9bG z*AsKiP#;!@({&W7S`6f*c!+W$84d6+YivcrI-2F)a_VJe3t`nMO`97V0IfYm;&fs# z~X+nzLsI-O)$yL?G3Kk zkUFUWWRc?yPAXe5acvUkg1xw@oI^u$m6WB4l-LIonCs)JO}zDr+`Jv~B||wrX;ZA# zTMo;tINF86hghV^fxw>}mUSAFQ|8IuBRDa|AkIszt>LDqT6SfZS1@^qR8Ei+x4#XY z#}q+1C@(cnAG6s zZiLP#m3B^HA;#TF1u6i8ao}R5WT#~33qE~#zrr{83ym37IcrNVIdrFM0(BY@r|yf0 zNljS-QPRsPrPEu-bk)i^V5!CkNw>Q4d&p3~P@paO!%~PT5<`M`ulZv~VfAS80cqs* zORb!X2L1#_bBV>FmYAoh4`($KiO9Vb(jYWQInV(Qw$)MSf{eoO_Pdjx)(QOq!>*+8s_;0Xef@*H1g^7yL9*Wj=P= z5=iXI+_f+0^0gt-0;ShscHK^>Ao=^I*3+z6YgI*dk$b}VXE?_o*je^$M?`T=g$>kE zqMKRJlq_@#ur@KtOJlJ|53(l?CliS(wHd@IHkeWXRf)LYsoE*H>C*U?d?MVPoK-^( zgfRID<`58nSzCVy!0~T$U&Hbn38m=w?hcnZwbg>ISzmjwrX6`KXVR9gGKM>fiFK4jBi3ODbGpL$7yj{t;rx$lI5ws)?22JJPSDsD7b2 zPv>}y)$Bf<6AGI6oM|gg#9k<;9WIL)y9qYmH`W=D;yM)OiX*W{7^)L((~-<{1P`6G;g-5 zMqzvOjRrZ=DkmMp1~%-&iEtIvxnF2$Khm^P5B3U)`CcVQB4l>~uc2aT>^A=Z^J#~f zbthDkq>x9%Lb-|LOuig;&#K|PtW_FJ(>oQFD>xoKZwP2wWb44(bD{AC2`oI6Enm^7 zAIyOb(7P5GpNDkZXwgK=EjpDBsY<^vV}eLmj=L30m8t4u%VzgHwInG6(_$f7j!_Zu zX9{Z=0c6ZelG=ZzK?GaIz>*MBPE=maYX^v3r;w9N{|A<^&?oWo*U+gkjq?#zZ>>^rdN`r zI?hFXm82vndMFJdJK@KcVjtq}&NW;wnRMq2$_Bi(*()B3xCiA7%Ns+H$zu?43$&-X z6Npm|gJKnZ{dR`DKEu8sxRb3ETU(^-cwxkONb0#dne^Dl5~Hn(x+CE&;#6xfXmcVnoPSSgC+eux}G1kun7FG;~&+!XHeJD4MEf@S(Z@Fh?I0COr|T-i@p;0QTnDYa!Jk>?x(tdtZT6`h&6Xh|-YiMvK_$SbNRb`TqdH4cMcvOsdP(N7b8oLYCrLx+zHL1)+LQ zSd^?`l>>Ig$A+3h91hros8AedQiWT@7;VOm+0JG`#3%rzYtWmBO$Ck|gz}{mbze>Y z0E~1j?=doo(R7=_k~?QwTAmg&X?ROVQxlabH2&mUQ5w5je+nU<*Tbc7sdeL7QES zcTiBKW~P7~=`gNm4PJWKHZjmQ^nEw^$7tcC;ug<&Cgevb>DrO1bBB0X z!mQ!bE~V(`9LJ@S4q+UiHJt=)9AIgswF3dubq$dVNJBHB;xsVgXAX-~An6NI5*g)Q zI>0+g%p<8-8!6HpTL62)z{a&&IbdMs+Bv9AAOF>Z*nX$~f zO3f`P{TU%hJ}FmN;4_+EEs~Sc07kk{n||m?(*unpTEnNz#||(GdPhzLNn1+poT>yL zlyC_RjvZeX@cUK3o75>NLlf2)FH0!dw{+OHbXK0}zHKcXqm)PHolA%b@C1{6Bcexz zo*p80nu)nb*_(01q?VgngRLm^$^i-hYNK!f)*n#V?FlI=XSS(rE@7sUjn+svJ6Rxm z*6STnu?$1v{t49T>?&c2mZp$^Rgtu)C;`^MAI=jjOliRD_IKj+zXWNOxhL6Mvvn}a z8NHIyLPEln;=S!NTqP+t@evMjvAZKi3$0XIueVW@{{WDryjC)%!C!b-3s{STr(44^ zR<|5XwGJrb)Zvv%R|AElu2q?~nNZPcK}&0H=R&I!?^)RxQokF}qN5%t$cy43p$DeV#ElNN@H`yp8*l!3rKNxCt z6IAXZn@U&=2)Mc>? z3YS-YPH7g`?5m~q(1W2D(k_ z5#6rI&*MB%gcP+TyDYb799R|tU4&_{-zW*b#Ya;SUm{Z6!NIIRo*>pMGD}WG&rJty zeUJ&gynCy^z{783DFeiM(r}`%+fJcQxk-|)Nz68#R0>%rO0DLCmlJzkI>V6M7|?Lq zs8htL*A=*t{H0<-!!ipTRH{s%9Nx}^JFcG2 zsX>TeggyyQ#GKk3CQdwx3WD}C%DkVc*FMVxc4S23p zy9?7q9Ksc)aVrbAPMcOo7^%rgp}}HQfE_3{(@>u8Qf+(1gH*`l^N(@N#u?$XolaPU zP19DEl1AZD?v(W(XaGn)Fyvuu<6>RB2TSd1B8)>${%<@1`bJGEy4+Y#>6!^TC?4@m zfK*Gzk>c6%7?gExK@KV5I-d^evW-;!wVv`?oJvYi;!c1n-~_lfQf_@>d~#}{JB1EQ z6@<-TOhnJxGql0*1drVcoVPm_vA@{&86yf+9+pDGQxjaJvQ=P(sjR_FsGYfh*b#Gn zkqe2(sS>eDnQRmcAt{M#gBHs#Bc`0G2j$4`rD4FJR&S+%$_2I1#&08Q@Rlic8=lp4 zr&CE{roaVl{{S_2OOV{b2@3cf4%#bt?j|N^hx`hWMH04Xvm|q6=8%AsvYSGdtva82 zBukLeECaMBDz`sDq9VbCzwNJqu$PoZVSfNrbUF<;i0f-(v~6(Hhq7|6vx!`5{xP2B zx>icGL#w(*Tjjn?qTp@o5#0I?=_BtAFdDdZ#5bw3u9e8Ga}&vC+A>y*wz;`CB-^E< zvX-P3MsC`eoj4iFT~Wr1%{Q42AR8R2UwDr&1?~93jvBV^4pcdqFOD(=G~`Y^7bi5E z$L&v%lFXs~@vR{2j>|bM9MyBd&VeL~gXvW)IDONv);y!MtVr+2x3e90T87id~ z>nRHpxo%Let|>z&-U(7b_l1b-q*uvU>U2IB+m1B(3O}~g+Yceeo|H*dhCoycvhE&) zfGyX3p|ufCWm985Fvv|zNEU*ClbOzJK?SRV0&Z_`1*~-Qi$}y=c@>%}$F@U^_*rK- znV3;mc!1hL7u4VDIz-=kT?lU*6i;@7!t}I^voihk#&H1dn1E+6ehR>dsc>bj*|2Hd_<6@7XuPsS4RS=}aSjyQ@8(MPvCGV7`Z zZnoG7H?Z#u^zjk z1-9I}>kM zSB%8yHYDi`F*WUoWCfHh3Q13OK|_4I0wbOyXLO`_963!<(z$dYuyr8Z0(@hSEAARm zy;#ByhLY33Ehr+v1H*2D4;7u#C+6_|E^1*apIXDAAO&;-pf)3KNJg`|MZB&Qq97$o zm`Z>*8I*J*uJD~_be+S8>8nlKd9@*42IKKCIapN(Mh}vGIX$d3;Btfb6$nd_)P&7{ z0ZCHO9QNSyiM4`2KP=GOW1>!+WMtgRq^Ur4*dIf9;$SMKTEkU_%3KR+ekEV?)ONyz zJmv(Wjb-N0M}Y_P%wvvTVvTuxDNk&S>lu2V_b_S!MvOUznOa;ZT9loA`+oTDqm(L} z#*HC)OL;0#-%dZ0o0`1O9cK_gHTYNo8!Ap zkF0N)d_e*YL8RlJGBZ{g8zr;%Ngsq7gGrSb^Gv08N$70`qnb?@F+yF_FazNQg&e2q z2z1`}jy4o>W~CUM_kcF@jtVh-9FgwWct8e4ODR1>bVUVsoAjRRgzWaA!r$zY59_nGU?a-?F&K~sWV2Hu}fsFm1~gSPxtYM zlN)CWQOV3HH!nLVGCwNfTxgWu%1OAmAc8!N;zT4jByi_ujZNnraXA*XsYN!h1xDln z;o%Nli3UPx>LZDIU1bYN1te|=g$bg}J3V&SNafRU74M=`GzviS&O5)_)&(09_9mwp z9K*FLAGOtznW}rMLIaHuN;8`Ug#`@;oYKtpA0aWk^4?ip-WaP#S?$X`2am%5y6 zZ>Uad+pe(Uhhv(D_p{e;XK>1yred@$)HXsJoEbvf8Vfj^Cga4Dc#kd>OP0)EyjL;p zsN-ZwiTM}uIVV$`T-==dYYLWeE?Dxpn+HbO4WiG7j+*jRK+nC`#NEWW0$&u!s!pKL zdRnXrC9ahaY#c?hpPiyk zH>x6JsfrHDoK2XgU^nDv?x$$gBPvbD=+~$l17JzD;hdQ5jz)Bi4%0jeR~2at&r^s^ zLQx^cjfpD*T(%e2!$S(gEi6t*>O@@QZX%e)SXP5xnrTfvCo~$GLWPK0PEu`QU~PSE zXt%`w05r%MwpKOxqPlS9QdVwIkE~i&2-m&_WSi^Z7INl5vUl-660yYUEiShzq4kMd zPPRxSD0{`Z=><$74!DVN%+SxJ3{1$-`kChwMi#DS-0+qtB~6^ zdn3;KGcGzk=Ia!{ky63@;n=^_QvHRGZ<$}C@iepJq|0agp$ zqM52x7I7q`$`H!iN)Il2oZun(W%O_lc(hKbUw6XMzr!^(@iUoYq-OX-J5sPf2Z);owiF&odVj8w2ZoiQF!IC6*#3lB>10OQnqX%BhWK=xx(oc^Hw>%geoXS z26AQ3b;*~Mq2db2j^xi=#H?f*?IXe@P@Sq#C9I}URam7Ff6%yc%`lzGDK=i_z#XFN zg5o?y@FQl$MR!u3BE%al1SvkFSh8d|7Vp@57lb`KOuupTB6Wd%v-ey`@gYP02+8|n zA1N<`FE~kbCT(dlSeehEswn2j)Pk5=Z(s=*3Ite!4}lS#$0r#kyOZRt6%)st8;E-@ z;#p+4`sNv6rBV;6Cdz0Va{IuGq<2WU@#`C$Tvv#b^)s0;=^T7DimF^C#IjYKK-hkj zSZNPDfSnsobCqJ?0H#%C8xdrkO^iD>H55)h+uRnG;+7vcmYPzjsWt+`jgp}Bxzj?D zK>!=x$4;>tFQD^XN~P>`h+d~+Nm_D=G!BgYlx*XLY$WRgv_@EQo}K*#m&({uGKDNdlNN)J;e3YmLP(cCEs+w7Z-Z*XDA ztviEugo_y8+Fg2VW@=@}Qt}Ed-E-{`>wAxsTH~GWK%UzVa1$IxT-1efVJMwbO}#HN zNaebe4K>pGcwWR1c8RV!?k{K2k<_&E7%Y8>-=oj}05ou?mJkAy)TCPD%Si53wtaG80vsR=^*1TWpO=nl8o#%DhZrP?kbmc{i$A5Bv6OEe5? zE|;m(?>LzU+(<_$#Hi#MfJj;vk^nik=wpynwmBzfC$)bIWpHg;jZ~9tHpIhjNVo;; z7LlEzNxtBaI_cIW;gJ?-Q}8mTma$7{S+jN8Pc2v2zb$r^e-o60VXeACAIjhh()|LtKkK?Bjyd#F^R#C8aokB^q&=#)k^)3M{3=VV+#~nN_#22QAI^+{9ibbsogYt4;~2p-IdX778;1eGZxt5aQ^N z${6FG0CrlJJs|ga%0*G;%B*#5{`wD=zCJs~n*_BaSItoXTMDMQQg<6fXt*>~L1 zV~N_DOH~wIX$m7_XlZ3}0B#3-9C9|GqTG%sGZ12S+VpMhILT7Iun>L9Cln~ zGcs=(`D6>YhSEs@Zc0i{o?yaSQ|2u;hvS1k-2$cJcM~mDX>yYTMHLi;-_H4M@`!mj zE95&I#f4Gvbe1V-JuI|3g$vyZ3jB;!@Ckn%J$&4Iy~z!*p>1l`|%wGvq65>!OqC z;};O*Lwv~l{m#4=nJJmaR(`doN(k4aK;oSuRu#E%6#25!vMYVTjQf=`(IO6Z>A^{M zUPiuzU)d%QUa&stHYdZ+ShnEuUc?;n5;QzQnmUz!OO77!ksZc!}l*)xH~QXaY4@&@A6?1GGu$LlwDX zG~8h+NT^HAftFUU?yE~TFa^jbYdALZ8VzEPjEigFTJY|f+3f{`{{WQ~l(>auTSO@; zwf5Ix7@j9>%})&a4MqWSVM5ai3s|r!9c(NP!>3rSCXW*84bu_LaD=3In?$@zahZ{e zj&zw$Jjg1Xq>!8UT(#}#Vk1MtOF>tfI*tbfJ1t1?-5kXbwQq6=KZ!Pr31rknQK9+7 z7=?;bIW1Tng@~|-`fPUSLa{KJ2G=(6umGKOfy6Zs9!goxI%4D{BJ4E0$EdJ6Z5)%( zjxWT^nxRtDMV3QJ*(m}unP;ilYY5Ud6swqrW9bH&mK7#e!nRsUeqtZTDq=bvc73~si?@7yA97y3C`1gw*k$I^GO|z!z zK2bLgKBE$1dkNu1$SDu3_m+hVTX3PR;(j<*=WJyI;s+ zJgm>Mrkpxv1tfg5glPgqH!)4dZDwWG+`mAfn0kxHDvpdsHtfYp#JQbIe5a1Q#AX`) z&FvkqA~rDW-B!a{l*vrnV_*SGmi?O$eg->XLn|-s7dV}JsC-nS;$jk~11eV8$hXe$#IUq2WHMt;5Yw^4L_XRb zNg6C%i+Y0*r-3o}=4gnRtFklF1ge!a%TD~YB&>YyNc>_Pur=mLj%56XRJEe-0t__q*y@c9%4EMaQ8D<0Nj>v z695VcI+wDl#AtLT64BFkxc4ytj*uV_BqCtzq&OfYi%PIJ5Fj>E=sU+i-nVpsZVYe& zCO|#3bmbbeG_^~2hTaj&IYuTXOJ+L33fgsKv!RA%8yrkiF;PqQ5Ys}_GCe1qH@1<% zOySJY8=Aev;c8SOtU*<{e=RwCqw|NBMuwg=#_jGLO;Od&r#z;V4%(6U-W>5$<}~rO z$aU~{Xv|T=MI|#yRKr86K)t`S3tmh^^F-+3pKl6vTPss{WoK};Ab$vYIh;uHz@$z5 zDaG1mEJ!Uno1X4LOO9TyPF^vu4^IU;`Ud%h^x?jr0kE4}<`8 zC6$#WJ9roX^qpC4D=UWL1C}gBK`*CM9Xe^Y=DI)!S+gAg954Z{9<*@fnGpC!upP5H zDhVdW05ZB#=!CPUFjJcXz*rM|LrwzhYcZz|#Zc#AMGC$2xz;1k7~+x1!vL{BPQSQn zeuS`AprrYN59J6^XzO-5(zAK}d?Dl@*_(KwHxQ$TB0{I_M+C#BoSgW{vL#RoWseGMbNdPXRAc3klw>VEMv~wqD zZHqSD4g2329f!Z8G7-dVS>k6ZWih)V7gq=3f zt7!^M;m~2*2yrupM_$Ra4S)!G{UERo_$nGgp5SOA<9I+H|JJXD-OK3@lg{UQd?B?P zkO)aT+rl_>!1XEiv{HUB1qM{A)^0!^LIb8osO~&MQboxC3-vleEbBTG_+ZjpQ!lE{ zAlYDRW8radeh?g^OW7q*b$FFPaC~@A#W^k+w=&$szqK_sg43ufuq~a%vYV5A`glh` zj~Ifj{DYfrdQGHENh!q^knqfs6T40)OV|(z(&JGM#aM2tVO8zskDsLo-zg@tFA zvy&34xYQv{1SttSWL9re5)sZ~ql7MDj2BgGRi~Sqk}4ri@|?<%VsjJ}l^sADYpg0X zgzSX37&}nUV(Hb(;r0_vr8k+j(9p=Y(sa)08Fw2Z-Oy}qb%ah#Zc?*14*NJ&IHf1_ zgv7+GiwZwhT_H+y#Dt{XAbz#45au&u-GDHJj|1lntvwQznylhEDN>Pe($#QzceY(O zx&E|P<#s;-jqP{DG|wWRNN6NAOK3Bp&7IxcH`su57SqhaF)9}=#{;r1J(#E7R(Wa- z&KtC~5<-QFR*UKZ)hYnnUXaHT3*rFUlFwn8dtxhgoETeLzq!Z(9Bc}#i4*@c+a==PC%V>4K zbyroqp$O|9Of;6!b)Z=slq7kR*X6Iq9Eg@}JGX z?@6Lq<>xIaa1n4vmex9N3gjlNSXAhUo|JV0+{V$|SpbxqTK@nDdJ?8HIN4bILYMyc z&HX4*X<3!5xXNr2hZFrPcGxd$$M_!tyIrCN7N$-a9uXj4U2jhv$R2lyDsC)!#>%h8TsoZKxnE+>Vic zpkDnAx3n=hZ9|b`kwxOv#WHyk4mHd|>g~!ljM;sfS#1tc0><|!CfW^5GVygBQxZ6N zGt{msJejua)ZCQ9*j?|LD9g5|tB}(5N{|M&O2NK>Sb$>7E*-6NBF7mN>T?k>RrrfYsAomK}A$|0by~dp(5}ocMsC2kn#JXl4VaA)Pt(F~ePPoFF zQj(=BQ)L67ze__5Ea&1(V@0dV3V$d+EM^w_mrv;m#g2q%M&RqT6g1>84|Zt7n7!9m zDKj+9fmm#|n*r1VrT+kgEMc4m`yb29sG?S3^{fk@a9ACUuN}G&DXHCx+fG!tr(IYe ztszZ=m#7-==dYx9P?`r5_Ex1xG_~@cmrG;?D7xCz3EJQb$1Lp|xEF+Unq<7qJ!wO# znF-}Qrp9C`7dE*YD`T`PP?|Z<_HUN5QmKc+P^`#6T2hp#pRz5XyeCoGHL5+9W$RCU zW0O4PpLt6{i9aagkWsZS*tj8KGY>5ZJ1Dr7AAk|fLbRAMhh({IG}ks+*@x}#*o4?@ zd~f+ds3^-Pzk-9c(?r95iLoGMac>gdE7soS=jI7q?grS+c5SCXnD;G`T>o zfoTf;!U{WPD)IPyZ42fQ>U+g#gN8%!wS zOyVTV*s*lm{q~MI1p>}FaT}y64MC*nw~gk%qZwe-c7R?to^W@UfA{r{SWtzjPp)NU zOBW^*bR#u>K(S7cSgJF%iA=c4gxFs8);VE7xrrWk{md2=U|nU$HBztfjvX{tRPiy( z6-KF@L#JJ1hff)h&$=UkWJOtEY+wNDn{nVs(8ms(uv~E2SB`w=v#sjtxVMU$bI(ZmmG;Ri>05%m)QaYFbDkX|HB)|q@q6LHiX%`fea!dekH&^88 za{cY+h_m&M3ZpZ19Eq$X#Ls;o8+EX} z2P{rMg%C*>vG9dz1EV2?@}v{{qq>Bg%FPXO;DjX#S3sa4ago6zg>baKD8v-m8nb1& zC*KHpO%R3TJK0uHzfqxy3RJc^Lie->WSWl&)Tzp9l|M>XcspR18wB@4(|e!V01qJ! z$0eL`A_`Kb7m>u2E5M6F?#?1&_I|5WxR94{o3jcsuBVuStE@Jp9_@iP0PXRIVUxJr z;n+~%-Yiu33sIPqX-aj5oG5lx#S(=9xkZhVegqhhr$Y`S{{UOz9vAIJEUEeviIS>i z%(-BY5~X}Xb-z%45h*1t{-kHy=tHz(3`5!4ZFIVeLHR;^(vvq^3m82;LjA3i)4zZ>Rjk=S&D1RCTd+BRKu#Ud9l&Fxxmm95)_jfaTkWOPsJ?MC0buH zUSgXvw#|qk#(~U|l?$aw(2zigyhksX{sm9uPtFpoGeD;&!cmX&1YMhn7Ty(*T$r)5l&YMMqHy|=m z;1?!jB^p3liv?~H*-^?C4YL7z0!D|%!X+iK9kYjtQ#puc*^-eYJf*F&kaq{vjkShy zj=;5!1K_s!bx3MOChG~ihfP#PaDDdAuUMa@nlzK2GH55UF-Y|$byao2#q z%3`cVL`Z6}EZVcQ01eKx1=Q2t?a3bEi8)QQF`@Qf8sPNHm*iG)m^CY0%6_j;`*ifp zO#ro!g&-XY0xhS&+()9vZTyUsm5PifiK)TCH!$X9xU9++B#WEqNIwXX87^Zoh&)Kd zl2|Vh%GRk*C33YUiYFRP(gF8ZnKl}qcw8NNn1?v1yYKg7s$BM3mxYj-5(hFqkJn+t^jwu4O~kJ>nO#g}|0O)VB3+A>aG4ALINl5L?A^6tw#9!LRd z89*e4zEyKYit@e5t&=#z!1w0-$0!;xWKY%^Q| zape=em6t@R^%2Cz(Mnk2gZzxF&B+6FH1dKEib=Xoo>q;PvXf0RTlPi8qLE#vx=oTD zT&nfiGXm(pkXW!AYZZKKJXkbM!7VJXUN3Q~gTwlqw4}<{&qIlLslA&}=tfhR5J(^q z8L03wd!ohXNbYvf#W;5xV3umD2$;;ExhIk=q^&#ZQb-*ZlWX}!&kYwALCn)cf0)M7 zeV}j^KCaxmD4n5CwJkWpQ`}QCAUAzSx~&OFDzUs+RWb|YEAXEZrg%p}nPs#tt%c@L z^9l-G-={i3No0e5V<7vsN^Cm8Tb#1Ecm&_E5!4Gt?O)wtPK^i? zAo>&tNFP7*S)OrTIgjTZKu&HUc6*kr&If4VG!;mds5-(@0#Z~Emx6ZFUSQv-jzyhf z=Nj-vPYln!L~71B)Tnj0GK8q8ASitG5qXBPE<_BUg^W%MroD{n64c!1b@IvG7qL=D zmilvBENr{i}Gq-7`R(=>&bnSI2vv?vRQTTn{Up`q8zScAEUJVY;lkv9zb39ix{ z5qE*Lz=lGRFEZLDrHHV~7A{gUoieK6ZLo^T?pQ=h;{H8Xaa^>MGxI8ZNG&U2YbsNT zDLQw_C*^34v7zfOZ;Tj`JWb)FHLHDWvZZFhwaQcoO2y8gSeuxI9i(yc8EiLG6yr&$ z<{(H_TLg{6Q;Et)reHLQ186t*Mmshu5+CJtH8)v8MB`uqsztejVs1Cz#u1MvLB@!E z!TAnv59_H=_a0>YKv(gJ7BxB!q3+1ey%)yz(+ z72n+d0PR&XSg5;(>aJ%Fl{+fp)S{%S_fvN_)2Q26XC@omb~B;n?I(l*#Iy329J=K< zn%;x{LS=Q+rOHO;$Id74%9qS%BPl}_Nf~E0vXV$KYDHw1;F+1n7=Ct@DxxRpk0PZa zFR3W^(l)inffu(}i=G$HsQxKe$he*h@hy%s;rV)-Ru3cuOg1lcI+0}!YREDg%%SF12q{`ZhvE*g zXT#0K+9G6%WpPhW&GuoRc2q6d>^QeO=~{_)L=$Z79YILyke#Dfh4_m4l=&8hFq~1A ztMGEC^z^#ZQ=nB632{Q~yo2@~Z!xhKwxdI+izsp;NMLxAz)F5Jr@M)8iB+2K&(lq> zED!XJ9`1JhfF(Uig|;M|eUEr~D9qhAn1rk@oK~Px2t389Bx~h(to6~s#Fn^smMZ;r6MvB^C+@8_Nh9MA#ZcR1J5LdDk7O#4YHbb~ zT-M5^sZA(fbd;#u(7`-vT+S)cU>GyE9S<2xpiQVtslYBqVgc*+VxvC=Yw(k?=I%&( z6x_BTWIrb2UTH$%N&Xwga#)-lGRaQPxk;AvjxB+WKNM&V%reFyl1Ws}ElMu7Kctsk zgQ@Yj9rTTL8yLIba#qEE5gR>OtV>iWuGAP9quBX~d@IOvzGx z*AR8G$ByyFtV-Bz=saJpc5+fAs_0cpiY%6=!93>2M7n@hRd2iizl1=|fk>N=Ee>`x z?SDtA)0Uc3yw{eV=(5JAp}Iw(h~T03lE$lmG)M70In~c3huv{ySJzOZW3A$R2$LSv zwlJG6xc1DXpIbzz5u}LSh`Vk`Ni?~6X40oDQ@QJ=`9xY{#oUV7T68Cz;|?iYqw2`1 zl1df5m-ct*dqb@aBH}PE9Xv?EhMuxoo|PmaL*8m-gWVwcl-Q7UN!}`WmA}N9iP0eV zM~ep*u-)GQGYLwYc^l<*zUs!lW8`BS#bV}-795pKY_QcaRJWXIUu9Y!AryLOxVsR% zK*TGmz9m{eR*eq3n6bkOBhA^nh3SZ;jLJH0Z_+LCsvu3+)bR_nYjRU=QeYOqO_n?X}fi=2x=)i&>Wcxe(IIvdw#GmboJ6HJP2 zINzDwxVR?%14w1Ug=?}!c17T^!jk5pHb0y^0n`l#;$n}B&CwPZAWm1@wvk6BStN7s z5yuU-O`+I{Wp;Mc!mGk_a#*5NSyJyLxotbAy1hoeaeKngQlh^yt;aQ0MtGMp>O=UYOqk51IG|#oM4e<( z#$0Bt@cOR%EHH_=X4k7kl&k_Tber4ZXq%4;lH6ufXl!fTRFvYCRkxCbu<}xnSy(z) z>T_5Kl^l9G4QsMiwv?qZs_A^c0+SM`iDYD?RvN5KzS9c@)*Vt-j-tmy=zOBW2!$bA zjj$@QN3@dPW-IOG*KznmbGX~6|ol)E#uUPx~Y;cv!5HkzO;gwn@DD*D6Uk~ zH##jkTwkHwYJFmdh{d3?$15ZoqoInKIwhnaF=q{_c-6Ah?7MCQ;)I{f7*sfy0G1@k zIm9l&^0Nw4^l6tER;QLiNe%O%2JX~o|?otVNaICnB}4*V(!iL+!1#q zlxJ8SZW6FO``Y}XEb+8RgzROGF@B8aB4sLVV?veO7?0tmKC)1-rs6?1KZG+VQ2b|N zku@uI-Wwb?ky0c5_kazgI+r!Ipa80t&F+{0G^C=`Z_@Aq(|IP^jUWT8+4hEVtKLZ7 z02|4~a>*C#3lh#!CKY|mbVZwJc)%8R8JjKI@x!)u5cXY0&(eS)3+^&++<}b2Trh!0<{NjypPg zE_g0VVaJf`Fx4dP^Srb3n`j>FPfh03C5Suz=O++iKbPaS?+fuBR zf_ycC!0fR;9Dw1|M9szeKycUrF2DhnrL;SS05BS>lDeos0;Zo?69ZW3+c#XA2WSG! zA=|)k*#k5HX}rlAzy?`&iZnYwbnGMr2;tM5?rYeMBaI!iK49;>HG@c5%b%ljPIlB# zuP(5M1Ga2P%PAu%MR(cNamV5Vx6Wl2z4PLUTaMwpmEkNb%Zc8B3Lh2 z?vu82>U5M(prr56!X*njod~vRtCMgYz=kx?t2=Ij=-L%RY}k|r)>H`Tkw`2a=_2vg zg3OFhDTQV#Cfy;ng{BPsO_{{l=z2s}JciP*B3@W2hGiQTnVwF9^O~c7SmKCT(vzKj znyjuSPbSrAtNZ=c& zaG==02KpcKj@TQBSXyjAFtdg>=D7zc+oW|m64Ba3>Qo`y5^F8M>4BU8>l`|6vTqI} zjM~YbI&eBb5!41^FAk(7n2R96q~)Lg*RK?|S8rH+o+&EtOU^RVW!dFAgWq#GR(}rZ z(LV?dnk%1mKmv6e>l_2ZaZ26*4whf)YhC%}SIeg~v3EK3^ps9wzBW#Ce@n=8~q_BBI?LBq0dwCbN- ziUPJ{=NbajURqCy8gpv(O$;c|3H#shOl^L7nc?27Vvm~Xkp{I1_RmP(63no2Gaxx%< z?KXCO!_7IDxxf4n!-(p1NPf#$m9}dLpj2*Y^))54t&39v{Fjh)AxSzBa1;%V;f#^m z`wEP=EgOb)iHYYbGOrT1<(y_+PFlgz%G8|Tbne(I%tdBclOV^-9nQ5zln*$Pwwx(S z(ljJEZKuG)DO((|x~>6B#FAx{D(=yJoFor$0uqvZ1&klv4x`&kn{la$WCLV2g%XeNvZUnP^HZ1(vqTlA?F(2(Q18q0OOU z6ry#ydbF5J0p|yTG(t%oE}(7WV-6uKQAo^;K~kAvL-aOm-(z$ITzOdA))&-IBqi~@ z+GMdU6_k*9%({f@w=Fr!t<-e#yefo_eLir_&6!bbt|eOeBx@Z^OGG{6wh0*Bg-T1O zF_S`GEeqYmDP=1{ZLVSgx22+g51&IKX2qzBSPr@{^UI@6C4SBnuVi^*!u%lOud={1Bgo@?TpxdcA*mG0MaBOrsr0hq>aS|Tm5p-qjqs8YWC*`RX z*94_TiXTMBFodRJO-LlEyXCnGN>#R_uSjNFj;*&Jz7y1(;=skT_EHr%<1ez6`^j%2 z(130Fqo<5DDD)kSh{=I*Jmws!)0Ty$GfdK-VCMrb)l3xSR+?xAwz$y3UOU+DiCc@D zbHr5Q#mUU2g*Pz7?7czMW(7Q}A+n&aGOdWx(AS5gcf_&I;k@hA{vp)lUKUAiVfIf# z+ocNA%qScA!dmn>p)ArhU&_kmu+L+L+#{wk~~RHmj=ok3&U@is~mnEVM!`| zP06Wt(%3_zGOlcpP?MJD#Y!N2x<^=(QdbB)ia32xm6aELH5E)HI`@Kkw@9`1uq1fe z(2h)BLC@_gBQJ+IV$`g%0vcK+7Jv=)TS!uly-JCN!w33nSOaWn(e}qoNTT!jzyNJbGk}=B7?$|sr zRz0Mp$_IHRYJ5wOO2K5^ZHs0(h3}N@sDxn2rS2~zZ525p_q3#?K&8YI6qRT}8-h9* zx`VP4RBM;tqrQo$WtQG;K}cG61a*#1DqAs8bX&h-ZaUBLHOJ)V5-i(fzP&r{TmY~D z8A%4p8(agtQs=^vE)#5G_;(=x01olfGU{zfWmOlLu?IyV#VI6{`l<)U#_-OYJE+f& zDcq+QPHEDGE!o^c_lWj%n|WZHBqOyfNgZ4iA5<+ z+o&0d+S&nqbZx@LY81GOjPFpWxK9^OeS7}jH7x4#r3G^C=Seml&~l+CPNRKcg@)Th zy2VFs&RpgnW#-5&lG>6-RH%{<$i&_bG{$o>o$6Gyza=P@4GZZ{!pe)9Az5cVf*4vw zMWwAv4D%XA$vIQ?O0d66>lOS|Nw`?b_K2n~y^AqSflx}O<|t?iI{;=9kWZ!I{9nR^ z&zQKt47G_c_9mLnOU+iE_IE~>aifa#T~`DL30T=+l+bw1ep1i*0S%+3YqmW*+VIIb>)C zET{l_KnFoMJX^eOBbESvC7DL>leQ1?aiO-6z_T-SL?r422W%ONT6zc$nyQj*BTf7u z0}s*Q^neVBl2SEE)NKLNVX4)$Y^~#`O@-Orw2mA!W)Weg@zbJyYGF-_jo>$FlFH6|iKmpXjBS_)HeVIJT0FeM3$=WE?^zx31 z8;5U4di{N`)y8rsGHjAt3!9A&v_(`#wbFv490dHxSRZ*q2j< zObw8&KpsbU4p6J7&I7yx8Zu0@mkwb78|)ha038{L2I{QXjYM?d&El#`<+7liQlPXb zbR%LTwgm6sHytJG3^7H-N)4=N#OjJd6r1YPqq+t99d(X2E+fgsZqFEJj+EzVvVcm@ zOQ}z>FhY(}y9IzV4DH+kt@7UD60+#rb;U7)?6ujpwZSY{?4?lw#wVnlLo;lpN@)%u zNm_H21m(T7@q;H6q_*aEIH+H7Z-zL3h_X{t&ktpum7Fr_bvHVbU{svLPP&WO`9d)9 zjscSbWEQOO;-kVzu>NHwAl<39u3OFaNhd&jQeyuA2N1Guwq;&iI(d>7LyHvNDaZ;= zFli;wpR1b$Br5wWOu0z-gBIB4rL!Q;G)Am(z-qS#-)^@;nD&`eD?4wn2~&2|X9F-E zw;~|Pq^;kj2_(;jDy|@CjS5k zkqD$FQnOh&&3IB>rKuU3Tb3tbm0fRZTpz*-OG(76DdHm(3iO3bDH&ZH!EvZMTts}W zdZFxUpUku@6~WU;5g4!QRGOy+Zx2!Iv!P3qr?u^$RV?UD>7V(iDyJ@xT?@{K* z*qlhe#7A(1hFiB-3TBwTxqmpF)8;nB2WCl?wMeby*)G!*eiIhFFCRa?!nzM<_emL0 zeqGLlG=BjLf5Y<|$;{y4`id#|;|xtWq@+70%1V?#7bqzL=S@z7&q(JP4N-pvFNc*$ z7m}nEqL12G@i%tUuxgwE~}JQ!eD1Kwd!QzOMQWZ)=O~;}!Gc;J5m9CoTq0 zXX;1h>GfIK%!V1AX!~TG<83IALCD(f2^I#xY)?x>Ec{}WU*=22!#K2EM`@-xI2Ls( z{{RGlf3s-DN!$6C%aIqU9A>F-lMG?{t5$YaVF;9(Wmd7U?yM3Gw9t(q4i>>k?Na#R zNTtt9NXp5%Dw>j=aHJ5X(!DN7Cg}=0Wz(&ML&<_$zQggzxeDBMgbq5VP6-vHqHb?hvwOFm%|8ZU@av-Sl4qfBx)1@ zAnCkrFy>hn%%sa5EK6|v6E6=!tC`!uK-`UPZimmoemLp@lEJ0-* znI&l$y98BdBooP+W}4i!LSHrWKPtX!Gb3MhV?rz}q>--hhH`|>E|rM5aa5_-C~SLu zElwa*Dd+^OrRLJ+WQ?lQymc1Z3!yYIc*_;jv34S*yF{0IO+57GY1G+BaaRNbb8&sP z^n}UT!dTX8^E^PMPD;;rpJrX$t{o56=s^Gtblw|hY=`_Q;8cX|CR-BBwCv2Zw9}1L z8DteYlmm1+k#Tg7wh2y}-WnBUrPp|q!@5NvRNHx%R3ud>gdxQ9xkM4mDbH|6o}j{2 z*rrr36S&m8Yga{PRYi%3V3x(mB}hohm62;)fn^I?{;_q5=}X9gJ=nbAwLLTmIc!GS zb4^H0CHK%TnR4zb${=lIok_Nr-X^ED`jI-&`rAk}tR-D?64*shkCY-r`MCTAMCL zXP4K&YIgF5WaxDtNSIfHZPPGwxOrXR^qYE{*mdRZnrqL(GGfPeYBZDNDgd=_5qz{@9ZiN10+YN}9OC zjHjxOcctXiS!Vi+All%KH9oO368aEwiVo2HKwb={rdCuHPEHbpB{nA8ZK?T0$2};G z2wN(z7x30}(;Ba|3$pI1NO*vAGV)HLcDMlUo7+y2Up3USgXl}Vcf`rswjaY4IZVc< zO>Jo)3zfFrwY9Yt(CHD}ex!uOe+#e#&m7l3U8RvNFqaZjF5oIds9J36MEUD&4ZMsY z%Shr@L9As@o!~AjE-;lc?6djMk`2-??)QPegf1?{QE20|Gdy|2lJ%UKD%f&ihu%%W zE=w(3w+cYo*BP!XJYn2wgh`MuwAKz7VzlvRS!s(t$rrIhqcGRwXt7(22yO`R30yI+ zNmTB6XmBCWEvgi3chVD*HibdcEUvXu{{WL_uOkyvfp-m7ihZr7^$fVZLz#`nQ+th5 z)J9W};Z}Ip_m?JIaQS>U7o^nMmOMG=Lwe9E5WlK(N0%=A+(jL zq^sUa$9yR^(LkSsHz#LMu;70ZBq(#@yDE-UozmR&o@~mKQ;NBmYX0=HmTtS{`)Rn`&5H9QKmO~^i`)I2}h3|uBxlV=2W=rvaUj>S@9dQoF4uazVZ z5I`T8g;F2T56{68e4G}@52Z0=$R3JVv~@f(Vrj^c@AX?G>ZLlkY3&19zMNa|rl zady<;-1LOQc)o&EiN+IYgrE{uj~i+<>!fJ7Ji3)Kvpg$tlI-8wne2BoX%$qG^{(5! z(Q9Z@pa6>}5*lRInwJAJYXNPmaCRaXV~9hwfhp3?=Sx6b=sZ6dMv;1luL{$fkw7{n zFtjGfo!c*rGFW<^Wo4WSnRH|zDK`Vei<4-XiFF#84*NcKPFEHZC+5PEl^ctN3y(4_ z6Ffy8V>%lYeV}_fxxgyjKDQ`t!rVq{17xoHjczP=5yh2ASCs|3DYoJWR086RYs)dvQJr0qa;-Fk` z^0Ov6tfq@KG@-rh2bmE@@Y^n9lVPHvuxD0YS6yOcBh+ScH*53iBa+_dNS}=nq*r%r z3^6go+MI?ZmfO0Q00(iQ2KO3>w8YB%yAliNS$;X;gsxD4>XIIpRqv6|H9^XL(7Jtk zM7OxbnL8wKE=v_DRVk-J<`{6cxpiDEm89#KU$0AzL|1V$(ur7AveKKBMJ=#|3jw90 zC7Jau@uN}4GZ=vOnh0sunig6&uEEdp*KjZ1n7!%1CsQG_r;7 zV{k^sEMds6o7}ZN3h{D7ja1P!Dncd@0DY36R2AX?=z3@(WJt_v@%35W3}Sg)OD}OR zGNjATAa%dGy>11*8$@m+7Nk9jbXrXsu8QolZ?JH7rq(dJwAixF+ zg$0V+We*@I5v}6Khsfeb$pp$N?Ri6`VJgwQvU00+Ae52#*!*K#f!u7T%&Cn25~0i2 zQay?EsPsaJ3iJZz@hFZuRBCkf0m~A$mNp6nH}t$WBq=J4;`)Ik`=gq@RI5lsKj|;zR6d!Ai~zxpk8A2I^=i+sumt4k=iN6M=)cn^C~d zgD&!rMujQ>k3y9QJ)All!JqAakF#~~qP<>jj= z4obR*5=NFH{{Vq85^y9&Ltn&x4Ab${x|^L~DBDF?g#+*+AkP<4TrzYZU3;>vPY>pp zr92*Fe?*|GkB@uth^`Efq`D2vvxY%sii%*xW}%ihe+KIfnMUa8o!2rXB=?WdmX(v?9)pI<7$}F~g~yvicqx zh~d-8c~ai#(gTT|1l05HFC3v}z;HTj403?VrUj#bV{%8F2nSf<+Brp25(hPny8i&Z zqrA>?71Z2bHdwI`%f>jSDkbqVPHTNPggCKUg-dQVRc`4}P(B9mile;5)a4BZ;EmyS za)$D^f*GGA*k9uhMG)s=M`c>5h}JH~8R!sn8=lx7)8 zv9PfN&$?mtPnN?j*FDP<;a6@-ePyJ#G5y`8?G7t$p<1Ma=@Jx(l7$;hJdk0QV3d%4 zP#ijpEQkQSBM`-D>^l3dHpfI^gJ`k4^shlV1%XM09=@F%h z$CS*>&`LEi)rx~ysgb9KM0dkEsKHaGB4lct!es-hLMCROseJ*`Beg@PJ-o~vVIXwV zHXIpDcEAZaP@|!>;7AV2q=Q<=XaGxTbZ@M14ov6N8xx`H02ySQDAxKwfax#mMd4=v zLxlqW0EBfqIBuow0*0a&Vrb5ppkuajjpm;NXi_+Jo0tj^<(xcKb9eyR2JrMmFwnDy z|In}Cn?!FPt`m$*8b}CCg5ofSb+&kUoAj^coPvZ)|AC=GTJ~$HY0t2`NPUYH;mpB z^3_FsX(%Urw%7BHHaAo%YE4R484S%lnIjMCga)n;$>XHccpqzL0EMm-chGsE*%|2Dd6ed{nCQ;E~ zXy2%~Hy%*PvrVd^@eM+Lrp1C0FvNod?~${a;yeZP>3eMnlA%e9yf-}L?8L%{ynsqC z)ftnR{I3kOEizWTMB|BZJ0mGap%*`#Bo(WjQgkF=y{3`H&+o84M&(wO^oA{`ys>pl)25Jv_f&a#i1XBo_(GHDa))+j zmxrn>PAcJ%nYG(nWy^+S^kKi=h%$ za=4YkSv+qbu3{3y=uizhfD)vwUg@|8MI9C66S#ct42hQ(q(k~#6oW(ta+q7n@mBq~$IZ_X|P$+k( zODb(n9J-JR+s5!QE0NNd#T2Ug5Q=LrlkDY}rkwyKLplmjn{-ZHE+LsA)X5Enu>*CE zBQ3nSA7#0w4xamDA#JMte$etFA~jJYu4F!vsHR7Xl@+UE^U3+J>S9vlC5v9p6L~Rh zAdZr{{4EAovB(SBZUmj9*Rj13w2oz2*;&~_qhu|GJ~@Puwp`Xwwfq5w9QuxF6N#$| z1u|{1-hH&qKJgyu%QS>0+Z_T`ZvbPqCWRga#I4{O3YRi$eWskJ6TOo-UBAgIKkb3N z&ZK4S0?f`f;pH+?MFrQw*2qZEsLLrp@4t0Ac=UzidxVz7VbUl0$tfU$m1R;$)hZi< z7ce8UdP@+@;Q6NNGHWfrEOVrSM%v{zwZYhkCa;;)=(`LPS$3&Krc`CX_U8)c3rF-$ z^Ua-P_0$gS&9AwNNvdS{?nDmOy`7sN;~X^K^EHwuWxxqjOHaMru+$y(HyVq?-WNAU zF`6An1mcr4fVAoeyjjVSkzzmG~Mnag-@g8AQnBt>Pm))!~7)ZZW^47bbLSSMI3Y|&nm0DMp_cdtc zW=J+EO4?KO)hQY13_bh#dc;H;q1L8bqQv2hf|kRi3AW>oDK$+adDUxSz}9E zXl^Q`Exm_>w029S( z!aRYrS&=NXF2I*l^@N^|DEz`A7ZcE#gloG-52G>FVa}iNE59kWggcA)QQ31BJ(aNg zSceZ{X?2o0b+^=Qq18qzy`wED6S!E|@?%a13X=|rU#OZ!S&4a+5S69SJ>sA*zJ}V7 z8UFwua>3#d*b@^YiH$uiG=!$DD3R@w_Oet4oaRoqO1DtG(yQrcb6s)~rpC(_;MPOS zLqLTD<^CCSwfNr!W=_v z=1Wr%Qde~MZ@dkFsF%ZRx2Eu$1AY2iZKt|5j#vq5h8PCxNCx`eIL@5uITW%x+D8tC znMXv30LEE%-tLeAiE`_{cVsnjx}6Lk)d955mImw!fpJzxV@=$VRw z!e3H?Pu(ybI}G5KS{f34f8dT#7*~c&vVxo53IR(>X-;UgfJAf+*BT4%3pn$yp_O<*2D2E5B!sCq2d$t3xWvnICruy&Ba&%%cn+G+ z$$*6v5=a{e07E9BFb$kVhx_@*PJsOCPzY22BP%7zl$5jY5u^u11f#R`cLy;9i|>2> z_zsT5o+@R~0`8O6;tDu+{h_x-(szIjWy~SH%m8S=H<%oz06D(eud<^68tSV&&gS9( z5|ydc&YeY!0*=-es`3@daam2SlhDEdUbRpQ-%%VDM#Dv=C?1i)M|mwU_^<=z037M6 zR#9}A0McPa8W`cjqKVw5(a|(^*_aD}DBoq`*4uRv#?A@4^q`(tzMw}e?FM#~+lUBR zup1ttIbw$^2JtSxg~}V0nh&9?jE@y4gs(yYxH(AacubXwOq-kn$U7QrT}GS^S0%zpF1pO~NhkD;xB5)IGbeHli5p%T z92c}2Y_2P%CDN3?F0qm3mYacbaBP1*ktP#yV-k~U(c-JEq|h~{Lb=h@v=l#eFO zfGP65#AvvFGyGnqR$Lv1YlggOsqk)f%6&z$^sVwtO1pK~Y)Sz+V?&Q8p;b6~j^;Ap z4KIw6>aJjyQ=i^?O?Gc7>H>0rJhiu+I^nCA@)9F>L)xbi_H&x{3FNKmWU9_fJXE5O z*zW;v3q@}c!mPVJnKKr50^&F;+G7v#u_^jF;@s7NRJ(wr-}O$Q{Njpy6UV#UA^&otN(q2e$ zwFMxX0zWShe2iTtQ?*A+o>kHSGRh?DrnyyNzerkPM*je3tPGwm3Ce8Z36?`{48#ki zWZeW@9Y>~-5?QHy$r$l!ey5oI66eHk%5hM%-XH%}1o+=W0Owzg;6 zZPbx#IGbk!Q=mF|!XphV?yC`9xY3?Ql;?{{KQJNwpEIm(J1tBkQ*je#thAEHswR>A zVKL^uBD<1f`=m0NnUq(G8vKMvj`4pHth~tQ#u{jGj6CZu6ig~jun0Ly2v>1IT@Cv5 zv`%sTh`PUW!?Ot3NhsVm`$y_R_C-N@g z_QLuP8^@ex%Iw$Ujf|yNf;4KCdAvlX5+|EMK~PFYYwT6sxg(*xM0`u+NLY}H?Rag1 zr|saFa}@P4GK~rP zTTz`>MY~R!mQxe$Cw^O<)VLFH3XrRBdjfQhv^I-p>}!kDP@bqaHc*vJs#&Ba-PNfq zcWe#yDNW7%;f#)j#ETqi;*}2);)-=Ks&XVMQgtg$DJ`W5R#n?^xFfxkR z`vbM0*!>^1TlQAoVfo%UXDDZQLfun^^mcJAC81HGO{14qlD=iM>MoTn2qhy?zrE+u z5n`y|R{sFK?-HF-sVRM#kd-{9RMH?a+_FROT*F4TL_jrGWLBz$8_lrWe8d&lQAt+X+$MKmq&GEAALG$y_7Z) zIyuuz>PD6(nAvcPit`lAT}Y%%x~Jr1r^*<;$w*nqH#-5+A=ouf?7 zVCUNfxq0Uum00(RA0a^`-o$Hk=q+;$so%_zLO-$=0-uz}63omrrk5?5ZY6pUHoxK_ z6XeAg7skHVbRG|+%QmAkI+WNngpvURskr>&CO#d=RI*WAJ(~EE)-bG1wBk8o>7}@o z+eD@Ng(q{TduX2=BuP$*HQDd9+_wk$m}d~BY_TaaC5BqhrdLDxbPYeY=^ zGkc-zd3qf_)Yw8>6v@{oDS$Y+q{uj>BGy<{)0=I2elZsmsnaA)SgfeJe#6+Y+M^$6ECD&$(sFs$B?RUetDNd+Sn?m- zfR5-$I_qPnTf}(rDq9k~3OQYrIDY39>SmDW;#4x!>-n7 zA-SP?g#qD|9gG>Pydwn2HiS!k5>hqQ&0*Rx+3q_HhIcrO#2(z633 ztE(BZsO*wXY`W@`Z46fNI69(cESIw+R|xSHN3z{nIByWCPf(`Z%ON&NbCjZcs8+qv z=$l4MjNw*Y(%lx=a_KD$RV64A{?PM@OJH96+<8WK!KblfuE^_H#V+waY!-nO%kbd4$ZDD@(fi~9BUzRjU zgR$G=M+KF`r_qb>xI@&(Q<`R4enSVby8nl%B(e9tEZydHwe=zk!uoSuQof~e9747Lv{Vq8eGeiiFuaA+rCv>#2?`g zaBi8*`=Y;ib=gM~@d8XtFv1eq_d?fVM~_&ud_++X!EBKDH~XJeDU>NyMYhoLSU>2P zZShN?-v_zVmF$^`_*XP1aIHlObq4&EJW-zAGzkadW1cdXFwtCzD}cLGHCpCS@ufX% zO|+Xm^<2it`^L&$$DN_MeFdY7UhGeV_^uT{Mszlp2~rlpN&r4%CB?lVoox%!nIn5M zVd?G+s8H(9hd1_Db7s!pfxgNeMTe9%Kg8@;Buvazgk-U-sg<8)4>GT^w1p4E5eZG9 z6l&9OY^@EHwJd;ypa75n76Z^iWo+tn3BOo`N)D5hz;T4A$u(DHOuUe!C=fva=zU^V zJi2#7a*m>u`$TX^_Ho3r*rrJqrMT!1gxk58>Ow#oeB(`rH;Rgx6fhi03_Qf$pj zs4ce;3RF6RG=(%I?n~j7yrFTV8bE`ctoZdi!%4JL>8m2>IgYo#kpx5Vhfyt&H-!8w zt#*a0HuUCWEEE>&i&sE)7rZWW(5&QRsK1^a;Mq(cBGkOHQj{ei3jwdl2&A77+b72w zL{;tTq$don;1ZQ3NjBJp4M&7Z;c{wY8KXmCfiW{!mW@NGB-!al!%EX!t_-JN3)`$) zY3JsO=IDO7qb6z%OVk=4&MD6!^pUwh(ZTUaI$U1SMZ`kUWy8v!#AkTxKBP{|I?*M$ zms5Z2-|>pK8Z9EutvMn|p>6F8QKPNdrA24y36iyJpBR1!ZcL6Hp{bwWY4p%ou~Ug~ zH+_SMPGtDnbIjbWVWWFLl!>W_mVyT(3Tp_S-aySmxy?{PKBqm3qUg9dO z=L73Q6VsAaB=wU~mrlq0Vo(Y}K4#`4=Etp2_Bm-RGX`-ApTzkF>J;Y#jW_|?#2%o7 zv5cP;jl-FDhE{gnZ!A?wQ8_bJE3vd7QM!d%6pkHvQXB;*P(_cSi7;a_MOJa9j;;t} z7HXEuB{V}%k>I1;Q3Bf^TSkWzwIa77raiScQq03ok8)u*2gO5w;|>WH952KP!4r>4 zJZ&oX*D`fERrb^54&z8}c(sm3dQI7BpqJCD* zRZyERP!iz-OZQ2?o#8Rhq~x(#SQs}JR=X(T049>8r3%RNV3L)h`sfG*jl@|(SGfXF zt&3d8ij(866?S%>bERzaQKg7lJJ#1@q&+RfEs06lQxpFHDsbeg%C4lg607*9Lm6H> z9Wvhptdb5Q#wl8&dOU%64xL8+tqLcgF*gbtkxP7el$XU=oz`CgP1?rb9ZB;BHhdgz zD5K&Y=M`O=C4xh;ZWdR#DIgDs35!W#LnS z@wkshR&2;o>A1x}QKrCr`_hwlLc#Dt^5ysw5u9v!GlgBlkKy-uQ;jW$dS1jIFr?fc zoHo@8v#&tn9b*NMsaJ}d`-)L0`Cmv&Rw~IOgu7D6&E;;Y(xu$nn1tOQ8xmo+1GY$6 zcVuyMA;y%4n^4e;ZSjWcj*K@D`!-TBl1h@;W#h8Y5|e*BCKQ;Kh&hb=HdkG>B5+tC21_>|?Pe46NY< z<*3V%Z|MADr;dC3Gy&*Iz!Bprsfa7L)YKcyS-T>*7FOmJGIhJaU& z(1CPqa`|F70Y6E$@BnlrNE*N?0-2nrcn;anOv1?X5x_8txk9XWf{t0%6+UWmsu4o0 z<2=$_+7u>(%F3_DNaTQ1QOmUT=0b=aMfCYYZCJF$)760Lb@zldLzZ%jyu*0u!+C%e z03M&CH&8)Jz&9O4bvhE&kqW!QH#vqpb~98(KC5fJpTn=u~9T)Zm$8I0K9FnEqK4GERpAhQ{FE z!&rJbh_b^&r74N5a;zyNZx2U5ax}1ZHYTw;W&79D#vhJLBg-2`^o}fUY-?zBOl`pL z2T?FCA=ETsT(DerfYDtrDBi+3M-C-QmbM8}bxd)ihOC-OhOhy;_i$bSGs>*4#6SX# zs$-J_Pyq9e(b_o^*mc&s$rm0_QPYylxdy}$02z;StZ)s6rivgrM^(4;z;Mdk&`Gg? z?VTpbRCMSMG8L$f0fn-p7y#dG!egLk3kO309KT`+US!7r>@fCGWk3O4N>>0H4@rf= zKxnF8Byxb!T!|{om`gx(WSuhVvcz-_shb4AcFlnLNY)Djz@bnbGYqlQhCoCBV|A?X zmaOV@aVI1>f+Nom;+T_}lgeyjBaIIxXs$#ZjB3Vmd4;2(bCR>0NZ=T! zC6zKQeW0MTW>p0M4zM6QOrqPvsR=N;)sB!fa>KF;1*53wWuiMmY}{arLe3khxa$fy zY$3v!P#Ywg{^=;y!W8J7z;X zhf#Zr^#I2x?U+NwCjBFTb|$1;lxdfgQI+tlfhz?=DY49vs(i1!2To$#zLCHM2KKr2 zj+|!e4kbIlBy#w9#022^f~Qf>m30bf_HS(MELlmuwmm`UM0UiqCTZ9i+VUTmlbV-i zU8fd?(E7?&u3Z`33B z!UBa%rXHA6uIdTYTooJsQAs#yWazsPcnVci zss%fl@3$VJTi1ciUersn?}tnpZ79XuqHU@2A?*8LJg!lAzXI zmZeIm(hAhj&UDa$x5^OEqBu^XVT@litKLSfOIA^B++$&X8z`Ftv@N@d&ZldK)V3UV z5VX+CH#SrjRCHI=gn~SPARBeOakI2MtkaOx)SVDKpJ{Em6@m?j2v01iq-$ksYv~-T ze>8Ic08!Ias$^>P^|)?8ep^36rKB%kiflTVS`zsS%Dk7f6(IE%BiCqC5^)sEQuFzW z6jm4vhc(I)H6Zl4I{3gG&Z22;RHfeL0Hk+&z6A#3Q42y@6+1w1skz1zQDJFfU=)Dj z^g^y|5aH+)Y>=xG2^+=F3!b(r^Wo}63^QJGQNqjVQ%)geD`|Qu3hE8|9l`1>V)-(q zqAqdggzsT$t9Y`60$fXp_O>_dm@`UN7ONF6n_<`jRo92m2p%}484yByN6O&;sO4ShL(}`(dl+H9; zb0dtK?lcNW1P>T~GuY!o1G7a*D#f&-4gR4>Q0kS71tgAy5vY!3dkTWwlzeZl%usO- z9-5O^^OUJfmhFCGAA2g2e6oUX($|QQ-43%_sl(LZ#H%s7NH+1v|f z7TWeE(cN|xLnX)hGnA}7Q<(?4?A%FSQ6EVL3))uWPBwp!kAxb_&q&Fv}H`wY{SPbuD>@_6I za=f((o?34*7O=eH*I&Qmt+weEPmCoj1T3RasKFv0Z)jMUuJv&m)aSQ&{#qG5$) z0{!HtErs=QLvn_#f1+2*^4uOeL%>Q=*bAnDNDbc-B3$kQPe zN|LoqOHHLDw##jyM%n`6m6rWAv5NvRXPtp&LZ@oT>)k)(qxeKFC!sG0)OM;WUNow< zk#)HvPAMHpMAJ(Aggb>?SKm=n<~kqT{ht_ynTST+6A*sn_l_5kM8|t=}EJjs}fJinw2$7E_+l8L(35(GDJt%On;&*0DcK#yjfr}QIw)IT z!W1ORXA-;XaASaCapZ{T9J$_Ey6voR>BDwqBTzkH02!JNn+*g2YCkkrac!U!jzI*ir(^iP@f~3TkfU2FX(3IX>Db2w z1(Ta`X2+xecbcClFoU#q*sdE`i@yoCsHnKZ{%V;u-N*@J914kK&7ImL7i%KtgCRc z7Le=ADMdxBmsOr@>YID^DK^p(7@db=H!X{L^b z-N#eqm{~yjMvfEexfL>0>60Rv#B49xeT2x@84^`IwnV{L2rBUg>EFPMM3~7>Z=jd4 z8u*dG+V26TlRGT6ILZ~7xt3C{?}l+=2d&63#PQdf7MUjSM{Y*(YZ4N;l`0cd_qmPD zBp{{4l#~>$J7g%vxo{IC(H=q z%HhmzSk(6$dcO$ksIm;3OIXvK($$q-d2-qu_msMgcny!Q2RIbv31Xu@q^a;etsomC z*K7QuuZs4C{uEEa!Pe}1*~7B@)-?^r$3_2;cZZ^oFCi#)sId zVQKlsX>Cg|9*(uc@In12iSjppWvo5pu}@>Bvo+=2l0xr;e1m)}HI zr)-idsjC)YnMu3eW>++$=j~l0?G;;XG#Av`ABfxjLazx|K6*rH0#_cUZ1!qm8B+K zUL402pudfU{9{GIV{R+rK+P@4ZP}Z)6?=zuHfhUIo0f6Fgfy~{Ma_T;%1Dce@Z>1u zEvt)IaCW%EQnktm3|47REOH+Af|H}N>&u$izR4p{MuPDJSBA%$)KpU|pWzir>ed>4 zRN1yy{O*x7GCB?W!LYpC#NWv#$7q=hh-Jh=*0|M1XAvV1%g8QU+K^LIk|bmZp2OJgm{XFdmV@CY{{UJ5Ad(3evC3_2QxT|G`C#QeEk>T5e=_-wJ1(VoeM!r6 z@Bl#AnxYZ*IIUuJVl~N8oKj^}`7;P9%-WHgP;QfJi;L+ESh^**XpRoa;e1CiHBM|Y zr>N624j^9Hhjm11e{>3V4m3)MJZnthE&`I6s5Q=!d4}0}plz8BBFohI5_bp8Lw926 ziToq%n})cInW^kMR6Me^SpbmZZLd(%fHA zVT^oRj@`#4h-lb`1bt`3lS41PNR4~^E z?y1##eDT$3O0>=9b6?~l(JCOjV|T#pb1jLnWW?OFB3&+^EHn+kDc;|lDlyzd*&=wE zkLi3j#dFP7*)G$o3^L+?wUVVET$_=t_0WiJNK|(hTpy`5!>LNt^)Q-+F^1T2rh>Cw zqPwlT_lPMM>(cRCn;xc-I~<2kv{x9Z{7}Gbze#g5a}Tu2(R7uzqJ7nXO^hcNCl|P! zlC*bl+@dhtoVz_Gk5YBb zu_KI_dQr@evvP+J2sS@0+;#08`5s9$hJwTba|a6&%Nu(pI7gXaS}S#M^( zI?M4kQM@mRkR5dv63;HcC?`;pvCJ)@*72X?IBux2!IsMnXM}A}Bq{levIc=#00+i1 z{tXsBArrezc9W)XqDfS$SqqpcDY{gW0r5MZK^D9>346XoEZM8#Qbj=%7|v;PFI=f= zCtoHz>K$UC=FPpvg5N$|#H+LhSPH5UDv!VMR3g z<(K4M0RI3snMZjSKE8U5EeVY5al~<`{A!WnW*eEMVi1Pvk_$s~4Y;75Vvuxs1G;jm z+X14qhNl*}4#ro^p13ucd3hF#2ue|q8xKf_COt$}#noxvE7Ts6l{qC_B??vdwuIab z2Tcq;83<@d%y7LNKWMkkN|3XA0<6hb-UO0GzFtu-KZs@QXg=f8v-FADi9_x4%&)Y7 z1=@KeBre(=bpHTsI+ciI6yhB1XR`(|m_;e&Gc5AUiAAo1b9)@X=zK&-(PLLc#iMZ% zU8^Y$NF@6XAdobGnfc4z~FJD zbm)M`7!q5EwE2o;>Oz@)B|6_ib~;)o;?1Gi9&prEHWXkQQR>aEYK*m#!-*CN z7wA+qBdE<9JabtUqOwuaO3Xvs0}jbZ8L4*y)Kj7Ylb9QAYs2&)txPj7HQGxTCS_<> zATH!u;0x$31TD=(MOk?~KjGZ25|s@hu#i(?1^g`;{wIpm%N%&=3Mw-zqo&0Gzft@%rZ#w1c9t(u74>r`zANU3ojC{>yHQVvxP zwj?UXBWA*;sgGlxo<*AQ$B2w^MwZP*l#~Y&2}vN7o});}aXdeS=)A+1S{6u^Q) zC5ptyzLgZ~13_eR?YT})DW8*+Lc?oxKV#JJI}pubil@~u`^$1o z<#$_9S-wD3ZG0?DS8<#^wP=%vCYD*X()bHOxH}OUOpvBrMpk(U=?x?;vyqLfXv1{( zURkx0V#@?AjLp$WRXVA~HHT(~#b@v_x8dPbyA&Cvc0P>alTT?SS0E=_MXr*z#Z3ns zF*-+iKN2CSz+7Z)Vs0GLxPpVuZ6V##;z>$@@w!Ng`M{SM2#Fjii7+c=gg%Olh}owT z-nW1`RB!Q!^w8~%#a^{ZOTnko>lSjobhafdks>3LAZum7D=od+PMkJ#bJ^aw>bm>>P3V$(4tMzaYZ{B zG#4o_)1dSVPGRZ+Fxxse96;cGFNg>!nP_t@qQ$`ukhtb(nbaQBcyk{hH8PVb;)RZNB%q&Li$n?Vui{IF zaXF0pKGJd0eX2oeO3tCym7IJ)RieIpEqM~-#CIb8C*Wmo2?C@P%{D&jNLR|o^N3Tz z;!2KN8gFh~s`+oBO)qS#8BgO3G(4nsT2XgY!Wgi{<)ckRa0LY=#Z2E=;G`*>rzO#4 zSl_I0P?C2HiFMz=!mLJ-PU;dGO^7DYlcJi3D%ATW3mWu}GpOcH(8RK|KL`^FG*U8M zC#-bortGp*cG>_68!6fVIQ0ez7aNEUGhRZV72I4DB{O(DWr#2xu}vi4m`-Gy_`(>Y zd^}nBbcE0t+^dCZV9*+m3W!*`NW61MS-CA-4kA!zqk1?l?`4WPU#mXio85>#!{{USiesJtE z4ND6a66ln;Q%g_5LdWrmN@Qn_g*=M>>AXmUh|_`JZfK`?kfuj?&ZNA;R}QII(~TVt zT3ryXVor0ko9rRBf`on{E=aOU8Y@^ji`wJlV~h@V5yq{kHba2*j)95xQurYCgn+?g7N=;A=R&hIPS)BRkQ&r{NT&!x$WT5#BZ+{z zmzzqqFrg;tJk6t^ZnCo8@By$U!GP_V(C{z?n*qT9ST1+AfEYw5rT|9G^G8mZIeDN1 zLTL+VT{`(k0Ob88b7cb@18J$9ZvY$WNO(X8J@yI?@R|dZ^NzEqB##J5(=@eI{jEJ= zNrB#Kb37>Fl+6zq=o<}87y!tpf!;ULjP4ZDW^FkTUg`R3|#o-oj?E5gi^Ri3%8@s)D_}VTTkI*6Ks`7 zQM@;UCC;g+x$5J8xJN8i3YtX52BsXVr%XC;?>eA=0Dp9F>CNIK-W;El%Sn|I(*a3R zREyb3>Xlz#_QF^U$VmfOLC~paGpK;-GX>rNGNn)ec9C$Tqw#Ws>~&XzHHd$A!=5axdkv4McC3FKiLCUIqO~t9=4`A1Do29K$p_=(6p~g>M^aK% zDV&*7)!vwG4H3{5i6YR0qT*(}wlLhp$R_Q|x}~v9r3g3i+$dc5LLcsQ+QS$%$t-6zR&n($ zM6@y=buFQhWDE2P?+a;ob5-rw%UfFk6GLuXPK)L@lMOra*~3Qxc&3qz6QA&4$EVPlD? z3YGy%a4n3XBnz!Bpr-fxH{Z%7W0rx5$59VEPhdxAlPpcjwVmJ!<}wfp(AeB?n)WL5He456H!(*6SIJ5^Dms@SRk}gtaGo=dv>2#BE;RuH4>j{ZCl{biLiKVDCDeIUo zGyoyqOp!U(y=|4nj_BOwy@Yi}g2M5hn3{$hmX%lvanGaPbpuiZ(@rfn9*56p>_Aa= zeyxdFxw>dQ$7JQES{*Ytbg%Ft6C>VyQIyvhq_F?iHaK`4b;$OgZk9 z>#dHEtY=wQou>G1-VL8z!!3z#X;Q?*pd!pnpaS4;D9Tz;P*Y?QY;0^qUEs;75oa0~ zd~l{BdxzL%-?y4z5z@s7KRqHtjr{~!8aq32wxPjlvUvq-mRg4~kV)&hMZnGB&eu6xdMQSSK}&@2o}RB~kc~VOy4YUsh>`$orp+ zXQWufhPa;&%F#HXAzG7BDwvyYMt!0z1MW$e8(K6MyJF4~PPX_?#V1rpoK3#jbXI7X zc`ZvehMEdaR3RZL1g%7n1%|ty6Bj%jwK5K6NUR!U$F|WbYX1NRx^=&{ZIK3fu>gMvjInLW8onKPZRQpd_uBjCqVI!L7Ca$h6v^PFtp{u0_r^MI z%d|HfR>LjU5zasz>t8{lhQxZu6sY4wH^)_1_#ZbZiKLKBqn}YzmmccTdj*sN0Z`~k zI>fwEy@n?m++T46=xY5wTCl{*jXCmGm4ZdI)e23oeQju!gENDoCTvPbkF@H%x+bqI zRqW+JCpL;B%zjaE47!S$QwjKhA6&1vid1bPBB`%lDIFn}`!TMMgk2UslWo^qtjnEKUe;5Uw0$`WbE%9R;u>^$KeR6qyeaR8$X&LG8@ zjkD~m1R*<==zb?Oa0Y5}mx!EunEwDV!VaNJxcOcITMnHOzH4B(f`YK(=fb97Hw0CK6-2?}kS44{i>N=4wHI@1m^MZ1il$gMs!xfIP#QJ)d1p#P z$+D6`8G70P6ZM(-WB^tODcbtSSP1#NR>R%YB!S~-NU^c0O1(C|>F)H_06Hw;x7VgZ0{#L6fgGs|*y#WWnw;SzpUxFPVw7{+ z5(WL11GSB!a&$!ikJ7+0Z7uAqf3jVhz^N)%plCo@*97@q$mUpXNT{n zyw+6?qVdoYpUEkyGkXt#fKaEWu%^*vXsAFPC#eO*@2qj1IE%xj8k6#biUCiWN^<5U z9YNOKkdvooUH)Q1fZt*xjOn$IsuBivNlXBCn<257m<|dl1?SWl4jq&LH831Aa}wr| z9S&qtp=$`>9A~KEUXjo_E247u7l00=tt|>0SilEg*uzNx*p8sU2O6n_#N&MGTkcCf zj`uAqDMkEKmtzQ_X`7ra#Vpci*k+>osr4kiV(p2Snq_9{4wT%75`EPXmfPES4wePN z>}5#dd+VfENoZ8wb!^dRNOWjgUcg7tnBtjs6tq`~e!gDi6oM>$L|4hznjcXtdxM>*DEwVY z5ZbvjcJH#J*k8p4y6k42!Z!+X+3tn%yb9YVr4%$YkawwlM$-&P{R;6T0i87A7o7>(&aB|*9 zmb&IOdY;AT_Dk&5FTiSeTj498dd1f? zBoojapxQH8c=bJ(BI_RuqvAm>)VL&6D)p*kHUY;F;z7`6aAy2WTH(v$L*+zS!%Lyn z{^xHQo}QF{22~WVZKqvw*{({N2FgZaPN+7p&}BMp8J}u!`)Xe@--FB1mRjO18Fq`C zBkyV84iBi4(F6Cx+%o(~MqWe`!*r7?!&+mz@~R9iV*3RWpWhl7$8w%b>~Q_E&Niiy zx3N9)4#Ac?Gmw#G+)KvNJTRp_Q=L#s8$lpi_@S3Vs>rmHNbZ=aluq#GOGq)D7ev3r(} z!#>b;eiK#aUS(-2TY%0=D3BGP0mP>;Nm1%=d+!ukqh*X)CaPHPhyA8Qh^tEbEmI}= z$Yden5-)JOD5#H)kq>x|^CNa3>`_a`l5;Ac&bL0ar!#0#2z*;{a)g8X;zV;kqfRzJ zo<=3Xbm{68i;Hqa(|6^`InY}=keh*V_N{w}b5Y7U6uvY+J%^=m+}KjRj(rbHtlzqW zqL6NUY(M}3tR=cSTR#TsV;a+{*l{QddSoT}Qgr&vo;^R?yfGZxp>jr3-B1?-OFtMq@5F z2TZqvv~{a^nHWZ&F;H;X3^t{oP&9)Qa(i_Nl&^|-lJyEwZocuoO044fB;1zS2ExYo zA2{CN$4M^6e=D|Eo*|xgqUxP>MM_b*B;S8nl+_WK;r4N=eH)17@3VnOKN##r+Ok&m z@TMiyQs{6k9K^hSe=L=|+ z32Zi)(n+>uP9nn&t#nns)05H)RgAOX-}HJUqkM`^YYhny`p07~MDrNxR~6wos?3`1 zktDQ(u}X*lq>mUU9V1azIvt&6{{X%B50^d%eGI93c&l6ViafB?%WQih0PqvEJ!1z~ zX6vslZqgi_M7;ZDN>)Pe=-o;Rw-z9gb8RgUb8yOPmoj8BQF9aXfo-OB2Qx&acj!=| zzvFn%Pa9t*S;kfrWJxGR}MZ-_=YJew-KjZ2R&ZE?-iz0My^% z8Vos9x9&rf8X+3p&7@0W2cNTTK{U)+OmW2KM?E1!eF?YDA@K_0J&Tz#J45kv5zuPW zRH|dE_F$q=b0{ew^u55a>ERVI#JQ5?Hdmcz4^7sl6zuBMw+Xo_Rn7i4i+p&sBEECn z>B>=4Af1NMHZjshZpPylRE+b9mTOfK0QE5sH2M!k7X85d8oWP3rP9e5WjL(1+b!_Kvzn$CX1`8VJ?#>1fS7o0iHV8wJ&dGnaCi zRYHD~rmP|HYw88td9@qpwAokQ_XG%#n3js3?H7kpCy1VzYUxRFA!KQ}>uvmEemAim zTQcYPHqoD>OI=y4(o#w5rJ}ZLa#D0c9CgH*?#^{*q*E%HxmT98%esMgKvJ$y=Bc;@ z>E#b&f|3zA9F8efC%BDCmaa6@@`^&ab8`8z-3s?yKnft+OM-8{kzt8Y#MulcxWiGw ztUpgvq4{Mh=|i_!ZAn&St+R2If;2HZMUk~pB0ES@+v6@8r{eiE=Ll>yH*FM^Bv_vl zuUnYsAwyl*&k~wlUG|+$Ww6n8w+Fmiwrr%|EZKm?@`C!1F;V_<;}X`Hk+0YuWp^?4@K1eR}Q8 zB<0Rft$dBtNI!%zlLhh>9E8`S1cM$`E3hG z2HT1JET-{VNm6wNlCVL_s|?9LAdqZgUL5Zm7@Rc~#=q`$t=YANOsLD|?u@_^pFZuc z7b}d33E^bh;MZrmZwMI(Wu%9G(uhe>_<$n6h~o7RIOo&`WZ4`He_>n!r`5K-Mt03iBB3)kgQWbJ9e{_!l z8z?$6(?jWo@k^LKkw~w&l@U&HOucV;Qm-4Njc!U5G#AstJCZiOC`=`}Cb&gkm&a4C z&7g-^n3r(ejR-2Wh(EqFS!1P|405z>(W&XCI;LCE0FaT;c@HR#ND|oliBW*!#e0Ki^1oL`94*_daUg-BYMKJ=Yv6hIp4qUL|a{s@*DI5=%QLG=Sp|B&A6p z5o6?TBBD8I*)hV(4&%=W>m8Eo>8eu{q{*$!?6{R_Yuuq>IdqK{4BjHXrCwZm88Ucz z#`<3ymxF=j z`BanwH4T2~%yACcZI6)AaN2t`^TV!l`Ne!?xh6=Hm1!i_Bwb-(6sZJQ`bD=7G8Ram zF}zzRf*9#fwcKdCo4epnqf17&9JM6MOp&Hoq}S2>ZjxloYNaJAW?>pQg$Cz=|F(gT2vVhc|M=By!FrD^95* z;Kdh(MT(IM`)BbSVY+FQX-AmnaU)&KTku$|*%v(N5EqA-eNLn-i<7yHh6S-jnU20F zrWzcIrW_Y-0_NTkD#+9!Fl{bR9+Ij=+IgdPoVrvGU4@U%IjHWD*_5EyaLEDW=C@F* zkIp0HNsh+Q>duTQJewvz4aw(^dnd}`6nj-MMp@+x3c(S#-+?$ zX3=06E45uG6SfglZF~GA$^yo+s12!pDMMx-L zXbvG|H8_fjGkvJy6eAubI`~IG$brlkFda78m$}z(2mt5QWw|84afk|{J)K#HSW+80 zQWZfkfRzsLjx=_~t{RX`>2XL|N}B;$4$23^(h(!5?oOh@=X*yEi3ih=`9j2)(g-?0 zaNli(FHr&0PGVhu2o493o_%sOFJYKKwoH%KbUO-9ah?!~%cPh1-uI4iS+&Fdu39J}?OhcFH{nA{~zt+>b67 zu_LLq#%Gcg+U^WXjzq{(#L%gip1)X-rbL!1JCgH(Q0A){aicWEyK|z)tO7*e@ zq>>Mnzk~pB2$-X}m0G6y7ywqvO$Wz;j)B!dBdh>&YSO8jNlJymjsSufYnFSvdBSMr zodi-!Bc~3WthXz8=ouyr_J9mcq^bZnni;f!4;;ua0ld?O+Q0^2;8X`}61zYaV&^F^ z1(}S_n!pxv9m=yDI%DO5tN?7G(t!XOi=5a1GFb}VIY420o|ig7Kx0IaXlWe)3J+KS z>dQA_9Rp~h@Bk@b^neVc6mJ{@65Io%C7n6WPNwkQkyaVGfadYaJ7&m}OP&$R3pJmo zWzM@`h6&>S~Va){^{ z%)kd&;m{W6FhBq$1yGtgfB)01i{av4)$%!*J8 zT2K^I_CZktG3YO^NGR#e%vw=Gg_M(GJP%mm!)+?Ih6Ame0bmFY225rl6BW}AOfxV61ip`~De7`)ub7Af z!s8OwS^6LVq?uRPEtOuwDLvv(OC9_nG!}IDT+{UF32A4Kc@rx}y+AiX9w4UHJw$S6 zVkqb94%5ooS^yH$0L4H$zfZUpPM37+n)_HDu-g`O@NP735l)n(sJMp;7Dy?$N>XzR z?vj-Y80}D9l6IQoRTrmOQPRb|4XluY1&I9N#l47PQwmhxo}o$!uJp@9F#fmiw4wnv z>PA(3W0z>{Zgdq+OVixdY^4kNkUxYSL!fK~;*m2@V2g5{X&=@1frUf%6CuhIT=yGD z)haiKuEyw0cH-(YA!zrlt&?!464Zkn zlIp*m!bQjgD_g{Qq1dtK!kG2kRakmWY8ewDOnC{@y5opa9v8N~?eDP`(kt>~(yz>y z8Cx}~^xAI|%M(&=g-y{a1*Iy+_8$9oxVlxkRj9brtR^YPpHwdFY3g;_eBLa16K*3b zQz7$n?zc{0*nZNTUQiCFF2)~G*hP{1g%XZpO3iL%(4gQ;GEAh6QXW_q1IN5gytjqP zQWBXnaE(Tvk8v$_PFSTzmfVE8NLK4)Iu=v6yPn5!q&C$KSroW!RcnWJ85xO#l|M>N zQ|25eK-$s*FSq~_5ATIFX9pX#U3O0owMSvsgH;Jx=I3R>2F_XZG^7Ky$nOpGNz+&{ zqpgg$_d(?o?UK_;77n3T^%ozI0xWnB z;hMC(wk4BoDVC{=)K~}Hm8axwMPO4Y;i@H9DEGxRe-fu6^sRiyJBPI9F?}`WoHk(9=^^D`E>xD(*(B*}D2;r5 zVTtViM40Y}GcVD&lMf+e5Q#d3wtk1c;sL*%{{S7~zT@3V1O3m;12=;xQ{2^s%hVFY z>ox!ssY-FT5OpU`T6NGH=pviiPS>et!fZ^MNGg4Ld!%3G7}j1MtI4jXBJ(IVT1tXX zrIeHDeGjZ90~qT57)~KVC1%_Dx!HG6<3#MF*+*`pa71-Vxg2WB+`<^q-p#eQDAjZq zs1uHqtSD%OUctnhD1thGMdEsXBEFNvX@OVZ90#0UjWmMT~M& zq71R#=N!tg3Cy4^xQBHJ(r-0QWn$^Eg3eLSo~5#soZhk3AfYDuTT!-`9&oWHn&}8| z_f?db?VY1ap-oLWu(!@pdkgiB*c@f0q5(>+m}vpS161}3fpW^XoB%DQUZ&`g-BI;` z1yra-F*%zz8|Zg{4mC#^$xYZ0qJGdIgQvnebWT4zEjoqr8###SbNRq@6E3xVz0l%DD&Vu)V>BvHzZu%4O-UFwqwPi>$mrF|;+Tec}4vHFONt&Wk za^)lq3;=c&B$kE95zsKXDil0~02!H3*f$sRfDQItyPNt5;2bPY-eo08AOfLr)&LW@ zl8CvETCJHMXo%w!j&d;STF|3yW0Z8;k*Bb?LL5z!qi+b{3ny^XY$r2Bs1A?;$a+*I zIh2cAcmO=TH47Plwe~OpuADrjsM}$*a)9R7XuZ$6V4xd?%ec|V;J7_wpk``B<{`Zx z18Fjj-ry2{d~(1!nk;DGDL!LJ;nQT!5nz+?fa*E(lRSV{cIyGr7d2N88>Lo-07TZ; zFRHa3FaeS3!X6iZDB!y`)W>nc06k$Mjwi31C zfG%a~61hfa1>>R(_Mep`Wnbq23PzkthMLD17$yK%HiZGp=MS_X0|&H$szd-~Ax`vw z4HH9k3+A@9B}2jhIGDnas=GisoYw3A00ea%G^x0VOG=7mP#L;#RnUyZD`j7O3LWEb zx^yt0C#MJa!&cyot4+=oRa_3qBOO{F94xs@{?(A=3EecF+l3t;L==@ofRYwg> zGd9bKIoU#jfxh5^ZjKfB=xZiS6^N3YYNsa^;M!^z{{SsAX(!2D-zaA*tN0H> zH%rX4J_zt?kHYyj#ET&-C>K_w?Y^Y%7!E&;mPbt1aJUp!!~U7Ae4?3VqQk>0C$zOC z%2qI2lPN9BR9Iw6zJEryn*5;JtXY<-!;CmlVC9xoeC$g5kPbAyHyUp&0RGn-MkgIxJL$TqMc>>FP$PL;niiqMJVaHh`*;)Fw5;h129RcBd`CB(WJy-j+hP+zlFG<1Rq@7<2qGD;O zcSQ9m$$5n#Ng+yQAfd$AjX@nn?FpQaBu8G;oI9A}B;8K6h0@`bc4L_}DwBISq~^{p zZ)0=QLkq_$=5j($vo5?UE! zPugjN!^~p*fbeax9N{+ZoOA5~TG`aPuagAx;#H)oT-E zfHm}v4x+=qxwFOvP^*vO`G+kpKG9QYJs)qwP0DU9aTR=KElSCFCqjyCdkWFnhI5f z5*lpmaOS1-Jz`DrY?Qp4pCV(3Lo9!`d+#5ex{ zmT~@kH2JTICLD-!gR#WV59bv7LpuAYhq#?FKt4ZTLOJ`&LEi!?r|sXu@u-*%R= z_8Y7uA!KSLog^HNZlsj-Cn!+X6`Crx-E{IfjqY6?7YGU7AGswYq^(X#W`a!c<&Bs6RbYadQxdYGcxKqb7WRzC@2icQcj?cFk`D8qpnm=nwR%Q zM4XFql5B?ZAR^bk!_5&MTnb~$h!^|`{^%5iRl`lMS*9K~OS=RTbkHMjj*!&29V=mL zh`wSDkH_jy5BQ|*Ma7}|d+Fr3@(CdabgU2!?QKBle4zJvHAfy*WPsw=9x%5Rt4z{r zT(!uog-XxnS1k|jlqi4(Rqb^i>4vAnN-Du*Ph!UK#IrQHHW4lWZ75D$rsCGwyc#Oj_qin}#?~7}{yf*rgD4H(Wg1&}gB8d$;(~kmhnX6I3C{LAkC{C9 zp(fP6CZ26px=2t5z{EHX$&gnTtp;($+yv$)=3?g;A_h)lO^oqt5)G6zpj1al=1i#w zj7KN2w+9^JrEE`3p!*!L&b1NU(_QW&lZnZtS5{2Mthk;O(#|Zz56&eg*=2xfpA9@C zFT~1`ZG{t6NQyGdjvR58e*#TPV(B!M8Db^s4X64^MW1`Ft)BLR_P(}>+&k6yU&v~E z73GU(S;un|i$apMKJYErgLLMw+sjz7OGzEOEyI9vtE9;LE1zR6ui#Q54o+jqjI~D< z(rHym)~jmvX||p@1F1G!XWd(8Wdm((s5%%{I31LPw;nNEyHp2Ulz9q6jhr};-3Ei2c{mwHP8(vs8-W! zQ2{A?Y=n!DR5rN)k!|8OM|_8(Y2h9O%D3dm^C%FbbB(l&S|sb6C~nj^)H_;jj17MPG) z4|ZPQ+Se`EpUA|iNRJdfJQTnZ7=Dp2GbW6o_HzwMup;)}Gg;?yFR>~@4v$a{&0nZq zzXK8C$t%%Q zsFi{RjjdT?jk+vG-;6vumEx@uVnSg7MPJB#Snu-ZbfFA5Q2=BK{&ILL+UFX|C7O1x2SD z<+_qWl5e>1?(6W2Xz*-^^C3Hlc!~Y>SX{cmT(ZFhB{l~7Za|By7<3}PEbWoc5a1TD zYEtaFELc)qY>VoY=(P3MDf}W@Ll#L2EbBPtoa~WU9Ol7kSNB{3=si08Bc~Z&JTbvj zGq~I{GKB@ptmjD@f)2O!{qYwoq{m>lFRqT?vdX2tnJxH6TPxhRharQ&@_xlqd=0s( zx1>N^$t;!f3K?v6v`xh-B28IIf87}D%RcMIyH9CPGA>pUE>b>s{3BJt=TcNu=f~8B zU6r`R_8yxQxs&x}S55TFM&oF=i!0=d9pluvntp`hP10r%LcEC)$*q~lJ zH3X&fqyckaf6crPAZa8;6Sh7b#K)5BX>H|bJL=#2FpWuyHY)XTh#OklRnu#y_iGDc z6E-kC8L5wDpSRXEFp+-?n;3(iw~;3iY1GM#?4)@J#pj;o{y6Mmnv!aC6u1Egp@_>X zL(U12gNj|1X&Bro=2OU+HzCAde>CO*#f~mD$C(y*EUrEz_IAWvKU$US%bb@Qhgt&m z^GGDczC7`n23VX%Vu@37nC;tAn{*oxK}v^_1|5>ID`HjPJXZC3lT=1^CFylCu(7?A zEe%x*v5unlxUBHzqN!Sk^Oj_a%(L(q21SnoPXG;9yH)3h(NmI0yml8HbN0FZhBSb2hveQVAoR75;R%!!xt&sIuwEH<#%^sXZmQB; z9aIidJjIh^=wiPw3)q(o{mD+%UkmYJjI7KurKoD!&6Vk6XspS@_e9uc>_;4Z*!os? zGnC?G-P~oml24&jL3mo^N?B9pM7sA4F$MxrOvJL@Y=20Bt-R7MVTnh+!_k*xjV+1N zuIjW<+#Lw`5e;b_Q##Dz47=?d(sxnUVyfHyL?xj~ota70>H&@mOxs1Dy`zUrt)R8t z=wLc#ZPMC>qks~xG?&xo9YDtVq>gCQq$p@lw!T8Iv~=L&VakwYL1`l3S`g5rEEP5; zh`#0%M_W0w)be#5Ax91-LY)ZO1A?BG&5%_A(=&}B)2wt2RZAtkIzVvf)AHUp(bUe2 z>I-AKeh?sH4sxbj(Lxj?<$H1*76#A&kgZDqtilw8v%5m3B4s*@!dn)FJk|zcpq}z? z^Zqd3i9+-U_xNWsOjkNZ<+h=%xBSd2#7~%y4X#6thWkX~J{?)PfL(1pYzChMm{MJs ziFuPVgnhRu^~I%$_3~W(Vn_NS9$6fDk>!a?kvwqk5+rNM3YL8iU%^5oLpo$R;GulQ zeIs*dlCvTtu$@%a60Jti`k5W$XxPjr2GHVmHq{wfmK%ua!={$Vf`G*9B|^y08~4y0A)5@0CT1gQ2?VwM7#=m#{l55G^SKiLEpf_0P4S5_5^b>l>xW{b3GRm=zQP9h+B#mQ~7HcY^73T#VvrWm=D}5mp zD$P{nCgM02b{j}gf`BMNNrH}>i#8Ae$WhE;CrrpTfDPv617ZL_|J1B0WUbcjO^Liu zW2kcRwlr@OwIL}hE{R!6e77mI4OZidIh}dc4HUJjt%Z^R=?N8L5k7kjhpY_gyCERu zT45};~b;5a^_x2`t2N}wrxnX z?9GEHTZ$(@kW@+db&gTgZG$q|Axu4Vk`y^=HY0F!(2lp-IY&)J*U;XIHa-VK9HWOp z6X2jM`>NYr?HoASvdrT}B}GIk<1MXY<9Op@TNXH0N$f{B%%r+=xc$%#ivlmEqUP5EBjtsiPK#@qnqsj(AzYJnE2Ym5t8pX{l&u7iqC25M zUD7Ufv{B9!_a!DGIF*Rnq0?6=maoZ_eft#Mv2}|fUTPOM>#R2z+Xl_92jaP^%{H4c zF`^Q*E3S!A%8*Gq*j~rN(2RIFfm51ORrrQjz%F+7zDW7@k#7;ddq* zacRpo>Ry*f>6Hme{v?a(9J&?EauGT0Ew=5fPzu%Rd$#=HLQTrF`NQ(H3Hf&Oz3hs0 zDFWqcZ6_$xQ@>4Z4lTU|n_NDtDydGCoOj-GSu0nDbDPffhal;pu% za_UGH3d)&;rB@*2N`V#|1!=q|CLL;pLoShX*|M~UU8&U8uqEahZlLOR2q{yU!M>Lk zx23g+*>KfR{ydjtU4D@6%x{*G^$Na?P& z@X&7zwXp5(He7PUp365oNFCELKB< zv`aXnvx-BhAz>YP2PyD9YREGfwpyrx#P0;1ZHVoJar&~Kr?j4d$?aIoC+Cglor zA!sT71{ci>MWuEVto=8G-Ir0iq-Kb=_SEn2{3AQXDrJr*u^V{R+2)@;i0jYNoDHU& z%4Qyv&@Y(iLdu#-Q>$52N!rQ>q%R!y+)Reko_ZM`!tEl5p{{{Uw!9_~J+VtPv#=RGEe7z2KDK&`u5 zT-O!^YjY7ZJuNa`C3bGNBQZ*o!qao8akA93=ygs46c*EnE(Kp)z#E(E);OKm^>QB$ z$2?Y_q19$+GhmuhC#Pg3UQjnm(xuEc(NQ+{2`B()HW6LMW7QV=ugIIj&Yg5DqKhn- zSzCa2)tdhR2*k-3)@aJ7l9f5&2qV@Q7RGtW1xMazx+AUG;1GHpzqv>K9nKyXz!P|&k( zelP*So{()u>K)Y`NZtT6nUhU8o?6LDhgbmZ%FhNYSFO5QItEqZhUGI5l&bq_v~&(b z*#1^n1Svr$uHVKIbls4|Qnl3b*?9?A)B>OZ^nd}Cp-fCUmCbd%$Akw5MW)eDNJ?}u z#sY5>WnGoA+BgGG{HkS{j#89^eK#BY z0+ZiC>1&HZY*h$XaH*ChZ0&6XcFs|vxw)BnrrDTEf(Lk#4T$jvtaRX_silV-Q;1nf zPP^Lh0nMP#m&KQJeWRdoaRmZyb>QTys%tMxn}5Rqq|Q{`60X_iIJVpXY!pfO#}1tt z8k_4DQb4~$dtN#RZHc8U*;cioEDl9lY1NRVBH<(*0owY)KwV6}s%p~U?=axf-(>h6 zkR3Ud8q*B|R4?VE0C1&oB5Fw}LJDj^9|!bA#t4uzGby0f4@R*nS=svS8}zVHVz8^Rm2qM~M1rvXCPK^|$=5_CpXaJpGY zQ)%x0QQHa<^OTgj*-0D6QvsH);q@?2F5(;k3jECMo`E@&<_vV`GU=S17Zx8l4xO1? zFsYk!oXQV|{{W024V6hTPd(QO%i|npQQelBOMq<%7H+vR8XDX9#{h3}9c9KHMp0yg zcxq0CqrToc83JseuB86}!w9iP=&!plgJlp%-aBU~MNBa;Rhdq$SMemmMICt>dfgXN z$oRsLmUrdkklEE&G0`IWMpd;W0wF_fo%soX-*@F51kQt~QjO4U;vhP5=iCy){a^!P zMJS&}WN3Pb0Lb$FocFYV4Dz)Aoz36_qh{s>jkSRQjjv!YrABFEXF8{$`3>Pbi*i&5TMU&2zbQLtTo$`V}3-CJ~jC4z5n>Sf!22@+B;7QfWOuOH9mh!o6IBjx- zAp`=muou+r3QmMQ$)Ur3Fwpx=%X=*Hevhs*-C7lur!$Sf3ME8&9bxF?(j~^oVcG|V z3gPuiVr4RHKQZ)d*;=w{QE)k;z#QoW5U*HT$*AUZ%U@spiPoRq4{W!(7)@lDD{p@(a@iyv%CX?$6K>D)e~qG`|s zo0WO%ez5FN)Qc^X!?L)hgv~Z_w7A;kl7*o_9-arUQd<#2i}*+R z3xH>7xzyri?3UD{bC9f*gSNoh6#oD~8qO*xOz_g2uLObe5bsZt0zLLYVN(^!)>FH* zYKR`8l1JqXe(Uobk3W+q2Wp?Lz%*ii<&B~80w>|-#`FIG3iuGNyq{>m^o8_9+oR?L zSiWALsZ@zmjvNWVvTt=trB(fv!#TSA2{^iZOKrjvzSSnm#>!~~e`H6NalFm156D*} z#aT2(@jr%ATwbNSOq>=g7iH0G?7BV25TXuM18qjOyjyU5L&VcW9wQdCRIe21kK!yT zI?U>AP^Y-2rbWM{WaTRt*S?!56Jl?8+H2IlD529uoOWifxr(rbE@8uUs#Uw69I4Ca z;q#227YduA^8~gBv=p{%DO6931{>j{QbU;?qvz|57}|RU%*mNYREFlMlIVE=kcFfs z)>1(L{9|Q^&*dd{C9kq@%?iHsx+Ytccn6zMxKLAM0HNV<4ySmqP*Dj93%N)hCh+WH42ryV;;s)xKvZzoI-fq1a^$Lz zhL`^UB@&a~zg>2V7{bWSoXk7M+D8GIHI(v9xRYRy}BI?ROOA5;!K_#<4QI+Y5C@wOKz43 zm}zNBSCH-q*6H5Y(jc_Z@fC2U50=6;r<{~hU!&EMaw#@aTXb&QmhPne-S#3Rr(;bJ z%Z*qXLT0UL5UFXjO%{^#Bq78C2)HR1Bg7rW#7=`E$b}uD_+yB0ldSzHlKU*S8)jhv zMFp@)NGc$0dt0W^{-cPTy@|Ul(rR)IR_Y64X-^PRl$5xX>+Y-+n;#UIiIPLnLRS{x zif$g_T{>cn&$2uw*3{gh06;^Hog6|^1)FsWO0IV~x^F)~PEATiRDoVUeO+!~>#lb9n zFNNk@qt(YYi&7k^gc}}Oj){30j#RBDT-Mt0*7gvUGT!?fW0&w$6n#PsmP@s@Ui6a!G`O9DXHmYNNs>N}0iLX=M)ETcoI7#^6V2>tlsO;S9x6 zfUH8$J$bq4p!ueLPU9SzJ$SS@NIytT0FD+aeST2&G2CSIb#47#@EyrhM+v>RDH z?G1*Y+8&-Yb>uf3jGDcLdqhvaKK2c-EUD%apu*NkRogaFNm8zK)C+WskF+>#8?NQ& z3zuHR_Tu&ylj2=D>O|@SnSHX8pd~8kp>S+L*6~8JxHQ*7%SEEB_-l-&I4Mw=z?iF9 zHwu#{Fy+cJtK9^yz@YgJ3~F&_@fD)3aMI}8;kN;spyQc0q?eJB;a*U5Ne2DG1+t$H z2!F=fn9_)}?MCu&ZY7(Vd0`;S`0h!!lyWjU%B9BKMKkUwG;}2E6pZM(Bd(wU5IBr_mc-01nKCPw=9`A! zYFcgdG~=eo3Q!mMn5$TuC+ao$sV?0871oJKL*O@aYgu}HwTE#kVJ*rx#JDD>!^Nzq zEgYBBfU$d8`gmwY-Z5^SkXoXB_G|4B{Pe4hO?Tdv$`@@^QPEne=HHYvlMtxPb}EyU zUNqF)GX;gaCzT~PNpmX3U{nqC>LCg=b;yPtu&N(GO-j-wj#g54GGG{CUkUDnZIZpub@lj5wVXg&y)2f<}r;x`7a! zsFxLIbA{DMxQ4{l2D6n@@*|M*i8?xxES2kXa+_a4t@MVuJ03?D58#|R*+NcgXp|-Q zGZ0i!oY-GY5_O4qq~^w?sG^=d@tS9gb=PJbQj0-FEvDx|e+!trgfx&RD;(|#_HCNt zYsp(LDTKJ%)Z3!rIg_v|1II&cL_G1nV>-!6g=u_6;RL#-sqU(yCc=tcWGUBFk`0PV zG_|^e5vLm1TwR@MtWkn{MOli=28mkRoRp!2sb8#Ba$&ARf^K7n*w27V_R3tsr{q#@ zmnD?rmLKC1n+th}DNC8u=$M=k?b^jtB%OIYmxY0IVeu+e$HpOL;S=OZhHmAFP%$iy zD`-6?@*GNq##I7;0%Ep!S|mnxbY>J9R#J7f;uPZ0@^)!0pkbO9W-!&va)QjPwRM5x zq(6&hB7BP6lcWCtB)E?@m768x1ps=3p^aV%>PVx^sF7SukxcxP=(dHI2l*x>G zcY#xhnZnfKe#2!4;iORJdzTo{#!AYXWkvaQZrkb~)h6jb5MdBxhBCdcu*+^CxxfX; zK?kkvWAV5IM6x+6`zd43<;4Z1IjqAYmf`B6oi24I_O|g&#;PY^WS3crhE7J*s)hC2 zW9bWn6C_l37MdIr$Gqo8SsIAQvVGq6$Dq*q#)D~+^y-%3^3+W*X zA7xvmK=~UGL{EE>2lKOs6_qrDhpOucs!5EA&TY?VdyXKe-CAxyjQ;=~!`|q%;j;8( z!)jQQ6rLGls6g>=5u*-MRxjRIu!&eOc#ekWlS(T2SWy#mOPI@}ip(xNV@(`XRJ?=b zgJg>~KpSiXK9I|HJGHzphh$Xi;8_5Ze*!E0P1Zf=XQ$%MHNxLliLeR7*Sc~-YyidVBERQv3%oiK5 zqdY9eSC;_|mvdNH3lro7Yw^!gOr*&gbWSW`i++=!)7=L%vTmhA#H1UDmsUl(B#L;o zGmUAj1_`o|0XI4uYt-uvtO*M7Sd64$K`e8uT<&~Hhg4`wkm*nu16_cJkkJBrUU3{$ zof1r{=xak`*RNP>B!^&$3)r`TvbdUzT&OUIIma;0fNlMxn+UGY#CT-9c=Zn!KmO~iqSE2qj$G&e!!C;Ga?e9FghvcoucTNT+BUIzKwN%@GxadFcl zMS@m^i^{Qz=E-QnCJb{?+BGIvMCwXbkU{YfpRkcX8JV)Ue%6 z)YN4iWR)8$At*kIu(*l%q?#j5ZZwqV=BTR=N;ssEu7r=uB#je~gWa*K7)>c=aF?1J zhchcrB2}a$3EzZ!OkwSjht%9|!74*fwy~msO2PHe!C+Uf z8M_m+nR67PS#wj9>>q$mkhCO%wOk!kzz=fgSXNMNoheaA&cX%&c|ODUL?bx2Uw z=u!Q~5Y?SdiGRX=*E5vFre2~F@&=bx^Lz zr%aheTcmL4zNb|JNGDMoIx9s%4h?$12AZW3>CO&=qyTlL6Qz^10CFbh!)C*A;~h8= z6P)3!bm6w!fd@zc+EnRK*YSda#Ju#sI`@vG0%6%Af^8k31vJlW8}A$gu}qa!J5G_u zxzspR`l3Lwx9^DZi1Lxzb=0_pvhYcm)@3-7> zI}u=iC~;*Qc+KiAC9L2V61E<4$><8Lr--=H6sd`Jxs#)ZeXp9Hl?b0HL&yLtF#`Tz zl|t4=xs1FjT#2c{jxW>k>uYVN5Tz%j(od#@#H?BRGA3>ww;!ol_AihS55gwLDGFFj zHEDGrJjQKtxaddmi3((QjO0qX9ZNO2nQ)*{p4k;!fsy9NCs91x=0LN$z zRks|VH64@=jiZeKgsZr!T94J{PnPh^wiFk1We^FduwHZ7D`C5{{VjoZ%C^YQY<+tGN|6rq;TF-e8^A*RG|Y%=oo-n z3~&wL>;P%H>xnuT0K{h&jqYJK0Z~{N%0awx!05L!9FEu<$+3k2h52ywa)9N%O$v@t z(4w7`X$1kyeXd!wAnB@sE&Q+==3O>Y(qaT*Jn8(uj_Y{kz8J3(Oz^T#MG8}l@d9Xb@+ zdw$T%b7@){coiX5BQOTt-w}N-Ba|%@{{V)3Q^C9)q02JzS2sP(RKtjE4t-L|7EW?3 zNS4tgqJ;uo%{#77_5z!}px~mAf`QZ@A6RgCjr8>7-Cbb1O3v3l z5z!-ohhz+@JHuF79EulA5}O$5(>%rJ!3p<8y!E40Clm2I$C87 z@*FcMQwUqD<*5M+P`caK?t7(OPOz47jyGj)E2D=~F5xQL`BcgEA?Zh4&@l3~LbkqD z>A4B(5HsSj$V!QW#K|?w(Wcm&`krj#Xn99b%PpxWApPBlBSJdGbX76dbnta0RH`J9 zPMp+Ak~{(%KbeMRg&}`bs3vlzCReLy66qdl)Tm$JA%=%6ba1s{Gg7nHHZ8hE{MTb| zfi{FSLX#W>%n4@^FV)O}N5Bwu{3C}=`jsiE#ml;}-j~oHBmUwF3px_>frp$y_f(|> z_*emP9Rs;PUTTuTb#}ZzJK0+4(G8GG%ONbpsq1zjx76&vL>~eybrv=|!dg3HnTKRsrQ%A% z60V`f=2lTM;&yIcTqR2c^a@br-%HrokPI@=>SHOy$)rC@rb{-jtZH2)S|09slB5gx z<#?YF zmOs6aa8%AL!jsC8SVZi+`-){N0JiE>kQ`;eO|rNJvmH`wp$yL^hB+A6!trZ@>ZPsf ztqxhnvRu@uCgtfx9o$XMXBs<&pcIkT5V(Yxtptqz=M?9(OIKP>p>qt8{bYgr;JHyT>y;!E)rKB{|$x!aP5RO}^Ie`QaEwm8i44++`sx(PycjxH}0-IEt zZSyeA}zR8u>&*Q zhHuL|ht!u)N*09$wy~iK8iFF)D1#Z?teq5; z*c;vzphA#?r_%m~qt)-SlTA?cD^xb&q+Y9Ju>R-7@Lg`AJQ+viVylZ~pAI?wt!Ge& z7?V%Fmg}pxlBH3X@`P}z?0+Mnjb{~0%sTrrO0>)Kbh_he3KsgwCfRT%`YB0wOq-}5 zcS8>7{DDZc4ju6lUZFcVOHm1$m3`DUf^~HXwqlvPE2cY9W0_@sf6qllCM#5f5sYn4k0aGN@_CcLXJ|fq@bS_bos{+ z6}8%vg&gI})S5{SrD$zr4Q{P9*ThAR3E3MYN2{`TYRP<4CNRDvbu7)bcG!KxY}W4O zHUM9yr_LRoI^7MaSmagaMi8mY3W4Re%VU>Z8DBss-cs#dD& zjZwps&N#ImXbMA3f^T7Q-}Sws>kNvlu<9q-!Y|02^RFpNSJ*%#C)B4%m_rtrZw|@7 zeqaGZ-OdibIO<|p>C9k>EU7C(bs7|sKO+T+p&-@@kZnVh6dhIcHzVf?OyfeXR|bcH z%z!QB9n^D4#;i#um0%NV8$#2wjU2VIvVy%fy`e%x`!e%W3p}>Xj`k7LhABEVMwYUo z+MI0tn`<08Z_8Iw@hr_S>lt=YNh9)(oH}f?FFB$d1I)m1?M!gt$I;D9+Ca6yup{Sq zEL9vd@bBq_gqg6~f!FHqe~s-Ovxx~xzX%+dQi_6{3Hw1l9ze$|=!2r+=_xt11O=&i zfIZb6FJq>#93?$IRTR{epxZ8iHh>H>DG0KZu!So`->LMD95|H}IWiKLbr;{p1ENB2 zht$4sTa0(~JDYxR3qyrP!SZ!5Ou9fV8z|i9elUjU?H#2hQm%5IRqghz2|9D%l;o@w zs>B^204h$gQ)II;04etrJp3c57}Cz+NrfWqI2=gmZGX-dB^~@XPBir8bXi>t2MsF9 zUzTdOP-LxOYtlH*otCDRJKil6!dcULpwiiGI@s9ZX5cs9<%?qcT(98-WVc0uHY!^iq4xs{M2} z9~kX`-%qmq>F#Kg);K8T{S2FC=9Q=&Q)@z4s~oy^3ll*$Cd2}44xUhuvC5U<-8~Hg zomPBF{xFu#Sdqk71((s4TOEk$_`(>p#KeXdmYN{}Lo$1$Z>adfXkDEdye{0jO_iwf zjs=P4W!hv}W4-ynkXWmy(HfmbY=nH{q8mCW!f87L9icjn*u(@It zVq>Qc)V)D3CimCE1GZ}}NY5LoL(&0awuwn*Uu6hO1FKS`qG1GH@K_CnLP5%Ypc{C? zkR0|aC9`5}3ZtT`O1QKTQf~@4#Y^{aINez%30FVi_?X9nIW8ne7 zoFvB7nw43$aSFk0#!D?vT%k>!o91PPQ1Bpw4xzSNCkOjYQn-lHTT;<4H=t7sRj=li5CQbw7eW~8 z@e77@&MnH8XB$eDYX#he4-JUWn6JPvmJMZPZ`QuTz*|9;GlPr@VO=&p|(6c z4(+7<8Azws!BP@JL#IWf)CBA3V0(gOo$U*YWU+1zpPG`HZegV%zVZmT*X<{CpIGBZ zMi&@5Cir0{M@+xI9O?1|GM$bbEnmWS_s)ENn>Wu?ZPmu#hJHw0xLk+?nwNb;^eH79+|#|-TbYkI{=INfgPIzy0j#K~C$ zIQ4^4#eS~Mtkq(gm($_TWMo~n)RB~(qiw;%xiUu&E`-$Miy~tVR8iu|h*(ug5~TJ%X8SJX@YSl~xtv;zb#PscanG%Y+n0ZetSZxK^yuwr$ zXHs9636F>f(?u^%_Rr8_m%xIJB&OH!`AO6YT1{ZQAIj+YdQKf;92il z#^C93r;I=0*w&%=#JGx^RIN%(8FCwNrC&%jcNlu)SobavZ=uv!?gimVP}?M}T3$mJ zN~%g}DYC%<3)x??bibfC5zz!0sc?3=!3pKn@JqyNcjO2P3r|~TCgAxCh~ri*G0x$) z8nCAkaV)i85jXTLeU^g?L&aQ|h|wwwAt*^3Yq;yAB|+68dWOTa9ZfDsR%&5MQK(La z8BidC+app4(1LpYF>!(#eF*ZEl}|HIcDFO^?2OAhBz3m2IET%X9|%dg!YWfz6!y!N z>YjiBbvA?LsMp~PPE;D;xgS6)}t|%+}ci%TKbGP;H`C zMVxG(yoCai4UU^b6I&tZyEl6kaK$`B#VO{CqErV6KDu=g7IM-(6=bje>IN8HHQ5P- zAo5n&30F+W(5K)mVHn+`vqNv$#}>$9JS|e9t!YHcWt}Cp8x;U93U6!tBJTrIRoJV@ zsk3%!R$jY6q~Zn^lKni1d69iVX;(&X4Lr3SOgy7%`wdvd;CxuB_Yq~P^2sfw>5@lL zf3yL%zrr*8bxA(dTX4HHUw$yEF^1Y|qc*-=xKGxr?&-W?XN}&*k}@Ng9XN4^`%>Ze z9H-1S^wgj#Y1A97wE=q(m}q?Tiw+j?J^GQeRFMk1Gh-QwB~n3|ua-;dI-)DMEyHQLgUYN` zQlRsip$ZluJ|FHOw=vBGTJ7^jn8DRLW+RpbC8Z=OU~EDE0Dh3{H`wFY_PIIBK753NsCihU2_aojO~fhNO~v z4yR~g@Wmppi7BqPG}@n*S+j2&3k013^BZptwub075aE?q4p!vnWSPu_-MNb>S!}C& z+?_|3vE6njNTK6@0jFs5@_34h;caiPlQfa`k($>xJqDT!pI9M2j7*|3{impNb2Cy? z?FBf~Ne!)Ab$U$b04o>SBw1kXw)=F5t|W-ch-E|LDZ@CI5!G5f)>>^^Yku)ZhgI9ET~*@@cSMehnpcOUS!{6 zl=$4xbwkUCun>u?M|H9eXEuqX~bUU!sHQg z)5ahv)1q31qL}apA8`+7`RuK_rLu(-Ev12L17bA>C5=%$r8ud>?$Pqst0lU1M32)Y zN(VQMfJi=uI@nN@MgYa!Bqo0fO^UpVPHW4Q6@WhTcT&DW7?V$!;UuP@sPe;+A+^UgX6j#UVwZ z8bw%XbmmxvV_S)rBCh*>qNBsQtd=OJp+w7@H~`%S*9UzMq-c0~Y*pn#!w7NymBoBK z?Ci6t=Y~jei}%u^Eo%@7*KHzXrD%+!LidDJ)#3a*EX$e^f0@=Z+(fCDcvYdc{P{^`K1|75sooJ68t2iQ_HBgq86M5NiR?W9I z*C^CQ&j+7Nr^%K1@#;hp?EQ~MBxukozg1R|?gXzzEh*ZL2@Xv=;3Y?QoO(3?|8s-|GhVf>d5E>*6CWek3 z%c-$-BE@5;@r9>i8lfjj;=j@p9?nrBy99(?)*e@(B^tC65DWp>avP@-MSBak5oqk5rNg`9j1DPCD#?C0|OM zlM0rY`^mWk`J}4QmMIWZ9Pld z_=5vhaFIMd?IBjciy0PH$vxy7SdWpn!XwWDko0o2PTUjPc7u%&lufNNuB$>8NlpE1 z1Xs_7XqOzxi~K{v`bQ8MIYUpjvARvc`5hv@cuA1UL^H?Tk6xwbdW_*swd5#VA4L^u z5hVtRF_L~nc0|2Xhwo*nN;uj#K{oB=N1-VhzL&Pb+jMD>8-(Ps~az*2YWBa|x5DfT%aUO7ioIf)n2@EmN|m#H}_ ztxd!xP_wF3ENPSM&3o#xi1LLG##VQd!)o_PFxazfQu)JC2>}C(xMbC7wHEu1TXB0I z#vX=B8k8(*IC(3HxH(cxCpV>zN){I}bh{;)OR7fLVF96X2`FxaUlR zJ{_URlX(y7g#+mlBO)xKC|OY(7?PP0#*Oq$5eu;fPiTc%$^gFwg&gV0aWWwc2D=g9 zhN{U@RDeRa1aAyVB9j}2xLm4bgt#aP_j2D)#v9W@taa#;@1X!V4q>4_K5*;=Grm}H zCL9uV8$qz~j)A7R?n11g@s0t}Vr)6Fj)Bo_%f~?3&3ITI5x@-{0}GAb64BFD#_b6U zH3+l^Lj~o405c$NAONd%w>B}r2-vji95a5`KKj>O^sY zpvEIeH-sItvdwi5M`$d}W&_dGg3tffs_D9_4v8^hcFtlagODAwpxTKL0k+BLU^IMnBml9W`EiV&D8A)6chyB5Gfcvohi{I z+V{7gj3nu&Fvet?M*)brJY!J6s(4C-l)slUR+6FJHw0=deBwNj3UIz=74dcIn!lgQ zp~Lr+n*RWaF~sO1wDLKWX_dT{-6G3X?QOh-IE9M2Ds_la9+0FhL|RIchUP$0D7)pIQ(;VC6VsY*@!G)Riv(9^mk zMcFr(AniVo+?LNvOSY1suvh}tF#=nTBau;8(6sX~?bHzXDz^5~ApGH`tWsjD56oIh zX<2~I;db68;>m{Og(f|-^KH}LM8m4G8e}->zS%FQ#G7jkR^x+|@(n^&x2zIg2q1YK zW1uvMu01l``d9$2PGPV!YjC8ME6-84q;OHw#B2Ug;n~FZg65h`s&emloCv>`m$}vy zpI^Rb1-z`QR2ep9SQbl}T0%e;32RL)=^gz}4yF*6RXMPWXc{NtRkS?~giCX>hRRKk zx(WE-VG9xxv4+~JODPLNTxosB8&Cx*O0+sdic}%S%GT{Sh91BRkW`L!xhxhNI;m@A zM4nl&x`H|llcZem*{rV3h~V(Q9gK4#6y`!y6qP30=z5Et;_4FAin+&02RQwNr+8~P zg|d~oLviBb(%2^@K(siP@-5QUF)hH!`7n>{J{nvA>0*uaK3@ zakv$Qm5AiMg_RY~)uxZpY$<#aj=n5K!i6Eh$U(+HEbQ5^h3XpIJ8YNG9C? z5X&7$F0qQ{m5yJRaFt6@<(z4Rl1-B?(o=nO%%O5furQ8-$pK5lAKu1czW5TA8gZ3y zsEdh=jwzLCVctrzbtga}3PPxX6zcGp!R$%pDRNnom69}4RXpZG4_j&vhe)u;%wk-P zY)I|!JtTjEsm>tzMC3F~PQX*1%}J=XHWSw$*0BBYRmMt*m{p4hs;}{X5LOtIX)?3) zwUo#{q!glUrq#-rVr1*hMty+yZaT$evT5JBDMHR~W$Glp8^l$VOES4Y^D@&9N-PBO z9uMSkDM;A{*^+vsg9)BXNu7*nV0&3`)>{>~S$Vd~Y81)mLM#SlwD9Jl`Vv6}S#}#* zCF6SyNd^ArEZSX_t5K)Ivy6`=h1?vV6PY0FQlJPRXl!B02|;+(CjBI?w%Jqk%7Ay3 zGLe2;rNUOs!5!2(4uD+d7BOeTO;r%{L~5};4KwtX9Y(4t7eBSA{tSJ zi#OpH6WiilILs{tw{xwP=mJ!>&6KoibT+x`7+y1l@Fhlr25%7xD$;;kO`UTnB>EVr zWYjU(l(|t$vW<5fmzZd!M{8#XOL=}Um9Vps#>^r7p^$ta4B-v92kWJG2X3~9@ykma zYRYKhwiR}dH0?%M<-6H|L9s%*jRu;F#lAPthc!g^?BB%ZJ4;d1hHCCwd6gt{2^pPX zH&JaxM5v361+CHvMxMuF?0PEL8l8dKnD%xO(i(6w*vODnO|EttdPJ;qWPF&@F;j5* zCzG5ufRU*sBGw&tiEAMZ;u`Erig3)ncGmbV4J?40TzD9HWUgd)j?PUd6Uo#W%G-rn z5CJ1^D0N9Omj;CmDd9MTEdX67P<&xxC{j6B&vdAPr%3Gy8{A-zX;WpReRaG$5fV6I z-eKjDVni%J;?U$(IC)am4qHVicW>~H3ORGH)Fj<3K7fl0=14X+@G;Yj>bXvCx`3mW z_So7vba$ASox&-QO59DZM#KIH?TMqEhv}=V{ZV@+zoX4%e4qp^#vc^$25hIy!Dndh z%1Gt!6_eJ$=^V4PHKgET*?$|4WocLv>6Yf+FPjx${Cgh z`VNEA5Z#MLwB<@lV#Q7-%K(KEKR*~r)0Z(@r!aMKD?3;yAKw5QsFG^1fTSc8A4|b! zC{NAdPoo_QZN(u9y~2)z;b>BjmW|1}cA2g(;x>+^4ID~~;+l(#6Zyi9BsCMbtqM`+ zHI($Se~bcz-2HV^>E)nVC&~k(hlQj?5?3N@7Uy|qp*=qcO9Qmt8+xGND|5Ov(CO(3 zupA0Jqd0k@*-BNJM2x^4;Ve<1F+*-^Gnok1_5(=moH%tlb1pVpD9i}dC;}l!2K5+2 z*fnWA&%4vpXbu^er6mgYa(pdl09#X;412&3M)AgU?@Kb$n;?)C@PsplS843k8VFGW z+mQ)6ghg4Vq+d%&Q1H#uU9SM3u22+(SxXyVcmU?2Mdl6AtuGxob%U#MITS^}(7*x$ zZmTmS?UJkbZyiSr%~!sZ1v3q#9j*rcw}ODwT?$-x*-Ak=l-O_S9I&xA?hk5mU^$g7 zlekE*K4e>XEG%+m8kVOwl_y(Uq$C9M%2P)}0~8&~a;BLin~t`G3PS-$q0CCmOeIQH z()r46b|T^$q1G;z)9!o37~qqV?Kx}vH!!OMJhe&sb(56a(mHXWR>mn0jH^yl;shu| zK$n&84bO~pNvQO~)_chxDBv8&Y259!zk~o~V-GB97OVJN!D5lJiD%_DDkIduDDO(w z+(&W1ePe)j%EZXA0N=z%07up^^K$^H11h1!z-=8bQ`K#M7+5i3OsM-(M!LsF&e43V zSZ^E>Bhi8yV&njCxas*qsO^t;2l1@V2&gb0QF>HevKDhK4Xbd46LFVxje(BQ)WvUT zJ_!!cPdPVCah2EQ8X3SgMM7CWqgn_BN|{Kq9Z9exX%b-coO_j7SED~fd2+LjEtlIR zD{aJ-tt50(Q~?n-F2lN!K->^WBjO?28ET2$z|Pl>(v*oh(JMxQFK(gx zMM~5{klQS}i-{!hWVmsqw)0CK@<>um`W^N1j@1dWBXQHRET%RKous8K%>YS4KuA&a zN_Ba}p*dLS+V}#6}o96JgSN=*{<#=1=@)Z%h z>{j2kV-}hM{K+ZgeArY*e7!$0`1AQPWbxiujv7(Yt@u3 zdBol?9mR}bp5?G{agz2OsrgGR{De^B=8H*kD1VFno93})DoV9U0oRo#h0IH)<e&vbSaA6sMHf zNm8>A02e1;2uj%MEQ5gDC>$-2II6VY^NVGt%BXjg>a^h4~?C-*7 z@NG58`MqkB>JL7(T#=aHCCCZ@4J{ciKQ672b;Cl5IW(NYGx9~U5mn4E#v@N6X|y4}2Hh*Pcr1Xc|BJ(8OQ-oA(FDX5Z9c_YU<$kfXp#%pO&dhT(hA|%VViPBxNJU9dNO$EuRGAs&^FSO#Kzm z@kq?{i;5i4Z+Nzpl0wHqH`v5k!NgK_Di+(%B+SSuPm~}yhSq!P0NHJS$xB}-KWJFP zXGU9z95119#!YWZDGkn~8@6(``)eH(n-wKj_!yIg(-SU40moHI`V}pTB;v}wk=IBh zn~M0KMU%^Q3DApP!!W;CZRK%eiWZ8x#EVxF zvtc|yP>RfnTXGYt(N6@M2ApwMQm<k>$*(6+!>-ToZarE3y|g|OgKfWLV^X(q&65pYCsTibHVshAR##krb>8W~XC zPG9L-6P?kK)eO$ClVjZ`_d)?T8^n3K9f=(~C*yDLCyfNXPwEi(a!vBC?=8#s6mCVV zp=+LpXs*tQSj!~iteQJOaP1RQAtq{F#RRN<;7V_P@$Xn)#u$XDj>%doLYIZ+CumbM zlIT+t^rs3PS^-ZrhcqEp)kP<3+qz=&7V7ylRpb*KHLXol*Ysd{VX4Ow97bc5k*FkX ze>jmI-N?z_w? zkh;MtwN_R1p6aIcBX0SK`4-Gvd6v_S@!YNsag|Ikr(9cKR#J?{$+gA(VyaGwX$njzU~f|ZTBB}yb;#0a^JQshH& zC#PTu6-{9`+Zwoei5K%4L@pujKaY_tFsBdxhr=dSP32MsWgw2Xx`nL}JWa_|SA>@n z9pRMx?jLz6GOs$WO2|FT#^a~}bhsKAnwG7`9>lHTbl=fZ{K&MTcS)%JdmUnIz`3w1o*_fb0f_Oe#y0&I@0QN2Qrps zP+V;$+7c|FJ~ksrn$Z~QaN=m;DQWt8jngc-l%V+mn0P?pVw8vUHh-Tcxo489d+NNzyP-bf5zt?!QDeM8%dsK_iuPHfnLIHl%exjrR1cWc7^a-J zEg>C>M(wx4v%{+V$^vZD$}4Q!OB3iKW-01JIU!8o_EF$Ow;U4uyN)fXhExg^lWT*} z=uf08E=>x=C~7QU4)#ODTr@~_i&A|HzNu4-DI>suk$8mol*d*khVzK>G82;sr*Q(5 z(+)kOHAyzY2|g=Y`uM|;mGTnTaI(A?#vBj{sbK1l(v;KQOI+2hd3Vqt1ekfHE@BgC zdoT}g^Gxf!ZnZ>N@R!JSWh`$1W6EAWZ7;}7HsB)Q1tg!qn2+FT zdy081;&y=HOI%f?Ju09x$7SZ6uX3`;9B?Cq(PH4 zAjbNdGQ03y3T z5#lmVJX!~F$1}tx$p|V{Xy6@5S)7p~6QQ|8t6tl@4u1?xw~cW4ExgKsm<@tD?m|G* z#^yA99}%zcl{`i&+*mtCNb?_Iw zChX-3c}~Z;i8QC@){7~o^M>ra$^+iFcW^Zk&1hDJF1Qa*Vt$b?Fi;aUBRk4_OB{>X z`0wKdf<*nM%PvyRbi7BFlEBxJ4KcW(5R`@ z1Jx#+8XVve6fQfKDeOsgH|*_+fNf;l>jDzS0~c`x`qPG8l@NezY)-!;7MNi~Nyu;9 z!i-du9hpj0Q|^@jZGQ`hy2Y_wkj*_M2%*u)t&|IAlLA-2mFf0FvG;0unTJjo#H6!PW4eVobn^hy zb*klG4Pl(I>W5(>$ZAx%YU_DkLROUypdZdFT-qfl*&BF?*-H;&med@VY$%Ns5Rjqq z%MWAY90W@OkpMA&VyeCYTaM9OOYIx|Q-wuV{Zf>TV%HZOrObss8LmVE#`tbxg6i3y zmv&juPribY@FYc)WTnW5DAzNcgfY!W20WLfrW`>@(4}O4L_)+Csla~M?bgzXdg2Cc z2RS0f{{XF-P=+ZYcP2`gjo8e>+I1=$T_o7}jbXbwL{2JpIi_NTDb`!$x_Y1lpTRNR zK|~YA{hF&7A2DqzeWdvkzwPa~l(kbpW!_LN6 zd5o#{$5bVGz9Qe0GCDVDu31?e1q{H@59z?)$gkB>o ztSF?|@6r^6$UP2=^wh68vvs7|N%HcJw?`5>&Cm{nTphK7!j2_fuVNW`!qAto&ZN(W zT*@>fcvCrJq9ws<@PHDP2~TS|4*T9XcEquhRJpN^f#EDxbPyZ_Gt2QGoN(wq-7zDo zRdMD_A;k((JCyDuxgemI)0rpBQTW4B#yGML-7gbLR+Dg~kCZVev^t%eGg8v;i)r{m zMF?uf7jAO>(0&l)XF^=FF@boRxQ1G}g`pINxj*Lre!c#{llJJskt4-0(5m18EZ>U1PQeWV$1^ z22iWO2aSvr29wOfPMoKbp|m9Fh?8w#0|8PF$5;T)(a3jz4#LnKPP)fH(U+A7R*;$l zeZi7C23ArR0mf%ku#SbAkI3@`a4b)mMIlz!1E%q2$<_)30;ZD2ghE>bX_wOEa1MfO zxCI(Bl4+R)5pf)#u{4}K5w_5sAZ8S@$4Kn~y23JzU<3cxtX?GH8g?3~s#=pcY7(5b z)|bmlYgMEuqbi9#+uJtAEPzQ$$PjfAz(R#B+Q7#}8wo~O;2Vs9HGt{3iyo1|N0BO2 zyC< z6{B2=%AwR4;3jgumrY)v)RRWbTC%8(Y)-?@(3ZyBjf_x)VS1wJWzJzmlBJCRaEp;| z!V5T^iQ1Kxn-kIo3~wcBPvHuLy;4nCUzc?%N%-xp^gC?`lC?)uFDjXel~`h0Wz-hK zr6`+Zo2i!+fS?HjTY?B9OL@f{l@iktllAwD3`opfPA+AnD4)8e5)a5i6l@1~2r|if>^bDiv7lz7ITDH zf@MqqiFLRZQZ)rC)H*db1oucA5qQ7hvs(PhtoViHb(4x@%9?kT%pUnjT5r`WLER@~ z;k;X2m5ww(*0_IFz}SLWv@&@sc`I#5AxR_>bkv)80|Ry@sInf-GE>+Jru{x;0TOj3 zyyUVhGo`?uVv_F`dX+SVHlu$us9x6EBc?pY zvlR2Ot_6@SSh^6C;4jho2C7+gl zzgv{dQ#VbVoF%Wm%;TteE(6laPFri^q)}(&ywN@ch<1Z2QZuE&LwgTqJ5r=NK%SIt`4C#AdO<{hF^q*lbG;f zw`AY1NLC~QOH&C#nsGX2X?(OPC*t7-;^2svLnLm({BduDSjx3Ps8#O{313;-IB4&nK?N89;=xtr_N_gwPYyme6qH_klq}6Z{$eHEBcXZ zvcqCYH0M+OJh(~o%P{B>CLF#)DT{{WQ1u9;WhoT-=M!Ua6ecCj{D?QW=>+3@d9T#$ zT@yRAMjk}n1=eq6wL0>F>Iqq~jOVmCeQ)GiaM@^e~7y4)ce0>VZ>Y?)#(t4Ce|{j8M#-K*s{t}k?NHb3r7mM<5m<~ zb$Pavqfa=}(mE30xcqJ++Z47UNf9=n#Qy*V>xh_Ws$OB22s;v!)O7~mD3+e2GWI3L z8|@)6ic2!n=?k+LkS8=n!- zK^Y`+ak30f@Gh-PQ4Dlo*Ka~(VQIBSttGcVoV6L9}0CwTR3Mi z1y)HS`u_k3nn7rC4hxrIu`=Pv+AgB2n|yVS+07$qFC8A4a`P#gU|nfCfPaaO>J2A)roeRyZPZxqFXJ3Q#9Iz~ z8gy08z1VO{6U?;RDprS5Rq;E(B=p0L0s(B0O|C(J4D@$fr#NmBw3F_r4KLvX1T8~s zO&gYyJcKqlC8qJjh98>tX^CQxEoVU_e61WhD-~O6Y+hVgTHu)B(UfgUopo$-(zBT8 zPF}t+9TQb<7fm?wW+mAKf)$XspU&`>baXHbwCua3xuy$1YMZDV+kK<9C5vk8xSDw= zSk9*1(Oi=o1t!`U?THh! zz`ksutN@G(aZ={$9m{JR6m3mB$qCD;H$MnS9r+q@EC-v_3K#T*f;jBq!yxH>Lpn$# zdcbtmo_!S%EOj66Xby>rjX84Tu2|?CiA!cSHa$deNzkWK5Eg7MOa~54ewL{hjfQ{- z=o|-|QhVMpzzikaN;8A$02(ejQ||}`BO{Y($}{QUV~0-F0=|Y-$#C~ov4+^BaBH%O z!?iZE{{YB5=*Sh&I5khqX$cl7-k~<&vC&;&EZ~=!psq!E(r$ws1DRHr2tZPIg&;Y! z+F5YjUno%6rd2c#dr0Ml7?UWHthe3^0IHTU$Hof-ZL+6S4#qiR&Y@mG?uZf5GdoRi z_u3a7W3~r5+RM_q6xtO>1gz#WGH1Pef4`J2fYoml%3>>_D$2hwcZD2gvp~xoZE$t8 zbV#9UU^)f2j-e)duc5Rk42>;qs^>x=15$q-y)3k$rKy*jH*LiD{{X+j7KDynMz>1s z873*1nMstbGK{hnTM`yJGV%}rDJNyCRA0g*!c-;hSMD{zbKE?eT$M$xTZtqCaHOaY zw3Q@~LGm#&GO?$yk#S7nPQrn@_dTol9;d)MW*&Av>eJ;N zTt#`M%;d2D03p)i)2f`4r{d~LuQy9mZy~|<*e3elPU+C-O^J%^^)0)Tac#e1;y87U zCHR|0ldQ`htD9vmTkfcfDLV~~#?j||UJVkXS%)U1I8uy6d~l)JNUxsTb%xlTrON~L zg~CYkv~0bV2ThbbT!?(6dp)GeE3(4XiQdh;M}HY& zY2j38GdDEfE%apx1$lBQL;wIMt-9+LDs_J%y~OA6=M`b@7`rme%!;O}%*{H6K+R$S zvUa%n!aPH+1n}T*2rAr2sW*zTLUJLHOq8CMKmy?1Bx~v-9&D?UCF92VvOlA@B<>H# zkEU#u(bS;R&DecfLaY`nlB=h32I4DoaO!K!pNe`}HhW-kDOgtpyFVbiiI9Z0>VE3e zm?&Iz5m}3b)ajFFmrAk>_H*r%im?qb#2Ig-J%zQc)n-Ch%4}SaGWUu{L2`WJ$#793 zJ|T{83UT!Zv_)~OSu6yda*`brtsKNmN|cZsxd{nU4S}#E^@-4ijk*xBOIGAt#Z%K< zL&KFfB+^#5YdpXOwF=O0ZnlX{Sru~}YAztC@k!P@T}Glh<9A{;QElCx`$f|@z7s7!X=2)1t)K&dkf3h2wF-VA*i-zdqoXtVDk1lnmA9`8e z0+kb#>IIIQ?H9Z}=@4?OBOelEoZ>Ag)tybM^tC2hq@J!IcUpf-4w)5{9Y7@O7MFji z38FX3xJb81O9--Va9a{gRp>XBRjSx!@lcfUT(MB+x8Y&$YnbY6B0fc9@Fizzj?azp z)}1Sk@Y+Wd@Wl*V$Bn#`GRUd}h+BFzADe`Pqo*&PF>izUxa$ut-Uxks8I%)V4pX{@^u364>qL9%91DO|C&Xpvaf}W<@?-4W8CSxXdY&FTw zaP@_SgJdCXpS+bP{s^XVqRPtF>|w*X4k(I^I&hxo=72A;1O;eD%CY|dWOA%7j{g7% z>6xB1@^0j`;Mc?@dLNWS&9Y;#cFUFG9U5HA)25&ISW4Ej`k^;5Ni5OIM zL%z<8H^LLx*r8IYji zeMpXg-0>3(`*YQqL#TW%-?RnCH}|?;sl}Y7a=4 z$c|c0B;a)$w6ub;9vOGpYA&R$*3wOs=ocv=N=O8rphOJLi7?!l-I8$|_53`_Ck9!j zF5AQP&`MRX198$Qa=K-{K1F8s_G+`lD%xp{N-0W~Bxlo5qusXJL-;15t%%7RV3gzSB}7m5JCvm?J2AP;P%^ zDg5C&C^cA`t#A^(z=zjV!EGQNy=2T6@G5lY~4M;qRC92%Rln)cV zw$dmwJ7vxo?PGT>E~bD|4!#iul7&>H;a2;?wH%|gh315?NXivxO`QxCcr4``4JyVI zn3EM&iq0aJdQtJ2r`u8%Jd`aGu}e#|Gm%=Nop6Q}dxqGaW{9zs)?8OCefEy2BY)2E zvc)}VGJL#?=yWx?{*#ZnWz&%$uQPC|kgb zh|WtLGS)NLT4S7Mq{@j__anT2baxg#>`dl2cw(EOabEF@d{OE^$jvNCI%LVWNU_3* znHd|nkB=s(k}gj&jP0^ODJItkbF^7OQ4(97muL-flMg0(ma9yqJmzeE+DCZ?_8R&1 zhoZ*XE7OTQU#LFcvAnVrj_DQyQNK<4LS;UOR8IG0?gPKYDw-yrN%nTs6mQq@5feUb z3(S*_8kzJdgmCkCVpR;b000Qb=gFy;P>mf)h31O+J0(R?&n6lkHznQWn06AOxgxXw z0JwVC04cNJq?@Pmgw0wAx@5oLrYjh}mdn@g<;t<(wCJJp5tZWc(=RYi(CFe9 zS5K66IqwI^r6j#~OwoAp&$U#w|q`+0TBZb0-V7LGC2?1kDB`{&dBihSg$N*+__JLVc@ z&;hTPSb@aitb(Gl>a5^D`!UZTpGa4Nu^LARLF zEVWq=O%Ht@w?Bt+u1WPI4Tgk%FdQWJ4|`cm$l6+}j$(EMkPplzIMLEtP_d00h^^jT z!OSC6D)%2dUK7agF{$E5XDV(pNe?tLbWpwi1QGlou%f^CgV{c%h02_#E1cN=jMyKU zR4Y-(5;RQ9KSy(yFoiPc(1ZMTj@^kC7*~k33>5f!RplW=sI`x%Ai^aDE@I;*iT?n? z{@0CFLS^dc7dmrO`@l?AI+ANK>*7F?D2pnwXfw?(%0FQ%(&C zKg4MXqqZn1^<+$JVJup9cHEn=jvY0VR4O(x(}#Xb>jlBqICNRkr&OVo>i`O7*K#~z z2WV{ZEf}z(wA=#^MU6=rFr{u{fC>`caCNo7g*9grp-#RaI8|k%DD(dSf;gfYgw0;G zne_v-IFN?SRFEA|BYVeKA?J}%Qy}~yv!UhK=9_J-03|U%_D2%n-@-bM9V#{?W^1_m z5)VZW-XNeH_V6UVaiX@hAYa$XDF~LYz z%T{I^7rpJ$6Q;%83n~^c%CLvWbemtp@P?(2u(ct}mRmCffJc$>h~tLb?I|+|+5j7B z?h0;r6saJC{{ArJax@{v$nl7HPV|b)vWrqZKjDdS%AYbcvDYC(fw-}Vcwq8DaZWT2 zsW#il*q9`fFnRz8w=N(9K%1LK1sf?q zv~)?woTmkwh~*u#468*3&>a-5d$G|W8W~IgbUAsT00Vg-0O{{Q0m!rfVl9Ph00LRf zqyTd!X~APr9BAm7o~5mnoQ4y~=$w^T@By~m<=_K9wS&BNz!0Rb zXy70J(5hN|&|!HO=@vjJT|hw=g)|1M&SWr?sMcG#^bj34*>oia_rFNs9cd+VV~koh z=N$GoTIq5J&Jrkh_?5#KFm$y(u8>T%L9X~C^lppWriog0N!*ZO3{o03p9n(~YK4)c z0*%xx6zjd?fDuX8c;E+ZAv?fuGUt&gcN8v^f~$DjVFAW7vlzZ*g{}3kGmARhk_UoP zFQ6U}l*smWX`EPFVOBu^q%c5>{qSjXI& z+|!=HDRQZ7;D_B(bqh*Vn-pJM-A2%*0MNwtHQ=>QfTt!D(V1;4QkOEt+)jk%QjN3& zTb_}}6S^71V}m$?r$rU^Wft^}Q(-U}q5p(NKu3}Dfw$#a4Dk;fe+k-NI%#AfSIc_38OiD;xWkr@^S~4pL zLnXu$oeoR7lkcMWlVx?k*|b#hB=Z$?m3ulFaj-q5<;*roI)tTq1J`I}qo!(n_%rQG z%-E^W`9e?XwxW0G`{6Ae92_lC4I*k?y%yYp9zp5#sUaiO5%RP)(Bc(R`Dhq@ErWHX zl%oAkhUf7xmMICk3m-#b0-$%5E-u@5GNd2I(aSnJ(voU^tn}JQwBVq?%2ukzv{YO{sFq|~u>iC0%@w(kc?q69T*$qJr$3R?PRP#Z4QAygB!1DsWlRdc@kkQ3QTg}#>RC(bIzH0~SH-Kf+ZM>qi)I~^=h|AF?7R6C zNj$e4?;$&Y3X+8ppwRV&oEl!&5}w12r|qV274s?|x+P*8kvO|1@vc)G(pN#RT4Gz4 z8JcO!D1=)pa}9+P?(FHdnk&X6J-0(?Sjq9ng0uabW?V$LROTI=y4q51zED=TK>#2N zd%$#wSaVwdrW+`X{dZ?I}DO&U*rMbz(6d$D0;@i<}l`MGo zb<)t8D;z}Kt=8V3!Zb;j)K==Lm6a(+QhuNdpW_Jc^8APTFPPl$1-9_>a@Pqdm!z=z zGo1sgZe`8%uqz`^5FyAdtI2+1Qydu@h^^3;{#1qi8&OKKr!HcJOZSvM`L}rWI>O)T zzf+&H5&SRXnZSHTn4`S$Wv6kZCj`B~5i2P3j9I>weo_fYrAGZ(=^p&e7-GUkdQbpF>H5Dv~$k74(FgMb7J~NlM1uQhg2XB1_z1IzEJZIdR@YjkK0z`K_jDw4@ZMfK&%UE=}SD z)f1rXjQy>uGdL=u)jpou+i+77>wOIFGXMRD_+gHrjkH1^)mjkr`PQQKL^5&}DH`DPh+Zgdm*|Y?TAiLr_5J z4<|!THgH_w+@nANn2P`vaCG@?3)CUNZ}E=|<>63ADk-AQRzog#%3Eg2^Ry(I&keuNhw3VE_z1}(Xv@oq6)I=ooqLb9TFJs zW_qrDBum(45aZg9!aSd6voR3IZ+;0(*AH*P^`z;e1w%t zXshfu-^x0rVpfX$}lG}+EI$Hi>@Zf<#JzFbep&FPd=-*6CyQ(G{QcbRfq<_A# z(E$^TW>B)uMPFgvI>!Z?lS{5J3eXvKJA|x~uaWBsVv*CM;t9nvOS0uJBqX@B6Jk++9-UJY&q$cEe z=?jZE&Sb?k>2?;k4a!sJ3bTh=ok%XrA;Z*eAvSc;e7`15mvsD00*w~2BNxTP6M9Pf;)T!kp8xg6t zhpD}xJizKoV|h9Rs)F7@PGUk*K|1sT@ya@lN4SV93xEBLI`FIWQ`n$t5_I86 z)s;|a%S?iq)-+wd+D6VNsRya?gtMY~=U+;)rDTr?;2jA^mn=e^Mr8FCfZ*jbF(CQ? zN^+CeNJ+yS%_TFZxS(t!wsMYOr?V^GC%yQ=V3Ey#kuY^#jCARNwwpn^Rv0^KMIx%mPl; z8<^<4bsS=qMZxLPI&kt{&7rt4&^c2qCBt(aM;WSSQ7x*F7M`Ntlype#;jDQ@sY*Rh zt4kTC7TQph9E6~!?V|qcmeVqAdke&cGn8`cy@e-UTdq*%nsKEz9+qw8_nmD*;VCIb zQm&e5c$FNz&S)VvCBkn}om{-rOJZTA6u8rgDOyxI5I{bjF)A-tA*n=3ORf4dfyR`i zsV3lpK_4i2A~Q`BK4qvl6j$kc_;M z3#o^h!>OBnnt~7E5>xynS}$XTGOX9Iyn-J>U2Sr$1tmZz5KuZ8%4gynWd0@OFi!$3bCz;tv^vR^+T1D`H#me~(DvGv3SW>v_d7%t=CTV|!Uzf<0nC z55T;y=0B5&(u#iKWB9MTccC(f*E)s?GDPDLeY7VheEX0Q<_9vfBG$db!UkJyU6HG**r?DagYmX!0zUoPMV z-MCUstSw`pIznd}lk6I{CI0{h_~S;vwB$%Q%g?DtGnoJ+d5azT>j`@tqFQ6R%{Pm< zX*Ehyxu)qZHv2@7A84e2w%2Qr6q}BK!!z7mb~L}a*ISaAez7Q^68oIjnL2lnN`W3a z8*QXP$sVN0GAMSK!*61@8mCCN%zf$El^`Ts_f3w#n?#sIYD|(-lGO^I4=LERP#i1HynZCoT9tgdoh9mdL8T7c6!P?KUn-WJt~qf@fG zG`w>(tUXpdkw0N6Hj)zLyxK=_g`JYWbwC4iXiF5gCS^N_)lLjfeNVIONQ0VgB)m~fwyqnr-6ojTEybZT66s29 za5I1hc|Az|@rdG8$+G_d9>`cU!9t2i+#kvz!)8A&MQU)7zh#%HN~>ctIG>0l+BHe+ zz6ht1+z!O`)~T}fnN^!OzA^NSo((nXrF zsC$M^(I^r)-GnLGcSDlZhCse%9V7=b+S&tqsMsh27EsTBeF*LpK`eWP4hpEbE`yzd zLfKf^Z7)0wAGN*S{kfPiC@4DzM4$Kf<|?}cQMMg)vi^fStN~* zn2OB%a^%Ul#jg`Ml~JrP9}r_>sy6E|f|Y zWXvVTRxhCn8-DTU5h!`F>ETPFOBWpb8MUQeeexm}b+aGG%($K|(_F+f$0S(yy^z}9 ztzo62jzx+qbAd9|F3yY)Ig=B`f-(ZZivfUdQ({r`2 z@`|k%OtGMt<7F1PB{we9fli<;wX&?YxVR~``t~wDR6|P#?(meUe~eQ2(*+)b}6_h@WC8HsMFgZwx-XZY)KGwTPMHaUaI_ zEx0|+0QkiWiRjT)9hVEL2?0)~%Qp9{G{23ZDV-{xwJsKNPN6L|{Q{C$cfmJR(7miI zbR_Hui#$@;VtmE73Ghpk^r@mP5)9(ZE5z9GSkiU=g5mTvCF&!{-W@XZaINCKXHL`%qsakvq+9zPkTQV+48L$+a z7>)X@;#*Q1m|VPX!qiMB9LWngmrtJ649#Y(*pE1CN#^O4$(6vS*F$})XS)CQ%FKpauQBk zn|bLKw#j0-i4@C=Bmf71gf(GcI`eY=`htB(5ycxg*%-T3&a$jNr&6@3Ex3}a5Ns|r zi@paFi`*Q?<<~MXt zt`&BxRSvx`HtWtAR}z-rLX>p40GnpEoeAj;N;WPsEgu;07YuR!Q8P@fl`YifM8ib^ z&`;hV8^kF(BrV7{SmCZV?58>=WL$b;Kqz;c<}3k!wvZA%Z4q*%HB5gSadwGt(5rEF zQB&@qCUcRUyJpMGM|fLv-mt$|%jS(T`xLe^@VB&`6CA79rq(2CEu4-t=}J?aXl-?7 zwf4L*J{_Uh<+4o*d9YeYQclWAx=+RDm2w{s`6s(IG*WP8s#M*sQE?L3B+jG@+Q)?>OT?EFlYFMcf14HZ31rQF$NEE@urykHU4&YpT+{!zp#49P-8*VyoBUQq?iYhZIXS+LMKVhrSN#4j> z^Q3gKHa3ZESsa>``f4f??xjF?+E_m$5poYe;qZQ-Wog+|ZiJyFK1DYKMMR-w^yu!= zrqx$;mo)^E1UVQX5|FZK^vP)w;~vCj#{U2mJM@d;vD93|+)<)D-HbnI8jBcag!2a3 zoI%sTMA&XH$f?+Sj4Q*HhbZr^%uF2Y+~^hHE^V)nhhiZQUu%vD%Su#O#0?+`Ifnvf zfU`3n(L; zy<#)mc^cZFblKB$<0E0YblH)}=FSMkG(g1m@i-Y0?$;x_O7J!VL zd%+VtCaSfKXow?}pqchi4VKwDsHGrW_>z1KCQ-Ag(PG>&;sm!4>5NZHEGf582-F)N z17dZG4Dis)JaW{9d)vf8^kOU01EF*0(8p5-h-5l#9CB(iGbK%1)Q_ z-ZZ=$az#fFk{VeI8HYHW&o)IuLS&5s3PU9Mr&Di8w@9vIC5`w~SHXmthB@;6A7LtS z7V|dJ3OQqUB|51k2PNDoBf(buqlZZgfV)T3u(?ZbsJ_>OgsbFAwD`grv#FB{3Gsr9 zkCG6j23_BRp8&V;rNlF6mQA zbc-EfEKs{)H?f3^Iz~k^H_k2yj#yFH!SuOmOu|;>h)&nF;BvE?XmxRp0iyX0w@6YrC8$_=Sdb|#d+F49`Fh7$#3*q7C!XQ^;V%Vp?_v%A z0DYk~XGOLl#w=CUblWKx2TT5NnmQ&d-12m`VYGDV$TC9v2uK_}4@o6M zUa*s*TBU@Un;z&t5B5Tong)j2r^Cc*3N7JnKXg0d2+(sRYBhWiZzSsSkFd2UkARNaX@cED977)*6bohD|?9MedJETOY2|7n84BpGqJ3wi>Bu3gtC=dV9sXBuyNek*C z%;2u1OD<$3Lr`HrDHTL6jYXrBbn+;vV`B+AjOeB$jZUx%M%z+$u)VDb6m)AcY}END z-7O^`oBPBa;Ub535b;7|8%i!tbfmPTHiRT3021H1uokzD<`U4fFbiuX!RZaLNY?X! zQQ+=j02x%~(361_;eZY;VZxS(@el}O6HrJ|Ae}D>L{U7jk?z995|6Tt3YCp96IA-k zT=t7Du3fUVASz+77KD`G=ua0Nr&3x^zWlNasy%FhnA_tCVvwVxa@?!R zp!@5Pm~CeL5>uD=#}Ya@xO6GExk~qv$OL?J{qP_=^h%yIp*{3`^HjuxHn|{MQMbI1qmToo&r8BO z`VJyJ@Us`Igz~g%T}dhq&PhEnF_??9?Byx8mj=T30Qm15YpUcf@8Tu6k1F0iU0udd z6+KB=aR6z~m2o+Rwg8~q-%@sqJ{K>C@MIkL^$dOnoo^A!l&sz6ng-u_v#3z?)DgIi z93^EO<3_9NoxrsQaRn@1Wr6jriw<)=Q?13o)EizF(Aph!@fMMSsZ;g&R4K|`Vqp)u zlw1jS(u*m}SgX9NB}uRVi|k<(bdFeG4=QehT$uvQIXg~fTKlQBPo>-X4B%@80odby zFm{hPoI8iXex|2hYcRKPJz>ikfd?u^swTqzFouO8(4;dhBTJs6Om|UIdd;Yt+1I5~ zwEqBUXi(f(`9x`R9*N5B9W~G4ysFRm7D4q&2tSlb;lGIHPDN`~m+iEm;M5{%8u(^v z!}5!^_97Dtv9&q+{RX5ZR1+~PI*F#qwT?s(;&s!!g(z$J#cp>*tbB!D3972G!}%$e zm6m2gdUl*HE)_2EE|i=2d&6_3uhJkm(;mHs`wQ^tSmCy&CZ1Vk+Jka(=}{-Tl=B~0 z7wC`$x?cB%h!nGu0aNNAS*Ng*fDhFxa^IA62S0(>W>W}am9AJNu~VZlnFC_;9JQ$V z5|e(HjxkYW8|}W>lgBTQzS0Q((xO%tCPN*Cu{6dEnQDGfSzcvfX*z3d!3N-hG$JNd zjTa5V&M;GPl_jZKfX_mx9DwRoAvM(+49Y<#GERU4ZG=LUTwShXso57e+1b*2h4NKK zBvKxidFg4UN-QoKDk~snJq_*aVG`lQDG{ZHh7%9sM9s2YNzrK_`5S5?dYzG~iIIqA zlB^>@NZB}cxTER-5zhYrFUWKDVpj&zpP7;}jFhG0MWz)tuzTXptw;x=vK-^78Ub?; zWBr7&RYWXMsVfc;$|f4Aw8}GQ8Qu&j2ug+S4YVhw_97Kur|K8_hrr#NS>vrp)dRej zsk6=kK)zs-l_VWUT{b#G8drUe+0N~GE%e2HVcUL^l*5+u4+Nji9#E~0>iq;?Wc+-- z9mv_j2oJj z8aiEbkgpPrLVi6jv`UN8G}VyudV-n7613S#xKQ&N7@V0IqnC!N)7&+kO-7uug|eWl z3u-U6w}GudzX^Rkp7@DM?HNxK%E~Gs2}-Ut?vHfnk-o>yE2kYSn-^$MVoG!LE^cIZ zkO>}k=@T(d$eCkAZL8xMs;h}YWmTB;xUloRtrn2jsh;M_8+hCl*!71jZjRL^bhz1Q zgLLQwEio+_n^0?2BIIAJcEX199pVR)%6SrsbOm>aP!<4sb%m)7xY*oDaal5@DRx-0 zvG%iG{{Vy!B?pEp<+zgVO!o#<`2PU7j(DNrimDbmRNKjA;0jf7oOB>*rL}~-qP#I_ z?Lo3tUtrpMj>wEe~ zM4f9lQfS>axcI$n(=Ng;Lq2V1zPE^E{)2+1ZvR0L-*~AfjIvbrMwg+HHO~?>SVZeRi zpn|~JIA%t(a#NLEQ?8fuj#0qm?r<5q_ z5L1#Y(;h;l-3v)j76WU-MGN^1IXg9~Rmvwpdu!{ga7npQHChW{FEyD5PGVF)DBv0J z^)hl->zkNXRUKPUxb)Tof~IZ2=(rhGeP9xD=3XeVBgpzd2R?q9-9ZN9OF#lfol0&@ z6oaQo1tX-15pn>4=-P~FEjAQ~0YivUO3{DB7~>U2vv`Cyeyv4G^MneaPcK<*;FTpq zQMXYEVL@tcscULwC+iwFO1h8YIuK)rO;;-1w@S(_euHR03fe_bPYW+m(m2i?X^Awl zoxLNLaMG1nQL!Z^1EzZ=zkKG795_`9T3i{Eu!ULEnwAvrba?L_0m-CO%0fv5i+te+ z4xK`TCdI~v3!oA2u;V8w*3h%2l}1p!(Nli#8%I+CwR74XHd;M)i3meBp2PmwjjUsu zju_~4HPV3&4?`WZhFQGGHv-^7kduz~X_I8>3OZp_n!;=buvx=}Je9VSWa|qOGgX)7 z8*`YFQly;>bW$Zh3wu#jX%bD-U06yQB%wtqRkLmfcHm!K;n>XJ?c)W~`%+7xiMJ6a zh+0lbX_5{}q>Y+#*;0e|RIR-s{Bx#pt1F`wVVTSsI_)~5%9xsEMJqzB)2Jfgj{*!@ zr(|ZRO1mX(QymiGESSc#jz}6~t`$pX3kWvRLrado4WqiYph$Q7CtVosjhCy-A2!q? zJh?G(=8FpB^I5oWPQKxl{KANbu=8g!@d!ExJ7ntUr`kJ>K>s=bHZnPoSarn=noK0j7$>VK?)pm+3xg3G3V9faqF zuYp{gG{tRj-xks9EUMDVnsS{mdUBrcG*0J0pfe_s{{R9U)mDosO4uP*_=6U0Y(^%h_ci!n-7cQ}UBUH}4k#n`5`BDQ z5AAHVQC~9u0D;G~mP?OjQ!7cFQQMNC^AVd&x1yE1Bh*OZ6#F3PIXqg?a zC4IXL%T(Gw@~@~c@%@sb+WuGbhjBf|CWJl+u9_w=qs|j#PfNcdv*J-_n!n6}x0#Cy zv_wyGEq`>byEMirZd|DHc}+Nk^cPOH_`~>l9gx%ZHsV`+ImWVzd0{fu6d7fcwsjC& zCqwpt9R|C^ia4DQNB2ZA(wW5atV-PzQix7fjqYr*($M}sTXz`C%tuvmZ2tfP>yov! zwjGtONjABrY!a7T0?rMMm2sF@0dp2_XYu^X?rZOm#o`G?wM+V8l>Y!XsLjl>;5(r1 zl%E|AhQm=Elcj5~Gm+iz(6Y|P{6E8#j4w{A%(9a7)1ikPB%iD*QbqOh1Hvli`V(T6 z4KHt8MMvSAt74MMTArD2Bkmfj$)doBs&wi%S{?_IxSOEtg78o<2Tg! z0s*u&HE41ValP#%XD}Spo6R^-`kj~oLcoq=hu3&sH9}@LvfM<)I3-O>Rzl2+&#<*- z%0RPAO+UnD)?xEd*_p+@80>@O74r&t7 z8@Q3ecd*3)dm+SKg7Ut8-ht)~3F)6Y;Ls2IAMi;1q(o;9~h!E|GqQE;PQyH&dgvd^( zGY>Laa2}{wx9^0{HkK|BvZ6Ti!zb{0o25D~?HTeLSKpI(=4|eC1o@qOqVI*vt~Nu> zj)lIml$ME7NL{lI@`$)l(%lG+TqL)$k;H3wiNN`Z1+_;g<;|^1 zGUy~6$~zz%*k;z(BVSmHnx7%;W6Q;!%{3|}2&7M?1!hS{o`GwjC0VcUYuC~s%O&hd zP@* zID?&9BxBgTY#{S>=Q)bgBPmLO@dy3PQ8<=SWq~mpqr7u<|6+96m=w4PE<(R zl-nF>!}F68=;hRC&K0Dj>ZVnq#q=J1bslje!?B%oH$96n(kYmsOx5!e?U64stJrJZ zK>&3oz?)dbUlWeeI}E9p=`8+HXv*YUmeFTWJ<9~tyC&1w$Sw&V=!rMwwQ_|a|OFwNSp6{AKv?b=fj;IPwCCW8GkeQiC z0?jNRh%oLMw$4sFA2_vHqdM(jLuELh^NeZNBCV5ivn<_HhtJbz0aVZOy(ktHe)XG7;9Iwe5dd0#fL z`oe}DaoWROim20+;G#mD9yzr?+Jv|yab#m*_U6vM2gy^%*&fIXI z@s*(cJci#$9L5dqlkoy6vg6WOW1W?O{m_2TGZ-vJhq%VtLr#V!PVK8U{-q)- za&Wpykjs3D6zw@|jKfr&h}s}a6NvhnX1%YxG$h&J#S&VHjx^N?uK&n-*!f zyZyy^5YD1$K6O;zBBzft>x- zs1%dqe}{}+sTHiXJ|eDRRJ1uI`dr~Q(@?Q%YotZX$a^0#s>5P$3CSnT7>i9Yf{`NO!OV_773T$@|!1}xyHg(qfeLtfc6b#MG3)P$Aq+A9;Q z6jUFRNxo(Bl0OJ~I|*bo6nU%*QA>p?ZemekMJIg@vD+I+yc`pVWq7|pN?rlRrkDwF zJ~tLV79jpG+=mdraL=#F#O;BBeWi@R7<4(>RJr zI;B~aZ^Uo=qgBCW)T^;g#6q_c_+uWbp-h#kv~Ck*yXbaS-8LdGBJCAYR7piLjv!OM zsO5bbTxgH7;&n+IXn)xaHA0gl?i=D$b<8%WULh|f1-DXnONr4#ZykIhE5l5Xvg}i5 z5v7`%tg2<5F6I6`V@-w>kykleXFnHlerESoWs^z3kq!OYk~;;VWzBAoLc?{ z!`w(#X_mc`abMD)s>Jw^2uX%qXi{W+$Nima7$pX3Tlws!{6q2d1k1R_yPax$Vy;ZD=DQb0F2o^yUX zAHgwSlZC!SxM!|p?BRAQmd2FlCgsT~*MCh$z7bU{ZZC3XyF?$x{6Iz!sTM&4GRe2c z(kJ5Kd_`nw=F%x9->2~njFWAp&_;)1J|e~?%Yxf^%}=k=MIB)l+0>%1{FbP26dL^ zO~!}96oj*bJuc+9&__fGlvGL;sn#44DrtC}%IcMQ5x6i=4o(@wY)h;-fDoa*qm2R_ z9A7^tikKP<#1OrAJ|YryjXy=dD&ml&l_VX<;9+MD{IJTNpuz)4Cz(i12EP*KnWLufDT3Dv#P)G$t>;NR` z;0CaUbk6o!gp~p=1aXQ&UUqb+VR6gICrVCXr8)nWdKc%#0~A| z02_7e6y%K_POR#iOEncZC7LSw#k9)>CV=@~o@nxgiTTDJ1ztHdttM zNsF_!i|MIxnZ%70tga+@7M0BTX%SH1=O(O~#@~1l6EQ9wS@8k855^mzNLFCE(ORa- zCEtEslqEoPB|p4FazfF<#?QM#=TzlDQ?$v3-6`s}GG%o?B1qU?IF62X5yTDD>PwiH zUU_+@8F{7N{l#BT4K)yQXGcR0K9*H7zZZ&6sTcgCu>oyDN}5s|R;MD5@P)(}dXP-A zA0P{@Nm9LT69l@QMgsC&D`{FN6O{GQH-s@riyTy@%HnKALn}c^VdBCTn*dAfEqPRR zxKRgAru)Ye>G1u>JjGIQx@fg3gz{`<+>)1JHs2u%=7FWRu@>6e$5XFCEm;}(!NQ50 zF)AxGwB&wW2`gj*l&uFtlmIj!_l5oKV)KLIEz>Hvj9o_W31dcaG@w&=3vE_X2=BMz zm5baD1Jp(8Dq5knX0!e8Y7-A7u=O5x?Np^LbfZ3n)F(ub6%*Dt&{*!s(ip>(T7-*F z7bIAuO1&iUH%gupYjq?jXi7*zG}H?Z2;tGQ;YJWL)EBBe^@`5Mm}UrCiRB>M zGE}79UMDTDXlg=-_lf*IGSV-|GnsD5N=r=3sOqxhs)Da@FLfnFI%;ogh>v5b2_7cW z(T#8wIz@*N+GplNO}L}nKyNZ&rSQb| zeAMcM-1`6!5b`-{Yc8Vd$ZS*q7P!_R&n@mcpf<8AbJ(b^%9WvpW$FyHt5`cY`${V) zJ1WIVZ9RLWYiN4LsPESrG}TBcr6kL)l_^Mi`l&8VGULcTsZklclr%7;&QOoRxSevC zu0~-)D`7N}K{l{?mC3v1moi7h3+to@P>=23!HS)Bx@t0Q^A@JUnnFR$>Ok+I79Hmh zK_vrRrv5PY9Ec|py{UCCYfeSnEjkc%AdSHuF=G}oJe(uqiqUdThrYjh7RrwW?r9ID-R{0tL5)Hn_q$mw7ePXeyWP$|tfZ=EI zVb#}Z>=v1J-rpz_VA9pI?IaJ-sQsdRqJ9jQvm)e&QCnI;mBLhP$5qg3#Ck1B0xTl! zKbPb&B~|cakB4e4Q>(a_K2)^Rl;(igAt^&hK~C99Z`>l*hj9J+9GS_-lCD*$k`J`Q zdDy6`VZg<*DJV*LivVn(HFY{!VMZTn{$IF@9KOpq>8gEFr$}{Wu~3?sZKpxDS2BxO z-$FqpJDZ3@Uq*EeZy2eQ6gsET^#=pb%hTInyZ6!UNywvrv{FWIJH(i~+)E?Z0$OTn znT=(iza&Z1)aADbMCwwb@C5orcMz?wkLby`dXq*{ZlQs&{RRjTLx|4ETB!RWS1RMD5 zV>I!!TE)HnlJ6LO1JBR_Zoa;R@{ zVgz-^S`ww9m)F7`FjD(N(va(GNtsGUbX_@)n-Owi7Vv&#t)#q;UNx7O!-y`ZB?(8o zO^41O#g)Eni<25$kk(OY6-;G!DRSy5I)%8E1RsbR{33sfkp;n>dVgn3V^w^+F#NMA zBzIAt{aEL`BqKnxob0z+d|XeZ2d$8Qgf;Jnd?a-#-IppU7IuAS#DE9-F~`OSgn_B{ zG?%QWEX2#Izh3439mr|%jfz;&!)LI4J%M32GzWljKk7nX7|!@;RM9&W(&>uKshO4O zw=fUM0vn$g+0~69eJ9yggDjgV3R&?|$v>1g?@aE2M8{_QI?w~zS~luXl74oCc<;I0 zAu2tZ@a;jRG^tbopheOGPQGA5mlD@gnrx~b&>ftWz6^^WQ}M;3A8GmtCa2Idqb zMbt2qyX2Iomb>akfcp8ulLLO0C@I7tedIvS9oHpL%b{QujBw%BHGxV5Aw$ye0nD7L%~aaV zn~;;z{Ue}vomiQI(Uw^WYg22$&K#=31BU4W7ZZ#{&C*(( zBQiifkm_PXv4q(-DF7dY8jhS<%s%9*w7su*U4ZS(PbY}9kx8o|Q%P)IT4*Oc+_?kY z3O6ce?<1fW8$XWF8C}mO@acFE_ z0Yc&y-JBkN%=5-e8PS%LVkXcpO`G@nI9*XB1RskGV~y( z8y4a1Q9cuGenus);r0CpQs!PqW%JF!l%;>mt6%2E6WR;$vrU8eQ6N~6OyE;4i?-@i zg?yO-pA1&0{CD!Wk-{eKcr==D&8vG9S2=w&G_yo#gjF-F=#@!iij$r zPFwsLh&cCTmVDmS@x4odxPn6w$@{Ynt3!ONN*pO#O^CkRU%jgZ?ecll3F?I(ff z7bB;)NIJe=mrKp}h|@NqN%hot!5HadQrv`XSJgX(B&x#v`eX8wM2!#CFO=@P?Y`b| zVxmKAlU=CkG85H&C5xX+ZpgJTiFw5+B}hUa8JSy`&?hmq)NQPFZD>+tTJ4$H6%=4` zCL2ZMoH^cQk$y_XyvBkPV2kQ?(|BGSof+B3v0hw7;w?vtbx8**DhioxmZeL&-OQcT ztz?o)tze_&v{*$|Q4Vsk^%aTw)U>3AAb&KcFtaH+n>Qik5JFU?d#Ujjy|s%-_Lo=9 zcSH$!cI0vKt|F*lIZ5h2DYvQfQzc>2lAxDcKJ#h>BpYwN(qTDUjqUS04aN5ixVY;a zGpI=i6dsYOHtR%w&Z;z>)`ETa}8E2A43M;nq4+lYEiOH zok|jvEGI7Nur>p&wS-B~` z3}xuHvbm}}H#F9)?R}GKpPWOs7m>oIgJ(edMe#=Jx0C1^(<8j5KqKL#RA-Y?C*oTTZ)+?Bij=iG5TzZ}rBvzhZ?Nu&QndREwTh0O z5oheo`|0jA#AE7GT;(BjIme}37A>twBhbdJJ4F_qEt0c=bwA}D619dL{UVw6*-sGb z9pV$_M}WVaF_8~Jmr>b^9)Em1Gbb{mcLOO({XntmdW~ZX#^cd8U*MIY@tKoE%1RwT zS`;j#k#IriLFo_^YjR6gQEzSj06D>0!&Ry(RMeEpv!|DE8gv_wGJq4}HI0V}oy~co zlRheBe8pJWy^j?wIZ_U#NeD|%=vI>hI zS2ZrXT~-z<2_%x0Z*n(?IaLxM%46-P!<2B}6-+Y1GE2C;?Tc6dt!y*`9gDOzBt1Qk zzkT?MZPG}0&Ga|37L!$iE8X9XONm<;uU*~EhLWty`o!* z9>wnf=@jX?m+7-b2zB%+E#|PfH}^^VK-iBxVlNR5udwzh7IDCwTQP_!2x@SjYm`!@ zo+kGyXypnw*SsulcfI2q#pBZ}MfMq5BpidB^pIk;qFQ1T8c8`Ol+Lz-=O`4s*cU2j z^#iF+{+EX!azr!7*nJpws?}CeK~l4Alqiir@dnyhbO&pBMCgn&g-OIC4No)@ezIA> z@K04TvJmJVBE&1g;^q|NXi8-FWCuc4ol>9(K1Lx?BFNv`mavK*ADGTSD?uNGP2pj3 z8p!D%KUgyiyIGN}IucLTGy%6#qhT6?ptgPh;6sE?9+jUNQnn@vO7sQ7LCP)$w&}b! zKj2#zVZ z55^i*4wX!5u*+^!stqZZoKjMGPd0MhMMl9S5qsRnB&=Lr9Ih)ocvC3l0+PSxbMGzo zRE1p}wE%3AEHdk$0FB`>f_sW{Yhobdt`SZOVrx?APM6BUtJca;yK!(54CRWi> zT>&=>8h~`akr3m8jb4yd-fq$K56hKA7eV?$DQI5?{lHA<3G>UB8?+$d@I z=?f5*iY^;tALSH?TQ4D2_kdWxuKOR(8<47_qdik{SzYH4f35!5hcrDCnv71wgQzn- z*49AIEI_`-{vI(Ik0fTUO0XO$S`ei4Rfl+VK5-gp5+ShP;p`16#v_rNkPDQW4uImB zITGRs)GEVYj8EAYT03)wRuTZkXQQD#K zhX`@vo@VH-A*HP+y2_A}3Fx!{tB(;JYK5s4YsL=BSeJw~1v@AdrgIX9n$KbCLPeqY zyBTV?9NrD~$i%!PbrO|Ox7ZpGyy`aovV?KqQx>x|%(i|Q_KCy1U1=qk(97g%+SHWm zxt0<)%EVLxg8Om#oozgQ8>YIpeLZXMO7SZMLJvpgWfCR%O z8LTcdqTBfxtJOr>vac~05URW)nN1d;%986!4WZB!1Btzoph*`5Z=_jcm92=A+nFo4 zc~p9;wIR)Ht3>GXBC*V%oRf-Ag34jUaIA{NsGP@WWm=%kuH(?hTRM?povAxBBZ!n_ zRq4nHsLQqq%0EaFHdT^I)6OHuH%2(|mG9ZZi|XOr`KQg2+`Eg)Qmr{oY(cpIB=z~j z)-y$p# zrR+S7gi~=?Q$*}Drd(q#dqM*IL}jNME#mCdm~=D>j>CA0*zz=yFdfw<;uB(x_MEgi z7A2uS#C#Ob5vfnex&bRe%Ww^iy$oA$*>pQ0Wrn0t{sop_3NZxM7^s4oX_BzkZ2%{r zy@!~vjgBc^{mKlHqDF9vvgR3_c9k%q7Rs*KKW(CX_qV3d`&KYLoKT=T#HyzyZ;{bw z0O+f4r;lG4asn9w+odXT)geO4x!=YwQ3lA>#@5WN*lk;+L{1=k7)mw?pQblXs%1Qv z9ZHg+eUhsi>Hgv<_?aqbvc(s(K8W}cJ?%7xwb(``QZJ&2m;KPZ04r3)R9jEhv#r3^ z-FjXuxH2NnmS``paVOgN`4=r|O&~2kaAZZ!KY$i%_*XI(3Q$9O9_{cETE% zKhm@kh2Pgx49gpc;+2dRGwkJ5!vMWaSe=&KBoe1U^8q&bM0XM7#vxN`ky&ljt(Q}} zR0>o+2Uu;29849)IourREWDtes8WeR_+LnE#>J*iTocC{el9{$GiIIf(<%7g8E9DG zRq(X6X|hrf;uYa#1M8s?!=zNleVgg^!lkl~L){eE2?x|=);gKe8sh#K)o?q9J7w0v z(MSp;4>4h59Bl0qtFgS{a+^HSCc#BO9+w)#9IDwO9E$4gZ#1cTxypP`;};&!TM)RS zJ>hOG)G)%*rd?Hs*(8+wuNNvMcA{cnF4MC0T&+)l+Rxe+0Q}VqPlivB{B!pu1e289 zaK=>zW?NAESyZ9ubs)t@5yRfnMErSclNsDsz;sKfy-RgyKj7TdegY{n@GWm0{JNG9 z;xCyUaTP9q45+4Ym84(vfh3^%AL9@l9C_?W*JJ6xmQz>Fm%Kss(jw(U@M7hhN`=;) zq0h3C7LH`Qpl$%vD4)W@5}~!O;_sjWETY5q`y^y1 zErrV+4WqOMcIvYXY_%U!W13Ohp?8NkjHxq{U>kkm`|e^q@b(;zLF=d2W$P%q6q9k{ zA}fs#CuVnP$e7#@Sm2>QKZKi_9_aP9zmzFTjx;y53HDG8kVb=nFF8`e zs{Uy*;7I!S>9f^L%&2be%(iKzQf=F(y0p8GCddJ`r}^cAYYYYJi{;24Q=A zZm54#i5gH+Eu#VPUQZRUhgo$CN`N{jAIO+~96=I%IPEb!)Xt!YnH-6br-`F$Dpj?i z^vLce2N(twV{~aLtfmwsDMWPOLfzw(0g}z5lmO*|fGU$5pfEU$!Z-$|LW2Mq+j0O7 zNPq!Bv;b`*SXu)q8DIeDTyzY^05Tyk9Wof<(4`lJP#D!N6$X$nnFPXgfK^D2kZA)= z$tyxyIbk^#jvPP#)33~1g=TPpX%i_(FC&AHxl!j7L z(n^U4NjE7-CdmYnY%Qt00C^3i2Uy@8x^sb*q=Eq(Ypeh{nA-{}TAwF~rIYm&4k@Sd zi*n{st;dqnu7cOUSS;w!{i~ zaM7)>%}!EMS+?6kSSwnT5;K)7>Xk3vPyh=8NF5*&(S;XnIa^4`G}u5i&UC|NX}X2K z-@*YRDt3=8GNProb#>A>BwcWKA58F0eHB23nhWbptnf;^sZ*CISx&0Vn`TJ^TNK|| zjhh~{DlUsznqezbuc(J*%PCSEw{^ri*$Ghm?a;+5jWSKxj=?i-31%60yrzg{cho7j z1+0Azq7c#1)WJ`#N?CRVIf-paJEcshrsLsgk0nEiiYYlUR&r%CUFK%8A!+DRO^EpQ zgo-+New><2{JRqNLrph2(pyLYAq_Yb-Mj$3g}O&y?sQ$z>#3;AJo8t`sg>Kzgrq`j z=>1{k6}psxa2hJVhSm`J63uF}p|Gt1x|4hOW{ybe5>*<3`buGfn+DQ{8&E#-R0>oN zg^2kWL*^}V8cbPFOtor^4b+v*CEIJ=Q%t&)oBV!oo?k(H(YZ*OaL-H1ygsRwxQ7Mw zQE?fN2vtaE0N)b%ZF%poqR*@du#E2u7Qet;xiB*oXL#FhFL@5bI39t&a= zRb`WwpD?1-$WOWytx!n0_#1pL|XLO?ns5R3@JY0xfikX2=<>(=^2h~`~A0l-OrbBds&H&~ZeiYb>RC!q@< z!#qs39L9-%!}?uDD!y=~&>27N?Hy^hCbTnR0VChE+*KyqHE?I^a389maH2qVwOVj(MUQ@q4aYL;GW7Cg0^ zhgz2?J_!%D2>2Vru;>hl921!?1+eft0MqFb zb%{yxpJAx`6HTNci8Br0qEb|-*Gbx@IX_|}j(+(X^ zEiR!gsE+mQl_yUKg`b336|QKLi$0y0z2XGSlhqlCNsOzf&m^S;Y7n&Qg{P<>5JuW* z8Og&#rdp|LL~-Ht+PU*I*@b3Ov}s3h<6zp}N*Y^jydezgGFGVuYF$$bMbyoTk6u|h zbAMFsJPai>tZMOo4ov)~EorzTLv4+>g{cW>Ww=wsy4M3|(J?0K(3GpZfUfF*Jw~Dx zD5)VaZYAjOyNVQU(^68;xJNOk5@wh;vhC4YBwG6Q1}kT9CP(oW5l4}ir?P}gAqZ>% zlq3Kx9a1Z1o$huD;Bp(IT~Bm~bILfPV^i5-x0Zz{*@xQ6(i`#H6`(gX!L5dqPI7R| zi;ZEa<#87nS%JE~Yg|~vYl%DI8=`e5tS{aWpA6VT;Pr>0kukRsFO9G~j}T6DqMbOU!fDO{)D(s0a+vanWz)NN*$UN1(MQrWSU8Und62SWp=pLO z18>>19`;a2oLEL_ktG4krns7iTXgux8NnjePHhtlL(HWqPJwAv!SK=!U>*9Ds$c$c ztf^2I(&I?z3RbZ_A-x-$NKhW`QVb%Fjnz|%NURm6L}yBFkV&>;H{3@+Yo{D~tiR`t zASY`i-+v2!5zsi_$thPa%9qTm>6{Qxp)tT5+yf}mrUPXm1wUZ;d|tTzOYw#!H+#uaBoqjRa3T9V>ZVbs8Og=IcPs_eR5 zLQ!C%2X@Be&v-ziPOXQz$u~{a9J8Vv$Qc&`Kqye@t&DI{q^SwVCNn7~m22Bge|&HS ztfOtIy>ugV+BgDATZr;_X>K^J3@i zTTvZM0?FZWK}u{>eGmH})D&WVoS7wLQPvBvHNBXytAlaj02nGPp`cFQA{3Z06;?S1 zLON*<#7u-j=fh^o5b)S}b*67XVB`jAs#|T0+=Tj^rUgp*QhJ1VXh? z4*viWJ3Z06Mo^r@I7No#D-!9=HzL@|mk1r;0VzUN_JK(6ZM;c_T|Wbojg|et*@K61 zZ8cK}AhR}rv>gaHwY_1M9vAwr5osaMp?Tp(l{8g zw9Hec(xG(n7jS(HIg6Re6c^en2Fp$G;*U`l54Sx$kZq|!aGPJqkH#-zh!P|(_buxp zevvsWwddqapQ}3MLx~so8yH&<&P{s_j2Px5!>iGzCLQG@?Z}!>F}rV|J8Qp$PR00< z118Ll7+$-Gs5!Kp?}4Jw)m)&$DF+HHD?w zc4*XPUP)6fI4_-*?2;5t!@5E03{i18bjxDT3~dnawSQyEJtA3Hl9bwIy_M#im_h-{ z8!G{812wEKasY|EA04UGzC$_qeXS7d9B_K2L<~r}@N!D0Gj>!ml$DX)Sk&0q^dn8< zR}aRy^LzOell&|};i(CgE!;CwSS~d(+wB#1g3>#xvGY%#OGA)f+&o?cxyC|-7x_qhdE17EsN${@+;+q)&gI*2WYaI5udgK|wEsnxg;l=UQ=S|he8 zM4MH4S1@e7HIy$SvaaSx>Qo&mSHxT5Ar?3~J-60oC25ZJQvpi;v^fq(BquuyE>9Iq zR4~m!335)SE>cjTa2!qYtavDNAcGI|5gpjL;Z15|f*7)%%|&E;1lzQ!l@q%!cbHM% zyWzj6giCez@;e=v=5~dpV4Opa>GFy~CFhjy*F1o%i(lCbNU+q{X1b13zSLr#)Jy52}XtC(Bxv`OKivl+=P#pW{N>M4@UQd`W;XDC#p(`PD{ zld1x(p|-@R-rK{F#neQmL#{1S@kS}LP8Fv^heaUM!jhV z1b7>dC{GVR4oUW7vs#frJYA6b>1vP`6O5%x^Kl*3{7Dx+vA)GCMt3TvZ*W?^C>VyF zGEI`FLoR-@9PW^OwSyp-mkHRR!-rq2P*!d1GmZw+;M0dXZRM%9v6|ztYTUKq=R>Q+ zKGqaI990udoH~^Nr3?2#>!MBV6)S_2+?(Q|6Wb3OQfF{+m?62A9|W>UxW7U)xFg_V z--O2D%!!^>h-KN26w~0IaYJH7 zk^$+~IHC=T-p57BImV^l1uJT1#2vx05X{iHlS8)tA9A%XPD6UB)P{ibh|wNwkJWC> z##0XaM4E~!%qQBL145*uQlEOj{h)X09XVx#aQlgl@ehZ--!KV%wiC?02bA;5z&x%xL=jA6{ zw81R8tj5Jz+ep96YGX0SVZKGj4?5;e;)Oc|6rv z+WKYO+!T;+v`fQ+`HjwWcQDl4j~_6%(saNZTZrZWu}MTK{-fQh_{i65Ld9wnPprL#jWES3rhy>Gj^5Z-P`6YVkEIs zA5$v-0Q;c)UYPd7MQ<_?i(g$7E$J5A79_VK=ADrzgOfq*Gha$b=A}}r9y%|0vXUZ~ z4Z@jue$p5sN%Sj~KP{_nr{8Jz`>L_-=t#L65PHN(eikh&8V(Im&IYQ?nzDkXrzVyH zk5G_2FKd%~X%9njxok81O^|W9d`U)K*4r+kaez(orNL#}!^ihUv^OEL9`HJPUl2+P zROOb;tw{w*Rqe}oWjkyyZK3$a#92IhRbaY)0i{u97$YpRiD;(e_ZPZ#B-n2pN`*+v zF!Z#gE!3<9OFJsGs9Qo5lVfiqV-r&%5!ZnjjWaY?W!9iuWyK_4?wy2l9D+#dPIiuO zhU~6Uht#I^`mjxh%o|4~l_5(TV+%LMYK}ZE3Vf>66>>^{6LJI#C5!OL{fV(%RdVV> z%Wxw8=}{s&nbxR4P`H;=!(gUa_Yjk~3WreBkhiCC4!2cd$)PghkkXPI7uYD+AKeI& z7ahs%hqx1ov1J{aoho%tw(0>>3%7Lj9pza08$~u;sxF?y*yFRy#&wP!%BEVqB<^PW zp?3sj>18Azk%%uce211Q7MvgAwKo)2WYF8TSaaM^AdetzV-aUNM2JR*@3tlom&R?h zms?8vqf$IY?eT^ptbMvF?vm~$?CUlvG$-9us5e_dS^?leCgb4~JR2kUrKoVnwWSx1 zvOLQ4inIoj6R7n*rY>PS zE9Dv?{{R=eK)b=rNc#>q%w-p}MzaWLvbEH{jfJg2c$XyvKNcP0`& zYHEyAkozC5P}U9y{b7T2NvAj8oZkry$(2mVadR+250kbiOCtXg8p zXpJcDR^J|7`a+_j4^Q6+&MO%_Fuog0ST>j*Kt19?BT<;fGujzH7RHB$hTE0_+0E58 zPA#bDl^c3=jLe?pv{Ad-a}2wRu=LApr#jMtK#L9zX-jfGXxct~cu&PyjuF-rh21F* z5VZMT#B5_x7F0cpVZ>N^Lyzp};h@-jN}z8oDE=XTCmEdq35GlNgk# zQl(iKc}DgZuo?v$dYvMli{Vt)nLh??CBjoC+N?I0Sx{0G0R(s$%{+AIwo|iWcnLHq ze{>TIhC68FrLj>QZ?2k+On`0*i9a~s@G#R8FU3mP-NS5yFU;ta-Y=ubsA8IliD@{I zJeh))UK&_}K|Z5sP1ve5D)X=J#Qpt`I_#@dLBlZR5}u=Fyu%wJ&TPSU$Dy`rhuhz93?WzD&Q z^nCi~brEw!U$1V2HUcbf}njMQXaN7(shJC3lBp@v$*b8ny-&lyy^_8XC zw}mq}hHyPAV&O@$O@?c91d*>;x!_)s2NStm^R$VY3#FO1l-hyo{>Zvpm5keMt7@2V zNWH^2?xls)6)gLS19av#Fg0S7nkCK#?NFoywNpV@{{RVnN2m$bA!Ol`<*_Ci>zO6# z*rJt=*&L;zX;;}&b0_f;S(k?HteXtonb*P?Mpp>UDd}c|L1M}Y_fMD`4}??a;Fma) zp`W8VHT*2h+v%PSg*?^rFYN$#7mC^NvP#i18Ia0x9}ps*l%$_}Ax1Vy)HNb`GvIuo zbwOsE%w^g-gtK4TR@b^nG0`V_kHksJD#BEjq)m=r_rOJMqTAppDi+sYj@!pH zof8w3SsI!SPy)cv+7)L8lC3T&%Cbx>4ltb~V*nm@rs74xf`HaU@}Jzm2SQy1$m0QH zAuo|3SFwheq;{HCa6yENFeQ%u_V9oX)6Cr$I>2;In<-j@XauHmrpF~w(~Qpd+c!k*LL(1Uw4c8u@5{IFk&W#wPt$(S)f=AmF4=ULEnyM;SC0 z!@*uV-|+$@Ly00!haYJ?K-=JVuM?r3$P>VJ(J+UiQkrC0V`vhQ4%pQgl$%FUzyhPE z40gGWoH7QpKy=nxGQw!#;LubQ1{Y;~BaH#4l%_ZaM8F2)YmT5da|J@c#s#1QATR;4 z+M}rIGQy6YfB}F3yZ{ye3cX{D4J9`S5`X{HtKV%73ldL-;?zmlrzk4JrQiWdB?&^_ zu_#7d#B{!ZpDXDB+cce6M#MrzBcAicV&W3TqdCO&8qye-nkX#Gn@Bo|R3)n!1sn zFd&dpQbA7X*4co#BS=V4+hR;Cg-#?%DPGH&M(ZOuN7)2{Vy>6#08ppH^h!*dE_;8p zt?PYPDQHRo*WS1!^x6Zoa@vw%w5cjdAoc1!BY{Jf_Y!H8OeoGDZc)E(dSz>wolWC4A(@jeg$^k9AvzlbW*)W@G` za_YN}y)L}LC>x|GjTUy>ZDB2q3H)z{*lMJyT1s7UA=1!oR#DH?0yQ=k&3%k@Gn74e z7qbJHnoZfa=2>+XS`+Nb%o5^sAw;L4(1=TrG*`|zkWB&EnrrJyf?X(9MTI2gIuJ&N z(bhD{$Jon??qaGu-VB^^CSjJ;Y0EYlld8E_-AC?#3_;>C^+S+j@heewmn>G4lKzS1 z}O88t$Z%_{TtWcyTHa!{JvU$GNB;1Kjx=UJ!+k?Fwx& zq@UF&9}bZ65^$$xjM-JZe*p+?#Te~DC&t5D>3BtN_t;-S$iujms;x?%H4RP4 z%sP}1E*whRI`|L?8gCBAdijWw{ROr*z_Qrg6D-Z3IK%BFDn<3%UqiKwPRBhgi8yL2 zDOfUZg0&~9lO6h6uBKf#x6xkuAnv#^JXs$gX`a_iIt#Ti- zRlSau*HPsUjFI-eM4#XmCZ<&Bwt7`ghS^fCMpgd+LgKU*H`7~#))Li

  • go#;J`c z)#qn{_W2saQ;G#PvYfb5E#M1j0DdscqBxl>cqvzxOVt@r;8eWBNvTS?arzaK97#K7 zX?IG%*jncC12lS)v9ZOLQYI%QSUFr_^h_N!O3+XWNIgLZLL#}kCM9G?;l~JB;b#!% zT9pMd^YV##yPJXoslB|@s5ZYykn(Dez)e#V92=|5*7%J#IKU{Ab=kRcf5R!WnE2?D zMya)pf!-B0_(ZN_>4QcgBG973T; zaS`)GTElf_C5-fwpLAv|o9~$<=(O03gq`86Q*hs)#HMB$N>vTv;_DwsEF8*!UW*55j9+x0jo4{{Zq$%(jVy=}M|Bz3g+P zDNiZZNJ@j&&@`;0F|i|ih*UAt+t5^{V{_R91kPdEijEwqfh=a`5hU`)jQ8-0kgSMwzHEvdPP7dY)LNC-`4X+86!jY>4i97rPis36+g`9!Ea zy+2W@5hnq0LU)B+Pi@vn_F9Xjg&|(*v#TiAOB~kg4N24TX9v5E^%Yd=PB^rv6i6*d zDi%3?wY<0UNba9Vku9I!k<>%}1GuO0J}#B$^#-g6{fvtrltIn>UoreopTKszP*y5! z;i^3CI%Ak9ZOXAy2s)+Z5ahblfIZ7uAxgJA|P>GI?A`^ zO2d`J(Zskt%ribzo2gAc*-D4oLXEHIruNu_8C;Rl=(&uwZY{BGWJ}Y%j94o&#qFs> zmcG44ksS`RTMp6Fi={(k0OC8R!uIZ;L)H-8GrYzQvBTyn>2~0xHsNhr>zek`98;k> zMn;2;DxIDyT{8^sE}tS?v8<}sGHx|6m%vg@!P?N5kw~s_aWOk|d%DDFIuwj9s>0?OlNOQB6Dd(4 zJBW_*b{^7cy*{9z2HM^uyv%Vy9y29-jUgT@XLQg+cg@a_DIKGr7ifD>(?Asq-)Jl- z-(qnH(=hqO>{*f+lp8qs%LU1C0!_&|#0MI2BoXW8BG(>D-4WU<7mK_esc-^soXS@H zD*eX*DqAA^EZ7X51l)+d!JowVkupMsCJ@Fg)LG1u6?EMy9zQsqr({P86tBokRC2gh zkdxD_D#TIMYK<cT&Dh8}!F>)(-SqCJ!T9W0`<7p~EMYd4h{{VzIrD8OjxF;6OV zDhH>i-_i>KVNa$5o?X<1Az*?C+(N8MM!K*ptq$sCLzZ>OReYz*tQvz!&P7s1E)*ri zC1XOBC^z)|Jcki& zuXqm7;7IW$ZntNUGMx^B-<)tPD)@ybFO@26fK7s~E%Ll}j#<+cFwieC%UVw2_t(U0 zzleYY{QZ439H?<3!C9=IA2O~!`WgS;h*M;dCdUwf98)Bb0CipyD-i9Bl&n=nwm0ASAIi6cm?HQk6kU+9R8m z_9*+q%ysE#;18WPqH1k6@<3K}+}p>g7KAgWLAqmA6OfH}w^-mECh2RYqbp~-;9)I+ z!G4^#)tN@e!WCd^$;lRqf`+?@<(w5%$pY9aBYm$NYywsix132p*4xKX!w`^qV#Vta zI*$)H<(;8bD>ltESb`6nCz!rM7Zf-rkH%oC{)C+)h^6`l(Lrn>}>N|5uDRcN3b5NZo3Vji(a&n^QUZw{i(q^Azr~w^| z64AkNg4{fqlaVm~LtFz0) zlWy=A1P+P>5J%$$ogZfLz7^uFPFAOhB@Deul9eiDg=B4NMxjn8Hu6OIwE%-_PL|m%Kxx=}WDT6AW3VF1CH~rCN7g1yt%(jdX z##6%%7E>nK0L{ND8)Y`WppZ?jG#z3J!>(KMCA`{E1}an267r&cd3l!WmvLuo%lTM% zMb0SbR98+`Wa0}<&r4Hgw9d4+!nNEB5Puk-T!@ME5!@7^Cy4mET8TWO8cUhb3ATP% zzES6=PLW&1WpIqViQF_)q>=PLNRv%5q%?tKp&$VsVZ^&;&k{PM-XM}h_A6dWeA)j1 z5a;=@_AX*&$e^Ay&OcG%^(IAxm8o?J^n`(PeszZ4v3$9e?3F!-`!&@#MKIM-$83qo za*3uC2-J|K%5IUipzGEfmP8sz{o0p^Gnn@nOrnD<@3gYeVqgT4SIHy-q>I>%hSwI0 z3=*V5$hRJ@#n>iSiui7$BQbX7T6M%N7s^nj3y`6y0PDO+mQ5&*qil4$5IsAE#bXQ2 zC@rd7*%IffQoE>&>2cI}YZ?AKnq{{S$eP%$U77l1>oW-pWpeH%#GQ%=u?8Sxdy?dj zn#ufsGlFW(%QouQBOy2x(`vG^q$|hJ#_JCh)pj$va3^Btj2I?roljkKELjt(RI8~v zEtiKeBpX3e}f4peE_Lf3VT+<%_QT>KuhyH%l`hUn%9)IyYP2LNDjh6(W= zWyLA-w5U3KdKm8xb~TV#2W-9DgzVyg_a$v-kwm7-sEb??)E^=)53ER%v_y-h zTz_W_V$TinD(J{q6l&{!+e}#^$y=JZ&THD?R~bfP2;M3iCzDIbJp2c6zBIPejtD zowA)JMS_!k94a4H;n)o8V6Gn0JsU*3~OJofcMU9U3^4b8heRdeZRIF1WIXf=vjaB5C zbUN8s<+$3CN>mf7t+-c9+S|g`!)$FTd@`tG`ifH`vfWBvOiaseIf`v&=^7iGY5*GA z7TDP!xI5ZLO0YeT6d^K|Sz-ZkXbpws>TW>?&lN4MS=AaJj5xDxH6)lvQEQP|{1V}fPNe+ur4$1oy6_9Vj!T;h1Kz#u7WiaC znjz(B((OuOT4g$|M1pkIC88^2+U(GmF_eR}m)T6p9}O!>2=W2$~lY z2N1F3&O614W|mbaHsc|r2L*~=XnTv^!0a^eik!O>@v&XP?%EiShZD-9;uL6=Wm|4H zlF%fjGT15G^o?kG^-aD}*~H{nk?r-sbBN~Ismp_%!IaweDz<}TulphX9(r~Y zky%t&Mq+0Onyjn9p`t;5@CZ;YFICU)JzWAT9=mq0d34z%Z+k-lNJPuz3o52`Bs%# zl4YQk%dInP+WMh-FV|?$aGCYd2R14y9(sZjNfC9VtZ00DJz>A6{*tE=a{Q|Dk1?qH zK!)U~R1t0cf^o0Xlp!jkXC=vPX*-1^+i&9-Uu^@QFD6r1?wKZScK>pBs3Pyb`Ht zO2cc&rVte{1)D1x8xw6t{{R@c;c~2-q8?~z8TxDTc#krr+(U_1-5~GeFYytj$4sc6 z!#Tvx1vJ#7wYo}+Gfa1!NIEEAT`YZiM2!P_j(-wq?@i$Pbn35}VR?OP%iiBwLhtWR-LLs`zqP-5~0bc*!tnS=iT zl(obmk@d?;N=9{I|LzOk#0zi4Z1d_+GNLlQ)w zL;^-Fm!)|u>7NT5Ja>1+@DxxjR z43CA65`#NJmEeU5EKiTOry zTWiuGP82?+W3h{{Y`#2}=1Z*(C~BK3DmD#Vdj6Yz$$ftEze1#OSEgs6*rqqYJmEd?7L z3~=eOB{uyXe8v`}C~QHF9UmMe+IF#qh;C%1_J-j}8Li|+p^4y(hohOIWZ)jr6r5U+ zGxA+OWo08@F7b#H;Tq&ij&#nxHNdjC^}C*zDN+@&K9`Ejyb7NDnKm3tkD4RRQ-#$W zK1pEnP&|%ndDvPia`2LeOZXF^ok&kLP+Y0y%%M%I^@V}-yg+fHQk9(slz^`h95^c~ zcy?B($1$xG2BQA}lyN!+ge0PUl;j6v4hcHObhmrJbV5~T48xg5=V(#GlDSo1QE2EH z5Y9oY0AXKqTR;Kj>LtCSjOCrlO7TIlwTvT4+ZHmD2zen%^e~#Ewk@gHXWLQ~4Z(y9 zM|N_Cxp{J{-!As>jvWzFQve{OfOWWzoJ{4^*lJ`RghG&(BwJaPHakaJICV>jR-!m` z)oJmX+Xxy2#nh7hu^AL?riZ7-BS}#uZfH9q<2qc}ZD{SBqbmhK>j`L57PRR=;Mx!e ze9%)en^?zA4dr)+sGK*;`NGyp8*#A}Gs3{5p&*XG?jyb-%>veiBT&KRFG(zgC;j|C zI74belA-m&y{sy@X+gS+cSzFdMUTW12g($iT!c8M%$4{vwUsuq5)|rCqtK8K$f_TX zcDa$|fj&f{!@NnCtsp7460m#-KfWhJh#+L)#|m1iiIJfZHaU|Z%L_+E3krwStYyZH zu-Gu6A?ylXAN?$V_t z<wo}0k)Ug6xukD!TUjBMG7~z$HYS; zs3D%V&rp(v0Y78KGJ2H!dcuN$6moFSTV<)}lBY<}d%BIF^oAuWE z!cKsxg|(&6lyD5fZCBnn0gK)+9Wkxa_U1SS7pdu-0I4~E>l|WE#F`npa-%3pKvnhE z$J5F>2VwOk2QzvB(mDpCv)RU)KyciqyxgqAEs7_OTIs@-QHyaz8ClMEgr;F6`W*TY5DYvFuPceCgl%-q} z3H2xA9n)cSCNU;2uTrFbO1*u9ZB$Sk%wzPLhi48Qr2j}YPQ;A+{ zD#rTU?sX@B7*>lKdm7a0HB*L@O;n{8w&tZ=4k1Z4H%_+SW3hzF8*X(L;fHZVw;8DN zxRRbSJX8eZLtyenlyv|L@1U`YOwiKFF?Kr@msH@ED*H`>eNDtdkm51P$|+pJlY5{f zdXulp5GdwUT~!*VD(fdAmriv8-+a81qv}TRbUH}dJL#s@y^tFu$TXxUrm8m}dfE^u za2uaA_g`&ix=@!<`lk6;`H1b&({+c^*EDnuTjH*;9XR++{{W-R)XJ6hkF1bS*~);F z{ETrkqQz9xPmtv5r7hOU0JA_$zfnKdCtnyER2i^%Kl<>62n@PB;zHrDacn%efHz zSkpsI#$FuD<9ch2IFXzKkyh0tbQ+BhQM60Lo5N&$n6;v>sP(sL>VB0w^^P}~%Q&rb zgdXw_f|FxnO~}$Oqms&*LWgQw56W>0n7Jvzbej-$x)r)yNfs$kI_N|_%w_B`IAUUN zgm{v2n^+-I^{HUWCIA5r%r&bnDI)e-y~Pu4PGWVAQQJ9KUlq)7!OFI9TtzAJlHOo1 zDN#vFjRUQMTnTUuY^#6;%r`7rg~uk6b@1*~CQgD$6(Kor#0>JtWB9DlTNtSq> zp-+n`j8i5>RmSfzBP}qt)(wtAf~6JlVjfFUmqyGRk5~2CU0o;yUX% za3CsiOA~Sm>K<(bl!K+S0c}mZplZEPt{6H4(?z|Y}>2MT2-|W<~L(+a!J33lOcwr zy_~qyqN6o3^Gmr~OAA6CWlAT#Wd#h!-bvVql@UB;BH6qOvKsIiVum_>@bF;5NF4j#l|C{voY=(2)y{*CsO zH*IH9fO~}4#ZMQ*sjEc%8C-TboLa%lX_hJT4RR_J=hv59v$QlFqVPj? zER#hba}u12w%TR4%tM&xM`X3Rd-d!UnmNLNTvYsWGTINkEeCM}U*t+geP;RCaHNZb9?y5bcLO&UTIKLO~v$y+&)JQi1`(VuFxg1Ji6uP zn@f$X5JG?=#w{a}^F&sPj^mdGX1hMlnvFRsRTxH}l=1;RL{TNI%ophf-$@ z$grh7F4#k^D((?+bK-g!EDmqe(@otCE54h8H-{5AaU92$Mh;aWDoyq_AG$hl*!oR# zDa;ZONx2CC55Nn;goE_BH?sT5=?b%gVbEszjySWJf53a%-&FTw$aqi zoSEz@+u2gvj-aa68kFnjcr4+(?**KhPkwPpJLSuN$24vx{h>_q}{$se?xrfa5bvs1zUs>9)TE12~Qhl_@mmR1lzBQmzMu`bR9| zLaX^PH1bW77KL=u#6oQC2zs?XbBF%r{gKafX?9e43*40cP*_pTa#ErjO!8e>P3@Q) z6#TkJ8wwn{eOh@ks&Z*TK_clPbUOTCJ42U;EjF;Fr!a&` zf=5pgH8CUtrG>{(W07ZCHK=p1REbNCYB$#L)^Q6o)6`H@6JR$Gix)?BT9YkVWkqNO zNCb~DYsWQEq^wQN;MNk3Y`N~NUf=M+;xn2AqG$$~b2fK7Lz?VPnhfm9@01IubTPxC zb^24vQE?*Ph85y2L7|As`h>X|lVc8JVkCs~g+OLb#vZW;UX0UqB^KN^C*3fKN{*#r zr|_E7sv%L&+~dX~C-CC$s&$DADjU$vAwxn2WhYoXOLTWZwJSC3{nNLBg$O%x^`=|YlJIKNNhT`8J`iotZCbDGyO7jE#>3)uA< zT0Gm2;bo2a8vY+Lk{#5Dr6-Aec6n5p)p$!e`9zEh@d%$HqPSSo3{$Yqjs^CeQL_W)HNyx zPVzt&HYZ4h#KT|6m4;eNMXX3Feo|?XyOPd<=5m`wOcvz%Gv`u6v+YNUh^SA~zP0H| z}#^9uD)-;PUiCE!dw~u=;<7#}OXi0fK3MS_$DpiiY zCLWU`u@g*Ko8l~kD;bcfNrWgJh$h4snud{G97y0))Yc`cQ>p3BkreZ|jB zG~ZaA%weIo z(iEZQKqfFbA)&NrV(k_8+7E`!%GIjWbRY&Q@}i|AEufiT9&%DIp;B&6!^p+=2|ZCy zw!{ponN9eDnq-_OrQ+cglSJ0wWogbRQNDyjg%z55jNKXQ_kz*ha$FrO76xH+YusB{ zYEax%WoUP}$;Wnhpm6;9w3}fnOzT?aL#>>vxUk;W7KT*G5|sk4*7uK$ zG|rqp(;bxMX;McO;O7M05yP3*(V>^Wh*Gl=@X`{P3_oSwFRz4Ezi3utD>BmM-$*vm zV1S}5ZD4)X^ ziMHh`1;Xt*qLka3%Y!lyu!{mZrAjyH(i3NBMfPgJKglY&mnsgS6N^DtMF4H*rJ)iQ zknnLzg(}WHkdSpC%Ril*zjQ4o#D2*)9-G5MlsCAm1vQ2$4$&&=45e;mVqlAEaOZRExYC#3lfzL2s@8h;1%bF_?n&!RHbE> zLZxPxoeR`vY1MTWH_-LgEby&}lVnrlP7y^T5Y99}1*eHY19UIEl02+LPa`pF!c2KJ z!ZMn}N$xmQk$YKL2+TGdZBr4kTGl1dEiY-5~iBa~1lil|^56Y{uBCiBerY zkuapqBr5E!Ln`vDjXxJIF~afW}NC>wf*+Nvi7*L zkWY+Q^F&TX;j!#oOQtg8$PPB*QsN2R5&;B6H!UoXm6XTYhlD7kR_jY)u#_2ayQaVe z6<=%h0xoc6w21S818`O?dk(nV+_QzbiFJjcNj51`OiX)?7q3Nq2ZF?ODgivRTiF1wE;PE#L%gE5&l|m95TV*96 zX<{NGA0i)Mj9UD}l;th;m8MEz#@i(9fOH=ZSZjz@JBYCs=20+8QlLoO1FTokF34rt zOAWToYDQ^d%~Tn3N#oNpfi08q7WnTMoC9_6+=ZN>tZ#;whUzmiZVMLNQ27|y<9d-t zHB8OIY-9X@txHWE8Y>ODJW``?1GIK=v^5!1EEluwNBi1ix$00hm7WQiU=6IXb8Y;5 zqY3TII-{$xpx~uWi#nfprp7$eBcn|OX&Hi2Yx3}(co%%<)#@D~yGX`NL@kn4`q(yNdNvPXh}Qm#Dh8@>mPS-EWc z8SW#8(eNA^R~RL6?j4+cuH)sLk2Bz+ZGDBo^4c_zmZVg;(+!PrB&(PbR#{@sBpYeD z@ewH@C1aLDj}km$QbT;%CHOy4c9SPid9@U&q_(7xb~lLm2N7a;cZ)OhtUoPOs5A7P zA%9mi+kqW;yJsz|u|9`$_L0Jk~w0$@Ln86|%=fxXR8m@^Kx&aY*K> zUnzuX6=z)%ZB?3Fw88?~aV08Bg~0|UVVx23D=8bbFJwBG4eE=iVc?@DFrrqG?jcgnA`bD+{8XOeBvBO0PqaYe$KJfr*a z-%b8HLNIR7OlMrHbIJz98yL|=QCQg%`&5O=P03FSg(M+Y8`&#|-or?<&J;4mR-Vk# zP@Ky`Ngx1C#qNCLJH^SO(+VAea>X-b^I@kg4n{&6D%<;^oGcHt)n$|p>FP!WhmHge{hHRUJ*gt z8qc3n*oy2@a~*Xg?-u$B%|c&@SgcSby`3ttBWP0OeLTZFx5XaCJ8bx`%GCC#RBfy^R{{Y~M{w5lUIAuk@ zV9KzmNg-FibVeJ9j+SWgJ4a>biVQ$(l#zw$q|6|pz!a0vi@>ILK^}O6+1`c36q5X_ zMP~L;O_lQm7@LobaU;)%Os}pY_A;NtPN~XT%Z+M7X4eD4&b{r^z>OfB)VTy>Ls^da`8j}IPqR9-D(d%CQ`Fk_8vJ5j21m+vFh^~r z%{UvXG?|1Q2{sD(gkCJ+m$?Q|Caw?0xO0do3Y2&>>c68ot`CLC0K}`Ynilme6dpyE zl)8iWk`L#2<(;BGV-C)gOh^=cnGCvq(|1n3fPo#ev_njN*@mfx^Eo1YsiF2wlB;}G ztSZh?80TfxB;jghvfG0~l?ds>19F9fnWYq;BWUTt*TQ^Ztzk6`udT+$=vls=rsP5# z6Bee?EHHOy+I@5e=YeHr!upZ;CL+%VVoY;)9^d5MHx{-O65GgDp#K05IIPRU#$3@h z8JgtAuNCl9m*1znTUYos3y+yLimbc^Zy!QrIGg4(6^SaQ78ZR92>aGd7;^?^{^l8jejNG0-+!WfMs@ z@QyGNlM?D-R)9!m+gVT$92`n)tCBs{>6ly?Lt@evH2hAwOJy0ZIzn{VtDvglQ6WiK zx=17E@P&9{b%=?aND1!g3Q!ZQ$0t(ugdh9 zb=aJ4bX!Zp8WfGhQ&6++i$iuO+7$N4u><7^6+(Wgg_x)U6oirHBdSdtYR0y!!!$HX z*cnei4ZnOn9KFWe4GLB*uV6LZiH8spebpO-`Pv@Y@)~#4m3%ktf~J<1Dwl1;pd{QM zLKFBHTAZWiH1VkuqYLqJR=Sj_w?eP}{t+S^Ng8}G??~blOo6OeLx{2r_;a?I(Bw*4 zEQu_19V^WaU5zzH7g@Y^#Fzjmg&Z>_!XN`OU$&4PGubXc29xLsjvO>rth+)$#m;~M z=9mC5aEJgmw2>XKHd~o0g232I2=Xe{BpjiaD{|JJKlYW%Sl&4@U! z*Bnwwy`e3gIkMAhnn}!eFq5YHZY{y7)M)|JGD3_1jDE+>jtUes<~^6=31iVat)Q4g z9Y))2i|e#-10kT2PmBNpRAq0MW4MH~r+$KlYLk-f&6NfU(3c7=m>`{U-%HzT>3HA; z#0i!~LSZsVT4fO8(#UY#c>%C1BTUD0Z6k+G0*@V|fG)US!{<1gRbrOYiDgff0JZIK zlB;ZWHn8)AwgI?@KO=?aXYlN-!k_jzqy(%XB`aD}XHPH@-AT|3YHzipiJY;z4lP8a z9Sn5gwuHLiDM{7@0;?3^CvdN_tC)wInq@8pAm1X7yxRN}JUk8Krw(H!O=v`P4VGID zB$ZnK0J=JG#u5(0LjZ<@TP~gv(JWX|Yq?OCR6HhXRj8+(%`& zn5q-J8RC1K1FeS@-lI<}H#*T5%1N+THyLfc?-lv+YD9?aT4pd|a+8v2Wm)AG+SZkg zLXbdHXE(%+B8qXMLNsVK6t+$J1)F%-6@KV$j*Z3~t+|WmCFUFi6D%IcJ=7t^l#dgA z2gV61I+-P_Rg9RTl5*ZFB$1Uxz#287_CNo+pQVW$7q~J9c&P$!*UJL zL3}&?e;Ac=gg2jx)Daoc6gw;Mqq{m+^&NiK4c6$-+65IOO!7d@0UuOB;ef zxdz@hHrmD~Vd6O^MahS%5gaM6J5p+OGeIo4+LPVYHb5Gz-^7ndy~RCT%B--VLy9PJ z{AQ&tp8o)R0u;mP(<+9_N`{1A)+C}a0Uc^*27NJ1t9?}Al}liok7%>uX>eZIjjx!E zAyjaZ7-NkUE*DQvw19`DrIM+((4pQ!i)d|mPMhWm0O@fNvheFB{YT-I#DA&SznjD9 z*QMVtWX~lm^Onv`*+r7DG|ZJay$9JF8$?NP=}8Z))`;!EdIXg+ojE$Dl+lxupK5kz zGKw8azNx0{O@oD923w11a}Q_}sO9krwf*YqGc7W0D_oS8mP_DYl#)`HPe2bZPPWzu z5K;>9^;+C%O68x<4bq23n|V?DvTwB|hG zT_R;!vozo@1F+;WQb_$>07*U~IV6%75%>P-EhC*zrjPNa-xVms+#=jgWQ{beQ=&`pHcQ(a zqAYvP;p(!;8)i}*QMZ-VpoK1ezmht}PX#+n;hj-a6y&K?>89z<6e(GhjLqHL);{1~ zYn$CS8iFC*e~0Ea(QDJxrg)(tF+WYZr{w6G%$W*_mxuZ3gzRT1AHBs9GAylj->ah{W-tx@*(Syiic5 zsg5+`WLTlWINDZ{IuN1jXqyMC@8CAo5s!ll5`0xdJsoPK(e!drz+t{8@8~NNrcE9U z@rV1<;F@(|wz={RKFqB^BwcJ-u#~KTMTTo!lkTV(g)RL*Qc~F6pkg_C{{Rp~{Hv&T zUFo?6A!txgw8XpU0^>{RVmd+}FOkufo5K#jH7z{ayYdoK@0N5t=9!#dJ+hlz{Zf>n zYgne{!Z{(hkE4+c3yX-;xBx!&5 z))>u&W!aBIBY|_Bkb6cmkEu;_mXNXBbr%gu?*-kvYxRn5@>2l%yp_07?xdf z(NDxpP6-KHr;PBJdFH+@M)p6`(+(RqW4*R$qF zo-r|mF`Lz9khy2czLp^-$H3{K@`?JH5uwwkW2uQ%1Wq;$^bQ~&@`e8ZC^a0T9wp)u zY2^udlBstRtCZh2cG~VBuo~K4C8*Svwme5#0sKS& zEU?Ui+U_~3&Gmo>22UbSEqaR$U;_`bZ7TR$xIhnE!jwkH;^tY~%U7V^q?BQk+WfBei z^e}2WM@+~eq$v%6JtLMBH*?rBMxyE*m_mc8(=a3jcwf>Mq$Y(^cu|xAkf@JX9K%VV zx?>#9OQ|_XxG-2zxG6LbfrLF z@Pk>}IaIy{P*9TE((3P})atMBwS;q7+7dXQvDF&C-fWt`ugbaTLyJSX zRqr-#2=Nd%LTFITu+03^b1ao1Kv`n?5z^ymO@#`!D9lw=nQjcjpjYmNSW(fM!OTo< zvH{#_9Ml>_%lHCKtDy)&$B7#J#3jv(Q5%Y`3Sx%pJE{%5Yyme&Bf#(Qj;YvbqeiJt zZy6OxB|#4aU6M!%R$sI01Ci8@RSOMIw#f~WhY+HbG_ZFY+e^Z=9HGb*H|tW!ZeccB zKQ9PNodsE=H^S1k$!$R=*Zq;t5bl8?D}Xr*v*|ucLXE!|9zf6;Ox1Anfe2|%$%_)S zq}?O0mEhEw%A>7ZwSAS#DCPk`r=jxy0Bj3mhFm))<{WV{btI(}>8m!>z_<-Mea>Mz z1e2xp-V)_!bkW|#xEf)B?9N;_u_N~zLR8MUoeEbDm|+?us1dm^*NDaF4>jz#cE~{q zaO|Jo9ZtlxM^zK4sBF5fCc1hO>TP|A@q+9sj(_r!XHeSmAK3(cH;&QE zH}I6((mBF`T27#Ws|bzj2>Qbmt@&KvO<=Y}HZu)amy zf)&t+UyLWh63^9FO<6*a0UkHBHu4Kt?By{yD(_|Gi-FT<9Kk@}ox!PjB$Q=Oo#0vM zSAZtn;jn(rG`y$88;{Byj}_cQ;kyeI(AO$~p2{O~A-@*K7AiPXm~C?kDqwf~I!9J& z<{lOD8^`4xZS1ZiPQUDjyiUV@A9J+46)jK}PK1u9UxamWGC|-baoOQdwWy(QwBMT6 z1Uv6-^cwebaeN`A$pU6-ETu#4tP%Lbi-~MYz>v73@P>s`mkV(VnXuK?)N-FYh*!Kc zbHYPWjpdWVxreFLmmEqa8AFaVPGp|hBUN6VfxQ3{0>Rq=kh9zJ(GqHgcPdEJ)ax zT)53Uvys7j7iYtq2F@9z%Trb^hM5ejTj*1i>UHZC{`lL!GGfC@ieTd133xVrYHdGR zBKxf^BwsQcQArl-bP#%Y#=jO#ale^OIO$?apI4jg^H7q-R3{4QPdc7+SIv;CMWI7% zq!W3_*C2+~sn}-M z%f>F2KBaV~FEGCmq__z$L#|Si6#LA!)jefg z%(<7DEQLIUAfZ9#jzUN#;^2X{w!AH>8zL_fc!16p$Ms5MhSbWbT&&7|=_l&k2Kp2% z1AhzXVJ;ReN{fZy9y=JSgG-s3aROkYkg`+;XBs&bZFMHs@zyIcV$#X6oua+C6;n?P zc&A#!b4m%9s&i7D))#ORq}ZEkK{mGV`&ShE2~ToQ@B^V?XDw{Jb4|OuiRlX_$G&)L#$V=b#YR!i zQ^*SlbD~c-LV8-`Tj>@NR55mQcv+98>by`B6FGU$qzAGKB&eib+U?dHlcn-Fxsqp% z+&`q_dbT7@Nw7;um0L;*%2Sy+Za?1Fhp;=ZGnp4Mv+FKQ;5OW%IIPUH_cfJUdyNS? zYj1_3%{LWZgifY~GOI6(TvVl3RLnN6Q}?o)bpyCby@)>Qfd@mTu$fCzr_@|a&)}9i zl*8B-MtY#)8$w!2NhAPB(@T-8V)%>?Q%JssO@{vfi?xYfD&e7CqPQNP!}9`R01%}X zzobf%o7@ziEw>Q98V?(%)J9oqDld=tHM%_do|XsLr&~we+W)DGcK}+T3S|xcqt~}!>w5wF199D5ozsL1fD&lqcd)}kyV#Zdy_Nv zmy};4ZhOhO-r~YIsRSbVigT!vn+xoJ2#Lh*hp}wSHpZ({ zID-zqYjdR^LHPq{&Xz(S982;sW*=D=vYti$L_;!LG05{Qeq0hqfc&DfNjl2XV>WR|hmH1b32Cmr-v!!j|H! zuSrU)6iV58c3DiYw?4Uqf|84yoSBWqj@Ku`I&qd!TBpfzQR13IoXK=iR2m@a97om! zs@EC2x`^N-SG0B!{`r^+k&Bo)rzB9Bchr(@5H<<|_9<1yw%kGoLv~SkqE(qU~=|cMsyJdZQ;iKCqeg6%;MIJvQq& zW@eQ-g*P`PIE9wf2vyrV*z5R3MpRD5$+OvGkFRkSa&DP0Ql^?VZC0`B6b`$1MQqg* zVnIGTV8{4fh+D>VblzQ=UT)uFDmN7ew|4jozoa zn}KVHuglDOJceVnPZ8bXE+cCXu)9k%Kyuwl*b*=Di%tt4UgdWaI!0OiF5Vt#EHIzZ z51q9pG_fdT?2cWnaa}5-LuOIJ6)=IBr2;g+P45x&awTCR?+W;bT&z=+-8p4bblW(D zgxyMMI_L%NQ@-0?D`&{EgDqzV_P%Qz;N{KEts-fJ7Sw}elI5*yX86P@VnnqvFYrHz zbu2K;$)=$SnyIPBS_&JeD`e}`bk^{l9mS~(dtI)vW(}<=*^*kAWx^K9(QS^PgJT@< zQy1biT81j(TRoz1A*)FcW~BlqGN*L7(F!8KpFR3RxMAV5lbxcoyG2ock)C3xk@a;6 zbUYL`Dz%m6zev*XuGMxb^AQfODnTQ!NSZ=q!K32k&C_U@r3UX(-AuIIx8)OHNa=4A zXrT6o53VhDMXw8&lP+pPsEYKHQ!S8Ev?Sbli^q!bIP^BV8%$EOU6;txAf`xWtjZNC zd8p~UcaU>7=UQhGOWD+gq=J>C^-0`B>^WRru4H_WPi9oNYJSV3hOhlMKm{_-s0Wz2 zRf>-37Te>bdOx!`uN_n7jL#K^M(AsJ?MQPDQRNs_!Q>|6&03h&M{=p`K=vKT=CI(x zdy@}>^w#F-RW-TpsR&K}Fo{OTE{ksLeSp&TANE_Iz%rd+6DqP|LrS0^%*Qg`n6Pv;CnE}`cNB5oAzQHeNW@u$?jwUivIW#;v^#A{;` z;>PrnTAwF?IP$=8wJMoWSoed8jgIAQNvhaTU3EH7-QRaSd}VJB59vu=f?)NM-ai z`5LyRBx~uIn5N6YxRc?XNPZlW3mKDQlhkS=wpi$tr)CD3Ef{So7j|mb<&!pmQ~}H5 z9h;#k2>f3p+G(m%Km-(#@Pt^Tj$R|A97l%c8bG^gQ%RQ_Wb5fJIMK{}K= zlW?Jbk5GKXYNAufZhKNmqM;`*;uux_I>WOYM8oWZS6x#MN|l?QT1U%B&he_5X@HbY zrqN2t=*AUj;n5|;Oc=)zX>Zft7v>=4J_g!E{vS4$N6QN+UWTcj&-kHoGhm^#xKpUz z1nvp7?fFKk61~bc+VU9v<;Rwb_;A$WH}M zP?Ub9(2UM9KI+eOY4P=n-Xn!mCgROShT)zx(D78Tn3tJsf-h|8xb+u`x5BhdSyLki z9C-Z9!c`|Gw6AbNNILo0?G`*Q2d8#L&7YzomKVb&vgw(0U24|*MY@7yCpsN@83!qc zDhUGm!t{+dV~0m{+Uquius18Sth|Jw5fp<k)&&|khtUIJdoTD&`dQ{_t1f*YB>o`H2V~CfG>U@^<<}WA%!tqy< zcFB>A7pK`v1E&X4S-7%_K{xR+iS~wlOwn-I=@P|L`C^yEC+H5`!e7vUL4`(V97??Y z=s#zPTEv&ra&2XKI;@NI@fI)PlRKAqmH*U z94zl*R?Z7;8R-_WISXB(w#R599w5gP3OzCd$ zBv#`80AQ+56Pr}bm|GJjj@Ho8%!@ za)d51;N?FUprUeJE5BVq_z@kjq8#JC$BUB8m zr)-LX0*1v&1Ng*gU{8?x%1Nq4ewmHhyt{~1#;7V6{NfH=JsKoKCt({~;QWnGF>dUv z>wEWa=e@oWSCfH@<*_zAOI*fYyTkeHE^lJuKJsp%Z9qD} zMGjfjVbN=KhT0aH(q+v1!)*>DKQktv=nQb}otbKJhX!R^0tkSP7Av;@9@dQGglQ^Q#^WhHE zbqq3jQ<~+_kdc3pA{3ikgt({7m$(PC{Ei^9RO&*yjRE-+5@WZ zz}I+~Ny8FRnmPcPU|^s%*Dsf7DYI8IIV{Txi+BgR4XNZMZ zAOF{=*{6c<`pOmHa1w)tB5M-B=cJ0|^0KP4H9NK>owNP_4~l^uzBl-CMcTbWXNokCS@ z4Zjaa?VUC$SaxE+GTehn0%gTyNK%4D`uB~8;|c({qX^DmnfZ!r&>Z=7lsRK@djp{c z#8~M8!-N3|y{sdmS?17R)jGf==B>3Qc7>cfH2Eb=8wCX0TbSv_aPfs1x7k}uSXN+3 z$~HYWgh?GH?_ucf9AxCNQ(+GzTKcxD{{Ru=0HM@rp*Qt|-M{-pI&f)mgUF&j zVc>Nn^st85v}{%06EbL+Kl03*f%?Wc{{Ta%TF{cGTVXocC`GmCMzFLcn$A@RI%1dh zm}xFw#5ko3+oh}ocag$2%OYZ971f)XeMU}Axl}hU4Uw7Vf|Q~<`FLv`Xz0sh%miGO zH7OI6&$lrmppjq~kgc@~5vj3B^}WPT;j=xHA?Czz_&r`!_8*oFrz@-@BFF0__4TxA zG0RdY=BQ2a%K=L9rbsw|8mTanTUt^ss|`@1ZKuX0F_JN17v9CKVrkjN(#w*Rw6^1W z*}~&!xWA5D^?~eh3e01UTydFd3Ib%QZW%hP!>x|`0BtR&B0&SZY_cp!RTG~qN~F1<4aAeCU3Mo> zOJozi!*LDjrY$3@!!8|DxMl5_q12N7Dqf_*fB**rPbo=RuqQD|3BJAGNK2Kv?ky@K zziLh-v&O6+L$0!b*>+&I>p+!q+(L*_Za}`4AlqXWTr_mbi1}TjJ=7(V-U^ZNHCduQ z2oZ9b1)V$}gWbgx8K-@mOiRl?>gF=oJknK=2bw1L$!_`pIg&`yIjf+wtq-kHhUT8b zMWcw7zNEd3YRodqwW?`B@%mTRraIHMR2s))nO@Otp zdx&!y*^LsH0`Wp?f^JhP2?5OQzRcJ+`oS(sV4EFD$S-^E4`jx&DiIlJWWBD_<)>+> zsnOCGO`Dr)WTa?h<`SWwAk(_7Z(s;FHz37aT{?W%)Rfm$Mb6RH89Ca_>ZNkshDKnK zYbjHb*E?>aNxxXJ!LmaWA#Vzu&Bdt$f6`Al-@(RKKYTmHbsNXbmRuK_kVK57CS|3$ zN5yi&n(kW>FH)9T+va7l7g91WHHW%8#?c03q&Ap1o*7jp8)+FPsZPlmrvA@5P4%~# zKdS3$3$VS4h`ElarW}Xri&J5BN*l;R6p5LKg_XHtY3ESl58gtO<&=#z%B_I~Gh2Q3 zI+@a~;VBN!DqGVNtDT_K7$Qv$q`IWJdnLBOz0;7MiQ3TBjv>F{Ren|4y)iP#b#kbg z1+t@+=_eN9ZBp8cu35mKqR;>(L=bc$A?I5%Mlo+x!y^q>+>)!X$I;b^hgVFV2o_7u z9IBLb3)pGgQOXjp8^&us9;mj*kmqAOI`0adWGxCyVZf7qhW1d>;DQasydtT^lhZZl zXzjf|@=3BwNhv-H=zR!=n-*}f4iQa8mnhu8&f`ipI(L$zV`6XX9MwX!k$;PPF;xqi z$_chWv>i1`)*poIM4~l3EaDwQf|CiEWRiuiyn;wdfI5N!`9i0SWDyx?FY~kC9woSg zAk(Q{W|jaTl2p=<**6-G0~8r?_-==%4QkgiT?WC_Z3xm=*`V`Tj~HJG`2f*8cv>>JwfScauJ~}R&_&ni3%fD32QdS6{JmuN(y%{ zw5a8q4b9|-p_Yc+Y|A|$&2g19@1AmV*%1A;tn6xu=UH8DV|DnM|ncY>3b`~ zNbQ_Ek{Hr!1SK-n#5nAmw&l%|R#Tf`q24z6Km(SUggg2-Gb5&iS~_s)N<5icJ)1HK zvGRcEvyyIJqi_JuIuQUGQ%#9eVlCm}0mG3!PDJP(6gDC{nZZ8%q{O#<7g$Kt4Gp0{ zXj7(H#TO`Wq0}2Kv$*)jZjN&{%`D3sDMsMvVJ+FzjO@!T!gAc&ICSWyv}8t3yFzT~ z$*#P))<7iKY7B4&)|ab@D zy6ZGlW*`LhJ{N-M!jNWYYcQ}BH%T3O^?|TR=qnIRORw3IoWa!T z)h6Tc_`rdoQ%d19w8H{n=gM4HT>uBd4R&|KIryiA)06bsnMrq3GKW!Qp+sE@8l^}# z(1ZT~2!v~)ei$4xnVPQC%(X`1dPdC5C0doF3%2gJ)k8z6)Lt8uuaKn!jfk;_@?CDr z{-$(q)1)I&-ww>u7&&eM|@o(JS!A({2Ovag(250I%#jt4;=@) zv$k-H%=c8B$r_9J!Q!Csnb48J$Z*`CThKyfm{f3`giuf=j}()Ch!ARQG|-u-aUzc{N?)29bW3VKx)u~5Cpgnepn{efTj(kz z6LjzWUzBv^2)fT2(uAlobS8{acz(TBP;DzH2kjlx@>CjwNTHJ8Eac;XQ*&=9le$!O`Iu75 zCF3QJ4LAoUhSFV_9@Z8tdEqP5eJ(fijy%nsSjRUJ(%Gc8#I-S$AQhfs5|EG+25k3>L9N|Q##(1sH9O4>G;_PIn95PQ6{Swx0+QHvbU`EHpL6KS$ zjFgltdWor})8||ES;Ui(B;78geWWN0d*iMSpg!z@EilbI$ zPN{M#wmCAZsrGoN)9Z4|Axy2O901r^M&&BXbp%`(gT`X~H21P!50ib5p}a?k(TVWf z%6#5zeC*wzVKDGHqfk;0E^)+f*q#I+%wP%wbt-9}$~rE2v8?%2jO%u;(cRq&l?? zROQor$2IhX!WXbgRk>X}LX?@}W+h^Iw34a!iohNrdcx(7nZ-LN4-49z#L{%S5}$E~ z{+FN1>tvS$kv8y#{cT^@)mK{T&*+of6?-B?%Bpdp} zP=%rP#hnwiyL?Q=cy6xS9Ey@qsXBsEPFE7L05`BF?^u;s#C*Iz;b?XlH!el#X?d2E z-X!z`TgH9jy^9THaQ2byry)pb`Xw2@de)UTwWO&wzLy6m)-L#753BSbX3RG| zl(>-Wp?TL6$p%6E={L7HpCROp0p+gfR-2v1u>Sx9lHUCeaS^0eE7iZJ5(MSc6qKO3xj`Q4udksUL}(Q4 zZdNpD%u2BORp2i8*pEPnSa(6Tr#q2MJC`?S5W@o*jzF@t* zp}Xa5i;YRJ1nFaVrJCKc!Y;-yv!@p(`#a)?sTIIgB>I;rI@-xna;W9cVVE0w9U(3j zaY~1?iaaqBQj_?32b%RIDxajgrQfH$-dlI*5q!x2jfl$+L`y3IqbbQ*BWRGB5^6;#91CqgGyf_+k9D;=Y{sCBzXc94}AYY=2e0m)<5nrDj3xtP)uPEY} zaSZ^al$AAo0arnOm)iXz8XY0e6MH_~ z)mr}mWI5*>otO5h2U4VhRbi+jGDs@Qb<`28agHHVz>d&z?$aw+TB1ObsI=>{naMdG z9pHhX12;pUxbuXL4j*MKMBOe@RKKe&P7qIkI$x|LP`d4*I*A(SP4hPM2(j@NhQ|q+ z*dvPr7|;zRmdNsj4FsnZCu_8WCi;|_+FQKo8K9*H0ztBy&Ao<% zScq?3s_ZLCGJ7j=8e@(%VKFwtO{oopOcV{pA8 zN}Q7YE_UlcCc|H|-8+l#ZK4XAnkDI?WOiP|u5nt0QF6A(Qx!K>;cV&#Z@ZfNbTM7T zWYNf%jy6i(4)DobE~g@vA6&yMlge8C;DSj?PmWQbI%qbE%(C$vlA^Sa4MFB4m|2)0 zHc+6e?P4rp%u(D#*-ki*v;{MVGp@=dT;`ft30Szcr$M36Z5oVxHnn9$@>4VLm$n5f z3|6M53Qw|6lr6;FS8c?AlA+zyC|csz2dRTE2HHCe^gSJ_E0m5k;YX@enSi&Yn@~^! z$0DtvxCeNL7&tm)omMJ)EbwwxdkC{7QfV%>pcR#ANwxehdwIhday0fGglv;_bjWaG zg7cEd4YI>(%8&r*TpqSw!tZP!~}qtF54RY@c{s^g38X z8ChmR0<`q2%s*X_XuPQcl+82%xk||IXl`wOmxiOA zOJV;24WW(x=pPTH6)`Valx#HY$`GaH0A?x|*FbOU67fAkW~j~m&XiOgn3$A3`3KUr z-fc%t@U_6bukeX2Y%ngkvBLLhv{~9yfT`*%%AJ={wq;7XZ*N5S4-KNnhn+R%MaZnK zEJ;oUA=K>`G(ckWv)y^5&P?Iy+j|{VwIE+yj@!CG)Nfx(Okz0h$Es#x@~CQ`zAE(pyF9r z9jvF3IJB^hn*k%>BYA~vP~_%U1ML(q;}6jl^Cs5<<;=wfZL^_$PN>3uHK zg-UHn@F^sMAxcA9NjpC`gLtUYCgoOXvo0hRwv=XIDDDa}gTGXtgf5d4$U?uv*}Nd? zUSZWVNxM%nzUurv)2E@Qb`-^Hf*n;G-^E60z|O z78k=l)tG;YVJQwJmyg*wxA>$*CT97 zpN7q;d6ijVOo+Tg<6AiGu-gQvsUZm$I$z)-W1W%ei(BlahgXMaQtdBrfPQ+#2N^qM zmKf0|9uZK znS+Yb^LR#-x`e%yTd`74h4;|HEKwV<&uR8%(~;z5So1%^I=47A98lv#>yr)4ORS}| zoj_8yKM|~T>>-cSSfM!fl*LE^&S=@oekaFW{b9(B$a}bHSxrs6hRR76BcTU)XF3;+ zib`wBVx3TpT%vx{O7AD-x5H@5@mT6b<{8=~KLI9@GfI}Wqm(RSlOm$VF2|Oj z$1)QXD#X=VwB8Hirdw37c&J*?<(#57@t2AL zlqrTt)LTo4iJK*CJ&qT-$?T)US8>%{6HfwAgK>Ks>*o|)R$USJmRKRFpF)^wO*CnA zGzYqnBL|x%rfG4;k(kOFkj*X% zR8I`?GqM{>)B$~-fGm6I0BPsaDR}HUk!8bVrdfGcv^Eqvh{aAcXkzT*I}w>AD{W>l zBn^oib%~RP8XIO;kAz9Zk6Rj)^r3>5#)7FhmlAGL3Q5;!oUjp|QGdeDKes6}^lehe z%%T~4TPs@tcd_%*@V^R%oUE1=N)(nPYwH_A(xLZ3{KO$T6IMe$EOsBmTto^|m`hHo z=R0UZR1dA9L^!7r4-#c#acBFTHB2HF^&#axfqOQvkZtRjeo(Idn?A6WUqkvb8+gTu9S8NeUihYk!5J zG_WVgd1azd&@r7q7q|5e0!a5rKamj{c$(%v8Q&wFUE$o7TIEfIllGDTKa^MG;UhmH zR5*r)I}&hp`B0@wFPNXYtA2M8SC@iu<+(Z>N|!P?Rq0PsT`fL>g@dvE-6FlMJjqGf z(5ADbA&N(DE?7vTBO@w=04_NkS7u=KFSt*!W^-xHVru`wV^tN zX)w6qW8obVXsx#4{;{=YObthR^LPD+AbuF@-4#8t8JLn1?mrF&YJ49OA`e27rZv>QmIHg?#U$v_BlOh{Ule6CVq4l1{deP~g|hpWPF2@gzC$!>uKXTbUcg=;t6$ zhZGG>q4A_jjzq|k#L=;EVZoCTKrzq@%d~YfloX`L4j9y!0OqMVOmGZqIdzT!tf`Eq z01TJ2zy@@f03jDJ0AiA01OL#e35q#ij9N4#&^UQLZwaACUPhFeG6*mn7g7^o?;T9( z!l|T(6@H(TaOtUHvMdSo7mhJV=rt(fz#tKS5xgaiBWb!s#L=^9B*zB@?gPQ?Pt*|2 zS!#ZJWFATHy4&aOusP!;aD&b*CR?F_TkD2n00lie5Y4(y3 zETN%3Bcvn=Bf`m9I(-ohtzi?DMXu#U52{HmqbNNI&2z8e5#;yy6}e^jz63OOs{R|F znWs*hI?IG1TLPaBoi>M4vQ%ec#dw6xp|zD=O`Q}sw@;KiW40=u#*Wt9Q?D;Oi?(GO zT-aLXIw&xj69UBPc<7dIG}BEGZKs9fqD-|E%g$X$NNnFkf^0rym{5^2_$bjZFgOz` zNWOdP2s&or`_(FR@BB%u^RBWQ76g^Hyy*k-Hr#0p%_?>{i*S&{Ki?*p&3&Yn-)M&C zS=mfXB-zBNI^_iFFVMv_@0~I8B@zig}XFjKi2#yt{j- z2_$|o5^9H{EhjQoF3rkUFzbpz9V`Gpf%AsNoGdR&mcb|ifI?8~g+QCDGm6zl{XZcb zupGQSSZPnpB_{TlBzoN3LYL@tcre9B+GJZ%+>L%(Ly7EhjL#G44%JsKmcPP2tNyPc zS0m3|JmC-T&{`2(E1jCf7;U9Eu%}j)B$W^FE@iQ|TO@<$144;UMQX-%O@7qQ9> zgmdrccEpt%3O6f2k&s1%*5##Uu=t;jkfhEuNB$+z>W|1ashMT8@@Uej z1R+^e8*o_M^~$8?9ygA*a*0R6OdjV8tPPs7`{> z8d4od^<}nNY?ppXp5OzAA=rl(Kxl54jHY< zHge6mOjC&l)><5JG`zh^hg~!T7;hAJ7bZb|B4PPT9v4isnsP8cgqq8kn>{eWOQ%v# zc%U0}B=piQusdWtoP;G-Up^40fzqQp^RSCFMP#w;FEi}SR7n7fkU`jjq~0QN4v9E~ z{{R?enxSIH>C&hT%S&PU>x`gY$t!5BRwvKp9fX{h%^i}b@?!+bBw3NgX@J<6k(pf~Nlf&aa^bvD?R4CM79t{{YKLo+$Io`jkHilU29hA-f+Q z%p6y51Jl(dFozsO+}y@%Bq=CLRz_o}Bg4YiyjF1-b?&+nu}+Qd(HtZCDHE82k`*y8 zJlv`rN-n-oZeb2BS__2bO^)Od&_Z~8mr3(NvO}sMMg)^It|#H?f^M0axpxy|(M4_k z=$XVaJ~g>ExHXGum`??gw7q!ep+4_E@oWOVT*c1@0Nw-)cx}%ml*i#NYh3nKRTZB6+CsK8VJ_YQC zmR@Cft)^ty6S9TJfrQVO#R@}L!@NsUr8M)>C`C!*JoL1i4kb<^O-NGQY1IVSgsBcL z#F7r45ZhKQ4}~G)h%p@&y7K~FVx^smn<>#LsM8%6P)R2!QVLDF^$`Yqnk2+<>ezTv zWagIo7f`~r7o1$=xCK)ZZ!Ki0=89}W0=votl98y>NUO;U=1qeeEK!N(aGPqw*oo0l zqEDbIjaL@1BiwE0hE!)817c5Dtj~q>M7()7+(YB3XXy0jUUunmpv!8wu^{#N2&;;= zO>A><8irX1034#)3GlH%{qY@-Bdu1!Qn|V=37X>G9cGJN0Fl5HE9E99Y zp$-A@%2SAPEV|o)O)LN|MrPG*P`e-O_{ALIq0qdz^($P-JfsDPYEiNZbaJ1TQb8gh zPZLCiFj`4a))N(A-54L0xZV*gbSX~EjLL(q@Tg+5l9{*~u(U~08nA;)+oUAvi8pdN zR(Fw=2npOniBN`Zq3||`)Tl#7y>fvsiDlO>GJv++NeTz3F=q|8Lky};FK|)b4NtbI zRH@2K>#$C$Qwk?cs<5(8nK5yPF15cgna8l=;WH}p0if<-zN8fk`1nM`MQB(WN=fCk zZf$X_DB+R0K4L6Ilnsb6(}zBGm`EV&;b;I)RFH=e$XhBZ+$|$m;0?tyhx2^JFPOBX zsFaXEL55;cwkI89WUZLrFa zmm2_RbrygQu$Gf`DFGn`LgQYZkN}COP?$;`VB8l^cn-c}{gKm#Iu$W=hf=#ZyrS15 zTYQ8l1(TD>nz|I)t>!HN9Lc&^m1~%b*lu@#;luWK98g<#By=5PplMTOJ+|vpWw&l` zabv$&8wxtApuYC0)Oi9;{!z<2M&mTu#3fCorDjmjgq=SK<(;EgU}~)2e9MxrLI>pt zaulG&RTG6X@3Io|N_Via*!bxQ)GI>_z7$MS0m_47Z?WIy9M&EgxQrg^k^%UG33C>) zoI}7?s*5hTZ<}-#9KS1GJK_g~ajSil>2*Zvj$54y98lNeaUAgu_(OkJ;Dt*BOFHy` z=ROpZm3L5D6Sx)wz2IQ+P_GE-V2lelT|$>S(O{GA5J48}uSi6)(4~sSM4t+$CF)^l zIi-sVN`=mf%nDVvh2ak^p=%W#3_-#s<`6mL6omtr{hy7Y9xFopB+ZoIu|&w?8cM=O zi$s~sxS*f1v+n-@!3$Eb&^>r2L7ZhqmYg}7m|J#Il5J(DLT#wDHz^8HqAOtBML&n} zv$9ielDUa>CBki#CDl`g^c+m$U3ugc04@XHg|&#zY+8aG&u@{V z1SJk2r62)gpaVc7mtj;XW${d_iOdw6c!DkY!i1cfuMwmq1(s7`xw!r@%L)?!VQ2m<;oKkG+m?GeGw)G|}Rqnq zCZ)+~L9?;C06P3*xuM5DsId_0!e>H>+GZpQS9a>r2X$xJj|}HnayUSmAyZb6EC= z2|_#uhvRVp!QH^vc1pOfXDx*U+*w-eZR-O#K1U9$=(3Qu$qco30br~R2p1Kn1i7*LZu%#s`-R@+!oI8!|K4M!KN6&c4LOHa$p zml93&PctAE0N+qP5px%%74lX}UJT(;j;UClPFN3WZgmgK<-NJ=AuCO{BodM>*6}kO zh?x-~c!P(V<8~1$Y~^*<5irrciXUiPq}ui%f|54}NSRhfPKCc_d}fY6;e;lvo6g9% zW!_Nks5sus7CIYR`)krG^JA@vnB*%sfkBv)q|C|8H|;*o+MShMu6w^^?R9uUxM@6c zM>4HQsP`)42jX-~fKe?_NFfdjDYYw7+QHdLR>NHnSl?peZoJIaOjIbi(T2UT8P?j2 zy4YJ!Cda#NP_4Aq+Q&1_)g8qW&Nx9ya+Sm8W!}|I(-e<@Mv;}s_b=hdscaQXq_rHyIXU!;25eabll8GWx)BMnXt5QlJ5J45}S(anpF4 zp+Bh+x*Q3-O(lVFH4XI;YOJ>EBt~Ij&lyyu3yXoh`Vk87@8~C05jPk+HNt9BtT9w- zYF47OxiKt-C3jnD3kx~|opiV&@H})OO2-=>;k3w7WN|hh1q+qQG63)WTZsY94fIL9 z@389}%N?x-Id4pmPjJ$Hfy3!MOCobr>2o5cn_Wq9x4%p*1&Api^tQUiRGqpkBeElR zZ7wa+ch> zZ3{}ihY*wD-Br#dOBz~NlC?=vo~5~<<|PL**gNJX*FXaI((%TGmrcNaEw#m*I>kdo z%%F0no7kb$=s``%9~jMXIQ%(&MZPDg5NrFTlsSpIWQ_7bEwrNA$Ol4u$tR_ZO7?uW zXlsd%#4g~4Vw&8t^fwHZ|r9c)6_ogIw0 z;W313GW6FJ6)5wmIYyW} z$<1v=t=1SwQ)BPiKN!wT;fXoPWo3Pr+fq~pxr%f!wGAU$tVQrsfpZw)_Um}9)pF1? zAqyoJ16$aEr-r)2$^vx}OSW$sk&fzq#Uw|u%Y9p5TGmdRf^QB*9p*$T48Jhm91>Z& zX$hcU+HENV`Nc+ME+}=%G#YPhPe^s_h}^}$5<5H8J3q^@h$u5bqU(8{mvEIORu?u& zPvL)zR^^_piBOFWUjjQ-(sBC;k*TRNbAv>wL?xnpiBTf{5fec3B&~A_CZIEczj-bo z-6Z&eG=$KBj>a@uyhhULvu&{XP$4OBlqtc`py(7wP&M*|G02s1#XbOL-X63rn-I^ z<)ivl*!o@*gP3Gn4cBG-Co6{M+j@28hIU&^0ZIbEq!j~uYDuv15pAnt3y6&EG1+cs z1J;p?@Y_7Xg>xQZIhUO$^nfG|pqpy~%iQC}M|y@7!?@*a%2JqdZ_KMQ+fgA+6MKb$ za+L$q!Vx|p#R`rqEN8O^W_cbAN-bKK-z7^VlWX)E4I?+i@sA_hp=*lJhV=Y! zz?7eCI?7fSkV&{Bz=*DS+9oV$SmBH}FNY=3D=L77kSvss2sOF$J5&xb#!_59lw92F ziERiM)Pa8?aw0}NPa~u^DQPPgiCkZ-ak<4YD6eOy9|YNIPwO2(_(rFN;MP8Sm05FY zB2F|#3j~0ZmB&EuT!ko~A$_9r94xJzsBdY!Vx+LVuSo?X#1HxE9e9S8LQwEs+8#8i zvYA8#Hu_ZC$qG8`QV6-WqAGaExT1auS#p?ukcvFJZ8j{B1ZCv6Ezt(MedFUrq#~Bm ztmMjqNb6&~TKhj0yX->Zr%Jn!(}mPeqEjvawql$5M#mI1uZfz=J7-t5Y{F{u5>&=4 zse_d^8l0*-5HI;dIbY^Ei3wWP0-x-KQEsx-x~3?#7QlTuRHE95?*eR)1@CKc3}l7QWKdf z79iWG=wlzBGqU#_HXL>sYGFLP42P#kZWFQHB};#Fm2Anh$`N2vKmz>)YWOFy1Be@c z?sRbiT9HwjlYL1}Wb;#U0Xau{*FPAvAhLS#roT*bVph1y(B!MiGE>%2AR)~GHZ}wu zZ*dOeT|Q`!BAxiHgN6#L&Qg`5VMS~c)e6)Qdd2=ZYDIjNGB`{n%5$l8qm|Z{7K7lV zn}`^OO<9~*F(N74MWl?&KuZ;7k}tJ^QAqbe9Z4G6GaP>ivL_eRx#9EH=(cPniKV!O zO>U(ou;Xqv779o^jkG6Tht52giQyh5;`$ogS+yY_hbrl*O{tN4jp7Q#No@%++;-wHpTthOg#wv&%V|1T6RGPP-)CXdAB!lsiQ6jkirA~^*`=G@ zB%hCrY#^y3nnZbVfa>oHXlR}|GY=-0g4=mII_$w$o=~3%OIr;$xx|>IPgj!7R+?0r ztfF(aQZ8IedXy1kat5QsToVv;Lt3%ibJELy?4{Z@o;uMB6Dmq74J5YvX306NYlPgJ zAI>tFG3jQ46SPr(ZCV?&Y)JZ6k}jjT^NF}#!X?a0@DHmW|Ja3fg z9m$zQPM0FraUb_O}o8 z2vGrHD#}3W2?FtB390fU$yYN56XM+U0ak6&6V)UF52!IAY%1JSj*D zVJ;_Q5L9S=$m?PpIWLIimn$@Yww4GW`NQ#>k0GY4fRi1BsFd2Es7fVB%Dmwj&RgGW zTWFK-Y-_QZ9r`%98 z2mvlyz~&wx6BcpYgvIrGn)~2oNhDuTFAu~+8}T;Sni7tvA>u9)qifrHUt7YPI6oL> zfE!9ysA@uxgyZ%lW)>{UWR0P?N|@_$HRVvz^oj`O1a%r1g_3S8elbi<;9Lbg#VOE| zl_>>X<72OourUuNO*^tgVXI>CdpvM~o*c@hN==*~bvgm^jE5b>ypD^`9}bdPrT+j3 z&o)}5c)55;volMvfdHnb%yc_MymAUkRI1 z_!OK*I)4$vldgCimHBd8p$~;*`3TH6H!&~6>P6OY zr|5{Of|ZMcPnXIRv50vGkA(bWnZQ#mQtFG(B;}JV`2)CqrETubc9ia1ua7p0c-Bl<>=wF`OoMWWXpc+86^ zG&UG}h!ePN(UnCCN!W`K64t{GB=X@$ZOWwtA(@8*jg2g{rvCr~arncjrZV;{Lx-KF zXn6G@xrHUCPl-xF{{Se*S_H>-dj`njhRI~1#4Dy?N8t&xq)p;SV@gIODse3>w+~dP z@A8G~65>GqBKA(L;DV=Q$F#6IBq*#8F_c2ohTKTyGP#-}@=Uh2)H*37esH@GC}|kc z*#!l*vXkNJM+YsXrzp0> zLqn+5eIdcFz7fEqg6x)kggThpK@6E!sDi?c6;o8^;M=S(P~MTp!q{zvq?ZD|1`yqf zsx&c-gEA^eXx%w)=zJkj62`Uu>CzM=*_N5eAuS3_={GVJ388i!Gd!~#qn2#7SLK`h zqI5>a@FPl{{TuJj&~ko62PU% zml%JEa`mKzHsTZyffxMZY&eT6@^HhECs#zy#6-yEvK+8c+-+fTAx_B74H<$VVgOqp zzy^cTw}9mw_a*vA4jjki)OL;mtQu2B05^~z17QL>2GB?_0sqmgClP45Vh(!KuCRtI z0s(|DGBWQjI4D-oaCG)D%w$Ox6aPe299H;&L88bx+v56v?*Dih9^buK45LX(*% zOvySC;tueWsMuxaUAo*iQj}C}pt_CChfPmN;~YnBUZA;PK)vB3pgU1@^;q0_-Z;P? zX7kn(bj0MjwV(qJEhy<60|57|ddC^lZEaXyI0mTz@4Rr~<7-C%!8G}4I&T~}#RYp2 z%wq*e%h6D`euj`r<_dIG!-dBb6L3_N73J>Sk#n>$L_IZa^<#a;I^>;tqM6A@d7Spc zi#8yIt900ablM1^5Q|Efm#5X71150*H`3zlTTO#n(3?wk9Ai!j+{CPnllATxJXF31n=Y{r%f7!%TvSv2JyqDS~Xeh zD5CVB0o#Qk!|x!DsUp@saEBWfIsKft`0oyD>z1oJrztg+a%W14k1f?`hrriRY!qy6 zI_VLz<4plA@m?2J9<8cYVR@Qq#)E6OyxYo1&wYGH#ww(!=-^>@1wANsurwg5X3a6~VVa~eEVi^UddMo|Ya<+);S zbpe&NdJ&u$OB8T8L5C)AbcDp4-uJc4IMB^|HuHd_d24+-A6V;lbdq>dY=JQ>qjJKs ze85-lg&_>ua$zzGX*oxEWCQm_u5I#;fw{{~L1=4Xk!Ruv{xRNX4s9VVyDp_z5Qm&2 zPXU(jBdkR6TZYoSLXcdW$+!zcjgSS>wAkr=zlFp|$2SHuIO;?UewQ)BskdoUsUFVq zikes1zv_)`;zVfhWYo4PGQyaJ#gb~LrBcqRMTdw7T>$dme!fvDO33asIyDX{QtH%$ zD^+clXBa?3N+`~kkeg_Grq{3=?*yk{qB~q86zaAisko-U;|XTiEfs154z`d~-ksB! z6sUu9q(aKw5+ID+a^ak=BbIs9HW&1a;~~NN!#E)8-U%?=BrT!{aH49V z!l`<-E>#W8y)I`%;l*VonQ#iSo7gExS+@2gV-G#VEs051o}*SM(wK5kC8q?Gw9PSA z*V-Fz+8aU8WhElS-8Tv&Lk+l&rZ-hevK0KDC6pjF?JPQ^jXm_`bvDrIg)A$?ph6r) zrgr;D(pjukDNQ9=gO9sQoC9#o<6%fA%zNnETts|(SoF6Up440}YlO6i8)5al+|$(H zkgzU+EIC6_zHfVBVq(vPm9jonNMmMGp9e}S?$xHp&9GwK5ZNbt7Rqwks3-3g0qdC& z3y39RHMsENW-$qLTRO1DA-U_afY;z*SpNWr=7L=QOk;R4ESk#`DsbJ^xi37EZ|NJS zDPa0$0{uqud4*bkFIq)@O_=B7TsEa9fRdt>O0rdAFP&V(p=r?XWoEv&v_93pzQaSo z!aOv^LkzsrWi3riPEN_N=3Pt9snE#H(&T7K0CQ5HCh;4>)UTBf#&jb%lR&4j#EcbEqJn92?yy-^tdO?m z7tBBw7R#7uK(H`MO|AL=03kI`V{$@@_AR5mg2Q~NI?TvgCk3wD`F3G!HnDpa-R0!I znNGR7M`VFMgFo5B4!3B*$vRhm@9 z;?|{0%zrphQB~4Z(k`v@Su5_Ha+`Fxg|)ZH>J%Icsmbv77QG@?yt7jZlbFr!q2Qur z7A!0Z@-3wucN&4DF_CpckYlhY0*Kujc`IKn-4w8` zGVk1*ECXaMSq7O%imcc)yF}c1El}jmI$Ng5wBY*0v>PctC>q5Si#UqxHu;yAQBfs1 z4pHE%X$=ky?-Vc(^4dyXaird5C;-~SHkyJ=ISJ5~tc5e!Mqd!it$yQ)HWnHmSdyhf zPBv!XpBLwNB~%QOS0?EJZIv5Z`+zo3@w7LW8k#!^Y1sM$;cpaK#SAo+EGs$zZF={G zwmxI=ia+7l=4>~*9@_%bc`RfKAV7yS(aSLhd7kKmv;lsOE{#-2 zq&*xBh;lk|Qs!AXNh;TK7C0fNn9QAte0zeWvDAyQa|sGc(nahp4?-`o8-o*6Yjh

    z~XeU(BYFE39l1JLy1K%0_KG=bzHa+h;+ zBZ3@RO{8r*?A!q=KRjEsN5#v}q$GI8>SL=C{tO6SM9Cf?(67A@#BdbWm2dD=&bjnT z%iIs4J;EW93I&y`FEU?#vTBMRU+Cri+=UeW-o$M(eEO3Q(d0vEPd=VRk`K~GV`0MV zZpjDBDvzaJ?W%1vi9t050WDy;M1hSl`1W-j<24Q_)d8c`_kvI&kbF8{Bf)fDOqLMp zG+TG{BRIL|-_H;{Q>Uvql`?@0peSiM(~MDyEEu@zfn1_>0Y_L55FVDSfyP5Oku8pV zDvAbXGQ`WJjyAcn*D{JTkHRYb18dvsV)+=VaHF*{kVAVI-fY8}`<^)|1=8*Fwa;v# z(@D;hMKR0iQys*-JrdErQ5g!#QIhS+beU=zg#wp`+cBl#X_jn}3Le229|-i`9 zmZ_>gqNt&ej}IiV`9OYJj#|=;XleJIh64uY!nc48{;9lg4B+20J(mviBG&a>u-ITbxjNfu7>mVw2}BE!G`4 zb+Z1O?{40@{ne$~BS()NU-jX(G?n%(^&4-$6Q4MJanh_Mv!mvW8T;z1GMVhvv17+X zj*P%udS@hrE99?Foib_SqJ`t%U-n+EQ-@8!YPyCDb?;n7P)*E_zy_rm)-oP#WY|9keT5r0X z35QzX+!k!Bt=@ouS;r}<7GW`VF;{{8cBgI^hwtpM-t?l}{7dK9G5~`lvb)jc45&p| z%xpWD+XI$s7=WY0@%!`V)$E3I$^gbn9t#RDL4l;GyhvC0+*A+vEr>&bU};F6-b&8TJCi^u0(MtL zxDT@RNr_99UU1TR#@9%^Jc7zZ5P#){r9dtukzEYU&Kc~;y%GPNhbj$ejGm(rK|o`= zneq<6Rj-XD-BFXH8{V@nn;&N`Dl=2Yj#^VGBVImVjZI7*yyVcH{_&v1m7?8xo~(4Aom8j(mCoz9gxc^YYe#M@%m{6VpEmt zZ394}vO=%8IylHt#CuKNG8qG{1`l!+_>GR9ET8|@GL>dk!R9TcJ9g~Yjp5J-4(!>v zb7$!X8`o&FRmC;R087M-P9}loY#ZAlm=Kcd>NQF-X57@oSqt9H z%*tD@`*82U!^c0VsycE0%oz-rK7XRB>eJ({DmT$rDQf#b6ir%o6f`l`s=&4q90 zU}NpXb00dw-{-Zk@QKr=&s~_hRGqW7Xj}Oq%+>$1x(k=DUHkg$ZyFjJzQI0UeR=WX zrL(8>M=Q!o*5#_-U%YV6bVZyjQW_NC=`qZA_$z_I5#!&8pZVsZ_ms<5ZrHl-qng_K zFRol~YP@;-&Ug2I_~D12e)yO{xy?d+q#s^uvqx&vyuBKZCr}L`YAb|;UkzKD zNdP-*)LsoivM2%jQEL6P@JHAs_V!|E;xYE(j`6F0CO-r;(juvI5DrtMPHd3q7aueiv{(Il;D`(R|1z^%bGl(jWjYed2+7rw0JR} zJ6Zx#waFBL1f6bs%{Zch&&d@9HQa-c%208C(9ACO>IWx;hRY{r2ulbqB#5C?f6~ z;OF0eKY^eN2(3K_jwO%-d%B+hm?7A>&@mBU>9E7~v?T|^%r4_V2b$9*p|s``TsY_1 z?Zvd_Ko}lj@C|6qffNq63uyM#D$_m^nf9>C6H%9rmI@U53^*A`3+L+Xs0f)~tS?tV zPA)2+SKOyk51)}FpvesY8}%EdTgR~wRE<M(ZKu+}2<{gIzOq z0aKh#f>%b01L5B$1jkSS{(Z`fq#uENmFDoBAC@xVmAPWT*CD%8r(Mjv zrbjEw(>gC^J}9T+IY4^%Lc7t8%p5_)0nuMX+^f#FpHCo)?@-&aIT?`lHk(u0vN?8v zsm%ojFbf@L)E;8^4w2*L2DAkCwoH!=ZLjuI+5`@iSEm^snb}gDD8d%dmqv`s#4SM2 z?vcBanW2o|%8PY1z#cPD0s<;89`t~nCwPRJL`c_4xWQ@D98Si=Dz~Cgk2H3k=n;C( z`H#o}QZrGg??}|9^4vQ%EHiRum1Jh9GJAA|yykm}!ypGmxlS6SlslM#h2?0@DsB}Z zb%QvL88vD|8L0I6Nez_?`Ni5iAd~m5Et#JbQ=P&MQ<5Aw+mZ(lDu}BUD?w6SxxKer z%Hhm%k>yIkl?b-A@KK62gBQxB4d7NuCi0tjj+ya65S_mehA5lKz_P(7f&<~`=yL5; z$evqq@0^p$Y`Qkox;j+sI09Dw!4D3sFBlC!fr98u%(bV)9 zdbRo{@ULOzK z9o?pZI}8j8?$T=ZIBfTgkf|j#!7v0CklJ%o`?ep4W%Rf>Sb5LM^f?~t%C?>qY!hH1 zp2h#r8Fr$Zr3ZTfz#hG$9r@A`yA~WREb;7s5F0EiI|029}Jscyk9b3~ltN7_1$1IfoI(KgDnG zT~zT!UBfR?ZjDfaz(lydnxeCg;Tu{}HULd~y%|J3Cq;%`aZ@2h9tt_=};5hXj|`D2QA1hTZB{R2>{)`dG1_>ePnSALrmct$sgchNJVf|piP zd0m5~A z`i9#DlyqO0H9UAiJX^H&OS>jc3V&zCU=P_QIl6_lz>StVQIoB!n-SZ@aq>^Aq)uT< zp)=>>(~_pM7GQp_ZZamh@*TU<3Z(Izb7)@LdoCy5iI3Pd<@CBNv38C#8Hieo>-dgJ9blUNl*? zKGIe*PME$uJkrs_>HIx-Bb($Sa+yAMPi#GuX#4Q32_cMR)&2b}ugXA&fD-nA>|7l{ zIdm~+Yd~xegHbd(WYC}TxpH#p> zo&YXAcWI@_mpI$(ZRED!kFWQLuan!cB`#jcCsErAVC&y|#Fi*+(#jU_ozeQIJ1+^6 zq93E{ChrJ7N4d4}G}4NcF-5nDoHpvV@?Od^S{jQk| z!~%)q(aL^uydjgQvq}4sP_cF02`QR-j!prY_k6UI@E3}Fp1bzZ&!4#Px*vEZIu95; zq^P}34qbs~!1&Bg8z$W{^%Knv&w1`|g(^C45M$&Uh1rTb;~*9P#pH0mTr1Yc1)^Hz zG%B5XKr_1hLZmE6e@8`4gHmf5L%cK1<8D#P81Lii41I{|3~@l!Zs;RHGHC?ykQNI1 zD?ZVnwrH>TNd$u0sHkIl=FSK}Ydvp40NU}#PHYkfAVn)$qNHx+^x>0AgXKAagZ0ZvS1xCL=|g_I$- zIyH9!GwY;GY1S;oPi!whH|r}T3|N}1Pb{xJyCh-6Ik$8xAWU*gX@4QixBY$$&jdc_V5%IvrahWRJVU2H~5ZFhD zn65KRd=r(xP_A;W4bn)_%m9#`qv5dPPkoz9st#F8qBX@FN^Lp?v{s1{xxxd!H3iAy zxDCnl(}-X+*8(;p^9pLkq+92-j7?US%=H}4_1cr!B7PV>WA5Cm`Q`yGaJ)Cq1@y@E zHEWC{WlCA-#`sX^nl)3Q)eTa^&MVm2<#y`PR+00wW^e#;BI?d}7b}&e`vDr1$aI^z z(GS*bnUDx=WM^YqS(M|WC)4U0q_QJWz_X5`~ymO=>uIo6B9g&$(? z1Op!9QzR(~Nr)PPE!pfX8M7Rj_LQ(K#R4E=AbyS`DvRy2=1n9pA;tCcGek3-VIDKt zbG+*wY}a|Lv(F1eYA23+GmsJN+&T=M2-_q5|1ghLu#*4?(5?CH3J)EqIzfTZ%;kqK z@I!;D;UuuQR6m$J+Lp(atJpfdJokovn@?3RzQ?c63(z{7VB_T9uXQFG-iFPeHwZK^ z)57#r*E1zbj??Q4sEpfJj=p6rD`eSP02`3y&JwW#*4Q+m zTFvik$qVQ{`6bmtSss;Xc}5EGuJIe464f)W?*m|$Jf$5?f-H*>Wgicx*2Vj7yYoNW ziC>=f;tTB5q*F*S-^NmrX%%-WTBG$G;-#;AgPjLV%9QYBfm`x|niKMb)GP5I`|#Vy z)Y{7Ub6%i?e2`Sx#0u!(% z|NgVACMGm8FtwKn4Qw6BFm;$=BI~ls2xFI!+MuQ$^4SX;Z(1iZ3TTwju>6MM$CxQL zuF}nr(CP!8-81*R?cWV*Vm^vPd9hhcUd05lPotm0k)aOXKW6G`<_c=nwoKJFR9%>@ zM&y>ZDQO}o@qFHgQaxjD;|Z9=k!ey@Oyxvai&~*`ECQ^ps@#eT@9`PR!fcpKwr3_d zMlyXu)E7CU)#IwtwdaO4xzQdT$VF|z+R#QP?Y^6cqs{&7M3V9hoom0sy;cb(&}>Ie zcG5na#V+&^(Usq-t(g83f|ARSxW=g=ajR91Zqa48ylp@Zf;GzWizf==86vLV(6h~a zd4mHpEXT4+=@Jxl%|Yw~*eXgZt&}rXgxi98YXLn&Y?mrTWcviP=KI{#+`R45&jIpC z0TK)WN-3n*fVM1g){kBx#Wb+4WR%?smNHzk*+r76PTd8fLEq_|?+QZ2sbu`TMpT%L zju_EGuRjBuJs(r%GJ#Q|!*15^OF8>1>3<*1oAT+hudj_iJ8<~xf|-Au`}?!c_GRxV zx_;?5#>98V4w~{-)O*pqZAk?%h^vvudhkCgMSeysTGkAvS|-W7K^xw6P^_5bV# z&578zV8O*E>GfBgmi}<>-~kJIP0iNQ=H}+aN@aA6R9ZM%Ic5B$u&~PO!$f>O>b1RW z&%q;ezVpxxdv}22$R&^9nzcX6u@ewiD@gI?b;HpqACBF8@;YnCoy?vx?A|{JiKmFE}r}eXhu>c+2(!$GwJsDsaB!RCVgx&!b0w zSyy+ZCTQ|x$M{u6MFjaohK}gDb@4oX>>D8at4f|@*9Ra^) z%;r(=G&Y@xn7L;f8Eb_MM;G2s++T~c^yt%<3UNXljlT&F0K)#WzgXEMcJ_BbJ4KU1 zpl+JA=`JX(g8&Fo44OskM+Pg2tw1JLW*&<&j6K@14MI*zt9yVk^V%bliATIX+d020 zMMGj@YmZ%^Ov57^Mwe$-Hvh%7pljWX5Er9!`4^jJXAWU<1#1CXrovs{MN$btp2v5JCFfq1Y`>`^6jvZ%}-d8f4MqS!?|v^pr)55930 zDP9dxD2o|8Ji@94r+I+6$Cz|Dk|HJpjOIt7YptkRdS!NeE$VgJ97q#z7s!QKt7zsd zrQYi_0*u#j0}}FK)FzZC9;!hFqX*lNGT`N~-rc4+ z!5qH;_N7vsP=XQ)e2H&m3k9P7l|+IW%CbE}%_WebdLofq(+`%T+B@u3PMq#~{It=3z{1pS*$fhsVI6)(dT3G9(u@4^rxk)IofY(x)r z%~0X@D++!ALMuR6WM6?YywKvbC=N$l6*9mY%yU6Gk?2)a&5*mf2VG?Z0&d^~d0Gz8 zoX=t^=V=SY1w(@xt>x!bVm`_!x6G1ofD~>zY1zc^G(R_sGKaaV>&3Gp0r`Gn(hf71Jf94 zo_y*fwr^I@pXQ#sHdZL`GU57F z{}Dyg8?glh(p;xT4CqWLw-}PPWHWMmBL-4}4926alrl^BILr004D-Ue8XUr<#aExx zX8qS4axnlH&k(;bxe;p^4L3>=YN*(r%XU^PRjOQo!zDAapa((NzjHSx9gWtAU4Nz=eg%S*^Vo^X6o>TG@?bPel`I8FQq_qS@&kN3l%KAdV@+2MtwG)cg6nTF zf&lvXL>lAvKsW6F?-@f!xcXw`sIN7IvWI1|ElB)|P>p+IdV0c=;`nTdhe}xu?8}Q3 zj6{;Tl{APCi>+0)(*?Eo=e|ZfcLlFd;B7*yChRATi4K#7R_#qwb6A&Q(hMfIq_B=d z)m@I!lQ`{eaviL(p;PNQBXsEf9uJdwjf;)U7);*kYr4^lxj5dr`<+qW(+a{u6wf*B z-6bZA!Ssn(f7w|VV|e8M;4q2mMij zY+^~1e5Fv;0Z~#=zB1NK6<52n8nKs`%M-RnD#dnByd~U9@ayYdVy2J!dg|bzgC1y1J{YF^&_MNfReT z3Ndt#EjhW}xyoAGlXe4_znDNc|ek>;|zzux?NmP{d9M1WBL*tjpIpH{E=~ zDTfigkm)|Hsf#!9nW~em@gJ$Bvwqx`uwwtG4s!~BXPONPs=m_l^JT#AM~~+GfP>$U z=!H!0Y2VQV;~Jw4i_olqQs?Sq4MaD7t)ZhBc$axb^rb$@OF+cAM(8IbZiO!t_IuY5 z?Ij-*6V|{YoFv?(U8Fu1QIjcn1`!Yi!8C~=Ol~74Ac)L;r#%U`Igzp28U6NwxJzRu ziB2iLFY*sCK!1kqk&dL+BQ=4OgnL#Xb}V9Gy(E@(NzgjOBV&Yqi+LJ{E9}JSw_B0@ z_j<{})j9-;5EiWu=8v5*%zrHd0BO(yH*su)#B+ow8E~KascofMYgKIJj>$X5ZrzZbq{=u$Pu>hz=v?7KigTG&nul{? zRK@Hm`Tx{8WSsb1ujWLN$uWu46VCM)X#)p)pG(X1@|t^+OlW-5^Jhb@ra%{ms(Rv%_Ej*vrYHeYt&!woZA=Ih$3k zz7LF6QwpLgnG$I2$^pXk!+gpd zpec(23%GyW+Z)b8NvxYL{9B)e08z}61NkaiepE15dTR2?&4By5p~9Tcl%(7GkTbJ9 zbZe@kso&&HMpH?wtJ#yS#6D4Jwc_m_13YClXQ6-U?K8!V{`L;omSLh))5`D$jVQ0J3$t=i>$-sSzdfVr1sHDo?*!0MmYR;F-Vv%YlucZLCjtLxz-$P(LeWoM-YJG^ixw?i9DJ!3C3UhWN*c zl`Dgb)&w%4eVW`9i?tgrM{Z8ukupOQU!b;(5nVWKZDW^RS$lh(rDj90C@$;um<*Sq z(ofuYoJ`gf-NOS^b?~G!`de?H19h0grUu{I=Q}}8X1%q3Vg$E zkZF?rZlK;7;;?+(3{D{=R!@K_S7wqQ08Uv71}dfOp`@1jh#gRuj3!B1omY?;+-sYa z1-k%K0lFY|U}g$hZAAjgJuMgl;7tk>Jtw{&Ue1;_>UHvo`Rqc4Mzu(3J(6LsILHuG z$|sW>x$1Z>Gv^MyGP@$R&WcwuQlQ9M1zle~8fMc$2y{}`=OF1IiE>B$1ar+1L^W)E zwo2sZYeHV>=kE#f_h37Jj}S;JozRpnIR}%lwnU=g$Oy)SObj!`DD>Em-B@4L5us0m zrnEp4dH0uVva(GEg&Pg1aHmEdYvoB%(S}C`Ny2sj2rsMr_Zs;K<(vs(zQDQ>5D2Wr z_;yVr`cfJwBs7DIOrUeT`j?!EPT-`rz@-7!IDy**>1;nY_jpIBvzgOlLb{_L=)y?D zEU)NxZD9KZZWOxRt1Hg<{S5sM+xh`xzb5PyCX?kQdHl>hJTguL(}5T~!$Kq?0DV!w1NhM}y4hdf)?w90l1nWm{P*%~U@|BO#=^t!WK~1OBPAt77O!Gg39J ze-vVj)d;n9yMwt`v?B*D$Vw7BW_S#M_4xKJBc8kR&d;CtDS-a)CoD*L9R4tF_;)GI zK&QIhB{#I`g2_f?uCZMk%oHkGt9mCet0Vk-tb&GV;2FkJYxo;4Ew|urUaf0FPv|we zC#;V7<%NWQgf>PpW6=J+ma ztxF7=?enioR|FO{OR)-p`zh|Z_a&l!MJ2a!gS+aJaqc3nMsRK zLL+Y9LO4Ykh+30P z3QS5-Sf8HK2aS3MVo~`lq`{q16qZr3<%P~_la8GFw9`<_EY$PfbXTdV2$)V3VJL zna!~_qvGYJUa-$k=YHpB%4U^cKkPve_AsYgRRxjv zKuO9=R%*bO{8qsi2l7~m%<)- zpOZJhIB%T{9LB-RTSTQ7sGqOt8^=OI=~*~}xE#)_(;FvhuiB=g^q?Gm)Yafg=l*#= z$!cf8!gDt^olcaL2CUq2F#O;)Mp5SUC5

    About

    For an overview and description of Transfeminine Science, please visit our Home page.

    Authors

    The authors for Transfeminine Science include Aly, Mitzi, Lain, Sam, and Luna.

    Aly

    Aly (“she/her”) is a transgender woman from California. She has a passionate interest in transfeminine hormone therapy. Aly began her transition in the early 2010s and has been studying the transgender medical literature since. She has a bachelor’s degree with summa cum laude distinction from a University of California. Aly also completed some of the pre-medicine curriculum and worked for a little under a year as an appointed volunteer faculty in research labs at the university.

    Aly was a volunteer editor on Wikipedia for many years. She was a prolific medical editor for the online encyclopedia and contributed a large amount of content in the area of sex hormone pharmacology over time. Since then, Aly decided to retire from Wikipedia editing. When Aly has included inline citations to Wikipedia on Transfeminine Science, they have usually been to content that she herself authored.

    Aly was closely involved with the online transgender community for many years, including on Reddit and Discord. On Reddit, she led r/MtFHRT for a few years, co-founded r/AskMtFHRT and r/TransBreastTimelines, and was previously a moderator of r/TransDIY.

    ➜ Articles by Aly

    Mitzi

    Mitzi (“she/they”) is a non-binary transfeminine person who lives in London, United Kingdom. She is prolifically active in DIY HRT communities, where she acts as an educator and advocates a harm reduction approach to self-medication. Mitzi frequently navigates situations that involve transgender homelessness, domestic violence, healthcare discrimination, and substance use both online and locally, and has held advisory roles for a variety of small grassroots organizations, including Trans Healthcare Network, Gender Construction Kit, and Bluelight.

    Mitzi has a broad interest in medical academia, with a particular passion for endocrinology and psychopharmacology. She is an outspoken critic of her country’s transgender healthcare system, and has self-medicated for the duration of her own transition.

    ➜ Articles by Mitzi

    Lain

    Lain (“they/them”) is non-binary and transfeminine. They completed a bachelor’s degree in applied mathematics and studied bioinformatics and computational biology at the Rochester Institute of Technology in New York. After withdrawing from their Ph.D. program, Lain migrated to the much warmer climes of the San Francisco Bay Area to work in tech.

    As a person entrenched in nightlife community, specifically raving, Lain reformed and ran a nightlife harm reduction non-profit chapter for over 3 years, Bay Area DanceSafe. At DanceSafe they produced harm reductive literature on pertinent drugs and organized harm reduction booths at various festivals and raves. Through this direct outreach to the nightlife community, Lain led volunteers providing peer education on drugs, consent, sex education, and other pertinent topics as well as substance adulterant testing and harm reduction interventions. As a chapter head, they advocated for the normalization of harm reduction and the reform of drug policy working with peer organizations such as the Drug Policy Alliance (DPA), the Students for Sensible Drug Policy (SSDP), the Multidisciplinary Association for Psychedelic Studies (MAPS), and also by speaking at several events in the Bay Area.

    As Lain began to medically transition, they began to passionately research endocrinology and transgender medicine. Lain was involved with Transfeminine Science for a few years and wrote several articles on this site. However, Lain has since moved on and is now no longer involved with this site.

    ➜ Articles by Lain

    Sam

    Sam (“she/her”) is a transgender woman from London, United Kingdom. She has no formal medical or research qualifications, but has an intense interest in evidence-based medicine and adherence to the scientific method and has contributed several articles on the subject of transfeminine hormone therapy to Transfeminine Science. Her major research interests include the relatively uncommon to rare adverse effects of hormone therapy in transfeminine people, such as thromboembolism and other cardiovascular diseases. Specifically, she is interested in how the safety of different gender-affirming hormone therapy medications and dosages might compare. Sam has been reading and keeping up to date with the formal medical literature since she began to hormonally transition in 2018.

    Sam was involved with Transfeminine Science for a few years and wrote several articles on this site. However, Sam has moved on and is now no longer writing new content for Transfeminine Science.

    ➜ Articles by Sam

    Luna

    Luna (Blahaj-type) (“she/they”) is a non-binary trans woman and computer scientist from the United Kingdom. She developed the advanced injectable estradiol simulator via modification of Aly’s original simulator code.

    Contact

    Transfeminine Science is no longer accepting contact inquiries. For questions and advice about hormone therapy, please refer instead to the online transgender community.

    History

    Transfeminine Science originated from the informational content on transfeminine hormone therapy that was created by transfeminine people in the r/MtFHRT community of the social media website Reddit. Aly began creating content in August 2018, with other authors soon joining the effort. The articles were later adapted and moved to Transfeminine Science, which was launched in October 2020. Transfeminine Science has served as a dedicated platform for the articles and for additional content since then.

    Disclaimer

    The writers of Transfeminine Science are not medical professionals nor academic researchers. Transfeminine Science articles emulate the format of scientific journal articles, because this is an excellent format for scientific writing, but Transfeminine Science itself is not a scientific journal. The content on this site has not been formally published nor scholarly peer-reviewed. Readers should not take the content on Transfeminine Science as authoritative, but only as a supplementary resource to the information contained in transgender care guidelines and the medical literature in general.

    Wherever possible, decisions about medical care should be made in partnership with a health care professional. We recognize that many transfeminine people are on do-it-yourself (DIY) hormone therapy however, and we aim to help inform this critical and underserved community of individuals as well.

    License

    Transfeminine Science is copyright of Aly and the other authors of Transfeminine Science. We reserve all rights. We ask that readers please don’t reproduce content from Transfeminine Science unless given permission from Aly (e.g., for translation projects). If permission to reproduce content is given, please appropriately attribute the content and link it back to the original page(s) on Transfeminine Science.

    \ No newline at end of file +About - Transfeminine Science Link

    About

    For an overview and description of Transfeminine Science, please visit our Home page.

    Authors

    The authors for Transfeminine Science include Aly, Lain, Sam, Mitzi, and Luna.

    Aly

    Aly (“she/her”) is a transgender woman from California. She has long had a passionate interest in transfeminine hormone therapy and pharmacology generally. Aly began her transition in the early 2010s and has studied the transgender medical literature since. She has a bachelor’s degree with summa cum laude distinction from a University of California. Aly also completed some of the pre-medicine curriculum and worked for about a year as an appointed volunteer faculty member in research labs at the university. Aside from medical areas, Aly has experience with computer programming and web development.

    Aly was a volunteer editor on Wikipedia for many years. She was a prolific medical editor at the online encyclopedia and contributed a large amount of content in the area of sex hormone pharmacology over time. Since then, Aly decided to retire from Wikipedia editing. When Aly has included inline citations to Wikipedia on Transfeminine Science, they have usually been to content that she herself authored.

    ➜ Articles by Aly

    Lain

    Lain (“they/them”) is non-binary and transfeminine. They completed a bachelor’s degree in applied mathematics and studied bioinformatics and computational biology at the Rochester Institute of Technology in New York. After withdrawing from their Ph.D. program, Lain migrated to the much warmer climes of the San Francisco Bay Area to work in tech.

    As a person entrenched in nightlife community, specifically raving, Lain reformed and ran a nightlife harm reduction non-profit chapter for over 3 years, Bay Area DanceSafe. At DanceSafe they produced harm reductive literature on pertinent drugs and organized harm reduction booths at various festivals and raves. Through this direct outreach to the nightlife community, Lain led volunteers providing peer education on drugs, consent, sex education, and other pertinent topics as well as substance adulterant testing and harm reduction interventions. As a chapter head, they advocated for the normalization of harm reduction and the reform of drug policy working with peer organizations such as the Drug Policy Alliance (DPA), the Students for Sensible Drug Policy (SSDP), the Multidisciplinary Association for Psychedelic Studies (MAPS), and also by speaking at several events in the Bay Area.

    As Lain began to medically transition, they began to passionately research endocrinology and transgender medicine and became involved with Transfeminine Science for a few years.

    ➜ Articles by Lain

    Sam

    Sam (“she/her”) is a transgender woman from London, United Kingdom. She has no formal medical or research qualifications, but has an intense interest in evidence-based medicine and adherence to the scientific method. Her major interests in transgender health include the relatively uncommon to rare adverse effects of hormone therapy in transfeminine people, such as thromboembolism and other cardiovascular diseases. Specifically, she is interested in how the safety of different hormone therapy medications and dosages might compare. Sam read and kept up to date with the formal medical literature since she began to hormonally transition in 2018. She was involved with Transfeminine Science for a few years and contributed several articles to the site.

    ➜ Articles by Sam

    Mitzi

    Mitzi (“she/they”) is a non-binary transfeminine person who lives in London, United Kingdom. She is prolifically active in DIY HRT communities, where she acts as an educator and advocates a harm reduction approach to self-medication. Mitzi frequently navigates situations that involve transgender homelessness, domestic violence, healthcare discrimination, and substance use both online and locally, and has held advisory roles for a variety of small grassroots organizations, including Trans Healthcare Network, Gender Construction Kit, and Bluelight.

    Mitzi has a broad interest in medical academia, with a particular passion for endocrinology and psychopharmacology. She is an outspoken critic of her country’s transgender healthcare system, and has self-medicated for the duration of her own transition.

    ➜ Articles by Mitzi

    Luna

    Luna (“she/they”) is a non-binary trans woman and computer scientist from the United Kingdom. She developed the advanced injectable estradiol simulator by modifying Aly’s original simulator code.

    Contact

    Transfeminine Science is no longer accepting contact inquiries. For questions and advice about hormone therapy, please refer instead to the online transgender community.

    History

    Transfeminine Science originated from the informational content on transfeminine hormone therapy that was created by transfeminine people in the transgender hormone therapy community on the social media website Reddit. Aly began creating content in August 2018, with other authors soon joining the effort. A couple years later, Aly developed and founded Transfeminine Science, which was launched in October 2020, and the existing content on Reddit was adapted and moved to the site. Transfeminine Science has served as a dedicated platform for the articles and for new content since it was started.

    Disclaimer

    The writers of Transfeminine Science are not medical professionals, academic researchers, or recognized experts in transgender health. Transfeminine Science articles emulate the format of scientific journal articles because this is an excellent format for scientific writing. However, it should be noted that Transfeminine Science itself is not a scientific journal and the content on this site has not been formally published nor scholarly peer-reviewed. Readers should not take the content on Transfeminine Science as authoritative. Instead, it should be considered as a supplementary resource to the information contained in transgender care guidelines and the medical literature in general.

    Transfeminine Science is not specifically aimed at transfeminine people on do-it-yourself (DIY) hormone therapy. Rather, it is intended for transfeminine people on hormone therapy generally, as well as for medical providers and academics in transgender health. The authors of Transfeminine Science feel that wherever possible, decisions about medical care should be made in partnership with a health care professional. We recognize that this is not the case for many however, due to choice or circumstances, and we aim to help inform this important and undeserved community of individuals as well.

    License

    Transfeminine Science is copyright of Aly and the other authors of Transfeminine Science. We reserve all rights. We ask that readers please don’t reproduce content from Transfeminine Science unless given permission from Aly (e.g., for translation projects). If permission to reproduce content has been given, we ask that the content be appropriately attributed and linked back to the original page(s) on this site.

    \ No newline at end of file diff --git a/transfemscience.org/articles-by-author/aly/index.html b/transfemscience.org/articles-by-author/aly/index.html index 87b64269..3cce5d0a 100644 --- a/transfemscience.org/articles-by-author/aly/index.html +++ b/transfemscience.org/articles-by-author/aly/index.html @@ -1 +1 @@ -Articles by Aly - Transfeminine Science Link

    Articles by Aly (Latest First)

       Filter by author: Aly | Lain | Sam | Mitzi | All

    \ No newline at end of file +Articles by Aly - Transfeminine Science Link

    Articles by Aly (Latest First)

       Filter by author: Aly | Lain | Sam | Mitzi | All

    \ No newline at end of file diff --git a/transfemscience.org/articles-by-author/lain/index.html b/transfemscience.org/articles-by-author/lain/index.html index ba9e97b2..cf1e3a34 100644 --- a/transfemscience.org/articles-by-author/lain/index.html +++ b/transfemscience.org/articles-by-author/lain/index.html @@ -1 +1 @@ -Articles by Lain - Transfeminine Science Link \ No newline at end of file +Articles by Lain - Transfeminine Science Link \ No newline at end of file diff --git a/transfemscience.org/articles-by-author/mitzi/index.html b/transfemscience.org/articles-by-author/mitzi/index.html index 8d3a86b7..ea2783e4 100644 --- a/transfemscience.org/articles-by-author/mitzi/index.html +++ b/transfemscience.org/articles-by-author/mitzi/index.html @@ -1 +1 @@ -Articles by Mitzi - Transfeminine Science Link

    Articles by Mitzi (Latest First)

       Filter by author: Aly | Lain | Sam | Mitzi | All

    \ No newline at end of file +Articles by Mitzi - Transfeminine Science Link

    Articles by Mitzi (Latest First)

       Filter by author: Aly | Lain | Sam | Mitzi | All

    \ No newline at end of file diff --git a/transfemscience.org/articles-by-author/sam/index.html b/transfemscience.org/articles-by-author/sam/index.html index c4b60baa..f5a6dec7 100644 --- a/transfemscience.org/articles-by-author/sam/index.html +++ b/transfemscience.org/articles-by-author/sam/index.html @@ -1 +1 @@ -Articles by Sam - Transfeminine Science Link \ No newline at end of file +Articles by Sam - Transfeminine Science Link \ No newline at end of file diff --git a/transfemscience.org/articles-by-date/index.html b/transfemscience.org/articles-by-date/index.html index ff104822..163d0960 100644 --- a/transfemscience.org/articles-by-date/index.html +++ b/transfemscience.org/articles-by-date/index.html @@ -1 +1 @@ -Articles by Date - Transfeminine Science Link

    Articles by Date (Latest First)

       Filter by author: Aly | Lain | Sam | Mitzi

    \ No newline at end of file +Articles by Date - Transfeminine Science Link

    Articles by Date (Latest First)

       Filter by author: Aly | Lain | Sam | Mitzi

    \ No newline at end of file diff --git a/transfemscience.org/articles/aqueous-suspensions/index.html b/transfemscience.org/articles/aqueous-suspensions/index.html index 23aba173..6607a056 100644 --- a/transfemscience.org/articles/aqueous-suspensions/index.html +++ b/transfemscience.org/articles/aqueous-suspensions/index.html @@ -1 +1 @@ -Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work - Transfeminine Science Link

    Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work

    By Aly | First published June 14, 2019 | Last modified August 2, 2022

    Abstract / TL;DR

    Depot injectable steroid preparations are formulated mainly as oil solutions and crystalline aqueous suspensions. Oil solutions of steroids are more well-known and widely used but aqueous suspensions also exist and continue to be employed in medicine. For example, depot medroxyprogesterone acetate and estradiol cypionate-containing combined injectable contraceptives are aqueous suspensions. Both oil solutions and aqueous suspensions produce a depot effect. However, they function in very different ways to produce this depot effect. Oil solutions form an oil depot at the site of injection which is slowly absorbed and from which the steroid slowly escapes, whereas aqueous suspensions deliver crystals of pure steroid which slowly dissolve and are absorbed. Aqueous suspensions are essentially like tiny pellet implants that can be injected instead of surgically inserted. Aqueous suspensions tend to have longer durations than oil solutions and can allow for much wider dosing intervals in comparison. The dissolution rates and durations of aqueous suspensions are highly dependent on crystal size. A limitation of aqueous suspensions is that they can cause pain and irritation at the site of injection in a way that oil solutions have not been associated with and this is likely responsible for their less widespread use. Aqueous suspensions of estradiol benzoate (Agofollin Depot) and progesterone (Agolutin Depot) remain limitedly and sporadically available and have much longer durations than the more common oil solutions of these steroids. These preparations may be potential options for use by transfeminine people.

    Introduction

    Depot injectable sex steroids are administered by intramuscular injection (into muscle) or subcutaneous injection (into fat) and are formulated in two main ways: 1) as oil solutions; and 2) as crystalline aqueous suspensions. What most transfeminine people are familiar with when it comes to injectable steroid preparations are oil solutions. This is how most common preparations like injectable estradiol valerate (Delestrogen, Progynon-Depot), estradiol cypionate (Depo-Estradiol), testosterone esters, progesterone, and hydroxyprogesterone caproate are formulated. However, injectable aqueous suspensions of sex steroids also exist and are used medically. The most major and well-known formulations include depot medroxyprogesterone acetate (Depo-Provera) and combined injectable contraceptives containing estradiol cypionate/medroxyprogesterone acetate (Cyclofem, Lunelle). Additionally, there exist more obscure preparations of aqueous suspensions such as estradiol benzoate (Agofollin Depot) and progesterone (Agolutin Depot) among others which are marketed in addition to the more common oil solutions of these steroids. These preparations may remain commercially available, including online from sites like EU Aibolit (Reddit). Many transfeminine people are unaware of what aqueous suspensions are or their medical availability. It is notable in this regard that aqueous suspensions are very different from oil solutions in their properties but can have much longer durations in comparison. This is potentially of therapeutic value especially in the case of otherwise shorter-acting injectables like progesterone. The purpose of this article is to shed light on injectable aqueous suspensions, describe how injectable oil solutions and aqueous suspensions work to achieve their depot effect and how they are different, and discuss how relevant aqueous suspensions can be obtained for medical use.

    How Depot Injectables Work

    Sex steroids are typically lipophilic (fat-soluble or “lipid-loving”) and hydrophobic (water-insoluble or “water-hating”). In other words, they dissolve in and are “attracted to” lipids (e.g., fats), and they are poorly soluble in and repelled by water. From chemistry, this is because sex steroids are very non-polar, whereas water is a quite polar molecule. As a result of their lipophilicity, sex steroids readily form clear homogenous solutions when mixed into oil—that is, they form oil solutions. In contrast, because sex steroids are hydrophobic, they do not easily form solutions when mixed into water—that is, they do not easily form aqueous solutions (like, e.g., salt and water). Instead of aqueous solutions, solid “clumps” or crystal particles of sex steroids can be mixed into and thereby suspended in water—that is, aqueous suspensions of sex steroid crystals can be made. Depot injectables are formulated as oil solutions or aqueous suspensions and these preparations have very different properties.

    Injectable Oil Solutions

    When an oil solution of a sex steroid is administered by intramuscular or subcutaneous injection, the solution is trapped within the tissue compartment it is injected into and remains there. As the tissue fluid is a water mixture, the oil solution stays together inside the tissue compartment and does not easily separate or distribute. This is because the lipophilic fats and sex steroids within the solution are attracted to each other and are repelled by water. Instead of rapidly dissolving, the fats and sex steroids at the edges of the oil solution are very slowly absorbed into the surrounding water. Once they have escaped the oil depot into the surrounding tissue fluid, they can be distributed into the bloodstream and then into other tissues to exert their biological effects. Eventually, the whole oil solution will be absorbed.

    Oftentimes sex steroids that are used by intramuscular or subcutaneous injection are esterified with one or more lipophilic hydrocarbon esters. These esters include fatty acids like propanoic acid (propionate), pentanoic acid (valerate), hexanoic acid (caproate), heptanoic acid (enanthate), decanoic acid (decanote or decylate), and undecanoic acid (undecylate or undecanoate) as well as cyclic compounds like benzoic acid (benzoate), cyclopentylpropanoic acid (cypionate), and phenylpropanoic acid (phenylpropionate), among many others. Examples of these sex steroid esters include the well-known estradiol valerate, estradiol cypionate, estradiol benzoate, hydroxyprogesterone caproate, and numerous others. The attachment of a lipophilic ester (e.g., valeric acid) to a sex steroid (e.g., estradiol) will increase the lipophilicity of the sex steroid compared to merely injecting the unesterified sex steroid in an oil solution. The longer the carbon atom chain in the case of the simple fatty acid esters (e.g., propionate, valerate, enanthate, undecylate), the more lipophilic the resulting esterified sex steroid will be. As a result, the injected sex steroid ester will escape the oil tissue depot more slowly, lengthening the amount of time it takes for the sex steroid ester to be absorbed and therefore its duration in the body. The tables here and here show the lengthening duration of estradiol with longer or bulkier and and more lipophilic esters. Whereas an intramuscular injection of estradiol or progesterone in oil solution has a duration of only around 2 days, an intramuscular injection of an oil solution of estradiol undecylate, an ester of estradiol with a long fatty acid chain, has a duration measured in months. And an intramuscular injection of an oil solution of hydroxyprogesterone caproate, an ester of a derivative of progesterone that has a medium-length fatty acid chain, has a duration measured in weeks.

    Most sex steroid esters themselves are biologically inactive. Once they have left the oil tissue depot, they are rapidly cleaved by esterase enzymes into free unesterified steroid (e.g., estradiol, testosterone) and the previously connected ester moiety (e.g., valeric acid). Hence, most sex steroid esters are prodrugs and are otherwise identical to their parent sex steroids in their biological actions. In the case of esters of estradiol and testosterone, this means that they are bioidentical just like the unesterified steroids. Certain synthetic progesterone derivatives like hydroxyprogesterone caproate and medroxyprogesterone acetate are however not prodrugs and are not meaningfully cleaved into the unesterified parent compound. Instead, they have intrinsic hormonal activity of their own and act without bioactivation.

    Injectable Aqueous Suspensions

    Aqueous suspensions of sex steroids also form an injection-site depot and achieve a long-lasting depot effect when administered by subcutaneous or intramuscular injection. However, they work in a completely different way than oil solutions. Aqueous suspensions of sex steroids consist of tiny crystal particles of pure sex steroid that are suspended in water. These sex steroid particles are highly lipophilic and hydrophobic. When injected, the hydrophilic water vehicle is rapidly mixed into the fluid of the tissue compartment and absorbed by the body. But the hydrophobic sex steroid crystals are not, and instead float about in the fluid of the tissue compartment. As with oil solutions, the sex steroids at the edges of the crystals very slowly dissolve off the surface of the crystals into the surrounding water and are then distributed into the circulation and tissues. Eventually, the crystal will be fully absorbed into the body, but only after a long period of time. The rate of absorption of the particles is dependent on the properties of the particle crystal lattice and varies depending on the compound.

    In the case of aqueous suspensions, the duration of the sex steroid is additionally highly dependent on particle size. These particle sizes have ranged from nanocrystalline to microcrystalline to macrocrystalline in their range. Almost always however it is microcrystalline particle sizes that have been used in injectable aqueous suspensions of sex steroids. (The present author has seen macrocrystalline preparations described a few times, specifically in research on combined injectable contraceptives (Garza-Flores, Del, & Perez-Palacios, 1992; Newton, d’Arcangues, & Hall, 1994; Sang, 1994), and is fairly sure that no such preparations have ever been marketed. On the other hand, nanocrystalline aqueous suspensions have been used with depot antipsychotics (Spanarello & Ferla, 2014; Correll et al., 2021).) Typically, there is a given particle size range for the formulation, such as 0.01 to 0.1 mm in diameter. The larger the particle sizes, the slower the absorption into the body, and the longer the duration of the preparation; the smaller the particle sizes, the faster the absorption, and the shorter the duration. When microcrystalline aqueous suspensions of sex steroids are manufactured nowadays, the particle sizes are defined and carefully controlled. Particle sizes influence the duration of injectable aqueous suspensions because they result in different surface areas from which sex steroid ester can escape particles. A single large particle has a smaller total surface area and hence dissolution rate than the same particle divided up into many smaller particles.

    Particle sizes are manipulated during manufacturing via micronization—the process of decreasing the diameter of larger particles, such as via milling or grinding. Whereas more micronization improves the absorption and bioavailability of estradiol and progesterone with oral administration by increasing the surface area available for absorption into the body (Wiki; Wiki), less micronization decreases the rate of absorption of crystalline aqueous suspensions via depot injection and thereby extends the durations of these preparations by decreasing the total surface area for absorption.

    There is a notable similarity of injectable aqueous suspensions of sex steroid to implantable sex steroid pellets, for instance of estradiol, testosterone, and progesterone (Wiki; Wiki; Wiki). Pellet implants are basically just pure crystalline sex steroid compressed into the shape of a small cylinder (Photo; Photo). They are inserted into subcutaneous fat in the body through a small incision using a large needle-like instrument called a trocar (Diagram). Once implanted, pellets slowly dissolve and absorb into the body over time, eventually disappearing completely. As they are nothing but pure crystalline hormone, there is no need for them to be removed or retrieved later on. In other words, implantation of a pellet is in a way the same thing as a subcutaneous injection of an aqueous suspension of sex steroid crystals—a single pellet is just one massive crystal instead of many tiny crystals suspended in water. And with very large crystals comes a very long duration—typically 6 months or more for each subcutaneous pellet of estradiol or testosterone (Kuhl, 2005; Wiki; Wiki). However, though injectable aqueous suspensions are typically much less prolonged than pellet implants, they have the advantages over pellets of being less expensive and not requiring a surgical incision. Due to the similarity between aqueous suspensions and pellet implants, aqueous suspensions have been described and marketed as “micropellets” in the past.

    Medical Use of Injectable Aqueous Suspensions

    Clinical Durations of Injectable Aqueous Suspensions

    Studies that have compared sex steroids in injectable oil solutions versus injectable aqueous suspensions have generally found that the durations are considerably longer with aqueous suspensions than with oil solutions. Whereas injectable estradiol and estrone in oil solution have durations of only about 1 to 2 days, aqueous suspensions of these steroids have durations of 2 to 7 days (Table). Moreover, whereas injectable estradiol benzoate in oil solution has a duration of 4 to 6 days, injectable estradiol benzoate as a microcrystalline aqueous suspension has a duration of 2 to 3 weeks (Table). Such a duration is on par with the duration of longer-acting injectable estradiol esters like estradiol cypionate in oil solution and estradiol enanthate in oil solution. In addition, whereas injectable progesterone in oil solution has a duration of about 2 to 3 days, injectable aqueous suspensions of progesterone have a duration in the range of 1 to 2 weeks (Table). This is a duration that is comparable to that of injectable hydroxyprogesterone caproate in oil solution. The prolonged duration of injectable progesterone suspensions is particularly notable as progesterone cannot be esterified and hence injectable progesterone in oil solution cannot be prolonged except with structural modification (as in progestins like hydroxyprogesterone caproate and dihydroxyprogesterone acetophenide) (Wiki). The duration of injectable testosterone propionate in oil solution is 3 to 4 days, in a suspension of small crystals (0.04–0.1 mm) is 8 days, and as commercial-size crystals (0.05–0.2 mm) is 12 days (Sinkula, 1978). Testosterone isobutyrate as an aqueous suspension is said to have a duration of 2 to 3 weeks (Sinkula, 1978; Table). Some injectable aqueous suspensions can have extremely prolonged durations. Depot medroxyprogesterone acetate for instance has a duration of at least 3 months and as long as 6 to 9 months (Wiki). It greatly outlasts the related injectable progestogen norethisterone enanthate in oil solution (Noristerat) (Bassol & Garza-Flores, 1994; Paulen & Curtis, 2009).

    Availability of Injectable Aqueous Suspensions

    A list of injectable aqueous suspensions of sex steroids that are known to have been marketed can be found here. Most of them were introduced in the 1950s and many of them have been discontinued, but several of the preparations remain available today. These include the single-drug preparations estradiol benzoate (Agofollin Depot, Ovocyclin M), progesterone (Agolutin Depot), testosterone isobutyrate (Agovirin Depot), and medroxyprogesterone acetate (Depo-Provera, Depo-SubQ Provera 104) as well as the combination preparations estradiol benzoate/testosterone isobutyrate (Folivirin, Femandren M) and estradiol cypionate/medroxyprogesterone acetate (Cyclofem, Lunelle). Among the more notable injectable aqueous suspensions that are no longer marketed include estradiol (Aquadiol, Diogyn, Progynon Aqueous Suspension, Progynon Micropellets), estrone (Estrone Aqueous Suspension, Kestrone, Theelin Aqueous), and testosterone (Andronaq, Sterotate, Virosterone) as well as the combination preparation estradiol benzoate/progesterone (Sistocyclin).

    Agofollin Depot (estradiol benzoate), Agolutin Depot (progesterone), and Folivirin (estradiol benzoate/testosterone isobutyrate) are all marketed today only in the Czech Republic and Slovakia in Central Europe. However, they all seem to be available from EU Aibolit, a common site that transgender people on do-it-yourself (DIY) hormone therapy obtain their medications from (Reddit). Here are the medication leaflets for all of these products (in Czech and translated into English):

    The company that manufactures these products, BB Pharma, is notably also the producer of the well-known Neofollin (injectable estradiol valerate in oil solution) in Europe.

    Injection Procedure for Injectable Aqueous Suspensions

    Aqueous suspensions require larger needle gauges (e.g., 20 or 21 gauge) than oil or aqueous solutions in order to allow the steroid crystals to pass through the needle lumen. The needle sizes may vary depending on the preparation and its crystal sizes. Injectable aqueous suspensions should be shaken adequately prior to injection as the crystals tend to aggregate. Aqueous suspensions are known to be more irritating and prone to causing pain and injection site reactions like redness and swelling than oil solutions, although this may vary depending on the preparation (Wiki; Wiki). This property is likely responsible for the discontinuation of many injectable suspensions and the greater popularity of injectable oil solutions. On the other hand, an advantage of aqueous suspensions over oil solutions is that in contrast them, there is no oil, and hence there is no risk of allergic reaction to the oil. As with injectable oil solutions, injectable aqueous suspensions are indicated for use specifically by intramuscular injection. Depot medroxyprogesterone acetate, which is available in both formulations for both intramuscular injection (Depo-Provera) and subcutaneous injection (Depo-SubQ Provera 104), is suggestive that aqueous suspensions have similar properties both by intramuscular and subcutaneous injection analogously to the case of injectable oil solutions (Wiki; Wiki). However, it should be noted that depot medroxyprogesterone acetate is formulated differently between these preparations.

    Update: Pharmaceutical Suspensions Discontinued

    Since this article was posted, Agofollin Depot (estradiol benzoate), Agolutin Depot (progesterone), and Folivirin (estradiol benzoate/testosterone isobutyrate) appear to have been discontinued by their manufacturer and seem to no longer be available from online pharmacies.

    References

    • Bassol, S., & Garza-Flores, J. (1994). Review of ovulation return upon discontinuation of once-a-month injectable contraceptives. Contraception, 49(5), 441–453. [DOI:10.1016/0010-7824(94)90003-5]
    • Correll, C. U., Kim, E., Sliwa, J. K., Hamm, W., Gopal, S., Mathews, M., Venkatasubramanian, R., & Saklad, S. R. (2021). Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. CNS Drugs, 35(1), 39–59. [DOI:10.1007/s40263-020-00779-5]
    • Garza-Flores, J., Cravioto, M. C., & Pérez-Palacios, G. (1992). Steroid injectable contraception: Current concepts and perspectives. In Sitruk-Ware, L. R., & Bardin, C. W. (Eds.). Contraception: Newer Pharmacological Agents, Devices, and Delivery Systems (pp. 41–70). New York: M. Dekker. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Newton, J. R., d’Arcangues, C., & Hall, P. E. (1994). A review of ‘once-a-month’ combined injectable contraceptives. Journal of Obstetrics and Gynaecology, 14(Suppl 1), S1–S34. [DOI:10.3109/01443619409027641]
    • Paulen, M. E., & Curtis, K. M. (2009). When can a woman have repeat progestogen-only injectables–depot medroxyprogesterone acetate or norethisterone enantate? Contraception, 80(4), 391–408. [DOI:10.1016/j.contraception.2009.03.023]
    • Sang, G. (1994). Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception, 49(4), 361–385. [DOI:10.1016/0010-7824(94)90033-7]
    • Sinkula, A. A. (1978). Methods to Achieve Sustained Drug Delivery. The Chemical Approach. In Robinson, J. R. (Ed.). Sustained and Controlled Release Drug Delivery Systems (pp. 411–555). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books] [PDF]
    • Spanarello, S., & Ferla, T. (2014). The Pharmacokinetics of Long-Acting Antipsychotic Medications. Current Clinical Pharmacology, 9(3), 310–317. [DOI:10.2174/15748847113089990051]
    \ No newline at end of file +Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work - Transfeminine Science Link

    Injectable Aqueous Suspensions of Sex Hormones and How Depot Injectables Work

    By Aly | First published June 14, 2019 | Last modified August 2, 2022

    Abstract / TL;DR

    Depot injectable steroid preparations are formulated mainly as oil solutions and crystalline aqueous suspensions. Oil solutions of steroids are more well-known and widely used but aqueous suspensions also exist and continue to be employed in medicine. For example, depot medroxyprogesterone acetate and estradiol cypionate-containing combined injectable contraceptives are aqueous suspensions. Both oil solutions and aqueous suspensions produce a depot effect. However, they function in very different ways to produce this depot effect. Oil solutions form an oil depot at the site of injection which is slowly absorbed and from which the steroid slowly escapes, whereas aqueous suspensions deliver crystals of pure steroid which slowly dissolve and are absorbed. Aqueous suspensions are essentially like tiny pellet implants that can be injected instead of surgically inserted. Aqueous suspensions tend to have longer durations than oil solutions and can allow for much wider dosing intervals in comparison. The dissolution rates and durations of aqueous suspensions are highly dependent on crystal size. A limitation of aqueous suspensions is that they can cause pain and irritation at the site of injection in a way that oil solutions have not been associated with and this is likely responsible for their less widespread use. Aqueous suspensions of estradiol benzoate (Agofollin Depot) and progesterone (Agolutin Depot) remain limitedly and sporadically available and have much longer durations than the more common oil solutions of these steroids. These preparations may be potential options for use by transfeminine people.

    Introduction

    Depot injectable sex steroids are administered by intramuscular injection (into muscle) or subcutaneous injection (into fat) and are formulated in two main ways: 1) as oil solutions; and 2) as crystalline aqueous suspensions. What most transfeminine people are familiar with when it comes to injectable steroid preparations are oil solutions. This is how most common preparations like injectable estradiol valerate (Delestrogen, Progynon-Depot), estradiol cypionate (Depo-Estradiol), testosterone esters, progesterone, and hydroxyprogesterone caproate are formulated. However, injectable aqueous suspensions of sex steroids also exist and are used medically. The most major and well-known formulations include depot medroxyprogesterone acetate (Depo-Provera) and combined injectable contraceptives containing estradiol cypionate/medroxyprogesterone acetate (Cyclofem, Lunelle). Additionally, there exist more obscure preparations of aqueous suspensions such as estradiol benzoate (Agofollin Depot) and progesterone (Agolutin Depot) among others which are marketed in addition to the more common oil solutions of these steroids. These preparations may remain commercially available, including online from sites like EU Aibolit (Reddit). Many transfeminine people are unaware of what aqueous suspensions are or their medical availability. It is notable in this regard that aqueous suspensions are very different from oil solutions in their properties but can have much longer durations in comparison. This is potentially of therapeutic value especially in the case of otherwise shorter-acting injectables like progesterone. The purpose of this article is to shed light on injectable aqueous suspensions, describe how injectable oil solutions and aqueous suspensions work to achieve their depot effect and how they are different, and discuss how relevant aqueous suspensions can be obtained for medical use.

    How Depot Injectables Work

    Sex steroids are typically lipophilic (fat-soluble or “lipid-loving”) and hydrophobic (water-insoluble or “water-hating”). In other words, they dissolve in and are “attracted to” lipids (e.g., fats), and they are poorly soluble in and repelled by water. From chemistry, this is because sex steroids are very non-polar, whereas water is a quite polar molecule. As a result of their lipophilicity, sex steroids readily form clear homogenous solutions when mixed into oil—that is, they form oil solutions. In contrast, because sex steroids are hydrophobic, they do not easily form solutions when mixed into water—that is, they do not easily form aqueous solutions (like, e.g., salt and water). Instead of aqueous solutions, solid “clumps” or crystal particles of sex steroids can be mixed into and thereby suspended in water—that is, aqueous suspensions of sex steroid crystals can be made. Depot injectables are formulated as oil solutions or aqueous suspensions and these preparations have very different properties.

    Injectable Oil Solutions

    When an oil solution of a sex steroid is administered by intramuscular or subcutaneous injection, the solution is trapped within the tissue compartment it is injected into and remains there. As the tissue fluid is a water mixture, the oil solution stays together inside the tissue compartment and does not easily separate or distribute. This is because the lipophilic fats and sex steroids within the solution are attracted to each other and are repelled by water. Instead of rapidly dissolving, the fats and sex steroids at the edges of the oil solution are very slowly absorbed into the surrounding water. Once they have escaped the oil depot into the surrounding tissue fluid, they can be distributed into the bloodstream and then into other tissues to exert their biological effects. Eventually, the whole oil solution will be absorbed.

    Oftentimes sex steroids that are used by intramuscular or subcutaneous injection are esterified with one or more lipophilic hydrocarbon esters. These esters include fatty acids like propanoic acid (propionate), pentanoic acid (valerate), hexanoic acid (caproate), heptanoic acid (enanthate), decanoic acid (decanote or decylate), and undecanoic acid (undecylate or undecanoate) as well as cyclic compounds like benzoic acid (benzoate), cyclopentylpropanoic acid (cypionate), and phenylpropanoic acid (phenylpropionate), among many others. Examples of these sex steroid esters include the well-known estradiol valerate, estradiol cypionate, estradiol benzoate, hydroxyprogesterone caproate, and numerous others. The attachment of a lipophilic ester (e.g., valeric acid) to a sex steroid (e.g., estradiol) will increase the lipophilicity of the sex steroid compared to merely injecting the unesterified sex steroid in an oil solution. The longer the carbon atom chain in the case of the simple fatty acid esters (e.g., propionate, valerate, enanthate, undecylate), the more lipophilic the resulting esterified sex steroid will be. As a result, the injected sex steroid ester will escape the oil tissue depot more slowly, lengthening the amount of time it takes for the sex steroid ester to be absorbed and therefore its duration in the body. The tables here and here show the lengthening duration of estradiol with longer or bulkier and and more lipophilic esters. Whereas an intramuscular injection of estradiol or progesterone in oil solution has a duration of only around 2 days, an intramuscular injection of an oil solution of estradiol undecylate, an ester of estradiol with a long fatty acid chain, has a duration measured in months. And an intramuscular injection of an oil solution of hydroxyprogesterone caproate, an ester of a derivative of progesterone that has a medium-length fatty acid chain, has a duration measured in weeks.

    Most sex steroid esters themselves are biologically inactive. Once they have left the oil tissue depot, they are rapidly cleaved by esterase enzymes into free unesterified steroid (e.g., estradiol, testosterone) and the previously connected ester moiety (e.g., valeric acid). Hence, most sex steroid esters are prodrugs and are otherwise identical to their parent sex steroids in their biological actions. In the case of esters of estradiol and testosterone, this means that they are bioidentical just like the unesterified steroids. Certain synthetic progesterone derivatives like hydroxyprogesterone caproate and medroxyprogesterone acetate are however not prodrugs and are not meaningfully cleaved into the unesterified parent compound. Instead, they have intrinsic hormonal activity of their own and act without bioactivation.

    Injectable Aqueous Suspensions

    Aqueous suspensions of sex steroids also form an injection-site depot and achieve a long-lasting depot effect when administered by subcutaneous or intramuscular injection. However, they work in a completely different way than oil solutions. Aqueous suspensions of sex steroids consist of tiny crystal particles of pure sex steroid that are suspended in water. These sex steroid particles are highly lipophilic and hydrophobic. When injected, the hydrophilic water vehicle is rapidly mixed into the fluid of the tissue compartment and absorbed by the body. But the hydrophobic sex steroid crystals are not, and instead float about in the fluid of the tissue compartment. As with oil solutions, the sex steroids at the edges of the crystals very slowly dissolve off the surface of the crystals into the surrounding water and are then distributed into the circulation and tissues. Eventually, the crystal will be fully absorbed into the body, but only after a long period of time. The rate of absorption of the particles is dependent on the properties of the particle crystal lattice and varies depending on the compound.

    In the case of aqueous suspensions, the duration of the sex steroid is additionally highly dependent on particle size. These particle sizes have ranged from nanocrystalline to microcrystalline to macrocrystalline in their range. Almost always however it is microcrystalline particle sizes that have been used in injectable aqueous suspensions of sex steroids. (The present author has seen macrocrystalline preparations described a few times, specifically in research on combined injectable contraceptives (Garza-Flores, Del, & Perez-Palacios, 1992; Newton, d’Arcangues, & Hall, 1994; Sang, 1994), and is fairly sure that no such preparations have ever been marketed. On the other hand, nanocrystalline aqueous suspensions have been used with depot antipsychotics (Spanarello & Ferla, 2014; Correll et al., 2021).) Typically, there is a given particle size range for the formulation, such as 0.01 to 0.1 mm in diameter. The larger the particle sizes, the slower the absorption into the body, and the longer the duration of the preparation; the smaller the particle sizes, the faster the absorption, and the shorter the duration. When microcrystalline aqueous suspensions of sex steroids are manufactured nowadays, the particle sizes are defined and carefully controlled. Particle sizes influence the duration of injectable aqueous suspensions because they result in different surface areas from which sex steroid ester can escape particles. A single large particle has a smaller total surface area and hence dissolution rate than the same particle divided up into many smaller particles.

    Particle sizes are manipulated during manufacturing via micronization—the process of decreasing the diameter of larger particles, such as via milling or grinding. Whereas more micronization improves the absorption and bioavailability of estradiol and progesterone with oral administration by increasing the surface area available for absorption into the body (Wiki; Wiki), less micronization decreases the rate of absorption of crystalline aqueous suspensions via depot injection and thereby extends the durations of these preparations by decreasing the total surface area for absorption.

    There is a notable similarity of injectable aqueous suspensions of sex steroid to implantable sex steroid pellets, for instance of estradiol, testosterone, and progesterone (Wiki; Wiki; Wiki). Pellet implants are basically just pure crystalline sex steroid compressed into the shape of a small cylinder (Photo; Photo). They are inserted into subcutaneous fat in the body through a small incision using a large needle-like instrument called a trocar (Diagram). Once implanted, pellets slowly dissolve and absorb into the body over time, eventually disappearing completely. As they are nothing but pure crystalline hormone, there is no need for them to be removed or retrieved later on. In other words, implantation of a pellet is in a way the same thing as a subcutaneous injection of an aqueous suspension of sex steroid crystals—a single pellet is just one massive crystal instead of many tiny crystals suspended in water. And with very large crystals comes a very long duration—typically 6 months or more for each subcutaneous pellet of estradiol or testosterone (Kuhl, 2005; Wiki; Wiki). However, though injectable aqueous suspensions are typically much less prolonged than pellet implants, they have the advantages over pellets of being less expensive and not requiring a surgical incision. Due to the similarity between aqueous suspensions and pellet implants, aqueous suspensions have been described and marketed as “micropellets” in the past.

    Medical Use of Injectable Aqueous Suspensions

    Clinical Durations of Injectable Aqueous Suspensions

    Studies that have compared sex steroids in injectable oil solutions versus injectable aqueous suspensions have generally found that the durations are considerably longer with aqueous suspensions than with oil solutions. Whereas injectable estradiol and estrone in oil solution have durations of only about 1 to 2 days, aqueous suspensions of these steroids have durations of 2 to 7 days (Table). Moreover, whereas injectable estradiol benzoate in oil solution has a duration of 4 to 6 days, injectable estradiol benzoate as a microcrystalline aqueous suspension has a duration of 2 to 3 weeks (Table). Such a duration is on par with the duration of longer-acting injectable estradiol esters like estradiol cypionate in oil solution and estradiol enanthate in oil solution. In addition, whereas injectable progesterone in oil solution has a duration of about 2 to 3 days, injectable aqueous suspensions of progesterone have a duration in the range of 1 to 2 weeks (Table). This is a duration that is comparable to that of injectable hydroxyprogesterone caproate in oil solution. The prolonged duration of injectable progesterone suspensions is particularly notable as progesterone cannot be esterified and hence injectable progesterone in oil solution cannot be prolonged except with structural modification (as in progestins like hydroxyprogesterone caproate and dihydroxyprogesterone acetophenide) (Wiki). The duration of injectable testosterone propionate in oil solution is 3 to 4 days, in a suspension of small crystals (0.04–0.1 mm) is 8 days, and as commercial-size crystals (0.05–0.2 mm) is 12 days (Sinkula, 1978). Testosterone isobutyrate as an aqueous suspension is said to have a duration of 2 to 3 weeks (Sinkula, 1978; Table). Some injectable aqueous suspensions can have extremely prolonged durations. Depot medroxyprogesterone acetate for instance has a duration of at least 3 months and as long as 6 to 9 months (Wiki). It greatly outlasts the related injectable progestogen norethisterone enanthate in oil solution (Noristerat) (Bassol & Garza-Flores, 1994; Paulen & Curtis, 2009).

    Availability of Injectable Aqueous Suspensions

    A list of injectable aqueous suspensions of sex steroids that are known to have been marketed can be found here. Most of them were introduced in the 1950s and many of them have been discontinued, but several of the preparations remain available today. These include the single-drug preparations estradiol benzoate (Agofollin Depot, Ovocyclin M), progesterone (Agolutin Depot), testosterone isobutyrate (Agovirin Depot), and medroxyprogesterone acetate (Depo-Provera, Depo-SubQ Provera 104) as well as the combination preparations estradiol benzoate/testosterone isobutyrate (Folivirin, Femandren M) and estradiol cypionate/medroxyprogesterone acetate (Cyclofem, Lunelle). Among the more notable injectable aqueous suspensions that are no longer marketed include estradiol (Aquadiol, Diogyn, Progynon Aqueous Suspension, Progynon Micropellets), estrone (Estrone Aqueous Suspension, Kestrone, Theelin Aqueous), and testosterone (Andronaq, Sterotate, Virosterone) as well as the combination preparation estradiol benzoate/progesterone (Sistocyclin).

    Agofollin Depot (estradiol benzoate), Agolutin Depot (progesterone), and Folivirin (estradiol benzoate/testosterone isobutyrate) are all marketed today only in the Czech Republic and Slovakia in Central Europe. However, they all seem to be available from EU Aibolit, a common site that transgender people on do-it-yourself (DIY) hormone therapy obtain their medications from (Reddit). Here are the medication leaflets for all of these products (in Czech and translated into English):

    The company that manufactures these products, BB Pharma, is notably also the producer of the well-known Neofollin (injectable estradiol valerate in oil solution) in Europe.

    Injection Procedure for Injectable Aqueous Suspensions

    Aqueous suspensions require larger needle gauges (e.g., 20 or 21 gauge) than oil or aqueous solutions in order to allow the steroid crystals to pass through the needle lumen. The needle sizes may vary depending on the preparation and its crystal sizes. Injectable aqueous suspensions should be shaken adequately prior to injection as the crystals tend to aggregate. Aqueous suspensions are known to be more irritating and prone to causing pain and injection site reactions like redness and swelling than oil solutions, although this may vary depending on the preparation (Wiki; Wiki). This property is likely responsible for the discontinuation of many injectable suspensions and the greater popularity of injectable oil solutions. On the other hand, an advantage of aqueous suspensions over oil solutions is that in contrast them, there is no oil, and hence there is no risk of allergic reaction to the oil. As with injectable oil solutions, injectable aqueous suspensions are indicated for use specifically by intramuscular injection. Depot medroxyprogesterone acetate, which is available in both formulations for both intramuscular injection (Depo-Provera) and subcutaneous injection (Depo-SubQ Provera 104), is suggestive that aqueous suspensions have similar properties both by intramuscular and subcutaneous injection analogously to the case of injectable oil solutions (Wiki; Wiki). However, it should be noted that depot medroxyprogesterone acetate is formulated differently between these preparations.

    Update: Pharmaceutical Suspensions Discontinued

    Since this article was posted, Agofollin Depot (estradiol benzoate), Agolutin Depot (progesterone), and Folivirin (estradiol benzoate/testosterone isobutyrate) appear to have been discontinued by their manufacturer and seem to no longer be available from online pharmacies.

    References

    • Bassol, S., & Garza-Flores, J. (1994). Review of ovulation return upon discontinuation of once-a-month injectable contraceptives. Contraception, 49(5), 441–453. [DOI:10.1016/0010-7824(94)90003-5]
    • Correll, C. U., Kim, E., Sliwa, J. K., Hamm, W., Gopal, S., Mathews, M., Venkatasubramanian, R., & Saklad, S. R. (2021). Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview. CNS Drugs, 35(1), 39–59. [DOI:10.1007/s40263-020-00779-5]
    • Garza-Flores, J., Cravioto, M. C., & Pérez-Palacios, G. (1992). Steroid injectable contraception: Current concepts and perspectives. In Sitruk-Ware, L. R., & Bardin, C. W. (Eds.). Contraception: Newer Pharmacological Agents, Devices, and Delivery Systems (pp. 41–70). New York: M. Dekker. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Newton, J. R., d’Arcangues, C., & Hall, P. E. (1994). A review of ‘once-a-month’ combined injectable contraceptives. Journal of Obstetrics and Gynaecology, 14(Suppl 1), S1–S34. [DOI:10.3109/01443619409027641]
    • Paulen, M. E., & Curtis, K. M. (2009). When can a woman have repeat progestogen-only injectables–depot medroxyprogesterone acetate or norethisterone enantate? Contraception, 80(4), 391–408. [DOI:10.1016/j.contraception.2009.03.023]
    • Sang, G. (1994). Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception, 49(4), 361–385. [DOI:10.1016/0010-7824(94)90033-7]
    • Sinkula, A. A. (1978). Methods to Achieve Sustained Drug Delivery. The Chemical Approach. In Robinson, J. R. (Ed.). Sustained and Controlled Release Drug Delivery Systems (pp. 411–555). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books] [PDF]
    • Spanarello, S., & Ferla, T. (2014). The Pharmacokinetics of Long-Acting Antipsychotic Medications. Current Clinical Pharmacology, 9(3), 310–317. [DOI:10.2174/15748847113089990051]
    \ No newline at end of file diff --git a/transfemscience.org/articles/bica-adoption/index.html b/transfemscience.org/articles/bica-adoption/index.html index efdbdddd..121de5f5 100644 --- a/transfemscience.org/articles/bica-adoption/index.html +++ b/transfemscience.org/articles/bica-adoption/index.html @@ -1 +1 @@ -Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy - Transfeminine Science Link

    Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy

    By Aly | First published July 1, 2020 | Last modified March 23, 2024

    Abstract / TL;DR

    Bicalutamide is an antiandrogen which was introduced for the treatment of prostate cancer many years ago. Cost precluded its widespread use for other indications for many years. However, its cost has since come down and bicalutamide is now seeing significant adoption for use in transfeminine hormone therapy as well as for treatment of androgen-dependent conditions in other populations like cisgender women. Bicalutamide has risks of certain rare adverse effects like liver toxicity which have generated concerns about its safety and have limited its use in transfeminine people. However, while still significant, these risks are low with appropriate monitoring and clinical management. Prominent researchers in transgender medicine have recently shown openness to bicalutamide for potential use in transfeminine people and have written positively about it. Bicalutamide could eventually come to be regarded as acceptably safe for use in transfeminine hormone therapy, similarly to other antiandrogens with rare risks like spironolactone and cyproterone acetate. However, more studies and characterization of bicalutamide in transfeminine people will likely be needed before it could see wider adoption in transgender medicine.

    History of Bicalutamide for Transfeminine People

    Bicalutamide (Casodex) is a nonsteroidal antiandrogen and selective antagonist of the androgen receptor which was originally introduced for the treatment of prostate cancer in cisgender men in 1995. Prostate cancer is an androgen-dependent disease, so antiandrogens are effective in treating it. Bicalutamide has major advantages over other antiandrogens such as spironolactone (Aldactone) and cyproterone acetate (Androcur) in terms of antiandrogenic potency, clinical effectiveness, pharmacological selectivity, and tolerability. It also has improved potency, pharmacokinetic properties, and tolerability, as well as far better safety, compared to the older nonsteroidal antiandrogens flutamide (Eulexin) and nilutamide (Anandron, Nilandron). However, use of bicalutamide as an antiandrogen in transfeminine hormone therapy is very recent. The employment of bicalutamide for transfeminine people was largely precluded for many years by the fact that bicalutamide had pharmaceutical patent protection and was very expensive. However, this changed with the availability of generic versions of bicalutamide starting in 2007 to 2009. In addition, newer and more effective antiandrogens like abiraterone acetate (Zytiga) in 2011 and enzalutamide (Xtandi) in 2012 were introduced and superseded bicalutamide as the standard-of-care antiandrogen for the treatment of prostate cancer. These developments have greatly reduced the cost of bicalutamide and it has gradually become much more affordable in the last decade.

    Before 2015, there were only a few mentions in the literature of bicalutamide for transfeminine people and a handful of anecdotal reports online of transfeminine people using it. The earliest clear mention of bicalutamide in the literature in the context of transfeminine hormone therapy was by Louis Gooren in 2011 (Gooren, 2011). Gooren is a major longtime researcher in the field of transgender medicine and is one of the coauthors of the Endocrine Society’s transgender hormone therapy guidelines (Hembree et al., 2009; Hembree et al., 2017). He and his colleagues at the Center of Expertise on Gender Dysphoria of the Vrije Universiteit Medical Center (VUMC) in Amsterdam, Netherlands had conducted studies on nilutamide (Anandron, Nilandron) as an antiandrogen for transfeminine people in the late 1980s and early 1990s (de Voogt et al., 1987a; de Voogt et al., 1987b; Gooren et al., 1987; Johannes et al., 1987; Rao et al., 1988; Asscheman, Gooren, & Peereboom-Wynia, 1989; van Kemenade et al., 1989; Wiki). However, they seem to have abandoned it—probably due to its high incidence of lung toxicity and other off-target side effects. Nonetheless, Gooren began including nonsteroidal antiandrogens like flutamide and nilutamide in his publications as potential treatment options for transfeminine hormone therapy starting in the 1990s (Asscheman & Gooren, 1992; Gooren, 1999). Subsequently, flutamide was included in transgender health guidelines and other publications, though not necessarily favorably (e.g., Israel & Tarver, 1997; Levy, Crown, & Reid, 2003; Dahl et al., 2006a; Dahl et al., 2006b; Hembree et al., 2009; Moreno-Pérez et al., 2012). As a researcher interested in nonsteroidal antiandrogens for transfeminine people, bicalutamide—with its far better safety profile than flutamide and nilutamide—may have been appealing to Gooren. However, Gooren and his colleagues didn’t conduct clinical studies on bicalutamide for transfeminine people and never went beyond brief mention of it for such uses in their publications. Nor did any other academics.

    Besides transfeminine people and men with prostate cancer, bicalutamide has been studied for use in the treatment of androgen-dependent conditions in other populations. For example, it has been used in the treatment of hirsutism (excessive facial/body hair growth) in cisgender women with and without polycystic ovary syndrome (PCOS) (Müderris, Bayram, & Güven, 1999; Müderris et al., 2002; Bahceci et al., 2004; Müderris & Öner, 2009; Moretti et al., 2016; Moretti et al., 2018; Wiki). Bicalutamide has also been studied in combination with anastrozole (Arimidex), an aromatase inhibitor, for the treatment of gonadotropin-independent precocious puberty in cisgender boys (Kreher et al., 2006; Lewis et al., 2009; Mitre & Lteif, 2009; Stenger et al., 2009; Lenz et al., 2010; Reiter et al., 2010; Tessaris et al., 2012; Özcabı et al., 2015; Kor, 2018; Arya & Davies, 2019; Nabhan & Eugster, 2019; Finkle et al., 2020; Gurnurkar, DiLillo, & Carakushansky, 2021; Wiki). This is a rare form of precocious puberty in which gonadotropin-releasing hormone modulators are not effective. A phase 2 clinical trial was completed and a New Drug Application (NDA) was submitted in the United States for treatment of the condition with bicalutamide and anastrozole, but the application was not approved due to inadequate evidence of effectiveness on the primary efficacy endpoint of limiting height (AstraZeneca, 2008). However, bicalutamide is still used off-label for this indication, and information on bicalutamide for this use is provided in the the Casodex Food and Drug Administration (FDA) label (FDA, 2017).

    Although there was little discussion or use of bicalutamide in transfeminine people prior to 2015, this started to change in mid-2015. At that time, the Wikipedia content for bicalutamide was greatly expanded, which made information about bicalutamide more accessible. In addition, certain transfeminine people, noting its advantages over existing options and its excellent potential for use in transfeminine hormone therapy, began advocating for use of bicalutamide in transfeminine people in online circles. A number of open-minded clinicians started adopting bicalutamide in transfeminine people around this time and thereafter as well. The first clinical study of bicalutamide in transfeminine people, which began in 2013, was published as an abstract in 2017 and as a full paper in 2019 (Neyman, Fuqua, & Eugster, 2017; Neyman, Fuqua, & Eugster, 2019). It was a small retrospective chart review of bicalutamide alone as a second-line puberty blocker in adolescent transgender girls for whom gonadotropin-releasing hormone analogues were denied by insurance. As of present, it remains the only published clinical data on bicalutamide in transfeminine people. It’s not exactly great data by any means, but it’s a study at least. The researchers who conducted the study had previously published on bicalutamide as a puberty blocker in boys with gonadotropin-independent precocious puberty (e.g., Lenz et al., 2010; Haddad & Eugster, 2012). While limited in its findings, Neyman, Fuqua, and Eugster (2019) helped to generate significant interest among clinicians and researchers in bicalutamide for use in transfeminine hormone therapy.

    In any case, due to the recent nature of bicalutamide as an option for use in transfeminine hormone therapy, as well as the lack of studies and characterization of bicalutamide in transfeminine people and concerns about its safety (see next section), bicalutamide isn’t widely used in transfeminine people at this time. In fact, transgender hormone therapy guidelines largely don’t even mention it still. At present, the use of bicalutamide in transfeminine people is mostly limited to a number of more flexible clinicians and to people in the transgender do-it-yourself (DIY) hormone therapy community.

    Concerns About Bicalutamide Limiting its Use

    The transgender medical community has been reluctant to endorse the use of bicalutamide in transfeminine people to date. This is because of the lack of clinical studies and characterization of bicalutamide in transfeminine people, most importantly in terms of safety. There have been concerns about rare instances of liver failure that have occurred with bicalutamide in men with prostate cancer (Wiki). The reported cases of liver toxicity with bicalutamide have generally been sudden-onset and severe. Rare liver toxicity is an acceptable risk in men with prostate cancer because the risk–benefit ratio of bicalutamide therapy is very favorable, with the benefit of treating prostate cancer vastly outweighing the harm of the very rare instances of liver problems. But transfeminine people are typically young and healthy, and bicalutamide isn’t treating a terminal illness when it’s used in us. If a transfeminine person develops liver failure and dies because of bicalutamide, that’s unnecessary harm and a life needlessly lost. Accordingly, the University of California San Francisco (UCSF) transgender care guidelines warn against use of bicalutamide in transfeminine people currently due to potential liver risks (Deutsch, 2016). Aside from risks, there is also a lack of data to guide appropriate dosing of bicalutamide in transfeminine people at this time. A typical bicalutamide dosage of 50 mg/day is being used and recommended, but this has been arbitrarily chosen with little basis to support it.

    To date, there are 10 published case reports of serious liver toxicity in association with bicalutamide (Table). All of these cases were in men with prostate cancer and all occurred within 6 months of initiation of bicalutamide therapy, with two of the cases resulting in death. While this is not a lot of cases and may seem reassuring, it must be noted that quantity of published case reports tends to vastly underestimate the true incidence of rare adverse reactions. As an example, there are around 50 published case reports of meningioma with cyproterone acetate (Table), but a recent large study by the French government found that there were more than 500 operated instances of meningioma in association with high-dose cyproterone acetate over an 8-year period in France alone (Aly, 2020). Accordingly, as of writing there are 40 reports of liver failure, including 25 consequent deaths, in association with bicalutamide in the U.S. FDA’s international MedWatch/FAERS database. (As well as 240 cases of interstitial lung disease associated with bicalutamide notably—relative to only 14 published case reports; Table.) Even with this database however, fewer than 10% of serious adverse reactions are estimated to be reported (Graham, Ahmad, & Piazza-Hepp, 2002). Hence, the true numbers may be much greater. These instances are merely co-occurrences, and causality in terms of bicalutamide and liver toxicity has not been established. But they are concerning nonetheless. There is additionally an unpublished case anecdote of death in a young transfeminine person associated with bicalutamide that’s been making its rounds through the transgender medical community. Per certain very credible people in the field of transgender medicine (e.g., Asa Radix and Zil Goldstein), she is said to have been a 20-year-old transgender girl in Texas taking bicalutamide with rapid-onset liver failure and no warning signs. This case has given clinicians and researchers who are aware of it reservations about the use of bicalutamide in hormone therapy for transfeminine people. Another case of liver failure and death in a transgender person over 60 years of age who was treated with bicalutamide has also been informally reported (QueerDoc).

    In any case, the reported cases of serious liver toxicity with bicalutamide in transgender people have not been published nor properly confirmed. In addition, the absolute incidence of liver toxicity with bicalutamide is likely to be very low. For instance, the incidence of abnormal liver function tests (i.e., elevated liver enzymes on blood work) was only 3.4% with high-dose (150 mg/day) bicalutamide monotherapy relative to 1.9% for placebo (a 1.5% difference attributable to bicalutamide) at 3.0 years of follow-up in the Early Prostate Cancer (EPC) clinical programme, a series of three phase 3 randomized controlled trials consisting of over 8,000 patients in which bicalutamide was evaluated for treatment of early prostate cancer (Anderson, 2003; Iversen et al., 2004; Wiki; Wiki). Moreover, there were no cases of serious liver toxicity or liver failure with bicalutamide in the initial clinical development programme of bicalutamide for advanced prostate cancer, in which almost 4,000 men were treated with bicalutamide (Blackledge, 1996; Kolvenbag & Blackledge, 1996; McLeod, 1997; Anderson, 2003; Iversen et al., 2004; Wiki). However, it should be noted that this was with careful monitoring of liver function in patients and with prompt discontinuation of bicalutamide upon detection of clinically concerning hepatic abnormalities. About 0.5 to 1.5% of men taking 50 to 150 mg/day bicalutamide in the major clinical programmes of bicalutamide for prostate cancer developed liver changes sufficiently marked that they required discontinuation (Blackledge, 1996; See et al., 2002; Wiki). Hence, regular liver monitoring is essential with bicalutamide to ensure that the possibility of severe liver toxicity is avoided.

    Bicalutamide has a much lower risk of liver toxicity than its analogue flutamide (Kolvenbag & Blackledge, 1996; Schellhammer et al., 1997; Thole et al., 2004; Manso et al., 2006; Table). However, it retains a small risk of liver toxicity of its own—one with the potential for serious consequences. Hence, caution is warranted with its use, and careful liver monitoring is a necessity for anyone taking it.

    Recent Developments and the Future

    Bicalutamide is currently being adopted and characterized for use in the treatment androgen-dependent skin and hair conditions in cisgender women. For instance, a rigorous Italian phase 3 randomized controlled trial of bicalutamide for hirsutism was recently published (Moretti et al., 2018). Retrospective chart reviews of bicalutamide for scalp hair loss in cisgender women have also been published recently (Fernandez-Nieto et al., 2019; Ismail et al., 2020; Fernandez-Nieto et al., 2020; Moussa et al., 2021). The hair loss studies have observed low though significant rates of liver changes with bicalutamide.

    Certain transgender medical researchers are showing interest in bicalutamide as well. Perhaps most notably, Wylie Hembree—the lead author of the Endocrine Society’s 2009 and 2017 transgender hormone therapy guidelines (Hembree et al., 2009; Hembree et al., 2017)—wrote positively about bicalutamide for transfeminine people in a recent review (Fishman, Paliou, Poretsky, & Hembree, 2019). He and his colleagues cited the recent phase 3 trial of bicalutamide for hirsutism in cisgender women and the study of bicalutamide as a puberty blocker in transgender girls in support of potential use of bicalutamide for transfeminine people. Guy T’Sjoen—another major researcher in transgender medicine and co-author of the Endocrine Society guidelines (Hembree et al., 2017; Mitchell, 2020)—seemed to show openness to bicalutamide with his colleagues in a recent review as well (Iwamoto et al., 2019). Researchers outside of the United States in particular may be more open to bicalutamide, owing to accumulating health concerns with cyproterone acetate—the most commonly used antiandrogen outside of the United States (Aly, 2020). John Randolph, a researcher at the University of Michigan, has also written positively about bicalutamide (Randolph, 2018), though he may have since changed his mind on it (Michigan Medicine, 2020). On the other hand, other authors have not been as welcoming of bicalutamide for transfeminine people (e.g., Hamidi & Davidge-Pitts, 2019; Cocchetti et al., 2020).

    The small risks of bicalutamide with appropriate monitoring may prove to be acceptable to the transgender medical community. This would perhaps be analogous to the rare incidences of serious adverse effects with say spironolactone (e.g., hyperkalemia) or cyproterone acetate (e.g., benign brain tumors, blood clots, breast cancer, liver toxicity). It’s possible that bicalutamide may not ultimately be recommended as a first-line therapy due to its risks. However, it could still be allowed as a second-line option when other antiandrogens are less feasible or not possible due to being for instance inadequately effective, poorly tolerated, contraindicated, or unavailable. The transgender medical community isn’t there at this time though. More developments—namely studies and characterization of bicalutamide in actual transfeminine people—are likely to be needed before bicalutamide could become more accepted for use in transfeminine people or recommended in transgender hormone therapy guidelines.

    Updates

    Update 1: Thompson et al. (2021) [Fenway Health Guidelines]

    In March 2021, the Fenway Health transgender health clinical practice guidelines were updated from the last version (October 2015) to the following latest edition (Aly, 2020):

    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]

    This update is notable as these guidelines included bicalutamide as an antiandrogen option for transfeminine people. While they did not recommend bicalutamide as a first-line agent due to its limited characterization in transfeminine people and its known small risk of liver toxicity, they were cautiously permissive of its use in transfeminine hormone therapy:

    Bicalutamide can be used for [gender-affirming hormone therapy], but there are very few studies examining its use and the relative risk/benefit for this purpose. Because of reported cases of fulminant hepatitis, consensus is that its use in gender affirming hormonal regimen should be carefully considered, used only after alternative options have been trialed or offered, and an in-depth discussion of these potential risks have been had.

    These are the first transgender care guidelines to allow the use of bicalutamide, and only the second guidelines to include bicalutamide. Previously, only the UCSF guidelines mentioned bicalutamide, but they were not permissive of its use in transfeminine people.

    Update 2: Tomson et al. (2021) [SAHCS Guidelines]

    In September 2021, the Southern African HIV Clinicians Society (SAHCS) published clinical guidelines for transgender care for the first time:

    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]

    Surprisingly, these guidelines not only included bicalutamide but recommended it as the preferred antiandrogen over spironolactone and cyproterone acetate. The reason stated for this was “less risk of neurosteroid depletion (does not cross blood-brain-barrier readily).” However, this supposed effect isn’t a known concern with antiandrogens besides 5α-reductase inhibitors, and bicalutamide actually does appear to be centrally permeable in humans (Wiki). Also surprisingly, no mention of liver toxicity or liver enzyme monitoring with bicalutamide was made in these guidelines. Considering these apparent oversights and others, these guidelines’s recommendations should probably be interpreted with caution.

    Update 3: Coleman et al. (2022) [WPATH SOC8 Guidelines]

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published (Coleman et al., 2022). The WPATH SOC8 are among the most important if not the most important transgender care guidelines that exist and that are consulted by health care professionals. These guidelines briefly discussed bicalutamide including in the following two instances:

    Bicalutamide is an antiandrogen that has been used in the treatment of prostate cancer. It competitively binds to the androgen receptor to block the binding of androgens. Data on the use of bicalutamide in trans feminine populations is very sparse and safety data is lacking. One small study looked at the use of bicalutamide 50 mg daily as a puberty blocker in 23 trans feminine adolescents who could not obtain treatment with a GnRH analogue (Neyman et al., 2019). All adolescents experienced breast development which is also commonly seen in men with prostate cancer who are treated with bicalutamide. Although rare, fulminant hepatotoxicity resulting in death has been described with bicalutamide (O’Bryant et al., 2008). Given that bicalutamide has not been adequately studied in trans feminine populations, we do not recommend its routine use.

    When selecting a medication, we advise using those which have been studied in multiple transgender populations (i.e., estrogen, cyproterone acetate, GnRH agonists) rather than medications with little to no peer-reviewed scientific studies (i.e., bicalutamide, rectal progesterone, etc.) (Angus et al., 2021; Butler et al., 2017; Efstathiou et al., 2019; Tosun et al., 2019).

    As can be seen, the WPATH SOC8 did not recommend the routine use of bicalutamide in transfeminine people owing to the lack of studies of it in this population and its potential risks. As touched on in the present article, it is likely that more studies of bicalutamide in transfeminine people will be needed before bicalutamide could become endorsed by major transgender care guidelines.

    Update 4: Jamie Reed 2023 Bicalutamide Liver Toxicity Case

    In February 2023, Jamie Reed, a former case manager at the The Washington University Transgender Center at St. Louis Children’s Hospital in St. Louis, Missouri, published the op-ed “I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle.” in a conservative online news outlet called The Free Press. In this article, Reed expressed that she had become disillusioned with the medical care of transgender youth and layed out her grievances. In addition however, she briefly described an additional case of liver toxicity with bicalutamide in a transfeminine person that had allegedly occurred at her center. This individual was said to be 15 years of age and was given bicalutamide as a puberty blocker by Dr. Christopher Lewis, one of the co-founders of the center. She was said to have subsequently developed liver toxicity and was taken off of bicalutamide. In an electronic message to the center, her mother said that they were “lucky her family was not the type to sue”. This instance, and Reed’s op-ed in general, were subsequently widely reported on in conservative news media, for instance on Fox News and in the Daily Mail (Google). In addition to her op-ed, Reed provided a sworn affidavit to the office of Republican Missouri attorney general Andrew Bailey, who proceeded to launch an investigation of the clinic (Missouri Government, 2023a). The following further information was released in the affidavit:

    One doctor at the Center, Dr. Chris Lewis, is giving patients a drug called Bicalutamide. The drug has a legitimate use for treating pancreatic cancer [sic], but it has a side effect of causing breasts to grow, and it can poison the liver. There are no clinical studies for using this drug for gender transitions, and there are no established standards of care for using this drug.

    Because of these risks and the lack of scientific studies, other centers that do gender transitions will not use Bicalutamide. The adult center affiliated with Washington University will not use this medication for this reason. But the Center treating children does.

    I know of at least one patient at the Center who was advised by the renal department to stop taking Bicalutamide because the child was experiencing liver damage. The child’s parent reported this to the Center through the patient’s online self-reporting medical chart (MyChart). The parent said they were not the type to sue, but “this could be a huge PR problem for you.”

    While unpublished and unverified like the earlier reports of liver toxicity with bicalutamide in transfeminine people, this case represents yet another report, and is notably by far the best-documented one. No other clinical details on the case were provided, and it is unclear whether it involved serious liver toxicity, merely asymptomatic liver function test abnormalities, or a clinical situation somewhere in-between these extremes. In any case, it does seem clear that this instance is not likely to have a positive influence on the further adoption of bicalutamide in transfeminine hormone therapy.

    Subsequent to the investigation of the clinic being launched, in April 2023, Missouri greatly restricted gender-affirming care for transgender youth and adults, with some of the most severe limits that have been enacted in the United States (Associated Press, 2023a; Missouri Government, 2023b). Bicalutamide and the liver toxicity instance were not further described with these developments. The new state law restricting gender-affirming care took effect August 28, 2023, and Washington University announced that it would stop prescribing puberty blockers and hormone therapy to transgender youth shortly thereafter (Associated Press, 2023b).

    A New York Times article with additional information on the case was also subsequently published (Ghorayshi, 2023 [Excerpts]). It was noted that the adolescent had been on bicalutamide for 1 year and definitely experienced hepatotoxicity. However, she also had a complicated medical history, including being immunocompromised, having recently had COVID-19, and having taken another drug known to be associated with hepatotoxicity. As such, the hepatotoxicity cannot be definitively attributed to bicalutamide, but it simultaneously cannot be ruled out that bicalutamide was involved or causative.

    Subsequent Burgener et al. (2023, 2024) Findings

    Following the preceding case, Dr. Lewis and colleagues went on to publish a conference abstract and preprint of a study of bicalutamide in transfeminine youth and young adults in which they stated that it does not increase liver enzymes in this population (Burgener et al., 2023; Burgener et al., 2024). However, a closer look at their data show that bicalutamide did statistically significantly elevate certain liver parameters relative to other antiandrogens, namely rates of elevated aspartate aminotransferase (AST) (upper limit of normal 10.7% vs. 1.5%, P = 0.02) (Burgener et al., 2024). Likewise, rates of elevated alanine aminotransferase (ALT) appeared to trend in the direction of being increased, though this was not statistically significant (upper limit of normal 16.7% vs. 11.6%, P = 0.37) (Burgener et al., 2024). In any case, rates of clinically significant elevations in liver enzymes with bicalutamide, defined as greater than three times the upper limit of normal, were not significantly increased in the study.

    On the basis of the relevant research in men with prostate cancer (Wiki), Dr. Lewis and colleagues’ study, with a bicalutamide-group sample size of only 84 transfeminine individuals, was clearly greatly underpowered for evaluating liver function changes. Per the Early Prostate Cancer trial of high-dose bicalutamide monotherapy in men with prostate cancer, elevated liver enzymes appear to occur with bicalutamide at a rate of only about 1.5% more than placebo, or roughly an additional 1 in every 66 people (Wiki). Based on power analysis, this would require a far larger sample size to have adequate statistical power and actually have a chance of achieving statistical significance.

    As such, it seems to the present author premature to conclude that bicalutamide does not elevate liver enzymes in transfeminine people.

    Dr. Lewis and colleagues didn’t mention in their study paper the transfeminine adolescent liver toxicity case reported by Jamie Reed that was said to have occurred at their clinic nor have they published a case report about this instance. Instead, only the following is stated:

    One case report published in 2024 described a transgender female adolescent prescribed bicalutamide 50 mg daily who presented to a hospital with liver toxicity that resolved after stopping bicalutamide (Wilde et al., 2024). This appears to be the first documented case of bicalutamide-induced hepatoxicity in a transgender female.

    While this case was, coincidentally, also a 17-year-old transfeminine adolescent (Wilde et al., 2024), this instance, per the medical histories and reporting authors/institutions, appears to be distinct from Dr. Lewis’s that was reported by Jamie Reed.

    However, Dr. Lewis and colleagues did note the following in their paper, which plausibly might have been the Jamie Reed case:

    There was one individual in whom bicalutamide was stopped after the follow-up period designated for the study. This individual developed ALT and AST >2x ULN after an episode of COVID and had a thorough hepatology evaluation. As ALT and AST were never > 3x ULN, it was not recommended that bicalutamide be stopped; however, ultimately a clinical decision was made to stop the medication and ALT and AST normalized.

    Another concern with Dr. Lewis and colleagues’ paper pertains to the following statements:

    Whereas bicalutamide doses for prostate cancer reach 150 mg daily, doses used in the care of AMAB transfeminine individuals are much lower (25-50 mg daily).

    Bicalutamide doses used in prostate cancer are up to 150 mg daily. Due to these concerns of liver toxicity, bicalutamide has not been routinely used as an anti-androgen in AMAB transfeminine individuals, despite the much lower doses needed in this population (∼25-50 mg daily).

    In actuality, bicalutamide is most widely used in prostate cancer, in the form of combined androgen blockade with surgical or medical castration, at a dosage of 50 mg/day, whereas the 150 mg/day dosage is used less commonly, in the form of monotherapy (Wiki). Among the published case reports of hepatotoxicity with bicalutamide in men with prostate cancer, half have been at a dose of 50 mg/day and the other half have been at a dose of 80 to 150 mg/day (Wiki). The two instances of death due to hepatotoxicity with bicalutamide were both at 50 mg/day. There is currently no evidence that the hepatotoxicity of bicalutamide is dose-dependent across its clinically used dosage range (Wiki), although employment of the lowest effective dose in transfeminine people nonetheless seems prudent just in case. Hence, in contrast to Dr. Lewis and colleague’s claims, a bicalutamide dosage of 50 mg/day is not less than that used in prostate cancer, and clearly retains substantial hepatotoxic potential.

    Update 5: New 2022, 2023, and 2024 Bicalutamide Publications

    2022

    • Angus, L., Nolan, B., Zajac, J., & Cheung, A. (November 2022). Use of bicalutamide as an androgen receptor antagonist in transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 280). [URL] [PDF] [Full Abstract Book]

    2023

    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (November 2023). Bicalutamide as an anti-androgen in trans people: a cross-sectional study. AusPATH 2023 Symposium. [URL] [PDF] [Slides] [Trans Health Research Blog Post]
    • Bambilla, A., Beal, C., & Vigil, P. (2023). Improving Access to Bicalutamide in Gender Affirming Medical Care. [Unpubished/pending publication] [QueerCME Blog Post]
    • Burgener, K., DeBosch, B., Lewis, C., Wallendorf, M., & Herrick, C. (May 2023). Assessment of Liver Function and Toxicity in Transgender Female Adolescents Prescribed Bicalutamide. Hormone Research in Paediatrics, 96(Suppl 3 [Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics]), 377–378 (abstract no. 6232). [DOI:10.1159/000531602] [PDF]
    • Gómez-Aguilar, F., Martínez-Sánchez, L., Arias-Constantí, V., Muñoz-Santanach, D., & Sarquella-Brugada, G. (2023). QT prolongation and Torsade de Pointes in a 13-year-old transgender adolescent in treatment with bicalutamide and tacrolimus. Clinical Toxicology, 61(Suppl 1 [43rd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 23–26 May 2023, Palma de Mallorca, Spain]), 81–82 (abstract no. 170). [DOI:10.1080/15563650.2023.2192024] [PDF] [Reactions Weekly]
    • Karakılıç Özturan, E., Öztürk, A. P., Baş, F., Erdoğdu, A. B., Kaptan, S., Kardelen Al, A. D., Poyrazoğlu, Ş., Yıldız, M., Direk, N., Yüksel, Ş., & Darendeliler, F. (2023). Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey. Journal of Clinical Research in Pediatric Endocrinology, 15(3), 276–284. [DOI:10.4274/jcrpe.galenos.2023.2023-1-13]
    • Vierregger, K., Tetzlaff, M., Zimmerman, B., Dunn, N., Finney, N., Lewis, K., Slomoff, R., & Strutner, S. (May 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. National Transgender Health Summit (NTHS) 2023 Symposium. [Event Agenda PDF] [Symposium Session] [Symposium Abstracts/Program Book]
    • Vierregger, K. S. (November 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH 2023 Symposium. [Symposium Schedule]
    • Warus, J. (November 2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH 2023 Symposium. [Symposium Schedule]
    • Wilde, B., Diamond, J. B., Laborda, T. J., Frank, L., O’Gorman, M. A., & Kocolas, I. (2023). Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent. Journal of Adolescent Health, 74(1), 202–204. [DOI:10.1016/j.jadohealth.2023.08.024]

    2024

    • Burgener, K., DeBosch, B., Wang, J., Lewis, C., & Herrick, C. J. (2024). Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study. medRxiv, preprint. [DOI:10.1101/2024.02.21.24302999v1] [PDF]
    • Fuqua, J. S., Shi, E., & Eugster, E. A. (2024). A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2023.2294321]
    • Shumer, D., & Roberts, S. A. (2024). Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents. Journal of Adolescent Health, 74(1), 5–6. [DOI:10.1016/j.jadohealth.2023.10.010]

    Update 6: Original Bicalutamide Liver and Lung Toxicity Analysis by Sam

    A few years ago back in 2021, Transfeminine Science author Sam conducted an original analysis of the incidence of liver and lung toxicity with bicalutamide in the published clinical trial literature. This project was never finished or made publicly available. However, with bicalutamide being increasingly studied and adopted for use in transfeminine people, it seems quite valuable and relevant today. As such, we have opted to now publish Sam’s analysis in this section.

    Sam’s analysis can be found in the provided document here. In terms of methodology, she searched PubMed for all clinical trials of bicalutamide, collated all of the relevant results into a table, and then calculated the incidences of serious liver toxicity and lung toxicity from those data. In clinical trials, adverse events are rated in terms of grades of severity, with a Grade 3 adverse event defined as “severe”, Grade 4 as “life-threatening”, and Grade 5 as “death” (Wiki).

    Of 229 results, 33 trials were found to be relevant and were included. Most of the trials were in men with prostate cancer, but a few were in women with cancer and boys with precocious puberty. Sam found that of a total of 7,703 evaluable participants, there were 2 instances of serious liver toxicity and 2 instances of serious lung toxicity with bicalutamide. This resulted in the same incidence rate of 0.026% (95% CI: 0.003% to 0.094%) or approximately 1 in 3,846 individuals for both liver toxicity and lung toxicity. Combining these toxicities resulted in a total incidence of serious liver or serious lung toxicity with bicalutamide of 0.052% (95% CI: 0.014% to 0.133%) or approximately 1 in 1,923 individuals. All of the observed toxicity events were rated as Grade 3 or 4. It should be noted that clinical trials of bicalutamide typically employ careful laboratory monitoring and assessment of clinical adverse events as well as prompt medication discontinuation upon unfavorable laboratory changes.

    While the confidence intervals (CIs) in Sam’s analysis were wide and hence the estimates are very rough, they provide an idea of the potential real-world risk of serious toxicity with bicalutamide in transfeminine people based on high-quality clinical data. Notably, they do not suffer from the problem of under-reporting of adverse events that occurs with published case reports, pharmacovigilance databases, and certain types of observational studies. However, limitations of Sam’s analysis include (1) toxicity incidence rates for non-bicalutamide-treated controls not being assessed and (2) most of the patients having cancer and being of older age, and hence the generalizability of the findings to healthy transfeminine people not being fully clear. In any case, I was surprised by how high the incidence rates were when I first saw her analysis, and I suspect that others may be as well.

    References

    • Anderson, J. (2003). The role of antiandrogen monotherapy in the treatment of prostate cancer. BJU International, 91(5), 455–461. [DOI:10.1046/j.1464-410X.2003.04026.x]
    • Angus, L., Nolan, B., Zajac, J., & Cheung, A. (2022). Use of bicalutamide as an androgen receptor antagonist in transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 280). [URL] [PDF] [Full Abstract Book]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (2023). Bicalutamide as an anti-androgen in trans people: a cross-sectional study. AusPATH 2023 Symposium. [URL] [PDF] [Slides] [Trans Health Research Blog Post]
    • Arya, V. B., & Davies, J. H. (2019). Idiopathic gonadotropin-independent precocious puberty - is regular surveillance required? Journal of Pediatric Endocrinology & Metabolism: JPEM, 32(4), 403–407. [DOI:10.1515/jpem-2018-0419]
    • Asscheman, H., Gooren, L. J., & Peereboom-Wynia, J. D. (1989). Reduction in undesired sexual hair growth with anandron in male-to-female transsexuals—experiences with a novel androgen receptor blocker. Clinical and Experimental Dermatology, 14(5), 361–363. [DOI:10.1111/j.1365-2230.1989.tb02585.x]
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • AstraZeneca. (2008). Clinical Review. NDA. 22-310/S-001. Casodex (bicalutamide) for Testotoxicosis. Food and Drug Administration/AstraZeneca Pharmaceuticals. [URL] [PDF]
    • Bahceci, M., Tuzcu, A., Canoruc, N., Tuzun, Y., Kidir, V., & Aslan, C. (2004). Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance. Hormone Research in Paediatrics, 62(6), 283–287. [DOI:10.1159/000081973]
    • Bailey, A. (2023 February 9). Missouri Attorney General Andrew Bailey Confirms Launch of Multi-Agency Investigation into St. Louis Transgender Center for Harming Hundreds of Children. Attorney General Andrew Bailey, Missouri Government. [URL] [Affadavit of Jamie Reed]
    • Bailey, A. (2023 April 13). Missouri Attorney General Andrew Bailey Promulgates Emergency Regulation Targeting Gender Transition Procedures for Minors. Attorney General Andrew Bailey, Missouri Government. [URL] [Emergency Regulation PDF]
    • Ballentine, S., & Hollingsworth, H. (2023 April 13). Missouri to limit gender-affirming care for minors, adults. Associated Press. [URL]
    • Bambilla, A., Beal, C., & Vigil, P. (2023). Improving Access to Bicalutamide in Gender Affirming Medical Care. [Unpubished/pending publication] [QueerCME Blog Post]
    • Blackledge, G. R. P. (1996). Clinical progress with a new antiandrogen, Casodex™ (bicalutamide). European Urology, 29(Suppl 2), 96–104. [DOI:10.1159/000473847]
    • Burgener, K., DeBosch, B., Lewis, C., Wallendorf, M., & Herrick, C. (2023). Assessment of Liver Function and Toxicity in Transgender Female Adolescents Prescribed Bicalutamide. Hormone Research in Paediatrics, 96(Suppl 3 [Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics]), 377–378 (abstract no. 6232). [DOI:10.1159/000531602] [PDF]
    • Burgener, K., DeBosch, B., Wang, J., Lewis, C., & Herrick, C. J. (2024). Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study. medRxiv, preprint. [DOI:10.1101/2024.02.21.24302999v1] [PDF]
    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Dahl, M., Feldman, J. L., Goldberg, J. M., & Jaberi, A. (2006). Physical aspects of transgender endocrine therapy. International Journal of Transgenderism, 9(3–4), 111–134. [DOI:10.1300/J485v09n03_06]
    • Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2006). Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy. Vancouver: Vancouver Coastal Health. [Google Scholar] [PDF]
    • de Voogt, H. J., Rao, B. R., Gooren, L. J. G., Geldof, A. A., & Bouman, F. G. (1987). Considerations About the Use of Anti-Androgenic Drugs in Male-to-Female Transsexuals. Tenth International Symposium on Gender Dysphoria, Diagnosis and Treatment of Transsexualism, Vrije Universiteit Amsterdam, The Netherlands, June 9–12, 1987. Harry Benjamin International Gender Dysphoria Association. [PDF]
    • de Voogt, H. J., Rao, B. R., Geldof, A. A., Gooren, L. J. G., & Bouman, F. G. (1987). Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate. The Prostate, 11(4), 305–311. [DOI:10.1002/pros.2990110403]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Fernandez-Nieto, D., Saceda-Corralo, D., Rodrigues-Barata, R., Hermosa-Gelbard, A., Moreno-Arrones, O., Jimenez-Cauhe, J., Ortega-Quijano, D., & Vano-Galvan, S. (2019). Oral bicalutamide for female pattern hair loss: A pilot study. Dermatologic Therapy, 32(6), e13096. [DOI:10.1111/dth.13096]
    • Fernandez-Nieto, D., Saceda-Corralo, D., Jimenez-Cauhe, J., Moreno-Arrones, O. M., Rodrigues-Barata, R., Hermosa-Gelbard, A., & Vano-Galvan, S. (2020). Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss. Journal of the American Academy of Dermatology, 83(5), e355–e356. [DOI:10.1016/j.jaad.2020.04.054]
    • Finkle, A., Zavertnik, S., Myers, S., Cormier, D., Heithaus, J., & Augustyn, M. (2020). Growing Up Fast: Managing Autism Spectrum Disorder and Precocious Puberty. Journal of Developmental and Behavioral Pediatrics: JDBP, 41(9), 740–742. [DOI:10.1097/DBP.0000000000000865]
    • Fishman, S. L., Paliou, M., Poretsky, L., & Hembree, W. C. (2019). Endocrine Care of Transgender Adults. In Poretsky, L., & Hembree, W. C. (Eds.). Transgender Medicine (pp. 143–163). Cham: Humana Press. [DOI:10.1007/978-3-030-05683-4_8]
    • Food and Drug Administration (FDA). (2017). CASODEX (bicalutamide) tablet, for oral use. [URL] [PDF]
    • Fuqua, J. S., Shi, E., & Eugster, E. A. (2024). A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2023.2294321]
    • Ghorayshi, A. (2023 August 29). How a Small Gender Clinic Landed in a Political Storm. The New York Times. [URL]
    • Gómez-Aguilar, F., Martínez-Sánchez, L., Arias-Constantí, V., Muñoz-Santanach, D., & Sarquella-Brugada, G. (2023). QT prolongation and Torsade de Pointes in a 13-year-old transgender adolescent in treatment with bicalutamide and tacrolimus. Clinical Toxicology, 61(Suppl 1 [43rd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 23–26 May 2023, Palma de Mallorca, Spain]), 81–82 (abstract no. 170). [DOI:10.1080/15563650.2023.2192024] [PDF] [Reactions Weekly]
    • Gooren, L., Spinder, T., Spijkstra, J. J., Van Kessel, H., Smals, A., Rao, B. R., & Hoogslag, M. (1987). Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen. The Journal of Clinical Endocrinology & Metabolism, 64(4), 763–770. [DOI:10.1210/jcem-64-4-763]
    • Gooren, L. J. G. (1999). Hormonal Sex Reassignment. International Journal of Transgenderism, 3(3), 1–7. [Google Scholar] [URL] [Alt]
    • Gooren, L. J. (2011). Care of transsexual persons. New England Journal of Medicine, 364(13), 1251–1257. [DOI:10.1056/NEJMcp1008161]
    • Graham, D. J., Ahmad, S. R., & Piazza‐Hepp, T. (2002). Spontaneous Reporting—USA. In Mann, R. D., & Andrews, E. B. (Eds.). Pharmacovigilance (pp. 219–227). Chichester: John Wiley & Sons. [DOI:10.1002/0470853093.ch17]
    • Gurnurkar, S., DiLillo, E., & Carakushansky, M. (2021). A Case of Familial Male-limited Precocious Puberty with a Novel Mutation. Journal of Clinical Research in Pediatric Endocrinology, 13(2), 239–244. [DOI:10.4274/jcrpe.galenos.2020.2020.0067]
    • Haddad, N. G., & Eugster, E. A. (2012). Peripheral Precocious Puberty: Interventions to Improve Growth. In Preedy, V. R. (Ed.). Handbook of Growth and Growth Monitoring in Health and Disease (pp. 1199–1212). New York: Springer. [DOI:10.1007/978-1-4419-1795-9_71]
    • Hamidi, O., & Davidge-Pitts, C. J. (2019). Transfeminine Hormone Therapy. Endocrinology and Metabolism Clinics, 48(2), 341–355. [DOI:10.1016/j.ecl.2019.02.001]
    • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Ismail, F. F., Meah, N., de Carvalho, L. T., Bhoyrul, B., Wall, D., & Sinclair, R. (2020). Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients. Journal of the American Academy of Dermatology, 83(5), 1478–1479. [DOI:10.1016/j.jaad.2020.03.034]
    • Israel, G. E., & Tarver, D. E. (1997). Transgender Care: Recommended Guidelines, Practical Information, and Personal Accounts (p. 66). Philadelphia: Temple University Press. [Google Scholar] [Google Books]
    • Iversen, P., Johansson, J. E., Lodding, P., Lukkarinen, O., Lundmo, P., Klarskov, P., Tammela, T. L., Tasdemir, I., Morris, T., Carroll, K., & Scandinavian Prostatic Cancer Group. (2004). Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6. The Journal of Urology, 172(5 Part 1), 1871–1876. [DOI:10.1097/01.ju.0000139719.99825.54]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819871166. [DOI:10.1177/2042018819871166]
    • Johannes, F. L. M., van Kemenade, M. A., Cohen-Kettenis, P. T., Cohen, L., & Gooren, L. J. G. (1987). Effects of RU 23.903 (Anandron) on Lateralization and Spatial Ability in Male-to-Female-Transsexuals. Tenth International Symposium on Gender Dysphoria, Diagnosis and Treatment of Transsexualism, Vrije Universiteit Amsterdam, The Netherlands, June 9–12, 1987. Harry Benjamin International Gender Dysphoria Association. [PDF]
    • Karakılıç Özturan, E., Öztürk, A. P., Baş, F., Erdoğdu, A. B., Kaptan, S., Kardelen Al, A. D., Poyrazoğlu, Ş., Yıldız, M., Direk, N., Yüksel, Ş., & Darendeliler, F. (2023). Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey. Journal of Clinical Research in Pediatric Endocrinology, 15(3), 276–284. [DOI:10.4274/jcrpe.galenos.2023.2023-1-13]
    • Kolvenbag, G. J., & Blackledge, G. R. (1996). Worldwide activity and safety of bicalutamide: a summary review. Urology, 47(1), 70–79. [DOI:10.1016/S0090-4295(96)80012-4]
    • Kor, Y. (2018). Central precocious puberty in a case of late-diagnosed familial testotoxicosis and long-term treatment monitoring. Hormones, 17(2), 275–278. [DOI:10.1007/s42000-018-0029-1]
    • Kreher, N. C., Pescovitz, O. H., Delameter, P., Tiulpakov, A., & Hochberg, Z. E. (2006). Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. The Journal of Pediatrics, 149(3), 416–420. [DOI:10.1016/j.jpeds.2006.04.027]
    • Lenz, A. M., Shulman, D., Eugster, E. A., Rahhal, S., Fuqua, J. S., Pescovitz, O. H., & Lewis, K. A. (2010). Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics, 126(3), e728–e733. [DOI:10.1542/peds.2010-0596]
    • Levy, A., Crown, A., & Reid, R. (2003). Endocrine intervention for transsexuals. Clinical Endocrinology, 59(4), 409–418. [DOI:10.1046/j.1365-2265.2003.01821.x]
    • Lewis, K. A., Lenz, A., Eugster, E. A., Fuqua, J. S., Pescovitz, O. H., Rahhal, S., & Shulman, D. (2009). Long term bicalutamide and 3rd generation aromatase inhibitor therapy in two boys with testotoxicosis. Hormone Research [in Paediatrics], 72(Suppl 3), 266–267 (PO2-189). [Google Scholar] [DOI:10.1159/000239668]
    • Manso, G., Thole, Z., Salgueiro, E., Revuelta, P., & Hidalgo, A. (2006). Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiology and Drug Safety, 15(4), 253–259. [DOI:10.1002/pds.1168]
    • McLeod, D. G. (1997). Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer. The Oncologist, 2(1), 18–27. [DOI:10.1634/theoncologist.2-1-18]
    • Michigan Medicine. (2020). Feminizing Gender-Affirming Hormone Care: The Michigan Medicine Approach. Ann Arbor: Michigan Medicine/University of Michigan. [URL] [PDF]
    • Mitchell, F. (2020). Guy T’Sjoen: collaborating to improve transgender wellbeing. The Lancet Diabetes & Endocrinology, 8(7), 568–568. [DOI:10.1016/S2213-8587(20)30192-3]
    • Mitre, N., & Lteif, A. (2009). Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. Journal of Pediatric Endocrinology and Metabolism, 22(12), 1163–1168. [DOI:10.1515/JPEM.2009.22.12.1163]
    • Moreno-Pérez, Ó., De Antonio, I. E., & Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN. (2012). Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN). Endocrinología y Nutrición (English Edition), 59(6), 367–382. [DOI:10.1016/j.endoen.2012.07.004]
    • Moretti, C. G., Guccione, L., Di Giacinto, P., Cannuccia, A., Meleca, C., Lanzolla, G., Andreadi, A., & Lauro, D. (2016). Efficacy and Safety of Myo-Inositol Supplementation in the Treatment of Obese Hirsute PCOS Women: Comparative Evaluation with OCP+Bicalutamide Therapy. Endocrine Reviews, 37(2 Suppl 1) (SUN-153). [URL] [DOI:10.1093/edrv/37.supp.1]
    • Moretti, C., Guccione, L., Di Giacinto, P., Simonelli, I., Exacoustos, C., Toscano, V., Motta, C., De Leo, V., Petraglia, F., & Lenzi, A. (2018). Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism: a double-blind randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism, 103(3), 824–838. [DOI:10.1210/jc.2017-01186]
    • Moussa, A., Kazmi, A., Bokhari, L., & Sinclair, R. D. (2022). Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients. Journal of the American Academy of Dermatology, 87(2), 488–490. [DOI:10.1016/j.jaad.2021.10.048]
    • Muderris, I. I., Bayram, F., & Guven, M. (1999). Bicalutamide 25 mg/day in the treatment of hirsutism. Human Reproduction, 14(Suppl 3), 366–366 (R-196). [DOI:10.1093/humrep/14.Suppl_3.366-a]
    • Müderris, I. I., Bayram, F., Özçelik, B., & Güven, M. (2002). New alternative treatment in hirsutism: bicalutamide 25 mg/day. Gynecological Endocrinology, 16(1), 63–66. [DOI:10.1080/gye.16.1.63.66]
    • Müderris, İ. İ., & Öner, G. (2009). Hirsutizm Tedavisinde Flutamid ve Bikalutamid Kullanımı. [Flutamide and Bicalutamide Treatment in Hirsutism.] Türkiye Klinikleri Endokrinoloji-Özel Dergisi, 2(2), 110–112. [ISSN:1308-0954] [URL] [PDF] [Translation]
    • Nabhan, Z. M., & Eugster, E. A. (2019). Testotoxicosis with an episodic course: an unusual case within a series. AACE Clinical Case Reports, 5(1), e50–e53. [DOI:10.4158/ACCR-2018-0246]
    • Neyman, A., Fuqua, J. S., & Eugster, E. A. (2017). Bicalutamide as an Androgen Blocker with Secondary Effect of Promoting Feminization in Male to Female (MTF) Transgender Adolescents. Hormone Research in Paediatrics, 88(Suppl 1 [10th Individual Abstracts for International Meeting of Pediatric Endocrinology: Free Communication and Poster Sessions, Abstracts]), 477–477 (abstract no. P3-605). [DOI:10.1159/000481424] [PDF]
    • Neyman, A., Fuqua, J. S., & Eugster, E. A. (2019). Bicalutamide as an androgen blocker with secondary effect of promoting feminization in male-to-female transgender adolescents. Journal of Adolescent Health, 64(4), 544–546. [DOI:10.1016/j.jadohealth.2018.10.296]
    • Özcabı, B., Ceylaner, S., Özcan, R., Büyükünal, C., Ercan, O., Tüysüz, B., & Evliyaoğlu, O. (2015). Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. Journal of Clinical Research in Pediatric Endocrinology, 7(3), 242–248. [DOI:10.4274/jcrpe.2067]
    • Randolph Jr, J. F. (2018). Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics and Gynecology, 61(4), 705–721. [DOI:10.1097/GRF.0000000000000396] [URL]
    • Rao, B. R., De Voogt, H. J., Geldof, A. A., Gooren, L. J. G., & Bouman, F. G. (1988). Merits and considerations in the use of anti-androgen. Journal of Steroid Biochemistry, 31(4), 731–737. [DOI:10.1016/0022-4731(88)90024-6]
    • Reed, J. (2023 February 9). I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle. The Free Press. [URL]
    • Reiter, E. O., Mauras, N., McCormick, K., Kulshreshtha, B., Amrhein, J., De Luca, F., O’Brien, S., Armstrong, J., & Melezinkova, H. (2010). Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). Journal of Pediatric Endocrinology & Metabolism: JPEM, 23(10), 999–1009. [DOI:10.1515/jpem.2010.161]
    • Salter, J., & Ballentine, S. (2023 September 12). Missouri clinics halt transgender care for minors in wake of new state law. Associated Press. [URL]
    • Schellhammer, P. F., Sharifi, R., Block, N. L., Soloway, M. S., Venner, P. M., Patterson, A. L., Sarosdy, M. F., Vogelzang, N. J., Schellenger, J. J., Kolvenbag, G. J., & Casodex Combination Study Group. (1997). Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Urology, 50(3), 330–336. [DOI:10.1016/s0090-4295(97)00279-3]
    • Shumer, D., & Roberts, S. A. (2024). Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents. Journal of Adolescent Health, 74(1), 5–6. [DOI:10.1016/j.jadohealth.2023.10.010]
    • See, W. A., Wirth, M. P., McLeod, D. G., Iversen, P., Klimberg, I., Gleason, D., Chodak, G., Montie, J., Tyrrell, C., Wallace, D. M., Delaere, K. P., Vaage, S., Tammela, T. L., Lukkarinen, O., Persson, B. E., Carroll, K., Kolvenbag, G. J., & Casodex Early Prostate Cancer Trialist Group. (2002). Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. The Journal of Urology, 168(2), 429–435. [DOI:10.1016/S0022-5347(05)64652-6]
    • Stenger, P. J., Wagner, L., Egelhoff, J., & Rose, S. R. (2009). Bicalutamide and letrozole treatment of precocious puberty due to elevated levels of human chorionic gonadotropin (hCG). Hormone Research [in Paediatrics], 72(Suppl 3), 391–391 (PO3-149). [Google Scholar] [DOI:10.1159/000239668]
    • Tessaris, D., Matarazzo, P., Mussa, A., Tuli, G., Verna, F., Fiore, L., & Lala, R. (2012). Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. Endocrine Journal, 59(2), 111–117. [DOI:10.1507/endocrj.ej11-0214]
    • Thole, Z., Manso, G., Salgueiro, E., Revuelta, P., & Hidalgo, A. (2004). Hepatotoxicity induced by antiandrogens: a review of the literature. Urologia Internationalis, 73(4), 289–295. [DOI:10.1159/000081585]
    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]
    • van Kemenade, J. F., Cohen-Kettenis, P. T., Cohen, L., & Gooren, L. J. (1989). Effects of the pure antiandrogen RU 23.903 (anandron) on sexuality, aggression, and mood in male-to-female transsexuals. Archives of Sexual Behavior, 18(3), 217–228. [DOI:10.1007/BF01543196]
    • Vierregger, K., Tetzlaff, M., Zimmerman, B., Dunn, N., Finney, N., Lewis, K., Slomoff, R., & Strutner, S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. National Transgender Health Summit (NTHS) 2023 Symposium. [Event Agenda PDF] [Symposium Session] [Symposium Abstracts/Program Book]
    • Vierregger, K. S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH 2023 Symposium. [Symposium Schedule]
    • Warus, J. (2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH 2023 Symposium. [Symposium Schedule]
    • Wilde, B., Diamond, J. B., Laborda, T. J., Frank, L., O’Gorman, M. A., & Kocolas, I. (2023). Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent. Journal of Adolescent Health, 74(1), 202–204. [DOI:10.1016/j.jadohealth.2023.08.024]
    \ No newline at end of file +Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy - Transfeminine Science Link

    Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy

    By Aly | First published July 1, 2020 | Last modified April 2, 2024

    Abstract / TL;DR

    Bicalutamide is an antiandrogen which was introduced for the treatment of prostate cancer many years ago. Cost precluded its widespread use for other indications for many years. However, its cost has since come down and bicalutamide is now seeing significant adoption for use in transfeminine hormone therapy as well as for treatment of androgen-dependent conditions in other populations like cisgender women. Bicalutamide has risks of certain rare adverse effects like liver toxicity which have generated concerns about its safety and have limited its use in transfeminine people. However, while still significant, these risks are low with appropriate monitoring and clinical management. Prominent researchers in transgender medicine have recently shown openness to bicalutamide for potential use in transfeminine people and have written positively about it. Bicalutamide could eventually come to be regarded as acceptably safe for use in transfeminine hormone therapy, similarly to other antiandrogens with rare risks like spironolactone and cyproterone acetate. However, more studies and characterization of bicalutamide in transfeminine people will likely be needed before it could see wider adoption in transgender medicine.

    History of Bicalutamide for Transfeminine People

    Bicalutamide (Casodex) is a nonsteroidal antiandrogen and selective antagonist of the androgen receptor which was originally introduced for the treatment of prostate cancer in cisgender men in 1995. Prostate cancer is an androgen-dependent disease, so antiandrogens are effective in treating it. Bicalutamide has major advantages over other antiandrogens such as spironolactone (Aldactone) and cyproterone acetate (Androcur) in terms of antiandrogenic potency, clinical effectiveness, pharmacological selectivity, and tolerability. It also has improved potency, pharmacokinetic properties, and tolerability, as well as far better safety, compared to the older nonsteroidal antiandrogens flutamide (Eulexin) and nilutamide (Anandron, Nilandron). However, use of bicalutamide as an antiandrogen in transfeminine hormone therapy is very recent. The employment of bicalutamide for transfeminine people was largely precluded for many years by the fact that bicalutamide had pharmaceutical patent protection and was very expensive. However, this changed with the availability of generic versions of bicalutamide starting in 2007 to 2009. In addition, newer and more effective antiandrogens like abiraterone acetate (Zytiga) in 2011 and enzalutamide (Xtandi) in 2012 were introduced and superseded bicalutamide as the standard-of-care antiandrogen for the treatment of prostate cancer. These developments have greatly reduced the cost of bicalutamide and it has gradually become much more affordable in the last decade.

    Before 2015, there were only a few mentions in the literature of bicalutamide for transfeminine people and a handful of anecdotal reports online of transfeminine people using it. The earliest clear mention of bicalutamide in the literature in the context of transfeminine hormone therapy was by Louis Gooren in 2011 (Gooren, 2011). Gooren is a major longtime researcher in the field of transgender medicine and is one of the coauthors of the Endocrine Society’s transgender hormone therapy guidelines (Hembree et al., 2009; Hembree et al., 2017). He and his colleagues at the Center of Expertise on Gender Dysphoria of the Vrije Universiteit Medical Center (VUMC) in Amsterdam, Netherlands had conducted studies on nilutamide (Anandron, Nilandron) as an antiandrogen for transfeminine people in the late 1980s and early 1990s (de Voogt et al., 1987a; de Voogt et al., 1987b; Gooren et al., 1987; Johannes et al., 1987; Rao et al., 1988; Asscheman, Gooren, & Peereboom-Wynia, 1989; van Kemenade et al., 1989; Wiki). However, they seem to have abandoned it—probably due to its high incidence of lung toxicity and other off-target side effects. Nonetheless, Gooren began including nonsteroidal antiandrogens like flutamide and nilutamide in his publications as potential treatment options for transfeminine hormone therapy starting in the 1990s (Asscheman & Gooren, 1992; Gooren, 1999). Subsequently, flutamide was included in transgender health guidelines and other publications, though not necessarily favorably (e.g., Israel & Tarver, 1997; Levy, Crown, & Reid, 2003; Dahl et al., 2006a; Dahl et al., 2006b; Hembree et al., 2009; Moreno-Pérez et al., 2012). As a researcher interested in nonsteroidal antiandrogens for transfeminine people, bicalutamide—with its far better safety profile than flutamide and nilutamide—may have been appealing to Gooren. However, Gooren and his colleagues didn’t conduct clinical studies on bicalutamide for transfeminine people and never went beyond brief mention of it for such uses in their publications. Nor did any other academics.

    Besides transfeminine people and men with prostate cancer, bicalutamide has been studied for use in the treatment of androgen-dependent conditions in other populations. For example, it has been used in the treatment of hirsutism (excessive facial/body hair growth) in cisgender women with and without polycystic ovary syndrome (PCOS) (Müderris, Bayram, & Güven, 1999; Müderris et al., 2002; Bahceci et al., 2004; Müderris & Öner, 2009; Moretti et al., 2016; Moretti et al., 2018; Wiki). Bicalutamide has also been studied in combination with anastrozole (Arimidex), an aromatase inhibitor, for the treatment of gonadotropin-independent precocious puberty in cisgender boys (Kreher et al., 2006; Lewis et al., 2009; Mitre & Lteif, 2009; Stenger et al., 2009; Lenz et al., 2010; Reiter et al., 2010; Tessaris et al., 2012; Özcabı et al., 2015; Kor, 2018; Arya & Davies, 2019; Nabhan & Eugster, 2019; Finkle et al., 2020; Gurnurkar, DiLillo, & Carakushansky, 2021; Wiki). This is a rare form of precocious puberty in which gonadotropin-releasing hormone modulators are not effective. A phase 2 clinical trial was completed and a New Drug Application (NDA) was submitted in the United States for treatment of the condition with bicalutamide and anastrozole, but the application was not approved due to inadequate evidence of effectiveness on the primary efficacy endpoint of limiting height (AstraZeneca, 2008). However, bicalutamide is still used off-label for this indication, and information on bicalutamide for this use is provided in the the Casodex Food and Drug Administration (FDA) label (FDA, 2017).

    Although there was little discussion or use of bicalutamide in transfeminine people prior to 2015, this started to change in mid-2015. At that time, the Wikipedia content for bicalutamide was greatly expanded, which made information about bicalutamide more accessible. In addition, certain transfeminine people, noting its advantages over existing options and its excellent potential for use in transfeminine hormone therapy, began advocating for use of bicalutamide in transfeminine people in online circles. A number of open-minded clinicians started adopting bicalutamide in transfeminine people around this time and thereafter as well. The first clinical study of bicalutamide in transfeminine people, which began in 2013, was published as an abstract in 2017 and as a full paper in 2019 (Neyman, Fuqua, & Eugster, 2017; Neyman, Fuqua, & Eugster, 2019). It was a small retrospective chart review of bicalutamide alone as a second-line puberty blocker in adolescent transgender girls for whom gonadotropin-releasing hormone analogues were denied by insurance. As of present, it remains the only published clinical data on bicalutamide in transfeminine people. It’s not exactly great data by any means, but it’s a study at least. The researchers who conducted the study had previously published on bicalutamide as a puberty blocker in boys with gonadotropin-independent precocious puberty (e.g., Lenz et al., 2010; Haddad & Eugster, 2012). While limited in its findings, Neyman, Fuqua, and Eugster (2019) helped to generate significant interest among clinicians and researchers in bicalutamide for use in transfeminine hormone therapy.

    In any case, due to the recent nature of bicalutamide as an option for use in transfeminine hormone therapy, as well as the lack of studies and characterization of bicalutamide in transfeminine people and concerns about its safety (see next section), bicalutamide isn’t widely used in transfeminine people at this time. In fact, transgender hormone therapy guidelines largely don’t even mention it still. At present, the use of bicalutamide in transfeminine people is mostly limited to a number of more flexible clinicians and to people in the transgender do-it-yourself (DIY) hormone therapy community.

    Concerns About Bicalutamide Limiting its Use

    The transgender medical community has been reluctant to endorse the use of bicalutamide in transfeminine people to date. This is because of the lack of clinical studies and characterization of bicalutamide in transfeminine people, most importantly in terms of safety. There have been concerns about rare instances of liver failure that have occurred with bicalutamide in men with prostate cancer (Wiki). The reported cases of liver toxicity with bicalutamide have generally been sudden-onset and severe. Rare liver toxicity is an acceptable risk in men with prostate cancer because the risk–benefit ratio of bicalutamide therapy is very favorable, with the benefit of treating prostate cancer vastly outweighing the harm of the very rare instances of liver problems. But transfeminine people are typically young and healthy, and bicalutamide isn’t treating a terminal illness when it’s used in us. If a transfeminine person develops liver failure and dies because of bicalutamide, that’s unnecessary harm and a life needlessly lost. Accordingly, the University of California San Francisco (UCSF) transgender care guidelines warn against use of bicalutamide in transfeminine people currently due to potential liver risks (Deutsch, 2016). Aside from risks, there is also a lack of data to guide appropriate dosing of bicalutamide in transfeminine people at this time. A typical bicalutamide dosage of 50 mg/day is being used and recommended, but this has been arbitrarily chosen with little basis to support it.

    To date, there are 10 published case reports of serious liver toxicity in association with bicalutamide (Table). All of these cases were in men with prostate cancer and all occurred within 6 months of initiation of bicalutamide therapy, with two of the cases resulting in death. While this is not a lot of cases and may seem reassuring, it must be noted that quantity of published case reports tends to vastly underestimate the true incidence of rare adverse reactions. As an example, there are around 50 published case reports of meningioma with cyproterone acetate (Table), but a recent large study by the French government found that there were more than 500 operated instances of meningioma in association with high-dose cyproterone acetate over an 8-year period in France alone (Aly, 2020). Accordingly, as of writing there are 40 reports of liver failure, including 25 consequent deaths, in association with bicalutamide in the U.S. FDA’s international MedWatch/FAERS database. (As well as 240 cases of interstitial lung disease associated with bicalutamide notably—relative to only 14 published case reports; Table.) Even with this database however, fewer than 10% of serious adverse reactions are estimated to be reported (Graham, Ahmad, & Piazza-Hepp, 2002). Hence, the true numbers may be much greater. These instances are merely co-occurrences, and causality in terms of bicalutamide and liver toxicity has not been established. But they are concerning nonetheless. There is additionally an unpublished case anecdote of death in a young transfeminine person associated with bicalutamide that’s been making its rounds through the transgender medical community. Per certain very credible people in the field of transgender medicine (e.g., Asa Radix and Zil Goldstein), she is said to have been a 20-year-old transgender girl in Texas taking bicalutamide with rapid-onset liver failure and no warning signs. This case has given clinicians and researchers who are aware of it reservations about the use of bicalutamide in hormone therapy for transfeminine people. Another case of liver failure and death in a transgender person over 60 years of age who was treated with bicalutamide has also been informally reported (QueerDoc).

    In any case, the reported cases of serious liver toxicity with bicalutamide in transgender people have not been published nor properly confirmed. In addition, the absolute incidence of liver toxicity with bicalutamide is likely to be very low. For instance, the incidence of abnormal liver function tests (i.e., elevated liver enzymes on blood work) was only 3.4% with high-dose (150 mg/day) bicalutamide monotherapy relative to 1.9% for placebo (a 1.5% difference attributable to bicalutamide) at 3.0 years of follow-up in the Early Prostate Cancer (EPC) clinical programme, a series of three phase 3 randomized controlled trials consisting of over 8,000 patients in which bicalutamide was evaluated for treatment of early prostate cancer (Anderson, 2003; Iversen et al., 2004; Wiki; Wiki). Moreover, there were no cases of serious liver toxicity or liver failure with bicalutamide in the initial clinical development programme of bicalutamide for advanced prostate cancer, in which almost 4,000 men were treated with bicalutamide (Blackledge, 1996; Kolvenbag & Blackledge, 1996; McLeod, 1997; Anderson, 2003; Iversen et al., 2004; Wiki). However, it should be noted that this was with careful monitoring of liver function in patients and with prompt discontinuation of bicalutamide upon detection of clinically concerning hepatic abnormalities. About 0.5 to 1.5% of men taking 50 to 150 mg/day bicalutamide in the major clinical programmes of bicalutamide for prostate cancer developed liver changes sufficiently marked that they required discontinuation (Blackledge, 1996; See et al., 2002; Wiki). Hence, regular liver monitoring is essential with bicalutamide to ensure that the possibility of severe liver toxicity is avoided.

    Bicalutamide has a much lower risk of liver toxicity than its analogue flutamide (Kolvenbag & Blackledge, 1996; Schellhammer et al., 1997; Thole et al., 2004; Manso et al., 2006; Table). However, it retains a small risk of liver toxicity of its own—one with the potential for serious consequences. Hence, caution is warranted with its use, and careful liver monitoring is a necessity for anyone taking it.

    Recent Developments and the Future

    Bicalutamide is currently being adopted and characterized for use in the treatment androgen-dependent skin and hair conditions in cisgender women. For instance, a rigorous Italian phase 3 randomized controlled trial of bicalutamide for hirsutism was recently published (Moretti et al., 2018). Retrospective chart reviews of bicalutamide for scalp hair loss in cisgender women have also been published recently (Fernandez-Nieto et al., 2019; Ismail et al., 2020; Fernandez-Nieto et al., 2020; Moussa et al., 2021). The hair loss studies have observed low though significant rates of liver changes with bicalutamide.

    Certain transgender medical researchers are showing interest in bicalutamide as well. Perhaps most notably, Wylie Hembree—the lead author of the Endocrine Society’s 2009 and 2017 transgender hormone therapy guidelines (Hembree et al., 2009; Hembree et al., 2017)—wrote positively about bicalutamide for transfeminine people in a recent review (Fishman, Paliou, Poretsky, & Hembree, 2019). He and his colleagues cited the recent phase 3 trial of bicalutamide for hirsutism in cisgender women and the study of bicalutamide as a puberty blocker in transgender girls in support of potential use of bicalutamide for transfeminine people. Guy T’Sjoen—another major researcher in transgender medicine and co-author of the Endocrine Society guidelines (Hembree et al., 2017; Mitchell, 2020)—seemed to show openness to bicalutamide with his colleagues in a recent review as well (Iwamoto et al., 2019). Researchers outside of the United States in particular may be more open to bicalutamide, owing to accumulating health concerns with cyproterone acetate—the most commonly used antiandrogen outside of the United States (Aly, 2020). John Randolph, a researcher at the University of Michigan, has also written positively about bicalutamide (Randolph, 2018), though he may have since changed his mind on it (Michigan Medicine, 2020). On the other hand, other authors have not been as welcoming of bicalutamide for transfeminine people (e.g., Hamidi & Davidge-Pitts, 2019; Cocchetti et al., 2020).

    The small risks of bicalutamide with appropriate monitoring may prove to be acceptable to the transgender medical community. This would perhaps be analogous to the rare incidences of serious adverse effects with say spironolactone (e.g., hyperkalemia) or cyproterone acetate (e.g., benign brain tumors, blood clots, breast cancer, liver toxicity). It’s possible that bicalutamide may not ultimately be recommended as a first-line therapy due to its risks. However, it could still be allowed as a second-line option when other antiandrogens are less feasible or not possible due to being for instance inadequately effective, poorly tolerated, contraindicated, or unavailable. The transgender medical community isn’t there at this time though. More developments—namely studies and characterization of bicalutamide in actual transfeminine people—are likely to be needed before bicalutamide could become more accepted for use in transfeminine people or recommended in transgender hormone therapy guidelines.

    Updates

    Update 1: Thompson et al. (2021) [Fenway Health Guidelines]

    In March 2021, the Fenway Health transgender health clinical practice guidelines were updated from the last version (October 2015) to the following latest edition (Aly, 2020):

    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]

    This update is notable as these guidelines included bicalutamide as an antiandrogen option for transfeminine people. While they did not recommend bicalutamide as a first-line agent due to its limited characterization in transfeminine people and its known small risk of liver toxicity, they were cautiously permissive of its use in transfeminine hormone therapy:

    Bicalutamide can be used for [gender-affirming hormone therapy], but there are very few studies examining its use and the relative risk/benefit for this purpose. Because of reported cases of fulminant hepatitis, consensus is that its use in gender affirming hormonal regimen should be carefully considered, used only after alternative options have been trialed or offered, and an in-depth discussion of these potential risks have been had.

    These are the first transgender care guidelines to allow the use of bicalutamide, and only the second guidelines to include bicalutamide. Previously, only the UCSF guidelines mentioned bicalutamide, but they were not permissive of its use in transfeminine people.

    Update 2: Tomson et al. (2021) [SAHCS Guidelines]

    In September 2021, the Southern African HIV Clinicians Society (SAHCS) published clinical guidelines for transgender care for the first time:

    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]

    Surprisingly, these guidelines not only included bicalutamide but recommended it as the preferred antiandrogen over spironolactone and cyproterone acetate. The reason stated for this was “less risk of neurosteroid depletion (does not cross blood-brain-barrier readily).” However, this supposed effect isn’t a known concern with antiandrogens besides 5α-reductase inhibitors, and bicalutamide actually does appear to be centrally permeable in humans (Wiki). Also surprisingly, no mention of liver toxicity or liver enzyme monitoring with bicalutamide was made in these guidelines. Considering these apparent oversights and others, these guidelines’s recommendations should probably be interpreted with caution.

    Update 3: Coleman et al. (2022) [WPATH SOC8 Guidelines]

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published (Coleman et al., 2022). The WPATH SOC8 are among the most important if not the most important transgender care guidelines that exist and that are consulted by health care professionals. These guidelines briefly discussed bicalutamide including in the following two instances:

    Bicalutamide is an antiandrogen that has been used in the treatment of prostate cancer. It competitively binds to the androgen receptor to block the binding of androgens. Data on the use of bicalutamide in trans feminine populations is very sparse and safety data is lacking. One small study looked at the use of bicalutamide 50 mg daily as a puberty blocker in 23 trans feminine adolescents who could not obtain treatment with a GnRH analogue (Neyman et al., 2019). All adolescents experienced breast development which is also commonly seen in men with prostate cancer who are treated with bicalutamide. Although rare, fulminant hepatotoxicity resulting in death has been described with bicalutamide (O’Bryant et al., 2008). Given that bicalutamide has not been adequately studied in trans feminine populations, we do not recommend its routine use.

    When selecting a medication, we advise using those which have been studied in multiple transgender populations (i.e., estrogen, cyproterone acetate, GnRH agonists) rather than medications with little to no peer-reviewed scientific studies (i.e., bicalutamide, rectal progesterone, etc.) (Angus et al., 2021; Butler et al., 2017; Efstathiou et al., 2019; Tosun et al., 2019).

    As can be seen, the WPATH SOC8 did not recommend the routine use of bicalutamide in transfeminine people owing to the lack of studies of it in this population and its potential risks. As touched on in the present article, it is likely that more studies of bicalutamide in transfeminine people will be needed before bicalutamide could become endorsed by major transgender care guidelines.

    Update 4: Jamie Reed 2023 Bicalutamide Liver Toxicity Case

    In February 2023, Jamie Reed, a former case manager at the The Washington University Transgender Center at St. Louis Children’s Hospital in St. Louis, Missouri, published the op-ed “I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle.” in a conservative online news outlet called The Free Press. In this article, Reed expressed that she had become disillusioned with the medical care of transgender youth and layed out her grievances. In addition however, she briefly described an additional case of liver toxicity with bicalutamide in a transfeminine person that had allegedly occurred at her center. This individual was said to be 15 years of age and was given bicalutamide as a puberty blocker by Dr. Christopher Lewis, one of the co-founders of the center. She was said to have subsequently developed liver toxicity and was taken off of bicalutamide. In an electronic message to the center, her mother said that they were “lucky her family was not the type to sue”. This instance, and Reed’s op-ed in general, were subsequently widely reported on in conservative news media, for instance on Fox News and in the Daily Mail (Google). In addition to her op-ed, Reed provided a sworn affidavit to the office of Republican Missouri attorney general Andrew Bailey, who proceeded to launch an investigation of the clinic (Missouri Government, 2023a). The following further information was released in the affidavit:

    One doctor at the Center, Dr. Chris Lewis, is giving patients a drug called Bicalutamide. The drug has a legitimate use for treating pancreatic cancer [sic], but it has a side effect of causing breasts to grow, and it can poison the liver. There are no clinical studies for using this drug for gender transitions, and there are no established standards of care for using this drug.

    Because of these risks and the lack of scientific studies, other centers that do gender transitions will not use Bicalutamide. The adult center affiliated with Washington University will not use this medication for this reason. But the Center treating children does.

    I know of at least one patient at the Center who was advised by the renal department to stop taking Bicalutamide because the child was experiencing liver damage. The child’s parent reported this to the Center through the patient’s online self-reporting medical chart (MyChart). The parent said they were not the type to sue, but “this could be a huge PR problem for you.”

    While unpublished and unverified like the earlier reports of liver toxicity with bicalutamide in transfeminine people, this case represents yet another report, and is notably by far the best-documented one. No other clinical details on the case were provided, and it is unclear whether it involved serious liver toxicity, merely asymptomatic liver function test abnormalities, or a clinical situation somewhere in-between these extremes. In any case, it does seem clear that this instance is not likely to have a positive influence on the further adoption of bicalutamide in transfeminine hormone therapy.

    Subsequent to the investigation of the clinic being launched, in April 2023, Missouri greatly restricted gender-affirming care for transgender youth and adults, with some of the most severe limits that have been enacted in the United States (Associated Press, 2023a; Missouri Government, 2023b). Bicalutamide and the liver toxicity instance were not further described with these developments. The new state law restricting gender-affirming care took effect August 28, 2023, and Washington University announced that it would stop prescribing puberty blockers and hormone therapy to transgender youth shortly thereafter (Associated Press, 2023b).

    A New York Times article with additional information on the case was also subsequently published (Ghorayshi, 2023 [Excerpts]). It was noted that the adolescent had been on bicalutamide for 1 year and definitely experienced hepatotoxicity. However, she also had a complicated medical history, including being immunocompromised, having recently had COVID-19, and having taken another drug known to be associated with hepatotoxicity. As such, the hepatotoxicity cannot be definitively attributed to bicalutamide, but it simultaneously cannot be ruled out that bicalutamide was involved or causative.

    Subsequent Burgener et al. (2023, 2024) Findings

    Following the preceding case, Lewis and colleagues went on to publish a conference abstract and preprint of a study of bicalutamide in transfeminine youth and young adults in which they stated that it does not increase liver enzymes in this population (Burgener et al., 2023; Burgener et al., 2024). However, a closer look at their data show that bicalutamide did statistically significantly elevate certain liver parameters relative to other antiandrogens, namely rates of elevated aspartate aminotransferase (AST) (upper limit of normal 10.7% vs. 1.5%, P = 0.02) (Burgener et al., 2024). Likewise, rates of elevated alanine aminotransferase (ALT) appeared to trend in the direction of being increased, though this was not statistically significant (upper limit of normal 16.7% vs. 11.6%, P = 0.37) (Burgener et al., 2024). In any case, rates of clinically significant elevations in liver enzymes with bicalutamide, defined as greater than three times the upper limit of normal, were not significantly increased in the study.

    On the basis of the relevant research in men with prostate cancer (Wiki), Lewis and colleagues’ study, with a bicalutamide-group sample size of only 84 transfeminine individuals, was clearly greatly underpowered for evaluating liver function changes. Per the Early Prostate Cancer trial of high-dose bicalutamide monotherapy in men with prostate cancer, elevated liver enzymes appear to occur with bicalutamide at a rate of only about 1.5% more than placebo, or roughly an additional 1 in every 66 people (Wiki). Based on power analysis, this would require a far larger sample size to have adequate statistical power and actually have a chance of achieving statistical significance.

    As such, it seems to the present author premature to conclude that bicalutamide does not elevate liver enzymes in transfeminine people.

    Lewis and colleagues didn’t mention in their study paper the transfeminine adolescent liver toxicity case reported by Jamie Reed that was said to have occurred at their clinic nor have they published a case report about this instance. Instead, only the following is stated:

    One case report published in 2024 described a transgender female adolescent prescribed bicalutamide 50 mg daily who presented to a hospital with liver toxicity that resolved after stopping bicalutamide (Wilde et al., 2024). This appears to be the first documented case of bicalutamide-induced hepatoxicity in a transgender female.

    While this case was, coincidentally, also a 17-year-old transfeminine adolescent (Wilde et al., 2024), this instance, per the medical histories and reporting authors/institutions, appears to be distinct from Dr. Lewis’s that was reported by Jamie Reed.

    However, Lewis and colleagues did note the following in their paper, which plausibly might have been the Jamie Reed case:

    There was one individual in whom bicalutamide was stopped after the follow-up period designated for the study. This individual developed ALT and AST >2x ULN after an episode of COVID and had a thorough hepatology evaluation. As ALT and AST were never > 3x ULN, it was not recommended that bicalutamide be stopped; however, ultimately a clinical decision was made to stop the medication and ALT and AST normalized.

    Another concern with Lewis and colleagues’ paper pertains to the following statements:

    Whereas bicalutamide doses for prostate cancer reach 150 mg daily, doses used in the care of AMAB transfeminine individuals are much lower (25-50 mg daily).

    Bicalutamide doses used in prostate cancer are up to 150 mg daily. Due to these concerns of liver toxicity, bicalutamide has not been routinely used as an anti-androgen in AMAB transfeminine individuals, despite the much lower doses needed in this population (∼25-50 mg daily).

    In actuality, bicalutamide is most widely used in prostate cancer, in the form of combined androgen blockade with surgical or medical castration, at a dosage of 50 mg/day, whereas the 150 mg/day dosage is used less commonly, in the form of monotherapy (Wiki). Moreover, only the 50 mg/day dosage is used in the United States, where monotherapy is not approved. Among the published case reports of hepatotoxicity with bicalutamide in men with prostate cancer, half have been at a dose of 50 mg/day and the other half have been at a dose of 80 to 150 mg/day (Wiki). The two instances of death due to hepatotoxicity with bicalutamide were both at 50 mg/day. There is currently no evidence that the hepatotoxicity of bicalutamide is dose-dependent across its clinically used dosage range (Wiki), although employment of the lowest effective dose in transfeminine people nonetheless seems prudent just in case. Hence, in contrast to Lewis and colleague’s claims, a bicalutamide dosage of 50 mg/day is not less than that generally used in prostate cancer, and clearly retains substantial hepatotoxic potential.

    Update 5: New Bicalutamide Publications in 2022 Through 2024

    • Angus, L., Nolan, B., Zajac, J., & Cheung, A. (November 2022). Use of bicalutamide as an androgen receptor antagonist in transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 280). [URL] [PDF] [Full Abstract Book]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (November 2023). Bicalutamide as an anti-androgen in trans people: a cross-sectional study. AusPATH 2023 Symposium. [URL] [PDF] [Slides] [Trans Health Research Blog Post]
    • Bambilla, A., Beal, C., & Vigil, P. (2023). Improving Access to Bicalutamide in Gender Affirming Medical Care. [Unpubished/pending publication] [QueerCME Blog Post]
    • Burgener, K., DeBosch, B., Lewis, C., Wallendorf, M., & Herrick, C. (May 2023). Assessment of Liver Function and Toxicity in Transgender Female Adolescents Prescribed Bicalutamide. Hormone Research in Paediatrics, 96(Suppl 3 [Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics]), 377–378 (abstract no. 6232). [DOI:10.1159/000531602] [PDF]
    • Gómez-Aguilar, F., Martínez-Sánchez, L., Arias-Constantí, V., Muñoz-Santanach, D., & Sarquella-Brugada, G. (2023). QT prolongation and Torsade de Pointes in a 13-year-old transgender adolescent in treatment with bicalutamide and tacrolimus. Clinical Toxicology, 61(Suppl 1 [43rd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 23–26 May 2023, Palma de Mallorca, Spain]), 81–82 (abstract no. 170). [DOI:10.1080/15563650.2023.2192024] [PDF] [Reactions Weekly]
    • Karakılıç Özturan, E., Öztürk, A. P., Baş, F., Erdoğdu, A. B., Kaptan, S., Kardelen Al, A. D., Poyrazoğlu, Ş., Yıldız, M., Direk, N., Yüksel, Ş., & Darendeliler, F. (2023). Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey. Journal of Clinical Research in Pediatric Endocrinology, 15(3), 276–284. [DOI:10.4274/jcrpe.galenos.2023.2023-1-13]
    • Vierregger, K., Tetzlaff, M., Zimmerman, B., Dunn, N., Finney, N., Lewis, K., Slomoff, R., & Strutner, S. (May 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. National Transgender Health Summit (NTHS) 2023 Symposium. [Event Agenda PDF] [Symposium Session] [Symposium Abstracts/Program Book]
    • Vierregger, K. S. (November 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 96–96 (abstract no. SAT-B2-T4). [Symposium Schedule] [PDF] [Full Abstract Book]
    • Warus, J. (November 2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 124–124 (abstract no. SUN-B1-T5). [Symposium Schedule] [PDF] [Full Abstract Book]
    • Wilde, B., Diamond, J. B., Laborda, T. J., Frank, L., O’Gorman, M. A., & Kocolas, I. (2023). Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent. Journal of Adolescent Health, 74(1), 202–204. [DOI:10.1016/j.jadohealth.2023.08.024]
    • Burgener, K., DeBosch, B., Wang, J., Lewis, C., & Herrick, C. J. (2024). Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study. medRxiv, preprint. [DOI:10.1101/2024.02.21.24302999v1] [PDF]
    • Fuqua, J. S., Shi, E., & Eugster, E. A. (2024). A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2023.2294321]
    • Shumer, D., & Roberts, S. A. (2024). Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents. Journal of Adolescent Health, 74(1), 5–6. [DOI:10.1016/j.jadohealth.2023.10.010]

    Update 6: Original Bicalutamide Liver and Lung Toxicity Analysis by Sam

    A few years ago back in 2021, Transfeminine Science author Sam conducted an original analysis of the incidence of liver and lung toxicity with bicalutamide in the published clinical trial literature. This project was never finished or made publicly available. However, with bicalutamide being increasingly studied and adopted for use in transfeminine people, it seems quite valuable and relevant today. As such, we have opted to now publish Sam’s analysis in this section.

    Sam’s analysis can be found in the provided document here. In terms of methodology, she searched PubMed for all clinical trials of bicalutamide, collated all of the relevant results into a table, and then calculated the incidences of serious liver toxicity and lung toxicity from those data. In clinical trials, adverse events are rated in terms of grades of severity, with a Grade 3 adverse event defined as “severe”, Grade 4 as “life-threatening”, and Grade 5 as “death” (Wiki).

    Of 229 results, 33 trials were found to be relevant and were included. Most of the trials were in men with prostate cancer, but a few were in women with cancer and boys with precocious puberty. Sam found that of a total of 7,703 evaluable participants, there were 2 instances of serious liver toxicity and 2 instances of serious lung toxicity with bicalutamide. This resulted in the same incidence rate of 0.026% (95% CI: 0.003% to 0.094%) or approximately 1 in 3,846 individuals for both liver toxicity and lung toxicity. Combining these toxicities resulted in a total incidence of serious liver or serious lung toxicity with bicalutamide of 0.052% (95% CI: 0.014% to 0.133%) or approximately 1 in 1,923 individuals. All of the observed toxicity events were rated as Grade 3 or 4. It should be noted that clinical trials of bicalutamide typically employ careful laboratory monitoring and assessment of clinical adverse events as well as prompt medication discontinuation upon unfavorable laboratory changes.

    While the confidence intervals (CIs) in Sam’s analysis were wide and hence the estimates are very rough, they provide an idea of the potential real-world risk of serious toxicity with bicalutamide in transfeminine people based on high-quality clinical data. Notably, they do not suffer from the problem of under-reporting of adverse events that occurs with published case reports, pharmacovigilance databases, and certain types of observational studies. However, limitations of Sam’s analysis include (1) toxicity incidence rates for non-bicalutamide-treated controls not being assessed and (2) most of the patients having cancer and being of older age, and hence the generalizability of the findings to healthy transfeminine people not being fully clear. In any case, I was surprised by how high the incidence rates were when I first saw her analysis, and I suspect that others may be as well.

    References

    • Anderson, J. (2003). The role of antiandrogen monotherapy in the treatment of prostate cancer. BJU International, 91(5), 455–461. [DOI:10.1046/j.1464-410X.2003.04026.x]
    • Angus, L., Nolan, B., Zajac, J., & Cheung, A. (2022). Use of bicalutamide as an androgen receptor antagonist in transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 280). [URL] [PDF] [Full Abstract Book]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (2023). Bicalutamide as an anti-androgen in trans people: a cross-sectional study. AusPATH 2023 Symposium. [URL] [PDF] [Slides] [Trans Health Research Blog Post]
    • Arya, V. B., & Davies, J. H. (2019). Idiopathic gonadotropin-independent precocious puberty - is regular surveillance required? Journal of Pediatric Endocrinology & Metabolism: JPEM, 32(4), 403–407. [DOI:10.1515/jpem-2018-0419]
    • Asscheman, H., Gooren, L. J., & Peereboom-Wynia, J. D. (1989). Reduction in undesired sexual hair growth with anandron in male-to-female transsexuals—experiences with a novel androgen receptor blocker. Clinical and Experimental Dermatology, 14(5), 361–363. [DOI:10.1111/j.1365-2230.1989.tb02585.x]
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • AstraZeneca. (2008). Clinical Review. NDA. 22-310/S-001. Casodex (bicalutamide) for Testotoxicosis. Food and Drug Administration/AstraZeneca Pharmaceuticals. [URL] [PDF]
    • Bahceci, M., Tuzcu, A., Canoruc, N., Tuzun, Y., Kidir, V., & Aslan, C. (2004). Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance. Hormone Research in Paediatrics, 62(6), 283–287. [DOI:10.1159/000081973]
    • Bailey, A. (2023 February 9). Missouri Attorney General Andrew Bailey Confirms Launch of Multi-Agency Investigation into St. Louis Transgender Center for Harming Hundreds of Children. Attorney General Andrew Bailey, Missouri Government. [URL] [Affadavit of Jamie Reed]
    • Bailey, A. (2023 April 13). Missouri Attorney General Andrew Bailey Promulgates Emergency Regulation Targeting Gender Transition Procedures for Minors. Attorney General Andrew Bailey, Missouri Government. [URL] [Emergency Regulation PDF]
    • Ballentine, S., & Hollingsworth, H. (2023 April 13). Missouri to limit gender-affirming care for minors, adults. Associated Press. [URL]
    • Bambilla, A., Beal, C., & Vigil, P. (2023). Improving Access to Bicalutamide in Gender Affirming Medical Care. [Unpubished/pending publication] [QueerCME Blog Post]
    • Blackledge, G. R. P. (1996). Clinical progress with a new antiandrogen, Casodex™ (bicalutamide). European Urology, 29(Suppl 2), 96–104. [DOI:10.1159/000473847]
    • Burgener, K., DeBosch, B., Lewis, C., Wallendorf, M., & Herrick, C. (2023). Assessment of Liver Function and Toxicity in Transgender Female Adolescents Prescribed Bicalutamide. Hormone Research in Paediatrics, 96(Suppl 3 [Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics]), 377–378 (abstract no. 6232). [DOI:10.1159/000531602] [PDF]
    • Burgener, K., DeBosch, B., Wang, J., Lewis, C., & Herrick, C. J. (2024). Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study. medRxiv, preprint. [DOI:10.1101/2024.02.21.24302999v1] [PDF]
    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Dahl, M., Feldman, J. L., Goldberg, J. M., & Jaberi, A. (2006). Physical aspects of transgender endocrine therapy. International Journal of Transgenderism, 9(3–4), 111–134. [DOI:10.1300/J485v09n03_06]
    • Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2006). Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy. Vancouver: Vancouver Coastal Health. [Google Scholar] [PDF]
    • de Voogt, H. J., Rao, B. R., Gooren, L. J. G., Geldof, A. A., & Bouman, F. G. (1987). Considerations About the Use of Anti-Androgenic Drugs in Male-to-Female Transsexuals. Tenth International Symposium on Gender Dysphoria, Diagnosis and Treatment of Transsexualism, Vrije Universiteit Amsterdam, The Netherlands, June 9–12, 1987. Harry Benjamin International Gender Dysphoria Association. [PDF]
    • de Voogt, H. J., Rao, B. R., Geldof, A. A., Gooren, L. J. G., & Bouman, F. G. (1987). Androgen action blockade does not result in reduction in size but changes histology of the normal human prostate. The Prostate, 11(4), 305–311. [DOI:10.1002/pros.2990110403]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Fernandez-Nieto, D., Saceda-Corralo, D., Rodrigues-Barata, R., Hermosa-Gelbard, A., Moreno-Arrones, O., Jimenez-Cauhe, J., Ortega-Quijano, D., & Vano-Galvan, S. (2019). Oral bicalutamide for female pattern hair loss: A pilot study. Dermatologic Therapy, 32(6), e13096. [DOI:10.1111/dth.13096]
    • Fernandez-Nieto, D., Saceda-Corralo, D., Jimenez-Cauhe, J., Moreno-Arrones, O. M., Rodrigues-Barata, R., Hermosa-Gelbard, A., & Vano-Galvan, S. (2020). Bicalutamide: A potential new oral antiandrogenic drug for female pattern hair loss. Journal of the American Academy of Dermatology, 83(5), e355–e356. [DOI:10.1016/j.jaad.2020.04.054]
    • Finkle, A., Zavertnik, S., Myers, S., Cormier, D., Heithaus, J., & Augustyn, M. (2020). Growing Up Fast: Managing Autism Spectrum Disorder and Precocious Puberty. Journal of Developmental and Behavioral Pediatrics: JDBP, 41(9), 740–742. [DOI:10.1097/DBP.0000000000000865]
    • Fishman, S. L., Paliou, M., Poretsky, L., & Hembree, W. C. (2019). Endocrine Care of Transgender Adults. In Poretsky, L., & Hembree, W. C. (Eds.). Transgender Medicine (pp. 143–163). Cham: Humana Press. [DOI:10.1007/978-3-030-05683-4_8]
    • Food and Drug Administration (FDA). (2017). CASODEX (bicalutamide) tablet, for oral use. [URL] [PDF]
    • Fuqua, J. S., Shi, E., & Eugster, E. A. (2024). A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2023.2294321]
    • Ghorayshi, A. (2023 August 29). How a Small Gender Clinic Landed in a Political Storm. The New York Times. [URL]
    • Gómez-Aguilar, F., Martínez-Sánchez, L., Arias-Constantí, V., Muñoz-Santanach, D., & Sarquella-Brugada, G. (2023). QT prolongation and Torsade de Pointes in a 13-year-old transgender adolescent in treatment with bicalutamide and tacrolimus. Clinical Toxicology, 61(Suppl 1 [43rd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 23–26 May 2023, Palma de Mallorca, Spain]), 81–82 (abstract no. 170). [DOI:10.1080/15563650.2023.2192024] [PDF] [Reactions Weekly]
    • Gooren, L., Spinder, T., Spijkstra, J. J., Van Kessel, H., Smals, A., Rao, B. R., & Hoogslag, M. (1987). Sex steroids and pulsatile luteinizing hormone release in men. Studies in estrogen-treated agonadal subjects and eugonadal subjects treated with a novel nonsteroidal antiandrogen. The Journal of Clinical Endocrinology & Metabolism, 64(4), 763–770. [DOI:10.1210/jcem-64-4-763]
    • Gooren, L. J. G. (1999). Hormonal Sex Reassignment. International Journal of Transgenderism, 3(3), 1–7. [Google Scholar] [URL] [Alt]
    • Gooren, L. J. (2011). Care of transsexual persons. New England Journal of Medicine, 364(13), 1251–1257. [DOI:10.1056/NEJMcp1008161]
    • Graham, D. J., Ahmad, S. R., & Piazza‐Hepp, T. (2002). Spontaneous Reporting—USA. In Mann, R. D., & Andrews, E. B. (Eds.). Pharmacovigilance (pp. 219–227). Chichester: John Wiley & Sons. [DOI:10.1002/0470853093.ch17]
    • Gurnurkar, S., DiLillo, E., & Carakushansky, M. (2021). A Case of Familial Male-limited Precocious Puberty with a Novel Mutation. Journal of Clinical Research in Pediatric Endocrinology, 13(2), 239–244. [DOI:10.4274/jcrpe.galenos.2020.2020.0067]
    • Haddad, N. G., & Eugster, E. A. (2012). Peripheral Precocious Puberty: Interventions to Improve Growth. In Preedy, V. R. (Ed.). Handbook of Growth and Growth Monitoring in Health and Disease (pp. 1199–1212). New York: Springer. [DOI:10.1007/978-1-4419-1795-9_71]
    • Hamidi, O., & Davidge-Pitts, C. J. (2019). Transfeminine Hormone Therapy. Endocrinology and Metabolism Clinics, 48(2), 341–355. [DOI:10.1016/j.ecl.2019.02.001]
    • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Ismail, F. F., Meah, N., de Carvalho, L. T., Bhoyrul, B., Wall, D., & Sinclair, R. (2020). Safety of oral bicalutamide in female pattern hair loss: A retrospective review of 316 patients. Journal of the American Academy of Dermatology, 83(5), 1478–1479. [DOI:10.1016/j.jaad.2020.03.034]
    • Israel, G. E., & Tarver, D. E. (1997). Transgender Care: Recommended Guidelines, Practical Information, and Personal Accounts (p. 66). Philadelphia: Temple University Press. [Google Scholar] [Google Books]
    • Iversen, P., Johansson, J. E., Lodding, P., Lukkarinen, O., Lundmo, P., Klarskov, P., Tammela, T. L., Tasdemir, I., Morris, T., Carroll, K., & Scandinavian Prostatic Cancer Group. (2004). Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6. The Journal of Urology, 172(5 Part 1), 1871–1876. [DOI:10.1097/01.ju.0000139719.99825.54]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819871166. [DOI:10.1177/2042018819871166]
    • Johannes, F. L. M., van Kemenade, M. A., Cohen-Kettenis, P. T., Cohen, L., & Gooren, L. J. G. (1987). Effects of RU 23.903 (Anandron) on Lateralization and Spatial Ability in Male-to-Female-Transsexuals. Tenth International Symposium on Gender Dysphoria, Diagnosis and Treatment of Transsexualism, Vrije Universiteit Amsterdam, The Netherlands, June 9–12, 1987. Harry Benjamin International Gender Dysphoria Association. [PDF]
    • Karakılıç Özturan, E., Öztürk, A. P., Baş, F., Erdoğdu, A. B., Kaptan, S., Kardelen Al, A. D., Poyrazoğlu, Ş., Yıldız, M., Direk, N., Yüksel, Ş., & Darendeliler, F. (2023). Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey. Journal of Clinical Research in Pediatric Endocrinology, 15(3), 276–284. [DOI:10.4274/jcrpe.galenos.2023.2023-1-13]
    • Kolvenbag, G. J., & Blackledge, G. R. (1996). Worldwide activity and safety of bicalutamide: a summary review. Urology, 47(1), 70–79. [DOI:10.1016/S0090-4295(96)80012-4]
    • Kor, Y. (2018). Central precocious puberty in a case of late-diagnosed familial testotoxicosis and long-term treatment monitoring. Hormones, 17(2), 275–278. [DOI:10.1007/s42000-018-0029-1]
    • Kreher, N. C., Pescovitz, O. H., Delameter, P., Tiulpakov, A., & Hochberg, Z. E. (2006). Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. The Journal of Pediatrics, 149(3), 416–420. [DOI:10.1016/j.jpeds.2006.04.027]
    • Lenz, A. M., Shulman, D., Eugster, E. A., Rahhal, S., Fuqua, J. S., Pescovitz, O. H., & Lewis, K. A. (2010). Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics, 126(3), e728–e733. [DOI:10.1542/peds.2010-0596]
    • Levy, A., Crown, A., & Reid, R. (2003). Endocrine intervention for transsexuals. Clinical Endocrinology, 59(4), 409–418. [DOI:10.1046/j.1365-2265.2003.01821.x]
    • Lewis, K. A., Lenz, A., Eugster, E. A., Fuqua, J. S., Pescovitz, O. H., Rahhal, S., & Shulman, D. (2009). Long term bicalutamide and 3rd generation aromatase inhibitor therapy in two boys with testotoxicosis. Hormone Research [in Paediatrics], 72(Suppl 3), 266–267 (PO2-189). [Google Scholar] [DOI:10.1159/000239668]
    • Manso, G., Thole, Z., Salgueiro, E., Revuelta, P., & Hidalgo, A. (2006). Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiology and Drug Safety, 15(4), 253–259. [DOI:10.1002/pds.1168]
    • McLeod, D. G. (1997). Tolerability of Nonsteroidal Antiandrogens in the Treatment of Advanced Prostate Cancer. The Oncologist, 2(1), 18–27. [DOI:10.1634/theoncologist.2-1-18]
    • Michigan Medicine. (2020). Feminizing Gender-Affirming Hormone Care: The Michigan Medicine Approach. Ann Arbor: Michigan Medicine/University of Michigan. [URL] [PDF]
    • Mitchell, F. (2020). Guy T’Sjoen: collaborating to improve transgender wellbeing. The Lancet Diabetes & Endocrinology, 8(7), 568–568. [DOI:10.1016/S2213-8587(20)30192-3]
    • Mitre, N., & Lteif, A. (2009). Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. Journal of Pediatric Endocrinology and Metabolism, 22(12), 1163–1168. [DOI:10.1515/JPEM.2009.22.12.1163]
    • Moreno-Pérez, Ó., De Antonio, I. E., & Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN. (2012). Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN). Endocrinología y Nutrición (English Edition), 59(6), 367–382. [DOI:10.1016/j.endoen.2012.07.004]
    • Moretti, C. G., Guccione, L., Di Giacinto, P., Cannuccia, A., Meleca, C., Lanzolla, G., Andreadi, A., & Lauro, D. (2016). Efficacy and Safety of Myo-Inositol Supplementation in the Treatment of Obese Hirsute PCOS Women: Comparative Evaluation with OCP+Bicalutamide Therapy. Endocrine Reviews, 37(2 Suppl 1), ?–? (abstract no. SUN-153). [URL] [DOI:10.1093/edrv/37.supp.1]
    • Moretti, C., Guccione, L., Di Giacinto, P., Simonelli, I., Exacoustos, C., Toscano, V., Motta, C., De Leo, V., Petraglia, F., & Lenzi, A. (2018). Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism: a double-blind randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism, 103(3), 824–838. [DOI:10.1210/jc.2017-01186]
    • Moussa, A., Kazmi, A., Bokhari, L., & Sinclair, R. D. (2022). Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients. Journal of the American Academy of Dermatology, 87(2), 488–490. [DOI:10.1016/j.jaad.2021.10.048]
    • Muderris, I. I., Bayram, F., & Guven, M. (1999). Bicalutamide 25 mg/day in the treatment of hirsutism. Human Reproduction, 14(Suppl 3), 366–366 (R-196). [DOI:10.1093/humrep/14.Suppl_3.366-a]
    • Müderris, I. I., Bayram, F., Özçelik, B., & Güven, M. (2002). New alternative treatment in hirsutism: bicalutamide 25 mg/day. Gynecological Endocrinology, 16(1), 63–66. [DOI:10.1080/gye.16.1.63.66]
    • Müderris, İ. İ., & Öner, G. (2009). Hirsutizm Tedavisinde Flutamid ve Bikalutamid Kullanımı. [Flutamide and Bicalutamide Treatment in Hirsutism.] Türkiye Klinikleri Endokrinoloji-Özel Dergisi, 2(2), 110–112. [ISSN:1308-0954] [URL] [PDF] [Translation]
    • Nabhan, Z. M., & Eugster, E. A. (2019). Testotoxicosis with an episodic course: an unusual case within a series. AACE Clinical Case Reports, 5(1), e50–e53. [DOI:10.4158/ACCR-2018-0246]
    • Neyman, A., Fuqua, J. S., & Eugster, E. A. (2017). Bicalutamide as an Androgen Blocker with Secondary Effect of Promoting Feminization in Male to Female (MTF) Transgender Adolescents. Hormone Research in Paediatrics, 88(Suppl 1 [10th Individual Abstracts for International Meeting of Pediatric Endocrinology: Free Communication and Poster Sessions, Abstracts]), 477–477 (abstract no. P3-605). [DOI:10.1159/000481424] [PDF]
    • Neyman, A., Fuqua, J. S., & Eugster, E. A. (2019). Bicalutamide as an androgen blocker with secondary effect of promoting feminization in male-to-female transgender adolescents. Journal of Adolescent Health, 64(4), 544–546. [DOI:10.1016/j.jadohealth.2018.10.296]
    • Özcabı, B., Ceylaner, S., Özcan, R., Büyükünal, C., Ercan, O., Tüysüz, B., & Evliyaoğlu, O. (2015). Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. Journal of Clinical Research in Pediatric Endocrinology, 7(3), 242–248. [DOI:10.4274/jcrpe.2067]
    • Randolph Jr, J. F. (2018). Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics and Gynecology, 61(4), 705–721. [DOI:10.1097/GRF.0000000000000396] [URL]
    • Rao, B. R., De Voogt, H. J., Geldof, A. A., Gooren, L. J. G., & Bouman, F. G. (1988). Merits and considerations in the use of anti-androgen. Journal of Steroid Biochemistry, 31(4), 731–737. [DOI:10.1016/0022-4731(88)90024-6]
    • Reed, J. (2023 February 9). I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle. The Free Press. [URL]
    • Reiter, E. O., Mauras, N., McCormick, K., Kulshreshtha, B., Amrhein, J., De Luca, F., O’Brien, S., Armstrong, J., & Melezinkova, H. (2010). Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). Journal of Pediatric Endocrinology & Metabolism: JPEM, 23(10), 999–1009. [DOI:10.1515/jpem.2010.161]
    • Salter, J., & Ballentine, S. (2023 September 12). Missouri clinics halt transgender care for minors in wake of new state law. Associated Press. [URL]
    • Schellhammer, P. F., Sharifi, R., Block, N. L., Soloway, M. S., Venner, P. M., Patterson, A. L., Sarosdy, M. F., Vogelzang, N. J., Schellenger, J. J., Kolvenbag, G. J., & Casodex Combination Study Group. (1997). Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Urology, 50(3), 330–336. [DOI:10.1016/s0090-4295(97)00279-3]
    • Shumer, D., & Roberts, S. A. (2024). Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents. Journal of Adolescent Health, 74(1), 5–6. [DOI:10.1016/j.jadohealth.2023.10.010]
    • See, W. A., Wirth, M. P., McLeod, D. G., Iversen, P., Klimberg, I., Gleason, D., Chodak, G., Montie, J., Tyrrell, C., Wallace, D. M., Delaere, K. P., Vaage, S., Tammela, T. L., Lukkarinen, O., Persson, B. E., Carroll, K., Kolvenbag, G. J., & Casodex Early Prostate Cancer Trialist Group. (2002). Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program. The Journal of Urology, 168(2), 429–435. [DOI:10.1016/S0022-5347(05)64652-6]
    • Stenger, P. J., Wagner, L., Egelhoff, J., & Rose, S. R. (2009). Bicalutamide and letrozole treatment of precocious puberty due to elevated levels of human chorionic gonadotropin (hCG). Hormone Research [in Paediatrics], 72(Suppl 3), 391–391 (PO3-149). [Google Scholar] [DOI:10.1159/000239668]
    • Tessaris, D., Matarazzo, P., Mussa, A., Tuli, G., Verna, F., Fiore, L., & Lala, R. (2012). Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. Endocrine Journal, 59(2), 111–117. [DOI:10.1507/endocrj.ej11-0214]
    • Thole, Z., Manso, G., Salgueiro, E., Revuelta, P., & Hidalgo, A. (2004). Hepatotoxicity induced by antiandrogens: a review of the literature. Urologia Internationalis, 73(4), 289–295. [DOI:10.1159/000081585]
    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]
    • van Kemenade, J. F., Cohen-Kettenis, P. T., Cohen, L., & Gooren, L. J. (1989). Effects of the pure antiandrogen RU 23.903 (anandron) on sexuality, aggression, and mood in male-to-female transsexuals. Archives of Sexual Behavior, 18(3), 217–228. [DOI:10.1007/BF01543196]
    • Vierregger, K., Tetzlaff, M., Zimmerman, B., Dunn, N., Finney, N., Lewis, K., Slomoff, R., & Strutner, S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. National Transgender Health Summit (NTHS) 2023 Symposium. [Event Agenda PDF] [Symposium Session] [Symposium Abstracts/Program Book]
    • Vierregger, K. S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 96–96 (abstract no. SAT-B2-T4). [Symposium Schedule] [PDF] [Full Abstract Book]
    • Warus, J. (2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 124–124 (abstract no. SUN-B1-T5). [Symposium Schedule] [PDF] [Full Abstract Book]
    • Wilde, B., Diamond, J. B., Laborda, T. J., Frank, L., O’Gorman, M. A., & Kocolas, I. (2023). Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent. Journal of Adolescent Health, 74(1), 202–204. [DOI:10.1016/j.jadohealth.2023.08.024]
    \ No newline at end of file diff --git a/transfemscience.org/articles/bone-shape-changes/index.html b/transfemscience.org/articles/bone-shape-changes/index.html index 36da3de9..2089282f 100644 --- a/transfemscience.org/articles/bone-shape-changes/index.html +++ b/transfemscience.org/articles/bone-shape-changes/index.html @@ -1 +1 @@ -On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy - Transfeminine Science Link

    On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy

    By Lain | First published May 9, 2020 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    TL;DR

    The studies here do not show significant hip bone growth in adult transfeminine individuals under hormone therapy. They do show, however significant feminizing body shape changes that seem to largely be explained by increased fat placement around the hips and butt.

    Introduction

    An area of interest that I’ve seen a number of times is how does gender-affirming hormone therapy (GAHT) affect bones, specifically in adult transgender individuals. Within the context of transfeminine individuals the interest is often related to whether or not GAHT can cause an increase in hip bone area and give a body shape that is more feminine or gynoid.

    However, one way to quantitatively measure these changes is via DXA scans. DXA or dual-energy X-ray absorptiometry is a non-invasive way to measure the distribution of different soft tissue types like fat and muscle as well as bone area and density. It is most commonly used to study bone mineral density (BMD) which is often used as a measure of bone health and when assessing risk for things like fractures or osteoporosis.

    To date there have been two studies that I am aware of that look at body composition changes beyond changes in fat/muscle composition or external factors like waist–hip ratio (WHR) which I will review here.

    Van Caenegem et al. (2014) - Preservation of Volumetric Bone Density and Geometry in Transwomen During Cross-Sex Hormonal Therapy: A Prospective Observational Study

    This study, a component of the European Network for the Investigation of Gender Incongruence (ENIGI) initiative (Kreukels et al., 2012) investigated a wide variety of body composition changes in a controlled cohort of 49 transfeminine individuals with a mean age of 33 (± 12) years with a minimum of 17 and a maximum of 67 years before starting GAHT with 1 and 2 year follow ups and compared them to a cohort of age matched cis men. The GAHT regimen used here was standardized at 4 mg estradiol valerate daily orally (or 100 μg transdermal estradiol if over 45) with 50 mg cyproterone acetate.

    Figure 1: Results of various bone parameters (Van Caenegem et al., 2014).

    With respect to bone area while there was – somewhat surprisingly – a significant difference between the control men and transfeminine individuals prior to starting GAHT in various bone area measurements and BMD there was no statistically significant change in bone area for hips, radius (lower arm bone), femoral neck (the length between the femoral head which fits into the pelvis and the rest of the femur) or lumbar spine (lower spine bones).

    However, despite this lack of change in total hip bone area – there were significant changes in WHR.

    Figure 2: Changes in body composition after 1 and 2 years of hormone therapy (Van Caenegem et al., 2014).

    You can see that while total hip bone area did not change significantly and neither did waist circumference – hip circumference and WHR ratio changed significantly – with WHR on average being what is considered a more feminine range.

    Lapauw et al. (2008) - Body Composition, Volumetric and Areal Bone Parameters in Male-to-Female Transsexual Persons

    This study is an earlier work by the same group out of Belgium. Unlike the previous one this one did not have a cohort that tracked before, and after beginning GAHT but rather compared individuals on GAHT with control cis men. Another area of difference is that everyone in this study had undergone gender confirmation surgery at least 3 years prior to being enrolled and had a mean age of 41 (± 7) years.

    Figure 3: Bone composition differences between the group of transfeminine individuals and cis men (Lapauw et al., 2008).

    These results again find no significant difference in total bone area of total hip or other specific areas looked at between the transfeminine individuals and the cis men. This study unfortunately did not also look at WHR or area specific body fat composition.

    Discussion

    Van Caenegem et al. (2014) paints a compelling picture of the changes experienced in transfeminine individuals under GAHT. While total bone area of the hip did not significantly change, WHR shrank due to an increase in hip circumference to a more gynoid distribution as has been reported a number of times in other places.

    That this is due to fat mass is further bolstered by Klaver et al. (2017) which looked at body composition changes in 179 transfeminine individuals at regional areas and found that the “gynoid” area – or area around the hips experienced a 34% increase in fat percentage (see Figure 4 below).

    Figure 4: Body composition changes in regions of DXA scans (Klaver et al., 2017).

    While it is worth noting that the GAHT regimen given to these individuals is fairly homogeneous it should be pointed out that it did cause significant changes in body fat and WHR.

    I believe this illustrates that the current evidence we have supports the idea that bone mass does not significantly change in adults under GAHT and that the primary contributor to changes in WHR and hip circumference are tissue focused – seemingly largely from increased fat deposition.

    References

    • Klaver, M., de Blok, C. J., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/eje-17-0496]
    • Kreukels, B., Haraldsen, I., De Cuypere, G., Richter-Appelt, H., Gijs, L., & Cohen-Kettenis, P. (2012). A European network for the investigation of gender incongruence: The ENIGI initiative. European Psychiatry, 27(6), 445–450. [DOI:10.1016/j.eurpsy.2010.04.009]
    • Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., Toye, K., Kaufman, J., & T’Sjoen, G. G. (2008). Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone, 43(6), 1016–1021. [DOI:10.1016/j.bone.2008.09.001]
    • Van Caenegem, E., Wierckx, K., Taes, Y., Schreiner, T., Vandewalle, S., Toye, K., Kaufman, J., & T’Sjoen, G. (2014). Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporosis International, 26(1), 35–47. [DOI:10.1007/s00198-014-2805-3]
    \ No newline at end of file +On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy - Transfeminine Science Link

    On Changes in Bone Shape in Transfeminine Individuals Under Gender-Affirming Hormone Therapy

    By Lain | First published May 9, 2020 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    TL;DR

    The studies here do not show significant hip bone growth in adult transfeminine individuals under hormone therapy. They do show, however significant feminizing body shape changes that seem to largely be explained by increased fat placement around the hips and butt.

    Introduction

    An area of interest that I’ve seen a number of times is how does gender-affirming hormone therapy (GAHT) affect bones, specifically in adult transgender individuals. Within the context of transfeminine individuals the interest is often related to whether or not GAHT can cause an increase in hip bone area and give a body shape that is more feminine or gynoid.

    However, one way to quantitatively measure these changes is via DXA scans. DXA or dual-energy X-ray absorptiometry is a non-invasive way to measure the distribution of different soft tissue types like fat and muscle as well as bone area and density. It is most commonly used to study bone mineral density (BMD) which is often used as a measure of bone health and when assessing risk for things like fractures or osteoporosis.

    To date there have been two studies that I am aware of that look at body composition changes beyond changes in fat/muscle composition or external factors like waist–hip ratio (WHR) which I will review here.

    Van Caenegem et al. (2014) - Preservation of Volumetric Bone Density and Geometry in Transwomen During Cross-Sex Hormonal Therapy: A Prospective Observational Study

    This study, a component of the European Network for the Investigation of Gender Incongruence (ENIGI) initiative (Kreukels et al., 2012) investigated a wide variety of body composition changes in a controlled cohort of 49 transfeminine individuals with a mean age of 33 (± 12) years with a minimum of 17 and a maximum of 67 years before starting GAHT with 1 and 2 year follow ups and compared them to a cohort of age matched cis men. The GAHT regimen used here was standardized at 4 mg estradiol valerate daily orally (or 100 μg transdermal estradiol if over 45) with 50 mg cyproterone acetate.

    Figure 1: Results of various bone parameters (Van Caenegem et al., 2014).

    With respect to bone area while there was – somewhat surprisingly – a significant difference between the control men and transfeminine individuals prior to starting GAHT in various bone area measurements and BMD there was no statistically significant change in bone area for hips, radius (lower arm bone), femoral neck (the length between the femoral head which fits into the pelvis and the rest of the femur) or lumbar spine (lower spine bones).

    However, despite this lack of change in total hip bone area – there were significant changes in WHR.

    Figure 2: Changes in body composition after 1 and 2 years of hormone therapy (Van Caenegem et al., 2014).

    You can see that while total hip bone area did not change significantly and neither did waist circumference – hip circumference and WHR ratio changed significantly – with WHR on average being what is considered a more feminine range.

    Lapauw et al. (2008) - Body Composition, Volumetric and Areal Bone Parameters in Male-to-Female Transsexual Persons

    This study is an earlier work by the same group out of Belgium. Unlike the previous one this one did not have a cohort that tracked before, and after beginning GAHT but rather compared individuals on GAHT with control cis men. Another area of difference is that everyone in this study had undergone gender confirmation surgery at least 3 years prior to being enrolled and had a mean age of 41 (± 7) years.

    Figure 3: Bone composition differences between the group of transfeminine individuals and cis men (Lapauw et al., 2008).

    These results again find no significant difference in total bone area of total hip or other specific areas looked at between the transfeminine individuals and the cis men. This study unfortunately did not also look at WHR or area specific body fat composition.

    Discussion

    Van Caenegem et al. (2014) paints a compelling picture of the changes experienced in transfeminine individuals under GAHT. While total bone area of the hip did not significantly change, WHR shrank due to an increase in hip circumference to a more gynoid distribution as has been reported a number of times in other places.

    That this is due to fat mass is further bolstered by Klaver et al. (2017) which looked at body composition changes in 179 transfeminine individuals at regional areas and found that the “gynoid” area – or area around the hips experienced a 34% increase in fat percentage (see Figure 4 below).

    Figure 4: Body composition changes in regions of DXA scans (Klaver et al., 2017).

    While it is worth noting that the GAHT regimen given to these individuals is fairly homogeneous it should be pointed out that it did cause significant changes in body fat and WHR.

    I believe this illustrates that the current evidence we have supports the idea that bone mass does not significantly change in adults under GAHT and that the primary contributor to changes in WHR and hip circumference are tissue focused – seemingly largely from increased fat deposition.

    References

    • Klaver, M., de Blok, C. J., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/eje-17-0496]
    • Kreukels, B., Haraldsen, I., De Cuypere, G., Richter-Appelt, H., Gijs, L., & Cohen-Kettenis, P. (2012). A European network for the investigation of gender incongruence: The ENIGI initiative. European Psychiatry, 27(6), 445–450. [DOI:10.1016/j.eurpsy.2010.04.009]
    • Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., Toye, K., Kaufman, J., & T’Sjoen, G. G. (2008). Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone, 43(6), 1016–1021. [DOI:10.1016/j.bone.2008.09.001]
    • Van Caenegem, E., Wierckx, K., Taes, Y., Schreiner, T., Vandewalle, S., Toye, K., Kaufman, J., & T’Sjoen, G. (2014). Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporosis International, 26(1), 35–47. [DOI:10.1007/s00198-014-2805-3]
    \ No newline at end of file diff --git a/transfemscience.org/articles/breast-cancer-suppl/index.html b/transfemscience.org/articles/breast-cancer-suppl/index.html index 46f151f8..2fc6068d 100644 --- a/transfemscience.org/articles/breast-cancer-suppl/index.html +++ b/transfemscience.org/articles/breast-cancer-suppl/index.html @@ -1 +1 @@ -The Possible Role of a Second X Chromosome in Breast Cancer Risk - Transfeminine Science Link

    The Possible Role of a Second X Chromosome in Breast Cancer Risk

    By Aly | First published April 25, 2020 | Last modified March 1, 2023

    Preface

    This is a short supplement article to the section in the main article on breast cancer risk with hormone therapy in transfeminine people that can be found here.

    Introduction

    The sex chromosomes include the X chromosome and the Y chromosome. Under normal biological circumstances, cisgender women have two X chromosomes (46,XX karyotype) while cisgender men (and transfeminine people) have one X chromosome and one Y chromosome (46,XY karyotype). The sex chromosomes determine whether the gonads will differentiate into ovaries or testes, and hence mediate a large portion of physical sexual dimorphism. However, the sex chromosomes also have effects in terms of sexual dimorphism that are independent of gonadal differentiation. Although hormone therapy appears to increase the risk of breast cancer in transfeminine people, so far breast cancer risk in transfeminine people seems to be much lower than that in cisgender women. There are a variety of possible reasons for this, as touched on elsewhere. One reason may be our lack of a second X chromosome—there is indication that our absence of a second X chromosome may be partially protective against breast cancer.

    X Chromosome Abnormalities and Breast Cancer

    The incidence of abnormal numbers of X chromosomes in cells (e.g., 45,X or 47,XXX karyotype) increases naturally with age (Barrios et al., 1991; Jacobs et al., 2013). X-chromosome gain is associated with more aggressive and poorly prognostic female breast cancer (Nakopoulou et al., 2007). Aberrant patterns of X-chromosome inactivation have been observed in female breast cancer cell lines and tissue specimens and are associated with worse survival rates (Lin et al., 2015; Chaligné et al., 2015). High incidence of X-chromosome gain has been observed in male breast cancer but not in control gynecomastic breast tissue (Di Oto et al., 2015; Di Oto et al., 2018). Additional findings and readings on X-chromosome abnormalities in breast cancer also exist (e.g., Spatz, Borg, & Feunteun, 2004; Sirchia, Tabano, & Miozzo, 2007; Chaligné & Heard, 2014; Richardson et al., 2006; Dawson, 1998).

    X Chromosomes and Breast Cancer Risk in Chromosomal Disorders and Intersexuality

    A variety of genetic disorders involving abnormal sex-chromosome configurations and/or intersexuality also provide insight on the possible involvement of X chromosomes in breast cancer risk. These conditions include Klinefelter’s syndrome (47,XXY male), complete androgen insensitivity syndrome (46,XY female), Turner syndrome (45,X or mixed 45,X/46,XX female), XX male syndrome (46,XX male), and X trisomy and tetrasomy (47,XXX and 48,XXXX female).

    Klinefelter’s Syndrome (47,XXY)

    Men with Klinefelter’s syndrome have a 47,XXY karyotype and hence an extra X chromosome. Because of their Y chromosome, men with Klinfelter’s syndrome have testes and develop normally as males. However, they have relatively low testosterone levels (about 260 ng/dL lower than usual), slightly increased estradiol levels (about 6 pg/mL more than normal), an increased ratio of estradiol to testosterone, and negligible progesterone (Wiki). In addition, men with Klinefelter’s syndrome show undermasculinization and sometimes have mild gynecomastia. The risk of breast cancer in men with Klinefelter’s syndrome is strongly increased relative to 46,XY men (Brinton, 2011; Sokol, 2012). The risk is estimated to be 20- to 60-fold higher in men with Klinefelter’s syndrome compared to 46,XY men and only 70% lower than the risk in 46,XX women (Brinton, 2011; Sokol, 2012; Swerdlow et al., 2005). The lifetime risk of breast cancer in men with Klinefelter’s syndrome is 4 to 8% (Sokol, 2012). Breast cancer risk in men with Klinefelter’s syndrome is much higher than that in almost any other known clinical situation in men. The typical age of diagnosis of breast cancer in men with Klinefelter’s syndrome is 58 years (Ferzoco & Ruddy, 2016). It is estimated that 7% of all men with breast cancer have Klinefelter’s syndrome (Ferzoco & Ruddy, 2016). Klinefelter’s syndrome suggests that breast cancer may be dependent on an extra X chromosome (Spatz, Borg, & Feunteun, 2004; Sacchi, 1993; Dawson, 1998), although disordered hormone levels may also be involved.

    Complete Androgen Insensitivity Syndrome (46,XY)

    Women with complete androgen insensitivity syndrome (CAIS) are individuals with a 46,XY karyotype and intra-abdominal testes who have a defective androgen receptor and hence are insensitive to the effects of androgens like testosterone. Due to their androgen insensitivity, CAIS women develop physically and behaviorally as females instead of as males. CAIS women naturally have male-range levels of sex hormones, including of testosterone, estradiol, and progesterone (Wiki). Relative to 46,XX women, testosterone levels are very high, estradiol levels relatively low (~35 pg/mL), and progesterone levels negligible. During adolescence, CAIS women undergo female puberty due to aromatization of testosterone into estradiol, and this results in feminization and excellent breast development, with breasts that are said to be somewhat above-average compared to those of 46,XX women.

    After puberty, all clinically diagnosed CAIS women undergo gonadectomy due to a high risk of testicular cancer that’s associated with their intra-abdominal testes. Following gonadectomy, CAIS women receive estrogen replacement therapy, oftentimes if not usually only at menopausal doses. A progestogen is not usually included since CAIS women don’t have uteruses and hence don’t require the endometrial protection afforded by progestogens. Despite a 1 in 20,000 incidence of CAIS in 46,XY individuals and hence the estimated existence of hundreds of thousands of CAIS women throughout the world, breast cancer has never been reported in a CAIS woman (Hughes et al., 2012; Tiefenbacher & Daxenbichler, 2008; Hughes, 2009). It’s unlikely that breast cancer doesn’t occur in women with CAIS, but rather it’s probable that it’s rare. It’s unknown why this is the case, but major possible reasons include the relatively low estrogen exposure, lack of progesterone, and the lack of a second X chromosome. Their androgen insensitivity is unlikely to be involved as androgens, via activation of the androgen receptor, are thought to be protective in terms of breast cancer risk (Dimitrakakis, 2011). CAIS women are fascinating because they suggest that considerable breast cancer incidence isn’t an inevitable companion of normal breast development.

    Turner Syndrome (45,X or Mixed 45,X/46,XX)

    Women with Turner syndrome have either a 45,X karyotype or a mosaic of 45,X and 46,XX karyotypes. They often though not always have gonadal failure and hence many of them fail to undergo puberty. Gonadal failure is much more prevalent in those with a 45,X karyotype than in mosaics. When gonadal failure occurs, hormone therapy is required. Women with Turner’s syndrome have uteruses, so those who have pubertal failure receive hormone replacement with both an estrogen and a progestogen. As with CAIS women, this is often with only menopausal replacement doses. The risk of breast cancer appears to be lower in women with Turner syndrome than in regular 46,XX women (Schoemaker et al., 2008; Bösze, Tóth, & Török, 2006; Viuff et al., 2020). For example, in one large cohort study of 3,425 women with Turner syndrome and an average of 17 years of follow up, the risk of breast cancer was significantly lower than in regular 46,XX women. Interestingly, the standardized incidence ratios were 0.2 (0.0–0.9) in those with a 45,X karyotype and 0.9 (0.3–2.0) in those with 45,X and 46,XX mosaicism. In other words, those with mosaicism had a risk of breast cancer similar to that of regular 46,XX women, whereas those with a 45,X chromosome had a significantly lower risk (Gravholt, 2008).

    XX Male Syndrome (46,XX)

    XX males have a 46,XX karyotype. In about 90% of cases, the condition is caused by translocation of the SRY gene, which encodes the protein testis-determining factor (TDF), onto an X chromosome. As a result of this, XX males develop testes instead of ovaries, in turn developing as males instead of as females. Three case reports of breast cancer in 46,XX males exist (Berglund et al., 2017). On the basis of these cases and the small total number of cases of XX male syndrome that have been reported, it has been said that XX males are at increased risk for breast cancer analogously to men with Klinefelter’s syndrome (Spatz, Borg, & Feunteun, 2004; Giammarini, 1980).

    X Trisomy (47,XXX) and Tetrasomy (48,XXXX)

    So far there is no evidence of increased breast cancer risk in 47,XXX (X trisomy) or 48,XXXX (X tetrasomy) females (Spatz, Borg, & Feunteun, 2004), although most cases of these syndromes go undetected and the conditions are understudied (Goldschmidt et al., 2010; Wiki). Additional X chromosomes are inactivated in these individuals, limiting—although not fully eliminating—phenotypical abnormalities, possibly including greater breast cancer risk.

    Conclusions

    Taken together, these findings from chromosomal disorders and intersex conditions suggest that having at least two X chromosomes may greatly increase the risk of breast cancer. In addition, CAIS women suggest that normal breast development with very low breast cancer risk is possible, provided of course that the person has only one X chromosome.

    References

    • Barrios, L., Caballín, M., Miró, R., Fuster, C., Guedea, F., Subias, A., & Egozcue, J. (1991). Chromosomal instability in breast cancer patients. Human Genetics, 88(1), 39–41. [DOI:10.1007/bf00204926]
    • Berglund, A., Johannsen, T., Stochholm, K., Aksglaede, L., Fedder, J., Viuff, M., Main, K., & Gravholt, C. (2017). Incidence, prevalence, diagnostic delay, morbidity, mortality and socioeconomic status in males with 46,XX disorders of sex development: a nationwide study. Human Reproduction, 32(8), 1751–1760. [DOI:10.1093/humrep/dex210]
    • Bösze, P., Tóth, A., & Török, M. (2006). Hormone Replacement and the Risk of Breast Cancer in Turner’s Syndrome. New England Journal of Medicine, 355(24), 2599–2600. [DOI:10.1056/nejmc062795]
    • Brinton, L. A. (2011). Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatrica, 100(6), 814–818. [DOI:10.1111/j.1651-2227.2010.02131.x]
    • Chaligné, R., & Heard, E. (2014). X-chromosome inactivation in development and cancer. FEBS Letters, 588(15), 2514–2522. [DOI:10.1016/j.febslet.2014.06.023]
    • Chaligné, R., Popova, T., Mendoza-Parra, M., Saleem, M. M., Gentien, D., Ban, K., Piolot, T., Leroy, O., Mariani, O., Gronemeyer, H., Vincent-Salomon, A., Stern, M., & Heard, E. (2015). The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer. Genome Research, 25(4), 488–503. [DOI:10.1101/gr.185926.114]
    • Dawson, P. J. (1998). A history of cancer of the male breast. In Peters, W. P., & Visscher, D. W. (Eds.). Breast Cancer (Advances in Oncobiology, Volume 2) (pp. 229–243). Stamford/London: Jai Press. [DOI:10.1016/s1569-254x(98)80011-3] [Google Books]
    • Di Oto, E., Monti, V., Cucchi, M. C., Masetti, R., Varga, Z., & Foschini, M. P. (2015). X chromosome gain in male breast cancer. Human Pathology, 46(12), 1908–1912. [DOI:10.1016/j.humpath.2015.08.008]
    • Di Oto, E., Biserni, G. B., Varga, Z., Morandi, L., Cucchi, M. C., Masetti, R., & Foschini, M. P. (2018). X chromosome gain is related to increased androgen receptor expression in male breast cancer. Virchows Archiv, 473(2), 155–163. [DOI:10.1007/s00428-018-2377-2]
    • Dimitrakakis, C. (2011). Androgens and Breast Cancer in Men and Women. Endocrinology and Metabolism Clinics of North America, 40(3), 533–547. [DOI:10.1016/j.ecl.2011.05.007]
    • Ferzoco, R. M., & Ruddy, K. J. (2015). The Epidemiology of Male Breast Cancer. Current Oncology Reports, 18(1), 1. [DOI:10.1007/s11912-015-0487-4]
    • Giammarini, A., Rocchi, M., Zennaro, W., & Filippi, G. (2008). XX Male with breast cancer. Clinical Genetics, 18(2), 103–108. [DOI:10.1111/j.1399-0004.1980.tb01019.x]
    • Goldschmidt, E., Márquez, M., Solari, A., Ziembar, M. I., & Laudicina, A. (2010). Variabilidad fenotípica en pacientes 47, XXX: Presentación de cuatro casos nuevos. [Phenotypic variability in 47, XXX patients. Clinical report of four new cases.] Archivos Argentinos de Pediatría, 108(4), e88–e91. [URL]
    • Gravholt, C. H. (2008). Epidemiology of Turner syndrome. The Lancet Oncology, 9(3), 193–195. [DOI:10.1016/s1470-2045(08)70045-7]
    • Hughes, I. A. (2010). Evaluation and Management of Disorders of Sex Development. In Brook, C. G. D., Clayton, P. E., & Brown, R. S. (Eds.). Brook’s Clinical Pediatric Endocrinology, 6th Edition (pp. 192–212). Oxford: Wiley-Blackwell. [DOI:10.1002/9781444316728.ch9]
    • Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012). Androgen insensitivity syndrome. The Lancet, 380(9851), 1419–1428. [DOI:10.1016/s0140-6736(12)60071-3]
    • Jacobs, P. A., Maloney, V., Cooke, R., Crolla, J. A., Ashworth, A., & Swerdlow, A. J. (2013). Male breast cancer, age and sex chromosome aneuploidy. British Journal of Cancer, 108(4), 959–963. [DOI:10.1038/bjc.2012.577]
    • Lin, I., Chen, D., Chang, Y., Lee, Y., Su, C., Cheng, C., Tsai, Y., Ng, S., Chen, H., Lee, M., Chen, H., Suen, S., Chen, Y., Liu, T., Chang, C., & Hsu, M. (2015). Hierarchical Clustering of Breast Cancer Methylomes Revealed Differentially Methylated and Expressed Breast Cancer Genes. PLOS ONE, 10(2), e0118453. [DOI:10.1371/journal.pone.0118453]
    • Nakopoulou, L., Panayotopoulou, E. G., Giannopoulou, I., Tsirmpa, I., Katsarou, S., Mylona, E., Alexandrou, P., & Keramopoulos, A. (2006). Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis. Journal of Clinical Pathology, 60(7), 808–815. [DOI:10.1136/jcp.2006.037838]
    • Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell, 9(2), 121–132. [DOI:10.1016/j.ccr.2006.01.013]
    • Sacchi, N. (1993). Constitutional Chromosome Aneuploidy and Cancer. In Kirsch, I. R. (Ed.). The Causes and Consequences of Chromosomal Aberrations (pp. 191–222). Boca Raton: CRC Press. [Google Books]
    • Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008). Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. The Lancet Oncology, 9(3), 239–246. [DOI:10.1016/s1470-2045(08)70033-0]
    • Sirchia, S. M., Tabano, S. M., & Miozzo, M. (2007). BRCA1 and X Chromosome Inactivation: Which is the Link? In Polinsky, K. R. (Ed.). Tumor Suppressor Genes (pp. 5–8). New York: Nova Biomedical Books. [Google Books]
    • Sokol, R. Z. (2012). It’s not all about the testes: medical issues in Klinefelter patients. Fertility and Sterility, 98(2), 261–265. [DOI:10.1016/j.fertnstert.2012.05.026]
    • Spatz, A., Borg, C., & Feunteun, J. (2004). X-Chromosome Genetics and Human Cancer. Nature Reviews Cancer, 4(8), 617–629. [DOI:10.1038/nrc1413]
    • Swerdlow, A. J., Schoemaker, M. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2005). Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study. JNCI: Journal of the National Cancer Institute, 97(16), 1204–1210. [DOI:10.1093/jnci/dji240]
    • Tiefenbacher, K., & Daxenbichler, G. (2008). The Role of Androgens in Normal and Malignant Breast Tissue. Breast Care, 3(5), 325–331. [DOI:10.1159/000158055]
    • Viuff, M. H., Stochholm, K., Lin, A., Berglund, A., Juul, S., & Gravholt, C. H. (2021). Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy. European Journal of Endocrinology, 184(1), 79–88. [DOI:10.1530/eje-20-0702]
    \ No newline at end of file +The Possible Role of a Second X Chromosome in Breast Cancer Risk - Transfeminine Science Link

    The Possible Role of a Second X Chromosome in Breast Cancer Risk

    By Aly | First published April 25, 2020 | Last modified March 1, 2023

    Preface

    This is a short supplement article to the section in the main article on breast cancer risk with hormone therapy in transfeminine people that can be found here.

    Introduction

    The sex chromosomes include the X chromosome and the Y chromosome. Under normal biological circumstances, cisgender women have two X chromosomes (46,XX karyotype) while cisgender men (and transfeminine people) have one X chromosome and one Y chromosome (46,XY karyotype). The sex chromosomes determine whether the gonads will differentiate into ovaries or testes, and hence mediate a large portion of physical sexual dimorphism. However, the sex chromosomes also have effects in terms of sexual dimorphism that are independent of gonadal differentiation. Although hormone therapy appears to increase the risk of breast cancer in transfeminine people, so far breast cancer risk in transfeminine people seems to be much lower than that in cisgender women. There are a variety of possible reasons for this, as touched on elsewhere. One reason may be our lack of a second X chromosome—there is indication that our absence of a second X chromosome may be partially protective against breast cancer.

    X Chromosome Abnormalities and Breast Cancer

    The incidence of abnormal numbers of X chromosomes in cells (e.g., 45,X or 47,XXX karyotype) increases naturally with age (Barrios et al., 1991; Jacobs et al., 2013). X-chromosome gain is associated with more aggressive and poorly prognostic female breast cancer (Nakopoulou et al., 2007). Aberrant patterns of X-chromosome inactivation have been observed in female breast cancer cell lines and tissue specimens and are associated with worse survival rates (Lin et al., 2015; Chaligné et al., 2015). High incidence of X-chromosome gain has been observed in male breast cancer but not in control gynecomastic breast tissue (Di Oto et al., 2015; Di Oto et al., 2018). Additional findings and readings on X-chromosome abnormalities in breast cancer also exist (e.g., Spatz, Borg, & Feunteun, 2004; Sirchia, Tabano, & Miozzo, 2007; Chaligné & Heard, 2014; Richardson et al., 2006; Dawson, 1998).

    X Chromosomes and Breast Cancer Risk in Chromosomal Disorders and Intersexuality

    A variety of genetic disorders involving abnormal sex-chromosome configurations and/or intersexuality also provide insight on the possible involvement of X chromosomes in breast cancer risk. These conditions include Klinefelter’s syndrome (47,XXY male), complete androgen insensitivity syndrome (46,XY female), Turner syndrome (45,X or mixed 45,X/46,XX female), XX male syndrome (46,XX male), and X trisomy and tetrasomy (47,XXX and 48,XXXX female).

    Klinefelter’s Syndrome (47,XXY)

    Men with Klinefelter’s syndrome have a 47,XXY karyotype and hence an extra X chromosome. Because of their Y chromosome, men with Klinfelter’s syndrome have testes and develop normally as males. However, they have relatively low testosterone levels (about 260 ng/dL lower than usual), slightly increased estradiol levels (about 6 pg/mL more than normal), an increased ratio of estradiol to testosterone, and negligible progesterone (Wiki). In addition, men with Klinefelter’s syndrome show undermasculinization and sometimes have mild gynecomastia. The risk of breast cancer in men with Klinefelter’s syndrome is strongly increased relative to 46,XY men (Brinton, 2011; Sokol, 2012). The risk is estimated to be 20- to 60-fold higher in men with Klinefelter’s syndrome compared to 46,XY men and only 70% lower than the risk in 46,XX women (Brinton, 2011; Sokol, 2012; Swerdlow et al., 2005). The lifetime risk of breast cancer in men with Klinefelter’s syndrome is 4 to 8% (Sokol, 2012). Breast cancer risk in men with Klinefelter’s syndrome is much higher than that in almost any other known clinical situation in men. The typical age of diagnosis of breast cancer in men with Klinefelter’s syndrome is 58 years (Ferzoco & Ruddy, 2016). It is estimated that 7% of all men with breast cancer have Klinefelter’s syndrome (Ferzoco & Ruddy, 2016). Klinefelter’s syndrome suggests that breast cancer may be dependent on an extra X chromosome (Spatz, Borg, & Feunteun, 2004; Sacchi, 1993; Dawson, 1998), although disordered hormone levels may also be involved.

    Complete Androgen Insensitivity Syndrome (46,XY)

    Women with complete androgen insensitivity syndrome (CAIS) are individuals with a 46,XY karyotype and intra-abdominal testes who have a defective androgen receptor and hence are insensitive to the effects of androgens like testosterone. Due to their androgen insensitivity, CAIS women develop physically and behaviorally as females instead of as males. CAIS women naturally have male-range levels of sex hormones, including of testosterone, estradiol, and progesterone (Wiki). Relative to 46,XX women, testosterone levels are very high, estradiol levels relatively low (~35 pg/mL), and progesterone levels negligible. During adolescence, CAIS women undergo female puberty due to aromatization of testosterone into estradiol, and this results in feminization and excellent breast development, with breasts that are said to be somewhat above-average compared to those of 46,XX women.

    After puberty, all clinically diagnosed CAIS women undergo gonadectomy due to a high risk of testicular cancer that’s associated with their intra-abdominal testes. Following gonadectomy, CAIS women receive estrogen replacement therapy, oftentimes if not usually only at menopausal doses. A progestogen is not usually included since CAIS women don’t have uteruses and hence don’t require the endometrial protection afforded by progestogens. Despite a 1 in 20,000 incidence of CAIS in 46,XY individuals and hence the estimated existence of hundreds of thousands of CAIS women throughout the world, breast cancer has never been reported in a CAIS woman (Hughes et al., 2012; Tiefenbacher & Daxenbichler, 2008; Hughes, 2009). It’s unlikely that breast cancer doesn’t occur in women with CAIS, but rather it’s probable that it’s rare. It’s unknown why this is the case, but major possible reasons include the relatively low estrogen exposure, lack of progesterone, and the lack of a second X chromosome. Their androgen insensitivity is unlikely to be involved as androgens, via activation of the androgen receptor, are thought to be protective in terms of breast cancer risk (Dimitrakakis, 2011). CAIS women are fascinating because they suggest that considerable breast cancer incidence isn’t an inevitable companion of normal breast development.

    Turner Syndrome (45,X or Mixed 45,X/46,XX)

    Women with Turner syndrome have either a 45,X karyotype or a mosaic of 45,X and 46,XX karyotypes. They often though not always have gonadal failure and hence many of them fail to undergo puberty. Gonadal failure is much more prevalent in those with a 45,X karyotype than in mosaics. When gonadal failure occurs, hormone therapy is required. Women with Turner’s syndrome have uteruses, so those who have pubertal failure receive hormone replacement with both an estrogen and a progestogen. As with CAIS women, this is often with only menopausal replacement doses. The risk of breast cancer appears to be lower in women with Turner syndrome than in regular 46,XX women (Schoemaker et al., 2008; Bösze, Tóth, & Török, 2006; Viuff et al., 2020). For example, in one large cohort study of 3,425 women with Turner syndrome and an average of 17 years of follow up, the risk of breast cancer was significantly lower than in regular 46,XX women. Interestingly, the standardized incidence ratios were 0.2 (0.0–0.9) in those with a 45,X karyotype and 0.9 (0.3–2.0) in those with 45,X and 46,XX mosaicism. In other words, those with mosaicism had a risk of breast cancer similar to that of regular 46,XX women, whereas those with a 45,X chromosome had a significantly lower risk (Gravholt, 2008).

    XX Male Syndrome (46,XX)

    XX males have a 46,XX karyotype. In about 90% of cases, the condition is caused by translocation of the SRY gene, which encodes the protein testis-determining factor (TDF), onto an X chromosome. As a result of this, XX males develop testes instead of ovaries, in turn developing as males instead of as females. Three case reports of breast cancer in 46,XX males exist (Berglund et al., 2017). On the basis of these cases and the small total number of cases of XX male syndrome that have been reported, it has been said that XX males are at increased risk for breast cancer analogously to men with Klinefelter’s syndrome (Spatz, Borg, & Feunteun, 2004; Giammarini, 1980).

    X Trisomy (47,XXX) and Tetrasomy (48,XXXX)

    So far there is no evidence of increased breast cancer risk in 47,XXX (X trisomy) or 48,XXXX (X tetrasomy) females (Spatz, Borg, & Feunteun, 2004), although most cases of these syndromes go undetected and the conditions are understudied (Goldschmidt et al., 2010; Wiki). Additional X chromosomes are inactivated in these individuals, limiting—although not fully eliminating—phenotypical abnormalities, possibly including greater breast cancer risk.

    Conclusions

    Taken together, these findings from chromosomal disorders and intersex conditions suggest that having at least two X chromosomes may greatly increase the risk of breast cancer. In addition, CAIS women suggest that normal breast development with very low breast cancer risk is possible, provided of course that the person has only one X chromosome.

    References

    • Barrios, L., Caballín, M., Miró, R., Fuster, C., Guedea, F., Subias, A., & Egozcue, J. (1991). Chromosomal instability in breast cancer patients. Human Genetics, 88(1), 39–41. [DOI:10.1007/bf00204926]
    • Berglund, A., Johannsen, T., Stochholm, K., Aksglaede, L., Fedder, J., Viuff, M., Main, K., & Gravholt, C. (2017). Incidence, prevalence, diagnostic delay, morbidity, mortality and socioeconomic status in males with 46,XX disorders of sex development: a nationwide study. Human Reproduction, 32(8), 1751–1760. [DOI:10.1093/humrep/dex210]
    • Bösze, P., Tóth, A., & Török, M. (2006). Hormone Replacement and the Risk of Breast Cancer in Turner’s Syndrome. New England Journal of Medicine, 355(24), 2599–2600. [DOI:10.1056/nejmc062795]
    • Brinton, L. A. (2011). Breast cancer risk among patients with Klinefelter syndrome. Acta Paediatrica, 100(6), 814–818. [DOI:10.1111/j.1651-2227.2010.02131.x]
    • Chaligné, R., & Heard, E. (2014). X-chromosome inactivation in development and cancer. FEBS Letters, 588(15), 2514–2522. [DOI:10.1016/j.febslet.2014.06.023]
    • Chaligné, R., Popova, T., Mendoza-Parra, M., Saleem, M. M., Gentien, D., Ban, K., Piolot, T., Leroy, O., Mariani, O., Gronemeyer, H., Vincent-Salomon, A., Stern, M., & Heard, E. (2015). The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer. Genome Research, 25(4), 488–503. [DOI:10.1101/gr.185926.114]
    • Dawson, P. J. (1998). A history of cancer of the male breast. In Peters, W. P., & Visscher, D. W. (Eds.). Breast Cancer (Advances in Oncobiology, Volume 2) (pp. 229–243). Stamford/London: Jai Press. [DOI:10.1016/s1569-254x(98)80011-3] [Google Books]
    • Di Oto, E., Monti, V., Cucchi, M. C., Masetti, R., Varga, Z., & Foschini, M. P. (2015). X chromosome gain in male breast cancer. Human Pathology, 46(12), 1908–1912. [DOI:10.1016/j.humpath.2015.08.008]
    • Di Oto, E., Biserni, G. B., Varga, Z., Morandi, L., Cucchi, M. C., Masetti, R., & Foschini, M. P. (2018). X chromosome gain is related to increased androgen receptor expression in male breast cancer. Virchows Archiv, 473(2), 155–163. [DOI:10.1007/s00428-018-2377-2]
    • Dimitrakakis, C. (2011). Androgens and Breast Cancer in Men and Women. Endocrinology and Metabolism Clinics of North America, 40(3), 533–547. [DOI:10.1016/j.ecl.2011.05.007]
    • Ferzoco, R. M., & Ruddy, K. J. (2015). The Epidemiology of Male Breast Cancer. Current Oncology Reports, 18(1), 1. [DOI:10.1007/s11912-015-0487-4]
    • Giammarini, A., Rocchi, M., Zennaro, W., & Filippi, G. (2008). XX Male with breast cancer. Clinical Genetics, 18(2), 103–108. [DOI:10.1111/j.1399-0004.1980.tb01019.x]
    • Goldschmidt, E., Márquez, M., Solari, A., Ziembar, M. I., & Laudicina, A. (2010). Variabilidad fenotípica en pacientes 47, XXX: Presentación de cuatro casos nuevos. [Phenotypic variability in 47, XXX patients. Clinical report of four new cases.] Archivos Argentinos de Pediatría, 108(4), e88–e91. [URL]
    • Gravholt, C. H. (2008). Epidemiology of Turner syndrome. The Lancet Oncology, 9(3), 193–195. [DOI:10.1016/s1470-2045(08)70045-7]
    • Hughes, I. A. (2010). Evaluation and Management of Disorders of Sex Development. In Brook, C. G. D., Clayton, P. E., & Brown, R. S. (Eds.). Brook’s Clinical Pediatric Endocrinology, 6th Edition (pp. 192–212). Oxford: Wiley-Blackwell. [DOI:10.1002/9781444316728.ch9]
    • Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012). Androgen insensitivity syndrome. The Lancet, 380(9851), 1419–1428. [DOI:10.1016/s0140-6736(12)60071-3]
    • Jacobs, P. A., Maloney, V., Cooke, R., Crolla, J. A., Ashworth, A., & Swerdlow, A. J. (2013). Male breast cancer, age and sex chromosome aneuploidy. British Journal of Cancer, 108(4), 959–963. [DOI:10.1038/bjc.2012.577]
    • Lin, I., Chen, D., Chang, Y., Lee, Y., Su, C., Cheng, C., Tsai, Y., Ng, S., Chen, H., Lee, M., Chen, H., Suen, S., Chen, Y., Liu, T., Chang, C., & Hsu, M. (2015). Hierarchical Clustering of Breast Cancer Methylomes Revealed Differentially Methylated and Expressed Breast Cancer Genes. PLOS ONE, 10(2), e0118453. [DOI:10.1371/journal.pone.0118453]
    • Nakopoulou, L., Panayotopoulou, E. G., Giannopoulou, I., Tsirmpa, I., Katsarou, S., Mylona, E., Alexandrou, P., & Keramopoulos, A. (2006). Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis. Journal of Clinical Pathology, 60(7), 808–815. [DOI:10.1136/jcp.2006.037838]
    • Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., & Ganesan, S. (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell, 9(2), 121–132. [DOI:10.1016/j.ccr.2006.01.013]
    • Sacchi, N. (1993). Constitutional Chromosome Aneuploidy and Cancer. In Kirsch, I. R. (Ed.). The Causes and Consequences of Chromosomal Aberrations (pp. 191–222). Boca Raton: CRC Press. [Google Books]
    • Schoemaker, M. J., Swerdlow, A. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2008). Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. The Lancet Oncology, 9(3), 239–246. [DOI:10.1016/s1470-2045(08)70033-0]
    • Sirchia, S. M., Tabano, S. M., & Miozzo, M. (2007). BRCA1 and X Chromosome Inactivation: Which is the Link? In Polinsky, K. R. (Ed.). Tumor Suppressor Genes (pp. 5–8). New York: Nova Biomedical Books. [Google Books]
    • Sokol, R. Z. (2012). It’s not all about the testes: medical issues in Klinefelter patients. Fertility and Sterility, 98(2), 261–265. [DOI:10.1016/j.fertnstert.2012.05.026]
    • Spatz, A., Borg, C., & Feunteun, J. (2004). X-Chromosome Genetics and Human Cancer. Nature Reviews Cancer, 4(8), 617–629. [DOI:10.1038/nrc1413]
    • Swerdlow, A. J., Schoemaker, M. J., Higgins, C. D., Wright, A. F., & Jacobs, P. A. (2005). Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study. JNCI: Journal of the National Cancer Institute, 97(16), 1204–1210. [DOI:10.1093/jnci/dji240]
    • Tiefenbacher, K., & Daxenbichler, G. (2008). The Role of Androgens in Normal and Malignant Breast Tissue. Breast Care, 3(5), 325–331. [DOI:10.1159/000158055]
    • Viuff, M. H., Stochholm, K., Lin, A., Berglund, A., Juul, S., & Gravholt, C. H. (2021). Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy. European Journal of Endocrinology, 184(1), 79–88. [DOI:10.1530/eje-20-0702]
    \ No newline at end of file diff --git a/transfemscience.org/articles/breast-cancer/index.html b/transfemscience.org/articles/breast-cancer/index.html index 7fc705be..94cc1ac2 100644 --- a/transfemscience.org/articles/breast-cancer/index.html +++ b/transfemscience.org/articles/breast-cancer/index.html @@ -1 +1 @@ -Breast Cancer Risk with Hormone Therapy in Transfeminine People - Transfeminine Science Link

    Breast Cancer Risk with Hormone Therapy in Transfeminine People

    By Aly | First published April 25, 2020 | Last modified May 8, 2023

    Abstract / TL;DR

    Estrogens and progestogens induce breast development and this may also increase the risk of breast cancer. Breast cancer risk increases exponentially with age in both women and men and is far greater in women than in men. Estrogens and progestogens have been linked to risk of breast cancer in numerous contexts, for instance ovarian activity, menopausal hormone therapy, antiestrogen therapy, and high-dose estrogen therapy, among others. Only a handful of studies have assessed the influence of estrogens and/or progestogens on breast cancer risk in transfeminine people. The available data are limited and have methodological limitations, but the best available evidence suggests that estrogen and progestogen therapy strongly increases the risk of breast cancer in transfeminine people, with the risk lying somewhere intermediate between that of cisgender women and cisgender men. More research is necessary to better-characterize the risk of breast cancer with hormone therapy in transfeminine people, particularly with longer follow-ups and different hormonal regimens (e.g., estrogen alone versus estrogen plus progestogen). Factors likely to modify breast cancer risk in transfeminine people include duration of hormone therapy, age at start of hormone therapy, concomitant long-term progestogen use, and dosages of estrogens and/or progestogens. Having a single X chromosome (as in transfeminine people and cisgender men) instead of having two (as in cisgender women) may be partially protective against breast cancer. Although the risk of breast cancer is likely increased in transfeminine people, the lifetime incidence is likely low, many years of hormonal exposure are likely required for the risk to accumulate, occurrence is usually in older age, and breast cancer is highly treatable. As such, concerns about breast cancer risk do not preclude hormone therapy for transfeminine people. In any case, breast cancer screening may be advisable in transfeminine people as with cisgender women.

    Introduction

    Estrogens and progestogens induce breast development in humans. This includes major roles for estrogens in pubertal breast development and progestogens in the breast changes that occur during pregnancy in preparation for lactation and breastfeeding. Breast cancer is far more common in cisgender women than in cisgender men, and hormones are well-known to be involved in the development and progression of breast cancer in cisgender women. For these reasons, it’s logical to assume that hormone therapy in transfeminine people might increase the risk of breast cancer. This is a review of this notion and of the available studies on the subject.

    Sex and Age as Breast Cancer Risk Factors

    The normal lifetime risk of breast cancer in women is about 1 in 8 or 12.5% (Ban & Godellas, 2014), whereas the normal lifetime risk of breast cancer in men is about 1 in 1,000 or 0.1% (Abdelwahab Yousef, 2017). The overall age-standardized risk of breast cancer in men is about 1 in 100,000 person–years (PY) (Abdelwahab Yousef, 2017; Ottini & Capalbo, 2017). In other words, 1 in 100,000 men are diagnosed with breast cancer every year on average. Fewer than 1% of all cases of breast cancer are in men (Abdelwahab Yousef, 2017; Sun et al., 2017). Thus, breast cancer is frequent in women but is extremely rare in men.

    After sex, age is the strongest known risk factor for breast cancer (Momenimovahed & Salehiniya, 2018). Breast cancer risk increases exponentially with age in premenopausal women (Dix & Cohen, 1982). The risk of breast cancer in women is about 1 in 600,000 at age 15; 1 in 75,000 at age 20; 1 in 1,500 at age 30; and 1 in 175 at age 40 (Anders et al., 2009). After menopause, which typically occurs at 50 years of age, breast cancer risk continues to increase but more slowly (Dix & Cohen, 1982; Benz, 2008; Colditz & Rosner, 2000). This is assumed to be due to the much lower levels of estradiol and progesterone in postmenopause (Dix & Cohen, 1982). It has been estimated that if it were not for menopause, there would be 6 times as many cases of breast cancer in women, and hence presumably that a majority of women would develop breast cancer in their lifetimes (Brisken, Hess, & Jeitziner, 2015). Similarly to the case in women, breast cancer risk in men increases exponentially up to about age 65, and thereafter increases somewhat more slowly (Ottini & Capalbo, 2017; Cancer Research UK). This may be related to andropause in older age and consequent lower levels of testosterone and estradiol (Satram, 2006). The typical age of diagnosis of breast cancer is around 60 years in women and 65–70 years in men (Ferzoco & Ruddy, 2016; Giordano, 2018). Figure 1 below shows the risk of breast cancer with age in women and men (Ottini & Capalbo, 2017).

    Figure 1: Age-specific incidence rates per 100,000 for male and female invasive breast cancer in White Americans from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) (2003–2012) (Ottini & Capalbo, 2017). Note that the male breast cancer and female breast cancer lines use different y-axes and corresponding scales (50× larger y-axis interval in the case of female breast cancer).

    Hormone Exposure in Women and Breast Cancer Risk

    Along with sex and age, research strongly implicates ovarian activity and ovarian hormones—like estradiol and progesterone—as major risk factors for breast cancer (Ban & Godellas, 2014). Later menarche, earlier menopause, and breastfeeding—all of which result in reduced lifetime ovarian hormone exposure—are associated with decreased risk of breast cancer (Ban & Godellas, 2014; Momenimovahed & Salehiniya, 2018). Surgical removal of the ovaries before 40 years of age is associated with a 50% decrease in lifetime risk of breast cancer (Ban & Godellas, 2014). Antiestrogens including selective estrogen receptor modulators (SERMs) like tamoxifen and aromatase inhibitors (AIs) like anastrozole can be used prophylactically long-term as chemoprevention against breast cancer in high-risk postmenopausal women, providing 50 to 70% reduction in breast cancer risk (Mocellin, Goodwin, & Pasquali, 2019; Nelson et al., 2019). Long-term estrogen and progestogen treatment has been found to produce breast cancer in non-human primates, and high doses may result in breast cancer developing at an earlier age than usual (Cline, 2007).

    Besides increasing breast cancer risk, ovarian sex hormones stimulate the progression of active breast cancer. Antiestrogens are effective in the treatment of active breast cancer (Lumachi, Santeufemia, & Basso, 2015), and antiprogestogens like onapristone and mifepristone have shown preliminary effectiveness in the treatment of breast cancer as well (Palmieri et al., 2014). Administration of physiological doses of estrogens to women with breast cancer appears to accelerate tumor progression (Herrmann, Adair, & Woodard, 1947; Nathanson, 1947; Gellhorn & Jones, 1949; Nathanson, 1951; Pearson et al., 1954; Pearson & Lipsett, 1956; Kennedy, 1956; Kennedy, 1957; Dworin, 1961; Kennedy, 1962; Green, Sethi, & Lindner, 1964; Kennedy, 1964; Stoll, 1973; Forrest, 1989).

    In accordance with the well-established relationships of ovarian activity and ovarian hormones with breast cancer risk, menopausal hormone therapy is associated with a higher risk of breast cancer in peri- and postmenopausal women (CGHFBC, 2019; Table). This is true both for therapy with an estrogen alone and to a greater extent with the combination of an estrogen and a progestogen (CGHFBC, 2019). In terms of absolute risk of breast cancer with menopausal hormone therapy, the incidence after 20 years of use is about 1.5-fold higher with an estrogen alone and about 2.5-fold higher with an estrogen plus a progestogen per a large recent meta-analysis of all of the available data (CGHFBC, 2019). Hence, the risk of breast cancer is higher with combined estrogen and progestogen therapy than with an estrogen alone. In the past it was thought that progestogens might be protective against breast cancer due to antiestrogenic effects in the breasts (Mauvais-Jarvis, Kuttenn, & Gompel, 1986; Wren & Eden, 1996; Gompel et al., 2002), but this proved not to be the case. The higher risk of breast cancer with menopausal hormone therapy was found to be causal in the Women’s Health Initiative (WHI), at least with the used regimen (specifically conjugated equine estrogens (CEEs) 0.625 mg/day plus medroxyprogesterone acetate (MPA) 2.5 mg/day) (about 1.25-fold higher risk after 5 years of therapy) (WGWHII, 2002; Chlebowski, Aragaki, & Anderson, 2015). The WHI was the largest randomized controlled trial (RCT) of hormone therapy ever conducted and allowed a rare chance to evaluate causation in terms of long-term health effects of hormonal agents.

    For a visualization of breast cancer risk with menopausal hormone therapy, Figure 2 below shows breast cancer risk over time based on modeling and data from the observational Nurses’ Health Study (NHS) (Colditz & Rozner, 2000). As can be seen, menopausal hormone therapy is associated with maintenance of the age-related exponential rate of increase in breast-cancer risk that is normally blunted by the onset of menopause.

    Figure 2: Incidence of breast cancer (in every 100,000 people per year) by age and hormone therapy status and type in postmenopausal women (Colditz & Rosner, 2000). Based on a Poisson regression model using data from the observational Nurses’ Health Study (Colditz & Rosner, 2000).

    Bioidentical hormones like estradiol and progesterone are associated with increased risk of breast cancer similarly to non-bioidentical hormonal agents like CEEs and MPA (CGHFBC, 2019; Table). The risk of breast cancer with estradiol does not appear to be different from that with CEEs (CGHFBC, 2019). Oral progesterone has not been associated with an increase in risk of breast cancer with less than 5 years of therapy on the basis of the available data, which is in contrast to progestins (Aly, 2018; CGHFBC, 2019; Stute, Wildt, & Neulen, 2018; Mirkin, 2018; Fournier et al., 2007). However, oral progesterone is associated with increased risk of breast cancer after more than 5 years of therapy, by which point the risk appears to be similar in magnitude to that with MPA (Aly, 2018; CGHFBC, 2019; Stute, Wildt, & Neulen, 2018; Mirkin, 2018; Fournier et al., 2007). The initial lower relative risk with oral progesterone might be related to the low levels of progesterone that oral progesterone achieves and hence its comparatively weak progestogenic strength (Aly, 2018; Kuhl & Schneider, 2013; Davey, 2018; Wiki; Graphs). As a result, a longer duration of therapy (and/or larger sample sizes) may be necessary before an increase in breast cancer risk with oral progesterone can be properly quantified (Aly, 2018; Kuhl & Schneider, 2013; Davey, 2018). Virtually no data are available on breast cancer risk with non-oral routes of progesterone at present (Aly, 2018; Stute, Wildt, & Neulen, 2018). However, non-oral and fully potent progesterone is anticipated by some researchers to have a similar risk of breast cancer as progestins not only with long-term use but also with short-term exposure (Aly, 2018; Kuhl & Schneider, 2013; Davey, 2018).

    Although the overall evidence including both prospective observational studies and RCTs shows an increased risk of breast cancer with estrogen alone therapy in menopausal women (CGHFBC, 2019), the available RCTs, namely the WHI, have so far been unable to show increased breast cancer risk with estrogen alone and have instead found a significant decrease in risk (RR 0.77, 95% CI 0.64–0.93) (CGHFBC, 2019; Table). Various hypotheses have been advanced to explain the conflicting findings. For instance, the women in the WHI, who constitute the vast majority of the RCT data, were atypical in that they were of relatively old age at start of hormone therapy (average 64 years) and were relatively overweight and obese (CGHFBC, 2019; Kuhl, 2005). Women who are overweight or obese are already at an increased risk of breast cancer and may experience no further increase with estrogen therapy (Kuhl, 2005). And women who have been deprived of estrogens for many years may experience paradoxical inhibitory effects on breast cancer risk, which is in contrast to women who start at menopause (also seen in the observational data) (Prentice, 2008; CGHFBC, 2019). This has been termed the “gap hypothesis” (Palmieri et al., 2014; Mueck & Ruan, 2011). More RCTs are needed to test these theories and determine the influence of estrogens on menopausal breast cancer risk.

    Paradoxically, estrogen and/or progestogen exposure can also decrease breast cancer risk and inhibit breast cancer progression under certain circumstances. For instance, pregnancy lasting more than 34 weeks in young women (<35 years of age) increases breast cancer risk in the short-term (<10 years), but is actually protective against breast cancer in the long-term (>20–25 years), with an up to 50% reduction in lifetime risk (Nichols et al., 2019; Husby et al., 2018). Extremely high levels of estrogens and progesterone occur during pregnancy (e.g., >12,500 pg/mL for estradiol at >34 weeks) (Graph), and animal studies suggest that these hormones are responsible for the protection (Rajkumar et al., 2003; Hilakivi-Clarke et al., 2012). High-dose estrogen therapy is an effective treatment against breast cancer in women who are at least 5 years postmenopausal, with similar effectiveness to antiestrogen therapy (Coelingh Bennink et al., 2017; Wiki). Conversely, high-dose estrogen therapy is not effective for breast cancer in premenopausal women, although it does work if massive doses are given (Coelingh Bennink et al., 2017; Wiki). However, these beneficial effects of estrogens and progestogens against breast cancer risk and progression occur under unusual circumstances (e.g., very high levels/doses and/or prolonged prior sex-hormone deficiency) and are not likely to be of relevance to transfeminine people.

    Estrogen Exposure in Men and Breast Cancer Risk

    In cisgender men, conditions related to lower androgen exposure and/or higher estrogen exposure are associated with increased risk of breast cancer (Ferzoco & Ruddy, 2016). These conditions include testicular problems and removal as well as liver disease (Abdelwahab Yousef, 2017). Testicular dysfunction and absence result in decreased androgen levels, while liver disease results in higher estrogen levels due to impaired metabolism of estrogens. Both types of conditions result in an increased ratio of estrogens to androgens, in turn causing greater estrogenic stimulation of the breasts. This is presumably responsible for the increased breast cancer risk. Breast conditions in men, like benign breast disease and gynecomastia, have also been associated with breast cancer risk (Sasco, Lowenfels, & Pasker-De Jong, 1993), although findings are mixed for gynecomastia (Giordano, 2005). In addition to health conditions, high-dose estrogen therapy for prostate cancer has been associated with increased breast cancer risk in cisgender men (Thellenberg et al., 2003; Karlsson et al., 2006).

    Studies of Breast Cancer Risk in Transfeminine People

    A companion doc for this article with a table of available studies on the risk of breast cancer with hormone therapy in transfeminine people can be found here. To date, three large cohorts and several smaller cohorts have evaluated breast cancer risk with transfeminine hormone therapy.

    Vrije Universiteit University Medical Center (VUMC) Studies

    Most of the studies in the table are by the Vrije Universiteit University Medical Center (VUMC) in Amsterdam, the Netherlands (Asscheman, Gooren, & Eklund, 1989; van Kesteren et al., 1997; Mueller & Gooren, 2008; Asscheman et al., 2011; Gooren et al., 2013; de Blok et al., 2018; de Blok et al., 2019). This clinic treats 95% of transgender people in the Netherlands (de Blok et al., 2019). The studies by the VUMC are all on largely the same evolving cohort of transgender women. For a couple of decades, the VUMC reported a low incidence of breast cancer that was not much higher than the rate expected in cisgender men (only 2 reported cases in 2,300 transgender women over an average duration of hormone therapy of about 20 years) (Gooren et al., 2013). The typical regimen used by the clinic was estrogen and high-dose cyproterone acetate. The studies did not did not use systematic screening for breast cancer and instead presumably relied on patient report for breast cancer diagnosis, raising the possibility of under-detection of cases (Feldman et al., 2016).

    In 2019, the VUMC did another follow-up study but this time switched to a new method of obtaining breast cancer diagnoses (de Blok et al., 2019). Instead of simply asking patients whether they’d been diagnosed with breast cancer, the researchers retrieved breast cancer diagnoses using an electronic system of patient records for all of the Netherlands called the Nationwide Network and Registry of Histopathology and Cytopathology in the Netherlands (PALGA). When they did this, their number of breast cancer cases shot up from 2 to 15. This resulted in a relative risk of breast cancer of almost 50-fold the expected risk and an absolute incidence of roughly 0.6% over a mean duration of hormone therapy of about 15 years. These findings supersede all of the previous research by the clinic and indicate that the true number of breast cancer cases in the VUMC cohort had been greatly underestimated in their previous studies. Very large increases in risk, such as the risk of lung cancer with smoking and the nearly 50-fold increase in breast cancer risk in this study, can be considered as likely causal. Accordingly, the increase in risk has been described by researchers using causal language (de Blok et al., 2019; Reactions Weekly, 2019). Prior to this study, it was thought that the increase in risk of breast cancer with hormone therapy in transfeminine people was low, but due to the new data, it’s now known that this isn’t necessarily the case (de Blok, Dreijerink, & Heijer, 2019).

    Veterans Health Administration (VHA) Study

    Another large cohort is the Veterans Health Administration (VHA) cohort in the United States (Brown & Jones, 2015; Brown, 2015). In 2015, a study was published using data from this cohort. The researchers reported 3 cases of breast cancer in about 3,500 people assigned male at birth with mean follow-up time of approximately 10 years. Hence, there was a rate of about 0.09% over an average duration of 10 years. Although the mean duration of follow up was shorter than in the VUMC cohort, the total follow-up time was similar. The VHA researchers reported the incidence of breast cancer as increased by 33-fold relative to the expected rate. This is somewhat strange in that it’s discrepant with the VUMC’s 2018 numbers (which reported a 46-fold increased risk based on diagnosis in 15 of 2,300 people and mean follow-up time of 15 years). In any case, the VHA concluded that the risk of breast cancer in transfeminine people was higher than that in cisgender men and higher than that reported by the earlier VUMC studies, but still lower than the risk in cisgender women.

    The VHA paper provided no specifics on what hormone therapy medications and doses were used, although since it included all patients treated by providers in the VHA system, the regimens are likely to have been quite variable. Because this was the United States, the typical regimen was probably estrogen plus spironolactone and no progestogen.

    There are a variety of problems with the VHA study that require discussion:

    • As with the earlier VUMC studies, the VHA study did not use systematic screening for breast cancer and presumably relied on patient report for breast cancer diagnoses, raising the possibility of under-detection of cases (Feldman et al., 2016).
    • The study was irrespective of hormone therapy (Feldman et al., 2016). Only some people in the cohort were on hormone therapy while others were not, and the researchers didn’t have full numbers on who was and who wasn’t. Moreover, an unknown percentage of people included in the cohort weren’t actually transgender—the researchers also included all cisgender men in the VHA system with a “transgender-related” diagnosis, which included transvestic fetishism (a.k.a. sexual crossdressing). Most of these individuals presumably were not on hormone therapy.
    • The follow-up times for those who were definitely on hormone therapy were very short. Of about 1,400 transfeminine people in the VHA cohort who were certainly on hormone therapy, the mean duration of use was only 5.5 years, and was less than 3 years for nearly half of the sample.
    • The VHA paper was very confusing and unclear. As an example, they misgendered transgender people, referring to them as “male” and “female” per birth sex, and wrote in such a way that made it difficult to understand who was who as well as who was and was not actually on hormone therapy. This was such that even some citing publications reporting on the study mistakenly got the risks for “male” and “female” switched (e.g., Dente et al., 2019).
    • To add further confusion, the VHA researchers reported 33 total cases of breast cancer in the exact same cohort of 5,100 total people assigned male or female at birth in two other papers published around the same time (Brown & Jones, 2014; Brown & Jones, 2016). For comparison, they only reported 10 total cases in the 2015 paper (3 in those assigned male at birth and 7 in people assigned female at birth). The reason for this discrepancy is unknown (Braun et al., 2017).

    Due to the various problems with the VHA study, its findings are of limited usefulness and should likely be considered with caution. The 2019 VUMC findings are of far better-quality data.

    Kaiser Permanente in California and Georgia Study

    The third and final large cohort study was by Kaiser Permanente in Northern California, Southern California, and Georgia in the United States (Silverberg et al., 2017). They reported the incidences of a variety of cancers in a combined cohort from three Kaiser sites consisting of about 2,800 transfeminine people. The mean duration of follow up in the study was only 4 years. The researchers did not report the incidence of any cancer that had an absolute occurrence of less than 5 cases, and breast cancer in transfeminine people was not included in the relevant table of results nor in the discussion in the paper. Hence, there were presumably fewer than 5 cases of breast cancer in the cohort of transfeminine people. However, T’Sjoen and colleagues, a very reputable group of researchers in the field of transgender medical research, reported in a citing publication that the Kaiser team found a higher risk of breast cancer in transfeminine people compared to cisgender men but a lower risk compared to cisgender women (T’Sjoen et al., 2019). Assuming this is accurate, which it likely is, the information was presumably obtained via personal communication with the Kaiser researchers. Limitations of the Kaiser study include lack of exact figures on breast cancer risk and a very short follow-up duration. In addition, cancer diagnoses were retrieved only from Kaiser’s own systems, and the extent to which screening was systematic, if at all, is unclear.

    The Kaiser researchers plan to do further studies in much larger cohorts via expansion to additional sites in the future (Silverberg et al., 2017). This is an exciting development, and should hopefully give us additional data on health risks in transgender people, including of breast cancer risk.

    Small Cohort Studies

    The remaining investigations of breast cancer risk in transfeminine people were small. One was 50 post-SRS transgender women by the Ghent University Hospital in Belgium who were followed up for an average of 11.4 years each, in whom no cases of breast cancer were seen (Wierckx et al., 2012). Another was 60 transgender women by the University Hospital Erlangen in Germany (Dittrich et al., 2005). No cases were seen in this cohort either, although the treatment period was only 2 years. The last was Harry Benjamin’s patient cohort; he communicated in his 1960s publications that he had treated about 150 transgender women with “medium to fairly large doses of estrogen” for varying periods of time (e.g., 3 months to 12 years) and hadn’t encountered any cases of breast cancer (Benjamin, 1964; Benjamin, 1966; Gooren et al., 2013). These cohorts are all too small and limited to provide meaningful quantification of breast cancer risk in transfeminine people.

    Discussion of the Available Studies

    Inconclusive Quantification of Breast Cancer Risk Due to Short Follow-Up Times

    The available studies on breast cancer risk in transfeminine people are inconclusive due to inadequate follow-up times (de Blok, Dreijerink, & Heijer, 2019; Mueller & Gooren, 2008; Gooren, 2011; Gooren et al., 2013; Brown & Jones, 2015). For instance the average durations of hormone therapy in the VUMC and VHA studies were only 10 to 20 years. Breast cancer incidence in cisgender women increases exponentially over decades during premenopause and is very rare until older age. The typical age of breast cancer diagnosis in cisgender women is 60 years, which includes about 50 years of premenopausal hormone exposure and about 10 years of postmenopausal hormone exposure. (The latter of which is not unimportant, as demonstrated by the greatly decreased risk of breast cancer with prophylactic antiestrogen therapy.) As such, due to the short follow-up times of the available studies of transfeminine hormone therapy and breast cancer risk, the true or lifetime risk of breast cancer in transfeminine people is not yet known (Mueller & Gooren, 2008).

    We do know however that hormone therapy in transfeminine people, at least with an estrogen plus a progestogen in the form of cyproterone acetate, appears to strongly increase the risk of breast cancer within about 15 years of use (de Blok, Dreijerink, & Heijer, 2019). Fortunately, the risk is intermediate between that in cisgender women and that in cisgender men (and not, e.g., greater than that in cisgender women). At the same time however, the risk is non-negligible, and the absolute incidence will only increase with longer follow-up times. In terms of lifetime risk, the incidence of breast cancer in transfeminine people is well on-track to be as high as single-digit percentages, at least based on the findings of de Blok et al. (2019) and their particular hormone therapy regimen.

    Breast Cancer Risk in Relation to Lifetime Hormone Exposure

    Transfeminine people may have a lower risk of breast cancer than cisgender women. This may due at least in part to a more limited amount of lifetime hormone exposure (Mueller & Gooren, 2008). This is based on the fact that, at least historically, transfeminine people have started hormone therapy on average at 30 or 40 years of age, which is decades after the age at which cisgender girls normally undergo puberty (Mueller & Gooren, 2008). Additionally, youth may represent a critical window of susceptibility for breast cancer risk (Biro & Wolff, 2011; Biro & Deardorff, 2013; Biro et al., 2020). However, the age at start of hormone therapy in transfeminine people has been decreasing in recent times (Mueller & Gooren, 2008), and nowadays many start hormones in their teens or early twenties. These individuals will have greater lifetime hormone exposure, and presumably greater breast cancer risk, than many of the transfeminine people of the past (Sutherland et al., 2020). Moreover, transfeminine people may be much less inclined to stop hormone therapy at the normal age of menopause in cisgender women (Mueller & Gooren, 2008). Many transfeminine people will likely stay on hormone therapy their entire lives. This additional exposure may further increase breast cancer risk (Mueller & Gooren, 2008).

    Breast Cancer Risk in Relation to Progestogens and Dosage

    Based on findings that breast cancer risk is higher with an estrogen plus progestogen relative to an estrogen alone in menopausal women, the risk of breast cancer with hormone therapy in transfeminine people may likewise be higher with combined estrogen and progestogen therapy (de Blok, Dreijerink, & Heijer, 2019). Hence, it’s possible that estrogen therapy without a progestogen could have a lower risk of breast cancer than that observed by the VUMC with an estrogen plus cyproterone acetate (de Blok, Dreijerink, & Heijer, 2019). It’s notable also that the doses of cyproterone acetate used by the VUMC result in rather extreme progestogenic exposure (Aly, 2019). The extent to which breast cancer risk with progestogens is dose-dependent is unknown. Whether or not estrogen dosage influences breast cancer risk, or if higher levels have greater risk, is unclear similarly. In any case, the fact that the use of estrogen–progestogen birth control in premenopausal women is associated with increased risk of breast cancer is suggestive that higher levels of estrogen and/or progestogen exposure may result in some degree of greater risk (Kahlenborn et al., 2006; Zhu et al., 2012; Ji et al., 2019). In addition, an older observational study reported a 4-fold greater risk of breast cancer in menopausal cisgender women treated with injectable estrogens than with oral estrogens or no hormone therapy (Hulka et al., 1982; Coe & Parks, 1989). This is notable as typical doses of injectable estrogens provide much greater estrogenic exposure than oral and other routes of estrogen (Göretzlehner et al., 2002; Aly, 2021). However, the study has important limitations, including only being a single study and being quite old.

    X Chromosomes and Breast Cancer Risk

    The sex chromosomes include the X chromosome and the Y chromosome. Cisgender women typically have two X chromosomes (46,XX karyotype), while cisgender men (and transfeminine people) typically have one X chromosome and one Y chromosome (46,XY karyotype). It’s possible that a 46,XX karyotype—specifically the presence of a second X chromosome—may be a major risk factor for breast cancer. X-chromosome gain and aberrant X-chromosome inactivation have been associated with breast cancer incidence and aggressiveness (Nakopoulou et al., 2007; Di Oto et al., 2015; Lin et al., 2015; Chaligné et al., 2015; Di Oto et al., 2018). In addition, breast cancer risk is markedly higher in men with Klinefelter’s syndrome (KS), who have a 46,XXY karyotype, than in regular men with a 46,XY karyotype. Conversely, breast cancer has never been reported in women with complete androgen insensitivity syndrome (CAIS), who have a 46,XY karyotype similarly to transfeminine people (Hughes et al., 2012; Tiefenbacher & Daxenbichler, 2008; Hughes, 2009). This is in spite of the fact that CAIS women have excellent breast development (Aly, 2020). However, hormonal abnormalities in people with KS and CAIS may alternatively contribute to differences in breast cancer risk and are thus a confounding variable. It’s notable in particular that CAIS women have relatively low estrogen exposure and little to no progesterone. In any case, the differences in breast cancer risk in conditions like KS and CAIS do not seem to be fully explainable by hormonal abnormalities. Thus, it’s possible that the lack of two X chromosomes in transfeminine people may indeed prove to be partially protective against breast cancer risk. For more in-depth information on this topic, see the supplemental article here.

    Summary and Conclusions

    Breast cancer risk is far higher in women than in men. The incidence of breast cancer increases exponentially with age and is very rare in younger people. There is strong basis to assume that estrogens and progestogens increase the risk of breast cancer, which can be inferred as a major mechanism for the sex differences in breast cancer risk. The available data do not indicate meaningful differences between bioidentical and non-bioidentical hormones in terms of breast cancer risk.

    Older studies of transfeminine hormone therapy and breast cancer risk found low incidences of breast cancer in transfeminine people. However, a recent study with better methodology than previous studies showed a nearly 50-fold increase in breast cancer risk. The hormone therapy regimen used by their cohort was specifically estrogen plus cyproterone acetate. It’s unknown whether other hormonal regimens, for instance estrogen alone or with a non-progestogenic antiandrogen, have similar risks. The available data on breast cancer risk in transfeminine people are limited by inadequate follow-up times. As a result, lifetime breast cancer risk is unknown. Based on available data however, we can project into the future and assume that the lifetime incidence of breast cancer in transfeminine people may be as high as single-digit percentages. This puts the risk of breast cancer in transfeminine people somewhere between that of cisgender men and cisgender women.

    Various factors may modify breast cancer risk with transfeminine hormone therapy. Examples include cumulative duration of use, age at start of therapy, long-term progestogen use, and possibly dosages of estrogens and/or progestogens. The lack of a second X chromosome in transfeminine people may be partially protective against breast cancer. Although breast cancer risk with transfeminine hormone therapy is something for transfeminine people to be aware of, particularly the probable contribution of progestogens to the risk, the lifetime incidence is likely to be low and the risk appears to be less than that of cisgender women. In addition, it takes many years of hormone exposure for breast cancer to occur and is generally restricted to old age. Also, breast cancer is a highly treatable disease, with excellent 5- and 10-year survival rates (Cancer.Net). For these reasons, concerns about breast cancer should most certainly not preclude hormone therapy for transfeminine people.

    The possibility of breast cancer with hormone therapy in transfeminine people does, however, highlight the importance of routine breast cancer screening in transfeminine people of appropriate age and duration of hormone exposure (Chowdhry & O’Connell, 2020). It’s likely advisable that transfeminine people on long-term hormone therapy follow the same breast cancer screening procedures as those of cisgender women (Chowdhry & O’Connell, 2020).

    References

    • Abdelwahab Yousef, A. J. (2017). Male Breast Cancer: Epidemiology and Risk Factors. Seminars in Oncology, 44(4), 267–272. [DOI:10.1053/j.seminoncol.2017.11.002]
    • Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. (2009). Breast Cancer Before Age 40 Years. Seminars in Oncology, 36(3), 237–249. [DOI:10.1053/j.seminoncol.2009.03.001]
    • Asscheman, H., Gooren, L., & Eklund, P. (1989). Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38(9), 869–873. [DOI:10.1016/0026-0495(89)90233-3]
    • Asscheman, H., Giltay, E. J., Megens, J. A., de Ronde, W., van Trotsenburg, M. A., & Gooren, L. J. (2011). A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 164(4), 635–642. [DOI:10.1530/eje-10-1038]
    • Ban, K. A., & Godellas, C. V. (2014). Epidemiology of Breast Cancer. Surgical Oncology Clinics of North America, 23(3), 409–422. [DOI:10.1016/j.soc.2014.03.011]
    • Benjamin, H. (1964). Clinical Aspects of Transsexualism in the Male and Female. American Journal of Psychotherapy, 18(3), 458–469. [DOI:10.1176/appi.psychotherapy.1964.18.3.458]
    • Benjamin, H. (1966). The Transsexual Phenomenon. New York: Julian Press. [Google Scholar] [Google Books] [PDF]
    • Benz, C. C. (2008). Impact of aging on the biology of breast cancer. Critical Reviews in Oncology/Hematology, 66(1), 65–74. [DOI:10.1016/j.critrevonc.2007.09.001]
    • Biro, F. M., & Wolff, M. S. (2011). Puberty as a Window of Susceptibility. In Russo, J. (Ed.). Environment and Breast Cancer (pp. 29–41). New York: Springer New York. [DOI:10.1007/978-1-4419-9896-5_2]
    • Biro, F. M., & Deardorff, J. (2013). Identifying Opportunities for Cancer Prevention During Preadolescence and Adolescence: Puberty as a Window of Susceptibility. Journal of Adolescent Health, 52(5), S15–S20. [DOI:10.1016/j.jadohealth.2012.09.019]
    • Biro, F. M., Huang, B., Wasserman, H., Gordon, C. M., & Pinney, S. M. (2021). Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk. Journal of Adolescent Health, 68(3), 517–522. [DOI:10.1016/j.jadohealth.2020.07.016]
    • Braun, H., Nash, R., Tangpricha, V., Brockman, J., Ward, K., & Goodman, M. (2017). Cancer in Transgender People: Evidence and Methodological Considerations. Epidemiologic Reviews, 39(1), 93–107. [DOI:10.1093/epirev/mxw003]
    • Brisken, C., Hess, K., & Jeitziner, R. (2015). Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis. Endocrinology, 156(10), 3442–3450. [DOI:10.1210/en.2015-1392]
    • Brown, G. R., & Jones, K. T. (2014). Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Research and Treatment, 149(1), 191–198. [DOI:10.1007/s10549-014-3213-2]
    • Brown, G. R., & Jones, K. T. (2014). Racial Health Disparities in a Cohort of 5,135 Transgender Veterans. Journal of Racial and Ethnic Health Disparities, 1(4), 257–266. [DOI:10.1007/s40615-014-0032-4]
    • Brown, G. R. (2015). Breast Cancer in Transgender Veterans: A Ten-Case Series. LGBT Health, 2(1), 77–80. [DOI:10.1089/lgbt.2014.0123]
    • Brown, G. R., & Jones, K. T. (2016). Mental Health and Medical Health Disparities in 5135 Transgender Veterans Receiving Healthcare in the Veterans Health Administration: A Case–Control Study. LGBT Health, 3(2), 122–131. [DOI:10.1089/lgbt.2015.0058]
    • Cancer Research UK. (2020). Breast cancer incidence (invasive) statistics. Cancer Research UK. [URL]
    • Cancer.Net. (2020). Breast Cancer: Statistics. American Society of Clinical Oncology. [URL]
    • Chaligné, R., Popova, T., Mendoza-Parra, M., Saleem, M. M., Gentien, D., Ban, K., Piolot, T., Leroy, O., Mariani, O., Gronemeyer, H., Vincent-Salomon, A., Stern, M., & Heard, E. (2015). The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer. Genome Research, 25(4), 488–503. [DOI:10.1101/gr.185926.114]
    • Chlebowski, R. T., Aragaki, A. K., & Anderson, G. L. (2015). Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women’s Health Initiative. Journal of the National Comprehensive Cancer Network, 13(7), 917–924. [DOI:10.6004/jnccn.2015.0106]
    • Chowdhry, D. N., & O’Connell, A. M. (2020). Breast Imaging in Transgender Patients. Journal of Breast Imaging, 2(2), 161–167. [DOI:10.1093/jbi/wbz092]
    • Cline, J. M. (2007). Assessing the mammary gland of nonhuman primates: effects of endogenous hormones and exogenous hormonal agents and growth factors. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 80(2), 126–146. [DOI:10.1002/bdrb.20112]
    • Coe, F. L., & Parks, J. H. (1989). The Risks of Oral Contraceptives and Estrogen Replacement Therapy. Perspectives in Biology and Medicine, 33(1), 86–106. [DOI:10.1353/pbm.1990.0026]
    • Coelingh Bennink, H. J., Verhoeven, C., Dutman, A. E., & Thijssen, J. (2017). The use of high-dose estrogens for the treatment of breast cancer. Maturitas, 95, 11–23. [DOI:10.1016/j.maturitas.2016.10.010]
    • Colditz, G. A. (2000). Cumulative Risk of Breast Cancer to Age 70 Years According to Risk Factor Status: Data from the Nurses’ Health Study. American Journal of Epidemiology, 152(10), 950–964. [DOI:10.1093/aje/152.10.950]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, R. H., & den Heijer, M. (2018). Breast cancer in transgender persons receiving gender affirming hormone treatment: results of a nationwide cohort study. Endocrine Abstracts, 56 [20th European Congress of Endocrinology 2018, 19–22 May 2018, Barcelona, Spain], 490–490 (abstract no. P955). [DOI:10.1530/endoabs.56.p955] [PDF]
    • de Blok, C. J., Dreijerink, K. M., & den Heijer, M. (2019). Cancer Risk in Transgender People. Endocrinology and Metabolism Clinics of North America, 48(2), 441–452. [DOI:10.1016/j.ecl.2019.02.005]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, 365, l1652. [DOI:10.1136/bmj.l1652]
    • Dente, E., Farneth, R., Purks, J., & Torelli, S. (2019). Evaluating risks, reported cases and screening recommendations for breast cancer in transgender patients. Georgetown Medical Review, 3(1). [DOI:10.52504/001c.7774]
    • Di Oto, E., Monti, V., Cucchi, M. C., Masetti, R., Varga, Z., & Foschini, M. P. (2015). X chromosome gain in male breast cancer. Human Pathology, 46(12), 1908–1912. [DOI:10.1016/j.humpath.2015.08.008]
    • Di Oto, E., Biserni, G. B., Varga, Z., Morandi, L., Cucchi, M. C., Masetti, R., & Foschini, M. P. (2018). X chromosome gain is related to increased androgen receptor expression in male breast cancer. Virchows Archiv, 473(2), 155–163. [DOI:10.1007/s00428-018-2377-2]
    • Dix, D., & Cohen, P. (1982). The incidence of breast cancer: analysis of the age dependence. Anticancer Research, 2(1-2), 23–7. [Google Scholar] [PubMed] [PDF]
    • Dworin, M. (1961). The Rationale of Endocrine Therapy in Breast Cancer. CA: A Cancer Journal for Clinicians, 11(2), 48–54. [DOI:10.3322/canjclin.11.2.48]
    • Feldman, J., Brown, G. R., Deutsch, M. B., Hembree, W., Meyer, W., Meyer-Bahlburg, H. F., Tangpricha, V., T’Sjoen, G., & Safer, J. D. (2016). Priorities for transgender medical and healthcare research. Current Opinion in Endocrinology, Diabetes & Obesity, 23(2), 180–187. [DOI:10.1097/med.0000000000000231]
    • Ferzoco, R. M., & Ruddy, K. J. (2016). The Epidemiology of Male Breast Cancer. Current Oncology Reports, 18, 1. [DOI:10.1007/s11912-015-0487-4]
    • Forrest, A. P. (1989). Endocrine management of breast cancer. Proceedings of the Royal Society of Edinburgh. Section B. Biological Sciences, 95 [Oestrogen and the Human Breast], 1–10. [DOI:10.1017/s0269727000010502]
    • Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103–111. [DOI:10.1007/s10549-007-9523-x]
    • Gellhorn, A., & Jones, L. O. (1949). Chemotherapy of malignant disease. The American Journal of Medicine, 6(2), 188–231. [DOI:10.1016/0002-9343(49)90017-0]
    • Giordano, S. H. (2005). A Review of the Diagnosis and Management of Male Breast Cancer. The Oncologist, 10(7), 471–479. [DOI:10.1634/theoncologist.10-7-471]
    • Giordano, S. H. (2018). Breast Cancer in Men. New England Journal of Medicine, 378(24), 2311–2320. [DOI:10.1056/nejmra1707939]
    • Gompel, A., Levy, D., Chaouat, M., Kazem, A., Hugol, D., Daraı̈, E., Decroix, Y., & Rostène, W. (2002). Is there a place for progestin agents in breast cancer prevention? International Congress Series, 1229, 143–150. [DOI:10.1016/s0531-5131(01)00467-8]
    • Gooren, L. J. (2011). Care of Transsexual Persons. New England Journal of Medicine, 364(13), 1251–1257. [DOI:10.1056/nejmcp1008161]
    • Gooren, L. J., van Trotsenburg, M. A., Giltay, E. J., & van Diest, P. J. (2013). Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment. The Journal of Sexual Medicine, 10(12), 3129–3134. [DOI:10.1111/jsm.12319]
    • Göretzlehner, G., Ackermann, W., Angelow, K., Bergmann, G., Bieck, E., Golbs, S., & Kliem, O. (2002). Pharmakokinetik von Estron, Estradiol, FSH, LH und Prolaktin nach intramuskulärer Applikation von 5 mg Estradiolvalerat. [Pharmacokinetics of estradiol valerate in postmenopausal women after intramuscular administration.] Journal für Menopause, 9(2), 46–49. [Google Scholar] [URL] [PDF] [Translation]
    • Green, R. B., Sethi, R. S., & Lindner, H. H. (1964). Treatment of advanced carcinoma of the breast. The American Journal of Surgery, 108(1), 107–121. [DOI:10.1016/0002-9610(64)90094-7]
    • Herrmann, J. B. (1947). Effect of estrogenic hormone on advanced carcinoma of the female breast. Archives of Surgery, 54(1), 1–9. [DOI:10.1001/archsurg.1947.01230070004001]
    • Hilakivi-Clarke, L., de Assis, S., Warri, A., & Luoto, R. (2012). Pregnancy hormonal environment and mother’s breast cancer risk. Hormone Molecular Biology and Clinical Investigation, 9(1), 11–23. [DOI:10.1515/hmbci-2012-0019]
    • Hughes, I. A. (2010). Evaluation and Management of Disorders of Sex Development. In Brook, C. G. D., Clayton, P. E., & Brown, R. S. (Eds.). Brook’s Clinical Pediatric Endocrinology, 6th Edition (pp. 192–212). Oxford: Wiley-Blackwell. [DOI:10.1002/9781444316728.ch9]
    • Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012). Androgen insensitivity syndrome. The Lancet, 380(9851), 1419–1428. [DOI:10.1016/s0140-6736(12)60071-3]
    • Hulka, B. S., Chambless, L. E., Deubner, D. C., & Wilkinson, W. E. (1982). Breast cancer and estrogen replacement therapy. American Journal of Obstetrics and Gynecology, 143(6), 638–644. [DOI:10.1016/0002-9378(82)90108-9]
    • Husby, A., Wohlfahrt, J., Øyen, N., & Melbye, M. (2018). Pregnancy duration and breast cancer risk. Nature Communications, 9(1), 4255. [DOI:10.1038/s41467-018-06748-3]
    • Ji, L., Jing, C., Zhuang, S., Pan, W., & Hu, X. (2019). Effect of age at first use of oral contraceptives on breast cancer risk. Medicine, 98(36), e15719–e15719. [DOI:10.1097/md.0000000000015719]
    • Kahlenborn, C., Modugno, F., Potter, D. M., & Severs, W. B. (2006). Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer: A Meta-analysis. Mayo Clinic Proceedings, 81(10), 1290–1302. [DOI:10.4065/81.10.1290]
    • Karlsson, C. T., Malmer, B., Wiklund, F., & Grönberg, H. (2006). Breast Cancer as a Second Primary in Patients With Prostate Cancer—Estrogen Treatment or Association With Family History of Cancer? Journal of Urology, 176(2), 538–543. [DOI:10.1016/j.juro.2006.03.036]
    • Kennedy, B.J. (1956). Effects of steroids in women with breast cancer. In Engle, E. T., & Pincus, G. (Eds.). Hormones and the Aging Process: Proceedings of a Conference Held at Arden House, Harriman, New York, 1955 (pp. 253–272). New York: Academic Press. [Google Scholar] [Google Books]
    • Kennedy, B. J. (1957). The Present Status of Hormone Therapy in Advanced Breast Cancer. Radiology, 69(3), 330–340. [DOI:10.1148/69.3.330]
    • Kennedy, B. J. (1962). Massive estrogen administration in premenopausal women with metastatic breast cancer. Cancer, 15(3), 641–648. [DOI:10.1002/1097-0142(196205/06)15:3<641::aid-cncr2820150330>3.0.co;2-9]
    • Kennedy, B. J. (1964). Estrogenic Hormone Therapy in Advanced Breast Cancer. Annals of Internal Medicine, 60(4), 718–718. [DOI:10.7326/0003-4819-60-4-718_1]
    • Kuhl, H. (2005). Breast cancer risk in the WHI study: The problem of obesity. Maturitas, 51(1), 83–97. [DOI:10.1016/j.maturitas.2005.02.018]
    • Kuhl, H., & Schneider, H. P. (2013). Progesterone – promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]
    • Lin, I., Chen, D., Chang, Y., Lee, Y., Su, C., Cheng, C., Tsai, Y., Ng, S., Chen, H., Lee, M., Chen, H., Suen, S., Chen, Y., Liu, T., Chang, C., & Hsu, M. (2015). Hierarchical Clustering of Breast Cancer Methylomes Revealed Differentially Methylated and Expressed Breast Cancer Genes. PLOS ONE, 10(2), e0118453. [DOI:10.1371/journal.pone.0118453]
    • Lumachi, F. (2015). Current medical treatment of estrogen receptor-positive breast cancer. World Journal of Biological Chemistry, 6(3), 231–239. [DOI:10.4331/wjbc.v6.i3.231]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1986). Antiestrogen action of progesterone in breast tissue. Breast Cancer Research and Treatment, 8(3), 179–188. [DOI:10.1007/bf01807330]
    • Mirkin, S. (2018). Evidence on the use of progesterone in menopausal hormone therapy. Climacteric, 21(4), 346–354. [DOI:10.1080/13697137.2018.1455657]
    • Mocellin, S., Goodwin, A., & Pasquali, S. (2019). Risk-reducing medications for primary breast cancer: a network meta-analysis. Cochrane Database of Systematic Reviews, 2019(4), CD012191. [DOI:10.1002/14651858.cd012191.pub2]
    • Momenimovahed, Z., & Salehiniya, H. (2019). Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy, 11, 151–164. [DOI:10.2147/bctt.s176070]
    • Mueck, A. O., & Ruan, X. (2011). Benefits and risks during HRT: main safety issue breast cancer. Hormone Molecular Biology and Clinical Investigation, 5(2), 105–116. [DOI:10.1515/hmbci.2011.014]
    • Mueller, A., & Gooren, L. (2008). Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 159(3), 197–202. [DOI:10.1530/eje-08-0289]
    • Nakopoulou, L., Panayotopoulou, E. G., Giannopoulou, I., Tsirmpa, I., Katsarou, S., Mylona, E., Alexandrou, P., & Keramopoulos, A. (2006). Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis. Journal of Clinical Pathology, 60(7), 808–815. [DOI:10.1136/jcp.2006.037838]
    • Nathanson, I. T. (1947). Hormonal Alteration of Advanced Cancer of the Breast. Surgical Clinics of North America, 27(5), 1144–1150. [DOI:10.1016/s0039-6109(16)32241-1]
    • Nathanson, I. T. (1951). Sex Hormones and Castration in Advanced Breast Cancer. Radiology, 56(4), 535–552. [DOI:10.1148/56.4.535]
    • Nelson, H. D., Fu, R., Zakher, B., Pappas, M., & McDonagh, M. (2019). Medication Use for the Risk Reduction of Primary Breast Cancer in Women. JAMA, 322(9), 868–886. [DOI:10.1001/jama.2019.5780]
    • Nichols, H. B., Schoemaker, M. J., Cai, J., Xu, J., Wright, L. B., Brook, M. N., Jones, M. E., Adami, H., Baglietto, L., Bertrand, K. A., Blot, W. J., Boutron-Ruault, M., Dorronsoro, M., Dossus, L., Eliassen, A. H., Giles, G. G., Gram, I. T., Hankinson, S. E., Hoffman-Bolton, J., Kaaks, R., Key, T. J., Kitahara, C. M., Larsson, S. C., Linet, M., Merritt, M. A., Milne, R. L., Pala, V., Palmer, J. R., Peeters, P. H., Riboli, E., Sund, M., Tamimi, R. M., Tjønneland, A., Trichopoulou, A., Ursin, G., Vatten, L., Visvanathan, K., Weiderpass, E., Wolk, A., Zheng, W., Weinberg, C. R., Swerdlow, A. J., & Sandler, D. P. (2018). Breast Cancer Risk After Recent Childbirth. Annals of Internal Medicine, 170(1), 22–31. [DOI:10.7326/m18-1323]
    • Ottini, L., & Capalbo, C. (2017). Male Breast Cancer. In Veronesi, U., Goldhirsch, A., Veronesi, P., Gentilini, O. D., & Leonardi, M. C. (Eds.). Breast Cancer: Innovations in Research and Management (pp. 753–762). Cham: Springer. [DOI:10.1007/978-3-319-48848-6_63]
    • Palmieri, C., Patten, D. K., Januszewski, A., Zucchini, G., & Howell, S. J. (2014). Breast cancer: Current and future endocrine therapies. Molecular and Cellular Endocrinology, 382(1), 695–723. [DOI:10.1016/j.mce.2013.08.001]
    • Pearson, O. H. (1954). Evaluation of endocrine therapy for advanced breast cancer. JAMA, 154(3), 234–239. [DOI:10.1001/jama.1954.02940370046013]
    • Pearson, O. H., & Lipsett, M. B. (1956). Endocrine Management of Metastatic Breast Cancer. Medical Clinics of North America, 40(3), 761–772. [DOI:10.1016/s0025-7125(16)34564-3]
    • Prentice, R. L. (2008). Women’s Health Initiative Studies of Postmenopausal Breast Cancer. In Li, J. J., Li, S. A., Mohla, S., Rochefort, H., & Maudelonde, T. (Eds.). Hormonal Carcinogenesis V (Advances in Experimental Medicine and Biology, Volume 617) (pp. 151–160). New York: Springer New York. [DOI:10.1007/978-0-387-69080-3_14]
    • Rajkumar, L., Guzman, R. C., Yang, J., Thordarson, G., Talamantes, F., & Nandi, S. (2003). Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Research, 6(1), R31. [DOI:10.1186/bcr734]
    • Reactions Weekly. (2019). Hormones increase breast cancer risk in Dutch transgender women. Reactions Weekly, 1754, 9–9. [DOI:10.1007/s40278-019-62242-2]
    • Sasco, A. J., Lowenfels, A. B., & Jong, P. P. (1993). Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. International Journal of Cancer, 53(4), 538–549. [DOI:10.1002/ijc.2910530403]
    • Satram, S. (2006). Genetic and environmental factors and male breast cancer risk. (Doctoral dissertation, University of California, Irvine.) [Google Scholar] [URL]
    • Silverberg, M. J., Nash, R., Becerra-Culqui, T. A., Cromwell, L., Getahun, D., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Slovis, J., Tangpricha, V., & Goodman, M. (2017). Cohort study of cancer risk among insured transgender people. Annals of Epidemiology, 27(8), 499–501. [DOI:10.1016/j.annepidem.2017.07.007]
    • Stoll, B. A. (1973). Hypothesis: Breast Cancer Regression under Oestrogen Therapy. BMJ, 3(5877), 446–450. [DOI:10.1136/bmj.3.5877.446]
    • Stute, P., Wildt, L., & Neulen, J. (2018). The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric, 21(2), 111–122. [DOI:10.1080/13697137.2017.1421925]
    • Sun, Y., Zhao, Z., Yang, Z., Xu, F., Lu, H., Zhu, Z., Shi, W., Jiang, J., Yao, P., & Zhu, H. (2017). Risk Factors and Preventions of Breast Cancer. International Journal of Biological Sciences, 13(11), 1387–1397. [DOI:10.7150/ijbs.21635]
    • Sutherland, N., Espinel, W., Grotzke, M., & Colonna, S. (2020). Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults. Journal of Genetic Counseling, 29(4), 625–633. [DOI:10.1002/jgc4.1278]
    • T’Sjoen, G., Arcelus, J., Gooren, L., Klink, D. T., & Tangpricha, V. (2018). Endocrinology of Transgender Medicine. Endocrine Reviews, 40(1), 97–117. [DOI:10.1210/er.2018-00011]
    • Thellenberg, C., Malmer, B., Tavelin, B., & Grönberg, H. (2003). Second Primary Cancers in Men With Prostate Cancer: An Increased Risk of Male Breast Cancer. Journal of Urology, 169(4), 1345–1348. [DOI:10.1097/01.ju.0000056706.88960.7c]
    • Tiefenbacher, K., & Daxenbichler, G. (2008). The Role of Androgens in Normal and Malignant Breast Tissue. Breast Care, 3(5), 325–331. [DOI:10.1159/000158055]
    • Van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47(3), 337–343. [DOI:10.1046/j.1365-2265.1997.2601068.x]
    • Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012). Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons. The Journal of Sexual Medicine, 9(10), 2641–2651. [DOI:10.1111/j.1743-6109.2012.02876.x]
    • Wren, B. G., & Eden, J. A. (1996). Do Progestogens Reduce The Risk of Breast Cancer? A Review of the Evidence. Menopause, 3(1), 4–12. [DOI:10.1097/00042192-199603010-00003]
    • Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321–333. [DOI:10.1001/jama.288.3.321]
    • Zhu, H., Lei, X., Feng, J., & Wang, Y. (2012). Oral contraceptive use and risk of breast cancer: A meta-analysis of prospective cohort studies. The European Journal of Contraception & Reproductive Health Care, 17(6), 402–414. [DOI:10.3109/13625187.2012.715357]
    \ No newline at end of file +Breast Cancer Risk with Hormone Therapy in Transfeminine People - Transfeminine Science Link

    Breast Cancer Risk with Hormone Therapy in Transfeminine People

    By Aly | First published April 25, 2020 | Last modified May 8, 2023

    Abstract / TL;DR

    Estrogens and progestogens induce breast development and this may also increase the risk of breast cancer. Breast cancer risk increases exponentially with age in both women and men and is far greater in women than in men. Estrogens and progestogens have been linked to risk of breast cancer in numerous contexts, for instance ovarian activity, menopausal hormone therapy, antiestrogen therapy, and high-dose estrogen therapy, among others. Only a handful of studies have assessed the influence of estrogens and/or progestogens on breast cancer risk in transfeminine people. The available data are limited and have methodological limitations, but the best available evidence suggests that estrogen and progestogen therapy strongly increases the risk of breast cancer in transfeminine people, with the risk lying somewhere intermediate between that of cisgender women and cisgender men. More research is necessary to better-characterize the risk of breast cancer with hormone therapy in transfeminine people, particularly with longer follow-ups and different hormonal regimens (e.g., estrogen alone versus estrogen plus progestogen). Factors likely to modify breast cancer risk in transfeminine people include duration of hormone therapy, age at start of hormone therapy, concomitant long-term progestogen use, and dosages of estrogens and/or progestogens. Having a single X chromosome (as in transfeminine people and cisgender men) instead of having two (as in cisgender women) may be partially protective against breast cancer. Although the risk of breast cancer is likely increased in transfeminine people, the lifetime incidence is likely low, many years of hormonal exposure are likely required for the risk to accumulate, occurrence is usually in older age, and breast cancer is highly treatable. As such, concerns about breast cancer risk do not preclude hormone therapy for transfeminine people. In any case, breast cancer screening may be advisable in transfeminine people as with cisgender women.

    Introduction

    Estrogens and progestogens induce breast development in humans. This includes major roles for estrogens in pubertal breast development and progestogens in the breast changes that occur during pregnancy in preparation for lactation and breastfeeding. Breast cancer is far more common in cisgender women than in cisgender men, and hormones are well-known to be involved in the development and progression of breast cancer in cisgender women. For these reasons, it’s logical to assume that hormone therapy in transfeminine people might increase the risk of breast cancer. This is a review of this notion and of the available studies on the subject.

    Sex and Age as Breast Cancer Risk Factors

    The normal lifetime risk of breast cancer in women is about 1 in 8 or 12.5% (Ban & Godellas, 2014), whereas the normal lifetime risk of breast cancer in men is about 1 in 1,000 or 0.1% (Abdelwahab Yousef, 2017). The overall age-standardized risk of breast cancer in men is about 1 in 100,000 person–years (PY) (Abdelwahab Yousef, 2017; Ottini & Capalbo, 2017). In other words, 1 in 100,000 men are diagnosed with breast cancer every year on average. Fewer than 1% of all cases of breast cancer are in men (Abdelwahab Yousef, 2017; Sun et al., 2017). Thus, breast cancer is frequent in women but is extremely rare in men.

    After sex, age is the strongest known risk factor for breast cancer (Momenimovahed & Salehiniya, 2018). Breast cancer risk increases exponentially with age in premenopausal women (Dix & Cohen, 1982). The risk of breast cancer in women is about 1 in 600,000 at age 15; 1 in 75,000 at age 20; 1 in 1,500 at age 30; and 1 in 175 at age 40 (Anders et al., 2009). After menopause, which typically occurs at 50 years of age, breast cancer risk continues to increase but more slowly (Dix & Cohen, 1982; Benz, 2008; Colditz & Rosner, 2000). This is assumed to be due to the much lower levels of estradiol and progesterone in postmenopause (Dix & Cohen, 1982). It has been estimated that if it were not for menopause, there would be 6 times as many cases of breast cancer in women, and hence presumably that a majority of women would develop breast cancer in their lifetimes (Brisken, Hess, & Jeitziner, 2015). Similarly to the case in women, breast cancer risk in men increases exponentially up to about age 65, and thereafter increases somewhat more slowly (Ottini & Capalbo, 2017; Cancer Research UK). This may be related to andropause in older age and consequent lower levels of testosterone and estradiol (Satram, 2006). The typical age of diagnosis of breast cancer is around 60 years in women and 65–70 years in men (Ferzoco & Ruddy, 2016; Giordano, 2018). Figure 1 below shows the risk of breast cancer with age in women and men (Ottini & Capalbo, 2017).

    Figure 1: Age-specific incidence rates per 100,000 for male and female invasive breast cancer in White Americans from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) (2003–2012) (Ottini & Capalbo, 2017). Note that the male breast cancer and female breast cancer lines use different y-axes and corresponding scales (50× larger y-axis interval in the case of female breast cancer).

    Hormone Exposure in Women and Breast Cancer Risk

    Along with sex and age, research strongly implicates ovarian activity and ovarian hormones—like estradiol and progesterone—as major risk factors for breast cancer (Ban & Godellas, 2014). Later menarche, earlier menopause, and breastfeeding—all of which result in reduced lifetime ovarian hormone exposure—are associated with decreased risk of breast cancer (Ban & Godellas, 2014; Momenimovahed & Salehiniya, 2018). Surgical removal of the ovaries before 40 years of age is associated with a 50% decrease in lifetime risk of breast cancer (Ban & Godellas, 2014). Antiestrogens including selective estrogen receptor modulators (SERMs) like tamoxifen and aromatase inhibitors (AIs) like anastrozole can be used prophylactically long-term as chemoprevention against breast cancer in high-risk postmenopausal women, providing 50 to 70% reduction in breast cancer risk (Mocellin, Goodwin, & Pasquali, 2019; Nelson et al., 2019). Long-term estrogen and progestogen treatment has been found to produce breast cancer in non-human primates, and high doses may result in breast cancer developing at an earlier age than usual (Cline, 2007).

    Besides increasing breast cancer risk, ovarian sex hormones stimulate the progression of active breast cancer. Antiestrogens are effective in the treatment of active breast cancer (Lumachi, Santeufemia, & Basso, 2015), and antiprogestogens like onapristone and mifepristone have shown preliminary effectiveness in the treatment of breast cancer as well (Palmieri et al., 2014). Administration of physiological doses of estrogens to women with breast cancer appears to accelerate tumor progression (Herrmann, Adair, & Woodard, 1947; Nathanson, 1947; Gellhorn & Jones, 1949; Nathanson, 1951; Pearson et al., 1954; Pearson & Lipsett, 1956; Kennedy, 1956; Kennedy, 1957; Dworin, 1961; Kennedy, 1962; Green, Sethi, & Lindner, 1964; Kennedy, 1964; Stoll, 1973; Forrest, 1989).

    In accordance with the well-established relationships of ovarian activity and ovarian hormones with breast cancer risk, menopausal hormone therapy is associated with a higher risk of breast cancer in peri- and postmenopausal women (CGHFBC, 2019; Table). This is true both for therapy with an estrogen alone and to a greater extent with the combination of an estrogen and a progestogen (CGHFBC, 2019). In terms of absolute risk of breast cancer with menopausal hormone therapy, the incidence after 20 years of use is about 1.5-fold higher with an estrogen alone and about 2.5-fold higher with an estrogen plus a progestogen per a large recent meta-analysis of all of the available data (CGHFBC, 2019). Hence, the risk of breast cancer is higher with combined estrogen and progestogen therapy than with an estrogen alone. In the past it was thought that progestogens might be protective against breast cancer due to antiestrogenic effects in the breasts (Mauvais-Jarvis, Kuttenn, & Gompel, 1986; Wren & Eden, 1996; Gompel et al., 2002), but this proved not to be the case. The higher risk of breast cancer with menopausal hormone therapy was found to be causal in the Women’s Health Initiative (WHI), at least with the used regimen (specifically conjugated equine estrogens (CEEs) 0.625 mg/day plus medroxyprogesterone acetate (MPA) 2.5 mg/day) (about 1.25-fold higher risk after 5 years of therapy) (WGWHII, 2002; Chlebowski, Aragaki, & Anderson, 2015). The WHI was the largest randomized controlled trial (RCT) of hormone therapy ever conducted and allowed a rare chance to evaluate causation in terms of long-term health effects of hormonal agents.

    For a visualization of breast cancer risk with menopausal hormone therapy, Figure 2 below shows breast cancer risk over time based on modeling and data from the observational Nurses’ Health Study (NHS) (Colditz & Rozner, 2000). As can be seen, menopausal hormone therapy is associated with maintenance of the age-related exponential rate of increase in breast-cancer risk that is normally blunted by the onset of menopause.

    Figure 2: Incidence of breast cancer (in every 100,000 people per year) by age and hormone therapy status and type in postmenopausal women (Colditz & Rosner, 2000). Based on a Poisson regression model using data from the observational Nurses’ Health Study (Colditz & Rosner, 2000).

    Bioidentical hormones like estradiol and progesterone are associated with increased risk of breast cancer similarly to non-bioidentical hormonal agents like CEEs and MPA (CGHFBC, 2019; Table). The risk of breast cancer with estradiol does not appear to be different from that with CEEs (CGHFBC, 2019). Oral progesterone has not been associated with an increase in risk of breast cancer with less than 5 years of therapy on the basis of the available data, which is in contrast to progestins (Aly, 2018; CGHFBC, 2019; Stute, Wildt, & Neulen, 2018; Mirkin, 2018; Fournier et al., 2007). However, oral progesterone is associated with increased risk of breast cancer after more than 5 years of therapy, by which point the risk appears to be similar in magnitude to that with MPA (Aly, 2018; CGHFBC, 2019; Stute, Wildt, & Neulen, 2018; Mirkin, 2018; Fournier et al., 2007). The initial lower relative risk with oral progesterone might be related to the low levels of progesterone that oral progesterone achieves and hence its comparatively weak progestogenic strength (Aly, 2018; Kuhl & Schneider, 2013; Davey, 2018; Wiki; Graphs). As a result, a longer duration of therapy (and/or larger sample sizes) may be necessary before an increase in breast cancer risk with oral progesterone can be properly quantified (Aly, 2018; Kuhl & Schneider, 2013; Davey, 2018). Virtually no data are available on breast cancer risk with non-oral routes of progesterone at present (Aly, 2018; Stute, Wildt, & Neulen, 2018). However, non-oral and fully potent progesterone is anticipated by some researchers to have a similar risk of breast cancer as progestins not only with long-term use but also with short-term exposure (Aly, 2018; Kuhl & Schneider, 2013; Davey, 2018).

    Although the overall evidence including both prospective observational studies and RCTs shows an increased risk of breast cancer with estrogen alone therapy in menopausal women (CGHFBC, 2019), the available RCTs, namely the WHI, have so far been unable to show increased breast cancer risk with estrogen alone and have instead found a significant decrease in risk (RR 0.77, 95% CI 0.64–0.93) (CGHFBC, 2019; Table). Various hypotheses have been advanced to explain the conflicting findings. For instance, the women in the WHI, who constitute the vast majority of the RCT data, were atypical in that they were of relatively old age at start of hormone therapy (average 64 years) and were relatively overweight and obese (CGHFBC, 2019; Kuhl, 2005). Women who are overweight or obese are already at an increased risk of breast cancer and may experience no further increase with estrogen therapy (Kuhl, 2005). And women who have been deprived of estrogens for many years may experience paradoxical inhibitory effects on breast cancer risk, which is in contrast to women who start at menopause (also seen in the observational data) (Prentice, 2008; CGHFBC, 2019). This has been termed the “gap hypothesis” (Palmieri et al., 2014; Mueck & Ruan, 2011). More RCTs are needed to test these theories and determine the influence of estrogens on menopausal breast cancer risk.

    Paradoxically, estrogen and/or progestogen exposure can also decrease breast cancer risk and inhibit breast cancer progression under certain circumstances. For instance, pregnancy lasting more than 34 weeks in young women (<35 years of age) increases breast cancer risk in the short-term (<10 years), but is actually protective against breast cancer in the long-term (>20–25 years), with an up to 50% reduction in lifetime risk (Nichols et al., 2019; Husby et al., 2018). Extremely high levels of estrogens and progesterone occur during pregnancy (e.g., >12,500 pg/mL for estradiol at >34 weeks) (Graph), and animal studies suggest that these hormones are responsible for the protection (Rajkumar et al., 2003; Hilakivi-Clarke et al., 2012). High-dose estrogen therapy is an effective treatment against breast cancer in women who are at least 5 years postmenopausal, with similar effectiveness to antiestrogen therapy (Coelingh Bennink et al., 2017; Wiki). Conversely, high-dose estrogen therapy is not effective for breast cancer in premenopausal women, although it does work if massive doses are given (Coelingh Bennink et al., 2017; Wiki). However, these beneficial effects of estrogens and progestogens against breast cancer risk and progression occur under unusual circumstances (e.g., very high levels/doses and/or prolonged prior sex-hormone deficiency) and are not likely to be of relevance to transfeminine people.

    Estrogen Exposure in Men and Breast Cancer Risk

    In cisgender men, conditions related to lower androgen exposure and/or higher estrogen exposure are associated with increased risk of breast cancer (Ferzoco & Ruddy, 2016). These conditions include testicular problems and removal as well as liver disease (Abdelwahab Yousef, 2017). Testicular dysfunction and absence result in decreased androgen levels, while liver disease results in higher estrogen levels due to impaired metabolism of estrogens. Both types of conditions result in an increased ratio of estrogens to androgens, in turn causing greater estrogenic stimulation of the breasts. This is presumably responsible for the increased breast cancer risk. Breast conditions in men, like benign breast disease and gynecomastia, have also been associated with breast cancer risk (Sasco, Lowenfels, & Pasker-De Jong, 1993), although findings are mixed for gynecomastia (Giordano, 2005). In addition to health conditions, high-dose estrogen therapy for prostate cancer has been associated with increased breast cancer risk in cisgender men (Thellenberg et al., 2003; Karlsson et al., 2006).

    Studies of Breast Cancer Risk in Transfeminine People

    A companion doc for this article with a table of available studies on the risk of breast cancer with hormone therapy in transfeminine people can be found here. To date, three large cohorts and several smaller cohorts have evaluated breast cancer risk with transfeminine hormone therapy.

    Vrije Universiteit University Medical Center (VUMC) Studies

    Most of the studies in the table are by the Vrije Universiteit University Medical Center (VUMC) in Amsterdam, the Netherlands (Asscheman, Gooren, & Eklund, 1989; van Kesteren et al., 1997; Mueller & Gooren, 2008; Asscheman et al., 2011; Gooren et al., 2013; de Blok et al., 2018; de Blok et al., 2019). This clinic treats 95% of transgender people in the Netherlands (de Blok et al., 2019). The studies by the VUMC are all on largely the same evolving cohort of transgender women. For a couple of decades, the VUMC reported a low incidence of breast cancer that was not much higher than the rate expected in cisgender men (only 2 reported cases in 2,300 transgender women over an average duration of hormone therapy of about 20 years) (Gooren et al., 2013). The typical regimen used by the clinic was estrogen and high-dose cyproterone acetate. The studies did not did not use systematic screening for breast cancer and instead presumably relied on patient report for breast cancer diagnosis, raising the possibility of under-detection of cases (Feldman et al., 2016).

    In 2019, the VUMC did another follow-up study but this time switched to a new method of obtaining breast cancer diagnoses (de Blok et al., 2019). Instead of simply asking patients whether they’d been diagnosed with breast cancer, the researchers retrieved breast cancer diagnoses using an electronic system of patient records for all of the Netherlands called the Nationwide Network and Registry of Histopathology and Cytopathology in the Netherlands (PALGA). When they did this, their number of breast cancer cases shot up from 2 to 15. This resulted in a relative risk of breast cancer of almost 50-fold the expected risk and an absolute incidence of roughly 0.6% over a mean duration of hormone therapy of about 15 years. These findings supersede all of the previous research by the clinic and indicate that the true number of breast cancer cases in the VUMC cohort had been greatly underestimated in their previous studies. Very large increases in risk, such as the risk of lung cancer with smoking and the nearly 50-fold increase in breast cancer risk in this study, can be considered as likely causal. Accordingly, the increase in risk has been described by researchers using causal language (de Blok et al., 2019; Reactions Weekly, 2019). Prior to this study, it was thought that the increase in risk of breast cancer with hormone therapy in transfeminine people was low, but due to the new data, it’s now known that this isn’t necessarily the case (de Blok, Dreijerink, & Heijer, 2019).

    Veterans Health Administration (VHA) Study

    Another large cohort is the Veterans Health Administration (VHA) cohort in the United States (Brown & Jones, 2015; Brown, 2015). In 2015, a study was published using data from this cohort. The researchers reported 3 cases of breast cancer in about 3,500 people assigned male at birth with mean follow-up time of approximately 10 years. Hence, there was a rate of about 0.09% over an average duration of 10 years. Although the mean duration of follow up was shorter than in the VUMC cohort, the total follow-up time was similar. The VHA researchers reported the incidence of breast cancer as increased by 33-fold relative to the expected rate. This is somewhat strange in that it’s discrepant with the VUMC’s 2018 numbers (which reported a 46-fold increased risk based on diagnosis in 15 of 2,300 people and mean follow-up time of 15 years). In any case, the VHA concluded that the risk of breast cancer in transfeminine people was higher than that in cisgender men and higher than that reported by the earlier VUMC studies, but still lower than the risk in cisgender women.

    The VHA paper provided no specifics on what hormone therapy medications and doses were used, although since it included all patients treated by providers in the VHA system, the regimens are likely to have been quite variable. Because this was the United States, the typical regimen was probably estrogen plus spironolactone and no progestogen.

    There are a variety of problems with the VHA study that require discussion:

    • As with the earlier VUMC studies, the VHA study did not use systematic screening for breast cancer and presumably relied on patient report for breast cancer diagnoses, raising the possibility of under-detection of cases (Feldman et al., 2016).
    • The study was irrespective of hormone therapy (Feldman et al., 2016). Only some people in the cohort were on hormone therapy while others were not, and the researchers didn’t have full numbers on who was and who wasn’t. Moreover, an unknown percentage of people included in the cohort weren’t actually transgender—the researchers also included all cisgender men in the VHA system with a “transgender-related” diagnosis, which included transvestic fetishism (a.k.a. sexual crossdressing). Most of these individuals presumably were not on hormone therapy.
    • The follow-up times for those who were definitely on hormone therapy were very short. Of about 1,400 transfeminine people in the VHA cohort who were certainly on hormone therapy, the mean duration of use was only 5.5 years, and was less than 3 years for nearly half of the sample.
    • The VHA paper was very confusing and unclear. As an example, they misgendered transgender people, referring to them as “male” and “female” per birth sex, and wrote in such a way that made it difficult to understand who was who as well as who was and was not actually on hormone therapy. This was such that even some citing publications reporting on the study mistakenly got the risks for “male” and “female” switched (e.g., Dente et al., 2019).
    • To add further confusion, the VHA researchers reported 33 total cases of breast cancer in the exact same cohort of 5,100 total people assigned male or female at birth in two other papers published around the same time (Brown & Jones, 2014; Brown & Jones, 2016). For comparison, they only reported 10 total cases in the 2015 paper (3 in those assigned male at birth and 7 in people assigned female at birth). The reason for this discrepancy is unknown (Braun et al., 2017).

    Due to the various problems with the VHA study, its findings are of limited usefulness and should likely be considered with caution. The 2019 VUMC findings are of far better-quality data.

    Kaiser Permanente in California and Georgia Study

    The third and final large cohort study was by Kaiser Permanente in Northern California, Southern California, and Georgia in the United States (Silverberg et al., 2017). They reported the incidences of a variety of cancers in a combined cohort from three Kaiser sites consisting of about 2,800 transfeminine people. The mean duration of follow up in the study was only 4 years. The researchers did not report the incidence of any cancer that had an absolute occurrence of less than 5 cases, and breast cancer in transfeminine people was not included in the relevant table of results nor in the discussion in the paper. Hence, there were presumably fewer than 5 cases of breast cancer in the cohort of transfeminine people. However, T’Sjoen and colleagues, a very reputable group of researchers in the field of transgender medical research, reported in a citing publication that the Kaiser team found a higher risk of breast cancer in transfeminine people compared to cisgender men but a lower risk compared to cisgender women (T’Sjoen et al., 2019). Assuming this is accurate, which it likely is, the information was presumably obtained via personal communication with the Kaiser researchers. Limitations of the Kaiser study include lack of exact figures on breast cancer risk and a very short follow-up duration. In addition, cancer diagnoses were retrieved only from Kaiser’s own systems, and the extent to which screening was systematic, if at all, is unclear.

    The Kaiser researchers plan to do further studies in much larger cohorts via expansion to additional sites in the future (Silverberg et al., 2017). This is an exciting development, and should hopefully give us additional data on health risks in transgender people, including of breast cancer risk.

    Small Cohort Studies

    The remaining investigations of breast cancer risk in transfeminine people were small. One was 50 post-SRS transgender women by the Ghent University Hospital in Belgium who were followed up for an average of 11.4 years each, in whom no cases of breast cancer were seen (Wierckx et al., 2012). Another was 60 transgender women by the University Hospital Erlangen in Germany (Dittrich et al., 2005). No cases were seen in this cohort either, although the treatment period was only 2 years. The last was Harry Benjamin’s patient cohort; he communicated in his 1960s publications that he had treated about 150 transgender women with “medium to fairly large doses of estrogen” for varying periods of time (e.g., 3 months to 12 years) and hadn’t encountered any cases of breast cancer (Benjamin, 1964; Benjamin, 1966; Gooren et al., 2013). These cohorts are all too small and limited to provide meaningful quantification of breast cancer risk in transfeminine people.

    Discussion of the Available Studies

    Inconclusive Quantification of Breast Cancer Risk Due to Short Follow-Up Times

    The available studies on breast cancer risk in transfeminine people are inconclusive due to inadequate follow-up times (de Blok, Dreijerink, & Heijer, 2019; Mueller & Gooren, 2008; Gooren, 2011; Gooren et al., 2013; Brown & Jones, 2015). For instance the average durations of hormone therapy in the VUMC and VHA studies were only 10 to 20 years. Breast cancer incidence in cisgender women increases exponentially over decades during premenopause and is very rare until older age. The typical age of breast cancer diagnosis in cisgender women is 60 years, which includes about 50 years of premenopausal hormone exposure and about 10 years of postmenopausal hormone exposure. (The latter of which is not unimportant, as demonstrated by the greatly decreased risk of breast cancer with prophylactic antiestrogen therapy.) As such, due to the short follow-up times of the available studies of transfeminine hormone therapy and breast cancer risk, the true or lifetime risk of breast cancer in transfeminine people is not yet known (Mueller & Gooren, 2008).

    We do know however that hormone therapy in transfeminine people, at least with an estrogen plus a progestogen in the form of cyproterone acetate, appears to strongly increase the risk of breast cancer within about 15 years of use (de Blok, Dreijerink, & Heijer, 2019). Fortunately, the risk is intermediate between that in cisgender women and that in cisgender men (and not, e.g., greater than that in cisgender women). At the same time however, the risk is non-negligible, and the absolute incidence will only increase with longer follow-up times. In terms of lifetime risk, the incidence of breast cancer in transfeminine people is well on-track to be as high as single-digit percentages, at least based on the findings of de Blok et al. (2019) and their particular hormone therapy regimen.

    Breast Cancer Risk in Relation to Lifetime Hormone Exposure

    Transfeminine people may have a lower risk of breast cancer than cisgender women. This may due at least in part to a more limited amount of lifetime hormone exposure (Mueller & Gooren, 2008). This is based on the fact that, at least historically, transfeminine people have started hormone therapy on average at 30 or 40 years of age, which is decades after the age at which cisgender girls normally undergo puberty (Mueller & Gooren, 2008). Additionally, youth may represent a critical window of susceptibility for breast cancer risk (Biro & Wolff, 2011; Biro & Deardorff, 2013; Biro et al., 2020). However, the age at start of hormone therapy in transfeminine people has been decreasing in recent times (Mueller & Gooren, 2008), and nowadays many start hormones in their teens or early twenties. These individuals will have greater lifetime hormone exposure, and presumably greater breast cancer risk, than many of the transfeminine people of the past (Sutherland et al., 2020). Moreover, transfeminine people may be much less inclined to stop hormone therapy at the normal age of menopause in cisgender women (Mueller & Gooren, 2008). Many transfeminine people will likely stay on hormone therapy their entire lives. This additional exposure may further increase breast cancer risk (Mueller & Gooren, 2008).

    Breast Cancer Risk in Relation to Progestogens and Dosage

    Based on findings that breast cancer risk is higher with an estrogen plus progestogen relative to an estrogen alone in menopausal women, the risk of breast cancer with hormone therapy in transfeminine people may likewise be higher with combined estrogen and progestogen therapy (de Blok, Dreijerink, & Heijer, 2019). Hence, it’s possible that estrogen therapy without a progestogen could have a lower risk of breast cancer than that observed by the VUMC with an estrogen plus cyproterone acetate (de Blok, Dreijerink, & Heijer, 2019). It’s notable also that the doses of cyproterone acetate used by the VUMC result in rather extreme progestogenic exposure (Aly, 2019). The extent to which breast cancer risk with progestogens is dose-dependent is unknown. Whether or not estrogen dosage influences breast cancer risk, or if higher levels have greater risk, is unclear similarly. In any case, the fact that the use of estrogen–progestogen birth control in premenopausal women is associated with increased risk of breast cancer is suggestive that higher levels of estrogen and/or progestogen exposure may result in some degree of greater risk (Kahlenborn et al., 2006; Zhu et al., 2012; Ji et al., 2019). In addition, an older observational study reported a 4-fold greater risk of breast cancer in menopausal cisgender women treated with injectable estrogens than with oral estrogens or no hormone therapy (Hulka et al., 1982; Coe & Parks, 1989). This is notable as typical doses of injectable estrogens provide much greater estrogenic exposure than oral and other routes of estrogen (Göretzlehner et al., 2002; Aly, 2021). However, the study has important limitations, including only being a single study and being quite old.

    X Chromosomes and Breast Cancer Risk

    The sex chromosomes include the X chromosome and the Y chromosome. Cisgender women typically have two X chromosomes (46,XX karyotype), while cisgender men (and transfeminine people) typically have one X chromosome and one Y chromosome (46,XY karyotype). It’s possible that a 46,XX karyotype—specifically the presence of a second X chromosome—may be a major risk factor for breast cancer. X-chromosome gain and aberrant X-chromosome inactivation have been associated with breast cancer incidence and aggressiveness (Nakopoulou et al., 2007; Di Oto et al., 2015; Lin et al., 2015; Chaligné et al., 2015; Di Oto et al., 2018). In addition, breast cancer risk is markedly higher in men with Klinefelter’s syndrome (KS), who have a 46,XXY karyotype, than in regular men with a 46,XY karyotype. Conversely, breast cancer has never been reported in women with complete androgen insensitivity syndrome (CAIS), who have a 46,XY karyotype similarly to transfeminine people (Hughes et al., 2012; Tiefenbacher & Daxenbichler, 2008; Hughes, 2009). This is in spite of the fact that CAIS women have excellent breast development (Aly, 2020). However, hormonal abnormalities in people with KS and CAIS may alternatively contribute to differences in breast cancer risk and are thus a confounding variable. It’s notable in particular that CAIS women have relatively low estrogen exposure and little to no progesterone. In any case, the differences in breast cancer risk in conditions like KS and CAIS do not seem to be fully explainable by hormonal abnormalities. Thus, it’s possible that the lack of two X chromosomes in transfeminine people may indeed prove to be partially protective against breast cancer risk. For more in-depth information on this topic, see the supplemental article here.

    Summary and Conclusions

    Breast cancer risk is far higher in women than in men. The incidence of breast cancer increases exponentially with age and is very rare in younger people. There is strong basis to assume that estrogens and progestogens increase the risk of breast cancer, which can be inferred as a major mechanism for the sex differences in breast cancer risk. The available data do not indicate meaningful differences between bioidentical and non-bioidentical hormones in terms of breast cancer risk.

    Older studies of transfeminine hormone therapy and breast cancer risk found low incidences of breast cancer in transfeminine people. However, a recent study with better methodology than previous studies showed a nearly 50-fold increase in breast cancer risk. The hormone therapy regimen used by their cohort was specifically estrogen plus cyproterone acetate. It’s unknown whether other hormonal regimens, for instance estrogen alone or with a non-progestogenic antiandrogen, have similar risks. The available data on breast cancer risk in transfeminine people are limited by inadequate follow-up times. As a result, lifetime breast cancer risk is unknown. Based on available data however, we can project into the future and assume that the lifetime incidence of breast cancer in transfeminine people may be as high as single-digit percentages. This puts the risk of breast cancer in transfeminine people somewhere between that of cisgender men and cisgender women.

    Various factors may modify breast cancer risk with transfeminine hormone therapy. Examples include cumulative duration of use, age at start of therapy, long-term progestogen use, and possibly dosages of estrogens and/or progestogens. The lack of a second X chromosome in transfeminine people may be partially protective against breast cancer. Although breast cancer risk with transfeminine hormone therapy is something for transfeminine people to be aware of, particularly the probable contribution of progestogens to the risk, the lifetime incidence is likely to be low and the risk appears to be less than that of cisgender women. In addition, it takes many years of hormone exposure for breast cancer to occur and is generally restricted to old age. Also, breast cancer is a highly treatable disease, with excellent 5- and 10-year survival rates (Cancer.Net). For these reasons, concerns about breast cancer should most certainly not preclude hormone therapy for transfeminine people.

    The possibility of breast cancer with hormone therapy in transfeminine people does, however, highlight the importance of routine breast cancer screening in transfeminine people of appropriate age and duration of hormone exposure (Chowdhry & O’Connell, 2020). It’s likely advisable that transfeminine people on long-term hormone therapy follow the same breast cancer screening procedures as those of cisgender women (Chowdhry & O’Connell, 2020).

    References

    • Abdelwahab Yousef, A. J. (2017). Male Breast Cancer: Epidemiology and Risk Factors. Seminars in Oncology, 44(4), 267–272. [DOI:10.1053/j.seminoncol.2017.11.002]
    • Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. (2009). Breast Cancer Before Age 40 Years. Seminars in Oncology, 36(3), 237–249. [DOI:10.1053/j.seminoncol.2009.03.001]
    • Asscheman, H., Gooren, L., & Eklund, P. (1989). Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38(9), 869–873. [DOI:10.1016/0026-0495(89)90233-3]
    • Asscheman, H., Giltay, E. J., Megens, J. A., de Ronde, W., van Trotsenburg, M. A., & Gooren, L. J. (2011). A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 164(4), 635–642. [DOI:10.1530/eje-10-1038]
    • Ban, K. A., & Godellas, C. V. (2014). Epidemiology of Breast Cancer. Surgical Oncology Clinics of North America, 23(3), 409–422. [DOI:10.1016/j.soc.2014.03.011]
    • Benjamin, H. (1964). Clinical Aspects of Transsexualism in the Male and Female. American Journal of Psychotherapy, 18(3), 458–469. [DOI:10.1176/appi.psychotherapy.1964.18.3.458]
    • Benjamin, H. (1966). The Transsexual Phenomenon. New York: Julian Press. [Google Scholar] [Google Books] [PDF]
    • Benz, C. C. (2008). Impact of aging on the biology of breast cancer. Critical Reviews in Oncology/Hematology, 66(1), 65–74. [DOI:10.1016/j.critrevonc.2007.09.001]
    • Biro, F. M., & Wolff, M. S. (2011). Puberty as a Window of Susceptibility. In Russo, J. (Ed.). Environment and Breast Cancer (pp. 29–41). New York: Springer New York. [DOI:10.1007/978-1-4419-9896-5_2]
    • Biro, F. M., & Deardorff, J. (2013). Identifying Opportunities for Cancer Prevention During Preadolescence and Adolescence: Puberty as a Window of Susceptibility. Journal of Adolescent Health, 52(5), S15–S20. [DOI:10.1016/j.jadohealth.2012.09.019]
    • Biro, F. M., Huang, B., Wasserman, H., Gordon, C. M., & Pinney, S. M. (2021). Pubertal Growth, IGF-1, and Windows of Susceptibility: Puberty and Future Breast Cancer Risk. Journal of Adolescent Health, 68(3), 517–522. [DOI:10.1016/j.jadohealth.2020.07.016]
    • Braun, H., Nash, R., Tangpricha, V., Brockman, J., Ward, K., & Goodman, M. (2017). Cancer in Transgender People: Evidence and Methodological Considerations. Epidemiologic Reviews, 39(1), 93–107. [DOI:10.1093/epirev/mxw003]
    • Brisken, C., Hess, K., & Jeitziner, R. (2015). Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis. Endocrinology, 156(10), 3442–3450. [DOI:10.1210/en.2015-1392]
    • Brown, G. R., & Jones, K. T. (2014). Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Research and Treatment, 149(1), 191–198. [DOI:10.1007/s10549-014-3213-2]
    • Brown, G. R., & Jones, K. T. (2014). Racial Health Disparities in a Cohort of 5,135 Transgender Veterans. Journal of Racial and Ethnic Health Disparities, 1(4), 257–266. [DOI:10.1007/s40615-014-0032-4]
    • Brown, G. R. (2015). Breast Cancer in Transgender Veterans: A Ten-Case Series. LGBT Health, 2(1), 77–80. [DOI:10.1089/lgbt.2014.0123]
    • Brown, G. R., & Jones, K. T. (2016). Mental Health and Medical Health Disparities in 5135 Transgender Veterans Receiving Healthcare in the Veterans Health Administration: A Case–Control Study. LGBT Health, 3(2), 122–131. [DOI:10.1089/lgbt.2015.0058]
    • Cancer Research UK. (2020). Breast cancer incidence (invasive) statistics. Cancer Research UK. [URL]
    • Cancer.Net. (2020). Breast Cancer: Statistics. American Society of Clinical Oncology. [URL]
    • Chaligné, R., Popova, T., Mendoza-Parra, M., Saleem, M. M., Gentien, D., Ban, K., Piolot, T., Leroy, O., Mariani, O., Gronemeyer, H., Vincent-Salomon, A., Stern, M., & Heard, E. (2015). The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer. Genome Research, 25(4), 488–503. [DOI:10.1101/gr.185926.114]
    • Chlebowski, R. T., Aragaki, A. K., & Anderson, G. L. (2015). Menopausal Hormone Therapy Influence on Breast Cancer Outcomes in the Women’s Health Initiative. Journal of the National Comprehensive Cancer Network, 13(7), 917–924. [DOI:10.6004/jnccn.2015.0106]
    • Chowdhry, D. N., & O’Connell, A. M. (2020). Breast Imaging in Transgender Patients. Journal of Breast Imaging, 2(2), 161–167. [DOI:10.1093/jbi/wbz092]
    • Cline, J. M. (2007). Assessing the mammary gland of nonhuman primates: effects of endogenous hormones and exogenous hormonal agents and growth factors. Birth Defects Research Part B: Developmental and Reproductive Toxicology, 80(2), 126–146. [DOI:10.1002/bdrb.20112]
    • Coe, F. L., & Parks, J. H. (1989). The Risks of Oral Contraceptives and Estrogen Replacement Therapy. Perspectives in Biology and Medicine, 33(1), 86–106. [DOI:10.1353/pbm.1990.0026]
    • Coelingh Bennink, H. J., Verhoeven, C., Dutman, A. E., & Thijssen, J. (2017). The use of high-dose estrogens for the treatment of breast cancer. Maturitas, 95, 11–23. [DOI:10.1016/j.maturitas.2016.10.010]
    • Colditz, G. A. (2000). Cumulative Risk of Breast Cancer to Age 70 Years According to Risk Factor Status: Data from the Nurses’ Health Study. American Journal of Epidemiology, 152(10), 950–964. [DOI:10.1093/aje/152.10.950]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, R. H., & den Heijer, M. (2018). Breast cancer in transgender persons receiving gender affirming hormone treatment: results of a nationwide cohort study. Endocrine Abstracts, 56 [20th European Congress of Endocrinology 2018, 19–22 May 2018, Barcelona, Spain], 490–490 (abstract no. P955). [DOI:10.1530/endoabs.56.p955] [PDF]
    • de Blok, C. J., Dreijerink, K. M., & den Heijer, M. (2019). Cancer Risk in Transgender People. Endocrinology and Metabolism Clinics of North America, 48(2), 441–452. [DOI:10.1016/j.ecl.2019.02.005]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, 365, l1652. [DOI:10.1136/bmj.l1652]
    • Dente, E., Farneth, R., Purks, J., & Torelli, S. (2019). Evaluating risks, reported cases and screening recommendations for breast cancer in transgender patients. Georgetown Medical Review, 3(1). [DOI:10.52504/001c.7774]
    • Di Oto, E., Monti, V., Cucchi, M. C., Masetti, R., Varga, Z., & Foschini, M. P. (2015). X chromosome gain in male breast cancer. Human Pathology, 46(12), 1908–1912. [DOI:10.1016/j.humpath.2015.08.008]
    • Di Oto, E., Biserni, G. B., Varga, Z., Morandi, L., Cucchi, M. C., Masetti, R., & Foschini, M. P. (2018). X chromosome gain is related to increased androgen receptor expression in male breast cancer. Virchows Archiv, 473(2), 155–163. [DOI:10.1007/s00428-018-2377-2]
    • Dix, D., & Cohen, P. (1982). The incidence of breast cancer: analysis of the age dependence. Anticancer Research, 2(1-2), 23–7. [Google Scholar] [PubMed] [PDF]
    • Dworin, M. (1961). The Rationale of Endocrine Therapy in Breast Cancer. CA: A Cancer Journal for Clinicians, 11(2), 48–54. [DOI:10.3322/canjclin.11.2.48]
    • Feldman, J., Brown, G. R., Deutsch, M. B., Hembree, W., Meyer, W., Meyer-Bahlburg, H. F., Tangpricha, V., T’Sjoen, G., & Safer, J. D. (2016). Priorities for transgender medical and healthcare research. Current Opinion in Endocrinology, Diabetes & Obesity, 23(2), 180–187. [DOI:10.1097/med.0000000000000231]
    • Ferzoco, R. M., & Ruddy, K. J. (2016). The Epidemiology of Male Breast Cancer. Current Oncology Reports, 18, 1. [DOI:10.1007/s11912-015-0487-4]
    • Forrest, A. P. (1989). Endocrine management of breast cancer. Proceedings of the Royal Society of Edinburgh. Section B. Biological Sciences, 95 [Oestrogen and the Human Breast], 1–10. [DOI:10.1017/s0269727000010502]
    • Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103–111. [DOI:10.1007/s10549-007-9523-x]
    • Gellhorn, A., & Jones, L. O. (1949). Chemotherapy of malignant disease. The American Journal of Medicine, 6(2), 188–231. [DOI:10.1016/0002-9343(49)90017-0]
    • Giordano, S. H. (2005). A Review of the Diagnosis and Management of Male Breast Cancer. The Oncologist, 10(7), 471–479. [DOI:10.1634/theoncologist.10-7-471]
    • Giordano, S. H. (2018). Breast Cancer in Men. New England Journal of Medicine, 378(24), 2311–2320. [DOI:10.1056/nejmra1707939]
    • Gompel, A., Levy, D., Chaouat, M., Kazem, A., Hugol, D., Daraı̈, E., Decroix, Y., & Rostène, W. (2002). Is there a place for progestin agents in breast cancer prevention? International Congress Series, 1229, 143–150. [DOI:10.1016/s0531-5131(01)00467-8]
    • Gooren, L. J. (2011). Care of Transsexual Persons. New England Journal of Medicine, 364(13), 1251–1257. [DOI:10.1056/nejmcp1008161]
    • Gooren, L. J., van Trotsenburg, M. A., Giltay, E. J., & van Diest, P. J. (2013). Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment. The Journal of Sexual Medicine, 10(12), 3129–3134. [DOI:10.1111/jsm.12319]
    • Göretzlehner, G., Ackermann, W., Angelow, K., Bergmann, G., Bieck, E., Golbs, S., & Kliem, O. (2002). Pharmakokinetik von Estron, Estradiol, FSH, LH und Prolaktin nach intramuskulärer Applikation von 5 mg Estradiolvalerat. [Pharmacokinetics of estradiol valerate in postmenopausal women after intramuscular administration.] Journal für Menopause, 9(2), 46–49. [Google Scholar] [URL] [PDF] [Translation]
    • Green, R. B., Sethi, R. S., & Lindner, H. H. (1964). Treatment of advanced carcinoma of the breast. The American Journal of Surgery, 108(1), 107–121. [DOI:10.1016/0002-9610(64)90094-7]
    • Herrmann, J. B. (1947). Effect of estrogenic hormone on advanced carcinoma of the female breast. Archives of Surgery, 54(1), 1–9. [DOI:10.1001/archsurg.1947.01230070004001]
    • Hilakivi-Clarke, L., de Assis, S., Warri, A., & Luoto, R. (2012). Pregnancy hormonal environment and mother’s breast cancer risk. Hormone Molecular Biology and Clinical Investigation, 9(1), 11–23. [DOI:10.1515/hmbci-2012-0019]
    • Hughes, I. A. (2010). Evaluation and Management of Disorders of Sex Development. In Brook, C. G. D., Clayton, P. E., & Brown, R. S. (Eds.). Brook’s Clinical Pediatric Endocrinology, 6th Edition (pp. 192–212). Oxford: Wiley-Blackwell. [DOI:10.1002/9781444316728.ch9]
    • Hughes, I. A., Davies, J. D., Bunch, T. I., Pasterski, V., Mastroyannopoulou, K., & MacDougall, J. (2012). Androgen insensitivity syndrome. The Lancet, 380(9851), 1419–1428. [DOI:10.1016/s0140-6736(12)60071-3]
    • Hulka, B. S., Chambless, L. E., Deubner, D. C., & Wilkinson, W. E. (1982). Breast cancer and estrogen replacement therapy. American Journal of Obstetrics and Gynecology, 143(6), 638–644. [DOI:10.1016/0002-9378(82)90108-9]
    • Husby, A., Wohlfahrt, J., Øyen, N., & Melbye, M. (2018). Pregnancy duration and breast cancer risk. Nature Communications, 9(1), 4255. [DOI:10.1038/s41467-018-06748-3]
    • Ji, L., Jing, C., Zhuang, S., Pan, W., & Hu, X. (2019). Effect of age at first use of oral contraceptives on breast cancer risk. Medicine, 98(36), e15719–e15719. [DOI:10.1097/md.0000000000015719]
    • Kahlenborn, C., Modugno, F., Potter, D. M., & Severs, W. B. (2006). Oral Contraceptive Use as a Risk Factor for Premenopausal Breast Cancer: A Meta-analysis. Mayo Clinic Proceedings, 81(10), 1290–1302. [DOI:10.4065/81.10.1290]
    • Karlsson, C. T., Malmer, B., Wiklund, F., & Grönberg, H. (2006). Breast Cancer as a Second Primary in Patients With Prostate Cancer—Estrogen Treatment or Association With Family History of Cancer? Journal of Urology, 176(2), 538–543. [DOI:10.1016/j.juro.2006.03.036]
    • Kennedy, B.J. (1956). Effects of steroids in women with breast cancer. In Engle, E. T., & Pincus, G. (Eds.). Hormones and the Aging Process: Proceedings of a Conference Held at Arden House, Harriman, New York, 1955 (pp. 253–272). New York: Academic Press. [Google Scholar] [Google Books]
    • Kennedy, B. J. (1957). The Present Status of Hormone Therapy in Advanced Breast Cancer. Radiology, 69(3), 330–340. [DOI:10.1148/69.3.330]
    • Kennedy, B. J. (1962). Massive estrogen administration in premenopausal women with metastatic breast cancer. Cancer, 15(3), 641–648. [DOI:10.1002/1097-0142(196205/06)15:3<641::aid-cncr2820150330>3.0.co;2-9]
    • Kennedy, B. J. (1964). Estrogenic Hormone Therapy in Advanced Breast Cancer. Annals of Internal Medicine, 60(4), 718–718. [DOI:10.7326/0003-4819-60-4-718_1]
    • Kuhl, H. (2005). Breast cancer risk in the WHI study: The problem of obesity. Maturitas, 51(1), 83–97. [DOI:10.1016/j.maturitas.2005.02.018]
    • Kuhl, H., & Schneider, H. P. (2013). Progesterone – promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]
    • Lin, I., Chen, D., Chang, Y., Lee, Y., Su, C., Cheng, C., Tsai, Y., Ng, S., Chen, H., Lee, M., Chen, H., Suen, S., Chen, Y., Liu, T., Chang, C., & Hsu, M. (2015). Hierarchical Clustering of Breast Cancer Methylomes Revealed Differentially Methylated and Expressed Breast Cancer Genes. PLOS ONE, 10(2), e0118453. [DOI:10.1371/journal.pone.0118453]
    • Lumachi, F. (2015). Current medical treatment of estrogen receptor-positive breast cancer. World Journal of Biological Chemistry, 6(3), 231–239. [DOI:10.4331/wjbc.v6.i3.231]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1986). Antiestrogen action of progesterone in breast tissue. Breast Cancer Research and Treatment, 8(3), 179–188. [DOI:10.1007/bf01807330]
    • Mirkin, S. (2018). Evidence on the use of progesterone in menopausal hormone therapy. Climacteric, 21(4), 346–354. [DOI:10.1080/13697137.2018.1455657]
    • Mocellin, S., Goodwin, A., & Pasquali, S. (2019). Risk-reducing medications for primary breast cancer: a network meta-analysis. Cochrane Database of Systematic Reviews, 2019(4), CD012191. [DOI:10.1002/14651858.cd012191.pub2]
    • Momenimovahed, Z., & Salehiniya, H. (2019). Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer: Targets and Therapy, 11, 151–164. [DOI:10.2147/bctt.s176070]
    • Mueck, A. O., & Ruan, X. (2011). Benefits and risks during HRT: main safety issue breast cancer. Hormone Molecular Biology and Clinical Investigation, 5(2), 105–116. [DOI:10.1515/hmbci.2011.014]
    • Mueller, A., & Gooren, L. (2008). Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 159(3), 197–202. [DOI:10.1530/eje-08-0289]
    • Nakopoulou, L., Panayotopoulou, E. G., Giannopoulou, I., Tsirmpa, I., Katsarou, S., Mylona, E., Alexandrou, P., & Keramopoulos, A. (2006). Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis. Journal of Clinical Pathology, 60(7), 808–815. [DOI:10.1136/jcp.2006.037838]
    • Nathanson, I. T. (1947). Hormonal Alteration of Advanced Cancer of the Breast. Surgical Clinics of North America, 27(5), 1144–1150. [DOI:10.1016/s0039-6109(16)32241-1]
    • Nathanson, I. T. (1951). Sex Hormones and Castration in Advanced Breast Cancer. Radiology, 56(4), 535–552. [DOI:10.1148/56.4.535]
    • Nelson, H. D., Fu, R., Zakher, B., Pappas, M., & McDonagh, M. (2019). Medication Use for the Risk Reduction of Primary Breast Cancer in Women. JAMA, 322(9), 868–886. [DOI:10.1001/jama.2019.5780]
    • Nichols, H. B., Schoemaker, M. J., Cai, J., Xu, J., Wright, L. B., Brook, M. N., Jones, M. E., Adami, H., Baglietto, L., Bertrand, K. A., Blot, W. J., Boutron-Ruault, M., Dorronsoro, M., Dossus, L., Eliassen, A. H., Giles, G. G., Gram, I. T., Hankinson, S. E., Hoffman-Bolton, J., Kaaks, R., Key, T. J., Kitahara, C. M., Larsson, S. C., Linet, M., Merritt, M. A., Milne, R. L., Pala, V., Palmer, J. R., Peeters, P. H., Riboli, E., Sund, M., Tamimi, R. M., Tjønneland, A., Trichopoulou, A., Ursin, G., Vatten, L., Visvanathan, K., Weiderpass, E., Wolk, A., Zheng, W., Weinberg, C. R., Swerdlow, A. J., & Sandler, D. P. (2018). Breast Cancer Risk After Recent Childbirth. Annals of Internal Medicine, 170(1), 22–31. [DOI:10.7326/m18-1323]
    • Ottini, L., & Capalbo, C. (2017). Male Breast Cancer. In Veronesi, U., Goldhirsch, A., Veronesi, P., Gentilini, O. D., & Leonardi, M. C. (Eds.). Breast Cancer: Innovations in Research and Management (pp. 753–762). Cham: Springer. [DOI:10.1007/978-3-319-48848-6_63]
    • Palmieri, C., Patten, D. K., Januszewski, A., Zucchini, G., & Howell, S. J. (2014). Breast cancer: Current and future endocrine therapies. Molecular and Cellular Endocrinology, 382(1), 695–723. [DOI:10.1016/j.mce.2013.08.001]
    • Pearson, O. H. (1954). Evaluation of endocrine therapy for advanced breast cancer. JAMA, 154(3), 234–239. [DOI:10.1001/jama.1954.02940370046013]
    • Pearson, O. H., & Lipsett, M. B. (1956). Endocrine Management of Metastatic Breast Cancer. Medical Clinics of North America, 40(3), 761–772. [DOI:10.1016/s0025-7125(16)34564-3]
    • Prentice, R. L. (2008). Women’s Health Initiative Studies of Postmenopausal Breast Cancer. In Li, J. J., Li, S. A., Mohla, S., Rochefort, H., & Maudelonde, T. (Eds.). Hormonal Carcinogenesis V (Advances in Experimental Medicine and Biology, Volume 617) (pp. 151–160). New York: Springer New York. [DOI:10.1007/978-0-387-69080-3_14]
    • Rajkumar, L., Guzman, R. C., Yang, J., Thordarson, G., Talamantes, F., & Nandi, S. (2003). Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Research, 6(1), R31. [DOI:10.1186/bcr734]
    • Reactions Weekly. (2019). Hormones increase breast cancer risk in Dutch transgender women. Reactions Weekly, 1754, 9–9. [DOI:10.1007/s40278-019-62242-2]
    • Sasco, A. J., Lowenfels, A. B., & Jong, P. P. (1993). Review article: Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. International Journal of Cancer, 53(4), 538–549. [DOI:10.1002/ijc.2910530403]
    • Satram, S. (2006). Genetic and environmental factors and male breast cancer risk. (Doctoral dissertation, University of California, Irvine.) [Google Scholar] [URL]
    • Silverberg, M. J., Nash, R., Becerra-Culqui, T. A., Cromwell, L., Getahun, D., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Slovis, J., Tangpricha, V., & Goodman, M. (2017). Cohort study of cancer risk among insured transgender people. Annals of Epidemiology, 27(8), 499–501. [DOI:10.1016/j.annepidem.2017.07.007]
    • Stoll, B. A. (1973). Hypothesis: Breast Cancer Regression under Oestrogen Therapy. BMJ, 3(5877), 446–450. [DOI:10.1136/bmj.3.5877.446]
    • Stute, P., Wildt, L., & Neulen, J. (2018). The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric, 21(2), 111–122. [DOI:10.1080/13697137.2017.1421925]
    • Sun, Y., Zhao, Z., Yang, Z., Xu, F., Lu, H., Zhu, Z., Shi, W., Jiang, J., Yao, P., & Zhu, H. (2017). Risk Factors and Preventions of Breast Cancer. International Journal of Biological Sciences, 13(11), 1387–1397. [DOI:10.7150/ijbs.21635]
    • Sutherland, N., Espinel, W., Grotzke, M., & Colonna, S. (2020). Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults. Journal of Genetic Counseling, 29(4), 625–633. [DOI:10.1002/jgc4.1278]
    • T’Sjoen, G., Arcelus, J., Gooren, L., Klink, D. T., & Tangpricha, V. (2018). Endocrinology of Transgender Medicine. Endocrine Reviews, 40(1), 97–117. [DOI:10.1210/er.2018-00011]
    • Thellenberg, C., Malmer, B., Tavelin, B., & Grönberg, H. (2003). Second Primary Cancers in Men With Prostate Cancer: An Increased Risk of Male Breast Cancer. Journal of Urology, 169(4), 1345–1348. [DOI:10.1097/01.ju.0000056706.88960.7c]
    • Tiefenbacher, K., & Daxenbichler, G. (2008). The Role of Androgens in Normal and Malignant Breast Tissue. Breast Care, 3(5), 325–331. [DOI:10.1159/000158055]
    • Van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47(3), 337–343. [DOI:10.1046/j.1365-2265.1997.2601068.x]
    • Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012). Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons. The Journal of Sexual Medicine, 9(10), 2641–2651. [DOI:10.1111/j.1743-6109.2012.02876.x]
    • Wren, B. G., & Eden, J. A. (1996). Do Progestogens Reduce The Risk of Breast Cancer? A Review of the Evidence. Menopause, 3(1), 4–12. [DOI:10.1097/00042192-199603010-00003]
    • Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321–333. [DOI:10.1001/jama.288.3.321]
    • Zhu, H., Lei, X., Feng, J., & Wang, Y. (2012). Oral contraceptive use and risk of breast cancer: A meta-analysis of prospective cohort studies. The European Journal of Contraception & Reproductive Health Care, 17(6), 402–414. [DOI:10.3109/13625187.2012.715357]
    \ No newline at end of file diff --git a/transfemscience.org/articles/buserelin-inexpensive/index.html b/transfemscience.org/articles/buserelin-inexpensive/index.html index 4f21afde..c829dff5 100644 --- a/transfemscience.org/articles/buserelin-inexpensive/index.html +++ b/transfemscience.org/articles/buserelin-inexpensive/index.html @@ -1 +1 @@ -Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies - Transfeminine Science Link

    Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies

    By Aly | First published August 26, 2018 | Last modified March 1, 2023

    Abstract / TL;DR

    Buserelin is a gonadotropin-releasing hormone (GnRH) agonist which is formulated as a nasal spray for use two or three times per day. GnRH agonists are the ideal antiandrogens for use in transfeminine hormone therapy. They can completely suppress gonadal testosterone production and have essentially no side effects or risks (when used in combination with estrogen therapy to avoid sex-hormone deficiency). This is in contrast to more commonly used antiandrogenic approaches in transfeminine hormone therapy like spironolactone, cyproterone acetate, and bicalutamide, as well as high-dose estradiol monotherapy, which all have efficacy, tolerability, and/or safety issues depending on the option in question. However, GnRH agonists have historically been extremely costly and consequently inaccessible for most transfeminine people. Recently, certain Eastern European online pharmacies have started selling buserelin nasal spray very inexpensively. Because of this, GnRH agonists, for the first time, appear to be an affordable antiandrogen option for any transfeminine person who desires them.

    Introduction

    Buserelin, also known by its major brand name Suprefact, is a gonadotropin-releasing hormone (GnRH) agonist. GnRH agonists are powerful functional antiandrogens which are able to reduce testosterone levels in people with testes to the female or castrate range (<50 ng/dL). On account of their effectiveness and selectivity, GnRH agonists—as well as GnRH antagonists—may be considered the ideal antiandrogens for use in transfeminine hormone therapy.

    Buserelin is one of two GnRH agonists—the other being nafarelin (Synarel)—that are available in the form of nasal sprays. Both are used three times per day at roughly 8-hour intervals. Nasal spray is an alternative means of administration for GnRH agonists relative to the more common (and invasive) routes of injection and implant. The use of GnRH agonists and antagonists in transfeminine people has traditionally been limited by their high cost, which is typically on the order of US$10,000 per year (Wiki).

    Recently, buserelin has become available very inexpensively from a number of Eastern European online pharmacies. The first such pharmacy was known as Cherry Pharmacy (Reddit; Reddit; Reddit; Reddit; Reddit). They sold buserelin nasal spray here (180 × 150-μg doses for US$29.60) and here (140 × 150-μg doses for US$28.50). Buserelin stopped being purchasable from Cherry Pharmacy by February 2019 and the site is now defunct (Reddit; Reddit; Reddit; Reddit; Reddit; Reddit). But other online pharmacies have since begun selling inexpensive buserelin nasal spray as well and as of February 2020 the product is once again available via these sources (Reddit). A site called diyhrt.cafe maintains a list of online pharmacies that sell buserelin and other GnRH agonists.

    Dosage and Testosterone Suppression

    Dosage information for buserelin nasal spray is as follows (Wiki; see page for sources):

    For prostate cancer, the dosage of buserelin by subcutaneous injection is 500 µg three times per day (once every 8 hours, 1,500 µg/day total) for one week and then 200 µg once daily thereafter. If buserelin is used as a nasal spray, the dosage for prostate cancer is 800 µg sprayed into the nostrils three times per day (once every 8 hours, 2,400 µg/day total) for one week followed by 400 µg sprayed into the nostrils three times per day (once every 8 hours, 1,200 µg/day total) thereafter. For endometriosis, buserelin is used specifically as a nasal spray and the dosage is the same as that used for prostate cancer. These dosages of buserelin for both subcutaneous injection and nasal spray have been found to decrease testosterone levels to castrate or near-castrate levels in men with prostate cancer, although suppression was more complete with subcutaneous injection presumably due to suboptimal absorption with intranasal administration.

    And suppression of testosterone levels with different buserelin nasal spray dosing regimens is as follows (Wiki; see page for sources):

    Buserelin has been found to suppress testosterone levels in men with prostate cancer from 426 ng/dL to 28 ng/dL (by 93.4%) with 200 μg by subcutaneous injection once per day and from 521 ng/dL to 53 ng/dL (by 89.8%) with 400 μg by nasal spray once every 8 hours (1,200 μg/day total). The difference in suppression may have been due to poor compliance [with the nasal spray formulation]. A few small studies have also assessed the suppression of testosterone levels with buserelin nasal spray twice a day instead of three times a day. One such study found that testosterone levels in men with prostate cancer were suppressed during treatment with buserelin from 332 ng/dL to 215 ng/dL (28.9% lower than controls) with 200 μg by nasal spray twice a day (400 μg/day total), from 840 ng/dL to 182 ng/dL (71.4% lower than controls) with 500 μg by nasal spray twice a day (1,000 μg/day total), and from 598 ng/dL to 126 ng/dL (80.4% lower than controls) with 50 μg by subcutaneous injection once a day.

    Although the absorption of buserelin as a nasal spray may be suboptimal compared to injectable forms, and although buserelin nasal spray by itself may only be able to achieve near-castrate levels of testosterone (rather than the low castrate levels more typical of castration/GnRH agonists and antagonists), estrogens are also usually taken by transfeminine people and are likewise potent antigonadotropins. It may be the case that if even relatively low doses of estradiol are combined with buserelin, testosterone will be more fully suppressed (into the castrate/female range (<50 ng/dL) or by around 95%) than suggested by studies of buserelin alone. This is notably seen with progestogens, in which high doses are able to maximally suppress testosterone levels by 50 to 70% (to around 200–300 ng/dL on average) but combination with low doses of estrogens are able to suppress testosterone levels by around 95% or into the low castrate range (to around 20–30 ng/dL on average) (Aly, 2019). Similar influences on testosterone levels might be expected with the combination of buserelin and an estrogen.

    If for whatever reason an estrogen is not desired (e.g., if the purpose is simple puberty blockade or non-conventional hormone therapy for non-binary transfeminine people; Aly, 2019), buserelin could alternatively be combined with low doses of a progestogen to more fully suppress testosterone levels. Or, as another option, buserelin could be combined with spironolactone or low-dose bicalutamide to block the actions of testosterone that remains unsuppressed.

    It’s possible to use buserelin twice a day instead of three times a day for greater convenience. However, this does appear to result in somewhat diminished effectiveness in terms of testosterone suppression (Faure et al., 1982; Tolis et al., 1983). In any case, if buserelin is combined with an estrogen or progestogen, due to the supplementary testosterone suppression that they are expected to provide, more complete suppression of testosterone levels may still be achieved, and hence the reduced effectiveness of twice-daily buserelin might not actually be that consequential.

    It should be noted that the Cherry Pharmacy buserelin nasal sprays contain 150 μg buserelin per spray, whereas the dosage information above assumes that the nasal spray can deliver an even 400 μg in sprays total per dose. Obviously, this isn’t possible with a nasal spray that delivers 150 μg per spray. Instead, such a product could be used to provide 300 μg per dose (two sprays) or 450 μg per dose (three sprays). If buserelin is combined with an estrogen or a progestogen, which will help suppress testosterone levels, it might be optimal to opt for the former lower buserelin amount of 300 μg per dose (two sprays). Conversely, if buserelin is not combined with a supplemental antigonadotropin, the latter higher buserelin amount of 450 μg per dose (three sprays) might be advisable. Alternatively, a person could administer a mix of 450 μg for the first dose, 300 μg for the second dose, and 450 μg for the third dose each day to achieve an even dosage of 1,200 μg per day (which would be equal in total dose to 400 μg three times per day and in line with the buserelin dosage information provided above).

    Costs of Different Dosing Regimens

    The costs of the buserelin nasal sprays from Cherry Pharmacy, dosed the recommended three times per day and not including tax or shipping and handling, break down as follows:

    Bottle versionDoses each dayaTotal per dayBottle will last…Cost per 30 days
    180x 150-μg doses300 μg, 300 μg, 300 μg900 μg30 daysUS$29.60
     450 μg, 300 μg, 450 μg1,200 μg22.5 daysUS$39.47
     450 μg, 450 μg, 450 μg1,350 μg20 daysUS$44.40
    140x 150-μg doses300 μg, 300 μg, 300 μg900 μg23.3 daysUS$36.64
     450 μg, 300 μg, 450 μg1,200 μg17.5 daysUS$48.86
     450 μg, 450 μg, 450 μg1,350 μg15.6 daysUS$54.96

    a One dose administered every 8 or so hours, 3 times per day in total.

    The most inexpensive dosing regimen would be the US$29.60 option, whereas a good balance between cost and effectiveness might be the US$39.47 option. If a person were to do twice daily administration of buserelin, a regimen of 600 μg in the morning and 600 μg in the evening (12-hour separation), for a total dosage per day of 1,200 μg, might be optimal. This is the same total daily dosage as the US$39.47 option, and hence would be the same cost.

    The preceding cost information is obsolete as Cherry Pharmacy is now defunct. However, other sources of buserelin nasal spray may have similar pricing. Hence, the breakdown may still have some relevance.

    Initiation of Therapy

    A higher dosage of buserelin is recommended during the first week of therapy in buserelin dosing materials. In addition, GnRH agonists cause a flare in testosterone levels during the first week of treatment, with testosterone levels returning to around baseline by the end of that week (Wiki). It takes about 2 to 4 weeks for GnRH agonists to reduce testosterone levels to the female or castrate range (<50 ng/dL) (Wiki). These considerations should be kept in mind when buserelin nasal spray as well as other GnRH agonists are used. The following passage provides more detail on the early dynamics of testosterone suppression with GnRH agonists and antagonists (Wiki; see page for sources):

    There are two types of GnRH modulators: GnRH agonists and GnRH antagonists. These medications have the opposite action on the GnRH receptor but paradoxically have the same therapeutic effects. GnRH agonists, such as leuprorelin (Lupron), goserelin (Zoladex), and buserelin (Suprefact), are GnRH receptor superagonists, and work by producing profound desensitization of the GnRH receptor such that the receptor becomes non-functional. This occurs because GnRH is normally released in pulses, but GnRH agonists are continuously present. At the initiation of treatment, GnRH agonists are associated with a “flare” effect on hormone levels due to acute overstimulation of the GnRH receptor. In men, [luteinzing hormone (LH)] levels increase by up to 800% while testosterone levels increase to about 140 to 200% of baseline. Gradually however, the GnRH receptor desensitizes; testosterone levels peak after about 2 to 4 days, return to baseline after about 7 to 8 days, and are reduced to castrate levels within 2 to 4 weeks. Antigonadotropins such as estrogens and cyproterone acetate can be used to diminish or prevent the testosterone flare caused by GnRH agonists. In contrast to GnRH agonists, GnRH antagonists, such as degarelix (Firmagon) and elagolix (Orilissa), work by binding to the GnRH receptor without activating it, thereby displacing GnRH from the receptor and preventing its activation. Unlike with GnRH agonists, there is no initial surge effect with GnRH antagonists, and the therapeutic effects are immediate; sex hormone levels are reduced to castrate levels within a few days.

    Discussion and Conclusions

    GnRH agonists and antagonists are the ideal antiandrogens for use in transfeminine hormone therapy. They are the most effective, best-tolerated, and safest antiandrogens that are currently available. One could conceptualize them essentially as a readily reversible orchiectomy and little else. When used in combination with an estrogen, GnRH agonists and antagonists have none of the side effects and risks of more mainstream antiandrogens like spironolactone, cyproterone acetate, and bicalutamide. They also have none of the potential efficacy concerns associated with antiandrogens that act mainly as androgen receptor antagonists, such as spironolactone and bicalutamide. GnRH agonists and antagonists allow for the use of essentially any dosage of estradiol without having to worry about testosterone suppression.

    Access to GnRH agonists and antagonists has been limited for transfeminine people due to the high costs of these medications and the fact that medical insurance usually denies them. As a result of the availability of inexpensive buserelin nasal spray from online pharmacies however, it would appear that GnRH agonists are now a practical and affordable option for essentially any transfeminine person who desires them. Provided one doesn’t mind the inconvenience of having to use a nasal spray multiple times per day, buserelin may be among the best available options for an antiandrogen in transfeminine people.

    References

    • Faure, N., Labrie, F., Lemay, A., Bélanger, A., Gourdeau, Y., Laroche, B., & Robert, G. (1982). Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertility and Sterility, 37(3), 416–424. [DOI:10.1016/S0015-0282(16)46107-8]
    • Tolis, G., Faure, N., Koutsilieris, M., Lemay, A., Klioze, S., Yakabow, A., & Fazekas, A. T. A. (1983). Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administration. Journal of Steroid Biochemistry, 19(1), 995–998. [DOI:10.1016/0022-4731(83)90045-6]
    \ No newline at end of file +Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies - Transfeminine Science Link

    Buserelin, a Gonadotropin-Releasing Hormone Agonist, is Inexpensively Available as a Nasal Spray From Online Pharmacies

    By Aly | First published August 26, 2018 | Last modified March 1, 2023

    Abstract / TL;DR

    Buserelin is a gonadotropin-releasing hormone (GnRH) agonist which is formulated as a nasal spray for use two or three times per day. GnRH agonists are the ideal antiandrogens for use in transfeminine hormone therapy. They can completely suppress gonadal testosterone production and have essentially no side effects or risks (when used in combination with estrogen therapy to avoid sex-hormone deficiency). This is in contrast to more commonly used antiandrogenic approaches in transfeminine hormone therapy like spironolactone, cyproterone acetate, and bicalutamide, as well as high-dose estradiol monotherapy, which all have efficacy, tolerability, and/or safety issues depending on the option in question. However, GnRH agonists have historically been extremely costly and consequently inaccessible for most transfeminine people. Recently, certain Eastern European online pharmacies have started selling buserelin nasal spray very inexpensively. Because of this, GnRH agonists, for the first time, appear to be an affordable antiandrogen option for any transfeminine person who desires them.

    Introduction

    Buserelin, also known by its major brand name Suprefact, is a gonadotropin-releasing hormone (GnRH) agonist. GnRH agonists are powerful functional antiandrogens which are able to reduce testosterone levels in people with testes to the female or castrate range (<50 ng/dL). On account of their effectiveness and selectivity, GnRH agonists—as well as GnRH antagonists—may be considered the ideal antiandrogens for use in transfeminine hormone therapy.

    Buserelin is one of two GnRH agonists—the other being nafarelin (Synarel)—that are available in the form of nasal sprays. Both are used three times per day at roughly 8-hour intervals. Nasal spray is an alternative means of administration for GnRH agonists relative to the more common (and invasive) routes of injection and implant. The use of GnRH agonists and antagonists in transfeminine people has traditionally been limited by their high cost, which is typically on the order of US$10,000 per year (Wiki).

    Recently, buserelin has become available very inexpensively from a number of Eastern European online pharmacies. The first such pharmacy was known as Cherry Pharmacy (Reddit; Reddit; Reddit; Reddit; Reddit). They sold buserelin nasal spray here (180 × 150-μg doses for US$29.60) and here (140 × 150-μg doses for US$28.50). Buserelin stopped being purchasable from Cherry Pharmacy by February 2019 and the site is now defunct (Reddit; Reddit; Reddit; Reddit; Reddit; Reddit). But other online pharmacies have since begun selling inexpensive buserelin nasal spray as well and as of February 2020 the product is once again available via these sources (Reddit). A site called diyhrt.cafe maintains a list of online pharmacies that sell buserelin and other GnRH agonists.

    Dosage and Testosterone Suppression

    Dosage information for buserelin nasal spray is as follows (Wiki; see page for sources):

    For prostate cancer, the dosage of buserelin by subcutaneous injection is 500 µg three times per day (once every 8 hours, 1,500 µg/day total) for one week and then 200 µg once daily thereafter. If buserelin is used as a nasal spray, the dosage for prostate cancer is 800 µg sprayed into the nostrils three times per day (once every 8 hours, 2,400 µg/day total) for one week followed by 400 µg sprayed into the nostrils three times per day (once every 8 hours, 1,200 µg/day total) thereafter. For endometriosis, buserelin is used specifically as a nasal spray and the dosage is the same as that used for prostate cancer. These dosages of buserelin for both subcutaneous injection and nasal spray have been found to decrease testosterone levels to castrate or near-castrate levels in men with prostate cancer, although suppression was more complete with subcutaneous injection presumably due to suboptimal absorption with intranasal administration.

    And suppression of testosterone levels with different buserelin nasal spray dosing regimens is as follows (Wiki; see page for sources):

    Buserelin has been found to suppress testosterone levels in men with prostate cancer from 426 ng/dL to 28 ng/dL (by 93.4%) with 200 μg by subcutaneous injection once per day and from 521 ng/dL to 53 ng/dL (by 89.8%) with 400 μg by nasal spray once every 8 hours (1,200 μg/day total). The difference in suppression may have been due to poor compliance [with the nasal spray formulation]. A few small studies have also assessed the suppression of testosterone levels with buserelin nasal spray twice a day instead of three times a day. One such study found that testosterone levels in men with prostate cancer were suppressed during treatment with buserelin from 332 ng/dL to 215 ng/dL (28.9% lower than controls) with 200 μg by nasal spray twice a day (400 μg/day total), from 840 ng/dL to 182 ng/dL (71.4% lower than controls) with 500 μg by nasal spray twice a day (1,000 μg/day total), and from 598 ng/dL to 126 ng/dL (80.4% lower than controls) with 50 μg by subcutaneous injection once a day.

    Although the absorption of buserelin as a nasal spray may be suboptimal compared to injectable forms, and although buserelin nasal spray by itself may only be able to achieve near-castrate levels of testosterone (rather than the low castrate levels more typical of castration/GnRH agonists and antagonists), estrogens are also usually taken by transfeminine people and are likewise potent antigonadotropins. It may be the case that if even relatively low doses of estradiol are combined with buserelin, testosterone will be more fully suppressed (into the castrate/female range (<50 ng/dL) or by around 95%) than suggested by studies of buserelin alone. This is notably seen with progestogens, in which high doses are able to maximally suppress testosterone levels by 50 to 70% (to around 200–300 ng/dL on average) but combination with low doses of estrogens are able to suppress testosterone levels by around 95% or into the low castrate range (to around 20–30 ng/dL on average) (Aly, 2019). Similar influences on testosterone levels might be expected with the combination of buserelin and an estrogen.

    If for whatever reason an estrogen is not desired (e.g., if the purpose is simple puberty blockade or non-conventional hormone therapy for non-binary transfeminine people; Aly, 2019), buserelin could alternatively be combined with low doses of a progestogen to more fully suppress testosterone levels. Or, as another option, buserelin could be combined with spironolactone or low-dose bicalutamide to block the actions of testosterone that remains unsuppressed.

    It’s possible to use buserelin twice a day instead of three times a day for greater convenience. However, this does appear to result in somewhat diminished effectiveness in terms of testosterone suppression (Faure et al., 1982; Tolis et al., 1983). In any case, if buserelin is combined with an estrogen or progestogen, due to the supplementary testosterone suppression that they are expected to provide, more complete suppression of testosterone levels may still be achieved, and hence the reduced effectiveness of twice-daily buserelin might not actually be that consequential.

    It should be noted that the Cherry Pharmacy buserelin nasal sprays contain 150 μg buserelin per spray, whereas the dosage information above assumes that the nasal spray can deliver an even 400 μg in sprays total per dose. Obviously, this isn’t possible with a nasal spray that delivers 150 μg per spray. Instead, such a product could be used to provide 300 μg per dose (two sprays) or 450 μg per dose (three sprays). If buserelin is combined with an estrogen or a progestogen, which will help suppress testosterone levels, it might be optimal to opt for the former lower buserelin amount of 300 μg per dose (two sprays). Conversely, if buserelin is not combined with a supplemental antigonadotropin, the latter higher buserelin amount of 450 μg per dose (three sprays) might be advisable. Alternatively, a person could administer a mix of 450 μg for the first dose, 300 μg for the second dose, and 450 μg for the third dose each day to achieve an even dosage of 1,200 μg per day (which would be equal in total dose to 400 μg three times per day and in line with the buserelin dosage information provided above).

    Costs of Different Dosing Regimens

    The costs of the buserelin nasal sprays from Cherry Pharmacy, dosed the recommended three times per day and not including tax or shipping and handling, break down as follows:

    Bottle versionDoses each dayaTotal per dayBottle will last…Cost per 30 days
    180x 150-μg doses300 μg, 300 μg, 300 μg900 μg30 daysUS$29.60
     450 μg, 300 μg, 450 μg1,200 μg22.5 daysUS$39.47
     450 μg, 450 μg, 450 μg1,350 μg20 daysUS$44.40
    140x 150-μg doses300 μg, 300 μg, 300 μg900 μg23.3 daysUS$36.64
     450 μg, 300 μg, 450 μg1,200 μg17.5 daysUS$48.86
     450 μg, 450 μg, 450 μg1,350 μg15.6 daysUS$54.96

    a One dose administered every 8 or so hours, 3 times per day in total.

    The most inexpensive dosing regimen would be the US$29.60 option, whereas a good balance between cost and effectiveness might be the US$39.47 option. If a person were to do twice daily administration of buserelin, a regimen of 600 μg in the morning and 600 μg in the evening (12-hour separation), for a total dosage per day of 1,200 μg, might be optimal. This is the same total daily dosage as the US$39.47 option, and hence would be the same cost.

    The preceding cost information is obsolete as Cherry Pharmacy is now defunct. However, other sources of buserelin nasal spray may have similar pricing. Hence, the breakdown may still have some relevance.

    Initiation of Therapy

    A higher dosage of buserelin is recommended during the first week of therapy in buserelin dosing materials. In addition, GnRH agonists cause a flare in testosterone levels during the first week of treatment, with testosterone levels returning to around baseline by the end of that week (Wiki). It takes about 2 to 4 weeks for GnRH agonists to reduce testosterone levels to the female or castrate range (<50 ng/dL) (Wiki). These considerations should be kept in mind when buserelin nasal spray as well as other GnRH agonists are used. The following passage provides more detail on the early dynamics of testosterone suppression with GnRH agonists and antagonists (Wiki; see page for sources):

    There are two types of GnRH modulators: GnRH agonists and GnRH antagonists. These medications have the opposite action on the GnRH receptor but paradoxically have the same therapeutic effects. GnRH agonists, such as leuprorelin (Lupron), goserelin (Zoladex), and buserelin (Suprefact), are GnRH receptor superagonists, and work by producing profound desensitization of the GnRH receptor such that the receptor becomes non-functional. This occurs because GnRH is normally released in pulses, but GnRH agonists are continuously present. At the initiation of treatment, GnRH agonists are associated with a “flare” effect on hormone levels due to acute overstimulation of the GnRH receptor. In men, [luteinzing hormone (LH)] levels increase by up to 800% while testosterone levels increase to about 140 to 200% of baseline. Gradually however, the GnRH receptor desensitizes; testosterone levels peak after about 2 to 4 days, return to baseline after about 7 to 8 days, and are reduced to castrate levels within 2 to 4 weeks. Antigonadotropins such as estrogens and cyproterone acetate can be used to diminish or prevent the testosterone flare caused by GnRH agonists. In contrast to GnRH agonists, GnRH antagonists, such as degarelix (Firmagon) and elagolix (Orilissa), work by binding to the GnRH receptor without activating it, thereby displacing GnRH from the receptor and preventing its activation. Unlike with GnRH agonists, there is no initial surge effect with GnRH antagonists, and the therapeutic effects are immediate; sex hormone levels are reduced to castrate levels within a few days.

    Discussion and Conclusions

    GnRH agonists and antagonists are the ideal antiandrogens for use in transfeminine hormone therapy. They are the most effective, best-tolerated, and safest antiandrogens that are currently available. One could conceptualize them essentially as a readily reversible orchiectomy and little else. When used in combination with an estrogen, GnRH agonists and antagonists have none of the side effects and risks of more mainstream antiandrogens like spironolactone, cyproterone acetate, and bicalutamide. They also have none of the potential efficacy concerns associated with antiandrogens that act mainly as androgen receptor antagonists, such as spironolactone and bicalutamide. GnRH agonists and antagonists allow for the use of essentially any dosage of estradiol without having to worry about testosterone suppression.

    Access to GnRH agonists and antagonists has been limited for transfeminine people due to the high costs of these medications and the fact that medical insurance usually denies them. As a result of the availability of inexpensive buserelin nasal spray from online pharmacies however, it would appear that GnRH agonists are now a practical and affordable option for essentially any transfeminine person who desires them. Provided one doesn’t mind the inconvenience of having to use a nasal spray multiple times per day, buserelin may be among the best available options for an antiandrogen in transfeminine people.

    References

    • Faure, N., Labrie, F., Lemay, A., Bélanger, A., Gourdeau, Y., Laroche, B., & Robert, G. (1982). Inhibition of serum androgen levels by chronic intranasal and subcutaneous administration of a potent luteinizing hormone-releasing hormone (LH-RH) agonist in adult men. Fertility and Sterility, 37(3), 416–424. [DOI:10.1016/S0015-0282(16)46107-8]
    • Tolis, G., Faure, N., Koutsilieris, M., Lemay, A., Klioze, S., Yakabow, A., & Fazekas, A. T. A. (1983). Suppression of testicular steroidogenesis by the GnRH agonistic analogue Buserelin (HOE-766) in patients with prostatic cancer: studies in relation to dose and route of administration. Journal of Steroid Biochemistry, 19(1), 995–998. [DOI:10.1016/0022-4731(83)90045-6]
    \ No newline at end of file diff --git a/transfemscience.org/articles/cpa-dosage/index.html b/transfemscience.org/articles/cpa-dosage/index.html index 28285434..33101e26 100644 --- a/transfemscience.org/articles/cpa-dosage/index.html +++ b/transfemscience.org/articles/cpa-dosage/index.html @@ -1 +1 @@ -Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People - Transfeminine Science Link

    Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People

    By Aly | First published July 1, 2019 | Last modified March 18, 2024

    Abstract / TL;DR

    Cyproterone acetate (CPA) is a progestogen and antiandrogen which is widely used in transfeminine hormone therapy. It is far more potent as a progestogen than as an androgen receptor antagonist. CPA has typically been used at doses of 1 to 2 mg/day as a progestogen in cisgender women and at doses of 50 to 300 mg/day as an antiandrogen. At typical antiandrogen doses of CPA, there is profound progestogenic overdosage as well as associated side effects and risks. CPA has antigonadotropic effects due to its progestogenic activity and thereby suppresses testosterone levels. By itself, CPA can maximally suppress testosterone levels by 50 to 70%, and in combination with even small amounts of estrogen, it can fully suppress gonadal testosterone production and thereby reduce testosterone levels by about 95%—or well into the female range. Although doses of CPA of 50 to 100 mg/day have been used in transfeminine people historically, it is now clear that 5 to 10 mg/day CPA has maximal or near-maximal effectiveness in terms of suppression of testosterone levels. CPA alone is most commonly available as 50-mg tablets. These tablets can be split with a pill cutter and taken once every day to once every other day to achieve an overall CPA dosage of 6.25 to 12.5 mg/day. These lower doses of CPA are not only much more cost-effective than traditional doses but are also likely to have better tolerability and safety. Due to the retained effectiveness of lower CPA doses and the known dose-dependent risks of CPA, doses of CPA used clinically in transfeminine people have been in a rapid decline.

    Introduction

    This article is about the dosage of cyproterone acetate (CPA), a progestin and antiandrogen, for use in hormone therapy for transfeminine people. It argues for the use of lower doses of CPA and goes fairly in-depth to justify these doses. If you are only interested in recommended doses of CPA for transfeminine people, they can be found in the Recommended Dosages section below.

    Potency, Conventional Dosages, and Health Risks

    CPA is a potent progestogen, with an ovulation-inhibiting dosage of about 1 mg/day and endometrial transformation dosage of about 1 to 3 mg/day in cisgender women (Wiki; Table; Endrikat et al., 2011). These dosages of CPA are similar in strength of progestogenic effect to those of normal progesterone production and levels during the luteal phase of the menstrual cycle in premenopausal women (which are about 25 mg/day and 15 ng/mL, respectively). In relation to the preceding, when CPA is used as a progestogen in cisgender women, for instance in birth control pills and menopausal hormone therapy preparations, it is formulated at a dose of 1 or 2 mg per tablet (Wiki).

    In contrast to its progestogenic activity, CPA is far less potent as an androgen receptor antagonist (Wiki). When used as an antiandrogen, it is generally given at a dosage of 50 to 300 mg/day, both in cisgender women and men. A dosage of 50 to 100 mg/day is typical for androgen-dependent skin and hair conditions like acne and hirsutism in women and a dosage of 100 to 300 mg/day is typically used for prostate cancer in men (specifically 100–200 mg/day for CPA combined with castration and 200–300 mg/day for CPA monotherapy) (Wiki). As such, CPA is generally formulated at a dose of 50 or 100 mg per tablet for use in androgen-dependent conditions (Wiki). As an antiandrogen, CPA has a dual mechanism of action of both suppressing testosterone levels via its progestogenic activity at low doses and additionally blocking the actions of testosterone directly at the androgen receptor at higher doses.

    Because CPA is so much more potent as a progestogen than as an androgen receptor antagonist, there is profound overdosage of progestogenic effect when CPA is used as an antiandrogen at typical clinical dosages. This is described in the following three literature excerpts by Jürgen Hammerstein, one of the scientists who developed CPA (Hammerstein et al., 1975; Hammerstein, 1990; Hammerstein, 1979):

    Like chlormadinone acetate, its parent compound, CPA is also a strong progestogen with the endometrial transformation dose of both drugs being between 20 and 30 mg. […] To take full therapeutic advantage of its antiandrogenicity, CPA must be administered in doses per month that are 30 times the physiological equivalent of progesterone production in the cycle. CPA, although the most useful compound available in this field at the moment, cannot be considered therefore an ideal antiandrogen, all the more as some of the side effects may be related to the progestational overdosage rather than to the administered antiandrogenic activity. […] Adverse reactions like tiredness, lassitude, and increase in body weight are possibly due to the enormous overdose of progestational activity in the formula which is necessary to take full advantage of the antiandrogenicity of CPA.

    Fixson (1963) tested CPA in ovariectomized women after pre-treatment with oestrogens; with a transformation dose of 20–30 mg this proved a powerful progestogen. The potency of CPA in the menses delay test is not exactly known, but has been estimated to be below 1 mg/day (Miller and Jacobs 1986). In relation to this progestational potency, its antiandrogenicity must be considered rather weak. Thus, in order to take full advantage of the latter, 100 mg CPA must be given daily, i.e. three times the cyclic transformation dose per day (Hammerstein and Cupceancu 1969); notably, this parameter is equivalent to the total progesterone production of a corpus luteum throughout its entire cyclic life span.

    CPA may be characterized endocrinologically as possessing strong progestational [and] moderate anti-androgenic […] potencies. […] Its progestational activity, in terms of the transformation dose in the oestrogen-primed human endometrium, is 20–30 mg [per month/cycle] which is comparable to that of chlormadinone acetate and other strong progestogens. To take full clinical advantage of its anti-androgenicity not less than 50–100 mg CPA must be taken orally per day, which totals 2 to 3 times the progestational activity the female organism is exposed to throughout a complete ovulatory menstrual cycle. Thus unless much lower and less efficacious doses of CPA are used, a tremendous progestational overdosage must be accepted. […] As already pointed out CPA is endocrinologically not a well-balanced compound because of the strong preponderance of the progestational over the anti-androgenic potency. A way to avoid the heavy progestogen overdosage inherent with the high-dose reverse sequential therapy would be to combine the low-dose contraceptive formulation just mentioned with a pure anti-androgen such as free cyproterone. […] It must be emphasized that CPA is far from being an ideal drug for the anti-androgenic treatment of hirsutism because its progestational potency is much too strong and it is not effective when administered topically. Therefore it is worthwhile looking for better-balanced anti-androgenic compounds for the future.

    The massive overdosage of progestogenic effect that occurs at such doses of CPA is likely responsible for the known adverse effects and risks of higher doses of CPA (Wiki). Examples of these side effects include fatigue, depression, weight gain, high prolactin levels (Wiki), benign brain tumors (Aly, 2020; Wiki; Table; Table), blood clots (Wiki), and cardiovascular problems (Wiki). Such risks are dose-dependent and have not been associated with 1 or 2 mg/day CPA (with the exception of an expected increase in the risk of blood clots in combination with oral estrogens for birth control or menopausal hormone therapy). The risk of liver toxicity with CPA is also dose-dependent, with elevated liver enzymes occurring mostly only at a dosage of 20 mg/day and above and rare cases of liver failure occurring almost exclusively at dosages of 100 mg/day and above (Wiki; Table). As such, there is good rationale for using the lowest possible effective dosage of CPA, an approach that is likely to minimize risks.

    In transfeminine people, CPA has historically been used at a dosage of 50 to 100 mg/day (e.g., Moore, Wisniewski, & Dobs, 2003). Some earlier papers have recommended even higher doses of CPA, for instance 100 to 150 mg/day (Asscheman & Gooren, 1993). In 2017, the Endocrine Society published the latest edition of their clinical practice guidelines on hormone therapy for transgender people and reduced their recommended dosage of CPA from 50–100 mg/day to 25–50 mg/day (Hembree et al., 2017; Hembree et al., 2009). This was motivated in part by increasing knowledge and awareness of the risks of higher doses of CPA and by findings that these lower doses of CPA were still effective. However, it is likely that even these new lower dosages are still far in excess of what is really needed.

    Testosterone Suppression with Low and High Doses

    Progestogens by themselves, including CPA, are able to considerably suppress testosterone levels in gonadally intact people assigned male at birth. Around a dozen small and low-quality but nonetheless notable studies of low-dose CPA from the 1970s and early 1980s found that 5 to 10 mg/day CPA suppressed testosterone levels by about 40 to 70% in healthy young men (Table 1). A couple of individual studies notably reported virtually identical suppression of testosterone levels with 5 mg/day versus 10 mg/day CPA (both ~50% suppression) (Wang & Yeung, 1980; Graph) and with 10 mg/day versus 20 mg/day CPA (both ~60–70% suppression) (Koch et al., 1976; Koch et al., 1975; Graph). This lack of additional testosterone suppression with a doubling of dosage within studies suggests that testosterone suppression with CPA might have actually been maximal at a dosage of only 5 or 10 mg/day. A more modern study, which used a newer and more reliable analytic method for quantification of blood testosterone, found that 10 mg/day CPA suppressed testosterone levels by 66%, from about 600 ± 150 ng/dL to about 185 ng/dL (Meriggiola et al., 2002a; Graph). Similarly, another more modern study found that 10 to 20 mg/day CPA suppressed testosterone levels by 65%, from about 431 ng/dL to about 149 ng/dL, with no reported differences between doses (Zitzmann et al., 2017; Graph).

    Table 1: Levels of testosterone and other sex hormones with CPA at low doses (5–30 mg/day):

    Treatment and subjectsFindingsSource(s)
    30 mg/day CPA in 5 normal malesT decreased “remarkably”. Exact values not given, but has graphs of T levels in a few individuals. After 30 mg/day, 5 mg/day was tried in one case and was not as effective in suppressing sperm production or T. Also reported decreases in gonadotropin excretion.Petry et al. (1972); Petry et al. (1970a); Petry et al. (1970b); Petry et al. (1970c)
    10 or 20 mg/day CPA in 15 normal healthy fertile males (age 25–35 years) (7 in 10 mg/day group and 8 in 20 mg/day group)“Androgens (mainly T)” decreased by 60% for both 10 and 20 mg/day. Inconsistent changes in LH and slight decrease in FSH. Exact values not given, except in graphs.Koch et al. (1976); Koch et al. (1975)
    0, 5, or 10 mg/day CPA in 18 healthy males (age 20–40 years) (6 in each group)T decreased, while LH and FSH were unchanged. No other details given, nor were exact hormone levels given.Roy et al. (1976)
    10 mg/day CPA in 10 young healthy fertile men (age mean 27.2 ± 3.2 (range 21–35) years)T decreased by 70%, DHT by 50%, LH by 30%, and FSH by 40%, while PRL increased by 75%. T was 495 ± 66 ng/dL before, 154 ± 23 ng/dL after 4 weeks, and 187 ± 38 ng/dL after 12 weeks. Also has values and graphs for other hormones.Moltz et al. (1980); Moltz et al. (1978a); Moltz et al. (1978b)
    5 or 10 mg/day CPA in 14 healthy males (age 20–40 years) (7 in each group)T decreased in both groups. No other details given, nor were exact hormone levels given.Roy & Chatterjee (1979a)
    10 mg/day CPA alone for 12–18 weeks then 75 mg/day mesterolone added in 3 normal fertile men (age 32–35 years)No information on T provided in this paper.Roy & Chatterjee (1979b)
    20 mg/day CPA in 10 healthy males (age 26–55 years)T decreased by 73% (range 71–75%), from 482 ng/dL (range 410–560 ng/dL) to 130 ng/dL (110–162 ng/dL). DHT decreased by 51% (range 47–55%), LH by 39% (range 34–45%), FSH by 66% (range 47–78%), 17-OH-P4 by 59%, A4 by 30%, TS by 34%, and DHTS by 35%. Also has exact values and graphs for other hormones.de la Torre (1979)
    5 or 10 mg/day CPA in 7 males (4 in each group; 1 received both 5 and 10 mg/day CPA at different times)T change was “−40%” or “–50%”. At 5 mg/day, T was 745 ng/dL before, 460 ng/dL with treatment (–38%), and 668 ng/dL after discontinuation. At 10 mg/day, T was 708 ng/dL before, 398 ng/dL with t (reatment–44%), and 670 ng/dL after discontinuation. Also reported LH and FSH levels.Føgh et al. (1979); Damgaard-Pederson et al. (1980); Føgh et al. (1980); Foegh (1983)
    0, 5, or 10 mg/day CPA in 25 normal healthy males (age 20–51 years); 7 in 5 mg group (mean 37 ± 10 years), 8 in 10 mg group (mean 32 ± 8 years), 10 in 0 mg group (mean 32 ± 10 years)At 5 mg/day, T decreased from 663 ± 120 ng/dL to 320 ± 160 ng/dL (−52%), and at 10 mg/day, T decreased from 692 ± 180 ng/dL to 340 ± 160 ng/dL (−51%). E2 decreased in parallel to T. At 5 mg/day, LH decreased from 2.1 ± 0.7 IU/L to 1.4 ± 0.5 IU/L (−33%), and at 10 mg/day, LH decreased from 2.3 ± 1.0 IU/L to 1.2 ± 0.5 IU/L (−48%). At 5 mg/day, FSH decreased from 3.1 ± 1.9 IU/L to 1.8 ± 0.9 IU/L (−42%), and at 10 mg/day, FSH decreased from 2.7 ± 1.0 IU/L to 1.5 ± 0.7 IU/L (−44%).Wang & Yeung (1980)
    10 or 25 mg/day CPA in 4 healthy men (age 29–37 years); 3 in 10 mg group, 1 in 25 mg groupT “slightly reduced”. E “more significantly lowered”. LH not significantly changed. FSH “reduced” in “more or less all cases”. Exact hormone levels not given, but graphs provided with the values.Fredricsson & Carlström (1981)
    10 or 20 mg/day CPA in 30 healthy males (age 21–38 years)T decreased by 70%, LH decreased by 35%, and “similar observations for FSH”. Exact values not provided.Moltz et al. (1982)
    10 mg/day CPA (also placebo and 2, 5, and 10 mg/day dienogest) in 5 healthy men in each groupWith CPA, T decreased from ~600 ± 150 ng/dL to ~185 ng/dL (–66 ± 4%). Also reported LH, FSH, and SHBG, as well as hormonal changes with placebo and dienogest (2, 5, and 10 mg/day).Meriggiola et al. (2002a)
    10 or 20 mg/day CPA in 14 healthy young men (7 in each group)T decreased from ~431 ng/dL at baseline to ~149 ng/dL with CPA (–65%) for the 10 and 20 mg/day doses combined. Values for dose subgroups not given. No significant differences between LH/FSH suppression between groups (which is indirectly suggestive of no differences in T suppression as well). Also reported hormone levels with other progestins.Zitzmann et al. (2017)

    These graphs adapted from some of the studies provide visualizations of some of the findings:

    Figures 1–4: Testosterone levels during treatment with low doses of CPA alone in men. Sources: Top: Moltz et al. (1980); Moltz et al. (1978a); Moltz et al. (1978b). Mid-left: Wang & Yeung (1980). Mid-right: Koch et al. (1976); Koch et al. (1975). Bottom: Meriggiola et al. (2002a). See also on Wikipedia: Gallery. The bottom graph is the 2002 study using DELFIA to quantify testosterone levels. This study also assessed different doses of dienogest (DNG), which has an ovulation-inhibiting dose of 1 mg/day similarly to CPA.

    Studies with other progestogens, such as desogestrel, dienogest, and medroxyprogesterone acetate, have consistently found that maximal suppression of testosterone levels in men occurs at a dosage that is between 5 and 10 times that of the ovulation-inhibiting dosage in cisgender women (Wiki; Wiki; Wiki). Another study is likewise suggestive of this for norethisterone acetate and levonorgestrel (Zitzmann et al., 2017; Graph). Along similar lines, doses of progestogens investigated for use in male hormonal contraception, in which the goal is antigonadotropic effects and the lowest fully effective dose is targeted, have been noted as being between 5 and 12 times the doses used in cisgender women (Foegh, 1983). Based on an ovulation-inhibiting dosage of CPA of 1 mg/day, these findings would imply that suppression of testosterone levels with CPA would likely be maximal at a dose of between 5 and 10 mg/day. In accordance, this dose range matches up with the findings of the studies above.

    Studies of much higher doses of CPA have shown little better suppression of testosterone levels than lower doses. Modern studies in healthy young adult and adolescent transfeminine people have found that 50 to 100 mg/day CPA alone suppresses testosterone levels by 46 to 61% (from 456–602 ng/dL to 226–294 ng/dL at 4–12 months) (Toorians et al., 2003; Giltay et al., 2004; T’Sjoen et al., 2005; Tack et al., 2017). Older studies in elderly men with prostate cancer have found greater suppression of testosterone levels with high-dose CPA monotherapy (by up to 70–80%, typically to between 50–200 ng/dL) (Gräf, Brotherton, & Neumann, 1974; Jacobi et al., 1980; Graph; Knuth, Hano, & Nieschlag, 1984; Graph; Schröder & Radlmaier, 2002; Nelson, 2012). The greater testosterone suppression in men with prostate cancer may be related to different blood-testing methodology between studies and/or to the fact that older men have weaker hypothalamic–pituitary–gonadal (HPG) axes and lower testosterone levels (Liu, Takahashi, & Veldhuis, 2017; Winters, Wang, & Fortigel Study Group, 2010).

    Although progestogens can considerably suppress testosterone levels at maximally effective dosages, it has been found that a “recovery” or “escape phenomenon”, in which testosterone levels eventually increase back to higher levels, occurs when progestogen monotherapy is used on a long-term basis. This has most notably been observed with the related progestogen megestrol acetate (Wiki), but has also been seen with CPA (Goldenberg & Bruchovsky, 1991; Saborowski, 1987; Jacobi, Tunn, & Senge, 1982). In one of these studies, testosterone levels were initially suppressed by CPA by about 70%, but increased back to about 50% of baseline between 6 and 12 months of therapy, remaining stable thereafter up to 24 months. The testosterone escape phenomenon should be kept in mind in the context of progestogen monotherapy for testosterone suppression. In contrast to progestogen monotherapy, this phenomenon has not been associated with combined estrogen and progestogen therapy.

    Testosterone Suppression in Combination with Estrogen

    CPA is generally used in combination with an estrogen in transfeminine people. Estrogens suppress testosterone levels similarly to progestogens. The combination of an estrogen and a progestogen is synergistic in terms of testosterone suppression and results in suppression of testosterone levels with lower doses than with either an estrogen or progestogen alone (Fink, 1979; Geller & Albert, 1983; Bastianelli et al., 2018). Although estrogens can suppress testosterone levels to an equivalent extent as surgical or medical castration (i.e., orchiectomy or GnRH agonists/antagonists), this usually requires relatively high estrogen levels, for instance in the range of 200 to 500 pg/mL (Wiki; Graphs). Because of the high and supraphysiological estradiol levels required for maximal or near-maximal suppression of testosterone levels, lower doses of estradiol are frequently combined with antiandrogens and/or progestogens to block or suppress remaining testosterone levels instead.

    The combination of estradiol and high doses of CPA (e.g., 50–100 mg/day) in transfeminine people has been shown to suppress testosterone levels into the normal female range (≤50 ng/dL or ≤1.7 nmol/L) in numerous studies (Giltay & Gooren, 2000; Giltay et al., 2000; Giltay et al., 2003; Giltay et al., 2004; Toorians et al., 2003; T’Sjoen et al., 2005; Slagter et al., 2006; T’Sjoen et al., 2009; Ott et al., 2011; Wierckx et al., 2012; Wierckx et al., 2014; Zubiaurre-Elorza et al., 2014; Fuss et al., 2015; Van Caenegem et al., 2015; Gava et al., 2016; Bultynck et al., 2017; Fung, Hellstern-Layefsky, & Lega, 2017; Kranz et al., 2017; Tack et al., 2017; Wiepjes et al., 2017; de Blok et al., 2018; Defreyne et al., 2018; Vita et al., 2018; Angus et al., 2019; Chen et al., 2019; Scharff et al., 2019; van Dijk et al., 2019; van Velzen et al., 2019; Vereecke, 2019; Vlot et al., 2019; Wiepjes et al., 2019; Kranz, Kaufmann, & Lanzenberger, 2020; Meyer et al., 2020; Gava et al., 2020; Sofer et al., 2020; Vereecke et al., 2021).

    In the 1980s and 1990s, clinical studies in men with prostate cancer showed that the combination of a high dosage of a progestogen, such as 100 to 300 mg/day CPA or 40 to 160 mg/day megestrol acetate, with a low dosage of an estrogen, such as 0.1 to 0.2 mg/day diethylstilbestrol or 0.5 to 1.5 mg/day oral estradiol, was able to completely suppress gonadal testosterone production and reduce testosterone levels well into the male castrate range (<50 ng/dL) (Geller et al., 1981a; Geller et al., 1981b; Geller & Albert, 1983; Goldenberg et al., 1988; Johnson et al., 1988; Geller, 1988; Venner et al., 1988; Geller, 1991; Goldenberg & Bruchovsky, 1991; Bruchovsky et al., 1993; Goldenberg et al., 1996). Similarly, a 1989 case series reported the same in three transfeminine people treated with CPA 100 mg/day and relatively low doses of estrogens (Jequier, Bullimore, & Bishop, 1989). Here is a noteworthy and informative literature excerpt on this topic in the context of prostate cancer (Schröder & Radlmaier, 2002):

    CPA, as mentioned earlier, leads to an incomplete suppression of plasma testosterone levels, which decrease by about 70% and remain at about three times castration values. In a very systematic approach to the problem, Rennie et al. (59) investigated and compared 12 different procedures of androgen deprivation. These authors found that the combination of CPA with an extremely low dose (0.1 mg/d) of [diethylstilbestrol (DES)] led to a very effective withdrawal of androgens in terms of plasma testosterone and tissue dihydrotestosterone. The same group later showed that 200 mg of CPA, and even 100 mg/day, was sufficient to achieve a similar endocrine response, which was correlated to very favorable clinical responses in a Phase II situation (60,61). The approach has many potential advantages, and, from an endocrinological point of view, is very logical: this regimen combines the testosterone-reducing effects of two compounds, therefore, only small amounts of estrogen are required to bring down plasma testosterone to approximately castrate levels. Once castrate levels have been achieved, only low doses of CPA are necessary to counteract remaining androgens, mainly of adrenal origin. The regimen was shown to be associated with few side effects and a very low cost. The combination of low-dose CPA with low-dose DES was never studied in a Phase III situation in comparison to standard management. Considering the endocrine results and the observations in patients treated with this regimen (60), this combination treatment is very likely to be competitive with other standard forms of therapy.

    A 2016 study of 50 mg/day CPA and 1 to 2 mg/day transdermal estradiol gel in transfeminine people showed that estradiol levels of about 45 pg/mL with CPA were insufficient to achieve female/castrate levels of testosterone, instead resulting in testosterone levels of about 120 to 190 ng/dL (Gava et al., 2016; Graph). Conversely, estradiol levels of about 85 pg/mL with CPA achieved complete suppression of gonadal testosterone production, with resulting testosterone levels of about 20 ng/dL. As such, a certain minimum level of estradiol with CPA appears to be required for complete testosterone suppression. A 2019 study of CPA and oral estradiol valerate in transfeminine people indicated that testosterone levels were still fully suppressed with median estradiol levels of 76 pg/mL and 25th percentile estradiol levels of 63 pg/mL (Angus et al., 2019; Graph).

    Figures 5–7: Testosterone levels with CPA plus low doses/levels of estrogens in men and transfeminine people. Sources: Top-left: Goldenberg et al. (1988). Top-right: Gava et al. (2016). Bottom: Angus et al. (2019). See also on Wikipedia: Gallery. Note for the graph on the top right that the mean transdermal estradiol dosage increased between 6 and 12 months and this was likely responsible for the improvement in testosterone suppression.

    Fung and colleagues showed that the combination of either 25 or 50 mg/day CPA with a moderate dosage of oral estradiol (~3.5 mg/day) or transdermal estradiol (~3.5 mg/day gel or ~100 μg/day patch) resulted in equivalent and complete suppression of gonadal testosterone production (~95% suppression of testosterone levels) in transfeminine people (Fung, Hellstern-Layefsky, & Lega, 2017). These dosages of estradiol would be expected to achieve estradiol levels of around 100 pg/mL on average (Aly, 2020; Wiki). This study was notably published 6 months before the 2017 second edition of the Endocrine Society guidelines were released (Hembree et al., 2017), and was probably responsible for the decrease in their recommended dosage of CPA from 50–100 mg/day to 25–50 mg/day.

    Few studies to date have assessed testosterone suppression with low-dose CPA in combination with a low or moderate dosage of an estrogen. However, based on the fact that 5 to 10 mg/day CPA alone is probably maximal in terms of suppression of testosterone levels, it is likely that such dosages of CPA will be similarly effective as higher dosages. In accordance, studies of 5 to 12.5 mg/day CPA plus upper physiological replacement dosages of testosterone have demonstrated undetectable gonadotropin levels (<0.5 IU/L) and hence complete suppression of testicular function in healthy young men (Meriggiola et al., 1998; Meriggiola et al., 2002b). Estradiol is a more powerful antigonadotropin than testosterone (Wiki), so these findings probably apply to CPA in combination with physiological replacement levels of estradiol as well (e.g., mean estradiol levels of 100–200 pg/mL).

    Accordingly, Meyer et al. (2020) assessed a dosage of CPA in combination with estradiol in 155 transfeminine people and found no difference in testosterone levels with 10, 25, or 50 mg/day CPA; testosterone levels were strongly suppressed with all three doses (to about 15–20 ng/dL on average, or into the lower end of the normal female range). The estradiol forms and doses used in this study were oral estradiol valerate (median 6 mg/day, range 3–10 mg/day), transdermal estradiol gel (median 2.25 mg/day, range 1.5–6 mg/day), and transdermal estradiol patches (100 μg/day in all cases). Estradiol levels were about 100 pg/mL on average, with an interquartile range (i.e., difference between 75th and 25th percentiles) of about 100 pg/mL. This study demonstrates that, provided estradiol levels are adequate, no more than 10 mg/day CPA is needed to fully suppress testosterone levels in transfeminine people. Another study likewise found no difference between <20 mg/day and >50 mg/day CPA in terms of testosterone suppression in transfeminine people (Even-Zohar et al., 2020).

    Even doses of CPA lower than 5 mg/day (e.g., 2 mg/day) may be usefully effective for testosterone suppression if combined with sufficient levels of estradiol, although this has not been studied and remains to be validated. But there is certainly precedent for the notion when looking at studies with other progestogens. As an example, one study using 10 mg/day oral medroxyprogesterone acetate (which is roughly equivalent to 1 mg/day CPA in terms of ovulation inhibition in premenopausal women; Table) observed 63% lower testosterone levels (215 ng/dL vs. 79 ng/dL) when added to estradiol and spironolactone therapy in transfeminine people (Jain, Kwan, & Forcier, 2019). Analogous effects on testosterone levels would be anticipated for very-low-dose CPA. Moreover, such dosages of CPA would have the advantage of actually being physiological in terms of progestogenic exposure.

    Clinical Adoption of Lower Doses

    In light of the risks of higher doses of CPA and the strong capacity for testosterone suppression of lower doses of CPA, lower doses of the medication are being increasingly adopted clinically in transfeminine hormone therapy. A number of literature sources evidence this by recommending and describing use of lower doses in transfeminine people (e.g., Lederbogen, 2009; Fung, Hellstern-Layefsky, & Lega, 2017; Heath & Wynne, 2019; Winkler-Crepaz et al., 2017; Mahfouda et al., 2018; Oliphant et al., 2018; Athanasoulia-Kaspar & Stalla, 2019; Bourns, 2019; Fuss et al., 2019; Jacobeit, 2019; Nota, den Heijer, & Gooren, 2019; ANZCTR, 2020; Meyer et al., 2020; T’Sjoen et al., 2020). In the case of Nota, den Heijer, & Gooren (2019), their newer recommendations for CPA of 10 to 50 mg/day and use for no longer than absolutely necessary are a major departure from their past extensive use and recommendation of 100 mg/day CPA (Asscheman & Gooren, 1993; Gooren, Giltay, & Bunck, 2008).

    Androgen Receptor Antagonism with Higher Doses

    The androgen receptor antagonism of CPA is relatively weak in terms of potency; dosages of CPA of 50 to 300 mg/day seem to be necessary for meaningful or considerable androgen receptor antagonism. Unfortunately, such doses also result in extreme progestogenic overdosage and are associated with considerably greater risks and adverse effects. As a result, the use of such doses of CPA should no longer be considered advisable. Instead, CPA should be used at lower doses simply as a progestogen to suppress testosterone levels. As such, the highest effective dosage of CPA for testosterone suppression, which is probably about 10 mg/day or less (12.5 mg/day also being acceptable), should be around the maximal dosage of CPA that is used in transfeminine people.

    It should be emphasized that since the combination of an estrogen and CPA can easily suppress testosterone levels well into the female/castrate range (typically to below average female levels), there isn’t necessarily a requirement for concomitant androgen receptor blockade. In any case, if androgen receptor antagonism to neutralize the remaining female/castrate levels of testosterone is still necessary or desired (e.g., to treat persisting acne or for some other purpose), a low dosage of a non-progestogenic androgen-receptor antagonist like spironolactone (e.g., 100–200 mg/day) or bicalutamide (e.g., 12.5–25 mg/day) can be added to CPA to more safely achieve this than use of higher CPA doses.

    Dosage for Testosterone Suppression

    Estrogen Plus Cyproterone Acetate

    The following recommended dosages of CPA in transfeminine people are for the combination of CPA with an estrogen and are specifically for achieving maximal suppression of testosterone levels:

    Table 2: Recommended doses of CPA in combination with estrogen for maximal testosterone suppression in transfeminine people:

    FormMin. dosageMax. dosageAmount
    10 mg tablets5 mg/day10 mg/day1/2 of a tablet to 1 whole tablet per day
    50 mg tablets6.25 mg/day12.5 mg/day1/8th of a tablet to 1/4th of a tablet per day

    Start with the minimum dosage of CPA for one month. After one month, have testosterone levels tested and confirm that they are in the normal female/castrate range (<50 ng/dL). Regardless of dosage, a concomitant minimum estradiol level of around 65 pg/mL needs to be attained in order to allow for complete suppression of testosterone levels with CPA. If testosterone levels aren’t sufficiently suppressed after a month and estradiol levels are adequate, increase to the maximum CPA dosage and re-check testosterone levels after another month. Alternatively, the dosage of estradiol can be increased instead; higher estradiol levels result in greater testosterone suppression as well.

    Cyproterone Acetate Alone

    The use of CPA alone (i.e., as a monotherapy for testosterone suppression) is not recommended due to the risk of decreased bone mineral density and other symptoms of sex-hormone deficiency (Wiki; Aly, 2019). In any case, the recommended dosages for CPA without an estrogen are essentially the same as those listed above of the combination of an estrogen with CPA for testosterone suppression. However, the higher CPA dose (10–12.5 mg/day) may be preferable for good measure in this scenario.

    Dosage for Progestogenic Effects

    The following recommended dosages of CPA in transfeminine people are for progestogenic effects similar to normal physiological exposure (equivalent of luteal-phase progesterone levels):

    Table 3: Recommended doses of CPA for physiological progestogenic effects in transfeminine people:

    FormDosageAmount
    10 mg tablets2.5 mg/day1/4th of a tablet per day
    50 mg tablets3.125 mg/day1/16th of a tablet per day

    Achieving Desired Dosages

    CPA is available pharmaceutically most widely as 50-mg tablets. This can make achieving desired low doses of CPA more difficult. For splitting CPA tablets into small fractions, a pill cutter can be used. Additionally, CPA can be taken once every 2 or 3 days instead of once every day to help further divide doses. It is notable that CPA has a relatively long half-life in the body of about 1.5 to 2 days (but possibly up to 4 days) (Wiki; Graph). Hence, taking it once every other day instead of once per day, or even less frequently like once every 3 days, has sound basis and is likely to be entirely viable.

    Updates

    Update 1: GoLoCypro Study (In-Progress)

    The GoLoCypro study (2019–2022) (more info) is being conducted by Dr. Judith Dean at the University of Queensland in Australia. It’s assessing the influence of estradiol plus CPA on testosterone levels at five different CPA dose levels (12.5 mg 2x/week, 12.5 mg/2 days, 12.5 mg/day, 25 mg/day, and 50 mg/day) in a total of 120 to 350 transfeminine people. CPA doses are being titrated to the minimum that maintain testosterone levels within the therapeutic goal range of 0.5 to 1.5 nmol/L (14–43 ng/dL). The study is among the first dose-ranging studies of CPA in transfeminine people to be conducted and is eagerly anticipated due to the valuable information that it should provide in terms of the minimum effective dosage of CPA for adequate testosterone suppression in transfeminine hormone therapy.

    Update 2: Kuijpers et al. (2021) and Even Zohar et al. (2021)

    In June 2021, the following study on low doses of CPA in transfeminine people by the European Network for the Investigation of Gender Incongruence (ENIGI) initiative was published online:

    • Kuijpers, S. M., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021). Toward a lowest effective dose of cyproterone acetate in trans women: Results from the ENIGI study. The Journal of Clinical Endocrinology & Metabolism, 106(10), e3936–e3945. [DOI:10.1210/clinem/dgab427]

    The study employed estradiol (2–6 mg/day oral (as estradiol valerate), 50–150 μg/day patch, or gel) plus five different dose levels of CPA—0 mg/day (no CPA), 10 mg/day, 25 mg/day, 50 mg/day, and 100 mg/day. It found incompletely suppressed testosterone in the no CPA group but full and equivalent testosterone suppression with all doses of CPA. The results were as follows:

    CPA dosage
    0 mg/day10 mg/day25 mg/day50 mg/day100 mg/day
    Initial subjects (n)34423459911
    Dose increased (n)1611120
    Dose decreased (n)004407
    T levels (nmol/L)5.50.90.91.10.9
    T levels (ng/dL)~160~26~26~32~26
    T <2 nmol/L [<~58 ng/dL] (%)46.392.396.293.4100.0

    Abbreviations: T = testosterone.

    The total numbers of subjects and blood tests after CPA dose increases/decreases were not provided. Hence, the exact total number of people and tests for the 10 mg/day group can’t be stated with certainty. The total number of tests for this group was at least 13 based on the testosterone suppression percentage provided however (92.3% or 12/13 but could potentially be 24/26, etc.). Regarding the small number of subjects/tests for the 10 mg/day group, the authors stated the following:

    This study is part of the ENIGI initiative, a multicenter prospective cohort study. The main treatment protocol for trans women in this study was 50 mg of CPA daily combined with estrogens. In the first year of study inclusion, a few participants received a dose of 100 mg of CPA. Shortly thereafter, inhospital protocol changed to 50 mg of CPA. As more health concerns related to CPA use were raised over the years, the dose was further lowered from 50 mg to 25 mg and, finally, to 10 mg. However, due to the coronavirus (COVID-19) pandemic, limited results of participants with 10 mg of CPA were available for analysis.

    Besides testosterone suppression, the study found that 10 mg/day CPA had less influence on prolactin and high-density lipoprotein (HDL) cholesterol levels than the higher doses of CPA. The study also assessed liver enzyme levels but found no differences between CPA doses.

    The authors concluded with the following:

    In conclusion, in this cohort of trans women, 10 mg of CPA was found to be effective in lowering testosterone concentrations to the range observed in cis women. A dose of 10 mg was equally effective as higher doses, was found to have less influence on prolactin concentrations and allows higher HDL-C concentrations to be maintained. While GnRH agonists are preferred over CPA due to the fewer associated long-term side effects, this study shows that CPA at a low dose is a viable option when GnRH agonists are contra-indicated, not available, or not reimbursed. Future research should focus on assessing the effectiveness of an even lower dose of CPA (e.g., 5 mg) and the potential long-term side effects.

    Around the same that this study was published, Guy T’Sjoen (one of the authors of the study) and other colleagues in a review of optimal hormone therapy for transfeminine people recommended a dosage of no more than 10 or 12.5 mg/day CPA for no longer than 2 years (Glintborg et al., 2021). T’Sjoen is notable in being regarded as one of the foremost experts in transgender medicine and is a coauthor of the Endocrine Society transgender care guidelines (Hembree et al., 2017).

    Shortly after the study of Kuijpers and colleagues and also in June 2021, Even Zohar and colleagues in Israel published the following study on low doses of CPA in transfeminine people:

    • Even Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. The Journal of Sexual Medicine, 18(7), 1292–1298. [10.1016/j.jsxm.2021.04.008]

    This study was initially reported as a conference abstract in May 2020 (Even-Zohar et al., 2020).

    In the introduction section of the paper, the authors stated the following:

    Treatment guidelines published by several organizations are available and assist clinicians in treating transgender women.4,7−9 A wide range of regimens for CPA administration have been proposed. By and large, the recommended doses have decreased over the years: doses of 50–100 mg/day were suggested in the 2009 Endocrine Society Guidelines,10 and amended to 25–50 mg/day in 2017.7 The proposed CPA doses were 12.5–25 mg/day in the 2019 guidelines of the Australian Professional Association for Transgender Health,4 and they were amended to 10–50 mg/day in the 2020 guidelines of the European Society for Sexual Medicine.8 There are no publications on data that compare different doses of CPA for efficacy or safety.

    The researchers found that estradiol plus low-dose CPA (10–20 mg/day) suppressed testosterone levels to an equivalent extent as estradiol plus high-dose CPA (50–100 mg/day). Testosterone levels were suppressed into the female/castrate range or near so in both groups (generally ≤2 nmol/L or ≤58 pg/mL). Of the 38 transfeminine people on low-dose CPA, 32 (84%) were on 10 mg/day CPA and 6 (16%) were on 20 mg/day CPA (mean dose 11.6 ± 3.7 mg/day). Estradiol was given as transdermal estradiol patch (mean dose 83.7 ± 36.5 μg/day), transdermal estradiol gel (mean dose 3.8 ± 1.2 g/day), or oral estradiol (mean dose 4.1 ± 1.7 mg/day). Mean estradiol levels ranged from ~110 to 350 pmol/L (~30–95 pg/mL) in the low- and high-dose CPA groups over the follow-up period. Besides showing equivalent testosterone suppression, prolactin levels were significantly lower with low-dose CPA than with high-dose CPA (398 ± 69 mIU/mL vs. 804 ± 121 mIU/mL at 12 months of hormone therapy, respectively).

    Based on their findings, the authors stated the following:

    We suggest an adjustment of current clinical practice guidelines to recommend lower doses of CPA for the treatment of transgender women.

    Both Kuijpers et al. (2021) and Even Zohar et al. (2021) claimed to be the first to demonstrate the efficacy of low-dose CPA in transfeminine people. However, that achievement actually appears to belong to Meyer et al. (2020), who in February 2020 found that estradiol plus 10, 25, or 50 mg/day CPA gave equivalent testosterone suppression across CPA doses in transfeminine people.

    Although their study was not about CPA and testosterone suppression, Lim et al. (2020) reported in May/July 2020 that testosterone levels in transfeminine people were median (IQR) 0.6 (0.4–1.0) nmol/L for oral estradiol and 0.9 (0.7–1.6) nmol/L for transdermal estradiol in a mixed group of transfeminine people (n=26 total) on estradiol plus low-dose CPA (12.5 (12.5–18.8) mg/day) (n=14), estradiol alone post-gonadectomy (n=9), and estradiol plus spironolactone (n=3).

    Update 3: Kumar et al. (2021) [Lower-Dose CPA Liver Failure Case]

    In December 2021, the following case report of fatal liver failure with low-dose CPA was published:

    • Kumar, P., Reddy, S., Kulkarni, A., Sharma, M., & Rao, P. N. (2021). Cyproterone acetate induced Acute liver failure: Case report and review of the literature. Journal of Clinical and Experimental Hepatology, 11(6), 739–741. [DOI:10.1016/j.jceh.2021.01.003]

    The case report describes a 30-year-old cisgender woman who was on 25 mg/day CPA for treatment of hirsutism (excessive facial/body hair growth) for 6 months and developed acute liver failure. Four days following hospitalization, she died. This is the second published case report of liver toxicity with CPA at a dosage below 100 mg/day (the first and only other case was at 50 mg/day) (Wiki; Table). It is also the first report of liver failure in a cisgender woman taking CPA. The case indicates that CPA even at a relatively low dose of 25 mg/day is not fully safe in terms of liver toxicity. It further emphasizes the importance of using the lowest effective doses of CPA in transfeminine people (no more than 10–12.5 mg/day).

    Update 4: Coleman et al. (2022) [WPATH SOC8 Guidelines]

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published and made recommendations for transgender hormone therapy for the first time (Coleman et al., 2022). These guidelines recommended a dose of CPA of 10 mg/day in transfeminine people (Coleman et al., 2022). This dose is substantially lower than previous doses recommended by transgender care guidelines and is the first time that major guidelines have recommended a CPA dosage this low. The WPATH SOC8 cited Kuijpers et al. (2021) in support of this recommendation (though notably not Even Zohar et al. (2021) or Meyer et al. (2020)) and also discussed the dose-dependent risks of CPA such as meningiomas and high prolactin levels (Coleman et al., 2022). Considering the key position and importance of the WPATH SOC in transgender health, it is likely that lower CPA doses in transfeminine hormone therapy will now be widely adopted throughout the world. Continued use of higher CPA doses should be considered out of step with current accepted evidence-based practice.

    Update 5: Collet et al. (2023)

    In October 2022, a study more carefully assessing androgen suppression with estradiol plus CPA in transfeminine people was published:

    • Collet, S., Gieles, N., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T’Sjoen, G. (2023). Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331–338. [DOI:10.1210/clinem/dgac576]

    This study was part of the European Network for the Investigation of Gender Incongruence (ENIGI) initiative, mostly including patients from the Amsterdam, Netherlands and Ghent, Belgium clinics.

    In the study, 275 transfeminine people were treated with estradiol plus CPA, and levels of total testosterone, free testosterone, and the adrenal androgens dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), and androstenedione (A4) were measured using liquid chromatography–mass spectrometry (LC–MS) at baseline and during follow-ups at 3 months, 12 months, 2 to 4 years, and after surgical gonadal removal (at which time CPA was discontinued). Estradiol was measured both with LC–MS (Amsterdam clinic) and with immunoassays (Ghent clinic). The forms and doses of estradiol used were most commonly oral estradiol valerate 4 mg/day or a transdermal estradiol patch 100 μg/day, while the dosage of CPA was usually 25 or 50 mg/day. About half of the transfeminine people eventually underwent surgical gonadal removal, usually after 2 years of hormone therapy.

    Median estradiol levels ranged from 49 to 75 pg/mL (180–275 pmol/L) with LC–MS and from 63 to 69 pg/mL (232–255 pmol/L) with immunoassays at different follow-ups. After 3 months of hormone therapy, total testosterone decreased by 97.1%, from 536 ng/dL (18.6 nmol/L) to 12 ng/dL (0.40 nmol/L), and free testosterone decreased by 98.3%, from 109 pg/mL (378 pmol/L) to 2.0 pg/mL (7.1 pmol/L). Thereafter, total and free testosterone levels remained stable. Levels of DHEA, DHEA-S, and A4 decreased by 24.9 to 28.0%, 20.1 to 23.5%, and 36.5%, respectively, and likewise did not further change after the first 3 to 12 months of hormone therapy. No changes in androgen levels occurred upon surgical gonadal removal with discontinuation of CPA. The authors noted that testosterone levels in the transfeminine people on hormone therapy in the study were similar to or lower than those in cisgender women.

    Update 6: Warzywoda et al. (2024) [GoLoCypro Study]

    The GoLoCypro study, by Judith Dean and colleagues, was published online in February 2024:

    • Warzywoda, S., Fowler, J. A., Wood, P., Bisshop, F., Russell, D., Luu, H., Kelly, M., Featherstone, V., & Dean, J. A. (2024). How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2317395]

    The following are some noteworthy excerpts from the paper:

    Of participants who completed the protocol, 74.0% (34/46) were able to achieve the target T-range (0.5–1.5 nmol/L) and 41.3% (19/46) were titrated to the lowest CPA level (12.5 mg cyproterone twice weekly).

    Almost all participants who completed the protocol (91.3.0%, 42/46) recorded their CPA levels as level 3 (12.5 mg daily/25 [mg] alternate days) or lower, with 69.0% (29/42) of these being able to achieve the target T-range. Of those that completed, 41.3% (19/46) were able to achieve the lowest CPA level (12.5 mg cyproterone twice week) with 57.9% (11/19) being able to achieve the target T-range.

    The study findings showed that for some patients, CPA doses as low as 12.5 mg on alternate days or less can successfully reduce testosterone to pre-menopausal ranges whilst ensuring testosterone was not over-suppressed.

    Our study found that doses of CPA lower than the standard dose (12.5 mg CPA daily and/or 25 mg alternate days) were achievable for suppression of testosterone. Several studies have supported this finding that a lower dosage (10 mg CPA daily) is effective in testosterone reduction in individuals undergoing hormone feminization (Even Zohar et al., 2021; Kuijpers et al., 2021). While not all individuals within our study were able to titrate down CPA dosages, almost a quarter of participants who completed the protocol were achieving target T-ranges on 12.5 mg CPA twice weekly (equivalent to 3.5 mg/daily). To our knowledge ours is the first study to demonstrate that doses lower than 10 mg/daily as well as alternate days or twice weekly CPA are clinically effective in maintaining testosterone reduction within target ranges.

    References

    • Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., Zajac, J. D., & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine Connections, 8(7), 935–940. [DOI:10.1530/ec-19-0272]
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • Athanasoulia-Kaspar, A. P., & Stalla, G. K. (2019). Endokrinologische Betreuung von Patienten mit Transsexualität. Geburtshilfe und Frauenheilkunde, 79(7), 672–675. [DOI:10.1055/a-0801-3319]
    • Bastianelli, C., Farris, M., Rosato, E., Brosens, I., & Benagiano, G. (2018). Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation. Expert Review of Clinical Pharmacology, 11(11), 1085–1098. [DOI:10.1080/17512433.2018.1536544]
    • Bourns, A. (2019). Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition. Toronto: Rainbow Health Ontario/Sherbourne Health. [URL] [PDF]
    • Bruchovsky, N., Larry Goldenberg, S., Akakura, K., & Rennie, P. S. (1993). Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol. Cancer, 72(5), 1685–1691. [DOI:10.1002/1097-0142(19930901)72:5<1685::aid-cncr2820720532>3.0.co;2-3]
    • Bultynck, C., Pas, C., Defreyne, J., Cosyns, M., den Heijer, M., & T’Sjoen, G. (2017). Self-perception of voice in transgender persons during cross-sex hormone therapy. The Laryngoscope, 127(12), 2796–2804. [DOI:10.1002/lary.26716]
    • Chen, H., Wiepjes, C. M., van Schoor, N. M., Heijboer, A. C., de Jongh, R. T., den Heijer, M., & Lips, P. (2019). Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People. The Journal of Clinical Endocrinology & Metabolism, 104(7), 2728–2734. [DOI:10.1210/jc.2018-02602]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Collet, S., Gieles, N., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T’Sjoen, G. (2023). Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331–338. [DOI:10.1210/clinem/dgac576]
    • Damgaard-Pedersen, F., & Føgh, M. (1980). The effect of cyproterone acetate on serum lipids in normal men. Acta Endocrinologica, 94(2), 280–283. [DOI:10.1530/acta.0.0940280]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • Defreyne, J., Vantomme, B., Van Caenegem, E., Wierckx, K., De Blok, C., Klaver, M., Nota, N. M., Van Dijk, D., Wiepjes, C. M., Den Heijer, M., & T’Sjoen, G. (2018). Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Andrology, 6(3), 446–454. [DOI:10.1111/andr.12485]
    • Endrikat, J., Gerlinger, C., Richard, S., Rosenbaum, P., & Düsterberg, B. (2011). Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide. Contraception, 84(6), 549–557. [DOI:10.1016/j.contraception.2011.04.009]
    • Even-Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2020). SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study. Journal of the Endocrine Society, 4(Suppl 1), A715–A715. [DOI:10.1210/jendso/bvaa046.1412]
    • Even Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. The Journal of Sexual Medicine, 18(7), 1292–1298. [DOI:10.1016/j.jsxm.2021.04.008]
    • Fink, G. (1979). Feedback Actions of Target Hormones on Hypothalamus and Pituitary With Special Reference to Gonadal Steroids. Annual Review of Physiology, 41(1), 571–585. [DOI:10.1146/annurev.ph.41.030179.003035]
    • Føgh, M., Corker, C. S., Hunter, W. M., McLean, H., Philip, J., Schou, G., & Shakkebæk, N. E. (1979). The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men. Acta Endocrinologica, 91(3), 545–552. [DOI:10.1530/acta.0.0910545]
    • Føgh, M., Knudsen, J. B., & Gormsen, J. (1980). Effect of cyproterone acetate on platelet aggregability, fibrinolytic activity and fibrinolytic capacity in normal men. Acta Endocrinologica, 94(3), 430–432. [DOI:10.1530/acta.0.0940430]
    • Foegh, M. (1983). Evaluation of Steroids as COntraceptives in Men. Acta Endocrinologica, 104(3 Suppl b), S9–S48. [DOI:10.1530/acta.0.104s009]
    • Fredricsson, B., & Carlström, K. (2009). Effects of Low Doses of Cyproterone Acetate on Sperm Morphology and some other Parameters of Reproduction in Normal Men. Andrologia, 13(4), 369–375. [DOI:10.1111/j.1439-0272.1981.tb00067.x]
    • Fung, R., Hellstern-Layefsky, M., & Lega, I. (2017). Is a lower dose of cyproterone acetate as effective at testosterone suppression in transgender women as higher doses? International Journal of Transgenderism, 18(2), 123–128. [DOI:10.1080/15532739.2017.1290566]
    • Fuss, J., Hellweg, R., Van Caenegem, E., Briken, P., Stalla, G. K., T’Sjoen, G., & Auer, M. K. (2015). Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF). European Neuropsychopharmacology, 25(1), 95–99. [DOI:10.1016/j.euroneuro.2014.11.019]
    • Fuss, J., Claro, L., Ising, M., Biedermann, S. V., Wiedemann, K., Stalla, G. K., Briken, P., & Auer, M. K. (2019). Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals. Psychoneuroendocrinology, 104, 228–237. [DOI:10.1016/j.psyneuen.2019.02.023]
    • Gava, G., Cerpolini, S., Martelli, V., Battista, G., Seracchioli, R., & Meriggiola, M. C. (2016). Cyproterone acetatevsleuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clinical Endocrinology, 85(2), 239–246. [DOI:10.1111/cen.13050]
    • Gava, G., Mancini, I., Alvisi, S., Seracchioli, R., & Meriggiola, M. C. (2020). A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen. European Journal of Endocrinology, 183(6), 561–569. [DOI:10.1530/eje-20-0370]
    • Geller, J., Albert, J., Yen, S. S., Geller, S., & Loza, D. (1981). Medical Castration of Males with Megestrol Acetate and Small Doses of Diethylstilbestrol*. The Journal of Clinical Endocrinology & Metabolism, 52(3), 576–580. [DOI:10.1210/jcem-52-3-576]
    • Geller, J., Albert, J., Yen, S. S., Geller, S., & Loza, D. (1981). Medical castration with megestrol acetate and minidose of diethylstilbestrol. Urology, 17(4 Suppl), 27–33. [Google Scholar] [PubMed]
    • Geller, J., & Albert, J. D. (1983). Comparison of various hormonal therapies for prostatic carcinoma. Seminars in Oncology, 10(4 Suppl 4), 34–41. [Google Scholar] [PubMed] [PDF]
    • Geller, J. (1988). Megestrol acetate and minidose estrogen in prostatic carcinoma. Urology, 32(3), 281–282. [DOI:10.1016/0090-4295(88)90402-5]
    • Geller J. (1991). Megestrol Acetate Plus Low-Dose Estrogen in the Management of Advanced Prostatic Carcinoma. The Urologic Clinics of North America, 18(1), 83–91. [DOI:10.1016/S0094-0143(21)01395-1] [Archive.org] [PDF]
    • Giltay, E. J., & Gooren, L. J. (2000). Effects of Sex Steroid Deprivation/Administration on Hair Growth and Skin Sebum Production in Transsexual Males and Females. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2913–2921. [DOI:10.1210/jcem.85.8.6710]
    • Giltay, E. J., Gooren, L. J., Emeis, J. J., Kooistra, T., & Stehouwer, C. D. (2000). Oral, but Not Transdermal, Administration of Estrogens Lowers Tissue-Type Plasminogen Activator Levels in Humans Without Affecting Endothelial Synthesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(5), 1396–1403. [DOI:10.1161/01.atv.20.5.1396]
    • Giltay, E. J., Verhoef, P., Gooren, L. J., Geleijnse, J. M., Schouten, E. G., & Stehouwer, C. D. (2003). Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals. Atherosclerosis, 168(1), 139–146. [DOI:10.1016/s0021-9150(03)00090-x]
    • Giltay, E. J., Gooren, L. J., Toorians, A. W., Katan, M. B., & Zock, P. L. (2004). Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. The American Journal of Clinical Nutrition, 80(5), 1167–1174. [DOI:10.1093/ajcn/80.5.1167]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/eje-21-0059]
    • Goldenberg, S. L., Bruchovsky, N., Rennie, P. S., & Coppin, C. M. (1988). The Combination of Cyproterone Acetate and Low Dose Diethylstilbestrol in the Treatment of Advanced Prostatic Carcinoma. Journal of Urology, 140(6), 1460–1465. [DOI:10.1016/s0022-5347(17)42073-8]
    • Goldenberg, S. L., & Bruchovsky, N. (1991). Use of Cyproterone Acetate in Prostate Cancer. The Urologic Clinics of North America, 18(1), 111–122. [DOI:10.1016/S0094-0143(21)01398-7] [Archive.org] [PDF]
    • Goldenberg, S., Bruchovsky, N., Gleave, M., & Sullivan, L. (1996). Low-dose cyproterone acetate plus mini-dose diethylstilbestrol—A protocol for reversible medical castration. Urology, 47(6), 882–884. [DOI:10.1016/s0090-4295(96)00048-9]
    • Gooren, L. J., Giltay, E. J., & Bunck, M. C. (2008). Long-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience. The Journal of Clinical Endocrinology & Metabolism, 93(1), 19–25. [DOI:10.1210/jc.2007-1809]
    • Gräf, K., Brotherton, J., & Neumann, F. (1974). Clinical Uses of Antiandrogens. In Hughes, A., Hasan, S. H., Oertel, G. W., Voss, H. E., Bahner, F., Neumann, F., Steinbeck, H., Gräf, K.-J., Brotherton, J., Horn, H. J., & Wagner, R. K. (Eds.). Androgens II and Antiandrogens / Androgene II und Antiandrogene (Handbuch der experimentellen Pharmakologie/Handbook of Experimental Pharmacology, Volume 35, Part 2) (pp. 485–542). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-80859-3_7]
    • Hammerstein, J., Meckies, J., Leo-Rossberg, I., Moltz, L., & Zielske, F. (1975). Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. Journal of Steroid Biochemistry, 6(6), 827–836. [DOI:10.1016/0022-4731(75)90311-8]
    • Hammerstein, J. (1979). Cyproterone Acetate. In Jacobs, H. S. (Ed.). Advances in Gynaecological Endocrinology: Proceedings of the Sixth Study Group of the Royal College of Obstetricians and Gynaecologists, 18th and 19th October, 1978 (pp. 367–382). London: The College. [Google Scholar] [Google Books] [PDF]
    • Hammerstein, J. (1990). Antiandrogens: Clinical Aspects. In Orfanos, C. E., & Happle, R. (Eds.). Hair and Hair Diseases (pp. 827–886). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-74612-3_35]
    • Heath, R. A., & Wynne, K. (2019). A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (p. 122). Santa Barbara: Praeger/ABC-CLIO. [Google Books]
    • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline [2nd Version]. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Jacobeit, J. W. (2019). Die hormonelle Behandlung von adulten Trans*Personen (in Deutschland). [Hormonal treatment of adult trans* persons (in Germany).] Journal für Klinische Endokrinologie und Stoffwechsel, 12(3), 102–110. [DOI:10.1007/s41969-019-00080-x]
    • Jacobi, G. H., Altwein, J. E., Kurth, K. H., Basting, R., & Hohenfellner, R. (1980). Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*. British Journal of Urology, 52(3), 208–215. [DOI:10.1111/j.1464-410x.1980.tb02961.x]
    • Jacobi, G. H., Tunn, U., & Senge, T. (1982). Clinical experience with cyproterone acetate for palliation of inoperable prostate cancer. In Jacobi, G. H., & Hohenfellner, R. (Eds.). Prostate Cancer (International Perspectives in Urology, Volume 3) (pp. 305–319). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Jequier, A. M., Bullimore, N. J., & Bishop, M. J. (2009). Cyproterone Acetate and a Small Dose of Oestrogen in the Pre-operative Management of Male Transsexuals. A Report of Three Cases. [Cyproteronacetat und kleine Östrogendosis in dem präoperativen Management männlicher Transsexueller. Bericht über drei Fälle.] Andrologia, 21(5), 456–461. [DOI:10.1111/j.1439-0272.1989.tb02447.x]
    • Johnson, D. E., Babaian, R. J., Swanson, D. A., Von Eschenbach, A. C., Wishnow, K. I., & Tenney, D. (1988). Medical castration using megestrol acetate and minidose estrogen. Urology, 31(5), 371–374. [DOI:10.1016/0090-4295(88)90726-1]
    • Knuth, U. A., Hano, R., & Nieschlag, E. (1984). Effect of Flutamide or Cyproterone Acetate on Pituitary and Testicular Hormones in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 59(5), 963–969. [DOI:10.1210/jcem-59-5-963]
    • Koch, U. J., Lorenz, F., Danehl, K., & Hammerstein, J. (1975). Über die Verwendbarkeit von Cyproteronacetat zur Fertilitätshemmung beim Mann. Morphologische Veränderungen und Einflüsse auf die Spermienmotilität. Archiv für Gynäkologie, 219(1–4), 581–582. [DOI:10.1007/bf00669258]
    • Koch, U., Lorenz, F., Danehl, K., Ericsson, R., Hasan, S., Keyserlingk, D., Lübke, K., Mehring, M., Römmler, A., Schwartz, U., & Hammerstein, J. (1976). Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers. Contraception, 14(2), 117–135. [DOI:10.1016/0010-7824(76)90081-0]
    • Kranz, G. S., Seiger, R., Kaufmann, U., Hummer, A., Hahn, A., Ganger, S., Tik, M., Windischberger, C., Kasper, S., & Lanzenberger, R. (2017). Effects of sex hormone treatment on white matter microstructure in individuals with gender dysphoria. NeuroImage, 150, 60–67. [DOI:10.1016/j.neuroimage.2017.02.027]
    • Kranz, G. S., Kaufmann, U., & Lanzenberger, R. (2019). Probing the Impact of Gender-Affirming Hormone Treatment on Odor Perception. Chemical Senses, 45(1), 37–44. [DOI:10.1093/chemse/bjz069]
    • Kuijpers, S. M., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021). Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. The Journal of Clinical Endocrinology & Metabolism, 106(10), e3936–e3945. [DOI:10.1210/clinem/dgab427]
    • Kumar, P., Reddy, S., Kulkarni, A., Sharma, M., & Rao, P. N. (2021). Cyproterone acetate induced acute liver failure: case report and review of the literature. Journal of Clinical and Experimental Hepatology, 11(6), 739–741. [DOI:10.1016/j.jceh.2021.01.003]
    • Lederbogen, S. (2009). Hormonbehandlung. PiD - Psychotherapie im Dialog, 10(1), 41–43. [DOI:10.1055/s-0028-1090190]
    • Lim, H. Y., Leemaqz, S. Y., Torkamani, N., Grossmann, M., Zajac, J. D., Nandurkar, H., Ho, P., & Cheung, A. S. (2020). Global Coagulation Assays in Transgender Women on Oral and Transdermal Estradiol Therapy. The Journal of Clinical Endocrinology & Metabolism, 105(7), e2369–e2377. [DOI:10.1210/clinem/dgaa262]
    • Liu, P. Y., Takahashi, P., & Veldhuis, J. D. (2017). An Ensemble Perspective of Aging-Related Hypoandrogenemia in Men. In Winters, S. J., & Huhtaniemi, I. T. (Eds.). Male Hypogonadism: Basic, Clinical and Therapeutic Principles, 2nd Edition (pp. 325–347). Cham: Springer. [DOI:10.1007/978-3-319-53298-1_16]
    • Mahfouda, S., Moore, J. K., Siafarikas, A., Hewitt, T., Ganti, U., Lin, A., & Zepf, F. D. (2019). Gender-affirming hormones and surgery in transgender children and adolescents. The Lancet Diabetes & Endocrinology, 7(6), 484–498. [DOI:10.1016/s2213-8587(18)30305-x]
    • Meriggiola, M. C., Bremner, W. J., Costantino, A., Di Cintio, G., & Flamigni, C. (1998). Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Human Reproduction, 13(5), 1225–1229. [DOI:10.1093/humrep/13.5.1225]
    • Meriggiola, M. C., Bremner, W. J., Costantino, A., Bertaccini, A., Morselli-Labate, A. M., Huebler, D., Kaufmann, G., Oettel, M., & Flamigni, C. (2002). Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 87(5), 2107–2113. [DOI:10.1210/jcem.87.5.8514]
    • Meriggiola, M. C., Costantino, A., Bremner, W. J., & Morselli-Labate, A. M. (2002). Higher Testosterone Dose Impairs Sperm Suppression Induced by a Combined Androgen‐Progestin Regimen. Journal of Andrology, 23(5), 684–690. [DOI:10.1002/j.1939-4640.2002.tb02311.x]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463] [PDF]
    • Moltz, L., Römmler, A., Schwartz, U., & Hammerstein, J. (1978). Effects of Cyproterone Acetate (CPA) on Pituitary Gonadotrophin Release and on Androgen Secretion Before and After LH-RH Double Stimulation Tests in Men. International Journal of Andrology, 1(Suppl 2b) [5th Annual Workshop on the Testis, Geilo, Norway, April 1978, Endocrine Approach to Male Contraception], 713–719. [DOI:10.1111/j.1365-2605.1978.tb00518.x]
    • Moltz, L., Römmler, A., Schwartz, U., Post, K., & Hammerstein, J. (1978). Cyproterone acetate (CPA)—a potential male contraceptive: further studies on the interactions with endocrine parameters. Journal of Steroid Biochemistry, 9(9), 865–865 (abstract no. 252). [DOI:10.1016/0022-4731(78)90952-4]
    • Moltz, L., Römmler, A., Post, K., Schwartz, U., & Hammerstein, J. (1980). Medium dose cyproterone acetate (CPA): Effects on hormone secretion and on spermatogenesis in men. Contraception, 21(4), 393–413. [DOI:10.1016/s0010-7824(80)80017-5]
    • Moltz, L., Koch, U., Schwartz, U., Rommler, A., & Hammerstein, J. (1982). Male fertility regulation with cyproterone acetate (CPA). Contraceptive Delivery Systems, 3(3/4) [Retroproductive Health Care International Symposium, October 10-15 1982 Maui, Hawaii, USA, Expanded Abstracts], 298–298 (abstract no. 293). [Google Scholar] [PDF]
    • Moore, E., Wisniewski, A., & Dobs, A. (2003). Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3467–3473. [DOI:10.1210/jc.2002-021967]
    • Nelson, J. B. (2012). Hormone Therapy for Prostate Cancer. In Wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. W., & Peters, C. A. (Eds.). Campbell-Walsh Urology, 10th Edition, Volume 2 (pp. 2920–2953). Philadelphia: Elsevier/Saunders. [Google Scholar] [Google Books]
    • Nota, N. M., den Heijer, M., Gooren, L. J. (2019). Evaluation and Treatment of Gender-Dysphoric/Gender Incongruent Adults. [Updated 2019 Jul 21]. In Feingold, K. R., Anawalt, B., Blackman, M. R., et al. (Eds.). Endotext [Internet]. South Dartmouth, Massachusetts: MDText.com. [PubMed]
    • Oliphant, J., Veale, J., Macdonald, J., Carroll, R., Johnson, R., Harte, M., Stephenson, C. & Bullock, J. (2018). Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa New Zealand. Waikato: Transgender Health Research Lab/University of Waikato. [URL] [PDF]
    • Ott, J., Aust, S., Promberger, R., Huber, J. C., & Kaufmann, U. (2011). Cross‐Sex Hormone Therapy Alters the Serum Lipid Profile: A Retrospective Cohort Study in 169 Transsexuals. The Journal of Sexual Medicine, 8(8), 2361–2369. [DOI:10.1111/j.1743-6109.2011.02311.x]
    • Petry, R., Mauss, J., Senge, T., & Rausch-Stroomann, J. (1970). Über den Einfluß von Cyproteronacetat, Norethisteronönanthat und Gestonoroncapronat auf die Hypophysen-Gonadenachse beim Mann. [Influence of Cyproterone-acetate, Norethisterone-enanthate and Gestonorone-capronate on the Hypophyseal-Gonadal-Axis in the Male.] In Kracht, J. (Ed.). Endokrinologie der Entwicklung und Reifung, 16. Symposion, Ulm, 26.-28. Februar 1970 (Symposion der Deutschen Gesellschaft für Endokrinologie, Volume 16) (pp. 428–430). Berlin: Springer. [Google Books] [DOI:10.1007/978-3-642-80591-2_118] [WorldCat] [PDF]
    • Petry, R., Rausch-Stroomann, J.-G., Berthold, K. Mauss, J., Ai, M., Senge, Th., & Vermeulen, A. (1970). Untersuchungen zum Wirkungsmechanismus der Antiandrogene Cyproteron und Cyproteronacetat beim Menschen (Gonadotropin-, Plasma-testosteron- und morphologische Keimdrüsenuntersuchungen). [Investigations on the mechanism of action of the antiandrogens cyproterone and cyproterone acetate in humans (gonadotropin, plasma testosterone, and morphological gonad investigations).] In Schlegel, B. (Ed.). Verhandlungen der Deutschen Gesellschaft für Innere Medizin: Sechsundsiebzigster Kongress Gehalten zu Wiesbaden vom 6. April – 9. April 1970 (Verhandlungen der Deutschen Gesellschaft für Innere Medizin, Volume 76) (pp. 873–876). München: Bergmann. [Google Scholar] [Google Books] [DOI:10.1007/978-3-642-85446-0] [WorldCat] [PDF]
    • Petry, R., Rausch-Stroomann, J. G., Mauss, J., Senge, Th., Ai, M., & Berthold, K. (1970). Investigations on the mode of action of the antiandrogens cyproterone and cyproterone acetate in man. / Investigations on the mechanism of action of anti androgenic cyproterone and cyproterone acetate in humans (gonadotropin, plasma testosterone, and morphological generative gland investigations). Medizinische Welt, 29, 1336–. [EurekaMag] [Cited by Koch et al. (1976)]
    • Petry, R., Mauss, J., Rausch-Stroomann, J. G., & Vermeulen, A. (1972). Reversible inhibition of spermatogenesis in men. Hormone and Metabolic Research, 4(5), 386–388. [DOI:10.1055/s-0028-1094040]
    • Roy, S., Chatterjee, S., Prasad, M., Poddar, A., Pandey, D., Pandey, H., & Jadhav, Y. (1976). Effects of cyproterone acetate on reproductive functions in normal human males. Contraception, 14(4), 403–423. [DOI:10.1016/s0010-7824(76)80055-8]
    • Roy, S., & Chatterjee, S. (1979). Studies with cyproterone acetate for male contraception. In James, V. H. T., & Pasqualini, J. R. (Eds.). Hormonal Steroids: Proceedings of the Fifth International Congress on Hormonal Steroids, New Delhi, India, October/November 1978 (pp. 675–680). Oxford: Pergamon Press. [DOI:10.1016/b978-0-08-023796-1.50099-2]
    • Roy, S., & Chatterjee, S. (1979). The Role of Antiandrogenic Action in Cyproterone Acetate-Induced Morphologic and Biochemical Changes in Human Semen. Fertility and Sterility, 32(1), 93–95. [DOI:10.1016/s0015-0282(16)44122-1]
    • Saborowski, K.-J. (1987). Konservative Therapie mit Cyproteronacetat und Estradiolundecylat beim Fortgeschrittenen Prostatacarcinom: Eine 5-Jahres-Studie. [Conservative Therapy with Cyproterone Acetate and Estradiol Undecylate in Advanced Prostate Cancer: A 5-Year Study.] (Doctoral dissertation, Ruhr-University Bochum.) [58 pages] [Google Scholar] [Google Books] [WorldCat] [PDF] [Translation]
    • Scharff, M., Wiepjes, C. M., Klaver, M., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2019). Change in grip strength in trans people and its association with lean body mass and bone density. Endocrine Connections, 8(7), 1020–1028. [DOI:10.1530/ec-19-0196]
    • Schröder, F. H., & Radlmaier, A. (2002). Steroidal Antiandrogens. In Jordan, C. V., & Furr, B. J. A. (Eds.). Hormone Therapy in Breast and Prostate Cancer (pp. 325–346). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-152-7_15]
    • Slagter, M. H., Gooren, L. J., de Ronde, W., Soosaipillai, A., Scorilas, A., Giltay, E. J., Paliouras, M., & Diamandis, E. P. (2006). Serum and Urine Tissue Kallikrein Concentrations in Male-to-Female Transsexuals Treated with Antiandrogens and Estrogens. Clinical Chemistry, 52(7), 1356–1365. [DOI:10.1373/clinchem.2006.068932]
    • Sofer, Y., Yaish, I., Yaron, M., Bach, M. Y., Stern, N., & Greenman, Y. (2020). Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocrine Practice, 26(8), 883–890. [DOI:10.4158/ep-2020-0032] [PDF]
    • T’Sjoen, G. G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186(1), 61–67. [DOI:10.1677/joe.1.06112]
    • T’Sjoen, G., Weyers, S., Taes, Y., Lapauw, B., Toye, K., Goemaere, S., & Kaufman, J. (2009). Prevalence of Low Bone Mass in Relation to Estrogen Treatment and Body Composition in Male-to-Female Transsexual Persons. Journal of Clinical Densitometry, 12(3), 306–313. [DOI:10.1016/j.jocd.2008.11.002]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, with Attention for Sexual Function and Satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • Tack, L. J., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine, 14(5), 747–757. [DOI:10.1016/j.jsxm.2017.03.251]
    • Toorians, A. W., Thomassen, M. C., Zweegman, S., Magdeleyns, E. J., Tans, G., Gooren, L. J., & Rosing, J. (2003). Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5723–5729. [DOI:10.1210/jc.2003-030520]
    • Torre, B. l., Norén, S., Hedman, M., & Diczfalusy, E. (1979). Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men. Contraception, 20(4), 377–396. [DOI:10.1016/s0010-7824(79)80048-7]
    • Van Caenegem, E., Wierckx, K., Taes, Y., Schreiner, T., Vandewalle, S., Toye, K., Kaufman, J., & T’Sjoen, G. (2014). Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporosis International, 26(1), 35–47. [DOI:10.1007/s00198-014-2805-3]
    • van Dijk, D., Dekker, M. J., Conemans, E. B., Wiepjes, C. M., de Goeij, E. G., Overbeek, K. A., Fisher, A. D., den Heijer, M., & T’Sjoen, G. (2019). Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People—Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 16(8), 1297–1309. [DOI:10.1016/j.jsxm.2019.05.009]
    • van Velzen, D. M., Paldino, A., Klaver, M., Nota, N. M., Defreyne, J., Hovingh, G. K., Thijs, A., Simsek, S., T’Sjoen, G., & den Heijer, M. (2019). Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen. The Journal of Clinical Endocrinology & Metabolism, 104(6), 1937–1947. [DOI:10.1210/jc.2018-02138]
    • Venner, P. M., Klotz, P. G., Klotz, L. H., Stewart, D. J., Davis, I. R., Orovan, W. L., & Ramsey, E. W. (1988). Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate. Seminars in Oncology, 15(2 Suppl 1), 62–67. [Google Scholar] [PubMed]
    • Vereecke, G. (2019). Characterisation of testicular function and spermatogenesis in transgender women. (Master’s thesis, Ghent University.) [PDF]
    • Vereecke, G., Defreyne, J., Van Saen, D., Collet, S., Van Dorpe, J., T’Sjoen, G., & Goossens, E. (2020). Characterisation of testicular function and spermatogenesis in transgender women. Human Reproduction, 36(1), 5–15. [DOI:10.1093/humrep/deaa254]
    • Vita, R., Settineri, S., Liotta, M., Benvenga, S., & Trimarchi, F. (2018). Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study. Maturitas, 107, 92–96. [DOI:10.1016/j.maturitas.2017.10.012]
    • Vlot, M. C., Wiepjes, C. M., Jongh, R. T., T’Sjoen, G., Heijboer, A. C., & den Heijer, M. (2019). Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen. Journal of Bone and Mineral Research, 34(10), 1862–1872. [DOI:10.1002/jbmr.3762]
    • Wang, C., & Yeung, K. (1980). Use of low-dosage oral cyproterone acetate as a male contraceptive. Contraception, 21(3), 245–272. [DOI:10.1016/0010-7824(80)90005-0]
    • Warzywoda, S., Fowler, J. A., Wood, P., Bisshop, F., Russell, D., Luu, H., Kelly, M., Featherstone, V., & Dean, J. A. (2024). How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2317395]
    • Wiepjes, C. M., Vlot, M. C., Klaver, M., Nota, N. M., de Blok, C. J., de Jongh, R. T., Lips, P., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study. Journal of Bone and Mineral Research, 32(6), 1252–1260. [DOI:10.1002/jbmr.3102]
    • Wiepjes, C. M., Vlot, M. C., de Blok, C. J., Nota, N. M., de Jongh, R. T., & den Heijer, M. (2019). Bone geometry and trabecular bone score in transgender people before and after short- and long-term hormonal treatment. Bone, 127, 280–286. [DOI:10.1016/j.bone.2019.06.029]
    • Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012). Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons. The Journal of Sexual Medicine, 9(10), 2641–2651. [DOI:10.1111/j.1743-6109.2012.02876.x]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    • Winkler-Crepaz, K., Müller, A., Böttcher, B., & Wildt, L. (2017). Hormonbehandlung bei Transgenderpatienten. [Hormone treatment of transgender patients.] Gynäkologische Endokrinologie, 15(1), 39–42. [DOI:10.1007/s10304-016-0116-9]
    • Winters, S. J., Wang, C., & (2009). LH and Non-SHBG Testosterone and Estradiol Levels During Testosterone Replacement of Hypogonadal Men: Further Evidence That Steroid Negative Feedback Increases as Men Grow Older. Journal of Andrology, 31(3), 281–287. [DOI:10.2164/jandrol.109.009035]
    • Zitzmann, M., Rohayem, J., Raidt, J., Kliesch, S., Kumar, N., Sitruk-Ware, R., & Nieschlag, E. (2017). Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial. Andrology, 5(3), 516–526. [DOI:10.1111/andr.12328]
    • Zubiaurre-Elorza, L., Junque, C., Gómez-Gil, E., & Guillamon, A. (2014). Effects of Cross-Sex Hormone Treatment on Cortical Thickness in Transsexual Individuals. The Journal of Sexual Medicine, 11(5), 1248–1261. [DOI:10.1111/jsm.12491]
    \ No newline at end of file +Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People - Transfeminine Science Link

    Low Doses of Cyproterone Acetate Are Maximally Effective for Testosterone Suppression in Transfeminine People

    By Aly | First published July 1, 2019 | Last modified March 30, 2024

    Abstract / TL;DR

    Cyproterone acetate (CPA) is a progestogen and antiandrogen which is widely used in transfeminine hormone therapy. It is far more potent as a progestogen than as an androgen receptor antagonist. CPA has typically been used at doses of 1 to 2 mg/day as a progestogen in cisgender women and at doses of 50 to 300 mg/day as an antiandrogen. At typical antiandrogen doses of CPA, there is profound progestogenic overdosage as well as associated side effects and risks. CPA has antigonadotropic effects due to its progestogenic activity and thereby suppresses testosterone levels. By itself, CPA can maximally suppress testosterone levels by 50 to 70%, and in combination with even small amounts of estrogen, it can fully suppress gonadal testosterone production and thereby reduce testosterone levels by about 95%—or well into the female range. Although doses of CPA of 50 to 100 mg/day have been used in transfeminine people historically, it is now clear that 5 to 10 mg/day CPA has maximal or near-maximal effectiveness in terms of suppression of testosterone levels. CPA alone is most commonly available as 50-mg tablets. These tablets can be split with a pill cutter and taken once every day to once every other day to achieve an overall CPA dosage of 6.25 to 12.5 mg/day. These lower doses of CPA are not only much more cost-effective than traditional doses but are also likely to have better tolerability and safety. Due to the retained effectiveness of lower CPA doses and the known dose-dependent risks of CPA, doses of CPA used clinically in transfeminine people have been in a rapid decline.

    Introduction

    This article is about the dosage of cyproterone acetate (CPA), a progestin and antiandrogen, for use in hormone therapy for transfeminine people. It argues for the use of lower doses of CPA and goes fairly in-depth to justify these doses. If you are only interested in recommended doses of CPA for transfeminine people, they can be found in the Recommended Dosages section below.

    Potency, Conventional Dosages, and Health Risks

    CPA is a potent progestogen, with an ovulation-inhibiting dosage of about 1 mg/day and endometrial transformation dosage of about 1 to 3 mg/day in cisgender women (Wiki; Table; Endrikat et al., 2011). These dosages of CPA are similar in strength of progestogenic effect to those of normal progesterone production and levels during the luteal phase of the menstrual cycle in premenopausal women (which are about 25 mg/day and 15 ng/mL, respectively). In relation to the preceding, when CPA is used as a progestogen in cisgender women, for instance in birth control pills and menopausal hormone therapy preparations, it is formulated at a dose of 1 or 2 mg per tablet (Wiki).

    In contrast to its progestogenic activity, CPA is far less potent as an androgen receptor antagonist (Wiki). When used as an antiandrogen, it is generally given at a dosage of 50 to 300 mg/day, both in cisgender women and men. A dosage of 50 to 100 mg/day is typical for androgen-dependent skin and hair conditions like acne and hirsutism in women and a dosage of 100 to 300 mg/day is typically used for prostate cancer in men (specifically 100–200 mg/day for CPA combined with castration and 200–300 mg/day for CPA monotherapy) (Wiki). As such, CPA is generally formulated at a dose of 50 or 100 mg per tablet for use in androgen-dependent conditions (Wiki). As an antiandrogen, CPA has a dual mechanism of action of both suppressing testosterone levels via its progestogenic activity at low doses and additionally blocking the actions of testosterone directly at the androgen receptor at higher doses.

    Because CPA is so much more potent as a progestogen than as an androgen receptor antagonist, there is profound overdosage of progestogenic effect when CPA is used as an antiandrogen at typical clinical dosages. This is described in the following three literature excerpts by Jürgen Hammerstein, one of the scientists who developed CPA (Hammerstein et al., 1975; Hammerstein, 1990; Hammerstein, 1979):

    Like chlormadinone acetate, its parent compound, CPA is also a strong progestogen with the endometrial transformation dose of both drugs being between 20 and 30 mg. […] To take full therapeutic advantage of its antiandrogenicity, CPA must be administered in doses per month that are 30 times the physiological equivalent of progesterone production in the cycle. CPA, although the most useful compound available in this field at the moment, cannot be considered therefore an ideal antiandrogen, all the more as some of the side effects may be related to the progestational overdosage rather than to the administered antiandrogenic activity. […] Adverse reactions like tiredness, lassitude, and increase in body weight are possibly due to the enormous overdose of progestational activity in the formula which is necessary to take full advantage of the antiandrogenicity of CPA.

    Fixson (1963) tested CPA in ovariectomized women after pre-treatment with oestrogens; with a transformation dose of 20–30 mg this proved a powerful progestogen. The potency of CPA in the menses delay test is not exactly known, but has been estimated to be below 1 mg/day (Miller and Jacobs 1986). In relation to this progestational potency, its antiandrogenicity must be considered rather weak. Thus, in order to take full advantage of the latter, 100 mg CPA must be given daily, i.e. three times the cyclic transformation dose per day (Hammerstein and Cupceancu 1969); notably, this parameter is equivalent to the total progesterone production of a corpus luteum throughout its entire cyclic life span.

    CPA may be characterized endocrinologically as possessing strong progestational [and] moderate anti-androgenic […] potencies. […] Its progestational activity, in terms of the transformation dose in the oestrogen-primed human endometrium, is 20–30 mg [per month/cycle] which is comparable to that of chlormadinone acetate and other strong progestogens. To take full clinical advantage of its anti-androgenicity not less than 50–100 mg CPA must be taken orally per day, which totals 2 to 3 times the progestational activity the female organism is exposed to throughout a complete ovulatory menstrual cycle. Thus unless much lower and less efficacious doses of CPA are used, a tremendous progestational overdosage must be accepted. […] As already pointed out CPA is endocrinologically not a well-balanced compound because of the strong preponderance of the progestational over the anti-androgenic potency. A way to avoid the heavy progestogen overdosage inherent with the high-dose reverse sequential therapy would be to combine the low-dose contraceptive formulation just mentioned with a pure anti-androgen such as free cyproterone. […] It must be emphasized that CPA is far from being an ideal drug for the anti-androgenic treatment of hirsutism because its progestational potency is much too strong and it is not effective when administered topically. Therefore it is worthwhile looking for better-balanced anti-androgenic compounds for the future.

    The massive overdosage of progestogenic effect that occurs at such doses of CPA is likely responsible for the known adverse effects and risks of higher doses of CPA (Wiki). Examples of these side effects include fatigue, depression, weight gain, high prolactin levels (Wiki), benign brain tumors (Aly, 2020; Wiki; Table; Table), blood clots (Wiki), and cardiovascular problems (Wiki). Such risks are dose-dependent and have not been associated with 1 or 2 mg/day CPA (with the exception of an expected increase in the risk of blood clots in combination with oral estrogens for birth control or menopausal hormone therapy). The risk of liver toxicity with CPA is also dose-dependent, with elevated liver enzymes occurring mostly only at a dosage of 20 mg/day and above and rare cases of liver failure occurring almost exclusively at dosages of 100 mg/day and above (Wiki; Table). As such, there is good rationale for using the lowest possible effective dosage of CPA, an approach that is likely to minimize risks.

    In transfeminine people, CPA has historically been used at a dosage of 50 to 100 mg/day (e.g., Moore, Wisniewski, & Dobs, 2003). Some earlier papers have recommended even higher doses of CPA, for instance 100 to 150 mg/day (Asscheman & Gooren, 1993). In 2017, the Endocrine Society published the latest edition of their clinical practice guidelines on hormone therapy for transgender people and reduced their recommended dosage of CPA from 50–100 mg/day to 25–50 mg/day (Hembree et al., 2017; Hembree et al., 2009). This was motivated in part by increasing knowledge and awareness of the risks of higher doses of CPA and by findings that these lower doses of CPA were still effective. However, it is likely that even these new lower dosages are still far in excess of what is really needed.

    Testosterone Suppression with Low and High Doses

    Progestogens by themselves, including CPA, are able to considerably suppress testosterone levels in gonadally intact people assigned male at birth. Around a dozen small and low-quality but nonetheless notable studies of low-dose CPA from the 1970s and early 1980s found that 5 to 10 mg/day CPA suppressed testosterone levels by about 40 to 70% in healthy young men (Table 1). A couple of individual studies notably reported virtually identical suppression of testosterone levels with 5 mg/day versus 10 mg/day CPA (both ~50% suppression) (Wang & Yeung, 1980; Graph) and with 10 mg/day versus 20 mg/day CPA (both ~60–70% suppression) (Koch et al., 1976; Koch et al., 1975; Graph). This lack of additional testosterone suppression with a doubling of dosage within studies suggests that testosterone suppression with CPA might have actually been maximal at a dosage of only 5 or 10 mg/day. A more modern study, which used a newer and more reliable analytic method for quantification of blood testosterone, found that 10 mg/day CPA suppressed testosterone levels by 66%, from about 600 ± 150 ng/dL to about 185 ng/dL (Meriggiola et al., 2002a; Graph). Similarly, another more modern study found that 10 to 20 mg/day CPA suppressed testosterone levels by 65%, from about 431 ng/dL to about 149 ng/dL, with no reported differences between doses (Zitzmann et al., 2017; Graph).

    Table 1: Levels of testosterone and other sex hormones with CPA at low doses (5–30 mg/day):

    Treatment and subjectsFindingsSource(s)
    30 mg/day CPA in 5 normal malesT decreased “remarkably”. Exact values not given, but has graphs of T levels in a few individuals. After 30 mg/day, 5 mg/day was tried in one case and was not as effective in suppressing sperm production or T. Also reported decreases in gonadotropin excretion.Petry et al. (1972); Petry et al. (1970a); Petry et al. (1970b); Petry et al. (1970c)
    10 or 20 mg/day CPA in 15 normal healthy fertile males (age 25–35 years) (7 in 10 mg/day group and 8 in 20 mg/day group)“Androgens (mainly T)” decreased by 60% for both 10 and 20 mg/day. Inconsistent changes in LH and slight decrease in FSH. Exact values not given, except in graphs.Koch et al. (1976); Koch et al. (1975)
    0, 5, or 10 mg/day CPA in 18 healthy males (age 20–40 years) (6 in each group)T decreased, while LH and FSH were unchanged. No other details given, nor were exact hormone levels given.Roy et al. (1976)
    10 mg/day CPA in 10 young healthy fertile men (age mean 27.2 ± 3.2 (range 21–35) years)T decreased by 70%, DHT by 50%, LH by 30%, and FSH by 40%, while PRL increased by 75%. T was 495 ± 66 ng/dL before, 154 ± 23 ng/dL after 4 weeks, and 187 ± 38 ng/dL after 12 weeks. Also has values and graphs for other hormones.Moltz et al. (1980); Moltz et al. (1978a); Moltz et al. (1978b)
    5 or 10 mg/day CPA in 14 healthy males (age 20–40 years) (7 in each group)T decreased in both groups. No other details given, nor were exact hormone levels given.Roy & Chatterjee (1979a)
    10 mg/day CPA alone for 12–18 weeks then 75 mg/day mesterolone added in 3 normal fertile men (age 32–35 years)No information on T provided in this paper.Roy & Chatterjee (1979b)
    20 mg/day CPA in 10 healthy males (age 26–55 years)T decreased by 73% (range 71–75%), from 482 ng/dL (range 410–560 ng/dL) to 130 ng/dL (110–162 ng/dL). DHT decreased by 51% (range 47–55%), LH by 39% (range 34–45%), FSH by 66% (range 47–78%), 17-OH-P4 by 59%, A4 by 30%, TS by 34%, and DHTS by 35%. Also has exact values and graphs for other hormones.de la Torre (1979)
    5 or 10 mg/day CPA in 7 males (4 in each group; 1 received both 5 and 10 mg/day CPA at different times)T change was “−40%” or “–50%”. At 5 mg/day, T was 745 ng/dL before, 460 ng/dL with treatment (–38%), and 668 ng/dL after discontinuation. At 10 mg/day, T was 708 ng/dL before, 398 ng/dL with t (reatment–44%), and 670 ng/dL after discontinuation. Also reported LH and FSH levels.Føgh et al. (1979); Damgaard-Pederson et al. (1980); Føgh et al. (1980); Foegh (1983)
    0, 5, or 10 mg/day CPA in 25 normal healthy males (age 20–51 years); 7 in 5 mg group (mean 37 ± 10 years), 8 in 10 mg group (mean 32 ± 8 years), 10 in 0 mg group (mean 32 ± 10 years)At 5 mg/day, T decreased from 663 ± 120 ng/dL to 320 ± 160 ng/dL (−52%), and at 10 mg/day, T decreased from 692 ± 180 ng/dL to 340 ± 160 ng/dL (−51%). E2 decreased in parallel to T. At 5 mg/day, LH decreased from 2.1 ± 0.7 IU/L to 1.4 ± 0.5 IU/L (−33%), and at 10 mg/day, LH decreased from 2.3 ± 1.0 IU/L to 1.2 ± 0.5 IU/L (−48%). At 5 mg/day, FSH decreased from 3.1 ± 1.9 IU/L to 1.8 ± 0.9 IU/L (−42%), and at 10 mg/day, FSH decreased from 2.7 ± 1.0 IU/L to 1.5 ± 0.7 IU/L (−44%).Wang & Yeung (1980)
    10 or 25 mg/day CPA in 4 healthy men (age 29–37 years); 3 in 10 mg group, 1 in 25 mg groupT “slightly reduced”. E “more significantly lowered”. LH not significantly changed. FSH “reduced” in “more or less all cases”. Exact hormone levels not given, but graphs provided with the values.Fredricsson & Carlström (1981)
    10 or 20 mg/day CPA in 30 healthy males (age 21–38 years)T decreased by 70%, LH decreased by 35%, and “similar observations for FSH”. Exact values not provided.Moltz et al. (1982)
    10 mg/day CPA (also placebo and 2, 5, and 10 mg/day dienogest) in 5 healthy men in each groupWith CPA, T decreased from ~600 ± 150 ng/dL to ~185 ng/dL (–66 ± 4%). Also reported LH, FSH, and SHBG, as well as hormonal changes with placebo and dienogest (2, 5, and 10 mg/day).Meriggiola et al. (2002a)
    10 or 20 mg/day CPA in 14 healthy young men (7 in each group)T decreased from ~431 ng/dL at baseline to ~149 ng/dL with CPA (–65%) for the 10 and 20 mg/day doses combined. Values for dose subgroups not given. No significant differences between LH/FSH suppression between groups (which is indirectly suggestive of no differences in T suppression as well). Also reported hormone levels with other progestins.Zitzmann et al. (2017)

    These graphs adapted from some of the studies provide visualizations of some of the findings:

    Figures 1–4: Testosterone levels during treatment with low doses of CPA alone in men. Sources: Top: Moltz et al. (1980); Moltz et al. (1978a); Moltz et al. (1978b). Mid-left: Wang & Yeung (1980). Mid-right: Koch et al. (1976); Koch et al. (1975). Bottom: Meriggiola et al. (2002a). See also on Wikipedia: Gallery. The bottom graph is the 2002 study using DELFIA to quantify testosterone levels. This study also assessed different doses of dienogest (DNG), which has an ovulation-inhibiting dose of 1 mg/day similarly to CPA.

    Studies with other progestogens, such as desogestrel, dienogest, and medroxyprogesterone acetate, have consistently found that maximal suppression of testosterone levels in men occurs at a dosage that is between 5 and 10 times that of the ovulation-inhibiting dosage in cisgender women (Wiki; Wiki; Wiki). Another study is likewise suggestive of this for norethisterone acetate and levonorgestrel (Zitzmann et al., 2017; Graph). Along similar lines, doses of progestogens investigated for use in male hormonal contraception, in which the goal is antigonadotropic effects and the lowest fully effective dose is targeted, have been noted as being between 5 and 12 times the doses used in cisgender women (Foegh, 1983). Based on an ovulation-inhibiting dosage of CPA of 1 mg/day, these findings would imply that suppression of testosterone levels with CPA would likely be maximal at a dose of between 5 and 10 mg/day. In accordance, this dose range matches up with the findings of the studies above.

    Studies of much higher doses of CPA have shown little better suppression of testosterone levels than lower doses. Modern studies in healthy young adult and adolescent transfeminine people have found that 50 to 100 mg/day CPA alone suppresses testosterone levels by 46 to 61% (from 456–602 ng/dL to 226–294 ng/dL at 4–12 months) (Toorians et al., 2003; Giltay et al., 2004; T’Sjoen et al., 2005; Tack et al., 2017). Older studies in elderly men with prostate cancer have found greater suppression of testosterone levels with high-dose CPA monotherapy (by up to 70–80%, typically to between 50–200 ng/dL) (Gräf, Brotherton, & Neumann, 1974; Jacobi et al., 1980; Graph; Knuth, Hano, & Nieschlag, 1984; Graph; Schröder & Radlmaier, 2002; Nelson, 2012). The greater testosterone suppression in men with prostate cancer may be related to different blood-testing methodology between studies and/or to the fact that older men have weaker hypothalamic–pituitary–gonadal (HPG) axes and lower testosterone levels (Liu, Takahashi, & Veldhuis, 2017; Winters, Wang, & Fortigel Study Group, 2010).

    Although progestogens can considerably suppress testosterone levels at maximally effective dosages, it has been found that a “recovery” or “escape phenomenon”, in which testosterone levels eventually increase back to higher levels, occurs when progestogen monotherapy is used on a long-term basis. This has most notably been observed with the related progestogen megestrol acetate (Wiki), but has also been seen with CPA (Goldenberg & Bruchovsky, 1991; Saborowski, 1987; Jacobi, Tunn, & Senge, 1982). In one of these studies, testosterone levels were initially suppressed by CPA by about 70%, but increased back to about 50% of baseline between 6 and 12 months of therapy, remaining stable thereafter up to 24 months. The testosterone escape phenomenon should be kept in mind in the context of progestogen monotherapy for testosterone suppression. In contrast to progestogen monotherapy, this phenomenon has not been associated with combined estrogen and progestogen therapy.

    Testosterone Suppression in Combination with Estrogen

    CPA is generally used in combination with an estrogen in transfeminine people. Estrogens suppress testosterone levels similarly to progestogens. The combination of an estrogen and a progestogen is synergistic in terms of testosterone suppression and results in suppression of testosterone levels with lower doses than with either an estrogen or progestogen alone (Fink, 1979; Geller & Albert, 1983; Bastianelli et al., 2018). Although estrogens can suppress testosterone levels to an equivalent extent as surgical or medical castration (i.e., orchiectomy or GnRH agonists/antagonists), this usually requires relatively high estrogen levels, for instance in the range of 200 to 500 pg/mL (Wiki; Graphs). Because of the high and supraphysiological estradiol levels required for maximal or near-maximal suppression of testosterone levels, lower doses of estradiol are frequently combined with antiandrogens and/or progestogens to block or suppress remaining testosterone levels instead.

    The combination of estradiol and high doses of CPA (e.g., 50–100 mg/day) in transfeminine people has been shown to suppress testosterone levels into the normal female range (≤50 ng/dL or ≤1.7 nmol/L) in numerous studies (Giltay & Gooren, 2000; Giltay et al., 2000; Giltay et al., 2003; Giltay et al., 2004; Toorians et al., 2003; T’Sjoen et al., 2005; Slagter et al., 2006; T’Sjoen et al., 2009; Ott et al., 2011; Wierckx et al., 2012; Wierckx et al., 2014; Zubiaurre-Elorza et al., 2014; Fuss et al., 2015; Van Caenegem et al., 2015; Gava et al., 2016; Bultynck et al., 2017; Fung, Hellstern-Layefsky, & Lega, 2017; Kranz et al., 2017; Tack et al., 2017; Wiepjes et al., 2017; de Blok et al., 2018; Defreyne et al., 2018; Vita et al., 2018; Angus et al., 2019; Chen et al., 2019; Scharff et al., 2019; van Dijk et al., 2019; van Velzen et al., 2019; Vereecke, 2019; Vlot et al., 2019; Wiepjes et al., 2019; Kranz, Kaufmann, & Lanzenberger, 2020; Meyer et al., 2020; Gava et al., 2020; Sofer et al., 2020; Vereecke et al., 2021).

    In the 1980s and 1990s, clinical studies in men with prostate cancer showed that the combination of a high dosage of a progestogen, such as 100 to 300 mg/day CPA or 40 to 160 mg/day megestrol acetate, with a low dosage of an estrogen, such as 0.1 to 0.2 mg/day diethylstilbestrol or 0.5 to 1.5 mg/day oral estradiol, was able to completely suppress gonadal testosterone production and reduce testosterone levels well into the male castrate range (<50 ng/dL) (Geller et al., 1981a; Geller et al., 1981b; Geller & Albert, 1983; Goldenberg et al., 1988; Johnson et al., 1988; Geller, 1988; Venner et al., 1988; Geller, 1991; Goldenberg & Bruchovsky, 1991; Bruchovsky et al., 1993; Goldenberg et al., 1996). Similarly, a 1989 case series reported the same in three transfeminine people treated with CPA 100 mg/day and relatively low doses of estrogens (Jequier, Bullimore, & Bishop, 1989). Here is a noteworthy and informative literature excerpt on this topic in the context of prostate cancer (Schröder & Radlmaier, 2002):

    CPA, as mentioned earlier, leads to an incomplete suppression of plasma testosterone levels, which decrease by about 70% and remain at about three times castration values. In a very systematic approach to the problem, Rennie et al. (59) investigated and compared 12 different procedures of androgen deprivation. These authors found that the combination of CPA with an extremely low dose (0.1 mg/d) of [diethylstilbestrol (DES)] led to a very effective withdrawal of androgens in terms of plasma testosterone and tissue dihydrotestosterone. The same group later showed that 200 mg of CPA, and even 100 mg/day, was sufficient to achieve a similar endocrine response, which was correlated to very favorable clinical responses in a Phase II situation (60,61). The approach has many potential advantages, and, from an endocrinological point of view, is very logical: this regimen combines the testosterone-reducing effects of two compounds, therefore, only small amounts of estrogen are required to bring down plasma testosterone to approximately castrate levels. Once castrate levels have been achieved, only low doses of CPA are necessary to counteract remaining androgens, mainly of adrenal origin. The regimen was shown to be associated with few side effects and a very low cost. The combination of low-dose CPA with low-dose DES was never studied in a Phase III situation in comparison to standard management. Considering the endocrine results and the observations in patients treated with this regimen (60), this combination treatment is very likely to be competitive with other standard forms of therapy.

    A 2016 study of 50 mg/day CPA and 1 to 2 mg/day transdermal estradiol gel in transfeminine people showed that estradiol levels of about 45 pg/mL with CPA were insufficient to achieve female/castrate levels of testosterone, instead resulting in testosterone levels of about 120 to 190 ng/dL (Gava et al., 2016; Graph). Conversely, estradiol levels of about 85 pg/mL with CPA achieved complete suppression of gonadal testosterone production, with resulting testosterone levels of about 20 ng/dL. As such, a certain minimum level of estradiol with CPA appears to be required for complete testosterone suppression. A 2019 study of CPA and oral estradiol valerate in transfeminine people indicated that testosterone levels were still fully suppressed with median estradiol levels of 76 pg/mL and 25th percentile estradiol levels of 63 pg/mL (Angus et al., 2019; Graph).

    Figures 5–7: Testosterone levels with CPA plus low doses/levels of estrogens in men and transfeminine people. Sources: Top-left: Goldenberg et al. (1988). Top-right: Gava et al. (2016). Bottom: Angus et al. (2019). See also on Wikipedia: Gallery. Note for the graph on the top right that the mean transdermal estradiol dosage increased between 6 and 12 months and this was likely responsible for the improvement in testosterone suppression.

    Fung and colleagues showed that the combination of either 25 or 50 mg/day CPA with a moderate dosage of oral estradiol (~3.5 mg/day) or transdermal estradiol (~3.5 mg/day gel or ~100 μg/day patch) resulted in equivalent and complete suppression of gonadal testosterone production (~95% suppression of testosterone levels) in transfeminine people (Fung, Hellstern-Layefsky, & Lega, 2017). These dosages of estradiol would be expected to achieve estradiol levels of around 100 pg/mL on average (Aly, 2020; Wiki). This study was notably published 6 months before the 2017 second edition of the Endocrine Society guidelines were released (Hembree et al., 2017), and was probably responsible for the decrease in their recommended dosage of CPA from 50–100 mg/day to 25–50 mg/day.

    Few studies to date have assessed testosterone suppression with low-dose CPA in combination with a low or moderate dosage of an estrogen. However, based on the fact that 5 to 10 mg/day CPA alone is probably maximal in terms of suppression of testosterone levels, it is likely that such dosages of CPA will be similarly effective as higher dosages. In accordance, studies of 5 to 12.5 mg/day CPA plus upper physiological replacement dosages of testosterone have demonstrated undetectable gonadotropin levels (<0.5 IU/L) and hence complete suppression of testicular function in healthy young men (Meriggiola et al., 1998; Meriggiola et al., 2002b). Estradiol is a more powerful antigonadotropin than testosterone (Wiki), so these findings probably apply to CPA in combination with physiological replacement levels of estradiol as well (e.g., mean estradiol levels of 100–200 pg/mL).

    Accordingly, Meyer et al. (2020) assessed a dosage of CPA in combination with estradiol in 155 transfeminine people and found no difference in testosterone levels with 10, 25, or 50 mg/day CPA; testosterone levels were strongly suppressed with all three doses (to about 15–20 ng/dL on average, or into the lower end of the normal female range). The estradiol forms and doses used in this study were oral estradiol valerate (median 6 mg/day, range 3–10 mg/day), transdermal estradiol gel (median 2.25 mg/day, range 1.5–6 mg/day), and transdermal estradiol patches (100 μg/day in all cases). Estradiol levels were about 100 pg/mL on average, with an interquartile range (i.e., difference between 75th and 25th percentiles) of about 100 pg/mL. This study demonstrates that, provided estradiol levels are adequate, no more than 10 mg/day CPA is needed to fully suppress testosterone levels in transfeminine people. Another study likewise found no difference between <20 mg/day and >50 mg/day CPA in terms of testosterone suppression in transfeminine people (Even-Zohar et al., 2020).

    Even doses of CPA lower than 5 mg/day (e.g., 2 mg/day) may be usefully effective for testosterone suppression if combined with sufficient levels of estradiol, although this has not been studied and remains to be validated. But there is certainly precedent for the notion when looking at studies with other progestogens. As an example, one study using 10 mg/day oral medroxyprogesterone acetate (which is roughly equivalent to 1 mg/day CPA in terms of ovulation inhibition in premenopausal women; Table) observed 63% lower testosterone levels (215 ng/dL vs. 79 ng/dL) when added to estradiol and spironolactone therapy in transfeminine people (Jain, Kwan, & Forcier, 2019). Analogous effects on testosterone levels would be anticipated for very-low-dose CPA. Moreover, such dosages of CPA would have the advantage of actually being physiological in terms of progestogenic exposure.

    Clinical Adoption of Lower Doses

    In light of the risks of higher doses of CPA and the strong capacity for testosterone suppression of lower doses of CPA, lower doses of the medication are being increasingly adopted clinically in transfeminine hormone therapy. A number of literature sources evidence this by recommending and describing use of lower doses in transfeminine people (e.g., Lederbogen, 2009; Fung, Hellstern-Layefsky, & Lega, 2017; Heath & Wynne, 2019; Winkler-Crepaz et al., 2017; Mahfouda et al., 2018; Oliphant et al., 2018; Athanasoulia-Kaspar & Stalla, 2019; Bourns, 2019; Fuss et al., 2019; Jacobeit, 2019; Nota, den Heijer, & Gooren, 2019; ANZCTR, 2020; Meyer et al., 2020; T’Sjoen et al., 2020). In the case of Nota, den Heijer, & Gooren (2019), their newer recommendations for CPA of 10 to 50 mg/day and use for no longer than absolutely necessary are a major departure from their past extensive use and recommendation of 100 mg/day CPA (Asscheman & Gooren, 1993; Gooren, Giltay, & Bunck, 2008).

    Androgen Receptor Antagonism with Higher Doses

    The androgen receptor antagonism of CPA is relatively weak in terms of potency; dosages of CPA of 50 to 300 mg/day seem to be necessary for meaningful or considerable androgen receptor antagonism. Unfortunately, such doses also result in extreme progestogenic overdosage and are associated with considerably greater risks and adverse effects. As a result, the use of such doses of CPA should no longer be considered advisable. Instead, CPA should be used at lower doses simply as a progestogen to suppress testosterone levels. As such, the highest effective dosage of CPA for testosterone suppression, which is probably about 10 mg/day or less (12.5 mg/day also being acceptable), should be around the maximal dosage of CPA that is used in transfeminine people.

    It should be emphasized that since the combination of an estrogen and CPA can easily suppress testosterone levels well into the female/castrate range (typically to below average female levels), there isn’t necessarily a requirement for concomitant androgen receptor blockade. In any case, if androgen receptor antagonism to neutralize the remaining female/castrate levels of testosterone is still necessary or desired (e.g., to treat persisting acne or for some other purpose), a low dosage of a non-progestogenic androgen-receptor antagonist like spironolactone (e.g., 100–200 mg/day) or bicalutamide (e.g., 12.5–25 mg/day) can be added to CPA to more safely achieve this than use of higher CPA doses.

    Dosage for Testosterone Suppression

    Estrogen Plus Cyproterone Acetate

    The following recommended dosages of CPA in transfeminine people are for the combination of CPA with an estrogen and are specifically for achieving maximal suppression of testosterone levels:

    Table 2: Recommended doses of CPA in combination with estrogen for maximal testosterone suppression in transfeminine people:

    FormMin. dosageMax. dosageAmount
    10 mg tablets5 mg/day10 mg/day1/2 of a tablet to 1 whole tablet per day
    50 mg tablets6.25 mg/day12.5 mg/day1/8th of a tablet to 1/4th of a tablet per day

    Start with the minimum dosage of CPA for one month. After one month, have testosterone levels tested and confirm that they are in the normal female/castrate range (<50 ng/dL). Regardless of dosage, a concomitant minimum estradiol level of around 65 pg/mL needs to be attained in order to allow for complete suppression of testosterone levels with CPA. If testosterone levels aren’t sufficiently suppressed after a month and estradiol levels are adequate, increase to the maximum CPA dosage and re-check testosterone levels after another month. Alternatively, the dosage of estradiol can be increased instead; higher estradiol levels result in greater testosterone suppression as well.

    Cyproterone Acetate Alone

    The use of CPA alone (i.e., as a monotherapy for testosterone suppression) is not recommended due to the risk of decreased bone mineral density and other symptoms of sex-hormone deficiency (Wiki; Aly, 2019). In any case, the recommended dosages for CPA without an estrogen are essentially the same as those listed above of the combination of an estrogen with CPA for testosterone suppression. However, the higher CPA dose (10–12.5 mg/day) may be preferable for good measure in this scenario.

    Dosage for Progestogenic Effects

    The following recommended dosages of CPA in transfeminine people are for progestogenic effects similar to normal physiological exposure (equivalent of luteal-phase progesterone levels):

    Table 3: Recommended doses of CPA for physiological progestogenic effects in transfeminine people:

    FormDosageAmount
    10 mg tablets2.5 mg/day1/4th of a tablet per day
    50 mg tablets3.125 mg/day1/16th of a tablet per day

    Achieving Desired Dosages

    CPA is available pharmaceutically most widely as 50-mg tablets. This can make achieving desired low doses of CPA more difficult. For splitting CPA tablets into small fractions, a pill cutter can be used. Additionally, CPA can be taken once every 2 or 3 days instead of once every day to help further divide doses. It is notable that CPA has a relatively long half-life in the body of about 1.5 to 2 days (but possibly up to 4 days) (Wiki; Graph). Hence, taking it once every other day instead of once per day, or even less frequently like once every 3 days, has sound basis and is likely to be entirely viable.

    Updates

    Update 1: GoLoCypro Study (In-Progress)

    The GoLoCypro study (2019–2022) (more info) is being conducted by Dr. Judith Dean at the University of Queensland in Australia. It’s assessing the influence of estradiol plus CPA on testosterone levels at five different CPA dose levels (12.5 mg 2x/week, 12.5 mg/2 days, 12.5 mg/day, 25 mg/day, and 50 mg/day) in a total of 120 to 350 transfeminine people. CPA doses are being titrated to the minimum that maintain testosterone levels within the therapeutic goal range of 0.5 to 1.5 nmol/L (14–43 ng/dL). The study is among the first dose-ranging studies of CPA in transfeminine people to be conducted and is eagerly anticipated due to the valuable information that it should provide in terms of the minimum effective dosage of CPA for adequate testosterone suppression in transfeminine hormone therapy.

    Update 2: Kuijpers et al. (2021) and Even Zohar et al. (2021)

    In June 2021, the following study on low doses of CPA in transfeminine people by the European Network for the Investigation of Gender Incongruence (ENIGI) initiative was published online:

    • Kuijpers, S. M., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021). Toward a lowest effective dose of cyproterone acetate in trans women: Results from the ENIGI study. The Journal of Clinical Endocrinology & Metabolism, 106(10), e3936–e3945. [DOI:10.1210/clinem/dgab427]

    The study employed estradiol (2–6 mg/day oral (as estradiol valerate), 50–150 μg/day patch, or gel) plus five different dose levels of CPA—0 mg/day (no CPA), 10 mg/day, 25 mg/day, 50 mg/day, and 100 mg/day. It found incompletely suppressed testosterone in the no CPA group but full and equivalent testosterone suppression with all doses of CPA. The results were as follows:

    CPA dosage
    0 mg/day10 mg/day25 mg/day50 mg/day100 mg/day
    Initial subjects (n)34423459911
    Dose increased (n)1611120
    Dose decreased (n)004407
    T levels (nmol/L)5.50.90.91.10.9
    T levels (ng/dL)~160~26~26~32~26
    T <2 nmol/L [<~58 ng/dL] (%)46.392.396.293.4100.0

    Abbreviations: T = testosterone.

    The total numbers of subjects and blood tests after CPA dose increases/decreases were not provided. Hence, the exact total number of people and tests for the 10 mg/day group can’t be stated with certainty. The total number of tests for this group was at least 13 based on the testosterone suppression percentage provided however (92.3% or 12/13 but could potentially be 24/26, etc.). Regarding the small number of subjects/tests for the 10 mg/day group, the authors stated the following:

    This study is part of the ENIGI initiative, a multicenter prospective cohort study. The main treatment protocol for trans women in this study was 50 mg of CPA daily combined with estrogens. In the first year of study inclusion, a few participants received a dose of 100 mg of CPA. Shortly thereafter, inhospital protocol changed to 50 mg of CPA. As more health concerns related to CPA use were raised over the years, the dose was further lowered from 50 mg to 25 mg and, finally, to 10 mg. However, due to the coronavirus (COVID-19) pandemic, limited results of participants with 10 mg of CPA were available for analysis.

    Besides testosterone suppression, the study found that 10 mg/day CPA had less influence on prolactin and high-density lipoprotein (HDL) cholesterol levels than the higher doses of CPA. The study also assessed liver enzyme levels but found no differences between CPA doses.

    The authors concluded with the following:

    In conclusion, in this cohort of trans women, 10 mg of CPA was found to be effective in lowering testosterone concentrations to the range observed in cis women. A dose of 10 mg was equally effective as higher doses, was found to have less influence on prolactin concentrations and allows higher HDL-C concentrations to be maintained. While GnRH agonists are preferred over CPA due to the fewer associated long-term side effects, this study shows that CPA at a low dose is a viable option when GnRH agonists are contra-indicated, not available, or not reimbursed. Future research should focus on assessing the effectiveness of an even lower dose of CPA (e.g., 5 mg) and the potential long-term side effects.

    Around the same that this study was published, Guy T’Sjoen (one of the authors of the study) and other colleagues in a review of optimal hormone therapy for transfeminine people recommended a dosage of no more than 10 or 12.5 mg/day CPA for no longer than 2 years (Glintborg et al., 2021). T’Sjoen is notable in being regarded as one of the foremost experts in transgender medicine and is a coauthor of the Endocrine Society transgender care guidelines (Hembree et al., 2017).

    Shortly after the study of Kuijpers and colleagues and also in June 2021, Even Zohar and colleagues in Israel published the following study on low doses of CPA in transfeminine people:

    • Even Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. The Journal of Sexual Medicine, 18(7), 1292–1298. [10.1016/j.jsxm.2021.04.008]

    This study was initially reported as a conference abstract in May 2020 (Even-Zohar et al., 2020).

    In the introduction section of the paper, the authors stated the following:

    Treatment guidelines published by several organizations are available and assist clinicians in treating transgender women.4,7−9 A wide range of regimens for CPA administration have been proposed. By and large, the recommended doses have decreased over the years: doses of 50–100 mg/day were suggested in the 2009 Endocrine Society Guidelines,10 and amended to 25–50 mg/day in 2017.7 The proposed CPA doses were 12.5–25 mg/day in the 2019 guidelines of the Australian Professional Association for Transgender Health,4 and they were amended to 10–50 mg/day in the 2020 guidelines of the European Society for Sexual Medicine.8 There are no publications on data that compare different doses of CPA for efficacy or safety.

    The researchers found that estradiol plus low-dose CPA (10–20 mg/day) suppressed testosterone levels to an equivalent extent as estradiol plus high-dose CPA (50–100 mg/day). Testosterone levels were suppressed into the female/castrate range or near so in both groups (generally ≤2 nmol/L or ≤58 pg/mL). Of the 38 transfeminine people on low-dose CPA, 32 (84%) were on 10 mg/day CPA and 6 (16%) were on 20 mg/day CPA (mean dose 11.6 ± 3.7 mg/day). Estradiol was given as transdermal estradiol patch (mean dose 83.7 ± 36.5 μg/day), transdermal estradiol gel (mean dose 3.8 ± 1.2 g/day), or oral estradiol (mean dose 4.1 ± 1.7 mg/day). Mean estradiol levels ranged from ~110 to 350 pmol/L (~30–95 pg/mL) in the low- and high-dose CPA groups over the follow-up period. Besides showing equivalent testosterone suppression, prolactin levels were significantly lower with low-dose CPA than with high-dose CPA (398 ± 69 mIU/mL vs. 804 ± 121 mIU/mL at 12 months of hormone therapy, respectively).

    Based on their findings, the authors stated the following:

    We suggest an adjustment of current clinical practice guidelines to recommend lower doses of CPA for the treatment of transgender women.

    Both Kuijpers et al. (2021) and Even Zohar et al. (2021) claimed to be the first to demonstrate the efficacy of low-dose CPA in transfeminine people. However, that achievement actually appears to belong to Meyer et al. (2020), who in February 2020 found that estradiol plus 10, 25, or 50 mg/day CPA gave equivalent testosterone suppression across CPA doses in transfeminine people.

    Although their study was not about CPA and testosterone suppression, Lim et al. (2020) reported in May/July 2020 that testosterone levels in transfeminine people were median (IQR) 0.6 (0.4–1.0) nmol/L for oral estradiol and 0.9 (0.7–1.6) nmol/L for transdermal estradiol in a mixed group of transfeminine people (n=26 total) on estradiol plus low-dose CPA (12.5 (12.5–18.8) mg/day) (n=14), estradiol alone post-gonadectomy (n=9), and estradiol plus spironolactone (n=3).

    Update 3: Kumar et al. (2021) [Lower-Dose CPA Liver Failure Case]

    In December 2021, the following case report of fatal liver failure with low-dose CPA was published:

    • Kumar, P., Reddy, S., Kulkarni, A., Sharma, M., & Rao, P. N. (2021). Cyproterone acetate induced Acute liver failure: Case report and review of the literature. Journal of Clinical and Experimental Hepatology, 11(6), 739–741. [DOI:10.1016/j.jceh.2021.01.003]

    The case report describes a 30-year-old cisgender woman who was on 25 mg/day CPA for treatment of hirsutism (excessive facial/body hair growth) for 6 months and developed acute liver failure. Four days following hospitalization, she died. This is the second published case report of liver toxicity with CPA at a dosage below 100 mg/day (the first and only other case was at 50 mg/day) (Wiki; Table). It is also the first report of liver failure in a cisgender woman taking CPA. The case indicates that CPA even at a relatively low dose of 25 mg/day is not fully safe in terms of liver toxicity. It further emphasizes the importance of using the lowest effective doses of CPA in transfeminine people (no more than 10–12.5 mg/day).

    Update 4: Coleman et al. (2022) [WPATH SOC8 Guidelines]

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published and made recommendations for transgender hormone therapy for the first time (Coleman et al., 2022). These guidelines recommended a dose of CPA of 10 mg/day in transfeminine people (Coleman et al., 2022). This dose is substantially lower than previous doses recommended by transgender care guidelines and is the first time that major guidelines have recommended a CPA dosage this low. The WPATH SOC8 cited Kuijpers et al. (2021) in support of this recommendation (though notably not Even Zohar et al. (2021) or Meyer et al. (2020)) and also discussed the dose-dependent risks of CPA such as meningiomas and high prolactin levels (Coleman et al., 2022). Considering the key position and importance of the WPATH SOC in transgender health, it is likely that lower CPA doses in transfeminine hormone therapy will now be widely adopted throughout the world. Continued use of higher CPA doses should be considered out of step with current accepted evidence-based practice.

    Update 5: Collet et al. (2023)

    In October 2022, a study more carefully assessing androgen suppression with estradiol plus CPA in transfeminine people was published:

    • Collet, S., Gieles, N., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T’Sjoen, G. (2023). Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331–338. [DOI:10.1210/clinem/dgac576]

    This study was part of the European Network for the Investigation of Gender Incongruence (ENIGI) initiative, mostly including patients from the Amsterdam, Netherlands and Ghent, Belgium clinics.

    In the study, 275 transfeminine people were treated with estradiol plus CPA, and levels of total testosterone, free testosterone, and the adrenal androgens dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), and androstenedione (A4) were measured using liquid chromatography–mass spectrometry (LC–MS) at baseline and during follow-ups at 3 months, 12 months, 2 to 4 years, and after surgical gonadal removal (at which time CPA was discontinued). Estradiol was measured both with LC–MS (Amsterdam clinic) and with immunoassays (Ghent clinic). The forms and doses of estradiol used were most commonly oral estradiol valerate 4 mg/day or a transdermal estradiol patch 100 μg/day, while the dosage of CPA was usually 25 or 50 mg/day. About half of the transfeminine people eventually underwent surgical gonadal removal, usually after 2 years of hormone therapy.

    Median estradiol levels ranged from 49 to 75 pg/mL (180–275 pmol/L) with LC–MS and from 63 to 69 pg/mL (232–255 pmol/L) with immunoassays at different follow-ups. After 3 months of hormone therapy, total testosterone decreased by 97.1%, from 536 ng/dL (18.6 nmol/L) to 12 ng/dL (0.40 nmol/L), and free testosterone decreased by 98.3%, from 109 pg/mL (378 pmol/L) to 2.0 pg/mL (7.1 pmol/L). Thereafter, total and free testosterone levels remained stable. Levels of DHEA, DHEA-S, and A4 decreased by 24.9 to 28.0%, 20.1 to 23.5%, and 36.5%, respectively, and likewise did not further change after the first 3 to 12 months of hormone therapy. No changes in androgen levels occurred upon surgical gonadal removal with discontinuation of CPA. The authors noted that testosterone levels in the transfeminine people on hormone therapy in the study were similar to or lower than those in cisgender women.

    Update 6: Warzywoda et al. (2024) [GoLoCypro Study]

    The GoLoCypro study, by Judith Dean and colleagues, was published online in February 2024:

    • Warzywoda, S., Fowler, J. A., Wood, P., Bisshop, F., Russell, D., Luu, H., Kelly, M., Featherstone, V., & Dean, J. A. (2024). How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2317395]

    The following are some noteworthy excerpts from the paper:

    Of participants who completed the protocol, 74.0% (34/46) were able to achieve the target T-range (0.5–1.5 nmol/L) and 41.3% (19/46) were titrated to the lowest CPA level (12.5 mg cyproterone twice weekly).

    Almost all participants who completed the protocol (91.3.0%, 42/46) recorded their CPA levels as level 3 (12.5 mg daily/25 [mg] alternate days) or lower, with 69.0% (29/42) of these being able to achieve the target T-range. Of those that completed, 41.3% (19/46) were able to achieve the lowest CPA level (12.5 mg cyproterone twice week) with 57.9% (11/19) being able to achieve the target T-range.

    The study findings showed that for some patients, CPA doses as low as 12.5 mg on alternate days or less can successfully reduce testosterone to pre-menopausal ranges whilst ensuring testosterone was not over-suppressed.

    Our study found that doses of CPA lower than the standard dose (12.5 mg CPA daily and/or 25 mg alternate days) were achievable for suppression of testosterone. Several studies have supported this finding that a lower dosage (10 mg CPA daily) is effective in testosterone reduction in individuals undergoing hormone feminization (Even Zohar et al., 2021; Kuijpers et al., 2021). While not all individuals within our study were able to titrate down CPA dosages, almost a quarter of participants who completed the protocol were achieving target T-ranges on 12.5 mg CPA twice weekly (equivalent to 3.5 mg/daily). To our knowledge ours is the first study to demonstrate that doses lower than 10 mg/daily as well as alternate days or twice weekly CPA are clinically effective in maintaining testosterone reduction within target ranges.

    Update 7: More New Low-Dose CPA Studies (2023–2024)

    Other new studies of low-dose CPA in transfeminine people have also been published in 2023 and 2024:

    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (November 2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (November 2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]
    • Flamant, T., Vervalcke, J., & T’Sjoen, G. (November 2023). Dose Reduction of Cyproterone Acetate in Trans Women and the Effect on Patient-reported Outcomes: Results from the ENIGI Study. Endocrine Abstracts, 97 [Belgian Endocrine Society 2023], 5–5 (abstract no. 007). [URL] [PDF]
    • Korpaisarn, S., Arunakul, J., Chaisuksombat, K., & Rattananukrom, T. (2023). A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment. Journal of the Endocrine Society, 7(Suppl 1), A1098–A1099 (abstract no. SAT397/bvad114.2068). [DOI:10.1210/jendso/bvad114.2068]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]

    References

    • Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., Zajac, J. D., & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine Connections, 8(7), 935–940. [DOI:10.1530/ec-19-0272]
    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • Athanasoulia-Kaspar, A. P., & Stalla, G. K. (2019). Endokrinologische Betreuung von Patienten mit Transsexualität. Geburtshilfe und Frauenheilkunde, 79(7), 672–675. [DOI:10.1055/a-0801-3319]
    • Bastianelli, C., Farris, M., Rosato, E., Brosens, I., & Benagiano, G. (2018). Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation. Expert Review of Clinical Pharmacology, 11(11), 1085–1098. [DOI:10.1080/17512433.2018.1536544]
    • Bourns, A. (2019). Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition. Toronto: Rainbow Health Ontario/Sherbourne Health. [URL] [PDF]
    • Bruchovsky, N., Larry Goldenberg, S., Akakura, K., & Rennie, P. S. (1993). Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol. Cancer, 72(5), 1685–1691. [DOI:10.1002/1097-0142(19930901)72:5<1685::aid-cncr2820720532>3.0.co;2-3]
    • Bultynck, C., Pas, C., Defreyne, J., Cosyns, M., den Heijer, M., & T’Sjoen, G. (2017). Self-perception of voice in transgender persons during cross-sex hormone therapy. The Laryngoscope, 127(12), 2796–2804. [DOI:10.1002/lary.26716]
    • Chen, H., Wiepjes, C. M., van Schoor, N. M., Heijboer, A. C., de Jongh, R. T., den Heijer, M., & Lips, P. (2019). Changes of Vitamin D-Binding Protein, and Total, Bioavailable, and Free 25-Hydroxyvitamin D in Transgender People. The Journal of Clinical Endocrinology & Metabolism, 104(7), 2728–2734. [DOI:10.1210/jc.2018-02602]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Collet, S., Gieles, N., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T’Sjoen, G. (2023). Changes in serum testosterone and adrenal androgen levels in transgender women with and without gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331–338. [DOI:10.1210/clinem/dgac576]
    • Damgaard-Pedersen, F., & Føgh, M. (1980). The effect of cyproterone acetate on serum lipids in normal men. Acta Endocrinologica, 94(2), 280–283. [DOI:10.1530/acta.0.0940280]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • Defreyne, J., Vantomme, B., Van Caenegem, E., Wierckx, K., De Blok, C., Klaver, M., Nota, N. M., Van Dijk, D., Wiepjes, C. M., Den Heijer, M., & T’Sjoen, G. (2018). Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Andrology, 6(3), 446–454. [DOI:10.1111/andr.12485]
    • Endrikat, J., Gerlinger, C., Richard, S., Rosenbaum, P., & Düsterberg, B. (2011). Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide. Contraception, 84(6), 549–557. [DOI:10.1016/j.contraception.2011.04.009]
    • Even-Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2020). SUN-042 Low Dose Cyproterone Acetate for the Treatment of Transgender Women - a Retrospective Study. Journal of the Endocrine Society, 4(Suppl 1), A715–A715. [DOI:10.1210/jendso/bvaa046.1412]
    • Even Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. The Journal of Sexual Medicine, 18(7), 1292–1298. [DOI:10.1016/j.jsxm.2021.04.008]
    • Fink, G. (1979). Feedback Actions of Target Hormones on Hypothalamus and Pituitary With Special Reference to Gonadal Steroids. Annual Review of Physiology, 41(1), 571–585. [DOI:10.1146/annurev.ph.41.030179.003035]
    • Flamant, T., Vervalcke, J., & T’Sjoen, G. (2023). Dose Reduction of Cyproterone Acetate in Trans Women and the Effect on Patient-reported Outcomes: Results from the ENIGI Study. Endocrine Abstracts, 97 [Belgian Endocrine Society 2023], 5–5 (abstract no. 007). [URL] [PDF]
    • Føgh, M., Corker, C. S., Hunter, W. M., McLean, H., Philip, J., Schou, G., & Shakkebæk, N. E. (1979). The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men. Acta Endocrinologica, 91(3), 545–552. [DOI:10.1530/acta.0.0910545]
    • Føgh, M., Knudsen, J. B., & Gormsen, J. (1980). Effect of cyproterone acetate on platelet aggregability, fibrinolytic activity and fibrinolytic capacity in normal men. Acta Endocrinologica, 94(3), 430–432. [DOI:10.1530/acta.0.0940430]
    • Foegh, M. (1983). Evaluation of Steroids as COntraceptives in Men. Acta Endocrinologica, 104(3 Suppl b), S9–S48. [DOI:10.1530/acta.0.104s009]
    • Fredricsson, B., & Carlström, K. (2009). Effects of Low Doses of Cyproterone Acetate on Sperm Morphology and some other Parameters of Reproduction in Normal Men. Andrologia, 13(4), 369–375. [DOI:10.1111/j.1439-0272.1981.tb00067.x]
    • Fung, R., Hellstern-Layefsky, M., & Lega, I. (2017). Is a lower dose of cyproterone acetate as effective at testosterone suppression in transgender women as higher doses? International Journal of Transgenderism, 18(2), 123–128. [DOI:10.1080/15532739.2017.1290566]
    • Fuss, J., Hellweg, R., Van Caenegem, E., Briken, P., Stalla, G. K., T’Sjoen, G., & Auer, M. K. (2015). Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF). European Neuropsychopharmacology, 25(1), 95–99. [DOI:10.1016/j.euroneuro.2014.11.019]
    • Fuss, J., Claro, L., Ising, M., Biedermann, S. V., Wiedemann, K., Stalla, G. K., Briken, P., & Auer, M. K. (2019). Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals. Psychoneuroendocrinology, 104, 228–237. [DOI:10.1016/j.psyneuen.2019.02.023]
    • Gava, G., Cerpolini, S., Martelli, V., Battista, G., Seracchioli, R., & Meriggiola, M. C. (2016). Cyproterone acetatevsleuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clinical Endocrinology, 85(2), 239–246. [DOI:10.1111/cen.13050]
    • Gava, G., Mancini, I., Alvisi, S., Seracchioli, R., & Meriggiola, M. C. (2020). A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen. European Journal of Endocrinology, 183(6), 561–569. [DOI:10.1530/eje-20-0370]
    • Geller, J., Albert, J., Yen, S. S., Geller, S., & Loza, D. (1981). Medical Castration of Males with Megestrol Acetate and Small Doses of Diethylstilbestrol*. The Journal of Clinical Endocrinology & Metabolism, 52(3), 576–580. [DOI:10.1210/jcem-52-3-576]
    • Geller, J., Albert, J., Yen, S. S., Geller, S., & Loza, D. (1981). Medical castration with megestrol acetate and minidose of diethylstilbestrol. Urology, 17(4 Suppl), 27–33. [Google Scholar] [PubMed]
    • Geller, J., & Albert, J. D. (1983). Comparison of various hormonal therapies for prostatic carcinoma. Seminars in Oncology, 10(4 Suppl 4), 34–41. [Google Scholar] [PubMed] [PDF]
    • Geller, J. (1988). Megestrol acetate and minidose estrogen in prostatic carcinoma. Urology, 32(3), 281–282. [DOI:10.1016/0090-4295(88)90402-5]
    • Geller J. (1991). Megestrol Acetate Plus Low-Dose Estrogen in the Management of Advanced Prostatic Carcinoma. The Urologic Clinics of North America, 18(1), 83–91. [DOI:10.1016/S0094-0143(21)01395-1] [Archive.org] [PDF]
    • Giltay, E. J., & Gooren, L. J. (2000). Effects of Sex Steroid Deprivation/Administration on Hair Growth and Skin Sebum Production in Transsexual Males and Females. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2913–2921. [DOI:10.1210/jcem.85.8.6710]
    • Giltay, E. J., Gooren, L. J., Emeis, J. J., Kooistra, T., & Stehouwer, C. D. (2000). Oral, but Not Transdermal, Administration of Estrogens Lowers Tissue-Type Plasminogen Activator Levels in Humans Without Affecting Endothelial Synthesis. Arteriosclerosis, Thrombosis, and Vascular Biology, 20(5), 1396–1403. [DOI:10.1161/01.atv.20.5.1396]
    • Giltay, E. J., Verhoef, P., Gooren, L. J., Geleijnse, J. M., Schouten, E. G., & Stehouwer, C. D. (2003). Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals. Atherosclerosis, 168(1), 139–146. [DOI:10.1016/s0021-9150(03)00090-x]
    • Giltay, E. J., Gooren, L. J., Toorians, A. W., Katan, M. B., & Zock, P. L. (2004). Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. The American Journal of Clinical Nutrition, 80(5), 1167–1174. [DOI:10.1093/ajcn/80.5.1167]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/eje-21-0059]
    • Goldenberg, S. L., Bruchovsky, N., Rennie, P. S., & Coppin, C. M. (1988). The Combination of Cyproterone Acetate and Low Dose Diethylstilbestrol in the Treatment of Advanced Prostatic Carcinoma. Journal of Urology, 140(6), 1460–1465. [DOI:10.1016/s0022-5347(17)42073-8]
    • Goldenberg, S. L., & Bruchovsky, N. (1991). Use of Cyproterone Acetate in Prostate Cancer. The Urologic Clinics of North America, 18(1), 111–122. [DOI:10.1016/S0094-0143(21)01398-7] [Archive.org] [PDF]
    • Goldenberg, S., Bruchovsky, N., Gleave, M., & Sullivan, L. (1996). Low-dose cyproterone acetate plus mini-dose diethylstilbestrol—A protocol for reversible medical castration. Urology, 47(6), 882–884. [DOI:10.1016/s0090-4295(96)00048-9]
    • Gooren, L. J., Giltay, E. J., & Bunck, M. C. (2008). Long-Term Treatment of Transsexuals with Cross-Sex Hormones: Extensive Personal Experience. The Journal of Clinical Endocrinology & Metabolism, 93(1), 19–25. [DOI:10.1210/jc.2007-1809]
    • Gräf, K., Brotherton, J., & Neumann, F. (1974). Clinical Uses of Antiandrogens. In Hughes, A., Hasan, S. H., Oertel, G. W., Voss, H. E., Bahner, F., Neumann, F., Steinbeck, H., Gräf, K.-J., Brotherton, J., Horn, H. J., & Wagner, R. K. (Eds.). Androgens II and Antiandrogens / Androgene II und Antiandrogene (Handbuch der experimentellen Pharmakologie/Handbook of Experimental Pharmacology, Volume 35, Part 2) (pp. 485–542). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-80859-3_7]
    • Hammerstein, J., Meckies, J., Leo-Rossberg, I., Moltz, L., & Zielske, F. (1975). Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism. Journal of Steroid Biochemistry, 6(6), 827–836. [DOI:10.1016/0022-4731(75)90311-8]
    • Hammerstein, J. (1979). Cyproterone Acetate. In Jacobs, H. S. (Ed.). Advances in Gynaecological Endocrinology: Proceedings of the Sixth Study Group of the Royal College of Obstetricians and Gynaecologists, 18th and 19th October, 1978 (pp. 367–382). London: The College. [Google Scholar] [Google Books] [PDF]
    • Hammerstein, J. (1990). Antiandrogens: Clinical Aspects. In Orfanos, C. E., & Happle, R. (Eds.). Hair and Hair Diseases (pp. 827–886). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-74612-3_35]
    • Heath, R. A., & Wynne, K. (2019). A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (p. 122). Santa Barbara: Praeger/ABC-CLIO. [Google Books]
    • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline [2nd Version]. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Jacobeit, J. W. (2019). Die hormonelle Behandlung von adulten Trans*Personen (in Deutschland). [Hormonal treatment of adult trans* persons (in Germany).] Journal für Klinische Endokrinologie und Stoffwechsel, 12(3), 102–110. [DOI:10.1007/s41969-019-00080-x]
    • Jacobi, G. H., Altwein, J. E., Kurth, K. H., Basting, R., & Hohenfellner, R. (1980). Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial*. British Journal of Urology, 52(3), 208–215. [DOI:10.1111/j.1464-410x.1980.tb02961.x]
    • Jacobi, G. H., Tunn, U., & Senge, T. (1982). Clinical experience with cyproterone acetate for palliation of inoperable prostate cancer. In Jacobi, G. H., & Hohenfellner, R. (Eds.). Prostate Cancer (International Perspectives in Urology, Volume 3) (pp. 305–319). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Jequier, A. M., Bullimore, N. J., & Bishop, M. J. (2009). Cyproterone Acetate and a Small Dose of Oestrogen in the Pre-operative Management of Male Transsexuals. A Report of Three Cases. [Cyproteronacetat und kleine Östrogendosis in dem präoperativen Management männlicher Transsexueller. Bericht über drei Fälle.] Andrologia, 21(5), 456–461. [DOI:10.1111/j.1439-0272.1989.tb02447.x]
    • Johnson, D. E., Babaian, R. J., Swanson, D. A., Von Eschenbach, A. C., Wishnow, K. I., & Tenney, D. (1988). Medical castration using megestrol acetate and minidose estrogen. Urology, 31(5), 371–374. [DOI:10.1016/0090-4295(88)90726-1]
    • Knuth, U. A., Hano, R., & Nieschlag, E. (1984). Effect of Flutamide or Cyproterone Acetate on Pituitary and Testicular Hormones in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 59(5), 963–969. [DOI:10.1210/jcem-59-5-963]
    • Koch, U. J., Lorenz, F., Danehl, K., & Hammerstein, J. (1975). Über die Verwendbarkeit von Cyproteronacetat zur Fertilitätshemmung beim Mann. Morphologische Veränderungen und Einflüsse auf die Spermienmotilität. Archiv für Gynäkologie, 219(1–4), 581–582. [DOI:10.1007/bf00669258]
    • Koch, U., Lorenz, F., Danehl, K., Ericsson, R., Hasan, S., Keyserlingk, D., Lübke, K., Mehring, M., Römmler, A., Schwartz, U., & Hammerstein, J. (1976). Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers. Contraception, 14(2), 117–135. [DOI:10.1016/0010-7824(76)90081-0]
    • Korpaisarn, S., Arunakul, J., Chaisuksombat, K., & Rattananukrom, T. (2023). A Low Dose Cyproterone Acetate In Feminizing Hormone Treatment. Journal of the Endocrine Society, 7(Suppl 1), A1098–A1099 (abstract no. SAT397/bvad114.2068). [DOI:10.1210/jendso/bvad114.2068]
    • Kranz, G. S., Seiger, R., Kaufmann, U., Hummer, A., Hahn, A., Ganger, S., Tik, M., Windischberger, C., Kasper, S., & Lanzenberger, R. (2017). Effects of sex hormone treatment on white matter microstructure in individuals with gender dysphoria. NeuroImage, 150, 60–67. [DOI:10.1016/j.neuroimage.2017.02.027]
    • Kranz, G. S., Kaufmann, U., & Lanzenberger, R. (2019). Probing the Impact of Gender-Affirming Hormone Treatment on Odor Perception. Chemical Senses, 45(1), 37–44. [DOI:10.1093/chemse/bjz069]
    • Kuijpers, S. M., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021). Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. The Journal of Clinical Endocrinology & Metabolism, 106(10), e3936–e3945. [DOI:10.1210/clinem/dgab427]
    • Kumar, P., Reddy, S., Kulkarni, A., Sharma, M., & Rao, P. N. (2021). Cyproterone acetate induced acute liver failure: case report and review of the literature. Journal of Clinical and Experimental Hepatology, 11(6), 739–741. [DOI:10.1016/j.jceh.2021.01.003]
    • Lederbogen, S. (2009). Hormonbehandlung. PiD - Psychotherapie im Dialog, 10(1), 41–43. [DOI:10.1055/s-0028-1090190]
    • Lim, H. Y., Leemaqz, S. Y., Torkamani, N., Grossmann, M., Zajac, J. D., Nandurkar, H., Ho, P., & Cheung, A. S. (2020). Global Coagulation Assays in Transgender Women on Oral and Transdermal Estradiol Therapy. The Journal of Clinical Endocrinology & Metabolism, 105(7), e2369–e2377. [DOI:10.1210/clinem/dgaa262]
    • Liu, P. Y., Takahashi, P., & Veldhuis, J. D. (2017). An Ensemble Perspective of Aging-Related Hypoandrogenemia in Men. In Winters, S. J., & Huhtaniemi, I. T. (Eds.). Male Hypogonadism: Basic, Clinical and Therapeutic Principles, 2nd Edition (pp. 325–347). Cham: Springer. [DOI:10.1007/978-3-319-53298-1_16]
    • Mahfouda, S., Moore, J. K., Siafarikas, A., Hewitt, T., Ganti, U., Lin, A., & Zepf, F. D. (2019). Gender-affirming hormones and surgery in transgender children and adolescents. The Lancet Diabetes & Endocrinology, 7(6), 484–498. [DOI:10.1016/s2213-8587(18)30305-x]
    • Meriggiola, M. C., Bremner, W. J., Costantino, A., Di Cintio, G., & Flamigni, C. (1998). Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Human Reproduction, 13(5), 1225–1229. [DOI:10.1093/humrep/13.5.1225]
    • Meriggiola, M. C., Bremner, W. J., Costantino, A., Bertaccini, A., Morselli-Labate, A. M., Huebler, D., Kaufmann, G., Oettel, M., & Flamigni, C. (2002). Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 87(5), 2107–2113. [DOI:10.1210/jcem.87.5.8514]
    • Meriggiola, M. C., Costantino, A., Bremner, W. J., & Morselli-Labate, A. M. (2002). Higher Testosterone Dose Impairs Sperm Suppression Induced by a Combined Androgen‐Progestin Regimen. Journal of Andrology, 23(5), 684–690. [DOI:10.1002/j.1939-4640.2002.tb02311.x]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463] [PDF]
    • Moltz, L., Römmler, A., Schwartz, U., & Hammerstein, J. (1978). Effects of Cyproterone Acetate (CPA) on Pituitary Gonadotrophin Release and on Androgen Secretion Before and After LH-RH Double Stimulation Tests in Men. International Journal of Andrology, 1(Suppl 2b) [5th Annual Workshop on the Testis, Geilo, Norway, April 1978, Endocrine Approach to Male Contraception], 713–719. [DOI:10.1111/j.1365-2605.1978.tb00518.x]
    • Moltz, L., Römmler, A., Schwartz, U., Post, K., & Hammerstein, J. (1978). Cyproterone acetate (CPA)—a potential male contraceptive: further studies on the interactions with endocrine parameters. Journal of Steroid Biochemistry, 9(9), 865–865 (abstract no. 252). [DOI:10.1016/0022-4731(78)90952-4]
    • Moltz, L., Römmler, A., Post, K., Schwartz, U., & Hammerstein, J. (1980). Medium dose cyproterone acetate (CPA): Effects on hormone secretion and on spermatogenesis in men. Contraception, 21(4), 393–413. [DOI:10.1016/s0010-7824(80)80017-5]
    • Moltz, L., Koch, U., Schwartz, U., Rommler, A., & Hammerstein, J. (1982). Male fertility regulation with cyproterone acetate (CPA). Contraceptive Delivery Systems, 3(3/4) [Retroproductive Health Care International Symposium, October 10-15 1982 Maui, Hawaii, USA, Expanded Abstracts], 298–298 (abstract no. 293). [Google Scholar] [PDF]
    • Moore, E., Wisniewski, A., & Dobs, A. (2003). Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse Effects. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3467–3473. [DOI:10.1210/jc.2002-021967]
    • Nelson, J. B. (2012). Hormone Therapy for Prostate Cancer. In Wein, A. J., Kavoussi, L. R., Novick, A. C., Partin, A. W., & Peters, C. A. (Eds.). Campbell-Walsh Urology, 10th Edition, Volume 2 (pp. 2920–2953). Philadelphia: Elsevier/Saunders. [Google Scholar] [Google Books]
    • Nota, N. M., den Heijer, M., Gooren, L. J. (2019). Evaluation and Treatment of Gender-Dysphoric/Gender Incongruent Adults. [Updated 2019 Jul 21]. In Feingold, K. R., Anawalt, B., Blackman, M. R., et al. (Eds.). Endotext [Internet]. South Dartmouth, Massachusetts: MDText.com. [PubMed]
    • Oliphant, J., Veale, J., Macdonald, J., Carroll, R., Johnson, R., Harte, M., Stephenson, C. & Bullock, J. (2018). Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa New Zealand. Waikato: Transgender Health Research Lab/University of Waikato. [URL] [PDF]
    • Ott, J., Aust, S., Promberger, R., Huber, J. C., & Kaufmann, U. (2011). Cross‐Sex Hormone Therapy Alters the Serum Lipid Profile: A Retrospective Cohort Study in 169 Transsexuals. The Journal of Sexual Medicine, 8(8), 2361–2369. [DOI:10.1111/j.1743-6109.2011.02311.x]
    • Petry, R., Mauss, J., Senge, T., & Rausch-Stroomann, J. (1970). Über den Einfluß von Cyproteronacetat, Norethisteronönanthat und Gestonoroncapronat auf die Hypophysen-Gonadenachse beim Mann. [Influence of Cyproterone-acetate, Norethisterone-enanthate and Gestonorone-capronate on the Hypophyseal-Gonadal-Axis in the Male.] In Kracht, J. (Ed.). Endokrinologie der Entwicklung und Reifung, 16. Symposion, Ulm, 26.-28. Februar 1970 (Symposion der Deutschen Gesellschaft für Endokrinologie, Volume 16) (pp. 428–430). Berlin: Springer. [Google Books] [DOI:10.1007/978-3-642-80591-2_118] [WorldCat] [PDF]
    • Petry, R., Rausch-Stroomann, J.-G., Berthold, K. Mauss, J., Ai, M., Senge, Th., & Vermeulen, A. (1970). Untersuchungen zum Wirkungsmechanismus der Antiandrogene Cyproteron und Cyproteronacetat beim Menschen (Gonadotropin-, Plasma-testosteron- und morphologische Keimdrüsenuntersuchungen). [Investigations on the mechanism of action of the antiandrogens cyproterone and cyproterone acetate in humans (gonadotropin, plasma testosterone, and morphological gonad investigations).] In Schlegel, B. (Ed.). Verhandlungen der Deutschen Gesellschaft für Innere Medizin: Sechsundsiebzigster Kongress Gehalten zu Wiesbaden vom 6. April – 9. April 1970 (Verhandlungen der Deutschen Gesellschaft für Innere Medizin, Volume 76) (pp. 873–876). München: Bergmann. [Google Scholar] [Google Books] [DOI:10.1007/978-3-642-85446-0] [WorldCat] [PDF]
    • Petry, R., Rausch-Stroomann, J. G., Mauss, J., Senge, Th., Ai, M., & Berthold, K. (1970). Investigations on the mode of action of the antiandrogens cyproterone and cyproterone acetate in man. / Investigations on the mechanism of action of anti androgenic cyproterone and cyproterone acetate in humans (gonadotropin, plasma testosterone, and morphological generative gland investigations). Medizinische Welt, 29, 1336–. [EurekaMag] [Cited by Koch et al. (1976)]
    • Petry, R., Mauss, J., Rausch-Stroomann, J. G., & Vermeulen, A. (1972). Reversible inhibition of spermatogenesis in men. Hormone and Metabolic Research, 4(5), 386–388. [DOI:10.1055/s-0028-1094040]
    • Roy, S., Chatterjee, S., Prasad, M., Poddar, A., Pandey, D., Pandey, H., & Jadhav, Y. (1976). Effects of cyproterone acetate on reproductive functions in normal human males. Contraception, 14(4), 403–423. [DOI:10.1016/s0010-7824(76)80055-8]
    • Roy, S., & Chatterjee, S. (1979). Studies with cyproterone acetate for male contraception. In James, V. H. T., & Pasqualini, J. R. (Eds.). Hormonal Steroids: Proceedings of the Fifth International Congress on Hormonal Steroids, New Delhi, India, October/November 1978 (pp. 675–680). Oxford: Pergamon Press. [DOI:10.1016/b978-0-08-023796-1.50099-2]
    • Roy, S., & Chatterjee, S. (1979). The Role of Antiandrogenic Action in Cyproterone Acetate-Induced Morphologic and Biochemical Changes in Human Semen. Fertility and Sterility, 32(1), 93–95. [DOI:10.1016/s0015-0282(16)44122-1]
    • Saborowski, K.-J. (1987). Konservative Therapie mit Cyproteronacetat und Estradiolundecylat beim Fortgeschrittenen Prostatacarcinom: Eine 5-Jahres-Studie. [Conservative Therapy with Cyproterone Acetate and Estradiol Undecylate in Advanced Prostate Cancer: A 5-Year Study.] (Doctoral dissertation, Ruhr-University Bochum.) [58 pages] [Google Scholar] [Google Books] [WorldCat] [PDF] [Translation]
    • Scharff, M., Wiepjes, C. M., Klaver, M., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2019). Change in grip strength in trans people and its association with lean body mass and bone density. Endocrine Connections, 8(7), 1020–1028. [DOI:10.1530/ec-19-0196]
    • Schröder, F. H., & Radlmaier, A. (2002). Steroidal Antiandrogens. In Jordan, C. V., & Furr, B. J. A. (Eds.). Hormone Therapy in Breast and Prostate Cancer (pp. 325–346). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-152-7_15]
    • Slagter, M. H., Gooren, L. J., de Ronde, W., Soosaipillai, A., Scorilas, A., Giltay, E. J., Paliouras, M., & Diamandis, E. P. (2006). Serum and Urine Tissue Kallikrein Concentrations in Male-to-Female Transsexuals Treated with Antiandrogens and Estrogens. Clinical Chemistry, 52(7), 1356–1365. [DOI:10.1373/clinchem.2006.068932]
    • Sofer, Y., Yaish, I., Yaron, M., Bach, M. Y., Stern, N., & Greenman, Y. (2020). Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocrine Practice, 26(8), 883–890. [DOI:10.4158/ep-2020-0032] [PDF]
    • T’Sjoen, G. G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186(1), 61–67. [DOI:10.1677/joe.1.06112]
    • T’Sjoen, G., Weyers, S., Taes, Y., Lapauw, B., Toye, K., Goemaere, S., & Kaufman, J. (2009). Prevalence of Low Bone Mass in Relation to Estrogen Treatment and Body Composition in Male-to-Female Transsexual Persons. Journal of Clinical Densitometry, 12(3), 306–313. [DOI:10.1016/j.jocd.2008.11.002]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, with Attention for Sexual Function and Satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • Tack, L. J., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine, 14(5), 747–757. [DOI:10.1016/j.jsxm.2017.03.251]
    • Toorians, A. W., Thomassen, M. C., Zweegman, S., Magdeleyns, E. J., Tans, G., Gooren, L. J., & Rosing, J. (2003). Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5723–5729. [DOI:10.1210/jc.2003-030520]
    • Torre, B. l., Norén, S., Hedman, M., & Diczfalusy, E. (1979). Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men. Contraception, 20(4), 377–396. [DOI:10.1016/s0010-7824(79)80048-7]
    • Van Caenegem, E., Wierckx, K., Taes, Y., Schreiner, T., Vandewalle, S., Toye, K., Kaufman, J., & T’Sjoen, G. (2014). Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational study. Osteoporosis International, 26(1), 35–47. [DOI:10.1007/s00198-014-2805-3]
    • van Dijk, D., Dekker, M. J., Conemans, E. B., Wiepjes, C. M., de Goeij, E. G., Overbeek, K. A., Fisher, A. D., den Heijer, M., & T’Sjoen, G. (2019). Explorative Prospective Evaluation of Short-Term Subjective Effects of Hormonal Treatment in Trans People—Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 16(8), 1297–1309. [DOI:10.1016/j.jsxm.2019.05.009]
    • van Velzen, D. M., Paldino, A., Klaver, M., Nota, N. M., Defreyne, J., Hovingh, G. K., Thijs, A., Simsek, S., T’Sjoen, G., & den Heijer, M. (2019). Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen. The Journal of Clinical Endocrinology & Metabolism, 104(6), 1937–1947. [DOI:10.1210/jc.2018-02138]
    • Venner, P. M., Klotz, P. G., Klotz, L. H., Stewart, D. J., Davis, I. R., Orovan, W. L., & Ramsey, E. W. (1988). Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate. Seminars in Oncology, 15(2 Suppl 1), 62–67. [Google Scholar] [PubMed]
    • Vereecke, G. (2019). Characterisation of testicular function and spermatogenesis in transgender women. (Master’s thesis, Ghent University.) [PDF]
    • Vereecke, G., Defreyne, J., Van Saen, D., Collet, S., Van Dorpe, J., T’Sjoen, G., & Goossens, E. (2020). Characterisation of testicular function and spermatogenesis in transgender women. Human Reproduction, 36(1), 5–15. [DOI:10.1093/humrep/deaa254]
    • Vita, R., Settineri, S., Liotta, M., Benvenga, S., & Trimarchi, F. (2018). Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: A cohort study. Maturitas, 107, 92–96. [DOI:10.1016/j.maturitas.2017.10.012]
    • Vlot, M. C., Wiepjes, C. M., Jongh, R. T., T’Sjoen, G., Heijboer, A. C., & den Heijer, M. (2019). Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen. Journal of Bone and Mineral Research, 34(10), 1862–1872. [DOI:10.1002/jbmr.3762]
    • Wang, C., & Yeung, K. (1980). Use of low-dosage oral cyproterone acetate as a male contraceptive. Contraception, 21(3), 245–272. [DOI:10.1016/0010-7824(80)90005-0]
    • Warzywoda, S., Fowler, J. A., Wood, P., Bisshop, F., Russell, D., Luu, H., Kelly, M., Featherstone, V., & Dean, J. A. (2024). How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2317395]
    • Wiepjes, C. M., Vlot, M. C., Klaver, M., Nota, N. M., de Blok, C. J., de Jongh, R. T., Lips, P., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study. Journal of Bone and Mineral Research, 32(6), 1252–1260. [DOI:10.1002/jbmr.3102]
    • Wiepjes, C. M., Vlot, M. C., de Blok, C. J., Nota, N. M., de Jongh, R. T., & den Heijer, M. (2019). Bone geometry and trabecular bone score in transgender people before and after short- and long-term hormonal treatment. Bone, 127, 280–286. [DOI:10.1016/j.bone.2019.06.029]
    • Wierckx, K., Mueller, S., Weyers, S., Van Caenegem, E., Roef, G., Heylens, G., & T’Sjoen, G. (2012). Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons. The Journal of Sexual Medicine, 9(10), 2641–2651. [DOI:10.1111/j.1743-6109.2012.02876.x]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    • Winkler-Crepaz, K., Müller, A., Böttcher, B., & Wildt, L. (2017). Hormonbehandlung bei Transgenderpatienten. [Hormone treatment of transgender patients.] Gynäkologische Endokrinologie, 15(1), 39–42. [DOI:10.1007/s10304-016-0116-9]
    • Winters, S. J., Wang, C., & (2009). LH and Non-SHBG Testosterone and Estradiol Levels During Testosterone Replacement of Hypogonadal Men: Further Evidence That Steroid Negative Feedback Increases as Men Grow Older. Journal of Andrology, 31(3), 281–287. [DOI:10.2164/jandrol.109.009035]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]
    • Zitzmann, M., Rohayem, J., Raidt, J., Kliesch, S., Kumar, N., Sitruk-Ware, R., & Nieschlag, E. (2017). Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial. Andrology, 5(3), 516–526. [DOI:10.1111/andr.12328]
    • Zubiaurre-Elorza, L., Junque, C., Gómez-Gil, E., & Guillamon, A. (2014). Effects of Cross-Sex Hormone Treatment on Cortical Thickness in Transsexual Individuals. The Journal of Sexual Medicine, 11(5), 1248–1261. [DOI:10.1111/jsm.12491]
    \ No newline at end of file diff --git a/transfemscience.org/articles/cpa-meningioma/index.html b/transfemscience.org/articles/cpa-meningioma/index.html index 7c583cfd..4cca3686 100644 --- a/transfemscience.org/articles/cpa-meningioma/index.html +++ b/transfemscience.org/articles/cpa-meningioma/index.html @@ -1 +1 @@ -Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People - Transfeminine Science Link

    Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People

    By Aly | First published April 24, 2020 | Last modified March 31, 2023

    Abstract / TL;DR

    Cyproterone acetate is a progestogen and antiandrogen commonly used in transfeminine hormone therapy. At the doses typically used in transfeminine people, it has extremely strong progestogenic effects. Whereas doses of around 2 or 3 mg/day have similar progestogenic effect as normal progesterone exposure during the luteal phase of the menstrual cycle in women, doses of cyproterone acetate of 25 to 100 mg/day have typically been used in transfeminine people. In 2018, the French government published findings from a large epidemiological study showing a strong and dose-dependent increase in the risk of meningiomas, a type of hormone-sensitive brain tumor, with typical high doses of cyproterone acetate. With cyproterone acetate used cyclically (20 days per month) at a dose of 50 mg/day for >5 years or 25 mg/day for >10 years, the risk of surgically operated meningioma was found to be increased by 20-fold. Subsequent studies have since replicated these results. Consequent to these findings, clinical use of cyproterone acetate has been restricted and its doses have been greatly reduced. Fortunately, cyproterone acetate is still a highly effective means of testosterone suppression in transfeminine people at much lower doses (e.g., 5–10 mg/day). Nonetheless, due to the risks of meningioma as well as various other complications, it is recommended that cyproterone acetate now be used cautiously and in a limited fashion in transfeminine people. For instance, it should only be used at low doses for a limited duration (e.g., 2 years) in people without known risk factors for meningiomas.

    Introduction

    Cyproterone acetate (CPA) is a progestogen and antiandrogen commonly used in transfeminine hormone therapy. Typical doses of CPA used in transfeminine hormone therapy have very strong progestogenic strength. Consequent to the strong progestogenic exposure, CPA is known to have a risk of meningioma, a rare and benign (non-cancerous) form of brain tumor. Meningiomas are tumors of the meninges, the membranes enveloping the brain and spinal cord. While not typically malignant (cancerous), meningiomas can nonetheless result in complications like visual disturbances, headaches, and seizures. They may necessitate brain surgery. Death has also resulted from CPA-induced meningioma. There is some more information on the topic of CPA and meningioma here on Wikipedia. A table of published case reports of meningioma with CPA can be found here on Wikipedia.

    Recent findings out of France indicate that the risk of meningioma with CPA is much higher than previously thought (ASNM/CNAM). This article discusses these findings and the implications for use of CPA in transfeminine people, including recommendations for use of CPA more safely.

    Recent French Findings

    Case reports of meningioma with CPA started in 2007. These reports caused the French government to add a warning to the CPA production information in 2011 and to undertake a large epidemiological investigation into the risk of meningioma with CPA. They announced their findings in 2018 and reported the following (ASNM/CNAM):

    • The study was very large with 290,000 person–years of CPA-treated follow up.
    • The risk of meningioma with CPA was increased 7-fold with >6 months of treatment at an average dosage ≥25 mg/day. It was increased 20-fold with 50 mg/day for 20 days per month for >5 years. It was likewise increased 20-fold with 25 mg/day for 20 days per month for >10 years. As such, the risk is strongly exposure-dependent in terms of dosage and duration of therapy.
    • The risk of surgically operated meningioma with CPA was around 4 in 1,000 patients per year with 50 mg/day for 20 days per month for >5 years. This underestimates the true incidence of meningioma with CPA since it only includes operated cases.
    • There were more than 500 operated cases of meningioma in association with CPA in France between 2007 and 2015. The unoperated incidence is unknown but likely to be much higher.
    • The population incidence of meningioma in general is strongly age-dependent. It’s 0.14 in 10,000 individuals per year at under 20 years of age and 4.9 in 10,000 individuals per year at above 85 years of age (a 35-fold difference). The average risk is 0.8 in 10,000 individuals per year. Accordingly, the risk of meningioma with CPA was found to be highly age-dependent as well.
    • The risk of meningioma decreases strongly after discontinuation of CPA.

    As a result of their findings, the following occurred (ASNM/CNAM):

    • A toll-free phone number was set up in France for inquiries about CPA and meningioma.
    • Recommendations were made such that all patients starting CPA should be given an MRI within 6 months of initiation of therapy. Subsequently, all patients taking CPA should get another MRI after 5 years of therapy and then an additional MRI every 2 years of therapy thereafter.
    • It was recommended that CPA not be used in postmenopausal women due to their age.
    • Whether CPA should be withdrawn from the market was discussed but was decided against. Part of this was related to the reliance of transfeminine people on CPA for hormone therapy.
    • CPA sales in France plummeted by 73% from September 2018 to September 2019. Sales of spironolactone increased by a lesser magnitude over the same time period.
    • France is also looking into meningioma risk with other high-dose progestogen formulations, including nomegestrol acetate (Lutenyl) and chlormadinone acetate (Luteran).
    • France requested that the European Medicines Agency (EMA) conduct a review of CPA and meningioma. This review began in mid-2019 (Chustecka, 2019). In February 2020, the EMA announced restrictions on the clinical CPA use in the European Union (EMA, 2020). These included use of CPA only after failure of other treatments and use of the lowest effective maintenance dose of CPA (EMA, 2020; Chustecka, 2020). The restrictions applied to formulations of CPA containing 10 mg/day CPA or more (EMA, 2020; Chustecka, 2019). The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom published a drug safety update for cyproterone acetate in June 2020 (MHRA, 2020).

    This 2018 French news article (translated from French to English via Google Translate) succinctly discusses some of the developments. Several recent literature publications have also discussed the topic (Schmutz, 2018; Gerson, 2018; Coubret et al., 2019; Plu-Bureau, 2019; Senofonte, Pallotti, & Lombardo, 2020). And long-form reports of the epidemiological study by the French government here (PDF; 128 pages) and here (PDF; 106 pages) provide more information. A more succinct report by the French government can also be found here (PDF; 9 pages; English translation here). Unfortunately however, many of these materials are in French or other non-English languages and translations are unavailable for English speakers (Google Translate is useful however).

    Implications for Transfeminine People

    CPA tends to be used at very high doses in transfeminine people. A dose of CPA of 2 or 3 mg/day is similar in progestogenic exposure to that occurring during the luteal phase of the menstrual cycle in women. Conversely, doses of CPA recommended by guidelines for use in transfeminine people typically range from 25 to 100 mg/day. This progestogenic exposure is similar to or greater than that during pregnancy in women, when progesterone levels increase by up to 20-fold relative to luteal levels. As such, it’s highly supraphysiological relative to typical circumstances in women. In addition to meningioma, high doses of CPA have been associated with blood clots, prolactinomas, and liver toxicity (Wiki; Aly, 2019). Long-term therapy with progestogens like CPA may increase the risk of breast cancer (Aly, 2020; Table; CGHFBC, 2019; de Blok et al., 2019) and cardiovascular problems as well (Table; Stefanick, 2010). There is also a great deal still unknown about high doses of CPA and their safety, as evidenced by the fact that we’re only uncovering the risk of meningioma with CPA now. It’s likely that using the lowest possible doses of CPA will minimize its various health risks.

    The doses of CPA used in transfeminine people tend to be far more than are necessary. CPA appears to have maximal effectiveness in terms of testosterone suppression at a dose of only 5 to 10 mg/day. See my article here for a review of this topic. The effectiveness of lower doses of CPA was recently validated by Meyer et al. (2020), who showed that in combination with estrogen, 10 mg/day CPA was no different from 50 mg/day CPA in terms of testosterone suppression in transfeminine people. It seems clear that transfeminine people should not use a dose of CPA higher than 10 or 12.5 mg/day at most. With 50-mg CPA tablets and a pill cutter, a total dose of CPA of 6.25 to 12.5 mg/day can be achieved by taking one-fourth of a tablet once every other day to once every day. As a result of new findings, published CPA dose recommendations for transfeminine people have gone down in the last few years (Aly, 2019). It is likely that this will continue to a greater extent in the future.

    Meningiomas express progesterone receptors and activation of these receptors is thought to stimulate growth of meningiomas (Marosi et al., 2008; Li et al., 2013). Other progestogens besides CPA as well as pregnancy have also been associated with meningioma, and spontaneous regression of meningiomas has been reported after pregnancy (Li et al., 2013; Wiki). The incidence of meningiomas is 2- to 3-fold higher in women than in men, and the female-to-male incidence ratio is greatest during the peak female reproductive years (Marosi et al., 2008; Wiemels, Wrensch, & Claus, 2010; Li et al., 2013; Wiki). The luteal phase of the menstrual cycle, when progesterone levels are increased, has been associated with exacerbation of meningiomas in women (Marosi et al., 2008; Li et al., 2013; Wiki). Meningioma has also been associated with birth control pills and menopausal hormone therapy (estrogen–progestogen preparations) (Li et al., 2013). As such, assuming these associations are indeed due to progesterone receptor activation, there may be no fully risk-free dosage of progestogens or CPA in terms of meningioma. Indeed, meningiomas have been reported even with 5 to 10 mg/day CPA, despite the relatively uncommon use of such doses historically (Table). In any case, the data indicate that the risk is dose-dependent, and hence that lower doses should have the least risk. A dose of 2 to 3 mg/day CPA continuously would presumably have minimal excess risk of meningioma relative to normal female physiological circumstances.

    Recommendations for Transfeminine People

    In light of the risks of CPA and its high testosterone-suppressing effectiveness even at low doses, the following recommendations for use of CPA in transfeminine people seem appropriate:

    • CPA should be used at the lowest effective dosage (generally 5–12.5 mg/day and no greater).
    • CPA should be used for a limited duration (e.g., a few years) and not long-term.
    • Other safer but similarly effective antiandrogenic approaches should be used instead of CPA where possible (e.g., GnRH modulators, gonadectomy, estradiol monotherapy, etc.).
    • CPA should be avoided in older individuals (e.g., >50 years of age).
    • CPA should not be used in people with a personal or family history of meningioma.
    • If possible, CPA should be used under supervision of a physician and people taking CPA should follow monitoring guidelines (e.g., regular MRIs as in France).

    At the same time it should be noted that the absolute incidence of meningioma with CPA is low. The risk is likely to be especially small in young people and with low CPA doses (e.g., 5–12.5 mg/day). Use of CPA in a more cautious and restricted fashion may allow for more acceptable safety. In any case, meningiomas and brain surgery are serious, so CPA should not be taken carelessly.

    Updates

    Update 1: Weill et al. (2021) [French Government Study]

    The French government study was finally published in the formal scientific literature in February 2021:

    • Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of High Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study. BMJ, 372, n37. [DOI:10.1136/bmj.n37]

    A Medscape article here covers the study and discusses consequent restrictions on CPA use.

    Update 2: Mikkelsen et al. (2021) [Danish National Study]

    A national study in Denmark was published in June 2021 and has replicated the findings:

    • Mikkelsen, A. P., Greiber, I. K., Scheller, N. M., Hilden, M., & Lidegaard, Ø. (2021). Cyproterone acetate and risk of meningioma: a nationwide cohort study. Journal of Neurology, Neurosurgery & Psychiatry, 93(2), 222–223. [DOI:10.1136/jnnp-2021-326138]

    Update 3: VUMC Switching From CPA to GnRH Agonists

    As of August 2020, the Vrije Universiteit Medical Center (VUMC) in Amsterdam is switching antiandrogen therapy of all transgender patients from cyproterone acetate to gonadotropin-releasing hormone (GnRH) agonists (VUMC, 2020). This was due to a Dutch Medicines Authority warning about meningiomas with CPA (VUMC, 2020). The VUMC is the home of the Center of Expertise on Gender Dysphoria, one of the largest care and research institutes for transgender hormone therapy in the world, and is highly influential in this area (Wiepjes et al., 2018; Bakker, 2021). The VUMC is said to be the provider of hormone therapy for about 95% of hormone-seeking transgender people in the Netherlands, and has treated about 10,000 transgender people since its gender clinic opened in 1972 (Wiepjes et al., 2018; Bakker, 2021).

    Update 4: Millward et al. (2021)

    In October 2021, a systematic review of meningiomas with CPA in transfeminine people was published:

    • Millward, C. P., Keshwara, S. M., Islim, A. I., Jenkinson, M. D., Alalade, A. F., & Gilkes, C. E. (2022). Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review. Transgender Health, 7(6), 473–483. [DOI:10.1089/trgh.2021.0025]

    Update 5: Lee et al. (2022)

    In February 2022, a systematic review and meta-analysis of meningiomas with CPA was published:

    • Lee, K. S., Zhang, J., Kirollos, R., Santarius, T., Nga, V., & Yeo, T. T. (2022). A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Scientific Reports, 12(1), 1942. [DOI:10.1038/s41598-022-05773-z]

    The paper was covered in the news on ScienceDaily and Medical Xpress.

    Update 6: Samoyeau et al. (2022)

    In September 2022, the following French study of meningioma incidence in people treated with high-dose progestin therapy following institution of systematic screening was published:

    • Samoyeau, T., Provost, C., Roux, A., Legrand, L., Dezamis, E., Plu-Bureau, G., Pallud, J., Oppenheim, C., & Benzakoun, J. (2022). Meningioma in patients exposed to progestin drugs: results from a real-life screening program. Journal of Neuro-Oncology, 160(1), 127–136. [DOI:10.1007/s11060-022-04124-2]

    The absolute incidence of meningiomas with CPA was 13 of 103 or a striking 13% of individuals. This was much higher than in the general population, in which rates of incidental meningiomas of about 1 to 2% have been observed. Moreover, the authors noted that the 13% figure observed in this study was likely an underestimate, as most cases of meningiomas with CPA were likely already diagnosed prior to the launch of systematic screening. Relative to the high absolute incidence, the year-adjusted incidence rate of meningiomas with CPA was 13.2 per 100,000 person–years. As with other studies, meningioma incidence was associated with longer CPA treatment duration, greater cumulative CPA dose, and older age. The incidence of meningiomas was much lower with two other progestins, nomegestrol acetate and chlormadinone acetate. These progestins tend to be used at much lower doses than CPA.

    References

    • Bakker, A. (2021). Een halve eeuw transgenderzorg aan de VU [Half a Century of Transgender Care at the VU]. Amsterdam: Boom. [Google Books] [WorldCat] [URL]
    • Bême. (2018 September 21). Androcur et risque de méningiomes: un numéro vert pour répondre aux patients. [Androcur and risk of meningiomas: a toll-free number to answer patients.] Doctissimo. [URL] [Translation]
    • Chustecka, Z. (2019 July 12). Risk of Meningioma With Cyproterone: EMA Review Begins. Medscape. [URL]
    • Chustecka, Z. (2020 February 14). EU Restricts High-Dose Cyproterone Because of Meningioma Risk. Medscape. [URL]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Coubret, A., Geniaux, H., & Buxeraud, J. (2019). Méningiomes et acétate de cyprotérone. Actualités Pharmaceutiques, 58(590), 55–56. [DOI:10.1016/j.actpha.2019.09.013]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, , l1652–l1652. [DOI:10.1136/bmj.l1652]
    • European Medicines Agency (EMA). (2020 February 14). Restrictions in use of cyproterone due to meningioma risk. European Medicines Agency. [URL] [PDF]
    • Gerson, M. (2018). Androcur®: cécité des prescripteurs. [Androcur®: blindness of the prescribers.] Médecine, 14(8), 346–348. [Google Scholar 1] [Google Scholar 2] [DOI:10.1684/med.10.1684/med.2018.367] [URL]
    • Lee, K. S., Zhang, J., Kirollos, R., Santarius, T., Nga, V., & Yeo, T. T. (2022). A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Scientific Reports, 12(1), 1942. [DOI:10.1038/s41598-022-05773-z]
    • Li, Q., Coulson, H., Klaassen, Z., Sharma, S., Ramalingam, P., Moses, K. A., & Terris, M. K. (2013). Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma. Prostate Cancer and Prostatic Diseases, 16(4), 387–390. [DOI:10.1038/pcan.2013.45]
    • Marosi, C., Hassler, M., Roessler, K., Reni, M., Sant, M., Mazza, E., & Vecht, C. (2008). Meningioma. Critical Reviews in Oncology/Hematology, 67(2), 153–171. [DOI:10.1016/j.critrevonc.2008.01.010]
    • Medicines and Healthcare products Regulatory Agency (MHRA). (2020 June 29). Cyproterone acetate: new advice to minimise risk of meningioma. GOV.UK. [URL]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463] [PDF]
    • Mikkelsen, A. P., Greiber, I. K., Scheller, N. M., Hilden, M., & Lidegaard, Ø. (2021). Cyproterone acetate and risk of meningioma: a nationwide cohort study. Journal of Neurology, Neurosurgery & Psychiatry, 93(2), 222–223. [DOI:10.1136/jnnp-2021-326138]
    • Millward, C. P., Keshwara, S. M., Islim, A. I., Jenkinson, M. D., Alalade, A. F., & Gilkes, C. E. (2022). Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review. Transgender Health, 7(6), 473–483. [DOI:10.1089/trgh.2021.0025]
    • Nelson, R. (2021 February 3). Increased Risk of Meningioma With Cyproterone Acetate Use. Medscape. [URL]
    • Plu-Bureau, G. (2019). Faut-il rayer l’acétate de cyprotérone de nos prescriptions ? Gynécologie Obstétrique Fertilité & Sénologie , 47(12), 823–824. [DOI:10.1016/j.gofs.2019.10.006]
    • Samoyeau, T., Provost, C., Roux, A., Legrand, L., Dezamis, E., Plu-Bureau, G., Pallud, J., Oppenheim, C., & Benzakoun, J. (2022). Meningioma in patients exposed to progestin drugs: results from a real-life screening program. Journal of Neuro-Oncology, 160(1), 127–136. [DOI:10.1007/s11060-022-04124-2]
    • Schmutz, J. (2018). Méningiomes et acétate de cyprotérone : mise au point. Annales de Dermatologie et de Vénéréologie, 145(5), 390–391. [DOI:10.1016/j.annder.2018.04.001]
    • Senofonte, G., Pallotti, F., & Lombardo, F. (2020). Ciproterone acetato e meningiomi: lo stato dell’arte. L’Endocrinologo, 21(3), 171–175. [DOI:10.1007/s40619-020-00746-8]
    • Stefanick, M. (2010). Postmenopausal hormone therapy and cardiovascular disease in women. Nutrition, Metabolism and Cardiovascular Diseases, 20(6), 451–458. [DOI:10.1016/j.numecd.2010.02.015]
    • University of Bristol. (2022 February 4). Widely-used hormone drug associated with increased risk of benign brain tumor at high doses. University of Bristol. [ScienceDaily] [Medical Xpress]
    • Vrije Universiteit Medical Center (VUMC). (2020). Wijzigingen medisch beleid hormoonbehandeling. [Changes in medical policy on hormone treatment.] Vrije Universiteit Medical Center. [URL]
    • Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of High Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study. BMJ, 372, n37. [DOI:10.1136/bmj.n37]
    • Wiemels, J., Wrensch, M., & Claus, E. B. (2010). Epidemiology and etiology of meningioma. Journal of Neuro-Oncology, 99(3), 307–314. [DOI:10.1007/s11060-010-0386-3]
    • Wiepjes, C. M., Nota, N. M., de Blok, C. J., Klaver, M., de Vries, A. L., Wensing-Kruger, S. A., de Jongh, R. T., Bouman, M., Steensma, T. D., Cohen-Kettenis, P., Gooren, L. J., Kreukels, B. P., & den Heijer, M. (2018). The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets. The Journal of Sexual Medicine, 15(4), 582–590. [DOI:10.1016/j.jsxm.2018.01.016]
    \ No newline at end of file +Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People - Transfeminine Science Link

    Recent Developments on Cyproterone Acetate and Meningioma Risk Out of France and Implications for Transfeminine People

    By Aly | First published April 24, 2020 | Last modified March 30, 2024

    Abstract / TL;DR

    Cyproterone acetate is a progestogen and antiandrogen commonly used in transfeminine hormone therapy. At the doses typically used in transfeminine people, it has extremely strong progestogenic effects. Whereas doses of around 2 or 3 mg/day have similar progestogenic effect as normal progesterone exposure during the luteal phase of the menstrual cycle in women, doses of cyproterone acetate of 25 to 100 mg/day have typically been used in transfeminine people. In 2018, the French government published findings from a large epidemiological study showing a strong and dose-dependent increase in the risk of meningiomas, a type of hormone-sensitive brain tumor, with typical high doses of cyproterone acetate. With cyproterone acetate used cyclically (20 days per month) at a dose of 50 mg/day for >5 years or 25 mg/day for >10 years, the risk of surgically operated meningioma was found to be increased by 20-fold. Subsequent studies have since replicated these results. Consequent to these findings, clinical use of cyproterone acetate has been restricted and its doses have been greatly reduced. Fortunately, cyproterone acetate is still a highly effective means of testosterone suppression in transfeminine people at much lower doses (e.g., 5–10 mg/day). Nonetheless, due to the risks of meningioma as well as various other complications, it is recommended that cyproterone acetate now be used cautiously and in a limited fashion in transfeminine people. For instance, it should only be used at low doses for a limited duration (e.g., 2 years) in people without known risk factors for meningiomas.

    Introduction

    Cyproterone acetate (CPA) is a progestogen and antiandrogen commonly used in transfeminine hormone therapy. Typical doses of CPA used in transfeminine hormone therapy have very strong progestogenic strength. Consequent to the strong progestogenic exposure, CPA is known to have a risk of meningioma, a rare and benign (non-cancerous) form of brain tumor. Meningiomas are tumors of the meninges, the membranes enveloping the brain and spinal cord. While not typically malignant (cancerous), meningiomas can nonetheless result in complications like visual disturbances, headaches, and seizures. They may necessitate brain surgery. Death has also resulted from CPA-induced meningioma. There is some more information on the topic of CPA and meningioma here on Wikipedia. A table of published case reports of meningioma with CPA can be found here on Wikipedia.

    Recent findings out of France indicate that the risk of meningioma with CPA is much higher than previously thought (ASNM/CNAM). This article discusses these findings and the implications for use of CPA in transfeminine people, including recommendations for use of CPA more safely.

    Recent French Findings

    Case reports of meningioma with CPA started in 2007. These reports caused the French government to add a warning to the CPA production information in 2011 and to undertake a large epidemiological investigation into the risk of meningioma with CPA. They announced their findings in 2018 and reported the following (ASNM/CNAM):

    • The study was very large with 290,000 person–years of CPA-treated follow up.
    • The risk of meningioma with CPA was increased 7-fold with >6 months of treatment at an average dosage ≥25 mg/day. It was increased 20-fold with 50 mg/day for 20 days per month for >5 years. It was likewise increased 20-fold with 25 mg/day for 20 days per month for >10 years. As such, the risk is strongly exposure-dependent in terms of dosage and duration of therapy.
    • The risk of surgically operated meningioma with CPA was around 4 in 1,000 patients per year with 50 mg/day for 20 days per month for >5 years. This underestimates the true incidence of meningioma with CPA since it only includes operated cases.
    • There were more than 500 operated cases of meningioma in association with CPA in France between 2007 and 2015. The unoperated incidence is unknown but likely to be much higher.
    • The population incidence of meningioma in general is strongly age-dependent. It’s 0.14 in 10,000 individuals per year at under 20 years of age and 4.9 in 10,000 individuals per year at above 85 years of age (a 35-fold difference). The average risk is 0.8 in 10,000 individuals per year. Accordingly, the risk of meningioma with CPA was found to be highly age-dependent as well.
    • The risk of meningioma decreases strongly after discontinuation of CPA.

    As a result of their findings, the following occurred (ASNM/CNAM):

    • A toll-free phone number was set up in France for inquiries about CPA and meningioma.
    • Recommendations were made such that all patients starting CPA should be given an MRI within 6 months of initiation of therapy. Subsequently, all patients taking CPA should get another MRI after 5 years of therapy and then an additional MRI every 2 years of therapy thereafter.
    • It was recommended that CPA not be used in postmenopausal women due to their age.
    • Whether CPA should be withdrawn from the market was discussed but was decided against. Part of this was related to the reliance of transfeminine people on CPA for hormone therapy.
    • CPA sales in France plummeted by 73% from September 2018 to September 2019. Sales of spironolactone increased by a lesser magnitude over the same time period.
    • France is also looking into meningioma risk with other high-dose progestogen formulations, including nomegestrol acetate (Lutenyl) and chlormadinone acetate (Luteran).
    • France requested that the European Medicines Agency (EMA) conduct a review of CPA and meningioma. This review began in mid-2019 (Chustecka, 2019). In February 2020, the EMA announced restrictions on the clinical CPA use in the European Union (EMA, 2020). These included use of CPA only after failure of other treatments and use of the lowest effective maintenance dose of CPA (EMA, 2020; Chustecka, 2020). The restrictions applied to formulations of CPA containing 10 mg/day CPA or more (EMA, 2020; Chustecka, 2019). The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom published a drug safety update for cyproterone acetate in June 2020 (MHRA, 2020).

    This 2018 French news article (translated from French to English via Google Translate) succinctly discusses some of the developments. Several recent literature publications have also discussed the topic (Schmutz, 2018; Gerson, 2018; Coubret et al., 2019; Plu-Bureau, 2019; Senofonte, Pallotti, & Lombardo, 2020). And long-form reports of the epidemiological study by the French government here (PDF; 128 pages) and here (PDF; 106 pages) provide more information. A more succinct report by the French government can also be found here (PDF; 9 pages; English translation here). Unfortunately however, many of these materials are in French or other non-English languages and translations are unavailable for English speakers (Google Translate is useful however).

    Implications for Transfeminine People

    CPA tends to be used at very high doses in transfeminine people. A dose of CPA of 2 or 3 mg/day is similar in progestogenic exposure to that occurring during the luteal phase of the menstrual cycle in women. Conversely, doses of CPA recommended by guidelines for use in transfeminine people typically range from 25 to 100 mg/day. This progestogenic exposure is similar to or greater than that during pregnancy in women, when progesterone levels increase by up to 20-fold relative to luteal levels. As such, it’s highly supraphysiological relative to typical circumstances in women. In addition to meningioma, high doses of CPA have been associated with blood clots, prolactinomas, and liver toxicity (Wiki; Aly, 2019). Long-term therapy with progestogens like CPA may increase the risk of breast cancer (Aly, 2020; Table; CGHFBC, 2019; de Blok et al., 2019) and cardiovascular problems as well (Table; Stefanick, 2010). There is also a great deal still unknown about high doses of CPA and their safety, as evidenced by the fact that we’re only uncovering the risk of meningioma with CPA now. It’s likely that using the lowest possible doses of CPA will minimize its various health risks.

    The doses of CPA used in transfeminine people tend to be far more than are necessary. CPA appears to have maximal effectiveness in terms of testosterone suppression at a dose of only 5 to 10 mg/day. See my article here for a review of this topic. The effectiveness of lower doses of CPA was recently validated by Meyer et al. (2020), who showed that in combination with estrogen, 10 mg/day CPA was no different from 50 mg/day CPA in terms of testosterone suppression in transfeminine people. It seems clear that transfeminine people should not use a dose of CPA higher than 10 or 12.5 mg/day at most. With 50-mg CPA tablets and a pill cutter, a total dose of CPA of 6.25 to 12.5 mg/day can be achieved by taking one-fourth of a tablet once every other day to once every day. As a result of new findings, published CPA dose recommendations for transfeminine people have gone down in the last few years (Aly, 2019). It is likely that this will continue to a greater extent in the future.

    Meningiomas express progesterone receptors and activation of these receptors is thought to stimulate growth of meningiomas (Marosi et al., 2008; Li et al., 2013). Other progestogens besides CPA as well as pregnancy have also been associated with meningioma, and spontaneous regression of meningiomas has been reported after pregnancy (Li et al., 2013; Wiki). The incidence of meningiomas is 2- to 3-fold higher in women than in men, and the female-to-male incidence ratio is greatest during the peak female reproductive years (Marosi et al., 2008; Wiemels, Wrensch, & Claus, 2010; Li et al., 2013; Wiki). The luteal phase of the menstrual cycle, when progesterone levels are increased, has been associated with exacerbation of meningiomas in women (Marosi et al., 2008; Li et al., 2013; Wiki). Meningioma has also been associated with birth control pills and menopausal hormone therapy (estrogen–progestogen preparations) (Li et al., 2013). As such, assuming these associations are indeed due to progesterone receptor activation, there may be no fully risk-free dosage of progestogens or CPA in terms of meningioma. Indeed, meningiomas have been reported even with 5 to 10 mg/day CPA, despite the relatively uncommon use of such doses historically (Table). In any case, the data indicate that the risk is dose-dependent, and hence that lower doses should have the least risk. A dose of 2 to 3 mg/day CPA continuously would presumably have minimal excess risk of meningioma relative to normal female physiological circumstances.

    Recommendations for Transfeminine People

    In light of the risks of CPA and its high testosterone-suppressing effectiveness even at low doses, the following recommendations for use of CPA in transfeminine people seem appropriate:

    • CPA should be used at the lowest effective dosage (generally 5–12.5 mg/day and no greater).
    • CPA should be used for a limited duration (e.g., a few years) and not long-term.
    • Other safer but similarly effective antiandrogenic approaches should be used instead of CPA where possible (e.g., GnRH modulators, gonadectomy, estradiol monotherapy, etc.).
    • CPA should be avoided in older individuals (e.g., >50 years of age).
    • CPA should not be used in people with a personal or family history of meningioma.
    • If possible, CPA should be used under supervision of a physician and people taking CPA should follow monitoring guidelines (e.g., regular MRIs as in France).

    At the same time it should be noted that the absolute incidence of meningioma with CPA is low. The risk is likely to be especially small in young people and with low CPA doses (e.g., 5–12.5 mg/day). Use of CPA in a more cautious and restricted fashion may allow for more acceptable safety. In any case, meningiomas and brain surgery are serious, so CPA should not be taken carelessly.

    Updates

    Update 1: Weill et al. (2021) [French Government Study]

    The French government study was finally published in the formal scientific literature in February 2021:

    • Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of High Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study. BMJ, 372, n37. [DOI:10.1136/bmj.n37]

    A Medscape article here covers the study and discusses consequent restrictions on CPA use.

    Update 2: Mikkelsen et al. (2021) [Danish National Study]

    A national study in Denmark was published in June 2021 and has replicated the findings:

    • Mikkelsen, A. P., Greiber, I. K., Scheller, N. M., Hilden, M., & Lidegaard, Ø. (2021). Cyproterone acetate and risk of meningioma: a nationwide cohort study. Journal of Neurology, Neurosurgery & Psychiatry, 93(2), 222–223. [DOI:10.1136/jnnp-2021-326138]

    Update 3: VUMC Switching From CPA to GnRH Agonists

    As of August 2020, the Vrije Universiteit Medical Center (VUMC) in Amsterdam is switching antiandrogen therapy of all transgender patients from cyproterone acetate to gonadotropin-releasing hormone (GnRH) agonists (VUMC, 2020). This was due to a Dutch Medicines Authority warning about meningiomas with CPA (VUMC, 2020). The VUMC is the home of the Center of Expertise on Gender Dysphoria, one of the largest care and research institutes for transgender hormone therapy in the world, and is highly influential in this area (Wiepjes et al., 2018; Bakker, 2021). The VUMC is said to be the provider of hormone therapy for about 95% of hormone-seeking transgender people in the Netherlands, and has treated about 10,000 transgender people since its gender clinic opened in 1972 (Wiepjes et al., 2018; Bakker, 2021).

    Update 4: Millward et al. (2021)

    In October 2021, a systematic review of meningiomas with CPA in transfeminine people was published:

    • Millward, C. P., Keshwara, S. M., Islim, A. I., Jenkinson, M. D., Alalade, A. F., & Gilkes, C. E. (2022). Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review. Transgender Health, 7(6), 473–483. [DOI:10.1089/trgh.2021.0025]

    Update 5: Lee et al. (2022)

    In February 2022, a systematic review and meta-analysis of meningiomas with CPA was published:

    • Lee, K. S., Zhang, J., Kirollos, R., Santarius, T., Nga, V., & Yeo, T. T. (2022). A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Scientific Reports, 12(1), 1942. [DOI:10.1038/s41598-022-05773-z]

    The paper was covered in the news on ScienceDaily and Medical Xpress.

    Update 6: Samoyeau et al. (2022)

    In September 2022, the following French study of meningioma incidence in people treated with high-dose progestin therapy following institution of systematic screening was published:

    • Samoyeau, T., Provost, C., Roux, A., Legrand, L., Dezamis, E., Plu-Bureau, G., Pallud, J., Oppenheim, C., & Benzakoun, J. (2022). Meningioma in patients exposed to progestin drugs: results from a real-life screening program. Journal of Neuro-Oncology, 160(1), 127–136. [DOI:10.1007/s11060-022-04124-2]

    The absolute incidence of meningiomas with CPA was 13 of 103 or a striking 13% of individuals. This was much higher than in the general population, in which rates of incidental meningiomas of about 1 to 2% have been observed. Moreover, the authors noted that the 13% figure observed in this study was likely an underestimate, as most cases of meningiomas with CPA were likely already diagnosed prior to the launch of systematic screening. Relative to the high absolute incidence, the year-adjusted incidence rate of meningiomas with CPA was 13.2 per 100,000 person–years. As with other studies, meningioma incidence was associated with longer CPA treatment duration, greater cumulative CPA dose, and older age. The incidence of meningiomas was much lower with two other progestins, nomegestrol acetate and chlormadinone acetate. These progestins tend to be used at much lower doses than CPA.

    Update 7: Roland et al. (2024)

    In March 2024, the following French study assessed meningioma risk with various progestogens:

    • Roland, N., Neumann, A., Hoisnard, L., Duranteau, L., Froelich, S., Zureik, M., & Weill, A. (2024). Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ, 384, e078078. [DOI:10.1136/bmj-2023-078078]

    The study found increased risk of surgically operated meningiomas not only with CPA but also with a variety of other progestogens, including nomegestrol acetate, chlormadinone acetate, medrogestone, injectable medroxyprogesterone acetate, and promegestone. Conversely, progesterone, dydrogesterone, and levonorgestrel intrauterine devices showed no increased risk of surgically operated meningiomas. No conclusions could be drawn for dienogest or hydroxyprogesterone caproate due to the small numbers of individuals who received these progestogens. Many other progestogens, such as most 19-nortestosterone derivatives, were not included or assessed in the study. CPA, related to the high doses used in its case, had by far the greatest risk of surgically operated meningiomas. These findings indicate that meningiomas are a dose-dependent risk of many different progestogens.

    References

    • Bakker, A. (2021). Een halve eeuw transgenderzorg aan de VU [Half a Century of Transgender Care at the VU]. Amsterdam: Boom. [Google Books] [WorldCat] [URL]
    • Bême. (2018 September 21). Androcur et risque de méningiomes: un numéro vert pour répondre aux patients. [Androcur and risk of meningiomas: a toll-free number to answer patients.] Doctissimo. [URL] [Translation]
    • Chustecka, Z. (2019 July 12). Risk of Meningioma With Cyproterone: EMA Review Begins. Medscape. [URL]
    • Chustecka, Z. (2020 February 14). EU Restricts High-Dose Cyproterone Because of Meningioma Risk. Medscape. [URL]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Coubret, A., Geniaux, H., & Buxeraud, J. (2019). Méningiomes et acétate de cyprotérone. Actualités Pharmaceutiques, 58(590), 55–56. [DOI:10.1016/j.actpha.2019.09.013]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, , l1652–l1652. [DOI:10.1136/bmj.l1652]
    • European Medicines Agency (EMA). (2020 February 14). Restrictions in use of cyproterone due to meningioma risk. European Medicines Agency. [URL] [PDF]
    • Gerson, M. (2018). Androcur®: cécité des prescripteurs. [Androcur®: blindness of the prescribers.] Médecine, 14(8), 346–348. [Google Scholar 1] [Google Scholar 2] [DOI:10.1684/med.10.1684/med.2018.367] [URL]
    • Lee, K. S., Zhang, J., Kirollos, R., Santarius, T., Nga, V., & Yeo, T. T. (2022). A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas. Scientific Reports, 12(1), 1942. [DOI:10.1038/s41598-022-05773-z]
    • Li, Q., Coulson, H., Klaassen, Z., Sharma, S., Ramalingam, P., Moses, K. A., & Terris, M. K. (2013). Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma. Prostate Cancer and Prostatic Diseases, 16(4), 387–390. [DOI:10.1038/pcan.2013.45]
    • Marosi, C., Hassler, M., Roessler, K., Reni, M., Sant, M., Mazza, E., & Vecht, C. (2008). Meningioma. Critical Reviews in Oncology/Hematology, 67(2), 153–171. [DOI:10.1016/j.critrevonc.2008.01.010]
    • Medicines and Healthcare products Regulatory Agency (MHRA). (2020 June 29). Cyproterone acetate: new advice to minimise risk of meningioma. GOV.UK. [URL]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463] [PDF]
    • Mikkelsen, A. P., Greiber, I. K., Scheller, N. M., Hilden, M., & Lidegaard, Ø. (2021). Cyproterone acetate and risk of meningioma: a nationwide cohort study. Journal of Neurology, Neurosurgery & Psychiatry, 93(2), 222–223. [DOI:10.1136/jnnp-2021-326138]
    • Millward, C. P., Keshwara, S. M., Islim, A. I., Jenkinson, M. D., Alalade, A. F., & Gilkes, C. E. (2022). Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review. Transgender Health, 7(6), 473–483. [DOI:10.1089/trgh.2021.0025]
    • Nelson, R. (2021 February 3). Increased Risk of Meningioma With Cyproterone Acetate Use. Medscape. [URL]
    • Plu-Bureau, G. (2019). Faut-il rayer l’acétate de cyprotérone de nos prescriptions ? Gynécologie Obstétrique Fertilité & Sénologie , 47(12), 823–824. [DOI:10.1016/j.gofs.2019.10.006]
    • Roland, N., Neumann, A., Hoisnard, L., Duranteau, L., Froelich, S., Zureik, M., & Weill, A. (2024). Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ, 384, e078078. [DOI:10.1136/bmj-2023-078078]
    • Samoyeau, T., Provost, C., Roux, A., Legrand, L., Dezamis, E., Plu-Bureau, G., Pallud, J., Oppenheim, C., & Benzakoun, J. (2022). Meningioma in patients exposed to progestin drugs: results from a real-life screening program. Journal of Neuro-Oncology, 160(1), 127–136. [DOI:10.1007/s11060-022-04124-2]
    • Schmutz, J. (2018). Méningiomes et acétate de cyprotérone : mise au point. Annales de Dermatologie et de Vénéréologie, 145(5), 390–391. [DOI:10.1016/j.annder.2018.04.001]
    • Senofonte, G., Pallotti, F., & Lombardo, F. (2020). Ciproterone acetato e meningiomi: lo stato dell’arte. L’Endocrinologo, 21(3), 171–175. [DOI:10.1007/s40619-020-00746-8]
    • Stefanick, M. (2010). Postmenopausal hormone therapy and cardiovascular disease in women. Nutrition, Metabolism and Cardiovascular Diseases, 20(6), 451–458. [DOI:10.1016/j.numecd.2010.02.015]
    • University of Bristol. (2022 February 4). Widely-used hormone drug associated with increased risk of benign brain tumor at high doses. University of Bristol. [ScienceDaily] [Medical Xpress]
    • Vrije Universiteit Medical Center (VUMC). (2020). Wijzigingen medisch beleid hormoonbehandeling. [Changes in medical policy on hormone treatment.] Vrije Universiteit Medical Center. [URL]
    • Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of High Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study. BMJ, 372, n37. [DOI:10.1136/bmj.n37]
    • Wiemels, J., Wrensch, M., & Claus, E. B. (2010). Epidemiology and etiology of meningioma. Journal of Neuro-Oncology, 99(3), 307–314. [DOI:10.1007/s11060-010-0386-3]
    • Wiepjes, C. M., Nota, N. M., de Blok, C. J., Klaver, M., de Vries, A. L., Wensing-Kruger, S. A., de Jongh, R. T., Bouman, M., Steensma, T. D., Cohen-Kettenis, P., Gooren, L. J., Kreukels, B. P., & den Heijer, M. (2018). The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets. The Journal of Sexual Medicine, 15(4), 582–590. [DOI:10.1016/j.jsxm.2018.01.016]
    \ No newline at end of file diff --git a/transfemscience.org/articles/e2-equivalent-doses/index.html b/transfemscience.org/articles/e2-equivalent-doses/index.html index 50037c37..a470ff64 100644 --- a/transfemscience.org/articles/e2-equivalent-doses/index.html +++ b/transfemscience.org/articles/e2-equivalent-doses/index.html @@ -1 +1 @@ -Approximate Comparable Dosages of Estradiol by Different Routes - Transfeminine Science Link

    Approximate Comparable Dosages of Estradiol by Different Routes

    By Aly | First published April 19, 2020 | Last modified April 13, 2023

    Preface

    Transfeminine people often ask about equivalent dosages of estradiol by different routes of administration. This page was put together to help facilitate answering these questions.

    Table of Comparable Estradiol Dosages

    The following is a table of estimated equivalent dosages of estradiol by different routes:

    RouteLow doseModerate doseHigh doseVery high dose
    Orala2 mg/day4 mg/day8 mg/day12 mg/day
    Sublingual/buccalb0.5–1 mg/day1–2 mg/day2–4 mg/day3–6 mg/day
    Transdermal patchc,d50–100 μg/day100–200 μg/day200–400 μg/day300–600 μg/day
    Transdermal gelc1.5 mg/day3 mg/day6 mg/day9 mg/day
    Injections (i.m. or s.c.)e1 mg/week2 mg/week4 mg/week6 mg/week
    Pellet implant (s.c.)25 mg/6 months50 mg/6 months100 mg/6 months150 mg/6 months
    ~Average estradiol level50 pg/mL
    (184 pmol/L)    		100 pg/mL
    (367 pmol/L)    		200 pg/mL
    (734 pmol/L)    		300 pg/mL
    (1101 pmol/L)
    Equivalent cycle phaseFollicularWhole cycleLutealOvulation

    a For oral estradiol. Oral estradiol 1.5 mg is equivalent to about 2 mg oral estradiol valerate (Wiki). b Based on sublingual estradiol having ~2- to 5-fold greater bioavailability than oral estradiol per studies (Wiki; Sam, 2021). c Much lower doses of transdermal estradiol can be used in the case of genital application relative to conventional skin sites (potentially e.g. 5-fold lower doses for similar estradiol levels) (Aly., 2019). d Different patch brands may result in differing estradiol levels (Rohr, Nauert, & Stehle, 1999; Langley et al., 2008; Farahmand & Maibach, 2009; Langley et al., 2015). e For i.m. or s.c. injection, total dose per week of an estradiol ester like estradiol valerate, estradiol cypionate, estradiol enanthate, or estradiol benzoate. Differences in molecular weight between these esters are minor (Table) and can be ignored for simplicity. Optimal injection intervals vary depending on the ester and doses should be scaled by injection interval to match the listed total dose per week (Aly, 2021).

    Notes

    1. These doses are not absolute and should be considered only a rough guideline. They represent a generalized model based on many different studies with often very different individual findings. There is also an assumption that estradiol levels scale linearly or proportionally with dose, which may or may not actually be the case. One study found lower bioavailability of oral estradiol at high doses for instance (Kuhnz, Gansau, & Mahler, 1993).
    2. These doses are approximate equivalent or comparable doses and don’t necessarily correspond to typical or recommended clinical doses. Injectable estradiol formulations are generally used at higher doses than other routes and forms of estradiol for instance (Aly, 2021).
    3. The comparable doses are based on total estradiol exposure rather than therapeutic estrogenic potency. Time-related variations in sex hormone levels have been reported to modify potency of sex hormone preparations (Aly, 2021). However, this has not been factored in to the table here due to a lack of available data and analysis on the influence. In any case, it may be relevant to routes with large fluctuations in estradiol levels like sublingual administration and shorter-acting injections.
    4. A transdermal estradiol spray sold under the brand name Lenzetto is available. In a study in postmenopausal women, mean baseline-adjusted estradiol levels with Lenzetto over the course of a week following achievement of steady state were about 6 pg/mL pre-treatment, 13 pg/mL with 1 spray/day (1.53 mg/day), 19 pg/mL with 2 sprays/day (3.06 mg/day), and 26 pg/mL with 3 sprays/day (4.59 mg/day) (Morton et al., 2009; Graph). Hence, this form of estradiol appears to achieve relatively low estradiol levels that likely aren’t well-suited for transfeminine people. No data are available on higher doses (i.e., more sprays per day) and so this formulation has not been included in the table.

    Discussion

    For reference, mean integrated levels of estradiol during the normal menstrual cycle in premenopausal cisgender women are about 100 pg/mL and during the luteal phase (the latter half of the menstrual cycle) are around 150 pg/mL (Graph; Graph; Aly, 2018). The total production of estradiol over a single menstrual cycle (i.e., one month) is about 6 mg on average (Rosenfield et al., 2008; Aly, 2018). Slightly higher doses are required for injectable estradiol esters relative to endogenous production amounts since they contain less estradiol by weight due to the ester components (Table).

    Note that there is high interindividual variability (i.e., variability between individuals) in terms of estradiol levels achieved with different forms and routes of estradiol. As an example, some people may get relatively low estradiol levels with the oral route and others may get relatively low levels with the transdermal route. Conversely, some people may get relatively high levels with the transdermal route or with injections. For data showing the substantial variability even with injections, see Aly (2021). Due to the variability in estradiol levels between individuals, the appropriate doses will often not be the same for different people. Doses should be adjusted as necessary based on blood work. It should also be noted that there are large time-dependent changes in estradiol levels with certain routes, namely sublingual or buccal administration (Graphs; Graph; Sam, 2021) and intramuscular or subcutaneous injection (Graphs; Aly, 2021). Due to these fluctuations, estradiol levels will be vastly different when measured at different time points with these routes (e.g., around peak versus around trough).

    For transfeminine people who have not yet undergone or do not plan to undergo gonadectomy, a high to very high dose of estradiol can be used to achieve strong suppression of testosterone levels. On average, the high dose will suppress testosterone levels by about 90%, to around 50 ng/dL (Wiki; Aly, 2018). Hence, the high to very high doses are indicated for estradiol monotherapy (i.e., estradiol alone without an antiandrogen). After gonadectomy, testosterone suppression is no longer needed and lower doses of estradiol, such as the moderate doses, can be used instead. High doses of estradiol are not necessarily required if estradiol is used in combination with an adequately effective antiandrogen, for instance cyproterone acetate, bicalutamide, or a gonadotropin-releasing hormone agonist or antagonist. Spironolactone, on the other hand, may often not be fully effective for opposing androgens (Aly, 2018).

    References

    General Sources

    • Aly. (2019). Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018). Transfeminine Science, oral-e2-leinung-2018. [Google Scholar] [URL]
    • Aly. (2021). An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations. Transfeminine Science, injectable-e2-meta-analysis. [Google Scholar] [URL]
    • Armston, A., & Wood, P. (2002). Hormone replacement therapy (oestradiol-only preparations): can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis? Annals of Clinical Biochemistry, 39(3), 184–193. [DOI:10.1258/0004563021902107]
    • Baker, V. L. (1994). Alternatives to Oral Estrogen Replacement: Transdermal Patches, Percutaneous Gels, Vaginal Creams and Rings, Implants, and Other Methods of Delivery. Obstetrics and Gynecology Clinics of North America, 21(2) [Primary Care of the Mature Woman], 271–297. [DOI:10.1016/S0889-8545(21)00629-X] [PDF]
    • Bruni, V., & Pampaloni, F. (2019). Hormone Replacement Therapy in Premature Ovarian Insufficiency. In Berga, S. L., Genazzani, A. R., Naftolin, F., & Petraglia, F. (Eds.). Menstrual Cycle Related Disorders (pp. 111–142). Cham: Springer. [DOI:10.1007/978-3-030-14358-9_10]
    • Farahmand, S., & Maibach, H. I. (2009). Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction. International Journal of Pharmaceutics, 367(1–2), 1–15. [DOI:10.1016/j.ijpharm.2008.11.020]
    • Herndon, J. S., Maheshwari, A. K., Nippoldt, T. B., Carlson, S. J., Davidge-Pitts, C. J., & Chang, A. Y. (2023). Comparison of Subcutaneous and Intramuscular Estradiol Regimens as part of Gender-Affirming Hormone Therapy. Endocrine Practice, 29(5), 356–361. [DOI:10.1016/j.eprac.2023.02.006] [URL] [PDF]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Lobo, R. A., & Cassidenti, D. L. (1992). Pharmacokinetics of Oral 17 β-Estradiol. The Journal of Reproductive Medicine, 37(1), 77–84. [Google Scholar] [PubMed] [PDF]
    • Sam. (2021). An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People. Transfeminine Science, sublingual-e2-transfem. [Google Scholar] [URL]
    • Simon, J. A., & Snabes, M. C. (2007). Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen. Expert Opinion on Investigational Drugs, 16(12), 2005–2020. [DOI:10.1517/13543784.16.12.2005]
    • Taboada, M., Santen, R., Lima, J., Hossain, J., Singh, R., Klein, K. O., & Mauras, N. (2011). Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome. The Journal of Clinical Endocrinology & Metabolism, 96(11), 3502–3510. [DOI:10.1210/jc.2011-1449]
    • Wikipedia. (2020, August 29). Pharmacokinetics of estradiol. Wikimedia Foundation. [URL]
    • Wikipedia. (2020, October 2). Template:Estrogen dosages for menopausal hormone therapy. Wikimedia Foundation. [URL]

    Inline Citations

    • Farahmand, S., & Maibach, H. I. (2009). Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction. International Journal of Pharmaceutics, 367(1–2), 1–15. [DOI:10.1016/j.ijpharm.2008.11.020]
    • Kuhnz, W., Gansau, C., & Mahler, M. (1993). Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43(9), 966–973. [Google Scholar] [PubMed] [PDF]
    • Langley, R. E., Godsland, I. F., Kynaston, H., Clarke, N. W., Rosen, S. D., Morgan, R. C., Pollock, P., Kockelbergh, R., Lalani, E., Dearnaley, D., Parmar, M., & Abel, P. D. (2008). Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU International, 102(4), 442–445. [DOI:10.1111/j.1464-410x.2008.07583.x]
    • Langley, R. E., Duong, T., Godsland, I. F., Kynaston, H., Kockelbergh, R., Rosen, S. D., Alhasso, A. A., Dearnaley, D. P., Clarke, N. W., Jovic, G., Carpenter, R., Bara, A., Welland, A., Parmar, M. K., & Abel, P. D. (2015). Oestrogen patches (OP) to treat prostate cancer (PC) – Are different commercial brands interchangeable? Maturitas, 81(1), 210–211. [DOI:10.1016/j.maturitas.2015.02.320]
    • Morton, T. L., Gattermeir, D. J., Petersen, C. A., Day, W. W., & Schumacher, R. J. (2009). Steady-State Pharmacokinetics Following Application of a Novel Transdermal Estradiol Spray in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology, 49(9), 1037–1046. [DOI:10.1177/0091270009339187]
    • Rohr, U. D., Nauert, C., & Stehle, B. (1999). 17β-Estradiol delivered by three different matrix patches 50 μg/day. Maturitas, 33(1), 45–58. [DOI:10.1016/s0378-5122(99)00039-0]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2008). Puberty and Its Disorders in the Female. In Sperling, M. A. (Ed.). Pediatric Endocrinology, 3rd Edition (pp. 530–609). Philadelphia: Saunders/Elsevier. [Google Scholar] [Google Books] [DOI:10.1016/b978-141604090-3.50019-3] [Archive.org]
    \ No newline at end of file +Approximate Comparable Dosages of Estradiol by Different Routes - Transfeminine Science Link

    Approximate Comparable Dosages of Estradiol by Different Routes

    By Aly | First published April 19, 2020 | Last modified April 13, 2023

    Preface

    Transfeminine people often ask about equivalent dosages of estradiol by different routes of administration. This page was put together to help facilitate answering these questions.

    Table of Comparable Estradiol Dosages

    The following is a table of estimated equivalent dosages of estradiol by different routes:

    RouteLow doseModerate doseHigh doseVery high dose
    Orala2 mg/day4 mg/day8 mg/day12 mg/day
    Sublingual/buccalb0.5–1 mg/day1–2 mg/day2–4 mg/day3–6 mg/day
    Transdermal patchc,d50–100 μg/day100–200 μg/day200–400 μg/day300–600 μg/day
    Transdermal gelc1.5 mg/day3 mg/day6 mg/day9 mg/day
    Injections (i.m. or s.c.)e1 mg/week2 mg/week4 mg/week6 mg/week
    Pellet implant (s.c.)25 mg/6 months50 mg/6 months100 mg/6 months150 mg/6 months
    ~Average estradiol level50 pg/mL
    (184 pmol/L)    		100 pg/mL
    (367 pmol/L)    		200 pg/mL
    (734 pmol/L)    		300 pg/mL
    (1101 pmol/L)
    Equivalent cycle phaseFollicularWhole cycleLutealOvulation

    a For oral estradiol. Oral estradiol 1.5 mg is equivalent to about 2 mg oral estradiol valerate (Wiki). b Based on sublingual estradiol having ~2- to 5-fold greater bioavailability than oral estradiol per studies (Wiki; Sam, 2021). c Much lower doses of transdermal estradiol can be used in the case of genital application relative to conventional skin sites (potentially e.g. 5-fold lower doses for similar estradiol levels) (Aly., 2019). d Different patch brands may result in differing estradiol levels (Rohr, Nauert, & Stehle, 1999; Langley et al., 2008; Farahmand & Maibach, 2009; Langley et al., 2015). e For i.m. or s.c. injection, total dose per week of an estradiol ester like estradiol valerate, estradiol cypionate, estradiol enanthate, or estradiol benzoate. Differences in molecular weight between these esters are minor (Table) and can be ignored for simplicity. Optimal injection intervals vary depending on the ester and doses should be scaled by injection interval to match the listed total dose per week (Aly, 2021).

    Notes

    1. These doses are not absolute and should be considered only a rough guideline. They represent a generalized model based on many different studies with often very different individual findings. There is also an assumption that estradiol levels scale linearly or proportionally with dose, which may or may not actually be the case. One study found lower bioavailability of oral estradiol at high doses for instance (Kuhnz, Gansau, & Mahler, 1993).
    2. These doses are approximate equivalent or comparable doses and don’t necessarily correspond to typical or recommended clinical doses. Injectable estradiol formulations are generally used at higher doses than other routes and forms of estradiol for instance (Aly, 2021).
    3. The comparable doses are based on total estradiol exposure rather than therapeutic estrogenic potency. Time-related variations in sex hormone levels have been reported to modify potency of sex hormone preparations (Aly, 2021). However, this has not been factored in to the table here due to a lack of available data and analysis on the influence. In any case, it may be relevant to routes with large fluctuations in estradiol levels like sublingual administration and shorter-acting injections.
    4. A transdermal estradiol spray sold under the brand name Lenzetto is available. In a study in postmenopausal women, mean baseline-adjusted estradiol levels with Lenzetto over the course of a week following achievement of steady state were about 6 pg/mL pre-treatment, 13 pg/mL with 1 spray/day (1.53 mg/day), 19 pg/mL with 2 sprays/day (3.06 mg/day), and 26 pg/mL with 3 sprays/day (4.59 mg/day) (Morton et al., 2009; Graph). Hence, this form of estradiol appears to achieve relatively low estradiol levels that likely aren’t well-suited for transfeminine people. No data are available on higher doses (i.e., more sprays per day) and so this formulation has not been included in the table.

    Discussion

    For reference, mean integrated levels of estradiol during the normal menstrual cycle in premenopausal cisgender women are about 100 pg/mL and during the luteal phase (the latter half of the menstrual cycle) are around 150 pg/mL (Graph; Graph; Aly, 2018). The total production of estradiol over a single menstrual cycle (i.e., one month) is about 6 mg on average (Rosenfield et al., 2008; Aly, 2018). Slightly higher doses are required for injectable estradiol esters relative to endogenous production amounts since they contain less estradiol by weight due to the ester components (Table).

    Note that there is high interindividual variability (i.e., variability between individuals) in terms of estradiol levels achieved with different forms and routes of estradiol. As an example, some people may get relatively low estradiol levels with the oral route and others may get relatively low levels with the transdermal route. Conversely, some people may get relatively high levels with the transdermal route or with injections. For data showing the substantial variability even with injections, see Aly (2021). Due to the variability in estradiol levels between individuals, the appropriate doses will often not be the same for different people. Doses should be adjusted as necessary based on blood work. It should also be noted that there are large time-dependent changes in estradiol levels with certain routes, namely sublingual or buccal administration (Graphs; Graph; Sam, 2021) and intramuscular or subcutaneous injection (Graphs; Aly, 2021). Due to these fluctuations, estradiol levels will be vastly different when measured at different time points with these routes (e.g., around peak versus around trough).

    For transfeminine people who have not yet undergone or do not plan to undergo gonadectomy, a high to very high dose of estradiol can be used to achieve strong suppression of testosterone levels. On average, the high dose will suppress testosterone levels by about 90%, to around 50 ng/dL (Wiki; Aly, 2018). Hence, the high to very high doses are indicated for estradiol monotherapy (i.e., estradiol alone without an antiandrogen). After gonadectomy, testosterone suppression is no longer needed and lower doses of estradiol, such as the moderate doses, can be used instead. High doses of estradiol are not necessarily required if estradiol is used in combination with an adequately effective antiandrogen, for instance cyproterone acetate, bicalutamide, or a gonadotropin-releasing hormone agonist or antagonist. Spironolactone, on the other hand, may often not be fully effective for opposing androgens (Aly, 2018).

    References

    General Sources

    • Aly. (2019). Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018). Transfeminine Science, oral-e2-leinung-2018. [Google Scholar] [URL]
    • Aly. (2021). An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations. Transfeminine Science, injectable-e2-meta-analysis. [Google Scholar] [URL]
    • Armston, A., & Wood, P. (2002). Hormone replacement therapy (oestradiol-only preparations): can the laboratory recommend a concentration of plasma oestradiol to protect against osteoporosis? Annals of Clinical Biochemistry, 39(3), 184–193. [DOI:10.1258/0004563021902107]
    • Baker, V. L. (1994). Alternatives to Oral Estrogen Replacement: Transdermal Patches, Percutaneous Gels, Vaginal Creams and Rings, Implants, and Other Methods of Delivery. Obstetrics and Gynecology Clinics of North America, 21(2) [Primary Care of the Mature Woman], 271–297. [DOI:10.1016/S0889-8545(21)00629-X] [PDF]
    • Bruni, V., & Pampaloni, F. (2019). Hormone Replacement Therapy in Premature Ovarian Insufficiency. In Berga, S. L., Genazzani, A. R., Naftolin, F., & Petraglia, F. (Eds.). Menstrual Cycle Related Disorders (pp. 111–142). Cham: Springer. [DOI:10.1007/978-3-030-14358-9_10]
    • Farahmand, S., & Maibach, H. I. (2009). Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction. International Journal of Pharmaceutics, 367(1–2), 1–15. [DOI:10.1016/j.ijpharm.2008.11.020]
    • Herndon, J. S., Maheshwari, A. K., Nippoldt, T. B., Carlson, S. J., Davidge-Pitts, C. J., & Chang, A. Y. (2023). Comparison of Subcutaneous and Intramuscular Estradiol Regimens as part of Gender-Affirming Hormone Therapy. Endocrine Practice, 29(5), 356–361. [DOI:10.1016/j.eprac.2023.02.006] [URL] [PDF]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Lobo, R. A., & Cassidenti, D. L. (1992). Pharmacokinetics of Oral 17 β-Estradiol. The Journal of Reproductive Medicine, 37(1), 77–84. [Google Scholar] [PubMed] [PDF]
    • Sam. (2021). An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People. Transfeminine Science, sublingual-e2-transfem. [Google Scholar] [URL]
    • Simon, J. A., & Snabes, M. C. (2007). Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen. Expert Opinion on Investigational Drugs, 16(12), 2005–2020. [DOI:10.1517/13543784.16.12.2005]
    • Taboada, M., Santen, R., Lima, J., Hossain, J., Singh, R., Klein, K. O., & Mauras, N. (2011). Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome. The Journal of Clinical Endocrinology & Metabolism, 96(11), 3502–3510. [DOI:10.1210/jc.2011-1449]
    • Wikipedia. (2020, August 29). Pharmacokinetics of estradiol. Wikimedia Foundation. [URL]
    • Wikipedia. (2020, October 2). Template:Estrogen dosages for menopausal hormone therapy. Wikimedia Foundation. [URL]

    Inline Citations

    • Farahmand, S., & Maibach, H. I. (2009). Transdermal drug pharmacokinetics in man: Interindividual variability and partial prediction. International Journal of Pharmaceutics, 367(1–2), 1–15. [DOI:10.1016/j.ijpharm.2008.11.020]
    • Kuhnz, W., Gansau, C., & Mahler, M. (1993). Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43(9), 966–973. [Google Scholar] [PubMed] [PDF]
    • Langley, R. E., Godsland, I. F., Kynaston, H., Clarke, N. W., Rosen, S. D., Morgan, R. C., Pollock, P., Kockelbergh, R., Lalani, E., Dearnaley, D., Parmar, M., & Abel, P. D. (2008). Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU International, 102(4), 442–445. [DOI:10.1111/j.1464-410x.2008.07583.x]
    • Langley, R. E., Duong, T., Godsland, I. F., Kynaston, H., Kockelbergh, R., Rosen, S. D., Alhasso, A. A., Dearnaley, D. P., Clarke, N. W., Jovic, G., Carpenter, R., Bara, A., Welland, A., Parmar, M. K., & Abel, P. D. (2015). Oestrogen patches (OP) to treat prostate cancer (PC) – Are different commercial brands interchangeable? Maturitas, 81(1), 210–211. [DOI:10.1016/j.maturitas.2015.02.320]
    • Morton, T. L., Gattermeir, D. J., Petersen, C. A., Day, W. W., & Schumacher, R. J. (2009). Steady-State Pharmacokinetics Following Application of a Novel Transdermal Estradiol Spray in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology, 49(9), 1037–1046. [DOI:10.1177/0091270009339187]
    • Rohr, U. D., Nauert, C., & Stehle, B. (1999). 17β-Estradiol delivered by three different matrix patches 50 μg/day. Maturitas, 33(1), 45–58. [DOI:10.1016/s0378-5122(99)00039-0]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2008). Puberty and Its Disorders in the Female. In Sperling, M. A. (Ed.). Pediatric Endocrinology, 3rd Edition (pp. 530–609). Philadelphia: Saunders/Elsevier. [Google Scholar] [Google Books] [DOI:10.1016/b978-141604090-3.50019-3] [Archive.org]
    \ No newline at end of file diff --git a/transfemscience.org/articles/ec508/index.html b/transfemscience.org/articles/ec508/index.html index 723a08d1..e44afcde 100644 --- a/transfemscience.org/articles/ec508/index.html +++ b/transfemscience.org/articles/ec508/index.html @@ -1 +1 @@ -EC508 (Estradiol Aminosulfonylbenzoylproline), a Unique and Highly Promising Estradiol Ester and Possible Oral Estradiol Form of the Future - Transfeminine Science Link

    EC508 (Estradiol Aminosulfonylbenzoylproline), a Unique and Highly Promising Estradiol Ester and Possible Oral Estradiol Form of the Future

    By Aly | First published August 2, 2018 | Last modified September 29, 2021

    EC508, also known as estradiol 17β-(1-(4-(aminosulfonyl)benzoyl)-L-proline), or somewhat more simply as estradiol aminosulfonylbenzoylproline, is an estradiol ester and prodrug of estradiol which is under development by a small pharmaceutical company called Evestra for potential medical use in menopausal hormone therapy and as a form of hormonal birth control in cisgender women. It is intended for oral administration similarly to certain other orally used estradiol esters and prodrugs like estradiol valerate and estradiol acetate. However, EC508 is very different from conventional estradiol esters, and is far more promising in comparison. This is because from a theoretical standpoint, despite the fact that it is intended for use as an oral form of estradiol, EC508 has a pharmacological profile by this route that is much more similar to that of non-oral estradiol forms like transdermal estradiol and injectable estradiol than to oral administration of estradiol or conventional estradiol esters.

    A “first pass” through the intestines and liver normally occurs with oral administration of drugs before they reach the bloodstream. Estradiol is highly susceptible to metabolism in the liver and intestines. For this reason, when estradiol is taken orally, it is overwhelmingly converted into metabolites such as estrone, estrone sulfate, various other estrogen conjugates, and hydroxylated metabolites. These metabolites of estradiol are mostly inactive as estrogens, and with oral administration, the major metabolites like estrone and estrone sulfate circulate in the blood at much higher levels than does estradiol. Although not currently known to be therapeutically consequential, the circulating metabolite profile of oral estradiol is very unphysiological relative to normal hormonal circumstances. The metabolism of estradiol with the oral first pass is so substantial that the oral bioavailability of estradiol, or the amount of an oral dose that reaches the blood as estradiol when compared to the same dose of estradiol infused directly into the blood, is only about 5%. Moreover, there is substantial variability between people in the bioavailability of oral estradiol, with one pharmacokinetic study reporting a range of 0.1 to 12% in different individuals (Wiki). The estradiol levels that are achieved with the same dose of oral estradiol vary considerably in different people, and varying degrees of first-pass metabolism certainly contribute to this. Conventional estradiol esters like estradiol valerate are little different than estradiol with oral administration, due to rapid and probably complete conversion into estradiol during the first pass.

    Another consequence of the first pass with oral estradiol is that much higher levels of estradiol are present in the liver than normal or with non-oral estradiol (Wiki). It is estimated that the exposure of the liver to estradiol is around 5 times greater with oral estradiol than with non-oral estradiol. This is of importance because the liver is an estrogen-sensitive organ, with significant expression of estrogen receptors. The liver synthesizes a large number of important proteins and other products that are then released into the bloodstream and regulate biological functions throughout the body. Through activation of estrogen receptors, estrogens can modulate the production of many such liver-derived products (Table). Some of the more well-known examples include sex hormone-binding globulin (SHBG) and blood lipids like cholesterol and triglycerides. Of particular therapeutic concern however is the influence of estradiol and other estrogens on the synthesis of coagulation factors. By modifying the liver synthesis of these proteins, estrogens can have procoagulatory effects and can increase the risk of blood clots and associated cardiovascular problems like stroke and heart attack (Aly, 2020). Physiological levels of estradiol normally only have a small influence on liver synthesis, and effects like strong procoagulation are specific to states of extremely high estradiol levels like pregnancy. However, oral estradiol, due to the liver first pass and particularly at high doses, can result in pregnancy-like changes in liver synthesis and hence on coagulation and associated health risks. This is not something that normally occurs with physiological doses of non-oral estradiol forms, which have a minimal influence even at higher levels (although very high doses of non-oral estradiol can certainly still have such effects).

    Because of the first pass and its low bioavailability, substantial variability, unphysiological metabolite pattern, greater impact on liver synthesis, and greater health risks, oral estradiol is a less favorable form of estradiol than are non-oral estradiol forms like transdermal and injectable estradiol. Consequently, it is generally recommended that non-oral estradiol be used instead of oral estradiol where possible. However, oral estradiol is less expensive than certain non-oral forms (e.g., transdermal), is very easy and convenient to use, and has ubiquitous availability (unlike e.g. injectables). As such, it continues to see widespread use, and remains probably the most commonly used form of estradiol in medicine.

    EC508 is special because although it is intended as an oral form of estradiol, it is not like oral estradiol or conventional orally used estradiol esters like estradiol valerate. EC508 is different because it appears to bypass the first pass that normally occurs with oral administration. Due to its unique ester, it seems to be resistant to metabolism in the intestines and liver, which limits its conversion into estradiol and estradiol metabolites at this time. This is also notably seen with certain other estrogen esters like estrone sulfate and estramustine phosphate (estradiol normustine phosphate). In addition, and more importantly, because of its unusual ester moiety, EC508 binds with high affinity to a protein called carbonic anhydrase II (CAII) in red blood cells. This binding causes EC508 to be rapidly accumulated and sequestered into blood cells. Estradiol normally goes through the hepatic portal vein, a blood vessel that carries blood from the gastrointestinal tract to the liver, to reach the liver. With EC508, it is taken up into blood cells so quickly that little ultimately seems to reach the liver. Instead, the red blood cells carry EC508 through the portal vein to the bloodstream, which it is then slowly released into. As with other estradiol esters, EC508 has little or no estrogenic activity itself and is only active after being converted into estradiol.

    In accordance with the fact that it bypasses the oral first pass, EC508 shows 100% bioavailability in animals. This can be compared in humans to about 5% for oral estradiol and about 43% for ethinylestradiol (EE)—a synthetic relative of estradiol with strongly improved metabolic stability (but also far greater influence on liver synthesis and related health risks than estradiol). As a result of its complete bioavailability, EC508 has 100 times the oral estrogenic potency of estradiol and 10 times that of ethinylestradiol in animals. As such, EC508 would be expected to be active in humans at microgram (μg) doses, similarly to the estimated delivery rates of transdermal estradiol patches (e.g., 25–100 μg/day) as well as to typical doses of ethinylestradiol (e.g., 5–50 μg/day) but in contrast to the 100-fold higher usual doses of oral estradiol (e.g., 0.5–10 mg/day). Further in accordance with it bypassing the oral first pass, EC508 and non-oral estradiol showed little or no effect on liver synthesis at assessed doses in animals, whereas oral estradiol and ethinylestradiol showed marked effects. Lastly, EC508 had a biological half-life of 5 hours in rats, which is relatively long for this species. For this reason, a long duration may be anticipated with EC508 in humans, in contrast to estradiol injected directly into the blood (which has a very short half-life) but similarly to oral, transdermal, and injectable estradiol.

    An earlier drug candidate called estradiol sulfamate (E2MATE; J995), which is likewise a special estradiol ester that binds to CAII and bypasses the oral first pass, was discovered by the same research group in the 1990s, and was likewise developed as a new form of oral estradiol. However, it was subsequently found that E2MATE is additionally a highly potent inhibitor of steroid sulfatase (STS) and prevents its own activation by this enzyme into estradiol in humans. This served to abolish its estrogenic effects in the case of humans and resulted in it being not useful for clinical estrogen therapy. E2MATE was also undesirably found to be substantially converted into estrone sulfamate (E1MATE; J994) during the first pass with oral administration. Consequent to these findings, E2MATE was eventually repurposed as an estrogen synthesis inhibitor for treatment of endometriosis, and as of 2017, remains under development for this indication. In contrast to E2MATE, EC508 is not converted into the corresponding estrone variant, and is not thought to be an STS inhibitor, so the problems that E2MATE had are not expected with it.

    Taken together, EC508 shows a preclinical and theoretical profile of being an oral form of estradiol that bypasses the first pass with oral administration. As a result, EC508 with oral administration undergoes little or no first-pass metabolism, has high bioavailability, and does not result in excessive estrogenic exposure in the liver. Consequently, EC508 is expected to be orally active at much lower doses than estradiol, to have reduced variability compared to estradiol, to lack an unphysiological metabolite pattern, and to not have disproportionate influence on estrogen-sensitive liver synthesis and associated health risks. In these regards, EC508 shows a favorable and advantageous profile relative to oral estradiol that is analogous to that with non-oral forms of estradiol like transdermal and injectable estradiol but with the convenience of oral administration. For these reasons, EC508 is a pharmaceutical candidate with the potential to supersede not only oral estradiol in clinical practice but also non-oral estradiol and even other clinically used estrogens like ethinylestradiol (e.g., in birth control pills). If it’s successfully developed and approved, EC508 would naturally one day be used in transfeminine hormone therapy as well.

    In addition to EC508, the researchers at Evestra synthesized a testosterone equivalent known as EC586 (testosterone 17β-(1-((5-(aminosulfonyl)-2-pyridinyl)carbonyl)-L-proline or slightly more simply as testosterone aminosulfonylpyridinylcarbonylproline). This testosterone ester shows analogous properties to those of EC508, and hence has the potential to be a non-oral-like form of oral testosterone with high bioavailability and potency, a long duration, and lack of disproportionate liver effects—and hence with major advantages over oral testosterone forms available today. In parallel to EC508, EC586 (or similar drugs) could someday be used in transmasculine hormone therapy. The prodrug approach used to create EC508 and EC586 also notably has the potential to be employed with many other drugs.

    Update: No Further Development

    Patents for EC508 were filed in 2014 and 2017 and publications describing it were published in the scientific literature in 2017. An Investigational New Drug (IND) application for EC508 was tentatively supposed to be filed with the Food and Drug Administration (FDA) in the United States in the second quarter of 2018 (Evestra). However, as of September 2021, there have been no further updates on the development of EC508. In addition, Evestra’s website has since been redesigned and its research pipeline page listing the status of EC508 has been removed. It’s unknown at this time if EC508 and EC586 are still under development or whether further updates on these compounds can be expected.

    References

    • Ahmed, G., Elger, W., Meece, F., Nair, H. B., Schneider, B., Wyrwa, R., & Nickisch, K. (2017). A prodrug design for improved oral absorption and reduced hepatic interaction. Bioorganic & Medicinal Chemistry, 25(20), 5569–5575. [DOI:10.1016/j.bmc.2017.08.027]
    • Elger, W., Schwarz, S., Hedden, A., Reddersen, G., & Schneider, B. (1995). Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. The Journal of Steroid Biochemistry and Molecular Biology, 55(3-4), 395–403. [DOI:10.1016/0960-0760(95)00214-6]
    • Elger, W., Palme, H. J., & Schwarz, S. (1998). Novel oestrogen sulfamates: a new approach to oral hormone therapy. Expert Opinion on Investigational Drugs, 7(4), 575–589. [DOI:10.1517/13543784.7.4.575]
    • Elger, W., Barth, A., Hedden, A., Reddersen, G., Ritter, P., Schneider, B., Züchner, J., Krahl, E., Müller, K., Oettel, M., & Schwarz, S. (2001). Estrogen Sulfamates: A New Approach to Oral Estrogen Therapy. Reproduction, Fertility, and Development, 13(4), 297–305. [DOI:10.1071/rd01029]
    • Elger, W., Wyrwa, R., Ahmed, G., Meece, F., Nair, H. B., Santhamma, B., Killeen, Z., Schneider, B., Meister, R., Schubert, H., & Nickisch, K. (2017). Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions. The Journal of Steroid Biochemistry and Molecular Biology, 165, 305–311. [DOI:10.1016/j.jsbmb.2016.07.008]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Nickisch, K., Santhamma, B., Ahmed, G., Meece, F., Elger, W., Wyrwa, R., & Nair, H. (2017). U.S. Patent No. 9,745,338. Washington, DC: U.S. Patent and Trademark Office. [US9745338B2]
    • Nickisch, K., Santhamma, B., Ahmed, G., Meece, F., Elger, W., Wyrwa, R., & Nair, H. (2019). U.S. Patent No. 10,273,263. Washington, DC: U.S. Patent and Trademark Office. [US10273263B2]
    • Potter, B. V. (2018). SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects. Journal of Molecular Endocrinology, 61(2), T233–T252. [DOI:10.1530/JME-18-0045]
    • Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013). Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception, 87(6), 706–727. [DOI:10.1016/j.contraception.2012.12.011]
    • Thomas, M. P., & Potter, B. V. (2015). Discovery and development of the aryl O-sulfamate pharmacophore for oncology and women’s health. Journal of Medicinal Chemistry, 58(19), 7634–7658. [DOI:10.1021/acs.jmedchem.5b00386]
    • Thomas, M. P., & Potter, B. V. (2015). Estrogen O-sulfamates and their analogues: clinical steroid sulfatase inhibitors with broad potential. The Journal of Steroid Biochemistry and Molecular Biology, 153, 160–169. [DOI:10.1016/j.jsbmb.2015.03.012]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    \ No newline at end of file +EC508 (Estradiol Aminosulfonylbenzoylproline), a Unique and Highly Promising Estradiol Ester and Possible Oral Estradiol Form of the Future - Transfeminine Science Link

    EC508 (Estradiol Aminosulfonylbenzoylproline), a Unique and Highly Promising Estradiol Ester and Possible Oral Estradiol Form of the Future

    By Aly | First published August 2, 2018 | Last modified September 29, 2021

    EC508, also known as estradiol 17β-(1-(4-(aminosulfonyl)benzoyl)-L-proline), or somewhat more simply as estradiol aminosulfonylbenzoylproline, is an estradiol ester and prodrug of estradiol which is under development by a small pharmaceutical company called Evestra for potential medical use in menopausal hormone therapy and as a form of hormonal birth control in cisgender women. It is intended for oral administration similarly to certain other orally used estradiol esters and prodrugs like estradiol valerate and estradiol acetate. However, EC508 is very different from conventional estradiol esters, and is far more promising in comparison. This is because from a theoretical standpoint, despite the fact that it is intended for use as an oral form of estradiol, EC508 has a pharmacological profile by this route that is much more similar to that of non-oral estradiol forms like transdermal estradiol and injectable estradiol than to oral administration of estradiol or conventional estradiol esters.

    A “first pass” through the intestines and liver normally occurs with oral administration of drugs before they reach the bloodstream. Estradiol is highly susceptible to metabolism in the liver and intestines. For this reason, when estradiol is taken orally, it is overwhelmingly converted into metabolites such as estrone, estrone sulfate, various other estrogen conjugates, and hydroxylated metabolites. These metabolites of estradiol are mostly inactive as estrogens, and with oral administration, the major metabolites like estrone and estrone sulfate circulate in the blood at much higher levels than does estradiol. Although not currently known to be therapeutically consequential, the circulating metabolite profile of oral estradiol is very unphysiological relative to normal hormonal circumstances. The metabolism of estradiol with the oral first pass is so substantial that the oral bioavailability of estradiol, or the amount of an oral dose that reaches the blood as estradiol when compared to the same dose of estradiol infused directly into the blood, is only about 5%. Moreover, there is substantial variability between people in the bioavailability of oral estradiol, with one pharmacokinetic study reporting a range of 0.1 to 12% in different individuals (Wiki). The estradiol levels that are achieved with the same dose of oral estradiol vary considerably in different people, and varying degrees of first-pass metabolism certainly contribute to this. Conventional estradiol esters like estradiol valerate are little different than estradiol with oral administration, due to rapid and probably complete conversion into estradiol during the first pass.

    Another consequence of the first pass with oral estradiol is that much higher levels of estradiol are present in the liver than normal or with non-oral estradiol (Wiki). It is estimated that the exposure of the liver to estradiol is around 5 times greater with oral estradiol than with non-oral estradiol. This is of importance because the liver is an estrogen-sensitive organ, with significant expression of estrogen receptors. The liver synthesizes a large number of important proteins and other products that are then released into the bloodstream and regulate biological functions throughout the body. Through activation of estrogen receptors, estrogens can modulate the production of many such liver-derived products (Table). Some of the more well-known examples include sex hormone-binding globulin (SHBG) and blood lipids like cholesterol and triglycerides. Of particular therapeutic concern however is the influence of estradiol and other estrogens on the synthesis of coagulation factors. By modifying the liver synthesis of these proteins, estrogens can have procoagulatory effects and can increase the risk of blood clots and associated cardiovascular problems like stroke and heart attack (Aly, 2020). Physiological levels of estradiol normally only have a small influence on liver synthesis, and effects like strong procoagulation are specific to states of extremely high estradiol levels like pregnancy. However, oral estradiol, due to the liver first pass and particularly at high doses, can result in pregnancy-like changes in liver synthesis and hence on coagulation and associated health risks. This is not something that normally occurs with physiological doses of non-oral estradiol forms, which have a minimal influence even at higher levels (although very high doses of non-oral estradiol can certainly still have such effects).

    Because of the first pass and its low bioavailability, substantial variability, unphysiological metabolite pattern, greater impact on liver synthesis, and greater health risks, oral estradiol is a less favorable form of estradiol than are non-oral estradiol forms like transdermal and injectable estradiol. Consequently, it is generally recommended that non-oral estradiol be used instead of oral estradiol where possible. However, oral estradiol is less expensive than certain non-oral forms (e.g., transdermal), is very easy and convenient to use, and has ubiquitous availability (unlike e.g. injectables). As such, it continues to see widespread use, and remains probably the most commonly used form of estradiol in medicine.

    EC508 is special because although it is intended as an oral form of estradiol, it is not like oral estradiol or conventional orally used estradiol esters like estradiol valerate. EC508 is different because it appears to bypass the first pass that normally occurs with oral administration. Due to its unique ester, it seems to be resistant to metabolism in the intestines and liver, which limits its conversion into estradiol and estradiol metabolites at this time. This is also notably seen with certain other estrogen esters like estrone sulfate and estramustine phosphate (estradiol normustine phosphate). In addition, and more importantly, because of its unusual ester moiety, EC508 binds with high affinity to a protein called carbonic anhydrase II (CAII) in red blood cells. This binding causes EC508 to be rapidly accumulated and sequestered into blood cells. Estradiol normally goes through the hepatic portal vein, a blood vessel that carries blood from the gastrointestinal tract to the liver, to reach the liver. With EC508, it is taken up into blood cells so quickly that little ultimately seems to reach the liver. Instead, the red blood cells carry EC508 through the portal vein to the bloodstream, which it is then slowly released into. As with other estradiol esters, EC508 has little or no estrogenic activity itself and is only active after being converted into estradiol.

    In accordance with the fact that it bypasses the oral first pass, EC508 shows 100% bioavailability in animals. This can be compared in humans to about 5% for oral estradiol and about 43% for ethinylestradiol (EE)—a synthetic relative of estradiol with strongly improved metabolic stability (but also far greater influence on liver synthesis and related health risks than estradiol). As a result of its complete bioavailability, EC508 has 100 times the oral estrogenic potency of estradiol and 10 times that of ethinylestradiol in animals. As such, EC508 would be expected to be active in humans at microgram (μg) doses, similarly to the estimated delivery rates of transdermal estradiol patches (e.g., 25–100 μg/day) as well as to typical doses of ethinylestradiol (e.g., 5–50 μg/day) but in contrast to the 100-fold higher usual doses of oral estradiol (e.g., 0.5–10 mg/day). Further in accordance with it bypassing the oral first pass, EC508 and non-oral estradiol showed little or no effect on liver synthesis at assessed doses in animals, whereas oral estradiol and ethinylestradiol showed marked effects. Lastly, EC508 had a biological half-life of 5 hours in rats, which is relatively long for this species. For this reason, a long duration may be anticipated with EC508 in humans, in contrast to estradiol injected directly into the blood (which has a very short half-life) but similarly to oral, transdermal, and injectable estradiol.

    An earlier drug candidate called estradiol sulfamate (E2MATE; J995), which is likewise a special estradiol ester that binds to CAII and bypasses the oral first pass, was discovered by the same research group in the 1990s, and was likewise developed as a new form of oral estradiol. However, it was subsequently found that E2MATE is additionally a highly potent inhibitor of steroid sulfatase (STS) and prevents its own activation by this enzyme into estradiol in humans. This served to abolish its estrogenic effects in the case of humans and resulted in it being not useful for clinical estrogen therapy. E2MATE was also undesirably found to be substantially converted into estrone sulfamate (E1MATE; J994) during the first pass with oral administration. Consequent to these findings, E2MATE was eventually repurposed as an estrogen synthesis inhibitor for treatment of endometriosis, and as of 2017, remains under development for this indication. In contrast to E2MATE, EC508 is not converted into the corresponding estrone variant, and is not thought to be an STS inhibitor, so the problems that E2MATE had are not expected with it.

    Taken together, EC508 shows a preclinical and theoretical profile of being an oral form of estradiol that bypasses the first pass with oral administration. As a result, EC508 with oral administration undergoes little or no first-pass metabolism, has high bioavailability, and does not result in excessive estrogenic exposure in the liver. Consequently, EC508 is expected to be orally active at much lower doses than estradiol, to have reduced variability compared to estradiol, to lack an unphysiological metabolite pattern, and to not have disproportionate influence on estrogen-sensitive liver synthesis and associated health risks. In these regards, EC508 shows a favorable and advantageous profile relative to oral estradiol that is analogous to that with non-oral forms of estradiol like transdermal and injectable estradiol but with the convenience of oral administration. For these reasons, EC508 is a pharmaceutical candidate with the potential to supersede not only oral estradiol in clinical practice but also non-oral estradiol and even other clinically used estrogens like ethinylestradiol (e.g., in birth control pills). If it’s successfully developed and approved, EC508 would naturally one day be used in transfeminine hormone therapy as well.

    In addition to EC508, the researchers at Evestra synthesized a testosterone equivalent known as EC586 (testosterone 17β-(1-((5-(aminosulfonyl)-2-pyridinyl)carbonyl)-L-proline or slightly more simply as testosterone aminosulfonylpyridinylcarbonylproline). This testosterone ester shows analogous properties to those of EC508, and hence has the potential to be a non-oral-like form of oral testosterone with high bioavailability and potency, a long duration, and lack of disproportionate liver effects—and hence with major advantages over oral testosterone forms available today. In parallel to EC508, EC586 (or similar drugs) could someday be used in transmasculine hormone therapy. The prodrug approach used to create EC508 and EC586 also notably has the potential to be employed with many other drugs.

    Update: No Further Development

    Patents for EC508 were filed in 2014 and 2017 and publications describing it were published in the scientific literature in 2017. An Investigational New Drug (IND) application for EC508 was tentatively supposed to be filed with the Food and Drug Administration (FDA) in the United States in the second quarter of 2018 (Evestra). However, as of September 2021, there have been no further updates on the development of EC508. In addition, Evestra’s website has since been redesigned and its research pipeline page listing the status of EC508 has been removed. It’s unknown at this time if EC508 and EC586 are still under development or whether further updates on these compounds can be expected.

    References

    • Ahmed, G., Elger, W., Meece, F., Nair, H. B., Schneider, B., Wyrwa, R., & Nickisch, K. (2017). A prodrug design for improved oral absorption and reduced hepatic interaction. Bioorganic & Medicinal Chemistry, 25(20), 5569–5575. [DOI:10.1016/j.bmc.2017.08.027]
    • Elger, W., Schwarz, S., Hedden, A., Reddersen, G., & Schneider, B. (1995). Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. The Journal of Steroid Biochemistry and Molecular Biology, 55(3-4), 395–403. [DOI:10.1016/0960-0760(95)00214-6]
    • Elger, W., Palme, H. J., & Schwarz, S. (1998). Novel oestrogen sulfamates: a new approach to oral hormone therapy. Expert Opinion on Investigational Drugs, 7(4), 575–589. [DOI:10.1517/13543784.7.4.575]
    • Elger, W., Barth, A., Hedden, A., Reddersen, G., Ritter, P., Schneider, B., Züchner, J., Krahl, E., Müller, K., Oettel, M., & Schwarz, S. (2001). Estrogen Sulfamates: A New Approach to Oral Estrogen Therapy. Reproduction, Fertility, and Development, 13(4), 297–305. [DOI:10.1071/rd01029]
    • Elger, W., Wyrwa, R., Ahmed, G., Meece, F., Nair, H. B., Santhamma, B., Killeen, Z., Schneider, B., Meister, R., Schubert, H., & Nickisch, K. (2017). Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions. The Journal of Steroid Biochemistry and Molecular Biology, 165, 305–311. [DOI:10.1016/j.jsbmb.2016.07.008]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Nickisch, K., Santhamma, B., Ahmed, G., Meece, F., Elger, W., Wyrwa, R., & Nair, H. (2017). U.S. Patent No. 9,745,338. Washington, DC: U.S. Patent and Trademark Office. [US9745338B2]
    • Nickisch, K., Santhamma, B., Ahmed, G., Meece, F., Elger, W., Wyrwa, R., & Nair, H. (2019). U.S. Patent No. 10,273,263. Washington, DC: U.S. Patent and Trademark Office. [US10273263B2]
    • Potter, B. V. (2018). SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects. Journal of Molecular Endocrinology, 61(2), T233–T252. [DOI:10.1530/JME-18-0045]
    • Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013). Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception, 87(6), 706–727. [DOI:10.1016/j.contraception.2012.12.011]
    • Thomas, M. P., & Potter, B. V. (2015). Discovery and development of the aryl O-sulfamate pharmacophore for oncology and women’s health. Journal of Medicinal Chemistry, 58(19), 7634–7658. [DOI:10.1021/acs.jmedchem.5b00386]
    • Thomas, M. P., & Potter, B. V. (2015). Estrogen O-sulfamates and their analogues: clinical steroid sulfatase inhibitors with broad potential. The Journal of Steroid Biochemistry and Molecular Biology, 153, 160–169. [DOI:10.1016/j.jsbmb.2015.03.012]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    \ No newline at end of file diff --git a/transfemscience.org/articles/endo-system-muscle/index.html b/transfemscience.org/articles/endo-system-muscle/index.html index e24f35ec..08013480 100644 --- a/transfemscience.org/articles/endo-system-muscle/index.html +++ b/transfemscience.org/articles/endo-system-muscle/index.html @@ -1 +1 @@ -The Relationship Between the Endocrine System and Muscle Mass - Transfeminine Science Link

    The Relationship Between the Endocrine System and Muscle Mass

    By Lain | First published August 12, 2019 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    Introduction

    As someone who has recently undergone dramatic physiological changes prior to gender-affirming hormone therapy (GAHT) and who recently began taking antiandrogens and estradiol I was extremely interested in the effects of GAHT on muscle mass. Looking through traditional trans resources and talking to various general providers and transcare specialists I largely received anecdote related to “you’ll lose muscle mass” when suppressing androgens and/or taking estradiol. I thought and hope others will find the digging I’ve done to try and collate research on this useful or interesting as well.

    Background

    A bit of basic background on muscles:

    • There are generally speaking two types of skeletal muscle fiber: type 1 (slow twitch) and type 2 (fast twitch).
    • Muscle cells called myocytes are filled with myofibrils – protein chains that contract, have large stores of glycogen as well as oxygen.
    • Muscular hypertrophy is the growth of muscle mass.
    • Most muscle mass building is via anaerobic (non-oxygenated) exercise.

    Lots of further reading can be found via Wikipedia on muscle tissue, skeletal muscle, muscular hypertrophy, and strength training.

    Impact of the Endocrine System on Muscle Mass

    While I initially sought out to find the effects of estrogens on muscle mass I was largely at a loss. I could find little information until I had a moment of clarity and realized that while estrogens do have interactions with the formation of muscle mass and muscle cells – the seemingly more important hormones are androgens and that is the presence or absence of testosterone that seems to have a far greater impact on muscle mass than the presence of estrogen. Something I would of course love to see would be studies similar to ones I look at below but with estrogens added in addition to androgens suppressed.

    Summary

    Testosterone from heavily androgen suppressed levels to above normal doses in assigned male at birth (AMAB) individuals seems to have a linear relationship to muscle mass. This seems to occur while maintaining the pre-existing distribution of both major skeletal muscle types (type I and type II). Further this seems to occur by an increase in the number of muscle cells (myonuclear number) as well as significant changes to their cellular structure – they add more myofibrils. This seems to be due to testosterone induced protein synthesis and prevention of protein degradation.

    Below I have included a number of papers I found interesting and drew these conclusions from, with takeaways, quotes I found interesting as well as graphs.

    Bhasin et al. (1996) - The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men

    The main takeaway from this paper is to illustrate that even in AMAB individuals without suppressed androgens – increasing testosterone is useful in increasing muscle mass – as measured by looking at fat free mass (FFM) and also a concordant decrease in body fat (BF) percentage.

    Our results show that supraphysiologic doses of testosterone, especially when combined with strength training, increase fat-free mass, muscle size, and strength in normal men when potentially confounding variables, such as nutritional intake and exercise stimulus, are standardized. The combination of strength training and testosterone produced greater increases in muscle size and strength than were achieved with either intervention alone. The combined regimen of testosterone and exercise led to an increase of 6.1 kg in fat-free mass over the course of 10 weeks; this increase entirely accounted for the changes in body weight.

    Mauras et al. (1998) - Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity

    This paper was the first that I found that really illustrated that suppression of testosterone down to levels that people on an antiandrogen often seek. You can see that fat free mass (bone and muscle mass) decreases while body fat percentage increased.

    Young men treated with a GnRHa were less efficient in their oxidation of fat, with a consequent decrease in the resting energy expenditure, which probably explains the increase in adiposity and the decrease in lean body mass observed during these experiments. The mechanisms for these findings are not completely understood; however, several considerations apply.

    In summary, severe androgen deficiency in young men was associated with decreased lean body mass and increased adiposity, decreased lipid oxidation and energy expenditure rates, decreased rates of whole body protein synthesis, and decreased leg muscle strength. These findings were not associated with changes in circulating amino acid concentrations. These changes were associated with decreased gene expression for IGF-I in muscle, but no peripheral decreases in GH and IGF-I production. We conclude that androgens can directly affect systemic protein synthesis, independent of the effect of peripheral GH and IGF-I. The latter may be important when an anabolic effect is the desired effect in the treatment of both elderly and young men.

    Bhasin et al. (2001) - Testosterone Dose-Response Relationships in Healthy Young Men

    Possibly one of the most interesting papers I found. Not only did they suppress AMAB individuals testosterone with a gonadotropin-releasing hormone agonist they then gave different groups varying levels of it so that you could actually plot a dose response curve. They measured a number of things outside of fat free mass such as leg press strength, fat mass, thigh muscle volume, etc..

    […] 61 eugonadal men, 18–35 yr, were randomized to one of five groups to receive monthly injections of a long-acting gonadotropin-releasing hormone (GnRH) agonist, to suppress endogenous testosterone secretion, and weekly injections of 25, 50, 125, 300, or 600 mg of testosterone enanthate for 20 wk. Energy and protein intakes were standardized. The administration of the GnRH agonist plus graded doses of testosterone resulted in mean nadir testosterone concentrations of 253, 306, 542, 1,345, and 2,370 ng/dl at the 25-, 50-, 125-, 300-, and 600-mg doses, respectively. Fat-free mass increased dose dependently in men receiving 125, 300, or 600 mg of testosterone weekly (change 13.4, 5.2, and 7.9 kg, respectively). The changes in fat-free mass were highly dependent on testosterone dose (P = 0.0001) and correlated with log testosterone concentrations (r = 0.73, P = 0.0001). Changes in leg press strength, leg power, thigh and quadriceps muscle volumes, hemoglobin, and IGF-I were positively correlated with testosterone concentrations, whereas changes in fat mass and plasma high-density lipoprotein (HDL) cholesterol were negatively correlated.

    Sinha-Hikim et al. (2002) - Testosterone-Induced Increase in Muscle Size in Healthy, Young Men is Associated with Muscle Fiber Hypertrophy

    While the previous papers looked at the relationship between muscle mass and other factors and testosterone – this paper looks at how that occurs. They again supress testosterone and then give different groups varying levels of it – only this time they take muscle biopsies and look at how the actual muscle groups differ.

    In healthy, young men, in whom testicular testosterone production had been suppressed by a GnRH agonist, administration of graded doses of testosterone was associated with dose dependent changes in circulating concentrations of total and free testosterone (7).

    Data presented in this manuscript demonstrate that testosterone-induced gains in muscle size were associated with a significant increase in muscle fiber cross-sectional area. The cross-sectional areas of both type I and type II fibers increased in proportion to testosterone concentrations. The relative proportion of type I and II fibers did not change significantly. We therefore conclude that testosterone increases skeletal muscle size primarily by inducing muscle fiber hypertrophy.

    In our study, the myonuclear number increased in direct relation to the increase in muscle fiber diameter. Therefore, it is possible that muscle fiber hypertrophy and increase in myonuclear number were preceded by testosterone induced increase in satellite cell number and their fusion with muscle fibers.

    Bhasin et al. (2003) - The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action

    A paper by the same research group as previous, this paper does a great job summarizing the effects of testosterone on muscle mass and its role in muscular hypertrophy. I’ve included here their table of its effects relevant to muscle mass.

    The change in percent satellite cell number correlated with changes in total and free testosterone concentrations (10). Satellite cell and mitochondrial areas were significantly higher and the nuclear to cytoplasmic ratio lower after treatment with 300 mg and 600 mg doses (10). These data demonstrate that testosterone-induced muscle fiber hypertrophy is associated with an increase in satellite cell number, a proportionate increase in myonuclear number, and changes in satellite cell ultrastructure. These alterations in satellite cell number and ultrastructure and muscle morphology cannot be explained by the muscle protein synthesis hypothesis.

    Testosterone has been reported to inhibit lipid uptake and lipoprotein lipase activity in adipocytes, and stimulate lipolysis (21), in part by increasing the number of lipolytic beta-adrenergic receptors.

    Table 1. Summary of the Observed Effects of Testosterone on Body Composition

    • Effects on Fat-Free Compartment
      • Increase in fat-free and lean body mass (2–14)
      • Increase in bone mass (52)
      • Increase in nitrogen retention in castrated male mammals, eunuchoidal men, women, and prepubertal boys (25–28)
    • Changes in Muscle Histomorphology
      • Increase in cross-sectional areas of both types I and II skeletal muscle fibers (9)
      • Increase in the number of myonuclei (10)
      • Increase in the number of satellite cells (10)
    • Changes in Protein Dynamics
      • Increase in nonoxidative leucine disappearance rate (14)
      • Increase in fractional synthesis rates of mixed skeletal muscle protein (11–14)
      • No net increase in protein balance, although net protein balance becomes less negative in fasting state (15,16)
      • Decrease in protein degradation by the arteriovenous difference method (15)
      • Decrease in proteasome-mediated protein degradation (15)
    • Effects of Fat Compartment
      • Decrease in whole-body fat mass in hypogonadal men treated with replacement doses of testosterone (3–6)
      • Decrease in whole-body fat mass in eugonadal men with supraphysiological doses of testosterone and other androgens (7)
      • Decrease in intra-abdominal fat mass in middle-aged men with low normal testosterone levels (25,26)
      • Increased lipolysis (26)
      • Regulation of lipoprotein lipase activity (52,53)
      • Decreased triglyceride assimilation in abdominal fat compartment (26)
      • Inhibits preadipocyte to adipocyte differentiation (52)
    • Note: Numbers in parentheses are reference numbers.

    References

    • Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men. New England Journal of Medicine, 335(1), 1–7. [DOI:10.1056/nejm199607043350101]
    • Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., Dzekov, J., Bross, R., Phillips, J., Sinha-Hikim, I., Shen, R., & Storer, T. W. (2001). Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism, 281(6), E1172–E1181. [DOI:10.1152/ajpendo.2001.281.6.e1172]
    • Bhasin, S., Taylor, W. E., Singh, R., Artaza, J., Sinha-Hikim, I., Jasuja, R., Choi, H., & Gonzalez-Cadavid, N. F. (2003). The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 58(12), M1103–M1110. [DOI:10.1093/gerona/58.12.m1103]
    • Mauras, N., Hayes, V., Welch, S., Rini, A., Helgeson, K., Dokler, M., Veldhuis, J. D., & Urban, R. J. (1998). Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity. The Journal of Clinical Endocrinology & Metabolism, 83(6), 1886–1892. [DOI:10.1210/jcem.83.6.4892]
    • Sinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A. B., Lee, M. I., Storer, T. W., Casaburi, R., Shen, R., & Bhasin, S. (2002). Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. American Journal of Physiology-Endocrinology and Metabolism, 283(1), E154–E164. [DOI:10.1152/ajpendo.00502.2001]
    \ No newline at end of file +The Relationship Between the Endocrine System and Muscle Mass - Transfeminine Science Link

    The Relationship Between the Endocrine System and Muscle Mass

    By Lain | First published August 12, 2019 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    Introduction

    As someone who has recently undergone dramatic physiological changes prior to gender-affirming hormone therapy (GAHT) and who recently began taking antiandrogens and estradiol I was extremely interested in the effects of GAHT on muscle mass. Looking through traditional trans resources and talking to various general providers and transcare specialists I largely received anecdote related to “you’ll lose muscle mass” when suppressing androgens and/or taking estradiol. I thought and hope others will find the digging I’ve done to try and collate research on this useful or interesting as well.

    Background

    A bit of basic background on muscles:

    • There are generally speaking two types of skeletal muscle fiber: type 1 (slow twitch) and type 2 (fast twitch).
    • Muscle cells called myocytes are filled with myofibrils – protein chains that contract, have large stores of glycogen as well as oxygen.
    • Muscular hypertrophy is the growth of muscle mass.
    • Most muscle mass building is via anaerobic (non-oxygenated) exercise.

    Lots of further reading can be found via Wikipedia on muscle tissue, skeletal muscle, muscular hypertrophy, and strength training.

    Impact of the Endocrine System on Muscle Mass

    While I initially sought out to find the effects of estrogens on muscle mass I was largely at a loss. I could find little information until I had a moment of clarity and realized that while estrogens do have interactions with the formation of muscle mass and muscle cells – the seemingly more important hormones are androgens and that is the presence or absence of testosterone that seems to have a far greater impact on muscle mass than the presence of estrogen. Something I would of course love to see would be studies similar to ones I look at below but with estrogens added in addition to androgens suppressed.

    Summary

    Testosterone from heavily androgen suppressed levels to above normal doses in assigned male at birth (AMAB) individuals seems to have a linear relationship to muscle mass. This seems to occur while maintaining the pre-existing distribution of both major skeletal muscle types (type I and type II). Further this seems to occur by an increase in the number of muscle cells (myonuclear number) as well as significant changes to their cellular structure – they add more myofibrils. This seems to be due to testosterone induced protein synthesis and prevention of protein degradation.

    Below I have included a number of papers I found interesting and drew these conclusions from, with takeaways, quotes I found interesting as well as graphs.

    Bhasin et al. (1996) - The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men

    The main takeaway from this paper is to illustrate that even in AMAB individuals without suppressed androgens – increasing testosterone is useful in increasing muscle mass – as measured by looking at fat free mass (FFM) and also a concordant decrease in body fat (BF) percentage.

    Our results show that supraphysiologic doses of testosterone, especially when combined with strength training, increase fat-free mass, muscle size, and strength in normal men when potentially confounding variables, such as nutritional intake and exercise stimulus, are standardized. The combination of strength training and testosterone produced greater increases in muscle size and strength than were achieved with either intervention alone. The combined regimen of testosterone and exercise led to an increase of 6.1 kg in fat-free mass over the course of 10 weeks; this increase entirely accounted for the changes in body weight.

    Mauras et al. (1998) - Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity

    This paper was the first that I found that really illustrated that suppression of testosterone down to levels that people on an antiandrogen often seek. You can see that fat free mass (bone and muscle mass) decreases while body fat percentage increased.

    Young men treated with a GnRHa were less efficient in their oxidation of fat, with a consequent decrease in the resting energy expenditure, which probably explains the increase in adiposity and the decrease in lean body mass observed during these experiments. The mechanisms for these findings are not completely understood; however, several considerations apply.

    In summary, severe androgen deficiency in young men was associated with decreased lean body mass and increased adiposity, decreased lipid oxidation and energy expenditure rates, decreased rates of whole body protein synthesis, and decreased leg muscle strength. These findings were not associated with changes in circulating amino acid concentrations. These changes were associated with decreased gene expression for IGF-I in muscle, but no peripheral decreases in GH and IGF-I production. We conclude that androgens can directly affect systemic protein synthesis, independent of the effect of peripheral GH and IGF-I. The latter may be important when an anabolic effect is the desired effect in the treatment of both elderly and young men.

    Bhasin et al. (2001) - Testosterone Dose-Response Relationships in Healthy Young Men

    Possibly one of the most interesting papers I found. Not only did they suppress AMAB individuals testosterone with a gonadotropin-releasing hormone agonist they then gave different groups varying levels of it so that you could actually plot a dose response curve. They measured a number of things outside of fat free mass such as leg press strength, fat mass, thigh muscle volume, etc..

    […] 61 eugonadal men, 18–35 yr, were randomized to one of five groups to receive monthly injections of a long-acting gonadotropin-releasing hormone (GnRH) agonist, to suppress endogenous testosterone secretion, and weekly injections of 25, 50, 125, 300, or 600 mg of testosterone enanthate for 20 wk. Energy and protein intakes were standardized. The administration of the GnRH agonist plus graded doses of testosterone resulted in mean nadir testosterone concentrations of 253, 306, 542, 1,345, and 2,370 ng/dl at the 25-, 50-, 125-, 300-, and 600-mg doses, respectively. Fat-free mass increased dose dependently in men receiving 125, 300, or 600 mg of testosterone weekly (change 13.4, 5.2, and 7.9 kg, respectively). The changes in fat-free mass were highly dependent on testosterone dose (P = 0.0001) and correlated with log testosterone concentrations (r = 0.73, P = 0.0001). Changes in leg press strength, leg power, thigh and quadriceps muscle volumes, hemoglobin, and IGF-I were positively correlated with testosterone concentrations, whereas changes in fat mass and plasma high-density lipoprotein (HDL) cholesterol were negatively correlated.

    Sinha-Hikim et al. (2002) - Testosterone-Induced Increase in Muscle Size in Healthy, Young Men is Associated with Muscle Fiber Hypertrophy

    While the previous papers looked at the relationship between muscle mass and other factors and testosterone – this paper looks at how that occurs. They again supress testosterone and then give different groups varying levels of it – only this time they take muscle biopsies and look at how the actual muscle groups differ.

    In healthy, young men, in whom testicular testosterone production had been suppressed by a GnRH agonist, administration of graded doses of testosterone was associated with dose dependent changes in circulating concentrations of total and free testosterone (7).

    Data presented in this manuscript demonstrate that testosterone-induced gains in muscle size were associated with a significant increase in muscle fiber cross-sectional area. The cross-sectional areas of both type I and type II fibers increased in proportion to testosterone concentrations. The relative proportion of type I and II fibers did not change significantly. We therefore conclude that testosterone increases skeletal muscle size primarily by inducing muscle fiber hypertrophy.

    In our study, the myonuclear number increased in direct relation to the increase in muscle fiber diameter. Therefore, it is possible that muscle fiber hypertrophy and increase in myonuclear number were preceded by testosterone induced increase in satellite cell number and their fusion with muscle fibers.

    Bhasin et al. (2003) - The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action

    A paper by the same research group as previous, this paper does a great job summarizing the effects of testosterone on muscle mass and its role in muscular hypertrophy. I’ve included here their table of its effects relevant to muscle mass.

    The change in percent satellite cell number correlated with changes in total and free testosterone concentrations (10). Satellite cell and mitochondrial areas were significantly higher and the nuclear to cytoplasmic ratio lower after treatment with 300 mg and 600 mg doses (10). These data demonstrate that testosterone-induced muscle fiber hypertrophy is associated with an increase in satellite cell number, a proportionate increase in myonuclear number, and changes in satellite cell ultrastructure. These alterations in satellite cell number and ultrastructure and muscle morphology cannot be explained by the muscle protein synthesis hypothesis.

    Testosterone has been reported to inhibit lipid uptake and lipoprotein lipase activity in adipocytes, and stimulate lipolysis (21), in part by increasing the number of lipolytic beta-adrenergic receptors.

    Table 1. Summary of the Observed Effects of Testosterone on Body Composition

    • Effects on Fat-Free Compartment
      • Increase in fat-free and lean body mass (2–14)
      • Increase in bone mass (52)
      • Increase in nitrogen retention in castrated male mammals, eunuchoidal men, women, and prepubertal boys (25–28)
    • Changes in Muscle Histomorphology
      • Increase in cross-sectional areas of both types I and II skeletal muscle fibers (9)
      • Increase in the number of myonuclei (10)
      • Increase in the number of satellite cells (10)
    • Changes in Protein Dynamics
      • Increase in nonoxidative leucine disappearance rate (14)
      • Increase in fractional synthesis rates of mixed skeletal muscle protein (11–14)
      • No net increase in protein balance, although net protein balance becomes less negative in fasting state (15,16)
      • Decrease in protein degradation by the arteriovenous difference method (15)
      • Decrease in proteasome-mediated protein degradation (15)
    • Effects of Fat Compartment
      • Decrease in whole-body fat mass in hypogonadal men treated with replacement doses of testosterone (3–6)
      • Decrease in whole-body fat mass in eugonadal men with supraphysiological doses of testosterone and other androgens (7)
      • Decrease in intra-abdominal fat mass in middle-aged men with low normal testosterone levels (25,26)
      • Increased lipolysis (26)
      • Regulation of lipoprotein lipase activity (52,53)
      • Decreased triglyceride assimilation in abdominal fat compartment (26)
      • Inhibits preadipocyte to adipocyte differentiation (52)
    • Note: Numbers in parentheses are reference numbers.

    References

    • Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal Men. New England Journal of Medicine, 335(1), 1–7. [DOI:10.1056/nejm199607043350101]
    • Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., Dzekov, J., Bross, R., Phillips, J., Sinha-Hikim, I., Shen, R., & Storer, T. W. (2001). Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism, 281(6), E1172–E1181. [DOI:10.1152/ajpendo.2001.281.6.e1172]
    • Bhasin, S., Taylor, W. E., Singh, R., Artaza, J., Sinha-Hikim, I., Jasuja, R., Choi, H., & Gonzalez-Cadavid, N. F. (2003). The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 58(12), M1103–M1110. [DOI:10.1093/gerona/58.12.m1103]
    • Mauras, N., Hayes, V., Welch, S., Rini, A., Helgeson, K., Dokler, M., Veldhuis, J. D., & Urban, R. J. (1998). Testosterone Deficiency in Young Men: Marked Alterations in Whole Body Protein Kinetics, Strength, and Adiposity. The Journal of Clinical Endocrinology & Metabolism, 83(6), 1886–1892. [DOI:10.1210/jcem.83.6.4892]
    • Sinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A. B., Lee, M. I., Storer, T. W., Casaburi, R., Shen, R., & Bhasin, S. (2002). Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. American Journal of Physiology-Endocrinology and Metabolism, 283(1), E154–E164. [DOI:10.1152/ajpendo.00502.2001]
    \ No newline at end of file diff --git a/transfemscience.org/articles/estrogens-blood-clots/index.html b/transfemscience.org/articles/estrogens-blood-clots/index.html index ac7c098f..3d9afb56 100644 --- a/transfemscience.org/articles/estrogens-blood-clots/index.html +++ b/transfemscience.org/articles/estrogens-blood-clots/index.html @@ -1 +1 @@ -Estrogens and Their Influences on Coagulation and Risk of Blood Clots - Transfeminine Science Link

    Estrogens and Their Influences on Coagulation and Risk of Blood Clots

    By Aly | First published October 20, 2020 | Last modified March 28, 2023

    Abstract / TL;DR

    Estrogens increase coagulation by activating estrogen receptors in the liver and thereby modulating the production of a variety of circulating coagulation factors. With sufficiently high exposure, this can result in an increase in the risk of blood clots as well as coagulation-associated cardiovascular complications like heart attack and stroke. However, the degrees of risk vary depending on the estrogen type, route, and dose. Non-bioidentical estrogens like ethinylestradiol have greater strength in the liver due to their relative resistance to metabolism and increase blood clot risk more readily than bioidentical estradiol, while oral administration of estradiol results in a first pass through the liver and has greater impact on blood clot risk than non-oral estradiol. Physiological estradiol levels with non-oral estradiol appear to have minimal to no risk of blood clots, whereas oral estradiol has significant risk and at high doses may have risk similar to that of the doses of ethinylestradiol in modern birth control pills. Higher estradiol levels with non-oral estradiol seem to have significant risk of blood clots and cardiovascular problems as well, although the risks appear to be lower than with ethinylestradiol-containing birth control pills. Absolute risks of blood clots are low but accumulate with time and add up on a population scale. In addition, a variety of risk factors, such as age, physical inactivity, concomitant progestogen use, and often-unknown thrombophilic abnormalities, can substantially augment risk. Due to their higher risks of blood clots, oral estradiol as well as excessive doses of non-oral estradiol should ideally be avoided in transfeminine people. This is particularly applicable in those with risk factors for blood clots. In any case, therapeutic considerations for transfeminine people include not only safety but also effectiveness, other factors like cost and convenience, and the natures of the alternative therapeutic options.

    Introduction

    Estrogens increase coagulation (blood clotting) and the risk of thrombosis, a cardiovascular event otherwise known as a blood clot. There are two major types of blood clots, which are categorized depending on whether they happen in a vein or in an artery: (1) venous thrombosis or venous thromboembolism (VTE); and (2) arterial thrombosis. VTE is a blood clot in a vein, a blood vessel that carries blood towards the heart. It comprises two different subtypes: (1) deep vein thrombosis (DVT), a clot in a vein of the leg or pelvic region; and (2) pulmonary embolism (PE), a clot that has broken free and blocked an artery in the lungs. Arterial thrombosis is a blood clot in an artery, a blood vessel that carries blood away from the heart. Arterial thrombosis can lead to myocardial infarction (MI; also known as heart attack) or cerebrovascular accident (CVA; also known as stroke). Blood clots are major health problems that can cause serious complications and even death. Estrogens, via increased coagulation with sufficiently high exposure, have the potential to heighten the risk of both venous and arterial thrombosis and hence to increase all of the aforementioned risks. The risk of blood clots with estrogens serves as a limiting factor in their use due to the potential health consequences.

    Estrogens are selective agonists of the estrogen receptors (ERs). They are thought to increase coagulation and hence blood clot risk by activating ERs. However, the impact on coagulation and risk of blood clots with estrogens varies due to factors like estrogen type, route, and dose. In addition, other factors, like concomitant progestogen use and a variety of non-hormonal factors, are known to modify the risk. The purpose of this article is to review the risks of blood clots with estrogens, the mechanisms underlying increased coagulation and blood clot risk with estrogens, and the reasons for differences among estrogens in terms of risk. Exploring these topics can inform estrogen dosing considerations in transfeminine people and help to minimize risks and optimize safety. Moreover, higher levels of estrogens are therapeutically useful for suppressing testosterone production in transfeminine people but may increase blood clot risk, and risk–benefit analysis is warranted in this context.

    Blood Clot Risks with Estrogens and Progestogens

    A variety of estrogens have been used in medicine. These include bioidentical estrogens like estradiol as well as non-bioidentical estrogens like conjugated estrogens (CEEs; Premarin), ethinylestradiol (EE), and diethylstilbestrol (DES). Estradiol is the major natural estrogen in the human body. CEEs deliver primarily estradiol as the active estrogen, but also contain significant quantities of naturally occurring equine (horse) estrogens such as equilin (7-dehydroestrone) and 17β-dihydroequilin (7-dehydroestradiol). EE and DES are synthetic estrogens that were created by humans and do not occur naturally. DES was discontinued decades ago and is relatively little-known today, but has significant historical importance. Estradiol is used in both oral and non-oral forms (e.g., transdermal patches), while the non-bioidentical estrogens have typically been used orally. For context, the table below shows some approximate comparable doses of these estrogens in terms of general estrogenicity.

    Table 1: Approximate or estimated comparable doses of estrogens in terms of general/systemic estrogenicity (Aly, 2020; Kuhl, 2005; Table; Table; Table):

    Estrogen type/routeVery low dose aLow dose aModerate dose bHigh dose
    Oral estradiol1 mg/day2 mg/day4 mg/day8 mg/day
    Transdermal estradiolc25 μg/day50 μg/day100 μg/day200 μg/day
    Oral conjugated estrogens0.625 mg/day1.25 mg/day2.5 mg/day5 mg/day
    Oral ethinylestradiol7.5 μg/day15 μg/day30 μg/day60 μg/day
    Oral diethylstilbestrol0.375 mg/day0.75 mg/day1.5 mg/day3 mg/day
    Comparable estradiol level~25 pg/mL~50 pg/mL~100 pg/mL~200 pg/mL

    a Menopausal replacement dosages. b Similar to normal mean/integrated estrogenic exposure during the menstrual cycle in premenopausal women (Aly, 2018). c Specifically transdermal patches.

    Estrogens were first associated with blood clots and associated cardiovascular complications in the 1960s and 1970s. Significant to substantial increases in these risks were found in clinical trials of high-dose DES (5 mg/day) for prostate cancer in men (VACURG, 1967; Byar, 1973; Turo et al., 2014), trials of moderate-dose CEEs (2.5–5 mg/day) for prevention of heart disease in men (Coronary Drug Project Research Group, 1970; Coronary Drug Project Research Group, 1973; Luria, 1989; Sudhir & Komesaroff, 1999; Dutra et al., 2019), and studies of early high-dose EE-containing birth control pills (50–150 μg/day) in premenopausal women (Gerstman et al., 1991; PCASRM, 2017; Table). The increase in cardiovascular events with DES in men with prostate cancer was sufficiently great that it actually cancelled out the benefits of its effects against prostate cancer in terms of overall mortality. The large increases in blood clots and cardiovascular problems seen in these studies resulted in alarm and concern about the safety of estrogens. Consequent to these events, estrogen doses were lowered. DES for prostate cancer was decreased to 1 to 3 mg/day and EE in birth control pills was decreased to 20 to 35 μg/day. Estrogens were also reduced to lower doses for other indications, such as menopausal hormone therapy. The dose reductions helped to lower the risks, although it did not eliminate them.

    In the Women’s Health Initiative (WHI) randomized controlled trials (RCTs), low-dose oral CEEs alone (0.625 mg/day) were shown to slightly increase the risk of blood clots (Anderson et al., 2004; Curb et al., 2006; Prentice & Anderson, 2008; Prentice, 2014; Table). In addition, the increase was considerably augmented by concomitant use of a low dose (2.5 mg/day) of the progestogen medroxyprogesterone acetate (MPA) (Rossouw et al., 2002; Cushman et al., 2004; Prentice & Anderson, 2008; Prentice, 2014; Table). Increased risk of blood clots with low-dose oral CEEs plus low-dose MPA was also shown in another large RCT, the Heart and Estrogen/Progestin Replacement Study (HERS) (Hulley et al., 1998; Grady et al., 2000). Other progestogens besides MPA are also associated with augmentation of blood clot risk related to oral estrogens (Rovinski et al., 2018; Scarabin, 2018; Oliver-Williams et al., 2019; Vinogradova, Coupland, & Hippisley-Cox, 2019; Table). Large observational studies have found low-dose oral estradiol (generally ≤2 mg/day) to be dose-dependently associated with increased risk of blood clots similarly to CEEs (Olié, Canonico, & Scarabin, 2010; Renoux, Dell’Aniello, & Suissa, 2010; Vinogradova, Coupland, & Hippisley-Cox, 2019; Konkle & Sood, 2019; Table). However, the risk with oral estradiol or with oral esterified estrogens (a CEEs-like preparation with reduced equine estrogen content) appears to be lower than with oral CEEs (Smith et al., 2004; Smith et al., 2014; Vinogradova, Coupland, & Hippisley-Cox, 2019; Table). On the other hand, in another large observational study, oral estradiol and oral CEEs both in combination with progestogens appeared to show similarly increased risk of blood clots (Roach et al., 2013). As with oral CEEs, progestogens appear to augment the blood clot risk with oral estradiol (Vinogradova, Coupland, & Hippisley-Cox, 2019; Table).

    In contrast to oral estrogens, transdermal estradiol at low to moderate doses (50–100 μg/day) has generally not been associated with increased coagulation nor with increased risk of blood clots or associated cardiovascular complications (Canonico et al., 2008; Hemelaar et al., 2008; Olié, Canonico, & Scarabin, 2010; Renoux, Dell’Aniello, & Suissa, 2010; Mohammed et al., 2015; Stuenkel et al., 2015; Bezwada, Shaikh, & Misra, 2017; Rovinski et al., 2018; Scarabin, 2018; Konkle & Sood, 2019; Oliver-Williams et al., 2019; Vinogradova, Coupland, & Hippisley-Cox, 2019; Abou-Ismail, Sridhar, & Nayak, 2020; Table). Similarly, the Menopause, Estrogen and Venous Events (MEVE) study found that oral estradiol was associated with a large increase in risk of blood clots in women with previous history of blood clots whereas transdermal estradiol (mean dose 50 μg/day) was associated with no risk increase (Olié et al., 2011). However, there are some exceptions on findings of transdermal estradiol and cardiovascular risks, for instance one observational study finding an increased risk of stroke with higher-dose (>50 μg/day) transdermal estradiol patches in menopausal women (Renoux et al., 2010; Oliver-Williams et al., 2019) and studies finding only small differences or no difference in coagulation between oral estradiol and transdermal estradiol in transfeminine people (Lim et al., 2020; Scheres et al., 2021). Studies are mixed on whether the combination of transdermal estradiol at menopausal doses with progestogens is associated with greater blood clot risk, with some finding no change and others finding increased risk (Rovinski et al., 2018; Scarabin, 2018; Vinogradova, Coupland, & Hippisley-Cox, 2019). It has been suggested that this may be related to the type of progestogen used (Scarabin, 2018).

    There is little quality clinical data at this time on the risk of blood clots with higher doses of oral or transdermal estradiol than those used in menopausal hormone therapy. In any case, risk of blood clots has been assessed limitedly in transfeminine hormone therapy with regimens containing oral estradiol (e.g., 2–8 mg/day) generally in combination with other agents (antiandrogens and/or progestogens). In these studies, blood clot risk has been reported to be increased to a greater extent than with the low doses of oral estradiol used in menopausal hormone therapy (Wierckx et al., 2013; Weinand & Safer, 2015; Arnold et al., 2016; Getahun et al., 2018; Irwig, 2018; Connelly et al., 2019; Connors & Middeldorp, 2019; Goldstein et al., 2019; Iwamoto et al., 2019; Khan et al., 2019; Konkle & Sood, 2019; Quinton, 2019; Swee, Javaid, & Quinton, 2019; Abou-Ismail, Sridhar, & Nayak, 2020).

    Whereas the WHI demonstrated causation for oral CEEs alone in terms of blood clot risk, no adequately powered RCTs have been conducted with oral or transdermal estradiol alone to establish causation in terms of blood clot risk at this time. Only very large and expensive trials would be able to show this due to the rarity of blood clots, and these studies have not been conducted to date. For similar reasons, RCTs demonstrating increased risk of blood clots with EE-containing birth control pills have also not been conducted at this time (Moores, Bilello, & Murin, 2004). In any case, causation has clearly been demonstrated with estrogens in other contexts, and this can be assumed as likely in the case of oral estradiol similarly. In addition, the Estrogen in Venous Thromboembolism Trial (EVTET), an RCT of low-dose (2 mg/day) oral estradiol plus the progestogen norethisterone acetate (NETA) versus placebo in postmenopausal women with history of previous blood clots, found that this hormone therapy regimen significantly increased coagulation and the incidence of blood clots (10.7% incidence with hormone therapy and 2.3% with placebo; P = 0.04) (Høibraaten et al., 2000; Høibraaten et al., 2001).

    Estradiol levels appear to not be associated with blood clot risk in premenopausal women (Holmegard et al., 2014). The fact that transdermal estradiol patches at 100 μg/day in menopausal women haven’t been associated with a greater risk of blood clots is notable as this dose achieves estradiol levels of around 100 pg/mL on average, which are similar to the mean integrated levels of estradiol during the normal menstrual cycle in premenopausal women (Aly, 2018; Wiki). Rates of blood clots are also similar between men—who have relatively low estradiol levels—and women after controlling for atypical hormonal states like pregnancy and use of birth control pills in women (Moores, Bilello, & Murin, 2004; Rosendaal, 2005; Montagnana et al., 2010; Roach et al., 2013). Interestingly however, men have a consistently higher incidence of recurrent blood clots than women (Roach et al., 2013). These findings suggest that physiological levels of estradiol and progesterone in premenopausal women may not meaningfully increase coagulation or blood clot risk. However, the available data are mixed, with some studies suggesting that estradiol and/or progesterone levels within physiological ranges may indeed influence coagulation (Chaireti et al., 2013) and blood clot risk in premenopausal and/or perimenopausal women (Simon et al., 2006; Canonico et al., 2014; Scheres et al., 2019).

    Modern combined birth control pills contain EE at moderately estrogenic doses (20–35 μg/day) and a physiological dose of a progestogen. They increase the risk of blood clots by several-fold (Konkle & Sood, 2019; Vinogradova, Coupland, & Hippisley-Cox, 2015; Table). In addition, they are associated with about a 1.5- to 2-fold increase in risk of heart attack and stroke (Lidegaard, 2014; Konkle & Sood, 2019). However, overall mortality is not increased with birth control pills—at least in the relatively young women in whom they are used (Hannaford et al., 2010). Per studies of menopausal hormone therapy, it is likely that the progestogen in EE-containing birth control pills augments the risk of blood clots with EE. Early high-dose birth control pills (50–100 μg/day) had as much as twice the risk of blood clots of modern birth control pills (Gerstman et al., 1991; PCASRM, 2017; Table). In contrast to the different blood clot risks between oral and transdermal estradiol, non-oral birth control forms containing EE, for instance transdermal birth control patches and vaginal birth control rings, are associated with similar increases in blood clot risk as EE-containing birth control pills (Plu-Bureau et al., 2013; PCASRM, 2017; Konkle & Sood, 2019; Abou-Ismail, Sridhar, & Nayak, 2020). Hence, unlike with estradiol, route of administration does not appear to modify blood clot risk with EE based on available data.

    High-dose estrogen therapy using oral synthetic estrogens like DES and EE in people with breast or prostate cancer has been found to strongly increase the risk of blood clots and associated cardiovascular complications (Phillips et al., 2014; Turo et al., 2014; Coelingh Bennink et al., 2017). This has also been the case with estramustine phosphate (EMP; estradiol normustine phosphate), an estradiol ester that is used at massive doses in prostate cancer (e.g., 140–1,400 mg/day orally) and that results in pregnancy levels of estradiol (Kitamura, 2001 [Graph]; Ravery et al., 2011). In the 1980s however, it was found that high-dose non-oral estradiol did not have the same cardiovascular risks as high-dose estrogen therapy with oral synthetic estrogens or EMP (von Schoultz et al., 1989; Ockrim & Abel, 2009). This included studies with polyestradiol phosphate (PEP), a long-lasting injectable prodrug of estradiol, and with high-dose transdermal estradiol gel (von Schoultz et al., 1989; Aly, 2019). However, subsequent larger and higher-quality studies found that although the cardiovascular risks with PEP were much lower than with high-dose oral synthetic estrogen therapy, they were nonetheless still increased (Hedlung et al., 2008; Ockrim & Abel, 2009; Hedlund et al., 2011; Sam, 2020). This includes an approximate 2-fold increase in the risk of blood clots with estradiol levels in the range of roughly 300 to 500 pg/mL (Sam, 2020). Studies using high-dose transdermal estradiol patches have not found significantly increased cardiovascular complications as of present (Langley et al., 2013; Sam, 2020). However, these studies have been relatively underpowered, which limits their interpretation. In any case, increased coagulation has been observed with high-dose transdermal estradiol patches (achieving estradiol levels of 350 to 500 pg/mL) (Bland et al., 2005) similarly to PEP (Mikkola et al., 1999). More data on the risk of blood clots and cardiovascular issues with high-dose transdermal estradiol patches should come in the future with PATCH and STAMPEDE—two large-scale clinical studies in the United Kingdom that are evaluating this form of estradiol for prostate cancer (Gilbert et al., 2018; Singla, Ghandour, & Raj, 2019).

    Injections of short-acting estradiol esters like estradiol valerate and estradiol cypionate are notable in that they are often used by transfeminine people and are generally used at doses that achieve high estradiol levels. As with high-dose transdermal estradiol patches, little to no quality data on the risk of blood clots exists for these preparations at present. Pyra and colleagues found that the risk of blood clots with injectable estradiol valerate in transfeminine people was increased by around 2-fold, but the confidence intervals were very wide and statistical significance was not reached (Pyra et al., 2020). The doses used in the whole population for the study were not provided, but in the actual VTE cases, the doses of injectable estradiol valerate were described and ranged from 4 to 20 mg once per week and 10 to 40 mg once every 2 weeks (Pyra et al., 2020). Studies have also assessed and found increased coagulation with high doses of estradiol valerate by injection in the range of 10 to 40 mg once every 2 weeks in men with prostate cancer (Kohli & McClellan, 2001; Kohli et al., 2004; Kohli, 2005). Increased coagulation has additionally been observed with the combination of 5 mg estradiol valerate and a progestogen once per month as a combined injectable contraceptive in premenopausal women (Meng et al., 1990; UN/WHO et al., 2003). It is unclear whether the high peaks in estradiol levels associated with short-acting injectable forms of estradiol are harmful in terms of coagulation and blood clot risk (Hembree et al., 2017). However, the increased risk of polycythemia with short-acting injectable testosterone esters relative to other non-oral forms of testosterone (Ohlander, Varghese, & Pastuszak, 2018) is indirectly suggestive that this could be the case. Accordingly, a study found increased coagulation in premenopausal women with a combined injectable contraceptive containing estradiol valerate but not with one employing the more prolonged and stable estradiol cypionate at the same dose (UN/WHO et al., 2003).

    Selective estrogen receptor modulators (SERMs) such as tamoxifen (Nolvadex) and raloxifene (Evista) increase the risk of blood clots similarly to estrogens (Park & Jordan, 2002; Fabian & Kimler, 2005). The risk appears to be elevated a few-fold similarly to what might be expected with moderate doses of oral estradiol or CEEs (Deitcher & Gomes, 2004; Iqbal et al., 2012; Konkle & Sood, 2019).

    Pregnancy is a time when estradiol and progesterone levels increase to extremely high concentrations (Graphs). Estradiol levels increase progressively throughout pregnancy to around 2,000 pg/mL on average at the end of the first trimester, to about 10,000 pg/mL on average at the end of the second trimester, and to around 20,000 pg/mL on average at the end of the third trimester (Kerlan et al., 1994 [Graph]; Schock et al., 2016). Coagulation is greatly increased during pregnancy, and the risk of blood clots is likewise strongly increased (Heit et al., 2000; Abdul Sultan et al., 2015; Heit, Spencer, & White, 2016; Table). Estradiol and progesterone levels are strongly correlated with the increases in coagulation during pregnancy (Bagot et al., 2019). The risk of blood clots with modern birth control pills is similar to that with pregnancy as a whole (Heit, Spencer, & White, 2016), while the increases in risk of blood clots with early high-dose EE-containing birth control pills and with high-dose oral synthetic estrogen therapy for breast and prostate cancer are comparable to the risk increase during late pregnancy. Estradiol levels also increase to very high concentrations during ovarian stimulation for in-vitro fertilization in premenopausal women, and this has been associated with increased coagulation and risk of blood clots as well (Westerlund et al., 2012; Rova, Passmark, & Lindqvist, 2012; Kasum et al., 2014).

    Due to their greater risks of cardiovascular problems as well as other concerns, DES has been virtually abandoned while EE has been discontinued for almost all indications except birth control. EE continues to be used in birth control because it is resistant to metabolism in the uterus and controls menstrual bleeding better than oral estradiol does (Stanczyk, Archer, & Bhavnani, 2013). CEEs are also being increasingly superseded by estradiol in medicine, although significant use of CEEs for hormone therapy in cisgender women continues. Transdermal estradiol is gaining momentum over oral estradiol in menopausal hormone therapy as well. Major transgender hormone therapy guidelines (see also Aly, 2020) recommend against the use of EE and CEEs in transfeminine people due to their greater risks and the inability to accurately monitor blood estrogen levels with these preparations (Coleman et al., 2012; Deutsch, 2016; Hembree et al., 2017). Estradiol is the estrogen that is almost exclusively used in transfeminine people today. Besides estrogen type, it has been recommended that transdermal estradiol be used instead of oral estradiol in transfeminine people who are over 40 or 45 years of age or are otherwise at risk for blood clots (Deutsch, 2016; Iwamoto et al., 2019; Glintborg et al., 2021). Menopausal hormone therapy guidelines similarly recommend the use of transdermal estradiol over oral estrogens in cisgender women who are at higher risk for blood clots (e.g., Stuenkel et al., 2015).

    As previously described, progestogens appear to augment the risk of blood clots with oral estrogens. Conversely, findings on the combination of non-oral estradiol and progestogens are mixed—with some studies finding increased risk and others finding no additional risk (Rovinski et al., 2018; Scarabin, 2018; Vinogradova, Coupland, & Hippisley-Cox, 2019). Progestogens by themselves do not usually increase coagulation (Kuhl, 1996; Schindler, 2003; Wiegratz & Kuhl, 2006; Sitruk-Ware & Nath, 2011; Sitruk-Ware & Nath, 2013; Skouby & Sidelmann, 2018) or blood clot risk (Blanco-Molina et al., 2012; Mantha et al., 2012; Tepper et al., 2016; Rott, 2019). However, depot MPA alone at birth control doses has uniquely been associated with a few-fold increase in blood clot risk (van Hylckama Vlieg, Helmerhorst, & Rosendaal, 2010; DeLoughery, 2011; Blanco-Molina et al., 2012; Gourdy et al., 2012; Mantha et al., 2012; Rott, 2019; Tepper et al., 2019). The reasons for this are unknown, but might relate to high peak MPA levels with depot injectables (Mantha et al., 2012) or the weak glucocorticoid activity of MPA (Kuhl & Stevenson, 2006; Sitruk-Ware & Nath, 2011). Besides physiological-dose MPA alone, high-dose progestogen therapy with MPA, megestrol acetate (MGA), and cyproterone acetate (CPA) has been associated with increased coagulation and blood clot risk (Schröder & Radlmaier, 2002; Schindler, 2003; Seaman et al., 2007; Garcia et al., 2013; Taylor & Pendleton, 2016). However, this was not the case with chlormadinone acetate (CMA) in a small study in women with prior history of blood clots (Conard et al., 2004). Risk of blood clots may also be increased for CPA in combination with estrogen in transfeminine people (Patel et al., 2022). In contrast to progestins, addition of oral progesterone to estrogen therapy is not associated with augmentation of blood clot risk (Scarabin, 2018; Oliver-Williams et al., 2019; Kaemmle et al., 2022). However, this may simply be due to the fact that oral progesterone produces low progesterone levels and has relatively weak progestogenic effects (Aly, 2018). Non-oral and fully potent progesterone has yet to be properly studied and hence its risk profile remains unknown (Aly, 2018).

    In a historically notable study conducted by the Center of Expertise on Gender Dysphoria (CEGD) at the Vrije Universiteit Medical Center (VUMC) in Amsterdam, the Netherlands in the 1980s, it was reported that the risk of blood clots with high-dose EE and CPA in transfeminine people was increased by 45-fold relative to the expected incidence in the general population (Asscheman, Gooren, & Eklund, 1989; Asscheman et al., 2014). Mortality also appeared to be elevated and other health risks were increased as well (Asscheman, Gooren, & Eklund, 1989; Gooren & T’Sjoen, 2018). A subsequent study in transfeminine people by the CEGD confirmed strongly increased coagulation with EE but much lower increases with oral or transdermal estradiol (Toorians et al., 2003). Upon the CEGD switching transfeminine people from high-dose EE to physiological doses of oral or transdermal estradiol (also usually in combination with CPA), the risks decreased considerably (van Kesteren et al., 1997; Asscheman et al., 2011; Asscheman et al., 2014). These findings were of major importance in the replacement of EE with estradiol in transfeminine hormone therapy, and have surely contributed significantly to apprehension about the use of high doses of estrogens in transfeminine people.

    Taken together, estrogens of all kinds have been shown to dose-dependently increase or be associated with increased risk of blood clots. These findings suggest that, provided of course sufficient exposure occurs, increased coagulation and blood clot risk are common properties of estrogens. However, synthetic and non-bioidentical estrogens have greater risk of blood clots than estradiol, and oral estradiol shows greater risk than non-oral estradiol. In fact, physiological estradiol levels in women and low to moderate doses of transdermal estradiol may have no significant risk of blood clots at all. Nonetheless, non-oral estradiol with sufficiently high exposure can increase blood clot risk just the same as other forms of estrogen. Concomitant therapy with progestogens appears to augment the risk of blood clots with estrogens and high doses may particularly amplify the risk.

    Risks with Different Hormonal Exposures

    The table below provides relative risk increases for blood clots with different types, routes, and doses of estrogens, as well as with SERMs, pregnancy, and high-dose CPA. It shows the greater risks of blood clots with (1) oral estradiol relative to non-oral estradiol; (2) estradiol compared to non-bioidentical estrogens; and (3) lower estrogen levels/doses relative to higher estrogen levels/doses.

    Table 2: Relative risks of blood clots with different hormonal exposures (see also Machin & Ragni, 2020):

    EstrogenBlood clot riskSource
    Oral E2 ≤1 mg/day1.2×Vinogradova et al. (2019) [Table]
    Oral E2 >1 mg/daya1.4×Vinogradova et al. (2019) [Table]
    Oral E2 ≤1 or >1 mg/daya + Pb1.4–1.8×Vinogradova et al. (2019) [Table]
    Transdermal E2 ≤50 μg/day0.9×Vinogradova et al. (2019) [Table]
    Transdermal E2 >50 μg/daya1.1×Vinogradova et al. (2019) [Table]
    Oral CEEs ≤0.625 mg/day1.4×Vinogradova et al. (2019) [Table]
    Oral CEEs >0.625 mg/daya1.7×Vinogradova et al. (2019) [Table]
    Oral CEEs ≤ or >0.625 mg/daya + Pb1.5–2.4×Vinogradova et al. (2019) [Table]
    Modern EE + P birth controlc4.2×Heit, Spencer, & White (2016)
    High-dose EE + P birth controlc4–10×dTchaikovski, Tans, & Rosing (2006);
    PCASRM (2017) [Table]
    High-dose PEP injectionse2.1×Sam (2020)
    High-dose oral DES, EE, or EMP5.7–10×Seaman et al. (2007); Ravery et al.
    (2011)    ; Klil-Drori et al. (2015)
    SERMs (tamoxifen, raloxifene)~1.5–3×Deitcher & Gomes (2004); Iqbal et al.
    (2012)    ; Konkle & Sood (2019)
    Pregnancy (overall)f4.0×Heit, Spencer, & White (2016)
    Pregnancy (3rd trimester)5.1–7.1×Abdul Sultan et al. (2015) [Table]
    High-dose CPA alone3–5×Seaman et al. (2007)

    Footnotes: a At typical menopausal replacement doses (i.e., not very high—probably no more than double the given dose). b MPA, norethisterone, norgestrel, or drospirenone. c Modern EE + P birth control contains 20–35 μg/day EE, while high-dose EE + P birth control used in the 1960s and 1970s contained 50–150 μg/day EE. d Risk around twice as high as modern birth control pills. e Unpublished original research/analysis with borderline statistical significance (95% CI 0.99–4.22). f Excluding the postpartum period. With the postpartum period included, the risk of blood clots with pregnancy is 5–10× (McLintock, 2014). Abbreviations: E2 = Estradiol; CEEs = Conjugated estrogens; EE = Ethinylestradiol; DES = Diethylstilbestrol; EMP = Estramustine phosphate; PEP = Polyestradiol phosphate; SERMs = Selective estrogen receptor modulators; CPA = Cyproterone acetate; P = Progestogen.

    Note that the values in the table are associations mostly from observational studies rather than from RCTs. Hence, in many cases, causation has not been definitively established. In addition, the values represent rough average values with often wide 95% confidence intervals. As a result, precision and accuracy of the estimates may in some cases be low. Also note that quantified blood clot risk will vary depending on the study and its definitions and methodology (including factors like sampling error, approach to control of confounding variables, and residual confounding influences).

    Mechanisms of Increased Coagulation with Estrogens

    The ERs are expressed in the liver and estrogens exert effects in this part of the body through these receptors (Eisenfeld & Aten, 1979; Eisenfeld & Aten, 1987; Sahlin & von Schoultz, 1999; Grossmann et al., 2019). Estrogens are thought to increase the risk of blood clots by activating liver ERs and thereby modulating the hepatic production of numerous different coagulation factors, both procoagulant and anticoagulant (Kuhl, 2005; Tchaikovski & Rosing, 2010; DeLoughery, 2011; Konkle & Sood, 2019). Most coagulation factors and their inhibitors are synthesized in the liver (Mammen, 1992; Amitrano et al., 2002; Peck-Radosavljevic, 2007). Following their synthesis, these coagulation factors are secreted by the liver into the bloodstream where they circulate and mediate their actions. Circulating levels of procoagulant factors like fibrinogen (factor I), prothrombin (factor II), factors VII, VIII, and X, anticoagulant factors like antithrombin, protein C, protein S, and tissue factor pathway inhibitor (TFPI), and fibrinolytic factors like plasminogen, tissue plasminogen activator (t-PA), and plasminogen activator inhibitor-1 (PAI-1), are all influenced by estrogens (Hemelaar et al., 2008; Doxufils, Morimont, & Bouvy, 2020). These estrogen-mediated changes in levels result in an overall procoagulatory effect, as assessed by markers of net coagulation activation like prothrombin fragment 1+2 (F1+2), D-dimer, and thrombin–antithrombin complex (TAT), as well as global coagulation assays like the endogenous thrombin potential-based activated protein C resistance test (The Oral Contraceptive and Hemostasis Study Group, 1999; Kohli, 2006; Hemelaar et al., 2008; Douxfils et al., 2020; Douxfils, Morimont, & Bouvy, 2020). The changes in levels of most coagulation factors caused by estrogens are relatively small and levels often remain within normal ranges. However, they combine and synergize to produce larger increases in global coagulation and clot risk (Douxfils et al., 2020; Douxfils, Morimont, & Bouvy, 2020; Reda et al., 2020).

    Aside from coagulation factors, estrogens also modulate the synthesis of numerous other liver products (Kuhl, 1999; Kuhl, 2005; Table). Examples include sex hormone-binding globulin (SHBG), corticosteroid-binding globulin (CBG), various other circulating binding proteins, angiotensinogen, lipoproteins, and triglycerides, among others. In accordance with the mechanisms underlying increased coagulation and blood clot risk with estrogens, the differences in risk of blood clots with different types and routes of estrogens are mirrored in their influences on estrogen-sensitive liver products. Put another way, different estrogens have different relative potency in the liver when compared to their estrogenic potency elsewhere in the body. Synthetic and non-bioidentical estrogens have greater impact on liver synthesis than estradiol, while oral administration of estradiol has greater influence on liver synthesis than non-oral routes like transdermal administration or intramuscular injection, and this is likely to explain the observed differences in coagulation and blood clot risk with these different estrogens. The table below shows the liver potency of different estrogenic exposures as measured by influence specifically on SHBG levels, one of the most sensitive and well-characterized estrogen-modulated liver products.

    Table 3: Relative increases in SHBG levels with different estrogenic exposures (see also Aly, 2020):

    EstrogenSHBG increaseSource
    E2 patch 50 μg/day1.1×Kuhl (2005)
    E2 patch 100 μg/day1.2×Shifren et al. (2008)
    Oral E2 1 mg/day1.6×Kuhl (1998)
    Oral E2 2 mg/day2.2×Kuhl (1998)
    Oral E2 4 mg/day1.9–3.2×Fåhraeus & Larsson-Cohn (1982); Gibney
    et al. (2005)    ; Ropponen et al. (2005)
    Oral EV 6 mg/day (~4.5 mg/day E2)a2.5–3.0×Dittrich et al. (2005); Mueller et al. (2005);
    Mueller et al. (2006)
    Oral CEEs 0.625 mg/day1.8×Kuhl (1998)
    Oral CEEs 1.25 mg/day2.2×Kuhl (1998)
    Oral EE 5 μg/day2.0×Kuhl (1999)
    Oral EE 10 μg/day3.0×Kuhl (1998)
    Oral EE 20 μg/day3.4×Kuhl (1998)
    Oral EE 50 μg/day4.0×Kuhl (1997)
    Modern EE + P birth controlb~3.0–4.0×Odlind et al. (2002)
    High-dose EE + P birth controlb~5–10×Hammond (2017)
    E2 patches 200 μg/day~1.5×Smith et al. (2020)
    E2 patches 300 μg/day~1.7×Smith et al. (2020)
    E2 patches 600 μg/day~2.3×Bland et al. (2005)
    High-dose E2 injectionsc1.7–3.2×Stege et al. (1988); Kronawitter et al.
    (2009)     [Table]; Mueller et al. (2011);
    Nelson et al. (2016)
    High-dose oral DES, EE, or EMP~5–10×von Schoultz et al. (1989)
    Pregnancy~5–10×Hammond (2017)

    Footnotes: a Due to differences in molecular weight, estradiol valerate has about 75% of the amount of estradiol as regular estradiol. Hence, 6 mg/day estradiol valerate is approximately equivalent to 4.5 mg/day estradiol. b Modern EE + P birth control contains 20–35 μg/day EE, while high-dose EE + P birth control used in the 1960s and 1970s contained 50–150 μg/day EE. c In the form of 320 mg/month PEP (~700 pg/mL estradiol), 100 mg/month estradiol undecylate (~500–600 pg/mL estradiol), or 10 mg/10 days estradiol valerate (~500–1,200 pg/mL peak estradiol; Graphs). Abbreviations: E2 = Estradiol; EV = Estradiol valerate; CEEs = Conjugated estrogens; EE = Ethinylestradiol; DES = Diethylstilbestrol; EMP = Estramustine phosphate; PEP = Polyestradiol phosphate; P = Progestogen.

    The increase in SHBG levels with estrogen therapy correlates with increases in coagulation and blood clot risk and can serve as a reliable surrogate indicator of these effects (Odlind et al., 2002; van Rooijen et al., 2004; van Vliet et al., 2005; Tchaikovski & Rosing, 2010; Raps et al., 2012; Stegeman et al., 2013; Hugon-Rodin et al., 2017; Eilertsen et al., 2019). The increases in SHBG levels and blood clot risk even appear quite similar to each other with modern birth control pills (both ~4-fold), high-dose oral synthetic estrogen therapy (both ~5–10-fold), and late pregnancy (both ~5–10-fold). When data on blood clot risk with a given estrogen route or dose are limited or unavailable—for instance with high-dose oral estradiol or high-dose estradiol ester injections—changes in SHBG levels can be used as a rough proxy or surrogate instead to estimate overall liver impact, magnitude of change in coagulation systems, and blood clot risk. It should be noted however that progestogens may augment the blood clot risk with estrogens without necessarily affecting SHBG levels or even while decreasing SHBG levels via concomitant androgenic activity (Kuhl, 2005; Vinogradova, Coupland, & Hippisley-Cox, 2019).

    Physiological levels of estradiol appear to have relatively minimal influence on liver synthesis (Eisenfeld & Aten, 1979; Lax, 1987; Kuhl, 2005). This is in accordance with the limited influence or non-influence of physiological estradiol levels in women on blood clot risk. It is thought that under normal physiological circumstances, estradiol is only supposed to considerably affect liver synthesis at very high levels—namely during pregnancy. The changes in synthesis of liver products during pregnancy presumably have important biological roles at this time (Eisenfeld & Aten, 1979). One of these is considered to be increased coagulation, as coagulation limits blood loss with childbirth and hence has survival benefits. Conversely, there is no obvious benefit to increased coagulation outside of pregnancy.

    Estradiol and the Liver First Pass with Oral Administration

    The oral route of administration is subject to a first pass through the liver via the hepatic portal vein which is not present with non-oral routes of administration (Pond & Tozer, 1984; Back & Rogers, 1987). As such, oral estradiol is subject to a hepatic first pass while this does not occur with non-oral forms of estradiol such as transdermal estradiol and injectable estradiol (Kuhl, 1998; Kuhl, 2005). This first pass results in disproportionate exposure of the liver to estradiol as well as disproportionate estrogenic impact on liver protein synthesis (Kuhl, 2005). Oral estradiol likewise has disproportionate estrogenic impact on the hepatic synthesis of coagulation factors (Kuhl, 1998; Kuhl, 2005). Due to the first pass, it is estimated that there is a 4- or 5-fold greater estrogenic impact of oral estradiol in the liver relative to non-oral estradiol (Kuhl, 2005). Due to the absence of the hepatic first pass with most non-oral routes, there is strong biological plausibility for the lower risk of blood clots that has been found with transdermal estradiol in comparison to oral estradiol in observational studies (Baber et al., 2016).

    Figure 1: Diagrammatic representation of increased coagulation via the liver first pass with oral estrogen therapy (Scarabin et al., 2020). Abbreviations: E = estrogen; trans = transdermal; AT = antithrombin; PS = protein S; TFPI = tissue factor protein inhibitor; II = prothrombin; VII = factor VII; PC = protein C; V = factor V; VTE = venous thromboembolism; CHD = coronary heart disease. Other terms: activated protein C resistance (APCR).

    Although oral estradiol has a much higher relative potential for blood clots due to the liver first pass, sufficiently high levels of estradiol will diffuse into the liver from the blood to act on this tissue regardless of route of administration. Hence, high levels of estradiol via non-oral routes (or produced by the body itself) can increase coagulation and blood clot risk similarly to the oral route. This is clearly evidenced by hyperestrogenic situations like pregnancy and ovarian stimulation for in-vitro fertilization, when estradiol levels increase to very high concentrations and substantially influence liver protein synthesis.

    Non-Bioidentical Estrogens and Resistance to Liver Metabolism

    Non-bioidentical estrogens such as EE, DES, and CEEs have greater impact on liver protein synthesis and risk of blood clots than either oral estradiol or non-oral estradiol (Kuhl, 1998; Kuhl, 2005; Phillips et al., 2014; Turo et al., 2014; Table). This is because the liver strongly metabolizes and inactivates estradiol, whereas non-bioidentical estrogens have differences in their chemical structures relative to estradiol that result in them being much more resistant to liver metabolism (Kuhl, 1998; Kuhl, 2005; Connors & Middeldorp, 2019; Swee, Javaid, & Quinton, 2019).

    EE can be considered as a case example. The oral bioavailability of EE is around 45%, while that of estradiol is only about 5% (Kuhl, 2005; Stanczyk, Archer, & Bhavnani, 2013). In addition, the blood half-life of EE is in the range of 5 to 30 hours, compared to less than 1 hour in the case of estradiol (White et al., 1998; Kuhl, 2005; Stanczyk, Archer, & Bhavnani, 2013). As a result of these and other differences, EE is approximately 120 times as potent as estradiol by weight in terms of general estrogenic effect (Kuhl, 2005; Table). Hence, EE is used clinically in μg doses whereas oral estradiol is used at over 100-fold higher mg doses. The pharmacokinetic differences between EE and estradiol reflect the strong resistance of EE to liver metabolism (Kuhl, 2005). EE, or 17α-ethynylestradiol, shows resistance to liver metabolism because of an ethynyl group at the C17α position which has been added to what is the otherwise unchanged structure of estradiol (Kuhl, 2005). This modification results in steric hindrance which blocks 17β-hydroxysteroid dehydrogenases (17β-HSDs) as well as conjugating enzymes like sulfotransferases and glucuronosyltransferases from metabolizing EE at the C17β hydroxyl group. 17β-HSDs normally convert estradiol into the weakly active estrone while the conjugating enzymes convert estradiol into inactive C17β estrogen sulfate and glucuronide conjugates like estrone sulfate (Kuhl, 2005). An “ethinylestrone” metabolite is in fact a structural impossibility due to the requirement of a double bond for a C17 ketone group—the needed C17α position is already occupied in EE by its ethynyl group. As such, the metabolism of estradiol into weakly active or inactive metabolites like estrone and estrone sulfate in the liver is protective against activation of hepatic ERs and procoagulation, and the lack of this with EE is responsible for its greater blood clot risk (Kuhl, 2005; Russell et al., 2017).

    Figure 2: Chemical structures of selected estrogens. The C17 position in the case of the steroidal estrogens (E2, E1, and EE) is at the top right of the steroid nucleus.

    Due to the marked resistance of EE to hepatic metabolism and inactivation, it persists for a long time in the liver—often cycling through it many times before finally being broken down. Moreover, EE shows several-fold disproportionate impact on liver protein synthesis at otherwise equivalent doses relative to oral estradiol (Kuhl, 2005; Table). Consequently, whereas EE has around 120-fold the general potency of oral estradiol, the liver potency of EE is around 350 to 1,500 times greater than that of oral estradiol (von Schoultz et al., 1989; Kuhl, 2005). A dose of EE of as little as 1 μg/day has been shown to impact liver metabolism (Speroff et al., 1996; Trémollieres, 2012). In addition, the fact that EE shows similar hepatic impact and risk of blood clots regardless of whether it is administered orally, transdermally, or vaginally indicates that unlike oral estradiol, the first pass through the liver with oral administration is not necessary for blood clot risk with EE (Plu-Bureau et al., 2013; PCASRM, 2017; Konkle & Sood, 2019). EE is so resistant to metabolism that it does not seem to matter how it is administered—the liver impact is substantial regardless of route. The greatly increased liver potency of EE results in its influence on coagulation and blood clot risk being much higher than that of estradiol at equivalent doses.

    CEEs show a few-fold disproportionate estrogenic impact on liver protein synthesis relative to oral estradiol but less than that of EE (Kuhl, 2005; Table). This can be attributed to the equine (horse) estrogens in CEEs, which humans are presumably not adapted to and which show resistance to liver metabolism in humans. DES, on the other hand, shows even greater estrogenic influence on the liver than EE (Kuhl, 2005; Table). The more disproportionate impact on liver synthesis of DES relative to EE or CEEs may be attributable to the fact that it is a nonsteroidal estrogen and is far removed in structure from steroidal estrogens. This is relevant as steroidal estrogens are susceptible to varying extents to robust steroid-metabolizing enzymes in the liver (Kuhl, 2005). As with EE, 17β-HSDs have no affinity for DES and the hydroxyl groups of DES are not oxidized to form estrone-like ketone metabolites (Jensen et al., 2010). Consequent to their resistance to liver metabolism relative to estradiol, CEEs and nonsteroidal estrogens like DES have greater impacts on coagulation and blood clot risk than equivalent doses of estradiol similarly to EE although to varying extents.

    When compared to transdermal estradiol rather than oral estradiol, the disproportionate influence of oral non-bioidentical estrogens on estrogen-modulated liver protein synthesis becomes extreme. With a little math, it quickly becomes apparent why high doses of these estrogens have influences on liver proteins and blood clot risks that are comparable to those during pregnancy. The table below shows some roughly calculated estimates for comparative liver strength of the different estrogens.

    Table 4: Roughly calculated ratios of liver estrogenic potency to general/systemic estrogenic potency with estrogens based on a selection of liver products (e.g., SHBG, others) (Kuhl, 2005; Table):

    EstrogenComparative liver potency
    Relative to oral E2Relative to transdermal E2
    Transdermal E2~0.25×a1.0×a
    Oral E21.0×~4.0×
    Oral CEEs1.3–4.5×~5.2–18×
    Oral EE2.9–5.0×~12–20×
    Oral DES5.7–7.5×~23–30×

    a Based on a study that found oral estradiol to have 4-fold greater effect on SHBG levels than transdermal estradiol when used at doses that produced similar estradiol levels (Nachtigall et al., 2000).

    Changes in liver protein synthesis induced by estrogens don’t scale linearly with dose or relative liver potency. There is progressive saturation in terms of changes in levels of SHBG and other liver products with estrogen dose—that is, higher doses have relatively diminished effect compared to lower doses (Kuhl, 1990; Kuhl, 1999). As an example, oral EE shows the following dose-dependent increases in SHBG levels: 2.0-fold at 5 μg/day, 3.0-fold at 10 μg/day, 3.4-fold at 20 μg/day, and 4.0-fold at 50 μg/day (Kuhl, 1998; Kuhl, 1999). These findings can be attributed to saturation of the competitive binding and/or activation of liver ERs by high estrogen concentrations (Kuhl, 1990). An implication of this dose-dependent saturation is that although for instance oral EE has much stronger potency in the liver than oral estradiol, oral estradiol can more quickly “catch up” to oral EE and other non-bioidentical estrogens in terms of liver impact than might be initially anticipated. Accordingly, oral estradiol has shown the following dose-dependent increases in SHBG levels: 1.6-fold at 1 mg/day, 2.2-fold at 2 mg/day, and 1.9- to 3.2-fold at 4 mg/day (Fåhraeus & Larsson-Cohn, 1982; Kuhl, 1998; Gibney et al., 2005; Ropponen et al., 2005). Hence, although oral EE may have roughly 3- to 5-fold higher liver potency than oral estradiol, a dose of oral estradiol near-equivalent to that of oral EE in terms of general estrogenic effect can increase SHBG levels to an extent that is only somewhat lower in comparison.

    Selective Estrogen Receptor Modulators and Metabolism Resistance

    SERMs like tamoxifen and raloxifene are essentially partial agonists of the ER. This is in contrast to estrogens—like estradiol, CEEs, EE, and DES—which act as full agonists of the ER. Similarly to nonsteroidal estrogens like DES, the clinically used SERMs are all nonsteroidal in structure and are strongly resistant to hepatic metabolism. In fact, certain SERMs, like tamoxifen and clomifene, are structurally related to and were derived from DES. SERMs show tissue differences in their ER-mediated effects, with estrogenic effects in some tissues (e.g., bone) and antiestrogenic effects in other tissues (e.g., breasts) (Lain, 2019; Table). Although there is variation between SERMs in terms of their effects in certain tissues (e.g., uterus), they are uniformly estrogenic in the liver. Consequently, SERMs show similar increases in blood clot risk as estrogens (Park & Jordan, 2002; Fabian & Kimler, 2005). As with non-bioidentical estrogens, the greater risk of blood clots with SERMs compared to oral estradiol can be attributed to their resistance to liver metabolism and hence to greater hepatic estrogenic potency. The SERMs that are used medically belong to diverse structural families (e.g., triphenylethylenes like tamoxifen and benzothiophenes like raloxifene). The only way in which SERMs of different structural classes are known to be related is in their shared interactions with the ERs.

    Figure 3: Chemical structures of selected SERMs. They are nonsteroidal in structure and include tamoxifen (a triphenylethylene) and raloxifene (a benzothiophene).

    Activation of the Estrogen Receptor is Specifically Responsible for Increased Coagulation with Estrogens and SERMs

    Findings from preclinical and genetic research provide direct evidence for ER activation being responsible for the increased blood clot risk with estrogens. In an important animal study, EE was administered to mice and changes in procoagulant and anticoagulant biomarkers were measured (Cleuren et al., 2010). EE caused changes in levels of a variety of coagulation factors (Cleuren et al., 2010). The researchers also assessed estradiol and observed comparable changes (Cleuren et al., 2010). Co-administration of the selective ER full antagonist fulvestrant with EE neutralized all of the EE-induced coagulatory changes (Cleuren et al., 2010). Additionally, EE showed no effect on coagulation factors in ERα knockout mice (Cleuren et al., 2010). These findings are consistent with human and mouse genome-wide association studies which have found estrogen response elements (EREs)—DNA sequences that act as binding sites for genes regulated by the ER—embedded in a large number of genes involved in coagulatory pathways (Cleuren et al., 2010; Stanczyk, Mathews, & Cortessis, 2017).

    The preceding findings are consistent with ER activation being responsible for increased coagulation and blood clot risk with estrogens and SERMs. This is in accordance with the fact that blood clot risk is a shared effect of selective ER agonists with highly diverse chemical structures, providing strong circumstantial support against a non-ER-mediated action of some sort being responsible (e.g., the weakly estrogenic metabolite estrone somehow mediating the blood clot risk with estradiol—Bagot et al., 2010). Increased coagulation and blood clot risk can thus be regarded as class effects of estrogens and SERMs—provided sufficiently high liver exposure. Due to differences in susceptibility to liver metabolism however, different ER agonists show differences in their relative impact on coagulation. Owing to estradiol’s lack of resistance to metabolism and its robust inactivation in the liver, the dosage requirements for increased coagulation and blood clot risk with estradiol—particularly in the case of non-oral estradiol—are greater than with non-bioidentical estrogens. Hence, estradiol, especially when administered via non-oral routes, is a safer form of estrogen therapy than other estrogens.

    Absolute Incidences and Risk Factors

    States of estrogen and/or progestogen exposure, such as exogenous hormone administration and pregnancy, are of course established risk factors for blood clots in women. In healthy young individuals without relevant risk factors for blood clots however, the incidence of blood clots is rare even in situations of considerably increased risk due to hormones (Rosendaal, 2005). The absolute incidence of VTE in non-pregnant women is only 1 to 5 of every 10,000 women each year (i.e., 0.01–0.05% per year) (PCASRM, 2017; Konkle & Sood, 2019). EE-containing birth control pills, which on average increase VTE risk by about 4-fold, are associated with an incidence of VTE of only 3 to 9 of every 10,000 women each year (i.e., 0.03–0.09% per year) (Konkle & Sood, 2019). Likewise, the absolute risk of blood clots during pregnancy, when estradiol and progesterone levels increase to extremely high concentrations and VTE risk is increased up to 7-fold (Abdul Sultan et al., 2015), is about 5 to 20 of every 10,000 women each year (i.e., 0.05–0.2% per year) (PCASRM, 2017; Konkle & Sood, 2019).

    Table 5: Absolute incidences of VTE with different estrogenic exposures in premenopausal women (Gerstman et al., 1991; Konkle & Sood, 2019; Douxfils, Morimont, & Bouvy, 2020):

    Group/therapyIncidence (women per year)
    Non-pregnant women1 to 5 in 10,000 (0.01–0.05%)a
    Modern birth control pills (<50 μg/day EE)3 to 12 in 10,000 (0.03–0.09%)
    High-dose birth control pills (>50 μg/day EE)~10 in 10,000 (0.1%)
    Pregnancy5 to 20 in 10,000 (0.05–0.2%)
    Postpartum period40 to 65 in 10,000 (0.4–0.65%)

    a 1–2/10,000 per year at <19 years of age, 2–3/10,000 per year at 20–29 years of age, 3–4/10,000 per year at 30–39 years of age, 5–7/10,000 per year at 40–49 years of age; roughly 3–4/10,000 per year for age 15–49 years overall (Rabe et al., 2011).

    In any case, the risks of VTE and cardiovascular events with high estrogen exposure accumulate over time and add up on a population scale. It is estimated that 22,000 instances of VTE occur due to birth control pills in Europe each year (Morimont, Dogné, & Douxfils, 2020) and that 300 to 400 healthy young women die due to blood clots caused by birth control pills in the United States every year (Keenan, Kerr, & Duane, 2019). Notably, non-EE-containing birth control pills—which instead of EE contain estradiol or estetrol—appear to have considerably reduced procoagulatory effects and/or risk of blood clots in comparison, and if they become more established, will likely eliminate a substantial number of these cases (Stanczyk, Archer, & Bhavnani, 2013; Dinger, Minh, & Heinemann, 2016; Grandi, Facchinetti, & Bitzer, 2017; Fruzzetti & Cagnacci, 2018; Grandi et al., 2019; Grandi et al., 2020; Douxfils, Morimont, & Bouvy, 2020; Reda et al., 2020; Morimont et al., 2021; Grandi, Facchinetti, Bitzer, 2022).

    In addition to time and population considerations, there are, besides estrogen and progestogen exposure, a variety of other known risk factors for blood clots, and these risk factors can substantially augment blood clot risk (Heit et al., 2000; Rosendaal, 2005). Age is among the strongest of the known risk factors (Rosendaal, 2005; Montagnana et al., 2010). Moreover, age is uniquely notable as a risk factor in that it is one that eventually becomes relevant to everyone. The risk of blood clots increases on the order of 100-fold going from ≤15 years of age (incidence <0.005–0.01% per year) to ≥80 years of age (incidence ~0.5–1.0% per year) (Rosendaal, 2005; Montagnana et al., 2010; Rabe et al., 2011). The figure below provides a graphical representation of the influence of age on risk of blood clots.

    Figure 4: Risk of first-incidence VTE (per 100,000 per year) by age group (in years) in men (black bars) and women (gray bars) (Oger, 2000; Rosendaal, 2005; Rosendaal, 2016).

    Other established risk factors for blood clots and associated cardiovascular problems include physical inactivity (due to, e.g., bed rest, long-distance travel, etc.), obesity, smoking, thrombophilic abnormalities, cancer, surgery, and HIV, among many others (Baron et al., 1998; Heit et al., 2000; Rosendaal, 2005; Lijfering, Rosendaal, & Cannegieter, 2010; Timp et al., 2013). In addition to age, physical inactivity is one of the most important risk factors for blood clots and mediates the risk increases for many of the others (Rosendaal, 2005). Smoking on its own is not consistently associated with increased risk of VTE (Lijfering, Rosendaal, & Cannegieter, 2010), but in combination with EE-containing birth control pills has been associated with a synergistic increase in VTE risk (Pomp, Rosendaal, & Doggen, 2008) as well as large increases in risk of heart attack—for instance 20-fold higher risk in heavy smokers (Kuhl, 1999). The table below shows the influence of a selection of known risk factors for VTE:

    Table 6: Non-exogenous-hormone risk factors for VTE and relative VTE risk increases (Baron et al., 1998; Heit et al., 2000; Rosendaal, 2005; Lijfering, Rosendaal, & Cannegieter, 2010; Timp et al., 2013):

    Risk factorRelative risk
    Age1–∞×
    Cancer2–20×a
    HIV3–10×
    Overweightness/obesity2–3×
    Surgery, trauma, immobilization5–50×
    Bed rest at home9×
    Air travel1.5–3×
    Smoking0.8–1.5×b
    Varicose veins1–4×
    Pregnancy4×
    Postpartum15–20×

    a Varies by type and stage of cancer (Baron et al., 1998; Timp et al., 2013). For breast and prostate cancer, one study found a 1.8-fold greater risk for breast cancer and 4.2-fold greater risk for prostate cancer relative to the general population (Baron et al., 1998). b Smoking on its own is not consistently associated with VTE (Lijfering, Rosendaal, & Cannegieter, 2010; Rabe et al., 2011).

    Thrombophilias, heritable and acquired, exist in significant percentages of the population and can lead to large increases in blood clot risk (Lijfering, Rosendaal, & Cannegieter, 2010). Moreover, they are often if not usually unknown (Morimont, Dogné, & Douxfils, 2020). This is due to the fact that screening for heritable thrombophilias is mainly based on family history, which has low sensitivity and poor predictive value for identifying people with these abnormalities (Morimont, Dogné, & Douxfils, 2020). Hence, many people are at increased risk of blood clots without realizing it. The table below shows the prevalences of a variety of thrombophilic abnormalities and their impacts on blood clot risk.

    Table 7: Prevalences of thrombophilic abnormalities and relative risk of VTE (Martinelli, Passamonti, & Bucciarelli, 2014; Mannucci & Franchini, 2015; see also Walker, 2009; Konkle & Sood, 2019).

    ThrombophiliaPrevalenceRelative risk
    General populationPeople with VTEFirst VTERecurrent VTE
    Antithrombin deficiency0.02–0.2%1%50×2.5×
    Protein C deficiency0.2–0.4%3%15×2.5×
    Protein S deficiency0.03–0.1%2%10×2.5×
    Factor V Leiden (het.)5%20%7×1.5×
    Factor V Leiden (homo.)0.02%1.5%80×–
    Prothrombin G20210A (het.)2%6%3–4×1.5×
    Prothrombin G20210A (homo.)0.02%<1%30×–
    Non-O blood group55–57%75%2×2×
    Antiphospholipid antibodies1–2%5–15%11×?
    Hyperhomocysteinemia5%10–15%1.5×?

    Blood clots are considered to be a multicausal disease (Rosendaal, 2005). The risk of blood clots and associated cardiovascular complications with hormonal exposure is highest when multiple risk factors combine in a given individual. Under what are among the most extreme of circumstances in terms of risk—elderly people with cancer who are on high-dose oral synthetic estrogen therapy (e.g., DES)—blood clot incidence can be as high as 15 to 28% and overall incidence of cardiovascular complications as great as 35% (Phillips et al., 2014; Sciarria et al., 2014; Turo et al., 2014). These adverse effects contribute to substantial morbidity and incidence of death in these populations. Most people are however at nowhere near as great of risk. Risk factors like age are why pregnant women can have massive levels of estradiol and progesterone with relatively little issue whereas elderly cancer patients on high-dose oral synthetic estrogen therapy have a considerable risk of death.

    In the VUMC studies that found 20- to 45-fold increased incidence of blood clots with high-dose EE and CPA over 5 to 10 years in transfeminine people, the absolute incidence of blood clots was approximately 6.3% (142/10,000 people per year) in the 1989 report and 5.5% (58/10,000 people per year) in the 1997 follow up (Asscheman, Gooren, & Eklund, 1989; van Kesteren et al., 1997; Asscheman et al., 2014; Goldstein et al., 2019; Min & Hopkins, 2021). In keeping with the known influence of age on blood clot risk, the absolute incidence was 2.1% in those under 40 years of age and 12% in those over 40 years of age in the 1989 study (Asscheman, Gooren, & Eklund, 1989; Asscheman et al., 2014). In about 70% of cases, there were—aside from age—no known risk factors for blood clots (Asscheman, Gooren, & Eklund, 1989; Asscheman et al., 2014). Following subsequent replacement of EE with low-to-moderate-dose transdermal estradiol in those over 40 years of age, the incidence of blood clots decreased substantially (with only one event occurring in the transdermal estradiol group) (van Kesteren et al., 1997; Asscheman et al., 2014; Min & Hopkins, 2021). A later study in 2013 by the Ghent University Hospital in Belgium observed a blood clot incidence of 5.1% in transfeminine people using mostly oral or transdermal estradiol with or without CPA over an average treatment period of 7.7 years (range 3 months to 35 years) (Wierckx et al., 2013; Min & Hopkins, 2021). Those who had blood clots often had other risk factors such as older age, smoking, immoblization due to surgery, or hypercoagulability (Wierckx et al., 2013; Min & Hopkins, 2021). In addition to cumulative exposure time, these studies further highlight the converging impact of multiple risk factors—with estrogen type, route, and dose, progestogen exposure, and age included among them—on the risk of blood clots.

    Therapeutic Implications for Transfeminine People

    Due to their greater risk of blood clots and cardiovascular problems, non-bioidentical estrogens like EE and CEEs are mostly no longer used in transfeminine people. Instead, estradiol, both in oral and non-oral forms, is used. Transgender clinical guidelines generally recommend keeping estradiol levels within normal physiological ranges for non-pregnant females of around 100 to 200 pg/mL regardless of whether the route of administration of estradiol is oral or non-oral (Aly, 2018). Higher estradiol levels are not currently known to have greater therapeutic benefit in terms of feminization or breast development (Nolan & Cheung, 2020). However, higher levels, in the range of 200 to 500 pg/mL, can provide additional therapeutic effect in the area of testosterone suppression—which can be indirectly beneficial to feminization if otherwise inadequate (Aly, 2018). Despite their recommendations for keeping estradiol levels in physiological ranges, transgender clinical guidelines notably recommend doses of estradiol ester injections that reach and even greatly exceed estradiol levels of 200 pg/mL (Aly, 2021).

    Based on the available research (e.g., the risk of blood clots with lower doses, comparative SHBG increases), it would not be surprising if high-dose oral estradiol (e.g., 8 mg/day) had similar risk of blood clots as the relatively lower amounts of EE in birth control pills. The risk is likely to be particularly great in combination with progestogens (e.g., CPA). Due to its greater and unnecessary risk of blood clots relative to non-oral estradiol, oral estradiol should ideally be avoided in transfeminine people—particularly in those with risk factors for blood clots such as older age (e.g., >40 years) or concomitant progestogen use. However, the convenience of oral estradiol and its relative inexpensiveness (compared to e.g. transdermal forms) are significant advantages that will also be considered by transfeminine people and their clinicians. In contrast to oral estradiol, non-oral estradiol—with estradiol levels kept in physiological ranges of for instance 100 to 200 pg/mL—appears to have minimal to no risk of blood clots. Hence, non-oral estradiol at these levels can be used in transfeminine people with little concern.

    In terms of higher estradiol levels delivered non-orally, the estimated 2-fold increase in risk of blood clots with estradiol levels of approximately 300 to 500 pg/mL (Sam, 2020) is notably lower than the average 4-fold increase in risk with widely used EE-containing birth control pills. Based on the usefulness of these levels for suppressing testosterone production and the widespread usage of EE-based birth control in cisgender women throughout the world, the degree of blood clot risk with high-dose non-oral estradiol, in reasonable amounts, could be considered therapeutically acceptable in transfeminine people (Haupt et al., 2020). This may be particularly true when high-dose non-oral estradiol monotherapy is compared to combination of estradiol with antiandrogens like spironolactone, CPA, or bicalutamide, which all have their own unique risks and drawbacks. In any case, as with oral estradiol, high estradiol levels with non-oral estradiol should ideally be avoided due to the additional risk they pose, and this is especially true in those with relevant risk factors for blood clots (e.g., older age). In addition, very high doses of non-oral estradiol resulting in estradiol levels above those required for testosterone suppression are difficult to justify as they pose further unnecessary risk and offer no clear additional therapeutic benefit.

    Prevention of Blood Clots

    The best way to prevent blood clots from happening is to avoid risk altogether. Avoiding use of oral estradiol, excessively high doses of non-oral estradiol, and progestogens when feasible and opting for safer therapeutic choices is recommended in this regard. In addition, avoiding use of such therapies in those with risk factors like older age (>40 years), known thrombophilic abnormalities, and sedentary lifestyle is advocated. Proactive behaviors like physical activity (e.g., walking, exercise), quitting smoking, and weight loss may help to reduce the risk of blood clots (Hibbs, 2008).

    Certain anticoagulant and antiplatelet medications are used to help prevent blood clots in high-risk individuals. Examples include low-dose aspirin (Mekaj, Daci, & Mekaj, 2015; Matharu et al., 2020), direct factor Xa inhibitors like rivaroxaban (Xarelto) (Blondon, 2020), and direct thrombin inhibitors like dabigatran (Pradaxa), among others. Aspirin has been found to be effective in the prevention of blood clots (Mekaj, Daci, & Mekaj, 2015; Matharu et al., 2020) and has been recommended for use specifically in transfeminine people on hormone therapy (Feldman & Goldberg, 2006; Deutsch, 2016). However, evidence is limited and conflicting for prevention of blood clots related to hormone therapy (Grady et al., 2000; Cushman et al., 2004) and use of aspirin in transfeminine people for such purposes has been recommended against by others (Shatzel, Connelly, & DeLoughery, 2017). Rivaroxaban has been associated with more than completely offset risk of blood clots with oral menopausal hormonal therapy (Blondon, 2020). In any case, no anticoagulants are currently approved or well-supported for preventing risk of blood clots with hormone therapy. Accordingly, clinical guidelines state that there is insufficient evidence to guide decision-making in this area at this time (e.g., McLintock, 2014). It should also be cautioned that anticoagulants have side effects and risks of their own and should be used carefully.

    Rutin, a naturally occurring flavonoid found in various plants and foods and available as a herbal supplement, has been suggested by some in the transfeminine community as a preventative against blood clots based on limited preclinical research (Jasuja et al., 2012; Choi et al., 2015). However, there is no clinical evidence to support its use or effectiveness at this time (e.g., Martinez-Zapata et al., 2016; Morling et al., 2018). Dose-finding studies to determine appropriate doses for efficacy also have not been performed. Flavonoids like rutin are notably known to have unfavorable dispositions in the body (e.g., very low bioavailability, high metabolism, short half-lives) and this has limited their usefulness by rendering them poorly active and therapeutically ineffective (Ma et al., 2014; Higdon et al., 2016; Cassidy & Minihane, 2017; Zhao, Yang, & Xie, 2019; Zhang et al., 2021). Lastly, the tolerability and safety of rutin have not been evaluated. For these reasons, use of rutin to lower the risk of blood clots in transfeminine people cannot be recommended at this time.

    Temporary discontinuation of estrogen therapy before surgery has traditionally been thought to help reduce the risk of blood clots during recovery based on theory and has been advised as well as mandated for transfeminine people undergoing surgical procedures (e.g., Asscheman et al., 2014). However, evidence is limited and inconclusive on this strategy at present and more research is needed to determine whether it is actually beneficial or not (Boskey, Taghinia, & Ganor, 2019; Nolan & Cheung, 2020; Haveles et al., 2021; Hontscharuk et al., 2021; Kozato et al., 2021; Nolan et al., 2021; Zucker, Reisman, & Safer, 2021). Recent studies have not found reduction in risk of blood clots with discontinuation of hormone therapy before surgery in transfeminine people but these studies have been underpowered and larger studies are needed (Blasdel et al., 2021). Temporarily stopping hormone therapy can be distressing for many transfeminine people and this should be weighed accordingly. A potential alternative to discontinuation of hormone therapy is temporary use of transdermal estradiol at physiological doses which has no known blood clot risk and is more likely to be safe.

    Updates

    Update 1: Langley et al. (2021) [PATCH Study Results]

    In February 2021, a report on long-term cardiovascular outcomes for the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial was published (Langley et al., 2021) [PDF; Supplementary appendix]. The PATCH trial is a large ongoing phase 2/3 randomized controlled trial of high-dose transdermal estradiol patches versus GnRH agonists for the treatment of prostate cancer in men (Langley et al., 2021). The estradiol patch dosage employed is specifically three to four 100 μg/day FemSeven or Progynova TS patches (Langley et al., 2021). In the February 2021 report of the study, 1,694 men were enrolled and randomized, with 790 included in the analysis for the GnRH agonist group and 904 included in the analysis for the estradiol patch group (Langley et al., 2021).

    In those given estradiol, the median estradiol level was around 215 pg/mL (5%–95% range ~100–550 pg/mL) (Langley et al., 2021). About 93% of the men in this group achieved suppression of testosterone levels into the castrate range (<50 ng/dL), which was notably equal to the rate of suppression in the GnRH agonist group (~93%) (Langley et al., 2021). However, actual testosterone levels—as opposed to rates of testosterone suppression—were not provided in this report and hence comparison between groups is unavailable for this metric (Langley et al., 2021). After about 4 years median follow up, there were no significant differences on a variety of cardiovascular outcomes between the estradiol group and the GnRH agonist group (Langley et al., 2021). Among these outcomes included VTE, thromboembolic stroke, and other arterial embolic events (Langley et al., 2021). These results are in contrast to previous large clinical trials of PEP in prostate cancer, which found increased cardiovascular morbidity and risk of VTE but notably involved higher estradiol levels than employed in the PATCH trial (Ockrim & Abel, 2009; Sam, 2020). Based on their promising safety findings, the PATCH researchers stated that transdermal estrogen should be reconsidered for the treatment of prostate cancer (Langley et al., 2021).

    These findings are reassuring and suggest that limitedly high levels of estradiol (e.g., 200–300 pg/mL perhaps) may likewise be acceptably safe in terms of blood clot and cardiovascular risk in transfeminine people. It should be noted however that the sample size of the trial, while large relative to previous clinical studies in this area, was underpowered for assessing risk of blood clots—which are relatively rare events that require very large samples to thoroughly quantify. Studies precisely assessing blood clot risk in peri- and postmenopausal women have included tens of thousands of individuals for instance. As such, while substantial increases in risk are not likely based on this trial, smaller increases in risk still cannot be ruled out at this time. It should additionally be noted that the robust testosterone suppression at the used doses in this study might not generalize to transfeminine people as a whole, as the men were mostly elderly and testosterone levels are known to decrease with age.

    Update 2: Totaro et al. (2021) and Kotamarti et al. (2021)

    In November 2021, the following systematic review and meta-analysis as well as meta-regression study of VTE risk with transfeminine hormone therapy was published:

    • Totaro, M., Palazzi, S., Castellini, C., Parisi, A., D’Amato, F., Tienforti, D., Baroni, M. G., Francavilla, S., & Barbonetti, A. (2021). Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study. Frontiers in Endocrinology, 12, 741866. [DOI:10.3389/fendo.2021.741866]

    This study is the largest of its kind that has been conducted to date. The meta-analysis included 18 studies totaling 11,542 transfeminine people on hormone therapy. The pooled prevalence of VTE was 2% with a 95% confidence interval of 1 to 3%. However, there was large variability between studies. In the meta-regression analysis, older age and longer length of estrogen therapy were significantly positively associated with VTE prevalence. When analysis was restricted to those greater than or equal to 37.5 years of age, the prevalence of VTE was 3% (95% CI: 0–5%). Conversely, in those less than 37.5 years of age, the prevalence of VTE was 0% (95% CI: 0–2%). VTE prevalence was 1% (95% CI: 0–3%) with greater than or equal to 4.4 years of estrogen therapy and was 0% (95% CI: 0–3%) with less than 4.4 years of estrogen therapy. With regard to the 0% estimates, it is not the case that there is truly no risk of VTE in these instances but rather it can be assumed that the risks are sufficiently low that the meta-analysis was not powered well enough to detect and quantify them.

    A limitation of the meta-analysis was that subgroup analyses based on estrogen type (i.e., estradiol vs. CEEs vs. EE) and route (e.g., oral estrogens or oral estradiol vs. transdermal estradiol) were said to not be possible due to insufficient data and hence were not performed. However, another recent meta-analysis published in July 2021, which analyzed much of the same literature as Totaro et al. (2021), did perform subgroup analyses by estrogen type and route. This publication is as follows:

    • Kotamarti, V. S., Greige, N., Heiman, A. J., Patel, A., & Ricci, J. A. (2021). Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine, 18(7), 1280–1291. [DOI:10.1016/j.jsxm.2021.04.006]

    And this is what they reported in terms of subgroup analyses for estrogen type and route:

    Because varying VTE rates have been reported with different estrogen regimens, analyses of VTE incidence were performed comparing oral or transdermal delivery, or the specific estrogen formulation. As many studies reported populations using mixed estrogen formulations or did not report the type of estrogen regimen, further statistical analysis could not be performed.

    Route of estrogen administration appeared to play a role in the AMAB population. [Oral] estrogens (7 studies; 34.0 VTE per 10,000 person-years) vs transdermal estrogens (3 studies, 11.2 VTE per 10,000 person-years). Additionally, estrogen formulation also appeared to have a difference VTE incidence. Ethinyl estradiol was also associated with increased VTE incidence (3 studies, 293.1 VTE per 10,000 person-years) followed by conjugated equine estrogens (1 study, 49.0 VTE per 10,000 person-years) and estradiol valerate (4 studies, 31.5 VTE per 10,000 person-years).

    It is unclear how accurate these precise numbers are due to the quality limitations of the underlying data. Moreover, antiandrogens (e.g., CPA) were not controlled for and as discussed by this article are likely to additionally influence VTE risk. In any case, the reported numbers are interesting and are in accordance with different estrogen types and routes varying in terms of VTE risk.

    References

    • Abdul Sultan, A., West, J., Stephansson, O., Grainge, M. J., Tata, L. J., Fleming, K. M., Humes, D., & Ludvigsson, J. F. (2015). Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study. BMJ Open, 5(11), e008864. [DOI:10.1136/bmjopen-2015-008864]
    • Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020). Estrogen and thrombosis: A bench to bedside review. Thrombosis Research, 192, 40–51. [DOI:10.1016/j.thromres.2020.05.008]
    • Amitrano, L., Guardascione, M. A., Brancaccio, V., & Balzano, A. (2002). Coagulation Disorders in Liver Disease. Seminars in Liver Disease, 22(1), 83–96. [DOI:10.1055/s-2002-23205]
    • Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., … & Women’s Health Initiative Steering Committee. (2004). Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial. JAMA, 291(14), 1701–1712. [DOI:10.1001/jama.291.14.1701]
    • Arnold, J. D., Sarkodie, E. P., Coleman, M. E., & Goldstein, D. A. (2016). Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol. The Journal of Sexual Medicine, 13(11), 1773–1777. [DOI:10.1016/j.jsxm.2016.09.001]
    • Asscheman, H., Gooren, L., & Eklund, P. (1989). Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38(9), 869–873. [DOI:10.1016/0026-0495(89)90233-3]
    • Asscheman, H., Giltay, E. J., Megens, J. A., de Ronde, W. (Pim), van Trotsenburg, M. A., & Gooren, L. J. (2011). A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 164(4), 635–642. [DOI:10.1530/eje-10-1038]
    • Asscheman, H., T’Sjoen, G., Lemaire, A., Mas, M., Meriggiola, M. C., Mueller, A., Kuhn, A., Dhejne, C., Morel-Journel, N., & Gooren, L. J. (2013). Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia, 46(7), 791–795. [DOI:10.1111/and.12150]
    • Baber, R. J., Panay, N., & Fenton, A. (2016). 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric, 19(2), 109–150. [DOI:10.3109/13697137.2015.1129166]
    • Back, D. J., & Rogers, S. M. (2007). Review: first-pass metabolism by the gastrointestinal mucosa. Alimentary Pharmacology & Therapeutics, 1(5), 339–357. [DOI:10.1111/j.1365-2036.1987.tb00634.x]
    • Bagot, C., Marsh, M., Whitehead, M., Sherwood, R., Roberts, L., Patel, R., & Arya, R. (2010). The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. Journal of Thrombosis and Haemostasis, 8(8), 1736–1744. [DOI:10.1111/j.1538-7836.2010.03953.x]
    • Bagot, C., Leishman, E., Onyiaodike, C., Jordan, F., Gibson, V., & Freeman, D. (2019). Changes in laboratory markers of thrombotic risk early in the first trimester of pregnancy may be linked to an increase in estradiol and progesterone. Thrombosis Research, 178, 47–53. [DOI:10.1016/j.thromres.2019.03.015]
    • Baron, J. A., Gridley, G., Weiderpass, E., Nyren, O., & Linet, M. (1998). Venous thromboembolism and cancer. The Lancet, 351(9109), 1077–1080. [DOI:10.1016/s0140-6736(97)10018-6]
    • Bezwada, P., Shaikh, A., & Misra, D. (2017). The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review. Journal of Women’s Health, 26(12), 1319–1325. [DOI:10.1089/jwh.2016.6151]
    • Blanco-Molina, M., Lozano, M., Cano, A., Cristobal, I., Pallardo, L., & Lete, I. (2012). Progestin-only contraception and venous thromboembolism. Thrombosis Research, 129(5), e257–e262. [DOI:10.1016/j.thromres.2012.02.042]
    • Bland, L. B., Garzotto, M., DeLoughery, T. G., Ryan, C. W., Schuff, K. G., Wersinger, E. M., Lemmon, D., & Beer, T. M. (2005). Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer, 103(4), 717–723. [DOI:10.1002/cncr.20857]
    • Blasdel, G., Shakir, N., Parker, A., Bluebond-Langner, R., & Zhao, L. (2021). Letter to the Editor from Blasdel et al: “No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-affirming Surgery”. The Journal of Clinical Endocrinology & Metabolism, 106(9), e3783–e3784. [DOI:10.1210/clinem/dgab243]
    • Blondon, M. (2020). Update On Oral Contraception And Venous Thromboembolism. HemaSphere Educational Updates in Hematology Book: 25th Congress of the European Hematology Association, Virtual Edition 2020, 4(S2). European Hematology Association. [Google Scholar] [DOI:10.1097/HS9.0000000000000444] [PDF]
    • Boskey, E. R., Taghinia, A. H., & Ganor, O. (2019). Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients. JAMA Surgery, 154(2), 159–169. [DOI:10.1001/jamasurg.2018.4598]
    • Byar, D. P. (1973). The veterans administration cooperative urological research group’s studies of cancer of the prostate. Cancer, 32(5), 1126–1130. [DOI:10.1002/1097-0142(197311)32:5<1126::aid-cncr2820320518>3.0.co;2-c]
    • Canonico, M., Plu-Bureau, G., Lowe, G. D., & Scarabin, P. (2008). Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ, 336(7655), 1227–1231. [DOI:10.1136/bmj.39555.441944.be]
    • Canonico, M., Plu-Bureau, G., O’Sullivan, M. J., Stefanick, M. L., Cochrane, B., Scarabin, P., & Manson, J. E. (2014). Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women. Menopause, 21(3), 214–220. [DOI:10.1097/gme.0b013e31829752e0]
    • Cassidy, A., & Minihane, A. (2017). The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. The American Journal of Clinical Nutrition, 105(1), 10–22. [DOI:10.3945/ajcn.116.136051]
    • Chaireti, R., Gustafsson, K. M., Bystrom, B., Bremme, K., & Lindahl, T. L. (2013). Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle. Human Reproduction, 28(7), 1846–1852. [DOI:10.1093/humrep/det092]
    • Choi, J., Kim, D., Park, S., Lee, H., Kim, K., Kim, K., Kim, M., Kim, S., & Kim, S. (2015). Anti-thrombotic effect of rutin isolated from Dendropanax morbifera Leveille. Journal of Bioscience and Bioengineering, 120(2), 181–186. [DOI:10.1016/j.jbiosc.2014.12.012]
    • Cleuren, A., Van der Linden, I., de Visser, Y., Wagenaar, G., Reitsma, P., & van Vlijmen, B. (2010). 17α‐Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α. Journal of Thrombosis and Haemostasis, 8(8), 1838–1846. [DOI:10.1111/j.1538-7836.2010.03930.x]
    • Coelingh Bennink, H. J., Verhoeven, C., Dutman, A. E., & Thijssen, J. (2017). The use of high-dose estrogens for the treatment of breast cancer. Maturitas, 95, 11–23. [DOI:10.1016/j.maturitas.2016.10.010]
    • Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., … & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism, 13(4), 165–232. [DOI:10.1080/15532739.2011.700873] [URL] [PDF]
    • Conard, J., Plu-Bureau, G., Bahi, N., Horellou, M., Pelissier, C., & Thalabard, J. (2004). Progestogen-only contraception in women at high risk of venous thromboembolism. Contraception, 70(6), 437–441. [DOI:10.1016/j.contraception.2004.07.009]
    • Connelly, P. J., Marie Freel, E., Perry, C., Ewan, J., Touyz, R. M., Currie, G., & Delles, C. (2019). Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults. Hypertension, 74(6), 1266–1274. [DOI:10.1161/hypertensionaha.119.13080]
    • Connors, J. M., & Middeldorp, S. (2019). Transgender patients and the role of the coagulation clinician. Journal of Thrombosis and Haemostasis, 17(11), 1790–1797. [DOI:10.1111/jth.14626]
    • Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Van Horn, L., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M., Lepine, L., Rodabough, R. J., Sidney, S., Uwaifo, G. I., & Rosendaal, F. R. (2006). Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus. Archives of Internal Medicine, 166(7), 772–772. [DOI:10.1001/archinte.166.7.772]
    • Cushman, M. (2004). Estrogen Plus Progestin and Risk of Venous Thrombosis. JAMA, 292(13), 1573–1580. [DOI:10.1001/jama.292.13.1573]
    • Deitcher, S. R., & Gomes, M. P. (2004). The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma. Cancer, 101(3), 439–449. [DOI:10.1002/cncr.20347]
    • DeLoughery, T. G. (2011). Estrogen and thrombosis: Controversies and common sense. Reviews in Endocrine and Metabolic Disorders, 12(2), 77–84. [DOI:10.1007/s11154-011-9178-0]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Dinger, J., Do Minh, T., & Heinemann, K. (2016). Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception, 94(4), 328–339. [DOI:10.1016/j.contraception.2016.06.010]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Douxfils, J., Morimont, L., & Bouvy, C. (2020). Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Seminars in Thrombosis and Hemostasis, 46(8), 872–886. [DOI:10.1055/s-0040-1714140]
    • Douxfils, J., Klipping, C., Duijkers, I., Kinet, V., Mawet, M., Maillard, C., Jost, M., Rosing, J., & Foidart, J. (2020). Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception, 102(6), 396–402. [DOI:10.1016/j.contraception.2020.08.015]
    • Dutra, E., Lee, J., Torbati, T., Garcia, M., Merz, C. N., & Shufelt, C. (2019). Cardiovascular implications of gender-affirming hormone treatment in the transgender population. Maturitas, 129, 45–49. [DOI:10.1016/j.maturitas.2019.08.010]
    • Eilertsen, A. L., Dahm, A. E., Høibraaten, E., Lofthus, C. M., Mowinckel, M., & Sandset, P. M. (2019). Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment. Blood Coagulation & Fibrinolysis, 30(1), 17–23. [DOI:10.1097/mbc.0000000000000784]
    • Eisenfeld, A. J., & Aten, R. F. (1979). Estrogen receptor in the mammalian liver. In Briggs, M. H., & Corbin, A. (Eds.). Advances in Steroid Biochemistry and Pharmacology, 7, 91–117. London: Academic Press. [Google Scholar] [PubMed]
    • Eisenfeld, A. J., & Aten, R. F. (1987). Estrogen receptors and androgen receptors in the mammalian liver. Journal of Steroid Biochemistry, 27(4–6), 1109–1118. [DOI:10.1016/0022-4731(87)90197-x]
    • Fabian, C. J., & Kimler, B. F. (2005). Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer. Journal of Clinical Oncology, 23(8), 1644–1655. [DOI:10.1200/jco.2005.11.005]
    • Fåhraeus, L., & Larsson-Cohn, U. (1982). Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17β to menopausal women. Acta Endocrinologica, 101(4), 592–596. [DOI:10.1530/acta.0.1010592]
    • Feldman, J. L., & Goldberg, J. (2006). Transgender Primary Medical Care: Suggested Guidelines for Clinicians in British Columbia. crhc/csac/Transcend Transgender Support & Education Society/Vancouver Coastal Health. [Google Scholar] [PDF]
    • Franchini, M., & Mannucci, P. M. (2015). Classic thrombophilic gene variants. Thrombosis and Haemostasis, 114(11), 885–889. [DOI:10.1160/th15-02-0141]
    • Fruzzetti, F., & Cagnacci, A. (2018). Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives? Open Access Journal of Contraception, 9, 75–79. [DOI:10.2147/oajc.s179673]
    • Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W. J., Stadel, B. V., & Lundin, F. E. (1991). Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease. American Journal of Epidemiology, 133(1), 32–37. [DOI:10.1093/oxfordjournals.aje.a115799]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons. Annals of Internal Medicine, 169(4), 205. [DOI:10.7326/m17-2785]
    • Gibney, J., Johannsson, G., Leung, K., & Ho, K. K. (2005). Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women. The Journal of Clinical Endocrinology & Metabolism, 90(7), 3897–3903. [DOI:10.1210/jc.2005-0173]
    • Gilbert, D. C., Duong, T., Sydes, M., Bara, A., Clarke, N., Abel, P., James, N., Langley, R., Parmar, M., & (2018). Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform. BJU International, 121(5), 680–683. [DOI:10.1111/bju.14153]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/eje-21-0059]
    • Goldstein, Z., Khan, M., Reisman, T., & Safer, J. D. (2019). Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. Journal of Blood Medicine, 10, 209–216. [DOI:10.2147/jbm.s166780]
    • Gooren, L. J., & T’Sjoen, G. (2018). Endocrine treatment of aging transgender people. Reviews in Endocrine and Metabolic Disorders, 19(3), 253–262. [DOI:10.1007/s11154-018-9449-0]
    • Gourdy, P., Bachelot, A., Catteau-Jonard, S., Chabbert-Buffet, N., Christin-Maître, S., Conard, J., Fredenrich, A., Gompel, A., Lamiche-Lorenzini, F., Moreau, C., Plu-Bureau, G., Vambergue, A., Vergès, B., & Kerlan, V. (2012). Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology. Annales d’Endocrinologie, 73(5), 469–487. [DOI:10.1016/j.ando.2012.09.001]
    • Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & (2000). Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study. Annals of Internal Medicine, 132(9), 689–696. [DOI:10.7326/0003-4819-132-9-200005020-00002]
    • Grandi, G., Facchinetti, F., & Bitzer, J. (2017). Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle? The European Journal of Contraception & Reproductive Health Care, 22(4), 245–246. [DOI:10.1080/13625187.2017.1372571]
    • Grandi, G., Barra, F., Ferrero, S., & Facchinetti, F. (2019). Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism, 14(3), 153–155. [DOI:10.1080/17446651.2019.1604217]
    • Grandi, G., Del Savio, M. C., Lopes da Silva-Filho, A., & Facchinetti, F. (2020). Estetrol (E4): the new estrogenic component of combined oral contraceptives. Expert Review of Clinical Pharmacology, 13(4), 327–330. [DOI:10.1080/17512433.2020.1750365]
    • Grandi, G., Facchinetti, F., & Bitzer, J. (2022). Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. The European Journal of Contraception & Reproductive Health Care, 27(2), 83–84. [DOI:10.1080/13625187.2022.2029397]
    • Grossmann, M., Wierman, M. E., Angus, P., & Handelsman, D. J. (2018). Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. Endocrine Reviews, 40(2), 417–446. [DOI:10.1210/er.2018-00158]
    • Hammond, G. L. (2017). Sex Hormone-Binding Globulin and the Metabolic Syndrome. In Winters, S. J., & Huhtaniemi, I. T. (Eds.). Male Hypogonadism: Basic, Clinical and Therapeutic Principles, 2nd Edition (pp. 305–324). Cham: Springer. [DOI:10.1007/978-3-319-53298-1_15]
    • Hannaford, P. C., Iversen, L., Macfarlane, T. V., Elliott, A. M., Angus, V., & Lee, A. J. (2010). Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ, 340, c927. [DOI:10.1136/bmj.c927]
    • Haupt, C., Henke, M., Kutschmar, A., Hauser, B., Baldinger, S., Saenz, S. R., & Schreiber, G. (2020). Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. Cochrane Database of Systematic Reviews, 2020(11), CD013138. [DOI:10.1002/14651858.cd013138.pub2]
    • Haveles, C. S., Wang, M. M., Arjun, A., Zaila, K. E., & Lee, J. C. (2020). Effect of Cross-Sex Hormone Therapy on Venous Thromboembolism Risk in Male-to-Female Gender-Affirming Surgery. Annals of Plastic Surgery, 86(1), 109–114. [DOI:10.1097/sap.0000000000002300]
    • Hedlund, P. O., Johansson, R., Damber, J. E., Hagerman, I., Henriksson, P., Iversen, P., Klarskov, P., Mogensen, P., Rasmussen, F., & Varenhorst, E. (2011). Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial. Scandinavian Journal of Urology and Nephrology, 45(5), 346–353. [DOI:10.3109/00365599.2011.585820]
    • Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (2000). Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine, 160(6), 809–815. [DOI:10.1001/archinte.160.6.809]
    • Heit, J. A., Spencer, F. A., & White, R. H. (2016). The epidemiology of venous thromboembolism. Journal of Thrombosis and Thrombolysis, 41(1), 3–14. [DOI:10.1007/s11239-015-1311-6]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658]
    • Hemelaar, M., van der Mooren, M. J., Rad, M., Kluft, C., & Kenemans, P. (2008). Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertility and Sterility, 90(3), 642–672. [DOI:10.1016/j.fertnstert.2007.07.1298]
    • Hibbs, D. (2008). Hormone replacement and the treatment of the transgender patient: A critical literature review. de Chesnay, M., & Anderson, B. (Eds.). Caring for the Vulnerable: Perspectives in Nursing Theory, Practice, and Research, 2nd Edition (pp. 351–362). Sudbury, Massachusetts: Jones & Barlett. [Google Scholar] [Google Books]
    • Higdon, J., Drake, V. J., Delage, B., & Crozier, A. (2016). Flavonoids. Corvallis, Oregon: Micronutrient Information Center, Linus Pauling Institute, Oregon State University. [URL]
    • Høibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., & Sandset, P. M. (2000). Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy. Thrombosis and Haemostasis, 84(12), 961–967. [DOI:10.1055/s-0037-1614156]
    • Høibraaten, E., Qvigstad, E., Andersen, T. O., Mowinckel, M., & Sandset, P. M. (2001). The Effects of Hormone Replacement Therapy (HRT) on Hemostatic Variables in Women with Previous Venous Thromboembolism – Results from a Randomized, Double-Blind, Clinical Trial. Thrombosis and Haemostasis, 85(5), 775–781. [DOI:10.1055/s-0037-1615717]
    • Holmegard, H., Nordestgaard, B., Schnohr, P., Tybjærg‐Hansen, A., & Benn, M. (2014). Endogenous sex hormones and risk of venous thromboembolism in women and men. Journal of Thrombosis and Haemostasis, 12(3), 297–305. [DOI:10.1111/jth.12484]
    • Hontscharuk, R., Alba, B., Manno, C., Pine, E., Deutsch, M. B., Coon, D., & Schechter, L. (2021). Perioperative Transgender Hormone Management: Avoiding Venous Thromboembolism and Other Complications. Plastic & Reconstructive Surgery, 147(4), 1008–1017. [DOI:10.1097/prs.0000000000007786]
    • Hugon-Rodin, J., Alhenc-Gelas, M., Hemker, H. C., Brailly-Tabard, S., Guiochon-Mantel, A., Plu-Bureau, G., & Scarabin, P. (2016). Sex hormone-binding globulin and thrombin generation in women using hormonal contraception. Biomarkers, 22(1), 81–85. [DOI:10.1080/1354750x.2016.1204010]
    • Hulley, S. (1998). Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women. JAMA, 280(7), 605–613. [DOI:10.1001/jama.280.7.605]
    • Iqbal, J., Ginsburg, O. M., Wijeratne, T. D., Howell, A., Evans, G., Sestak, I., & Narod, S. A. (2012). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review. Cancer Treatment Reviews, 38(4), 318–328. [DOI:10.1016/j.ctrv.2011.06.009]
    • Irwig, M. S. (2018). Cardiovascular health in transgender people. Reviews in Endocrine and Metabolic Disorders, 19(3), 243–251. [DOI:10.1007/s11154-018-9454-3]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Jasuja, R., Passam, F. H., Kennedy, D. R., Kim, S. H., van Hessem, L., Lin, L., Bowley, S. R., Joshi, S. S., Dilks, J. R., Furie, B., Furie, B. C., & Flaumenhaft, R. (2012). Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. Journal of Clinical Investigation, 122(6), 2104–2113. [DOI:10.1172/jci61228]
    • Jensen, E. V., Jacobson, H. I., Walf, A. A., & Frye, C. A. (2010). Estrogen action: A historic perspective on the implications of considering alternative approaches. Physiology & Behavior, 99(2), 151–162. [DOI:10.1016/j.physbeh.2009.08.013]
    • Kaemmle, L. M., Stadler, A., Janka, H., von Wolff, M., & Stute, P. (2022). The impact of micronized progesterone on cardiovascular events – a systematic review. Climacteric, 25(4), 327–336. [DOI:10.1080/13697137.2021.2022644]
    • Kasum, M., Danolić, D., Orešković, S., Ježek, D., Beketić-Orešković, L., & Pekez, M. (2014). Thrombosis following ovarian hyperstimulation syndrome. Gynecological Endocrinology, 30(11), 764–768. [DOI:10.3109/09513590.2014.927858]
    • Keenan, L., Kerr, T., Duane, M., & Van Gundy, K. (2018). Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis. The Linacre Quarterly, 85(4), 470–477. [DOI:10.1177/0024363918816683]
    • Kerlan, V., Nahoul, K., Martelot, M., & Bercovici, J. (1994). Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clinical Endocrinology, 40(2), 263–267. [DOI:10.1111/j.1365-2265.1994.tb02478.x]
    • Khan, J., Schmidt, R. L., Spittal, M. J., Goldstein, Z., Smock, K. J., & Greene, D. N. (2019). Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. Clinical Chemistry, 65(1), 57–66. [DOI:10.1373/clinchem.2018.288316]
    • Kitamura, T. (2001). Necessity of re‐evaluation of estramustine phosphate sodium (EMP) as a treatment option for first‐line monotherapy in advanced prostate cancer. International Journal of Urology, 8(2), 33–36. [DOI:10.1046/j.1442-2042.2001.00254.x]
    • Klil-Drori, A. J., Yin, H., Tagalakis, V., Aprikian, A., & Azoulay, L. (2016). Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism. European Urology, 70(1), 56–61. [DOI:10.1016/j.eururo.2015.06.022]
    • Kohli, M., & McClellan, J. (2001). Parenteral Estrogen Therapy in Advanced Prostate Cancer: Retrospective Analysis of Intra-Muscular Estradiol Valerate in “Hormone Refractory” Prostate Disease. In Grunberg, S. M. (Ed.). Proceedings of the American Society of Clinical Oncology [Proc Am Soc Clin Oncol / Proceedings of ASCO], 20 [Thirty-Seventh Annual Meeting of the American Society of Clinical Oncology, May 12–15, 2001, San Francisco, California], 164b–164b (abstract no. 2407). Baltimore: Lippincott Williams & Wilkins. [ISSN:1081-0641] [ISBN-10:0-9664495-3-3] [Google Scholar] [WorldCat 1] [WorldCat 2] [WorldCat 3] [PDF]
    • Kohli, M., Alikhan, M. A., Spencer, H. J., & Carter, G. (2004). Phase I trial of intramuscular estradiol valerate (I/M-E) in hormone refractory prostate cancer. Journal of Clinical Oncology, 22(14 Suppl) [40th Annual Meeting of the American Society of Clinical Oncology: June 5–8, 2004, Ernest N. Morial Convention Center, New Orleans, Louisiana, Annual Meeting Proceedings], 436–436 (abstract no. 4726). [DOI:10.1200/jco.2004.22.90140.4726] [Google Books] [PDF]
    • Kohli, M. (2006). Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer, 106(1), 234–235. [DOI:10.1002/cncr.21528]
    • Konkle, B. A., & Sood, S. L. (2019). Thrombotic Risk of Contraceptives and Other Hormonal Therapies. In Kitchens, C. S., Kessler, C. M., Konkle, B. A., Streiff, M. B., & Garcia, D. A. (Eds.). Consultative Hemostasis and Thrombosis, 4th Edition (pp. 637–650). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-46202-0.00031-5]
    • Kotamarti, V. S., Greige, N., Heiman, A. J., Patel, A., & Ricci, J. A. (2021). Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine, 18(7), 1280–1291. [DOI:10.1016/j.jsxm.2021.04.006]
    • Kozato, A., Fox, G. W., Yong, P. C., Shin, S. J., Avanessian, B. K., Ting, J., Ling, Y., Karim, S., Safer, J. D., & Pang, J. H. (2021). No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery. The Journal of Clinical Endocrinology & Metabolism, 106(4), 1586–1590. [DOI:10.1210/clinem/dgaa966]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265] [Table]
    • Kuhl, H. (1990). Ovulationshemmer: Die Bedeutung der Östrogendosis. [Ovulation Preventives: The Significance of the Estrogen Dose. / Ovulation Inhibitors: The Significance of Estrogen Dose.] Geburtshilfe und Frauenheilkunde, 50(12), 910–922. [Google Scholar 1] [Google Scholar 2] [PubMed] [DOI:10.1055/s-2008-1026392] [Translation]
    • Kuhl, H. (1996). Effects of progestogens on haemostasis. Maturitas, 24(1–2), 1–19. [DOI:10.1016/0378-5122(96)00994-2]
    • Kuhl, H. (1997). Metabolische Effekte der Östrogene und Gestagene. [Metabolic Effects of Estrogens and Progestogens.] Der Gynäkologe, 30(4), 357–369. [DOI:10.1007/pl00003042]
    • Kuhl, H. (1998). Adverse effects of estrogen treatment: natural vs. synthetic estrogens. In Lippert, T. H., Mueck, A. O., & Ginsburg, J. (Eds.). Sex Steroids and the Cardiovascular System: The Proceedings of the 1st Interdisciplinary Workshop, Tuebingen, Germany, October 1996. Parthenon Publishing Group, New York, London (pp. 201–210). London/New York: Parthenon. [Google Scholar] [Google Books] [PDF]
    • Kuhl, H. (1999). Hormonal contraception. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 363–407). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_18] [PDF]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H., & Stevenson, J. (2006). The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits – an attempt to interpret the Women’s Health Initiative results. Gynecological Endocrinology, 22(6), 303–317. [DOI:10.1080/09513590600717368]
    • Langley, R. E., Cafferty, F. H., Alhasso, A. A., Rosen, S. D., Sundaram, S. K., Freeman, S. C., Pollock, P., Jinks, R. C., Godsland, I. F., Kockelbergh, R., Clarke, N. W., Kynaston, H. G., Parmar, M. K., & Abel, P. D. (2013). Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09). The Lancet Oncology, 14(4), 306–316. [DOI:10.1016/s1470-2045(13)70025-1]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., Paez, E., Robinson, A., McFarlane, J., Deighan, J. V., Marshall, J., Forcat, S., Weiss, M., Kockelbergh, R., Alhasso, A., Kynaston, H., & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/s0140-6736(21)00100-8] [PDF] [Supplementary appendix]
    • Lax, E. (1987). Mechanisms of physiological and pharmacological sex hormone action on the mammalian liver. Journal of Steroid Biochemistry, 27(4–6), 1119–1128. [DOI:10.1016/0022-4731(87)90198-1]
    • Lidegaard, Ø. (2014). Hormonal contraception, thrombosis and age. Expert Opinion on Drug Safety, 13(10), 1353–1360. [DOI:10.1517/14740338.2014.950654]
    • Lijfering, W. M., Rosendaal, F. R., & Cannegieter, S. C. (2010). Risk factors for venous thrombosis - current understanding from an epidemiological point of view. British Journal of Haematology, 149(6), 824–833. [DOI:10.1111/j.1365-2141.2010.08206.x]
    • Lim, H. Y., Leemaqz, S. Y., Torkamani, N., Grossmann, M., Zajac, J. D., Nandurkar, H., Ho, P., & Cheung, A. S. (2020). Global Coagulation Assays in Transgender Women on Oral and Transdermal Estradiol Therapy. The Journal of Clinical Endocrinology & Metabolism, 105(7), e2369–e2377. [DOI:10.1210/clinem/dgaa262]
    • Luria, M. H. (1989). Estrogen and coronary arterial disease in men. International Journal of Cardiology, 25(2), 159–166. [DOI:10.1016/0167-5273(89)90102-2]
    • Ma, Y., Zeng, M., Sun, R., & Hu, M. (2015). Disposition of Flavonoids Impacts their Efficacy and Safety. Current Drug Metabolism, 15(9), 841–864. [DOI:10.2174/1389200216666150206123719]
    • Machin, N., & Ragni, M. V. (2020). Hormones and thrombosis: risk across the reproductive years and beyond. Translational Research, 225, 9–19. [DOI:10.1016/j.trsl.2020.06.011]
    • Mammen, E. F. (1992). Coagulation Abnormalities in Liver Disease. Hematology/Oncology Clinics of North America, 6(6), 1247–1257. [DOI:10.1016/s0889-8588(18)30273-9]
    • Mantha, S., Karp, R., Raghavan, V., Terrin, N., Bauer, K. A., & Zwicker, J. I. (2012). Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ, 345, e4944. [DOI:10.1136/bmj.e4944]
    • Martinelli, I., Passamonti, S. M., & Bucciarelli, P. (2014). Thrombophilic states. In Biller, J., & Ferro, J. M. (Eds.). Neurologic Aspects of Systemic Disease Part II (Handbook of Clinical Neurology, Volume 120) (pp. 1061–1071). Philadelphia: Elsevier. [DOI:10.1016/b978-0-7020-4087-0.00071-1]
    • Martinez-Zapata, M. J., Vernooij, R. W., Uriona Tuma, S. M., Stein, A. T., Moreno, R. M., Vargas, E., Capellà, D., & Bonfill Cosp, X. (2016). Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews, 2016(4), CD003229. [DOI:10.1002/14651858.cd003229.pub3]
    • Matharu, G. S., Kunutsor, S. K., Judge, A., Blom, A. W., & Whitehouse, M. R. (2020). Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement. JAMA Internal Medicine, 180(3), 376–384. [DOI:10.1001/jamainternmed.2019.6108]
    • McLintock, C. (2014). Thromboembolism in pregnancy: Challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves. Best Practice & Research Clinical Obstetrics & Gynaecology, 28(4), 519–536. [DOI:10.1016/j.bpobgyn.2014.03.001]
    • Mekaj, A., Mekaj, Y., & Daci, F. (2015). New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Therapeutics and Clinical Risk Management, 11, 1449–1456. [DOI:10.2147/tcrm.s92222]
    • Mellinger, G. T., Bailar, J. C., Arduino, L. J., & the Veterans Administration Cooperative Urological Research Group. (1967). Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group. Surgery Gynecology & Obstetrics, 124(5), 1011–1017. [Google Scholar] [PubMed]
    • Meng, Y., Jiang, H., Chen, A., Lu, F., Yang, H., Shen, M. Z., Sun, D., Shao, Q., & Fotherby, K. (1990). Hemostatic changes in women using a monthly injectable contraceptive for one year. Contraception, 42(4), 455–466. [DOI:10.1016/0010-7824(90)90052-w]
    • Mikkola, A., Ruutu, M., Aro, J., Rannikko, S., & Salo, J. (1999). The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium. Annales Chirurgiae et Gynaecologiae, 88(1), 18–21. [Google Scholar] [PubMed] [PDF]
    • Min, L. L., & Hopkins, R. (2021). Endocrinological Care for Patients Undergoing Gender Affirmation (Including Risk of Thromboembolic Events). In Nikolavsky, D., & Blakely, S. A. (Eds.). Urological Care for the Transgender Patient: A Comprehensive Guide (pp. 23–36). Cham: Springer. [DOI:10.1007/978-3-030-18533-6_3]
    • Mohammed, K., Abu Dabrh, A. M., Benkhadra, K., Al Nofal, A., Carranza Leon, B. G., Prokop, L. J., Montori, V. M., Faubion, S. S., & Murad, M. H. (2015). Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4012–4020. [DOI:10.1210/jc.2015-2237]
    • Montagnana, M., Favaloro, E. J., Franchini, M., Guidi, G. C., & Lippi, G. (2009). The role of ethnicity, age and gender in venous thromboembolism. Journal of Thrombosis and Thrombolysis, 29(4), 489–496. [DOI:10.1007/s11239-009-0365-8]
    • Moores, L., Bilello, K. L., & Murin, S. (2004). Sex and gender issues and venous thromboembolism. Clinics in Chest Medicine, 25(2), 281–297. [DOI:10.1016/j.ccm.2004.01.013]
    • Morimont, L., Dogné, J., & Douxfils, J. (2020). Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40–51). Thrombosis Research, 193, 221–223. [DOI:10.1016/j.thromres.2020.08.006]
    • Morimont, L., Haguet, H., Dogné, J., Gaspard, U., & Douxfils, J. (2021). Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology, 12, 769187. [DOI:10.3389/fendo.2021.769187]
    • Morling, J. R., Broderick, C., Yeoh, S. E., & Kolbach, D. N. (2018). Rutosides for treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews, 2018(11), CD005625. [DOI:10.1002/14651858.cd005625.pub4]
    • Mueller, A., Dittrich, R., Binder, H., Kuehnel, W., Maltaris, T., Hoffmann, I., & Beckmann, M. W. (2005). High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. European Journal of Endocrinology, 153(1), 107–113. [DOI:10.1530/eje.1.01943]
    • Mueller, A., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Dittrich, R. (2006). Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female Transsexuals. Hormone and Metabolic Research, 38(3), 183–187. [DOI:10.1055/s-2006-925198]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • Nachtigall, L. E., Raju, U., Banerjee, S., Wan, L., & Levitz, M. (2000). Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies. Menopause, 7(4), 243–250. [DOI:10.1097/00042192-200007040-00006]
    • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016]
    • Nolan, B. J., & Cheung, A. S. (2020). Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy. The Yale Journal of Biology and Medicine, 93(4), 539–548. [PubMed] [PubMed Central]
    • Nolan, B. J., & Cheung, A. S. (2021). Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review. Transgender Health, 6(3), 125–131. [DOI:10.1089/trgh.2020.0077]
    • Nolan, I. T., Haley, C., Morrison, S. D., Pannucci, C. J., & Satterwhite, T. (2021). Estrogen Continuation and Venous Thromboembolism in Penile Inversion Vaginoplasty. The Journal of Sexual Medicine, 18(1), 193–200. [DOI:10.1016/j.jsxm.2020.10.018]
    • Ockrim, J., & Abel, P. D. (2009). Androgen deprivation therapy for prostate cancer – the potential of parenteral estrogen. Central European Journal of Urology, 62, 132–140. [DOI:10.5173/ceju.2009.03.art1]
    • Odlind, V., Milsom, I., Persson, I., & Victor, A. (2002). Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?: A discussion based on recent recommendations from the European agency for evaluation of medicinal products regarding third generation oral contraceptive pills. Acta Obstetricia et Gynecologica Scandinavica, 81(6), 482–490. [DOI:10.1080/j.1600-0412.2002.810603.x] [URL]
    • Oger, E., & (2000). Incidence of Venous Thromboembolism: A Community-based Study in Western France. Thrombosis and Haemostasis, 83(5), 657–660. [DOI:10.1055/s-0037-1613887]
    • Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018). Erythrocytosis Following Testosterone Therapy. Sexual Medicine Reviews, 6(1), 77–85. [DOI:10.1016/j.sxmr.2017.04.001]
    • Olié, V., Canonico, M., & Scarabin, P. (2010). Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Current Opinion in Hematology, 17(5), 457–463. [DOI:10.1097/moh.0b013e32833c07bc]
    • Olié, V., Plu-Bureau, G., Conard, J., Horellou, M., Canonico, M., & Scarabin, P. (2011). Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause, 18(5), 488–493. [DOI:10.1097/gme.0b013e3181f9f7c3]
    • Oliver-Williams, C., Glisic, M., Shahzad, S., Brown, E., Pellegrino Baena, C., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2018). The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update, 25(2), 257–271. [DOI:10.1093/humupd/dmy039]
    • Olov Hedlund, P., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., Olov Hedlund, P., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., & The SPCG-5 Study Group. (2008). Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology, 42(3), 220–229. [DOI:10.1080/00365590801943274]
    • Park, W. (2002). Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends in Molecular Medicine, 8(2), 82–88. [DOI:10.1016/s1471-4914(02)02282-7]
    • Patel, K. T., Adeel, S., Rodrigues Miragaya, J., & Tangpricha, V. (2022). Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocrine Practice, 28(12), 1244–1252. [DOI:10.1016/j.eprac.2022.08.012]
    • Peck-Radosavljevic, M. (2007). Review article: coagulation disorders in chronic liver disease. Alimentary Pharmacology & Therapeutics, 26, 21–28. [DOI:10.1111/j.1365-2036.2007.03509.x]
    • Pfeifer, S., Butts, S., Dumesic, D., Fossum, G., Gracia, C., La Barbera, A., Mersereau, J., Odem, R., Penzias, A., Pisarska, M., Rebar, R., Reindollar, R., Rosen, M., Sandlow, J., Sokol, R., Vernon, M., & Widra, E. (2017). Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertility and Sterility, 107(1), 43–51. [DOI:10.1016/j.fertnstert.2016.09.027]
    • Phillips, I., Shah, S. I., Duong, T., Abel, P., & Langley, R. E. (2014). Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer. Oncology & Hematology Review, 10(1), 42–47. [PubMed Central] [DOI:10.17925/ohr.2014.10.1.42] [URL]
    • Plu-Bureau, G., Maitrot-Mantelet, L., Hugon-Rodin, J., & Canonico, M. (2013). Hormonal contraceptives and venous thromboembolism: An epidemiological update. Best Practice & Research Clinical Endocrinology & Metabolism, 27(1), 25–34. [DOI:10.1016/j.beem.2012.11.002]
    • Pomp, E. R., Rosendaal, F. R., & Doggen, C. J. (2008). Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology, 83(2), 97–102. [DOI:10.1002/ajh.21059]
    • Pond, S. M., & Tozer, T. N. (1984). First-Pass Elimination. Clinical Pharmacokinetics, 9(1), 1–25. [DOI:10.2165/00003088-198409010-00001]
    • Prentice, R. L., & Anderson, G. L. (2008). The Women’s Health Initiative: Lessons Learned. Annual Review of Public Health, 29(1), 131–150. [DOI:10.1146/annurev.publhealth.29.020907.090947]
    • Prentice, R. (2014). Postmenopausal Hormone Therapy and the Risks of Coronary Heart Disease, Breast Cancer, and Stroke. Seminars in Reproductive Medicine, 32(6), 419–425. [DOI:10.1055/s-0034-1384624]
    • Pyra, M., Casimiro, I., Rusie, L., Ross, N., Blum, C., Keglovitz Baker, K., Baker, A., & Schneider, J. (2020). An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy. Transgender Health, 5(1), 1–9. [DOI:10.1089/trgh.2019.0061]
    • Quinton, R., & Swee, D. S. (2019). Hormone replacement therapy: transgender studies show safety of estradiol. BMJ, 364, l600. [DOI:10.1136/bmj.l600]
    • Rabe, T., Luxembourg, B., Ludwig, M., Dinger, J. C., Bauersachs, R., Rott, H., Mueck, A. O., & Albring, C. (2011). Contraception and Thrombophilia - A statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.). Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 8(Special Issue 1), 178–218. [URL]
    • Raps, M., Helmerhorst, F., Fleischer, K., Thomassen, S., Rosendaal, F., Rosing, J., Ballieux, B., & Van Vliet, H. (2012). Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives. Journal of Thrombosis and Haemostasis, 10(6), 992–997. [DOI:10.1111/j.1538-7836.2012.04720.x]
    • Ravery, V., Fizazi, K., Oudard, S., Drouet, L., Eymard, J., Culine, S., Gravis, G., Hennequin, C., & Zerbib, M. (2011). The use of estramustine phosphate in the modern management of advanced prostate cancer. BJU International, 108(11), 1782–1786. [DOI:10.1111/j.1464-410x.2011.10201.x]
    • Reda, S., Morimont, L., Douxfils, J., & Rühl, H. (2020). Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests? Hämostaseologie, 40(3), 364–378. [DOI:10.1055/a-1153-5824]
    • Renoux, C., Dell’Aniello, S., & Suissa, S. (2010). Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. Journal of Thrombosis and Haemostasis, 8(5), 979–986. [DOI:10.1111/j.1538-7836.2010.03839.x]
    • Renoux, C., Dell’Aniello, S., Garbe, E., & Suissa, S. (2010). Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ, 340, c2519. [DOI:10.1136/bmj.c2519]
    • Roach, R., Lijfering, W., Helmerhorst, F., Cannegieter, S., Rosendaal, F., & van Hylckama Vlieg, A. (2013). The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. Journal of Thrombosis and Haemostasis, 11(1), 124–131. [DOI:10.1111/jth.12060]
    • Roach, R. E., Lijfering, W. M., Rosendaal, F. R., Cannegieter, S. C., & le Cessie, S. (2014). Sex Difference in Risk of Second but Not of First Venous Thrombosis. Circulation, 129(1), 51–56. [DOI:10.1161/circulationaha.113.004768]
    • Rooijen, M., Silveira, A., Hamsten, A., & Bremme, K. (2004). Sex hormone–binding globulin—A surrogate marker for the prothrombotic effects of combined oral contraceptives. American Journal of Obstetrics and Gynecology, 190(2), 332–337. [DOI:10.1016/s0002-9378(03)00950-5]
    • Ropponen, A., Aittomäki, K., Vihma, V., Tikkanen, M. J., & Ylikorkala, O. (2005). Effects of Oral and Transdermal Estradiol Administration on Levels of Sex Hormone-Binding Globulin in Postmenopausal Women with and without a History of Intrahepatic Cholestasis of Pregnancy. The Journal of Clinical Endocrinology & Metabolism, 90(6), 3431–3434. [DOI:10.1210/jc.2005-0352]
    • Rosendaal, F. R. (2005). Venous thrombosis: the role of genes, environment, and behavior. Hematology American Society of Hematology Education Program, 2005(1), 1–12. [Google Scholar] [DOI:10.1182/asheducation-2005.1.1] [URL]
    • Rosendaal, F. R. (2016). Causes of venous thrombosis. Thrombosis Journal, 14(Suppl 1) [State of the Art 2016: Research and Review from the 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis], 24. [DOI:10.1186/s12959-016-0108-y]
    • Rott, H. (2019). Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen. Hämostaseologie, 39(1), 42–48. [DOI:10.1055/s-0039-1677806]
    • Rova, K., Passmark, H., & Lindqvist, P. G. (2012). Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertility and Sterility, 97(1), 95–100. [DOI:10.1016/j.fertnstert.2011.10.038]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
    • Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J. L., & Bort-Martí, S. (2013). Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database of Systematic Reviews, 2019(3), CD004310. [DOI:10.1002/14651858.cd004310.pub3]
    • Russell, N., Cheung, A., & Grossmann, M. (2017). Estradiol for the mitigation of adverse effects of androgen deprivation therapy. Endocrine-Related Cancer, 24(8), R297–R313. [DOI:10.1530/erc-17-0153]
    • Sahlin, L., & Schoultz, B. V. (1999). Liver Inclusive Protein, Lipid and Carbohydrate Metabolism. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 163–178). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_8] [PDF]
    • Scarabin, P. (2018). Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis. Climacteric, 21(4), 341–345. [DOI:10.1080/13697137.2018.1446931]
    • Scarabin, P., Canonico, M., Plu-Bureau, G., & Oger, E. (2020). Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone? Heart, 106(16), 1278–1278. [DOI:10.1136/heartjnl-2020-316907]
    • Scheres, L. J., van Hylckama Vlieg, A., Ballieux, B. E., Fauser, B. C., Rosendaal, F. R., Middeldorp, S., & Cannegieter, S. C. (2019). Endogenous sex hormones and risk of venous thromboembolism in young women. Journal of Thrombosis and Haemostasis, 17(8), 1297–1304. [DOI:10.1111/jth.14474]
    • Scheres, L. J., Selier, N. L., Nota, N. M., van Diemen, J. J., Cannegieter, S. C., & den Heijer, M. (2021). Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen. Journal of Thrombosis and Haemostasis, 19(4), 1029–1037. [DOI:10.1111/jth.15256]
    • Schindler, A. E. (2003). Differential effects of progestins on hemostasis. Maturitas, 46, 31–37. [DOI:10.1016/j.maturitas.2003.09.016]
    • Schock, H., Zeleniuch-Jacquotte, A., Lundin, E., Grankvist, K., Lakso, H., Idahl, A., Lehtinen, M., Surcel, H., & Fortner, R. T. (2016). Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy and Childbirth, 16(1), 146. [DOI:10.1186/s12884-016-0937-5]
    • Schröder, F. H., & Radlmaier, A. (2002). Steroidal Antiandrogens. In Jordan, C. V., & Furr, B. J. A. (Eds.). Hormone Therapy in Breast and Prostate Cancer (pp. 325–346). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-152-7_15]
    • Sciarra, A., Gentile, V., Cattarino, S., Gentilucci, A., Alfarone, A., D’Eramo, G., & Salciccia, S. (2014). Oral ethinylestradiol in castration-resistant prostate cancer: A 10-year experience. International Journal of Urology, 22(1), 98–103. [DOI:10.1111/iju.12613]
    • Seaman, H. E., Langley, S. E., Farmer, R. D., & de Vries, C. S. (2007). Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database. BJU International, 99(6), 1398–1403. [DOI:10.1111/j.1464-410x.2007.06859.x]
    • Shatzel, J. J., Connelly, K. J., & DeLoughery, T. G. (2017). Thrombotic issues in transgender medicine: A review. American Journal of Hematology, 92(2), 204–208. [DOI:10.1002/ajh.24593]
    • Shifren, J. L., Rifai, N., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2008). A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1702–1710. [DOI:10.1210/jc.2007-2193]
    • Simon, T., De Jonage-Canonico, M. B., Oger, E., Wahl, D., Conard, J., Meyer, G., Emmerich, J., Barrellier, M., Guiraud, A., & Scarabin, P. (2006). Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. Journal of Thrombosis and Haemostasis, 4(1), 71–76. [DOI:10.1111/j.1538-7836.2005.01693.x]
    • Singla, N., Ghandour, R. A., & Raj, G. V. (2019). Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer. Expert Opinion on Investigational Drugs, 28(3), 249–259. [DOI:10.1080/13543784.2019.1570130]
    • Sitruk-Ware, R., & Nath, A. (2011). Metabolic effects of contraceptive steroids. Reviews in Endocrine and Metabolic Disorders, 12(2), 63–75. [DOI:10.1007/s11154-011-9182-4]
    • Sitruk-Ware, R., & Nath, A. (2013). Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research Clinical Endocrinology & Metabolism, 27(1), 13–24. [DOI:10.1016/j.beem.2012.09.004]
    • Skouby, S. O., & Sidelmann, J. J. (2018). Impact of progestogens on hemostasis. Hormone Molecular Biology and Clinical Investigation, 37(2), 20180041. [DOI:10.1515/hmbci-2018-0041]
    • Smith, K., Galazi, M., Openshaw, M. R., Wilson, P., Sarker, S. J., O’Brien, N., Alifrangis, C., Stebbing, J., & Shamash, J. (2020). The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. Clinical Genitourinary Cancer, 18(3), e217–e223. [DOI:10.1016/j.clgc.2019.09.019]
    • Smith, N. L. (2004). Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous Thrombosis. JAMA, 292(13), 1581–1587. [DOI:10.1001/jama.292.13.1581]
    • Smith, N. L., Blondon, M., Wiggins, K. L., Harrington, L. B., van Hylckama Vlieg, A., Floyd, J. S., Hwang, M., Bis, J. C., McKnight, B., Rice, K. M., Lumley, T., Rosendaal, F. R., Heckbert, S. R., & Psaty, B. M. (2014). Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens. JAMA Internal Medicine, 174(1), 25–34. [DOI:10.1001/jamainternmed.2013.11074]
    • Speroff, L. (1996). The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study). JAMA, 276(17), 1397–1403. [DOI:10.1001/jama.1996.03540170041030]
    • Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013). Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception, 87(6), 706–727. [DOI:10.1016/j.contraception.2012.12.011]
    • Stanczyk, F. Z., Mathews, B. W., & Cortessis, V. K. (2017). Does the type of progestin influence the production of clotting factors? Contraception, 95(2), 113–116. [DOI:10.1016/j.contraception.2016.07.007]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., & Pousette, A. (1988). Single drug polyestradiol phosphate therapy in prostatic cancer. American Journal of Clinical Oncology, 11(Suppl 2), S101–S103. [DOI:10.1097/00000421-198801102-00024] [PDF]
    • Stegeman, B., Raps, M., Helmerhorst, F., Vos, H., van Vliet, H., Rosendaal, F., & van Hylckama Vlieg, A. (2013). Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone‐binding globulin levels in premenopausal women. Journal of Thrombosis and Haemostasis, 11(1), 203–205. [DOI:10.1111/jth.12054]
    • Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015). Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011. [DOI:10.1210/jc.2015-2236]
    • Sudhir, K., & Komesaroff, P. A. (1999). Cardiovascular Actions of Estrogens in Men. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3411–3415. [DOI:10.1210/jcem.84.10.5954]
    • Swee, D. S., Javaid, U., & Quinton, R. (2019). Estrogen Replacement in Young Hypogonadal Women—Transferrable Lessons From the Literature Related to the Care of Young Women With Premature Ovarian Failure and Transgender Women. Frontiers in Endocrinology, 10, 685. [DOI:10.3389/fendo.2019.00685]
    • Tadd, W., & Bayer, A. (2006). Dignity in health and social care for older Europeans: implications of a European project. Aging Health, 2(5), 771–779. [DOI:10.2217/1745509x.2.5.771]
    • Taylor, J. K., & Pendleton, N. (2016). Progesterone therapy for the treatment of non-cancer cachexia: a systematic review. BMJ Supportive & Palliative Care, 6(3), 276–286. [DOI:10.1136/bmjspcare-2015-001041]
    • Tchaikovski, S. N., & Rosing, J. (2010). Mechanisms of Estrogen-Induced Venous Thromboembolism. Thrombosis Research, 126(1), 5–11. [DOI:10.1016/j.thromres.2010.01.045]
    • Tepper, N. K., Whiteman, M. K., Marchbanks, P. A., James, A. H., & Curtis, K. M. (2016). Progestin-only contraception and thromboembolism: A systematic review. Contraception, 94(6), 678–700. [DOI:10.1016/j.contraception.2016.04.014]
    • Tepper, N. K., Jeng, G., Curtis, K. M., Boutot, M. E., Boulet, S. L., & Whiteman, M. K. (2019). Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum. Obstetrics & Gynecology, 133(3), 533–540. [DOI:10.1097/aog.0000000000003135]
    • The Coronary Drug Project Research Group. (1970). The Coronary Drug Project. JAMA, 214(7), 1303–1313. [DOI:10.1001/jama.1970.03180070069012]
    • The Coronary Drug Project Research Group. (1973). The Coronary Drug Project. JAMA, 226(6), 652–657. [DOI:10.1001/jama.1973.03230060030009]
    • The Oral Contraceptive and Hemostasis Study Group. (1999). An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Contraception, 59(6), 345–355. [DOI:10.1016/s0010-7824(99)00044-x]
    • Timp, J. F., Braekkan, S. K., Versteeg, H. H., & Cannegieter, S. C. (2013). Epidemiology of cancer-associated venous thrombosis. Blood, 122(10), 1712–1723. [DOI:10.1182/blood-2013-04-460121]
    • Toorians, A. W., Thomassen, M. C., Zweegman, S., Magdeleyns, E. J., Tans, G., Gooren, L. J., & Rosing, J. (2003). Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5723–5729. [DOI:10.1210/jc.2003-030520]
    • Totaro, M., Palazzi, S., Castellini, C., Parisi, A., D’Amato, F., Tienforti, D., Baroni, M. G., Francavilla, S., & Barbonetti, A. (2021). Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study. Frontiers in Endocrinology, 12, 741866. [DOI:10.3389/fendo.2021.741866]
    • Trémollieres, F. (2012). Contraception orale estro-progestative: quelle différence entre éthinylestradiol et estradiol? [Oral combined contraception: Is there any difference between ethinyl-estradiol and estradiol?] Gynécologie Obstétrique & Fertilité, 40(2), 109–115. [DOI:10.1016/j.gyobfe.2011.10.009]
    • Turo, R., Smolski, M., Esler, R., Kujawa, M. L., Bromage, S. J., Oakley, N., Adeyoju, A., Brown, S. C., Brough, R., Sinclair, A., & Collins, G. N. (2013). Diethylstilboestrol for the treatment of prostate cancer: past, present and future. Scandinavian Journal of Urology, 48(1), 4–14. [DOI:10.3109/21681805.2013.861508]
    • United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, & Task Force on Long-acting Systemic Agents for Fertility Regulation. (2003). Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem® and Mesigyna®) and one oral contraceptive (Ortho-Novum 1/35®) on coagulation and fibrinolysis. Contraception, 68(3), 159–176. [DOI:10.1016/s0010-7824(03)00164-1]
    • van Hylckama Vlieg, A., Helmerhorst, F. M., & Rosendaal, F. R. (2010). The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(11), 2297–2300. [DOI:10.1161/atvbaha.110.211482]
    • Van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47(3), 337–343. [DOI:10.1046/j.1365-2265.1997.2601068.x]
    • van Vliet, H. A., Frolich, M., Christella, M., Thomassen, L., Doggen, C. J., Rosendaal, F. R., Rosing, J., & Helmerhorst, F. M. (2005). Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. Human Reproduction, 20(2), 563–568. [DOI:10.1093/humrep/deh612]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2015). Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 350, h2135. [DOI:10.1136/bmj.h2135]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. [DOI:10.1136/bmj.k4810]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Walker, I. D. (2010). Obstetrics, Contraception, and Estrogen Replacement. In Key, N., Makris, M., O’Shaughnessy, D., & Lillicrap, D. (Eds.). Practical Hemostasis and Thrombosis, 2nd Edition (pp. 247–257). Oxford: Wiley-Blackwell. [DOI:10.1002/9781444306286.ch24]
    • Weinand, J. D., & Safer, J. D. (2015). Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals. Journal of Clinical & Translational Endocrinology, 2(2), 55–60. [DOI:10.1016/j.jcte.2015.02.003]
    • Westerlund, E., Henriksson, P., Wallén, H., Hovatta, O., Wallberg, K. R., & Antovic, A. (2012). Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thrombosis Research, 130(4), 649–653. [DOI:10.1016/j.thromres.2011.11.024]
    • White, C. M., Ferraro‐Borgida, M. J., Fossati, A. T., McGill, C. C., Ahlberg, A. W., Feng, Y. J., Heller, G. V., & Chow, M. S. (1998). The Pharmacokinetics of Intravenous Estradiol—A Preliminary Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 18(6), 1343–1346. [DOI:10.1002/j.1875-9114.1998.tb03157.x]
    • Wiegratz, I., & Kuhl, H. (2006). Metabolic and clinical effects of progestogens. The European Journal of Contraception & Reproductive Health Care, 11(3), 153–161. [DOI:10.1080/13625180600772741]
    • Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T’Sjoen, G. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study. European Journal of Endocrinology, 169(4), 471–478. [DOI:10.1530/eje-13-0493]
    • Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321–333. [DOI:10.1001/jama.288.3.321]
    • Zhang, M., Zhu, S., Yang, W., Huang, Q., & Ho, C. (2021). The biological fate and bioefficacy of citrus flavonoids: bioavailability, biotransformation, and delivery systems. Food & Function, 12(8), 3307–3323. [DOI:10.1039/d0fo03403g]
    • Zhao, J., Yang, J., & Xie, Y. (2019). Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. International Journal of Pharmaceutics, 570, 118642. [DOI:10.1016/j.ijpharm.2019.118642]
    • Zucker, R., Reisman, T., & Safer, J. D. (2021). Minimizing Venous Thromboembolism in Feminizing Hormone Therapy: Applying Lessons From Cisgender Women and Previous Data. Endocrine Practice, 27(6), 621–625. [DOI:10.1016/j.eprac.2021.03.010]
    \ No newline at end of file +Estrogens and Their Influences on Coagulation and Risk of Blood Clots - Transfeminine Science Link

    Estrogens and Their Influences on Coagulation and Risk of Blood Clots

    By Aly | First published October 20, 2020 | Last modified March 28, 2023

    Abstract / TL;DR

    Estrogens increase coagulation by activating estrogen receptors in the liver and thereby modulating the production of a variety of circulating coagulation factors. With sufficiently high exposure, this can result in an increase in the risk of blood clots as well as coagulation-associated cardiovascular complications like heart attack and stroke. However, the degrees of risk vary depending on the estrogen type, route, and dose. Non-bioidentical estrogens like ethinylestradiol have greater strength in the liver due to their relative resistance to metabolism and increase blood clot risk more readily than bioidentical estradiol, while oral administration of estradiol results in a first pass through the liver and has greater impact on blood clot risk than non-oral estradiol. Physiological estradiol levels with non-oral estradiol appear to have minimal to no risk of blood clots, whereas oral estradiol has significant risk and at high doses may have risk similar to that of the doses of ethinylestradiol in modern birth control pills. Higher estradiol levels with non-oral estradiol seem to have significant risk of blood clots and cardiovascular problems as well, although the risks appear to be lower than with ethinylestradiol-containing birth control pills. Absolute risks of blood clots are low but accumulate with time and add up on a population scale. In addition, a variety of risk factors, such as age, physical inactivity, concomitant progestogen use, and often-unknown thrombophilic abnormalities, can substantially augment risk. Due to their higher risks of blood clots, oral estradiol as well as excessive doses of non-oral estradiol should ideally be avoided in transfeminine people. This is particularly applicable in those with risk factors for blood clots. In any case, therapeutic considerations for transfeminine people include not only safety but also effectiveness, other factors like cost and convenience, and the natures of the alternative therapeutic options.

    Introduction

    Estrogens increase coagulation (blood clotting) and the risk of thrombosis, a cardiovascular event otherwise known as a blood clot. There are two major types of blood clots, which are categorized depending on whether they happen in a vein or in an artery: (1) venous thrombosis or venous thromboembolism (VTE); and (2) arterial thrombosis. VTE is a blood clot in a vein, a blood vessel that carries blood towards the heart. It comprises two different subtypes: (1) deep vein thrombosis (DVT), a clot in a vein of the leg or pelvic region; and (2) pulmonary embolism (PE), a clot that has broken free and blocked an artery in the lungs. Arterial thrombosis is a blood clot in an artery, a blood vessel that carries blood away from the heart. Arterial thrombosis can lead to myocardial infarction (MI; also known as heart attack) or cerebrovascular accident (CVA; also known as stroke). Blood clots are major health problems that can cause serious complications and even death. Estrogens, via increased coagulation with sufficiently high exposure, have the potential to heighten the risk of both venous and arterial thrombosis and hence to increase all of the aforementioned risks. The risk of blood clots with estrogens serves as a limiting factor in their use due to the potential health consequences.

    Estrogens are selective agonists of the estrogen receptors (ERs). They are thought to increase coagulation and hence blood clot risk by activating ERs. However, the impact on coagulation and risk of blood clots with estrogens varies due to factors like estrogen type, route, and dose. In addition, other factors, like concomitant progestogen use and a variety of non-hormonal factors, are known to modify the risk. The purpose of this article is to review the risks of blood clots with estrogens, the mechanisms underlying increased coagulation and blood clot risk with estrogens, and the reasons for differences among estrogens in terms of risk. Exploring these topics can inform estrogen dosing considerations in transfeminine people and help to minimize risks and optimize safety. Moreover, higher levels of estrogens are therapeutically useful for suppressing testosterone production in transfeminine people but may increase blood clot risk, and risk–benefit analysis is warranted in this context.

    Blood Clot Risks with Estrogens and Progestogens

    A variety of estrogens have been used in medicine. These include bioidentical estrogens like estradiol as well as non-bioidentical estrogens like conjugated estrogens (CEEs; Premarin), ethinylestradiol (EE), and diethylstilbestrol (DES). Estradiol is the major natural estrogen in the human body. CEEs deliver primarily estradiol as the active estrogen, but also contain significant quantities of naturally occurring equine (horse) estrogens such as equilin (7-dehydroestrone) and 17β-dihydroequilin (7-dehydroestradiol). EE and DES are synthetic estrogens that were created by humans and do not occur naturally. DES was discontinued decades ago and is relatively little-known today, but has significant historical importance. Estradiol is used in both oral and non-oral forms (e.g., transdermal patches), while the non-bioidentical estrogens have typically been used orally. For context, the table below shows some approximate comparable doses of these estrogens in terms of general estrogenicity.

    Table 1: Approximate or estimated comparable doses of estrogens in terms of general/systemic estrogenicity (Aly, 2020; Kuhl, 2005; Table; Table; Table):

    Estrogen type/routeVery low dose aLow dose aModerate dose bHigh dose
    Oral estradiol1 mg/day2 mg/day4 mg/day8 mg/day
    Transdermal estradiolc25 μg/day50 μg/day100 μg/day200 μg/day
    Oral conjugated estrogens0.625 mg/day1.25 mg/day2.5 mg/day5 mg/day
    Oral ethinylestradiol7.5 μg/day15 μg/day30 μg/day60 μg/day
    Oral diethylstilbestrol0.375 mg/day0.75 mg/day1.5 mg/day3 mg/day
    Comparable estradiol level~25 pg/mL~50 pg/mL~100 pg/mL~200 pg/mL

    a Menopausal replacement dosages. b Similar to normal mean/integrated estrogenic exposure during the menstrual cycle in premenopausal women (Aly, 2018). c Specifically transdermal patches.

    Estrogens were first associated with blood clots and associated cardiovascular complications in the 1960s and 1970s. Significant to substantial increases in these risks were found in clinical trials of high-dose DES (5 mg/day) for prostate cancer in men (VACURG, 1967; Byar, 1973; Turo et al., 2014), trials of moderate-dose CEEs (2.5–5 mg/day) for prevention of heart disease in men (Coronary Drug Project Research Group, 1970; Coronary Drug Project Research Group, 1973; Luria, 1989; Sudhir & Komesaroff, 1999; Dutra et al., 2019), and studies of early high-dose EE-containing birth control pills (50–150 μg/day) in premenopausal women (Gerstman et al., 1991; PCASRM, 2017; Table). The increase in cardiovascular events with DES in men with prostate cancer was sufficiently great that it actually cancelled out the benefits of its effects against prostate cancer in terms of overall mortality. The large increases in blood clots and cardiovascular problems seen in these studies resulted in alarm and concern about the safety of estrogens. Consequent to these events, estrogen doses were lowered. DES for prostate cancer was decreased to 1 to 3 mg/day and EE in birth control pills was decreased to 20 to 35 μg/day. Estrogens were also reduced to lower doses for other indications, such as menopausal hormone therapy. The dose reductions helped to lower the risks, although it did not eliminate them.

    In the Women’s Health Initiative (WHI) randomized controlled trials (RCTs), low-dose oral CEEs alone (0.625 mg/day) were shown to slightly increase the risk of blood clots (Anderson et al., 2004; Curb et al., 2006; Prentice & Anderson, 2008; Prentice, 2014; Table). In addition, the increase was considerably augmented by concomitant use of a low dose (2.5 mg/day) of the progestogen medroxyprogesterone acetate (MPA) (Rossouw et al., 2002; Cushman et al., 2004; Prentice & Anderson, 2008; Prentice, 2014; Table). Increased risk of blood clots with low-dose oral CEEs plus low-dose MPA was also shown in another large RCT, the Heart and Estrogen/Progestin Replacement Study (HERS) (Hulley et al., 1998; Grady et al., 2000). Other progestogens besides MPA are also associated with augmentation of blood clot risk related to oral estrogens (Rovinski et al., 2018; Scarabin, 2018; Oliver-Williams et al., 2019; Vinogradova, Coupland, & Hippisley-Cox, 2019; Table). Large observational studies have found low-dose oral estradiol (generally ≤2 mg/day) to be dose-dependently associated with increased risk of blood clots similarly to CEEs (Olié, Canonico, & Scarabin, 2010; Renoux, Dell’Aniello, & Suissa, 2010; Vinogradova, Coupland, & Hippisley-Cox, 2019; Konkle & Sood, 2019; Table). However, the risk with oral estradiol or with oral esterified estrogens (a CEEs-like preparation with reduced equine estrogen content) appears to be lower than with oral CEEs (Smith et al., 2004; Smith et al., 2014; Vinogradova, Coupland, & Hippisley-Cox, 2019; Table). On the other hand, in another large observational study, oral estradiol and oral CEEs both in combination with progestogens appeared to show similarly increased risk of blood clots (Roach et al., 2013). As with oral CEEs, progestogens appear to augment the blood clot risk with oral estradiol (Vinogradova, Coupland, & Hippisley-Cox, 2019; Table).

    In contrast to oral estrogens, transdermal estradiol at low to moderate doses (50–100 μg/day) has generally not been associated with increased coagulation nor with increased risk of blood clots or associated cardiovascular complications (Canonico et al., 2008; Hemelaar et al., 2008; Olié, Canonico, & Scarabin, 2010; Renoux, Dell’Aniello, & Suissa, 2010; Mohammed et al., 2015; Stuenkel et al., 2015; Bezwada, Shaikh, & Misra, 2017; Rovinski et al., 2018; Scarabin, 2018; Konkle & Sood, 2019; Oliver-Williams et al., 2019; Vinogradova, Coupland, & Hippisley-Cox, 2019; Abou-Ismail, Sridhar, & Nayak, 2020; Table). Similarly, the Menopause, Estrogen and Venous Events (MEVE) study found that oral estradiol was associated with a large increase in risk of blood clots in women with previous history of blood clots whereas transdermal estradiol (mean dose 50 μg/day) was associated with no risk increase (Olié et al., 2011). However, there are some exceptions on findings of transdermal estradiol and cardiovascular risks, for instance one observational study finding an increased risk of stroke with higher-dose (>50 μg/day) transdermal estradiol patches in menopausal women (Renoux et al., 2010; Oliver-Williams et al., 2019) and studies finding only small differences or no difference in coagulation between oral estradiol and transdermal estradiol in transfeminine people (Lim et al., 2020; Scheres et al., 2021). Studies are mixed on whether the combination of transdermal estradiol at menopausal doses with progestogens is associated with greater blood clot risk, with some finding no change and others finding increased risk (Rovinski et al., 2018; Scarabin, 2018; Vinogradova, Coupland, & Hippisley-Cox, 2019). It has been suggested that this may be related to the type of progestogen used (Scarabin, 2018).

    There is little quality clinical data at this time on the risk of blood clots with higher doses of oral or transdermal estradiol than those used in menopausal hormone therapy. In any case, risk of blood clots has been assessed limitedly in transfeminine hormone therapy with regimens containing oral estradiol (e.g., 2–8 mg/day) generally in combination with other agents (antiandrogens and/or progestogens). In these studies, blood clot risk has been reported to be increased to a greater extent than with the low doses of oral estradiol used in menopausal hormone therapy (Wierckx et al., 2013; Weinand & Safer, 2015; Arnold et al., 2016; Getahun et al., 2018; Irwig, 2018; Connelly et al., 2019; Connors & Middeldorp, 2019; Goldstein et al., 2019; Iwamoto et al., 2019; Khan et al., 2019; Konkle & Sood, 2019; Quinton, 2019; Swee, Javaid, & Quinton, 2019; Abou-Ismail, Sridhar, & Nayak, 2020).

    Whereas the WHI demonstrated causation for oral CEEs alone in terms of blood clot risk, no adequately powered RCTs have been conducted with oral or transdermal estradiol alone to establish causation in terms of blood clot risk at this time. Only very large and expensive trials would be able to show this due to the rarity of blood clots, and these studies have not been conducted to date. For similar reasons, RCTs demonstrating increased risk of blood clots with EE-containing birth control pills have also not been conducted at this time (Moores, Bilello, & Murin, 2004). In any case, causation has clearly been demonstrated with estrogens in other contexts, and this can be assumed as likely in the case of oral estradiol similarly. In addition, the Estrogen in Venous Thromboembolism Trial (EVTET), an RCT of low-dose (2 mg/day) oral estradiol plus the progestogen norethisterone acetate (NETA) versus placebo in postmenopausal women with history of previous blood clots, found that this hormone therapy regimen significantly increased coagulation and the incidence of blood clots (10.7% incidence with hormone therapy and 2.3% with placebo; P = 0.04) (Høibraaten et al., 2000; Høibraaten et al., 2001).

    Estradiol levels appear to not be associated with blood clot risk in premenopausal women (Holmegard et al., 2014). The fact that transdermal estradiol patches at 100 μg/day in menopausal women haven’t been associated with a greater risk of blood clots is notable as this dose achieves estradiol levels of around 100 pg/mL on average, which are similar to the mean integrated levels of estradiol during the normal menstrual cycle in premenopausal women (Aly, 2018; Wiki). Rates of blood clots are also similar between men—who have relatively low estradiol levels—and women after controlling for atypical hormonal states like pregnancy and use of birth control pills in women (Moores, Bilello, & Murin, 2004; Rosendaal, 2005; Montagnana et al., 2010; Roach et al., 2013). Interestingly however, men have a consistently higher incidence of recurrent blood clots than women (Roach et al., 2013). These findings suggest that physiological levels of estradiol and progesterone in premenopausal women may not meaningfully increase coagulation or blood clot risk. However, the available data are mixed, with some studies suggesting that estradiol and/or progesterone levels within physiological ranges may indeed influence coagulation (Chaireti et al., 2013) and blood clot risk in premenopausal and/or perimenopausal women (Simon et al., 2006; Canonico et al., 2014; Scheres et al., 2019).

    Modern combined birth control pills contain EE at moderately estrogenic doses (20–35 μg/day) and a physiological dose of a progestogen. They increase the risk of blood clots by several-fold (Konkle & Sood, 2019; Vinogradova, Coupland, & Hippisley-Cox, 2015; Table). In addition, they are associated with about a 1.5- to 2-fold increase in risk of heart attack and stroke (Lidegaard, 2014; Konkle & Sood, 2019). However, overall mortality is not increased with birth control pills—at least in the relatively young women in whom they are used (Hannaford et al., 2010). Per studies of menopausal hormone therapy, it is likely that the progestogen in EE-containing birth control pills augments the risk of blood clots with EE. Early high-dose birth control pills (50–100 μg/day) had as much as twice the risk of blood clots of modern birth control pills (Gerstman et al., 1991; PCASRM, 2017; Table). In contrast to the different blood clot risks between oral and transdermal estradiol, non-oral birth control forms containing EE, for instance transdermal birth control patches and vaginal birth control rings, are associated with similar increases in blood clot risk as EE-containing birth control pills (Plu-Bureau et al., 2013; PCASRM, 2017; Konkle & Sood, 2019; Abou-Ismail, Sridhar, & Nayak, 2020). Hence, unlike with estradiol, route of administration does not appear to modify blood clot risk with EE based on available data.

    High-dose estrogen therapy using oral synthetic estrogens like DES and EE in people with breast or prostate cancer has been found to strongly increase the risk of blood clots and associated cardiovascular complications (Phillips et al., 2014; Turo et al., 2014; Coelingh Bennink et al., 2017). This has also been the case with estramustine phosphate (EMP; estradiol normustine phosphate), an estradiol ester that is used at massive doses in prostate cancer (e.g., 140–1,400 mg/day orally) and that results in pregnancy levels of estradiol (Kitamura, 2001 [Graph]; Ravery et al., 2011). In the 1980s however, it was found that high-dose non-oral estradiol did not have the same cardiovascular risks as high-dose estrogen therapy with oral synthetic estrogens or EMP (von Schoultz et al., 1989; Ockrim & Abel, 2009). This included studies with polyestradiol phosphate (PEP), a long-lasting injectable prodrug of estradiol, and with high-dose transdermal estradiol gel (von Schoultz et al., 1989; Aly, 2019). However, subsequent larger and higher-quality studies found that although the cardiovascular risks with PEP were much lower than with high-dose oral synthetic estrogen therapy, they were nonetheless still increased (Hedlung et al., 2008; Ockrim & Abel, 2009; Hedlund et al., 2011; Sam, 2020). This includes an approximate 2-fold increase in the risk of blood clots with estradiol levels in the range of roughly 300 to 500 pg/mL (Sam, 2020). Studies using high-dose transdermal estradiol patches have not found significantly increased cardiovascular complications as of present (Langley et al., 2013; Sam, 2020). However, these studies have been relatively underpowered, which limits their interpretation. In any case, increased coagulation has been observed with high-dose transdermal estradiol patches (achieving estradiol levels of 350 to 500 pg/mL) (Bland et al., 2005) similarly to PEP (Mikkola et al., 1999). More data on the risk of blood clots and cardiovascular issues with high-dose transdermal estradiol patches should come in the future with PATCH and STAMPEDE—two large-scale clinical studies in the United Kingdom that are evaluating this form of estradiol for prostate cancer (Gilbert et al., 2018; Singla, Ghandour, & Raj, 2019).

    Injections of short-acting estradiol esters like estradiol valerate and estradiol cypionate are notable in that they are often used by transfeminine people and are generally used at doses that achieve high estradiol levels. As with high-dose transdermal estradiol patches, little to no quality data on the risk of blood clots exists for these preparations at present. Pyra and colleagues found that the risk of blood clots with injectable estradiol valerate in transfeminine people was increased by around 2-fold, but the confidence intervals were very wide and statistical significance was not reached (Pyra et al., 2020). The doses used in the whole population for the study were not provided, but in the actual VTE cases, the doses of injectable estradiol valerate were described and ranged from 4 to 20 mg once per week and 10 to 40 mg once every 2 weeks (Pyra et al., 2020). Studies have also assessed and found increased coagulation with high doses of estradiol valerate by injection in the range of 10 to 40 mg once every 2 weeks in men with prostate cancer (Kohli & McClellan, 2001; Kohli et al., 2004; Kohli, 2005). Increased coagulation has additionally been observed with the combination of 5 mg estradiol valerate and a progestogen once per month as a combined injectable contraceptive in premenopausal women (Meng et al., 1990; UN/WHO et al., 2003). It is unclear whether the high peaks in estradiol levels associated with short-acting injectable forms of estradiol are harmful in terms of coagulation and blood clot risk (Hembree et al., 2017). However, the increased risk of polycythemia with short-acting injectable testosterone esters relative to other non-oral forms of testosterone (Ohlander, Varghese, & Pastuszak, 2018) is indirectly suggestive that this could be the case. Accordingly, a study found increased coagulation in premenopausal women with a combined injectable contraceptive containing estradiol valerate but not with one employing the more prolonged and stable estradiol cypionate at the same dose (UN/WHO et al., 2003).

    Selective estrogen receptor modulators (SERMs) such as tamoxifen (Nolvadex) and raloxifene (Evista) increase the risk of blood clots similarly to estrogens (Park & Jordan, 2002; Fabian & Kimler, 2005). The risk appears to be elevated a few-fold similarly to what might be expected with moderate doses of oral estradiol or CEEs (Deitcher & Gomes, 2004; Iqbal et al., 2012; Konkle & Sood, 2019).

    Pregnancy is a time when estradiol and progesterone levels increase to extremely high concentrations (Graphs). Estradiol levels increase progressively throughout pregnancy to around 2,000 pg/mL on average at the end of the first trimester, to about 10,000 pg/mL on average at the end of the second trimester, and to around 20,000 pg/mL on average at the end of the third trimester (Kerlan et al., 1994 [Graph]; Schock et al., 2016). Coagulation is greatly increased during pregnancy, and the risk of blood clots is likewise strongly increased (Heit et al., 2000; Abdul Sultan et al., 2015; Heit, Spencer, & White, 2016; Table). Estradiol and progesterone levels are strongly correlated with the increases in coagulation during pregnancy (Bagot et al., 2019). The risk of blood clots with modern birth control pills is similar to that with pregnancy as a whole (Heit, Spencer, & White, 2016), while the increases in risk of blood clots with early high-dose EE-containing birth control pills and with high-dose oral synthetic estrogen therapy for breast and prostate cancer are comparable to the risk increase during late pregnancy. Estradiol levels also increase to very high concentrations during ovarian stimulation for in-vitro fertilization in premenopausal women, and this has been associated with increased coagulation and risk of blood clots as well (Westerlund et al., 2012; Rova, Passmark, & Lindqvist, 2012; Kasum et al., 2014).

    Due to their greater risks of cardiovascular problems as well as other concerns, DES has been virtually abandoned while EE has been discontinued for almost all indications except birth control. EE continues to be used in birth control because it is resistant to metabolism in the uterus and controls menstrual bleeding better than oral estradiol does (Stanczyk, Archer, & Bhavnani, 2013). CEEs are also being increasingly superseded by estradiol in medicine, although significant use of CEEs for hormone therapy in cisgender women continues. Transdermal estradiol is gaining momentum over oral estradiol in menopausal hormone therapy as well. Major transgender hormone therapy guidelines (see also Aly, 2020) recommend against the use of EE and CEEs in transfeminine people due to their greater risks and the inability to accurately monitor blood estrogen levels with these preparations (Coleman et al., 2012; Deutsch, 2016; Hembree et al., 2017). Estradiol is the estrogen that is almost exclusively used in transfeminine people today. Besides estrogen type, it has been recommended that transdermal estradiol be used instead of oral estradiol in transfeminine people who are over 40 or 45 years of age or are otherwise at risk for blood clots (Deutsch, 2016; Iwamoto et al., 2019; Glintborg et al., 2021). Menopausal hormone therapy guidelines similarly recommend the use of transdermal estradiol over oral estrogens in cisgender women who are at higher risk for blood clots (e.g., Stuenkel et al., 2015).

    As previously described, progestogens appear to augment the risk of blood clots with oral estrogens. Conversely, findings on the combination of non-oral estradiol and progestogens are mixed—with some studies finding increased risk and others finding no additional risk (Rovinski et al., 2018; Scarabin, 2018; Vinogradova, Coupland, & Hippisley-Cox, 2019). Progestogens by themselves do not usually increase coagulation (Kuhl, 1996; Schindler, 2003; Wiegratz & Kuhl, 2006; Sitruk-Ware & Nath, 2011; Sitruk-Ware & Nath, 2013; Skouby & Sidelmann, 2018) or blood clot risk (Blanco-Molina et al., 2012; Mantha et al., 2012; Tepper et al., 2016; Rott, 2019). However, depot MPA alone at birth control doses has uniquely been associated with a few-fold increase in blood clot risk (van Hylckama Vlieg, Helmerhorst, & Rosendaal, 2010; DeLoughery, 2011; Blanco-Molina et al., 2012; Gourdy et al., 2012; Mantha et al., 2012; Rott, 2019; Tepper et al., 2019). The reasons for this are unknown, but might relate to high peak MPA levels with depot injectables (Mantha et al., 2012) or the weak glucocorticoid activity of MPA (Kuhl & Stevenson, 2006; Sitruk-Ware & Nath, 2011). Besides physiological-dose MPA alone, high-dose progestogen therapy with MPA, megestrol acetate (MGA), and cyproterone acetate (CPA) has been associated with increased coagulation and blood clot risk (Schröder & Radlmaier, 2002; Schindler, 2003; Seaman et al., 2007; Garcia et al., 2013; Taylor & Pendleton, 2016). However, this was not the case with chlormadinone acetate (CMA) in a small study in women with prior history of blood clots (Conard et al., 2004). Risk of blood clots may also be increased for CPA in combination with estrogen in transfeminine people (Patel et al., 2022). In contrast to progestins, addition of oral progesterone to estrogen therapy is not associated with augmentation of blood clot risk (Scarabin, 2018; Oliver-Williams et al., 2019; Kaemmle et al., 2022). However, this may simply be due to the fact that oral progesterone produces low progesterone levels and has relatively weak progestogenic effects (Aly, 2018). Non-oral and fully potent progesterone has yet to be properly studied and hence its risk profile remains unknown (Aly, 2018).

    In a historically notable study conducted by the Center of Expertise on Gender Dysphoria (CEGD) at the Vrije Universiteit Medical Center (VUMC) in Amsterdam, the Netherlands in the 1980s, it was reported that the risk of blood clots with high-dose EE and CPA in transfeminine people was increased by 45-fold relative to the expected incidence in the general population (Asscheman, Gooren, & Eklund, 1989; Asscheman et al., 2014). Mortality also appeared to be elevated and other health risks were increased as well (Asscheman, Gooren, & Eklund, 1989; Gooren & T’Sjoen, 2018). A subsequent study in transfeminine people by the CEGD confirmed strongly increased coagulation with EE but much lower increases with oral or transdermal estradiol (Toorians et al., 2003). Upon the CEGD switching transfeminine people from high-dose EE to physiological doses of oral or transdermal estradiol (also usually in combination with CPA), the risks decreased considerably (van Kesteren et al., 1997; Asscheman et al., 2011; Asscheman et al., 2014). These findings were of major importance in the replacement of EE with estradiol in transfeminine hormone therapy, and have surely contributed significantly to apprehension about the use of high doses of estrogens in transfeminine people.

    Taken together, estrogens of all kinds have been shown to dose-dependently increase or be associated with increased risk of blood clots. These findings suggest that, provided of course sufficient exposure occurs, increased coagulation and blood clot risk are common properties of estrogens. However, synthetic and non-bioidentical estrogens have greater risk of blood clots than estradiol, and oral estradiol shows greater risk than non-oral estradiol. In fact, physiological estradiol levels in women and low to moderate doses of transdermal estradiol may have no significant risk of blood clots at all. Nonetheless, non-oral estradiol with sufficiently high exposure can increase blood clot risk just the same as other forms of estrogen. Concomitant therapy with progestogens appears to augment the risk of blood clots with estrogens and high doses may particularly amplify the risk.

    Risks with Different Hormonal Exposures

    The table below provides relative risk increases for blood clots with different types, routes, and doses of estrogens, as well as with SERMs, pregnancy, and high-dose CPA. It shows the greater risks of blood clots with (1) oral estradiol relative to non-oral estradiol; (2) estradiol compared to non-bioidentical estrogens; and (3) lower estrogen levels/doses relative to higher estrogen levels/doses.

    Table 2: Relative risks of blood clots with different hormonal exposures (see also Machin & Ragni, 2020):

    EstrogenBlood clot riskSource
    Oral E2 ≤1 mg/day1.2×Vinogradova et al. (2019) [Table]
    Oral E2 >1 mg/daya1.4×Vinogradova et al. (2019) [Table]
    Oral E2 ≤1 or >1 mg/daya + Pb1.4–1.8×Vinogradova et al. (2019) [Table]
    Transdermal E2 ≤50 μg/day0.9×Vinogradova et al. (2019) [Table]
    Transdermal E2 >50 μg/daya1.1×Vinogradova et al. (2019) [Table]
    Oral CEEs ≤0.625 mg/day1.4×Vinogradova et al. (2019) [Table]
    Oral CEEs >0.625 mg/daya1.7×Vinogradova et al. (2019) [Table]
    Oral CEEs ≤ or >0.625 mg/daya + Pb1.5–2.4×Vinogradova et al. (2019) [Table]
    Modern EE + P birth controlc4.2×Heit, Spencer, & White (2016)
    High-dose EE + P birth controlc4–10×dTchaikovski, Tans, & Rosing (2006);
    PCASRM (2017) [Table]
    High-dose PEP injectionse2.1×Sam (2020)
    High-dose oral DES, EE, or EMP5.7–10×Seaman et al. (2007); Ravery et al.
    (2011)    ; Klil-Drori et al. (2015)
    SERMs (tamoxifen, raloxifene)~1.5–3×Deitcher & Gomes (2004); Iqbal et al.
    (2012)    ; Konkle & Sood (2019)
    Pregnancy (overall)f4.0×Heit, Spencer, & White (2016)
    Pregnancy (3rd trimester)5.1–7.1×Abdul Sultan et al. (2015) [Table]
    High-dose CPA alone3–5×Seaman et al. (2007)

    Footnotes: a At typical menopausal replacement doses (i.e., not very high—probably no more than double the given dose). b MPA, norethisterone, norgestrel, or drospirenone. c Modern EE + P birth control contains 20–35 μg/day EE, while high-dose EE + P birth control used in the 1960s and 1970s contained 50–150 μg/day EE. d Risk around twice as high as modern birth control pills. e Unpublished original research/analysis with borderline statistical significance (95% CI 0.99–4.22). f Excluding the postpartum period. With the postpartum period included, the risk of blood clots with pregnancy is 5–10× (McLintock, 2014). Abbreviations: E2 = Estradiol; CEEs = Conjugated estrogens; EE = Ethinylestradiol; DES = Diethylstilbestrol; EMP = Estramustine phosphate; PEP = Polyestradiol phosphate; SERMs = Selective estrogen receptor modulators; CPA = Cyproterone acetate; P = Progestogen.

    Note that the values in the table are associations mostly from observational studies rather than from RCTs. Hence, in many cases, causation has not been definitively established. In addition, the values represent rough average values with often wide 95% confidence intervals. As a result, precision and accuracy of the estimates may in some cases be low. Also note that quantified blood clot risk will vary depending on the study and its definitions and methodology (including factors like sampling error, approach to control of confounding variables, and residual confounding influences).

    Mechanisms of Increased Coagulation with Estrogens

    The ERs are expressed in the liver and estrogens exert effects in this part of the body through these receptors (Eisenfeld & Aten, 1979; Eisenfeld & Aten, 1987; Sahlin & von Schoultz, 1999; Grossmann et al., 2019). Estrogens are thought to increase the risk of blood clots by activating liver ERs and thereby modulating the hepatic production of numerous different coagulation factors, both procoagulant and anticoagulant (Kuhl, 2005; Tchaikovski & Rosing, 2010; DeLoughery, 2011; Konkle & Sood, 2019). Most coagulation factors and their inhibitors are synthesized in the liver (Mammen, 1992; Amitrano et al., 2002; Peck-Radosavljevic, 2007). Following their synthesis, these coagulation factors are secreted by the liver into the bloodstream where they circulate and mediate their actions. Circulating levels of procoagulant factors like fibrinogen (factor I), prothrombin (factor II), factors VII, VIII, and X, anticoagulant factors like antithrombin, protein C, protein S, and tissue factor pathway inhibitor (TFPI), and fibrinolytic factors like plasminogen, tissue plasminogen activator (t-PA), and plasminogen activator inhibitor-1 (PAI-1), are all influenced by estrogens (Hemelaar et al., 2008; Doxufils, Morimont, & Bouvy, 2020). These estrogen-mediated changes in levels result in an overall procoagulatory effect, as assessed by markers of net coagulation activation like prothrombin fragment 1+2 (F1+2), D-dimer, and thrombin–antithrombin complex (TAT), as well as global coagulation assays like the endogenous thrombin potential-based activated protein C resistance test (The Oral Contraceptive and Hemostasis Study Group, 1999; Kohli, 2006; Hemelaar et al., 2008; Douxfils et al., 2020; Douxfils, Morimont, & Bouvy, 2020). The changes in levels of most coagulation factors caused by estrogens are relatively small and levels often remain within normal ranges. However, they combine and synergize to produce larger increases in global coagulation and clot risk (Douxfils et al., 2020; Douxfils, Morimont, & Bouvy, 2020; Reda et al., 2020).

    Aside from coagulation factors, estrogens also modulate the synthesis of numerous other liver products (Kuhl, 1999; Kuhl, 2005; Table). Examples include sex hormone-binding globulin (SHBG), corticosteroid-binding globulin (CBG), various other circulating binding proteins, angiotensinogen, lipoproteins, and triglycerides, among others. In accordance with the mechanisms underlying increased coagulation and blood clot risk with estrogens, the differences in risk of blood clots with different types and routes of estrogens are mirrored in their influences on estrogen-sensitive liver products. Put another way, different estrogens have different relative potency in the liver when compared to their estrogenic potency elsewhere in the body. Synthetic and non-bioidentical estrogens have greater impact on liver synthesis than estradiol, while oral administration of estradiol has greater influence on liver synthesis than non-oral routes like transdermal administration or intramuscular injection, and this is likely to explain the observed differences in coagulation and blood clot risk with these different estrogens. The table below shows the liver potency of different estrogenic exposures as measured by influence specifically on SHBG levels, one of the most sensitive and well-characterized estrogen-modulated liver products.

    Table 3: Relative increases in SHBG levels with different estrogenic exposures (see also Aly, 2020):

    EstrogenSHBG increaseSource
    E2 patch 50 μg/day1.1×Kuhl (2005)
    E2 patch 100 μg/day1.2×Shifren et al. (2008)
    Oral E2 1 mg/day1.6×Kuhl (1998)
    Oral E2 2 mg/day2.2×Kuhl (1998)
    Oral E2 4 mg/day1.9–3.2×Fåhraeus & Larsson-Cohn (1982); Gibney
    et al. (2005)    ; Ropponen et al. (2005)
    Oral EV 6 mg/day (~4.5 mg/day E2)a2.5–3.0×Dittrich et al. (2005); Mueller et al. (2005);
    Mueller et al. (2006)
    Oral CEEs 0.625 mg/day1.8×Kuhl (1998)
    Oral CEEs 1.25 mg/day2.2×Kuhl (1998)
    Oral EE 5 μg/day2.0×Kuhl (1999)
    Oral EE 10 μg/day3.0×Kuhl (1998)
    Oral EE 20 μg/day3.4×Kuhl (1998)
    Oral EE 50 μg/day4.0×Kuhl (1997)
    Modern EE + P birth controlb~3.0–4.0×Odlind et al. (2002)
    High-dose EE + P birth controlb~5–10×Hammond (2017)
    E2 patches 200 μg/day~1.5×Smith et al. (2020)
    E2 patches 300 μg/day~1.7×Smith et al. (2020)
    E2 patches 600 μg/day~2.3×Bland et al. (2005)
    High-dose E2 injectionsc1.7–3.2×Stege et al. (1988); Kronawitter et al.
    (2009)     [Table]; Mueller et al. (2011);
    Nelson et al. (2016)
    High-dose oral DES, EE, or EMP~5–10×von Schoultz et al. (1989)
    Pregnancy~5–10×Hammond (2017)

    Footnotes: a Due to differences in molecular weight, estradiol valerate has about 75% of the amount of estradiol as regular estradiol. Hence, 6 mg/day estradiol valerate is approximately equivalent to 4.5 mg/day estradiol. b Modern EE + P birth control contains 20–35 μg/day EE, while high-dose EE + P birth control used in the 1960s and 1970s contained 50–150 μg/day EE. c In the form of 320 mg/month PEP (~700 pg/mL estradiol), 100 mg/month estradiol undecylate (~500–600 pg/mL estradiol), or 10 mg/10 days estradiol valerate (~500–1,200 pg/mL peak estradiol; Graphs). Abbreviations: E2 = Estradiol; EV = Estradiol valerate; CEEs = Conjugated estrogens; EE = Ethinylestradiol; DES = Diethylstilbestrol; EMP = Estramustine phosphate; PEP = Polyestradiol phosphate; P = Progestogen.

    The increase in SHBG levels with estrogen therapy correlates with increases in coagulation and blood clot risk and can serve as a reliable surrogate indicator of these effects (Odlind et al., 2002; van Rooijen et al., 2004; van Vliet et al., 2005; Tchaikovski & Rosing, 2010; Raps et al., 2012; Stegeman et al., 2013; Hugon-Rodin et al., 2017; Eilertsen et al., 2019). The increases in SHBG levels and blood clot risk even appear quite similar to each other with modern birth control pills (both ~4-fold), high-dose oral synthetic estrogen therapy (both ~5–10-fold), and late pregnancy (both ~5–10-fold). When data on blood clot risk with a given estrogen route or dose are limited or unavailable—for instance with high-dose oral estradiol or high-dose estradiol ester injections—changes in SHBG levels can be used as a rough proxy or surrogate instead to estimate overall liver impact, magnitude of change in coagulation systems, and blood clot risk. It should be noted however that progestogens may augment the blood clot risk with estrogens without necessarily affecting SHBG levels or even while decreasing SHBG levels via concomitant androgenic activity (Kuhl, 2005; Vinogradova, Coupland, & Hippisley-Cox, 2019).

    Physiological levels of estradiol appear to have relatively minimal influence on liver synthesis (Eisenfeld & Aten, 1979; Lax, 1987; Kuhl, 2005). This is in accordance with the limited influence or non-influence of physiological estradiol levels in women on blood clot risk. It is thought that under normal physiological circumstances, estradiol is only supposed to considerably affect liver synthesis at very high levels—namely during pregnancy. The changes in synthesis of liver products during pregnancy presumably have important biological roles at this time (Eisenfeld & Aten, 1979). One of these is considered to be increased coagulation, as coagulation limits blood loss with childbirth and hence has survival benefits. Conversely, there is no obvious benefit to increased coagulation outside of pregnancy.

    Estradiol and the Liver First Pass with Oral Administration

    The oral route of administration is subject to a first pass through the liver via the hepatic portal vein which is not present with non-oral routes of administration (Pond & Tozer, 1984; Back & Rogers, 1987). As such, oral estradiol is subject to a hepatic first pass while this does not occur with non-oral forms of estradiol such as transdermal estradiol and injectable estradiol (Kuhl, 1998; Kuhl, 2005). This first pass results in disproportionate exposure of the liver to estradiol as well as disproportionate estrogenic impact on liver protein synthesis (Kuhl, 2005). Oral estradiol likewise has disproportionate estrogenic impact on the hepatic synthesis of coagulation factors (Kuhl, 1998; Kuhl, 2005). Due to the first pass, it is estimated that there is a 4- or 5-fold greater estrogenic impact of oral estradiol in the liver relative to non-oral estradiol (Kuhl, 2005). Due to the absence of the hepatic first pass with most non-oral routes, there is strong biological plausibility for the lower risk of blood clots that has been found with transdermal estradiol in comparison to oral estradiol in observational studies (Baber et al., 2016).

    Figure 1: Diagrammatic representation of increased coagulation via the liver first pass with oral estrogen therapy (Scarabin et al., 2020). Abbreviations: E = estrogen; trans = transdermal; AT = antithrombin; PS = protein S; TFPI = tissue factor protein inhibitor; II = prothrombin; VII = factor VII; PC = protein C; V = factor V; VTE = venous thromboembolism; CHD = coronary heart disease. Other terms: activated protein C resistance (APCR).

    Although oral estradiol has a much higher relative potential for blood clots due to the liver first pass, sufficiently high levels of estradiol will diffuse into the liver from the blood to act on this tissue regardless of route of administration. Hence, high levels of estradiol via non-oral routes (or produced by the body itself) can increase coagulation and blood clot risk similarly to the oral route. This is clearly evidenced by hyperestrogenic situations like pregnancy and ovarian stimulation for in-vitro fertilization, when estradiol levels increase to very high concentrations and substantially influence liver protein synthesis.

    Non-Bioidentical Estrogens and Resistance to Liver Metabolism

    Non-bioidentical estrogens such as EE, DES, and CEEs have greater impact on liver protein synthesis and risk of blood clots than either oral estradiol or non-oral estradiol (Kuhl, 1998; Kuhl, 2005; Phillips et al., 2014; Turo et al., 2014; Table). This is because the liver strongly metabolizes and inactivates estradiol, whereas non-bioidentical estrogens have differences in their chemical structures relative to estradiol that result in them being much more resistant to liver metabolism (Kuhl, 1998; Kuhl, 2005; Connors & Middeldorp, 2019; Swee, Javaid, & Quinton, 2019).

    EE can be considered as a case example. The oral bioavailability of EE is around 45%, while that of estradiol is only about 5% (Kuhl, 2005; Stanczyk, Archer, & Bhavnani, 2013). In addition, the blood half-life of EE is in the range of 5 to 30 hours, compared to less than 1 hour in the case of estradiol (White et al., 1998; Kuhl, 2005; Stanczyk, Archer, & Bhavnani, 2013). As a result of these and other differences, EE is approximately 120 times as potent as estradiol by weight in terms of general estrogenic effect (Kuhl, 2005; Table). Hence, EE is used clinically in μg doses whereas oral estradiol is used at over 100-fold higher mg doses. The pharmacokinetic differences between EE and estradiol reflect the strong resistance of EE to liver metabolism (Kuhl, 2005). EE, or 17α-ethynylestradiol, shows resistance to liver metabolism because of an ethynyl group at the C17α position which has been added to what is the otherwise unchanged structure of estradiol (Kuhl, 2005). This modification results in steric hindrance which blocks 17β-hydroxysteroid dehydrogenases (17β-HSDs) as well as conjugating enzymes like sulfotransferases and glucuronosyltransferases from metabolizing EE at the C17β hydroxyl group. 17β-HSDs normally convert estradiol into the weakly active estrone while the conjugating enzymes convert estradiol into inactive C17β estrogen sulfate and glucuronide conjugates like estrone sulfate (Kuhl, 2005). An “ethinylestrone” metabolite is in fact a structural impossibility due to the requirement of a double bond for a C17 ketone group—the needed C17α position is already occupied in EE by its ethynyl group. As such, the metabolism of estradiol into weakly active or inactive metabolites like estrone and estrone sulfate in the liver is protective against activation of hepatic ERs and procoagulation, and the lack of this with EE is responsible for its greater blood clot risk (Kuhl, 2005; Russell et al., 2017).

    Figure 2: Chemical structures of selected estrogens. The C17 position in the case of the steroidal estrogens (E2, E1, and EE) is at the top right of the steroid nucleus.

    Due to the marked resistance of EE to hepatic metabolism and inactivation, it persists for a long time in the liver—often cycling through it many times before finally being broken down. Moreover, EE shows several-fold disproportionate impact on liver protein synthesis at otherwise equivalent doses relative to oral estradiol (Kuhl, 2005; Table). Consequently, whereas EE has around 120-fold the general potency of oral estradiol, the liver potency of EE is around 350 to 1,500 times greater than that of oral estradiol (von Schoultz et al., 1989; Kuhl, 2005). A dose of EE of as little as 1 μg/day has been shown to impact liver metabolism (Speroff et al., 1996; Trémollieres, 2012). In addition, the fact that EE shows similar hepatic impact and risk of blood clots regardless of whether it is administered orally, transdermally, or vaginally indicates that unlike oral estradiol, the first pass through the liver with oral administration is not necessary for blood clot risk with EE (Plu-Bureau et al., 2013; PCASRM, 2017; Konkle & Sood, 2019). EE is so resistant to metabolism that it does not seem to matter how it is administered—the liver impact is substantial regardless of route. The greatly increased liver potency of EE results in its influence on coagulation and blood clot risk being much higher than that of estradiol at equivalent doses.

    CEEs show a few-fold disproportionate estrogenic impact on liver protein synthesis relative to oral estradiol but less than that of EE (Kuhl, 2005; Table). This can be attributed to the equine (horse) estrogens in CEEs, which humans are presumably not adapted to and which show resistance to liver metabolism in humans. DES, on the other hand, shows even greater estrogenic influence on the liver than EE (Kuhl, 2005; Table). The more disproportionate impact on liver synthesis of DES relative to EE or CEEs may be attributable to the fact that it is a nonsteroidal estrogen and is far removed in structure from steroidal estrogens. This is relevant as steroidal estrogens are susceptible to varying extents to robust steroid-metabolizing enzymes in the liver (Kuhl, 2005). As with EE, 17β-HSDs have no affinity for DES and the hydroxyl groups of DES are not oxidized to form estrone-like ketone metabolites (Jensen et al., 2010). Consequent to their resistance to liver metabolism relative to estradiol, CEEs and nonsteroidal estrogens like DES have greater impacts on coagulation and blood clot risk than equivalent doses of estradiol similarly to EE although to varying extents.

    When compared to transdermal estradiol rather than oral estradiol, the disproportionate influence of oral non-bioidentical estrogens on estrogen-modulated liver protein synthesis becomes extreme. With a little math, it quickly becomes apparent why high doses of these estrogens have influences on liver proteins and blood clot risks that are comparable to those during pregnancy. The table below shows some roughly calculated estimates for comparative liver strength of the different estrogens.

    Table 4: Roughly calculated ratios of liver estrogenic potency to general/systemic estrogenic potency with estrogens based on a selection of liver products (e.g., SHBG, others) (Kuhl, 2005; Table):

    EstrogenComparative liver potency
    Relative to oral E2Relative to transdermal E2
    Transdermal E2~0.25×a1.0×a
    Oral E21.0×~4.0×
    Oral CEEs1.3–4.5×~5.2–18×
    Oral EE2.9–5.0×~12–20×
    Oral DES5.7–7.5×~23–30×

    a Based on a study that found oral estradiol to have 4-fold greater effect on SHBG levels than transdermal estradiol when used at doses that produced similar estradiol levels (Nachtigall et al., 2000).

    Changes in liver protein synthesis induced by estrogens don’t scale linearly with dose or relative liver potency. There is progressive saturation in terms of changes in levels of SHBG and other liver products with estrogen dose—that is, higher doses have relatively diminished effect compared to lower doses (Kuhl, 1990; Kuhl, 1999). As an example, oral EE shows the following dose-dependent increases in SHBG levels: 2.0-fold at 5 μg/day, 3.0-fold at 10 μg/day, 3.4-fold at 20 μg/day, and 4.0-fold at 50 μg/day (Kuhl, 1998; Kuhl, 1999). These findings can be attributed to saturation of the competitive binding and/or activation of liver ERs by high estrogen concentrations (Kuhl, 1990). An implication of this dose-dependent saturation is that although for instance oral EE has much stronger potency in the liver than oral estradiol, oral estradiol can more quickly “catch up” to oral EE and other non-bioidentical estrogens in terms of liver impact than might be initially anticipated. Accordingly, oral estradiol has shown the following dose-dependent increases in SHBG levels: 1.6-fold at 1 mg/day, 2.2-fold at 2 mg/day, and 1.9- to 3.2-fold at 4 mg/day (Fåhraeus & Larsson-Cohn, 1982; Kuhl, 1998; Gibney et al., 2005; Ropponen et al., 2005). Hence, although oral EE may have roughly 3- to 5-fold higher liver potency than oral estradiol, a dose of oral estradiol near-equivalent to that of oral EE in terms of general estrogenic effect can increase SHBG levels to an extent that is only somewhat lower in comparison.

    Selective Estrogen Receptor Modulators and Metabolism Resistance

    SERMs like tamoxifen and raloxifene are essentially partial agonists of the ER. This is in contrast to estrogens—like estradiol, CEEs, EE, and DES—which act as full agonists of the ER. Similarly to nonsteroidal estrogens like DES, the clinically used SERMs are all nonsteroidal in structure and are strongly resistant to hepatic metabolism. In fact, certain SERMs, like tamoxifen and clomifene, are structurally related to and were derived from DES. SERMs show tissue differences in their ER-mediated effects, with estrogenic effects in some tissues (e.g., bone) and antiestrogenic effects in other tissues (e.g., breasts) (Lain, 2019; Table). Although there is variation between SERMs in terms of their effects in certain tissues (e.g., uterus), they are uniformly estrogenic in the liver. Consequently, SERMs show similar increases in blood clot risk as estrogens (Park & Jordan, 2002; Fabian & Kimler, 2005). As with non-bioidentical estrogens, the greater risk of blood clots with SERMs compared to oral estradiol can be attributed to their resistance to liver metabolism and hence to greater hepatic estrogenic potency. The SERMs that are used medically belong to diverse structural families (e.g., triphenylethylenes like tamoxifen and benzothiophenes like raloxifene). The only way in which SERMs of different structural classes are known to be related is in their shared interactions with the ERs.

    Figure 3: Chemical structures of selected SERMs. They are nonsteroidal in structure and include tamoxifen (a triphenylethylene) and raloxifene (a benzothiophene).

    Activation of the Estrogen Receptor is Specifically Responsible for Increased Coagulation with Estrogens and SERMs

    Findings from preclinical and genetic research provide direct evidence for ER activation being responsible for the increased blood clot risk with estrogens. In an important animal study, EE was administered to mice and changes in procoagulant and anticoagulant biomarkers were measured (Cleuren et al., 2010). EE caused changes in levels of a variety of coagulation factors (Cleuren et al., 2010). The researchers also assessed estradiol and observed comparable changes (Cleuren et al., 2010). Co-administration of the selective ER full antagonist fulvestrant with EE neutralized all of the EE-induced coagulatory changes (Cleuren et al., 2010). Additionally, EE showed no effect on coagulation factors in ERα knockout mice (Cleuren et al., 2010). These findings are consistent with human and mouse genome-wide association studies which have found estrogen response elements (EREs)—DNA sequences that act as binding sites for genes regulated by the ER—embedded in a large number of genes involved in coagulatory pathways (Cleuren et al., 2010; Stanczyk, Mathews, & Cortessis, 2017).

    The preceding findings are consistent with ER activation being responsible for increased coagulation and blood clot risk with estrogens and SERMs. This is in accordance with the fact that blood clot risk is a shared effect of selective ER agonists with highly diverse chemical structures, providing strong circumstantial support against a non-ER-mediated action of some sort being responsible (e.g., the weakly estrogenic metabolite estrone somehow mediating the blood clot risk with estradiol—Bagot et al., 2010). Increased coagulation and blood clot risk can thus be regarded as class effects of estrogens and SERMs—provided sufficiently high liver exposure. Due to differences in susceptibility to liver metabolism however, different ER agonists show differences in their relative impact on coagulation. Owing to estradiol’s lack of resistance to metabolism and its robust inactivation in the liver, the dosage requirements for increased coagulation and blood clot risk with estradiol—particularly in the case of non-oral estradiol—are greater than with non-bioidentical estrogens. Hence, estradiol, especially when administered via non-oral routes, is a safer form of estrogen therapy than other estrogens.

    Absolute Incidences and Risk Factors

    States of estrogen and/or progestogen exposure, such as exogenous hormone administration and pregnancy, are of course established risk factors for blood clots in women. In healthy young individuals without relevant risk factors for blood clots however, the incidence of blood clots is rare even in situations of considerably increased risk due to hormones (Rosendaal, 2005). The absolute incidence of VTE in non-pregnant women is only 1 to 5 of every 10,000 women each year (i.e., 0.01–0.05% per year) (PCASRM, 2017; Konkle & Sood, 2019). EE-containing birth control pills, which on average increase VTE risk by about 4-fold, are associated with an incidence of VTE of only 3 to 9 of every 10,000 women each year (i.e., 0.03–0.09% per year) (Konkle & Sood, 2019). Likewise, the absolute risk of blood clots during pregnancy, when estradiol and progesterone levels increase to extremely high concentrations and VTE risk is increased up to 7-fold (Abdul Sultan et al., 2015), is about 5 to 20 of every 10,000 women each year (i.e., 0.05–0.2% per year) (PCASRM, 2017; Konkle & Sood, 2019).

    Table 5: Absolute incidences of VTE with different estrogenic exposures in premenopausal women (Gerstman et al., 1991; Konkle & Sood, 2019; Douxfils, Morimont, & Bouvy, 2020):

    Group/therapyIncidence (women per year)
    Non-pregnant women1 to 5 in 10,000 (0.01–0.05%)a
    Modern birth control pills (<50 μg/day EE)3 to 12 in 10,000 (0.03–0.09%)
    High-dose birth control pills (>50 μg/day EE)~10 in 10,000 (0.1%)
    Pregnancy5 to 20 in 10,000 (0.05–0.2%)
    Postpartum period40 to 65 in 10,000 (0.4–0.65%)

    a 1–2/10,000 per year at <19 years of age, 2–3/10,000 per year at 20–29 years of age, 3–4/10,000 per year at 30–39 years of age, 5–7/10,000 per year at 40–49 years of age; roughly 3–4/10,000 per year for age 15–49 years overall (Rabe et al., 2011).

    In any case, the risks of VTE and cardiovascular events with high estrogen exposure accumulate over time and add up on a population scale. It is estimated that 22,000 instances of VTE occur due to birth control pills in Europe each year (Morimont, Dogné, & Douxfils, 2020) and that 300 to 400 healthy young women die due to blood clots caused by birth control pills in the United States every year (Keenan, Kerr, & Duane, 2019). Notably, non-EE-containing birth control pills—which instead of EE contain estradiol or estetrol—appear to have considerably reduced procoagulatory effects and/or risk of blood clots in comparison, and if they become more established, will likely eliminate a substantial number of these cases (Stanczyk, Archer, & Bhavnani, 2013; Dinger, Minh, & Heinemann, 2016; Grandi, Facchinetti, & Bitzer, 2017; Fruzzetti & Cagnacci, 2018; Grandi et al., 2019; Grandi et al., 2020; Douxfils, Morimont, & Bouvy, 2020; Reda et al., 2020; Morimont et al., 2021; Grandi, Facchinetti, Bitzer, 2022).

    In addition to time and population considerations, there are, besides estrogen and progestogen exposure, a variety of other known risk factors for blood clots, and these risk factors can substantially augment blood clot risk (Heit et al., 2000; Rosendaal, 2005). Age is among the strongest of the known risk factors (Rosendaal, 2005; Montagnana et al., 2010). Moreover, age is uniquely notable as a risk factor in that it is one that eventually becomes relevant to everyone. The risk of blood clots increases on the order of 100-fold going from ≤15 years of age (incidence <0.005–0.01% per year) to ≥80 years of age (incidence ~0.5–1.0% per year) (Rosendaal, 2005; Montagnana et al., 2010; Rabe et al., 2011). The figure below provides a graphical representation of the influence of age on risk of blood clots.

    Figure 4: Risk of first-incidence VTE (per 100,000 per year) by age group (in years) in men (black bars) and women (gray bars) (Oger, 2000; Rosendaal, 2005; Rosendaal, 2016).

    Other established risk factors for blood clots and associated cardiovascular problems include physical inactivity (due to, e.g., bed rest, long-distance travel, etc.), obesity, smoking, thrombophilic abnormalities, cancer, surgery, and HIV, among many others (Baron et al., 1998; Heit et al., 2000; Rosendaal, 2005; Lijfering, Rosendaal, & Cannegieter, 2010; Timp et al., 2013). In addition to age, physical inactivity is one of the most important risk factors for blood clots and mediates the risk increases for many of the others (Rosendaal, 2005). Smoking on its own is not consistently associated with increased risk of VTE (Lijfering, Rosendaal, & Cannegieter, 2010), but in combination with EE-containing birth control pills has been associated with a synergistic increase in VTE risk (Pomp, Rosendaal, & Doggen, 2008) as well as large increases in risk of heart attack—for instance 20-fold higher risk in heavy smokers (Kuhl, 1999). The table below shows the influence of a selection of known risk factors for VTE:

    Table 6: Non-exogenous-hormone risk factors for VTE and relative VTE risk increases (Baron et al., 1998; Heit et al., 2000; Rosendaal, 2005; Lijfering, Rosendaal, & Cannegieter, 2010; Timp et al., 2013):

    Risk factorRelative risk
    Age1–∞×
    Cancer2–20×a
    HIV3–10×
    Overweightness/obesity2–3×
    Surgery, trauma, immobilization5–50×
    Bed rest at home9×
    Air travel1.5–3×
    Smoking0.8–1.5×b
    Varicose veins1–4×
    Pregnancy4×
    Postpartum15–20×

    a Varies by type and stage of cancer (Baron et al., 1998; Timp et al., 2013). For breast and prostate cancer, one study found a 1.8-fold greater risk for breast cancer and 4.2-fold greater risk for prostate cancer relative to the general population (Baron et al., 1998). b Smoking on its own is not consistently associated with VTE (Lijfering, Rosendaal, & Cannegieter, 2010; Rabe et al., 2011).

    Thrombophilias, heritable and acquired, exist in significant percentages of the population and can lead to large increases in blood clot risk (Lijfering, Rosendaal, & Cannegieter, 2010). Moreover, they are often if not usually unknown (Morimont, Dogné, & Douxfils, 2020). This is due to the fact that screening for heritable thrombophilias is mainly based on family history, which has low sensitivity and poor predictive value for identifying people with these abnormalities (Morimont, Dogné, & Douxfils, 2020). Hence, many people are at increased risk of blood clots without realizing it. The table below shows the prevalences of a variety of thrombophilic abnormalities and their impacts on blood clot risk.

    Table 7: Prevalences of thrombophilic abnormalities and relative risk of VTE (Martinelli, Passamonti, & Bucciarelli, 2014; Mannucci & Franchini, 2015; see also Walker, 2009; Konkle & Sood, 2019).

    ThrombophiliaPrevalenceRelative risk
    General populationPeople with VTEFirst VTERecurrent VTE
    Antithrombin deficiency0.02–0.2%1%50×2.5×
    Protein C deficiency0.2–0.4%3%15×2.5×
    Protein S deficiency0.03–0.1%2%10×2.5×
    Factor V Leiden (het.)5%20%7×1.5×
    Factor V Leiden (homo.)0.02%1.5%80×–
    Prothrombin G20210A (het.)2%6%3–4×1.5×
    Prothrombin G20210A (homo.)0.02%<1%30×–
    Non-O blood group55–57%75%2×2×
    Antiphospholipid antibodies1–2%5–15%11×?
    Hyperhomocysteinemia5%10–15%1.5×?

    Blood clots are considered to be a multicausal disease (Rosendaal, 2005). The risk of blood clots and associated cardiovascular complications with hormonal exposure is highest when multiple risk factors combine in a given individual. Under what are among the most extreme of circumstances in terms of risk—elderly people with cancer who are on high-dose oral synthetic estrogen therapy (e.g., DES)—blood clot incidence can be as high as 15 to 28% and overall incidence of cardiovascular complications as great as 35% (Phillips et al., 2014; Sciarria et al., 2014; Turo et al., 2014). These adverse effects contribute to substantial morbidity and incidence of death in these populations. Most people are however at nowhere near as great of risk. Risk factors like age are why pregnant women can have massive levels of estradiol and progesterone with relatively little issue whereas elderly cancer patients on high-dose oral synthetic estrogen therapy have a considerable risk of death.

    In the VUMC studies that found 20- to 45-fold increased incidence of blood clots with high-dose EE and CPA over 5 to 10 years in transfeminine people, the absolute incidence of blood clots was approximately 6.3% (142/10,000 people per year) in the 1989 report and 5.5% (58/10,000 people per year) in the 1997 follow up (Asscheman, Gooren, & Eklund, 1989; van Kesteren et al., 1997; Asscheman et al., 2014; Goldstein et al., 2019; Min & Hopkins, 2021). In keeping with the known influence of age on blood clot risk, the absolute incidence was 2.1% in those under 40 years of age and 12% in those over 40 years of age in the 1989 study (Asscheman, Gooren, & Eklund, 1989; Asscheman et al., 2014). In about 70% of cases, there were—aside from age—no known risk factors for blood clots (Asscheman, Gooren, & Eklund, 1989; Asscheman et al., 2014). Following subsequent replacement of EE with low-to-moderate-dose transdermal estradiol in those over 40 years of age, the incidence of blood clots decreased substantially (with only one event occurring in the transdermal estradiol group) (van Kesteren et al., 1997; Asscheman et al., 2014; Min & Hopkins, 2021). A later study in 2013 by the Ghent University Hospital in Belgium observed a blood clot incidence of 5.1% in transfeminine people using mostly oral or transdermal estradiol with or without CPA over an average treatment period of 7.7 years (range 3 months to 35 years) (Wierckx et al., 2013; Min & Hopkins, 2021). Those who had blood clots often had other risk factors such as older age, smoking, immoblization due to surgery, or hypercoagulability (Wierckx et al., 2013; Min & Hopkins, 2021). In addition to cumulative exposure time, these studies further highlight the converging impact of multiple risk factors—with estrogen type, route, and dose, progestogen exposure, and age included among them—on the risk of blood clots.

    Therapeutic Implications for Transfeminine People

    Due to their greater risk of blood clots and cardiovascular problems, non-bioidentical estrogens like EE and CEEs are mostly no longer used in transfeminine people. Instead, estradiol, both in oral and non-oral forms, is used. Transgender clinical guidelines generally recommend keeping estradiol levels within normal physiological ranges for non-pregnant females of around 100 to 200 pg/mL regardless of whether the route of administration of estradiol is oral or non-oral (Aly, 2018). Higher estradiol levels are not currently known to have greater therapeutic benefit in terms of feminization or breast development (Nolan & Cheung, 2020). However, higher levels, in the range of 200 to 500 pg/mL, can provide additional therapeutic effect in the area of testosterone suppression—which can be indirectly beneficial to feminization if otherwise inadequate (Aly, 2018). Despite their recommendations for keeping estradiol levels in physiological ranges, transgender clinical guidelines notably recommend doses of estradiol ester injections that reach and even greatly exceed estradiol levels of 200 pg/mL (Aly, 2021).

    Based on the available research (e.g., the risk of blood clots with lower doses, comparative SHBG increases), it would not be surprising if high-dose oral estradiol (e.g., 8 mg/day) had similar risk of blood clots as the relatively lower amounts of EE in birth control pills. The risk is likely to be particularly great in combination with progestogens (e.g., CPA). Due to its greater and unnecessary risk of blood clots relative to non-oral estradiol, oral estradiol should ideally be avoided in transfeminine people—particularly in those with risk factors for blood clots such as older age (e.g., >40 years) or concomitant progestogen use. However, the convenience of oral estradiol and its relative inexpensiveness (compared to e.g. transdermal forms) are significant advantages that will also be considered by transfeminine people and their clinicians. In contrast to oral estradiol, non-oral estradiol—with estradiol levels kept in physiological ranges of for instance 100 to 200 pg/mL—appears to have minimal to no risk of blood clots. Hence, non-oral estradiol at these levels can be used in transfeminine people with little concern.

    In terms of higher estradiol levels delivered non-orally, the estimated 2-fold increase in risk of blood clots with estradiol levels of approximately 300 to 500 pg/mL (Sam, 2020) is notably lower than the average 4-fold increase in risk with widely used EE-containing birth control pills. Based on the usefulness of these levels for suppressing testosterone production and the widespread usage of EE-based birth control in cisgender women throughout the world, the degree of blood clot risk with high-dose non-oral estradiol, in reasonable amounts, could be considered therapeutically acceptable in transfeminine people (Haupt et al., 2020). This may be particularly true when high-dose non-oral estradiol monotherapy is compared to combination of estradiol with antiandrogens like spironolactone, CPA, or bicalutamide, which all have their own unique risks and drawbacks. In any case, as with oral estradiol, high estradiol levels with non-oral estradiol should ideally be avoided due to the additional risk they pose, and this is especially true in those with relevant risk factors for blood clots (e.g., older age). In addition, very high doses of non-oral estradiol resulting in estradiol levels above those required for testosterone suppression are difficult to justify as they pose further unnecessary risk and offer no clear additional therapeutic benefit.

    Prevention of Blood Clots

    The best way to prevent blood clots from happening is to avoid risk altogether. Avoiding use of oral estradiol, excessively high doses of non-oral estradiol, and progestogens when feasible and opting for safer therapeutic choices is recommended in this regard. In addition, avoiding use of such therapies in those with risk factors like older age (>40 years), known thrombophilic abnormalities, and sedentary lifestyle is advocated. Proactive behaviors like physical activity (e.g., walking, exercise), quitting smoking, and weight loss may help to reduce the risk of blood clots (Hibbs, 2008).

    Certain anticoagulant and antiplatelet medications are used to help prevent blood clots in high-risk individuals. Examples include low-dose aspirin (Mekaj, Daci, & Mekaj, 2015; Matharu et al., 2020), direct factor Xa inhibitors like rivaroxaban (Xarelto) (Blondon, 2020), and direct thrombin inhibitors like dabigatran (Pradaxa), among others. Aspirin has been found to be effective in the prevention of blood clots (Mekaj, Daci, & Mekaj, 2015; Matharu et al., 2020) and has been recommended for use specifically in transfeminine people on hormone therapy (Feldman & Goldberg, 2006; Deutsch, 2016). However, evidence is limited and conflicting for prevention of blood clots related to hormone therapy (Grady et al., 2000; Cushman et al., 2004) and use of aspirin in transfeminine people for such purposes has been recommended against by others (Shatzel, Connelly, & DeLoughery, 2017). Rivaroxaban has been associated with more than completely offset risk of blood clots with oral menopausal hormonal therapy (Blondon, 2020). In any case, no anticoagulants are currently approved or well-supported for preventing risk of blood clots with hormone therapy. Accordingly, clinical guidelines state that there is insufficient evidence to guide decision-making in this area at this time (e.g., McLintock, 2014). It should also be cautioned that anticoagulants have side effects and risks of their own and should be used carefully.

    Rutin, a naturally occurring flavonoid found in various plants and foods and available as a herbal supplement, has been suggested by some in the transfeminine community as a preventative against blood clots based on limited preclinical research (Jasuja et al., 2012; Choi et al., 2015). However, there is no clinical evidence to support its use or effectiveness at this time (e.g., Martinez-Zapata et al., 2016; Morling et al., 2018). Dose-finding studies to determine appropriate doses for efficacy also have not been performed. Flavonoids like rutin are notably known to have unfavorable dispositions in the body (e.g., very low bioavailability, high metabolism, short half-lives) and this has limited their usefulness by rendering them poorly active and therapeutically ineffective (Ma et al., 2014; Higdon et al., 2016; Cassidy & Minihane, 2017; Zhao, Yang, & Xie, 2019; Zhang et al., 2021). Lastly, the tolerability and safety of rutin have not been evaluated. For these reasons, use of rutin to lower the risk of blood clots in transfeminine people cannot be recommended at this time.

    Temporary discontinuation of estrogen therapy before surgery has traditionally been thought to help reduce the risk of blood clots during recovery based on theory and has been advised as well as mandated for transfeminine people undergoing surgical procedures (e.g., Asscheman et al., 2014). However, evidence is limited and inconclusive on this strategy at present and more research is needed to determine whether it is actually beneficial or not (Boskey, Taghinia, & Ganor, 2019; Nolan & Cheung, 2020; Haveles et al., 2021; Hontscharuk et al., 2021; Kozato et al., 2021; Nolan et al., 2021; Zucker, Reisman, & Safer, 2021). Recent studies have not found reduction in risk of blood clots with discontinuation of hormone therapy before surgery in transfeminine people but these studies have been underpowered and larger studies are needed (Blasdel et al., 2021). Temporarily stopping hormone therapy can be distressing for many transfeminine people and this should be weighed accordingly. A potential alternative to discontinuation of hormone therapy is temporary use of transdermal estradiol at physiological doses which has no known blood clot risk and is more likely to be safe.

    Updates

    Update 1: Langley et al. (2021) [PATCH Study Results]

    In February 2021, a report on long-term cardiovascular outcomes for the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial was published (Langley et al., 2021) [PDF; Supplementary appendix]. The PATCH trial is a large ongoing phase 2/3 randomized controlled trial of high-dose transdermal estradiol patches versus GnRH agonists for the treatment of prostate cancer in men (Langley et al., 2021). The estradiol patch dosage employed is specifically three to four 100 μg/day FemSeven or Progynova TS patches (Langley et al., 2021). In the February 2021 report of the study, 1,694 men were enrolled and randomized, with 790 included in the analysis for the GnRH agonist group and 904 included in the analysis for the estradiol patch group (Langley et al., 2021).

    In those given estradiol, the median estradiol level was around 215 pg/mL (5%–95% range ~100–550 pg/mL) (Langley et al., 2021). About 93% of the men in this group achieved suppression of testosterone levels into the castrate range (<50 ng/dL), which was notably equal to the rate of suppression in the GnRH agonist group (~93%) (Langley et al., 2021). However, actual testosterone levels—as opposed to rates of testosterone suppression—were not provided in this report and hence comparison between groups is unavailable for this metric (Langley et al., 2021). After about 4 years median follow up, there were no significant differences on a variety of cardiovascular outcomes between the estradiol group and the GnRH agonist group (Langley et al., 2021). Among these outcomes included VTE, thromboembolic stroke, and other arterial embolic events (Langley et al., 2021). These results are in contrast to previous large clinical trials of PEP in prostate cancer, which found increased cardiovascular morbidity and risk of VTE but notably involved higher estradiol levels than employed in the PATCH trial (Ockrim & Abel, 2009; Sam, 2020). Based on their promising safety findings, the PATCH researchers stated that transdermal estrogen should be reconsidered for the treatment of prostate cancer (Langley et al., 2021).

    These findings are reassuring and suggest that limitedly high levels of estradiol (e.g., 200–300 pg/mL perhaps) may likewise be acceptably safe in terms of blood clot and cardiovascular risk in transfeminine people. It should be noted however that the sample size of the trial, while large relative to previous clinical studies in this area, was underpowered for assessing risk of blood clots—which are relatively rare events that require very large samples to thoroughly quantify. Studies precisely assessing blood clot risk in peri- and postmenopausal women have included tens of thousands of individuals for instance. As such, while substantial increases in risk are not likely based on this trial, smaller increases in risk still cannot be ruled out at this time. It should additionally be noted that the robust testosterone suppression at the used doses in this study might not generalize to transfeminine people as a whole, as the men were mostly elderly and testosterone levels are known to decrease with age.

    Update 2: Totaro et al. (2021) and Kotamarti et al. (2021)

    In November 2021, the following systematic review and meta-analysis as well as meta-regression study of VTE risk with transfeminine hormone therapy was published:

    • Totaro, M., Palazzi, S., Castellini, C., Parisi, A., D’Amato, F., Tienforti, D., Baroni, M. G., Francavilla, S., & Barbonetti, A. (2021). Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study. Frontiers in Endocrinology, 12, 741866. [DOI:10.3389/fendo.2021.741866]

    This study is the largest of its kind that has been conducted to date. The meta-analysis included 18 studies totaling 11,542 transfeminine people on hormone therapy. The pooled prevalence of VTE was 2% with a 95% confidence interval of 1 to 3%. However, there was large variability between studies. In the meta-regression analysis, older age and longer length of estrogen therapy were significantly positively associated with VTE prevalence. When analysis was restricted to those greater than or equal to 37.5 years of age, the prevalence of VTE was 3% (95% CI: 0–5%). Conversely, in those less than 37.5 years of age, the prevalence of VTE was 0% (95% CI: 0–2%). VTE prevalence was 1% (95% CI: 0–3%) with greater than or equal to 4.4 years of estrogen therapy and was 0% (95% CI: 0–3%) with less than 4.4 years of estrogen therapy. With regard to the 0% estimates, it is not the case that there is truly no risk of VTE in these instances but rather it can be assumed that the risks are sufficiently low that the meta-analysis was not powered well enough to detect and quantify them.

    A limitation of the meta-analysis was that subgroup analyses based on estrogen type (i.e., estradiol vs. CEEs vs. EE) and route (e.g., oral estrogens or oral estradiol vs. transdermal estradiol) were said to not be possible due to insufficient data and hence were not performed. However, another recent meta-analysis published in July 2021, which analyzed much of the same literature as Totaro et al. (2021), did perform subgroup analyses by estrogen type and route. This publication is as follows:

    • Kotamarti, V. S., Greige, N., Heiman, A. J., Patel, A., & Ricci, J. A. (2021). Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine, 18(7), 1280–1291. [DOI:10.1016/j.jsxm.2021.04.006]

    And this is what they reported in terms of subgroup analyses for estrogen type and route:

    Because varying VTE rates have been reported with different estrogen regimens, analyses of VTE incidence were performed comparing oral or transdermal delivery, or the specific estrogen formulation. As many studies reported populations using mixed estrogen formulations or did not report the type of estrogen regimen, further statistical analysis could not be performed.

    Route of estrogen administration appeared to play a role in the AMAB population. [Oral] estrogens (7 studies; 34.0 VTE per 10,000 person-years) vs transdermal estrogens (3 studies, 11.2 VTE per 10,000 person-years). Additionally, estrogen formulation also appeared to have a difference VTE incidence. Ethinyl estradiol was also associated with increased VTE incidence (3 studies, 293.1 VTE per 10,000 person-years) followed by conjugated equine estrogens (1 study, 49.0 VTE per 10,000 person-years) and estradiol valerate (4 studies, 31.5 VTE per 10,000 person-years).

    It is unclear how accurate these precise numbers are due to the quality limitations of the underlying data. Moreover, antiandrogens (e.g., CPA) were not controlled for and as discussed by this article are likely to additionally influence VTE risk. In any case, the reported numbers are interesting and are in accordance with different estrogen types and routes varying in terms of VTE risk.

    References

    • Abdul Sultan, A., West, J., Stephansson, O., Grainge, M. J., Tata, L. J., Fleming, K. M., Humes, D., & Ludvigsson, J. F. (2015). Defining venous thromboembolism and measuring its incidence using Swedish health registries: a nationwide pregnancy cohort study. BMJ Open, 5(11), e008864. [DOI:10.1136/bmjopen-2015-008864]
    • Abou-Ismail, M. Y., Citla Sridhar, D., & Nayak, L. (2020). Estrogen and thrombosis: A bench to bedside review. Thrombosis Research, 192, 40–51. [DOI:10.1016/j.thromres.2020.05.008]
    • Amitrano, L., Guardascione, M. A., Brancaccio, V., & Balzano, A. (2002). Coagulation Disorders in Liver Disease. Seminars in Liver Disease, 22(1), 83–96. [DOI:10.1055/s-2002-23205]
    • Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., … & Women’s Health Initiative Steering Committee. (2004). Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial. JAMA, 291(14), 1701–1712. [DOI:10.1001/jama.291.14.1701]
    • Arnold, J. D., Sarkodie, E. P., Coleman, M. E., & Goldstein, D. A. (2016). Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol. The Journal of Sexual Medicine, 13(11), 1773–1777. [DOI:10.1016/j.jsxm.2016.09.001]
    • Asscheman, H., Gooren, L., & Eklund, P. (1989). Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38(9), 869–873. [DOI:10.1016/0026-0495(89)90233-3]
    • Asscheman, H., Giltay, E. J., Megens, J. A., de Ronde, W. (Pim), van Trotsenburg, M. A., & Gooren, L. J. (2011). A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. European Journal of Endocrinology, 164(4), 635–642. [DOI:10.1530/eje-10-1038]
    • Asscheman, H., T’Sjoen, G., Lemaire, A., Mas, M., Meriggiola, M. C., Mueller, A., Kuhn, A., Dhejne, C., Morel-Journel, N., & Gooren, L. J. (2013). Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia, 46(7), 791–795. [DOI:10.1111/and.12150]
    • Baber, R. J., Panay, N., & Fenton, A. (2016). 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric, 19(2), 109–150. [DOI:10.3109/13697137.2015.1129166]
    • Back, D. J., & Rogers, S. M. (2007). Review: first-pass metabolism by the gastrointestinal mucosa. Alimentary Pharmacology & Therapeutics, 1(5), 339–357. [DOI:10.1111/j.1365-2036.1987.tb00634.x]
    • Bagot, C., Marsh, M., Whitehead, M., Sherwood, R., Roberts, L., Patel, R., & Arya, R. (2010). The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. Journal of Thrombosis and Haemostasis, 8(8), 1736–1744. [DOI:10.1111/j.1538-7836.2010.03953.x]
    • Bagot, C., Leishman, E., Onyiaodike, C., Jordan, F., Gibson, V., & Freeman, D. (2019). Changes in laboratory markers of thrombotic risk early in the first trimester of pregnancy may be linked to an increase in estradiol and progesterone. Thrombosis Research, 178, 47–53. [DOI:10.1016/j.thromres.2019.03.015]
    • Baron, J. A., Gridley, G., Weiderpass, E., Nyren, O., & Linet, M. (1998). Venous thromboembolism and cancer. The Lancet, 351(9109), 1077–1080. [DOI:10.1016/s0140-6736(97)10018-6]
    • Bezwada, P., Shaikh, A., & Misra, D. (2017). The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review. Journal of Women’s Health, 26(12), 1319–1325. [DOI:10.1089/jwh.2016.6151]
    • Blanco-Molina, M., Lozano, M., Cano, A., Cristobal, I., Pallardo, L., & Lete, I. (2012). Progestin-only contraception and venous thromboembolism. Thrombosis Research, 129(5), e257–e262. [DOI:10.1016/j.thromres.2012.02.042]
    • Bland, L. B., Garzotto, M., DeLoughery, T. G., Ryan, C. W., Schuff, K. G., Wersinger, E. M., Lemmon, D., & Beer, T. M. (2005). Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer, 103(4), 717–723. [DOI:10.1002/cncr.20857]
    • Blasdel, G., Shakir, N., Parker, A., Bluebond-Langner, R., & Zhao, L. (2021). Letter to the Editor from Blasdel et al: “No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-affirming Surgery”. The Journal of Clinical Endocrinology & Metabolism, 106(9), e3783–e3784. [DOI:10.1210/clinem/dgab243]
    • Blondon, M. (2020). Update On Oral Contraception And Venous Thromboembolism. HemaSphere Educational Updates in Hematology Book: 25th Congress of the European Hematology Association, Virtual Edition 2020, 4(S2). European Hematology Association. [Google Scholar] [DOI:10.1097/HS9.0000000000000444] [PDF]
    • Boskey, E. R., Taghinia, A. H., & Ganor, O. (2019). Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients. JAMA Surgery, 154(2), 159–169. [DOI:10.1001/jamasurg.2018.4598]
    • Byar, D. P. (1973). The veterans administration cooperative urological research group’s studies of cancer of the prostate. Cancer, 32(5), 1126–1130. [DOI:10.1002/1097-0142(197311)32:5<1126::aid-cncr2820320518>3.0.co;2-c]
    • Canonico, M., Plu-Bureau, G., Lowe, G. D., & Scarabin, P. (2008). Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ, 336(7655), 1227–1231. [DOI:10.1136/bmj.39555.441944.be]
    • Canonico, M., Plu-Bureau, G., O’Sullivan, M. J., Stefanick, M. L., Cochrane, B., Scarabin, P., & Manson, J. E. (2014). Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women. Menopause, 21(3), 214–220. [DOI:10.1097/gme.0b013e31829752e0]
    • Cassidy, A., & Minihane, A. (2017). The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. The American Journal of Clinical Nutrition, 105(1), 10–22. [DOI:10.3945/ajcn.116.136051]
    • Chaireti, R., Gustafsson, K. M., Bystrom, B., Bremme, K., & Lindahl, T. L. (2013). Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle. Human Reproduction, 28(7), 1846–1852. [DOI:10.1093/humrep/det092]
    • Choi, J., Kim, D., Park, S., Lee, H., Kim, K., Kim, K., Kim, M., Kim, S., & Kim, S. (2015). Anti-thrombotic effect of rutin isolated from Dendropanax morbifera Leveille. Journal of Bioscience and Bioengineering, 120(2), 181–186. [DOI:10.1016/j.jbiosc.2014.12.012]
    • Cleuren, A., Van der Linden, I., de Visser, Y., Wagenaar, G., Reitsma, P., & van Vlijmen, B. (2010). 17α‐Ethinylestradiol rapidly alters transcript levels of murine coagulation genes via estrogen receptor α. Journal of Thrombosis and Haemostasis, 8(8), 1838–1846. [DOI:10.1111/j.1538-7836.2010.03930.x]
    • Coelingh Bennink, H. J., Verhoeven, C., Dutman, A. E., & Thijssen, J. (2017). The use of high-dose estrogens for the treatment of breast cancer. Maturitas, 95, 11–23. [DOI:10.1016/j.maturitas.2016.10.010]
    • Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., … & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism, 13(4), 165–232. [DOI:10.1080/15532739.2011.700873] [URL] [PDF]
    • Conard, J., Plu-Bureau, G., Bahi, N., Horellou, M., Pelissier, C., & Thalabard, J. (2004). Progestogen-only contraception in women at high risk of venous thromboembolism. Contraception, 70(6), 437–441. [DOI:10.1016/j.contraception.2004.07.009]
    • Connelly, P. J., Marie Freel, E., Perry, C., Ewan, J., Touyz, R. M., Currie, G., & Delles, C. (2019). Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults. Hypertension, 74(6), 1266–1274. [DOI:10.1161/hypertensionaha.119.13080]
    • Connors, J. M., & Middeldorp, S. (2019). Transgender patients and the role of the coagulation clinician. Journal of Thrombosis and Haemostasis, 17(11), 1790–1797. [DOI:10.1111/jth.14626]
    • Curb, J. D., Prentice, R. L., Bray, P. F., Langer, R. D., Van Horn, L., Barnabei, V. M., Bloch, M. J., Cyr, M. G., Gass, M., Lepine, L., Rodabough, R. J., Sidney, S., Uwaifo, G. I., & Rosendaal, F. R. (2006). Venous Thrombosis and Conjugated Equine Estrogen in Women Without a Uterus. Archives of Internal Medicine, 166(7), 772–772. [DOI:10.1001/archinte.166.7.772]
    • Cushman, M. (2004). Estrogen Plus Progestin and Risk of Venous Thrombosis. JAMA, 292(13), 1573–1580. [DOI:10.1001/jama.292.13.1573]
    • Deitcher, S. R., & Gomes, M. P. (2004). The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma. Cancer, 101(3), 439–449. [DOI:10.1002/cncr.20347]
    • DeLoughery, T. G. (2011). Estrogen and thrombosis: Controversies and common sense. Reviews in Endocrine and Metabolic Disorders, 12(2), 77–84. [DOI:10.1007/s11154-011-9178-0]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Dinger, J., Do Minh, T., & Heinemann, K. (2016). Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception, 94(4), 328–339. [DOI:10.1016/j.contraception.2016.06.010]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Douxfils, J., Morimont, L., & Bouvy, C. (2020). Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk. Seminars in Thrombosis and Hemostasis, 46(8), 872–886. [DOI:10.1055/s-0040-1714140]
    • Douxfils, J., Klipping, C., Duijkers, I., Kinet, V., Mawet, M., Maillard, C., Jost, M., Rosing, J., & Foidart, J. (2020). Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters. Contraception, 102(6), 396–402. [DOI:10.1016/j.contraception.2020.08.015]
    • Dutra, E., Lee, J., Torbati, T., Garcia, M., Merz, C. N., & Shufelt, C. (2019). Cardiovascular implications of gender-affirming hormone treatment in the transgender population. Maturitas, 129, 45–49. [DOI:10.1016/j.maturitas.2019.08.010]
    • Eilertsen, A. L., Dahm, A. E., Høibraaten, E., Lofthus, C. M., Mowinckel, M., & Sandset, P. M. (2019). Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment. Blood Coagulation & Fibrinolysis, 30(1), 17–23. [DOI:10.1097/mbc.0000000000000784]
    • Eisenfeld, A. J., & Aten, R. F. (1979). Estrogen receptor in the mammalian liver. In Briggs, M. H., & Corbin, A. (Eds.). Advances in Steroid Biochemistry and Pharmacology, 7, 91–117. London: Academic Press. [Google Scholar] [PubMed]
    • Eisenfeld, A. J., & Aten, R. F. (1987). Estrogen receptors and androgen receptors in the mammalian liver. Journal of Steroid Biochemistry, 27(4–6), 1109–1118. [DOI:10.1016/0022-4731(87)90197-x]
    • Fabian, C. J., & Kimler, B. F. (2005). Selective Estrogen-Receptor Modulators for Primary Prevention of Breast Cancer. Journal of Clinical Oncology, 23(8), 1644–1655. [DOI:10.1200/jco.2005.11.005]
    • Fåhraeus, L., & Larsson-Cohn, U. (1982). Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17β to menopausal women. Acta Endocrinologica, 101(4), 592–596. [DOI:10.1530/acta.0.1010592]
    • Feldman, J. L., & Goldberg, J. (2006). Transgender Primary Medical Care: Suggested Guidelines for Clinicians in British Columbia. crhc/csac/Transcend Transgender Support & Education Society/Vancouver Coastal Health. [Google Scholar] [PDF]
    • Franchini, M., & Mannucci, P. M. (2015). Classic thrombophilic gene variants. Thrombosis and Haemostasis, 114(11), 885–889. [DOI:10.1160/th15-02-0141]
    • Fruzzetti, F., & Cagnacci, A. (2018). Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives? Open Access Journal of Contraception, 9, 75–79. [DOI:10.2147/oajc.s179673]
    • Gerstman, B. B., Piper, J. M., Tomita, D. K., Ferguson, W. J., Stadel, B. V., & Lundin, F. E. (1991). Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic Disease. American Journal of Epidemiology, 133(1), 32–37. [DOI:10.1093/oxfordjournals.aje.a115799]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons. Annals of Internal Medicine, 169(4), 205. [DOI:10.7326/m17-2785]
    • Gibney, J., Johannsson, G., Leung, K., & Ho, K. K. (2005). Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women. The Journal of Clinical Endocrinology & Metabolism, 90(7), 3897–3903. [DOI:10.1210/jc.2005-0173]
    • Gilbert, D. C., Duong, T., Sydes, M., Bara, A., Clarke, N., Abel, P., James, N., Langley, R., Parmar, M., & (2018). Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform. BJU International, 121(5), 680–683. [DOI:10.1111/bju.14153]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/eje-21-0059]
    • Goldstein, Z., Khan, M., Reisman, T., & Safer, J. D. (2019). Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. Journal of Blood Medicine, 10, 209–216. [DOI:10.2147/jbm.s166780]
    • Gooren, L. J., & T’Sjoen, G. (2018). Endocrine treatment of aging transgender people. Reviews in Endocrine and Metabolic Disorders, 19(3), 253–262. [DOI:10.1007/s11154-018-9449-0]
    • Gourdy, P., Bachelot, A., Catteau-Jonard, S., Chabbert-Buffet, N., Christin-Maître, S., Conard, J., Fredenrich, A., Gompel, A., Lamiche-Lorenzini, F., Moreau, C., Plu-Bureau, G., Vambergue, A., Vergès, B., & Kerlan, V. (2012). Hormonal contraception in women at risk of vascular and metabolic disorders: Guidelines of the French Society of Endocrinology. Annales d’Endocrinologie, 73(5), 469–487. [DOI:10.1016/j.ando.2012.09.001]
    • Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., & (2000). Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study. Annals of Internal Medicine, 132(9), 689–696. [DOI:10.7326/0003-4819-132-9-200005020-00002]
    • Grandi, G., Facchinetti, F., & Bitzer, J. (2017). Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle? The European Journal of Contraception & Reproductive Health Care, 22(4), 245–246. [DOI:10.1080/13625187.2017.1372571]
    • Grandi, G., Barra, F., Ferrero, S., & Facchinetti, F. (2019). Estradiol in non-oral hormonal contraception: a “long and winding road”. Expert Review of Endocrinology & Metabolism, 14(3), 153–155. [DOI:10.1080/17446651.2019.1604217]
    • Grandi, G., Del Savio, M. C., Lopes da Silva-Filho, A., & Facchinetti, F. (2020). Estetrol (E4): the new estrogenic component of combined oral contraceptives. Expert Review of Clinical Pharmacology, 13(4), 327–330. [DOI:10.1080/17512433.2020.1750365]
    • Grandi, G., Facchinetti, F., & Bitzer, J. (2022). Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. The European Journal of Contraception & Reproductive Health Care, 27(2), 83–84. [DOI:10.1080/13625187.2022.2029397]
    • Grossmann, M., Wierman, M. E., Angus, P., & Handelsman, D. J. (2018). Reproductive Endocrinology of Nonalcoholic Fatty Liver Disease. Endocrine Reviews, 40(2), 417–446. [DOI:10.1210/er.2018-00158]
    • Hammond, G. L. (2017). Sex Hormone-Binding Globulin and the Metabolic Syndrome. In Winters, S. J., & Huhtaniemi, I. T. (Eds.). Male Hypogonadism: Basic, Clinical and Therapeutic Principles, 2nd Edition (pp. 305–324). Cham: Springer. [DOI:10.1007/978-3-319-53298-1_15]
    • Hannaford, P. C., Iversen, L., Macfarlane, T. V., Elliott, A. M., Angus, V., & Lee, A. J. (2010). Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ, 340, c927. [DOI:10.1136/bmj.c927]
    • Haupt, C., Henke, M., Kutschmar, A., Hauser, B., Baldinger, S., Saenz, S. R., & Schreiber, G. (2020). Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. Cochrane Database of Systematic Reviews, 2020(11), CD013138. [DOI:10.1002/14651858.cd013138.pub2]
    • Haveles, C. S., Wang, M. M., Arjun, A., Zaila, K. E., & Lee, J. C. (2020). Effect of Cross-Sex Hormone Therapy on Venous Thromboembolism Risk in Male-to-Female Gender-Affirming Surgery. Annals of Plastic Surgery, 86(1), 109–114. [DOI:10.1097/sap.0000000000002300]
    • Hedlund, P. O., Johansson, R., Damber, J. E., Hagerman, I., Henriksson, P., Iversen, P., Klarskov, P., Mogensen, P., Rasmussen, F., & Varenhorst, E. (2011). Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial. Scandinavian Journal of Urology and Nephrology, 45(5), 346–353. [DOI:10.3109/00365599.2011.585820]
    • Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (2000). Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine, 160(6), 809–815. [DOI:10.1001/archinte.160.6.809]
    • Heit, J. A., Spencer, F. A., & White, R. H. (2016). The epidemiology of venous thromboembolism. Journal of Thrombosis and Thrombolysis, 41(1), 3–14. [DOI:10.1007/s11239-015-1311-6]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658]
    • Hemelaar, M., van der Mooren, M. J., Rad, M., Kluft, C., & Kenemans, P. (2008). Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertility and Sterility, 90(3), 642–672. [DOI:10.1016/j.fertnstert.2007.07.1298]
    • Hibbs, D. (2008). Hormone replacement and the treatment of the transgender patient: A critical literature review. de Chesnay, M., & Anderson, B. (Eds.). Caring for the Vulnerable: Perspectives in Nursing Theory, Practice, and Research, 2nd Edition (pp. 351–362). Sudbury, Massachusetts: Jones & Barlett. [Google Scholar] [Google Books]
    • Higdon, J., Drake, V. J., Delage, B., & Crozier, A. (2016). Flavonoids. Corvallis, Oregon: Micronutrient Information Center, Linus Pauling Institute, Oregon State University. [URL]
    • Høibraaten, E., Qvigstad, E., Arnesen, H., Larsen, S., Wickstrøm, E., & Sandset, P. M. (2000). Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy. Thrombosis and Haemostasis, 84(12), 961–967. [DOI:10.1055/s-0037-1614156]
    • Høibraaten, E., Qvigstad, E., Andersen, T. O., Mowinckel, M., & Sandset, P. M. (2001). The Effects of Hormone Replacement Therapy (HRT) on Hemostatic Variables in Women with Previous Venous Thromboembolism – Results from a Randomized, Double-Blind, Clinical Trial. Thrombosis and Haemostasis, 85(5), 775–781. [DOI:10.1055/s-0037-1615717]
    • Holmegard, H., Nordestgaard, B., Schnohr, P., Tybjærg‐Hansen, A., & Benn, M. (2014). Endogenous sex hormones and risk of venous thromboembolism in women and men. Journal of Thrombosis and Haemostasis, 12(3), 297–305. [DOI:10.1111/jth.12484]
    • Hontscharuk, R., Alba, B., Manno, C., Pine, E., Deutsch, M. B., Coon, D., & Schechter, L. (2021). Perioperative Transgender Hormone Management: Avoiding Venous Thromboembolism and Other Complications. Plastic & Reconstructive Surgery, 147(4), 1008–1017. [DOI:10.1097/prs.0000000000007786]
    • Hugon-Rodin, J., Alhenc-Gelas, M., Hemker, H. C., Brailly-Tabard, S., Guiochon-Mantel, A., Plu-Bureau, G., & Scarabin, P. (2016). Sex hormone-binding globulin and thrombin generation in women using hormonal contraception. Biomarkers, 22(1), 81–85. [DOI:10.1080/1354750x.2016.1204010]
    • Hulley, S. (1998). Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women. JAMA, 280(7), 605–613. [DOI:10.1001/jama.280.7.605]
    • Iqbal, J., Ginsburg, O. M., Wijeratne, T. D., Howell, A., Evans, G., Sestak, I., & Narod, S. A. (2012). Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: A systematic review. Cancer Treatment Reviews, 38(4), 318–328. [DOI:10.1016/j.ctrv.2011.06.009]
    • Irwig, M. S. (2018). Cardiovascular health in transgender people. Reviews in Endocrine and Metabolic Disorders, 19(3), 243–251. [DOI:10.1007/s11154-018-9454-3]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Jasuja, R., Passam, F. H., Kennedy, D. R., Kim, S. H., van Hessem, L., Lin, L., Bowley, S. R., Joshi, S. S., Dilks, J. R., Furie, B., Furie, B. C., & Flaumenhaft, R. (2012). Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. Journal of Clinical Investigation, 122(6), 2104–2113. [DOI:10.1172/jci61228]
    • Jensen, E. V., Jacobson, H. I., Walf, A. A., & Frye, C. A. (2010). Estrogen action: A historic perspective on the implications of considering alternative approaches. Physiology & Behavior, 99(2), 151–162. [DOI:10.1016/j.physbeh.2009.08.013]
    • Kaemmle, L. M., Stadler, A., Janka, H., von Wolff, M., & Stute, P. (2022). The impact of micronized progesterone on cardiovascular events – a systematic review. Climacteric, 25(4), 327–336. [DOI:10.1080/13697137.2021.2022644]
    • Kasum, M., Danolić, D., Orešković, S., Ježek, D., Beketić-Orešković, L., & Pekez, M. (2014). Thrombosis following ovarian hyperstimulation syndrome. Gynecological Endocrinology, 30(11), 764–768. [DOI:10.3109/09513590.2014.927858]
    • Keenan, L., Kerr, T., Duane, M., & Van Gundy, K. (2018). Systematic Review of Hormonal Contraception and Risk of Venous Thrombosis. The Linacre Quarterly, 85(4), 470–477. [DOI:10.1177/0024363918816683]
    • Kerlan, V., Nahoul, K., Martelot, M., & Bercovici, J. (1994). Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clinical Endocrinology, 40(2), 263–267. [DOI:10.1111/j.1365-2265.1994.tb02478.x]
    • Khan, J., Schmidt, R. L., Spittal, M. J., Goldstein, Z., Smock, K. J., & Greene, D. N. (2019). Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. Clinical Chemistry, 65(1), 57–66. [DOI:10.1373/clinchem.2018.288316]
    • Kitamura, T. (2001). Necessity of re‐evaluation of estramustine phosphate sodium (EMP) as a treatment option for first‐line monotherapy in advanced prostate cancer. International Journal of Urology, 8(2), 33–36. [DOI:10.1046/j.1442-2042.2001.00254.x]
    • Klil-Drori, A. J., Yin, H., Tagalakis, V., Aprikian, A., & Azoulay, L. (2016). Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism. European Urology, 70(1), 56–61. [DOI:10.1016/j.eururo.2015.06.022]
    • Kohli, M., & McClellan, J. (2001). Parenteral Estrogen Therapy in Advanced Prostate Cancer: Retrospective Analysis of Intra-Muscular Estradiol Valerate in “Hormone Refractory” Prostate Disease. In Grunberg, S. M. (Ed.). Proceedings of the American Society of Clinical Oncology [Proc Am Soc Clin Oncol / Proceedings of ASCO], 20 [Thirty-Seventh Annual Meeting of the American Society of Clinical Oncology, May 12–15, 2001, San Francisco, California], 164b–164b (abstract no. 2407). Baltimore: Lippincott Williams & Wilkins. [ISSN:1081-0641] [ISBN-10:0-9664495-3-3] [Google Scholar] [WorldCat 1] [WorldCat 2] [WorldCat 3] [PDF]
    • Kohli, M., Alikhan, M. A., Spencer, H. J., & Carter, G. (2004). Phase I trial of intramuscular estradiol valerate (I/M-E) in hormone refractory prostate cancer. Journal of Clinical Oncology, 22(14 Suppl) [40th Annual Meeting of the American Society of Clinical Oncology: June 5–8, 2004, Ernest N. Morial Convention Center, New Orleans, Louisiana, Annual Meeting Proceedings], 436–436 (abstract no. 4726). [DOI:10.1200/jco.2004.22.90140.4726] [Google Books] [PDF]
    • Kohli, M. (2006). Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer, 106(1), 234–235. [DOI:10.1002/cncr.21528]
    • Konkle, B. A., & Sood, S. L. (2019). Thrombotic Risk of Contraceptives and Other Hormonal Therapies. In Kitchens, C. S., Kessler, C. M., Konkle, B. A., Streiff, M. B., & Garcia, D. A. (Eds.). Consultative Hemostasis and Thrombosis, 4th Edition (pp. 637–650). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-46202-0.00031-5]
    • Kotamarti, V. S., Greige, N., Heiman, A. J., Patel, A., & Ricci, J. A. (2021). Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review. The Journal of Sexual Medicine, 18(7), 1280–1291. [DOI:10.1016/j.jsxm.2021.04.006]
    • Kozato, A., Fox, G. W., Yong, P. C., Shin, S. J., Avanessian, B. K., Ting, J., Ling, Y., Karim, S., Safer, J. D., & Pang, J. H. (2021). No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery. The Journal of Clinical Endocrinology & Metabolism, 106(4), 1586–1590. [DOI:10.1210/clinem/dgaa966]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265] [Table]
    • Kuhl, H. (1990). Ovulationshemmer: Die Bedeutung der Östrogendosis. [Ovulation Preventives: The Significance of the Estrogen Dose. / Ovulation Inhibitors: The Significance of Estrogen Dose.] Geburtshilfe und Frauenheilkunde, 50(12), 910–922. [Google Scholar 1] [Google Scholar 2] [PubMed] [DOI:10.1055/s-2008-1026392] [Translation]
    • Kuhl, H. (1996). Effects of progestogens on haemostasis. Maturitas, 24(1–2), 1–19. [DOI:10.1016/0378-5122(96)00994-2]
    • Kuhl, H. (1997). Metabolische Effekte der Östrogene und Gestagene. [Metabolic Effects of Estrogens and Progestogens.] Der Gynäkologe, 30(4), 357–369. [DOI:10.1007/pl00003042]
    • Kuhl, H. (1998). Adverse effects of estrogen treatment: natural vs. synthetic estrogens. In Lippert, T. H., Mueck, A. O., & Ginsburg, J. (Eds.). Sex Steroids and the Cardiovascular System: The Proceedings of the 1st Interdisciplinary Workshop, Tuebingen, Germany, October 1996. Parthenon Publishing Group, New York, London (pp. 201–210). London/New York: Parthenon. [Google Scholar] [Google Books] [PDF]
    • Kuhl, H. (1999). Hormonal contraception. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 363–407). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_18] [PDF]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H., & Stevenson, J. (2006). The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits – an attempt to interpret the Women’s Health Initiative results. Gynecological Endocrinology, 22(6), 303–317. [DOI:10.1080/09513590600717368]
    • Langley, R. E., Cafferty, F. H., Alhasso, A. A., Rosen, S. D., Sundaram, S. K., Freeman, S. C., Pollock, P., Jinks, R. C., Godsland, I. F., Kockelbergh, R., Clarke, N. W., Kynaston, H. G., Parmar, M. K., & Abel, P. D. (2013). Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09). The Lancet Oncology, 14(4), 306–316. [DOI:10.1016/s1470-2045(13)70025-1]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., Paez, E., Robinson, A., McFarlane, J., Deighan, J. V., Marshall, J., Forcat, S., Weiss, M., Kockelbergh, R., Alhasso, A., Kynaston, H., & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/s0140-6736(21)00100-8] [PDF] [Supplementary appendix]
    • Lax, E. (1987). Mechanisms of physiological and pharmacological sex hormone action on the mammalian liver. Journal of Steroid Biochemistry, 27(4–6), 1119–1128. [DOI:10.1016/0022-4731(87)90198-1]
    • Lidegaard, Ø. (2014). Hormonal contraception, thrombosis and age. Expert Opinion on Drug Safety, 13(10), 1353–1360. [DOI:10.1517/14740338.2014.950654]
    • Lijfering, W. M., Rosendaal, F. R., & Cannegieter, S. C. (2010). Risk factors for venous thrombosis - current understanding from an epidemiological point of view. British Journal of Haematology, 149(6), 824–833. [DOI:10.1111/j.1365-2141.2010.08206.x]
    • Lim, H. Y., Leemaqz, S. Y., Torkamani, N., Grossmann, M., Zajac, J. D., Nandurkar, H., Ho, P., & Cheung, A. S. (2020). Global Coagulation Assays in Transgender Women on Oral and Transdermal Estradiol Therapy. The Journal of Clinical Endocrinology & Metabolism, 105(7), e2369–e2377. [DOI:10.1210/clinem/dgaa262]
    • Luria, M. H. (1989). Estrogen and coronary arterial disease in men. International Journal of Cardiology, 25(2), 159–166. [DOI:10.1016/0167-5273(89)90102-2]
    • Ma, Y., Zeng, M., Sun, R., & Hu, M. (2015). Disposition of Flavonoids Impacts their Efficacy and Safety. Current Drug Metabolism, 15(9), 841–864. [DOI:10.2174/1389200216666150206123719]
    • Machin, N., & Ragni, M. V. (2020). Hormones and thrombosis: risk across the reproductive years and beyond. Translational Research, 225, 9–19. [DOI:10.1016/j.trsl.2020.06.011]
    • Mammen, E. F. (1992). Coagulation Abnormalities in Liver Disease. Hematology/Oncology Clinics of North America, 6(6), 1247–1257. [DOI:10.1016/s0889-8588(18)30273-9]
    • Mantha, S., Karp, R., Raghavan, V., Terrin, N., Bauer, K. A., & Zwicker, J. I. (2012). Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ, 345, e4944. [DOI:10.1136/bmj.e4944]
    • Martinelli, I., Passamonti, S. M., & Bucciarelli, P. (2014). Thrombophilic states. In Biller, J., & Ferro, J. M. (Eds.). Neurologic Aspects of Systemic Disease Part II (Handbook of Clinical Neurology, Volume 120) (pp. 1061–1071). Philadelphia: Elsevier. [DOI:10.1016/b978-0-7020-4087-0.00071-1]
    • Martinez-Zapata, M. J., Vernooij, R. W., Uriona Tuma, S. M., Stein, A. T., Moreno, R. M., Vargas, E., Capellà, D., & Bonfill Cosp, X. (2016). Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews, 2016(4), CD003229. [DOI:10.1002/14651858.cd003229.pub3]
    • Matharu, G. S., Kunutsor, S. K., Judge, A., Blom, A. W., & Whitehouse, M. R. (2020). Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement. JAMA Internal Medicine, 180(3), 376–384. [DOI:10.1001/jamainternmed.2019.6108]
    • McLintock, C. (2014). Thromboembolism in pregnancy: Challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of anticoagulation in women with mechanical prosthetic heart valves. Best Practice & Research Clinical Obstetrics & Gynaecology, 28(4), 519–536. [DOI:10.1016/j.bpobgyn.2014.03.001]
    • Mekaj, A., Mekaj, Y., & Daci, F. (2015). New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Therapeutics and Clinical Risk Management, 11, 1449–1456. [DOI:10.2147/tcrm.s92222]
    • Mellinger, G. T., Bailar, J. C., Arduino, L. J., & the Veterans Administration Cooperative Urological Research Group. (1967). Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group. Surgery Gynecology & Obstetrics, 124(5), 1011–1017. [Google Scholar] [PubMed]
    • Meng, Y., Jiang, H., Chen, A., Lu, F., Yang, H., Shen, M. Z., Sun, D., Shao, Q., & Fotherby, K. (1990). Hemostatic changes in women using a monthly injectable contraceptive for one year. Contraception, 42(4), 455–466. [DOI:10.1016/0010-7824(90)90052-w]
    • Mikkola, A., Ruutu, M., Aro, J., Rannikko, S., & Salo, J. (1999). The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium. Annales Chirurgiae et Gynaecologiae, 88(1), 18–21. [Google Scholar] [PubMed] [PDF]
    • Min, L. L., & Hopkins, R. (2021). Endocrinological Care for Patients Undergoing Gender Affirmation (Including Risk of Thromboembolic Events). In Nikolavsky, D., & Blakely, S. A. (Eds.). Urological Care for the Transgender Patient: A Comprehensive Guide (pp. 23–36). Cham: Springer. [DOI:10.1007/978-3-030-18533-6_3]
    • Mohammed, K., Abu Dabrh, A. M., Benkhadra, K., Al Nofal, A., Carranza Leon, B. G., Prokop, L. J., Montori, V. M., Faubion, S. S., & Murad, M. H. (2015). Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 100(11), 4012–4020. [DOI:10.1210/jc.2015-2237]
    • Montagnana, M., Favaloro, E. J., Franchini, M., Guidi, G. C., & Lippi, G. (2009). The role of ethnicity, age and gender in venous thromboembolism. Journal of Thrombosis and Thrombolysis, 29(4), 489–496. [DOI:10.1007/s11239-009-0365-8]
    • Moores, L., Bilello, K. L., & Murin, S. (2004). Sex and gender issues and venous thromboembolism. Clinics in Chest Medicine, 25(2), 281–297. [DOI:10.1016/j.ccm.2004.01.013]
    • Morimont, L., Dogné, J., & Douxfils, J. (2020). Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40–51). Thrombosis Research, 193, 221–223. [DOI:10.1016/j.thromres.2020.08.006]
    • Morimont, L., Haguet, H., Dogné, J., Gaspard, U., & Douxfils, J. (2021). Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk. Frontiers in Endocrinology, 12, 769187. [DOI:10.3389/fendo.2021.769187]
    • Morling, J. R., Broderick, C., Yeoh, S. E., & Kolbach, D. N. (2018). Rutosides for treatment of post-thrombotic syndrome. Cochrane Database of Systematic Reviews, 2018(11), CD005625. [DOI:10.1002/14651858.cd005625.pub4]
    • Mueller, A., Dittrich, R., Binder, H., Kuehnel, W., Maltaris, T., Hoffmann, I., & Beckmann, M. W. (2005). High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. European Journal of Endocrinology, 153(1), 107–113. [DOI:10.1530/eje.1.01943]
    • Mueller, A., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Dittrich, R. (2006). Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female Transsexuals. Hormone and Metabolic Research, 38(3), 183–187. [DOI:10.1055/s-2006-925198]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • Nachtigall, L. E., Raju, U., Banerjee, S., Wan, L., & Levitz, M. (2000). Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies. Menopause, 7(4), 243–250. [DOI:10.1097/00042192-200007040-00006]
    • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016]
    • Nolan, B. J., & Cheung, A. S. (2020). Estradiol Therapy in the Perioperative Period: Implications for Transgender People Undergoing Feminizing Hormone Therapy. The Yale Journal of Biology and Medicine, 93(4), 539–548. [PubMed] [PubMed Central]
    • Nolan, B. J., & Cheung, A. S. (2021). Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review. Transgender Health, 6(3), 125–131. [DOI:10.1089/trgh.2020.0077]
    • Nolan, I. T., Haley, C., Morrison, S. D., Pannucci, C. J., & Satterwhite, T. (2021). Estrogen Continuation and Venous Thromboembolism in Penile Inversion Vaginoplasty. The Journal of Sexual Medicine, 18(1), 193–200. [DOI:10.1016/j.jsxm.2020.10.018]
    • Ockrim, J., & Abel, P. D. (2009). Androgen deprivation therapy for prostate cancer – the potential of parenteral estrogen. Central European Journal of Urology, 62, 132–140. [DOI:10.5173/ceju.2009.03.art1]
    • Odlind, V., Milsom, I., Persson, I., & Victor, A. (2002). Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?: A discussion based on recent recommendations from the European agency for evaluation of medicinal products regarding third generation oral contraceptive pills. Acta Obstetricia et Gynecologica Scandinavica, 81(6), 482–490. [DOI:10.1080/j.1600-0412.2002.810603.x] [URL]
    • Oger, E., & (2000). Incidence of Venous Thromboembolism: A Community-based Study in Western France. Thrombosis and Haemostasis, 83(5), 657–660. [DOI:10.1055/s-0037-1613887]
    • Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018). Erythrocytosis Following Testosterone Therapy. Sexual Medicine Reviews, 6(1), 77–85. [DOI:10.1016/j.sxmr.2017.04.001]
    • Olié, V., Canonico, M., & Scarabin, P. (2010). Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women. Current Opinion in Hematology, 17(5), 457–463. [DOI:10.1097/moh.0b013e32833c07bc]
    • Olié, V., Plu-Bureau, G., Conard, J., Horellou, M., Canonico, M., & Scarabin, P. (2011). Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause, 18(5), 488–493. [DOI:10.1097/gme.0b013e3181f9f7c3]
    • Oliver-Williams, C., Glisic, M., Shahzad, S., Brown, E., Pellegrino Baena, C., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2018). The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update, 25(2), 257–271. [DOI:10.1093/humupd/dmy039]
    • Olov Hedlund, P., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., Olov Hedlund, P., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., & The SPCG-5 Study Group. (2008). Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology, 42(3), 220–229. [DOI:10.1080/00365590801943274]
    • Park, W. (2002). Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends in Molecular Medicine, 8(2), 82–88. [DOI:10.1016/s1471-4914(02)02282-7]
    • Patel, K. T., Adeel, S., Rodrigues Miragaya, J., & Tangpricha, V. (2022). Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocrine Practice, 28(12), 1244–1252. [DOI:10.1016/j.eprac.2022.08.012]
    • Peck-Radosavljevic, M. (2007). Review article: coagulation disorders in chronic liver disease. Alimentary Pharmacology & Therapeutics, 26, 21–28. [DOI:10.1111/j.1365-2036.2007.03509.x]
    • Pfeifer, S., Butts, S., Dumesic, D., Fossum, G., Gracia, C., La Barbera, A., Mersereau, J., Odem, R., Penzias, A., Pisarska, M., Rebar, R., Reindollar, R., Rosen, M., Sandlow, J., Sokol, R., Vernon, M., & Widra, E. (2017). Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertility and Sterility, 107(1), 43–51. [DOI:10.1016/j.fertnstert.2016.09.027]
    • Phillips, I., Shah, S. I., Duong, T., Abel, P., & Langley, R. E. (2014). Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer. Oncology & Hematology Review, 10(1), 42–47. [PubMed Central] [DOI:10.17925/ohr.2014.10.1.42]
    • Plu-Bureau, G., Maitrot-Mantelet, L., Hugon-Rodin, J., & Canonico, M. (2013). Hormonal contraceptives and venous thromboembolism: An epidemiological update. Best Practice & Research Clinical Endocrinology & Metabolism, 27(1), 25–34. [DOI:10.1016/j.beem.2012.11.002]
    • Pomp, E. R., Rosendaal, F. R., & Doggen, C. J. (2008). Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology, 83(2), 97–102. [DOI:10.1002/ajh.21059]
    • Pond, S. M., & Tozer, T. N. (1984). First-Pass Elimination. Clinical Pharmacokinetics, 9(1), 1–25. [DOI:10.2165/00003088-198409010-00001]
    • Prentice, R. L., & Anderson, G. L. (2008). The Women’s Health Initiative: Lessons Learned. Annual Review of Public Health, 29(1), 131–150. [DOI:10.1146/annurev.publhealth.29.020907.090947]
    • Prentice, R. (2014). Postmenopausal Hormone Therapy and the Risks of Coronary Heart Disease, Breast Cancer, and Stroke. Seminars in Reproductive Medicine, 32(6), 419–425. [DOI:10.1055/s-0034-1384624]
    • Pyra, M., Casimiro, I., Rusie, L., Ross, N., Blum, C., Keglovitz Baker, K., Baker, A., & Schneider, J. (2020). An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy. Transgender Health, 5(1), 1–9. [DOI:10.1089/trgh.2019.0061]
    • Quinton, R., & Swee, D. S. (2019). Hormone replacement therapy: transgender studies show safety of estradiol. BMJ, 364, l600. [DOI:10.1136/bmj.l600]
    • Rabe, T., Luxembourg, B., Ludwig, M., Dinger, J. C., Bauersachs, R., Rott, H., Mueck, A. O., & Albring, C. (2011). Contraception and Thrombophilia - A statement from the German Society of Gynecological Endocrinology and Reproductive Medicine (DGGEF e. V.) and the Professional Association of the German Gynaecologists (BVF e. V.). Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 8(Special Issue 1), 178–218. [URL]
    • Raps, M., Helmerhorst, F., Fleischer, K., Thomassen, S., Rosendaal, F., Rosing, J., Ballieux, B., & Van Vliet, H. (2012). Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives. Journal of Thrombosis and Haemostasis, 10(6), 992–997. [DOI:10.1111/j.1538-7836.2012.04720.x]
    • Ravery, V., Fizazi, K., Oudard, S., Drouet, L., Eymard, J., Culine, S., Gravis, G., Hennequin, C., & Zerbib, M. (2011). The use of estramustine phosphate in the modern management of advanced prostate cancer. BJU International, 108(11), 1782–1786. [DOI:10.1111/j.1464-410x.2011.10201.x]
    • Reda, S., Morimont, L., Douxfils, J., & Rühl, H. (2020). Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests? Hämostaseologie, 40(3), 364–378. [DOI:10.1055/a-1153-5824]
    • Renoux, C., Dell’Aniello, S., & Suissa, S. (2010). Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. Journal of Thrombosis and Haemostasis, 8(5), 979–986. [DOI:10.1111/j.1538-7836.2010.03839.x]
    • Renoux, C., Dell’Aniello, S., Garbe, E., & Suissa, S. (2010). Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ, 340, c2519. [DOI:10.1136/bmj.c2519]
    • Roach, R., Lijfering, W., Helmerhorst, F., Cannegieter, S., Rosendaal, F., & van Hylckama Vlieg, A. (2013). The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy. Journal of Thrombosis and Haemostasis, 11(1), 124–131. [DOI:10.1111/jth.12060]
    • Roach, R. E., Lijfering, W. M., Rosendaal, F. R., Cannegieter, S. C., & le Cessie, S. (2014). Sex Difference in Risk of Second but Not of First Venous Thrombosis. Circulation, 129(1), 51–56. [DOI:10.1161/circulationaha.113.004768]
    • Rooijen, M., Silveira, A., Hamsten, A., & Bremme, K. (2004). Sex hormone–binding globulin—A surrogate marker for the prothrombotic effects of combined oral contraceptives. American Journal of Obstetrics and Gynecology, 190(2), 332–337. [DOI:10.1016/s0002-9378(03)00950-5]
    • Ropponen, A., Aittomäki, K., Vihma, V., Tikkanen, M. J., & Ylikorkala, O. (2005). Effects of Oral and Transdermal Estradiol Administration on Levels of Sex Hormone-Binding Globulin in Postmenopausal Women with and without a History of Intrahepatic Cholestasis of Pregnancy. The Journal of Clinical Endocrinology & Metabolism, 90(6), 3431–3434. [DOI:10.1210/jc.2005-0352]
    • Rosendaal, F. R. (2005). Venous thrombosis: the role of genes, environment, and behavior. Hematology American Society of Hematology Education Program, 2005(1), 1–12. [Google Scholar] [DOI:10.1182/asheducation-2005.1.1] [URL]
    • Rosendaal, F. R. (2016). Causes of venous thrombosis. Thrombosis Journal, 14(Suppl 1) [State of the Art 2016: Research and Review from the 9th Congress of the Asian-Pacific Society on Thrombosis and Hemostasis], 24. [DOI:10.1186/s12959-016-0108-y]
    • Rott, H. (2019). Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen. Hämostaseologie, 39(1), 42–48. [DOI:10.1055/s-0039-1677806]
    • Rova, K., Passmark, H., & Lindqvist, P. G. (2012). Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertility and Sterility, 97(1), 95–100. [DOI:10.1016/j.fertnstert.2011.10.038]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
    • Ruiz Garcia, V., López-Briz, E., Carbonell Sanchis, R., Gonzalvez Perales, J. L., & Bort-Martí, S. (2013). Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database of Systematic Reviews, 2019(3), CD004310. [DOI:10.1002/14651858.cd004310.pub3]
    • Russell, N., Cheung, A., & Grossmann, M. (2017). Estradiol for the mitigation of adverse effects of androgen deprivation therapy. Endocrine-Related Cancer, 24(8), R297–R313. [DOI:10.1530/erc-17-0153]
    • Sahlin, L., & Schoultz, B. V. (1999). Liver Inclusive Protein, Lipid and Carbohydrate Metabolism. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 163–178). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_8] [PDF]
    • Scarabin, P. (2018). Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis. Climacteric, 21(4), 341–345. [DOI:10.1080/13697137.2018.1446931]
    • Scarabin, P., Canonico, M., Plu-Bureau, G., & Oger, E. (2020). Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone? Heart, 106(16), 1278–1278. [DOI:10.1136/heartjnl-2020-316907]
    • Scheres, L. J., van Hylckama Vlieg, A., Ballieux, B. E., Fauser, B. C., Rosendaal, F. R., Middeldorp, S., & Cannegieter, S. C. (2019). Endogenous sex hormones and risk of venous thromboembolism in young women. Journal of Thrombosis and Haemostasis, 17(8), 1297–1304. [DOI:10.1111/jth.14474]
    • Scheres, L. J., Selier, N. L., Nota, N. M., van Diemen, J. J., Cannegieter, S. C., & den Heijer, M. (2021). Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen. Journal of Thrombosis and Haemostasis, 19(4), 1029–1037. [DOI:10.1111/jth.15256]
    • Schindler, A. E. (2003). Differential effects of progestins on hemostasis. Maturitas, 46, 31–37. [DOI:10.1016/j.maturitas.2003.09.016]
    • Schock, H., Zeleniuch-Jacquotte, A., Lundin, E., Grankvist, K., Lakso, H., Idahl, A., Lehtinen, M., Surcel, H., & Fortner, R. T. (2016). Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy and Childbirth, 16(1), 146. [DOI:10.1186/s12884-016-0937-5]
    • Schröder, F. H., & Radlmaier, A. (2002). Steroidal Antiandrogens. In Jordan, C. V., & Furr, B. J. A. (Eds.). Hormone Therapy in Breast and Prostate Cancer (pp. 325–346). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-152-7_15]
    • Sciarra, A., Gentile, V., Cattarino, S., Gentilucci, A., Alfarone, A., D’Eramo, G., & Salciccia, S. (2014). Oral ethinylestradiol in castration-resistant prostate cancer: A 10-year experience. International Journal of Urology, 22(1), 98–103. [DOI:10.1111/iju.12613]
    • Seaman, H. E., Langley, S. E., Farmer, R. D., & de Vries, C. S. (2007). Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database. BJU International, 99(6), 1398–1403. [DOI:10.1111/j.1464-410x.2007.06859.x]
    • Shatzel, J. J., Connelly, K. J., & DeLoughery, T. G. (2017). Thrombotic issues in transgender medicine: A review. American Journal of Hematology, 92(2), 204–208. [DOI:10.1002/ajh.24593]
    • Shifren, J. L., Rifai, N., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2008). A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1702–1710. [DOI:10.1210/jc.2007-2193]
    • Simon, T., De Jonage-Canonico, M. B., Oger, E., Wahl, D., Conard, J., Meyer, G., Emmerich, J., Barrellier, M., Guiraud, A., & Scarabin, P. (2006). Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. Journal of Thrombosis and Haemostasis, 4(1), 71–76. [DOI:10.1111/j.1538-7836.2005.01693.x]
    • Singla, N., Ghandour, R. A., & Raj, G. V. (2019). Investigational luteinizing hormone releasing hormone (LHRH) agonists and other hormonal agents in early stage clinical trials for prostate cancer. Expert Opinion on Investigational Drugs, 28(3), 249–259. [DOI:10.1080/13543784.2019.1570130]
    • Sitruk-Ware, R., & Nath, A. (2011). Metabolic effects of contraceptive steroids. Reviews in Endocrine and Metabolic Disorders, 12(2), 63–75. [DOI:10.1007/s11154-011-9182-4]
    • Sitruk-Ware, R., & Nath, A. (2013). Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills. Best Practice & Research Clinical Endocrinology & Metabolism, 27(1), 13–24. [DOI:10.1016/j.beem.2012.09.004]
    • Skouby, S. O., & Sidelmann, J. J. (2018). Impact of progestogens on hemostasis. Hormone Molecular Biology and Clinical Investigation, 37(2), 20180041. [DOI:10.1515/hmbci-2018-0041]
    • Smith, K., Galazi, M., Openshaw, M. R., Wilson, P., Sarker, S. J., O’Brien, N., Alifrangis, C., Stebbing, J., & Shamash, J. (2020). The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. Clinical Genitourinary Cancer, 18(3), e217–e223. [DOI:10.1016/j.clgc.2019.09.019]
    • Smith, N. L. (2004). Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous Thrombosis. JAMA, 292(13), 1581–1587. [DOI:10.1001/jama.292.13.1581]
    • Smith, N. L., Blondon, M., Wiggins, K. L., Harrington, L. B., van Hylckama Vlieg, A., Floyd, J. S., Hwang, M., Bis, J. C., McKnight, B., Rice, K. M., Lumley, T., Rosendaal, F. R., Heckbert, S. R., & Psaty, B. M. (2014). Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens. JAMA Internal Medicine, 174(1), 25–34. [DOI:10.1001/jamainternmed.2013.11074]
    • Speroff, L. (1996). The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study). JAMA, 276(17), 1397–1403. [DOI:10.1001/jama.1996.03540170041030]
    • Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013). Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception, 87(6), 706–727. [DOI:10.1016/j.contraception.2012.12.011]
    • Stanczyk, F. Z., Mathews, B. W., & Cortessis, V. K. (2017). Does the type of progestin influence the production of clotting factors? Contraception, 95(2), 113–116. [DOI:10.1016/j.contraception.2016.07.007]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., & Pousette, A. (1988). Single drug polyestradiol phosphate therapy in prostatic cancer. American Journal of Clinical Oncology, 11(Suppl 2), S101–S103. [DOI:10.1097/00000421-198801102-00024] [PDF]
    • Stegeman, B., Raps, M., Helmerhorst, F., Vos, H., van Vliet, H., Rosendaal, F., & van Hylckama Vlieg, A. (2013). Effect of ethinylestradiol dose and progestagen in combined oral contraceptives on plasma sex hormone‐binding globulin levels in premenopausal women. Journal of Thrombosis and Haemostasis, 11(1), 203–205. [DOI:10.1111/jth.12054]
    • Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015). Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 100(11), 3975–4011. [DOI:10.1210/jc.2015-2236]
    • Sudhir, K., & Komesaroff, P. A. (1999). Cardiovascular Actions of Estrogens in Men. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3411–3415. [DOI:10.1210/jcem.84.10.5954]
    • Swee, D. S., Javaid, U., & Quinton, R. (2019). Estrogen Replacement in Young Hypogonadal Women—Transferrable Lessons From the Literature Related to the Care of Young Women With Premature Ovarian Failure and Transgender Women. Frontiers in Endocrinology, 10, 685. [DOI:10.3389/fendo.2019.00685]
    • Tadd, W., & Bayer, A. (2006). Dignity in health and social care for older Europeans: implications of a European project. Aging Health, 2(5), 771–779. [DOI:10.2217/1745509x.2.5.771]
    • Taylor, J. K., & Pendleton, N. (2016). Progesterone therapy for the treatment of non-cancer cachexia: a systematic review. BMJ Supportive & Palliative Care, 6(3), 276–286. [DOI:10.1136/bmjspcare-2015-001041]
    • Tchaikovski, S. N., & Rosing, J. (2010). Mechanisms of Estrogen-Induced Venous Thromboembolism. Thrombosis Research, 126(1), 5–11. [DOI:10.1016/j.thromres.2010.01.045]
    • Tepper, N. K., Whiteman, M. K., Marchbanks, P. A., James, A. H., & Curtis, K. M. (2016). Progestin-only contraception and thromboembolism: A systematic review. Contraception, 94(6), 678–700. [DOI:10.1016/j.contraception.2016.04.014]
    • Tepper, N. K., Jeng, G., Curtis, K. M., Boutot, M. E., Boulet, S. L., & Whiteman, M. K. (2019). Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum. Obstetrics & Gynecology, 133(3), 533–540. [DOI:10.1097/aog.0000000000003135]
    • The Coronary Drug Project Research Group. (1970). The Coronary Drug Project. JAMA, 214(7), 1303–1313. [DOI:10.1001/jama.1970.03180070069012]
    • The Coronary Drug Project Research Group. (1973). The Coronary Drug Project. JAMA, 226(6), 652–657. [DOI:10.1001/jama.1973.03230060030009]
    • The Oral Contraceptive and Hemostasis Study Group. (1999). An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Contraception, 59(6), 345–355. [DOI:10.1016/s0010-7824(99)00044-x]
    • Timp, J. F., Braekkan, S. K., Versteeg, H. H., & Cannegieter, S. C. (2013). Epidemiology of cancer-associated venous thrombosis. Blood, 122(10), 1712–1723. [DOI:10.1182/blood-2013-04-460121]
    • Toorians, A. W., Thomassen, M. C., Zweegman, S., Magdeleyns, E. J., Tans, G., Gooren, L. J., & Rosing, J. (2003). Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5723–5729. [DOI:10.1210/jc.2003-030520]
    • Totaro, M., Palazzi, S., Castellini, C., Parisi, A., D’Amato, F., Tienforti, D., Baroni, M. G., Francavilla, S., & Barbonetti, A. (2021). Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study. Frontiers in Endocrinology, 12, 741866. [DOI:10.3389/fendo.2021.741866]
    • Trémollieres, F. (2012). Contraception orale estro-progestative: quelle différence entre éthinylestradiol et estradiol? [Oral combined contraception: Is there any difference between ethinyl-estradiol and estradiol?] Gynécologie Obstétrique & Fertilité, 40(2), 109–115. [DOI:10.1016/j.gyobfe.2011.10.009]
    • Turo, R., Smolski, M., Esler, R., Kujawa, M. L., Bromage, S. J., Oakley, N., Adeyoju, A., Brown, S. C., Brough, R., Sinclair, A., & Collins, G. N. (2013). Diethylstilboestrol for the treatment of prostate cancer: past, present and future. Scandinavian Journal of Urology, 48(1), 4–14. [DOI:10.3109/21681805.2013.861508]
    • United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, & Task Force on Long-acting Systemic Agents for Fertility Regulation. (2003). Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem® and Mesigyna®) and one oral contraceptive (Ortho-Novum 1/35®) on coagulation and fibrinolysis. Contraception, 68(3), 159–176. [DOI:10.1016/s0010-7824(03)00164-1]
    • van Hylckama Vlieg, A., Helmerhorst, F. M., & Rosendaal, F. R. (2010). The Risk of Deep Venous Thrombosis Associated With Injectable Depot–Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(11), 2297–2300. [DOI:10.1161/atvbaha.110.211482]
    • Van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47(3), 337–343. [DOI:10.1046/j.1365-2265.1997.2601068.x]
    • van Vliet, H. A., Frolich, M., Christella, M., Thomassen, L., Doggen, C. J., Rosendaal, F. R., Rosing, J., & Helmerhorst, F. M. (2005). Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. Human Reproduction, 20(2), 563–568. [DOI:10.1093/humrep/deh612]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2015). Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 350, h2135. [DOI:10.1136/bmj.h2135]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. [DOI:10.1136/bmj.k4810]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Walker, I. D. (2010). Obstetrics, Contraception, and Estrogen Replacement. In Key, N., Makris, M., O’Shaughnessy, D., & Lillicrap, D. (Eds.). Practical Hemostasis and Thrombosis, 2nd Edition (pp. 247–257). Oxford: Wiley-Blackwell. [DOI:10.1002/9781444306286.ch24]
    • Weinand, J. D., & Safer, J. D. (2015). Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals. Journal of Clinical & Translational Endocrinology, 2(2), 55–60. [DOI:10.1016/j.jcte.2015.02.003]
    • Westerlund, E., Henriksson, P., Wallén, H., Hovatta, O., Wallberg, K. R., & Antovic, A. (2012). Detection of a procoagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis. Thrombosis Research, 130(4), 649–653. [DOI:10.1016/j.thromres.2011.11.024]
    • White, C. M., Ferraro‐Borgida, M. J., Fossati, A. T., McGill, C. C., Ahlberg, A. W., Feng, Y. J., Heller, G. V., & Chow, M. S. (1998). The Pharmacokinetics of Intravenous Estradiol—A Preliminary Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 18(6), 1343–1346. [DOI:10.1002/j.1875-9114.1998.tb03157.x]
    • Wiegratz, I., & Kuhl, H. (2006). Metabolic and clinical effects of progestogens. The European Journal of Contraception & Reproductive Health Care, 11(3), 153–161. [DOI:10.1080/13625180600772741]
    • Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T’Sjoen, G. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study. European Journal of Endocrinology, 169(4), 471–478. [DOI:10.1530/eje-13-0493]
    • Writing Group for the Women’s Health Initiative Investigators. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288(3), 321–333. [DOI:10.1001/jama.288.3.321]
    • Zhang, M., Zhu, S., Yang, W., Huang, Q., & Ho, C. (2021). The biological fate and bioefficacy of citrus flavonoids: bioavailability, biotransformation, and delivery systems. Food & Function, 12(8), 3307–3323. [DOI:10.1039/d0fo03403g]
    • Zhao, J., Yang, J., & Xie, Y. (2019). Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. International Journal of Pharmaceutics, 570, 118642. [DOI:10.1016/j.ijpharm.2019.118642]
    • Zucker, R., Reisman, T., & Safer, J. D. (2021). Minimizing Venous Thromboembolism in Feminizing Hormone Therapy: Applying Lessons From Cisgender Women and Previous Data. Endocrine Practice, 27(6), 621–625. [DOI:10.1016/j.eprac.2021.03.010]
    \ No newline at end of file diff --git a/transfemscience.org/articles/genital-e2-application/index.html b/transfemscience.org/articles/genital-e2-application/index.html index 18320df7..66a343b0 100644 --- a/transfemscience.org/articles/genital-e2-application/index.html +++ b/transfemscience.org/articles/genital-e2-application/index.html @@ -1 +1 @@ -Genital Application via the Scrotum and Neolabia for Greatly Enhanced Absorption of Transdermal Estradiol in Transfeminine People - Transfeminine Science Link

    Genital Application via the Scrotum and Neolabia for Greatly Enhanced Absorption of Transdermal Estradiol in Transfeminine People

    By Aly | First published March 29, 2019 | Last modified April 27, 2022

    Abstract / TL;DR

    Genital skin, such as scrotal, penile, and labial skin, appears to have enhanced capacity for absorption relative to other skin areas. Hormonal medications like estradiol and testosterone used transdermally are normally applied to skin sites like the arms, buttocks, and abdomen. These medications have been limitedly studied by genital application. A single 100 μg/day transdermal estradiol patch normally achieves estradiol levels of around 100 pg/mL on average. An Argentinian clinical study of scrotally applied transdermal estradiol patches in men with prostate cancer found that scrotal administration resulted in much higher estradiol levels than forearm application and that a single 100 μg/day transdermal estradiol patch applied to the scrotum produced mean estradiol levels of 500 pg/mL. This is in line with roughly 5-fold higher estradiol levels with scrotal application relative to conventional skin sites. Genital application of transdermal estradiol gel has not been evaluated, but studies of testosterone gel and cream applied scrotally have found 5- to 8-fold higher testosterone levels than with application to conventional skin sites. Based on the chemical similarity of estradiol to testosterone and the comparably much higher estradiol levels with scrotal estradiol patches, this is likely to generalize to estradiol gel. The enhanced absorption of estradiol afforded by genital administration may be useful in transfeminine hormone therapy. Genital application may be used for achieving better estradiol levels in those who have less satisfactory estradiol levels with the transdermal route and for achieving higher estradiol levels for purposes of testosterone suppression, for instance with high-dose estradiol monotherapy.

    Introduction

    Estradiol is available for use in a variety of forms and by different routes (Wiki). One of these routes is transdermal administration, which includes estradiol patches, estradiol gels, and estradiol emulsions and sprays (Wiki). Estradiol patches and gels are by far the most commonly used forms by this route however. Conventional skin sites by which transdermal estradiol is administered include the arms and the abdomen. Typically, estradiol patches achieve estradiol levels of around 50 to 100 pg/mL per 100 μg/day patch, while estradiol gel achieves estradiol levels of around 100 pg/mL per 3 mg/day estradiol (Aly, 2020; Wiki). However, there is substantial variability between people in estradiol levels achieved with both estradiol patches and gels (Wiki). Some individuals obtain estradiol levels higher or lower than others with the same form and dose of transdermal estradiol. In a subset of people, estradiol levels may be too low for optimal therapeutic efficacy and testosterone suppression may consequently be inadequate. It may also be difficult to obtain the high estradiol levels needed for high-dose estradiol monotherapy with transdermal estradiol in people who opt for this particular therapeutic approach.

    In the 1960s, a clinical study of the transdermal absorption of hydrocortisone applied to different skin sites in humans was published (Feldmann & Maibach, 1967 [Materials]). Hydrocortisone is also known as cortisol and is notable in being a steroid hormone closely related structurally to sex hormones like estradiol and testosterone. In the study, a solution of radiolabeled hydrocortisone was applied to a variety of different skin sites in men and then subsequent urinary excretion of the radioactive material (hydrocortisone and its metabolites) was quantified (Feldmann & Maibach, 1967). The researchers found that the radioactivity excreted varied considerably by application site and was dramatically higher than with the forearm and other sites in the case of application to the scrotum (Feldmann & Maibach, 1967). Relative to the forearm (1.0), the recovery of radioactivity from greatest to least was scrotum (42.0), jaw angle (13.0), forehead (6.0), underarm (3.6), scalp (3.5), back (1.7), palm of hand (0.8), ankle (0.4), and sole of foot (0.1) (Feldmann & Maibach, 1967). This study was the first to indicate that transdermal absorption via genital skin such as scrotum can be markedly higher compared to other skin areas.

    Findings that hydrocortisone and other medications are absorbed much better by scrotal application raised the question of whether estradiol and testosterone would similarly have greater bioavailability by genital administration. This was eventually confirmed in the case of testosterone and led to the development of scrotal testosterone patches (brand name Testoderm) in the 1980s and their marketing approval in the United States in 1993 (Place et al., 1990; Mazer et al., 1992; Atkinson, Chang, & Snyder, 1998). Conversely, scrotal application of transdermal estradiol, perhaps owing to the much more limited use of estrogens in men, was seemingly never investigated. Recently however, the present author came upon the following obscure study on scrotum application of transdermal estradiol patches as a form of high-dose estrogen therapy for men with prostate cancer:

    • Premoli, F., Re, I., Asenjo, G., Maximino, G., & Micheletti, L. (2005). Tratamiento del Cáncer de Próstata Avanzado con Estrógenos Transdérmicos Escrotales (ETE). [Transdermal Scrotal Estrogen Patches (TSEP) in the Treatment of Advanced Prostate Cancer.] Revista Argentina de Urología, 70(4), 231–241. [Google Scholar] [URL] [PDF] [Translation]

    This study would appear to be the first and currently only study to investigate scrotal application of transdermal estradiol. Previous searches had missed it due to the paper being in a non-English language. Before the findings of the study are discussed, some further background and reasoning for the concept of scrotal administration of transdermal estradiol will be provided. Interested readers who would prefer to just go straight to the results of the study can skip to the Study Findings section below.

    Further Background

    Estrogens are used at high doses in the treatment of prostate cancer in men as a means of androgen deprivation therapy due to their potent functional antiandrogenic effects. They produce these antiandrogenic effects by suppressing gonadal testosterone production via their antigonadotropic effects and additionally by increasing sex hormone-binding globulin (SHBG) production and levels and thereby decreasing the fraction of free and hence bioactive androgens. High-dose estrogen therapy has comparable effectiveness to gonadectomy and gonadotropin-releasing hormone (GnRH) agonists and antagonists for this use but have some advantages and disadvantages in comparison. Advantages of estrogens include reduced hot flashes, preservation of bone density, some retainment of sexual interest, better quality of life, and far lower cost. Disadvantages include feminization and gynecomastia (breast development in cisgender men, which is undesirable for men of course) and cardiovascular toxicity. Parenteral and bioidentical forms of estradiol, for instance injectable estradiol esters and transdermal estradiol, are preferred over oral and non-bioidentical estrogens like diethylstilbestrol, ethinylestradiol, and conjugated estrogens due to their far lower propensity for cardiovascular toxicity (Aly, 2020).

    For prostate cancer, injections of estradiol esters are effective, but the long-acting estradiol esters like polyestradiol phosphate and estradiol undecylate that have traditionally been used to treat prostate cancer have been discontinued. Shorter-acting estradiol esters like estradiol valerate and estradiol cypionate can be used but need to be injected frequently (e.g., weekly) and have limited availability in many parts of the world. Injections are also inconvenient and can be anxiety-provoking and painful. Transdermal estradiol patches can be effective, but generally three or four large 100 μg/day patches are required for adequate testosterone suppression (Ockrim, Lalani, & Abel, 2006; Langley et al., 2008; Langley et al., 2021). Using this many patches at the same time can be uncomfortable and expensive. Transdermal estradiol gel has been used to treat prostate cancer as well, but very high doses of estradiol have been required by this route (≥6 mg/day), and even then, only limitedly high estradiol levels and incomplete suppression of testosterone levels have been achieved (Aly, 2019).

    Transdermally administered medications are absorbed through the skin. The capacity for absorption of skin varies for different skin areas. It has been known for decades that scrotal skin has a far higher capacity for absorption of medications than do most other skin sites (Feldmann & Maibach, 1967 [Materials]; Wiki). It is notable in this regard that the first transdermal testosterone patches to be introduced for medical use were scrotal patches. This was due to the large amounts of hormone that needed to be delivered in men in the case of testosterone. Non-scrotal testosterone patches were only introduced later, and had to be larger in size in comparison to scrotal testosterone patches to deliver the same amount of hormone (Behre & Nieschlag, 2012; Khera, 2013). Based on the preceding, and with estradiol closely related to testosterone structurally, scrotal application of transdermal estradiol formulations may likewise have much greater absorption than with conventional skin sites.

    Premoli et al. (2005), the study cited in the Introduction section of this article, assessed the use of a single transdermal estradiol patch worn on the scrotum to treat prostate cancer. These researchers are from Argentina, a country in which poverty is high. Many people have considerable difficulty affording medications in this part of the world. In addition to the advantages of estrogen therapy over conventional antiandrogen therapy, the economic aspect was the motivation for their research. Essentially, their goal was to achieve, via a parenteral and hence less toxic route, high levels of estradiol that could fully suppress testosterone levels and treat prostate cancer while remaining affordable and reasonably convenient. The therapeutic goals of many transfeminine people, aside from treating prostate cancer, are quite similar. Hence, this therapy could be of value for transfeminine hormone therapy as well.

    Sublingual estradiol via sublingual administration of oral estradiol tablets serves the purpose of achieving higher estradiol levels and testosterone suppression relative to oral estradiol for many transfeminine people. But sublingual administration of estradiol has some drawbacks, for instance a short duration, large fluctuations in estradiol levels, and some exposure of the liver to excessive estradiol levels in turn likely resulting in greater health risks like blood clots and cardiovascular problems (Sam, 2021; Wiki). Hence, an alternative option with more steady and sustained estradiol levels would be favorable.

    Study Findings

    First, Premoli et al. (2005) conducted a crossover proof-of-concept pilot experiment with two men with prostate cancer to assess whether scrotal transdermal estradiol is absorbed better than non-scrotal transdermal estradiol. One of the men used a 50 μg/day transdermal estradiol patch on the forearm first and subsequently on the scrotum, while the other man used a 100 μg/day transdermal estradiol patch on the forearm initially and then on the scrotum. The researchers found that maximal estradiol levels were much higher with scrotal application compared to application to the forearm:

    Table 1: Estradiol levels with estradiol patches applied to the forearm versus scrotum in a pilot study:

    PatientEstradiol patch doseApplication siteMaximal estradiol levelDifference
    Patient #150 μg/dayForearm55 pg/mL–
      Scrotum200 pg/mL3.6-fold
    Patient #2100 μg/dayForearm180 pg/mL–
      Scrotum500 pg/mL2.8-fold

    Here is a graph of the results of the initial pilot “mini study” with the full levels (n = 2, crossover design):

    Figure 1: Estradiol levels with transdermal estradiol patches applied to the scrotum in two men with prostate cancer in a crossover design (Premoli et al., 2005). Following this initial pilot experiment, estradiol levels were measured with continuous scrotally applied 100 μg/day transdermal estradiol patches in a larger sample of 35 men with prostate cancer and mean estradiol levels of around 500 pg/mL were observed (Premoli et al., 2005).

    After the pilot “mini study”, Premoli et al. (2005) conducted a full prostate cancer study with 35 patients, each patient wearing one 100 μg/day transdermal estradiol patch on the scrotum. Analogously to the pilot study, estradiol levels of around 500 pg/mL were produced on average in the full sample of men, with a range of estradiol levels across patients of about 125 to 1,200 pg/mL. This wide range is consistent with the high interindividual variability in estradiol levels achieved with estradiol by the transdermal route in general (Wiki). With application to conventional skin sites, a single 100 μg/day estradiol patch will only achieve estradiol levels of around 100 pg/mL on average (Wiki; Graphs). In addition, two to six estradiol patches were reported in one study to achieve mean estradiol levels of only about 200 to 400 pg/mL (Graph; Ockrim, Lalani, & Abel, 2006). Taken together, it seems that scrotal application of transdermal estradiol patches may result in at least about 5-fold or greater bioavailability compared to placement of the patches on non-scrotal skin. This marked increase in bioavailability is analogous to the increase in bioavailability afforded by taking oral estradiol tablets sublingually (about 2- to 5-fold increase) (Wiki).

    The mean levels of estradiol observed in the study (i.e., 500 pg/mL) are known to be sufficient for strong suppression of gonadal testosterone production and by extension circulating testosterone levels, with estradiol levels of ≥200 pg/mL known to suppress testosterone levels by ≥90% on average (Aly, 2018; Wiki). Unfortunately, Premoli and colleagues were not able to obtain data on testosterone suppression in most of the men in their study because at the start of the study almost all of the men already had low pre-treatment testosterone levels (mean 28 ng/dL, range 10–90 ng/dL). This was due to concomitant androgen deprivation therapy with conventional approaches like gonadectomy and GnRH modulators. In any case, the researchers reported that in two men who were not on conventional androgen deprivation therapy and who had male-range initial testosterone levels, treatment with intermittent scrotal transdermal estradiol patches resulted in testosterone levels that were 10 to 30 ng/dL during the “on” periods and 200 to 600 ng/dL during the “off” periods. This is consistent with strong suppression of testosterone levels by high estradiol levels as expected based on other clinical studies.

    Implications for Transfeminine People

    The findings of Premoli et al. (2005) are important as they provide valuable information supporting an additional option for enhancing the effectiveness of estradiol in transfeminine hormone therapy. Transfeminine people who have not undergone vaginoplasty can apply transdermal estradiol patches to the scrotum and those who have undergone vaginoplasty may be able to apply transdermal estradiol to the neolabia. Scrotal or neolabial application of transdermal estradiol may be useful for improving estradiol levels in those with low estradiol levels when applied to conventional skin sites, for allowing for lower doses and hence reduced costs, or for achieving higher estradiol levels for the purpose of testosterone suppression as in for instance high-dose estradiol monotherapy. Moreover, this approach for achieving higher estradiol levels may be advantageous relative to alternatives like sublingual and rectal estradiol in terms of considerations like stability of estradiol levels and potentially convenience.

    Aside from transdermal estradiol patches, other transdermal forms of estradiol like transdermal estradiol gel may also achieve much higher estradiol levels by genital application similarly. It is also notable that it may not be necessary to apply estradiol gel to a large area of skin as a study of transdermal estradiol gel found that the smaller the area of application, the greater the estradiol levels achieved (Järvinen et al., 1997; Graph). Higher estradiol levels with estradiol gel by the scrotal or neolabial route still remains to be tested and confirmed however. In any case, if it does work, it has a major advantage relative to patches of only needing to be applied once a day instead of having to be worn constantly. It is notable that 100 μg/day estradiol patches can be quite large (Table). Scrotal testosterone patches were discontinued because they were too large and irritating, which is easy to imagine in practice. However, lower-dose estradiol patches like 50 or 75 μg/day are smaller in size (Table) and may be more practical and tolerable than higher-dose patches for scrotal use while still potentially achieving high levels of estradiol.

    Another interesting thought relates to potential therapeutic use of transdermal progesterone. Very low but nonetheless significant circulating levels of progesterone (~0.75 ng/mL) have been observed with transdermal progesterone creams (Wiki). Because of the low progesterone levels achieved with transdermal progesterone and its lack of clear clinical effectiveness, no transdermal forms of progesterone are approved for medical use at this time. Transdermal progesterone could potentially be made more effective by scrotal application similarly to estradiol and testosterone. Whether this would translate into transdermal progesterone having actual therapeutic usefulness is unknown and possibly unlikely however—the circulating levels of progesterone that occur with transdermal progesterone may just be too low even with scrotal administration. Another issue is the genital skin has high expression of 5α-reductase, a major metabolizing enzyme for progesterone. In any case, it would nonetheless be very interesting for scrotal application of transdermal progesterone formulations to be evaluated.

    In summary, Premoli et al. (2005) has shown that scrotal application of transdermal estradiol achieves much higher estradiol levels than non-scrotal application. This was already known to be the case for testosterone, but prior to this study there were no published data on this issue for estradiol.

    Additional Topics on Genital Application of Estradiol

    Patch Sizes and Selection

    There are widely different sizes of transdermal estradiol patches in terms of brands (e.g., Climara, Vivelle, Vivelle-Dot, etc.), doses (i.e., 14 to 100 μg/day), and durations (i.e., designed for once weekly or twice weekly use) (Table). Estradiol patches range in size from smaller than a United States dime (1.65 cm2) to almost as large as a typical coffee cup base (44 cm2). This is a more than 25-fold range in size! In the case of 50 μg/day estradiol patches, sizes range from 3.3 to 22 cm2, and in the case of 100 μg/day patches, sizes range from 6.6 to 44 cm2. Wearing very large transdermal estradiol patches on the scrotum is obviously not going to be easy nor comfortable. The preceding linked table may be useful for helping to determine what the best patch brand and dose for a given person and their personal circumstances would be. Patches may also be cut and this may also be helpful.

    Cutting and Adhesing Patches

    Some but not all transdermal estradiol patches can be cut into smaller portions. As some estradiol patches are quite large, the possibility of cutting them could be useful in the context of genital application. See the following literature excerpts for some information (Matthews et al., 2017; Klein et al., 2018; Norjavaara, Ankarberg-Lindgren, & Kriström, 2016; Rosenfield, Kiess, & Keizer-Schramad, 2006):

    Matrix patches are self-adhesive and release approximately 25 µg 17β-oestradiol/24 hours. Since the oestradiol is evenly distributed throughout the patch, the patches can be cut to provide the required dose. Practically, patches are cut into half or quarter as more complex divisions would be prone to inaccuracies and impracticable. Unused patch fractions may be stored in their packaging in the fridge for up to 1 week. The patch (or patch fraction) should be applied to clean dry skin over the buttocks or hips using Opsite® (a transparent adhesive film) if necessary to ensure good adhesion. […] Transdermal patches may be more difficult to use particularly when cutting patches to small sizes as they may fall off and require tape support.

    Currently, the lowest-dose patch commercially available delivers 14 μg/d E2, and the most widely used low-dose patches deliver 25 μg/d. One method to deliver lower doses is to cut the patch in smaller pieces. Patches with a matrix design can be easily cut, whereas patches with a reservoir technology should not be cut. The disadvantages of cutting patches are that handling the smaller pieces may be difficult and cutting the patches is not recommended by the products’ labels. However, there is clinical experience with this, especially in Scandinavia. There, a group showed that a fractionated patch dose (one-quarter patch of a 25-μg dose approximately equals 6.2 μg or even less) applied overnight mimicked the normal, early-morning serum E2 peak and fell back to baseline within a few hours of patch removal (17).

    For transdermal administration, gel and patches are available; dosing by cutting patches is more reliable when titrating the E2 serum level, and the delivery can be stopped in the morning by just taking the patch away when mimicking the circadian rhythm seen in early spontaneous puberty (Fig. 1). […] Our present recommendation is to use E2 matrix patches when available. Matrix patches are stable and have a homogenous E2 layer over the total surface and can therefore be cut into individualized doses. However, matrix patches are available with different patch areas for the same dose from different brands. The larger the patch area, the easier to cut the patch into smaller pieces for the target dose.

    This is to be compared to the reservoir patches which have a separate drug layer with a liquid compartment containing a drug solution or suspension separated by the adhesive layer. By cutting such a patch, the liquid compartment will be destroyed and the drug will leak out.

    It is unknown how to best deliver estradiol doses below 14 μg daily. While a European matrix patch can apparently be cut into quarters so the estrogen can be delivered overnight, the US manufacturers recommend against this and our limited experience has yielded erratic plasma estradiol levels, which suggests that these patches may not be uniformly impregnated with estradiol.

    Almost all estradiol patches available today are matrix patches. Estraderm, a reservoir patch, is one of the only exceptions. It is discontinued in the United States but may still be used in the United Kingdom.

    Tegaderm, a transparent film dressing, is another option for helping to hold patches in place (Reddit).

    Penile Skin Application

    Penile skin seems to have similar absorptive characteristics to scrotal skin and hence may also allow for improved absorption with transdermal application. As such, it could be useful as a supplement or alternative to scrotal application of transdermal estradiol. See the following literature excerpt for some more information on penile application (Hairston, Becher, & McVary, 2006):

    […] topical penile therapy has a unique set of anatomic and physiological issues that must be considered. There are several anatomic/fascial layers between the penile skin and the corpora cavernosa. The tunica albuginea is presumed to be difficult to penetrate because of its thick layers of collagen. Therefore, topical treatment trials have emphasized exposure to the glans penis because it has direct venous communication to the corpora cavernosa (40,41). The skin itself is a relatively impermeable tissue because of the stratum corneum. The horny cells at the stratum corneum are bonded with a very tight intercellular lipid matrix bilayer that makes the passage of drugs challenging (42). To overcome this barrier, investigators have used penetration enhancers that permeate this layer and reach the subdermis. Fortunately, the penis and scrotum are unique in that their stratum corneum is the most permeable of all anatomic locations tested. Depending on the molecular structure of the agent tested, there can be nearly 100% absorption of topical agents applied to these areas. Exposure to the glans affords a more easily “breached” layer. Other skin regions (e.g., back and palms) are particularly impermeable (43). An additional factor confounding efficient delivery of drug is the rich vasculature of the deep dermis that may “steal” the drugs to the systemic circulation.

    Hence, if more skin area is desired for application of estradiol gel or patches, use of penile skin could possibly work as well. This may notably also be relevant to vaginal administration for most post-vaginoplasty transfeminine people (i.e., via penile inversion) as the neovaginal lining is penile skin. However, no studies exist on the absorptive effectiveness of neovaginal administration.

    Genital Application of Estradiol Gel and Cream

    Two clinical studies on scrotal application of transdermal testosterone gel and cream in men have been published:

    • Iyer, R., Mok, S. F., Savkovic, S., Turner, L., Fraser, G., Desai, R., Jayadev, V., Conway, A. J., & Handelsman, D. J. (2017). Pharmacokinetics of testosterone cream applied to scrotal skin. Andrology, 5(4), 725–731. [DOI:10.1111/andr.12357]
    • Kuhnert, B., Byrne, M., Simoni, M., Kopcke, W., Gerss, J., Lemmnitz, G., & Nieschlag, E. (2005). Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. European Journal of Endocrinology, 153(2), 317–326. [DOI:10.1530/eje.1.01964]

    Here are some relevant excerpts from the first paper (which also briefly describe the findings of the second paper):

    Scrotal skin is thin and has high steroid permeability, but the pharmacokinetics of testosterone via the scrotal skin route has not been studied in detail. The aim of this study was to define the pharmacokinetics of testosterone [cream] delivered via the scrotal skin route. The study was a single‐center, three‐phase cross‐over pharmacokinetic study of three single doses (12.5, 25, 50 mg) of testosterone cream administered in random sequence on different days with at least 2 days between doses to healthy eugonadal volunteers with endogenous testosterone suppressed by administration of nandrolone decanoate.

    The bioavailability of testosterone via the scrotal skin is striking[ly] higher than for abdominal skin. Using the same testosterone cream and steroid LC-MS assay measurements, in this study a Cmax (4.6 ng/mL, 16.0 nM) was achieved with the lowest dose (12.5 mg) applied to the scrotal skin whereas applying 100 mg testosterone cream to the abdominal skin produced a Cmax of 16.3 nmol/L (4.7 ng/mL). This suggests an about eightfold increase in testosterone bioavailability, using the scrotal compared with abdominal skin routes.

    One previous study has reported that the pharmacokinetics of scrotal application of testosterone gel was similar to that of a scrotal testosterone patch or a fivefold larger dose of non-scrotal testosterone gel, consistent with at least a fivefold higher transdermal bioavailability of testosterone (Kuhnert et al., 2005). Other studies assessing pharmacokinetics of testosterone application to non-scrotal skin have yielded variable time of peak concentration (Tmax) ranging from 6–16 h (Marbury et al., 2003; Miller et al., 2011; Olsson et al., 2014) but similar peak concentration (Cmax) as scrotal skin application (Rolf et al., 2002; Bouloux, 2005; Olsson et al., 2014).

    We conclude that the scrotal administration of testosterone in a cream formulation provides high bioavailability, dose-dependent peak serum testosterone concentration, and tolerability with a much lower dose relative to the non-scrotal transdermal route.

    Based on the findings of these studies, maximal testosterone levels with testosterone gel or cream are about 5- to 8-fold higher with with scrotal application than with application to conventional skin sites (e.g., abdomen). This is analogous to the 5-fold higher testosterone levels that have been achieved with scrotal testosterone patches compared to non-scrotal testosterone patches.

    Estradiol is very similar to testosterone in chemical structure and chemical properties (e.g., lipophilicity and likely absorption characteristics). Hence, although there is currently no research assessing scrotal/neolabial application of transdermal estradiol gel or cream, or showing definitively that it achieves greater estradiol levels than conventional transdermal application, we can infer that because this has been demonstrated for testosterone, it is likely to be the case with estradiol as well. This is particularly true considering that far higher estradiol levels have already been shown with scrotal application of transdermal estradiol patches compared to non-scrotal application of such patches.

    Consequently, scrotal/neolabial administration of transdermal estradiol gel or cream is likely to be a powerful alternative option for achieving high estradiol levels similarly to scrotal/neolabial application of transdermal estradiol patches. Scrotal/neolabial application of transdermal estradiol preparations may allow for greater efficacy and considerably reduced cost compared to conventional transdermal application of such formulations. In addition, whereas patches must be worn constantly and scrotal/neolabial application of such patches may be uncomfortable and inconvenient compared to conventional transdermal application, gels and creams are applied once per day and dry rapidly. Scrotal/neolabial application of patches also requires hair removal and can leave difficult-to-remove adhesive residues as well as cause adhesion-related local skin reactions. In contrast, this is not the case with gels or creams either. As such, estradiol preparations like gel or cream may be the preferred type of transdermal formulation for scrotal/neolabial use.

    One possible caveat to scrotal/neolabial application is that transdermal estradiol gels are hydroalcoholic gels and consequently have the potential to irritate the skin and burn or sting when applied to the genital region. A potential solution to this is the use of transdermal estradiol preparations containing less or no alcohol, such as creams (e.g., compounded and over-the-counter products) and emulsions (e.g., Estrasorb), instead of hydroalcoholic gels. There is also a transdermal estradiol aerosol spray product (brand name Evamist) that may be another alternative option.

    Taken together, transdermal testosterone gel or cream applied to scrotal skin is absorbed much better and results in approximately 5- to 8-fold higher testosterone levels than when applied to conventional skin sites. The same is likely also true for estradiol due to the close structural similarity of estradiol to testosterone and due to estradiol patches having been shown to be absorbed substantially better when applied to scrotal skin than to conventional skin sites.

    Safety of Genital Application of Estradiol

    Some have expressed concern as to the safety of genital application of estradiol. For instance, it has been asked whether estradiol applied to the scrotum might increase risk of testicular cancer or prostate cancer due to the high local estradiol concentrations that might result. Large observational studies of transfeminine people on standard hormone therapy have found no increase in risk of testicular cancer (Bensley et al., 2021; de Nie et al., 2021) or prostate cancer (de Nie et al., 2020). In fact, risk of prostate cancer in transfeminine people appears to be substantially decreased with standard hormone therapy (de Nie et al., 2020). Additionally, androgen deprivation reduces prostate cancer risk and progression in cisgender men, and high-dose estrogen therapy is effective for the treatment of this cancer, with a longstanding history of use (Ockrim, Lalani, & Abel, 2006; Norman et al., 2008; Langley et al., 2021). Hence, while we do not have the data needed to answer the question of whether very high local concentrations of estradiol in the testes or prostate might increase cancer risk in these tissues, the available circumstantial clinical evidence is not suggestive of such and this is reassuring.

    References

    • Atkinson, L. E., Chang, Y. L., & Snyder, P. J. (1998). Long-term experience with testosterone replacement through scrotal skin. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 365–388). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_13]
    • Behre, H. M., & Nieschlag, E. (2012). Testosterone preparations for clinical use in males. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 309–335). Cambridge/New York: Cambridge University Press. [DOI:10.1017/CBO9781139003353.016]
    • Bensley, J. G., Cheung, A. S., Grossmann, M., & Papa, N. (2022). Testicular Cancer in Trans People Using Feminising Hormone Therapy–A Brief Review. Urology, 160, 1–4. [DOI:10.1016/j.urology.2021.11.014]
    • de Nie, I., de Blok, C., van der Sluis, T. M., Barbé, E., Pigot, G., Wiepjes, C. M., Nota, N. M., van Mello, N. M., Valkenburg, N. E., Huirne, J., Gooren, L., van Moorselaar, R., Dreijerink, K., & den Heijer, M. (2020). Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment. The Journal of Clinical Endocrinology and Metabolism, 105(9), e3293–e3299. [DOI:10.1210/clinem/dgaa412]
    • de Nie, I., Wiepjes, C. M., Blok, C. J., Moorselaar, R. J., Pigot, G. L., van der Sluis, T. M., Barbé, E., van der Voorn, P., van Mello, N. M., Huirne, J., & den Heijer, M. (2021). Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study. BJU International, 129(4), 491–497. [DOI:10.1111/bju.15575]
    • Feldmann, R. J., & Maibach, H. I. (1967). Regional variation in percutaneous penetration of 14C cortisol in man. The Journal of Investigative Dermatology, 48(2), 181–183. [DOI:10.1038/jid.1967.29]
    • Hairston, J. C., Becher, E., & McVary, K. T. (2006). Topical and Intra-Urethral Therapy. In Mulcahy, J. J. (Ed.). Male Sexual Function: A Guide to Clinical Management, 2nd Edition (Current Clinical Urology) (pp. 303–321). Totowa: Humana Press. [DOI:10.1007/978-1-59745-155-0_14] [Google Books]
    • Iyer, R., Mok, S. F., Savkovic, S., Turner, L., Fraser, G., Desai, R., Jayadev, V., Conway, A. J., & Handelsman, D. J. (2017). Pharmacokinetics of testosterone cream applied to scrotal skin. Andrology, 5(4), 725–731. [DOI:10.1111/andr.12357]
    • Järvinen, A., Granander, M., Nykänen, S., Laine, T., Geurts, P., & Viitanen, A. (1997). Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: effects of application area and washing. British Journal of Obstetrics and Gynaecology, 104(Suppl 16), 14–18. [DOI:10.1111/j.1471-0528.1997.tb11562.x]
    • Khera, M. (2013). Treatment Options for Testosterone Replacement Therapy. In Hellstrom, W. J. G. (Ed.). Androgen Deficiency and Testosterone Replacement: Current Controversies and Strategies (pp. 129–139). Totowa: Humana Press. [DOI:10.1007/978-1-62703-179-0_10]
    • Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T., & Mauras, N. (2018). Estrogen replacement in Turner syndrome: literature review and practical considerations. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1790–1803. [DOI:10.1210/jc.2017-02183]
    • Kuhnert, B., Byrne, M., Simoni, M., Kopcke, W., Gerss, J., Lemmnitz, G., & Nieschlag, E. (2005). Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. European Journal of Endocrinology, 153(2), 317–326. [DOI:10.1530/eje.1.01964]
    • Langley, R. E., Godsland, I. F., Kynaston, H., Clarke, N. W., Rosen, S. D., Morgan, R. C., Pollock, P., Kockelbergh, R., Lalani, e., Dearnaley, D., Parmar, M., & Abel, P. D. (2008). Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first‐line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU International, 102(4), 442–445. [DOI:10.1111/j.1464-410X.2008.07583.x]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., … & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/S0140-6736(21)00100-8]
    • Matthews, D., Bath, L., Högler, W., Mason, A., Smyth, A., & Skae, M. (2017). Hormone supplementation for pubertal induction in girls. Archives of Disease in Childhood, 102(10), 975–980. [DOI:10.1136/archdischild-2016-311372]
    • Mazer, N. A., Heiber, W. E., Moellmer, J. F., Meikle, A. W., Stringham, J. D., Sanders, S. W., Tolman, K. G., & Odell, W. D. (1992). Enhanced transdermal delivery of testosterone: a new physiological approach for androgen replacement in hypogonadal men. Journal of Controlled Release, 19(1–3), 347–361. [DOI:10.1016/0168-3659(92)90089-A]
    • Norjavaara, E., Ankarberg-Lindgren, C., & Kriström, B. (2016). Sex steroid replacement therapy in female hypogonadism from childhood to young adulthood. In Bourguignon J.-P., Parent A.-S. (Eds.). Puberty from Bench to Clinic. Lessons for Clinical Management of Pubertal Disorders (Endocrine Development, Volume 29) (pp. 198–213). Basel: Karger. [DOI:10.1159/000438892]
    • Norman, G., Dean, M. E., Langley, R. E., Hodges, Z. C., Ritchie, G., Parmar, M. K., Sydes, M. R., Abel, P., & Eastwood, A. J. (2008). Parenteral oestrogen in the treatment of prostate cancer: a systematic review. British Journal of Cancer, 98(4), 697–707. [DOI:10.1038/sj.bjc.6604230]
    • Ockrim, J., Lalani, E. N., & Abel, P. (2006). Therapy insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature clinical practice Oncology, 3(10), 552–563. [DOI:10.1038/ncponc0602]
    • Place, V. A., Atkinson, L., Prather, D. A., Trunnell, N., & Yates, F. E. (1990). Transdermal testosterone replacement through genital skin. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 1st Edition (pp. 165–181). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-662-00814-0_9]
    • Premoli, F., Re, I., Asenjo, G., Maximino, G., & Micheletti, L. (2005). Tratamiento del Cáncer de Próstata Avanzado con Estrógenos Transdérmicos Escrotales (ETE). [Transdermal Scrotal Estrogen Patches (TSEP) in the Treatment of Advanced Prostate Cancer.] Revista Argentina de Urología, 70(4), 231–241. [Google Scholar] [URL] [PDF] [Translation]
    • Rosenfield, R. L., Kiess, W., & de Muinck Keizer-Schrama, S. (2006). Physiologic induction of puberty in Turner syndrome with very low-dose estradiol. International Congress Series, 1298, 71–79. [DOI:10.1016/j.ics.2006.07.003]
    \ No newline at end of file +Genital Application via the Scrotum and Neolabia for Greatly Enhanced Absorption of Transdermal Estradiol in Transfeminine People - Transfeminine Science Link

    Genital Application via the Scrotum and Neolabia for Greatly Enhanced Absorption of Transdermal Estradiol in Transfeminine People

    By Aly | First published March 29, 2019 | Last modified April 27, 2022

    Abstract / TL;DR

    Genital skin, such as scrotal, penile, and labial skin, appears to have enhanced capacity for absorption relative to other skin areas. Hormonal medications like estradiol and testosterone used transdermally are normally applied to skin sites like the arms, buttocks, and abdomen. These medications have been limitedly studied by genital application. A single 100 μg/day transdermal estradiol patch normally achieves estradiol levels of around 100 pg/mL on average. An Argentinian clinical study of scrotally applied transdermal estradiol patches in men with prostate cancer found that scrotal administration resulted in much higher estradiol levels than forearm application and that a single 100 μg/day transdermal estradiol patch applied to the scrotum produced mean estradiol levels of 500 pg/mL. This is in line with roughly 5-fold higher estradiol levels with scrotal application relative to conventional skin sites. Genital application of transdermal estradiol gel has not been evaluated, but studies of testosterone gel and cream applied scrotally have found 5- to 8-fold higher testosterone levels than with application to conventional skin sites. Based on the chemical similarity of estradiol to testosterone and the comparably much higher estradiol levels with scrotal estradiol patches, this is likely to generalize to estradiol gel. The enhanced absorption of estradiol afforded by genital administration may be useful in transfeminine hormone therapy. Genital application may be used for achieving better estradiol levels in those who have less satisfactory estradiol levels with the transdermal route and for achieving higher estradiol levels for purposes of testosterone suppression, for instance with high-dose estradiol monotherapy.

    Introduction

    Estradiol is available for use in a variety of forms and by different routes (Wiki). One of these routes is transdermal administration, which includes estradiol patches, estradiol gels, and estradiol emulsions and sprays (Wiki). Estradiol patches and gels are by far the most commonly used forms by this route however. Conventional skin sites by which transdermal estradiol is administered include the arms and the abdomen. Typically, estradiol patches achieve estradiol levels of around 50 to 100 pg/mL per 100 μg/day patch, while estradiol gel achieves estradiol levels of around 100 pg/mL per 3 mg/day estradiol (Aly, 2020; Wiki). However, there is substantial variability between people in estradiol levels achieved with both estradiol patches and gels (Wiki). Some individuals obtain estradiol levels higher or lower than others with the same form and dose of transdermal estradiol. In a subset of people, estradiol levels may be too low for optimal therapeutic efficacy and testosterone suppression may consequently be inadequate. It may also be difficult to obtain the high estradiol levels needed for high-dose estradiol monotherapy with transdermal estradiol in people who opt for this particular therapeutic approach.

    In the 1960s, a clinical study of the transdermal absorption of hydrocortisone applied to different skin sites in humans was published (Feldmann & Maibach, 1967 [Materials]). Hydrocortisone is also known as cortisol and is notable in being a steroid hormone closely related structurally to sex hormones like estradiol and testosterone. In the study, a solution of radiolabeled hydrocortisone was applied to a variety of different skin sites in men and then subsequent urinary excretion of the radioactive material (hydrocortisone and its metabolites) was quantified (Feldmann & Maibach, 1967). The researchers found that the radioactivity excreted varied considerably by application site and was dramatically higher than with the forearm and other sites in the case of application to the scrotum (Feldmann & Maibach, 1967). Relative to the forearm (1.0), the recovery of radioactivity from greatest to least was scrotum (42.0), jaw angle (13.0), forehead (6.0), underarm (3.6), scalp (3.5), back (1.7), palm of hand (0.8), ankle (0.4), and sole of foot (0.1) (Feldmann & Maibach, 1967). This study was the first to indicate that transdermal absorption via genital skin such as scrotum can be markedly higher compared to other skin areas.

    Findings that hydrocortisone and other medications are absorbed much better by scrotal application raised the question of whether estradiol and testosterone would similarly have greater bioavailability by genital administration. This was eventually confirmed in the case of testosterone and led to the development of scrotal testosterone patches (brand name Testoderm) in the 1980s and their marketing approval in the United States in 1993 (Place et al., 1990; Mazer et al., 1992; Atkinson, Chang, & Snyder, 1998). Conversely, scrotal application of transdermal estradiol, perhaps owing to the much more limited use of estrogens in men, was seemingly never investigated. Recently however, the present author came upon the following obscure study on scrotum application of transdermal estradiol patches as a form of high-dose estrogen therapy for men with prostate cancer:

    • Premoli, F., Re, I., Asenjo, G., Maximino, G., & Micheletti, L. (2005). Tratamiento del Cáncer de Próstata Avanzado con Estrógenos Transdérmicos Escrotales (ETE). [Transdermal Scrotal Estrogen Patches (TSEP) in the Treatment of Advanced Prostate Cancer.] Revista Argentina de Urología, 70(4), 231–241. [Google Scholar] [URL] [PDF] [Translation]

    This study would appear to be the first and currently only study to investigate scrotal application of transdermal estradiol. Previous searches had missed it due to the paper being in a non-English language. Before the findings of the study are discussed, some further background and reasoning for the concept of scrotal administration of transdermal estradiol will be provided. Interested readers who would prefer to just go straight to the results of the study can skip to the Study Findings section below.

    Further Background

    Estrogens are used at high doses in the treatment of prostate cancer in men as a means of androgen deprivation therapy due to their potent functional antiandrogenic effects. They produce these antiandrogenic effects by suppressing gonadal testosterone production via their antigonadotropic effects and additionally by increasing sex hormone-binding globulin (SHBG) production and levels and thereby decreasing the fraction of free and hence bioactive androgens. High-dose estrogen therapy has comparable effectiveness to gonadectomy and gonadotropin-releasing hormone (GnRH) agonists and antagonists for this use but have some advantages and disadvantages in comparison. Advantages of estrogens include reduced hot flashes, preservation of bone density, some retainment of sexual interest, better quality of life, and far lower cost. Disadvantages include feminization and gynecomastia (breast development in cisgender men, which is undesirable for men of course) and cardiovascular toxicity. Parenteral and bioidentical forms of estradiol, for instance injectable estradiol esters and transdermal estradiol, are preferred over oral and non-bioidentical estrogens like diethylstilbestrol, ethinylestradiol, and conjugated estrogens due to their far lower propensity for cardiovascular toxicity (Aly, 2020).

    For prostate cancer, injections of estradiol esters are effective, but the long-acting estradiol esters like polyestradiol phosphate and estradiol undecylate that have traditionally been used to treat prostate cancer have been discontinued. Shorter-acting estradiol esters like estradiol valerate and estradiol cypionate can be used but need to be injected frequently (e.g., weekly) and have limited availability in many parts of the world. Injections are also inconvenient and can be anxiety-provoking and painful. Transdermal estradiol patches can be effective, but generally three or four large 100 μg/day patches are required for adequate testosterone suppression (Ockrim, Lalani, & Abel, 2006; Langley et al., 2008; Langley et al., 2021). Using this many patches at the same time can be uncomfortable and expensive. Transdermal estradiol gel has been used to treat prostate cancer as well, but very high doses of estradiol have been required by this route (≥6 mg/day), and even then, only limitedly high estradiol levels and incomplete suppression of testosterone levels have been achieved (Aly, 2019).

    Transdermally administered medications are absorbed through the skin. The capacity for absorption of skin varies for different skin areas. It has been known for decades that scrotal skin has a far higher capacity for absorption of medications than do most other skin sites (Feldmann & Maibach, 1967 [Materials]; Wiki). It is notable in this regard that the first transdermal testosterone patches to be introduced for medical use were scrotal patches. This was due to the large amounts of hormone that needed to be delivered in men in the case of testosterone. Non-scrotal testosterone patches were only introduced later, and had to be larger in size in comparison to scrotal testosterone patches to deliver the same amount of hormone (Behre & Nieschlag, 2012; Khera, 2013). Based on the preceding, and with estradiol closely related to testosterone structurally, scrotal application of transdermal estradiol formulations may likewise have much greater absorption than with conventional skin sites.

    Premoli et al. (2005), the study cited in the Introduction section of this article, assessed the use of a single transdermal estradiol patch worn on the scrotum to treat prostate cancer. These researchers are from Argentina, a country in which poverty is high. Many people have considerable difficulty affording medications in this part of the world. In addition to the advantages of estrogen therapy over conventional antiandrogen therapy, the economic aspect was the motivation for their research. Essentially, their goal was to achieve, via a parenteral and hence less toxic route, high levels of estradiol that could fully suppress testosterone levels and treat prostate cancer while remaining affordable and reasonably convenient. The therapeutic goals of many transfeminine people, aside from treating prostate cancer, are quite similar. Hence, this therapy could be of value for transfeminine hormone therapy as well.

    Sublingual estradiol via sublingual administration of oral estradiol tablets serves the purpose of achieving higher estradiol levels and testosterone suppression relative to oral estradiol for many transfeminine people. But sublingual administration of estradiol has some drawbacks, for instance a short duration, large fluctuations in estradiol levels, and some exposure of the liver to excessive estradiol levels in turn likely resulting in greater health risks like blood clots and cardiovascular problems (Sam, 2021; Wiki). Hence, an alternative option with more steady and sustained estradiol levels would be favorable.

    Study Findings

    First, Premoli et al. (2005) conducted a crossover proof-of-concept pilot experiment with two men with prostate cancer to assess whether scrotal transdermal estradiol is absorbed better than non-scrotal transdermal estradiol. One of the men used a 50 μg/day transdermal estradiol patch on the forearm first and subsequently on the scrotum, while the other man used a 100 μg/day transdermal estradiol patch on the forearm initially and then on the scrotum. The researchers found that maximal estradiol levels were much higher with scrotal application compared to application to the forearm:

    Table 1: Estradiol levels with estradiol patches applied to the forearm versus scrotum in a pilot study:

    PatientEstradiol patch doseApplication siteMaximal estradiol levelDifference
    Patient #150 μg/dayForearm55 pg/mL–
      Scrotum200 pg/mL3.6-fold
    Patient #2100 μg/dayForearm180 pg/mL–
      Scrotum500 pg/mL2.8-fold

    Here is a graph of the results of the initial pilot “mini study” with the full levels (n = 2, crossover design):

    Figure 1: Estradiol levels with transdermal estradiol patches applied to the scrotum in two men with prostate cancer in a crossover design (Premoli et al., 2005). Following this initial pilot experiment, estradiol levels were measured with continuous scrotally applied 100 μg/day transdermal estradiol patches in a larger sample of 35 men with prostate cancer and mean estradiol levels of around 500 pg/mL were observed (Premoli et al., 2005).

    After the pilot “mini study”, Premoli et al. (2005) conducted a full prostate cancer study with 35 patients, each patient wearing one 100 μg/day transdermal estradiol patch on the scrotum. Analogously to the pilot study, estradiol levels of around 500 pg/mL were produced on average in the full sample of men, with a range of estradiol levels across patients of about 125 to 1,200 pg/mL. This wide range is consistent with the high interindividual variability in estradiol levels achieved with estradiol by the transdermal route in general (Wiki). With application to conventional skin sites, a single 100 μg/day estradiol patch will only achieve estradiol levels of around 100 pg/mL on average (Wiki; Graphs). In addition, two to six estradiol patches were reported in one study to achieve mean estradiol levels of only about 200 to 400 pg/mL (Graph; Ockrim, Lalani, & Abel, 2006). Taken together, it seems that scrotal application of transdermal estradiol patches may result in at least about 5-fold or greater bioavailability compared to placement of the patches on non-scrotal skin. This marked increase in bioavailability is analogous to the increase in bioavailability afforded by taking oral estradiol tablets sublingually (about 2- to 5-fold increase) (Wiki).

    The mean levels of estradiol observed in the study (i.e., 500 pg/mL) are known to be sufficient for strong suppression of gonadal testosterone production and by extension circulating testosterone levels, with estradiol levels of ≥200 pg/mL known to suppress testosterone levels by ≥90% on average (Aly, 2018; Wiki). Unfortunately, Premoli and colleagues were not able to obtain data on testosterone suppression in most of the men in their study because at the start of the study almost all of the men already had low pre-treatment testosterone levels (mean 28 ng/dL, range 10–90 ng/dL). This was due to concomitant androgen deprivation therapy with conventional approaches like gonadectomy and GnRH modulators. In any case, the researchers reported that in two men who were not on conventional androgen deprivation therapy and who had male-range initial testosterone levels, treatment with intermittent scrotal transdermal estradiol patches resulted in testosterone levels that were 10 to 30 ng/dL during the “on” periods and 200 to 600 ng/dL during the “off” periods. This is consistent with strong suppression of testosterone levels by high estradiol levels as expected based on other clinical studies.

    Implications for Transfeminine People

    The findings of Premoli et al. (2005) are important as they provide valuable information supporting an additional option for enhancing the effectiveness of estradiol in transfeminine hormone therapy. Transfeminine people who have not undergone vaginoplasty can apply transdermal estradiol patches to the scrotum and those who have undergone vaginoplasty may be able to apply transdermal estradiol to the neolabia. Scrotal or neolabial application of transdermal estradiol may be useful for improving estradiol levels in those with low estradiol levels when applied to conventional skin sites, for allowing for lower doses and hence reduced costs, or for achieving higher estradiol levels for the purpose of testosterone suppression as in for instance high-dose estradiol monotherapy. Moreover, this approach for achieving higher estradiol levels may be advantageous relative to alternatives like sublingual and rectal estradiol in terms of considerations like stability of estradiol levels and potentially convenience.

    Aside from transdermal estradiol patches, other transdermal forms of estradiol like transdermal estradiol gel may also achieve much higher estradiol levels by genital application similarly. It is also notable that it may not be necessary to apply estradiol gel to a large area of skin as a study of transdermal estradiol gel found that the smaller the area of application, the greater the estradiol levels achieved (Järvinen et al., 1997; Graph). Higher estradiol levels with estradiol gel by the scrotal or neolabial route still remains to be tested and confirmed however. In any case, if it does work, it has a major advantage relative to patches of only needing to be applied once a day instead of having to be worn constantly. It is notable that 100 μg/day estradiol patches can be quite large (Table). Scrotal testosterone patches were discontinued because they were too large and irritating, which is easy to imagine in practice. However, lower-dose estradiol patches like 50 or 75 μg/day are smaller in size (Table) and may be more practical and tolerable than higher-dose patches for scrotal use while still potentially achieving high levels of estradiol.

    Another interesting thought relates to potential therapeutic use of transdermal progesterone. Very low but nonetheless significant circulating levels of progesterone (~0.75 ng/mL) have been observed with transdermal progesterone creams (Wiki). Because of the low progesterone levels achieved with transdermal progesterone and its lack of clear clinical effectiveness, no transdermal forms of progesterone are approved for medical use at this time. Transdermal progesterone could potentially be made more effective by scrotal application similarly to estradiol and testosterone. Whether this would translate into transdermal progesterone having actual therapeutic usefulness is unknown and possibly unlikely however—the circulating levels of progesterone that occur with transdermal progesterone may just be too low even with scrotal administration. Another issue is the genital skin has high expression of 5α-reductase, a major metabolizing enzyme for progesterone. In any case, it would nonetheless be very interesting for scrotal application of transdermal progesterone formulations to be evaluated.

    In summary, Premoli et al. (2005) has shown that scrotal application of transdermal estradiol achieves much higher estradiol levels than non-scrotal application. This was already known to be the case for testosterone, but prior to this study there were no published data on this issue for estradiol.

    Additional Topics on Genital Application of Estradiol

    Patch Sizes and Selection

    There are widely different sizes of transdermal estradiol patches in terms of brands (e.g., Climara, Vivelle, Vivelle-Dot, etc.), doses (i.e., 14 to 100 μg/day), and durations (i.e., designed for once weekly or twice weekly use) (Table). Estradiol patches range in size from smaller than a United States dime (1.65 cm2) to almost as large as a typical coffee cup base (44 cm2). This is a more than 25-fold range in size! In the case of 50 μg/day estradiol patches, sizes range from 3.3 to 22 cm2, and in the case of 100 μg/day patches, sizes range from 6.6 to 44 cm2. Wearing very large transdermal estradiol patches on the scrotum is obviously not going to be easy nor comfortable. The preceding linked table may be useful for helping to determine what the best patch brand and dose for a given person and their personal circumstances would be. Patches may also be cut and this may also be helpful.

    Cutting and Adhesing Patches

    Some but not all transdermal estradiol patches can be cut into smaller portions. As some estradiol patches are quite large, the possibility of cutting them could be useful in the context of genital application. See the following literature excerpts for some information (Matthews et al., 2017; Klein et al., 2018; Norjavaara, Ankarberg-Lindgren, & Kriström, 2016; Rosenfield, Kiess, & Keizer-Schramad, 2006):

    Matrix patches are self-adhesive and release approximately 25 µg 17β-oestradiol/24 hours. Since the oestradiol is evenly distributed throughout the patch, the patches can be cut to provide the required dose. Practically, patches are cut into half or quarter as more complex divisions would be prone to inaccuracies and impracticable. Unused patch fractions may be stored in their packaging in the fridge for up to 1 week. The patch (or patch fraction) should be applied to clean dry skin over the buttocks or hips using Opsite® (a transparent adhesive film) if necessary to ensure good adhesion. […] Transdermal patches may be more difficult to use particularly when cutting patches to small sizes as they may fall off and require tape support.

    Currently, the lowest-dose patch commercially available delivers 14 μg/d E2, and the most widely used low-dose patches deliver 25 μg/d. One method to deliver lower doses is to cut the patch in smaller pieces. Patches with a matrix design can be easily cut, whereas patches with a reservoir technology should not be cut. The disadvantages of cutting patches are that handling the smaller pieces may be difficult and cutting the patches is not recommended by the products’ labels. However, there is clinical experience with this, especially in Scandinavia. There, a group showed that a fractionated patch dose (one-quarter patch of a 25-μg dose approximately equals 6.2 μg or even less) applied overnight mimicked the normal, early-morning serum E2 peak and fell back to baseline within a few hours of patch removal (17).

    For transdermal administration, gel and patches are available; dosing by cutting patches is more reliable when titrating the E2 serum level, and the delivery can be stopped in the morning by just taking the patch away when mimicking the circadian rhythm seen in early spontaneous puberty (Fig. 1). […] Our present recommendation is to use E2 matrix patches when available. Matrix patches are stable and have a homogenous E2 layer over the total surface and can therefore be cut into individualized doses. However, matrix patches are available with different patch areas for the same dose from different brands. The larger the patch area, the easier to cut the patch into smaller pieces for the target dose.

    This is to be compared to the reservoir patches which have a separate drug layer with a liquid compartment containing a drug solution or suspension separated by the adhesive layer. By cutting such a patch, the liquid compartment will be destroyed and the drug will leak out.

    It is unknown how to best deliver estradiol doses below 14 μg daily. While a European matrix patch can apparently be cut into quarters so the estrogen can be delivered overnight, the US manufacturers recommend against this and our limited experience has yielded erratic plasma estradiol levels, which suggests that these patches may not be uniformly impregnated with estradiol.

    Almost all estradiol patches available today are matrix patches. Estraderm, a reservoir patch, is one of the only exceptions. It is discontinued in the United States but may still be used in the United Kingdom.

    Tegaderm, a transparent film dressing, is another option for helping to hold patches in place (Reddit).

    Penile Skin Application

    Penile skin seems to have similar absorptive characteristics to scrotal skin and hence may also allow for improved absorption with transdermal application. As such, it could be useful as a supplement or alternative to scrotal application of transdermal estradiol. See the following literature excerpt for some more information on penile application (Hairston, Becher, & McVary, 2006):

    […] topical penile therapy has a unique set of anatomic and physiological issues that must be considered. There are several anatomic/fascial layers between the penile skin and the corpora cavernosa. The tunica albuginea is presumed to be difficult to penetrate because of its thick layers of collagen. Therefore, topical treatment trials have emphasized exposure to the glans penis because it has direct venous communication to the corpora cavernosa (40,41). The skin itself is a relatively impermeable tissue because of the stratum corneum. The horny cells at the stratum corneum are bonded with a very tight intercellular lipid matrix bilayer that makes the passage of drugs challenging (42). To overcome this barrier, investigators have used penetration enhancers that permeate this layer and reach the subdermis. Fortunately, the penis and scrotum are unique in that their stratum corneum is the most permeable of all anatomic locations tested. Depending on the molecular structure of the agent tested, there can be nearly 100% absorption of topical agents applied to these areas. Exposure to the glans affords a more easily “breached” layer. Other skin regions (e.g., back and palms) are particularly impermeable (43). An additional factor confounding efficient delivery of drug is the rich vasculature of the deep dermis that may “steal” the drugs to the systemic circulation.

    Hence, if more skin area is desired for application of estradiol gel or patches, use of penile skin could possibly work as well. This may notably also be relevant to vaginal administration for most post-vaginoplasty transfeminine people (i.e., via penile inversion) as the neovaginal lining is penile skin. However, no studies exist on the absorptive effectiveness of neovaginal administration.

    Genital Application of Estradiol Gel and Cream

    Two clinical studies on scrotal application of transdermal testosterone gel and cream in men have been published:

    • Iyer, R., Mok, S. F., Savkovic, S., Turner, L., Fraser, G., Desai, R., Jayadev, V., Conway, A. J., & Handelsman, D. J. (2017). Pharmacokinetics of testosterone cream applied to scrotal skin. Andrology, 5(4), 725–731. [DOI:10.1111/andr.12357]
    • Kuhnert, B., Byrne, M., Simoni, M., Kopcke, W., Gerss, J., Lemmnitz, G., & Nieschlag, E. (2005). Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. European Journal of Endocrinology, 153(2), 317–326. [DOI:10.1530/eje.1.01964]

    Here are some relevant excerpts from the first paper (which also briefly describe the findings of the second paper):

    Scrotal skin is thin and has high steroid permeability, but the pharmacokinetics of testosterone via the scrotal skin route has not been studied in detail. The aim of this study was to define the pharmacokinetics of testosterone [cream] delivered via the scrotal skin route. The study was a single‐center, three‐phase cross‐over pharmacokinetic study of three single doses (12.5, 25, 50 mg) of testosterone cream administered in random sequence on different days with at least 2 days between doses to healthy eugonadal volunteers with endogenous testosterone suppressed by administration of nandrolone decanoate.

    The bioavailability of testosterone via the scrotal skin is striking[ly] higher than for abdominal skin. Using the same testosterone cream and steroid LC-MS assay measurements, in this study a Cmax (4.6 ng/mL, 16.0 nM) was achieved with the lowest dose (12.5 mg) applied to the scrotal skin whereas applying 100 mg testosterone cream to the abdominal skin produced a Cmax of 16.3 nmol/L (4.7 ng/mL). This suggests an about eightfold increase in testosterone bioavailability, using the scrotal compared with abdominal skin routes.

    One previous study has reported that the pharmacokinetics of scrotal application of testosterone gel was similar to that of a scrotal testosterone patch or a fivefold larger dose of non-scrotal testosterone gel, consistent with at least a fivefold higher transdermal bioavailability of testosterone (Kuhnert et al., 2005). Other studies assessing pharmacokinetics of testosterone application to non-scrotal skin have yielded variable time of peak concentration (Tmax) ranging from 6–16 h (Marbury et al., 2003; Miller et al., 2011; Olsson et al., 2014) but similar peak concentration (Cmax) as scrotal skin application (Rolf et al., 2002; Bouloux, 2005; Olsson et al., 2014).

    We conclude that the scrotal administration of testosterone in a cream formulation provides high bioavailability, dose-dependent peak serum testosterone concentration, and tolerability with a much lower dose relative to the non-scrotal transdermal route.

    Based on the findings of these studies, maximal testosterone levels with testosterone gel or cream are about 5- to 8-fold higher with with scrotal application than with application to conventional skin sites (e.g., abdomen). This is analogous to the 5-fold higher testosterone levels that have been achieved with scrotal testosterone patches compared to non-scrotal testosterone patches.

    Estradiol is very similar to testosterone in chemical structure and chemical properties (e.g., lipophilicity and likely absorption characteristics). Hence, although there is currently no research assessing scrotal/neolabial application of transdermal estradiol gel or cream, or showing definitively that it achieves greater estradiol levels than conventional transdermal application, we can infer that because this has been demonstrated for testosterone, it is likely to be the case with estradiol as well. This is particularly true considering that far higher estradiol levels have already been shown with scrotal application of transdermal estradiol patches compared to non-scrotal application of such patches.

    Consequently, scrotal/neolabial administration of transdermal estradiol gel or cream is likely to be a powerful alternative option for achieving high estradiol levels similarly to scrotal/neolabial application of transdermal estradiol patches. Scrotal/neolabial application of transdermal estradiol preparations may allow for greater efficacy and considerably reduced cost compared to conventional transdermal application of such formulations. In addition, whereas patches must be worn constantly and scrotal/neolabial application of such patches may be uncomfortable and inconvenient compared to conventional transdermal application, gels and creams are applied once per day and dry rapidly. Scrotal/neolabial application of patches also requires hair removal and can leave difficult-to-remove adhesive residues as well as cause adhesion-related local skin reactions. In contrast, this is not the case with gels or creams either. As such, estradiol preparations like gel or cream may be the preferred type of transdermal formulation for scrotal/neolabial use.

    One possible caveat to scrotal/neolabial application is that transdermal estradiol gels are hydroalcoholic gels and consequently have the potential to irritate the skin and burn or sting when applied to the genital region. A potential solution to this is the use of transdermal estradiol preparations containing less or no alcohol, such as creams (e.g., compounded and over-the-counter products) and emulsions (e.g., Estrasorb), instead of hydroalcoholic gels. There is also a transdermal estradiol aerosol spray product (brand name Evamist) that may be another alternative option.

    Taken together, transdermal testosterone gel or cream applied to scrotal skin is absorbed much better and results in approximately 5- to 8-fold higher testosterone levels than when applied to conventional skin sites. The same is likely also true for estradiol due to the close structural similarity of estradiol to testosterone and due to estradiol patches having been shown to be absorbed substantially better when applied to scrotal skin than to conventional skin sites.

    Safety of Genital Application of Estradiol

    Some have expressed concern as to the safety of genital application of estradiol. For instance, it has been asked whether estradiol applied to the scrotum might increase risk of testicular cancer or prostate cancer due to the high local estradiol concentrations that might result. Large observational studies of transfeminine people on standard hormone therapy have found no increase in risk of testicular cancer (Bensley et al., 2021; de Nie et al., 2021) or prostate cancer (de Nie et al., 2020). In fact, risk of prostate cancer in transfeminine people appears to be substantially decreased with standard hormone therapy (de Nie et al., 2020). Additionally, androgen deprivation reduces prostate cancer risk and progression in cisgender men, and high-dose estrogen therapy is effective for the treatment of this cancer, with a longstanding history of use (Ockrim, Lalani, & Abel, 2006; Norman et al., 2008; Langley et al., 2021). Hence, while we do not have the data needed to answer the question of whether very high local concentrations of estradiol in the testes or prostate might increase cancer risk in these tissues, the available circumstantial clinical evidence is not suggestive of such and this is reassuring.

    References

    • Atkinson, L. E., Chang, Y. L., & Snyder, P. J. (1998). Long-term experience with testosterone replacement through scrotal skin. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 365–388). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_13]
    • Behre, H. M., & Nieschlag, E. (2012). Testosterone preparations for clinical use in males. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 309–335). Cambridge/New York: Cambridge University Press. [DOI:10.1017/CBO9781139003353.016]
    • Bensley, J. G., Cheung, A. S., Grossmann, M., & Papa, N. (2022). Testicular Cancer in Trans People Using Feminising Hormone Therapy–A Brief Review. Urology, 160, 1–4. [DOI:10.1016/j.urology.2021.11.014]
    • de Nie, I., de Blok, C., van der Sluis, T. M., Barbé, E., Pigot, G., Wiepjes, C. M., Nota, N. M., van Mello, N. M., Valkenburg, N. E., Huirne, J., Gooren, L., van Moorselaar, R., Dreijerink, K., & den Heijer, M. (2020). Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment. The Journal of Clinical Endocrinology and Metabolism, 105(9), e3293–e3299. [DOI:10.1210/clinem/dgaa412]
    • de Nie, I., Wiepjes, C. M., Blok, C. J., Moorselaar, R. J., Pigot, G. L., van der Sluis, T. M., Barbé, E., van der Voorn, P., van Mello, N. M., Huirne, J., & den Heijer, M. (2021). Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study. BJU International, 129(4), 491–497. [DOI:10.1111/bju.15575]
    • Feldmann, R. J., & Maibach, H. I. (1967). Regional variation in percutaneous penetration of 14C cortisol in man. The Journal of Investigative Dermatology, 48(2), 181–183. [DOI:10.1038/jid.1967.29]
    • Hairston, J. C., Becher, E., & McVary, K. T. (2006). Topical and Intra-Urethral Therapy. In Mulcahy, J. J. (Ed.). Male Sexual Function: A Guide to Clinical Management, 2nd Edition (Current Clinical Urology) (pp. 303–321). Totowa: Humana Press. [DOI:10.1007/978-1-59745-155-0_14] [Google Books]
    • Iyer, R., Mok, S. F., Savkovic, S., Turner, L., Fraser, G., Desai, R., Jayadev, V., Conway, A. J., & Handelsman, D. J. (2017). Pharmacokinetics of testosterone cream applied to scrotal skin. Andrology, 5(4), 725–731. [DOI:10.1111/andr.12357]
    • Järvinen, A., Granander, M., Nykänen, S., Laine, T., Geurts, P., & Viitanen, A. (1997). Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: effects of application area and washing. British Journal of Obstetrics and Gynaecology, 104(Suppl 16), 14–18. [DOI:10.1111/j.1471-0528.1997.tb11562.x]
    • Khera, M. (2013). Treatment Options for Testosterone Replacement Therapy. In Hellstrom, W. J. G. (Ed.). Androgen Deficiency and Testosterone Replacement: Current Controversies and Strategies (pp. 129–139). Totowa: Humana Press. [DOI:10.1007/978-1-62703-179-0_10]
    • Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T., & Mauras, N. (2018). Estrogen replacement in Turner syndrome: literature review and practical considerations. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1790–1803. [DOI:10.1210/jc.2017-02183]
    • Kuhnert, B., Byrne, M., Simoni, M., Kopcke, W., Gerss, J., Lemmnitz, G., & Nieschlag, E. (2005). Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. European Journal of Endocrinology, 153(2), 317–326. [DOI:10.1530/eje.1.01964]
    • Langley, R. E., Godsland, I. F., Kynaston, H., Clarke, N. W., Rosen, S. D., Morgan, R. C., Pollock, P., Kockelbergh, R., Lalani, e., Dearnaley, D., Parmar, M., & Abel, P. D. (2008). Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first‐line hormonal therapy in patients with locally advanced or metastatic prostate cancer. BJU International, 102(4), 442–445. [DOI:10.1111/j.1464-410X.2008.07583.x]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., … & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/S0140-6736(21)00100-8]
    • Matthews, D., Bath, L., Högler, W., Mason, A., Smyth, A., & Skae, M. (2017). Hormone supplementation for pubertal induction in girls. Archives of Disease in Childhood, 102(10), 975–980. [DOI:10.1136/archdischild-2016-311372]
    • Mazer, N. A., Heiber, W. E., Moellmer, J. F., Meikle, A. W., Stringham, J. D., Sanders, S. W., Tolman, K. G., & Odell, W. D. (1992). Enhanced transdermal delivery of testosterone: a new physiological approach for androgen replacement in hypogonadal men. Journal of Controlled Release, 19(1–3), 347–361. [DOI:10.1016/0168-3659(92)90089-A]
    • Norjavaara, E., Ankarberg-Lindgren, C., & Kriström, B. (2016). Sex steroid replacement therapy in female hypogonadism from childhood to young adulthood. In Bourguignon J.-P., Parent A.-S. (Eds.). Puberty from Bench to Clinic. Lessons for Clinical Management of Pubertal Disorders (Endocrine Development, Volume 29) (pp. 198–213). Basel: Karger. [DOI:10.1159/000438892]
    • Norman, G., Dean, M. E., Langley, R. E., Hodges, Z. C., Ritchie, G., Parmar, M. K., Sydes, M. R., Abel, P., & Eastwood, A. J. (2008). Parenteral oestrogen in the treatment of prostate cancer: a systematic review. British Journal of Cancer, 98(4), 697–707. [DOI:10.1038/sj.bjc.6604230]
    • Ockrim, J., Lalani, E. N., & Abel, P. (2006). Therapy insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature clinical practice Oncology, 3(10), 552–563. [DOI:10.1038/ncponc0602]
    • Place, V. A., Atkinson, L., Prather, D. A., Trunnell, N., & Yates, F. E. (1990). Transdermal testosterone replacement through genital skin. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 1st Edition (pp. 165–181). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-662-00814-0_9]
    • Premoli, F., Re, I., Asenjo, G., Maximino, G., & Micheletti, L. (2005). Tratamiento del Cáncer de Próstata Avanzado con Estrógenos Transdérmicos Escrotales (ETE). [Transdermal Scrotal Estrogen Patches (TSEP) in the Treatment of Advanced Prostate Cancer.] Revista Argentina de Urología, 70(4), 231–241. [Google Scholar] [URL] [PDF] [Translation]
    • Rosenfield, R. L., Kiess, W., & de Muinck Keizer-Schrama, S. (2006). Physiologic induction of puberty in Turner syndrome with very low-dose estradiol. International Congress Series, 1298, 71–79. [DOI:10.1016/j.ics.2006.07.003]
    \ No newline at end of file diff --git a/transfemscience.org/articles/high-dose-transdermal-e2/index.html b/transfemscience.org/articles/high-dose-transdermal-e2/index.html index 33f58428..de1cead1 100644 --- a/transfemscience.org/articles/high-dose-transdermal-e2/index.html +++ b/transfemscience.org/articles/high-dose-transdermal-e2/index.html @@ -1 +1 @@ -A Review of Studies on Estradiol Levels and Testosterone Suppression with High-Dose Transdermal Estradiol Gel and Ointment in Cisgender Men with Prostate Cancer - Transfeminine Science Link

    A Review of Studies on Estradiol Levels and Testosterone Suppression with High-Dose Transdermal Estradiol Gel and Ointment in Cisgender Men with Prostate Cancer

    By Aly | First published June 30, 2019 | Last modified November 2, 2022

    Abstract / TL;DR

    High-dose estradiol monotherapy, generally used non-orally, is a therapeutic approach for testosterone suppression which is sometimes used in transfeminine people and men with prostate cancer. Limited data are available for this approach with certain forms of estradiol, so considering research in other patient populations besides transfeminine people can provide valuable information. In the 1970s and 1980s, studies were conducted on high-dose transdermal estradiol gel and ointment for the treatment of prostate cancer in men. Estradiol at 3 to 20 mg/day appeared to give 84 to 473 pg/mL estradiol and 105 to 260 ng/dL testosterone in these men. While informative, the findings of the studies are only so useful due to various unfortunate limitations. In any case, it’s apparent that transdermal estradiol gel and related forms don’t seem to be well-suited for achieving the high levels of estradiol that are needed for robust testosterone suppression with high-dose estradiol monotherapy in men with prostate cancer or transfeminine people. High-dose transdermal estradiol patches, or alternatively genital application of transdermal estradiol forms, may be more useful options for this approach on the other hand.

    Introduction

    High-dose estrogen monotherapy is a means of testosterone suppression which is sometimes used to treat prostate cancer in men. High-dose parenteral estradiol therapy is one particular approach used for this purpose which has less toxicity compared to use of oral and synthetic estrogens. In the late 1970s and early 1980s, high-dose transdermal estradiol gel/ointment was assessed by French researchers in three clinical studies for the treatment of prostate cancer (Steg & Benoit, 1979; Steg et al., 1979; Steg et al., 1980; Steg et al., 1983; Steg & Benoit, 1983; Benoit, 1985). The dosages used in the studies ranged from 3 to 20 mg/day. For comparison, typical doses of transdermal estradiol gel used in transfeminine hormone therapy to achieve physiological estradiol levels range from about 1 to 6 mg/day.

    High-dose estradiol monotherapy, generally administered parenterally, is sometimes used as a means of suppressing testosterone levels in transfeminine hormone therapy similarly to the hormonal treatment of prostate cancer. This approach omits the use of antiandrogens and their costs, side effects, and risks, though at the same time incurs risks of higher estradiol exposure. There is limited information available on estradiol levels and testosterone suppression with high-dose estradiol gel and similar forms. Hence, a review of the relevant details from the studies of high-dose estradiol gel for prostate cancer is of value as it can be used to inform the use of high-dose estradiol monotherapy in transfeminine people.

    The French studies in question appear to be the only clinical studies of high-dose transdermal estradiol gel/ointment for prostate cancer that have been published. This is in contrast to high-dose transdermal estradiol patches and injectable estradiol esters like polyestradiol phosphate (PEP) and estradiol undecylate (EU), which have been much more widely used in men with prostate cancer.

    Data and Excerpts

    A Note on Estradiol Delivery Rates

    The authors use “γ” (“gamma”) as a unit in their papers. This is a now-deprecated non-SI unit of mass equal to 1 μg (Wiki). That is, “1 γ” means the same thing as “1 μg”. The researchers provided values using this unit as an estimate of the amount of estradiol actually absorbed into the body after taking into account the “cutaneous absorption coefficient” (i.e., transdermal bioavailability) of estradiol. However, when compared to established μg/day values for commercial transdermal estradiol patches and the estradiol levels associated with these patches, the values in the papers are very different from what would be expected. For this reason, and because estimates for transdermal estradiol patches were more rigorously determined and likely to be correct, the delivery rates reported by the authors are probably not accurate. It was important to include them in this article nonetheless however because the researchers modified their transdermal estradiol formulations between their studies, resulting in inconsistencies between the estradiol doses in gel/ointment and their estimated delivery values.

    Study 1: Estradiol Gel 3 mg/day versus 6 mg/day

    The following three papers pertain to the first study:

    1. Steg, A., & Benoit, G. (1979). Percutaneous 17 β-estradiol in treatment of cancer of prostate. Urology, 14(4), 373–375. [Google Scholar] [PubMed] [DOI:10.1016/0090-4295(79)90083-9] [PDF]
    2. Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1979). Cancer de la prostate: effets métaboliques des bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effect of percutaneous beta-estradiol. / Prostatic carcinoma: metabolic effect of percutaneous beta-estradiol.] La Nouvelle Presse Medicale, 8(46), 3801–3802. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]
    3. Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1980). Cancer de la prostate: Effets métaboliques du bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effects of percutaneously administered beta-estradiol.] Revue Médicale de la Suisse Romande, 100(11), 895–897. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]

    In the study, 21 men with prostate cancer were divided into two groups and treated for 1 month with:

    1. 3 mg/day (“300 μg/day”) estradiol in 5 g/day gel applied to the abdomen in one daily dose
    2. 6 mg/day (“600 μg/day”) estradiol in 10 g/day gel applied to the abdomen in two daily divided doses

    Hormone levels in the study were as follows:

    Estradiol levelsTestosterone levels
    Pre-treatment23.2 ± 10.8 pg/mLPre-treatment341 ± 180 ng/dL
    E2 gel 3 mg/day84.2 ± 54.3 pg/mLE2 gel 3 mg/day188 ± 125 ng/dL
    E2 gel 6 mg/day184.7 ± 98.46 pg/mLE2 gel 6 mg/day105 ± 113 ng/dL
    Estrone levelsDHT levels
    Pre-treatment37.6 ± 16.2 pg/mLPre-treatment36 ± 27 ng/dL
    E2 gel 3 mg/day86.7 ± 42.5 pg/mLE2 gel 3 mg/day23 ± 14 ng/dL
    E2 gel 6 mg/day150.9 ± 101.4 pg/mLE2 gel 6 mg/day12 ± 12 ng/dL
    LH levelsFSH levels
    Pre-treatment6.21 ± 6.2 mIU/mLPre-treatment7.56 ± 4.9 mIU/mL
    E2 gel 3 mg/day4.15 ± 3.3 mIU/mLE2 gel 3 mg/day6.44 ± 5.0 mIU/mL
    E2 gel 6 mg/day3.41 ± 3.2 mIU/mLE2 gel 6 mg/day4.13 ± 5.0 mIU/mL

    The researchers stated that the testosterone levels resulting with 6 mg/day estradiol gel (105 ± 113 ng/) were similar to those that are known to occur with 3 mg/day oral diethylstilbestrol. However, this seems to be a somewhat inaccurate statement as 3 mg/day oral diethylstilbestrol has been found to consistently suppress testosterone levels into the castrate range (≤50 ng/dL) in studies (Wiki).

    Study 2: Estradiol Ointment 10 mg/day versus Diethylstilbestrol Oral 3 mg/day

    The following paper pertains to the second study:

    • Steg, A., Benoit, G., Maisonneuve, P., Tallet, F., Nahoul, K., Sultan, Y., Raichwarg, D., & Limouzin-Lamotte, M. A. (1983). Étude comparative du diéthylstilboestrol et du 17 bêta-oestradiol per-cutané dans le traitement du cancer de la prostate. [A comparative study of percutaneous 17 beta-estradiol and diethylstilbestrol in the treatment of prostatic cancer.] Annales d’Urologie, 17(4), 197–202. [Google Scholar] [PDF]

    In the study, 56 men with prostate cancer were divided into two groups and treated for 3 months with:

    1. 10 mg/day (“600 μg/day”) estradiol in “ointment” applied to the abdomen in two daily divided doses
    2. 3 mg/day oral diethylstilbestrol in three daily divided doses

    Hormone levels in the study were as follows:

    Estradiol levelsTestosterone levels
    Pre-treatment (E2 group)30 pg/mLPre-treatment (E2 group)450 ng/dL
    E2 ointment 10 mg/day107 ± 81 pg/mLE2 ointment 10 mg/day180 ± 160 ng/dL
    Pre-treatment (DES group)26 pg/mLPre-treatment (DES group)420 ± 130 ng/dL
    DES oral 3 mg/day19 pg/mLDES oral 3 mg/day51 ± 0.9 ng/dL
    LH levelsFSH levels
    Pre-treatment (E2 group)3.2 mIU/mLPre-treatment (E2 group)4.7 mIU/mL
    E2 ointment 10 mg/day2.0 ± 0.9 mIU/mLE2 ointment 10 mg/day1.7 mIU/mL
    Pre-treatment (DES group)4.0 ± 3.2 mIU/mLPre-treatment (DES group)5.8 mIU/mL
    DES oral 3 mg/day1.6 ± 1.2 mIU/mLDES oral 3 mg/day1.7 mIU/mL

    Some SDs (±) are missing in the table above because not all were provided in the original paper. The SDs that were included above were actually reported in the paper for Study 3.

    Some noteworthy translated excerpts from the paper:

    This study shows that the clinical effects were more dramatic in the DES group, with a sharper drop in the free plasma testosterone level, than in the E2 group.

    E2 has been administered too weakly because it is too low in the commercially used ointment and because application to the thick abdominal skin has a lower absorption coefficient than a thinner skin such as forearms for example. It is possible that a dose equivalent to 15 or 20 mg of gel, applied on the forearms, may allow to lower the testosterone below [100 ng/dL]. The marketing of a more concentrated ointment is therefore desirable, as well as the use of a more efficient absorption site.

    The search for new estrogens and new routes of administration is therefore necessary: E2, a natural female hormone, induces no thromboembolic events. It seems to us, therefore, that a larger dose must be proposed to be as effective as 3 mg DES. A gel twice more concentrated is therefore currently under study.

    The double-concentration estradiol gel was subsequently reported in Study 3 (see below).

    It should be noted that the transdermal estradiol formulation in this study is different from that used in Study 1. Specifically, “6 mg/day estradiol gel” was stated to deliver “600 μg/day estradiol” in Study 1, whereas “10 mg/day estradiol ointment” was stated to deliver “600 μg/day estradiol” in Study 2. These apparent discrepancies might be of relevance to the unexpectedly lower estradiol levels and testosterone suppression in Study 2 compared to Study 1.

    Study 3: Estradiol Ointment 20 mg/day versus Bilateral Orchiectomy

    The following paper pertains to the third study:

    • Steg, A., & Benoit, G. (1983). Étude comparative de fortes doses d’oestradiol-17 β administrées par voie per-cutanée et de l’orchidectomie bilatérale dans le traitement du cancer de la prostate. [Prostatic carcinoma. Bilateral orchiectomy versus percutaneous administration of large doses of 17 β-estradiol. A comparative study. / Comparative study of percutaneous administration of large doses of 17β œstradiol and bilateral orchidectomy in prostatic carcinoma.] Annales d’Urologie, 17(5), 286–288. [Google Scholar] [Pascal and Francis] [PDF]

    In the study, 38 men with prostate cancer were divided into two groups and treated for 1 month with:

    1. 20 mg/day (“1200 μg/day”) estradiol in an ointment applied to the skin in four daily divided doses
    2. Bilateral orchiectomy (i.e., surgical removal of the testes)

    Hormone levels in the study were as follows:

    ConditionEstradiol levelsTestosterone levelsLH levels
    Pre-treatment (E2 group)52 ± 30 pg/mL460 ± 230 ng/dL2.6 ± 0.9 mIU/mL
    E2 ointment 20 mg/day473 ± 375 pg/mL260 ± 160 ng/dL1.7 ± 0.8 mIU/mL
    Pre-treatment (orchi group)Not reported500 ± 160 ng/dL5.5 ± 6 mIU/mL
    Bilateral orchiectomyNot reported20 ± 10 ng/dL19 ± 8 mIU/mL

    Some noteworthy translated excerpts from the paper:

    The purpose of this study was to determine whether hormonal efficacy [in the treatment of prostate cancer] was enhanced by the administration of large doses of E2. […] The study shows that, whereas orchiectomy lowers plasma testosterone levels dramatically, E2, at [the double dose used in this study compared to our previous study] (1200 [μg] versus 600 [μg]), surprisingly does not further lower it at all, but plasma E2 is substantially increased.

    We have found that the administration of E2 causes significant biological changes; E2 is well-absorbed, testosterone is lowered, and LH and FSH are also lowered. But when comparing these effects with those obtained by castration, and with those also observed after administration of 3 mg of diethylstilbestrol (in our previous study), the results are much less brilliant. Indeed: the plasma testosterone is moderately lowered by E2 whereas the fall is much more pronounced with DES and is spectacular with castration; pituitary suppression is comparable with E2 and DES and of course orchiectomy increases LH; and if we compare the results obtained before and after treatment, it is clear that if before treatment the figures are comparable, after treatment the fall is pronounced only with DES and especially with orchiectomy.

    The objective of this study was to determine whether doubling the dose of E2 enhances its antiandrogenic effect. [With both a lower dose and a higher dose], E2 is very well-absorbed. [With both doses], the pituitary suppression is identical, but on the other hand, not only is plasma testosterone not lower with [the higher dose], but it seems to be even [higher than with the lower dose]. This difference is also found clinically since with [the higher dose], 10% of patients were improved while with [the lower dose], 30% improvement was obtained.

    How can this result be explained? Perhaps this is due to the contrary effects of E2 on androgens. Indeed: E2 on the one hand suppresses pituitary activity, which leads to a fall of testicular testosterone secretion, and at the same time E2 decreases 5α-reductase activity in the prostate; on the other hand, E2 causes an increase in SHBG and competes with free testosterone binding to SHBG and in this way increases the proportion of active free testosterone. In addition, testosterone also increases the level of cytoplasmic androgen receptors.

    This work shows that E2 is well-absorbed percutaneously and causes practically no cardiovascular events. On the other hand, it appears that the antiandrogenic effect is significantly less by this route than that obtained by diethylstilbestrol and castration, and that in any case, we cannot improve the efficacy by increasing the dose of E2.

    The finding that the 20 mg/day estradiol ointment resulted in less suppression of testosterone levels than the 10 mg/day estradiol ointment despite markedly higher estradiol levels is surprising. However, the researchers’ theoretical explanation of the result seems questionable. Abundant clinical research with high-dose estradiol for prostate cancer (e.g., transdermal patches, injectable polyestradiol phosphate injections, injectable estradiol undecylate) has shown stronger testosterone suppression with high estradiol levels in this range or below and seems to thoroughly contradict their results. Studies have consistently shown that estradiol levels of 200 to 500 pg/mL and above suppress testosterone levels by 90% and greater (to ~50 ng/dL and below) (Wiki; Graphs). Instead of the authors’ interpretation of their unexpected results, it seems possible that the testosterone assays for this study may have been inaccurate or perhaps some other methodological problem may have been responsible.

    The concentration and dosage of estradiol ointment in this study were double those of Study 2, yet the estradiol levels measured in this study were almost 5-fold higher than those in Study 2. It’s possible that the higher concentration of ointment used may have resulted in disproportionately greater absorption, as one study found that the smaller the application area of estradiol gel (and hence higher the post-application concentration), the greater the resulting estradiol levels (Graph). On the other hand, it’s possible that the estradiol assays were inaccurate (as also suggested for testosterone above). Lastly, in contrast to the previous two papers, the authors don’t state where the ointment was applied in this study. It was probably the abdomen similarly, but this isn’t certain; they may have used one or more other locations with differing skin permeability (as they discussed the possibility of doing in Study 1). It’d be expected that they’d mention this change though, which perhaps makes the possibility unlikely.

    Review Article

    A review of hormone therapy for prostate cancer was also published by one of the researchers:

    • Benoit, G. (1985). Que Penser du Traitement Hormonal du Cancer de la Prostate / Hormonothérapie du Cancer de la Prostate. [Thoughts on the Hormonal Treatment of Prostate Cancer / Hormone Therapy of Prostate Cancer.] Gazette Médicale, 92(5), 33–39. [Google Scholar] [PDF] [Translation]

    In the paper, she briefly mentioned her and her colleagues’ studies on high-dose transdermal estradiol gel/ointment for prostate cancer and provided some additional information pertaining to these studies. Here are the relevant translated excerpts from the paper:

    In a study in Cochin (16), the efficacy of diethylstilbestrol was 50% of objective responses, but at a cost of 23% of thromboembolic events. These thromboembolic events are similar to the accidents that occur in women taking oral estrogen–progestogens. These are oral synthetic estrogens. In a series of diethylstilbestrol-treated prostate cancers, Steg (16) has shown that this treatment induces an increase in triglycerides and a decrease in coagulation factor VIII. Abbou (1) found, on his behalf, an increase in circulating immune complexes in patients with thrombosis under synthetic estrogen–progestogen therapy.

    It therefore seems to us no longer possible to prescribe diethylstilbestrol as first intention. To reduce these cardiovascular events, most authors have tried to use natural estrogens administered intramuscularly, subcutaneously, or percutaneously. Cochin’s experience of using a natural estrogen (17-beta-estradiol) percutaneously has shown that this treatment may be effective, but that it is very difficult to administer: one in two patients is unable to apply the treatment correctly and regularly, which greatly reduces the use of such treatment (15).

    As an indication, we report several studies made successively in Cochin (16, 17) with diethylstilbestrol, a natural estrogen (17-beta-estradiol), testicular pulpectomy, and an LHRH analogue administered subcutaneously.

    The results confirm that diethylstilbestrol causes thromboembolic events. These different estrogenic treatments promote gynecomastia. Medical castration by LHRH analogues or surgical pulpectomy causes hot flushes. All these treatments reach, in a variable way, libido and sexual potency. This last effect is complex: it is known that castration, in young men, after puberty, does not regularly cause impotence, as shown by the history of castrates. However, it is necessary to warn the patient that each of these treatments can reach his manhood.

    Synthetic estrogens, especially diethylstilbestrol, should no longer be used as first-line agents in the treatment of metastatic prostate cancer because of their thromboembolic risk. Natural estrogens do not seem efficient enough to be used regularly. Complete castration performs excessive mutilation. In our opinion, only testicular pulpectomy, LHRH analogues, and antiandrogens remain in competition.

    The review also contains the following adapted summary table of data from their studies:

     DESE2 gel/ointmentOrchiectomyGnRH analogue
    Testosterone levels50 ng/dL100 ng/dL20 ng/dL50 ng/dL
    50% partial remission50%30%33%41%
    Cardiovascular events23%0%0%0%

    The gonadotropin-releasing hormone (GnRH) analogue data were from other studies and papers by the same researchers (Steg et al., 1984; Steg et al., 1985a; Steg et al., 1985b). These studies did not assess transdermal estradiol and hence are not otherwise discussed in the present article.

    The authors’ comments in this paper raise the additional question of whether inconsistent and suboptimal exposure to estradiol gel/ointment may have influenced the findings of their studies.

    Summary and Discussion

    In the reviewed clinical studies of high-dose transdermal estradiol gel/ointment in men with prostate cancer, the following results were obtained in terms of changes in measured hormone levels:

    Estradiol doseEstradiol levelsTestosterone levels
    Before treatment23–52 pg/mL341–460 ng/dL
    3 mg/day gel (“300 μg/day”)84 pg/mL188 ng/dL
    6 mg/day gel (“600 μg/day”)185 pg/mL105 ng/dL
    10 mg/day ointment (“600 μg/day”)107 pg/mL180 ng/dL
    20 mg/day ointment (“1200 μg/day”)473 pg/mL260 ng/dL

    Unfortunately, the data reported in these studies is not as useful as might have been hoped. This is due to inconsistencies with the transdermal estradiol formulations and doses used, reported issues with patient compliance in terms of consistent and correct administration, inconsistencies with the measured estradiol and testosterone levels, and omission of certain important details (e.g., ointment concentrations, gel/ointment compositions and differences, how the estimated estradiol delivery rates were determined, etc.). As a result of these limitations, there may be only so much that can be taken away from the studies.

    In any case, these studies do contribute to an impression that transdermal estradiol gel achieves relatively low estradiol levels and is relatively weak in terms of estrogenic strength even when used at high doses. Other studies of high-dose transdermal estradiol gel/cream, for instance at doses of 3 to 8 mg/day, have reported relatively low estradiol levels similarly, for instance 100 to 200 pg/mL on average (e.g., Lauritzen, 1990; Wiki). Based on these studies, transdermal estradiol gel doesn’t seem to be a very effective or affordable way of achieving the estradiol levels that are needed for adequate suppression of testosterone levels with high-dose estradiol monotherapy in transfeminine people.

    In contrast to transdermal estradiol gel, transdermal estradiol patches can consistently achieve much higher estradiol levels and testosterone suppression in comparison (Wiki). About 50 to 100 pg/mL estradiol per 100 μg/day estradiol patch appears to be achieved on average, and multiple 100 μg/day patches up to as high as eight at a time appear to result in approximately linear increases in estradiol levels (Aly, 2020; Wiki). The consistent and higher estradiol levels with estradiol patches makes them generally a more favorable form of estradiol for transdermal administration than estradiol gel and related formulations. Additionally, genital application of transdermal estradiol gel and other transdermal estradiol formulations can allow for dramatically higher estradiol levels (e.g., 5- to 8-fold) than application to conventional transdermal skin sites (e.g., forearm, abdomen) (Aly, 2019). This may also provide transdermal estradiol formulations with greater potential for high-dose estradiol monotherapy.

    References

    • Benoit, G. (1985). Que Penser du Traitement Hormonal du Cancer de la Prostate / Hormonothérapie du Cancer de la Prostate. [Thoughts on the Hormonal Treatment of Prostate Cancer / Hormone Therapy of Prostate Cancer.] Gazette Médicale, 92(5), 33–39. [Google Scholar] [PDF] [Translation]
    • Lauritzen, C. (1990). Clinical use of oestrogens and progestogens. Maturitas, 12(3), 199–214. [DOI:10.1016/0378-5122(90)90004-P]
    • Steg, A., & Benoit, G. (1979). Percutaneous 17 β-estradiol in treatment of cancer of prostate. Urology, 14(4), 373–375. [Google Scholar] [PubMed] [DOI:10.1016/0090-4295(79)90083-9] [PDF]
    • Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1979). Cancer de la prostate: effets métaboliques des bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effect of percutaneous beta-estradiol. / Prostatic carcinoma: metabolic effect of percutaneous beta-estradiol.] La Nouvelle Presse Medicale, 8(46), 3801–3802. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]
    • Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1980). Cancer de la prostate: Effets métaboliques du bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effects of percutaneously administered beta-estradiol.] Revue Médicale de la Suisse Romande, 100(11), 895–897. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]
    • Steg, A., Benoit, G., Maisonneuve, P., Tallet, F., Nahoul, K., Sultan, Y., Raichwarg, D., & Limouzin-Lamotte, M. A. (1983). Étude comparative du diéthylstilboestrol et du 17 bêta-oestradiol per-cutané dans le traitement du cancer de la prostate. [A comparative study of percutaneous 17 beta-estradiol and diethylstilbestrol in the treatment of prostatic cancer.] Annales d’Urologie, 17(4), 197–202. [Google Scholar] [PDF]
    • Steg, A., & Benoit, G. (1983). Étude comparative de fortes doses d’oestradiol-17 β administrées par voie per-cutanée et de l’orchidectomie bilatérale dans le traitement du cancer de la prostate. [Prostatic carcinoma. Bilateral orchiectomy versus percutaneous administration of large doses of 17 β-estradiol. A comparative study. / Comparative study of percutaneous administration of large doses of 17β œstradiol and bilateral orchidectomy in prostatic carcinoma.] Annales d’Urologie, 17(5), 286–288. [Google Scholar] [Pascal and Francis] [PDF]
    • Steg, A., Chiche, R., Boccon-Gibod, L., Debré, B., Duchier, J., & Schally, A. V. (1984). Traitement du cancer de la prostate par un agoniste de la LH-RH: le D Trp 6 LH-RH: Résultats préliminaires à propos de trente observations. [Treatment of prostatic cancer with an LH-RH agonist: the D Trp6 LH-RH. Preliminary results in 30 cases. / Treatment of prostate cancer with D Trp6 LH-RH, an LH-RH agonist. Preliminary results of thirty cases.] Annales d’Urologie, 18(6), 388–392. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Steg, A., Chiche, R., Boccon-Gibod, L., & Debre, B. (1985). Traitement du cancer de la prostate évolué par un agoniste de la gonadoréline, le DTrp6 LH-RH. Quarante et une observations. [Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases.] La Presse Médicale (Paris, France: 1983), 14(40), 2045–2048. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Steg, A., Chiche, R., Boccon-Gibod, L., Debre, B., & Duchier, J. (1985). Traitement du cancer de la prostate par un agoniste de la LH-RH: le D Trp6 LH-RH―résultats préliminaires à propos de trente observations. [Treatment of prostate cancer with D-TRP6 LH-RH, an LH-RH agonist—preliminary results in 30 cases.] La Semaine des Hôpitaux de Paris, 61(10), 615–618. [Google Scholar 1] [Google Scholar 2]
    \ No newline at end of file +A Review of Studies on Estradiol Levels and Testosterone Suppression with High-Dose Transdermal Estradiol Gel and Ointment in Cisgender Men with Prostate Cancer - Transfeminine Science Link

    A Review of Studies on Estradiol Levels and Testosterone Suppression with High-Dose Transdermal Estradiol Gel and Ointment in Cisgender Men with Prostate Cancer

    By Aly | First published June 30, 2019 | Last modified November 2, 2022

    Abstract / TL;DR

    High-dose estradiol monotherapy, generally used non-orally, is a therapeutic approach for testosterone suppression which is sometimes used in transfeminine people and men with prostate cancer. Limited data are available for this approach with certain forms of estradiol, so considering research in other patient populations besides transfeminine people can provide valuable information. In the 1970s and 1980s, studies were conducted on high-dose transdermal estradiol gel and ointment for the treatment of prostate cancer in men. Estradiol at 3 to 20 mg/day appeared to give 84 to 473 pg/mL estradiol and 105 to 260 ng/dL testosterone in these men. While informative, the findings of the studies are only so useful due to various unfortunate limitations. In any case, it’s apparent that transdermal estradiol gel and related forms don’t seem to be well-suited for achieving the high levels of estradiol that are needed for robust testosterone suppression with high-dose estradiol monotherapy in men with prostate cancer or transfeminine people. High-dose transdermal estradiol patches, or alternatively genital application of transdermal estradiol forms, may be more useful options for this approach on the other hand.

    Introduction

    High-dose estrogen monotherapy is a means of testosterone suppression which is sometimes used to treat prostate cancer in men. High-dose parenteral estradiol therapy is one particular approach used for this purpose which has less toxicity compared to use of oral and synthetic estrogens. In the late 1970s and early 1980s, high-dose transdermal estradiol gel/ointment was assessed by French researchers in three clinical studies for the treatment of prostate cancer (Steg & Benoit, 1979; Steg et al., 1979; Steg et al., 1980; Steg et al., 1983; Steg & Benoit, 1983; Benoit, 1985). The dosages used in the studies ranged from 3 to 20 mg/day. For comparison, typical doses of transdermal estradiol gel used in transfeminine hormone therapy to achieve physiological estradiol levels range from about 1 to 6 mg/day.

    High-dose estradiol monotherapy, generally administered parenterally, is sometimes used as a means of suppressing testosterone levels in transfeminine hormone therapy similarly to the hormonal treatment of prostate cancer. This approach omits the use of antiandrogens and their costs, side effects, and risks, though at the same time incurs risks of higher estradiol exposure. There is limited information available on estradiol levels and testosterone suppression with high-dose estradiol gel and similar forms. Hence, a review of the relevant details from the studies of high-dose estradiol gel for prostate cancer is of value as it can be used to inform the use of high-dose estradiol monotherapy in transfeminine people.

    The French studies in question appear to be the only clinical studies of high-dose transdermal estradiol gel/ointment for prostate cancer that have been published. This is in contrast to high-dose transdermal estradiol patches and injectable estradiol esters like polyestradiol phosphate (PEP) and estradiol undecylate (EU), which have been much more widely used in men with prostate cancer.

    Data and Excerpts

    A Note on Estradiol Delivery Rates

    The authors use “γ” (“gamma”) as a unit in their papers. This is a now-deprecated non-SI unit of mass equal to 1 μg (Wiki). That is, “1 γ” means the same thing as “1 μg”. The researchers provided values using this unit as an estimate of the amount of estradiol actually absorbed into the body after taking into account the “cutaneous absorption coefficient” (i.e., transdermal bioavailability) of estradiol. However, when compared to established μg/day values for commercial transdermal estradiol patches and the estradiol levels associated with these patches, the values in the papers are very different from what would be expected. For this reason, and because estimates for transdermal estradiol patches were more rigorously determined and likely to be correct, the delivery rates reported by the authors are probably not accurate. It was important to include them in this article nonetheless however because the researchers modified their transdermal estradiol formulations between their studies, resulting in inconsistencies between the estradiol doses in gel/ointment and their estimated delivery values.

    Study 1: Estradiol Gel 3 mg/day versus 6 mg/day

    The following three papers pertain to the first study:

    1. Steg, A., & Benoit, G. (1979). Percutaneous 17 β-estradiol in treatment of cancer of prostate. Urology, 14(4), 373–375. [Google Scholar] [PubMed] [DOI:10.1016/0090-4295(79)90083-9] [PDF]
    2. Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1979). Cancer de la prostate: effets métaboliques des bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effect of percutaneous beta-estradiol. / Prostatic carcinoma: metabolic effect of percutaneous beta-estradiol.] La Nouvelle Presse Medicale, 8(46), 3801–3802. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]
    3. Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1980). Cancer de la prostate: Effets métaboliques du bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effects of percutaneously administered beta-estradiol.] Revue Médicale de la Suisse Romande, 100(11), 895–897. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]

    In the study, 21 men with prostate cancer were divided into two groups and treated for 1 month with:

    1. 3 mg/day (“300 μg/day”) estradiol in 5 g/day gel applied to the abdomen in one daily dose
    2. 6 mg/day (“600 μg/day”) estradiol in 10 g/day gel applied to the abdomen in two daily divided doses

    Hormone levels in the study were as follows:

    Estradiol levelsTestosterone levels
    Pre-treatment23.2 ± 10.8 pg/mLPre-treatment341 ± 180 ng/dL
    E2 gel 3 mg/day84.2 ± 54.3 pg/mLE2 gel 3 mg/day188 ± 125 ng/dL
    E2 gel 6 mg/day184.7 ± 98.46 pg/mLE2 gel 6 mg/day105 ± 113 ng/dL
    Estrone levelsDHT levels
    Pre-treatment37.6 ± 16.2 pg/mLPre-treatment36 ± 27 ng/dL
    E2 gel 3 mg/day86.7 ± 42.5 pg/mLE2 gel 3 mg/day23 ± 14 ng/dL
    E2 gel 6 mg/day150.9 ± 101.4 pg/mLE2 gel 6 mg/day12 ± 12 ng/dL
    LH levelsFSH levels
    Pre-treatment6.21 ± 6.2 mIU/mLPre-treatment7.56 ± 4.9 mIU/mL
    E2 gel 3 mg/day4.15 ± 3.3 mIU/mLE2 gel 3 mg/day6.44 ± 5.0 mIU/mL
    E2 gel 6 mg/day3.41 ± 3.2 mIU/mLE2 gel 6 mg/day4.13 ± 5.0 mIU/mL

    The researchers stated that the testosterone levels resulting with 6 mg/day estradiol gel (105 ± 113 ng/) were similar to those that are known to occur with 3 mg/day oral diethylstilbestrol. However, this seems to be a somewhat inaccurate statement as 3 mg/day oral diethylstilbestrol has been found to consistently suppress testosterone levels into the castrate range (≤50 ng/dL) in studies (Wiki).

    Study 2: Estradiol Ointment 10 mg/day versus Diethylstilbestrol Oral 3 mg/day

    The following paper pertains to the second study:

    • Steg, A., Benoit, G., Maisonneuve, P., Tallet, F., Nahoul, K., Sultan, Y., Raichwarg, D., & Limouzin-Lamotte, M. A. (1983). Étude comparative du diéthylstilboestrol et du 17 bêta-oestradiol per-cutané dans le traitement du cancer de la prostate. [A comparative study of percutaneous 17 beta-estradiol and diethylstilbestrol in the treatment of prostatic cancer.] Annales d’Urologie, 17(4), 197–202. [Google Scholar] [PDF]

    In the study, 56 men with prostate cancer were divided into two groups and treated for 3 months with:

    1. 10 mg/day (“600 μg/day”) estradiol in “ointment” applied to the abdomen in two daily divided doses
    2. 3 mg/day oral diethylstilbestrol in three daily divided doses

    Hormone levels in the study were as follows:

    Estradiol levelsTestosterone levels
    Pre-treatment (E2 group)30 pg/mLPre-treatment (E2 group)450 ng/dL
    E2 ointment 10 mg/day107 ± 81 pg/mLE2 ointment 10 mg/day180 ± 160 ng/dL
    Pre-treatment (DES group)26 pg/mLPre-treatment (DES group)420 ± 130 ng/dL
    DES oral 3 mg/day19 pg/mLDES oral 3 mg/day51 ± 0.9 ng/dL
    LH levelsFSH levels
    Pre-treatment (E2 group)3.2 mIU/mLPre-treatment (E2 group)4.7 mIU/mL
    E2 ointment 10 mg/day2.0 ± 0.9 mIU/mLE2 ointment 10 mg/day1.7 mIU/mL
    Pre-treatment (DES group)4.0 ± 3.2 mIU/mLPre-treatment (DES group)5.8 mIU/mL
    DES oral 3 mg/day1.6 ± 1.2 mIU/mLDES oral 3 mg/day1.7 mIU/mL

    Some SDs (±) are missing in the table above because not all were provided in the original paper. The SDs that were included above were actually reported in the paper for Study 3.

    Some noteworthy translated excerpts from the paper:

    This study shows that the clinical effects were more dramatic in the DES group, with a sharper drop in the free plasma testosterone level, than in the E2 group.

    E2 has been administered too weakly because it is too low in the commercially used ointment and because application to the thick abdominal skin has a lower absorption coefficient than a thinner skin such as forearms for example. It is possible that a dose equivalent to 15 or 20 mg of gel, applied on the forearms, may allow to lower the testosterone below [100 ng/dL]. The marketing of a more concentrated ointment is therefore desirable, as well as the use of a more efficient absorption site.

    The search for new estrogens and new routes of administration is therefore necessary: E2, a natural female hormone, induces no thromboembolic events. It seems to us, therefore, that a larger dose must be proposed to be as effective as 3 mg DES. A gel twice more concentrated is therefore currently under study.

    The double-concentration estradiol gel was subsequently reported in Study 3 (see below).

    It should be noted that the transdermal estradiol formulation in this study is different from that used in Study 1. Specifically, “6 mg/day estradiol gel” was stated to deliver “600 μg/day estradiol” in Study 1, whereas “10 mg/day estradiol ointment” was stated to deliver “600 μg/day estradiol” in Study 2. These apparent discrepancies might be of relevance to the unexpectedly lower estradiol levels and testosterone suppression in Study 2 compared to Study 1.

    Study 3: Estradiol Ointment 20 mg/day versus Bilateral Orchiectomy

    The following paper pertains to the third study:

    • Steg, A., & Benoit, G. (1983). Étude comparative de fortes doses d’oestradiol-17 β administrées par voie per-cutanée et de l’orchidectomie bilatérale dans le traitement du cancer de la prostate. [Prostatic carcinoma. Bilateral orchiectomy versus percutaneous administration of large doses of 17 β-estradiol. A comparative study. / Comparative study of percutaneous administration of large doses of 17β œstradiol and bilateral orchidectomy in prostatic carcinoma.] Annales d’Urologie, 17(5), 286–288. [Google Scholar] [Pascal and Francis] [PDF]

    In the study, 38 men with prostate cancer were divided into two groups and treated for 1 month with:

    1. 20 mg/day (“1200 μg/day”) estradiol in an ointment applied to the skin in four daily divided doses
    2. Bilateral orchiectomy (i.e., surgical removal of the testes)

    Hormone levels in the study were as follows:

    ConditionEstradiol levelsTestosterone levelsLH levels
    Pre-treatment (E2 group)52 ± 30 pg/mL460 ± 230 ng/dL2.6 ± 0.9 mIU/mL
    E2 ointment 20 mg/day473 ± 375 pg/mL260 ± 160 ng/dL1.7 ± 0.8 mIU/mL
    Pre-treatment (orchi group)Not reported500 ± 160 ng/dL5.5 ± 6 mIU/mL
    Bilateral orchiectomyNot reported20 ± 10 ng/dL19 ± 8 mIU/mL

    Some noteworthy translated excerpts from the paper:

    The purpose of this study was to determine whether hormonal efficacy [in the treatment of prostate cancer] was enhanced by the administration of large doses of E2. […] The study shows that, whereas orchiectomy lowers plasma testosterone levels dramatically, E2, at [the double dose used in this study compared to our previous study] (1200 [μg] versus 600 [μg]), surprisingly does not further lower it at all, but plasma E2 is substantially increased.

    We have found that the administration of E2 causes significant biological changes; E2 is well-absorbed, testosterone is lowered, and LH and FSH are also lowered. But when comparing these effects with those obtained by castration, and with those also observed after administration of 3 mg of diethylstilbestrol (in our previous study), the results are much less brilliant. Indeed: the plasma testosterone is moderately lowered by E2 whereas the fall is much more pronounced with DES and is spectacular with castration; pituitary suppression is comparable with E2 and DES and of course orchiectomy increases LH; and if we compare the results obtained before and after treatment, it is clear that if before treatment the figures are comparable, after treatment the fall is pronounced only with DES and especially with orchiectomy.

    The objective of this study was to determine whether doubling the dose of E2 enhances its antiandrogenic effect. [With both a lower dose and a higher dose], E2 is very well-absorbed. [With both doses], the pituitary suppression is identical, but on the other hand, not only is plasma testosterone not lower with [the higher dose], but it seems to be even [higher than with the lower dose]. This difference is also found clinically since with [the higher dose], 10% of patients were improved while with [the lower dose], 30% improvement was obtained.

    How can this result be explained? Perhaps this is due to the contrary effects of E2 on androgens. Indeed: E2 on the one hand suppresses pituitary activity, which leads to a fall of testicular testosterone secretion, and at the same time E2 decreases 5α-reductase activity in the prostate; on the other hand, E2 causes an increase in SHBG and competes with free testosterone binding to SHBG and in this way increases the proportion of active free testosterone. In addition, testosterone also increases the level of cytoplasmic androgen receptors.

    This work shows that E2 is well-absorbed percutaneously and causes practically no cardiovascular events. On the other hand, it appears that the antiandrogenic effect is significantly less by this route than that obtained by diethylstilbestrol and castration, and that in any case, we cannot improve the efficacy by increasing the dose of E2.

    The finding that the 20 mg/day estradiol ointment resulted in less suppression of testosterone levels than the 10 mg/day estradiol ointment despite markedly higher estradiol levels is surprising. However, the researchers’ theoretical explanation of the result seems questionable. Abundant clinical research with high-dose estradiol for prostate cancer (e.g., transdermal patches, injectable polyestradiol phosphate injections, injectable estradiol undecylate) has shown stronger testosterone suppression with high estradiol levels in this range or below and seems to thoroughly contradict their results. Studies have consistently shown that estradiol levels of 200 to 500 pg/mL and above suppress testosterone levels by 90% and greater (to ~50 ng/dL and below) (Wiki; Graphs). Instead of the authors’ interpretation of their unexpected results, it seems possible that the testosterone assays for this study may have been inaccurate or perhaps some other methodological problem may have been responsible.

    The concentration and dosage of estradiol ointment in this study were double those of Study 2, yet the estradiol levels measured in this study were almost 5-fold higher than those in Study 2. It’s possible that the higher concentration of ointment used may have resulted in disproportionately greater absorption, as one study found that the smaller the application area of estradiol gel (and hence higher the post-application concentration), the greater the resulting estradiol levels (Graph). On the other hand, it’s possible that the estradiol assays were inaccurate (as also suggested for testosterone above). Lastly, in contrast to the previous two papers, the authors don’t state where the ointment was applied in this study. It was probably the abdomen similarly, but this isn’t certain; they may have used one or more other locations with differing skin permeability (as they discussed the possibility of doing in Study 1). It’d be expected that they’d mention this change though, which perhaps makes the possibility unlikely.

    Review Article

    A review of hormone therapy for prostate cancer was also published by one of the researchers:

    • Benoit, G. (1985). Que Penser du Traitement Hormonal du Cancer de la Prostate / Hormonothérapie du Cancer de la Prostate. [Thoughts on the Hormonal Treatment of Prostate Cancer / Hormone Therapy of Prostate Cancer.] Gazette Médicale, 92(5), 33–39. [Google Scholar] [PDF] [Translation]

    In the paper, she briefly mentioned her and her colleagues’ studies on high-dose transdermal estradiol gel/ointment for prostate cancer and provided some additional information pertaining to these studies. Here are the relevant translated excerpts from the paper:

    In a study in Cochin (16), the efficacy of diethylstilbestrol was 50% of objective responses, but at a cost of 23% of thromboembolic events. These thromboembolic events are similar to the accidents that occur in women taking oral estrogen–progestogens. These are oral synthetic estrogens. In a series of diethylstilbestrol-treated prostate cancers, Steg (16) has shown that this treatment induces an increase in triglycerides and a decrease in coagulation factor VIII. Abbou (1) found, on his behalf, an increase in circulating immune complexes in patients with thrombosis under synthetic estrogen–progestogen therapy.

    It therefore seems to us no longer possible to prescribe diethylstilbestrol as first intention. To reduce these cardiovascular events, most authors have tried to use natural estrogens administered intramuscularly, subcutaneously, or percutaneously. Cochin’s experience of using a natural estrogen (17-beta-estradiol) percutaneously has shown that this treatment may be effective, but that it is very difficult to administer: one in two patients is unable to apply the treatment correctly and regularly, which greatly reduces the use of such treatment (15).

    As an indication, we report several studies made successively in Cochin (16, 17) with diethylstilbestrol, a natural estrogen (17-beta-estradiol), testicular pulpectomy, and an LHRH analogue administered subcutaneously.

    The results confirm that diethylstilbestrol causes thromboembolic events. These different estrogenic treatments promote gynecomastia. Medical castration by LHRH analogues or surgical pulpectomy causes hot flushes. All these treatments reach, in a variable way, libido and sexual potency. This last effect is complex: it is known that castration, in young men, after puberty, does not regularly cause impotence, as shown by the history of castrates. However, it is necessary to warn the patient that each of these treatments can reach his manhood.

    Synthetic estrogens, especially diethylstilbestrol, should no longer be used as first-line agents in the treatment of metastatic prostate cancer because of their thromboembolic risk. Natural estrogens do not seem efficient enough to be used regularly. Complete castration performs excessive mutilation. In our opinion, only testicular pulpectomy, LHRH analogues, and antiandrogens remain in competition.

    The review also contains the following adapted summary table of data from their studies:

     DESE2 gel/ointmentOrchiectomyGnRH analogue
    Testosterone levels50 ng/dL100 ng/dL20 ng/dL50 ng/dL
    50% partial remission50%30%33%41%
    Cardiovascular events23%0%0%0%

    The gonadotropin-releasing hormone (GnRH) analogue data were from other studies and papers by the same researchers (Steg et al., 1984; Steg et al., 1985a; Steg et al., 1985b). These studies did not assess transdermal estradiol and hence are not otherwise discussed in the present article.

    The authors’ comments in this paper raise the additional question of whether inconsistent and suboptimal exposure to estradiol gel/ointment may have influenced the findings of their studies.

    Summary and Discussion

    In the reviewed clinical studies of high-dose transdermal estradiol gel/ointment in men with prostate cancer, the following results were obtained in terms of changes in measured hormone levels:

    Estradiol doseEstradiol levelsTestosterone levels
    Before treatment23–52 pg/mL341–460 ng/dL
    3 mg/day gel (“300 μg/day”)84 pg/mL188 ng/dL
    6 mg/day gel (“600 μg/day”)185 pg/mL105 ng/dL
    10 mg/day ointment (“600 μg/day”)107 pg/mL180 ng/dL
    20 mg/day ointment (“1200 μg/day”)473 pg/mL260 ng/dL

    Unfortunately, the data reported in these studies is not as useful as might have been hoped. This is due to inconsistencies with the transdermal estradiol formulations and doses used, reported issues with patient compliance in terms of consistent and correct administration, inconsistencies with the measured estradiol and testosterone levels, and omission of certain important details (e.g., ointment concentrations, gel/ointment compositions and differences, how the estimated estradiol delivery rates were determined, etc.). As a result of these limitations, there may be only so much that can be taken away from the studies.

    In any case, these studies do contribute to an impression that transdermal estradiol gel achieves relatively low estradiol levels and is relatively weak in terms of estrogenic strength even when used at high doses. Other studies of high-dose transdermal estradiol gel/cream, for instance at doses of 3 to 8 mg/day, have reported relatively low estradiol levels similarly, for instance 100 to 200 pg/mL on average (e.g., Lauritzen, 1990; Wiki). Based on these studies, transdermal estradiol gel doesn’t seem to be a very effective or affordable way of achieving the estradiol levels that are needed for adequate suppression of testosterone levels with high-dose estradiol monotherapy in transfeminine people.

    In contrast to transdermal estradiol gel, transdermal estradiol patches can consistently achieve much higher estradiol levels and testosterone suppression in comparison (Wiki). About 50 to 100 pg/mL estradiol per 100 μg/day estradiol patch appears to be achieved on average, and multiple 100 μg/day patches up to as high as eight at a time appear to result in approximately linear increases in estradiol levels (Aly, 2020; Wiki). The consistent and higher estradiol levels with estradiol patches makes them generally a more favorable form of estradiol for transdermal administration than estradiol gel and related formulations. Additionally, genital application of transdermal estradiol gel and other transdermal estradiol formulations can allow for dramatically higher estradiol levels (e.g., 5- to 8-fold) than application to conventional transdermal skin sites (e.g., forearm, abdomen) (Aly, 2019). This may also provide transdermal estradiol formulations with greater potential for high-dose estradiol monotherapy.

    References

    • Benoit, G. (1985). Que Penser du Traitement Hormonal du Cancer de la Prostate / Hormonothérapie du Cancer de la Prostate. [Thoughts on the Hormonal Treatment of Prostate Cancer / Hormone Therapy of Prostate Cancer.] Gazette Médicale, 92(5), 33–39. [Google Scholar] [PDF] [Translation]
    • Lauritzen, C. (1990). Clinical use of oestrogens and progestogens. Maturitas, 12(3), 199–214. [DOI:10.1016/0378-5122(90)90004-P]
    • Steg, A., & Benoit, G. (1979). Percutaneous 17 β-estradiol in treatment of cancer of prostate. Urology, 14(4), 373–375. [Google Scholar] [PubMed] [DOI:10.1016/0090-4295(79)90083-9] [PDF]
    • Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1979). Cancer de la prostate: effets métaboliques des bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effect of percutaneous beta-estradiol. / Prostatic carcinoma: metabolic effect of percutaneous beta-estradiol.] La Nouvelle Presse Medicale, 8(46), 3801–3802. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]
    • Steg, A., Benoit, G., Limouzin-Lamotte, A., Mahoudeau, J., Caillens, M., & Raichvarg, D. (1980). Cancer de la prostate: Effets métaboliques du bêta-estradiol par voie percutanée. [Cancer of the prostate: metabolic effects of percutaneously administered beta-estradiol.] Revue Médicale de la Suisse Romande, 100(11), 895–897. [Google Scholar 1] [Google Scholar 2] [Pascal and Francis] [PubMed] [PDF]
    • Steg, A., Benoit, G., Maisonneuve, P., Tallet, F., Nahoul, K., Sultan, Y., Raichwarg, D., & Limouzin-Lamotte, M. A. (1983). Étude comparative du diéthylstilboestrol et du 17 bêta-oestradiol per-cutané dans le traitement du cancer de la prostate. [A comparative study of percutaneous 17 beta-estradiol and diethylstilbestrol in the treatment of prostatic cancer.] Annales d’Urologie, 17(4), 197–202. [Google Scholar] [PDF]
    • Steg, A., & Benoit, G. (1983). Étude comparative de fortes doses d’oestradiol-17 β administrées par voie per-cutanée et de l’orchidectomie bilatérale dans le traitement du cancer de la prostate. [Prostatic carcinoma. Bilateral orchiectomy versus percutaneous administration of large doses of 17 β-estradiol. A comparative study. / Comparative study of percutaneous administration of large doses of 17β œstradiol and bilateral orchidectomy in prostatic carcinoma.] Annales d’Urologie, 17(5), 286–288. [Google Scholar] [Pascal and Francis] [PDF]
    • Steg, A., Chiche, R., Boccon-Gibod, L., Debré, B., Duchier, J., & Schally, A. V. (1984). Traitement du cancer de la prostate par un agoniste de la LH-RH: le D Trp 6 LH-RH: Résultats préliminaires à propos de trente observations. [Treatment of prostatic cancer with an LH-RH agonist: the D Trp6 LH-RH. Preliminary results in 30 cases. / Treatment of prostate cancer with D Trp6 LH-RH, an LH-RH agonist. Preliminary results of thirty cases.] Annales d’Urologie, 18(6), 388–392. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Steg, A., Chiche, R., Boccon-Gibod, L., & Debre, B. (1985). Traitement du cancer de la prostate évolué par un agoniste de la gonadoréline, le DTrp6 LH-RH. Quarante et une observations. [Treatment of advanced prostatic cancer with a gonadorelin agonist, dTrp6 LHRH. 41 cases.] La Presse Médicale (Paris, France: 1983), 14(40), 2045–2048. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Steg, A., Chiche, R., Boccon-Gibod, L., Debre, B., & Duchier, J. (1985). Traitement du cancer de la prostate par un agoniste de la LH-RH: le D Trp6 LH-RH―résultats préliminaires à propos de trente observations. [Treatment of prostate cancer with D-TRP6 LH-RH, an LH-RH agonist—preliminary results in 30 cases.] La Semaine des Hôpitaux de Paris, 61(10), 615–618. [Google Scholar 1] [Google Scholar 2]
    \ No newline at end of file diff --git a/transfemscience.org/articles/hormone-levels-female-puberty/index.html b/transfemscience.org/articles/hormone-levels-female-puberty/index.html index c1a5ddd7..b079eb55 100644 --- a/transfemscience.org/articles/hormone-levels-female-puberty/index.html +++ b/transfemscience.org/articles/hormone-levels-female-puberty/index.html @@ -1 +1 @@ -Hormone Levels During Normal Puberty in Cisgender Girls - Transfeminine Science Link

    Hormone Levels During Normal Puberty in Cisgender Girls

    By Aly | First published April 29, 2020 | Last modified April 7, 2023

    Preface

    This is a collection of published data on hormone levels throughout normal puberty in cisgender girls. Levels of estrogens (estradiol and estrone), progesterone, and androgens are included. Data are limited to those determined with mass spectrometry-based analytic techniques wherever available.

    Estrogen Levels

    Esoterix/LabCorp (2020)

    Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]:

    Table: Estradiol and estrone levels in cisgender girls and women (HPLC–MS/MS):

      Estradiol Estrone 
    Life stageAge (years)Mean (pg/mL)Range (pg/mL)Mean (pg/mL)Range (pg/mL)
    Tanner stage 1<9.28.05.0–20134.0–29
    Tanner stage 29.2–13.71610–242110–33
    Tanner stage 310.0–14.4257.0–603015–43
    Tanner stage 410.7–15.64721–853616–77
    Tanner stage 511.8–18.611034–1706129–105
    Adult follicular>18.0?30–100?30–100
    Adult luteal>18.0?70–300?90–160

    Figure: Mean (± ref. range) estradiol and estrone levels in normal female puberty (HPLC–MS/MS):

    Frederiksen et al. (2020)

    Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., Main, K. M., Andersson, A. M., & Juul, A. (2020). Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS. The Journal of Clinical Endocrinology & Metabolism, 105(3), 754–768. [DOI:10.1210/clinem/dgz196]:

    (The graphs below were created from analysis of this study by Sam.)

    Figure: Mean (± SD) estradiol and estrone levels in normal female puberty (LC–MS/MS):

    Figure: Median (± SD) estradiol and estrone levels in normal female puberty (LC–MS/MS):

    The lower estradiol and estrone levels in TS5 relative to TS4 are likely due to sampling error.

    Kushnir et al. (2008)

    Kushnir, M. M., Rockwood, A. L., Bergquist, J., Varshavsky, M., Roberts, W. L., Yue, B., Bunker, A. M., & Meikle, A. W. (2008). High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. American Journal of Clinical Pathology, 129(4), 530–539. [DOI:10.1309/LC03BHQ5XJPJYEKG]:

    Table: Estradiol and estrone levels in cisgender girls and women (LC–MS/MS):

     EstradiolEstrone
    Life stage or age (years)Ref. range (pg/mL)Ref. range (pg/mL)
    Tanner stage 1<55<26
    Tanner stage 22–1331–39
    Tanner stage 312–2778–117
    Tanner stage 4/52–2594–109
    Before menarche1–84<41
    After menarche3–2644–113
    7–9 years<35<25
    10–12 years<87<42
    13–15 years9–2488–105
    16–17 years2–2664–133
    Postmenopausal (41–63 years)2–213–32

    Figure: Median estradiol and estrone levels around puberty in cisgender girls (LC–MS/MS):

    It should be noted however that this study has been criticized on methodological grounds (Ankarberg-Lindgren & Norjavaara, 2009a; Ankarberg-Lindgren & Norjavaara, 2009b).

    Janfaza et al. (2006)

    Janfaza, M., Sherman, T. I., Larmore, K. A., Brown-Dawson, J., & Klein, K. O. (2006). Estradiol levels and secretory dynamics in normal girls and boys as determined by an ultrasensitive bioassay: a 10 year experience. Journal of Pediatric Endocrinology and Metabolism, 19(7), 901–910. [DOI:10.1515/JPEM.2006.19.7.901]:

    Table: Estradiol levels in 375 cisgender girls (RCBA—ultrasensitive recombinant cell bioassay):

    Pubertal stagenMean age (years)Mean estradiol (pg/mL)Estradiol range (pg/mL)
    11478.7 ± 1.71.6 ± 2.6<0.02–18
    26811.1 ± 1.16.9 ± 1.1<0.02–40
    35511.9 ± 1.123 ± 33<0.02–147
    46813.4 ± 1.427 ± 380.10–270
    53715.0 ± 1.648 ± 650.49–306

    Madsen et al. (2020)

    Madsen, A., Bruserud, I. S., Bertelsen, B. E., Roelants, M., Oehme, N. H. B., Viste, K., Bjerknes, R., Almås, B., Rosendahl, K., Mellgren, G., Sagen, J. V., & Juliusson, P. B. (2020). Hormone references for ultrasound breast staging and endocrine profiling to detect female onset of puberty. The Journal of Clinical Endocrinology & Metabolism, 105(12), e4886–e4895. [DOI:10.1210/clinem/dgaa679]:

    Table: Estradiol and estrone levels in cisgender girls (LC–MS/MS):

    Estradiol (pg/mL)Estrone (pg/mL)
    Tanner stagenMedianRange (2.5–97.5%)MedianRange (2.5–97.5%)
    B12601.30.24–103.81.2–10
    B2696.51.6–569.23.5–32
    B363–66251.2–77213.2–52
    B473–78487.1–2193211–108
    B576–814113–2683615–129

    Other Studies

    • Courant, F., Aksglaede, L., Antignac, J. P., Monteau, F., Sorensen, K., Andersson, A. M., Skakkebaek, N. E., Juul, A., & Bizec, B. L. (2010). Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. The Journal of Clinical Endocrinology & Metabolism, 95(1), 82–92. [DOI:10.1210/jc.2009-1140]
    • Biro, F. M., Pinney, S. M., Huang, B., Baker, E. R., Walt Chandler, D., & Dorn, L. D. (2014). Hormone changes in peripubertal girls. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3829–3835. [DOI:10.1210/jc.2013-4528]
    • Ankarberg-Lindgren, C., Dahlgren, J., & Andersson, M. X. (2018). High-sensitivity quantification of serum androstenedione, testosterone, dihydrotestosterone, estrone and estradiol by gas chromatography–tandem mass spectrometry with sex-and puberty-specific reference intervals. The Journal of Steroid Biochemistry and Molecular Biology, 183, 116–124. [DOI:10.1016/j.jsbmb.2018.06.005]
      • Note: Has estrone sulfate levels in the different Tanner breast stages.
    • Bae, Y. J., Zeidler, R., Baber, R., Vogel, M., Wirkner, K., Loeffler, M., Ceglarek, U., Kiess, W., Körner, A., Thiery, J., & Kratzsch, J. (2019). Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: Effect of age, gender, puberty, and oral contraceptives. The Journal of Steroid Biochemistry and Molecular Biology, 193, 105409. [DOI:10.1016/j.jsbmb.2019.105409]

    Progesterone Levels

    Esoterix/LabCorp (2020)

    Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF] [Alt] [Alt]:

    Table: Progesterone levels in cisgender girls and women (HPLC–MS/MS):

    Life stage / age (years)Range (ng/mL)
    <10 years≤0.26
    11 years≤2.6
    12 years≤8.6
    13 years≤6.9
    14 years≤12.0
    15 years≤10.8
    16 years≤12.9
    Adult early follicular (days 1–6)≤0.17
    Adult late follicular (days 7–12)≤1.4
    Adult mid-cycle (days 13–15)≤15.6
    Adult luteal (days 16–28)*≤25.6
    Postmenopausal≤0.10
    Pregnancy first trimester6.3–45.5
    Pregnancy second trimester15.4–52.1
    Pregnancy third trimester25.0–99.9

    Note: Luteal progesterone peaked from 3.5 to 37.5 ng/dL ranging on cycle days 17 to 23.

    Progesterone levels in males: ≤0.15 ng/mL (age 1–16 years) and ≤0.11 ng/mL (adult).

    Fisher, Salameh, & Furlanetto / Quest Diagnostics (2007)

    Fisher, D. A., Salameh, W., & Furlanetto, R. W. (2007). [The Quest Diagnostics Manual:] Endocrinology: Test Selection and Interpretation, 4th Edition. San Juan Capistrano, California: Quest Diagnostics. [Google Scholar] [Google Books] [WorldCat] [PDF] [Alt PDF] [Alt]:

    Table: Progesterone levels in cisgender girls and women (LC–MS/MS):

    Life stage / ageRange (ng/mL)
    5–9 years≤0.6
    10–13 years≤10.2
    14–17 years≤11.9
    Adult early follicular≤0.6
    Adult late follicular≤14.5
    Adult mid-cycle≤16.1
    Adult luteal≤31.4
    Postmenopausal≤0.2

    Progesterone levels in males: ≤1.2 ng/mL (age 5–17 years) and ≤0.3 ng/mL (adult).

    Wu (2006)

    Wu, A. H. B. (2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition. St Louis: Saunders/Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF] [Alt]:

    Table: Progesterone levels in cisgender girls and women (RIA):

    Life stageRange (ng/dL)
    Tanner stage 1≤0.33
    Tanner stage 2≤0.55
    Tanner stage 3≤4.5
    Tanner stage 4≤13.0
    Tanner stage 5≤9.5
    Adult follicular0.15–0.70
    Adult luteal2.0–25.0
    Adult postmenopausal≤0.40
    Pregnancy first trimester10.3–44.0
    Pregnancy second trimester19.5–82.5
    Pregnancy third trimester65.0–229.0

    Progesterone levels in males: <0.10–1.1 ng/mL (age 1–10 years + puberty) and 0.13–0.97 ng/mL (adult).

    Note: RIA gives less accurate and often overestimated values relative to MS-based techniques.

    Kühnel (2000)

    Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]:

    Table: Progesterone levels in cisgender girls and women (IA):

    Life stage / age (years)nMedian (ng/mL)Range (variable) (ng/mL)
    7–8 years240.500.25–0.99
    9–10 years400.550.13–1.00
    11 years220.660.37–0.92
    12 years170.780.49–1.68
    13 years250.720.40–1.46
    14 years301.200.56–12.3
    15 years481.400.70–13.4
    16 years405.00.65–14.5
    17 years301.400.77–11.3
    18–19 years122.41.27–13.0
    Tanner stage 1280.460.23–0.77
    Tanner stage 2–3700.700.36–2.2
    Tanner stage 4301.250.57–9.5
    Tanner stage 5662.40.75–14.6
    Adult follicular3820.47ND–1.13
    Adult mid-follicular (days 5–11)1860.43ND–0.98
    Adult mid-cycle271.060.48–1.72
    Adult luteal3238.90.95–21
    Adult mid-luteal (days 7–8)5413.16.0–24
    Pregnancy first trimester2822.29.3–33.2
    Pregnancy second trimester1035.429.5–50.0
    Pregnancy third trimester810283.1–160

    Abbreviations/etc.: n = tests, not subjects; range = 90%, 95%, or absolute range; ND = not detectable.

    Note: IA gives less accurate and often overestimated values relative to MS-based techniques.

    Other Studies

    • Ceglarek, U., Werner, M., Kortz, L., Körner, A., Kiess, W., Thiery, J., & Kratzsch, J. (2010). Preclinical challenges in steroid analysis of human samples. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 505–512. [DOI:10.1016/j.jsbmb.2010.03.039]

    Androgen Levels

    Esoterix/LabCorp (2020)

    Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]:

    Table: Total testosterone levels in cisgender girls and women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.24.9<2.5–10
    Tanner stage 29.2–13.7187–28
    Tanner stage 310.0–14.42515–35
    Tanner stage 410.7–15.62213–32
    Tanner stage 511.8–18.62820–38
    Adult premenopausal>18.0?10–55
    Adult postmenopausal⪆50 years?7–40

    Table: Dihydrotesterone (DHT) levels in cisgender girls and women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.2?<3
    Tanner stage 29.2–13.785–12
    Tanner stage 310.0–14.4127–19
    Tanner stage 410.7–15.674–13
    Tanner stage 511.8–18.693–18
    Adult>18.0?4–22

    Table: Androstenedione levels in cisgender girls and women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.2<10<10–17
    Tanner stage 29.2–13.73310–72
    Tanner stage 310.0–14.49750–170
    Tanner stage 410.7–15.610547–208
    Tanner stage 511.8–18.613750–224
    Adult premenopausal18–40 years?28–230
    Adult postmenopausal⪆50 years?<10–93

    Table: Dehydroepiandrosterone sulfate (DHEA-S) levels in cisgender girls/women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.24019–144
    Tanner stage 29.2–13.77234–129
    Tanner stage 310.0–14.48832–226
    Tanner stage 410.7–15.612058–260
    Tanner stage 511.8–18.614844–248
    Adult premenopausal18–50 years?17–372
    Adult postmenopausal⪆50 years?<215

    ARUP Laboratories (Undated)

    ARUP Laboratories. (Undated). Testosterone, Free and Total, Includes Sex Hormone-Binding Globulin (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy). ARUP Laboratories. [URL] [Alt]:

    Table: Total and free testosterone levels in cisgender girls and women (LC–MS/MS):

    Life stage / ageTotal: Range (ng/dL)Free: Range (pg/mL)
    Tanner stage 12–17 ng/dL<2.2
    Tanner stage 25–40 ng/dL0.4–4.5
    Tanner stage 310–63 ng/dL1.3–7.5
    Tanner stage 411–62 ng/dL1.1–15.5
    Tanner stage 511–62 ng/dL0.8–9.2
    1–6 years<30 ng/dL<0.6
    7–9 years1–11 ng/dL0.6–1.8
    10–11 years3–32 ng/dL0.1–3.5
    12–13 years6–50 ng/dL0.9–6.8
    14–15 years6–52 ng/dL1.2–7.5
    16–17 years9–58 ng/dL1.2–9.9
    18–30 years9–55 ng/dL0.8–7.4
    31–40 years9–55 ng/dL1.3–9.2
    41–51 years9–55 ng/dL1.1–5.8
    Postmenopausal5–32 ng/dL0.6–3.8

    Other Studies

    • Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Pattison, E. G., Bunker, A. M., Fitzgerald, R. L., & Meikle, A. W. (2006). Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clinical Chemistry, 52(1), 120–128. [DOI:10.1373/clinchem.2005.052167]
    • Kushnir, M. M., Blamires, T., Rockwood, A. L., Roberts, W. L., Yue, B., Erdogan, E., Bunker, A. M., & Meikle, A. W. (2010). LC-MS/MS assay for androstenedione, dehydroepiandrosterone and testosterone with pediatric and adult reference intervals. Clinical Chemistry, 56(7), 1138–1147. [DOI:10.1373/clinchem.2010.143222]

    Prolactin Levels

    • Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]

    References

    • Ankarberg-Lindgren, C., & Norjavaara, E. (2009). Are Estradiol Results Determined by the Tandem Mass Spectrometry Assay Clinically Useful for Children? American Journal of Clinical Pathology, 131(5), 746–750. [DOI:10.1309/ajcpnanprf50lchn]
    • Ankarberg-Lindgren, C., & Norjavaara, E. (2009). Estradiol in Pediatric Endocrinology. American Journal of Clinical Pathology, 132(6), 978–980. [DOI:10.1309/ajcpa65ouufasoan]
    • Ankarberg-Lindgren, C., Dahlgren, J., & Andersson, M. X. (2018). High-sensitivity quantification of serum androstenedione, testosterone, dihydrotestosterone, estrone and estradiol by gas chromatography–tandem mass spectrometry with sex-and puberty-specific reference intervals. The Journal of Steroid Biochemistry and Molecular Biology, 183, 116–124. [DOI:10.1016/j.jsbmb.2018.06.005]
    • ARUP Laboratories. (Undated). Testosterone, Free and Total, Includes Sex Hormone-Binding Globulin (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy). ARUP Laboratories. [URL] [Alt]:
    • Bae, Y. J., Zeidler, R., Baber, R., Vogel, M., Wirkner, K., Loeffler, M., Ceglarek, U., Kiess, W., Körner, A., Thiery, J., & Kratzsch, J. (2019). Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: Effect of age, gender, puberty, and oral contraceptives. The Journal of Steroid Biochemistry and Molecular Biology, 193, 105409. [DOI:10.1016/j.jsbmb.2019.105409]
    • Biro, F. M., Pinney, S. M., Huang, B., Baker, E. R., Walt Chandler, D., & Dorn, L. D. (2014). Hormone changes in peripubertal girls. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3829–3835. [DOI:10.1210/jc.2013-4528]
    • Ceglarek, U., Werner, M., Kortz, L., Körner, A., Kiess, W., Thiery, J., & Kratzsch, J. (2010). Preclinical challenges in steroid analysis of human samples. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 505–512. [DOI:10.1016/j.jsbmb.2010.03.039]
    • Courant, F., Aksglaede, L., Antignac, J. P., Monteau, F., Sorensen, K., Andersson, A. M., Skakkebaek, N. E., Juul, A., & Bizec, B. L. (2010). Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. The Journal of Clinical Endocrinology & Metabolism, 95(1), 82–92. [DOI:10.1210/jc.2009-1140]
    • Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]
    • Fisher, D. A., Salameh, W., & Furlanetto, R. W. (2007). [The Quest Diagnostics Manual:] Endocrinology: Test Selection and Interpretation, 4th Edition. San Juan Capistrano, California: Quest Diagnostics. [Google Scholar] [Google Books] [WorldCat] [PDF] [Alt PDF]
    • Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., Main, K. M., Andersson, A. M., & Juul, A. (2020). Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS. The Journal of Clinical Endocrinology & Metabolism, 105(3), 754–768. [DOI:10.1210/clinem/dgz196]
    • Janfaza, M., Sherman, T. I., Larmore, K. A., Brown-Dawson, J., & Klein, K. O. (2006). Estradiol levels and secretory dynamics in normal girls and boys as determined by an ultrasensitive bioassay: a 10 year experience. Journal of Pediatric Endocrinology and Metabolism, 19(7), 901–910. [DOI:10.1515/JPEM.2006.19.7.901]
    • Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Pattison, E. G., Bunker, A. M., Fitzgerald, R. L., & Meikle, A. W. (2006). Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clinical Chemistry, 52(1), 120–128. [DOI:10.1373/clinchem.2005.052167]
    • Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]
    • Kushnir, M. M., Rockwood, A. L., Bergquist, J., Varshavsky, M., Roberts, W. L., Yue, B., Bunker, A. M., & Meikle, A. W. (2008). High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. American Journal of Clinical Pathology, 129(4), 530–539. [DOI:10.1309/LC03BHQ5XJPJYEKG]
    • Kushnir, M. M., Blamires, T., Rockwood, A. L., Roberts, W. L., Yue, B., Erdogan, E., Bunker, A. M., & Meikle, A. W. (2010). LC-MS/MS assay for androstenedione, dehydroepiandrosterone and testosterone with pediatric and adult reference intervals. Clinical Chemistry, 56(7), 1138–1147. [DOI:10.1373/clinchem.2010.143222]
    • Madsen, A., Bruserud, I. S., Bertelsen, B. E., Roelants, M., Oehme, N. H. B., Viste, K., Bjerknes, R., Almås, B., Rosendahl, K., Mellgren, G., Sagen, J. V., & Juliusson, P. B. (2020). Hormone references for ultrasound breast staging and endocrine profiling to detect female onset of puberty. The Journal of Clinical Endocrinology & Metabolism, 105(12), e4886–e4895. [DOI:10.1210/clinem/dgaa679]
    • Wu, A. H. B. (2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition. St Louis: Saunders/Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    \ No newline at end of file +Hormone Levels During Normal Puberty in Cisgender Girls - Transfeminine Science Link

    Hormone Levels During Normal Puberty in Cisgender Girls

    By Aly | First published April 29, 2020 | Last modified April 7, 2023

    Preface

    This is a collection of published data on hormone levels throughout normal puberty in cisgender girls. Levels of estrogens (estradiol and estrone), progesterone, and androgens are included. Data are limited to those determined with mass spectrometry-based analytic techniques wherever available.

    Estrogen Levels

    Esoterix/LabCorp (2020)

    Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]:

    Table: Estradiol and estrone levels in cisgender girls and women (HPLC–MS/MS):

      Estradiol Estrone 
    Life stageAge (years)Mean (pg/mL)Range (pg/mL)Mean (pg/mL)Range (pg/mL)
    Tanner stage 1<9.28.05.0–20134.0–29
    Tanner stage 29.2–13.71610–242110–33
    Tanner stage 310.0–14.4257.0–603015–43
    Tanner stage 410.7–15.64721–853616–77
    Tanner stage 511.8–18.611034–1706129–105
    Adult follicular>18.0?30–100?30–100
    Adult luteal>18.0?70–300?90–160

    Figure: Mean (± ref. range) estradiol and estrone levels in normal female puberty (HPLC–MS/MS):

    Frederiksen et al. (2020)

    Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., Main, K. M., Andersson, A. M., & Juul, A. (2020). Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS. The Journal of Clinical Endocrinology & Metabolism, 105(3), 754–768. [DOI:10.1210/clinem/dgz196]:

    (The graphs below were created from analysis of this study by Sam.)

    Figure: Mean (± SD) estradiol and estrone levels in normal female puberty (LC–MS/MS):

    Figure: Median (± SD) estradiol and estrone levels in normal female puberty (LC–MS/MS):

    The lower estradiol and estrone levels in TS5 relative to TS4 are likely due to sampling error.

    Kushnir et al. (2008)

    Kushnir, M. M., Rockwood, A. L., Bergquist, J., Varshavsky, M., Roberts, W. L., Yue, B., Bunker, A. M., & Meikle, A. W. (2008). High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. American Journal of Clinical Pathology, 129(4), 530–539. [DOI:10.1309/LC03BHQ5XJPJYEKG]:

    Table: Estradiol and estrone levels in cisgender girls and women (LC–MS/MS):

     EstradiolEstrone
    Life stage or age (years)Ref. range (pg/mL)Ref. range (pg/mL)
    Tanner stage 1<55<26
    Tanner stage 22–1331–39
    Tanner stage 312–2778–117
    Tanner stage 4/52–2594–109
    Before menarche1–84<41
    After menarche3–2644–113
    7–9 years<35<25
    10–12 years<87<42
    13–15 years9–2488–105
    16–17 years2–2664–133
    Postmenopausal (41–63 years)2–213–32

    Figure: Median estradiol and estrone levels around puberty in cisgender girls (LC–MS/MS):

    It should be noted however that this study has been criticized on methodological grounds (Ankarberg-Lindgren & Norjavaara, 2009a; Ankarberg-Lindgren & Norjavaara, 2009b).

    Janfaza et al. (2006)

    Janfaza, M., Sherman, T. I., Larmore, K. A., Brown-Dawson, J., & Klein, K. O. (2006). Estradiol levels and secretory dynamics in normal girls and boys as determined by an ultrasensitive bioassay: a 10 year experience. Journal of Pediatric Endocrinology and Metabolism, 19(7), 901–910. [DOI:10.1515/JPEM.2006.19.7.901]:

    Table: Estradiol levels in 375 cisgender girls (RCBA—ultrasensitive recombinant cell bioassay):

    Pubertal stagenMean age (years)Mean estradiol (pg/mL)Estradiol range (pg/mL)
    11478.7 ± 1.71.6 ± 2.6<0.02–18
    26811.1 ± 1.16.9 ± 1.1<0.02–40
    35511.9 ± 1.123 ± 33<0.02–147
    46813.4 ± 1.427 ± 380.10–270
    53715.0 ± 1.648 ± 650.49–306

    Madsen et al. (2020)

    Madsen, A., Bruserud, I. S., Bertelsen, B. E., Roelants, M., Oehme, N. H. B., Viste, K., Bjerknes, R., Almås, B., Rosendahl, K., Mellgren, G., Sagen, J. V., & Juliusson, P. B. (2020). Hormone references for ultrasound breast staging and endocrine profiling to detect female onset of puberty. The Journal of Clinical Endocrinology & Metabolism, 105(12), e4886–e4895. [DOI:10.1210/clinem/dgaa679]:

    Table: Estradiol and estrone levels in cisgender girls (LC–MS/MS):

    Estradiol (pg/mL)Estrone (pg/mL)
    Tanner stagenMedianRange (2.5–97.5%)MedianRange (2.5–97.5%)
    B12601.30.24–103.81.2–10
    B2696.51.6–569.23.5–32
    B363–66251.2–77213.2–52
    B473–78487.1–2193211–108
    B576–814113–2683615–129

    Other Studies

    • Courant, F., Aksglaede, L., Antignac, J. P., Monteau, F., Sorensen, K., Andersson, A. M., Skakkebaek, N. E., Juul, A., & Bizec, B. L. (2010). Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. The Journal of Clinical Endocrinology & Metabolism, 95(1), 82–92. [DOI:10.1210/jc.2009-1140]
    • Biro, F. M., Pinney, S. M., Huang, B., Baker, E. R., Walt Chandler, D., & Dorn, L. D. (2014). Hormone changes in peripubertal girls. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3829–3835. [DOI:10.1210/jc.2013-4528]
    • Ankarberg-Lindgren, C., Dahlgren, J., & Andersson, M. X. (2018). High-sensitivity quantification of serum androstenedione, testosterone, dihydrotestosterone, estrone and estradiol by gas chromatography–tandem mass spectrometry with sex-and puberty-specific reference intervals. The Journal of Steroid Biochemistry and Molecular Biology, 183, 116–124. [DOI:10.1016/j.jsbmb.2018.06.005]
      • Note: Has estrone sulfate levels in the different Tanner breast stages.
    • Bae, Y. J., Zeidler, R., Baber, R., Vogel, M., Wirkner, K., Loeffler, M., Ceglarek, U., Kiess, W., Körner, A., Thiery, J., & Kratzsch, J. (2019). Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: Effect of age, gender, puberty, and oral contraceptives. The Journal of Steroid Biochemistry and Molecular Biology, 193, 105409. [DOI:10.1016/j.jsbmb.2019.105409]

    Progesterone Levels

    Esoterix/LabCorp (2020)

    Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF] [Alt] [Alt]:

    Table: Progesterone levels in cisgender girls and women (HPLC–MS/MS):

    Life stage / age (years)Range (ng/mL)
    <10 years≤0.26
    11 years≤2.6
    12 years≤8.6
    13 years≤6.9
    14 years≤12.0
    15 years≤10.8
    16 years≤12.9
    Adult early follicular (days 1–6)≤0.17
    Adult late follicular (days 7–12)≤1.4
    Adult mid-cycle (days 13–15)≤15.6
    Adult luteal (days 16–28)*≤25.6
    Postmenopausal≤0.10
    Pregnancy first trimester6.3–45.5
    Pregnancy second trimester15.4–52.1
    Pregnancy third trimester25.0–99.9

    Note: Luteal progesterone peaked from 3.5 to 37.5 ng/dL ranging on cycle days 17 to 23.

    Progesterone levels in males: ≤0.15 ng/mL (age 1–16 years) and ≤0.11 ng/mL (adult).

    Fisher, Salameh, & Furlanetto / Quest Diagnostics (2007)

    Fisher, D. A., Salameh, W., & Furlanetto, R. W. (2007). [The Quest Diagnostics Manual:] Endocrinology: Test Selection and Interpretation, 4th Edition. San Juan Capistrano, California: Quest Diagnostics. [Google Scholar] [Google Books] [WorldCat] [PDF] [Alt PDF] [Alt]:

    Table: Progesterone levels in cisgender girls and women (LC–MS/MS):

    Life stage / ageRange (ng/mL)
    5–9 years≤0.6
    10–13 years≤10.2
    14–17 years≤11.9
    Adult early follicular≤0.6
    Adult late follicular≤14.5
    Adult mid-cycle≤16.1
    Adult luteal≤31.4
    Postmenopausal≤0.2

    Progesterone levels in males: ≤1.2 ng/mL (age 5–17 years) and ≤0.3 ng/mL (adult).

    Wu (2006)

    Wu, A. H. B. (2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition. St Louis: Saunders/Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF] [Alt]:

    Table: Progesterone levels in cisgender girls and women (RIA):

    Life stageRange (ng/dL)
    Tanner stage 1≤0.33
    Tanner stage 2≤0.55
    Tanner stage 3≤4.5
    Tanner stage 4≤13.0
    Tanner stage 5≤9.5
    Adult follicular0.15–0.70
    Adult luteal2.0–25.0
    Adult postmenopausal≤0.40
    Pregnancy first trimester10.3–44.0
    Pregnancy second trimester19.5–82.5
    Pregnancy third trimester65.0–229.0

    Progesterone levels in males: <0.10–1.1 ng/mL (age 1–10 years + puberty) and 0.13–0.97 ng/mL (adult).

    Note: RIA gives less accurate and often overestimated values relative to MS-based techniques.

    Kühnel (2000)

    Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]:

    Table: Progesterone levels in cisgender girls and women (IA):

    Life stage / age (years)nMedian (ng/mL)Range (variable) (ng/mL)
    7–8 years240.500.25–0.99
    9–10 years400.550.13–1.00
    11 years220.660.37–0.92
    12 years170.780.49–1.68
    13 years250.720.40–1.46
    14 years301.200.56–12.3
    15 years481.400.70–13.4
    16 years405.00.65–14.5
    17 years301.400.77–11.3
    18–19 years122.41.27–13.0
    Tanner stage 1280.460.23–0.77
    Tanner stage 2–3700.700.36–2.2
    Tanner stage 4301.250.57–9.5
    Tanner stage 5662.40.75–14.6
    Adult follicular3820.47ND–1.13
    Adult mid-follicular (days 5–11)1860.43ND–0.98
    Adult mid-cycle271.060.48–1.72
    Adult luteal3238.90.95–21
    Adult mid-luteal (days 7–8)5413.16.0–24
    Pregnancy first trimester2822.29.3–33.2
    Pregnancy second trimester1035.429.5–50.0
    Pregnancy third trimester810283.1–160

    Abbreviations/etc.: n = tests, not subjects; range = 90%, 95%, or absolute range; ND = not detectable.

    Note: IA gives less accurate and often overestimated values relative to MS-based techniques.

    Other Studies

    • Ceglarek, U., Werner, M., Kortz, L., Körner, A., Kiess, W., Thiery, J., & Kratzsch, J. (2010). Preclinical challenges in steroid analysis of human samples. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 505–512. [DOI:10.1016/j.jsbmb.2010.03.039]

    Androgen Levels

    Esoterix/LabCorp (2020)

    Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]:

    Table: Total testosterone levels in cisgender girls and women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.24.9<2.5–10
    Tanner stage 29.2–13.7187–28
    Tanner stage 310.0–14.42515–35
    Tanner stage 410.7–15.62213–32
    Tanner stage 511.8–18.62820–38
    Adult premenopausal>18.0?10–55
    Adult postmenopausal⪆50 years?7–40

    Table: Dihydrotesterone (DHT) levels in cisgender girls and women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.2?<3
    Tanner stage 29.2–13.785–12
    Tanner stage 310.0–14.4127–19
    Tanner stage 410.7–15.674–13
    Tanner stage 511.8–18.693–18
    Adult>18.0?4–22

    Table: Androstenedione levels in cisgender girls and women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.2<10<10–17
    Tanner stage 29.2–13.73310–72
    Tanner stage 310.0–14.49750–170
    Tanner stage 410.7–15.610547–208
    Tanner stage 511.8–18.613750–224
    Adult premenopausal18–40 years?28–230
    Adult postmenopausal⪆50 years?<10–93

    Table: Dehydroepiandrosterone sulfate (DHEA-S) levels in cisgender girls/women (HPLC–MS/MS):

    Life stageAge (years)Mean (ng/dL)Range (ng/dL)
    Tanner stage 1<9.24019–144
    Tanner stage 29.2–13.77234–129
    Tanner stage 310.0–14.48832–226
    Tanner stage 410.7–15.612058–260
    Tanner stage 511.8–18.614844–248
    Adult premenopausal18–50 years?17–372
    Adult postmenopausal⪆50 years?<215

    ARUP Laboratories (Undated)

    ARUP Laboratories. (Undated). Testosterone, Free and Total, Includes Sex Hormone-Binding Globulin (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy). ARUP Laboratories. [URL] [Alt]:

    Table: Total and free testosterone levels in cisgender girls and women (LC–MS/MS):

    Life stage / ageTotal: Range (ng/dL)Free: Range (pg/mL)
    Tanner stage 12–17 ng/dL<2.2
    Tanner stage 25–40 ng/dL0.4–4.5
    Tanner stage 310–63 ng/dL1.3–7.5
    Tanner stage 411–62 ng/dL1.1–15.5
    Tanner stage 511–62 ng/dL0.8–9.2
    1–6 years<30 ng/dL<0.6
    7–9 years1–11 ng/dL0.6–1.8
    10–11 years3–32 ng/dL0.1–3.5
    12–13 years6–50 ng/dL0.9–6.8
    14–15 years6–52 ng/dL1.2–7.5
    16–17 years9–58 ng/dL1.2–9.9
    18–30 years9–55 ng/dL0.8–7.4
    31–40 years9–55 ng/dL1.3–9.2
    41–51 years9–55 ng/dL1.1–5.8
    Postmenopausal5–32 ng/dL0.6–3.8

    Other Studies

    • Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Pattison, E. G., Bunker, A. M., Fitzgerald, R. L., & Meikle, A. W. (2006). Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clinical Chemistry, 52(1), 120–128. [DOI:10.1373/clinchem.2005.052167]
    • Kushnir, M. M., Blamires, T., Rockwood, A. L., Roberts, W. L., Yue, B., Erdogan, E., Bunker, A. M., & Meikle, A. W. (2010). LC-MS/MS assay for androstenedione, dehydroepiandrosterone and testosterone with pediatric and adult reference intervals. Clinical Chemistry, 56(7), 1138–1147. [DOI:10.1373/clinchem.2010.143222]

    Prolactin Levels

    • Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]

    References

    • Ankarberg-Lindgren, C., & Norjavaara, E. (2009). Are Estradiol Results Determined by the Tandem Mass Spectrometry Assay Clinically Useful for Children? American Journal of Clinical Pathology, 131(5), 746–750. [DOI:10.1309/ajcpnanprf50lchn]
    • Ankarberg-Lindgren, C., & Norjavaara, E. (2009). Estradiol in Pediatric Endocrinology. American Journal of Clinical Pathology, 132(6), 978–980. [DOI:10.1309/ajcpa65ouufasoan]
    • Ankarberg-Lindgren, C., Dahlgren, J., & Andersson, M. X. (2018). High-sensitivity quantification of serum androstenedione, testosterone, dihydrotestosterone, estrone and estradiol by gas chromatography–tandem mass spectrometry with sex-and puberty-specific reference intervals. The Journal of Steroid Biochemistry and Molecular Biology, 183, 116–124. [DOI:10.1016/j.jsbmb.2018.06.005]
    • ARUP Laboratories. (Undated). Testosterone, Free and Total, Includes Sex Hormone-Binding Globulin (Adult Females, Children, or Individuals on Testosterone-Suppressing Hormone Therapy). ARUP Laboratories. [URL] [Alt]:
    • Bae, Y. J., Zeidler, R., Baber, R., Vogel, M., Wirkner, K., Loeffler, M., Ceglarek, U., Kiess, W., Körner, A., Thiery, J., & Kratzsch, J. (2019). Reference intervals of nine steroid hormones over the life-span analyzed by LC-MS/MS: Effect of age, gender, puberty, and oral contraceptives. The Journal of Steroid Biochemistry and Molecular Biology, 193, 105409. [DOI:10.1016/j.jsbmb.2019.105409]
    • Biro, F. M., Pinney, S. M., Huang, B., Baker, E. R., Walt Chandler, D., & Dorn, L. D. (2014). Hormone changes in peripubertal girls. The Journal of Clinical Endocrinology & Metabolism, 99(10), 3829–3835. [DOI:10.1210/jc.2013-4528]
    • Ceglarek, U., Werner, M., Kortz, L., Körner, A., Kiess, W., Thiery, J., & Kratzsch, J. (2010). Preclinical challenges in steroid analysis of human samples. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 505–512. [DOI:10.1016/j.jsbmb.2010.03.039]
    • Courant, F., Aksglaede, L., Antignac, J. P., Monteau, F., Sorensen, K., Andersson, A. M., Skakkebaek, N. E., Juul, A., & Bizec, B. L. (2010). Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. The Journal of Clinical Endocrinology & Metabolism, 95(1), 82–92. [DOI:10.1210/jc.2009-1140]
    • Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]
    • Fisher, D. A., Salameh, W., & Furlanetto, R. W. (2007). [The Quest Diagnostics Manual:] Endocrinology: Test Selection and Interpretation, 4th Edition. San Juan Capistrano, California: Quest Diagnostics. [Google Scholar] [Google Books] [WorldCat] [PDF] [Alt PDF]
    • Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., Main, K. M., Andersson, A. M., & Juul, A. (2020). Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS. The Journal of Clinical Endocrinology & Metabolism, 105(3), 754–768. [DOI:10.1210/clinem/dgz196]
    • Janfaza, M., Sherman, T. I., Larmore, K. A., Brown-Dawson, J., & Klein, K. O. (2006). Estradiol levels and secretory dynamics in normal girls and boys as determined by an ultrasensitive bioassay: a 10 year experience. Journal of Pediatric Endocrinology and Metabolism, 19(7), 901–910. [DOI:10.1515/JPEM.2006.19.7.901]
    • Kushnir, M. M., Rockwood, A. L., Roberts, W. L., Pattison, E. G., Bunker, A. M., Fitzgerald, R. L., & Meikle, A. W. (2006). Performance characteristics of a novel tandem mass spectrometry assay for serum testosterone. Clinical Chemistry, 52(1), 120–128. [DOI:10.1373/clinchem.2005.052167]
    • Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]
    • Kushnir, M. M., Rockwood, A. L., Bergquist, J., Varshavsky, M., Roberts, W. L., Yue, B., Bunker, A. M., & Meikle, A. W. (2008). High-sensitivity tandem mass spectrometry assay for serum estrone and estradiol. American Journal of Clinical Pathology, 129(4), 530–539. [DOI:10.1309/LC03BHQ5XJPJYEKG]
    • Kushnir, M. M., Blamires, T., Rockwood, A. L., Roberts, W. L., Yue, B., Erdogan, E., Bunker, A. M., & Meikle, A. W. (2010). LC-MS/MS assay for androstenedione, dehydroepiandrosterone and testosterone with pediatric and adult reference intervals. Clinical Chemistry, 56(7), 1138–1147. [DOI:10.1373/clinchem.2010.143222]
    • Madsen, A., Bruserud, I. S., Bertelsen, B. E., Roelants, M., Oehme, N. H. B., Viste, K., Bjerknes, R., Almås, B., Rosendahl, K., Mellgren, G., Sagen, J. V., & Juliusson, P. B. (2020). Hormone references for ultrasound breast staging and endocrine profiling to detect female onset of puberty. The Journal of Clinical Endocrinology & Metabolism, 105(12), e4886–e4895. [DOI:10.1210/clinem/dgaa679]
    • Wu, A. H. B. (2006). Tietz Clinical Guide to Laboratory Tests, 4th Edition. St Louis: Saunders/Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    \ No newline at end of file diff --git a/transfemscience.org/articles/hormones-fat-metabolism-suppl/index.html b/transfemscience.org/articles/hormones-fat-metabolism-suppl/index.html index f077a53f..b7357bf5 100644 --- a/transfemscience.org/articles/hormones-fat-metabolism-suppl/index.html +++ b/transfemscience.org/articles/hormones-fat-metabolism-suppl/index.html @@ -1 +1 @@ -Sources/Excerpts: On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy - Transfeminine Science Link

    Sources/Excerpts: On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy

    By Lain | First published September 4, 2019 | Last modified October 5, 2020

    Preface

    These are my raw notes that include a large number of raw quotes from various source materials as well as some thoughts of mine. These are far more detailed than my writeup and again are largely just quotes. This page is a supplement and the main article can be found here.

    Pedersen et al. (2004)

    Pedersen, S. B., Kristensen, K., Hermann, P. A., Katzenellenbogen, J. A., & Richelsen, B. (2004). Estrogen Controls Lipolysis by Up-Regulating α2A-Adrenergic Receptors Directly in Human Adipose Tissue through the Estrogen Receptor α. Implications for the Female Fat Distribution. The Journal of Clinical Endocrinology & Metabolism, 89(4), 1869–1878. [DOI:10.1210/jc.2003-031327]

    Power & Schulkin (1998)

    Power, M. L., & Schulkin, J. (2008). Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. British Journal of Nutrition, 99(5), 931–940. [DOI:10.1017/s0007114507853347]:

    Women have greater adipose stores in thighs and buttocks(8); men tend to be more likely to have significant amounts of abdominal fat, and to be more susceptible to abdominal adiposity(8). Women have larger stores of subcutaneous fat; men are more likely to have visceral fat(11).

    Interestingly, not only do men on average have a greater proportion of fat as visceral fat, it would appear that turnover of visceral fat is higher in men compared with women. Men have consistently been shown to have greater rates of both fatty acid release (lipolysis) and fatty acid uptake (lipogenesis) in visceral fat compared with women(6). Adrenergic stimulation increases splanchnic fatty acid release in men but not in women(24). Thus, not only are men more susceptible to excess visceral fat, the effects of visceral fat on health may differ between the sexes as well.

    At rest, women shunt more circulating NEFA into re-esterification pathways than do men(32). Women have higher VLDL-TAG production rates than men, but similar circulating concentrations(7). This is further evidence that women have higher rates of re-esterfication and thus reuptake of NEFA into adipose tissue than do men. In the basal condition, women are physiologically adapted to store fat more so than are men.

    Women have higher rates of fat uptake into leg fat depots than do men(33). Rates of fatty acid release from abdominal adipose tissue are higher in women than men, but they are lower from gluteal or femoral adipose tissue(6). After feeding, fatty acid uptake is higher in abdominal adipose tissue relative to gluteal or femoral in both men and women. However, in women the majority of fatty acid uptake in abdominal adipose tissue is into subcutaneous fat, while in men a larger proportion goes into visceral fat(6). These findings are consistent with women being more likely to store fat subcutaneously and preferentially in the gluteal and femoral regions compared with men.

    Women have higher rates of fat oxidation than men during sustained bouts of increased energy expenditure, such as endurance training. Men are more likely to up regulate glucose and amino acid metabolism during sustained exercise bouts(34,35). The difference is associated with oestrogen. Giving exogenous oestrogen to males decreases carbohydrate and amino acid metabolism during exercise, and increases fat oxidation(36). Thus it would appear that women are more physiologically geared to use fat as a metabolic fuel under conditions of sustained increased demand, while men rely more on glucose and protein metabolism.

    Testosterone acts to increase lipolysis, inhibit lipoprotein lipase activity, and decrease TAG accumulation in adipose tissue. Lowering circulating testosterone levels in healthy young men increases total adipose tissue, with the largest percentage increase occurring in subcutaneous adipose tissue; raising circulating testosterone decreases total adipose tissue(37). Oestrogens play multiple roles in the regulation of adipose tissue, in both men and women. Oestradiol has direct effects on adipose tissue, and also acts centrally to affect food intake and energy expenditure. Androgens appear to block proliferation and differentiation of preadipocytes(38). Oestradiol enhances proliferation of preadipocytes from both men and women in vitro(39). The effect was greater in preadipoces from females compared with those from males.

    Adipose tissues express both androgen and oestrogen receptors. Visceral fat has higher levels of androgen and oestrogen receptors than does subcutaneous fat, and this is true for both men and women(42). Both the a and b oestrogen receptors are found in adipose tissue(41). In subcutaneous fat, oestradiol acts through the a receptor to up regulate α2A-adrenergic receptors which results in decreased lipolysis. In contrast, oestradiol does not appear to affect the concentration of α2A-adrenergic receptors in adipocytes from visceral fat(41). Subcutaneous adipocytes from premenopausal women have higher α2A-adrenergic receptor density and lower lipolytic activity in response to adrenaline than do subcutaneous adipocytes from men(43).

    Adipose tissue serves as an endocrine organ, producing leptin and many other regulatory peptides (Table 1). Adipose tissue is a source of steroids, either stored or metabolically converted from precursors. For example, oestrone is converted to oestradiol and androstendione is converted to testosterone in adipose tissue (Table 1).

    Reubinoff et al. (1995)

    Reubinoff, B. E., Grubstein, A., Meirow, D., Berry, E., Schenker, J. G., & Brzezinski, A. (1995). Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertility and Sterility, 63(3), 516–521. [DOI:10.1016/s0015-0282(16)57419-6]:

    The levels of the enzyme lipoprotein lipase (LPL) activity in adipocytes serve as a reliable indicator of fat formation and accumulation. Lypolisis, on the other hand, is the enzymatic degradation of lipids within the adipocyte. During their reproductive period of life, women have a higher femoral than abdominal LPL activity (14).

    Progesterone stimulates femoral LPL activity, whereas T inhibits it. Estradiol (on a short-term basis) is lipolytic.

    Nedungadi & Clegg (2009)

    Nedungadi, T. P., & Clegg, D. J. (2009). Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases. Journal of Cardiovascular Translational Research, 2(3), 321–327. [DOI:10.1007/s12265-009-9101-1]:

    Lipoprotein lipase (LPL) is the major enzyme involved in the fatty acid uptake and is the key regulator of fat accumulation in various adipose tissues. Higher LPL tissue activity is associated with the development of abdominal visceral obesity. Men have a higher level of LPL activity than premenopausal women.

    The lipolytic pathway involves the breakdown of energy stored in the form of triglycerides and is initiated when the energy supply from the metabolic fuels is depleted. There is a higher amount of lipolytic activity in the visceral fat when compared to the subcutaneous fat in premenopausal women as compared to the post menopausal women lacking estrogen [37, 45, 46]. Hence, in women, there is less visceral obesity in comparison to men [34]. Catecholamines trigger lipolysis via α-1, α-2, and α-3 adrenergic receptors, while they inhibit lipolysis via the α-2 adrenergic receptors [35].

    In visceral adipose tissue, there is an increase in the expression of androgen receptors in males relative to estrogen receptors. Adipose tissue-specific androgen receptor knockout mice have increased intraadipose tissue estradiol levels, which precedes subcutaneous obesity [60].

    Body weight is regulated through coordinated metabolic processes. This includes peripheral signals called “adiposity signals” such as leptin and insulin [59], whose circulating levels are proportional to adipose tissue mass [13, 50]. These adiposity signals interact with the brain to regulate energy homeostasis. There are critical brain regions responsible for mediating these effects, specifically in the hypothalamus [47, 49]. Leptin and insulin have receptors in these critical brain regions and influence release and activity of different neuronal populations known to be involved in body weight regulation.

    Leptin is secreted at a higher rate from subcutaneous fat than from visceral fat, thus circulating leptin correlates better with total subcutaneous fat than with total body fat. Insulin secretion is better correlated with visceral fat; thus, its levels better reflect visceral rather than total body adiposity [58]. Male rats are relatively more sensitive to the catabolic action of insulin delivered into the brain [14], whereas female rats are relatively more sensitive to the catabolic action of leptin delivered into the brain [16]. A comparable phenomenon has been reported in a recent study in humans, suggesting that men lose more body weight and body fat and change their waist circumference following intranasal insulin administration when compared to women [61]. Intranasal insulin administration increases insulin concentration of the cerebrospinal fluid and thereby alters brain functions. Therefore, sexually differential sensitivity to the catabolic effects of insulin exists in rodents and humans.

    Uniquely, despite having higher circulating leptin levels, females have been demonstrated to be more sensitive to the anorexigenic effects of leptin [15]. Female rats are more responsive than males to the effects of centrally administered leptin to decrease food intake and body weight, and this has been demonstrated to be due to increased leptininduced Stat3 activation in the basal hypothalamus [5, 29]. So, an increase in the Stat3 signaling translates to an increase in the energy expenditure by leptin and also increased SNS regulation.

    Among the two major estrogen receptor subtypes, it is believed that ERα mediates the anti-obesity effect in both males and females [41, 43, 55]. Studies with ERα null mice demonstrated obesity and had a massive increase in the adipose tissue [32, 48], whereas ERβ null mice were not obese. Heine et al. reported that male and female mice with a targeted deletion in the ERα subunit have increased adiposity in both sexes.

    Clegg et al. (2006)

    Clegg, D. J., Brown, L. M., Woods, S. C., & Benoit, S. C. (2006). Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes, 55(4), 978–987. [DOI:10.2337/diabetes.55.04.06.db05-1339]:

    These data indicate that estrogen acts within the brain to increase leptin sensitivity, decrease insulin sensitivity, and favor subcutaneous over visceral fat.

    Thus, when systemic estrogen is present (intact females and males or OVX females administered subcutaneous estrogen), leptin is catabolic in the brain, whereas when estrogen is low (OVX females and intact males), leptin is relatively ineffective. Conversely, estrogen reduces the sensitivity of the brain to the anorexigenic action of insulin.

    An important implication from these findings is that gonadal steroids mediate body fat distribution and interact with the integrated adiposity message conveyed to the brain by leptin and insulin, resulting in differential sensitivity to these signals in males and females.

    This implies that the relative amount of androgens and estrogens is a key determinant of the brain’s sensitivity to the catabolic actions of insulin and leptin, with proportionally more estrogen favoring leptin sensitivity and proportionally less estrogen favoring insulin sensitivity. Finally, our data suggest that estrogen’s direct actions in the brain determine body fat distribution.

    Note: I would love to see a study of trans women who on GAHT gained or lost weight and correlations with different gene polymorphisms for estrogen receptor alpha and leptin receptors.

    Mauvais-Jarvis, Clegg, & Hevener (2013)

    Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]:

    In postmenopausal women, however, when the ovaries fail to produce E2 and in men—who have naturally low levels of circulating E2—E2 does not function as a circulating hormone; rather, it is synthesized in extragonadal sites such as breast, brain, muscle, bone, and adipose tissue where it acts locally as a paracrine or intracrine factor (8).

    EST is a cytosolic enzyme that provides a molecular switch in target cells that inhibits estrogen activity by conjugating a sulfonate group to estrogens, thereby preventing binding to estrogen receptors and enhancing urinary excretion of the hormone.

    Early studies of the reproductive actions of estrogens led to the establishment of a paradigm in which classical nuclear ERs acted as ligand-activated transcription factors (11). ER modulation of gene transcription is a highly dynamic process. The ER exists in 2 main forms, ER and ER, each of which has multiple isoforms and exhibit distinct tissue expression patterns and functions (12). The classical “genomic” mechanism of ER action typically occurs within hours, leading to activation or repression of target genes. In this classic signaling pathway, ligandactivated ER dissociates from its chaperone heat-shock protein and binds as a dimer either directly to an estrogen response element (ERE) in target gene promoters or indirectly to activator protein 1 or specificity protein 1 response elements through protein tethering to DNA (13). After binding, these ER dimers interact with cofactors (coactivators or cosuppressors) to regulate gene expression.

    Cellular estrogenic action depends on: 1) the ER signaling and sensitivity; 2) the activity of enzymes like aromatase involved in the biosynthesis of E2 from androgenic precursors; and 3) the inactivation of E2 in E2 sulfate (E2-S) by the estrogen sulfotransferase (EST).

    Although reproductive functions are mostly mediated via classical nuclear ER acting as ligand-activated transcription factors, a large component of ER actions related to energy metabolism also involves extranuclear ERs, indirectly modulating gene expression or acting independently of nuclear events (18). E2 can activate rapid signals Figure 1. Figure 1. Origin of circulating and tissue estrogens. A, In healthy premenopausal women, estrogen (E2) is produced by the ovaries and functions as a circulating hormone that acts on distant target tissues. Here WAT is represented. B, In postmenopausal women and in men, E2 does not function as a circulating hormone; rather, it is synthesized in extragonadal sites from circulating androgenic precursors such as T, androstenedione (4A), or dehydroepiandrosterone (DHEA). Cellular estrogenic action depends on: 1) the ER signaling and sensitivity; 2) the activity of enzymes like aromatase involved in the biosynthesis of E2 from androgenic precursors; and 3) the inactivation of E2 in E2 sulfate (E2-S) by the estrogen sulfotransferase (EST).

    E2 can activate rapid signals that act within seconds or minutes via extranuclear and membrane-associated forms of ERs (19). ER and ER are localized to caveolae where they congregate with other signaling molecules, thereby facilitating interaction and rapid intracellular signaling. These signal proteins include G proteins, growth factor receptors, tyrosine kinases (Src), linker proteins (MNAR), and orphan G protein-coupled receptors. This multiprotein complex provides the necessary interactions for membrane ER to activate growth factor receptors and G proteins. In turn, these E2-induced rapid signals modify protein function via phosphorylation. However, they can also modulate gene expression and thus the production of proteins.

    ER deficiency in both male and female mice causes increased body weight and adiposity predominately through reduced energy expenditure and slight increases in food intake.

    These effects of E2 are mediated via MC4 receptor because E2 is unable to induce anorexia when the MC4 receptor antagonists Shu 9119 or agouti-related peptide (AgRP) are applied concomitantly with E2 administration in rats (70).

    Mice with small hairpin RNA-mediated ERgene silencing as well as transgenic mice in which ER has been selectively deleted from SF1-containing neurons of the VMH, develop reduced sensitivity to E2-induced weight loss, increased visceral fat deposition, and reductions in energy expenditure. All of these results occur without an impact on food intake (60, 78), supporting the notion that ER signaling in VMN neurons plays an important role in regulating physical activity, thermogenesis, and fat distribution.

    Collectively, these findings suggest that ER in the brainstem, and specifically the [nucleus tractus solitarius (NTS)], is an additional site mediating the anorexigenic effects of estrogens.

    Subcutaneous adipose tissue permits efficient storage of maximal calories per unit volume of tissue.

    Estrogens are produced in the adipocytes (via aromatization from androgenic precursors) and increase in proportion to total body adiposity (132, 133).

    E2 also suppresses white adipose tissue (WAT) accumulation by decreasing fatty acid and triglyceride synthesis and lipogenesis.

    Extensive evidence demonstrates that E2 has direct effects on cultured adipocytes with the overall effect of inhibiting lipogenesis and adipogenesis.

    […] suggesting that the absence of E2 promotes immune cell inflammation. Indeed, circulating levels of proinflammatory cytokines are elevated in women after natural or surgical menopause.

    Macrophages are elemental players in innate and adaptive immunity; over the past decade their roles in modulating whole-body metabolism and insulin sensitivity have been topics of increasing interest (295, 296).

    […] EST terminates estrogen activity and represents an important parameter of estrogen output upstream of ER. With regard to metabolism, EST is highly expressed in WAT of male mice, but it is not detectable in WAT of normal cycling female mice (320).

    Note: Interesting to see if trans folks on GAHT have different type 2 diabetes probability than normal population.

    An obvious explanation for these observations is that EST expression is high in male WAT (320) to protect from excessive estrogen actions. It follows that EST suppression produces WAT estrogen excess leading to inflammation. Consistent with this possibility is the observation that E2 treatment leading to high blood concentrations produces WAT inflammation even in females (193).

    Note: Makes you wonder if there is potential for higher WAT inflammation in trans folks – especially whne many have E2 levels higher than folks with estrogen producing genitals.

    There are reports suggesting that oral E2 may exacerbate insulin resistance and adipocytokine parameters, worsening cardiovascular risk (329). Transdermal E2, however, has minimal effects on insulin resistance and results in higher adiponectin. This suggests that transdermal E2 may be a preferable treatment compared to oral CEE for obese women with metabolic syndrome.

    The authors concluded that in women without diabetes, both oral and transdermal estrogen, with or without progestin, increase lean body mass, reduce abdominal fat, improve insulin resistance, decrease LDL/high-density lipoprotein-cholesterol ratio, and decrease blood pressure.

    B. Effect of selective estrogen receptor modulators and aromatase inhibitors on metabolism.

    In fact, tamoxifen therapy in a case-control study breast cancer survivor was associated with a 24% increased risk of developing diabetes.

    In OVX mice, raloxifene reversed OVX-induced increases in food intake, body weight, fat mass, and hyperleptinemia to an extent similar to that of E2. This suggests that in rodents, raloxifene acts as an ER agonist in hypothalamic neurons and fat.

    Sullivan et al (356) looked at the effect of a novel SERM (GSK232802A) on body weight, food intake, physical activity, and metabolic rate in an OVX nonhuman primate model. They observed that GSK232802A produced a 5% decrease in weight and reduced adiposity by suppressing food intake and increasing activity. These results occurred without changes in energy expenditure, suggesting that GSK232802A treatment may counteract postmenopausal obesity (356).

    Schiffer et al. (2017)

    Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. W. (2017). MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. European Journal of Endocrinology, 177(3), R125–R143. [DOI:10.1530/eje-17-0124]:

    Delineating the specific effects of androgen deprivation therapy in this patient population is clouded by co-administration of relatively large doses of oestrogen. Male-to-female transgender patients on combined estrogen and anti-androgen treatment develop an adverse lipid profile.

    Cross-sectional studies analysing age-advanced men, men across different ages and obese vs non-obese men consistently support the association between low T and increased fat mass compared to eugonadal controls (107, 142, 143). BMI negatively correlates with total and free T (142, 144), and waist circumference is negatively associated with total T in men.

    T administration in men reduces accumulation of visceral and retroperitoneal fat compared to controls, but not in SC depots; hypogonadal men also have increased visceral fat mass.

    Mueller et al. (2011)

    Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074]:

    When the BMI values were compared, there was a significant increase during cross-sex hormone treatment with oestrogens in the absence of testosterone after 12 months and after 24 months. Moreover, total fat mass increased also during the study period, while total lean mass decreased significantly.

    Recently, Lapauw et al. reported that in MtFs treated with female steroid hormones over an average of 8 years, total lean mass was approximately 20% lower whereas total fat mass was about 30% higher in comparison with a male control group (Lapauw et al., 2008). In this study, transsexuals had been treated with either ethinyl oestradiol, oestradiol valerate, or conjugated equine oestrogens combined with cyproterone acetate (Lapauw et al., 2008).

    In MtFs treated with ethinyl oestradiol and antiandrogens, a significant increase in all subcutaneous fat depots, with a lesser but proportional and significant increase in the visceral fat depot and a decrease in thigh muscle area, was reported.

    With regard to body composition and bone mineral density, there appears to be no difference when GnRH agonists are used for complete androgen deprivation in MtFs. In comparison with commonly used hormone regimens, the complication rates appear to be lower in patients receiving the treatment regimen described here, as reported earlier.

    \ No newline at end of file +Sources/Excerpts: On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy - Transfeminine Science Link

    Sources/Excerpts: On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy

    By Lain | First published September 4, 2019 | Last modified October 5, 2020

    Preface

    These are my raw notes that include a large number of raw quotes from various source materials as well as some thoughts of mine. These are far more detailed than my writeup and again are largely just quotes. This page is a supplement and the main article can be found here.

    Pedersen et al. (2004)

    Pedersen, S. B., Kristensen, K., Hermann, P. A., Katzenellenbogen, J. A., & Richelsen, B. (2004). Estrogen Controls Lipolysis by Up-Regulating α2A-Adrenergic Receptors Directly in Human Adipose Tissue through the Estrogen Receptor α. Implications for the Female Fat Distribution. The Journal of Clinical Endocrinology & Metabolism, 89(4), 1869–1878. [DOI:10.1210/jc.2003-031327]

    Power & Schulkin (1998)

    Power, M. L., & Schulkin, J. (2008). Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. British Journal of Nutrition, 99(5), 931–940. [DOI:10.1017/s0007114507853347]:

    Women have greater adipose stores in thighs and buttocks(8); men tend to be more likely to have significant amounts of abdominal fat, and to be more susceptible to abdominal adiposity(8). Women have larger stores of subcutaneous fat; men are more likely to have visceral fat(11).

    Interestingly, not only do men on average have a greater proportion of fat as visceral fat, it would appear that turnover of visceral fat is higher in men compared with women. Men have consistently been shown to have greater rates of both fatty acid release (lipolysis) and fatty acid uptake (lipogenesis) in visceral fat compared with women(6). Adrenergic stimulation increases splanchnic fatty acid release in men but not in women(24). Thus, not only are men more susceptible to excess visceral fat, the effects of visceral fat on health may differ between the sexes as well.

    At rest, women shunt more circulating NEFA into re-esterification pathways than do men(32). Women have higher VLDL-TAG production rates than men, but similar circulating concentrations(7). This is further evidence that women have higher rates of re-esterfication and thus reuptake of NEFA into adipose tissue than do men. In the basal condition, women are physiologically adapted to store fat more so than are men.

    Women have higher rates of fat uptake into leg fat depots than do men(33). Rates of fatty acid release from abdominal adipose tissue are higher in women than men, but they are lower from gluteal or femoral adipose tissue(6). After feeding, fatty acid uptake is higher in abdominal adipose tissue relative to gluteal or femoral in both men and women. However, in women the majority of fatty acid uptake in abdominal adipose tissue is into subcutaneous fat, while in men a larger proportion goes into visceral fat(6). These findings are consistent with women being more likely to store fat subcutaneously and preferentially in the gluteal and femoral regions compared with men.

    Women have higher rates of fat oxidation than men during sustained bouts of increased energy expenditure, such as endurance training. Men are more likely to up regulate glucose and amino acid metabolism during sustained exercise bouts(34,35). The difference is associated with oestrogen. Giving exogenous oestrogen to males decreases carbohydrate and amino acid metabolism during exercise, and increases fat oxidation(36). Thus it would appear that women are more physiologically geared to use fat as a metabolic fuel under conditions of sustained increased demand, while men rely more on glucose and protein metabolism.

    Testosterone acts to increase lipolysis, inhibit lipoprotein lipase activity, and decrease TAG accumulation in adipose tissue. Lowering circulating testosterone levels in healthy young men increases total adipose tissue, with the largest percentage increase occurring in subcutaneous adipose tissue; raising circulating testosterone decreases total adipose tissue(37). Oestrogens play multiple roles in the regulation of adipose tissue, in both men and women. Oestradiol has direct effects on adipose tissue, and also acts centrally to affect food intake and energy expenditure. Androgens appear to block proliferation and differentiation of preadipocytes(38). Oestradiol enhances proliferation of preadipocytes from both men and women in vitro(39). The effect was greater in preadipoces from females compared with those from males.

    Adipose tissues express both androgen and oestrogen receptors. Visceral fat has higher levels of androgen and oestrogen receptors than does subcutaneous fat, and this is true for both men and women(42). Both the a and b oestrogen receptors are found in adipose tissue(41). In subcutaneous fat, oestradiol acts through the a receptor to up regulate α2A-adrenergic receptors which results in decreased lipolysis. In contrast, oestradiol does not appear to affect the concentration of α2A-adrenergic receptors in adipocytes from visceral fat(41). Subcutaneous adipocytes from premenopausal women have higher α2A-adrenergic receptor density and lower lipolytic activity in response to adrenaline than do subcutaneous adipocytes from men(43).

    Adipose tissue serves as an endocrine organ, producing leptin and many other regulatory peptides (Table 1). Adipose tissue is a source of steroids, either stored or metabolically converted from precursors. For example, oestrone is converted to oestradiol and androstendione is converted to testosterone in adipose tissue (Table 1).

    Reubinoff et al. (1995)

    Reubinoff, B. E., Grubstein, A., Meirow, D., Berry, E., Schenker, J. G., & Brzezinski, A. (1995). Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertility and Sterility, 63(3), 516–521. [DOI:10.1016/s0015-0282(16)57419-6]:

    The levels of the enzyme lipoprotein lipase (LPL) activity in adipocytes serve as a reliable indicator of fat formation and accumulation. Lypolisis, on the other hand, is the enzymatic degradation of lipids within the adipocyte. During their reproductive period of life, women have a higher femoral than abdominal LPL activity (14).

    Progesterone stimulates femoral LPL activity, whereas T inhibits it. Estradiol (on a short-term basis) is lipolytic.

    Nedungadi & Clegg (2009)

    Nedungadi, T. P., & Clegg, D. J. (2009). Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases. Journal of Cardiovascular Translational Research, 2(3), 321–327. [DOI:10.1007/s12265-009-9101-1]:

    Lipoprotein lipase (LPL) is the major enzyme involved in the fatty acid uptake and is the key regulator of fat accumulation in various adipose tissues. Higher LPL tissue activity is associated with the development of abdominal visceral obesity. Men have a higher level of LPL activity than premenopausal women.

    The lipolytic pathway involves the breakdown of energy stored in the form of triglycerides and is initiated when the energy supply from the metabolic fuels is depleted. There is a higher amount of lipolytic activity in the visceral fat when compared to the subcutaneous fat in premenopausal women as compared to the post menopausal women lacking estrogen [37, 45, 46]. Hence, in women, there is less visceral obesity in comparison to men [34]. Catecholamines trigger lipolysis via α-1, α-2, and α-3 adrenergic receptors, while they inhibit lipolysis via the α-2 adrenergic receptors [35].

    In visceral adipose tissue, there is an increase in the expression of androgen receptors in males relative to estrogen receptors. Adipose tissue-specific androgen receptor knockout mice have increased intraadipose tissue estradiol levels, which precedes subcutaneous obesity [60].

    Body weight is regulated through coordinated metabolic processes. This includes peripheral signals called “adiposity signals” such as leptin and insulin [59], whose circulating levels are proportional to adipose tissue mass [13, 50]. These adiposity signals interact with the brain to regulate energy homeostasis. There are critical brain regions responsible for mediating these effects, specifically in the hypothalamus [47, 49]. Leptin and insulin have receptors in these critical brain regions and influence release and activity of different neuronal populations known to be involved in body weight regulation.

    Leptin is secreted at a higher rate from subcutaneous fat than from visceral fat, thus circulating leptin correlates better with total subcutaneous fat than with total body fat. Insulin secretion is better correlated with visceral fat; thus, its levels better reflect visceral rather than total body adiposity [58]. Male rats are relatively more sensitive to the catabolic action of insulin delivered into the brain [14], whereas female rats are relatively more sensitive to the catabolic action of leptin delivered into the brain [16]. A comparable phenomenon has been reported in a recent study in humans, suggesting that men lose more body weight and body fat and change their waist circumference following intranasal insulin administration when compared to women [61]. Intranasal insulin administration increases insulin concentration of the cerebrospinal fluid and thereby alters brain functions. Therefore, sexually differential sensitivity to the catabolic effects of insulin exists in rodents and humans.

    Uniquely, despite having higher circulating leptin levels, females have been demonstrated to be more sensitive to the anorexigenic effects of leptin [15]. Female rats are more responsive than males to the effects of centrally administered leptin to decrease food intake and body weight, and this has been demonstrated to be due to increased leptininduced Stat3 activation in the basal hypothalamus [5, 29]. So, an increase in the Stat3 signaling translates to an increase in the energy expenditure by leptin and also increased SNS regulation.

    Among the two major estrogen receptor subtypes, it is believed that ERα mediates the anti-obesity effect in both males and females [41, 43, 55]. Studies with ERα null mice demonstrated obesity and had a massive increase in the adipose tissue [32, 48], whereas ERβ null mice were not obese. Heine et al. reported that male and female mice with a targeted deletion in the ERα subunit have increased adiposity in both sexes.

    Clegg et al. (2006)

    Clegg, D. J., Brown, L. M., Woods, S. C., & Benoit, S. C. (2006). Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes, 55(4), 978–987. [DOI:10.2337/diabetes.55.04.06.db05-1339]:

    These data indicate that estrogen acts within the brain to increase leptin sensitivity, decrease insulin sensitivity, and favor subcutaneous over visceral fat.

    Thus, when systemic estrogen is present (intact females and males or OVX females administered subcutaneous estrogen), leptin is catabolic in the brain, whereas when estrogen is low (OVX females and intact males), leptin is relatively ineffective. Conversely, estrogen reduces the sensitivity of the brain to the anorexigenic action of insulin.

    An important implication from these findings is that gonadal steroids mediate body fat distribution and interact with the integrated adiposity message conveyed to the brain by leptin and insulin, resulting in differential sensitivity to these signals in males and females.

    This implies that the relative amount of androgens and estrogens is a key determinant of the brain’s sensitivity to the catabolic actions of insulin and leptin, with proportionally more estrogen favoring leptin sensitivity and proportionally less estrogen favoring insulin sensitivity. Finally, our data suggest that estrogen’s direct actions in the brain determine body fat distribution.

    Note: I would love to see a study of trans women who on GAHT gained or lost weight and correlations with different gene polymorphisms for estrogen receptor alpha and leptin receptors.

    Mauvais-Jarvis, Clegg, & Hevener (2013)

    Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]:

    In postmenopausal women, however, when the ovaries fail to produce E2 and in men—who have naturally low levels of circulating E2—E2 does not function as a circulating hormone; rather, it is synthesized in extragonadal sites such as breast, brain, muscle, bone, and adipose tissue where it acts locally as a paracrine or intracrine factor (8).

    EST is a cytosolic enzyme that provides a molecular switch in target cells that inhibits estrogen activity by conjugating a sulfonate group to estrogens, thereby preventing binding to estrogen receptors and enhancing urinary excretion of the hormone.

    Early studies of the reproductive actions of estrogens led to the establishment of a paradigm in which classical nuclear ERs acted as ligand-activated transcription factors (11). ER modulation of gene transcription is a highly dynamic process. The ER exists in 2 main forms, ER and ER, each of which has multiple isoforms and exhibit distinct tissue expression patterns and functions (12). The classical “genomic” mechanism of ER action typically occurs within hours, leading to activation or repression of target genes. In this classic signaling pathway, ligandactivated ER dissociates from its chaperone heat-shock protein and binds as a dimer either directly to an estrogen response element (ERE) in target gene promoters or indirectly to activator protein 1 or specificity protein 1 response elements through protein tethering to DNA (13). After binding, these ER dimers interact with cofactors (coactivators or cosuppressors) to regulate gene expression.

    Cellular estrogenic action depends on: 1) the ER signaling and sensitivity; 2) the activity of enzymes like aromatase involved in the biosynthesis of E2 from androgenic precursors; and 3) the inactivation of E2 in E2 sulfate (E2-S) by the estrogen sulfotransferase (EST).

    Although reproductive functions are mostly mediated via classical nuclear ER acting as ligand-activated transcription factors, a large component of ER actions related to energy metabolism also involves extranuclear ERs, indirectly modulating gene expression or acting independently of nuclear events (18). E2 can activate rapid signals Figure 1. Figure 1. Origin of circulating and tissue estrogens. A, In healthy premenopausal women, estrogen (E2) is produced by the ovaries and functions as a circulating hormone that acts on distant target tissues. Here WAT is represented. B, In postmenopausal women and in men, E2 does not function as a circulating hormone; rather, it is synthesized in extragonadal sites from circulating androgenic precursors such as T, androstenedione (4A), or dehydroepiandrosterone (DHEA). Cellular estrogenic action depends on: 1) the ER signaling and sensitivity; 2) the activity of enzymes like aromatase involved in the biosynthesis of E2 from androgenic precursors; and 3) the inactivation of E2 in E2 sulfate (E2-S) by the estrogen sulfotransferase (EST).

    E2 can activate rapid signals that act within seconds or minutes via extranuclear and membrane-associated forms of ERs (19). ER and ER are localized to caveolae where they congregate with other signaling molecules, thereby facilitating interaction and rapid intracellular signaling. These signal proteins include G proteins, growth factor receptors, tyrosine kinases (Src), linker proteins (MNAR), and orphan G protein-coupled receptors. This multiprotein complex provides the necessary interactions for membrane ER to activate growth factor receptors and G proteins. In turn, these E2-induced rapid signals modify protein function via phosphorylation. However, they can also modulate gene expression and thus the production of proteins.

    ER deficiency in both male and female mice causes increased body weight and adiposity predominately through reduced energy expenditure and slight increases in food intake.

    These effects of E2 are mediated via MC4 receptor because E2 is unable to induce anorexia when the MC4 receptor antagonists Shu 9119 or agouti-related peptide (AgRP) are applied concomitantly with E2 administration in rats (70).

    Mice with small hairpin RNA-mediated ERgene silencing as well as transgenic mice in which ER has been selectively deleted from SF1-containing neurons of the VMH, develop reduced sensitivity to E2-induced weight loss, increased visceral fat deposition, and reductions in energy expenditure. All of these results occur without an impact on food intake (60, 78), supporting the notion that ER signaling in VMN neurons plays an important role in regulating physical activity, thermogenesis, and fat distribution.

    Collectively, these findings suggest that ER in the brainstem, and specifically the [nucleus tractus solitarius (NTS)], is an additional site mediating the anorexigenic effects of estrogens.

    Subcutaneous adipose tissue permits efficient storage of maximal calories per unit volume of tissue.

    Estrogens are produced in the adipocytes (via aromatization from androgenic precursors) and increase in proportion to total body adiposity (132, 133).

    E2 also suppresses white adipose tissue (WAT) accumulation by decreasing fatty acid and triglyceride synthesis and lipogenesis.

    Extensive evidence demonstrates that E2 has direct effects on cultured adipocytes with the overall effect of inhibiting lipogenesis and adipogenesis.

    […] suggesting that the absence of E2 promotes immune cell inflammation. Indeed, circulating levels of proinflammatory cytokines are elevated in women after natural or surgical menopause.

    Macrophages are elemental players in innate and adaptive immunity; over the past decade their roles in modulating whole-body metabolism and insulin sensitivity have been topics of increasing interest (295, 296).

    […] EST terminates estrogen activity and represents an important parameter of estrogen output upstream of ER. With regard to metabolism, EST is highly expressed in WAT of male mice, but it is not detectable in WAT of normal cycling female mice (320).

    Note: Interesting to see if trans folks on GAHT have different type 2 diabetes probability than normal population.

    An obvious explanation for these observations is that EST expression is high in male WAT (320) to protect from excessive estrogen actions. It follows that EST suppression produces WAT estrogen excess leading to inflammation. Consistent with this possibility is the observation that E2 treatment leading to high blood concentrations produces WAT inflammation even in females (193).

    Note: Makes you wonder if there is potential for higher WAT inflammation in trans folks – especially whne many have E2 levels higher than folks with estrogen producing genitals.

    There are reports suggesting that oral E2 may exacerbate insulin resistance and adipocytokine parameters, worsening cardiovascular risk (329). Transdermal E2, however, has minimal effects on insulin resistance and results in higher adiponectin. This suggests that transdermal E2 may be a preferable treatment compared to oral CEE for obese women with metabolic syndrome.

    The authors concluded that in women without diabetes, both oral and transdermal estrogen, with or without progestin, increase lean body mass, reduce abdominal fat, improve insulin resistance, decrease LDL/high-density lipoprotein-cholesterol ratio, and decrease blood pressure.

    B. Effect of selective estrogen receptor modulators and aromatase inhibitors on metabolism.

    In fact, tamoxifen therapy in a case-control study breast cancer survivor was associated with a 24% increased risk of developing diabetes.

    In OVX mice, raloxifene reversed OVX-induced increases in food intake, body weight, fat mass, and hyperleptinemia to an extent similar to that of E2. This suggests that in rodents, raloxifene acts as an ER agonist in hypothalamic neurons and fat.

    Sullivan et al (356) looked at the effect of a novel SERM (GSK232802A) on body weight, food intake, physical activity, and metabolic rate in an OVX nonhuman primate model. They observed that GSK232802A produced a 5% decrease in weight and reduced adiposity by suppressing food intake and increasing activity. These results occurred without changes in energy expenditure, suggesting that GSK232802A treatment may counteract postmenopausal obesity (356).

    Schiffer et al. (2017)

    Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. W. (2017). MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. European Journal of Endocrinology, 177(3), R125–R143. [DOI:10.1530/eje-17-0124]:

    Delineating the specific effects of androgen deprivation therapy in this patient population is clouded by co-administration of relatively large doses of oestrogen. Male-to-female transgender patients on combined estrogen and anti-androgen treatment develop an adverse lipid profile.

    Cross-sectional studies analysing age-advanced men, men across different ages and obese vs non-obese men consistently support the association between low T and increased fat mass compared to eugonadal controls (107, 142, 143). BMI negatively correlates with total and free T (142, 144), and waist circumference is negatively associated with total T in men.

    T administration in men reduces accumulation of visceral and retroperitoneal fat compared to controls, but not in SC depots; hypogonadal men also have increased visceral fat mass.

    Mueller et al. (2011)

    Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074]:

    When the BMI values were compared, there was a significant increase during cross-sex hormone treatment with oestrogens in the absence of testosterone after 12 months and after 24 months. Moreover, total fat mass increased also during the study period, while total lean mass decreased significantly.

    Recently, Lapauw et al. reported that in MtFs treated with female steroid hormones over an average of 8 years, total lean mass was approximately 20% lower whereas total fat mass was about 30% higher in comparison with a male control group (Lapauw et al., 2008). In this study, transsexuals had been treated with either ethinyl oestradiol, oestradiol valerate, or conjugated equine oestrogens combined with cyproterone acetate (Lapauw et al., 2008).

    In MtFs treated with ethinyl oestradiol and antiandrogens, a significant increase in all subcutaneous fat depots, with a lesser but proportional and significant increase in the visceral fat depot and a decrease in thigh muscle area, was reported.

    With regard to body composition and bone mineral density, there appears to be no difference when GnRH agonists are used for complete androgen deprivation in MtFs. In comparison with commonly used hormone regimens, the complication rates appear to be lower in patients receiving the treatment regimen described here, as reported earlier.

    \ No newline at end of file diff --git a/transfemscience.org/articles/hormones-fat-metabolism/index.html b/transfemscience.org/articles/hormones-fat-metabolism/index.html index 81f031c5..8751acf4 100644 --- a/transfemscience.org/articles/hormones-fat-metabolism/index.html +++ b/transfemscience.org/articles/hormones-fat-metabolism/index.html @@ -1 +1 @@ -On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy - Transfeminine Science Link

    On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy

    By Lain | First published September 4, 2019 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    Preface

    If you are into the technical details I would urge you after reading through this to look through my notes as they go into even more gory details.

    Much like my previous post this post is inspired by my personal journey in gender-affirming hormone therapy (GAHT) and my desire to understand how GAHT will impact me along with my attempts to optimize it for my desired bodily outcome. I have tried to provide an ultra high level summary/abstract, an in-depth writeup of my literature review and finally my raw notes and quotes upon which I based this article on. As always I welcome feedback. I found writing this to be especially challenging both because I struggled to find the right ‘voice’ and technical level in my writeup, and also with translating cis-focused academic literature into trans-inclusive language. Please know that while all mistakes are mine, my intentions are never to offend, erase, or exclude.

    Summary

    Within the context of transfeminine hormone therapy, it’s often stated that people will have a more feminine fat distribution, gaining fat around their thighs and buttocks (a gynoid fat distribution).

    This appears to occur due to both the presence of estrogens as well as the absence of testosterone. Some ways in which estrogens cause this to happen are by directly acting on estrogen receptors in fat deposits in these areas and increasing fat cell growth (adipogenesis) and decreasing fat metabolism in the aforementioned areas (lipolysis).

    In addition to directly acting on fat cells, estrogens also act on parts of the brain, specifically the hypothalamus, a center for regulating body fat and body metabolism. In the hypothalamus, estrogen receptors interact with leptin – a hormone associated with body fat regulation – as well with as a number of other hormones and elements that modify the hypothalamus. In general, estrogens effects on the hypothalamus seem to reduce appetite and increase fat metabolism.

    These two major actions of estrogens on fat metabolism seem to result in the understanding that estrogens cause subcutaneous fat distributed gynoid, that is resistant to metabolism, while at the same time reducing hunger and increasing overall metabolism.

    In keeping with this, there is some research to indicate that transfeminine populations increase their total body fat percentage under GAHT, however, there is some research that shows there is also an increase in total BMI as well.

    My review of the literature has made me consider that looking at the genes of transfeminine individuals about to start (or already taking) GAHT could possibly help people understand if they are at risk for disproportionate weight gain due to GAHT and whether other interventional actions could be taken.

    The rest of this post will go into much greater detail on how estrogens impact fat metabolism and deposition.

    Background

    When talking about fat distribution in humans we often talk about a feminine (gynoid) or masculine (android) distribution of fat. Gynoid fat distribution is typically characterized as fat deposited in the thighs and buttocks whereas an android fat distribution is characterized by abdominal fat. In addition a gynoid fat distribution is characterized by having a much higher percentage of subcutaneous fat (fat under the skin) as opposed to visceral fat (fat inside the abdominal cavity – for instance around the organs). This seems to likely be due to the fact that subcutaneous fat depots are among the most efficient ways to store calories per volume of tissue (Clegg et al., 2006). This is an especially important distinction as visceral fat is highly correlated with cardiovascular disease. Following along with that research shows that premenopausal natal women are far less likely to experience cardiovascular disease.

    These different fat distributions are ultimately achieved by fat being metabolised (lipolysis) and synthesized (lipogenesis) at different levels in different fat tissues.

    There are many ways in which sex hormones mediate lipolysis (fat metabolism) and lipogenesis (fat generation). These effects can be categorized broadly as either direct or peripheral. Direct actions typically mean estrogen or androgen receptor modulation on fat cells (adipocytes) directly whereas peripheral actions are the effects of estrogen or androgen within the brain to cause downstream impact on various aspects of metabolism including rate of fat metabolism, rate of fat uptake and hunger.

    As fat is the major store of energy in the body, fat can be viewed as an organ and in fact an endocrine organ (Power & Schulkin, 2008). It produces leptin, a hormone that is central to maintaining body fat percentage as it is part of the leptin/ghrelin/insulin hormone system involved in hunger, and energy homeostasis. Leptin along with insulin are peripheral “adiposity signals” and their circulating levels are relative to the percentage of body fat.

    Direct Effects

    Direct effects of sex hormones on fat distribution are those which directly modulate fat cells as opposed to peripheral affects which result from downstream modulation of other signaling pathways. Adipose tissue contains both estrogen and androgen receptors with visceral fat having a higher concentration of both receptors (Power & Schulkin, 2008).

    Below are some of the direct effects of hormones:

    • In subcutaneous fat estradiol acts through the estrogen receptor alpha subtype (ERα) to upregulate α2A-adrenergic receptors (increase the density of this receptor in the fat cells) which result in decreased lipolysis whereas estradiol does not seem to impact the concentration of α2A-adrenergic receptors in visceral fat (Power & Schulkin, 2008).

    • Fatty acid uptake is the incorporation of fatty acids into fat cells. Rates of fatty acid uptake are lower in natal women compared to men, in the buttocks and thighs – and after eating, fatty acid uptake is higher in both natal women and men in the abdomen but with women it is stored largely subcutaneously vs. viscerally (interabdominally) in natal men (Power & Schulkin, 2008).

    • Estrogen is associated with higher rates of fat metabolism during sustained bouts of increased energy usage whereas natal men are more likely to up regulate glucose and amino acid metabolism. When given exogenous estrogen, natal men decrease carbohydrate and amino acid metabolism and increase fat metabolism (Power & Schulkin, 2008).

    • Testosterone increases lipolysis (breakdown of fat), inhibits lipoprotein lipase activity (an enzyme that converts triglycerides into fatty acids suitable for cellular metabolism), and decreases triglyceride (TAG – a fatty acid) accumulation in adipose tissue. With this occurring largely in subcutaneous adipose tissue (Power & Schulkin, 2008).

    • The estrogen receptor α subunit (ERα) appears to be responsible for anti-obesity effects (Nedungadi & Clegg, 2009).

    • Androgens also appear to block the proliferation and differentiation of preadipocytes – this ties in with them also directing stem cells to create muscle cells (Power & Schulkin, 2008).

    • Conflictingly somewhat,there is also evidence to support the fact that estradiol suppresses white adipose tissue accumulation by decreasing triglyceride (TAG) and fatty acid synthesis as well as lipogenesis (fat uptake and storage) (Power & Schulkin, 2008).

    Peripheral Effects

    Peripheral effects of hormones are those mediated largely through the brain. Rather than acting directly on fat cells both androgens and estrogens act on parts of the brain – often the effect is on the hypothalamus – a center for regulating various metabolic activities like fat metabolism, (more broadly called energy homeostasis). Some of the effects hormones may cause include regulating hunger, regulating the rate of various tissues metabolism, and regulating the uptake of fat into tissues.

    Leptin and Hormones

    Leptin is a hormone secreted from fat and is one of the ways in which hunger is mediated. Increased leptin correlates with decreased hunger and decreased total weight. Leptin is secreted from subcutaneous fat at a higher rate than visceral fat (Power & Schulkin, 2008), thus as estrogen mediates a higher proportion of subcutaneous fat more leptin is found in the body. In addition estrogen in the hypothalamus causes increased sensitivity to leptin which results in decreased hunger (anorexigenic effects) (Nedungadi & Clegg, 2009; Clegg et al., 2006; Mauvais-Jarvis, Clegg, & Hevener, 2013). The brainstem (specifically the NTS – nucleus tractus solitarius) is also a source of anorexigenic effects via the estrogen receptor (Mauvais-Jarvis, Clegg, & Hevener, 2013). In addition leptin can also cause an increase in energy expenditure – via the Stat3 signaling pathway in the hypothalamus (Nedungadi & Clegg, 2009). When estrogen is not present but androgens are, insulin signaling pathways are far more responsible for mediating hunger and energy expenditure (Nedungadi & Clegg, 2009). In natal men, low testosterone is correlated with increased fat mass, probably because neither the insulin pathway for reducing hunger or the leptin one is very active (Schiffer et al., 2017).

    Obviously any conclusions we wish to draw about how a standard transfeminine hormone therapy regimen of androgen suppression and estrogens addition is speculative and based upon knowledge of how hormones interact with fat. Despite this, I think we can make some statements which are reasonable (and also backed up by observational evidence):

    • As testosterone decreases, overall body fat increases (because testosterone inhibits fat cell formation and decreases fat uptake overall (Power & Schulkin, 2008).

    • Subcutaneous fat deposits begin to increase.

      • This likely occurs by increased lipogenesis mediated by upregulation of α2A-adrenergic receptors and decrease LPL (lipoprotein lipase) in SC fat.

    • Visceral fat may decrease relative to total body fat possibly because of leptin pathways (Nedungadi & Clegg, 2009; Clegg et al., 2006). While visceral fat may decrease relative to total body fat the rate of turnover of visceral fat decreases, so both the uptake as well as the metabolism of visceral fat decreases (Power & Schulkin, 2008).

    • The leptin pathway becomes sensitized and the insulin pathway becomes less sensitive.

    • Total body fat increases, especially subcutaneous fat causing total overall leptin to increase. This may cause a decrease in appetite and weight loss in general.

    • When undergoing exercise more fat will be burned than amino acids (proteins) and carbohydrates.

    However, somewhat at odds with what the actions of transfeminine hormone therapy seem likely to be, the research we have on transgender populations suggests an overall increase in weight:

    • During GAHT over 12 to 24 months total fat mass increased and total non fat mass decreased (Mueller et al., 2011).

    • Over an average of 8 years total lean mass (not body fat) was approximately 20% lower whereas total fat mass was about 30% higher in comparison with a control group of cis men (Mueller et al., 2011).

    • When treated with ethinyl estradiol and antiandrogens subcutaneous fat depots increased significantly and a proportional increase in visceral fat was also observed (Mueller et al., 2011).

    There is at least some evidence (Belisle & Love, 1986) to suggest that this maybe due to cyproterone acetate, a commonly prescribed antiandrogen outside of the U.S., causing weight gain. I believe that there is not nearly enough research to draw really solid conclusions as there are so many confounding factors related to weight loss.

    In addition I would love to see studies that relate genetics to the effects of GAHT on weight and body mass. For instance it may be possible to identify in advance, genetic polymorphisms that would cause say weight gain under GAHT (due to a specific phenotype of something involved in leptin signaling pathways) and create an intervention prior to or during GAHT.

    References

    • Belisle, S., & Love, E. J. (1986). Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study. Fertility and Sterility, 46(6), 1015–1020. [DOI:10.1016/s0015-0282(16)49873-0]
    • Clegg, D. J., Brown, L. M., Woods, S. C., & Benoit, S. C. (2006). Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes, 55(4), 978–987. [DOI:10.2337/diabetes.55.04.06.db05-1339]
    • Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074]
    • Nedungadi, T. P., & Clegg, D. J. (2009). Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases. Journal of Cardiovascular Translational Research, 2(3), 321–327. [DOI:10.1007/s12265-009-9101-1]
    • Power, M. L., & Schulkin, J. (2008). Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. British Journal of Nutrition, 99(5), 931–940. [DOI:10.1017/s0007114507853347]
    • Reubinoff, B. E., Grubstein, A., Meirow, D., Berry, E., Schenker, J. G., & Brzezinski, A. (1995). Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertility and Sterility, 63(3), 516–521. [DOI:10.1016/s0015-0282(16)57419-6]
    • Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. W. (2017). MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. European Journal of Endocrinology, 177(3), R125–R143. [DOI:10.1530/eje-17-0124]
    \ No newline at end of file +On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy - Transfeminine Science Link

    On the Impact of Sex Hormones on Fat Metabolism with an Eye Towards Transfeminine Hormone Therapy

    By Lain | First published September 4, 2019 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    Preface

    If you are into the technical details I would urge you after reading through this to look through my notes as they go into even more gory details.

    Much like my previous post this post is inspired by my personal journey in gender-affirming hormone therapy (GAHT) and my desire to understand how GAHT will impact me along with my attempts to optimize it for my desired bodily outcome. I have tried to provide an ultra high level summary/abstract, an in-depth writeup of my literature review and finally my raw notes and quotes upon which I based this article on. As always I welcome feedback. I found writing this to be especially challenging both because I struggled to find the right ‘voice’ and technical level in my writeup, and also with translating cis-focused academic literature into trans-inclusive language. Please know that while all mistakes are mine, my intentions are never to offend, erase, or exclude.

    Summary

    Within the context of transfeminine hormone therapy, it’s often stated that people will have a more feminine fat distribution, gaining fat around their thighs and buttocks (a gynoid fat distribution).

    This appears to occur due to both the presence of estrogens as well as the absence of testosterone. Some ways in which estrogens cause this to happen are by directly acting on estrogen receptors in fat deposits in these areas and increasing fat cell growth (adipogenesis) and decreasing fat metabolism in the aforementioned areas (lipolysis).

    In addition to directly acting on fat cells, estrogens also act on parts of the brain, specifically the hypothalamus, a center for regulating body fat and body metabolism. In the hypothalamus, estrogen receptors interact with leptin – a hormone associated with body fat regulation – as well with as a number of other hormones and elements that modify the hypothalamus. In general, estrogens effects on the hypothalamus seem to reduce appetite and increase fat metabolism.

    These two major actions of estrogens on fat metabolism seem to result in the understanding that estrogens cause subcutaneous fat distributed gynoid, that is resistant to metabolism, while at the same time reducing hunger and increasing overall metabolism.

    In keeping with this, there is some research to indicate that transfeminine populations increase their total body fat percentage under GAHT, however, there is some research that shows there is also an increase in total BMI as well.

    My review of the literature has made me consider that looking at the genes of transfeminine individuals about to start (or already taking) GAHT could possibly help people understand if they are at risk for disproportionate weight gain due to GAHT and whether other interventional actions could be taken.

    The rest of this post will go into much greater detail on how estrogens impact fat metabolism and deposition.

    Background

    When talking about fat distribution in humans we often talk about a feminine (gynoid) or masculine (android) distribution of fat. Gynoid fat distribution is typically characterized as fat deposited in the thighs and buttocks whereas an android fat distribution is characterized by abdominal fat. In addition a gynoid fat distribution is characterized by having a much higher percentage of subcutaneous fat (fat under the skin) as opposed to visceral fat (fat inside the abdominal cavity – for instance around the organs). This seems to likely be due to the fact that subcutaneous fat depots are among the most efficient ways to store calories per volume of tissue (Clegg et al., 2006). This is an especially important distinction as visceral fat is highly correlated with cardiovascular disease. Following along with that research shows that premenopausal natal women are far less likely to experience cardiovascular disease.

    These different fat distributions are ultimately achieved by fat being metabolised (lipolysis) and synthesized (lipogenesis) at different levels in different fat tissues.

    There are many ways in which sex hormones mediate lipolysis (fat metabolism) and lipogenesis (fat generation). These effects can be categorized broadly as either direct or peripheral. Direct actions typically mean estrogen or androgen receptor modulation on fat cells (adipocytes) directly whereas peripheral actions are the effects of estrogen or androgen within the brain to cause downstream impact on various aspects of metabolism including rate of fat metabolism, rate of fat uptake and hunger.

    As fat is the major store of energy in the body, fat can be viewed as an organ and in fact an endocrine organ (Power & Schulkin, 2008). It produces leptin, a hormone that is central to maintaining body fat percentage as it is part of the leptin/ghrelin/insulin hormone system involved in hunger, and energy homeostasis. Leptin along with insulin are peripheral “adiposity signals” and their circulating levels are relative to the percentage of body fat.

    Direct Effects

    Direct effects of sex hormones on fat distribution are those which directly modulate fat cells as opposed to peripheral affects which result from downstream modulation of other signaling pathways. Adipose tissue contains both estrogen and androgen receptors with visceral fat having a higher concentration of both receptors (Power & Schulkin, 2008).

    Below are some of the direct effects of hormones:

    • In subcutaneous fat estradiol acts through the estrogen receptor alpha subtype (ERα) to upregulate α2A-adrenergic receptors (increase the density of this receptor in the fat cells) which result in decreased lipolysis whereas estradiol does not seem to impact the concentration of α2A-adrenergic receptors in visceral fat (Power & Schulkin, 2008).

    • Fatty acid uptake is the incorporation of fatty acids into fat cells. Rates of fatty acid uptake are lower in natal women compared to men, in the buttocks and thighs – and after eating, fatty acid uptake is higher in both natal women and men in the abdomen but with women it is stored largely subcutaneously vs. viscerally (interabdominally) in natal men (Power & Schulkin, 2008).

    • Estrogen is associated with higher rates of fat metabolism during sustained bouts of increased energy usage whereas natal men are more likely to up regulate glucose and amino acid metabolism. When given exogenous estrogen, natal men decrease carbohydrate and amino acid metabolism and increase fat metabolism (Power & Schulkin, 2008).

    • Testosterone increases lipolysis (breakdown of fat), inhibits lipoprotein lipase activity (an enzyme that converts triglycerides into fatty acids suitable for cellular metabolism), and decreases triglyceride (TAG – a fatty acid) accumulation in adipose tissue. With this occurring largely in subcutaneous adipose tissue (Power & Schulkin, 2008).

    • The estrogen receptor α subunit (ERα) appears to be responsible for anti-obesity effects (Nedungadi & Clegg, 2009).

    • Androgens also appear to block the proliferation and differentiation of preadipocytes – this ties in with them also directing stem cells to create muscle cells (Power & Schulkin, 2008).

    • Conflictingly somewhat,there is also evidence to support the fact that estradiol suppresses white adipose tissue accumulation by decreasing triglyceride (TAG) and fatty acid synthesis as well as lipogenesis (fat uptake and storage) (Power & Schulkin, 2008).

    Peripheral Effects

    Peripheral effects of hormones are those mediated largely through the brain. Rather than acting directly on fat cells both androgens and estrogens act on parts of the brain – often the effect is on the hypothalamus – a center for regulating various metabolic activities like fat metabolism, (more broadly called energy homeostasis). Some of the effects hormones may cause include regulating hunger, regulating the rate of various tissues metabolism, and regulating the uptake of fat into tissues.

    Leptin and Hormones

    Leptin is a hormone secreted from fat and is one of the ways in which hunger is mediated. Increased leptin correlates with decreased hunger and decreased total weight. Leptin is secreted from subcutaneous fat at a higher rate than visceral fat (Power & Schulkin, 2008), thus as estrogen mediates a higher proportion of subcutaneous fat more leptin is found in the body. In addition estrogen in the hypothalamus causes increased sensitivity to leptin which results in decreased hunger (anorexigenic effects) (Nedungadi & Clegg, 2009; Clegg et al., 2006; Mauvais-Jarvis, Clegg, & Hevener, 2013). The brainstem (specifically the NTS – nucleus tractus solitarius) is also a source of anorexigenic effects via the estrogen receptor (Mauvais-Jarvis, Clegg, & Hevener, 2013). In addition leptin can also cause an increase in energy expenditure – via the Stat3 signaling pathway in the hypothalamus (Nedungadi & Clegg, 2009). When estrogen is not present but androgens are, insulin signaling pathways are far more responsible for mediating hunger and energy expenditure (Nedungadi & Clegg, 2009). In natal men, low testosterone is correlated with increased fat mass, probably because neither the insulin pathway for reducing hunger or the leptin one is very active (Schiffer et al., 2017).

    Obviously any conclusions we wish to draw about how a standard transfeminine hormone therapy regimen of androgen suppression and estrogens addition is speculative and based upon knowledge of how hormones interact with fat. Despite this, I think we can make some statements which are reasonable (and also backed up by observational evidence):

    • As testosterone decreases, overall body fat increases (because testosterone inhibits fat cell formation and decreases fat uptake overall (Power & Schulkin, 2008).

    • Subcutaneous fat deposits begin to increase.

      • This likely occurs by increased lipogenesis mediated by upregulation of α2A-adrenergic receptors and decrease LPL (lipoprotein lipase) in SC fat.

    • Visceral fat may decrease relative to total body fat possibly because of leptin pathways (Nedungadi & Clegg, 2009; Clegg et al., 2006). While visceral fat may decrease relative to total body fat the rate of turnover of visceral fat decreases, so both the uptake as well as the metabolism of visceral fat decreases (Power & Schulkin, 2008).

    • The leptin pathway becomes sensitized and the insulin pathway becomes less sensitive.

    • Total body fat increases, especially subcutaneous fat causing total overall leptin to increase. This may cause a decrease in appetite and weight loss in general.

    • When undergoing exercise more fat will be burned than amino acids (proteins) and carbohydrates.

    However, somewhat at odds with what the actions of transfeminine hormone therapy seem likely to be, the research we have on transgender populations suggests an overall increase in weight:

    • During GAHT over 12 to 24 months total fat mass increased and total non fat mass decreased (Mueller et al., 2011).

    • Over an average of 8 years total lean mass (not body fat) was approximately 20% lower whereas total fat mass was about 30% higher in comparison with a control group of cis men (Mueller et al., 2011).

    • When treated with ethinyl estradiol and antiandrogens subcutaneous fat depots increased significantly and a proportional increase in visceral fat was also observed (Mueller et al., 2011).

    There is at least some evidence (Belisle & Love, 1986) to suggest that this maybe due to cyproterone acetate, a commonly prescribed antiandrogen outside of the U.S., causing weight gain. I believe that there is not nearly enough research to draw really solid conclusions as there are so many confounding factors related to weight loss.

    In addition I would love to see studies that relate genetics to the effects of GAHT on weight and body mass. For instance it may be possible to identify in advance, genetic polymorphisms that would cause say weight gain under GAHT (due to a specific phenotype of something involved in leptin signaling pathways) and create an intervention prior to or during GAHT.

    References

    • Belisle, S., & Love, E. J. (1986). Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study. Fertility and Sterility, 46(6), 1015–1020. [DOI:10.1016/s0015-0282(16)49873-0]
    • Clegg, D. J., Brown, L. M., Woods, S. C., & Benoit, S. C. (2006). Gonadal Hormones Determine Sensitivity to Central Leptin and Insulin. Diabetes, 55(4), 978–987. [DOI:10.2337/diabetes.55.04.06.db05-1339]
    • Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074]
    • Nedungadi, T. P., & Clegg, D. J. (2009). Sexual Dimorphism in Body Fat Distribution and Risk for Cardiovascular Diseases. Journal of Cardiovascular Translational Research, 2(3), 321–327. [DOI:10.1007/s12265-009-9101-1]
    • Power, M. L., & Schulkin, J. (2008). Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. British Journal of Nutrition, 99(5), 931–940. [DOI:10.1017/s0007114507853347]
    • Reubinoff, B. E., Grubstein, A., Meirow, D., Berry, E., Schenker, J. G., & Brzezinski, A. (1995). Effects of low-dose estrogen oral contraceptives on weight, body composition, and fat distribution in young women. Fertility and Sterility, 63(3), 516–521. [DOI:10.1016/s0015-0282(16)57419-6]
    • Schiffer, L., Kempegowda, P., Arlt, W., & O’Reilly, M. W. (2017). MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. European Journal of Endocrinology, 177(3), R125–R143. [DOI:10.1530/eje-17-0124]
    \ No newline at end of file diff --git a/transfemscience.org/articles/index.html b/transfemscience.org/articles/index.html index 2c0f7ef1..da35fffd 100644 --- a/transfemscience.org/articles/index.html +++ b/transfemscience.org/articles/index.html @@ -1 +1 @@ -Articles - Transfeminine Science Link

    Articles

    General Articles

    Special Topics

    Estrogens

    Antiandrogens

    Progestogens

    Other Medications

    General Effects and Risks

    Miscellaneous

    Data, Analysis, and Literature

    \ No newline at end of file +Articles - Transfeminine Science Link

    Articles

    General Articles

    Special Topics

    Estrogens

    Antiandrogens

    Progestogens

    Other Medications

    General Effects and Risks

    Data, Analysis, and Literature

    \ No newline at end of file diff --git a/transfemscience.org/articles/injectable-e2-meta-analysis/index.html b/transfemscience.org/articles/injectable-e2-meta-analysis/index.html index 691d3b28..580920f9 100644 --- a/transfemscience.org/articles/injectable-e2-meta-analysis/index.html +++ b/transfemscience.org/articles/injectable-e2-meta-analysis/index.html @@ -1 +1 @@ -An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations - Transfeminine Science Link

    An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations

    By Aly | First published July 16, 2021 | Last modified March 18, 2024

    Abstract / TL;DR

    Injectable estradiol preparations such as estradiol valerate and estradiol cypionate in oil are frequently used as estrogens in transfeminine hormone therapy. However, there is little characterization of these preparations in transfeminine people and dosing recommendations by transgender health guidelines appear to be based on expert opinion rather than on clinical data. To help shed light on the properties of injectable estradiol and to better inform dosing considerations in transfeminine people, an informal meta-analysis of available clinical data on estradiol concentration–time curves with major injectable estradiol formulations was conducted. The included preparations were injectable estradiol benzoate in oil, estradiol valerate in oil, estradiol cypionate both in oil and as a suspension, estradiol enanthate in oil, estradiol undecylate in oil, and polyestradiol phosphate. The literature was searched for clinical concentration–time data with these injectable estradiol esters and these data were collected and analyzed. Meta-analysis consisted of data for each injectable estradiol preparation being processed and fit with pharmacokinetic models. Selected pharmacokinetic parameters were additionally determined and reported. The results of this work were discussed with regard to characteristics of injectable estradiol preparations like curve shapes, durations, estrogenic exposure, and variability between people and studies. Recommendations for injectable estradiol preparations by transgender health guidelines were also explored in light of the present results. Current guidelines recommend doses of these preparations that appear to be highly excessive with injection intervals that are too widely spaced. Based on the findings of the present meta-analysis, recommendations by guidelines should be reassessed. Finally, the fitted curves in this work were incorporated into an interactive web-based injectable estradiol simulator intended for use by transfeminine people and their medical providers to help guide therapeutic decisions.

    Introduction

    Estradiol is the main estrogen used in transfeminine hormone therapy and is available in a variety of different forms for use by different routes of administration. The most commonly employed forms are oral, sublingual, transdermal, and injectable preparations. Injectable estradiol preparations have been discontinued in many countries and hence are unavailable for use in transfeminine hormone therapy in many parts of the world, for instance in most of Europe (Glintborg et al., 2021). However, they are still used by many transfeminine people particularly in the United States and in the do-it-yourself (DIY) community. The most commonly used forms include estradiol valerate, estradiol cypionate, and estradiol enanthate all in oil. Injectable estradiol preparations have certain advantages over other estradiol forms that make them a popular choice for use in transfeminine hormone therapy. These include often lower cost, capacity to easily achieve higher estradiol levels that can be useful for testosterone suppression, less frequent administration, and theoretically reduced health risks relative to oral estradiol at equivalent doses due to the lack of the first pass with this route (Aly, 2020). The higher estradiol levels with injections are particularly useful for estradiol monotherapy, in which an antiandrogen is not used.

    Clinically used injectable estradiol preparations are formulated not as estradiol but as estradiol esters. When injected into muscle or fat in oil solutions or crystalline aqueous suspensions, these estradiol esters form depots at the injection site from which they are slowly released. Subsequent to release, estradiol esters are rapidly metabolized into estradiol and hence act as prodrugs. When estradiol itself is given by intramuscular injection in an aqueous solution or oil solution, it is rapidly absorbed and has a very short duration. Due to having lipophilic esters, most clinically used injectable estradiol esters are more fat-soluble than estradiol (as measured by oil–water partition coefficient (P)) (Table). When these esters are administered as oil solutions by intramuscular or subcutaneous injection, their increased lipophilicity causes them to be released from the injection-site depot more slowly than estradiol and to therefore have longer durations. In the case of fatty acid esters, the longer the chain length of the ester—as in e.g. estradiol valerate (5 carbons) vs. estradiol enanthate (7 carbons) vs. estradiol undecylate (10 carbons)—the greater the fat solubility, the slower the rate of release from the depot, and the longer the time to peak levels and duration (Edkins, 1959; Sinkula, 1978; Chien, 1981; Kuhl, 2005; Kalicharan, 2017; Vhora et al., 2019). The durations of both injectable oil solutions and aqueous suspensions depend on the ester and its particular physicochemical properties, but the characteristics of these preparations are different and they work in distinct ways to produce their depot effects (Enever et al., 1983; Aly, 2019). The durations of oil solutions are dependent on the lipophilicity of the ester as well as oil vehicle, whereas the durations of aqueous suspensions depend on the properties of the ester crystal lattice as well as crystal sizes (Chien, 1981; Enever et al., 1983; Aly, 2019). The polymeric estradiol ester polyestradiol phosphate is more hydrophilic (water-soluble) than estradiol and works differently than other injectable estradiol preparations. Ιt is composed of many estradiol molecules linked together via phosphate esters (on average 13 molecules of estradiol per one molecule of polyestradiol phosphate) and has a prolonged duration due to slow cleavage into estradiol following injection. Estradiol esters are able to substantially prolong the duration of estradiol when used as injectables and these preparations have durations ranging from days to months depending on the ester and how it is formulated (Table).

    There is very little in the way of research and review on the pharmacokinetics of injectable estradiol preparations in the transgender health literature. Transgender hormone therapy guidelines presently offer only brief descriptions and dosing recommendations that appear to be based mainly on expert opinion for this form of estradiol (e.g., Deutsch, 2016a; Hembree et al., 2017). Many studies assessing the pharmacokinetics and concentration–time profiles of injectable estradiol preparations have been published but are largely confined to cisgender women and men rather than transgender people. These studies are scattered throughout the literature and have not been comprehensively reviewed or analyzed. Some review material exists on the pharmacokinetics of injectable estradiol preparations for use in hormonal birth control and menopausal hormone therapy in cisgender women (e.g., Düsterberg & Nishino, 1982; Kuhl, 1986; Kuhl, 1990; Garza-Flores, 1994; Kuhl, 2005) and androgen deprivation therapy for prostate cancer in cisgender men (e.g., Gunnarsson & Norlén, 1988). However, these publications discuss only small selections of the available research. Data on repeated administration of injectable estradiol preparations are more rare but have also been published (e.g., Gooren et al., 1984 [Graph]; various others). Multi-dose simulation has been done previously for polyestradiol phosphate (Henriksson et al., 1999; Johansson & Gunnarsson, 2000). However, it has not been explored for other injectable estradiol preparations to date. In contrast to injectable estradiol, excellent review literature and simulation exists for injectable testosterone preparations (e.g., Behre, Oberpenning, & Nieschlag, 1990; Behre & Nieschlag, 1998; Behre et al., 2004; Nieschlag & Behre, 2010; Nieschlag & Behre, 2012).

    In order to aid understanding of concentration–time profiles with injectable estradiol preparations, I’ve developed an interactive web-based injectable estradiol simulator for transfeminine people and their medical providers. During work on this simulator, it became apparent that there is substantial variability in estradiol levels and curve shapes between different studies even with the same injectable estradiol ester. The injectable estradiol simulator was originally designed to simulate curves from only a single well-known pharmacokinetic study that directly compared estradiol benzoate, estradiol valerate, and estradiol cypionate in oil (Oriowo et al., 1980 [Graph]). However, due to the considerable differences in estradiol levels and curves across studies, it was decided that relying on only one study for such a project would be untenable. Instead, for the simulations to be reasonably accurate to the available data, many studies would need to be incorporated. Including additional studies would also allow for inclusion of other injectable estradiol esters in the simulator. As a result, the present work—an informal meta-analysis of estradiol curves with injectable estradiol formulations—was conducted for the simulator project.

    Methods

    A literature search was performed to identify studies reporting clinical estradiol concentration–time data with major injectable estradiol formulations (Table 1). All of these preparations have been used in transfeminine hormone therapy at one time or another in different parts of the world, although only estradiol valerate in oil and estradiol cypionate in oil are widely used today. Some of the injectable preparations included have notably been discontinued. Acceptable data for the search included mean and individual estradiol concentration data and Cmax estradiol levels (mean peak estradiol levels of individual subjects at time Tmax). Databases like PubMed, Google Scholar, and WorldCat were searched using relevant keywords (e.g., estradiol ester names and variations thereof as well as major brand names). Publications with relevant information were catalogued for data collection. Only single-dose data and multi-dose data that allowed estradiol levels to return to baseline between doses (as in e.g. repeated once-monthly combined injectable contraceptives) were included. Studies were included regardless of the hypothalamic–pituitary–gonadal axis (HPG axis) status of the participants. The study selection criteria aimed to maximize data inclusion due to scarcity of data for several preparations. If however there were many studies for a specific preparation, studies with only 1 or 2 subjects were generally skipped due to the limited additional value that they would provide. When data were in figures in papers—as was generally the case—they were extracted from the graphs using WebPlotDigitizer.

    Table 1: Major injectable estradiol formulations (ordered roughly from shortest- to longest-acting):

    Estradiol esterAbbr.FormMajor brand names
    Estradiol benzoateEBOil solutionProgynon-B
    Estradiol valerateEVOil solutionDelestrogen, Mesigyna,a Progynon Depot
    Estradiol cypionateECOil solutionDepo-Estradiol
      Aqueous suspensionbCyclofem,a Lunellea
    Estradiol enanthateEEnOil solutionPerlutal,a Topasela
    Estradiol undecylatecEUOil solutionDelestrec, Progynon Depot 100
    Polyestradiol phosphatecPEPAqueous solutionEstradurin

    a As combined injectable contraceptives also including a progestin (norethisterone enanthate (NETE), medroxyprogesterone acetate (MPA), or dihydroxyprogesterone acetophenide (DHPA)). b Microcrystalline particle size. c No longer marketed.

    Following their collection, data were processed, aggregated, and modeled. Data were adjusted for endogenous estradiol production and were normalized by dose. Adjustment for endogenous estradiol production was generally done via subtraction of baseline estradiol levels. In a number of cases however, subtraction of trough estradiol levels or of estradiol levels from a control group was required instead. Data were also weighted by sample size. In a handful of instances, certain missing information (e.g., time to peak levels, baseline levels, subject body weights) was filled in with reasonable assumptions to help maximize data inclusion. Data were processed in the form of mean estradiol curve data rather than individual-subject data (except for rare n=1 studies). The combined processed data from all studies for each injectable estradiol preparation were fit via least squares regression to one-, two-, and three-compartment pharmacokinetic models with first-order absorption and elimination that were obtained from the literature and other sources (e.g., Colburn, 1981; Wagner, 1993; Fisher & Shafer, 2007; Lixoft, 2008; Abuhelwa, Foster, & Upton, 2015; Certara, 2020). These models fit most curves from individual studies very well. Fitting the combined curve fits of all individual studies (as opposed to fitting all of the combined processed data directly) was additionally evaluated for each injectable estradiol preparation, and if it was feasible for the preparation and allowed for better fitting results, was employed instead. Fitting directly to the combined processed data has the effect of weighting individual studies by quantity of time points, whereas fitting the combined curve fits of studies eliminates this. The Akaike information criterion (AIC) was used to help guide model selection for fitting of the preparations. Curve fitting was performed using the Python library Lmfit with the Levenberg–Marquardt algorithm. Cmax concentrations are a different form of data than mean curve estradiol concentration–time data, and for this reason, were not included in the fitting unless data were very limited for a given injectable estradiol preparation. Outlying data were also excluded from fitting in a number of instances and this allowed for improved curve fits with more uniform area-under-the-curve levels. The main criterion used for excluding curves was fit area-under-the-curve levels that deviated considerably from what was typical for the injectable estradiol preparations (generally less than about 50% of the average or greater than about 150% of the average).

    A selection of pharmacokinetic parameters were calculated for each injectable estradiol preparation using the single-dose fit curves and compartmental pharmacokinetic analyses. These parameters included maximal or peak concentrations of estradiol after a single dose scaled to 5 mg (Cmax), time to maximal concentrations of estradiol after a single dose (Tmax), total area-under-the-curve concentrations of estradiol after a single dose (AUC0–∞), terminal elimination half-life after a single dose (t1/2), and the terminal 90% life after a single dose (t90%) (calculated as t1/2 × 3.322). In addition, selected pharmacokinetic parameters were calculated for simulated repeated administration of each injectable preparation at steady state with a dose and dose interval of 5 mg once every 7 days using the single-dose fit curves and compartmental pharmacokinetic analyses. These parameters included time to peak concentrations of estradiol (Tmax), peak and trough concentrations of estradiol (Cmax and Cmin, respectively), peak–trough difference (PTD; Cmax – Cmin), peak–trough ratio (PTR; Cmax ÷ Cmin), and integrated mean concentrations of estradiol (Cavg). Simulation of repeated administration was performed by stacking estradiol levels for multiple injections. Cmax and Tmax were defined and calculated in general as peak estradiol level and time to peak level of the fit mean curve as opposed to the mean peak level and mean time to peak level of individual subjects. This is because the latter would not be possible to compute as most studies reported only estradiol mean curve data. Pharmacokinetic parameters were calculated using relevant pharmacokinetic equations and, as a sanity check, were compared against those computed by PKSolver, a Microsoft Excel pharmacokinetics add-in program (Zhang et al., 2010).

    Results

    The figures in the subsequent sections show the original data from studies adjusted for endogenous estradiol levels and normalized to a common dose as well as the curve fits to the data (or alternatively the curve fits of the fits of the data depending on the preparation) for the included injectable estradiol preparations. Estradiol benzoate, estradiol cypionate in oil, and estradiol cypionate suspension were fit to the fits of all individual studies for these preparations, whereas estradiol enanthate, estradiol undecylate, and polyestradiol phosphate were fit directly to the combined processed data for these esters. In the case of estradiol valerate, the two fitting approaches gave nearly identical curves, and so fitting the combined processed original data was done for simplicity for this preparation. Cmax studies were excluded in the fitting for all preparations except estradiol enanthate, for which available estradiol concentration–time data were otherwise very limited. The data for the injectable estradiol preparations were generally fit best by a three-compartment pharmacokinetic model (Desmos). As a result, and for consistency, this model was used in the fitting of all preparations.

    Estradiol Benzoate

    Injectable estradiol benzoate has been extensively used in the past in scientific research, most notably in studies elucidating the function and dynamics of the HPG axis. One such use of estradiol benzoate has been the estrogen provocation test, a diagnostic test of HPG axis function. Due to its use in research, substantial estradiol concentration–time data with injectable estradiol benzoate exists. A total of 26 publications and concentration–time data for 355 individual injections were identified (Table 2).

    Table 2: Studies of injectable estradiol benzoate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    G753Gonadectomized/postmenopausal women27.6 mgGeppert (1975); Leyendecker et al. (1975)
    K7510Normal premenopausal women~0.15 mgKeye & Jaffe (1975)
    S75a10Amenorrheic premenopausal women1 mgShaw et al. (1975)
    S75b15Normal premenopausal women0.5 mgShaw, Butt, & London (1975)
    S75b25Normal premenopausal women1.5 mgShaw, Butt, & London (1975)
    S75b35Normal premenopausal women2.5 mgShaw, Butt, & London (1975)
    L763Normal premenopausal women3 mgLeyendecker et al. (1976)
    C7822Infertile anovulatory premenopausal women1 mgCanales et al. (1978)
    S786Normal premenopausal women2.5 mgShaw (1978)
    T7819Premenopausal women with hyperprolactinemia (n=12) and after prolactin normalization (n=7) (2 injections per subject for 7 of 12 subjects)1 mgTravaglini et al. (1978)
    T7918Premenopausal women with hyperprolactinemia (n=9) given estradiol benzoate alone and then in combination with progesterone (2 injections per subject)1 mgTravaglini et al. (1979)
    O8010Premenopausal women on a combined birth control pill5 mgOriowo et al. (1980)
    C8114Lactating postpartum women (n=7) (2 injections per subject)3 mgCanales et al. (1981)
    W8119Premenopausal women with prolactinomas and hyperprolactinemia1 mgWhite et al. (1981)
    S822Men with XX male syndrome5 mgSchweikert et al. (1982)
    B8310Normal premenopausal women (n=5) not on and then on danazol (2 injections per subject)5 mgBraun, Wildt, & Leyendecker (1983)
    K8422Gonadectomized premenopausal women on oral combined hormone therapy1 mgKemeter et al. (1984)
    V847Premenopausal women with alcoholism and cirrhosis or fatty liver disease5 mgVälimäki et al. (1984)
    G8510Transfeminine people not on hormone therapy (n=5) and normal men (n=5)2 mgGoodman et al. (1985)
    A8618Infertile ovulatory premenopausal women with transient hyperprolactinemia (n=9) and normal premenopausal women (n=9)~5 mgAisaka et al. (1986)
    C8627Perimenopausal women with dysfunctional uterine bleeding2 mgCano et al. (1986)
    M875Normal premenopausal women10 mgMessinis & Templeton (1987a); Messinis & Templeton (1987b)
    S8711Normal premenopausal women1 mgSumioki (1987)
    B8920Infertile ovulatory premenopausal women (n=10) not on and then on a GnRH agonist (2 injections per subject)2 mgBider et al. (1989)
    V9349Premenopausal women on a GnRH agonist with gynecological disorders (n=15) or undergoing fertility treatment (n=6) (2–3 injections per subject)2.5 mgVizziello et al. (1993)
    E0625Premenopausal women with premenstrual mood disturbances (n=13) and normal premenopausal women (n=12)~2.5 mgEriksson et al. (2006)

    a Total number of injections, not total number of subjects.

    A number of studies were excluded from fitting due to much higher or lower area-under-the-curve levels than average. A couple of studies were omitted from the meta-analysis as they only reported total estrogen levels rather than estradiol levels with estradiol benzoate (Akande, 1974; Weiss, Nachtigall, & Ganguly, 1976). Two studies were omitted due partly to being very old and using very early and inaccurate blood tests (Varangot & Cedard, 1957; Ittrich & Pots, 1965 [Graph]). The processed original data and fit of fits curve for estradiol benzoate are shown in Figure 1.

    Figure 1: Published estradiol concentration–time curves and fit of fit curves (thick black or white line) with a single intramuscular injection of estradiol benzoate in oil solution over a period of 7 days. Each curve was adjusted for endogenous estradiol levels, normalized to a dose of 5 mg, and fit with a compartmental pharmacokinetic model. Following this, the combined fit curves of the individual studies were fit using the same pharmacokinetic model. The original data from the studies for estradiol benzoate are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Valerate

    Studies with curve data on injectable estradiol valerate come from its use in menopausal hormone therapy and other therapeutic indications for estrogens, its use in combined injectable contraceptives, and use in scientific research. A total of 28 publications and concentration–time data for 309 individual injections were identified for estradiol valerate (Table 3).

    Table 3: Studies of injectable estradiol valerate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    S717512Premenopausal women with menstrual migraine (n=10) and amenorrheic/postmenopausal women with history of menstrual migraine (n=2)5⁠–⁠20 mgSomerville (1971); Somerville (1972a); Somerville (1972b); Somerville (1972c); Somerville (1975)
    G753Gonadectomized/postmenopausal women26.2 mgGeppert (1975); Leyendecker et al. (1975)
    V75a4Unknown/not described10 mgVermeulen (1975)
    V75b2Unknown/not described4 mgVermeulen (1975)
    O809Premenopausal women on a combined birth control pill5 mgOriowo et al. (1980)
    R806Gonadectomized/postmenopausal women10 mgRauramo et al. (1980); Rauramo, Punnonen, & Grönroos (1981)
    B8210Normal premenopausal women with bromocriptine administration20 mgBlackwell, Boots, & Potter (1982)
    D833Normal postmenopausal women4 mgDüsterberg, & Wendt (1983)
    A857Normal premenopausal women5 mgAedo et al. (1985)
    D852Gonadectomized/postmenopausal women4 mgDüsterberg & Nishino (1982); Düsterberg, Schmidt-Gollwitzer, & Hümpel (1985)
    R877Normal young men10 mgReimann et al. (1987)
    S87a8Normal premenopausal women5 mgSang et al. (1987)
    S87b8Normal premenopausal women2.5 mgSang et al. (1987)
    S87c20Gonadectomized/postmenopausal women10 mgSherwin et al. (1987); Sherwin (1988)
    G8854Normally cycling transmasculine people not on hormone therapy (n=31), transfeminine people not on hormone therapy (n=14), and gonadally intact transfeminine people on oral estrogen therapy (n=9)10 mgGoh & Ratnam (1988)
    G9012Normally cycling transmasculine people not on hormone therapy10 mgGoh & Ratnam (1990)
    G94a8Normal premenopausal women5 mgGarza-Flores (1994)
    G94c5Normal premenopausal women5 mgGarza-Flores (1994)
    J949Normal young men10 mgJilma et al. (1994)
    G985Men with Klinfelter’s syndrome10 mgGoh & Lee (1998)
    G0217Normal postmenopausal women5 mgGöretzlehner et al. (2002)
    K0610Normal menopausal women2 mgKerdelhué et al. (2006)
    V1132Normal young men5 mgValle Alvarez (2011)
    S1248Normal postmenopausal women (n=24) given Estradiol-Depot 10 mg and then Progynon Depot-10 (2 injections per subject)10 mgSchug, Donath, & Blume (2012)

    a Total number of injections, not total number of subjects.

    A few of these studies were excluded from fitting due generally to much higher or lower area-under-the-curve levels than average or due to being Cmax data. One study was omitted as it only reported estrone levels rather than estradiol levels (Ibrahim, 1996). Another study was not included due to being in pregnant women with concomitant pregnancy termination (Garner & Armstrong, 1977). One last study was omitted due partly to being very old and using very early and inaccurate blood tests (Ittrich & Pots, 1965 [Graph]). The processed original data and fit curve for estradiol valerate are shown in Figure 2.

    Figure 2: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of estradiol valerate in oil solution over a period of 30 days. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 10 mg, and fit with a compartmental pharmacokinetic model. Fitting of the combined fits of individual studies for this preparation was explored but gave a nearly identical overall curve, so the overall fit curve for the combined processed original data was used for simplicity for this preparation. The original data from the studies for estradiol valerate are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Cypionate Oil

    Estradiol cypionate in oil is used in menopausal hormone therapy and for other estrogen indications. However, its use has been more limited relative to other injectable estradiol preparations, like estradiol valerate. Only a handful of studies with relevant data were identified for estradiol cypionate in oil. This included 4 publications and estradiol concentration–time data for 49 individual injections (Table 4).

    Table 4: Studies of injectable estradiol cypionate in oil (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    R736Hypogonadal adolescent girls1⁠–⁠2 mgRosenfield et al. (1973); Rosenfield & Fang (1974)
    B80~5Normal premenopausal women10 mgBuckman et al. (1980)
    O8010Premenopausal women on a combined birth control pill5 mgOriowo et al. (1980)
    L9628Postmenopausal women with history of hormonal migraine (n=16) and without (n=12) initially on oral estrogen therapy (discontinued upon injection)5 mgLichten et al. (1996)

    a Total number of injections, not total number of subjects.

    No curves were excluded from fitting in the case of this preparation. The processed original data and fit of fit curves for estradiol cypionate in oil are shown in Figure 3.

    Figure 3: Published estradiol concentration–time curves and fit of fit curves (thick black or white line) with a single intramuscular injection of estradiol cypionate in oil solution over a period of 30 days. Each curve was adjusted for endogenous estradiol levels, normalized to a dose of 5 mg, and fit with a compartmental pharmacokinetic model. Following this, the combined fit curves of the individual studies were fit using the same pharmacokinetic model. The original data from the studies for estradiol cypionate in oil are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Cypionate Suspension

    Estradiol cypionate suspension has been used exclusively in combined injectable contraceptives. For this reason, many relatively high quality pharmacokinetic studies with this injectable preparation have been conducted. A total of 9 publications and estradiol concentration–time data for 131 individual injections were identified for estradiol cypionate suspension (Table 5).

    Table 5: Studies of injectable estradiol cypionate suspension (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    F8211Normal premenopausal women5 mgFotherby et al. (1982)
    A858Normal premenopausal women5 mgAedo et al. (1985)
    G87a7Normal premenopausal women5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87b8Normal premenopausal women5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87c7Normal premenopausal women5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87d8Normal premenopausal women2.5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87e8Normal premenopausal women2.5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87f6Normal premenopausal women2.5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    Z989Normal premenopausal women5 mgZhou et al. (1998)
    R9914Healthy surgically sterile premenopausal women5 mgRahimy & Ryan (1999); Rahimy, Ryan, & Hopkins (1999)
    S11a15Normal premenopausal women5 mgSierra-Ramírez et al. (2011)
    S11bb15Normal premenopausal women5 mgSierra-Ramírez et al. (2011)
    T1315Normal premenopausal women5 mgThurman et al. (2013)

    a Total number of injections, not total number of subjects. b By subcutaneous injection rather than intramuscular injection.

    One of these studies used subcutaneous injection instead of the usual intramuscular injection but the resulting curve was very similar to the curve for intramuscular injection in the same study (Sierra-Ramírez et al., 2011 [Graph]). Several Cmax studies were excluded from fitting for this preparation. One pharmacokinetic study only measured estradiol cypionate levels rather than estradiol levels and hence was not included (Martins et al., 2019 [Graph]). The processed original data and fit of fit curves for estradiol cypionate suspension are shown in Figure 4.

    Figure 4: Published estradiol concentration–time curves and fit of fits curve (thick black or white line) with a single intramuscular (or in one case subcutaneous) injection of a microcrystalline aqueous suspension of estradiol cypionate over a period of 30 days. Each curve was adjusted for endogenous estradiol levels, normalized to a dose of 5 mg, and fit with a compartmental pharmacokinetic model. Following this, the combined fit curves of the individual studies were fit using the same pharmacokinetic model. The original data from the studies for estradiol cypionate suspension are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Enanthate

    Estradiol enanthate has been used exclusively in combined injectable contraceptives. Several pharmacokinetic studies have been conducted with it because of this. A total of 7 publications and concentration–time data for 270 individual injections were identified for estradiol enanthate (Table 6).

    Table 6: Studies of injectable estradiol enanthate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    R86a1Normal premenopausal woman5 mgRecio et al. (1986)
    R86b1Normal premenopausal woman10 mgRecio et al. (1986)
    W863Normal postmenopausal women10 mgWiemeyer et al. (1986); Wiemeyer et al. (1987)
    S8814Normal premenopausal women10 mgSchiavon et al. (1988)
    G8910Normal premenopausal women10 mgGarza-Flores et al. (1989)
    G94a9Normal premenopausal women10 mgGarza-Flores (1994)
    G94b9Normal premenopausal women5 mgGarza-Flores (1994)
    G94c7Normal premenopausal women10 mgGarza-Flores (1994)
    M95216Normal premenopausal women10 mgMartinez (1995)

    a Total number of injections, not total number of subjects.

    Of the available data, 216 of the injections were from a single study and mainly included only Cmax levels. Wiemeyer et al. (1986) was excluded from fitting due to having unusually high area-under-the-curve levels with a small sample size (n=3). Because of the scarcity of estradiol concentration–time data available for estradiol enanthate, Cmax studies were included in the fitting for this preparation. The processed original data and fit curve for estradiol enanthate are shown in Figure 5.

    Figure 5: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of estradiol enanthate in oil solution over a period of 30 days. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 10 mg, and fit with a compartmental pharmacokinetic model. The original data from the studies for estradiol enanthate are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Undecylate

    Estradiol undecylate was formerly used in the treatment of prostate cancer and in menopausal hormone therapy as well as for other estrogen therapeutic indications. However, it was discontinued many years ago and is no longer used today. Nonetheless, estradiol undecylate is of significant historical interest as an injectable estradiol preparation. A total of 3 publications and estradiol concentration–time data for 7 individual injections were identified for estradiol undecylate (Table 7).

    Table 7: Studies of injectable estradiol undecylate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    G753Gonadectomized/postmenopausal women32.3 mgGeppert (1975)/Leyendecker et al. (1975) [Graph]
    V754Unknown/not described100 mgVermeulen (1975)/Vermeulen (1977) [Graph]

    a Total number of injections, not total number of subjects.

    Unfortunately, the identified data were of very low quality, with small sample sizes and considerable variations in estradiol levels. Moreover, estradiol undecylate is a very long-acting injectable estradiol ester with a duration measured in months, and the follow up in these studies only went to about 2 weeks post-injection. For these reasons, it was not possible to fit the data for estradiol undecylate in a reasonably accurate way—as suggested by area-under-the-curve estradiol levels that were only around one-third those of the other non-polymeric injectable estradiol esters. Limited multi-dose hormone concentration–time data also exist for estradiol undecylate, but these data could not be incorporated (Jacobi & Altwein, 1979 [Graph]; Jacobi et al., 1980 [Graph]; Derra, 1981 [Graph]). The processed original data and fit curve for estradiol undecylate are shown in Figure 6.

    Figure 6: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of estradiol undecylate in oil solution over a period of 90 days. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 50 mg, and fit with a compartmental pharmacokinetic model. The original data from the studies for estradiol undecylate are also provided elsewhere (Spreadsheet; Plotly).

    Polyestradiol Phosphate

    Polyestradiol phosphate has been used primarily in the treatment of prostate cancer but has also been used for estrogen therapeutic indications like treatment of breast cancer and menopausal hormone therapy. While this injectable estradiol preparation has been used widely in the past, it appears to have recently been discontinued. All of the identified studies with estradiol concentration–time data on polyestradiol phosphate were in men with prostate cancer. A total of 11 publications and concentration–time data for 114 individual injections were identified for polyestradiol phosphate (Table 8).

    Table 8: Studies of injectable polyestradiol phosphate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    J7616Men with prostate cancer160 mgJönsson (1976)
    L7910Men with prostate cancer80 mgLeinonen et al. (1979)
    L808Men with prostate cancer80 mgLeinonen (1980)
    J824Men with prostate cancer80 mgJacobi (1982)
    N87a3Men with prostate cancer80 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87b3Men with prostate cancer160 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87c3Men with prostate cancer240 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87d4Men with prostate cancer80 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87e4Men with prostate cancer160 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87f4Men with prostate cancer240 mgNorlén (1987); Gunnarsson & Norlén (1988)
    S88a9Men with prostate cancer160 mgStege et al. (1988); Stege et al. (1989)
    S88b9Men with prostate cancer240 mgStege et al. (1988); Stege et al. (1989)
    S88c9Men with prostate cancer320 mgStege et al. (1988); Stege et al. (1989)
    S9611Men with prostate cancer320 mgStege et al. (1996)
    H9917Men with prostate cancer240 mgHenriksson et al. (1999); Johansson & Gunnarsson (2000)

    a Total number of injections, not total number of subjects.

    A few older and strongly outlying studies were excluded from the fitting. The processed original data and fit curve for polyestradiol phosphate are shown in Figure 7.

    Figure 7: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of an aqueous solution of polyestradiol phosphate over a period of 90 days. The graph was clipped to maximum estradiol levels of 600 pg/mL (~2,200 pmol/L) for better viewability. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 160 mg, and fit with a compartmental pharmacokinetic model. The original data from the studies for polyestradiol phosphate are also provided elsewhere (Spreadsheet; Plotly).

    Other Injectable Estradiol Preparations

    A number of clinical studies with estradiol concentration–time data for other injectable estradiol preparations were also identified during literature search:

    These preparations were not included in the present meta-analysis due to their relative obscurity and the limited data available for them. In addition, there were concerns about fitting the used pharmacokinetic models to the formulations with multiple estradiol components and to the microsphere formulations.

    No estradiol concentration–time data were identified for certain other injectable estradiol forms of interest, like unesterified estradiol in aqueous solution, estradiol benzoate as a microcrystalline aqueous suspension (Agofollin Depot; Ovocyclin M), or estradiol benzoate butyrate/dihydroxyprogesterone acetophenide in oil (Redimen, Soluna, Unijab) (another lesser-known combined injectable contraceptive).

    All Injectable Estradiol Preparations Together

    Figure 8 shows the curve fits for all of the injectable estradiol preparations scaled to a single dose of 5 mg (or equivalent) together in the same figure. The dose for polyestradiol phosphate was scaled to be about 6.5 times higher than the other injectable estradiol preparations in order to make it roughly equivalent to them in terms of total estradiol exposure. This was because polyestradiol phosphate was found to produce much lower area-under-the-curve estradiol levels than the other injectable estradiol preparations (see the Discussion section). Estradiol undecylate was not included in Figure 8 as a decent fit curve could not be obtained for it due to the very limited data available for this preparation.

    Figure 8: Curve fits of published estradiol concentration–time data with different injectable estradiol preparations by intramuscular injection scaled to equivalent doses and plotted over a period of 20 days in a single combined graph. Polyestradiol phosphate is scaled to a 6.5-fold higher dose that is roughly equivalent to that for the other esters as it gave total estradiol levels that were around 6 or 7 times lower than the other esters at the same dose. An alternative version of this figure without estradiol benzoate and with the x-axis spanning 30 days is also provided (Graph).

    Figure 9 shows simulated curves at steady state for repeated administration of all of the injectable estradiol preparations scaled to a dose of 5 mg (or equivalent) once every 7 days. As with the previous figure, the dose for polyestradiol phosphate was scaled to be about 6.5 times higher than the other injectable estradiol preparations and estradiol undecylate was not included in the figure.

    Figure 9: Simulated curves at steady state for repeated administration of different injectable estradiol preparations by intramuscular injection scaled to equivalent doses and plotted over three injection cycles. This simulation was based on the fit curves of the published single-dose estradiol concentration–time data reported in this meta-analysis. Polyestradiol phosphate is scaled to a 6.5-fold higher dose that is roughly equivalent to that for the other esters as it gave total estradiol levels that were around 6 or 7 times lower than the other esters at the same dose. An alternative version of this figure without estradiol benzoate is also provided (Graph).

    For more simulated estradiol concentration–time curves with repeated injections of these injectable estradiol preparations, please see the accompanying interactive web simulator.

    Selected Pharmacokinetic Parameters

    The table below shows selected pharmacokinetic parameters for the fit curves of the included injectable estradiol preparations (Table 9). Estradiol undecylate was not included in the table due to the lack of data needed to achieve a decent curve fit for this preparation and the uncertainty of its parameters.

    Table 9: Selected pharmacokinetic parameters for estradiol with injectable estradiol preparations following a single 5 mg dose by intramuscular injection:

    Estradiol preparationTmax
    (d)    		Cmax
    (pg/mL)    		t1/2
    (d)    		t90%
    (d)    		AUC0–∞
    (pg•d/mL)
    Estradiol benzoate in oil0.659711.23.92410
    Estradiol valerate in oil2.12953.09.91886
    Estradiol cypionate oil4.31556.722.32150
    Estradiol cypionate suspension1.22415.116.92096
    Estradiol enanthate in oil6.51604.615.12183
    Polyestradiol phosphate a18.03428.494.22117

    a Scaled instead to a single 32.5 mg injection (6.5 times higher dose than with the other esters).

    The table below shows selected pharmacokinetic parameters for simulated curves at steady state with repeated administration of the included injectable estradiol preparations (Table 10). As with the previous table, estradiol undecylate was not included.

    Table 10: Selected pharmacokinetic parameters for estradiol with injectable estradiol preparations with simulated repeated administration of 5 mg once every 7 days by intramuscular injection:

    Estradiol preparationTmax
    (d)    		Cmax
    (pg/mL)    		Cmin
    (pg/mL)    		Peak–trough
    diff. (pg/mL)    		Peak–trough
    ratio    		Cavg
    (pg/mL)
    Estradiol benzoate in oil0.649902996235344
    Estradiol valerate in oil1.93841422422.7269
    Estradiol cypionate oil3.1339262771.3307
    Estradiol cypionate suspension1.04041892142.1299
    Estradiol enanthate in oil4.0329288411.1312
    Polyestradiol phosphate a3.230429951.0302

    a Scaled instead to repeated injections of 32.5 mg every 7 days (6.5 times higher dose than with the other esters).

    Terminal half-life (t1/2) is the time for the concentration of estradiol to decrease by 50% after pseudo-equilibrium of distribution has been reached—not the time required for half of an administered dose of the estradiol ester to be eliminated (Toutain & Bousquet-Mélou, 2004). It is calculated using only the terminal portion of a concentration–time curve, without the absorption or distribution phases influencing it (Toutain & Bousquet-Mélou, 2004). Due to flip–flop kinetics with depot injectables and the very short blood half-life of estradiol (~0.5–2 hours), what is being described by the terminal half-life in the case of depot estradiol injectables is not actually elimination of estradiol from blood but rather is the absorption of estradiol from the injection-site depot (Toutain & Bousquet-Mélou, 2004; Yáñez et al., 2011).

    Discussion

    Data Quality, Limitations, and Variability Between Studies

    The accuracies of the curve fits for the different included injectable estradiol preparations are limited by the available data for these preparations. The quantity and quality of data are variable among these preparations. In some cases, such as with estradiol valerate in oil and estradiol cypionate in suspension, the data are overall quite good. In other instances, such as with estradiol cypionate in oil and estradiol enanthate in oil, the available data are more limited. There was undersampling of certain parts of the concentration–time curve with some preparations, for instance estradiol benzoate in oil (the early curve), estradiol enanthate in oil (much of the curve), and polyestradiol phosphate (the late curve). In the case of estradiol undecylate in oil, the available data for this preparation weren’t adequate to achieve a decent curve fit at all. The fit curves and calculated pharmacokinetic parameters of the included injectable estradiol preparations should be interpreted with the imperfect data in mind. For example, the curve shapes and pharmacokinetic parameters for the different preparations should not be taken as precise determinations in most cases but instead as rough estimates that would no doubt change with more and better data. Indeed, the fits and pharmacokinetic parameters were often noticeably sensitive to the influences of individual studies. Modeling decisions, such as the choice of pharmacokinetic model, or whether to fit directly to the combined processed data versus to the fits of individual studies, also yielded significantly different curve fits as well as calculated pharmacokinetic parameters.

    Due to scarcity of data for several injectable estradiol preparations, the study selection criteria maximized data inclusion in order to allow for better curve fits at the risk of including potentially less reliable data. As examples, studies were included regardless of the status of the HPG axis of the participants, and Cmax data were included in the fitting if data were very limited. In the case of HPG axis state, studies with cycling women may result in greater error due to more variable levels of endogenous estradiol. Moreover, acute high levels of estradiol can induce a surge in luteinizing hormone levels after several days in gonadally intact women, and this may cause a delayed bump in estradiol levels (Wiki). One of the more overt instances of this can be seen in a study of estradiol benzoate in such women (Shaw, 1978 [Graph]). Many if not most of the included studies with estradiol benzoate involved women with intact HPG axes, whereas studies of this sort were uncommon with the other preparations. In the case of Cmax data, these data when Cmax corresponds to the mean of individual peaks are a different type of data than the peak of the mean curve of all individuals. Cmax levels can differ in both magnitude and timing compared to the mean curve peak (e.g., Oriowo et al., 1980 [Graph]; Rahimy, Ryan, & Hopkins, 1999). This is because for instance not all individuals peak at the same time and this variability in time to peak normally serves to dilute peak levels for the mean curve when compared to individual maximal concentrations. However, Cmax levels are in any case generally in the vicinity of the mean curve peak. While Cmax levels were excluded in the fitting for most injectable estradiol preparations, they were included in the case of estradiol enanthate. This was because the available mean and individual estradiol curve data were very limited for this specific preparation, and inclusion of Cmax data allowed for improved fitting in spite of its limitations. Lastly, some of the included data was once-monthly multi-dose, and research with once-monthly estradiol enanthate-containing combined injectable contraceptives has found that the time to peak levels may shift with repeated long-term use (Schiavon et al., 1988; Garza-Flores, 1994).

    There was considerable variability between studies in terms of estradiol levels and concentration–time curve shapes with the same injectable estradiol preparation. The reasons for the large variability across studies are not fully clear. In any case, there are many potential factors that may contribute to this variability. These include preparation- and injection-related factors like formulation (e.g., oil vehicle, other components and excipients, concentration, particle size), injection volume, site of injection (e.g., buttocks, thigh, upper arm), injection technique (e.g., force of injection—and resulting depot droplet dimensions), and syringe dead space. They additionally include various subject- and research-related variables like differing blood-testing methodology, differing sample characteristics (e.g., age, weight, gender, ethnicity, physical activity, HPG axis state), and sampling error (Sinkula, 1978; Chien, 1981; Minto et al., 1997; Larsen & Larsen, 2009; Larsen et al., 2009; Florence, 2010; Larsen, Thing, & Larsen, 2012; Kalicharan, 2017). Older studies, which used potentially less accurate blood tests and tended to have smaller numbers of subjects, seemed to particularly add to the variability between studies. These studies may represent less reliable data than more recent research with larger sample sizes. The exclusion criteria helped to remove outliers for the different injectable estradiol preparations however. This meta-analysis does not take into account the potential factors underlying the variability between studies. To do so would be difficult, as in many cases information on these variables is not provided in individual studies and research quantifying their precise influences and relative importances is limited.

    It is in any case known from other studies that different oil vehicles are absorbed at different rates from the injection site (Svendsen & Aaes‐Jørgensen, 1979; Schultz et al., 1998; Larsen et al., 2001) and can result in different concentration–time curve shapes (Ballard, 1978 [Excerpt]; Knudsen, Hansen, & Larsen, 1985). This is thought to be due to differences in oil lipophilicity and depot release rates. Viscosity of oils has also been hypothesized to potentially influence rate of depot escape (Schug, Donath, & Blume, 2012). However, research so far has not supported this hypothesis (Larsen & Larsen, 2009; Larsen, Thing, & Larsen, 2012). Oil vehicles can vary with injectable estradiol preparations even for the same estradiol ester. For instance, pharmaceutical estradiol valerate is formulated in sesame oil, castor oil, or sunflower oil depending on the preparation (Table). It is notable however that these three oils have similar lipophilicities (Table). On the other hand, homebrewed injectable estradiol preparations used by DIY transfeminine people often employ medium-chain triglyceride (MCT) oil as the oil vehicle. This oil (in the proprietary form of Viscoleo) has notably been found to be much more rapidly absorbed than conventional oils like sesame oil and castor oil in animals (Svendsen & Aaes‐Jørgensen, 1979; Schultz et al., 1998; Larsen et al., 2001). In addition, although based on very limited data, MCT oil has been found to give spikier and shorter-lasting depot injectable curves in humans (Knudsen, Hansen, & Larsen, 1985). As such, injectable estradiol preparations using MCT oil as the vehicle may have differing and less favorable concentration–time curve shapes than pharmaceutical injectable estradiol products. Other excipients, like benzyl alcohol, as well as factors like injection site and volume, have additionally been found to influence pharmacokinetic properties with depot injectables (Minto et al., 1997; Kalicharan, Schot, & Vromans, 2016). Excipients besides oil vehicle also vary by formulation (Table).

    An implication of the variability between studies is that there is not a single estradiol concentration–time curve for a given injectable estradiol preparation but rather there are many, with these curves determined by variables such as formulation, dose/administration, and subject characteristics, among others. Hence, the curve fits determined in this meta-analysis represent only an estimation of the most typical and hence likely case, but the true curve for a preparation in a given context may be quite different.

    Fitting all studies for a given injectable estradiol preparation individually first, and then fitting the fits of these studies, allowed for improved curve fits relative to directly fitting all of the combined processed original data for the preparation. The latter approach has limitations in that it has the effect of inherently weighting individual studies by quantity of time points (resulting in studies with greater time sampling having greater influence on the fit). Additionally, and more problematically, this approach can lead to distortions in curve shape due to different studies sampling different portions of the curve to differing extents in conjunction with systematic differences in curves between these studies. These are problems that fitting the fits of individual studies instead can solve. However, it is not possible to fit all individual studies, as some studies have limited time sampling and curve characterization which precludes fitting them appropriately. Cmax data are an example of this, which on their own cannot be fit properly. As such, it was not possible to fit the fits of the individual studies for all injectable estradiol preparations. Consequently, the fitting approach in this regard was not the same across esters, with some fit instead directly to the combined processed original data (e.g., estradiol enanthate, polyestradiol phosphate).

    In spite of the various limitations of this work, aggregated analysis and modeling with injectable estradiol preparations has not previously been done. This informal meta-analysis provides among the most detailed insight into estradiol levels and curve shapes with these preparations available to date.

    Durations and Curve Shapes

    The curve shapes of non-polymeric injectable estradiol esters in oil relate strongly to lipophilicity. The more lipophilic the ester, the lower the peak levels and the more protracted the estradiol concentration–time curve. Accordingly, estradiol benzoate, one of the least lipophilic estradiol esters, has one of the spikiest curves and shortest durations, whereas more lipophilic estradiol esters, like estradiol cypionate in oil and estradiol enanthate, have comparatively flatter curves with delayed peaks and longer durations.

    Duration of Estradiol Valerate

    The estradiol concentration–time curve for injectable estradiol valerate in the well-known Oriowo et al. (1980) [Graph] study is notably spikier and shorter-lasting than the overall curve for estradiol valerate in this meta-analysis. On the other hand, the overall curve for injectable estradiol valerate in this meta-analysis was similar to (and considerably influenced by) the curves from several relatively recent and presumably better-quality studies of this injectable estradiol ester (e.g., Göretzlehner et al., 2002; Valle Alvarez, 2011; Schug, Donath, & Blume, 2012). It’s noteworthy that Oriowo et al. (1980) used a peanut oil-based formulation of estradiol valerate that differed from pharmaceutical injectable estradiol valerate preparations, which generally use sesame oil or castor oil as the carrier (as well as other excipients) (Table). This may have influenced the curve shape of estradiol valerate in Oriowo et al. (1980). The study also had a small sample size relative to the more recent studies (n=9 versus n=17, n=32, and n=24×2, respectively). Based on the newer and overall data, estradiol valerate appears to have a curve that is noticeably flatter and more prolonged than that suggested by Oriowo et al. (1980).

    Duration of Estradiol Cypionate in Oil versus Estradiol Enanthate

    Available estradiol concentration–time data for injectable estradiol cypionate in oil and estradiol enanthate in oil are more limited than with several of the other injectable estradiol preparations, and no direct comparisons of these two preparations exist at present. Based on some of the available literature on these injectable estradiol esters, most notably discussion by Oriowo et al. (1980) and a review of the pharmacokinetics of combined injectable contraceptives (Garza-Flores, 1994 [Graph]), it seemed that the duration of estradiol enanthate in oil was longer than that of estradiol cypionate in oil. However, this was based on limited research from separate and hence indirectly comparative studies of these esters. The estradiol cypionate in oil data from the relevant Garza-Flores (1994) figure was based on Oriowo et al. (1980) [Graph], and there are reasons to be cautious about relying on these data alone. The main concern is that curve shapes with the same injectable estradiol preparation can vary considerably across studies, as the present meta-analysis has shown. The reasons for this have yet to be fully clarified as already discussed, but among other factors may include varying formulations across studies of the same injectable estradiol ester. It is notable in this regard that Oriowo et al. (1980) used a formulation of estradiol cypionate that differs from conventional pharmaceutical estradiol cypionate in oil preparations—specifically, the study used a peanut oil-based formulation (with few other specifics) rather than the cottonseed oil-based preparation employed in marketed pharmaceutical formulations (Table). The study also had a somewhat small sample size (n=10) and may have had significant sampling error. Hence, single studies, perhaps particularly Oriowo et al. (1980), should be interpreted cautiously.

    A small but interesting pharmacokinetic study which directly compared injectable testosterone cypionate (n=6) and testosterone enanthate (n=6) both in oil is relevant to the topic in question. This study found that equivalent doses of these testosterone esters using otherwise identical formulations produced virtually identical testosterone concentration–time curves (Schulte-Beerbühl & Nieschlag, 1980 [Graph]). The findings of this study are consistent with the fact that the lipophilicities of testosterone cypionate and testosterone enanthate (as measured by predicted log P) are very similar when directly compared (e.g., 5.1 vs. 5.11 with ALOGPS, 6.29 vs. 6.11 with ChemAxon logP, and 6.4 vs. 6.3 with XLogP3, respectively (Table). This of course is of importance as lipophilicity is thought to be the key factor determining the release kinetics of oil-based depot injectables (Sinkula, 1978; Shah, 2007; Larsen & Larsen, 2009; Larsen, Thing, & Larsen, 2012; Shahiwala, Mehta, & Momin, 2018). Analogously similar lipophilicities can be seen when comparing estradiol cypionate and estradiol enanthate, which employ the same ester moieties (e.g., predicted log P values of 6.47 vs. 6.45 with ALOGPS and 7.1 vs. 7.0 with XLogP3, respectively) (Table). Hence, on a theoretical level, injectable estradiol cypionate and estradiol enanthate, like injectable testosterone cypionate and testosterone enanthate, might be expected to produce very similar curves—at least provided all other variables, such as formulation, are held constant.

    The present meta-analysis found that the overall estradiol curve for estradiol cypionate in oil was significantly less spikey and more prolonged than that observed in Oriowo et al. (1980). It is noteworthy in this regard that all of the other studies included for estradiol cypionate in oil specifically employed pharmaceutical Depo-Estradiol and that the overall curve for this preparation appears to be more consistent with its licensed injection interval for use in menopausal hormone therapy (1–5 mg once every 3–4 weeks) (Depo-Estradiol Label). Moreover, this meta-analysis found that injectable estradiol cypionate in oil and estradiol enanthate in oil had fairly similar and comparably flat and prolonged estradiol concentration–time curves. However, estradiol cypionate in oil appeared to peak earlier than estradiol enanthate, while estradiol enanthate was eliminated more rapidly than estradiol cypionate in oil in the terminal portion of the curve. In any case, the available concentration–time data for these preparations are limited, and the present work is not able to determine whether these estradiol esters have truly differing pharmacokinetic properties, as the apparent differences between the curves for these preparations may simply be due to statistical error. Taken together, estradiol cypionate in oil may have a less spikey and longer-lasting curve than that implied by Oriowo et al. (1980), and estradiol cypionate in oil and estradiol enanthate may have more similar curves than has been previously assumed.

    Curve Shape of Estradiol Cypionate Suspension

    While estradiol cypionate as an aqueous suspension is a relatively long-lasting injectable estradiol preparation similarly to estradiol cypionate in oil and estradiol enanthate in oil, it seems to differ in the shape of its estradiol concentration–time curve from these preparations. Estradiol cypionate as a suspension has a curve that appears to peak significantly earlier than estradiol cypionate in oil and other longer-acting oil-based injectable estradiol preparations. This might relate to the differing mechanisms of depot action and unique properties of injectable aqueous suspensions (Aly, 2019). In line with this notion, injectable medroxyprogesterone acetate suspension (Depo-Provera) also appears to peak rapidly despite having a very long duration (longer durations tending to be associated with delayed peaks in the case of oil-based depot injectables) (Graphs). Although aqueous suspensions generally last longer than oil solutions as injectables (Enever et al., 1983; Aly, 2019), this is not always the case, and estradiol cypionate suspension interestingly seems to be shorter-acting than estradiol cypionate in oil.

    Estradiol Exposure and Potency

    The average estradiol levels with the non-polymeric injectable estradiol esters when scaled to a dose and dosing interval of 5 mg every 7 days were around 300 pg/mL (~1,100 pmol/L). For comparison, in premenopausal cisgender women, estradiol production is on average about 200 μg/day (or 6 mg per month/cycle) and mean estradiol levels are around 100 pg/mL (~370 pmol/L) (Aly, 2019). After adjusting for the molecular weight of the ester, the estradiol levels for a given dose of non-polymeric injectable estradiol esters are in fairly close agreement with the estradiol levels for an equal quantity of estradiol produced endogenously by the ovaries in premenopausal cisgender women (very roughly around 1.2 mg estradiol per 7 days for injectable estradiol esters and 1.4 mg estradiol per 7 days for ovarian production to achieve average integrated estradiol levels of around 100 pg/mL). The preceding is in accordance with the fact that injectable estradiol valerate has been reported to have approximately 100% bioavailability (with this being less characterized but likely also the case for the other non-polymeric injectable estradiol esters) (Düsterberg & Nishino, 1982; Seibert & Günzel, 1994).

    Although non-polymeric injectable estradiol esters have differing estradiol concentration–time curve shapes, they all appear to achieve fairly similar area-under-the-curve levels of estradiol when compared to one another. This is in accordance with the fact that differences in molecular weight and hence estradiol content with the different estradiol esters are fairly minor (all of the assessed non-polymeric esters range from 62 to 76% of that of estradiol in terms of estradiol content, and all but estradiol undecylate are in the range of 69 to 76%) (Table). The appearance of differences in area-under-the-curve levels of estradiol in the present meta-analysis is probably just due to statistical error, and true differences cannot be established by this meta-analysis. An implication of the similar area-under-the-curve estradiol levels with the different non-polymeric injectable estradiol esters is that these preparations can all be expected to deliver a roughly comparable amount of estradiol for the same dose.

    On the other hand, the polymeric ester polyestradiol phosphate appears to produce around 6- to 7-fold lower area-under-the-curve and average estradiol levels than non-polymeric estradiol esters. This suggests that the estradiol in polyestradiol phosphate is not 100% bioavailable, and is supported by the fact that this ester is used clinically at substantially higher dosages than other injectable estradiol esters (40–320 mg/month), even for the same indications such as menopausal hormone therapy and treatment of prostate cancer (Wiki; Estradurin Labels). This does not seem to have been previously described in the literature, and the reasons for it are unknown. It seems possible that polyestradiol phosphate may be partially excreted before it can be cleaved into estradiol and thereby rendered partly inactive, in turn necessitating the use of higher doses to achieve the same estradiol levels and therapeutic effect.

    Although two given injectable estradiol preparations may produce equivalent total estradiol levels, this does not necessarily mean that they will always have the same estrogenic potency (i.e., strength of effect at a given dose). It is plausible that spikier estradiol concentration–time curves, like with estradiol benzoate, may have overall lower estrogenic potency than more steady curves, like with estradiol enanthate. This is because estrogen receptors for a given tissue should become saturated at a certain point due to the finite quantity of available receptors in the tissue. As a result, high peak estradiol levels with spikier curves may effectively be “wasted” to varying extents in different tissues. On the other hand, more spikey estradiol curves, due to higher peak estradiol levels, might have greater influence on tissues that require high estradiol levels for effect such as the liver (and by extension on coagulation and associated health risks) (Aly, 2020). However, these possibilities are speculative and theoretical. Although some literature exists that is relevant to this issue (e.g., Parkes, 1937; Bradbury, Long, & Durham, 1953), there is very little research in this area. Consequently, it is not currently possible to take into account time-related variations in estradiol levels or differing estradiol curve shapes when assessing the comparative estrogenic potency between injectable estradiol preparations (or between other estradiol forms/routes). It is also noteworthy that these variations depend on injection interval and may be reduced with shorter injection intervals that maintain steadier estradiol levels, which must also be considered.

    Variability Between Individuals

    There is substantial variation in total estradiol levels and curve shapes between people with the same injectable estradiol preparation. Indicators of interindividual variability such as standard deviation or 95% range have not been included in this meta-analysis at this time due to the large amount of additional time and work this would require (e.g., additional extraction of error bars from all studies and analysis). In any case, individual studies that were included show this marked interindividual variation (e.g., Oriowo et al., 1980; Derra, 1981 [Graph]; Aedo et al., 1985 [Graphs]; Sang et al., 1987 [Graphs]; Rahimy & Ryan, 1999 [Graph]; Valle Alvarez, 2011 [Graph]; Schug, Donath, & Blume, 2012 [Graphs]). Highly variable estradiol levels are already well-established with oral and transdermal estradiol (Kuhl, 2005; Wiki). Less variability might be expected with non-polymeric injectable estradiol esters since these preparations appear to have approximately complete bioavailability. However, it seems that even with injectable forms of estradiol, the variability between people is still quite substantial. An implication of this is that the appropriate dose and dosing interval of an injectable estradiol formulation for a given person will vary considerably. This emphasizes the importance of blood work to ensure that injectable estradiol preparations are neither overdosed—which can increase health risks such as blood clots (Aly, 2020)—nor underdosed—which may result in suboptimal testosterone suppression and therapeutic efficacy.

    Insights for Clinical Guidelines and Dosing Recommendations

    Clinical guidelines for transgender health (see also Aly (2020)) provide recommendations on doses and dosing intervals of injectable estradiol valerate in oil and estradiol cypionate in oil (Table 11). Dosing recommendations are not given for other injectable estradiol preparations, which are much less commonly used in transgender medicine. The recommended doses for estradiol valerate and estradiol cypionate vary widely depending on the guidelines, whereas the recommended intervals are consistently once every 1 to 2 weeks. The doses for estradiol valerate range from 2 to 20 mg/week or 5 to 80 mg/2 weeks and the doses for estradiol cypionate range from <1 to 10 mg/week or <2 to 80 mg/2 weeks. For reference, the Endocrine Society guidelines and the University of California, San Francisco (UCSF) guidelines are the most major clinical guidelines for transgender hormone therapy at present (Aly, 2020). The Endocrine Society guidelines recommend 5 to 30 mg/2 weeks or 2 to 10 mg/week for either estradiol valerate or estradiol cypionate (Hembree et al., 2017). Conversely, the UCSF guidelines recommend <20 to 40 mg/2 weeks for estradiol valerate and <2 to 5 mg/2 weeks for estradiol cypionate (with the option to divide dose into weekly injections if cyclical side effects occur) (Deutsch, 2016a).

    Table 11: Recommended doses and injection intervals of injectable estradiol preparations (specifically estradiol valerate and estradiol cypionate) in transgender medicine clinical guidelinesa:

    GuidelinesEster(s)Dose ranges and intervals
    Endocrine Society / Hembree et al. (2017)Estradiol valerate or cypionate5–30 mg/2 weeks or 2–10 mg/week i.m.
    UCSF / Deutsch (2016b)Estradiol valerateInitial–low: <20 mg/2 weeks i.m.
    Initial: 20 mg/2 weeks i.m.
    Maximum: 40 mg/2 weeks i.m.
    Note: “May divide dose into weekly injections for cyclical symptoms”
    Note: Specifically for transfeminine adults
     Estradiol cypionateInitial–low: <2 mg/2 weeks i.m.
    Initial: 2 mg/2 weeks i.m.
    Maximum: 5 mg/2 weeks i.m.
    Note: “May divide dose into weekly injections for cyclical symptoms”
    Note: Specifically for transfeminine adults
    UCSF / Olson-Kennedy et al. (2016)Estradiol valerate5–20 mg/2 weeks
    Maximum: 30–40 mg/2 weeks
    Note: Specifically for transfeminine youth
     Estradiol cypionate2–10 mg/week
    Note: Specifically for transfeminine youth
    Fenway Health / Cavanaugh et al. (2015)Estradiol valerateInitial: 5–10 mg/week i.m.
    Usual: 20 mg/2 weeks i.m.
    Maximum: 40 mg/2 weeks i.m.
     Estradiol cypionateInitial: 2.5 mg/2 weeks i.m.
    Usual: 5 mg/2 weeks i.m.
    Maximum: 10 mg/2 weeks i.m.
    Callen-Lorde (2018)Estradiol valerateInitial: 10–20 mg/2 weeks
    Maximum: 20–40 mg/2 weeks
     Estradiol cypionateInitial: 2.5 mg/2 weeks
    Maximum: 5 mg/2 weeks
    Davidson et al. / Tom Waddell Health Center (2013)Estradiol valerate or cypionateInitial: 20–40 mg/2 weeks i.m.
    Average: 40 mg/2 weeks i.m.
    Maximum: 40–80 mg/2 weeks i.m.
    Bourns / Sherbourne Health / Rainbow Health Ontario (2019)Estradiol valerateInitial: 3–4 mg/week or 6–8 mg/2 weeks
    Usual: Variable
    Maximum: 10 mg/week
    Trans Care BC (2021)Estradiol valerateInitial: 5 mg/week i.m. or s.c.
    Usual: 10–20 mg/week i.m. or s.c.
    Every 2 weeks at 2x dose may be tolerated in some
    Dahl et al. / Vancouver Coastal Health (2015)Estradiol valerate20–40 mg/2 weeks i.m.
    Note: “Alternative estrogen therapy for 3–6 months only”
    European Society for Sexual Medicine / T’Sjoen et al. (2020)Estradiol valerate5–30 mg/1–2 weeks i.m.
     Estradiol cypionate2–10 mg/week i.m.
    TransLine (2019)Estradiol valerateInitial/Usual: 5–10 mg/week
    Maximum: 20 mg/week
     Estradiol cypionateInitial/Usual: 1.25–2.5 mg/week
    Maximum: 5 mg/week

    a Several other guidelines recommend doses and intervals that appear to be taken directly from the Endocrine Society or UCSF guidelines and thus are not listed here but can be found elsewhere (Aly, 2020).

    A number of concerns arise when the doses and intervals of injectable estradiol valerate and estradiol cypionate recommended by the major transgender clinical guidelines are considered in the context of the present informal meta-analysis and when they are compared between guidelines. Based on the present work, dosages of injectable preparations recommended by the major transgender clinical guidelines appear to result in estradiol exposure that is markedly higher than that with the recommended dosages for other routes and forms of estradiol (e.g., oral or transdermal). Whereas a dosage of 5 mg/week of any non-polymeric injectable estradiol ester appears to give average estradiol levels of around 300 pg/mL (~1,100 pmol/L), which are already supraphysiological, doses of injectable estradiol valerate or estradiol cypionate recommended by guidelines are as high as 15 to 20 mg per week. The average estradiol concentrations that would be expected to result from such doses per this meta-analysis (e.g., ~600–1,200 pg/mL or 2,200–4,400 pmol/L at 10–20 mg/week) (Figure 10) would vastly exceed the ranges for estradiol levels in transfeminine people advised by the same guidelines (generally about 50–200 pg/mL or ~180–730 pmol/L) (Table). This is not merely theoretical; for example, a study that used 40 mg/week estradiol valerate by intramuscular injection in cisgender women with estrogen deficiency to produce “pseudopregnancy” reported measured estradiol levels of about 2,500 pg/mL (~9,200 pmol/L) at 3 months and 3,100 pg/mL (~11,400 pmol/L) at 6 months of treatment (Ulrich, Pfeifer, & Lauritzen, 1994). Moreover, highly supraphysiological estradiol levels with guideline-based injectable estradiol doses are not unexpected when normal production of estradiol in premenopausal cisgender women is considered (~1.4 mg per week or 6 mg per month/cycle giving mean estradiol levels of ~100 pg/mL or 370 pmol/L) (Aly, 2019). Clinical safety data on high doses of injectable estradiol esters like estradiol valerate and estradiol cypionate are lacking at present, but excessive estrogenic exposure is known to increase the risk of health complications such as blood clots (Aly, 2020). The very high doses of these preparations that are recommended by guidelines should raise considerable reservations about their safety.

    Figure 10: Simulated estradiol levels with injectable estradiol valerate at the doses and interval (5–40 mg/2 weeks) preferentially recommended by current major transgender care guidelines. Steady-state estradiol levels are reached by about the second or third injection with this injection interval and levels do not further accumulate. An alternative version of this figure with half-doses at a once-weekly interval (i.e., 2.5–20 mg/week) is also provided (Graph).

    The present author elsewhere has listed doses of injectable estradiol preparations that are roughly comparable in terms of total estradiol exposure to doses for other estradiol forms and routes used in transfeminine people (Aly, 2020). These doses range from about 1 to 6 mg per week for “low dose” to “very high dose” therapy with non-polymeric injectable estradiol esters (Graph). This dose range for injectable estradiol is likely to be more appropriate for use in transfeminine people than current recommendations by many guidelines. Although high estradiol levels can be useful in transfeminine hormone therapy when antiandrogens are not used due to their greater efficacy than physiological levels in terms of testosterone suppression, only modestly supraphysiological estradiol levels (e.g., ~200–300 pg/mL or 730–1,100 pmol/L) appear to be required for strong testosterone suppression (Aly, 2019; Langley et al., 2021; Aly, 2020). In relation to this, doses of injectable estradiol need not be excessive.

    Some guidelines, such as the Endocrine Society guidelines, recommend the same doses and intervals for both estradiol valerate and estradiol cypionate, whereas other guidelines, such as the UCSF guidelines, recommend different doses for these two injectable estradiol esters. Concerningly, the doses for estradiol valerate and estradiol cypionate recommended by the UCSF guidelines differ by roughly an order of magnitude (<20 to 40 mg/2 weeks for estradiol valerate and <2 to 5 mg/2 weeks for estradiol cypionate). These estradiol esters appear to produce similar average estradiol levels (e.g., around 300 pg/mL or 1,100 pmol/L at a dosage of 5 mg/week) and have concentration–time curve shapes that are not extremely different, with estradiol cypionate being only somewhat flatter and more prolonged than estradiol valerate. As such, it would appear that similar doses should be appropriate for these esters. This is supported by the fact that the same doses of estradiol valerate and estradiol cypionate are used in combined injectable contraceptives in cisgender women (both 5 mg once per month) and that these doses were carefully determined during an intensive clinical development programme for these preparations (Garza-Flores, 1994; Newton, d’Arcangues, & Hall, 1994; Sang, 1994; Toppozada, 1994). This programme notably included dose-ranging and direct-comparison studies. Based on the present analysis, the current recommendations by the UCSF guidelines may result in marked overdosage in the case of estradiol valerate and potential underdosage in the case of estradiol cypionate.

    Transgender health guidelines recommend an injection interval for estradiol valerate and estradiol cypionate in oil of once every 1 to 2 weeks. Although an injection interval of 2 weeks seems technically feasible in the case of both of these preparations, such an interval would appear to result in substantial fluctuations in estradiol levels, with high peak levels and low troughs. This is particularly true in the case of the shorter-acting estradiol valerate (Figures 10, 11). Considering the wide fluctuations and unknown effects of this variability, as well as the fact that testosterone suppression when applicable may depend on sustained higher estradiol levels, it may be advisable that a once-weekly interval be preferentially recommended for these preparations. This would achieve steadier estradiol levels and would reduce potential problems due to high or low estradiol levels (Figure 11). Alternatively, a shorter interval of once every 5 days may be used with estradiol valerate to further reduce the variability in estradiol levels that occurs with this preparation (Figure 11). On the other hand, an injection interval of once every 10 days to 2 weeks may be practical and allowable in the case of the longer-acting estradiol cypionate in oil (as well as estradiol enanthate) (Figure 11)—provided that the injection cycles are well-tolerated and testosterone suppression remains adequate. When selecting different injection intervals, doses should be scaled by the interval to maintain equivalent total estradiol exposure (e.g., 3.5 mg/5 days, 5 mg/7 days, 7 mg/10 days, or 10 mg/14 days for high-dose non-polymeric injectable estradiol esters).

    Figure 11: Simulated estradiol levels with a high dosage of injectable estradiol valerate or estradiol cypionate in oil at different injection intervals (doses scaled by interval to be equivalent in total estradiol exposure).

    With the preceding concerns about the doses and intervals of injectable estradiol preparations recommended by transgender care guidelines considered, the question of how these recommendations were determined arises. Unfortunately, current guidelines do not generally describe how they arrived at their recommendations nor do they usually cite sources to support them. It is notable that the UCSF guidelines recommend doses and intervals for injectable estradiol preparations that are nearly identical to those advised by Christian Hamburger and Harry Benjamin in the late 1960s in the first medical textbook on transgender people (Hamburger & Benjamin, 1969). These authors recommended a dose of 10–40 mg/2 weeks for estradiol valerate and of 2–5 mg/2 weeks for estradiol cypionate (although Benjamin additionally stated that after 4–8 months, the same doses could be used at a longer injection interval of once every 4 weeks). These recommendations were notably made before estradiol blood tests became practicably available and were prior to the advent of modern pharmacokinetic studies. Hence, the recommendations for at least these guidelines appear to be based mainly on past expert opinion and long-standing historical precedent rather than on pharmacokinetic or clinical data. The same is likely to also be true for most other guidelines. High doses with certain injectable estradiol preparations (namely estradiol valerate) were probably originally employed for the purpose of achieving longer durations and more convenient injection intervals. This was notably prior to the risks of excessive estrogenic exposure like blood clots becoming known, and these doses may simply have never been revised.

    The reasons that dose recommendations for injectable estradiol in transfeminine people have remained as they have for so long may be related to several factors. These include (1) a long-standing lack of research and funding in transgender health; (2) injectable estradiol not being widely available or as commonly used as other forms of estradiol; and (3) many clinicians only testing estradiol levels at trough (right before the next injection) with injectable estradiol preparations (e.g., Mueller et al., 2011; Chantrapanichkul et al., 2021; Cirrincione et al., 2021). The latter point is noteworthy as trough levels only describe the lowest point of the estradiol concentration–time curve with injectable estradiol preparations, and can give a very misleading impression of average or total estradiol exposure. In any case, the very high estradiol levels with currently recommended doses of injectable estradiol forms for transfeminine people have not gone unnoticed in the literature (e.g., Gooren, 2005; Spack, 2013; Deutsch, 2014; Glintborg et al., 2021; Tassinari & Maranghi, 2021; Le, Huang, & Cirrincione, 2022). Additionally, clinical studies in transfeminine people have reported high to very high estradiol levels with typical clinical doses of injectable estradiol (e.g., Kronawitter et al., 2009 [Table]; Mueller et al., 2011 [Table]; Sharula et al., 2012 [Data]; Nelson et al., 2016 [Table]; LaBudde, Craig, & Spratt, 2020; Chantrapanichkul et al., 2021 [Table]; Cirrincione et al., 2021 [Table]).

    Among the surveyed guidelines for transgender hormone therapy, only the UCSF guidelines (Deutsch, 2016b) and the Sherbourne Health/Rainbow Health Ontario guidelines (Bourns, 2019) referenced pharmacokinetic literature in their discussion of injectable estradiol. The specific publications cited by these guidelines were Düsterberg & Nishino (1982), Sierra-Ramírez et al. (2011), and Thurman et al. (2013). Although it is favorable to see guidelines considering published pharmacokinetic data for informing use of these preparations, there are a few concerns about the studies that were cited. Düsterberg & Nishino (1982) in its study of injectable estradiol valerate had a very small sample size (n=2), and this study was excluded as an outlier in the present meta-analysis due to unusually high estradiol levels. The findings of Düsterberg & Nishino (1982) also do not seem to have actually been used to guide dosing recommendations in the case of the UCSF guidelines, since if this were the case, the recommended doses should have been much lower. On the other hand, Bourns (2019) cited the same study and recommended injectable estradiol valerate at doses of 3–4 mg/week or 6–8 mg/2 weeks. These doses are well below those recommended by other transgender care guidelines and appear to be more appropriate for use in transfeminine people in light of the present meta-analysis. Sierra-Ramírez et al. (2011) and Thurman et al. (2013), although better-quality studies than Düsterberg & Nishino (1982), described injectable estradiol cypionate suspension rather than estradiol cypionate in oil. The oil-based version of estradiol cypionate is the form normally used in transfeminine hormone therapy, and there are important differences between these estradiol cypionate preparations such that pharmacokinetic studies for the suspension can’t necessarily be generalized to the oil solution. These preparations do in any case produce similar total estradiol levels however and hence doses should be comparable for them.

    This meta-analysis is only informal and unpublished research. Nonetheless, based on the results of this work and the preceding discussion, current dosing recommendations for injectable estradiol preparations by most transgender clinical guidelines appear to be highly excessive and likely unsafe, with injection intervals that may additionally be too widely spaced. Transgender care guidelines should consider reassessing these recommendations, and the transgender medical community should make an effort to better characterize the pharmacokinetics and optimal dosing schemes of injectable estradiol preparations in transfeminine people in the future. Since clinical data on these preparations are scarce and will probably remain so in the near-term, use of published pharmacokinetic data may be further considered for guiding dosing recommendations for injectable estradiol. As identified and catalogued by this meta-analysis, there is a wealth of existing data that could be used to better inform transgender care guidelines in terms of the use of injectable estradiol preparations in transfeminine people.

    Interactive Web Simulator

    This informal meta-analysis of estradiol concentration–time data with injectable estradiol preparations was conducted for the purpose of deriving accurate and representative estradiol curves for incorporation into a web-based injectable estradiol simulator intended for use by transfeminine people and their clinicians. This web app is able to simulate both single-injection curves and repeated-injection curves with these preparations. An informational page for this simulator can be found at the following location:

    And the injectable estradiol simulator itself can be found at the following page:

    Future Possibilities

    There are various possibilities for further work on this project in the future. For example, assessment of interindividual variability for estradiol levels with injectable estradiol preparations could be included in the meta-analysis. As another example, it would be fairly straightforward and valuable to expand the meta-analysis as well as simulator to other hormonal preparations such as injectable testosterone preparations and other estradiol routes and forms like oral estradiol, sublingual estradiol, and estradiol pellets. Pharmacokinetic literature for some of these preparations has already been collected by this author. However, these future possibilities would require much additional time and effort to complete.

    Special Thanks

    A special thank you to Violet and Lila for their indispensable input and guidance on modeling topics during the work on this project. An additional thanks to Violet for deriving a special three-compartment pharmacokinetic model that was used in this work. Please also check out Violet’s own projects Tilia—an effort to empower trans people with tools to manage their hormonal transitions—and TransKit—a work-in-progress pharmacokinetic simulation library specifically tailored for transgender hormone therapy. Lastly, thank you to all the peer reviewers who carefully reviewed this article prior to it being posted.

    Updates

    Update 1: WPATH SOC8 Guidelines

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published and made recommendations on transgender hormone therapy for the first time (Coleman et al., 2022). These guidelines are among the most highly regarded and consulted transgender care guidelines that exist. In terms of the recommended doses of hormonal medications for transgender people, the WPATH SOC8 appear to have largely copied the Endocrine Society’s 2017 guidelines on transgender hormone therapy (Hembree et al., 2017). More specifically, in the case of injectable estradiol preparations for transfeminine people, doses of 5–30 mg/2 weeks or 2–10 mg/week estradiol valerate or estradiol cypionate were recommended. There was no discussion of injectable estradiol in the guidelines besides the preceding doses and intervals being included in a table, and no literature citations were included to support these doses. As described in the present work, these recommendations include doses and intervals that appear to be highly excessive, too widely spaced, and likely unsafe. As such, major transgender care guidelines unfortunately continue to make uncited recommendations for injectable estradiol in transfeminine people that are out of step with insights available from abundant published pharmacokinetic data and are likely inadvisable, with the possibility of substantial safety risks.

    Update 2: Literature Mentions

    The following publications in the literature have cited or mentioned Transfeminine Science’s injectable estradiol simulator and/or meta-analysis since the project was published in mid-2021:

    Hughes et al. (2022)

    Hughes, J. H., Woo, K. H., Keizer, R. J., & Goswami, S. (2022). Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care. Clinical Pharmacology & Therapeutics, 113(3), 565–574. [DOI:10.1002/cpt.2799]:

    Lastly, we recommend that developers of [clinical decision support software (CDSS)] for dosing take an iterative and participatory approach to designing systems. By involving stakeholders in the design process, they will develop solutions that best suit users’ needs and are more likely to be adopted and used correctly. This participatory approach should involve interviews and usability testing with clinicians. Formal usability testing and analysis with real end users can improve the quality and usefulness of a system.88 Though patients themselves are not typically the end users of CDSS, their expertise (especially that of marginalized groups and organized patient advocacy organizations) can also inform CDSS developers. As an example, transgender people have compiled their own resources to understanding dosing regimens in the absence of clear clinical guidelines.89 Developers of CDSS could provide a great deal of value to these patient populations, and improve their software’s utility, by working with them to understand their needs from a dosing tool.

    89. Aly, W. An interactive web simulator for estradiol levels with injectable estradiol esters. Transfeminine Science <https://transfemscience.org/articles/injectable-e2-simulator-release/> (2021) Accessed November 1, 2022.

    Jaafar et al. (2022)

    Jaafar, S., Torres-Leguizamon, M., Duplessy, C., & Stambolis-Ruhstorfer, M. (2022). Hormonothérapie injectable et réduction des risques: pratiques, difficultés, santé des personnes trans en France. [Hormone replacement therapy injections and harm reduction: practices, difficulties, and transgender people’s health in France.] Sante Publique, 34(HS2), 109–122. [Google Scholar] [PubMed] [DOI:10.3917/spub.hs2.0109] [Translated]:

    With regard to feminizing [substitutive hormone therapy (HS)], there are no specialty injectables based on estrogens in the French pharmacopoeia. This makes it impossible to set up estrogen monotherapies which require high dosages that are more difficult to obtain with specialties with other galenic forms [5]. Faced with this lack of care, some trans women and transfeminine people obtain estradiol-based injectable solutions on the Internet or through other sources [6]. […]

    5. Aly. An informal meta-analysis of estradiol curves with injectable estradiol preparations [Internet]. Transfem Sci. 2021 July 16. [Visited on 29/12/2022]. Online : https://transfemscience.org/articles/injectable-e2-meta-analysis/.

    Linet (2023)

    Linet, T. (2023). Prise en charge endocrinologique d’une personne trans. [Endocrinological care of a trans person.] In Faucher, P., Hassoun, D., & Linet, T. (Eds.). Santé sexuelle et reproductive des personnes LGBT [Sexual and Reproductive Health of LGBT People] (pp. 109–124). Issy-les-Moulineaux, France: Elsevier Masson. [Google Books] [URL] [WorldCat] [Excerpt] [Translated]:

    Choice of estrogen.

    Estradiol is generally the most prescribed estrogen. It is given orally or sublingually in transfeminine people with no significant cardiovascular risk factors. For others, the percutaneous form (patches, gel) is recommended.

    The starting dose is 2 mg of estradiol orally with a step increase of 2 mg every 2 to 3 months until the optimal dose is reached [1]. For the patches, the initial dosage and the increments are 50 or 100 μg, and for the gel 2.5 g. This means that the optimal dose is generally 6 to 8 mg per day for the oral route, 3 to 4 mg for the sublingual route, and 300 to 400 μg for the patches (see table 11.1).

    It may happen in consultation that the person does not wish to use the prescribed estrogens and wishes to continue the self-prescription of injectable estrogens. It is then possible to evaluate with them the most suitable dosage using the Transfem Science Injection Simulator (https://transfemscience.org/misc/injectable-e2-simulator/). Risk prevention related to injections (needles) can be done. Associations can help the person find 25 G needles of 40 mm useful this type of treatment.

    Update 3: Herndon et al. (2023)

    In March 2023, the following study on injectable estradiol in transfeminine people was published online:

    • Herndon, J. S., Maheshwari, A. K., Nippoldt, T. B., Carlson, S. J., Davidge-Pitts, C. J., & Chang, A. Y. (2023). Comparison of Subcutaneous and Intramuscular Estradiol Regimens as part of Gender-Affirming Hormone Therapy. Endocrine Practice, 29(5), 356–361. [DOI:10.1016/j.eprac.2023.02.006] [URL]

    The study was a retrospective analysis of individualized injectable estradiol in adult transfeminine people who received hormone therapy at the Mayo Clinic. Doses of injectable estradiol were adjusted by clinical providers based on estradiol levels, testosterone suppression, and feminization goals, and subsequently these clinical data were retrospectively studied by Mayo Clinic researchers. The primary aim of the study was to compare injectable estradiol by intramuscular versus subcutaneous routes. However, other general considerations for injectable estradiol, such as dosing, estradiol levels, testosterone suppression, type of injectable estradiol ester (estradiol valerate vs. estradiol cypionate), and estradiol monotherapy versus concomitant use of antiandrogens, were also assessed. The paper noted that the study was the largest to assess injectable estradiol in transfeminine people to date and was the first to directly compare intramuscular and subcutaneous injectable estradiol routes in transfeminine people.

    Injectable estradiol doses were adjusted to achieve estradiol and testosterone levels within therapeutic ranges defined by the Endocrine Society 2017 guidelines (>100 pg/mL [367 pg/mL] for estradiol and <50 ng/dL [<1.7 nmol/L] for testosterone). Estradiol levels were measured exclusively using liquid chromatography–tandem mass spectrometry (LC–MS/MS), while the assay method for measuring testosterone levels was not specified. In terms of when in the injection cycle estradiol levels were measured, the authors stated the following: (1) “Timing of estradiol blood draw in relation to injection was not protocolized” and (2) “In our practice, although estradiol concentrations were generally checked midway through the injection cycle, we were unable to document with certainty the timing of the estradiol lab testing which may have influenced the results and/or the outliers”. Only the most recent blood test for each individual was analyzed, with the results of earlier tests discarded. Doses were analyzed in per-week amounts, regardless of dosing frequency (either once weekly or once every two weeks).

    There were a total of 130 transfeminine people on injectable estradiol who were analyzed in the study. Of these individuals, 56 received intramuscular (i.m.) injections and 74 received subcutaneous (s.c.) injections. The median duration of therapy for injectable estradiol was 3.0 years for both routes. The vast majority of people used weekly injections (91.1% for i.m., 98.6% for s.c.), whereas the small remainder (n=6) injected once every 2 weeks. Similarly, the great majority used injectable estradiol valerate (89.3% for i.m., 86.5% for s.c.), while a small subset (n=16) used injectable estradiol cypionate. The authors did not state the injectable vehicles, but they can be confidently assumed to have both been in oil. The treatment-individualized doses per week of injectable estradiol were median 4 mg (interquartile range (IQR) 3–5.15 mg; range 1–8 mg) for the i.m. route and median 3.75 mg (IQR 3–4 mg; range 1–8 mg) for the s.c. route, with the differences in doses between groups being slightly but significantly different (p = 0.005). For the small number of people on two-week injection cycles, the doses for the combined i.m. and s.c. groups were median 8.5 mg (range 6–16 mg) every 2 weeks. Estradiol levels with injectable estradiol were median 189.5 pg/mL (IQR 126.8–252.5 or 122.5–257 pg/mL; range ~33–575 pg/mL] for i.m. and median 196 pg/mL (IQR 125.3–298.5 pg/mL; range ~23–581 pg/mL) for s.c., with the differences between groups not being significantly different (p = 0.70). The percentages of individuals with estradiol levels in target range (>100 pg/mL) were 78.6% for i.m. and 82.4% for s.c. The estradiol doses and levels of individual patients for each route were also provided in the paper (Graph). It can be seen that more individuals clustered into the higher range of doses with i.m. than with s.c. injections.

    In the case of estradiol valerate versus estradiol cypionate, dose per week for i.m. with estradiol valerate was median 4 mg (IQR 3–5.45 mg) and with estradiol cypionate was median 4 mg (IQR 2.25–5 mg). In the case of s.c., dose per week with estradiol valerate was median 4 mg (IQR 3–4 mg) and with estradiol cypionate was median 3 mg (IQR 2–3 mg). The doses between estradiol valerate and estradiol cypionate were not significantly different in the case of i.m. (p = 0.51), but were significantly different in the case of s.c. (p = 0.025). Estradiol levels with the two different injectable estradiol esters were not provided.

    On multiple regression analysis, injectable estradiol dose was significantly positively associated with estradiol levels (p < 0.001) following adjustment for several variables (injection route, body mass index (BMI), antiandrogen use, gonadectomy status). Each 1 mg per week in dose was associated with estradiol levels that were increased by (estimate ± standard error) 57.42 ± 10.46 pg/mL. No other variable, including notably BMI, was significantly associated with estradiol levels. According to the authors, the dose-dependently higher estradiol levels with injectable estradiol suggested the need to start at lower doses that are gradually increased in conjunction with close monitoring of hormone levels.

    Testosterone levels in those with gonads were 11 ng/dL (IQR 0–19.8 ng/dL) for i.m. and 11 ng/dL (0–20 ng/dL) for s.c., with levels not significantly different between groups (p = 0.92). Adequate testosterone suppression (<50 ng/dL) in those with gonads was achieved in 84.6% with i.m. and 86.6% with s.c. In the small subset of individuals on injections every two weeks (n=6), 100% of individuals achieved target estradiol and testosterone levels. A majority of individuals on injectable estradiol in the study concomitantly used an antiandrogen, with this usually being spironolactone or finasteride. In a minority of individuals, injectable estradiol monotherapy, without concomitant use of an antiandrogen, was employed and hormone levels were measured (n=17). In this subgroup, estradiol levels were median 220 pg/mL (IQR 180–264 pg/mL) at a dose per week of median 4 mg (IQR 3–6 mg), with estradiol levels noticeably higher than in the overall group. In terms of hormone levels for those on injectable estradiol monotherapy, 100% achieved therapeutic estradiol levels (>100 pg/mL) and 88.2% achieved target testosterone levels (<50 ng/dL). The authors noted that most individuals on injectable estradiol monotherapy were able to adequately suppress testosterone, but that higher doses and levels of estradiol may be needed for testosterone suppression in this context.

    Herndon et al. (2023) noted that existing recommendations for injectable estradiol in transfeminine people suggest doses of 2 to 10 mg per week or 5 to 30 mg every 2 weeks, referencing the Endocrine Society 2017 guidelines (Hembree et al., 2017) and UCSF 2016 guidelines (Deutsch, 2016a). They also noted that the UCSF 2016 guidelines recommended lower doses of estradiol cypionate than estradiol valerate, which they attributed to pharmacokinetic differences between the esters (citing Oriowo et al. (1980) for this claim). However, the authors noted that the differences between estradiol valerate and estradiol cypionate doses they observed were small, and questioned the clinical relevance of the differences. The authors also tactfully critiqued dosing recommendations by existing guidelines, and suggested their own data to guide dosing instead, with the following relevant excerpts:

    Prior studies used for development of guidelines for parenteral doses are suboptimal given their small sample sizes or pre-specificized [gender-affirming hormone therapy (GAHT)] protocols with no adjustment of estradiol doses or no information on hormone concentrations achieved. [Discussion of Deutsch, Bhakri, & Kubicek (2015) and Mueller et al. (2011) …]

    Overall, the studies used to support the current dosing recommendation guidelines for parenteral estradiol dosing are limited, incomplete with regards to hormone concentrations achieved, and do not provide SC as an available option. The doses of estradiol used in this study (with either SC or IM approach), were successful in achieving serum estradiol concentrations at the cisgender female range. Most importantly, as compared to current available guidelines and consensus statements [1, 2], these doses of estradiol valerate are less than half of what is recommended for both initial and maintenance dosing and achieved suppression of testosterone.

    Lower doses of parenteral injections than previously described in clinical practice guidelines achieved therapeutic estradiol concentrations. Our data can serve as a dosing guide for initial and maintenance use of parenteral estradiol, which is different than what has been previously described.

    Herndon et al. (2023) concluded that injectable estradiol by both i.m. and s.c. routes is effective in achieving therapeutic estradiol levels in transfeminine people. They noted that there were not meaningful differences between i.m. and s.c. in terms of dose, although i.m. may require slightly higher doses than s.c. to achieve therapeutic estradiol levels. The authors stated that doses of injectable estradiol to achieve therapeutic estradiol levels in transfeminine people were lower than previously recommended by guidelines and other publications. They concluded that clinical use of injectable estradiol in transfeminine people should include discussion of both i.m. and s.c. routes and invidiualization by patient. Finally, they called for more clinical studies on injectable estradiol in transfeminine people to evaluate clinical outcomes, feminization, and additional risks and benefits of this route compared to other routes.

    The findings of Herndon et al. (2023) are pleasingly consistent with the results of the present meta-analysis. Based on the findings of this meta-analysis, assuming a linear relationship between dose and estradiol levels, estradiol levels with non-polymeric injectable estradiol esters, like estradiol valerate and estradiol cypionate in oil via intramuscular injection, increase by around 60 pg/mL on average for each 1 mg per week in dose (with Herndon et al. (2023) finding a value of 57 pg/mL per 1 mg using a multiple linear regression model). In relation to this, mean integrated estradiol levels of around 250 pg/mL on average would be expected at a dosage of 4 mg once per week. Accordingly, Herndon et al. (2023) found median estradiol levels of 190 to 196 pg/mL at per-week median doses of 3.75 to 4 mg. Similarly, the present work recommended injectable estradiol doses with non-polymeric esters of 1 to 6 mg per week (to achieve mean integrated estradiol levels of roughly 50–300 pg/mL), which is comparable to the range of about 2 to 6 mg per week used in most transfeminine people in Herndon et al. (2023) (to achieve estradiol levels of at least 100 pg/mL, along with adequate testosterone suppression). Additionally, it was noted in this meta-analysis—based on clinical research in cisgender men with prostate cancer—that only modestly supraphysiological estradiol levels, of no more than approximately 200 to 300 pg/mL, are likely to be needed for strong testosterone suppression in transfeminine people. This has likewise been confirmed with solid clinical data in transfeminine people by Herndon et al. (2023), with 88% of those on injectable estradiol monotherapy having testosterone levels of <50 ng/dL at a median injectable estradiol dose of 4 mg/week and with median estradiol levels of 220 pg/mL. It is the opinion of the present author that Herndon et al. (2023) is a very important and formative study, with clinical implications that go far beyond merely supporting the s.c. use of injectable estradiol. The study represents the first major step in the published literature to correcting the dosing and intervals of injectable estradiol in transgender care guidelines and in transgender health generally. I commend the researchers for their work.

    Update 4: Rothman et al. (2024)

    In February 2024, the following review on injectable estradiol in transfeminine people was published online:

    • Rothman, M. S., Hamnvik, O. P. R., Davidge-Pitts, C., Safer, J. D., Ariel, D., Tangpricha, V., Abramowitz, J., Soe, K., Sarvaideo, J., Kelley, C., Irwig, M. S., & Iwamoto, S. J. (2024). Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. Transgender Health, ahead of print. [DOI:10.1089/trgh.2023.0209]

    Here is the abstract of the paper:

    Injectable estrogens are options for gender-affirming hormone therapy per guidelines, which suggest intramuscular dosages of 5–30 mg every 2 weeks or 2–10 mg weekly with estradiol cypionate or valerate interchangeably. Data among transgender and gender-diverse patients are limited due to local unavailability and concerns around laboratory assay variability and estradiol (E2) level fluctuation. We note a concerning trend where patients are prescribed high-dose injections based on the guidelines leading to serum E2 levels well above the range recommended in the same guidelines. Our review indicates that 5 mg weekly or lower should be prescribed when initiating injectable estrogens to avoid supraphysiologic E2 levels.

    Supplementary Material

    References

    • Abuhelwa, A. Y., Foster, D. J., & Upton, R. N. (2015). ADVAN-style analytical solutions for common pharmacokinetic models. Journal of Pharmacological and Toxicological Methods, 73, 42–48. [DOI:10.1016/j.vascn.2015.03.004]
    • Aedo, A. R., Landgren, B. M., Johannisson, E., & Diczfalusy, E. (1985). Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception, 31(5), 453–469. [DOI:10.1016/0010-7824(85)90081-2]
    • Aisaka, K., Ando, S., Kokubo, K., Yoshida, K., & Mori, H. (1986). いわゆる潜在性高prolactin血症患者におけるprolactin分泌予備能の検討. [Studies on Prolactin Secreting Capacity in the Ovulatory Infertile Patients with Transient Hyperprolactinemia.] 日本内分泌学会雑誌 / Nihon Naibunpi Gakkai Zasshi / Folia Endocrinologica Japonica, 62(5), 662–671. [DOI:10.1507/endocrine1927.62.5_662]
    • Akande, E. O. (1974). The effect of oestrogen on plasma levels of luteinizing hormone in euthyroid and thyrotoxic postmenopausal women. The Journal of Obstetrics and Gynaecology of the British Commonwealth / BJOG, 81(10), 795–803. [DOI:10.1111/j.1471-0528.1974.tb00383.x]
    • Ballard, B. E. (1978). An Overview of Prolonged Action Drug Dosage Forms. In Robinson, J. R. (Ed.). Sustained and Controlled Release Drug Delivery Systems (pp. 1–69). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books]
    • Behre, H. M., Oberpenning, F., & Nieschlag, E. (1990). Comparative pharmacokinetics of androgen preparations: application of computer analysis and simulation. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 1st Edition (pp. 115–135). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-662-00814-0_6]
    • Behre, H. M., & Nieschlag, E. (1998). Comparative pharmacokinetics of testosterone esters. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 329–348). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_11]
    • Behre, H. M., Wang, C., Handelsman, D. J., & Nieschlag, E. (2004). Pharmacology of testosterone preparations. Testosterone: Action · Deficiency · Substitution, 3rd Edition (pp. 405–444). Cambridge/New York: Cambridge University Press. [DOI:10.1017/CBO9780511545221.015] [PDF]
    • Behre, H. M., & Nieschlag, E. (2012). Testosterone preparations for clinical use in males. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 309–335). Cambridge/New York: Cambridge University Press. [DOI:10.1017/CBO9781139003353.016]
    • Bider, D., Ben-Rafael, Z., Shalev, J., Goldenberg, M., Mashiach, S., & Blankstein, J. (1989). Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist. Fertility and Sterility, 51(4), 578–581. [DOI:10.1016/S0015-0282(16)60602-7]
    • Blackwell, R. E., Boots, L. R., & Potter Jr, H. D. (1982). Evaluation of Delestrogen and Parlodel as a luteolytic agent in humans. Fertility and Sterility, 37(2), 213–217. [DOI:10.1016/S0015-0282(16)46042-5]
    • Bourns, A. (2019). Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition. Toronto: Rainbow Health Ontario/Sherbourne Health. [URL] [PDF]
    • Bradbury, J. T., Long, R. C., & Durham, W. C. (1953). Progesterone and estrogen requirements to induce and maintain decidua. Fertility and Sterility, 4(1), 63–75. [DOI:10.1016/S0015-0282(16)31145-1]
    • Braun, P., Wildt, L., & Leyendecker, G. (1983). The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle. Fertility and Sterility, 40(1), 37–44. [DOI:10.1016/S0015-0282(16)47174-8]
    • Buckman, M. T., Johnson, J., Ellis, H., Srivastava, L., & Peake, G. T. (1980). Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate. Metabolism, 29(9), 803–805. [DOI:10.1016/0026-0495(80)90117-1]
    • Callen-Lorde Community Health Center. (2018). Protocols for the Provision of Hormone Therapy. New York City: Callen-Lorde Community Health Center. [URL] [PDF]
    • Canales, E. S., Cabezas, A., Vázquez-Matute, L., & Zárate, A. (1978). Induction of ovulation with clomiphene and estradiol benzoate in anovulatory women refractory to clomiphene alone. Fertility and Sterility, 29(5), 496–499. [DOI:10.1016/S0015-0282(16)43271-1]
    • Canales, E. S., Fonseca, M. E., Mason, M., & Zárate, A. (1981). Feedback effect of estradiol on follicle-stimulating hormone and prolactin secretion during the puerperium. International Journal of Gynecology & Obstetrics, 19(1), 79–81. [DOI:10.1016/0020-7292(81)90043-6]
    • Cano, A., Gimeno, F., Fuente, T., Parrilla, J. J., & Abad, L. (1986). The positive feedback of estradiol on gonadotropin secretion in women with perimenopausal dysfunctional uterine bleeding. European Journal of Obstetrics & Gynecology and Reproductive Biology, 22(5–6), 353–358. [DOI:10.1016/0028-2243(86)90125-5]
    • Cavanaugh, T., Hopwood, R., Gonzalez, A., & Thompson, J. (2015). The Medical Care of Transgender Persons. Boston: Fenway Health. [URL] [PDF]
    • Certara. (2020). Certara Phoenix Assistance > Modeling > Least-Squares Regression Model Calculations > Pharmacokinetic Models. [URL]
    • Chantrapanichkul, P., Stevenson, M. O., Suppakitjanusant, P., Goodman, M., & Tangpricha, V. (2021). Serum Hormone Concentrations in Transgender Individuals Receiving Gender-Affirming Hormone Therapy: A Longitudinal Retrospective Cohort Study. Endocrine Practice, 27(1), 27–33. [DOI:10.4158/EP-2020-0414] [PDF] [Table]
    • Chien, Y. W. (1981). Long-acting parenteral drug formulations. Journal of Parenteral Science and Technology / PDA Journal of Pharmaceutical Science and Technology, 35(3), 106–139. [Google Scholar] [URL] [PDF]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual estradiol is associated with higher estrone concentrations than transdermal or injectable preparations in transgender women and gender nonbinary adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249] [PDF] [Table]
    • Colburn, W. A. (1981). Simultaneous pharmacokinetic and pharmacodynamic modeling. Journal of Pharmacokinetics and Biopharmaceutics, 9(3), 367–388. [DOI:10.1007/BF01059272]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2015). Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy. Vancouver: Vancouver Coastal Health. [Google Scholar] [PDF]
    • Davidson, A., Franicevich, J., Freeman, M., Lin, R., Martinez, L., Monihan, M., Porch, M., Samuel, L., Stukalin, R., Vormohr, J., & Zevin, B. (2013). Protocols for Hormonal Reassignment of Gender. San Francisco: San Francisco Department of Public Health/Tom Waddell Health Center. [Google Scholar] [PDF]
    • Depo®-Estradiol Estradiol Cypionate Label. U.S. Food and Drug Administration/Pharmacia & Upjohn (Pfizer). [URL] [PDF]
    • Derra, C. (1981). Hormonprofile unter Östrogen- und Antiandrogentherapie bei Patienten mit Prostatakarzinom: Östradiolundecylat versus Cyproteronacetat. [Hormone Profiles under Estrogen and Antiandrogen Therapy in Patients with Prostate Cancer: Estradiol Undecylate versus Cyproterone Acetate.] (Doctoral dissertation, University of Mainz.) [Google Scholar] [WorldCat] [PDF] [Translation]
    • Deutsch, M. (2014). Medical Transition. In Erickson-Schroth, L. (Ed.). Trans Bodies, Trans Selves: A Resource for the Transgender Community, 1st Edition (pp. 241–264). Oxford: Oxford University Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of Cross-Sex Hormone Treatment on Transgender Women and Men. Obstetrics & Gynecology, 125(3), 605–610. [DOI:10.1097/AOG.0000000000000692]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Düsterberg, B., & Nishino, Y. (1982). Pharmacokinetic and pharmacological features of oestradiol valerate. Maturitas, 4(4), 315–324. [DOI:10.1016/0378-5122(82)90064-0]
    • Düsterberg, B., & Wendt, H. (1983). Plasma levels of dehydroepiandrosterone and 17β-estradiol after intramuscular administration of Gynodian-Depot® in 3 women. Hormones, 17(2), 84–89. [DOI:10.1159/000179680]
    • Düsterberg, B., Schmidt-Gollwitzer, M., & Hümpel, M. (1985). Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women. Hormone Research in Paediatrics, 21(3), 145–154. [DOI:10.1159/000180039]
    • Edkins, R. P. (1959). The Modification of the Duration of Drug Action: Pharmaceutical Considerations. Journal of Pharmacy and Pharmacology, 11(Suppl 1), 54T–66T. [DOI:10.1111/j.2042-7158.1959.tb10412.x]
    • Enever, R. P., Fotherby, K., Naderi, S., & Lewis, G. A. (1983). Long-acting contraceptive agents: The influence of physicochemical properties of some esters of norethisterone upon the plasma levels of free norethisterone. Steroids, 41(3), 381–396. [DOI:10.1016/0039-128X(83)90109-5]
    • Eriksson, O., Bäckström, T., Stridsberg, M., Hammarlund-Udenaes, M., & Naessén, T. (2006). Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology, 31(4), 415–427. [DOI:10.1016/j.psyneuen.2005.10.004]
    • Espino y Sosa, S., Cortés Fuentes, M., Gómez Rico, J. A., & Cortés Bonilla, M. (2019). Non-polymeric Microspheres for the Therapeutic Use of Estrogens: An Innovative Technology. In Khan, W. A. (Ed.). Estrogen. London: IntechOpen. [DOI:10.5772/intechopen.82553]
    • Estradurin® Polyestradiol Phosphate Labels. Pharmanovia. [URL] [DOCs/PDFs]
    • Fisher, D., & Shafer, S. (2007). Fisher/Shafer NONMEM Workshop Pharmacokinetic and Pharmacodynamic Analysis with NONMEM. Basic Concepts. [PDF]
    • Florence, A. T. (2010). Looking at Formulations. In Florence, A. T. An Introduction to Clinical Pharmaceutics (pp. 69–100). London/Chicago: Pharmaceutical Press. [Google Scholar] [Google Books]
    • Fotherby, K., Benagiano, G., Toppozada, H. K., Abdel-Rahman, A., Navaroli, F., Arce, B., Ramos-Cordero, R., Gual, C., Landgren, B. M., & Johannisson, E. (1982). A preliminary pharmacological trial of the monthly injectable contraceptive Cycloprovera. Contraception, 25(3), 261–272. [DOI:10.1016/0010-7824(82)90049-X]
    • Garner, P. R., & Armstrong, D. T. (1977). The effect of human chorionic gonadotropin and estradiol-17β on the maintenance of the human corpus luteum of early pregnancy. American Journal of Obstetrics and Gynecology, 128(5), 469–475. [DOI:10.1016/0002-9378(77)90026-6]
    • Garza-Flores, J., Rodriguez, V., Perez-Palacios, G., Virutamasen, P., Tang-Keow, P., Konsayreepong, R., Kovacs, L., Koloszar, S., & Hall, P. E. (1987). A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. Contraception, 36(4), 441–457. [DOI:10.1016/0010-7824(87)90093-X]
    • Garza-Flores, J., Alba, V. M., Cravioto, M. C., Hernandez, L., Perez-Palacios, G., Alvarado, G., Rivera, R., Recio, R., & Bassol, S. (1989). Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin. Contraception, 39(5), 519–529. [DOI:10.1016/0010-7824(89)90107-8]
    • Garza-Flores, J., Fatinikun, T., Hernandez, L., Ramos, I., Cardenas, M., & Menjivar, M. (1991). A pilot study on the assessment of a progesterone/estradiol sustained release as once-a-month-injectable contraceptive. Contraception, 44(1), 45–59. [DOI:10.1016/0010-7824(91)90105-O]
    • Garza-Flores, J. (1994). Pharmacokinetics of once-a-month injectable contraceptives. Contraception, 49(4), 347–359. [DOI:10.1016/0010-7824(94)90032-9]
    • Geppert, G. (1975). Untersuchungen zur Pharmakokinetik von Östradiol-17β, Östradiol-Benzoat, Östradiol-Valerianat und Östradiol-Undezylat bei der Frau: Der Verlauf der Konzentrationen von Östradiol-17β, Östron, LH und FSH im Serum. [Studies on the Pharmacokinetics of Estradiol-17β, Estradiol Benzoate, Estradiol Valerate, and Estradiol Undecylate in Women: The Course of the Relationships Between Estradiol-17β, Estrone, LH, and FSH in Serum.] (Doctoral dissertation, University of Bonn.) [Google Scholar] [WorldCat] [PDF] [Translation]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). Management of endocrine disease: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/EJE-21-0059]
    • Goh, H. H., & Ratnam, S. S. (1988). The LH surge in humans: its mechanism and sex difference. Gynecological Endocrinology, 2(2), 165–182. [DOI:10.3109/09513598809023624]
    • Goh, H. H., & Ratnam, S. S. (1990). Effect of estrogens on prolactin secretion in transsexual subjects. Archives of Sexual Behavior, 19(5), 507–516. [DOI:10.1007/BF02442351]
    • Goh, V. H. H., & Lee, K. O. (1998). Does a positive oestrogen feedback on the hypothalamic-pituitary axis exist concurrently with a defective testosterone feedback in Klinefelter’s syndrome? Hormone Research in Paediatrics, 50(3), 160–165. [DOI:10.1159/000023266]
    • Goodman, R. E., Anderson, D. C., Bu’Lock, D. E., Sheffield, B., Lynch, S. S., & Butt, W. R. (1985). Study of the effect of estradiol on gonadotrophin levels in untreated male-to-female transsexuals. Archives of Sexual Behavior, 14(2), 141–146. [DOI:10.1007/BF01541659]
    • Gooren, L. J. G., Rao, B. R., Van Kessel, H., & Harmsen-Louman, W. (1984). Estrogen positive feedback on LH secretion in transsexuality. Psychoneuroendocrinology, 9(3), 249–259. [DOI:10.1016/0306-4530(84)90004-0]
    • Gooren, L. (2005). Hormone treatment of the adult transsexual patient. Hormone Research in Paediatrics, 64(Suppl 2), 31–36. [DOI:10.1159/000087751]
    • Göretzlehner, G., Ackermann, W., Angelow, K., Bergmann, G., Bieck, E., Golbs, S., & Kliem, O. (2002). Pharmakokinetik von Estron, Estradiol, FSH, LH und Prolaktin nach intramuskulärer Applikation von 5 mg Estradiolvalerat. [Pharmacokinetics of estradiol valerate in postmenopausal women after intramuscular administration.] Journal für Menopause, 9(2), 46–49. [Google Scholar] [URL] [PDF] [Translation]
    • Gorton, N., Jaffe, J. M., Thompson, J., Menkin, D., Nesteby, A., Dunn, D., Baker, K. K., Harbatkin, D., Do, T., Radix, A., Meacher, P., Goldstein, Z., Carpenter, W., Caine, M., Henn, S., Murayama, R., Feldmann, J., & Zayas, S. (2019). TransLine Gender Affirming Hormone Therapy Prescriber Guidelines. San Francisco: Lyon-Martin Health Services/TransLine. [URL] [PDF]
    • Gunnarsson, P. O., & Norlén, B. J. (1988). Clinical pharmacology of polyestradiol phosphate. The Prostate, 13(4), 299–304. [DOI:10.1002/pros.2990130405]
    • Hamburger, C., & Benjamin, H. (1969). Endocrine Treatment of Male and Female Transsexualism / Appendix for the Practicing Physician: Suggestions and Guidelines for the Management of Transsexuals. In Green, R., & Money, J. (Eds.). Transsexualism and Sex Reassignment (pp. 291–307). Baltimore: John Hopkins University Press. [Google Scholar] [Google Books] [PDF]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658]
    • Henriksson, P., Carlström, K., Pousette, A., Gunnarsson, P. O., Johansson, C. J., Eriksson, B., Altersgård-Brorsson, A. K., Nordle, O., & Stege, R. (1999). Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen. The Prostate, 40(2), 76–82. [DOI:10.1002/(SICI)1097-0045(19990701)40:2<76::AID-PROS2>3.0.CO;2-Q]
    • Herndon, J. S., Maheshwari, A. K., Nippoldt, T. B., Carlson, S. J., Davidge-Pitts, C. J., & Chang, A. Y. (2023). Comparison of Subcutaneous and Intramuscular Estradiol Regimens as part of Gender-Affirming Hormone Therapy. Endocrine Practice, 29(5), 356–361. [DOI:10.1016/j.eprac.2023.02.006] [URL] [PDF]
    • Hughes, J. H., Woo, K. H., Keizer, R. J., & Goswami, S. (2022). Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care. Clinical Pharmacology & Therapeutics, 113(3), 565–574. [DOI:10.1002/cpt.2799]:
    • Ibrahim, S. (1996/1998). Pharmakokinetische Untersuchungen mit Östradiolvalerat und Hydroxyprogesteroncaproat in Depotform nach einmaliger Applikation bei 24 postmenopausalen Frauen. [Pharmacokinetic studies with estradiol valerate and hydroxyprogesterone caproate in depot form after a single application in 24 postmenopausal women.] (Doctoral dissertation, Dresden University of Technology.) [Google Scholar] [WorldCat] [Partial PDF]
    • Ittrich, G., & Pots, P. (1965). Östrogenbestimmungen in Blut und Urin nach Verabreichung von Östrogenen. [Estrogen determinations in blood and urine after administration of estrogens.] In Kraatz, H. (Ed.). International Symposium der Gynäkologischen Endokrinologie vom 15. bis 18. Mai 1963. / Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse für Medizin, 1965(1), 53–56. [ISSN:0568-4250] [WorldCat 1] [WorldCat 2] [WorldCat 3] [PDF] [Translation]
    • Jaafar, S., Torres-Leguizamon, M., Duplessy, C., & Stambolis-Ruhstorfer, M. (2022). Hormonothérapie injectable et réduction des risques: pratiques, difficultés, santé des personnes trans en France. [Hormone replacement therapy injections and harm reduction: practices, difficulties, and transgender people’s health in France.] Sante Publique, 34(HS2), 109–122. [Google Scholar] [PubMed] [DOI:10.3917/spub.hs2.0109]
    • Jacobi, G. H., & Altwein, J. E. (1979). Bromocriptin als Palliativtherapie beim fortgeschrittenen Prostatakarzinom. [Bromocriptine for palliation of advanced prostatic carcinoma. Experimental and clinical profile of a drug.] Urologia Internationalis, 34(4), 266–290. [DOI:10.1159/000280272]
    • Jacobi, G. H., Altwein, J. E., Kurth, K. H., Basting, R., & Hohenfellner, R. (1980). Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial. British Journal of Urology, 52(3), 208–215. [DOI:10.1111/j.1464-410X.1980.tb02961.x]
    • Jacobi, G. R. (1982). Experimental Rationale for the Investigation of Antiprolactins as Palliative Treatment for Prostate Cancer. In Jacobi, G. H., & Hohenfellner, R. (Eds.). Prostate Cancer (International Perspectives in Urology, Volume 3) (pp. 419–431). Baltimore/London: Williams & Wilkins. [Google Scholar] [Google Books]
    • Jilma, B., Eichler, H. G., Breiteneder, H., Wolzt, M., Aringer, M., Graninger, W., Röhrer, C., Veitl, M., & Wagner, O. F. (1994). Effects of 17β-estradiol on circulating adhesion molecules. The Journal of Clinical Endocrinology and Metabolism, 79(6), 1619–1624. [DOI:10.1210/jcem.79.6.7527406]
    • Johansson, C. J., & Gunnarsson, P. O. (2000). Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer. The Prostate, 44(1), 26–30. [DOI:10.1002/1097-0045(20000615)44:1<26::AID-PROS4>3.0.CO;2-P]
    • Jones, T. M., Fang, V. S., Landau, R. L., & Rosenfield, R. (1978). Direct inhibition of Leydig cell function by estradiol. The Journal of Clinical Endocrinology and Metabolism, 47(6), 1368–1373. [DOI:10.1210/jcem-47-6-1368]
    • Jönsson, G., Olsson, A. M., Luttrop, W., Cekan, Z., Purvis, K., & Diczfalusy, E. (1976). Treatment of prostatic carcinoma with various types of estrogen derivatives. In Munson, P. L., Diczfalusy, E., Glover, J., Olson, R. E., Harris, R. S., Thimann, K. V., Loraine, J. A., & Wool, I. G. (Eds.). Vitamins & Hormones, Volume 33 (pp. 351–376). New York/San Francisco/London: Academic Press. [DOI:10.1016/S0083-6729(08)60965-6]
    • Kalicharan, R. W., Schot, P., & Vromans, H. (2016). Fundamental understanding of drug absorption from a parenteral oil depot. European Journal of Pharmaceutical Sciences, 83, 19–27. [DOI:10.1016/j.ejps.2015.12.011]
    • Kalicharan, R. W. (2017). New Insights into Drug Absorption from Oil Depots. (Doctoral dissertation, Utrecht University.) [Google Scholar] [URL] [PDF]
    • Kemeter, P., Bernaschek, G., Altmann, G., & Feichtinger, W. (1984). The effect of 2 mg estradiol-17β plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17β, progesterone, testosterone and prolactin after ovarectomy. Archives of Gynecology, 234(3), 219–229. [DOI:10.1007/BF00570759]
    • Kerdelhué, B., Andrews, M. C., Zhao, Y., Scholler, R., & Jones Jr, H. W. (2006). Short term changes in melatonin and cortisol serum levels after a single administration of estrogen to menopausal women. Neuroendocrinology Letters, 27(5), 659–664. [Google Scholar] [URL] [PDF]
    • Keye, W. R., & Jaffe, R. B. (1975). Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. I. Effects of varying duration of estradiol administration. The Journal of Clinical Endocrinology and Metabolism, 41(6), 1003–1008. [DOI:10.1210/jcem-41-6-1003]
    • Knudsen, P., Hansen, L. B., & Larsen, N. E. (1985). Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment. Acta Psychiatrica Scandinavica, 72(S322), 7–10. [DOI:10.1111/j.1600-0447.1985.tb08535.x]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265] [Table]
    • Kuhl, H. (1986). Hormonsubstitution durch Injektionspräparate und Hautimplantate. [Hormone substitution by injectable preparations and skin implants.] Der Gynäkologe, 19(4), 241–247. [Google Scholar] [PubMed] [PDF] [Translation]
    • Kuhl, H. (1990). Pharmacokinetics of oestrogens and progestogens. Maturitas, 12(3), 171–197. [DOI:10.1016/0378-5122(90)90003-O]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • LaBudde, J. A., Craig, W. Y., & Spratt, D. I. (2020). Initial Evaluation of Safety and Efficacy of Administration of Estradiol (E2) by Subcutaneous (SC) Injections to Male-to-Female (MTF) Transgender Patients. Fertility and Sterility, 114(3), e91–e91. [DOI:10.1016/j.fertnstert.2020.08.277]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., … & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/S0140-6736(21)00100-8]
    • Larsen, S. W., Rinvar, E., Svendsen, O., Lykkesfeldt, J., Friis, G. J., & Larsen, C. (2001). Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs. International Journal of Pharmaceutics, 230(1–2), 67–75. [DOI:10.1016/S0378-5173(01)00860-2]
    • Larsen, S. W., & Larsen, C. (2009). Critical factors influencing the in vivo performance of long-acting lipophilic solutions—impact on in vitro release method design. The AAPS Journal, 11(4), 762–770. [DOI:10.1208/s12248-009-9153-9]
    • Larsen, C., Larsen, S. W., Jensen, H., Yaghmur, A., & Østergaard, J. (2009). Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opinion on Drug Delivery, 6(12), 1283–1295. [DOI:10.1517/17425240903307431]
    • Larsen, S. W., Thing, M. A., & Larsen, C. (2012). Oily (lipophilic) solutions and suspensions. In Wright, J. C., & Burgess, D. J. (Eds.). Long Acting Injections and Implants (Advances in Delivery Science and Technology) (pp. 113–135). Boston: Springer. [DOI:10.1007/978-1-4614-0554-2_7]
    • Le, A., Huang, K. J., & Cirrincione, L. R. (2022). Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine. Trends in Pharmacological Sciences, 43(7), 582–592. [DOI:10.1016/j.tips.2022.03.006]
    • Leinonen, P., Hammond, G. L., Lukkarinen, O., & Vihko, R. (1979). Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma. Investigative Urology, 17(1), 24–27. [Google Scholar] [PubMed]
    • Leinonen, P. (1980). Estrone and estradiol concentrations in the testis and spermatic and peripheral venous blood of elderly men: the influence of estrogen treatment. Journal of Steroid Biochemistry, 13(7), 737–742. [DOI:10.1016/0022-4731(80)90225-3]
    • Leyendecker, G., Geppert, G., Nocke, W., & Ufer, J. (1975). Untersuchungen zur Pharmakokinetik von Östradiol-17β, Östradiol-Benzoat, Östradiol-Valerianat und Östradiol-Undezylat bei der Frau: Der Verlauf der Konzentrationen von Östradiol-17β, Östron, LH und FSH im Serum. [Estradiol-17β, Estrone, LH and FSH in Serum After Administration of Estradiol-17β, Estradiol-Benzoate, Estradiol-Valeriate and Estradiol-Undecylate in the Female.] Geburtshilfe und Frauenheilkunde, 35(5), 370–374. [Google Scholar] [PubMed] [PDF] [Translation]
    • Leyendecker, G., Wildt, L., Gips, H., Nocke, W., & Plotz, E. J. (1976). Experimental studies on the positive feedback effect of progesterone, 17α-hydroxyprogesterone and 20α-dihydroprogesterone on the pituitary release of LH and FSH in the human female. Archiv für Gynäkologie, 221(1), 29–45. [DOI:10.1007/BF00667679]
    • Lichten, E. M., Lichten, J. B., Whitty, A., & Pieper, D. (1996). The confirmation of a biochemical marker for women’s hormonal migraine: The depo‐estradiol challenge test. Headache: The Journal of Head and Face Pain, 36(6), 367–371. [DOI:10.1046/j.1526-4610.1996.3606367.x]
    • Linet, T. (2023). Prise en charge endocrinologique d’une personne trans. [Endocrinological care of a trans person.] In Faucher, P., Hassoun, D., & Linet, T. (Eds.). Santé sexuelle et reproductive des personnes LGBT [Sexual and Reproductive Health of LGBT People] (pp. 109–124). Issy-les-Moulineaux, France: Elsevier Masson. [Google Books] [URL] [WorldCat] [Excerpt]
    • Lixsoft. (2008). Mathematical Expressions of the Pharmacokinetic and Pharmacodynamic Models Implemented in the Monolix Software. [PDF]
    • Martinez, G. (1995). Estradiol and Progesterone Serum Levels in Women Using the Once-a-month Injectable Contraceptive Perlutal. / Benagiano, G., Bianchi, P., von Kesserü, E., Castañeda, A., Correa, J. E., & Martínez, G. (1995). Session 19 what is new about injectable contraceptives? Advances in Contraception, 11(1), 39–42. [DOI:10.1007/BF02436100]
    • Martins, R. S., Antunes, N. J., Comerlatti, G., Caraccio, G., Moreno, R. A., Frecentese, F., Caliendo, G., & De Nucci, G. (2019). Quantification of estradiol cypionate in plasma by liquid chromatography coupled with tandem mass spectrometry: Application in a pharmacokinetic study in healthy female volunteers. Journal of Pharmaceutical and Biomedical Analysis, 170, 273–278. [DOI:10.1016/j.jpba.2019.03.053]
    • Messinis, I. E., & Templeton, A. (1987). Effect of high dose exogenous oestrogen on midcycle luteinizing hormone surge in human spontaneous cycles. Clinical Endocrinology, 27(4), 453–459. [DOI:10.1111/j.1365-2265.1987.tb01173.x]
    • Messinis, I. E., & Templeton, A. A. (1987). Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. Reproduction, 79(2), 549–554. [DOI:10.1530/jrf.0.0790549]
    • Minto, C. F., Howe, C., Wishart, S., Conway, A. J., & Handelsman, D. J. (1997). Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. Journal of Pharmacology and Experimental Therapeutics, 281(1), 93–102. [URL]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • Newton, J. R., d’Arcangues, C., & Hall, P. E. (1994). A review of ‘once-a-month’ combined injectable contraceptives. Journal of Obstetrics and Gynaecology, 14(Suppl 1), S1–S34. [DOI:10.3109/01443619409027641]
    • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016] [Table]
    • Nieschlag, E., & Behre, H. M. (2010). Testosterone therapy. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Andrology (pp. 437–455). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-540-78355-8_21] [PDF]
    • Norlén, B. J., Fritjofsson, Å., Grönquist, L., Gunnarsson, P. O., Johansson, S. Å., & Plym-Forshell, G. (1987). Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer. European Urology, 13, 193–197. [DOI:10.1159/000472772]
    • Olson-Kennedy, J., Rosenthal, S. M., Hastings, J., & Wesp, L. (2016). Health considerations for gender non-conforming children and transgender adolescents. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 186–199). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Oriowo, M. A., Landgren, B. M., Stenström, B., & Diczfalusy, E. (1980). A comparison of the pharmacokinetic properties of three estradiol esters. Contraception, 21(4), 415–424. [DOI:10.1016/S0010-7824(80)80018-7]
    • Parkes, A. S. (1937). Relative duration of action of various esters of oestrone, oestradiol and oestriol. Biochemical Journal, 31(4), 579–585. [DOI:10.1042/bj0310579]
    • Presl, J., Horejsi, J., Štroufová, A., & Herzmann, J. (1976). Sexual maturation in girls and the development of estrogen-induced gonadotropic hormone release. Annales de Biologie Animale, Biochimie, Biophysique, 16(3), 377–383. [DOI:10.1051/rnd:19760314]
    • Rahimy, M. H., & Ryan, K. K. (1999). Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women. Contraception, 60(4), 189–200. [DOI:10.1016/s0010-7824(99)00081-5]
    • Rahimy, M. H., Ryan, K. K., & Hopkins, N. K. (1999). Lunelle™ monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women. Contraception, 60(4), 209–214. [DOI:10.1016/S0010-7824(99)00086-4]
    • Rauramo, L., Punnonen, R., Kaihola, H. L., & Grönroos, M. (1980). Serum oestrone, oestradiol and oestriol concentrations in castrated women during intramuscular oestradiolvalerate and oestradiolbenzoate-oestradiolphenylpropionate therapy. Maturitas, 2(1), 53–58. [DOI:10.1016/0378-5122(80)90060-2]
    • Rauramo, L., Punnonen, R., & Grönroos, M. (1981). Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments. Maturitas, 3(2), 183–186. [DOI:10.1016/0378-5122(81)90010-4]
    • Recio, R., Garza-Flores, J., Schiavon, R., Reyes, A., Diaz-Sanchez, V., Valles, V., Luz de la Cruz, D., Oropeza, G., & Perez-Palacios, G. (1986). Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive. Contraception, 33(6), 579–589. [DOI:10.1016/0010-7824(86)90046-6]
    • Reimann, I. W., Britzelmeier, C., Haber, P., Wollmann, H., Antonin, K. H., & Bieck, P. R. (1987). Influence of Oestradiol on Alpha2-Adrenoceptor Binding Sites on Intact Platelets of Young Male Volunteers. European Journal of Clinical Pharmacology, 33(2), 147–150. [DOI:10.1007/BF00544558]
    • Rosenfield, R. L., Fang, V. S., Dupon, C., Kim, M. H., & Refetoff, S. (1973). The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner’s syndrome. The Journal of Clinical Endocrinology and Metabolism, 37(4), 574–580. [DOI:10.1210/jcem-37-4-574]
    • Rosenfield, R. L., & Fang, V. S. (1974). The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. The Journal of Pediatrics, 85(6), 830–837. [DOI:10.1016/S0022-3476(74)80355-0]
    • Rothman, M. S., Hamnvik, O. P. R., Davidge-Pitts, C., Safer, J. D., Ariel, D., Tangpricha, V., Abramowitz, J., Soe, K., Sarvaideo, J., Kelley, C., Irwig, M. S., & Iwamoto, S. J. (2024). Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. Transgender Health, ahead of print. [DOI:10.1089/trgh.2023.0209]
    • Sang, G. W., Ge, J. L., Liu, X. H., Shao, Q. X., Zhao, X. J., & Mao, S. M. (1987). 不同剂量庚炔诺酮单独或配伍戊酸雌二醇后的药代动力学及药效学. [Pharmacokinetics and pharmacodynamics of different doses of norethisterone enanthate alone and in combination with estradiol valerate.] 中国 临 床药理 学杂志 / Chinese Journal of Clinical Pharmacology, 3(1), 7–18. [Google Scholar] [CNKI] [DOI:10.13699/j.cnki.1001-6821.1987.01.002] [PDF]
    • Sang, G. W. (1994). Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception, 49(4), 361–385. [DOI:10.1016/0010-7824(94)90033-7]
    • Schiavon, R., Benavides, S., Oropeza, G., Garza-Flores, J., Recio, R., Díaz-Sanchez, V., & Pérez-Palacios, G. (1988). Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive. Contraception, 37(6), 591–598. [DOI:10.1016/0010-7824(88)90005-4]
    • Schug, B. S., Donath, F., & Blume, H. H. (2012). Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers. International Journal of Clinical Pharmacology and Therapeutics, 50(2), 100–117. [Google Scholar] [DOI:10.5414/cp201589] [PDF]
    • Schulte-Beerbühl, M., & Nieschlag, E. (1980). Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertility and Sterility, 33(2), 201–203. [DOI:10.1016/S0015-0282(16)44543-7]
    • Schultz, K., Møllgaard, B., Fisher, A. N., Illum, L., & Larsen, C. (1998). Intramuscular rate of disappearance of oily vehicles in rabbits investigated by gamma-scintigraphy. International Journal of Pharmaceutics, 169(1), 121–126. [DOI:10.1016/S0378-5173(98)00121-5]
    • Schweikert, H. U., Weissbach, L., Leyendecker, G., Schwinger, E., Wartenberg, H., & Krück, F. (1982). Clinical, endocrinological, and cytological characterization of two 46, XX males. The Journal of Clinical Endocrinology & Metabolism, 54(4), 745–752. [DOI:10.1210/jcem-54-4-745]
    • Seibert, B., & Günzel, P. (1994). Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna®. Contraception, 49(4), 303–333. [DOI:10.1016/0010-7824(94)90030-2]
    • Shah, J. C. (2007). Controlled Release – Small Molecules. In Stella, V. J., Borchardt, R. T., Hageman, M. J., Oliyai, R., Maag, H., & Tilley, J. W. (Eds.). Prodrugs: Challenges and Rewards, Part 1 (Biotechnology: Pharmaceutical Aspects, Volume V) (pp. 357–377). New York: Springer. [DOI:10.1007/978-0-387-49785-3_9]
    • Sharula, Chekir, C., Emi, Y., Arai, F., Kikuchi, Y., Sasaki, A., Matsuda, M., Shimizu, K., Tabuchi, K., Kamada, Y., Hiramatsu, Y., & Nakatsuka, M. (2012). Altered arterial stiffness in male‐to‐female transsexuals undergoing hormonal treatment. Journal of Obstetrics and Gynaecology Research, 38(6), 932–940. [DOI:10.1111/j.1447-0756.2011.01815.x] [Data]
    • Shaw, R. W., Butt, W. R., London, D. R., & Marshall, J. C. (1975). The oestrogen provocation test: a method of assessing the hypothalamic‐pituitary axis in patients with amenorrhoea. Clinical Endocrinology, 4(3), 267–276. [DOI:10.1111/j.1365-2265.1975.tb01534.x]
    • Shaw, R. W., Butt, W. R., & London, D. R. (1975). The effect of oestrogen pretreatment on subsequent response to luteinizing hormone releasing hormone in normal women. Clinical Endocrinology, 4(3), 297–304. [DOI:10.1111/j.1365-2265.1975.tb01537.x]
    • Shaw, R. W. (1978). Neuroendocrinology of the menstrual cycle in humans. Clinics in Endocrinology and Metabolism, 7(3), 531–559. [DOI:10.1016/S0300-595X(78)80008-5]
    • Shahiwala, A., Mehta, T. A., & Momin, M. M. (2018). Parenteral drug delivery systems. In Misra, A., & Shahiwala, A. (Eds.). In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes (pp. 283–318). Boca Raton: CRC Press. [DOI:10.1201/b22448-9] [Google Books]
    • Sherwin, B. B., & Gelfand, M. M. (1987). Individual differences in mood with menopausal replacement therapy: Possible role of sex hormone-binding globulin. Journal of Psychosomatic Obstetrics & Gynecology, 6(2), 121–131. [DOI:10.3109/01674828709016773]
    • Sherwin, B. B., Gelfand, M. M., Schucher, R., & Gabor, J. (1987). Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations. American Journal of Obstetrics and Gynecology, 156(2), 414–419. [DOI:10.1016/0002-9378(87)90295-X]
    • Sherwin, B. B. (1988). Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. Journal of Affective Disorders, 14(2), 177–187. [DOI:10.1016/0165-0327(88)90061-4]
    • Sierra-Ramírez, J. A., Lara-Ricalde, R., Lujan, M., Velázquez-Ramírez, N., Godínez-Victoria, M., Hernádez-Munguía, I. A., Padilla, A., & Garza-Flores, J. (2011). Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg). Contraception, 84(6), 565–570. [DOI:10.1016/j.contraception.2011.03.014]
    • Sinkula, A. A. (1978). Methods to Achieve Sustained Drug Delivery. The Chemical Approach. In Robinson, J. R. (Ed.). Sustained and Controlled Release Drug Delivery Systems (pp. 411–555). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books] [PDF]
    • Somerville, B. W. (1971). The Role of Oestradiol in Menstrual Migraine. In Somerville, B. W. The Influence of Progesterone and Oestradiol on Migraine (Doctoral dissertation, University of New South Wales) (pp. 93–104). [Google Scholar] [URL] [WorldCat] [PDF]
    • Somerville, B. W. (1972). The Role of Estradiol Withdrawal in the Etiology of Menstrual Migraine. Neurology, 22(4), 355–365. [DOI:10.1212/WNL.22.4.355]
    • Somerville, B. W. (1972). The influence of progesterone and estradiol upon migraine. Headache: The Journal of Head and Face Pain, 12(3), 93–102. [DOI:10.1111/j.1526-4610.1972.hed1203093.x]
    • Somerville, B. W. (1972). The Influence of Hormones Upon Migraine in Women. Medical Journal of Australia, 2(S2), 6–11. [DOI:10.5694/j.1326-5377.1972.tb93039.x]
    • Somerville, B. W. (1975). Estrogen‐withdrawal migraine: I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology, 25(3), 239–244. [DOI:10.1212/wnl.25.3.239]
    • Spack, N. P. (2013). Management of transgenderism. JAMA, 309(5), 478–484. [DOI:10.1001/jama.2012.165234]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., & Pousette, A. (1988). Single drug polyestradiol phosphate therapy in prostatic cancer. American Journal of Clinical Oncology, 11(Suppl 2), S101–S103. [DOI:10.1097/00000421-198801102-00024] [PDF]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & von Schoultz, B. (1989). Single‐drug parenteral estrogen treatment in prostatic cancer: A study of two maintenance‐dose regimens. The Prostate, 14(2), 183–188. [DOI:10.1002/pros.2990140211]
    • Stege, R., Gunnarsson, P. O., Johansson, C. J., Olsson, P., Pousette, Å., & Carlström, K. (1996). Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients. The Prostate, 28(5), 307–310. [DOI:10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8]
    • Sumioki, H. (1987). ヒト排卵機構とGonadotropin分泌調節における “β-Endorphinおよびβ-Lipotropin” の役割に関する研究. [The Role of “β-Endorphin & β-Lipotropin” on the Gonadotropin Regulation in the Mechanism of Human Ovulation.] Folia Endocrinologica Japonica, 63(10), 1289–1307. [DOI:10.1507/endocrine1927.63.10_1289]
    • Svendsen, O., & Aaes‐Jørgensen, T. (1979). Studies on the fate of vegetable oil after intramuscular injection into experimental animals. Acta Pharmacologica et Toxicologica, 45(5), 352–378. [DOI:10.1111/j.1600-0773.1979.tb02404.x]
    • Tassinari, R., & Maranghi, F. (2021). Rodent Model of Gender-Affirming Hormone Therapies as Specific Tool for Identifying Susceptibility and Vulnerability of Transgender People and Future Applications for Risk Assessment. International Journal of Environmental Research and Public Health, 18(23), 12640. [DOI:10.3390/ijerph182312640]
    • Thurman, A., Kimble, T., Hall, P., Schwartz, J. L., & Archer, D. F. (2013). Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics. Contraception, 87(6), 738–743. [DOI:10.1016/j.contraception.2012.11.010]
    • Toppozada, M. K. (1994). Existing once-a-month combined injectable contraceptives. Contraception, 49(4), 293–301. [DOI:10.1016/0010-7824(94)90029-9]
    • Toutain, P. L., & Bousquet-Mélou, A. (2004). Plasma terminal half-life. Journal of Veterinary Pharmacology and Therapeutics, 27(6), 427–439. [DOI:10.1111/j.1365-2885.2004.00600.x]
    • Trans Care BC. (2021). Gender-affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care Toolkit. Vancouver: Provincial Health Services Authority/Trans Care BC. [URL] [PDF]
    • Travaglini, P., Ambrosi, B., Beck-Peccoz, P., Elli, R., Rondena, M., Bara, R., & Weber, G. (1978). Hypothalamic-pituitary-ovarian function in hyperprolactinemic women. Journal of Endocrinological Investigation, 1(1), 39–45. [DOI:10.1007/BF03346769]
    • Travaglini, P., Elli, R., Ambrosi, B., Ballabio, M., Moriondo, P., & Faglia, G. (1979). Serum LH increase after estradiol and progesterone administration in hyperprolactinemic women. Journal of Endocrinological Investigation, 2(4), 407–411. [DOI:10.1007/BF03349341]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine position statement “assessment and hormonal management in adolescent and adult trans people, with attention for sexual function and satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • Ulrich, U., Pfeifer, T., & Lauritzen, C. (1994). Rapid Increase in Lumbar Spine Bone Density in Osteopenic Women by High-Dose Intramuscular Estrogen-Progestogen Injections. Hormone and Metabolic Research, 26(9), 428–431. [DOI:10.1055/s-2007-1001723]
    • Välimäki, M., Pelkonen, R., Salaspuro, M., Härkönen, M., Hirvonen, E., & Ylikahri, R. (1984). Sex hormones in amenorrheic women with alcoholic liver disease. The Journal of Clinical Endocrinology and Metabolism, 59(1), 133–138. [DOI:10.1210/jcem-59-1-133]
    • Valle Alvarez, D. C. (2011). Efecto de una Dosis de 50 mg de Enantato de Noretisterona y 5 mg de Valerato de Estradiol en los Niveles de Testosterona Total en Hombres Mexicanos Sanos. [Effect of a Dose of 50 mg of Norethisterone Enanthate and 5 mg of Estradiol Valerate on Total Testosterone Levels in Healthy Mexican Men.] (Masters thesis, National Polytechnic Institute of Mexico.) [Google Scholar] [URL] [PDF] [Translation]
    • Varangot, J., & Cedard, L. (1957). Modifications des Œstrogènes Sanguins Après Administration Intramusculaire de Benzoate d’Œstradiol. [Changes in Serum Estrogens After Intramuscular Administration of Estradiol Benzoate.] Comptes Rendus des Séances de la Société de Biologie et de ses Filiales, 151(10), 1707–1712. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
    • Vermeulen, A. (1975). Longacting steroid preparations. Acta Clinica Belgica, 30(1), 48–55. [DOI:10.1080/17843286.1975.11716973]
    • Vermeulen, A. (1977). Transport and Distribution of Androgens at Different Ages. In Martini, L., & Motta, M. (Eds.). Androgens and Antiandrogens (pp. 53–65). New York: Raven Press. [Google Scholar] [Google Books] [WorldCat]
    • Vhora, I., Bardoliwala, D., Ranamalla, S. R., & Javia, A. (2019). Parenteral controlled and prolonged drug delivery systems: therapeutic needs and formulation strategies. In Misra A., & Shahiwala, A. (Eds.). Novel Drug Delivery Technologies (pp. 183–260). Singapore: Springer. [DOI:10.1007/978-981-13-3642-3_7]
    • Vizziello, G., D’Amato, G., Trentadue, R., & Fanizza, G. (1993). Studio dinamico del blocco ipofisario indotto dalla triptorelina, mediante test all’estradiolo benzoato. [Estradiol benzoate test in the study of pituitary block induced by triptorelin.] Minerva Ginecologica, 45(4), 185–189. [Google Scholar] [PubMed] [PDF] [Translation]
    • Wagner, J. G. (1993). Pharmacokinetics for the Pharmaceutical Scientist. Lancaster/Basel: Technomic. [DOI:10.1201/9780203743652] [Google Books]
    • Weiss, G., Nachtigall, L. E., & Ganguly, M. (1976). Induction of an LH surge with estradiol benzoate. A clinical test of pituitary-hypothalamic axis competence. Obstetrics and Gynecology, 47(4), 415–418. [URL]
    • White, M. C., Rosenstock, J., Anapliotou, M., Mashiter, K., & Joplin, G. F. (1981). Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas. The Lancet, 317(8235), 1394–1396. [DOI:10.1016/S0140-6736(81)92571-X]
    • Wiemeyer, J. C., Fernandez, M., Moguilevsky, J. A., & Sagasta, C. L. (1986). Pharmacokinetic Studies of Estradiol Enantate in Menopausic Women. Arzneimittel-Forschung, 36(11), 1674–1677. [Google Scholar] [PubMed] [PDF]
    • Wiemeyer, J. C., Fernandez, M., Sagasta, C. L., & Moguilevsky, J. A. (1987). Estudos farmacocinéticos do enantato de estradiol em mulheres na menopausa. [Pharmacokinetic studies of estradiol enantate in menopausic women.] Jornal Brasileiro de Ginecologia, 97(9), 497–501. [Google Scholar] [LILACS] [PDF]
    • Yan, J., Pan, J., Chang, Y., & Kang, J. (1987). The effect of monthly injectable contraceptive megestrol acetate compound on pituitary-ovarian function. 上海第二医科大学学报(英文版) / Journal of Shanghai Second Medical University / Medical Bulletin of Shanghai Jiaotong University, 1(2), 7–12. [Google Scholar] [CNKI] [PDF]
    • Yáñez, J. A., Remsberg, C. M., Sayre, C. L., Forrest, M. L., & Davies, N. M. (2011). Flip-flop pharmacokinetics–delivering a reversal of disposition: challenges and opportunities during drug development. Therapeutic Delivery, 2(5), 643–672. [DOI:10.4155/tde.11.19]
    • Zhang, Y., Huo, M., Zhou, J., & Xie, S. (2010). PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine, 99(3), 306–314. [DOI:10.1016/j.cmpb.2010.01.007]
    • Zhou, X. F., Shao, Q. X., Han, X. J., Weng, L. J., & Sang, G. W. (1998). Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem® in Chinese women. Contraception, 57(6), 405–411. [DOI:10.1016/S0010-7824(98)00048-1]
    \ No newline at end of file +An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations - Transfeminine Science Link

    An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations

    By Aly | First published July 16, 2021 | Last modified April 3, 2024

    Abstract / TL;DR

    Injectable estradiol preparations such as estradiol valerate and estradiol cypionate in oil are frequently used as estrogens in transfeminine hormone therapy. However, there is little characterization of these preparations in transfeminine people and dosing recommendations by transgender health guidelines appear to be based on expert opinion rather than on clinical data. To help shed light on the properties of injectable estradiol and to better inform dosing considerations in transfeminine people, an informal meta-analysis of available clinical data on estradiol concentration–time curves with major injectable estradiol formulations was conducted. The included preparations were injectable estradiol benzoate in oil, estradiol valerate in oil, estradiol cypionate both in oil and as a suspension, estradiol enanthate in oil, estradiol undecylate in oil, and polyestradiol phosphate. The literature was searched for clinical concentration–time data with these injectable estradiol esters and these data were collected and analyzed. Meta-analysis consisted of data for each injectable estradiol preparation being processed and fit with pharmacokinetic models. Selected pharmacokinetic parameters were additionally determined and reported. The results of this work were discussed with regard to characteristics of injectable estradiol preparations like curve shapes, durations, estrogenic exposure, and variability between people and studies. Recommendations for injectable estradiol preparations by transgender health guidelines were also explored in light of the present results. Current guidelines recommend doses of these preparations that appear to be highly excessive with injection intervals that are too widely spaced. Based on the findings of the present meta-analysis, recommendations by guidelines should be reassessed. Finally, the fitted curves in this work were incorporated into an interactive web-based injectable estradiol simulator intended for use by transfeminine people and their medical providers to help guide therapeutic decisions.

    Introduction

    Estradiol is the main estrogen used in transfeminine hormone therapy and is available in a variety of different forms for use by different routes of administration. The most commonly employed forms are oral, sublingual, transdermal, and injectable preparations. Injectable estradiol preparations have been discontinued in many countries and hence are unavailable for use in transfeminine hormone therapy in many parts of the world, for instance in most of Europe (Glintborg et al., 2021). However, they are still used by many transfeminine people particularly in the United States and in the do-it-yourself (DIY) community. The most commonly used forms include estradiol valerate, estradiol cypionate, and estradiol enanthate all in oil. Injectable estradiol preparations have certain advantages over other estradiol forms that make them a popular choice for use in transfeminine hormone therapy. These include often lower cost, capacity to easily achieve higher estradiol levels that can be useful for testosterone suppression, less frequent administration, and theoretically reduced health risks relative to oral estradiol at equivalent doses due to the lack of the first pass with this route (Aly, 2020). The higher estradiol levels with injections are particularly useful for estradiol monotherapy, in which an antiandrogen is not used.

    Clinically used injectable estradiol preparations are formulated not as estradiol but as estradiol esters. When injected into muscle or fat in oil solutions or crystalline aqueous suspensions, these estradiol esters form depots at the injection site from which they are slowly released. Subsequent to release, estradiol esters are rapidly metabolized into estradiol and hence act as prodrugs. When estradiol itself is given by intramuscular injection in an aqueous solution or oil solution, it is rapidly absorbed and has a very short duration. Due to having lipophilic esters, most clinically used injectable estradiol esters are more fat-soluble than estradiol (as measured by oil–water partition coefficient (P)) (Table). When these esters are administered as oil solutions by intramuscular or subcutaneous injection, their increased lipophilicity causes them to be released from the injection-site depot more slowly than estradiol and to therefore have longer durations. In the case of fatty acid esters, the longer the chain length of the ester—as in e.g. estradiol valerate (5 carbons) vs. estradiol enanthate (7 carbons) vs. estradiol undecylate (10 carbons)—the greater the fat solubility, the slower the rate of release from the depot, and the longer the time to peak levels and duration (Edkins, 1959; Sinkula, 1978; Chien, 1981; Kuhl, 2005; Kalicharan, 2017; Vhora et al., 2019). The durations of both injectable oil solutions and aqueous suspensions depend on the ester and its particular physicochemical properties, but the characteristics of these preparations are different and they work in distinct ways to produce their depot effects (Enever et al., 1983; Aly, 2019). The durations of oil solutions are dependent on the lipophilicity of the ester as well as oil vehicle, whereas the durations of aqueous suspensions depend on the properties of the ester crystal lattice as well as crystal sizes (Chien, 1981; Enever et al., 1983; Aly, 2019). The polymeric estradiol ester polyestradiol phosphate is more hydrophilic (water-soluble) than estradiol and works differently than other injectable estradiol preparations. Ιt is composed of many estradiol molecules linked together via phosphate esters (on average 13 molecules of estradiol per one molecule of polyestradiol phosphate) and has a prolonged duration due to slow cleavage into estradiol following injection. Estradiol esters are able to substantially prolong the duration of estradiol when used as injectables and these preparations have durations ranging from days to months depending on the ester and how it is formulated (Table).

    There is very little in the way of research and review on the pharmacokinetics of injectable estradiol preparations in the transgender health literature. Transgender hormone therapy guidelines presently offer only brief descriptions and dosing recommendations that appear to be based mainly on expert opinion for this form of estradiol (e.g., Deutsch, 2016a; Hembree et al., 2017). Many studies assessing the pharmacokinetics and concentration–time profiles of injectable estradiol preparations have been published but are largely confined to cisgender women and men rather than transgender people. These studies are scattered throughout the literature and have not been comprehensively reviewed or analyzed. Some review material exists on the pharmacokinetics of injectable estradiol preparations for use in hormonal birth control and menopausal hormone therapy in cisgender women (e.g., Düsterberg & Nishino, 1982; Kuhl, 1986; Kuhl, 1990; Garza-Flores, 1994; Kuhl, 2005) and androgen deprivation therapy for prostate cancer in cisgender men (e.g., Gunnarsson & Norlén, 1988). However, these publications discuss only small selections of the available research. Data on repeated administration of injectable estradiol preparations are more rare but have also been published (e.g., Gooren et al., 1984 [Graph]; various others). Multi-dose simulation has been done previously for polyestradiol phosphate (Henriksson et al., 1999; Johansson & Gunnarsson, 2000). However, it has not been explored for other injectable estradiol preparations to date. In contrast to injectable estradiol, excellent review literature and simulation exists for injectable testosterone preparations (e.g., Behre, Oberpenning, & Nieschlag, 1990; Behre & Nieschlag, 1998; Behre et al., 2004; Nieschlag & Behre, 2010; Nieschlag & Behre, 2012).

    In order to aid understanding of concentration–time profiles with injectable estradiol preparations, I’ve developed an interactive web-based injectable estradiol simulator for transfeminine people and their medical providers. During work on this simulator, it became apparent that there is substantial variability in estradiol levels and curve shapes between different studies even with the same injectable estradiol ester. The injectable estradiol simulator was originally designed to simulate curves from only a single well-known pharmacokinetic study that directly compared estradiol benzoate, estradiol valerate, and estradiol cypionate in oil (Oriowo et al., 1980 [Graph]). However, due to the considerable differences in estradiol levels and curves across studies, it was decided that relying on only one study for such a project would be untenable. Instead, for the simulations to be reasonably accurate to the available data, many studies would need to be incorporated. Including additional studies would also allow for inclusion of other injectable estradiol esters in the simulator. As a result, the present work—an informal meta-analysis of estradiol curves with injectable estradiol formulations—was conducted for the simulator project.

    Methods

    A literature search was performed to identify studies reporting clinical estradiol concentration–time data with major injectable estradiol formulations (Table 1). All of these preparations have been used in transfeminine hormone therapy at one time or another in different parts of the world, although only estradiol valerate in oil and estradiol cypionate in oil are widely used today. Some of the injectable preparations included have notably been discontinued. Acceptable data for the search included mean and individual estradiol concentration data and Cmax estradiol levels (mean peak estradiol levels of individual subjects at time Tmax). Databases like PubMed, Google Scholar, and WorldCat were searched using relevant keywords (e.g., estradiol ester names and variations thereof as well as major brand names). Publications with relevant information were catalogued for data collection. Only single-dose data and multi-dose data that allowed estradiol levels to return to baseline between doses (as in e.g. repeated once-monthly combined injectable contraceptives) were included. Studies were included regardless of the hypothalamic–pituitary–gonadal axis (HPG axis) status of the participants. The study selection criteria aimed to maximize data inclusion due to scarcity of data for several preparations. If however there were many studies for a specific preparation, studies with only 1 or 2 subjects were generally skipped due to the limited additional value that they would provide. When data were in figures in papers—as was generally the case—they were extracted from the graphs using WebPlotDigitizer.

    Table 1: Major injectable estradiol formulations (ordered roughly from shortest- to longest-acting):

    Estradiol esterAbbr.FormMajor brand names
    Estradiol benzoateEBOil solutionProgynon-B
    Estradiol valerateEVOil solutionDelestrogen, Mesigyna,a Progynon Depot
    Estradiol cypionateECOil solutionDepo-Estradiol
      Aqueous suspensionbCyclofem,a Lunellea
    Estradiol enanthateEEnOil solutionPerlutal,a Topasela
    Estradiol undecylatecEUOil solutionDelestrec, Progynon Depot 100
    Polyestradiol phosphatecPEPAqueous solutionEstradurin

    a As combined injectable contraceptives also including a progestin (norethisterone enanthate (NETE), medroxyprogesterone acetate (MPA), or dihydroxyprogesterone acetophenide (DHPA)). b Microcrystalline particle size. c No longer marketed.

    Following their collection, data were processed, aggregated, and modeled. Data were adjusted for endogenous estradiol production and were normalized by dose. Adjustment for endogenous estradiol production was generally done via subtraction of baseline estradiol levels. In a number of cases however, subtraction of trough estradiol levels or of estradiol levels from a control group was required instead. Data were also weighted by sample size. In a handful of instances, certain missing information (e.g., time to peak levels, baseline levels, subject body weights) was filled in with reasonable assumptions to help maximize data inclusion. Data were processed in the form of mean estradiol curve data rather than individual-subject data (except for rare n=1 studies). The combined processed data from all studies for each injectable estradiol preparation were fit via least squares regression to one-, two-, and three-compartment pharmacokinetic models with first-order absorption and elimination that were obtained from the literature and other sources (e.g., Colburn, 1981; Wagner, 1993; Fisher & Shafer, 2007; Lixoft, 2008; Abuhelwa, Foster, & Upton, 2015; Certara, 2020). These models fit most curves from individual studies very well. Fitting the combined curve fits of all individual studies (as opposed to fitting all of the combined processed data directly) was additionally evaluated for each injectable estradiol preparation, and if it was feasible for the preparation and allowed for better fitting results, was employed instead. Fitting directly to the combined processed data has the effect of weighting individual studies by quantity of time points, whereas fitting the combined curve fits of studies eliminates this. The Akaike information criterion (AIC) was used to help guide model selection for fitting of the preparations. Curve fitting was performed using the Python library Lmfit with the Levenberg–Marquardt algorithm. Cmax concentrations are a different form of data than mean curve estradiol concentration–time data, and for this reason, were not included in the fitting unless data were very limited for a given injectable estradiol preparation. Outlying data were also excluded from fitting in a number of instances and this allowed for improved curve fits with more uniform area-under-the-curve levels. The main criterion used for excluding curves was fit area-under-the-curve levels that deviated considerably from what was typical for the injectable estradiol preparations (generally less than about 50% of the average or greater than about 150% of the average).

    A selection of pharmacokinetic parameters were calculated for each injectable estradiol preparation using the single-dose fit curves and compartmental pharmacokinetic analyses. These parameters included maximal or peak concentrations of estradiol after a single dose scaled to 5 mg (Cmax), time to maximal concentrations of estradiol after a single dose (Tmax), total area-under-the-curve concentrations of estradiol after a single dose (AUC0–∞), terminal elimination half-life after a single dose (t1/2), and the terminal 90% life after a single dose (t90%) (calculated as t1/2 × 3.322). In addition, selected pharmacokinetic parameters were calculated for simulated repeated administration of each injectable preparation at steady state with a dose and dose interval of 5 mg once every 7 days using the single-dose fit curves and compartmental pharmacokinetic analyses. These parameters included time to peak concentrations of estradiol (Tmax), peak and trough concentrations of estradiol (Cmax and Cmin, respectively), peak–trough difference (PTD; Cmax – Cmin), peak–trough ratio (PTR; Cmax ÷ Cmin), and integrated mean concentrations of estradiol (Cavg). Simulation of repeated administration was performed by stacking estradiol levels for multiple injections. Cmax and Tmax were defined and calculated in general as peak estradiol level and time to peak level of the fit mean curve as opposed to the mean peak level and mean time to peak level of individual subjects. This is because the latter would not be possible to compute as most studies reported only estradiol mean curve data. Pharmacokinetic parameters were calculated using relevant pharmacokinetic equations and, as a sanity check, were compared against those computed by PKSolver, a Microsoft Excel pharmacokinetics add-in program (Zhang et al., 2010).

    Results

    The figures in the subsequent sections show the original data from studies adjusted for endogenous estradiol levels and normalized to a common dose as well as the curve fits to the data (or alternatively the curve fits of the fits of the data depending on the preparation) for the included injectable estradiol preparations. Estradiol benzoate, estradiol cypionate in oil, and estradiol cypionate suspension were fit to the fits of all individual studies for these preparations, whereas estradiol enanthate, estradiol undecylate, and polyestradiol phosphate were fit directly to the combined processed data for these esters. In the case of estradiol valerate, the two fitting approaches gave nearly identical curves, and so fitting the combined processed original data was done for simplicity for this preparation. Cmax studies were excluded in the fitting for all preparations except estradiol enanthate, for which available estradiol concentration–time data were otherwise very limited. The data for the injectable estradiol preparations were generally fit best by a three-compartment pharmacokinetic model (Desmos). As a result, and for consistency, this model was used in the fitting of all preparations.

    Estradiol Benzoate

    Injectable estradiol benzoate has been extensively used in the past in scientific research, most notably in studies elucidating the function and dynamics of the HPG axis. One such use of estradiol benzoate has been the estrogen provocation test, a diagnostic test of HPG axis function. Due to its use in research, substantial estradiol concentration–time data with injectable estradiol benzoate exists. A total of 26 publications and concentration–time data for 355 individual injections were identified (Table 2).

    Table 2: Studies of injectable estradiol benzoate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    G753Gonadectomized/postmenopausal women27.6 mgGeppert (1975); Leyendecker et al. (1975)
    K7510Normal premenopausal women~0.15 mgKeye & Jaffe (1975)
    S75a10Amenorrheic premenopausal women1 mgShaw et al. (1975)
    S75b15Normal premenopausal women0.5 mgShaw, Butt, & London (1975)
    S75b25Normal premenopausal women1.5 mgShaw, Butt, & London (1975)
    S75b35Normal premenopausal women2.5 mgShaw, Butt, & London (1975)
    L763Normal premenopausal women3 mgLeyendecker et al. (1976)
    C7822Infertile anovulatory premenopausal women1 mgCanales et al. (1978)
    S786Normal premenopausal women2.5 mgShaw (1978)
    T7819Premenopausal women with hyperprolactinemia (n=12) and after prolactin normalization (n=7) (2 injections per subject for 7 of 12 subjects)1 mgTravaglini et al. (1978)
    T7918Premenopausal women with hyperprolactinemia (n=9) given estradiol benzoate alone and then in combination with progesterone (2 injections per subject)1 mgTravaglini et al. (1979)
    O8010Premenopausal women on a combined birth control pill5 mgOriowo et al. (1980)
    C8114Lactating postpartum women (n=7) (2 injections per subject)3 mgCanales et al. (1981)
    W8119Premenopausal women with prolactinomas and hyperprolactinemia1 mgWhite et al. (1981)
    S822Men with XX male syndrome5 mgSchweikert et al. (1982)
    B8310Normal premenopausal women (n=5) not on and then on danazol (2 injections per subject)5 mgBraun, Wildt, & Leyendecker (1983)
    K8422Gonadectomized premenopausal women on oral combined hormone therapy1 mgKemeter et al. (1984)
    V847Premenopausal women with alcoholism and cirrhosis or fatty liver disease5 mgVälimäki et al. (1984)
    G8510Transfeminine people not on hormone therapy (n=5) and normal men (n=5)2 mgGoodman et al. (1985)
    A8618Infertile ovulatory premenopausal women with transient hyperprolactinemia (n=9) and normal premenopausal women (n=9)~5 mgAisaka et al. (1986)
    C8627Perimenopausal women with dysfunctional uterine bleeding2 mgCano et al. (1986)
    M875Normal premenopausal women10 mgMessinis & Templeton (1987a); Messinis & Templeton (1987b)
    S8711Normal premenopausal women1 mgSumioki (1987)
    B8920Infertile ovulatory premenopausal women (n=10) not on and then on a GnRH agonist (2 injections per subject)2 mgBider et al. (1989)
    V9349Premenopausal women on a GnRH agonist with gynecological disorders (n=15) or undergoing fertility treatment (n=6) (2–3 injections per subject)2.5 mgVizziello et al. (1993)
    E0625Premenopausal women with premenstrual mood disturbances (n=13) and normal premenopausal women (n=12)~2.5 mgEriksson et al. (2006)

    a Total number of injections, not total number of subjects.

    A number of studies were excluded from fitting due to much higher or lower area-under-the-curve levels than average. A couple of studies were omitted from the meta-analysis as they only reported total estrogen levels rather than estradiol levels with estradiol benzoate (Akande, 1974; Weiss, Nachtigall, & Ganguly, 1976). Two studies were omitted due partly to being very old and using very early and inaccurate blood tests (Varangot & Cedard, 1957; Ittrich & Pots, 1965 [Graph]). The processed original data and fit of fits curve for estradiol benzoate are shown in Figure 1.

    Figure 1: Published estradiol concentration–time curves and fit of fit curves (thick black or white line) with a single intramuscular injection of estradiol benzoate in oil solution over a period of 7 days. Each curve was adjusted for endogenous estradiol levels, normalized to a dose of 5 mg, and fit with a compartmental pharmacokinetic model. Following this, the combined fit curves of the individual studies were fit using the same pharmacokinetic model. The original data from the studies for estradiol benzoate are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Valerate

    Studies with curve data on injectable estradiol valerate come from its use in menopausal hormone therapy and other therapeutic indications for estrogens, its use in combined injectable contraceptives, and use in scientific research. A total of 28 publications and concentration–time data for 309 individual injections were identified for estradiol valerate (Table 3).

    Table 3: Studies of injectable estradiol valerate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    S717512Premenopausal women with menstrual migraine (n=10) and amenorrheic/postmenopausal women with history of menstrual migraine (n=2)5⁠–⁠20 mgSomerville (1971); Somerville (1972a); Somerville (1972b); Somerville (1972c); Somerville (1975)
    G753Gonadectomized/postmenopausal women26.2 mgGeppert (1975); Leyendecker et al. (1975)
    V75a4Unknown/not described10 mgVermeulen (1975)
    V75b2Unknown/not described4 mgVermeulen (1975)
    O809Premenopausal women on a combined birth control pill5 mgOriowo et al. (1980)
    R806Gonadectomized/postmenopausal women10 mgRauramo et al. (1980); Rauramo, Punnonen, & Grönroos (1981)
    B8210Normal premenopausal women with bromocriptine administration20 mgBlackwell, Boots, & Potter (1982)
    D833Normal postmenopausal women4 mgDüsterberg, & Wendt (1983)
    A857Normal premenopausal women5 mgAedo et al. (1985)
    D852Gonadectomized/postmenopausal women4 mgDüsterberg & Nishino (1982); Düsterberg, Schmidt-Gollwitzer, & Hümpel (1985)
    R877Normal young men10 mgReimann et al. (1987)
    S87a8Normal premenopausal women5 mgSang et al. (1987)
    S87b8Normal premenopausal women2.5 mgSang et al. (1987)
    S87c20Gonadectomized/postmenopausal women10 mgSherwin et al. (1987); Sherwin (1988)
    G8854Normally cycling transmasculine people not on hormone therapy (n=31), transfeminine people not on hormone therapy (n=14), and gonadally intact transfeminine people on oral estrogen therapy (n=9)10 mgGoh & Ratnam (1988)
    G9012Normally cycling transmasculine people not on hormone therapy10 mgGoh & Ratnam (1990)
    G94a8Normal premenopausal women5 mgGarza-Flores (1994)
    G94c5Normal premenopausal women5 mgGarza-Flores (1994)
    J949Normal young men10 mgJilma et al. (1994)
    G985Men with Klinfelter’s syndrome10 mgGoh & Lee (1998)
    G0217Normal postmenopausal women5 mgGöretzlehner et al. (2002)
    K0610Normal menopausal women2 mgKerdelhué et al. (2006)
    V1132Normal young men5 mgValle Alvarez (2011)
    S1248Normal postmenopausal women (n=24) given Estradiol-Depot 10 mg and then Progynon Depot-10 (2 injections per subject)10 mgSchug, Donath, & Blume (2012)

    a Total number of injections, not total number of subjects.

    A few of these studies were excluded from fitting due generally to much higher or lower area-under-the-curve levels than average or due to being Cmax data. One study was omitted as it only reported estrone levels rather than estradiol levels (Ibrahim, 1996). Another study was not included due to being in pregnant women with concomitant pregnancy termination (Garner & Armstrong, 1977). One last study was omitted due partly to being very old and using very early and inaccurate blood tests (Ittrich & Pots, 1965 [Graph]). The processed original data and fit curve for estradiol valerate are shown in Figure 2.

    Figure 2: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of estradiol valerate in oil solution over a period of 30 days. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 10 mg, and fit with a compartmental pharmacokinetic model. Fitting of the combined fits of individual studies for this preparation was explored but gave a nearly identical overall curve, so the overall fit curve for the combined processed original data was used for simplicity for this preparation. The original data from the studies for estradiol valerate are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Cypionate Oil

    Estradiol cypionate in oil is used in menopausal hormone therapy and for other estrogen indications. However, its use has been more limited relative to other injectable estradiol preparations, like estradiol valerate. Only a handful of studies with relevant data were identified for estradiol cypionate in oil. This included 4 publications and estradiol concentration–time data for 49 individual injections (Table 4).

    Table 4: Studies of injectable estradiol cypionate in oil (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    R736Hypogonadal adolescent girls1⁠–⁠2 mgRosenfield et al. (1973); Rosenfield & Fang (1974)
    B80~5Normal premenopausal women10 mgBuckman et al. (1980)
    O8010Premenopausal women on a combined birth control pill5 mgOriowo et al. (1980)
    L9628Postmenopausal women with history of hormonal migraine (n=16) and without (n=12) initially on oral estrogen therapy (discontinued upon injection)5 mgLichten et al. (1996)

    a Total number of injections, not total number of subjects.

    No curves were excluded from fitting in the case of this preparation. The processed original data and fit of fit curves for estradiol cypionate in oil are shown in Figure 3.

    Figure 3: Published estradiol concentration–time curves and fit of fit curves (thick black or white line) with a single intramuscular injection of estradiol cypionate in oil solution over a period of 30 days. Each curve was adjusted for endogenous estradiol levels, normalized to a dose of 5 mg, and fit with a compartmental pharmacokinetic model. Following this, the combined fit curves of the individual studies were fit using the same pharmacokinetic model. The original data from the studies for estradiol cypionate in oil are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Cypionate Suspension

    Estradiol cypionate suspension has been used exclusively in combined injectable contraceptives. For this reason, many relatively high quality pharmacokinetic studies with this injectable preparation have been conducted. A total of 9 publications and estradiol concentration–time data for 131 individual injections were identified for estradiol cypionate suspension (Table 5).

    Table 5: Studies of injectable estradiol cypionate suspension (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    F8211Normal premenopausal women5 mgFotherby et al. (1982)
    A858Normal premenopausal women5 mgAedo et al. (1985)
    G87a7Normal premenopausal women5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87b8Normal premenopausal women5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87c7Normal premenopausal women5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87d8Normal premenopausal women2.5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87e8Normal premenopausal women2.5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    G87f6Normal premenopausal women2.5 mgGarza-Flores et al. (1987); Garza-Flores (1994)
    Z989Normal premenopausal women5 mgZhou et al. (1998)
    R9914Healthy surgically sterile premenopausal women5 mgRahimy & Ryan (1999); Rahimy, Ryan, & Hopkins (1999)
    S11a15Normal premenopausal women5 mgSierra-Ramírez et al. (2011)
    S11bb15Normal premenopausal women5 mgSierra-Ramírez et al. (2011)
    T1315Normal premenopausal women5 mgThurman et al. (2013)

    a Total number of injections, not total number of subjects. b By subcutaneous injection rather than intramuscular injection.

    One of these studies used subcutaneous injection instead of the usual intramuscular injection but the resulting curve was very similar to the curve for intramuscular injection in the same study (Sierra-Ramírez et al., 2011 [Graph]). Several Cmax studies were excluded from fitting for this preparation. One pharmacokinetic study only measured estradiol cypionate levels rather than estradiol levels and hence was not included (Martins et al., 2019 [Graph]). The processed original data and fit of fit curves for estradiol cypionate suspension are shown in Figure 4.

    Figure 4: Published estradiol concentration–time curves and fit of fits curve (thick black or white line) with a single intramuscular (or in one case subcutaneous) injection of a microcrystalline aqueous suspension of estradiol cypionate over a period of 30 days. Each curve was adjusted for endogenous estradiol levels, normalized to a dose of 5 mg, and fit with a compartmental pharmacokinetic model. Following this, the combined fit curves of the individual studies were fit using the same pharmacokinetic model. The original data from the studies for estradiol cypionate suspension are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Enanthate

    Estradiol enanthate has been used exclusively in combined injectable contraceptives. Several pharmacokinetic studies have been conducted with it because of this. A total of 7 publications and concentration–time data for 270 individual injections were identified for estradiol enanthate (Table 6).

    Table 6: Studies of injectable estradiol enanthate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    R86a1Normal premenopausal woman5 mgRecio et al. (1986)
    R86b1Normal premenopausal woman10 mgRecio et al. (1986)
    W863Normal postmenopausal women10 mgWiemeyer et al. (1986); Wiemeyer et al. (1987)
    S8814Normal premenopausal women10 mgSchiavon et al. (1988)
    G8910Normal premenopausal women10 mgGarza-Flores et al. (1989)
    G94a9Normal premenopausal women10 mgGarza-Flores (1994)
    G94b9Normal premenopausal women5 mgGarza-Flores (1994)
    G94c7Normal premenopausal women10 mgGarza-Flores (1994)
    M95216Normal premenopausal women10 mgMartinez (1995)

    a Total number of injections, not total number of subjects.

    Of the available data, 216 of the injections were from a single study and mainly included only Cmax levels. Wiemeyer et al. (1986) was excluded from fitting due to having unusually high area-under-the-curve levels with a small sample size (n=3). Because of the scarcity of estradiol concentration–time data available for estradiol enanthate, Cmax studies were included in the fitting for this preparation. The processed original data and fit curve for estradiol enanthate are shown in Figure 5.

    Figure 5: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of estradiol enanthate in oil solution over a period of 30 days. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 10 mg, and fit with a compartmental pharmacokinetic model. The original data from the studies for estradiol enanthate are also provided elsewhere (Spreadsheet; Plotly).

    Estradiol Undecylate

    Estradiol undecylate was formerly used in the treatment of prostate cancer and in menopausal hormone therapy as well as for other estrogen therapeutic indications. However, it was discontinued many years ago and is no longer used today. Nonetheless, estradiol undecylate is of significant historical interest as an injectable estradiol preparation. A total of 4 publications and estradiol concentration–time data for 7 individual injections were identified for estradiol undecylate (Table 7).

    Table 7: Studies of injectable estradiol undecylate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    G753Gonadectomized/postmenopausal women32.3 mgGeppert (1975)/Leyendecker et al. (1975) [Graph]
    V754Unknown/not described100 mgVermeulen (1975)/Vermeulen (1977) [Graph]

    a Total number of injections, not total number of subjects.

    Unfortunately, the identified data were of very low quality, with small sample sizes and considerable variations in estradiol levels. Moreover, estradiol undecylate is a very long-acting injectable estradiol ester with a duration measured in months, and the follow up in these studies only went to about 2 weeks post-injection. For these reasons, it was not possible to fit the data for estradiol undecylate in a reasonably accurate way—as suggested by area-under-the-curve estradiol levels that were only around one-third those of the other non-polymeric injectable estradiol esters. Limited multi-dose hormone concentration–time data also exist for estradiol undecylate, but these data could not be incorporated (Jacobi & Altwein, 1979 [Graph]; Jacobi et al., 1980 [Graph]; Derra, 1981 [Graph]). The processed original data and fit curve for estradiol undecylate are shown in Figure 6.

    Figure 6: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of estradiol undecylate in oil solution over a period of 90 days. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 50 mg, and fit with a compartmental pharmacokinetic model. The original data from the studies for estradiol undecylate are also provided elsewhere (Spreadsheet; Plotly).

    Polyestradiol Phosphate

    Polyestradiol phosphate has been used primarily in the treatment of prostate cancer but has also been used for estrogen therapeutic indications like treatment of breast cancer and menopausal hormone therapy. While this injectable estradiol preparation has been used widely in the past, it appears to have recently been discontinued. All of the identified studies with estradiol concentration–time data on polyestradiol phosphate were in men with prostate cancer. A total of 11 publications and concentration–time data for 114 individual injections were identified for polyestradiol phosphate (Table 8).

    Table 8: Studies of injectable polyestradiol phosphate (Spreadsheet; Plotly):

    StudynaSubjectsDoseReference(s)
    J7616Men with prostate cancer160 mgJönsson (1976)
    L7910Men with prostate cancer80 mgLeinonen et al. (1979)
    L808Men with prostate cancer80 mgLeinonen (1980)
    J824Men with prostate cancer80 mgJacobi (1982)
    N87a3Men with prostate cancer80 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87b3Men with prostate cancer160 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87c3Men with prostate cancer240 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87d4Men with prostate cancer80 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87e4Men with prostate cancer160 mgNorlén (1987); Gunnarsson & Norlén (1988)
    N87f4Men with prostate cancer240 mgNorlén (1987); Gunnarsson & Norlén (1988)
    S88a9Men with prostate cancer160 mgStege et al. (1988); Stege et al. (1989)
    S88b9Men with prostate cancer240 mgStege et al. (1988); Stege et al. (1989)
    S88c9Men with prostate cancer320 mgStege et al. (1988); Stege et al. (1989)
    S9611Men with prostate cancer320 mgStege et al. (1996)
    H9917Men with prostate cancer240 mgHenriksson et al. (1999); Johansson & Gunnarsson (2000)

    a Total number of injections, not total number of subjects.

    A few older and strongly outlying studies were excluded from the fitting. The processed original data and fit curve for polyestradiol phosphate are shown in Figure 7.

    Figure 7: Published estradiol concentration–time curves and fit curve (thick black or white line) with a single intramuscular injection of an aqueous solution of polyestradiol phosphate over a period of 90 days. The graph was clipped to maximum estradiol levels of 600 pg/mL (~2,200 pmol/L) for better viewability. Curves were adjusted for endogenous estradiol levels, normalized to a dose of 160 mg, and fit with a compartmental pharmacokinetic model. The original data from the studies for polyestradiol phosphate are also provided elsewhere (Spreadsheet; Plotly).

    Other Injectable Estradiol Preparations

    A number of clinical studies with estradiol concentration–time data for other injectable estradiol preparations were also identified during literature search:

    These preparations were not included in the present meta-analysis due to their relative obscurity and the limited data available for them. In addition, there were concerns about fitting the used pharmacokinetic models to the formulations with multiple estradiol components and to the microsphere formulations.

    No estradiol concentration–time data were identified for certain other injectable estradiol forms of interest, like unesterified estradiol in aqueous solution, estradiol benzoate as a microcrystalline aqueous suspension (Agofollin Depot; Ovocyclin M), or estradiol benzoate butyrate/dihydroxyprogesterone acetophenide in oil (Redimen, Soluna, Unijab) (another lesser-known combined injectable contraceptive).

    All Injectable Estradiol Preparations Together

    Figure 8 shows the curve fits for all of the injectable estradiol preparations scaled to a single dose of 5 mg (or equivalent) together in the same figure. The dose for polyestradiol phosphate was scaled to be about 6.5 times higher than the other injectable estradiol preparations in order to make it roughly equivalent to them in terms of total estradiol exposure. This was because polyestradiol phosphate was found to produce much lower area-under-the-curve estradiol levels than the other injectable estradiol preparations (see the Discussion section). Estradiol undecylate was not included in Figure 8 as a decent fit curve could not be obtained for it due to the very limited data available for this preparation.

    Figure 8: Curve fits of published estradiol concentration–time data with different injectable estradiol preparations by intramuscular injection scaled to equivalent doses and plotted over a period of 20 days in a single combined graph. Polyestradiol phosphate is scaled to a 6.5-fold higher dose that is roughly equivalent to that for the other esters as it gave total estradiol levels that were around 6 or 7 times lower than the other esters at the same dose. An alternative version of this figure without estradiol benzoate and with the x-axis spanning 30 days is also provided (Graph).

    Figure 9 shows simulated curves at steady state for repeated administration of all of the injectable estradiol preparations scaled to a dose of 5 mg (or equivalent) once every 7 days. As with the previous figure, the dose for polyestradiol phosphate was scaled to be about 6.5 times higher than the other injectable estradiol preparations and estradiol undecylate was not included in the figure.

    Figure 9: Simulated curves at steady state for repeated administration of different injectable estradiol preparations by intramuscular injection scaled to equivalent doses and plotted over three injection cycles. This simulation was based on the fit curves of the published single-dose estradiol concentration–time data reported in this meta-analysis. Polyestradiol phosphate is scaled to a 6.5-fold higher dose that is roughly equivalent to that for the other esters as it gave total estradiol levels that were around 6 or 7 times lower than the other esters at the same dose. An alternative version of this figure without estradiol benzoate is also provided (Graph).

    For more simulated estradiol concentration–time curves with repeated injections of these injectable estradiol preparations, please see the accompanying interactive web simulator.

    Selected Pharmacokinetic Parameters

    The table below shows selected pharmacokinetic parameters for the fit curves of the included injectable estradiol preparations (Table 9). Estradiol undecylate was not included in the table due to the lack of data needed to achieve a decent curve fit for this preparation and the uncertainty of its parameters.

    Table 9: Selected pharmacokinetic parameters for estradiol with injectable estradiol preparations following a single 5 mg dose by intramuscular injection:

    Estradiol preparationTmax
    (d)    		Cmax
    (pg/mL)    		t1/2
    (d)    		t90%
    (d)    		AUC0–∞
    (pg•d/mL)
    Estradiol benzoate in oil0.659711.23.92410
    Estradiol valerate in oil2.12953.09.91886
    Estradiol cypionate oil4.31556.722.32150
    Estradiol cypionate suspension1.22415.116.92096
    Estradiol enanthate in oil6.51604.615.12183
    Polyestradiol phosphate a18.03428.494.22117

    a Scaled instead to a single 32.5 mg injection (6.5 times higher dose than with the other esters).

    The table below shows selected pharmacokinetic parameters for simulated curves at steady state with repeated administration of the included injectable estradiol preparations (Table 10). As with the previous table, estradiol undecylate was not included.

    Table 10: Selected pharmacokinetic parameters for estradiol with injectable estradiol preparations with simulated repeated administration of 5 mg once every 7 days by intramuscular injection:

    Estradiol preparationTmax
    (d)    		Cmax
    (pg/mL)    		Cmin
    (pg/mL)    		Peak–trough
    diff. (pg/mL)    		Peak–trough
    ratio    		Cavg
    (pg/mL)
    Estradiol benzoate in oil0.649902996235344
    Estradiol valerate in oil1.93841422422.7269
    Estradiol cypionate oil3.1339262771.3307
    Estradiol cypionate suspension1.04041892142.1299
    Estradiol enanthate in oil4.0329288411.1312
    Polyestradiol phosphate a3.230429951.0302

    a Scaled instead to repeated injections of 32.5 mg every 7 days (6.5 times higher dose than with the other esters).

    Terminal half-life (t1/2) is the time for the concentration of estradiol to decrease by 50% after pseudo-equilibrium of distribution has been reached—not the time required for half of an administered dose of the estradiol ester to be eliminated (Toutain & Bousquet-Mélou, 2004). It is calculated using only the terminal portion of a concentration–time curve, without the absorption or distribution phases influencing it (Toutain & Bousquet-Mélou, 2004). Due to flip–flop kinetics with depot injectables and the very short blood half-life of estradiol (~0.5–2 hours), what is being described by the terminal half-life in the case of depot estradiol injectables is not actually elimination of estradiol from blood but rather is the absorption of estradiol from the injection-site depot (Toutain & Bousquet-Mélou, 2004; Yáñez et al., 2011).

    Discussion

    Data Quality, Limitations, and Variability Between Studies

    The accuracies of the curve fits for the different included injectable estradiol preparations are limited by the available data for these preparations. The quantity and quality of data are variable among these preparations. In some cases, such as with estradiol valerate in oil and estradiol cypionate in suspension, the data are overall quite good. In other instances, such as with estradiol cypionate in oil and estradiol enanthate in oil, the available data are more limited. There was undersampling of certain parts of the concentration–time curve with some preparations, for instance estradiol benzoate in oil (the early curve), estradiol enanthate in oil (much of the curve), and polyestradiol phosphate (the late curve). In the case of estradiol undecylate in oil, the available data for this preparation weren’t adequate to achieve a decent curve fit at all. The fit curves and calculated pharmacokinetic parameters of the included injectable estradiol preparations should be interpreted with the imperfect data in mind. For example, the curve shapes and pharmacokinetic parameters for the different preparations should not be taken as precise determinations in most cases but instead as rough estimates that would no doubt change with more and better data. Indeed, the fits and pharmacokinetic parameters were often noticeably sensitive to the influences of individual studies. Modeling decisions, such as the choice of pharmacokinetic model, or whether to fit directly to the combined processed data versus to the fits of individual studies, also yielded significantly different curve fits as well as calculated pharmacokinetic parameters.

    Due to scarcity of data for several injectable estradiol preparations, the study selection criteria maximized data inclusion in order to allow for better curve fits at the risk of including potentially less reliable data. As examples, studies were included regardless of the status of the HPG axis of the participants, and Cmax data were included in the fitting if data were very limited. In the case of HPG axis state, studies with cycling women may result in greater error due to more variable levels of endogenous estradiol. Moreover, acute high levels of estradiol can induce a surge in luteinizing hormone levels after several days in gonadally intact women, and this may cause a delayed bump in estradiol levels (Wiki). One of the more overt instances of this can be seen in a study of estradiol benzoate in such women (Shaw, 1978 [Graph]). Many if not most of the included studies with estradiol benzoate involved women with intact HPG axes, whereas studies of this sort were uncommon with the other preparations. In the case of Cmax data, these data when Cmax corresponds to the mean of individual peaks are a different type of data than the peak of the mean curve of all individuals. Cmax levels can differ in both magnitude and timing compared to the mean curve peak (e.g., Oriowo et al., 1980 [Graph]; Rahimy, Ryan, & Hopkins, 1999). This is because for instance not all individuals peak at the same time and this variability in time to peak normally serves to dilute peak levels for the mean curve when compared to individual maximal concentrations. However, Cmax levels are in any case generally in the vicinity of the mean curve peak. While Cmax levels were excluded in the fitting for most injectable estradiol preparations, they were included in the case of estradiol enanthate. This was because the available mean and individual estradiol curve data were very limited for this specific preparation, and inclusion of Cmax data allowed for improved fitting in spite of its limitations. Lastly, some of the included data was once-monthly multi-dose, and research with once-monthly estradiol enanthate-containing combined injectable contraceptives has found that the time to peak levels may shift with repeated long-term use (Schiavon et al., 1988; Garza-Flores, 1994).

    There was considerable variability between studies in terms of estradiol levels and concentration–time curve shapes with the same injectable estradiol preparation. The reasons for the large variability across studies are not fully clear. In any case, there are many potential factors that may contribute to this variability. These include preparation- and injection-related factors like formulation (e.g., oil vehicle, other components and excipients, concentration, particle size), injection volume, site of injection (e.g., buttocks, thigh, upper arm), injection technique (e.g., force of injection—and resulting depot droplet dimensions), and syringe dead space. They additionally include various subject- and research-related variables like differing blood-testing methodology, differing sample characteristics (e.g., age, weight, gender, ethnicity, physical activity, HPG axis state), and sampling error (Sinkula, 1978; Chien, 1981; Minto et al., 1997; Larsen & Larsen, 2009; Larsen et al., 2009; Florence, 2010; Larsen, Thing, & Larsen, 2012; Kalicharan, 2017). Older studies, which used potentially less accurate blood tests and tended to have smaller numbers of subjects, seemed to particularly add to the variability between studies. These studies may represent less reliable data than more recent research with larger sample sizes. The exclusion criteria helped to remove outliers for the different injectable estradiol preparations however. This meta-analysis does not take into account the potential factors underlying the variability between studies. To do so would be difficult, as in many cases information on these variables is not provided in individual studies and research quantifying their precise influences and relative importances is limited.

    It is in any case known from other studies that different oil vehicles are absorbed at different rates from the injection site (Svendsen & Aaes‐Jørgensen, 1979; Schultz et al., 1998; Larsen et al., 2001) and can result in different concentration–time curve shapes (Ballard, 1978 [Excerpt]; Knudsen, Hansen, & Larsen, 1985). This is thought to be due to differences in oil lipophilicity and depot release rates. Viscosity of oils has also been hypothesized to potentially influence rate of depot escape (Schug, Donath, & Blume, 2012). However, research so far has not supported this hypothesis (Larsen & Larsen, 2009; Larsen, Thing, & Larsen, 2012). Oil vehicles can vary with injectable estradiol preparations even for the same estradiol ester. For instance, pharmaceutical estradiol valerate is formulated in sesame oil, castor oil, or sunflower oil depending on the preparation (Table). It is notable however that these three oils have similar lipophilicities (Table). On the other hand, homebrewed injectable estradiol preparations used by DIY transfeminine people often employ medium-chain triglyceride (MCT) oil as the oil vehicle. This oil (in the proprietary form of Viscoleo) has notably been found to be much more rapidly absorbed than conventional oils like sesame oil and castor oil in animals (Svendsen & Aaes‐Jørgensen, 1979; Schultz et al., 1998; Larsen et al., 2001). In addition, although based on very limited data, MCT oil has been found to give spikier and shorter-lasting depot injectable curves in humans (Knudsen, Hansen, & Larsen, 1985). As such, injectable estradiol preparations using MCT oil as the vehicle may have differing and less favorable concentration–time curve shapes than pharmaceutical injectable estradiol products. Other excipients, like benzyl alcohol, as well as factors like injection site and volume, have additionally been found to influence pharmacokinetic properties with depot injectables (Minto et al., 1997; Kalicharan, Schot, & Vromans, 2016). Excipients besides oil vehicle also vary by formulation (Table).

    An implication of the variability between studies is that there is not a single estradiol concentration–time curve for a given injectable estradiol preparation but rather there are many, with these curves determined by variables such as formulation, dose/administration, and subject characteristics, among others. Hence, the curve fits determined in this meta-analysis represent only an estimation of the most typical and hence likely case, but the true curve for a preparation in a given context may be quite different.

    Fitting all studies for a given injectable estradiol preparation individually first, and then fitting the fits of these studies, allowed for improved curve fits relative to directly fitting all of the combined processed original data for the preparation. The latter approach has limitations in that it has the effect of inherently weighting individual studies by quantity of time points (resulting in studies with greater time sampling having greater influence on the fit). Additionally, and more problematically, this approach can lead to distortions in curve shape due to different studies sampling different portions of the curve to differing extents in conjunction with systematic differences in curves between these studies. These are problems that fitting the fits of individual studies instead can solve. However, it is not possible to fit all individual studies, as some studies have limited time sampling and curve characterization which precludes fitting them appropriately. Cmax data are an example of this, which on their own cannot be fit properly. As such, it was not possible to fit the fits of the individual studies for all injectable estradiol preparations. Consequently, the fitting approach in this regard was not the same across esters, with some fit instead directly to the combined processed original data (e.g., estradiol enanthate, polyestradiol phosphate).

    In spite of the various limitations of this work, aggregated analysis and modeling with injectable estradiol preparations has not previously been done. This informal meta-analysis provides among the most detailed insight into estradiol levels and curve shapes with these preparations available to date.

    Durations and Curve Shapes

    The curve shapes of non-polymeric injectable estradiol esters in oil relate strongly to lipophilicity. The more lipophilic the ester, the lower the peak levels and the more protracted the estradiol concentration–time curve. Accordingly, estradiol benzoate, one of the least lipophilic estradiol esters, has one of the spikiest curves and shortest durations, whereas more lipophilic estradiol esters, like estradiol cypionate in oil and estradiol enanthate, have comparatively flatter curves with delayed peaks and longer durations.

    Duration of Estradiol Valerate

    The estradiol concentration–time curve for injectable estradiol valerate in the well-known Oriowo et al. (1980) [Graph] study is notably spikier and shorter-lasting than the overall curve for estradiol valerate in this meta-analysis. On the other hand, the overall curve for injectable estradiol valerate in this meta-analysis was similar to (and considerably influenced by) the curves from several relatively recent and presumably better-quality studies of this injectable estradiol ester (e.g., Göretzlehner et al., 2002; Valle Alvarez, 2011; Schug, Donath, & Blume, 2012). It’s noteworthy that Oriowo et al. (1980) used a peanut oil-based formulation of estradiol valerate that differed from pharmaceutical injectable estradiol valerate preparations, which generally use sesame oil or castor oil as the carrier (as well as other excipients) (Table). This may have influenced the curve shape of estradiol valerate in Oriowo et al. (1980). The study also had a small sample size relative to the more recent studies (n=9 versus n=17, n=32, and n=24×2, respectively). Based on the newer and overall data, estradiol valerate appears to have a curve that is noticeably flatter and more prolonged than that suggested by Oriowo et al. (1980).

    Duration of Estradiol Cypionate in Oil versus Estradiol Enanthate

    Available estradiol concentration–time data for injectable estradiol cypionate in oil and estradiol enanthate in oil are more limited than with several of the other injectable estradiol preparations, and no direct comparisons of these two preparations exist at present. Based on some of the available literature on these injectable estradiol esters, most notably discussion by Oriowo et al. (1980) and a review of the pharmacokinetics of combined injectable contraceptives (Garza-Flores, 1994 [Graph]), it seemed that the duration of estradiol enanthate in oil was longer than that of estradiol cypionate in oil. However, this was based on limited research from separate and hence indirectly comparative studies of these esters. The estradiol cypionate in oil data from the relevant Garza-Flores (1994) figure was based on Oriowo et al. (1980) [Graph], and there are reasons to be cautious about relying on these data alone. The main concern is that curve shapes with the same injectable estradiol preparation can vary considerably across studies, as the present meta-analysis has shown. The reasons for this have yet to be fully clarified as already discussed, but among other factors may include varying formulations across studies of the same injectable estradiol ester. It is notable in this regard that Oriowo et al. (1980) used a formulation of estradiol cypionate that differs from conventional pharmaceutical estradiol cypionate in oil preparations—specifically, the study used a peanut oil-based formulation (with few other specifics) rather than the cottonseed oil-based preparation employed in marketed pharmaceutical formulations (Table). The study also had a somewhat small sample size (n=10) and may have had significant sampling error. Hence, single studies, perhaps particularly Oriowo et al. (1980), should be interpreted cautiously.

    A small but interesting pharmacokinetic study which directly compared injectable testosterone cypionate (n=6) and testosterone enanthate (n=6) both in oil is relevant to the topic in question. This study found that equivalent doses of these testosterone esters using otherwise identical formulations produced virtually identical testosterone concentration–time curves (Schulte-Beerbühl & Nieschlag, 1980 [Graph]). The findings of this study are consistent with the fact that the lipophilicities of testosterone cypionate and testosterone enanthate (as measured by predicted log P) are very similar when directly compared (e.g., 5.1 vs. 5.11 with ALOGPS, 6.29 vs. 6.11 with ChemAxon logP, and 6.4 vs. 6.3 with XLogP3, respectively (Table). This of course is of importance as lipophilicity is thought to be the key factor determining the release kinetics of oil-based depot injectables (Sinkula, 1978; Shah, 2007; Larsen & Larsen, 2009; Larsen, Thing, & Larsen, 2012; Shahiwala, Mehta, & Momin, 2018). Analogously similar lipophilicities can be seen when comparing estradiol cypionate and estradiol enanthate, which employ the same ester moieties (e.g., predicted log P values of 6.47 vs. 6.45 with ALOGPS and 7.1 vs. 7.0 with XLogP3, respectively) (Table). Hence, on a theoretical level, injectable estradiol cypionate and estradiol enanthate, like injectable testosterone cypionate and testosterone enanthate, might be expected to produce very similar curves—at least provided all other variables, such as formulation, are held constant.

    The present meta-analysis found that the overall estradiol curve for estradiol cypionate in oil was significantly less spikey and more prolonged than that observed in Oriowo et al. (1980). It is noteworthy in this regard that all of the other studies included for estradiol cypionate in oil specifically employed pharmaceutical Depo-Estradiol and that the overall curve for this preparation appears to be more consistent with its licensed injection interval for use in menopausal hormone therapy (1–5 mg once every 3–4 weeks) (Depo-Estradiol Label). Moreover, this meta-analysis found that injectable estradiol cypionate in oil and estradiol enanthate in oil had fairly similar and comparably flat and prolonged estradiol concentration–time curves. However, estradiol cypionate in oil appeared to peak earlier than estradiol enanthate, while estradiol enanthate was eliminated more rapidly than estradiol cypionate in oil in the terminal portion of the curve. In any case, the available concentration–time data for these preparations are limited, and the present work is not able to determine whether these estradiol esters have truly differing pharmacokinetic properties, as the apparent differences between the curves for these preparations may simply be due to statistical error. Taken together, estradiol cypionate in oil may have a less spikey and longer-lasting curve than that implied by Oriowo et al. (1980), and estradiol cypionate in oil and estradiol enanthate may have more similar curves than has been previously assumed.

    Curve Shape of Estradiol Cypionate Suspension

    While estradiol cypionate as an aqueous suspension is a relatively long-lasting injectable estradiol preparation similarly to estradiol cypionate in oil and estradiol enanthate in oil, it seems to differ in the shape of its estradiol concentration–time curve from these preparations. Estradiol cypionate as a suspension has a curve that appears to peak significantly earlier than estradiol cypionate in oil and other longer-acting oil-based injectable estradiol preparations. This might relate to the differing mechanisms of depot action and unique properties of injectable aqueous suspensions (Aly, 2019). In line with this notion, injectable medroxyprogesterone acetate suspension (Depo-Provera) also appears to peak rapidly despite having a very long duration (longer durations tending to be associated with delayed peaks in the case of oil-based depot injectables) (Graphs). Although aqueous suspensions generally last longer than oil solutions as injectables (Enever et al., 1983; Aly, 2019), this is not always the case, and estradiol cypionate suspension interestingly seems to be shorter-acting than estradiol cypionate in oil.

    Estradiol Exposure and Potency

    The average estradiol levels with the non-polymeric injectable estradiol esters when scaled to a dose and dosing interval of 5 mg every 7 days were around 300 pg/mL (~1,100 pmol/L). For comparison, in premenopausal cisgender women, estradiol production is on average about 200 μg/day (or 6 mg per month/cycle) and mean estradiol levels are around 100 pg/mL (~370 pmol/L) (Aly, 2019). After adjusting for the molecular weight of the ester, the estradiol levels for a given dose of non-polymeric injectable estradiol esters are in fairly close agreement with the estradiol levels for an equal quantity of estradiol produced endogenously by the ovaries in premenopausal cisgender women (very roughly around 1.2 mg estradiol per 7 days for injectable estradiol esters and 1.4 mg estradiol per 7 days for ovarian production to achieve average integrated estradiol levels of around 100 pg/mL). The preceding is in accordance with the fact that injectable estradiol valerate has been reported to have approximately 100% bioavailability (with this being less characterized but likely also the case for the other non-polymeric injectable estradiol esters) (Düsterberg & Nishino, 1982; Seibert & Günzel, 1994).

    Although non-polymeric injectable estradiol esters have differing estradiol concentration–time curve shapes, they all appear to achieve fairly similar area-under-the-curve levels of estradiol when compared to one another. This is in accordance with the fact that differences in molecular weight and hence estradiol content with the different estradiol esters are fairly minor (all of the assessed non-polymeric esters range from 62 to 76% of that of estradiol in terms of estradiol content, and all but estradiol undecylate are in the range of 69 to 76%) (Table). The appearance of differences in area-under-the-curve levels of estradiol in the present meta-analysis is probably just due to statistical error, and true differences cannot be established by this meta-analysis. An implication of the similar area-under-the-curve estradiol levels with the different non-polymeric injectable estradiol esters is that these preparations can all be expected to deliver a roughly comparable amount of estradiol for the same dose.

    On the other hand, the polymeric ester polyestradiol phosphate appears to produce around 6- to 7-fold lower area-under-the-curve and average estradiol levels than non-polymeric estradiol esters. This suggests that the estradiol in polyestradiol phosphate is not 100% bioavailable, and is supported by the fact that this ester is used clinically at substantially higher dosages than other injectable estradiol esters (40–320 mg/month), even for the same indications such as menopausal hormone therapy and treatment of prostate cancer (Wiki; Estradurin Labels). This does not seem to have been previously described in the literature, and the reasons for it are unknown. It seems possible that polyestradiol phosphate may be partially excreted before it can be cleaved into estradiol and thereby rendered partly inactive, in turn necessitating the use of higher doses to achieve the same estradiol levels and therapeutic effect.

    Although two given injectable estradiol preparations may produce equivalent total estradiol levels, this does not necessarily mean that they will always have the same estrogenic potency (i.e., strength of effect at a given dose). It is plausible that spikier estradiol concentration–time curves, like with estradiol benzoate, may have overall lower estrogenic potency than more steady curves, like with estradiol enanthate. This is because estrogen receptors for a given tissue should become saturated at a certain point due to the finite quantity of available receptors in the tissue. As a result, high peak estradiol levels with spikier curves may effectively be “wasted” to varying extents in different tissues. On the other hand, more spikey estradiol curves, due to higher peak estradiol levels, might have greater influence on tissues that require high estradiol levels for effect such as the liver (and by extension on coagulation and associated health risks) (Aly, 2020). However, these possibilities are speculative and theoretical. Although some literature exists that is relevant to this issue (e.g., Parkes, 1937; Bradbury, Long, & Durham, 1953), there is very little research in this area. Consequently, it is not currently possible to take into account time-related variations in estradiol levels or differing estradiol curve shapes when assessing the comparative estrogenic potency between injectable estradiol preparations (or between other estradiol forms/routes). It is also noteworthy that these variations depend on injection interval and may be reduced with shorter injection intervals that maintain steadier estradiol levels, which must also be considered.

    Variability Between Individuals

    There is substantial variation in total estradiol levels and curve shapes between people with the same injectable estradiol preparation. Indicators of interindividual variability such as standard deviation or 95% range have not been included in this meta-analysis at this time due to the large amount of additional time and work this would require (e.g., additional extraction of error bars from all studies and analysis). In any case, individual studies that were included show this marked interindividual variation (e.g., Oriowo et al., 1980; Derra, 1981 [Graph]; Aedo et al., 1985 [Graphs]; Sang et al., 1987 [Graphs]; Rahimy & Ryan, 1999 [Graph]; Valle Alvarez, 2011 [Graph]; Schug, Donath, & Blume, 2012 [Graphs]). Highly variable estradiol levels are already well-established with oral and transdermal estradiol (Kuhl, 2005; Wiki). Less variability might be expected with non-polymeric injectable estradiol esters since these preparations appear to have approximately complete bioavailability. However, it seems that even with injectable forms of estradiol, the variability between people is still quite substantial. An implication of this is that the appropriate dose and dosing interval of an injectable estradiol formulation for a given person will vary considerably. This emphasizes the importance of blood work to ensure that injectable estradiol preparations are neither overdosed—which can increase health risks such as blood clots (Aly, 2020)—nor underdosed—which may result in suboptimal testosterone suppression and therapeutic efficacy.

    Insights for Clinical Guidelines and Dosing Recommendations

    Clinical guidelines for transgender health (see also Aly (2020)) provide recommendations on doses and dosing intervals of injectable estradiol valerate in oil and estradiol cypionate in oil (Table 11). Dosing recommendations are not given for other injectable estradiol preparations, which are much less commonly used in transgender medicine. The recommended doses for estradiol valerate and estradiol cypionate vary widely depending on the guidelines, whereas the recommended intervals are consistently once every 1 to 2 weeks. The doses for estradiol valerate range from 2 to 20 mg/week or 5 to 80 mg/2 weeks and the doses for estradiol cypionate range from <1 to 10 mg/week or <2 to 80 mg/2 weeks. For reference, the Endocrine Society guidelines and the University of California, San Francisco (UCSF) guidelines are the most major clinical guidelines for transgender hormone therapy at present (Aly, 2020). The Endocrine Society guidelines recommend 5 to 30 mg/2 weeks or 2 to 10 mg/week for either estradiol valerate or estradiol cypionate (Hembree et al., 2017). Conversely, the UCSF guidelines recommend <20 to 40 mg/2 weeks for estradiol valerate and <2 to 5 mg/2 weeks for estradiol cypionate (with the option to divide dose into weekly injections if cyclical side effects occur) (Deutsch, 2016a).

    Table 11: Recommended doses and injection intervals of injectable estradiol preparations (specifically estradiol valerate and estradiol cypionate) in transgender medicine clinical guidelinesa:

    GuidelinesEster(s)Dose ranges and intervals
    Endocrine Society / Hembree et al. (2017)Estradiol valerate or cypionate5–30 mg/2 weeks or 2–10 mg/week i.m.
    UCSF / Deutsch (2016b)Estradiol valerateInitial–low: <20 mg/2 weeks i.m.
    Initial: 20 mg/2 weeks i.m.
    Maximum: 40 mg/2 weeks i.m.
    Note: “May divide dose into weekly injections for cyclical symptoms”
    Note: Specifically for transfeminine adults
     Estradiol cypionateInitial–low: <2 mg/2 weeks i.m.
    Initial: 2 mg/2 weeks i.m.
    Maximum: 5 mg/2 weeks i.m.
    Note: “May divide dose into weekly injections for cyclical symptoms”
    Note: Specifically for transfeminine adults
    UCSF / Olson-Kennedy et al. (2016)Estradiol valerate5–20 mg/2 weeks
    Maximum: 30–40 mg/2 weeks
    Note: Specifically for transfeminine youth
     Estradiol cypionate2–10 mg/week
    Note: Specifically for transfeminine youth
    Fenway Health / Cavanaugh et al. (2015)Estradiol valerateInitial: 5–10 mg/week i.m.
    Usual: 20 mg/2 weeks i.m.
    Maximum: 40 mg/2 weeks i.m.
     Estradiol cypionateInitial: 2.5 mg/2 weeks i.m.
    Usual: 5 mg/2 weeks i.m.
    Maximum: 10 mg/2 weeks i.m.
    Callen-Lorde (2018)Estradiol valerateInitial: 10–20 mg/2 weeks
    Maximum: 20–40 mg/2 weeks
     Estradiol cypionateInitial: 2.5 mg/2 weeks
    Maximum: 5 mg/2 weeks
    Davidson et al. / Tom Waddell Health Center (2013)Estradiol valerate or cypionateInitial: 20–40 mg/2 weeks i.m.
    Average: 40 mg/2 weeks i.m.
    Maximum: 40–80 mg/2 weeks i.m.
    Bourns / Sherbourne Health / Rainbow Health Ontario (2019)Estradiol valerateInitial: 3–4 mg/week or 6–8 mg/2 weeks
    Usual: Variable
    Maximum: 10 mg/week
    Trans Care BC (2021)Estradiol valerateInitial: 5 mg/week i.m. or s.c.
    Usual: 10–20 mg/week i.m. or s.c.
    Every 2 weeks at 2x dose may be tolerated in some
    Dahl et al. / Vancouver Coastal Health (2015)Estradiol valerate20–40 mg/2 weeks i.m.
    Note: “Alternative estrogen therapy for 3–6 months only”
    European Society for Sexual Medicine / T’Sjoen et al. (2020)Estradiol valerate5–30 mg/1–2 weeks i.m.
     Estradiol cypionate2–10 mg/week i.m.
    TransLine (2019)Estradiol valerateInitial/Usual: 5–10 mg/week
    Maximum: 20 mg/week
     Estradiol cypionateInitial/Usual: 1.25–2.5 mg/week
    Maximum: 5 mg/week

    a Several other guidelines recommend doses and intervals that appear to be taken directly from the Endocrine Society or UCSF guidelines and thus are not listed here but can be found elsewhere (Aly, 2020).

    A number of concerns arise when the doses and intervals of injectable estradiol valerate and estradiol cypionate recommended by the major transgender clinical guidelines are considered in the context of the present informal meta-analysis and when they are compared between guidelines. Based on the present work, dosages of injectable preparations recommended by the major transgender clinical guidelines appear to result in estradiol exposure that is markedly higher than that with the recommended dosages for other routes and forms of estradiol (e.g., oral or transdermal). Whereas a dosage of 5 mg/week of any non-polymeric injectable estradiol ester appears to give average estradiol levels of around 300 pg/mL (~1,100 pmol/L), which are already supraphysiological, doses of injectable estradiol valerate or estradiol cypionate recommended by guidelines are as high as 15 to 20 mg per week. The average estradiol concentrations that would be expected to result from such doses per this meta-analysis (e.g., ~600–1,200 pg/mL or 2,200–4,400 pmol/L at 10–20 mg/week) (Figure 10) would vastly exceed the ranges for estradiol levels in transfeminine people advised by the same guidelines (generally about 50–200 pg/mL or ~180–730 pmol/L) (Table). This is not merely theoretical; for example, a study that used 40 mg/week estradiol valerate by intramuscular injection in cisgender women with estrogen deficiency to produce “pseudopregnancy” reported measured estradiol levels of about 2,500 pg/mL (~9,200 pmol/L) at 3 months and 3,100 pg/mL (~11,400 pmol/L) at 6 months of treatment (Ulrich, Pfeifer, & Lauritzen, 1994). Moreover, highly supraphysiological estradiol levels with guideline-based injectable estradiol doses are not unexpected when normal production of estradiol in premenopausal cisgender women is considered (~1.4 mg per week or 6 mg per month/cycle giving mean estradiol levels of ~100 pg/mL or 370 pmol/L) (Aly, 2019). Clinical safety data on high doses of injectable estradiol esters like estradiol valerate and estradiol cypionate are lacking at present, but excessive estrogenic exposure is known to increase the risk of health complications such as blood clots (Aly, 2020). The very high doses of these preparations that are recommended by guidelines should raise considerable reservations about their safety.

    Figure 10: Simulated estradiol levels with injectable estradiol valerate at the doses and interval (5–40 mg/2 weeks) preferentially recommended by current major transgender care guidelines. Steady-state estradiol levels are reached by about the second or third injection with this injection interval and levels do not further accumulate. An alternative version of this figure with half-doses at a once-weekly interval (i.e., 2.5–20 mg/week) is also provided (Graph).

    The present author elsewhere has listed doses of injectable estradiol preparations that are roughly comparable in terms of total estradiol exposure to doses for other estradiol forms and routes used in transfeminine people (Aly, 2020). These doses range from about 1 to 6 mg per week for “low dose” to “very high dose” therapy with non-polymeric injectable estradiol esters (Graph). This dose range for injectable estradiol is likely to be more appropriate for use in transfeminine people than current recommendations by many guidelines. Although high estradiol levels can be useful in transfeminine hormone therapy when antiandrogens are not used due to their greater efficacy than physiological levels in terms of testosterone suppression, only modestly supraphysiological estradiol levels (e.g., ~200–300 pg/mL or 730–1,100 pmol/L) appear to be required for strong testosterone suppression (Aly, 2019; Langley et al., 2021; Aly, 2020). In relation to this, doses of injectable estradiol need not be excessive.

    Some guidelines, such as the Endocrine Society guidelines, recommend the same doses and intervals for both estradiol valerate and estradiol cypionate, whereas other guidelines, such as the UCSF guidelines, recommend different doses for these two injectable estradiol esters. Concerningly, the doses for estradiol valerate and estradiol cypionate recommended by the UCSF guidelines differ by roughly an order of magnitude (<20 to 40 mg/2 weeks for estradiol valerate and <2 to 5 mg/2 weeks for estradiol cypionate). These estradiol esters appear to produce similar average estradiol levels (e.g., around 300 pg/mL or 1,100 pmol/L at a dosage of 5 mg/week) and have concentration–time curve shapes that are not extremely different, with estradiol cypionate being only somewhat flatter and more prolonged than estradiol valerate. As such, it would appear that similar doses should be appropriate for these esters. This is supported by the fact that the same doses of estradiol valerate and estradiol cypionate are used in combined injectable contraceptives in cisgender women (both 5 mg once per month) and that these doses were carefully determined during an intensive clinical development programme for these preparations (Garza-Flores, 1994; Newton, d’Arcangues, & Hall, 1994; Sang, 1994; Toppozada, 1994). This programme notably included dose-ranging and direct-comparison studies. Based on the present analysis, the current recommendations by the UCSF guidelines may result in marked overdosage in the case of estradiol valerate and potential underdosage in the case of estradiol cypionate.

    Transgender health guidelines recommend an injection interval for estradiol valerate and estradiol cypionate in oil of once every 1 to 2 weeks. Although an injection interval of 2 weeks seems technically feasible in the case of both of these preparations, such an interval would appear to result in substantial fluctuations in estradiol levels, with high peak levels and low troughs. This is particularly true in the case of the shorter-acting estradiol valerate (Figures 10, 11). Considering the wide fluctuations and unknown effects of this variability, as well as the fact that testosterone suppression when applicable may depend on sustained higher estradiol levels, it may be advisable that a once-weekly interval be preferentially recommended for these preparations. This would achieve steadier estradiol levels and would reduce potential problems due to high or low estradiol levels (Figure 11). Alternatively, a shorter interval of once every 5 days may be used with estradiol valerate to further reduce the variability in estradiol levels that occurs with this preparation (Figure 11). On the other hand, an injection interval of once every 10 days to 2 weeks may be practical and allowable in the case of the longer-acting estradiol cypionate in oil (as well as estradiol enanthate) (Figure 11)—provided that the injection cycles are well-tolerated and testosterone suppression remains adequate. When selecting different injection intervals, doses should be scaled by the interval to maintain equivalent total estradiol exposure (e.g., 3.5 mg/5 days, 5 mg/7 days, 7 mg/10 days, or 10 mg/14 days for high-dose non-polymeric injectable estradiol esters).

    Figure 11: Simulated estradiol levels with a high dosage of injectable estradiol valerate or estradiol cypionate in oil at different injection intervals (doses scaled by interval to be equivalent in total estradiol exposure).

    With the preceding concerns about the doses and intervals of injectable estradiol preparations recommended by transgender care guidelines considered, the question of how these recommendations were determined arises. Unfortunately, current guidelines do not generally describe how they arrived at their recommendations nor do they usually cite sources to support them. It is notable that the UCSF guidelines recommend doses and intervals for injectable estradiol preparations that are nearly identical to those advised by Christian Hamburger and Harry Benjamin in the late 1960s in the first medical textbook on transgender people (Hamburger & Benjamin, 1969). These authors recommended a dose of 10–40 mg/2 weeks for estradiol valerate and of 2–5 mg/2 weeks for estradiol cypionate (although Benjamin additionally stated that after 4–8 months, the same doses could be used at a longer injection interval of once every 4 weeks). These recommendations were notably made before estradiol blood tests became practicably available and were prior to the advent of modern pharmacokinetic studies. Hence, the recommendations for at least these guidelines appear to be based mainly on past expert opinion and long-standing historical precedent rather than on pharmacokinetic or clinical data. The same is likely to also be true for most other guidelines. High doses with certain injectable estradiol preparations (namely estradiol valerate) were probably originally employed for the purpose of achieving longer durations and more convenient injection intervals. This was notably prior to the risks of excessive estrogenic exposure like blood clots becoming known, and these doses may simply have never been revised.

    The reasons that dose recommendations for injectable estradiol in transfeminine people have remained as they have for so long may be related to several factors. These include (1) a long-standing lack of research and funding in transgender health; (2) injectable estradiol not being widely available or as commonly used as other forms of estradiol; and (3) many clinicians only testing estradiol levels at trough (right before the next injection) with injectable estradiol preparations (e.g., Mueller et al., 2011; Chantrapanichkul et al., 2021; Cirrincione et al., 2021). The latter point is noteworthy as trough levels only describe the lowest point of the estradiol concentration–time curve with injectable estradiol preparations, and can give a very misleading impression of average or total estradiol exposure. In any case, the very high estradiol levels with currently recommended doses of injectable estradiol forms for transfeminine people have not gone unnoticed in the literature (e.g., Gooren, 2005; Spack, 2013; Deutsch, 2014; Glintborg et al., 2021; Tassinari & Maranghi, 2021; Le, Huang, & Cirrincione, 2022). Additionally, clinical studies in transfeminine people have reported high to very high estradiol levels with typical clinical doses of injectable estradiol (e.g., Kronawitter et al., 2009 [Table]; Mueller et al., 2011 [Table]; Sharula et al., 2012 [Data]; Nelson et al., 2016 [Table]; LaBudde, Craig, & Spratt, 2020; Chantrapanichkul et al., 2021 [Table]; Cirrincione et al., 2021 [Table]).

    Among the surveyed guidelines for transgender hormone therapy, only the UCSF guidelines (Deutsch, 2016b) and the Sherbourne Health/Rainbow Health Ontario guidelines (Bourns, 2019) referenced pharmacokinetic literature in their discussion of injectable estradiol. The specific publications cited by these guidelines were Düsterberg & Nishino (1982), Sierra-Ramírez et al. (2011), and Thurman et al. (2013). Although it is favorable to see guidelines considering published pharmacokinetic data for informing use of these preparations, there are a few concerns about the studies that were cited. Düsterberg & Nishino (1982) in its study of injectable estradiol valerate had a very small sample size (n=2), and this study was excluded as an outlier in the present meta-analysis due to unusually high estradiol levels. The findings of Düsterberg & Nishino (1982) also do not seem to have actually been used to guide dosing recommendations in the case of the UCSF guidelines, since if this were the case, the recommended doses should have been much lower. On the other hand, Bourns (2019) cited the same study and recommended injectable estradiol valerate at doses of 3–4 mg/week or 6–8 mg/2 weeks. These doses are well below those recommended by other transgender care guidelines and appear to be more appropriate for use in transfeminine people in light of the present meta-analysis. Sierra-Ramírez et al. (2011) and Thurman et al. (2013), although better-quality studies than Düsterberg & Nishino (1982), described injectable estradiol cypionate suspension rather than estradiol cypionate in oil. The oil-based version of estradiol cypionate is the form normally used in transfeminine hormone therapy, and there are important differences between these estradiol cypionate preparations such that pharmacokinetic studies for the suspension can’t necessarily be generalized to the oil solution. These preparations do in any case produce similar total estradiol levels however and hence doses should be comparable for them.

    This meta-analysis is only informal and unpublished research. Nonetheless, based on the results of this work and the preceding discussion, current dosing recommendations for injectable estradiol preparations by most transgender clinical guidelines appear to be highly excessive and likely unsafe, with injection intervals that may additionally be too widely spaced. Transgender care guidelines should consider reassessing these recommendations, and the transgender medical community should make an effort to better characterize the pharmacokinetics and optimal dosing schemes of injectable estradiol preparations in transfeminine people in the future. Since clinical data on these preparations are scarce and will probably remain so in the near-term, use of published pharmacokinetic data may be further considered for guiding dosing recommendations for injectable estradiol. As identified and catalogued by this meta-analysis, there is a wealth of existing data that could be used to better inform transgender care guidelines in terms of the use of injectable estradiol preparations in transfeminine people.

    Interactive Web Simulator

    This informal meta-analysis of estradiol concentration–time data with injectable estradiol preparations was conducted for the purpose of deriving accurate and representative estradiol curves for incorporation into a web-based injectable estradiol simulator intended for use by transfeminine people and their clinicians. This web app is able to simulate both single-injection curves and repeated-injection curves with these preparations. An informational page for this simulator can be found at the following location:

    And the injectable estradiol simulator itself can be found at the following page:

    Future Possibilities

    There are various possibilities for further work on this project in the future. For example, assessment of interindividual variability for estradiol levels with injectable estradiol preparations could be included in the meta-analysis. As another example, it would be fairly straightforward and valuable to expand the meta-analysis as well as simulator to other hormonal preparations such as injectable testosterone preparations and other estradiol routes and forms like oral estradiol, sublingual estradiol, and estradiol pellets. Pharmacokinetic literature for some of these preparations has already been collected by this author. However, these future possibilities would require much additional time and effort to complete.

    Special Thanks

    A special thank you to Violet and Lila for their indispensable input and guidance on modeling topics during the work on this project. An additional thanks to Violet for deriving a special three-compartment pharmacokinetic model that was used in this work. Please also check out Violet’s own projects Tilia—an effort to empower trans people with tools to manage their hormonal transitions—and TransKit—a work-in-progress pharmacokinetic simulation library specifically tailored for transgender hormone therapy. Lastly, thank you to all the peer reviewers who carefully reviewed this article prior to it being posted.

    Updates

    Update 1: WPATH SOC8 Guidelines

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published and made recommendations on transgender hormone therapy for the first time (Coleman et al., 2022). These guidelines are among the most highly regarded and consulted transgender care guidelines. In terms of the recommended doses of hormonal medications for transgender people, the WPATH SOC8 appear to have largely copied the Endocrine Society’s 2017 guidelines on transgender hormone therapy (Hembree et al., 2017). More specifically, in the case of injectable estradiol preparations for transfeminine people, doses of 5–30 mg/2 weeks or 2–10 mg/week estradiol valerate or estradiol cypionate were recommended. There was no discussion of injectable estradiol in the guidelines besides the preceding doses and intervals being included in a table, and no literature citations were included to support these doses. As described in the present work, these recommendations include doses and intervals that appear to be highly excessive, too widely spaced, and are likely unsafe. As such, major transgender care guidelines unfortunately continue to make uncited recommendations for injectable estradiol in transfeminine people that are out of step with insights available from abundant published pharmacokinetic data. These recommendations are likely inadvisable, with the possibility of substantial safety risks.

    Update 2: Literature Mentions

    The following publications in the literature have cited or mentioned Transfeminine Science’s injectable estradiol simulator and/or meta-analysis since the project was published in mid-2021:

    Hughes et al. (2022)

    Hughes, J. H., Woo, K. H., Keizer, R. J., & Goswami, S. (2022). Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care. Clinical Pharmacology & Therapeutics, 113(3), 565–574. [DOI:10.1002/cpt.2799]:

    Lastly, we recommend that developers of [clinical decision support software (CDSS)] for dosing take an iterative and participatory approach to designing systems. By involving stakeholders in the design process, they will develop solutions that best suit users’ needs and are more likely to be adopted and used correctly. This participatory approach should involve interviews and usability testing with clinicians. Formal usability testing and analysis with real end users can improve the quality and usefulness of a system.88 Though patients themselves are not typically the end users of CDSS, their expertise (especially that of marginalized groups and organized patient advocacy organizations) can also inform CDSS developers. As an example, transgender people have compiled their own resources to understanding dosing regimens in the absence of clear clinical guidelines.89 Developers of CDSS could provide a great deal of value to these patient populations, and improve their software’s utility, by working with them to understand their needs from a dosing tool.

    89. Aly, W. An interactive web simulator for estradiol levels with injectable estradiol esters. Transfeminine Science <https://transfemscience.org/articles/injectable-e2-simulator-release/> (2021) Accessed November 1, 2022.

    Jaafar et al. (2022)

    Jaafar, S., Torres-Leguizamon, M., Duplessy, C., & Stambolis-Ruhstorfer, M. (2022). Hormonothérapie injectable et réduction des risques: pratiques, difficultés, santé des personnes trans en France. [Hormone replacement therapy injections and harm reduction: practices, difficulties, and transgender people’s health in France.] Sante Publique, 34(HS2), 109–122. [Google Scholar] [PubMed] [DOI:10.3917/spub.hs2.0109] [Translated]:

    With regard to feminizing [substitutive hormone therapy (HS)], there are no specialty injectables based on estrogens in the French pharmacopoeia. This makes it impossible to set up estrogen monotherapies which require high dosages that are more difficult to obtain with specialties with other galenic forms [5]. Faced with this lack of care, some trans women and transfeminine people obtain estradiol-based injectable solutions on the Internet or through other sources [6]. […]

    5. Aly. An informal meta-analysis of estradiol curves with injectable estradiol preparations [Internet]. Transfem Sci. 2021 July 16. [Visited on 29/12/2022]. Online : https://transfemscience.org/articles/injectable-e2-meta-analysis/.

    Linet (2023)

    Linet, T. (2023). Prise en charge endocrinologique d’une personne trans. [Endocrinological care of a trans person.] In Faucher, P., Hassoun, D., & Linet, T. (Eds.). Santé sexuelle et reproductive des personnes LGBT [Sexual and Reproductive Health of LGBT People] (pp. 109–124). Issy-les-Moulineaux, France: Elsevier Masson. [Google Books] [URL] [WorldCat] [Excerpt] [Translated]:

    Choice of estrogen.

    Estradiol is generally the most prescribed estrogen. It is given orally or sublingually in transfeminine people with no significant cardiovascular risk factors. For others, the percutaneous form (patches, gel) is recommended.

    The starting dose is 2 mg of estradiol orally with a step increase of 2 mg every 2 to 3 months until the optimal dose is reached [1]. For the patches, the initial dosage and the increments are 50 or 100 μg, and for the gel 2.5 g. This means that the optimal dose is generally 6 to 8 mg per day for the oral route, 3 to 4 mg for the sublingual route, and 300 to 400 μg for the patches (see table 11.1).

    It may happen in consultation that the person does not wish to use the prescribed estrogens and wishes to continue the self-prescription of injectable estrogens. It is then possible to evaluate with them the most suitable dosage using the Transfem Science Injection Simulator (https://transfemscience.org/misc/injectable-e2-simulator/). Risk prevention related to injections (needles) can be done. Associations can help the person find 25 G needles of 40 mm useful this type of treatment.

    Update 3: Herndon et al. (2023)

    In March 2023, the following study on injectable estradiol in transfeminine people was published online:

    • Herndon, J. S., Maheshwari, A. K., Nippoldt, T. B., Carlson, S. J., Davidge-Pitts, C. J., & Chang, A. Y. (2023). Comparison of Subcutaneous and Intramuscular Estradiol Regimens as part of Gender-Affirming Hormone Therapy. Endocrine Practice, 29(5), 356–361. [DOI:10.1016/j.eprac.2023.02.006] [URL]

    The study was a retrospective analysis of individualized injectable estradiol in adult transfeminine people who received hormone therapy at the Mayo Clinic. Doses of injectable estradiol were adjusted by clinical providers based on estradiol levels, testosterone suppression, and feminization goals, and subsequently these clinical data were retrospectively studied by Mayo Clinic researchers. The primary aim of the study was to compare injectable estradiol by intramuscular versus subcutaneous routes. However, other general considerations for injectable estradiol, such as dosing, estradiol levels, testosterone suppression, type of injectable estradiol ester (estradiol valerate vs. estradiol cypionate), and estradiol monotherapy versus concomitant use of antiandrogens, were also assessed. The paper noted that the study was the largest to assess injectable estradiol in transfeminine people to date and was the first to directly compare intramuscular and subcutaneous injectable estradiol routes in transfeminine people.

    Injectable estradiol doses were adjusted to achieve estradiol and testosterone levels within therapeutic ranges defined by the Endocrine Society 2017 guidelines (>100 pg/mL [367 pg/mL] for estradiol and <50 ng/dL [<1.7 nmol/L] for testosterone). Estradiol levels were measured exclusively using liquid chromatography–tandem mass spectrometry (LC–MS/MS), while the assay method for measuring testosterone levels was not specified. In terms of when in the injection cycle estradiol levels were measured, the authors stated the following: (1) “Timing of estradiol blood draw in relation to injection was not protocolized” and (2) “In our practice, although estradiol concentrations were generally checked midway through the injection cycle, we were unable to document with certainty the timing of the estradiol lab testing which may have influenced the results and/or the outliers”. Only the most recent blood test for each individual was analyzed, with the results of earlier tests discarded. Doses were analyzed in per-week amounts, regardless of dosing frequency (either once weekly or once every two weeks).

    There were a total of 130 transfeminine people on injectable estradiol who were analyzed in the study. Of these individuals, 56 received intramuscular (i.m.) injections and 74 received subcutaneous (s.c.) injections. The median duration of therapy for injectable estradiol was 3.0 years for both routes. The vast majority of people used weekly injections (91.1% for i.m., 98.6% for s.c.), whereas the small remainder (n=6) injected once every 2 weeks. Similarly, the great majority used injectable estradiol valerate (89.3% for i.m., 86.5% for s.c.), while a small subset (n=16) used injectable estradiol cypionate. The authors did not state the injectable vehicles, but they can be confidently assumed to have both been in oil. The treatment-individualized doses per week of injectable estradiol were median 4 mg (interquartile range (IQR) 3–5.15 mg; range 1–8 mg) for the i.m. route and median 3.75 mg (IQR 3–4 mg; range 1–8 mg) for the s.c. route, with the differences in doses between groups being slightly but significantly different (p = 0.005). For the small number of people on two-week injection cycles, the doses for the combined i.m. and s.c. groups were median 8.5 mg (range 6–16 mg) every 2 weeks. Estradiol levels with injectable estradiol were median 189.5 pg/mL (IQR 126.8–252.5 or 122.5–257 pg/mL; range ~33–575 pg/mL] for i.m. and median 196 pg/mL (IQR 125.3–298.5 pg/mL; range ~23–581 pg/mL) for s.c., with the differences between groups not being significantly different (p = 0.70). The percentages of individuals with estradiol levels in target range (>100 pg/mL) were 78.6% for i.m. and 82.4% for s.c. The estradiol doses and levels of individual patients for each route were also provided in the paper (Graph). It can be seen that more individuals clustered into the higher range of doses with i.m. than with s.c. injections.

    In the case of estradiol valerate versus estradiol cypionate, dose per week for i.m. with estradiol valerate was median 4 mg (IQR 3–5.45 mg) and with estradiol cypionate was median 4 mg (IQR 2.25–5 mg). In the case of s.c., dose per week with estradiol valerate was median 4 mg (IQR 3–4 mg) and with estradiol cypionate was median 3 mg (IQR 2–3 mg). The doses between estradiol valerate and estradiol cypionate were not significantly different in the case of i.m. (p = 0.51), but were significantly different in the case of s.c. (p = 0.025). Estradiol levels with the two different injectable estradiol esters were not provided.

    On multiple regression analysis, injectable estradiol dose was significantly positively associated with estradiol levels (p < 0.001) following adjustment for several variables (injection route, body mass index (BMI), antiandrogen use, gonadectomy status). Each 1 mg per week in dose was associated with estradiol levels that were increased by (estimate ± standard error) 57.42 ± 10.46 pg/mL. No other variable, including notably BMI, was significantly associated with estradiol levels. According to the authors, the dose-dependently higher estradiol levels with injectable estradiol suggested the need to start at lower doses that are gradually increased in conjunction with close monitoring of hormone levels.

    Testosterone levels in those with gonads were 11 ng/dL (IQR 0–19.8 ng/dL) for i.m. and 11 ng/dL (0–20 ng/dL) for s.c., with levels not significantly different between groups (p = 0.92). Adequate testosterone suppression (<50 ng/dL) in those with gonads was achieved in 84.6% with i.m. and 86.6% with s.c. In the small subset of individuals on injections every two weeks (n=6), 100% of individuals achieved target estradiol and testosterone levels. A majority of individuals on injectable estradiol in the study concomitantly used an antiandrogen, with this usually being spironolactone or finasteride. In a minority of individuals, injectable estradiol monotherapy, without concomitant use of an antiandrogen, was employed and hormone levels were measured (n=17). In this subgroup, estradiol levels were median 220 pg/mL (IQR 180–264 pg/mL) at a dose per week of median 4 mg (IQR 3–6 mg), with estradiol levels noticeably higher than in the overall group. In terms of hormone levels for those on injectable estradiol monotherapy, 100% achieved therapeutic estradiol levels (>100 pg/mL) and 88.2% achieved target testosterone levels (<50 ng/dL). The authors noted that most individuals on injectable estradiol monotherapy were able to adequately suppress testosterone, but that higher doses and levels of estradiol may be needed for testosterone suppression in this context.

    Herndon et al. (2023) noted that existing recommendations for injectable estradiol in transfeminine people suggest doses of 2 to 10 mg per week or 5 to 30 mg every 2 weeks, referencing the Endocrine Society 2017 guidelines (Hembree et al., 2017) and UCSF 2016 guidelines (Deutsch, 2016a). They also noted that the UCSF 2016 guidelines recommended lower doses of estradiol cypionate than estradiol valerate, which they attributed to pharmacokinetic differences between the esters (citing Oriowo et al. (1980) for this claim). However, the authors noted that the differences between estradiol valerate and estradiol cypionate doses they observed were small, and questioned the clinical relevance of the differences. The authors also tactfully critiqued dosing recommendations by existing guidelines, and suggested their own data to guide dosing instead, with the following relevant excerpts:

    Prior studies used for development of guidelines for parenteral doses are suboptimal given their small sample sizes or pre-specificized [gender-affirming hormone therapy (GAHT)] protocols with no adjustment of estradiol doses or no information on hormone concentrations achieved. [Discussion of Deutsch, Bhakri, & Kubicek (2015) and Mueller et al. (2011) …]

    Overall, the studies used to support the current dosing recommendation guidelines for parenteral estradiol dosing are limited, incomplete with regards to hormone concentrations achieved, and do not provide SC as an available option. The doses of estradiol used in this study (with either SC or IM approach), were successful in achieving serum estradiol concentrations at the cisgender female range. Most importantly, as compared to current available guidelines and consensus statements [1, 2], these doses of estradiol valerate are less than half of what is recommended for both initial and maintenance dosing and achieved suppression of testosterone.

    Lower doses of parenteral injections than previously described in clinical practice guidelines achieved therapeutic estradiol concentrations. Our data can serve as a dosing guide for initial and maintenance use of parenteral estradiol, which is different than what has been previously described.

    Herndon et al. (2023) concluded that injectable estradiol by both i.m. and s.c. routes is effective in achieving therapeutic estradiol levels in transfeminine people. They noted that there were not meaningful differences between i.m. and s.c. in terms of dose, although i.m. may require slightly higher doses than s.c. to achieve therapeutic estradiol levels. The authors stated that doses of injectable estradiol to achieve therapeutic estradiol levels in transfeminine people were lower than previously recommended by guidelines and other publications. They concluded that clinical use of injectable estradiol in transfeminine people should include discussion of both i.m. and s.c. routes and invidiualization by patient. Finally, they called for more clinical studies on injectable estradiol in transfeminine people to evaluate clinical outcomes, feminization, and additional risks and benefits of this route compared to other routes.

    The findings of Herndon et al. (2023) are pleasingly consistent with the results of the present meta-analysis. Based on the findings of this meta-analysis, assuming a linear relationship between dose and estradiol levels, estradiol levels with non-polymeric injectable estradiol esters, like estradiol valerate and estradiol cypionate in oil via intramuscular injection, increase by around 60 pg/mL on average for each 1 mg per week in dose (with Herndon et al. (2023) finding a value of 57 pg/mL per 1 mg using a multiple linear regression model). In relation to this, mean integrated estradiol levels of around 250 pg/mL on average would be expected at a dosage of 4 mg once per week. Accordingly, Herndon et al. (2023) found median estradiol levels of 190 to 196 pg/mL at per-week median doses of 3.75 to 4 mg. Similarly, the present work recommended injectable estradiol doses with non-polymeric esters of 1 to 6 mg per week (to achieve mean integrated estradiol levels of roughly 50–300 pg/mL), which is comparable to the range of about 2 to 6 mg per week used in most transfeminine people in Herndon et al. (2023) (to achieve estradiol levels of at least 100 pg/mL, along with adequate testosterone suppression). Additionally, it was noted in this meta-analysis—based on clinical research in cisgender men with prostate cancer—that only modestly supraphysiological estradiol levels, of no more than approximately 200 to 300 pg/mL, are likely to be needed for strong testosterone suppression in transfeminine people. This has likewise been confirmed with solid clinical data in transfeminine people by Herndon et al. (2023), with 88% of those on injectable estradiol monotherapy having testosterone levels of <50 ng/dL at a median injectable estradiol dose of 4 mg/week and with median estradiol levels of 220 pg/mL. It is the opinion of the present author that Herndon et al. (2023) is a very important and formative study, with clinical implications that go far beyond merely supporting the s.c. use of injectable estradiol. The study represents the first major step in the published literature to correcting the dosing and intervals of injectable estradiol in transgender care guidelines and in transgender health generally. I commend the researchers for their work.

    Update 4: Rothman et al. (2024)

    In February 2024, the following review on injectable estradiol in transfeminine people was published online:

    • Rothman, M. S., Hamnvik, O. P. R., Davidge-Pitts, C., Safer, J. D., Ariel, D., Tangpricha, V., Abramowitz, J., Soe, K., Sarvaideo, J., Kelley, C., Irwig, M. S., & Iwamoto, S. J. (2024). Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. Transgender Health, ahead of print. [DOI:10.1089/trgh.2023.0209]

    Here is the abstract of the paper:

    Injectable estrogens are options for gender-affirming hormone therapy per guidelines, which suggest intramuscular dosages of 5–30 mg every 2 weeks or 2–10 mg weekly with estradiol cypionate or valerate interchangeably. Data among transgender and gender-diverse patients are limited due to local unavailability and concerns around laboratory assay variability and estradiol (E2) level fluctuation. We note a concerning trend where patients are prescribed high-dose injections based on the guidelines leading to serum E2 levels well above the range recommended in the same guidelines. Our review indicates that 5 mg weekly or lower should be prescribed when initiating injectable estrogens to avoid supraphysiologic E2 levels.

    Supplementary Material

    References

    • Abuhelwa, A. Y., Foster, D. J., & Upton, R. N. (2015). ADVAN-style analytical solutions for common pharmacokinetic models. Journal of Pharmacological and Toxicological Methods, 73, 42–48. [DOI:10.1016/j.vascn.2015.03.004]
    • Aedo, A. R., Landgren, B. M., Johannisson, E., & Diczfalusy, E. (1985). Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations. Contraception, 31(5), 453–469. [DOI:10.1016/0010-7824(85)90081-2]
    • Aisaka, K., Ando, S., Kokubo, K., Yoshida, K., & Mori, H. (1986). いわゆる潜在性高prolactin血症患者におけるprolactin分泌予備能の検討. [Studies on Prolactin Secreting Capacity in the Ovulatory Infertile Patients with Transient Hyperprolactinemia.] 日本内分泌学会雑誌 / Nihon Naibunpi Gakkai Zasshi / Folia Endocrinologica Japonica, 62(5), 662–671. [DOI:10.1507/endocrine1927.62.5_662]
    • Akande, E. O. (1974). The effect of oestrogen on plasma levels of luteinizing hormone in euthyroid and thyrotoxic postmenopausal women. The Journal of Obstetrics and Gynaecology of the British Commonwealth / BJOG, 81(10), 795–803. [DOI:10.1111/j.1471-0528.1974.tb00383.x]
    • Ballard, B. E. (1978). An Overview of Prolonged Action Drug Dosage Forms. In Robinson, J. R. (Ed.). Sustained and Controlled Release Drug Delivery Systems (pp. 1–69). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books]
    • Behre, H. M., Oberpenning, F., & Nieschlag, E. (1990). Comparative pharmacokinetics of androgen preparations: application of computer analysis and simulation. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 1st Edition (pp. 115–135). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-662-00814-0_6]
    • Behre, H. M., & Nieschlag, E. (1998). Comparative pharmacokinetics of testosterone esters. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 329–348). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_11]
    • Behre, H. M., Wang, C., Handelsman, D. J., & Nieschlag, E. (2004). Pharmacology of testosterone preparations. Testosterone: Action · Deficiency · Substitution, 3rd Edition (pp. 405–444). Cambridge/New York: Cambridge University Press. [DOI:10.1017/CBO9780511545221.015] [PDF]
    • Behre, H. M., & Nieschlag, E. (2012). Testosterone preparations for clinical use in males. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 309–335). Cambridge/New York: Cambridge University Press. [DOI:10.1017/CBO9781139003353.016]
    • Bider, D., Ben-Rafael, Z., Shalev, J., Goldenberg, M., Mashiach, S., & Blankstein, J. (1989). Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist. Fertility and Sterility, 51(4), 578–581. [DOI:10.1016/S0015-0282(16)60602-7]
    • Blackwell, R. E., Boots, L. R., & Potter Jr, H. D. (1982). Evaluation of Delestrogen and Parlodel as a luteolytic agent in humans. Fertility and Sterility, 37(2), 213–217. [DOI:10.1016/S0015-0282(16)46042-5]
    • Bourns, A. (2019). Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition. Toronto: Rainbow Health Ontario/Sherbourne Health. [URL] [PDF]
    • Bradbury, J. T., Long, R. C., & Durham, W. C. (1953). Progesterone and estrogen requirements to induce and maintain decidua. Fertility and Sterility, 4(1), 63–75. [DOI:10.1016/S0015-0282(16)31145-1]
    • Braun, P., Wildt, L., & Leyendecker, G. (1983). The effect of danazol on gonadotropin secretion during the follicular phase of the menstrual cycle. Fertility and Sterility, 40(1), 37–44. [DOI:10.1016/S0015-0282(16)47174-8]
    • Buckman, M. T., Johnson, J., Ellis, H., Srivastava, L., & Peake, G. T. (1980). Differential lipemic and proteinemic response to oral ethinyl estradiol and parenteral estradiol cypionate. Metabolism, 29(9), 803–805. [DOI:10.1016/0026-0495(80)90117-1]
    • Callen-Lorde Community Health Center. (2018). Protocols for the Provision of Hormone Therapy. New York City: Callen-Lorde Community Health Center. [URL] [PDF]
    • Canales, E. S., Cabezas, A., Vázquez-Matute, L., & Zárate, A. (1978). Induction of ovulation with clomiphene and estradiol benzoate in anovulatory women refractory to clomiphene alone. Fertility and Sterility, 29(5), 496–499. [DOI:10.1016/S0015-0282(16)43271-1]
    • Canales, E. S., Fonseca, M. E., Mason, M., & Zárate, A. (1981). Feedback effect of estradiol on follicle-stimulating hormone and prolactin secretion during the puerperium. International Journal of Gynecology & Obstetrics, 19(1), 79–81. [DOI:10.1016/0020-7292(81)90043-6]
    • Cano, A., Gimeno, F., Fuente, T., Parrilla, J. J., & Abad, L. (1986). The positive feedback of estradiol on gonadotropin secretion in women with perimenopausal dysfunctional uterine bleeding. European Journal of Obstetrics & Gynecology and Reproductive Biology, 22(5–6), 353–358. [DOI:10.1016/0028-2243(86)90125-5]
    • Cavanaugh, T., Hopwood, R., Gonzalez, A., & Thompson, J. (2015). The Medical Care of Transgender Persons. Boston: Fenway Health. [URL] [PDF]
    • Certara. (2020). Certara Phoenix Assistance > Modeling > Least-Squares Regression Model Calculations > Pharmacokinetic Models. [URL]
    • Chantrapanichkul, P., Stevenson, M. O., Suppakitjanusant, P., Goodman, M., & Tangpricha, V. (2021). Serum Hormone Concentrations in Transgender Individuals Receiving Gender-Affirming Hormone Therapy: A Longitudinal Retrospective Cohort Study. Endocrine Practice, 27(1), 27–33. [DOI:10.4158/EP-2020-0414] [PDF] [Table]
    • Chien, Y. W. (1981). Long-acting parenteral drug formulations. Journal of Parenteral Science and Technology / PDA Journal of Pharmaceutical Science and Technology, 35(3), 106–139. [Google Scholar] [URL] [PDF]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual estradiol is associated with higher estrone concentrations than transdermal or injectable preparations in transgender women and gender nonbinary adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249] [PDF] [Table]
    • Colburn, W. A. (1981). Simultaneous pharmacokinetic and pharmacodynamic modeling. Journal of Pharmacokinetics and Biopharmaceutics, 9(3), 367–388. [DOI:10.1007/BF01059272]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2015). Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy. Vancouver: Vancouver Coastal Health. [Google Scholar] [PDF]
    • Davidson, A., Franicevich, J., Freeman, M., Lin, R., Martinez, L., Monihan, M., Porch, M., Samuel, L., Stukalin, R., Vormohr, J., & Zevin, B. (2013). Protocols for Hormonal Reassignment of Gender. San Francisco: San Francisco Department of Public Health/Tom Waddell Health Center. [Google Scholar] [PDF]
    • Depo®-Estradiol Estradiol Cypionate Label. U.S. Food and Drug Administration/Pharmacia & Upjohn (Pfizer). [URL] [PDF]
    • Derra, C. (1981). Hormonprofile unter Östrogen- und Antiandrogentherapie bei Patienten mit Prostatakarzinom: Östradiolundecylat versus Cyproteronacetat. [Hormone Profiles under Estrogen and Antiandrogen Therapy in Patients with Prostate Cancer: Estradiol Undecylate versus Cyproterone Acetate.] (Doctoral dissertation, University of Mainz.) [Google Scholar] [WorldCat] [PDF] [Translation]
    • Deutsch, M. (2014). Medical Transition. In Erickson-Schroth, L. (Ed.). Trans Bodies, Trans Selves: A Resource for the Transgender Community, 1st Edition (pp. 241–264). Oxford: Oxford University Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of Cross-Sex Hormone Treatment on Transgender Women and Men. Obstetrics & Gynecology, 125(3), 605–610. [DOI:10.1097/AOG.0000000000000692]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Düsterberg, B., & Nishino, Y. (1982). Pharmacokinetic and pharmacological features of oestradiol valerate. Maturitas, 4(4), 315–324. [DOI:10.1016/0378-5122(82)90064-0]
    • Düsterberg, B., & Wendt, H. (1983). Plasma levels of dehydroepiandrosterone and 17β-estradiol after intramuscular administration of Gynodian-Depot® in 3 women. Hormones, 17(2), 84–89. [DOI:10.1159/000179680]
    • Düsterberg, B., Schmidt-Gollwitzer, M., & Hümpel, M. (1985). Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women. Hormone Research in Paediatrics, 21(3), 145–154. [DOI:10.1159/000180039]
    • Edkins, R. P. (1959). The Modification of the Duration of Drug Action: Pharmaceutical Considerations. Journal of Pharmacy and Pharmacology, 11(Suppl 1), 54T–66T. [DOI:10.1111/j.2042-7158.1959.tb10412.x]
    • Enever, R. P., Fotherby, K., Naderi, S., & Lewis, G. A. (1983). Long-acting contraceptive agents: The influence of physicochemical properties of some esters of norethisterone upon the plasma levels of free norethisterone. Steroids, 41(3), 381–396. [DOI:10.1016/0039-128X(83)90109-5]
    • Eriksson, O., Bäckström, T., Stridsberg, M., Hammarlund-Udenaes, M., & Naessén, T. (2006). Differential response to estrogen challenge test in women with and without premenstrual dysphoria. Psychoneuroendocrinology, 31(4), 415–427. [DOI:10.1016/j.psyneuen.2005.10.004]
    • Espino y Sosa, S., Cortés Fuentes, M., Gómez Rico, J. A., & Cortés Bonilla, M. (2019). Non-polymeric Microspheres for the Therapeutic Use of Estrogens: An Innovative Technology. In Khan, W. A. (Ed.). Estrogen. London: IntechOpen. [DOI:10.5772/intechopen.82553]
    • Estradurin® Polyestradiol Phosphate Labels. Pharmanovia. [URL] [DOCs/PDFs]
    • Fisher, D., & Shafer, S. (2007). Fisher/Shafer NONMEM Workshop Pharmacokinetic and Pharmacodynamic Analysis with NONMEM. Basic Concepts. [PDF]
    • Florence, A. T. (2010). Looking at Formulations. In Florence, A. T. An Introduction to Clinical Pharmaceutics (pp. 69–100). London/Chicago: Pharmaceutical Press. [Google Scholar] [Google Books]
    • Fotherby, K., Benagiano, G., Toppozada, H. K., Abdel-Rahman, A., Navaroli, F., Arce, B., Ramos-Cordero, R., Gual, C., Landgren, B. M., & Johannisson, E. (1982). A preliminary pharmacological trial of the monthly injectable contraceptive Cycloprovera. Contraception, 25(3), 261–272. [DOI:10.1016/0010-7824(82)90049-X]
    • Garner, P. R., & Armstrong, D. T. (1977). The effect of human chorionic gonadotropin and estradiol-17β on the maintenance of the human corpus luteum of early pregnancy. American Journal of Obstetrics and Gynecology, 128(5), 469–475. [DOI:10.1016/0002-9378(77)90026-6]
    • Garza-Flores, J., Rodriguez, V., Perez-Palacios, G., Virutamasen, P., Tang-Keow, P., Konsayreepong, R., Kovacs, L., Koloszar, S., & Hall, P. E. (1987). A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera. Contraception, 36(4), 441–457. [DOI:10.1016/0010-7824(87)90093-X]
    • Garza-Flores, J., Alba, V. M., Cravioto, M. C., Hernandez, L., Perez-Palacios, G., Alvarado, G., Rivera, R., Recio, R., & Bassol, S. (1989). Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin. Contraception, 39(5), 519–529. [DOI:10.1016/0010-7824(89)90107-8]
    • Garza-Flores, J., Fatinikun, T., Hernandez, L., Ramos, I., Cardenas, M., & Menjivar, M. (1991). A pilot study on the assessment of a progesterone/estradiol sustained release as once-a-month-injectable contraceptive. Contraception, 44(1), 45–59. [DOI:10.1016/0010-7824(91)90105-O]
    • Garza-Flores, J. (1994). Pharmacokinetics of once-a-month injectable contraceptives. Contraception, 49(4), 347–359. [DOI:10.1016/0010-7824(94)90032-9]
    • Geppert, G. (1975). Untersuchungen zur Pharmakokinetik von Östradiol-17β, Östradiol-Benzoat, Östradiol-Valerianat und Östradiol-Undezylat bei der Frau: Der Verlauf der Konzentrationen von Östradiol-17β, Östron, LH und FSH im Serum. [Studies on the Pharmacokinetics of Estradiol-17β, Estradiol Benzoate, Estradiol Valerate, and Estradiol Undecylate in Women: The Course of the Relationships Between Estradiol-17β, Estrone, LH, and FSH in Serum.] (Doctoral dissertation, University of Bonn.) [Google Scholar] [WorldCat] [PDF] [Translation]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). Management of endocrine disease: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/EJE-21-0059]
    • Goh, H. H., & Ratnam, S. S. (1988). The LH surge in humans: its mechanism and sex difference. Gynecological Endocrinology, 2(2), 165–182. [DOI:10.3109/09513598809023624]
    • Goh, H. H., & Ratnam, S. S. (1990). Effect of estrogens on prolactin secretion in transsexual subjects. Archives of Sexual Behavior, 19(5), 507–516. [DOI:10.1007/BF02442351]
    • Goh, V. H. H., & Lee, K. O. (1998). Does a positive oestrogen feedback on the hypothalamic-pituitary axis exist concurrently with a defective testosterone feedback in Klinefelter’s syndrome? Hormone Research in Paediatrics, 50(3), 160–165. [DOI:10.1159/000023266]
    • Goodman, R. E., Anderson, D. C., Bu’Lock, D. E., Sheffield, B., Lynch, S. S., & Butt, W. R. (1985). Study of the effect of estradiol on gonadotrophin levels in untreated male-to-female transsexuals. Archives of Sexual Behavior, 14(2), 141–146. [DOI:10.1007/BF01541659]
    • Gooren, L. J. G., Rao, B. R., Van Kessel, H., & Harmsen-Louman, W. (1984). Estrogen positive feedback on LH secretion in transsexuality. Psychoneuroendocrinology, 9(3), 249–259. [DOI:10.1016/0306-4530(84)90004-0]
    • Gooren, L. (2005). Hormone treatment of the adult transsexual patient. Hormone Research in Paediatrics, 64(Suppl 2), 31–36. [DOI:10.1159/000087751]
    • Göretzlehner, G., Ackermann, W., Angelow, K., Bergmann, G., Bieck, E., Golbs, S., & Kliem, O. (2002). Pharmakokinetik von Estron, Estradiol, FSH, LH und Prolaktin nach intramuskulärer Applikation von 5 mg Estradiolvalerat. [Pharmacokinetics of estradiol valerate in postmenopausal women after intramuscular administration.] Journal für Menopause, 9(2), 46–49. [Google Scholar] [URL] [PDF] [Translation]
    • Gorton, N., Jaffe, J. M., Thompson, J., Menkin, D., Nesteby, A., Dunn, D., Baker, K. K., Harbatkin, D., Do, T., Radix, A., Meacher, P., Goldstein, Z., Carpenter, W., Caine, M., Henn, S., Murayama, R., Feldmann, J., & Zayas, S. (2019). TransLine Gender Affirming Hormone Therapy Prescriber Guidelines. San Francisco: Lyon-Martin Health Services/TransLine. [URL] [PDF]
    • Gunnarsson, P. O., & Norlén, B. J. (1988). Clinical pharmacology of polyestradiol phosphate. The Prostate, 13(4), 299–304. [DOI:10.1002/pros.2990130405]
    • Hamburger, C., & Benjamin, H. (1969). Endocrine Treatment of Male and Female Transsexualism / Appendix for the Practicing Physician: Suggestions and Guidelines for the Management of Transsexuals. In Green, R., & Money, J. (Eds.). Transsexualism and Sex Reassignment (pp. 291–307). Baltimore: John Hopkins University Press. [Google Scholar] [Google Books] [PDF]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658]
    • Henriksson, P., Carlström, K., Pousette, A., Gunnarsson, P. O., Johansson, C. J., Eriksson, B., Altersgård-Brorsson, A. K., Nordle, O., & Stege, R. (1999). Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen. The Prostate, 40(2), 76–82. [DOI:10.1002/(SICI)1097-0045(19990701)40:2<76::AID-PROS2>3.0.CO;2-Q]
    • Herndon, J. S., Maheshwari, A. K., Nippoldt, T. B., Carlson, S. J., Davidge-Pitts, C. J., & Chang, A. Y. (2023). Comparison of Subcutaneous and Intramuscular Estradiol Regimens as part of Gender-Affirming Hormone Therapy. Endocrine Practice, 29(5), 356–361. [DOI:10.1016/j.eprac.2023.02.006] [URL] [PDF]
    • Hughes, J. H., Woo, K. H., Keizer, R. J., & Goswami, S. (2022). Clinical Decision Support for Precision Dosing: Opportunities for Enhanced Equity and Inclusion in Health Care. Clinical Pharmacology & Therapeutics, 113(3), 565–574. [DOI:10.1002/cpt.2799]:
    • Ibrahim, S. (1996/1998). Pharmakokinetische Untersuchungen mit Östradiolvalerat und Hydroxyprogesteroncaproat in Depotform nach einmaliger Applikation bei 24 postmenopausalen Frauen. [Pharmacokinetic studies with estradiol valerate and hydroxyprogesterone caproate in depot form after a single application in 24 postmenopausal women.] (Doctoral dissertation, Dresden University of Technology.) [Google Scholar] [WorldCat] [Partial PDF]
    • Ittrich, G., & Pots, P. (1965). Östrogenbestimmungen in Blut und Urin nach Verabreichung von Östrogenen. [Estrogen determinations in blood and urine after administration of estrogens.] In Kraatz, H. (Ed.). International Symposium der Gynäkologischen Endokrinologie vom 15. bis 18. Mai 1963. / Abhandlungen der Deutschen Akademie der Wissenschaften zu Berlin, Klasse für Medizin, 1965(1), 53–56. [ISSN:0568-4250] [WorldCat 1] [WorldCat 2] [WorldCat 3] [PDF] [Translation]
    • Jaafar, S., Torres-Leguizamon, M., Duplessy, C., & Stambolis-Ruhstorfer, M. (2022). Hormonothérapie injectable et réduction des risques: pratiques, difficultés, santé des personnes trans en France. [Hormone replacement therapy injections and harm reduction: practices, difficulties, and transgender people’s health in France.] Sante Publique, 34(HS2), 109–122. [Google Scholar] [PubMed] [DOI:10.3917/spub.hs2.0109]
    • Jacobi, G. H., & Altwein, J. E. (1979). Bromocriptin als Palliativtherapie beim fortgeschrittenen Prostatakarzinom. [Bromocriptine for palliation of advanced prostatic carcinoma. Experimental and clinical profile of a drug.] Urologia Internationalis, 34(4), 266–290. [DOI:10.1159/000280272]
    • Jacobi, G. H., Altwein, J. E., Kurth, K. H., Basting, R., & Hohenfellner, R. (1980). Treatment of advanced prostatic cancer with parenteral cyproterone acetate: a phase III randomised trial. British Journal of Urology, 52(3), 208–215. [DOI:10.1111/j.1464-410X.1980.tb02961.x]
    • Jacobi, G. R. (1982). Experimental Rationale for the Investigation of Antiprolactins as Palliative Treatment for Prostate Cancer. In Jacobi, G. H., & Hohenfellner, R. (Eds.). Prostate Cancer (International Perspectives in Urology, Volume 3) (pp. 419–431). Baltimore/London: Williams & Wilkins. [Google Scholar] [Google Books]
    • Jilma, B., Eichler, H. G., Breiteneder, H., Wolzt, M., Aringer, M., Graninger, W., Röhrer, C., Veitl, M., & Wagner, O. F. (1994). Effects of 17β-estradiol on circulating adhesion molecules. The Journal of Clinical Endocrinology and Metabolism, 79(6), 1619–1624. [DOI:10.1210/jcem.79.6.7527406]
    • Johansson, C. J., & Gunnarsson, P. O. (2000). Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer. The Prostate, 44(1), 26–30. [DOI:10.1002/1097-0045(20000615)44:1<26::AID-PROS4>3.0.CO;2-P]
    • Jones, T. M., Fang, V. S., Landau, R. L., & Rosenfield, R. (1978). Direct inhibition of Leydig cell function by estradiol. The Journal of Clinical Endocrinology and Metabolism, 47(6), 1368–1373. [DOI:10.1210/jcem-47-6-1368]
    • Jönsson, G., Olsson, A. M., Luttrop, W., Cekan, Z., Purvis, K., & Diczfalusy, E. (1976). Treatment of prostatic carcinoma with various types of estrogen derivatives. In Munson, P. L., Diczfalusy, E., Glover, J., Olson, R. E., Harris, R. S., Thimann, K. V., Loraine, J. A., & Wool, I. G. (Eds.). Vitamins & Hormones, Volume 33 (pp. 351–376). New York/San Francisco/London: Academic Press. [DOI:10.1016/S0083-6729(08)60965-6]
    • Kalicharan, R. W., Schot, P., & Vromans, H. (2016). Fundamental understanding of drug absorption from a parenteral oil depot. European Journal of Pharmaceutical Sciences, 83, 19–27. [DOI:10.1016/j.ejps.2015.12.011]
    • Kalicharan, R. W. (2017). New Insights into Drug Absorption from Oil Depots. (Doctoral dissertation, Utrecht University.) [Google Scholar] [URL] [PDF]
    • Kemeter, P., Bernaschek, G., Altmann, G., & Feichtinger, W. (1984). The effect of 2 mg estradiol-17β plus 1 mg estriol, sequentially combined with 1 mg norethisteroneacetate, on LH, FSH, estradiol-17β, progesterone, testosterone and prolactin after ovarectomy. Archives of Gynecology, 234(3), 219–229. [DOI:10.1007/BF00570759]
    • Kerdelhué, B., Andrews, M. C., Zhao, Y., Scholler, R., & Jones Jr, H. W. (2006). Short term changes in melatonin and cortisol serum levels after a single administration of estrogen to menopausal women. Neuroendocrinology Letters, 27(5), 659–664. [Google Scholar] [URL] [PDF]
    • Keye, W. R., & Jaffe, R. B. (1975). Strength-duration characteristics of estrogen effects on gonadotropin response to gonadotropin-releasing hormone in women. I. Effects of varying duration of estradiol administration. The Journal of Clinical Endocrinology and Metabolism, 41(6), 1003–1008. [DOI:10.1210/jcem-41-6-1003]
    • Knudsen, P., Hansen, L. B., & Larsen, N. E. (1985). Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment. Acta Psychiatrica Scandinavica, 72(S322), 7–10. [DOI:10.1111/j.1600-0447.1985.tb08535.x]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265] [Table]
    • Kuhl, H. (1986). Hormonsubstitution durch Injektionspräparate und Hautimplantate. [Hormone substitution by injectable preparations and skin implants.] Der Gynäkologe, 19(4), 241–247. [Google Scholar] [PubMed] [PDF] [Translation]
    • Kuhl, H. (1990). Pharmacokinetics of oestrogens and progestogens. Maturitas, 12(3), 171–197. [DOI:10.1016/0378-5122(90)90003-O]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • LaBudde, J. A., Craig, W. Y., & Spratt, D. I. (2020). Initial Evaluation of Safety and Efficacy of Administration of Estradiol (E2) by Subcutaneous (SC) Injections to Male-to-Female (MTF) Transgender Patients. Fertility and Sterility, 114(3), e91–e91. [DOI:10.1016/j.fertnstert.2020.08.277]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., … & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/S0140-6736(21)00100-8]
    • Larsen, S. W., Rinvar, E., Svendsen, O., Lykkesfeldt, J., Friis, G. J., & Larsen, C. (2001). Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs. International Journal of Pharmaceutics, 230(1–2), 67–75. [DOI:10.1016/S0378-5173(01)00860-2]
    • Larsen, S. W., & Larsen, C. (2009). Critical factors influencing the in vivo performance of long-acting lipophilic solutions—impact on in vitro release method design. The AAPS Journal, 11(4), 762–770. [DOI:10.1208/s12248-009-9153-9]
    • Larsen, C., Larsen, S. W., Jensen, H., Yaghmur, A., & Østergaard, J. (2009). Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opinion on Drug Delivery, 6(12), 1283–1295. [DOI:10.1517/17425240903307431]
    • Larsen, S. W., Thing, M. A., & Larsen, C. (2012). Oily (lipophilic) solutions and suspensions. In Wright, J. C., & Burgess, D. J. (Eds.). Long Acting Injections and Implants (Advances in Delivery Science and Technology) (pp. 113–135). Boston: Springer. [DOI:10.1007/978-1-4614-0554-2_7]
    • Le, A., Huang, K. J., & Cirrincione, L. R. (2022). Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine. Trends in Pharmacological Sciences, 43(7), 582–592. [DOI:10.1016/j.tips.2022.03.006]
    • Leinonen, P., Hammond, G. L., Lukkarinen, O., & Vihko, R. (1979). Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma. Investigative Urology, 17(1), 24–27. [Google Scholar] [PubMed]
    • Leinonen, P. (1980). Estrone and estradiol concentrations in the testis and spermatic and peripheral venous blood of elderly men: the influence of estrogen treatment. Journal of Steroid Biochemistry, 13(7), 737–742. [DOI:10.1016/0022-4731(80)90225-3]
    • Leyendecker, G., Geppert, G., Nocke, W., & Ufer, J. (1975). Untersuchungen zur Pharmakokinetik von Östradiol-17β, Östradiol-Benzoat, Östradiol-Valerianat und Östradiol-Undezylat bei der Frau: Der Verlauf der Konzentrationen von Östradiol-17β, Östron, LH und FSH im Serum. [Estradiol-17β, Estrone, LH and FSH in Serum After Administration of Estradiol-17β, Estradiol-Benzoate, Estradiol-Valeriate and Estradiol-Undecylate in the Female.] Geburtshilfe und Frauenheilkunde, 35(5), 370–374. [Google Scholar] [PubMed] [PDF] [Translation]
    • Leyendecker, G., Wildt, L., Gips, H., Nocke, W., & Plotz, E. J. (1976). Experimental studies on the positive feedback effect of progesterone, 17α-hydroxyprogesterone and 20α-dihydroprogesterone on the pituitary release of LH and FSH in the human female. Archiv für Gynäkologie, 221(1), 29–45. [DOI:10.1007/BF00667679]
    • Lichten, E. M., Lichten, J. B., Whitty, A., & Pieper, D. (1996). The confirmation of a biochemical marker for women’s hormonal migraine: The depo‐estradiol challenge test. Headache: The Journal of Head and Face Pain, 36(6), 367–371. [DOI:10.1046/j.1526-4610.1996.3606367.x]
    • Linet, T. (2023). Prise en charge endocrinologique d’une personne trans. [Endocrinological care of a trans person.] In Faucher, P., Hassoun, D., & Linet, T. (Eds.). Santé sexuelle et reproductive des personnes LGBT [Sexual and Reproductive Health of LGBT People] (pp. 109–124). Issy-les-Moulineaux, France: Elsevier Masson. [Google Books] [URL] [WorldCat] [Excerpt]
    • Lixsoft. (2008). Mathematical Expressions of the Pharmacokinetic and Pharmacodynamic Models Implemented in the Monolix Software. [PDF]
    • Martinez, G. (1995). Estradiol and Progesterone Serum Levels in Women Using the Once-a-month Injectable Contraceptive Perlutal. / Benagiano, G., Bianchi, P., von Kesserü, E., Castañeda, A., Correa, J. E., & Martínez, G. (1995). Session 19 what is new about injectable contraceptives? Advances in Contraception, 11(1), 39–42. [DOI:10.1007/BF02436100]
    • Martins, R. S., Antunes, N. J., Comerlatti, G., Caraccio, G., Moreno, R. A., Frecentese, F., Caliendo, G., & De Nucci, G. (2019). Quantification of estradiol cypionate in plasma by liquid chromatography coupled with tandem mass spectrometry: Application in a pharmacokinetic study in healthy female volunteers. Journal of Pharmaceutical and Biomedical Analysis, 170, 273–278. [DOI:10.1016/j.jpba.2019.03.053]
    • Messinis, I. E., & Templeton, A. (1987). Effect of high dose exogenous oestrogen on midcycle luteinizing hormone surge in human spontaneous cycles. Clinical Endocrinology, 27(4), 453–459. [DOI:10.1111/j.1365-2265.1987.tb01173.x]
    • Messinis, I. E., & Templeton, A. A. (1987). Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. Reproduction, 79(2), 549–554. [DOI:10.1530/jrf.0.0790549]
    • Minto, C. F., Howe, C., Wishart, S., Conway, A. J., & Handelsman, D. J. (1997). Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. Journal of Pharmacology and Experimental Therapeutics, 281(1), 93–102. [URL]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • Newton, J. R., d’Arcangues, C., & Hall, P. E. (1994). A review of ‘once-a-month’ combined injectable contraceptives. Journal of Obstetrics and Gynaecology, 14(Suppl 1), S1–S34. [DOI:10.3109/01443619409027641]
    • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016] [Table]
    • Nieschlag, E., & Behre, H. M. (2010). Testosterone therapy. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Andrology (pp. 437–455). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-540-78355-8_21] [PDF]
    • Norlén, B. J., Fritjofsson, Å., Grönquist, L., Gunnarsson, P. O., Johansson, S. Å., & Plym-Forshell, G. (1987). Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer. European Urology, 13, 193–197. [DOI:10.1159/000472772]
    • Olson-Kennedy, J., Rosenthal, S. M., Hastings, J., & Wesp, L. (2016). Health considerations for gender non-conforming children and transgender adolescents. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 186–199). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Oriowo, M. A., Landgren, B. M., Stenström, B., & Diczfalusy, E. (1980). A comparison of the pharmacokinetic properties of three estradiol esters. Contraception, 21(4), 415–424. [DOI:10.1016/S0010-7824(80)80018-7]
    • Parkes, A. S. (1937). Relative duration of action of various esters of oestrone, oestradiol and oestriol. Biochemical Journal, 31(4), 579–585. [DOI:10.1042/bj0310579]
    • Presl, J., Horejsi, J., Štroufová, A., & Herzmann, J. (1976). Sexual maturation in girls and the development of estrogen-induced gonadotropic hormone release. Annales de Biologie Animale, Biochimie, Biophysique, 16(3), 377–383. [DOI:10.1051/rnd:19760314]
    • Rahimy, M. H., & Ryan, K. K. (1999). Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women. Contraception, 60(4), 189–200. [DOI:10.1016/s0010-7824(99)00081-5]
    • Rahimy, M. H., Ryan, K. K., & Hopkins, N. K. (1999). Lunelle™ monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): steady-state pharmacokinetics of MPA and E2 in surgically sterile women. Contraception, 60(4), 209–214. [DOI:10.1016/S0010-7824(99)00086-4]
    • Rauramo, L., Punnonen, R., Kaihola, H. L., & Grönroos, M. (1980). Serum oestrone, oestradiol and oestriol concentrations in castrated women during intramuscular oestradiolvalerate and oestradiolbenzoate-oestradiolphenylpropionate therapy. Maturitas, 2(1), 53–58. [DOI:10.1016/0378-5122(80)90060-2]
    • Rauramo, L., Punnonen, R., & Grönroos, M. (1981). Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments. Maturitas, 3(2), 183–186. [DOI:10.1016/0378-5122(81)90010-4]
    • Recio, R., Garza-Flores, J., Schiavon, R., Reyes, A., Diaz-Sanchez, V., Valles, V., Luz de la Cruz, D., Oropeza, G., & Perez-Palacios, G. (1986). Pharmacodynamic assessment of dihydroxyprogesterone acetophenide plus estradiol enanthate as a monthly injectable contraceptive. Contraception, 33(6), 579–589. [DOI:10.1016/0010-7824(86)90046-6]
    • Reimann, I. W., Britzelmeier, C., Haber, P., Wollmann, H., Antonin, K. H., & Bieck, P. R. (1987). Influence of Oestradiol on Alpha2-Adrenoceptor Binding Sites on Intact Platelets of Young Male Volunteers. European Journal of Clinical Pharmacology, 33(2), 147–150. [DOI:10.1007/BF00544558]
    • Rosenfield, R. L., Fang, V. S., Dupon, C., Kim, M. H., & Refetoff, S. (1973). The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner’s syndrome. The Journal of Clinical Endocrinology and Metabolism, 37(4), 574–580. [DOI:10.1210/jcem-37-4-574]
    • Rosenfield, R. L., & Fang, V. S. (1974). The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. The Journal of Pediatrics, 85(6), 830–837. [DOI:10.1016/S0022-3476(74)80355-0]
    • Rothman, M. S., Hamnvik, O. P. R., Davidge-Pitts, C., Safer, J. D., Ariel, D., Tangpricha, V., Abramowitz, J., Soe, K., Sarvaideo, J., Kelley, C., Irwig, M. S., & Iwamoto, S. J. (2024). Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. Transgender Health, ahead of print. [DOI:10.1089/trgh.2023.0209]
    • Sang, G. W., Ge, J. L., Liu, X. H., Shao, Q. X., Zhao, X. J., & Mao, S. M. (1987). 不同剂量庚炔诺酮单独或配伍戊酸雌二醇后的药代动力学及药效学. [Pharmacokinetics and pharmacodynamics of different doses of norethisterone enanthate alone and in combination with estradiol valerate.] 中国 临 床药理 学杂志 / Chinese Journal of Clinical Pharmacology, 3(1), 7–18. [Google Scholar] [CNKI] [DOI:10.13699/j.cnki.1001-6821.1987.01.002] [PDF]
    • Sang, G. W. (1994). Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception, 49(4), 361–385. [DOI:10.1016/0010-7824(94)90033-7]
    • Schiavon, R., Benavides, S., Oropeza, G., Garza-Flores, J., Recio, R., Díaz-Sanchez, V., & Pérez-Palacios, G. (1988). Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive. Contraception, 37(6), 591–598. [DOI:10.1016/0010-7824(88)90005-4]
    • Schug, B. S., Donath, F., & Blume, H. H. (2012). Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers. International Journal of Clinical Pharmacology and Therapeutics, 50(2), 100–117. [Google Scholar] [DOI:10.5414/cp201589] [PDF]
    • Schulte-Beerbühl, M., & Nieschlag, E. (1980). Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate or testosterone cypionate. Fertility and Sterility, 33(2), 201–203. [DOI:10.1016/S0015-0282(16)44543-7]
    • Schultz, K., Møllgaard, B., Fisher, A. N., Illum, L., & Larsen, C. (1998). Intramuscular rate of disappearance of oily vehicles in rabbits investigated by gamma-scintigraphy. International Journal of Pharmaceutics, 169(1), 121–126. [DOI:10.1016/S0378-5173(98)00121-5]
    • Schweikert, H. U., Weissbach, L., Leyendecker, G., Schwinger, E., Wartenberg, H., & Krück, F. (1982). Clinical, endocrinological, and cytological characterization of two 46, XX males. The Journal of Clinical Endocrinology & Metabolism, 54(4), 745–752. [DOI:10.1210/jcem-54-4-745]
    • Seibert, B., & Günzel, P. (1994). Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna®. Contraception, 49(4), 303–333. [DOI:10.1016/0010-7824(94)90030-2]
    • Shah, J. C. (2007). Controlled Release – Small Molecules. In Stella, V. J., Borchardt, R. T., Hageman, M. J., Oliyai, R., Maag, H., & Tilley, J. W. (Eds.). Prodrugs: Challenges and Rewards, Part 1 (Biotechnology: Pharmaceutical Aspects, Volume V) (pp. 357–377). New York: Springer. [DOI:10.1007/978-0-387-49785-3_9]
    • Sharula, Chekir, C., Emi, Y., Arai, F., Kikuchi, Y., Sasaki, A., Matsuda, M., Shimizu, K., Tabuchi, K., Kamada, Y., Hiramatsu, Y., & Nakatsuka, M. (2012). Altered arterial stiffness in male‐to‐female transsexuals undergoing hormonal treatment. Journal of Obstetrics and Gynaecology Research, 38(6), 932–940. [DOI:10.1111/j.1447-0756.2011.01815.x] [Data]
    • Shaw, R. W., Butt, W. R., London, D. R., & Marshall, J. C. (1975). The oestrogen provocation test: a method of assessing the hypothalamic‐pituitary axis in patients with amenorrhoea. Clinical Endocrinology, 4(3), 267–276. [DOI:10.1111/j.1365-2265.1975.tb01534.x]
    • Shaw, R. W., Butt, W. R., & London, D. R. (1975). The effect of oestrogen pretreatment on subsequent response to luteinizing hormone releasing hormone in normal women. Clinical Endocrinology, 4(3), 297–304. [DOI:10.1111/j.1365-2265.1975.tb01537.x]
    • Shaw, R. W. (1978). Neuroendocrinology of the menstrual cycle in humans. Clinics in Endocrinology and Metabolism, 7(3), 531–559. [DOI:10.1016/S0300-595X(78)80008-5]
    • Shahiwala, A., Mehta, T. A., & Momin, M. M. (2018). Parenteral drug delivery systems. In Misra, A., & Shahiwala, A. (Eds.). In-Vitro and In-Vivo Tools in Drug Delivery Research for Optimum Clinical Outcomes (pp. 283–318). Boca Raton: CRC Press. [DOI:10.1201/b22448-9] [Google Books]
    • Sherwin, B. B., & Gelfand, M. M. (1987). Individual differences in mood with menopausal replacement therapy: Possible role of sex hormone-binding globulin. Journal of Psychosomatic Obstetrics & Gynecology, 6(2), 121–131. [DOI:10.3109/01674828709016773]
    • Sherwin, B. B., Gelfand, M. M., Schucher, R., & Gabor, J. (1987). Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations. American Journal of Obstetrics and Gynecology, 156(2), 414–419. [DOI:10.1016/0002-9378(87)90295-X]
    • Sherwin, B. B. (1988). Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. Journal of Affective Disorders, 14(2), 177–187. [DOI:10.1016/0165-0327(88)90061-4]
    • Sierra-Ramírez, J. A., Lara-Ricalde, R., Lujan, M., Velázquez-Ramírez, N., Godínez-Victoria, M., Hernádez-Munguía, I. A., Padilla, A., & Garza-Flores, J. (2011). Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg). Contraception, 84(6), 565–570. [DOI:10.1016/j.contraception.2011.03.014]
    • Sinkula, A. A. (1978). Methods to Achieve Sustained Drug Delivery. The Chemical Approach. In Robinson, J. R. (Ed.). Sustained and Controlled Release Drug Delivery Systems (pp. 411–555). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books] [PDF]
    • Somerville, B. W. (1971). The Role of Oestradiol in Menstrual Migraine. In Somerville, B. W. The Influence of Progesterone and Oestradiol on Migraine (Doctoral dissertation, University of New South Wales) (pp. 93–104). [Google Scholar] [URL] [WorldCat] [PDF]
    • Somerville, B. W. (1972). The Role of Estradiol Withdrawal in the Etiology of Menstrual Migraine. Neurology, 22(4), 355–365. [DOI:10.1212/WNL.22.4.355]
    • Somerville, B. W. (1972). The influence of progesterone and estradiol upon migraine. Headache: The Journal of Head and Face Pain, 12(3), 93–102. [DOI:10.1111/j.1526-4610.1972.hed1203093.x]
    • Somerville, B. W. (1972). The Influence of Hormones Upon Migraine in Women. Medical Journal of Australia, 2(S2), 6–11. [DOI:10.5694/j.1326-5377.1972.tb93039.x]
    • Somerville, B. W. (1975). Estrogen‐withdrawal migraine: I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology, 25(3), 239–244. [DOI:10.1212/wnl.25.3.239]
    • Spack, N. P. (2013). Management of transgenderism. JAMA, 309(5), 478–484. [DOI:10.1001/jama.2012.165234]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., & Pousette, A. (1988). Single drug polyestradiol phosphate therapy in prostatic cancer. American Journal of Clinical Oncology, 11(Suppl 2), S101–S103. [DOI:10.1097/00000421-198801102-00024] [PDF]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & von Schoultz, B. (1989). Single‐drug parenteral estrogen treatment in prostatic cancer: A study of two maintenance‐dose regimens. The Prostate, 14(2), 183–188. [DOI:10.1002/pros.2990140211]
    • Stege, R., Gunnarsson, P. O., Johansson, C. J., Olsson, P., Pousette, Å., & Carlström, K. (1996). Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients. The Prostate, 28(5), 307–310. [DOI:10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8]
    • Sumioki, H. (1987). ヒト排卵機構とGonadotropin分泌調節における “β-Endorphinおよびβ-Lipotropin” の役割に関する研究. [The Role of “β-Endorphin & β-Lipotropin” on the Gonadotropin Regulation in the Mechanism of Human Ovulation.] Folia Endocrinologica Japonica, 63(10), 1289–1307. [DOI:10.1507/endocrine1927.63.10_1289]
    • Svendsen, O., & Aaes‐Jørgensen, T. (1979). Studies on the fate of vegetable oil after intramuscular injection into experimental animals. Acta Pharmacologica et Toxicologica, 45(5), 352–378. [DOI:10.1111/j.1600-0773.1979.tb02404.x]
    • Tassinari, R., & Maranghi, F. (2021). Rodent Model of Gender-Affirming Hormone Therapies as Specific Tool for Identifying Susceptibility and Vulnerability of Transgender People and Future Applications for Risk Assessment. International Journal of Environmental Research and Public Health, 18(23), 12640. [DOI:10.3390/ijerph182312640]
    • Thurman, A., Kimble, T., Hall, P., Schwartz, J. L., & Archer, D. F. (2013). Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics. Contraception, 87(6), 738–743. [DOI:10.1016/j.contraception.2012.11.010]
    • Toppozada, M. K. (1994). Existing once-a-month combined injectable contraceptives. Contraception, 49(4), 293–301. [DOI:10.1016/0010-7824(94)90029-9]
    • Toutain, P. L., & Bousquet-Mélou, A. (2004). Plasma terminal half-life. Journal of Veterinary Pharmacology and Therapeutics, 27(6), 427–439. [DOI:10.1111/j.1365-2885.2004.00600.x]
    • Trans Care BC. (2021). Gender-affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care Toolkit. Vancouver: Provincial Health Services Authority/Trans Care BC. [URL] [PDF]
    • Travaglini, P., Ambrosi, B., Beck-Peccoz, P., Elli, R., Rondena, M., Bara, R., & Weber, G. (1978). Hypothalamic-pituitary-ovarian function in hyperprolactinemic women. Journal of Endocrinological Investigation, 1(1), 39–45. [DOI:10.1007/BF03346769]
    • Travaglini, P., Elli, R., Ambrosi, B., Ballabio, M., Moriondo, P., & Faglia, G. (1979). Serum LH increase after estradiol and progesterone administration in hyperprolactinemic women. Journal of Endocrinological Investigation, 2(4), 407–411. [DOI:10.1007/BF03349341]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine position statement “assessment and hormonal management in adolescent and adult trans people, with attention for sexual function and satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • Ulrich, U., Pfeifer, T., & Lauritzen, C. (1994). Rapid Increase in Lumbar Spine Bone Density in Osteopenic Women by High-Dose Intramuscular Estrogen-Progestogen Injections. Hormone and Metabolic Research, 26(9), 428–431. [DOI:10.1055/s-2007-1001723]
    • Välimäki, M., Pelkonen, R., Salaspuro, M., Härkönen, M., Hirvonen, E., & Ylikahri, R. (1984). Sex hormones in amenorrheic women with alcoholic liver disease. The Journal of Clinical Endocrinology and Metabolism, 59(1), 133–138. [DOI:10.1210/jcem-59-1-133]
    • Valle Alvarez, D. C. (2011). Efecto de una Dosis de 50 mg de Enantato de Noretisterona y 5 mg de Valerato de Estradiol en los Niveles de Testosterona Total en Hombres Mexicanos Sanos. [Effect of a Dose of 50 mg of Norethisterone Enanthate and 5 mg of Estradiol Valerate on Total Testosterone Levels in Healthy Mexican Men.] (Masters thesis, National Polytechnic Institute of Mexico.) [Google Scholar] [URL] [PDF] [Translation]
    • Varangot, J., & Cedard, L. (1957). Modifications des Œstrogènes Sanguins Après Administration Intramusculaire de Benzoate d’Œstradiol. [Changes in Serum Estrogens After Intramuscular Administration of Estradiol Benzoate.] Comptes Rendus des Séances de la Société de Biologie et de ses Filiales, 151(10), 1707–1712. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
    • Vermeulen, A. (1975). Longacting steroid preparations. Acta Clinica Belgica, 30(1), 48–55. [DOI:10.1080/17843286.1975.11716973]
    • Vermeulen, A. (1977). Transport and Distribution of Androgens at Different Ages. In Martini, L., & Motta, M. (Eds.). Androgens and Antiandrogens (pp. 53–65). New York: Raven Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [Excerpt]
    • Vhora, I., Bardoliwala, D., Ranamalla, S. R., & Javia, A. (2019). Parenteral controlled and prolonged drug delivery systems: therapeutic needs and formulation strategies. In Misra A., & Shahiwala, A. (Eds.). Novel Drug Delivery Technologies (pp. 183–260). Singapore: Springer. [DOI:10.1007/978-981-13-3642-3_7]
    • Vizziello, G., D’Amato, G., Trentadue, R., & Fanizza, G. (1993). Studio dinamico del blocco ipofisario indotto dalla triptorelina, mediante test all’estradiolo benzoato. [Estradiol benzoate test in the study of pituitary block induced by triptorelin.] Minerva Ginecologica, 45(4), 185–189. [Google Scholar] [PubMed] [PDF] [Translation]
    • Wagner, J. G. (1993). Pharmacokinetics for the Pharmaceutical Scientist. Lancaster/Basel: Technomic. [DOI:10.1201/9780203743652] [Google Books]
    • Weiss, G., Nachtigall, L. E., & Ganguly, M. (1976). Induction of an LH surge with estradiol benzoate. A clinical test of pituitary-hypothalamic axis competence. Obstetrics and Gynecology, 47(4), 415–418. [URL]
    • White, M. C., Rosenstock, J., Anapliotou, M., Mashiter, K., & Joplin, G. F. (1981). Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas. The Lancet, 317(8235), 1394–1396. [DOI:10.1016/S0140-6736(81)92571-X]
    • Wiemeyer, J. C., Fernandez, M., Moguilevsky, J. A., & Sagasta, C. L. (1986). Pharmacokinetic Studies of Estradiol Enantate in Menopausic Women. Arzneimittel-Forschung, 36(11), 1674–1677. [Google Scholar] [PubMed] [PDF]
    • Wiemeyer, J. C., Fernandez, M., Sagasta, C. L., & Moguilevsky, J. A. (1987). Estudos farmacocinéticos do enantato de estradiol em mulheres na menopausa. [Pharmacokinetic studies of estradiol enantate in menopausic women.] Jornal Brasileiro de Ginecologia, 97(9), 497–501. [Google Scholar] [LILACS] [PDF]
    • Yan, J., Pan, J., Chang, Y., & Kang, J. (1987). The effect of monthly injectable contraceptive megestrol acetate compound on pituitary-ovarian function. 上海第二医科大学学报(英文版) / Journal of Shanghai Second Medical University / Medical Bulletin of Shanghai Jiaotong University, 1(2), 7–12. [Google Scholar] [CNKI] [PDF]
    • Yáñez, J. A., Remsberg, C. M., Sayre, C. L., Forrest, M. L., & Davies, N. M. (2011). Flip-flop pharmacokinetics–delivering a reversal of disposition: challenges and opportunities during drug development. Therapeutic Delivery, 2(5), 643–672. [DOI:10.4155/tde.11.19]
    • Zhang, Y., Huo, M., Zhou, J., & Xie, S. (2010). PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine, 99(3), 306–314. [DOI:10.1016/j.cmpb.2010.01.007]
    • Zhou, X. F., Shao, Q. X., Han, X. J., Weng, L. J., & Sang, G. W. (1998). Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem® in Chinese women. Contraception, 57(6), 405–411. [DOI:10.1016/S0010-7824(98)00048-1]
    \ No newline at end of file diff --git a/transfemscience.org/articles/injectable-e2-simulator-release/index.html b/transfemscience.org/articles/injectable-e2-simulator-release/index.html index b9fa65b0..c1e10e33 100644 --- a/transfemscience.org/articles/injectable-e2-simulator-release/index.html +++ b/transfemscience.org/articles/injectable-e2-simulator-release/index.html @@ -1 +1 @@ -An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters - Transfeminine Science Link

    An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters

    By Aly | First published July 16, 2021 | Last modified April 12, 2023

    Links to go straight to the simulator: Original Simulator and Advanced Simulator

    Estradiol is frequently used in injectable form in transfeminine hormone therapy. Injectable estradiol is employed in the form of estradiol esters such as estradiol valerate and estradiol cypionate, which are prodrugs of estradiol that are slowly released from a depot formed at the injection site. These esters are most commonly formulated as oil solutions and are administered via intramuscular or subcutaneous injection. Injectable estradiol is a popular choice among transfeminine people as well as some clinical providers as it has a number of advantages over other estradiol routes and forms. For instance, it allows for easy and inexpensive attainment of higher estradiol levels that can be useful in transfeminine people for achieving better testosterone suppression. This is particularly true in the case of estradiol monotherapy, a therapeutic approach in which an antiandrogen isn’t employed.

    Clinically used injectable estradiol preparations were developed many decades ago and are not as commonly used in medicine as estradiol preparations like oral and transdermal estradiol. In fact, injectable estradiol has been discontinued in many countries in favor of non-injectable preparations. In relation to the preceding, research and review material on the pharmacokinetics of these preparations are limited and are scattered throughout the scientific literature. For most of the published concentration–time curves of circulating estradiol with injectable estradiol esters, only a single injection has been administered and the different doses that have been employed have been few. The scarce and obscure information on the pharmacokinetics of these formulations presents challenges for transfeminine people and their clinicians when it comes to understanding the estradiol levels that may result with injectable estradiol preparations. This is particularly true in relation to repeated injections of injectable estradiol formulations at varying doses and injection intervals, which is how these preparations are used in transfeminine hormone therapy. A proper understanding of the estradiol levels with injectable estradiol is important for transfeminine people for avoiding estradiol levels that are too low—which can result in inadequate testosterone suppression and therapeutic efficacy—while also avoiding estradiol levels that are too high—which may produce unnecessary side effects and risks (e.g., Aly, 2020).

    To help with overcoming these obstacles, I’ve developed an interactive web app for simulating estradiol levels with injectable estradiol preparations. This simulator can be found at the following page:

    Here is a screenshot of the simulator that shows what it looks like and what it can do:

    The app simulates estradiol levels with a selection of major injectable estradiol preparations. These preparations include injectable estradiol benzoate (EB) in oil, estradiol valerate (EV) in oil, estradiol cypionate (EC) in oil and as a microcrystalline aqueous suspension, estradiol enanthate (EEn) in oil, estradiol undecylate (EU) in oil, and polyestradiol phosphate (PEP). Options are available in the simulator for specifying injectable estradiol dose (mg), single versus repeated injections, injection interval (days, weeks, or months), units for estradiol concentrations (pg/mL or pmol/L), x-axis maximum value (or time interval to graph) (days), and y-axis max value (or estradiol concentration interval to graph) (pg/mL or pmol/L). One preparation can be simulated at a time or all of the supported injectable estradiol preparations can be graphed together at the same time. When all injectable preparations are simulated at once, the legend can be interacted with to hide or show individual preparations.

    The estradiol curves produced by the app are simulations based on available data from published studies with the supported injectable estradiol preparations. The accuracy of the curves is limited by the quality and quantity of these data. In other words, the curves are only estimates, and true estradiol levels with a given preparation may be different than what is shown. It is notable in this regard that estradiol curves with a given injectable estradiol preparation vary considerably between studies, with different levels and curve shapes apparent. There are many potential factors which may contribute to this variability, such as formulation, injection specifics (like injection site, volume, and technique), the type and calibration of blood test used, differing subject characteristics (like age, weight, etc.), and research matters like sampling error. The simulator is not able to take into account these potential variables as data on their influences are scarce and not well-defined. An assumption of the simulator is that estradiol levels and curve shapes scale linearly with dose, which may or may not actually be the case. Lastly, it must be made clear that the estradiol curves correspond to the averages of many people, and individual estradiol levels and curve shapes vary substantially even with the same injectable estradiol preparation. For these varied reasons, the simulator cannot tell a given person what their exact estradiol levels with a given injectable estradiol regimen will be. It can only be used as a guide to roughly estimate where one’s estradiol levels most plausibly could be. In relation to this, estradiol levels, as well as testosterone suppression, should be monitored and verified with blood work to ensure that they are in desired ranges.

    A literature review and informal meta-analysis of available estradiol concentration–time data with injectable estradiol preparations was conducted to determine the appropriate estradiol curves for the different estradiol esters included in the simulator. Data were collected from the literature, processed, and modeled using pharmacokinetic models. This work can be found at the following page:

    The meta-analysis was not able to derive a reasonable curve for injectable estradiol undecylate due to lack of adequate published data for this ester for modeling. Because of the historical and theoretical importance of estradiol undecylate as an injectable estradiol ester however, it was desirable to nonetheless construct a curve of some form for estradiol undecylate so that it could be included in the simulator. In order to do this, a curve was instead fit to a well-known study for injectable testosterone undecanoate (testosterone undecylate; TU) (Behre et al., 1999) and area-under-the-curve estradiol levels were scaled to be appropriate for those with a given dose of estradiol undecylate based on data with other injectable estradiol preparations. This approach is reasonable as estradiol undecylate and testosterone undecanoate have fairly similar fat solubilities (Table) due to being very similar in chemical structure and as fat solubility is the key property dictating the release rates and curve shapes of these preparations. Accordingly, the resulting curve for estradiol undecylate roughly accords with the reported clinical durations of this ester (Table). In any case, it should be cautioned that the estradiol undecylate curve is not based on real data for this estradiol ester and is only hypothetical or “just for fun”.

    The simulator and the curves for the different injectable preparations included may be updated in the future with improvements and new features. Extension of the simulator to other hormonal preparations like injectable testosterone, sublingual estradiol, and estradiol pellets would be fairly straightforward and could be done in the future. However, it would require additional meta-analysis and much further work.

    A special thank you to Violet and Lila for their indispensable input and guidance on modeling topics during the work on this project. An additional thanks to Violet for deriving a special three-compartment pharmacokinetic model that was used in the simulator. Please also check out Violet’s own work-in-progress TransKit and Tilia projects—pharmacokinetic tools tailored for transgender hormone therapy.

    Updates

    Update 1: New Advanced Simulator

    Since the release of the injectable estradiol simulator, a more advanced version of the simulator with additional options and functionality has been developed. This advanced simulator was created by Luna via modification of Aly’s original simulator code. It uses the same data (i.e. injectable estradiol curves) as the original simulator, but has the following new features: (1) simulate multiple traces at once; (2) stop after X doses (dose limit); (3) start trace at steady state; and (4) show cis woman menstrual cycle (median, 5th percentile, and 95th percentile estradiol levels; data from Abbott (2009)). The advanced injectable estradiol simulator was released on October 5, 2022 and can be found at the following page:

    Here is a screenshot of the advanced simulator and its capabilities:

    Update 2: Literature Mentions

    Since Transfeminine Science’s injectable estradiol simulator was released in mid-2021, it has been mentioned and cited in the scientific literature in a number of publications (see Aly, 2021).

    References

    • Abbott Laboratories. (2009). Estradiol. Architect System. Abbott Park, Illinois/Wiesbaden, Germany: Abbott Laboratories. [PDF]
    • Behre, H. M., Abshagen, K., Oettel, M., Hubler, D., & Nieschlag, E. (1999). Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. European Journal of Endocrinology, 140(5), 414–419. [DOI:10.1530/eje.0.1400414]
    \ No newline at end of file +An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters - Transfeminine Science Link

    An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters

    By Aly | First published July 16, 2021 | Last modified April 12, 2023

    Links to go straight to the simulator: Original Simulator and Advanced Simulator

    Estradiol is frequently used in injectable form in transfeminine hormone therapy. Injectable estradiol is employed in the form of estradiol esters such as estradiol valerate and estradiol cypionate, which are prodrugs of estradiol that are slowly released from a depot formed at the injection site. These esters are most commonly formulated as oil solutions and are administered via intramuscular or subcutaneous injection. Injectable estradiol is a popular choice among transfeminine people as well as some clinical providers as it has a number of advantages over other estradiol routes and forms. For instance, it allows for easy and inexpensive attainment of higher estradiol levels that can be useful in transfeminine people for achieving better testosterone suppression. This is particularly true in the case of estradiol monotherapy, a therapeutic approach in which an antiandrogen isn’t employed.

    Clinically used injectable estradiol preparations were developed many decades ago and are not as commonly used in medicine as estradiol preparations like oral and transdermal estradiol. In fact, injectable estradiol has been discontinued in many countries in favor of non-injectable preparations. In relation to the preceding, research and review material on the pharmacokinetics of these preparations are limited and are scattered throughout the scientific literature. For most of the published concentration–time curves of circulating estradiol with injectable estradiol esters, only a single injection has been administered and the different doses that have been employed have been few. The scarce and obscure information on the pharmacokinetics of these formulations presents challenges for transfeminine people and their clinicians when it comes to understanding the estradiol levels that may result with injectable estradiol preparations. This is particularly true in relation to repeated injections of injectable estradiol formulations at varying doses and injection intervals, which is how these preparations are used in transfeminine hormone therapy. A proper understanding of the estradiol levels with injectable estradiol is important for transfeminine people for avoiding estradiol levels that are too low—which can result in inadequate testosterone suppression and therapeutic efficacy—while also avoiding estradiol levels that are too high—which may produce unnecessary side effects and risks (e.g., Aly, 2020).

    To help with overcoming these obstacles, I’ve developed an interactive web app for simulating estradiol levels with injectable estradiol preparations. This simulator can be found at the following page:

    Here is a screenshot of the simulator that shows what it looks like and what it can do:

    The app simulates estradiol levels with a selection of major injectable estradiol preparations. These preparations include injectable estradiol benzoate (EB) in oil, estradiol valerate (EV) in oil, estradiol cypionate (EC) in oil and as a microcrystalline aqueous suspension, estradiol enanthate (EEn) in oil, estradiol undecylate (EU) in oil, and polyestradiol phosphate (PEP). Options are available in the simulator for specifying injectable estradiol dose (mg), single versus repeated injections, injection interval (days, weeks, or months), units for estradiol concentrations (pg/mL or pmol/L), x-axis maximum value (or time interval to graph) (days), and y-axis max value (or estradiol concentration interval to graph) (pg/mL or pmol/L). One preparation can be simulated at a time or all of the supported injectable estradiol preparations can be graphed together at the same time. When all injectable preparations are simulated at once, the legend can be interacted with to hide or show individual preparations.

    The estradiol curves produced by the app are simulations based on available data from published studies with the supported injectable estradiol preparations. The accuracy of the curves is limited by the quality and quantity of these data. In other words, the curves are only estimates, and true estradiol levels with a given preparation may be different than what is shown. It is notable in this regard that estradiol curves with a given injectable estradiol preparation vary considerably between studies, with different levels and curve shapes apparent. There are many potential factors which may contribute to this variability, such as formulation, injection specifics (like injection site, volume, and technique), the type and calibration of blood test used, differing subject characteristics (like age, weight, etc.), and research matters like sampling error. The simulator is not able to take into account these potential variables as data on their influences are scarce and not well-defined. An assumption of the simulator is that estradiol levels and curve shapes scale linearly with dose, which may or may not actually be the case. Lastly, it must be made clear that the estradiol curves correspond to the averages of many people, and individual estradiol levels and curve shapes vary substantially even with the same injectable estradiol preparation. For these varied reasons, the simulator cannot tell a given person what their exact estradiol levels with a given injectable estradiol regimen will be. It can only be used as a guide to roughly estimate where one’s estradiol levels most plausibly could be. In relation to this, estradiol levels, as well as testosterone suppression, should be monitored and verified with blood work to ensure that they are in desired ranges.

    A literature review and informal meta-analysis of available estradiol concentration–time data with injectable estradiol preparations was conducted to determine the appropriate estradiol curves for the different estradiol esters included in the simulator. Data were collected from the literature, processed, and modeled using pharmacokinetic models. This work can be found at the following page:

    The meta-analysis was not able to derive a reasonable curve for injectable estradiol undecylate due to lack of adequate published data for this ester for modeling. Because of the historical and theoretical importance of estradiol undecylate as an injectable estradiol ester however, it was desirable to nonetheless construct a curve of some form for estradiol undecylate so that it could be included in the simulator. In order to do this, a curve was instead fit to a well-known study for injectable testosterone undecanoate (testosterone undecylate; TU) (Behre et al., 1999) and area-under-the-curve estradiol levels were scaled to be appropriate for those with a given dose of estradiol undecylate based on data with other injectable estradiol preparations. This approach is reasonable as estradiol undecylate and testosterone undecanoate have fairly similar fat solubilities (Table) due to being very similar in chemical structure and as fat solubility is the key property dictating the release rates and curve shapes of these preparations. Accordingly, the resulting curve for estradiol undecylate roughly accords with the reported clinical durations of this ester (Table). In any case, it should be cautioned that the estradiol undecylate curve is not based on real data for this estradiol ester and is only hypothetical or “just for fun”.

    The simulator and the curves for the different injectable preparations included may be updated in the future with improvements and new features. Extension of the simulator to other hormonal preparations like injectable testosterone, sublingual estradiol, and estradiol pellets would be fairly straightforward and could be done in the future. However, it would require additional meta-analysis and much further work.

    A special thank you to Violet and Lila for their indispensable input and guidance on modeling topics during the work on this project. An additional thanks to Violet for deriving a special three-compartment pharmacokinetic model that was used in the simulator. Please also check out Violet’s own work-in-progress TransKit and Tilia projects—pharmacokinetic tools tailored for transgender hormone therapy.

    Updates

    Update 1: New Advanced Simulator

    Since the release of the injectable estradiol simulator, a more advanced version of the simulator with additional options and functionality has been developed. This advanced simulator was created by Luna via modification of Aly’s original simulator code. It uses the same data (i.e. injectable estradiol curves) as the original simulator, but has the following new features: (1) simulate multiple traces at once; (2) stop after X doses (dose limit); (3) start trace at steady state; and (4) show cis woman menstrual cycle (median, 5th percentile, and 95th percentile estradiol levels; data from Abbott (2009)). The advanced injectable estradiol simulator was released on October 5, 2022 and can be found at the following page:

    Here is a screenshot of the advanced simulator and its capabilities:

    Update 2: Literature Mentions

    Since Transfeminine Science’s injectable estradiol simulator was released in mid-2021, it has been mentioned and cited in the scientific literature in a number of publications (see Aly, 2021).

    References

    • Abbott Laboratories. (2009). Estradiol. Architect System. Abbott Park, Illinois/Wiesbaden, Germany: Abbott Laboratories. [PDF]
    • Behre, H. M., Abshagen, K., Oettel, M., Hubler, D., & Nieschlag, E. (1999). Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. European Journal of Endocrinology, 140(5), 414–419. [DOI:10.1530/eje.0.1400414]
    \ No newline at end of file diff --git a/transfemscience.org/articles/nandrolone/index.html b/transfemscience.org/articles/nandrolone/index.html index e25ce13d..524da80f 100644 --- a/transfemscience.org/articles/nandrolone/index.html +++ b/transfemscience.org/articles/nandrolone/index.html @@ -1 +1 @@ -Nandrolone as a Potential Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People - Transfeminine Science Link

    Nandrolone as a Potential Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People

    By Aly | First published March 20, 2020 | Last modified March 23, 2023

    Abstract / TL;DR

    Nandrolone, or 19-nortestosterone, is a unique androgen and anabolic steroid which is used in the form of injectable ester prodrugs like nandrolone decanoate. It is closely related to testosterone structurally but has a number of important pharmacological differences in comparison. These differences include inactivation by 5α-reductase rather than potentiation, less or no conversion into estradiol, and much greater progestogenic activity. The inactivation of nandrolone by 5α-reductase results in nandrolone theoretically having much lower androgenic strength than testosterone in skin, hair follicles, and the prostate, among other tissues. Consequently, nandrolone may have less propensity for oily skin, acne, facial/body hair growth, scalp hair loss, and prostate problems than testosterone. On the other hand, nandrolone is theoretically expected to have full androgenic efficacy in most other tissues, including bone, fat, and muscle (and hence of masculine skeletal, fat, and muscular changes). This is also likely to be the case when it comes to voice, bottom growth, and sexual function. The reduced androgenic impact of nandrolone in skin and hair follicles relative to testosterone make it a favorable potential alternative option for androgen therapy both for transfeminine people and for some transmasculine people.

    Introduction

    Nandrolone, also known chemically as 19-nortestosterone (19-NT), is an androgen and anabolic steroid (AAS) similarly to testosterone (T). It is used as a medication by intramuscular or subcutaneous injection in the form of longer-acting esters like nandrolone decanoate (ND; Deca-Durabolin) and nandrolone phenylpropionate (NPP; Durabolin), which are converted into nandrolone in the body. This is analogous to longer-acting testosterone esters like testosterone enanthate (TE) and testosterone undecanoate (TU) and their conversion in the body into testosterone. Nandrolone is used in medicine for a variety of indications that benefit from anabolic effects in tissues like muscle, bone, and kidneys. Examples include wasting syndromes, osteoporosis, kidney disease, and anemia. It is used not only in men but also in women, for instance to prevent and treat postmenopausal osteoporosis in women who can’t tolerate estrogens or in whom estrogens can’t be taken. Nandrolone has additionally been advocated for use in androgen replacement therapy for women (Davis, 1999).

    Nandrolone is closely related to testosterone in terms of chemical structure, pharmacodynamic actions, and disposition in the body. At the same time however, nandrolone has a key difference from testosterone that makes it a very favorable alternative option for use as an androgen in transgender hormone therapy. This is the case not only for transfeminine people but also for transmasculine people. This property of nandrolone is that it is inactivated by 5α-reductase in tissues that express this enzyme. This is in contrast to testosterone, which is potentiated in such tissues via conversion into dihydrotestosterone (DHT). Because of this difference, nandrolone has normal androgenic effects in most of the body but a greatly reduced potential for androgenic effects in skin and hair follicles relative to testosterone. As a result, nandrolone has a variably reduced potential for androgenic skin and hair side effects such as oily skin, acne, facial and body hair growth, and scalp hair loss.

    Because of its favorable profile relative to testosterone, nandrolone has been advocated for use in androgen replacement therapy in cisgender men (Wu & Kovac, 2016; Pan & Kovac, 2016). It has also been studied for use in male hormonal contraception as an alternative and replacement for testosterone (Knuth et al., 1986; Nieschlag, 2010; Nieschlag & Behre, 2012). Nandrolone is advantageous for cisgender men not only due to preservation of scalp hair but also due to its lower stimulation of the prostate gland. As a result of its more favorable profile in terms of skin and hair follicles, nandrolone is an underappreciated alternative possibility relative to testosterone for use not only in cisgender people but also in transfeminine and transmasculine people.

    Chemistry of Nandrolone

    Nandrolone is chemically known as 19-nortestosterone. It is very close to testosterone in terms of chemical structure, the only difference between the two compounds being that the C19 methyl group of testosterone has been removed in the case of nandrolone. Nandrolone is not a synthetic compound; it occurs naturally in the human body in trace amounts as an intermediate in the conversion of testosterone to estradiol by the enzyme aromatase (Bricout & White, 2004). As such, although nandrolone couldn’t be said to be “bioidentical”, it’s quite similar to testosterone.

    Figure: Chemical structures of testosterone and nandrolone (19-nortestosterone). The structural difference between testosterone and nandrolone is at the C19 position and is highlighted by the circled areas.

    A variety of AAS chemical derivatives of nandrolone exist. Examples include normethandrone (17α-methyl-19-nortestosterone), norethandrolone (17α-ethyl-19-nortestosterone), trestolone (7α-methyl-19-nortestosterone; MENT), dimethandrolone (DMA; 7α,11β-dimethyl-19-nortestosterone), and 11β-methyl-19-nortestosterone (11β-MNT). The latter three have been proposed and/or studied for use in androgen replacement therapy and male hormonal contraception similarly to nandrolone (Sundaram, Kumar, & Bardin, 1994; Sundaram & Kumar, 2002; Anderson et al., 2003; Buvat et al., 2013; Nieschlag, Kumar, & Sitruk-Ware, 2013; Thirumalai et al., 2019; Wu et al., 2019; Yuen et al., 2020). The first male oral contraceptive pills to be marketed may end up containing dimethandrolone and/or 11β-MNT.

    Pharmacology of Nandrolone

    Androgenic Activity and 5α-Reductase

    Nandrolone is an agonist of the androgen receptor (AR) similarly to testosterone. It shows higher affinity for the AR than does testosterone and has almost no binding affinity for sex hormone-binding globulin (SHBG) however. For these reasons, nandrolone has about 2.5- to 5-fold higher potency than testosterone in rats on measures of general AR agonistic strength, such as stimulation of muscle growth (Sundaram et al., 1995; Tóth & Zakár, 1986; Wiki; Winters, 1976). It is likewise a more potent AAS than testosterone in humans, and is used medically at lower doses in comparison (Wiki).

    Testosterone is a substrate for 5α-reductase in tissues that express this enzyme like skin, hair follicles, prostate gland, and seminal vesicles, among others. It is converted by 5α-reductase into dihydrotestosterone (DHT), an androgen with much higher AR affinity and AR agonistic potency than that of testosterone (Wiki). Consequently, it is estimated that the effects of testosterone are potentiated by 2- to 3-fold via conversion into DHT in tissues that express 5α-reductase (Sundaram et al., 1995). The role of DHT in the effects of testosterone is demonstrated by a rare intersex condition known as 5α-reductase type 2 deficiency, as well as by 5α-reductase inhibitors (5α-RIs) like finasteride and dutasteride (Wiki; Wiki). Men with 5α-reductase type 2 deficiency are reported to have reduced facial hair, a female-like pattern of body hair (with terminal hair largely restricted to the underarms and lower pubic triangle), and no scalp hair recession in the temples nor scalp hair loss in general. Conversely, other aspects of male secondary sexual development, like voice deepening, muscle growth, bone changes, and pubertal penile enlargement, are all normal in the condition. In addition, no feminization or gynecomastia occurs. Hence, adults with 5α-reductase type 2 deficiency have a masculine appearance (Imperato-McGinley & Peterson, 1976; Peterson et al., 1977; Photos). In published photographs of individuals with the condition however, features like lack of body hair and rounded feminine hairlines can be noted.

    5α-Reductase inhibitors have similar effects relative to the profile of 5α-reductase type 2 deficiency. For this reason, they are used in the treatment and prevention of scalp hair loss in men and off-label for hirsutism (excessive facial/body hair growth) in women. They greatly slow the rate of scalp hair loss over time in men. For example, a large 5-year randomized controlled trial showed that in men with diagnosed scalp hair loss, 100% of those who received placebo had significant further scalp hair loss whereas only 35% of those who received finasteride had further scalp hair loss (Propecia label). Low-quality evidence suggests that finasteride has similar effectiveness to antiandrogens like spironolactone and flutamide in the treatment of hirsutism in women (Barrionuevo et al., 2018; van Zuuren et al., 2015). Dutasteride has similar or greater effectiveness than finasteride for scalp hair loss in men (Arif et al., 2017), whereas it hasn’t yet been studied in the treatment of hirsutism (Wiki).

    5α-Reductase is the key to the favorable differences between testosterone and nandrolone. Both testosterone and nandrolone are substrates for 5α-reductase and have similar affinity for this enzyme (Tóth & Zakár, 1986). But whereas testosterone is potentiated via conversion into DHT in tissues that express 5α-reductase, nandrolone is inactivated by 5α-reductase in these tissues (Kicman, 2008; Tóth, 2009). This is because the 5α-reduced metabolite of nandrolone, 5α-dihydronandrolone (DHN), is a weaker AR agonist with much lower affinity for the AR than nandrolone (Tóth & Zakár, 1986; Kumar et al., 1999). The following table shows AR and SHBG relative binding affinities (RBA) of testosterone, nandrolone, trestolone, and their 5α-reduced forms (Kumar et al., 1999):

    SteroidAR RBASHBG RBA
    Testosterone100%100%
    5α-Dihydrotestosterone290%340%
    Nandrolone230%5%
    5α-Dihydronandrolone10%5%
    Trestolone380%6%
    5α-Dihydrotrestolone30%2%

    In rodents, although nandrolone has about 3-fold higher anabolic or muscle-stimulating potency than testosterone, its androgenic potency in the prostate gland and seminal vesicles is only about 20 to 40% of that of testosterone (Sundaram et al., 1995; Tóth & Zakár, 1986; Wiki). This works out to an approximate 11:1 dissociation between the effects of nandrolone in tissues with little or no 5α-reductase (muscle) versus with high 5α-reductase (prostate gland, seminal vesicles) in rodents (Wiki). The exact ratio of potency between these tissues in humans is unknown, and extrapolation from rodents should be cautioned against. In any case, an analogous dissociation of some level can be anticipated. As such, nandrolone can be expected to have high AR agonistic strength in most of the body, where 5α-reductase has minimal expression (e.g., fat, muscle, bone), but much lower potency in tissues with high 5α-reductase expression, like skin, hair follicles, the prostate gland, and the seminal vesicles.

    It’s important to be clear that nandrolone is not simply akin to taking testosterone with a 5α-reductase inhibitor like dutasteride to block 5α-reductase. This is because nandrolone isn’t merely not potentiated by 5α-reductase, it’s weakened by 5α-reductase. For this reason, 5α-reductase inhibitors actually increase the androgenic strength of nandrolone in tissues that express 5α-reductase like the prostate gland in rodents (Sundaram et al., 1995). (And, for this reason, nandrolone should not be taken with a 5α-reductase inhibitor, in contrast to testosterone.) In other words, nandrolone goes beyond testosterone plus a 5α-reductase inhibitor in terms of the dissociation of its potency between tissues that express 5α-reductase and tissues that do not. As a result, nandrolone has much lower androgenic strength in such tissues than does the combination of testosterone plus a 5α-reductase inhibitor. Nandrolone also appears to have lower strength in tissues that express 5α-reductase than do most other AAS, for instance synthetic DHT derivatives like oxandrolone and stanozolol (Tóth & Zakár, 1986). This is because these AAS are not substrates for 5α-reductase and hence are neither potentiated nor weakened by 5α-reductase, similarly to testosterone with a 5α-reductase inhibitor. The inactivation of nandrolone by 5α-reductase makes it very unique among AAS and AR agonists. Only nandrolone and a few of its derivatives like normethandrone and norethandrolone have this very special property.

    Testosterone and nandrolone may also be non-identical in their androgenic actions and effects for reasons other than metabolism. This is because different AR agonists including strong androgens like testosterone and DHT, weak androgens like dehydroepiandrosterone (DHEA) and androstenedione (A4), and predominantly anabolic androgens like nandrolone, oxandrolone, and stanozolol, have been shown to produce differential AR-mediated changes in gene expression (Holterhus, Piefke, & Hiort, 2002; Kicman, 2008; Hiort, 2013). However, nandrolone was more similar in its profile to testosterone than the synthetic AAS. In any case, the clinical implications of these differences in relation to therapeutic use of testosterone versus nandrolone, if any, are unknown.

    Estrogenic Activity and Estradiol Replacement

    Testosterone is aromatized in small amounts into estradiol, and for this reason, testosterone has estrogenic activity. This is important as estradiol is critical for maintaining healthy bone mineral density in men (and hence preventing bone loss and osteopenia/osteoporosis) and also has many other important physiological effects in men (Simpson & Jones, 2007; Wibowo, Schellhammer, & Wassersug, 2011; Cooke et al., 2017; Russell & Grossmann, 2019). It may have positive effects on sexual desire in men as well (Wibowo & Wassersug, 2013). As such, all men need some estradiol.

    In relation to the fact that nandrolone is an intermediate in the aromatase-mediated reaction that converts testosterone into estradiol, both testosterone and nandrolone are transformed into estradiol, and hence estradiol is their specific estrogen metabolite. Paradoxically however, whereas it has the same potential for 5α-reduction as testosterone, nandrolone as a medication is aromatized into estradiol virtually not at all (Handelsman, 2016). In accordance, nandrolone suppresses estradiol levels in men and results in low estradiol levels even at very high doses (Friedl, 1991; Hobbs et al., 1993; Hobbs, Jones, & Plymate, 1996; Behre et al., 2001). The following table gives an example of estradiol (E2) levels in men with high-dose testosterone versus high-dose nandrolone (Friedl, 1991):

    Drug and doseE2 beforeE2 afterChange
    Testosterone enanthate 300 mg/week i.m.32 ± 4.6 pg/mL79 ± 9.3 pg/mL+147%
    Nandrolone decanoate 300 mg/week i.m.40 ± 6.0 pg/mL14 ± 1.6 pg/mL–65%

    Testosterone and nandrolone themselves don’t have significant affinity for the estrogen receptors nor intrinsic estrogenic activity outside of aromatization to estradiol (Kuiper et al., 1997; Table). Although androgens also help to maintain bone mineral density and AAS like nandrolone are used to treat osteoporosis in postmenopausal women (Geusens, 1995; Ebeling, 2010), estrogens are comparatively much more important for maintenance of bone mineral density and prevention of osteoporosis in both men and women (Wiki). Studies of high-dose nandrolone and androstanolone (DHT) have shown that these non-aromatizable AAS are not adequate for maintenance of bone mineral density in men, whereas the aromatizable testosterone is effective for such purposes (Ronald et al., 1998; Crawford et al., 2003; Lemmey et al., 2013; Sartorius, Ly, & Handelsman, 2014; Čeponis et al., 2017). Non-aromatizable AAS are likewise inferior to estrogen and estrogen–progestogen therapy for maintaining bone mineral density in postmenopausal women (Lauritzen, 1984 [Graph]; Hassager et al., 1991).

    Because of its minimal conversion into estradiol, nandrolone should be used as an androgen in transmasculine people only in combination with low-dose estradiol to replace the lost estradiol that would otherwise be provided by testosterone. Estradiol levels in men are on average around 30 pg/mL, and estradiol levels of at least 20 to 30 pg/mL appear to be necessary for maintenance of bone density in men (Doran et al., 2001). A low-dose transdermal estradiol patch, for instance 14 to 25 μg/day, is likely to be adequate for achieving such levels. Alternatively, another option like transdermal estradiol gel (e.g., 0.75–1 mg/day) or low-dose oral estradiol (e.g., 0.5–1 mg/day) may be used instead.

    Progestogenic Activity

    A little-known fact about testosterone is that it has weak affinity for the progesterone receptor (PR) and is a weak progestogen (Wiki; Bardin & Janne, 1986). This property probably has no significance under normal physiological circumstances, but testosterone can in any case produce progestogenic effects such as endometrial transformation and progesterone-like lobuloalveolar development of the breasts at very high doses (Bourg, 1950; Bässler, 1970; Jänne et al., 1978; Bardin & Janne, 1986).

    Nandrolone likewise has progestogenic activity. However, the progestogenic activity of nandrolone is greatly enhanced relative to that of testosterone. The affinity of nandrolone for the PR is 5- to 20-fold higher than that of testosterone and its progestogenic potency is correspondingly improved (Wiki; Wiki; Bardin & Janne, 1986). Despite this however, the progestogenic potency of nandrolone is still relatively low. For instance, its affinity for the PR is only about 10 to 20% of that of progesterone and the nandrolone-derived progestin norethisterone (also known as 17α-ethynyl-19-nortestosterone). At the same time however, nandrolone is used at relatively large doses compared to norethisterone. This may help to compensate for its lower progestogenic potency and may allow for significant progestogenic effects at typical clinical doses (Camerino & Sciaky, 1975).

    The following table shows human and rabbit PR RBAs and relative progestogenic activity (as measured by in-vivo induction of uteroglobin synthesis in rabbit uterus) of progesterone and several AAS including testosterone and nandrolone (Jänne et al., 1978; Bardin & Janne, 1986):

    SteroidhPR RBArbPR RBAProgestogenic activity (rabbit)
    Progesterone100%100%100%
    Testosterone1.6%1.6%0.9%
    Dihydrotestosterone3.3%3.3%1.9%
    Nandrolone8.9%12%5.2%
    Methyltestosterone4.6%3.4%0.6%
    Norethandrolone130%70%115%

    The development of nandrolone was an intermediate step in the eventual development of the 19-nortestosterone group of progestins, which are widely used in hormonal birth control. These include progestins like norethisterone and levonorgestrel, among many others.

    Advantages of Nandrolone Over Testosterone

    Because of its substantially lower androgenic strength in tissues that have high 5α-reductase expression relative to tissues that have minimal or no 5α-reductase expression, nandrolone is likely to have normal androgenic effects in muscle, bone, fat, and most other tissues but much weaker androgenic strength in skin and hair follicles than equivalent doses of testosterone. As a result of this, although nandrolone has high capacity for producing most aspects of masculinization, it has a lower potential for many of the undesirable androgenic skin and hair side effects of testosterone, including oily skin, acne, facial and body hair growth, and scalp hair loss. This may allow for unique advantages of nandrolone over testosterone in transfeminine and transmasculine hormone therapy.

    The benefits of nandrolone are expected to partially differ in transfeminine people relative to transmasculine people however. This is due to the different doses of nandrolone used in these individuals, namely low, female replacement doses in transfeminine people and full, male replacement doses in transmasculine people. As an example, transmasculine people taking full male androgen replacement doses should probably expect no less oily skin or acne with nandrolone than with testosterone. This is because very low levels of testosterone are necessary for such effects, as evidenced by the fact that acne prevalence and severity is similar in females compared to males (Skroza et al., 2018) despite the fact that testosterone levels are 20-fold lower in women than in men (Styne & Grumbach, 2016). Conversely, transfeminine people taking nandrolone at doses equivalent to the effect of testosterone levels in the normal female range may experience less or possibly no oily skin or acne with nandrolone compared to use of testosterone instead. This is due to the equivalent testosterone levels being far closer to the biological threshold for manifestation of such effects.

    Nandrolone can be anticipated to have far less potential for scalp hair loss relative to testosterone in transmasculine people (Wu & Kovac, 2016; Pan & Kovac, 2016). This is related to the lack of scalp hair loss in men with 5α-reductase type 2 deficiency and the high effectiveness of 5α-reductase inhibitors for scalp hair loss. However, nandrolone is theoretically even better than testosterone plus a 5α-reductase inhibitor when it comes to preservation of scalp hair. This is because again, nandrolone is not simply not potentiated, but is inactivated in tissues that express 5α-reductase. Nandrolone replacement of testosterone represents a highly promising treatment for scalp hair loss in men that offers potentially superior effectiveness to 5α-reductase inhibitors. Moreover, since nandrolone isn’t an inhibitor of 5α-reductase, it doesn’t interfere with 5α-reduced neurosteroid synthesis. Hence, nandrolone doesn’t have the possible psychiatric side effects that have been associated with 5α-reductase inhibitors, for instance depression (Irwig, 2015; Kuhl & Wiegratz, 2017; Wiki).

    On the basis of 5α-reductase type 2 deficiency, nandrolone may be expected to produce reduced facial and particularly body hair growth relative to testosterone in transmasculine people. Essentially no body or facial hair growth is likely to occur with nandrolone at doses equivalent to female-range testosterone levels in transfeminine people, and even at supraphysiological levels, facial and body hair growth is likely to be less than with testosterone. However, facial and body hirsutism have nonetheless been reported with nandrolone at postmenopausal osteoporosis doses (Need et al., 1989; Passeri et al., 1993; Geusens, 1995; Flicker et al., 1997).

    For transmasculine people who want the benefits of nandrolone except the lesser facial hair growth, topical testosterone to the beard area can potentially be used in conjunction with nandrolone injections to restore full facial hair growth. Another possibility for achieving effects of both testosterone and nandrolone in transmasculine people could be to start on testosterone and use it for a few years, allowing for facial/body hair growth and hairline masculinization, and then switch from testosterone to nandrolone for long-term therapy, allowing for preservation of scalp hair.

    One of the reasons that nandrolone is attractive for androgen replacement therapy in cisgender men is that it has very weak relative effects in the prostate gland compared to testosterone. This is due to inactivation of nandrolone in the prostate gland by 5α-reductase similarly to other tissues that express this enzyme. It is anticipated that long-term androgen replacement therapy with nandrolone might allow for a reduced risk of enlarged prostate and prostate cancer compared to testosterone in men (Wu & Kovac, 2016; Pan & Kovac, 2016). As transfeminine people also have prostate glands, the weak effects of nandrolone in the prostate are potentially of relevance to us as well. However, due to estrogen therapy and androgen deprivation, the prostate is atrophied in transfeminine people and prostate cancer is very rare (Wiki). In relation to this, the favorable prostate profile of nandrolone may be of little significance for transfeminine people.

    Although nandrolone is quite promising for transgender hormone therapy, it is important to be clear that there are currently no quality clinical studies comparing it to testosterone and showing that it is less androgenic in terms of skin and hair effects (even if there is strong theoretical basis for this notion, particularly in the case of scalp hair loss). Nor are there any studies demonstrating with certainty that it is as effective as testosterone in terms of inducing general masculinization. Moreover, the appropriate dosages of nandrolone for use in androgen replacement in women and men are uncertain. Finally, nandrolone has been little-studied for androgen replacement and its long-term tolerability and health safety for this use haven’t been properly characterized. For these reasons, androgen replacement with nandrolone in cisgender men and transmasculine people is an experimental therapy. Additional research is needed to properly characterize nandrolone for this indication.

    Androgen Replacement in Transfeminine People

    Some believe that testosterone is important in women for mood, well-being, energy, sexual desire and function, general health, and for other reasons. Androgen levels and activity may be low in many transfeminine people due to hormone therapy and/or gonadectomy, raising concerns about androgen deficiency. However, there is little or no change in androgen levels with natural menopause in cisgender women and only a small decrease in androgen levels with ovariectomy in women (Liu & Handelsman, 1998). Moreover, there is inadequate evidence to support claims of benefit with androgen replacement therapy in women at present, and there are no well-supported benefits of female-range doses of testosterone (Wiki). For these reasons, androgen replacement therapy in women is controversial (Liu & Handelsman, 1998).

    Testosterone does stimulate sexual desire in women, but only at levels that are above the normal female range (>50 ng/dL) (Cappelletti & Wallen, 2016; Wiki). And even with high testosterone levels of 80 to 150 ng/dL, stimulation of sexual desire in women is modest (Cappelletti & Wallen, 2016; Wiki). It is likely that estradiol rather than testosterone (or progesterone) is the key sex hormone for sexual desire in women (Cappelletti & Wallen, 2016; Aly, 2020).

    Androgens can have detrimental effects in transfeminine people. They can cause androgenic and masculinizing effects like oily skin, acne, seborrhea, facial/body hair growth, scalp hair loss, and voice deepening, among others. In addition, androgens oppose the effects of estrogens in the breasts, and may inhibit breast development even with low-level exposure or physiological levels in females (Dimitrakakis et al., 2003; Peters et al., 2011; Sas et al., 2014; Barbieri, 2017).

    For these reasons, transfeminine people don’t necessarily require androgen replacement, and it shouldn’t be routinely used out of concern of androgen deficiency. In any case, some transfeminine people insist on androgen replacement, and others desire supraphysiological levels of androgens for purposes like stimulating libido or helping to build and maintain muscle mass. There is some evidence that even physiological levels of testosterone may help to support muscle mass in women (Huang & Basaria, 2017). Moreover, in transfeminine people who are fully hormonally transitioned, breast development is complete, and hence inhibition of the breasts by androgens is no longer a concern. Another potentially useful indication of androgens in transfeminine people is to counteract cellulite (Wiki; Gruber et al., 2002; Avram, 2004). Since nandrolone has full androgenic potential in fat tissue, it may be similarly effective as testosterone for this purpose. However, there are no good studies of androgens for treatment of cellulite at this time.

    Although androgen replacement therapy isn’t recommended for cisgender women or transfeminine people because of a lack of evidence of benefit and potential adverse effects, nandrolone is a very favorable alternative to testosterone for such purposes in those who nonetheless opt for such therapy. This is due to its improved skin and hair profile and hence a probable lower risk of undesirable effects.

    Additional Topics on Nandrolone

    This section is for additional topics on nandrolone as an androgen in transfeminine and transmasculine people, including its availability, dosage, androgenic/masculinizing effects besides skin and hair (e.g., voice deepening, bottom growth/clitoral enlargement, sexual effects), and liver safety.

    Availability of Nandrolone

    Nandrolone esters remain widely available for medical use throughout the world (Drugs.com). However, the availability of AAS, including nandrolone esters, has become increasingly limited over time. The shorter-acting ester nandrolone phenylpropionate is no longer available in the United States or many other countries, and the more favorable longer-acting nandrolone decanoate was discontinued in the United States in 2019. However, nandrolone decanoate remains available from compounding pharmacies in the United States, for instance AnazaoHealth. It is only available from this particular pharmacy at a very high concentration of 200 mg/mL however, which although a potentially workable concentration for use in transmasculine people, is likely completely impractical for use in transfeminine people. Compounding pharmacies might be able to do custom concentrations upon request though.

    Another potential means of delivering nandrolone is via an orally active nandrolone androgen prohormone like 19-nordehydroepiandrosterone (19-nor-DHEA). This compound is converted into nandrolone analogously to the use of DHEA as a prohormone of testosterone (Wiki). It is sold as an over-the-counter supplement from certain online vendors, similarly to DHEA. 19-Nor-DHEA may be a more suitable option for transfeminine people due to the lower doses needed and less suitable for transmasculine people due to the much higher doses required.

    Dosage of Nandrolone

    The dosage of nandrolone for use in androgen replacement therapy in women and men hasn’t been established. Hence, we don’t completely know what the appropriate dose is for use in transfeminine and transmasculine hormone therapy. In any case, it is possible for us to estimate.

    Nandrolone is closely related to testosterone but is roughly 3-fold more potent in rodents (Tóth & Zakár, 1986). We’re not sure how much more potent nandrolone is in humans in comparison. Some clinical studies comparing nandrolone and testosterone have been conducted but we nonetheless don’t have exact figures at this time (Neff et al., 1981; Friedl et al., 1989; Friedl, 1991; Hobbs et al., 1993; Hobbs, Jones, & Plymate, 1996; Crawford et al., 2003; Gold et al., 2006; Sardar et al., 2010). In any case, 150–200 mg/2 weeks nandrolone decanoate i.m. resulted in changes in body composition that were about twice as large as those of 200–250 mg/2 weeks testosterone esters i.m. in men with wasting conditions (Crawford et al., 2003; Gold et al., 2006; Sardar et al., 2010). The findings of these studies are roughly in line with 3-fold greater potency of nandrolone relative to testosterone.

    One review recommended a clinical dose range in males of 50–400 mg/2–4 weeks for testosterone enanthate or cypionate but 50–100/3–4 weeks for nandrolone decanoate (Hickson et al., 1989). This is also in line with several-fold higher potency of nandrolone relative to testosterone.

    Dosage for Transmasculine People

    A typical dosage of testosterone enanthate for use in androgen replacement therapy in cisgender and transgender men is 50 to 100 mg once per week by intramuscular injection (Wiki; Wiki). Hence, an appropriate dosage of nandrolone decanoate, assuming 3-fold greater potency than testosterone, might be about 16.7 to 33.3 mg once per week by intramuscular injection (ignoring the small differences in molecular weight between testosterone enanthate and nandrolone decanoate). However, it must be emphasized that these doses are merely educated guesses. It’s notable that these doses are quite similar to those used in postmenopausal osteoporosis in women (about 12.5 to 25 mg per week total). Hence, although such doses have certainly been associated with masculinizing effects in women, they might be suboptimal in terms of masculinization for transmasculine people. Consequently, it’s possible that a higher dose, like 50 mg once per week, might be more appropriate. In addition to weekly use, nandrolone decanoate has a duration suitable for use once every 2 weeks (Graphs).

    Nandrolone hexyloxyphenylpropionate (NHPP; brand name Anadur) was studied as a male hormonal contraceptive by the World Health Organization and others at a dose of 200 mg/3 weeks i.m. in combination with depot medroxyprogesterone acetate (Knuth et al., 1986; Nieschlag, 2010; Nieschlag & Behre, 2012). It was used as a replacement and alternative for testosterone and was given at a dosage of about 66.7 mg once per week. However, this was an intentionally supraphysiological dosage which was selected to achieve a male contraceptive effect, as suggested by suppression of gonadotropins to undetectable levels (Knuth et al., 1985). Hence, although safe and well-tolerated in limited studies, it might be a high dosage for transmasculine hormone therapy. Very high doses of nandrolone can reproduce the full spectrum of androgenic effects of testosterone, and hence doses of nandrolone that are too high may serve to nullify its advantages over testosterone (van der Vies, 1985).

    Dosage for Transfeminine People

    In postmenopausal women, nandrolone decanoate has been used for general androgen replacement at a dose of 25 to 50 mg once every 6 to 12 weeks (about 2–8 mg/week or 0.29–1.14 mg/day), and for prevention and treatment of osteoporosis at a dose of 50 mg once every 2 to 4 weeks (about 12.5–25 mg/week or 1.8–3.6 mg/day) (Wiki; Table). However, these doses of nandrolone decanoate are likely to be highly excessive for physiological androgen replacement in women and transfeminine people and are probably also spaced too widely in terms of dosing interval. This is based on the following: (1) normal production of testosterone in premenopausal women is about 150 μg/day; (2) nandrolone is more potent as an androgen receptor agonist than testosterone; and (3) pharmacokinetic concentration–time curves for nandrolone decanoate suggest that an appropriate dosing interval is once every 1 to 2 weeks (Graphs). Indeed, nandrolone decanoate at 50 mg/2–4 weeks has been found to produce significant masculinizing effects in women with long-term use (Geusens, 1995; Wiki). Since nandrolone has high theoretical masculinizing potential in most tissues in the body, like muscle, bone, fat, and vocal tissue, it’s very important that transfeminine people don’t take doses that are too large.

    Androgenic and Masculinizing Effects Besides Skin and Hair

    Nandrolone has sometimes been described as “non-masculinizing” or “minimally virilizing”, but this is misleading and inaccurate. Nandrolone has high theoretical potential to produce masculinizing skeletal, fat, and muscular effects, like growth of muscles, widening of shoulders, masculine enlargement, elongation, and shaping of bones, and masculine distribution of fat. It also has high capacity to produce voice deepening (the vocal tissue notably being part muscle). The only clear differences in masculinizing effect between nandrolone and testosterone are that nandrolone has a greatly reduced theoretical potential for androgenic effect in skin and hair follicles. Succinctly, nandrolone could be thought of as testosterone with minimization of the undesirable skin and hair effects.

    Voice Deepening with Nandrolone

    The vocal tissue, consisting of the vocal cords and the larynx, are part muscle, and 5α-reductase is expressed minimally or not at all in this tissue (Bhagavan, 2002; Kicman, 2008). Accordingly, voice deepening is normal in individuals with 5α-reductase type 2 deficiency (Imperato-McGinley & Zhu, 2002). As such, nandrolone would be expected to produce voice deepening similarly to testosterone. In accordance, voice deepening has been reported with nandrolone in women at doses used in postmenopausal osteoporosis (Gerritsma et al., 1994; Geusens, 1995; Frisoli et al., 2005). There are case reports of severe and complete masculinization of the voice in women treated with excessive doses of nandrolone (Damsté, 1964; Brodnitz, 1971; Baker, 1999). Voice changes have also been seen with nandrolone derivatives like normethandrone (Feldman et al., 1960).

    Bottom Growth with Nandrolone

    DHT is required for normal male sexual differentiation of the genitals during prenatal development. This is evidenced by 5α-reductase type 2 deficiency, in which the genitals are ambiguous but overall more female-like at birth and in childhood (Wiki). Although DHT is critical for prenatal genital masculinization, the same may not be true for pubertal development of the penis (Hiort, 2013). Individuals with 5α-reductase type 2 deficiency undergo masculinization of the genitals at puberty such that a small and near-functional penis develops (Peterson et al., 1977; Marks, 2004; Hiort, 2013; Photos). This is so striking that males with 5α-reductase type 2 deficiency in the Dominican Republic are referred to as “guevedoces”, which is said to literally mean “penis at 12”.

    As 5α-reductase may not be critical for penile enlargement at puberty, nandrolone may allow for no less bottom growth (clitoral enlargement) in transmasculine people than does testosterone. Indeed, nandrolone has been reported to produce clitoral enlargement as a side effect in women and penile growth in prepubertal boys (Camerino & Sala, 1960; Camerino & Sciaky, 1975). Similar findings have been made for derivatives of nandrolone like normethandrone and norethandrolone (Feldman et al., 1960; Roche, Towns, & Wettenhall, 1963; Kirschvink et al., 1963; Prunty et al., 1958).

    Sexual Effects of Nandrolone

    Libido is normal in men with 5α-reductase type 2 deficiency (Imperato-McGinley & Zhu, 2002; Azzouni et al., 2012) and 5α-reductase inhibitors have only a small negative effect on sexual desire and function in men (Trost, Saitz, & Hellstrom, 2013; Mella et al., 2010; Hirshburg et al., 2016). Accordingly, nandrolone has been shown to maintain sexual function in men similarly to testosterone (Schürmeyer et al., 1984; Knuth et al., 1985; Knuth et al., 1986; Knuth et al., 1989; Behre et al., 1992; WHO, 1993; Behre et al., 2001). This has included libido, erection frequency, erectile function, and sexual activity. Trestolone has also been shown to maintain sexual desire and function in men similarly to testosterone (Suvisaari, 2000; Anderson et al., 1999; Anderson et al., 2003). In addition, use of trestolone for the treatment of breast cancer in women stimulated libido to such an extent that many of the women felt uncomfortable and chose to discontinue it (Suvisaari, 2000).

    Liver Safety of Nandrolone

    Nandrolone is not a 17α-alkylated steroid. Hence, unlike most orally used synthetic AAS like methyltestosterone, stanozolol, and oxandrolone, but similarly to testosterone, nandrolone has no risk of the liver toxicity associated with 17α-alkylated AAS (Handelsman, 2016).

    Updates

    Update 1: Cocchetti et al. (2020)

    Since this article was published, a review suggesting nandrolone as a potential component of transgender hormone therapy for non-binary individuals has been published:

    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]

    The review includes the following excerpts on nandrolone:

    Other options may include nandrolone, an anabolic steroid administered via intramuscular injection, which is not as optimal a substrate for 5α-reductase as testosterone, but it has a stronger effect compared to the testosterone on target tissues devoid of 5α-reductase activity (e.g., muscular tissue) [15]. Indeed, nandrolone can be theoretically used in non-binary [assigned female at birth (AFAB)] individuals requesting masculinization of body shape (i.e., increased muscle mass) with a limited increase in facial and body hair. Regarding the safety profile of this compound, data are limited by the fact that most observations come from the setting of androgenic-anabolic steroid (AAS) abuse [16,17], thus their applicability to appropriate medical therapy is limited [18]. In this setting, concerns about cardiomyopathy and coronary artery disease risk emerged [19], although associated with the administration of nandrolone at extremely higher dosages [20]. Furthermore, nandrolone use does not seem associated to hepatotoxicity, since, as an injectable oil, it is not subject to first-pass hepatic metabolism.

    Moreover, some AFAB transgender individuals can benefit from testosterone therapy combined with 5α-reductase inhibitors or from treatment with nandrolone (an androgenic compound less prone to 5α reduction) in case they wish only a partial virilization (i.e., voice deepening and lean mass increase without facial and body hair increase).

    These researchers are at the Florence University Hospital in Italy and are notably part of the European Network for the Investigation of Gender Incongruence (ENIGI).

    Update 2: Vetri et al. (2021) [Preprint]

    In addition to the above review, a second review suggesting nandrolone as a potential option for hormone therapy in non-binary individuals has been published (as a preprint):

    • Vetri, M., Cataldi, A., Naselli, A., & Vetri, A. (2021). Transsexualism Ethiology and Medical Management: Between Scientific Evidence and Personal Experiences. Preprints, 2021030172. [DOI:10.20944/preprints202103.0172.v1]:

    With the following relevant excerpt:

    In [female-to-males] (FtMs) requesting partial masculinization, it may be possible to reduce the dose of testosterone or substitute it with nandrolone, an anabolic steroid administered via intramuscular injection. So, we must accept alternative hormonal treatment regimens, other than those reported in current guidelines, for such nonbinary transgender individuals, to try to improve their psychological well-being and quality of life [40].

    However, this preprint article appears to have never ended up being accepted for publication.

    Update 3: Cocchetti et al. (2020) and Iuliano et al. (2021)

    Further articles have mentioned nandrolone as a hypothetical option for transgender people, for instance Cocchetti et al. (2020):

    Another hypothetic option [for management of hypoactive sexual desire disorder in transgender women] may include nandrolone, an androgenic compound administered via intramuscular injection, less prone to 5-alpha reduction anabolic steroid leading to limited virilizing dermatological undesired effects [72]. However, data on its efficacy on sexual desire are not yet available.

    And Iuliano et al. (2021):

    Actually, the classic view of gender binarism and [gender-affirming hormone therapy (GAHT)] should be reconsidered because of the increasing prevalence of non-binary individuals experiencing [gender dysphoria (GD)]. Therefore, new therapeutic strategies should be also considered [17]. Since there is a lack in standardized hormonal treatment protocols for non-binary [assigned female at birth (AFAB)], GAHT goals should be adjusted according to patients’ needs in order to improve the self-perception and the quality of life [18]. For instance, different testosterone doses and/or other androgen preparations (i.e., nandrolone) are suggested to modulate the requested body changes [18], even if serious ethical concerns on some drugs exist.

    References

    • Anderson, R. A., Martin, C. W., Kung, A. W., Everington, D., Pun, T. C., Tan, K. C., Bancroft, J., Sundaram, K., Moo-Young, A. J., & Baird, D. T. (1999). 7α-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3556–3562. [DOI:10.1210/jcem.84.10.6028]
    • Anderson, R. A., Wallace, A. M., Sattar, N., Kumar, N., & Sundaram, K. (2003). Evidence for Tissue Selectivity of the Synthetic Androgen 7α-Methyl-19-Nortestosterone in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism, 88(6), 2784–2793. [DOI:10.1210/jc.2002-021960]
    • Arif, T., Dorjay, K., Adil, M., & Sami, M. (2017). Dutasteride in Androgenetic Alopecia: An Update. Current Clinical Pharmacology, 12(1), 31–35. [DOI:10.2174/1574884712666170310111125]
    • Avram, M. M. (2004). Cellulite: a review of its physiology and treatment. Journal of Cosmetic and Laser Therapy, 6(4), 181–185. [DOI:10.1080/14764170410003057]
    • Azzouni, F., Godoy, A., Li, Y., & Mohler, J. (2012). The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases. Advances in Urology, 2012 (Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back), 530121. [DOI:10.1155/2012/530121]
    • Baker, J. (1999). A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents. Journal of Voice, 13(4), 496–507. [DOI:10.1016/s0892-1997(99)80005-8]
    • Barbieri, R. L. (2019). Breast. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 248–255.e3). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/B978-0-323-47912-7.00010-X]
    • Bardin, C. W., & Janne, O. A. (1986). Steroids of One Class Can Mimic, Inhibit and Potentiate the Biological Effects of Other Steroid Classes When Administered at High Doses. In Gregoire, A. T., & Blye, R. P. (Eds.). Contraceptive Steroids: Pharmacology and Safety (pp. 123–143). Boston, MA: Springer US. [DOI:10.1007/978-1-4613-2241-2_6]
    • Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1258–1264. [DOI:10.1210/jc.2017-02052]
    • Bässler, R. (1970). The Morphology of Hormone Induced Structural Changes in the Female Breast. In Altmann, H.-W., et al. (Eds.). Current Topics in Pathology: Ergebnisse der Pathology, Volume 53 (pp. 1–89). Heidelberg: Springer Berlin. [DOI:10.1007/978-3-662-30514-0_1] [PDF]
    • Behre, H. M., Nashan, D., Hubert, W., & Nieschlag, E. (1992). Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. The Journal of Clinical Endocrinology & Metabolism, 74(1), 84–90. [DOI:10.1210/jcem.74.1.1727833]
    • Behre, H., Kliesch, S., Lemcke, B., von Eckardstein, S., & Nieschlag, E. (2001). Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. Human Reproduction, 16(12), 2570–2577. [DOI:10.1093/humrep/16.12.2570]
    • Bhagavan, N. V. (2002). Endocrine Metabolism V: Reproductive System. In Bhagavan, N. V. Medical Biochemistry, 4th Edition (pp. 781–801). San Diego: Harcourt/Academic Press. [Google Books] [WorldCat]
    • Bourg, R. (1950). Activité sécrétrice des glandes mammaires; consécutive a des doses massives de testostérone chez la femme après castration. [Secretory activity of the mammary glands; sequellae of massive testosterone doses in women following castration.] Annales d’Endocrinologie, 11(3), 254–260. [Google Scholar] [PubMed] [PDF]
    • Bricout, V., & Wright, F. (2004). Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances? European Journal of Applied Physiology, 92(1–2), 1–12. [DOI:10.1007/s00421-004-1051-3]
    • Brodnitz, F. S. (1971). Hormones and the human voice. Bulletin of the New York Academy of Medicine, 47(2), 183–191. [Google Scholar] [PubMed] [PubMed Central]
    • Buvat, J., Maggi, M., Guay, A., & Torres, L. O. (2013). Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment. The Journal of Sexual Medicine, 10(1), 245–284. [DOI:10.1111/j.1743-6109.2012.02783.x]
    • Camerino, B., & Sala, G. (1960). Anabolic Steroids. In Jucker, E. (Ed.). Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des Recherches Pharmaceutiques, Volume 2 (pp. 71–134). Basel: Birkhäuser Basel. [DOI:10.1007/978-3-0348-7038-2_2]
    • Camerino, B., & Sciaky, R. (1975). Structure and effects of anabolic steroids. Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, 1(2), 233–275. [DOI:10.1016/0306-039x(75)90007-0]
    • Cappelletti, M., & Wallen, K. (2016). Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior, 78, 178–193. [DOI:10.1016/j.yhbeh.2015.11.003]
    • Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017). Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products. In Simoni, M., & Huhtaniemi, I. T. (Eds.). Endocrinology of the Testis and Male Reproduction (pp. 373–394). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-44441-3_11]
    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]
    • Cocchetti, C., Ristori, J., Mazzoli, F., Vignozzi, L., Maggi, M., & Fisher, A. D. (2020). Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. International journal of Impotence Research, 33(7), 703–709. [DOI:10.1038/s41443-021-00409-8]
    • Cooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017). Estrogens in Male Physiology. Physiological Reviews, 97(3), 995–1043. [DOI:10.1152/physrev.00018.2016]
    • Crawford, B. A., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003). Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment. The Journal of Clinical Endocrinology & Metabolism, 88(7), 3167–3176. [DOI:10.1210/jc.2002-021827]
    • Damsté, P. (1964). Virilization of the Voice due to Anabolic Stereoids. Folia Phoniatrica et Logopaedica, 16(1), 10–18. [DOI:10.1159/000262980]
    • Davis, S. (1999). The therapeutic use of androgens in women. The Journal of Steroid Biochemistry and Molecular Biology, 69(1–6), 177–184. [DOI:10.1016/s0960-0760(99)00054-0]
    • Dimitrakakis, C., Zhou, J., Wang, J., Belanger, A., LaBrie, F., Cheng, C., Powell, D., & Bondy, C. (2003). A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause, 10(4), 292–298. [DOI:10.1097/01.gme.0000055522.67459.89]
    • Doran, P. M., Riggs, B. L., Atkinson, E. J., & Khosla, S. (2001). Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men. Journal of Bone and Mineral Research, 16(11), 2118–2125. [DOI:10.1359/jbmr.2001.16.11.2118]
    • Drugs.com. International > Nandrolone. Drugs.com. [URL]
    • Ebeling, P. R. (2010). Androgens and osteoporosis. Current Opinion in Endocrinology, Diabetes & Obesity, 17(3), 284–292. [DOI:10.1097/med.0b013e328339658c]
    • Feldman, E. B., Carter, A. C., Kossa, J. L., McCarrick, J. F., & Schwartz, H. L. (1960). Endocrinologic and Metabolic Effects of 17α-Methyl-19-nortestosterone in Women. The Journal of Clinical Endocrinology & Metabolism, 20(6), 842–857. [DOI:10.1210/jcem-20-6-842]
    • Flicker, L., Hopper, J. L., Larkins, R. G., Lichtenstein, M., Buirski, G., & Wark, J. D. (1997). Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis. Osteoporosis International, 7(1), 29–35. [DOI:10.1007/bf01623456]
    • Friedl, K. E., Jones, R. E., Hannan, C. J., & Plymate, S. R. (1989). The Administration of Pharmacological Doses of Testosterone or 19-Nortestosterone to Normal Men is Not Associated with Increased Insulin Secretion or Impaired Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism, 68(5), 971–975. [DOI:10.1210/jcem-68-5-971]
    • Friedl, K. E., Dettori, J. R., Hannan, C. J., Patience, T. H., & Plymate, S. R. (1991). Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men. The Journal of Steroid Biochemistry and Molecular Biology, 40(4–6), 607–612, IN5–IN6. [DOI:10.1016/0960-0760(91)90283-b]
    • Frisoli, A., Chaves, P. H., Pinheiro, M. M., & Szejnfeld, V. L. (2005). The Effect of Nandrolone Decanoate on Bone Mineral Density, Muscle Mass, and Hemoglobin Levels in Elderly Women With Osteoporosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60(5), 648–653. [DOI:10.1093/gerona/60.5.648]
    • Gerritsma, E. J., Brocaar, M. P., Hakkesteegt, M. M., & Birkenhäger, J. C. (1994). Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year. Clinical Otolaryngology, 19(1), 79–84. [DOI:10.1111/j.1365-2273.1994.tb01153.x]
    • Geusens, P. (1995). Nandrolone decanoate: Pharmacological properties and therapeutic use in osteoporosis. Clinical Rheumatology, 14(S3), 32–39. [DOI:10.1007/bf02210686]
    • Gold, J., Batterham, M., Rekers, H., Harms, M., Geurts, T., Helmyr, P., Silva de Mendonca, J., Falleiros Carvalho, L., Panos, G., Pinchera, A., Aiuti, F., Lee, C., Horban, A., Gatell, J., Phanuphak, P., Prasithsirikul, W., Gazzard, B., Bloch, M., & Danner, S. (2006). Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Medicine, 7(3), 146–155. [DOI:10.1111/j.1468-1293.2006.00358.x]
    • Gruber, C. J., Wieser, F., Gruber, I. M., Ferlitsch, K., Gruber, D. M., & Huber, J. C. (2002). Current concepts in aesthetic endocrinology. Gynecological Endocrinology, 16(6), 431–441. [DOI:10.1080/gye.16.6.431.441]
    • Hamdy, R. C., Moore, S. W., Whalen, K. E., & Landy, C. (1998). Nandrolone Decanoate for Men With Osteoporosis. American Journal of Therapeutics, 5(2), 89–96. [DOI:10.1097/00045391-199803000-00006]
    • Handelsman, D. J. (2016). Androgen Physiology, Pharmacology, and Abuse. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition, Volume 2 (pp. 2368–2393.e16). Philadelphia: Saunders/Elsevier. [Google Books] [DOI:10.1016/B978-0-323-18907-1.00138-4]
    • Hassager, C., Jensen, L., Johansen, J., Riis, B., Melkko, J., Pødenphant, J., Risteli, L., Christiansen, C., & Risteli, J. (1991). The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: The effect of nandrolone decanoate and female sex hormones. Metabolism, 40(2), 205–208. [DOI:10.1016/0026-0495(91)90176-w]
    • Hickson, R. C., Ball, K. L., & Falduto, M. T. (1989). Adverse Effects of Anabolic Steroids. Medical Toxicology and Adverse Drug Experience, 4(4), 254–271. [DOI:10.1007/bf03259912]
    • Hiort, O. (2013). The differential role of androgens in early human sex development. BMC Medicine, 11(1), 152. [DOI:10.1186/1741-7015-11-152]
    • Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. The Journal of Clinical and Aesthetic Dermatology, 9(7), 56–62. [Google Scholar] [PubMed] [PubMed Central]
    • Hobbs, C. J., Plymate, S. R., Rosen, C. J., & Adler, R. A. (1993). Testosterone administration increases insulin-like growth factor-I levels in normal men. The Journal of Clinical Endocrinology & Metabolism, 77(3), 776–779. [DOI:10.1210/jcem.77.3.7690364]
    • Hobbs, C. J., Jones, R. E., & Plymate, S. R. (1996). Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. The Journal of Clinical Endocrinology & Metabolism, 81(4), 1582–1585. [DOI:10.1210/jcem.81.4.8636371]
    • Holterhus, P., Piefke, S., & Hiort, O. (2002). Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. The Journal of Steroid Biochemistry and Molecular Biology, 82(4–5), 269–275. [DOI:10.1016/s0960-0760(02)00220-0]
    • Huang, G., & Basaria, S. (2017). The Case for Androgens in Menopausal Women: When and How? In Pal, L., & Sayegh, R. A. (Eds.). Essentials of Menopause Management: A Case-Based Approach (pp. 173–196). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-42451-4_10]
    • Imperato-McGinley, J., & Peterson, R. E. (1976). Male pseudohermaphroditism: The complexities of male phenotypic development. The American Journal of Medicine, 61(2), 251–272. [DOI:10.1016/0002-9343(76)90175-3]
    • Imperato-McGinley, J., & Zhu, Y. (2002). Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Molecular and Cellular Endocrinology, 198(1–2), 51–59. [DOI:10.1016/s0303-7207(02)00368-4]
    • Irwig, M. S. (2015). Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia. Current Opinion in Endocrinology, Diabetes & Obesity, 22(3), 248–253. [DOI:10.1097/med.0000000000000158]
    • Iuliano, S., Izzo, G., Zagari, M. C., Vergine, M., Brunetti, F. S., Brunetti, A., Di Luigi, L., & Aversa, A. (2021). Endocrine management of transgender adults: a clinical approach. Sexes, 2(1), 104–118. [DOI:10.3390/sexes2010009]
    • Jänne, O., Hemminki, S., Isomaa, V., Kokko, E., Torkkeli, H., Torkkeli, T., & Vierikko, P. (1978). Progestational Activity of Natural and Synthetic Androgens. International Journal of Andrology, 1(s2a) [Endocrine Approach to Male Contraception: Transactions of the Fifth Annual Workshop on the Testis, Held at Geilo, Norway on April 2-5, 1978], 162–174. [DOI:10.1111/j.1365-2605.1978.tb00015.x]
    • Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502–521. [DOI:10.1038/bjp.2008.165]
    • Kirschvink, J. F. (1963). Studies of Anabolic Steroids. American Journal of Diseases of Children, 106(4), 368–368. [DOI:10.1001/archpedi.1963.02080050370005]
    • Knuth, U. A., Behre, H., Belkien, L., Bents, H., & Nieschlag, E. (1985). Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation. Fertility and Sterility, 44(6), 814–821. [DOI:10.1016/s0015-0282(16)49043-6]
    • Knuth, U. A., Behre, H., Belkien, L., Bents, H., & Nieschlag, E. (1986). 19-Nortestosterone for male fertility regulation. In Zatuchni, G. I., Goldsmith, A., Spieler, J. M., & Sciarra, J. J. (Eds.). Male Contraception: Advances and Future Prospects: Proceedings of an International Workshop on Male Contraception, Advances and Future Prospects, May 28-31, 1985, Geneva, Switzerland (pp. 320–328). Philadelphia: Harper and Row. [Google Scholar] [Google Books] [WorldCat] [PDF]
    • Knuth, U. A., Yeung, C., & Nieschlag, E. (1989). Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. Fertility and Sterility, 51(6), 1011–1018. [DOI:10.1016/s0015-0282(16)60735-5]
    • Kuhl, H., & Wiegratz, I. (2017). Das Post-Finasterid-Syndrom. [Post Finasteride Syndrome.] Gynäkologische Endokrinologie, 15(2), 153–163. [DOI:10.1007/s10304-017-0126-2]
    • Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J. (1997). Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β. Endocrinology, 138(3), 863–870. [DOI:10.1210/endo.138.3.4979]
    • Kumar, N., Crozat, A., Li, F., Catterall, J., Bardin, C., & Sundaram, K. (1999). 7α-methyl-19-nortestosterone, a synthetic androgen with high potency: structure-activity comparisons with other androgens. The Journal of Steroid Biochemistry and Molecular Biology, 71(5–6), 213–222. [DOI:10.1016/s0960-0760(99)00143-0]
    • Lauritzen, C. (1984). Pre- and Postmenopause. In Platt, D. (Ed.). Geriatrics 3: Gynecology · Orthopaedics · Anesthesiology · Surgery · Otorhinolaryngology · Ophthalmology · Dermatology (pp. 2–45). Berlin/Heidelberg: Springer Berlin Heidelberg. [DOI:10.1007/978-3-642-68976-5_1]
    • Lemmey, A. B., Elamanchi, S. R., Marcora, S. M., Casanova, F., & Maddison, P. J. (2013). Efficacy of nandrolone decanoate in treating rheumatoid cachexia in male rheumatoid arthritis patients. In Matsuno, H. (Ed.). Innovative Rheumatology (pp. 271–285). Rijeka, Croatia: InTech. [DOI:10.5772/53236]
    • Liu, P. Y., & Handelsman, D. J. (1998). Androgen therapy in non-gonadal disease. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 473–512). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_17]
    • Marks, L. S. (2004). 5α-reductase: history and clinical importance. Reviews in Urology, 6(Suppl 9), S11–S21. [Google Scholar] [PubMed] [PubMed Central]
    • Mella, J. M., Perret, M. C., Manzotti, M., Catalano, H. N., & Guyatt, G. (2010). Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia. Archives of Dermatology, 146(10), 1141–1150. [DOI:10.1001/archdermatol.2010.256]
    • Need, A. (1989). Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone, 10(1), 3–6. [DOI:10.1016/8756-3282(89)90139-7]
    • Neff, M. S., Goldberg, J., Slifkin, R. F., Eiser, A. R., Calamia, V., Kaplan, M., Baez, A., Gupta, S., & Mattoo, N. (1981). A Comparison of Androgens for Anemia in Patients on Hemodialysis. New England Journal of Medicine, 304(15), 871–875. [DOI:10.1056/nejm198104093041504]
    • Nieschlag, E. (2010). Clinical trials in male hormonal contraception. Contraception, 82(5), 457–470. [DOI:10.1016/j.contraception.2010.03.020]
    • Nieschlag, E., & Behre, H. M. (2012). The essential role of testosterone in hormonal male contraception. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 470–493). Cambridge/New York: Cambridge University Press. [DOI:10.1017/cbo9781139003353.023]
    • Nieschlag, E., Kumar, N., & Sitruk-Ware, R. (2013). 7α-Methyl-19-nortestosterone (MENTR): the Population Council’s contribution to research on male contraception and treatment of hypogonadism. Contraception, 87(3), 288–295. [DOI:10.1016/j.contraception.2012.08.036]
    • Pan, M. M., & Kovac, J. R. (2016). Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness. Translational Andrology and Urology, 5(2), 213–219. [DOI:10.21037/tau.2016.03.03]
    • Passeri, M., Pedrazzoni, M., Pioli, G., Butturini, L., Ruys, A., & Cortenraad, M. (1993). Effects of nandrolone decanoate on bone mass in established osteoporosis. Maturitas, 17(3), 211–219. [DOI:10.1016/0378-5122(93)90049-n]
    • Peters, A. A., Ingman, W. V., Tilley, W. D., & Butler, L. M. (2011). Differential Effects of Exogenous Androgen and an Androgen Receptor Antagonist in the Peri- and Postpubertal Murine Mammary Gland. Endocrinology, 152(10), 3728–3737. [DOI:10.1210/en.2011-1133]
    • Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Sturla, E. (1977). Male pseudohermaphroditism due to steroid 5α-reductase deficiency. The American Journal of Medicine, 62(2), 170–191. [DOI:10.1016/0002-9343(77)90313-8]
    • Propecia Finasteride Label. U.S. Food and Drug Administration. [URL] [PDF]
    • Prunty, F. T., Brooks, R. V., Clayton, B. E., & McSwiney, R. R. (1958). Some Effects of 17α-Ethyl-19-Nortestosterone in Man. Proceedings of the Royal Society of Medicine, 51(7), 557–558. [Google Scholar] [PubMed] [PubMed Central]
    • Roche, A., Towns, J. W., & Wettenhall, H. (1963). Influence of norethandrolone on the stature of short children. The Journal of Pediatrics, 63(5), 967–976. [DOI:10.1016/s0022-3476(63)80228-0]
    • Russell, N., & Grossmann, M. (2019). MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone. European Journal of Endocrinology, 181(1), R23–R43. [DOI:10.1530/eje-18-1000]
    • Sardar, P., Jha, A., Roy, D., Majumdar, U., Guha, P., Roy, S., Banerjee, R., Banerjee, A. K., & Bandyopadhyay, D. (2010). Therapeutic Effects of Nandrolone and Testosterone in Adult Male HIV Patients With AIDS Wasting Syndrome (AWS): A Randomized, Double-Blind, Placebo-Controlled Trial. HIV Clinical Trials, 11(4), 220–229. [DOI:10.1310/hct1104-220]
    • Sartorius, G. A., Ly, L. P., & Handelsman, D. J. (2014). Male Sexual Function Can Be Maintained Without Aromatization: Randomized Placebo‐Controlled Trial of Dihydrotestosterone (DHT) in Healthy, Older Men for 24 Months. The Journal of Sexual Medicine, 11(10), 2562–2570. [DOI:10.1111/jsm.12550]
    • Sas, T., Gault, E., Zeger Bardsley, M., Menke, L., Freriks, K., Perry, R., Otten, B., de Muinck Keizer-Schrama, S., Timmers, H., Wit, J., Ross, J., & Donaldson, M. (2014). Safety and Efficacy of Oxandrolone in Growth Hormone-Treated Girls with Turner Syndrome: Evidence from Recent Studies and Recommendations for Use. Hormone Research in Paediatrics, 81(5), 289–297. [DOI:10.1159/000358195]
    • Schürmeyer, T., Belkien, L., Knuth, U., & Nieschlag, E. (1984). Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. The Lancet, 323(8374), 417–420. [DOI:10.1016/s0140-6736(84)91752-5]
    • Simpson, E. R., & Jones, M. E. (2007). Of Mice and Men: The Many Guises of Estrogens. In Korach, K. S., & Wintermantel, T. (Eds.). Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, Volume 2006/1) (pp. 45–68). Berlin/Heidelberg: Springer. [DOI:10.1007/2789_2006_016]
    • Skroza, N., Tolino, E., Mambrin, A., Zuber, S., Balduzzi, V., Marchesiello, A., Bernardini, N., Proietti, I., & Potenza, C. (2018). Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients. The Journal of Clinical and Aesthetic Dermatology, 11(1), 21–25. [Google Scholar] [PubMed] [PubMed Central] [URL]
    • Styne, D. M., & Grumbach, M. M. (2016). Physiology and Disorders of Puberty. In Melmed, S., Polonsky, K. S., Larsen, P. R., Kronenberg, & H. M. (Eds.). Williams Textbook of Endocrinology, 13th Edition (pp. 1074–1218). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-29738-7.00025-3]
    • Sundaram, K., & Kumar, N. (2000). 7alpha-Methyl-19-nortestosterone (MENT): the optimal androgen for male contraception and replacement therapy. International Journal of Andrology, 23(S2), 13–15. [DOI:10.1046/j.1365-2605.2000.00004.x]
    • Sundaram, K., Kumar, N., & Bardin, C. W. (1994). 7α-Methyl-19-nortestosterone: An Ideal Androgen for Replacement Therapy. In Bardin, W. C. (Ed.). Proceedings of the 1992 Laurentian Hormone Conference (Recent Progress in Hormone Research, Volume 49) (pp. 373–376). San Diego: Academic Press. [DOI:10.1016/b978-0-12-571149-4.50027-1]
    • Sundaram, K., Kumar, N., Monder, C., & Bardin, C. (1995). Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens. The Journal of Steroid Biochemistry and Molecular Biology, 53(1–6), 253–257. [DOI:10.1016/0960-0760(95)00056-6]
    • Suvisaari, J. (2000). 7α-Methyl-19-Nortestosterone (MENT): Pharmacokinetics and Antigonadotropic Effects in Men. (Doctoral dissertation, University of Helsinki.) Helsinki: University of Helsinki. [Google Scholar] [URL] [PDF]
    • Thirumalai, A., Ceponis, J., Amory, J. K., Swerdloff, R., Surampudi, V., Liu, P. Y., Bremner, W. J., Harvey, E., Blithe, D. L., Lee, M. S., Hull, L., Wang, C., & Page, S. T. (2018). Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill. The Journal of Clinical Endocrinology & Metabolism, 104(2), 423–432. [DOI:10.1210/jc.2018-01452]
    • Tóth, M. (2009). Mioanabolikus Szteroidok és Szelektív Androgénreceptormodulátorok: Hatásmechanizmus és Terápiás Perspektívák. [Myoanabolic Steroids and Selective Androgen Receptor Modulators: Mechanism of Action and Perspectives. Orvosi Hetilap, 150(45), 2051–2059. [DOI:10.1556/oh.2009.28739] [Translation]
    • Tóth, M., & Zakár, T. (1986). Classification of Anabolic Steroids Using the Method of Competitive Metabolism. Experimental and Clinical Endocrinology & Diabetes, 87(2), 125–132. [DOI:10.1055/s-0029-1210533]
    • Trost, L., Saitz, T. R., & Hellstrom, W. J. (2013). Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review. Sexual Medicine Reviews, 1(1), 24–41. [DOI:10.1002/smrj.3]
    • van der Vies, J. (1985). Implications of basic pharmacology in the therapy with esters of nandrolone. Acta Endocrinologica, 110(3 Suppl a), S38–S44. [DOI:10.1530/acta.0.109s0038]
    • van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015). Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews, 2015, CD010334. [DOI:10.1002/14651858.cd010334.pub2]
    • Vetri, M., Cataldi, A., Naselli, A., & Vetri, A. (2021). Transsexualism Ethiology and Medical Management: Between Scientific Evidence and Personal Experiences. Preprints, 2021030172. [DOI:10.20944/preprints202103.0172.v1]
    • Wibowo, E., Schellhammer, P., & Wassersug, R. J. (2011). Role of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation Therapy. Journal of Urology, 185(1), 17–23. [DOI:10.1016/j.juro.2010.08.094]
    • Wibowo, E., & Wassersug, R. J. (2013). The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy. Critical Reviews in Oncology/Hematology, 87(3), 224–238. [DOI:10.1016/j.critrevonc.2013.01.006]
    • Winters, S. J. (1990). Androgens: Endocrine Physiology and Pharmacology. In Lin, G. C., & Erinoff, L. (Eds.). Anabolic Steroid Abuse (National Institute on Drug Abuse Research Monograph Series, Volume 102) (pp. 113–130). Rockville, Maryland: National Institute on Drug Abuse/U.S. Department of Health and Human Services. [Google Scholar] [PubMed] [Google Books] [PDF]
    • World Health Organization & Task Force on Methods for the Regulation of Male Fertility. (1993). Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertility and Sterility, 60(6), 1062–1068. [DOI:10.1016/s0015-0282(16)56411-5]
    • Wu, C., & Kovac, J. R. (2016). Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health. Current Urology Reports, 17(10), 72. [DOI:10.1007/s11934-016-0629-8]
    • Wu, S., Yuen, F., Swerdloff, R. S., Pak, Y., Thirumalai, A., Liu, P. Y., Amory, J. K., Bai, F., Hull, L., Blithe, D. L., Anawalt, B. D., Parman, T., Kim, K., Lee, M. S., Bremner, W. J., Page, S. T., & Wang, C. (2018). Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men. The Journal of Clinical Endocrinology & Metabolism, 104(3), 629–638. [DOI:10.1210/jc.2018-01528]
    • Yuen, F., Thirumalai, A., Pham, C., Swerdloff, R. S., Anawalt, B. D., Liu, P. Y., Amory, J. K., Bremner, W. J., Dart, C., Wu, H., Hull, L., Blithe, D. L., Long, J., Wang, C., & Page, S. T. (2020). Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men. The Journal of Clinical Endocrinology & Metabolism, 105(3), e835–e847. [DOI:10.1210/clinem/dgaa032]
    \ No newline at end of file +Nandrolone as a Potential Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People - Transfeminine Science Link

    Nandrolone as a Potential Alternative Androgen with Reduced Androgenic Side Effects for Transfeminine and Transmasculine People

    By Aly | First published March 20, 2020 | Last modified March 23, 2023

    Abstract / TL;DR

    Nandrolone, or 19-nortestosterone, is a unique androgen and anabolic steroid which is used in the form of injectable ester prodrugs like nandrolone decanoate. It is closely related to testosterone structurally but has a number of important pharmacological differences in comparison. These differences include inactivation by 5α-reductase rather than potentiation, less or no conversion into estradiol, and much greater progestogenic activity. The inactivation of nandrolone by 5α-reductase results in nandrolone theoretically having much lower androgenic strength than testosterone in skin, hair follicles, and the prostate, among other tissues. Consequently, nandrolone may have less propensity for oily skin, acne, facial/body hair growth, scalp hair loss, and prostate problems than testosterone. On the other hand, nandrolone is theoretically expected to have full androgenic efficacy in most other tissues, including bone, fat, and muscle (and hence of masculine skeletal, fat, and muscular changes). This is also likely to be the case when it comes to voice, bottom growth, and sexual function. The reduced androgenic impact of nandrolone in skin and hair follicles relative to testosterone make it a favorable potential alternative option for androgen therapy both for transfeminine people and for some transmasculine people.

    Introduction

    Nandrolone, also known chemically as 19-nortestosterone (19-NT), is an androgen and anabolic steroid (AAS) similarly to testosterone (T). It is used as a medication by intramuscular or subcutaneous injection in the form of longer-acting esters like nandrolone decanoate (ND; Deca-Durabolin) and nandrolone phenylpropionate (NPP; Durabolin), which are converted into nandrolone in the body. This is analogous to longer-acting testosterone esters like testosterone enanthate (TE) and testosterone undecanoate (TU) and their conversion in the body into testosterone. Nandrolone is used in medicine for a variety of indications that benefit from anabolic effects in tissues like muscle, bone, and kidneys. Examples include wasting syndromes, osteoporosis, kidney disease, and anemia. It is used not only in men but also in women, for instance to prevent and treat postmenopausal osteoporosis in women who can’t tolerate estrogens or in whom estrogens can’t be taken. Nandrolone has additionally been advocated for use in androgen replacement therapy for women (Davis, 1999).

    Nandrolone is closely related to testosterone in terms of chemical structure, pharmacodynamic actions, and disposition in the body. At the same time however, nandrolone has a key difference from testosterone that makes it a very favorable alternative option for use as an androgen in transgender hormone therapy. This is the case not only for transfeminine people but also for transmasculine people. This property of nandrolone is that it is inactivated by 5α-reductase in tissues that express this enzyme. This is in contrast to testosterone, which is potentiated in such tissues via conversion into dihydrotestosterone (DHT). Because of this difference, nandrolone has normal androgenic effects in most of the body but a greatly reduced potential for androgenic effects in skin and hair follicles relative to testosterone. As a result, nandrolone has a variably reduced potential for androgenic skin and hair side effects such as oily skin, acne, facial and body hair growth, and scalp hair loss.

    Because of its favorable profile relative to testosterone, nandrolone has been advocated for use in androgen replacement therapy in cisgender men (Wu & Kovac, 2016; Pan & Kovac, 2016). It has also been studied for use in male hormonal contraception as an alternative and replacement for testosterone (Knuth et al., 1986; Nieschlag, 2010; Nieschlag & Behre, 2012). Nandrolone is advantageous for cisgender men not only due to preservation of scalp hair but also due to its lower stimulation of the prostate gland. As a result of its more favorable profile in terms of skin and hair follicles, nandrolone is an underappreciated alternative possibility relative to testosterone for use not only in cisgender people but also in transfeminine and transmasculine people.

    Chemistry of Nandrolone

    Nandrolone is chemically known as 19-nortestosterone. It is very close to testosterone in terms of chemical structure, the only difference between the two compounds being that the C19 methyl group of testosterone has been removed in the case of nandrolone. Nandrolone is not a synthetic compound; it occurs naturally in the human body in trace amounts as an intermediate in the conversion of testosterone to estradiol by the enzyme aromatase (Bricout & White, 2004). As such, although nandrolone couldn’t be said to be “bioidentical”, it’s quite similar to testosterone.

    Figure: Chemical structures of testosterone and nandrolone (19-nortestosterone). The structural difference between testosterone and nandrolone is at the C19 position and is highlighted by the circled areas.

    A variety of AAS chemical derivatives of nandrolone exist. Examples include normethandrone (17α-methyl-19-nortestosterone), norethandrolone (17α-ethyl-19-nortestosterone), trestolone (7α-methyl-19-nortestosterone; MENT), dimethandrolone (DMA; 7α,11β-dimethyl-19-nortestosterone), and 11β-methyl-19-nortestosterone (11β-MNT). The latter three have been proposed and/or studied for use in androgen replacement therapy and male hormonal contraception similarly to nandrolone (Sundaram, Kumar, & Bardin, 1994; Sundaram & Kumar, 2002; Anderson et al., 2003; Buvat et al., 2013; Nieschlag, Kumar, & Sitruk-Ware, 2013; Thirumalai et al., 2019; Wu et al., 2019; Yuen et al., 2020). The first male oral contraceptive pills to be marketed may end up containing dimethandrolone and/or 11β-MNT.

    Pharmacology of Nandrolone

    Androgenic Activity and 5α-Reductase

    Nandrolone is an agonist of the androgen receptor (AR) similarly to testosterone. It shows higher affinity for the AR than does testosterone and has almost no binding affinity for sex hormone-binding globulin (SHBG) however. For these reasons, nandrolone has about 2.5- to 5-fold higher potency than testosterone in rats on measures of general AR agonistic strength, such as stimulation of muscle growth (Sundaram et al., 1995; Tóth & Zakár, 1986; Wiki; Winters, 1976). It is likewise a more potent AAS than testosterone in humans, and is used medically at lower doses in comparison (Wiki).

    Testosterone is a substrate for 5α-reductase in tissues that express this enzyme like skin, hair follicles, prostate gland, and seminal vesicles, among others. It is converted by 5α-reductase into dihydrotestosterone (DHT), an androgen with much higher AR affinity and AR agonistic potency than that of testosterone (Wiki). Consequently, it is estimated that the effects of testosterone are potentiated by 2- to 3-fold via conversion into DHT in tissues that express 5α-reductase (Sundaram et al., 1995). The role of DHT in the effects of testosterone is demonstrated by a rare intersex condition known as 5α-reductase type 2 deficiency, as well as by 5α-reductase inhibitors (5α-RIs) like finasteride and dutasteride (Wiki; Wiki). Men with 5α-reductase type 2 deficiency are reported to have reduced facial hair, a female-like pattern of body hair (with terminal hair largely restricted to the underarms and lower pubic triangle), and no scalp hair recession in the temples nor scalp hair loss in general. Conversely, other aspects of male secondary sexual development, like voice deepening, muscle growth, bone changes, and pubertal penile enlargement, are all normal in the condition. In addition, no feminization or gynecomastia occurs. Hence, adults with 5α-reductase type 2 deficiency have a masculine appearance (Imperato-McGinley & Peterson, 1976; Peterson et al., 1977; Photos). In published photographs of individuals with the condition however, features like lack of body hair and rounded feminine hairlines can be noted.

    5α-Reductase inhibitors have similar effects relative to the profile of 5α-reductase type 2 deficiency. For this reason, they are used in the treatment and prevention of scalp hair loss in men and off-label for hirsutism (excessive facial/body hair growth) in women. They greatly slow the rate of scalp hair loss over time in men. For example, a large 5-year randomized controlled trial showed that in men with diagnosed scalp hair loss, 100% of those who received placebo had significant further scalp hair loss whereas only 35% of those who received finasteride had further scalp hair loss (Propecia label). Low-quality evidence suggests that finasteride has similar effectiveness to antiandrogens like spironolactone and flutamide in the treatment of hirsutism in women (Barrionuevo et al., 2018; van Zuuren et al., 2015). Dutasteride has similar or greater effectiveness than finasteride for scalp hair loss in men (Arif et al., 2017), whereas it hasn’t yet been studied in the treatment of hirsutism (Wiki).

    5α-Reductase is the key to the favorable differences between testosterone and nandrolone. Both testosterone and nandrolone are substrates for 5α-reductase and have similar affinity for this enzyme (Tóth & Zakár, 1986). But whereas testosterone is potentiated via conversion into DHT in tissues that express 5α-reductase, nandrolone is inactivated by 5α-reductase in these tissues (Kicman, 2008; Tóth, 2009). This is because the 5α-reduced metabolite of nandrolone, 5α-dihydronandrolone (DHN), is a weaker AR agonist with much lower affinity for the AR than nandrolone (Tóth & Zakár, 1986; Kumar et al., 1999). The following table shows AR and SHBG relative binding affinities (RBA) of testosterone, nandrolone, trestolone, and their 5α-reduced forms (Kumar et al., 1999):

    SteroidAR RBASHBG RBA
    Testosterone100%100%
    5α-Dihydrotestosterone290%340%
    Nandrolone230%5%
    5α-Dihydronandrolone10%5%
    Trestolone380%6%
    5α-Dihydrotrestolone30%2%

    In rodents, although nandrolone has about 3-fold higher anabolic or muscle-stimulating potency than testosterone, its androgenic potency in the prostate gland and seminal vesicles is only about 20 to 40% of that of testosterone (Sundaram et al., 1995; Tóth & Zakár, 1986; Wiki). This works out to an approximate 11:1 dissociation between the effects of nandrolone in tissues with little or no 5α-reductase (muscle) versus with high 5α-reductase (prostate gland, seminal vesicles) in rodents (Wiki). The exact ratio of potency between these tissues in humans is unknown, and extrapolation from rodents should be cautioned against. In any case, an analogous dissociation of some level can be anticipated. As such, nandrolone can be expected to have high AR agonistic strength in most of the body, where 5α-reductase has minimal expression (e.g., fat, muscle, bone), but much lower potency in tissues with high 5α-reductase expression, like skin, hair follicles, the prostate gland, and the seminal vesicles.

    It’s important to be clear that nandrolone is not simply akin to taking testosterone with a 5α-reductase inhibitor like dutasteride to block 5α-reductase. This is because nandrolone isn’t merely not potentiated by 5α-reductase, it’s weakened by 5α-reductase. For this reason, 5α-reductase inhibitors actually increase the androgenic strength of nandrolone in tissues that express 5α-reductase like the prostate gland in rodents (Sundaram et al., 1995). (And, for this reason, nandrolone should not be taken with a 5α-reductase inhibitor, in contrast to testosterone.) In other words, nandrolone goes beyond testosterone plus a 5α-reductase inhibitor in terms of the dissociation of its potency between tissues that express 5α-reductase and tissues that do not. As a result, nandrolone has much lower androgenic strength in such tissues than does the combination of testosterone plus a 5α-reductase inhibitor. Nandrolone also appears to have lower strength in tissues that express 5α-reductase than do most other AAS, for instance synthetic DHT derivatives like oxandrolone and stanozolol (Tóth & Zakár, 1986). This is because these AAS are not substrates for 5α-reductase and hence are neither potentiated nor weakened by 5α-reductase, similarly to testosterone with a 5α-reductase inhibitor. The inactivation of nandrolone by 5α-reductase makes it very unique among AAS and AR agonists. Only nandrolone and a few of its derivatives like normethandrone and norethandrolone have this very special property.

    Testosterone and nandrolone may also be non-identical in their androgenic actions and effects for reasons other than metabolism. This is because different AR agonists including strong androgens like testosterone and DHT, weak androgens like dehydroepiandrosterone (DHEA) and androstenedione (A4), and predominantly anabolic androgens like nandrolone, oxandrolone, and stanozolol, have been shown to produce differential AR-mediated changes in gene expression (Holterhus, Piefke, & Hiort, 2002; Kicman, 2008; Hiort, 2013). However, nandrolone was more similar in its profile to testosterone than the synthetic AAS. In any case, the clinical implications of these differences in relation to therapeutic use of testosterone versus nandrolone, if any, are unknown.

    Estrogenic Activity and Estradiol Replacement

    Testosterone is aromatized in small amounts into estradiol, and for this reason, testosterone has estrogenic activity. This is important as estradiol is critical for maintaining healthy bone mineral density in men (and hence preventing bone loss and osteopenia/osteoporosis) and also has many other important physiological effects in men (Simpson & Jones, 2007; Wibowo, Schellhammer, & Wassersug, 2011; Cooke et al., 2017; Russell & Grossmann, 2019). It may have positive effects on sexual desire in men as well (Wibowo & Wassersug, 2013). As such, all men need some estradiol.

    In relation to the fact that nandrolone is an intermediate in the aromatase-mediated reaction that converts testosterone into estradiol, both testosterone and nandrolone are transformed into estradiol, and hence estradiol is their specific estrogen metabolite. Paradoxically however, whereas it has the same potential for 5α-reduction as testosterone, nandrolone as a medication is aromatized into estradiol virtually not at all (Handelsman, 2016). In accordance, nandrolone suppresses estradiol levels in men and results in low estradiol levels even at very high doses (Friedl, 1991; Hobbs et al., 1993; Hobbs, Jones, & Plymate, 1996; Behre et al., 2001). The following table gives an example of estradiol (E2) levels in men with high-dose testosterone versus high-dose nandrolone (Friedl, 1991):

    Drug and doseE2 beforeE2 afterChange
    Testosterone enanthate 300 mg/week i.m.32 ± 4.6 pg/mL79 ± 9.3 pg/mL+147%
    Nandrolone decanoate 300 mg/week i.m.40 ± 6.0 pg/mL14 ± 1.6 pg/mL–65%

    Testosterone and nandrolone themselves don’t have significant affinity for the estrogen receptors nor intrinsic estrogenic activity outside of aromatization to estradiol (Kuiper et al., 1997; Table). Although androgens also help to maintain bone mineral density and AAS like nandrolone are used to treat osteoporosis in postmenopausal women (Geusens, 1995; Ebeling, 2010), estrogens are comparatively much more important for maintenance of bone mineral density and prevention of osteoporosis in both men and women (Wiki). Studies of high-dose nandrolone and androstanolone (DHT) have shown that these non-aromatizable AAS are not adequate for maintenance of bone mineral density in men, whereas the aromatizable testosterone is effective for such purposes (Ronald et al., 1998; Crawford et al., 2003; Lemmey et al., 2013; Sartorius, Ly, & Handelsman, 2014; Čeponis et al., 2017). Non-aromatizable AAS are likewise inferior to estrogen and estrogen–progestogen therapy for maintaining bone mineral density in postmenopausal women (Lauritzen, 1984 [Graph]; Hassager et al., 1991).

    Because of its minimal conversion into estradiol, nandrolone should be used as an androgen in transmasculine people only in combination with low-dose estradiol to replace the lost estradiol that would otherwise be provided by testosterone. Estradiol levels in men are on average around 30 pg/mL, and estradiol levels of at least 20 to 30 pg/mL appear to be necessary for maintenance of bone density in men (Doran et al., 2001). A low-dose transdermal estradiol patch, for instance 14 to 25 μg/day, is likely to be adequate for achieving such levels. Alternatively, another option like transdermal estradiol gel (e.g., 0.75–1 mg/day) or low-dose oral estradiol (e.g., 0.5–1 mg/day) may be used instead.

    Progestogenic Activity

    A little-known fact about testosterone is that it has weak affinity for the progesterone receptor (PR) and is a weak progestogen (Wiki; Bardin & Janne, 1986). This property probably has no significance under normal physiological circumstances, but testosterone can in any case produce progestogenic effects such as endometrial transformation and progesterone-like lobuloalveolar development of the breasts at very high doses (Bourg, 1950; Bässler, 1970; Jänne et al., 1978; Bardin & Janne, 1986).

    Nandrolone likewise has progestogenic activity. However, the progestogenic activity of nandrolone is greatly enhanced relative to that of testosterone. The affinity of nandrolone for the PR is 5- to 20-fold higher than that of testosterone and its progestogenic potency is correspondingly improved (Wiki; Wiki; Bardin & Janne, 1986). Despite this however, the progestogenic potency of nandrolone is still relatively low. For instance, its affinity for the PR is only about 10 to 20% of that of progesterone and the nandrolone-derived progestin norethisterone (also known as 17α-ethynyl-19-nortestosterone). At the same time however, nandrolone is used at relatively large doses compared to norethisterone. This may help to compensate for its lower progestogenic potency and may allow for significant progestogenic effects at typical clinical doses (Camerino & Sciaky, 1975).

    The following table shows human and rabbit PR RBAs and relative progestogenic activity (as measured by in-vivo induction of uteroglobin synthesis in rabbit uterus) of progesterone and several AAS including testosterone and nandrolone (Jänne et al., 1978; Bardin & Janne, 1986):

    SteroidhPR RBArbPR RBAProgestogenic activity (rabbit)
    Progesterone100%100%100%
    Testosterone1.6%1.6%0.9%
    Dihydrotestosterone3.3%3.3%1.9%
    Nandrolone8.9%12%5.2%
    Methyltestosterone4.6%3.4%0.6%
    Norethandrolone130%70%115%

    The development of nandrolone was an intermediate step in the eventual development of the 19-nortestosterone group of progestins, which are widely used in hormonal birth control. These include progestins like norethisterone and levonorgestrel, among many others.

    Advantages of Nandrolone Over Testosterone

    Because of its substantially lower androgenic strength in tissues that have high 5α-reductase expression relative to tissues that have minimal or no 5α-reductase expression, nandrolone is likely to have normal androgenic effects in muscle, bone, fat, and most other tissues but much weaker androgenic strength in skin and hair follicles than equivalent doses of testosterone. As a result of this, although nandrolone has high capacity for producing most aspects of masculinization, it has a lower potential for many of the undesirable androgenic skin and hair side effects of testosterone, including oily skin, acne, facial and body hair growth, and scalp hair loss. This may allow for unique advantages of nandrolone over testosterone in transfeminine and transmasculine hormone therapy.

    The benefits of nandrolone are expected to partially differ in transfeminine people relative to transmasculine people however. This is due to the different doses of nandrolone used in these individuals, namely low, female replacement doses in transfeminine people and full, male replacement doses in transmasculine people. As an example, transmasculine people taking full male androgen replacement doses should probably expect no less oily skin or acne with nandrolone than with testosterone. This is because very low levels of testosterone are necessary for such effects, as evidenced by the fact that acne prevalence and severity is similar in females compared to males (Skroza et al., 2018) despite the fact that testosterone levels are 20-fold lower in women than in men (Styne & Grumbach, 2016). Conversely, transfeminine people taking nandrolone at doses equivalent to the effect of testosterone levels in the normal female range may experience less or possibly no oily skin or acne with nandrolone compared to use of testosterone instead. This is due to the equivalent testosterone levels being far closer to the biological threshold for manifestation of such effects.

    Nandrolone can be anticipated to have far less potential for scalp hair loss relative to testosterone in transmasculine people (Wu & Kovac, 2016; Pan & Kovac, 2016). This is related to the lack of scalp hair loss in men with 5α-reductase type 2 deficiency and the high effectiveness of 5α-reductase inhibitors for scalp hair loss. However, nandrolone is theoretically even better than testosterone plus a 5α-reductase inhibitor when it comes to preservation of scalp hair. This is because again, nandrolone is not simply not potentiated, but is inactivated in tissues that express 5α-reductase. Nandrolone replacement of testosterone represents a highly promising treatment for scalp hair loss in men that offers potentially superior effectiveness to 5α-reductase inhibitors. Moreover, since nandrolone isn’t an inhibitor of 5α-reductase, it doesn’t interfere with 5α-reduced neurosteroid synthesis. Hence, nandrolone doesn’t have the possible psychiatric side effects that have been associated with 5α-reductase inhibitors, for instance depression (Irwig, 2015; Kuhl & Wiegratz, 2017; Wiki).

    On the basis of 5α-reductase type 2 deficiency, nandrolone may be expected to produce reduced facial and particularly body hair growth relative to testosterone in transmasculine people. Essentially no body or facial hair growth is likely to occur with nandrolone at doses equivalent to female-range testosterone levels in transfeminine people, and even at supraphysiological levels, facial and body hair growth is likely to be less than with testosterone. However, facial and body hirsutism have nonetheless been reported with nandrolone at postmenopausal osteoporosis doses (Need et al., 1989; Passeri et al., 1993; Geusens, 1995; Flicker et al., 1997).

    For transmasculine people who want the benefits of nandrolone except the lesser facial hair growth, topical testosterone to the beard area can potentially be used in conjunction with nandrolone injections to restore full facial hair growth. Another possibility for achieving effects of both testosterone and nandrolone in transmasculine people could be to start on testosterone and use it for a few years, allowing for facial/body hair growth and hairline masculinization, and then switch from testosterone to nandrolone for long-term therapy, allowing for preservation of scalp hair.

    One of the reasons that nandrolone is attractive for androgen replacement therapy in cisgender men is that it has very weak relative effects in the prostate gland compared to testosterone. This is due to inactivation of nandrolone in the prostate gland by 5α-reductase similarly to other tissues that express this enzyme. It is anticipated that long-term androgen replacement therapy with nandrolone might allow for a reduced risk of enlarged prostate and prostate cancer compared to testosterone in men (Wu & Kovac, 2016; Pan & Kovac, 2016). As transfeminine people also have prostate glands, the weak effects of nandrolone in the prostate are potentially of relevance to us as well. However, due to estrogen therapy and androgen deprivation, the prostate is atrophied in transfeminine people and prostate cancer is very rare (Wiki). In relation to this, the favorable prostate profile of nandrolone may be of little significance for transfeminine people.

    Although nandrolone is quite promising for transgender hormone therapy, it is important to be clear that there are currently no quality clinical studies comparing it to testosterone and showing that it is less androgenic in terms of skin and hair effects (even if there is strong theoretical basis for this notion, particularly in the case of scalp hair loss). Nor are there any studies demonstrating with certainty that it is as effective as testosterone in terms of inducing general masculinization. Moreover, the appropriate dosages of nandrolone for use in androgen replacement in women and men are uncertain. Finally, nandrolone has been little-studied for androgen replacement and its long-term tolerability and health safety for this use haven’t been properly characterized. For these reasons, androgen replacement with nandrolone in cisgender men and transmasculine people is an experimental therapy. Additional research is needed to properly characterize nandrolone for this indication.

    Androgen Replacement in Transfeminine People

    Some believe that testosterone is important in women for mood, well-being, energy, sexual desire and function, general health, and for other reasons. Androgen levels and activity may be low in many transfeminine people due to hormone therapy and/or gonadectomy, raising concerns about androgen deficiency. However, there is little or no change in androgen levels with natural menopause in cisgender women and only a small decrease in androgen levels with ovariectomy in women (Liu & Handelsman, 1998). Moreover, there is inadequate evidence to support claims of benefit with androgen replacement therapy in women at present, and there are no well-supported benefits of female-range doses of testosterone (Wiki). For these reasons, androgen replacement therapy in women is controversial (Liu & Handelsman, 1998).

    Testosterone does stimulate sexual desire in women, but only at levels that are above the normal female range (>50 ng/dL) (Cappelletti & Wallen, 2016; Wiki). And even with high testosterone levels of 80 to 150 ng/dL, stimulation of sexual desire in women is modest (Cappelletti & Wallen, 2016; Wiki). It is likely that estradiol rather than testosterone (or progesterone) is the key sex hormone for sexual desire in women (Cappelletti & Wallen, 2016; Aly, 2020).

    Androgens can have detrimental effects in transfeminine people. They can cause androgenic and masculinizing effects like oily skin, acne, seborrhea, facial/body hair growth, scalp hair loss, and voice deepening, among others. In addition, androgens oppose the effects of estrogens in the breasts, and may inhibit breast development even with low-level exposure or physiological levels in females (Dimitrakakis et al., 2003; Peters et al., 2011; Sas et al., 2014; Barbieri, 2017).

    For these reasons, transfeminine people don’t necessarily require androgen replacement, and it shouldn’t be routinely used out of concern of androgen deficiency. In any case, some transfeminine people insist on androgen replacement, and others desire supraphysiological levels of androgens for purposes like stimulating libido or helping to build and maintain muscle mass. There is some evidence that even physiological levels of testosterone may help to support muscle mass in women (Huang & Basaria, 2017). Moreover, in transfeminine people who are fully hormonally transitioned, breast development is complete, and hence inhibition of the breasts by androgens is no longer a concern. Another potentially useful indication of androgens in transfeminine people is to counteract cellulite (Wiki; Gruber et al., 2002; Avram, 2004). Since nandrolone has full androgenic potential in fat tissue, it may be similarly effective as testosterone for this purpose. However, there are no good studies of androgens for treatment of cellulite at this time.

    Although androgen replacement therapy isn’t recommended for cisgender women or transfeminine people because of a lack of evidence of benefit and potential adverse effects, nandrolone is a very favorable alternative to testosterone for such purposes in those who nonetheless opt for such therapy. This is due to its improved skin and hair profile and hence a probable lower risk of undesirable effects.

    Additional Topics on Nandrolone

    This section is for additional topics on nandrolone as an androgen in transfeminine and transmasculine people, including its availability, dosage, androgenic/masculinizing effects besides skin and hair (e.g., voice deepening, bottom growth/clitoral enlargement, sexual effects), and liver safety.

    Availability of Nandrolone

    Nandrolone esters remain widely available for medical use throughout the world (Drugs.com). However, the availability of AAS, including nandrolone esters, has become increasingly limited over time. The shorter-acting ester nandrolone phenylpropionate is no longer available in the United States or many other countries, and the more favorable longer-acting nandrolone decanoate was discontinued in the United States in 2019. However, nandrolone decanoate remains available from compounding pharmacies in the United States, for instance AnazaoHealth. It is only available from this particular pharmacy at a very high concentration of 200 mg/mL however, which although a potentially workable concentration for use in transmasculine people, is likely completely impractical for use in transfeminine people. Compounding pharmacies might be able to do custom concentrations upon request though.

    Another potential means of delivering nandrolone is via an orally active nandrolone androgen prohormone like 19-nordehydroepiandrosterone (19-nor-DHEA). This compound is converted into nandrolone analogously to the use of DHEA as a prohormone of testosterone (Wiki). It is sold as an over-the-counter supplement from certain online vendors, similarly to DHEA. 19-Nor-DHEA may be a more suitable option for transfeminine people due to the lower doses needed and less suitable for transmasculine people due to the much higher doses required.

    Dosage of Nandrolone

    The dosage of nandrolone for use in androgen replacement therapy in women and men hasn’t been established. Hence, we don’t completely know what the appropriate dose is for use in transfeminine and transmasculine hormone therapy. In any case, it is possible for us to estimate.

    Nandrolone is closely related to testosterone but is roughly 3-fold more potent in rodents (Tóth & Zakár, 1986). We’re not sure how much more potent nandrolone is in humans in comparison. Some clinical studies comparing nandrolone and testosterone have been conducted but we nonetheless don’t have exact figures at this time (Neff et al., 1981; Friedl et al., 1989; Friedl, 1991; Hobbs et al., 1993; Hobbs, Jones, & Plymate, 1996; Crawford et al., 2003; Gold et al., 2006; Sardar et al., 2010). In any case, 150–200 mg/2 weeks nandrolone decanoate i.m. resulted in changes in body composition that were about twice as large as those of 200–250 mg/2 weeks testosterone esters i.m. in men with wasting conditions (Crawford et al., 2003; Gold et al., 2006; Sardar et al., 2010). The findings of these studies are roughly in line with 3-fold greater potency of nandrolone relative to testosterone.

    One review recommended a clinical dose range in males of 50–400 mg/2–4 weeks for testosterone enanthate or cypionate but 50–100/3–4 weeks for nandrolone decanoate (Hickson et al., 1989). This is also in line with several-fold higher potency of nandrolone relative to testosterone.

    Dosage for Transmasculine People

    A typical dosage of testosterone enanthate for use in androgen replacement therapy in cisgender and transgender men is 50 to 100 mg once per week by intramuscular injection (Wiki; Wiki). Hence, an appropriate dosage of nandrolone decanoate, assuming 3-fold greater potency than testosterone, might be about 16.7 to 33.3 mg once per week by intramuscular injection (ignoring the small differences in molecular weight between testosterone enanthate and nandrolone decanoate). However, it must be emphasized that these doses are merely educated guesses. It’s notable that these doses are quite similar to those used in postmenopausal osteoporosis in women (about 12.5 to 25 mg per week total). Hence, although such doses have certainly been associated with masculinizing effects in women, they might be suboptimal in terms of masculinization for transmasculine people. Consequently, it’s possible that a higher dose, like 50 mg once per week, might be more appropriate. In addition to weekly use, nandrolone decanoate has a duration suitable for use once every 2 weeks (Graphs).

    Nandrolone hexyloxyphenylpropionate (NHPP; brand name Anadur) was studied as a male hormonal contraceptive by the World Health Organization and others at a dose of 200 mg/3 weeks i.m. in combination with depot medroxyprogesterone acetate (Knuth et al., 1986; Nieschlag, 2010; Nieschlag & Behre, 2012). It was used as a replacement and alternative for testosterone and was given at a dosage of about 66.7 mg once per week. However, this was an intentionally supraphysiological dosage which was selected to achieve a male contraceptive effect, as suggested by suppression of gonadotropins to undetectable levels (Knuth et al., 1985). Hence, although safe and well-tolerated in limited studies, it might be a high dosage for transmasculine hormone therapy. Very high doses of nandrolone can reproduce the full spectrum of androgenic effects of testosterone, and hence doses of nandrolone that are too high may serve to nullify its advantages over testosterone (van der Vies, 1985).

    Dosage for Transfeminine People

    In postmenopausal women, nandrolone decanoate has been used for general androgen replacement at a dose of 25 to 50 mg once every 6 to 12 weeks (about 2–8 mg/week or 0.29–1.14 mg/day), and for prevention and treatment of osteoporosis at a dose of 50 mg once every 2 to 4 weeks (about 12.5–25 mg/week or 1.8–3.6 mg/day) (Wiki; Table). However, these doses of nandrolone decanoate are likely to be highly excessive for physiological androgen replacement in women and transfeminine people and are probably also spaced too widely in terms of dosing interval. This is based on the following: (1) normal production of testosterone in premenopausal women is about 150 μg/day; (2) nandrolone is more potent as an androgen receptor agonist than testosterone; and (3) pharmacokinetic concentration–time curves for nandrolone decanoate suggest that an appropriate dosing interval is once every 1 to 2 weeks (Graphs). Indeed, nandrolone decanoate at 50 mg/2–4 weeks has been found to produce significant masculinizing effects in women with long-term use (Geusens, 1995; Wiki). Since nandrolone has high theoretical masculinizing potential in most tissues in the body, like muscle, bone, fat, and vocal tissue, it’s very important that transfeminine people don’t take doses that are too large.

    Androgenic and Masculinizing Effects Besides Skin and Hair

    Nandrolone has sometimes been described as “non-masculinizing” or “minimally virilizing”, but this is misleading and inaccurate. Nandrolone has high theoretical potential to produce masculinizing skeletal, fat, and muscular effects, like growth of muscles, widening of shoulders, masculine enlargement, elongation, and shaping of bones, and masculine distribution of fat. It also has high capacity to produce voice deepening (the vocal tissue notably being part muscle). The only clear differences in masculinizing effect between nandrolone and testosterone are that nandrolone has a greatly reduced theoretical potential for androgenic effect in skin and hair follicles. Succinctly, nandrolone could be thought of as testosterone with minimization of the undesirable skin and hair effects.

    Voice Deepening with Nandrolone

    The vocal tissue, consisting of the vocal cords and the larynx, are part muscle, and 5α-reductase is expressed minimally or not at all in this tissue (Bhagavan, 2002; Kicman, 2008). Accordingly, voice deepening is normal in individuals with 5α-reductase type 2 deficiency (Imperato-McGinley & Zhu, 2002). As such, nandrolone would be expected to produce voice deepening similarly to testosterone. In accordance, voice deepening has been reported with nandrolone in women at doses used in postmenopausal osteoporosis (Gerritsma et al., 1994; Geusens, 1995; Frisoli et al., 2005). There are case reports of severe and complete masculinization of the voice in women treated with excessive doses of nandrolone (Damsté, 1964; Brodnitz, 1971; Baker, 1999). Voice changes have also been seen with nandrolone derivatives like normethandrone (Feldman et al., 1960).

    Bottom Growth with Nandrolone

    DHT is required for normal male sexual differentiation of the genitals during prenatal development. This is evidenced by 5α-reductase type 2 deficiency, in which the genitals are ambiguous but overall more female-like at birth and in childhood (Wiki). Although DHT is critical for prenatal genital masculinization, the same may not be true for pubertal development of the penis (Hiort, 2013). Individuals with 5α-reductase type 2 deficiency undergo masculinization of the genitals at puberty such that a small and near-functional penis develops (Peterson et al., 1977; Marks, 2004; Hiort, 2013; Photos). This is so striking that males with 5α-reductase type 2 deficiency in the Dominican Republic are referred to as “guevedoces”, which is said to literally mean “penis at 12”.

    As 5α-reductase may not be critical for penile enlargement at puberty, nandrolone may allow for no less bottom growth (clitoral enlargement) in transmasculine people than does testosterone. Indeed, nandrolone has been reported to produce clitoral enlargement as a side effect in women and penile growth in prepubertal boys (Camerino & Sala, 1960; Camerino & Sciaky, 1975). Similar findings have been made for derivatives of nandrolone like normethandrone and norethandrolone (Feldman et al., 1960; Roche, Towns, & Wettenhall, 1963; Kirschvink et al., 1963; Prunty et al., 1958).

    Sexual Effects of Nandrolone

    Libido is normal in men with 5α-reductase type 2 deficiency (Imperato-McGinley & Zhu, 2002; Azzouni et al., 2012) and 5α-reductase inhibitors have only a small negative effect on sexual desire and function in men (Trost, Saitz, & Hellstrom, 2013; Mella et al., 2010; Hirshburg et al., 2016). Accordingly, nandrolone has been shown to maintain sexual function in men similarly to testosterone (Schürmeyer et al., 1984; Knuth et al., 1985; Knuth et al., 1986; Knuth et al., 1989; Behre et al., 1992; WHO, 1993; Behre et al., 2001). This has included libido, erection frequency, erectile function, and sexual activity. Trestolone has also been shown to maintain sexual desire and function in men similarly to testosterone (Suvisaari, 2000; Anderson et al., 1999; Anderson et al., 2003). In addition, use of trestolone for the treatment of breast cancer in women stimulated libido to such an extent that many of the women felt uncomfortable and chose to discontinue it (Suvisaari, 2000).

    Liver Safety of Nandrolone

    Nandrolone is not a 17α-alkylated steroid. Hence, unlike most orally used synthetic AAS like methyltestosterone, stanozolol, and oxandrolone, but similarly to testosterone, nandrolone has no risk of the liver toxicity associated with 17α-alkylated AAS (Handelsman, 2016).

    Updates

    Update 1: Cocchetti et al. (2020)

    Since this article was published, a review suggesting nandrolone as a potential component of transgender hormone therapy for non-binary individuals has been published:

    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]

    The review includes the following excerpts on nandrolone:

    Other options may include nandrolone, an anabolic steroid administered via intramuscular injection, which is not as optimal a substrate for 5α-reductase as testosterone, but it has a stronger effect compared to the testosterone on target tissues devoid of 5α-reductase activity (e.g., muscular tissue) [15]. Indeed, nandrolone can be theoretically used in non-binary [assigned female at birth (AFAB)] individuals requesting masculinization of body shape (i.e., increased muscle mass) with a limited increase in facial and body hair. Regarding the safety profile of this compound, data are limited by the fact that most observations come from the setting of androgenic-anabolic steroid (AAS) abuse [16,17], thus their applicability to appropriate medical therapy is limited [18]. In this setting, concerns about cardiomyopathy and coronary artery disease risk emerged [19], although associated with the administration of nandrolone at extremely higher dosages [20]. Furthermore, nandrolone use does not seem associated to hepatotoxicity, since, as an injectable oil, it is not subject to first-pass hepatic metabolism.

    Moreover, some AFAB transgender individuals can benefit from testosterone therapy combined with 5α-reductase inhibitors or from treatment with nandrolone (an androgenic compound less prone to 5α reduction) in case they wish only a partial virilization (i.e., voice deepening and lean mass increase without facial and body hair increase).

    These researchers are at the Florence University Hospital in Italy and are notably part of the European Network for the Investigation of Gender Incongruence (ENIGI).

    Update 2: Vetri et al. (2021) [Preprint]

    In addition to the above review, a second review suggesting nandrolone as a potential option for hormone therapy in non-binary individuals has been published (as a preprint):

    • Vetri, M., Cataldi, A., Naselli, A., & Vetri, A. (2021). Transsexualism Ethiology and Medical Management: Between Scientific Evidence and Personal Experiences. Preprints, 2021030172. [DOI:10.20944/preprints202103.0172.v1]:

    With the following relevant excerpt:

    In [female-to-males] (FtMs) requesting partial masculinization, it may be possible to reduce the dose of testosterone or substitute it with nandrolone, an anabolic steroid administered via intramuscular injection. So, we must accept alternative hormonal treatment regimens, other than those reported in current guidelines, for such nonbinary transgender individuals, to try to improve their psychological well-being and quality of life [40].

    However, this preprint article appears to have never ended up being accepted for publication.

    Update 3: Cocchetti et al. (2020) and Iuliano et al. (2021)

    Further articles have mentioned nandrolone as a hypothetical option for transgender people, for instance Cocchetti et al. (2020):

    Another hypothetic option [for management of hypoactive sexual desire disorder in transgender women] may include nandrolone, an androgenic compound administered via intramuscular injection, less prone to 5-alpha reduction anabolic steroid leading to limited virilizing dermatological undesired effects [72]. However, data on its efficacy on sexual desire are not yet available.

    And Iuliano et al. (2021):

    Actually, the classic view of gender binarism and [gender-affirming hormone therapy (GAHT)] should be reconsidered because of the increasing prevalence of non-binary individuals experiencing [gender dysphoria (GD)]. Therefore, new therapeutic strategies should be also considered [17]. Since there is a lack in standardized hormonal treatment protocols for non-binary [assigned female at birth (AFAB)], GAHT goals should be adjusted according to patients’ needs in order to improve the self-perception and the quality of life [18]. For instance, different testosterone doses and/or other androgen preparations (i.e., nandrolone) are suggested to modulate the requested body changes [18], even if serious ethical concerns on some drugs exist.

    References

    • Anderson, R. A., Martin, C. W., Kung, A. W., Everington, D., Pun, T. C., Tan, K. C., Bancroft, J., Sundaram, K., Moo-Young, A. J., & Baird, D. T. (1999). 7α-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3556–3562. [DOI:10.1210/jcem.84.10.6028]
    • Anderson, R. A., Wallace, A. M., Sattar, N., Kumar, N., & Sundaram, K. (2003). Evidence for Tissue Selectivity of the Synthetic Androgen 7α-Methyl-19-Nortestosterone in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism, 88(6), 2784–2793. [DOI:10.1210/jc.2002-021960]
    • Arif, T., Dorjay, K., Adil, M., & Sami, M. (2017). Dutasteride in Androgenetic Alopecia: An Update. Current Clinical Pharmacology, 12(1), 31–35. [DOI:10.2174/1574884712666170310111125]
    • Avram, M. M. (2004). Cellulite: a review of its physiology and treatment. Journal of Cosmetic and Laser Therapy, 6(4), 181–185. [DOI:10.1080/14764170410003057]
    • Azzouni, F., Godoy, A., Li, Y., & Mohler, J. (2012). The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases. Advances in Urology, 2012 (Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back), 530121. [DOI:10.1155/2012/530121]
    • Baker, J. (1999). A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents. Journal of Voice, 13(4), 496–507. [DOI:10.1016/s0892-1997(99)80005-8]
    • Barbieri, R. L. (2019). Breast. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 248–255.e3). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/B978-0-323-47912-7.00010-X]
    • Bardin, C. W., & Janne, O. A. (1986). Steroids of One Class Can Mimic, Inhibit and Potentiate the Biological Effects of Other Steroid Classes When Administered at High Doses. In Gregoire, A. T., & Blye, R. P. (Eds.). Contraceptive Steroids: Pharmacology and Safety (pp. 123–143). Boston, MA: Springer US. [DOI:10.1007/978-1-4613-2241-2_6]
    • Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1258–1264. [DOI:10.1210/jc.2017-02052]
    • Bässler, R. (1970). The Morphology of Hormone Induced Structural Changes in the Female Breast. In Altmann, H.-W., et al. (Eds.). Current Topics in Pathology: Ergebnisse der Pathology, Volume 53 (pp. 1–89). Heidelberg: Springer Berlin. [DOI:10.1007/978-3-662-30514-0_1] [PDF]
    • Behre, H. M., Nashan, D., Hubert, W., & Nieschlag, E. (1992). Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. The Journal of Clinical Endocrinology & Metabolism, 74(1), 84–90. [DOI:10.1210/jcem.74.1.1727833]
    • Behre, H., Kliesch, S., Lemcke, B., von Eckardstein, S., & Nieschlag, E. (2001). Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. Human Reproduction, 16(12), 2570–2577. [DOI:10.1093/humrep/16.12.2570]
    • Bhagavan, N. V. (2002). Endocrine Metabolism V: Reproductive System. In Bhagavan, N. V. Medical Biochemistry, 4th Edition (pp. 781–801). San Diego: Harcourt/Academic Press. [Google Books] [WorldCat]
    • Bourg, R. (1950). Activité sécrétrice des glandes mammaires; consécutive a des doses massives de testostérone chez la femme après castration. [Secretory activity of the mammary glands; sequellae of massive testosterone doses in women following castration.] Annales d’Endocrinologie, 11(3), 254–260. [Google Scholar] [PubMed] [PDF]
    • Bricout, V., & Wright, F. (2004). Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances? European Journal of Applied Physiology, 92(1–2), 1–12. [DOI:10.1007/s00421-004-1051-3]
    • Brodnitz, F. S. (1971). Hormones and the human voice. Bulletin of the New York Academy of Medicine, 47(2), 183–191. [Google Scholar] [PubMed] [PubMed Central]
    • Buvat, J., Maggi, M., Guay, A., & Torres, L. O. (2013). Testosterone Deficiency in Men: Systematic Review and Standard Operating Procedures for Diagnosis and Treatment. The Journal of Sexual Medicine, 10(1), 245–284. [DOI:10.1111/j.1743-6109.2012.02783.x]
    • Camerino, B., & Sala, G. (1960). Anabolic Steroids. In Jucker, E. (Ed.). Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des Recherches Pharmaceutiques, Volume 2 (pp. 71–134). Basel: Birkhäuser Basel. [DOI:10.1007/978-3-0348-7038-2_2]
    • Camerino, B., & Sciaky, R. (1975). Structure and effects of anabolic steroids. Pharmacology & Therapeutics. Part B: General and Systematic Pharmacology, 1(2), 233–275. [DOI:10.1016/0306-039x(75)90007-0]
    • Cappelletti, M., & Wallen, K. (2016). Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior, 78, 178–193. [DOI:10.1016/j.yhbeh.2015.11.003]
    • Čeponis, J., Wang, C., Swerdloff, R. S., & Liu, P. Y. (2017). Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products. In Simoni, M., & Huhtaniemi, I. T. (Eds.). Endocrinology of the Testis and Male Reproduction (pp. 373–394). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-44441-3_11]
    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]
    • Cocchetti, C., Ristori, J., Mazzoli, F., Vignozzi, L., Maggi, M., & Fisher, A. D. (2020). Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians. International journal of Impotence Research, 33(7), 703–709. [DOI:10.1038/s41443-021-00409-8]
    • Cooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017). Estrogens in Male Physiology. Physiological Reviews, 97(3), 995–1043. [DOI:10.1152/physrev.00018.2016]
    • Crawford, B. A., Liu, P. Y., Kean, M. T., Bleasel, J. F., & Handelsman, D. J. (2003). Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment. The Journal of Clinical Endocrinology & Metabolism, 88(7), 3167–3176. [DOI:10.1210/jc.2002-021827]
    • Damsté, P. (1964). Virilization of the Voice due to Anabolic Stereoids. Folia Phoniatrica et Logopaedica, 16(1), 10–18. [DOI:10.1159/000262980]
    • Davis, S. (1999). The therapeutic use of androgens in women. The Journal of Steroid Biochemistry and Molecular Biology, 69(1–6), 177–184. [DOI:10.1016/s0960-0760(99)00054-0]
    • Dimitrakakis, C., Zhou, J., Wang, J., Belanger, A., LaBrie, F., Cheng, C., Powell, D., & Bondy, C. (2003). A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause, 10(4), 292–298. [DOI:10.1097/01.gme.0000055522.67459.89]
    • Doran, P. M., Riggs, B. L., Atkinson, E. J., & Khosla, S. (2001). Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men. Journal of Bone and Mineral Research, 16(11), 2118–2125. [DOI:10.1359/jbmr.2001.16.11.2118]
    • Drugs.com. International > Nandrolone. Drugs.com. [URL]
    • Ebeling, P. R. (2010). Androgens and osteoporosis. Current Opinion in Endocrinology, Diabetes & Obesity, 17(3), 284–292. [DOI:10.1097/med.0b013e328339658c]
    • Feldman, E. B., Carter, A. C., Kossa, J. L., McCarrick, J. F., & Schwartz, H. L. (1960). Endocrinologic and Metabolic Effects of 17α-Methyl-19-nortestosterone in Women. The Journal of Clinical Endocrinology & Metabolism, 20(6), 842–857. [DOI:10.1210/jcem-20-6-842]
    • Flicker, L., Hopper, J. L., Larkins, R. G., Lichtenstein, M., Buirski, G., & Wark, J. D. (1997). Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis. Osteoporosis International, 7(1), 29–35. [DOI:10.1007/bf01623456]
    • Friedl, K. E., Jones, R. E., Hannan, C. J., & Plymate, S. R. (1989). The Administration of Pharmacological Doses of Testosterone or 19-Nortestosterone to Normal Men is Not Associated with Increased Insulin Secretion or Impaired Glucose Tolerance. The Journal of Clinical Endocrinology & Metabolism, 68(5), 971–975. [DOI:10.1210/jcem-68-5-971]
    • Friedl, K. E., Dettori, J. R., Hannan, C. J., Patience, T. H., & Plymate, S. R. (1991). Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men. The Journal of Steroid Biochemistry and Molecular Biology, 40(4–6), 607–612, IN5–IN6. [DOI:10.1016/0960-0760(91)90283-b]
    • Frisoli, A., Chaves, P. H., Pinheiro, M. M., & Szejnfeld, V. L. (2005). The Effect of Nandrolone Decanoate on Bone Mineral Density, Muscle Mass, and Hemoglobin Levels in Elderly Women With Osteoporosis: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 60(5), 648–653. [DOI:10.1093/gerona/60.5.648]
    • Gerritsma, E. J., Brocaar, M. P., Hakkesteegt, M. M., & Birkenhäger, J. C. (1994). Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year. Clinical Otolaryngology, 19(1), 79–84. [DOI:10.1111/j.1365-2273.1994.tb01153.x]
    • Geusens, P. (1995). Nandrolone decanoate: Pharmacological properties and therapeutic use in osteoporosis. Clinical Rheumatology, 14(S3), 32–39. [DOI:10.1007/bf02210686]
    • Gold, J., Batterham, M., Rekers, H., Harms, M., Geurts, T., Helmyr, P., Silva de Mendonca, J., Falleiros Carvalho, L., Panos, G., Pinchera, A., Aiuti, F., Lee, C., Horban, A., Gatell, J., Phanuphak, P., Prasithsirikul, W., Gazzard, B., Bloch, M., & Danner, S. (2006). Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting. HIV Medicine, 7(3), 146–155. [DOI:10.1111/j.1468-1293.2006.00358.x]
    • Gruber, C. J., Wieser, F., Gruber, I. M., Ferlitsch, K., Gruber, D. M., & Huber, J. C. (2002). Current concepts in aesthetic endocrinology. Gynecological Endocrinology, 16(6), 431–441. [DOI:10.1080/gye.16.6.431.441]
    • Hamdy, R. C., Moore, S. W., Whalen, K. E., & Landy, C. (1998). Nandrolone Decanoate for Men With Osteoporosis. American Journal of Therapeutics, 5(2), 89–96. [DOI:10.1097/00045391-199803000-00006]
    • Handelsman, D. J. (2016). Androgen Physiology, Pharmacology, and Abuse. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition, Volume 2 (pp. 2368–2393.e16). Philadelphia: Saunders/Elsevier. [Google Books] [DOI:10.1016/B978-0-323-18907-1.00138-4]
    • Hassager, C., Jensen, L., Johansen, J., Riis, B., Melkko, J., Pødenphant, J., Risteli, L., Christiansen, C., & Risteli, J. (1991). The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: The effect of nandrolone decanoate and female sex hormones. Metabolism, 40(2), 205–208. [DOI:10.1016/0026-0495(91)90176-w]
    • Hickson, R. C., Ball, K. L., & Falduto, M. T. (1989). Adverse Effects of Anabolic Steroids. Medical Toxicology and Adverse Drug Experience, 4(4), 254–271. [DOI:10.1007/bf03259912]
    • Hiort, O. (2013). The differential role of androgens in early human sex development. BMC Medicine, 11(1), 152. [DOI:10.1186/1741-7015-11-152]
    • Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. The Journal of Clinical and Aesthetic Dermatology, 9(7), 56–62. [Google Scholar] [PubMed] [PubMed Central]
    • Hobbs, C. J., Plymate, S. R., Rosen, C. J., & Adler, R. A. (1993). Testosterone administration increases insulin-like growth factor-I levels in normal men. The Journal of Clinical Endocrinology & Metabolism, 77(3), 776–779. [DOI:10.1210/jcem.77.3.7690364]
    • Hobbs, C. J., Jones, R. E., & Plymate, S. R. (1996). Nandrolone, a 19-nortestosterone, enhances insulin-independent glucose uptake in normal men. The Journal of Clinical Endocrinology & Metabolism, 81(4), 1582–1585. [DOI:10.1210/jcem.81.4.8636371]
    • Holterhus, P., Piefke, S., & Hiort, O. (2002). Anabolic steroids, testosterone-precursors and virilizing androgens induce distinct activation profiles of androgen responsive promoter constructs. The Journal of Steroid Biochemistry and Molecular Biology, 82(4–5), 269–275. [DOI:10.1016/s0960-0760(02)00220-0]
    • Huang, G., & Basaria, S. (2017). The Case for Androgens in Menopausal Women: When and How? In Pal, L., & Sayegh, R. A. (Eds.). Essentials of Menopause Management: A Case-Based Approach (pp. 173–196). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-42451-4_10]
    • Imperato-McGinley, J., & Peterson, R. E. (1976). Male pseudohermaphroditism: The complexities of male phenotypic development. The American Journal of Medicine, 61(2), 251–272. [DOI:10.1016/0002-9343(76)90175-3]
    • Imperato-McGinley, J., & Zhu, Y. (2002). Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Molecular and Cellular Endocrinology, 198(1–2), 51–59. [DOI:10.1016/s0303-7207(02)00368-4]
    • Irwig, M. S. (2015). Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia. Current Opinion in Endocrinology, Diabetes & Obesity, 22(3), 248–253. [DOI:10.1097/med.0000000000000158]
    • Iuliano, S., Izzo, G., Zagari, M. C., Vergine, M., Brunetti, F. S., Brunetti, A., Di Luigi, L., & Aversa, A. (2021). Endocrine management of transgender adults: a clinical approach. Sexes, 2(1), 104–118. [DOI:10.3390/sexes2010009]
    • Jänne, O., Hemminki, S., Isomaa, V., Kokko, E., Torkkeli, H., Torkkeli, T., & Vierikko, P. (1978). Progestational Activity of Natural and Synthetic Androgens. International Journal of Andrology, 1(s2a) [Endocrine Approach to Male Contraception: Transactions of the Fifth Annual Workshop on the Testis, Held at Geilo, Norway on April 2-5, 1978], 162–174. [DOI:10.1111/j.1365-2605.1978.tb00015.x]
    • Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502–521. [DOI:10.1038/bjp.2008.165]
    • Kirschvink, J. F. (1963). Studies of Anabolic Steroids. American Journal of Diseases of Children, 106(4), 368–368. [DOI:10.1001/archpedi.1963.02080050370005]
    • Knuth, U. A., Behre, H., Belkien, L., Bents, H., & Nieschlag, E. (1985). Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation. Fertility and Sterility, 44(6), 814–821. [DOI:10.1016/s0015-0282(16)49043-6]
    • Knuth, U. A., Behre, H., Belkien, L., Bents, H., & Nieschlag, E. (1986). 19-Nortestosterone for male fertility regulation. In Zatuchni, G. I., Goldsmith, A., Spieler, J. M., & Sciarra, J. J. (Eds.). Male Contraception: Advances and Future Prospects: Proceedings of an International Workshop on Male Contraception, Advances and Future Prospects, May 28-31, 1985, Geneva, Switzerland (pp. 320–328). Philadelphia: Harper and Row. [Google Scholar] [Google Books] [WorldCat] [PDF]
    • Knuth, U. A., Yeung, C., & Nieschlag, E. (1989). Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception. Fertility and Sterility, 51(6), 1011–1018. [DOI:10.1016/s0015-0282(16)60735-5]
    • Kuhl, H., & Wiegratz, I. (2017). Das Post-Finasterid-Syndrom. [Post Finasteride Syndrome.] Gynäkologische Endokrinologie, 15(2), 153–163. [DOI:10.1007/s10304-017-0126-2]
    • Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J. (1997). Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β. Endocrinology, 138(3), 863–870. [DOI:10.1210/endo.138.3.4979]
    • Kumar, N., Crozat, A., Li, F., Catterall, J., Bardin, C., & Sundaram, K. (1999). 7α-methyl-19-nortestosterone, a synthetic androgen with high potency: structure-activity comparisons with other androgens. The Journal of Steroid Biochemistry and Molecular Biology, 71(5–6), 213–222. [DOI:10.1016/s0960-0760(99)00143-0]
    • Lauritzen, C. (1984). Pre- and Postmenopause. In Platt, D. (Ed.). Geriatrics 3: Gynecology · Orthopaedics · Anesthesiology · Surgery · Otorhinolaryngology · Ophthalmology · Dermatology (pp. 2–45). Berlin/Heidelberg: Springer Berlin Heidelberg. [DOI:10.1007/978-3-642-68976-5_1]
    • Lemmey, A. B., Elamanchi, S. R., Marcora, S. M., Casanova, F., & Maddison, P. J. (2013). Efficacy of nandrolone decanoate in treating rheumatoid cachexia in male rheumatoid arthritis patients. In Matsuno, H. (Ed.). Innovative Rheumatology (pp. 271–285). Rijeka, Croatia: InTech. [DOI:10.5772/53236]
    • Liu, P. Y., & Handelsman, D. J. (1998). Androgen therapy in non-gonadal disease. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 473–512). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_17]
    • Marks, L. S. (2004). 5α-reductase: history and clinical importance. Reviews in Urology, 6(Suppl 9), S11–S21. [Google Scholar] [PubMed] [PubMed Central]
    • Mella, J. M., Perret, M. C., Manzotti, M., Catalano, H. N., & Guyatt, G. (2010). Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia. Archives of Dermatology, 146(10), 1141–1150. [DOI:10.1001/archdermatol.2010.256]
    • Need, A. (1989). Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis. Bone, 10(1), 3–6. [DOI:10.1016/8756-3282(89)90139-7]
    • Neff, M. S., Goldberg, J., Slifkin, R. F., Eiser, A. R., Calamia, V., Kaplan, M., Baez, A., Gupta, S., & Mattoo, N. (1981). A Comparison of Androgens for Anemia in Patients on Hemodialysis. New England Journal of Medicine, 304(15), 871–875. [DOI:10.1056/nejm198104093041504]
    • Nieschlag, E. (2010). Clinical trials in male hormonal contraception. Contraception, 82(5), 457–470. [DOI:10.1016/j.contraception.2010.03.020]
    • Nieschlag, E., & Behre, H. M. (2012). The essential role of testosterone in hormonal male contraception. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 470–493). Cambridge/New York: Cambridge University Press. [DOI:10.1017/cbo9781139003353.023]
    • Nieschlag, E., Kumar, N., & Sitruk-Ware, R. (2013). 7α-Methyl-19-nortestosterone (MENTR): the Population Council’s contribution to research on male contraception and treatment of hypogonadism. Contraception, 87(3), 288–295. [DOI:10.1016/j.contraception.2012.08.036]
    • Pan, M. M., & Kovac, J. R. (2016). Beyond testosterone cypionate: evidence behind the use of nandrolone in male health and wellness. Translational Andrology and Urology, 5(2), 213–219. [DOI:10.21037/tau.2016.03.03]
    • Passeri, M., Pedrazzoni, M., Pioli, G., Butturini, L., Ruys, A., & Cortenraad, M. (1993). Effects of nandrolone decanoate on bone mass in established osteoporosis. Maturitas, 17(3), 211–219. [DOI:10.1016/0378-5122(93)90049-n]
    • Peters, A. A., Ingman, W. V., Tilley, W. D., & Butler, L. M. (2011). Differential Effects of Exogenous Androgen and an Androgen Receptor Antagonist in the Peri- and Postpubertal Murine Mammary Gland. Endocrinology, 152(10), 3728–3737. [DOI:10.1210/en.2011-1133]
    • Peterson, R. E., Imperato-McGinley, J., Gautier, T., & Sturla, E. (1977). Male pseudohermaphroditism due to steroid 5α-reductase deficiency. The American Journal of Medicine, 62(2), 170–191. [DOI:10.1016/0002-9343(77)90313-8]
    • Propecia Finasteride Label. U.S. Food and Drug Administration. [URL] [PDF]
    • Prunty, F. T., Brooks, R. V., Clayton, B. E., & McSwiney, R. R. (1958). Some Effects of 17α-Ethyl-19-Nortestosterone in Man. Proceedings of the Royal Society of Medicine, 51(7), 557–558. [Google Scholar] [PubMed] [PubMed Central]
    • Roche, A., Towns, J. W., & Wettenhall, H. (1963). Influence of norethandrolone on the stature of short children. The Journal of Pediatrics, 63(5), 967–976. [DOI:10.1016/s0022-3476(63)80228-0]
    • Russell, N., & Grossmann, M. (2019). MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone. European Journal of Endocrinology, 181(1), R23–R43. [DOI:10.1530/eje-18-1000]
    • Sardar, P., Jha, A., Roy, D., Majumdar, U., Guha, P., Roy, S., Banerjee, R., Banerjee, A. K., & Bandyopadhyay, D. (2010). Therapeutic Effects of Nandrolone and Testosterone in Adult Male HIV Patients With AIDS Wasting Syndrome (AWS): A Randomized, Double-Blind, Placebo-Controlled Trial. HIV Clinical Trials, 11(4), 220–229. [DOI:10.1310/hct1104-220]
    • Sartorius, G. A., Ly, L. P., & Handelsman, D. J. (2014). Male Sexual Function Can Be Maintained Without Aromatization: Randomized Placebo‐Controlled Trial of Dihydrotestosterone (DHT) in Healthy, Older Men for 24 Months. The Journal of Sexual Medicine, 11(10), 2562–2570. [DOI:10.1111/jsm.12550]
    • Sas, T., Gault, E., Zeger Bardsley, M., Menke, L., Freriks, K., Perry, R., Otten, B., de Muinck Keizer-Schrama, S., Timmers, H., Wit, J., Ross, J., & Donaldson, M. (2014). Safety and Efficacy of Oxandrolone in Growth Hormone-Treated Girls with Turner Syndrome: Evidence from Recent Studies and Recommendations for Use. Hormone Research in Paediatrics, 81(5), 289–297. [DOI:10.1159/000358195]
    • Schürmeyer, T., Belkien, L., Knuth, U., & Nieschlag, E. (1984). Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. The Lancet, 323(8374), 417–420. [DOI:10.1016/s0140-6736(84)91752-5]
    • Simpson, E. R., & Jones, M. E. (2007). Of Mice and Men: The Many Guises of Estrogens. In Korach, K. S., & Wintermantel, T. (Eds.). Tissue-Specific Estrogen Action: Novel Mechanisms, Novel Ligands, Novel Therapies (Ernst Schering Foundation Symposium Proceedings, Volume 2006/1) (pp. 45–68). Berlin/Heidelberg: Springer. [DOI:10.1007/2789_2006_016]
    • Skroza, N., Tolino, E., Mambrin, A., Zuber, S., Balduzzi, V., Marchesiello, A., Bernardini, N., Proietti, I., & Potenza, C. (2018). Adult Acne Versus Adolescent Acne: A Retrospective Study of 1,167 Patients. The Journal of Clinical and Aesthetic Dermatology, 11(1), 21–25. [Google Scholar] [PubMed] [PubMed Central] [URL]
    • Styne, D. M., & Grumbach, M. M. (2016). Physiology and Disorders of Puberty. In Melmed, S., Polonsky, K. S., Larsen, P. R., Kronenberg, & H. M. (Eds.). Williams Textbook of Endocrinology, 13th Edition (pp. 1074–1218). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-29738-7.00025-3]
    • Sundaram, K., & Kumar, N. (2000). 7alpha-Methyl-19-nortestosterone (MENT): the optimal androgen for male contraception and replacement therapy. International Journal of Andrology, 23(S2), 13–15. [DOI:10.1046/j.1365-2605.2000.00004.x]
    • Sundaram, K., Kumar, N., & Bardin, C. W. (1994). 7α-Methyl-19-nortestosterone: An Ideal Androgen for Replacement Therapy. In Bardin, W. C. (Ed.). Proceedings of the 1992 Laurentian Hormone Conference (Recent Progress in Hormone Research, Volume 49) (pp. 373–376). San Diego: Academic Press. [DOI:10.1016/b978-0-12-571149-4.50027-1]
    • Sundaram, K., Kumar, N., Monder, C., & Bardin, C. (1995). Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens. The Journal of Steroid Biochemistry and Molecular Biology, 53(1–6), 253–257. [DOI:10.1016/0960-0760(95)00056-6]
    • Suvisaari, J. (2000). 7α-Methyl-19-Nortestosterone (MENT): Pharmacokinetics and Antigonadotropic Effects in Men. (Doctoral dissertation, University of Helsinki.) Helsinki: University of Helsinki. [Google Scholar] [URL] [PDF]
    • Thirumalai, A., Ceponis, J., Amory, J. K., Swerdloff, R., Surampudi, V., Liu, P. Y., Bremner, W. J., Harvey, E., Blithe, D. L., Lee, M. S., Hull, L., Wang, C., & Page, S. T. (2018). Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill. The Journal of Clinical Endocrinology & Metabolism, 104(2), 423–432. [DOI:10.1210/jc.2018-01452]
    • Tóth, M. (2009). Mioanabolikus Szteroidok és Szelektív Androgénreceptormodulátorok: Hatásmechanizmus és Terápiás Perspektívák. [Myoanabolic Steroids and Selective Androgen Receptor Modulators: Mechanism of Action and Perspectives. Orvosi Hetilap, 150(45), 2051–2059. [DOI:10.1556/oh.2009.28739] [Translation]
    • Tóth, M., & Zakár, T. (1986). Classification of Anabolic Steroids Using the Method of Competitive Metabolism. Experimental and Clinical Endocrinology & Diabetes, 87(2), 125–132. [DOI:10.1055/s-0029-1210533]
    • Trost, L., Saitz, T. R., & Hellstrom, W. J. (2013). Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review. Sexual Medicine Reviews, 1(1), 24–41. [DOI:10.1002/smrj.3]
    • van der Vies, J. (1985). Implications of basic pharmacology in the therapy with esters of nandrolone. Acta Endocrinologica, 110(3 Suppl a), S38–S44. [DOI:10.1530/acta.0.109s0038]
    • van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015). Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews, 2015, CD010334. [DOI:10.1002/14651858.cd010334.pub2]
    • Vetri, M., Cataldi, A., Naselli, A., & Vetri, A. (2021). Transsexualism Ethiology and Medical Management: Between Scientific Evidence and Personal Experiences. Preprints, 2021030172. [DOI:10.20944/preprints202103.0172.v1]
    • Wibowo, E., Schellhammer, P., & Wassersug, R. J. (2011). Role of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation Therapy. Journal of Urology, 185(1), 17–23. [DOI:10.1016/j.juro.2010.08.094]
    • Wibowo, E., & Wassersug, R. J. (2013). The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy. Critical Reviews in Oncology/Hematology, 87(3), 224–238. [DOI:10.1016/j.critrevonc.2013.01.006]
    • Winters, S. J. (1990). Androgens: Endocrine Physiology and Pharmacology. In Lin, G. C., & Erinoff, L. (Eds.). Anabolic Steroid Abuse (National Institute on Drug Abuse Research Monograph Series, Volume 102) (pp. 113–130). Rockville, Maryland: National Institute on Drug Abuse/U.S. Department of Health and Human Services. [Google Scholar] [PubMed] [Google Books] [PDF]
    • World Health Organization & Task Force on Methods for the Regulation of Male Fertility. (1993). Comparison of two androgens plus depot-medroxyprogesterone acetate for suppression to azoospermia in Indonesian men. Fertility and Sterility, 60(6), 1062–1068. [DOI:10.1016/s0015-0282(16)56411-5]
    • Wu, C., & Kovac, J. R. (2016). Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health. Current Urology Reports, 17(10), 72. [DOI:10.1007/s11934-016-0629-8]
    • Wu, S., Yuen, F., Swerdloff, R. S., Pak, Y., Thirumalai, A., Liu, P. Y., Amory, J. K., Bai, F., Hull, L., Blithe, D. L., Anawalt, B. D., Parman, T., Kim, K., Lee, M. S., Bremner, W. J., Page, S. T., & Wang, C. (2018). Safety and Pharmacokinetics of Single-Dose Novel Oral Androgen 11β-Methyl-19-Nortestosterone-17β-Dodecylcarbonate in Men. The Journal of Clinical Endocrinology & Metabolism, 104(3), 629–638. [DOI:10.1210/jc.2018-01528]
    • Yuen, F., Thirumalai, A., Pham, C., Swerdloff, R. S., Anawalt, B. D., Liu, P. Y., Amory, J. K., Bremner, W. J., Dart, C., Wu, H., Hull, L., Blithe, D. L., Long, J., Wang, C., & Page, S. T. (2020). Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonadotropins in Healthy Men. The Journal of Clinical Endocrinology & Metabolism, 105(3), e835–e847. [DOI:10.1210/clinem/dgaa032]
    \ No newline at end of file diff --git a/transfemscience.org/articles/nonbinary-transfem-overview/index.html b/transfemscience.org/articles/nonbinary-transfem-overview/index.html index 782a16f7..d76734de 100644 --- a/transfemscience.org/articles/nonbinary-transfem-overview/index.html +++ b/transfemscience.org/articles/nonbinary-transfem-overview/index.html @@ -1 +1 @@ -An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People - Transfeminine Science Link

    An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People

    By Aly | First published June 13, 2019 | Last modified September 26, 2022

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    Abstract / TL;DR

    Transfeminine people who are non-binary often desire different and more partial feminizing and demasculinizing changes compared to what occurs with conventional transfeminine hormone therapy. For example, non-binary transfeminine people may seek an intermediate physical and hormonal state between what is typical for males and females, may desire substantial or full feminization and demasculinization without breast development, may want to have a more sexually neutral or androgynous appearance, or may wish for feminization but concomitant preservation of more male-typical sexual desire and capacity. These partial goals for transfeminine hormone therapy are being increasingly encountered, but therapeutic methods for achieving them have not yet been studied or established in transgender medicine. Nonetheless, there are a variety of hormonal approaches by which such outcomes could theoretically be achieved. Demasculinization can be produced via partial to full testosterone suppression or blockade using varied doses of antiandrogens, progestogens, and/or gonadotropin-releasing hormone modulators. Feminization and other estrogenic effects with less or no breast development may be produced with selective estrogen receptor modulators or low doses of estradiol. Certain other hormonal agents can be used to achieve various specific effects, like 5α-reductase inhibitors to reduce body hair growth and scalp hair loss, topical androgens applied to the breasts to reduce breast development, and the androgen and anabolic steroid nandrolone decanoate as an alternative to testosterone with less effect in skin and hair follicles. Besides hormonal means, breast removal surgery can be sought to negate breast development. Health risks, particularly those related to androgen deprivation without adequate estrogenic replacement, are a concern with partial approaches to hormone therapy. One such risk, bone density loss, may be reduced with calcium and vitamin D supplementation, bisphosphonates, and weight-bearing exercise. There is increasing interest in partial approaches to hormone therapy in transgender health, so hopefully they will become better characterized and more available and utilized in transgender people in the future.

    Introduction

    “Non-binary” is a term that refers to transgender people who do not identify within the gender binary. Despite the fact that they do not identify as either male or female, many non-binary transmasculine and transfeminine people pursue hormone therapy just like transgender men and women. While some non-binary individuals opt for a full hormonal transition similarly to most binary-identified transgender people, many non-binary people would prefer only a partial hormonal transition. This could be to achieve an intermediate area between masculine and feminine characteristics, to achieve a more sexually neutral appearance, or to induce some but not all aspects of masculinization or feminization.

    There are also individuals who seek hormonal feminization and/or demasculinization but do not actually identify as transgender. These cisgender-identified individuals often refer to themselves as “femboys”. Communities of these individuals exist on social media sites like Reddit (e.g., r/FemboyTransition). Feminization-inclined cisgender people who pursue hormonal transition often have similar preferences as transfeminine non-binary people—one of the most common of which is feminization without breast development. Sometimes these initially cisgender-identified hormonally transitioning individuals end up progressing to a transgender identity with time.

    Partial approaches to hormonal transition and even widespread identification as non-binary are fairly recent developments. There is very little written on non-conventional approaches to hormone therapy of this sort in the published literature. Moreover, there are no available standards or guidelines for such therapy at this time. A number of recent reviews have started to discuss possibilities for non-binary hormone therapy however (Richards et al., 2016; Seal, 2017; Bass et al., 2018; Cocchetti et al., 2020). There is currently a discordance between the number of people who desire non-conventional hormonal transition and the clinical establishment of such therapy. Consequently, an exploration of the possibilities from a theoretical standpoint would be of value and is the aim of this review.

    As a disclaimer, the ideas in this article are experimental and preliminary. No studies with the goal of partial hormonal transition in transgender people have been conducted as of present and there is no data or evidence in non-binary people to inform the use of such approaches. Instead, we can only extrapolate from theory and research in other groups of people at this time. Examples of these other groups in the case of transfeminine non-binary hormone therapy include cisgender men undergoing hormone therapy for prostate cancer, cisgender men going through treatment for gynecomastia (male breast development), and transgender women undergoing hormone therapy. For these reasons, the present discussion is exploratory and should not be taken as therapeutic recommendations.

    Conventional Transfeminine Hormone Therapy

    The goal of therapy in conventional hormone therapy for transgender women is to produce the maximum degrees of demasculinization and feminization—including breast development—that are possible. This is achieved by suppressing testosterone levels and increasing estradiol levels such that they are both within normal adult female ranges. Alternatively, the actions of testosterone can be blocked instead of full suppression of testosterone levels. The relevant hormonal changes are accomplished through the administration of hormonal medications including estrogens, progestogens, and/or antiandrogens. Estrogens produce feminization, including breast development, while testosterone suppression causes demasculinization—as well as disinhibits feminization. Estrogens, progestogens, and antiandrogens can all contribute to testosterone suppression.

    The specific medications used in conventional transfeminine hormone therapy include estradiol and estradiol esters such as estradiol valerate; antiandrogens like spironolactone, bicalutamide, and gonadotropin-releasing hormone (GnRH) agonists and antagonists; and progestogens such as progesterone and cyproterone acetate (CPA). Androgen synthesis inhibitors such as the 5α-reductase inhibitors (5α-RIs) are also used. 5α-RIs inhibit the metabolism of testosterone into the more potent dihydrotestosterone (DHT), a conversion which only occurs in certain tissues. They have limited tissue-selective antiandrogenic effects, for instance in skin and hair follicles.

    The therapeutic goals of a subset of non-binary transfeminine people are equivalent to those of transgender women and hence are compatible with the effects of conventional transfeminine hormone therapy. That is, the maximum possible feminization, including breast development, and demasculinization are the aims of therapy. Non-binary transfeminine people with these preferences can simply use conventional transfeminine hormone therapy for their hormonal transition as opposed to more experimental and non-conventional partial approaches.

    For a comprehensive introduction to conventional transfeminine hormone therapy, see this article:

    The above article is intended to provide everything one needs to know to achieve a basic understanding of the subject. If you are new to the topic of transgender hormone therapy, it is highly recommended reading prior to continuing in the current article. The introduction covers the sex hormones, their effects, specific hormonal medications used, routes, and dosages for this type of hormone therapy. Much of this information is also applicable to non-conventional transfeminine hormone therapy.

    Partial Transfeminine Hormone Therapy

    Some non-binary transfeminine people (as well as cisgender-identified individuals seeking hormonal feminization) desire only partial feminization and/or demasculinization. Depending on the specific aims, this can be more complicated and require more thought than conventional transfeminine hormone therapy. The following goals of partial transfeminine hormone therapy may be encountered:

    • An intermediate physical and hormonal state between male and female
    • A more sexually neutral or androgynous appearance that is not necessarily masculine or feminine
    • Substantial or maximal feminization and demasculinization with little or no breast development
    • Substantial or maximal feminization and demasculinization with minimal or no loss of sexual desire, sexual function (i.e., erectile and orgasmic capacity), and/or fertility

    The first of these goals is fairly straightforward in that it can entail what is essentially conventional transfeminine hormone therapy using lower medication doses. This will result in partial testosterone suppression and a mixture of both androgens and estrogens as major active sex hormones. The second goal involves deprivation of both androgens and estrogens. While possible, this can have negative consequences as sex hormones are important for maintaining certain aspects of health and well-being. There are potential ways to avoid or mitigate such consequences however. The third and fourth goals are also technically possible but are more difficult to achieve and are likely to require more specialized and potentially complex hormonal approaches.

    Suppression and Blockade of Testosterone

    If the goal of non-binary transfeminine hormone therapy is simply to achieve an androgynous appearance with minimal or no feminization, this can be achieved via deprivation of testosterone without concomitant administration of an estrogen. There are multiple ways to achieve androgen deprivation or testosterone suppression in people assigned male at birth. These include high-dose progestogen therapy, medical and surgical castration with GnRH agonists/antagonists or gonadectomy, high-dose androgen receptor antagonist therapy, and a few other other possibilities. In this section, I’ll discuss androgen deprivation largely from the standpoint of efficacy. There are problems with androgen deprivation alone in terms of tolerability and safety due to the co-consequence of estrogen deficiency however, which I’ll discuss in the subsequent section.

    Testosterone Suppression with High Doses of Progestogens

    Androgen deprivation can be achieved with high doses of progestogens, which suppress testosterone levels by up to 50 to 70% (Aly, 2019). This is a substantial decrease in testosterone levels, but is not quite into the female range. Androgen receptor antagonists can additionally be included to block the remaining testosterone that is not suppressed if desired. For these purposes, low-dose cyproterone acetate (e.g., 5.0–12.5 mg/day) (Aly, 2019) plus bicalutamide (e.g., 12.5–50 mg/day) or spironolactone (e.g., 200–400 mg/day) is likely to be an effective regimen. As an alternative to cyproterone acetate, high doses of other progestogens, such as just about any other progestin, or alternatively rectal progesterone (Aly, 2018), can be used instead.

    Testosterone Suppression with Medical or Surgical Castration

    GnRH agonists and antagonists are another option for testosterone suppression. These medications suppress testosterone levels by about 95%, or into the normal female range or male castrate range (<50 ng/dL). However, GnRH agonists and antagonists are very expensive, although there may be some viable options for obtaining them more cheaply (e.g., certain online pharmacies) (Aly, 2019).

    Gonadectomy, or surgical removal of the gonads, can be performed as a more permanent alternative to GnRH agonists and antagonists. However, this procedure is expensive (a few thousand dollars USD), requires minor surgery, and can be more difficult to obtain. Most surgeons require letters from gender therapists and real-life experience; informed-consent surgeons do exist however. Gonadectomy is also irreversible, notably resulting in permanent loss of testes and sterility. In any case, gonadectomy is far less expensive and more convenient than GnRH agonists and antagonists in the long run.

    Testosterone Blockade with Antiandrogens

    Androgen receptor antagonists like bicalutamide and spironolactone act by directly binding to the androgen receptor and displacing androgens like testosterone and DHT from the receptor, thereby preventing its activation by these androgens. This is in contrast to therapies that act by suppressing androgen production and levels.

    High-dose bicalutamide monotherapy (e.g., 150–300 mg/day) is a possible approach for androgen deprivation therapy. However, bicalutamide monotherapy increases testosterone and hence estradiol levels. The testosterone will be blocked by bicalutamide and will not have effects, but estradiol is increased to a concentration range that allows for marked or full feminization, including breast development. In addition, bicalutamide alone, even at very high doses, might not be enough to completely block male-range testosterone. With these considerations, if the goal is full demasculinization with no feminization or breast development, bicalutamide monotherapy is not something that, at least alone, can achieve this.

    High-dose bicalutamide is expensive and potentially cost-prohibitive. High-dose spironolactone monotherapy is not a good option for this route as it is a relatively weak antiandrogen and likely falls far short of being able to handle male-range levels of testosterone (at least 200 mg/day appears to be required to fully block female testosterone levels) (Aly, 2018; Wiki). Concomitant partial suppression of testosterone and estrogen levels via additional use of a progestogen (e.g., cyproterone acetate) may be a more feasible option than an androgen receptor antagonist alone.

    Some potentially major advantages of high-dose bicalutamide monotherapy are that in contrast to marked or full suppression of testosterone levels, bicalutamide monotherapy largely preserves sexual desire and erectile function and likely does not result in infertility.

    Other Options for Testosterone Suppression

    Another option is only partial demasculinization, which can be achieved essentially by using lower dosages of the medications discussed above (e.g., cyproterone acetate, bicalutamide). If desired, 5α-reductase inhibitors can be added in this context to more substantially decrease scalp hair loss and body hair growth. Note that if testosterone is more fully suppressed or blocked however, there is likely to be little or no benefit with 5α-reductase inhibitors.

    Yet another possibility could be to incorporate low-dose nandrolone decanoate, an androgen receptor agonist and anabolic–androgenic steroid (AAS) with much less masculinizing/androgenic effect in skin and hair follicles (Aly, 2020). This AAS will help to suppress and replace testosterone levels. Nandrolone decanoate might also have the benefit of helping to maintain sexual desire and function. However, nandrolone decanoate was recently discontinued in the United States. Oxandrolone is another, similar AAS, but has been associated with liver toxicity.

    Estrogen Deficiency and Replacement

    While androgen deprivation therapy is effective for achieving the desired changes—specifically demasculinization without feminization—it is not recommended by itself. This is because estradiol is produced from testosterone and hence androgen deprivation results in estrogen deficiency as well. Estrogens are essential for maintaining bone density in both men and women, and without them, a person will quickly lose bone mass, eventually develop osteoporosis, and be at a high risk for bone fractures. Skeletal and postural disfigurement may also eventually occur (Figure; Figure). In addition, the person is likely to experience other menopause-like symptoms, such as hot flashes, mood and sleep problems, sexual dysfunction (e.g., low sexual desire, erectile dysfunction), and accelerated aging of the skin (Wiki). An increased risk of weight gain, type 2 diabetes, cardiovascular disease, and dementia may be associated with sex hormone deficiency as well. As such, extended deprivation of both androgens and estrogens with no estrogenic supplementation is not advisable.

    With that said, a couple of clarifications should be made. Due to preservation of estradiol levels, high-dose bicalutamide monotherapy has minimal to no risk of bone density loss or most other menopausal symptoms. In addition, the low-dose cyproterone acetate plus low-dose bicalutamide option may have less of a risk of menopausal symptoms and possibly osteoporosis as well. This is because high-dose progestogens (of which “low-dose” cyproterone acetate certainly qualifies) can help treat certain menopausal symptoms such as hot flashes and possibly bone density loss, and also because some estradiol will be preserved (since testosterone will only be suppressed by 70 to 80% rather than more fully). With that said however, in the latter case, it is probably best not to take any risks.

    Selective Estrogen Receptor Modulators (SERMs)

    Instead of only androgen and estrogen deprivation, the inclusion of selective estrogen receptor modulators (SERMs), so-called partial estrogens, can be employed. These medications are partial agonists of the estrogen receptor, and have mixed estrogenic and antiestrogenic effects depending on the tissue. For example, the SERM raloxifene has estrogenic effects in bone, fat tissue, and the liver, but antiestrogenic effects in the breasts. In general, SERMs reduce bone density loss and osteoporosis risk while not causing breast development (and actually blocking it). A full list of SERMs can be found here. However, practically speaking, only raloxifene (Evista), tamoxifen (Nolvadex), and toremifene (Fareston) are available, inexpensive, and commonly used. For an overview of the estrogenic and antiestrogenic effects of the different SERMs in different tissues, see here. In general, SERMs have a fairly similar pattern of effects. Although we have some idea of the differential tissue effects of SERMs, in many cases we do not know how they behave in specific tissues. For example, only a single clinical study has shown that a SERM, specifically raloxifene, has estrogenic effects in fat tissue (Francucci et al., 2014). In addition, it is less clear how SERMs behave in, for example, skin, or in most of the brain.

    SERMs also have various side effects. For instance, SERMs commonly produce hot flashes as an adverse effect. However, the fairly recently introduced combination of bazedoxifene/conjugated estrogens (Duavee) has been found to reduce the incidence of hot flashes in postmenopausal women (Duavee label). It is still on-patent and hence is expensive however. In any case, SERMs are also likely to produce other menopause-like symptoms. Additionally, SERMs have estrogenic effects in the liver and therefore influence production of coagulation factors and decrease production of insulin-like growth factor-1 (IGF-1), among other potentially undesirable changes. Due to the increase in coagulation with SERMs, they have a notable risk of blood clots and cardiovascular complications like stroke (Aly, 2020). Some SERMs, like tamoxifen, also have unique off-target actions and risks, for instance rare liver toxicity. Raloxifene is a more selective and probably safer SERM than tamoxifen.

    SERMs are effective for maintaining bone density. However, they are, unfortunately, only partially estrogenic in bone and hence are submaximally effective for such purposes—they are significantly more effective than no treatment at all but are not as effective as estrogens (Dane et al., 2007; Zirilli et al., 2009; Birzniece et al., 2012; Vestergaard, 2012). Indeed, SERMs have actually been found to significantly antagonize the effects of estradiol on bone, for instance on bone density in premenopausal women (Powles et al., 1996; Burshell et al., 1999) and on bone maturation and growth plate closure in cisgender girls with precocious puberty (Passone et al., 2015). One study in elderly men suggested that 60 mg/day raloxifene is maximally equivalent in terms of bone density effect to estradiol levels of about 26 pg/mL (Doran et al., 2001; Palacios et al., 2020). Below this estradiol level, raloxifene was estrogenic on bone density, whereas above this level, it was antiestrogenic on bone density (Doran et al., 2001; Palacios et al., 2020). As such, although SERMs increase bone density in the context of very low estradiol levels, they are not as effective as estrogens in terms of maintaining bone density and they may still allow for significantly decreased bone density when added to androgen deprivation in non-binary transfeminine people.

    Low-Dose Estrogen Supplementation

    An alternative to SERMs for avoiding estrogen deficiency is low-dose estrogen therapy. A dosage of oral estradiol of about 1 to 2 mg/day or estradiol levels of about 30 to 50 pg/mL (via another route, for instance transdermal patches) is all that is needed for complete or near-complete prevention of bone density loss (Barbieri, 1992; Roux, 1997; Hadji, Colli, & Regidor, 2019). Moreover, estradiol has a better tolerability and safety profile than SERMs, with a much lower risk of blood clots (Aly, 2020).

    A problem with estrogen therapy however is that in the absence of androgens, estrogens even at low levels will induce substantial feminization and breast development. Estradiol levels in normal cisgender girls gradually increase from around 5 to 10 pg/mL at the start of puberty to 50 or 60 pg/mL by late puberty, and these low levels produce full developent of the female secondary sex characteristics (Aly, 2020). Similarly, cisgender females with complete androgen insensitivity syndrome (CAIS) have estradiol levels of only about 35 pg/mL on average yet have complete feminization and excellent breast development (Aly, 2020; Table). Hence, the addition of low-dose estradiol to androgen deprivation would likely be a full transition. Very low doses of estradiol, for instance 0.5 mg/day oral estradiol or a 14 μg/day estradiol patch, achieving estradiol levels of only maybe 20 pg/mL, may be feasible and may result in less feminization. But, while effective for improving bone density (Dane et al., 2007; Birzniece et al., 2012), such doses/levels would not fully protect against bone density loss and other menopause-like symptoms and would likely still produce at least partial feminization. It is notable that even GnRH agonists/antagonists and gonadectomy alone—which reduce estradiol levels to around 10 pg/mL—have a rate of mild gynecomastia of as high as 15% (Di Lorenzo et al., 2005).

    Other Therapies for Bone Maintenance

    In addition to SERMs and estrogens, other measures to maintain bone mineral density are effective and could be included for further benefit to bone health. Examples include calcium supplementation, vitamin D supplementation, and bisphosphonates like alendronic acid (Fosamax) and zoledronic acid (Zometa) (Chen, Ko, & Chen, 2019; Rizzoli, 2018). Bisphosphonates have adverse effects and risks however. Weight-bearing exercise is also beneficial for bone density (Rizzoli, 2018).

    Interestingly, spironolactone was found at 100 mg/day to fully prevent GnRH agonist-induced bone density loss in women in a small randomized controlled trial (Moghetti et al., 1999). The authors hypothesized that this was due to its antimineralocorticoid activity, as aldosterone is negatively correlated with bone density (Moghetti et al., 1999). However, in another study, 100 mg/day spironolactone did not prevent bone density loss caused by high-dose progestogen therapy in the form of 5 mg/day lynestrenol in women (Preželj & Kocijančič, 1994; Preželj & Kocijančič, 1999). Hence, spironolactone should not be relied upon for preservation of bone density.

    Onset and Reversibility of Bone Loss

    Certain medications used in premenopausal women suppress gonadal sex hormone production and are associated with decreased bone density. These therapies can provide insight on the risk of bone density loss that may occur in non-binary transfeminine people deprived of sex hormones. Examples of such medications include progestogen-only birth control, which partially suppresses estradiol levels (to around 20–50 pg/mL) (Hadji, Colli, & Regidor, 2019), and GnRH agonists/antagonists, which partially to fully suppress estradiol levels depending on the medication and dose. Minimal or no bone density loss occurs with estradiol levels of 30 to 50 pg/mL, whereas significant bone density loss occurs with estradiol levels of 20 to 30 pg/mL (Hadji, Colli, & Regidor, 2019). Reassuringly however, bone density has been found to substantially or fully recover within a few years following discontinuation of progestogen-only birth control in young premenopausal women (Nelson, 2010). Along similar lines, therapy with the GnRH antagonist elagolix is considered to be acceptably safe in premenopausal women for up to 2 years at a dose that results in partial suppression of estradiol levels (to about 40 pg/mL) and for up to 6 months at a dose that results in maximal suppression of estradiol levels (to about 10 pg/mL) (Wiki). As such, a limited period of sex hormone deprivation—for instance as a trial of non-binary transfeminine hormone therapy—may be reasonably safe in terms of bone health. Long-term therapy should include adequate measures to avoid bone density loss however.

    Prevention of Breast Development

    Estrogen Blockade and Suppression

    If the goal is to produce full demasculinization and some or full feminization with the sole exception of breast development, there are a number of ways to possibly achieve this. Androgen deprivation without estrogen supplementation will achieve demasculinization without any feminization or breast development (except for bicalutamide monotherapy of course). However, it is not recommended for reasons described above and would not provide feminization. SERMs are an option; in addition to their capacity to treat osteoporosis, they are used to treat gynecomastia in men, and are capable of fully blocking gynecomastia induced by estrogens when used at sufficient doses (Fentiman, 2018). However, SERMs may allow for only partial feminization rather than full. Aromatase inhibitors, in contrast to SERMs, have no apparent place in this form of hormone therapy, as they are, surprisingly, poorly effective for prevention of gynecomastia (Fagerlund et al., 2015; Bedognetti et al., 2010).

    Selective Estrogen Receptor Modulators and Testosterone Elevation

    SERMs can be used to prevent breast development, as previously described. A problem with the use of SERMs for this purpose however is that when they are used in people assigned male at birth in whom the gonads are intact and testosterone levels are not suppressed, they will induce substantial increases in gonadal testosterone production and circulating testosterone levels. In men with hypogonadism and consequent low testosterone levels, the SERMs clomifene (20–50 mg/day) and enclomifene (12.5–25 mg/day) increase testosterone levels from about 200–300 ng/dL to about 450–600 ng/dL on average (a change of about 2.0- to 2.5-fold, with an absolute increase of 250–400 ng/dL in this patient population) (Bach, Najari, & Kashanian, 2016; Trost & Khera, 2014). Because they are so effective at increasing testosterone levels, SERMs are used to treat male hypogonadism as an alternative to exogenous testosterone administration. Worse still, SERMs appear to cause even greater increases in testosterone levels in non-hypogonadal men. One study found that 50 mg/day clomifene increased testosterone levels by about 850 ng/dL in healthy younger men and by about 500 ng/dL in elderly men (Trost & Khera, 2014). Similarly, strong increases in testosterone levels have been observed with partial suppression of estradiol levels via aromatase inhibition in young and older men (T’Sjoen et al., 2005; Raven et al., 2006; de Ronde et al., 2009).

    If testosterone levels are suppressed, increases in testosterone levels with SERMs will, depending on the degree of testosterone suppression, be less applicable (e.g., with high-dose progestogen therapy) or not applicable at all (e.g., with medical/surgical castration). However, if a SERM is combined with, say, bicalutamide alone, the situation may become even worse. This is because bicalutamide itself produces considerable increases in testosterone levels similarly to SERMs. In elderly men with prostate cancer, bicalutamide monotherapy induces a 1.5- to 2.0-fold rise in testosterone levels, increasing them from about 300–400 ng/dL to about 500–600 ng/dL (an absolute change of about 150–250 ng/dL) (Wiki). In healthy younger men, bicalutamide may increase testosterone levels into the upper end of the normal male range (potentially into the range of around 900–1,200 ng/dL) (Wiki).

    As bicalutamide is a competitive antagonist of the androgen receptor, its efficacy is fundamentally both dose-dependent and dependent on testosterone levels. Consequently, in combination with a SERM, it is possible that testosterone levels will become too high for bicalutamide to block. Moreover, endogenous androgens and estrogens are together responsible for maintaining normal homeostatic negative feedback on the hypothalamic–pituitary–gonadal axis (HPG axis) in people assigned male at birth. It seems logical that with little to suppress the axis, gonadal production and hence circulating levels of testosterone and estradiol may simply continue to rise until they overwhelm bicalutamide and/or the SERM it is combined with and restore negative feedback on the HPG axis. For these reasons, it is possible that the combination of bicalutamide and a SERM alone might not be a practical option for non-conventional feminizing hormone therapy.

    With all of that said however, the combination of bicalutamide and tamoxifen has been assessed in various studies in men with prostate cancer (PubMed), and increases in testosterone levels have, rather surprisingly, not been a problem in these studies. In terms of the findings, bicalutamide and tamoxifen together do, as expected, increase total testosterone levels. However, the rise in total testosterone levels is not much different from that which occurs with bicalutamide alone. Moreover, free testosterone levels are either increased to a certain degree or are not actually raised at all (Boccardo et al., 2005; Saltzstein et al., 2005; Fradet et al., 2007). This is thought to be due to the fact that SERMs have potent estrogenic effects in the liver and result in increased production of sex hormone-binding globulin (SHBG), consequently reducing the fraction of free and hence bioactive testosterone in the circulation. This serves to offset the biological influence of the increase in total testosterone levels. In accordance, and reassuringly, unfavorable changes in markers of androgen receptor signaling, like higher prostate-specific antigen (PSA) levels, have not been observed relative to bicalutamide alone in the studies.

    It is not clear why studies of bicalutamide plus tamoxifen have observed increases in total testosterone levels that are not that different from those of bicalutamide alone. Whatever the reason, these studies suggest that the combination of bicalutamide and tamoxifen (or certain other SERMs) might actually be feasible still for non-conventional feminizing hormone therapy. With that said however, elderly men are a different patient population than non-binary transfeminine people. Older men have diminished increases in testosterone levels with bicalutamide and SERMs compared to healthy young men. In relation to this, the combination might not be as favorable for younger people assigned male at birth.

    Tamoxifen very well may be exchangeable with raloxifene for use in combination with bicalutamide. However, it should be noted that in contrast to tamoxifen, raloxifene has never been studied in combination with bicalutamide. Or, at least, not in gonadally intact men; one study of bicalutamide with raloxifene in castrated men with prostate cancer does exist, but that does not provide much in the way of useful information (Ho et al., 2017). Nor has raloxifene actually been properly studied for prevention of gynecomastia. A single retrospective chart review reported that it was effective for pubertal gynecomastia in boys (Lawrence et al., 2004). But that is all the data we have. Conversely, there are many high-quality studies of tamoxifen for prevention of gynecomastia, including in combination with bicalutamide.

    In any case, used by themselves in men, raloxifene has been found to result in lower increases in testosterone levels than tamoxifen or toremifene (Tsourdi et al., 2009). As such, bicalutamide and raloxifene together may indeed be similar in terms of testosterone levels relative to the combination of bicalutamide and tamoxifen. This might just be due to raloxifene having lower efficacy as a SERM than tamoxifen or toremifene at the relevant clinical doses however (Tsourdi et al., 2009).

    Topical Androgens

    Another possibility for prevention of breast development is topical application of a non-aromatizable androgen (i.e., an androgen that cannot be converted into an estrogen)—namely dihydrotestosterone (DHT; Andractim)—to the breasts. Androgens substantially oppose the actions of estrogens in the breasts, and both topical and systemic DHT have been reported to be effective in the treatment of gynecomastia similarly to SERMs in a number of small studies (Kuhn et al., 1982; Kuhn et al., 1983a; Kuhn et al., 1983b; Eberle & Keenan, 1985; Eberle, Sparrow, & Keenan, 1986; Caron et al., 1987; Keenan, Fagan, & Richards, 1989; De Corrado et al., 1998; Benveniste, Simon, & Herson, 2001). Other systemic androgens like nandrolone (Heresová et al., 1981; Heresová & Vrzanova, 2003) and danazol (Buckle, 1980; Ting, Chow, & Leung, 2000) have been reported to be effective as well.

    Unfortunately, pharmaceutical topical DHT is only available today in France (Drugs.com). Some compounding pharmacies in certain countries might provide topical DHT preparations. However, DHT does not seem to be available from any compounding pharmacies in the United States. In contrast to DHT, testosterone readily converts into estradiol via aromatization and can actually induce some gynecomastia due to excessive estrogenic exposure. As such, unlike non-aromatizable androgens like DHT, use of testosterone for this purpose is likely inappropriate. There are few or no other options for topical androgens besides testosterone and DHT, so the practicality of this approach is limited.

    In contrast to SERMs, topical androgens may not be fully effective for preventing breast development. Whereas SERMs can abolish breast development caused by estrogens, sufficient exposure to estrogens can still mediate significant breast development even in the context of strong androgenic exposure. In addition, topical application of androgens to the breasts is likely to cause local body hair growth and other local androgenic effects, like masculine skin changes, oily skin, and acne. For many transfeminine individuals, such changes would probably be unacceptable. Lastly, there is a risk of systemic distribution of the topically applied androgen (Kuhn et al., 1983a), and hence of elevated circulating androgen levels and androgenic effects elsewhere in the body. This risk would be lessened in combination with an androgen receptor antagonist like bicalutamide. However, androgen receptor antagonists also have the potential to block the local effects of the topical androgen.

    Breast Removal Surgery and Breast Irradiation

    Two non-medication-based alternatives for prevention of breast development are prophylactic surgical breast removal and prophylactic breast irradiation.

    If there is no excess skin, mastectomy, or breast removal surgery, can remove the breasts without leaving obvious scars, as was the case in this young transgender man. Mastectomy is a highly effective means of preventing breast development. Of course, it requires surgery however.

    Exposure of the breasts to radiation inhibits subsequent breast development (Photos). Irradiation of the breasts is an inexpensive, easy, and effective technique that is commonly used as prophylaxis against gynecomastia in men with prostate cancer treated with estrogens or high-dose bicalutamide monotherapy (Viani, da Silva, & Stefano, 2012). It is less effective than SERMs however and generally only reduces the severity of gynecomastia rather than fully prevents it (Viani, da Silva, & Stefano, 2012). More concerningly, there is a theoretical increased risk of breast cancer with exposure of the breasts to radiation (Aksnessæther et al., 2018). Research has found a 100-fold higher incidence of breast cancer in young women whose breasts were exposed to radiation during childhood as a consequence of radiotherapy for cancer when compared to other young women (Zacharin, 2010). On the other hand, limited available evidence so far suggests minimal if any increase in breast cancer incidence in elderly men on androgen deprivation and/or estrogen therapy treated with breast irradiation to prevent gynecomastia (Aksnessæther et al., 2018; Viani, da Silva, & Stefano, 2012). However, cancer radiotherapy and other forms of radiation exposure increase the risk of breast cancer in men, particularly those exposed at a young age (Niewoehner, 2008; Giordano, 2005). In addition to theoretical cancer risk, heart and lung issues have been associated with breast irradiation in elderly men with prostate cancer (Tunio et al., 2012; Viani, da Silva, & Stefano, 2012). Due to these health risks, breast irradiation for prevention of breast development is an inadvisable option.

    An obvious drawback of breast development prevention with both surgical breast removal and prophylactic breast irradiation is that they are irreversible. If the person ever changes their mind about not wanting breasts or eventually decides to fully transition (a not uncommon occurrence), there is no going back on the choice to permanently negate breast development.

    Degree, Onset, and Reversibility of Breast Development

    For reasons that are not entirely clear, it is notable that transfeminine people tend to have poor or suboptimal breast development relative to cisgender women (Wierckx, Gooren, & T’Sjoen, 2014; de Blok et al., 2018; Reisman, Goldstein, & Safer, 2019). Likewise, in generally elderly men with prostate cancer, high-dose bicalutamide monotherapy and high-dose estrogen therapy both cause high rates of gynecomastia but produce only mild-to-moderate gynecomastia in 90% of cases (Wiki; Ockrim et al., 2003). (Whether their advanced age is a factor here or not is uncertain but could be involved however.) Hence, any person who was assigned male at birth should, generally speaking or on average, not necessarily expect a marked degree of breast development. Small breasts should generally be anticipated as the most likely outcome. There are always exceptions however, with a subset of transfeminine people experiencing substantial breast development. Hence, the degree of breast development one experiences is a matter of chance, and caution should be advised.

    There are a few things to be aware of about breast development. One is that it happens slowly and is not something that becomes substantial overnight. Another is that will not continue to progress if hormones are withdrawn. And finally, it seems to be at least partially reversible if medications are discontinued within a certain amount of time (e.g., one year) (Mancino, Young, & Bland, 2018; Kanakis et al., 2019). However, a study found that bicalutamide monotherapy-induced gynecomastia outcome was worse if tamoxifen was introduced within a month of symptom onset rather than used from the start of therapy (Serretta et al. 2012). In any case, for the preceding reasons, a given individual could self-monitor their breast development, and, if it becomes too much for their liking, alter their medication regimen as desired in order to prevent further or reverse existing breast growth. Hence, breast development may not be something that should be feared excessively.

    Updates

    Update 1: Xu et al. (2021)

    In June 2021, the following review on SERMs for non-binary transfeminine people was published:

    • Xu, J. Y., O’Connell, M. A., Notini, L., Cheung, A. S., Zwickl, S., & Pang, K. C. (2021). Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care? Frontiers in Endocrinology, 12, 701364. [DOI:10.3389/fendo.2021.701364]

    The article is the first literature of its kind. In relation to the lack of evidence for the efficacy and safety of SERMs in non-binary transfeminine hormone therapy at present, it stated that SERMs should not be routinely recommended to non-binary transfeminine people. However, it was cautiously permissive of their use in non-binary transfeminine people who request them and provide informed consent. The review concluded that SERMs are a theoretically attractive potential option for non-binary transfeminine hormone therapy and called for clinical research on them for these purposes.

    Ada S. Cheung of Trans Health Research in Australia is a co-author on the paper.

    A handful of additional but more limited mentions as well as use instances of SERMs for non-binary transfeminine and transmasculine people have also occurred previously in the literature (Carswell & Roberts, 2017; Moser & Devereux, 2019; Pang et al., 2020; Naroji et al., 2021).

    Update 2: van Dijken et al. (2022) and Cocchetti et al. (2022)

    In March 2022, one of the first studies on tailored hormone therapy for non-binary people was published:

    • van Dijken, J. B., Steensma, T. D., Wensing-Kruger, S. A., Heijer, M. D., & Dreijerink, K. M. (2022). Tailored Gender-Affirming Hormone Treatment in Nonbinary Transgender Individuals: A Retrospective Study in a Referral Center Cohort. Transgender Health, 8(3), 220–225. [DOI:10.1089/trgh.2021.0032]

    Moreover, a review of the work by the European Network for the Investigation of Gender Incongruence (ENIGI) described future plans for research by the ENIGI into hormone therapy for non-binary people:

    • Cocchetti, C., Romani, A., Collet, S., Greenman, Y., Schreiner, T., Wiepjes, C., den Heijer, M., T’Sjoen, G., & Fisher, A. D. (2022). The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives. Journal of Clinical Medicine, 11(7), 1784. [DOI:10.3390/jcm11071784]

    Here are some excerpts from the review:

    The main future perspectives [of the ENIGI] should include the evaluation of the efficacy and safety of non-standardized hormonal treatment in non-binary trans people.

    Regarding GAHT protocols, all participants were treated in line with the World Professional Association for Transgender Health (WPATH) recommendations [2]. Originally, the binary conception of gender was also extended to the transgender experience, limiting hormonal treatment protocols to obtaining a full virilization or feminization/de-virilization. In line with that, trans AMAB (assigned male at birth) people received both anti-androgens and estrogens aimed at obtaining estradiol and testosterone levels within the adult cisgender women’s range.

    Trans AFAB (assigned female at birth) people received—still in a binary perspective of gender—T treatment to obtain full virilization, following the same principles of hormone replacement treatment in hypogonadal cisgender men.

    Despite growing evidence based on data from many participants, there are still many questions that need to be answered. First of all, to date the ENIGI collaboration has evaluated only the efficacy and safety profile of standardized GAHT in trans people requesting full de-/masculinization or de-/feminization. However, non-binary transgender people represent a growing body of those who refer to gender clinics, and requests for non-standardized GAHT are increasing [42,43]. In line with this, some authors hypothesized both pharmacological and non-pharmacological strategies to respond to the different requests of non-binary people [44,45]. Given the complete lack of data on the efficacy and safety of these treatments, the ENIGI collaboration should focus more on this issue in the near future, and given the large number of participants, individualized variations in hormone treatment are now welcomed.

    Supplementary Material

    An interesting anecdotal report of hormone therapy with bicalutamide 50 mg/day, cyproterone acetate 12.5 mg/day, and raloxifene 60 mg/day in a formerly self-identified femboy can be found here (PDF).

    References

    • Aksnessæther, B. Y., Solberg, A., Klepp, O. H., Myklebust, T. Å., Skovlund, E., Hoff, S. R., Vatten, L. J., & Lund, J. (2018). Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer? International Journal of Radiation Oncology*Biology*Physics, 101(1), 211–216. [DOI:10.1016/j.ijrobp.2018.01.096]
    • Bach, P. V., Najari, B. B., & Kashanian, J. A. (2016). Adjunct Management of Male Hypogonadism. Current Sexual Health Reports, 8(4), 231–239. [DOI:10.1007/s11930-016-0089-7]
    • Barbieri, R. L. (1992). Hormone treatment of endometriosis: The estrogenthreshold hypothesis. American Journal of Obstetrics and Gynecology, 166(2), 740–745. [DOI:10.1016/0002-9378(92)91706-g]
    • Bass, M., Gonzalez, L. J., Colip, L., Sharon, N., & Conklin, J. (2018). Rethinking gender: The nonbinary approach. American Journal of Health-System Pharmacy, 75(22), 1821–1823. [DOI:10.2146/ajhp180236]
    • Bedognetti, D., Rubagotti, A., Zoppoli, G., & Boccardo, F. (2010). Gynaecomastia: The Anastrozole Paradox. Journal of Pediatric Endocrinology and Metabolism, 23(1–2), 205–206. [DOI:10.1515/jpem.2010.23.1-2.205]
    • Benveniste, O., Simon, A., & Herson, S. (2001). Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the Literature. Clinical Infectious Diseases, 33(6), 891–893. [DOI:10.1086/322637]
    • Birzniece, V., Meinhardt, U. J., Gibney, J., Johannsson, G., Armstrong, N., Baxter, R. C., & Ho, K. K. (2012). Differential Effects of Raloxifene and Estrogen on Body Composition in Growth Hormone-Replaced Hypopituitary Women. The Journal of Clinical Endocrinology & Metabolism, 97(3), 1005–1012. [DOI:10.1210/jc.2011-2837]
    • Boccardo, F., Rubagotti, A., Battaglia, M., Di Tonno, P., Selvaggi, F., Conti, G., Comeri, G., Bertaccini, A., Martorana, G., Galassi, P., Zattoni, F., Macchiarella, A., Siragusa, A., Muscas, G., Durand, F., Potenzoni, D., Manganelli, A., Ferraris, V., & Montefiore, F. (2005). Evaluation of Tamoxifen and Anastrozole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Cancer. Journal of Clinical Oncology, 23(4), 808–815. [DOI:10.1200/jco.2005.12.013]
    • Buckle, R. (1980). Danazol in the Treatment of Gynaecomastia. Drugs, 19(5), 356–361. [DOI:10.2165/00003495-198019050-00005]
    • Burshell, A. L., Anderson, S. J., Leib, E. S., Johnston, C. C., & Costantino, J. P. (1999). The effect of tamoxifen on pre and postmenopausal bone. Journal of Bone and Mineral Research, 14(Suppl 1), S158–S158. [Google Scholar]
    • Caron, P., Khoury, J. M., Bennet, A., & Louvet, J. P. (1987). Treatment of pubertal gynecomastia with percutaneous dihydrotestosterone gel - long-term clinical outcome. La Semaine des Hôpitaux, 63, 2167–2170. [Google Scholar]
    • Carswell, J. M., & Roberts, S. A. (2017). Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents. Transgender Health, 2(1), 195–201. [DOI:10.1089/trgh.2017.0021]
    • Chen, L., Ko, N., & Chen, K. (2019). Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. International Journal of Molecular Sciences, 20(9), 2213. [DOI:10.3390/ijms20092213]
    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]
    • Cocchetti, C., Romani, A., Collet, S., Greenman, Y., Schreiner, T., Wiepjes, C., den Heijer, M., T’Sjoen, G., & Fisher, A. D. (2022). The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives. Journal of Clinical Medicine, 11(7), 1784. [DOI:10.3390/jcm11071784]
    • De Corrado, G., Vetri, M., Padova, G., & Pezzino, V. (1998). Effect of prolonged treatment with percutaneous dihydrotestosterone (DHT) in persistent pubertal gynaecomastia (PPG). International Journal of Andrology, 21, 40–40. [Google Scholar]
    • Dane, C., Dane, B., Cetin, A., & Erginbas, M. (2007). Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. Gynecological Endocrinology, 23(7), 398–403. [DOI:10.1080/09513590701414907]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de G. Buff Passone, C., Kuperman, H., Cabral de Menezes-Filho, H., Spassapan Oliveira Esteves, L., Lana Obata Giroto, R., & Damiani, D. (2015). Tamoxifen Improves Final Height Prediction in Girls with McCune-Albright Syndrome: A Long Follow-Up. Hormone Research in Paediatrics, 84(3), 184–189. [DOI:10.1159/000435881]
    • de Ronde, W., ten Kulve, J., Woerdeman, J., Kaufman, J., & de Jong, F. H. (2009). Effects of oestradiol on gonadotrophin levels in normal and castrated men. Clinical Endocrinology, 71(6), 874–879. [DOI:10.1111/j.1365-2265.2009.03573.x]
    • Di Lorenzo, G., Autorino, R., Perdonà, S., & De Placido, S. (2005). Management of gynaecomastia in patients with prostate cancer: a systematic review. The Lancet Oncology, 6(12), 972–979. [DOI:10.1016/s1470-2045(05)70464-2]
    • Doran, P. M., Riggs, B. L., Atkinson, E. J., & Khosla, S. (2001). Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men. Journal of Bone and Mineral Research, 16(11), 2118–2125. [DOI:10.1359/jbmr.2001.16.11.2118]
    • Eberle, A. J., & Keenan, B. S. (1985). Treatment of persistent pubertal gynecomastia with dehydrotestosterone heptanoate (DHT-hp). Pediatric Research, 19(4), 185A–185A (abstract no. 448). [DOI:10.1203/00006450-198504000-00478]
    • Eberle, A. J., Sparrow, J. T., & Keenan, B. S. (1986). Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate. The Journal of Pediatrics, 109(1), 144–149. [DOI:10.1016/s0022-3476(86)80596-0]
    • Fagerlund, A., Cormio, L., Palangi, L., Lewin, R., Santanelli di Pompeo, F., Elander, A., & Selvaggi, G. (2015). Gynecomastia in Patients with Prostate Cancer: A Systematic Review. PLOS ONE, 10(8), e0136094. [DOI:10.1371/journal.pone.0136094]
    • Fentiman, I. S. (2018). Managing Male Mammary Maladies. European Journal of Breast Health, 14(1), 5–9. [DOI:10.5152/ejbh.2017.3841]
    • Fradet, Y., Egerdie, B., Andersen, M., Tammela, T. L., Nachabe, M., Armstrong, J., Morris, T., & Navani, S. (2007). Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study. European Urology, 52(1), 106–115. [DOI:10.1016/j.eururo.2007.01.031]
    • Francucci, C. M., Pantaleo, D., Iori, N., Camilletti, A., Massi, F., & Boscaro, M. (2005). Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation, 28(9), 623–631. [DOI:10.1007/bf03347261]
    • Giordano, S. H. (2005). A Review of the Diagnosis and Management of Male Breast Cancer. The Oncologist, 10(7), 471–479. [DOI:10.1634/theoncologist.10-7-471]
    • Hadji, P., Colli, E., & Regidor, P. (2019). Bone health in estrogen-free contraception. Osteoporosis International, 30(12), 2391–2400. [DOI:10.1007/s00198-019-05103-6]
    • Heresová, J., Hampl, R., Kuska, L., & Stárka, L. (1981). Podávání nandrolondekanoátu nemocným s gynekomastií [Nandrolone decanoate administered to patients with Gynaecomastia]. Casopis Lekaru Ceskych, 120(52), 1602–1605. [Google Scholar] [PubMed]
    • Heresová, J., & Vrzáňová, M. (2003). Gynekomasti. Interní Medicína Pro Praxi, 5(1), 6–9. [URL] [PDF]
    • Ho, T. H., Nunez-Nateras, R., Hou, Y., Bryce, A. H., Northfelt, D. W., Dueck, A. C., Wong, B., Stanton, M. L., Joseph, R. W., & Castle, E. P. (2017). A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 15(2), 196–202.e1. [DOI:10.1016/j.clgc.2016.08.026]
    • Kanakis, G. A., Nordkap, L., Bang, A. K., Calogero, A. E., Bártfai, G., Corona, G., Forti, G., Toppari, J., Goulis, D. G., & Jørgensen, N. (2019). EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology, 7(6), 778–793. [DOI:10.1111/andr.12636]
    • Keenan, B. S., Fagan, C. J., & Richards, G. E. (1989). Adolescent gynecomastia in lean and obese subjects - radiographic characteristics and response to therapy with dihydrotestosterone enanthate (DHT-EN). Clinical Research, 37(1), A50–A50. [Google Scholar]
    • Kuhn, J. M., Laudat, M. H., Rieu, M., Roca, R., Wolf, L. M., Luton, J. P., & Bricaire, H. (1982). Sex steroid studies and dihydrotestosterone (DHT) treatment in idiopathic and hypogonadic gynecomastia. Journal of Steroid Biochemistry and Molecular Biology 17(3), R81–R81 (abstract no. 242). [Google Scholar]
    • Kuhn, J. M., Laudat, M. H., Roca, R., Dugue, M. A., Luton, J. P., & Bricaire, H. (1983). Gynécomasties: effet du traitement prolongé par la dihydrotestostérone par voie per-cutanée [Gynecomastia: effect of prolonged treatment with dihydrotestosterone by the percutaneous route]. Presse Medicale, 12(1), 21–25. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Kuhn, J., Roca, R., Laudat, M., Rieu, M., Luton, J., & Bricaire, H. (1983). Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone. Clinical Endocrinology, 19(4), 513–520. [DOI:10.1111/j.1365-2265.1983.tb00026.x]
    • Lawrence, S. E., Arnold Faught, K., Vethamuthu, J., & Lawson, M. L. (2004). Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. The Journal of Pediatrics, 145(1), 71–76. [DOI:10.1016/j.jpeds.2004.03.057]
    • Mancino, A. T., Young, Z. T., & Bland, K. I. (2018). Gynecomastia. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 104–115.e5). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00007-6]
    • Moghetti, P., Castello, R., Zamberlan, N., Rossini, M., Gatti, D., Negri, C., Tosi, F., Muggeo, M., & Adami, S. (1999). Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist. The Journal of Clinical Endocrinology & Metabolism, 84(4), 1250–1254. [DOI:10.1210/jcem.84.4.5606]
    • Moser, C., & Devereux, M. (2019). The Medical Management of Gender Dysphoric, Gender Fluid, Gender Nonconforming, Gender Queer, Nonbinary, and Transgender Patients: One Clinic’s Approach. Current Sexual Health Reports, 11(4), 421–429. [DOI:10.1007/s11930-019-00221-y]
    • Naroji, S., Shimy, K., Delot, E., & Gomez-Lobo, V. (2021). 59. Tamoxifen for Puberty Induction and Bone Mineral Density Protection in a Gender Non Binary Patient With 46, XY Complete Gonadal Dysgenesis: A Case Report. Journal of Pediatric and Adolescent Gynecology, 34(2), 262–262 (abstract no. 59). [DOI:10.1016/j.jpag.2021.02.063]
    • Nelson, A. L. (2010). DMPA: battered and bruised but still needed and used in the USA. Expert Review of Obstetrics & Gynecology, 5(6), 673–686. [DOI:10.1586/eog.10.60]
    • Niewoehner, C. B., & Schorer, A. E. (2008). Gynaecomastia and breast cancer in men. BMJ, 336(7646), 709–713. [DOI:10.1136/bmj.39511.493391.be]
    • Ockrim, J., Lalani, E., Laniado, M., Carter, S. S., & Abel, P. (2003). Transdermal Estradiol Therapy for Advanced Prostate Cancer—Forward to the Past? Journal of Urology, 169(5), 1735–1737. [DOI:10.1097/01.ju.0000061024.75334.40]
    • Palacios, S., Regidor, P., Colli, E., Skouby, S. O., Apter, D., Roemer, T., Egarter, C., Nappi, R. E., Skřivánek, A., Jakimiuk, A. J., Weyers, S., Ács, N., Elia, D., Gemzell Danielsson, K., & Bitzer, J. (2020). Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature. The European Journal of Contraception & Reproductive Health Care, 25(3), 221–227. [DOI:10.1080/13625187.2020.1743828]
    • Pang, K. C., Notini, L., McDougall, R., Gillam, L., Savulescu, J., Wilkinson, D., Clark, B. A., Olson-Kennedy, J., Telfer, M. M., & Lantos, J. D. (2020). Long-term Puberty Suppression for a Nonbinary Teenager. Pediatrics, 145(2), e20191606. [DOI:10.1542/peds.2019-1606]
    • Powles, T. J., Hickish, T., Kanis, J. A., Tidy, A., & Ashley, S. (1996). Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. Journal of Clinical Oncology, 14(1), 78–84. [DOI:10.1200/jco.1996.14.1.78]
    • Preželj, J., & Kocijančič, A. (1994). Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess. Hormone and Metabolic Research, 26(1), 46–48. [DOI:10.1055/s-2007-1000771]
    • Prezelj, J., & Kocijancic, A. (1999). Comment on Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist. The Journal of Clinical Endocrinology & Metabolism, 84(12), 4747–4751. [DOI:10.1210/jcem.84.12.4747a]
    • Raven, G., de Jong, F. H., Kaufman, J., & de Ronde, W. (2006). In Men, Peripheral Estradiol Levels Directly Reflect the Action of Estrogens at the Hypothalamo-Pituitary Level to Inhibit Gonadotropin Secretion. The Journal of Clinical Endocrinology & Metabolism, 91(9), 3324–3328. [DOI:10.1210/jc.2006-0462]
    • Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A Review of Breast Development in Cisgender Women and Implications for Transgender Women. Endocrine Practice, 25(12), 1338–1345. [DOI:10.4158/ep-2019-0183]
    • Richards, C., Bouman, W. P., Seal, L., Barker, M. J., Nieder, T. O., & T’Sjoen, G. (2016). Non-binary or genderqueer genders. International Review of Psychiatry, 28(1), 95–102. [DOI:10.3109/09540261.2015.1106446]
    • Rizzoli, R. (2018). Postmenopausal osteoporosis: Assessment and management. Best Practice & Research Clinical Endocrinology & Metabolism, 32(5), 739–757. [DOI:10.1016/j.beem.2018.09.005]
    • Roux, C. (1997). Estrogen therapy in postmenopausal osteoporosis. What we know and what we don’t. Revue du Rhumatisme (English Ed.), 64(6), 402–409. [Google Scholar] [PubMed] [PDF]
    • Saltzstein, D., Sieber, P., Morris, T., & Gallo, J. (2005). Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer and Prostatic Diseases, 8(1), 75–83. [DOI:10.1038/sj.pcan.4500782]
    • Seal, L. (2017). Adult Endocrinology. In Richards, C., Bouman, W. P., & Barker, M.-J. (Eds.). Genderqueer and Non-Binary Genders (Critical and Applied Approaches in Sexuality, Gender and Identity) (pp. 183–223). London: Palgrave Macmillan UK. [DOI:10.1057/978-1-137-51053-2_10]
    • Serretta, V., Altieri, V., Morgia, G., Nicolosi, F., De Grande, G., Mazza, R., Melloni, D., Allegro, R., Ferraù, F., & Gebbia, V. (2012). A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia. Clinical Genitourinary Cancer, 10(3), 174–179. [DOI:10.1016/j.clgc.2012.03.002]
    • T’Sjoen, G. G., Giagulli, V. A., Delva, H., Crabbe, P., De Bacquer, D., & Kaufman, J. (2005). Comparative Assessment in Young and Elderly Men of the Gonadotropin Response to Aromatase Inhibition. The Journal of Clinical Endocrinology & Metabolism, 90(10), 5717–5722. [DOI:10.1210/jc.2005-0982]
    • Ting, A. C., Chow, L. W., & Leung, Y. (2000). Comparison of Tamoxifen with Danazol in the Management of Idiopathic Gynecomastia. The American Surgeon, 66(1), 38–40. [DOI:10.1177/000313480006600108]
    • Trost, L. W., & Khera, M. (2014). Alternative Treatment Modalities for the Hypogonadal Patient. Current Urology Reports, 15(7), 417. [DOI:10.1007/s11934-014-0417-2]
    • Tsourdi, E., Kourtis, A., Farmakiotis, D., Katsikis, I., Salmas, M., & Panidis, D. (2009). The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia. Fertility and Sterility, 91(4), 1427–1430. [DOI:10.1016/j.fertnstert.2008.06.002]
    • Tunio, M., Al-Asiri, M., Al-Amro, A., Bayoumi, Y., & Fareed, M. (2012). Optimal Prophylactic and Definitive Therapy for Bicalutamide-Induced Gynecomastia: Results of a Meta-analysis. Current Oncology, 19(4), 280–288. [DOI:10.3747/co.19.993]
    • van Dijken, J. B., Steensma, T. D., Wensing-Kruger, S. A., Heijer, M. D., & Dreijerink, K. M. (2022). Tailored Gender-Affirming Hormone Treatment in Nonbinary Transgender Individuals: A Retrospective Study in a Referral Center Cohort. Transgender Health, 8(3), 220–225. [DOI:10.1089/trgh.2021.0032]
    • Vestergaard, P. (2012). Raloxifene for the treatment of postmenopausal osteoporosis. International Journal of Clinical Rheumatology, 7(3), 261–269. [Google Scholar] [DOI:10.2217/ijr.12.19] [PDF]
    • Viani, G. A., Bernardes da Silva, L. G., & Stefano, E. J. (2012). Prevention of Gynecomastia and Breast Pain Caused by Androgen Deprivation Therapy in Prostate Cancer: Tamoxifen or Radiotherapy? International Journal of Radiation Oncology*Biology*Physics, 83(4), e519–e524. [DOI:10.1016/j.ijrobp.2012.01.036]
    • Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]
    • Xu, J. Y., O’Connell, M. A., Notini, L., Cheung, A. S., Zwickl, S., & Pang, K. C. (2021). Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care? Frontiers in Endocrinology, 12, 701364. [DOI:10.3389/fendo.2021.701364]
    • Zacharin, M. (2009). Disorders of ovarian function in childhood and adolescence: evolving needs of the growing child. An endocrine perspective. BJOG: An International Journal of Obstetrics & Gynaecology, 117(2), 156–162. [DOI:10.1111/j.1471-0528.2009.02399.x]
    • Zirilli, L., Maffei, L., Meunier, P., Chavassieux, P., Carani, C., & Rochira, V. (2009). The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency. Bone, 45(5), 827–832. [DOI:10.1016/j.bone.2009.03.672]
    \ No newline at end of file +An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People - Transfeminine Science Link

    An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People

    By Aly | First published June 13, 2019 | Last modified September 26, 2022

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    Abstract / TL;DR

    Transfeminine people who are non-binary often desire different and more partial feminizing and demasculinizing changes compared to what occurs with conventional transfeminine hormone therapy. For example, non-binary transfeminine people may seek an intermediate physical and hormonal state between what is typical for males and females, may desire substantial or full feminization and demasculinization without breast development, may want to have a more sexually neutral or androgynous appearance, or may wish for feminization but concomitant preservation of more male-typical sexual desire and capacity. These partial goals for transfeminine hormone therapy are being increasingly encountered, but therapeutic methods for achieving them have not yet been studied or established in transgender medicine. Nonetheless, there are a variety of hormonal approaches by which such outcomes could theoretically be achieved. Demasculinization can be produced via partial to full testosterone suppression or blockade using varied doses of antiandrogens, progestogens, and/or gonadotropin-releasing hormone modulators. Feminization and other estrogenic effects with less or no breast development may be produced with selective estrogen receptor modulators or low doses of estradiol. Certain other hormonal agents can be used to achieve various specific effects, like 5α-reductase inhibitors to reduce body hair growth and scalp hair loss, topical androgens applied to the breasts to reduce breast development, and the androgen and anabolic steroid nandrolone decanoate as an alternative to testosterone with less effect in skin and hair follicles. Besides hormonal means, breast removal surgery can be sought to negate breast development. Health risks, particularly those related to androgen deprivation without adequate estrogenic replacement, are a concern with partial approaches to hormone therapy. One such risk, bone density loss, may be reduced with calcium and vitamin D supplementation, bisphosphonates, and weight-bearing exercise. There is increasing interest in partial approaches to hormone therapy in transgender health, so hopefully they will become better characterized and more available and utilized in transgender people in the future.

    Introduction

    “Non-binary” is a term that refers to transgender people who do not identify within the gender binary. Despite the fact that they do not identify as either male or female, many non-binary transmasculine and transfeminine people pursue hormone therapy just like transgender men and women. While some non-binary individuals opt for a full hormonal transition similarly to most binary-identified transgender people, many non-binary people would prefer only a partial hormonal transition. This could be to achieve an intermediate area between masculine and feminine characteristics, to achieve a more sexually neutral appearance, or to induce some but not all aspects of masculinization or feminization.

    There are also individuals who seek hormonal feminization and/or demasculinization but do not actually identify as transgender. These cisgender-identified individuals often refer to themselves as “femboys”. Communities of these individuals exist on social media sites like Reddit (e.g., r/FemboyTransition). Feminization-inclined cisgender people who pursue hormonal transition often have similar preferences as transfeminine non-binary people—one of the most common of which is feminization without breast development. Sometimes these initially cisgender-identified hormonally transitioning individuals end up progressing to a transgender identity with time.

    Partial approaches to hormonal transition and even widespread identification as non-binary are fairly recent developments. There is very little written on non-conventional approaches to hormone therapy of this sort in the published literature. Moreover, there are no available standards or guidelines for such therapy at this time. A number of recent reviews have started to discuss possibilities for non-binary hormone therapy however (Richards et al., 2016; Seal, 2017; Bass et al., 2018; Cocchetti et al., 2020). There is currently a discordance between the number of people who desire non-conventional hormonal transition and the clinical establishment of such therapy. Consequently, an exploration of the possibilities from a theoretical standpoint would be of value and is the aim of this review.

    As a disclaimer, the ideas in this article are experimental and preliminary. No studies with the goal of partial hormonal transition in transgender people have been conducted as of present and there is no data or evidence in non-binary people to inform the use of such approaches. Instead, we can only extrapolate from theory and research in other groups of people at this time. Examples of these other groups in the case of transfeminine non-binary hormone therapy include cisgender men undergoing hormone therapy for prostate cancer, cisgender men going through treatment for gynecomastia (male breast development), and transgender women undergoing hormone therapy. For these reasons, the present discussion is exploratory and should not be taken as therapeutic recommendations.

    Conventional Transfeminine Hormone Therapy

    The goal of therapy in conventional hormone therapy for transgender women is to produce the maximum degrees of demasculinization and feminization—including breast development—that are possible. This is achieved by suppressing testosterone levels and increasing estradiol levels such that they are both within normal adult female ranges. Alternatively, the actions of testosterone can be blocked instead of full suppression of testosterone levels. The relevant hormonal changes are accomplished through the administration of hormonal medications including estrogens, progestogens, and/or antiandrogens. Estrogens produce feminization, including breast development, while testosterone suppression causes demasculinization—as well as disinhibits feminization. Estrogens, progestogens, and antiandrogens can all contribute to testosterone suppression.

    The specific medications used in conventional transfeminine hormone therapy include estradiol and estradiol esters such as estradiol valerate; antiandrogens like spironolactone, bicalutamide, and gonadotropin-releasing hormone (GnRH) agonists and antagonists; and progestogens such as progesterone and cyproterone acetate (CPA). Androgen synthesis inhibitors such as the 5α-reductase inhibitors (5α-RIs) are also used. 5α-RIs inhibit the metabolism of testosterone into the more potent dihydrotestosterone (DHT), a conversion which only occurs in certain tissues. They have limited tissue-selective antiandrogenic effects, for instance in skin and hair follicles.

    The therapeutic goals of a subset of non-binary transfeminine people are equivalent to those of transgender women and hence are compatible with the effects of conventional transfeminine hormone therapy. That is, the maximum possible feminization, including breast development, and demasculinization are the aims of therapy. Non-binary transfeminine people with these preferences can simply use conventional transfeminine hormone therapy for their hormonal transition as opposed to more experimental and non-conventional partial approaches.

    For a comprehensive introduction to conventional transfeminine hormone therapy, see this article:

    The above article is intended to provide everything one needs to know to achieve a basic understanding of the subject. If you are new to the topic of transgender hormone therapy, it is highly recommended reading prior to continuing in the current article. The introduction covers the sex hormones, their effects, specific hormonal medications used, routes, and dosages for this type of hormone therapy. Much of this information is also applicable to non-conventional transfeminine hormone therapy.

    Partial Transfeminine Hormone Therapy

    Some non-binary transfeminine people (as well as cisgender-identified individuals seeking hormonal feminization) desire only partial feminization and/or demasculinization. Depending on the specific aims, this can be more complicated and require more thought than conventional transfeminine hormone therapy. The following goals of partial transfeminine hormone therapy may be encountered:

    • An intermediate physical and hormonal state between male and female
    • A more sexually neutral or androgynous appearance that is not necessarily masculine or feminine
    • Substantial or maximal feminization and demasculinization with little or no breast development
    • Substantial or maximal feminization and demasculinization with minimal or no loss of sexual desire, sexual function (i.e., erectile and orgasmic capacity), and/or fertility

    The first of these goals is fairly straightforward in that it can entail what is essentially conventional transfeminine hormone therapy using lower medication doses. This will result in partial testosterone suppression and a mixture of both androgens and estrogens as major active sex hormones. The second goal involves deprivation of both androgens and estrogens. While possible, this can have negative consequences as sex hormones are important for maintaining certain aspects of health and well-being. There are potential ways to avoid or mitigate such consequences however. The third and fourth goals are also technically possible but are more difficult to achieve and are likely to require more specialized and potentially complex hormonal approaches.

    Suppression and Blockade of Testosterone

    If the goal of non-binary transfeminine hormone therapy is simply to achieve an androgynous appearance with minimal or no feminization, this can be achieved via deprivation of testosterone without concomitant administration of an estrogen. There are multiple ways to achieve androgen deprivation or testosterone suppression in people assigned male at birth. These include high-dose progestogen therapy, medical and surgical castration with GnRH agonists/antagonists or gonadectomy, high-dose androgen receptor antagonist therapy, and a few other other possibilities. In this section, I’ll discuss androgen deprivation largely from the standpoint of efficacy. There are problems with androgen deprivation alone in terms of tolerability and safety due to the co-consequence of estrogen deficiency however, which I’ll discuss in the subsequent section.

    Testosterone Suppression with High Doses of Progestogens

    Androgen deprivation can be achieved with high doses of progestogens, which suppress testosterone levels by up to 50 to 70% (Aly, 2019). This is a substantial decrease in testosterone levels, but is not quite into the female range. Androgen receptor antagonists can additionally be included to block the remaining testosterone that is not suppressed if desired. For these purposes, low-dose cyproterone acetate (e.g., 5.0–12.5 mg/day) (Aly, 2019) plus bicalutamide (e.g., 12.5–50 mg/day) or spironolactone (e.g., 200–400 mg/day) is likely to be an effective regimen. As an alternative to cyproterone acetate, high doses of other progestogens, such as just about any other progestin, or alternatively rectal progesterone (Aly, 2018), can be used instead.

    Testosterone Suppression with Medical or Surgical Castration

    GnRH agonists and antagonists are another option for testosterone suppression. These medications suppress testosterone levels by about 95%, or into the normal female range or male castrate range (<50 ng/dL). However, GnRH agonists and antagonists are very expensive, although there may be some viable options for obtaining them more cheaply (e.g., certain online pharmacies) (Aly, 2019).

    Gonadectomy, or surgical removal of the gonads, can be performed as a more permanent alternative to GnRH agonists and antagonists. However, this procedure is expensive (a few thousand dollars USD), requires minor surgery, and can be more difficult to obtain. Most surgeons require letters from gender therapists and real-life experience; informed-consent surgeons do exist however. Gonadectomy is also irreversible, notably resulting in permanent loss of testes and sterility. In any case, gonadectomy is far less expensive and more convenient than GnRH agonists and antagonists in the long run.

    Testosterone Blockade with Antiandrogens

    Androgen receptor antagonists like bicalutamide and spironolactone act by directly binding to the androgen receptor and displacing androgens like testosterone and DHT from the receptor, thereby preventing its activation by these androgens. This is in contrast to therapies that act by suppressing androgen production and levels.

    High-dose bicalutamide monotherapy (e.g., 150–300 mg/day) is a possible approach for androgen deprivation therapy. However, bicalutamide monotherapy increases testosterone and hence estradiol levels. The testosterone will be blocked by bicalutamide and will not have effects, but estradiol is increased to a concentration range that allows for marked or full feminization, including breast development. In addition, bicalutamide alone, even at very high doses, might not be enough to completely block male-range testosterone. With these considerations, if the goal is full demasculinization with no feminization or breast development, bicalutamide monotherapy is not something that, at least alone, can achieve this.

    High-dose bicalutamide is expensive and potentially cost-prohibitive. High-dose spironolactone monotherapy is not a good option for this route as it is a relatively weak antiandrogen and likely falls far short of being able to handle male-range levels of testosterone (at least 200 mg/day appears to be required to fully block female testosterone levels) (Aly, 2018; Wiki). Concomitant partial suppression of testosterone and estrogen levels via additional use of a progestogen (e.g., cyproterone acetate) may be a more feasible option than an androgen receptor antagonist alone.

    Some potentially major advantages of high-dose bicalutamide monotherapy are that in contrast to marked or full suppression of testosterone levels, bicalutamide monotherapy largely preserves sexual desire and erectile function and likely does not result in infertility.

    Other Options for Testosterone Suppression

    Another option is only partial demasculinization, which can be achieved essentially by using lower dosages of the medications discussed above (e.g., cyproterone acetate, bicalutamide). If desired, 5α-reductase inhibitors can be added in this context to more substantially decrease scalp hair loss and body hair growth. Note that if testosterone is more fully suppressed or blocked however, there is likely to be little or no benefit with 5α-reductase inhibitors.

    Yet another possibility could be to incorporate low-dose nandrolone decanoate, an androgen receptor agonist and anabolic–androgenic steroid (AAS) with much less masculinizing/androgenic effect in skin and hair follicles (Aly, 2020). This AAS will help to suppress and replace testosterone levels. Nandrolone decanoate might also have the benefit of helping to maintain sexual desire and function. However, nandrolone decanoate was recently discontinued in the United States. Oxandrolone is another, similar AAS, but has been associated with liver toxicity.

    Estrogen Deficiency and Replacement

    While androgen deprivation therapy is effective for achieving the desired changes—specifically demasculinization without feminization—it is not recommended by itself. This is because estradiol is produced from testosterone and hence androgen deprivation results in estrogen deficiency as well. Estrogens are essential for maintaining bone density in both men and women, and without them, a person will quickly lose bone mass, eventually develop osteoporosis, and be at a high risk for bone fractures. Skeletal and postural disfigurement may also eventually occur (Figure; Figure). In addition, the person is likely to experience other menopause-like symptoms, such as hot flashes, mood and sleep problems, sexual dysfunction (e.g., low sexual desire, erectile dysfunction), and accelerated aging of the skin (Wiki). An increased risk of weight gain, type 2 diabetes, cardiovascular disease, and dementia may be associated with sex hormone deficiency as well. As such, extended deprivation of both androgens and estrogens with no estrogenic supplementation is not advisable.

    With that said, a couple of clarifications should be made. Due to preservation of estradiol levels, high-dose bicalutamide monotherapy has minimal to no risk of bone density loss or most other menopausal symptoms. In addition, the low-dose cyproterone acetate plus low-dose bicalutamide option may have less of a risk of menopausal symptoms and possibly osteoporosis as well. This is because high-dose progestogens (of which “low-dose” cyproterone acetate certainly qualifies) can help treat certain menopausal symptoms such as hot flashes and possibly bone density loss, and also because some estradiol will be preserved (since testosterone will only be suppressed by 70 to 80% rather than more fully). With that said however, in the latter case, it is probably best not to take any risks.

    Selective Estrogen Receptor Modulators (SERMs)

    Instead of only androgen and estrogen deprivation, the inclusion of selective estrogen receptor modulators (SERMs), so-called partial estrogens, can be employed. These medications are partial agonists of the estrogen receptor, and have mixed estrogenic and antiestrogenic effects depending on the tissue. For example, the SERM raloxifene has estrogenic effects in bone, fat tissue, and the liver, but antiestrogenic effects in the breasts. In general, SERMs reduce bone density loss and osteoporosis risk while not causing breast development (and actually blocking it). A full list of SERMs can be found here. However, practically speaking, only raloxifene (Evista), tamoxifen (Nolvadex), and toremifene (Fareston) are available, inexpensive, and commonly used. For an overview of the estrogenic and antiestrogenic effects of the different SERMs in different tissues, see here. In general, SERMs have a fairly similar pattern of effects. Although we have some idea of the differential tissue effects of SERMs, in many cases we do not know how they behave in specific tissues. For example, only a single clinical study has shown that a SERM, specifically raloxifene, has estrogenic effects in fat tissue (Francucci et al., 2014). In addition, it is less clear how SERMs behave in, for example, skin, or in most of the brain.

    SERMs also have various side effects. For instance, SERMs commonly produce hot flashes as an adverse effect. However, the fairly recently introduced combination of bazedoxifene/conjugated estrogens (Duavee) has been found to reduce the incidence of hot flashes in postmenopausal women (Duavee label). It is still on-patent and hence is expensive however. In any case, SERMs are also likely to produce other menopause-like symptoms. Additionally, SERMs have estrogenic effects in the liver and therefore influence production of coagulation factors and decrease production of insulin-like growth factor-1 (IGF-1), among other potentially undesirable changes. Due to the increase in coagulation with SERMs, they have a notable risk of blood clots and cardiovascular complications like stroke (Aly, 2020). Some SERMs, like tamoxifen, also have unique off-target actions and risks, for instance rare liver toxicity. Raloxifene is a more selective and probably safer SERM than tamoxifen.

    SERMs are effective for maintaining bone density. However, they are, unfortunately, only partially estrogenic in bone and hence are submaximally effective for such purposes—they are significantly more effective than no treatment at all but are not as effective as estrogens (Dane et al., 2007; Zirilli et al., 2009; Birzniece et al., 2012; Vestergaard, 2012). Indeed, SERMs have actually been found to significantly antagonize the effects of estradiol on bone, for instance on bone density in premenopausal women (Powles et al., 1996; Burshell et al., 1999) and on bone maturation and growth plate closure in cisgender girls with precocious puberty (Passone et al., 2015). One study in elderly men suggested that 60 mg/day raloxifene is maximally equivalent in terms of bone density effect to estradiol levels of about 26 pg/mL (Doran et al., 2001; Palacios et al., 2020). Below this estradiol level, raloxifene was estrogenic on bone density, whereas above this level, it was antiestrogenic on bone density (Doran et al., 2001; Palacios et al., 2020). As such, although SERMs increase bone density in the context of very low estradiol levels, they are not as effective as estrogens in terms of maintaining bone density and they may still allow for significantly decreased bone density when added to androgen deprivation in non-binary transfeminine people.

    Low-Dose Estrogen Supplementation

    An alternative to SERMs for avoiding estrogen deficiency is low-dose estrogen therapy. A dosage of oral estradiol of about 1 to 2 mg/day or estradiol levels of about 30 to 50 pg/mL (via another route, for instance transdermal patches) is all that is needed for complete or near-complete prevention of bone density loss (Barbieri, 1992; Roux, 1997; Hadji, Colli, & Regidor, 2019). Moreover, estradiol has a better tolerability and safety profile than SERMs, with a much lower risk of blood clots (Aly, 2020).

    A problem with estrogen therapy however is that in the absence of androgens, estrogens even at low levels will induce substantial feminization and breast development. Estradiol levels in normal cisgender girls gradually increase from around 5 to 10 pg/mL at the start of puberty to 50 or 60 pg/mL by late puberty, and these low levels produce full developent of the female secondary sex characteristics (Aly, 2020). Similarly, cisgender females with complete androgen insensitivity syndrome (CAIS) have estradiol levels of only about 35 pg/mL on average yet have complete feminization and excellent breast development (Aly, 2020; Table). Hence, the addition of low-dose estradiol to androgen deprivation would likely be a full transition. Very low doses of estradiol, for instance 0.5 mg/day oral estradiol or a 14 μg/day estradiol patch, achieving estradiol levels of only maybe 20 pg/mL, may be feasible and may result in less feminization. But, while effective for improving bone density (Dane et al., 2007; Birzniece et al., 2012), such doses/levels would not fully protect against bone density loss and other menopause-like symptoms and would likely still produce at least partial feminization. It is notable that even GnRH agonists/antagonists and gonadectomy alone—which reduce estradiol levels to around 10 pg/mL—have a rate of mild gynecomastia of as high as 15% (Di Lorenzo et al., 2005).

    Other Therapies for Bone Maintenance

    In addition to SERMs and estrogens, other measures to maintain bone mineral density are effective and could be included for further benefit to bone health. Examples include calcium supplementation, vitamin D supplementation, and bisphosphonates like alendronic acid (Fosamax) and zoledronic acid (Zometa) (Chen, Ko, & Chen, 2019; Rizzoli, 2018). Bisphosphonates have adverse effects and risks however. Weight-bearing exercise is also beneficial for bone density (Rizzoli, 2018).

    Interestingly, spironolactone was found at 100 mg/day to fully prevent GnRH agonist-induced bone density loss in women in a small randomized controlled trial (Moghetti et al., 1999). The authors hypothesized that this was due to its antimineralocorticoid activity, as aldosterone is negatively correlated with bone density (Moghetti et al., 1999). However, in another study, 100 mg/day spironolactone did not prevent bone density loss caused by high-dose progestogen therapy in the form of 5 mg/day lynestrenol in women (Preželj & Kocijančič, 1994; Preželj & Kocijančič, 1999). Hence, spironolactone should not be relied upon for preservation of bone density.

    Onset and Reversibility of Bone Loss

    Certain medications used in premenopausal women suppress gonadal sex hormone production and are associated with decreased bone density. These therapies can provide insight on the risk of bone density loss that may occur in non-binary transfeminine people deprived of sex hormones. Examples of such medications include progestogen-only birth control, which partially suppresses estradiol levels (to around 20–50 pg/mL) (Hadji, Colli, & Regidor, 2019), and GnRH agonists/antagonists, which partially to fully suppress estradiol levels depending on the medication and dose. Minimal or no bone density loss occurs with estradiol levels of 30 to 50 pg/mL, whereas significant bone density loss occurs with estradiol levels of 20 to 30 pg/mL (Hadji, Colli, & Regidor, 2019). Reassuringly however, bone density has been found to substantially or fully recover within a few years following discontinuation of progestogen-only birth control in young premenopausal women (Nelson, 2010). Along similar lines, therapy with the GnRH antagonist elagolix is considered to be acceptably safe in premenopausal women for up to 2 years at a dose that results in partial suppression of estradiol levels (to about 40 pg/mL) and for up to 6 months at a dose that results in maximal suppression of estradiol levels (to about 10 pg/mL) (Wiki). As such, a limited period of sex hormone deprivation—for instance as a trial of non-binary transfeminine hormone therapy—may be reasonably safe in terms of bone health. Long-term therapy should include adequate measures to avoid bone density loss however.

    Prevention of Breast Development

    Estrogen Blockade and Suppression

    If the goal is to produce full demasculinization and some or full feminization with the sole exception of breast development, there are a number of ways to possibly achieve this. Androgen deprivation without estrogen supplementation will achieve demasculinization without any feminization or breast development (except for bicalutamide monotherapy of course). However, it is not recommended for reasons described above and would not provide feminization. SERMs are an option; in addition to their capacity to treat osteoporosis, they are used to treat gynecomastia in men, and are capable of fully blocking gynecomastia induced by estrogens when used at sufficient doses (Fentiman, 2018). However, SERMs may allow for only partial feminization rather than full. Aromatase inhibitors, in contrast to SERMs, have no apparent place in this form of hormone therapy, as they are, surprisingly, poorly effective for prevention of gynecomastia (Fagerlund et al., 2015; Bedognetti et al., 2010).

    Selective Estrogen Receptor Modulators and Testosterone Elevation

    SERMs can be used to prevent breast development, as previously described. A problem with the use of SERMs for this purpose however is that when they are used in people assigned male at birth in whom the gonads are intact and testosterone levels are not suppressed, they will induce substantial increases in gonadal testosterone production and circulating testosterone levels. In men with hypogonadism and consequent low testosterone levels, the SERMs clomifene (20–50 mg/day) and enclomifene (12.5–25 mg/day) increase testosterone levels from about 200–300 ng/dL to about 450–600 ng/dL on average (a change of about 2.0- to 2.5-fold, with an absolute increase of 250–400 ng/dL in this patient population) (Bach, Najari, & Kashanian, 2016; Trost & Khera, 2014). Because they are so effective at increasing testosterone levels, SERMs are used to treat male hypogonadism as an alternative to exogenous testosterone administration. Worse still, SERMs appear to cause even greater increases in testosterone levels in non-hypogonadal men. One study found that 50 mg/day clomifene increased testosterone levels by about 850 ng/dL in healthy younger men and by about 500 ng/dL in elderly men (Trost & Khera, 2014). Similarly, strong increases in testosterone levels have been observed with partial suppression of estradiol levels via aromatase inhibition in young and older men (T’Sjoen et al., 2005; Raven et al., 2006; de Ronde et al., 2009).

    If testosterone levels are suppressed, increases in testosterone levels with SERMs will, depending on the degree of testosterone suppression, be less applicable (e.g., with high-dose progestogen therapy) or not applicable at all (e.g., with medical/surgical castration). However, if a SERM is combined with, say, bicalutamide alone, the situation may become even worse. This is because bicalutamide itself produces considerable increases in testosterone levels similarly to SERMs. In elderly men with prostate cancer, bicalutamide monotherapy induces a 1.5- to 2.0-fold rise in testosterone levels, increasing them from about 300–400 ng/dL to about 500–600 ng/dL (an absolute change of about 150–250 ng/dL) (Wiki). In healthy younger men, bicalutamide may increase testosterone levels into the upper end of the normal male range (potentially into the range of around 900–1,200 ng/dL) (Wiki).

    As bicalutamide is a competitive antagonist of the androgen receptor, its efficacy is fundamentally both dose-dependent and dependent on testosterone levels. Consequently, in combination with a SERM, it is possible that testosterone levels will become too high for bicalutamide to block. Moreover, endogenous androgens and estrogens are together responsible for maintaining normal homeostatic negative feedback on the hypothalamic–pituitary–gonadal axis (HPG axis) in people assigned male at birth. It seems logical that with little to suppress the axis, gonadal production and hence circulating levels of testosterone and estradiol may simply continue to rise until they overwhelm bicalutamide and/or the SERM it is combined with and restore negative feedback on the HPG axis. For these reasons, it is possible that the combination of bicalutamide and a SERM alone might not be a practical option for non-conventional feminizing hormone therapy.

    With all of that said however, the combination of bicalutamide and tamoxifen has been assessed in various studies in men with prostate cancer (PubMed), and increases in testosterone levels have, rather surprisingly, not been a problem in these studies. In terms of the findings, bicalutamide and tamoxifen together do, as expected, increase total testosterone levels. However, the rise in total testosterone levels is not much different from that which occurs with bicalutamide alone. Moreover, free testosterone levels are either increased to a certain degree or are not actually raised at all (Boccardo et al., 2005; Saltzstein et al., 2005; Fradet et al., 2007). This is thought to be due to the fact that SERMs have potent estrogenic effects in the liver and result in increased production of sex hormone-binding globulin (SHBG), consequently reducing the fraction of free and hence bioactive testosterone in the circulation. This serves to offset the biological influence of the increase in total testosterone levels. In accordance, and reassuringly, unfavorable changes in markers of androgen receptor signaling, like higher prostate-specific antigen (PSA) levels, have not been observed relative to bicalutamide alone in the studies.

    It is not clear why studies of bicalutamide plus tamoxifen have observed increases in total testosterone levels that are not that different from those of bicalutamide alone. Whatever the reason, these studies suggest that the combination of bicalutamide and tamoxifen (or certain other SERMs) might actually be feasible still for non-conventional feminizing hormone therapy. With that said however, elderly men are a different patient population than non-binary transfeminine people. Older men have diminished increases in testosterone levels with bicalutamide and SERMs compared to healthy young men. In relation to this, the combination might not be as favorable for younger people assigned male at birth.

    Tamoxifen very well may be exchangeable with raloxifene for use in combination with bicalutamide. However, it should be noted that in contrast to tamoxifen, raloxifene has never been studied in combination with bicalutamide. Or, at least, not in gonadally intact men; one study of bicalutamide with raloxifene in castrated men with prostate cancer does exist, but that does not provide much in the way of useful information (Ho et al., 2017). Nor has raloxifene actually been properly studied for prevention of gynecomastia. A single retrospective chart review reported that it was effective for pubertal gynecomastia in boys (Lawrence et al., 2004). But that is all the data we have. Conversely, there are many high-quality studies of tamoxifen for prevention of gynecomastia, including in combination with bicalutamide.

    In any case, used by themselves in men, raloxifene has been found to result in lower increases in testosterone levels than tamoxifen or toremifene (Tsourdi et al., 2009). As such, bicalutamide and raloxifene together may indeed be similar in terms of testosterone levels relative to the combination of bicalutamide and tamoxifen. This might just be due to raloxifene having lower efficacy as a SERM than tamoxifen or toremifene at the relevant clinical doses however (Tsourdi et al., 2009).

    Topical Androgens

    Another possibility for prevention of breast development is topical application of a non-aromatizable androgen (i.e., an androgen that cannot be converted into an estrogen)—namely dihydrotestosterone (DHT; Andractim)—to the breasts. Androgens substantially oppose the actions of estrogens in the breasts, and both topical and systemic DHT have been reported to be effective in the treatment of gynecomastia similarly to SERMs in a number of small studies (Kuhn et al., 1982; Kuhn et al., 1983a; Kuhn et al., 1983b; Eberle & Keenan, 1985; Eberle, Sparrow, & Keenan, 1986; Caron et al., 1987; Keenan, Fagan, & Richards, 1989; De Corrado et al., 1998; Benveniste, Simon, & Herson, 2001). Other systemic androgens like nandrolone (Heresová et al., 1981; Heresová & Vrzanova, 2003) and danazol (Buckle, 1980; Ting, Chow, & Leung, 2000) have been reported to be effective as well.

    Unfortunately, pharmaceutical topical DHT is only available today in France (Drugs.com). Some compounding pharmacies in certain countries might provide topical DHT preparations. However, DHT does not seem to be available from any compounding pharmacies in the United States. In contrast to DHT, testosterone readily converts into estradiol via aromatization and can actually induce some gynecomastia due to excessive estrogenic exposure. As such, unlike non-aromatizable androgens like DHT, use of testosterone for this purpose is likely inappropriate. There are few or no other options for topical androgens besides testosterone and DHT, so the practicality of this approach is limited.

    In contrast to SERMs, topical androgens may not be fully effective for preventing breast development. Whereas SERMs can abolish breast development caused by estrogens, sufficient exposure to estrogens can still mediate significant breast development even in the context of strong androgenic exposure. In addition, topical application of androgens to the breasts is likely to cause local body hair growth and other local androgenic effects, like masculine skin changes, oily skin, and acne. For many transfeminine individuals, such changes would probably be unacceptable. Lastly, there is a risk of systemic distribution of the topically applied androgen (Kuhn et al., 1983a), and hence of elevated circulating androgen levels and androgenic effects elsewhere in the body. This risk would be lessened in combination with an androgen receptor antagonist like bicalutamide. However, androgen receptor antagonists also have the potential to block the local effects of the topical androgen.

    Breast Removal Surgery and Breast Irradiation

    Two non-medication-based alternatives for prevention of breast development are prophylactic surgical breast removal and prophylactic breast irradiation.

    If there is no excess skin, mastectomy, or breast removal surgery, can remove the breasts without leaving obvious scars, as was the case in this young transgender man. Mastectomy is a highly effective means of preventing breast development. Of course, it requires surgery however.

    Exposure of the breasts to radiation inhibits subsequent breast development (Photos). Irradiation of the breasts is an inexpensive, easy, and effective technique that is commonly used as prophylaxis against gynecomastia in men with prostate cancer treated with estrogens or high-dose bicalutamide monotherapy (Viani, da Silva, & Stefano, 2012). It is less effective than SERMs however and generally only reduces the severity of gynecomastia rather than fully prevents it (Viani, da Silva, & Stefano, 2012). More concerningly, there is a theoretical increased risk of breast cancer with exposure of the breasts to radiation (Aksnessæther et al., 2018). Research has found a 100-fold higher incidence of breast cancer in young women whose breasts were exposed to radiation during childhood as a consequence of radiotherapy for cancer when compared to other young women (Zacharin, 2010). On the other hand, limited available evidence so far suggests minimal if any increase in breast cancer incidence in elderly men on androgen deprivation and/or estrogen therapy treated with breast irradiation to prevent gynecomastia (Aksnessæther et al., 2018; Viani, da Silva, & Stefano, 2012). However, cancer radiotherapy and other forms of radiation exposure increase the risk of breast cancer in men, particularly those exposed at a young age (Niewoehner, 2008; Giordano, 2005). In addition to theoretical cancer risk, heart and lung issues have been associated with breast irradiation in elderly men with prostate cancer (Tunio et al., 2012; Viani, da Silva, & Stefano, 2012). Due to these health risks, breast irradiation for prevention of breast development is an inadvisable option.

    An obvious drawback of breast development prevention with both surgical breast removal and prophylactic breast irradiation is that they are irreversible. If the person ever changes their mind about not wanting breasts or eventually decides to fully transition (a not uncommon occurrence), there is no going back on the choice to permanently negate breast development.

    Degree, Onset, and Reversibility of Breast Development

    For reasons that are not entirely clear, it is notable that transfeminine people tend to have poor or suboptimal breast development relative to cisgender women (Wierckx, Gooren, & T’Sjoen, 2014; de Blok et al., 2018; Reisman, Goldstein, & Safer, 2019). Likewise, in generally elderly men with prostate cancer, high-dose bicalutamide monotherapy and high-dose estrogen therapy both cause high rates of gynecomastia but produce only mild-to-moderate gynecomastia in 90% of cases (Wiki; Ockrim et al., 2003). (Whether their advanced age is a factor here or not is uncertain but could be involved however.) Hence, any person who was assigned male at birth should, generally speaking or on average, not necessarily expect a marked degree of breast development. Small breasts should generally be anticipated as the most likely outcome. There are always exceptions however, with a subset of transfeminine people experiencing substantial breast development. Hence, the degree of breast development one experiences is a matter of chance, and caution should be advised.

    There are a few things to be aware of about breast development. One is that it happens slowly and is not something that becomes substantial overnight. Another is that will not continue to progress if hormones are withdrawn. And finally, it seems to be at least partially reversible if medications are discontinued within a certain amount of time (e.g., one year) (Mancino, Young, & Bland, 2018; Kanakis et al., 2019). However, a study found that bicalutamide monotherapy-induced gynecomastia outcome was worse if tamoxifen was introduced within a month of symptom onset rather than used from the start of therapy (Serretta et al. 2012). In any case, for the preceding reasons, a given individual could self-monitor their breast development, and, if it becomes too much for their liking, alter their medication regimen as desired in order to prevent further or reverse existing breast growth. Hence, breast development may not be something that should be feared excessively.

    Updates

    Update 1: Xu et al. (2021)

    In June 2021, the following review on SERMs for non-binary transfeminine people was published:

    • Xu, J. Y., O’Connell, M. A., Notini, L., Cheung, A. S., Zwickl, S., & Pang, K. C. (2021). Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care? Frontiers in Endocrinology, 12, 701364. [DOI:10.3389/fendo.2021.701364]

    The article is the first literature of its kind. In relation to the lack of evidence for the efficacy and safety of SERMs in non-binary transfeminine hormone therapy at present, it stated that SERMs should not be routinely recommended to non-binary transfeminine people. However, it was cautiously permissive of their use in non-binary transfeminine people who request them and provide informed consent. The review concluded that SERMs are a theoretically attractive potential option for non-binary transfeminine hormone therapy and called for clinical research on them for these purposes.

    Ada S. Cheung of Trans Health Research in Australia is a co-author on the paper.

    A handful of additional but more limited mentions as well as use instances of SERMs for non-binary transfeminine and transmasculine people have also occurred previously in the literature (Carswell & Roberts, 2017; Moser & Devereux, 2019; Pang et al., 2020; Naroji et al., 2021).

    Update 2: van Dijken et al. (2022) and Cocchetti et al. (2022)

    In March 2022, one of the first studies on tailored hormone therapy for non-binary people was published:

    • van Dijken, J. B., Steensma, T. D., Wensing-Kruger, S. A., Heijer, M. D., & Dreijerink, K. M. (2022). Tailored Gender-Affirming Hormone Treatment in Nonbinary Transgender Individuals: A Retrospective Study in a Referral Center Cohort. Transgender Health, 8(3), 220–225. [DOI:10.1089/trgh.2021.0032]

    Moreover, a review of the work by the European Network for the Investigation of Gender Incongruence (ENIGI) described future plans for research by the ENIGI into hormone therapy for non-binary people:

    • Cocchetti, C., Romani, A., Collet, S., Greenman, Y., Schreiner, T., Wiepjes, C., den Heijer, M., T’Sjoen, G., & Fisher, A. D. (2022). The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives. Journal of Clinical Medicine, 11(7), 1784. [DOI:10.3390/jcm11071784]

    Here are some excerpts from the review:

    The main future perspectives [of the ENIGI] should include the evaluation of the efficacy and safety of non-standardized hormonal treatment in non-binary trans people.

    Regarding GAHT protocols, all participants were treated in line with the World Professional Association for Transgender Health (WPATH) recommendations [2]. Originally, the binary conception of gender was also extended to the transgender experience, limiting hormonal treatment protocols to obtaining a full virilization or feminization/de-virilization. In line with that, trans AMAB (assigned male at birth) people received both anti-androgens and estrogens aimed at obtaining estradiol and testosterone levels within the adult cisgender women’s range.

    Trans AFAB (assigned female at birth) people received—still in a binary perspective of gender—T treatment to obtain full virilization, following the same principles of hormone replacement treatment in hypogonadal cisgender men.

    Despite growing evidence based on data from many participants, there are still many questions that need to be answered. First of all, to date the ENIGI collaboration has evaluated only the efficacy and safety profile of standardized GAHT in trans people requesting full de-/masculinization or de-/feminization. However, non-binary transgender people represent a growing body of those who refer to gender clinics, and requests for non-standardized GAHT are increasing [42,43]. In line with this, some authors hypothesized both pharmacological and non-pharmacological strategies to respond to the different requests of non-binary people [44,45]. Given the complete lack of data on the efficacy and safety of these treatments, the ENIGI collaboration should focus more on this issue in the near future, and given the large number of participants, individualized variations in hormone treatment are now welcomed.

    Supplementary Material

    An interesting anecdotal report of hormone therapy with bicalutamide 50 mg/day, cyproterone acetate 12.5 mg/day, and raloxifene 60 mg/day in a formerly self-identified femboy can be found here (PDF).

    References

    • Aksnessæther, B. Y., Solberg, A., Klepp, O. H., Myklebust, T. Å., Skovlund, E., Hoff, S. R., Vatten, L. J., & Lund, J. (2018). Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer? International Journal of Radiation Oncology*Biology*Physics, 101(1), 211–216. [DOI:10.1016/j.ijrobp.2018.01.096]
    • Bach, P. V., Najari, B. B., & Kashanian, J. A. (2016). Adjunct Management of Male Hypogonadism. Current Sexual Health Reports, 8(4), 231–239. [DOI:10.1007/s11930-016-0089-7]
    • Barbieri, R. L. (1992). Hormone treatment of endometriosis: The estrogenthreshold hypothesis. American Journal of Obstetrics and Gynecology, 166(2), 740–745. [DOI:10.1016/0002-9378(92)91706-g]
    • Bass, M., Gonzalez, L. J., Colip, L., Sharon, N., & Conklin, J. (2018). Rethinking gender: The nonbinary approach. American Journal of Health-System Pharmacy, 75(22), 1821–1823. [DOI:10.2146/ajhp180236]
    • Bedognetti, D., Rubagotti, A., Zoppoli, G., & Boccardo, F. (2010). Gynaecomastia: The Anastrozole Paradox. Journal of Pediatric Endocrinology and Metabolism, 23(1–2), 205–206. [DOI:10.1515/jpem.2010.23.1-2.205]
    • Benveniste, O., Simon, A., & Herson, S. (2001). Successful Percutaneous Dihydrotestosterone Treatment of Gynecomastia Occurring during Highly Active Antiretroviral Therapy: Four Cases and a Review of the Literature. Clinical Infectious Diseases, 33(6), 891–893. [DOI:10.1086/322637]
    • Birzniece, V., Meinhardt, U. J., Gibney, J., Johannsson, G., Armstrong, N., Baxter, R. C., & Ho, K. K. (2012). Differential Effects of Raloxifene and Estrogen on Body Composition in Growth Hormone-Replaced Hypopituitary Women. The Journal of Clinical Endocrinology & Metabolism, 97(3), 1005–1012. [DOI:10.1210/jc.2011-2837]
    • Boccardo, F., Rubagotti, A., Battaglia, M., Di Tonno, P., Selvaggi, F., Conti, G., Comeri, G., Bertaccini, A., Martorana, G., Galassi, P., Zattoni, F., Macchiarella, A., Siragusa, A., Muscas, G., Durand, F., Potenzoni, D., Manganelli, A., Ferraris, V., & Montefiore, F. (2005). Evaluation of Tamoxifen and Anastrozole in the Prevention of Gynecomastia and Breast Pain Induced by Bicalutamide Monotherapy of Prostate Cancer. Journal of Clinical Oncology, 23(4), 808–815. [DOI:10.1200/jco.2005.12.013]
    • Buckle, R. (1980). Danazol in the Treatment of Gynaecomastia. Drugs, 19(5), 356–361. [DOI:10.2165/00003495-198019050-00005]
    • Burshell, A. L., Anderson, S. J., Leib, E. S., Johnston, C. C., & Costantino, J. P. (1999). The effect of tamoxifen on pre and postmenopausal bone. Journal of Bone and Mineral Research, 14(Suppl 1), S158–S158. [Google Scholar]
    • Caron, P., Khoury, J. M., Bennet, A., & Louvet, J. P. (1987). Treatment of pubertal gynecomastia with percutaneous dihydrotestosterone gel - long-term clinical outcome. La Semaine des Hôpitaux, 63, 2167–2170. [Google Scholar]
    • Carswell, J. M., & Roberts, S. A. (2017). Induction and Maintenance of Amenorrhea in Transmasculine and Nonbinary Adolescents. Transgender Health, 2(1), 195–201. [DOI:10.1089/trgh.2017.0021]
    • Chen, L., Ko, N., & Chen, K. (2019). Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions. International Journal of Molecular Sciences, 20(9), 2213. [DOI:10.3390/ijms20092213]
    • Cocchetti, C., Ristori, J., Romani, A., Maggi, M., & Fisher, A. D. (2020). Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals. Journal of Clinical Medicine, 9(6), 1609. [DOI:10.3390/jcm9061609]
    • Cocchetti, C., Romani, A., Collet, S., Greenman, Y., Schreiner, T., Wiepjes, C., den Heijer, M., T’Sjoen, G., & Fisher, A. D. (2022). The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives. Journal of Clinical Medicine, 11(7), 1784. [DOI:10.3390/jcm11071784]
    • De Corrado, G., Vetri, M., Padova, G., & Pezzino, V. (1998). Effect of prolonged treatment with percutaneous dihydrotestosterone (DHT) in persistent pubertal gynaecomastia (PPG). International Journal of Andrology, 21, 40–40. [Google Scholar]
    • Dane, C., Dane, B., Cetin, A., & Erginbas, M. (2007). Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis. Gynecological Endocrinology, 23(7), 398–403. [DOI:10.1080/09513590701414907]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de G. Buff Passone, C., Kuperman, H., Cabral de Menezes-Filho, H., Spassapan Oliveira Esteves, L., Lana Obata Giroto, R., & Damiani, D. (2015). Tamoxifen Improves Final Height Prediction in Girls with McCune-Albright Syndrome: A Long Follow-Up. Hormone Research in Paediatrics, 84(3), 184–189. [DOI:10.1159/000435881]
    • de Ronde, W., ten Kulve, J., Woerdeman, J., Kaufman, J., & de Jong, F. H. (2009). Effects of oestradiol on gonadotrophin levels in normal and castrated men. Clinical Endocrinology, 71(6), 874–879. [DOI:10.1111/j.1365-2265.2009.03573.x]
    • Di Lorenzo, G., Autorino, R., Perdonà, S., & De Placido, S. (2005). Management of gynaecomastia in patients with prostate cancer: a systematic review. The Lancet Oncology, 6(12), 972–979. [DOI:10.1016/s1470-2045(05)70464-2]
    • Doran, P. M., Riggs, B. L., Atkinson, E. J., & Khosla, S. (2001). Effects of Raloxifene, a Selective Estrogen Receptor Modulator, on Bone Turnover Markers and Serum Sex Steroid and Lipid Levels in Elderly Men. Journal of Bone and Mineral Research, 16(11), 2118–2125. [DOI:10.1359/jbmr.2001.16.11.2118]
    • Eberle, A. J., & Keenan, B. S. (1985). Treatment of persistent pubertal gynecomastia with dehydrotestosterone heptanoate (DHT-hp). Pediatric Research, 19(4), 185A–185A (abstract no. 448). [DOI:10.1203/00006450-198504000-00478]
    • Eberle, A. J., Sparrow, J. T., & Keenan, B. S. (1986). Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate. The Journal of Pediatrics, 109(1), 144–149. [DOI:10.1016/s0022-3476(86)80596-0]
    • Fagerlund, A., Cormio, L., Palangi, L., Lewin, R., Santanelli di Pompeo, F., Elander, A., & Selvaggi, G. (2015). Gynecomastia in Patients with Prostate Cancer: A Systematic Review. PLOS ONE, 10(8), e0136094. [DOI:10.1371/journal.pone.0136094]
    • Fentiman, I. S. (2018). Managing Male Mammary Maladies. European Journal of Breast Health, 14(1), 5–9. [DOI:10.5152/ejbh.2017.3841]
    • Fradet, Y., Egerdie, B., Andersen, M., Tammela, T. L., Nachabe, M., Armstrong, J., Morris, T., & Navani, S. (2007). Tamoxifen as Prophylaxis for Prevention of Gynaecomastia and Breast Pain Associated with Bicalutamide 150mg Monotherapy in Patients with Prostate Cancer: A Randomised, Placebo-Controlled, Dose–Response Study. European Urology, 52(1), 106–115. [DOI:10.1016/j.eururo.2007.01.031]
    • Francucci, C. M., Pantaleo, D., Iori, N., Camilletti, A., Massi, F., & Boscaro, M. (2005). Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation, 28(9), 623–631. [DOI:10.1007/bf03347261]
    • Giordano, S. H. (2005). A Review of the Diagnosis and Management of Male Breast Cancer. The Oncologist, 10(7), 471–479. [DOI:10.1634/theoncologist.10-7-471]
    • Hadji, P., Colli, E., & Regidor, P. (2019). Bone health in estrogen-free contraception. Osteoporosis International, 30(12), 2391–2400. [DOI:10.1007/s00198-019-05103-6]
    • Heresová, J., Hampl, R., Kuska, L., & Stárka, L. (1981). Podávání nandrolondekanoátu nemocným s gynekomastií [Nandrolone decanoate administered to patients with Gynaecomastia]. Casopis Lekaru Ceskych, 120(52), 1602–1605. [Google Scholar] [PubMed]
    • Heresová, J., & Vrzáňová, M. (2003). Gynekomasti. Interní Medicína Pro Praxi, 5(1), 6–9. [URL] [PDF]
    • Ho, T. H., Nunez-Nateras, R., Hou, Y., Bryce, A. H., Northfelt, D. W., Dueck, A. C., Wong, B., Stanton, M. L., Joseph, R. W., & Castle, E. P. (2017). A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 15(2), 196–202.e1. [DOI:10.1016/j.clgc.2016.08.026]
    • Kanakis, G. A., Nordkap, L., Bang, A. K., Calogero, A. E., Bártfai, G., Corona, G., Forti, G., Toppari, J., Goulis, D. G., & Jørgensen, N. (2019). EAA clinical practice guidelines—gynecomastia evaluation and management. Andrology, 7(6), 778–793. [DOI:10.1111/andr.12636]
    • Keenan, B. S., Fagan, C. J., & Richards, G. E. (1989). Adolescent gynecomastia in lean and obese subjects - radiographic characteristics and response to therapy with dihydrotestosterone enanthate (DHT-EN). Clinical Research, 37(1), A50–A50. [Google Scholar]
    • Kuhn, J. M., Laudat, M. H., Rieu, M., Roca, R., Wolf, L. M., Luton, J. P., & Bricaire, H. (1982). Sex steroid studies and dihydrotestosterone (DHT) treatment in idiopathic and hypogonadic gynecomastia. Journal of Steroid Biochemistry and Molecular Biology 17(3), R81–R81 (abstract no. 242). [Google Scholar]
    • Kuhn, J. M., Laudat, M. H., Roca, R., Dugue, M. A., Luton, J. P., & Bricaire, H. (1983). Gynécomasties: effet du traitement prolongé par la dihydrotestostérone par voie per-cutanée [Gynecomastia: effect of prolonged treatment with dihydrotestosterone by the percutaneous route]. Presse Medicale, 12(1), 21–25. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Kuhn, J., Roca, R., Laudat, M., Rieu, M., Luton, J., & Bricaire, H. (1983). Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone. Clinical Endocrinology, 19(4), 513–520. [DOI:10.1111/j.1365-2265.1983.tb00026.x]
    • Lawrence, S. E., Arnold Faught, K., Vethamuthu, J., & Lawson, M. L. (2004). Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. The Journal of Pediatrics, 145(1), 71–76. [DOI:10.1016/j.jpeds.2004.03.057]
    • Mancino, A. T., Young, Z. T., & Bland, K. I. (2018). Gynecomastia. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 104–115.e5). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00007-6]
    • Moghetti, P., Castello, R., Zamberlan, N., Rossini, M., Gatti, D., Negri, C., Tosi, F., Muggeo, M., & Adami, S. (1999). Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist. The Journal of Clinical Endocrinology & Metabolism, 84(4), 1250–1254. [DOI:10.1210/jcem.84.4.5606]
    • Moser, C., & Devereux, M. (2019). The Medical Management of Gender Dysphoric, Gender Fluid, Gender Nonconforming, Gender Queer, Nonbinary, and Transgender Patients: One Clinic’s Approach. Current Sexual Health Reports, 11(4), 421–429. [DOI:10.1007/s11930-019-00221-y]
    • Naroji, S., Shimy, K., Delot, E., & Gomez-Lobo, V. (2021). 59. Tamoxifen for Puberty Induction and Bone Mineral Density Protection in a Gender Non Binary Patient With 46, XY Complete Gonadal Dysgenesis: A Case Report. Journal of Pediatric and Adolescent Gynecology, 34(2), 262–262 (abstract no. 59). [DOI:10.1016/j.jpag.2021.02.063]
    • Nelson, A. L. (2010). DMPA: battered and bruised but still needed and used in the USA. Expert Review of Obstetrics & Gynecology, 5(6), 673–686. [DOI:10.1586/eog.10.60]
    • Niewoehner, C. B., & Schorer, A. E. (2008). Gynaecomastia and breast cancer in men. BMJ, 336(7646), 709–713. [DOI:10.1136/bmj.39511.493391.be]
    • Ockrim, J., Lalani, E., Laniado, M., Carter, S. S., & Abel, P. (2003). Transdermal Estradiol Therapy for Advanced Prostate Cancer—Forward to the Past? Journal of Urology, 169(5), 1735–1737. [DOI:10.1097/01.ju.0000061024.75334.40]
    • Palacios, S., Regidor, P., Colli, E., Skouby, S. O., Apter, D., Roemer, T., Egarter, C., Nappi, R. E., Skřivánek, A., Jakimiuk, A. J., Weyers, S., Ács, N., Elia, D., Gemzell Danielsson, K., & Bitzer, J. (2020). Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature. The European Journal of Contraception & Reproductive Health Care, 25(3), 221–227. [DOI:10.1080/13625187.2020.1743828]
    • Pang, K. C., Notini, L., McDougall, R., Gillam, L., Savulescu, J., Wilkinson, D., Clark, B. A., Olson-Kennedy, J., Telfer, M. M., & Lantos, J. D. (2020). Long-term Puberty Suppression for a Nonbinary Teenager. Pediatrics, 145(2), e20191606. [DOI:10.1542/peds.2019-1606]
    • Powles, T. J., Hickish, T., Kanis, J. A., Tidy, A., & Ashley, S. (1996). Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women. Journal of Clinical Oncology, 14(1), 78–84. [DOI:10.1200/jco.1996.14.1.78]
    • Preželj, J., & Kocijančič, A. (1994). Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess. Hormone and Metabolic Research, 26(1), 46–48. [DOI:10.1055/s-2007-1000771]
    • Prezelj, J., & Kocijancic, A. (1999). Comment on Spironolactone, But Not Flutamide, Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist. The Journal of Clinical Endocrinology & Metabolism, 84(12), 4747–4751. [DOI:10.1210/jcem.84.12.4747a]
    • Raven, G., de Jong, F. H., Kaufman, J., & de Ronde, W. (2006). In Men, Peripheral Estradiol Levels Directly Reflect the Action of Estrogens at the Hypothalamo-Pituitary Level to Inhibit Gonadotropin Secretion. The Journal of Clinical Endocrinology & Metabolism, 91(9), 3324–3328. [DOI:10.1210/jc.2006-0462]
    • Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A Review of Breast Development in Cisgender Women and Implications for Transgender Women. Endocrine Practice, 25(12), 1338–1345. [DOI:10.4158/ep-2019-0183]
    • Richards, C., Bouman, W. P., Seal, L., Barker, M. J., Nieder, T. O., & T’Sjoen, G. (2016). Non-binary or genderqueer genders. International Review of Psychiatry, 28(1), 95–102. [DOI:10.3109/09540261.2015.1106446]
    • Rizzoli, R. (2018). Postmenopausal osteoporosis: Assessment and management. Best Practice & Research Clinical Endocrinology & Metabolism, 32(5), 739–757. [DOI:10.1016/j.beem.2018.09.005]
    • Roux, C. (1997). Estrogen therapy in postmenopausal osteoporosis. What we know and what we don’t. Revue du Rhumatisme (English Ed.), 64(6), 402–409. [Google Scholar] [PubMed] [PDF]
    • Saltzstein, D., Sieber, P., Morris, T., & Gallo, J. (2005). Prevention and management of bicalutamide-induced gynecomastia and breast pain: randomized endocrinologic and clinical studies with tamoxifen and anastrozole. Prostate Cancer and Prostatic Diseases, 8(1), 75–83. [DOI:10.1038/sj.pcan.4500782]
    • Seal, L. (2017). Adult Endocrinology. In Richards, C., Bouman, W. P., & Barker, M.-J. (Eds.). Genderqueer and Non-Binary Genders (Critical and Applied Approaches in Sexuality, Gender and Identity) (pp. 183–223). London: Palgrave Macmillan UK. [DOI:10.1057/978-1-137-51053-2_10]
    • Serretta, V., Altieri, V., Morgia, G., Nicolosi, F., De Grande, G., Mazza, R., Melloni, D., Allegro, R., Ferraù, F., & Gebbia, V. (2012). A Randomized Trial Comparing Tamoxifen Therapy vs. Tamoxifen Prophylaxis in Bicalutamide-Induced Gynecomastia. Clinical Genitourinary Cancer, 10(3), 174–179. [DOI:10.1016/j.clgc.2012.03.002]
    • T’Sjoen, G. G., Giagulli, V. A., Delva, H., Crabbe, P., De Bacquer, D., & Kaufman, J. (2005). Comparative Assessment in Young and Elderly Men of the Gonadotropin Response to Aromatase Inhibition. The Journal of Clinical Endocrinology & Metabolism, 90(10), 5717–5722. [DOI:10.1210/jc.2005-0982]
    • Ting, A. C., Chow, L. W., & Leung, Y. (2000). Comparison of Tamoxifen with Danazol in the Management of Idiopathic Gynecomastia. The American Surgeon, 66(1), 38–40. [DOI:10.1177/000313480006600108]
    • Trost, L. W., & Khera, M. (2014). Alternative Treatment Modalities for the Hypogonadal Patient. Current Urology Reports, 15(7), 417. [DOI:10.1007/s11934-014-0417-2]
    • Tsourdi, E., Kourtis, A., Farmakiotis, D., Katsikis, I., Salmas, M., & Panidis, D. (2009). The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitary-testicular axis in men with idiopathic oligozoospermia. Fertility and Sterility, 91(4), 1427–1430. [DOI:10.1016/j.fertnstert.2008.06.002]
    • Tunio, M., Al-Asiri, M., Al-Amro, A., Bayoumi, Y., & Fareed, M. (2012). Optimal Prophylactic and Definitive Therapy for Bicalutamide-Induced Gynecomastia: Results of a Meta-analysis. Current Oncology, 19(4), 280–288. [DOI:10.3747/co.19.993]
    • van Dijken, J. B., Steensma, T. D., Wensing-Kruger, S. A., Heijer, M. D., & Dreijerink, K. M. (2022). Tailored Gender-Affirming Hormone Treatment in Nonbinary Transgender Individuals: A Retrospective Study in a Referral Center Cohort. Transgender Health, 8(3), 220–225. [DOI:10.1089/trgh.2021.0032]
    • Vestergaard, P. (2012). Raloxifene for the treatment of postmenopausal osteoporosis. International Journal of Clinical Rheumatology, 7(3), 261–269. [Google Scholar] [DOI:10.2217/ijr.12.19] [PDF]
    • Viani, G. A., Bernardes da Silva, L. G., & Stefano, E. J. (2012). Prevention of Gynecomastia and Breast Pain Caused by Androgen Deprivation Therapy in Prostate Cancer: Tamoxifen or Radiotherapy? International Journal of Radiation Oncology*Biology*Physics, 83(4), e519–e524. [DOI:10.1016/j.ijrobp.2012.01.036]
    • Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]
    • Xu, J. Y., O’Connell, M. A., Notini, L., Cheung, A. S., Zwickl, S., & Pang, K. C. (2021). Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care? Frontiers in Endocrinology, 12, 701364. [DOI:10.3389/fendo.2021.701364]
    • Zacharin, M. (2009). Disorders of ovarian function in childhood and adolescence: evolving needs of the growing child. An endocrine perspective. BJOG: An International Journal of Obstetrics & Gynaecology, 117(2), 156–162. [DOI:10.1111/j.1471-0528.2009.02399.x]
    • Zirilli, L., Maffei, L., Meunier, P., Chavassieux, P., Carani, C., & Rochira, V. (2009). The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency. Bone, 45(5), 827–832. [DOI:10.1016/j.bone.2009.03.672]
    \ No newline at end of file diff --git a/transfemscience.org/articles/oral-e2-leinung-2018/index.html b/transfemscience.org/articles/oral-e2-leinung-2018/index.html index 3b9fce5a..e3d60263 100644 --- a/transfemscience.org/articles/oral-e2-leinung-2018/index.html +++ b/transfemscience.org/articles/oral-e2-leinung-2018/index.html @@ -1 +1 @@ -Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018) - Transfeminine Science Link

    Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018)

    By Aly | First published March 27, 2019 | Last modified February 17, 2023

    Abstract / TL;DR

    Analysis has been performed and information is provided on estradiol and testosterone levels with different doses of oral estradiol alone or in combination with antiandrogens including spironolactone (200 mg/day) and finasteride (5 mg/day) in transfeminine people based on published data from Leinung et al. (2018). With oral estradiol alone, mean estradiol levels ranged from 39 to 159 pg/mL across a dose range of 1 to 8 mg/day and mean testosterone levels ranged from 160 ng/dL at estradiol levels of <50 pg/mL to 44–61 ng/dL at estradiol levels of >100 pg/mL. Finasteride was associated with higher testosterone levels at all estradiol dose levels while spironolactone was associated with lower estradiol levels but only at an oral estradiol dose of 8 mg/day and not at other doses (2–6 mg/day). Mean testosterone levels in post-gonadectomy transfeminine people were 22 ng/dL. These findings suggest that oral estradiol dose-dependently suppresses testosterone levels and that estradiol and testosterone levels with oral estradiol may be modified by antiandrogens in transfeminine people.

    Introduction

    A retrospective chart study which quantified estradiol levels and suppression of testosterone levels with oral estradiol alone and in combination with an antiandrogen in a large sample of transfeminine people in the United States was published in May 2018 by Leinung and colleagues. The sample size for the study was 166 transfeminine people and estradiol and testosterone levels were determined with chemiluminescent immunoassay (CLIA). Here is the citation for the study:

    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]

    This is a very useful study because it has data in transfeminine people that can provide precise estimates for answers to several open questions about transfeminine hormone therapy. These include what estradiol levels will be achieved with different doses of oral estradiol, how much testosterone levels will be suppressed with different doses/levels of estradiol, and the influence of certain antiandrogens—specifically spironolactone and finasteride—on estradiol and testosterone levels with oral estradiol.

    I’ve digitized and recreated the two main graphs of interest from the paper. These new graphs are of higher image quality than the originals and I feel have an improved appearance. They aren’t perfect replicas of the originals (overlapping data points in the original graphs prevented this from being possible), but they should be quite close (e.g., ± 4 data points). In addition to the remade graphs, I’ve created two new graphs using data from the figures in the paper. These new graphs are variations of the originals that I think may be more understandable and useful. The four graphs are shown below (Figures 1–4). A supplementary spreadsheet containing the extracted data used to create these graphs can be found here. Some of the raw data in the spreadsheet is also included below in the Data Tables section.

    As this study was not a randomized controlled trial (RCT) and was instead a retrospective chart review, there are limitations with these data that must be noted. For example, estradiol levels with different doses of oral estradiol may be inaccurate to a degree because transfeminine people in the study had their doses adjusted based on hormone levels (e.g., low/unsatisfactory estradiol levels or testosterone suppression resulting in increased doses and high/excessive estradiol levels resulting in dose decreases). In any case, estradiol levels with oral estradiol in this study were fairly similar to those that have been reported in other studies (e.g., Lobo & Cassidenti, 1992; Kuhl, 2005; Wiki; Graphs). It should also be noted that hormone levels vary by study and blood-testing methodology used.

    Graphs

    Recreated Graphs

    Figure 1: Estradiol levels (pg/mL) with different doses (mg/day) of oral estradiol (E2) in transfeminine people. Estradiol levels are represented by blue circles (●) with oral estradiol alone, by red squares (■) with oral estradiol plus finasteride, and by green diamonds (◆) with oral estradiol plus spironolactone. The lines of colors corresponding to those of the points represent linear trendlines for the data points. This figure has also been uploaded to and can be found on Wikipedia (Wiki).
    Figure 2: Testosterone levels (ng/dL) at different levels of estradiol (pg/mL) with oral estradiol (E2) in transfeminine people. Testosterone levels are represented by blue circles (●) with oral estradiol alone, by red squares (■) with oral estradiol plus finasteride, and by green diamonds (◆) with oral estradiol plus spironolactone. The dashed horizontal grey line is the mean testosterone level in a comparison group of post-gonadectomy transfeminine people (21.7 ± 12.4 ng/dL, with 13 determinations below 10 ng/dL, the lower limit of detection for the assay). This figure has also been uploaded to and can be found on Wikipedia (Wiki).

    New Graphs

    Figure 3: Estradiol levels (pg/mL) with 1 to 8 mg/day oral estradiol (E2) alone (blue line) or in combination with 200 mg/day oral spironolactone (green line) in transfeminine people. The oral estradiol alone group is actually a combination of oral estradiol alone and oral estradiol taken together with finasteride (5 mg/day); these two groups showed no significant differences in estradiol levels in the original data so they were combined for this graph. Estradiol levels with estradiol alone versus estradiol plus spironolactone seemed to be different only at the highest oral estradiol dose level (8 mg/day). The error bars represent standard deviations from the mean. This figure has also been uploaded to and can be found on Wikipedia (Wiki).
    Figure 4: Testosterone levels (ng/dL) at different ranges of estradiol levels (pg/mL) with oral estradiol (E2) alone (blue line) or in combination with 5 mg/day finasteride (red line) or 200 mg/day oral spironolactone (green line) in transfeminine people. The typical oral estradiol doses (mg/day) for each range of estradiol levels are also provided. The dashed horizontal purple line is the upper limit for the normal female or castrate range (~50 ng/dL), while the dashed horizontal grey line is the mean testosterone level in a comparison group of post-gonadectomy transfeminine people (21.7 ± 12.4 ng/dL, with 13 determinations below 10 ng/dL, the lower limit of detection for the assay). The error bars represent standard deviations from the mean. This figure has also been uploaded to and can be found on Wikipedia (Wiki).

    Data Tables

    Estradiol Levels with Oral Estradiol

    Table 1: Estradiol levels with different doses of oral estradiol alonea in transfeminine people:

    DosagenEstradiol level (mean ± SD)
    1 mg/day539 ± 25 pg/mL
    2 mg/day2462 ± 23 pg/mL
    4 mg/day34102 ± 59 pg/mL
    6 mg/day80125 ± 62 pg/mL
    8 mg/day24159 ± 76 pg/mL

    a Actually pooled data for oral estradiol alone and oral estradiol combined with finasteride (5 mg/day); these two groups showed no significant differences in estradiol levels in the original data so they were pooled together for this table.

    Testosterone Levels with Oral Estradiol

    Table 2: Testosterone levels at different estradiol levels with oral estradiol alonea in transfeminine people:

    Estradiol level rangenEstradiol level (mean ± SD)Testosterone level (mean ± SD)
    <50 pg/mL1133 ± 8.4 pg/mL160 ± 139 ng/dL
    50–100 pg/mL2476 ± 15 pg/mL83 ± 106 ng/dL
    100–150 pg/mL21125 ± 14 pg/mL50 ± 37 ng/dL
    150–200 pg/mL8170 ± 15 pg/mL61 ± 57 ng/dL
    200–250 pg/mL4227 ± 14 pg/mL44 ± 33 ng/dL

    a Only oral estradiol alone; oral estradiol combined with finasteride or spironolactone not included.

    Update: Jain, Kwan, & Forcier (2019)

    Shortly following the publication of Leinung et al. (2018), Jain and colleagues published a similar study of sublingual estradiol in combination with spironolactone and with or without medroxyprogesterone acetate in transfeminine people (Jain, Kwan, & Forcier, 2019).

    Supplementary Material

    References

    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone acetate in Gender-Affirming therapy for Transwomen: results from a retrospective study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Lobo, R. A., & Cassidenti, D. L. (1992). Pharmacokinetics of Oral 17 β-Estradiol. The Journal of Reproductive Medicine, 37(1), 77–84. [Google Scholar] [PubMed] [PDF]
    \ No newline at end of file +Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018) - Transfeminine Science Link

    Analysis of Estradiol and Testosterone Levels with Oral Estradiol in Transfeminine People Based on Leinung et al. (2018)

    By Aly | First published March 27, 2019 | Last modified February 17, 2023

    Abstract / TL;DR

    Analysis has been performed and information is provided on estradiol and testosterone levels with different doses of oral estradiol alone or in combination with antiandrogens including spironolactone (200 mg/day) and finasteride (5 mg/day) in transfeminine people based on published data from Leinung et al. (2018). With oral estradiol alone, mean estradiol levels ranged from 39 to 159 pg/mL across a dose range of 1 to 8 mg/day and mean testosterone levels ranged from 160 ng/dL at estradiol levels of <50 pg/mL to 44–61 ng/dL at estradiol levels of >100 pg/mL. Finasteride was associated with higher testosterone levels at all estradiol dose levels while spironolactone was associated with lower estradiol levels but only at an oral estradiol dose of 8 mg/day and not at other doses (2–6 mg/day). Mean testosterone levels in post-gonadectomy transfeminine people were 22 ng/dL. These findings suggest that oral estradiol dose-dependently suppresses testosterone levels and that estradiol and testosterone levels with oral estradiol may be modified by antiandrogens in transfeminine people.

    Introduction

    A retrospective chart study which quantified estradiol levels and suppression of testosterone levels with oral estradiol alone and in combination with an antiandrogen in a large sample of transfeminine people in the United States was published in May 2018 by Leinung and colleagues. The sample size for the study was 166 transfeminine people and estradiol and testosterone levels were determined with chemiluminescent immunoassay (CLIA). Here is the citation for the study:

    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]

    This is a very useful study because it has data in transfeminine people that can provide precise estimates for answers to several open questions about transfeminine hormone therapy. These include what estradiol levels will be achieved with different doses of oral estradiol, how much testosterone levels will be suppressed with different doses/levels of estradiol, and the influence of certain antiandrogens—specifically spironolactone and finasteride—on estradiol and testosterone levels with oral estradiol.

    I’ve digitized and recreated the two main graphs of interest from the paper. These new graphs are of higher image quality than the originals and I feel have an improved appearance. They aren’t perfect replicas of the originals (overlapping data points in the original graphs prevented this from being possible), but they should be quite close (e.g., ± 4 data points). In addition to the remade graphs, I’ve created two new graphs using data from the figures in the paper. These new graphs are variations of the originals that I think may be more understandable and useful. The four graphs are shown below (Figures 1–4). A supplementary spreadsheet containing the extracted data used to create these graphs can be found here. Some of the raw data in the spreadsheet is also included below in the Data Tables section.

    As this study was not a randomized controlled trial (RCT) and was instead a retrospective chart review, there are limitations with these data that must be noted. For example, estradiol levels with different doses of oral estradiol may be inaccurate to a degree because transfeminine people in the study had their doses adjusted based on hormone levels (e.g., low/unsatisfactory estradiol levels or testosterone suppression resulting in increased doses and high/excessive estradiol levels resulting in dose decreases). In any case, estradiol levels with oral estradiol in this study were fairly similar to those that have been reported in other studies (e.g., Lobo & Cassidenti, 1992; Kuhl, 2005; Wiki; Graphs). It should also be noted that hormone levels vary by study and blood-testing methodology used.

    Graphs

    Recreated Graphs

    Figure 1: Estradiol levels (pg/mL) with different doses (mg/day) of oral estradiol (E2) in transfeminine people. Estradiol levels are represented by blue circles (●) with oral estradiol alone, by red squares (■) with oral estradiol plus finasteride, and by green diamonds (◆) with oral estradiol plus spironolactone. The lines of colors corresponding to those of the points represent linear trendlines for the data points. This figure has also been uploaded to and can be found on Wikipedia (Wiki).
    Figure 2: Testosterone levels (ng/dL) at different levels of estradiol (pg/mL) with oral estradiol (E2) in transfeminine people. Testosterone levels are represented by blue circles (●) with oral estradiol alone, by red squares (■) with oral estradiol plus finasteride, and by green diamonds (◆) with oral estradiol plus spironolactone. The dashed horizontal grey line is the mean testosterone level in a comparison group of post-gonadectomy transfeminine people (21.7 ± 12.4 ng/dL, with 13 determinations below 10 ng/dL, the lower limit of detection for the assay). This figure has also been uploaded to and can be found on Wikipedia (Wiki).

    New Graphs

    Figure 3: Estradiol levels (pg/mL) with 1 to 8 mg/day oral estradiol (E2) alone (blue line) or in combination with 200 mg/day oral spironolactone (green line) in transfeminine people. The oral estradiol alone group is actually a combination of oral estradiol alone and oral estradiol taken together with finasteride (5 mg/day); these two groups showed no significant differences in estradiol levels in the original data so they were combined for this graph. Estradiol levels with estradiol alone versus estradiol plus spironolactone seemed to be different only at the highest oral estradiol dose level (8 mg/day). The error bars represent standard deviations from the mean. This figure has also been uploaded to and can be found on Wikipedia (Wiki).
    Figure 4: Testosterone levels (ng/dL) at different ranges of estradiol levels (pg/mL) with oral estradiol (E2) alone (blue line) or in combination with 5 mg/day finasteride (red line) or 200 mg/day oral spironolactone (green line) in transfeminine people. The typical oral estradiol doses (mg/day) for each range of estradiol levels are also provided. The dashed horizontal purple line is the upper limit for the normal female or castrate range (~50 ng/dL), while the dashed horizontal grey line is the mean testosterone level in a comparison group of post-gonadectomy transfeminine people (21.7 ± 12.4 ng/dL, with 13 determinations below 10 ng/dL, the lower limit of detection for the assay). The error bars represent standard deviations from the mean. This figure has also been uploaded to and can be found on Wikipedia (Wiki).

    Data Tables

    Estradiol Levels with Oral Estradiol

    Table 1: Estradiol levels with different doses of oral estradiol alonea in transfeminine people:

    DosagenEstradiol level (mean ± SD)
    1 mg/day539 ± 25 pg/mL
    2 mg/day2462 ± 23 pg/mL
    4 mg/day34102 ± 59 pg/mL
    6 mg/day80125 ± 62 pg/mL
    8 mg/day24159 ± 76 pg/mL

    a Actually pooled data for oral estradiol alone and oral estradiol combined with finasteride (5 mg/day); these two groups showed no significant differences in estradiol levels in the original data so they were pooled together for this table.

    Testosterone Levels with Oral Estradiol

    Table 2: Testosterone levels at different estradiol levels with oral estradiol alonea in transfeminine people:

    Estradiol level rangenEstradiol level (mean ± SD)Testosterone level (mean ± SD)
    <50 pg/mL1133 ± 8.4 pg/mL160 ± 139 ng/dL
    50–100 pg/mL2476 ± 15 pg/mL83 ± 106 ng/dL
    100–150 pg/mL21125 ± 14 pg/mL50 ± 37 ng/dL
    150–200 pg/mL8170 ± 15 pg/mL61 ± 57 ng/dL
    200–250 pg/mL4227 ± 14 pg/mL44 ± 33 ng/dL

    a Only oral estradiol alone; oral estradiol combined with finasteride or spironolactone not included.

    Update: Jain, Kwan, & Forcier (2019)

    Shortly following the publication of Leinung et al. (2018), Jain and colleagues published a similar study of sublingual estradiol in combination with spironolactone and with or without medroxyprogesterone acetate in transfeminine people (Jain, Kwan, & Forcier, 2019).

    Supplementary Material

    References

    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone acetate in Gender-Affirming therapy for Transwomen: results from a retrospective study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Lobo, R. A., & Cassidenti, D. L. (1992). Pharmacokinetics of Oral 17 β-Estradiol. The Journal of Reproductive Medicine, 37(1), 77–84. [Google Scholar] [PubMed] [PDF]
    \ No newline at end of file diff --git a/transfemscience.org/articles/oral-p4-low-levels-literature/index.html b/transfemscience.org/articles/oral-p4-low-levels-literature/index.html index 427d0dcc..aca8503f 100644 --- a/transfemscience.org/articles/oral-p4-low-levels-literature/index.html +++ b/transfemscience.org/articles/oral-p4-low-levels-literature/index.html @@ -1 +1 @@ -Sources/Excerpts: Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects - Transfeminine Science Link

    Sources/Excerpts: Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects

    By Aly | First published August 4, 2018 | Last modified September 25, 2022

    Preface

    This is a literature sources/excerpts supplement to the main article which can be found here.

    Excerpts From Literature Reviews

    de Ziegler et al. (1998)

    de Ziegler, D., Fanchin, R., de Moustier, B., & Bulletti, C. (1998). The hormonal control of endometrial receptivity: estrogen (E2) and progesterone. Journal of Reproductive Immunology, 39(1–2), 149–166. [DOI:10.1016/S0165-0378(98)00019-9]:

    4.2. The oral route paradox and the methodological flaws in progesterone measurement

    High levels of progesterone have been reported after oral administration of micronized progesterone (Simon et al., 1993). Yet, despite the high levels reported, the same authors describe incomplete endometrial effects. Today, we believe that the apparent paradox between high progesterone levels and minimal endometrial effects characteristic of oral progesterone has been elucidated by Nahoul et al. (1987, 1993) revealing methodological flaw in the measurement of plasma progesterone after oral administration. Indeed, while direct RIA for progesterone is valid for the measurement of plasma levels in the luteal phase of the menstrual cycle, this is not the case after oral administration. In an elegant paper, Nahoul et al. (1987) showed that because of the high levels of progesterone metabolites encountered after oral administration direct RIA measured values 3–5 times higher than those determined when measurements are conducted after extraction and separation on celite columns using an appropriate assay. Nahoul et al. (1993) showed that plasma levels of progesterone were only minimally elevated after oral ingestion of 100 mg of progesterone (barely reaching 1 ng/ml) and, particularly, were markedly lower than after vaginal administration of the same amounts of progesterone.

    de Ziegler & Fanchin (2000)

    de Ziegler, D., & Fanchin, R. (2000). Progesterone and progestins: applications in gynecology. Steroids, 65(10–11), 671–679. [DOI:10.1016/S0039-128X(00)00123-9]:

    3.1. Oral progesterone

    Progesterone is nearly entirely absorbed after oral ingestion when prepared in micronized form. Yet, because of intense inactivation by metabolism during first liver pass, the bioavailability of oral progesterone is notoriously poor at <10% [25]. This poor bioavailability explains that despite the large amounts used (up to 600 mg/day), oral progesterone fails to trigger the full array of endometrial changes seen in the late luteal phase of the menstrual cycle. Particularly, the last step of these changes (the predecidual transformation of stroma cells) fails to be induced by oral progesterone [3].

    Some confusion has existed over these findings. Early reports claimed high plasma progesterone levels after oral administration of progesterone. However, fairly low plasma levels of progesterone have been reported when the hormone is given orally, and proper assays are used. Circulating levels of progesterone and its metabolites, determined by sufficiently specific assays, after oral and vaginal administration of 100 mg of progesterone are illustrated in Fig. 4. As can be seen, when taken orally, progesterone accounts for less than 10%, whereas most of ingested progesterone is transformed to 5α-reduced metabolites. The metabolites of progesterone that bind to the GABAA receptor complex are responsible for drowsiness and other neurologic side effects. Interestingly, however, erroneous readings of circulating progesterone have been obtained after oral intake of progesterone when plasma levels are measured by direct radio-immunoassays. Direct assays have only been validated for measurements of progesterone in the luteal phase of the menstrual cycle. After oral ingestion, the unusually high levels of progesterone metabolites alter the validity of progesterone measurements by direct assays because antibody specificity is insufficient in these unusual circumstances. Conversely, when progesterone is measured after separation on celite columns, plasma progesterone levels are low after oral ingestion; these low levels are concordant with the incomplete secretory transformation of the endometrium observed [25], [26].

    Similarly, repeated daily administration of nasal progesterone failed to induce predecidual changes of endometrial stroma, a finding in accordance with the low levels of plasma progesterone achieved (from 2 to 5 ng/ml).

    Because transdermal administration of progesterone is impractical, the vaginal route has long been regarded as the best, if not the only, alternate option for delivering progesterone non-orally to women. With the advent of IVF and other assisted reproductive procedures, interest has refocused on vaginal progesterone. Ultimately, the data suggest that vaginal progesterone is more than merely a non-oral alternative. Early work undoubtedly showed the high efficacy of vaginal progesterone at duplicating all the endometrial changes of the luteal phase. We now know, however, that this is not solely dependent on plasma levels, which remain lower than seen in the luteal phase of the menstrual cycle [30,31].

    Stanczyk (2000)

    Stanczyk, F. Z. (2000). Pharmacokinetics of progesterone administered orally and parenterally. In Sitruk-Ware, R., & Mishell, D. R. (Eds.). Progestins and Antiprogestins in Clinical Practice (pp. 393–400). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books]:

    Progesterone is measured by immunoassay methods that include radioimmunoassay, chemiluminescent immunoassay, fluoroimmunoassay, and enzyme immunoassay. […] Although “direct” immunoassays (i.e., without a purification step) are used most commonly for quantifying progesterone in serum or plasma, such assays should not be used when measuring progesterone in samples obtained following exogenous administration of progesterone. This is because high concentrations of both unconjugated and conjugated progesterone metabolites are found in serum following oral progesterone dosing, which results in overestimated progesterone values. To obtain absolute progesterone levels, it is essential to subject samples to purification (e.g., organic solvent extraction and chromatography) before quantification by immunoassay.

    Kuhl (2005)

    Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]:

    The oral application of progesterone is associated with an extensive metabolism in the gastrointestinal tract and the liver, which results in high, but individually variable, concentrations of circulating metabolites. Consequently, the investigation of the pharmacokinetics of progesterone by means of radioimmunoassay (RIA) may be hampered by falsely high progesterone levels due to a relative pronounced cross-reactivity of progesterone metabolites. Therefore, either the gas chromatography/mass spectrometry (GC/MS) method or RIA after chromatographic separation are suitable for the measurement of progesterone. This problem is less pronounced after vaginal administration of progesterone owing to the relative low degree of metabolism213.

    Wheeler & Barnard (2010)

    Wheeler, M. J., & Barnard, G. (2010). Immunoassay of Steroids. In Makin, H., & Gower, D. (Eds.). Steroid Analysis (pp. 283–327). Dordrecht: Springer. [DOI:10.1023/b135931_4]:

    In addition, there is a more critical requirement for improved antibody specificity in non-extraction procedures because of the presence of relatively high concentrations of steroid conjugates (glucuronides and sulphates) in unextracted serum. This is particularly true in the case of samples from patients undergoing hormone replacement therapy, which may involve the administration of oestradiol, progesterone and/or testosterone in a variety of combinations and by a variety of routes (e.g. intramuscular, oral, nasal, intravaginal or percutaneous). The route of administration profoundly affects the metabolism of the hormone and leads to the formation of particular profiles of steroid conjugates, some of which may cross-react significantly in the immunoassay (Nisbet and Jomain, 1987; Nahoul et al., 1989). In many cases, commercial direct procedures may be totally inappropriate for use in these situations.

    Kuhl (2011)

    Kuhl, H. (2011). Pharmacology of progestogens. Journal für Reproduktionsmedizin und Endokrinologie [Journal of Reproductive Medicine and Endocrinology], 8(1), 157–177. [URL] [PDF]:

    Progesterone is an important intermediate in the ovarian and adrenal steroid synthesis, but larger amounts are produced only in the corpus luteum and the placenta. During the luteal phase, serum concentrations of 25 ng/ml are reached which may increase during pregnancy up to 200 ng/ml. […]

    […] the half-lives [of progesterone in the circulation] are only 6 min (t1/2α) and 42 min (t1/2β). Progesterone is rapidly metabolised, predominantly by reduction of the keto groups and the Δ4- double bond, and the pattern of metabolites depends largely on the route of administration. The oral application of progesterone is associated with an extensive metabolism in the gastrointestinal tract and the liver which results in high, but individually variable concentrations of circulating metabolites. Consequently, the investigation of the pharmacokinetics of progesterone by means of RIA may be hampered by falsely high progesterone levels due to a relatively pronounced cross-reactivity of progesterone metabolites. Therefore, either the GC/MS method or radioimmunoassay (RIA) after chromatographic separation are suitable for the measurement of progesterone. This problem is less pronounced after vaginal administration of progesterone owing to the relatively low degree of metabolism [54].

    After oral administration, progesterone can be metabolised to more than 30 metabolites, among which some exert specific physiological activities. The most important pathway is the formation of 5α-pregnanolone and 5β-pregnanolone that exert considerable sedative effects after binding to the GABAA receptor. Further metabolites were 20-dihydroprogesterone that has 25–50% of the progestogenic potency of progesterone, 11-deoxycorticosterone (DOC) that is a potent mineralocorticoid, 17α-hydroxyprogesterone, and the inactive end-product pregnanediol (Fig. 7).

    There are large interindividual differences in the pattern of metabolites circulating after oral administration [55]. The low oral bioavailability could be increased by the use of micronized progesterone suspended in oil and packaged in a gelatine capsule.

    Pharmacokinetics A single oral dose of 100 mg progesterone contained in a gelatine capsule led to a rapid rise in serum progesterone as measured by liquid chromatography–mass spectrometry to a peak level of 1.5–2.2 ng/ml after 1–2 h. Thereafter the levels decreased rapidly to baseline levels within 4–6 h [53, 55]. However, determination by means of RIA revealed a mean peak level of 19.4 ng/ml suggesting a high cross reaction of progesterone metabolites [54]. There was a pronounced rise in the serum levels of 5α- and 5β-pregnanolone up to a maximum of 14 ng/ml and 3.6 ng/ml after 2 h. The DOC levels rose from 120 pg/ml to 680 pg/ml after 2 h and decreased rapidly thereafter [56].

    The results cast some doubts on the reliability of progesterone determinations by RIA if metabolites are not separated by means of chromatographically in advance.

    After oral intake of 200 mg progesterone, the peak levels of progesterone as measured by RIA after 4 h were 12 ng/ml, while 5α- and 5β-pregnanolone reached serum concentrations of 30 ng/ml and 60 ng/ml [55]. Further metabolites were 20-dihydroprogesterone, DOC, 17α-hydroxyprogesterone, and pregnanediol (Fig. 7).

    The results of a large prospective study indicate that oral and transdermal treatment with progesterone does not protect from estrogen-induced endometrial cancer in postmenopausal women. Compared with women treated with estrogen-only preparations who showed an elevated relative risk of 2.52 (95%-CI: 1.7–3.57), the risk of endometrial cancer did not differ significantly during therapy with estrogen plus progesterone (relative risk 2.42; 95%-CI: 1.53–3.83). Contrary to this, synthetic progestogens reduced the estrogen-dependent risk significantly [57]. The lack of endometrial protection during oral progesterone therapy may be explained by the low progesterone serum levels measured with reliable methods. The same phenomenon may also explain the results of another cohort study that, in contrast to synthetic progestins, the addition of progesterone to estrogen therapy did not increase the risk of breast cancer [58, 59].

    The finding of an elevated risk of endometrial cancer in postmenopausal women during treatment with estrogens and oral progesterone are in contradiction to various trials that did not find any increase in the rate of endometrial hyperplasia in women treated with estrogens and 200 mg sequential progesterone or 100 mg continuous progesterone [60–62]. However, the effect of oral treatment with progesterone on estrogenized postmenopausal endometria is dose-dependent, and during the use of 200 mg no full secretory transformation was observed, whereas the daily dose of 300 mg seems to be appropriate as an alternative to synthetic progestogens for therapy [63].

    Kuhl & Schneider (2013)

    Kuhl, H., & Schneider, H. P. G. (2013). Progesterone – promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]:

    The problem of measurement of progesterone levels by RIA

    Oral treatment is associated with a rapid metabolism of micronized progesterone in the intestinal mucosa and during the first liver passage. Although the bioavailability of orally administered progesterone is improved by suspending micronized particles of progesterone in oil, the serum concentrations of progesterone are very low when measured with exact methods like liquid chromatography–mass spectrometry (Table 5) 93. Contrary to this, the metabolism of endogenous progesterone in the luteal phase and of vaginally administered progesterone is low and does not compromise measurement of serum progesterone by RIA methods.

    After oral administration of progesterone, however, large amounts of certain progesterone metabolites are circulating which have a more or less pronounced binding affinity to the relatively unspecific antiserum against progesterone used in the RIA. Therefore, if not separated from progesterone, these metabolites will cause falsely high progesterone serum concentrations when using a RIA (Figure 5). Therefore, after oral treatment with micronized progesterone, the separation of progesterone from its metabolites by an appropriate chromatographic system is mandatory 93–95.

    After oral administration of 100 mg and 200 mg micronized progesterone to premenopausal women during the follicular phase, average peak levels of 1.5 ± 0.2 ng/ml and 4.70 ± 1.14 ng/ml, respectively, were measured after 2–3 h using a reliable RIA method after adequate chromatographic separation 94.

    A direct comparison of the progesterone levels measured by either a direct RIA or liquid chromatography–mass spectrometry revealed that, after vaginal administration of 90 mg of progesterone gel, both methods resulted in similar mean peak levels of 8 ng/ml. Contrary to this, after oral administration of 100 mg progesterone per capsule, the mean peak level of progesterone was measured as 15 ng/ml using the RIA method compared to 2 ng/ml using the gold-standard method of liquid chromatography–mass spectrometry (Figure 5, Table 5) 93.

    Micronized progesterone and risk of endometrial cancer

    The EPIC cohort study, carried out with 115 000 postmenopausal women, revealed that estrogen-only therapy yielded a 2.52-fold increase in the relative risk of endometrial cancer which was prevented by the addition of progesterone derivatives or nortestosterone derivatives. Contrary to this, progesterone was not able to protect from the development of estrogen-induced endometrial cancer, increasing the relative risk up to 2.42 96.

    Randomized trials revealed that, after treatment of postmenopausal women with oral or percutaneous estrogens and cyclic addition of oral micronized progesterone, the rate of endometrial hyperplasia was not elevated and was similar to that in the placebo group 102,103.

    The lack of endometrial hyperplasia was interpreted as evidence for a sufficient protective effect on the endometrium by oral use of micronized progesterone. However, the results of these studies refer to surrogate parameters which cannot be transferred to the clinical endpoint of endometrial cancer. The oral use of daily 200 mg micronized progesterone causes peak levels of progesterone of less than 5 ng/ml, provided that adequate methods are used for measurement of the serum levels 94. In face of the large interindividual variations in the pharmacokinetics of progesterone, there will be women with serum progesterone levels too low for a long-term protection of the endometrium 93–95.

    On the other hand, the mitosis rate in invasive breast carcinomas has been observed to reach a maximum during the luteal phase. Very likely, endogenous progesterone in synergism with estradiol is responsible for an increase in mammary epithelial proliferation, vascularity, breast tenderness and mammographic density.

    In the 2005 report of the French E3N cohort study, no effect of percutaneous estradiol, with or without the addition of oral micronized progesterone, was found on postmenopausal breast cancer risk, in contrast to an unfavorable effect of combined synthetic progestins. The publication in 2008 revealed that oral micronized progesterone even prevented an estrogen-induced rise in breast cancer risk. In 2009, a new report did not present risk data based on the total case numbers of the three treatment groups. Instead, the cases were divided into eight subgroups according to the gap time between menopause and initiation of HRT and the duration of HRT. Importantly, long-term treatment with estrogen and micronized progesterone was found to increase significantly the risk of breast cancer.

    It is hard to believe that progesterone does not promote the estrogen-related risk of breast cancer or even has a favorable effect. […] The oral dose of 100 mg or 200 mg progesterone is too low for endometrial protection in all women, as demonstrated by an increased risk of endometrial cancer. The rapid inactivation of progesterone in the intestinal mucosa and the liver causes very low progesterone serum levels which have been measured using reliable methods (e.g. liquid chromatography–mass spectrometry) instead of a RIA which is compromised by cross-reactions of certain progesterone metabolites. Therefore, a weak proliferative effect of the low progesterone levels may need a longer time interval of oral treatment with micronized progesterone, until an increase in breast cancer can be demonstrated.

    The available knowledge suggests that, similar to synthetic progestins, HRT with micronized progesterone may promote the growth of small breast carcinomas which may have developed during the fertile phase of the women. Whether or not there are differences between the various progestogens remains to be elucidated.

    North American Menopause Society (2017)

    North American Menopause Society. (2017). The 2017 hormone therapy position statement of the North American Menopause Society. Menopause, 24(7), 728–753. [DOI:10.1097/gme.0000000000000921]:

    A higher incidence of breast cancer was seen in the WHI for CEE + MPA compared with placebo, but a reduced incidence with CEE alone (Figure 1).14 Observational studies have suggested that the risk of breast cancer may be less with the use of micronized progesterone (MP) compared with synthetic progestogens,15,16 but the bioavailability of oral and transdermal progesterone is poor.

    Micronized progesterone needs to be adequately dosed for endometrial protection.17-19 Improperly formulated or dosed or delivery issues with estrogen plus MP combinations have potentially serious health consequences, including increased risk of endometrial neoplasia.20 In women using EPT, unscheduled bleeding occurring more than 6 months after initiation should be investigated.

    In a meta-analysis of trials of women who began HT treatment fewer than 10 years after menopause onset or who were aged younger than 60 years, strong evidence of increased risk of VTE was found in the HT group compared with placebo (RR 1.74; 95% CI, 1.11-2.73).177 […] Micronized progesterone may be less thrombogenic than other progestins.190 […]

    Some but not all observational data suggest that MP may have less effect on breast cancer risk, whereas more potent progestogens such as MPA may have a more adverse effect,15,204 but randomized trials are needed.

    Davey (2018)

    Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]:

    Oral and vaginal micronized progesterone

    Oral micronized progesterone

    In postmenopausal women with an intact uterus receiving estrogen, the addition of progesterone or progestins is regarded as essential to prevent endometrial hyperplasia and carcinoma. The combination of a progestin with estrogen increases the risk of breast carcinoma and VTE and the risk varies with the type of progestin. Oral micronized progesterone (MP) has been claimed not to increase the risk of breast cancer. When administered orally, MP is rapidly metabolized in the intestinal mucosa and the liver, and the plasma levels of progesterone are very low when measured by specific liquid chromatography and mass spectrometry (LC-MS)31.

    Oral administration of MP 100 mg daily results in peak levels of less than 2.2 ± 3.06 ng/ml measured by LC-MS. With the doses of MP currently used clinically, the concentrations of MP in the plasma may be insufficient to prevent endometrial hyperplasia and carcinoma when estrogens are given in the short term but may increase the risk when given in the long term (more than 5 years)32. At the same time, the low plasma concentrations of MP following oral administration have may have a weak effect on breast tissue and may not increase the risk of breast carcinoma in the short term but may increase the risk in the long term.

    The low plasma concentrations of MP may also have less effect on blood coagulation and on the risk of VTE. The claim that MP does not cause endometrial hyperplasia and carcinoma and is not associated with an increased risk of breast cancer and VTE, however, has been disputed and is discussed in the following sections.

    Oral micronized progesterone, oral progestins, endometrial hyperplasia and carcinoma

    After a review of 40 studies, an expert committee concluded that oral MP, if applied sequentially for 12–14 days/month at 200 mg/day, provides endometrial protection for up to 5 years33. In the European EPIC study of 115 474 postmenopausal women in Europe, the risk of endometrial carcinoma was increased both in current estrogen-only users (RR 2.52, 95% CI 1.77–3.57) and in current estrogen–progestin users (RR 1.41, 95% CI 1.08–1.83)34. In estrogen–progestin users, the risk of endometrial carcinoma depended on the type of progestin, the regimen – sequential or continuous – and duration of use. The risk of endometrial carcinoma was not increased in synthetic progestin users but was significantly increased in MP users (RR 2.42, 95% CI 1.53–3.8).

    In an analysis of the 65 360 women in the French cohort of the EPIC study, the risk of endometrial cancer was increased in estrogen plus MP users (RR 1.80, 95% CI 1.38–2.34) compared with never users and increased with increased duration of use: <5 years, RR = 1.3 (95% CI 0.99–1.97), and >5 years, RR = 2.66 (95% CI 1.87–3.77). The risk of endometrial cancer with the use of estrogens and progestins other than MP was not increased35.

    In a systematic review of 28 studies, continuous combined estrogen–progestin therapy had a lower risk of endometrial cancer than sequential estrogen–progestin therapy. The risk of endometrial cancer was increased with MP given either continuously or sequentially36. The claim that oral MP can prevent the increased incidence of endometrial hyperplasia and carcinoma in postmenopausal women treated with estrogens has not been substantiated.

    Oral micronized progesterone, oral progestins and breast cancer

    Breast carcinoma is the most common carcinoma in women and an increase in the risk of breast cancer is the most serious risk associated with MHT. The WHI trial of CEE + MPA was terminated prematurely because of the increased risk of breast cancer (RR 1.26, 95% CI 1.00–1.59)2. In the CEE-only arm of the WHI trial, in contrast, the risk of breast cancer was decreased (RR 0.77, 95% CI 0.59–1.01)3.

    The Million Women Study reported that the risk of breast cancer was increased both in estrogen–progestin users (RR 2.00, 95% CI 1.88–2.12) and in estrogen-only users (RR 1.30, 95% CI 1.21–1.45) and that the increase in risk for combined estrogen–progestin users was significantly greater than in estrogen-only users37.

    The UK Generations Study of 58 148 menopausal women followed for 6 years (median 5.4 years) found that the risk of breast cancer was increased in current estrogen plus progestogen users (RR 2.74, 95% CI 2.05–3.6) but was not increased in estrogen-only users (RR 1.00, 95% CI 0.66–1.54)38.

    In the first report of the French cohort of the E3N-EPIC study in 2005, in 54 548 postmenopausal women with a mean duration of use of MHT of 2.8 years, the risk of breast cancer was found not to be significantly increased with MHT with MP (RR 0.9, 95% CI 0.7–1.2) but was increased with MHT containing synthetic progestins (RR 1.4, 95% CI 1.2–1.7)39. In a later report of the E3N study in 2009, the risk of breast cancer was found to be increased with MHT with MP if MHT was initiated in the 3-year period following onset of the menopause and continued for 5 or more years (RR 1.54, 95% CI 1.28–1.86) but was not increased if initiated after 3 years (RR 1.00, 95% CI 0.68–1.47)40.

    A separate French CECILE case–control study of 1555 menopausal women (739 cases and 816 matched controls) found that, compared with never use, the risk of breast cancer was increased with current use of estrogen plus synthetic progestins for 4 or more years (RR 2.07, 95% CI 1.26–3.39) but was not increased with estrogen plus MP for the same period (RR 0.79, 95% CI 0.37–1.71)41.

    A number of factors influence the increase in risk of breast cancer associated with MHT including the interval between the menopause and starting MHT (gap time), duration of MHT, and body weight and body mass index; the interpretation of the effect of MP and progestins on risk of breast cancer may be difficult. It has been suggested that the low plasma concentrations of MP given orally may have a weak effect on breast tissue and may not increase the risk of breast carcinoma over short periods, but may increase the risk with longer periods of 5 years or more32. MHT is usually initiated for the relief of menopausal symptoms within a year or so of the menopause and it is often necessary to continue MHT for more than 5 years. An increased risk of breast cancer with oral MP given for 5 years or more cannot be ruled out, and a possible reduction in risk of breast cancer with MP cannot be regarded as a reason for preferring MP to progestins in MHT in the light of the increased risk of endometrial hyperplasia and carcinoma with MP.

    Oral micronized progesterone, progestins and venous thromboembolism

    Most studies have shown an increased risk of VTE with MHT with combined estrogen and progestin compared with estrogen only, and the risk appears to vary with different progestins. In the CEE + MPA arm of the WHI trial, the risk of VTE in women age 50–59 was increased (RR 1.27, 95% CI 1.19–4.33), but in the CEE-only arm the risk was not significantly increased (RR 1.22, 95% CI 0.62–2.42)2,3.

    The UK NHS record linkage study reported that the risk of VTE was significantly greater for estrogen–progestin than for oral estrogen-only therapy (RR 2.07, 95% CI 1.86–2.31 vs. RR 1.42, 95% CI 1.21–1.66). The risk of VTE with MPA was greater (RR 2.67, 95% CI 2.25–3.17) than with other progestins (RR 1.91, 95% CI 1.69-2.17), heterogeneity = 0.000723.

    A Dutch study found that the risk of VTE was increased with oral CEE and MPA (RR 4.0, 95% CI 1.8–8.2) and with oral estradiol plus norethisterone acetate (RR 3.9, 95% CI 1.5–10.7) compared with oral estrogen-only MHT and that there was no significant difference between the progestins24.

    In a Swedish study, the risk of VTE in combined estrogen–progestogen users was double that of estrogen-only users (RR 2.18, 95% CI 1.21–3.92, p = 0.009). The risk was increased by both medroxyprogesterone acetate (MPA) (RR 2.94, 95% CI 1.67–5.36) and norethisterone acetate (RR 2.25, 95% CI 1.50–3.40) and there was no significant difference between the progestins25.

    It has been claimed that the risk of VTE is less with MHT with MP than with other progestins. In the E3N study of 80 308 postmenopausal women with 549 cases of incident VTE, the risk for VTE was not significantly increased with the use of estrogens combined with MP (RR 0.9, 95% CI 0.6–1.5), nortestosterone derivatives (RR 1.4, 95% CI 0.7–2.4) or pregnane derivatives including MPA (RR 1.3, 95% CI 0.9–2.0), compared with oral estrogens only but was increased with norpregnane derivatives combined with estrogens (RR 1.8, 95% CI 1.2–2.7)21.

    In the four studies of transdermal estrogens with oral MP or progestins, the risk of VTE was not increased20,23–25. The use of transdermal rather than oral estrogens in all women receiving MHT would obviate any possible increased risk of VTE with all types of progestins as well as with MP and is another good reason for using transdermal estrogens in preference to oral estrogens in all perimenopausal and postmenopausal women.

    Kuhl & Wiegratz (2021)

    Kuhl, H., & Wiegratz, I. (2021). Pharmakokinetik und Pharmakodynamik der in der Assistierten Reproduktion Verwendeten Gestagene. [Pharmacokinetics and Pharmacodynamics of Progestogens Used in Assisted Reproduction.] Gynäkologische Endokrinologie [Gynecological Endocrinology], 19, 105–117. [Google Scholar] [DOI:10.1007/s10304-020-00372-5] [Translation] [Translated]:

    Abstract

    […] Oral administration of progesterone causes extensive metabolism resulting in the formation of more than 30 metabolites, some of which may cause anesthetic/sedative effects. The use of a direct radioimmunoassay (RIA) without prior separation of progesterone from its metabolites may simulate falsely high serum concentrations of progesterone owing to cross-reaction of some metabolites with the specific antiserum of the RIA. This effect is not observed after parenteral treatment with progesterone due to minimal metabolism. […]

    Progesterone pharmacokinetics

    Problems with the determination of progesterone in serum

    Because of the large number of progesterone metabolites that circulate in variable concentrations after oral administration, false-high progesterone levels must be expected when using an immunoassay. The cause is the cross-reactions of some progesterone metabolites, such as 5α- and 5β-DHP and 5α-pregnan-3β-ol-20-one [13]. For this reason, a radioimmunoassay (RIA) can only be used, for example, if the progesterone has previously been isolated by means of a suitable chromatographic separation. The determination of progesterone with exact liquid or gas chromatography-mass spectrometry (LC-MS or GC-MS; [14]; Table 1) is more reliable, albeit more complex.

    The problem of cross-reactions does not play an essential role in parenteral progesterone treatment due to the low metabolism of progesterone. The specificity of the antiserum used is of particular importance for the comparability of the results of different RIAs, as it influences the cross-reactivity of the numerous progesterone metabolites [11].

    The determination of the progesterone level, which was measured after oral administration of a capsule containing 100 mg of micronized progesterone, resulted in a false high peak value of 19.4 ng/mL in the RIA, which was 8 times as high as that with the exact LC-MS method which determined a true value of 2.4 ng/mL (Table 1). The cause was metabolites, the high concentrations of which simulated a false high concentration via a cross-reaction with the RIA antiserum [11]. In contrast, after intravaginal application of a gel containing 90 mg of progesterone, the metabolism of progesterone and thus the influence of cross-reactions is so low that the progesterone concentration of 10.5 ng/mL measured with the RIA agrees with the result of the exact LC-MS method (Table 1; [11]).

    “Enzyme-linked immunosorbent assay”

    As with the RIA, the “enzyme-linked immunosorbent assay” (ELISA) is a procedure based on an immune reaction between an antigen and a specific antibody. For this purpose, a specific antibody is produced in a separate standard process for the antigen, for example progesterone, which binds the antigen with high affinity. An enzyme is coupled to this specific antibody that cleaves an added chromogen, producing a dye, the intensity of which is measured in a photometer. The measured intensity of the color correlates with the concentration of the antigen (for example progesterone).

    With regard to the cross-reaction of some progesterone metabolites, which leads to false high values of the progesterone concentration, the same restriction applies to the ELISA as to the direct RIA (Table 1).

    Summary

    If a progesterone determination is carried out in the serum after oral progesterone application in the RIA or in the ELISA without prior chromatographic separation, one measures incorrectly high progesterone values, since progesterone metabolites are also measured! This problem does not exist with parenteral application (intravaginal, intramuscular, or subcutaneous).

    Oral application of progesterone

    After separation of important progesterone metabolites by means of column chromatography, an increase in progesterone in the serum to a maximum of 4.7 ± 1.15 ng/mL was found in the RIA after oral administration of 200 mg micronized progesterone [14].

    Summary

    In summary, it can be stated that oral administration of 100 to 200 mg progesterone leads to an increase in serum levels to around 3–5 ng/mL, provided the laboratory diagnostics are carried out correctly, i.e. after chromatographic separation.

    Conclusion for practice

    • After oral progesterone administration, more than 30 metabolites are formed, which in immunoassays can cause false high results of the systemic progesterone concentration. This problem can only be solved by prior chromatographic separation of the progesterone or by direct measurement methods.

    Individual Studies and Papers

    Comparative Immunoassay versus Immunoassay with Chromatography or Mass Spectrometry Studies

    • Nahoul, K., Dehennin, L., & Scholler, R. (1987). Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. Journal of Steroid Biochemistry, 26(2), 241–249. [DOI:10.1016/0022-4731(87)90078-1]
    • Levine, H., & Watson, N. (2000). Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility, 73(3), 516–521. [DOI:10.1016/S0015-0282(99)00553-1]
    • Sapin, R., Neamtu, D., Gasser, F., Ohl, J., Grunenberger, F., & Grucker, D. (2000). De la prudence lors de l’utilisation des dosages directs de progestérone. [Caution when using direct progesterone assays.] Immuno-analyse et Biologie Spécialisée, 3(15), 203–204. [DOI:10.1016/S0923-2532(00)80010-1] [Translation]

    Non-Comparative Immunoassay with Adequate Chromatography or Mass Spectrometry Studies

    • Nahoul, K., Dehennin, L., Jondet, M., & Roger, M. (1993). Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas, 16(3), 185–202. [DOI:10.1016/0378-5122(93)90064-O]
    • Lobo, R. A., Liu, J., Stanczyk, F. Z., Constantine, G. D., Pickar, J. H., Shadiack, A. M., Bernick, B., & Mirkin, S. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause (New York, NY), 26(7), 720–727.[DOI:10.1097/GME.0000000000001306]

    Commentaries on Studies

    • Nahoul, K., & de Ziegler, D. (1994). “Validity” of serum progesterone levels after oral progesterone. Fertility and Sterility, 61(4), 790–791. [DOI:10.1016/S0015-0282(16)56666-7]
    \ No newline at end of file +Sources/Excerpts: Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects - Transfeminine Science Link

    Sources/Excerpts: Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects

    By Aly | First published August 4, 2018 | Last modified September 25, 2022

    Preface

    This is a literature sources/excerpts supplement to the main article which can be found here.

    Excerpts From Literature Reviews

    de Ziegler et al. (1998)

    de Ziegler, D., Fanchin, R., de Moustier, B., & Bulletti, C. (1998). The hormonal control of endometrial receptivity: estrogen (E2) and progesterone. Journal of Reproductive Immunology, 39(1–2), 149–166. [DOI:10.1016/S0165-0378(98)00019-9]:

    4.2. The oral route paradox and the methodological flaws in progesterone measurement

    High levels of progesterone have been reported after oral administration of micronized progesterone (Simon et al., 1993). Yet, despite the high levels reported, the same authors describe incomplete endometrial effects. Today, we believe that the apparent paradox between high progesterone levels and minimal endometrial effects characteristic of oral progesterone has been elucidated by Nahoul et al. (1987, 1993) revealing methodological flaw in the measurement of plasma progesterone after oral administration. Indeed, while direct RIA for progesterone is valid for the measurement of plasma levels in the luteal phase of the menstrual cycle, this is not the case after oral administration. In an elegant paper, Nahoul et al. (1987) showed that because of the high levels of progesterone metabolites encountered after oral administration direct RIA measured values 3–5 times higher than those determined when measurements are conducted after extraction and separation on celite columns using an appropriate assay. Nahoul et al. (1993) showed that plasma levels of progesterone were only minimally elevated after oral ingestion of 100 mg of progesterone (barely reaching 1 ng/ml) and, particularly, were markedly lower than after vaginal administration of the same amounts of progesterone.

    de Ziegler & Fanchin (2000)

    de Ziegler, D., & Fanchin, R. (2000). Progesterone and progestins: applications in gynecology. Steroids, 65(10–11), 671–679. [DOI:10.1016/S0039-128X(00)00123-9]:

    3.1. Oral progesterone

    Progesterone is nearly entirely absorbed after oral ingestion when prepared in micronized form. Yet, because of intense inactivation by metabolism during first liver pass, the bioavailability of oral progesterone is notoriously poor at <10% [25]. This poor bioavailability explains that despite the large amounts used (up to 600 mg/day), oral progesterone fails to trigger the full array of endometrial changes seen in the late luteal phase of the menstrual cycle. Particularly, the last step of these changes (the predecidual transformation of stroma cells) fails to be induced by oral progesterone [3].

    Some confusion has existed over these findings. Early reports claimed high plasma progesterone levels after oral administration of progesterone. However, fairly low plasma levels of progesterone have been reported when the hormone is given orally, and proper assays are used. Circulating levels of progesterone and its metabolites, determined by sufficiently specific assays, after oral and vaginal administration of 100 mg of progesterone are illustrated in Fig. 4. As can be seen, when taken orally, progesterone accounts for less than 10%, whereas most of ingested progesterone is transformed to 5α-reduced metabolites. The metabolites of progesterone that bind to the GABAA receptor complex are responsible for drowsiness and other neurologic side effects. Interestingly, however, erroneous readings of circulating progesterone have been obtained after oral intake of progesterone when plasma levels are measured by direct radio-immunoassays. Direct assays have only been validated for measurements of progesterone in the luteal phase of the menstrual cycle. After oral ingestion, the unusually high levels of progesterone metabolites alter the validity of progesterone measurements by direct assays because antibody specificity is insufficient in these unusual circumstances. Conversely, when progesterone is measured after separation on celite columns, plasma progesterone levels are low after oral ingestion; these low levels are concordant with the incomplete secretory transformation of the endometrium observed [25], [26].

    Similarly, repeated daily administration of nasal progesterone failed to induce predecidual changes of endometrial stroma, a finding in accordance with the low levels of plasma progesterone achieved (from 2 to 5 ng/ml).

    Because transdermal administration of progesterone is impractical, the vaginal route has long been regarded as the best, if not the only, alternate option for delivering progesterone non-orally to women. With the advent of IVF and other assisted reproductive procedures, interest has refocused on vaginal progesterone. Ultimately, the data suggest that vaginal progesterone is more than merely a non-oral alternative. Early work undoubtedly showed the high efficacy of vaginal progesterone at duplicating all the endometrial changes of the luteal phase. We now know, however, that this is not solely dependent on plasma levels, which remain lower than seen in the luteal phase of the menstrual cycle [30,31].

    Stanczyk (2000)

    Stanczyk, F. Z. (2000). Pharmacokinetics of progesterone administered orally and parenterally. In Sitruk-Ware, R., & Mishell, D. R. (Eds.). Progestins and Antiprogestins in Clinical Practice (pp. 393–400). New York/Basel: Marcel Dekker. [Google Scholar] [Google Books]:

    Progesterone is measured by immunoassay methods that include radioimmunoassay, chemiluminescent immunoassay, fluoroimmunoassay, and enzyme immunoassay. […] Although “direct” immunoassays (i.e., without a purification step) are used most commonly for quantifying progesterone in serum or plasma, such assays should not be used when measuring progesterone in samples obtained following exogenous administration of progesterone. This is because high concentrations of both unconjugated and conjugated progesterone metabolites are found in serum following oral progesterone dosing, which results in overestimated progesterone values. To obtain absolute progesterone levels, it is essential to subject samples to purification (e.g., organic solvent extraction and chromatography) before quantification by immunoassay.

    Kuhl (2005)

    Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]:

    The oral application of progesterone is associated with an extensive metabolism in the gastrointestinal tract and the liver, which results in high, but individually variable, concentrations of circulating metabolites. Consequently, the investigation of the pharmacokinetics of progesterone by means of radioimmunoassay (RIA) may be hampered by falsely high progesterone levels due to a relative pronounced cross-reactivity of progesterone metabolites. Therefore, either the gas chromatography/mass spectrometry (GC/MS) method or RIA after chromatographic separation are suitable for the measurement of progesterone. This problem is less pronounced after vaginal administration of progesterone owing to the relative low degree of metabolism213.

    Wheeler & Barnard (2010)

    Wheeler, M. J., & Barnard, G. (2010). Immunoassay of Steroids. In Makin, H., & Gower, D. (Eds.). Steroid Analysis (pp. 283–327). Dordrecht: Springer. [DOI:10.1023/b135931_4]:

    In addition, there is a more critical requirement for improved antibody specificity in non-extraction procedures because of the presence of relatively high concentrations of steroid conjugates (glucuronides and sulphates) in unextracted serum. This is particularly true in the case of samples from patients undergoing hormone replacement therapy, which may involve the administration of oestradiol, progesterone and/or testosterone in a variety of combinations and by a variety of routes (e.g. intramuscular, oral, nasal, intravaginal or percutaneous). The route of administration profoundly affects the metabolism of the hormone and leads to the formation of particular profiles of steroid conjugates, some of which may cross-react significantly in the immunoassay (Nisbet and Jomain, 1987; Nahoul et al., 1989). In many cases, commercial direct procedures may be totally inappropriate for use in these situations.

    Kuhl (2011)

    Kuhl, H. (2011). Pharmacology of progestogens. Journal für Reproduktionsmedizin und Endokrinologie [Journal of Reproductive Medicine and Endocrinology], 8(1), 157–177. [URL] [PDF]:

    Progesterone is an important intermediate in the ovarian and adrenal steroid synthesis, but larger amounts are produced only in the corpus luteum and the placenta. During the luteal phase, serum concentrations of 25 ng/ml are reached which may increase during pregnancy up to 200 ng/ml. […]

    […] the half-lives [of progesterone in the circulation] are only 6 min (t1/2α) and 42 min (t1/2β). Progesterone is rapidly metabolised, predominantly by reduction of the keto groups and the Δ4- double bond, and the pattern of metabolites depends largely on the route of administration. The oral application of progesterone is associated with an extensive metabolism in the gastrointestinal tract and the liver which results in high, but individually variable concentrations of circulating metabolites. Consequently, the investigation of the pharmacokinetics of progesterone by means of RIA may be hampered by falsely high progesterone levels due to a relatively pronounced cross-reactivity of progesterone metabolites. Therefore, either the GC/MS method or radioimmunoassay (RIA) after chromatographic separation are suitable for the measurement of progesterone. This problem is less pronounced after vaginal administration of progesterone owing to the relatively low degree of metabolism [54].

    After oral administration, progesterone can be metabolised to more than 30 metabolites, among which some exert specific physiological activities. The most important pathway is the formation of 5α-pregnanolone and 5β-pregnanolone that exert considerable sedative effects after binding to the GABAA receptor. Further metabolites were 20-dihydroprogesterone that has 25–50% of the progestogenic potency of progesterone, 11-deoxycorticosterone (DOC) that is a potent mineralocorticoid, 17α-hydroxyprogesterone, and the inactive end-product pregnanediol (Fig. 7).

    There are large interindividual differences in the pattern of metabolites circulating after oral administration [55]. The low oral bioavailability could be increased by the use of micronized progesterone suspended in oil and packaged in a gelatine capsule.

    Pharmacokinetics A single oral dose of 100 mg progesterone contained in a gelatine capsule led to a rapid rise in serum progesterone as measured by liquid chromatography–mass spectrometry to a peak level of 1.5–2.2 ng/ml after 1–2 h. Thereafter the levels decreased rapidly to baseline levels within 4–6 h [53, 55]. However, determination by means of RIA revealed a mean peak level of 19.4 ng/ml suggesting a high cross reaction of progesterone metabolites [54]. There was a pronounced rise in the serum levels of 5α- and 5β-pregnanolone up to a maximum of 14 ng/ml and 3.6 ng/ml after 2 h. The DOC levels rose from 120 pg/ml to 680 pg/ml after 2 h and decreased rapidly thereafter [56].

    The results cast some doubts on the reliability of progesterone determinations by RIA if metabolites are not separated by means of chromatographically in advance.

    After oral intake of 200 mg progesterone, the peak levels of progesterone as measured by RIA after 4 h were 12 ng/ml, while 5α- and 5β-pregnanolone reached serum concentrations of 30 ng/ml and 60 ng/ml [55]. Further metabolites were 20-dihydroprogesterone, DOC, 17α-hydroxyprogesterone, and pregnanediol (Fig. 7).

    The results of a large prospective study indicate that oral and transdermal treatment with progesterone does not protect from estrogen-induced endometrial cancer in postmenopausal women. Compared with women treated with estrogen-only preparations who showed an elevated relative risk of 2.52 (95%-CI: 1.7–3.57), the risk of endometrial cancer did not differ significantly during therapy with estrogen plus progesterone (relative risk 2.42; 95%-CI: 1.53–3.83). Contrary to this, synthetic progestogens reduced the estrogen-dependent risk significantly [57]. The lack of endometrial protection during oral progesterone therapy may be explained by the low progesterone serum levels measured with reliable methods. The same phenomenon may also explain the results of another cohort study that, in contrast to synthetic progestins, the addition of progesterone to estrogen therapy did not increase the risk of breast cancer [58, 59].

    The finding of an elevated risk of endometrial cancer in postmenopausal women during treatment with estrogens and oral progesterone are in contradiction to various trials that did not find any increase in the rate of endometrial hyperplasia in women treated with estrogens and 200 mg sequential progesterone or 100 mg continuous progesterone [60–62]. However, the effect of oral treatment with progesterone on estrogenized postmenopausal endometria is dose-dependent, and during the use of 200 mg no full secretory transformation was observed, whereas the daily dose of 300 mg seems to be appropriate as an alternative to synthetic progestogens for therapy [63].

    Kuhl & Schneider (2013)

    Kuhl, H., & Schneider, H. P. G. (2013). Progesterone – promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]:

    The problem of measurement of progesterone levels by RIA

    Oral treatment is associated with a rapid metabolism of micronized progesterone in the intestinal mucosa and during the first liver passage. Although the bioavailability of orally administered progesterone is improved by suspending micronized particles of progesterone in oil, the serum concentrations of progesterone are very low when measured with exact methods like liquid chromatography–mass spectrometry (Table 5) 93. Contrary to this, the metabolism of endogenous progesterone in the luteal phase and of vaginally administered progesterone is low and does not compromise measurement of serum progesterone by RIA methods.

    After oral administration of progesterone, however, large amounts of certain progesterone metabolites are circulating which have a more or less pronounced binding affinity to the relatively unspecific antiserum against progesterone used in the RIA. Therefore, if not separated from progesterone, these metabolites will cause falsely high progesterone serum concentrations when using a RIA (Figure 5). Therefore, after oral treatment with micronized progesterone, the separation of progesterone from its metabolites by an appropriate chromatographic system is mandatory 93–95.

    After oral administration of 100 mg and 200 mg micronized progesterone to premenopausal women during the follicular phase, average peak levels of 1.5 ± 0.2 ng/ml and 4.70 ± 1.14 ng/ml, respectively, were measured after 2–3 h using a reliable RIA method after adequate chromatographic separation 94.

    A direct comparison of the progesterone levels measured by either a direct RIA or liquid chromatography–mass spectrometry revealed that, after vaginal administration of 90 mg of progesterone gel, both methods resulted in similar mean peak levels of 8 ng/ml. Contrary to this, after oral administration of 100 mg progesterone per capsule, the mean peak level of progesterone was measured as 15 ng/ml using the RIA method compared to 2 ng/ml using the gold-standard method of liquid chromatography–mass spectrometry (Figure 5, Table 5) 93.

    Micronized progesterone and risk of endometrial cancer

    The EPIC cohort study, carried out with 115 000 postmenopausal women, revealed that estrogen-only therapy yielded a 2.52-fold increase in the relative risk of endometrial cancer which was prevented by the addition of progesterone derivatives or nortestosterone derivatives. Contrary to this, progesterone was not able to protect from the development of estrogen-induced endometrial cancer, increasing the relative risk up to 2.42 96.

    Randomized trials revealed that, after treatment of postmenopausal women with oral or percutaneous estrogens and cyclic addition of oral micronized progesterone, the rate of endometrial hyperplasia was not elevated and was similar to that in the placebo group 102,103.

    The lack of endometrial hyperplasia was interpreted as evidence for a sufficient protective effect on the endometrium by oral use of micronized progesterone. However, the results of these studies refer to surrogate parameters which cannot be transferred to the clinical endpoint of endometrial cancer. The oral use of daily 200 mg micronized progesterone causes peak levels of progesterone of less than 5 ng/ml, provided that adequate methods are used for measurement of the serum levels 94. In face of the large interindividual variations in the pharmacokinetics of progesterone, there will be women with serum progesterone levels too low for a long-term protection of the endometrium 93–95.

    On the other hand, the mitosis rate in invasive breast carcinomas has been observed to reach a maximum during the luteal phase. Very likely, endogenous progesterone in synergism with estradiol is responsible for an increase in mammary epithelial proliferation, vascularity, breast tenderness and mammographic density.

    In the 2005 report of the French E3N cohort study, no effect of percutaneous estradiol, with or without the addition of oral micronized progesterone, was found on postmenopausal breast cancer risk, in contrast to an unfavorable effect of combined synthetic progestins. The publication in 2008 revealed that oral micronized progesterone even prevented an estrogen-induced rise in breast cancer risk. In 2009, a new report did not present risk data based on the total case numbers of the three treatment groups. Instead, the cases were divided into eight subgroups according to the gap time between menopause and initiation of HRT and the duration of HRT. Importantly, long-term treatment with estrogen and micronized progesterone was found to increase significantly the risk of breast cancer.

    It is hard to believe that progesterone does not promote the estrogen-related risk of breast cancer or even has a favorable effect. […] The oral dose of 100 mg or 200 mg progesterone is too low for endometrial protection in all women, as demonstrated by an increased risk of endometrial cancer. The rapid inactivation of progesterone in the intestinal mucosa and the liver causes very low progesterone serum levels which have been measured using reliable methods (e.g. liquid chromatography–mass spectrometry) instead of a RIA which is compromised by cross-reactions of certain progesterone metabolites. Therefore, a weak proliferative effect of the low progesterone levels may need a longer time interval of oral treatment with micronized progesterone, until an increase in breast cancer can be demonstrated.

    The available knowledge suggests that, similar to synthetic progestins, HRT with micronized progesterone may promote the growth of small breast carcinomas which may have developed during the fertile phase of the women. Whether or not there are differences between the various progestogens remains to be elucidated.

    North American Menopause Society (2017)

    North American Menopause Society. (2017). The 2017 hormone therapy position statement of the North American Menopause Society. Menopause, 24(7), 728–753. [DOI:10.1097/gme.0000000000000921]:

    A higher incidence of breast cancer was seen in the WHI for CEE + MPA compared with placebo, but a reduced incidence with CEE alone (Figure 1).14 Observational studies have suggested that the risk of breast cancer may be less with the use of micronized progesterone (MP) compared with synthetic progestogens,15,16 but the bioavailability of oral and transdermal progesterone is poor.

    Micronized progesterone needs to be adequately dosed for endometrial protection.17-19 Improperly formulated or dosed or delivery issues with estrogen plus MP combinations have potentially serious health consequences, including increased risk of endometrial neoplasia.20 In women using EPT, unscheduled bleeding occurring more than 6 months after initiation should be investigated.

    In a meta-analysis of trials of women who began HT treatment fewer than 10 years after menopause onset or who were aged younger than 60 years, strong evidence of increased risk of VTE was found in the HT group compared with placebo (RR 1.74; 95% CI, 1.11-2.73).177 […] Micronized progesterone may be less thrombogenic than other progestins.190 […]

    Some but not all observational data suggest that MP may have less effect on breast cancer risk, whereas more potent progestogens such as MPA may have a more adverse effect,15,204 but randomized trials are needed.

    Davey (2018)

    Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]:

    Oral and vaginal micronized progesterone

    Oral micronized progesterone

    In postmenopausal women with an intact uterus receiving estrogen, the addition of progesterone or progestins is regarded as essential to prevent endometrial hyperplasia and carcinoma. The combination of a progestin with estrogen increases the risk of breast carcinoma and VTE and the risk varies with the type of progestin. Oral micronized progesterone (MP) has been claimed not to increase the risk of breast cancer. When administered orally, MP is rapidly metabolized in the intestinal mucosa and the liver, and the plasma levels of progesterone are very low when measured by specific liquid chromatography and mass spectrometry (LC-MS)31.

    Oral administration of MP 100 mg daily results in peak levels of less than 2.2 ± 3.06 ng/ml measured by LC-MS. With the doses of MP currently used clinically, the concentrations of MP in the plasma may be insufficient to prevent endometrial hyperplasia and carcinoma when estrogens are given in the short term but may increase the risk when given in the long term (more than 5 years)32. At the same time, the low plasma concentrations of MP following oral administration have may have a weak effect on breast tissue and may not increase the risk of breast carcinoma in the short term but may increase the risk in the long term.

    The low plasma concentrations of MP may also have less effect on blood coagulation and on the risk of VTE. The claim that MP does not cause endometrial hyperplasia and carcinoma and is not associated with an increased risk of breast cancer and VTE, however, has been disputed and is discussed in the following sections.

    Oral micronized progesterone, oral progestins, endometrial hyperplasia and carcinoma

    After a review of 40 studies, an expert committee concluded that oral MP, if applied sequentially for 12–14 days/month at 200 mg/day, provides endometrial protection for up to 5 years33. In the European EPIC study of 115 474 postmenopausal women in Europe, the risk of endometrial carcinoma was increased both in current estrogen-only users (RR 2.52, 95% CI 1.77–3.57) and in current estrogen–progestin users (RR 1.41, 95% CI 1.08–1.83)34. In estrogen–progestin users, the risk of endometrial carcinoma depended on the type of progestin, the regimen – sequential or continuous – and duration of use. The risk of endometrial carcinoma was not increased in synthetic progestin users but was significantly increased in MP users (RR 2.42, 95% CI 1.53–3.8).

    In an analysis of the 65 360 women in the French cohort of the EPIC study, the risk of endometrial cancer was increased in estrogen plus MP users (RR 1.80, 95% CI 1.38–2.34) compared with never users and increased with increased duration of use: <5 years, RR = 1.3 (95% CI 0.99–1.97), and >5 years, RR = 2.66 (95% CI 1.87–3.77). The risk of endometrial cancer with the use of estrogens and progestins other than MP was not increased35.

    In a systematic review of 28 studies, continuous combined estrogen–progestin therapy had a lower risk of endometrial cancer than sequential estrogen–progestin therapy. The risk of endometrial cancer was increased with MP given either continuously or sequentially36. The claim that oral MP can prevent the increased incidence of endometrial hyperplasia and carcinoma in postmenopausal women treated with estrogens has not been substantiated.

    Oral micronized progesterone, oral progestins and breast cancer

    Breast carcinoma is the most common carcinoma in women and an increase in the risk of breast cancer is the most serious risk associated with MHT. The WHI trial of CEE + MPA was terminated prematurely because of the increased risk of breast cancer (RR 1.26, 95% CI 1.00–1.59)2. In the CEE-only arm of the WHI trial, in contrast, the risk of breast cancer was decreased (RR 0.77, 95% CI 0.59–1.01)3.

    The Million Women Study reported that the risk of breast cancer was increased both in estrogen–progestin users (RR 2.00, 95% CI 1.88–2.12) and in estrogen-only users (RR 1.30, 95% CI 1.21–1.45) and that the increase in risk for combined estrogen–progestin users was significantly greater than in estrogen-only users37.

    The UK Generations Study of 58 148 menopausal women followed for 6 years (median 5.4 years) found that the risk of breast cancer was increased in current estrogen plus progestogen users (RR 2.74, 95% CI 2.05–3.6) but was not increased in estrogen-only users (RR 1.00, 95% CI 0.66–1.54)38.

    In the first report of the French cohort of the E3N-EPIC study in 2005, in 54 548 postmenopausal women with a mean duration of use of MHT of 2.8 years, the risk of breast cancer was found not to be significantly increased with MHT with MP (RR 0.9, 95% CI 0.7–1.2) but was increased with MHT containing synthetic progestins (RR 1.4, 95% CI 1.2–1.7)39. In a later report of the E3N study in 2009, the risk of breast cancer was found to be increased with MHT with MP if MHT was initiated in the 3-year period following onset of the menopause and continued for 5 or more years (RR 1.54, 95% CI 1.28–1.86) but was not increased if initiated after 3 years (RR 1.00, 95% CI 0.68–1.47)40.

    A separate French CECILE case–control study of 1555 menopausal women (739 cases and 816 matched controls) found that, compared with never use, the risk of breast cancer was increased with current use of estrogen plus synthetic progestins for 4 or more years (RR 2.07, 95% CI 1.26–3.39) but was not increased with estrogen plus MP for the same period (RR 0.79, 95% CI 0.37–1.71)41.

    A number of factors influence the increase in risk of breast cancer associated with MHT including the interval between the menopause and starting MHT (gap time), duration of MHT, and body weight and body mass index; the interpretation of the effect of MP and progestins on risk of breast cancer may be difficult. It has been suggested that the low plasma concentrations of MP given orally may have a weak effect on breast tissue and may not increase the risk of breast carcinoma over short periods, but may increase the risk with longer periods of 5 years or more32. MHT is usually initiated for the relief of menopausal symptoms within a year or so of the menopause and it is often necessary to continue MHT for more than 5 years. An increased risk of breast cancer with oral MP given for 5 years or more cannot be ruled out, and a possible reduction in risk of breast cancer with MP cannot be regarded as a reason for preferring MP to progestins in MHT in the light of the increased risk of endometrial hyperplasia and carcinoma with MP.

    Oral micronized progesterone, progestins and venous thromboembolism

    Most studies have shown an increased risk of VTE with MHT with combined estrogen and progestin compared with estrogen only, and the risk appears to vary with different progestins. In the CEE + MPA arm of the WHI trial, the risk of VTE in women age 50–59 was increased (RR 1.27, 95% CI 1.19–4.33), but in the CEE-only arm the risk was not significantly increased (RR 1.22, 95% CI 0.62–2.42)2,3.

    The UK NHS record linkage study reported that the risk of VTE was significantly greater for estrogen–progestin than for oral estrogen-only therapy (RR 2.07, 95% CI 1.86–2.31 vs. RR 1.42, 95% CI 1.21–1.66). The risk of VTE with MPA was greater (RR 2.67, 95% CI 2.25–3.17) than with other progestins (RR 1.91, 95% CI 1.69-2.17), heterogeneity = 0.000723.

    A Dutch study found that the risk of VTE was increased with oral CEE and MPA (RR 4.0, 95% CI 1.8–8.2) and with oral estradiol plus norethisterone acetate (RR 3.9, 95% CI 1.5–10.7) compared with oral estrogen-only MHT and that there was no significant difference between the progestins24.

    In a Swedish study, the risk of VTE in combined estrogen–progestogen users was double that of estrogen-only users (RR 2.18, 95% CI 1.21–3.92, p = 0.009). The risk was increased by both medroxyprogesterone acetate (MPA) (RR 2.94, 95% CI 1.67–5.36) and norethisterone acetate (RR 2.25, 95% CI 1.50–3.40) and there was no significant difference between the progestins25.

    It has been claimed that the risk of VTE is less with MHT with MP than with other progestins. In the E3N study of 80 308 postmenopausal women with 549 cases of incident VTE, the risk for VTE was not significantly increased with the use of estrogens combined with MP (RR 0.9, 95% CI 0.6–1.5), nortestosterone derivatives (RR 1.4, 95% CI 0.7–2.4) or pregnane derivatives including MPA (RR 1.3, 95% CI 0.9–2.0), compared with oral estrogens only but was increased with norpregnane derivatives combined with estrogens (RR 1.8, 95% CI 1.2–2.7)21.

    In the four studies of transdermal estrogens with oral MP or progestins, the risk of VTE was not increased20,23–25. The use of transdermal rather than oral estrogens in all women receiving MHT would obviate any possible increased risk of VTE with all types of progestins as well as with MP and is another good reason for using transdermal estrogens in preference to oral estrogens in all perimenopausal and postmenopausal women.

    Kuhl & Wiegratz (2021)

    Kuhl, H., & Wiegratz, I. (2021). Pharmakokinetik und Pharmakodynamik der in der Assistierten Reproduktion Verwendeten Gestagene. [Pharmacokinetics and Pharmacodynamics of Progestogens Used in Assisted Reproduction.] Gynäkologische Endokrinologie [Gynecological Endocrinology], 19, 105–117. [Google Scholar] [DOI:10.1007/s10304-020-00372-5] [Translation] [Translated]:

    Abstract

    […] Oral administration of progesterone causes extensive metabolism resulting in the formation of more than 30 metabolites, some of which may cause anesthetic/sedative effects. The use of a direct radioimmunoassay (RIA) without prior separation of progesterone from its metabolites may simulate falsely high serum concentrations of progesterone owing to cross-reaction of some metabolites with the specific antiserum of the RIA. This effect is not observed after parenteral treatment with progesterone due to minimal metabolism. […]

    Progesterone pharmacokinetics

    Problems with the determination of progesterone in serum

    Because of the large number of progesterone metabolites that circulate in variable concentrations after oral administration, false-high progesterone levels must be expected when using an immunoassay. The cause is the cross-reactions of some progesterone metabolites, such as 5α- and 5β-DHP and 5α-pregnan-3β-ol-20-one [13]. For this reason, a radioimmunoassay (RIA) can only be used, for example, if the progesterone has previously been isolated by means of a suitable chromatographic separation. The determination of progesterone with exact liquid or gas chromatography-mass spectrometry (LC-MS or GC-MS; [14]; Table 1) is more reliable, albeit more complex.

    The problem of cross-reactions does not play an essential role in parenteral progesterone treatment due to the low metabolism of progesterone. The specificity of the antiserum used is of particular importance for the comparability of the results of different RIAs, as it influences the cross-reactivity of the numerous progesterone metabolites [11].

    The determination of the progesterone level, which was measured after oral administration of a capsule containing 100 mg of micronized progesterone, resulted in a false high peak value of 19.4 ng/mL in the RIA, which was 8 times as high as that with the exact LC-MS method which determined a true value of 2.4 ng/mL (Table 1). The cause was metabolites, the high concentrations of which simulated a false high concentration via a cross-reaction with the RIA antiserum [11]. In contrast, after intravaginal application of a gel containing 90 mg of progesterone, the metabolism of progesterone and thus the influence of cross-reactions is so low that the progesterone concentration of 10.5 ng/mL measured with the RIA agrees with the result of the exact LC-MS method (Table 1; [11]).

    “Enzyme-linked immunosorbent assay”

    As with the RIA, the “enzyme-linked immunosorbent assay” (ELISA) is a procedure based on an immune reaction between an antigen and a specific antibody. For this purpose, a specific antibody is produced in a separate standard process for the antigen, for example progesterone, which binds the antigen with high affinity. An enzyme is coupled to this specific antibody that cleaves an added chromogen, producing a dye, the intensity of which is measured in a photometer. The measured intensity of the color correlates with the concentration of the antigen (for example progesterone).

    With regard to the cross-reaction of some progesterone metabolites, which leads to false high values of the progesterone concentration, the same restriction applies to the ELISA as to the direct RIA (Table 1).

    Summary

    If a progesterone determination is carried out in the serum after oral progesterone application in the RIA or in the ELISA without prior chromatographic separation, one measures incorrectly high progesterone values, since progesterone metabolites are also measured! This problem does not exist with parenteral application (intravaginal, intramuscular, or subcutaneous).

    Oral application of progesterone

    After separation of important progesterone metabolites by means of column chromatography, an increase in progesterone in the serum to a maximum of 4.7 ± 1.15 ng/mL was found in the RIA after oral administration of 200 mg micronized progesterone [14].

    Summary

    In summary, it can be stated that oral administration of 100 to 200 mg progesterone leads to an increase in serum levels to around 3–5 ng/mL, provided the laboratory diagnostics are carried out correctly, i.e. after chromatographic separation.

    Conclusion for practice

    • After oral progesterone administration, more than 30 metabolites are formed, which in immunoassays can cause false high results of the systemic progesterone concentration. This problem can only be solved by prior chromatographic separation of the progesterone or by direct measurement methods.

    Individual Studies and Papers

    Comparative Immunoassay versus Immunoassay with Chromatography or Mass Spectrometry Studies

    • Nahoul, K., Dehennin, L., & Scholler, R. (1987). Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. Journal of Steroid Biochemistry, 26(2), 241–249. [DOI:10.1016/0022-4731(87)90078-1]
    • Levine, H., & Watson, N. (2000). Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility, 73(3), 516–521. [DOI:10.1016/S0015-0282(99)00553-1]
    • Sapin, R., Neamtu, D., Gasser, F., Ohl, J., Grunenberger, F., & Grucker, D. (2000). De la prudence lors de l’utilisation des dosages directs de progestérone. [Caution when using direct progesterone assays.] Immuno-analyse et Biologie Spécialisée, 3(15), 203–204. [DOI:10.1016/S0923-2532(00)80010-1] [Translation]

    Non-Comparative Immunoassay with Adequate Chromatography or Mass Spectrometry Studies

    • Nahoul, K., Dehennin, L., Jondet, M., & Roger, M. (1993). Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas, 16(3), 185–202. [DOI:10.1016/0378-5122(93)90064-O]
    • Lobo, R. A., Liu, J., Stanczyk, F. Z., Constantine, G. D., Pickar, J. H., Shadiack, A. M., Bernick, B., & Mirkin, S. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause (New York, NY), 26(7), 720–727.[DOI:10.1097/GME.0000000000001306]

    Commentaries on Studies

    • Nahoul, K., & de Ziegler, D. (1994). “Validity” of serum progesterone levels after oral progesterone. Fertility and Sterility, 61(4), 790–791. [DOI:10.1016/S0015-0282(16)56666-7]
    \ No newline at end of file diff --git a/transfemscience.org/articles/oral-p4-low-levels/index.html b/transfemscience.org/articles/oral-p4-low-levels/index.html index 9be5997a..ebe75ba6 100644 --- a/transfemscience.org/articles/oral-p4-low-levels/index.html +++ b/transfemscience.org/articles/oral-p4-low-levels/index.html @@ -1 +1 @@ -Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects - Transfeminine Science Link

    Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects

    By Aly | First published August 4, 2018 | Last modified March 30, 2023

    Abstract / TL;DR

    Oral progesterone is the most widely used form of progesterone in transfeminine hormone therapy. Because of previous studies using inaccurate blood tests (immunoassays without adequate chromatographic purification), it was thought that typical therapeutic dosages of oral progesterone produced progesterone levels that reached typical luteal-phase levels in cisgender women (which range from about 7 to 22 ng/mL). However, newer studies using more accurate blood tests (immunoassays with adequate purification and mass spectrometry-based assays) have shown that 100 mg/day progesterone—with or without food—achieves very low peak progesterone levels of only about 2 to 3 ng/mL and average progesterone levels over 24 hours of only about 0.1 to 0.6 ng/mL. In accordance, oral progesterone has often shown only weak progestogenic effects in clinical studies. Higher doses of oral progesterone that might achieve better levels are limited by persistingly low progesterone levels, pronounced neurosteroid side effects caused by the first pass of progesterone through the liver, and substantial variability between individuals. While the progesterone levels with oral progesterone are apparently sufficient for endometrial protection in cisgender women, they are unlikely to be adequate for desired effects in transfeminine people. For these reasons, transfeminine people and their clinicians may wish to avoid oral progesterone if the aim is therapeutic progestogenic effects. Instead, non-oral forms of progesterone with greater bioavailability like rectal or injectable progesterone can be used. Alternatively, progestins, which are likewise fully effective progestogens, can be employed.

    Introduction

    The major female sex hormones are estrogens and progestogens, and both may be used in transfeminine hormone therapy. Progestogens are useful in transfeminine people for helping to suppress testosterone levels and possibly though not certainly influencing breast development. Progestogens include progesterone as well as synthetic progestogens known as progestins. Progesterone has relatively unfavorable pharmacokinetics, which has been overcome with progestins. However, progestins have differing pharmacodynamic properties compared to progesterone, which can potentially be unfavorable. As such, there is interest in using progesterone instead of progestins in transfeminine people and other populations like cisgender women despite its poor pharmacokinetic properties.

    Progesterone is available in formulations for use via a variety of different routes, including oral, sublingual, topical, vaginal, rectal, and injectable administration (Wiki; Table). Among these routes, oral administration is the easiest and most convenient, and in relation to this, oral progesterone is the most widely used form of progesterone in transfeminine people. However, the pharmacokinetic problems of progesterone limit the favorability of oral progesterone. Moreover, these limitations of oral progesterone actually appear to be much more substantial than is generally realized, a fact that has been obscured by methodological limitations of many—but not all—of the pharmacokinetic studies that have characterized oral progesterone. The purpose of this article is to explain and review these findings, as well as to explore solutions and alternatives to oral progesterone for progestogen therapy in transfeminine people.

    Progesterone Levels with Oral Progesterone

    Oral micronized progesterone, or simply oral progesterone, is the form of progesterone that is used by the oral route as a pharmaceutical medication. It is an oil suspension of micronized progesterone crystals contained in gelatin capsules. The formulation is marketed under brand names including Prometrium, Utrogestan, and Microgest, among many others. Oral progesterone has very low bioavailability (≤10%) due to the first pass through the intestines and liver with oral administration. As a result of the first pass, most of the delivered progesterone with oral progesterone is metabolized into neurosteroid metabolites such as allopregnanolone and pregnanolone before reaching the bloodstream (de Lignieres, Dennerstein, & Backstrom, 1995). This is why oral progesterone has alcohol-like side effects like sedation that are not shared by typical doses of non-oral progesterone such as vaginal progesterone or progesterone by injection. In spite of the low bioavailability of oral progesterone, typical clinical doses of oral progesterone, such as 100 to 300 mg/day, have been reported to produce progesterone levels measured with immunoassays that are similar to those in the normal luteal phase of the menstrual cycle in cisgender women (Simon et al., 1993). For this reason, it has been believed that oral progesterone can achieve high and physiologically adequate levels of progesterone.

    Figure 1: Progesterone levels during the menstrual cycle in normal premenopausal women (Stricker et al., 2006). The dashed horizontal lines are the mean levels for each curve and the dashed vertical line demarcates mid-cycle (when ovulation occurs). Progesterone levels are normally elevated only during the luteal phase.
    Figure 2: Progesterone levels measured by immunoassay after single 100 to 300 mg doses of oral micronized progesterone in postmenopausal women (Simon et al., 1993). The horizontal dashed lines are mean levels over 24 hours. Progesterone levels appeared to reach concentrations comparable to normal luteal-phase levels. However, these levels were in fact not accurate due to the use of immunoassays (Nahoul & de Ziegler, 1994).

    It is now clear that this is not actually the case. Immunoassay is an earlier analytic method that can have issues with accuracy and reliability. In the case of progesterone, the problem with the use of immunoassays is that they have poor specificity in terms of their determinations. The antiserum used in determinations of progesterone with immunoassays cross-reacts with metabolites of progesterone like 5α-dihydroprogesterone, allopregnanolone, and pregnanolone and counts them towards the total for progesterone. Due to the high circulating levels of progesterone metabolites that are formed during the first pass with oral administration, this cross-reactivity has resulted in studies that have used immunoassays (e.g., Simon et al., 1993, among many others) markedly overestimating progesterone levels with oral progesterone (Nahoul et al., 1993; Nahoul & de Ziegler, 1994). Studies that have used analytic methods with better specificity, including liquid chromatography–mass spectrometry (LC–MS)—regarded as the “gold standard” for clinical quantification of sex-hormone levels (Kuhl & Schneider, 2013; Woodward & Rumsby, 2019; Conklin & Knezevic, 2020)—as well as immunoassays in conjunction with adequate chromatographic separation, have found that progesterone levels with oral administration of progesterone are in fact very low (Nahoul, Dehennin, & Scholler, 1987; Nahoul & de Ziegler, 1994; Levine & Watson, 2000; Kuhl, 2011; Kuhl & Schneider, 2013; Davey, 2018).

    A notable study using LC–MS found maximal progesterone levels of only about 2 ng/mL and average progesterone levels over a period of 24 hours of only about 0.14 ng/mL after a single 100 mg dose of oral progesterone (Levine & Watson, 2000; Kuhl & Schneider, 2013). Another more recent study with LC–MS found progesterone levels of around 2.5 to 3 ng/mL at peak and average progesterone levels over 24 hours of around 0.6 ng/mL after a single 100 mg dose of oral progesterone with food (Lobo et al., 2019). (It should be noted that intake with food is known to increase the bioavailability of oral progesterone by a few-fold (Wiki; Bijuva FDA Label; Simon et al., 1993; Prometrium FDA Review, 1996; Pickar et al., 2015).) These progesterone levels are well below normal luteal-phase levels of progesterone, which range from 7 to 22 ng/mL with LC–MS (Nakamoto, 2016). Studies that have directly compared quantification of progesterone with immunoassays against more reliable methods have found that immunoassays overestimate progesterone levels by 5- to 8-fold (Nahoul, Dehennin, & Scholler, 1987; Nahoul & de Ziegler, 1994; Levine & Watson, 2000; Kuhl, 2011; Kuhl & Schneider, 2013; Davey, 2018). In one small study of a few individuals, the degree of overestimation varied from 2-fold to 40-fold with several different commercial immunoassays (Sapin et al., 2000). These findings are obscure and still relatively little-known in the scientific and medical communities. In any case, it is clear that oral progesterone achieves progesterone levels that are far lower than once thought and are well below the luteal-phase levels that would be therapeutically desirable for transfeminine people.

    Figure 3: Progesterone levels measured by immunoassay or LC–MS after a single dose of oral or vaginal micronized progesterone in postmenopausal women (Levine & Watson, 2000; Kuhl & Schneider, 2013). Levels of progesterone with oral progesterone measured by immunoassay were falsely high due to cross-reactivity. Conversely, progesterone levels measured by LC–MS or with vaginal progesterone can be considered accurate.
    Figure 4: Progesterone levels measured by LC–MS with 100 mg/day oral micronized progesterone taken with food in postmenopausal women (Lobo et al., 2019). The horizontal dashed line is the mean level over 24 hours. Food increases progesterone levels with oral progesterone by about 2- to 3-fold (Bijuva FDA Label; Simon et al., 1993). The progesterone levels measured in this study can be considered accurate to due to the use of LC–MS.

    Therapeutic Implications

    Progestogenic Potency and Effects

    A variety of perplexing findings on the clinical progestogenic effects of oral progesterone have been made over the decades and can now be readily explained by the newer data on oral progesterone with better analytic methods. Oral progesterone is used in clinical medicine mainly to protect the endometrium from unopposed stimulation by estrogens in menopausal cisgender women and is able to reliably prevent endometrial hyperplasia induced by estrogens even with the low progesterone levels that typical clinical doses achieve (Wiki). However, oral progesterone failed to provide adequate protection against estrogen-mediated endometrial cancer risk in a large observational study (Davey, 2018). Oral progesterone even at very high doses also is unable to produce full endometrial transformation—a normal effect of luteal-phase levels of progesterone—whereas vaginal and injectable progesterone are effective (de Ziegler et al., 2013). For this reason, oral progesterone, in contrast to parenteral progesterone, is considered to be inappropriate for use in assisted reproduction (de Ziegler et al., 2013). Oral progesterone additionally failed to suppress testosterone levels even at high doses (400 mg/day) in cisgender males (Trollan et al., 1993; Wiki). Conversely, progestins, rectal progesterone, and injectable progesterone can all produce robust testosterone suppression in cisgender males (Wiki; Aly, 2019). Similarly, oral progesterone has little or no apparent antigonadotropic effect in menopausal cisgender women, which is again in notable contrast to progestins (Holst, 1983; Holst et al., 1983; Ottosson, 1984; Maxson & Hargrove, 1985; Saarikoski, Yliskosk, & Penttilä, 1990).

    Unlike other clinically used progestogens, the addition of oral progesterone to estrogen therapy in menopausal women has not been associated with increased risk of venous thromboembolism (VTE; blood clots) (Wiki). Nor has it been associated with increased breast cancer risk in the short-term (<5 years of therapy) (Wiki). However, with long-term use (≥5 years), the combination of estrogen plus oral progesterone is associated with significantly greater risk of breast cancer relative to estrogen alone similarly to other progestogens (Aly, 2020; Sam, 2020; Wiki; Table). This has been said to be consistent with a weak proliferative effect of oral progesterone on the breasts such that a longer duration of exposure is necessary for a quantifiable increase in breast cancer risk to manifest (Kuhl & Schneider, 2013; Davey, 2018). It is also consistent with preclinical research, which clearly suggests a carcinogenic role for progesterone and progesterone receptor activation in the breast (Kuhl & Schneider, 2013; Trabert et al., 2020). The preceding clinical findings on endometrial efficacy, testosterone and gonadotropin suppression, VTE risk, and breast cancer risk with oral progesterone are in contrast to those with almost all clinically used progestins (with the exception of the oral progesterone-like dydrogesterone). These previously perplexing discrepancies can be readily explained by the very low levels of progesterone that are now known to be achieved with oral progesterone.

    Bioavailability, Half-Life, and Duration

    Considering the much lower levels of progesterone observed with oral progesterone in studies using reliable analytic methods, the bioavailability of oral progesterone needs to be reassessed. In studies with immunoassays, the bioavailability of oral progesterone has been reported to be around 10% (Wiki). The true oral bioavailability of progesterone is unknown at this time as studies with reliable analytic methods have not been conducted. In any case, it can be assumed that it may be closer to around 1 or 2% based on the findings that immunoassays overestimate progesterone levels by 5- to 8-fold.

    The elimination half-life of progesterone with oral progesterone has been determined in studies employing immunoassays to be 16 to 18 hours (Wiki). Based on the fact that the blood half-life of progesterone administered by intravenous injection is very short at a range of only 3 minutes to 1.5 hours (Wiki), the reported half-life of progesterone with oral progesterone is much longer than one would expect. Oral estradiol has a relatively long half-life of 13 to 20 hours due to formation with the first pass of a circulating reservoir of estrogen conjugates that are slowly converted back into estradiol (Kuhl, 2005; Wiki). In contrast to estradiol however, progesterone itself has no available hydroxyl groups for conjugation and an analogous circulating reservoir of progesterone conjugates that can be converted back into progesterone is not known to be the case (Kuhl, 2005).

    Studies with more reliable analytic methods like LC–MS have found a half-life of progesterone with oral progesterone of 5 to 10 hours and a duration of highly elevated progesterone levels of only about 4 to 8 hours (Wiki; Graphs). These findings indicate that oral progesterone has a much shorter duration than previously thought as well. As such, if oral progesterone is used, it may be advisable to take it in divided doses multiple times per day to allow for more sustained progestogenic exposure.

    Higher Oral Progesterone Doses and Neurosteroid Side Effects

    Use of higher doses of oral progesterone than typical doses is likely to achieve dose-dependently higher progesterone levels (Table). However, based on how low progesterone levels are with oral progesterone using reliable analytic techniques, even very high doses would still be expected to achieve only low progesterone levels in most cases. Moreover, high doses of oral progesterone result in very high levels of its neurosteroid metabolites and have been found to produce substantial alcohol-like side effects (i.e., central depression and effects within that umbrella) (Wiki; Wiki). These limitations are likely to preclude higher doses of oral progesterone from being practical.

    Figure 5: Levels of progesterone, allopregnanolone, and pregnanolone in premenopausal women following a single dose of oral progesterone or vaginal progesterone (as a suppository) (de Lignieres, Dennerstein, & Backstrom, 1995). Allopregnanolone and pregnanolone levels were determined by MS-based assays while progesterone levels were measured by immunoassay with chromatographic separation. Hence, the levels should be reliable.

    A Note on Oral Progesterone’s Metabolites

    Although progesterone levels with oral progesterone are very low, the metabolites of progesterone are formed in disproportionate amounts with the first pass (Sitruk-Ware et al., 1987; de Lignieres, Dennerstein, & Backstrom, 1995; de Lignieres, 1999; de Ziegler & Fanchin, 2000; Lobo, 2000; Kuhl, 2005). Moreover, while much less potent than progesterone, some of these metabolites have been found to have progestogenic activity similarly to progesterone (e.g., Besch et al., 1965; Junkermann, Runnebaum, & Lisboa, 1977; Lobo, 2000). This activity derives either from them having intrinsic progestogenic activity of their own or from being converted back into progesterone or other progestogenic metabolites (including in an intracrine fashion within tissues, for instance in the uterus). Examples of such metabolites include 20α-dihydroprogesterone, 20β-dihydroprogesterone, 5α-dihydroprogesterone, 3β-dihydroprogesterone, allopregnanolone, and 11-deoxycorticosterone. If the metabolites of oral progesterone contribute significantly to its progestogenic activity, then the progestogenic strength of oral progesterone would be greater than that implied by the progesterone levels that occur with it alone. However, this possibility is only theoretical and there is little literature discussing it. More research would be needed to determine if the metabolites of oral progesterone do indeed play a meaningful role in its progestogenic potency. In any case, oral progesterone is still a relatively weak progestogen based on clinical studies of its progestogenic effects.

    Alternative Options to Oral Progesterone

    Non-Oral Forms of Progesterone

    Non-oral forms of progesterone, such as vaginal progesterone, rectal progesterone, sublingual progesterone, and progesterone by injection, have been found to achieve much higher progesterone levels than oral progesterone (Wiki). They can be used instead of oral progesterone to achieve higher and more adequate progesterone levels. Unfortunately however, while more effective than oral progesterone, non-oral progesterone routes have various limitations of their own.

    Vaginal progesterone is of course not possible in transfeminine people who have not undergone vaginoplasty. And in those who have undergone vaginoplasty, the lining of the neovagina is either skin (penile inversion vaginoplasty) or intestine (sigmoid colon vaginoplasty) rather than the normal vaginal mucosa. As such, the absorptive characteristics of neovaginal administration are likely not the same as vaginal administration (Aly, 2018). It is notable that transdermal progesterone achieves very low progesterone levels similarly to oral progesterone and is not a good option for progesterone therapy (Wiki; Hermann et al., 2005; Graph). Progesterone levels with neovaginal administration of progesterone in those who have undergone penile inversion vaginoplasty are likely to be low similarly.

    Rectal progesterone is an excellent route that achieves high progesterone levels comparable to the levels of progesterone that occur during the normal luteal phase (Wiki; Graphs). It has a somewhat short duration and twice daily use may be warranted for more sustained levels however. A more important problem is that the availability of pharmaceutical rectal progesterone suppositories throughout the world is limited and they are not marketed in most countries (Wiki). In any case, rectal progesterone suppositories may be available from compounding pharmacies in some countries. In addition, oral micronized progesterone capsules are available ubiquitously and have been administered vaginally instead of orally with success (Miles et al., 1994; Wang et al., 2019). Administration of oral micronized progesterone capsules rectally instead of orally likewise may be effective and may achieve much higher progesterone levels than oral administration (Aly, 2018). However, rectal administration of oral progesterone capsules has not been formally studied. Although rectal progesterone is effective, it is fairly inconvenient. This may be especially true with long-term therapy. In any case, of the available non-oral forms of progesterone, rectal progesterone is probably the best overall.

    Figure 6: Progesterone levels with a single suppository containing 100 mg progesterone administered rectally or vaginally in premenopausal women (Chakmakjian & Zachariah, 1987).

    Sublingual progesterone appears to achieve high and more physiological progesterone levels than oral progesterone but has a short duration of highly elevated progesterone levels similarly and necessitates administration several times per day (Wiki; Graph). Moreover, although sublingual progesterone may have been more widely available in the past (Wiki), it is available today only in a couple of Eastern European countries (Wiki). It might be available from compounding pharmacies in some countries however. While never formally studied, it may be possible to use oral micronized progesterone capsules sublingually instead of orally. However, this route is complicated by the fact that this form of progesterone is suspended in oil within gelatin capsules. Hence, sublingual administration of oral micronized progesterone is likely to be difficult and potentially unpleasant.

    Progesterone by intramuscular or subcutaneous injection can easily achieve very high progesterone levels (Wiki; Graphs; Wiki; Graph). However, progesterone administered by this route has a relatively short duration when compared to other injectable sex-hormone formulations and requires injection once every 1 to 3 days. This is simply too frequent for most people, especially with long-term therapy. In addition, progesterone by subcutaneous injection, which is more convenient than progesterone by intramuscular injection, has limited availability and is marketed mostly only in Europe (Wiki). In contrast to other sex hormones like estradiol and testosterone, progesterone esters that are more fat-soluble than progesterone and extend its duration when used in injectable form are not possible since progesterone has no free hydroxyl groups available for esterification. Injectable aqueous suspensions of progesterone that had much longer durations than the oil solutions and aqueous solutions that are used by injection today were previously available (Wiki; Wiki; Aly, 2019). However, they were associated with painful injection site reactions and this led to their discontinuation. In any case, injectable aqueous suspensions of progesterone do actually seem to remain available for people in a couple of Eastern European countries today (Aly, 2019).

    Progestins as Alternative Progestogens

    As an alternative to progesterone, progestins may be used as progestogens instead (Aly, 2018). Many progestins have off-target actions such as weak androgenic and/or glucocorticoid activity that make them unfavorable for use in transfeminine hormone therapy (Kuhl, 2005; Aly, 2018). Examples of such progestins include medroxyprogesterone acetate (MPA) and most of the 19-nortestosterone derivatives like norethisterone and levonorgestrel (Kuhl, 2005; Aly, 2018). In any case, there are a number of progestins with more favorable profiles that can be used instead and with fewer concerns (Kuhl, 2005). Some examples of such progestins include low-dose cyproterone acetate (CPA) (Aly, 2019), drospirenone, dienogest, nomegestrol acetate (NOMAC), hydroxyprogesterone caproate (OHPC), and dihydroxyprogesterone acetophenide (DHPA; also known as algestone acetophenide). These are all progestogens without undesirable off-target activities (Kuhl, 2005). Dydrogesterone is another progestin without unfavorable off-target activity but has an atypical progestogenic profile and isn’t guaranteed to produce the same full spectrum of progestogenic effect as non-oral progesterone and other progestogens (Wiki). In contrast to progesterone, no progestins are known to produce neurosteroid metabolites or associated activity (Kuhl, 2005).

    Summary and Conclusions

    In conclusion, oral progesterone achieves very low progesterone levels at typical clinical doses and produces only weak progestogenic effects that seem to be far from physiologically adequate. Although use of higher doses of oral progesterone is likely to achieve higher progesterone levels, such doses are likely to be impractical because progesterone levels will still be low even at higher doses and the neurosteroid side effects of oral progesterone will be much more substantial and difficult to tolerate.

    Due to its limitations, transfeminine people and clinicians treating them may wish to avoid oral progesterone if the intended goal is to produce therapeutic progestogenic effects. Instead, non-oral progesterone routes, such as rectal and injected progesterone, although with various limitations such as limited availability and inconvenience, can be used. Alternatively, progestins, particularly those with more favorable profiles, can be used instead of progesterone altogether.

    Oral progesterone may perhaps be most appropriately conceptualized as a potent neurosteroid prodrug with weak progestogenic effects. Conversely, non-oral progesterone, as well as progestins, can be regarded as potent progestogens with either physiological or no neurosteroid effects, respectively.

    Additional Content

    Literature

    The sources and excerpts collected here go in-depth on much of what has been described in this article on the topic of the measurement problems and low progesterone levels with oral progesterone.

    References

    • Besch, P. K., Barry, R. D., Vorys, N., Stevens, V., & Ullery, J. C. (1965). A review of some aspects of the metabolism of progestational agents. Metabolism, 14(3), 432–443. [DOI:10.1016/0026-0495(65)90031-4]
    • Bijuva Estradiol/Progesterone Label. U.S. Food and Drug Administration. [URL] [PDF]
    • Chakmakjian, Z. H., & Zachariah, N. Y. (1987). Bioavailability of progesterone with different modes of administration. The Journal of Reproductive Medicine, 32(6), 443–448. [Google Scholar] [PubMed] [PDF]
    • Conklin, S. E., & Knezevic, C. E. (2020). Advancements in the gold standard: Measuring steroid sex hormones by mass spectrometry. Clinical Biochemistry, 82, 21–32. [DOI:10.1016/j.clinbiochem.2020.03.008]
    • Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]
    • de Lignières, B., Dennerstein, L., & Backstrom, T. (1995). Influence of route of administration on progesterone metabolism. Maturitas, 21(3), 251–257. [DOI:10.1016/0378-5122(94)00882-8]
    • de Lignières, B. (1999). Oral micronized progesterone. Clinical Therapeutics, 21(1), 41–60. [DOI:10.1016/S0149-2918(00)88267-3]
    • de Ziegler, D., & Fanchin, R. (2000). Progesterone and progestins: applications in gynecology. Steroids, 65(10–11), 671–679. [DOI:10.1016/S0039-128X(00)00123-9]
    • de Ziegler, D., Streuli, I., Marszalek, A., Gayet, V., & Chapron, C. (2013). Preparing the Endometrium to Maximize Success: The Dynamics of Artificial Cycles. In Sauer, M. V. (Ed.). Principles of Oocyte and Embryo Donation, 2nd Edition (pp. 109–127). London: Springer. [DOI:10.1007/978-1-4471-2392-7_9]
    • Hermann, A. C., Nafziger, A. N., Victory, J., Kulawy, R., Rocci Jr, M. L., & Bertino Jr, J. S. (2005). Over‐the‐Counter Progesterone Cream Produces Significant Drug Exposure Compared to a Food and Drug Administration‐Approved Oral Progesterone Product. The Journal of Clinical Pharmacology, 45(6), 614–619. [DOI:10.1177/0091270005276621]
    • Holst, J. (1983). Percutaneous estrogen therapy: Endometrial response and metabolic effects. Acta Obstetricia et Gynecologica Scandinavica, 62(Suppl 115), 4–30. [DOI:10.3109/00016348309155363]
    • Holst, J., Cajander, S., Carlström, K., Damber, M. G., & von Schoultz, B. (1983). Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone-effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein. Maturitas, 5(1), 1–8. [DOI:10.1016/0378-5122(83)90015-4]
    • Junkermann, H., Runnebaum, B., & Lisboa, B. P. (1977). New progesterone metabolites in human myometrium. Steroids, 30(1), 1–14. [DOI:10.1016/0039-128X(77)90131-3]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H. (2011). Pharmacology of progestogens. Journal für Reproduktionsmedizin und Endokrinologie [Journal of Reproductive Medicine and Endocrinology], 8(1), 157–177. [URL]
    • Kuhl, H., & Schneider, H. P. G. (2013). Progesterone–promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]
    • Lobo, R. A. (2000). Progestogens. In Lobo, R. A., Kelsey, J., & Marcus, R. (Eds.). Menopause: Biology and Pathobiology (pp. 429–444). Burlington: Academic Press. [Google Books]
    • Lobo, R. A., Liu, J., Stanczyk, F. Z., Constantine, G. D., Pickar, J. H., Shadiack, A. M., Bernick, B., & Mirkin, S. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause (New York, NY), 26(7), 720–727.[DOI:10.1097/GME.0000000000001306]
    • Levine, H., & Watson, N. (2000). Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility, 73(3), 516–521. [DOI:10.1016/S0015-0282(99)00553-1]
    • Maxson, W. S., & Hargrove, J. T. (1985). Bioavailability of oral micronized progesterone. Fertility and Sterility, 44(5), 622–626. [DOI:10.1016/S0015-0282(16)48977-6]
    • Miles, R. A., Paulson, R. J., Lobo, R. A., Press, M. F., Dahmoush, L., & Sauer, M. V. (1994). Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertility and Sterility, 62(3), 485–490. [DOI:10.1016/S0015-0282(16)56935-0]
    • Nahoul, K., Dehennin, L., & Scholler, R. (1987). Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. Journal of Steroid Biochemistry, 26(2), 241–249. [DOI:10.1016/0022-4731(87)90078-1]
    • Nahoul, K., Dehennin, L., Jondet, M., & Roger, M. (1993). Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas, 16(3), 185–202. [DOI:10.1016/0378-5122(93)90064-O]
    • Nahoul, K., & de Ziegler, D. (1994). “ Validity” of serum progesterone levels after oral progesterone. Fertility and Sterility, 61(4), 790–792. [DOI:10.1016/S0015-0282(16)56666-7]
    • Nakamoto, J. (2016). Endocrine Testing. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition (pp. 2655–2688.e1). Philadelphia: Saunders/Elsevier. [DOI:10.1016/B978-0-323-18907-1.00154-2]
    • Ottosson, U. B. (1984). Oral progesterone and estrogen/progestogen therapy: effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins. Acta Obstetricia et Gynecologica Scandinavica, 63(Suppl 127), 1–37. [DOI:10.3109/00016348409157016]
    • Pickar, J. H., Bon, C., Amadio, J. M., Mirkin, S., & Bernick, B. (2015). Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. Menopause (New York, NY), 22(12), 1308–1316. [DOI:10.1097/GME.0000000000000467]
    • Prometrium FDA Review 1996. Application Number: NDA 19-781. Clinical Pharmacology and Biopharmaceutics Review(s) [Prometrium]. Center for Drug Evaluation and Research, U.S. Food and Drug Administration. [PDF]
    • Saarikoski, S., Yliskosk, M., & Penttilä, I. (1990). Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders. Maturitas, 12(2), 89–97. [DOI:10.1016/0378-5122(90)90086-L]
    • Sapin, R., Neamtu, D., Gasser, F., Ohl, J., Grunenberger, F., & Grucker, D. (2000). De la prudence lors de l’utilisation des dosages directs de progestérone. [Caution when using direct progesterone assays.] Immuno-analyse et Biologie Spécialisée, 3(15), 203–204. [DOI:10.1016/S0923-2532(00)80010-1] [Translation]
    • Simon, J. A., Robinson, D. E., Andrews, M. C., Hildebrand III, J. R., Rocci Jr, M. L., Blake, R. E., & Hodgen, G. D. (1993). The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertility and Sterility, 60(1), 26–33. [DOI:10.1016/S0015-0282(16)56031-2]
    • Sitruk-Ware, R., Bricaire, C., De Lignieres, B., Yaneva, H., & Mauvais-Jarvis, P. (1987). Oral micronized progesterone: Bioavailability pharmacokinetics, pharmacological and therapeutic implications—A review. Contraception, 36(4), 373–402. [DOI:10.1016/0010-7824(87)90088-6]
    • Stricker, R., Eberhart, R., Chevailler, M. C., Quinn, F. A., Bischof, P., & Stricker, R. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer. Clinical Chemistry and Laboratory Medicine (CCLM), 44(7), 883–887. [DOI:10.1515/CCLM.2006.160]
    • Tollan, A., Øian, P., Kjeldsen, S. E., Eide, I., & Maltau, J. M. (1993). Progesterone reduces sympathetic tone without changing blood pressure or fluid balance in men. Gynecologic and Obstetric Investigation, 36(4), 234–238. [DOI:10.1159/000292636]
    • Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z. (2020). Progesterone and breast cancer. Endocrine Reviews, 41(2), 320–344. [DOI:10.1210/endrev/bnz001]
    • Wang, H., Liu, M., Fu, Q., & Deng, C. (2019). Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study. Drug Design, Development and Therapy, 13, 2475–2482. [DOI:10.2147/dddt.s204624]
    • Woodward, G. M., & Rumsby, G. (2019). Steroid Profiling: Analytical Perspectives. In Rumsby, G., Woodward, G. M. (Eds.). Disorders of Steroidogenesis: Guide to Steroid Profiling and Biochemical Diagnosis (pp. 27–40). Cham: Springer. [DOI:10.1007/978-3-319-96364-8_3]
    \ No newline at end of file +Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects - Transfeminine Science Link

    Oral Progesterone Achieves Very Low Levels of Progesterone and Has Only Weak Progestogenic Effects

    By Aly | First published August 4, 2018 | Last modified March 30, 2023

    Abstract / TL;DR

    Oral progesterone is the most widely used form of progesterone in transfeminine hormone therapy. Because of previous studies using inaccurate blood tests (immunoassays without adequate chromatographic purification), it was thought that typical therapeutic dosages of oral progesterone produced progesterone levels that reached typical luteal-phase levels in cisgender women (which range from about 7 to 22 ng/mL). However, newer studies using more accurate blood tests (immunoassays with adequate purification and mass spectrometry-based assays) have shown that 100 mg/day progesterone—with or without food—achieves very low peak progesterone levels of only about 2 to 3 ng/mL and average progesterone levels over 24 hours of only about 0.1 to 0.6 ng/mL. In accordance, oral progesterone has often shown only weak progestogenic effects in clinical studies. Higher doses of oral progesterone that might achieve better levels are limited by persistingly low progesterone levels, pronounced neurosteroid side effects caused by the first pass of progesterone through the liver, and substantial variability between individuals. While the progesterone levels with oral progesterone are apparently sufficient for endometrial protection in cisgender women, they are unlikely to be adequate for desired effects in transfeminine people. For these reasons, transfeminine people and their clinicians may wish to avoid oral progesterone if the aim is therapeutic progestogenic effects. Instead, non-oral forms of progesterone with greater bioavailability like rectal or injectable progesterone can be used. Alternatively, progestins, which are likewise fully effective progestogens, can be employed.

    Introduction

    The major female sex hormones are estrogens and progestogens, and both may be used in transfeminine hormone therapy. Progestogens are useful in transfeminine people for helping to suppress testosterone levels and possibly though not certainly influencing breast development. Progestogens include progesterone as well as synthetic progestogens known as progestins. Progesterone has relatively unfavorable pharmacokinetics, which has been overcome with progestins. However, progestins have differing pharmacodynamic properties compared to progesterone, which can potentially be unfavorable. As such, there is interest in using progesterone instead of progestins in transfeminine people and other populations like cisgender women despite its poor pharmacokinetic properties.

    Progesterone is available in formulations for use via a variety of different routes, including oral, sublingual, topical, vaginal, rectal, and injectable administration (Wiki; Table). Among these routes, oral administration is the easiest and most convenient, and in relation to this, oral progesterone is the most widely used form of progesterone in transfeminine people. However, the pharmacokinetic problems of progesterone limit the favorability of oral progesterone. Moreover, these limitations of oral progesterone actually appear to be much more substantial than is generally realized, a fact that has been obscured by methodological limitations of many—but not all—of the pharmacokinetic studies that have characterized oral progesterone. The purpose of this article is to explain and review these findings, as well as to explore solutions and alternatives to oral progesterone for progestogen therapy in transfeminine people.

    Progesterone Levels with Oral Progesterone

    Oral micronized progesterone, or simply oral progesterone, is the form of progesterone that is used by the oral route as a pharmaceutical medication. It is an oil suspension of micronized progesterone crystals contained in gelatin capsules. The formulation is marketed under brand names including Prometrium, Utrogestan, and Microgest, among many others. Oral progesterone has very low bioavailability (≤10%) due to the first pass through the intestines and liver with oral administration. As a result of the first pass, most of the delivered progesterone with oral progesterone is metabolized into neurosteroid metabolites such as allopregnanolone and pregnanolone before reaching the bloodstream (de Lignieres, Dennerstein, & Backstrom, 1995). This is why oral progesterone has alcohol-like side effects like sedation that are not shared by typical doses of non-oral progesterone such as vaginal progesterone or progesterone by injection. In spite of the low bioavailability of oral progesterone, typical clinical doses of oral progesterone, such as 100 to 300 mg/day, have been reported to produce progesterone levels measured with immunoassays that are similar to those in the normal luteal phase of the menstrual cycle in cisgender women (Simon et al., 1993). For this reason, it has been believed that oral progesterone can achieve high and physiologically adequate levels of progesterone.

    Figure 1: Progesterone levels during the menstrual cycle in normal premenopausal women (Stricker et al., 2006). The dashed horizontal lines are the mean levels for each curve and the dashed vertical line demarcates mid-cycle (when ovulation occurs). Progesterone levels are normally elevated only during the luteal phase.
    Figure 2: Progesterone levels measured by immunoassay after single 100 to 300 mg doses of oral micronized progesterone in postmenopausal women (Simon et al., 1993). The horizontal dashed lines are mean levels over 24 hours. Progesterone levels appeared to reach concentrations comparable to normal luteal-phase levels. However, these levels were in fact not accurate due to the use of immunoassays (Nahoul & de Ziegler, 1994).

    It is now clear that this is not actually the case. Immunoassay is an earlier analytic method that can have issues with accuracy and reliability. In the case of progesterone, the problem with the use of immunoassays is that they have poor specificity in terms of their determinations. The antiserum used in determinations of progesterone with immunoassays cross-reacts with metabolites of progesterone like 5α-dihydroprogesterone, allopregnanolone, and pregnanolone and counts them towards the total for progesterone. Due to the high circulating levels of progesterone metabolites that are formed during the first pass with oral administration, this cross-reactivity has resulted in studies that have used immunoassays (e.g., Simon et al., 1993, among many others) markedly overestimating progesterone levels with oral progesterone (Nahoul et al., 1993; Nahoul & de Ziegler, 1994). Studies that have used analytic methods with better specificity, including liquid chromatography–mass spectrometry (LC–MS)—regarded as the “gold standard” for clinical quantification of sex-hormone levels (Kuhl & Schneider, 2013; Woodward & Rumsby, 2019; Conklin & Knezevic, 2020)—as well as immunoassays in conjunction with adequate chromatographic separation, have found that progesterone levels with oral administration of progesterone are in fact very low (Nahoul, Dehennin, & Scholler, 1987; Nahoul & de Ziegler, 1994; Levine & Watson, 2000; Kuhl, 2011; Kuhl & Schneider, 2013; Davey, 2018).

    A notable study using LC–MS found maximal progesterone levels of only about 2 ng/mL and average progesterone levels over a period of 24 hours of only about 0.14 ng/mL after a single 100 mg dose of oral progesterone (Levine & Watson, 2000; Kuhl & Schneider, 2013). Another more recent study with LC–MS found progesterone levels of around 2.5 to 3 ng/mL at peak and average progesterone levels over 24 hours of around 0.6 ng/mL after a single 100 mg dose of oral progesterone with food (Lobo et al., 2019). (It should be noted that intake with food is known to increase the bioavailability of oral progesterone by a few-fold (Wiki; Bijuva FDA Label; Simon et al., 1993; Prometrium FDA Review, 1996; Pickar et al., 2015).) These progesterone levels are well below normal luteal-phase levels of progesterone, which range from 7 to 22 ng/mL with LC–MS (Nakamoto, 2016). Studies that have directly compared quantification of progesterone with immunoassays against more reliable methods have found that immunoassays overestimate progesterone levels by 5- to 8-fold (Nahoul, Dehennin, & Scholler, 1987; Nahoul & de Ziegler, 1994; Levine & Watson, 2000; Kuhl, 2011; Kuhl & Schneider, 2013; Davey, 2018). In one small study of a few individuals, the degree of overestimation varied from 2-fold to 40-fold with several different commercial immunoassays (Sapin et al., 2000). These findings are obscure and still relatively little-known in the scientific and medical communities. In any case, it is clear that oral progesterone achieves progesterone levels that are far lower than once thought and are well below the luteal-phase levels that would be therapeutically desirable for transfeminine people.

    Figure 3: Progesterone levels measured by immunoassay or LC–MS after a single dose of oral or vaginal micronized progesterone in postmenopausal women (Levine & Watson, 2000; Kuhl & Schneider, 2013). Levels of progesterone with oral progesterone measured by immunoassay were falsely high due to cross-reactivity. Conversely, progesterone levels measured by LC–MS or with vaginal progesterone can be considered accurate.
    Figure 4: Progesterone levels measured by LC–MS with 100 mg/day oral micronized progesterone taken with food in postmenopausal women (Lobo et al., 2019). The horizontal dashed line is the mean level over 24 hours. Food increases progesterone levels with oral progesterone by about 2- to 3-fold (Bijuva FDA Label; Simon et al., 1993). The progesterone levels measured in this study can be considered accurate to due to the use of LC–MS.

    Therapeutic Implications

    Progestogenic Potency and Effects

    A variety of perplexing findings on the clinical progestogenic effects of oral progesterone have been made over the decades and can now be readily explained by the newer data on oral progesterone with better analytic methods. Oral progesterone is used in clinical medicine mainly to protect the endometrium from unopposed stimulation by estrogens in menopausal cisgender women and is able to reliably prevent endometrial hyperplasia induced by estrogens even with the low progesterone levels that typical clinical doses achieve (Wiki). However, oral progesterone failed to provide adequate protection against estrogen-mediated endometrial cancer risk in a large observational study (Davey, 2018). Oral progesterone even at very high doses also is unable to produce full endometrial transformation—a normal effect of luteal-phase levels of progesterone—whereas vaginal and injectable progesterone are effective (de Ziegler et al., 2013). For this reason, oral progesterone, in contrast to parenteral progesterone, is considered to be inappropriate for use in assisted reproduction (de Ziegler et al., 2013). Oral progesterone additionally failed to suppress testosterone levels even at high doses (400 mg/day) in cisgender males (Trollan et al., 1993; Wiki). Conversely, progestins, rectal progesterone, and injectable progesterone can all produce robust testosterone suppression in cisgender males (Wiki; Aly, 2019). Similarly, oral progesterone has little or no apparent antigonadotropic effect in menopausal cisgender women, which is again in notable contrast to progestins (Holst, 1983; Holst et al., 1983; Ottosson, 1984; Maxson & Hargrove, 1985; Saarikoski, Yliskosk, & Penttilä, 1990).

    Unlike other clinically used progestogens, the addition of oral progesterone to estrogen therapy in menopausal women has not been associated with increased risk of venous thromboembolism (VTE; blood clots) (Wiki). Nor has it been associated with increased breast cancer risk in the short-term (<5 years of therapy) (Wiki). However, with long-term use (≥5 years), the combination of estrogen plus oral progesterone is associated with significantly greater risk of breast cancer relative to estrogen alone similarly to other progestogens (Aly, 2020; Sam, 2020; Wiki; Table). This has been said to be consistent with a weak proliferative effect of oral progesterone on the breasts such that a longer duration of exposure is necessary for a quantifiable increase in breast cancer risk to manifest (Kuhl & Schneider, 2013; Davey, 2018). It is also consistent with preclinical research, which clearly suggests a carcinogenic role for progesterone and progesterone receptor activation in the breast (Kuhl & Schneider, 2013; Trabert et al., 2020). The preceding clinical findings on endometrial efficacy, testosterone and gonadotropin suppression, VTE risk, and breast cancer risk with oral progesterone are in contrast to those with almost all clinically used progestins (with the exception of the oral progesterone-like dydrogesterone). These previously perplexing discrepancies can be readily explained by the very low levels of progesterone that are now known to be achieved with oral progesterone.

    Bioavailability, Half-Life, and Duration

    Considering the much lower levels of progesterone observed with oral progesterone in studies using reliable analytic methods, the bioavailability of oral progesterone needs to be reassessed. In studies with immunoassays, the bioavailability of oral progesterone has been reported to be around 10% (Wiki). The true oral bioavailability of progesterone is unknown at this time as studies with reliable analytic methods have not been conducted. In any case, it can be assumed that it may be closer to around 1 or 2% based on the findings that immunoassays overestimate progesterone levels by 5- to 8-fold.

    The elimination half-life of progesterone with oral progesterone has been determined in studies employing immunoassays to be 16 to 18 hours (Wiki). Based on the fact that the blood half-life of progesterone administered by intravenous injection is very short at a range of only 3 minutes to 1.5 hours (Wiki), the reported half-life of progesterone with oral progesterone is much longer than one would expect. Oral estradiol has a relatively long half-life of 13 to 20 hours due to formation with the first pass of a circulating reservoir of estrogen conjugates that are slowly converted back into estradiol (Kuhl, 2005; Wiki). In contrast to estradiol however, progesterone itself has no available hydroxyl groups for conjugation and an analogous circulating reservoir of progesterone conjugates that can be converted back into progesterone is not known to be the case (Kuhl, 2005).

    Studies with more reliable analytic methods like LC–MS have found a half-life of progesterone with oral progesterone of 5 to 10 hours and a duration of highly elevated progesterone levels of only about 4 to 8 hours (Wiki; Graphs). These findings indicate that oral progesterone has a much shorter duration than previously thought as well. As such, if oral progesterone is used, it may be advisable to take it in divided doses multiple times per day to allow for more sustained progestogenic exposure.

    Higher Oral Progesterone Doses and Neurosteroid Side Effects

    Use of higher doses of oral progesterone than typical doses is likely to achieve dose-dependently higher progesterone levels (Table). However, based on how low progesterone levels are with oral progesterone using reliable analytic techniques, even very high doses would still be expected to achieve only low progesterone levels in most cases. Moreover, high doses of oral progesterone result in very high levels of its neurosteroid metabolites and have been found to produce substantial alcohol-like side effects (i.e., central depression and effects within that umbrella) (Wiki; Wiki). These limitations are likely to preclude higher doses of oral progesterone from being practical.

    Figure 5: Levels of progesterone, allopregnanolone, and pregnanolone in premenopausal women following a single dose of oral progesterone or vaginal progesterone (as a suppository) (de Lignieres, Dennerstein, & Backstrom, 1995). Allopregnanolone and pregnanolone levels were determined by MS-based assays while progesterone levels were measured by immunoassay with chromatographic separation. Hence, the levels should be reliable.

    A Note on Oral Progesterone’s Metabolites

    Although progesterone levels with oral progesterone are very low, the metabolites of progesterone are formed in disproportionate amounts with the first pass (Sitruk-Ware et al., 1987; de Lignieres, Dennerstein, & Backstrom, 1995; de Lignieres, 1999; de Ziegler & Fanchin, 2000; Lobo, 2000; Kuhl, 2005). Moreover, while much less potent than progesterone, some of these metabolites have been found to have progestogenic activity similarly to progesterone (e.g., Besch et al., 1965; Junkermann, Runnebaum, & Lisboa, 1977; Lobo, 2000). This activity derives either from them having intrinsic progestogenic activity of their own or from being converted back into progesterone or other progestogenic metabolites (including in an intracrine fashion within tissues, for instance in the uterus). Examples of such metabolites include 20α-dihydroprogesterone, 20β-dihydroprogesterone, 5α-dihydroprogesterone, 3β-dihydroprogesterone, allopregnanolone, and 11-deoxycorticosterone. If the metabolites of oral progesterone contribute significantly to its progestogenic activity, then the progestogenic strength of oral progesterone would be greater than that implied by the progesterone levels that occur with it alone. However, this possibility is only theoretical and there is little literature discussing it. More research would be needed to determine if the metabolites of oral progesterone do indeed play a meaningful role in its progestogenic potency. In any case, oral progesterone is still a relatively weak progestogen based on clinical studies of its progestogenic effects.

    Alternative Options to Oral Progesterone

    Non-Oral Forms of Progesterone

    Non-oral forms of progesterone, such as vaginal progesterone, rectal progesterone, sublingual progesterone, and progesterone by injection, have been found to achieve much higher progesterone levels than oral progesterone (Wiki). They can be used instead of oral progesterone to achieve higher and more adequate progesterone levels. Unfortunately however, while more effective than oral progesterone, non-oral progesterone routes have various limitations of their own.

    Vaginal progesterone is of course not possible in transfeminine people who have not undergone vaginoplasty. And in those who have undergone vaginoplasty, the lining of the neovagina is either skin (penile inversion vaginoplasty) or intestine (sigmoid colon vaginoplasty) rather than the normal vaginal mucosa. As such, the absorptive characteristics of neovaginal administration are likely not the same as vaginal administration (Aly, 2018). It is notable that transdermal progesterone achieves very low progesterone levels similarly to oral progesterone and is not a good option for progesterone therapy (Wiki; Hermann et al., 2005; Graph). Progesterone levels with neovaginal administration of progesterone in those who have undergone penile inversion vaginoplasty are likely to be low similarly.

    Rectal progesterone is an excellent route that achieves high progesterone levels comparable to the levels of progesterone that occur during the normal luteal phase (Wiki; Graphs). It has a somewhat short duration and twice daily use may be warranted for more sustained levels however. A more important problem is that the availability of pharmaceutical rectal progesterone suppositories throughout the world is limited and they are not marketed in most countries (Wiki). In any case, rectal progesterone suppositories may be available from compounding pharmacies in some countries. In addition, oral micronized progesterone capsules are available ubiquitously and have been administered vaginally instead of orally with success (Miles et al., 1994; Wang et al., 2019). Administration of oral micronized progesterone capsules rectally instead of orally likewise may be effective and may achieve much higher progesterone levels than oral administration (Aly, 2018). However, rectal administration of oral progesterone capsules has not been formally studied. Although rectal progesterone is effective, it is fairly inconvenient. This may be especially true with long-term therapy. In any case, of the available non-oral forms of progesterone, rectal progesterone is probably the best overall.

    Figure 6: Progesterone levels with a single suppository containing 100 mg progesterone administered rectally or vaginally in premenopausal women (Chakmakjian & Zachariah, 1987).

    Sublingual progesterone appears to achieve high and more physiological progesterone levels than oral progesterone but has a short duration of highly elevated progesterone levels similarly and necessitates administration several times per day (Wiki; Graph). Moreover, although sublingual progesterone may have been more widely available in the past (Wiki), it is available today only in a couple of Eastern European countries (Wiki). It might be available from compounding pharmacies in some countries however. While never formally studied, it may be possible to use oral micronized progesterone capsules sublingually instead of orally. However, this route is complicated by the fact that this form of progesterone is suspended in oil within gelatin capsules. Hence, sublingual administration of oral micronized progesterone is likely to be difficult and potentially unpleasant.

    Progesterone by intramuscular or subcutaneous injection can easily achieve very high progesterone levels (Wiki; Graphs; Wiki; Graph). However, progesterone administered by this route has a relatively short duration when compared to other injectable sex-hormone formulations and requires injection once every 1 to 3 days. This is simply too frequent for most people, especially with long-term therapy. In addition, progesterone by subcutaneous injection, which is more convenient than progesterone by intramuscular injection, has limited availability and is marketed mostly only in Europe (Wiki). In contrast to other sex hormones like estradiol and testosterone, progesterone esters that are more fat-soluble than progesterone and extend its duration when used in injectable form are not possible since progesterone has no free hydroxyl groups available for esterification. Injectable aqueous suspensions of progesterone that had much longer durations than the oil solutions and aqueous solutions that are used by injection today were previously available (Wiki; Wiki; Aly, 2019). However, they were associated with painful injection site reactions and this led to their discontinuation. In any case, injectable aqueous suspensions of progesterone do actually seem to remain available for people in a couple of Eastern European countries today (Aly, 2019).

    Progestins as Alternative Progestogens

    As an alternative to progesterone, progestins may be used as progestogens instead (Aly, 2018). Many progestins have off-target actions such as weak androgenic and/or glucocorticoid activity that make them unfavorable for use in transfeminine hormone therapy (Kuhl, 2005; Aly, 2018). Examples of such progestins include medroxyprogesterone acetate (MPA) and most of the 19-nortestosterone derivatives like norethisterone and levonorgestrel (Kuhl, 2005; Aly, 2018). In any case, there are a number of progestins with more favorable profiles that can be used instead and with fewer concerns (Kuhl, 2005). Some examples of such progestins include low-dose cyproterone acetate (CPA) (Aly, 2019), drospirenone, dienogest, nomegestrol acetate (NOMAC), hydroxyprogesterone caproate (OHPC), and dihydroxyprogesterone acetophenide (DHPA; also known as algestone acetophenide). These are all progestogens without undesirable off-target activities (Kuhl, 2005). Dydrogesterone is another progestin without unfavorable off-target activity but has an atypical progestogenic profile and isn’t guaranteed to produce the same full spectrum of progestogenic effect as non-oral progesterone and other progestogens (Wiki). In contrast to progesterone, no progestins are known to produce neurosteroid metabolites or associated activity (Kuhl, 2005).

    Summary and Conclusions

    In conclusion, oral progesterone achieves very low progesterone levels at typical clinical doses and produces only weak progestogenic effects that seem to be far from physiologically adequate. Although use of higher doses of oral progesterone is likely to achieve higher progesterone levels, such doses are likely to be impractical because progesterone levels will still be low even at higher doses and the neurosteroid side effects of oral progesterone will be much more substantial and difficult to tolerate.

    Due to its limitations, transfeminine people and clinicians treating them may wish to avoid oral progesterone if the intended goal is to produce therapeutic progestogenic effects. Instead, non-oral progesterone routes, such as rectal and injected progesterone, although with various limitations such as limited availability and inconvenience, can be used. Alternatively, progestins, particularly those with more favorable profiles, can be used instead of progesterone altogether.

    Oral progesterone may perhaps be most appropriately conceptualized as a potent neurosteroid prodrug with weak progestogenic effects. Conversely, non-oral progesterone, as well as progestins, can be regarded as potent progestogens with either physiological or no neurosteroid effects, respectively.

    Additional Content

    Literature

    The sources and excerpts collected here go in-depth on much of what has been described in this article on the topic of the measurement problems and low progesterone levels with oral progesterone.

    References

    • Besch, P. K., Barry, R. D., Vorys, N., Stevens, V., & Ullery, J. C. (1965). A review of some aspects of the metabolism of progestational agents. Metabolism, 14(3), 432–443. [DOI:10.1016/0026-0495(65)90031-4]
    • Bijuva Estradiol/Progesterone Label. U.S. Food and Drug Administration. [URL] [PDF]
    • Chakmakjian, Z. H., & Zachariah, N. Y. (1987). Bioavailability of progesterone with different modes of administration. The Journal of Reproductive Medicine, 32(6), 443–448. [Google Scholar] [PubMed] [PDF]
    • Conklin, S. E., & Knezevic, C. E. (2020). Advancements in the gold standard: Measuring steroid sex hormones by mass spectrometry. Clinical Biochemistry, 82, 21–32. [DOI:10.1016/j.clinbiochem.2020.03.008]
    • Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]
    • de Lignières, B., Dennerstein, L., & Backstrom, T. (1995). Influence of route of administration on progesterone metabolism. Maturitas, 21(3), 251–257. [DOI:10.1016/0378-5122(94)00882-8]
    • de Lignières, B. (1999). Oral micronized progesterone. Clinical Therapeutics, 21(1), 41–60. [DOI:10.1016/S0149-2918(00)88267-3]
    • de Ziegler, D., & Fanchin, R. (2000). Progesterone and progestins: applications in gynecology. Steroids, 65(10–11), 671–679. [DOI:10.1016/S0039-128X(00)00123-9]
    • de Ziegler, D., Streuli, I., Marszalek, A., Gayet, V., & Chapron, C. (2013). Preparing the Endometrium to Maximize Success: The Dynamics of Artificial Cycles. In Sauer, M. V. (Ed.). Principles of Oocyte and Embryo Donation, 2nd Edition (pp. 109–127). London: Springer. [DOI:10.1007/978-1-4471-2392-7_9]
    • Hermann, A. C., Nafziger, A. N., Victory, J., Kulawy, R., Rocci Jr, M. L., & Bertino Jr, J. S. (2005). Over‐the‐Counter Progesterone Cream Produces Significant Drug Exposure Compared to a Food and Drug Administration‐Approved Oral Progesterone Product. The Journal of Clinical Pharmacology, 45(6), 614–619. [DOI:10.1177/0091270005276621]
    • Holst, J. (1983). Percutaneous estrogen therapy: Endometrial response and metabolic effects. Acta Obstetricia et Gynecologica Scandinavica, 62(Suppl 115), 4–30. [DOI:10.3109/00016348309155363]
    • Holst, J., Cajander, S., Carlström, K., Damber, M. G., & von Schoultz, B. (1983). Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone-effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein. Maturitas, 5(1), 1–8. [DOI:10.1016/0378-5122(83)90015-4]
    • Junkermann, H., Runnebaum, B., & Lisboa, B. P. (1977). New progesterone metabolites in human myometrium. Steroids, 30(1), 1–14. [DOI:10.1016/0039-128X(77)90131-3]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H. (2011). Pharmacology of progestogens. Journal für Reproduktionsmedizin und Endokrinologie [Journal of Reproductive Medicine and Endocrinology], 8(1), 157–177. [URL]
    • Kuhl, H., & Schneider, H. P. G. (2013). Progesterone–promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]
    • Lobo, R. A. (2000). Progestogens. In Lobo, R. A., Kelsey, J., & Marcus, R. (Eds.). Menopause: Biology and Pathobiology (pp. 429–444). Burlington: Academic Press. [Google Books]
    • Lobo, R. A., Liu, J., Stanczyk, F. Z., Constantine, G. D., Pickar, J. H., Shadiack, A. M., Bernick, B., & Mirkin, S. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause (New York, NY), 26(7), 720–727.[DOI:10.1097/GME.0000000000001306]
    • Levine, H., & Watson, N. (2000). Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility, 73(3), 516–521. [DOI:10.1016/S0015-0282(99)00553-1]
    • Maxson, W. S., & Hargrove, J. T. (1985). Bioavailability of oral micronized progesterone. Fertility and Sterility, 44(5), 622–626. [DOI:10.1016/S0015-0282(16)48977-6]
    • Miles, R. A., Paulson, R. J., Lobo, R. A., Press, M. F., Dahmoush, L., & Sauer, M. V. (1994). Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertility and Sterility, 62(3), 485–490. [DOI:10.1016/S0015-0282(16)56935-0]
    • Nahoul, K., Dehennin, L., & Scholler, R. (1987). Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone. Journal of Steroid Biochemistry, 26(2), 241–249. [DOI:10.1016/0022-4731(87)90078-1]
    • Nahoul, K., Dehennin, L., Jondet, M., & Roger, M. (1993). Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone. Maturitas, 16(3), 185–202. [DOI:10.1016/0378-5122(93)90064-O]
    • Nahoul, K., & de Ziegler, D. (1994). “ Validity” of serum progesterone levels after oral progesterone. Fertility and Sterility, 61(4), 790–792. [DOI:10.1016/S0015-0282(16)56666-7]
    • Nakamoto, J. (2016). Endocrine Testing. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition (pp. 2655–2688.e1). Philadelphia: Saunders/Elsevier. [DOI:10.1016/B978-0-323-18907-1.00154-2]
    • Ottosson, U. B. (1984). Oral progesterone and estrogen/progestogen therapy: effects of natural and synthetic hormones on subfractions of HDL cholesterol and liver proteins. Acta Obstetricia et Gynecologica Scandinavica, 63(Suppl 127), 1–37. [DOI:10.3109/00016348409157016]
    • Pickar, J. H., Bon, C., Amadio, J. M., Mirkin, S., & Bernick, B. (2015). Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. Menopause (New York, NY), 22(12), 1308–1316. [DOI:10.1097/GME.0000000000000467]
    • Prometrium FDA Review 1996. Application Number: NDA 19-781. Clinical Pharmacology and Biopharmaceutics Review(s) [Prometrium]. Center for Drug Evaluation and Research, U.S. Food and Drug Administration. [PDF]
    • Saarikoski, S., Yliskosk, M., & Penttilä, I. (1990). Sequential use of norethisterone and natural progesterone in pre-menopausal bleeding disorders. Maturitas, 12(2), 89–97. [DOI:10.1016/0378-5122(90)90086-L]
    • Sapin, R., Neamtu, D., Gasser, F., Ohl, J., Grunenberger, F., & Grucker, D. (2000). De la prudence lors de l’utilisation des dosages directs de progestérone. [Caution when using direct progesterone assays.] Immuno-analyse et Biologie Spécialisée, 3(15), 203–204. [DOI:10.1016/S0923-2532(00)80010-1] [Translation]
    • Simon, J. A., Robinson, D. E., Andrews, M. C., Hildebrand III, J. R., Rocci Jr, M. L., Blake, R. E., & Hodgen, G. D. (1993). The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertility and Sterility, 60(1), 26–33. [DOI:10.1016/S0015-0282(16)56031-2]
    • Sitruk-Ware, R., Bricaire, C., De Lignieres, B., Yaneva, H., & Mauvais-Jarvis, P. (1987). Oral micronized progesterone: Bioavailability pharmacokinetics, pharmacological and therapeutic implications—A review. Contraception, 36(4), 373–402. [DOI:10.1016/0010-7824(87)90088-6]
    • Stricker, R., Eberhart, R., Chevailler, M. C., Quinn, F. A., Bischof, P., & Stricker, R. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer. Clinical Chemistry and Laboratory Medicine (CCLM), 44(7), 883–887. [DOI:10.1515/CCLM.2006.160]
    • Tollan, A., Øian, P., Kjeldsen, S. E., Eide, I., & Maltau, J. M. (1993). Progesterone reduces sympathetic tone without changing blood pressure or fluid balance in men. Gynecologic and Obstetric Investigation, 36(4), 234–238. [DOI:10.1159/000292636]
    • Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z. (2020). Progesterone and breast cancer. Endocrine Reviews, 41(2), 320–344. [DOI:10.1210/endrev/bnz001]
    • Wang, H., Liu, M., Fu, Q., & Deng, C. (2019). Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study. Drug Design, Development and Therapy, 13, 2475–2482. [DOI:10.2147/dddt.s204624]
    • Woodward, G. M., & Rumsby, G. (2019). Steroid Profiling: Analytical Perspectives. In Rumsby, G., Woodward, G. M. (Eds.). Disorders of Steroidogenesis: Guide to Steroid Profiling and Biochemical Diagnosis (pp. 27–40). Cham: Springer. [DOI:10.1007/978-3-319-96364-8_3]
    \ No newline at end of file diff --git a/transfemscience.org/articles/oral-vs-transdermal-e2-suppl/index.html b/transfemscience.org/articles/oral-vs-transdermal-e2-suppl/index.html index 08c847fe..be61e73c 100644 --- a/transfemscience.org/articles/oral-vs-transdermal-e2-suppl/index.html +++ b/transfemscience.org/articles/oral-vs-transdermal-e2-suppl/index.html @@ -1 +1 @@ -Sources/Excerpts: Reviews, Cohort Studies and Randomised Controlled Trials Comparing the Feminising Efficacy of Estradiol Administered by Oral and Non-Oral Routes - Transfeminine Science Link

    Sources/Excerpts: Reviews, Cohort Studies and Randomised Controlled Trials Comparing the Feminising Efficacy of Estradiol Administered by Oral and Non-Oral Routes

    By Sam | First published April 10, 2020 | Last modified October 5, 2020

    Preface

    This is a sources and excerpts supplement to the main article which can be found here.

    Shah et al. (2014)

    Shah, S., Forghani, N., Durham, E., & Neely, E. K. (2014). A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. International Journal of Pediatric Endocrinology, 2014(1), 12. [DOI:10.1186/1687-9856-2014-12]:

    History and physical exams, including assessment of feminization by Tanner staging and breast diameter were obtained at baseline and every 6 months for 24 months.

    The proportion of subjects in each group reaching Tanner 3 breast stage at each 6 month interval is shown in Figure 3. All subjects in the TBE and OBE group were feminized by 18 months, […]

    Wierckx et al. (2014)

    Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A. D., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐sex hormone therapy in trans persons is safe and effective at short‐time follow‐up: results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]:

    Antiandrogen with estrogen treatment resulted in a significant increase (average 3.3 cm) in breast circumference at the nipple, with a wide interindividual range of increase. Trans women using oral estrogens experienced similar changes in physical measures as those using transdermal estrogens (Table 3).

    We found no changes in night sweats, abdominal pain, anxiety, irritability, palpitations, skin dryness, joint pain, muscle soreness, headache, mood swings, fatigue, concentration difficulties, memory, or sleep-related problems (data not shown). There were no significant differences in the presence of treatment related symptoms at the 3-month time point between trans women treated with oral or transdermal estrogen.

    […] In addition, trans women using oral EV showed significantly higher E1/E2 ratio than those using transdermal therapy. A lower E1/E2 ratio has been reported in postmenopausal women receiving transdermal hormone replacement therapy [40]. No other differences were observed between these two modes of estrogen treatment, suggesting both are equally effective.

    de Blok et al. (2018)

    de Blok, C. J. M., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2018). Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]:

    Because most transwomen (99%) in this study received cyproterone acetate as antiandrogen treatment, no analyses on treatment regimen other than oral vs transdermal estradiol administration route could be performed.

    Transwomen treated with transdermal estradiol had a faster increase in breast-chest difference until 6 months after initializing treatment. However, breast development after 1 year of treatment did not differ between oral and transdermal estradiol administration [Fig. 5(e)].

    Klaver et al. (2018)

    Klaver, M., de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., Dekker, M. J. H. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/EJE-17-0496]:

    Subgroups in transwomen were oral estradiol and transdermal estradiol. In these analyses, only transwomen and transmen using the same type of treatment during the whole year were included. Analyses on sex hormone levels were performed in quartiles of Z-scores, which is described in more detail below.

    Sixty five transwomen using oral estrogens, 49 transwomen using transdermal estrogens, 41 transmen using T esters, 34 transmen using T gel and 30 transmen using T undecanoate were included. Crude analyses in transwomen showed a trend toward a larger change in some body fat outcomes in persons using oral estradiol compared with persons using transdermal estradiol, but after adjustment for BMI at the start and age, these differences disappeared (Supplementary Table 1).

    Klein et al. (2018)

    Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T. C. J., & Mauras, N. (2018). The Journal of Clinical Endocrinology & Metabolism, 103(5), 1790–1803. [DOI:10.1210/jc.2017-02183]:

    Incremental dose increases at approximately 6-month intervals can mimic the normal pubertal tempo until adult dosing is reached over 2 to 3 years. This theoretically translates into a 25% to 100% increase in dose every 6 months for four to six dose changes between the initiation and adult doses portrayed in the Table 1. However, no studies to date have rigorously studied outcomes in relation to the rate of dose increase for the different preparations.

    In general, the studies summarized in Table 3 report onset of breast buds within 6 months in most girls (17, 18, 22, 23, 27). Each of these regimens results in pubertal stage 4 breasts in an average of 2.25 years, which is similar to that in girls with TS who have spontaneous puberty (1.9 years), as well as in the general population (23).

    \ No newline at end of file +Sources/Excerpts: Reviews, Cohort Studies and Randomised Controlled Trials Comparing the Feminising Efficacy of Estradiol Administered by Oral and Non-Oral Routes - Transfeminine Science Link

    Sources/Excerpts: Reviews, Cohort Studies and Randomised Controlled Trials Comparing the Feminising Efficacy of Estradiol Administered by Oral and Non-Oral Routes

    By Sam | First published April 10, 2020 | Last modified October 5, 2020

    Preface

    This is a sources and excerpts supplement to the main article which can be found here.

    Shah et al. (2014)

    Shah, S., Forghani, N., Durham, E., & Neely, E. K. (2014). A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. International Journal of Pediatric Endocrinology, 2014(1), 12. [DOI:10.1186/1687-9856-2014-12]:

    History and physical exams, including assessment of feminization by Tanner staging and breast diameter were obtained at baseline and every 6 months for 24 months.

    The proportion of subjects in each group reaching Tanner 3 breast stage at each 6 month interval is shown in Figure 3. All subjects in the TBE and OBE group were feminized by 18 months, […]

    Wierckx et al. (2014)

    Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A. D., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐sex hormone therapy in trans persons is safe and effective at short‐time follow‐up: results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]:

    Antiandrogen with estrogen treatment resulted in a significant increase (average 3.3 cm) in breast circumference at the nipple, with a wide interindividual range of increase. Trans women using oral estrogens experienced similar changes in physical measures as those using transdermal estrogens (Table 3).

    We found no changes in night sweats, abdominal pain, anxiety, irritability, palpitations, skin dryness, joint pain, muscle soreness, headache, mood swings, fatigue, concentration difficulties, memory, or sleep-related problems (data not shown). There were no significant differences in the presence of treatment related symptoms at the 3-month time point between trans women treated with oral or transdermal estrogen.

    […] In addition, trans women using oral EV showed significantly higher E1/E2 ratio than those using transdermal therapy. A lower E1/E2 ratio has been reported in postmenopausal women receiving transdermal hormone replacement therapy [40]. No other differences were observed between these two modes of estrogen treatment, suggesting both are equally effective.

    de Blok et al. (2018)

    de Blok, C. J. M., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2018). Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]:

    Because most transwomen (99%) in this study received cyproterone acetate as antiandrogen treatment, no analyses on treatment regimen other than oral vs transdermal estradiol administration route could be performed.

    Transwomen treated with transdermal estradiol had a faster increase in breast-chest difference until 6 months after initializing treatment. However, breast development after 1 year of treatment did not differ between oral and transdermal estradiol administration [Fig. 5(e)].

    Klaver et al. (2018)

    Klaver, M., de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., Dekker, M. J. H. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/EJE-17-0496]:

    Subgroups in transwomen were oral estradiol and transdermal estradiol. In these analyses, only transwomen and transmen using the same type of treatment during the whole year were included. Analyses on sex hormone levels were performed in quartiles of Z-scores, which is described in more detail below.

    Sixty five transwomen using oral estrogens, 49 transwomen using transdermal estrogens, 41 transmen using T esters, 34 transmen using T gel and 30 transmen using T undecanoate were included. Crude analyses in transwomen showed a trend toward a larger change in some body fat outcomes in persons using oral estradiol compared with persons using transdermal estradiol, but after adjustment for BMI at the start and age, these differences disappeared (Supplementary Table 1).

    Klein et al. (2018)

    Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T. C. J., & Mauras, N. (2018). The Journal of Clinical Endocrinology & Metabolism, 103(5), 1790–1803. [DOI:10.1210/jc.2017-02183]:

    Incremental dose increases at approximately 6-month intervals can mimic the normal pubertal tempo until adult dosing is reached over 2 to 3 years. This theoretically translates into a 25% to 100% increase in dose every 6 months for four to six dose changes between the initiation and adult doses portrayed in the Table 1. However, no studies to date have rigorously studied outcomes in relation to the rate of dose increase for the different preparations.

    In general, the studies summarized in Table 3 report onset of breast buds within 6 months in most girls (17, 18, 22, 23, 27). Each of these regimens results in pubertal stage 4 breasts in an average of 2.25 years, which is similar to that in girls with TS who have spontaneous puberty (1.9 years), as well as in the general population (23).

    \ No newline at end of file diff --git a/transfemscience.org/articles/oral-vs-transdermal-e2/index.html b/transfemscience.org/articles/oral-vs-transdermal-e2/index.html index b41c8f56..7b111f35 100644 --- a/transfemscience.org/articles/oral-vs-transdermal-e2/index.html +++ b/transfemscience.org/articles/oral-vs-transdermal-e2/index.html @@ -1 +1 @@ -Oral versus Transdermal Estradiol in Feminising Hormone Therapy for Transgender Individuals - Transfeminine Science Link

    Oral versus Transdermal Estradiol in Feminising Hormone Therapy for Transgender Individuals

    By Sam | First published April 11, 2020 | Last modified October 5, 2020

    Abstract / TL;DR

    In the modern world, the oral and transdermal routes are by far the most common means to administer exogenous estradiol and are widely used as a component of gender-affirming hormone therapy. Current clinical evidence shows no difference in feminising efficacy between these formulations at equivalent doses. Although both are well tolerated in general, the oral route is unphysiological in its metabolism and is associated with a significantly greater incidence of cardiovascular and thromboembolic complications. At low adult replacement doses, transdermal forms do not have these disadvantages and may be superior to their oral counterparts in feminising hormone therapy.

    Introduction

    Estrogen replacement is both an important and necessary intervention for many transgender people (Hembree et al., 2017; Cheung et al., 2019). In the past, feminising therapy in this group was done using high dose estrogen monotherapy with parenteral esters of estradiol such as estradiol valerate or estradiol undecylate (Benjamin, 1967; Hamburger, 1969). Non-bioidentical oral estrogens such as conjugated equine estrogens and ethinylestradiol were also widely used (Meyer et al., 1986; Meyer, Walker & Suplee, 1989). However, with the significant progress made in drug development, bioidentical estradiol became widely available as oral and transdermal formulations for gender-affirming hormone therapy.

    Today, some transgender individuals prefer to use injectable formulations of estradiol (Geffen et al., 2018). Nonetheless, the oral and transdermal routes of administration are used almost without exception for therapy in Europe and some other parts of the world and are probably most commonplace (Fisher & Maggi, 2015; Hamidi & Davidge-Pitts, 2019; Seal, 2019). Many people receiving or eager to start hormone therapy may be interested to know what data exists regarding differences between oral and transdermal estradiol. As we require long-term therapy with these formulations, a discussion regarding adverse effects between these routes of administration may also be of importance. Although the focus of this review is largely on oral estradiol as compared with transdermal estradiol, a good amount of the discussion specific to transdermal estradiol can likely be extrapolated to other non-oral routes of administration when the doses have similar potency. For instance, estradiol administered by intramuscular or subcutaneous injection is a non-oral route of administration.

    Pharmacology

    Oral estradiol includes pill or tablet formulations, while transdermal estradiol is most commonly available as patches or gels (Kuhl, 2005). Oral estradiol and transdermal gel is usually administered once per day (Rohr, Volko & Schindler 2014). However, doses may be split and taken twice-daily. Theoretically, this would result in more stable estradiol levels, although is obviously less convenient. Estradiol pills may also be administered by the sublingual or buccal routes (Casper & Yen, 1981; Wren et al., 2003). Although some literature exists regarding their use for therapy in feminising hormone therapy, usage of these routes is probably still relatively rare in clinical practice (Jain, Kwan & Forcier 2019). In this review, I have used the term “oral estradiol” to refer only to the swallowing of estradiol tablets. Estradiol patches are applied and worn continuously. Different brands exist and transdermal patches are available for twice-weekly or weekly administration. A 50 μg/day dosage delivered by transdermal patch is considered to have similar potency to a 1 to 2 mg/day dosage of oral estradiol and to a 1.5 mg/day dosage of transdermal gel (Kuhl, 2005; Järvinen, Nykänen & Paasiniemi, 1999). However, as there is massive interindividual variability, these doses likely will not correspond to one another on an individual basis.

    Estradiol is secreted by the ovaries into systematic circulation. As a result, the liver is not disproportionately exposed to the effects of the hormone (Gravholt et al., 2017). Transdermal estradiol is effective in mimicking this behaviour. However, orally administered estradiol, owing to passage through the gastrointestinal tract, is associated with disproportionate estrogenic exposure in the liver (Bińkowska, 2014). This behaviour gives rise to a number of differences between oral and transdermal estradiol. One such difference is that about 95% of oral estradiol is metabolised, as a consequence of the first pass effect, into estrone and other clinically weak/insignificant estrogens (Kuhz, Blode & Zimmermann, 1993). The ratio of estrone to estradiol is close to 1:1 in adult women and pubertal girls and with transdermal formulations (Kuhl, 2005; Frederiksen et al., 2020). However, with a dose of oral estradiol, postmenopausal women have been found to have about 5 times the concentration of estrone as estradiol (Kuhl, 2005). In some patients, the concentration of estrone may be 20 times higher than that of estradiol (Kuhnz, Gansau & Mahler, 1993). For this reason, the metabolism of oral estradiol has been described as unphysiologic (Gravholt et al., 2017; Mauras et al., 2019).

    Efficacy

    A subject of great interest to many transgender people taking feminising hormone therapy seems to be concerning which regimens might be most “effective”. In particular, satisfactory breast development is often sought after. However, to date, no randomised controlled trials assessing the efficacy of different gender-affirming hormone regimens have been conducted (Reisman, Goldstein & Safer, 2019; Iwamoto et al., 2019). Moreover, there are no measures of breast development or other effects of transition that are universally agreed upon by the scientific community. For this reason, it is difficult to directly compare the findings of many studies.

    Nonetheless, a number of observational studies have studied and quantified feminisation experienced with hormone therapy. In one prospective study, transgender women (n = 53) were treated with cyproterone acetate plus either oral or transdermal estradiol (Wierckx et al., 2014). It was noted that after 1 year, there was no apparent difference in physical measures such as breast circumference between the oral and transdermal groups. Another longitudinal and multicentre study of transgender women (n = 229) attending clinics in the Netherlands, Belgium and Italy also reported that the increase in breast-chest difference following 1 year of therapy did not differ between those using oral and transdermal formulations (de Blok et al., 2018). As a result of unsatisfactory development, many transgender women seek breast augmentation (Seal, 2016; de Blok et al., 2020). Although breast development itself was not measured, it is interesting to note that one retrospective study found no statistical difference in the rate of augmentation requests between users of different estrogen types (Seal et al., 2012). This suggests that oral estradiol valerate might be no more or less effective than the other estrogens in the study (oral conjugated estrogens and oral ethinylestradiol) in attaining a satisfying amount of breast development. Finally, it has been reported in a large cohort study of transgender women (n = 179) that percent changes in gynoid and android fat, total body fat and total lean body mass were not statistically different between the oral and transdermal estradiol groups if BMI and age were controlled for (Klaver et al., 2018).

    Estrogen replacement, being a necessary therapy for the vast majority of individuals with Turner syndrome, has also been studied in adolescent girls (Gravholt et al., 2017; Klein & Phillips, 2019). Girls treated with low dose oral estradiol (n = 56) were described in one study as having “similar” breast development to the normal Dutch population (Bannink et al., 2009). Other studies of puberty induction therapy have found that patients using low doses of transdermal estradiol gel (n = 21) and low dose intramuscular estradiol cypionate (n = 14) also all achieved breast Tanner stage 4 or 5 at final follow-up (Piippo et al., 2004; Rosenfield et al., 2005). A small randomised controlled trial of hypogonadal girls (n = 12) demonstrated that the response to oral and transdermal estradiol at comparable doses was near identical (Shah et al., 2014). All the girls receiving bioidentical estrogens achieved Tanner stage 3 or greater after 18 months of treatment, irrespective of route of administration. Interestingly, a cross sectional study of breast development in women with differences of sex development (DSD), including those with Turner syndrome, reported that breast satisfaction in the sample group was much lower than in women without a DSD (van de Grift & Kreukels, 2019). Some studies have found that breast development, in addition to breast satisfaction, seems to be poorer in Turner syndrome girls than in normal cisgender girls (Guo et al., 2019). Nevertheless, a recent review concluded that all these different regimens seemed to result in similar feminising outcomes (Klein et al., 2018).

    In summary, current clinical evidence appears to show no difference in objectively measured outcomes between therapy with different routes of administration when the doses have comparable potency. Rather, when taken together, these findings indicate that the extent of breast development and other feminisation is independent of what route of administration is used (excerpts).

    Safety and Tolerability

    In the past, estrogens in general have been associated with a greater overall incidence of adverse cardiovascular and thromboembolic events (Kuhl, 2005). These events can include deep vein thrombosis and myocardial infarction. Such complications of therapy have been attributed to estrogenic activity in the liver which, at sufficient exposure, causes an increased synthesis of liver proteins such as as sex-hormone binding globulin (von Schoultz et al., 1989; Ockrim, Lalani & Abel, 2006). Synthesis rates of lipids and coagulation factors have also been found to change. However, the type and route of administration of estrogen has been shown to modify risk (Olié, Canonico & Scarabin, 2011; Oliver-Williams et al., 2018).

    Synthetic and non-bioidentical estrogens are more resistant to enzymatic metabolism by the liver and have disproportionate estrogenic effects relative to bioidentical estrogens such as estradiol (Kuhl, 2005). Because of this behaviour, they contribute to a much greater synthesis of liver proteins and are associated with a significantly higher risk of venous thromboembolism and other cardiovascular complications (Henriksson & Edhag, 1986; Kuhl, 2005; Lycette et al., 2006). A 2015 retrospective case-control study found that venous thromboembolism was 2 to 5 times more common in young women using combined oral contraceptives containing ethinylestradiol and other synthetic progestins than in non users (Vinogradova, Coupland & Hippisley-Cox, 2015). In 2019, the same authors published another case-control study; this time investigating women receiving hormone therapy at the menopause (Vinogradova, Coupland & Hippisley-Cox, 2019). A key finding was that low doses of oral estradiol (2 mg/day or less) were associated with a slight but significant increase in the incidence of venous thromboembolism, while low transdermal doses (100 μg/day or less) were not. This has also been reported by the ESTHER case-control and E3N cohort studies (Scarabin, 2014). Therefore, a strong advantage of transdermal estradiol over oral estradiol is that the incidence of venous thromboembolism is lower (Files & Kling, 2020). As with the synthetic estrogens, this difference is thought to be attributable to the disproportionate amount of estrogenic exposure in the liver that occurs with oral administration (Olié, Canonico & Scarabin, 2011). Nevertheless, high dose polyestradiol phosphate (160 to 240 mg/month) administered by intramuscular injection has been associated with significantly increased cardiovascular and thromboembolic morbidity and mortality in at least one large study of prostate cancer patients (Mikkola et al., 2005; Mikkola et al., 2007). While the increased incidence of these adverse events is clearly much lower than with oral estradiol, it is much less clear if it may be entirely eliminated by non-oral routes of administration at higher doses (Sam, 2020).

    It is difficult to accurately determine the incidence of venous thromboembolism in transgender people receiving hormone therapy because of the diverse range of regimens employed in different geographical regions; which may confer different risks (Goldstein et al., 2019). Moreover, although a number of observational and retrospective studies have reported risk as low or relatively insignificant in our community, most are not adequately powered to accurately report risk (Khan et al., 2019). Based on the available evidence, we can probably safely assume that the incidence is low overall with modern regimens (Getahun et al., 2018; Ott et al., 2010; Pyra et al., 2020). It is particularly of note that these complications are, thankfully, mostly confined to people at higher baseline risk such as elderly individuals or those with inherited mutations that predispose to such toxicity (Silverstein et al., 1998; Bezgin et al., 2016). The absolute risk is likely low for most people. Nonetheless, the association between estrogens and adverse cardiovascular and thromboembolic events is of obvious importance. In the future, I intend on posting a more comprehensive evaluation of these complications with different doses and formulations of estrogens.

    Summary and Conclusions

    In conclusion, oral and transdermal estradiol is metabolised differently. Perhaps most significantly, a dose of oral estadiol is predominantly converted by the liver into estrone and other estrogen metabolites before it enters circulation. By contrast, transdermal estradiol bypasses the liver and the conversion of the medication into these weak estrogens is mostly avoided. On average, a transdermal patch that delivers a 50 μg/day dose is thought to have similar estrogenic potency to a 1 to 2 mg/day dose of oral estradiol and to a 1.5 mg/day dose of transdermal gel.

    In spite of these difference, there appears to be no evidence that oral estradiol provides more effective feminisation than transdermal estradiol or vice versa if the doses are similar. Instead, the existing clinical evidence seems to show that the extent of feminising changes such as breast development and fat distribution is independent of the route that estradiol is administered by. Contrariwise, there is a good amount of epidemiological evidence that oral estradiol is associated with a higher incidence of venous thrombosis than is transdermal estradiol at a comparable dose. For this reason, transdermal estradiol at physiological doses is likely safer than oral estradiol in long term gender affirming hormone therapy. I intend to discuss, in more detail, the subject of cardiovascular and thromboembolic toxicity with different doses and types of estrogens in a future review.

    References

    • Bannink, E. M., Van Sassen, C., Van Buuren, S., De Jong, F. H., Lequin, M., Mulder, P. G., & De Muinck Keizer-Schrama, S. M. (2009). Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clinical Endocrinology, 70(2), 265–273. [DOI:10.1111/j.1365-2265.2008.03446.x]
    • Benjamin, H. (1967). Transvestism and Transsexualism in the male and female. Journal of Sex Research, 3(2), 107–127. [DOI:10.1080/00224496709550519]
    • Bezgin, T., Kaymaz, C., Akbal, Ö., Yılmaz, F., Tokgöz, H. C., & Özdemir, N. (2016). Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. Clinical and Applied Thrombosis/Hemostasis, 24(1), 100–106. [DOI:10.1177/1076029616672585]
    • Bińkowska, M. (2014). Featured paper Menopausal hormone therapy and venous thromboembolism. Przegląd Menopauzalny [Menopausal Review], 13(5), 267–272. [DOI:10.5114/pm.2014.46468]
    • Casper, R. F., & Yen, S. S. (1981). Rapid absorption of micronized estradiol-17β following sublingual administration. Obstetrics and Gynecology, 57(1), 62–64. [Google Scholar] [PubMed] [URL] [PDF]
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de Blok, C. J., Staphorsius, A. S., Wiepjes, C. M., Smit, J. M., Nanayakkara, P. W., & den Heijer, M. (2019). Frequency, Determinants, and Satisfaction of Breast Augmentation in Trans Women Receiving Hormone Treatment. The Journal of Sexual Medicine, 17(2), 342–348. [DOI:10.1016/j.jsxm.2019.10.021]
    • Files, J., & Kling, J. M. (2019). Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review. Expert Opinion on Drug Delivery, 17(4), 543–549. [DOI:10.1080/17425247.2020.1700949]
    • Fisher, A. D., & Maggi, M. (2015). Endocrine Treatment of Transsexual Male-to-Female Persons. In Trombetta, C., Liguori, G., & Bertolotto, M. (Eds.). Management of Gender Dysphoria: A Multidisciplinary Approach (pp. 83–91). Milano: Springer Milan. [DOI:10.1007/978-88-470-5696-1_10]
    • Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., Main, K. M., Andersson, A., & Juul, A. (2019). Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS. The Journal of Clinical Endocrinology & Metabolism, 105(3), 754–768. [DOI:10.1210/clinem/dgz196]
    • Geffen, S., Horn, T., Smith, K. J., & Cahill, S. (2018). Advocacy for Gender Affirming Care: Learning from the Injectable Estrogen Shortage. Transgender Health, 3(1), 42–44. [DOI:10.1089/trgh.2017.0025]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/m17-2785]
    • Goldstein, Z., Khan, M., Reisman, T., & Safer, J. D. (2019). Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. Journal of Blood Medicine, 10, 209–216. [DOI:10.2147/jbm.s166780]
    • Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., Sandberg, D. E., Sas, T. C., Silberbach, M., Söderström-Anttila, V., Stochholm, K., van Alfen-van derVelden, J. A., Woelfle, J., Backeljauw, P. F., & the International Turner Syndrome Consensus Group. (2017). Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. European Journal of Endocrinology, 177(3), G1–G70. [DOI:10.1530/eje-17-0430]
    • Guo, S., Zhang, J., Li, Y., Ma, H., Chen, Q., Chen, H., & Du, M. (2019). The pubertal development mode of Chinese girls with turner syndrome undergoing hormone replacement therapy. BMC Endocrine Disorders, 19(1), 72. [DOI:10.1186/s12902-019-0403-2]
    • Hamburger, C., & Benjamin, H. (1969). Endocrine Treatment of Male and Female Transsexualism / Appendix for the Practicing Physician: Suggestions and Guidelines for the Management of Transsexuals. In Green, R., & Money, J. (Eds.). Transsexualism and Sex Reassignment (pp. 291–307). Baltimore: John Hopkins University Press. [Google Scholar] [Google Books] [PDF]
    • Hamidi, O., & Davidge-Pitts, C. J. (2019). Transfeminine Hormone Therapy. Endocrinology and Metabolism Clinics of North America, 48(2), 341–355. [DOI:10.1016/j.ecl.2019.02.001]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline [2nd Version]. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Henriksson, P., & Edhag, O. (1986). Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. BMJ, 293(6544), 413–415. [DOI:10.1136/bmj.293.6544.413]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Järvinen, A., Nykänen, S., & Paasiniemi, L. (1999). Absorption and bioavailability of oestradiol from a gel, a patch and a tablet. Maturitas, 32(2), 103–113. [DOI:10.1016/s0378-5122(99)00021-3]
    • Khan, J., Schmidt, R. L., Spittal, M. J., Goldstein, Z., Smock, K. J., & Greene, D. N. (2019). Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. Clinical Chemistry, 65(1), 57–66. [DOI:10.1373/clinchem.2018.288316]
    • Klaver, M., de Blok, C. J., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/eje-17-0496]
    • Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T. C., & Mauras, N. (2018). Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1790–1803. [DOI:10.1210/jc.2017-02183]
    • Klein, K. O., & Phillips, S. A. (2019). Review of Hormone Replacement Therapy in Girls and Adolescents with Hypogonadism. Journal of Pediatric and Adolescent Gynecology, 32(5), 460–468. [DOI:10.1016/j.jpag.2019.04.010]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhnz, W., Blode, H., & Zimmermann, H. (1993). Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 261–322). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_15]
    • Kuhnz, W., Gansau, C., & Mahler, M. (1993). Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43(9), 966–973. [Google Scholar] [PubMed] [PDF]
    • Mauras, N., Torres-Santiago, L., Santen, R., Mericq, V., Ross, J., Colon-Otero, G., Damaso, L., Hossain, J., Wang, Q., Mesaros, C., & Blair, I. A. (2018). Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome. Clinical Endocrinology, 90(1), 155–161. [DOI:10.1111/cen.13869]
    • Meyer, W. J., Walker, P. A., & Suplee, Z. R. (1981). A survey of transsexual hormonal treatment in twenty gender‐treatment centers. The Journal of Sex Research, 17(4), 344–349. [DOI:10.1080/00224498109551125]
    • Meyer, W. J., Webb, A., Stuart, C. A., Finkelstein, J. W., Lawrence, B., & Walker, P. A. (1986). Physical and hormonal evaluation of transsexual patients: A longitudinal study. Archives of Sexual Behavior, 15(2), 121–138. [DOI:10.1007/bf01542220]
    • Mikkola, A., Aro, J., Rannikko, S., Oksanen, H., Ruutu, M., & (2005). Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate. Scandinavian Journal of Urology and Nephrology, 39(4), 294–300. [DOI:10.1080/00365590510031228]
    • Mikkola, A., Aro, J., Rannikko, S., Ruutu, M., & (2007). Ten-year survival and cardiovascular mortality in patients with advanced prostate cancer primarily treated by intramuscular polyestradiol phosphate or orchiectomy. The Prostate, 67(4), 447–455. [DOI:10.1002/pros.20547]
    • Ockrim, J., Lalani, E., & Abel, P. (2006). Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature Clinical Practice Oncology, 3(10), 552–563. [DOI:10.1038/ncponc0602]
    • Olié, V., Canonico, M., & Scarabin, P. (2011). Postmenopausal hormone therapy and venous thromboembolism. Thrombosis Research, 127, S26–S29. [DOI:10.1016/s0049-3848(11)70008-1]
    • Oliver-Williams, C., Glisic, M., Shahzad, S., Brown, E., Pellegrino Baena, C., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2018). The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update, 25(2), 257–271. [DOI:10.1093/humupd/dmy039]
    • Ott, J., Kaufmann, U., Bentz, E., Huber, J. C., & Tempfer, C. B. (2010). Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertility and Sterility, 93(4), 1267–1272. [DOI:10.1016/j.fertnstert.2008.12.017]
    • Piippo, S., Lenko, H., Kainulainen, P., & Sipilä, I. (2004). Use of Percutaneous Estrogen Gel for Induction of Puberty in Girls with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism, 89(7), 3241–3247. [DOI:10.1210/jc.2003-032069]
    • Pyra, M., Casimiro, I., Rusie, L., Ross, N., Blum, C., Keglovitz Baker, K., Baker, A., & Schneider, J. (2020). An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy. Transgender Health, 5(1), 1–9. [DOI:10.1089/trgh.2019.0061]
    • Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A Review of Breast Development in Cisgender Women and Implications for Transgender Women. Endocrine Practice, 25(12), 1338–1345. [DOI:10.4158/ep-2019-0183]
    • Rohr, U. D., Volko, C. D., & Schindler, A. E. (2014). Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women. Hormone Molecular Biology and Clinical Investigation, 18(3), 123–126. [DOI:10.1515/hmbci-2013-0047]
    • Rosenfield, R. L., Devine, N., Hunold, J. J., Mauras, N., Moshang, T., & Root, A. W. (2005). Salutary Effects of Combining Early Very Low-Dose Systemic Estradiol with Growth Hormone Therapy in Girls with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6424–6430. [DOI:10.1210/jc.2005-1081]
    • Scarabin, P. (2014). Hormone Therapy and Venous Thromboembolism among Postmenopausal Women. Frontiers of Hormone Research, 43, 21–32. / Granata, R., & Isgaard, J. (Eds.). Cardiovascular Issues in Endocrinology (Frontiers of Hormone Research, Volume 43) (pp. 21–32). Basel: Karger. [DOI:10.1159/000360554] [Google Books]
    • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422–4428. [DOI:10.1210/jc.2012-2030]
    • Seal, L. J. (2015). A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria. Annals of Clinical Biochemistry, 53(1), 10–20. [DOI:10.1177/0004563215587763]
    • Seal, L. J. (2019). Cardiovascular disease in transgendered people: A review of the literature and discussion of risk. JRSM Cardiovascular Disease, 8, 204800401988074. [DOI:10.1177/2048004019880745]
    • Shah, S., Forghani, N., Durham, E., & Neely, E. K. (2014). A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. International Journal of Pediatric Endocrinology, 2014(1), 12. [DOI:10.1186/1687-9856-2014-12]
    • Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (1998). Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine, 158(6), 585–593. [DOI:10.1001/archinte.158.6.585]
    • van de Grift, T. C., Kreukels, B. P., & (2019). Breast development and satisfaction in women with disorders/differences of sex development. Human Reproduction, 34(12), 2410–2417. [DOI:10.1093/humrep/dez230]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2015). Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 350, h2135. [DOI:10.1136/bmj.h2135]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. [DOI:10.1136/bmj.k4810]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    • Wren, B. G., Day, R. O., McLachlan, A. J., & Williams, K. M. (2003). Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women. Climacteric, 6(2), 104–111. [DOI:10.1080/cmt.6.2.104.111]
    \ No newline at end of file +Oral versus Transdermal Estradiol in Feminising Hormone Therapy for Transgender Individuals - Transfeminine Science Link

    Oral versus Transdermal Estradiol in Feminising Hormone Therapy for Transgender Individuals

    By Sam | First published April 11, 2020 | Last modified October 5, 2020

    Abstract / TL;DR

    In the modern world, the oral and transdermal routes are by far the most common means to administer exogenous estradiol and are widely used as a component of gender-affirming hormone therapy. Current clinical evidence shows no difference in feminising efficacy between these formulations at equivalent doses. Although both are well tolerated in general, the oral route is unphysiological in its metabolism and is associated with a significantly greater incidence of cardiovascular and thromboembolic complications. At low adult replacement doses, transdermal forms do not have these disadvantages and may be superior to their oral counterparts in feminising hormone therapy.

    Introduction

    Estrogen replacement is both an important and necessary intervention for many transgender people (Hembree et al., 2017; Cheung et al., 2019). In the past, feminising therapy in this group was done using high dose estrogen monotherapy with parenteral esters of estradiol such as estradiol valerate or estradiol undecylate (Benjamin, 1967; Hamburger, 1969). Non-bioidentical oral estrogens such as conjugated equine estrogens and ethinylestradiol were also widely used (Meyer et al., 1986; Meyer, Walker & Suplee, 1989). However, with the significant progress made in drug development, bioidentical estradiol became widely available as oral and transdermal formulations for gender-affirming hormone therapy.

    Today, some transgender individuals prefer to use injectable formulations of estradiol (Geffen et al., 2018). Nonetheless, the oral and transdermal routes of administration are used almost without exception for therapy in Europe and some other parts of the world and are probably most commonplace (Fisher & Maggi, 2015; Hamidi & Davidge-Pitts, 2019; Seal, 2019). Many people receiving or eager to start hormone therapy may be interested to know what data exists regarding differences between oral and transdermal estradiol. As we require long-term therapy with these formulations, a discussion regarding adverse effects between these routes of administration may also be of importance. Although the focus of this review is largely on oral estradiol as compared with transdermal estradiol, a good amount of the discussion specific to transdermal estradiol can likely be extrapolated to other non-oral routes of administration when the doses have similar potency. For instance, estradiol administered by intramuscular or subcutaneous injection is a non-oral route of administration.

    Pharmacology

    Oral estradiol includes pill or tablet formulations, while transdermal estradiol is most commonly available as patches or gels (Kuhl, 2005). Oral estradiol and transdermal gel is usually administered once per day (Rohr, Volko & Schindler 2014). However, doses may be split and taken twice-daily. Theoretically, this would result in more stable estradiol levels, although is obviously less convenient. Estradiol pills may also be administered by the sublingual or buccal routes (Casper & Yen, 1981; Wren et al., 2003). Although some literature exists regarding their use for therapy in feminising hormone therapy, usage of these routes is probably still relatively rare in clinical practice (Jain, Kwan & Forcier 2019). In this review, I have used the term “oral estradiol” to refer only to the swallowing of estradiol tablets. Estradiol patches are applied and worn continuously. Different brands exist and transdermal patches are available for twice-weekly or weekly administration. A 50 μg/day dosage delivered by transdermal patch is considered to have similar potency to a 1 to 2 mg/day dosage of oral estradiol and to a 1.5 mg/day dosage of transdermal gel (Kuhl, 2005; Järvinen, Nykänen & Paasiniemi, 1999). However, as there is massive interindividual variability, these doses likely will not correspond to one another on an individual basis.

    Estradiol is secreted by the ovaries into systematic circulation. As a result, the liver is not disproportionately exposed to the effects of the hormone (Gravholt et al., 2017). Transdermal estradiol is effective in mimicking this behaviour. However, orally administered estradiol, owing to passage through the gastrointestinal tract, is associated with disproportionate estrogenic exposure in the liver (Bińkowska, 2014). This behaviour gives rise to a number of differences between oral and transdermal estradiol. One such difference is that about 95% of oral estradiol is metabolised, as a consequence of the first pass effect, into estrone and other clinically weak/insignificant estrogens (Kuhz, Blode & Zimmermann, 1993). The ratio of estrone to estradiol is close to 1:1 in adult women and pubertal girls and with transdermal formulations (Kuhl, 2005; Frederiksen et al., 2020). However, with a dose of oral estradiol, postmenopausal women have been found to have about 5 times the concentration of estrone as estradiol (Kuhl, 2005). In some patients, the concentration of estrone may be 20 times higher than that of estradiol (Kuhnz, Gansau & Mahler, 1993). For this reason, the metabolism of oral estradiol has been described as unphysiologic (Gravholt et al., 2017; Mauras et al., 2019).

    Efficacy

    A subject of great interest to many transgender people taking feminising hormone therapy seems to be concerning which regimens might be most “effective”. In particular, satisfactory breast development is often sought after. However, to date, no randomised controlled trials assessing the efficacy of different gender-affirming hormone regimens have been conducted (Reisman, Goldstein & Safer, 2019; Iwamoto et al., 2019). Moreover, there are no measures of breast development or other effects of transition that are universally agreed upon by the scientific community. For this reason, it is difficult to directly compare the findings of many studies.

    Nonetheless, a number of observational studies have studied and quantified feminisation experienced with hormone therapy. In one prospective study, transgender women (n = 53) were treated with cyproterone acetate plus either oral or transdermal estradiol (Wierckx et al., 2014). It was noted that after 1 year, there was no apparent difference in physical measures such as breast circumference between the oral and transdermal groups. Another longitudinal and multicentre study of transgender women (n = 229) attending clinics in the Netherlands, Belgium and Italy also reported that the increase in breast-chest difference following 1 year of therapy did not differ between those using oral and transdermal formulations (de Blok et al., 2018). As a result of unsatisfactory development, many transgender women seek breast augmentation (Seal, 2016; de Blok et al., 2020). Although breast development itself was not measured, it is interesting to note that one retrospective study found no statistical difference in the rate of augmentation requests between users of different estrogen types (Seal et al., 2012). This suggests that oral estradiol valerate might be no more or less effective than the other estrogens in the study (oral conjugated estrogens and oral ethinylestradiol) in attaining a satisfying amount of breast development. Finally, it has been reported in a large cohort study of transgender women (n = 179) that percent changes in gynoid and android fat, total body fat and total lean body mass were not statistically different between the oral and transdermal estradiol groups if BMI and age were controlled for (Klaver et al., 2018).

    Estrogen replacement, being a necessary therapy for the vast majority of individuals with Turner syndrome, has also been studied in adolescent girls (Gravholt et al., 2017; Klein & Phillips, 2019). Girls treated with low dose oral estradiol (n = 56) were described in one study as having “similar” breast development to the normal Dutch population (Bannink et al., 2009). Other studies of puberty induction therapy have found that patients using low doses of transdermal estradiol gel (n = 21) and low dose intramuscular estradiol cypionate (n = 14) also all achieved breast Tanner stage 4 or 5 at final follow-up (Piippo et al., 2004; Rosenfield et al., 2005). A small randomised controlled trial of hypogonadal girls (n = 12) demonstrated that the response to oral and transdermal estradiol at comparable doses was near identical (Shah et al., 2014). All the girls receiving bioidentical estrogens achieved Tanner stage 3 or greater after 18 months of treatment, irrespective of route of administration. Interestingly, a cross sectional study of breast development in women with differences of sex development (DSD), including those with Turner syndrome, reported that breast satisfaction in the sample group was much lower than in women without a DSD (van de Grift & Kreukels, 2019). Some studies have found that breast development, in addition to breast satisfaction, seems to be poorer in Turner syndrome girls than in normal cisgender girls (Guo et al., 2019). Nevertheless, a recent review concluded that all these different regimens seemed to result in similar feminising outcomes (Klein et al., 2018).

    In summary, current clinical evidence appears to show no difference in objectively measured outcomes between therapy with different routes of administration when the doses have comparable potency. Rather, when taken together, these findings indicate that the extent of breast development and other feminisation is independent of what route of administration is used (excerpts).

    Safety and Tolerability

    In the past, estrogens in general have been associated with a greater overall incidence of adverse cardiovascular and thromboembolic events (Kuhl, 2005). These events can include deep vein thrombosis and myocardial infarction. Such complications of therapy have been attributed to estrogenic activity in the liver which, at sufficient exposure, causes an increased synthesis of liver proteins such as as sex-hormone binding globulin (von Schoultz et al., 1989; Ockrim, Lalani & Abel, 2006). Synthesis rates of lipids and coagulation factors have also been found to change. However, the type and route of administration of estrogen has been shown to modify risk (Olié, Canonico & Scarabin, 2011; Oliver-Williams et al., 2018).

    Synthetic and non-bioidentical estrogens are more resistant to enzymatic metabolism by the liver and have disproportionate estrogenic effects relative to bioidentical estrogens such as estradiol (Kuhl, 2005). Because of this behaviour, they contribute to a much greater synthesis of liver proteins and are associated with a significantly higher risk of venous thromboembolism and other cardiovascular complications (Henriksson & Edhag, 1986; Kuhl, 2005; Lycette et al., 2006). A 2015 retrospective case-control study found that venous thromboembolism was 2 to 5 times more common in young women using combined oral contraceptives containing ethinylestradiol and other synthetic progestins than in non users (Vinogradova, Coupland & Hippisley-Cox, 2015). In 2019, the same authors published another case-control study; this time investigating women receiving hormone therapy at the menopause (Vinogradova, Coupland & Hippisley-Cox, 2019). A key finding was that low doses of oral estradiol (2 mg/day or less) were associated with a slight but significant increase in the incidence of venous thromboembolism, while low transdermal doses (100 μg/day or less) were not. This has also been reported by the ESTHER case-control and E3N cohort studies (Scarabin, 2014). Therefore, a strong advantage of transdermal estradiol over oral estradiol is that the incidence of venous thromboembolism is lower (Files & Kling, 2020). As with the synthetic estrogens, this difference is thought to be attributable to the disproportionate amount of estrogenic exposure in the liver that occurs with oral administration (Olié, Canonico & Scarabin, 2011). Nevertheless, high dose polyestradiol phosphate (160 to 240 mg/month) administered by intramuscular injection has been associated with significantly increased cardiovascular and thromboembolic morbidity and mortality in at least one large study of prostate cancer patients (Mikkola et al., 2005; Mikkola et al., 2007). While the increased incidence of these adverse events is clearly much lower than with oral estradiol, it is much less clear if it may be entirely eliminated by non-oral routes of administration at higher doses (Sam, 2020).

    It is difficult to accurately determine the incidence of venous thromboembolism in transgender people receiving hormone therapy because of the diverse range of regimens employed in different geographical regions; which may confer different risks (Goldstein et al., 2019). Moreover, although a number of observational and retrospective studies have reported risk as low or relatively insignificant in our community, most are not adequately powered to accurately report risk (Khan et al., 2019). Based on the available evidence, we can probably safely assume that the incidence is low overall with modern regimens (Getahun et al., 2018; Ott et al., 2010; Pyra et al., 2020). It is particularly of note that these complications are, thankfully, mostly confined to people at higher baseline risk such as elderly individuals or those with inherited mutations that predispose to such toxicity (Silverstein et al., 1998; Bezgin et al., 2016). The absolute risk is likely low for most people. Nonetheless, the association between estrogens and adverse cardiovascular and thromboembolic events is of obvious importance. In the future, I intend on posting a more comprehensive evaluation of these complications with different doses and formulations of estrogens.

    Summary and Conclusions

    In conclusion, oral and transdermal estradiol is metabolised differently. Perhaps most significantly, a dose of oral estadiol is predominantly converted by the liver into estrone and other estrogen metabolites before it enters circulation. By contrast, transdermal estradiol bypasses the liver and the conversion of the medication into these weak estrogens is mostly avoided. On average, a transdermal patch that delivers a 50 μg/day dose is thought to have similar estrogenic potency to a 1 to 2 mg/day dose of oral estradiol and to a 1.5 mg/day dose of transdermal gel.

    In spite of these difference, there appears to be no evidence that oral estradiol provides more effective feminisation than transdermal estradiol or vice versa if the doses are similar. Instead, the existing clinical evidence seems to show that the extent of feminising changes such as breast development and fat distribution is independent of the route that estradiol is administered by. Contrariwise, there is a good amount of epidemiological evidence that oral estradiol is associated with a higher incidence of venous thrombosis than is transdermal estradiol at a comparable dose. For this reason, transdermal estradiol at physiological doses is likely safer than oral estradiol in long term gender affirming hormone therapy. I intend to discuss, in more detail, the subject of cardiovascular and thromboembolic toxicity with different doses and types of estrogens in a future review.

    References

    • Bannink, E. M., Van Sassen, C., Van Buuren, S., De Jong, F. H., Lequin, M., Mulder, P. G., & De Muinck Keizer-Schrama, S. M. (2009). Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clinical Endocrinology, 70(2), 265–273. [DOI:10.1111/j.1365-2265.2008.03446.x]
    • Benjamin, H. (1967). Transvestism and Transsexualism in the male and female. Journal of Sex Research, 3(2), 107–127. [DOI:10.1080/00224496709550519]
    • Bezgin, T., Kaymaz, C., Akbal, Ö., Yılmaz, F., Tokgöz, H. C., & Özdemir, N. (2016). Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study. Clinical and Applied Thrombosis/Hemostasis, 24(1), 100–106. [DOI:10.1177/1076029616672585]
    • Bińkowska, M. (2014). Featured paper Menopausal hormone therapy and venous thromboembolism. Przegląd Menopauzalny [Menopausal Review], 13(5), 267–272. [DOI:10.5114/pm.2014.46468]
    • Casper, R. F., & Yen, S. S. (1981). Rapid absorption of micronized estradiol-17β following sublingual administration. Obstetrics and Gynecology, 57(1), 62–64. [Google Scholar] [PubMed] [URL] [PDF]
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de Blok, C. J., Staphorsius, A. S., Wiepjes, C. M., Smit, J. M., Nanayakkara, P. W., & den Heijer, M. (2019). Frequency, Determinants, and Satisfaction of Breast Augmentation in Trans Women Receiving Hormone Treatment. The Journal of Sexual Medicine, 17(2), 342–348. [DOI:10.1016/j.jsxm.2019.10.021]
    • Files, J., & Kling, J. M. (2019). Transdermal delivery of bioidentical estrogen in menopausal hormone therapy: a clinical review. Expert Opinion on Drug Delivery, 17(4), 543–549. [DOI:10.1080/17425247.2020.1700949]
    • Fisher, A. D., & Maggi, M. (2015). Endocrine Treatment of Transsexual Male-to-Female Persons. In Trombetta, C., Liguori, G., & Bertolotto, M. (Eds.). Management of Gender Dysphoria: A Multidisciplinary Approach (pp. 83–91). Milano: Springer Milan. [DOI:10.1007/978-88-470-5696-1_10]
    • Frederiksen, H., Johannsen, T. H., Andersen, S. E., Albrethsen, J., Landersoe, S. K., Petersen, J. H., Andersen, A. N., Vestergaard, E. T., Schorring, M. E., Linneberg, A., Main, K. M., Andersson, A., & Juul, A. (2019). Sex-specific Estrogen Levels and Reference Intervals from Infancy to Late Adulthood Determined by LC-MS/MS. The Journal of Clinical Endocrinology & Metabolism, 105(3), 754–768. [DOI:10.1210/clinem/dgz196]
    • Geffen, S., Horn, T., Smith, K. J., & Cahill, S. (2018). Advocacy for Gender Affirming Care: Learning from the Injectable Estrogen Shortage. Transgender Health, 3(1), 42–44. [DOI:10.1089/trgh.2017.0025]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/m17-2785]
    • Goldstein, Z., Khan, M., Reisman, T., & Safer, J. D. (2019). Managing the risk of venous thromboembolism in transgender adults undergoing hormone therapy. Journal of Blood Medicine, 10, 209–216. [DOI:10.2147/jbm.s166780]
    • Gravholt, C. H., Andersen, N. H., Conway, G. S., Dekkers, O. M., Geffner, M. E., Klein, K. O., Lin, A. E., Mauras, N., Quigley, C. A., Rubin, K., Sandberg, D. E., Sas, T. C., Silberbach, M., Söderström-Anttila, V., Stochholm, K., van Alfen-van derVelden, J. A., Woelfle, J., Backeljauw, P. F., & the International Turner Syndrome Consensus Group. (2017). Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. European Journal of Endocrinology, 177(3), G1–G70. [DOI:10.1530/eje-17-0430]
    • Guo, S., Zhang, J., Li, Y., Ma, H., Chen, Q., Chen, H., & Du, M. (2019). The pubertal development mode of Chinese girls with turner syndrome undergoing hormone replacement therapy. BMC Endocrine Disorders, 19(1), 72. [DOI:10.1186/s12902-019-0403-2]
    • Hamburger, C., & Benjamin, H. (1969). Endocrine Treatment of Male and Female Transsexualism / Appendix for the Practicing Physician: Suggestions and Guidelines for the Management of Transsexuals. In Green, R., & Money, J. (Eds.). Transsexualism and Sex Reassignment (pp. 291–307). Baltimore: John Hopkins University Press. [Google Scholar] [Google Books] [PDF]
    • Hamidi, O., & Davidge-Pitts, C. J. (2019). Transfeminine Hormone Therapy. Endocrinology and Metabolism Clinics of North America, 48(2), 341–355. [DOI:10.1016/j.ecl.2019.02.001]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline [2nd Version]. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Henriksson, P., & Edhag, O. (1986). Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. BMJ, 293(6544), 413–415. [DOI:10.1136/bmj.293.6544.413]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Järvinen, A., Nykänen, S., & Paasiniemi, L. (1999). Absorption and bioavailability of oestradiol from a gel, a patch and a tablet. Maturitas, 32(2), 103–113. [DOI:10.1016/s0378-5122(99)00021-3]
    • Khan, J., Schmidt, R. L., Spittal, M. J., Goldstein, Z., Smock, K. J., & Greene, D. N. (2019). Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. Clinical Chemistry, 65(1), 57–66. [DOI:10.1373/clinchem.2018.288316]
    • Klaver, M., de Blok, C. J., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/eje-17-0496]
    • Klein, K. O., Rosenfield, R. L., Santen, R. J., Gawlik, A. M., Backeljauw, P. F., Gravholt, C. H., Sas, T. C., & Mauras, N. (2018). Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. The Journal of Clinical Endocrinology & Metabolism, 103(5), 1790–1803. [DOI:10.1210/jc.2017-02183]
    • Klein, K. O., & Phillips, S. A. (2019). Review of Hormone Replacement Therapy in Girls and Adolescents with Hypogonadism. Journal of Pediatric and Adolescent Gynecology, 32(5), 460–468. [DOI:10.1016/j.jpag.2019.04.010]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhnz, W., Blode, H., & Zimmermann, H. (1993). Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 261–322). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_15]
    • Kuhnz, W., Gansau, C., & Mahler, M. (1993). Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43(9), 966–973. [Google Scholar] [PubMed] [PDF]
    • Mauras, N., Torres-Santiago, L., Santen, R., Mericq, V., Ross, J., Colon-Otero, G., Damaso, L., Hossain, J., Wang, Q., Mesaros, C., & Blair, I. A. (2018). Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome. Clinical Endocrinology, 90(1), 155–161. [DOI:10.1111/cen.13869]
    • Meyer, W. J., Walker, P. A., & Suplee, Z. R. (1981). A survey of transsexual hormonal treatment in twenty gender‐treatment centers. The Journal of Sex Research, 17(4), 344–349. [DOI:10.1080/00224498109551125]
    • Meyer, W. J., Webb, A., Stuart, C. A., Finkelstein, J. W., Lawrence, B., & Walker, P. A. (1986). Physical and hormonal evaluation of transsexual patients: A longitudinal study. Archives of Sexual Behavior, 15(2), 121–138. [DOI:10.1007/bf01542220]
    • Mikkola, A., Aro, J., Rannikko, S., Oksanen, H., Ruutu, M., & (2005). Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate. Scandinavian Journal of Urology and Nephrology, 39(4), 294–300. [DOI:10.1080/00365590510031228]
    • Mikkola, A., Aro, J., Rannikko, S., Ruutu, M., & (2007). Ten-year survival and cardiovascular mortality in patients with advanced prostate cancer primarily treated by intramuscular polyestradiol phosphate or orchiectomy. The Prostate, 67(4), 447–455. [DOI:10.1002/pros.20547]
    • Ockrim, J., Lalani, E., & Abel, P. (2006). Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature Clinical Practice Oncology, 3(10), 552–563. [DOI:10.1038/ncponc0602]
    • Olié, V., Canonico, M., & Scarabin, P. (2011). Postmenopausal hormone therapy and venous thromboembolism. Thrombosis Research, 127, S26–S29. [DOI:10.1016/s0049-3848(11)70008-1]
    • Oliver-Williams, C., Glisic, M., Shahzad, S., Brown, E., Pellegrino Baena, C., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2018). The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update, 25(2), 257–271. [DOI:10.1093/humupd/dmy039]
    • Ott, J., Kaufmann, U., Bentz, E., Huber, J. C., & Tempfer, C. B. (2010). Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertility and Sterility, 93(4), 1267–1272. [DOI:10.1016/j.fertnstert.2008.12.017]
    • Piippo, S., Lenko, H., Kainulainen, P., & Sipilä, I. (2004). Use of Percutaneous Estrogen Gel for Induction of Puberty in Girls with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism, 89(7), 3241–3247. [DOI:10.1210/jc.2003-032069]
    • Pyra, M., Casimiro, I., Rusie, L., Ross, N., Blum, C., Keglovitz Baker, K., Baker, A., & Schneider, J. (2020). An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy. Transgender Health, 5(1), 1–9. [DOI:10.1089/trgh.2019.0061]
    • Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A Review of Breast Development in Cisgender Women and Implications for Transgender Women. Endocrine Practice, 25(12), 1338–1345. [DOI:10.4158/ep-2019-0183]
    • Rohr, U. D., Volko, C. D., & Schindler, A. E. (2014). Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women. Hormone Molecular Biology and Clinical Investigation, 18(3), 123–126. [DOI:10.1515/hmbci-2013-0047]
    • Rosenfield, R. L., Devine, N., Hunold, J. J., Mauras, N., Moshang, T., & Root, A. W. (2005). Salutary Effects of Combining Early Very Low-Dose Systemic Estradiol with Growth Hormone Therapy in Girls with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6424–6430. [DOI:10.1210/jc.2005-1081]
    • Scarabin, P. (2014). Hormone Therapy and Venous Thromboembolism among Postmenopausal Women. Frontiers of Hormone Research, 43, 21–32. / Granata, R., & Isgaard, J. (Eds.). Cardiovascular Issues in Endocrinology (Frontiers of Hormone Research, Volume 43) (pp. 21–32). Basel: Karger. [DOI:10.1159/000360554] [Google Books]
    • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422–4428. [DOI:10.1210/jc.2012-2030]
    • Seal, L. J. (2015). A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria. Annals of Clinical Biochemistry, 53(1), 10–20. [DOI:10.1177/0004563215587763]
    • Seal, L. J. (2019). Cardiovascular disease in transgendered people: A review of the literature and discussion of risk. JRSM Cardiovascular Disease, 8, 204800401988074. [DOI:10.1177/2048004019880745]
    • Shah, S., Forghani, N., Durham, E., & Neely, E. K. (2014). A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. International Journal of Pediatric Endocrinology, 2014(1), 12. [DOI:10.1186/1687-9856-2014-12]
    • Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (1998). Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine, 158(6), 585–593. [DOI:10.1001/archinte.158.6.585]
    • van de Grift, T. C., Kreukels, B. P., & (2019). Breast development and satisfaction in women with disorders/differences of sex development. Human Reproduction, 34(12), 2410–2417. [DOI:10.1093/humrep/dez230]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2015). Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 350, h2135. [DOI:10.1136/bmj.h2135]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. [DOI:10.1136/bmj.k4810]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    • Wren, B. G., Day, R. O., McLachlan, A. J., & Williams, K. M. (2003). Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women. Climacteric, 6(2), 104–111. [DOI:10.1080/cmt.6.2.104.111]
    \ No newline at end of file diff --git a/transfemscience.org/articles/pep-cardiovascular-analysis/index.html b/transfemscience.org/articles/pep-cardiovascular-analysis/index.html index ded5bdbd..818618d6 100644 --- a/transfemscience.org/articles/pep-cardiovascular-analysis/index.html +++ b/transfemscience.org/articles/pep-cardiovascular-analysis/index.html @@ -1 +1 @@ -Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer - Transfeminine Science Link

    Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer

    By Sam | First published April 6, 2020 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    In the late 1980s, there was a renewed interest in the Nordic countries for estrogen therapy as a treatment for prostate cancer. The reason for this was that, in small pilot studies, high doses of polyestradiol phosphate (PEP) administered parenterally did not seem to result in a greater incidence of cardiovascular complications (Henriksson et al., 1988; Stege et al., 1989; Carlström et al., 1989; Henriksson et al., 1999). This finding was in direct contrast to earlier studies that had reported significantly greater incidences of cardiovascular morbidity and mortality in elderly male prostate cancer patients treated with oral ethinylestradiol (EE) and diethylstilbestrol (DES) (Bailar & Byar, 1972; Henriksson & Edhag, 1986).

    At sufficient exposure, systemic estrogenic activity has been associated with a greater synthesis of liver proteins, lipids and coagulation factors such as sex-hormone binding globulin (SHBG) and triglycerides (Ottosson et al., 1986). In turn, many of these unphysiologic homeostatic changes are correlated with increased cardiovascular and thromboembolic toxicity (Scarabin, 2014; Seal, 2019; Khan et al., 2019). In addition to pure estrogens, raloxifene usage also has been shown to confer increased risk of venous thromboembolism (Vinogradova, Coupland & Hippisley-Cox, 2019). This is of significance as it was also found in the pilot studies that, while high dose EE therapy greatly increased the synthesis of SHBG and coagulation factor VIII, the effect was significantly less marked with parenteral PEP (Stege et al., 1988; Henriksson et al., 1990). However, both have been shown to induce a significant decrease in antithrombin III; a liver protein that prevents the formation of abnormal blood clots (Aro et al., 1990). By contrast, LHRH agonists do not appear to alter the production of this protein (Varenhorst et al., 1986). These differences were attributed to the disproportionate estrogenic exposure that occurs within the liver relative to other tissues via the oral route (von Schoultz et al., 1989; Ockrim, Lalani & Abel, 2006). Moreover, synthetic estrogens such as EE are resistant to enzymatic liver metabolism due to their augmented or non steroidal chemical structures and cause further disproportionate hepatic receptor activation (Kuhl, 2005). For this reason, intramuscular therapy with PEP; a prodrug for estradiol, was predicted to have much lesser cardiovascular and thromboembolic toxicity than with conventional estrogen therapy (Hedlund, 1999).

    During the 1990s and 2000s, several multicenter clinical trials were conducted to establish the efficacy and safety of high dose parenteral estradiol therapy; as compared to bilateral orchiectomy or LHRH agonists (Lycette et al., 2006). The results of these clinical trials are of obvious importance to gender affirming hormone therapy as transgender women usually require long term use of estrogen formulations and a good number choose parenteral forms. It may not be possible to extrapolate these findings to all doses and types of estrogen esters. Nonetheless, these clinical trials give us some idea of the cardiovascular and thromboembolic toxicity of parenteral estradiol. For reference, a 160 to 240 mg/month dose of PEP has been found to produce estradiol levels of between approximately 300 to 500 pg/mL at steady state (Graph). It is obvious from findings that parenteral PEP is associated with a much lesser incidence of adverse cardiovascular and thromboembolic events than was oral EE (Mikkola et al., 1998; Hedlund & Henriksson, 2000; Hedlund et al., 2002). However, it is much less clear if toxicity is eliminated completely. In most of these studies there was inadequate sample power to show if the incidence was changed significantly (Bishop et al., 1989; Lukkarinen & Kontturi, 1994). Nevertheless, one of the largest studies did conclude that parenteral PEP ought not to be used as primary therapy for prostate cancer because of a significant increase in the incidence of such complications (Mikkola et al., 2005; Mikkola et al., 2007). The results of this clinical trial are probably one factor in why the use of high dose estrogen therapy in the treatment of prostate cancer diminished thereafter in many countries.

    I thought it would be interesting to bring together all of the data in a pooled meta-analysis. In total, there were six different clinical trials evaluating polyestradiol phosphate. I noted the number of cardiovascular and thromboembolic events in each study for the treatment group exposed to high dose parenteral estradiol and for the comparison group (which had no exposure to estrogens). Unfortunately, one of these clinical trials (FinnProstate-4) did not differentiate between which complications were cardiovascular and which were thromboembolic and so it was not possible to include. There was patient follow-up for a total of 1,890 patients. From this information, I was able to calculate the odds of cardiovascular and thromboembolic complications in patients exposed to therapy for each individual study and for the overall sample. In addition, I calculated a 95% confidence interval. I may turn these findings into part of a more comprehensive article in the future. For now, I have presented them here in the form of some (hopefully useful) infographics (Sources for reference values in Fig. 4 were Vinogradova, Coupland & Hippisley-Cox, 2019 and Langley et al., 2013).

    The sources for each study can be found here.

    Pooling together the findings of six randomised controlled trials reveals that parenteral estrogen therapy is associated with an increased incidence of cardiovascular and thromboembolic complications; both separately and combined. Nevertheless, due to poor study precision, the exact risk with high doses of parenteral estrogens remains to be accurately quantified.

    Figure 1: Odds of CVD with parenteral PEP vs. orchiectomy or LHRH agonist (p = 0.0017; significant at p<0.01).
    Figure 2: Odds of VTE with parenteral PEP vs. orchiectomy or LHRH agonist (p = 0.052; significant at p<0.10).
    Figure 3: Combined odds of VTE and CVD with parenteral PEP vs. orchiectomy or LHRH agonist (p = 0.0003).
    Figure 4: Odds of VTE with parenteral PEP compared to other formulations and doses.

    References

    • Aro, J. L., Haapiainen, R. K., Rannikko, S. A., & Alfthan, O. S. (1989). High Dose Polyoestradiol Phosphate with and without Acetosalicylic Acid versus Orchiectomy in the Treatment of Prostatic Cancer. British Journal of Urology, 63(5), 512–514. [DOI:10.1111/j.1464-410x.1989.tb05946.x]
    • Aro, J., Haapiainen, R., Rasi, V., Rannikko, S., & Alfthan, O. (1990). The Effect of Parenteral Estrogen versus Orchiectomy on Blood Coagulation and Fibrinolysis in Prostatic Cancer Patients. European Urology, 17(2), 161–165. [DOI:10.1159/000464026]
    • Aro, J., Ruutu, M., Juusela, H., Hansson, E., & Permi, J. (1993). Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group. Annales Chirurgiae et Gynaecologiae, 82(Supplementum 206), 5–8. [Google Scholar] [PubMed] [PDF]
    • Bailar, J. C., Byar, D. P., & (1970). Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer, 26(2), 257–261. [DOI:10.1002/1097-0142(197008)26:2<257::aid-cncr2820260203>3.0.co;2-9]
    • Bishop, M. C., Lemberger, R. J., Selby, C., & Lawrence, W. T. (1989). Oestrogen Dosage in Prostatic Cancer: the Threshold Effect? British Journal of Urology, 64(3), 290–296. [DOI:10.1111/j.1464-410x.1989.tb06016.x]
    • Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., Stege, R., & von Schoultz, B. (1989). A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy. The Prostate, 14(2), 177–182. [DOI:10.1002/pros.2990140210]
    • Haapiainen, R., Rannikko, S., & Alfthan, O. (1990). Comparison of Primary Orchiectomy and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Cancer. British Journal of Urology, 66(1), 94–97. [DOI:10.1111/j.1464-410x.1990.tb14872.x]
    • Hedlund, P. O. (1999). The Scandinavian Prostatic Cancer Group: A Short Review of its History and Work. Scandinavian Journal of Urology and Nephrology, 33(203), 53–56. [DOI:10.1080/003655999750016285-2]
    • Hedlund, P. O., & Henriksson, P. (2000). Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. Urology, 55(3), 328–332. [DOI:10.1016/s0090-4295(99)00580-4]
    • Hedlund, P. O., Ala-Opas, M., Brekkan, E., Damber, J. E., Damber, L., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Pousette, Å., Rasmussen, F., Salo, J., Vaage, S., & Varenhorst, E. (2002). Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology, 36(6), 405–413. [DOI:10.1080/003655902762467549]
    • Hedlund, P. O., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., Olov Hedlund, P., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., , & (2008). Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology, 42(3), 220–229. [DOI:10.1080/00365590801943274]
    • Hedlund, P. O., Johansson, R., Damber, J. E., Hagerman, I., Henriksson, P., Iversen, P., Klarskov, P., Mogensen, P., Rasmussen, F., & Varenhorst, E. (2011). Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial. Scandinavian Journal of Urology and Nephrology, 45(5), 346–353. [DOI:10.3109/00365599.2011.585820]
    • Henriksson, P., & Edhag, O. (1986). Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. BMJ, 293(6544), 413–415. [DOI:10.1136/bmj.293.6544.413]
    • Henriksson, P., Eriksson, A., Stege, R., Collste, L., Pousette, Å., Von Schoultz, B., & Carlström, K. (1988). Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate. The Prostate, 13(3), 257–261. [DOI:10.1002/pros.2990130308]
    • Henriksson, P., Blombäck, M., Eriksson, A., Stege, R., & Carlström, K. (1990). Effect of Parenteral Oestrogen on the Coagulation System in Patients with Prostatic Carcinoma. British Journal of Urology, 65(3), 282–285. [DOI:10.1111/j.1464-410x.1990.tb14728.x]
    • Henriksson, P., Carlström, K., Pousette, A., Gunnarsson, P. O., Johansson, C. J., Eriksson, B., Altersgård-Brorsson, A. K., Nordle, O., & Stege, R. (1999). Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen. The Prostate, 40(2), 76–82. [DOI:10.1002/(SICI)1097-0045(19990701)40:2<76::AID-PROS2>3.0.CO;2-Q]
    • Jacobi, G. H., Altwein, J. E., Kurth, K. H., Basting, R., & Hohenfellner, R. (1980). Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial. British Journal of Urology, 52(3), 208–215. [DOI:10.1111/j.1464-410x.1980.tb02961.x]
    • Jacobi, G. H., Tunn, U., & Senge, T. (1982). Clinical experience with cyproterone acetate for palliation of inoperable prostate cancer. In Jacobi, G. H., & Hohenfellner, R. (Eds.). Prostate Cancer (International Perspectives in Urology, Volume 3) (pp. 305–319). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Khan, J., Schmidt, R. L., Spittal, M. J., Goldstein, Z., Smock, K. J., & Greene, D. N. (2019). Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. Clinical Chemistry, 65(1), 57–66. [DOI:10.1373/clinchem.2018.288316]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Langley, R. E., Cafferty, F. H., Alhasso, A. A., Rosen, S. D., Sundaram, S. K., Freeman, S. C., Pollock, P., Jinks, R. C., Godsland, I. F., Kockelbergh, R., Clarke, N. W., Kynaston, H. G., Parmar, M. K., & Abel, P. D. (2013). Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09). The Lancet Oncology, 14(4), 306–316. [DOI:10.1016/s1470-2045(13)70025-1]
    • Lukkarinen, O., Kontturi, M., & (1994). Comparison of a Long-Acting LHRH Agonist and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Carcinoma. Scandinavian Journal of Urology and Nephrology, 28(2), 171–178. [DOI:10.3109/00365599409180495]
    • Lycette, J. L., Bland, L. B., Garzotto, M., & Beer, T. M. (2006). Parenteral Estrogens for Prostate Cancer: Can a New Route of Administration Overcome Old Toxicities? Clinical Genitourinary Cancer, 5(3), 198–205. [DOI:10.3816/cgc.2006.n.037]
    • Mikkola, A. K., Ruutu, M. L., Aro, J. L., Rannikko, S. A., Salo, J. O., & the Finnprostate Group. (1998). Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. BJU International, 82(1), 63–68. [DOI:10.1046/j.1464-410x.1998.00688.x]
    • Mikkola, A., Aro, J., Rannikko, S., Oksanen, H., Ruutu, M., & (2005). Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate. Scandinavian Journal of Urology and Nephrology, 39(4), 294–300. [DOI:10.1080/00365590510031228]
    • Mikkola, A., Aro, J., Rannikko, S., Ruutu, M., & (2007). Ten-year survival and cardiovascular mortality in patients with advanced prostate cancer primarily treated by intramuscular polyestradiol phosphate or orchiectomy. The Prostate, 67(4), 447–455. [DOI:10.1002/pros.20547]
    • Namer, M. (1988). Clinical applications of antiandrogens. Journal of Steroid Biochemistry, 31(4), 719–729. [DOI:10.1016/0022-4731(88)90023-4]
    • Ockrim, J., Lalani, E., & Abel, P. (2006). Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature Clinical Practice Oncology, 3(10), 552–563. [DOI:10.1038/ncponc0602]
    • Ottosson, U., Carlström, K., Johansson, B., & von Schoultz, B. (1986). Estrogen Induction of Liver Proteins and High-Density Lipoprotein Cholesterol: Comparison between Estradiol Valerate and Ethinyl Estradiol. Gynecologic and Obstetric Investigation, 22(4), 198–205. [DOI:10.1159/000298914]
    • Scarabin, P. (2014). Hormone Therapy and Venous Thromboembolism among Postmenopausal Women. Frontiers of Hormone Research, 43, 21–32. / Granata, R., & Isgaard, J. (Eds.). Cardiovascular Issues in Endocrinology (Frontiers of Hormone Research, Volume 43) (pp. 21–32). Basel: Karger. [DOI:10.1159/000360554] [Google Books]
    • Schröder, F. H., & Radlmaier, A. (2002). Steroidal Antiandrogens. In Jordan, C. V., & Furr, B. J. A. (Eds.). Hormone Therapy in Breast and Prostate Cancer (pp. 325–346). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-152-7_15]
    • Seal, L. J. (2019). Cardiovascular disease in transgendered people: A review of the literature and discussion of risk. JRSM Cardiovascular Disease, 8, 204800401988074. [DOI:10.1177/2048004019880745]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & von Schoultz, B. (1989). Single-drug parenteral estrogen treatment in prostatic cancer: A study of two maintenance-dose regimens. The Prostate, 14(2), 183–188. [DOI:10.1002/pros.2990140211]
    • Tunn, U. W., Radlmaier, A., & Neumann, F. (1988). Antiandrogens in Cancer Treatment. In Stoll, B. A. (Ed.). Endocrine Management of Cancer: Contemporary Therapy (Contemporary Therapy, Volume 2) (pp. 43–56). Basel: Karger. [DOI:10.1159/000415355]
    • Varenhorst, E., Svensson, M., Hjertberg, H., & Malmqvist, E. (1986). Antithrombin III concentration, thrombosis, and treatment with luteinising hormone releasing hormone agonist in prostatic carcinoma. BMJ, 292(6525), 935–936. [DOI:10.1136/bmj.292.6525.935]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. [DOI:10.1136/bmj.k4810]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Wenderoth, U. K., & Jacobi, G. H. (1983). Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate. World Journal of Urology, 1(1), 40–48. [DOI:10.1007/bf00326861]
    \ No newline at end of file +Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer - Transfeminine Science Link

    Analysis of Cardiovascular and Thromboembolic Toxicity with High Dose Parenteral Polyestradiol Phosphate in the Treatment of Prostate Cancer

    By Sam | First published April 6, 2020 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    In the late 1980s, there was a renewed interest in the Nordic countries for estrogen therapy as a treatment for prostate cancer. The reason for this was that, in small pilot studies, high doses of polyestradiol phosphate (PEP) administered parenterally did not seem to result in a greater incidence of cardiovascular complications (Henriksson et al., 1988; Stege et al., 1989; Carlström et al., 1989; Henriksson et al., 1999). This finding was in direct contrast to earlier studies that had reported significantly greater incidences of cardiovascular morbidity and mortality in elderly male prostate cancer patients treated with oral ethinylestradiol (EE) and diethylstilbestrol (DES) (Bailar & Byar, 1972; Henriksson & Edhag, 1986).

    At sufficient exposure, systemic estrogenic activity has been associated with a greater synthesis of liver proteins, lipids and coagulation factors such as sex-hormone binding globulin (SHBG) and triglycerides (Ottosson et al., 1986). In turn, many of these unphysiologic homeostatic changes are correlated with increased cardiovascular and thromboembolic toxicity (Scarabin, 2014; Seal, 2019; Khan et al., 2019). In addition to pure estrogens, raloxifene usage also has been shown to confer increased risk of venous thromboembolism (Vinogradova, Coupland & Hippisley-Cox, 2019). This is of significance as it was also found in the pilot studies that, while high dose EE therapy greatly increased the synthesis of SHBG and coagulation factor VIII, the effect was significantly less marked with parenteral PEP (Stege et al., 1988; Henriksson et al., 1990). However, both have been shown to induce a significant decrease in antithrombin III; a liver protein that prevents the formation of abnormal blood clots (Aro et al., 1990). By contrast, LHRH agonists do not appear to alter the production of this protein (Varenhorst et al., 1986). These differences were attributed to the disproportionate estrogenic exposure that occurs within the liver relative to other tissues via the oral route (von Schoultz et al., 1989; Ockrim, Lalani & Abel, 2006). Moreover, synthetic estrogens such as EE are resistant to enzymatic liver metabolism due to their augmented or non steroidal chemical structures and cause further disproportionate hepatic receptor activation (Kuhl, 2005). For this reason, intramuscular therapy with PEP; a prodrug for estradiol, was predicted to have much lesser cardiovascular and thromboembolic toxicity than with conventional estrogen therapy (Hedlund, 1999).

    During the 1990s and 2000s, several multicenter clinical trials were conducted to establish the efficacy and safety of high dose parenteral estradiol therapy; as compared to bilateral orchiectomy or LHRH agonists (Lycette et al., 2006). The results of these clinical trials are of obvious importance to gender affirming hormone therapy as transgender women usually require long term use of estrogen formulations and a good number choose parenteral forms. It may not be possible to extrapolate these findings to all doses and types of estrogen esters. Nonetheless, these clinical trials give us some idea of the cardiovascular and thromboembolic toxicity of parenteral estradiol. For reference, a 160 to 240 mg/month dose of PEP has been found to produce estradiol levels of between approximately 300 to 500 pg/mL at steady state (Graph). It is obvious from findings that parenteral PEP is associated with a much lesser incidence of adverse cardiovascular and thromboembolic events than was oral EE (Mikkola et al., 1998; Hedlund & Henriksson, 2000; Hedlund et al., 2002). However, it is much less clear if toxicity is eliminated completely. In most of these studies there was inadequate sample power to show if the incidence was changed significantly (Bishop et al., 1989; Lukkarinen & Kontturi, 1994). Nevertheless, one of the largest studies did conclude that parenteral PEP ought not to be used as primary therapy for prostate cancer because of a significant increase in the incidence of such complications (Mikkola et al., 2005; Mikkola et al., 2007). The results of this clinical trial are probably one factor in why the use of high dose estrogen therapy in the treatment of prostate cancer diminished thereafter in many countries.

    I thought it would be interesting to bring together all of the data in a pooled meta-analysis. In total, there were six different clinical trials evaluating polyestradiol phosphate. I noted the number of cardiovascular and thromboembolic events in each study for the treatment group exposed to high dose parenteral estradiol and for the comparison group (which had no exposure to estrogens). Unfortunately, one of these clinical trials (FinnProstate-4) did not differentiate between which complications were cardiovascular and which were thromboembolic and so it was not possible to include. There was patient follow-up for a total of 1,890 patients. From this information, I was able to calculate the odds of cardiovascular and thromboembolic complications in patients exposed to therapy for each individual study and for the overall sample. In addition, I calculated a 95% confidence interval. I may turn these findings into part of a more comprehensive article in the future. For now, I have presented them here in the form of some (hopefully useful) infographics (Sources for reference values in Fig. 4 were Vinogradova, Coupland & Hippisley-Cox, 2019 and Langley et al., 2013).

    The sources for each study can be found here.

    Pooling together the findings of six randomised controlled trials reveals that parenteral estrogen therapy is associated with an increased incidence of cardiovascular and thromboembolic complications; both separately and combined. Nevertheless, due to poor study precision, the exact risk with high doses of parenteral estrogens remains to be accurately quantified.

    Figure 1: Odds of CVD with parenteral PEP vs. orchiectomy or LHRH agonist (p = 0.0017; significant at p<0.01).
    Figure 2: Odds of VTE with parenteral PEP vs. orchiectomy or LHRH agonist (p = 0.052; significant at p<0.10).
    Figure 3: Combined odds of VTE and CVD with parenteral PEP vs. orchiectomy or LHRH agonist (p = 0.0003).
    Figure 4: Odds of VTE with parenteral PEP compared to other formulations and doses.

    References

    • Aro, J. L., Haapiainen, R. K., Rannikko, S. A., & Alfthan, O. S. (1989). High Dose Polyoestradiol Phosphate with and without Acetosalicylic Acid versus Orchiectomy in the Treatment of Prostatic Cancer. British Journal of Urology, 63(5), 512–514. [DOI:10.1111/j.1464-410x.1989.tb05946.x]
    • Aro, J., Haapiainen, R., Rasi, V., Rannikko, S., & Alfthan, O. (1990). The Effect of Parenteral Estrogen versus Orchiectomy on Blood Coagulation and Fibrinolysis in Prostatic Cancer Patients. European Urology, 17(2), 161–165. [DOI:10.1159/000464026]
    • Aro, J., Ruutu, M., Juusela, H., Hansson, E., & Permi, J. (1993). Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group. Annales Chirurgiae et Gynaecologiae, 82(Supplementum 206), 5–8. [Google Scholar] [PubMed] [PDF]
    • Bailar, J. C., Byar, D. P., & (1970). Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer, 26(2), 257–261. [DOI:10.1002/1097-0142(197008)26:2<257::aid-cncr2820260203>3.0.co;2-9]
    • Bishop, M. C., Lemberger, R. J., Selby, C., & Lawrence, W. T. (1989). Oestrogen Dosage in Prostatic Cancer: the Threshold Effect? British Journal of Urology, 64(3), 290–296. [DOI:10.1111/j.1464-410x.1989.tb06016.x]
    • Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., Stege, R., & von Schoultz, B. (1989). A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy. The Prostate, 14(2), 177–182. [DOI:10.1002/pros.2990140210]
    • Haapiainen, R., Rannikko, S., & Alfthan, O. (1990). Comparison of Primary Orchiectomy and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Cancer. British Journal of Urology, 66(1), 94–97. [DOI:10.1111/j.1464-410x.1990.tb14872.x]
    • Hedlund, P. O. (1999). The Scandinavian Prostatic Cancer Group: A Short Review of its History and Work. Scandinavian Journal of Urology and Nephrology, 33(203), 53–56. [DOI:10.1080/003655999750016285-2]
    • Hedlund, P. O., & Henriksson, P. (2000). Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality. Urology, 55(3), 328–332. [DOI:10.1016/s0090-4295(99)00580-4]
    • Hedlund, P. O., Ala-Opas, M., Brekkan, E., Damber, J. E., Damber, L., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Pousette, Å., Rasmussen, F., Salo, J., Vaage, S., & Varenhorst, E. (2002). Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer - Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology, 36(6), 405–413. [DOI:10.1080/003655902762467549]
    • Hedlund, P. O., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., Olov Hedlund, P., Damber, J., Hagerman, I., Haukaas, S., Henriksson, P., Iversen, P., Johansson, R., Klarskov, P., Lundbeck, F., Rasmussen, F., Varenhorst, E., Viitanen, J., , & (2008). Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: Part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian Journal of Urology and Nephrology, 42(3), 220–229. [DOI:10.1080/00365590801943274]
    • Hedlund, P. O., Johansson, R., Damber, J. E., Hagerman, I., Henriksson, P., Iversen, P., Klarskov, P., Mogensen, P., Rasmussen, F., & Varenhorst, E. (2011). Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial. Scandinavian Journal of Urology and Nephrology, 45(5), 346–353. [DOI:10.3109/00365599.2011.585820]
    • Henriksson, P., & Edhag, O. (1986). Orchidectomy versus oestrogen for prostatic cancer: cardiovascular effects. BMJ, 293(6544), 413–415. [DOI:10.1136/bmj.293.6544.413]
    • Henriksson, P., Eriksson, A., Stege, R., Collste, L., Pousette, Å., Von Schoultz, B., & Carlström, K. (1988). Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate. The Prostate, 13(3), 257–261. [DOI:10.1002/pros.2990130308]
    • Henriksson, P., Blombäck, M., Eriksson, A., Stege, R., & Carlström, K. (1990). Effect of Parenteral Oestrogen on the Coagulation System in Patients with Prostatic Carcinoma. British Journal of Urology, 65(3), 282–285. [DOI:10.1111/j.1464-410x.1990.tb14728.x]
    • Henriksson, P., Carlström, K., Pousette, A., Gunnarsson, P. O., Johansson, C. J., Eriksson, B., Altersgård-Brorsson, A. K., Nordle, O., & Stege, R. (1999). Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen. The Prostate, 40(2), 76–82. [DOI:10.1002/(SICI)1097-0045(19990701)40:2<76::AID-PROS2>3.0.CO;2-Q]
    • Jacobi, G. H., Altwein, J. E., Kurth, K. H., Basting, R., & Hohenfellner, R. (1980). Treatment of Advanced Prostatic Cancer with Parenteral Cyproterone Acetate: A Phase III Randomised Trial. British Journal of Urology, 52(3), 208–215. [DOI:10.1111/j.1464-410x.1980.tb02961.x]
    • Jacobi, G. H., Tunn, U., & Senge, T. (1982). Clinical experience with cyproterone acetate for palliation of inoperable prostate cancer. In Jacobi, G. H., & Hohenfellner, R. (Eds.). Prostate Cancer (International Perspectives in Urology, Volume 3) (pp. 305–319). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Khan, J., Schmidt, R. L., Spittal, M. J., Goldstein, Z., Smock, K. J., & Greene, D. N. (2019). Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis. Clinical Chemistry, 65(1), 57–66. [DOI:10.1373/clinchem.2018.288316]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Langley, R. E., Cafferty, F. H., Alhasso, A. A., Rosen, S. D., Sundaram, S. K., Freeman, S. C., Pollock, P., Jinks, R. C., Godsland, I. F., Kockelbergh, R., Clarke, N. W., Kynaston, H. G., Parmar, M. K., & Abel, P. D. (2013). Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09). The Lancet Oncology, 14(4), 306–316. [DOI:10.1016/s1470-2045(13)70025-1]
    • Lukkarinen, O., Kontturi, M., & (1994). Comparison of a Long-Acting LHRH Agonist and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Carcinoma. Scandinavian Journal of Urology and Nephrology, 28(2), 171–178. [DOI:10.3109/00365599409180495]
    • Lycette, J. L., Bland, L. B., Garzotto, M., & Beer, T. M. (2006). Parenteral Estrogens for Prostate Cancer: Can a New Route of Administration Overcome Old Toxicities? Clinical Genitourinary Cancer, 5(3), 198–205. [DOI:10.3816/cgc.2006.n.037]
    • Mikkola, A. K., Ruutu, M. L., Aro, J. L., Rannikko, S. A., Salo, J. O., & the Finnprostate Group. (1998). Parenteral polyoestradiol phosphate vs orchidectomy in the treatment of advanced prostatic cancer. Efficacy and cardiovascular complications: a 2-year follow-up report of a national, prospective prostatic cancer study. BJU International, 82(1), 63–68. [DOI:10.1046/j.1464-410x.1998.00688.x]
    • Mikkola, A., Aro, J., Rannikko, S., Oksanen, H., Ruutu, M., & (2005). Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate. Scandinavian Journal of Urology and Nephrology, 39(4), 294–300. [DOI:10.1080/00365590510031228]
    • Mikkola, A., Aro, J., Rannikko, S., Ruutu, M., & (2007). Ten-year survival and cardiovascular mortality in patients with advanced prostate cancer primarily treated by intramuscular polyestradiol phosphate or orchiectomy. The Prostate, 67(4), 447–455. [DOI:10.1002/pros.20547]
    • Namer, M. (1988). Clinical applications of antiandrogens. Journal of Steroid Biochemistry, 31(4), 719–729. [DOI:10.1016/0022-4731(88)90023-4]
    • Ockrim, J., Lalani, E., & Abel, P. (2006). Therapy Insight: parenteral estrogen treatment for prostate cancer—a new dawn for an old therapy. Nature Clinical Practice Oncology, 3(10), 552–563. [DOI:10.1038/ncponc0602]
    • Ottosson, U., Carlström, K., Johansson, B., & von Schoultz, B. (1986). Estrogen Induction of Liver Proteins and High-Density Lipoprotein Cholesterol: Comparison between Estradiol Valerate and Ethinyl Estradiol. Gynecologic and Obstetric Investigation, 22(4), 198–205. [DOI:10.1159/000298914]
    • Scarabin, P. (2014). Hormone Therapy and Venous Thromboembolism among Postmenopausal Women. Frontiers of Hormone Research, 43, 21–32. / Granata, R., & Isgaard, J. (Eds.). Cardiovascular Issues in Endocrinology (Frontiers of Hormone Research, Volume 43) (pp. 21–32). Basel: Karger. [DOI:10.1159/000360554] [Google Books]
    • Schröder, F. H., & Radlmaier, A. (2002). Steroidal Antiandrogens. In Jordan, C. V., & Furr, B. J. A. (Eds.). Hormone Therapy in Breast and Prostate Cancer (pp. 325–346). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-152-7_15]
    • Seal, L. J. (2019). Cardiovascular disease in transgendered people: A review of the literature and discussion of risk. JRSM Cardiovascular Disease, 8, 204800401988074. [DOI:10.1177/2048004019880745]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & von Schoultz, B. (1989). Single-drug parenteral estrogen treatment in prostatic cancer: A study of two maintenance-dose regimens. The Prostate, 14(2), 183–188. [DOI:10.1002/pros.2990140211]
    • Tunn, U. W., Radlmaier, A., & Neumann, F. (1988). Antiandrogens in Cancer Treatment. In Stoll, B. A. (Ed.). Endocrine Management of Cancer: Contemporary Therapy (Contemporary Therapy, Volume 2) (pp. 43–56). Basel: Karger. [DOI:10.1159/000415355]
    • Varenhorst, E., Svensson, M., Hjertberg, H., & Malmqvist, E. (1986). Antithrombin III concentration, thrombosis, and treatment with luteinising hormone releasing hormone agonist in prostatic carcinoma. BMJ, 292(6525), 935–936. [DOI:10.1136/bmj.292.6525.935]
    • Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ, 364, k4810. [DOI:10.1136/bmj.k4810]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Wenderoth, U. K., & Jacobi, G. H. (1983). Gonadotropin-releasing hormone analogues for palliation of carcinoma of the prostate. World Journal of Urology, 1(1), 40–48. [DOI:10.1007/bf00326861]
    \ No newline at end of file diff --git a/transfemscience.org/articles/progestogens-breast-cancer/index.html b/transfemscience.org/articles/progestogens-breast-cancer/index.html index 0e9d0fb7..3643d10e 100644 --- a/transfemscience.org/articles/progestogens-breast-cancer/index.html +++ b/transfemscience.org/articles/progestogens-breast-cancer/index.html @@ -1 +1 @@ -Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk - Transfeminine Science Link

    Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk

    By Sam | First published February 14, 2020 | Last modified October 5, 2020

    Introduction

    Breast cancer is the most common invasive cancer in women. The worldwide incidence in this group is about 1 in 8 (Balasubramanian et al., 2019; McGuire et al., 2015). There are likely many genetic, hormonal and lifestyle factors that influence risk. For instance, breast cancer is strongly associated with age. Indeed, only 7% of breast cancer cases have been found to be in women under 40 years old (Anders et al., 2009).

    Sex steroids have profound influences on the breast. Mammary gland development begins during embryogenesis and marked differentiation takes place in the adult female at puberty and during pregnancy as a consequence of such influences (Javed et al., 2013; Sun et al., 2018; Leitch et al., 2018). Estrogens such as estradiol, in tandem with growth factors, promote morphological breast development at puberty while androgens inhibit (Hynes et al., 2010; Dimitrakakis et al., 2009). Moreover, estradiol and progesterone act synergistically to induce lobuloalveolar development in preparation for lactation. Owing to the effect of sex steroids, there is a positive relationship between breast development and breast cancer (Folkerd et al., 2013; Rezvanpour et al., 2016). In accordance, it is well established in large epidemiological studies that use of estrogen medications are strongly associated with an increased risk of breast cancer relative to non-use (Kotsopoulos, 2019). Women with larger breasts and hence more breast tissue are also apparently at a greater risk for breast cancer (Jansen et al., 2014).

    Some patients and clinicians believe that progesterone may have benefits to breast development or otherwise. However, the use of progesterone in transfeminine hormone therapy for these hypothetical benefits is controversial and not evidence-based (Hembree et al., 2017; Wierckx et al., 2014; Randolph, 2018). It is sometimes argued that because these benefits are unsupported and usage is associated with an increased risk of cancer, progestogens (and specifically progesterone) ought not to be indicated for therapy in transgender women (Coxon et al., 2018). I decided to evaluate the strength of this claim in a short literature review.

    Predictive Endocrine Markers of Breast Cancer

    Oophorectomy (removal of the ovaries) can be used both as effective active treatment and prophylaxis against breast cancer (Singh, 2012; Moscucci et al., 2007). A large meta-analysis of over 100 epidemiological studies determined that both younger age at menarche and older age at menopause were associated with a greater risk of breast cancer (CGHFBC, 2012). While it is not clear how much this risk is attributable to estrogens vs progestogens, these findings are definitive evidence that breast cancer risk is linked to and enhanced by exposure to ovarian steroids.

    High mammographic density is thought to be an important risk factor for breast cancer (Boyd et al., 2011; McCormack et al., 2006). Owing to this, it is interesting to note that use of hormone replacement therapy at the menopause is associated with both higher breast density and a higher incidence of breast cancer (Azam et al., 2018; CGHFBC, 2019). However, evidence suggesting association between sex hormones and breast cancer is conflicting. One study found no association between levels of free or total estradiol and breast density, but a positive association between levels of progesterone. (Sprague et al., 2010). Contrariwise, other studies reported no association between estradiol and progesterone and a negative association between estradiol and breast density, respectively (Jung et al., 2015; Tamimi et al., 2005). A review reported that in therapy with estrogens plus oral progesterone, breast density was increased significantly in three studies but unchanged in two other studies (Mirkin, 2018). Even though mammographic density is an important marker of breast cancer, the effects of sex steroids on this variable appear to be highly inconsistent between different studies. There may not be much to be learned from these findings.

    Epidemiological Data

    The risk of breast cancer with different estrogen and progestogen medications in menopausal hormone therapy has also been directly assessed by high-quality meta-analysis and with large sample sizes in the E3N/E3N-EPIC studies (CGHFBC, 2019; Fournier et al., 2014). In these trials, women using estradiol in combination with the synthetic progestins such as medroxyprogesterone acetate and chlormadinone acetate, have been found to have significantly greater rates of breast cancer relative to estradiol alone (Fournier et al., 2008; Lambrinoudaki, 2014). Conversely, in these large observational studies, the use of estradiol in combination with oral micronised progesterone has not been associated with a higher risk of breast cancer in the short term.

    On the basis of these findings, it has been claimed that micronized progesterone differs from synthetic progestins in that it is not associated with a higher risk of developing breast cancer (Regidor, 2014; Yang et al., 2016; Rymer et al., 2019). But this does not appear to be the case. In the E3N-EPIC cohort, the relative risks (RR) [95% confidence interval (CI)] of breast cancer with transdermal estrogens and oral micronised progesterone were 0.9 [0.6–1.4], 0.7 [0.4–1.2] and 1.2 [0.7–2.0] at less than 2 years, between 2 to 4 years and at over 4 years of use, respectively (Mirkin, 2018). However, in contrast to these short-term findings, long-term observational studies have consistently found the use of micronized oral progesterone to be associated with higher breast cancer risk. In the same cohort, the relative risks of estrogens plus oral progesterone were reported between 4 to 6 years and beyond 6 years as 1.26 [0.87–1.82] and 1.22 [0.89–1.67], respectively (Fournier et al., 2008). At the conclusion of this study, the relative risks for estrogen plus oral progesterone were determined to be 1.13 [0.99–1.29] and 1.31 [1.15–1.48] below 5 years and at and beyond 5 years (Fournier et al., 2014). A recent systematic review concluded, on the basis of these findings, that breast cancer risk is not increased in the short-term by oral progesterone in combination with estrogens, but that long-term exposure has greater risk (Stute et al., 2018). The more recent CGHFBC meta-analysis determined that relative risk for estrogens plus oral progesterone was 0.91 [0.47–1.78] at less 5 years of use (CGHFBC, 2019; Table). Yet, in the long term, after 5 to 14 years of exposure, the risk was increased to 2.05 [1.38–3.06] and hence as high as medroxyprogesterone acetate and other oral progestins (2.07 [1.96–2.19]). There is no adequately powered evidence to demonstrate that estrogens plus micronized progesterone is associated with a lower incidence of breast cancer.

    The notion that micronized progesterone does not increase the risk of breast cancer had been criticised before the long-term follow up of the E3N cohort and CGHFBC meta-analysis (Kuhl et al., 2013). It is important to consider the pharmacology of oral progesterone. Unlike with the synthetic progestins, this route of administration is associated with rapid metabolism and marked inactivation of the active medication into metabolites of progesterone by the gastrointestinal tract (Lobo et al., 2019; Levine et al., 2001). As a result, bioavailability is very low and, in accordance, oral progesterone is considerably less potent than the oral progestins (Davey et al., 2018; Kuhl, 2005). Taking the fact that it is far less potent into consideration, it would seem logical to assume as a default null hypothesis that breast cancer takes longer to appear and may be less common with oral progesterone (Kuhl et al., 2013). It is difficult to rationalise why all these other progestins, in spite of their different structures and biochemistry, would increase the incidence of breast cancer while micronized progesterone would not or have even an opposing effect. Conversely, other parenteral routes of progesterone such as vaginal or rectal administration have considerably higher bioavailability and more potent systematic effects (Kuhl, 2005). These non-oral routes likely have a similar incidence of breast cancer to those of the synthetic progestins.

    In the CGHFBC meta-analysis, it was found that bioidentical estradiol has a similar, if not greater, incidence to conjugated (and therefore non-bioidentical) estrogens (1.78 (1.58–1.99) vs 1.68 [1.57–1.80]) (CGHFBC, 2019). Therefore, the rate of breast cancer with bioidentical estrogen usage is not significantly lower than with non-bioidentical estrogen usage. This is of note because, unlike oral progesterone and its synthetic derivatives, oral estradiol can have similar potency to these conjugated estrogens at practical clinical doses (Kuhl, 2005). One might expect the same to be true of bioidentical and non-identical progestogens at comparable potencies. The ELITE trial reported that there were more cases of breast cancer in a group of women using estradiol and relatively low-dose vaginal progesterone (45 mg/day) versus controls (Hodis et al., 2016). However, as the sample sizes were not large enough, it is not possible to attribute the higher rate of breast cancer to parenteral progesterone (Stute et al., 2018). Higher quality evidence is necessary to confirm, beyond a shadow of a doubt, that parenteral progesterone does in fact have comparable breast cancer risk to oral progestins.

    Breast Cancer in Transgender Women

    There is a positive association between breast cancer risk and a greater volume of breast tissue (Jansen et al., 2014; Eriksson et al., 2012). As transgender women develop breast tissue from hormone therapy, one might expect to find that their breast cancer rate would also increase. Surprisingly, however, the findings of epidemiological studies investigating the rate of breast cancer in transgender women are conflicting. Two large cohort studies (n = 2,307 and n = 1,259, respectively) reported no greater risk relative to cisgender men (Gooren et al., 2013a; Brown et al., 2014). However, another more recent study (n = 2,260) found a rate of breast cancer in transgender women that was between that of cisgender men and cisgender women (de Blok et al., 2019). The reason for this enormous difference in findings is unclear. A recent review found that there were just 20 cases of breast cancer in transgender women reported in the literature and hence almost as many as in transgender men (Hartley et al., 2018). It is of note that another review found only 7 reported cases of prostate cancer in transgender women (Gooren et al., 2013b). In accordance, prostate cancer seems to be an exceptionally rare diagnosis. One could argue on this basis, that the occurrence of breast cancer in transgender women is possibly also very rare.

    Nonetheless, we should probably take the available evidence with some scepticism. It is well-known breast cancer takes many years to appear; after many decades of hormone exposure. Data from SEER in 2004 found that the incidences of breast cancer in women at 30, 40 and 50 years of age were only 1 in 1,523, 1 in 173 and 1 in 45, respectively (Anders et al., 2009). Given the secretion of ovarian steroid hormones begins at about 10-years-old in cisgender females, by the age of 50 these women have had about 40 years of exposure. But the follow-up times in these epidemiological studies of transgender women are very short in comparison (typically less than 20 years) and, following a similar timeframe of hormone exposure, breast cancer risk may be higher (Gooren et al., 2013a; Brown et al., 2014). This is particularly relevant because there appears to have been a recent surge in the number of transgender people commencing hormone therapy at a young age (MacGregor et al., 2019; Cartaya et al., 2018). Klinefelter syndrome affects about 1 in 600 men and, usually being accompanied by a state of mild hypoandrogenism and mild hyperestrogenism, these men develop gynecomastia (Høst et al., 2014). It is of note that the breast cancer risk for Klinefelter syndrome males is significantly higher (about 3% absolute risk) that the rest of the male population (Niewoehner et al., 2008). As transgender women effectively achieve a induced state of marked “hypoandrogenism” and “hyperestrogenism” with hormone therapy, their breast cancer risk may theoretically be at least as high, or higher, than these males with Klinefelter syndrome. A recent case report concluded that the risk of breast cancer in transgender women is “acceptably safe in the short term” but that “the safety and potential risks in the longer term are unknown at present” (Sattari, 2015). As the incidence appears to be low, breast cancer may not be an overwhelming concern for transgender women. It is not, at present, possible to be sure.

    Summary and Conclusions

    Based on all available evidence, as with estrogens, progestogen usage appears to be associated with a higher incidence of breast cancer. Longer and more intense exposure may exemplify risk. This is likely the case for both synthetic progestins and bioidentical progesterone (particularly with some parenteral routes). However, more rigorous and adequately powered studies on breast cancer risk with these routes of progesterone administration are necessary to confirm this.

    Because breast cancer in transgender women may not be nearly as common as breast cancer in cisgender women, it could be argued that the increased risk associated with progestogen exposure is of far lesser significance. Contrariwise, it cannot be argued that progesterone has no effect on or reduces the incidence of breast cancer. Given the limited and conflicting evidence for the notion that breast cancer remains very low in transgender women with long-term therapy, it ought not to be dismissed that an increased risk of breast cancer may form the basis of contraindication for progesterone therapy. This may be a particularly important consideration for those with a family history of the disease. Nonetheless, based on the extremely low number of case reports of breast cancer in transgender women, progestogens and progesterone might be well tolerated in this respect; even over long periods of time. There are probably more convincing reasons for us not to add micronised progesterone to our regimens.

    References

    • Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. (2009). Breast Cancer Before Age 40 Years. Seminars in Oncology, 36(3), 237–249. [DOI:10.1053/j.seminoncol.2009.03.001]
    • Azam, S., Lange, T., Huynh, S., Aro, A. R., von Euler-Chelpin, M., Vejborg, I., Tjønneland, A., Lynge, E., & Andersen, Z. J. (2018). Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study. Cancer Causes & Control, 29(6), 495–505. [DOI:10.1007/s10552-018-1033-0]
    • Balasubramanian, R., Rolph, R., Morgan, C., & Hamed, H. (2019). Genetics of breast cancer: management strategies and risk-reducing surgery. British Journal of Hospital Medicine, 80(12), 720–725. [DOI:10.12968/hmed.2019.80.12.720]
    • Boyd, N. F., Martin, L. J., Yaffe, M. J., & Minkin, S. (2011). Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Research, 13(6), 223. [DOI:10.1186/bcr2942]
    • Brown, G. R., & Jones, K. T. (2014). Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Research and Treatment, 149(1), 191–198. [DOI:10.1007/s10549-014-3213-2]
    • Cartaya, J., & Lopez, X. (2018). Gender dysphoria in youth. Current Opinion in Endocrinology & Diabetes and Obesity, 25(1), 44–48. [DOI:10.1097/med.0000000000000378]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncology, 13(11), 1141–1151. [DOI:10.1016/s1470-2045(12)70425-4]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Coxon, J., & Seal, L. (2018). Hormone management of trans women. Trends in Urology & Men’s Health, 9(6), 10–14. [DOI:10.1002/tre.663]
    • Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, 365, l1652. [DOI:10.1136/bmj.l1652]
    • Dimitrakakis, C., & Bondy, C. (2009). Androgens and the breast. Breast Cancer Research, 11(5), 212. [DOI:10.1186/bcr2413]
    • Eriksson, N., Benton, G. M., Do, C. B., Kiefer, A. K., Mountain, J. L., Hinds, D. A., Francke, U., & Tung, J. Y. (2012). Genetic variants associated with breast size also influence breast cancer risk. BMC Medical Genetics, 13(1), 53. [DOI:10.1186/1471-2350-13-53]
    • Folkerd, E., & Dowsett, M. (2013). Sex hormones and breast cancer risk and prognosis. The Breast, 22, S38–S43. [DOI:10.1016/j.breast.2013.07.007]
    • Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103–111. [DOI:10.1007/s10549-007-9523-x]
    • Fournier, A., Mesrine, S., Dossus, L., Boutron-Ruault, M., Clavel-Chapelon, F., & Chabbert-Buffet, N. (2014). Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. Breast Cancer Research and Treatment, 145(2), 535–543. [DOI:10.1007/s10549-014-2934-6]
    • Gooren, L., & Morgentaler, A. (2013). Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia, 46(10), 1156–1160. [DOI:10.1111/and.12208]
    • Gooren, L. J., van Trotsenburg, M. A., Giltay, E. J., & van Diest, P. J. (2013). Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment. The Journal of Sexual Medicine, 10(12), 3129–3134. [DOI:10.1111/jsm.12319]
    • Hartley, R. L., Stone, J. P., & Temple-Oberle, C. (2018). Breast cancer in transgender patients: A systematic review. Part 1: Male to female. European Journal of Surgical Oncology, 44(10), 1455–1462. [DOI:10.1016/j.ejso.2018.06.035]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., Stanczyk, F. Z., Selzer, R. H., & Azen, S. P. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. New England Journal of Medicine, 374(13), 1221–1231. [DOI:10.1056/nejmoa1505241]
    • Høst, C., Skakkebæk, A., Groth, K. A., & Bojesen, A. (2014). The role of hypogonadism in Klinefelter syndrome. Asian Journal of Andrology, 16(2), 185–191. [DOI:10.4103/1008-682X.122201]
    • Hynes, N. E., & Watson, C. J. (2010). Mammary Gland Growth Factors: Roles in Normal Development and in Cancer. Cold Spring Harbor Perspectives in Biology, 2(8), a003186. [DOI:10.1101/cshperspect.a003186]
    • Jansen, L., Backstein, R., & Brown, M. (2014). Breast size and breast cancer: A systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery, 67(12), 1615–1623. [DOI:10.1016/j.bjps.2014.10.001]
    • Jung, S., Stanczyk, F. Z., Egleston, B. L., Snetselaar, L. G., Stevens, V. J., Shepherd, J. A., Van Horn, L., LeBlanc, E. S., Paris, K., Klifa, C., & Dorgan, J. F. (2015). Endogenous Sex Hormones and Breast Density in Young Women. Cancer Epidemiology, Biomarkers & Prevention, 24(2), 369–378. [DOI:10.1158/1055-9965.epi-14-0939]
    • Kotsopoulos, J. (2019). Menopausal hormones: definitive evidence for breast cancer. The Lancet, 394(10204), 1116–1118. [DOI:10.1016/s0140-6736(19)31901-4]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H., & Schneider, H. P. (2013). Progesterone – promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]
    • Lambrinoudaki, I. (2014). Progestogens in postmenopausal hormone therapy and the risk of breast cancer. Maturitas, 77(4), 311–317. [DOI:10.1016/j.maturitas.2014.01.001]
    • Leitch, A. M., & Ashfaq, R. (2018). Discharges and Secretions of the Nipple. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 57–78.e3). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00004-0]
    • Levine, H., & Watson, N. (2000). Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility, 73(3), 516–521. [DOI:10.1016/s0015-0282(99)00553-1]
    • Lobo, R. A., Liu, J., Stanczyk, F. Z., Constantine, G. D., Pickar, J. H., Shadiack, A. M., Bernick, B., & Mirkin, S. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause, 26(7), 720–727. [DOI:10.1097/gme.0000000000001306]
    • Lteif, A., & Javed, A. (2013). Development of the Human Breast. Seminars in Plastic Surgery, 27(1), 5–12. [DOI:10.1055/s-0033-1343989]
    • MacGregor, E. A., & van den Brink, A. M. (2019). Transgender and Migraine. In van den Brink, A. M., & MacGregor, E. A. (Eds.). Gender and Migraine (pp. 113–127). Cham: Springer International Publishing. [DOI:10.1007/978-3-030-02988-3_9]
    • McCormack, V. A., & dos Santos Silva, I. (2006). Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention, 15(6), 1159–1169. [DOI:10.1158/1055-9965.epi-06-0034]
    • McGuire, A., Brown, J. A., Malone, C., McLaughlin, R., & Kerin, M. J. (2015). Effects of age on the detection and management of breast cancer. Cancers, 7(2), 908–929. [DOI:10.3390/cancers7020815]
    • Mirkin, S. (2018). Evidence on the use of progesterone in menopausal hormone therapy. Climacteric, 21(4), 346–354. [DOI:10.1080/13697137.2018.1455657]
    • Moscucci, O., & Clarke, A. (2007). Prophylactic oophorectomy: a historical perspective. Journal of Epidemiology & Community Health, 61(3), 182–184. [DOI:10.1136/jech.2006.046474]
    • Niewoehner, C. B., & Schorer, A. E. (2008). Gynaecomastia and breast cancer in men. BMJ, 336(7646), 709–713. [DOI:10.1136/bmj.39511.493391.be]
    • Randolph, J. F. (2018). Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics & Gynecology, 61(4), 705–721. [DOI:10.1097/grf.0000000000000396]
    • Regidor, P. (2014). Progesterone in Peri- and Postmenopause: A Review. Geburtshilfe und Frauenheilkunde, 74(11), 995–1002. [DOI:10.1055/s-0034-1383297]
    • Rezvanpour, A., & Don-Wauchope, A. C. (2016). Clinical implications of estrone sulfate measurement in laboratory medicine. Critical Reviews in Clinical Laboratory Sciences, 54(2), 73–86. [DOI:10.1080/10408363.2016.1252310]
    • Rymer, J., Brian, K., & Regan, L. (2019). HRT and breast cancer risk. BMJ, 367, l5928. [DOI:10.1136/bmj.l5928]
    • Sattari, M. (2015). Breast Cancer in Male-to-Female Transgender Patients: A Case for Caution. Clinical Breast Cancer, 15(1), e67–e69. [DOI:10.1016/j.clbc.2014.08.004]
    • Singh, G. (2012). Oophorectomy in Breast Cancer—Controversies and Current Status. Indian Journal of Surgery, 74(3), 210–212. [DOI:10.1007/s12262-012-0584-7]
    • Sprague, B. L., Trentham-Dietz, A., Gangnon, R. E., Buist, D. S., Burnside, E. S., Bowles, E. J., Stanczyk, F. Z., & Sisney, G. S. (2010). Circulating Sex Hormones and Mammographic Breast Density among Postmenopausal Women. Hormones and Cancer, 2(1), 62–72. [DOI:10.1007/s12672-010-0056-0]
    • Stute, P., Wildt, L., & Neulen, J. (2018). The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric, 21(2), 111–122. [DOI:10.1080/13697137.2017.1421925]
    • Sun, S. X., Bostanci, Z., Kass, R. B., Mancino, A. T., Rosenbloom, A. L., Klimberg, V. S., & Bland, K. I. (2018). Breast Physiology. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 37–56.e6). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00003-9]
    • Tamimi, R. M., Hankinson, S. E., Colditz, G. A., & Byrne, C. (2005). Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women. Cancer Epidemiology, Biomarkers & Prevention, 14(11), 2641–2647. [DOI:10.1158/1055-9965.epi-05-0558]
    • Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]
    • Yang, Z., Hu, Y., Zhang, J., Xu, L., Zeng, R., & Kang, D. (2016). Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Gynecological Endocrinology, 33(2), 87–92. [DOI:10.1080/09513590.2016.1248932]
    \ No newline at end of file +Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk - Transfeminine Science Link

    Progestogens and Breast Cancer in Transgender Women: A Review and Discussion of Risk

    By Sam | First published February 14, 2020 | Last modified October 5, 2020

    Introduction

    Breast cancer is the most common invasive cancer in women. The worldwide incidence in this group is about 1 in 8 (Balasubramanian et al., 2019; McGuire et al., 2015). There are likely many genetic, hormonal and lifestyle factors that influence risk. For instance, breast cancer is strongly associated with age. Indeed, only 7% of breast cancer cases have been found to be in women under 40 years old (Anders et al., 2009).

    Sex steroids have profound influences on the breast. Mammary gland development begins during embryogenesis and marked differentiation takes place in the adult female at puberty and during pregnancy as a consequence of such influences (Javed et al., 2013; Sun et al., 2018; Leitch et al., 2018). Estrogens such as estradiol, in tandem with growth factors, promote morphological breast development at puberty while androgens inhibit (Hynes et al., 2010; Dimitrakakis et al., 2009). Moreover, estradiol and progesterone act synergistically to induce lobuloalveolar development in preparation for lactation. Owing to the effect of sex steroids, there is a positive relationship between breast development and breast cancer (Folkerd et al., 2013; Rezvanpour et al., 2016). In accordance, it is well established in large epidemiological studies that use of estrogen medications are strongly associated with an increased risk of breast cancer relative to non-use (Kotsopoulos, 2019). Women with larger breasts and hence more breast tissue are also apparently at a greater risk for breast cancer (Jansen et al., 2014).

    Some patients and clinicians believe that progesterone may have benefits to breast development or otherwise. However, the use of progesterone in transfeminine hormone therapy for these hypothetical benefits is controversial and not evidence-based (Hembree et al., 2017; Wierckx et al., 2014; Randolph, 2018). It is sometimes argued that because these benefits are unsupported and usage is associated with an increased risk of cancer, progestogens (and specifically progesterone) ought not to be indicated for therapy in transgender women (Coxon et al., 2018). I decided to evaluate the strength of this claim in a short literature review.

    Predictive Endocrine Markers of Breast Cancer

    Oophorectomy (removal of the ovaries) can be used both as effective active treatment and prophylaxis against breast cancer (Singh, 2012; Moscucci et al., 2007). A large meta-analysis of over 100 epidemiological studies determined that both younger age at menarche and older age at menopause were associated with a greater risk of breast cancer (CGHFBC, 2012). While it is not clear how much this risk is attributable to estrogens vs progestogens, these findings are definitive evidence that breast cancer risk is linked to and enhanced by exposure to ovarian steroids.

    High mammographic density is thought to be an important risk factor for breast cancer (Boyd et al., 2011; McCormack et al., 2006). Owing to this, it is interesting to note that use of hormone replacement therapy at the menopause is associated with both higher breast density and a higher incidence of breast cancer (Azam et al., 2018; CGHFBC, 2019). However, evidence suggesting association between sex hormones and breast cancer is conflicting. One study found no association between levels of free or total estradiol and breast density, but a positive association between levels of progesterone. (Sprague et al., 2010). Contrariwise, other studies reported no association between estradiol and progesterone and a negative association between estradiol and breast density, respectively (Jung et al., 2015; Tamimi et al., 2005). A review reported that in therapy with estrogens plus oral progesterone, breast density was increased significantly in three studies but unchanged in two other studies (Mirkin, 2018). Even though mammographic density is an important marker of breast cancer, the effects of sex steroids on this variable appear to be highly inconsistent between different studies. There may not be much to be learned from these findings.

    Epidemiological Data

    The risk of breast cancer with different estrogen and progestogen medications in menopausal hormone therapy has also been directly assessed by high-quality meta-analysis and with large sample sizes in the E3N/E3N-EPIC studies (CGHFBC, 2019; Fournier et al., 2014). In these trials, women using estradiol in combination with the synthetic progestins such as medroxyprogesterone acetate and chlormadinone acetate, have been found to have significantly greater rates of breast cancer relative to estradiol alone (Fournier et al., 2008; Lambrinoudaki, 2014). Conversely, in these large observational studies, the use of estradiol in combination with oral micronised progesterone has not been associated with a higher risk of breast cancer in the short term.

    On the basis of these findings, it has been claimed that micronized progesterone differs from synthetic progestins in that it is not associated with a higher risk of developing breast cancer (Regidor, 2014; Yang et al., 2016; Rymer et al., 2019). But this does not appear to be the case. In the E3N-EPIC cohort, the relative risks (RR) [95% confidence interval (CI)] of breast cancer with transdermal estrogens and oral micronised progesterone were 0.9 [0.6–1.4], 0.7 [0.4–1.2] and 1.2 [0.7–2.0] at less than 2 years, between 2 to 4 years and at over 4 years of use, respectively (Mirkin, 2018). However, in contrast to these short-term findings, long-term observational studies have consistently found the use of micronized oral progesterone to be associated with higher breast cancer risk. In the same cohort, the relative risks of estrogens plus oral progesterone were reported between 4 to 6 years and beyond 6 years as 1.26 [0.87–1.82] and 1.22 [0.89–1.67], respectively (Fournier et al., 2008). At the conclusion of this study, the relative risks for estrogen plus oral progesterone were determined to be 1.13 [0.99–1.29] and 1.31 [1.15–1.48] below 5 years and at and beyond 5 years (Fournier et al., 2014). A recent systematic review concluded, on the basis of these findings, that breast cancer risk is not increased in the short-term by oral progesterone in combination with estrogens, but that long-term exposure has greater risk (Stute et al., 2018). The more recent CGHFBC meta-analysis determined that relative risk for estrogens plus oral progesterone was 0.91 [0.47–1.78] at less 5 years of use (CGHFBC, 2019; Table). Yet, in the long term, after 5 to 14 years of exposure, the risk was increased to 2.05 [1.38–3.06] and hence as high as medroxyprogesterone acetate and other oral progestins (2.07 [1.96–2.19]). There is no adequately powered evidence to demonstrate that estrogens plus micronized progesterone is associated with a lower incidence of breast cancer.

    The notion that micronized progesterone does not increase the risk of breast cancer had been criticised before the long-term follow up of the E3N cohort and CGHFBC meta-analysis (Kuhl et al., 2013). It is important to consider the pharmacology of oral progesterone. Unlike with the synthetic progestins, this route of administration is associated with rapid metabolism and marked inactivation of the active medication into metabolites of progesterone by the gastrointestinal tract (Lobo et al., 2019; Levine et al., 2001). As a result, bioavailability is very low and, in accordance, oral progesterone is considerably less potent than the oral progestins (Davey et al., 2018; Kuhl, 2005). Taking the fact that it is far less potent into consideration, it would seem logical to assume as a default null hypothesis that breast cancer takes longer to appear and may be less common with oral progesterone (Kuhl et al., 2013). It is difficult to rationalise why all these other progestins, in spite of their different structures and biochemistry, would increase the incidence of breast cancer while micronized progesterone would not or have even an opposing effect. Conversely, other parenteral routes of progesterone such as vaginal or rectal administration have considerably higher bioavailability and more potent systematic effects (Kuhl, 2005). These non-oral routes likely have a similar incidence of breast cancer to those of the synthetic progestins.

    In the CGHFBC meta-analysis, it was found that bioidentical estradiol has a similar, if not greater, incidence to conjugated (and therefore non-bioidentical) estrogens (1.78 (1.58–1.99) vs 1.68 [1.57–1.80]) (CGHFBC, 2019). Therefore, the rate of breast cancer with bioidentical estrogen usage is not significantly lower than with non-bioidentical estrogen usage. This is of note because, unlike oral progesterone and its synthetic derivatives, oral estradiol can have similar potency to these conjugated estrogens at practical clinical doses (Kuhl, 2005). One might expect the same to be true of bioidentical and non-identical progestogens at comparable potencies. The ELITE trial reported that there were more cases of breast cancer in a group of women using estradiol and relatively low-dose vaginal progesterone (45 mg/day) versus controls (Hodis et al., 2016). However, as the sample sizes were not large enough, it is not possible to attribute the higher rate of breast cancer to parenteral progesterone (Stute et al., 2018). Higher quality evidence is necessary to confirm, beyond a shadow of a doubt, that parenteral progesterone does in fact have comparable breast cancer risk to oral progestins.

    Breast Cancer in Transgender Women

    There is a positive association between breast cancer risk and a greater volume of breast tissue (Jansen et al., 2014; Eriksson et al., 2012). As transgender women develop breast tissue from hormone therapy, one might expect to find that their breast cancer rate would also increase. Surprisingly, however, the findings of epidemiological studies investigating the rate of breast cancer in transgender women are conflicting. Two large cohort studies (n = 2,307 and n = 1,259, respectively) reported no greater risk relative to cisgender men (Gooren et al., 2013a; Brown et al., 2014). However, another more recent study (n = 2,260) found a rate of breast cancer in transgender women that was between that of cisgender men and cisgender women (de Blok et al., 2019). The reason for this enormous difference in findings is unclear. A recent review found that there were just 20 cases of breast cancer in transgender women reported in the literature and hence almost as many as in transgender men (Hartley et al., 2018). It is of note that another review found only 7 reported cases of prostate cancer in transgender women (Gooren et al., 2013b). In accordance, prostate cancer seems to be an exceptionally rare diagnosis. One could argue on this basis, that the occurrence of breast cancer in transgender women is possibly also very rare.

    Nonetheless, we should probably take the available evidence with some scepticism. It is well-known breast cancer takes many years to appear; after many decades of hormone exposure. Data from SEER in 2004 found that the incidences of breast cancer in women at 30, 40 and 50 years of age were only 1 in 1,523, 1 in 173 and 1 in 45, respectively (Anders et al., 2009). Given the secretion of ovarian steroid hormones begins at about 10-years-old in cisgender females, by the age of 50 these women have had about 40 years of exposure. But the follow-up times in these epidemiological studies of transgender women are very short in comparison (typically less than 20 years) and, following a similar timeframe of hormone exposure, breast cancer risk may be higher (Gooren et al., 2013a; Brown et al., 2014). This is particularly relevant because there appears to have been a recent surge in the number of transgender people commencing hormone therapy at a young age (MacGregor et al., 2019; Cartaya et al., 2018). Klinefelter syndrome affects about 1 in 600 men and, usually being accompanied by a state of mild hypoandrogenism and mild hyperestrogenism, these men develop gynecomastia (Høst et al., 2014). It is of note that the breast cancer risk for Klinefelter syndrome males is significantly higher (about 3% absolute risk) that the rest of the male population (Niewoehner et al., 2008). As transgender women effectively achieve a induced state of marked “hypoandrogenism” and “hyperestrogenism” with hormone therapy, their breast cancer risk may theoretically be at least as high, or higher, than these males with Klinefelter syndrome. A recent case report concluded that the risk of breast cancer in transgender women is “acceptably safe in the short term” but that “the safety and potential risks in the longer term are unknown at present” (Sattari, 2015). As the incidence appears to be low, breast cancer may not be an overwhelming concern for transgender women. It is not, at present, possible to be sure.

    Summary and Conclusions

    Based on all available evidence, as with estrogens, progestogen usage appears to be associated with a higher incidence of breast cancer. Longer and more intense exposure may exemplify risk. This is likely the case for both synthetic progestins and bioidentical progesterone (particularly with some parenteral routes). However, more rigorous and adequately powered studies on breast cancer risk with these routes of progesterone administration are necessary to confirm this.

    Because breast cancer in transgender women may not be nearly as common as breast cancer in cisgender women, it could be argued that the increased risk associated with progestogen exposure is of far lesser significance. Contrariwise, it cannot be argued that progesterone has no effect on or reduces the incidence of breast cancer. Given the limited and conflicting evidence for the notion that breast cancer remains very low in transgender women with long-term therapy, it ought not to be dismissed that an increased risk of breast cancer may form the basis of contraindication for progesterone therapy. This may be a particularly important consideration for those with a family history of the disease. Nonetheless, based on the extremely low number of case reports of breast cancer in transgender women, progestogens and progesterone might be well tolerated in this respect; even over long periods of time. There are probably more convincing reasons for us not to add micronised progesterone to our regimens.

    References

    • Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. (2009). Breast Cancer Before Age 40 Years. Seminars in Oncology, 36(3), 237–249. [DOI:10.1053/j.seminoncol.2009.03.001]
    • Azam, S., Lange, T., Huynh, S., Aro, A. R., von Euler-Chelpin, M., Vejborg, I., Tjønneland, A., Lynge, E., & Andersen, Z. J. (2018). Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study. Cancer Causes & Control, 29(6), 495–505. [DOI:10.1007/s10552-018-1033-0]
    • Balasubramanian, R., Rolph, R., Morgan, C., & Hamed, H. (2019). Genetics of breast cancer: management strategies and risk-reducing surgery. British Journal of Hospital Medicine, 80(12), 720–725. [DOI:10.12968/hmed.2019.80.12.720]
    • Boyd, N. F., Martin, L. J., Yaffe, M. J., & Minkin, S. (2011). Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Research, 13(6), 223. [DOI:10.1186/bcr2942]
    • Brown, G. R., & Jones, K. T. (2014). Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Research and Treatment, 149(1), 191–198. [DOI:10.1007/s10549-014-3213-2]
    • Cartaya, J., & Lopez, X. (2018). Gender dysphoria in youth. Current Opinion in Endocrinology & Diabetes and Obesity, 25(1), 44–48. [DOI:10.1097/med.0000000000000378]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncology, 13(11), 1141–1151. [DOI:10.1016/s1470-2045(12)70425-4]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Coxon, J., & Seal, L. (2018). Hormone management of trans women. Trends in Urology & Men’s Health, 9(6), 10–14. [DOI:10.1002/tre.663]
    • Davey, D. A. (2018). Menopausal hormone therapy: a better and safer future. Climacteric, 21(5), 454–461. [DOI:10.1080/13697137.2018.1439915]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, 365, l1652. [DOI:10.1136/bmj.l1652]
    • Dimitrakakis, C., & Bondy, C. (2009). Androgens and the breast. Breast Cancer Research, 11(5), 212. [DOI:10.1186/bcr2413]
    • Eriksson, N., Benton, G. M., Do, C. B., Kiefer, A. K., Mountain, J. L., Hinds, D. A., Francke, U., & Tung, J. Y. (2012). Genetic variants associated with breast size also influence breast cancer risk. BMC Medical Genetics, 13(1), 53. [DOI:10.1186/1471-2350-13-53]
    • Folkerd, E., & Dowsett, M. (2013). Sex hormones and breast cancer risk and prognosis. The Breast, 22, S38–S43. [DOI:10.1016/j.breast.2013.07.007]
    • Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103–111. [DOI:10.1007/s10549-007-9523-x]
    • Fournier, A., Mesrine, S., Dossus, L., Boutron-Ruault, M., Clavel-Chapelon, F., & Chabbert-Buffet, N. (2014). Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. Breast Cancer Research and Treatment, 145(2), 535–543. [DOI:10.1007/s10549-014-2934-6]
    • Gooren, L., & Morgentaler, A. (2013). Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens. Andrologia, 46(10), 1156–1160. [DOI:10.1111/and.12208]
    • Gooren, L. J., van Trotsenburg, M. A., Giltay, E. J., & van Diest, P. J. (2013). Breast Cancer Development in Transsexual Subjects Receiving Cross-Sex Hormone Treatment. The Journal of Sexual Medicine, 10(12), 3129–3134. [DOI:10.1111/jsm.12319]
    • Hartley, R. L., Stone, J. P., & Temple-Oberle, C. (2018). Breast cancer in transgender patients: A systematic review. Part 1: Male to female. European Journal of Surgical Oncology, 44(10), 1455–1462. [DOI:10.1016/j.ejso.2018.06.035]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., Stanczyk, F. Z., Selzer, R. H., & Azen, S. P. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol. New England Journal of Medicine, 374(13), 1221–1231. [DOI:10.1056/nejmoa1505241]
    • Høst, C., Skakkebæk, A., Groth, K. A., & Bojesen, A. (2014). The role of hypogonadism in Klinefelter syndrome. Asian Journal of Andrology, 16(2), 185–191. [DOI:10.4103/1008-682X.122201]
    • Hynes, N. E., & Watson, C. J. (2010). Mammary Gland Growth Factors: Roles in Normal Development and in Cancer. Cold Spring Harbor Perspectives in Biology, 2(8), a003186. [DOI:10.1101/cshperspect.a003186]
    • Jansen, L., Backstein, R., & Brown, M. (2014). Breast size and breast cancer: A systematic review. Journal of Plastic, Reconstructive & Aesthetic Surgery, 67(12), 1615–1623. [DOI:10.1016/j.bjps.2014.10.001]
    • Jung, S., Stanczyk, F. Z., Egleston, B. L., Snetselaar, L. G., Stevens, V. J., Shepherd, J. A., Van Horn, L., LeBlanc, E. S., Paris, K., Klifa, C., & Dorgan, J. F. (2015). Endogenous Sex Hormones and Breast Density in Young Women. Cancer Epidemiology, Biomarkers & Prevention, 24(2), 369–378. [DOI:10.1158/1055-9965.epi-14-0939]
    • Kotsopoulos, J. (2019). Menopausal hormones: definitive evidence for breast cancer. The Lancet, 394(10204), 1116–1118. [DOI:10.1016/s0140-6736(19)31901-4]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H., & Schneider, H. P. (2013). Progesterone – promoter or inhibitor of breast cancer. Climacteric, 16(Suppl 1), 54–68. [DOI:10.3109/13697137.2013.768806]
    • Lambrinoudaki, I. (2014). Progestogens in postmenopausal hormone therapy and the risk of breast cancer. Maturitas, 77(4), 311–317. [DOI:10.1016/j.maturitas.2014.01.001]
    • Leitch, A. M., & Ashfaq, R. (2018). Discharges and Secretions of the Nipple. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 57–78.e3). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00004-0]
    • Levine, H., & Watson, N. (2000). Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women. Fertility and Sterility, 73(3), 516–521. [DOI:10.1016/s0015-0282(99)00553-1]
    • Lobo, R. A., Liu, J., Stanczyk, F. Z., Constantine, G. D., Pickar, J. H., Shadiack, A. M., Bernick, B., & Mirkin, S. (2019). Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause, 26(7), 720–727. [DOI:10.1097/gme.0000000000001306]
    • Lteif, A., & Javed, A. (2013). Development of the Human Breast. Seminars in Plastic Surgery, 27(1), 5–12. [DOI:10.1055/s-0033-1343989]
    • MacGregor, E. A., & van den Brink, A. M. (2019). Transgender and Migraine. In van den Brink, A. M., & MacGregor, E. A. (Eds.). Gender and Migraine (pp. 113–127). Cham: Springer International Publishing. [DOI:10.1007/978-3-030-02988-3_9]
    • McCormack, V. A., & dos Santos Silva, I. (2006). Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis. Cancer Epidemiology, Biomarkers & Prevention, 15(6), 1159–1169. [DOI:10.1158/1055-9965.epi-06-0034]
    • McGuire, A., Brown, J. A., Malone, C., McLaughlin, R., & Kerin, M. J. (2015). Effects of age on the detection and management of breast cancer. Cancers, 7(2), 908–929. [DOI:10.3390/cancers7020815]
    • Mirkin, S. (2018). Evidence on the use of progesterone in menopausal hormone therapy. Climacteric, 21(4), 346–354. [DOI:10.1080/13697137.2018.1455657]
    • Moscucci, O., & Clarke, A. (2007). Prophylactic oophorectomy: a historical perspective. Journal of Epidemiology & Community Health, 61(3), 182–184. [DOI:10.1136/jech.2006.046474]
    • Niewoehner, C. B., & Schorer, A. E. (2008). Gynaecomastia and breast cancer in men. BMJ, 336(7646), 709–713. [DOI:10.1136/bmj.39511.493391.be]
    • Randolph, J. F. (2018). Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics & Gynecology, 61(4), 705–721. [DOI:10.1097/grf.0000000000000396]
    • Regidor, P. (2014). Progesterone in Peri- and Postmenopause: A Review. Geburtshilfe und Frauenheilkunde, 74(11), 995–1002. [DOI:10.1055/s-0034-1383297]
    • Rezvanpour, A., & Don-Wauchope, A. C. (2016). Clinical implications of estrone sulfate measurement in laboratory medicine. Critical Reviews in Clinical Laboratory Sciences, 54(2), 73–86. [DOI:10.1080/10408363.2016.1252310]
    • Rymer, J., Brian, K., & Regan, L. (2019). HRT and breast cancer risk. BMJ, 367, l5928. [DOI:10.1136/bmj.l5928]
    • Sattari, M. (2015). Breast Cancer in Male-to-Female Transgender Patients: A Case for Caution. Clinical Breast Cancer, 15(1), e67–e69. [DOI:10.1016/j.clbc.2014.08.004]
    • Singh, G. (2012). Oophorectomy in Breast Cancer—Controversies and Current Status. Indian Journal of Surgery, 74(3), 210–212. [DOI:10.1007/s12262-012-0584-7]
    • Sprague, B. L., Trentham-Dietz, A., Gangnon, R. E., Buist, D. S., Burnside, E. S., Bowles, E. J., Stanczyk, F. Z., & Sisney, G. S. (2010). Circulating Sex Hormones and Mammographic Breast Density among Postmenopausal Women. Hormones and Cancer, 2(1), 62–72. [DOI:10.1007/s12672-010-0056-0]
    • Stute, P., Wildt, L., & Neulen, J. (2018). The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric, 21(2), 111–122. [DOI:10.1080/13697137.2017.1421925]
    • Sun, S. X., Bostanci, Z., Kass, R. B., Mancino, A. T., Rosenbloom, A. L., Klimberg, V. S., & Bland, K. I. (2018). Breast Physiology. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 37–56.e6). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00003-9]
    • Tamimi, R. M., Hankinson, S. E., Colditz, G. A., & Byrne, C. (2005). Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women. Cancer Epidemiology, Biomarkers & Prevention, 14(11), 2641–2647. [DOI:10.1158/1055-9965.epi-05-0558]
    • Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]
    • Yang, Z., Hu, Y., Zhang, J., Xu, L., Zeng, R., & Kang, D. (2016). Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis. Gynecological Endocrinology, 33(2), 87–92. [DOI:10.1080/09513590.2016.1248932]
    \ No newline at end of file diff --git a/transfemscience.org/articles/progestogens-breast-dev/index.html b/transfemscience.org/articles/progestogens-breast-dev/index.html index c38b2782..e1a3244c 100644 --- a/transfemscience.org/articles/progestogens-breast-dev/index.html +++ b/transfemscience.org/articles/progestogens-breast-dev/index.html @@ -1 +1 @@ -A Comprehensive Review of the Potential of Progestogens for Enhancing Breast Development in Transfeminine People - Transfeminine Science Link

    A Comprehensive Review of the Potential of Progestogens for Enhancing Breast Development in Transfeminine People

    By Aly | First published February 14, 2020 | Last modified March 29, 2024

    Abstract / TL;DR

    The major female sex hormones are estrogen and progesterone. Both of these hormones are known to be importantly involved in the development of the breasts at different stages of life. Speculation, use, and anecdotes of progestogens for enhancing breast development in transfeminine people date back to at least the 1960s. A limited number of clinical studies have assessed breast development with progestogens in transfeminine people, but current evidence on progestogens for improving breast development is of very low quality and is inconclusive. Studies of progestogens and breast development in cisgender girls and women are similarly limited. In any case, more studies evaluating progestogens and breast development are currently underway. The possible role of progestogens in enhancing breast development can also be informed by indirect and circumstantial evidence, including notably findings on progesterone and breast changes during normal puberty, the menstrual cycle, and pregnancy in humans and animals. Available evidence overall is not suggestive of an essential role for progesterone in breast growth during puberty, but progesterone does have a clear and key role in lobuloalveolar development of the breasts during pregnancy. However, breast changes in pregnancy revert following cessation of lactation and breastfeeding. Progesterone may additionally contribute to reversible breast enlargement during the luteal phase of the menstrual cycle. There are some findings to suggest that progestogens may have antiestrogenic effects in the breasts and may have a stunting influence on breast development if introduced too early following initiation of hormone therapy. However, more research is needed to assess this possibility. In any case, if progestogens are used, it may be advisable to delay their introduction until most or all estrogen-mediated breast development is complete. Options for progestogen therapy in transfeminine people include bioidentical progesterone and progestins. However, oral progesterone has major bioavailability problems and does not achieve satisfactory progesterone levels. Progestogens, including progesterone, have been variously linked to significant health risks, which is an important consideration in terms of their use in transfeminine people. Overall, based on current knowledge, progestogens do not seem to be promising for lastingly improving breast development in transfeminine people, but more research and data are still needed for clear conclusions.

    Introduction

    Breast development in terms of size and shape is often less than desired in transfeminine people, and there is a need for therapeutic approaches that improve breast growth in this population. There are two major types of female hormones, estrogens and progestogens. Estrogens are almost universally employed in transfeminine hormone therapy, while progestogens are used in a subset of transfeminine people. Progestogens that have been commonly employed in transfeminine people include bioidentical progesterone, the progestin (synthetic progestogen) medroxyprogesterone acetate (MPA), and the strongly progestogenic antiandrogen cyproterone acetate (CPA). Estrogens are the major mediators of feminization and breast development in females. However, progestogens also have physiological effects on the breasts, and in relation to this, may or may not provide benefits to breast development as well.

    The topic of progestogens and breast development has been discussed for many years in the transgender community and is a controversial subject (Coleman et al., 2012). Use of progestogens to improve breast development in transfeminine people goes back at least as far as Harry Benjamin and Christian Hamburger in the 1960s (Benjamin, 1966; Benjamin, 1967; Hamburger & Benjamin, 1969; Wiki). Arguments have been made both for (e.g., Bevan, 2012; Bellwether, 2019; Bevan, 2019) and against (e.g., Curtis, 2009) a possible role of progestogens in terms of breast development. It is often claimed that progestogens can enhance breast development or are even required for full breast development in cisgender females and transfeminine people. With respect to the latter, it is sometimes said that progestogens are necessary for people to move from Tanner stage 4 to Tanner stage 5 pubertal breast development and that progestogens help to fill and round out the breasts (e.g., Vorherr, 1974a; Basson & Prior, 1998; Kaiser & Ho, 2015; Prior, 2011; Prior, 2019a; Prior, 2020). It has even been claimed by some that without progestogens, the breasts will remain conical and “pointy” like they are in the earlier Tanner stages. On the other extreme, certain critics have claimed that there are “no biologically significant progesterone receptor sites for biological males” and that progesterone is not produced during normal female puberty until after breast development has been fully completed (Barrett, 2009; Seal, 2017; Coxon & Seal, 2018; Price, McManus, & Barrett, 2019; Richards & Barrett, 2020). In turn, these particular authors have argued against the use of progestogens in transfeminine people in various of their publications (Google Scholar). In general, the use of progestogens in transfeminine people has longstandingly been controversial, with positions both for and against (Sam, 2020).

    The purpose of this article is to review the available direct and circumstantial evidence on the topic of progestogens and breast development in order to help inform whether progestogen therapy may be able to enhance breast development in transfeminine people. Aside from an involvement in breast development, progestogens are not otherwise currently thought to be or known to be involved in physical feminization (e.g., Coleman et al., 2012; Gooren, 2016). In relation to this, the present article will limit its discussion to breast development with progestogens, and will not explore feminization in general.

    Progestogen Therapy and Breast Development in Humans

    Progestogens and Breast Development in Transfeminine People

    At present, only a limited number of studies have assessed breast development with progestogen therapy in transfeminine people. These studies have employed either bioidentical progesterone or a progestin like MPA or CPA. The subject of and the available data on progestogens and breast development in transfeminine people has also been partly reviewed in papers including Wierckx, Gooren, & T’Sjoen (2014), Reisman, Goldstein, & Safer (2019), Patel et al. (2020), Patel et al. (2022), Milionis, Ilias, & Koukkou (2022), Coleman et al. (2022), and Berliere et al. (2023).

    Orentreich & Durr (1974) was one of the earliest studies on breast development in transfeminine people. They employed combinations of estrogens and progestogens as well as gonadectomy to produce feminization and breast development in a case series of 5 transfeminine people. The employed estrogens were estradiol valerate 30 mg/2 weeks by intramuscular injection and oral conjugated estrogens 1.25–5.0 mg/day and the used progestogens were “60 mg medroxyprogesterone caproate” every 2 weeks by intramuscular injection and oral medroxyprogesterone acetate 0–10 mg/day. Medroxyprogesterone caproate (MPC) has never been used pharmaceutically, so this was likely a typo and the actual progestogen employed was likely either MPA or hydroxyprogesterone caproate (OHPC). The authors reported that estrogen and progestogen therapy produced modest to significant breast development in the transfeminine people that was not strictly dose-related and included clinical photographs of the breasts. They concluded that the breast development was comparable to that of adult cisgender women. Orentreich and colleagues also discussed the topic of lobuloalveolar maturation of the breasts, which was known to be progestogen-dependent, but noted that they had not done histological assessment and that the degree of lobuloalveolar development of the breasts does not necessarily correlate with clinical breast size per findings in cisgender women. The findings of Orentreich and colleagues are limited by methodological problems like lack of objective measurements, lack of estrogen-only controls, and the small sample size of only 5 transfeminine people, and hence the study is of limited value in terms of assessing the involvement of progestogens in breast development.

    Meyer et al. (1986) assessed the effects of progestogens added to estrogen therapy on breast development and other clinical parameters in transfeminine people. Of the 60 transfeminine people in the study, 15 (25%) received an oral progestogen, usually MPA at a dosage of 10 mg/day, for “at least for a short time”, and with only 8 (13.3%) receiving progestogen therapy for the full treatment period. In an earlier report of the study, it was noted that in 90% of observation periods the dose was 10 mg/day and for the remainder it was 20 mg/day (Meyer et al., 1981). A dosage of 10 mg/day MPA is roughly comparable to luteal-phase progesterone exposure in terms of progestogenic potency (Wiki). Breast development was measured in the study via breast hemicircumference (Diagram). Progestogen therapy was reported to not modify estrogen-induced changes, including laboratory measurements, hormone levels, and physical parameters like weight and breast growth. The lack of apparent changes in hormone levels is unexpected, as MPA in higher-quality studies has shown clear testosterone suppression (e.g., Jain, Kwan, & Forcier, 2019; Wiki). Meyer and colleagues concluded that adding progestogens to estrogen does not seem to enhance breast development in transfeminine people. However, they noted that the number of individuals who received progestogens was small and further studies were needed.

    Prior et al. (1986) and Prior, Vigna, & Watson (1989) studied estrogen, high-dose spironolactone (100–600 mg/day), and MPA (10–20 mg/day cylically or continuously) in transfeminine people who were either pre-hormone therapy or had previously been on higher doses of estrogens (and/or progestogens) without spironolactone prior to the study. The researchers reported that following 12 months of treatment with the study’s hormone therapy regimen, there was increased breast size and increased nipple development. Most individuals reached an A cup size, or approximately 8 to 14 cm in diameter of breast tissue, by the end of the study. Breast development was measured in part with photographic documentation. Although breast development reportedly improved, the researchers themselves noted that it was difficult to determine whether the enhanced breast development could be attributed to spironolactone or to MPA. Moreover, testosterone suppression was inadequate before the study and improved with the study’s hormone therapy regimen, which may have helped to improve breast development regardless of any potential direct progestogenic action of MPA on the breasts. Finally, it is possible that breast development with estrogen may not yet have been complete, and that the improved breast development may have simply been continued progression due to estrogen alone. In other publications, Jerilynn Prior, the lead study author, has claimed that progesterone enhances breast development, and has cited the preceding studies by her in support of this claim (Prior, 2011; Prior, 2019a; Prior, 2019b; Prior, 2020). However, her claim is not well-supported due to the study limitations discussed.

    Dittrich et al. (2005) reported that the combination of oral estradiol valerate and a gonadotropin-releasing hormone (GnRH) agonist for 2 years in transfeminine people resulted in self-reported breast cup sizes of C cup or greater in 5%, B cup in 30%, A cup in 35%, and less than A cup in 30%. They noted however that 70% of the individuals were unsatisfied with their breast development and wished to undergo breast augmentation surgery. The researchers claimed that the regimen had similar effectiveness in terms of feminization, including increases in breast size, compared to prior reported treatment regimens of ethinylestradiol and CPA. No other details or specifics were given. The claim about similar breast development to regimens containing CPA is relevant as CPA is a very strong progestogen at the doses used historically in transfeminine people (Aly, 2019). It should be cautioned however that this study did not actually employ or study progestogen therapy itself. In addition, self-reported breast cup size is a subjective and low-quality means of measuring breast development and size. As such, the findings of this study are of questionable value in terms of understanding progestogens and breast development.

    Estrogen is primarily involved in ductal development of the breasts, whereas progesterone is mainly involved in lobuloalveolar development. Kanhai et al. (2000) compared internal histological breast tissue changes with estrogen and CPA 100 mg/day (i.e. very-high-dose progestogen) therapy in 14 transfeminine people versus nonsteroidal antiandrogen monotherapy with flutamide or bicalutamide in 2 cisgender men with prostate cancer. Both types of treatments block androgens, increase estrogen levels, and are known to induce breast development or gynecomastia at similarly high rates. However, nonsteroidal antiandrogen monotherapy differs from combined estrogen and progestogen therapy in that it lacks any progestogenic effects. In the transfeminine people, full lobuloalveolar formation was apparent in the biopsied breast tissue, whereas in the men with prostate cancer, only “moderate” and incomplete lobuloalveolar maturation was found. It was also noted that lobuloalveolar formation tended to regress upon discontinuation of CPA following gonadectomy in transfeminine people. The researchers concluded that progestogenic exposure is needed for the breasts to fully develop on a histological level and for the breast tissue of transfeminine people to completely mimic the histology of the mature female breast. While the findings of this study are interesting, they only concern tissue characteristics and do not actually provide any information about breast development in terms of physical form or appearance. With regard to this, tissue-level differences may or may not translate to relevant differences in for instance breast size or shape. As such, the study is of limited value in understanding whether progestogens improve breast development in transfeminine people in the ways that are actually valued.

    Seal and colleagues conducted a retrospective chart review assessing clinical predictors for surgical breast augmentation in transfeminine people (Seal et al., 2012). In the transfeminine people who underwent breast augmentation, significantly more of them were taking spironolactone than were those who did not undergo breast augmentation. Conversely, the differential rates of use of specific antiandrogens were not significantly discordant between those who did and did not undergo breast augmentation in the case of the other prescribed antiandrogens, including cyproterone acetate, the 5α-reductase inhibitors, and GnRH analogues. However, this study had many methodological limitations, including the use of almost three dozen t-tests with no adjustment for multiple comparisons (and hence risk of false positives and concerns about p-hacking), small sample sizes for individual antiandrogens, use of undergoing breast augmentation as a surrogate for breast development with no actual physical measurement of the breasts or breast sizes, and a correlational design with lack of control for potential confounding variables. As such, the study does not show that different antiandrogens result in differences in breast development, and its findings must be considered with due caution.

    Jain, Kwan, & Forcier (2019) studied sublingual estradiol and spironolactone with and without MPA in 92 transfeminine people. MPA was given at a dose of 5 to 10 mg/day sublingually or at a dose of 150 mg once every 3 months by intramuscular injection. Of 39 transfeminine people who received MPA, 26 (67%) self-reported improved breast development. No further details were provided, but measurement of breast development was presumably subjective and anecdotal. Igo & Visram (2021) studied addition of progesterone to hormone therapy in transfeminine people. Progesterone was provided as 100 mg micronized progesterone (probably oral) and was prescribed when progesterone was specifically requested by the patient or when the patient expressed dissatisfaction with feminization and/or breast development. Of 190 individuals, 51 (26.8%) received progesterone therapy. Treatment with progesterone on average began after 12.7 months of estradiol therapy, and the mean total follow-up time was 14.3 months of hormone therapy. Of those who received progesterone, only 6 (11.8%) reported benefit to breast development. No further details were provided, but as with other studies, breast development was likely quantified anecdotally via self-report. As breast development does not appear to have been objectively measured or compared to a control group in either Jain, Kwan, & Forcier (2019) or Igo & Visram (2021), the findings of these studies are limitedly informative.

    Nolan and colleagues assessed the short-term effects of low-dose oral micronized progesterone on breast development in transfeminine people on stable hormone therapy in a prospective controlled study (Nolan et al., 2022a; Nolan et al., 2022b). Progesterone was given at a dose of 100 mg/day for 3 months to 23 transfeminine people and findings were compared to those of a control group of 19 transfeminine people. Breast development was measured using self-reported Tanner stage, with participants provided photographs of different Tanner stages to self-select from. At the end of the 3 months, Tanner stage was not significantly different between groups (mean 3.5, 95% CI 3.2–3.7 for progesterone vs. mean 3.6, 95% CI 3.3–3.9 for controls; p = 0.42). A limitation of this study is that oral progesterone has very low bioavailability and 100 mg/day oral progesterone achieves very low progesterone levels that are well below normal luteal-phase progesterone levels (Aly, 2018a; Wiki). As such, progestogenic exposure in this study, and notably also in Igo & Visram (2021) and other studies, is likely to have been inadequate. Besides the issue of progestogenic strength, the very short duration of the study (3 months) and the reliance on self-reported subjective Tanner stages (as opposed to more objective physical breast measurements) are also major limitations. In any case, this study is of higher quality than previous studies, and is notably likely to continue and report further follow-up at later points in the future.

    Bahr et al. (2024) conducted a retrospective chart review at their clinic and compared 29 transfeminine people who had received progestogens versus 59 transfeminine people who had not. The form of progestogen used was oral or rectal progesterone in 93% of cases and MPA by intramuscular injection in the remaining 7% of cases. Of those who took progesterone, 25 (93%) used it orally and 2 (7%) used oral progesterone capsules rectally. Progestogen doses were not reported, except that 100 mg progesterone capsules were employed. Most of those in the progestogen-treated group (59%) had started it 1 to 6 months following initiation of standard hormone therapy. The researchers found that progestogen-treated group had significantly better self-reported breast development satisfaction (rated as satisfied, neutral, or unsatisfied) compared to the group that did not receive progestogens at 6 months (satisfied: 53.8% vs. 19.6%; p = 0.004) and 9 months (satisfied: 71.4% vs. 20.8%; p = 0.003) of hormone therapy. Limitations of this study include the lack of objective measurement of breast development, the restrospective nature of the study, and the lack of randomization of treatment, among others.

    Aside from the above studies, a variety of other studies have also reported breast development with estrogen and CPA in transfeminine people. These studies have often employed objective physical measurements of breast development (e.g., breast volume, breast–chest difference, breast cup size, breast hemicircumference). However, they have lacked comparison groups, thereby precluding comparison of progestogenic versus non-progestogenic hormone therapy. In addition, CPA is unusual among progestogens in that it is employed at very high doses in transfeminine people (Aly, 2019), which may result in different and potentially stunted outcomes in terms of breast development than more physiological progestogenic exposure. As such, most studies of breast development with estrogen and CPA in transfeminine people have not been discussed in the present section and are instead discussed elsewhere in this article (see the section below). In any case, to briefly summarize the findings, breast development in transfeminine people with estrogen and CPA has generally been poor in these studies. The outcomes have included incomplete maturation in terms of Tanner staging (stage 2–4), small cup sizes, small breast volumes, and breasts much smaller in size than those in cisgender women.

    The findings from the preceding studies in transfeminine people are of very low-quality due to methodological limitations, including lack of control groups, lack of randomization, reliance on poor measures of breast development (e.g., subjective and self-report) rather than objective physical measurements (Wiki), short treatment durations, and small sample sizes, among others. This may explain the conflicting results of the studies. More research is still needed to assess the influence of progestogens on breast development in transfeminine people. There is specifically a need for randomized controlled trials (RCTs) of feminizing hormone therapy with versus without progestogen therapy that employ objective measures of breast development, have adequate sample sizes, and have sufficient follow-up durations. Additional variables like progestogen type, route, dose, and timing of introduction would also be of value to explore. A 2014 review on hormone therapy in transfeminine people summarizes the state of research on progestogens and breast development in transfeminine people, with their conclusions still holding true today (Wierckx, Gooren, & T’Sjoen, 2014):

    Our knowledge concerning the natural history and effects of different cross-sex hormone therapies on breast development in trans women is extremely sparse and based on low quality of evidence. Current evidence does not provide evidence that progestogens enhance breast development in trans women. Neither do they prove the absence of such an effect. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions.

    Accordingly, reviews and guidelines have concluded that there is currently no reliable evidence that progestogens included in hormone therapy are of benefit or are not of benefit for breast development in transfeminine people (Wierckx, Gooren, & T’Sjoen, 2014; Reisman, Goldstein, & Safer, 2019; Patel et al., 2022; Milionis, Ilias, & Koukkou, 2022; Coleman et al., 2022; Berliere et al., 2023).

    Future Studies Currently Underway

    Several studies of progesterone and other progestogens in transfeminine people are currently underway. These studies include (1) an RCT of oral progesterone added to hormone therapy by Sandeep Dhindsa and colleagues in St. Louis, Missouri in the United States (ClinicalTrials.gov; MediFind; ICH GCP); (2) a prospective observational study and/or RCT of addition of oral progesterone to hormone therapy by Ada Cheung and colleagues in Melbourne, Australia (University of Melbourne; University of Melbourne); (3) an RCT of estradiol plus spironolactone versus estradiol plus CPA also by Ada Cheung and colleagues (update: see below) (ANZCTR; WHO ICTRP; Trans Health Research [Flyer] [Poster]; University of Melbourne); and (4) a large RCT of oral progesterone at different doses added to hormone therapy by Martin den Heijer and colleagues at the Vrije Universiteit University Medical Center (VUMC) in Amsterdam, the Netherlands (Dijkman et al., 2023a; General Info/Links; Info Sheet Dutch; Info Sheet English Translated). Unfortunately however, all of the studies using progesterone employ oral progesterone, which has major bioavailability and potency problems (Aly, 2018a; Wiki). In any case, it was said that the VUMC researchers may follow their trial up with studies of other progesterone routes (General Info/Links). The preceding studies may provide more insight on the question of whether progestogen therapy is of therapeutic benefit to breast development in transfeminine people.

    Progestogens and Breast Development in Cisgender Females

    To date, there appear to be no useful studies on breast development with progesterone or other progestogens in cisgender females. There seem to mostly only be a few brief and conflicting anecdotal clinical statements in this area that are scattered throughout the literature. These include the following literature excerpts, which are specifically in the context of progestogens as part of puberty induction in cisgender girls and women with delayed or absent puberty due to hypogonadism:

    I […] performed studies on three women lacking mammary development and exhibiting signs of marked hypogonadism. […] Corpus luteum extract, 5 international units daily for a period of thirty days, when given alone produced no detectable change in the breasts. This is in accord with the experimental observations on animals of Turner,2 Corner 3 and others. When, however, patients were given alternate daily injections of 1 international unit of progesterone and from 20,000 to 50,000 international units of estrone or of estradiol benzoate, breast growth was more rapid than that produced by the estrogenic hormones alone. The simultaneous use of the corpus luteum and estrogenic therapy definitely produced a much firmer breast growth, which was distinctly lobular to palpation, whereas the growth produced by the estrogenic hormones alone was smooth and the borders of the glandular tissue were difficult to define. Rapid regression in the size of the breasts followed the omission of the hormone injections, but the regression was less rapid when the combined therapy had been used. [MacBryde (1939)]

    There are authorities who consider that breast growth is better if a progestogen is combined with oestrogen for the latter part of the cycle of treatment (Capraro, 1971). Shearman (1971) employs sequential therapy in his cases. Huffman (1971) however, does not believe that there is any improvement with the addition of progestogens. [Dewhurst (1971a)]

    The effects of progesterone on the human breast remain obscure. Although widely stated to cause glandular development, the evidence for this is slender (Benson et al 1959). [Shearman (1972a)]

    Many people use oestrogens alone, but the addition of a progestin for 6 or 10 days each month gives much better cycle control and appears to cause better breast development. [Shearman (1972b)]

    Some authorities consider that breast growth is better if a progestogen is given for the latter part of each course of treatment. [Capraro & Dewhurst (1975)]

    It has been suggested that progestins be added during the last week of each cycle of estrogen therapy in order to develop more rounded breasts rather than the conical breasts many of these patients develop, but we have been unable to detect any difference in breast contour with or without progestins. [Davajan & Kletzky (1979)]

    I have been satisfied that the addition of a progestogen was necessary to get a good breast response to hormone treatment although the progestogen, as I have said, is required after the first year if the uterus is present. [Dewhurst (1982)]

    In addition to the preceding instances, Werner (1935) and Geschickter (1945) assessed the effects of progesterone on the breasts in cisgender women. Werner (1935) attempted to induce lactation in 8 surgically gonadectomized cisgender women with combinations of estrogen, progesterone, and prolactin, all in the form of crude extracts by injection. In two women who were given progesterone, he claimed that a marked increase in the size of the breasts beyond that with estrogen alone was observed. Additionally, he claimed that the breasts were more firm, the glandular tissue “more tortuous and nodular”, and the nipples more prominent. He was not successful in inducing lactation in the women in this study. The doses of hormones used were unclear as they were in the form of extracts, and were likely supraphysiological, potentially pregnancy-like due to the nature of the experiment. Werner’s study was also briefly discussed by Nelson (1936), among other citations. Geschickter (1945) observed lobuloalveolar growth on histological examination with administration of progesterone for 6 weeks to 2 months in one woman but not in another woman. However, the exterior physical changes of the breasts were not assessed or reported by this author and hence his findings are limitedly informative.

    Surprisingly, there have been few analogous studies of the effects of progestogens on the breasts in cisgender girls and women following the preceding reports and anecdotes. Although there are very little data on progestogens and breast growth in cisgender females, clinical studies are finally starting to look more closely at the specifics of hormonal medications, including progestogens, in terms of breast development in girls undergoing puberty induction (e.g., Rodari et al., 2023). As such, future studies may provide more insight on the subject of progestogens and breast development in cisgender females.

    Progesterone and its Physiological Role in Breast Development in Humans

    Progesterone and Breast Development in Puberty

    The role of progesterone in breast development and its possible usefulness for helping with breast development in transfeminine hormone therapy can be informed by the normal biological circumstances of puberty in cisgender females. Puberty in cisgender girls usually starts around age 11 (range 8–13 years) and completes around age 15 years (range 12–19 years), taking on average 3 to 4 years (but with a range of about 1.5–6 years in most cases) (Schauffler, 1942; Marshall & Tanner, 1969; Marshall, 1978; Begley, Firth, & Hoult, 1980; Drife, 1986). Progesterone essentially does not appear during puberty until ovulatory menstrual cycles begin. Menarche, the onset of menstruation and hence of menstrual cycling, occurs on average at Tanner breast stage 4 or about 13 years of age, although it occurs at Tanner breast stage 3 or Tanner breast stage 5 in significant subsets of girls (26% for Tanner stage 3, 62% for Tanner stage 4, and 10% for Tanner stage 5) (Marshall & Tanner, 1969; Marshall, 1978; Drife, 1986; Hillard, 2007). Hence, the appearance of progesterone in normal female puberty is a relatively late event (Scott et al., 1950; Marshall, 1978; Begley, Firth, & Hoult, 1980; Drife, 1986), and most breast development appears to be complete by menarche and thus by the time that progesterone is first produced (Huffman, Dewhurst, & Capraro, 1981; Drife, 1982). Moreover, a small but significant subset of girls reaches Tanner breast stage 5 and hence fully developed breasts before menarche (Edmonds, 1989), which suggests that progesterone may not be essential for complete pubertal breast development.

    The reproductive axis in pubertal and adolescent cisgender girls is immature (Rosenfield, 2013; Gunn et al., 2018; Carlson & Shaw, 2019; Sun et al., 2019). In the first 1 to 2 years postmenarche, most menstrual cycles are anovulatory (i.e., ovulation does not occur) (Döring, 1963 [Table]; Apter, 1980; Lemarchand-Béraud et al., 1982; Talbert et al., 1985; Venturoli et al., 1987; Rosenfield, 2013; Gunn et al., 2018; Carlson & Shaw, 2019). Without ovulation, the corpus luteum doesn’t form from a ruptured ovarian follicle and progesterone production doesn’t commence. Only about half of menstrual cycles are ovulatory by Tanner breast stage 5 (Talbert et al., 1985). In addition, menstrual cycles are unusually long for some time after menarche (e.g., 50 days vs. 28 days for adult cycles) and thus there are fewer menstrual cycles per reproductive year (Rosenfield, 2013; Gunn et al., 2018; Carlson & Shaw, 2019). Luteal-phase progesterone levels are also lower in postmenarche adolescents than in adulthood even when ovulation does occur (McArthur, 1966 [Figure]; Lemarchand-Béraud et al., 1982; Apter et al., 1987; Venturoli et al., 1987; Venturoli et al., 1989; Sun et al., 2019). Consequently, progesterone exposure is sporadic and relatively limited even during late female puberty. Moreover, this is the case not only by the time of Tanner stage 5, but for many years after it as well. It takes more than 6 years after menarche for menstrual cycling to become fully mature and consistently ovulatory (Lemarchand-Béraud et al., 1982; Venturoli et al., 1987; Carlson & Shaw, 2019). Over this period of time, the rate of ovulatory cycles increases progressively until it reaches approximately 100% (Lemarchand-Béraud et al., 1982; Venturoli et al., 1987; Carlson & Shaw, 2019). Only then is full adult-level exposure to progesterone finally achieved (Lemarchand-Béraud et al., 1982; Venturoli et al., 1987).

    Only a handful of studies and sources have reported progesterone levels during puberty across Tanner stages or by age in cisgender girls (e.g., Sizonenko, 1978 [Graph]; Kühnel, 2000; Lee, 2001 [Table]; Aly, 2020a). They corroborate the above findings with regard to limited progesterone exposure during puberty. The “A Girl’s First Period Study” is an ambitious research project announced in 2022 that aims to better characterize reproductive hormone levels in pubertal and adolescent girls and may shed more light on the physiological role of progesterone during puberty (Lucien et al., 2022). The researchers have specifically highlighted the possible role of progesterone in breast development as part of their interests:

    Does exposure to low levels of [progesterone (P4)], as occurs before menarche, during anovulatory cycles with some degree of follicle luteinization, and during early, immature ovulatory cycles play an important role in normal breast development during puberty? This question has important clinical implications as hormone replacement during puberty does not typically include low-dose P4; rather, it is conducted using a staggered approach of estrogen-only therapy followed by the addition of full adult doses of exogenous P4 only after 2 years or when breakthrough bleeding occurs.27 This is done to avoid development of tubular breasts, although there are limited data linking early P4 exposure to suboptimal breast development.28

    Taken together, production of progesterone is a late event in normal female puberty, and even once it does begin, exposure to progesterone is low and sporadic until well after puberty has completed. Moreover, a subset of girls complete breast development before progesterone production starts. These facts call into some question the role of progesterone in breast development in female puberty, as most breast development appears to be complete prior to the appearance of progesterone. However, more research is still needed on the role of progesterone in breast development during normal puberty.

    On the basis of normal female puberty, it seems it may be advisable that if progestogens are introduced in an attempt to enhance breast development in transfeminine people, their introduction be delayed until after 2 or 3 years of hormone therapy, so as to mimic the normal progestogenic exposure of puberty.

    Progesterone and Breast Development in Pregnancy

    During pregnancy, under the influence of ovarian hyperstimulation and placental formation, there are profound changes in hormonal profiles, including of hormones like estrogen, progesterone, and prolactin, among many others (Table 1). Comparing hormone levels during the menstrual cycle to those during the third trimester of pregnancy, estradiol levels increase on the order of 100-fold, progesterone levels increase on the order of 10- to 20-fold, and prolactin levels increase by around 10-fold (Table 1). Levels of numerous other hormones also change considerably during pregnancy, for instance other estrogens besides estradiol, androgens, gonadotropins (e.g., human choronic gonadotropin or hCG), human placental lactogen (hPL), relaxin, adrenocorticotropic hormone (ACTH), cortisol, aldosterone, growth hormone (GH), and insulin-like growth factor 1 (IGF-1), among others (Goodman, 2009 [Figure]; Mesiano, 2019). These hormones are variously produced by the ovaries, the placenta, and the pituitary gland, among other glands. In response to the myriad hormonal changes during pregnancy, there are dramatic changes to the breasts, which prepare the mother for postpartum lactation and breastfeeding.

    Table 1: Changes in hormone levels (estradiol, progesterone, and prolactin) during normal pregnancy:

    HormoneNon-PregnantFirst TrimesterSecond TrimesterThird Trimester
    Estradiol100 (~5–750) pg/mL1,000–5,000 pg/mL5,000–15,000 pg/mL10,000–40,000 pg/mL
    Progesterone8.9 (1.0–24) ng/mLa22 (5–75 ng/mL)35 (15–85) ng/mL102 (25–280) ng/mL
    Prolactin13.0 (4.6–37) ng/mL16 (3.2–43 ng/mL)49 (13–166) ng/mL113 (13–318) ng/mL

    Note: Values are median (range) or range. Footnotes: a Specifically during the luteal phase of the menstrual cycle. Sources: estradiol (Aly, 2018b; Wiki; Wiki); progesterone (Kühnel, 2000; Aly, 2020a; Wiki; Wiki); and prolactin (Kühnel, 2000; Wiki).

    Prior to pregnancy, there is significant although fairly minimal lobuloalveolar development of the breasts with each menstrual-cycle luteal phase (Scott et al., 1950; Drife, 1984; Drife, 1989; Drife, 1990; Pocock, Richards, & Richards, 2013; Johnson & Cutler, 2016; Alekseev, 2021). During pregnancy however, the breasts undergo much more considerable lobuloalveolar development and achieve full maturity. This allows for milk production and lactation following childbirth. During pregnancy, the breasts progressively and considerably increase in size (Hytten, 1954a; Hytten, 1954b; Baird, Hytten, & Thomson,1958; Hytten & Thomson, 1965; Hytten & Leitch, 1971a; Hytten & Leitch, 1971b; Hytten, 1976; Thoresen & Wesche, 1988; Cox et al., 1994; Whiteley, 1994; Cox et al., 1999; Cregan & Hartmann, 1999; Kent et al., 1999; Galbarczyk, 2011; Abduljalil et al., 2012; Bayer et al., 2014; Lawrence & Lawrence, 2015; Żelaźniewicz & Pawłowski, 2015; Dallman et al., 2017; Drąsutis, 2017; Żelaźniewicz & Pawłowski, 2019). Quantitative clinical studies have found the breasts to increase on average by about 100 to 300 mL (range -20 to 880 mL) in volume, or by about 200 to 400 g in mass, going from early pregnancy to late pregnancy or early postpartum (Hytten & Thomson, 1965; Hytten & Thomson, 1968; Hytten & Leitch, 1971a; Hytten & Leitch, 1971b; Hytten, 1976; Thoresen & Wesche, 1988; Whiteley, 1994; Hartmann et al., 1996; Cox et al., 1999; Cregan & Hartmann, 1999; Kent et al., 1999; Wright, 2015; Bayer et al., 2014; Żelaźniewicz & Pawłowski, 2015; Drąsutis, 2017; Żelaźniewicz & Pawłowski, 2019). The breasts can reportedly increase as much two to three times in size in some women (Greydanus et al., 2010). There is marked variation between individuals in the breast size increases during pregnancy (Hytten & Thomson, 1965; Hytten & Leitch, 1971a; Hassiotou & Geddes, 2013; Bayer et al., 2014). Increases in breast size are inversely associated with age, with considerably greater increases in younger women than in older women (e.g., +234–258 mL in <20 years vs. +79–131 mL in >30 years) (Hytten & Baird, 1958; Hytten & Leitch, 1971a [Excerpt]; Hytten, 1976). In addition to overall breast size, the nipples and areolae increase in size during pregnancy (Hytten & Baird, 1958; Hytten & Leitch, 1971a; Rohn, 1989; Cox et al., 1999; Hassiotou & Geddes, 2013; Thanaboonyawat et al., 2013; Park et al., 2014). They also become more darkly pigmented, reaching a dark brown or even black color (Dickson & Hewer, 1950; Thody & Smith, 1977; Wade, Wade, & Jones, 1978; Wong & Ellis, 1984; Elling & Powell, 1997; Muzaffar, Hussain, & Haroon, 1998; Muallem & Rubeiz, 2006; Nussbaum & Benedetto, 2006; Olanrewaju et al., 2017). The breasts become capable of lactation by 3 to 4 months of pregnancy (Walker, Baker, & Lamb, 2013; Pipkin, 2019; Pocock, Richards, & Richards, 2013; Wright, 2015; Lawrence & Lawrence, 2015). However, maturation of the breasts for lactation does not appear to be complete until at least about 6.5 months of pregnancy (Hassiotou & Geddes, 2013). Photographic timelines of women throughout pregnancy provide a visual impression of the breast changes that occur during this time (caution—NSFW: Reddit; More).

    There are large and dramatic changes in levels of numerous hormones during pregnancy, and the exact hormones responsible for the breast changes during pregnancy are not known (Hytten & Leitch, 1971a; Hytten, 1976). However, it is considered likely, on the basis of animal studies, that a variety of hormones, including estrogen, progesterone, prolactin, placental lactogen, glucocorticoids, and growth hormone, are all importantly involved in different aspects of the maturation (Hytten & Leitch, 1971a; Hytten, 1976; Cox et al., 1999). Moreover, in a quantitative clinical study of breast changes during pregnancy, increases in breast volume and areola size were positively correlated with levels of hPL, while increases in nipple size were positively correlated with levels of prolactin (Cox et al., 1999). Progesterone and prolactin have specifically been implicated in the lobuloalveolar development of the breasts during pregnancy (Bässler, 1970; Lee & Ormandy, 2012; Obr & Edwards, 2012). Both hormones appear to be independently essential in normal lobuloalveolar growth per animal studies (Obr & Edwards, 2012; McNally & Stein, 2017; Hannan et al., 2023). Prolactin likewise appears to be essential in humans, based on case reports of lactation failure in women with isolated prolactin deficiency (Buhimschi, 2004). Conversely, hPL may not be essential for lactation based on case reports of normal lactation in women with very low levels of hPL during pregnancy (Gaede, Trolle, & Pedersen, 1978; Hannan et al., 2023).

    Following childbirth and lactation, the breasts undergo a process known as post-lactational involution and return to a pre-pregnancy-like state (Dickson & Hewer, 1950; Ingleby, Moore, & Gershon-Cohen, 1957; Harley, 1969; Gershon-Cohen, 1970; Petrakis, 1978; Huffman, Dewhurst, & Capraro, 1981; Drife, 1986; Caro, 1987; Tanos & Brisken, 2008; Radisky & Hartmann, 2009; Fridriksdottir, Petersen, & Rønnov-Jessen, 2011; Hassiotou & Geddes, 2013; Sun et al., 2018; Alex, Bhandary, & McGuire, 2020). This involves massive cell death and regression of the lobuloalveolar development and other breast changes that occurred during pregnancy (Radisky & Hartmann, 2009; Alex, Bhandary, & McGuire, 2020). With involution, there is, on the basis of quantitative clinical studies, a complete reversion to pre-pregnancy breast size, or even to a slightly smaller breast size (Kent et al., 1999 [Figure]; Jernström et al., 2005; Dorgan et al., 2013; Lim et al., 2018). The same reversion has also been observed in gestational macromastia (breast hypertrophy of pregnancy), with striking and complete or near-complete regressions in breast size reported—although often with concomitant sagging and deformity that necessitates surgical intervention (Moss, 1968; van der Meulen, 1974 [Figure]; Swelstad et al., 2006; Naik et al., 2015). Following involution, it is also impossible to reliably distinguish between nulliparous and parous breasts even with internal histological examination (Drife, 1986). However, the parous breasts are not exactly the same as they were before pregnancy—the breasts remain more complex on a histological level (Dickson & Hewer, 1950; Gershon-Cohen, 1970; Hytten, 1976; Drife, 1986; Drife, 1989; Jeruss, 2006; Fridriksdottir, Petersen, & Rønnov-Jessen, 2011; Hassiotou & Geddes, 2013; Lewin, 2016; Sun et al., 2019), tend to be looser, more flaccid, and more pendulous due to stretching of skin and ligaments (Begley, Firth, & Hoult, 1980; Duncan, 2010; Rauh et al., 2013; Lewin, 2016), and the nipples and areolae remain more maturely developed and pigmented (Dickson & Hewer, 1950; Hytten & Baird, 1958; Hytten, 1976; Nussbaum & Benedetto, 2006; Sanuki, Fukuma, & Uchida, 2009; Thanaboonyawat et al., 2013; Park et al., 2014). In terms of subjective perceptions, some women perceive their breasts to be larger following pregnancy, whereas others perceive them to be smaller (Rauh et al., 2013; Lewin, 2016). Pregnancy can temporarily improve breast size in women with small breasts (Capraro & Dewhurst, 1975; Petrakis, 1978; Huffman, Dewhurst, & Capraro, 1981), but it has been said that the subsequent regressions in breast size after pregnancy can be “disturbing” (Capraro & Dewhurst, 1975). Following the first pregnancy and post-lactational involution, the breasts undergo the same cycle of expansion and regression with each subsequent pregnancy (Hassiotou & Geddes, 2013).

    On the basis of the preceding, in spite of rather extreme hormonal stimulation, the breast changes of pregnancy, although quite dramatic, are essentially temporary and fully reversible, remaining only as long as continuous hormonal exposure is maintained. This hormonal stimulation includes exposure to extremely high levels of progesterone. It would seem, based on pregnancy, that once pubertal breast development is completed, the breasts are rather unamenable to permanent further growth, whether that involves exposure to progestogens or to a variety of other hormones known to act on the breasts.

    Breast Composition and Lobuloalveolar Tissue Proportion

    The breasts are made up of two main types of tissue: (1) epithelial tissue, the actual functional internal mammary glandular tissue, including ducts and alveoli or lobules; and (2) stromal tissue, a mixture of connective tissue and adipose (fat) tissue. Lobuloalveolar development refers to growth and maturation of the alveoli and lobules, and hence is a form of epithelial or glandular development. Progestogens are involved primarily in lobuloalveolar development of the breasts, which is the type of breast development that is necessary for lactation and breastfeeding and that occurs mainly during pregnancy.

    In women who are not pregnant or lactating, studies have found that only about 5 to 20% of the volume of the breasts is composed of epithelial tissue on average, while the remaining 80 to 95% is composed of stromal tissue (Hutson, Cowen, & Bird, 1985; Drife, 1986; Drife, 1989; Bryant et al., 1998; Gertig et al., 1999; Howard & Gusterson, 2000; Cline & Wood, 2006; Lorincz & Sukumar, 2006; Wilson et al., 2006; Xu et al., 2010; Pandya & Moore, 2011; Hagisawa, Shimura, & Arisaka, 2012; Sandhu et al., 2016; Rosenfield, Cooke, & Radovick, 2021; Wiki). More specifically, one major study in in reproductive-age women found that the breasts are about 10 to 20% epithelial tissue, 10 to 35% fat tissue, and 60 to 80% connective tissue (Hutson, Cowen, & Bird, 1985; Wilson et al., 2006). Conflictingly however, a couple of studies that employed mammography have reported higher breast glandular proportions ranging from 35 to 48% (Klein et al., 1997; Jamal et al., 2004; Duncan, 2010). Aside from glandular tissue, other studies have found breast fat percentages of mean 26 to 48% (range 2 to 78%) (Lejour, 1994; Lejour, 1997; Vandeweyer & Hertens, 2002). Similarly to the findings of most studies of women’s breasts in general, only a small proportion of the breasts is glandular tissue (e.g., 1–7%) in women who have macromastia (breast hypertrophy, or extremely large breasts) (Bames, 1948; Cruz-Korchin et al., 2001).

    During pregnancy and lactation in humans, the breasts undergo dramatic changes, and epithelial tissue comes to make up a much greater proportion of the breasts (Ramsay et al., 2005; Bland, Copeland, & Klimberg, 2018). In fact, sources state that glandular tissue comprises a majority of the breast during pregnancy and lactation, with one study of lactating women finding that the breasts were composed 63% (range 46–83%) of glandular tissue (Ramsay et al., 2005). This is not merely due to lobuloalveolar development and glandular growth, but is also due to a marked reversible reduction in mammary adipose tissue (Wang & Scherer, 2019; Alex, Bhandary, & McGuire, 2020). In any case, under more normal physiological circumstances and progesterone exposure, the contribution of lobuloalveolar tissue to the size of the breasts would appear to be quite small. In relation to this, outside of pregnancy levels of progesterone, the significance of progestogen-mediated breast lobuloalveolar growth in terms of breast size is unclear but seemingly questionable (Orentreich & Durr, 1974; Wierkcx, Gooren, & T’Sjoen, 2014).

    Breast Development in Cisgender Women with Complete Androgen Insensitivity Syndrome and Consequent Absence of Progesterone

    It has been claimed that progesterone helps to move transfeminine people and cisgender females from Tanner stage 4 to 5 breast development and that it helps to round out the breasts (e.g., Vorherr, 1974a; Prior, 2011; Prior, 2019a; Prior, 2020). It has also sometimes been claimed in the online transgender community that cisgender women with complete androgen insensitivity syndrome (CAIS), an experiment of nature of women who lack progesterone, are stuck at Tanner stage 4 breast growth and have “cone-shaped” breasts due to their absence of progesterone. In actuality however, there is no good evidence at this time that progesterone is required for normal pubertal breast development, that progesterone is needed to reach Tanner stage 5, or that it helps to round out the breasts. Such claims are contradicted by extensive available literature and evidence, including notably the literature on CAIS women themselves.

    Women with CAIS are individuals who have a 46,XY karyotype (i.e., are genetically “male”), testes, and who would otherwise have physically developed as males, but did not because they have a mutation in the gene encoding the androgen receptor that makes them completely insensitive to the effects of androgens. There are also incomplete forms of the syndrome, like partial androgen insensitivity syndrome (PAIS) and mild androgen insensitivity syndrome (MAIS). CAIS women have a male-typical hormonal profile, generated by their testes, including high male-range levels of testosterone, low female-range estradiol levels, and negligible progesterone levels (Wiki; Table). Instead of developing physically as males however, CAIS women are perfectly phenotypically female, with a normal female body, vagina, and breasts (Wiki; Photo). Their testosterone has been unable to masculinize them, while their estradiol, unopposed by androgens, is able to fully feminize them. The internal reproductive system in CAIS women is essentially that of an underdeveloped male, with testes instead of ovaries, and no uterus. The vagina is often short and is blind-ending with no cervix, which is related to their lack of a uterus. CAIS women are also described as feminine in terms of behavior, gender, and sexuality.

    Women with CAIS have breast development that is described throughout the literature as “good”, “excellent”, “normal”, “full”, “complete”, “well-developed”, “overdeveloped”, “generous”, “enhanced”, “typically above-average”, “large”, and even “voluptuous” (Morris, 1953; Simmer, Pion, & Dignam, 1965; Hertz et al., 1966; Valentine, 1969; Adams et al., 1970; Polani, 1970; Weisberg, Malkasian, & Pratt, 1970; Dewhurst, 1971b; Perez-Palacios & Jaffe, 1972; Glenn, 1976; Dewhurst & Spence, 1977; Rutgers & Scully, 1991; Patterson, McPhaul, & Hughes, 1994; Quigley et al., 1995; McPhaul, 2002; Galani et al., 2008; Oakes et al., 2008; Tiefenbacher & Daxenbichler, 2008; Barbieri, 2019). John McLean Morris, the gynecologist who reviewed and summarized all of the existing scientific literature on CAIS women in 1953 (including 82 cases) and gave their condition the now-abandoned name “testicular feminization”, described their breasts as “unusually large” and “jumbo-sized” (Morris, 1953; Quigley et al., 1995). He additionally said in his famous 1953 review that they had “normal female breasts, often with a tendency to be overdeveloped” (Morris, 1953). Per another author, “Probably under no other circumstance does breast development in the [‘male’] reach the florid degree seen in testicular feminization” (Wilson, 1968).

    Despite claims that CAIS women have generous breast sizes however, in actuality, some CAIS women have large breasts, while some have small breasts, with one study finding a wide range of breast size measurements of 16×14 cm to 41×31 cm (Wisniewski et al., 2000). Moreover, the breasts of CAIS women have never been directly compared to those of normal women. Hence, there are no clear data at this time that the breasts of CAIS women are actually larger than average for women. The variation in breast growth in CAIS women parallels the same large variation in breast size between individuals that is seen in cisgender women in general. Here is a collection of photos of CAIS women and their breast development from published case reports and reviews throughout the literature. As can be seen from these photos, breast development in CAIS women is normal and often excellent, although subject to considerable variation between individuals in terms of breast size and shape as in women generally.

    If CAIS women truly do have enhanced breast development and breast sizes compared to normal women, it may be that their androgen insensitivity, and hence lack of inhibition of estrogen-mediated breast development by androgens, is responsible for this (Wilson, 1968; Sobrinho, Kase, & Grunt, 1971; Andler & Zachmann, 1979; Zachmann et al., 1986; Patterson, McPhaul, & Hughes, 1994; Barbieri, 2019). Another theoretical possibility is that the high testosterone levels may be aromatized into greater amounts of estradiol locally within the breasts and other tissues in CAIS women and that this may somehow allow for enhanced breast development (Ladjouze & Donaldson, 2019).

    Baron evaluated a total of 41 people with androgen insensitivity syndrome (AIS) and found that 97% of CAIS women had normal breast development while 63% of individuals with “incomplete AIS” (likely PAIS) had normal breast development (Baron, 1993; Baron, 1994a; Baron, 1994b). In another earlier published study of 50 CAIS females by Sir Christopher John Dewhurst, 76% were rated as having full breast development, 7% as having moderate breast development, 5% as having “mild” breast development, and 0% as having absent breast development (Dewhurst, 1971b). Hence, based on findings in large samples of CAIS females, most to almost all have normal or full breast development. That a minority of CAIS females have had less breast growth may be due to factors like low and inadequate estradiol levels in some individuals, young age at time of assessment by which breast development has not fully completed, and/or a small subset of women in general having underdeveloped or small breasts.

    CAIS women have never been described in the literature as having “cone-shaped”, “pointy”, or otherwise abnormal breasts. The only exception is that they are often said to have nipples and areolas that are described as “juvenile”, “infantile”, “small”, “pale”, and “non-pigmented” (e.g., Photo) (e.g., Morris, 1953; Morris & Mahesh, 1963; Simmer, Pion, & Dignam, 1965; Dewhurst, 1967; Khoo & Mackay, 1972; Perez-Palacios & Jaffe, 1972; Dewhurst & Spence, 1977). This has been said to be the case regardless of breast size or maturation (Khoo & Mackay, 1972). A possible reason for this phenomenon is that estradiol levels in CAIS women are relatively low, only about 35 pg/mL (130 pmol/L) on average (Wiki; Table). This is relevant as estrogens are known to concentration-dependently produce nipple and areolar pigmentation and enlargement (Davis et al., 1945; Kennedy & Nathanson, 1953). In contrast to estrogens, progestogens have not been implicated in nipple or areolar pigmentation. Hence, it seems that higher estrogen levels may be necessary for full adult-like nipple and areolar maturation.

    CAIS women are able to reach Tanner stage 5 breast development and hence full maturation of the breasts similarly to normal women (Quigley, 1988; Quigley et al., 1995; Gordon & Laufer, 2005; Finkenzeller & Loveless, 2007; Cheikhelard et al., 2008; Ramos et al., 2018; Arya et al., 2021; Zhang et al., 2021). One gynecologist, Robert Rebar, has claimed in his publications over several decades, including in reviews and book chapters, that CAIS women usually only reach Tanner stage 3 breast development (Kustin & Rebar, 1987; Rebar, 1988; Rebar, 1990; Simpson & Rebar, 1990; Rebar, 1993; Rebar, 1996; Wellons & Rebar, 2013; Wellons, Weeber, & Rebar, 2017). However, this claim conflicts with the statements of other researchers and with studies and case reports of CAIS women. In one book chapter, Rebar said that CAIS females undergo breast development and feminization and that the breasts contain normal ductal and glandular tissue, but stated that “the areolae are pale and poorly developed (Tanner stage 3)” (Rebar, 1993). This suggests that he may have been meant Tanner stage 3 in terms of nipple and areolar maturation rather than breast growth as a whole (Rebar, 1993). Aside from CAIS females, even individuals with PAIS often have substantial breast growth and female-like breasts (e.g., Saito et al., 2014; Lee et al., 2015). Additionally, PAIS females treated with estrogen therapy have similarly been reported to reach Tanner breast stage 5 (Guaragna-Filho et al., 2023).

    Despite their often large breasts, CAIS women are said to have relatively little breast glandular tissue, as opposed to fat and connective tissue, and to have minimal breast lobuloalveolar development (Morris, 1953; Morris & Mahesh, 1963; Simmer, Pion, & Dignam, 1965; McMillan, 1966; Perez-Palacios & Jaffe, 1972; Dewhurst & Spence, 1977; Shapiro, 1982). This is in accordance with the lack of progesterone in CAIS women, since progesterone is important in mediating lobuloalveolar growth. The retained breast sizes of CAIS women despite reduced glandular and lobuloalveolar structures is consistent with the fact that the breasts are composed mostly of stromal adipose and connective tissue. Hence, as touched on previously in this article, greater glandular or lobuloalveolar formation in the breasts may not necessarily translate to greater breast size, which seems readily apparent in CAIS women.

    The normal and excellent breast development of CAIS women is notable because these individuals, owing to their testes and hence absence of significant gonadal progesterone production, have very low and negligible levels of progesterone (Wiki; Table; Barbieri, 2019). CAIS womens’ normal breast development, often large breasts, and ability to reach complete breast maturation, as measured by the Tanner scale, are collectively suggestive that progesterone is not required for normal or complete pubertal breast development (Barbieri, 2019). In any case, it must be noted and cautioned again that the breasts of CAIS women have never been directly compared to those in normal women. In addition, quantitative studies of the breasts of CAIS women are very scarce, and much of our knowledge in this area is based on anecdotal clinical experience and subjective breast evaluation. This in large part due to the rarity of CAIS women and the difficulty in obtaining decent samples of them for study. Furthermore, CAIS women also have other differences from regular women besides their lack of progesterone, for instance their relatively low circulating estradiol levels, high testosterone levels (which can be aromatized into estradiol within tissues like the breasts), androgen insensitivity, and XY karyotype, among others. Hence, the insights into breast development provided by CAIS women come with a variety of caveats.

    Interestingly, in spite of their well-developed breasts, breast cancer has never been reported in CAIS women, and would appear to be very rare in these individuals (Aly, 2020b; Aly, 2020c). This may be related to factors like the lack of progesterone and lobuloalveolar maturation in CAIS women and/or their absence of a second X chromosome (Aly, 2020b; Aly, 2020c). CAIS women suggest that breast cancer is not an inherent eventual consequence of excellent breast development.

    Menstrual Cycles and Temporary Cyclic Breast Enlargement

    The breasts fluctuate in size across the menstrual cycle, with significant enlargement apparent during the luteal phase of each cycle (Shuttleworth, 1938 [Figure]; Ingleby, 1949; Scott et al., 1950; Milligan, Drife, & Short, 1975; Drife, 1982; Malini, Smith, & Goldzieher, 1985; Drife, 1989; Fowler et al., 1990; Graham et al., 1995; Jemström & Olsson, 1997; Hussain et al., 1999; Hussain, Brooks, & Percy, 2008; Wang et al., 2019; Rix et al., 2023). This is experienced by women as a sense of fullness, as well as tingling sensations and tenderness (Shuttleworth, 1938 [Figure]; Milligan, Drife, & Short, 1975; Laessle et al., 1990; Jemström & Olsson, 1997). The change in the volume of the breasts has been reported to be approximately 75 to 100 mL on average, with volume falling to as low as 90% of mean volume during the follicular phase or at ovulation and increasing to up to 110% of average volume during the luteal phase (or about 15 to 20% mean total change from smallest to largest volume) (Milligan, Drife, & Short, 1975; Malini et al., 1985; Drife, 1989; Fowler et al., 1990; Hussain et al., 1999; Hussain, Brooks, & Percy, 2008; Rix et al., 2023). However, more recent studies using better measurement methods of breast volume suggest more modest changes, like a decrease in breast volume of 4 to 10% during the follicular phase and an increase in breast volume of 3 to 21% during the luteal phase (Rix et al., 2023). The changes in breast size have also been described as an increase of one-third of a bra cup size (37 mL or 35 g) on average and up to one bra cup size in some (Rix et al., 2023). There is substantial variation between individuals in the changes in breast volume across the menstrual cycle, ranging from no change to up to a 40 to 45% increase in the most extreme cases (Ingleby, 1949; Malini, Smith, & Goldzieher, 1985; Fowler et al., 1990; Hussain et al., 1999; Hussain, Brooks, & Percy, 2008; Rix et al., 2023).

    The enlargement of the breasts during the luteal phase of the menstrual cycle is believed to be due to temporary glandular and stromal tissue growth, luminal dilation of the ducts and alveoli, fluid retention in the glandular and stromal structures, and increased vascularization and blood flow (Scott et al., 1950; Drife, 1989; Fowler et al., 1990; Hussain et al., 1999; Alekseev, 2021; Biswas et al., 2022). However, studies suggest that most of the changes are merely due to water fluctuations and that change in breast glandular volume change is relatively small (Rix et al., 2023). The breast changes during the menstrual cycle have been positively correlated with increased levels of estradiol and progesterone during the luteal phase (Jemström & Olsson, 1997; Clendenen et al., 2013; Rix et al., 2023). In addition, estrogen therapy has been found to reversibly increase breast size (e.g., Hartmann et al., 1998) and estradiol levels are positively associated with breast tenderness (e.g., de Lignières & Mauvais-Jarvis, 1981; Sitruk-Ware et al., 1984). Both estradiol and progesterone can promote water retention via distinct hormonal mechanisms as well as mediate breast glandular growth and changes (Rix et al., 2023). As such, the breast changes during the menstrual cycle are assumed to be due to changing levels of estradiol and progesterone, though it is noteworthy that progesterone has been particularly implicated owing to the breast volume increase occurring during the luteal phase (Lawrence & Lawrence, 2015; Rix et al., 2023). There is a delay in breast volume increases following the peaks of estradiol and progesterone levels during the menstrual cycle and hence the changes are not instantaneous (Rix et al., 2023).

    Combined oral contraceptives, which are estrogen–progestogen preparations, as well as menopausal estrogen–progestogen hormone therapy, may produce temporary breast enlargement and feelings of breast fullness analogous to those that occur during the luteal phase of the menstrual cycle (Milligan, Drife, & Short, 1975; Dennerstein et al., 1980 [Figure]; Malini, Smith, & Goldzieher, 1985; Jemström & Olsson, 1997; Jernström et al., 2005). In one study, breast volume was around 100 mL greater (~30% higher) in women who were currently taking oral contraceptives relative to those who had not taken or had previously taken oral contraceptives (Jemström & Olsson, 1997). In some women, the increase in breast size with oral contraceptives was subjectively reported to be up to a single bra cup size in volume (Jemström & Olsson, 1997). However, in another study by the same group of researchers that had a much larger sample size (n=258 vs. n=65), breast volumes were not significantly different between current hormonal contraceptive users and non-users (Jernström et al., 2005). Additionally, another study found no significant differences in breast volume in women between different estrogen–progestogen oral contraceptives that had 6.25-fold variation in dose of the same progestin (0.4 to 2.5 mg/day norethisterone) as well as non-users (Malini, Smith, & Goldzieher, 1985). However, this study was underpowered due to small sample sizes (n=5 to n=15 per group) (Malini, Smith, & Goldzieher, 1985).

    Engman et al. (2008) conducted an RCT of treatment with mifepristone, a selective progesterone receptor modulator (SPRM) with predominantly antiprogestogenic effects, versus placebo for 3 months in normally cycling premenopausal cisgender women, and evaluated the effects of this progesterone receptor blockade on the breasts. They found that mifepristone significantly reduced Ki-67 index, a measure of cellular proliferation in the breasts, and reduced subjectively rated symptom scores on the Breast Symptom Index (BSI). More specifically, breast soreness, breast swelling, sense of increased breast volume, and the total breast symptoms score were all significantly reduced on the BSI. However, breast volume was not objectively measured in this study. A major limitation of this study is that mifepristone inhibits ovulation and modifies levels of estradiol and other hormones (Spitz et al., 1989; Spitz et al., 1994; Engman et al., 2008, Spitz, 2010). As such, it is unclear whether the effects observed by Engman and colleagues were specifically due to progesterone receptor antagonism in the breasts or due to disruption of the hypothalamic–pituitary–gonadal (HPG) axis, for instance lowered estradiol levels.

    An interesting case report of an adult woman with CAIS documented a significant increase in breast volume with combined estrogen–progestogen therapy relative to estrogen monotherapy (Dijkman et al., 2023b). The woman was started on cyclic oral estradiol 2 mg/day and dydrogesterone 10 mg/day and subjectively experienced breast pain and fluctuations in breast volume of about one cup size while on this regimen. Subsequently, she was switched to oral estradiol valerate 3 mg/day monotherapy and the fluctuations in breast volume ceased. However, her overall breast volume was reduced as well, and the woman decided to resume combined estradiol and dydrogesterone therapy. Her clinicians proceeded to measure her breast volume using 3D body scanning. Her left breast was 758 mL and right breast was 673 mL with estrogen monotherapy, and her breasts increased to respective volumes of 875 mL and 784 mL during combined estrogen–progestogen therapy, giving net volume increases of 117 mL (+16%) and 111 mL (+17%). These differences in volume corresponded to an almost one bra cup difference in size. The researchers noted that estradiol and progesterone are associated with cyclical breast changes, and hypothesized that the changes in their patient were due to increased fluid retention in the breasts. Taken together, the case report demonstrates that progestogens can cause rapid and considerable reversible breast enlargement in some women analogous to that during the normal menstrual cycle.

    Progesterone and Mammary Development in Animals

    Progesterone and Pubertal Mammary Development in Animals

    Knockout of the progesterone receptor (PR) in female mice results in complete infertility and severely compromised ovarian and uterine functions (Lydon et al., 1995; Ismail et al., 2003). On the other hand, pubertal mammary development in progesterone-receptor knockout mice is normal and morphologically indistinguishable from that of regular mice (Soyal et al., 2002; Ismail et al., 2003; Fernandez-Valdivia et al., 2005). This is in contrast to the case of estrogen receptor alpha (ERα) knockout mice, in which pubertal mammary development is abolished (Ismail et al., 2003; Fernandez-Valdivia et al., 2005; Wiki; Wiki). However, subsequent studies revealed that mammary ductal development during puberty, while eventually normal, is delayed in female mice that have loss of progesterone production, loss of the progesterone receptor, or progesterone receptor antagonism with mifepristone (Shi, Lydon, & Zhang, 2004). In other words, progesterone stimulates and accelerates ductal development during puberty, and hence appears to have a significant physiological role in early mammary development during puberty. The stimulation of ductal development by progesterone appears to be mediated by induction of the expression of amphiregulin in mammary ducts and terminal end buds (Kariagina et al., 2010; Aupperlee et al., 2013). This growth factor is an agonist of the epidermal growth factor receptor (EGFR), and is also notably the major growth factor that estrogen induces the expression of to mediate mammary gland development during puberty (Ciarloni, Mallepell, & Brisken, 2007; LaMarca & Rosen, 2007; McBryan et al., 2008). In any case, as mammary ductal development during puberty without progesterone is delayed, but eventually normal, it has been concluded that progesterone is dispensable for pubertal mammary gland development in mice (Soyal et al., 2002; Ismail et al., 2003; Fernandez-Valdivia et al., 2005).

    Although progesterone does not seem to be essential in normal pubertal mammary development in mice, studies have interestingly found that it is able to substitute for estrogen in mediating pubertal ductal mammary development in this species. Ruan, Monaco, & Kleinberg (2005) studied the effects of various combinations of exogenous estradiol, progesterone, and IGF-1 on mammary development in oophorectomized female IGF-1-knockout mice. In terms of stimulation of ductal development to occupy the mammary gland fat pad, the combination of progesterone and IGF-1 produced 92% occupation, estradiol and IGF-1 resulted in 92% occupation, estradiol, progesterone, and IGF-1 achieved 96% occupation, and IGF-1 alone resulted in only 28% occupation (Ruan, Monaco, & Kleinberg, 2005; Kleinberg & Ruan, 2008). In terms of gross anatomical appearance, the ductal tree with progesterone and IGF-1 was said to resemble that of a normal fully developed pubertal mammary gland (Ruan, Monaco, & Kleinberg, 2005). However, differences in mammary development between the combination of estradiol and IGF-1 and the combination of progesterone and IGF-1 were apparent, with estradiol and IGF-1 having greater effect on terminal end bud formation, ductal decorations, and slight alveolar maturation, and progesterone and IGF-1 having more effect on ductal formation, extension, and branching (Ruan, Monaco, & Kleinberg, 2005; Kleinberg & Ruan, 2008). The effects of progesterone on mammary development were reversed by the progesterone receptor antagonist mifepristone (Ruan, Monaco, & Kleinberg, 2005). Only the combination of estradiol, progesterone, and IGF-1 produced mammary development that resembled that during mid-pregnancy, with full maturation of secretory alveolar structures (Ruan, Monaco, & Kleinberg, 2005; Kleinberg & Ruan, 2008).

    Aside from the preceding studies, a number of other studies have also found increased ductal branching of mammary glands during puberty with exogenous progesterone administration in mice (Atwood et al., 2000; Hovey et al., 2001; Satoh et al., 2007; Aupperlee et al., 2013).

    A limitation of studies that have used exogenous progesterone to stimulate pubertal ductal mammary development in mice is that the doses of progesterone employed, in conjunction with other hormones like estradiol, have been sufficient to mediate mammary growth to a level typical of pregnancy, with robust maturation of mammary lobuloalveolar structures (e.g., Skarda, Fremrová, & Bezecnyý, 1989; Ruan, Monaco, & Kleinberg, 2005). Pregnancy is a time when hormone levels are much higher than usual. Hence, the progesterone exposure in these studies may have been supraphysiological relative to normal puberty, and may have produced effects on mammary growth that would not otherwise occur during this time. Accordingly, Skarda, Fremrová, & Bezecnyý (1989) found that whereas untreated normal female mice naturally grew to a mammary gland area of 26.4 mm2 and normal female mice treated with exogenous estradiol grew to a mammary gland area of 25.3 mm2, normal female mice treated with exogenous estradiol and progesterone grew to a mammary gland area of 43.5 mm2 and with exogenous progesterone alone to a mammary gland area of 64.6 mm2. The untreated control mice did not show alveolar buds, whereas the progesterone-treated groups did have alveolar maturation, indicating supraphysiological and pregnancy-like development compared to non-pregnant mice (Skarda, Fremrová, & Bezecnyý, 1989). In any case, one study employed low doses of progesterone (0.1 mg/day), one-tenth of that used in most other studies (1 mg/day), and found that progesterone still stimulated significant ductal development in mice at these doses (Aupperlee et al., 2013; Berryhill, Trott, & Hovey, 2016). Hence, progesterone is still able to stimulate some level of ductal growth in mice even at lower levels.

    Although progestogens by themselves can apparently stimulate normal pubertal mammary development in lieu of estrogen exposure in mice, it is not clear that they do so similarly in humans. It is well-known that progestogens alone, without concomitant estrogenic activity, do not generally produce breast development in humans. As an example, progestogens, for instance MPA and CPA, have been used as puberty blockers in boys and girls at very high doses, and do not produce breast development in this context, instead causing arrest and regression of breast development via gonadal suppression (Lyon, De Bruyn, & Grant, 1985; Fuqua & Eugster, 2022). Cases of gynecomastia in boys have occurred with CPA, but only in a minority and with this easily attributable to other causes than progestogenic activity, for instance the antiandrogenic activity of CPA and disruption of the HPG axis (Kauli et al., 1984; Laron & Kauli, 2000). Similarly, progestogens like MPA and CPA have been used at very high doses in men to treat prostate conditions and sexual disorders, and likewise do not usually produce gynecomastia under these circumstances. Rates of gynecomastia with CPA used in the treatment of prostate cancer are low and are not noticeably different from the rates with surgical or medical castration (~10%) (Fourcade & McLeod, 2004; Di Lorenzo et al., 2005). This is in major contrast to the high rates of gynecomastia with estrogens and nonsteroidal antiandrogens (up to 70–80%) (Fourcade & McLeod, 2004; Di Lorenzo et al., 2005; Deepinder & Braunstein, 2012). Species differences may be present such that progestogens can produce robust pubertal mammary development in mice but do not do so in humans.

    Progesterone and Gestational Mammary Development in Animals

    As in humans, pregnancy results in increased levels of estrogen, progesterone, prolactin, and many other hormones in various animal species like rodents and non-human primates (Hasan, 1974; Cowie, Forsyth, & Hart, 1980; Pasqualini & Kincl, 1985; Günzel et al., 1987; Seibert & Günzel, 1994). Along with this, there are dramatic changes in the mammary glands (Cowie, Forsyth, & Hart, 1980; Richert et al., 2000; Cline & Wood, 2008; McNally & Stein, 2017). This includes extensive lobuloalveolar maturation of the mammary glands in preparation of lactation and nursing (Cowie, Forsyth, & Hart, 1980; Richert et al., 2000; Cline & Wood, 2008; McNally & Stein, 2017). Permanently enlarged breasts, mainly due to accumulation of abundant adipose tissue during puberty, is unique to humans, and in animal species, although there is significant growth with puberty (e.g., Geschickter, 1945 [Figure]), the exterior mammae enlarge considerably only with pregnancy (Pawłowski & Żelaźniewicz, 2021). In the case of macaques, there is a roughly 10- to 20-fold increase in the glandular tissue during pregnancy (Cline & Wood, 2008).

    Administration of exogenous estradiol and progesterone in specific amounts to virgin adult females of various animal species, including rodents, results in mammary development that is very similar to that which occurs normally during pregnancy (Nelson, 1936; Turner, 1939; Folley, 1940; Folley, 1947; Folley & Malpress, 1948; Folley, 1950; Folley, 1952; Folley, 1956; Lyons, 1958; Lyons, Li, & Johnson, 1958; Cowie & Folley, 1961; Jacbosohn, 1961; Cole & Hopkins, 1962; Lloyd & Leathem, 1964; Meites, 1966; Bässler, 1970; Ceriani, 1974; Vorherr, 1974b; Cowie, Forsyth, & Hart, 1980; Tucker, 2000; Kleinberg, 2006; Kleinberg & Ruan, 2008; Kleinberg et al., 2009; Kleinberg & Barcellos-Hoff, 2011). High levels of prolactin also occur in this context, as estrogen and progesterone induce production and secretion of prolactin from the pituitary gland (Ceriani, 1974; Bethea, Kohama, & Pecins-Thompson, 1997; Camilletti et al., 2019). Although estradiol and progesterone alone seem to be adequate for producing full pregnancy-type mammary development in many species, the combination of estradiol, progesterone, and placental lactogen in rhesus monkeys produced considerably less lactational activity than occurs during normal pregnancy in this species (Beck, 1972; Cowie, Forsyth, & Hart, 1980). In relation to this, placental lactogen and/or additional hormonal factors may also be necessary for complete pregnancy-like mammary gland maturation in primates (Beck, 1972; Cowie, Forsyth, & Hart, 1980).

    As with humans, following cessation of lactation and nursing, the mammary glands are well-known to undergo post-lactational involution and to return to a pre-pregnancy-like state in animals, including in rodents and monkeys (Richert et al., 2000; Cline & Wood, 2006; Cline & Wood, 2008; Fridriksdottir, Petersen, & Rnnov-Jessen, 2011; McNally & Stein, 2017).

    Breast Changes with Therapeutic Pseudopregnancy

    Therapeutic or pharmacological pseudopregnancy is a type of hormone therapy that attempts to replicate the hormonal mileu of pregnancy for certain medical indications in cisgender females by administering exogenous hormones. In practice, this has involved the administration of very high doses of estrogens and progestogens, with most other pregnancy hormones not included. Therapeutic pseudopregnancy was first developed in the 1950s and is largely no longer used in medicine today (Kaiser, 1993).

    The effects of therapeutic pseudopregnancy on the breasts are of interest due to the breast changes that occur during pregnancy, for instance lobuloalveolar development and substantial reversible breast enlargement. In the 1980s, Lauritzen and colleagues conducted a study of therapeutic pseudopregnancy for treatment of breast hypoplasia (small/underdeveloped breasts) in cisgender women (Lauritzen, 1980; Lauritzen, 1982; Lauritzen, 1989; Göretzlehner & Lauritzen, 1992). They employed the estrogen estradiol valerate 40 mg/week and the progestogen hydroxyprogesterone caproate (OHPC) 250 to 500 mg/week both by intramuscular injection for 4 to 5 months. The estradiol valerate dosage employed was very high, with other studies by the same authors reporting that this dosage of estradiol valerate resulted in first-trimester pregnancy levels of estradiol in women (~3,000 pg/mL [~11,000 pmol/L]) (Ulrich, Pfeifer, & Lauritzen, 1994; Ulrich et al., 1995). These estradiol levels are roughly 30 times the normal concentrations outside of pregnancy (Aly, 2018b). Similarly, the OHPC doses were very high, with 250 to 500 mg per month being similar in strength to luteal-phase progestogenic exposure (Wiki). Hence, as the same OHPC doses were used weekly in the study, the doses were roughly around 4.5 times luteal-phase exposure and thus were analogously similar to first- or second-trimester progesterone levels in terms of strength (Aly, 2020d). The authors noted that they had initially tried lower hormone doses, similar to those originally used in the 1950s, but did not achieve significant breast growth with these doses, and so increased the dosage. Breast changes were measured in the study with a tape measure (applied horizontally and vertically to the breast area), photographs, breast imaging using mammography and sonography, and, later in the study, plasticine impressions/molds with determination of the filling volume.

    Lauritzen and colleagues reported the study findings in four different publications with different follow-up times and growing sample sizes. In the final follow-up, a total of 221 women had been treated. In the second follow-up, when 78 women had been treated, it was noted that 29 of the cases (37%) were less than 18 years old. However, in the final follow-up of 221 women, the age range was listed as 18 to 42 years. The researchers found that breast volume increased by 10 to 30% above baseline in 65% of the women. This was also accompanied by breast tenderness in almost all of the women, though the breast tenderness progressively declined during the treatment period. Other breast-related side effects like pigmentation and stretch marks were rarely observed. Prolactin levels slightly increased to 14 to 28 pg/mL by the end of treatment. Breast imaging showed an increase in the density of breast glandular tissue. The researchers claimed that the increase in breast size in their study was due to increased adipose tissue, water retention, and moderate hypertrophy of the glandular tissue.

    Following treatment discontinuation, the increases in breast volume gradually and partially regressed in 40% of the women, to an increase of 10 to 20% above baseline. However, the authors claimed that the regression in breast volume could be reduced with adequate-dose combined estrogen–progestogen birth control pills or with topical estrogen and progestogen therapy applied to the breasts. In addition, they noted that therapeutic pseudopregnancy could be repeated to increase breast volume again. This was performed in a subset of the women, with treatment repeated 1 to 2 times after 6 months. In the second follow-up, which had 78 women, it was noted that 12 women (15%) had undergone multiple treatments. Aside from Lauritzen and colleagues, many other researchers have also reported substantial or full regression in breast size following estrogen and/or progestogen therapy to increase breast size in cisgender women (e.g., Cernea, 1944; Müller, 1953; Anderson, 1962; Bruck & Müller, 1967; Keller, 1984; Kaiser & Leidenberger, 1991; Keller, 1995; Hartmann et al., 1998).

    The findings of Lauritzen and colleagues were reported very informally, in the form of non-peer-reviewed book chapters, conference papers, and medical magazines, and were never published in a peer-reviewed journal article. In relation to this, the methodology and results of the study were only briefly and imprecisely described. There are also additional concerns related to study design, such as lack of controls, randomization, and the quality of the breast measurement methods. As a result of the preceding issues, it is difficult to fully interpret the results of the study and to have complete confidence in its findings. In any case, Lauritzen and colleages’ results suggest that treatment with high-dose combined estrogen–progestogen therapy, achieving earlier-pregnancy estrogenic and progestogenic exposure, may be able to produce a significant temporary increase in breast size and a smaller long-term increase. The findings of a permanent increase in breast size conflict with those of other researchers who have reported complete regression in breast changes following treatment discontinuation. Moreover, the results are contradicted by findings in pregnant women, who, as described previously, show complete reversion to pre-pregnancy breast size or to even slightly smaller breasts following cessation of lactation.

    It is difficult to evaluate the relative roles of the estrogen and the progestogen in the findings of Lauritzen and colleagues, as there were no comparison groups employing estrogen or progestogen therapy alone in the study. Both estrogens and progestogens have been implicated in causing breast enlargement and plausibly could have contributed to the breast changes. As such, it is unclear to what extent the breast changes were specifically due to progestogenic exposure rather than to estrogenic exposure.

    The breast size increases observed by Lauritzen and colleagues were seemingly more modest relative to those that occur normally during pregnancy. They also lacked certain characteristics of pregnancy-related breast changes, like nipple and areolar pigmentation. The reasons for this are not fully clear. The subject populations between these studies were different, for instance in terms of factors like initial breast size and age, which may be contributing reasons. Another possible contributing factor is that only estrogen and progestogen levels increased in the study, whereas levels of other pregnancy hormones, besides the slight increase in prolactin levels, did not increase. These other pregnancy hormones, for instance hPL and IGF-1, may also be involved in breast development during pregnancy. Finally, the treatment duration was only 4 to 5 months, and the estrogen and progestogen exposure was only similar to that during early-to-mid pregnancy, whereas normal pregnancy lasts 9 months and involves continued dramatic increases in estrogen and progesterone levels through to childbirth.

    It should be noted that, owing to the highly supraphysiological estrogen and progestogen levels required, which can cause serious health complications like blood clots and cardiovascular problems (Aly, 2020e), as well as the small to negligible lasting increase in breast volume, therapeutic pseudopregnancy is inadvisable for transfeminine people and should not be pursued or employed. Nonetheless, the historical findings of therapeutic pseudopregnancy for increasing breast size in cisgender females are of significant theoretical interest in exploring the roles of estrogens and progestogens in breast growth.

    Early Progestogen Exposure and the Possibility of Suboptimal Breast Development

    While progestogens are typically sought after by transfeminine people for their potential in improving breast development, there have also been various suggestions in the literature that early or premature exposure to progestogens may result in suboptimal breast development and that progestogens may suppress or reduce estrogen-mediated breast development. These suggestions include progestogens having known antiestrogenic effects in the breasts, animal studies finding stunted mammary development with high doses of progestogens, clinical publications cautioning against premature introduction of progestogens in female puberty induction due to concerns about possibly stunted breast growth, clinical use of progestogens to treat macromastia in cisgender females, poor breast development with estrogen therapy in cisgender girls with a disorder of sexual development that results in high progesterone exposure, and breast development with estrogen and CPA (a very strong progestogen) typically being poor in transfeminine people. As with the question of whether progestogens can enhance breast development, it is currently unknown whether progestogens could worsen breast development. It is also unknown what dosage level and timing of introduction would be required for such an effect. In any case, for informational purposes, the preceding topics will each be discussed in the subsequent sections.

    Antiestrogenic Effects of Progestogens in the Breasts

    Progestogens are well-known to have potent functional antiestrogenic effects in tissues such as the uterus, vagina, and cervix (Wiki). The antiestrogenic effects of progestogens in the uterus are in fact the reason that they are used in menopausal hormone therapy—to prevent the risks of endometrial hyperplasia and endometrial cancer that unopposed estrogen therapy otherwise produces (Wiki). Progestogens also appear to have antiestrogenic effects in the breasts (Mauvais-Jarvis, Kuttenn, & Gompel, 1986a; Mauvais-Jarvis, Kuttenn, & Gompel, 1986b; Mauvais-Jarvis, Kuttenn, & Gompel, 1987; Mauvais-Jarvis et al., 1987; Kuttenn et al., 1994; Wren & Eden, 1996; Plu-Bureau, Touraine, & Mauvais-Jarvis, 1999; Wiki). This may include by inhibiting estrogen synthesis and enhancing estrogen inactivation in the breasts (Pasqualini, 2007; Pasqualini, 2009) and by reducing expression of the estrogen receptors in the breasts (Mauvais-Jarvis, Kuttenn, & Gompel, 1986b; Malet et al., 1991; Kuttenn et al., 1994; Wren & Eden, 1996; Graham & Clarke, 1997; Plu-Bureau, Touraine, & Mauvais-Jarvis, 1999). Clinical studies have found that direct application of topical progesterone to the breasts suppresses estradiol-mediated breast cell proliferation, although this may be due to the delivery of supraphysiological levels of progesterone in the breasts (Barrat et al., 1990; Chang et al., 1995; Foidart et al., 1996; Spicer, Ursin, & Pike, 1996; Foidart et al., 1998; de Lignières, 2002; Gompel & Plu-Bureau, 2018; Trabert et al., 2020). In accordance with their antiestrogenic effects in the breasts, progestogens are considered to be useful in treating estrogen-dependent benign breast disorders such as breast pain, nodularity, and fibrocystic breast disease (Mauvais-Jarvis, Sitruk-Ware, & Kuttenn, 1981; Winkler et al., 2001; Schindler, 2011; Wiki; Wiki; Wiki). Progestogens have also been reported to antagonize nipple and areolar hyperpigmentation induced by high-dose estrogen therapy (Crowley & Macdonald, 1965). In contrast to the preceding findings however, the addition of a progestogen to an estrogen in menopausal hormone therapy has been shown to significantly increase the risk of breast cancer (Aly, 2020a; Wiki). In any case, the antiestrogenic effects of progestogens in the breasts provide a plausible potential mechanism by which they might limit estrogen-mediated breast development. However, an alternative possible mechanism is that such actions may be related to simultaneous induction of ductal development and lobuloalveolar maturation, the latter of which is notably not normal for puberty (Randolph, 2018).

    Stunted Mammary Growth with Progestogens in Animal Studies

    Animal studies using progestogens including bioidentical progesterone and chlormadinone acetate (CMA), a progestin closely related to CPA, have found that high doses of these progestogens substantially stunt mammary gland development in rabbits, whereas lower doses do not do so (Lyons & McGinty, 1941; Beyer, Cruz, & Martinez-Manautou, 1970). See here for relevant literature excerpts as well as figures from these studies. Lyons & McGinty (1941) [Figure] found that estrogen alone induced ductal mammary development and estrogen plus progesterone 0.25 to 1 mg/day produced ductal development and slight to “fair” lobuloalveolar development. Conversely, estrogen plus progesterone 4 to 8 mg/day, which were 4- to 8-fold higher doses of progesterone than the most optimal dose, produced stunted mammary development with inhibited ductal development, only slight lobuloalveolar development, and, at the highest dosage, resulted in a much smaller mammary gland in terms of size than in the ≤1 mg/day groups. They concluded that high doses of progesterone are inhibitory and result in relatively poor mammary development. In the paper, doses of progesterone in international units (IU) were reported, but a citing review, Pfeiffer (1943), indicated that 1 IU progesterone is equal to 1 mg progesterone. As such, the milligram doses are listed above instead. Beyer, Cruz, & Martinez-Manautou (1970) [Figure] found that estrogen alone produced good ductal development without lobuloalveolar growth (mean mammary area = 376 mm2) and both estrogen plus CMA 0.5 mg/day and estrogen plus progesterone 2.5 mg/day produced optimal ductal and lobuloalveolar development (mean mammary area = 765 mm2 and mean mammary area = 688 mm2, respectively). Conversely, estrogen plus CMA 2.5 mg/day, a 5-fold higher dose of CMA than the optimal dose, resulted in dramatically reduced ductal development and mammary gland size albeit with significant lobuloalveolar growth (mean mammary area = 284 mm2). The authors concluded that moderate doses of progestogens stimulate mammary gland growth whereas large doses inhibit mammary gland development.

    While these animal studies are suggestive that high doses of progestogens may be able to stunt breast development in humans, this is far from a certainty. There are species differences in hormone-mediated mammary development such that findings in one species, such as rabbits, may not translate to another species, like humans, or sometimes even to closely related species, like rats or guinea pigs (Bässler, 1970). As far as the present author is aware, stunted mammary development with high doses of progestogens has not been studied or reported in other animal species, for instance other rodent species or monkeys. It is also unclear that the doses employed in these animal studies are necessarily relevant to progestogen therapy in humans. This is because pregnancy levels of progesterone, which are much higher than luteal-phase progesterone levels, are necessary for substantial mammary lobuloalveolar development, and the doses of progestogens used in these studies were above that magnitude of progestogenic exposure. Hence, the doses may have corresponded to what in humans would be extremely high doses. However, such doses could still be relevant in the case of CPA used as an antiandrogen in humans, as CPA is used in this context at very high doses (see section below). The present author is unaware of any animal studies finding that physiological non-pregnancy levels of progesterone have any stunting or other adverse influence on mammary development, suggesting that only high doses of progestogens may have such effects. Finally, it seems notable that the estrogen and progestogen were initiated simultaneously in these animal studies and yet produced optimal pregnancy-like mammary development at the right doses. This suggests that early or immediate progestogen exposure might not be unfavorable in terms of breast development in humans. However, once again species differences may be present and confirmatory clinical studies are needed in humans.

    Clinical Publications Cautioning Against Premature Introduction of Progestogens Due to Possibly Stunted Breast Development

    A large number of clinical publications largely in the pediatric endocrinology literature have warned that premature exposure to progestogens during for instance puberty induction may result in suboptimal breast development in cisgender girls and/or transfeminine people (Zacharin, 2000; Bondy et al., 2007; Colvin, Devineni, & Ashraf, 2014; Wierckx, Gooren, & T’Sjoen, 2014; Kaiser & Ho, 2015; Bauman, Novello, & Kreitzer, 2016; Gawlik et al., 2016; Randolph, 2018; Donaldson et al., 2019; Heath & Wynne, 2019a; Heath & Wynne, 2019b; Iwamoto et al., 2019; Crowley & Pitteloud, 2020; Naseem, Lokman, & Fitzgerald, 2021; Federici et al., 2022; Lucien et al., 2022; Rothman & Iwamoto, 2022). The full relevant excerpts from these sources can be found here. In relation to these claims, and in order to mimic normal female puberty, a progestogen is not typically added to estrogen therapy during puberty induction in cisgender girls with delayed puberty until after about 2 to 3 years of treatment, by which point breast growth is generally considered complete. Additionally, progestogens are generally never added as part of puberty induction in transfeminine adolescents. Despite the preceding widespread literature statements and accepted clinical practices in the field of puberty induction however, it is important to note that the claims that premature introduction of progestogens might stunt breast development in this context are currently not based on any actual reliable clinical evidence and hence remain unsubstantiated. It is not even clear that these statements are based on anecdotal clinical experience as opposed to simple conjecture. The absence of data in this area may finally change in the future as more clinical studies of progestogens in puberty induction in cisgender girls are conducted (e.g., Rodari et al., 2023).

    Rodari and colleagues studied optimization of puberty induction with estrogen therapy followed by eventual introduction of progestogen therapy in 49 cisgender girls with hypogonadism (e.g., Rodari et al., 2022; Rodari, 2022; Rodari et al., 2023). The researchers employed incrementally titrated low-dose transdermal estradiol to mimic the low and gradually increasing estradiol levels during normal puberty and added a progestogen only once menstrual bleeding began. The total duration of treatment was mean 2.65 ± 1 years, the time of first menstrual bleeding occurrence was 2.3 ± 1 years, and the time of progestogen introduction was median 2.22 years (IQR 1.56–2.87 years). Of the girls, 90% reached Tanner breast stage 4, but only 41% reached Tanner breast stage 5. Reaching the final Tanner breast stage was significantly associated with the number of estradiol dose increases (i.e., gradual estradiol dose titration) and the estradiol dose at progestogen introduction. The researchers interpreted the latter finding as progestogen exposure potentially hampering breast development. They questioned introducing progestogen therapy in the presence of incompletely developed breasts and suggested that instead of adding a progestogen upon onset of menstrual bleeding, clinicians should consider slightly reducing the estradiol dosage to delay progestogen introduction until the breasts complete maturation. While interesting, it must be noted that the findings of Rodari and colleagues are merely correlational, are open to multiple interpretations, and do not causally show that progestogens impair breast maturation.

    Progestogens in the Treatment of Breast Hypertrophy

    Low progesterone levels have been suggested as a possible contributing factor in the development of pubertal macromastia (breast hypertrophy) (Sun et al., 2018). A number of case reports and series of progestogens in the treatment of pubertal macromastia have been published (Sperling & Gold, 1973; Boyce, Hoffman, & Mathes, 1984; Ryan & Pernoll, 1985; Aritaki et al., 1992; Gliosci & Presutti, 1993; Sridhar & Jaya Sinha, 1995; Baker et al., 2001; Dancey et al., 2008; Bland, Howard, Romrell, 2009; Hoppe et al., 2011; Sun et al., 2018). Progestogens such as dydrogesterone, MPA, and CPA were used for this purpose in an attempt to stop or slow the growth of the breasts under the assumption that they are functionally antiestrogenic in breast tissue. Clinical success in these limited cases was mixed. Due to the self-resolving nature of pubertal macromastia (i.e., breast development stops on its own eventually) and other methodological limitations, such as very small numbers of individuals and lack of untreated control groups, it is difficult to draw any reliable conclusions about effectiveness from these reports.

    More recently, a couple of studies, both by the same group of researchers, assessed the impact of different types of hormonal contraception on macromastia in adolescent cisgender females with macromastia (Nuzzi et al., 2021; Nuzzi et al., 2022). They found that use of progestin-only contraceptives were associated with significantly more breast tissue removed upon surgical breast reduction (959.9 g/m2 vs. 735.9 g/m2 [+30%]; p = 0.04) and worse clinical symptoms (e.g., breast pain—odds ratio, 4.94, p = 0.005) relative to non-users of hormonal contraception (Nuzzi et al., 2021). Conversely, use of combined oral contraceptives, which are estrogen–progestogen preparations, were associated with significantly less breast tissue removed with breast reduction (639.5 g/m2 vs. 735.9 g/m2 [−13%]; p = 0.003), though not with any differences in clinical symptoms, relative to those naive to hormonal contraception (Nuzzi et al., 2022). It should be noted that progestin-only contraceptives suppress the HPG axis and result in low estradiol levels, whereas combined oral contraceptives suppress the HPG axis and lower estradiol production but simultaneously supplement estrogen signaling by delivering exogenous estrogen. This difference may somehow be responsible for the opposite influence of estrogen–progestogen therapy versus progestogen-alone therapy on macromastia severity. While the findings of Nuzzi and colleagues are interesting, it is noteworthy that the methodology and findings of their research were criticized on various grounds in a letter to the editor concerning one of the articles (Karp, 2022).

    Poor Breast Development in 17α-Hydroxylase/17,20-Lyase Deficiency

    Poor breast development with exogenous estrogen therapy has been reported in cisgender girls with 17α-hydroxylase/17,20-lyase deficiency, and prior exposure to high progesterone levels consequent to the condition has been hypothesized to be responsible for this (Turan et al., 2009; Athanasoulia et al., 2013; Deeb et al., 2015; Çamtosun et al., 2017; Fernández-Cancio et al., 2017; Kardelen et al., 2018). However, this is only speculation, and at this time, there is no causal evidence or other substantiation that progesterone specifically is responsible for the observations of poor breast growth.

    Non-Comparative Clinical Studies of Breast Development with Estrogen and Cyproterone Acetate in Transfeminine People

    The possibility of suboptimal breast development with premature exposure to progestogens is of particular relevance in the case of CPA used as an antiandrogen in transfeminine people. This is because CPA is a potent progestogen in addition to antiandrogen, starts to be taken at the initiation of hormone therapy, and happens to be used in transfeminine people at doses that result in very strong to profound progestogenic exposure (Aly, 2019). In terms of progestogenic strength, CPA at a dosage of 2 mg/day is comparable to the progesterone exposure during the luteal phase of the menstrual cycle (Aly, 2019; Wiki). For comparison, CPA has been used in transfeminine people at doses ranging from 10 to 100 mg/day (Aly, 2019). This would mean that CPA provides roughly 6.25 times the progestogenic impact of luteal-phase progesterone exposure at a dosage of 12.5 mg/day, 12.5 times the impact at 25 mg/day, 25 times the impact at 50 mg/day, and 50 times the impact at 100 mg/day. Moreover, this does not consider the fact that progesterone is only produced during the luteal phase, or half of the menstrual cycle, whereas CPA is taken continuously every day of the month. The preceding magnitudes of progestogenic exposure with CPA are on par with and even beyond those during pregnancy. Only recently have lower doses of CPA (e.g., ≤12.5 mg/day) started to be used in transfeminine hormone therapy.

    Studies in pubertal and adolescent transfeminine people given GnRH agonists to block puberty plus estrogen therapy have reported good breast development in these individuals as assessed by subjective clinical impression or Tanner staging (de Vries et al., 2010; Hannema et al., 2017). However, quality objective measures of breast development were not employed in these studies. Conversely, non-comparative studies using estrogen plus CPA in adult transfeminine people have commonly reported modest breast development, including incomplete breast development only to Tanner stage 2 to 4, small breast cup sizes, and small breast volumes (Kanhai et al., 1999; Sosa et al., 2003; Sosa et al., 2004; Wierckx et al., 2014; Fisher et al., 2016; Tack et al., 2017; de Blok et al., 2018; Reisman, Goldstein, & Safer, 2019; Meyer et al., 2020; de Blok et al., 2021). Additionally, breast sizes smaller than those in cisgender women have been reported (Asscheman & Gooren, 1992; Kanhai et al., 1999). In one study, breast development with estrogen plus CPA was also poor in late-adolescent transfeminine people (Tack et al., 2017). However, in this particular study, the estrogen dose used was likely too low and resulted in inadequate estradiol levels, as noted by the authors themselves, and this is a potential confounding factor in their findings (Tack et al., 2017). In any case, breast growth with estrogen plus CPA in transfeminine people would seem to consistently be poor. In contrast to the regimen of estrogen and CPA, breast development with other hormone therapy regimens, for instance estrogen with non-progestogenic antiandrogens like spironolactone, bicalutamide, and GnRH modulators, has not been nearly as well-studied in comparison, and hence comparisons of outcomes between regimens is difficult.

    In one of the highest quality studies of estrogen and CPA and breast development in adult transfeminine people, breast volume measured with 3D body scanning (Vectra XT) was approximately mean 100 mL (95% CI ~75–125 mL; range up to ~750 mL), equating to less than an A cup size on average, after 3 years of hormone therapy with estrogen and CPA in 69 transfeminine people (de Blok et al., 2021 [Figure]). In this study, breast changes over time had clearly plateaued, suggesting that breast development was either complete or was nearly so (de Blok et al., 2021 [Figure]). Although most of the transfeminine people in this study had less than an A cup breast size (71%), a minority had cup sizes ranging from an A cup (9%), B cup (16%), C cup (3%), to E cup (1%) (de Blok et al., 2021 [Figure]). For comparison, a study of normative data on breast volumes in cisgender women, using a different 3D body scanning device (Artec Eva 3D), found breast volumes of median ~515 mL and mean ~650 mL (IQR ~310–850 mL; range ~50–3,100 mL) in 378 cisgender women (Coltman, Steele, & McGhee, 2017). As such, adult transfeminine people treated with estrogen and CPA would appear to have substantially smaller breasts than cisgender women. However, it must be emphasized that the preceding data come from separate clinical studies and hence are not directly comparative. It is noteworthy in this regard that breast volumes can vary considerably between different studies even using similar measurement methods (e.g., magnetic resonance imaging) (Sindi et al., 2019 [Table]). Hence, there is a need for studies directly comparing breast volumes in transfeminine people to those in cisgender women using the same measurement method in order to comparatively evaluate breast development.

    Regardless of the preceding, transfeminine people could simply have poor breast development in general without this necessarily being related to CPA or progestogenic exposure. Indeed, a more recent study in transfeminine people who underwent pubertal suppression in adolescence, presumably with GnRH agonists and then estrogen therapy, found similarly poor breast development as has been reported in adults (Boogers et al., 2022; c.f. de Blok et al., 2021). This study used breast volume via 3D body scanning to measure breast development and found a mean breast volume of 114 mL (IQR 58–203 mL), equating to less than an A cup size, after 4.2 years of hormone therapy (Boogers et al., 2022). It was notably conducted by the same group of researchers who did the earlier higher-quality study in adult transfeminine people, and hence likely used the same 3D scanning method (de Blok et al., 2021).

    No directly comparative studies of breast development with CPA versus other antiandrogens in transfeminine people are currently available. Hence, it’s not fully known whether the findings are specific to CPA or also generalize to other antiandrogens that are not also strongly progestogenic. The RCT of estradiol and spironolactone versus estradiol and CPA in transfeminine people by Ada Cheung and colleagues that is currently underway in Australia may provide more insight on this issue, as spironolactone is only a weakly or clinically non-progestogenic antiandrogen (Aly, 2018b; Wiki).

    Additional Considerations for Progestogen Therapy and Breast Development in Transfeminine People

    Anecdotes About Progestogens and Breast Development

    Many transfeminine people who have taken progestogens as part of hormone therapy have anedotally reported that the progestogens improved their breast development. At the same time, many other transfeminine people have anecdotally reported no benefit of progestogens to breast development. It must be cautioned in general that anecdotal reports are unreliable and represent a very low form of medical evidence. This is because subjective observations and attributions are often erroneous. Perceptions can be faulty and inaccurate, especially with slowly developing physical changes, and true physical changes can be due to coincidence and unrelated confounding factors rather than due to a person’s causal attributions. A couple notable examples of potential confounding factors with regard to progestogens and breast development include: (1) continued breast development from estrogen acting on its own; and (2) temporary breast enlargement due to local fluid retention, increased blood flow, and reversible lobuloalveolar growth caused by progestogens. Such factors have the potential to mislead, and may contribute significantly to anecdotal reports of enhanced breast development with progestogens in transfeminine people. Clinical studies that are well-designed, controlled, and employ reliable objective measures, with long-term follow-up and eventual discontinuation of the progestogen to control for reversible effects, are needed to properly evaluate the effects of progestogens on breast development.

    Therapeutic Limitations of Oral Progesterone

    Oral progesterone producles very low progesterone levels and has only weak progestogenic effects even at high doses (Aly, 2018a; Wiki). These low progesterone levels are likely to be inadequate in terms of desired physiological progestogenic effects, for instance in the breasts. Oral progesterone also uniquely has potent neurosteroid actions via active metabolites like allopregnanolone, which can result in prominent side effects such as alcohol-like central nervous system inhibition as well as mood swings (Aly, 2018b; Wiki; Wiki). These neurosteroid effects are dose-dependent and are more severe at high doses. Non-oral progesterone forms like rectal or injectable progesterone or progestins, which do not have the preceding problems, can be used instead to avoid such concerns (Aly, 2018a; Aly, 2018b).

    Tolerability and Safety Considerations for Progestogens

    Progestogens have a variety of tolerability issues and safety risks (Aly, 2018b). Examples of such risks variously include adverse mood changes, breast cancer, blood clots, cardiovascular complications, benign brain tumors including prolactinomas and meningiomas, and off-target actions with undesirable effects (e.g., androgenic or glucocorticoid activity), among others (Aly, 2018b). CPA at high doses also uniquely has a significant risk of serious liver toxicity (Aly, 2018b). The risks of progestogens vary depending on the specific progestogen and dosage, but all progestogens, including even bioidentical progesterone, have significant known risks. The risks of progestogens, along with lack of evidence of beneficial effects in terms of feminization, well-being, and health, in transfeminine people, are why there are concerns about and restrictions on their use in transfeminine people (Aly, 2018b). However, cisgender women naturally have progesterone in their bodies, and the absolute risks of progestogens are low (Aly, 2018b). The risks of progestogens can be minimized by use for a limited duration of time (e.g., a few years), by using the lowest dosages expected to be effective in terms of desired effects, and by selection of progestogens with more favorable pharmacological profiles (Aly, 2018a; Aly, 2018b).

    Updates

    Update 1: Angus et al. (2023–2024)

    It was previously reported in this article that an RCT assessing breast development with estradiol plus spironolactone versus estradiol plus CPA in transfeminine people was being conducted by Ada Cheung and colleagues. This study could provide more insight into breast development with progestogens, as CPA is a very potent progestogen whereas spironolactone is not meaningfully progestogenic. Cheung and colleagues’ study, led by Lachlan Angus, has now been published in the form of the following two conference abstracts, with a journal article also currently in the process of being published:

    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (November 2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (November 2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]

    The study assessed estradiol plus spironolactone 100 mg/day versus estradiol plus CPA 12.5 mg/day in 55 transfeminine people, with 27 in the spironolactone group and 28 in the CPA group. Hormone therapy duration, at least at this follow-up point in the study, was 6 months. The measures of breast development included breast–chest difference (primary) and estimated breast volume (secondary).

    Breast development, measured by breast–chest difference (mean ± SD), was 8.3 ± 2.7 cm with spironolactone and 9.2 ± 3.0 cm with CPA, with the differences between groups not statistically significant (p = 0.27). In addition, breast development, measured by estimated breast volume (mean ± SD), was 158 ± 112 mL with spironolactone and 190 ± 159 mL with CPA, with the differences between groups not statistically significant (p = 0.39). There was variability between individuals in estimated breast volume, with breast volume measurements ranging from 20 to 788 mL. Besides breast growth, the researchers found that CPA also resulted in a greater increase in body fat percentage and gynoid fat compared to spironolactone. Estradiol levels were comparable between antiandrogen groups, whereas total testosterone levels were (mean ± SD) 4.29 ± 5.44 nmol/L (124 ± 157 ng/dL) with spironolactone and 1.48 ± 3.45 nmol/L (43 ± 99 ng/dL) with CPA, a difference that was statistically significant (p = 0.04).

    The researchers concluded that there was no difference in breast development with spironolactone versus CPA in their study and that antiandrogen choice should be individualized based on patient and clinician preference as well as consideration of associated side effects. Moreover, they concluded that further research is needed to optimize breast development in transfeminine people.

    The measure of breast volume in the study was the BreastIdea Volume Estimator, a freely available web app that employs 2D photography to provide an estimate of breast volume (Mikołajczyk, Kasielska-Trojan, & Antoszewski, 2019; Kasielska-Trojan, Mikołajczyk, & Antoszewski, 2020). This breast volume measure has been validated in both cisgender women and cisgender men (Mikołajczyk, Kasielska-Trojan, & Antoszewski, 2019; Kasielska-Trojan, Mikołajczyk, & Antoszewski, 2020). Additionally, Cheung and Angus, along with other colleagues, notably including some of the original developers of the BreastIdea Volume Estimator, validated the BreastIdea Volume Estimator in cisgender men and transfeminine people in the following 2022 conference abstract study:

    • Angus, L., Mikolajczyk, M., Cheung, A., Zajac, J., Antoszewski, B., & Kasielska-Trojan, A. (2022). Estimation of breast volume in transgender women using 2D photography: validation of the BreastIdea Volume Estimator in men and transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 279). [URL] [PDF] [Full Abstract Book]

    In studies by the developers of the BreastIdea Volume Estimator, they reported breast volumes measured with the tool in cisgender women. These estimated breast volumes can provide comparison to the breast-volume findings in transfeminine people by Cheung and Angus and colleagues. The developers of the BreastIdea Volume Estimator reported that breast volume (mean ± SD) in cisgender women with normal breasts (n=30) was 283 ± 144 mL and in cisgender women with macromastia or gigantomastia (n=35) was 888 ± 277 mL (Kasielska-Trojan, Zawadzki, & Antoszewski, 2022). In another study, they reported that breast volume (mean ± SD) in cisgender women was 272 ± 150 mL, with a range of 99 to 694 mL (Kasielska-Trojan, Mikołajczyk, & Antoszewski, 2020).

    Although the BreastIdea Volume Estimator is an interesting and promising tool for quantifying breast development, it has notable limitations, such as its resolution and accuracy being much less than that with 3D scanners like the Artec Eva and Vectra XT (Mikołajczyk, Kasielska-Trojan, & Antoszewski, 2019). Vectra and Artec 3D scanners have been and are being employed to measure breast development with hormone therapy in other studies in transfeminine people (de Blok et al., 2021; Boogers et al., 2022; Dijkman et al., 2023a; Dijkman et al., 2023b; Lopez et al., 2023). The accuracy limitations of the BreastIdea Volume Estimator may explain why the breast volume findings with it in transfeminine people and cisgender women were different from those seen in other studies that employed more advanced 3D scanning methods. Aside from the breast volume measurement, breast–chest difference also has limitations as a measure of breast development in transfeminine people, for instance failing to identify continued breast growth that can be detected with breast volume measurement (de Blok et al., 2021).

    Besides the employed measurement methods for breast development, limitations of Lachlan Angus and colleagues’ RCT of breast development with spironolactone and CPA in transfeminine people include its limited duration of follow-up of only 6 months, the fact that testosterone levels were non-equivalent between the spironolactone and CPA groups, and its limited sample size. The incompletely suppressed testosterone levels with spironolactone are notable as androgens oppose estrogen-mediated breast development and could have reduced breast development in the spironolactone group. The limited sample size of the study was responsible for the numeric difference in breast measurements between antiandrogen groups not being statistically significant. In any case, Angus and colleagues’ findings are suggestive that CPA, which is highly progestogenic, neither enhances nor stunts breast development, at least relative to non-progestogenic spironolactone for up to 6 months of hormone therapy. It seems likely that the RCT will continue to longer follow-up times and durations of hormone therapy in the future.

    Update 2: Tim, Jeroen, & T’Sjoen (2023) and Yang et al. (2024)

    The following two recent studies provide additional information on the topic of breast development with progestogen exposure—specifically with CPA—in transfeminine people:

    • Tim, F., Jeroen, V., & T’Sjoen, G. (November 2023). Dose Reduction of Cyproterone Acetate in Trans Women and the Effect on Patient-reported Outcomes: Results from the ENIGI Study. Endocrine Abstracts, 97 [Belgian Endocrine Society 2023], 5–5 (abstract no. 007). [URL] [PDF]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]

    In the first study, Tim, Jeroen, & T’Sjoen (2023), clinical outcomes in transfeminine people at the University of Ghent, Belgium clinic were compared in 72 people taking CPA at low doses (10–12.5 mg/day) or high doses (25–50 mg/day). Testosterone suppression was equivalent between the two dose groups. Breast development satisfaction, measured with the Body Image Scale, was not significantly different with low-dose CPA versus high-dose CPA following 1 year of hormone therapy (p = 0.078). However, the p-value indicates that there was almost a statistically significant difference between groups, though it was not stated which group was numerically higher in terms of satisfaction. In any case, the researchers stated that breast development satisfaction was “non-inferior” with low-dose CPA compared to high-dose CPA, which seems suggestive that satisfaction may have been higher in the high-dose CPA group. These findings suggest that higher doses of CPA may not stunt breast development relative to doses of CPA that are lower, although still quite high in terms of progestogenic activity.

    In the second study, Yang et al. (2024), clinical outcomes in transfeminine people at the Peking University Third Hospital in China with estradiol plus spironolactone (n=43) versus estradiol plus CPA (n=53) were retrospectively compared. Testosterone levels were much higher in the spironolactone group relative to the CPA group (374 ng/dL [13.0 nmol/L] vs. 20 ng/dL [0.7 nmol/L]; p < 0.001) and duration of hormone therapy was shorter in the spironolactone group than in the CPA group (median 12 months vs. 18 months). Breast development satisfaction, measured with a visual analogue scale (VAS), was median 6.0 (IQR 4.0–7.0) with spironolactone and 6.0 (IQR 4.0–7.0) with CPA, and was not statistically different. On the other hand, the CPA group outperformed the spironolactone group in terms of several other VAS-based clinical-outcome measures, including figure feminization, testicular atrophy, decreased penile erections, and in terms of a composite overall satifaction score. These findings suggest, as with the RCT by Lachlan Angus and colleagues, that spironolactone and CPA result in similar breast development in transfeminine people despite differences in testosterone levels and other clinical outcomes.

    A major limitation of both Tim, Jeroen, & T’Sjoen (2023) and Yang et al. (2024) is the use of subjective self-report measures of breast development as opposed to objective physical measurements.

    References

    • Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012). Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy. Clinical Pharmacokinetics, 51(6), 365–396. [DOI:10.2165/11597440-000000000-00000]
    • Adams, R. D., Kliman, B., Federman, D. D., Ulfelder, H. S., & Holmes, L. B. (1970). Syndromes of Testicular Feminization. Clinical Pediatrics, 9(3), 165–178. [DOI:10.1177/000992287000900312]
    • Alekseev, N. P. (2021). Origin and Development of the Mammary Glands. In Alekseev, N. P. Physiology of Human Female Lactation (pp. 11–66). Cham: Springer. [DOI:10.1007/978-3-030-66364-3_2]
    • Alex, A., Bhandary, E., & McGuire, K. P. (2020). Anatomy and Physiology of the Breast during Pregnancy and Lactation. In Alipour, S., & Omranipour, R. (Eds.). Diseases of the Breast during Pregnancy and Lactation (Advances in Experimental Medicine and Biology, Volume 1252) (pp. 3–7). Cham: Springer. [DOI:10.1007/978-3-030-41596-9]
    • Anderson, W. A. (1962). Experimental stimulation of breast development in the teen-age female. The Journal of the Medical Society of New Jersey, 59, 541–543. [Google Scholar] [PubMed] [PDF]
    • Andler, W., & Zachmann, M. (1979). Spontaneous breast development in an adolescent girl with testicular feminization after castration in early childhood. The Journal of Pediatrics, 94(2), 304–305. [DOI:10.1016/s0022-3476(79)80852-5]
    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]
    • Angus, L., Mikolajczyk, M., Cheung, A., Zajac, J., Antoszewski, B., & Kasielska-Trojan, A. (2022). Estimation of breast volume in transgender women using 2D photography: validation of the BreastIdea Volume Estimator in men and transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 279). [URL] [PDF] [Full Abstract Book]
    • Apter, D. (1980). Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clinical Endocrinology, 12(2), 107–120. [DOI:10.1111/j.1365-2265.1980.tb02125.x]
    • Apter, D., Räisänen, I., Ylöstalo, P., & Vihko, R. (1987). Follicular growth in relation to serum hormonal patterns in adolescent compared with adult menstrual cycles. Fertility and Sterility, 47(1), 82–88. [DOI:10.1016/s0015-0282(16)49940-1]
    • Aritaki, S., Miyazawa, H., Ogihara, M., Ushio, M., & Izumizawa, A. (1992). An Endocrinological Study of Persistent Pubertal Macromastia. The Tohoku Journal of Experimental Medicine, 167(3), 189–196. [DOI:10.1620/tjem.167.189]
    • Arya, S., Barnabas, R., Lila, A. R., Sarathi, V., Memon, S. S., Bhandare, V. V., Thakkar, K., Patil, V., Shah, N. S., Kunwar, A., & Bandgar, T. (2021). Clinical, Hormonal, Genetic, and Molecular Characteristics in Androgen Insensitivity Syndrome in an Asian Indian Cohort from a Single Centre in Western India. Sexual Development, 15(4), 253–261. [DOI:10.1159/000517763]
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • Athanasoulia, A., Auer, M., Riepe, F., & Stalla, G. (2013). Rare Missense P450c17 (CYP17A1) Mutation in Exon 1 as a Cause of 46,XY Disorder of Sexual Development: Implications of Breast Tissue ‘Unresponsiveness’ despite Adequate Estradiol Substitution. Sexual Development, 7(4), 212–215. [DOI:10.1159/000348301]
    • Atwood, C., Hovey, R., Glover, J., Chepko, G., Ginsburg, E., Robison, W., & Vonderhaar, B. (2000). Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. Journal of Endocrinology, 167(1), 39–52. [DOI:10.1677/joe.0.1670039]
    • Aupperlee, M. D., Leipprandt, J. R., Bennett, J. M., Schwartz, R. C., & Haslam, S. Z. (2013). Amphiregulin mediates progesterone-induced mammary ductal development during puberty. Breast Cancer Research, 15(3), R44. [DOI:10.1186/bcr3431]
    • Bahr, C., Ewald, J., Dragovich, R., & Gothard, M. D. (2024). Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy. Journal of the American Pharmacists Association, 64(1), 268–272. [DOI:10.1016/j.japh.2023.08.001]
    • Baird, D., Hytten, F. E., & Thomson, A. M. (1958). Age and Human Reproduction. BJOG, 65(6), 865–876. [DOI:10.1111/j.1471-0528.1958.tb08582.x]
    • Baker, S. B., Burkey, B. A., Thornton, P., & LaRossa, D. (2001). Juvenile Gigantomastia: Presentation of Four Cases and Review of the Literature. Annals of Plastic Surgery, 46(5), 517–526. [DOI:10.1097/00000637-200105000-00011]
    • Bames, H. O. (1948). Reduction of massive breast hypertrophy. Plastic and Reconstructive Surgery, 3(5), 560–569. [DOI:10.1097/00006534-194809000-00006]
    • Barbieri, R. L. (2019). Breast. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 248–255.e3). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/B978-0-323-47912-7.00010-X]
    • Baron, J. (1993). Zespół braku wrazliwości na androgeny. Studium kliniczne i endokrynologiczne 40 osobników [Androgen insensitivity syndrome. Clinical and endocrinologic study of 40 cases]. Endokrynologia Polska, 44(2), 175–186. [Google Scholar] [PubMed]
    • Baron, J. (1994). Klasyczne i niepełne zespoły braku wrazliwości na androgeny [Classical and incomplete androgen insensitivity syndromes]. Ginekologia Polska, 65(7), 377–386. [Google Scholar] [PubMed]
    • Baron, J. (1994). Niepełny lub cześciowy zespół braku wrazliwości na androgeny [Partial androgen insensitivity syndrome]. Ginekologia Polska, 65(6), 319–325. [Google Scholar] [PubMed]
    • Barrat, J., de Lignières, B., Marpeau, L., Larue, L., Fournier, S., Nahoul, K., Linares, G., Giorgi, H., & Contesso, G. (1990). Effet in vivo de l’administration locale de progestérone sur l’activité mitotique des galactophores humains. Résultat d’une étude pilote. [The in vivo effect of the local administration of progesterone on the mitotic activity of human ductal breast tissue. Results of a pilot study.] Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 19(3), 269–274. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Barrett, J. (2009). The clinical risks associated with the diagnosis and management of disorders of gender identity. Clinical Risk, 15(4), 131–134. [DOI:10.1258/cr.2008.080069]
    • Bässler, R. (1970). The Morphology of Hormone Induced Structural Changes in the Female Breast. In Altmann, H.-W., et al. (Eds.). Current Topics in Pathology: Ergebnisse der Pathology, Volume 53 (pp. 1–89). Heidelberg: Springer Berlin. [DOI:10.1007/978-3-662-30514-0_1] [PDF]
    • Basson, R., & Prior, J. C. (1998). Hormonal Therapy of Gender Dysphoria: The Male-to-Female Transsexual. In Denny, D. (Ed.). Concepts in Transgender Identity (Garland Gay and Lesbian Studies, Volume 11) (pp. 277–296). New York: Garland Publishing Inc. [Google Scholar] [Google Books] [DOI:10.4324/9780203775134-19] [PDF]
    • Bauman, A., Novello, L., & Kreitzer, P. (2016). Endocrine Disorders and Delayed Puberty. In Appelbaum, H. (Ed.). Abnormal Female Puberty: A Clinical Casebook (pp. 87–107). Cham: Springer. [DOI:10.1007/978-3-319-27225-2_5]
    • Bayer, C. M., Bani, M. R., Schneider, M., Dammer, U., Raabe, E., Haeberle, L., Faschingbauer, F., Schneeberger, S., Renner, S. P., Fischer, D., Schulz-Wendtland, R., Fasching, P. A., Beckmann, M. W., & Jud, S. M. (2014). Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE study. European Journal of Cancer Prevention, 23(3), 151–157. [DOI:10.1097/cej.0b013e3283651ccb]
    • Beck, P. (1972). Lactogenic Activity of Human Chorionic Somatomammotropin in Rhesus Monkeys. Experimental Biology and Medicine, 140(1), 183–187. [DOI:10.3181/00379727-140-36422]
    • Begley, D. J., Firth, J. A., & Hoult, J. R. (1980). The Breast and Lactation. In Begley, D. J., Firth, J. A., & Hoult, J. R. Human Reproduction and Developmental Biology (pp. 204–219). London: Macmillan Education UK. [DOI:10.1007/978-1-349-16260-4_14]
    • Bellwether, C. J. (2020). Why Should a Transfeminine Person Consider Progesterone? Google Docs. [URL]
    • Benjamin, H. (1966). Nonsurgical Management of Transsexualism. In Benjamin, H. The Transsexual Phenomenon (pp. 86–99). New York: Julian Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Benjamin, H. (1967). Transvestism and Transsexualism in the male and female. Journal of Sex Research, 3(2), 107–127. [DOI:10.1080/00224496709550519]
    • Berliere, M., Coche, M., Lacroix, C., Riggi, J., Coyette, M., Coulie, J., Galant, C., Fellah, L., Leconte, I., Maiter, D., Duhoux, F. P., & François, A. (2022). Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender Women. Cancers, 15(1), 245. [DOI:10.3390/cancers15010245]
    • Berryhill, G. E., Trott, J. F., & Hovey, R. C. (2016). Mammary gland development—It’s not just about estrogen. Journal of Dairy Science, 99(1), 875–883. [DOI:10.3168/jds.2015-10105]
    • Bethea, C. L., Kohama, S. G., & Pecins-Thompson, M. (1997). Pituitary and Brain Actions of Estrogen and Progesterone in the Regulation of Primate Prolactin Secretion. In Pavlik, E. J. (Ed.). Estrogens, Progestins, and Their Antagonists: Functions and Mechanisms of Action (pp. 3–46). Boston: Birkhäuser. [DOI:10.1007/978-1-4612-2004-6_1]
    • Bevan, D. J. (2012). Progesterone for Breast Development? / Should Male-to-Female Transsexuals Take Progesterone as part of Hormone Therapy (HT) for Better Breast Development? Biopsychology of TSTG / Transgender Forum. [URL 1] [URL 2]
    • Bevan, D. J. (2019). Grow Your Own : Breast Development Update. Transgender Forum. [URL]
    • Beyer, C., Cruz, M. L., & Martinez-Manautou, J. (1970). Effect of Chlormadinone Acetate on Mammary Development and Lactation in the Rabbit. Endocrinology, 86(5), 1172–1174. [DOI:10.1210/endo-86-5-1172]
    • Biswas, S. K., Banerjee, S., Baker, G. W., Kuo, C., & Chowdhury, I. (2022). The Mammary Gland: Basic Structure and Molecular Signaling during Development. International Journal of Molecular Sciences, 23(7), 3883. [DOI:10.3390/ijms23073883]
    • Bland, K. I., Copeland, E. M., & Klimberg, V. S. (2018). Anatomy of the Breast, Axilla, Chest Wall, and Related Metastatic Sites. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 20–36.e2). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00002-7]
    • Bland, K. I., Harrison Howard, J., & Romrell, L. J. (2009). Congenital and Acquired Disturbances of Breast Development and Growth. In Bland, K. I., & Copeland, E. M. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 4th Edition (pp. 189–207). Philadelphia: Saunders/Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Bondy, C. A., & Turner Syndrome Consensus Study Group. (2007). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. The Journal of Clinical Endocrinology & Metabolism, 92(1), 10–25. [DOI:10.1210/jc.2006-1374]
    • Boogers, L., Infirri, S. S., Bouchareb, A., de Blok, C., Liberton, N., van Trotsenburg, P., Dreijerink, K., den Heijer, M., Wiepjes, C., & Hannema, S. (2022). The effect of timing of puberty suppression on breast development in trans girls; a cross-sectional study. Hormone Research in Paediatrics, 95(Suppl 2) [60th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), Rome, Italy, September 15–17, 2022], 390–391 (abstract no. P1-379). [Google Scholar] [DOI:10.1159/000525606] [URL] [PDF 1] [PDF 2]
    • Boyce, S. W., Hoffman, P. G., & Mathes, S. J. (1984). Recurrent Macromastia after Subcutaneous Mastectomy. Annals of Plastic Surgery, 13(6), 511–518. [DOI:10.1097/00000637-198412000-00008]
    • Bruck, H. G., & Müller, G. (1967). Zur Hormontherapie der Hypoplastischen Weiblichen Brust. [On Hormonal Therapy of the Hypoplastic Female Breast.] Ästhetische Medizin [Ästhetische Medizin : Kongreß-Organ der Deutschen Gesellschaft für die Ästhetische Medizin und ihre Grenzgebiete], 16(12), 365–366. [ISSN:0400-6755] [Google Scholar] [PubMed] [WorldCat] [PDF] [Translation]
    • Bryant, R., Underwood, A., Robinson, A., Stephenson, T., & Underwood, J. (1998). Determination of breast tissue composition for improved accuracy in estimating radiation doses and risks in mammographic screening. The Breast, 7(2), 95–98. [DOI:10.1016/s0960-9776(98)90064-9]
    • Buhimschi, C. S. (2004). Endocrinology of lactation. Obstetrics and Gynecology Clinics of North America, 31(4), 963–979. [DOI:10.1016/j.ogc.2004.08.002]
    • Camilletti, M. A., Abeledo-Machado, A., Faraoni, E. Y., Thomas, P., & Díaz-Torga, G. (2019). New insights into progesterone actions on prolactin secretion and prolactinoma development. Steroids, 152, 108496. [DOI:10.1016/j.steroids.2019.108496]
    • Çamtosun, E., Şıklar, Z., Ceylaner, S., Kocaay, P., & Berberoğlu, M. (2017). Delayed Diagnosis of a 17-Hydroxylase/17,20-Lyase Deficient Patient Presenting as a 46,XY Female: A Low Normal Potassium Level Can Be an Alerting Diagnostic Sign. Journal of Clinical Research in Pediatric Endocrinology, 9(2), 163–167. [DOI:10.4274/jcrpe.3839]
    • Capraro, V. J., & Dewhurst, C. J. (1975). Breast Disorders in Childhood and Adolescence. Clinical Obstetrics and Gynecology, 18(2), 25–50. [DOI:10.1097/00003081-197506000-00003]
    • Carlson, L. J., & Shaw, N. D. (2019). Development of Ovulatory Menstrual Cycles in Adolescent Girls. Journal of Pediatric and Adolescent Gynecology, 32(3), 249–253. [DOI:10.1016/j.jpag.2019.02.119]
    • Caro, T. M. (1987). Human breasts: Unsupported hypotheses reviewed. Human Evolution, 2(3), 271–282. [DOI:10.1007/bf03016112]
    • Ceriani, R. L. (1974). Hormones and Other Factors Controlling Growth in the Mammary Gland: A Review. Journal of Investigative Dermatology, 63(1), 93–108. [DOI:10.1111/1523-1747.ep12678104]
    • Cernea, R. (1944). Lokale Hormonbehandlung bei Mammaatrophie und Unterentwicklung. [Local Hormone Treatment in Mammary Atrophy and Underdevelopment.] Medizinische Klinik, 40(11/12), 169–170. [Google Scholar] [PDF] [Translation]
    • Chang, K., Lee, T. T., Linares-Cruz, G., Fournier, S., & de Ligniéres, B. (1995). Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertility and Sterility, 63(4), 785–791. [DOI:10.1016/s0015-0282(16)57482-2]
    • Cheikhelard, A., Morel, Y., Thibaud, E., Lortat-Jacob, S., Jaubert, F., Polak, M., & Nihoul-Fekete, C. (2008). Long-Term Followup and Comparison Between Genotype and Phenotype in 29 Cases of Complete Androgen Insensitivity Syndrome. Journal of Urology, 180(4), 1496–1501. [DOI:10.1016/j.juro.2008.06.045]
    • Ciarloni, L., Mallepell, S., & Brisken, C. (2007). Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development. Proceedings of the National Academy of Sciences, 104(13), 5455–5460. [DOI:10.1073/pnas.0611647104]
    • Clendenen, T. V., Kim, S., Moy, L., Wan, L., Rusinek, H., Stanczyk, F. Z., Pike, M. C., & Zeleniuch-Jacquotte, A. (2013). Magnetic Resonance Imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magnetic Resonance Imaging, 31(1), 1–9. [DOI:10.1016/j.mri.2012.06.022]
    • Cline, J. M., & Wood, C. E. (2006). Hormonal Effects on the Mammary Gland of Postmenopausal Nonhuman Primates. Breast Disease, 24(1), 59–70. [DOI:10.3233/bd-2006-24105]
    • Cline, J. M., & Wood, C. E. (2008). The Mammary Glands of Macaques. Toxicologic Pathology, 36(7 Suppl), 130S–141S. [DOI:10.1177/0192623308327411]
    • Cole, R. D., & Hopkins, T. R. (1962). A Biochemical Test of Artificial Mammogenesis and Lactogenesis As Models of the Natural Processes. Endocrinology, 70(3), 375–380. [DOI:10.1210/endo-70-3-375]
    • Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., Lev, A. I., Mayer, G., Meyer-Bahlburg, H., Hall, B. P., Pfaefflin, F., Rachlin, K., Robinson, B., Schechter, L. S., Tangpricha, V., van Trotsenburg, M., Vitale, A., Winter, S., Whittle, S., Wylie, K. R., & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism, 13(4), 165–232. [DOI:10.1080/15532739.2011.700873] [URL] [PDF]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Coltman, C. E., Steele, J. R., & McGhee, D. E. (2017). Breast volume is affected by body mass index but not age. Ergonomics, 60(11), 1576–1585. [DOI:10.1080/00140139.2017.1330968]
    • Colvin, C., Devineni, G., & Ashraf, A. P. (2014). Delayed Puberty. In Bandeira, F., Gharib, H., Golbert, A., Griz, L., & Faria, M. (Eds.). Endocrinology and Diabetes (pp. 203–217). New York: Springer. [DOI:10.1007/978-1-4614-8684-8_17]
    • Cowie, A. T., & Folley, S. J. (1961). The Mammary Gland and Lactation. In Young, W. C. (Ed.). Sex and Internal Secretions, 3rd Edition, Volume I (pp. 590–642). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Cowie, A. T., Forsyth, I. A., & Hart, I. C. (1980). Growth and Development of the Mammary Gland. In Cowie, A. T., Forsyth, I. A., & Hart, I. C. Hormonal Control of Lactation (Monographs on Endocrinology, Volume 15) (pp. 58–145). Berlin/Heidelberg: Springer Berlin Heidelberg. [DOI:10.1007/978-3-642-81389-4_3]
    • Cox, D. B., Kent, J. C., Casey, T. M., Owens, R. A., & Hartmann, P. E. (1999). Breast Growth and the Urinary Excretion of Lactose During Human Pregnancy and Early Lactation: Endocrine Relationships. Experimental Physiology, 84(2), 421–434. [DOI:10.1111/j.1469-445x.1999.01807.x]
    • Cox, C. B., Kent, J. C., Owens, R., & Hartmann, P. E. (1994). Mammary morphological and functional changes during pregnancy in women. In Thompson, J. (Ed.). Proceedings of the Twenty-Sixth Annual Conference, Hilton Hotel, Brisbane, 26–28 September, 1994 [The Australian Society for Reproductive Biology Inc., Twenty Sixth Annual Conference, The Hilton Hotel, Brisbane, September 26 - 28 1994, Programme and Miniposters of Papers] (pp. 47–47). Australia: Australian Society for Reproductive Biology. [Google Scholar] [WorldCat] [URL] [PDF]
    • Coxon, J., & Seal, L. (2018). Hormone management of trans women. Trends in Urology & Men’s Health, 9(6), 10–14. [DOI:10.1002/tre.663]
    • Cregan, M. D., & Hartmann, P. E. (1999). Computerized Breast Measurement from Conception to Weaning: Clinical Implications. Journal of Human Lactation, 15(2), 89–96. [DOI:10.1177/089033449901500202]
    • Crowley, L. G., & Macdonald, I. (1965). Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal woman. Cancer, 18(4), 436–446. [DOI:10.1002/1097-0142(196504)18:4<436::aid-cncr2820180407>3.0.co;2-d]
    • Crowley, W. F., & Pitteloud, N. (2020). Approach to the patient with delayed puberty. UpToDate. [Google Scholar] [URL]
    • Cruz-Korchin, N., Korchin, L., González-Keelan, C., Climent, C., & Morales, I. (2002). Macromastia. Plastic and Reconstructive Surgery, 109(1), 64–68. [DOI:10.1097/00006534-200201000-00011]
    • Curtis, R. J. (2009 July 10). The Lowdown on Progesterone. London: The London Gender Clinic. [Google Scholar] [URL] [PDF]
    • Dallmann, A., Ince, I., Meyer, M., Willmann, S., Eissing, T., & Hempel, G. (2017). Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. Clinical Pharmacokinetics, 56(11), 1303–1330. [DOI:10.1007/s40262-017-0539-z]
    • Dancey, A., Khan, M., Dawson, J., & Peart, F. (2008). Gigantomastia – a classification and review of the literature. Journal of Plastic, Reconstructive & Aesthetic Surgery, 61(5), 493–502. [DOI:10.1016/j.bjps.2007.10.041]
    • Davajan, V., & Kletzky, O. A. (1979). Amenorrhea without Galactorrhea or Hirsutism. In Mishell, D. R., & Davajan, V. (Eds.). Reproductive Endocrinology, Infertility, and Contraception (pp. 219–248). Philadelphia: F. A. Davis Co. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Davis, M. E., Boynton, M. W., Ferguson, J. H., & Rothman, S. (1945). Studies on Pigmentation of Endocrine Origin. The Journal of Clinical Endocrinology & Metabolism, 5(3), 138–146. [DOI:10.1210/jcem-5-3-138]
    • de Blok, C. J., Dijkman, B. A., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K. M., & den Heijer, M. (2021). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de Lignières, B. (2002). Effects of progestogens on the postmenopausal breast. Climacteric, 5(3), 229–235. [DOI:10.1080/cmt.5.3.229.235]
    • de Lignières, B., & Mauvais-Jarvis, P. (1981). Hormonal Dependence of Benign Breast Disease, Gynecomastia and Breast Cancer. In Hollman, K. H., Brux, J., & Verley, J. M. (Eds.). New Frontiers in Mammary Pathology (pp. 287–308). Boston: Springer US. [DOI:10.1007/978-1-4757-0019-0_17]
    • de Vries, A. L., Steensma, T. D., Wagemaar, E. C. F., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2010). Puberty suppression followed by cross-sex hormones and gender reassignment surgery: A prospective follow-up of gender dysphoric adolescents into adulthood. In de Vries, A. L. (Ed.). Gender Dysphoria in Adolescents: Mental Health and Treatment Evaluation (pp. 91–106). (Doctoral thesis, Vrije Universiteit Amsterdam.) [Google Scholar] [URL] [PDF]
    • Deeb, A., Al Suwaidi, H., Attia, S., & Al Ameri, A. (2015). 17-hydroxylase/17,20-lyase deficiency due to a R96Q mutation causing hypertension and poor breast development. Endocrinology, Diabetes & Metabolism Case Reports, 2015(1), 15-0069. [DOI:10.1530/EDM-15-0069]
    • Deepinder, F., & Braunstein, G. D. (2012). Drug-induced gynecomastia: an evidence-based review. Expert Opinion on Drug Safety, 11(5), 779–795. [DOI:10.1517/14740338.2012.712109]
    • Dennerstein, L., Burrows, G. D., Hyman, G. J., & Sharpe, K. (1980). Some clinical effects of oestrogen-progestogen therapy in surgically castrated women. Maturitas, 2(1), 19–28. [DOI:10.1016/0378-5122(80)90056-0]
    • Dewhurst, C. J. (1967). The XY Female. BJOG, 74(3), 353–366. [DOI:10.1111/j.1471-0528.1967.tb03959.x]
    • Dewhurst, C. J. (1971). Sex Chromosome Abnormalities and the Gynaecologist. BJOG, 78(12), 1058–1076. [DOI:10.1111/j.1471-0528.1971.tb00227.x]
    • Dewhurst, C. J. (1971). The XY female. American Journal of Obstetrics and Gynecology, 109(5) [Transactions of the Eighty-First Annual Meeting of the American Association of Obstetricians and Gynecologists], 675–688. [DOI:10.1016/0002-9378(71)90753-8]
    • Dewhurst, C. J., & Spence, J. E. (1977). The XY female. British Journal of Hospital Medicine, 17(5), 498, 501–506. [Google Scholar] [PubMed] [PDF]
    • Dewhurst, J. (1982). Breast Hypoplasia. In Bruni, V., Gasparri, F., Dewhurst, J., & Rey-Stocker, I. (Eds.). Pediatric and Adolescent Gynaecology [Proceedings of the IVth International Symposium, Florence, October 5-7, 1978] (pp. 205–212). Rome, Italy: Serono Symposia. [Google Scholar] [Google Books] [WorldCat] [PDF]
    • Di Lorenzo, G., Autorino, R., Perdonà, S., & De Placido, S. (2005). Management of gynaecomastia in patients with prostate cancer: a systematic review. The Lancet Oncology, 6(12), 972–979. [DOI:10.1016/s1470-2045(05)70464-2]
    • Dickson, L. M., & Hewer, E. E. (1950). The structure of the breast. In Saner, F. D. (Ed.). The Breast: Structure, Function, Disease (pp. 1–52). Baltimore: William & Wilins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Dijkman, B. A., Blok, C. J., Dreijerink, K. M., & den Heijer, M. (2023). Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS). Endocrinology, Diabetes & Metabolism Case Reports, 2023(2), 22-0346. [DOI:10.1530/edm-22-0346]
    • Dijkman, B. A., Helder, D., Boogers, L. S., Gieles, N. C., van Heesewijk, J. O., Slaa, S. t., Liberton, N. P., Wiepjes, C. M., de Blok, C. J., den Heijer, M., & Dreijerink, K. M. (2023). Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial. BMC Pharmacology and Toxicology, 24(1), 80. [DOI:10.1186/s40360-023-00724-4]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Donaldson, M., Kriström, B., Ankarberg-Lindgren, C., Verlinde, S., van Alfen-van der Velden, J., Gawlik, A., van Gelder, M., Sas, T., & (2019). Optimal Pubertal Induction in Girls with Turner Syndrome Using Either Oral or Transdermal Estradiol: A Proposed Modern Strategy. Hormone Research in Paediatrics, 91(3), 153–163. [DOI:10.1159/000500050]
    • Dorgan, J. F., Klifa, C., Deshmukh, S., Egleston, B. L., Shepherd, J. A., Kwiterovich, P. O., Van Horn, L., Snetselaar, L. G., Stevens, V. J., Robson, A. M., Lasser, N. L., & Hylton, N. M. (2013). Menstrual and reproductive characteristics and breast density in young women. Cancer Causes & Control, 24(11), 1973–1983. [DOI:10.1007/s10552-013-0273-2]
    • Döring, G. K. (1963). Über die relative Häufigkeit des anovulatorischen Cyclus im Leben der Frau. [On the relative frequency of the anovulatory cycle in women’s lives.] Archiv für Gynäkologie, 199(2), 115–123. [DOI:10.1007/bf00668062]
    • Drąsutis, J. (2017). Changes in breast morphological parameters, body size and shape, blood serum prolactin and lipids during pregnancy, multiple relationships of these indicators and morphological markers for health risk. (Doctoral dissertation, Vilniaus Universitetas.) [Google Scholar] [URL]
    • Drife, J. O. (1982). The effects of parity and the menstrual cycle on the normal mammary gland and their possible relationship to malignant change. (Doctoral dissertation, University of Edinburgh). [Google Scholar] [Google Books] [WorldCat] [URL 1] [URL 2] [PDF]
    • Drife, J. O. (1984). The pill and the breast. IPPF Medical Bulletin, 18(6), 1–2. [Google Scholar] [PubMed]
    • Drife, J. O. (1986). Breast Development in Puberty. Annals of the New York Academy of Sciences, 464(1) [Endocrinology of the Breast: Basic and Clinical Aspects], 58–65. [DOI:10.1111/j.1749-6632.1986.tb15993.x]
    • Drife, J. O. (1989). Breast modifications during the menstrual cycle. Supplement to International Journal of Gynecology and Obstetrics, 1, 19–24. / International Journal of Gynecology and Obstetrics, 1989(Suppl 1), 19–24. [Google Scholar] [PubMed] [Archive.org]
    • Drife, J. O. (1990). Premenopausal Hormone Therapy. In Drife, J. O., & Studd, J. W. W. (Eds.). HRT and Osteoporosis (pp. 351–362). London: Springer London. [DOI:10.1007/978-1-4471-1799-5_25]
    • Duncan, M. (2010). Sexual Selection and Human Breast Morphology. (Doctoral dissertation, Te Herenga Waka-Victoria University of Wellington.) [Google Scholar] [URL]
    • Edmonds, D. K. (1989). Normal Puberty. In Edmonds, D. K. Dewhurst’s Practical Paediatric and Adolescent Gynaecology, 2nd Edition (pp. 56–62). London: Butterworths. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [Archive.org]
    • Elling, S. V., & Powell, F. C. (1997). Physiological changes in the skin during pregnancy. Clinics in Dermatology, 15(1), 35–43. [DOI:10.1016/s0738-081x(96)00108-3]
    • Engman, M., Skoog, L., Soderqvist, G., & Gemzell-Danielsson, K. (2008). The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology. Human Reproduction, 23(9), 2072–2079. [DOI:10.1093/humrep/den228]
    • Federici, S., Goggi, G., Quinton, R., Giovanelli, L., Persani, L., Cangiano, B., & Bonomi, M. (2021). New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature. Endocrine Reviews, 43(5), 824–851. [DOI:10.1210/endrev/bnab043]
    • Fernández-Cancio, M., García-García, E., González-Cejudo, C., Martínez-Maestre, M., Mangas-Cruz, M., Guerra-Junior, G., Pandi de Mello, M., Arnhold, I. J., Nishi, M. Y., Bilharinho Mendonça, B., García-Arumí, E., Audí, L., Tizzano, E., & Carrascosa, A. (2017). Discordant Genotypic Sex and Phenotype Variations in Two Spanish Siblings with 17α-Hydroxylase/17,20-Lyase Deficiency Carrying the Most Prevalent Mutated CYP17A1 Alleles of Brazilian Patients. Sexual Development, 11(2), 70–77. [DOI:10.1159/000468160]
    • Fernandez-Valdivia, R., Mukherjee, A., Mulac-Jericevic, B., Conneely, O. M., DeMayo, F. J., Amato, P., & Lydon, J. P. (2005). Revealing Progesterone’s Role in Uterine and Mammary Gland Biology: Insights from the Mouse. Seminars in Reproductive Medicine, 23(1), 22–37. [DOI:10.1055/s-2005-864031]
    • Finkenzeller, D. A., & Loveless, M. B. (2007). Pediatric Gynecology. In Fortner, K. B., Szymanski, L. M., Fox, H. E., & Wallach, E. E. (Eds.). The Johns Hopkins Manual of Gynecology and Obstetrics, 3rd Edition (Spiral Manual Series) (pp. 363–379). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Fisher, A. D., Castellini, G., Ristori, J., Casale, H., Cassioli, E., Sensi, C., Fanni, E., Amato, A. M., Bettini, E., Mosconi, M., Dèttore, D., Ricca, V., & Maggi, M. (2016). Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data. The Journal of Clinical Endocrinology & Metabolism, 101(11), 4260–4269. [DOI:10.1210/jc.2016-1276]
    • Foidart, J. M., Colin, C., Denoo, X., Desreux, J., Fournier, S., & de Linières, B. (1996). Influence of percutaneous administration of estradiol and progesterone on the proliferation of human breast epithelial cells. In Calvo, F., Crépin, M., & Magdelenat, H. (Eds.). Breast Cancer: Advances in Biology and Therapeutics [21st Meeting of the International Association for Breast Cancer Research, July 3-4-5, 1996, Paris] (pp. 329–334). Montrouge/Paris: John Libbey Eurotext. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Foidart, J., Colin, C., Denoo, X., Desreux, J., Béliard, A., Fournier, S., & de Lignières, B. (1998). Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells. Fertility and Sterility, 69(5), 963–969. [DOI:10.1016/s0015-0282(98)00042-9]
    • Folley, S. J. (1940). Lactation. Biological Reviews, 15(4), 421–458. [DOI:10.1111/j.1469-185x.1940.tb00947.x]
    • Folley, S. J. (1947). Endocrine Control of the Mammary Gland. British Medical Bulletin, 5(2–3), 130–134. [DOI:10.1093/oxfordjournals.bmb.a073121]
    • Folley, S. J. (1950). Lactational Physiology. In Bowes, K. (Ed.). Modern Trends in Obstetrics and Gynaecology (pp. 441–453). London: Butterworth. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Folley, S. J. (1952). Lactation. In Parkes, A. S. (Ed.). Marshall’s Physiology of Reproduction, 3rd Edition, Volume II (pp. 525–647). Longmans, Green & Co.: London. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Folley, S. J. (1956). Recent Studies on the Development of the Mammary Gland. In Folley, S. J. The Physiology and Biochemistry of Lactation, 1st Edition (pp. 1–22). Edinburgh: Oliver & Boyd. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Folley, S. J., & Malpress, F. H. (1948). Hormonal Control of Mammary Growth. In Pincus, G., & Thimann, K. V. (Eds.). The Hormones: Physiology, Chemistry and Applications, Volume I (pp. 695–743). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Fourcade, R., & McLeod, D. (2004). Tolerability of Antiandrogens in the Treatment of Prostate Cancer. UroOncology, 4(1), 5–13. [DOI:10.1080/1561095042000191655]
    • Fowler, P. A., Casey, C. E., Cameron, G. G., Foster, M. A., & Knight, C. H. (1990). Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. BJOG, 97(7), 595–602. [DOI:10.1111/j.1471-0528.1990.tb02546.x]
    • Fridriksdottir, A. J., Petersen, O. W., & Rnnov-Jessen, L. (2011). Mammary gland stem cells: current status and future challenges. The International Journal of Developmental Biology, 55(7–8–9), 719–729. [DOI:10.1387/ijdb.113373af]
    • Fuqua, J. S., & Eugster, E. A. (2022). History of Puberty: Normal and Precocious. Hormone Research in Paediatrics, 95(6), 568–578. [DOI:10.1159/000526464]
    • Gaede, P., Trolle, D., & Pedersen, H. (1978). Extremely low placental lactogen hormone (hpl) values in an otherwise uneventful pregnancy preceding delivery of a normal baby. Acta Obstetricia et Gynecologica Scandinavica, 57(3), 203–209. [DOI:10.3109/00016347809154883]
    • Galani, A., Kitsiou-Tzeli, S., Sofokleous, C., Kanavakis, E., & Kalpini-Mavrou, A. (2008). Androgen insensitivity syndrome: clinical features and molecular defects. Hormones, 7(3), 217–229. [DOI:10.14310/horm.2002.1201]
    • Galbarczyk, A. (2011). Unexpected changes in maternal breast size during pregnancy in relation to infant sex: An evolutionary interpretation. American Journal of Human Biology, 23(4), 560–562. [DOI:10.1002/ajhb.21177]
    • Gawlik, A., Hankus, M., Such, K., Drosdzol-Cop, A., Madej, P., Borkowska, M., Zachurzok, A., & Malecka-Tendera, E. (2016). Hypogonadism and Sex Steroid Replacement Therapy in Girls with Turner Syndrome. Journal of Pediatric and Adolescent Gynecology, 29(6), 542–550. [DOI:10.1016/j.jpag.2016.03.005]
    • Gershon-Cohen, J. (1970). The Normal Breast. In Gershon-Cohen, J. Atlas of Mammography (pp. 23–38). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-85678-5_4] [Google Books]
    • Gertig, D. M., Stillman, I. E., Byrne, C., Spiegelman, D., Schnitt, S. J., Connolly, J. L., Colditz, G. A., & Hunter, D. J. (1999). Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiology, Biomarkers & Prevention, 8(10), 873–879. [Google Scholar] [PubMed] [URL]
    • Geschickter, C. F. (1945). Endocrine Physiology of the Breast. In Geschickter, C. F. Diseases of the Breast: Diagnosis, Pathology, Treatment, 2nd Edition (pp. 42–81). Philadelphia: J.B. Lippincott. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Glenn, J. F. (1976). Testicular feminization syndrome current clinical considerations. Urology, 7(6), 569–577. [DOI:10.1016/0090-4295(76)90079-0]
    • Gliosci, A., & Presutti, F. (1993). Virginal gigantomastia: Validity of combined surgical and hormonal treatments. Aesthetic Plastic Surgery, 17(1), 61–65. [DOI:10.1007/bf00455051]
    • Gompel, A., & Plu-Bureau, G. (2018). Progesterone, progestins and the breast in menopause treatment. Climacteric, 21(4), 326–332. [DOI:10.1080/13697137.2018.1476483]
    • Goodman, H. M. (2009). Hormonal Control of Pregnancy and Lactation. In Goodman, H. M. Basic Medical Endocrinology, 4th Edition (pp. 277–301). Amsterdam: Academic Press/Elsevier. [DOI:10.1016/b978-0-12-373975-9.00014-8]
    • Gooren, L. J. (2016). Hormone Treatment of Adult Transgender People. In Ettner, R., Monstrey, S., & Coleman, E. (Eds.). Principles of Transgender Medicine and Surgery, 2nd Edition (pp. 167–179). New York: Routledge. [Google Scholar] [Google Books] [DOI:10.4324/9781315718972-11]
    • Gordon, C. M., & Laufer, M. R. (2005) The Physiology of Puberty. In Emans, S. J., Laufer, M. R., & Goldstein, D. P. (Eds.). Pediatric and Adolescent Gynecology, 5th Edition (pp. 120–155). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Göretzlehner, G. & Lauritzen, C. (1992). Hormontherapie bei Gynäkologischen Erkrankungen [Hormone Therapy for Gynecological Diseases]. In Göretzlehner, G. & Lauritzen, C. Praktische Hormontherapie in der Gynäkologie, 1. Auflage [Practical Hormone Therapy in Gynecology, 1st Edition] (pp. 245–299). Berlin/New York: de Gruyter. [DOI:10.1515/9783112417706-007] [Google Books] [PDF] [Translation]
    • Graham, J. D., & Clarke, C. L. (1997). Physiological Action of Progesterone in Target Tissues. Endocrine Reviews, 18(4), 502–519. [DOI:10.1210/edrv.18.4.0308]
    • Graham, S. J., Stanchev, P. L., Lloyd‐Smith, J. O., Bronskill, M. J., & Plewes, D. B. (1995). Changes in Fibroglandular Volume and Water Content of Breast Tissue During the Menstrual Cycle Observed by MR Imaging at 1.5 T. Journal of Magnetic Resonance Imaging, 5(6), 695–701. [DOI:10.1002/jmri.1880050613]
    • Greydanus, D. E., Omar, H. A., Matytsina, L. A., & Tsitsika, A. (2010). Breast Disorders in Children and Adolescents. In Omar, H. A., Greydanus, D. E., Tsitsika, A. K., Patel, D. R., & Merrick, J. (Eds.). Pediatric and Adolescent Sexuality and Gynecology: Principles for the Primary Care Clinician (pp. 245–316). Hauppauge: Nova Science Publishers. [Google Scholar] [Google Books] [URL] [OpenLibrary] [WorldCat] [PDF]
    • Guaragna-Filho, G., Guerra-Junior, G., Tadokoro-Cuccaro, R., Hughes, I. A., Barros, B. A., Hiort, O., Balsamo, A., Guran, T., Holterhus, P. M., Hannema, S., Poyrazoglu, S., Darendeliler, F., Bryce, J., Ahmed, S. F., & Quigley, C. A. (2023). Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls. Sexual Development, 17(1), 16–25. [DOI:10.1159/000526997]
    • Gunn, H. M., Tsai, M., McRae, A., & Steinbeck, K. S. (2018). Menstrual Patterns in the First Gynecological Year: A Systematic Review. Journal of Pediatric and Adolescent Gynecology, 31(6), 557–565.e6. [DOI:10.1016/j.jpag.2018.07.009]
    • Günzel, P., Hasan, S. H., Düsterberg, B., Hümpel, M., Putz, B., & Lehmann, M. (1987). Zur toxikologischen Prüfung von Steroidhormonen. [For the Toxicological Testing of Steroid Hormones.] In Burger, O. K., Grosdanoff, P., Henschler, D., Kraupp, O., & Schnieders, B. (Eds.). Aktuelle Probleme der Biomedizin (pp. 93–112). Berlin/New York: De Gruyter. [Google Scholar] [Google Books] [DOI:10.1515/9783110898231-014]
    • Hagisawa, S., Shimura, N., & Arisaka, O. (2012). Effect of Excess Estrogen on Breast and External Genitalia Development in Growth Hormone Deficiency. Journal of Pediatric and Adolescent Gynecology, 25(3), e61–e63. [DOI:10.1016/j.jpag.2011.11.005]
    • Hamburger, C., & Benjamin, H. (1969). Endocrine Treatment of Male and Female Transsexualism / Appendix for the Practicing Physician: Suggestions and Guidelines for the Management of Transsexuals. In Green, R., & Money, J. (Eds.). Transsexualism and Sex Reassignment (pp. 291–307). Baltimore: John Hopkins University Press. [Google Scholar] [Google Books] [PDF]
    • Hannan, F. M., Elajnaf, T., Vandenberg, L. N., Kennedy, S. H., & Thakker, R. V. (2022). Hormonal regulation of mammary gland development and lactation. Nature Reviews Endocrinology, 19(1), 46–61. [DOI:10.1038/s41574-022-00742-y]
    • Hannema, S. E., Schagen, S. E., Cohen-Kettenis, P. T., & Delemarre-van de Waal, H. A. (2017). Efficacy and Safety of Pubertal Induction Using 17β-Estradiol in Transgirls. The Journal of Clinical Endocrinology & Metabolism, 102(7), 2356–2363. [DOI:10.1210/jc.2017-00373]
    • Harley, J. M. G. (1969). The endocrine control of the breasts. The Practitioner, 203(1214), 153–157. [Google Scholar] [Google Books] [PubMed] [DOI:10.5555/19700402477] [HathiTrust]
    • Hartmann, B. W., Laml, T., Albrecht, A. E., Huber, J. C., & Kirchengast, S. (1998). Hormonal Breast Augmentation: Prognostic Relevance of Insulin-Like Growth Factor-I. Gynecological Endocrinology, 12(2), 123–127. [DOI:10.3109/09513599809024960]
    • Hartmann, P. E., Owens, R. A., Cox, D. B., & Kent, J. C. (1996). Breast Development and Control of Milk Synthesis. Food and Nutrition Bulletin, 17(4), 1–12. [DOI:10.1177/156482659601700404]
    • Hasan, S. (1974). Steroid Hormone Levels During Pregnancy in Various Species. In Bernhard, S., & Raspé, G. (Ed.). Hormones and Embryonic Development (Advances in the Biosciences, Volume 13) (pp. 181–197). Oxford/New York: Pergamon Press. [Google Scholar] [Google Books] [DOI:10.1016/b978-0-08-018239-1.50014-3] [OpenLibrary] [Archive.org]
    • Hassiotou, F., & Geddes, D. (2012). Anatomy of the human mammary gland: Current status of knowledge. Clinical Anatomy, 26(1), 29–48. [DOI:10.1002/ca.22165]
    • Heath, R. A., & Wynne, K. (2019). Children and Adolescents. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 87–106). Santa Barbara: Praeger/ABC-CLIO. [Google Books]
    • Heath, R. A., & Wynne, K. (2019). Hormone and Surgical Therapies for Adults. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 107–146). Santa Barbara: Praeger/ABC-CLIO. [Google Books]
    • Hertz, R., Odell, W. D., & Ross, G. T. (1966). Diagnostic Implications of Primary Amenorrhea: Combined Clinical Staff Conference at the National Institutes of Health. Annals of Internal Medicine, 65(4), 800–820. [DOI:10.7326/0003-4819-65-4-800]
    • Hillard, P. J. A. (2007). Benign Diseases of the Female Reproductive Tract. In Berek, J. S., & Novak, E. (Eds.). Berek & Novak’s Gynecology, 14th Edition (pp. 431–496). Philadelphia: Lippincott Williams and Wilkins. [Google Scholar] [OpenLibrary] [WorldCat] [Archive.org]
    • Hoppe, I. C., Patel, P. P., Singer-Granick, C. J., & Granick, M. S. (2011). Virginal Mammary Hypertrophy: A Meta-Analysis and Treatment Algorithm. Plastic and Reconstructive Surgery, 127(6), 2224–2231. [DOI:10.1097/prs.0b013e3182131bd1]
    • Hovey, R. C., Trott, J. F., Ginsburg, E., Goldhar, A., Sasaki, M. M., Fountain, S. J., Sundararajan, K., & Vonderhaar, B. K. (2001). Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Developmental Dynamics, 222(2), 192–205. [DOI:10.1002/dvdy.1179]
    • Howard, B. A., & Gusterson, B. A. (2000). Human Breast Development. Journal of Mammary Gland Biology and Neoplasia, 5(2), 119–137. [DOI:10.1023/a:1026487120779]
    • Huffman, J., Dewhurst, C. J., & Capraro, V. J. (1981). The Breast and its Disorders in Childhood and Adolescence. In Huffman, J., Dewhurst, J., & Capraro, V. The Gynecology of Childhood and Adolescence, 2nd Edition (pp. 542–559). Philadelphia: Saunders. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Hussain, Z., Brooks, J., & Percy, D. (2008). Menstrual variation of breast volume and T2 relaxation times in cyclical mastalgia. Radiography, 14(1), 8–16. [DOI:10.1016/j.radi.2006.07.003]
    • Hussain, Z., Roberts, N., Whitehouse, G. H., García-Fiñana, M., & Percy, D. (1999). Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. The British Journal of Radiology, 72(855), 236–245. [DOI:10.1259/bjr.72.855.10396212]
    • Hutson, S. W., Cowen, P. N., & Bird, C. C. (1985). Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. Journal of Clinical Pathology, 38(3), 281–287. [DOI:10.1136/jcp.38.3.281]
    • Hytten, F. E. (1954). Clinical and Chemical Studies in Human Lactation–VI. BMJ, 1(4867), 912–915. [DOI:10.1136/bmj.1.4867.912]
    • Hytten, F. E. (1954). Observations on Human Lactation. (Doctor’s thesis, University of Aberdeen.) [Google Scholar] [Google Books] [URL] [WorldCat]
    • Hytten, F. E. (1976). The physiology of lactation. International Journal of Food Sciences and Nutrition, 30(4), 225–232. [DOI:10.3109/09637487609142745]
    • Hytten, F. E., & Baird, D. (1958). The Development of the Nipple in Pregnancy. The Lancet, 271(7032), 1201–1204. [DOI:10.1016/s0140-6736(58)91908-1]
    • Hytten, F. E., & Leitch, I. (1971). Preparations for Breast Feeding. In Hytten, F. E., & Leitch, I. The Physiology of Human Pregnancy, 2nd Edition (pp. 234–241). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Hytten, F. E., & Leitch, I. (1971). Preparations for Breast Feeding. In Hytten, F. E., & Leitch, I. The Physiology of Human Pregnancy, 2nd Edition (pp. 234–241). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Hytten, F. E., & Thomson, A. M. (1965). Pregnancy, childbirth and lactation. In Edholm, O. G., & Bacharach, A. L. (Eds.). The Physiology of Human Survival (pp. 327–350). London/New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Hytten, F. E., & Thomson, A. M. (1968). Maternal physiological adjustments. In Assali, N. S. (Ed.). The Maternal Organism, Volume I (Biology of Gestation) (pp. 449–479). New York: Academic Press. [Google Scholar] [Google Books] [WorldCat]
    • Igo, J., & Visram, H. (2021). Progesterone Therapy Use and Safety in Male to Female Transgender Patients. Canadian Journal of Diabetes, 45(7 Suppl), S39–S39 (abstract no. 109). [DOI:10.1016/j.jcjd.2021.09.119]
    • Ingleby, H. (1949). Changes in breast volume in a group of normal young women. Bulletin of the International Association of Medical Museums, 29, 87–92. [Google Scholar] [Google Books] [HathiTrust]
    • Ingleby, H., Moore, L., & Gershon-Cohen, J. (1957). Gestational breast changes: x-ray studies of the human breast. Obstetrics & Gynecology, 10(2), 149–157. [Google Scholar] [PubMed] [URL]
    • Ismail, P. M., Amato, P., Soyal, S. M., DeMayo, F. J., Conneely, O. M., O’Malley, B. W., & Lydon, J. P. (2003). Progesterone involvement in breast development and tumorigenesis—as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids, 68(10–13), 779–787. [DOI:10.1016/s0039-128x(03)00133-8]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Jacobsohn, D. (1961). Hormonal Regulation of Mammary Gland Growth. In Kon, S. K., & Cowie, A. T. (Eds.). Milk: The Mammary Gland and Its Secretion, Volume 1 (pp. 127–160). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Jamal, N., Ng, K., McLean, D., Looi, L., & Moosa, F. (2004). Mammographic Breast Glandularity in Malaysian Women: Data Derived from Radiography. American Journal of Roentgenology, 182(3), 713–717. [DOI:10.2214/ajr.182.3.1820713]
    • Jemstrom, H., & Olsson, H. (1997). Breast Size in Relation to Endogenous Hormone Levels, Body Constitution, and Oral Contraceptive Use in Healthy Nulligravid Women Aged 19-25 Years. American Journal of Epidemiology, 145(7), 571–580. [DOI:10.1093/oxfordjournals.aje.a009153]
    • Jernström, H., Sandberg, T., Bågeman, E., Borg, Å., & Olsson, H. (2005). Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. British Journal of Cancer, 92(5), 857–866. [DOI:10.1038/sj.bjc.6602389]
    • Jeruss, J. S. (2006). Molecular Basis of Breast Cancer. In Winchester, D. J., Winchester, D. P., Hudis, C. A., & Norton, L. (Eds.). Breast Cancer, 2nd Edition (pp. 83–95). Hamilton: B.C. Decker. [Google Scholar] [Google Books] [WorldCat]
    • Johnson, M. C., & Cutler, M. L. (2016). Anatomy and Physiology of the Breast. In Jatoi, I., & Rody, A. (Eds.). Management of Breast Diseases (pp. 1–39). Cham: Springer. [DOI:10.1007/978-3-319-46356-8_1]
    • Kaiser, R. (1993). Gestagen-Östrogen-Kombinationen in der Gynäkologie. Zur Geschichte, Dosierung und Anwendung eines Hormonprinzips. [Gestagen-Oestrogen Combinations in Gynaecology. History, Dosage and Use of a Hormonal Principle.] Geburtshilfe und Frauenheilkunde, 53(7), 503–513. [Google Scholar] [PubMed] [DOI:10.1055/s-2007-1022924]
    • Kaiser, R., & Leidenberger, F. (1991). Hormonbehandlung bei Benign Mammaerkrankungen: Mammahypoplasie. [Hormonal Treatment in Benign Breast Diseases: Breast Hypoplasia.] In Kaiser, R., & Leidenberger, F. Hormonbehandlung in der Gynäkologischen Praxis, 7. Auflage [Hormone Treatment in Gynecological Practice, 7th Edition] (pp. 138–138). Stuttgart: Georg Thieme Verlag. [Google Books] [OpenLibrary] [WorldCat] [PDF] [Translation]
    • Kaiser, U., & Ho, K. K. (2015). Pituitary Physiology and Diagnostic Evaluation. In Melmed, S., Polonsky, K. S., Larsen, P. R., Kronenberg, & H. M. (Eds.). Williams Textbook of Endocrinology, 13th Edition (pp. 176–231). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-29738-7.00008-3] [Google Books]
    • Kanhai, R. C., Hage, J. J., Asscheman, H., Mulder, W. J., & Hage, J. J. (1999). Augmentation Mammaplasty in Male-to-Female Transsexuals. Plastic and Reconstructive Surgery, 104(2), 542–549. [DOI:10.1097/00006534-199908000-00040]
    • Kanhai, R. C., Hage, J. J., van Diest, P. J., Bloemena, E., & Mulder, J. W. (2000). Short-Term and Long-Term Histologic Effects of Castration and Estrogen Treatment on Breast Tissue of 14 Male-to-Female Transsexuals in Comparison With Two Chemically Castrated Men. The American Journal of Surgical Pathology, 24(1), 74–80. [DOI:10.1097/00000478-200001000-00009]
    • Kardelen, A. D., Toksoy, G., Baş, F., Yavaş Abalı, Z., Gençay, G., Poyrazoğlu, Ş., Bundak, R., Altunoğlu, U., Avcı, Ş., Najaflı, A., Uyguner, O., Karaman, B., Başaran, S., & Darendeliler, F. (2018). A Rare Cause of Congenital Adrenal Hyperplasia: Clinical and Genetic Findings and Follow-up Characteristics of Six Patients with 17-Hydroxylase Deficiency Including Two Novel Mutations. Journal of Clinical Research in Pediatric Endocrinology, 10(3), 206–215. [DOI:10.4274/jcrpe.0032]
    • Kariagina, A., Xie, J., Leipprandt, J. R., & Haslam, S. Z. (2010). Amphiregulin Mediates Estrogen, Progesterone, and EGFR Signaling in the Normal Rat Mammary Gland and in Hormone-Dependent Rat Mammary Cancers. Hormones and Cancer, 1(5), 229–244. [DOI:10.1007/s12672-010-0048-0]
    • Karp, N. S. (2022). Discussion: The Impact of Combined Oral Contraceptives on Adolescents with Macromastia. Plastic & Reconstructive Surgery, 150(4), 739–740. [DOI:10.1097/prs.0000000000009514]
    • Kasielska-Trojan, A., Mikołajczyk, M., & Antoszewski, B. (2020). BreastIdea Volume Estimator: A New Tool for Breast Volume Estimation—Presentation and Validation for Women. Plastic & Reconstructive Surgery, 146(6), 744e–748e. [DOI:10.1097/prs.0000000000007373]
    • Kasielska-Trojan, A., Zawadzki, T., & Antoszewski, B. (2022). Breast Fluctuating Asymmetry in Women with Macromastia/Gigantomastia. International Journal of Environmental Research and Public Health, 19(24), 16895. [DOI:10.3390/ijerph192416895]
    • Kauli, R., Pertzelan, A., Ben‐Zeev, Z., Lewin, R. P., Kaufman, H., Schally, A. C., Schally, A. V., & Laron, Z. (1984). Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate—further experience. Clinical Endocrinology, 20(4), 377–387. [DOI:10.1111/j.1365-2265.1984.tb03433.x]
    • Keller, P. J. (1984). Diagnostik und Therapie wichtiger hormonaler Störungen: Mammahypoplasie. [Diagnosis and Treatment of Important Hormonal Disorders: Mammary Hypoplasia.] In Keller, P. J. Hormonale Störungen in der Gynäkologie: Diagnostik und Behandlung, 3. Auflage [Hormonal Disorders in Gynecology: Diagnosis and Treatment, 3rd Edition] (Kliniktaschenbücher) (pp. 133–134). Berlin/Heidelberg: Springer. [Google Books] [DOI:10.1007/978-3-662-00442-5_3]
    • Keller, P. J. (1995). Diagnostik und Therapie wichtiger Störungen: Mammahypoplasie. [Diagnosis and Treatment of Important Disorders: Mammary Hypoplasia.] In Keller, P. J. Hormon- und Fertilitätsstörungen in der Gynäkologie, 4. Auflage [Hormonal and Fertility Disorders in Gynecology, 4th Edition] (pp. 145–146). Berlin/Heidelberg: Springer. [Google Books] [DOI:10.1007/978-3-662-12026-2_3]
    • Kennedy, B. J. (1953). Effects of intensive sex steroid hormone therapy in advanced breast cancer. JAMA, 152(12), 1135–1141. [DOI:10.1001/jama.1953.63690120004013]
    • Kent, J. C., Mitoulas, L., Cox, D. B., Owens, R. A., & Hartmann, P. E. (1999). Breast Volume and Milk Production During Extended Lactation in Women. Experimental Physiology, 84(2), 435–447. [DOI:10.1111/j.1469-445x.1999.01808.x]
    • Khoo, S. K., & Mackay, E. V. (1972). Testicular Feminization: The Clinical Features, Endocrine Function and Gonadal Pathology in Six Patients. Australian and New Zealand Journal of Obstetrics and Gynaecology, 12(1), 1–13. [DOI:10.1111/j.1479-828x.1972.tb00721.x]
    • Klein, R., Aichinger, H., Dierker, J., Jansen, J. T., Joite-Barfuß, S., Säbel, M., Schulz-Wendtland, R., & Zoetelief, J. (1997). Determination of average glandular dose with modern mammography units for two large groups of patients. Physics in Medicine and Biology, 42(4), 651–671. [DOI:10.1088/0031-9155/42/4/004]
    • Kleinberg, D. L. (2006). Endocrinology of lactation. In DeGroot, L. J., & Jameson, J. L. (Eds). Endocrinology, 5th Edition (pp. 3461–3473). Philadelphia: Elsevier Saunders. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Kleinberg, D. L., & Barcellos-Hoff, M. H. (2011). The Pivotal Role of Insulin-Like Growth Factor I in Normal Mammary Development. Endocrinology and Metabolism Clinics of North America, 40(3), 461–471. [DOI:10.1016/j.ecl.2011.06.001]
    • Kleinberg, D. L., & Ruan, W. (2008). IGF-I, GH, and Sex Steroid Effects in Normal Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia, 13(4), 353–360. [DOI:10.1007/s10911-008-9103-7]
    • Kleinberg, D. L., Wood, T. L., Furth, P. A., & Lee, A. V. (2008). Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions. Endocrine Reviews, 30(1), 51–74. [DOI:10.1210/er.2008-0022]
    • Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]
    • Kustin, J., & Rebar, R. W. (1987). Menstrual Disorders in the Adolescent Age Group. Primary Care: Clinics in Office Practice, 14(1), 139–166. [DOI:10.1016/s0095-4543(21)01004-6]
    • Kutten, F., Malet, C., & Leygue, E. (1994). Antiestrogen action of progestogens in human breast cells. In Berg, G., & Hammar, M. (Eds.). The Modern Management of the Menopause: A Perspective for the 21st Century [The Proceedings of the VII International Congress on the Menopause, Stockholm, Sweden 1993] (pp. 419–433). Canforth: Parthenon. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Ladjouze, A., & Donaldson, M. (2019). Primary gonadal failure. Best Practice & Research Clinical Endocrinology & Metabolism, 33(3), 101295. [DOI:10.1016/j.beem.2019.101295]
    • Laessle, R. G., Tuschi, R. J., Schweiger, U., & Pirke, K. M. (1990). Mood changes and physical complaints during the normal menstrual cycle in healthy young women. Psychoneuroendocrinology, 15(2), 131–138. [DOI:10.1016/0306-4530(90)90021-z]
    • LaMarca, H. L., & Rosen, J. M. (2007). Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Research, 9(4), 304. [DOI:10.1186/bcr1740]
    • Laron, Z., & Kauli, R. (2000). Experience with Cyproterone Acetate in the Treatment of Precocious Puberty. Journal of Pediatric Endocrinology and Metabolism, 13(Suppl 1), 805–810. [DOI:10.1515/jpem.2000.13.s1.805]
    • Lauritzen, C. (1980 October 27). Hormonkur Kann Hypoplastischer Mamma Aufhelfen. [Hormone Therapy Can Help Hypoplastic Breasts.] Selecta: Medizin aktuell; das Magazin für ärztliche Fortbildung [Selecta: Medicine Currently; the Magazine for Medical Training], 22(43), 3798–3801. Planegg: Selecta-Verlag. [ISSN:0582-4877] [WorldCat] [PDF] [Translation]
    • Lauritzen, C. (1982). Treatment of mammary- and uterus hypoplasia by estrogen-progestagen pseudopregnancy. In Richter, K., Huber, A., Terruhn, V. (Eds.) 1. Europäisches Symposium für Kinder- und Jugendgynäkologie. München 19.-21.3.1981, Band 2 [First European Symposium on Pediatric and Adolescent Gynaecology. München, March 19–21, 1981, Volume 2] (pp. 487–489). Friedrichsdorf/Taunus: Milupa-Aktiengesellschaft, Wissenschaftliche Abteilung. [Google Scholar] [PDF]
    • Lauritzen, C. (1989). Hormonelle Substitutionstherapie zur Brustvergrößerung. [Hormonal Substitution Therapy for Breast Enlargement.] In Beller, F. K. & Seitzer, D. (Eds.). 7. Siebte Wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie, Münster, 25. - 27. September 1987: Ausgewählte Referate [7th Scientific Conference of the German Society for Senology, Münster, [Germany,] September 25–27, 1987: Selected Papers] (pp. 39–41). Mülheim, Germany: H.U.F. Verlag. [Google Scholar] [WorldCat 1] [WorldCat 2] [WorldCat 3] [Cited By 1] [Cited By 2] [Cited By 3] [PDF] [Translation]
    • Lawrence, R. A., & Lawrence, R. M. (2015). Physiology of Lactation. In Lawrence, R. A., & Lawrence, R. M. Breastfeeding: A Guide for the Medical Profession, 8th Edition (pp. 56–90). Philadelphia: Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Lee, H. J., & Ormandy, C. J. (2012). Interplay between progesterone and prolactin in mammary development and implications for breast cancer. Molecular and Cellular Endocrinology, 357(1–2), 101–107. [DOI:10.1016/j.mce.2011.09.020]
    • Lee, P. A. (2001). Physiology of Puberty. In Becker, K. L., Bilezikian, J. P., Bremner, W. J., Hung, W., Kahn, C. R., Loriaux, D. L., Nylén, E. S., Rebar, R. W., Robertson, G. L., Snider, R. H., Wartofsky, L. (Eds.). Principles and Practice of Endocrinology and Metabolism, 3rd Edition (pp. 885–893). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [Archive.org] [OpenLibrary] [WorldCat]
    • Lee, S. W., Kwak, D. S., Jung, I. S., Kwak, J. H., Park, J. H., Hong, S. M., Lee, C. B., Park, Y. S., Kim, D. S., Choi, W. H., & Ahn, Y. H. (2015). Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia. Endocrinology and Metabolism, 30(2), 226–230. [DOI:10.3803/enm.2015.30.2.226]
    • Lejour, M. (1994). Vertical Mammaplasty and Liposuction of the Breast. Plastic and Reconstructive Surgery, 94(1), 100–114. [DOI:10.1097/00006534-199407000-00010]
    • Lejour, M. (1997). Evaluation of Fat in Breast Tissue Removed by Vertical Mammaplasty. Plastic and Reconstructive Surgery, 99(2), 386–393. [DOI:10.1097/00006534-199702000-00012]
    • Lemarchand-Béraud, T., Zufferey, M., Reymond, M., & Rey, I. (1982). Maturation of the Hypothalamo-Pituitary-Ovarian Axis in Adolescent Girls. The Journal of Clinical Endocrinology & Metabolism, 54(2), 241–246. [DOI:10.1210/jcem-54-2-241]
    • Lewin, R. (2016). Breast Hypertrophy and Outcome of Breast Reduction Surgery. (Doctoral thesis, University of Gothenburg. Sahlgrenska Academy.) [Google Scholar] [URL]
    • Lim, L. Y., Ho, P. J., Liu, J., Chay, W. Y., Tan, M., Hartman, M., & Li, J. (2018). Determinants of breast size in Asian women. Scientific Reports, 8(1), 1201. [DOI:10.1038/s41598-018-19437-4]
    • Lloyd, C. W., & Leathem, J. H. (1964). Growth and development of the breast and lactation. In Lloyd, C. W. (Ed.). Human Reproduction and Sexual Behavior (pp. 117–134). Philadelphia: Lea & Febiger. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Lopez, X., Panton, J., Nagarkar, P., Preston, S., Abramowitz, J., & Amirlak, B. (2023). Initial Assessment of VECTRA Three-Dimensional Imaging to Accurately Simulate Breast Volume Changes in Transfeminine Patients: A Mannequin Study. Aesthetic Surgery Journal Open Forum, 5, online ahead of print. [DOI:10.1093/asjof/ojad015]
    • Lorincz, A. M., & Sukumar, S. (2006). Molecular links between obesity and breast cancer. Endocrine-Related Cancer, 13(2), 279–292. [DOI:10.1677/erc.1.00729]
    • Lucien, J. N., Ortega, M. T., Calvert, M. E., Smith, C., White, X., Rogers, H., Mosley, B., Agrawal, R., Drude, A., McGee, C., George, M., Brown, A., Downey, K., Wild, C., Njunge, A., Kuzmiak, C. M., Zava, D., Zava, T., Pollard, J., Francis, J., Beery, B. L., Harlin, M., Gonzalez, G. R., & Shaw, N. D. (2022). The Launch of A Girl’s First Period Study: Demystifying Reproductive Hormone Profiles in Adolescent Girls. Journal of Pediatric and Adolescent Gynecology, 35(4), 420–425. [DOI:10.1016/j.jpag.2021.12.018]
    • Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O’Malley, B. W. (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes & Development, 9(18), 2266–2278. [DOI:10.1101/gad.9.18.2266]
    • Lyon, A. J., De Bruyn, R., & Grant, D. B. (1985). Isosexual Precocious Puberty in Girls. Acta Paediatrica, 74(6), 950–955. [DOI:10.1111/j.1651-2227.1985.tb10063.x]
    • Lyons, W. R. (1958). Hormonal synergism in mammary growth. Proceedings of the Royal Society of London. Series B - Biological Sciences, 149(936), 303–325. [DOI:10.1098/rspb.1958.0071]
    • Lyons, W. R., & McGinty, D. A. (1941). Effects of estrone and progesterone on male rabbit mammary glands. I. Varying doses of progesterone. Proceedings of the Society for Experimental Biology and Medicine, 48(1), 83–86. [DOI:10.3181/00379727-48-13227]
    • Lyons, W. R., Li, C. H., & Johnson, R. E. (1958). The Hormonal Control of Mammary Growth and Lactation. In Pincus, G. (Ed.). Recent Progress in Hormone Research, Volume 14 [Proceedings of the Laurentian Hormone Conference 1957, Held at Mont Tremblant, Quebec] (pp. 219–254). New York/London: Academic Press. [Google Scholar] [Google Books] [PubMed] [OpenLibrary] [WorldCat] [PDF]
    • MacBryde, C. M. (1939). The Production of Breast Growth in the Human Female. Journal of the American Medical Association, 112(11), 1045–1049. [DOI:10.1001/jama.1939.02800110025006]
    • Malet, C., Gompel, A., Yaneva, H., Cren, H., Fidji, N., Mowszowicz, I., Kuttenn, F., & Mauvais-Jarvis, P. (1991). Estradiol and Progesterone Receptors in Cultured Normal Human Breast Epithelial Cells and Fibroblasts: Immunocytochemical Studies. The Journal of Clinical Endocrinology & Metabolism, 73(1), 8–17. [DOI:10.1210/jcem-73-1-8]
    • Malini, S., Smith, E. O., & Goldzieher, J. W. (1985). Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Obstetrics and Gynecology, 66(4), 538–541. [Google Scholar] [PubMed] [URL] [PDF]
    • Marshall, W. A. (1978). Puberty. In Falkner, F., & Tanner, J. M. (Eds.). Human Growth: Postnatal Growth (pp. 141–181). Boston: Springer US. [DOI:10.1007/978-1-4684-2622-9_6]
    • Marshall, W. A., & Tanner, J. M. (1969). Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood, 44(235), 291–303. [DOI:10.1136/adc.44.235.291]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1986). Antiestrogen action of progesterone in breast tissue. Breast Cancer Research and Treatment, 8(3), 179–188. [DOI:10.1007/bf01807330]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1986). Estradiol/Progesterone Interaction in Normal and Pathologic Breast Cells. Annals of the New York Academy of Sciences, 464(1), 152–167. [DOI:10.1111/j.1749-6632.1986.tb16002.x]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1987). Antiestrogen Action of Progesterone in Breast Tissue. Hormone Research, 28(2–4), 212–218. [DOI:10.1159/000180946]
    • Mauvais-Jarvis, P., Kuttenn, F., Gompel, A., & Benotmane, A. (1987). Action anti-estrogène de la progestérone dans le sein. [Antiestrogen action of progesterone in the breast]. Pathologie-Biologie, 35(7), 1081–1086. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Mauvais-Jarvis, P., Sitruk-Ware, R., & Kuttenn, F. (1981). Benign Breast Disease. In McGuire, W. L. (Ed.). Breast Cancer 4: Advances in Research and Treatment (pp. 51–94). Boston: Springer US. [DOI:10.1007/978-1-4615-6571-0_3]
    • McArthur, J. W. (1966). The Reproductive Endocrinology of Adolescence. In Heald, F. P. (Ed.). Adolescent Gynecology (pp. 9–20). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • McBryan, J., Howlin, J., Napoletano, S., & Martin, F. (2008). Amphiregulin: Role in Mammary Gland Development and Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 13(2), 159–169. [DOI:10.1007/s10911-008-9075-7]
    • McDonough, P. G., Spicer, D. V., Ursin, G., & Pike, M. C. (1996). Progesterone Concentrations—Physiologic or Pharmacologic? Fertility and Sterility, 65(5), 1077–1078. [DOI:10.1016/s0015-0282(16)58295-8]
    • McMillan, M. (1966). Five cases of testicular feminisation including one with a teratoma of the testis. The Journal of Pathology and Bacteriology, 91(2), 417–427. [DOI:10.1002/path.1700910216]
    • McNally, S., & Stein, T. (2016). Overview of Mammary Gland Development: A Comparison of Mouse and Human. In Martin, F., Stein, T., & Howlin, J. (Eds.). Mammary Gland Development (Methods in Molecular Biology, Volume 1501) (pp. 1–17). New York: Springer New York. [DOI:10.1007/978-1-4939-6475-8_1]
    • McPhaul, M. J. (2002). Androgen receptor mutations and androgen insensitivity. Molecular and Cellular Endocrinology, 198(1–2), 61–67. [DOI:10.1016/s0303-7207(02)00369-6]
    • Meites, J. (1966). Control of mammary growth and lactation. In Martini, L., & Ganong, W. F. (Eds.). Neuroendocrinology, Volume I (pp. 669–707). New York: Academic Press. [Google Scholar] [Google Books] [DOI:10.1016/B978-1-4832-3228-7.50023-2] [OpenLibrary] [WorldCat]
    • Mesiano, S. (2019). Endocrinology of Human Pregnancy and Fetal-Placental Neuroendocrine Development. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 256–284.e9). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/b978-0-323-47912-7.00011-1]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463]
    • Meyer, W. J., Finkelstein, J. W., Stuart, C. A., Webb, A., Smith, E. R., Payer, A. F., & Walker, P. A. (1981). Physical and hormonal evaluation of transsexual patients during hormonal therapy. Archives of Sexual Behavior, 10(4), 347–356. [DOI:10.1007/bf01565538]
    • Meyer, W. J., Webb, A., Stuart, C. A., Finkelstein, J. W., Lawrence, B., & Walker, P. A. (1986). Physical and hormonal evaluation of transsexual patients: A longitudinal study. Archives of Sexual Behavior, 15(2), 121–138. [DOI:10.1007/bf01542220]
    • Mikołajczyk, M., Kasielska-Trojan, A., & Antoszewski, B. (2019). A New Tool for Breast Anthropometric Measurements: Presentation and Validation for Women and Men. Aesthetic Plastic Surgery, 43(5), 1160–1170. [DOI:10.1007/s00266-019-01467-6]
    • Milionis, C., Ilias, I., & Koukkou, E. (2022). Progesterone in gender-affirming therapy of trans women. World Journal of Biological Chemistry, 13(3), 66–71. [DOI:10.4331/wjbc.v13.i3.66]
    • Milligan, D., Drife, J. O., & Short, R. V. (1975). Changes in breast volume during normal menstrual cycle and after oral contraceptives. BMJ, 4(5995), 494–496. [DOI:10.1136/bmj.4.5995.494]
    • Morris, J. M. (1953). The syndrome of testicular feminization in male pseudohermaphrodites. American Journal of Obstetrics and Gynecology, 65(6), 1192–1211. [DOI:10.1016/0002-9378(53)90359-7]
    • Morris, J. M., & Mahesh, V. B. (1963). Further observations on the syndrome, “testicular feminization”. American Journal of Obstetrics and Gynecology, 87(6), 731–748. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF]
    • Moss, W. M. (1968). Gigantomastia With Pregnancy. Archives of Surgery, 96(1), 27–32. [DOI:10.1001/archsurg.1968.01330190029007]
    • Muallem, M. M., & Rubeiz, N. G. (2006). Physiological and biological skin changes in pregnancy. Clinics in Dermatology, 24(2), 80–83. [DOI:10.1016/j.clindermatol.2005.10.002]
    • Müller, C. (1953). Zur Hormonalen Kosmetik der Weiblichen Brust: Wirkung und Nebenwirkung Östrogenhaltiger Kosmetischer Präparate. [Hormonal Cosmetics of the Female Breast: Effects and Side Effects of Estrogen-Containing Cosmetic Preparations.] Schweizerische Medizinische Wochenschrift [Swiss Medical Weekly], 83(4), 81–84. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
    • Muzaffar, F., Hussain, I., & Haroon, T. S. (1998). Physiologic skin changes during pregnancy: a study of 140 cases. International Journal of Dermatology, 37(6), 429–431. [DOI:10.1046/j.1365-4362.1998.00281.x]
    • Naik, M., Diwakar, R. K., Patre, S., & Singh, S. (2015). Gigantomastia: A Rare Complication In Pregnancy. Journal of Medical Science and Clinical Research, 3(7), 6873–6876. [Google Scholar] [URL] [PDF]
    • Naseem, H., Lokman, M., & Fitzgerald, C. (2021). Management of congenital hypogonadotropic hypogonadism in females. Human Fertility, 26(3), 622–631. [DOI:10.1080/14647273.2021.1998929]
    • Nelson, W. O. (1936). Endocrine Control of the Mammary Gland. Physiological Reviews, 16(3), 488–526. [DOI:10.1152/physrev.1936.16.3.488]
    • Nolan, B. J., Frydman, A. S., Leemaqz, S. Y., Carroll, M., Grossmann, M., Zajac, J. D., & Cheung, A. S. (2022). Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study. Endocrine Connections, 11(5), e220170. [DOI:10.1530/EC-22-0170]
    • Nolan, B. J., Frydman, A. S., Leemaqz, S. Y., Carroll, M., Grossmann, M., Zajac, J. D., & Cheung, A. S. (2022). Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study. Journal of the Endocrine Society, 6(Suppl 1), A653–A654 (abstract no. LBODP089). [DOI:10.1210/jendso/bvac150.1351]
    • Nussbaum, R., & Benedetto, A. V. (2006). Cosmetic aspects of pregnancy. Clinics in Dermatology, 24(2), 133–141. [DOI:10.1016/j.clindermatol.2005.10.007]
    • Nuzzi, L. C., Pramanick, T., Massey, G. G., Walsh, L. R., McNamara, C. T., Firriolo, J. M., DiVasta, A. D., & Labow, B. I. (2021). The Impact of Progestin-only Contraception on Adolescents with Macromastia. Plastic and Reconstructive Surgery - Global Open, 9(2), e3421. [DOI:10.1097/gox.0000000000003421]
    • Nuzzi, L. C., Pramanick, T., Massey, G. G., Walsh, L. R., McNamara, C. T., Firriolo, J. M., DiVasta, A. D., & Labow, B. I. (2022). The Impact of Combined Oral Contraceptives on Adolescents with Macromastia. Plastic and Reconstructive Surgery, 150(4), 731–738. [DOI:10.1097/prs.0000000000009513]
    • Oakes, M. B., Eyvazzadeh, A. D., Quint, E., & Smith, Y. R. (2008). Complete Androgen Insensitivity Syndrome—A Review. Journal of Pediatric and Adolescent Gynecology, 21(6), 305–310. [DOI:10.1016/j.jpag.2007.09.006]
    • Obr, A. E., & Edwards, D. P. (2012). The biology of progesterone receptor in the normal mammary gland and in breast cancer. Molecular and Cellular Endocrinology, 357(1–2), 4–17. [DOI:10.1016/j.mce.2011.10.030]
    • Olanrewaju, F., Onayemi, O., Olasode, O., Adeyemi, A., Oninla, A., Oripelaye, M., Ezejiofor, O., & Oke, O. (2017). Prevalence and Pattern of Pigmentary Changes among Primigravidae Attending a Tertiary Health Facility in South-Western Nigeria. British Journal of Medicine and Medical Research, 21(5), 1–9. [DOI:10.9734/bjmmr/2017/33382]
    • Orentreich, N., & Durr, N. P. (1974). Mammogenesis in Transsexuals. Journal of Investigative Dermatology, 63(1), 142–146. [DOI:10.1111/1523-1747.ep12678272]
    • Pandya, S., & Moore, R. G. (2011). Breast Development and Anatomy. Clinical Obstetrics & Gynecology, 54(1), 91–95. [DOI:10.1097/grf.0b013e318207ffe9]
    • Park, I. Y., Kim, M. R., Jo, H. H., Lee, M. K., & Kim, M. J. (2014). Association of the Nipple-Areola Complexes with Age, Parity, and Breastfeeding in Korean Premenopausal Women. Journal of Human Lactation, 30(4), 474–479. [DOI:10.1177/0890334414549049]
    • Pasqualini, J. R. (2007). Progestins and breast cancer. Gynecological Endocrinology, 23(Suppl 1), 32–41. [DOI:10.1080/09513590701585003]
    • Pasqualini, J. R. (2009). Breast cancer and steroid metabolizing enzymes: The role of progestogens. Maturitas, 65(Suppl 1), S17–S21. [DOI:10.1016/j.maturitas.2009.11.006]
    • Pasqualini, J. R., & Kincl, F. A. (1985). Hormone Production and Concentrations During Pregnancy in Humans and in Other Mammalian Species. In Pasqualini, J. R., & Kincl, F. A. Hormones and the Fetus, Volume I: Production, Concentration and Metabolism During Pregnancy (pp. 173–334). Oxford: Pergamon Press. [DOI:10.1016/b978-0-08-019708-1.50007-6]
    • Patel, H., Arruarana, V., Yao, L., Cui, X., & Ray, E. (2020). Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review. Endocrine, 68(1), 6–15. [DOI:10.1007/s12020-020-02197-5]
    • Patel, K. T., Adeel, S., Rodrigues Miragaya, J., & Tangpricha, V. (2022). Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocrine Practice, 28(12), 1244–1252. [DOI:10.1016/j.eprac.2022.08.012]
    • Patterson, M. N., McPhaul, M. J., & Hughes, I. A. (1994). Androgen insensitivity syndrome. Baillière’s Clinical Endocrinology and Metabolism, 8(2), 379–404. [DOI:10.1016/s0950-351x(05)80258-7]
    • Pawłowski, B., & Żelaźniewicz, A. (2021). The evolution of perennially enlarged breasts in women: a critical review and a novel hypothesis. Biological Reviews, 96(6), 2794–2809. [DOI:10.1111/brv.12778]
    • Perez-Palacios, G., & Jaffe, R. B. (1972). The Syndrome of Testicular Feminization. Pediatric Clinics of North America, 19(3), 653–667. [DOI:10.1016/s0031-3955(16)32744-4]
    • Petrakis, N. (1978). Recurrent extreme breast involution following pregnancy and susceptibility to breast cancer: A hypothesis. Medical Hypotheses, 4(3), 268–272. [DOI:10.1016/0306-9877(78)90006-3]
    • Pfeiffer, C. A. (1943). Endocrinology of Reproduction. Annual Review of Physiology, 5(1), 413–452. [DOI:10.1146/annurev.ph.05.030143.002213]
    • Pipkin, F. B. (2019). Physiological Changes in Pregnancy. In Symonds, I. M., & Arulkumaran, S. (Eds.). Essential Obstetrics and Gynaecology, 6th Edition (pp. 22–40). Edinburgh: Elsevier. [Google Books] [OpenLibrary] [WorldCat]
    • Plu-Bureau, G., Touraine, P., & Mauvais-Jarvis, P. (1999). Interactions Between Estradiol and Progesterone in Normal Breast: Implications for Mammary Carcinogenesis. In Manni, A. (Ed.). Endocrinology of Breast Cancer (Contemporary Endocrinology, Volume 11) (pp. 21–37). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-699-7_2] [OpenLibrary] [Archive.org]
    • Pocock, G., Richards, C. D., & Richards, D. A. (2013). Fertilization, Pregnancy, and Lactation. In Pocock, G., Richards, C. D., & Richards, D. A. Human Physiology, 4th Edition (pp. 655–752). Oxford: Oxford University Press. [Google Scholar] [Google Books]
    • Polani, P. E. (1970). Hormonal and clinical aspects of hermaphroditism and the testicular feminizing syndrome in man. Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 259(828), 187–206. [DOI:10.1098/rstb.1970.0058]
    • Price, S., McManus, J., & Barrett, J. (2019). The transgender population: improving awareness for gynaecologists and their role in the provision of care. The Obstetrician & Gynaecologist, 21(1), 11–20. [DOI:10.1111/tog.12521]
    • Prior, J. C. (2011). Progesterone for Symptomatic Perimenopause Treatment - Progesterone politics, physiology and potential for perimenopause. Facts, Views & Vision in ObGyn, 3(2), 109–120. [PubMed] [PubMed Central] [PDF]
    • Prior, J. C. (2019). Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1181–1186. [DOI:10.1210/jc.2018-01777]
    • Prior, J. C. (2019). Response to Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3129–3130. [DOI:10.1210/jc.2019-00524]
    • Prior, J. C. (2020). Women’s Reproductive System as Balanced Estradiol and Progesterone Actions—A revolutionary, paradigm-shifting concept in women’s health. Drug Discovery Today: Disease Models, 32(Part B), 31–40. [DOI:10.1016/j.ddmod.2020.11.005]
    • Prior, J. C., Vigna, Y. M., & Watson, D. (1989). Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Archives of Sexual Behavior, 18(1), 49–57. [DOI:10.1007/bf01579291]
    • Prior, J. C., Vigna, Y. M., Watson, D., Diewold, P., & Robinow, O. (1986). Spironolactone in the presurgical therapy of male to female transsexuals: Philosophy and experience of the Vancouver Gender Dysphoria Clinic. Journal of Sex Information & Education Council of Canada, 1(1), 1–7. [Google Scholar] [PDF]
    • Quigley, C. A. (1998). The androgen receptor: Physiology and pathophysiology. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 33–106). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_2]
    • Quigley, C. A., Bellis, A. D., Marschke, K. B., El-Awady, M. K., Wilson, E. M., & French, F. S. (1995). Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives. Endocrine Reviews, 16(3), 271–321. [DOI:10.1210/edrv-16-3-271]
    • Radisky, D. C., & Hartmann, L. C. (2009). Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical Studies. Journal of Mammary Gland Biology and Neoplasia, 14(2), 181–191. [DOI:10.1007/s10911-009-9123-y]
    • Ramos, L., Chávez, B., Mares, L., Valdés, E., & Vilchis, F. (2018). Mutational analysis of the androgen receptor (NR3C4) gene in patients with 46,XY DSD. Gene, 641, 86–93. [DOI:10.1016/j.gene.2017.10.038]
    • Ramsay, D. T., Kent, J. C., Hartmann, R. A., & Hartmann, P. E. (2005). Anatomy of the lactating human breast redefined with ultrasound imaging. Journal of Anatomy, 206(6), 525–534. [DOI:10.1111/j.1469-7580.2005.00417.x]
    • Randolph, J. F. (2018). Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics & Gynecology, 61(4), 705–721. [DOI:10.1097/grf.0000000000000396]
    • Rauh, C., Faschingbauer, F., Haeberle, L., Jud, S. M., Heusinger, K., Fasching, P. A., Goecke, T. W., Rajakaruna, N., Voigt, F., Bani, M. R., Lux, M. P., Renner, S. P., Loehberg, C. R., Hartmann, A., Schulz-Wendtland, R., Beckmann, M. W., & Bayer, C. M. (2013). Factors influencing breast changes after pregnancy. European Journal of Cancer Prevention, 22(3), 259–261. [DOI:10.1097/cej.0b013e328359cb81]
    • Rebar, R. W. (1988). The Ovaries. In Wyngaarden, J. B., & Smith, L. H. (Eds.). Cecil Textbook of Medicine, 18th Edition (pp. 1425–1446). Philadelphia: W. B. Saunders. [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Rebar, R. W. (1990). Disorders of Menstruation, Ovulation, and Sexual Response. In Becker, K. L., Bilezikian, J. P., Bremner, W. J., Hung, W., Kahn, C. R., Loriaux, D. L., Rebar, R. W., Robertson, G. L., & Wartofsky, L. (Eds.). Principles and Practice of Endocrinology and Metabolism, 1st Edition (pp. 798–814). Philadelphia: Lippincott. [Google Scholar—3rd/2001 Edition] [Google Books—3rd/2001 Edition] [OpenLibrary] [WorldCat] [Archive.org]
    • Rebar, R. W. (1993). Normal and Abnormal Sexual Differentiation and Pubertal Development. In Moore, T. R., Reiter, R. C., Rebar, R. W., & Baker, W. (Eds.). Gynecology & Obstetrics: A Longitudinal Approach (pp. 97–133). New York: Churchill Livingstone. [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Rebar, R. W. (1996). Puberty. In Berek, J. S., Adashi, E. Y., & Hillard, P. A. (Eds.). Novak’s Gynecology, 12th Edition (pp. 771–807). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A Review of Breast Development in Cisgender Women and Implications for Transgender Women. Endocrine Practice, 25(12), 1338–1345. [DOI:10.4158/ep-2019-0183]
    • Richards, C., & Barrett, J. (2020). Physical Treatments for Trans People and Their Interactions with Psychiatric Treatments. In Richards, C., & Barrett, J. Trans and Non-binary Gender Healthcare for Psychiatrists, Psychologists, and Other Health Professionals (pp. 31–44). Cambridge: Cambridge University Press. [DOI:10.1017/9781108628419.003]
    • Richert, M. M., Schwertfeger, K. L., Ryder, J. W., & Anderson, S. M. (2000). An Atlas of Mouse Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia, 5(2), 227–241. [DOI:10.1023/a:1026499523505]
    • Rix, J., Mills, C., Ross, E., Allen, S., Lai, A., & Wakefield-Scurr, J. (2023). Breast volume fluctuations are associated with oestradiol and progesterone changes across the menstrual cycle. Research Square, preprint. [Google Scholar] [DOI:10.21203/rs.3.rs-3753080/v1] [PDF]
    • Rodari, G. (2022). Pubertal induction in girls with hypogonadism: estrogen replacement therapy outcomes and optimization of progesterone introduction. (Doctoral thesis, Università degli Studi di Milano.) [URL]
    • Rodari, G., Federici, S., Cattoni, A., Todisco, T., Ubertini, G., Giacchetti, F., Profka, E., Dall’Antonia, A., Cangiano, B., Arosio, M., Bonomi, M., Cappa, M., & Giavoli, C. (2022). Pubertal induction in girls with hypogonadism: insight into estrogen replacement therapy outcomes and optimization of progesterone introduction. Endocrine Abstracts, 81 [24th European Congress of Endocrinology 2022 21–24 May 2022, Milan, Italy], 107–107 (abstract no. RC12.7). [DOI:10.1530/endoabs.81.rc12.7] [PDF]
    • Rodari, G., Federici, S., Todisco, T., Ubertini, G., Cattoni, A., Pagano, M., Giacchetti, F., Profka, E., Citterio, V., Messetti, D., Collini, V., Soranna, D., Carbone, E., Arosio, M., Mantovani, G., Persani, L., Cappa, M., Bonomi, M., & Giavoli, C. (2023). Towards an individualized management of pubertal induction in girls with hypogonadism: insight into the best replacement outcomes from a large multicentre registry. European Journal of Endocrinology, 188(6), 467–476. [DOI:10.1093/ejendo/lvad056]
    • Rohn, R. D. (1989). Nipple (papilla) development in girls: III. Journal of Adolescent Health Care, 10(1), 39–40. [DOI:10.1016/0197-0070(89)90045-4]
    • Rosenfield, R. L. (2013). Adolescent Anovulation: Maturational Mechanisms and Implications. The Journal of Clinical Endocrinology & Metabolism, 98(9), 3572–3583. [DOI:10.1210/jc.2013-1770]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021). Puberty in the Female and Its Disorders. In Sperling, M. A., Majzoub, J. A., Menon, R. K., & Stratakis, C. A. (Eds.). Sperling Pediatric Endocrinology, 5th Edition (pp. 528–626). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-62520-3.00016-6]
    • Rothman, M. S., & Iwamoto, S. J. (2022). Feminizing Gender-Affirming Hormone Therapy: Special Considerations for Older Adults. In Davis, T. F. (Ed.). A Case-Based Guide to Clinical Endocrinology (pp. 513–523). Cham: Springer. [DOI:10.1007/978-3-030-84367-0_58]
    • Ruan, W., Monaco, M. E., & Kleinberg, D. L. (2005). Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action. Endocrinology, 146(3), 1170–1178. [DOI:10.1210/en.2004-1360]
    • Rutgers, J. L., & Scully, R. E. (1991). The Androgen Insensitivity Syndrome (Testicular Feminization). International Journal of Gynecological Pathology, 10(2), 126–144. [DOI:10.1097/00004347-199104000-00002]
    • Ryan, R. F., & Pernoll, M. L. (1985). Virginal Hypertrophy. Plastic and Reconstructive Surgery, 75(5), 737–742. [DOI:10.1097/00006534-198505000-00024]
    • Saito, R., Yamamoto, Y., Goto, M., Araki, S., Kubo, K., Kawagoe, R., Kawada, Y., Kusuhara, K., Igarashi, M., & Fukami, M. (2014). Tamoxifen Treatment for Pubertal Gynecomastia in Two Siblings with Partial Androgen Insensitivity Syndrome. Hormone Research in Paediatrics, 81(3), 211–216. [DOI:10.1159/000356923]
    • Sandhu, R., Chollet-Hinton, L., Kirk, E. L., Midkiff, B., & Troester, M. A. (2016). Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma. Human Pathology, 48, 60–68. [DOI:10.1016/j.humpath.2015.09.031]
    • Sanuki, J., Fukuma, E., & Uchida, Y. (2008). Morphologic Study of Nipple-Areola Complex in 600 Breasts. Aesthetic Plastic Surgery, 33(3), 295–297. [DOI:10.1007/s00266-008-9194-y]
    • Satoh, K., Hovey, R. C., Malewski, T., Warri, A., Goldhar, A. S., Ginsburg, E., Saito, K., Lydon, J. P., & Vonderhaar, B. K. (2007). Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene, 26(54), 7526–7534. [DOI:10.1038/sj.onc.1210555]
    • Schauffler, G. C. (1942). Disorders During Adolescence—The Onset of Menstruation. In Schauffler, G. C. Pediatric Gynecology; with Sections on Urology and Proctology, 1st Edition (pp. 169–211). Chicago: Year Book. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL]
    • Schindler, A. E. (2010). Dydrogesterone and other progestins in benign breast disease: an overview. Archives of Gynecology and Obstetrics, 283(2), 369–371. [DOI:10.1007/s00404-010-1456-7]
    • Scott, P. P., Greene, R., Lane-Roberts, C. S., & Swain, V. (1950). The Function of the Breast. In Saner, F. D. (Ed.). The Breast: Structure, Function, Disease (pp. 53–86). Baltimore: Williams and Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [PDF]
    • Seal, L. (2017). Adult Endocrinology. In Richards, C., Bouman, W. P., & Barker, M.-J. (Eds.). Genderqueer and Non-Binary Genders (Critical and Applied Approaches in Sexuality, Gender and Identity) (pp. 183–223). London: Palgrave Macmillan UK. [DOI:10.1057/978-1-137-51053-2_10]
    • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422–4428. [DOI:10.1210/jc.2012-2030]
    • Seibert, B., & Günzel, P. (1994). Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna®. Contraception, 49(4), 303–333. [DOI:10.1016/0010-7824(94)90030-2]
    • Shapiro, L. R. (1982). Disorders of Female Sex Differentiation. In Blaustein, A. (Ed.). Pathology of the Female Genital Tract, 2nd Edition (pp. 479–510). New York: Springer New York. [DOI:10.1007/978-1-4757-1767-9_20]
    • Shearman, R. P. (1972). Ovarian Function and its Control. In Shearman, R. P. (Ed.). Human Reproductive Physiology, 1st Edition (pp. 45–90). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Shearman, R. P. (1972). Primary Ammenorhoea. In Dewhurst, C. J. (Ed.). Integrated Obstetrics and Gynaecology for Postgraduates, 1st Edition (pp. 55–62). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Shi, H. Y., Lydon, J. P., & Zhang, M. (2004). Hormonal Defect in Maspin Heterozygous Mice Reveals a Role of Progesterone in Pubertal Ductal Development. Molecular Endocrinology, 18(9), 2196–2207. [DOI:10.1210/me.2004-0052]
    • Shuttleworth, F. K. (1938). The Adolescent Period: A Graphic and Pictorial Atlas (Monographs of the Society for Research in Child Development, Volume 3, Number 3 / Serial No. 16). Washington, D. C.: Society for Research in Child Development. [Google Scholar] [Google Books] [DOI:10.2307/1165482]
    • Simmer, H. H., Pion, R. J., & Dignam, W. J. (1965). Testicular Feminization: Endocrine Function of Feminizing Testes, Comparison with Normal Testes. Springfield, Illinois: Thomas. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Simpson, J. L., & Rebar, R. W. (1990). Normal and Abnormal Sexual Differentiation and Development. In Becker, K. L., Bilezikian, J. P., Bremner, W. J., Hung, W., Kahn, C. R., Loriaux, D. L., Rebar, R. W., Robertson, G. L., & Wartofsky, L. (Eds.). Principles and Practice of Endocrinology and Metabolism, 1st Edition (pp. 710–739). Philadelphia: Lippincott. [Google Scholar] [Google Books—3rd/2001 Edition] [OpenLibrary] [WorldCat] [Archive.org]
    • Sindi, R., Sá Dos Reis, C., Bennett, C., Stevenson, G., & Sun, Z. (2019). Quantitative Measurements of Breast Density Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 8(5), 745. [DOI:10.3390/jcm8050745]
    • Sitruk-Ware, R., Basdevant, A., de Lignières, B., & Mauvais-Jarvis, P. (1984). Percutaneous oestrogen therapy. In van Herendael, H., van Herendael, B., Riphagen, F. E., Goessens, L., & van der Plas, H. (Eds.). The Climacteric: An Update: Proceedings of the fourth Jan Palfijn Symposium, European Conference on the Menopause, held in Antwerp, Belgium, on September 1–2, 1983, under the auspices of ‘De Vereniging voor Nederlandstalige gynecologen van België’ and ‘The International Menopause Society’ (pp. 127–139). Lancaster: MTP Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [DOI:10.1007/978-94-009-5608-7_14]
    • Sizonenko, P. C. (1978). Endocrinology in Preadolescents and Adolescents. American Journal of Diseases of Children, 132(7), 704–712. [DOI:10.1001/archpedi.1978.02120320064015]
    • Skarda, J., Fremrová, V., & Bezecný, I. (1989). Progesterone alone is responsible for stimulation of the growth of ducts and of mammary alveolar structures in mice. Endocrinologia Experimentalis, 23(1), 17–28. [Google Scholar] [PubMed] [PDF]
    • Sobrinho, L. G., Kase, N., & Grunt, J. A. (1971). Spontaneous pubertal breast growth in a castrated patient with the syndrome of testicular feminization. The Yale Journal of Biology and Medicine, 44(2), 225–9. [Google Scholar] [PubMed] [PubMed Central] [PDF]
    • Sosa, M., Jódar, E., Arbelo, E., Domínguez, C., Saavedra, P., Torres, A., Salido, E., de Tejada, M. J., & Hernández, D. (2003). Bone Mass, Bone Turnover, Vitamin D, and Estrogen Receptor Gene Polymorphisms in Male to Female Transsexuals. Journal of Clinical Densitometry, 6(3), 297–304. [DOI:10.1385/jcd:6:3:297]
    • Sosa, M., Jódar, E., Arbelo, E., Domı́nguez, C., Saavedra, P., Torres, A., Salido, E., Limiñana, J., Gómez de Tejada, M. J., & Hernández, D. (2004). Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: effects of estrogen treatment. European Journal of Internal Medicine, 15(4), 231–237. [DOI:10.1016/j.ejim.2004.04.009]
    • Soyal, S., Ismail, P. M., Li, J., Mulac-Jericevic, B., Conneely, O. M., & Lydon, J. P. (2002). Progesterone receptors - animal models and cell signaling in breast cancer: Progesterone’s role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Research, 4(5), 191. [DOI:10.1186/bcr451]
    • Sperling, R. L., & Gold, J. J. (1973). Use of an anti-estrogen after a reduction mammaplasty to prevent recurrence of virginal hypertrophy of breasts. Plastic and Reconstructive Surgery, 52(4), 439–442. [DOI:10.1097/00006534-197352040-00030]
    • Spitz, I. M., Shoupe, D., Sitruk-Ware, R., & Mishell, D. R. (1989). Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women. Journal of Reproduction and Fertility Supplement, 37, 253–260. [Google Scholar] [PubMed]
    • Spitz, I., Croxatto, H., Lahteenmaki, P., Heikinheimo, O., & Bardin, C. (1994). Effect of mifepristone on inhibition of ovulation and induction of luteolysis. Human Reproduction, 9(Suppl 1), 69–76. [DOI:10.1093/humrep/9.suppl_1.69]
    • Spitz, I. M. (2010). Mifepristone: where do we come from and where are we going? Contraception, 82(5), 442–452. [DOI:10.1016/j.contraception.2009.12.012]
    • Sridhar, G. R., & Sinha, M. J. (1995). Macromastia in adolescent girls. Indian Pediatrics, 32(4), 496–499. [Google Scholar] [PubMed] [PDF]
    • Sun, B. Z., Kangarloo, T., Adams, J. M., Sluss, P. M., Welt, C. K., Chandler, D. W., Zava, D. T., McGrath, J. A., Umbach, D. M., Hall, J. E., & Shaw, N. D. (2018). Healthy Post-Menarchal Adolescent Girls Demonstrate Multi-Level Reproductive Axis Immaturity. The Journal of Clinical Endocrinology & Metabolism, 104(2), 613–623. [DOI:10.1210/jc.2018-00595]
    • Sun, S. X., Bostanci, Z., Kass, R. B., Mancino, A. T., Rosenbloom, A. L., Klimberg, V. S., & Bland, K. I. (2018). Breast Physiology: Normal and Abnormal Development and Function. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 37–56.e6). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00003-9]
    • Swelstad, M. R., Swelstad, B. B., Rao, V. K., & Gutowski, K. A. (2006). Management of Gestational Gigantomastia. Plastic and Reconstructive Surgery, 118(4), 840–848. [DOI:10.1097/01.prs.0000232364.40958.47]
    • Tack, L. J., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine, 14(5), 747–757. [DOI:10.1016/j.jsxm.2017.03.251]
    • Talbert, L. M., Hammond, M. G., Groff, T., & Udry, J. R. (1985). Relationship of age and pubertal development to ovulation in adolescent girls. Obstetrics & Gynecology, 66(4), 542–544. [Google Scholar] [PubMed] [URL]
    • Tanos, T., & Brisken, C. (2008). What Signals Operate in the Mammary Niche? Breast Disease, 29(1), 69–82. [DOI:10.3233/bd-2008-29108]
    • Thanaboonyawat, I., Chanprapaph, P., Lattalapkul, J., & Rongluen, S. (2013). Pilot Study of Normal Development of Nipples during Pregnancy. Journal of Human Lactation, 29(4), 480–483. [DOI:10.1177/0890334413493350]
    • Thody, A. J., & Smith, A. G. (1977). Hormones and Skin Pigmentation in the Mammal. International Journal of Dermatology, 16(8), 657–664. [DOI:10.1111/j.1365-4362.1977.tb01876.x]
    • Thoresen, M., & Wesche, J. (1988). Doppler measurements of changes in human mammary and uterine blood flow during pregnancy and lactation. Acta Obstetricia et Gynecologica Scandinavica, 67(8), 741–745. [DOI:10.3109/00016349809004301]
    • Tiefenbacher, K., & Daxenbichler, G. (2008). The Role of Androgens in Normal and Malignant Breast Tissue. Breast Care, 3(5), 325–331. [DOI:10.1159/000158055]
    • Tim, F., Jeroen, V., & T’Sjoen, G. (2023). Dose Reduction of Cyproterone Acetate in Trans Women and the Effect on Patient-reported Outcomes: Results from the ENIGI Study. Endocrine Abstracts, 97 [Belgian Endocrine Society 2023], 5–5 (abstract no. 007). [URL] [PDF]
    • Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z. (2019). Progesterone and Breast Cancer. Endocrine Reviews, 41(2), 320–344. [DOI:10.1210/endrev/bnz001]
    • Tucker, H. (2000). Hormones, Mammary Growth, and Lactation: a 41-Year Perspective. Journal of Dairy Science, 83(4), 874–884. [DOI:10.3168/jds.s0022-0302(00)74951-4]
    • Turan, S., Bereket, A., Guran, T., Akcay, T., Papari-Zareei, M., & Auchus, R. J. (2009). Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair. European Journal of Endocrinology, 160(2), 325–330. [DOI:10.1530/eje-08-0632]
    • Turner, C. W. (1939). The Mammary Glands. In Allen, E., Danforth, C. H., & Doisy, E. A. (Eds.). Sex and Internal Secretions: A Survey of Recent Research, 2nd Edition (pp. 740–803). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Ulrich, U., Pfeifer, T., & Lauritzen, C. (1994). Rapid Increase in Lumbar Spine Bone Density in Osteopenic Women by High-Dose Intramuscular Estrogen-Progestogen Injections. Hormone and Metabolic Research, 26(9), 428–431. [DOI:10.1055/s-2007-1001723]
    • Ulrich, U., Pfeifer, T., Buck, G., Keckstein, J., & Lauritzen, C. (1995). High-dose estrogen-progestogen injections in gonadal dysgenesis, ovarian hypoplasia, and androgen insensitivity syndrome: Impact on bone density. Adolescent and Pediatric Gynecology, 8(1), 20–23. [DOI:10.1016/s0932-8610(12)80156-3]
    • Valentine, G. H. (1969). Chromosome Anomalies in the Female. In Valentine, G. H. The Chromosome Disorders: An Introduction for Clinicians, 2nd Edition (pp. 126–143). London: W. Heinemann Medical Books. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • van der Meulen, A. J. (1974). An unusual case of massive hypertrophy of the breasts. South African Medical Journal=Suid-Afrikaanse Tydskrif vir Geneeskunde, 48(34), 1465–1466. [Google Scholar] [PubMed] [URL 1] [URL 2]
    • Vandeweyer, E., & Hertens, D. (2002). Quantification of glands and fat in breast tissue: An experimental determination. Annals of Anatomy - Anatomischer Anzeiger, 184(2), 181–184. [DOI:10.1016/s0940-9602(02)80016-4]
    • Venturoli, S., Fabbri, R., Porcu, E., Paradisi, R., Orsini, L. F., Brondelli, L., Ruggeri, S., & Flamigni, C. (1989). Endocrine and ovarian parameters at various frequencies of ovulation in adolescents. Archives of Gynecology and Obstetrics, 246(2), 107–114. [DOI:10.1007/bf00934127]
    • Venturoli, S., Porcu, E., Fabbri, R., Magrini, O., Paradisi, R., Pallotti, G., Gammi, L., & Flamigni, C. (1987). Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertility and Sterility, 48(1), 78–85. [DOI:10.1016/s0015-0282(16)59294-2]
    • Vorherr, H. (1974). Development of the Female Breast. In Vorherr, H. The Breast: Morphology, Physiology, and Lactation (pp. 1–19). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Vorherr, H. (1974). Morphology of the Mature Female Breast. In Vorherr, H. The Breast: Morphology, Physiology, and Lactation (pp. 20–70). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Wade, T. R., Wade, S. L., & Jones, H. E. (1978). Skin changes and diseases associated with pregnancy. Obstetrics and Gynecology, 52(2), 233–242. [Google Scholar] [PubMed] [URL]
    • Walker, M., Baker, G., & Lamb, M. (2013). Physiology of the Breast During Pregnancy and Lactation. In Mannel, R., Martens, P. J., & Walker, M. (Eds.). Core Curriculum for Lactation Consultant Practice, 3rd Edition (pp. 287–300). Burlington: Jones & Bartlett Learning. [Google Scholar] [Google Books—2013/3rd Edition] [Google Books—2008/2nd Edition] [OpenLibrary] [WorldCat]
    • Wang, C., Luan, J., Cheng, H., Chen, L., Li, Z., Panayi, A. C., & Liu, C. (2018). Menstrual Cycle-Related Fluctuations in Breast Volume Measured Using Three-Dimensional Imaging: Implications for Volumetric Evaluation in Breast Augmentation. Aesthetic Plastic Surgery, 43(1), 1–6. [DOI:10.1007/s00266-018-1243-6]
    • Wang, Q. A., & Scherer, P. E. (2019). Remodeling of Murine Mammary Adipose Tissue during Pregnancy, Lactation, and Involution. Journal of Mammary Gland Biology and Neoplasia, 24(3), 207–212. [DOI:10.1007/s10911-019-09434-2]
    • Weisberg, M. G., Malkasian, G. D., & Pratt, J. H. (1970). Testicular feminization syndrome. American Journal of Obstetrics and Gynecology, 107(8), 1181–1187. [DOI:10.1016/s0002-9378(15)30367-7]
    • Wellons, M. F., & Rebar, R. W. (2013). Amenorrhea. In Falcone, T., & Hurd, W. W. (Eds.). Clinical Reproductive Medicine and Surgery: A Practical Guide, 2nd Edition (pp. 105–112). New York: Springer New York. [DOI:10.1007/978-1-4614-6837-0_7]
    • Wellons, M. F., Weeber, K. M., & Rebar, R. W. (2017). Amenorrhea. In Falcone, T., & Hurd, W. W. (Eds.). Clinical Reproductive Medicine and Surgery, 3rd Edition (pp. 109–122). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-52210-4_6]
    • Werner, A. A. (1935). Experiment to produce lactation in castrate women. Endocrinology, 19(2), 144–150. [DOI:10.1210/endo-19-2-144]
    • Whiteley, S. (1994). Predictors of Milk Production in Lactating Women. (Master’s thesis, The Open University.) [Google Scholar] [DOI:10.21954/ou.ro.0000fe02] [URL]
    • Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    • Wilson, J. D. (1968 March 28). Medical Grand Rounds: Testicular Feminization. Parkland Memorial Hospital, UT Southwestern Medical Center. [Google Scholar] [URL] [PDF]
    • Wilson, C. L., Sims, A. H., Howell, A., Miller, C. J., & Clarke, R. B. (2006). Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocrine-Related Cancer, 13(2), 617–628. [DOI:10.1677/erc.1.01165]
    • Winkler, U. H., Schindler, A. E., Brinkmann, U. S., Ebert, C., & Oberhoff, C. (2001). Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecological Endocrinology, 15(Suppl 6), 37–43. [DOI:10.1080/gye.15.s6.37.43]
    • Wisniewski, A. B., Migeon, C. J., Meyer-Bahlburg, H. F., Gearhart, J. P., Berkovitz, G. D., Brown, T. R., & Money, J. (2000). Complete Androgen Insensitivity Syndrome: Long-Term Medical, Surgical, and Psychosexual Outcome. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2664–2669. [DOI:10.1210/jcem.85.8.6742]
    • Wong, R. C., & Ellis, C. N. (1984). Physiologic skin changes in pregnancy. Journal of the American Academy of Dermatology, 10(6), 929–940. [DOI:10.1016/s0190-9622(84)80305-9]
    • Wren, B. G., & Eden, J. A. (1996). Do Progestogens Reduce The Risk of Breast Cancer? A Review of the Evidence. Menopause, 3(1), 4–12. [DOI:10.1097/00042192-199603010-00003]
    • Wright, E. M. (2015). Breastfeeding and the Mother–Newborn Dyad (pp. 1157–1182). In King, T. L., Brucker, M. C., Kriebs, J. M., Fahey, J. O., Gegor, C. L., & Varney, H. (Eds.). Varney’s Midwifery, 5th Edition. Burlington: Jones & Bartlett Learning. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Xu, P., Ye, W., Zhong, S., Li, H., Feng, E., Lin, S. H., Kuo, C. T., Liu, J. Y., & Lin, Y. C. (2010). Leptin and zeranol up-regulate cyclin D1 expression in primary cultured normal human breast pre-adipocytes. Molecular Medicine Reports, 3(6), 983–990. [DOI:10.3892/mmr.2010.370]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]
    • Zacharin, M. (2000). Use of androgens and oestrogens in adolescents - A review of hormone replacement treatment. Journal of Pediatric Endocrinology and Metabolism, 13(1), 3–12. [DOI:10.1515/JPEM.2000.13.1.3]
    • Zachmann, M., Prader, A., Sobel, E. H., Crigler, J. F., Ritzén, E. M., Atarés, M., & Ferrandez, A. (1986). Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogens in pubertal growth of girls. The Journal of Pediatrics, 108(5), 694–697. [DOI:10.1016/s0022-3476(86)81043-5]
    • Żelaźniewicz, A., & Pawłowski, B. (2015). Breast size and asymmetry during pregnancy in dependence of a fetus’s sex. American Journal of Human Biology, 27(5), 690–696. [DOI:10.1002/ajhb.22716]
    • Żelaźniewicz, A., & Pawłowski, B. (2018). Maternal breast volume in pregnancy and lactation capacity. American Journal of Physical Anthropology, 168(1), 180–189. [DOI:10.1002/ajpa.23734]
    • Zhang, D., Yao, F., Tian, T., Deng, S., Luo, M., & Tian, Q. (2021). Clinical characteristics and molecular genetics of complete androgen insensitivity syndrome patients: a series study of 30 cases from a Chinese tertiary medical center. Fertility and Sterility, 115(5), 1270–1279. [DOI:10.1016/j.fertnstert.2020.12.008]
    \ No newline at end of file +A Comprehensive Review of the Potential of Progestogens for Enhancing Breast Development in Transfeminine People - Transfeminine Science Link

    A Comprehensive Review of the Potential of Progestogens for Enhancing Breast Development in Transfeminine People

    By Aly | First published February 14, 2020 | Last modified April 1, 2024

    Abstract / TL;DR

    The major female sex hormones are estrogen and progesterone. Both of these hormones are known to be importantly involved in the development of the breasts at different stages of life. Speculation, use, and anecdotes of progestogens for enhancing breast development in transfeminine people date back to at least the 1960s. A limited number of clinical studies have assessed breast development with progestogens in transfeminine people, but current evidence on progestogens for improving breast development is of very low quality and is inconclusive. Studies of progestogens and breast development in cisgender girls and women are similarly limited. In any case, more studies evaluating progestogens and breast development are currently underway. The possible role of progestogens in enhancing breast development can also be informed by indirect and circumstantial evidence, including notably findings on progesterone and breast changes during normal puberty, the menstrual cycle, and pregnancy in humans and animals. Available evidence overall is not suggestive of an essential role for progesterone in breast growth during puberty, but progesterone does have a clear and key role in lobuloalveolar development of the breasts during pregnancy. However, breast changes in pregnancy revert following cessation of lactation and breastfeeding. Progesterone may additionally contribute to reversible breast enlargement during the luteal phase of the menstrual cycle. There are some findings to suggest that progestogens may have antiestrogenic effects in the breasts and may have a stunting influence on breast development if introduced too early following initiation of hormone therapy. However, more research is needed to assess this possibility. In any case, if progestogens are used, it may be advisable to delay their introduction until most or all estrogen-mediated breast development is complete. Options for progestogen therapy in transfeminine people include bioidentical progesterone and progestins. However, oral progesterone has major bioavailability problems and does not achieve satisfactory progesterone levels. Progestogens, including progesterone, have been variously linked to significant health risks, which is an important consideration in terms of their use in transfeminine people. Overall, based on current knowledge, progestogens do not seem to be promising for lastingly improving breast development in transfeminine people, but more research and data are still needed for clear conclusions.

    Introduction

    Breast development in terms of size and shape is often less than desired in transfeminine people, and there is a need for therapeutic approaches that improve breast growth in this population. There are two major types of female hormones, estrogens and progestogens. Estrogens are almost universally employed in transfeminine hormone therapy, while progestogens are used in a subset of transfeminine people. Progestogens that have been commonly employed in transfeminine people include bioidentical progesterone, the progestin (synthetic progestogen) medroxyprogesterone acetate (MPA), and the strongly progestogenic antiandrogen cyproterone acetate (CPA). Estrogens are the major mediators of feminization and breast development in females. However, progestogens also have physiological effects on the breasts, and in relation to this, may or may not provide benefits to breast development as well.

    The topic of progestogens and breast development has been discussed for many years in the transgender community and is a controversial subject (Coleman et al., 2012). Use of progestogens to improve breast development in transfeminine people goes back at least as far as Harry Benjamin and Christian Hamburger in the 1960s (Benjamin, 1966; Benjamin, 1967; Hamburger & Benjamin, 1969; Wiki). Arguments have been made both for (e.g., Bevan, 2012; Bellwether, 2019; Bevan, 2019) and against (e.g., Curtis, 2009) a possible role of progestogens in terms of breast development. It is often claimed that progestogens can enhance breast development or are even required for full breast development in cisgender females and transfeminine people. With respect to the latter, it is sometimes said that progestogens are necessary for people to move from Tanner stage 4 to Tanner stage 5 pubertal breast development and that progestogens help to fill and round out the breasts (e.g., Vorherr, 1974a; Basson & Prior, 1998; Kaiser & Ho, 2015; Prior, 2011; Prior, 2019a; Prior, 2020). It has even been claimed by some that without progestogens, the breasts will remain conical and “pointy” like they are in the earlier Tanner stages. On the other extreme, certain critics have claimed that there are “no biologically significant progesterone receptor sites for biological males” and that progesterone is not produced during normal female puberty until after breast development has been fully completed (Barrett, 2009; Seal, 2017; Coxon & Seal, 2018; Price, McManus, & Barrett, 2019; Richards & Barrett, 2020). In turn, these particular authors have argued against the use of progestogens in transfeminine people in various of their publications (Google Scholar). In general, the use of progestogens in transfeminine people has longstandingly been controversial, with positions both for and against (Sam, 2020).

    The purpose of this article is to review the available direct and circumstantial evidence on the topic of progestogens and breast development in order to help inform whether progestogen therapy may be able to enhance breast development in transfeminine people. Aside from an involvement in breast development, progestogens are not otherwise currently thought to be or known to be involved in physical feminization (e.g., Coleman et al., 2012; Gooren, 2016). In relation to this, the present article will limit its discussion to breast development with progestogens, and will not explore feminization in general.

    Progestogen Therapy and Breast Development in Humans

    Progestogens and Breast Development in Transfeminine People

    At present, only a limited number of studies have assessed breast development with progestogen therapy in transfeminine people. These studies have employed either bioidentical progesterone or a progestin like MPA or CPA. The subject of and the available data on progestogens and breast development in transfeminine people has also been partly reviewed in papers including Wierckx, Gooren, & T’Sjoen (2014), Reisman, Goldstein, & Safer (2019), Patel et al. (2020), Patel et al. (2022), Milionis, Ilias, & Koukkou (2022), Coleman et al. (2022), and Berliere et al. (2023).

    Orentreich & Durr (1974) was one of the earliest studies on breast development in transfeminine people. They employed combinations of estrogens and progestogens as well as gonadectomy to produce feminization and breast development in a case series of 5 transfeminine people. The employed estrogens were estradiol valerate 30 mg/2 weeks by intramuscular injection and oral conjugated estrogens 1.25–5.0 mg/day and the used progestogens were “60 mg medroxyprogesterone caproate” every 2 weeks by intramuscular injection and oral medroxyprogesterone acetate 0–10 mg/day. Medroxyprogesterone caproate (MPC) has never been used pharmaceutically, so this was likely a typo and the actual progestogen employed was likely either MPA or hydroxyprogesterone caproate (OHPC). The authors reported that estrogen and progestogen therapy produced modest to significant breast development in the transfeminine people that was not strictly dose-related and included clinical photographs of the breasts. They concluded that the breast development was comparable to that of adult cisgender women. Orentreich and colleagues also discussed the topic of lobuloalveolar maturation of the breasts, which was known to be progestogen-dependent, but noted that they had not done histological assessment and that the degree of lobuloalveolar development of the breasts does not necessarily correlate with clinical breast size per findings in cisgender women. The findings of Orentreich and colleagues are limited by methodological problems like lack of objective measurements, lack of estrogen-only controls, and the small sample size of only 5 transfeminine people, and hence the study is of limited value in terms of assessing the involvement of progestogens in breast development.

    Meyer et al. (1986) assessed the effects of progestogens added to estrogen therapy on breast development and other clinical parameters in transfeminine people. Of the 60 transfeminine people in the study, 15 (25%) received an oral progestogen, usually MPA at a dosage of 10 mg/day, for “at least for a short time”, and with only 8 (13.3%) receiving progestogen therapy for the full treatment period. In an earlier report of the study, it was noted that in 90% of observation periods the dose was 10 mg/day and for the remainder it was 20 mg/day (Meyer et al., 1981). A dosage of 10 mg/day MPA is roughly comparable to luteal-phase progesterone exposure in terms of progestogenic potency (Wiki). Breast development was measured in the study via breast hemicircumference (Diagram). Progestogen therapy was reported to not modify estrogen-induced changes, including laboratory measurements, hormone levels, and physical parameters like weight and breast growth. The lack of apparent changes in hormone levels is unexpected, as MPA in higher-quality studies has shown clear testosterone suppression (e.g., Jain, Kwan, & Forcier, 2019; Wiki). Meyer and colleagues concluded that adding progestogens to estrogen does not seem to enhance breast development in transfeminine people. However, they noted that the number of individuals who received progestogens was small and further studies were needed.

    Prior et al. (1986) and Prior, Vigna, & Watson (1989) studied estrogen, high-dose spironolactone (100–600 mg/day), and MPA (10–20 mg/day cylically or continuously) in transfeminine people who were either pre-hormone therapy or had previously been on higher doses of estrogens (and/or progestogens) without spironolactone prior to the study. The researchers reported that following 12 months of treatment with the study’s hormone therapy regimen, there was increased breast size and increased nipple development. Most individuals reached an A cup size, or approximately 8 to 14 cm in diameter of breast tissue, by the end of the study. Breast development was measured in part with photographic documentation. Although breast development reportedly improved, the researchers themselves noted that it was difficult to determine whether the enhanced breast development could be attributed to spironolactone or to MPA. Moreover, testosterone suppression was inadequate before the study and improved with the study’s hormone therapy regimen, which may have helped to improve breast development regardless of any potential direct progestogenic action of MPA on the breasts. Finally, it is possible that breast development with estrogen may not yet have been complete, and that the improved breast development may have simply been continued progression due to estrogen alone. In other publications, Jerilynn Prior, the lead study author, has claimed that progesterone enhances breast development, and has cited the preceding studies by her in support of this claim (Prior, 2011; Prior, 2019a; Prior, 2019b; Prior, 2020). However, her claim is not well-supported due to the study limitations discussed.

    Dittrich et al. (2005) reported that the combination of oral estradiol valerate and a gonadotropin-releasing hormone (GnRH) agonist for 2 years in transfeminine people resulted in self-reported breast cup sizes of C cup or greater in 5%, B cup in 30%, A cup in 35%, and less than A cup in 30%. They noted however that 70% of the individuals were unsatisfied with their breast development and wished to undergo breast augmentation surgery. The researchers claimed that the regimen had similar effectiveness in terms of feminization, including increases in breast size, compared to prior reported treatment regimens of ethinylestradiol and CPA. No other details or specifics were given. The claim about similar breast development to regimens containing CPA is relevant as CPA is a very strong progestogen at the doses used historically in transfeminine people (Aly, 2019). It should be cautioned however that this study did not actually employ or study progestogen therapy itself. In addition, self-reported breast cup size is a subjective and low-quality means of measuring breast development and size. As such, the findings of this study are of questionable value in terms of understanding progestogens and breast development.

    Estrogen is primarily involved in ductal development of the breasts, whereas progesterone is mainly involved in lobuloalveolar development. Kanhai et al. (2000) compared internal histological breast tissue changes with estrogen and CPA 100 mg/day (i.e. very-high-dose progestogen) therapy in 14 transfeminine people versus nonsteroidal antiandrogen monotherapy with flutamide or bicalutamide in 2 cisgender men with prostate cancer. Both types of treatments block androgens, increase estrogen levels, and are known to induce breast development or gynecomastia at similarly high rates. However, nonsteroidal antiandrogen monotherapy differs from combined estrogen and progestogen therapy in that it lacks any progestogenic effects. In the transfeminine people, full lobuloalveolar formation was apparent in the biopsied breast tissue, whereas in the men with prostate cancer, only “moderate” and incomplete lobuloalveolar maturation was found. It was also noted that lobuloalveolar formation tended to regress upon discontinuation of CPA following gonadectomy in transfeminine people. The researchers concluded that progestogenic exposure is needed for the breasts to fully develop on a histological level and for the breast tissue of transfeminine people to completely mimic the histology of the mature female breast. While the findings of this study are interesting, they only concern tissue characteristics and do not actually provide any information about breast development in terms of physical form or appearance. With regard to this, tissue-level differences may or may not translate to relevant differences in for instance breast size or shape. As such, the study is of limited value in understanding whether progestogens improve breast development in transfeminine people in the ways that are actually valued.

    Seal and colleagues conducted a retrospective chart review assessing clinical predictors for surgical breast augmentation in transfeminine people (Seal et al., 2012). In the transfeminine people who underwent breast augmentation, significantly more of them were taking spironolactone than were those who did not undergo breast augmentation. Conversely, the differential rates of use of specific antiandrogens were not significantly discordant between those who did and did not undergo breast augmentation in the case of the other prescribed antiandrogens, including cyproterone acetate, the 5α-reductase inhibitors, and GnRH analogues. However, this study had many methodological limitations, including the use of almost three dozen t-tests with no adjustment for multiple comparisons (and hence risk of false positives and concerns about p-hacking), small sample sizes for individual antiandrogens, use of undergoing breast augmentation as a surrogate for breast development with no actual physical measurement of the breasts or breast sizes, and a correlational design with lack of control for potential confounding variables. As such, the study does not show that different antiandrogens result in differences in breast development, and its findings must be considered with due caution.

    Jain, Kwan, & Forcier (2019) studied sublingual estradiol and spironolactone with and without MPA in 92 transfeminine people. MPA was given at a dose of 5 to 10 mg/day sublingually or at a dose of 150 mg once every 3 months by intramuscular injection. Of 39 transfeminine people who received MPA, 26 (67%) self-reported improved breast development. No further details were provided, but measurement of breast development was presumably subjective and anecdotal. Igo & Visram (2021) studied addition of progesterone to hormone therapy in transfeminine people. Progesterone was provided as 100 mg micronized progesterone (probably oral) and was prescribed when progesterone was specifically requested by the patient or when the patient expressed dissatisfaction with feminization and/or breast development. Of 190 individuals, 51 (26.8%) received progesterone therapy. Treatment with progesterone on average began after 12.7 months of estradiol therapy, and the mean total follow-up time was 14.3 months of hormone therapy. Of those who received progesterone, only 6 (11.8%) reported benefit to breast development. No further details were provided, but as with other studies, breast development was likely quantified anecdotally via self-report. As breast development does not appear to have been objectively measured or compared to a control group in either Jain, Kwan, & Forcier (2019) or Igo & Visram (2021), the findings of these studies are limitedly informative.

    Nolan and colleagues assessed the short-term effects of low-dose oral micronized progesterone on breast development in transfeminine people on stable hormone therapy in a prospective controlled study (Nolan et al., 2022a; Nolan et al., 2022b). Progesterone was given at a dose of 100 mg/day for 3 months to 23 transfeminine people and findings were compared to those of a control group of 19 transfeminine people. Breast development was measured using self-reported Tanner stage, with participants provided photographs of different Tanner stages to self-select from. At the end of the 3 months, Tanner stage was not significantly different between groups (mean 3.5, 95% CI 3.2–3.7 for progesterone vs. mean 3.6, 95% CI 3.3–3.9 for controls; p = 0.42). A limitation of this study is that oral progesterone has very low bioavailability and 100 mg/day oral progesterone achieves very low progesterone levels that are well below normal luteal-phase progesterone levels (Aly, 2018a; Wiki). As such, progestogenic exposure in this study, and notably also in Igo & Visram (2021) and other studies, is likely to have been inadequate. Besides the issue of progestogenic strength, the very short duration of the study (3 months) and the reliance on self-reported subjective Tanner stages (as opposed to more objective physical breast measurements) are also major limitations. In any case, this study is of higher quality than previous studies, and is notably likely to continue and report further follow-up at later points in the future.

    Bahr et al. (2024) conducted a retrospective chart review at their clinic and compared 29 transfeminine people who had received progestogens versus 59 transfeminine people who had not. The form of progestogen used was oral or rectal progesterone in 93% of cases and MPA by intramuscular injection in the remaining 7% of cases. Of those who took progesterone, 25 (93%) used it orally and 2 (7%) used oral progesterone capsules rectally. Progestogen doses were not reported, except that 100 mg progesterone capsules were employed. Most of those in the progestogen-treated group (59%) had started it 1 to 6 months following initiation of standard hormone therapy. The researchers found that progestogen-treated group had significantly better self-reported breast development satisfaction (rated as satisfied, neutral, or unsatisfied) compared to the group that did not receive progestogens at 6 months (satisfied: 53.8% vs. 19.6%; p = 0.004) and 9 months (satisfied: 71.4% vs. 20.8%; p = 0.003) of hormone therapy. Limitations of this study include the lack of objective measurement of breast development, the restrospective nature of the study, and the lack of randomization of treatment, among others.

    Aside from the above studies, a variety of other studies have also reported breast development with estrogen and CPA in transfeminine people. These studies have often employed objective physical measurements of breast development (e.g., breast volume, breast–chest difference, breast cup size, breast hemicircumference). However, they have lacked comparison groups, thereby precluding comparison of progestogenic versus non-progestogenic hormone therapy. In addition, CPA is unusual among progestogens in that it is employed at very high doses in transfeminine people (Aly, 2019), which may result in different and potentially stunted outcomes in terms of breast development than more physiological progestogenic exposure. As such, most studies of breast development with estrogen and CPA in transfeminine people have not been discussed in the present section and are instead discussed elsewhere in this article (see the section below). In any case, to briefly summarize the findings, breast development in transfeminine people with estrogen and CPA has generally been poor in these studies. The outcomes have included incomplete maturation in terms of Tanner staging (stage 2–4), small cup sizes, small breast volumes, and breasts much smaller in size than those in cisgender women.

    The findings from the preceding studies in transfeminine people are of very low-quality due to methodological limitations, including lack of control groups, lack of randomization, reliance on poor measures of breast development (e.g., subjective and self-report) rather than objective physical measurements (Wiki), short treatment durations, and small sample sizes, among others. This may explain the conflicting results of the studies. More research is still needed to assess the influence of progestogens on breast development in transfeminine people. There is specifically a need for randomized controlled trials (RCTs) of feminizing hormone therapy with versus without progestogen therapy that employ objective measures of breast development, have adequate sample sizes, and have sufficient follow-up durations. Additional variables like progestogen type, route, dose, and timing of introduction would also be of value to explore. A 2014 review on hormone therapy in transfeminine people summarizes the state of research on progestogens and breast development in transfeminine people, with their conclusions still holding true today (Wierckx, Gooren, & T’Sjoen, 2014):

    Our knowledge concerning the natural history and effects of different cross-sex hormone therapies on breast development in trans women is extremely sparse and based on low quality of evidence. Current evidence does not provide evidence that progestogens enhance breast development in trans women. Neither do they prove the absence of such an effect. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions.

    Accordingly, reviews and guidelines have concluded that there is currently no reliable evidence that progestogens included in hormone therapy are of benefit or are not of benefit for breast development in transfeminine people (Wierckx, Gooren, & T’Sjoen, 2014; Reisman, Goldstein, & Safer, 2019; Patel et al., 2022; Milionis, Ilias, & Koukkou, 2022; Coleman et al., 2022; Berliere et al., 2023).

    Future Studies Currently Underway

    Several studies of progesterone and other progestogens in transfeminine people are currently underway. These studies include (1) an RCT of oral progesterone added to hormone therapy by Sandeep Dhindsa and colleagues in St. Louis, Missouri in the United States (ClinicalTrials.gov; MediFind; ICH GCP); (2) a prospective observational study and/or RCT of addition of oral progesterone to hormone therapy by Ada Cheung and colleagues in Melbourne, Australia (University of Melbourne; University of Melbourne); (3) an RCT of estradiol plus spironolactone versus estradiol plus CPA also by Ada Cheung and colleagues (update: see below) (ANZCTR; WHO ICTRP; Trans Health Research [Flyer] [Poster]; University of Melbourne); and (4) a large RCT of oral progesterone at different doses added to hormone therapy by Martin den Heijer and colleagues at the Vrije Universiteit University Medical Center (VUMC) in Amsterdam, the Netherlands (Dijkman et al., 2023a; General Info/Links; Info Sheet Dutch; Info Sheet English Translated). Unfortunately however, all of the studies using progesterone employ oral progesterone, which has major bioavailability and potency problems (Aly, 2018a; Wiki). In any case, it was said that the VUMC researchers may follow their trial up with studies of other progesterone routes (General Info/Links). The preceding studies may provide more insight on the question of whether progestogen therapy is of therapeutic benefit to breast development in transfeminine people.

    Progestogens and Breast Development in Cisgender Females

    To date, there appear to be no useful studies on breast development with progesterone or other progestogens in cisgender females. There seem to mostly only be a few brief and conflicting anecdotal clinical statements in this area that are scattered throughout the literature. These include the following literature excerpts, which are specifically in the context of progestogens as part of puberty induction in cisgender girls and women with delayed or absent puberty due to hypogonadism:

    I […] performed studies on three women lacking mammary development and exhibiting signs of marked hypogonadism. […] Corpus luteum extract, 5 international units daily for a period of thirty days, when given alone produced no detectable change in the breasts. This is in accord with the experimental observations on animals of Turner,2 Corner 3 and others. When, however, patients were given alternate daily injections of 1 international unit of progesterone and from 20,000 to 50,000 international units of estrone or of estradiol benzoate, breast growth was more rapid than that produced by the estrogenic hormones alone. The simultaneous use of the corpus luteum and estrogenic therapy definitely produced a much firmer breast growth, which was distinctly lobular to palpation, whereas the growth produced by the estrogenic hormones alone was smooth and the borders of the glandular tissue were difficult to define. Rapid regression in the size of the breasts followed the omission of the hormone injections, but the regression was less rapid when the combined therapy had been used. [MacBryde (1939)]

    There are authorities who consider that breast growth is better if a progestogen is combined with oestrogen for the latter part of the cycle of treatment (Capraro, 1971). Shearman (1971) employs sequential therapy in his cases. Huffman (1971) however, does not believe that there is any improvement with the addition of progestogens. [Dewhurst (1971a)]

    The effects of progesterone on the human breast remain obscure. Although widely stated to cause glandular development, the evidence for this is slender (Benson et al 1959). [Shearman (1972a)]

    Many people use oestrogens alone, but the addition of a progestin for 6 or 10 days each month gives much better cycle control and appears to cause better breast development. [Shearman (1972b)]

    Some authorities consider that breast growth is better if a progestogen is given for the latter part of each course of treatment. [Capraro & Dewhurst (1975)]

    It has been suggested that progestins be added during the last week of each cycle of estrogen therapy in order to develop more rounded breasts rather than the conical breasts many of these patients develop, but we have been unable to detect any difference in breast contour with or without progestins. [Davajan & Kletzky (1979)]

    I have been satisfied that the addition of a progestogen was necessary to get a good breast response to hormone treatment although the progestogen, as I have said, is required after the first year if the uterus is present. [Dewhurst (1982)]

    In addition to the preceding instances, Werner (1935) and Geschickter (1945) assessed the effects of progesterone on the breasts in cisgender women. Werner (1935) attempted to induce lactation in 8 surgically gonadectomized cisgender women with combinations of estrogen, progesterone, and prolactin, all in the form of crude extracts by injection. In two women who were given progesterone, he claimed that a marked increase in the size of the breasts beyond that with estrogen alone was observed. Additionally, he claimed that the breasts were more firm, the glandular tissue “more tortuous and nodular”, and the nipples more prominent. He was not successful in inducing lactation in the women in this study. The doses of hormones used were unclear as they were in the form of extracts, and were likely supraphysiological, potentially pregnancy-like due to the nature of the experiment. Werner’s study was also briefly discussed by Nelson (1936), among other citations. Geschickter (1945) observed lobuloalveolar growth on histological examination with administration of progesterone for 6 weeks to 2 months in one woman but not in another woman. However, the exterior physical changes of the breasts were not assessed or reported by this author and hence his findings are limitedly informative.

    Surprisingly, there have been few analogous studies of the effects of progestogens on the breasts in cisgender girls and women following the preceding reports and anecdotes. Although there are very little data on progestogens and breast growth in cisgender females, clinical studies are finally starting to look more closely at the specifics of hormonal medications, including progestogens, in terms of breast development in girls undergoing puberty induction (e.g., Rodari et al., 2023). As such, future studies may provide more insight on the subject of progestogens and breast development in cisgender females.

    Progesterone and its Physiological Role in Breast Development in Humans

    Progesterone and Breast Development in Puberty

    The role of progesterone in breast development and its possible usefulness for helping with breast development in transfeminine hormone therapy can be informed by the normal biological circumstances of puberty in cisgender females. Puberty in cisgender girls usually starts around age 11 (range 8–13 years) and completes around age 15 years (range 12–19 years), taking on average 3 to 4 years (but with a range of about 1.5–6 years in most cases) (Schauffler, 1942; Marshall & Tanner, 1969; Marshall, 1978; Begley, Firth, & Hoult, 1980; Drife, 1986). Progesterone essentially does not appear during puberty until ovulatory menstrual cycles begin. Menarche, the onset of menstruation and hence of menstrual cycling, occurs on average at Tanner breast stage 4 or about 13 years of age, although it occurs at Tanner breast stage 3 or Tanner breast stage 5 in significant subsets of girls (26% for Tanner stage 3, 62% for Tanner stage 4, and 10% for Tanner stage 5) (Marshall & Tanner, 1969; Marshall, 1978; Drife, 1986; Hillard, 2007). Hence, the appearance of progesterone in normal female puberty is a relatively late event (Scott et al., 1950; Marshall, 1978; Begley, Firth, & Hoult, 1980; Drife, 1986), and most breast development appears to be complete by menarche and thus by the time that progesterone is first produced (Huffman, Dewhurst, & Capraro, 1981; Drife, 1982). Moreover, a small but significant subset of girls reaches Tanner breast stage 5 and hence fully developed breasts before menarche (Edmonds, 1989), which suggests that progesterone may not be essential for complete pubertal breast development.

    The reproductive axis in pubertal and adolescent cisgender girls is immature (Rosenfield, 2013; Gunn et al., 2018; Carlson & Shaw, 2019; Sun et al., 2019). In the first 1 to 2 years postmenarche, most menstrual cycles are anovulatory (i.e., ovulation does not occur) (Döring, 1963 [Table]; Apter, 1980; Lemarchand-Béraud et al., 1982; Talbert et al., 1985; Venturoli et al., 1987; Rosenfield, 2013; Gunn et al., 2018; Carlson & Shaw, 2019). Without ovulation, the corpus luteum doesn’t form from a ruptured ovarian follicle and progesterone production doesn’t commence. Only about half of menstrual cycles are ovulatory by Tanner breast stage 5 (Talbert et al., 1985). In addition, menstrual cycles are unusually long for some time after menarche (e.g., 50 days vs. 28 days for adult cycles) and thus there are fewer menstrual cycles per reproductive year (Rosenfield, 2013; Gunn et al., 2018; Carlson & Shaw, 2019). Luteal-phase progesterone levels are also lower in postmenarche adolescents than in adulthood even when ovulation does occur (McArthur, 1966 [Figure]; Lemarchand-Béraud et al., 1982; Apter et al., 1987; Venturoli et al., 1987; Venturoli et al., 1989; Sun et al., 2019). Consequently, progesterone exposure is sporadic and relatively limited even during late female puberty. Moreover, this is the case not only by the time of Tanner stage 5, but for many years after it as well. It takes more than 6 years after menarche for menstrual cycling to become fully mature and consistently ovulatory (Lemarchand-Béraud et al., 1982; Venturoli et al., 1987; Carlson & Shaw, 2019). Over this period of time, the rate of ovulatory cycles increases progressively until it reaches approximately 100% (Lemarchand-Béraud et al., 1982; Venturoli et al., 1987; Carlson & Shaw, 2019). Only then is full adult-level exposure to progesterone finally achieved (Lemarchand-Béraud et al., 1982; Venturoli et al., 1987).

    Only a handful of studies and sources have reported progesterone levels during puberty across Tanner stages or by age in cisgender girls (e.g., Sizonenko, 1978 [Graph]; Kühnel, 2000; Lee, 2001 [Table]; Aly, 2020a). They corroborate the above findings with regard to limited progesterone exposure during puberty. The “A Girl’s First Period Study” is an ambitious research project announced in 2022 that aims to better characterize reproductive hormone levels in pubertal and adolescent girls and may shed more light on the physiological role of progesterone during puberty (Lucien et al., 2022). The researchers have specifically highlighted the possible role of progesterone in breast development as part of their interests:

    Does exposure to low levels of [progesterone (P4)], as occurs before menarche, during anovulatory cycles with some degree of follicle luteinization, and during early, immature ovulatory cycles play an important role in normal breast development during puberty? This question has important clinical implications as hormone replacement during puberty does not typically include low-dose P4; rather, it is conducted using a staggered approach of estrogen-only therapy followed by the addition of full adult doses of exogenous P4 only after 2 years or when breakthrough bleeding occurs.27 This is done to avoid development of tubular breasts, although there are limited data linking early P4 exposure to suboptimal breast development.28

    Taken together, production of progesterone is a late event in normal female puberty, and even once it does begin, exposure to progesterone is low and sporadic until well after puberty has completed. Moreover, a subset of girls complete breast development before progesterone production starts. These facts call into some question the role of progesterone in breast development in female puberty, as most breast development appears to be complete prior to the appearance of progesterone. However, more research is still needed on the role of progesterone in breast development during normal puberty.

    On the basis of normal female puberty, it seems it may be advisable that if progestogens are introduced in an attempt to enhance breast development in transfeminine people, their introduction be delayed until after 2 or 3 years of hormone therapy, so as to mimic the normal progestogenic exposure of puberty.

    Progesterone and Breast Development in Pregnancy

    During pregnancy, under the influence of ovarian hyperstimulation and placental formation, there are profound changes in hormonal profiles, including of hormones like estrogen, progesterone, and prolactin, among many others (Table 1). Comparing hormone levels during the menstrual cycle to those during the third trimester of pregnancy, estradiol levels increase on the order of 100-fold, progesterone levels increase on the order of 10- to 20-fold, and prolactin levels increase by around 10-fold (Table 1). Levels of numerous other hormones also change considerably during pregnancy, for instance other estrogens besides estradiol, androgens, gonadotropins (e.g., human choronic gonadotropin or hCG), human placental lactogen (hPL), relaxin, adrenocorticotropic hormone (ACTH), cortisol, aldosterone, growth hormone (GH), and insulin-like growth factor 1 (IGF-1), among others (Goodman, 2009 [Figure]; Mesiano, 2019). These hormones are variously produced by the ovaries, the placenta, and the pituitary gland, among other glands. In response to the myriad hormonal changes during pregnancy, there are dramatic changes to the breasts, which prepare the mother for postpartum lactation and breastfeeding.

    Table 1: Changes in hormone levels (estradiol, progesterone, and prolactin) during normal pregnancy:

    HormoneNon-PregnantFirst TrimesterSecond TrimesterThird Trimester
    Estradiol100 (~5–750) pg/mL1,000–5,000 pg/mL5,000–15,000 pg/mL10,000–40,000 pg/mL
    Progesterone8.9 (1.0–24) ng/mLa22 (5–75 ng/mL)35 (15–85) ng/mL102 (25–280) ng/mL
    Prolactin13.0 (4.6–37) ng/mL16 (3.2–43 ng/mL)49 (13–166) ng/mL113 (13–318) ng/mL

    Note: Values are median (range) or range. Footnotes: a Specifically during the luteal phase of the menstrual cycle. Sources: estradiol (Aly, 2018b; Wiki; Wiki); progesterone (Kühnel, 2000; Aly, 2020a; Wiki; Wiki); and prolactin (Kühnel, 2000; Wiki).

    Prior to pregnancy, there is significant although fairly minimal lobuloalveolar development of the breasts with each menstrual-cycle luteal phase (Scott et al., 1950; Drife, 1984; Drife, 1989; Drife, 1990; Pocock, Richards, & Richards, 2013; Johnson & Cutler, 2016; Alekseev, 2021). During pregnancy however, the breasts undergo much more considerable lobuloalveolar development and achieve full maturity. This allows for milk production and lactation following childbirth. During pregnancy, the breasts progressively and considerably increase in size (Hytten, 1954a; Hytten, 1954b; Baird, Hytten, & Thomson,1958; Hytten & Thomson, 1965; Hytten & Leitch, 1971a; Hytten & Leitch, 1971b; Hytten, 1976; Thoresen & Wesche, 1988; Cox et al., 1994; Whiteley, 1994; Cox et al., 1999; Cregan & Hartmann, 1999; Kent et al., 1999; Galbarczyk, 2011; Abduljalil et al., 2012; Bayer et al., 2014; Lawrence & Lawrence, 2015; Żelaźniewicz & Pawłowski, 2015; Dallman et al., 2017; Drąsutis, 2017; Żelaźniewicz & Pawłowski, 2019). Quantitative clinical studies have found the breasts to increase on average by about 100 to 300 mL (range -20 to 880 mL) in volume, or by about 200 to 400 g in mass, going from early pregnancy to late pregnancy or early postpartum (Hytten & Thomson, 1965; Hytten & Thomson, 1968; Hytten & Leitch, 1971a; Hytten & Leitch, 1971b; Hytten, 1976; Thoresen & Wesche, 1988; Whiteley, 1994; Hartmann et al., 1996; Cox et al., 1999; Cregan & Hartmann, 1999; Kent et al., 1999; Wright, 2015; Bayer et al., 2014; Żelaźniewicz & Pawłowski, 2015; Drąsutis, 2017; Żelaźniewicz & Pawłowski, 2019). The breasts can reportedly increase as much two to three times in size in some women (Greydanus et al., 2010). There is marked variation between individuals in the breast size increases during pregnancy (Hytten & Thomson, 1965; Hytten & Leitch, 1971a; Hassiotou & Geddes, 2013; Bayer et al., 2014). Increases in breast size are inversely associated with age, with considerably greater increases in younger women than in older women (e.g., +234–258 mL in <20 years vs. +79–131 mL in >30 years) (Hytten & Baird, 1958; Hytten & Leitch, 1971a [Excerpt]; Hytten, 1976). In addition to overall breast size, the nipples and areolae increase in size during pregnancy (Hytten & Baird, 1958; Hytten & Leitch, 1971a; Rohn, 1989; Cox et al., 1999; Hassiotou & Geddes, 2013; Thanaboonyawat et al., 2013; Park et al., 2014). They also become more darkly pigmented, reaching a dark brown or even black color (Dickson & Hewer, 1950; Thody & Smith, 1977; Wade, Wade, & Jones, 1978; Wong & Ellis, 1984; Elling & Powell, 1997; Muzaffar, Hussain, & Haroon, 1998; Muallem & Rubeiz, 2006; Nussbaum & Benedetto, 2006; Olanrewaju et al., 2017). The breasts become capable of lactation by 3 to 4 months of pregnancy (Walker, Baker, & Lamb, 2013; Pipkin, 2019; Pocock, Richards, & Richards, 2013; Wright, 2015; Lawrence & Lawrence, 2015). However, maturation of the breasts for lactation does not appear to be complete until at least about 6.5 months of pregnancy (Hassiotou & Geddes, 2013). Photographic timelines of women throughout pregnancy provide a visual impression of the breast changes that occur during this time (caution—NSFW: Reddit; More).

    There are large and dramatic changes in levels of numerous hormones during pregnancy, and the exact hormones responsible for the breast changes during pregnancy are not known (Hytten & Leitch, 1971a; Hytten, 1976). However, it is considered likely, on the basis of animal studies, that a variety of hormones, including estrogen, progesterone, prolactin, placental lactogen, glucocorticoids, and growth hormone, are all importantly involved in different aspects of the maturation (Hytten & Leitch, 1971a; Hytten, 1976; Cox et al., 1999). Moreover, in a quantitative clinical study of breast changes during pregnancy, increases in breast volume and areola size were positively correlated with levels of hPL, while increases in nipple size were positively correlated with levels of prolactin (Cox et al., 1999). Progesterone and prolactin have specifically been implicated in the lobuloalveolar development of the breasts during pregnancy (Bässler, 1970; Lee & Ormandy, 2012; Obr & Edwards, 2012). Both hormones appear to be independently essential in normal lobuloalveolar growth per animal studies (Obr & Edwards, 2012; McNally & Stein, 2017; Hannan et al., 2023). Prolactin likewise appears to be essential in humans, based on case reports of lactation failure in women with isolated prolactin deficiency (Buhimschi, 2004). Conversely, hPL may not be essential for lactation based on case reports of normal lactation in women with very low levels of hPL during pregnancy (Gaede, Trolle, & Pedersen, 1978; Hannan et al., 2023).

    Following childbirth and lactation, the breasts undergo a process known as post-lactational involution and return to a pre-pregnancy-like state (Dickson & Hewer, 1950; Ingleby, Moore, & Gershon-Cohen, 1957; Harley, 1969; Gershon-Cohen, 1970; Petrakis, 1978; Huffman, Dewhurst, & Capraro, 1981; Drife, 1986; Caro, 1987; Tanos & Brisken, 2008; Radisky & Hartmann, 2009; Fridriksdottir, Petersen, & Rønnov-Jessen, 2011; Hassiotou & Geddes, 2013; Sun et al., 2018; Alex, Bhandary, & McGuire, 2020). This involves massive cell death and regression of the lobuloalveolar development and other breast changes that occurred during pregnancy (Radisky & Hartmann, 2009; Alex, Bhandary, & McGuire, 2020). With involution, there is, on the basis of quantitative clinical studies, a complete reversion to pre-pregnancy breast size, or even to a slightly smaller breast size (Kent et al., 1999 [Figure]; Jernström et al., 2005; Dorgan et al., 2013; Lim et al., 2018). The same reversion has also been observed in gestational macromastia (breast hypertrophy of pregnancy), with striking and complete or near-complete regressions in breast size reported—although often with concomitant sagging and deformity that necessitates surgical intervention (Moss, 1968; van der Meulen, 1974 [Figure]; Swelstad et al., 2006; Naik et al., 2015). Following involution, it is also impossible to reliably distinguish between nulliparous and parous breasts even with internal histological examination (Drife, 1986). However, the parous breasts are not exactly the same as they were before pregnancy—the breasts remain more complex on a histological level (Dickson & Hewer, 1950; Gershon-Cohen, 1970; Hytten, 1976; Drife, 1986; Drife, 1989; Jeruss, 2006; Fridriksdottir, Petersen, & Rønnov-Jessen, 2011; Hassiotou & Geddes, 2013; Lewin, 2016; Sun et al., 2019), tend to be looser, more flaccid, and more pendulous due to stretching of skin and ligaments (Begley, Firth, & Hoult, 1980; Duncan, 2010; Rauh et al., 2013; Lewin, 2016), and the nipples and areolae remain more maturely developed and pigmented (Dickson & Hewer, 1950; Hytten & Baird, 1958; Hytten, 1976; Nussbaum & Benedetto, 2006; Sanuki, Fukuma, & Uchida, 2009; Thanaboonyawat et al., 2013; Park et al., 2014). In terms of subjective perceptions, some women perceive their breasts to be larger following pregnancy, whereas others perceive them to be smaller (Rauh et al., 2013; Lewin, 2016). Pregnancy can temporarily improve breast size in women with small breasts (Capraro & Dewhurst, 1975; Petrakis, 1978; Huffman, Dewhurst, & Capraro, 1981), but it has been said that the subsequent regressions in breast size after pregnancy can be “disturbing” (Capraro & Dewhurst, 1975). Following the first pregnancy and post-lactational involution, the breasts undergo the same cycle of expansion and regression with each subsequent pregnancy (Hassiotou & Geddes, 2013).

    On the basis of the preceding, in spite of rather extreme hormonal stimulation, the breast changes of pregnancy, although quite dramatic, are essentially temporary and fully reversible, remaining only as long as continuous hormonal exposure is maintained. This hormonal stimulation includes exposure to extremely high levels of progesterone. It would seem, based on pregnancy, that once pubertal breast development is completed, the breasts are rather unamenable to permanent further growth, whether that involves exposure to progestogens or to a variety of other hormones known to act on the breasts.

    Breast Composition and Lobuloalveolar Tissue Proportion

    The breasts are made up of two main types of tissue: (1) epithelial tissue, the actual functional internal mammary glandular tissue, including ducts and alveoli or lobules; and (2) stromal tissue, a mixture of connective tissue and adipose (fat) tissue. Lobuloalveolar development refers to growth and maturation of the alveoli and lobules, and hence is a form of epithelial or glandular development. Progestogens are involved primarily in lobuloalveolar development of the breasts, which is the type of breast development that is necessary for lactation and breastfeeding and that occurs mainly during pregnancy.

    In women who are not pregnant or lactating, studies have found that only about 5 to 20% of the volume of the breasts is composed of epithelial tissue on average, while the remaining 80 to 95% is composed of stromal tissue (Hutson, Cowen, & Bird, 1985; Drife, 1986; Drife, 1989; Bryant et al., 1998; Gertig et al., 1999; Howard & Gusterson, 2000; Cline & Wood, 2006; Lorincz & Sukumar, 2006; Wilson et al., 2006; Xu et al., 2010; Pandya & Moore, 2011; Hagisawa, Shimura, & Arisaka, 2012; Sandhu et al., 2016; Rosenfield, Cooke, & Radovick, 2021; Wiki). More specifically, one major study in in reproductive-age women found that the breasts are about 10 to 20% epithelial tissue, 10 to 35% fat tissue, and 60 to 80% connective tissue (Hutson, Cowen, & Bird, 1985; Wilson et al., 2006). Conflictingly however, a couple of studies that employed mammography have reported higher breast glandular proportions ranging from 35 to 48% (Klein et al., 1997; Jamal et al., 2004; Duncan, 2010). Aside from glandular tissue, other studies have found breast fat percentages of mean 26 to 48% (range 2 to 78%) (Lejour, 1994; Lejour, 1997; Vandeweyer & Hertens, 2002). Similarly to the findings of most studies of women’s breasts in general, only a small proportion of the breasts is glandular tissue (e.g., 1–7%) in women who have macromastia (breast hypertrophy, or extremely large breasts) (Bames, 1948; Cruz-Korchin et al., 2001).

    During pregnancy and lactation in humans, the breasts undergo dramatic changes, and epithelial tissue comes to make up a much greater proportion of the breasts (Ramsay et al., 2005; Bland, Copeland, & Klimberg, 2018). In fact, sources state that glandular tissue comprises a majority of the breast during pregnancy and lactation, with one study of lactating women finding that the breasts were composed 63% (range 46–83%) of glandular tissue (Ramsay et al., 2005). This is not merely due to lobuloalveolar development and glandular growth, but is also due to a marked reversible reduction in mammary adipose tissue (Wang & Scherer, 2019; Alex, Bhandary, & McGuire, 2020). In any case, under more normal physiological circumstances and progesterone exposure, the contribution of lobuloalveolar tissue to the size of the breasts would appear to be quite small. In relation to this, outside of pregnancy levels of progesterone, the significance of progestogen-mediated breast lobuloalveolar growth in terms of breast size is unclear but seemingly questionable (Orentreich & Durr, 1974; Wierkcx, Gooren, & T’Sjoen, 2014).

    Breast Development in Cisgender Women with Complete Androgen Insensitivity Syndrome and Consequent Absence of Progesterone

    It has been claimed that progesterone helps to move transfeminine people and cisgender females from Tanner stage 4 to 5 breast development and that it helps to round out the breasts (e.g., Vorherr, 1974a; Prior, 2011; Prior, 2019a; Prior, 2020). It has also sometimes been claimed in the online transgender community that cisgender women with complete androgen insensitivity syndrome (CAIS), an experiment of nature of women who lack progesterone, are stuck at Tanner stage 4 breast growth and have “cone-shaped” breasts due to their absence of progesterone. In actuality however, there is no good evidence at this time that progesterone is required for normal pubertal breast development, that progesterone is needed to reach Tanner stage 5, or that it helps to round out the breasts. Such claims are contradicted by extensive available literature and evidence, including notably the literature on CAIS women themselves.

    Women with CAIS are individuals who have a 46,XY karyotype (i.e., are genetically “male”), testes, and who would otherwise have physically developed as males, but did not because they have a mutation in the gene encoding the androgen receptor that makes them completely insensitive to the effects of androgens. There are also incomplete forms of the syndrome, like partial androgen insensitivity syndrome (PAIS) and mild androgen insensitivity syndrome (MAIS). CAIS women have a male-typical hormonal profile, generated by their testes, including high male-range levels of testosterone, low female-range estradiol levels, and negligible progesterone levels (Wiki; Table). Instead of developing physically as males however, CAIS women are perfectly phenotypically female, with a normal female body, vagina, and breasts (Wiki; Photo). Their testosterone has been unable to masculinize them, while their estradiol, unopposed by androgens, is able to fully feminize them. The internal reproductive system in CAIS women is essentially that of an underdeveloped male, with testes instead of ovaries, and no uterus. The vagina is often short and is blind-ending with no cervix, which is related to their lack of a uterus. CAIS women are also described as feminine in terms of behavior, gender, and sexuality.

    Women with CAIS have breast development that is described throughout the literature as “good”, “excellent”, “normal”, “full”, “complete”, “well-developed”, “overdeveloped”, “generous”, “enhanced”, “typically above-average”, “large”, and even “voluptuous” (Morris, 1953; Simmer, Pion, & Dignam, 1965; Hertz et al., 1966; Valentine, 1969; Adams et al., 1970; Polani, 1970; Weisberg, Malkasian, & Pratt, 1970; Dewhurst, 1971b; Perez-Palacios & Jaffe, 1972; Glenn, 1976; Dewhurst & Spence, 1977; Rutgers & Scully, 1991; Patterson, McPhaul, & Hughes, 1994; Quigley et al., 1995; McPhaul, 2002; Galani et al., 2008; Oakes et al., 2008; Tiefenbacher & Daxenbichler, 2008; Barbieri, 2019). John McLean Morris, the gynecologist who reviewed and summarized all of the existing scientific literature on CAIS women in 1953 (including 82 cases) and gave their condition the now-abandoned name “testicular feminization”, described their breasts as “unusually large” and “jumbo-sized” (Morris, 1953; Quigley et al., 1995). He additionally said in his famous 1953 review that they had “normal female breasts, often with a tendency to be overdeveloped” (Morris, 1953). Per another author, “Probably under no other circumstance does breast development in the [‘male’] reach the florid degree seen in testicular feminization” (Wilson, 1968).

    Despite claims that CAIS women have generous breast sizes however, in actuality, some CAIS women have large breasts, while some have small breasts, with one study finding a wide range of breast size measurements of 16×14 cm to 41×31 cm (Wisniewski et al., 2000). Moreover, the breasts of CAIS women have never been directly compared to those of normal women. Hence, there are no clear data at this time that the breasts of CAIS women are actually larger than average for women. The variation in breast growth in CAIS women parallels the same large variation in breast size between individuals that is seen in cisgender women in general. Here is a collection of photos of CAIS women and their breast development from published case reports and reviews throughout the literature. As can be seen from these photos, breast development in CAIS women is normal and often excellent, although subject to considerable variation between individuals in terms of breast size and shape as in women generally.

    If CAIS women truly do have enhanced breast development and breast sizes compared to normal women, it may be that their androgen insensitivity, and hence lack of inhibition of estrogen-mediated breast development by androgens, is responsible for this (Wilson, 1968; Sobrinho, Kase, & Grunt, 1971; Andler & Zachmann, 1979; Zachmann et al., 1986; Patterson, McPhaul, & Hughes, 1994; Barbieri, 2019). Another theoretical possibility is that the high testosterone levels may be aromatized into greater amounts of estradiol locally within the breasts and other tissues in CAIS women and that this may somehow allow for enhanced breast development (Ladjouze & Donaldson, 2019).

    Baron evaluated a total of 41 people with androgen insensitivity syndrome (AIS) and found that 97% of CAIS women had normal breast development while 63% of individuals with “incomplete AIS” (likely PAIS) had normal breast development (Baron, 1993; Baron, 1994a; Baron, 1994b). In another earlier published study of 50 CAIS females, by Sir Christopher John Dewhurst, 76% were rated as having full breast development, 14% as having moderate breast development, 10% as having “mild” breast development, and 0% as having absent breast development (Dewhurst, 1971b). Hence, based on findings in large samples of CAIS females, most to almost all have normal or full breast development. That a minority of CAIS females have had less breast growth may be due to factors like low and inadequate estradiol levels in some individuals, young age at time of assessment by which breast development has not fully completed, and/or a small subset of women in general having underdeveloped or small breasts.

    CAIS women have never been described in the literature as having “cone-shaped”, “pointy”, or otherwise abnormal breasts. The only exception is that they are often said to have nipples and areolas that are described as “juvenile”, “infantile”, “small”, “pale”, and “non-pigmented” (e.g., Photo) (e.g., Morris, 1953; Morris & Mahesh, 1963; Simmer, Pion, & Dignam, 1965; Dewhurst, 1967; Khoo & Mackay, 1972; Perez-Palacios & Jaffe, 1972; Dewhurst & Spence, 1977). This has been said to be the case regardless of breast size or maturation (Khoo & Mackay, 1972). A possible reason for this phenomenon is that estradiol levels in CAIS women are relatively low, only about 35 pg/mL (130 pmol/L) on average (Wiki; Table). This is relevant as estrogens are known to concentration-dependently produce nipple and areolar pigmentation and enlargement (Davis et al., 1945; Kennedy & Nathanson, 1953). In contrast to estrogens, progestogens have not been implicated in nipple or areolar pigmentation. Hence, it seems that higher estrogen levels may be necessary for full adult-like nipple and areolar maturation.

    CAIS women are able to reach Tanner stage 5 breast development and hence full maturation of the breasts similarly to normal women (Quigley, 1988; Quigley et al., 1995; Gordon & Laufer, 2005; Finkenzeller & Loveless, 2007; Cheikhelard et al., 2008; Ramos et al., 2018; Arya et al., 2021; Zhang et al., 2021). One gynecologist, Robert Rebar, has claimed in his publications over several decades, including in reviews and book chapters, that CAIS women usually only reach Tanner stage 3 breast development (Kustin & Rebar, 1987; Rebar, 1988; Rebar, 1990; Simpson & Rebar, 1990; Rebar, 1993; Rebar, 1996; Wellons & Rebar, 2013; Wellons, Weeber, & Rebar, 2017). However, this claim conflicts with the statements of other researchers and with studies and case reports of CAIS women. In one book chapter, Rebar said that CAIS females undergo breast development and feminization and that the breasts contain normal ductal and glandular tissue, but stated that “the areolae are pale and poorly developed (Tanner stage 3)” (Rebar, 1993). This suggests that he may have been meant Tanner stage 3 in terms of nipple and areolar maturation rather than breast growth as a whole (Rebar, 1993). Aside from CAIS females, even individuals with PAIS often have substantial breast growth and female-like breasts (e.g., Saito et al., 2014; Lee et al., 2015). Additionally, PAIS females treated with estrogen therapy have similarly been reported to reach Tanner breast stage 5 (Guaragna-Filho et al., 2023).

    Despite their often large breasts, CAIS women are said to have relatively little breast glandular tissue, as opposed to fat and connective tissue, and to have minimal breast lobuloalveolar development (Morris, 1953; Morris & Mahesh, 1963; Simmer, Pion, & Dignam, 1965; McMillan, 1966; Perez-Palacios & Jaffe, 1972; Dewhurst & Spence, 1977; Shapiro, 1982). This is in accordance with the lack of progesterone in CAIS women, since progesterone is important in mediating lobuloalveolar growth. The retained breast sizes of CAIS women despite reduced glandular and lobuloalveolar structures is consistent with the fact that the breasts are composed mostly of stromal adipose and connective tissue. Hence, as touched on previously in this article, greater glandular or lobuloalveolar formation in the breasts may not necessarily translate to greater breast size, which seems readily apparent in CAIS women.

    The normal and excellent breast development of CAIS women is notable because these individuals, owing to their testes and hence absence of significant gonadal progesterone production, have very low and negligible levels of progesterone (Wiki; Table; Barbieri, 2019). CAIS womens’ normal breast development, often large breasts, and ability to reach complete breast maturation, as measured by the Tanner scale, are collectively suggestive that progesterone is not required for normal or complete pubertal breast development (Barbieri, 2019). In any case, it must be noted and cautioned again that the breasts of CAIS women have never been directly compared to those in normal women. In addition, quantitative studies of the breasts of CAIS women are very scarce, and much of our knowledge in this area is based on anecdotal clinical experience and subjective breast evaluation. This is in large part due to the rarity of CAIS women and the difficulty in obtaining decent samples of them for study. Furthermore, CAIS women also have other differences from regular women besides their lack of progesterone, for instance their relatively low circulating estradiol levels, high testosterone levels (which can be aromatized into estradiol within tissues like the breasts), androgen insensitivity, and XY karyotype, among others. Hence, the insights into breast development provided by CAIS women come with a variety of caveats.

    Interestingly, in spite of their well-developed breasts, breast cancer has never been reported in CAIS women, and would appear to be very rare in these individuals (Aly, 2020b; Aly, 2020c). This may be related to factors like the lack of progesterone and lobuloalveolar maturation in CAIS women and/or their absence of a second X chromosome (Aly, 2020b; Aly, 2020c). CAIS women suggest that breast cancer is not an inherent eventual consequence of excellent breast development.

    Menstrual Cycles and Temporary Cyclic Breast Enlargement

    The breasts fluctuate in size across the menstrual cycle, with significant enlargement apparent during the luteal phase of each cycle (Shuttleworth, 1938 [Figure]; Ingleby, 1949; Scott et al., 1950; Milligan, Drife, & Short, 1975; Drife, 1982; Malini, Smith, & Goldzieher, 1985; Drife, 1989; Fowler et al., 1990; Graham et al., 1995; Jemström & Olsson, 1997; Hussain et al., 1999; Hussain, Brooks, & Percy, 2008; Wang et al., 2019; Rix et al., 2023). This is experienced by women as a sense of fullness, as well as tingling sensations and tenderness (Shuttleworth, 1938 [Figure]; Milligan, Drife, & Short, 1975; Laessle et al., 1990; Jemström & Olsson, 1997). The change in the volume of the breasts has been reported to be approximately 75 to 100 mL on average, with volume falling to as low as 90% of mean volume during the follicular phase or at ovulation and increasing to up to 110% of average volume during the luteal phase (or about 15 to 20% mean total change from smallest to largest volume) (Milligan, Drife, & Short, 1975; Malini et al., 1985; Drife, 1989; Fowler et al., 1990; Hussain et al., 1999; Hussain, Brooks, & Percy, 2008; Rix et al., 2023). However, more recent studies using better measurement methods of breast volume suggest more modest changes, like a decrease in breast volume of 4 to 10% during the follicular phase and an increase in breast volume of 3 to 21% during the luteal phase (Rix et al., 2023). The changes in breast size have also been described as an increase of one-third of a bra cup size (37 mL or 35 g) on average and up to one bra cup size in some (Rix et al., 2023). There is substantial variation between individuals in the changes in breast volume across the menstrual cycle, ranging from no change to up to a 40 to 45% increase in the most extreme cases (Ingleby, 1949; Malini, Smith, & Goldzieher, 1985; Fowler et al., 1990; Hussain et al., 1999; Hussain, Brooks, & Percy, 2008; Rix et al., 2023).

    The enlargement of the breasts during the luteal phase of the menstrual cycle is believed to be due to temporary glandular and stromal tissue growth, luminal dilation of the ducts and alveoli, fluid retention in the glandular and stromal structures, and increased vascularization and blood flow (Scott et al., 1950; Drife, 1989; Fowler et al., 1990; Hussain et al., 1999; Alekseev, 2021; Biswas et al., 2022). However, studies suggest that most of the changes are merely due to water fluctuations and that change in breast glandular volume change is relatively small (Rix et al., 2023). The breast changes during the menstrual cycle have been positively correlated with increased levels of estradiol and progesterone during the luteal phase (Jemström & Olsson, 1997; Clendenen et al., 2013; Rix et al., 2023). In addition, estrogen therapy has been found to reversibly increase breast size (e.g., Hartmann et al., 1998) and estradiol levels are positively associated with breast tenderness (e.g., de Lignières & Mauvais-Jarvis, 1981; Sitruk-Ware et al., 1984). Both estradiol and progesterone can promote water retention via distinct hormonal mechanisms as well as mediate breast glandular growth and changes (Rix et al., 2023). As such, the breast changes during the menstrual cycle are assumed to be due to changing levels of estradiol and progesterone, though it is noteworthy that progesterone has been particularly implicated owing to the breast volume increase occurring during the luteal phase (Lawrence & Lawrence, 2015; Rix et al., 2023). There is a delay in breast volume increases following the peaks of estradiol and progesterone levels during the menstrual cycle and hence the changes are not instantaneous (Rix et al., 2023).

    Combined oral contraceptives, which are estrogen–progestogen preparations, as well as menopausal estrogen–progestogen hormone therapy, may produce temporary breast enlargement and feelings of breast fullness analogous to those that occur during the luteal phase of the menstrual cycle (Milligan, Drife, & Short, 1975; Dennerstein et al., 1980 [Figure]; Malini, Smith, & Goldzieher, 1985; Jemström & Olsson, 1997; Jernström et al., 2005). In one study, breast volume was around 100 mL greater (~30% higher) in women who were currently taking oral contraceptives relative to those who had not taken or had previously taken oral contraceptives (Jemström & Olsson, 1997). In some women, the increase in breast size with oral contraceptives was subjectively reported to be up to a single bra cup size in volume (Jemström & Olsson, 1997). However, in another study by the same group of researchers that had a much larger sample size (n=258 vs. n=65), breast volumes were not significantly different between current hormonal contraceptive users and non-users (Jernström et al., 2005). Additionally, another study found no significant differences in breast volume in women between different estrogen–progestogen oral contraceptives that had 6.25-fold variation in dose of the same progestin (0.4 to 2.5 mg/day norethisterone) as well as non-users (Malini, Smith, & Goldzieher, 1985). However, this study was underpowered due to small sample sizes (n=5 to n=15 per group) (Malini, Smith, & Goldzieher, 1985).

    Engman et al. (2008) conducted an RCT of treatment with mifepristone, a selective progesterone receptor modulator (SPRM) with predominantly antiprogestogenic effects, versus placebo for 3 months in normally cycling premenopausal cisgender women, and evaluated the effects of this progesterone receptor blockade on the breasts. They found that mifepristone significantly reduced Ki-67 index, a measure of cellular proliferation in the breasts, and reduced subjectively rated symptom scores on the Breast Symptom Index (BSI). More specifically, breast soreness, breast swelling, sense of increased breast volume, and the total breast symptoms score were all significantly reduced on the BSI. However, breast volume was not objectively measured in this study. A major limitation of this study is that mifepristone inhibits ovulation and modifies levels of estradiol and other hormones (Spitz et al., 1989; Spitz et al., 1994; Engman et al., 2008, Spitz, 2010). As such, it is unclear whether the effects observed by Engman and colleagues were specifically due to progesterone receptor antagonism in the breasts or due to disruption of the hypothalamic–pituitary–gonadal (HPG) axis, for instance lowered estradiol levels.

    An interesting case report of an adult woman with CAIS documented a significant increase in breast volume with combined estrogen–progestogen therapy relative to estrogen monotherapy (Dijkman et al., 2023b). The woman was started on cyclic oral estradiol 2 mg/day and dydrogesterone 10 mg/day and subjectively experienced breast pain and fluctuations in breast volume of about one cup size while on this regimen. Subsequently, she was switched to oral estradiol valerate 3 mg/day monotherapy and the fluctuations in breast volume ceased. However, her overall breast volume was reduced as well, and the woman decided to resume combined estradiol and dydrogesterone therapy. Her clinicians proceeded to measure her breast volume using 3D body scanning. Her left breast was 758 mL and right breast was 673 mL with estrogen monotherapy, and her breasts increased to respective volumes of 875 mL and 784 mL during combined estrogen–progestogen therapy, giving net volume increases of 117 mL (+16%) and 111 mL (+17%). These differences in volume corresponded to an almost one bra cup difference in size. The researchers noted that estradiol and progesterone are associated with cyclical breast changes, and hypothesized that the changes in their patient were due to increased fluid retention in the breasts. Taken together, the case report demonstrates that progestogens can cause rapid and considerable reversible breast enlargement in some women analogous to that during the normal menstrual cycle.

    Progesterone and Mammary Development in Animals

    Progesterone and Pubertal Mammary Development in Animals

    Knockout of the progesterone receptor (PR) in female mice results in complete infertility and severely compromised ovarian and uterine functions (Lydon et al., 1995; Ismail et al., 2003). On the other hand, pubertal mammary development in progesterone-receptor knockout mice is normal and morphologically indistinguishable from that of regular mice (Soyal et al., 2002; Ismail et al., 2003; Fernandez-Valdivia et al., 2005). This is in contrast to the case of estrogen receptor alpha (ERα) knockout mice, in which pubertal mammary development is abolished (Ismail et al., 2003; Fernandez-Valdivia et al., 2005; Wiki; Wiki). However, subsequent studies revealed that mammary ductal development during puberty, while eventually normal, is delayed in female mice that have loss of progesterone production, loss of the progesterone receptor, or progesterone receptor antagonism with mifepristone (Shi, Lydon, & Zhang, 2004). In other words, progesterone stimulates and accelerates ductal development during puberty, and hence appears to have a significant physiological role in early mammary development during puberty. The stimulation of ductal development by progesterone appears to be mediated by induction of the expression of amphiregulin in mammary ducts and terminal end buds (Kariagina et al., 2010; Aupperlee et al., 2013). This growth factor is an agonist of the epidermal growth factor receptor (EGFR), and is also notably the major growth factor that estrogen induces the expression of to mediate mammary gland development during puberty (Ciarloni, Mallepell, & Brisken, 2007; LaMarca & Rosen, 2007; McBryan et al., 2008). In any case, as mammary ductal development during puberty without progesterone is delayed, but eventually normal, it has been concluded that progesterone is dispensable for pubertal mammary gland development in mice (Soyal et al., 2002; Ismail et al., 2003; Fernandez-Valdivia et al., 2005).

    Although progesterone does not seem to be essential in normal pubertal mammary development in mice, studies have interestingly found that it is able to substitute for estrogen in mediating pubertal ductal mammary development in this species. Ruan, Monaco, & Kleinberg (2005) studied the effects of various combinations of exogenous estradiol, progesterone, and IGF-1 on mammary development in oophorectomized female IGF-1-knockout mice. In terms of stimulation of ductal development to occupy the mammary gland fat pad, the combination of progesterone and IGF-1 produced 92% occupation, estradiol and IGF-1 resulted in 92% occupation, estradiol, progesterone, and IGF-1 achieved 96% occupation, and IGF-1 alone resulted in only 28% occupation (Ruan, Monaco, & Kleinberg, 2005; Kleinberg & Ruan, 2008). In terms of gross anatomical appearance, the ductal tree with progesterone and IGF-1 was said to resemble that of a normal fully developed pubertal mammary gland (Ruan, Monaco, & Kleinberg, 2005). However, differences in mammary development between the combination of estradiol and IGF-1 and the combination of progesterone and IGF-1 were apparent, with estradiol and IGF-1 having greater effect on terminal end bud formation, ductal decorations, and slight alveolar maturation, and progesterone and IGF-1 having more effect on ductal formation, extension, and branching (Ruan, Monaco, & Kleinberg, 2005; Kleinberg & Ruan, 2008). The effects of progesterone on mammary development were reversed by the progesterone receptor antagonist mifepristone (Ruan, Monaco, & Kleinberg, 2005). Only the combination of estradiol, progesterone, and IGF-1 produced mammary development that resembled that during mid-pregnancy, with full maturation of secretory alveolar structures (Ruan, Monaco, & Kleinberg, 2005; Kleinberg & Ruan, 2008).

    Aside from the preceding studies, a number of other studies have also found increased ductal branching of mammary glands during puberty with exogenous progesterone administration in mice (Atwood et al., 2000; Hovey et al., 2001; Satoh et al., 2007; Aupperlee et al., 2013).

    A limitation of studies that have used exogenous progesterone to stimulate pubertal ductal mammary development in mice is that the doses of progesterone employed, in conjunction with other hormones like estradiol, have been sufficient to mediate mammary growth to a level typical of pregnancy, with robust maturation of mammary lobuloalveolar structures (e.g., Škarda, Fremrová, & Bezecný, 1989; Ruan, Monaco, & Kleinberg, 2005). Pregnancy is a time when hormone levels are much higher than usual. Hence, the progesterone exposure in these studies may have been supraphysiological relative to normal puberty, and may have produced effects on mammary growth that would not otherwise occur during this time. Accordingly, Škarda, Fremrová, & Bezecný (1989) found that whereas untreated normal female mice naturally grew to a mammary gland area of 26.4 mm2 and normal female mice treated with exogenous estradiol grew to a mammary gland area of 25.3 mm2, normal female mice treated with exogenous estradiol and progesterone grew to a mammary gland area of 43.5 mm2 and with exogenous progesterone alone to a mammary gland area of 64.6 mm2. The untreated control mice did not show alveolar buds, whereas the progesterone-treated groups did have alveolar maturation, indicating supraphysiological and pregnancy-like development compared to non-pregnant mice (Škarda, Fremrová, & Bezecný, 1989). In any case, one study employed low doses of progesterone (0.1 mg/day), one-tenth of that used in most other studies (1 mg/day), and found that progesterone still stimulated significant ductal development in mice at these doses (Aupperlee et al., 2013; Berryhill, Trott, & Hovey, 2016). Hence, progesterone is still able to stimulate some level of ductal growth in mice even at lower levels.

    Although progestogens by themselves can apparently stimulate normal pubertal mammary development in lieu of estrogen exposure in mice, it is not clear that they do so similarly in humans. It is well-known that progestogens alone, without concomitant estrogenic activity, do not generally produce breast development in humans. As an example, progestogens, for instance MPA and CPA, have been used as puberty blockers in boys and girls at very high doses, and do not produce breast development in this context, instead causing arrest and regression of breast development via gonadal suppression (Lyon, De Bruyn, & Grant, 1985; Fuqua & Eugster, 2022). Cases of gynecomastia in boys have occurred with CPA, but only in a minority and with this easily attributable to other causes than progestogenic activity, for instance the antiandrogenic activity of CPA and disruption of the HPG axis (Kauli et al., 1984; Laron & Kauli, 2000). Similarly, progestogens like MPA and CPA have been used at very high doses in men to treat prostate conditions and sexual disorders, and likewise do not usually produce gynecomastia under these circumstances. Rates of gynecomastia with CPA used in the treatment of prostate cancer are low and are not noticeably different from the rates with surgical or medical castration (~10%) (Fourcade & McLeod, 2004; Di Lorenzo et al., 2005). This is in major contrast to the high rates of gynecomastia with estrogens and nonsteroidal antiandrogens (up to 70–80%) (Fourcade & McLeod, 2004; Di Lorenzo et al., 2005; Deepinder & Braunstein, 2012). Species differences may be present such that progestogens can produce robust pubertal mammary development in mice but do not do so in humans.

    Progesterone and Gestational Mammary Development in Animals

    As in humans, pregnancy results in increased levels of estrogen, progesterone, prolactin, and many other hormones in various animal species like rodents and non-human primates (Hasan, 1974; Cowie, Forsyth, & Hart, 1980; Pasqualini & Kincl, 1985; Günzel et al., 1987; Seibert & Günzel, 1994). Along with this, there are dramatic changes in the mammary glands (Cowie, Forsyth, & Hart, 1980; Richert et al., 2000; Cline & Wood, 2008; McNally & Stein, 2017). This includes extensive lobuloalveolar maturation of the mammary glands in preparation of lactation and nursing (Cowie, Forsyth, & Hart, 1980; Richert et al., 2000; Cline & Wood, 2008; McNally & Stein, 2017). Permanently enlarged breasts, mainly due to accumulation of abundant adipose tissue during puberty, is unique to humans, and in animal species, although there is significant growth with puberty (e.g., Geschickter, 1945 [Figure]), the exterior mammae enlarge considerably only with pregnancy (Pawłowski & Żelaźniewicz, 2021). In the case of macaques, there is a roughly 10- to 20-fold increase in the glandular tissue during pregnancy (Cline & Wood, 2008).

    Administration of exogenous estradiol and progesterone in specific amounts to virgin adult females of various animal species, including rodents, results in mammary development that is very similar to that which occurs normally during pregnancy (Nelson, 1936; Turner, 1939; Folley, 1940; Folley, 1947; Folley & Malpress, 1948; Folley, 1950; Folley, 1952; Folley, 1956; Lyons, 1958; Lyons, Li, & Johnson, 1958; Cowie & Folley, 1961; Jacbosohn, 1961; Cole & Hopkins, 1962; Lloyd & Leathem, 1964; Meites, 1966; Bässler, 1970; Ceriani, 1974; Vorherr, 1974b; Cowie, Forsyth, & Hart, 1980; Tucker, 2000; Kleinberg, 2006; Kleinberg & Ruan, 2008; Kleinberg et al., 2009; Kleinberg & Barcellos-Hoff, 2011). High levels of prolactin also occur in this context, as estrogen and progesterone induce production and secretion of prolactin from the pituitary gland (Ceriani, 1974; Bethea, Kohama, & Pecins-Thompson, 1997; Camilletti et al., 2019). Although estradiol and progesterone alone seem to be adequate for producing full pregnancy-type mammary development in many species, the combination of estradiol, progesterone, and placental lactogen in rhesus monkeys produced considerably less lactational activity than occurs during normal pregnancy in this species (Beck, 1972; Cowie, Forsyth, & Hart, 1980). In relation to this, placental lactogen and/or additional hormonal factors may also be necessary for complete pregnancy-like mammary gland maturation in primates (Beck, 1972; Cowie, Forsyth, & Hart, 1980).

    As with humans, following cessation of lactation and nursing, the mammary glands are well-known to undergo post-lactational involution and to return to a pre-pregnancy-like state in animals, including in rodents and monkeys (Richert et al., 2000; Cline & Wood, 2006; Cline & Wood, 2008; Fridriksdottir, Petersen, & Rnnov-Jessen, 2011; McNally & Stein, 2017).

    Breast Changes with Therapeutic Pseudopregnancy

    Therapeutic or pharmacological pseudopregnancy is a type of hormone therapy that attempts to replicate the hormonal mileu of pregnancy for certain medical indications in cisgender females by administering exogenous hormones. In practice, this has involved the administration of very high doses of estrogens and progestogens, with most other pregnancy hormones not included. Therapeutic pseudopregnancy was first developed in the 1950s and is largely no longer used in medicine today (Kaiser, 1993).

    The effects of therapeutic pseudopregnancy on the breasts are of interest due to the breast changes that occur during pregnancy, for instance lobuloalveolar development and substantial reversible breast enlargement. In the 1980s, Lauritzen and colleagues conducted a study of therapeutic pseudopregnancy for treatment of breast hypoplasia (small/underdeveloped breasts) in cisgender women (Lauritzen, 1980; Lauritzen, 1982; Lauritzen, 1989; Göretzlehner & Lauritzen, 1992). They employed the estrogen estradiol valerate 40 mg/week and the progestogen hydroxyprogesterone caproate (OHPC) 250 to 500 mg/week both by intramuscular injection for 4 to 5 months. The estradiol valerate dosage employed was very high, with other studies by the same authors reporting that this dosage of estradiol valerate resulted in first-trimester pregnancy levels of estradiol in women (~3,000 pg/mL [~11,000 pmol/L]) (Ulrich, Pfeifer, & Lauritzen, 1994; Ulrich et al., 1995). These estradiol levels are roughly 30 times the normal concentrations outside of pregnancy (Aly, 2018b). Similarly, the OHPC doses were very high, with 250 to 500 mg per month being similar in strength to luteal-phase progestogenic exposure (Wiki). Hence, as the same OHPC doses were used weekly in the study, the doses were roughly around 4.5 times luteal-phase exposure and thus were analogously similar to first- or second-trimester progesterone levels in terms of strength (Aly, 2020d). The authors noted that they had initially tried lower hormone doses, similar to those originally used in the 1950s, but did not achieve significant breast growth with these doses, and so increased the dosage. Breast changes were measured in the study with a tape measure (applied horizontally and vertically to the breast area), photographs, breast imaging using mammography and sonography, and, later in the study, plasticine impressions/molds with determination of the filling volume.

    Lauritzen and colleagues reported the study findings in four different publications with different follow-up times and growing sample sizes. In the final follow-up, a total of 221 women had been treated. In the second follow-up, when 78 women had been treated, it was noted that 29 of the cases (37%) were less than 18 years old. However, in the final follow-up of 221 women, the age range was listed as 18 to 42 years. The researchers found that breast volume increased by 10 to 30% above baseline in 65% of the women. This was also accompanied by breast tenderness in almost all of the women, though the breast tenderness progressively declined during the treatment period. Other breast-related side effects like pigmentation and stretch marks were rarely observed. Prolactin levels slightly increased to 14 to 28 pg/mL by the end of treatment. Breast imaging showed an increase in the density of breast glandular tissue. The researchers claimed that the increase in breast size in their study was due to increased adipose tissue, water retention, and moderate hypertrophy of the glandular tissue.

    Following treatment discontinuation, the increases in breast volume gradually and partially regressed in 40% of the women, to an increase of 10 to 20% above baseline. However, the authors claimed that the regression in breast volume could be reduced with adequate-dose combined estrogen–progestogen birth control pills or with topical estrogen and progestogen therapy applied to the breasts. In addition, they noted that therapeutic pseudopregnancy could be repeated to increase breast volume again. This was performed in a subset of the women, with treatment repeated 1 to 2 times after 6 months. In the second follow-up, which had 78 women, it was noted that 12 women (15%) had undergone multiple treatments. Aside from Lauritzen and colleagues, many other researchers have also reported substantial or full regression in breast size following estrogen and/or progestogen therapy to increase breast size in cisgender women (e.g., Cernea, 1944; Müller, 1953; Anderson, 1962; Bruck & Müller, 1967; Keller, 1984; Kaiser & Leidenberger, 1991; Keller, 1995; Hartmann et al., 1998).

    The findings of Lauritzen and colleagues were reported very informally, in the form of non-peer-reviewed book chapters, conference papers, and medical magazines, and were never published in a peer-reviewed journal article. In relation to this, the methodology and results of the study were only briefly and imprecisely described. There are also additional concerns related to study design, such as lack of controls, randomization, and the quality of the breast measurement methods. As a result of the preceding issues, it is difficult to fully interpret the results of the study and to have complete confidence in its findings. In any case, Lauritzen and colleages’ results suggest that treatment with high-dose combined estrogen–progestogen therapy, achieving earlier-pregnancy estrogenic and progestogenic exposure, may be able to produce a significant temporary increase in breast size and a smaller long-term increase. The findings of a permanent increase in breast size conflict with those of other researchers who have reported complete regression in breast changes following treatment discontinuation. Moreover, the results are contradicted by findings in pregnant women, who, as described previously, show complete reversion to pre-pregnancy breast size or to even slightly smaller breasts following cessation of lactation.

    It is difficult to evaluate the relative roles of the estrogen and the progestogen in the findings of Lauritzen and colleagues, as there were no comparison groups employing estrogen or progestogen therapy alone in the study. Both estrogens and progestogens have been implicated in causing breast enlargement and plausibly could have contributed to the breast changes. As such, it is unclear to what extent the breast changes were specifically due to progestogenic exposure rather than to estrogenic exposure.

    The breast size increases observed by Lauritzen and colleagues were seemingly more modest relative to those that occur normally during pregnancy. They also lacked certain characteristics of pregnancy-related breast changes, like nipple and areolar pigmentation. The reasons for this are not fully clear. The subject populations between these studies were different, for instance in terms of factors like initial breast size and age, which may be contributing reasons. Another possible contributing factor is that only estrogen and progestogen levels increased in the study, whereas levels of other pregnancy hormones, besides the slight increase in prolactin levels, did not increase. These other pregnancy hormones, for instance hPL and IGF-1, may also be involved in breast development during pregnancy. Finally, the treatment duration was only 4 to 5 months, and the estrogen and progestogen exposure was only similar to that during early-to-mid pregnancy, whereas normal pregnancy lasts 9 months and involves continued dramatic increases in estrogen and progesterone levels through to childbirth.

    It should be noted that, owing to the highly supraphysiological estrogen and progestogen levels required, which can cause serious health complications like blood clots and cardiovascular problems (Aly, 2020e), as well as the small to negligible lasting increase in breast volume, therapeutic pseudopregnancy is inadvisable for transfeminine people and should not be pursued or employed. Nonetheless, the historical findings of therapeutic pseudopregnancy for increasing breast size in cisgender females are of significant theoretical interest in exploring the roles of estrogens and progestogens in breast growth.

    Early Progestogen Exposure and the Possibility of Suboptimal Breast Development

    While progestogens are typically sought after by transfeminine people for their potential in improving breast development, there have also been various suggestions in the literature that early or premature exposure to progestogens may result in suboptimal breast development and that progestogens may suppress or reduce estrogen-mediated breast development. These suggestions include progestogens having known antiestrogenic effects in the breasts, animal studies finding stunted mammary development with high doses of progestogens, clinical publications cautioning against premature introduction of progestogens in female puberty induction due to concerns about possibly stunted breast growth, clinical use of progestogens to treat macromastia in cisgender females, poor breast development with estrogen therapy in cisgender girls with a disorder of sexual development that results in high progesterone exposure, and breast development with estrogen and CPA (a very strong progestogen) typically being poor in transfeminine people. As with the question of whether progestogens can enhance breast development, it is currently unknown whether progestogens could worsen breast development. It is also unknown what dosage level and timing of introduction would be required for such an effect. In any case, for informational purposes, the preceding topics will each be discussed in the subsequent sections.

    Antiestrogenic Effects of Progestogens in the Breasts

    Progestogens are well-known to have potent functional antiestrogenic effects in tissues such as the uterus, vagina, and cervix (Wiki). The antiestrogenic effects of progestogens in the uterus are in fact the reason that they are used in menopausal hormone therapy—to prevent the risks of endometrial hyperplasia and endometrial cancer that unopposed estrogen therapy otherwise produces (Wiki). Progestogens also appear to have antiestrogenic effects in the breasts (Mauvais-Jarvis, Kuttenn, & Gompel, 1986a; Mauvais-Jarvis, Kuttenn, & Gompel, 1986b; Mauvais-Jarvis, Kuttenn, & Gompel, 1987; Mauvais-Jarvis et al., 1987; Kuttenn et al., 1994; Wren & Eden, 1996; Plu-Bureau, Touraine, & Mauvais-Jarvis, 1999; Wiki). This may include by inhibiting estrogen synthesis and enhancing estrogen inactivation in the breasts (Pasqualini, 2007; Pasqualini, 2009) and by reducing expression of the estrogen receptors in the breasts (Mauvais-Jarvis, Kuttenn, & Gompel, 1986b; Malet et al., 1991; Kuttenn et al., 1994; Wren & Eden, 1996; Graham & Clarke, 1997; Plu-Bureau, Touraine, & Mauvais-Jarvis, 1999). Clinical studies have found that direct application of topical progesterone to the breasts suppresses estradiol-mediated breast cell proliferation, although this may be due to the delivery of supraphysiological levels of progesterone in the breasts (Barrat et al., 1990; Chang et al., 1995; Foidart et al., 1996; Spicer, Ursin, & Pike, 1996; Foidart et al., 1998; de Lignières, 2002; Gompel & Plu-Bureau, 2018; Trabert et al., 2020). In accordance with their antiestrogenic effects in the breasts, progestogens are considered to be useful in treating estrogen-dependent benign breast disorders such as breast pain, nodularity, and fibrocystic breast disease (Mauvais-Jarvis, Sitruk-Ware, & Kuttenn, 1981; Winkler et al., 2001; Schindler, 2011; Wiki; Wiki; Wiki). Progestogens have also been reported to antagonize nipple and areolar hyperpigmentation induced by high-dose estrogen therapy (Crowley & Macdonald, 1965). In contrast to the preceding findings however, the addition of a progestogen to an estrogen in menopausal hormone therapy has been shown to significantly increase the risk of breast cancer (Aly, 2020a; Wiki). In any case, the antiestrogenic effects of progestogens in the breasts provide a plausible potential mechanism by which they might limit estrogen-mediated breast development. However, an alternative possible mechanism is that such actions may be related to simultaneous induction of ductal development and lobuloalveolar maturation, the latter of which is notably not normal for puberty (Randolph, 2018).

    Stunted Mammary Growth with Progestogens in Animal Studies

    Animal studies using progestogens including bioidentical progesterone and chlormadinone acetate (CMA), a progestin closely related to CPA, have found that high doses of these progestogens substantially stunt mammary gland development in rabbits, whereas lower doses do not do so (Lyons & McGinty, 1941; Beyer, Cruz, & Martinez-Manautou, 1970). See here for relevant literature excerpts as well as figures from these studies. Lyons & McGinty (1941) [Figure] found that estrogen alone induced ductal mammary development and estrogen plus progesterone 0.25 to 1 mg/day produced ductal development and slight to “fair” lobuloalveolar development. Conversely, estrogen plus progesterone 4 to 8 mg/day, which were 4- to 8-fold higher doses of progesterone than the most optimal dose, produced stunted mammary development with inhibited ductal development, only slight lobuloalveolar development, and, at the highest dosage, resulted in a much smaller mammary gland in terms of size than in the ≤1 mg/day groups. They concluded that high doses of progesterone are inhibitory and result in relatively poor mammary development. In the paper, doses of progesterone in international units (IU) were reported, but a citing review, Pfeiffer (1943), indicated that 1 IU progesterone is equal to 1 mg progesterone. As such, the milligram doses are listed above instead. Beyer, Cruz, & Martinez-Manautou (1970) [Figure] found that estrogen alone produced good ductal development without lobuloalveolar growth (mean mammary area = 376 mm2) and both estrogen plus CMA 0.5 mg/day and estrogen plus progesterone 2.5 mg/day produced optimal ductal and lobuloalveolar development (mean mammary area = 765 mm2 and mean mammary area = 688 mm2, respectively). Conversely, estrogen plus CMA 2.5 mg/day, a 5-fold higher dose of CMA than the optimal dose, resulted in dramatically reduced ductal development and mammary gland size albeit with significant lobuloalveolar growth (mean mammary area = 284 mm2). The authors concluded that moderate doses of progestogens stimulate mammary gland growth whereas large doses inhibit mammary gland development.

    While these animal studies are suggestive that high doses of progestogens may be able to stunt breast development in humans, this is far from a certainty. There are species differences in hormone-mediated mammary development such that findings in one species, such as rabbits, may not translate to another species, like humans, or sometimes even to closely related species, like rats or guinea pigs (Bässler, 1970). As far as the present author is aware, stunted mammary development with high doses of progestogens has not been studied or reported in other animal species, for instance other rodent species or monkeys. It is also unclear that the doses employed in these animal studies are necessarily relevant to progestogen therapy in humans. This is because pregnancy levels of progesterone, which are much higher than luteal-phase progesterone levels, are necessary for substantial mammary lobuloalveolar development, and the doses of progestogens used in these studies were above that magnitude of progestogenic exposure. Hence, the doses may have corresponded to what in humans would be extremely high doses. However, such doses could still be relevant in the case of CPA used as an antiandrogen in humans, as CPA is used in this context at very high doses (see section below). The present author is unaware of any animal studies finding that physiological non-pregnancy levels of progesterone have any stunting or other adverse influence on mammary development, suggesting that only high doses of progestogens may have such effects. Finally, it seems notable that the estrogen and progestogen were initiated simultaneously in these animal studies and yet produced optimal pregnancy-like mammary development at the right doses. This suggests that early or immediate progestogen exposure might not be unfavorable in terms of breast development in humans. However, once again species differences may be present and confirmatory clinical studies are needed in humans.

    Clinical Publications Cautioning Against Premature Introduction of Progestogens Due to Possibly Stunted Breast Development

    A large number of clinical publications largely in the pediatric endocrinology literature have warned that premature exposure to progestogens during for instance puberty induction may result in suboptimal breast development in cisgender girls and/or transfeminine people (Zacharin, 2000; Bondy et al., 2007; Colvin, Devineni, & Ashraf, 2014; Wierckx, Gooren, & T’Sjoen, 2014; Kaiser & Ho, 2015; Bauman, Novello, & Kreitzer, 2016; Gawlik et al., 2016; Randolph, 2018; Donaldson et al., 2019; Heath & Wynne, 2019a; Heath & Wynne, 2019b; Iwamoto et al., 2019; Crowley & Pitteloud, 2020; Naseem, Lokman, & Fitzgerald, 2021; Federici et al., 2022; Lucien et al., 2022; Rothman & Iwamoto, 2022). The full relevant excerpts from these sources can be found here. In relation to these claims, and in order to mimic normal female puberty, a progestogen is not typically added to estrogen therapy during puberty induction in cisgender girls with delayed puberty until after about 2 to 3 years of treatment, by which point breast growth is generally considered complete. Additionally, progestogens are generally never added as part of puberty induction in transfeminine adolescents. Despite the preceding widespread literature statements and accepted clinical practices in the field of puberty induction however, it is important to note that the claims that premature introduction of progestogens might stunt breast development in this context are currently not based on any actual reliable clinical evidence and hence remain unsubstantiated. It is not even clear that these statements are based on anecdotal clinical experience as opposed to simple conjecture. The absence of data in this area may finally change in the future as more clinical studies of progestogens in puberty induction in cisgender girls are conducted (e.g., Rodari et al., 2023).

    Rodari and colleagues studied optimization of puberty induction with estrogen therapy followed by eventual introduction of progestogen therapy in 49 cisgender girls with hypogonadism (e.g., Rodari et al., 2022; Rodari, 2022; Rodari et al., 2023). The researchers employed incrementally titrated low-dose transdermal estradiol to mimic the low and gradually increasing estradiol levels during normal puberty and added a progestogen only once menstrual bleeding began. The total duration of treatment was mean 2.65 ± 1 years, the time of first menstrual bleeding occurrence was 2.3 ± 1 years, and the time of progestogen introduction was median 2.22 years (IQR 1.56–2.87 years). Of the girls, 90% reached Tanner breast stage 4, but only 41% reached Tanner breast stage 5. Reaching the final Tanner breast stage was significantly associated with the number of estradiol dose increases (i.e., gradual estradiol dose titration) and the estradiol dose at progestogen introduction. The researchers interpreted the latter finding as progestogen exposure potentially hampering breast development. They questioned introducing progestogen therapy in the presence of incompletely developed breasts and suggested that instead of adding a progestogen upon onset of menstrual bleeding, clinicians should consider slightly reducing the estradiol dosage to delay progestogen introduction until the breasts complete maturation. While interesting, it must be noted that the findings of Rodari and colleagues are merely correlational, are open to multiple interpretations, and do not causally show that progestogens impair breast maturation.

    Progestogens in the Treatment of Breast Hypertrophy

    Low progesterone levels have been suggested as a possible contributing factor in the development of pubertal macromastia (breast hypertrophy) (Sun et al., 2018). A number of case reports and series of progestogens in the treatment of pubertal macromastia have been published (Sperling & Gold, 1973; Boyce, Hoffman, & Mathes, 1984; Ryan & Pernoll, 1985; Aritaki et al., 1992; Gliosci & Presutti, 1993; Sridhar & Jaya Sinha, 1995; Baker et al., 2001; Dancey et al., 2008; Bland, Howard, Romrell, 2009; Hoppe et al., 2011; Sun et al., 2018). Progestogens such as dydrogesterone, MPA, and CPA were used for this purpose in an attempt to stop or slow the growth of the breasts under the assumption that they are functionally antiestrogenic in breast tissue. Clinical success in these limited cases was mixed. Due to the self-resolving nature of pubertal macromastia (i.e., breast development stops on its own eventually) and other methodological limitations, such as very small numbers of individuals and lack of untreated control groups, it is difficult to draw any reliable conclusions about effectiveness from these reports.

    More recently, a couple of studies, both by the same group of researchers, assessed the impact of different types of hormonal contraception on macromastia in adolescent cisgender females with macromastia (Nuzzi et al., 2021; Nuzzi et al., 2022). They found that use of progestin-only contraceptives were associated with significantly more breast tissue removed upon surgical breast reduction (959.9 g/m2 vs. 735.9 g/m2 [+30%]; p = 0.04) and worse clinical symptoms (e.g., breast pain—odds ratio, 4.94, p = 0.005) relative to non-users of hormonal contraception (Nuzzi et al., 2021). Conversely, use of combined oral contraceptives, which are estrogen–progestogen preparations, were associated with significantly less breast tissue removed with breast reduction (639.5 g/m2 vs. 735.9 g/m2 [−13%]; p = 0.003), though not with any differences in clinical symptoms, relative to those naive to hormonal contraception (Nuzzi et al., 2022). It should be noted that progestin-only contraceptives suppress the HPG axis and result in low estradiol levels, whereas combined oral contraceptives suppress the HPG axis and lower estradiol production but simultaneously supplement estrogen signaling by delivering exogenous estrogen. This difference may somehow be responsible for the opposite influence of estrogen–progestogen therapy versus progestogen-alone therapy on macromastia severity. While the findings of Nuzzi and colleagues are interesting, it is noteworthy that the methodology and findings of their research were criticized on various grounds in a letter to the editor concerning one of the articles (Karp, 2022).

    Santen et al. (2024), in a case series of cisgender girls with juvenile gigantomastia, noted that breast growth continues for only a number of years following onset and hence there must be some form of stop signal that is activated and that prevents further breast growth. They speculated that this signal may be related to apoptosis (programmed cell death). Santen and colleagues noted that in adult cisgender women, proliferation of breast cells is increased during the follicular phase of the menstrual cycle, whereas apoptosis in breast cells is increased during the luteal phase of the cycle. They hypothesized that the apoptosis during the luteal phase may block further breast development. Since progesterone is produced during the luteal phase and may mediate said apoptosis, this would substantiate the use of progestogens in the treatment of breast hypertrophy. However, the researchers noted that no data exist on apoptosis in the breasts of girls with juvenile gigantomastia. Moreover, an important point against the authors’ hypothesis is that breast growth gradually ceases in people without luteal phases or progestogenic exposure, for instance CAIS women, transfeminine people, and other examples.

    Poor Breast Development in 17α-Hydroxylase/17,20-Lyase Deficiency

    Poor breast development with exogenous estrogen therapy has been reported in cisgender girls with 17α-hydroxylase/17,20-lyase deficiency, and prior exposure to high progesterone levels consequent to the condition has been hypothesized to be responsible for this (Turan et al., 2009; Athanasoulia et al., 2013; Deeb et al., 2015; Çamtosun et al., 2017; Fernández-Cancio et al., 2017; Kardelen et al., 2018). However, this is only speculation, and at this time, there is no causal evidence or other substantiation that progesterone specifically is responsible for the observations of poor breast growth.

    Non-Comparative Clinical Studies of Breast Development with Estrogen and Cyproterone Acetate in Transfeminine People

    The possibility of suboptimal breast development with premature exposure to progestogens is of particular relevance in the case of CPA used as an antiandrogen in transfeminine people. This is because CPA is a potent progestogen in addition to antiandrogen, starts to be taken at the initiation of hormone therapy, and happens to be used in transfeminine people at doses that result in very strong to profound progestogenic exposure (Aly, 2019). In terms of progestogenic strength, CPA at a dosage of 2 mg/day is comparable to the progesterone exposure during the luteal phase of the menstrual cycle (Aly, 2019; Wiki). For comparison, CPA has been used in transfeminine people at doses ranging from 10 to 100 mg/day (Aly, 2019). This would mean that CPA provides roughly 6.25 times the progestogenic impact of luteal-phase progesterone exposure at a dosage of 12.5 mg/day, 12.5 times the impact at 25 mg/day, 25 times the impact at 50 mg/day, and 50 times the impact at 100 mg/day. Moreover, this does not consider the fact that progesterone is only produced during the luteal phase, or half of the menstrual cycle, whereas CPA is taken continuously every day of the month. The preceding magnitudes of progestogenic exposure with CPA are on par with and even beyond those during pregnancy. Only recently have lower doses of CPA (e.g., ≤12.5 mg/day) started to be used in transfeminine hormone therapy.

    Studies in pubertal and adolescent transfeminine people given GnRH agonists to block puberty plus estrogen therapy have reported good breast development in these individuals as assessed by subjective clinical impression or Tanner staging (de Vries et al., 2010; Hannema et al., 2017). However, quality objective measures of breast development were not employed in these studies. Conversely, non-comparative studies using estrogen plus CPA in adult transfeminine people have commonly reported modest breast development, including incomplete breast development only to Tanner stage 2 to 4, small breast cup sizes, and small breast volumes (Kanhai et al., 1999; Sosa et al., 2003; Sosa et al., 2004; Wierckx et al., 2014; Fisher et al., 2016; Tack et al., 2017; de Blok et al., 2018; Reisman, Goldstein, & Safer, 2019; Meyer et al., 2020; de Blok et al., 2021). Additionally, breast sizes smaller than those in cisgender women have been reported (Asscheman & Gooren, 1992; Kanhai et al., 1999). In one study, breast development with estrogen plus CPA was also poor in late-adolescent transfeminine people (Tack et al., 2017). However, in this particular study, the estrogen dose used was likely too low and resulted in inadequate estradiol levels, as noted by the authors themselves, and this is a potential confounding factor in their findings (Tack et al., 2017). In any case, breast growth with estrogen plus CPA in transfeminine people would seem to consistently be poor. In contrast to the regimen of estrogen and CPA, breast development with other hormone therapy regimens, for instance estrogen with non-progestogenic antiandrogens like spironolactone, bicalutamide, and GnRH modulators, has not been nearly as well-studied in comparison, and hence comparisons of outcomes between regimens is difficult.

    In one of the highest quality studies of estrogen and CPA and breast development in adult transfeminine people, breast volume measured with 3D body scanning (Vectra XT) was approximately mean 100 mL (95% CI ~75–125 mL; range up to ~750 mL), equating to less than an A cup size on average, after 3 years of hormone therapy with estrogen and CPA in 69 transfeminine people (de Blok et al., 2021 [Figure]). In this study, breast changes over time had clearly plateaued, suggesting that breast development was either complete or was nearly so (de Blok et al., 2021 [Figure]). Although most of the transfeminine people in this study had less than an A cup breast size (71%), a minority had cup sizes ranging from an A cup (9%), B cup (16%), C cup (3%), to E cup (1%) (de Blok et al., 2021 [Figure]). For comparison, a study of normative data on breast volumes in cisgender women, using a different 3D body scanning device (Artec Eva 3D), found breast volumes of median ~515 mL and mean ~650 mL (IQR ~310–850 mL; range ~50–3,100 mL) in 378 cisgender women (Coltman, Steele, & McGhee, 2017). As such, adult transfeminine people treated with estrogen and CPA would appear to have substantially smaller breasts than cisgender women. However, it must be emphasized that the preceding data come from separate clinical studies and hence are not directly comparative. It is noteworthy in this regard that breast volumes can vary considerably between different studies even using similar measurement methods (e.g., magnetic resonance imaging) (Sindi et al., 2019 [Table]). Hence, there is a need for studies directly comparing breast volumes in transfeminine people to those in cisgender women using the same measurement method in order to comparatively evaluate breast development.

    Regardless of the preceding, transfeminine people could simply have poor breast development in general without this necessarily being related to CPA or progestogenic exposure. Indeed, a more recent study in transfeminine people who underwent pubertal suppression in adolescence, presumably with GnRH agonists and then estrogen therapy, found similarly poor breast development as has been reported in adults (Boogers et al., 2022; c.f. de Blok et al., 2021). This study used breast volume via 3D body scanning to measure breast development and found a mean breast volume of 114 mL (IQR 58–203 mL), equating to less than an A cup size, after 4.2 years of hormone therapy (Boogers et al., 2022). It was notably conducted by the same group of researchers who did the earlier higher-quality study in adult transfeminine people, and hence likely used the same 3D scanning method (de Blok et al., 2021).

    No directly comparative studies of breast development with CPA versus other antiandrogens in transfeminine people are currently available. Hence, it’s not fully known whether the findings are specific to CPA or also generalize to other antiandrogens that are not also strongly progestogenic. The RCT of estradiol and spironolactone versus estradiol and CPA in transfeminine people by Ada Cheung and colleagues that is currently underway in Australia may provide more insight on this issue, as spironolactone is only a weakly or clinically non-progestogenic antiandrogen (Aly, 2018b; Wiki).

    Additional Considerations for Progestogen Therapy and Breast Development in Transfeminine People

    Anecdotes About Progestogens and Breast Development

    Many transfeminine people who have taken progestogens as part of hormone therapy have anedotally reported that the progestogens improved their breast development. At the same time, many other transfeminine people have anecdotally reported no benefit of progestogens to breast development. It must be cautioned in general that anecdotal reports are unreliable and represent a very low form of medical evidence. This is because subjective observations and attributions are often erroneous. Perceptions can be faulty and inaccurate, especially with slowly developing physical changes, and true physical changes can be due to coincidence and unrelated confounding factors rather than due to a person’s causal attributions. A couple notable examples of potential confounding factors with regard to progestogens and breast development include: (1) continued breast development from estrogen acting on its own; and (2) temporary breast enlargement due to local fluid retention, increased blood flow, and reversible lobuloalveolar growth caused by progestogens. Such factors have the potential to mislead, and may contribute significantly to anecdotal reports of enhanced breast development with progestogens in transfeminine people. Clinical studies that are well-designed, controlled, and employ reliable objective measures, with long-term follow-up and eventual discontinuation of the progestogen to control for reversible effects, are needed to properly evaluate the effects of progestogens on breast development.

    Therapeutic Limitations of Oral Progesterone

    Oral progesterone producles very low progesterone levels and has only weak progestogenic effects even at high doses (Aly, 2018a; Wiki). These low progesterone levels are likely to be inadequate in terms of desired physiological progestogenic effects, for instance in the breasts. Oral progesterone also uniquely has potent neurosteroid actions via active metabolites like allopregnanolone, which can result in prominent side effects such as alcohol-like central nervous system inhibition as well as mood swings (Aly, 2018b; Wiki; Wiki). These neurosteroid effects are dose-dependent and are more severe at high doses. Non-oral progesterone forms like rectal or injectable progesterone or progestins, which do not have the preceding problems, can be used instead to avoid such concerns (Aly, 2018a; Aly, 2018b).

    Tolerability and Safety Considerations for Progestogens

    Progestogens have a variety of tolerability issues and safety risks (Aly, 2018b). Examples of such risks variously include adverse mood changes, breast cancer, blood clots, cardiovascular complications, benign brain tumors including prolactinomas and meningiomas, and off-target actions with undesirable effects (e.g., androgenic or glucocorticoid activity), among others (Aly, 2018b). CPA at high doses also uniquely has a significant risk of serious liver toxicity (Aly, 2018b). The risks of progestogens vary depending on the specific progestogen and dosage, but all progestogens, including even bioidentical progesterone, have significant known risks. The risks of progestogens, along with lack of evidence of beneficial effects in terms of feminization, well-being, and health, in transfeminine people, are why there are concerns about and restrictions on their use in transfeminine people (Aly, 2018b). However, cisgender women naturally have progesterone in their bodies, and the absolute risks of progestogens are low (Aly, 2018b). The risks of progestogens can be minimized by use for a limited duration of time (e.g., a few years), by using the lowest dosages expected to be effective in terms of desired effects, and by selection of progestogens with more favorable pharmacological profiles (Aly, 2018a; Aly, 2018b).

    Updates

    Update 1: Angus et al. (2023–2024)

    It was previously reported in this article that an RCT assessing breast development with estradiol plus spironolactone versus estradiol plus CPA in transfeminine people was being conducted by Ada Cheung and colleagues. This study could provide more insight into breast development with progestogens, as CPA is a very potent progestogen whereas spironolactone is not meaningfully progestogenic. Cheung and colleagues’ study, led by Lachlan Angus, has now been published in the form of the following two conference abstracts, with a journal article also currently in the process of being published:

    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (November 2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (November 2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]

    The study assessed estradiol plus spironolactone 100 mg/day versus estradiol plus CPA 12.5 mg/day in 55 transfeminine people, with 27 in the spironolactone group and 28 in the CPA group. Hormone therapy duration, at least at this follow-up point in the study, was 6 months. The measures of breast development included breast–chest difference (primary) and estimated breast volume (secondary).

    Breast development, measured by breast–chest difference (mean ± SD), was 8.3 ± 2.7 cm with spironolactone and 9.2 ± 3.0 cm with CPA, with the differences between groups not statistically significant (p = 0.27). In addition, breast development, measured by estimated breast volume (mean ± SD), was 158 ± 112 mL with spironolactone and 190 ± 159 mL with CPA, with the differences between groups not statistically significant (p = 0.39). There was variability between individuals in estimated breast volume, with breast volume measurements ranging from 20 to 788 mL. Besides breast growth, the researchers found that CPA also resulted in a greater increase in body fat percentage and gynoid fat compared to spironolactone. Estradiol levels were comparable between antiandrogen groups, whereas total testosterone levels were (mean ± SD) 4.29 ± 5.44 nmol/L (124 ± 157 ng/dL) with spironolactone and 1.48 ± 3.45 nmol/L (43 ± 99 ng/dL) with CPA, a difference that was statistically significant (p = 0.04).

    The researchers concluded that there was no difference in breast development with spironolactone versus CPA in their study and that antiandrogen choice should be individualized based on patient and clinician preference as well as consideration of associated side effects. Moreover, they concluded that further research is needed to optimize breast development in transfeminine people.

    The measure of breast volume in the study was the BreastIdea Volume Estimator, a freely available web app that employs 2D photography to provide an estimate of breast volume (Mikołajczyk, Kasielska-Trojan, & Antoszewski, 2019; Kasielska-Trojan, Mikołajczyk, & Antoszewski, 2020). This breast volume measure has been validated in both cisgender women and cisgender men (Mikołajczyk, Kasielska-Trojan, & Antoszewski, 2019; Kasielska-Trojan, Mikołajczyk, & Antoszewski, 2020). Additionally, Cheung and Angus, along with other colleagues, notably including some of the original developers of the BreastIdea Volume Estimator, validated the BreastIdea Volume Estimator in cisgender men and transfeminine people in the following 2022 conference abstract study:

    • Angus, L., Mikolajczyk, M., Cheung, A., Zajac, J., Antoszewski, B., & Kasielska-Trojan, A. (2022). Estimation of breast volume in transgender women using 2D photography: validation of the BreastIdea Volume Estimator in men and transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 279). [URL] [PDF] [Full Abstract Book]

    In studies by the developers of the BreastIdea Volume Estimator, they reported breast volumes measured with the tool in cisgender women. These estimated breast volumes can provide comparison to the breast-volume findings in transfeminine people by Cheung and Angus and colleagues. The developers of the BreastIdea Volume Estimator reported that breast volume (mean ± SD) in cisgender women with normal breasts (n=30) was 283 ± 144 mL and in cisgender women with macromastia or gigantomastia (n=35) was 888 ± 277 mL (Kasielska-Trojan, Zawadzki, & Antoszewski, 2022). In another study, they reported that breast volume (mean ± SD) in cisgender women was 272 ± 150 mL, with a range of 99 to 694 mL (Kasielska-Trojan, Mikołajczyk, & Antoszewski, 2020).

    Although the BreastIdea Volume Estimator is an interesting and promising tool for quantifying breast development, it has notable limitations, such as its resolution and accuracy being much less than that with 3D scanners like the Artec Eva and Vectra XT (Mikołajczyk, Kasielska-Trojan, & Antoszewski, 2019). Vectra and Artec 3D scanners have been and are being employed to measure breast development with hormone therapy in other studies in transfeminine people (de Blok et al., 2021; Boogers et al., 2022; Dijkman et al., 2023a; Dijkman et al., 2023b; Lopez et al., 2023). The accuracy limitations of the BreastIdea Volume Estimator may explain why the breast volume findings with it in transfeminine people and cisgender women were different from those seen in other studies that employed more advanced 3D scanning methods. Aside from the breast volume measurement, breast–chest difference also has limitations as a measure of breast development in transfeminine people, for instance failing to identify continued breast growth that can be detected with breast volume measurement (de Blok et al., 2021).

    Besides the employed measurement methods for breast development, limitations of Lachlan Angus and colleagues’ RCT of breast development with spironolactone and CPA in transfeminine people include its limited duration of follow-up of only 6 months, the fact that testosterone levels were non-equivalent between the spironolactone and CPA groups, and its limited sample size. The incompletely suppressed testosterone levels with spironolactone are notable as androgens oppose estrogen-mediated breast development and could have reduced breast development in the spironolactone group. The limited sample size of the study was responsible for the numeric difference in breast measurements between antiandrogen groups not being statistically significant. In any case, Angus and colleagues’ findings are suggestive that CPA, which is highly progestogenic, neither enhances nor stunts breast development, at least relative to non-progestogenic spironolactone for up to 6 months of hormone therapy. It seems likely that the RCT will continue to longer follow-up times and durations of hormone therapy in the future.

    Update 2: Flamant, Vervalcke, & T’Sjoen (2023) and Yang et al. (2024)

    The following two recent studies provide additional information on the topic of breast development with progestogen exposure—specifically with CPA—in transfeminine people:

    • Flamant, T., Vervalcke, J., & T’Sjoen, G. (November 2023). Dose Reduction of Cyproterone Acetate in Trans Women and the Effect on Patient-reported Outcomes: Results from the ENIGI Study. Endocrine Abstracts, 97 [Belgian Endocrine Society 2023], 5–5 (abstract no. 007). [URL] [PDF]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]

    In the first study, Flamant, Vervalcke, & T’Sjoen (2023), clinical outcomes in transfeminine people at the University of Ghent, Belgium clinic were compared in 72 people taking CPA at low doses (10–12.5 mg/day) or high doses (25–50 mg/day). Testosterone suppression was equivalent between the two dose groups. Breast development satisfaction, measured with the Body Image Scale, was not significantly different with low-dose CPA versus high-dose CPA following 1 year of hormone therapy (p = 0.078). However, the p-value indicates that there was almost a statistically significant difference between groups, though it was not stated which group was numerically higher in terms of satisfaction. In any case, the researchers stated that breast development satisfaction was “non-inferior” with low-dose CPA compared to high-dose CPA, which seems suggestive that satisfaction may have been higher in the high-dose CPA group. These findings suggest that higher doses of CPA may not stunt breast development relative to doses of CPA that are lower, although still quite high in terms of progestogenic activity.

    In the second study, Yang et al. (2024), clinical outcomes in transfeminine people at the Peking University Third Hospital in China with estradiol plus spironolactone (n=43) versus estradiol plus CPA (n=53) were retrospectively compared. Testosterone levels were much higher in the spironolactone group relative to the CPA group (374 ng/dL [13.0 nmol/L] vs. 20 ng/dL [0.7 nmol/L]; p < 0.001) and duration of hormone therapy was shorter in the spironolactone group than in the CPA group (median 12 months vs. 18 months). Breast development satisfaction, measured with a visual analogue scale (VAS), was median 6.0 (IQR 4.0–7.0) with spironolactone and 6.0 (IQR 4.0–7.0) with CPA, and was not statistically different. On the other hand, the CPA group outperformed the spironolactone group in terms of several other VAS-based clinical-outcome measures, including figure feminization, testicular atrophy, decreased penile erections, and in terms of a composite overall satifaction score. These findings suggest, as with the RCT by Lachlan Angus and colleagues, that spironolactone and CPA result in similar breast development in transfeminine people despite differences in testosterone levels and other clinical outcomes.

    A major limitation of both Flamant, Vervalcke, & T’Sjoen (2023) and Yang et al. (2024) is the use of subjective self-report measures of breast development as opposed to objective physical measurements.

    References

    • Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012). Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy. Clinical Pharmacokinetics, 51(6), 365–396. [DOI:10.2165/11597440-000000000-00000]
    • Adams, R. D., Kliman, B., Federman, D. D., Ulfelder, H. S., & Holmes, L. B. (1970). Syndromes of Testicular Feminization. Clinical Pediatrics, 9(3), 165–178. [DOI:10.1177/000992287000900312]
    • Alekseev, N. P. (2021). Origin and Development of the Mammary Glands. In Alekseev, N. P. Physiology of Human Female Lactation (pp. 11–66). Cham: Springer. [DOI:10.1007/978-3-030-66364-3_2]
    • Alex, A., Bhandary, E., & McGuire, K. P. (2020). Anatomy and Physiology of the Breast during Pregnancy and Lactation. In Alipour, S., & Omranipour, R. (Eds.). Diseases of the Breast during Pregnancy and Lactation (Advances in Experimental Medicine and Biology, Volume 1252) (pp. 3–7). Cham: Springer. [DOI:10.1007/978-3-030-41596-9]
    • Anderson, W. A. (1962). Experimental stimulation of breast development in the teen-age female. The Journal of the Medical Society of New Jersey, 59, 541–543. [Google Scholar] [PubMed] [PDF]
    • Andler, W., & Zachmann, M. (1979). Spontaneous breast development in an adolescent girl with testicular feminization after castration in early childhood. The Journal of Pediatrics, 94(2), 304–305. [DOI:10.1016/s0022-3476(79)80852-5]
    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]
    • Angus, L., Mikolajczyk, M., Cheung, A., Zajac, J., Antoszewski, B., & Kasielska-Trojan, A. (2022). Estimation of breast volume in transgender women using 2D photography: validation of the BreastIdea Volume Estimator in men and transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 279). [URL] [PDF] [Full Abstract Book]
    • Apter, D. (1980). Serum steroids and pituitary hormones in female puberty: a partly longitudinal study. Clinical Endocrinology, 12(2), 107–120. [DOI:10.1111/j.1365-2265.1980.tb02125.x]
    • Apter, D., Räisänen, I., Ylöstalo, P., & Vihko, R. (1987). Follicular growth in relation to serum hormonal patterns in adolescent compared with adult menstrual cycles. Fertility and Sterility, 47(1), 82–88. [DOI:10.1016/s0015-0282(16)49940-1]
    • Aritaki, S., Miyazawa, H., Ogihara, M., Ushio, M., & Izumizawa, A. (1992). An Endocrinological Study of Persistent Pubertal Macromastia. The Tohoku Journal of Experimental Medicine, 167(3), 189–196. [DOI:10.1620/tjem.167.189]
    • Arya, S., Barnabas, R., Lila, A. R., Sarathi, V., Memon, S. S., Bhandare, V. V., Thakkar, K., Patil, V., Shah, N. S., Kunwar, A., & Bandgar, T. (2021). Clinical, Hormonal, Genetic, and Molecular Characteristics in Androgen Insensitivity Syndrome in an Asian Indian Cohort from a Single Centre in Western India. Sexual Development, 15(4), 253–261. [DOI:10.1159/000517763]
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • Athanasoulia, A., Auer, M., Riepe, F., & Stalla, G. (2013). Rare Missense P450c17 (CYP17A1) Mutation in Exon 1 as a Cause of 46,XY Disorder of Sexual Development: Implications of Breast Tissue ‘Unresponsiveness’ despite Adequate Estradiol Substitution. Sexual Development, 7(4), 212–215. [DOI:10.1159/000348301]
    • Atwood, C., Hovey, R., Glover, J., Chepko, G., Ginsburg, E., Robison, W., & Vonderhaar, B. (2000). Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. Journal of Endocrinology, 167(1), 39–52. [DOI:10.1677/joe.0.1670039]
    • Aupperlee, M. D., Leipprandt, J. R., Bennett, J. M., Schwartz, R. C., & Haslam, S. Z. (2013). Amphiregulin mediates progesterone-induced mammary ductal development during puberty. Breast Cancer Research, 15(3), R44. [DOI:10.1186/bcr3431]
    • Bahr, C., Ewald, J., Dragovich, R., & Gothard, M. D. (2024). Effects of progesterone on gender affirmation outcomes as part of feminizing hormone therapy. Journal of the American Pharmacists Association, 64(1), 268–272. [DOI:10.1016/j.japh.2023.08.001]
    • Baird, D., Hytten, F. E., & Thomson, A. M. (1958). Age and Human Reproduction. BJOG, 65(6), 865–876. [DOI:10.1111/j.1471-0528.1958.tb08582.x]
    • Baker, S. B., Burkey, B. A., Thornton, P., & LaRossa, D. (2001). Juvenile Gigantomastia: Presentation of Four Cases and Review of the Literature. Annals of Plastic Surgery, 46(5), 517–526. [DOI:10.1097/00000637-200105000-00011]
    • Bames, H. O. (1948). Reduction of massive breast hypertrophy. Plastic and Reconstructive Surgery, 3(5), 560–569. [DOI:10.1097/00006534-194809000-00006]
    • Barbieri, R. L. (2019). Breast. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 248–255.e3). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/B978-0-323-47912-7.00010-X]
    • Baron, J. (1993). Zespół braku wrazliwości na androgeny. Studium kliniczne i endokrynologiczne 40 osobników [Androgen insensitivity syndrome. Clinical and endocrinologic study of 40 cases]. Endokrynologia Polska, 44(2), 175–186. [Google Scholar] [PubMed]
    • Baron, J. (1994). Klasyczne i niepełne zespoły braku wrazliwości na androgeny [Classical and incomplete androgen insensitivity syndromes]. Ginekologia Polska, 65(7), 377–386. [Google Scholar] [PubMed]
    • Baron, J. (1994). Niepełny lub cześciowy zespół braku wrazliwości na androgeny [Partial androgen insensitivity syndrome]. Ginekologia Polska, 65(6), 319–325. [Google Scholar] [PubMed]
    • Barrat, J., de Lignières, B., Marpeau, L., Larue, L., Fournier, S., Nahoul, K., Linares, G., Giorgi, H., & Contesso, G. (1990). Effet in vivo de l’administration locale de progestérone sur l’activité mitotique des galactophores humains. Résultat d’une étude pilote. [The in vivo effect of the local administration of progesterone on the mitotic activity of human ductal breast tissue. Results of a pilot study.] Journal de Gynecologie, Obstetrique et Biologie de la Reproduction, 19(3), 269–274. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Barrett, J. (2009). The clinical risks associated with the diagnosis and management of disorders of gender identity. Clinical Risk, 15(4), 131–134. [DOI:10.1258/cr.2008.080069]
    • Bässler, R. (1970). The Morphology of Hormone Induced Structural Changes in the Female Breast. In Altmann, H.-W., et al. (Eds.). Current Topics in Pathology: Ergebnisse der Pathology, Volume 53 (pp. 1–89). Heidelberg: Springer Berlin. [DOI:10.1007/978-3-662-30514-0_1] [PDF]
    • Basson, R., & Prior, J. C. (1998). Hormonal Therapy of Gender Dysphoria: The Male-to-Female Transsexual. In Denny, D. (Ed.). Concepts in Transgender Identity (Garland Gay and Lesbian Studies, Volume 11) (pp. 277–296). New York: Garland Publishing Inc. [Google Scholar] [Google Books] [DOI:10.4324/9780203775134-19] [PDF]
    • Bauman, A., Novello, L., & Kreitzer, P. (2016). Endocrine Disorders and Delayed Puberty. In Appelbaum, H. (Ed.). Abnormal Female Puberty: A Clinical Casebook (pp. 87–107). Cham: Springer. [DOI:10.1007/978-3-319-27225-2_5]
    • Bayer, C. M., Bani, M. R., Schneider, M., Dammer, U., Raabe, E., Haeberle, L., Faschingbauer, F., Schneeberger, S., Renner, S. P., Fischer, D., Schulz-Wendtland, R., Fasching, P. A., Beckmann, M. W., & Jud, S. M. (2014). Assessment of breast volume changes during human pregnancy using a three-dimensional surface assessment technique in the prospective CGATE study. European Journal of Cancer Prevention, 23(3), 151–157. [DOI:10.1097/cej.0b013e3283651ccb]
    • Beck, P. (1972). Lactogenic Activity of Human Chorionic Somatomammotropin in Rhesus Monkeys. Experimental Biology and Medicine, 140(1), 183–187. [DOI:10.3181/00379727-140-36422]
    • Begley, D. J., Firth, J. A., & Hoult, J. R. (1980). The Breast and Lactation. In Begley, D. J., Firth, J. A., & Hoult, J. R. Human Reproduction and Developmental Biology (pp. 204–219). London: Macmillan Education UK. [DOI:10.1007/978-1-349-16260-4_14]
    • Bellwether, C. J. (2020). Why Should a Transfeminine Person Consider Progesterone? Google Docs. [URL]
    • Benjamin, H. (1966). Nonsurgical Management of Transsexualism. In Benjamin, H. The Transsexual Phenomenon (pp. 86–99). New York: Julian Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Benjamin, H. (1967). Transvestism and Transsexualism in the male and female. Journal of Sex Research, 3(2), 107–127. [DOI:10.1080/00224496709550519]
    • Berliere, M., Coche, M., Lacroix, C., Riggi, J., Coyette, M., Coulie, J., Galant, C., Fellah, L., Leconte, I., Maiter, D., Duhoux, F. P., & François, A. (2022). Effects of Hormones on Breast Development and Breast Cancer Risk in Transgender Women. Cancers, 15(1), 245. [DOI:10.3390/cancers15010245]
    • Berryhill, G. E., Trott, J. F., & Hovey, R. C. (2016). Mammary gland development—It’s not just about estrogen. Journal of Dairy Science, 99(1), 875–883. [DOI:10.3168/jds.2015-10105]
    • Bethea, C. L., Kohama, S. G., & Pecins-Thompson, M. (1997). Pituitary and Brain Actions of Estrogen and Progesterone in the Regulation of Primate Prolactin Secretion. In Pavlik, E. J. (Ed.). Estrogens, Progestins, and Their Antagonists: Functions and Mechanisms of Action (pp. 3–46). Boston: Birkhäuser. [DOI:10.1007/978-1-4612-2004-6_1]
    • Bevan, D. J. (2012). Progesterone for Breast Development? / Should Male-to-Female Transsexuals Take Progesterone as part of Hormone Therapy (HT) for Better Breast Development? Biopsychology of TSTG / Transgender Forum. [URL 1] [URL 2]
    • Bevan, D. J. (2019). Grow Your Own : Breast Development Update. Transgender Forum. [URL]
    • Beyer, C., Cruz, M. L., & Martinez-Manautou, J. (1970). Effect of Chlormadinone Acetate on Mammary Development and Lactation in the Rabbit. Endocrinology, 86(5), 1172–1174. [DOI:10.1210/endo-86-5-1172]
    • Biswas, S. K., Banerjee, S., Baker, G. W., Kuo, C., & Chowdhury, I. (2022). The Mammary Gland: Basic Structure and Molecular Signaling during Development. International Journal of Molecular Sciences, 23(7), 3883. [DOI:10.3390/ijms23073883]
    • Bland, K. I., Copeland, E. M., & Klimberg, V. S. (2018). Anatomy of the Breast, Axilla, Chest Wall, and Related Metastatic Sites. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 20–36.e2). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00002-7]
    • Bland, K. I., Harrison Howard, J., & Romrell, L. J. (2009). Congenital and Acquired Disturbances of Breast Development and Growth. In Bland, K. I., & Copeland, E. M. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 4th Edition (pp. 189–207). Philadelphia: Saunders/Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Bondy, C. A., & Turner Syndrome Consensus Study Group. (2007). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. The Journal of Clinical Endocrinology & Metabolism, 92(1), 10–25. [DOI:10.1210/jc.2006-1374]
    • Boogers, L., Infirri, S. S., Bouchareb, A., de Blok, C., Liberton, N., van Trotsenburg, P., Dreijerink, K., den Heijer, M., Wiepjes, C., & Hannema, S. (2022). The effect of timing of puberty suppression on breast development in trans girls; a cross-sectional study. Hormone Research in Paediatrics, 95(Suppl 2) [60th Annual Meeting of the European Society for Paediatric Endocrinology (ESPE), Rome, Italy, September 15–17, 2022], 390–391 (abstract no. P1-379). [Google Scholar] [DOI:10.1159/000525606] [URL] [PDF 1] [PDF 2]
    • Boyce, S. W., Hoffman, P. G., & Mathes, S. J. (1984). Recurrent Macromastia after Subcutaneous Mastectomy. Annals of Plastic Surgery, 13(6), 511–518. [DOI:10.1097/00000637-198412000-00008]
    • Bruck, H. G., & Müller, G. (1967). Zur Hormontherapie der Hypoplastischen Weiblichen Brust. [On Hormonal Therapy of the Hypoplastic Female Breast.] Ästhetische Medizin [Ästhetische Medizin : Kongreß-Organ der Deutschen Gesellschaft für die Ästhetische Medizin und ihre Grenzgebiete], 16(12), 365–366. [ISSN:0400-6755] [Google Scholar] [PubMed] [WorldCat] [PDF] [Translation]
    • Bryant, R., Underwood, A., Robinson, A., Stephenson, T., & Underwood, J. (1998). Determination of breast tissue composition for improved accuracy in estimating radiation doses and risks in mammographic screening. The Breast, 7(2), 95–98. [DOI:10.1016/s0960-9776(98)90064-9]
    • Buhimschi, C. S. (2004). Endocrinology of lactation. Obstetrics and Gynecology Clinics of North America, 31(4), 963–979. [DOI:10.1016/j.ogc.2004.08.002]
    • Camilletti, M. A., Abeledo-Machado, A., Faraoni, E. Y., Thomas, P., & Díaz-Torga, G. (2019). New insights into progesterone actions on prolactin secretion and prolactinoma development. Steroids, 152, 108496. [DOI:10.1016/j.steroids.2019.108496]
    • Çamtosun, E., Şıklar, Z., Ceylaner, S., Kocaay, P., & Berberoğlu, M. (2017). Delayed Diagnosis of a 17-Hydroxylase/17,20-Lyase Deficient Patient Presenting as a 46,XY Female: A Low Normal Potassium Level Can Be an Alerting Diagnostic Sign. Journal of Clinical Research in Pediatric Endocrinology, 9(2), 163–167. [DOI:10.4274/jcrpe.3839]
    • Capraro, V. J., & Dewhurst, C. J. (1975). Breast Disorders in Childhood and Adolescence. Clinical Obstetrics and Gynecology, 18(2), 25–50. [DOI:10.1097/00003081-197506000-00003]
    • Carlson, L. J., & Shaw, N. D. (2019). Development of Ovulatory Menstrual Cycles in Adolescent Girls. Journal of Pediatric and Adolescent Gynecology, 32(3), 249–253. [DOI:10.1016/j.jpag.2019.02.119]
    • Caro, T. M. (1987). Human breasts: Unsupported hypotheses reviewed. Human Evolution, 2(3), 271–282. [DOI:10.1007/bf03016112]
    • Ceriani, R. L. (1974). Hormones and Other Factors Controlling Growth in the Mammary Gland: A Review. Journal of Investigative Dermatology, 63(1), 93–108. [DOI:10.1111/1523-1747.ep12678104]
    • Cernea, R. (1944). Lokale Hormonbehandlung bei Mammaatrophie und Unterentwicklung. [Local Hormone Treatment in Mammary Atrophy and Underdevelopment.] Medizinische Klinik, 40(11/12), 169–170. [Google Scholar] [PDF] [Translation]
    • Chang, K., Lee, T. T., Linares-Cruz, G., Fournier, S., & de Ligniéres, B. (1995). Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo. Fertility and Sterility, 63(4), 785–791. [DOI:10.1016/s0015-0282(16)57482-2]
    • Cheikhelard, A., Morel, Y., Thibaud, E., Lortat-Jacob, S., Jaubert, F., Polak, M., & Nihoul-Fekete, C. (2008). Long-Term Followup and Comparison Between Genotype and Phenotype in 29 Cases of Complete Androgen Insensitivity Syndrome. Journal of Urology, 180(4), 1496–1501. [DOI:10.1016/j.juro.2008.06.045]
    • Ciarloni, L., Mallepell, S., & Brisken, C. (2007). Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development. Proceedings of the National Academy of Sciences, 104(13), 5455–5460. [DOI:10.1073/pnas.0611647104]
    • Clendenen, T. V., Kim, S., Moy, L., Wan, L., Rusinek, H., Stanczyk, F. Z., Pike, M. C., & Zeleniuch-Jacquotte, A. (2013). Magnetic Resonance Imaging (MRI) of hormone-induced breast changes in young premenopausal women. Magnetic Resonance Imaging, 31(1), 1–9. [DOI:10.1016/j.mri.2012.06.022]
    • Cline, J. M., & Wood, C. E. (2006). Hormonal Effects on the Mammary Gland of Postmenopausal Nonhuman Primates. Breast Disease, 24(1), 59–70. [DOI:10.3233/bd-2006-24105]
    • Cline, J. M., & Wood, C. E. (2008). The Mammary Glands of Macaques. Toxicologic Pathology, 36(7 Suppl), 130S–141S. [DOI:10.1177/0192623308327411]
    • Cole, R. D., & Hopkins, T. R. (1962). A Biochemical Test of Artificial Mammogenesis and Lactogenesis As Models of the Natural Processes. Endocrinology, 70(3), 375–380. [DOI:10.1210/endo-70-3-375]
    • Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., Lev, A. I., Mayer, G., Meyer-Bahlburg, H., Hall, B. P., Pfaefflin, F., Rachlin, K., Robinson, B., Schechter, L. S., Tangpricha, V., van Trotsenburg, M., Vitale, A., Winter, S., Whittle, S., Wylie, K. R., & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism, 13(4), 165–232. [DOI:10.1080/15532739.2011.700873] [URL] [PDF]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Coltman, C. E., Steele, J. R., & McGhee, D. E. (2017). Breast volume is affected by body mass index but not age. Ergonomics, 60(11), 1576–1585. [DOI:10.1080/00140139.2017.1330968]
    • Colvin, C., Devineni, G., & Ashraf, A. P. (2014). Delayed Puberty. In Bandeira, F., Gharib, H., Golbert, A., Griz, L., & Faria, M. (Eds.). Endocrinology and Diabetes (pp. 203–217). New York: Springer. [DOI:10.1007/978-1-4614-8684-8_17]
    • Cowie, A. T., & Folley, S. J. (1961). The Mammary Gland and Lactation. In Young, W. C. (Ed.). Sex and Internal Secretions, 3rd Edition, Volume I (pp. 590–642). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Cowie, A. T., Forsyth, I. A., & Hart, I. C. (1980). Growth and Development of the Mammary Gland. In Cowie, A. T., Forsyth, I. A., & Hart, I. C. Hormonal Control of Lactation (Monographs on Endocrinology, Volume 15) (pp. 58–145). Berlin/Heidelberg: Springer Berlin Heidelberg. [DOI:10.1007/978-3-642-81389-4_3]
    • Cox, D. B., Kent, J. C., Casey, T. M., Owens, R. A., & Hartmann, P. E. (1999). Breast Growth and the Urinary Excretion of Lactose During Human Pregnancy and Early Lactation: Endocrine Relationships. Experimental Physiology, 84(2), 421–434. [DOI:10.1111/j.1469-445x.1999.01807.x]
    • Cox, C. B., Kent, J. C., Owens, R., & Hartmann, P. E. (1994). Mammary morphological and functional changes during pregnancy in women. In Thompson, J. (Ed.). Proceedings of the Twenty-Sixth Annual Conference, Hilton Hotel, Brisbane, 26–28 September, 1994 [The Australian Society for Reproductive Biology Inc., Twenty Sixth Annual Conference, The Hilton Hotel, Brisbane, September 26 - 28 1994, Programme and Miniposters of Papers] (pp. 47–47). Australia: Australian Society for Reproductive Biology. [Google Scholar] [WorldCat] [URL] [PDF]
    • Coxon, J., & Seal, L. (2018). Hormone management of trans women. Trends in Urology & Men’s Health, 9(6), 10–14. [DOI:10.1002/tre.663]
    • Cregan, M. D., & Hartmann, P. E. (1999). Computerized Breast Measurement from Conception to Weaning: Clinical Implications. Journal of Human Lactation, 15(2), 89–96. [DOI:10.1177/089033449901500202]
    • Crowley, L. G., & Macdonald, I. (1965). Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal woman. Cancer, 18(4), 436–446. [DOI:10.1002/1097-0142(196504)18:4<436::aid-cncr2820180407>3.0.co;2-d]
    • Crowley, W. F., & Pitteloud, N. (2020). Approach to the patient with delayed puberty. UpToDate. [Google Scholar] [URL]
    • Cruz-Korchin, N., Korchin, L., González-Keelan, C., Climent, C., & Morales, I. (2002). Macromastia. Plastic and Reconstructive Surgery, 109(1), 64–68. [DOI:10.1097/00006534-200201000-00011]
    • Curtis, R. J. (2009 July 10). The Lowdown on Progesterone. London: The London Gender Clinic. [Google Scholar] [URL] [PDF]
    • Dallmann, A., Ince, I., Meyer, M., Willmann, S., Eissing, T., & Hempel, G. (2017). Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. Clinical Pharmacokinetics, 56(11), 1303–1330. [DOI:10.1007/s40262-017-0539-z]
    • Dancey, A., Khan, M., Dawson, J., & Peart, F. (2008). Gigantomastia – a classification and review of the literature. Journal of Plastic, Reconstructive & Aesthetic Surgery, 61(5), 493–502. [DOI:10.1016/j.bjps.2007.10.041]
    • Davajan, V., & Kletzky, O. A. (1979). Amenorrhea without Galactorrhea or Hirsutism. In Mishell, D. R., & Davajan, V. (Eds.). Reproductive Endocrinology, Infertility, and Contraception (pp. 219–248). Philadelphia: F. A. Davis Co. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Davis, M. E., Boynton, M. W., Ferguson, J. H., & Rothman, S. (1945). Studies on Pigmentation of Endocrine Origin. The Journal of Clinical Endocrinology & Metabolism, 5(3), 138–146. [DOI:10.1210/jcem-5-3-138]
    • de Blok, C. J., Dijkman, B. A., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K. M., & den Heijer, M. (2021). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de Lignières, B. (2002). Effects of progestogens on the postmenopausal breast. Climacteric, 5(3), 229–235. [DOI:10.1080/cmt.5.3.229.235]
    • de Lignières, B., & Mauvais-Jarvis, P. (1981). Hormonal Dependence of Benign Breast Disease, Gynecomastia and Breast Cancer. In Hollman, K. H., Brux, J., & Verley, J. M. (Eds.). New Frontiers in Mammary Pathology (pp. 287–308). Boston: Springer US. [DOI:10.1007/978-1-4757-0019-0_17]
    • de Vries, A. L., Steensma, T. D., Wagemaar, E. C. F., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2010). Puberty suppression followed by cross-sex hormones and gender reassignment surgery: A prospective follow-up of gender dysphoric adolescents into adulthood. In de Vries, A. L. (Ed.). Gender Dysphoria in Adolescents: Mental Health and Treatment Evaluation (pp. 91–106). (Doctoral thesis, Vrije Universiteit Amsterdam.) [Google Scholar] [URL] [PDF]
    • Deeb, A., Al Suwaidi, H., Attia, S., & Al Ameri, A. (2015). 17-hydroxylase/17,20-lyase deficiency due to a R96Q mutation causing hypertension and poor breast development. Endocrinology, Diabetes & Metabolism Case Reports, 2015(1), 15-0069. [DOI:10.1530/EDM-15-0069]
    • Deepinder, F., & Braunstein, G. D. (2012). Drug-induced gynecomastia: an evidence-based review. Expert Opinion on Drug Safety, 11(5), 779–795. [DOI:10.1517/14740338.2012.712109]
    • Dennerstein, L., Burrows, G. D., Hyman, G. J., & Sharpe, K. (1980). Some clinical effects of oestrogen-progestogen therapy in surgically castrated women. Maturitas, 2(1), 19–28. [DOI:10.1016/0378-5122(80)90056-0]
    • Dewhurst, C. J. (1967). The XY Female. BJOG, 74(3), 353–366. [DOI:10.1111/j.1471-0528.1967.tb03959.x]
    • Dewhurst, C. J. (1971). Sex Chromosome Abnormalities and the Gynaecologist. BJOG, 78(12), 1058–1076. [DOI:10.1111/j.1471-0528.1971.tb00227.x]
    • Dewhurst, C. J. (1971). The XY female. American Journal of Obstetrics and Gynecology, 109(5) [Transactions of the Eighty-First Annual Meeting of the American Association of Obstetricians and Gynecologists], 675–688. [DOI:10.1016/0002-9378(71)90753-8]
    • Dewhurst, C. J., & Spence, J. E. (1977). The XY female. British Journal of Hospital Medicine, 17(5), 498, 501–506. [Google Scholar] [PubMed] [PDF]
    • Dewhurst, J. (1982). Breast Hypoplasia. In Bruni, V., Gasparri, F., Dewhurst, J., & Rey-Stocker, I. (Eds.). Pediatric and Adolescent Gynaecology [Proceedings of the IVth International Symposium, Florence, October 5-7, 1978] (pp. 205–212). Rome, Italy: Serono Symposia. [Google Scholar] [Google Books] [WorldCat] [PDF]
    • Di Lorenzo, G., Autorino, R., Perdonà, S., & De Placido, S. (2005). Management of gynaecomastia in patients with prostate cancer: a systematic review. The Lancet Oncology, 6(12), 972–979. [DOI:10.1016/s1470-2045(05)70464-2]
    • Dickson, L. M., & Hewer, E. E. (1950). The structure of the breast. In Saner, F. D. (Ed.). The Breast: Structure, Function, Disease (pp. 1–52). Baltimore: William & Wilins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [PDF]
    • Dijkman, B. A., Blok, C. J., Dreijerink, K. M., & den Heijer, M. (2023). Progestin-related breast volume changes in a woman with complete androgen insensitivity syndrome (CAIS). Endocrinology, Diabetes & Metabolism Case Reports, 2023(2), 22-0346. [DOI:10.1530/edm-22-0346]
    • Dijkman, B. A., Helder, D., Boogers, L. S., Gieles, N. C., van Heesewijk, J. O., Slaa, S. t., Liberton, N. P., Wiepjes, C. M., de Blok, C. J., den Heijer, M., & Dreijerink, K. M. (2023). Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial. BMC Pharmacology and Toxicology, 24(1), 80. [DOI:10.1186/s40360-023-00724-4]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Donaldson, M., Kriström, B., Ankarberg-Lindgren, C., Verlinde, S., van Alfen-van der Velden, J., Gawlik, A., van Gelder, M., Sas, T., & (2019). Optimal Pubertal Induction in Girls with Turner Syndrome Using Either Oral or Transdermal Estradiol: A Proposed Modern Strategy. Hormone Research in Paediatrics, 91(3), 153–163. [DOI:10.1159/000500050]
    • Dorgan, J. F., Klifa, C., Deshmukh, S., Egleston, B. L., Shepherd, J. A., Kwiterovich, P. O., Van Horn, L., Snetselaar, L. G., Stevens, V. J., Robson, A. M., Lasser, N. L., & Hylton, N. M. (2013). Menstrual and reproductive characteristics and breast density in young women. Cancer Causes & Control, 24(11), 1973–1983. [DOI:10.1007/s10552-013-0273-2]
    • Döring, G. K. (1963). Über die relative Häufigkeit des anovulatorischen Cyclus im Leben der Frau. [On the relative frequency of the anovulatory cycle in women’s lives.] Archiv für Gynäkologie, 199(2), 115–123. [DOI:10.1007/bf00668062]
    • Drąsutis, J. (2017). Changes in breast morphological parameters, body size and shape, blood serum prolactin and lipids during pregnancy, multiple relationships of these indicators and morphological markers for health risk. (Doctoral dissertation, Vilniaus Universitetas.) [Google Scholar] [URL]
    • Drife, J. O. (1982). The effects of parity and the menstrual cycle on the normal mammary gland and their possible relationship to malignant change. (Doctoral dissertation, University of Edinburgh). [Google Scholar] [Google Books] [WorldCat] [URL] [PDF]
    • Drife, J. O. (1984). The pill and the breast. IPPF Medical Bulletin, 18(6), 1–2. [Google Scholar] [PubMed]
    • Drife, J. O. (1986). Breast Development in Puberty. Annals of the New York Academy of Sciences, 464(1) [Endocrinology of the Breast: Basic and Clinical Aspects], 58–65. [DOI:10.1111/j.1749-6632.1986.tb15993.x]
    • Drife, J. O. (1989). Breast modifications during the menstrual cycle. Supplement to International Journal of Gynecology and Obstetrics, 1, 19–24. / International Journal of Gynecology and Obstetrics, 1989(Suppl 1), 19–24. [Google Scholar] [PubMed] [Archive.org]
    • Drife, J. O. (1990). Premenopausal Hormone Therapy. In Drife, J. O., & Studd, J. W. W. (Eds.). HRT and Osteoporosis (pp. 351–362). London: Springer London. [DOI:10.1007/978-1-4471-1799-5_25]
    • Duncan, M. (2010). Sexual Selection and Human Breast Morphology. (Doctoral dissertation, Te Herenga Waka-Victoria University of Wellington.) [Google Scholar] [URL]
    • Edmonds, D. K. (1989). Normal Puberty. In Edmonds, D. K. Dewhurst’s Practical Paediatric and Adolescent Gynaecology, 2nd Edition (pp. 56–62). London: Butterworths. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [Archive.org]
    • Elling, S. V., & Powell, F. C. (1997). Physiological changes in the skin during pregnancy. Clinics in Dermatology, 15(1), 35–43. [DOI:10.1016/s0738-081x(96)00108-3]
    • Engman, M., Skoog, L., Soderqvist, G., & Gemzell-Danielsson, K. (2008). The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology. Human Reproduction, 23(9), 2072–2079. [DOI:10.1093/humrep/den228]
    • Federici, S., Goggi, G., Quinton, R., Giovanelli, L., Persani, L., Cangiano, B., & Bonomi, M. (2021). New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature. Endocrine Reviews, 43(5), 824–851. [DOI:10.1210/endrev/bnab043]
    • Fernández-Cancio, M., García-García, E., González-Cejudo, C., Martínez-Maestre, M., Mangas-Cruz, M., Guerra-Junior, G., Pandi de Mello, M., Arnhold, I. J., Nishi, M. Y., Bilharinho Mendonça, B., García-Arumí, E., Audí, L., Tizzano, E., & Carrascosa, A. (2017). Discordant Genotypic Sex and Phenotype Variations in Two Spanish Siblings with 17α-Hydroxylase/17,20-Lyase Deficiency Carrying the Most Prevalent Mutated CYP17A1 Alleles of Brazilian Patients. Sexual Development, 11(2), 70–77. [DOI:10.1159/000468160]
    • Fernandez-Valdivia, R., Mukherjee, A., Mulac-Jericevic, B., Conneely, O. M., DeMayo, F. J., Amato, P., & Lydon, J. P. (2005). Revealing Progesterone’s Role in Uterine and Mammary Gland Biology: Insights from the Mouse. Seminars in Reproductive Medicine, 23(1), 22–37. [DOI:10.1055/s-2005-864031]
    • Finkenzeller, D. A., & Loveless, M. B. (2007). Pediatric Gynecology. In Fortner, K. B., Szymanski, L. M., Fox, H. E., & Wallach, E. E. (Eds.). The Johns Hopkins Manual of Gynecology and Obstetrics, 3rd Edition (Spiral Manual Series) (pp. 363–379). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Fisher, A. D., Castellini, G., Ristori, J., Casale, H., Cassioli, E., Sensi, C., Fanni, E., Amato, A. M., Bettini, E., Mosconi, M., Dèttore, D., Ricca, V., & Maggi, M. (2016). Cross-Sex Hormone Treatment and Psychobiological Changes in Transsexual Persons: Two-Year Follow-Up Data. The Journal of Clinical Endocrinology & Metabolism, 101(11), 4260–4269. [DOI:10.1210/jc.2016-1276]
    • Foidart, J. M., Colin, C., Denoo, X., Desreux, J., Fournier, S., & de Linières, B. (1996). Influence of percutaneous administration of estradiol and progesterone on the proliferation of human breast epithelial cells. In Calvo, F., Crépin, M., & Magdelenat, H. (Eds.). Breast Cancer: Advances in Biology and Therapeutics [21st Meeting of the International Association for Breast Cancer Research, July 3-4-5, 1996, Paris] (pp. 329–334). Montrouge/Paris: John Libbey Eurotext. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Foidart, J., Colin, C., Denoo, X., Desreux, J., Béliard, A., Fournier, S., & de Lignières, B. (1998). Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells. Fertility and Sterility, 69(5), 963–969. [DOI:10.1016/s0015-0282(98)00042-9]
    • Folley, S. J. (1940). Lactation. Biological Reviews, 15(4), 421–458. [DOI:10.1111/j.1469-185x.1940.tb00947.x]
    • Folley, S. J. (1947). Endocrine Control of the Mammary Gland. British Medical Bulletin, 5(2–3), 130–134. [DOI:10.1093/oxfordjournals.bmb.a073121]
    • Folley, S. J. (1950). Lactational Physiology. In Bowes, K. (Ed.). Modern Trends in Obstetrics and Gynaecology (pp. 441–453). London: Butterworth. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Folley, S. J. (1952). Lactation. In Parkes, A. S. (Ed.). Marshall’s Physiology of Reproduction, 3rd Edition, Volume II (pp. 525–647). Longmans, Green & Co.: London. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Folley, S. J. (1956). Recent Studies on the Development of the Mammary Gland. In Folley, S. J. The Physiology and Biochemistry of Lactation, 1st Edition (pp. 1–22). Edinburgh: Oliver & Boyd. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Folley, S. J., & Malpress, F. H. (1948). Hormonal Control of Mammary Growth. In Pincus, G., & Thimann, K. V. (Eds.). The Hormones: Physiology, Chemistry and Applications, Volume I (pp. 695–743). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Fourcade, R., & McLeod, D. (2004). Tolerability of Antiandrogens in the Treatment of Prostate Cancer. UroOncology, 4(1), 5–13. [DOI:10.1080/1561095042000191655]
    • Fowler, P. A., Casey, C. E., Cameron, G. G., Foster, M. A., & Knight, C. H. (1990). Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. BJOG, 97(7), 595–602. [DOI:10.1111/j.1471-0528.1990.tb02546.x]
    • Fridriksdottir, A. J., Petersen, O. W., & Rnnov-Jessen, L. (2011). Mammary gland stem cells: current status and future challenges. The International Journal of Developmental Biology, 55(7–8–9), 719–729. [DOI:10.1387/ijdb.113373af]
    • Fuqua, J. S., & Eugster, E. A. (2022). History of Puberty: Normal and Precocious. Hormone Research in Paediatrics, 95(6), 568–578. [DOI:10.1159/000526464]
    • Gaede, P., Trolle, D., & Pedersen, H. (1978). Extremely low placental lactogen hormone (hpl) values in an otherwise uneventful pregnancy preceding delivery of a normal baby. Acta Obstetricia et Gynecologica Scandinavica, 57(3), 203–209. [DOI:10.3109/00016347809154883]
    • Galani, A., Kitsiou-Tzeli, S., Sofokleous, C., Kanavakis, E., & Kalpini-Mavrou, A. (2008). Androgen insensitivity syndrome: clinical features and molecular defects. Hormones, 7(3), 217–229. [DOI:10.14310/horm.2002.1201]
    • Galbarczyk, A. (2011). Unexpected changes in maternal breast size during pregnancy in relation to infant sex: An evolutionary interpretation. American Journal of Human Biology, 23(4), 560–562. [DOI:10.1002/ajhb.21177]
    • Gawlik, A., Hankus, M., Such, K., Drosdzol-Cop, A., Madej, P., Borkowska, M., Zachurzok, A., & Malecka-Tendera, E. (2016). Hypogonadism and Sex Steroid Replacement Therapy in Girls with Turner Syndrome. Journal of Pediatric and Adolescent Gynecology, 29(6), 542–550. [DOI:10.1016/j.jpag.2016.03.005]
    • Gershon-Cohen, J. (1970). The Normal Breast. In Gershon-Cohen, J. Atlas of Mammography (pp. 23–38). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-85678-5_4] [Google Books]
    • Gertig, D. M., Stillman, I. E., Byrne, C., Spiegelman, D., Schnitt, S. J., Connolly, J. L., Colditz, G. A., & Hunter, D. J. (1999). Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiology, Biomarkers & Prevention, 8(10), 873–879. [Google Scholar] [PubMed] [URL]
    • Geschickter, C. F. (1945). Endocrine Physiology of the Breast. In Geschickter, C. F. Diseases of the Breast: Diagnosis, Pathology, Treatment, 2nd Edition (pp. 42–81). Philadelphia: J.B. Lippincott. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Glenn, J. F. (1976). Testicular feminization syndrome current clinical considerations. Urology, 7(6), 569–577. [DOI:10.1016/0090-4295(76)90079-0]
    • Gliosci, A., & Presutti, F. (1993). Virginal gigantomastia: Validity of combined surgical and hormonal treatments. Aesthetic Plastic Surgery, 17(1), 61–65. [DOI:10.1007/bf00455051]
    • Gompel, A., & Plu-Bureau, G. (2018). Progesterone, progestins and the breast in menopause treatment. Climacteric, 21(4), 326–332. [DOI:10.1080/13697137.2018.1476483]
    • Goodman, H. M. (2009). Hormonal Control of Pregnancy and Lactation. In Goodman, H. M. Basic Medical Endocrinology, 4th Edition (pp. 277–301). Amsterdam: Academic Press/Elsevier. [DOI:10.1016/b978-0-12-373975-9.00014-8]
    • Gooren, L. J. (2016). Hormone Treatment of Adult Transgender People. In Ettner, R., Monstrey, S., & Coleman, E. (Eds.). Principles of Transgender Medicine and Surgery, 2nd Edition (pp. 167–179). New York: Routledge. [Google Scholar] [Google Books] [DOI:10.4324/9781315718972-11]
    • Gordon, C. M., & Laufer, M. R. (2005) The Physiology of Puberty. In Emans, S. J., Laufer, M. R., & Goldstein, D. P. (Eds.). Pediatric and Adolescent Gynecology, 5th Edition (pp. 120–155). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Göretzlehner, G. & Lauritzen, C. (1992). Hormontherapie bei Gynäkologischen Erkrankungen [Hormone Therapy for Gynecological Diseases]. In Göretzlehner, G. & Lauritzen, C. Praktische Hormontherapie in der Gynäkologie, 1. Auflage [Practical Hormone Therapy in Gynecology, 1st Edition] (pp. 245–299). Berlin/New York: de Gruyter. [DOI:10.1515/9783112417706-007] [Google Books] [PDF] [Translation]
    • Graham, J. D., & Clarke, C. L. (1997). Physiological Action of Progesterone in Target Tissues. Endocrine Reviews, 18(4), 502–519. [DOI:10.1210/edrv.18.4.0308]
    • Graham, S. J., Stanchev, P. L., Lloyd‐Smith, J. O., Bronskill, M. J., & Plewes, D. B. (1995). Changes in Fibroglandular Volume and Water Content of Breast Tissue During the Menstrual Cycle Observed by MR Imaging at 1.5 T. Journal of Magnetic Resonance Imaging, 5(6), 695–701. [DOI:10.1002/jmri.1880050613]
    • Greydanus, D. E., Omar, H. A., Matytsina, L. A., & Tsitsika, A. (2010). Breast Disorders in Children and Adolescents. In Omar, H. A., Greydanus, D. E., Tsitsika, A. K., Patel, D. R., & Merrick, J. (Eds.). Pediatric and Adolescent Sexuality and Gynecology: Principles for the Primary Care Clinician (pp. 245–316). Hauppauge: Nova Science Publishers. [Google Scholar] [Google Books] [URL] [OpenLibrary] [WorldCat] [PDF]
    • Guaragna-Filho, G., Guerra-Junior, G., Tadokoro-Cuccaro, R., Hughes, I. A., Barros, B. A., Hiort, O., Balsamo, A., Guran, T., Holterhus, P. M., Hannema, S., Poyrazoglu, S., Darendeliler, F., Bryce, J., Ahmed, S. F., & Quigley, C. A. (2023). Pubertal and Gonadal Outcomes in 46,XY Individuals with Partial Androgen Insensitivity Syndrome Raised as Girls. Sexual Development, 17(1), 16–25. [DOI:10.1159/000526997]
    • Gunn, H. M., Tsai, M., McRae, A., & Steinbeck, K. S. (2018). Menstrual Patterns in the First Gynecological Year: A Systematic Review. Journal of Pediatric and Adolescent Gynecology, 31(6), 557–565.e6. [DOI:10.1016/j.jpag.2018.07.009]
    • Günzel, P., Hasan, S. H., Düsterberg, B., Hümpel, M., Putz, B., & Lehmann, M. (1987). Zur toxikologischen Prüfung von Steroidhormonen. [For the Toxicological Testing of Steroid Hormones.] In Burger, O. K., Grosdanoff, P., Henschler, D., Kraupp, O., & Schnieders, B. (Eds.). Aktuelle Probleme der Biomedizin (pp. 93–112). Berlin/New York: De Gruyter. [Google Scholar] [Google Books] [DOI:10.1515/9783110898231-014]
    • Hagisawa, S., Shimura, N., & Arisaka, O. (2012). Effect of Excess Estrogen on Breast and External Genitalia Development in Growth Hormone Deficiency. Journal of Pediatric and Adolescent Gynecology, 25(3), e61–e63. [DOI:10.1016/j.jpag.2011.11.005]
    • Hamburger, C., & Benjamin, H. (1969). Endocrine Treatment of Male and Female Transsexualism / Appendix for the Practicing Physician: Suggestions and Guidelines for the Management of Transsexuals. In Green, R., & Money, J. (Eds.). Transsexualism and Sex Reassignment (pp. 291–307). Baltimore: John Hopkins University Press. [Google Scholar] [Google Books] [PDF]
    • Hannan, F. M., Elajnaf, T., Vandenberg, L. N., Kennedy, S. H., & Thakker, R. V. (2022). Hormonal regulation of mammary gland development and lactation. Nature Reviews Endocrinology, 19(1), 46–61. [DOI:10.1038/s41574-022-00742-y]
    • Hannema, S. E., Schagen, S. E., Cohen-Kettenis, P. T., & Delemarre-van de Waal, H. A. (2017). Efficacy and Safety of Pubertal Induction Using 17β-Estradiol in Transgirls. The Journal of Clinical Endocrinology & Metabolism, 102(7), 2356–2363. [DOI:10.1210/jc.2017-00373]
    • Harley, J. M. G. (1969). The endocrine control of the breasts. The Practitioner, 203(1214), 153–157. [Google Scholar] [Google Books] [PubMed] [DOI:10.5555/19700402477] [HathiTrust]
    • Hartmann, B. W., Laml, T., Albrecht, A. E., Huber, J. C., & Kirchengast, S. (1998). Hormonal Breast Augmentation: Prognostic Relevance of Insulin-Like Growth Factor-I. Gynecological Endocrinology, 12(2), 123–127. [DOI:10.3109/09513599809024960]
    • Hartmann, P. E., Owens, R. A., Cox, D. B., & Kent, J. C. (1996). Breast Development and Control of Milk Synthesis. Food and Nutrition Bulletin, 17(4), 1–12. [DOI:10.1177/156482659601700404]
    • Hasan, S. (1974). Steroid Hormone Levels During Pregnancy in Various Species. In Bernhard, S., & Raspé, G. (Ed.). Hormones and Embryonic Development (Advances in the Biosciences, Volume 13) (pp. 181–197). Oxford/New York: Pergamon Press. [Google Scholar] [Google Books] [DOI:10.1016/b978-0-08-018239-1.50014-3] [OpenLibrary] [Archive.org]
    • Hassiotou, F., & Geddes, D. (2012). Anatomy of the human mammary gland: Current status of knowledge. Clinical Anatomy, 26(1), 29–48. [DOI:10.1002/ca.22165]
    • Heath, R. A., & Wynne, K. (2019). Children and Adolescents. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 87–106). Santa Barbara: Praeger/ABC-CLIO. [Google Books]
    • Heath, R. A., & Wynne, K. (2019). Hormone and Surgical Therapies for Adults. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 107–146). Santa Barbara: Praeger/ABC-CLIO. [Google Books]
    • Hertz, R., Odell, W. D., & Ross, G. T. (1966). Diagnostic Implications of Primary Amenorrhea: Combined Clinical Staff Conference at the National Institutes of Health. Annals of Internal Medicine, 65(4), 800–820. [DOI:10.7326/0003-4819-65-4-800]
    • Hillard, P. J. A. (2007). Benign Diseases of the Female Reproductive Tract. In Berek, J. S., & Novak, E. (Eds.). Berek & Novak’s Gynecology, 14th Edition (pp. 431–496). Philadelphia: Lippincott Williams and Wilkins. [Google Scholar] [OpenLibrary] [WorldCat] [Archive.org]
    • Hoppe, I. C., Patel, P. P., Singer-Granick, C. J., & Granick, M. S. (2011). Virginal Mammary Hypertrophy: A Meta-Analysis and Treatment Algorithm. Plastic and Reconstructive Surgery, 127(6), 2224–2231. [DOI:10.1097/prs.0b013e3182131bd1]
    • Hovey, R. C., Trott, J. F., Ginsburg, E., Goldhar, A., Sasaki, M. M., Fountain, S. J., Sundararajan, K., & Vonderhaar, B. K. (2001). Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Developmental Dynamics, 222(2), 192–205. [DOI:10.1002/dvdy.1179]
    • Howard, B. A., & Gusterson, B. A. (2000). Human Breast Development. Journal of Mammary Gland Biology and Neoplasia, 5(2), 119–137. [DOI:10.1023/a:1026487120779]
    • Huffman, J., Dewhurst, C. J., & Capraro, V. J. (1981). The Breast and its Disorders in Childhood and Adolescence. In Huffman, J., Dewhurst, J., & Capraro, V. The Gynecology of Childhood and Adolescence, 2nd Edition (pp. 542–559). Philadelphia: Saunders. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Hussain, Z., Brooks, J., & Percy, D. (2008). Menstrual variation of breast volume and T2 relaxation times in cyclical mastalgia. Radiography, 14(1), 8–16. [DOI:10.1016/j.radi.2006.07.003]
    • Hussain, Z., Roberts, N., Whitehouse, G. H., García-Fiñana, M., & Percy, D. (1999). Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. The British Journal of Radiology, 72(855), 236–245. [DOI:10.1259/bjr.72.855.10396212]
    • Hutson, S. W., Cowen, P. N., & Bird, C. C. (1985). Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. Journal of Clinical Pathology, 38(3), 281–287. [DOI:10.1136/jcp.38.3.281]
    • Hytten, F. E. (1954). Clinical and Chemical Studies in Human Lactation–VI. BMJ, 1(4867), 912–915. [DOI:10.1136/bmj.1.4867.912]
    • Hytten, F. E. (1954). Observations on Human Lactation. (Doctor’s thesis, University of Aberdeen.) [Google Scholar] [Google Books] [URL] [WorldCat]
    • Hytten, F. E. (1976). The physiology of lactation. International Journal of Food Sciences and Nutrition, 30(4), 225–232. [DOI:10.3109/09637487609142745]
    • Hytten, F. E., & Baird, D. (1958). The Development of the Nipple in Pregnancy. The Lancet, 271(7032), 1201–1204. [DOI:10.1016/s0140-6736(58)91908-1]
    • Hytten, F. E., & Leitch, I. (1971). Preparations for Breast Feeding. In Hytten, F. E., & Leitch, I. The Physiology of Human Pregnancy, 2nd Edition (pp. 234–241). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Hytten, F. E., & Leitch, I. (1971). Preparations for Breast Feeding. In Hytten, F. E., & Leitch, I. The Physiology of Human Pregnancy, 2nd Edition (pp. 234–241). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Hytten, F. E., & Thomson, A. M. (1965). Pregnancy, childbirth and lactation. In Edholm, O. G., & Bacharach, A. L. (Eds.). The Physiology of Human Survival (pp. 327–350). London/New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Hytten, F. E., & Thomson, A. M. (1968). Maternal physiological adjustments. In Assali, N. S. (Ed.). The Maternal Organism, Volume I (Biology of Gestation) (pp. 449–479). New York: Academic Press. [Google Scholar] [Google Books] [WorldCat]
    • Igo, J., & Visram, H. (2021). Progesterone Therapy Use and Safety in Male to Female Transgender Patients. Canadian Journal of Diabetes, 45(7 Suppl), S39–S39 (abstract no. 109). [DOI:10.1016/j.jcjd.2021.09.119]
    • Ingleby, H. (1949). Changes in breast volume in a group of normal young women. Bulletin of the International Association of Medical Museums, 29, 87–92. [Google Scholar] [Google Books] [HathiTrust]
    • Ingleby, H., Moore, L., & Gershon-Cohen, J. (1957). Gestational breast changes: x-ray studies of the human breast. Obstetrics & Gynecology, 10(2), 149–157. [Google Scholar] [PubMed] [URL]
    • Ismail, P. M., Amato, P., Soyal, S. M., DeMayo, F. J., Conneely, O. M., O’Malley, B. W., & Lydon, J. P. (2003). Progesterone involvement in breast development and tumorigenesis—as revealed by progesterone receptor “knockout” and “knockin” mouse models. Steroids, 68(10–13), 779–787. [DOI:10.1016/s0039-128x(03)00133-8]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Jacobsohn, D. (1961). Hormonal Regulation of Mammary Gland Growth. In Kon, S. K., & Cowie, A. T. (Eds.). Milk: The Mammary Gland and Its Secretion, Volume 1 (pp. 127–160). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Jamal, N., Ng, K., McLean, D., Looi, L., & Moosa, F. (2004). Mammographic Breast Glandularity in Malaysian Women: Data Derived from Radiography. American Journal of Roentgenology, 182(3), 713–717. [DOI:10.2214/ajr.182.3.1820713]
    • Jemstrom, H., & Olsson, H. (1997). Breast Size in Relation to Endogenous Hormone Levels, Body Constitution, and Oral Contraceptive Use in Healthy Nulligravid Women Aged 19-25 Years. American Journal of Epidemiology, 145(7), 571–580. [DOI:10.1093/oxfordjournals.aje.a009153]
    • Jernström, H., Sandberg, T., Bågeman, E., Borg, Å., & Olsson, H. (2005). Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. British Journal of Cancer, 92(5), 857–866. [DOI:10.1038/sj.bjc.6602389]
    • Jeruss, J. S. (2006). Molecular Basis of Breast Cancer. In Winchester, D. J., Winchester, D. P., Hudis, C. A., & Norton, L. (Eds.). Breast Cancer, 2nd Edition (pp. 83–95). Hamilton: B.C. Decker. [Google Scholar] [Google Books] [WorldCat]
    • Johnson, M. C., & Cutler, M. L. (2016). Anatomy and Physiology of the Breast. In Jatoi, I., & Rody, A. (Eds.). Management of Breast Diseases (pp. 1–39). Cham: Springer. [DOI:10.1007/978-3-319-46356-8_1]
    • Kaiser, R. (1993). Gestagen-Östrogen-Kombinationen in der Gynäkologie. Zur Geschichte, Dosierung und Anwendung eines Hormonprinzips. [Gestagen-Oestrogen Combinations in Gynaecology. History, Dosage and Use of a Hormonal Principle.] Geburtshilfe und Frauenheilkunde, 53(7), 503–513. [Google Scholar] [PubMed] [DOI:10.1055/s-2007-1022924]
    • Kaiser, R., & Leidenberger, F. (1991). Hormonbehandlung bei Benign Mammaerkrankungen: Mammahypoplasie. [Hormonal Treatment in Benign Breast Diseases: Breast Hypoplasia.] In Kaiser, R., & Leidenberger, F. Hormonbehandlung in der Gynäkologischen Praxis, 7. Auflage [Hormone Treatment in Gynecological Practice, 7th Edition] (pp. 138–138). Stuttgart: Georg Thieme Verlag. [Google Books] [OpenLibrary] [WorldCat] [PDF] [Translation]
    • Kaiser, U., & Ho, K. K. (2015). Pituitary Physiology and Diagnostic Evaluation. In Melmed, S., Polonsky, K. S., Larsen, P. R., Kronenberg, & H. M. (Eds.). Williams Textbook of Endocrinology, 13th Edition (pp. 176–231). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-29738-7.00008-3] [Google Books]
    • Kanhai, R. C., Hage, J. J., Asscheman, H., Mulder, W. J., & Hage, J. J. (1999). Augmentation Mammaplasty in Male-to-Female Transsexuals. Plastic and Reconstructive Surgery, 104(2), 542–549. [DOI:10.1097/00006534-199908000-00040]
    • Kanhai, R. C., Hage, J. J., van Diest, P. J., Bloemena, E., & Mulder, J. W. (2000). Short-Term and Long-Term Histologic Effects of Castration and Estrogen Treatment on Breast Tissue of 14 Male-to-Female Transsexuals in Comparison With Two Chemically Castrated Men. The American Journal of Surgical Pathology, 24(1), 74–80. [DOI:10.1097/00000478-200001000-00009]
    • Kardelen, A. D., Toksoy, G., Baş, F., Yavaş Abalı, Z., Gençay, G., Poyrazoğlu, Ş., Bundak, R., Altunoğlu, U., Avcı, Ş., Najaflı, A., Uyguner, O., Karaman, B., Başaran, S., & Darendeliler, F. (2018). A Rare Cause of Congenital Adrenal Hyperplasia: Clinical and Genetic Findings and Follow-up Characteristics of Six Patients with 17-Hydroxylase Deficiency Including Two Novel Mutations. Journal of Clinical Research in Pediatric Endocrinology, 10(3), 206–215. [DOI:10.4274/jcrpe.0032]
    • Kariagina, A., Xie, J., Leipprandt, J. R., & Haslam, S. Z. (2010). Amphiregulin Mediates Estrogen, Progesterone, and EGFR Signaling in the Normal Rat Mammary Gland and in Hormone-Dependent Rat Mammary Cancers. Hormones and Cancer, 1(5), 229–244. [DOI:10.1007/s12672-010-0048-0]
    • Karp, N. S. (2022). Discussion: The Impact of Combined Oral Contraceptives on Adolescents with Macromastia. Plastic & Reconstructive Surgery, 150(4), 739–740. [DOI:10.1097/prs.0000000000009514]
    • Kasielska-Trojan, A., Mikołajczyk, M., & Antoszewski, B. (2020). BreastIdea Volume Estimator: A New Tool for Breast Volume Estimation—Presentation and Validation for Women. Plastic & Reconstructive Surgery, 146(6), 744e–748e. [DOI:10.1097/prs.0000000000007373]
    • Kasielska-Trojan, A., Zawadzki, T., & Antoszewski, B. (2022). Breast Fluctuating Asymmetry in Women with Macromastia/Gigantomastia. International Journal of Environmental Research and Public Health, 19(24), 16895. [DOI:10.3390/ijerph192416895]
    • Kauli, R., Pertzelan, A., Ben‐Zeev, Z., Lewin, R. P., Kaufman, H., Schally, A. C., Schally, A. V., & Laron, Z. (1984). Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate—further experience. Clinical Endocrinology, 20(4), 377–387. [DOI:10.1111/j.1365-2265.1984.tb03433.x]
    • Keller, P. J. (1984). Diagnostik und Therapie wichtiger hormonaler Störungen: Mammahypoplasie. [Diagnosis and Treatment of Important Hormonal Disorders: Mammary Hypoplasia.] In Keller, P. J. Hormonale Störungen in der Gynäkologie: Diagnostik und Behandlung, 3. Auflage [Hormonal Disorders in Gynecology: Diagnosis and Treatment, 3rd Edition] (Kliniktaschenbücher) (pp. 133–134). Berlin/Heidelberg: Springer. [Google Books] [DOI:10.1007/978-3-662-00442-5_3]
    • Keller, P. J. (1995). Diagnostik und Therapie wichtiger Störungen: Mammahypoplasie. [Diagnosis and Treatment of Important Disorders: Mammary Hypoplasia.] In Keller, P. J. Hormon- und Fertilitätsstörungen in der Gynäkologie, 4. Auflage [Hormonal and Fertility Disorders in Gynecology, 4th Edition] (pp. 145–146). Berlin/Heidelberg: Springer. [Google Books] [DOI:10.1007/978-3-662-12026-2_3]
    • Kennedy, B. J. (1953). Effects of intensive sex steroid hormone therapy in advanced breast cancer. JAMA, 152(12), 1135–1141. [DOI:10.1001/jama.1953.63690120004013]
    • Kent, J. C., Mitoulas, L., Cox, D. B., Owens, R. A., & Hartmann, P. E. (1999). Breast Volume and Milk Production During Extended Lactation in Women. Experimental Physiology, 84(2), 435–447. [DOI:10.1111/j.1469-445x.1999.01808.x]
    • Khoo, S. K., & Mackay, E. V. (1972). Testicular Feminization: The Clinical Features, Endocrine Function and Gonadal Pathology in Six Patients. Australian and New Zealand Journal of Obstetrics and Gynaecology, 12(1), 1–13. [DOI:10.1111/j.1479-828x.1972.tb00721.x]
    • Klein, R., Aichinger, H., Dierker, J., Jansen, J. T., Joite-Barfuß, S., Säbel, M., Schulz-Wendtland, R., & Zoetelief, J. (1997). Determination of average glandular dose with modern mammography units for two large groups of patients. Physics in Medicine and Biology, 42(4), 651–671. [DOI:10.1088/0031-9155/42/4/004]
    • Kleinberg, D. L. (2006). Endocrinology of lactation. In DeGroot, L. J., & Jameson, J. L. (Eds). Endocrinology, 5th Edition (pp. 3461–3473). Philadelphia: Elsevier Saunders. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Kleinberg, D. L., & Barcellos-Hoff, M. H. (2011). The Pivotal Role of Insulin-Like Growth Factor I in Normal Mammary Development. Endocrinology and Metabolism Clinics of North America, 40(3), 461–471. [DOI:10.1016/j.ecl.2011.06.001]
    • Kleinberg, D. L., & Ruan, W. (2008). IGF-I, GH, and Sex Steroid Effects in Normal Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia, 13(4), 353–360. [DOI:10.1007/s10911-008-9103-7]
    • Kleinberg, D. L., Wood, T. L., Furth, P. A., & Lee, A. V. (2008). Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions. Endocrine Reviews, 30(1), 51–74. [DOI:10.1210/er.2008-0022]
    • Kühnel, W. (2000). IMMULITE® and IMMULITE® 2000 Reference Range Compendium, First English Edition. Los Angeles, California: Diagnostic Products Corporation. [Google Scholar] [URL] [PDF 1] [PDF 2]
    • Kustin, J., & Rebar, R. W. (1987). Menstrual Disorders in the Adolescent Age Group. Primary Care: Clinics in Office Practice, 14(1), 139–166. [DOI:10.1016/s0095-4543(21)01004-6]
    • Kutten, F., Malet, C., & Leygue, E. (1994). Antiestrogen action of progestogens in human breast cells. In Berg, G., & Hammar, M. (Eds.). The Modern Management of the Menopause: A Perspective for the 21st Century [The Proceedings of the VII International Congress on the Menopause, Stockholm, Sweden 1993] (pp. 419–433). Canforth: Parthenon. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [PDF]
    • Ladjouze, A., & Donaldson, M. (2019). Primary gonadal failure. Best Practice & Research Clinical Endocrinology & Metabolism, 33(3), 101295. [DOI:10.1016/j.beem.2019.101295]
    • Laessle, R. G., Tuschi, R. J., Schweiger, U., & Pirke, K. M. (1990). Mood changes and physical complaints during the normal menstrual cycle in healthy young women. Psychoneuroendocrinology, 15(2), 131–138. [DOI:10.1016/0306-4530(90)90021-z]
    • LaMarca, H. L., & Rosen, J. M. (2007). Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Research, 9(4), 304. [DOI:10.1186/bcr1740]
    • Laron, Z., & Kauli, R. (2000). Experience with Cyproterone Acetate in the Treatment of Precocious Puberty. Journal of Pediatric Endocrinology and Metabolism, 13(Suppl 1), 805–810. [DOI:10.1515/jpem.2000.13.s1.805]
    • Lauritzen, C. (1980 October 27). Hormonkur Kann Hypoplastischer Mamma Aufhelfen. [Hormone Therapy Can Help Hypoplastic Breasts.] Selecta: Medizin aktuell; das Magazin für ärztliche Fortbildung [Selecta: Medicine Currently; the Magazine for Medical Training], 22(43), 3798–3801. Planegg: Selecta-Verlag. [ISSN:0582-4877] [WorldCat] [PDF] [Translation]
    • Lauritzen, C. (1982). Treatment of mammary- and uterus hypoplasia by estrogen-progestagen pseudopregnancy. In Richter, K., Huber, A., Terruhn, V. (Eds.) 1. Europäisches Symposium für Kinder- und Jugendgynäkologie. München 19.-21.3.1981, Band 2 [First European Symposium on Pediatric and Adolescent Gynaecology. München, March 19–21, 1981, Volume 2] (pp. 487–489). Friedrichsdorf/Taunus: Milupa-Aktiengesellschaft, Wissenschaftliche Abteilung. [Google Scholar] [PDF]
    • Lauritzen, C. (1989). Hormonelle Substitutionstherapie zur Brustvergrößerung. [Hormonal Substitution Therapy for Breast Enlargement.] In Beller, F. K. & Seitzer, D. (Eds.). 7. Siebte Wissenschaftliche Tagung der Deutschen Gesellschaft für Senologie, Münster, 25. - 27. September 1987: Ausgewählte Referate [7th Scientific Conference of the German Society for Senology, Münster, [Germany,] September 25–27, 1987: Selected Papers] (pp. 39–41). Mülheim, Germany: H.U.F. Verlag. [Google Scholar] [WorldCat 1] [WorldCat 2] [WorldCat 3] [Cited By 1] [Cited By 2] [Cited By 3] [PDF] [Translation]
    • Lawrence, R. A., & Lawrence, R. M. (2015). Physiology of Lactation. In Lawrence, R. A., & Lawrence, R. M. Breastfeeding: A Guide for the Medical Profession, 8th Edition (pp. 56–90). Philadelphia: Elsevier. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Lee, H. J., & Ormandy, C. J. (2012). Interplay between progesterone and prolactin in mammary development and implications for breast cancer. Molecular and Cellular Endocrinology, 357(1–2), 101–107. [DOI:10.1016/j.mce.2011.09.020]
    • Lee, P. A. (2001). Physiology of Puberty. In Becker, K. L., Bilezikian, J. P., Bremner, W. J., Hung, W., Kahn, C. R., Loriaux, D. L., Nylén, E. S., Rebar, R. W., Robertson, G. L., Snider, R. H., Wartofsky, L. (Eds.). Principles and Practice of Endocrinology and Metabolism, 3rd Edition (pp. 885–893). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Lee, S. W., Kwak, D. S., Jung, I. S., Kwak, J. H., Park, J. H., Hong, S. M., Lee, C. B., Park, Y. S., Kim, D. S., Choi, W. H., & Ahn, Y. H. (2015). Partial Androgen Insensitivity Syndrome Presenting with Gynecomastia. Endocrinology and Metabolism, 30(2), 226–230. [DOI:10.3803/enm.2015.30.2.226]
    • Lejour, M. (1994). Vertical Mammaplasty and Liposuction of the Breast. Plastic and Reconstructive Surgery, 94(1), 100–114. [DOI:10.1097/00006534-199407000-00010]
    • Lejour, M. (1997). Evaluation of Fat in Breast Tissue Removed by Vertical Mammaplasty. Plastic and Reconstructive Surgery, 99(2), 386–393. [DOI:10.1097/00006534-199702000-00012]
    • Lemarchand-Béraud, T., Zufferey, M., Reymond, M., & Rey, I. (1982). Maturation of the Hypothalamo-Pituitary-Ovarian Axis in Adolescent Girls. The Journal of Clinical Endocrinology & Metabolism, 54(2), 241–246. [DOI:10.1210/jcem-54-2-241]
    • Lewin, R. (2016). Breast Hypertrophy and Outcome of Breast Reduction Surgery. (Doctoral thesis, University of Gothenburg. Sahlgrenska Academy.) [Google Scholar] [URL]
    • Lim, L. Y., Ho, P. J., Liu, J., Chay, W. Y., Tan, M., Hartman, M., & Li, J. (2018). Determinants of breast size in Asian women. Scientific Reports, 8(1), 1201. [DOI:10.1038/s41598-018-19437-4]
    • Lloyd, C. W., & Leathem, J. H. (1964). Growth and development of the breast and lactation. In Lloyd, C. W. (Ed.). Human Reproduction and Sexual Behavior (pp. 117–134). Philadelphia: Lea & Febiger. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Lopez, X., Panton, J., Nagarkar, P., Preston, S., Abramowitz, J., & Amirlak, B. (2023). Initial Assessment of VECTRA Three-Dimensional Imaging to Accurately Simulate Breast Volume Changes in Transfeminine Patients: A Mannequin Study. Aesthetic Surgery Journal Open Forum, 5, online ahead of print. [DOI:10.1093/asjof/ojad015]
    • Lorincz, A. M., & Sukumar, S. (2006). Molecular links between obesity and breast cancer. Endocrine-Related Cancer, 13(2), 279–292. [DOI:10.1677/erc.1.00729]
    • Lucien, J. N., Ortega, M. T., Calvert, M. E., Smith, C., White, X., Rogers, H., Mosley, B., Agrawal, R., Drude, A., McGee, C., George, M., Brown, A., Downey, K., Wild, C., Njunge, A., Kuzmiak, C. M., Zava, D., Zava, T., Pollard, J., Francis, J., Beery, B. L., Harlin, M., Gonzalez, G. R., & Shaw, N. D. (2022). The Launch of A Girl’s First Period Study: Demystifying Reproductive Hormone Profiles in Adolescent Girls. Journal of Pediatric and Adolescent Gynecology, 35(4), 420–425. [DOI:10.1016/j.jpag.2021.12.018]
    • Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O’Malley, B. W. (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes & Development, 9(18), 2266–2278. [DOI:10.1101/gad.9.18.2266]
    • Lyon, A. J., De Bruyn, R., & Grant, D. B. (1985). Isosexual Precocious Puberty in Girls. Acta Paediatrica, 74(6), 950–955. [DOI:10.1111/j.1651-2227.1985.tb10063.x]
    • Lyons, W. R. (1958). Hormonal synergism in mammary growth. Proceedings of the Royal Society of London. Series B - Biological Sciences, 149(936), 303–325. [DOI:10.1098/rspb.1958.0071]
    • Lyons, W. R., & McGinty, D. A. (1941). Effects of estrone and progesterone on male rabbit mammary glands. I. Varying doses of progesterone. Proceedings of the Society for Experimental Biology and Medicine, 48(1), 83–86. [DOI:10.3181/00379727-48-13227]
    • Lyons, W. R., Li, C. H., & Johnson, R. E. (1958). The Hormonal Control of Mammary Growth and Lactation. In Pincus, G. (Ed.). Recent Progress in Hormone Research, Volume 14 [Proceedings of the Laurentian Hormone Conference 1957, Held at Mont Tremblant, Quebec] (pp. 219–254). New York/London: Academic Press. [Google Scholar] [Google Books] [PubMed] [OpenLibrary] [WorldCat] [PDF]
    • MacBryde, C. M. (1939). The Production of Breast Growth in the Human Female. Journal of the American Medical Association, 112(11), 1045–1049. [DOI:10.1001/jama.1939.02800110025006]
    • Malet, C., Gompel, A., Yaneva, H., Cren, H., Fidji, N., Mowszowicz, I., Kuttenn, F., & Mauvais-Jarvis, P. (1991). Estradiol and Progesterone Receptors in Cultured Normal Human Breast Epithelial Cells and Fibroblasts: Immunocytochemical Studies. The Journal of Clinical Endocrinology & Metabolism, 73(1), 8–17. [DOI:10.1210/jcem-73-1-8]
    • Malini, S., Smith, E. O., & Goldzieher, J. W. (1985). Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Obstetrics and Gynecology, 66(4), 538–541. [Google Scholar] [PubMed] [URL] [PDF]
    • Marshall, W. A. (1978). Puberty. In Falkner, F., & Tanner, J. M. (Eds.). Human Growth: Postnatal Growth (pp. 141–181). Boston: Springer US. [DOI:10.1007/978-1-4684-2622-9_6]
    • Marshall, W. A., & Tanner, J. M. (1969). Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood, 44(235), 291–303. [DOI:10.1136/adc.44.235.291]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1986). Antiestrogen action of progesterone in breast tissue. Breast Cancer Research and Treatment, 8(3), 179–188. [DOI:10.1007/bf01807330]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1986). Estradiol/Progesterone Interaction in Normal and Pathologic Breast Cells. Annals of the New York Academy of Sciences, 464(1), 152–167. [DOI:10.1111/j.1749-6632.1986.tb16002.x]
    • Mauvais-Jarvis, P., Kuttenn, F., & Gompel, A. (1987). Antiestrogen Action of Progesterone in Breast Tissue. Hormone Research, 28(2–4), 212–218. [DOI:10.1159/000180946]
    • Mauvais-Jarvis, P., Kuttenn, F., Gompel, A., & Benotmane, A. (1987). Action anti-estrogène de la progestérone dans le sein. [Antiestrogen action of progesterone in the breast]. Pathologie-Biologie, 35(7), 1081–1086. [Google Scholar 1] [Google Scholar 2] [PubMed]
    • Mauvais-Jarvis, P., Sitruk-Ware, R., & Kuttenn, F. (1981). Benign Breast Disease. In McGuire, W. L. (Ed.). Breast Cancer 4: Advances in Research and Treatment (pp. 51–94). Boston: Springer US. [DOI:10.1007/978-1-4615-6571-0_3]
    • McArthur, J. W. (1966). The Reproductive Endocrinology of Adolescence. In Heald, F. P. (Ed.). Adolescent Gynecology (pp. 9–20). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • McBryan, J., Howlin, J., Napoletano, S., & Martin, F. (2008). Amphiregulin: Role in Mammary Gland Development and Breast Cancer. Journal of Mammary Gland Biology and Neoplasia, 13(2), 159–169. [DOI:10.1007/s10911-008-9075-7]
    • McDonough, P. G., Spicer, D. V., Ursin, G., & Pike, M. C. (1996). Progesterone Concentrations—Physiologic or Pharmacologic? Fertility and Sterility, 65(5), 1077–1078. [DOI:10.1016/s0015-0282(16)58295-8]
    • McMillan, M. (1966). Five cases of testicular feminisation including one with a teratoma of the testis. The Journal of Pathology and Bacteriology, 91(2), 417–427. [DOI:10.1002/path.1700910216]
    • McNally, S., & Stein, T. (2016). Overview of Mammary Gland Development: A Comparison of Mouse and Human. In Martin, F., Stein, T., & Howlin, J. (Eds.). Mammary Gland Development (Methods in Molecular Biology, Volume 1501) (pp. 1–17). New York: Springer New York. [DOI:10.1007/978-1-4939-6475-8_1]
    • McPhaul, M. J. (2002). Androgen receptor mutations and androgen insensitivity. Molecular and Cellular Endocrinology, 198(1–2), 61–67. [DOI:10.1016/s0303-7207(02)00369-6]
    • Meites, J. (1966). Control of mammary growth and lactation. In Martini, L., & Ganong, W. F. (Eds.). Neuroendocrinology, Volume I (pp. 669–707). New York: Academic Press. [Google Scholar] [Google Books] [DOI:10.1016/B978-1-4832-3228-7.50023-2] [OpenLibrary] [WorldCat]
    • Mesiano, S. (2019). Endocrinology of Human Pregnancy and Fetal-Placental Neuroendocrine Development. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 256–284.e9). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/b978-0-323-47912-7.00011-1]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463]
    • Meyer, W. J., Finkelstein, J. W., Stuart, C. A., Webb, A., Smith, E. R., Payer, A. F., & Walker, P. A. (1981). Physical and hormonal evaluation of transsexual patients during hormonal therapy. Archives of Sexual Behavior, 10(4), 347–356. [DOI:10.1007/bf01565538]
    • Meyer, W. J., Webb, A., Stuart, C. A., Finkelstein, J. W., Lawrence, B., & Walker, P. A. (1986). Physical and hormonal evaluation of transsexual patients: A longitudinal study. Archives of Sexual Behavior, 15(2), 121–138. [DOI:10.1007/bf01542220]
    • Mikołajczyk, M., Kasielska-Trojan, A., & Antoszewski, B. (2019). A New Tool for Breast Anthropometric Measurements: Presentation and Validation for Women and Men. Aesthetic Plastic Surgery, 43(5), 1160–1170. [DOI:10.1007/s00266-019-01467-6]
    • Milionis, C., Ilias, I., & Koukkou, E. (2022). Progesterone in gender-affirming therapy of trans women. World Journal of Biological Chemistry, 13(3), 66–71. [DOI:10.4331/wjbc.v13.i3.66]
    • Milligan, D., Drife, J. O., & Short, R. V. (1975). Changes in breast volume during normal menstrual cycle and after oral contraceptives. BMJ, 4(5995), 494–496. [DOI:10.1136/bmj.4.5995.494]
    • Morris, J. M. (1953). The syndrome of testicular feminization in male pseudohermaphrodites. American Journal of Obstetrics and Gynecology, 65(6), 1192–1211. [DOI:10.1016/0002-9378(53)90359-7]
    • Morris, J. M., & Mahesh, V. B. (1963). Further observations on the syndrome, “testicular feminization”. American Journal of Obstetrics and Gynecology, 87(6), 731–748. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF]
    • Moss, W. M. (1968). Gigantomastia With Pregnancy. Archives of Surgery, 96(1), 27–32. [DOI:10.1001/archsurg.1968.01330190029007]
    • Muallem, M. M., & Rubeiz, N. G. (2006). Physiological and biological skin changes in pregnancy. Clinics in Dermatology, 24(2), 80–83. [DOI:10.1016/j.clindermatol.2005.10.002]
    • Müller, C. (1953). Zur Hormonalen Kosmetik der Weiblichen Brust: Wirkung und Nebenwirkung Östrogenhaltiger Kosmetischer Präparate. [Hormonal Cosmetics of the Female Breast: Effects and Side Effects of Estrogen-Containing Cosmetic Preparations.] Schweizerische Medizinische Wochenschrift [Swiss Medical Weekly], 83(4), 81–84. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
    • Muzaffar, F., Hussain, I., & Haroon, T. S. (1998). Physiologic skin changes during pregnancy: a study of 140 cases. International Journal of Dermatology, 37(6), 429–431. [DOI:10.1046/j.1365-4362.1998.00281.x]
    • Naik, M., Diwakar, R. K., Patre, S., & Singh, S. (2015). Gigantomastia: A Rare Complication In Pregnancy. Journal of Medical Science and Clinical Research, 3(7), 6873–6876. [Google Scholar] [URL] [PDF]
    • Naseem, H., Lokman, M., & Fitzgerald, C. (2021). Management of congenital hypogonadotropic hypogonadism in females. Human Fertility, 26(3), 622–631. [DOI:10.1080/14647273.2021.1998929]
    • Nelson, W. O. (1936). Endocrine Control of the Mammary Gland. Physiological Reviews, 16(3), 488–526. [DOI:10.1152/physrev.1936.16.3.488]
    • Nolan, B. J., Frydman, A. S., Leemaqz, S. Y., Carroll, M., Grossmann, M., Zajac, J. D., & Cheung, A. S. (2022). Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study. Endocrine Connections, 11(5), e220170. [DOI:10.1530/EC-22-0170]
    • Nolan, B. J., Frydman, A. S., Leemaqz, S. Y., Carroll, M., Grossmann, M., Zajac, J. D., & Cheung, A. S. (2022). Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study. Journal of the Endocrine Society, 6(Suppl 1), A653–A654 (abstract no. LBODP089). [DOI:10.1210/jendso/bvac150.1351]
    • Nussbaum, R., & Benedetto, A. V. (2006). Cosmetic aspects of pregnancy. Clinics in Dermatology, 24(2), 133–141. [DOI:10.1016/j.clindermatol.2005.10.007]
    • Nuzzi, L. C., Pramanick, T., Massey, G. G., Walsh, L. R., McNamara, C. T., Firriolo, J. M., DiVasta, A. D., & Labow, B. I. (2021). The Impact of Progestin-only Contraception on Adolescents with Macromastia. Plastic and Reconstructive Surgery - Global Open, 9(2), e3421. [DOI:10.1097/gox.0000000000003421]
    • Nuzzi, L. C., Pramanick, T., Massey, G. G., Walsh, L. R., McNamara, C. T., Firriolo, J. M., DiVasta, A. D., & Labow, B. I. (2022). The Impact of Combined Oral Contraceptives on Adolescents with Macromastia. Plastic and Reconstructive Surgery, 150(4), 731–738. [DOI:10.1097/prs.0000000000009513]
    • Oakes, M. B., Eyvazzadeh, A. D., Quint, E., & Smith, Y. R. (2008). Complete Androgen Insensitivity Syndrome—A Review. Journal of Pediatric and Adolescent Gynecology, 21(6), 305–310. [DOI:10.1016/j.jpag.2007.09.006]
    • Obr, A. E., & Edwards, D. P. (2012). The biology of progesterone receptor in the normal mammary gland and in breast cancer. Molecular and Cellular Endocrinology, 357(1–2), 4–17. [DOI:10.1016/j.mce.2011.10.030]
    • Olanrewaju, F., Onayemi, O., Olasode, O., Adeyemi, A., Oninla, A., Oripelaye, M., Ezejiofor, O., & Oke, O. (2017). Prevalence and Pattern of Pigmentary Changes among Primigravidae Attending a Tertiary Health Facility in South-Western Nigeria. British Journal of Medicine and Medical Research, 21(5), 1–9. [DOI:10.9734/bjmmr/2017/33382]
    • Orentreich, N., & Durr, N. P. (1974). Mammogenesis in Transsexuals. Journal of Investigative Dermatology, 63(1), 142–146. [DOI:10.1111/1523-1747.ep12678272]
    • Pandya, S., & Moore, R. G. (2011). Breast Development and Anatomy. Clinical Obstetrics & Gynecology, 54(1), 91–95. [DOI:10.1097/grf.0b013e318207ffe9]
    • Park, I. Y., Kim, M. R., Jo, H. H., Lee, M. K., & Kim, M. J. (2014). Association of the Nipple-Areola Complexes with Age, Parity, and Breastfeeding in Korean Premenopausal Women. Journal of Human Lactation, 30(4), 474–479. [DOI:10.1177/0890334414549049]
    • Pasqualini, J. R. (2007). Progestins and breast cancer. Gynecological Endocrinology, 23(Suppl 1), 32–41. [DOI:10.1080/09513590701585003]
    • Pasqualini, J. R. (2009). Breast cancer and steroid metabolizing enzymes: The role of progestogens. Maturitas, 65(Suppl 1), S17–S21. [DOI:10.1016/j.maturitas.2009.11.006]
    • Pasqualini, J. R., & Kincl, F. A. (1985). Hormone Production and Concentrations During Pregnancy in Humans and in Other Mammalian Species. In Pasqualini, J. R., & Kincl, F. A. Hormones and the Fetus, Volume I: Production, Concentration and Metabolism During Pregnancy (pp. 173–334). Oxford: Pergamon Press. [DOI:10.1016/b978-0-08-019708-1.50007-6]
    • Patel, H., Arruarana, V., Yao, L., Cui, X., & Ray, E. (2020). Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review. Endocrine, 68(1), 6–15. [DOI:10.1007/s12020-020-02197-5]
    • Patel, K. T., Adeel, S., Rodrigues Miragaya, J., & Tangpricha, V. (2022). Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocrine Practice, 28(12), 1244–1252. [DOI:10.1016/j.eprac.2022.08.012]
    • Patterson, M. N., McPhaul, M. J., & Hughes, I. A. (1994). Androgen insensitivity syndrome. Baillière’s Clinical Endocrinology and Metabolism, 8(2), 379–404. [DOI:10.1016/s0950-351x(05)80258-7]
    • Pawłowski, B., & Żelaźniewicz, A. (2021). The evolution of perennially enlarged breasts in women: a critical review and a novel hypothesis. Biological Reviews, 96(6), 2794–2809. [DOI:10.1111/brv.12778]
    • Perez-Palacios, G., & Jaffe, R. B. (1972). The Syndrome of Testicular Feminization. Pediatric Clinics of North America, 19(3), 653–667. [DOI:10.1016/s0031-3955(16)32744-4]
    • Petrakis, N. (1978). Recurrent extreme breast involution following pregnancy and susceptibility to breast cancer: A hypothesis. Medical Hypotheses, 4(3), 268–272. [DOI:10.1016/0306-9877(78)90006-3]
    • Pfeiffer, C. A. (1943). Endocrinology of Reproduction. Annual Review of Physiology, 5(1), 413–452. [DOI:10.1146/annurev.ph.05.030143.002213]
    • Pipkin, F. B. (2019). Physiological Changes in Pregnancy. In Symonds, I. M., & Arulkumaran, S. (Eds.). Essential Obstetrics and Gynaecology, 6th Edition (pp. 22–40). Edinburgh: Elsevier. [Google Books] [OpenLibrary] [WorldCat]
    • Plu-Bureau, G., Touraine, P., & Mauvais-Jarvis, P. (1999). Interactions Between Estradiol and Progesterone in Normal Breast: Implications for Mammary Carcinogenesis. In Manni, A. (Ed.). Endocrinology of Breast Cancer (Contemporary Endocrinology, Volume 11) (pp. 21–37). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-59259-699-7_2] [OpenLibrary] [Archive.org]
    • Pocock, G., Richards, C. D., & Richards, D. A. (2013). Fertilization, Pregnancy, and Lactation. In Pocock, G., Richards, C. D., & Richards, D. A. Human Physiology, 4th Edition (pp. 655–752). Oxford: Oxford University Press. [Google Scholar] [Google Books]
    • Polani, P. E. (1970). Hormonal and clinical aspects of hermaphroditism and the testicular feminizing syndrome in man. Philosophical Transactions of the Royal Society of London. B, Biological Sciences, 259(828), 187–206. [DOI:10.1098/rstb.1970.0058]
    • Price, S., McManus, J., & Barrett, J. (2019). The transgender population: improving awareness for gynaecologists and their role in the provision of care. The Obstetrician & Gynaecologist, 21(1), 11–20. [DOI:10.1111/tog.12521]
    • Prior, J. C. (2011). Progesterone for Symptomatic Perimenopause Treatment - Progesterone politics, physiology and potential for perimenopause. Facts, Views & Vision in ObGyn, 3(2), 109–120. [PubMed] [PubMed Central] [PDF]
    • Prior, J. C. (2019). Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1181–1186. [DOI:10.1210/jc.2018-01777]
    • Prior, J. C. (2019). Response to Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3129–3130. [DOI:10.1210/jc.2019-00524]
    • Prior, J. C. (2020). Women’s Reproductive System as Balanced Estradiol and Progesterone Actions—A revolutionary, paradigm-shifting concept in women’s health. Drug Discovery Today: Disease Models, 32(Part B), 31–40. [DOI:10.1016/j.ddmod.2020.11.005]
    • Prior, J. C., Vigna, Y. M., & Watson, D. (1989). Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Archives of Sexual Behavior, 18(1), 49–57. [DOI:10.1007/bf01579291]
    • Prior, J. C., Vigna, Y. M., Watson, D., Diewold, P., & Robinow, O. (1986). Spironolactone in the presurgical therapy of male to female transsexuals: Philosophy and experience of the Vancouver Gender Dysphoria Clinic. Journal of Sex Information & Education Council of Canada, 1(1), 1–7. [Google Scholar] [PDF]
    • Quigley, C. A. (1998). The androgen receptor: Physiology and pathophysiology. In Nieschlag, E., & Behre, H. M. (Eds.). Testosterone: Action · Deficiency · Substitution, 2nd Edition (pp. 33–106). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-72185-4_2]
    • Quigley, C. A., Bellis, A. D., Marschke, K. B., El-Awady, M. K., Wilson, E. M., & French, F. S. (1995). Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives. Endocrine Reviews, 16(3), 271–321. [DOI:10.1210/edrv-16-3-271]
    • Radisky, D. C., & Hartmann, L. C. (2009). Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical Studies. Journal of Mammary Gland Biology and Neoplasia, 14(2), 181–191. [DOI:10.1007/s10911-009-9123-y]
    • Ramos, L., Chávez, B., Mares, L., Valdés, E., & Vilchis, F. (2018). Mutational analysis of the androgen receptor (NR3C4) gene in patients with 46,XY DSD. Gene, 641, 86–93. [DOI:10.1016/j.gene.2017.10.038]
    • Ramsay, D. T., Kent, J. C., Hartmann, R. A., & Hartmann, P. E. (2005). Anatomy of the lactating human breast redefined with ultrasound imaging. Journal of Anatomy, 206(6), 525–534. [DOI:10.1111/j.1469-7580.2005.00417.x]
    • Randolph, J. F. (2018). Gender-Affirming Hormone Therapy for Transgender Females. Clinical Obstetrics & Gynecology, 61(4), 705–721. [DOI:10.1097/grf.0000000000000396]
    • Rauh, C., Faschingbauer, F., Haeberle, L., Jud, S. M., Heusinger, K., Fasching, P. A., Goecke, T. W., Rajakaruna, N., Voigt, F., Bani, M. R., Lux, M. P., Renner, S. P., Loehberg, C. R., Hartmann, A., Schulz-Wendtland, R., Beckmann, M. W., & Bayer, C. M. (2013). Factors influencing breast changes after pregnancy. European Journal of Cancer Prevention, 22(3), 259–261. [DOI:10.1097/cej.0b013e328359cb81]
    • Rebar, R. W. (1988). The Ovaries. In Wyngaarden, J. B., & Smith, L. H. (Eds.). Cecil Textbook of Medicine, 18th Edition (pp. 1425–1446). Philadelphia: W. B. Saunders. [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Rebar, R. W. (1990). Disorders of Menstruation, Ovulation, and Sexual Response. In Becker, K. L., Bilezikian, J. P., Bremner, W. J., Hung, W., Kahn, C. R., Loriaux, D. L., Rebar, R. W., Robertson, G. L., & Wartofsky, L. (Eds.). Principles and Practice of Endocrinology and Metabolism, 1st Edition (pp. 798–814). Philadelphia: Lippincott. [Google Scholar—3rd/2001 Edition] [Google Books—3rd/2001 Edition] [OpenLibrary] [WorldCat] [Archive.org]
    • Rebar, R. W. (1993). Normal and Abnormal Sexual Differentiation and Pubertal Development. In Moore, T. R., Reiter, R. C., Rebar, R. W., & Baker, W. (Eds.). Gynecology & Obstetrics: A Longitudinal Approach (pp. 97–133). New York: Churchill Livingstone. [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Rebar, R. W. (1996). Puberty. In Berek, J. S., Adashi, E. Y., & Hillard, P. A. (Eds.). Novak’s Gynecology, 12th Edition (pp. 771–807). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A Review of Breast Development in Cisgender Women and Implications for Transgender Women. Endocrine Practice, 25(12), 1338–1345. [DOI:10.4158/ep-2019-0183]
    • Richards, C., & Barrett, J. (2020). Physical Treatments for Trans People and Their Interactions with Psychiatric Treatments. In Richards, C., & Barrett, J. Trans and Non-binary Gender Healthcare for Psychiatrists, Psychologists, and Other Health Professionals (pp. 31–44). Cambridge: Cambridge University Press. [DOI:10.1017/9781108628419.003]
    • Richert, M. M., Schwertfeger, K. L., Ryder, J. W., & Anderson, S. M. (2000). An Atlas of Mouse Mammary Gland Development. Journal of Mammary Gland Biology and Neoplasia, 5(2), 227–241. [DOI:10.1023/a:1026499523505]
    • Rix, J., Mills, C., Ross, E., Allen, S., Lai, A., & Wakefield-Scurr, J. (2023). Breast volume fluctuations are associated with oestradiol and progesterone changes across the menstrual cycle. Research Square, preprint. [Google Scholar] [DOI:10.21203/rs.3.rs-3753080/v1] [PDF]
    • Rodari, G. (2022). Pubertal induction in girls with hypogonadism: estrogen replacement therapy outcomes and optimization of progesterone introduction. (Doctoral thesis, Università degli Studi di Milano.) [URL]
    • Rodari, G., Federici, S., Cattoni, A., Todisco, T., Ubertini, G., Giacchetti, F., Profka, E., Dall’Antonia, A., Cangiano, B., Arosio, M., Bonomi, M., Cappa, M., & Giavoli, C. (2022). Pubertal induction in girls with hypogonadism: insight into estrogen replacement therapy outcomes and optimization of progesterone introduction. Endocrine Abstracts, 81 [24th European Congress of Endocrinology 2022 21–24 May 2022, Milan, Italy], 107–107 (abstract no. RC12.7). [DOI:10.1530/endoabs.81.rc12.7] [PDF]
    • Rodari, G., Federici, S., Todisco, T., Ubertini, G., Cattoni, A., Pagano, M., Giacchetti, F., Profka, E., Citterio, V., Messetti, D., Collini, V., Soranna, D., Carbone, E., Arosio, M., Mantovani, G., Persani, L., Cappa, M., Bonomi, M., & Giavoli, C. (2023). Towards an individualized management of pubertal induction in girls with hypogonadism: insight into the best replacement outcomes from a large multicentre registry. European Journal of Endocrinology, 188(6), 467–476. [DOI:10.1093/ejendo/lvad056]
    • Rohn, R. D. (1989). Nipple (papilla) development in girls: III. Journal of Adolescent Health Care, 10(1), 39–40. [DOI:10.1016/0197-0070(89)90045-4]
    • Rosenfield, R. L. (2013). Adolescent Anovulation: Maturational Mechanisms and Implications. The Journal of Clinical Endocrinology & Metabolism, 98(9), 3572–3583. [DOI:10.1210/jc.2013-1770]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021). Puberty in the Female and Its Disorders. In Sperling, M. A., Majzoub, J. A., Menon, R. K., & Stratakis, C. A. (Eds.). Sperling Pediatric Endocrinology, 5th Edition (pp. 528–626). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-62520-3.00016-6]
    • Rothman, M. S., & Iwamoto, S. J. (2022). Feminizing Gender-Affirming Hormone Therapy: Special Considerations for Older Adults. In Davis, T. F. (Ed.). A Case-Based Guide to Clinical Endocrinology (pp. 513–523). Cham: Springer. [DOI:10.1007/978-3-030-84367-0_58]
    • Ruan, W., Monaco, M. E., & Kleinberg, D. L. (2005). Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action. Endocrinology, 146(3), 1170–1178. [DOI:10.1210/en.2004-1360]
    • Rutgers, J. L., & Scully, R. E. (1991). The Androgen Insensitivity Syndrome (Testicular Feminization). International Journal of Gynecological Pathology, 10(2), 126–144. [DOI:10.1097/00004347-199104000-00002]
    • Ryan, R. F., & Pernoll, M. L. (1985). Virginal Hypertrophy. Plastic and Reconstructive Surgery, 75(5), 737–742. [DOI:10.1097/00006534-198505000-00024]
    • Saito, R., Yamamoto, Y., Goto, M., Araki, S., Kubo, K., Kawagoe, R., Kawada, Y., Kusuhara, K., Igarashi, M., & Fukami, M. (2014). Tamoxifen Treatment for Pubertal Gynecomastia in Two Siblings with Partial Androgen Insensitivity Syndrome. Hormone Research in Paediatrics, 81(3), 211–216. [DOI:10.1159/000356923]
    • Sandhu, R., Chollet-Hinton, L., Kirk, E. L., Midkiff, B., & Troester, M. A. (2016). Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma. Human Pathology, 48, 60–68. [DOI:10.1016/j.humpath.2015.09.031]
    • Santen, R. J., Karaguzel, G., Livaoglu, M., Yue, W., Cline, J. M., Ratan, A., & Sasano, H. (2024). Role of ERα and aromatase in juvenile gigantomastia. The Journal of Clinical Endocrinology and Metabolism, online ahead of print. [DOI:10.1210/clinem/dgae019]
    • Sanuki, J., Fukuma, E., & Uchida, Y. (2008). Morphologic Study of Nipple-Areola Complex in 600 Breasts. Aesthetic Plastic Surgery, 33(3), 295–297. [DOI:10.1007/s00266-008-9194-y]
    • Satoh, K., Hovey, R. C., Malewski, T., Warri, A., Goldhar, A. S., Ginsburg, E., Saito, K., Lydon, J. P., & Vonderhaar, B. K. (2007). Progesterone enhances branching morphogenesis in the mouse mammary gland by increased expression of Msx2. Oncogene, 26(54), 7526–7534. [DOI:10.1038/sj.onc.1210555]
    • Schauffler, G. C. (1942). Disorders During Adolescence—The Onset of Menstruation. In Schauffler, G. C. Pediatric Gynecology; with Sections on Urology and Proctology, 1st Edition (pp. 169–211). Chicago: Year Book. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL]
    • Schindler, A. E. (2010). Dydrogesterone and other progestins in benign breast disease: an overview. Archives of Gynecology and Obstetrics, 283(2), 369–371. [DOI:10.1007/s00404-010-1456-7]
    • Scott, P. P., Greene, R., Lane-Roberts, C. S., & Swain, V. (1950). The Function of the Breast. In Saner, F. D. (Ed.). The Breast: Structure, Function, Disease (pp. 53–86). Baltimore: Williams and Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [PDF]
    • Seal, L. (2017). Adult Endocrinology. In Richards, C., Bouman, W. P., & Barker, M.-J. (Eds.). Genderqueer and Non-Binary Genders (Critical and Applied Approaches in Sexuality, Gender and Identity) (pp. 183–223). London: Palgrave Macmillan UK. [DOI:10.1057/978-1-137-51053-2_10]
    • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422–4428. [DOI:10.1210/jc.2012-2030]
    • Seibert, B., & Günzel, P. (1994). Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna®. Contraception, 49(4), 303–333. [DOI:10.1016/0010-7824(94)90030-2]
    • Shapiro, L. R. (1982). Disorders of Female Sex Differentiation. In Blaustein, A. (Ed.). Pathology of the Female Genital Tract, 2nd Edition (pp. 479–510). New York: Springer New York. [DOI:10.1007/978-1-4757-1767-9_20]
    • Shearman, R. P. (1972). Ovarian Function and its Control. In Shearman, R. P. (Ed.). Human Reproductive Physiology, 1st Edition (pp. 45–90). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Shearman, R. P. (1972). Primary Ammenorhoea. In Dewhurst, C. J. (Ed.). Integrated Obstetrics and Gynaecology for Postgraduates, 1st Edition (pp. 55–62). Oxford: Blackwell Scientific Publications. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • Shi, H. Y., Lydon, J. P., & Zhang, M. (2004). Hormonal Defect in Maspin Heterozygous Mice Reveals a Role of Progesterone in Pubertal Ductal Development. Molecular Endocrinology, 18(9), 2196–2207. [DOI:10.1210/me.2004-0052]
    • Shuttleworth, F. K. (1938). The Adolescent Period: A Graphic and Pictorial Atlas (Monographs of the Society for Research in Child Development, Volume 3, Number 3 / Serial No. 16). Washington, D. C.: Society for Research in Child Development. [Google Scholar] [Google Books] [DOI:10.2307/1165482]
    • Simmer, H. H., Pion, R. J., & Dignam, W. J. (1965). Testicular Feminization: Endocrine Function of Feminizing Testes, Comparison with Normal Testes. Springfield, Illinois: Thomas. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Simpson, J. L., & Rebar, R. W. (1990). Normal and Abnormal Sexual Differentiation and Development. In Becker, K. L., Bilezikian, J. P., Bremner, W. J., Hung, W., Kahn, C. R., Loriaux, D. L., Rebar, R. W., Robertson, G. L., & Wartofsky, L. (Eds.). Principles and Practice of Endocrinology and Metabolism, 1st Edition (pp. 710–739). Philadelphia: Lippincott. [Google Scholar] [Google Books—3rd/2001 Edition] [OpenLibrary] [WorldCat] [Archive.org]
    • Sindi, R., Sá Dos Reis, C., Bennett, C., Stevenson, G., & Sun, Z. (2019). Quantitative Measurements of Breast Density Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 8(5), 745. [DOI:10.3390/jcm8050745]
    • Sitruk-Ware, R., Basdevant, A., de Lignières, B., & Mauvais-Jarvis, P. (1984). Percutaneous oestrogen therapy. In van Herendael, H., van Herendael, B., Riphagen, F. E., Goessens, L., & van der Plas, H. (Eds.). The Climacteric: An Update: Proceedings of the fourth Jan Palfijn Symposium, European Conference on the Menopause, held in Antwerp, Belgium, on September 1–2, 1983, under the auspices of ‘De Vereniging voor Nederlandstalige gynecologen van België’ and ‘The International Menopause Society’ (pp. 127–139). Lancaster: MTP Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [DOI:10.1007/978-94-009-5608-7_14]
    • Sizonenko, P. C. (1978). Endocrinology in Preadolescents and Adolescents. American Journal of Diseases of Children, 132(7), 704–712. [DOI:10.1001/archpedi.1978.02120320064015]
    • Škarda, J., Fremrová, V., & Bezecný, I. (1989). Progesterone alone is responsible for stimulation of the growth of ducts and of mammary alveolar structures in mice. Endocrinologia Experimentalis, 23(1), 17–28. [Google Scholar] [PubMed] [PDF]
    • Sobrinho, L. G., Kase, N., & Grunt, J. A. (1971). Spontaneous pubertal breast growth in a castrated patient with the syndrome of testicular feminization. The Yale Journal of Biology and Medicine, 44(2), 225–9. [Google Scholar] [PubMed] [PubMed Central] [PDF]
    • Sosa, M., Jódar, E., Arbelo, E., Domínguez, C., Saavedra, P., Torres, A., Salido, E., de Tejada, M. J., & Hernández, D. (2003). Bone Mass, Bone Turnover, Vitamin D, and Estrogen Receptor Gene Polymorphisms in Male to Female Transsexuals. Journal of Clinical Densitometry, 6(3), 297–304. [DOI:10.1385/jcd:6:3:297]
    • Sosa, M., Jódar, E., Arbelo, E., Domı́nguez, C., Saavedra, P., Torres, A., Salido, E., Limiñana, J., Gómez de Tejada, M. J., & Hernández, D. (2004). Serum lipids and estrogen receptor gene polymorphisms in male-to-female transsexuals: effects of estrogen treatment. European Journal of Internal Medicine, 15(4), 231–237. [DOI:10.1016/j.ejim.2004.04.009]
    • Soyal, S., Ismail, P. M., Li, J., Mulac-Jericevic, B., Conneely, O. M., & Lydon, J. P. (2002). Progesterone receptors - animal models and cell signaling in breast cancer: Progesterone’s role in mammary gland development and tumorigenesis as disclosed by experimental mouse genetics. Breast Cancer Research, 4(5), 191. [DOI:10.1186/bcr451]
    • Sperling, R. L., & Gold, J. J. (1973). Use of an anti-estrogen after a reduction mammaplasty to prevent recurrence of virginal hypertrophy of breasts. Plastic and Reconstructive Surgery, 52(4), 439–442. [DOI:10.1097/00006534-197352040-00030]
    • Spitz, I. M., Shoupe, D., Sitruk-Ware, R., & Mishell, D. R. (1989). Response to the antiprogestagen RU 486 (mifepristone) during early pregnancy and the menstrual cycle in women. Journal of Reproduction and Fertility Supplement, 37, 253–260. [Google Scholar] [PubMed]
    • Spitz, I., Croxatto, H., Lahteenmaki, P., Heikinheimo, O., & Bardin, C. (1994). Effect of mifepristone on inhibition of ovulation and induction of luteolysis. Human Reproduction, 9(Suppl 1), 69–76. [DOI:10.1093/humrep/9.suppl_1.69]
    • Spitz, I. M. (2010). Mifepristone: where do we come from and where are we going? Contraception, 82(5), 442–452. [DOI:10.1016/j.contraception.2009.12.012]
    • Sridhar, G. R., & Sinha, M. J. (1995). Macromastia in adolescent girls. Indian Pediatrics, 32(4), 496–499. [Google Scholar] [PubMed] [PDF]
    • Sun, B. Z., Kangarloo, T., Adams, J. M., Sluss, P. M., Welt, C. K., Chandler, D. W., Zava, D. T., McGrath, J. A., Umbach, D. M., Hall, J. E., & Shaw, N. D. (2018). Healthy Post-Menarchal Adolescent Girls Demonstrate Multi-Level Reproductive Axis Immaturity. The Journal of Clinical Endocrinology & Metabolism, 104(2), 613–623. [DOI:10.1210/jc.2018-00595]
    • Sun, S. X., Bostanci, Z., Kass, R. B., Mancino, A. T., Rosenbloom, A. L., Klimberg, V. S., & Bland, K. I. (2018). Breast Physiology: Normal and Abnormal Development and Function. In Bland, K. I., Copeland, E. M., Klimberg, V. S., Gradishar, W. J., White, J., & Korourian, S. (Eds.). The Breast: Comprehensive Management of Benign and Malignant Diseases, 5th Edition (pp. 37–56.e6). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-35955-9.00003-9]
    • Swelstad, M. R., Swelstad, B. B., Rao, V. K., & Gutowski, K. A. (2006). Management of Gestational Gigantomastia. Plastic and Reconstructive Surgery, 118(4), 840–848. [DOI:10.1097/01.prs.0000232364.40958.47]
    • Tack, L. J., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine, 14(5), 747–757. [DOI:10.1016/j.jsxm.2017.03.251]
    • Talbert, L. M., Hammond, M. G., Groff, T., & Udry, J. R. (1985). Relationship of age and pubertal development to ovulation in adolescent girls. Obstetrics & Gynecology, 66(4), 542–544. [Google Scholar] [PubMed] [URL]
    • Tanos, T., & Brisken, C. (2008). What Signals Operate in the Mammary Niche? Breast Disease, 29(1), 69–82. [DOI:10.3233/bd-2008-29108]
    • Thanaboonyawat, I., Chanprapaph, P., Lattalapkul, J., & Rongluen, S. (2013). Pilot Study of Normal Development of Nipples during Pregnancy. Journal of Human Lactation, 29(4), 480–483. [DOI:10.1177/0890334413493350]
    • Thody, A. J., & Smith, A. G. (1977). Hormones and Skin Pigmentation in the Mammal. International Journal of Dermatology, 16(8), 657–664. [DOI:10.1111/j.1365-4362.1977.tb01876.x]
    • Thoresen, M., & Wesche, J. (1988). Doppler measurements of changes in human mammary and uterine blood flow during pregnancy and lactation. Acta Obstetricia et Gynecologica Scandinavica, 67(8), 741–745. [DOI:10.3109/00016349809004301]
    • Tiefenbacher, K., & Daxenbichler, G. (2008). The Role of Androgens in Normal and Malignant Breast Tissue. Breast Care, 3(5), 325–331. [DOI:10.1159/000158055]
    • Tim, F., Jeroen, V., & T’Sjoen, G. (2023). Dose Reduction of Cyproterone Acetate in Trans Women and the Effect on Patient-reported Outcomes: Results from the ENIGI Study. Endocrine Abstracts, 97 [Belgian Endocrine Society 2023], 5–5 (abstract no. 007). [URL] [PDF]
    • Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z. (2019). Progesterone and Breast Cancer. Endocrine Reviews, 41(2), 320–344. [DOI:10.1210/endrev/bnz001]
    • Tucker, H. (2000). Hormones, Mammary Growth, and Lactation: a 41-Year Perspective. Journal of Dairy Science, 83(4), 874–884. [DOI:10.3168/jds.s0022-0302(00)74951-4]
    • Turan, S., Bereket, A., Guran, T., Akcay, T., Papari-Zareei, M., & Auchus, R. J. (2009). Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair. European Journal of Endocrinology, 160(2), 325–330. [DOI:10.1530/eje-08-0632]
    • Turner, C. W. (1939). The Mammary Glands. In Allen, E., Danforth, C. H., & Doisy, E. A. (Eds.). Sex and Internal Secretions: A Survey of Recent Research, 2nd Edition (pp. 740–803). Baltimore: Williams & Wilkins. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Ulrich, U., Pfeifer, T., & Lauritzen, C. (1994). Rapid Increase in Lumbar Spine Bone Density in Osteopenic Women by High-Dose Intramuscular Estrogen-Progestogen Injections. Hormone and Metabolic Research, 26(9), 428–431. [DOI:10.1055/s-2007-1001723]
    • Ulrich, U., Pfeifer, T., Buck, G., Keckstein, J., & Lauritzen, C. (1995). High-dose estrogen-progestogen injections in gonadal dysgenesis, ovarian hypoplasia, and androgen insensitivity syndrome: Impact on bone density. Adolescent and Pediatric Gynecology, 8(1), 20–23. [DOI:10.1016/s0932-8610(12)80156-3]
    • Valentine, G. H. (1969). Chromosome Anomalies in the Female. In Valentine, G. H. The Chromosome Disorders: An Introduction for Clinicians, 2nd Edition (pp. 126–143). London: W. Heinemann Medical Books. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]
    • van der Meulen, A. J. (1974). An unusual case of massive hypertrophy of the breasts. South African Medical Journal=Suid-Afrikaanse Tydskrif vir Geneeskunde, 48(34), 1465–1466. [Google Scholar] [PubMed] [URL 1] [URL 2]
    • Vandeweyer, E., & Hertens, D. (2002). Quantification of glands and fat in breast tissue: An experimental determination. Annals of Anatomy - Anatomischer Anzeiger, 184(2), 181–184. [DOI:10.1016/s0940-9602(02)80016-4]
    • Venturoli, S., Fabbri, R., Porcu, E., Paradisi, R., Orsini, L. F., Brondelli, L., Ruggeri, S., & Flamigni, C. (1989). Endocrine and ovarian parameters at various frequencies of ovulation in adolescents. Archives of Gynecology and Obstetrics, 246(2), 107–114. [DOI:10.1007/bf00934127]
    • Venturoli, S., Porcu, E., Fabbri, R., Magrini, O., Paradisi, R., Pallotti, G., Gammi, L., & Flamigni, C. (1987). Postmenarchal evolution of endocrine pattern and ovarian aspects in adolescents with menstrual irregularities. Fertility and Sterility, 48(1), 78–85. [DOI:10.1016/s0015-0282(16)59294-2]
    • Vorherr, H. (1974). Development of the Female Breast. In Vorherr, H. The Breast: Morphology, Physiology, and Lactation (pp. 1–19). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Vorherr, H. (1974). Morphology of the Mature Female Breast. In Vorherr, H. The Breast: Morphology, Physiology, and Lactation (pp. 20–70). New York: Academic Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Wade, T. R., Wade, S. L., & Jones, H. E. (1978). Skin changes and diseases associated with pregnancy. Obstetrics and Gynecology, 52(2), 233–242. [Google Scholar] [PubMed] [URL]
    • Walker, M., Baker, G., & Lamb, M. (2013). Physiology of the Breast During Pregnancy and Lactation. In Mannel, R., Martens, P. J., & Walker, M. (Eds.). Core Curriculum for Lactation Consultant Practice, 3rd Edition (pp. 287–300). Burlington: Jones & Bartlett Learning. [Google Scholar] [Google Books—2013/3rd Edition] [Google Books—2008/2nd Edition] [OpenLibrary] [WorldCat]
    • Wang, C., Luan, J., Cheng, H., Chen, L., Li, Z., Panayi, A. C., & Liu, C. (2018). Menstrual Cycle-Related Fluctuations in Breast Volume Measured Using Three-Dimensional Imaging: Implications for Volumetric Evaluation in Breast Augmentation. Aesthetic Plastic Surgery, 43(1), 1–6. [DOI:10.1007/s00266-018-1243-6]
    • Wang, Q. A., & Scherer, P. E. (2019). Remodeling of Murine Mammary Adipose Tissue during Pregnancy, Lactation, and Involution. Journal of Mammary Gland Biology and Neoplasia, 24(3), 207–212. [DOI:10.1007/s10911-019-09434-2]
    • Weisberg, M. G., Malkasian, G. D., & Pratt, J. H. (1970). Testicular feminization syndrome. American Journal of Obstetrics and Gynecology, 107(8), 1181–1187. [DOI:10.1016/s0002-9378(15)30367-7]
    • Wellons, M. F., & Rebar, R. W. (2013). Amenorrhea. In Falcone, T., & Hurd, W. W. (Eds.). Clinical Reproductive Medicine and Surgery: A Practical Guide, 2nd Edition (pp. 105–112). New York: Springer New York. [DOI:10.1007/978-1-4614-6837-0_7]
    • Wellons, M. F., Weeber, K. M., & Rebar, R. W. (2017). Amenorrhea. In Falcone, T., & Hurd, W. W. (Eds.). Clinical Reproductive Medicine and Surgery, 3rd Edition (pp. 109–122). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-52210-4_6]
    • Werner, A. A. (1935). Experiment to produce lactation in castrate women. Endocrinology, 19(2), 144–150. [DOI:10.1210/endo-19-2-144]
    • Whiteley, S. (1994). Predictors of Milk Production in Lactating Women. (Master’s thesis, The Open University.) [Google Scholar] [DOI:10.21954/ou.ro.0000fe02] [URL]
    • Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical Review: Breast Development in Trans Women Receiving Cross-Sex Hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    • Wilson, J. D. (1968 March 28). Medical Grand Rounds: Testicular Feminization. Parkland Memorial Hospital, UT Southwestern Medical Center. [Google Scholar] [URL] [PDF]
    • Wilson, C. L., Sims, A. H., Howell, A., Miller, C. J., & Clarke, R. B. (2006). Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocrine-Related Cancer, 13(2), 617–628. [DOI:10.1677/erc.1.01165]
    • Winkler, U. H., Schindler, A. E., Brinkmann, U. S., Ebert, C., & Oberhoff, C. (2001). Cyclic progestin therapy for the management of mastopathy and mastodynia. Gynecological Endocrinology, 15(Suppl 6), 37–43. [DOI:10.1080/gye.15.s6.37.43]
    • Wisniewski, A. B., Migeon, C. J., Meyer-Bahlburg, H. F., Gearhart, J. P., Berkovitz, G. D., Brown, T. R., & Money, J. (2000). Complete Androgen Insensitivity Syndrome: Long-Term Medical, Surgical, and Psychosexual Outcome. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2664–2669. [DOI:10.1210/jcem.85.8.6742]
    • Wong, R. C., & Ellis, C. N. (1984). Physiologic skin changes in pregnancy. Journal of the American Academy of Dermatology, 10(6), 929–940. [DOI:10.1016/s0190-9622(84)80305-9]
    • Wren, B. G., & Eden, J. A. (1996). Do Progestogens Reduce The Risk of Breast Cancer? A Review of the Evidence. Menopause, 3(1), 4–12. [DOI:10.1097/00042192-199603010-00003]
    • Wright, E. M. (2015). Breastfeeding and the Mother–Newborn Dyad (pp. 1157–1182). In King, T. L., Brucker, M. C., Kriebs, J. M., Fahey, J. O., Gegor, C. L., & Varney, H. (Eds.). Varney’s Midwifery, 5th Edition. Burlington: Jones & Bartlett Learning. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Xu, P., Ye, W., Zhong, S., Li, H., Feng, E., Lin, S. H., Kuo, C. T., Liu, J. Y., & Lin, Y. C. (2010). Leptin and zeranol up-regulate cyclin D1 expression in primary cultured normal human breast pre-adipocytes. Molecular Medicine Reports, 3(6), 983–990. [DOI:10.3892/mmr.2010.370]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]
    • Zacharin, M. (2000). Use of androgens and oestrogens in adolescents - A review of hormone replacement treatment. Journal of Pediatric Endocrinology and Metabolism, 13(1), 3–12. [DOI:10.1515/JPEM.2000.13.1.3]
    • Zachmann, M., Prader, A., Sobel, E. H., Crigler, J. F., Ritzén, E. M., Atarés, M., & Ferrandez, A. (1986). Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogens in pubertal growth of girls. The Journal of Pediatrics, 108(5), 694–697. [DOI:10.1016/s0022-3476(86)81043-5]
    • Żelaźniewicz, A., & Pawłowski, B. (2015). Breast size and asymmetry during pregnancy in dependence of a fetus’s sex. American Journal of Human Biology, 27(5), 690–696. [DOI:10.1002/ajhb.22716]
    • Żelaźniewicz, A., & Pawłowski, B. (2018). Maternal breast volume in pregnancy and lactation capacity. American Journal of Physical Anthropology, 168(1), 180–189. [DOI:10.1002/ajpa.23734]
    • Zhang, D., Yao, F., Tian, T., Deng, S., Luo, M., & Tian, Q. (2021). Clinical characteristics and molecular genetics of complete androgen insensitivity syndrome patients: a series study of 30 cases from a Chinese tertiary medical center. Fertility and Sterility, 115(5), 1270–1279. [DOI:10.1016/j.fertnstert.2020.12.008]
    \ No newline at end of file diff --git a/transfemscience.org/articles/progestogens-early-exposure-breast-dev/index.html b/transfemscience.org/articles/progestogens-early-exposure-breast-dev/index.html index 72abf76a..053a7e81 100644 --- a/transfemscience.org/articles/progestogens-early-exposure-breast-dev/index.html +++ b/transfemscience.org/articles/progestogens-early-exposure-breast-dev/index.html @@ -1 +1 @@ -Literature on Early Progestogen Exposure and Breast Development - Transfeminine Science Link

    Literature on Early Progestogen Exposure and Breast Development

    By Aly | First published July 21, 2019 | Last modified May 15, 2023

    Preface

    This is a sources and excerpts supplement for the main article section which can be found here.

    Animal Studies

    Lyons & McGinty (1941)

    Lyons, W. R., & McGinty, D. A. (1941). Effects of estrone and progesterone on male rabbit mammary glands. I. Varying doses of progesterone. Proceedings of the Society for Experimental Biology and Medicine, 48(1), 83–86. [DOI:10.3181/00379727-48-13227]:

    Summary. Eighteen doses of 0.25, 1.0, 4.0 and 8.0 I.U. of crystalline progesterone were given, simultaneously with 120 I.U. of estrone, to immature male rabbits during a period of 4 weeks. Of these 4 levels of progesterone, the 1.0 I.U. dose synergized best although the prolactational proliferation induced was not maximal. The 4.0 and 8.0 I.U. doses of progesterone were apparently inhibiting as shown by the relatively poor mammary growth obtained.

    [Introduction.] Turner and Frank1 showed that whereas estrogen caused growth of the duct system and slight lobule proliferation in the male rabbit mammary gland, the combination of estrogen and progestogen caused lobule-alveolar growth simulating that seen in pregnancy. The hormones used were impure, but were assayed for rat units of estrogen and rabbit units of progestogen and judged by the results, were uncontaminated, one with the other. Until recently few investigators have had at their disposal sufficient progesterone with which to investigate this problem further, and, as, far as we are aware, the doses of estrone and progesterone that will synergize best to cause optimal mammary growth have not as yet been satisfactorily determined in any animal form. In the preliminary investigation reported herein, an attempt was made to determine the approximate dose of progesterone that would function optimally with a given daily dose (120 I.U.) of estrone in causing prolactational* growth of the male rabbit mammary gland.

    Experimental. Immature, New Zealand White male rabbits weighing approximately 1.5 kg at the beginning of the experiment were treated in groups of 3 with 18 daily doses (Monday through Friday, from 2/28/39 until 3/23/39) of the following:

    Group 1, 120 I.U. of estrone (theelin); Group 2, 1 I.U. of progesterone; Group 3, 120 I.U. of E and 0.25 I.U. of P; Group 4, 120 I. U. of E and 1 I.U. of P; Group 5, 1201 I.U. of E and 4 I.U. of P; Group 6, 120 I.U. of E and 8 I.U. of P. The 2 hormones were given separately, subcutaneously, in peanut oil. On 3/28/39, 5 days after the last injection, a biopsy specimen of the second left (thoracic) mammary gland was taken from each animal, fixed in formol, stained in toto with alum-carmine and cleared in methyl salicylate.

    Results. The maniniary spreads from Group 1, showed that the dose of 120 I.U. of E produced good duct growth with almost negligible alveolar formation (Fig. 2). Those from Group 2 (1 I.U. of P) showed but little more development than that seen in normal immature rabbit glands (Fig. 1). The duct system of the glands from animals in Group 3 (120 I.U. of E plus 0.25 I.U. of P) was as extensive as that seen in animals treated with 120 I.U. of E alone, but the main ducts were narrower and, as though in compensation. more alveolar buds were present. Thus, just as progesterone in some experimental animals prevents the estrogen-induced uterine dilatation and stimulates a proliferation of luminal and glandular epithelium, so also in the rabbit it counteracts an estrogen-induced mammary duct dilatation and permits instead an extensive alveolar proliferation. The amount of incomplete lobule formation shown in Fig. 3 was found typical of all rabbits in this group and probably may be interpreted as barely minimal prolactational proliferation in response to a low dose of progesterone. The glands from animals in Group 4 (120 I.U. of E and 1.0 I.U. of P) showed the best evidence of synergism obtained in this preliminary experiment (Fig. 4), although judged on the basis of a set of glands taken at different stages of pregnancy, they could not be said to show maximal prolactational proliferation. Interesting results were obtained in Groups 5 and 6, where 2 of the animals in Group 5 and all in Group 6 showed only scanty alveolar development and an inhibition of the duct growth (Fig. 5). The third animal in Group 5 showed good prolactational development with no inhibition of duct growth, indicating that 4 I.U. of progesterone approximated the border-line inhibiting dose when given with 120 I.U. of estrone by this particular routine.

    All figures represent approximately one-half of a male rabbit mammary spread fixed in formol and stained in alum-carmine. × 1.5.

    Treatment was as follows:

    FIG. 1. None. Control gland.

    FIG. 2. 18 subcutaneous doses of 120 I.U. estrone in oil over a 28-day period. Duct growth with almost no alveolar development.

    FIG. 3. 18 subcutaneous doses of 120 I.U. estrone and 0.25 I.U. progesterone over same period. Very little prolactational proliferation.

    FIG. 4. 18 subcutaneous doses of 120 I.U. estrone and 1 I.U. progesterone over same period. Fair prolactational proliferation.

    FIG. 5. 18 subcutaneous doses of 120 I.U. estrone and 8 I.U. progesterone over same period. Inhibited duct growth and only slight alveolar development.

    Beyer, Cruz, & Martinez-Manautou (1970)

    Beyer, C., Cruz, M. L., & Martinez-Manautou, J. (1970). Effect of Chlormadinone Acetate on Mammary Development and Lactation in the Rabbit. Endocrinology, 86(5), 1172–1174. [DOI:10.1210/endo-86-5-1172]:

    ABSTRACT. The effect of chlormadinone acetate (CA) on mammary growth and lactation was studied in the New Zealand white rabbit. Mammary development studies were performed in 5-month males castrated prepuberally. All rabbits were treated for 28 days. Ten μg estrone (E) produced good ductal development without alveolar growth (mean mammary area = 376 mm2). CA alone did not stimulate mammary growth. Administration of 0.5 mg CA plus 10 μg E produced optimal ductal and alveolar development (mean mammary area = 765 mm2). By contrast, a larger dose of CA (2.5 mg) combined with 10 μg E resulted in a much smaller mammary response (mean mammary area = 284 mm2). Administration of 100 μg or 2.5 mg CA from day 10 to 25 of lactation neither inhibited nor facilitated milk production in lactating rabbits. It is concluded that prolonged administration of CA when combined with estrogen stimulates mammary growth at moderate doses (0.5 mg) and inhibits it at large doses (2.5 mg). CA has no clear effect on milk production and/or removal in lactating rabbits. (Endocrinology 86: 1172, 1970)

    [Introduction]

    CHLORMADINONE acetate (CA) is a potent progestational steroid widely employed in controlling human fertility (1). It has been reported that prolonged treatment with some progestational compounds can alter mammary structure and lactation in some mammalian species, including women (2). Yet no detailed study has been done on the action of CA on the mammary gland. Therefore, we considered it interesting to analyze the effect of prolonged administration of CA upon mammary growth and lactation in New Zealand white rabbits.

    Results

    The mammary glands of the control castrated males were not visible. When studied microscopically, they were found to consist of short primary ducts that hardly extended beyond the nipple area. Injections of 500 μg CA did not stimulate mammary growth. Administration of 10 μg E induced clear growth and ramification of the ductal system. The mean area (376 ± 41 mm2 SE) occupied by these glands was significantly larger than in the control or CA treated rabbits. These glands were composed exclusively of ductal epithelium without alveoli. Combined administration of 10 μg E and 2.5 mg progesterone (P) resulted in a good ductoalveolar development. As can be seen in Fig. 1A the ducts were almost covered with alveoli. The area occupied by these glands was significantly larger than that of the E treated rabbits (688 ± 77 mm2 SE, group 3 vs. 4, p = .004, U test). No milk secretion was noted. Administration of both E and CA at the low dose level (0.5 mg) produced marked ducto-alveolar development (Fig. 1B). The mammary area in these animals was more extended than in all other treated groups (765 ± 358 mm2 SE) but also no mammary secretion was observed. Injections of E plus 2.5 mg CA resulted in a dramatic reduction in mammary extension (284 ± 38 mm2 SE), when compared with the effects obtained with the low dose of CA (group 5 vs. group 6, p = .004, U test). Limited ductal extension and ramification was noted, though alveolar development existed (Fig. 1C).

    FIG. 1. Whole mounts of mammary glands showing development after diverse treatments: A) estrone (10 μg) plus 2 mg progesterone; B) estrone (10 μg) plus 0.5 mg chlormadinone acetate; C) estrone (10 μg) plus 2.5 mg chlormadinone acetate. Note that the large dosage of chlormadinone acetate resulted in poor development of the ductal system.

    Discussion

    Our observations indicate that CA alone does not exert any clear effect on mammary gland growth. Similarly, P per se lacks stimulatory effects on mammary development in the gonadectomized rabbit (3). On the other hand, when low doses of CA (0.5 mg) were combined with E, maximal ducto-alveolar development occurred. The development of these glands was comparable to that observed in late pregnancy in the rabbit. The fact that the mammary growth obtained with 0.5 mg CA plus E was greater than that found after combination of P and E agrees with the observation that CA is a more potent progestational agent than P (4).

    […] It is interesting that CA in large doses inhibited mammary growth. Similarly, Lyons and McGinty (7) reported an inhibitory effect of large dosages of P (8 mg) in the intact male rabbit treated with estrogen. This inhibitory effect is probably due to the antiestrogenic action of these compounds (8).

    In summary, prolonged administration of CA, when acting on an estrogenic background, might influence mammary development in the rabbit, stimulating it at moderate and inhibiting it at high doses. By contrast, CA has no significant effect on milk production or removal.

    Clinical Publications

    Zacharin (2000)

    Zacharin, M. (2000). Use of androgens and oestrogens in adolescents - A review of hormone replacement treatment. Journal of Pediatric Endocrinology and Metabolism, 13(1), 3–12. [DOI:10.1515/JPEM.2000.13.1.3]:

    Progestogen is not required for induction of puberty. Cyclical progestogen should be added when the oestradiol dosage reaches the equivalent of 15 μg/day of ethinyl oestradiol, at which time breakthrough bleeding is almost inevitable, or earlier if vaginal bleeding has already occurred.

    Emans (2005)

    Emans, S. J. (2005). Delayed Puberty. In Emans, S. J., Laufer, M. R., Goldstein, D. P. (Eds.). Pediatric & Adolescent Gynecology, 5th Edition (pp. 181–213). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [WorldCat] [Archive.org]:

    Oral contraceptives are not recommended for initial therapy because they contain progestin throughout the cycle, which is not a physiologic approach to the induction of normal breast development. During normal puberty, there is a long period of unopposed low levels of estrogen until ovulatory cycles begin (see Chapter 4). There has been speculation that particular doses of progestin or estrogen may be more likely to lead to tubular breasts, but a randomized study has not been done.

    […] The timing of the introduction of progestin varies among centers. Although in the past some girls received unopposed estrogen daily until breakthrough bleeding occurred, we believe that this method should be discouraged because adolescents benefit from a predictable onset of menses, and many girls experience significant dysfunctional bleeding that may require intervention. We suggest the addition of a short course of progestin (5 or 10 mg of medroxyprogesterone) to the continuous estrogen within 2 to 3 months of the Phase 2 increase in dose: e.g., daily estrogen plus medroxyprogesterone 10 mg each day for the first 5 days of each month. This dose of progestin is used only until breast development is completed over the next 6 months and then the dose of progestin is increased to 10 days and ultimately to 12 to 14 days for optimal protection of the endometrium if long-term hormone replacement is planned.

    Bondy et al. (2007)

    Bondy, C. A., & Turner Syndrome Consensus Study Group. (2007). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. The Journal of Clinical Endocrinology & Metabolism, 92(1), 10–25. [DOI:10.1210/jc.2006-1374]:

    To allow for normal breast and uterine development, it seems advisable to delay the addition of progestin at least 2 yr after starting estrogen or until breakthrough bleeding occurs. The use of oral contraceptive pills to achieve pubertal development is best avoided, because the synthetic estrogen doses in most formulations are too high and the typical synthetic progestin may interfere with optimal breast and uterine development.

    Colvin, Devineni, & Ashraf (2014)

    Colvin, C., Devineni, G., & Ashraf, A. P. (2014). Delayed Puberty. In Bandeira, F., Gharib, H., Golbert, A., Griz, L., & Faria, M. (Eds.). Endocrinology and Diabetes (pp. 203–217). New York: Springer. [DOI:10.1007/978-1-4614-8684-8_17]:

    Initial therapy is with estrogen alone to maximize breast growth and to induce uterine and endometrial proliferation. Adding a progestin prematurely or administering combinations of estrogens and progestins early on may reduce ultimate breast size. Progestin is added to mimic the normal menstrual cycle after breast growth ceases (when full contour breast growth plateaus) or menses occur.

    Wierckx, Gooren, & T’Sjoen (2014)

    Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical review: breast development in trans women receiving cross-sex hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]:

    The available evidence does not provide support for better effects on breast size of adding progestogens to cross-sex hormone administration in trans women as suggested by some authors [14,18,48–51]. However, it should be said that the quality and amount of available evidence are extremely poor and hamper any firm conclusion at this moment. Also, many centers use antiandrogens with some progestational action and complicate the available evidence. In addition, some occasionally use progestins to lower testosterone levels after maximum estrogen levels when a patient cannot tolerate an estrogen-based regimen, abnormal psychological irritability, and mammary tenderness [52,53]. Furthermore, all progestogens by definition have some progestational activity, but they differ in chemical structure, metabolism, pharmacokinetics, affinity, potency, and efficacy via steroid receptors and intracellular action. All these differences can translate into very different biological and clinical effects and advocate the absence of a class effect of progestogens [54].

    Nevertheless, breast development in trans women might be similar as in cisgender women indicating a major role for estrogen rather than progesterone in the early stages of breast development. The central role of estradiol in initiating breast growth at puberty is revealed by the poor-developed breast of estrogen receptor-alpha knockout mice [55], whereas progesterone knockout mice showed to have a morphologically indistinguishable ductal architecture from wild-type virgin mice [56]. Moreover, during pubertal induction in girls, early administration of progesterone is not recommended as premature initiation of progestin therapy can compromise ultimate breast growth [57]. It is however of note that progesterone is known to be an important determinant of the histology of the breast in cis women. When the mammary epithelial of the progesterone knockout mouse is transplanted into a wild-type parous mouse, the obligatory role of progesterone in acinar and lobular development is demonstrated [58,59]. Additionally, other theoretical advantages of progesterone administration might be the fact that breast epithelium exhibits maximal proliferation in the luteal phase of menstruation, when progesterone levels are at their highest [60] and increased mammographic breast density is observed when progestogens are administered [61]. However, importantly, there is no evidence that these histological and mammographic differences result in clinically significant breast size differences. Another consideration is that the increased breast density by progestogens rapidly decreases after hormone withdrawal [62], which raises the question how long progestogens then should be prescribed.

    Kaiser & Ho (2015)

    Kaiser, U., & Ho, K. K. (2015). Pituitary Physiology and Diagnostic Evaluation. In Melmed, S., Polonsky, K. S., Larsen, P. R., Kronenberg, & H. M. (Eds.). Williams Textbook of Endocrinology, 13th Edition (pp. 176–231). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-29738-7.00008-3] [Google Books]:

    Sex Steroid Replacement Therapy. Estrogen or testosterone replacement is required for inducing and maintaining primary and secondary sexual characteristics [in patients with delayed puberty due to hypogonadism], […] Initial therapy should consist of estrogen alone to maximize breast growth and to induce uterine and endometrial proliferation. […] A progestin eventually needs to be added to prevent endometrial hyperplasia but should be avoided before completion of breast development, because it is likely to reduce ultimate breast size.

    Bauman, Novello, & Kreitzer (2016)

    Bauman, A., Novello, L., & Kreitzer, P. (2016). Endocrine Disorders and Delayed Puberty. In Appelbaum, H. (Ed.). Abnormal Female Puberty: A Clinical Casebook (pp. 87–107). Cham: Springer. [DOI:10.1007/978-3-319-27225-2_5]:

    Depending upon when ovarian failure occurs, it may also be necessary to assist in the completion of puberty if pubertal progression was interrupted. If the breasts are not fully developed, lower doses of estrogen replacement must be initiated to allow for pubertal progression. Estrogen is gradually increased to adult or maintenance replacement dosing and then progesterone is added to protect the endometrium from long-term complications associated with unopposed estrogen. Pubertal induction is initiated with estrogen treatment alone followed by the sequential addition of progesterone. Progesterone is added sequentially, rather than concomitantly, in order to allow for estrogen to independently stimulate normal breast development because early progesterone exposure to the breast tissue can result in tubular breast formation [12].

    To induce puberty, the patient will first receive low-dose estrogen, which can be given orally or transdermally. The dose is increased slowly over 2 years. This allows the patient to undergo the physical changes of puberty, including breast development. The slow increase of estradiol will also provide the opportunity for continued vertical growth. After about 12–24 months of unopposed estrogen, or if a patient experiences vaginal bleeding, she is given progesterone in cycles [47]. If the progesterone is given too early, it may result in breast deformity, but it must be started once the patient develops a uterine lining to prevent endometrial hyperplasia [40].

    Gawlik et al. (2016)

    Gawlik, A., Hankus, M., Such, K., Drosdzol-Cop, A., Madej, P., Borkowska, M., Zachurzok, A., & Malecka-Tendera, E. (2016). Hypogonadism and sex steroid replacement therapy in girls with Turner syndrome. Journal of Pediatric and Adolescent Gynecology, 29(6), 542–550. [DOI:10.1016/j.jpag.2016.03.005]:

    It is advisable to delay the addition of progestin [in hypogonadal cisgender girls] by at least 2 years or until breakthrough bleeding occurs, so as to enable normal breast and uterine development.

    Randolph (2018)

    Randolph, J. F. (2018). Gender-affirming hormone therapy for transgender females. Clinical Obstetrics and Gynecology, 61(4), 705–721. [DOI:10.1097/GRF.0000000000000396]:

    The use of progesterone, or progestins, to enhance breast development is controversial and not based on any reliable evidence. Although there are many anecdotal reports of breast growth with the addition of such agents to estrogen therapy in transwomen, no objective clinical trials are available to provide guidance on choice of medication, dose, duration, or response rate. Extrapolation from the experience in inducing breast growth in adolescent girls with absent or delayed pubertal development suggests that simultaneous initial administration of progestins with estrogen may result in abnormal and limited growth due to the simultaneous induction of ductal proliferation and terminal lobular differentiation. It is therefore recommended to initiate breast growth with estrogen alone until stability is reached with a consideration for trial of progesterone/progestin at that time. The risks of long-term progesterone/progestin therapy are unknown in transwomen. […] In view of the known course of development in normal puberty, and a description of abnormal breast growth with the early addition of progestins, it seems prudent to hold off on adding progesterone/progestin therapy until initial estrogen-induced ductal growth is complete.

    Donaldson et al. (2019)

    Donaldson, M., Kriström, B., Ankarberg-Lindgren, C., Verlinde, S., van Alfen-van der Velden, J., Gawlik, A., van Gelder, M. M. H. J., & Sas, T. (2019). Optimal pubertal induction in girls with Turner syndrome using either oral or transdermal estradiol: a proposed modern strategy. Hormone Research in Paediatrics, 91(3), 153–163. [DOI:10.1159/000500050]:

    In contrast to the Cincinnati guidelines [12], advice from gynaecology and reproductive endocrine colleagues indicated that oral progesterone should not be given pre-emptively after 2 years, or automatically at the time of the first breakthrough bleed. Instead, to allow maximum time for uterine and breast development with unopposed estrogen, it was recommended that pubertal staging and where possible pelvic ultrasound examination should be carried out at the time of bleeding so that uterine size and endometrial thickness could be determined. In cases where the endometrium is still thin and the uterus relatively small, progesterone treatment should be deferred, but introduced if ultrasound shows a mature uterus with thick endometrium.

    Heath & Wynne (2019)

    Heath, R. A., & Wynne, K. (2019). [Chapter 6:] Children and Adolescents. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 87–106). Santa Barbara: Praeger/ABC-CLIO. [Google Books]:

    In young people assigned female at birth, the first sign of estrogen exposure is usually the development of breast buds that slowly progress toward a mature breast size and shape. The beginning of breast development coincides with a growth spurt and an increase in body fat. Hair develops gradually in the armpits and pubic region. The menstrual cycle indicated by monthly periods usually starts around two years later, after breast growth is well underway. During puberty, progesterone is not made until the ovaries have started to produce eggs, at a point when breast development has finished.

    Heath, R. A., & Wynne, K. (2019). [Chapter 7:] Hormone and Surgical Therapies for Adults. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 107–146). Santa Barbara: Praeger/ABC-CLIO. [Google Books]:

    Progesterone is not involved in breast development in cisgender females. The levels of progesterone only increase late in puberty when breast development is complete.28 Progesterone is therefore not included in the initiating hormonal regimens for young cisgender women who have not spontaneously entered puberty.29 Neither does the current available evidence suggest that progestins enhance breast development for transgender women. However, there is insufficient high-quality evidence to form an absolute conclusion regarding the usefulness of progestins, and some Internet resources and clinical services still recommend their use.

    These excerpts are somewhat inaccurate though—menarche occurs on average during Tanner breast stage 4, and in the first year after menarche a minority of cycles are ovulatory, resulting in significant although intermittent progesterone exposure (Aly, 2020).

    Iwamoto et al. (2019)

    Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819871166. [DOI:10.1177/2042018819871166]:

    Pubertal data in people assigned female at birth (AFAB) (e.g. girls with Turner syndrome) argue for delaying progesterone as it causes ductal differentiation and may interfere with optimal breast development.68

    Crowley & Pitteloud (2020)

    Crowley, W. F., & Pitteloud, N. (2020). Approach to the patient with delayed puberty. UpToDate. [Google Scholar] [URL]:

    The initial estradiol doses used are below those required to induce menstruation. We add cyclic progestin therapy after two years of estradiol or when breakthrough bleeding occurs on unopposed estradiol. Our first choice for progestin therapy is oral micronized progesterone 200 mg days 1 to 12 of the calendar month. The progestin should not be added until there is substantial breast development that is not solely confined to the areolae and full contour breast growth has plateaued, because premature initiation of progestin therapy can compromise ultimate breast growth.

    Naseem, Lokman, & Fitzgerald (2021)

    Naseem, H., Lokman, M., & Fitzgerald, C. (2021). Management of congenital hypogonadotropic hypogonadism in females. Human Fertility, advance online publcation. [DOI:10.1080/14647273.2021.1998929]:

    The aims of pubertal induction in CHH, are to achieve timely secondary sex characteristics which include breast and uterine development, to attain projected final height, acquire peak bone mass, optimise reproductive potential and maintain psychological well-being. It is important to recognise that randomised controlled trials on hormonal treatment in CHH are scarce, and data on clinical observational studies are also limited. Primary variables to determine the dose of hormone replacement therapy are age, patient satisfaction and clinical response.

    Most breast development occurs in the two years of unopposed oestrogen prior to menarche. It has been stated that progesterone should be deferred until after adequate development of breast and uterus are achieved or with first breakthrough bleeding (Shifren, Gass, & NAMS Recommendations for Clinical Care of Midlife Women Working Group, 2014). However, if at first breakthrough bleed, B4 breast development or mature sonographic uterine dimensions have not been achieved, a rational approach is to slightly reduce oestradiol dose whilst continuing to defer progesterone treatment. Cyclical progestogens found in pre-packed preparations for post-menopausal women can be used or prescribed separately for 12 to 14 days in each cycle.

    The combined oral contraceptive pill’s (COCP) relatively higher dose of oestrogen and progestogen in early puberty would disrupt breast development causing breast hypoplasia, leading to early epiphyseal closure and reduced bone mass (Matthews et al., 2017). Although COCP is commonly used as HRT after puberty, its use is not endorsed by the European Consensus Guidelines for CHH, which instead recommends oestradiol-based HRT (Boehm et al., 2015). Evidence suggests that COCP does not provide optimal oestrogen replacement in young women postpuberty and the use of COCP represents inadequate treatment in these women (O’Donnell et al., 2012; Swee et al., 2019).

    Federici et al. (2022)

    Federici, S., Goggi, G., Quinton, R., Giovanelli, L., Persani, L., Cangiano, B., & Bonomi, M. (2022). New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature. Endocrine Reviews, 43(5), 824–851. [DOI:10.1210/endrev/bnab043]:

    Induction of puberty in females

    In females, adequate maturation of secondary sex characteristics is achieved with estrogen alone, while the main role of progesterone is to prevent endometrial hyperplasia. Indeed, clinical experience suggests that premature treatment with a progestogen may be deleterious to both final breast and probably also final uterine maturation.

    In summary, treatment should be initiated with a starting dose of approximately 10% of the adult replacement dose and increased (by increments of of 1.5 to 2-fold) every 6 months over a 2 to 3-year period (or less in older adolescents or young women). After at least 2 years of unopposed oestrogen, or if more than one episode of significant breakthrough bleeding occurs, it is necessary to consider a progestin to induce withdrawal bleeding, but only if adult breast and uterine conformation has been achieved. We recommend that, if symptoms of endometrial hyperplasia develop when breasts or uterus are not yet fully developed, then a slight reduction in 17β-E2 dose should be considered instead of introducing the progestin, although we acknowledge the lack of direct evidence. However, in recognition that physiologically progesterone levels only rise substantially in the late stages of puberty (174), when ovulatory cycling becomes effective, and that it plays a role in both the breast and the uterus (175), it seems to us that following this approach that aims to recapitulate normal physiology represents the path of lowest risk.

    Lucien et al. (2022)

    Lucien, J. N., Ortega, M. T., Calvert, M. E., Smith, C., White, X., Rogers, H., Mosley, B., Agrawal, R., Drude, A., McGee, C., George, M., Brown, A., Downey, K., Wild, C., Njunge, A., Kuzmiak, C. M., Zava, D., Zava, T., Pollard, J., Francis, J., Beery, B. L., Harlin, M., Gonzalez, G. R., & Shaw, N. D. (2022). The Launch of A Girl’s First Period Study: Demystifying Reproductive Hormone Profiles in Adolescent Girls. Journal of Pediatric and Adolescent Gynecology, 35(4), 420–425. [DOI:10.1016/j.jpag.2021.12.018]:

    Does exposure to low levels of [progesterone (P4)], as occurs before menarche, during anovulatory cycles with some degree of follicle luteinization, and during early, immature ovulatory cycles play an important role in normal breast development during puberty? This question has important clinical implications as hormone replacement during puberty does not typically include low-dose P4; rather, it is conducted using a staggered approach of estrogen-only therapy followed by the addition of full adult doses of exogenous P4 only after 2 years or when breakthrough bleeding occurs.27 This is done to avoid development of tubular breasts, although there are limited data linking early P4 exposure to suboptimal breast development.28

    Rothman & Iwamoto (2022)

    Rothman, M. S., & Iwamoto, S. J. (2022). Feminizing Gender-Affirming Hormone Therapy: Special Considerations for Older Adults. In Davis, T. F. (Ed.). A Case-Based Guide to Clinical Endocrinology (pp. 513–523). Cham: Springer International Publishing. [DOI:10.1007/978-3-030-84367-0_58]:

    What Role Does Progesterone Have in Breast Development and Feminizing GAHT?

    Although progesterone does not appear in feminizing GAHT recommendations in WPATH or the Endocrine Society clinical practice guidelines, many patients have questions surrounding its role in breast growth. We lack evidence for beneft from progesterone [6] in transfeminine patients although its use has been advocated for by some [7]. Much of what we know about progesterone’s risks and benefts come from data in cisgender female populations. In cisgender girls, early use of progesterone may lead to premature ductal differentiation and may be suboptimal for breast growth (e.g., Turner syndrome) [8]. […] Studies exploring progesterone’s impact on breast development have not found a difference in breast growth or referrals for breast augmentation surgery when progestins are added to estrogen treatment relative to estrogen alone [6]. In JD’s case, we would encourage her to start with estrogen and spironolactone and then reassess goals for breast growth after 1–2 years on this regimen.

    \ No newline at end of file +Literature on Early Progestogen Exposure and Breast Development - Transfeminine Science Link

    Literature on Early Progestogen Exposure and Breast Development

    By Aly | First published July 21, 2019 | Last modified March 31, 2024

    Preface

    This is a sources and excerpts supplement for the main article section which can be found here.

    Animal Studies

    Lyons & McGinty (1941)

    Lyons, W. R., & McGinty, D. A. (1941). Effects of estrone and progesterone on male rabbit mammary glands. I. Varying doses of progesterone. Proceedings of the Society for Experimental Biology and Medicine, 48(1), 83–86. [DOI:10.3181/00379727-48-13227]:

    Summary. Eighteen doses of 0.25, 1.0, 4.0 and 8.0 I.U. of crystalline progesterone were given, simultaneously with 120 I.U. of estrone, to immature male rabbits during a period of 4 weeks. Of these 4 levels of progesterone, the 1.0 I.U. dose synergized best although the prolactational proliferation induced was not maximal. The 4.0 and 8.0 I.U. doses of progesterone were apparently inhibiting as shown by the relatively poor mammary growth obtained.

    [Introduction.] Turner and Frank1 showed that whereas estrogen caused growth of the duct system and slight lobule proliferation in the male rabbit mammary gland, the combination of estrogen and progestogen caused lobule-alveolar growth simulating that seen in pregnancy. The hormones used were impure, but were assayed for rat units of estrogen and rabbit units of progestogen and judged by the results, were uncontaminated, one with the other. Until recently few investigators have had at their disposal sufficient progesterone with which to investigate this problem further, and, as, far as we are aware, the doses of estrone and progesterone that will synergize best to cause optimal mammary growth have not as yet been satisfactorily determined in any animal form. In the preliminary investigation reported herein, an attempt was made to determine the approximate dose of progesterone that would function optimally with a given daily dose (120 I.U.) of estrone in causing prolactational* growth of the male rabbit mammary gland.

    Experimental. Immature, New Zealand White male rabbits weighing approximately 1.5 kg at the beginning of the experiment were treated in groups of 3 with 18 daily doses (Monday through Friday, from 2/28/39 until 3/23/39) of the following:

    Group 1, 120 I.U. of estrone (theelin); Group 2, 1 I.U. of progesterone; Group 3, 120 I.U. of E and 0.25 I.U. of P; Group 4, 120 I. U. of E and 1 I.U. of P; Group 5, 1201 I.U. of E and 4 I.U. of P; Group 6, 120 I.U. of E and 8 I.U. of P. The 2 hormones were given separately, subcutaneously, in peanut oil. On 3/28/39, 5 days after the last injection, a biopsy specimen of the second left (thoracic) mammary gland was taken from each animal, fixed in formol, stained in toto with alum-carmine and cleared in methyl salicylate.

    Results. The maniniary spreads from Group 1, showed that the dose of 120 I.U. of E produced good duct growth with almost negligible alveolar formation (Fig. 2 [E Alone]). Those from Group 2 (1 I.U. of P) showed but little more development than that seen in normal immature rabbit glands (Fig. 1 [Untreated]). The duct system of the glands from animals in Group 3 (120 I.U. of E plus 0.25 I.U. of P) was as extensive as that seen in animals treated with 120 I.U. of E alone, but the main ducts were narrower and, as though in compensation. more alveolar buds were present. Thus, just as progesterone in some experimental animals prevents the estrogen-induced uterine dilatation and stimulates a proliferation of luminal and glandular epithelium, so also in the rabbit it counteracts an estrogen-induced mammary duct dilatation and permits instead an extensive alveolar proliferation. The amount of incomplete lobule formation shown in Fig. 3 [E + P4 0.25 mg] was found typical of all rabbits in this group and probably may be interpreted as barely minimal prolactational proliferation in response to a low dose of progesterone. The glands from animals in Group 4 (120 I.U. of E and 1.0 I.U. of P) showed the best evidence of synergism obtained in this preliminary experiment (Fig. 4 [E + P4 1 mg]), although judged on the basis of a set of glands taken at different stages of pregnancy, they could not be said to show maximal prolactational proliferation. Interesting results were obtained in Groups 5 and 6, where 2 of the animals in Group 5 and all in Group 6 showed only scanty alveolar development and an inhibition of the duct growth (Fig. 5 [E + P4 8 mg]). The third animal in Group 5 showed good prolactational development with no inhibition of duct growth, indicating that 4 I.U. of progesterone approximated the border-line inhibiting dose when given with 120 I.U. of estrone by this particular routine.

    All figures represent approximately one-half of a male rabbit mammary spread fixed in formol and stained in alum-carmine. × 1.5.

    Treatment was as follows:

    FIG. 1. None. Control gland. [Untreated]

    FIG. 2. 18 subcutaneous doses of 120 I.U. estrone in oil over a 28-day period. Duct growth with almost no alveolar development. [E Alone]

    FIG. 3. 18 subcutaneous doses of 120 I.U. estrone and 0.25 I.U. progesterone over same period. Very little prolactational proliferation. [E + P4 0.25 mg]

    FIG. 4. 18 subcutaneous doses of 120 I.U. estrone and 1 I.U. progesterone over same period. Fair prolactational proliferation. [E + P4 1 mg]

    FIG. 5. 18 subcutaneous doses of 120 I.U. estrone and 8 I.U. progesterone over same period. Inhibited duct growth and only slight alveolar development. [E + P4 8 mg]

    Note: A citing review indicated that 1 IU progesterone is equal to 1 mg progesterone (Pfeiffer, 1943).

    Beyer, Cruz, & Martinez-Manautou (1970)

    Beyer, C., Cruz, M. L., & Martinez-Manautou, J. (1970). Effect of Chlormadinone Acetate on Mammary Development and Lactation in the Rabbit. Endocrinology, 86(5), 1172–1174. [DOI:10.1210/endo-86-5-1172]:

    ABSTRACT. The effect of chlormadinone acetate (CA) on mammary growth and lactation was studied in the New Zealand white rabbit. Mammary development studies were performed in 5-month males castrated prepuberally. All rabbits were treated for 28 days. Ten μg estrone (E) produced good ductal development without alveolar growth (mean mammary area = 376 mm2). CA alone did not stimulate mammary growth. Administration of 0.5 mg CA plus 10 μg E produced optimal ductal and alveolar development (mean mammary area = 765 mm2). By contrast, a larger dose of CA (2.5 mg) combined with 10 μg E resulted in a much smaller mammary response (mean mammary area = 284 mm2). Administration of 100 μg or 2.5 mg CA from day 10 to 25 of lactation neither inhibited nor facilitated milk production in lactating rabbits. It is concluded that prolonged administration of CA when combined with estrogen stimulates mammary growth at moderate doses (0.5 mg) and inhibits it at large doses (2.5 mg). CA has no clear effect on milk production and/or removal in lactating rabbits. (Endocrinology 86: 1172, 1970)

    [Introduction]

    CHLORMADINONE acetate (CA) is a potent progestational steroid widely employed in controlling human fertility (1). It has been reported that prolonged treatment with some progestational compounds can alter mammary structure and lactation in some mammalian species, including women (2). Yet no detailed study has been done on the action of CA on the mammary gland. Therefore, we considered it interesting to analyze the effect of prolonged administration of CA upon mammary growth and lactation in New Zealand white rabbits.

    Results

    The mammary glands of the control castrated males were not visible. When studied microscopically, they were found to consist of short primary ducts that hardly extended beyond the nipple area. Injections of 500 μg CA did not stimulate mammary growth. Administration of 10 μg E induced clear growth and ramification of the ductal system. The mean area (376 ± 41 mm2 SE) occupied by these glands was significantly larger than in the control or CA treated rabbits. These glands were composed exclusively of ductal epithelium without alveoli. Combined administration of 10 μg E and 2.5 mg progesterone (P) resulted in a good ductoalveolar development. As can be seen in Fig. 1A [E + P4 2.5 mg] the ducts were almost covered with alveoli. The area occupied by these glands was significantly larger than that of the E treated rabbits (688 ± 77 mm2 SE, group 3 vs. 4, p = .004, U test). No milk secretion was noted. Administration of both E and CA at the low dose level (0.5 mg) produced marked ducto-alveolar development (Fig. 1B [E + CMA 0.5 mg]). The mammary area in these animals was more extended than in all other treated groups (765 ± 358 mm2 SE) but also no mammary secretion was observed. Injections of E plus 2.5 mg CA resulted in a dramatic reduction in mammary extension (284 ± 38 mm2 SE), when compared with the effects obtained with the low dose of CA (group 5 vs. group 6, p = .004, U test). Limited ductal extension and ramification was noted, though alveolar development existed (Fig. 1C [E + CMA 2.5 mg]).

    FIG. 1. Whole mounts of mammary glands showing development after diverse treatments: A) estrone (10 μg) plus 2 mg progesterone [E + P4 2.5 mg]; B) estrone (10 μg) plus 0.5 mg chlormadinone acetate [E + CMA 0.5 mg]; C) estrone (10 μg) plus 2.5 mg chlormadinone acetate [E + CMA 2.5 mg]. Note that the large dosage of chlormadinone acetate resulted in poor development of the ductal system.

    Discussion

    Our observations indicate that CA alone does not exert any clear effect on mammary gland growth. Similarly, P per se lacks stimulatory effects on mammary development in the gonadectomized rabbit (3). On the other hand, when low doses of CA (0.5 mg) were combined with E, maximal ducto-alveolar development occurred. The development of these glands was comparable to that observed in late pregnancy in the rabbit. The fact that the mammary growth obtained with 0.5 mg CA plus E was greater than that found after combination of P and E agrees with the observation that CA is a more potent progestational agent than P (4).

    […] It is interesting that CA in large doses inhibited mammary growth. Similarly, Lyons and McGinty (7) reported an inhibitory effect of large dosages of P (8 mg) in the intact male rabbit treated with estrogen. This inhibitory effect is probably due to the antiestrogenic action of these compounds (8).

    In summary, prolonged administration of CA, when acting on an estrogenic background, might influence mammary development in the rabbit, stimulating it at moderate and inhibiting it at high doses. By contrast, CA has no significant effect on milk production or removal.

    Clinical Publications

    Zacharin (2000)

    Zacharin, M. (2000). Use of androgens and oestrogens in adolescents - A review of hormone replacement treatment. Journal of Pediatric Endocrinology and Metabolism, 13(1), 3–12. [DOI:10.1515/JPEM.2000.13.1.3]:

    Progestogen is not required for induction of puberty. Cyclical progestogen should be added when the oestradiol dosage reaches the equivalent of 15 μg/day of ethinyl oestradiol, at which time breakthrough bleeding is almost inevitable, or earlier if vaginal bleeding has already occurred.

    Emans (2005)

    Emans, S. J. (2005). Delayed Puberty. In Emans, S. J., Laufer, M. R., Goldstein, D. P. (Eds.). Pediatric & Adolescent Gynecology, 5th Edition (pp. 181–213). Philadelphia: Lippincott Williams & Wilkins. [Google Scholar] [Google Books] [WorldCat] [Archive.org]:

    Oral contraceptives are not recommended for initial therapy because they contain progestin throughout the cycle, which is not a physiologic approach to the induction of normal breast development. During normal puberty, there is a long period of unopposed low levels of estrogen until ovulatory cycles begin (see Chapter 4). There has been speculation that particular doses of progestin or estrogen may be more likely to lead to tubular breasts, but a randomized study has not been done.

    […] The timing of the introduction of progestin varies among centers. Although in the past some girls received unopposed estrogen daily until breakthrough bleeding occurred, we believe that this method should be discouraged because adolescents benefit from a predictable onset of menses, and many girls experience significant dysfunctional bleeding that may require intervention. We suggest the addition of a short course of progestin (5 or 10 mg of medroxyprogesterone) to the continuous estrogen within 2 to 3 months of the Phase 2 increase in dose: e.g., daily estrogen plus medroxyprogesterone 10 mg each day for the first 5 days of each month. This dose of progestin is used only until breast development is completed over the next 6 months and then the dose of progestin is increased to 10 days and ultimately to 12 to 14 days for optimal protection of the endometrium if long-term hormone replacement is planned.

    Bondy et al. (2007)

    Bondy, C. A., & Turner Syndrome Consensus Study Group. (2007). Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. The Journal of Clinical Endocrinology & Metabolism, 92(1), 10–25. [DOI:10.1210/jc.2006-1374]:

    To allow for normal breast and uterine development, it seems advisable to delay the addition of progestin at least 2 yr after starting estrogen or until breakthrough bleeding occurs. The use of oral contraceptive pills to achieve pubertal development is best avoided, because the synthetic estrogen doses in most formulations are too high and the typical synthetic progestin may interfere with optimal breast and uterine development.

    Colvin, Devineni, & Ashraf (2014)

    Colvin, C., Devineni, G., & Ashraf, A. P. (2014). Delayed Puberty. In Bandeira, F., Gharib, H., Golbert, A., Griz, L., & Faria, M. (Eds.). Endocrinology and Diabetes (pp. 203–217). New York: Springer. [DOI:10.1007/978-1-4614-8684-8_17]:

    Initial therapy is with estrogen alone to maximize breast growth and to induce uterine and endometrial proliferation. Adding a progestin prematurely or administering combinations of estrogens and progestins early on may reduce ultimate breast size. Progestin is added to mimic the normal menstrual cycle after breast growth ceases (when full contour breast growth plateaus) or menses occur.

    Wierckx, Gooren, & T’Sjoen (2014)

    Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical review: breast development in trans women receiving cross-sex hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]:

    The available evidence does not provide support for better effects on breast size of adding progestogens to cross-sex hormone administration in trans women as suggested by some authors [14,18,48–51]. However, it should be said that the quality and amount of available evidence are extremely poor and hamper any firm conclusion at this moment. Also, many centers use antiandrogens with some progestational action and complicate the available evidence. In addition, some occasionally use progestins to lower testosterone levels after maximum estrogen levels when a patient cannot tolerate an estrogen-based regimen, abnormal psychological irritability, and mammary tenderness [52,53]. Furthermore, all progestogens by definition have some progestational activity, but they differ in chemical structure, metabolism, pharmacokinetics, affinity, potency, and efficacy via steroid receptors and intracellular action. All these differences can translate into very different biological and clinical effects and advocate the absence of a class effect of progestogens [54].

    Nevertheless, breast development in trans women might be similar as in cisgender women indicating a major role for estrogen rather than progesterone in the early stages of breast development. The central role of estradiol in initiating breast growth at puberty is revealed by the poor-developed breast of estrogen receptor-alpha knockout mice [55], whereas progesterone knockout mice showed to have a morphologically indistinguishable ductal architecture from wild-type virgin mice [56]. Moreover, during pubertal induction in girls, early administration of progesterone is not recommended as premature initiation of progestin therapy can compromise ultimate breast growth [57]. It is however of note that progesterone is known to be an important determinant of the histology of the breast in cis women. When the mammary epithelial of the progesterone knockout mouse is transplanted into a wild-type parous mouse, the obligatory role of progesterone in acinar and lobular development is demonstrated [58,59]. Additionally, other theoretical advantages of progesterone administration might be the fact that breast epithelium exhibits maximal proliferation in the luteal phase of menstruation, when progesterone levels are at their highest [60] and increased mammographic breast density is observed when progestogens are administered [61]. However, importantly, there is no evidence that these histological and mammographic differences result in clinically significant breast size differences. Another consideration is that the increased breast density by progestogens rapidly decreases after hormone withdrawal [62], which raises the question how long progestogens then should be prescribed.

    Kaiser & Ho (2015)

    Kaiser, U., & Ho, K. K. (2015). Pituitary Physiology and Diagnostic Evaluation. In Melmed, S., Polonsky, K. S., Larsen, P. R., Kronenberg, & H. M. (Eds.). Williams Textbook of Endocrinology, 13th Edition (pp. 176–231). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-29738-7.00008-3] [Google Books]:

    Sex Steroid Replacement Therapy. Estrogen or testosterone replacement is required for inducing and maintaining primary and secondary sexual characteristics [in patients with delayed puberty due to hypogonadism], […] Initial therapy should consist of estrogen alone to maximize breast growth and to induce uterine and endometrial proliferation. […] A progestin eventually needs to be added to prevent endometrial hyperplasia but should be avoided before completion of breast development, because it is likely to reduce ultimate breast size.

    Bauman, Novello, & Kreitzer (2016)

    Bauman, A., Novello, L., & Kreitzer, P. (2016). Endocrine Disorders and Delayed Puberty. In Appelbaum, H. (Ed.). Abnormal Female Puberty: A Clinical Casebook (pp. 87–107). Cham: Springer. [DOI:10.1007/978-3-319-27225-2_5]:

    Depending upon when ovarian failure occurs, it may also be necessary to assist in the completion of puberty if pubertal progression was interrupted. If the breasts are not fully developed, lower doses of estrogen replacement must be initiated to allow for pubertal progression. Estrogen is gradually increased to adult or maintenance replacement dosing and then progesterone is added to protect the endometrium from long-term complications associated with unopposed estrogen. Pubertal induction is initiated with estrogen treatment alone followed by the sequential addition of progesterone. Progesterone is added sequentially, rather than concomitantly, in order to allow for estrogen to independently stimulate normal breast development because early progesterone exposure to the breast tissue can result in tubular breast formation [12].

    To induce puberty, the patient will first receive low-dose estrogen, which can be given orally or transdermally. The dose is increased slowly over 2 years. This allows the patient to undergo the physical changes of puberty, including breast development. The slow increase of estradiol will also provide the opportunity for continued vertical growth. After about 12–24 months of unopposed estrogen, or if a patient experiences vaginal bleeding, she is given progesterone in cycles [47]. If the progesterone is given too early, it may result in breast deformity, but it must be started once the patient develops a uterine lining to prevent endometrial hyperplasia [40].

    Gawlik et al. (2016)

    Gawlik, A., Hankus, M., Such, K., Drosdzol-Cop, A., Madej, P., Borkowska, M., Zachurzok, A., & Malecka-Tendera, E. (2016). Hypogonadism and sex steroid replacement therapy in girls with Turner syndrome. Journal of Pediatric and Adolescent Gynecology, 29(6), 542–550. [DOI:10.1016/j.jpag.2016.03.005]:

    It is advisable to delay the addition of progestin [in hypogonadal cisgender girls] by at least 2 years or until breakthrough bleeding occurs, so as to enable normal breast and uterine development.

    Randolph (2018)

    Randolph, J. F. (2018). Gender-affirming hormone therapy for transgender females. Clinical Obstetrics and Gynecology, 61(4), 705–721. [DOI:10.1097/GRF.0000000000000396]:

    The use of progesterone, or progestins, to enhance breast development is controversial and not based on any reliable evidence. Although there are many anecdotal reports of breast growth with the addition of such agents to estrogen therapy in transwomen, no objective clinical trials are available to provide guidance on choice of medication, dose, duration, or response rate. Extrapolation from the experience in inducing breast growth in adolescent girls with absent or delayed pubertal development suggests that simultaneous initial administration of progestins with estrogen may result in abnormal and limited growth due to the simultaneous induction of ductal proliferation and terminal lobular differentiation. It is therefore recommended to initiate breast growth with estrogen alone until stability is reached with a consideration for trial of progesterone/progestin at that time. The risks of long-term progesterone/progestin therapy are unknown in transwomen. […] In view of the known course of development in normal puberty, and a description of abnormal breast growth with the early addition of progestins, it seems prudent to hold off on adding progesterone/progestin therapy until initial estrogen-induced ductal growth is complete.

    Donaldson et al. (2019)

    Donaldson, M., Kriström, B., Ankarberg-Lindgren, C., Verlinde, S., van Alfen-van der Velden, J., Gawlik, A., van Gelder, M. M. H. J., & Sas, T. (2019). Optimal pubertal induction in girls with Turner syndrome using either oral or transdermal estradiol: a proposed modern strategy. Hormone Research in Paediatrics, 91(3), 153–163. [DOI:10.1159/000500050]:

    In contrast to the Cincinnati guidelines [12], advice from gynaecology and reproductive endocrine colleagues indicated that oral progesterone should not be given pre-emptively after 2 years, or automatically at the time of the first breakthrough bleed. Instead, to allow maximum time for uterine and breast development with unopposed estrogen, it was recommended that pubertal staging and where possible pelvic ultrasound examination should be carried out at the time of bleeding so that uterine size and endometrial thickness could be determined. In cases where the endometrium is still thin and the uterus relatively small, progesterone treatment should be deferred, but introduced if ultrasound shows a mature uterus with thick endometrium.

    Heath & Wynne (2019)

    Heath, R. A., & Wynne, K. (2019). [Chapter 6:] Children and Adolescents. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 87–106). Santa Barbara: Praeger/ABC-CLIO. [Google Books]:

    In young people assigned female at birth, the first sign of estrogen exposure is usually the development of breast buds that slowly progress toward a mature breast size and shape. The beginning of breast development coincides with a growth spurt and an increase in body fat. Hair develops gradually in the armpits and pubic region. The menstrual cycle indicated by monthly periods usually starts around two years later, after breast growth is well underway. During puberty, progesterone is not made until the ovaries have started to produce eggs, at a point when breast development has finished.

    Heath, R. A., & Wynne, K. (2019). [Chapter 7:] Hormone and Surgical Therapies for Adults. In Heath, R. A., & Wynne, K. A Guide to Transgender Health: State-of-the-art Information for Gender-Affirming People and Their Supporters (pp. 107–146). Santa Barbara: Praeger/ABC-CLIO. [Google Books]:

    Progesterone is not involved in breast development in cisgender females. The levels of progesterone only increase late in puberty when breast development is complete.28 Progesterone is therefore not included in the initiating hormonal regimens for young cisgender women who have not spontaneously entered puberty.29 Neither does the current available evidence suggest that progestins enhance breast development for transgender women. However, there is insufficient high-quality evidence to form an absolute conclusion regarding the usefulness of progestins, and some Internet resources and clinical services still recommend their use.

    These excerpts are somewhat inaccurate though—menarche occurs on average during Tanner breast stage 4, and in the first year after menarche a minority of cycles are ovulatory, resulting in significant although intermittent progesterone exposure (Aly, 2020).

    Iwamoto et al. (2019)

    Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819871166. [DOI:10.1177/2042018819871166]:

    Pubertal data in people assigned female at birth (AFAB) (e.g. girls with Turner syndrome) argue for delaying progesterone as it causes ductal differentiation and may interfere with optimal breast development.68

    Crowley & Pitteloud (2020)

    Crowley, W. F., & Pitteloud, N. (2020). Approach to the patient with delayed puberty. UpToDate. [Google Scholar] [URL]:

    The initial estradiol doses used are below those required to induce menstruation. We add cyclic progestin therapy after two years of estradiol or when breakthrough bleeding occurs on unopposed estradiol. Our first choice for progestin therapy is oral micronized progesterone 200 mg days 1 to 12 of the calendar month. The progestin should not be added until there is substantial breast development that is not solely confined to the areolae and full contour breast growth has plateaued, because premature initiation of progestin therapy can compromise ultimate breast growth.

    Naseem, Lokman, & Fitzgerald (2021)

    Naseem, H., Lokman, M., & Fitzgerald, C. (2021). Management of congenital hypogonadotropic hypogonadism in females. Human Fertility, advance online publcation. [DOI:10.1080/14647273.2021.1998929]:

    The aims of pubertal induction in CHH, are to achieve timely secondary sex characteristics which include breast and uterine development, to attain projected final height, acquire peak bone mass, optimise reproductive potential and maintain psychological well-being. It is important to recognise that randomised controlled trials on hormonal treatment in CHH are scarce, and data on clinical observational studies are also limited. Primary variables to determine the dose of hormone replacement therapy are age, patient satisfaction and clinical response.

    Most breast development occurs in the two years of unopposed oestrogen prior to menarche. It has been stated that progesterone should be deferred until after adequate development of breast and uterus are achieved or with first breakthrough bleeding (Shifren, Gass, & NAMS Recommendations for Clinical Care of Midlife Women Working Group, 2014). However, if at first breakthrough bleed, B4 breast development or mature sonographic uterine dimensions have not been achieved, a rational approach is to slightly reduce oestradiol dose whilst continuing to defer progesterone treatment. Cyclical progestogens found in pre-packed preparations for post-menopausal women can be used or prescribed separately for 12 to 14 days in each cycle.

    The combined oral contraceptive pill’s (COCP) relatively higher dose of oestrogen and progestogen in early puberty would disrupt breast development causing breast hypoplasia, leading to early epiphyseal closure and reduced bone mass (Matthews et al., 2017). Although COCP is commonly used as HRT after puberty, its use is not endorsed by the European Consensus Guidelines for CHH, which instead recommends oestradiol-based HRT (Boehm et al., 2015). Evidence suggests that COCP does not provide optimal oestrogen replacement in young women postpuberty and the use of COCP represents inadequate treatment in these women (O’Donnell et al., 2012; Swee et al., 2019).

    Federici et al. (2022)

    Federici, S., Goggi, G., Quinton, R., Giovanelli, L., Persani, L., Cangiano, B., & Bonomi, M. (2022). New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature. Endocrine Reviews, 43(5), 824–851. [DOI:10.1210/endrev/bnab043]:

    Induction of puberty in females

    In females, adequate maturation of secondary sex characteristics is achieved with estrogen alone, while the main role of progesterone is to prevent endometrial hyperplasia. Indeed, clinical experience suggests that premature treatment with a progestogen may be deleterious to both final breast and probably also final uterine maturation.

    In summary, treatment should be initiated with a starting dose of approximately 10% of the adult replacement dose and increased (by increments of of 1.5 to 2-fold) every 6 months over a 2 to 3-year period (or less in older adolescents or young women). After at least 2 years of unopposed oestrogen, or if more than one episode of significant breakthrough bleeding occurs, it is necessary to consider a progestin to induce withdrawal bleeding, but only if adult breast and uterine conformation has been achieved. We recommend that, if symptoms of endometrial hyperplasia develop when breasts or uterus are not yet fully developed, then a slight reduction in 17β-E2 dose should be considered instead of introducing the progestin, although we acknowledge the lack of direct evidence. However, in recognition that physiologically progesterone levels only rise substantially in the late stages of puberty (174), when ovulatory cycling becomes effective, and that it plays a role in both the breast and the uterus (175), it seems to us that following this approach that aims to recapitulate normal physiology represents the path of lowest risk.

    Lucien et al. (2022)

    Lucien, J. N., Ortega, M. T., Calvert, M. E., Smith, C., White, X., Rogers, H., Mosley, B., Agrawal, R., Drude, A., McGee, C., George, M., Brown, A., Downey, K., Wild, C., Njunge, A., Kuzmiak, C. M., Zava, D., Zava, T., Pollard, J., Francis, J., Beery, B. L., Harlin, M., Gonzalez, G. R., & Shaw, N. D. (2022). The Launch of A Girl’s First Period Study: Demystifying Reproductive Hormone Profiles in Adolescent Girls. Journal of Pediatric and Adolescent Gynecology, 35(4), 420–425. [DOI:10.1016/j.jpag.2021.12.018]:

    Does exposure to low levels of [progesterone (P4)], as occurs before menarche, during anovulatory cycles with some degree of follicle luteinization, and during early, immature ovulatory cycles play an important role in normal breast development during puberty? This question has important clinical implications as hormone replacement during puberty does not typically include low-dose P4; rather, it is conducted using a staggered approach of estrogen-only therapy followed by the addition of full adult doses of exogenous P4 only after 2 years or when breakthrough bleeding occurs.27 This is done to avoid development of tubular breasts, although there are limited data linking early P4 exposure to suboptimal breast development.28

    Rothman & Iwamoto (2022)

    Rothman, M. S., & Iwamoto, S. J. (2022). Feminizing Gender-Affirming Hormone Therapy: Special Considerations for Older Adults. In Davis, T. F. (Ed.). A Case-Based Guide to Clinical Endocrinology (pp. 513–523). Cham: Springer International Publishing. [DOI:10.1007/978-3-030-84367-0_58]:

    What Role Does Progesterone Have in Breast Development and Feminizing GAHT?

    Although progesterone does not appear in feminizing GAHT recommendations in WPATH or the Endocrine Society clinical practice guidelines, many patients have questions surrounding its role in breast growth. We lack evidence for beneft from progesterone [6] in transfeminine patients although its use has been advocated for by some [7]. Much of what we know about progesterone’s risks and benefts come from data in cisgender female populations. In cisgender girls, early use of progesterone may lead to premature ductal differentiation and may be suboptimal for breast growth (e.g., Turner syndrome) [8]. […] Studies exploring progesterone’s impact on breast development have not found a difference in breast growth or referrals for breast augmentation surgery when progestins are added to estrogen treatment relative to estrogen alone [6]. In JD’s case, we would encourage her to start with estrogen and spironolactone and then reassess goals for breast growth after 1–2 years on this regimen.

    \ No newline at end of file diff --git a/transfemscience.org/articles/progestogens-sexual-desire/index.html b/transfemscience.org/articles/progestogens-sexual-desire/index.html index bcb3fb7c..3c6fc0ae 100644 --- a/transfemscience.org/articles/progestogens-sexual-desire/index.html +++ b/transfemscience.org/articles/progestogens-sexual-desire/index.html @@ -1 +1 @@ -The Influence of Progesterone and Other Progestogens on Sexual Desire and Function - Transfeminine Science Link

    The Influence of Progesterone and Other Progestogens on Sexual Desire and Function

    By Aly | First published January 9, 2020 | Last modified March 22, 2024

    Abstract / TL;DR

    Many transfeminine people believe on the basis of anecdotes that progesterone increases sexual desire. A review was conducted to assess the available evidence for the possibility that progesterone and/or progestogens increase sexual desire. Both animal studies as well as clinical studies with progesterone and progestins were considered. Progesterone has shown no indication of stimulatory effects on sexual desire or behavior in humans and non-human primates. High doses of progestogens have however been found to inhibit sexual desire in humans and non-human primates. More research is necessary to further characterize the role of progesterone and other progestogens in sexual desire in humans. In any case, available evidence does not support a positive role of these hormonal agents in sexual desire. Instead, sexual desire is more related to androgens and estrogens in men and women, respectively.

    Introduction

    Based on anecdotal experience, some people in the transfeminine community believe that progesterone has positive effects on sexual desire. This is such that even memes about progesterone and libido have been made (Reddit). In addition to anecdotes, some researchers have theorized that progesterone may be positively involved in sexual desire in cisgender women (Regan, 1999). Some have also argued that the neurosteroid metabolites of progesterone like allopregnanolone and pregnanolone may provide special benefits on sexual desire that are not shared with progestins. I’ve reviewed the available evidence and literature to assess whether progesterone or other progestogens indeed improve sexual desire function in cisgender women and might be useful for this in transfeminine people.

    Animal Studies

    Correlational

    Progesterone levels are strongly and consistently negatively associated with female sexual desire and behavior in most animal species (Roney, 2015). This includes in monkeys and apes (Roney, 2015).

    Experimental

    Non-Human Primates

    Progesterone, both alone and when added to an estrogen, has been shown to inhibit sexual behavior and receptivity in female monkeys in many studies (Luttge, 1971; Baum et al., 1976; Baum et al., 1977a; Michael et al., 1967). This inhibition is often marked. Likewise, subcutaneous implants of progesterone were shown to suppress sexual behavior in testosterone-treated castrated male monkeys (Zumpe, Clancy, & Michael, 1997). As the male monkeys were castrated and treated with testosterone, this was not due to decreased testosterone levels (which remained unchanged), and could only have been due to the other effects of progesterone. Similar findings have been made for the progestin medroxyprogesterone acetate (MPA) (Michael & Zumpe, 1993; Zumpe et al., 1991; Zumpe & Michael, 1988).

    The following excerpt from a review is notable on the topic of progesterone and sexual behavior in primates (Baum, 1983):

    The early work of Ball (1941) and of Michael et al. (1968) showed that progesterone acts in the female rhesus monkey to reduce the likelihood of copulation. In contrast to non primate females, no facilitatory action of progesterone on any aspect of feminine sexuality has ever been convincingly demonstrated in primates.

    One study in female monkeys found that MPA inhibited sexual behavior while progesterone did not (Pazol et al., 2004). However, MPA is a much more potent progestogen than progesterone, and the progesterone levels were very low (2 ng/mL). Hence, the progesterone levels in this study may have been too low for adequate physiological effect, which might explain the conflicting finding compared to other studies. Another study found increased sexual receptivity in castrated female monkeys treated with a combination of an estrogen and parenteral progesterone (Baum et al., 1977b). However, this was relative to a baseline of castration, and the changes may have only been due to the estrogen. Indeed, the same researchers reported decreased sexual receptivity with the addition of progesterone to estrogen in other studies (Baum et al., 1976; Baum et al., 1977a).

    Mifepristone, a progesterone receptor antagonist, showed no apparent effect on sexual behavior in either female or male monkeys (Nadler et al., 1985).

    Rodents

    A notable exception when it comes to progesterone and sexual behavior in animals is female rodents, in which progesterone is stimulatory and induces lordosis (Frye, 2007). Allopregnanolone is involved in the facilitatory effects of progesterone on female sexual behavior in rodents, but has mixed effects, showing either augmentation or inhibition depending on the specifics (King, 2013; Frye, 2007). However, progesterone stimulates sexual behavior in female rodents only acutely, and is actually inhibitory with continuous administration (Pazol et al., 2004; Pazol et al., 2006). Studies in estrogen-primed intact male rats have found that progesterone given systemically does not induce lordosis (Ward et al., 1977). Interestingly however, lordosis was found to be induced in some male rats when progesterone was injected directly into a specific part of the hypothalamus (Ward et al., 1977). The prosexual effects of progesterone in female rodents may be mediated via non-genomic mechanisms, for instance actions of progesterone’s neurosteroid metabolites (Delville, 1991).

    In addition to female rodents, research has found that progesterone is involved in normal sexual behavior in male rats (Witt et al., 1995; Andersen & Tufik, 2006). In male rats, castration greatly decreases levels of both testosterone and progesterone and markedly reduces sexual behavior (Witt et al., 1995). Low-dose progesterone administration, resulting in low but physiological male-range levels of progesterone, significantly restores sexual behavior (Witt et al., 1995). Additionally, when testosterone is concomitantly administered, progesterone augments the improvement caused by testosterone and is required for sexual behavior to be fully restored (Witt et al., 1995). The effects are mimicked by progestins like promegestone and blocked by the progesterone receptor antagonist mifepristone, suggesting that they are due specifically to activation of the progesterone receptor (Witt et al., 1995).

    However, the findings in male rats probably do not apply to primates. As already described, mifepristone, in contrast to male rats, has no influence on sexual behavior in male monkeys (Nadler et al., 1985). Similarly, a study in castrated male monkeys given testosterone in combination with a relatively low dose of progesterone—resulting in roughly doubled progesterone levels relative to normal male levels—found no difference in sexual behavior compared to castrated male monkeys given testosterone alone (Buhl, Jensen, & Phoenix, 1978). Hence, neither progesterone receptor antagonism nor restoration of progesterone levels following castration seems to influence sexual behavior in male primates. It’s also notable that unlike in male rodents, castration doesn’t appear to reduce progesterone levels in either male monkeys (Zumpe, Clancy, & Michael, 1997) or humans (Waxman et al., 2013). As such, even if the rodent findings did apply to humans, castrated men have normal male-range progesterone levels and would in theory have all the progesterone needed to maintain sexual desire.

    The findings on male-range progesterone levels and sexual behavior in male rats are also in contrast to research with higher, supraphysiological levels of progesterone (Hawley & Mosura, 2019). This degree of progesterone exposure has been shown to inhibit sexual behavior in males of most or all species examined, notably including male rats (Hawley & Mosura, 2019). This is the case regardless of influence on testosterone levels (Hawley & Mosura, 2019).

    Other Species

    Progestogens are used to inhibit heat in female dogs and cats (Neumann, 1978).

    Clinical Research

    Correlational

    Progesterone levels in women are negatively associated, in some studies strongly, with sexual desire and behavior in women (Shirazi et al., 2019; Roney, 2015; Roney & Simmons, 2013; Roney & Simmons, 2016; Roney, 2019). One conflicting study reported a positive association of luteal-phase progesterone levels with initiation of sexual activity with partners, but the same researchers had contradictory findings in a subsequent study (Holder & Mong, 2017; Roney, 2015; Jones et al., 2019).

    Sexual desire is progressively decreased in women during pregnancy, a state characterized by very high levels of estrogens, progesterone, and prolactin (Regan et al., 2003; Gałązka et al., 2014). However, many confounding factors exist (e.g., the other hormonal changes, or being pregnant), and hence causation of the changes can’t necessarily be attributed to progesterone. The observations do suggest that very high levels of an estrogen and progesterone may be unlikely to increase sexual desire however.

    Experimental

    Progestins

    A 2013 meta-analysis reported that combined birth control pills, containing both ethinylestradiol and a progestogen, result in either unchanged or increased sexual desire in most women (85%) and decreased sexual desire in a small percentage of women (15%) (Pastor et al., 2013). However, changes in sexual desire seem to be related to the ethinylestradiol component rather than to the progestin component; decreased sexual desire was only associated with birth control pills containing low-dose estrogen (20 μg ethinylestradiol) (Pastor et al., 2013). The fact that combined birth control pills infrequently decrease sexual desire in women is notable because these medications suppress ovulation and hence completely prevent the increase in progesterone levels during the luteal phase. As such, progesterone levels, and by extension circulating levels of allopregnanolone and pregnanolone, remain very low at all times. This suggests little or no importance of the neurosteroid metabolites of progesterone for sexual desire in women.

    The fact that combined birth control pills don’t generally affect sexual desire in women is also potentially surprising because total and free testosterone levels are greatly decreased by them due to the ethinylestradiol component (Zimmerman et al., 2014). This is, however, in accordance with accumulating evidence suggesting that physiological levels of androgens in women have little or no involvement in sexual desire (Cappelletti & Wallen, 2016). Rather than progesterone or androgens, what seems to be important for sexual desire in women is estradiol, especially acutely at periovulatory levels (Cappelletti & Wallen, 2016).

    A small minority of women treated with depot medroxyprogesterone acetate (DMPA) alone for birth control report decreased libido and only 2.3% cite it as a reason for discontinuation (Schaffir, 2006). A study of 80 women treated with DMPA alone for birth control monitored sexual function and found no difference from baseline to 4 months of therapy (Schaffir, 2006). Findings have been similar for subcutaneous birth control implants with nomegestrol acetate and levonorgestrel (Schaffir, 2006). A randomized controlled trial of 150 women given combined birth control pills, progestin-only birth control pills, and placebo found no difference in sexual desire or activity between progestin-only pills and placebo (Schaffir, 2006).

    The addition of a progestin to an estrogen in hormone therapy for menopausal women has been found not to improve sexual desire or function to a greater extent than an estrogen alone in individual studies (Çayan et al., 2008; Myers et al., 1990; Sherwin, 1991; Savolainen-Peltonen et al., 2014; Dennerstein et al., 1980; Alexander et al., 2004; Saadat et al., 2002; Davis et al., 2004; Modelska & Milián, 2004; Sandhu et al., 2011). A couple of studies have found that improvement in sexual desire/function is better with an estrogen alone than with an estrogen plus a progestin, suggesting that progestins might have an adverse influence (Çayan et al., 2008; Dennerstein et al., 1980; Kovalevsky, 2005; Castelo-Branco et al., 2007). Overall however, the available research suggests no change in sexual desire/function with addition of a progestin to an estrogen in menopausal hormone therapy (Sandhu et al., 2011).

    Interestingly, a 2018 meta-analysis reported a higher standardized mean difference (SMD) for improvement of sexual desire/function in studies with an estrogen plus a progestogen relative to studies using an estrogen alone (Javadivala et al., 2019). However, there was differing methodology (e.g., sexual measures) and high heterogeneity across studies, as well as a limited number of included studies (particularly of estrogen only). These issues make conclusions on the basis of the differing SMDs problematic. Indeed, the finding is contradicted by individual studies that have included both estrogen only and estrogen plus progestogen groups (see the sources above).

    Besides progestogenic activity, it has been suggested that androgenic progestins, like most of the testosterone derivatives, might provide better effects on sexual desire/function than non-androgenic progestins (Graziottin & Serafini, 2011). However, aside from the case of the atypical agent tibolone (Biglia et al., 2010), this has not actually been assessed or shown in any clinical trials (Schaffir, 2006).

    The addition of dydrogesterone to hormone therapy for transgender women to improve sexual desire showed no effect, whereas transdermal testosterone was effective (Kronawitter et al., 2009).

    A 1975 study published as an abstract with little additional information claimed that some premenopausal women with “frigidity” had high progesterone levels and that treatment with levonorgestrel alone to suppress progesterone levels could increase libido in these women (Kristoffersen & Lebech, 1975). This is very low-quality information however.

    Progesterone

    Available clinical studies of progesterone and sexual desire in women have observed no changes (Worsley et al., 2016). Neither 200 mg/day oral progesterone nor 10 mg/day oral MPA had any influence on mood or libido in estrogen-treated postmenopausal women in a randomized controlled trial (Saadat et al., 2002). Likewise, treatment of pharmacologically hypogonadal women with 400 mg/day vaginal progesterone suppositories alone did not significantly alter any domain of sexual function in another randomized controlled trial (Schmidt et al., 2009). Treatment of women with subcutaneous implants of progesterone alone for gynecological disorders has been reported to decrease sexual desire in an uncontrolled clinical study (Regan, 1999). Conversely, a retrospective chart review of 137 women with severe premenstrual syndrome treated during the luteal phase with 100–200+ mg/day vaginal progesterone suppositories alone for birth control reported that decreased libido was a side effect in 1 woman (0.7%) (Dalton, Guthrie, & Dalton, 1987).

    One study assessed the influence on mood and libido of estradiol plus cyclic 200 mg/day oral progesterone in premenopausal women and estradiol plus cyclic 200 mg/day vaginal progesterone in perimenopausal women (Nappi et al., 2004). The premenopausal women were suffering from menstrual irregularities, depression, and sexual dysfunction, while the perimenopausal women were presumably experiencing menopausal symptoms. A significant improvement in libido, sexual arousal, and pain was observed with therapy in the premenopausal women who had a concomitant improvement in anxiety, irritability, and appetite, but not in those who remained depressed. The findings in the perimenopausal women were similar; the hormonal therapy improved sexual desire only in those who experienced improvement in anxiety, panic, and tension, but not in those in whom depression remained. The findings of this study, although interesting, are unfortunately confounded by the lack of an estradiol-only control group, and so can’t necessarily be attributed to progesterone. Moreover, the findings are confounded by the presence and alleviation of the mood symptoms, anxiety, and other problems in the women; it’s possible that estradiol and progesterone did not increase sexual desire themselves but rather it was the improvement of the other symptoms that produced the changes.

    Another randomized controlled trial found that an estrogen plus 1.25 mg/day methyltestosterone and 100 mg/day oral progesterone significantly improved sexual desire and function relative to placebo in postmenopausal women (Blümel et al., 2008). However, this study was confounded by the presence of methyltestosterone and the lack of a no-progesterone control group.

    Transdermal progesterone cream at a dosage of 32 mg/day had no influence on sexual desire or other parameters in postmenopausal women (Wren et al., 2003; Worsley et al., 2016).

    A recent chapter in a book on progestogens included the following passage (Nadjafi-Triebsch, 2015):

    Progesterone improves sexual performance in [male] rats [13]. Consequently, progesterone should also improve sexual performance in men due to similarities to human neuro-endocrine mechanisms. Indeed, patients receiving progesterone reported more frequent morning erections and distinctively improved sexual performance.

    However, no source or other information (e.g., study design, route/dosage, etc.) was provided. The claim was probably based on anecdotal clinical experience. In addition, the chapter makes some problematic statements like “progesterone prevents prostate cancer” and “progesterone treats autism”, along with ample reference to low-quality unpublished clinical experience, that seriously hurt its credibility.

    High-Dose Progestogens in Men

    High-dose progestogen monotherapy with cyproterone acetate (CPA) or MPA is widely used to suppress sexual desire and function in men with sexual deviance, including hypersexuality, paraphilias, and sex offenses (Wiki; Codispoti, 2008). This therapy results in strong sexual suppression and is very effective. Its efficacy is thought to be due to suppression of testosterone levels. However, there is some evidence that progestogenic activity in the brain itself and/or increased prolactin levels secondary to progestogenic activity may also be involved (Zumpe, Clancy, & Michael, 1997; Rastrelli, Corona, & Maggi, 2015; Wiki). Although estrogens suppress testosterone levels and increase prolactin levels similarly to progestogens and have likewise been used in the treatment of male sexual deviance (Wiki; Wiki), they are also known to have beneficial effects on sexual desire in both women and men (Wallen et al., 1984; Wibowo, Schellhammer, & Wasserug, 2011; Cappelletti & Wallen, 2016; Santoro et al., 2016; Gilbert et al., 2017). In relation to this, estrogens may not result in the same degree of suppression of sexual desire and function as progestogens. As with CPA and MPA, progesterone alone by intramuscular injection has been found to substantially suppress sexual desire and function in men (Wiki; Regan, 1999).

    Conclusion

    Taken together, there appears to be little or no evidence that progesterone or other progestogens improve sexual desire or function in humans. Instead, the available evidence suggests that progestogens are likely to result in either unchanged or decreased sexual desire and function. Decreased sexual desire/function may be especially likely at high doses. In any case, more research on progestogens and sexual desire, particularly with non-oral progesterone, is warranted.

    References

    • Alexander, J. L., Kotz, K., Dennerstein, L., Kutner, S. J., Wallen, K., & Notelovitz, M. (2004). The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause, 11(6), 749–765. [DOI:10.1097/01.gme.0000142887.31811.97]
    • Andersen, M. L., & Tufik, S. (2006). Does male sexual behavior require progesterone? Brain Research Reviews, 51(1), 136–143. [DOI:10.1016/j.brainresrev.2005.10.005]
    • Baum, M. J., Everitt, B. J., Herbert, J., Keverne, E. B., & de Greef, W. J. (1976). Reduction of sexual interaction in rhesus monkeys by a vaginal action of progesterone. Nature, 263(5578), 606–608. [DOI:10.1038/263606a0]
    • Baum, M. J., Everitt, B. J., Herbert, J., & Keverne, E. B. (1977). Hormonal basis of proceptivity and receptivity in female primates. Archives of Sexual Behavior, 6(3), 173–192. [DOI:10.1007/bf01541126]
    • Baum, M., Keverne, E., Everitt, B., Herbert, J., & De Greef, W. (1977). Effects of progesterone and estradiol on sexual attractivity of female rhesus monkeys. Physiology & Behavior, 18(4), 659–670. [DOI:10.1016/0031-9384(77)90064-6]
    • Baum, M. J. (1983). Hormonal Modulation of Sexuality in Female Primates. BioScience, 33(9), 578–582. [DOI:10.2307/1309209]
    • Biglia, N., Maffei, S., Lello, S., & Nappi, R. E. (2010). Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecological Endocrinology, 26(11), 804–814. [DOI:10.3109/09513590.2010.495437]
    • Blümel, J. E., Del Pino, M., Aprikian, D., Vallejo, S., Sarrá, S., & Castelo-Branco, C. (2008). Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction. Gynecological Endocrinology, 24(12), 691–695. [DOI:10.1080/09513590802454919]
    • Buhl, A. (1978). Influence of progesterone on sexual behavior in castrated male rhesus monkeys treated with testosterone. Hormones and Behavior, 10(3), 258–263. [DOI:10.1016/0018-506x(78)90070-3]
    • Cappelletti, M., & Wallen, K. (2016). Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior, 78, 178–193. [DOI:10.1016/j.yhbeh.2015.11.003]
    • Castelo-Branco, C., Cancelo, M. J., & Chedraui, P. (2007). Female sexual dysfunction in postmenopausal women. Expert Opinion on Therapeutic Patents, 17(6), 639–647. [DOI:10.1517/13543776.17.6.639]
    • Çayan, F., Dilek, U., Pata, Ö., & Dilek, S. (2008). Comparison of the Effects of Hormone Therapy Regimens, Oral and Vaginal Estradiol, Estradiol+Drospirenone and Tibolone, on Sexual Function in Healthy Postmenopausal Women. The Journal of Sexual Medicine, 5(1), 132–138. [DOI:10.1111/j.1743-6109.2007.00635.x]
    • Codispoti, V. L. (2008). Pharmacology of Sexually Compulsive Behavior. Psychiatric Clinics of North America, 31(4), 671–679. [DOI:10.1016/j.psc.2008.06.002]
    • Dalton, M. E., Guthrie, K. A., & Dalton, K. (1987). A preliminary study into the efficacy of progesterone suppositories as a contraceptive for women with severe premenstrual syndrome. The British Journal of Family Planning, 13(3), 87–89. [Google Scholar] [PDF]
    • Davis, S. R., Guay, A. T., Shifren, J. L., & Mazer, N. A. (2004). Endocrine Aspects of Female Sexual Dysfunction. The Journal of Sexual Medicine, 1(1), 82–86. [DOI:10.1111/j.1743-6109.2004.10112.x]
    • Delville, Y. (1991). Progesterone-facilitated sexual receptivity: A review of arguments supporting a nongenomic mechanism. Neuroscience & Biobehavioral Reviews, 15(3), 407–414. [DOI:10.1016/s0149-7634(05)80033-8]
    • Dennerstein, L., Burrows, G. D., Wood, C., & Hyman, G. (1980). Hormones and sexuality: effect of estrogen and progestogen. Obstetrics & Gynecology, 56(3), 316–322. [Google Scholar] [PubMed] [URL] [PDF]
    • Frye, C. A. (2007). Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacology Biochemistry and Behavior, 86(2), 209–219. [DOI:10.1016/j.pbb.2006.07.033]
    • Gałązka, I., Drosdzol-Cop, A., Naworska, B., Czajkowska, M., & Skrzypulec-Plinta, V. (2015). Changes in the Sexual Function During Pregnancy. The Journal of Sexual Medicine, 12(2), 445–454. [DOI:10.1111/jsm.12747]
    • Gilbert, D. C., Duong, T., Kynaston, H. G., Alhasso, A. A., Cafferty, F. H., Rosen, S. D., Kanaga-Sundaram, S., Dixit, S., Laniado, M., Madaan, S., Collins, G., Pope, A., Welland, A., Nankivell, M., Wassersug, R., Parmar, M. K., Langley, R. E., & Abel, P. D. (2016). Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. BJU International, 119(5), 667–675. [DOI:10.1111/bju.13687]
    • Graziottin, A., & Serafini, A. (2011). Medical Treatments for Sexual Problems in Women. In Mulhall, J. P., Incrocci, L., Goldstein, I., & Rosen, R. (Eds.). Cancer and Sexual Health (pp. 627–641). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-60761-916-1_40]
    • Hawley, W. R., & Mosura, D. E. (2019). Effects of progesterone treatment during adulthood on consummatory and motivational aspects of sexual behavior in male rats. Behavioural Pharmacology, 30(7), 617–622. [DOI:10.1097/fbp.0000000000000490]
    • Holder, M. K., & Mong, J. A. (2017). The Role of Ovarian Hormones and the Medial Amygdala in Sexual Motivation. Current Sexual Health Reports, 9(4), 262–270. [DOI:10.1007/s11930-017-0131-4]
    • Javadivala, Z., Merghati-Khoei, E., Asghari Jafarabadi, M., Allahverdipour, H., Mirghafourvand, M., Nadrian, H., & Kouzekanani, K. (2018). Efficacy of pharmacological and non-pharmacological interventions on low sexual interest/arousal of peri- and post-menopausal women: a meta-analysis. Sexual and Relationship Therapy, 34(2), 242–270. [DOI:10.1080/14681994.2018.1446515]
    • Jones, B. C., Hahn, A. C., & DeBruine, L. M. (2019). Ovulation, Sex Hormones, and Women’s Mating Psychology. Trends in Cognitive Sciences, 23(1), 51–62. [DOI:10.1016/j.tics.2018.10.008]
    • King, S. R. (2012). Neurosteroids and the Nervous System. In King, S. R. Neurosteroids and the Nervous System (pp. 1–122). New York: Springer New York. [DOI:10.1007/978-1-4614-5559-2_1]
    • Kovalevsky, G. (2005). Female Sexual Dysfunction and Use of Hormone Therapy in Postmenopausal Women. Seminars in Reproductive Medicine, 23(2), 180–187. [DOI:10.1055/s-2005-869486]
    • Kristoffersen, K., & Lebech, P. E. (1975). May Hyperprogesteronaemia Cause Frigidity? Acta Obstetricia et Gynecologica Scandinavica, 54(S47), 42–42. [DOI:10.3109/00016347509158744]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265]
    • Luttge, W. G. (1971). The role of gonadal hormones in the sexual behavior of the rhesus monkey and human: A literature survey. Archives of Sexual Behavior, 1(1), 61–88. [DOI:10.1007/bf01540937]
    • Michael, R. P., Saayman, G. S., & Zumpe, D. (1967). Inhibition of sexual receptivity by progesterone in rhesus monkeys. Journal of Endocrinology, 39(2), 309–310. [DOI:10.1677/joe.0.0390309]
    • Michael, R. P., & Zumpe, D. (1993). Medroxyprogesterone acetate decreases the sexual activity of male cynomolgus monkeys (Macaca fascicularis): An action on the brain? Physiology & Behavior, 53(4), 783–788. [DOI:10.1016/0031-9384(93)90189-m]
    • Modelska, K., & Milián, M. L. (2004). Treatment of female sexual dysfunction in postmenopausal women—What is the evidence? Reviews in Gynaecological Practice, 4(2), 121–132. [DOI:10.1016/j.rigp.2004.01.001]
    • Myers, L. S., Dixen, J., Morrissette, D., Carmichael, M., & Davidson, J. M. (1990). Effects of Estrogen, Androgen, and Progestin on Sexual Psychophysiology and Behavior in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 70(4), 1124–1131. [DOI:10.1210/jcem-70-4-1124]
    • Nadjafi-Triebsch, C. (2015). Progestogens in Non-gynecological Indications. In Carp, H. J. A. (Ed.). Progestogens in Obstetrics and Gynecology (pp. 191–202). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-14385-9_14]
    • Nadler, R. D., Roth-Meyer, C., & Baulieu, E.-E. (1985). Behavioral and Endocrine Consequences of Long-Term Antiprogesterone (RU 486) Administration to Cynomolgus Monkeys: Preliminary Results. In Baulieu, E.-E., & Segal, S. J. (Eds.). The Antiprogestin Steroid RU 486 and Human Fertility Control (pp. 169–177). Boston: Springer US. [DOI:10.1007/978-1-4684-1242-0_14]
    • Nappi, R. E., Sommacal, A., Sances, G., Abbiati, I., Ferdeghini, F., Vercesi, C., Albani, F., & Polatti, F. (2004). Progesterone supplementation on mood and sexual well-being. Gynecological Endocrinology, 18(Suppl 1 [Abstracts of the 11th World Congress of Gynecological Endocrinology, Florence, Italy, February 26-29, 2004]), 133–134 (abstract no. S9). [Google Scholar] [PubMed] [URL] [PDF]
    • Neumann, F. (1978). The physiological action of progesterone and the pharmacological effects of progestogens – a short review. Postgraduate Medical Journal, 54(Suppl 2), 11–24. [Google Scholar] [PubMed] [PDF]
    • Pastor, Z., Holla, K., & Chmel, R. (2013). The influence of combined oral contraceptives on female sexual desire: A systematic review. The European Journal of Contraception & Reproductive Health Care, 18(1), 27–43. [DOI:10.3109/13625187.2012.728643]
    • Pazol, K., Wilson, M. E., & Wallen, K. (2004). Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2998–3006. [DOI:10.1210/jc.2003-032086]
    • Pazol, K., Northcutt, K. V., Wilson, M. E., & Wallen, K. (2006). Medroxyprogesterone acetate acutely facilitates and sequentially inhibits sexual behavior in female rats. Hormones and Behavior, 49(1), 105–113. [DOI:10.1016/j.yhbeh.2005.05.008]
    • Rastrelli, G., Corona, G., & Maggi, M. (2015). The role of prolactin in andrology: what is new? Reviews in Endocrine and Metabolic Disorders, 16(3), 233–248. [DOI:10.1007/s11154-015-9322-3]
    • Regan, P. C. (1999). Hormonal correlates and causes of sexual desire: A review. The Canadian Journal of Human Sexuality, 8(1), 1–16. [Google Scholar] [URL] [PDF 1] [PDF 2]
    • Regan, P. C., Lyle, J. L., Otto, A. L., & Joshi, A. (2003). Pregnancy and changes in female sexual desire: a review. Social Behavior and Personality, 31(6), 603–611. [DOI:10.2224/sbp.2003.31.6.603]
    • Roney, J. R., & Simmons, Z. L. (2013). Hormonal predictors of sexual motivation in natural menstrual cycles. Hormones and Behavior, 63(4), 636–645. [DOI:10.1016/j.yhbeh.2013.02.013]
    • Roney, J. R. (2014). An Evolutionary Functional Analysis of the Hormonal Predictors of Women’s Sexual Motivation. In Shackelford, T. K., & Hansen, R. D. (Eds.). The Evolution of Sexuality (pp. 99–121). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-09384-0_6]
    • Roney, J. R., & Simmons, Z. L. (2016). Within-cycle fluctuations in progesterone negatively predict changes in both in-pair and extra-pair desire among partnered women. Hormones and Behavior, 81, 45–52. [DOI:10.1016/j.yhbeh.2016.03.008]
    • Roney, J. R. (2019). Evolutionary Perspectives on Hypoactive Sexual Desire Disorder in Women. Current Sexual Health Reports, 11(4), 243–250. [DOI:10.1007/s11930-019-00223-w]
    • Saadat, P., Boostanfar, R., Poysky, J., Munevar, C., Stanczyk, F., Buckwalter, G., & Roy, S. (2002). A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on mood and libido. Fertility and Sterility, 77(Suppl 3 [Abstracts of the 50th Annual Meeting of the Pacific Coast Reproductive Society. April 17-21, 2002. Rancho Mirage, California, USA]), S21–S21 (abstract no. P-28). [Google Scholar] [PubMed] [DOI:10.1016/s0015-0282(02)03053-4]
    • Sandhu, K. S., Melman, A., & Mikhail, M. S. (2011). Impact of Hormones on Female Sexual Function and Dysfunction. Female Pelvic Medicine & Reconstructive Surgery, 17(1), 8–16. [DOI:10.1097/spv.0b013e318204491f]
    • Santoro, N., Worsley, R., Miller, K. K., Parish, S. J., & Davis, S. R. (2016). Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction. The Journal of Sexual Medicine, 13(3), 305–316. [DOI:10.1016/j.jsxm.2015.11.015]
    • Savolainen-Peltonen, H., Hautamäki, H., Tuomikoski, P., Ylikorkala, O., & Mikkola, T. S. (2014). Health-related quality of life in women with or without hot flashes. Menopause, 21(7), 732–739. [DOI:10.1097/gme.0000000000000120]
    • Schaffir, J. (2006). Hormonal Contraception and Sexual Desire: A Critical Review. Journal of Sex & Marital Therapy, 32(4), 305–314. [DOI:10.1080/00926230600666311]
    • Schmidt, P. J., Steinberg, E. M., Negro, P. P., Haq, N., Gibson, C., & Rubinow, D. R. (2008). Pharmacologically Induced Hypogonadism and Sexual Function in Healthy Young Women and Men. Neuropsychopharmacology, 34(3), 565–576. [DOI:10.1038/npp.2008.24]
    • Sherwin, B. B. (1991). The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 72(2), 336–343. [DOI:10.1210/jcem-72-2-336]
    • Shirazi, T. N., Self, H., Dawood, K., Rosenfield, K. A., Penke, L., Carré, J. M., Ortiz, T., & Puts, D. A. (2019). Hormonal predictors of women’s sexual motivation. Evolution and Human Behavior, 40(3), 336–344. [DOI:10.1016/j.evolhumbehav.2019.02.002]
    • Wallen, K. (1984). Periovulatory changes in female sexual behavior and patterns of ovarian steroid secretion in group-living rhesus monkeys. Hormones and Behavior, 18(4), 431–450. [DOI:10.1016/0018-506x(84)90028-x]
    • Ward, I. L., Franck, J. E., & Crowley, W. R. (1977). Central progesterone induces female sexual behavior in estrogen-primed intact male rats. Journal of Comparative and Physiological Psychology, 91(6), 1417–1423. [DOI:10.1037/h0077419]
    • Waxman, J. H., Wass, J. A., Hendry, W. F., Whitfield, H. N., Bary, P., Besser, G. M., Malpas, J. S., & Oliver, R. T. (1983). Treatment of Advanced Prostatic Cancer with Buserelin, an Analogue of Gonadotrophin Releasing Hormone. British Journal of Urology, 55(6), 737–742. [DOI:10.1111/j.1464-410x.1983.tb03416.x]
    • Wibowo, E., Schellhammer, P., & Wassersug, R. J. (2011). Role of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation Therapy. Journal of Urology, 185(1), 17–23. [DOI:10.1016/j.juro.2010.08.094]
    • Witt, D. M., Young, L. J., & Crews, D. (1995). Progesterone modulation of androgen-dependent sexual behavior in male rats. Physiology & Behavior, 57(2), 307–313. [DOI:10.1016/0031-9384(94)00247-3]
    • Worsley, R., Santoro, N., Miller, K. K., Parish, S. J., & Davis, S. R. (2016). Hormones and Female Sexual Dysfunction: Beyond Estrogens and Androgens—Findings From the Fourth International Consultation on Sexual Medicine. The Journal of Sexual Medicine, 13(3), 283–290. [DOI:10.1016/j.jsxm.2015.12.014]
    • Wren, B. G., Champion, S. M., Willetts, K., Manga, R. Z., & Eden, J. A. (2003). Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause, 10(1), 13–18. [DOI:10.1097/00042192-200310010-00004]
    • Zimmerman, Y., Eijkemans, M. J., Coelingh Bennink, H. J., Blankenstein, M. A., & Fauser, B. C. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. [DOI:10.1093/humupd/dmt038]
    • Zumpe, D., & Michael, R. P. (1988). Effects of medroxyprogesterone acetate on plasma testosterone and sexual behavior in male cynomolgus monkeys (Macaca fascicularis). Physiology & Behavior, 42(4), 343–349. [DOI:10.1016/0031-9384(88)90275-2]
    • Zumpe, D. (1991). Medroxyprogesterone acetate, aggression, and sexual behavior in male cynomolgus monkeys (Macaca fascicularis). Hormones and Behavior, 25(3), 394–409. [DOI:10.1016/0018-506x(91)90010-f]
    • Zumpe, D., Clancy, A. N., & Michael, R. P. (1997). Effects of Progesterone on the Sexual Behavior of Castrated, Testosterone-Treated Male Cynomolgus Monkeys (Macaca Fascicularis). Physiology & Behavior, 62(1), 61–67. [DOI:10.1016/s0031-9384(97)00135-2]
    \ No newline at end of file +The Influence of Progesterone and Other Progestogens on Sexual Desire and Function - Transfeminine Science Link

    The Influence of Progesterone and Other Progestogens on Sexual Desire and Function

    By Aly | First published January 9, 2020 | Last modified March 22, 2024

    Abstract / TL;DR

    Many transfeminine people believe on the basis of anecdotes that progesterone increases sexual desire. A review was conducted to assess the available evidence for the possibility that progesterone and/or progestogens increase sexual desire. Both animal studies as well as clinical studies with progesterone and progestins were considered. Progesterone has shown no indication of stimulatory effects on sexual desire or behavior in humans and non-human primates. High doses of progestogens have however been found to inhibit sexual desire in humans and non-human primates. More research is necessary to further characterize the role of progesterone and other progestogens in sexual desire in humans. In any case, available evidence does not support a positive role of these hormonal agents in sexual desire. Instead, sexual desire is more related to androgens and estrogens in men and women, respectively.

    Introduction

    Based on anecdotal experience, some people in the transfeminine community believe that progesterone has positive effects on sexual desire. This is such that even memes about progesterone and libido have been made (Reddit). In addition to anecdotes, some researchers have theorized that progesterone may be positively involved in sexual desire in cisgender women (Regan, 1999). Some have also argued that the neurosteroid metabolites of progesterone like allopregnanolone and pregnanolone may provide special benefits on sexual desire that are not shared with progestins. I’ve reviewed the available evidence and literature to assess whether progesterone or other progestogens indeed improve sexual desire function in cisgender women and might be useful for this in transfeminine people.

    Animal Studies

    Correlational

    Progesterone levels are strongly and consistently negatively associated with female sexual desire and behavior in most animal species (Roney, 2015). This includes in monkeys and apes (Roney, 2015).

    Experimental

    Non-Human Primates

    Progesterone, both alone and when added to an estrogen, has been shown to inhibit sexual behavior and receptivity in female monkeys in many studies (Luttge, 1971; Baum et al., 1976; Baum et al., 1977a; Michael et al., 1967). This inhibition is often marked. Likewise, subcutaneous implants of progesterone were shown to suppress sexual behavior in testosterone-treated castrated male monkeys (Zumpe, Clancy, & Michael, 1997). As the male monkeys were castrated and treated with testosterone, this was not due to decreased testosterone levels (which remained unchanged), and could only have been due to the other effects of progesterone. Similar findings have been made for the progestin medroxyprogesterone acetate (MPA) (Michael & Zumpe, 1993; Zumpe et al., 1991; Zumpe & Michael, 1988).

    The following excerpt from a review is notable on the topic of progesterone and sexual behavior in primates (Baum, 1983):

    The early work of Ball (1941) and of Michael et al. (1968) showed that progesterone acts in the female rhesus monkey to reduce the likelihood of copulation. In contrast to non primate females, no facilitatory action of progesterone on any aspect of feminine sexuality has ever been convincingly demonstrated in primates.

    One study in female monkeys found that MPA inhibited sexual behavior while progesterone did not (Pazol et al., 2004). However, MPA is a much more potent progestogen than progesterone, and the progesterone levels were very low (2 ng/mL). Hence, the progesterone levels in this study may have been too low for adequate physiological effect, which might explain the conflicting finding compared to other studies. Another study found increased sexual receptivity in castrated female monkeys treated with a combination of an estrogen and parenteral progesterone (Baum et al., 1977b). However, this was relative to a baseline of castration, and the changes may have only been due to the estrogen. Indeed, the same researchers reported decreased sexual receptivity with the addition of progesterone to estrogen in other studies (Baum et al., 1976; Baum et al., 1977a).

    Mifepristone, a progesterone receptor antagonist, showed no apparent effect on sexual behavior in either female or male monkeys (Nadler et al., 1985).

    Rodents

    A notable exception when it comes to progesterone and sexual behavior in animals is female rodents, in which progesterone is stimulatory and induces lordosis (Frye, 2007). Allopregnanolone is involved in the facilitatory effects of progesterone on female sexual behavior in rodents, but has mixed effects, showing either augmentation or inhibition depending on the specifics (King, 2013; Frye, 2007). However, progesterone stimulates sexual behavior in female rodents only acutely, and is actually inhibitory with continuous administration (Pazol et al., 2004; Pazol et al., 2006). Studies in estrogen-primed intact male rats have found that progesterone given systemically does not induce lordosis (Ward et al., 1977). Interestingly however, lordosis was found to be induced in some male rats when progesterone was injected directly into a specific part of the hypothalamus (Ward et al., 1977). The prosexual effects of progesterone in female rodents may be mediated via non-genomic mechanisms, for instance actions of progesterone’s neurosteroid metabolites (Delville, 1991).

    In addition to female rodents, research has found that progesterone is involved in normal sexual behavior in male rats (Witt et al., 1995; Andersen & Tufik, 2006). In male rats, castration greatly decreases levels of both testosterone and progesterone and markedly reduces sexual behavior (Witt et al., 1995). Low-dose progesterone administration, resulting in low but physiological male-range levels of progesterone, significantly restores sexual behavior (Witt et al., 1995). Additionally, when testosterone is concomitantly administered, progesterone augments the improvement caused by testosterone and is required for sexual behavior to be fully restored (Witt et al., 1995). The effects are mimicked by progestins like promegestone and blocked by the progesterone receptor antagonist mifepristone, suggesting that they are due specifically to activation of the progesterone receptor (Witt et al., 1995).

    However, the findings in male rats probably do not apply to primates. As already described, mifepristone, in contrast to male rats, has no influence on sexual behavior in male monkeys (Nadler et al., 1985). Similarly, a study in castrated male monkeys given testosterone in combination with a relatively low dose of progesterone—resulting in roughly doubled progesterone levels relative to normal male levels—found no difference in sexual behavior compared to castrated male monkeys given testosterone alone (Buhl, Jensen, & Phoenix, 1978). Hence, neither progesterone receptor antagonism nor restoration of progesterone levels following castration seems to influence sexual behavior in male primates. It’s also notable that unlike in male rodents, castration doesn’t appear to reduce progesterone levels in either male monkeys (Zumpe, Clancy, & Michael, 1997) or humans (Waxman et al., 2013). As such, even if the rodent findings did apply to humans, castrated men have normal male-range progesterone levels and would in theory have all the progesterone needed to maintain sexual desire.

    The findings on male-range progesterone levels and sexual behavior in male rats are also in contrast to research with higher, supraphysiological levels of progesterone (Hawley & Mosura, 2019). This degree of progesterone exposure has been shown to inhibit sexual behavior in males of most or all species examined, notably including male rats (Hawley & Mosura, 2019). This is the case regardless of influence on testosterone levels (Hawley & Mosura, 2019).

    Other Species

    Progestogens are used to inhibit heat in female dogs and cats (Neumann, 1978).

    Clinical Research

    Correlational

    Progesterone levels in women are negatively associated, in some studies strongly, with sexual desire and behavior in women (Shirazi et al., 2019; Roney, 2015; Roney & Simmons, 2013; Roney & Simmons, 2016; Roney, 2019). One conflicting study reported a positive association of luteal-phase progesterone levels with initiation of sexual activity with partners, but the same researchers had contradictory findings in a subsequent study (Holder & Mong, 2017; Roney, 2015; Jones et al., 2019).

    Sexual desire is progressively decreased in women during pregnancy, a state characterized by very high levels of estrogens, progesterone, and prolactin (Regan et al., 2003; Gałązka et al., 2014). However, many confounding factors exist (e.g., the other hormonal changes, or being pregnant), and hence causation of the changes can’t necessarily be attributed to progesterone. The observations do suggest that very high levels of an estrogen and progesterone may be unlikely to increase sexual desire however.

    Experimental

    Progestins

    A 2013 meta-analysis reported that combined birth control pills, containing both ethinylestradiol and a progestogen, result in either unchanged or increased sexual desire in most women (85%) and decreased sexual desire in a small percentage of women (15%) (Pastor et al., 2013). However, changes in sexual desire seem to be related to the ethinylestradiol component rather than to the progestin component; decreased sexual desire was only associated with birth control pills containing low-dose estrogen (20 μg ethinylestradiol) (Pastor et al., 2013). The fact that combined birth control pills infrequently decrease sexual desire in women is notable because these medications suppress ovulation and hence completely prevent the increase in progesterone levels during the luteal phase. As such, progesterone levels, and by extension circulating levels of allopregnanolone and pregnanolone, remain very low at all times. This suggests little or no importance of the neurosteroid metabolites of progesterone for sexual desire in women.

    The fact that combined birth control pills don’t generally affect sexual desire in women is also potentially surprising because total and free testosterone levels are greatly decreased by them due to the ethinylestradiol component (Zimmerman et al., 2014). This is, however, in accordance with accumulating evidence suggesting that physiological levels of androgens in women have little or no involvement in sexual desire (Cappelletti & Wallen, 2016). Rather than progesterone or androgens, what seems to be important for sexual desire in women is estradiol, especially acutely at periovulatory levels (Cappelletti & Wallen, 2016).

    A small minority of women treated with depot medroxyprogesterone acetate (DMPA) alone for birth control report decreased libido and only 2.3% cite it as a reason for discontinuation (Schaffir, 2006). A study of 80 women treated with DMPA alone for birth control monitored sexual function and found no difference from baseline to 4 months of therapy (Schaffir, 2006). Findings have been similar for subcutaneous birth control implants with nomegestrol acetate and levonorgestrel (Schaffir, 2006). A randomized controlled trial of 150 women given combined birth control pills, progestin-only birth control pills, and placebo found no difference in sexual desire or activity between progestin-only pills and placebo (Schaffir, 2006).

    The addition of a progestin to an estrogen in hormone therapy for menopausal women has been found not to improve sexual desire or function to a greater extent than an estrogen alone in individual studies (Çayan et al., 2008; Myers et al., 1990; Sherwin, 1991; Savolainen-Peltonen et al., 2014; Dennerstein et al., 1980; Alexander et al., 2004; Saadat et al., 2002; Davis et al., 2004; Modelska & Milián, 2004; Sandhu et al., 2011). A couple of studies have found that improvement in sexual desire/function is better with an estrogen alone than with an estrogen plus a progestin, suggesting that progestins might have an adverse influence (Çayan et al., 2008; Dennerstein et al., 1980; Kovalevsky, 2005; Castelo-Branco et al., 2007). Overall however, the available research suggests no change in sexual desire/function with addition of a progestin to an estrogen in menopausal hormone therapy (Sandhu et al., 2011).

    Interestingly, a 2018 meta-analysis reported a higher standardized mean difference (SMD) for improvement of sexual desire/function in studies with an estrogen plus a progestogen relative to studies using an estrogen alone (Javadivala et al., 2019). However, there was differing methodology (e.g., sexual measures) and high heterogeneity across studies, as well as a limited number of included studies (particularly of estrogen only). These issues make conclusions on the basis of the differing SMDs problematic. Indeed, the finding is contradicted by individual studies that have included both estrogen only and estrogen plus progestogen groups (see the sources above).

    Besides progestogenic activity, it has been suggested that androgenic progestins, like most of the testosterone derivatives, might provide better effects on sexual desire/function than non-androgenic progestins (Graziottin & Serafini, 2011). However, aside from the case of the atypical agent tibolone (Biglia et al., 2010), this has not actually been assessed or shown in any clinical trials (Schaffir, 2006).

    The addition of dydrogesterone to hormone therapy for transgender women to improve sexual desire showed no effect, whereas transdermal testosterone was effective (Kronawitter et al., 2009).

    A 1975 study published as an abstract with little additional information claimed that some premenopausal women with “frigidity” had high progesterone levels and that treatment with levonorgestrel alone to suppress progesterone levels could increase libido in these women (Kristoffersen & Lebech, 1975). This is very low-quality information however.

    Progesterone

    Available clinical studies of progesterone and sexual desire in women have observed no changes (Worsley et al., 2016). Neither 200 mg/day oral progesterone nor 10 mg/day oral MPA had any influence on mood or libido in estrogen-treated postmenopausal women in a randomized controlled trial (Saadat et al., 2002). Likewise, treatment of pharmacologically hypogonadal women with 400 mg/day vaginal progesterone suppositories alone did not significantly alter any domain of sexual function in another randomized controlled trial (Schmidt et al., 2009). Treatment of women with subcutaneous implants of progesterone alone for gynecological disorders has been reported to decrease sexual desire in an uncontrolled clinical study (Regan, 1999). Conversely, a retrospective chart review of 137 women with severe premenstrual syndrome treated during the luteal phase with 100–200+ mg/day vaginal progesterone suppositories alone for birth control reported that decreased libido was a side effect in 1 woman (0.7%) (Dalton, Guthrie, & Dalton, 1987).

    One study assessed the influence on mood and libido of estradiol plus cyclic 200 mg/day oral progesterone in premenopausal women and estradiol plus cyclic 200 mg/day vaginal progesterone in perimenopausal women (Nappi et al., 2004). The premenopausal women were suffering from menstrual irregularities, depression, and sexual dysfunction, while the perimenopausal women were presumably experiencing menopausal symptoms. A significant improvement in libido, sexual arousal, and pain was observed with therapy in the premenopausal women who had a concomitant improvement in anxiety, irritability, and appetite, but not in those who remained depressed. The findings in the perimenopausal women were similar; the hormonal therapy improved sexual desire only in those who experienced improvement in anxiety, panic, and tension, but not in those in whom depression remained. The findings of this study, although interesting, are unfortunately confounded by the lack of an estradiol-only control group, and so can’t necessarily be attributed to progesterone. Moreover, the findings are confounded by the presence and alleviation of the mood symptoms, anxiety, and other problems in the women; it’s possible that estradiol and progesterone did not increase sexual desire themselves but rather it was the improvement of the other symptoms that produced the changes.

    Another randomized controlled trial found that an estrogen plus 1.25 mg/day methyltestosterone and 100 mg/day oral progesterone significantly improved sexual desire and function relative to placebo in postmenopausal women (Blümel et al., 2008). However, this study was confounded by the presence of methyltestosterone and the lack of a no-progesterone control group.

    Transdermal progesterone cream at a dosage of 32 mg/day had no influence on sexual desire or other parameters in postmenopausal women (Wren et al., 2003; Worsley et al., 2016).

    A recent chapter in a book on progestogens included the following passage (Nadjafi-Triebsch, 2015):

    Progesterone improves sexual performance in [male] rats [13]. Consequently, progesterone should also improve sexual performance in men due to similarities to human neuro-endocrine mechanisms. Indeed, patients receiving progesterone reported more frequent morning erections and distinctively improved sexual performance.

    However, no source or other information (e.g., study design, route/dosage, etc.) was provided. The claim was probably based on anecdotal clinical experience. In addition, the chapter makes some problematic statements like “progesterone prevents prostate cancer” and “progesterone treats autism”, along with ample reference to low-quality unpublished clinical experience, that seriously hurt its credibility.

    High-Dose Progestogens in Men

    High-dose progestogen monotherapy with cyproterone acetate (CPA) or MPA is widely used to suppress sexual desire and function in men with sexual deviance, including hypersexuality, paraphilias, and sex offenses (Wiki; Codispoti, 2008). This therapy results in strong sexual suppression and is very effective. Its efficacy is thought to be due to suppression of testosterone levels. However, there is some evidence that progestogenic activity in the brain itself and/or increased prolactin levels secondary to progestogenic activity may also be involved (Zumpe, Clancy, & Michael, 1997; Rastrelli, Corona, & Maggi, 2015; Wiki). Although estrogens suppress testosterone levels and increase prolactin levels similarly to progestogens and have likewise been used in the treatment of male sexual deviance (Wiki; Wiki), they are also known to have beneficial effects on sexual desire in both women and men (Wallen et al., 1984; Wibowo, Schellhammer, & Wasserug, 2011; Cappelletti & Wallen, 2016; Santoro et al., 2016; Gilbert et al., 2017). In relation to this, estrogens may not result in the same degree of suppression of sexual desire and function as progestogens. As with CPA and MPA, progesterone alone by intramuscular injection has been found to substantially suppress sexual desire and function in men (Wiki; Regan, 1999).

    Conclusion

    Taken together, there appears to be little or no evidence that progesterone or other progestogens improve sexual desire or function in humans. Instead, the available evidence suggests that progestogens are likely to result in either unchanged or decreased sexual desire and function. Decreased sexual desire/function may be especially likely at high doses. In any case, more research on progestogens and sexual desire, particularly with non-oral progesterone, is warranted.

    References

    • Alexander, J. L., Kotz, K., Dennerstein, L., Kutner, S. J., Wallen, K., & Notelovitz, M. (2004). The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials. Menopause, 11(6), 749–765. [DOI:10.1097/01.gme.0000142887.31811.97]
    • Andersen, M. L., & Tufik, S. (2006). Does male sexual behavior require progesterone? Brain Research Reviews, 51(1), 136–143. [DOI:10.1016/j.brainresrev.2005.10.005]
    • Baum, M. J., Everitt, B. J., Herbert, J., Keverne, E. B., & de Greef, W. J. (1976). Reduction of sexual interaction in rhesus monkeys by a vaginal action of progesterone. Nature, 263(5578), 606–608. [DOI:10.1038/263606a0]
    • Baum, M. J., Everitt, B. J., Herbert, J., & Keverne, E. B. (1977). Hormonal basis of proceptivity and receptivity in female primates. Archives of Sexual Behavior, 6(3), 173–192. [DOI:10.1007/bf01541126]
    • Baum, M., Keverne, E., Everitt, B., Herbert, J., & De Greef, W. (1977). Effects of progesterone and estradiol on sexual attractivity of female rhesus monkeys. Physiology & Behavior, 18(4), 659–670. [DOI:10.1016/0031-9384(77)90064-6]
    • Baum, M. J. (1983). Hormonal Modulation of Sexuality in Female Primates. BioScience, 33(9), 578–582. [DOI:10.2307/1309209]
    • Biglia, N., Maffei, S., Lello, S., & Nappi, R. E. (2010). Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecological Endocrinology, 26(11), 804–814. [DOI:10.3109/09513590.2010.495437]
    • Blümel, J. E., Del Pino, M., Aprikian, D., Vallejo, S., Sarrá, S., & Castelo-Branco, C. (2008). Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction. Gynecological Endocrinology, 24(12), 691–695. [DOI:10.1080/09513590802454919]
    • Buhl, A. (1978). Influence of progesterone on sexual behavior in castrated male rhesus monkeys treated with testosterone. Hormones and Behavior, 10(3), 258–263. [DOI:10.1016/0018-506x(78)90070-3]
    • Cappelletti, M., & Wallen, K. (2016). Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior, 78, 178–193. [DOI:10.1016/j.yhbeh.2015.11.003]
    • Castelo-Branco, C., Cancelo, M. J., & Chedraui, P. (2007). Female sexual dysfunction in postmenopausal women. Expert Opinion on Therapeutic Patents, 17(6), 639–647. [DOI:10.1517/13543776.17.6.639]
    • Çayan, F., Dilek, U., Pata, Ö., & Dilek, S. (2008). Comparison of the Effects of Hormone Therapy Regimens, Oral and Vaginal Estradiol, Estradiol+Drospirenone and Tibolone, on Sexual Function in Healthy Postmenopausal Women. The Journal of Sexual Medicine, 5(1), 132–138. [DOI:10.1111/j.1743-6109.2007.00635.x]
    • Codispoti, V. L. (2008). Pharmacology of Sexually Compulsive Behavior. Psychiatric Clinics of North America, 31(4), 671–679. [DOI:10.1016/j.psc.2008.06.002]
    • Dalton, M. E., Guthrie, K. A., & Dalton, K. (1987). A preliminary study into the efficacy of progesterone suppositories as a contraceptive for women with severe premenstrual syndrome. The British Journal of Family Planning, 13(3), 87–89. [Google Scholar] [PDF]
    • Davis, S. R., Guay, A. T., Shifren, J. L., & Mazer, N. A. (2004). Endocrine Aspects of Female Sexual Dysfunction. The Journal of Sexual Medicine, 1(1), 82–86. [DOI:10.1111/j.1743-6109.2004.10112.x]
    • Delville, Y. (1991). Progesterone-facilitated sexual receptivity: A review of arguments supporting a nongenomic mechanism. Neuroscience & Biobehavioral Reviews, 15(3), 407–414. [DOI:10.1016/s0149-7634(05)80033-8]
    • Dennerstein, L., Burrows, G. D., Wood, C., & Hyman, G. (1980). Hormones and sexuality: effect of estrogen and progestogen. Obstetrics & Gynecology, 56(3), 316–322. [Google Scholar] [PubMed] [URL] [PDF]
    • Frye, C. A. (2007). Progestins influence motivation, reward, conditioning, stress, and/or response to drugs of abuse. Pharmacology Biochemistry and Behavior, 86(2), 209–219. [DOI:10.1016/j.pbb.2006.07.033]
    • Gałązka, I., Drosdzol-Cop, A., Naworska, B., Czajkowska, M., & Skrzypulec-Plinta, V. (2015). Changes in the Sexual Function During Pregnancy. The Journal of Sexual Medicine, 12(2), 445–454. [DOI:10.1111/jsm.12747]
    • Gilbert, D. C., Duong, T., Kynaston, H. G., Alhasso, A. A., Cafferty, F. H., Rosen, S. D., Kanaga-Sundaram, S., Dixit, S., Laniado, M., Madaan, S., Collins, G., Pope, A., Welland, A., Nankivell, M., Wassersug, R., Parmar, M. K., Langley, R. E., & Abel, P. D. (2016). Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. BJU International, 119(5), 667–675. [DOI:10.1111/bju.13687]
    • Graziottin, A., & Serafini, A. (2011). Medical Treatments for Sexual Problems in Women. In Mulhall, J. P., Incrocci, L., Goldstein, I., & Rosen, R. (Eds.). Cancer and Sexual Health (pp. 627–641). Totowa, New Jersey: Humana Press. [DOI:10.1007/978-1-60761-916-1_40]
    • Hawley, W. R., & Mosura, D. E. (2019). Effects of progesterone treatment during adulthood on consummatory and motivational aspects of sexual behavior in male rats. Behavioural Pharmacology, 30(7), 617–622. [DOI:10.1097/fbp.0000000000000490]
    • Holder, M. K., & Mong, J. A. (2017). The Role of Ovarian Hormones and the Medial Amygdala in Sexual Motivation. Current Sexual Health Reports, 9(4), 262–270. [DOI:10.1007/s11930-017-0131-4]
    • Javadivala, Z., Merghati-Khoei, E., Asghari Jafarabadi, M., Allahverdipour, H., Mirghafourvand, M., Nadrian, H., & Kouzekanani, K. (2018). Efficacy of pharmacological and non-pharmacological interventions on low sexual interest/arousal of peri- and post-menopausal women: a meta-analysis. Sexual and Relationship Therapy, 34(2), 242–270. [DOI:10.1080/14681994.2018.1446515]
    • Jones, B. C., Hahn, A. C., & DeBruine, L. M. (2019). Ovulation, Sex Hormones, and Women’s Mating Psychology. Trends in Cognitive Sciences, 23(1), 51–62. [DOI:10.1016/j.tics.2018.10.008]
    • King, S. R. (2012). Neurosteroids and the Nervous System. In King, S. R. Neurosteroids and the Nervous System (pp. 1–122). New York: Springer New York. [DOI:10.1007/978-1-4614-5559-2_1]
    • Kovalevsky, G. (2005). Female Sexual Dysfunction and Use of Hormone Therapy in Postmenopausal Women. Seminars in Reproductive Medicine, 23(2), 180–187. [DOI:10.1055/s-2005-869486]
    • Kristoffersen, K., & Lebech, P. E. (1975). May Hyperprogesteronaemia Cause Frigidity? Acta Obstetricia et Gynecologica Scandinavica, 54(S47), 42–42. [DOI:10.3109/00016347509158744]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265]
    • Luttge, W. G. (1971). The role of gonadal hormones in the sexual behavior of the rhesus monkey and human: A literature survey. Archives of Sexual Behavior, 1(1), 61–88. [DOI:10.1007/bf01540937]
    • Michael, R. P., Saayman, G. S., & Zumpe, D. (1967). Inhibition of sexual receptivity by progesterone in rhesus monkeys. Journal of Endocrinology, 39(2), 309–310. [DOI:10.1677/joe.0.0390309]
    • Michael, R. P., & Zumpe, D. (1993). Medroxyprogesterone acetate decreases the sexual activity of male cynomolgus monkeys (Macaca fascicularis): An action on the brain? Physiology & Behavior, 53(4), 783–788. [DOI:10.1016/0031-9384(93)90189-m]
    • Modelska, K., & Milián, M. L. (2004). Treatment of female sexual dysfunction in postmenopausal women—What is the evidence? Reviews in Gynaecological Practice, 4(2), 121–132. [DOI:10.1016/j.rigp.2004.01.001]
    • Myers, L. S., Dixen, J., Morrissette, D., Carmichael, M., & Davidson, J. M. (1990). Effects of Estrogen, Androgen, and Progestin on Sexual Psychophysiology and Behavior in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 70(4), 1124–1131. [DOI:10.1210/jcem-70-4-1124]
    • Nadjafi-Triebsch, C. (2015). Progestogens in Non-gynecological Indications. In Carp, H. J. A. (Ed.). Progestogens in Obstetrics and Gynecology (pp. 191–202). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-14385-9_14]
    • Nadler, R. D., Roth-Meyer, C., & Baulieu, E.-E. (1985). Behavioral and Endocrine Consequences of Long-Term Antiprogesterone (RU 486) Administration to Cynomolgus Monkeys: Preliminary Results. In Baulieu, E.-E., & Segal, S. J. (Eds.). The Antiprogestin Steroid RU 486 and Human Fertility Control (pp. 169–177). Boston: Springer US. [DOI:10.1007/978-1-4684-1242-0_14]
    • Nappi, R. E., Sommacal, A., Sances, G., Abbiati, I., Ferdeghini, F., Vercesi, C., Albani, F., & Polatti, F. (2004). Progesterone supplementation on mood and sexual well-being. Gynecological Endocrinology, 18(Suppl 1 [Abstracts of the 11th World Congress of Gynecological Endocrinology, Florence, Italy, February 26-29, 2004]), 133–134 (abstract no. S9). [Google Scholar] [PubMed] [URL] [PDF]
    • Neumann, F. (1978). The physiological action of progesterone and the pharmacological effects of progestogens – a short review. Postgraduate Medical Journal, 54(Suppl 2), 11–24. [Google Scholar] [PubMed] [PDF]
    • Pastor, Z., Holla, K., & Chmel, R. (2013). The influence of combined oral contraceptives on female sexual desire: A systematic review. The European Journal of Contraception & Reproductive Health Care, 18(1), 27–43. [DOI:10.3109/13625187.2012.728643]
    • Pazol, K., Wilson, M. E., & Wallen, K. (2004). Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2998–3006. [DOI:10.1210/jc.2003-032086]
    • Pazol, K., Northcutt, K. V., Wilson, M. E., & Wallen, K. (2006). Medroxyprogesterone acetate acutely facilitates and sequentially inhibits sexual behavior in female rats. Hormones and Behavior, 49(1), 105–113. [DOI:10.1016/j.yhbeh.2005.05.008]
    • Rastrelli, G., Corona, G., & Maggi, M. (2015). The role of prolactin in andrology: what is new? Reviews in Endocrine and Metabolic Disorders, 16(3), 233–248. [DOI:10.1007/s11154-015-9322-3]
    • Regan, P. C. (1999). Hormonal correlates and causes of sexual desire: A review. The Canadian Journal of Human Sexuality, 8(1), 1–16. [Google Scholar] [URL] [PDF 1] [PDF 2]
    • Regan, P. C., Lyle, J. L., Otto, A. L., & Joshi, A. (2003). Pregnancy and changes in female sexual desire: a review. Social Behavior and Personality, 31(6), 603–611. [DOI:10.2224/sbp.2003.31.6.603]
    • Roney, J. R., & Simmons, Z. L. (2013). Hormonal predictors of sexual motivation in natural menstrual cycles. Hormones and Behavior, 63(4), 636–645. [DOI:10.1016/j.yhbeh.2013.02.013]
    • Roney, J. R. (2014). An Evolutionary Functional Analysis of the Hormonal Predictors of Women’s Sexual Motivation. In Shackelford, T. K., & Hansen, R. D. (Eds.). The Evolution of Sexuality (pp. 99–121). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-09384-0_6]
    • Roney, J. R., & Simmons, Z. L. (2016). Within-cycle fluctuations in progesterone negatively predict changes in both in-pair and extra-pair desire among partnered women. Hormones and Behavior, 81, 45–52. [DOI:10.1016/j.yhbeh.2016.03.008]
    • Roney, J. R. (2019). Evolutionary Perspectives on Hypoactive Sexual Desire Disorder in Women. Current Sexual Health Reports, 11(4), 243–250. [DOI:10.1007/s11930-019-00223-w]
    • Saadat, P., Boostanfar, R., Poysky, J., Munevar, C., Stanczyk, F., Buckwalter, G., & Roy, S. (2002). A randomized prospective study comparing the effects of micronized progesterone and medroxyprogesterone acetate on mood and libido. Fertility and Sterility, 77(Suppl 3 [Abstracts of the 50th Annual Meeting of the Pacific Coast Reproductive Society. April 17-21, 2002. Rancho Mirage, California, USA]), S21–S21 (abstract no. P-28). [Google Scholar] [PubMed] [DOI:10.1016/s0015-0282(02)03053-4]
    • Sandhu, K. S., Melman, A., & Mikhail, M. S. (2011). Impact of Hormones on Female Sexual Function and Dysfunction. Female Pelvic Medicine & Reconstructive Surgery, 17(1), 8–16. [DOI:10.1097/spv.0b013e318204491f]
    • Santoro, N., Worsley, R., Miller, K. K., Parish, S. J., & Davis, S. R. (2016). Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction. The Journal of Sexual Medicine, 13(3), 305–316. [DOI:10.1016/j.jsxm.2015.11.015]
    • Savolainen-Peltonen, H., Hautamäki, H., Tuomikoski, P., Ylikorkala, O., & Mikkola, T. S. (2014). Health-related quality of life in women with or without hot flashes. Menopause, 21(7), 732–739. [DOI:10.1097/gme.0000000000000120]
    • Schaffir, J. (2006). Hormonal Contraception and Sexual Desire: A Critical Review. Journal of Sex & Marital Therapy, 32(4), 305–314. [DOI:10.1080/00926230600666311]
    • Schmidt, P. J., Steinberg, E. M., Negro, P. P., Haq, N., Gibson, C., & Rubinow, D. R. (2008). Pharmacologically Induced Hypogonadism and Sexual Function in Healthy Young Women and Men. Neuropsychopharmacology, 34(3), 565–576. [DOI:10.1038/npp.2008.24]
    • Sherwin, B. B. (1991). The Impact of Different Doses of Estrogen and Progestin on Mood and Sexual Behavior in Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism, 72(2), 336–343. [DOI:10.1210/jcem-72-2-336]
    • Shirazi, T. N., Self, H., Dawood, K., Rosenfield, K. A., Penke, L., Carré, J. M., Ortiz, T., & Puts, D. A. (2019). Hormonal predictors of women’s sexual motivation. Evolution and Human Behavior, 40(3), 336–344. [DOI:10.1016/j.evolhumbehav.2019.02.002]
    • Wallen, K. (1984). Periovulatory changes in female sexual behavior and patterns of ovarian steroid secretion in group-living rhesus monkeys. Hormones and Behavior, 18(4), 431–450. [DOI:10.1016/0018-506x(84)90028-x]
    • Ward, I. L., Franck, J. E., & Crowley, W. R. (1977). Central progesterone induces female sexual behavior in estrogen-primed intact male rats. Journal of Comparative and Physiological Psychology, 91(6), 1417–1423. [DOI:10.1037/h0077419]
    • Waxman, J. H., Wass, J. A., Hendry, W. F., Whitfield, H. N., Bary, P., Besser, G. M., Malpas, J. S., & Oliver, R. T. (1983). Treatment of Advanced Prostatic Cancer with Buserelin, an Analogue of Gonadotrophin Releasing Hormone. British Journal of Urology, 55(6), 737–742. [DOI:10.1111/j.1464-410x.1983.tb03416.x]
    • Wibowo, E., Schellhammer, P., & Wassersug, R. J. (2011). Role of Estrogen in Normal Male Function: Clinical Implications for Patients With Prostate Cancer on Androgen Deprivation Therapy. Journal of Urology, 185(1), 17–23. [DOI:10.1016/j.juro.2010.08.094]
    • Witt, D. M., Young, L. J., & Crews, D. (1995). Progesterone modulation of androgen-dependent sexual behavior in male rats. Physiology & Behavior, 57(2), 307–313. [DOI:10.1016/0031-9384(94)00247-3]
    • Worsley, R., Santoro, N., Miller, K. K., Parish, S. J., & Davis, S. R. (2016). Hormones and Female Sexual Dysfunction: Beyond Estrogens and Androgens—Findings From the Fourth International Consultation on Sexual Medicine. The Journal of Sexual Medicine, 13(3), 283–290. [DOI:10.1016/j.jsxm.2015.12.014]
    • Wren, B. G., Champion, S. M., Willetts, K., Manga, R. Z., & Eden, J. A. (2003). Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause, 10(1), 13–18. [DOI:10.1097/00042192-200310010-00004]
    • Zimmerman, Y., Eijkemans, M. J., Coelingh Bennink, H. J., Blankenstein, M. A., & Fauser, B. C. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. [DOI:10.1093/humupd/dmt038]
    • Zumpe, D., & Michael, R. P. (1988). Effects of medroxyprogesterone acetate on plasma testosterone and sexual behavior in male cynomolgus monkeys (Macaca fascicularis). Physiology & Behavior, 42(4), 343–349. [DOI:10.1016/0031-9384(88)90275-2]
    • Zumpe, D. (1991). Medroxyprogesterone acetate, aggression, and sexual behavior in male cynomolgus monkeys (Macaca fascicularis). Hormones and Behavior, 25(3), 394–409. [DOI:10.1016/0018-506x(91)90010-f]
    • Zumpe, D., Clancy, A. N., & Michael, R. P. (1997). Effects of Progesterone on the Sexual Behavior of Castrated, Testosterone-Treated Male Cynomolgus Monkeys (Macaca Fascicularis). Physiology & Behavior, 62(1), 61–67. [DOI:10.1016/s0031-9384(97)00135-2]
    \ No newline at end of file diff --git a/transfemscience.org/articles/progestogens-transfem-excerpts/index.html b/transfemscience.org/articles/progestogens-transfem-excerpts/index.html index 7cad80c8..e56846cc 100644 --- a/transfemscience.org/articles/progestogens-transfem-excerpts/index.html +++ b/transfemscience.org/articles/progestogens-transfem-excerpts/index.html @@ -1 +1 @@ -Sources/Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy - Transfeminine Science Link

    Sources/Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy

    By Sam | First published April 18, 2020 | Last modified October 5, 2020

    Oriel (2000)

    Oriel, K. A. (2000). Clinical update: Medical care of transsexual patients. Journal of the Gay and Lesbian Medical Association, 4(4), 185–194. [DOI:10.1023/a:1026563806480]:

    The use of progesterone to augment breast development is controversial in physicians treating MTF transsexuals. When deciding on a hormone regimen, prescribers should remember that it is estrogen that causes the serious side effects, so the lowest effective dose should be used.

    […] Progesterone is the third and optional component of the MTF regimen. Although some physicians working with transgendered patients do not prescribe progesterone, others argue feminization involves the actions of both estrogen and progesterone (31). Medroxyprogesterone is a weak antiandrogen, and testosterone suppression may be accomplished with lower doses of estrogen. Medroxyprogesterone is less androgenic than norethindrone and norgestrel. Progesterone is important for breast development (24). Unlike estrogen, progesterone does not carry the risk of thromboembolism, prolactinoma, and myocardial infarction. Although it has been noted that doses of 20–40 mg per day are required to suppress luteinizing hormone (20), medroxyprogesterone acetate may become androgenic at higher doses, so others (5) recommend 10 mg a day. Micronized progesterone (Prometrium) is advantageous because it has a more favorable side effect profile (anxiety and irritability) than medroxyprogesterone. It is also less androgenic when higher progesterone doses are needed, but is more costly.

    Dittrich et al. (2005)

    Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M. W., & Mueller, A. (2005). Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]:

    Ethinyl oestradiol was no more effective in comparison with the oestradiol-17β valerate administered in the regimen studied here. Similar efficacy in terms of feminisation, e. g., increases in breast size, were achieved in the present study group compared to prior reported treatment regimes using cyproterone acetate and ethinyl oestradiol. The use of a progestin as part of the endocrine treatment regime of male-to-female transsexuals is still controversial; however, advantages in only a couple of patients with abnormal psychological irritability and mammary tenderness could be observed (Michel et al., 2001).

    Gooren, Giltay, & Bunck (2008)

    Gooren, L. J., Giltay, E. J., & Bunck, M. C. (2008). Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. The Journal of Clinical Endocrinology & Metabolism, 93(1), 19–25. [DOI:10.1210/jc.2007-1809]:

    There is no evidence that progestagens add to the feminization process of M2F. In female reproductive endocrinology, progesterone prepares the uterus for conception and the breasts for lactation. Some patients strongly believe that progestagens are a necessary addition to estrogens in their feminization process. But this is not the case, and progestagens may have side effects, such as salt/water retention leading to elevated blood pressure or venous varicosis. In the large-scale study of postmenopausal hormone use in women, the combination of estrogens and progestagens appeared to be associated with a higher incidence of breast cancer (4) and cardiovascular disease.

    Gooren (2011)

    Gooren, L. J. (2011). Care of transsexual persons. New England Journal of Medicine, 364(13), 1251–1257. [DOI:10.1056/nejmcp1008161]:

    Although progestins suppress androgen production, they have no role in the feminization of the body and may have harmful metabolic effects; consequently, progestins should be discontinued after orchiectomy.24 In postmenopausal women, progestins combined with estrogens increase the risk of breast cancer.25

    Wierckx, Gooren, T’Sjoen (2014)

    Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical review: breast development in trans women receiving cross-sex hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]:

    With regard to the hormonal impact on female breast development, the classic view is that estrogens induce proliferation, whereas progestins cause differentiation in female breast development [2,3]. It is widely assumed that progestins have no significant role in the formation of the volume of the breasts, the reason why it is not included in endocrine treatment of girls with Turner and juvenile trans women persons [1].

    […] Although there is undeniably a role of progesterone in breast development and lactation, it is uncertain whether the treatment of progestogens adds much to the volume of the breasts, the concern of trans women. […] In the medical profession and even more in the transsexual community, there has been an ongoing debate for many years on the potential benefit of adding progestogens to estrogen use in trans women’s hormonal treatment, especially concerning its role in the volume/size breast development and maintenance. Progestagen treatment is also often requested by trans women themselves as it is their perception that their treatment should closely mimic hormonal treatment of hypogonadal women requiring hormone treatment. However, for the latter group, addition of progestogens has a different relevance, specifically the modifying estrogen effects on the uterus potentially inducing cancerous development.

    […] Few studies have investigated the effects of cross-sex hormone treatment on breast volume. Meyer et al. [17] investigated breast growth in 52 trans women during cross-sex hormone treatment. Notably, 41 trans women received cross-sex hormone treatment with a median of 26.4 months before inclusion in the study. Different estrogen regimes (ethinyl estradiol [EE], conjugated estrogen, or both) were analyzed, and 15 trans women of their sample (28%) additionally received a progestational agent. No difference in breast size was observed between trans women who received progestogens compared with the others.

    […] The available evidence does not provide support for better effects on breast size of adding progestogens to cross-sex hormone administration in trans women as suggested by some authors [14,18,48–51]. However, it should be said that the quality and amount of available evidence are extremely poor and hamper any firm conclusion at this moment.

    […] Our knowledge concerning the natural history and effects of different cross-sex hormone therapies including progestogens on breast development in trans women is extremely sparse and based on low quality of evidence. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions.

    Deutsch (2016)

    Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California, San Francisco. [URL] [PDF]:

    There have been no well-designed studies of the role of progestagens in feminizing hormone regimens. Many transgender women and providers alike report an anecdotal improved breast and/or areolar development, mood, or libido with the use of progestagens.[17,18] There is no evidence to suggest that using progestagens in the setting of transgender care are harmful. In reality some patients may respond favorably to progestagens while others may find negative effects on mood. While progestagens have some anti-androgen effect through central blockade of gonadotropins, there is also a theoretical risk of a direct androgenizing effect of progestagens. This class includes micronized bioidentical progesterone (Prometrium) as well as a number of synthetic progestins. The most commonly used synthetic progestin in the context of transgender care is the oral medroxyprogesterone acetate (Provera).

    While concerns exist from the Women’s Health Initiative (WHI) regarding risks of cardiovascular disease and breast cancer in the setting of medroxyprogesterone use, these concerns likely do not apply in the context of transgender care for several reasons. First, the transgender women may be at lower risk of breast cancer than non-transgender women. Second, this arm of the WHI involved the use of conjugated equine estrogens in combination with medroxyprogesterone in a sample of menopausal women, some of whom were as long as 10 years post-menopausal at the time of hormone initiation. Third, while statistically significant, the clinical significance of the findings in the WHI was subtle at best. The study aimed to evaluate the role of menopausal hormone therapy in the prevention of chronic disease. The actual findings in the conjugated equine estrogen plus medroxyprogesterone group were an excess absolute risk per 10 000 person-years of 7 more cardiac events events, 8 more strokes, 8 more pulmonary emboli, and 8 more invasive breast cancers, with no change in overall mortality.[19] As such this arm of the WHI was stopped early, and it was concluded that combined menopausal hormone therapy is not indicated for prevention of chronic disease.

    In the setting of gender-affirming care, there are numerous differences to the findings of the WHI: populations tend to be younger, equine estrogens are not used, and the emphasis is on genderaffirming interventions which have numerous benefits on mental health and quality of life, rather than prevention. Considering these differences in demographics and goals of therapy, extremely modest increase in overall risk, and lack of difference in mortality, as well as more recent reassuring data with other forms of estrogen, the risks of using progestagens in transgender women are likely minimal or even absent (Grading: NT O M). Injected depomedroxyprogesterone acetate (Depo-Provera®) is less commonly used in transgender women. Other synthetic progestins may be used as necessitated by formulary limitations; some evidence suggests that norpregnane derived progestins (norethindrone, norgestrel) may have an increased risk of venous thromboembolism.[20]

    Tangpricha & den Heijer (2017)

    Tangpricha, V., & den Heijer, M. (2017). Oestrogen and anti-androgen therapy for transgender women. The Lancet Diabetes & Endocrinology, 5(4), 291–300. [DOI:10.1016/S2213-8587(16)30319-9]:

    Some patients request progesterone for enhanced breast growth. However, there have not been any well designed studies to assess the eff ectiveness of progesterone to improve breast development. Results of studies of progesterone combined with oestrogen in postmenopausal cis-gender women—ie, women who are not transgender—suggest that progesterone combined with oestrogen might be associated with an increased risk of cardiovascular disease.21 In fact, in a population-based study of premenopausal cis-gender women, taking oral contraceptives including progesterone with or without oestrogen was associated with increased risk of thromboembolism.22

    Hembree et al. (2017)

    Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline [2nd Version]. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]:

    In the future, we need more rigorous evaluations of the effectiveness and safety of endocrine and surgical protocols. Specifically, endocrine treatment protocols for GD/gender incongruence should include the careful assessment of the following: (1) the effects of prolonged delay of puberty in adolescents on bone health, gonadal function, and the brain (including effects on cognitive, emotional, social, and sexual development); (2) the effects of treatment in adults on sex hormone levels; (3) the requirement for and the effects of progestins and other agents used to suppress endogenous sex steroids during treatment; and (4) the risks and benefits of gender-affirming hormone treatment in older transgender people.

    […] Although the time course of breast development in transgender females has been studied (150), precise information about other changes induced by sex hormones is lacking (141). There is a great deal of variability among individuals, as evidenced during pubertal development. We all know that a major concern for transgender females is breast development. If we work with estrogens, the result will be often not what the transgender female expects. Alternatively, there are transgender females who report an anecdotal improved breast development, mood, or sexual desire with the use of progestogens. However, there have been no well-designed studies of the role of progestogens in feminizing hormone regimens, so the question is still open. Our knowledge concerning the natural history and effects of different cross-sex hormone therapies on breast development in transgender females is extremely sparse and based on the low quality of evidence. Current evidence does not indicate that progestogens enhance breast development in transgender females, nor does evidence prove the absence of such an effect. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions (162).

    Coxon & Seal (2018)

    Coxon, J., & Seal, L. (2018). Hormone management of trans women. Trends in Urology & Men’s Health, 9(6), 10–14. [DOI:10.1002/tre.663]:

    Progesterone is recommended by some gender clinics internationally, but rarely in the UK. Some trans women strongly believe that it should be added, to enhance breast development. A meta-analysis found no additional benefit for breast development when comparing progesterone plus oestrogen to oestrogen alone.17 We advise patients that oestrogen-only hormone therapy is the best and safest option, as progesterone is not produced during the breast development phase of physiological female puberty, and trans women do not have endometria to protect. At a cellular level, progesterone reverses oestrogen induced cell proliferation and, more importantly, evidence in cis women has shown that adding progesterone to oestrogen therapy is associated with increased risk of cardiovascular disease and breast cancer.18

    Prior (2019)

    Prior, J. C. (2019). Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1181–1186. [DOI:10.1210/jc.2018-01777]:

    Oral micronized progesterone, a fundamental ovarian steroid, molecularly identical to the natural hormone, should be added to E2 for transgender women based on physiology and emerging evidence of the importance of progesterone with E2 for ciswomen’s bone and likely cardiovascular health. Progesterone will probably prevent at least some of the negative cardiovascular system and bone health effects reported in transgender women on current long-term, E/E2-only, or E/E2 antiandrogen CHT. Progesterone will also aid antiandrogen effects through different pathways than spironolactone or cyproterone acetate and may promote feminine physiological breast maturation, while also aiding disturbed sleep and perhaps decreasing anxiety. It may also facilitate transgender women’s acceptance of physiological (rather than high) E2 doses ideally delivered transdermally. Evidence is mounting that ciswomen’s lifelong health is enhanced by sufficient P4 (normally ovulatory) within regular estradiol-sufficient monthly menstrual cycles. I believe it is time that we now follow current guidelines and provide transgender women with these P4 or progesterone benefits in their CHT.

    Iwamoto et al. (2019)

    Iwamoto, S. J., T’Sjoen, G., Safer, J. D., Davidge-Pitts, C. J., Wierman, M. E., Glodowski, M. B., & Rothman, M. S. (2019). Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3127–3128. [DOI:10.1210/jc.2019-00249]:

    We respect Dr. Jerilynn C. Prior’s many contributions to endocrinology and transgender (trans) health. Yet, we have multiple concerns about her Perspective(1) which is limited to her clinical experience, assumptions taken from in vitro and animal data, and selected data from cisgender (cis) women, whose female gender identity aligns with their natal sex.

    […] Prior asserts that P4 with estradiol (E2) will optimize breast maturation and size, but P4 causes ductal differentiation in puberty and has not been shown to enhance breast development in trans women(2). Prior argues that bone mineral density (BMD) improves with P4. However, selected studies from her meta-analysis were limited by significant heterogeneity of hormone dose, race and range of years after menopause(3). Although Prior states that low BMD is a major risk for trans women “on long-term” hormones, the major concerns are low baseline BMD before pharmacologic gender-affirming hormone therapy (GAHT) and monitoring after gonadectomy and cessation of GAHT(4). Recent ten-year GAHT data (without P4) showed gains in lumbar spine Z-scores of trans women(4).

    We also object to Prior’s assumption that P4 will decrease breast cancer risk in trans women based on the French E3N self-administered questionnaire study in cis women. Randomized controlled trial (RCT) data from the Women’s Health Initiative (WHI) demonstrated increased invasive breast cancer during the intervention, postintervention and cumulative follow-up in the conjugated equine estrogen (CEE)+medroxyprogesterone (MPA) group compared to CEE alone(5).

    Lastly, Prior’s statement of cardiovascular benefits with progestins conflicts with WHI data which revealed increased coronary heart disease in women ≥20 years past menopause onset and higher risk of stroke and blood clots in the CEE+MPA group during cumulative follow-up(5). Recent data raise concerns for higher risks of blood clots and stroke among trans women on GAHT compared to reference women and men(6).

    […] To conclude that oral micronized P4 will be positive for bone and cardiovascular health based on selected data in menopausal cis women is premature and potentially dangerous. Further, we know that clinical assumptions based on observational data, murine studies, cell models and personal experience can lead to risks to patients. Our transgender patients deserve the benefits of rigorous RCT data so we can provide evidence-based recommendations regarding the risks and benefits of GAHT.

    Cheung et al. (2019)

    Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]:

    Despite anecdotal reports that progestins increase breast growth, no data support their use. Healthy postmenopausal women who received estradiol with progestins had increased risk of coronary heart disease compared with placebo34 (not reported with estradiol alone42). Progestins can also increase risk of thrombosis, bloating, nausea and weight gain and are not recommended.10 Cyproterone acetate, a commonly used anti-androgen agent, has progestogenic effects.

    Iwamoto et al. (2019)

    Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819871166. [DOI:10.1177/2042018819871166]:

    Alternative anti-androgen therapies exist that have not yet been substantiated for routine use by supporting research. Progesterone is discussed in the breast development section, but we do not recommend its routine use in TW until more rigorous studies demonstrate potential benefits outweigh any risks.40

    […] The impact of various combinations of different oestrogens, anti-androgens and progestogens on breast development was previously reviewed by Wierckx and colleagues,67 who concluded that current evidence did not support or refute any enhancement of breast development with progestogens. Pubertal data in people assigned female at birth (AFAB) (e.g. girls with Turner syndrome) argue for delaying progesterone as it causes ductal differentiation and may interfere with optimal breast development.68 Due to unsatisfactory effects of GAHT alone on breast growth and development, 60–70% of all TW sought additional surgical breast augmentation.67 Articles on breast development in TW report inconclusive results, possibly due to differences in methodology and the lack of prospective RCTs. Prior69 recently published on the potential benefits of progesterone use on breast development (among other conclusions) in TW but the perspective was limited to clinical experience, assumptions taken from in vitro and animal data, and selected data from cis women.40 It would be worthwhile for future studies to use volume measurements for examining hormonally induced breast development in TW over a longer follow-up period in a large cohort, which may result in the identification of predictive markers for breast development.62 Additionally, rigorous prospective RCTs of oestrogen and oestrogen plus progesterone may provide more conclusive data to guide routine use of progesterone for breast development.

    T’Sjoen et al. (2020)

    T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, with Attention for Sexual Function and Satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]:

    To induce (more) feminine secondary sex characteristics and/or to reduce the masculine ones, estrogens and/or antiandrogens can be used. The debate on the use of progesterone is ongoing, caused by a lack of data.3 A wide range of estrogenic compounds exists, of which 17beta-estradiol (oral 2–6 mg/d or transdermal) represents the treatment of choice. Estrogen dosage should be adjusted to maintain serum estradiol at the level for premenopausal women (100–200 pg/mL), although timing of treatment intake may affect blood concentrations. The most commonly used antiandrogen drug in Europe is cyproterone acetate (oral 10–50 mg, once daily), a progestin with antiandrogenic properties. GnRHa are also effective in reducing testosterone levels with a low risk of adverse effects.3

    Reisman (2020)

    Reisman, T. (2020). Breast imaging in transgender individuals. In Legato, M. J. (Ed.). The Plasticity of Sex: The Molecular Biology and Clinical Features of Genomic Sex, Gender Identity and Sexual Behavior (pp. 187–205). London: Academic Press. [DOI:10.1016/B978-0-12-815968-2.00016-5]:

    While the role of estrogen in breast growth has been most clearly established, other hormones have also been implicated in breast development. In his 1958 study, Lyon demonstrated in oophorectomized, adrenalectomized, and hypophysectomized rodents that estrogen, growth hormone, and corticosteroids are all required for ductal develoment.10 Progesterone does not appear to be important for either early pubertal duct development or breast growth. However, with increasing levels throughout pregnancy, progesterone is reported to mediate the lobular alveolar development facilitating lactation.

    \ No newline at end of file +Sources/Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy - Transfeminine Science Link

    Sources/Excerpts: Perspectives and Opinions of Clinicians and Researchers Concerning the Use of Progestogens in Transfeminine Hormone Therapy

    By Sam | First published April 18, 2020 | Last modified October 5, 2020

    Oriel (2000)

    Oriel, K. A. (2000). Clinical update: Medical care of transsexual patients. Journal of the Gay and Lesbian Medical Association, 4(4), 185–194. [DOI:10.1023/a:1026563806480]:

    The use of progesterone to augment breast development is controversial in physicians treating MTF transsexuals. When deciding on a hormone regimen, prescribers should remember that it is estrogen that causes the serious side effects, so the lowest effective dose should be used.

    […] Progesterone is the third and optional component of the MTF regimen. Although some physicians working with transgendered patients do not prescribe progesterone, others argue feminization involves the actions of both estrogen and progesterone (31). Medroxyprogesterone is a weak antiandrogen, and testosterone suppression may be accomplished with lower doses of estrogen. Medroxyprogesterone is less androgenic than norethindrone and norgestrel. Progesterone is important for breast development (24). Unlike estrogen, progesterone does not carry the risk of thromboembolism, prolactinoma, and myocardial infarction. Although it has been noted that doses of 20–40 mg per day are required to suppress luteinizing hormone (20), medroxyprogesterone acetate may become androgenic at higher doses, so others (5) recommend 10 mg a day. Micronized progesterone (Prometrium) is advantageous because it has a more favorable side effect profile (anxiety and irritability) than medroxyprogesterone. It is also less androgenic when higher progesterone doses are needed, but is more costly.

    Dittrich et al. (2005)

    Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M. W., & Mueller, A. (2005). Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]:

    Ethinyl oestradiol was no more effective in comparison with the oestradiol-17β valerate administered in the regimen studied here. Similar efficacy in terms of feminisation, e. g., increases in breast size, were achieved in the present study group compared to prior reported treatment regimes using cyproterone acetate and ethinyl oestradiol. The use of a progestin as part of the endocrine treatment regime of male-to-female transsexuals is still controversial; however, advantages in only a couple of patients with abnormal psychological irritability and mammary tenderness could be observed (Michel et al., 2001).

    Gooren, Giltay, & Bunck (2008)

    Gooren, L. J., Giltay, E. J., & Bunck, M. C. (2008). Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. The Journal of Clinical Endocrinology & Metabolism, 93(1), 19–25. [DOI:10.1210/jc.2007-1809]:

    There is no evidence that progestagens add to the feminization process of M2F. In female reproductive endocrinology, progesterone prepares the uterus for conception and the breasts for lactation. Some patients strongly believe that progestagens are a necessary addition to estrogens in their feminization process. But this is not the case, and progestagens may have side effects, such as salt/water retention leading to elevated blood pressure or venous varicosis. In the large-scale study of postmenopausal hormone use in women, the combination of estrogens and progestagens appeared to be associated with a higher incidence of breast cancer (4) and cardiovascular disease.

    Gooren (2011)

    Gooren, L. J. (2011). Care of transsexual persons. New England Journal of Medicine, 364(13), 1251–1257. [DOI:10.1056/nejmcp1008161]:

    Although progestins suppress androgen production, they have no role in the feminization of the body and may have harmful metabolic effects; consequently, progestins should be discontinued after orchiectomy.24 In postmenopausal women, progestins combined with estrogens increase the risk of breast cancer.25

    Wierckx, Gooren, T’Sjoen (2014)

    Wierckx, K., Gooren, L., & T’Sjoen, G. (2014). Clinical review: breast development in trans women receiving cross-sex hormones. The Journal of Sexual Medicine, 11(5), 1240–1247. [DOI:10.1111/jsm.12487]:

    With regard to the hormonal impact on female breast development, the classic view is that estrogens induce proliferation, whereas progestins cause differentiation in female breast development [2,3]. It is widely assumed that progestins have no significant role in the formation of the volume of the breasts, the reason why it is not included in endocrine treatment of girls with Turner and juvenile trans women persons [1].

    […] Although there is undeniably a role of progesterone in breast development and lactation, it is uncertain whether the treatment of progestogens adds much to the volume of the breasts, the concern of trans women. […] In the medical profession and even more in the transsexual community, there has been an ongoing debate for many years on the potential benefit of adding progestogens to estrogen use in trans women’s hormonal treatment, especially concerning its role in the volume/size breast development and maintenance. Progestagen treatment is also often requested by trans women themselves as it is their perception that their treatment should closely mimic hormonal treatment of hypogonadal women requiring hormone treatment. However, for the latter group, addition of progestogens has a different relevance, specifically the modifying estrogen effects on the uterus potentially inducing cancerous development.

    […] Few studies have investigated the effects of cross-sex hormone treatment on breast volume. Meyer et al. [17] investigated breast growth in 52 trans women during cross-sex hormone treatment. Notably, 41 trans women received cross-sex hormone treatment with a median of 26.4 months before inclusion in the study. Different estrogen regimes (ethinyl estradiol [EE], conjugated estrogen, or both) were analyzed, and 15 trans women of their sample (28%) additionally received a progestational agent. No difference in breast size was observed between trans women who received progestogens compared with the others.

    […] The available evidence does not provide support for better effects on breast size of adding progestogens to cross-sex hormone administration in trans women as suggested by some authors [14,18,48–51]. However, it should be said that the quality and amount of available evidence are extremely poor and hamper any firm conclusion at this moment.

    […] Our knowledge concerning the natural history and effects of different cross-sex hormone therapies including progestogens on breast development in trans women is extremely sparse and based on low quality of evidence. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions.

    Deutsch (2016)

    Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. Center of Excellence for Transgender Health, Department of Family and Community Medicine, University of California, San Francisco. [URL] [PDF]:

    There have been no well-designed studies of the role of progestagens in feminizing hormone regimens. Many transgender women and providers alike report an anecdotal improved breast and/or areolar development, mood, or libido with the use of progestagens.[17,18] There is no evidence to suggest that using progestagens in the setting of transgender care are harmful. In reality some patients may respond favorably to progestagens while others may find negative effects on mood. While progestagens have some anti-androgen effect through central blockade of gonadotropins, there is also a theoretical risk of a direct androgenizing effect of progestagens. This class includes micronized bioidentical progesterone (Prometrium) as well as a number of synthetic progestins. The most commonly used synthetic progestin in the context of transgender care is the oral medroxyprogesterone acetate (Provera).

    While concerns exist from the Women’s Health Initiative (WHI) regarding risks of cardiovascular disease and breast cancer in the setting of medroxyprogesterone use, these concerns likely do not apply in the context of transgender care for several reasons. First, the transgender women may be at lower risk of breast cancer than non-transgender women. Second, this arm of the WHI involved the use of conjugated equine estrogens in combination with medroxyprogesterone in a sample of menopausal women, some of whom were as long as 10 years post-menopausal at the time of hormone initiation. Third, while statistically significant, the clinical significance of the findings in the WHI was subtle at best. The study aimed to evaluate the role of menopausal hormone therapy in the prevention of chronic disease. The actual findings in the conjugated equine estrogen plus medroxyprogesterone group were an excess absolute risk per 10 000 person-years of 7 more cardiac events events, 8 more strokes, 8 more pulmonary emboli, and 8 more invasive breast cancers, with no change in overall mortality.[19] As such this arm of the WHI was stopped early, and it was concluded that combined menopausal hormone therapy is not indicated for prevention of chronic disease.

    In the setting of gender-affirming care, there are numerous differences to the findings of the WHI: populations tend to be younger, equine estrogens are not used, and the emphasis is on genderaffirming interventions which have numerous benefits on mental health and quality of life, rather than prevention. Considering these differences in demographics and goals of therapy, extremely modest increase in overall risk, and lack of difference in mortality, as well as more recent reassuring data with other forms of estrogen, the risks of using progestagens in transgender women are likely minimal or even absent (Grading: NT O M). Injected depomedroxyprogesterone acetate (Depo-Provera®) is less commonly used in transgender women. Other synthetic progestins may be used as necessitated by formulary limitations; some evidence suggests that norpregnane derived progestins (norethindrone, norgestrel) may have an increased risk of venous thromboembolism.[20]

    Tangpricha & den Heijer (2017)

    Tangpricha, V., & den Heijer, M. (2017). Oestrogen and anti-androgen therapy for transgender women. The Lancet Diabetes & Endocrinology, 5(4), 291–300. [DOI:10.1016/S2213-8587(16)30319-9]:

    Some patients request progesterone for enhanced breast growth. However, there have not been any well designed studies to assess the eff ectiveness of progesterone to improve breast development. Results of studies of progesterone combined with oestrogen in postmenopausal cis-gender women—ie, women who are not transgender—suggest that progesterone combined with oestrogen might be associated with an increased risk of cardiovascular disease.21 In fact, in a population-based study of premenopausal cis-gender women, taking oral contraceptives including progesterone with or without oestrogen was associated with increased risk of thromboembolism.22

    Hembree et al. (2017)

    Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline [2nd Version]. The Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]:

    In the future, we need more rigorous evaluations of the effectiveness and safety of endocrine and surgical protocols. Specifically, endocrine treatment protocols for GD/gender incongruence should include the careful assessment of the following: (1) the effects of prolonged delay of puberty in adolescents on bone health, gonadal function, and the brain (including effects on cognitive, emotional, social, and sexual development); (2) the effects of treatment in adults on sex hormone levels; (3) the requirement for and the effects of progestins and other agents used to suppress endogenous sex steroids during treatment; and (4) the risks and benefits of gender-affirming hormone treatment in older transgender people.

    […] Although the time course of breast development in transgender females has been studied (150), precise information about other changes induced by sex hormones is lacking (141). There is a great deal of variability among individuals, as evidenced during pubertal development. We all know that a major concern for transgender females is breast development. If we work with estrogens, the result will be often not what the transgender female expects. Alternatively, there are transgender females who report an anecdotal improved breast development, mood, or sexual desire with the use of progestogens. However, there have been no well-designed studies of the role of progestogens in feminizing hormone regimens, so the question is still open. Our knowledge concerning the natural history and effects of different cross-sex hormone therapies on breast development in transgender females is extremely sparse and based on the low quality of evidence. Current evidence does not indicate that progestogens enhance breast development in transgender females, nor does evidence prove the absence of such an effect. This prevents us from drawing any firm conclusion at this moment and demonstrates the need for further research to clarify these important clinical questions (162).

    Coxon & Seal (2018)

    Coxon, J., & Seal, L. (2018). Hormone management of trans women. Trends in Urology & Men’s Health, 9(6), 10–14. [DOI:10.1002/tre.663]:

    Progesterone is recommended by some gender clinics internationally, but rarely in the UK. Some trans women strongly believe that it should be added, to enhance breast development. A meta-analysis found no additional benefit for breast development when comparing progesterone plus oestrogen to oestrogen alone.17 We advise patients that oestrogen-only hormone therapy is the best and safest option, as progesterone is not produced during the breast development phase of physiological female puberty, and trans women do not have endometria to protect. At a cellular level, progesterone reverses oestrogen induced cell proliferation and, more importantly, evidence in cis women has shown that adding progesterone to oestrogen therapy is associated with increased risk of cardiovascular disease and breast cancer.18

    Prior (2019)

    Prior, J. C. (2019). Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1181–1186. [DOI:10.1210/jc.2018-01777]:

    Oral micronized progesterone, a fundamental ovarian steroid, molecularly identical to the natural hormone, should be added to E2 for transgender women based on physiology and emerging evidence of the importance of progesterone with E2 for ciswomen’s bone and likely cardiovascular health. Progesterone will probably prevent at least some of the negative cardiovascular system and bone health effects reported in transgender women on current long-term, E/E2-only, or E/E2 antiandrogen CHT. Progesterone will also aid antiandrogen effects through different pathways than spironolactone or cyproterone acetate and may promote feminine physiological breast maturation, while also aiding disturbed sleep and perhaps decreasing anxiety. It may also facilitate transgender women’s acceptance of physiological (rather than high) E2 doses ideally delivered transdermally. Evidence is mounting that ciswomen’s lifelong health is enhanced by sufficient P4 (normally ovulatory) within regular estradiol-sufficient monthly menstrual cycles. I believe it is time that we now follow current guidelines and provide transgender women with these P4 or progesterone benefits in their CHT.

    Iwamoto et al. (2019)

    Iwamoto, S. J., T’Sjoen, G., Safer, J. D., Davidge-Pitts, C. J., Wierman, M. E., Glodowski, M. B., & Rothman, M. S. (2019). Letter to the Editor: “Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen”. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3127–3128. [DOI:10.1210/jc.2019-00249]:

    We respect Dr. Jerilynn C. Prior’s many contributions to endocrinology and transgender (trans) health. Yet, we have multiple concerns about her Perspective(1) which is limited to her clinical experience, assumptions taken from in vitro and animal data, and selected data from cisgender (cis) women, whose female gender identity aligns with their natal sex.

    […] Prior asserts that P4 with estradiol (E2) will optimize breast maturation and size, but P4 causes ductal differentiation in puberty and has not been shown to enhance breast development in trans women(2). Prior argues that bone mineral density (BMD) improves with P4. However, selected studies from her meta-analysis were limited by significant heterogeneity of hormone dose, race and range of years after menopause(3). Although Prior states that low BMD is a major risk for trans women “on long-term” hormones, the major concerns are low baseline BMD before pharmacologic gender-affirming hormone therapy (GAHT) and monitoring after gonadectomy and cessation of GAHT(4). Recent ten-year GAHT data (without P4) showed gains in lumbar spine Z-scores of trans women(4).

    We also object to Prior’s assumption that P4 will decrease breast cancer risk in trans women based on the French E3N self-administered questionnaire study in cis women. Randomized controlled trial (RCT) data from the Women’s Health Initiative (WHI) demonstrated increased invasive breast cancer during the intervention, postintervention and cumulative follow-up in the conjugated equine estrogen (CEE)+medroxyprogesterone (MPA) group compared to CEE alone(5).

    Lastly, Prior’s statement of cardiovascular benefits with progestins conflicts with WHI data which revealed increased coronary heart disease in women ≥20 years past menopause onset and higher risk of stroke and blood clots in the CEE+MPA group during cumulative follow-up(5). Recent data raise concerns for higher risks of blood clots and stroke among trans women on GAHT compared to reference women and men(6).

    […] To conclude that oral micronized P4 will be positive for bone and cardiovascular health based on selected data in menopausal cis women is premature and potentially dangerous. Further, we know that clinical assumptions based on observational data, murine studies, cell models and personal experience can lead to risks to patients. Our transgender patients deserve the benefits of rigorous RCT data so we can provide evidence-based recommendations regarding the risks and benefits of GAHT.

    Cheung et al. (2019)

    Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]:

    Despite anecdotal reports that progestins increase breast growth, no data support their use. Healthy postmenopausal women who received estradiol with progestins had increased risk of coronary heart disease compared with placebo34 (not reported with estradiol alone42). Progestins can also increase risk of thrombosis, bloating, nausea and weight gain and are not recommended.10 Cyproterone acetate, a commonly used anti-androgen agent, has progestogenic effects.

    Iwamoto et al. (2019)

    Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 2042018819871166. [DOI:10.1177/2042018819871166]:

    Alternative anti-androgen therapies exist that have not yet been substantiated for routine use by supporting research. Progesterone is discussed in the breast development section, but we do not recommend its routine use in TW until more rigorous studies demonstrate potential benefits outweigh any risks.40

    […] The impact of various combinations of different oestrogens, anti-androgens and progestogens on breast development was previously reviewed by Wierckx and colleagues,67 who concluded that current evidence did not support or refute any enhancement of breast development with progestogens. Pubertal data in people assigned female at birth (AFAB) (e.g. girls with Turner syndrome) argue for delaying progesterone as it causes ductal differentiation and may interfere with optimal breast development.68 Due to unsatisfactory effects of GAHT alone on breast growth and development, 60–70% of all TW sought additional surgical breast augmentation.67 Articles on breast development in TW report inconclusive results, possibly due to differences in methodology and the lack of prospective RCTs. Prior69 recently published on the potential benefits of progesterone use on breast development (among other conclusions) in TW but the perspective was limited to clinical experience, assumptions taken from in vitro and animal data, and selected data from cis women.40 It would be worthwhile for future studies to use volume measurements for examining hormonally induced breast development in TW over a longer follow-up period in a large cohort, which may result in the identification of predictive markers for breast development.62 Additionally, rigorous prospective RCTs of oestrogen and oestrogen plus progesterone may provide more conclusive data to guide routine use of progesterone for breast development.

    T’Sjoen et al. (2020)

    T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, with Attention for Sexual Function and Satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]:

    To induce (more) feminine secondary sex characteristics and/or to reduce the masculine ones, estrogens and/or antiandrogens can be used. The debate on the use of progesterone is ongoing, caused by a lack of data.3 A wide range of estrogenic compounds exists, of which 17beta-estradiol (oral 2–6 mg/d or transdermal) represents the treatment of choice. Estrogen dosage should be adjusted to maintain serum estradiol at the level for premenopausal women (100–200 pg/mL), although timing of treatment intake may affect blood concentrations. The most commonly used antiandrogen drug in Europe is cyproterone acetate (oral 10–50 mg, once daily), a progestin with antiandrogenic properties. GnRHa are also effective in reducing testosterone levels with a low risk of adverse effects.3

    Reisman (2020)

    Reisman, T. (2020). Breast imaging in transgender individuals. In Legato, M. J. (Ed.). The Plasticity of Sex: The Molecular Biology and Clinical Features of Genomic Sex, Gender Identity and Sexual Behavior (pp. 187–205). London: Academic Press. [DOI:10.1016/B978-0-12-815968-2.00016-5]:

    While the role of estrogen in breast growth has been most clearly established, other hormones have also been implicated in breast development. In his 1958 study, Lyon demonstrated in oophorectomized, adrenalectomized, and hypophysectomized rodents that estrogen, growth hormone, and corticosteroids are all required for ductal develoment.10 Progesterone does not appear to be important for either early pubertal duct development or breast growth. However, with increasing levels throughout pregnancy, progesterone is reported to mediate the lobular alveolar development facilitating lactation.

    \ No newline at end of file diff --git a/transfemscience.org/articles/puberty-blockers/index.html b/transfemscience.org/articles/puberty-blockers/index.html index 56dc48f8..4f61332c 100644 --- a/transfemscience.org/articles/puberty-blockers/index.html +++ b/transfemscience.org/articles/puberty-blockers/index.html @@ -1 +1 @@ -Puberty Blockers: A Review of GnRH Analogues in Transgender Youth - Transfeminine Science Link

    Puberty Blockers: A Review of GnRH Analogues in Transgender Youth

    By Mitzi | First published January 30, 2022 | Last modified January 31, 2022

    Abstract / TL;DR

    Puberty blockers are medications used to pause puberty in both cisgender and transgender youth. For the latter, significant evidence suggests that they improve well-being, psychological functioning, and risk of suicidality, both during puberty and in later life. Their effects are reversible upon discontinuation. Current evidence does not suggest any negative impact on cognitive development, IQ, or fertility. A minor impact on bone density may exist, affecting primarily transgender girls, but little high quality data is available. Based on limited data, prescribers may wish to consider calcium supplementation in transgender teens receiving puberty blockers, and may wish to prefer transdermal delivery over oral estrogens in transgender girls starting hormone therapy in order to optimise bone density outcomes. There is a lack of evidence supporting the common belief that most children grow out of gender dysphoria (“desistance”), as widely cited data describing the rate at which this happens appears highly unreliable. Puberty blockers are difficult to access, and many Western countries have sharply restricted their use recently, in a trend condemned by numerous medical associations. Randomised controlled trials on puberty blockers can likely never be performed, but nonetheless, there is clear evidence they offer significant benefit, and have relatively minor risks.

    Introduction

    Puberty blockers, also known as gonadotropin-releasing hormone (GnRH) analogues, were introduced for medical use in the 1980s (Swerdloff & Heber, 1983). Originally developed to supersede other therapies in the treatment of prostate cancer, they were soon adapted for paediatric use, revolutionising the treatment of precocious puberty: a rare condition in which puberty begins before the age of 8 (in natal girls) or 9 (in natal boys). Precocious puberty is associated with several negative consequences, such as short stature, teasing, bullying, and worse mental health outcomes. By reversibly pausing puberty for several years in children with this condition, outcomes are often significantly improved, and puberty blockers remain the mainstay treatment for this condition several decades later.

    In the 1990s, puberty blockers began to be used in transgender adolescents, as a way of pausing their unwanted puberty, and giving them more time to consider their future (Cohen-Kettenis & van Goozen, 1998). The protocol for this, originally develped by the Dutch VUmc clinic, has sometimes been referred to as the “Dutch Method.” Cohen-Kettenis et al. (2011) published a study following one such Dutch patient 22 years later. Since then, the use of puberty blockers has increased tremendously with the increase in patients seeking transgender healthcare.

    Recently, puberty blockers have been the subject of controversy, with legal proceedings seeking to prohibit their use across several countries. Notably, their use was temporarily stopped in the United Kingdom in December 2020 following a ruling in the Bell v. Tavistock case, which was appealed in 2021. Also in 2021, Arkansas became the first U.S. state to make it illegal for doctors to prescribe puberty blockers, with several other states pursuing similar legislation. Critics express concern about the safety of puberty blockers, their reversibility, and effectiveness.

    This article seeks to review the literature on the use and safety of puberty blockers in transgender youth, examining their safety, and arguments for and against their use in a comprehensive way. While rarely, alternative medications like the progestin medroxyprogesterone acetate have been used for this, this article mainly focuses on GnRH agonists: by far the most widely used class of medication for puberty blockade, and what’s most commonly colloquially referred to as “puberty blockers.”

    Mechanism of Action

    GnRH is a naturally occurring hormone in humans responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. Through this mechanism, the body produces its gonadal estrogen and testosterone. GnRH agonists bind to the GnRH receptor and activate it, causing it to be continuously stimulated. This causes an initial increase of LH and FSH, then over the course of several weeks, causes the pituitary gland to become desensitised, pausing the natural sex hormone production for the duration the medication is taken. When the medication is stopped, its effect is reversed, with normal sex hormone production resuming about a week after the medication clears the body (Cedrin-Durnerin et al., 2000).

    GnRH agonists are prescribed as an injection administered every one to six months, a surgically implanted pellet once per year, or a nasal spray administered two to three times per day. A short-acting daily injection exists, but is not used for puberty blockade in clinical practise. Common examples of GnRH agonists include leuprorelin (Lupron; Eligard), triptorelin (Decapeptyl), goserelin (Zoladex), histrelin (Supprelin LA), nafarelin (Synarel) and buserelin (Suprefact).

    Like GnRH agonists, GnRH antagonists bind to the GnRH receptor, however, they do not stimulate it. Instead, they compete with the body’s own GnRH, rendering it ineffective. As a result, they achieve similar effects without causing an initial increase in hormone levels. Also unlike GnRH agonists, oral formulations of GnRH antagonists exist, allowing some of them to be taken as a daily pill. Common examples include elagolix (Orilissa), degarelix (Firmagon), cetrorelix (Cetrotide), ganirelix (Orgalutran; Antagon) and relugolix (Orgovyx; Relumina). Unfortunately, being much newer drugs, GnRH antagonists are not normally used as puberty blockers at the moment.

    In gender dysphoric youth, GnRH agonists are prescribed after the onset of puberty. GnRH agonists are not prescribed to children who have not yet started puberty, but may be started at any point during puberty to pause further changes (Hembree et al., 2017).

    Quality of Evidence

    In medicine, the gold standard for evidence is the randomised controlled trial, or RCT. In a nutshell, participants are randomly assigned into two or more treatment groups (arms), such that the only difference between arms is the treatment they receive. Commonly, one group receives a placebo, while another receives the treatment being studied. The ideal RCT is blinded, meaning neither participants nor investigators of the study know which group is receiving which treatment. No such trials have been performed with puberty blockers, giving rise to concerns that there could be insufficient evidence available for their use.

    Unfortunately, RCTs may not be practically possible for puberty blockers, and are unlikely to ever be performed. A good summary of the reasons for this is provided by Giordano & Holm (2020):

    There are two main practical problems that preclude conducting a RCT.

    First, patients who approach clinics for help because of distress caused by the first signs of puberty will be unlikely to accept to be a part of a RCT. Medications are needed within a relatively short period of time, at pain of treatment being less effective or ineffective. Recruitment would thus be hard if not impossible.

    Second, the ideal RCT is either double blind, i.e. neither researchers nor participants know who gets the active drug, or it assesses outcomes using blinded observers when treatment allocation cannot be hidden from participants. Blinding is necessary in order to reduce bias in outcome assessments. But, a RCT of puberty delay could not maintain blinding. Because GnRHa are effective in delaying puberty it would soon become evident to participants, researchers and outcome assessors who was in the active treatment arm and who was not. This breakdown of blinding would mean that there would be potential bias in the outcome assessments, both in relation to biological and psychological outcomes. It would also mean that participants allocated to the non-treatment arm of the study would be likely to either withdraw from the study at a much higher rate than in the treatment arm introducing potential bias, and/or be more likely not to adhere to the trial but seek puberty delaying treatment outside of the trial thereby adding a confounder.

    Mul et al. (2001) ran into this problem conducting a similar study on teens with precocious puberty:

    In the original study design a third arm with untreated children was scheduled as a control group. It was decided to omit this control group from the study design after it appeared that the parents of all patients who were randomized in the untreated control group refused further participation in the study as GnRHa treatment could be obtained elsewhere.

    Besides practical limitations, such RCTs are likely to be unethical. Evidence suggests withholding puberty blockers may cause lasting harm in itself. To knowingly cause such harm to the control group of an RCT is likely to be morally unacceptable, and such an RCT would be unlikely to receive approval from an ethical review board.

    This is not to say that studies evaluating such outcomes don’t exist at all: for example, while not randomised or blinded, Costa et al. (2015) compares 101 patients receiving psychological support and puberty blockers to 100 patients receiving psychological support alone. The results of this study are further outlined below.

    As a result of these limitations, this article mainly cites cohort studies, making the argument that sufficient other high-quality studies exist to reach well-supported conclusions: a practise sometimes required in other areas of medicine as well. Because this is the only way we can practically evaluate puberty blockers and RCTs are likely impossible, it seems disingenuous to make the claim that lack of RCTs equate to lack of evidence around puberty blockers, as this standard of evidence can never be met, and the claim ignores a substantial existing body of literature.

    Suicidality and Well-being

    A significant body of evidence associates the use of puberty blockers in those who want such treatment with improved psychological well-being: the primary argument for their use.

    While different studies use different methodologies, three standardised psychological questionnaires are typically used to evaluate well-being: the Children’s Global Assessment Scale (CGAS), the Child Behavior Checklist (CBCL), and the Youth Self-Report (YSR). All three are aimed at evaluating psychological functioning and problematic behaviour: typically, the CGAS is administered by a clinician, the CBCL is filled out by a parent or guardian, and the YSR is filled out by a child themselves. It’s important to note that scores in these assessments are known to markedly worsen in adolescence in general, with the onset of psychological difficulties and self-harm often appearing during puberty (Verhuist et al., 2003; Nock et al., 2013; Morey et al., 2017; Jung et al., 2018).

    One of the largest studies to investigate well-being to date has been Turban et al. (2020). It surveyed 20,619 American transgender adults. 3,494 (16.9%) reported that they ever wanted to receive puberty blockers. Of those, only 89 received them. In total, 75.3% of those who received puberty blockers reported ever experiencing suicidal thoughts, compared to 90.2% of those who did not. After controlling for demographic variables like income, family support, and education level, puberty blockers remained significantly associated with decreased odds of lifetime suicidal ideation.

    A similarly large survey by Green et al. (2021) included 11,914 Americans aged 13–24 who identified as transgender or nonbinary. The study compares those who received hormone therapy or puberty blockers to those who wished to receive them, but didn’t. It finds that in those who received treatment, rates of depression, suicidal ideation, and suicide attempts were significantly lower. This remained true of those aged 13–17, who were significantly more likely to receive puberty blockers specifically.

    Costa et al. (2015) studied 201 gender dysphoric adolescents who presented at the British Tavistock and Portman NHS Gender Identity Development Service. Of them, half were considered eligible for puberty blockers immediately, receiving them in addition to psychological support. The other half were not considered immediately eligible for puberty blockers, citing reasons such as psychiatric problems or conflicts with parents and siblings. These patients received only psychological support for the following 18 months. All patients’ global psychological functioning was assessed using the CGAS questionnaire. Both groups showed significantly improved psychological functioning with psychological support, but the group receiving only psychological support stalled and showed no further improvement towards the end of the study, while those receiving puberty blockers continued to show greater improvement. The authors point out that the eventual CGAS score of the group receiving puberty blockers coincided almost perfectly with those found in a sample of children/adolescents without observed psychological/psychiatric symptoms.

    Figure 1: CGAS scores of psychological functioning in transgender teens receiving puberty blockers and psychological support, compared to those receiving psychological support alone in Costa et al. (2015).

    A later study at the same British gender identity clinic, Carmichael et al. (2021), received widespread media coverage in the United Kingdom following its mixed findings. It followed 44 gender dysphoric adolescents who received puberty blockers. CGAS scores were higher than the 2015 study at baseline, and showed slower and more modest improvement. The study reached contradictory conclusions, with improvements reported in some questionnaires, but not others, even for comparable measurements. Interestingly, in some of the researchers’ measures of well-being, social acceptance, and self-perception, adolescents themselves reported significant improvements, while their parents reported almost no improvement. The study characterises participants’ overall experiences with puberty blockers as positive, but is difficult to draw any conclusions from.

    De Vries et al. (2011) and de Vries et al. (2014) investigate the psychological outcomes of the same cohort of transgender adolescents receiving puberty blockers at the VUmc gender clinic in the Netherlands. Both investigate psychological outcomes in a range of tests, with the 2014 study providing long-term follow-up many years after puberty blockers, and after gender reassignment surgery. In the studied cohort, psychological functioning improves and depression decreases over time, as evidenced by standardised tests, including CGAS scores. Significant improvements in well-being are reported both during treatment with puberty blockers, and in the years after, with hormone therapy and surgery. Unlike Carmichael et al., CBCL and YSR scores improve.

    Van der Miesen et al. (2020) charts psychological well-being across 3 groups of Dutch adolescents: 272 transgender adolescents who haven’t yet received puberty blockers, 178 adolescents receiving puberty blockers, and 651 cisgender adolescents from the general population. The study finds poorer psychological functioning in those before treatment, while psychological functioning and well-being is similar to cisgender adolescents in those receiving pubertal suppression. These findings are in line with Costa et al. (2015), which noted that those receiving puberty blockers reached CGAS scores comparable to the general (age-matched) population.

    Figure 2: Percentages of teens who report suicidality in van der Miesen et al. (2020). Suicidality was defined as endorsing the statement “I deliberately try to hurt or kill myself” or “I think about killing myself.” Suicidality among Dutch transgender youth has not significantly changed over time, making cohort differences unlikely (Arnoldussen et al., 2020).

    In addition to the studies listed above, several smaller, less focused studies have also assessed the well-being of transgender adolescents receiving puberty blockers and reported overall positive experiences (Khatchadourian et al., 2014; Achille et al., 2020; Kuper et al., 2020). No studies report a decline in psychological functioning or notably negative psychological outcomes with the use of puberty blockers.

    In combination, this strongly suggests that puberty blockers improve well-being and psychological functioning in children who experience gender dysphoria. In addition, it suggests that inappropriately withholding them may lead to worse later-life outcomes, such as increased suicidality.

    Counterintuitively, several of the studies listed do note that puberty blockers don’t reduce gender dysphoria (de Vries et al., 2011; Carmichael et al., 2021). It’s important to be aware that this finding refers to the wish to transition, rather than psychological well-being. The finding is based on the Utrecht Gender Dysphoria Scale questionnaire (de Vries et al., 2006). To illustrate, the version for transmasculine youth asks patients whether they endorse such statements as “I prefer to behave like a boy”, “I wish I had been born as a boy”, “I hate having breasts”, and “every time someone treats me like a girl, I feel hurt.”

    When studies note that puberty blockers don’t reduce gender dysphoria, this means children don’t stop identifying as transgender after receiving puberty blockers. They continue to want to transition. De Vries et al. (2011) points out this is the expected outcome:

    As expected, puberty suppression did not result in an amelioration of gender dysphoria. Previous studies have shown that only gender reassignment consisting of cross-sex hormone treatment and surgery may end the actual gender dysphoria. None of the gender dysphoric adolescents in this study renounced their wish for gender reassignment during puberty suppression. This finding supports earlier studies showing that young adolescents who had been carefully diagnosed show persisting gender dysphoria into late adolescence or young adulthood

    Fertility

    Unlike hormone therapy, no risk of permanent infertility is believed to exist with the use of puberty blockers. Several long-term follow-up studies of patients treated with puberty blockers have found normal fertility. Among others, Feuillan et al. (1999), Heger et al. (1999), Heger et al. (2006) and Lazar et al. (2014) find no indication of impaired fertility in patients treated with puberty blockers for precocious puberty. In the years and decades following their treatments, the several hundred patients in these studies are found to conceive normally without an increased need for assisted reproductive technology, and with uneventful pregnancies. Despite several decades of use, no reports exist in literature of permanent infertility linked to puberty blockers. Interestingly, transgender populations do have higher rates of sperm abnormalities than cisgender populations, before any medical treatment has taken place (Li et al., 2018; Rodriguez-Wallberg et al., 2021).

    In contrast, hormone therapy may cause permanent infertility (Hembree et al., 2017; Cheng et al., 2019). If fertility preservation has not been accessed before beginning treatment, puberty blockers must be stopped to do so, ideally before hormone therapy begins. When puberty blockers are stopped, unwanted sex characteristics continue to develop. Transgender people may find this extremely distressing, which may be one reason for them to not pursue fertility preservation.

    No data exists on the exact length of time for which puberty blockers need to be stopped before full fertility is restored, and it likely varies depending on the age puberty blockers were initiated. Bertelloni et al. (2000) found spermarche took place between 0.7 to 3 years after discontinuation of puberty blockers in boys treated for precocious puberty. Barnard et al. (2019) report on the case of a single transgender patient who had been receiving puberty blockers for 6 months, from the age of 17. Three months after the last dose of monthly leuprorelin, no viable sperm sample could be produced. Five months after, their sample was viable.

    Regardless of this, transgender individuals are extremely unlikely to use fertility preservation, with some estimates suggesting utilisation rates below 5% in North America (Chen et al., 2017; Nahata et al., 2017). In one piece of research, Pang et al. (2020) questioned 102 transgender Australian teens on their reasons for declining fertility preservation. The following statistics were gathered:

    Figure 3: Australian transgender teens’ reasons for declining fertility preservation in Pang et al. (2020).

    As such, there is no evidence-based reason to believe puberty blockers could cause infertility, with fertility returning when they are discontinued. However, due to low discontinuation rates for puberty blockers and low fertility preservation rates, those who start puberty blockers and persist are unlikely to have biological children. Clinical guidelines recommend that adolescents seeking puberty blockers should be counselled on options for fertility preservation, and parents should be involved in this (Hembree et al., 2017).

    Bone Density

    Bone density is a measure of the amount of bone mineral present in bone tissue. Bone density is measured using imaging techniques, such as DEXA scans: a type of X-ray. It is used to predict patients’ risk of breaking bones. The clinical terms for low bone density are osteopenia, and in more severe cases, osteoporosis, which is common among the elderly. For the purposes of this review, the most relevant measurement of bone density is the z-score, which expresses a patient’s bone density in comparison to other people of the same age and sex. A z-score of 0 indicates bone density equal to the general population. Small deviations, such as -0.2, may not always be relevant, but z-scores below -1 may be cause for concern.

    There are concerns around the effects of puberty blockers on bone health. Puberty is a critical time for the accrual of bone density: a process largely driven by sex hormones. This process is delayed in those receiving puberty blockers, leading to temporary lower bone density and z-scores compared to peers going through puberty normally. While these short-term z-scores are not particularly relevant, long-term outcomes are very important: the question becomes what z-scores look like in the long term, into adulthood, and whether the use of puberty blockers has any impact on later-life fracture risk. Literature on this is uncertain.

    Klink et al. (2015) finds that in both trans girls and trans boys, z-scores are lower both before treatment, and after long-term follow-up. The study suggests a small negative effect on final bone density from the use of puberty blockers, although many measurements fail to reach statistical significance. The study records notably lower final z-scores for trans girls than trans boys.

    Vlot et al. (2017) finds that 2 years after beginning hormone therapy, z-scores were returning towards normal. In trans boys, final z-scores were negligibly lower, while in trans girls, the effect was much more pronounced, with meaningfully lower z-scores both before and after treatment.

    In line with this, Schagen et al. (2020) finds that in its cohort, final z-scores normalised after 3 years of hormone therapy for trans boys, while they remained meaningfully low both before and after treatment for trans girls.

    Figure 4: Bone Mineral Apparent Density (BMAD) of the lumbar spine across multiple studies, relative to sex assigned at birth. Three measurements are taken in each study: the initiation of puberty blockers, the initiation of hormone therapy, and one measurement after several years of hormone therapy. A z-score below -1 is commonly considered to be clinically relevant osteopenia, while a score below -2.5 is considered to be osteoporosis. The figure illustrates that trans girls tend to have significantly lower bone density before, during, and after treatment, while this is not the case for trans boys. Trans girls also tend to receive puberty blockers for a longer time.

    Guaraldi et al. (2016) find in their literature review that in those receiving puberty blockers for precocious puberty, bone mineral density is lower than that of untreated peers during treatment with puberty blockers, then typically recovers when puberty is initiated, with long-term follow-up showing little difference to the general population. Combined with the results of trans boys, this suggests that not puberty blockers themselves, but rather, subsequent suboptimal hormone therapy in trans girls could potentially be to blame for their more pronounced negative outcomes.

    The hormone therapy prescribed to trans girls in the listed studies may be suboptimal in several ways. To begin with, all three use very low adult maintenance dosages of no more than 2 mg oral estradiol in transfeminine patients. Such a dose is likely to produce serum estradiol levels of roughly 50 pg/ml on average: below the average estradiol exposure of cis women (Aly, 2018; Aly, 2020). Many clinical guidelines recommend higher levels, which some research suggests could have a small positive effect on final bone density compared to lower dosages (Roux, 1997; Riggs et al., 2012). Indeed, the authors of all three studies themselves note their doses were low and may have been inadequate for optimal bone density.

    Also significantly, all studies use oral estrogens. Oral estrogens significantly reduce IGF-1 levels (Isotton et al., 2012; Southmayd & De Souza, 2017), which is thought to play a vital role in bone density accrual, and strongly correlates with bone density (Barake, Klibanski & Tritos, 2014; Locatelli & Bianchi, 2014; Ekbote et al., 2015; Lindsey & Mohan, 2016; Barake et al., 2018). Some experts have recommended transdermal estrogens over oral estrogens to improve bone density outcomes in girls suffering from Turner syndrome (Davenport, 2010), and tentative evidence appears to support the practise (Zaiem et al., 2017). As such, while not currently discussed in most clinical guidelines, the prevalence of oral estrogens in transgender teens is a concern, and avoiding them in favour of transdermal estrogens could lead to improved final bone density.

    As a final confounding factor, none of the studies control for lifestyle factors associated with lower bone density, such as exercise, smoking, vitamin D, and calcium intake. These factors have a significant effect on bone density. Transgender people are more likely to smoke, less likely to exercise, and less likely to consume adequate calcium, both as teens and as adults (Jones et al., 2018; Kidd, Dolezal & Bockting, 2018). This is believed to be the reason transgender people of all ages tend to have lower bone density before any treatment is initiated. Without controlling for these factors, which may distort the available data significantly, it’s difficult to draw confident conclusions from these studies, and a causal link between the use of puberty blockers and lower final bone density remains unproven. If such a link does exist, the effect seems unlikely to be dramatic, and unlikely to outweigh the benefits of puberty blockers.

    In a noteworthy study, Antoniazzi et al. (2003) report that in those receiving puberty blockers for precocious puberty, bone mineral density is better preserved through calcium supplementation. Calcium intake is often inadequate in transgender youth (Lee et al., 2020), and therefore warrants further study for improving their bone mineral density. Alongside calcium, lifestyle interventions, the use of transdermal instead of oral estrogens, and the avoidance of subphysiological adult dosages of estradiol could all potentially improve bone-related outcomes over current clinical practise.

    IQ and Cognitive Development

    One possible concern is the impact of puberty blockers on IQ and cognitive development. Very little research on the subject exists, with commonly cited critical studies investigating sheep rather than humans (Hough et al., 2017), or being case studies of a single patient (Schneider et al., 2017). Only two larger studies investigate this:

    Staphorsius et al. (2015), the only study to investigate this in a transgender population, evaluated performance in the standardised Tower of London test, as well as IQ scores. The study found no significant differences in executive functioning between the two groups. IQ was slightly lower in transgender girls receiving puberty suppression than the control group, but the same was not true in a statistically relevant way of transgender boys. Age differences, lifestyle factors, and a very low sample size may all explain these differences.

    Wojniusz et al. (2016) assessed 15 girls suffering from precocious puberty and treated with a puberty blocker. The 15 girls were compared with 15 age-matched controls. Both groups showed similar IQ scores.

    Neither study has very many participants, records baseline cognitive performance, or controls for confounding factors. As such, very few conclusions can be drawn from them. Decades of clinical experience with the use of puberty blockers in children suggests it’s unlikely any particularly dramatic effect on IQ exists, but without much larger, higher quality studies, no conclusion on this can be reached, and further research is needed.

    Desistance

    Discontinuation rates for patients on puberty blockers are very low, with fewer than 5% of teens typically stopping them without going on to hormone therapy (Wiepjes et al., 2018; Brik et al., 2020; Kuper et al., 2020). A potential concern is that this could mean puberty blockers put children on an almost guaranteed path towards gender transition, when they might otherwise change their minds.

    Surprisingly, while a commonly held belief suggests most gender dysphoric children will grow out of it without treatment at a later age, little convincing evidence supports this claim. While existing studies report desistance rates ranging from 43% (Wallien & Cohen-Kettenis, 2008) to 88% (Drummond et al., 2008), they often contain significant methodological issues.

    Historically, in the 20th century, a transgender identity was viewed as a negative outcome: it was something for a patient to be cured of, for example through aversion therapy. Since then, a cultural shift towards transgender people has taken place. Older studies into desistance rates are often reflective of this. As an example, Kosky (1987) describes eight boys who were hospitalised in a psychiatric unit for displaying effeminate behaviour and cross-dressing, where they received intensive treatment aimed at curing them. Today, these behaviours are more accepted, and they are not necessarily viewed as the same thing as a transgender gender identity. Clearly, a study like this cannot be used to estimate the desistance rates of today’s gender dysphoric children.

    Other studies describing the 1960s through 1980s are similar (Bakwin, 1968; Lebovitz, 1972; Zuger, 1978; Money & Russo, 1979; Davenport, 1986). Many predate the DSM-III, and thus the existence of formal diagnostic criteria. Few studied self-reported gender identity: instead, they tend to study gender non-conforming behaviour, such as cross-dressing, that doesn’t necessarily constitute a transgender identity. Many of them try to discourage patients as a core part of their treatment, sometimes in ways that are now banned across much of the world as conversion therapy. Combined with a drastically changed society, extrapolating modern transgender desistance rates from these studies is unreasonable.

    A small number of more recent studies do exist. The highest desistance rates found in modern literature are approximately 88%, reported by three frequently cited Canadian studies: Drummond et al. (2008), Drummond et al. (2018), and Singh, Bradley & Zucker (2021). Unfortunately, these studies appear to be at a high risk of bias: calling their credibility into question, the clinic in which they took place was closed in 2015, amidst allegations of conversion therapy. An independent review found that it “cannot state that the clinic does not practice reparative approaches.” In the review, many children and their parents report feeling the clinic was invasive and intimidating to them. Some instances include:

    Assessments are described as intrusive and even traumatic by some, who described feeling “poked and prodded”. One way mirror and multiple observers create discomfort. Many questions were felt to be irrelevant, unnecessarily intrusive (particularly those regarding sexual fantasies), especially when asked without context, rationale, and what seems to be inadequate or even absent informed consent. Also, it is unclear whether any potential benefit of this line of questioning to the patient was explained. Parents of younger clients report their child appearing to be and later reporting feeling they were very uncomfortable with the way they were asked about their gender variance “as if my child was not okay as a person.” One parent described feeling “dismissed” when she spoke to clinicians about this.

    Patients reported feeling intimidated to question Dr. Zucker regarding their concerns and were not offered the opportunity to decline. Multiple informants commented on this.

    Chart documentation revealed statements reflecting that the diversity of gender expression and variance are not accepted equally. One example is of a child for whom all gender and body dysphoria had resolved and multiple informants indicated sustained good mood and satisfaction with social and academic functioning. Despite this, the parents of the child were advised at discharge to encourage the child to spend more time with cisgendered boys because he had effeminate speech and mannerisms. These were not goals of the client or family.

    This may explain why these studies find a much higher desistance rate than other modern literature, and makes them very unlikely to be representative figures. As an alternative possibility, Steensma & Cohen-Kettenis (2018) suggest that differences in the local social climate regarding gender variance may have also been an important contributing factor.

    Steensma et al. (2011) and Steensma et al. (2013) set out to investigate factors that could contribute to the persistence or desistance of gender dysphoria in children. The 2011 study reports a desistance rate of 45%, while the 2013 study reports 73%. The figures have been criticised because all children lost to follow-up are assumed to have desisted, which may or may not have inflated their number. More importantly however, in Steensma & Cohen-Kettenis (2018), the authors themselves argue they’ve been cited out of context, and their figures can’t be used to extrapolate desistance rates:

    Unlike what is suggested, we have not studied the gender identities of the children. Instead we have studied the persistence and desistence of children’s distress caused by the gender incongruence they experience to the point that they seek clinical assistance. […] Using the term desistence in this way does not imply anything about the identity of the desisters. The children could still be hesitating, searching, fluctuating, or exploring with regard to their gender experience and expression, and trying to figure out how they wanted to live. Apparently, they no longer desired some form of gender-affirming treatment at that point in their lives.

    Again, because of the purpose and the design of this study we did not report prevalence numbers in the sample under study. Furthermore, the sample in the 2013 study did not include children in the younger age spectrum of the referred population to the Amsterdam clinic. Reporting prevalence of persistence and/or desistance in this sample would therefore not be reliable.

    The only other modern study into persistence rates has been Wallien & Cohen-Kettenis (2008). The study appears to be of higher quality and provides the most convincing estimate available: a 27% persistence rate and a 43% desistance rate over the course of (on average) 10 years. The remaining 30% of participants were lost to follow-up.

    Several further problems cast doubt on the data presented in all of these studies, including Wallien & Cohen-Kettenis (2008). Firstly: children are diagnosed using DSM-III and DSM-IV criteria, which are dated by today’s standards. In these older criteria, gender identity was not a diagnostic requirement: a child could be diagnosed with a gender identity disorder for a range of gender non-conforming behaviours, without themselves identifying as a different gender, or experiencing distress with their gender role or sex characteristics (Temple Newhook et al., 2018).

    Strikingly, with the exception of Steensma et al. (2011), all studies include a significant number of children who never actually met then-current DSM diagnostic criteria for Gender Identity Disorder: in the case of Wallien & Cohen-Kettenis (2008), a quarter of all participants. These participants have been assumed to be transgender for the purposes of extrapolating desistance rates, but held a diagnosis of Gender Identity Disorder Not Otherwise Specified: a broad category described by the DSM as representing those who may not necessarily seek medical transition, but may transiently cross-dress, be preoccupied with castration, or be intersex and experience gender dysphoria. These participants’ exact circumstances are not described by the researchers, but both Wallien & Cohen-Kettenis and Steensma et al. report in their studies that all, or nearly all persisters met DSM diagnostic criteria, while only about half of desisters did.

    Outside of this, there is a lack of long-term follow-up. A gender dysphoric child might desist in transitioning during their teens, but go on to transition in adulthood, for example because of peer pressure or lack of parental acceptance. Whether this happens at any significant rate has not been studied.

    The studies do suggest that for an unknown percentage of children, gender dysphoria will resolve over time, but the high desistance rates often cited as an established fact don’t appear to be supported by evidence. Concerns that puberty blockers cause children to transition when they otherwise would’ve aged out of gender dysphoria appear misplaced: children whose dysphoria persisted were much more likely to have met the diagnostic criteria to receive puberty blockers.

    Current literature on this will likely soon be superseded by higher-quality data, with several very large, well-funded studies into gender dysphoric youth now underway the United States (Olson-Kennedy et al., 2019), Australia (Tollit et al., 2019) and the United Kingdom (Kennedy et al., 2019).

    Desistance and persistence rates can suggest a binary view, and should be seen in a greater context. Because children’s needs change over time, a hypothetical child might feel uncertain about their gender, possibly even receive puberty blockers, and then later decide they do not wish to transition. In such a case, puberty blockers may have met their needs at the time, and were not automatically harmful or regrettable, particularly due to their reversible nature. Neither being transgender, nor being cisgender should be seen as a negative outcome. In their critical commentary, Temple Newhook et al. (2018) write that it is important to respect children’s wishes and autonomy, and move away from the question of, “How should children’s gender identities develop over time?” toward a more useful question: “How should children best be supported as their gender identity develops?”

    Regret

    In light of persistence and desistance rates, it makes sense to ask how patients themselves feel about their treatment with puberty blockers, and whether they regret receiving them. Limited research exists on the subject:

    A large retrospective review of the medical files of all 6,793 patients treated at the Dutch VUmc clinic between 1972 and 2015 found that 14 patients (0.2%) regretted their treatment in total. This included patients who received puberty suppression, hormone therapy, and/or surgery. Notably, 5 of them regretted their treatment because of a lack of social acceptance (Wiepjes et al., 2018).

    De Vries et al. (2014), found none of the 55 transgender patients they followed regretted receiving puberty blockers, hormone therapy, or surgery. Psychological well-being continued to improve in their cohort, both with puberty blockers, hormone therapy, and later gender reassignment surgery.

    Vrouenraets et al. (2016) interviewed 13 adolescents who had been seen at a Dutch gender identity clinic, twelve of whom had received puberty blockers. Asked about long-term risks, most responded that they were significantly outweighed by puberty blockers allowing them to live a more happy life. Quotes from the interviewed children in the study include:

    The possible long-term consequences are incomparable with the unhappy feeling that you have and will keep having if you don’t receive treatment with puberty suppression. (trans boy; age: 18)

    It isn’t a choice, even though a lot of people think that. Well, actually it is a choice: living a happy life or living an unhappy life. (trans girl; age: 14)

    They also comment on the increasing attention to transgender people in media, with one child saying:

    Thanks to media coverage I learned that gender dysphoria exists; that someone can have these feelings and that you can get treatment for it. Beforehand I thought I was the only one like this. (trans boy; age: 18)

    Ease of Access

    While large geographic differences exist, on the whole, access to puberty blockers is often difficult.

    In the United States, Turban et al. (2020) found that access to puberty blockers was associated with a greater household income, noting that the annual cost of them ranges from $4,000 to $25,000 and insurance coverage was unavailable to many. It also found that transgender teens were less likely to receive puberty blockers if they did not identify as heterosexual or binary. Of those who received puberty blockers, 60% reported traveling <25 miles for gender-affirming care, 29% travelled between 25 and 100 miles, and 11% travelled >100 miles. As of 2021, several states are pursuing regulation banning the use of puberty blockers, with Arkansas having become the first to pass such a law. Several large professional bodies representing thousands of medical experts have condemned this type of regulation (American Academy of Child and Adolescent Psychiatry, 2019; American Medical Association, 2021; Endocrine Society, 2021).

    In the United Kingdom, waiting lists as long as 4 years or more exist for initial intake appointments for puberty blockers. Legislative changes in light of Bell v. Tavistock complicated access dramatically: in the nine months between the ruling and its reversal, no under-17s received puberty blockers under the public healthcare sytem, and reports described the care of adolescents over 16, who were not affected by the judgement, being discontinued as well. Restrictions in light of Bell v. Tavistock were condemned by WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusPATH, and PATHA, the leading medical associations for transgender health, who released a statement saying they believe it will cause significant harm to the affected patients (WPATH, 2020), as well as Amnesty International UK and Liberty (Amnesty International UK, 2020).

    In Sweden, the Astrid Lindgren Children’s Hospital, a part of the Karolinska University Hospital, has recently stopped prescribing puberty blockers, citing the Bell v. Tavistock case as their motivation.

    In Finland, new prescriber guidelines for treating gender dysphoric teens were released in 2020 (Society for Evidence Based Medicine, 2021). They broke with WPATH guidelines, instead recommending that gender dysphoric teens receive psychosocial support and psychotherapy as a first-line treatment, and discouraging the use of puberty blockers, with the addition of much stricter criteria for their use. The Finnish health authority has stated that these recommendations will not be revised until further research is available.

    A similar trend of increasing wait times and difficult access holds in many other countries, with the process to receive puberty blockers sometimes taking up to several years. Because of their time-sensitive nature in preventing unwanted permanent changes, long-term outcomes are likely to be worse with slower treatment. Some evidence supports this: for example, one study found that reducing treatment wait times led to reduced depression and anxiety compared to historical controls (Dahlgren Allen et al., 2021).

    Conclusion

    Unknowns exist around puberty blockers in transgender youth, but their risks seem to be relatively minor based on available research, while clear evidence associates their use with improved well-being, psychological functioning, and reduced suicidality.

    Based on parallels from research in cisgender teens treated for precocious puberty, as well as limited studies and clinical experience with transgender teens, it’s unlikely that puberty suppression has a dramatic negative effect on children’s final bone density, lifetime fracture risk, IQ, or cognitive development when prescribed in line with medical guidelines. However, there is insufficient evidence to determine whether or not they have any impact at all.

    Although not supported by conclusive evidence, the use of puberty blockers may have a modest negative impact on bone density. This could be related to the use of puberty blockers themselves, but could also be related to suboptimal hormone therapy regimens after their use, particularly in transgender girls, as well as lifestyle factors. Studies investigating this suffer from significant methodological issues, and a definitive causal link remains unproven. Based on limited evidence, prescribers may wish to consider calcium supplementation in transgender teens receiving puberty blockers, and may wish to avoid oral estrogens in transgender girls beginning hormone therapy.

    Compared to their cisgender peers, transgender adolescents who take puberty blockers are less likely to choose to have biological children, but puberty blockers do not permanently affect fertility.

    Widely cited statistics around children growing out of gender dysphoria (“desistance”) as they grow older are based on highly unreliable data. Surprisingly, based on current evidence, we cannot reasonably guess the rate at which this happens. Regardless, desistance rates are not an argument for or against the use of puberty blockers. It is important to respect children’s wishes and autonomy, and to find the best way to support them as their gender identity develops, without imposing the idea that either a transgender or a cisgender gender identity is a bad outcome.

    Very few patients who receive puberty blockers experience regret. In broader context, for the small minority of adult transgender patients who report feeling regret after undergoing hormone therapy or surgery, a common reason for that is a lack of social acceptance.

    More high-quality research is urgently needed in this field. In particular, the effects of puberty blockers on IQ and cognitive development, bone outcomes, and desistance remain understudied subjects. Randomised controlled trials on puberty blockers are not available, and likely cannot be performed for both practical and ethical reasons. This should not be seen as a reason to discard all other research on the subject, or to label their use as experimental, as it is a standard of evidence that can never be met.

    Puberty blockers are extremely difficult for patients to access in many countries, including the United States, the United Kingdom, and parts of Europe. Several countries have recently banned their use, or further restricted it significantly. This review provides further evidence supporting WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusAPTH, PATHA, the Endocrine Society, the American Academy of Child and Adolescent Psychiatry, and the American Medical Association in condemning recent attempts to bar transgender teens from receiving gender-affirming care, including puberty blockers. To better support gender dysphoric children, barriers of access should instead be reduced where possible.

    References

    • Achille, C., Taggart, T., Eaton, N. R., Osipoff, J., Tafuri, K., Lane, A., & Wilson, T. A. (2020). Longitudinal impact of gender-affirming endocrine intervention on the mental health and well-being of transgender youths: preliminary results. International Journal of Pediatric Endocrinology, 2020, 8. [DOI:10.1186/s13633-020-00078-2]
    • Antoniazzi, F., Zamboni, G., Bertoldo, F., Lauriola, S., Mengarda, F., Pietrobelli, A., & Tatò, L. (2003). Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. The Journal of Clinical Endocrinology and Metabolism, 88(3), 1096–1101. [DOI:10.1210/jc.2002-021154]
    • Arnoldussen, M., Steensma, T. D., Popma, A., van der Miesen, A., Twisk, J., & de Vries, A. (2020). Re-evaluation of the Dutch approach: are recently referred transgender youth different compared to earlier referrals? European Child & Adolescent Psychiatry, 29(6), 803–811. [DOI:10.1007/s00787-019-01394-6]
    • Bakwin, H. (1968). Deviant gender-role behavior in children: relation to homosexuality. Pediatrics, 41(3), 620–629. [PubMed] [DOI:10.1542/peds.41.3.620]
    • Barake, M., Klibanski, A., & Tritos, N. A. (2014). Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. The Journal of Clinical Endocrinology and Metabolism, 99(3), 852–860. [DOI:10.1210/jc.2013-3921]
    • Barake, M., Arabi, A., Nakhoul, N., El-Hajj Fuleihan, G., El Ghandour, S., Klibanski, A., & Tritos, N. A. (2018). Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis. Endocrine, 59(1), 39–49. [DOI:10.1007/s12020-017-1440-0]
    • Barnard, E. P., Dhar, C. P., Rothenberg, S. S., Menke, M. N., Witchel, S. F., Montano, G. T., Orwig, K. E., & Valli-Pulaski, H. (2019). Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients. Pediatrics, 144(3), e20183943. [DOI:10.1542/peds.2018-3943]
    • Bertelloni, S., Baroncelli, G. I., Ferdeghini, M., Menchini-Fabris, F., & Saggese, G. (2000). Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. European Journal of Pediatrics, 159(5), 369–374. [DOI:10.1007/s004310051289]
    • Brik, T., Vrouenraets, L., de Vries, M. C., & Hannema, S. E. (2020). Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria. Archives of Sexual Behavior, 49(7), 2611–2618. [DOI:10.1007/s10508-020-01660-8]
    • Carmichael, P., Butler, G., Masic, U., Cole, T. J., De Stavola, B. L., Davidson, S., Skageberg, E. M., Khadr, S., & Viner, R. M. (2021). Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK. PloS One, 16(2), e0243894. [DOI:10.1371/journal.pone.0243894]
    • Cedrin-Durnerin, I., Bidart, J. M., Robert, P., Wolf, J. P., Uzan, M., & Hugues, J. N. (2000). Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization. Human Reproduction, 15(5), 1009–1014. [DOI:10.1093/humrep/15.5.1009]
    • Chen, D., Simons, L., Johnson, E. K., Lockart, B. A., & Finlayson, C. (2017). Fertility Preservation for Transgender Adolescents. The Journal of Adolescent Health, 61(1), 120–123. [DOI:10.1016/j.jadohealth.2017.01.022]
    • Cheng, P. J., Pastuszak, A. W., Myers, J. B., Goodwin, I. A., & Hotaling, J. M. (2019). Fertility concerns of the transgender patient. Translational Andrology and Urology, 8(3), 209–218. [DOI:10.21037/tau.2019.05.09]
    • Cohen-Kettenis, P. T., & van Goozen, S. H. (1998). Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent. European Child & Adolescent Psychiatry, 7(4), 246–248. [DOI:10.1007/s007870050073]
    • Cohen-Kettenis, P. T., Schagen, S. E., Steensma, T. D., de Vries, A. L., & Delemarre-van de Waal, H. A. (2011). Puberty suppression in a gender-dysphoric adolescent: a 22-year follow-up. Archives of Sexual Behavior, 40(4), 843–847. [DOI:10.1007/s10508-011-9758-9]
    • Costa, R., Dunsford, M., Skagerberg, E., Holt, V., Carmichael, P., & Colizzi, M. (2015). Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria. The Journal of Sexual Medicine, 12(11), 2206–2214. [DOI:10.1111/jsm.13034]
    • Dahlgren Allen, S., Tollit, M. A., McDougall, R., Eade, D., Hoq, M., & Pang, K. C. (2021). A Waitlist Intervention for Transgender Young People and Psychosocial Outcomes. Pediatrics, 148(2), e2020042762. [DOI:10.1542/peds.2020-042762]
    • Davenport, C. W. (1986). A follow-up study of 10 feminine boys. Archives of Sexual Behavior, 15(6), 511–517. [DOI:10.1007/BF01542316]
    • Davenport M. L. (2010). Approach to the patient with Turner syndrome. The Journal of Clinical Endocrinology and Metabolism, 95(4), 1487–1495. [DOI:10.1210/jc.2009-0926]
    • de Vries, A. L. C., Cohen-Kettenis, P. T., & Delemarre-van de Waal, H. (2006). Clinical Management of Gender Dysphoria in Adolescents. International Journal of Transgenderism, 9(4), 83–94. [DOI:10.1300/J485v09n03_04]
    • de Vries, A. L., Steensma, T. D., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2011). Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. The Journal of Sexual Medicine, 8(8), 2276–2283. [DOI:10.1111/j.1743-6109.2010.01943.x]
    • de Vries, A. L., McGuire, J. K., Steensma, T. D., Wagenaar, E. C., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2014). Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics, 134(4), 696–704. [DOI:10.1542/peds.2013-2958]
    • Drummond, K. D., Bradley, S. J., Peterson-Badali, M., & Zucker, K. J. (2008). A follow-up study of girls with gender identity disorder. Developmental Psychology, 44(1), 34–45. [DOI:10.1037/0012-1649.44.1.34]
    • Drummond, K. D., Bradley, S. J., Peterson-Badali, M., VanderLaan, D. P., & Zucker, K. J. (2018). Behavior Problems and Psychiatric Diagnoses in Girls with Gender Identity Disorder: A Follow-Up Study. Journal of Sex & Marital Therapy, 44(2), 172–187. [DOI:10.1080/0092623X.2017.1340382]
    • Ekbote, V. H., Khadilkar, V. V., Khadilkar, A. V., Mughal, Z., Chiplonkar, S. A., Palande, S. A., Phanse-Gupte, S. S., Patwardhan, V. G., & Shilvant, D. S. (2015). Relationship of insulin-like growth factor 1 and bone parameters in 7–15 years old apparently, healthy Indian children. Indian Journal of Endocrinology and Metabolism, 19(6), 770–774. [DOI:10.4103/2230-8210.167549]
    • Feuillan, P. P., Jones, J. V., Barnes, K., Oerter-Klein, K., & Cutler, G. B., Jr. (1999). Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. The Journal of Clinical Endocrinology and Metabolism, 84(1), 44–49. [DOI:10.1210/jcem.84.1.5409]
    • Giordano, S., & Holm, S. (2020). Is puberty delaying treatment ‘experimental treatment’? International Journal of Transgender Health, 21(2), 113–121. [DOI:10.1080/26895269.2020.1747768]
    • Green, A. E., DeChants, J. P., Price, M. N., & Davis, C. K. (2022). Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth. Journal of Adolescent Health, 70(4), 643–649. [DOI:10.1016/j.jadohealth.2021.10.036]
    • Guaraldi, F., Beccuti, G., Gori, D., & Ghizzoni, L. (2016). MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty. European Journal of Endocrinology, 174(3), R79–R87. [DOI:10.1530/EJE-15-0590]
    • Heger, S., Partsch, C. J., & Sippell, W. G. (1999). Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. The Journal of Clinical Endocrinology and Metabolism, 84(12), 4583–4590. [DOI:10.1210/jcem.84.12.6203]
    • Heger, S., Müller, M., Ranke, M., Schwarz, H. P., Waldhauser, F., Partsch, C. J., & Sippell, W. G. (2006). Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Molecular and Cellular Endocrinology, 254–255, 217–220. [DOI:10.1016/j.mce.2006.04.012]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658]
    • Hough, D., Bellingham, M., Haraldsen, I. R., McLaughlin, M., Robinson, J. E., Solbakk, A. K., & Evans, N. P. (2017). A reduction in long-term spatial memory persists after discontinuation of peripubertal GnRH agonist treatment in sheep. Psychoneuroendocrinology, 77, 1–8. [DOI:10.1016/j.psyneuen.2016.11.029]
    • Isotton, A. L., Wender, M. C., Casagrande, A., Rollin, G., & Czepielewski, M. A. (2012). Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study. European Journal of Endocrinology, 166(2), 207–213. [DOI:10.1530/EJE-11-0560]
    • Jones, B. A., Haycraft, E., Bouman, W. P., & Arcelus, J. (2018). The Levels and Predictors of Physical Activity Engagement Within the Treatment-Seeking Transgender Population: A Matched Control Study. Journal of Physical Activity & Health, 15(2), 99–107. [DOI:10.1123/jpah.2017-0298]
    • Jung, K. Y., Kim, T., Hwang, S. Y., Lee, T. R., Yoon, H., Shin, T. G., Sim, M. S., Cha, W. C., & Jeon, H. J. (2018). Deliberate Self-harm among Young People Begins to Increase at the Very Early Age: a Nationwide Study. Journal of Korean Medical Science, 33(30), e191. [DOI:10.3346/jkms.2018.33.e191]
    • Kennedy, E., Spinner, L., Lane, C., Stynes, H., Ranieri, V., Carmichael, P., Omar, R., Vickerstaff, V., Hunter, R., Wright, T., Senior, R., Butler, G., Baron-Cohen, S., Young, B., & King, M. (2021). Longitudinal Outcomes of Gender Identity in Children (LOGIC): protocol for a prospective longitudinal cohort study of children referred to the UK gender identity development service. BMJ Open, 11(9), e045628. [DOI:10.1136/bmjopen-2020-045628]
    • Khatchadourian, K., Amed, S., & Metzger, D. L. (2014). Clinical management of youth with gender dysphoria in Vancouver. The Journal of Pediatrics, 164(4), 906–911. [DOI:10.1016/j.jpeds.2013.10.068]
    • Kidd, J. D., Dolezal, C., & Bockting, W. O. (2018). The Relationship Between Tobacco Use and Legal Document Gender-Marker Change, Hormone Use, and Gender-Affirming Surgery in a United States Sample of Trans-Feminine and Trans-Masculine Individuals: Implications for Cardiovascular Health. LGBT Health, 5(7), 401–411. [DOI:10.1089/lgbt.2018.0103]
    • Klink, D., Caris, M., Heijboer, A., van Trotsenburg, M., & Rotteveel, J. (2015). Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria. The Journal of Clinical Endocrinology and Metabolism, 100(2), E270–E275. [DOI:10.1210/jc.2014-2439]
    • Kosky, R. J. (1987). Gender-disordered children: does inpatient treatment help? The Medical Journal of Australia, 146(11), 565–569. [DOI:10.5694/j.1326-5377.1987.tb120415.x]
    • Kuper, L. E., Stewart, S., Preston, S., Lau, M., & Lopez, X. (2020). Body Dissatisfaction and Mental Health Outcomes of Youth on Gender-Affirming Hormone Therapy. Pediatrics, 145(4), e20193006. [DOI:10.1542/peds.2019-3006]
    • Lazar, L., Meyerovitch, J., de Vries, L., Phillip, M., & Lebenthal, Y. (2014). Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades. Clinical Endocrinology, 80(4), 570–576. [DOI:10.1111/cen.12319]
    • Lebovitz, P. S. (1972). Feminine behavior in boys: aspects of its outcome. The American Journal of Psychiatry, 128(10), 1283–1289. [DOI:10.1176/ajp.128.10.1283]
    • Lee, J. Y., Finlayson, C., Olson-Kennedy, J., Garofalo, R., Chan, Y. M., Glidden, D. V., & Rosenthal, S. M. (2020). Low Bone Mineral Density in Early Pubertal Transgender/Gender Diverse Youth: Findings From the Trans Youth Care Study. Journal of the Endocrine Society, 4(9), bvaa065. [DOI:10.1210/jendso/bvaa065]
    • Li, K., Rodriguez, D., Gabrielsen, J. S., Centola, G. M., & Tanrikut, C. (2018). Sperm cryopreservation of transgender individuals: trends and findings in the past decade. Andrology, 6(6), 860–864. [DOI:10.1111/andr.12527]
    • Lindsey, R. C., & Mohan, S. (2016). Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Molecular and Cellular Endocrinology, 432, 44–55. [DOI:10.1016/j.mce.2015.09.017]
    • Locatelli, V., & Bianchi, V. E. (2014). Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis. International Journal of Endocrinology, 2014, 235060. [DOI:10.1155/2014/235060]
    • Money, J., & Russo, A. J. (1979). Homosexual outcome of discordant gender identity/role in childhood: Longitudinal follow-up. Journal of Pediatric Psychology, 4(1), 29–41. [DOI:10.1093/jpepsy/4.1.29]
    • Morey, Y., Mellon, D., Dailami, N., Verne, J., & Tapp, A. (2017). Adolescent self-harm in the community: an update on prevalence using a self-report survey of adolescents aged 13–18 in England. Journal of Public Health, 39(1), 58–64. [DOI:10.1093/pubmed/fdw010]
    • Mul, D., Versluis-den Bieman, H. J., Slijper, F. M., Oostdijk, W., Waelkens, J. J., & Drop, S. L. (2001). Psychological assessments before and after treatment of early puberty in adopted children. Acta Paediatrica, 90(9), 965–971. [DOI:10.1080/080352501316978011]
    • Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low Fertility Preservation Utilization Among Transgender Youth. The Journal of Adolescent Health, 61(1), 40–44. [DOI:10.1016/j.jadohealth.2016.12.012]
    • Nock, M. K., Green, J. G., Hwang, I., McLaughlin, K. A., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2013). Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry, 70(3), 300–310. [DOI:10.1001/2013.jamapsychiatry.55]
    • Olson-Kennedy, J., Chan, Y. M., Garofalo, R., Spack, N., Chen, D., Clark, L., Ehrensaft, D., Hidalgo, M., Tishelman, A., & Rosenthal, S. (2019). Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study. JMIR Research Protocols, 8(7), e14434. [DOI:10.2196/14434]
    • Pang, K. C., Peri, A., Chung, H. E., Telfer, M., Elder, C. V., Grover, S., & Jayasinghe, Y. (2020). Rates of Fertility Preservation Use Among Transgender Adolescents. JAMA Pediatrics, 174(9), 890–891. [DOI:10.1001/jamapediatrics.2020.0264]
    • Riggs, M. M., Bennetts, M., van der Graaf, P. H., & Martin, S. W. (2012). Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis. CPT: Pharmacometrics & Systems Pharmacology, 1(10), e11. [DOI:10.1038/psp.2012.10]
    • Rodriguez-Wallberg, K. A., Häljestig, J., Arver, S., Johansson, A., & Lundberg, F. E. (2021). Sperm quality in transgender women before or after gender affirming hormone therapy—A prospective cohort study. Andrology, 9(6), 1773–1780. [DOI:10.1111/andr.12999]
    • Roux, C. (1997). Estrogen therapy in postmenopausal osteoporosis. What we know and what we don’t. Revue du Rhumatisme (English Ed.), 64(6), 402–409. [Google Scholar] [PubMed] [PDF]
    • Schagen, S., Wouters, F. M., Cohen-Kettenis, P. T., Gooren, L. J., & Hannema, S. E. (2020). Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones. The Journal of Clinical Endocrinology and Metabolism, 105(12), e4252–e4263. [DOI:10.1210/clinem/dgaa604]
    • Schneider, M. A., Spritzer, P. M., Soll, B., Fontanari, A., Carneiro, M., Tovar-Moll, F., Costa, A. B., da Silva, D. C., Schwarz, K., Anes, M., Tramontina, S., & Lobato, M. (2017). Brain Maturation, Cognition and Voice Pattern in a Gender Dysphoria Case under Pubertal Suppression. Frontiers in Human Neuroscience, 11, 528. [DOI:10.3389/fnhum.2017.00528]
    • Singh, D., Bradley, S. J., & Zucker, K. J. (2021). A Follow-Up Study of Boys With Gender Identity Disorder. Frontiers in Psychiatry, 12, 632784. [DOI:10.3389/fpsyt.2021.632784]
    • Southmayd, E. A., & De Souza, M. J. (2017). A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health. Growth Hormone & IGF Research, 32, 2–13. [DOI:10.1016/j.ghir.2016.09.001]
    • Staphorsius, A. S., Kreukels, B. P., Cohen-Kettenis, P. T., Veltman, D. J., Burke, S. M., Schagen, S. E., Wouters, F. M., Delemarre-van de Waal, H. A., & Bakker, J. (2015). Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria. Psychoneuroendocrinology, 56, 190–199. [DOI:10.1016/j.psyneuen.2015.03.007]
    • Steensma, T. D., Biemond, R., de Boer, F., & Cohen-Kettenis, P. T. (2011). Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clinical Child Psychology and Psychiatry, 16(4), 499–516. [DOI:10.1177/1359104510378303]
    • Steensma, T. D., McGuire, J. K., Kreukels, B. P., Beekman, A. J., & Cohen-Kettenis, P. T. (2013). Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 52(6), 582–590. [DOI:10.1016/j.jaac.2013.03.016]
    • Steensma, T. D., & Cohen-Kettenis, P. T. (2018). A critical commentary on “A critical commentary on follow-up studies and “desistence” theories about transgender and gender non-conforming children”. International Journal of Transgenderism, 19(2), 225–230. [DOI:10.1080/15532739.2018.1468292]
    • Swerdloff, R. S., & Heber, D. (1983). Superactive gonadotropin-releasing hormone agonists. Annual Review of Medicine, 34, 491–500. [DOI:10.1146/annurev.me.34.020183.002423]
    • Temple Newhook, J., Pyne, J., Winters, K., Feder, S., Holmes, C., Tosh, J., Sinnott, M.-L., Jamieson, A., & Pickett, S. (2018). A critical commentary on follow-up studies and “desistance” theories about transgender and gender-nonconforming children. International Journal of Transgenderism, 19(2), 212–224. [DOI:10.1080/15532739.2018.1456390]
    • Tollit, M. A., Pace, C. C., Telfer, M., Hoq, M., Bryson, J., Fulkoski, N., Cooper, C., & Pang, K. C. (2019). What are the health outcomes of trans and gender diverse young people in Australia? Study protocol for the Trans20 longitudinal cohort study. BMJ Open, 9(11), e032151. [DOI:10.1136/bmjopen-2019-032151]
    • Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S. (2020). Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation. Pediatrics, 145(2), e20191725. [DOI:10.1542/peds.2019-1725]
    • van der Miesen, A., Steensma, T. D., de Vries, A., Bos, H., & Popma, A. (2020). Psychological Functioning in Transgender Adolescents Before and After Gender-Affirmative Care Compared With Cisgender General Population Peers. The Journal of Adolescent Health, 66(6), 699–704. [DOI:10.1016/j.jadohealth.2019.12.018]
    • Verhulst, F. C., Achenbach, T. M., van der Ende, J., Erol, N., Lambert, M. C., Leung, P. W., Silva, M. A., Zilber, N., & Zubrick, S. R. (2003). Comparisons of problems reported by youths from seven countries. The American Journal of Psychiatry, 160(8), 1479–1485. [DOI:10.1176/appi.ajp.160.8.1479]
    • Vlot, M. C., Klink, D. T., den Heijer, M., Blankenstein, M. A., Rotteveel, J., & Heijboer, A. C. (2017). Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone, 95, 11–19. [DOI:10.1016/j.bone.2016.11.008]
    • Vrouenraets, L. J., Fredriks, A. M., Hannema, S. E., Cohen-Kettenis, P. T., & de Vries, M. C. (2016). Perceptions of Sex, Gender, and Puberty Suppression: A Qualitative Analysis of Transgender Youth. Archives of Sexual Behavior, 45(7), 1697–1703. [DOI:10.1007/s10508-016-0764-9]
    • Wallien, M. S., & Cohen-Kettenis, P. T. (2008). Psychosexual outcome of gender-dysphoric children. Journal of the American Academy of Child and Adolescent Psychiatry, 47(12), 1413–1423. [DOI:10.1097/CHI.0b013e31818956b9]
    • Wiepjes, C. M., Nota, N. M., de Blok, C., Klaver, M., de Vries, A., Wensing-Kruger, S. A., de Jongh, R. T., Bouman, M. B., Steensma, T. D., Cohen-Kettenis, P., Gooren, L., Kreukels, B., & den Heijer, M. (2018). The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets. The Journal of Sexual Medicine, 15(4), 582–590. [DOI:10.1016/j.jsxm.2018.01.016]
    • Wojniusz, S., Callens, N., Sütterlin, S., Andersson, S., De Schepper, J., Gies, I., Vanbesien, J., De Waele, K., Van Aken, S., Craen, M., Vögele, C., Cools, M., & Haraldsen, I. R. (2016). Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty. Frontiers in Psychology, 7, 1053. [DOI:10.3389/fpsyg.2016.01053]
    • Zaiem, F., Alahdab, F., Al Nofal, A., Murad, M. H., & Javed, A. (2017). Oral Versus Transdermal Estrogen In Turner Syndrome: A Systematic Review And Meta-Analysis. Endocrine Practice, 23(4), 408–421. [DOI:10.4158/ep161622.or]
    • Zuger, B. (1978). Effeminate behavior present in boys from childhood: ten additional years of follow-up. Comprehensive Psychiatry, 19(4), 363–369. [DOI:10.1016/0010-440x(78)90019-6]
    \ No newline at end of file +Puberty Blockers: A Review of GnRH Analogues in Transgender Youth - Transfeminine Science Link

    Puberty Blockers: A Review of GnRH Analogues in Transgender Youth

    By Mitzi | First published January 30, 2022 | Last modified January 31, 2022

    Abstract / TL;DR

    Puberty blockers are medications used to pause puberty in both cisgender and transgender youth. For the latter, significant evidence suggests that they improve well-being, psychological functioning, and risk of suicidality, both during puberty and in later life. Their effects are reversible upon discontinuation. Current evidence does not suggest any negative impact on cognitive development, IQ, or fertility. A minor impact on bone density may exist, affecting primarily transgender girls, but little high quality data is available. Based on limited data, prescribers may wish to consider calcium supplementation in transgender teens receiving puberty blockers, and may wish to prefer transdermal delivery over oral estrogens in transgender girls starting hormone therapy in order to optimise bone density outcomes. There is a lack of evidence supporting the common belief that most children grow out of gender dysphoria (“desistance”), as widely cited data describing the rate at which this happens appears highly unreliable. Puberty blockers are difficult to access, and many Western countries have sharply restricted their use recently, in a trend condemned by numerous medical associations. Randomised controlled trials on puberty blockers can likely never be performed, but nonetheless, there is clear evidence they offer significant benefit, and have relatively minor risks.

    Introduction

    Puberty blockers, also known as gonadotropin-releasing hormone (GnRH) analogues, were introduced for medical use in the 1980s (Swerdloff & Heber, 1983). Originally developed to supersede other therapies in the treatment of prostate cancer, they were soon adapted for paediatric use, revolutionising the treatment of precocious puberty: a rare condition in which puberty begins before the age of 8 (in natal girls) or 9 (in natal boys). Precocious puberty is associated with several negative consequences, such as short stature, teasing, bullying, and worse mental health outcomes. By reversibly pausing puberty for several years in children with this condition, outcomes are often significantly improved, and puberty blockers remain the mainstay treatment for this condition several decades later.

    In the 1990s, puberty blockers began to be used in transgender adolescents, as a way of pausing their unwanted puberty, and giving them more time to consider their future (Cohen-Kettenis & van Goozen, 1998). The protocol for this, originally develped by the Dutch VUmc clinic, has sometimes been referred to as the “Dutch Method.” Cohen-Kettenis et al. (2011) published a study following one such Dutch patient 22 years later. Since then, the use of puberty blockers has increased tremendously with the increase in patients seeking transgender healthcare.

    Recently, puberty blockers have been the subject of controversy, with legal proceedings seeking to prohibit their use across several countries. Notably, their use was temporarily stopped in the United Kingdom in December 2020 following a ruling in the Bell v. Tavistock case, which was appealed in 2021. Also in 2021, Arkansas became the first U.S. state to make it illegal for doctors to prescribe puberty blockers, with several other states pursuing similar legislation. Critics express concern about the safety of puberty blockers, their reversibility, and effectiveness.

    This article seeks to review the literature on the use and safety of puberty blockers in transgender youth, examining their safety, and arguments for and against their use in a comprehensive way. While rarely, alternative medications like the progestin medroxyprogesterone acetate have been used for this, this article mainly focuses on GnRH agonists: by far the most widely used class of medication for puberty blockade, and what’s most commonly colloquially referred to as “puberty blockers.”

    Mechanism of Action

    GnRH is a naturally occurring hormone in humans responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland. Through this mechanism, the body produces its gonadal estrogen and testosterone. GnRH agonists bind to the GnRH receptor and activate it, causing it to be continuously stimulated. This causes an initial increase of LH and FSH, then over the course of several weeks, causes the pituitary gland to become desensitised, pausing the natural sex hormone production for the duration the medication is taken. When the medication is stopped, its effect is reversed, with normal sex hormone production resuming about a week after the medication clears the body (Cedrin-Durnerin et al., 2000).

    GnRH agonists are prescribed as an injection administered every one to six months, a surgically implanted pellet once per year, or a nasal spray administered two to three times per day. A short-acting daily injection exists, but is not used for puberty blockade in clinical practise. Common examples of GnRH agonists include leuprorelin (Lupron; Eligard), triptorelin (Decapeptyl), goserelin (Zoladex), histrelin (Supprelin LA), nafarelin (Synarel) and buserelin (Suprefact).

    Like GnRH agonists, GnRH antagonists bind to the GnRH receptor, however, they do not stimulate it. Instead, they compete with the body’s own GnRH, rendering it ineffective. As a result, they achieve similar effects without causing an initial increase in hormone levels. Also unlike GnRH agonists, oral formulations of GnRH antagonists exist, allowing some of them to be taken as a daily pill. Common examples include elagolix (Orilissa), degarelix (Firmagon), cetrorelix (Cetrotide), ganirelix (Orgalutran; Antagon) and relugolix (Orgovyx; Relumina). Unfortunately, being much newer drugs, GnRH antagonists are not normally used as puberty blockers at the moment.

    In gender dysphoric youth, GnRH agonists are prescribed after the onset of puberty. GnRH agonists are not prescribed to children who have not yet started puberty, but may be started at any point during puberty to pause further changes (Hembree et al., 2017).

    Quality of Evidence

    In medicine, the gold standard for evidence is the randomised controlled trial, or RCT. In a nutshell, participants are randomly assigned into two or more treatment groups (arms), such that the only difference between arms is the treatment they receive. Commonly, one group receives a placebo, while another receives the treatment being studied. The ideal RCT is blinded, meaning neither participants nor investigators of the study know which group is receiving which treatment. No such trials have been performed with puberty blockers, giving rise to concerns that there could be insufficient evidence available for their use.

    Unfortunately, RCTs may not be practically possible for puberty blockers, and are unlikely to ever be performed. A good summary of the reasons for this is provided by Giordano & Holm (2020):

    There are two main practical problems that preclude conducting a RCT.

    First, patients who approach clinics for help because of distress caused by the first signs of puberty will be unlikely to accept to be a part of a RCT. Medications are needed within a relatively short period of time, at pain of treatment being less effective or ineffective. Recruitment would thus be hard if not impossible.

    Second, the ideal RCT is either double blind, i.e. neither researchers nor participants know who gets the active drug, or it assesses outcomes using blinded observers when treatment allocation cannot be hidden from participants. Blinding is necessary in order to reduce bias in outcome assessments. But, a RCT of puberty delay could not maintain blinding. Because GnRHa are effective in delaying puberty it would soon become evident to participants, researchers and outcome assessors who was in the active treatment arm and who was not. This breakdown of blinding would mean that there would be potential bias in the outcome assessments, both in relation to biological and psychological outcomes. It would also mean that participants allocated to the non-treatment arm of the study would be likely to either withdraw from the study at a much higher rate than in the treatment arm introducing potential bias, and/or be more likely not to adhere to the trial but seek puberty delaying treatment outside of the trial thereby adding a confounder.

    Mul et al. (2001) ran into this problem conducting a similar study on teens with precocious puberty:

    In the original study design a third arm with untreated children was scheduled as a control group. It was decided to omit this control group from the study design after it appeared that the parents of all patients who were randomized in the untreated control group refused further participation in the study as GnRHa treatment could be obtained elsewhere.

    Besides practical limitations, such RCTs are likely to be unethical. Evidence suggests withholding puberty blockers may cause lasting harm in itself. To knowingly cause such harm to the control group of an RCT is likely to be morally unacceptable, and such an RCT would be unlikely to receive approval from an ethical review board.

    This is not to say that studies evaluating such outcomes don’t exist at all: for example, while not randomised or blinded, Costa et al. (2015) compares 101 patients receiving psychological support and puberty blockers to 100 patients receiving psychological support alone. The results of this study are further outlined below.

    As a result of these limitations, this article mainly cites cohort studies, making the argument that sufficient other high-quality studies exist to reach well-supported conclusions: a practise sometimes required in other areas of medicine as well. Because this is the only way we can practically evaluate puberty blockers and RCTs are likely impossible, it seems disingenuous to make the claim that lack of RCTs equate to lack of evidence around puberty blockers, as this standard of evidence can never be met, and the claim ignores a substantial existing body of literature.

    Suicidality and Well-being

    A significant body of evidence associates the use of puberty blockers in those who want such treatment with improved psychological well-being: the primary argument for their use.

    While different studies use different methodologies, three standardised psychological questionnaires are typically used to evaluate well-being: the Children’s Global Assessment Scale (CGAS), the Child Behavior Checklist (CBCL), and the Youth Self-Report (YSR). All three are aimed at evaluating psychological functioning and problematic behaviour: typically, the CGAS is administered by a clinician, the CBCL is filled out by a parent or guardian, and the YSR is filled out by a child themselves. It’s important to note that scores in these assessments are known to markedly worsen in adolescence in general, with the onset of psychological difficulties and self-harm often appearing during puberty (Verhuist et al., 2003; Nock et al., 2013; Morey et al., 2017; Jung et al., 2018).

    One of the largest studies to investigate well-being to date has been Turban et al. (2020). It surveyed 20,619 American transgender adults. 3,494 (16.9%) reported that they ever wanted to receive puberty blockers. Of those, only 89 received them. In total, 75.3% of those who received puberty blockers reported ever experiencing suicidal thoughts, compared to 90.2% of those who did not. After controlling for demographic variables like income, family support, and education level, puberty blockers remained significantly associated with decreased odds of lifetime suicidal ideation.

    A similarly large survey by Green et al. (2021) included 11,914 Americans aged 13–24 who identified as transgender or nonbinary. The study compares those who received hormone therapy or puberty blockers to those who wished to receive them, but didn’t. It finds that in those who received treatment, rates of depression, suicidal ideation, and suicide attempts were significantly lower. This remained true of those aged 13–17, who were significantly more likely to receive puberty blockers specifically.

    Costa et al. (2015) studied 201 gender dysphoric adolescents who presented at the British Tavistock and Portman NHS Gender Identity Development Service. Of them, half were considered eligible for puberty blockers immediately, receiving them in addition to psychological support. The other half were not considered immediately eligible for puberty blockers, citing reasons such as psychiatric problems or conflicts with parents and siblings. These patients received only psychological support for the following 18 months. All patients’ global psychological functioning was assessed using the CGAS questionnaire. Both groups showed significantly improved psychological functioning with psychological support, but the group receiving only psychological support stalled and showed no further improvement towards the end of the study, while those receiving puberty blockers continued to show greater improvement. The authors point out that the eventual CGAS score of the group receiving puberty blockers coincided almost perfectly with those found in a sample of children/adolescents without observed psychological/psychiatric symptoms.

    Figure 1: CGAS scores of psychological functioning in transgender teens receiving puberty blockers and psychological support, compared to those receiving psychological support alone in Costa et al. (2015).

    A later study at the same British gender identity clinic, Carmichael et al. (2021), received widespread media coverage in the United Kingdom following its mixed findings. It followed 44 gender dysphoric adolescents who received puberty blockers. CGAS scores were higher than the 2015 study at baseline, and showed slower and more modest improvement. The study reached contradictory conclusions, with improvements reported in some questionnaires, but not others, even for comparable measurements. Interestingly, in some of the researchers’ measures of well-being, social acceptance, and self-perception, adolescents themselves reported significant improvements, while their parents reported almost no improvement. The study characterises participants’ overall experiences with puberty blockers as positive, but is difficult to draw any conclusions from.

    De Vries et al. (2011) and de Vries et al. (2014) investigate the psychological outcomes of the same cohort of transgender adolescents receiving puberty blockers at the VUmc gender clinic in the Netherlands. Both investigate psychological outcomes in a range of tests, with the 2014 study providing long-term follow-up many years after puberty blockers, and after gender reassignment surgery. In the studied cohort, psychological functioning improves and depression decreases over time, as evidenced by standardised tests, including CGAS scores. Significant improvements in well-being are reported both during treatment with puberty blockers, and in the years after, with hormone therapy and surgery. Unlike Carmichael et al., CBCL and YSR scores improve.

    Van der Miesen et al. (2020) charts psychological well-being across 3 groups of Dutch adolescents: 272 transgender adolescents who haven’t yet received puberty blockers, 178 adolescents receiving puberty blockers, and 651 cisgender adolescents from the general population. The study finds poorer psychological functioning in those before treatment, while psychological functioning and well-being is similar to cisgender adolescents in those receiving pubertal suppression. These findings are in line with Costa et al. (2015), which noted that those receiving puberty blockers reached CGAS scores comparable to the general (age-matched) population.

    Figure 2: Percentages of teens who report suicidality in van der Miesen et al. (2020). Suicidality was defined as endorsing the statement “I deliberately try to hurt or kill myself” or “I think about killing myself.” Suicidality among Dutch transgender youth has not significantly changed over time, making cohort differences unlikely (Arnoldussen et al., 2020).

    In addition to the studies listed above, several smaller, less focused studies have also assessed the well-being of transgender adolescents receiving puberty blockers and reported overall positive experiences (Khatchadourian et al., 2014; Achille et al., 2020; Kuper et al., 2020). No studies report a decline in psychological functioning or notably negative psychological outcomes with the use of puberty blockers.

    In combination, this strongly suggests that puberty blockers improve well-being and psychological functioning in children who experience gender dysphoria. In addition, it suggests that inappropriately withholding them may lead to worse later-life outcomes, such as increased suicidality.

    Counterintuitively, several of the studies listed do note that puberty blockers don’t reduce gender dysphoria (de Vries et al., 2011; Carmichael et al., 2021). It’s important to be aware that this finding refers to the wish to transition, rather than psychological well-being. The finding is based on the Utrecht Gender Dysphoria Scale questionnaire (de Vries et al., 2006). To illustrate, the version for transmasculine youth asks patients whether they endorse such statements as “I prefer to behave like a boy”, “I wish I had been born as a boy”, “I hate having breasts”, and “every time someone treats me like a girl, I feel hurt.”

    When studies note that puberty blockers don’t reduce gender dysphoria, this means children don’t stop identifying as transgender after receiving puberty blockers. They continue to want to transition. De Vries et al. (2011) points out this is the expected outcome:

    As expected, puberty suppression did not result in an amelioration of gender dysphoria. Previous studies have shown that only gender reassignment consisting of cross-sex hormone treatment and surgery may end the actual gender dysphoria. None of the gender dysphoric adolescents in this study renounced their wish for gender reassignment during puberty suppression. This finding supports earlier studies showing that young adolescents who had been carefully diagnosed show persisting gender dysphoria into late adolescence or young adulthood

    Fertility

    Unlike hormone therapy, no risk of permanent infertility is believed to exist with the use of puberty blockers. Several long-term follow-up studies of patients treated with puberty blockers have found normal fertility. Among others, Feuillan et al. (1999), Heger et al. (1999), Heger et al. (2006) and Lazar et al. (2014) find no indication of impaired fertility in patients treated with puberty blockers for precocious puberty. In the years and decades following their treatments, the several hundred patients in these studies are found to conceive normally without an increased need for assisted reproductive technology, and with uneventful pregnancies. Despite several decades of use, no reports exist in literature of permanent infertility linked to puberty blockers. Interestingly, transgender populations do have higher rates of sperm abnormalities than cisgender populations, before any medical treatment has taken place (Li et al., 2018; Rodriguez-Wallberg et al., 2021).

    In contrast, hormone therapy may cause permanent infertility (Hembree et al., 2017; Cheng et al., 2019). If fertility preservation has not been accessed before beginning treatment, puberty blockers must be stopped to do so, ideally before hormone therapy begins. When puberty blockers are stopped, unwanted sex characteristics continue to develop. Transgender people may find this extremely distressing, which may be one reason for them to not pursue fertility preservation.

    No data exists on the exact length of time for which puberty blockers need to be stopped before full fertility is restored, and it likely varies depending on the age puberty blockers were initiated. Bertelloni et al. (2000) found spermarche took place between 0.7 to 3 years after discontinuation of puberty blockers in boys treated for precocious puberty. Barnard et al. (2019) report on the case of a single transgender patient who had been receiving puberty blockers for 6 months, from the age of 17. Three months after the last dose of monthly leuprorelin, no viable sperm sample could be produced. Five months after, their sample was viable.

    Regardless of this, transgender individuals are extremely unlikely to use fertility preservation, with some estimates suggesting utilisation rates below 5% in North America (Chen et al., 2017; Nahata et al., 2017). In one piece of research, Pang et al. (2020) questioned 102 transgender Australian teens on their reasons for declining fertility preservation. The following statistics were gathered:

    Figure 3: Australian transgender teens’ reasons for declining fertility preservation in Pang et al. (2020).

    As such, there is no evidence-based reason to believe puberty blockers could cause infertility, with fertility returning when they are discontinued. However, due to low discontinuation rates for puberty blockers and low fertility preservation rates, those who start puberty blockers and persist are unlikely to have biological children. Clinical guidelines recommend that adolescents seeking puberty blockers should be counselled on options for fertility preservation, and parents should be involved in this (Hembree et al., 2017).

    Bone Density

    Bone density is a measure of the amount of bone mineral present in bone tissue. Bone density is measured using imaging techniques, such as DEXA scans: a type of X-ray. It is used to predict patients’ risk of breaking bones. The clinical terms for low bone density are osteopenia, and in more severe cases, osteoporosis, which is common among the elderly. For the purposes of this review, the most relevant measurement of bone density is the z-score, which expresses a patient’s bone density in comparison to other people of the same age and sex. A z-score of 0 indicates bone density equal to the general population. Small deviations, such as -0.2, may not always be relevant, but z-scores below -1 may be cause for concern.

    There are concerns around the effects of puberty blockers on bone health. Puberty is a critical time for the accrual of bone density: a process largely driven by sex hormones. This process is delayed in those receiving puberty blockers, leading to temporary lower bone density and z-scores compared to peers going through puberty normally. While these short-term z-scores are not particularly relevant, long-term outcomes are very important: the question becomes what z-scores look like in the long term, into adulthood, and whether the use of puberty blockers has any impact on later-life fracture risk. Literature on this is uncertain.

    Klink et al. (2015) finds that in both trans girls and trans boys, z-scores are lower both before treatment, and after long-term follow-up. The study suggests a small negative effect on final bone density from the use of puberty blockers, although many measurements fail to reach statistical significance. The study records notably lower final z-scores for trans girls than trans boys.

    Vlot et al. (2017) finds that 2 years after beginning hormone therapy, z-scores were returning towards normal. In trans boys, final z-scores were negligibly lower, while in trans girls, the effect was much more pronounced, with meaningfully lower z-scores both before and after treatment.

    In line with this, Schagen et al. (2020) finds that in its cohort, final z-scores normalised after 3 years of hormone therapy for trans boys, while they remained meaningfully low both before and after treatment for trans girls.

    Figure 4: Bone Mineral Apparent Density (BMAD) of the lumbar spine across multiple studies, relative to sex assigned at birth. Three measurements are taken in each study: the initiation of puberty blockers, the initiation of hormone therapy, and one measurement after several years of hormone therapy. A z-score below -1 is commonly considered to be clinically relevant osteopenia, while a score below -2.5 is considered to be osteoporosis. The figure illustrates that trans girls tend to have significantly lower bone density before, during, and after treatment, while this is not the case for trans boys. Trans girls also tend to receive puberty blockers for a longer time.

    Guaraldi et al. (2016) find in their literature review that in those receiving puberty blockers for precocious puberty, bone mineral density is lower than that of untreated peers during treatment with puberty blockers, then typically recovers when puberty is initiated, with long-term follow-up showing little difference to the general population. Combined with the results of trans boys, this suggests that not puberty blockers themselves, but rather, subsequent suboptimal hormone therapy in trans girls could potentially be to blame for their more pronounced negative outcomes.

    The hormone therapy prescribed to trans girls in the listed studies may be suboptimal in several ways. To begin with, all three use very low adult maintenance dosages of no more than 2 mg oral estradiol in transfeminine patients. Such a dose is likely to produce serum estradiol levels of roughly 50 pg/ml on average: below the average estradiol exposure of cis women (Aly, 2018; Aly, 2020). Many clinical guidelines recommend higher levels, which some research suggests could have a small positive effect on final bone density compared to lower dosages (Roux, 1997; Riggs et al., 2012). Indeed, the authors of all three studies themselves note their doses were low and may have been inadequate for optimal bone density.

    Also significantly, all studies use oral estrogens. Oral estrogens significantly reduce IGF-1 levels (Isotton et al., 2012; Southmayd & De Souza, 2017), which is thought to play a vital role in bone density accrual, and strongly correlates with bone density (Barake, Klibanski & Tritos, 2014; Locatelli & Bianchi, 2014; Ekbote et al., 2015; Lindsey & Mohan, 2016; Barake et al., 2018). Some experts have recommended transdermal estrogens over oral estrogens to improve bone density outcomes in girls suffering from Turner syndrome (Davenport, 2010), and tentative evidence appears to support the practise (Zaiem et al., 2017). As such, while not currently discussed in most clinical guidelines, the prevalence of oral estrogens in transgender teens is a concern, and avoiding them in favour of transdermal estrogens could lead to improved final bone density.

    As a final confounding factor, none of the studies control for lifestyle factors associated with lower bone density, such as exercise, smoking, vitamin D, and calcium intake. These factors have a significant effect on bone density. Transgender people are more likely to smoke, less likely to exercise, and less likely to consume adequate calcium, both as teens and as adults (Jones et al., 2018; Kidd, Dolezal & Bockting, 2018). This is believed to be the reason transgender people of all ages tend to have lower bone density before any treatment is initiated. Without controlling for these factors, which may distort the available data significantly, it’s difficult to draw confident conclusions from these studies, and a causal link between the use of puberty blockers and lower final bone density remains unproven. If such a link does exist, the effect seems unlikely to be dramatic, and unlikely to outweigh the benefits of puberty blockers.

    In a noteworthy study, Antoniazzi et al. (2003) report that in those receiving puberty blockers for precocious puberty, bone mineral density is better preserved through calcium supplementation. Calcium intake is often inadequate in transgender youth (Lee et al., 2020), and therefore warrants further study for improving their bone mineral density. Alongside calcium, lifestyle interventions, the use of transdermal instead of oral estrogens, and the avoidance of subphysiological adult dosages of estradiol could all potentially improve bone-related outcomes over current clinical practise.

    IQ and Cognitive Development

    One possible concern is the impact of puberty blockers on IQ and cognitive development. Very little research on the subject exists, with commonly cited critical studies investigating sheep rather than humans (Hough et al., 2017), or being case studies of a single patient (Schneider et al., 2017). Only two larger studies investigate this:

    Staphorsius et al. (2015), the only study to investigate this in a transgender population, evaluated performance in the standardised Tower of London test, as well as IQ scores. The study found no significant differences in executive functioning between the two groups. IQ was slightly lower in transgender girls receiving puberty suppression than the control group, but the same was not true in a statistically relevant way of transgender boys. Age differences, lifestyle factors, and a very low sample size may all explain these differences.

    Wojniusz et al. (2016) assessed 15 girls suffering from precocious puberty and treated with a puberty blocker. The 15 girls were compared with 15 age-matched controls. Both groups showed similar IQ scores.

    Neither study has very many participants, records baseline cognitive performance, or controls for confounding factors. As such, very few conclusions can be drawn from them. Decades of clinical experience with the use of puberty blockers in children suggests it’s unlikely any particularly dramatic effect on IQ exists, but without much larger, higher quality studies, no conclusion on this can be reached, and further research is needed.

    Desistance

    Discontinuation rates for patients on puberty blockers are very low, with fewer than 5% of teens typically stopping them without going on to hormone therapy (Wiepjes et al., 2018; Brik et al., 2020; Kuper et al., 2020). A potential concern is that this could mean puberty blockers put children on an almost guaranteed path towards gender transition, when they might otherwise change their minds.

    Surprisingly, while a commonly held belief suggests most gender dysphoric children will grow out of it without treatment at a later age, little convincing evidence supports this claim. While existing studies report desistance rates ranging from 43% (Wallien & Cohen-Kettenis, 2008) to 88% (Drummond et al., 2008), they often contain significant methodological issues.

    Historically, in the 20th century, a transgender identity was viewed as a negative outcome: it was something for a patient to be cured of, for example through aversion therapy. Since then, a cultural shift towards transgender people has taken place. Older studies into desistance rates are often reflective of this. As an example, Kosky (1987) describes eight boys who were hospitalised in a psychiatric unit for displaying effeminate behaviour and cross-dressing, where they received intensive treatment aimed at curing them. Today, these behaviours are more accepted, and they are not necessarily viewed as the same thing as a transgender gender identity. Clearly, a study like this cannot be used to estimate the desistance rates of today’s gender dysphoric children.

    Other studies describing the 1960s through 1980s are similar (Bakwin, 1968; Lebovitz, 1972; Zuger, 1978; Money & Russo, 1979; Davenport, 1986). Many predate the DSM-III, and thus the existence of formal diagnostic criteria. Few studied self-reported gender identity: instead, they tend to study gender non-conforming behaviour, such as cross-dressing, that doesn’t necessarily constitute a transgender identity. Many of them try to discourage patients as a core part of their treatment, sometimes in ways that are now banned across much of the world as conversion therapy. Combined with a drastically changed society, extrapolating modern transgender desistance rates from these studies is unreasonable.

    A small number of more recent studies do exist. The highest desistance rates found in modern literature are approximately 88%, reported by three frequently cited Canadian studies: Drummond et al. (2008), Drummond et al. (2018), and Singh, Bradley & Zucker (2021). Unfortunately, these studies appear to be at a high risk of bias: calling their credibility into question, the clinic in which they took place was closed in 2015, amidst allegations of conversion therapy. An independent review found that it “cannot state that the clinic does not practice reparative approaches.” In the review, many children and their parents report feeling the clinic was invasive and intimidating to them. Some instances include:

    Assessments are described as intrusive and even traumatic by some, who described feeling “poked and prodded”. One way mirror and multiple observers create discomfort. Many questions were felt to be irrelevant, unnecessarily intrusive (particularly those regarding sexual fantasies), especially when asked without context, rationale, and what seems to be inadequate or even absent informed consent. Also, it is unclear whether any potential benefit of this line of questioning to the patient was explained. Parents of younger clients report their child appearing to be and later reporting feeling they were very uncomfortable with the way they were asked about their gender variance “as if my child was not okay as a person.” One parent described feeling “dismissed” when she spoke to clinicians about this.

    Patients reported feeling intimidated to question Dr. Zucker regarding their concerns and were not offered the opportunity to decline. Multiple informants commented on this.

    Chart documentation revealed statements reflecting that the diversity of gender expression and variance are not accepted equally. One example is of a child for whom all gender and body dysphoria had resolved and multiple informants indicated sustained good mood and satisfaction with social and academic functioning. Despite this, the parents of the child were advised at discharge to encourage the child to spend more time with cisgendered boys because he had effeminate speech and mannerisms. These were not goals of the client or family.

    This may explain why these studies find a much higher desistance rate than other modern literature, and makes them very unlikely to be representative figures. As an alternative possibility, Steensma & Cohen-Kettenis (2018) suggest that differences in the local social climate regarding gender variance may have also been an important contributing factor.

    Steensma et al. (2011) and Steensma et al. (2013) set out to investigate factors that could contribute to the persistence or desistance of gender dysphoria in children. The 2011 study reports a desistance rate of 45%, while the 2013 study reports 73%. The figures have been criticised because all children lost to follow-up are assumed to have desisted, which may or may not have inflated their number. More importantly however, in Steensma & Cohen-Kettenis (2018), the authors themselves argue they’ve been cited out of context, and their figures can’t be used to extrapolate desistance rates:

    Unlike what is suggested, we have not studied the gender identities of the children. Instead we have studied the persistence and desistence of children’s distress caused by the gender incongruence they experience to the point that they seek clinical assistance. […] Using the term desistence in this way does not imply anything about the identity of the desisters. The children could still be hesitating, searching, fluctuating, or exploring with regard to their gender experience and expression, and trying to figure out how they wanted to live. Apparently, they no longer desired some form of gender-affirming treatment at that point in their lives.

    Again, because of the purpose and the design of this study we did not report prevalence numbers in the sample under study. Furthermore, the sample in the 2013 study did not include children in the younger age spectrum of the referred population to the Amsterdam clinic. Reporting prevalence of persistence and/or desistance in this sample would therefore not be reliable.

    The only other modern study into persistence rates has been Wallien & Cohen-Kettenis (2008). The study appears to be of higher quality and provides the most convincing estimate available: a 27% persistence rate and a 43% desistance rate over the course of (on average) 10 years. The remaining 30% of participants were lost to follow-up.

    Several further problems cast doubt on the data presented in all of these studies, including Wallien & Cohen-Kettenis (2008). Firstly: children are diagnosed using DSM-III and DSM-IV criteria, which are dated by today’s standards. In these older criteria, gender identity was not a diagnostic requirement: a child could be diagnosed with a gender identity disorder for a range of gender non-conforming behaviours, without themselves identifying as a different gender, or experiencing distress with their gender role or sex characteristics (Temple Newhook et al., 2018).

    Strikingly, with the exception of Steensma et al. (2011), all studies include a significant number of children who never actually met then-current DSM diagnostic criteria for Gender Identity Disorder: in the case of Wallien & Cohen-Kettenis (2008), a quarter of all participants. These participants have been assumed to be transgender for the purposes of extrapolating desistance rates, but held a diagnosis of Gender Identity Disorder Not Otherwise Specified: a broad category described by the DSM as representing those who may not necessarily seek medical transition, but may transiently cross-dress, be preoccupied with castration, or be intersex and experience gender dysphoria. These participants’ exact circumstances are not described by the researchers, but both Wallien & Cohen-Kettenis and Steensma et al. report in their studies that all, or nearly all persisters met DSM diagnostic criteria, while only about half of desisters did.

    Outside of this, there is a lack of long-term follow-up. A gender dysphoric child might desist in transitioning during their teens, but go on to transition in adulthood, for example because of peer pressure or lack of parental acceptance. Whether this happens at any significant rate has not been studied.

    The studies do suggest that for an unknown percentage of children, gender dysphoria will resolve over time, but the high desistance rates often cited as an established fact don’t appear to be supported by evidence. Concerns that puberty blockers cause children to transition when they otherwise would’ve aged out of gender dysphoria appear misplaced: children whose dysphoria persisted were much more likely to have met the diagnostic criteria to receive puberty blockers.

    Current literature on this will likely soon be superseded by higher-quality data, with several very large, well-funded studies into gender dysphoric youth now underway the United States (Olson-Kennedy et al., 2019), Australia (Tollit et al., 2019) and the United Kingdom (Kennedy et al., 2019).

    Desistance and persistence rates can suggest a binary view, and should be seen in a greater context. Because children’s needs change over time, a hypothetical child might feel uncertain about their gender, possibly even receive puberty blockers, and then later decide they do not wish to transition. In such a case, puberty blockers may have met their needs at the time, and were not automatically harmful or regrettable, particularly due to their reversible nature. Neither being transgender, nor being cisgender should be seen as a negative outcome. In their critical commentary, Temple Newhook et al. (2018) write that it is important to respect children’s wishes and autonomy, and move away from the question of, “How should children’s gender identities develop over time?” toward a more useful question: “How should children best be supported as their gender identity develops?”

    Regret

    In light of persistence and desistance rates, it makes sense to ask how patients themselves feel about their treatment with puberty blockers, and whether they regret receiving them. Limited research exists on the subject:

    A large retrospective review of the medical files of all 6,793 patients treated at the Dutch VUmc clinic between 1972 and 2015 found that 14 patients (0.2%) regretted their treatment in total. This included patients who received puberty suppression, hormone therapy, and/or surgery. Notably, 5 of them regretted their treatment because of a lack of social acceptance (Wiepjes et al., 2018).

    De Vries et al. (2014), found none of the 55 transgender patients they followed regretted receiving puberty blockers, hormone therapy, or surgery. Psychological well-being continued to improve in their cohort, both with puberty blockers, hormone therapy, and later gender reassignment surgery.

    Vrouenraets et al. (2016) interviewed 13 adolescents who had been seen at a Dutch gender identity clinic, twelve of whom had received puberty blockers. Asked about long-term risks, most responded that they were significantly outweighed by puberty blockers allowing them to live a more happy life. Quotes from the interviewed children in the study include:

    The possible long-term consequences are incomparable with the unhappy feeling that you have and will keep having if you don’t receive treatment with puberty suppression. (trans boy; age: 18)

    It isn’t a choice, even though a lot of people think that. Well, actually it is a choice: living a happy life or living an unhappy life. (trans girl; age: 14)

    They also comment on the increasing attention to transgender people in media, with one child saying:

    Thanks to media coverage I learned that gender dysphoria exists; that someone can have these feelings and that you can get treatment for it. Beforehand I thought I was the only one like this. (trans boy; age: 18)

    Ease of Access

    While large geographic differences exist, on the whole, access to puberty blockers is often difficult.

    In the United States, Turban et al. (2020) found that access to puberty blockers was associated with a greater household income, noting that the annual cost of them ranges from $4,000 to $25,000 and insurance coverage was unavailable to many. It also found that transgender teens were less likely to receive puberty blockers if they did not identify as heterosexual or binary. Of those who received puberty blockers, 60% reported traveling <25 miles for gender-affirming care, 29% travelled between 25 and 100 miles, and 11% travelled >100 miles. As of 2021, several states are pursuing regulation banning the use of puberty blockers, with Arkansas having become the first to pass such a law. Several large professional bodies representing thousands of medical experts have condemned this type of regulation (American Academy of Child and Adolescent Psychiatry, 2019; American Medical Association, 2021; Endocrine Society, 2021).

    In the United Kingdom, waiting lists as long as 4 years or more exist for initial intake appointments for puberty blockers. Legislative changes in light of Bell v. Tavistock complicated access dramatically: in the nine months between the ruling and its reversal, no under-17s received puberty blockers under the public healthcare sytem, and reports described the care of adolescents over 16, who were not affected by the judgement, being discontinued as well. Restrictions in light of Bell v. Tavistock were condemned by WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusPATH, and PATHA, the leading medical associations for transgender health, who released a statement saying they believe it will cause significant harm to the affected patients (WPATH, 2020), as well as Amnesty International UK and Liberty (Amnesty International UK, 2020).

    In Sweden, the Astrid Lindgren Children’s Hospital, a part of the Karolinska University Hospital, has recently stopped prescribing puberty blockers, citing the Bell v. Tavistock case as their motivation.

    In Finland, new prescriber guidelines for treating gender dysphoric teens were released in 2020 (Society for Evidence Based Medicine, 2021). They broke with WPATH guidelines, instead recommending that gender dysphoric teens receive psychosocial support and psychotherapy as a first-line treatment, and discouraging the use of puberty blockers, with the addition of much stricter criteria for their use. The Finnish health authority has stated that these recommendations will not be revised until further research is available.

    A similar trend of increasing wait times and difficult access holds in many other countries, with the process to receive puberty blockers sometimes taking up to several years. Because of their time-sensitive nature in preventing unwanted permanent changes, long-term outcomes are likely to be worse with slower treatment. Some evidence supports this: for example, one study found that reducing treatment wait times led to reduced depression and anxiety compared to historical controls (Dahlgren Allen et al., 2021).

    Conclusion

    Unknowns exist around puberty blockers in transgender youth, but their risks seem to be relatively minor based on available research, while clear evidence associates their use with improved well-being, psychological functioning, and reduced suicidality.

    Based on parallels from research in cisgender teens treated for precocious puberty, as well as limited studies and clinical experience with transgender teens, it’s unlikely that puberty suppression has a dramatic negative effect on children’s final bone density, lifetime fracture risk, IQ, or cognitive development when prescribed in line with medical guidelines. However, there is insufficient evidence to determine whether or not they have any impact at all.

    Although not supported by conclusive evidence, the use of puberty blockers may have a modest negative impact on bone density. This could be related to the use of puberty blockers themselves, but could also be related to suboptimal hormone therapy regimens after their use, particularly in transgender girls, as well as lifestyle factors. Studies investigating this suffer from significant methodological issues, and a definitive causal link remains unproven. Based on limited evidence, prescribers may wish to consider calcium supplementation in transgender teens receiving puberty blockers, and may wish to avoid oral estrogens in transgender girls beginning hormone therapy.

    Compared to their cisgender peers, transgender adolescents who take puberty blockers are less likely to choose to have biological children, but puberty blockers do not permanently affect fertility.

    Widely cited statistics around children growing out of gender dysphoria (“desistance”) as they grow older are based on highly unreliable data. Surprisingly, based on current evidence, we cannot reasonably guess the rate at which this happens. Regardless, desistance rates are not an argument for or against the use of puberty blockers. It is important to respect children’s wishes and autonomy, and to find the best way to support them as their gender identity develops, without imposing the idea that either a transgender or a cisgender gender identity is a bad outcome.

    Very few patients who receive puberty blockers experience regret. In broader context, for the small minority of adult transgender patients who report feeling regret after undergoing hormone therapy or surgery, a common reason for that is a lack of social acceptance.

    More high-quality research is urgently needed in this field. In particular, the effects of puberty blockers on IQ and cognitive development, bone outcomes, and desistance remain understudied subjects. Randomised controlled trials on puberty blockers are not available, and likely cannot be performed for both practical and ethical reasons. This should not be seen as a reason to discard all other research on the subject, or to label their use as experimental, as it is a standard of evidence that can never be met.

    Puberty blockers are extremely difficult for patients to access in many countries, including the United States, the United Kingdom, and parts of Europe. Several countries have recently banned their use, or further restricted it significantly. This review provides further evidence supporting WPATH, EPATH, USPATH, AsiaPATH, CPATH, AusAPTH, PATHA, the Endocrine Society, the American Academy of Child and Adolescent Psychiatry, and the American Medical Association in condemning recent attempts to bar transgender teens from receiving gender-affirming care, including puberty blockers. To better support gender dysphoric children, barriers of access should instead be reduced where possible.

    References

    • Achille, C., Taggart, T., Eaton, N. R., Osipoff, J., Tafuri, K., Lane, A., & Wilson, T. A. (2020). Longitudinal impact of gender-affirming endocrine intervention on the mental health and well-being of transgender youths: preliminary results. International Journal of Pediatric Endocrinology, 2020, 8. [DOI:10.1186/s13633-020-00078-2]
    • Antoniazzi, F., Zamboni, G., Bertoldo, F., Lauriola, S., Mengarda, F., Pietrobelli, A., & Tatò, L. (2003). Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. The Journal of Clinical Endocrinology and Metabolism, 88(3), 1096–1101. [DOI:10.1210/jc.2002-021154]
    • Arnoldussen, M., Steensma, T. D., Popma, A., van der Miesen, A., Twisk, J., & de Vries, A. (2020). Re-evaluation of the Dutch approach: are recently referred transgender youth different compared to earlier referrals? European Child & Adolescent Psychiatry, 29(6), 803–811. [DOI:10.1007/s00787-019-01394-6]
    • Bakwin, H. (1968). Deviant gender-role behavior in children: relation to homosexuality. Pediatrics, 41(3), 620–629. [PubMed] [DOI:10.1542/peds.41.3.620]
    • Barake, M., Klibanski, A., & Tritos, N. A. (2014). Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. The Journal of Clinical Endocrinology and Metabolism, 99(3), 852–860. [DOI:10.1210/jc.2013-3921]
    • Barake, M., Arabi, A., Nakhoul, N., El-Hajj Fuleihan, G., El Ghandour, S., Klibanski, A., & Tritos, N. A. (2018). Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis. Endocrine, 59(1), 39–49. [DOI:10.1007/s12020-017-1440-0]
    • Barnard, E. P., Dhar, C. P., Rothenberg, S. S., Menke, M. N., Witchel, S. F., Montano, G. T., Orwig, K. E., & Valli-Pulaski, H. (2019). Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients. Pediatrics, 144(3), e20183943. [DOI:10.1542/peds.2018-3943]
    • Bertelloni, S., Baroncelli, G. I., Ferdeghini, M., Menchini-Fabris, F., & Saggese, G. (2000). Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. European Journal of Pediatrics, 159(5), 369–374. [DOI:10.1007/s004310051289]
    • Brik, T., Vrouenraets, L., de Vries, M. C., & Hannema, S. E. (2020). Trajectories of Adolescents Treated with Gonadotropin-Releasing Hormone Analogues for Gender Dysphoria. Archives of Sexual Behavior, 49(7), 2611–2618. [DOI:10.1007/s10508-020-01660-8]
    • Carmichael, P., Butler, G., Masic, U., Cole, T. J., De Stavola, B. L., Davidson, S., Skageberg, E. M., Khadr, S., & Viner, R. M. (2021). Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK. PloS One, 16(2), e0243894. [DOI:10.1371/journal.pone.0243894]
    • Cedrin-Durnerin, I., Bidart, J. M., Robert, P., Wolf, J. P., Uzan, M., & Hugues, J. N. (2000). Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short-term protocol for in-vitro fertilization. Human Reproduction, 15(5), 1009–1014. [DOI:10.1093/humrep/15.5.1009]
    • Chen, D., Simons, L., Johnson, E. K., Lockart, B. A., & Finlayson, C. (2017). Fertility Preservation for Transgender Adolescents. The Journal of Adolescent Health, 61(1), 120–123. [DOI:10.1016/j.jadohealth.2017.01.022]
    • Cheng, P. J., Pastuszak, A. W., Myers, J. B., Goodwin, I. A., & Hotaling, J. M. (2019). Fertility concerns of the transgender patient. Translational Andrology and Urology, 8(3), 209–218. [DOI:10.21037/tau.2019.05.09]
    • Cohen-Kettenis, P. T., & van Goozen, S. H. (1998). Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent. European Child & Adolescent Psychiatry, 7(4), 246–248. [DOI:10.1007/s007870050073]
    • Cohen-Kettenis, P. T., Schagen, S. E., Steensma, T. D., de Vries, A. L., & Delemarre-van de Waal, H. A. (2011). Puberty suppression in a gender-dysphoric adolescent: a 22-year follow-up. Archives of Sexual Behavior, 40(4), 843–847. [DOI:10.1007/s10508-011-9758-9]
    • Costa, R., Dunsford, M., Skagerberg, E., Holt, V., Carmichael, P., & Colizzi, M. (2015). Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria. The Journal of Sexual Medicine, 12(11), 2206–2214. [DOI:10.1111/jsm.13034]
    • Dahlgren Allen, S., Tollit, M. A., McDougall, R., Eade, D., Hoq, M., & Pang, K. C. (2021). A Waitlist Intervention for Transgender Young People and Psychosocial Outcomes. Pediatrics, 148(2), e2020042762. [DOI:10.1542/peds.2020-042762]
    • Davenport, C. W. (1986). A follow-up study of 10 feminine boys. Archives of Sexual Behavior, 15(6), 511–517. [DOI:10.1007/BF01542316]
    • Davenport M. L. (2010). Approach to the patient with Turner syndrome. The Journal of Clinical Endocrinology and Metabolism, 95(4), 1487–1495. [DOI:10.1210/jc.2009-0926]
    • de Vries, A. L. C., Cohen-Kettenis, P. T., & Delemarre-van de Waal, H. (2006). Clinical Management of Gender Dysphoria in Adolescents. International Journal of Transgenderism, 9(4), 83–94. [DOI:10.1300/J485v09n03_04]
    • de Vries, A. L., Steensma, T. D., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2011). Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. The Journal of Sexual Medicine, 8(8), 2276–2283. [DOI:10.1111/j.1743-6109.2010.01943.x]
    • de Vries, A. L., McGuire, J. K., Steensma, T. D., Wagenaar, E. C., Doreleijers, T. A., & Cohen-Kettenis, P. T. (2014). Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics, 134(4), 696–704. [DOI:10.1542/peds.2013-2958]
    • Drummond, K. D., Bradley, S. J., Peterson-Badali, M., & Zucker, K. J. (2008). A follow-up study of girls with gender identity disorder. Developmental Psychology, 44(1), 34–45. [DOI:10.1037/0012-1649.44.1.34]
    • Drummond, K. D., Bradley, S. J., Peterson-Badali, M., VanderLaan, D. P., & Zucker, K. J. (2018). Behavior Problems and Psychiatric Diagnoses in Girls with Gender Identity Disorder: A Follow-Up Study. Journal of Sex & Marital Therapy, 44(2), 172–187. [DOI:10.1080/0092623X.2017.1340382]
    • Ekbote, V. H., Khadilkar, V. V., Khadilkar, A. V., Mughal, Z., Chiplonkar, S. A., Palande, S. A., Phanse-Gupte, S. S., Patwardhan, V. G., & Shilvant, D. S. (2015). Relationship of insulin-like growth factor 1 and bone parameters in 7–15 years old apparently, healthy Indian children. Indian Journal of Endocrinology and Metabolism, 19(6), 770–774. [DOI:10.4103/2230-8210.167549]
    • Feuillan, P. P., Jones, J. V., Barnes, K., Oerter-Klein, K., & Cutler, G. B., Jr. (1999). Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. The Journal of Clinical Endocrinology and Metabolism, 84(1), 44–49. [DOI:10.1210/jcem.84.1.5409]
    • Giordano, S., & Holm, S. (2020). Is puberty delaying treatment ‘experimental treatment’? International Journal of Transgender Health, 21(2), 113–121. [DOI:10.1080/26895269.2020.1747768]
    • Green, A. E., DeChants, J. P., Price, M. N., & Davis, C. K. (2022). Association of Gender-Affirming Hormone Therapy With Depression, Thoughts of Suicide, and Attempted Suicide Among Transgender and Nonbinary Youth. Journal of Adolescent Health, 70(4), 643–649. [DOI:10.1016/j.jadohealth.2021.10.036]
    • Guaraldi, F., Beccuti, G., Gori, D., & Ghizzoni, L. (2016). MANAGEMENT OF ENDOCRINE DISEASE: Long-term outcomes of the treatment of central precocious puberty. European Journal of Endocrinology, 174(3), R79–R87. [DOI:10.1530/EJE-15-0590]
    • Heger, S., Partsch, C. J., & Sippell, W. G. (1999). Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function. The Journal of Clinical Endocrinology and Metabolism, 84(12), 4583–4590. [DOI:10.1210/jcem.84.12.6203]
    • Heger, S., Müller, M., Ranke, M., Schwarz, H. P., Waldhauser, F., Partsch, C. J., & Sippell, W. G. (2006). Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function. Molecular and Cellular Endocrinology, 254–255, 217–220. [DOI:10.1016/j.mce.2006.04.012]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658]
    • Hough, D., Bellingham, M., Haraldsen, I. R., McLaughlin, M., Robinson, J. E., Solbakk, A. K., & Evans, N. P. (2017). A reduction in long-term spatial memory persists after discontinuation of peripubertal GnRH agonist treatment in sheep. Psychoneuroendocrinology, 77, 1–8. [DOI:10.1016/j.psyneuen.2016.11.029]
    • Isotton, A. L., Wender, M. C., Casagrande, A., Rollin, G., & Czepielewski, M. A. (2012). Effects of oral and transdermal estrogen on IGF1, IGFBP3, IGFBP1, serum lipids, and glucose in patients with hypopituitarism during GH treatment: a randomized study. European Journal of Endocrinology, 166(2), 207–213. [DOI:10.1530/EJE-11-0560]
    • Jones, B. A., Haycraft, E., Bouman, W. P., & Arcelus, J. (2018). The Levels and Predictors of Physical Activity Engagement Within the Treatment-Seeking Transgender Population: A Matched Control Study. Journal of Physical Activity & Health, 15(2), 99–107. [DOI:10.1123/jpah.2017-0298]
    • Jung, K. Y., Kim, T., Hwang, S. Y., Lee, T. R., Yoon, H., Shin, T. G., Sim, M. S., Cha, W. C., & Jeon, H. J. (2018). Deliberate Self-harm among Young People Begins to Increase at the Very Early Age: a Nationwide Study. Journal of Korean Medical Science, 33(30), e191. [DOI:10.3346/jkms.2018.33.e191]
    • Kennedy, E., Spinner, L., Lane, C., Stynes, H., Ranieri, V., Carmichael, P., Omar, R., Vickerstaff, V., Hunter, R., Wright, T., Senior, R., Butler, G., Baron-Cohen, S., Young, B., & King, M. (2021). Longitudinal Outcomes of Gender Identity in Children (LOGIC): protocol for a prospective longitudinal cohort study of children referred to the UK gender identity development service. BMJ Open, 11(9), e045628. [DOI:10.1136/bmjopen-2020-045628]
    • Khatchadourian, K., Amed, S., & Metzger, D. L. (2014). Clinical management of youth with gender dysphoria in Vancouver. The Journal of Pediatrics, 164(4), 906–911. [DOI:10.1016/j.jpeds.2013.10.068]
    • Kidd, J. D., Dolezal, C., & Bockting, W. O. (2018). The Relationship Between Tobacco Use and Legal Document Gender-Marker Change, Hormone Use, and Gender-Affirming Surgery in a United States Sample of Trans-Feminine and Trans-Masculine Individuals: Implications for Cardiovascular Health. LGBT Health, 5(7), 401–411. [DOI:10.1089/lgbt.2018.0103]
    • Klink, D., Caris, M., Heijboer, A., van Trotsenburg, M., & Rotteveel, J. (2015). Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria. The Journal of Clinical Endocrinology and Metabolism, 100(2), E270–E275. [DOI:10.1210/jc.2014-2439]
    • Kosky, R. J. (1987). Gender-disordered children: does inpatient treatment help? The Medical Journal of Australia, 146(11), 565–569. [DOI:10.5694/j.1326-5377.1987.tb120415.x]
    • Kuper, L. E., Stewart, S., Preston, S., Lau, M., & Lopez, X. (2020). Body Dissatisfaction and Mental Health Outcomes of Youth on Gender-Affirming Hormone Therapy. Pediatrics, 145(4), e20193006. [DOI:10.1542/peds.2019-3006]
    • Lazar, L., Meyerovitch, J., de Vries, L., Phillip, M., & Lebenthal, Y. (2014). Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades. Clinical Endocrinology, 80(4), 570–576. [DOI:10.1111/cen.12319]
    • Lebovitz, P. S. (1972). Feminine behavior in boys: aspects of its outcome. The American Journal of Psychiatry, 128(10), 1283–1289. [DOI:10.1176/ajp.128.10.1283]
    • Lee, J. Y., Finlayson, C., Olson-Kennedy, J., Garofalo, R., Chan, Y. M., Glidden, D. V., & Rosenthal, S. M. (2020). Low Bone Mineral Density in Early Pubertal Transgender/Gender Diverse Youth: Findings From the Trans Youth Care Study. Journal of the Endocrine Society, 4(9), bvaa065. [DOI:10.1210/jendso/bvaa065]
    • Li, K., Rodriguez, D., Gabrielsen, J. S., Centola, G. M., & Tanrikut, C. (2018). Sperm cryopreservation of transgender individuals: trends and findings in the past decade. Andrology, 6(6), 860–864. [DOI:10.1111/andr.12527]
    • Lindsey, R. C., & Mohan, S. (2016). Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Molecular and Cellular Endocrinology, 432, 44–55. [DOI:10.1016/j.mce.2015.09.017]
    • Locatelli, V., & Bianchi, V. E. (2014). Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis. International Journal of Endocrinology, 2014, 235060. [DOI:10.1155/2014/235060]
    • Money, J., & Russo, A. J. (1979). Homosexual outcome of discordant gender identity/role in childhood: Longitudinal follow-up. Journal of Pediatric Psychology, 4(1), 29–41. [DOI:10.1093/jpepsy/4.1.29]
    • Morey, Y., Mellon, D., Dailami, N., Verne, J., & Tapp, A. (2017). Adolescent self-harm in the community: an update on prevalence using a self-report survey of adolescents aged 13–18 in England. Journal of Public Health, 39(1), 58–64. [DOI:10.1093/pubmed/fdw010]
    • Mul, D., Versluis-den Bieman, H. J., Slijper, F. M., Oostdijk, W., Waelkens, J. J., & Drop, S. L. (2001). Psychological assessments before and after treatment of early puberty in adopted children. Acta Paediatrica, 90(9), 965–971. [DOI:10.1080/080352501316978011]
    • Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low Fertility Preservation Utilization Among Transgender Youth. The Journal of Adolescent Health, 61(1), 40–44. [DOI:10.1016/j.jadohealth.2016.12.012]
    • Nock, M. K., Green, J. G., Hwang, I., McLaughlin, K. A., Sampson, N. A., Zaslavsky, A. M., & Kessler, R. C. (2013). Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents: results from the National Comorbidity Survey Replication Adolescent Supplement. JAMA Psychiatry, 70(3), 300–310. [DOI:10.1001/2013.jamapsychiatry.55]
    • Olson-Kennedy, J., Chan, Y. M., Garofalo, R., Spack, N., Chen, D., Clark, L., Ehrensaft, D., Hidalgo, M., Tishelman, A., & Rosenthal, S. (2019). Impact of Early Medical Treatment for Transgender Youth: Protocol for the Longitudinal, Observational Trans Youth Care Study. JMIR Research Protocols, 8(7), e14434. [DOI:10.2196/14434]
    • Pang, K. C., Peri, A., Chung, H. E., Telfer, M., Elder, C. V., Grover, S., & Jayasinghe, Y. (2020). Rates of Fertility Preservation Use Among Transgender Adolescents. JAMA Pediatrics, 174(9), 890–891. [DOI:10.1001/jamapediatrics.2020.0264]
    • Riggs, M. M., Bennetts, M., van der Graaf, P. H., & Martin, S. W. (2012). Integrated pharmacometrics and systems pharmacology model-based analyses to guide GnRH receptor modulator development for management of endometriosis. CPT: Pharmacometrics & Systems Pharmacology, 1(10), e11. [DOI:10.1038/psp.2012.10]
    • Rodriguez-Wallberg, K. A., Häljestig, J., Arver, S., Johansson, A., & Lundberg, F. E. (2021). Sperm quality in transgender women before or after gender affirming hormone therapy—A prospective cohort study. Andrology, 9(6), 1773–1780. [DOI:10.1111/andr.12999]
    • Roux, C. (1997). Estrogen therapy in postmenopausal osteoporosis. What we know and what we don’t. Revue du Rhumatisme (English Ed.), 64(6), 402–409. [Google Scholar] [PubMed] [PDF]
    • Schagen, S., Wouters, F. M., Cohen-Kettenis, P. T., Gooren, L. J., & Hannema, S. E. (2020). Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones. The Journal of Clinical Endocrinology and Metabolism, 105(12), e4252–e4263. [DOI:10.1210/clinem/dgaa604]
    • Schneider, M. A., Spritzer, P. M., Soll, B., Fontanari, A., Carneiro, M., Tovar-Moll, F., Costa, A. B., da Silva, D. C., Schwarz, K., Anes, M., Tramontina, S., & Lobato, M. (2017). Brain Maturation, Cognition and Voice Pattern in a Gender Dysphoria Case under Pubertal Suppression. Frontiers in Human Neuroscience, 11, 528. [DOI:10.3389/fnhum.2017.00528]
    • Singh, D., Bradley, S. J., & Zucker, K. J. (2021). A Follow-Up Study of Boys With Gender Identity Disorder. Frontiers in Psychiatry, 12, 632784. [DOI:10.3389/fpsyt.2021.632784]
    • Southmayd, E. A., & De Souza, M. J. (2017). A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health. Growth Hormone & IGF Research, 32, 2–13. [DOI:10.1016/j.ghir.2016.09.001]
    • Staphorsius, A. S., Kreukels, B. P., Cohen-Kettenis, P. T., Veltman, D. J., Burke, S. M., Schagen, S. E., Wouters, F. M., Delemarre-van de Waal, H. A., & Bakker, J. (2015). Puberty suppression and executive functioning: An fMRI-study in adolescents with gender dysphoria. Psychoneuroendocrinology, 56, 190–199. [DOI:10.1016/j.psyneuen.2015.03.007]
    • Steensma, T. D., Biemond, R., de Boer, F., & Cohen-Kettenis, P. T. (2011). Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clinical Child Psychology and Psychiatry, 16(4), 499–516. [DOI:10.1177/1359104510378303]
    • Steensma, T. D., McGuire, J. K., Kreukels, B. P., Beekman, A. J., & Cohen-Kettenis, P. T. (2013). Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 52(6), 582–590. [DOI:10.1016/j.jaac.2013.03.016]
    • Steensma, T. D., & Cohen-Kettenis, P. T. (2018). A critical commentary on “A critical commentary on follow-up studies and “desistence” theories about transgender and gender non-conforming children”. International Journal of Transgenderism, 19(2), 225–230. [DOI:10.1080/15532739.2018.1468292]
    • Swerdloff, R. S., & Heber, D. (1983). Superactive gonadotropin-releasing hormone agonists. Annual Review of Medicine, 34, 491–500. [DOI:10.1146/annurev.me.34.020183.002423]
    • Temple Newhook, J., Pyne, J., Winters, K., Feder, S., Holmes, C., Tosh, J., Sinnott, M.-L., Jamieson, A., & Pickett, S. (2018). A critical commentary on follow-up studies and “desistance” theories about transgender and gender-nonconforming children. International Journal of Transgenderism, 19(2), 212–224. [DOI:10.1080/15532739.2018.1456390]
    • Tollit, M. A., Pace, C. C., Telfer, M., Hoq, M., Bryson, J., Fulkoski, N., Cooper, C., & Pang, K. C. (2019). What are the health outcomes of trans and gender diverse young people in Australia? Study protocol for the Trans20 longitudinal cohort study. BMJ Open, 9(11), e032151. [DOI:10.1136/bmjopen-2019-032151]
    • Turban, J. L., King, D., Carswell, J. M., & Keuroghlian, A. S. (2020). Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation. Pediatrics, 145(2), e20191725. [DOI:10.1542/peds.2019-1725]
    • van der Miesen, A., Steensma, T. D., de Vries, A., Bos, H., & Popma, A. (2020). Psychological Functioning in Transgender Adolescents Before and After Gender-Affirmative Care Compared With Cisgender General Population Peers. The Journal of Adolescent Health, 66(6), 699–704. [DOI:10.1016/j.jadohealth.2019.12.018]
    • Verhulst, F. C., Achenbach, T. M., van der Ende, J., Erol, N., Lambert, M. C., Leung, P. W., Silva, M. A., Zilber, N., & Zubrick, S. R. (2003). Comparisons of problems reported by youths from seven countries. The American Journal of Psychiatry, 160(8), 1479–1485. [DOI:10.1176/appi.ajp.160.8.1479]
    • Vlot, M. C., Klink, D. T., den Heijer, M., Blankenstein, M. A., Rotteveel, J., & Heijboer, A. C. (2017). Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents. Bone, 95, 11–19. [DOI:10.1016/j.bone.2016.11.008]
    • Vrouenraets, L. J., Fredriks, A. M., Hannema, S. E., Cohen-Kettenis, P. T., & de Vries, M. C. (2016). Perceptions of Sex, Gender, and Puberty Suppression: A Qualitative Analysis of Transgender Youth. Archives of Sexual Behavior, 45(7), 1697–1703. [DOI:10.1007/s10508-016-0764-9]
    • Wallien, M. S., & Cohen-Kettenis, P. T. (2008). Psychosexual outcome of gender-dysphoric children. Journal of the American Academy of Child and Adolescent Psychiatry, 47(12), 1413–1423. [DOI:10.1097/CHI.0b013e31818956b9]
    • Wiepjes, C. M., Nota, N. M., de Blok, C., Klaver, M., de Vries, A., Wensing-Kruger, S. A., de Jongh, R. T., Bouman, M. B., Steensma, T. D., Cohen-Kettenis, P., Gooren, L., Kreukels, B., & den Heijer, M. (2018). The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets. The Journal of Sexual Medicine, 15(4), 582–590. [DOI:10.1016/j.jsxm.2018.01.016]
    • Wojniusz, S., Callens, N., Sütterlin, S., Andersson, S., De Schepper, J., Gies, I., Vanbesien, J., De Waele, K., Van Aken, S., Craen, M., Vögele, C., Cools, M., & Haraldsen, I. R. (2016). Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty. Frontiers in Psychology, 7, 1053. [DOI:10.3389/fpsyg.2016.01053]
    • Zaiem, F., Alahdab, F., Al Nofal, A., Murad, M. H., & Javed, A. (2017). Oral Versus Transdermal Estrogen In Turner Syndrome: A Systematic Review And Meta-Analysis. Endocrine Practice, 23(4), 408–421. [DOI:10.4158/ep161622.or]
    • Zuger, B. (1978). Effeminate behavior present in boys from childhood: ten additional years of follow-up. Comprehensive Psychiatry, 19(4), 363–369. [DOI:10.1016/0010-440x(78)90019-6]
    \ No newline at end of file diff --git a/transfemscience.org/articles/serms-transfem-suppl/index.html b/transfemscience.org/articles/serms-transfem-suppl/index.html index 287aa13e..f801cac1 100644 --- a/transfemscience.org/articles/serms-transfem-suppl/index.html +++ b/transfemscience.org/articles/serms-transfem-suppl/index.html @@ -1 +1 @@ -Sources/Excerpts: A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy - Transfeminine Science Link

    Sources/Excerpts: A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy

    By Lain | First published October 5, 2019 | Last modified June 3, 2021

    Preface

    This page is a sources and excerpts supplement to the main article which can be found here.

    Maximov, Lee, & Jordan (2013)

    Maximov, P. Y., Lee, T. M., & Jordan, V. C. (2013). The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice. Current Clinical Pharmacology, 8(2), 135–155. [DOI:10.2174/1574884711308020006]:

    However, although these SERMs have many benefits, they also have some potentially serious adverse effects, such as thromboembolic disorders and, in the case of tamoxifen, uterine cancer. These adverse effects represent a major concern given that long-term therapy is required to prevent osteoporosis or prevent and treat breast cancer.

    The search for the ‘ideal’ SERM, which would have estrogenic effects on bone and serum lipids, neutral effects on the uterus, and antiestrogenic effects on breast tissue, but none of the adverse effects associated with current therapies, is currently under way.

    Note: Serum lipids are like HDL/LDL cholesterol.

    There are two ERs referred to as α and β [82-84]. Each receptor protein is encoded on different chromosomes, and have homology as members of the steroid receptor superfamily. There are distinct patterns of distribution and distinct and subtle differences in structure and ligand binding affinity [85]. The ratio of ERα and ERβ at a target site may be an additional dimension for tissue modulation. A high ERα: ERβ ratio correlates well with high levels of cellular proliferation whereas the predominance of functional ERβ over ERα correlates with repression of proliferation [86-89]. Indeed, the ratio of ERs in normal and neoplasic breast tissue could be important for the long-term success of chemoprevention with SERMs.

    Kraichely and co-workers [97] demonstrated the important observation that agonists for ERα and ERβ produce subtle quantitative differences with the interaction of members of the SRC family (SRC 1, 2 and 3) and that the coactivator can enhance ligand affinity for the ER.

    Evidence has now accumulated to document that the broad spectrum of ligands that bind to the ER can create a broad range of ER complexes that are either fully estrogenic or antiestrogenic at a particular target site [100]. Thus a mechanistic model of estrogen action and antiestrogen action (Fig. 2) has emerged based on the shape of the ligand that programs the complex for future action.

    Thus for effective gene transcription, programmed and targeted by the shape and phosphorylation status of the ER and coactivators, a dynamic and cyclic process of remodeling capacity is required for transcriptional assembly [103] that is immediately followed by the routine destruction of transcription complexes by the proteasome. Estrogen and SERM-ER complexes have distinct accumulation patterns in the target cell nucleus [104,105] because they are destroyed at different rates.

    Raloxifene lacks estrogenic activity in the uterus and has not demonstrated tamoxifen-like effects in the uterus either histopathologically or ultrasonographically [116], but it has been associated with adverse effects such as VTE and vasomotor symptoms, including hot flushes.

    Perhaps the reason for this difference in effect is related to differences on the agents’ effect on inflammation as the agents influence C-reactive protein (CRP) differently. Estrogen and tibolone increase levels of CRP [192], raloxifene and arzoxifene have no effect on CRP levels, and lasofoxifene decreases CRP levels [55]. All decrease LDL levels.

    Brzozowski et al. (1997)

    Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Ohman, L., Greene, G. L., Gustafsson, J. A., & Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389(6652), 753–758. [DOI:10.1038/39645]:

    The overall architecture of the ER LBD (helices H3–H12) is similar to that seen in the crystal structures of other nuclear receptor LBDs6–8, and emphasizes the universal nature of this fold within this receptor superfamily9. The LBD is folded into a three-layered antiparallel a-helical sandwich comprising a central core layer of three helices (H5/6, H9 and H10) sandwiched between two additional layers of helices (H1–4 and H7, H8, H11). This helical arrangement creates a ‘wedge-shaped’ molecular scaffold that maintains a sizeable ligandbinding cavity at the narrower end of the domain. The remaining secondary structural elements, a small two-stranded antiparallel β-sheet (S1 and S2) and H12, are located at this ligand-binding portion of the molecule, and flank the main three-layered motif (Fig. 1a).

    E2 binds diagonally across the cavity between H11, H3 and H6 and adopts a low-energy conformation. The phenolic hydroxyl of the A-ring (O3; see Fig. 2c for atom numbering) nestles between H3 and H6 and makes direct hydrogen bonds to the carboxylate of Glu 353, the guanidinium group of Arg 394, and a water molecule. The 17-β hydroxyl (O17) of the Dring makes a single hydrogen bond with His 524 in H11. The remainder of the molecule participates in a number of hydrophobic contactsthat are concentrated overthe A, A/B interface and D-rings.

    The ER is unique among the steroid receptors in its ability to embrace a wide variety of non-steroidal compounds. Although the ‘pincer-like’ arrangement around the A-ring imposes an absolute requirement on effective ligands to contain an aromatic ring, the remainder of the binding pocket can accept a number of different hydrophobic groups12,13. This overall promiscuity can be attributed to the size of the cavity, which has a probe accessible volume (450 A˚3) nearly twice that of E2’s molecular volume (245 A˚3). The length and breadth of the E2 skeleton is well matched by the receptor, but there are large unoccupied cavities opposite the α face of the B-ring and the β face of the C-ring (Fig. 2a). The positions of these preformed cavities are similar to those predicted from binding studies12.

    Note: This may be why things like bisphenol A (BPA) and other random chemicals bind to the estrogen receptor.

    Rosano et al. (2011)

    Rosano, C., Stec-Martyna, E., Lappano, R., & Maggiolini, M. (2011). Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators. Current Medicinal Chemistry, 18(8), 1188–1194. [DOI:10.2174/092986711795029645]:

    These two zinc fingers are responsible for the binding of ERα to the estrogen response elements (EREs) located in the promoter regions of target genes. The P-box sequence is identical in the two ER isoforms, suggesting that ERα and ERβ bind EREs with similar specificity and affinity.

    Pure anti-estrogen development has also included a further class of molecules represented by the inhibitors of aromatase enzymatic activity, which increases estrogen availability at tissue levels converting androgens into estrogens.

    4OHT binds to ERs within the same binding pocket that recognises E2 and produces a nuclear complex which decreases DNA synthesis and inhibits the action of estrogens [24]. Moreover, the complex between ER and 4OHT recruits co-repressor proteins like NCoR and SMRT, which contribute to the antagonist effects of 4OHT [78].

    In particular, the position of H12 shifts from the ligand binding pocket to cover a part of the co-activator binding groove, which is formed by residues belonging to H3, H4 and H5 [24]. The receptor recognition of 4OHT is dictated by the phenolic “A ring” and the bulky side chain.

    […] whilst the bulky side chain protruding from the binding cavity displaces H12 and allows a conformation that inhibits the coactivator recruitment.

    1ERR - raloxifene / er_alpha pddb. 1ERE [ estradiol / er_alpha pddb.

    Next, the long hydrophobic side chain of RAL makes extensive contacts with the hydrophobic residues of the receptor allowing the displacement of H12 similar to 4OHT.

    Comparable to other SERMs, Lasofoxifene diverts the receptor from its agonistbound conformation by displacing the C-terminal AF-2 helix 12 into the site at which the LXXLL motif of coactivator proteins would otherwise be able to bind. LAS achieves this effect by occupying the space normally filled by residue Leu540, as well as by modulating the conformation of residues of helix 11.

    In addition to these features of SERM recognition, a large alkyl “pendant” side chain, terminating in a pyrollidine head group, threads its way from the ligand-binding pocket out toward the surface of the protein, where it directly interferes with the correct positioning of the AF-2 helix.

    Nilsson & Gustafsson (2010)

    Nilsson, S., & Gustafsson, J. (2010). Estrogen Receptors: Therapies Targeted to Receptor Subtypes. Clinical Pharmacology & Therapeutics, 89(1), 44–55. [DOI:10.1038/clpt.2010.226]:

    Like other members of the nuclear receptor family, the ERs are best known as transcription factors, regulating the transcriptional activity of target genes in cells in response to the natural hormone 17β-estradiol (E2) or to synthetic nonhormonal agonists and antagonists1 (Figure 1). In more recent years, we have also learned that the effects of E2 can have a very rapid onset, within seconds to minutes. These effects may be mediated by membrane-localized ERα and ERβ, respectively (after exposure to ligand stimuli), or by membrane receptors that are genetically and structurally unrelated to ERα and ERβ, for example, GPR30 (G-protein coupled receptor 30).

    An increase in the expression of ERβ relative to ERα was shown to inhibit the ERα response to E2, silence the partial ERα-mediated agonism of tamoxifen, and potentiate its antagonism.10 In mice, the level of expression of genes induced by E2 in bone were, on average, 85% higher in the absence of ERβ than in its presence, thereby suggesting that ERβ has an opposing effect on ERα-mediated gene transcription.11

    In some organs, ERα and ERβ are expressed at similar levels, sometimes in different cell types within the same organ, whereas in others, one or the other subtype predominates. ERα is predominantly expressed in the uterus, prostate (stroma), ovary (theca cells), testes (Leydig cells), epididymis, bone, breast, liver, kidney, white adipose tissue, and various regions of the brain. ERβ is predominantly expressed in the colon, prostate (epithelium), testis, ovary (granulosa cells), bone marrow, salivary gland, vascular endothelium, lung, bladder, and certain regions of the brain (Figure 3).1,4

    In summary, the metabolic findings in knockout mice and in aromatase-deficient or ERα-deficient patients, and the use of ER subtype-selective ligands, suggest a major role for ERα in the maintenance of metabolic control. ERβ may, however, have an opposite effect, especially when unopposed, resulting in a perturbed energy balance and an increased risk for the development of diabetes. Unopposed ERβ activity is a possible explanation for the diabetic phenotype of the male patient with homozygous loss of ERα function. Both ER subtypes are reported to have roles in the prevention of atherosclerotic lesion development, although seemingly through different mechanisms.

    SERMs such as tamoxifen and raloxifene and the pure antagonist ICI 182,780, however, antagonize the neuroprotective effects of E2 after experimentally induced ischemia.36

    Note: It seems likely to me that in general oral raloxifene would not cause gynoid fat distribution due to its ERα antagonist and ERα-mediated anti-lipolytic pathways in subcutaneous fat – I was wrong.

    Studies in the aromatase/αERKO recombinant mouse model confirmed the important role of ERα in the development of the mammary gland. Treatment of ovariectomized rats with the ERβ-selective agonist ERB-041 resulted in no observable effects on rat mammary tissue, suggesting that ERβ-selective agonists are nonmammotrophic.1

    In summary, estrogens are of fundamental importance in the development of the mammary gland, and ERα is the primary ER subtype mediating the effects of estrogens. ERβ, however, may play an important role in controlling the mammotrophic effects of ERα and may be an important novel target for endocrine therapy in breast cancer.

    In summary, tissues of the urogenital tract are dependent on estrogens for proper growth, development, and functional integrity. ERα is uterotrophic and mediates uterine proliferative responses to E2. It is also the ER subtype that plays the most important role in the feedback on the hypothalamic–pituitary–gonadal axis and the regulation of LH and follicle-stimulating hormone levels. ERβ has an important role in folliculogenesis and ovulation and may have very important therapeutic implications in the diseased prostate, as a drug target in benign prostatic hyperplasia and in both castrate-responsive and castrateresistant prostate cancer.

    Greene (2000)

    Greene, G. (2000). Comparative Structural Analysis of ERa and ERb Bound to Selective Estrogen Agonists and Antagonists. Chicago: The University of Chicago. [Google Scholar] [URL] [PDF]:

    The structures of the LBD complexed with E2 and RAL show that, although both ligands bind at the same site within the core of the LBD (Brzozowski et al. 1997), each of these ligands induces a different conform”ation of helix 12. Whereas helix 12 in the E2-LBD complex packs against helices 3, 5/6, and 11 in a conformation that has been observed for the corresponding helix in other agonist-bound NR LBD structures, helix 12 in the RAL-LBD complex is bound in a hydrophobic groove composed of residues from helices 3 and 5. This alternative orientation of helix 12 partially buries residues in the groove that are necessary for AF-2 activity, suggesting that RAL and possibly other antagonists block AF-2 function by disrupting the topography of the AF-2 surface.

    Shiau et al. (1998)

    Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998). The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen. Cell, 95(7), 927–937. [DOI:10.1016/s0092-8674(00)81717-1]:

    Several proteins, including SRC-1/N-CoA1 (Onate et al., 1995; Kamei et al., 1996), GRIP1/TIF2/N-CoA2 (Hong et al., 1996; Voegel et al., 1996; Torchia et al., 1997;), p/CIP/RAC3/ACTR/AIB1 (Anzick et al., 1997; Chen et al., 1997; Li et al., 1997; Torchia et al., 1997), and CBP/ p300 (Hanstein et al., 1996), associate in a ligand-dependent manner with the ERa. These proteins have been classified as transcriptional coactivators because they enhance ligand-dependent transcriptional activation by the ERa as well as by several other NRs (Horwitz et al., 1996; Glass et al., 1997). SRC-1 and GRIP1 bind to the agonist-bound LBDs of both the human thyroid receptor b (TRb) and human ERa using the putative AF-2 interaction surface (Feng et al., 1998). Members of the p160 family of coactivators, such as SRC-1 and GRIP1, as well as other coactivators, recognize agonist-bound NR LBDs through a short signature sequence motif, LXXLL (where L is leucine and X is any amino acid), known as the NR box (Le Douarin et al., 1996; Heery et al., 1997; Torchia et al., 1997; Ding et al., 1998). Mutagenesis studies indicate that the affinity of coactivators for NR LBDs is determined principally, if not exclusively, by these NR boxes (Le Douarin et al., 1996; Heery et al., 1997; Torchia et al., 1997; Ding et al., 1998).

    Rambhatla, Mills, & Rajfer (2016)

    Rambhatla, A., Mills, J. N., & Rajfer, J. (2016). The Role of Estrogen Modulators in Male Hypogonadism and Infertility. Reviews in Urology, 18(2), 66–72. [PubMed] [PubMed Central] [DOI:10.3909/riu0711]:

    To circumvent the inhibition of LH and FSH from the pituitary by exogenous testosterone, a common strategy used by male reproductive and sexual medicine specialists, in which the goal is to increase testosterone levels while maintaining spermatogenesis, is to use SERMs and/or AIs instead of exogenous testosterone.

    Clomiphene citrate works as an estrogen antagonist at the level of the pituitary gland and thus stimulates the release of LH and FSH, which in turn drives both the steroidogenic and spermatogenic functions of the testes.

    Other studies have also found that aside from improvement in serum testosterone levels, clomiphene therapy also leads to significant improvement in bone mineral density, as well as androgen deficiency in the aging male (ADAM) scores without any significant adverse events.

    Tamoxifen citrate is another oral SERM that was approved in the 1970s for the treatment of breast cancer. It has tissue specific action and acts as an estrogen receptor blocker in breast tissue and exhibits agonistic properties in the bone and uterus.9 Although its use is primarily in women, in men’s health it is used off-label and acts as an estrogen antagonist in the hypothalamus and pituitary gland.23 Because of its mechanism of action, tamoxifen results in the inhibition of the negative feedback of estrogen at the hypothalamus and pituitary gland, and results in the release of LH and FSH, which in turn increases testosterone biosynthesis and “stimulates” spermatogenesis.

    Tsourdi and colleagues23 looked at the effects of three SERMs—tamoxifen, toremifine, and raloxifene—on the hypothalamic-pituitary axis in men with oligospermia. They found that after 3 months of treatment with each of these SERMs, there was a statistically significant increase in serum gonadotropins, testosterone, and semen parameters.

    Tamoxifen, given its estrogen antagonist properties in the breast, as well as AIs, has also been used in the treatment of gynecomastia. Much of the data stem from boys with pubertal gynecomastia and in men with prostate cancer on antiandrogen therapy; there is evidence that these medications are effective in the treatment of gynecomastia.43-45 Their use in the treatment of gynecomastia induced by exogenous testosterone therapy is largely anecdotal and not evidence based.46 However, the manipulation of estrogen levels in men may not be without consequences. We know that estrogen receptors are present throughout the body and play a role in bone health, body composition, cardiovascular well being, libido and sexual function, and testicular steroidogenesis and spermatogenesis.47-49 Although a high estradiol level may have a negative impact on fertility, a level that is excessively low may not be desirable either.

    Kunath et al. (2012)

    Kunath, F., Keck, B., Antes, G., Wullich, B., & Meerpohl, J. J. (2012). Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Medicine, 10(1), 96. [DOI:10.1186/1741-7015-10-96]:

    Our results suggest that tamoxifen has a beneficial effect if compared to no treatment for the prevention of breast events. However, not all patients need prophylaxis to prevent the development of breast events induced by non-steroidal antiandrogen therapy [26,27], and not all patients with gynecomastia require treatment [28]. Therefore, a patient-oriented, pragmatic approach appears reasonable. This approach was also proposed by van Poppel and by Di Lorenzo et al. [14,15,27]. Before starting non-steroidal antiandrogen treatment (either with non-steroidal monotherapy or in combination with LHRH analogues), patients should be informed about the likelihood of breast events and about possible prophylactic therapy options. As recommended earlier by Di Lorenzo et al. [14,15], we also suggest that the physician could wait for the occurrence of breast events in selected patients. Prophylaxis should be started only if the patient is afraid of developing gynecomastia or breast pain.

    Jover-Mengual et al. (2017)

    Jover-Mengual, T., Castelló-Ruiz, M., Burguete, M. C., Jorques, M., López-Morales, M. A., Aliena-Valero, A., Jurado-Rodríguez, A., Pérez, S., Centeno, J. M., Miranda, F. J., Alborch, E., Torregrosa, G., & Salom, J. B. (2017). Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol. The Journal of Steroid Biochemistry and Molecular Biology, 171, 296–304. [DOI:10.1016/j.jsbmb.2017.05.001]:

    Note: This shows some variances and similarities in how various estrogen receptor pathways in the brain of mice are with estradiol versus bazedoxifene.

    Simpkins et al. [2] provided the first evidence that estrogens (specifically 17β-estradiol, E2) exerted neuroprotective effects in the now widely used rodent model of AIS, namely the middle cerebral artery occlusion (MCAO) model. The authors suggested that estrogens may be a useful therapy to protect neurons against the damaging effects of stroke.

    Bazedoxifene acetate (BZA) is the first of the third-generation SERMs approved for the treatment of postmenopausal women at risk for, or presenting with, osteoporosis in Europe and Japan [21]. Due to its favorable preclinical effects, BZA has been selected to combine with conjugated estrogens (CE) resulting in CE/BZA as a new progestin-free hormone therapy option for alleviating estrogen deficiency symptoms in postmenopausal women [22]. As for neural tissue, BZA had been reported to prevent neuronal loss in the hippocampus of rats exposed to excitotoxic kainic acid [23], and to decrease the inflammatory response of astrocytes exposed to lipopolysaccharide [24].

    Both BZA and E2 significantly counteracted the ischemia-induced downregulation of ERα mRNA expression in the ipsilateral hemisphere.

    As for the effect of the estrogenic compounds, BZA significantly counteracted the ischemia-induced downregulation of ERβ mRNA expression, while E2 was without significant effect.

    As for the effect of the estrogenic compounds, neither BZA nor E2 had a significant effect on GPER mRNA expression in the ipsilateral hemisphere.

    BZA but not E2 significantly attenuated the ischemia-induced endogenous phosphorylation of ERK1 in the ipsilateral hemisphere (Fig. 6A and B). While p-ERK2 levels were significantly reduced in the ipsilateral hemisphere in animals treated with BZA, there was no significant change in animals treated with E2.

    The hypothesis that the neuroprotective mechanism of the SERM, tamoxifen, could be due to its ability to attenuate apoptotic cell death was first suggested and verified by Wakade et al. [11], and subsequently confirmed by Zou et al. [17]. By contrast, the SERM, raloxifene, has been recently reported to have no effect on the hypoxia-induced increase of caspase-3 activity in cultured hippocampal cells [20]. Therefore, our results lend support to the view that, as in the case of E2, SERMs (specifically BZA) are effective anti-apoptotic drugs in stroke.

    Wibowo et al. (2016)

    Wibowo, E., Pollock, P. A., Hollis, N., & Wassersug, R. J. (2016). Tamoxifen in men: a review of adverse events. Andrology, 4(5), 776–788. [DOI:10.1111/andr.12197]:

    Five RCTs have investigated the effect of tamoxifen on men with infertility, and the ages of the participants ranged between 18 and 44 years old (unspecified in two studies). These men (n = 321) were treated daily with 20 or 30 mg tamoxifen for 3–6 months. Three studies reported minimal or no side effects (AinMelk et al., 1987; Maier & Hienert, 1990; Cakan et al., 2009), one study (Kotoulas et al., 1994) reported three men lost their libido, and another study (Maier & Hienert, 1988) reported gastrointestinal events. From these studies, only three men stopped tamoxifen treatment, but the reason was not specified.

    Studies in women indicate that genetic variants of cytochrome P450 enzymes may be associated with the presence and severity of tamoxifen AEs. For example, one study on postmenopausal women with ER-positive breast cancer reported that women with CYP2D6 phenotypes, that either are poor or intermediate metabolizer of tamoxifen, have increased risk of developing hot flashes (Regan et al., 2012). In another study, women who are carriers of a variant of CYP3A4 are more likely to experience severe hot flashes (Baxter et al., 2014). However, to date, it remains unclear whether cytochrome P450 enzymes genetic variations can influence the incidences and severity of such AEs in men.

    Other AEs also seems to occur more frequently in women than in men including gastrointestinal problems, cardiovascular events, musculoskeletal problems, fatigue, and mood disturbances.

    The mechanism(s) to account for the sex difference in tamoxifen AE is/are not understood. However, if this sex difference is real, one possible factor is a difference in activity of cytochrome P450 enzymes that metabolize tamoxifen in the liver (Anderson, 2008; Schmetzer & Florcken, 2012; Spoletini et al., 2012), and thus may influence the bioavailability of more potent tamoxifen metabolites. Furthermore, there may also be sex difference in the distribution of ERs in various organs, as already documented for different brain areas (Kruijver et al., 2003). However, one needs to keep in mind that the low incidence of reported AEs in men on tamoxifen may also be as a result of the fact that these AEs are not thoroughly evaluated in many studies, especially in the non-RCTs. A rigorous assessment of tamoxifen AEs in male populations has yet to be undertaken.

    Kuiper et al. (1997)

    Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J. (1997). Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β. Endocrinology, 138(3), 863–870. [DOI:10.1210/endo.138.3.4979]

    Note: Only skimmed – looked at relative binding affinities (RBAs) and noted no raloxifene – going to search for other new papers with more info on RBAs.

    Rabe et al. (2016)

    Rabe, T., Bruyniks, N., Merkle, E., Hadji, P., Kuhl, H., Ahrendt, H. J., Albring, C., Bitzer, J., Egarter, C., Kiesel, L., König, K., Merki Feld, G., Mueck, A. O., Sänger, N., Windler, E. (2016). Selective Estrogen Receptor Modulators–an Update (Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine [DGGEF] and the German Professional Association of Gynecologists [BVF]). Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 12(4), 287–317. [Google Scholar] [URL] [PDF]:

    It is probable that due to the binding of the SERMs to the ER certain co-factors are activated which, either as co-activators or as co-repressors, lead to different gene activations and deactivations in target tissues. Alternative explanations relate to a different affinity to ER and ER or activation of ER and ER, respectively.

    Receptor Distribution Both ERs are expressed in various tissue types, but there are some notable differences in their expression pattern [4]: – ERα: endometrium, breast cancer cells, stromal cells of the ovary and hypothalamus [5] – ERβ: kidney, brain, bone, heart, lung, intestinal mucosa, prostate, and endothelial cells [6]

    Polymorphism: Various polymorphisms of ERα- and ERβ-gene have been described.

    Various ligands differ in their affinity for the alpha and beta isoforms of the estrogen receptor: – 17-estradiol binds equally well to both receptors – Estrone and raloxifene preferentially bind to the receptor alpha (ERα) – Estriol and genistein preferentially bind to the beta receptor (ERβ)

    Selective estrogen receptor modulators preferably bind to the α- or β-subtype of the receptor. In addition, the different estrogen receptor combinations can react differently to the different ligands, thus tissue-specific agonist and antagonist effects arise [7]. The ratio of the concentration of α- to β-subtype plays a role in certain diseases.

    The concept of selective estrogen receptor modulators is based on the ability to influence the interaction with other ER proteins such as transcriptional co-activators or co-repressors, based on the conformational changes in the ligand-receptor complex which is different between SERMs and estrogen and also different for different SERMs. Since the ratio of co-activators and co-repressors is different in various tissues [9], the same ligand may act as an agonist in one tissue (provided that the co-activators predominate) and as an antagonist in other tissues (where co-repressors dominate).

    Note: Also worth pointing out that it’s tamoxifene’s metabolites that are the active ingredients and should probably have been included here.

    Tamoxifene induces the recruitment of co-repressors to target gene promoters in mammary cells. In endometrial cells, tamoxifene, in contrast to raloxifene, acts like an estrogen by stimulating the recruitment of co-activators to a subset of genes.

    Raloxifene induces the recruitment of co-repressors to target gene promoters in mammary cells [9].

    Raloxifene: Non-genomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene have been found by Simoncini et al (2002) [29]. This pathway might be important to understand the different effects of SERMs on the cardiovascular system.

    [Tamoxifen:] Transcription of E-responsive genes(s) is attenuated because AF2 is inactive, and co-activator binding is attenuated by the T-ER complex; partial agonist activity results from AF1, which remains active in the T-ER complex.

    [New SERM:] Afimoxifene: (4-hydroxytamoxifene) is a selective estrogen receptor modulator which is the active metabolite of tamoxifene [66]. Afimoxifene is a transdermal gel formulation and is being developed by Ascend Therapeutics, Inc. under the trademark TamoGel. Afimoxifene has completed a phase II clinical trial for the treatment of cyclical mastalgia [198].

    Gruber et al. (2002)

    Gruber, C. J., Tschugguel, W., Schneeberger, C., & Huber, J. C. (2002). Production and actions of estrogens. New England Journal of Medicine, 346(5), 340–352. [DOI:10.1056/NEJMra000471]:

    Pickar, Boucher, & Morgenstern (2018)

    Pickar, J. H., Boucher, M., & Morgenstern, D. (2018). Tissue selective estrogen complex (TSEC): a review. Menopause, 25(9), 1033–1045. [DOI:10.1097/gme.0000000000001095]:

    The combination of estrogens and a SERM is sometimes referred to as a tissue selective estrogen complex (TSEC), although this term is not formally recognized by health authorities.

    The question then arose, in the late 1990s, as to whether a combination of SERMs and estrogens might produce estrogen agonist and antagonist effects distinct from that of either component alone and come closer to achieving that goal.54

    A key finding from the preclinical “proof of concept” investigation in ovariectomized rats was that BZA could completely counter CE’s stimulatory effects on the endometrium (based on uterine wet weight) when adequately dosed without attenuating CE’s beneficial effects on vasomotor instability, lipids, or bone,54 which supported clinical evaluation of this combination.

    In a clinical trial of raloxifene 60 mg/d combined with oral 17β-estradiol 1 mg/d (n = 61) compared with raloxifene alone (n = 62) in postmenopausal women with prior HT use, the TSEC combination significantly (P < 0.001) reduced the frequency of VMS compared with baseline and with raloxifene alone.

    It may be possible to create a TSEC combination that uses 17β-estradiol rather than CE in combination with a SERM; however, results cannot be assumed to be comparable to those with CE/BZA without clinical testing. Due to the unique profile of each TSEC, each individual TSEC combination needs to be evaluated separately in clinical studies to identify appropriate doses and assess safety and efficacy.

    Liu, Han, & Smith (2013)

    Liu, S., Han, S. J., & Smith, C. L. (2013). Cooperative Activation of Gene Expression by Agonists and Antagonists Mediated by Estrogen Receptor Heteroligand Dimer Complexes. Molecular Pharmacology, 83(5), 1066–1077. [DOI:10.1124/mol.112.084228]:

    Moreover, antagonist-bound ERs adopt a distinct conformation that enables them to preferentially interact with corepressors rather than coactivators (Huang et al., 2010), thereby reinforcing their negative regulatory properties.

    We demonstrate that ER agonist/antagonist combined treatment can cooperatively activate gene expression through an ER-HLD complex consisting of one receptor monomer bound to agonist and another occupied by antagonist. This cooperative activation of gene expression can be enhanced by an SRC-3 coactivator, and requires both ligand-bound subunits to bind to DNA and both AF-1 domains within the ER-HLD for maximal transcriptional activity. Moreover, ER-HLD complexes can activate transcription in the context of a natural promoter, and taken together, these findings demonstrate that ERs bound to different classes of ligands can form dimers that promote gene expression.

    Crystal structures of the ERα LBDs bound to either E2 or raloxifene reveal that both ligands bind to the same pocket, and that the overall homodimeric arrangement is the same regardless of whether the LBD is agonist- or antagonist-bound.

    Relative to costimulation by agonist/antagonist, the AF-1 domain is important for the partial agonist activity of SERMs such as tamoxifen (McInerney et al., 1996), and SRC-1 can bind to both the AF-1 and AF-2 domains of ERα through the coactivator’s Q-rich region and LXXLL motifs, respectively (Mérot et al., 2004). This raises the possibility that SRC-3 interacts with ER-HLDs through different AF domains on distinct subunits [e.g., AF-2 on agonist-bound ER(GSCKV) and AF-1 on antagonist-bound ER-G521R] to induce maximal transcriptional activity.

    Thornton (2007)

    Thornton, J. (2007). Effect of estrogens on skin aging and the potential role of SERMs. Clinical Interventions in Aging, 2(3), 283–297. [DOI:10.2147/cia.s798]:

    A number of studies have shown that estrogens have many important beneficial and protective roles in skin physiology (reviewed in Thornton 2002, 2005). They have been shown to accelerate cutaneous wound healing (Ashcroft and Ashworth 2003), while a significant number of women notice an improvement in inflammatory skin disorders such as psoriasis during pregnancy (Dunna and Finlay 1989; Boyd et al 1996; Raychaudhuri et al 2003). Estrogens also offer some degree of protection against skin photoaging (Weinstock 1994; Tsukahara et al 2001, 2004) and epidemiological studies indicate that the mortality rates from both non-melanoma skin cancers (Weinstock 1994) and melanoma (Miller and MacNeil 1997) are significantly lower in women.

    Many women report a sudden onset of skin aging several months after menopausal symptoms begin. The menopause causes hypoestrogenism, accelerating age-related deterioration, which results in thinner skin, an increase in number and depth of wrinkles, increased skin dryness, and decreased skin firmness and elasticity (Brincat 2000). Hormone replacement therapy (HRT) has been shown to increase epidermal hydration, skin elasticity, skin thickness (Sator et al 2001), and also reduces skin wrinkles (Phillips et al 2001). Furthermore, the content and quality of collagen and the level of vascularization is enhanced (Brincat et al 1987).

    More recently, specific antibodies have demonstrated ERβ, but not ERα is expressed by dermal fibroblasts in the papillary dermis of human scalp skin in both sexes (Thornton et al 2003), whereas primary cultures of human dermal fibroblasts from female skin have been shown to express both mRNA and protein for ERα and ERβ (Haczynski et al 2002).

    In addition, in female hair follicles the phytoestrogen, genistein inhibits hair shaft elongation to a similar extent as 17β-estradiol. Since genistein preferentially binds to ERβ, this opens the possibility that the inhibition of hair growth in response to 17β-estradiol may be mediated via ERβ rather than ERα (Nelson 2006). Therefore the development of selective estrogen receptor ligands may provide important clinical applications for the prevention and treatment of disorders of hair growth.

    A histopathological assessment of rat skin following subcutaneous administration of tamoxifen observed that tamoxifen treatment resulted in the appearance of abnormal hair follicles, epidermal atrophy and increased dermal fibrosis, particularly around the hair follicles (Inaloz et al 2002). There have been reports of tamoxifen treatment causing diffuse thinning of the hair with moderate receding of the frontal hair line (Ayoub et al 1997) and the development of alopecia on the crown, which was reversed when treatment was stopped.

    We have recently reported that tamoxifen alone has no effect on human hair shaft elongation in organ culture, suggesting it is not an estrogen agonist (Nelson 2006). However, a 10-fold excess of tamoxifen incubated in combination with 17β-estradiol eliminated the inhibitory effect of 17β-estradiol, suggesting that tamoxifen acts as an antagonist of estrogen in the female scalp hair follicle (Nelson 2006).

    Another study has shown that raloxfine has a stronger positive stimulatory effect on collagen biosynthesis than 17β-estradiol (Surazynski et al 2003) and that in contrast to estradiol, raloxifene inhibits the expression of MMP-9.

    Mauvais-Jarvis, Clegg, & Hevener (2013)

    Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]:

    However, tamoxifen treatment is associated with an increased risk of developing fatty liver (steatosis) (337–339), with approximately 43% of breast cancer patients treated with tamoxifen developing hepatic steatosis (339). The exact mechanism by which this occurs is still unclear.

    In the hypothalamus, tamoxifen appears to act as an ER agonist.

    In OVX mice, raloxifene reversed OVX-induced increases in food intake, body weight, fat mass, and hyperleptinemia to an extent similar to that of E2. This suggests that in rodents, raloxifene acts as an ER agonist in hypothalamic neurons and fat (346). In postmenopausal women, raloxifene prevents the shift from android to gynoid fat distribution, increases in abdominal adiposity (347), as well as total increases in adiposity (348). The absence of significant effect on body weight in women (349) could be due to the concomitant increase in lean mass and water after raloxifene treatment (350).

    Nonetheless, in healthy and diabetic postmenopausal women, short-term raloxifene treatment did not impact fasting glucose, glucose tolerance, or indices of-cell function and sensitivity (351, 352). However, it decreased hepatic insulin extraction and, as a result, increased insulin half-life (352). Additionally, in the Multiple Outcomes of Raloxifene Evaluation trial, 3-year raloxifene treatment of postmenopausal women with or without type 2 diabetes reduced total cholesterol and LDL-cholesterol but had no effect on glycemic control compared to placebo (349). Thus, there is no argument for an effect of raloxifene in improving glucose homeostasis in postmenopausal women with type 2 diabetes. In fact, women with a previous history of hypertriglyceridemia who receive oral estrogen therapy are at risk for clinically relevant progression in this existing risk factor during raloxifene therapy.

    In preclinical studies, the TSEC partnering bazedoxifene with CEE seemed to provide these benefits. Thus far, the effect of TSEC partnering bazedoxifene on glucose and energy metabolism is unknown.

    Tommaselli et al. (2006)

    Tommaselli, G. A., Di Carlo, C., Di Spiezio Sardo, A., Bifulco, G., Cirillo, D., Guida, M., Capasso, R., & Nappi, C. (2006). Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause, 13(4), 660–668. [DOI:10.1097/01.gme.0000227335.27996.d8]:

    At the end of the study, untreated women showed increased total and percentage of fat mass and increased serum leptin levels compared with baseline values, whereas women treated with HT showed no significant changes. These data seem to indicate that the main determinant of leptin levels in postmenopausal women is body fat content, whereas hypoestrogenism does not seem to influence these levels.

    Women in group C showed no significant changes in fat mass, in total and at all areas evaluated, after 1 year of treatment with raloxifene (Fig. 1A-D). No significant changes were observed in lean mass, both total and at all areas evaluated (Fig. 2A-D). The same was observed for the percentage of fat mass (Fig. 3A-D).

    We did not detect significant changes in serum leptin levels in subjects in group B and C throughout the study (group B: 16.3 [4.2/39.8] ng/mL vs 17.0 [5.6 /28.7] ng/mL; group C: 15.1 [6.7/26.5] ng/mL vs 17.5 [6.7/29.8] ng/mL).

    The present study, although hampered by the limited sample size, seems to confirm that postmenopausal hypoestrogenism leads to increased fat content and suggests that both raloxifene and tibolone may have a role in preventing the changes of body composition induced by postmenopausal hypoestrogenism.

    Francucci et al. (2005)

    Francucci, C. M., Pantaleo, D., Iori, N., Camilletti, A., Massi, F., & Boscaro, M. (2005). Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation, 28(9), 623–631. [DOI:10.1007/bf03347261]:

    For the first time, our results suggest that RLX, most likely because of its estrogen-agonist action, might prevent the shift to a more central fat dis- tribution associated with menopause. In fact, we have found in RLX-users, in relation to controls, no substantial changes in body weight during the 12 months of treatment, a significant lower fat mass in trunk and abdominal region (ROI-L2-4) and a trend towards higher fat depots in legs. At variance, after 1 yr we observed in untreated post-menopausal women a not significant increase of body weight and fat mass in central and trunk region with a decrease in legs. Therefore, RLX could have, similar to the estrogens, different effects on several regional fat tissues. In fact, in pre-menopausal women the gluteo-femoral adipocytes have a low lipolytic activity with tendency towards larger fat cells in the femoral region, while the adipocytes in the central fat depot have a high basal lipolysis with smaller fat cells (32). Besides, the estrogens would seem to enhance the lipoprotein-lipase (LPL) activity, the key enzyme in the regulation of fatty acid deposi- tion, of gluteofemoral fat cells and to decrease the visceral LPL activity (33).

    Jacobsen et al. (2010)

    Jacobsen, D. E., Samson, M. M., Emmelot-Vonk, M. H., & Verhaar, H. J. (2010). Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial. European Journal of Endocrinology, 162(2), 371–376. [DOI:10.1530/eje-09-0619]:

    Repeated measurement analysis showed there to be a significant increase in FFM at 3, 6, and 12 months in the raloxifene group (P=0.05) as well as an increase in TBW (P=0.02; Table 2). At 12 months, the mean increase in FFM was 0.83 (2.4) kg in the raloxifene group compared with 0.03 (1.5) kg in the placebo group (P=0.05), and the mean increase in TBW was 0.6 (1.8) litres compared with a decrease of 0.06 (1.1) litres in the placebo group (P=0.02).

    In our study, we found an increase in the FFM after supplementation with raloxifene, which could be partly explained by the increase in the TBW content, a known effect of raloxifene supplementation. However, the increase in the TBW content could not explain the whole increase in the FFM, and also the amount of physical activity was comparable between both groups during the study. This means that there is also a real change in body composition with an increase in lean body mass. The results of our study are comparable with some other studies, but in most of these studies there were problems with the design of the study (no blinding, no placebo group, too small groups, and a too short intervention period).

    The increase in FFM was not accompanied by an increase in muscle strength and muscle power in our study. Muscle strength is a key factor in maintaining independence in elderly people. There are no other studies concerning raloxifene and muscle strength or power. Studies concerning HRT (estrogen and progestagens) show conflicting results: two randomized controlled trials with no effect (38, 39) and three randomized controlled trials with significant increase in muscle strength (11–13).

    Komm & Mirkin (2014)

    Komm, B. S., & Mirkin, S. (2014). An overview of current and emerging SERMs. The Journal of Steroid Biochemistry and Molecular Biology, 143, 207–222. [DOI:10.1016/j.jsbmb.2014.03.003]:

    Raloxifene binds with high affinity to ERα, with 46% relative binding affinity for human ERα compared with 17β-estradiol, and with a 26% relative binding affinity for rat ERβ compared with 17β-estradiol

    Note: A lot more on this article but this was the only relevant thing I really cared about at the time.

    Smith & O’Malley (2004)

    Smith, C. L., & O’Malley, B. W. (2004). Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocrine Reviews, 25(1), 45–71. [DOI:10.1210/er.2003-0023]:

    For instance, in the absence of endogenous estrogens, tamoxifen frequently exhibits weak estrogenic activity, such as modest stimulation of uterine wet weight and bone density in ovariectomized rats, whereas in the presence of estradiol, it can serve as an antiestrogen, inhibiting responses to a level corresponding to the comparatively modest agonist activity of tamoxifen itself.

    However, because neither tamoxifen nor raloxifene possesses significant estrogen-like activity in the CNS, there is clearly a market for other SERMs to fill this niche.

    It is also noteworthy that SERMs likely exist in nature. For instance, the estrone metabolite, Δ8,9- dehydroestrone sulfate suppresses hot flushes in postmenopausal women, an estrogenic action. However, it is unable to significantly affect certain other parameters associated with estrogenic responses such as total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol (23).

    […] raloxifene and 4HT block the ligand-activated AF-2 domain and particularly in the case of 4HT, leave AF-1 able to initiate gene expression.

    As a result, 4HT and raloxifene stimulate gene expression in some, but not all, contexts, and these antiestrogens are therefore classified as SERMs.

    For ER, 4HT and raloxifene also inhibit its AF-2 domain, and due to the relatively poor AF-1 activity of the receptor, these ligands generally block ER transcriptional activity measured on EREs (61, 78, 79).

    It should be noted that 4HT and raloxifene also exert effects on the transcriptional activity of both ER and ER tethered to DNA indirectly through interaction with other transcription factors such as activator protein 1 (AP-1) and Sp1 (80, 81). In this context, the agonist activities of these ligands also is apparent in a cell-specific manner.

    For ERE-dependent gene expression, tamoxifen is a partial agonist of ER but is generally unable to stimulate ER transcriptional activity (61, 171, 173). Conversely, when assessing ER activity on AP-1 containing reporter genes, tamoxifen will stimulate ER and ER transcriptional activity.

    Carneiro, de Cassia de Maio Dardes, & Haidar (2012)

    Carneiro, A. L., de Cassia de Maio Dardes, R., & Haidar, M. A. (2012). Estrogens plus raloxifene on endometrial safety and menopausal symptoms—semisystematic review. Menopause, 19(7), 830–834. [DOI:10.1097/gme.0b013e31824a74ce]:

    Most of the studies found a benefit profile with association of RLX and E on women’s quality of life, satisfaction with the treatment, and vaginal dryness. Nevertheless, different qualityof-life scales and visual scales were used to access mainly vasomotor symptoms, which could limit further comparison.

    Arevalo et al. (2010)

    Arevalo, M. A., Santos-Galindo, M., Lagunas, N., Azcoitia, I., & Garcia-Segura, L. M. (2010). Selective estrogen receptor modulators as brain therapeutic agents. Journal of Molecular Endocrinology, 46(1), R1–R9. [DOI:10.1677/jme-10-0122]:

    The neuroprotective actions of tamoxifen and raloxifene, two SERMs that are currently used in clinical practice for the treatment of breast cancer and osteoporosis, have been assessed in different experimental models of neural dysfunction. These include animal models of traumatic injury of the central nervous system and peripheral nerves, stroke, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, cognitive decline, and mood disorders (Fig. 1). This section is a succinct description of the main findings of these experimental studies, including the limited available information from human studies.

    In spite of the neuroprotective actions of tamoxifen in different forms of neural injury, it is unclear whether this molecule may have some benefits for cognition in humans. Indeed, several studies suggest an increased risk of cognitive impairment in women receiving tamoxifen for the treatment of breast cancer, including worse performance in visual memory, word fluency, immediate verbal memory, visuospatial ability, and processing speed tasks (Paganini-Hill & Clark 2000, Shilling et al. 2003, Palmer et al. 2008, Phillips et al. 2010, Schilder et al. 2010). However, other studies have not detected a significant effect of tamoxifen on cognition (Debess et al. 2010).

    In contrast to the potential negative effects of tamoxifen on cognition, the results of the multiple outcomes of raloxifene evaluation randomized trial suggest that raloxifene prevents cognitive decline in postmenopausal women (Yaffe et al. 2005). The results of a recent randomized, double-blind, placebo-controlled trial also suggest that raloxifene improves verbal memory in late postmenopausal women ( Jacobsen et al. 2010). In addition, raloxifene treatment enhances brain activation during performance on a face-encoding paradigm and during recognition of familiar items in healthy elderly men.

    In agreement with this possibility, we have recently observed that both tamoxifen and raloxifene improve hippocampus-dependent memory in androgen-deprived male rats (N Lagunas, I Calmarza-Font, D Grassi & LM Garcia-Segura, unpublished observations).

    Tamoxifen reduces amphetamine-induced manic-like behavioral alterations in rats (Einat et al. 2007) and reduces acute manic episodes in women with bipolar affective disorder (Kulkarni et al. 2006, Zarate et al. 2007). Raloxifene reduces anxiety behavior, assessed in the elevated plus maze test, on ovariectomized rats (Walf & Frye 2010) and decreases anxiety (Strickler et al. 2000, Florio et al. 2001) and depression (Carranza-Lira et al. 2004, Grigoriadis et al. 2005, Sugiyama et al. 2007) in postmenopausal women. Recent clinical studies also suggest the potential application of raloxifene hydrochloride (120 mg/day oral) for the treatment of postmenopausal women with schizophrenia.

    Other neuroprotective mechanisms of SERMs are mediated by classical ERs, since they are inhibited by ER antagonists, such as ICI 182 780 (Zhang et al. 2009). The neuroprotective signaling of SERMs may involve the activation of kinases, such as mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K), and Akt (Du et al. 2004, Lee et al. 2009a,b), and the phosphorylation of CREB (Sharma et al. 2007) or the inhibition of nuclear factor (NF)-kB-induced transcription (Cerciat et al. 2010). Through these mechanisms, SERMs control synaptic transmission and the expression of molecules involved in the regulation of cell death, oxidative stress, and inflammation.

    Raloxifene may also regulate opiate and GABAergic neurotransmission by the modulation of the levels of b-endorphin and neuroactive steroids respectively. Chronic raloxifene administration to postmeInopausal women increases plasma levels of b-endorphin and tetrahydroprogesterone (allopregnanolone), an anxiolytic metabolite of progesterone that modulates GABAA receptors.

    These findings suggest that raloxifene may regulate synaptic function by the modulation of local levels of neuroactive substances within the brain.

    In general, there is still poor knowledge of the precise molecular targets of SERMs in the nervous system. Although some key molecules have been identified, such as MAPK, PI3K/Akt, CREB, and NF-kB, the molecular mechanisms involved in the neuroprotective actions of SERMs should be investigated with more detail in the different cellular populations of the nervous system.

    Lawrence et al. (2004)

    Lawrence, S. E., Arnold Faught, K., Vethamuthu, J., & Lawson, M. L. (2004). Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. The Journal of Pediatrics, 145(1), 71–76. [DOI:10.1016/j.jpeds.2004.03.057]:

    Results: Mean (SD) age of treated subjects was 14.6 (1.5) years with gynecomastia duration of 28.3 (16.4) months. Mean reduction in breast nodule diameter was 2.1 cm (95% CI 1.7, 2.7, P < .0001) after treatment with tamoxifen and 2.5 cm (95% CI 1.7, 3.3, P < .0001) with raloxifene. Some improvement was seen in 86% of patients receiving tamoxifen and in 91% receiving raloxifene, but a greater proportion had a significant decrease (>50%) with raloxifene (86%) than tamoxifen (41%). No side effects were seen in any patients.

    Surazynski et al. (2003)

    Surazynski, A., Jarzabek, K., Haczynski, J., Laudanski, P., Palka, J., & Wolczynski, S. (2003). Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. International Journal of Molecular Medicine, 12(5), 803–809. [DOI:10.3892/ijmm.12.5.803]:

    Raloxifene had stronger positive stimulative effects on collagen biosynthesis, through different biochemical mechanisms, than estradiol in human skin fibroblasts and might reverse some of the postmenopausal changes in skin or connective tissue. Increase of collagen synthesis induced by raloxifene may be activated by both estrogen receptor dependent and independent pathways such as up-regulation of estrogen receptors, up-regulation of IGF receptor, transcriptional regulation of collagen genes by estrogen receptor-raloxifene complex, increasing of prolidase activity or finally by inhibition of MMP-9 expression.

    \ No newline at end of file +Sources/Excerpts: A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy - Transfeminine Science Link

    Sources/Excerpts: A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy

    By Lain | First published October 5, 2019 | Last modified June 3, 2021

    Preface

    This page is a sources and excerpts supplement to the main article which can be found here.

    Maximov, Lee, & Jordan (2013)

    Maximov, P. Y., Lee, T. M., & Jordan, V. C. (2013). The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice. Current Clinical Pharmacology, 8(2), 135–155. [DOI:10.2174/1574884711308020006]:

    However, although these SERMs have many benefits, they also have some potentially serious adverse effects, such as thromboembolic disorders and, in the case of tamoxifen, uterine cancer. These adverse effects represent a major concern given that long-term therapy is required to prevent osteoporosis or prevent and treat breast cancer.

    The search for the ‘ideal’ SERM, which would have estrogenic effects on bone and serum lipids, neutral effects on the uterus, and antiestrogenic effects on breast tissue, but none of the adverse effects associated with current therapies, is currently under way.

    Note: Serum lipids are like HDL/LDL cholesterol.

    There are two ERs referred to as α and β [82-84]. Each receptor protein is encoded on different chromosomes, and have homology as members of the steroid receptor superfamily. There are distinct patterns of distribution and distinct and subtle differences in structure and ligand binding affinity [85]. The ratio of ERα and ERβ at a target site may be an additional dimension for tissue modulation. A high ERα: ERβ ratio correlates well with high levels of cellular proliferation whereas the predominance of functional ERβ over ERα correlates with repression of proliferation [86-89]. Indeed, the ratio of ERs in normal and neoplasic breast tissue could be important for the long-term success of chemoprevention with SERMs.

    Kraichely and co-workers [97] demonstrated the important observation that agonists for ERα and ERβ produce subtle quantitative differences with the interaction of members of the SRC family (SRC 1, 2 and 3) and that the coactivator can enhance ligand affinity for the ER.

    Evidence has now accumulated to document that the broad spectrum of ligands that bind to the ER can create a broad range of ER complexes that are either fully estrogenic or antiestrogenic at a particular target site [100]. Thus a mechanistic model of estrogen action and antiestrogen action (Fig. 2) has emerged based on the shape of the ligand that programs the complex for future action.

    Thus for effective gene transcription, programmed and targeted by the shape and phosphorylation status of the ER and coactivators, a dynamic and cyclic process of remodeling capacity is required for transcriptional assembly [103] that is immediately followed by the routine destruction of transcription complexes by the proteasome. Estrogen and SERM-ER complexes have distinct accumulation patterns in the target cell nucleus [104,105] because they are destroyed at different rates.

    Raloxifene lacks estrogenic activity in the uterus and has not demonstrated tamoxifen-like effects in the uterus either histopathologically or ultrasonographically [116], but it has been associated with adverse effects such as VTE and vasomotor symptoms, including hot flushes.

    Perhaps the reason for this difference in effect is related to differences on the agents’ effect on inflammation as the agents influence C-reactive protein (CRP) differently. Estrogen and tibolone increase levels of CRP [192], raloxifene and arzoxifene have no effect on CRP levels, and lasofoxifene decreases CRP levels [55]. All decrease LDL levels.

    Brzozowski et al. (1997)

    Brzozowski, A. M., Pike, A. C., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Ohman, L., Greene, G. L., Gustafsson, J. A., & Carlquist, M. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature, 389(6652), 753–758. [DOI:10.1038/39645]:

    The overall architecture of the ER LBD (helices H3–H12) is similar to that seen in the crystal structures of other nuclear receptor LBDs6–8, and emphasizes the universal nature of this fold within this receptor superfamily9. The LBD is folded into a three-layered antiparallel a-helical sandwich comprising a central core layer of three helices (H5/6, H9 and H10) sandwiched between two additional layers of helices (H1–4 and H7, H8, H11). This helical arrangement creates a ‘wedge-shaped’ molecular scaffold that maintains a sizeable ligandbinding cavity at the narrower end of the domain. The remaining secondary structural elements, a small two-stranded antiparallel β-sheet (S1 and S2) and H12, are located at this ligand-binding portion of the molecule, and flank the main three-layered motif (Fig. 1a).

    E2 binds diagonally across the cavity between H11, H3 and H6 and adopts a low-energy conformation. The phenolic hydroxyl of the A-ring (O3; see Fig. 2c for atom numbering) nestles between H3 and H6 and makes direct hydrogen bonds to the carboxylate of Glu 353, the guanidinium group of Arg 394, and a water molecule. The 17-β hydroxyl (O17) of the Dring makes a single hydrogen bond with His 524 in H11. The remainder of the molecule participates in a number of hydrophobic contactsthat are concentrated overthe A, A/B interface and D-rings.

    The ER is unique among the steroid receptors in its ability to embrace a wide variety of non-steroidal compounds. Although the ‘pincer-like’ arrangement around the A-ring imposes an absolute requirement on effective ligands to contain an aromatic ring, the remainder of the binding pocket can accept a number of different hydrophobic groups12,13. This overall promiscuity can be attributed to the size of the cavity, which has a probe accessible volume (450 A˚3) nearly twice that of E2’s molecular volume (245 A˚3). The length and breadth of the E2 skeleton is well matched by the receptor, but there are large unoccupied cavities opposite the α face of the B-ring and the β face of the C-ring (Fig. 2a). The positions of these preformed cavities are similar to those predicted from binding studies12.

    Note: This may be why things like bisphenol A (BPA) and other random chemicals bind to the estrogen receptor.

    Rosano et al. (2011)

    Rosano, C., Stec-Martyna, E., Lappano, R., & Maggiolini, M. (2011). Structure-Based Approach for the Discovery of Novel Selective Estrogen Receptor Modulators. Current Medicinal Chemistry, 18(8), 1188–1194. [DOI:10.2174/092986711795029645]:

    These two zinc fingers are responsible for the binding of ERα to the estrogen response elements (EREs) located in the promoter regions of target genes. The P-box sequence is identical in the two ER isoforms, suggesting that ERα and ERβ bind EREs with similar specificity and affinity.

    Pure anti-estrogen development has also included a further class of molecules represented by the inhibitors of aromatase enzymatic activity, which increases estrogen availability at tissue levels converting androgens into estrogens.

    4OHT binds to ERs within the same binding pocket that recognises E2 and produces a nuclear complex which decreases DNA synthesis and inhibits the action of estrogens [24]. Moreover, the complex between ER and 4OHT recruits co-repressor proteins like NCoR and SMRT, which contribute to the antagonist effects of 4OHT [78].

    In particular, the position of H12 shifts from the ligand binding pocket to cover a part of the co-activator binding groove, which is formed by residues belonging to H3, H4 and H5 [24]. The receptor recognition of 4OHT is dictated by the phenolic “A ring” and the bulky side chain.

    […] whilst the bulky side chain protruding from the binding cavity displaces H12 and allows a conformation that inhibits the coactivator recruitment.

    1ERR - raloxifene / er_alpha pddb. 1ERE [ estradiol / er_alpha pddb.

    Next, the long hydrophobic side chain of RAL makes extensive contacts with the hydrophobic residues of the receptor allowing the displacement of H12 similar to 4OHT.

    Comparable to other SERMs, Lasofoxifene diverts the receptor from its agonistbound conformation by displacing the C-terminal AF-2 helix 12 into the site at which the LXXLL motif of coactivator proteins would otherwise be able to bind. LAS achieves this effect by occupying the space normally filled by residue Leu540, as well as by modulating the conformation of residues of helix 11.

    In addition to these features of SERM recognition, a large alkyl “pendant” side chain, terminating in a pyrollidine head group, threads its way from the ligand-binding pocket out toward the surface of the protein, where it directly interferes with the correct positioning of the AF-2 helix.

    Nilsson & Gustafsson (2010)

    Nilsson, S., & Gustafsson, J. (2010). Estrogen Receptors: Therapies Targeted to Receptor Subtypes. Clinical Pharmacology & Therapeutics, 89(1), 44–55. [DOI:10.1038/clpt.2010.226]:

    Like other members of the nuclear receptor family, the ERs are best known as transcription factors, regulating the transcriptional activity of target genes in cells in response to the natural hormone 17β-estradiol (E2) or to synthetic nonhormonal agonists and antagonists1 (Figure 1). In more recent years, we have also learned that the effects of E2 can have a very rapid onset, within seconds to minutes. These effects may be mediated by membrane-localized ERα and ERβ, respectively (after exposure to ligand stimuli), or by membrane receptors that are genetically and structurally unrelated to ERα and ERβ, for example, GPR30 (G-protein coupled receptor 30).

    An increase in the expression of ERβ relative to ERα was shown to inhibit the ERα response to E2, silence the partial ERα-mediated agonism of tamoxifen, and potentiate its antagonism.10 In mice, the level of expression of genes induced by E2 in bone were, on average, 85% higher in the absence of ERβ than in its presence, thereby suggesting that ERβ has an opposing effect on ERα-mediated gene transcription.11

    In some organs, ERα and ERβ are expressed at similar levels, sometimes in different cell types within the same organ, whereas in others, one or the other subtype predominates. ERα is predominantly expressed in the uterus, prostate (stroma), ovary (theca cells), testes (Leydig cells), epididymis, bone, breast, liver, kidney, white adipose tissue, and various regions of the brain. ERβ is predominantly expressed in the colon, prostate (epithelium), testis, ovary (granulosa cells), bone marrow, salivary gland, vascular endothelium, lung, bladder, and certain regions of the brain (Figure 3).1,4

    In summary, the metabolic findings in knockout mice and in aromatase-deficient or ERα-deficient patients, and the use of ER subtype-selective ligands, suggest a major role for ERα in the maintenance of metabolic control. ERβ may, however, have an opposite effect, especially when unopposed, resulting in a perturbed energy balance and an increased risk for the development of diabetes. Unopposed ERβ activity is a possible explanation for the diabetic phenotype of the male patient with homozygous loss of ERα function. Both ER subtypes are reported to have roles in the prevention of atherosclerotic lesion development, although seemingly through different mechanisms.

    SERMs such as tamoxifen and raloxifene and the pure antagonist ICI 182,780, however, antagonize the neuroprotective effects of E2 after experimentally induced ischemia.36

    Note: It seems likely to me that in general oral raloxifene would not cause gynoid fat distribution due to its ERα antagonist and ERα-mediated anti-lipolytic pathways in subcutaneous fat – I was wrong.

    Studies in the aromatase/αERKO recombinant mouse model confirmed the important role of ERα in the development of the mammary gland. Treatment of ovariectomized rats with the ERβ-selective agonist ERB-041 resulted in no observable effects on rat mammary tissue, suggesting that ERβ-selective agonists are nonmammotrophic.1

    In summary, estrogens are of fundamental importance in the development of the mammary gland, and ERα is the primary ER subtype mediating the effects of estrogens. ERβ, however, may play an important role in controlling the mammotrophic effects of ERα and may be an important novel target for endocrine therapy in breast cancer.

    In summary, tissues of the urogenital tract are dependent on estrogens for proper growth, development, and functional integrity. ERα is uterotrophic and mediates uterine proliferative responses to E2. It is also the ER subtype that plays the most important role in the feedback on the hypothalamic–pituitary–gonadal axis and the regulation of LH and follicle-stimulating hormone levels. ERβ has an important role in folliculogenesis and ovulation and may have very important therapeutic implications in the diseased prostate, as a drug target in benign prostatic hyperplasia and in both castrate-responsive and castrateresistant prostate cancer.

    Greene (2000)

    Greene, G. (2000). Comparative Structural Analysis of ERa and ERb Bound to Selective Estrogen Agonists and Antagonists. Chicago: The University of Chicago. [Google Scholar] [URL] [PDF]:

    The structures of the LBD complexed with E2 and RAL show that, although both ligands bind at the same site within the core of the LBD (Brzozowski et al. 1997), each of these ligands induces a different conform”ation of helix 12. Whereas helix 12 in the E2-LBD complex packs against helices 3, 5/6, and 11 in a conformation that has been observed for the corresponding helix in other agonist-bound NR LBD structures, helix 12 in the RAL-LBD complex is bound in a hydrophobic groove composed of residues from helices 3 and 5. This alternative orientation of helix 12 partially buries residues in the groove that are necessary for AF-2 activity, suggesting that RAL and possibly other antagonists block AF-2 function by disrupting the topography of the AF-2 surface.

    Shiau et al. (1998)

    Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998). The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen. Cell, 95(7), 927–937. [DOI:10.1016/s0092-8674(00)81717-1]:

    Several proteins, including SRC-1/N-CoA1 (Onate et al., 1995; Kamei et al., 1996), GRIP1/TIF2/N-CoA2 (Hong et al., 1996; Voegel et al., 1996; Torchia et al., 1997;), p/CIP/RAC3/ACTR/AIB1 (Anzick et al., 1997; Chen et al., 1997; Li et al., 1997; Torchia et al., 1997), and CBP/ p300 (Hanstein et al., 1996), associate in a ligand-dependent manner with the ERa. These proteins have been classified as transcriptional coactivators because they enhance ligand-dependent transcriptional activation by the ERa as well as by several other NRs (Horwitz et al., 1996; Glass et al., 1997). SRC-1 and GRIP1 bind to the agonist-bound LBDs of both the human thyroid receptor b (TRb) and human ERa using the putative AF-2 interaction surface (Feng et al., 1998). Members of the p160 family of coactivators, such as SRC-1 and GRIP1, as well as other coactivators, recognize agonist-bound NR LBDs through a short signature sequence motif, LXXLL (where L is leucine and X is any amino acid), known as the NR box (Le Douarin et al., 1996; Heery et al., 1997; Torchia et al., 1997; Ding et al., 1998). Mutagenesis studies indicate that the affinity of coactivators for NR LBDs is determined principally, if not exclusively, by these NR boxes (Le Douarin et al., 1996; Heery et al., 1997; Torchia et al., 1997; Ding et al., 1998).

    Rambhatla, Mills, & Rajfer (2016)

    Rambhatla, A., Mills, J. N., & Rajfer, J. (2016). The Role of Estrogen Modulators in Male Hypogonadism and Infertility. Reviews in Urology, 18(2), 66–72. [PubMed] [PubMed Central] [DOI:10.3909/riu0711]:

    To circumvent the inhibition of LH and FSH from the pituitary by exogenous testosterone, a common strategy used by male reproductive and sexual medicine specialists, in which the goal is to increase testosterone levels while maintaining spermatogenesis, is to use SERMs and/or AIs instead of exogenous testosterone.

    Clomiphene citrate works as an estrogen antagonist at the level of the pituitary gland and thus stimulates the release of LH and FSH, which in turn drives both the steroidogenic and spermatogenic functions of the testes.

    Other studies have also found that aside from improvement in serum testosterone levels, clomiphene therapy also leads to significant improvement in bone mineral density, as well as androgen deficiency in the aging male (ADAM) scores without any significant adverse events.

    Tamoxifen citrate is another oral SERM that was approved in the 1970s for the treatment of breast cancer. It has tissue specific action and acts as an estrogen receptor blocker in breast tissue and exhibits agonistic properties in the bone and uterus.9 Although its use is primarily in women, in men’s health it is used off-label and acts as an estrogen antagonist in the hypothalamus and pituitary gland.23 Because of its mechanism of action, tamoxifen results in the inhibition of the negative feedback of estrogen at the hypothalamus and pituitary gland, and results in the release of LH and FSH, which in turn increases testosterone biosynthesis and “stimulates” spermatogenesis.

    Tsourdi and colleagues23 looked at the effects of three SERMs—tamoxifen, toremifine, and raloxifene—on the hypothalamic-pituitary axis in men with oligospermia. They found that after 3 months of treatment with each of these SERMs, there was a statistically significant increase in serum gonadotropins, testosterone, and semen parameters.

    Tamoxifen, given its estrogen antagonist properties in the breast, as well as AIs, has also been used in the treatment of gynecomastia. Much of the data stem from boys with pubertal gynecomastia and in men with prostate cancer on antiandrogen therapy; there is evidence that these medications are effective in the treatment of gynecomastia.43-45 Their use in the treatment of gynecomastia induced by exogenous testosterone therapy is largely anecdotal and not evidence based.46 However, the manipulation of estrogen levels in men may not be without consequences. We know that estrogen receptors are present throughout the body and play a role in bone health, body composition, cardiovascular well being, libido and sexual function, and testicular steroidogenesis and spermatogenesis.47-49 Although a high estradiol level may have a negative impact on fertility, a level that is excessively low may not be desirable either.

    Kunath et al. (2012)

    Kunath, F., Keck, B., Antes, G., Wullich, B., & Meerpohl, J. J. (2012). Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Medicine, 10(1), 96. [DOI:10.1186/1741-7015-10-96]:

    Our results suggest that tamoxifen has a beneficial effect if compared to no treatment for the prevention of breast events. However, not all patients need prophylaxis to prevent the development of breast events induced by non-steroidal antiandrogen therapy [26,27], and not all patients with gynecomastia require treatment [28]. Therefore, a patient-oriented, pragmatic approach appears reasonable. This approach was also proposed by van Poppel and by Di Lorenzo et al. [14,15,27]. Before starting non-steroidal antiandrogen treatment (either with non-steroidal monotherapy or in combination with LHRH analogues), patients should be informed about the likelihood of breast events and about possible prophylactic therapy options. As recommended earlier by Di Lorenzo et al. [14,15], we also suggest that the physician could wait for the occurrence of breast events in selected patients. Prophylaxis should be started only if the patient is afraid of developing gynecomastia or breast pain.

    Jover-Mengual et al. (2017)

    Jover-Mengual, T., Castelló-Ruiz, M., Burguete, M. C., Jorques, M., López-Morales, M. A., Aliena-Valero, A., Jurado-Rodríguez, A., Pérez, S., Centeno, J. M., Miranda, F. J., Alborch, E., Torregrosa, G., & Salom, J. B. (2017). Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol. The Journal of Steroid Biochemistry and Molecular Biology, 171, 296–304. [DOI:10.1016/j.jsbmb.2017.05.001]:

    Note: This shows some variances and similarities in how various estrogen receptor pathways in the brain of mice are with estradiol versus bazedoxifene.

    Simpkins et al. [2] provided the first evidence that estrogens (specifically 17β-estradiol, E2) exerted neuroprotective effects in the now widely used rodent model of AIS, namely the middle cerebral artery occlusion (MCAO) model. The authors suggested that estrogens may be a useful therapy to protect neurons against the damaging effects of stroke.

    Bazedoxifene acetate (BZA) is the first of the third-generation SERMs approved for the treatment of postmenopausal women at risk for, or presenting with, osteoporosis in Europe and Japan [21]. Due to its favorable preclinical effects, BZA has been selected to combine with conjugated estrogens (CE) resulting in CE/BZA as a new progestin-free hormone therapy option for alleviating estrogen deficiency symptoms in postmenopausal women [22]. As for neural tissue, BZA had been reported to prevent neuronal loss in the hippocampus of rats exposed to excitotoxic kainic acid [23], and to decrease the inflammatory response of astrocytes exposed to lipopolysaccharide [24].

    Both BZA and E2 significantly counteracted the ischemia-induced downregulation of ERα mRNA expression in the ipsilateral hemisphere.

    As for the effect of the estrogenic compounds, BZA significantly counteracted the ischemia-induced downregulation of ERβ mRNA expression, while E2 was without significant effect.

    As for the effect of the estrogenic compounds, neither BZA nor E2 had a significant effect on GPER mRNA expression in the ipsilateral hemisphere.

    BZA but not E2 significantly attenuated the ischemia-induced endogenous phosphorylation of ERK1 in the ipsilateral hemisphere (Fig. 6A and B). While p-ERK2 levels were significantly reduced in the ipsilateral hemisphere in animals treated with BZA, there was no significant change in animals treated with E2.

    The hypothesis that the neuroprotective mechanism of the SERM, tamoxifen, could be due to its ability to attenuate apoptotic cell death was first suggested and verified by Wakade et al. [11], and subsequently confirmed by Zou et al. [17]. By contrast, the SERM, raloxifene, has been recently reported to have no effect on the hypoxia-induced increase of caspase-3 activity in cultured hippocampal cells [20]. Therefore, our results lend support to the view that, as in the case of E2, SERMs (specifically BZA) are effective anti-apoptotic drugs in stroke.

    Wibowo et al. (2016)

    Wibowo, E., Pollock, P. A., Hollis, N., & Wassersug, R. J. (2016). Tamoxifen in men: a review of adverse events. Andrology, 4(5), 776–788. [DOI:10.1111/andr.12197]:

    Five RCTs have investigated the effect of tamoxifen on men with infertility, and the ages of the participants ranged between 18 and 44 years old (unspecified in two studies). These men (n = 321) were treated daily with 20 or 30 mg tamoxifen for 3–6 months. Three studies reported minimal or no side effects (AinMelk et al., 1987; Maier & Hienert, 1990; Cakan et al., 2009), one study (Kotoulas et al., 1994) reported three men lost their libido, and another study (Maier & Hienert, 1988) reported gastrointestinal events. From these studies, only three men stopped tamoxifen treatment, but the reason was not specified.

    Studies in women indicate that genetic variants of cytochrome P450 enzymes may be associated with the presence and severity of tamoxifen AEs. For example, one study on postmenopausal women with ER-positive breast cancer reported that women with CYP2D6 phenotypes, that either are poor or intermediate metabolizer of tamoxifen, have increased risk of developing hot flashes (Regan et al., 2012). In another study, women who are carriers of a variant of CYP3A4 are more likely to experience severe hot flashes (Baxter et al., 2014). However, to date, it remains unclear whether cytochrome P450 enzymes genetic variations can influence the incidences and severity of such AEs in men.

    Other AEs also seems to occur more frequently in women than in men including gastrointestinal problems, cardiovascular events, musculoskeletal problems, fatigue, and mood disturbances.

    The mechanism(s) to account for the sex difference in tamoxifen AE is/are not understood. However, if this sex difference is real, one possible factor is a difference in activity of cytochrome P450 enzymes that metabolize tamoxifen in the liver (Anderson, 2008; Schmetzer & Florcken, 2012; Spoletini et al., 2012), and thus may influence the bioavailability of more potent tamoxifen metabolites. Furthermore, there may also be sex difference in the distribution of ERs in various organs, as already documented for different brain areas (Kruijver et al., 2003). However, one needs to keep in mind that the low incidence of reported AEs in men on tamoxifen may also be as a result of the fact that these AEs are not thoroughly evaluated in many studies, especially in the non-RCTs. A rigorous assessment of tamoxifen AEs in male populations has yet to be undertaken.

    Kuiper et al. (1997)

    Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J. (1997). Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β. Endocrinology, 138(3), 863–870. [DOI:10.1210/endo.138.3.4979]

    Note: Only skimmed – looked at relative binding affinities (RBAs) and noted no raloxifene – going to search for other new papers with more info on RBAs.

    Rabe et al. (2016)

    Rabe, T., Bruyniks, N., Merkle, E., Hadji, P., Kuhl, H., Ahrendt, H. J., Albring, C., Bitzer, J., Egarter, C., Kiesel, L., König, K., Merki Feld, G., Mueck, A. O., Sänger, N., Windler, E. (2016). Selective Estrogen Receptor Modulators–an Update (Joint Statement by the German Society for Gynecological Endocrinology and Reproductive Medicine [DGGEF] and the German Professional Association of Gynecologists [BVF]). Journal für Reproduktionsmedizin und Endokrinologie-Journal of Reproductive Medicine and Endocrinology, 12(4), 287–317. [Google Scholar] [URL] [PDF]:

    It is probable that due to the binding of the SERMs to the ER certain co-factors are activated which, either as co-activators or as co-repressors, lead to different gene activations and deactivations in target tissues. Alternative explanations relate to a different affinity to ER and ER or activation of ER and ER, respectively.

    Receptor Distribution Both ERs are expressed in various tissue types, but there are some notable differences in their expression pattern [4]: – ERα: endometrium, breast cancer cells, stromal cells of the ovary and hypothalamus [5] – ERβ: kidney, brain, bone, heart, lung, intestinal mucosa, prostate, and endothelial cells [6]

    Polymorphism: Various polymorphisms of ERα- and ERβ-gene have been described.

    Various ligands differ in their affinity for the alpha and beta isoforms of the estrogen receptor: – 17-estradiol binds equally well to both receptors – Estrone and raloxifene preferentially bind to the receptor alpha (ERα) – Estriol and genistein preferentially bind to the beta receptor (ERβ)

    Selective estrogen receptor modulators preferably bind to the α- or β-subtype of the receptor. In addition, the different estrogen receptor combinations can react differently to the different ligands, thus tissue-specific agonist and antagonist effects arise [7]. The ratio of the concentration of α- to β-subtype plays a role in certain diseases.

    The concept of selective estrogen receptor modulators is based on the ability to influence the interaction with other ER proteins such as transcriptional co-activators or co-repressors, based on the conformational changes in the ligand-receptor complex which is different between SERMs and estrogen and also different for different SERMs. Since the ratio of co-activators and co-repressors is different in various tissues [9], the same ligand may act as an agonist in one tissue (provided that the co-activators predominate) and as an antagonist in other tissues (where co-repressors dominate).

    Note: Also worth pointing out that it’s tamoxifene’s metabolites that are the active ingredients and should probably have been included here.

    Tamoxifene induces the recruitment of co-repressors to target gene promoters in mammary cells. In endometrial cells, tamoxifene, in contrast to raloxifene, acts like an estrogen by stimulating the recruitment of co-activators to a subset of genes.

    Raloxifene induces the recruitment of co-repressors to target gene promoters in mammary cells [9].

    Raloxifene: Non-genomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene have been found by Simoncini et al (2002) [29]. This pathway might be important to understand the different effects of SERMs on the cardiovascular system.

    [Tamoxifen:] Transcription of E-responsive genes(s) is attenuated because AF2 is inactive, and co-activator binding is attenuated by the T-ER complex; partial agonist activity results from AF1, which remains active in the T-ER complex.

    [New SERM:] Afimoxifene: (4-hydroxytamoxifene) is a selective estrogen receptor modulator which is the active metabolite of tamoxifene [66]. Afimoxifene is a transdermal gel formulation and is being developed by Ascend Therapeutics, Inc. under the trademark TamoGel. Afimoxifene has completed a phase II clinical trial for the treatment of cyclical mastalgia [198].

    Gruber et al. (2002)

    Gruber, C. J., Tschugguel, W., Schneeberger, C., & Huber, J. C. (2002). Production and actions of estrogens. New England Journal of Medicine, 346(5), 340–352. [DOI:10.1056/NEJMra000471]:

    Pickar, Boucher, & Morgenstern (2018)

    Pickar, J. H., Boucher, M., & Morgenstern, D. (2018). Tissue selective estrogen complex (TSEC): a review. Menopause, 25(9), 1033–1045. [DOI:10.1097/gme.0000000000001095]:

    The combination of estrogens and a SERM is sometimes referred to as a tissue selective estrogen complex (TSEC), although this term is not formally recognized by health authorities.

    The question then arose, in the late 1990s, as to whether a combination of SERMs and estrogens might produce estrogen agonist and antagonist effects distinct from that of either component alone and come closer to achieving that goal.54

    A key finding from the preclinical “proof of concept” investigation in ovariectomized rats was that BZA could completely counter CE’s stimulatory effects on the endometrium (based on uterine wet weight) when adequately dosed without attenuating CE’s beneficial effects on vasomotor instability, lipids, or bone,54 which supported clinical evaluation of this combination.

    In a clinical trial of raloxifene 60 mg/d combined with oral 17β-estradiol 1 mg/d (n = 61) compared with raloxifene alone (n = 62) in postmenopausal women with prior HT use, the TSEC combination significantly (P < 0.001) reduced the frequency of VMS compared with baseline and with raloxifene alone.

    It may be possible to create a TSEC combination that uses 17β-estradiol rather than CE in combination with a SERM; however, results cannot be assumed to be comparable to those with CE/BZA without clinical testing. Due to the unique profile of each TSEC, each individual TSEC combination needs to be evaluated separately in clinical studies to identify appropriate doses and assess safety and efficacy.

    Liu, Han, & Smith (2013)

    Liu, S., Han, S. J., & Smith, C. L. (2013). Cooperative Activation of Gene Expression by Agonists and Antagonists Mediated by Estrogen Receptor Heteroligand Dimer Complexes. Molecular Pharmacology, 83(5), 1066–1077. [DOI:10.1124/mol.112.084228]:

    Moreover, antagonist-bound ERs adopt a distinct conformation that enables them to preferentially interact with corepressors rather than coactivators (Huang et al., 2010), thereby reinforcing their negative regulatory properties.

    We demonstrate that ER agonist/antagonist combined treatment can cooperatively activate gene expression through an ER-HLD complex consisting of one receptor monomer bound to agonist and another occupied by antagonist. This cooperative activation of gene expression can be enhanced by an SRC-3 coactivator, and requires both ligand-bound subunits to bind to DNA and both AF-1 domains within the ER-HLD for maximal transcriptional activity. Moreover, ER-HLD complexes can activate transcription in the context of a natural promoter, and taken together, these findings demonstrate that ERs bound to different classes of ligands can form dimers that promote gene expression.

    Crystal structures of the ERα LBDs bound to either E2 or raloxifene reveal that both ligands bind to the same pocket, and that the overall homodimeric arrangement is the same regardless of whether the LBD is agonist- or antagonist-bound.

    Relative to costimulation by agonist/antagonist, the AF-1 domain is important for the partial agonist activity of SERMs such as tamoxifen (McInerney et al., 1996), and SRC-1 can bind to both the AF-1 and AF-2 domains of ERα through the coactivator’s Q-rich region and LXXLL motifs, respectively (Mérot et al., 2004). This raises the possibility that SRC-3 interacts with ER-HLDs through different AF domains on distinct subunits [e.g., AF-2 on agonist-bound ER(GSCKV) and AF-1 on antagonist-bound ER-G521R] to induce maximal transcriptional activity.

    Thornton (2007)

    Thornton, J. (2007). Effect of estrogens on skin aging and the potential role of SERMs. Clinical Interventions in Aging, 2(3), 283–297. [DOI:10.2147/cia.s798]:

    A number of studies have shown that estrogens have many important beneficial and protective roles in skin physiology (reviewed in Thornton 2002, 2005). They have been shown to accelerate cutaneous wound healing (Ashcroft and Ashworth 2003), while a significant number of women notice an improvement in inflammatory skin disorders such as psoriasis during pregnancy (Dunna and Finlay 1989; Boyd et al 1996; Raychaudhuri et al 2003). Estrogens also offer some degree of protection against skin photoaging (Weinstock 1994; Tsukahara et al 2001, 2004) and epidemiological studies indicate that the mortality rates from both non-melanoma skin cancers (Weinstock 1994) and melanoma (Miller and MacNeil 1997) are significantly lower in women.

    Many women report a sudden onset of skin aging several months after menopausal symptoms begin. The menopause causes hypoestrogenism, accelerating age-related deterioration, which results in thinner skin, an increase in number and depth of wrinkles, increased skin dryness, and decreased skin firmness and elasticity (Brincat 2000). Hormone replacement therapy (HRT) has been shown to increase epidermal hydration, skin elasticity, skin thickness (Sator et al 2001), and also reduces skin wrinkles (Phillips et al 2001). Furthermore, the content and quality of collagen and the level of vascularization is enhanced (Brincat et al 1987).

    More recently, specific antibodies have demonstrated ERβ, but not ERα is expressed by dermal fibroblasts in the papillary dermis of human scalp skin in both sexes (Thornton et al 2003), whereas primary cultures of human dermal fibroblasts from female skin have been shown to express both mRNA and protein for ERα and ERβ (Haczynski et al 2002).

    In addition, in female hair follicles the phytoestrogen, genistein inhibits hair shaft elongation to a similar extent as 17β-estradiol. Since genistein preferentially binds to ERβ, this opens the possibility that the inhibition of hair growth in response to 17β-estradiol may be mediated via ERβ rather than ERα (Nelson 2006). Therefore the development of selective estrogen receptor ligands may provide important clinical applications for the prevention and treatment of disorders of hair growth.

    A histopathological assessment of rat skin following subcutaneous administration of tamoxifen observed that tamoxifen treatment resulted in the appearance of abnormal hair follicles, epidermal atrophy and increased dermal fibrosis, particularly around the hair follicles (Inaloz et al 2002). There have been reports of tamoxifen treatment causing diffuse thinning of the hair with moderate receding of the frontal hair line (Ayoub et al 1997) and the development of alopecia on the crown, which was reversed when treatment was stopped.

    We have recently reported that tamoxifen alone has no effect on human hair shaft elongation in organ culture, suggesting it is not an estrogen agonist (Nelson 2006). However, a 10-fold excess of tamoxifen incubated in combination with 17β-estradiol eliminated the inhibitory effect of 17β-estradiol, suggesting that tamoxifen acts as an antagonist of estrogen in the female scalp hair follicle (Nelson 2006).

    Another study has shown that raloxfine has a stronger positive stimulatory effect on collagen biosynthesis than 17β-estradiol (Surazynski et al 2003) and that in contrast to estradiol, raloxifene inhibits the expression of MMP-9.

    Mauvais-Jarvis, Clegg, & Hevener (2013)

    Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]:

    However, tamoxifen treatment is associated with an increased risk of developing fatty liver (steatosis) (337–339), with approximately 43% of breast cancer patients treated with tamoxifen developing hepatic steatosis (339). The exact mechanism by which this occurs is still unclear.

    In the hypothalamus, tamoxifen appears to act as an ER agonist.

    In OVX mice, raloxifene reversed OVX-induced increases in food intake, body weight, fat mass, and hyperleptinemia to an extent similar to that of E2. This suggests that in rodents, raloxifene acts as an ER agonist in hypothalamic neurons and fat (346). In postmenopausal women, raloxifene prevents the shift from android to gynoid fat distribution, increases in abdominal adiposity (347), as well as total increases in adiposity (348). The absence of significant effect on body weight in women (349) could be due to the concomitant increase in lean mass and water after raloxifene treatment (350).

    Nonetheless, in healthy and diabetic postmenopausal women, short-term raloxifene treatment did not impact fasting glucose, glucose tolerance, or indices of-cell function and sensitivity (351, 352). However, it decreased hepatic insulin extraction and, as a result, increased insulin half-life (352). Additionally, in the Multiple Outcomes of Raloxifene Evaluation trial, 3-year raloxifene treatment of postmenopausal women with or without type 2 diabetes reduced total cholesterol and LDL-cholesterol but had no effect on glycemic control compared to placebo (349). Thus, there is no argument for an effect of raloxifene in improving glucose homeostasis in postmenopausal women with type 2 diabetes. In fact, women with a previous history of hypertriglyceridemia who receive oral estrogen therapy are at risk for clinically relevant progression in this existing risk factor during raloxifene therapy.

    In preclinical studies, the TSEC partnering bazedoxifene with CEE seemed to provide these benefits. Thus far, the effect of TSEC partnering bazedoxifene on glucose and energy metabolism is unknown.

    Tommaselli et al. (2006)

    Tommaselli, G. A., Di Carlo, C., Di Spiezio Sardo, A., Bifulco, G., Cirillo, D., Guida, M., Capasso, R., & Nappi, C. (2006). Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause, 13(4), 660–668. [DOI:10.1097/01.gme.0000227335.27996.d8]:

    At the end of the study, untreated women showed increased total and percentage of fat mass and increased serum leptin levels compared with baseline values, whereas women treated with HT showed no significant changes. These data seem to indicate that the main determinant of leptin levels in postmenopausal women is body fat content, whereas hypoestrogenism does not seem to influence these levels.

    Women in group C showed no significant changes in fat mass, in total and at all areas evaluated, after 1 year of treatment with raloxifene (Fig. 1A-D). No significant changes were observed in lean mass, both total and at all areas evaluated (Fig. 2A-D). The same was observed for the percentage of fat mass (Fig. 3A-D).

    We did not detect significant changes in serum leptin levels in subjects in group B and C throughout the study (group B: 16.3 [4.2/39.8] ng/mL vs 17.0 [5.6 /28.7] ng/mL; group C: 15.1 [6.7/26.5] ng/mL vs 17.5 [6.7/29.8] ng/mL).

    The present study, although hampered by the limited sample size, seems to confirm that postmenopausal hypoestrogenism leads to increased fat content and suggests that both raloxifene and tibolone may have a role in preventing the changes of body composition induced by postmenopausal hypoestrogenism.

    Francucci et al. (2005)

    Francucci, C. M., Pantaleo, D., Iori, N., Camilletti, A., Massi, F., & Boscaro, M. (2005). Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation, 28(9), 623–631. [DOI:10.1007/bf03347261]:

    For the first time, our results suggest that RLX, most likely because of its estrogen-agonist action, might prevent the shift to a more central fat dis- tribution associated with menopause. In fact, we have found in RLX-users, in relation to controls, no substantial changes in body weight during the 12 months of treatment, a significant lower fat mass in trunk and abdominal region (ROI-L2-4) and a trend towards higher fat depots in legs. At variance, after 1 yr we observed in untreated post-menopausal women a not significant increase of body weight and fat mass in central and trunk region with a decrease in legs. Therefore, RLX could have, similar to the estrogens, different effects on several regional fat tissues. In fact, in pre-menopausal women the gluteo-femoral adipocytes have a low lipolytic activity with tendency towards larger fat cells in the femoral region, while the adipocytes in the central fat depot have a high basal lipolysis with smaller fat cells (32). Besides, the estrogens would seem to enhance the lipoprotein-lipase (LPL) activity, the key enzyme in the regulation of fatty acid deposi- tion, of gluteofemoral fat cells and to decrease the visceral LPL activity (33).

    Jacobsen et al. (2010)

    Jacobsen, D. E., Samson, M. M., Emmelot-Vonk, M. H., & Verhaar, H. J. (2010). Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial. European Journal of Endocrinology, 162(2), 371–376. [DOI:10.1530/eje-09-0619]:

    Repeated measurement analysis showed there to be a significant increase in FFM at 3, 6, and 12 months in the raloxifene group (P=0.05) as well as an increase in TBW (P=0.02; Table 2). At 12 months, the mean increase in FFM was 0.83 (2.4) kg in the raloxifene group compared with 0.03 (1.5) kg in the placebo group (P=0.05), and the mean increase in TBW was 0.6 (1.8) litres compared with a decrease of 0.06 (1.1) litres in the placebo group (P=0.02).

    In our study, we found an increase in the FFM after supplementation with raloxifene, which could be partly explained by the increase in the TBW content, a known effect of raloxifene supplementation. However, the increase in the TBW content could not explain the whole increase in the FFM, and also the amount of physical activity was comparable between both groups during the study. This means that there is also a real change in body composition with an increase in lean body mass. The results of our study are comparable with some other studies, but in most of these studies there were problems with the design of the study (no blinding, no placebo group, too small groups, and a too short intervention period).

    The increase in FFM was not accompanied by an increase in muscle strength and muscle power in our study. Muscle strength is a key factor in maintaining independence in elderly people. There are no other studies concerning raloxifene and muscle strength or power. Studies concerning HRT (estrogen and progestagens) show conflicting results: two randomized controlled trials with no effect (38, 39) and three randomized controlled trials with significant increase in muscle strength (11–13).

    Komm & Mirkin (2014)

    Komm, B. S., & Mirkin, S. (2014). An overview of current and emerging SERMs. The Journal of Steroid Biochemistry and Molecular Biology, 143, 207–222. [DOI:10.1016/j.jsbmb.2014.03.003]:

    Raloxifene binds with high affinity to ERα, with 46% relative binding affinity for human ERα compared with 17β-estradiol, and with a 26% relative binding affinity for rat ERβ compared with 17β-estradiol

    Note: A lot more on this article but this was the only relevant thing I really cared about at the time.

    Smith & O’Malley (2004)

    Smith, C. L., & O’Malley, B. W. (2004). Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocrine Reviews, 25(1), 45–71. [DOI:10.1210/er.2003-0023]:

    For instance, in the absence of endogenous estrogens, tamoxifen frequently exhibits weak estrogenic activity, such as modest stimulation of uterine wet weight and bone density in ovariectomized rats, whereas in the presence of estradiol, it can serve as an antiestrogen, inhibiting responses to a level corresponding to the comparatively modest agonist activity of tamoxifen itself.

    However, because neither tamoxifen nor raloxifene possesses significant estrogen-like activity in the CNS, there is clearly a market for other SERMs to fill this niche.

    It is also noteworthy that SERMs likely exist in nature. For instance, the estrone metabolite, Δ8,9- dehydroestrone sulfate suppresses hot flushes in postmenopausal women, an estrogenic action. However, it is unable to significantly affect certain other parameters associated with estrogenic responses such as total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol (23).

    […] raloxifene and 4HT block the ligand-activated AF-2 domain and particularly in the case of 4HT, leave AF-1 able to initiate gene expression.

    As a result, 4HT and raloxifene stimulate gene expression in some, but not all, contexts, and these antiestrogens are therefore classified as SERMs.

    For ER, 4HT and raloxifene also inhibit its AF-2 domain, and due to the relatively poor AF-1 activity of the receptor, these ligands generally block ER transcriptional activity measured on EREs (61, 78, 79).

    It should be noted that 4HT and raloxifene also exert effects on the transcriptional activity of both ER and ER tethered to DNA indirectly through interaction with other transcription factors such as activator protein 1 (AP-1) and Sp1 (80, 81). In this context, the agonist activities of these ligands also is apparent in a cell-specific manner.

    For ERE-dependent gene expression, tamoxifen is a partial agonist of ER but is generally unable to stimulate ER transcriptional activity (61, 171, 173). Conversely, when assessing ER activity on AP-1 containing reporter genes, tamoxifen will stimulate ER and ER transcriptional activity.

    Carneiro, de Cassia de Maio Dardes, & Haidar (2012)

    Carneiro, A. L., de Cassia de Maio Dardes, R., & Haidar, M. A. (2012). Estrogens plus raloxifene on endometrial safety and menopausal symptoms—semisystematic review. Menopause, 19(7), 830–834. [DOI:10.1097/gme.0b013e31824a74ce]:

    Most of the studies found a benefit profile with association of RLX and E on women’s quality of life, satisfaction with the treatment, and vaginal dryness. Nevertheless, different qualityof-life scales and visual scales were used to access mainly vasomotor symptoms, which could limit further comparison.

    Arevalo et al. (2010)

    Arevalo, M. A., Santos-Galindo, M., Lagunas, N., Azcoitia, I., & Garcia-Segura, L. M. (2010). Selective estrogen receptor modulators as brain therapeutic agents. Journal of Molecular Endocrinology, 46(1), R1–R9. [DOI:10.1677/jme-10-0122]:

    The neuroprotective actions of tamoxifen and raloxifene, two SERMs that are currently used in clinical practice for the treatment of breast cancer and osteoporosis, have been assessed in different experimental models of neural dysfunction. These include animal models of traumatic injury of the central nervous system and peripheral nerves, stroke, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, cognitive decline, and mood disorders (Fig. 1). This section is a succinct description of the main findings of these experimental studies, including the limited available information from human studies.

    In spite of the neuroprotective actions of tamoxifen in different forms of neural injury, it is unclear whether this molecule may have some benefits for cognition in humans. Indeed, several studies suggest an increased risk of cognitive impairment in women receiving tamoxifen for the treatment of breast cancer, including worse performance in visual memory, word fluency, immediate verbal memory, visuospatial ability, and processing speed tasks (Paganini-Hill & Clark 2000, Shilling et al. 2003, Palmer et al. 2008, Phillips et al. 2010, Schilder et al. 2010). However, other studies have not detected a significant effect of tamoxifen on cognition (Debess et al. 2010).

    In contrast to the potential negative effects of tamoxifen on cognition, the results of the multiple outcomes of raloxifene evaluation randomized trial suggest that raloxifene prevents cognitive decline in postmenopausal women (Yaffe et al. 2005). The results of a recent randomized, double-blind, placebo-controlled trial also suggest that raloxifene improves verbal memory in late postmenopausal women ( Jacobsen et al. 2010). In addition, raloxifene treatment enhances brain activation during performance on a face-encoding paradigm and during recognition of familiar items in healthy elderly men.

    In agreement with this possibility, we have recently observed that both tamoxifen and raloxifene improve hippocampus-dependent memory in androgen-deprived male rats (N Lagunas, I Calmarza-Font, D Grassi & LM Garcia-Segura, unpublished observations).

    Tamoxifen reduces amphetamine-induced manic-like behavioral alterations in rats (Einat et al. 2007) and reduces acute manic episodes in women with bipolar affective disorder (Kulkarni et al. 2006, Zarate et al. 2007). Raloxifene reduces anxiety behavior, assessed in the elevated plus maze test, on ovariectomized rats (Walf & Frye 2010) and decreases anxiety (Strickler et al. 2000, Florio et al. 2001) and depression (Carranza-Lira et al. 2004, Grigoriadis et al. 2005, Sugiyama et al. 2007) in postmenopausal women. Recent clinical studies also suggest the potential application of raloxifene hydrochloride (120 mg/day oral) for the treatment of postmenopausal women with schizophrenia.

    Other neuroprotective mechanisms of SERMs are mediated by classical ERs, since they are inhibited by ER antagonists, such as ICI 182 780 (Zhang et al. 2009). The neuroprotective signaling of SERMs may involve the activation of kinases, such as mitogen-activated protein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K), and Akt (Du et al. 2004, Lee et al. 2009a,b), and the phosphorylation of CREB (Sharma et al. 2007) or the inhibition of nuclear factor (NF)-kB-induced transcription (Cerciat et al. 2010). Through these mechanisms, SERMs control synaptic transmission and the expression of molecules involved in the regulation of cell death, oxidative stress, and inflammation.

    Raloxifene may also regulate opiate and GABAergic neurotransmission by the modulation of the levels of b-endorphin and neuroactive steroids respectively. Chronic raloxifene administration to postmeInopausal women increases plasma levels of b-endorphin and tetrahydroprogesterone (allopregnanolone), an anxiolytic metabolite of progesterone that modulates GABAA receptors.

    These findings suggest that raloxifene may regulate synaptic function by the modulation of local levels of neuroactive substances within the brain.

    In general, there is still poor knowledge of the precise molecular targets of SERMs in the nervous system. Although some key molecules have been identified, such as MAPK, PI3K/Akt, CREB, and NF-kB, the molecular mechanisms involved in the neuroprotective actions of SERMs should be investigated with more detail in the different cellular populations of the nervous system.

    Lawrence et al. (2004)

    Lawrence, S. E., Arnold Faught, K., Vethamuthu, J., & Lawson, M. L. (2004). Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. The Journal of Pediatrics, 145(1), 71–76. [DOI:10.1016/j.jpeds.2004.03.057]:

    Results: Mean (SD) age of treated subjects was 14.6 (1.5) years with gynecomastia duration of 28.3 (16.4) months. Mean reduction in breast nodule diameter was 2.1 cm (95% CI 1.7, 2.7, P < .0001) after treatment with tamoxifen and 2.5 cm (95% CI 1.7, 3.3, P < .0001) with raloxifene. Some improvement was seen in 86% of patients receiving tamoxifen and in 91% receiving raloxifene, but a greater proportion had a significant decrease (>50%) with raloxifene (86%) than tamoxifen (41%). No side effects were seen in any patients.

    Surazynski et al. (2003)

    Surazynski, A., Jarzabek, K., Haczynski, J., Laudanski, P., Palka, J., & Wolczynski, S. (2003). Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. International Journal of Molecular Medicine, 12(5), 803–809. [DOI:10.3892/ijmm.12.5.803]:

    Raloxifene had stronger positive stimulative effects on collagen biosynthesis, through different biochemical mechanisms, than estradiol in human skin fibroblasts and might reverse some of the postmenopausal changes in skin or connective tissue. Increase of collagen synthesis induced by raloxifene may be activated by both estrogen receptor dependent and independent pathways such as up-regulation of estrogen receptors, up-regulation of IGF receptor, transcriptional regulation of collagen genes by estrogen receptor-raloxifene complex, increasing of prolidase activity or finally by inhibition of MMP-9 expression.

    \ No newline at end of file diff --git a/transfemscience.org/articles/serms-transfem/index.html b/transfemscience.org/articles/serms-transfem/index.html index 093744b3..c86146af 100644 --- a/transfemscience.org/articles/serms-transfem/index.html +++ b/transfemscience.org/articles/serms-transfem/index.html @@ -1 +1 @@ -A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy - Transfeminine Science Link

    A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy

    By Lain | First published October 5, 2019 | Last modified October 6, 2020

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    Personal Statement

    As with my other articles, this one was borne out of a personal need to understand. Like many transfeminine non-binary individuals, my desired gender-affirming hormone therapy (GAHT) outcome is a minimization of breast development with effective feminization elsewhere. From Aly’s excellent resource on non-binary hormone therapy (Aly, 2019) came my knowledge of raloxifene and a desire to fully understand as precisely as possible its actions. I hope this article is illuminative to others undergoing similar experiences and that together we can build an even greater understanding in creating ourselves.

    Executive Summary

    I encourage everyone that wishes a deeper understanding to read the sections below and for those that desire more knowledge to read the supplement page provided.

    Selective estrogen receptor modulators (SERMs) work by blocking or activating different estrogen receptors at different levels. Since different tissues have different ratios of these estrogen receptors SERMs act like estrogens in some tissues and block estrogens in other tissues.

    The main SERM up for consideration for transgender GAHT is raloxifene as of the two widely available, generic SERMs, it has the best safety profile and most relevant research.

    Raloxifene acts largely antiestrogenically in breast tissue. It helps to prevent and treat breast cancer. It seems to act estrogenically in various tissues of interest to transgender individuals. It produces a gynoid (feminine) fat distribution, it causes estrogenic like actions on skin, and helps prevent osteoporosis by maintaining bone mineral density. Further it seems to have some estrogenic actions in the brain.

    A TSEC of estradiol and raloxifene may warrant further study for transfeminine individuals. The reasons for discontinuation of research of combined estradiol and raloxifene were due to endometrial thickening and as transfeminine individuals (intersex individuals excepted) do not have an endometrium this is not a cause for concern.

    Lastly, this article would be remiss if not to end with a major word of caution. There is to my knowledge, no published research on SERMs in transgender individuals. There is no long term research on raloxifene or tamoxifen on natal men. Finally, the mechanism of action of SERMs in general is that they partially suppress various types of estrogen receptor activity. They are far away from being fully characterized and it may be the case that the subtle ways in which they differ from estradiol may cause unforeseen long term consequences to transfeminine individuals.

    That being said, they are an exciting frontier in the area of non-binary transfeminine gender-affirming hormone therapy (GAHT).

    Introduction

    While many people that begin a path of transfeminine GAHT do so with the desire to fully develop breasts there exists a sizable number of people, many on the non-binary transfeminine spectrum who wish to medically feminize themselves with little breast development. Because of this, raloxifene, a selective estrogen receptor modulator (SERM), has become talked about as a potential way to achieve this. A second-generation SERM, it was developed to prevent and treat breast cancer and (in the U.S.) prevent osteoporosis. In this article, I will review the estrogen receptor, the mechanism of action of SERMs and how they work in various relevant tissues, as well as discuss a few tissue-selective estrogen complexes (TSEC) that may be of interest.

    Background

    For an extremely in-depth review of the estrogen receptors, how they form, and the compounds that bind to them, I recommend Ascenzi, Bocedi, & Marino (2006).

    Estrogen Receptors

    Estrogens are compounds that cause changes in cells by binding to various estrogen receptors. These receptors are complexes consisting of proteins and other molecules. This binding causes a conformational change (change in shape) in the receptor that then results in some change in cell activity.

    The main types of estrogen receptors are estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) as well as G protein-coupled estrogen receptor (GPER). The classical way in which estrogens were thought to have an impact is via ERα and ERβ. These are part of the nuclear receptor family. They exist on the nuclear membrane and once bound to an estrogen these receptors form a complicated biological machine that then causes a change in gene expression.

    This estrogen receptor complex comes to exist due to the estrogen receptor containing many binding domains and on these domains other proteins or molecules can bind that then cause the estrogen receptor complex to be either activated, repressed, or destroyed.

    In addition to the classic method of estrogen activation, there exists also GPER activity. G protein-coupled receptors are a huge super family of receptors that are membrane bound (they exist inside the cell membrane) and GPER receptors cause non genomic changes that can result in rapid actions within the cell as there is not a delay of having to generate RNA and then proteins. While there is some research into the role of SERMs with GPERs, much of the focus of research and this article will concern ourselves with classic estrogen receptor activity.

    Selective Estrogen Receptor Modulators (SERMs)

    Estradiol is the classic molecule that binds to the various estrogen receptors. Estradiol is an agonist of the estrogen receptors in that it activates them to action. In contrast, there exist full estrogen receptor antagonists such as fulvestrant (ICI-182,780), a compound that completely blocks the estrogen receptors from activating. SERMs are molecules that bind to the various estrogen receptors in a way that is at least partially different from estradiol. This means that in some contexts it is an antagonist (antiestrogenic) and in others it is an agonist (estrogenic) of the estrogen receptors. SERMs work by binding to ERα and ERβ and GPER at relatively different rates compared to estradiol and acting as either a full or partial antagonist at the receptor. Because different tissues have different ratios of expression of these receptors, the subsequent result is that SERMs act like estradiol in some tissues and act to suppress estradiol like actions in others.

    At a molecular level, this occurs because a SERM is a different shape than estradiol and when it binds to the estrogen receptors its shape and the subsequent change in shape of the estrogen receptor may physically prevent (sterically inhibit) another compound or compounds that would need to bind to the estrogen receptor as well to activate its activity.

    Originally developed for the treatment of breast cancer, the currently developed SERMs all display some similar properties. They act antiestrogenically in breast tissue, with many acting estrogenically on cholesterol and bones, and thus have found use as a preventative measure for osteoporosis in postmenopausal women. The first SERM to become available was tamoxifen in 1978, with second-generation SERM raloxifene becoming available in 1997 (in the U.S.). More recently, there have been a number of new third-generation SERMs developed, such as bazedoxifene, lasofoxifene, and ospemifene. However, as these are still under patent they are expensive and therefore do not currently make good candidates for GAHT.

    Tissue-Selective Estrogen Complexes (TSECs)

    Tissue-selective estrogen complexes (TSECs) are a combination of a SERM with an estrogen. The goal in their development was to create a unique mixture of estrogenic and antiestrogenic effects that would combine the antiestrogenic effects of some SERMs in the breasts (to prevent breast cancer) and endometrium (to prevent endometrial cancer), while maintaining the positive effects of estrogens in postmenopausal women such as improved bone density, cardiovascular health and weight maintenance. The only currently approved TSEC is a combination of conjugated equine estrogens (CEE) with bazedoxifene (CEE/BZA). An abandoned TSEC, estradiol/raloxifene, will also be considered in this article – as its reasons for abandonment are largely irrelevant to transfeminine people undergoing GAHT and has a number of advantages over CEE/BZA such as availability and lower risk of complications for transfeminine individuals.

    Safety Studies

    The two generically available SERMs, raloxifene and tamoxifen, have both undergone long-term, large-scale studies, specifically the Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) (Davis et al., 2013) study for tamoxifen, showing that its largest risk is endometrial cancer. However, it has significant risk of other serious side effects such as reduced cognition, liver toxicity, and various negative cardiovascular issues (fatty liver disease, deep vein thrombosis, etc…).

    Raloxifene similarly had the Multiple Outcomes of Raloxifene Evaluation (MORE) (Ettinger, 1999) and Raloxifene Use for The Heart (RUTH) (Wenger et al., 2002) studies conducted and together they had the Study of Tamoxifen and Raloxifene (STAR) (Vogel et al., 2006) study, which shows that while it still has an increased risk of deep vein thrombosis, it is lower than tamoxifen and it does not have the other negative side effects associated with tamoxifen.

    Tissue-Specific Effects of SERMs

    In Breasts

    Both tamoxifen and raloxifene have been shown to act antiestrogenically in the breast, and indeed this is the main reason for their development as drugs. They are both shown to decrease the risk of breast cancer in natal women and both have been shown to be effective in treating gynecomastia (male breast growth) (Lawrence et al., 2004; Kunath et al., 2012). The exact mechanism of action of both raloxifene and tamoxifen in the breast is still not entirely known. While they induce estrogen receptor changes, there are also several pathways that are not via the estrogen receptor they are involved with that may mediate their anti-breast cancer action and subsequently their anti-breast development activity.

    In Fat

    Changes in fat distribution and metabolism are a major aspect of GAHT (see Lain (2019) for an in-depth look on changes in fat distribution and metabolism with GAHT). Gynoid fat distribution occurs via both peripheral activity often by the leptin–ghrelin hormone system, and raloxifene seems to act estrogenically on the leptin-ghrelin hormone system helping to prevent abdominal adiposity (Tommaselli et al., 2006; Mauvais-Jarvis, Clegg, & Hevener, 2013). It also appears to act estrogenically directly in fat tissue (adipose tissue) (Francucci et al., 2005), again helping to increase subcutaneous fat around the thighs and buttocks that is a primary characteristic of gynoid fat distribution. In addition in postmenopausal women, it is found to reduce total cholesterol and LDL cholesterol. However, it does not appear to impact glycemic index, meaning that it does not help prevent postmenopausal type 2 diabetes. It is unknown how exactly this may map to transfeminine individuals.

    In Muscle

    While muscle mass is strongly mediated via testosterone (see Lain (2019), a review on muscle mass and testosterone), there also seems to be a correlation between estrogen and muscle mass. Postmenopausal natal women undergo significant sarcopenia (age-related muscle mass loss) that can be prevented or minimized via estrogen GAHT. Similar to estrogens, raloxifene also helps increase muscle mass in postmenopausal women and prevent loss of muscle mass (Jacobsen et al., 2010). Because the exact mechanism of action by which the estrogen receptors mediates muscle strength is unknown, it is hard to understand how this translates to transfeminine individuals. However, it does point to estrogenic action in muscle tissue.

    In Skin

    In classic transfeminine hormone therapy, the softening of skin is often one of the first noticeable effects. In addition in postmenopausal women, a lack of estrogen can cause thinner skin and decreased elasticity, which is preventable via GAHT. In studies, tamoxifen appears to cause abnormal hair follicles, skin atrophy, and even possibly alopecia (hair loss) developing on the crown of the head; this and direct evidence suggests that tamoxifen is an antagonist of the estrogen receptor in hair follicles (Thornton, 2007). However, there is some evidence to suggest that raloxifene has a positive estrogenic effect on collagen biosynthesis in human skin (Surazynski et al., 2003).

    In Testes

    SERMs such as raloxifene and tamoxifen have been found to cause an increase in serum gonadotropins (luteinizing hormone and follicle stimulating hormone) as well as a concurrent increase in testosterone (Rambhatla, Mills, & Rajfer, 2016). This highlights the importance of using an antiandrogen in conjunction with a SERM in GAHT.

    In the Brain

    The estrogen receptors have significant impact on brain function. Estradiol GAHT has been associated with antidepressant effects in postmenopausal women and estrogen receptors mediate significant changes in the hypothalamus related to maintaining body fat percentage and hunger. SERMs in general appear to act on the brain both via the estrogen receptor as well as via non-estrogen-receptor-mediated pathways.

    Tamoxifen in animal models has neuroprotective effects for a number of modes of neural dysfunction including traumatic injury, Parkinson’s disease, Alzheimer’s disease, and mania. However, in some trials, it is also associated with cognitive impairment, including visual memory, verbal memory, visuospatial ability, and speed processing tasks (Arevalo et al., 2010).

    Raloxifene does not appear to have negative cognitive implications as tamoxifen does. However, it is shown to act at least partially estrogenically in the hypothalamus, to reduce anxiety in ovariectomized rats, and to decrease anxiety and depression in postmenopausal women. It may also regulate opioid and GABAergic activity by modulating endorphin levels and has been shown to positively impact schizophrenia (Arevalo et al., 2010).

    SERMs in general and raloxifene in particular seem to have some estrogenic like actions in the brain, though it does not seem to be especially significant (Smith & O’Malley, 2004). However, it is still very far from understood all of its actions in the brain as estrogen receptors are found throughout.

    Tissue-Specific Effects of TSECs

    Up till now, we have only talked about individual compounds. However, TSECs came to be developed by the thinking that by combining an estrogen with a SERM you could get a different effect profile. The only currently medically approved TSEC is CEE/BZA. Specifically, the goal for TSECs was to gain many of the beneficial aspects of estrogen GAHT in postmenopausal natal women while blocking the increased risks of breast cancer and endometrial thickening associated with it. In studies of ovariectomized rats, bazedoxifene was found to maintain its antiestrogenic activity in the endometrium without attenuating the estrogen’s positive effects in movement, fat or bone (Pickar, Boucher, & Morgenstern, 2018).

    CEE/BZA while approved for postmenopausal women presents a potentially higher risk for transgender individuals due to its increased risk of deep vein thrombosis, and is less affordable being unavailable as a generic formulation. That being the case another TSEC – a combination of raloxifene and estradiol – has had a number of clinical studies performed on it. It was ultimately abandoned by the medical community due to causing endometrial thickening, again something not typically of concern to transfeminine individuals undergoing GAHT. In the studies performed, raloxifene plus estradiol seemed to reduce many postmenopausal symptoms, such as hot flashes, vaginal dryness, and overall treatment satisfaction, compared to just raloxifene (Carneiro, de Cassia de Maio Dardes, & Haidar, 2012).

    Discussion

    The primary driver of interest in using SERMs in GAHT is their antiestrogenic effects in the breasts with potential for feminization in other tissues. Of the two affordable and available SERMs, raloxifene by far seems to be the one that has the best safety profile, while also being most effective in the literal research we have on preventing breast growth.

    That being said, TSECs seem to be a potentially untapped area of research. Raloxifene and estradiol, while potentially unsafe for those with uteruses, may be well-tolerated by those without. Research into the potential efficacy of raloxifene plus estradiol both in preventing breast growth and relative rate and degree of feminization otherwise versus estradiol alone and raloxifene alone could potentially yield extremely interesting results for transfeminine individuals seeking GAHT that includes minimal breast development.

    Ultimately, SERMs, and how different they are from estradiol, is still far from being understood. While we have some knowledge that they are generally safe long-term, this information applies pretty much exclusively to postmenopausal natal women, though there is some indication that tamoxifen has a low incidence of adverse effects in natal men (Wibowo et al., 2016). Because estrogen receptors and their actions in a wide variety of tissues are extremely complex and multifactorial, this means that each SERM and TSEC must be evaluated extremely carefully across these tissues to fully understand it.

    References

    • Arevalo, M. A., Santos-Galindo, M., Lagunas, N., Azcoitia, I., & Garcia-Segura, L. M. (2010). Selective estrogen receptor modulators as brain therapeutic agents. Journal of Molecular Endocrinology, 46(1), R1–R9. [DOI:10.1677/jme-10-0122]
    • Ascenzi, P., Bocedi, A., & Marino, M. (2006). Structure–function relationship of estrogen receptor α and β: Impact on human health. Molecular Aspects of Medicine, 27(4), 299–402. [DOI:10.1016/j.mam.2006.07.001]
    • Carneiro, A. L., de Cassia de Maio Dardes, R., & Haidar, M. A. (2012). Estrogens plus raloxifene on endometrial safety and menopausal symptoms—semisystematic review. Menopause, 19(7), 830–834. [DOI:10.1097/gme.0b013e31824a74ce]
    • Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H., Badran, A., Bonfill, X., Bradbury, J., Clarke, M., Collins, R., Davis, S. R., Delmestri, A., Forbes, J. F., Haddad, P., Hou, M., Inbar, M., Khaled, H., Kielanowska, J., Kwan, W., Mathew, B. S., Mittra, I., Müller, B., Nicolucci, A., Peralta, O., Pernas, F., Petruzelka, L., Pienkowski, T., Radhika, R., Rajan, B., Rubach, M. T., Tort, S., Urrútia, G., Valentini, M., Wang, Y., & Peto, R. (2013). Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. The Lancet, 381(9869), 805–816. [DOI:10.1016/s0140-6736(12)61963-1]
    • Ettinger, B. (1999). Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial. JAMA, 282(7), 637–645. [DOI:10.1001/jama.282.7.637]
    • Francucci, C. M., Pantaleo, D., Iori, N., Camilletti, A., Massi, F., & Boscaro, M. (2005). Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation, 28(9), 623–631. [DOI:10.1007/bf03347261]
    • Jacobsen, D. E., Samson, M. M., Emmelot-Vonk, M. H., & Verhaar, H. J. (2010). Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial. European Journal of Endocrinology, 162(2), 371–376. [DOI:10.1530/eje-09-0619]
    • Kunath, F., Keck, B., Antes, G., Wullich, B., & Meerpohl, J. J. (2012). Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Medicine, 10(1), 96. [DOI:10.1186/1741-7015-10-96]
    • Lawrence, S. E., Arnold Faught, K., Vethamuthu, J., & Lawson, M. L. (2004). Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. The Journal of Pediatrics, 145(1), 71–76. [DOI:10.1016/j.jpeds.2004.03.057]
    • Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]
    • Pickar, J. H., Boucher, M., & Morgenstern, D. (2018). Tissue selective estrogen complex (TSEC): a review. Menopause, 25(9), 1033–1045. [DOI:10.1097/gme.0000000000001095]
    • Rambhatla, A., Mills, J. N., & Rajfer, J. (2016). The Role of Estrogen Modulators in Male Hypogonadism and Infertility. Reviews in Urology, 18(2), 66–72. [PubMed] [PubMed Central] [DOI:10.3909/riu0711]
    • Smith, C. L., & O’Malley, B. W. (2004). Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocrine Reviews, 25(1), 45–71. [DOI:10.1210/er.2003-0023]
    • Surazynski, A., Jarzabek, K., Haczynski, J., Laudanski, P., Palka, J., & Wolczynski, S. (2003). Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. International Journal of Molecular Medicine, 12(5), 803–809. [DOI:10.3892/ijmm.12.5.803]
    • Thornton, J. (2007). Effect of estrogens on skin aging and the potential role of SERMs. Clinical Interventions in Aging, 2(3), 283–297. [DOI:10.2147/cia.s798]
    • Tommaselli, G. A., Di Carlo, C., Di Spiezio Sardo, A., Bifulco, G., Cirillo, D., Guida, M., Capasso, R., & Nappi, C. (2006). Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause, 13(4), 660–668. [DOI:10.1097/01.gme.0000227335.27996.d8]
    • Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Jr, Wade, J. L., 3rd, Robidoux, A., Margolese, R. G., James, J., Lippman, S. M., Runowicz, C. D., Ganz, P. A., Reis, S. E., McCaskill-Stevens, W., Ford, L. G., Jordan, V. C., … National Surgical Adjuvant Breast and Bowel Project (NSABP) (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA, 295(23), 2727–2741. [DOI:10.1001/jama.295.23.joc60074]
    • Wenger, N. K., Barrett-Connor, E., Collins, P., Grady, D., Kornitzer, M., Mosca, L., Sashegyi, A., Baygani, S. K., Anderson, P. W., & Moscarelli, E. (2002). Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. The American Journal of Cardiology, 90(11), 1204–1210. [DOI:10.1016/s0002-9149(02)02835-7]
    • Wibowo, E., Pollock, P. A., Hollis, N., & Wassersug, R. J. (2016). Tamoxifen in men: a review of adverse events. Andrology, 4(5), 776–788. [DOI:10.1111/andr.12197]
    \ No newline at end of file +A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy - Transfeminine Science Link

    A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy

    By Lain | First published October 5, 2019 | Last modified October 6, 2020

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    Personal Statement

    As with my other articles, this one was borne out of a personal need to understand. Like many transfeminine non-binary individuals, my desired gender-affirming hormone therapy (GAHT) outcome is a minimization of breast development with effective feminization elsewhere. From Aly’s excellent resource on non-binary hormone therapy (Aly, 2019) came my knowledge of raloxifene and a desire to fully understand as precisely as possible its actions. I hope this article is illuminative to others undergoing similar experiences and that together we can build an even greater understanding in creating ourselves.

    Executive Summary

    I encourage everyone that wishes a deeper understanding to read the sections below and for those that desire more knowledge to read the supplement page provided.

    Selective estrogen receptor modulators (SERMs) work by blocking or activating different estrogen receptors at different levels. Since different tissues have different ratios of these estrogen receptors SERMs act like estrogens in some tissues and block estrogens in other tissues.

    The main SERM up for consideration for transgender GAHT is raloxifene as of the two widely available, generic SERMs, it has the best safety profile and most relevant research.

    Raloxifene acts largely antiestrogenically in breast tissue. It helps to prevent and treat breast cancer. It seems to act estrogenically in various tissues of interest to transgender individuals. It produces a gynoid (feminine) fat distribution, it causes estrogenic like actions on skin, and helps prevent osteoporosis by maintaining bone mineral density. Further it seems to have some estrogenic actions in the brain.

    A TSEC of estradiol and raloxifene may warrant further study for transfeminine individuals. The reasons for discontinuation of research of combined estradiol and raloxifene were due to endometrial thickening and as transfeminine individuals (intersex individuals excepted) do not have an endometrium this is not a cause for concern.

    Lastly, this article would be remiss if not to end with a major word of caution. There is to my knowledge, no published research on SERMs in transgender individuals. There is no long term research on raloxifene or tamoxifen on natal men. Finally, the mechanism of action of SERMs in general is that they partially suppress various types of estrogen receptor activity. They are far away from being fully characterized and it may be the case that the subtle ways in which they differ from estradiol may cause unforeseen long term consequences to transfeminine individuals.

    That being said, they are an exciting frontier in the area of non-binary transfeminine gender-affirming hormone therapy (GAHT).

    Introduction

    While many people that begin a path of transfeminine GAHT do so with the desire to fully develop breasts there exists a sizable number of people, many on the non-binary transfeminine spectrum who wish to medically feminize themselves with little breast development. Because of this, raloxifene, a selective estrogen receptor modulator (SERM), has become talked about as a potential way to achieve this. A second-generation SERM, it was developed to prevent and treat breast cancer and (in the U.S.) prevent osteoporosis. In this article, I will review the estrogen receptor, the mechanism of action of SERMs and how they work in various relevant tissues, as well as discuss a few tissue-selective estrogen complexes (TSEC) that may be of interest.

    Background

    For an extremely in-depth review of the estrogen receptors, how they form, and the compounds that bind to them, I recommend Ascenzi, Bocedi, & Marino (2006).

    Estrogen Receptors

    Estrogens are compounds that cause changes in cells by binding to various estrogen receptors. These receptors are complexes consisting of proteins and other molecules. This binding causes a conformational change (change in shape) in the receptor that then results in some change in cell activity.

    The main types of estrogen receptors are estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) as well as G protein-coupled estrogen receptor (GPER). The classical way in which estrogens were thought to have an impact is via ERα and ERβ. These are part of the nuclear receptor family. They exist on the nuclear membrane and once bound to an estrogen these receptors form a complicated biological machine that then causes a change in gene expression.

    This estrogen receptor complex comes to exist due to the estrogen receptor containing many binding domains and on these domains other proteins or molecules can bind that then cause the estrogen receptor complex to be either activated, repressed, or destroyed.

    In addition to the classic method of estrogen activation, there exists also GPER activity. G protein-coupled receptors are a huge super family of receptors that are membrane bound (they exist inside the cell membrane) and GPER receptors cause non genomic changes that can result in rapid actions within the cell as there is not a delay of having to generate RNA and then proteins. While there is some research into the role of SERMs with GPERs, much of the focus of research and this article will concern ourselves with classic estrogen receptor activity.

    Selective Estrogen Receptor Modulators (SERMs)

    Estradiol is the classic molecule that binds to the various estrogen receptors. Estradiol is an agonist of the estrogen receptors in that it activates them to action. In contrast, there exist full estrogen receptor antagonists such as fulvestrant (ICI-182,780), a compound that completely blocks the estrogen receptors from activating. SERMs are molecules that bind to the various estrogen receptors in a way that is at least partially different from estradiol. This means that in some contexts it is an antagonist (antiestrogenic) and in others it is an agonist (estrogenic) of the estrogen receptors. SERMs work by binding to ERα and ERβ and GPER at relatively different rates compared to estradiol and acting as either a full or partial antagonist at the receptor. Because different tissues have different ratios of expression of these receptors, the subsequent result is that SERMs act like estradiol in some tissues and act to suppress estradiol like actions in others.

    At a molecular level, this occurs because a SERM is a different shape than estradiol and when it binds to the estrogen receptors its shape and the subsequent change in shape of the estrogen receptor may physically prevent (sterically inhibit) another compound or compounds that would need to bind to the estrogen receptor as well to activate its activity.

    Originally developed for the treatment of breast cancer, the currently developed SERMs all display some similar properties. They act antiestrogenically in breast tissue, with many acting estrogenically on cholesterol and bones, and thus have found use as a preventative measure for osteoporosis in postmenopausal women. The first SERM to become available was tamoxifen in 1978, with second-generation SERM raloxifene becoming available in 1997 (in the U.S.). More recently, there have been a number of new third-generation SERMs developed, such as bazedoxifene, lasofoxifene, and ospemifene. However, as these are still under patent they are expensive and therefore do not currently make good candidates for GAHT.

    Tissue-Selective Estrogen Complexes (TSECs)

    Tissue-selective estrogen complexes (TSECs) are a combination of a SERM with an estrogen. The goal in their development was to create a unique mixture of estrogenic and antiestrogenic effects that would combine the antiestrogenic effects of some SERMs in the breasts (to prevent breast cancer) and endometrium (to prevent endometrial cancer), while maintaining the positive effects of estrogens in postmenopausal women such as improved bone density, cardiovascular health and weight maintenance. The only currently approved TSEC is a combination of conjugated equine estrogens (CEE) with bazedoxifene (CEE/BZA). An abandoned TSEC, estradiol/raloxifene, will also be considered in this article – as its reasons for abandonment are largely irrelevant to transfeminine people undergoing GAHT and has a number of advantages over CEE/BZA such as availability and lower risk of complications for transfeminine individuals.

    Safety Studies

    The two generically available SERMs, raloxifene and tamoxifen, have both undergone long-term, large-scale studies, specifically the Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) (Davis et al., 2013) study for tamoxifen, showing that its largest risk is endometrial cancer. However, it has significant risk of other serious side effects such as reduced cognition, liver toxicity, and various negative cardiovascular issues (fatty liver disease, deep vein thrombosis, etc…).

    Raloxifene similarly had the Multiple Outcomes of Raloxifene Evaluation (MORE) (Ettinger, 1999) and Raloxifene Use for The Heart (RUTH) (Wenger et al., 2002) studies conducted and together they had the Study of Tamoxifen and Raloxifene (STAR) (Vogel et al., 2006) study, which shows that while it still has an increased risk of deep vein thrombosis, it is lower than tamoxifen and it does not have the other negative side effects associated with tamoxifen.

    Tissue-Specific Effects of SERMs

    In Breasts

    Both tamoxifen and raloxifene have been shown to act antiestrogenically in the breast, and indeed this is the main reason for their development as drugs. They are both shown to decrease the risk of breast cancer in natal women and both have been shown to be effective in treating gynecomastia (male breast growth) (Lawrence et al., 2004; Kunath et al., 2012). The exact mechanism of action of both raloxifene and tamoxifen in the breast is still not entirely known. While they induce estrogen receptor changes, there are also several pathways that are not via the estrogen receptor they are involved with that may mediate their anti-breast cancer action and subsequently their anti-breast development activity.

    In Fat

    Changes in fat distribution and metabolism are a major aspect of GAHT (see Lain (2019) for an in-depth look on changes in fat distribution and metabolism with GAHT). Gynoid fat distribution occurs via both peripheral activity often by the leptin–ghrelin hormone system, and raloxifene seems to act estrogenically on the leptin-ghrelin hormone system helping to prevent abdominal adiposity (Tommaselli et al., 2006; Mauvais-Jarvis, Clegg, & Hevener, 2013). It also appears to act estrogenically directly in fat tissue (adipose tissue) (Francucci et al., 2005), again helping to increase subcutaneous fat around the thighs and buttocks that is a primary characteristic of gynoid fat distribution. In addition in postmenopausal women, it is found to reduce total cholesterol and LDL cholesterol. However, it does not appear to impact glycemic index, meaning that it does not help prevent postmenopausal type 2 diabetes. It is unknown how exactly this may map to transfeminine individuals.

    In Muscle

    While muscle mass is strongly mediated via testosterone (see Lain (2019), a review on muscle mass and testosterone), there also seems to be a correlation between estrogen and muscle mass. Postmenopausal natal women undergo significant sarcopenia (age-related muscle mass loss) that can be prevented or minimized via estrogen GAHT. Similar to estrogens, raloxifene also helps increase muscle mass in postmenopausal women and prevent loss of muscle mass (Jacobsen et al., 2010). Because the exact mechanism of action by which the estrogen receptors mediates muscle strength is unknown, it is hard to understand how this translates to transfeminine individuals. However, it does point to estrogenic action in muscle tissue.

    In Skin

    In classic transfeminine hormone therapy, the softening of skin is often one of the first noticeable effects. In addition in postmenopausal women, a lack of estrogen can cause thinner skin and decreased elasticity, which is preventable via GAHT. In studies, tamoxifen appears to cause abnormal hair follicles, skin atrophy, and even possibly alopecia (hair loss) developing on the crown of the head; this and direct evidence suggests that tamoxifen is an antagonist of the estrogen receptor in hair follicles (Thornton, 2007). However, there is some evidence to suggest that raloxifene has a positive estrogenic effect on collagen biosynthesis in human skin (Surazynski et al., 2003).

    In Testes

    SERMs such as raloxifene and tamoxifen have been found to cause an increase in serum gonadotropins (luteinizing hormone and follicle stimulating hormone) as well as a concurrent increase in testosterone (Rambhatla, Mills, & Rajfer, 2016). This highlights the importance of using an antiandrogen in conjunction with a SERM in GAHT.

    In the Brain

    The estrogen receptors have significant impact on brain function. Estradiol GAHT has been associated with antidepressant effects in postmenopausal women and estrogen receptors mediate significant changes in the hypothalamus related to maintaining body fat percentage and hunger. SERMs in general appear to act on the brain both via the estrogen receptor as well as via non-estrogen-receptor-mediated pathways.

    Tamoxifen in animal models has neuroprotective effects for a number of modes of neural dysfunction including traumatic injury, Parkinson’s disease, Alzheimer’s disease, and mania. However, in some trials, it is also associated with cognitive impairment, including visual memory, verbal memory, visuospatial ability, and speed processing tasks (Arevalo et al., 2010).

    Raloxifene does not appear to have negative cognitive implications as tamoxifen does. However, it is shown to act at least partially estrogenically in the hypothalamus, to reduce anxiety in ovariectomized rats, and to decrease anxiety and depression in postmenopausal women. It may also regulate opioid and GABAergic activity by modulating endorphin levels and has been shown to positively impact schizophrenia (Arevalo et al., 2010).

    SERMs in general and raloxifene in particular seem to have some estrogenic like actions in the brain, though it does not seem to be especially significant (Smith & O’Malley, 2004). However, it is still very far from understood all of its actions in the brain as estrogen receptors are found throughout.

    Tissue-Specific Effects of TSECs

    Up till now, we have only talked about individual compounds. However, TSECs came to be developed by the thinking that by combining an estrogen with a SERM you could get a different effect profile. The only currently medically approved TSEC is CEE/BZA. Specifically, the goal for TSECs was to gain many of the beneficial aspects of estrogen GAHT in postmenopausal natal women while blocking the increased risks of breast cancer and endometrial thickening associated with it. In studies of ovariectomized rats, bazedoxifene was found to maintain its antiestrogenic activity in the endometrium without attenuating the estrogen’s positive effects in movement, fat or bone (Pickar, Boucher, & Morgenstern, 2018).

    CEE/BZA while approved for postmenopausal women presents a potentially higher risk for transgender individuals due to its increased risk of deep vein thrombosis, and is less affordable being unavailable as a generic formulation. That being the case another TSEC – a combination of raloxifene and estradiol – has had a number of clinical studies performed on it. It was ultimately abandoned by the medical community due to causing endometrial thickening, again something not typically of concern to transfeminine individuals undergoing GAHT. In the studies performed, raloxifene plus estradiol seemed to reduce many postmenopausal symptoms, such as hot flashes, vaginal dryness, and overall treatment satisfaction, compared to just raloxifene (Carneiro, de Cassia de Maio Dardes, & Haidar, 2012).

    Discussion

    The primary driver of interest in using SERMs in GAHT is their antiestrogenic effects in the breasts with potential for feminization in other tissues. Of the two affordable and available SERMs, raloxifene by far seems to be the one that has the best safety profile, while also being most effective in the literal research we have on preventing breast growth.

    That being said, TSECs seem to be a potentially untapped area of research. Raloxifene and estradiol, while potentially unsafe for those with uteruses, may be well-tolerated by those without. Research into the potential efficacy of raloxifene plus estradiol both in preventing breast growth and relative rate and degree of feminization otherwise versus estradiol alone and raloxifene alone could potentially yield extremely interesting results for transfeminine individuals seeking GAHT that includes minimal breast development.

    Ultimately, SERMs, and how different they are from estradiol, is still far from being understood. While we have some knowledge that they are generally safe long-term, this information applies pretty much exclusively to postmenopausal natal women, though there is some indication that tamoxifen has a low incidence of adverse effects in natal men (Wibowo et al., 2016). Because estrogen receptors and their actions in a wide variety of tissues are extremely complex and multifactorial, this means that each SERM and TSEC must be evaluated extremely carefully across these tissues to fully understand it.

    References

    • Arevalo, M. A., Santos-Galindo, M., Lagunas, N., Azcoitia, I., & Garcia-Segura, L. M. (2010). Selective estrogen receptor modulators as brain therapeutic agents. Journal of Molecular Endocrinology, 46(1), R1–R9. [DOI:10.1677/jme-10-0122]
    • Ascenzi, P., Bocedi, A., & Marino, M. (2006). Structure–function relationship of estrogen receptor α and β: Impact on human health. Molecular Aspects of Medicine, 27(4), 299–402. [DOI:10.1016/j.mam.2006.07.001]
    • Carneiro, A. L., de Cassia de Maio Dardes, R., & Haidar, M. A. (2012). Estrogens plus raloxifene on endometrial safety and menopausal symptoms—semisystematic review. Menopause, 19(7), 830–834. [DOI:10.1097/gme.0b013e31824a74ce]
    • Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H., Badran, A., Bonfill, X., Bradbury, J., Clarke, M., Collins, R., Davis, S. R., Delmestri, A., Forbes, J. F., Haddad, P., Hou, M., Inbar, M., Khaled, H., Kielanowska, J., Kwan, W., Mathew, B. S., Mittra, I., Müller, B., Nicolucci, A., Peralta, O., Pernas, F., Petruzelka, L., Pienkowski, T., Radhika, R., Rajan, B., Rubach, M. T., Tort, S., Urrútia, G., Valentini, M., Wang, Y., & Peto, R. (2013). Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. The Lancet, 381(9869), 805–816. [DOI:10.1016/s0140-6736(12)61963-1]
    • Ettinger, B. (1999). Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial. JAMA, 282(7), 637–645. [DOI:10.1001/jama.282.7.637]
    • Francucci, C. M., Pantaleo, D., Iori, N., Camilletti, A., Massi, F., & Boscaro, M. (2005). Effects of raloxifene on body fat distribution and lipid profile in healthy post-menopausal women. Journal of Endocrinological Investigation, 28(9), 623–631. [DOI:10.1007/bf03347261]
    • Jacobsen, D. E., Samson, M. M., Emmelot-Vonk, M. H., & Verhaar, H. J. (2010). Raloxifene and body composition and muscle strength in postmenopausal women: a randomized, double-blind, placebo-controlled trial. European Journal of Endocrinology, 162(2), 371–376. [DOI:10.1530/eje-09-0619]
    • Kunath, F., Keck, B., Antes, G., Wullich, B., & Meerpohl, J. J. (2012). Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review. BMC Medicine, 10(1), 96. [DOI:10.1186/1741-7015-10-96]
    • Lawrence, S. E., Arnold Faught, K., Vethamuthu, J., & Lawson, M. L. (2004). Beneficial effects of raloxifene and tamoxifen in the treatment of pubertal gynecomastia. The Journal of Pediatrics, 145(1), 71–76. [DOI:10.1016/j.jpeds.2004.03.057]
    • Mauvais-Jarvis, F., Clegg, D. J., & Hevener, A. L. (2013). The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocrine Reviews, 34(3), 309–338. [DOI:10.1210/er.2012-1055]
    • Pickar, J. H., Boucher, M., & Morgenstern, D. (2018). Tissue selective estrogen complex (TSEC): a review. Menopause, 25(9), 1033–1045. [DOI:10.1097/gme.0000000000001095]
    • Rambhatla, A., Mills, J. N., & Rajfer, J. (2016). The Role of Estrogen Modulators in Male Hypogonadism and Infertility. Reviews in Urology, 18(2), 66–72. [PubMed] [PubMed Central] [DOI:10.3909/riu0711]
    • Smith, C. L., & O’Malley, B. W. (2004). Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocrine Reviews, 25(1), 45–71. [DOI:10.1210/er.2003-0023]
    • Surazynski, A., Jarzabek, K., Haczynski, J., Laudanski, P., Palka, J., & Wolczynski, S. (2003). Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. International Journal of Molecular Medicine, 12(5), 803–809. [DOI:10.3892/ijmm.12.5.803]
    • Thornton, J. (2007). Effect of estrogens on skin aging and the potential role of SERMs. Clinical Interventions in Aging, 2(3), 283–297. [DOI:10.2147/cia.s798]
    • Tommaselli, G. A., Di Carlo, C., Di Spiezio Sardo, A., Bifulco, G., Cirillo, D., Guida, M., Capasso, R., & Nappi, C. (2006). Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause, 13(4), 660–668. [DOI:10.1097/01.gme.0000227335.27996.d8]
    • Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Jr, Wade, J. L., 3rd, Robidoux, A., Margolese, R. G., James, J., Lippman, S. M., Runowicz, C. D., Ganz, P. A., Reis, S. E., McCaskill-Stevens, W., Ford, L. G., Jordan, V. C., … National Surgical Adjuvant Breast and Bowel Project (NSABP) (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA, 295(23), 2727–2741. [DOI:10.1001/jama.295.23.joc60074]
    • Wenger, N. K., Barrett-Connor, E., Collins, P., Grady, D., Kornitzer, M., Mosca, L., Sashegyi, A., Baygani, S. K., Anderson, P. W., & Moscarelli, E. (2002). Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. The American Journal of Cardiology, 90(11), 1204–1210. [DOI:10.1016/s0002-9149(02)02835-7]
    • Wibowo, E., Pollock, P. A., Hollis, N., & Wassersug, R. J. (2016). Tamoxifen in men: a review of adverse events. Andrology, 4(5), 776–788. [DOI:10.1111/andr.12197]
    \ No newline at end of file diff --git a/transfemscience.org/articles/shbg-unimportant-suppl/index.html b/transfemscience.org/articles/shbg-unimportant-suppl/index.html index faea800b..c63cd008 100644 --- a/transfemscience.org/articles/shbg-unimportant-suppl/index.html +++ b/transfemscience.org/articles/shbg-unimportant-suppl/index.html @@ -1 +1 @@ -Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy - Transfeminine Science Link

    Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy

    By Aly | First published July 8, 2020 | Last modified March 14, 2023

    Preface

    This article is a supplement to the article here. It was originally just for calculation of free sex hormone levels but I decided to add some other content to it as well.

    Calculation of Free Hormone Levels

    Spreadsheet Calculator (Mazer, 2009)

    A researcher developed and published a “user-friendly” spreadsheet that can be used to calculate free and bioavailable levels of several steroid hormones (Mazer, 2009). This spreadsheet approach is analogous to how free hormone levels are calculated with actual conventional blood work. Total hormone levels and levels of plasma proteins like albumin and SHBG are taken as inputs by the spreadsheet, and free and bioavailable hormone levels are given as outputs.

    The spreadsheet is supplementary material for Mazer (2009) and is behind a paywall. Because of this, I’ve uploaded a copy of the original spreadsheet here (Microsoft Excel or XLS format).

    If you’re curious how SHBG may be influencing your free estradiol percentage, you can use the spreadsheet to get an estimate. If you don’t have albumin, CBG, or cortisol values, you can use the default input values in the spreadsheet. If you don’t have other input values (e.g., estrone or SHBG), you can input representative values that are sensible for your scenario. It should be noted that calculated free hormone levels are only estimates and hence can be inaccurate. In any case, they are generally fairly close to the values that would be obtained with actual measurement. Use of default input values as opposed to real measured numbers may further contribute to inaccuracy.

    Some Experimentation with the Calculator

    Here are the results of some experimentation I did with the calculator:

    Table: Relationships between SHBG levels and calculated free estradiol fraction at fixed estradiol levels:

    SHBGEstradiol fixed ≤1,000 pg/mLEstradiol fixed 20,000 pg/mL
    LevelChange aFree E2 fractionChange aFree E2 fractionChange a
    0 nmol/L0.0×3.26%+77.2%3.26%+37.0%
    25 nmol/L0.5×2.36%+28.3%2.78%+16.8%
    50 nmol/L1.0×1.84%0%2.38%0%
    75 nmol/L1.5×1.50%–18.5%2.04%–14.3%
    100 nmol/L2.0×1.27%–31.0%1.77%–25.6%
    125 nmol/L2.5×1.10%–40.2%1.54%–35.3%
    150 nmol/L3.0×0.97%–47.3%1.36%–42.9%
    200 nmol/L4.0×0.79%–57.1%1.08%–54.6%
    250 nmol/L5.0×0.66%–64.1%0.89%–62.6%
    300 nmol/L6.0×0.57%–69.0%0.75%–68.5%
    350 nmol/L7.0×0.50%–72.8%0.65%–72.7%
    400 nmol/L8.0×0.44%–76.1%0.57%–76.1%

    a Change relative to a reasonable non-pregnancy physiological value (specifically 50 nmol/L for SHBG, 1.84% for free E2 at a fixed level of ≤1,000 pg/mL, 2.38% for free E2 at a fixed level of 20,000 pg/mL).

    Androgen levels were set to female levels, estrone levels were set to be the same as estradiol levels, and all other inputs besides SHBG and total estradiol levels were left as the defaults. There was very little variation in free estradiol fractions with different estradiol levels at and below 1,000 pg/mL for each given level of SHBG (hence why the table says “Estradiol fixed ≤1,000 pg/mL”).

    The estradiol levels fixed to ≤1,000 pg/mL are intended to represent typical therapeutic circumstances while the estradiol levels fixed to 20,000 pg/mL are supposed to represent late pregnancy.

    Note that since estradiol induces SHBG production, SHBG levels are strongly correlated with estradiol levels. Generally speaking, when estradiol is low, SHBG will also be low, and when estradiol is high, SHBG will also be high. Hence, having highly divergent SHBG and estradiol levels as in the table would be very unusual and is physiologically unrealistic. It is only explored here as a thought experiment.

    Note again that these free estradiol numbers are calculated and hence are only estimates.

    Other Papers on Calculation of Free Hormone Levels

    Aside from Mazer (2009), other papers like Vermeulen, Verdonck, & Kaufman (1999) and Rinaldi et al. (2002) also discuss calculation of free sex hormone levels and the validity of this approach.

    Other Online Free Hormone Calculators

    Another tool for calculating free estradiol and testosterone can be found here. Various other free testosterone calculators also exist on the web (Google Search).

    Additional Literature on SHBG and Free Estradiol

    Additional SHBG and Free Estradiol Clinical Studies

    Some more good studies on SHBG and free estradiol that weren’t discussed in the main article:

    Miscellaneous

    A case report of a young woman with estrogen insensitivity syndrome (EIS) (i.e., defective ERα) suggests that the ERα is the specific estrogen receptor that is responsible for increased SHBG production and levels with estrogens (Quaynor et al., 2013). Due to her EIS and lack of negative feedback on the hypothalamus–pituitary–gonadal axis, the woman had estradiol levels of as high as 3,500 pg/mL. In spite of this however, her SHBG levels remained less than 50 nmol/L. During pregnancy, at the point in the second trimester at which estradiol levels reach 3,000 pg/mL, SHBG levels are normally around 300 nmol/L on average (a 6-fold increase from a pre-pregnancy baseline of about 50 nmol/L).

    References

    • Ben-Rafael, Z., Mastroianni, L., Meloni, F., Strauss, J. F., & Flickinger, G. L. (1986). Changes in serum sex hormone-binding globulin, free estradiol, and testosterone during gonadotropin treatment. Fertility and Sterility, 46(4), 593–598. [DOI:10.1016/s0015-0282(16)49633-0]
    • Carlström, K., Pschera, H., & Lunell, N. (1988). Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sex-hormone-binding globulin during simultaneous vaginal administration of 17β-oestradiol and progesterone in the pre- and post-menopause. Maturitas, 10(4), 307–316. [DOI:10.1016/0378-5122(88)90066-7]
    • Elaut, E., De Cuypere, G., De Sutter, P., Gijs, L., Van Trotsenburg, M., Heylens, G., Kaufman, J., Rubens, R., & T’Sjoen, G. (2008). Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels. European Journal of Endocrinology, 158(3), 393–399. [DOI:10.1530/eje-07-0511]
    • Jasonni, V., Bulletti, C., Naldi, S., Ciotti, P., Di Cosmo, D., Lazzaretto, R., & Flamigni, C. (1988). Biological and endocrine aspects of transdermal 17β-oestradiol administration in post-menopausal women. Maturitas, 10(4), 263–270. [DOI:10.1016/0378-5122(88)90062-x]
    • Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., Toye, K., Kaufman, J., & T’Sjoen, G. G. (2008). Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone, 43(6), 1016–1021. [DOI:10.1016/j.bone.2008.09.001]
    • Mazer, N. A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: With illustrative examples from male and female populations. Steroids, 74(6), 512–519. [DOI:10.1016/j.steroids.2009.01.008]
    • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016]
    • Odlind, V., Elamsson, K., Englund, D. E., Victor, A., & Johansson, E. D. (1982). Effects of oestradiol on sex hormone binding globulin. Acta Endocrinologica, 101(2), 248–253. [DOI:10.1530/acta.0.1010248] [PDF]
    • Quaynor, S. D., Stradtman, E. W., Kim, H., Shen, Y., Chorich, L. P., Schreihofer, D. A., & Layman, L. C. (2013). Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor α Variant. New England Journal of Medicine, 369(2), 164–171. [DOI:10.1056/nejmoa1303611]
    • Rinaldi, S., Geay, A., Déchaud, H., Biessy, C., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R. E., Riboli, E., Toniolo, P., & Kaaks, R. (2002). Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiology and Prevention Biomarkers, 11(10), 1065–1071. [Google Scholar] [PubMed] [URL]
    • Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3666–3672. [DOI:10.1210/jcem.84.10.6079]
    \ No newline at end of file +Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy - Transfeminine Science Link

    Supplement: The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy

    By Aly | First published July 8, 2020 | Last modified March 14, 2023

    Preface

    This article is a supplement to the article here. It was originally just for calculation of free sex hormone levels but I decided to add some other content to it as well.

    Calculation of Free Hormone Levels

    Spreadsheet Calculator (Mazer, 2009)

    A researcher developed and published a “user-friendly” spreadsheet that can be used to calculate free and bioavailable levels of several steroid hormones (Mazer, 2009). This spreadsheet approach is analogous to how free hormone levels are calculated with actual conventional blood work. Total hormone levels and levels of plasma proteins like albumin and SHBG are taken as inputs by the spreadsheet, and free and bioavailable hormone levels are given as outputs.

    The spreadsheet is supplementary material for Mazer (2009) and is behind a paywall. Because of this, I’ve uploaded a copy of the original spreadsheet here (Microsoft Excel or XLS format).

    If you’re curious how SHBG may be influencing your free estradiol percentage, you can use the spreadsheet to get an estimate. If you don’t have albumin, CBG, or cortisol values, you can use the default input values in the spreadsheet. If you don’t have other input values (e.g., estrone or SHBG), you can input representative values that are sensible for your scenario. It should be noted that calculated free hormone levels are only estimates and hence can be inaccurate. In any case, they are generally fairly close to the values that would be obtained with actual measurement. Use of default input values as opposed to real measured numbers may further contribute to inaccuracy.

    Some Experimentation with the Calculator

    Here are the results of some experimentation I did with the calculator:

    Table: Relationships between SHBG levels and calculated free estradiol fraction at fixed estradiol levels:

    SHBGEstradiol fixed ≤1,000 pg/mLEstradiol fixed 20,000 pg/mL
    LevelChange aFree E2 fractionChange aFree E2 fractionChange a
    0 nmol/L0.0×3.26%+77.2%3.26%+37.0%
    25 nmol/L0.5×2.36%+28.3%2.78%+16.8%
    50 nmol/L1.0×1.84%0%2.38%0%
    75 nmol/L1.5×1.50%–18.5%2.04%–14.3%
    100 nmol/L2.0×1.27%–31.0%1.77%–25.6%
    125 nmol/L2.5×1.10%–40.2%1.54%–35.3%
    150 nmol/L3.0×0.97%–47.3%1.36%–42.9%
    200 nmol/L4.0×0.79%–57.1%1.08%–54.6%
    250 nmol/L5.0×0.66%–64.1%0.89%–62.6%
    300 nmol/L6.0×0.57%–69.0%0.75%–68.5%
    350 nmol/L7.0×0.50%–72.8%0.65%–72.7%
    400 nmol/L8.0×0.44%–76.1%0.57%–76.1%

    a Change relative to a reasonable non-pregnancy physiological value (specifically 50 nmol/L for SHBG, 1.84% for free E2 at a fixed level of ≤1,000 pg/mL, 2.38% for free E2 at a fixed level of 20,000 pg/mL).

    Androgen levels were set to female levels, estrone levels were set to be the same as estradiol levels, and all other inputs besides SHBG and total estradiol levels were left as the defaults. There was very little variation in free estradiol fractions with different estradiol levels at and below 1,000 pg/mL for each given level of SHBG (hence why the table says “Estradiol fixed ≤1,000 pg/mL”).

    The estradiol levels fixed to ≤1,000 pg/mL are intended to represent typical therapeutic circumstances while the estradiol levels fixed to 20,000 pg/mL are supposed to represent late pregnancy.

    Note that since estradiol induces SHBG production, SHBG levels are strongly correlated with estradiol levels. Generally speaking, when estradiol is low, SHBG will also be low, and when estradiol is high, SHBG will also be high. Hence, having highly divergent SHBG and estradiol levels as in the table would be very unusual and is physiologically unrealistic. It is only explored here as a thought experiment.

    Note again that these free estradiol numbers are calculated and hence are only estimates.

    Other Papers on Calculation of Free Hormone Levels

    Aside from Mazer (2009), other papers like Vermeulen, Verdonck, & Kaufman (1999) and Rinaldi et al. (2002) also discuss calculation of free sex hormone levels and the validity of this approach.

    Other Online Free Hormone Calculators

    Another tool for calculating free estradiol and testosterone can be found here. Various other free testosterone calculators also exist on the web (Google Search).

    Additional Literature on SHBG and Free Estradiol

    Additional SHBG and Free Estradiol Clinical Studies

    Some more good studies on SHBG and free estradiol that weren’t discussed in the main article:

    Miscellaneous

    A case report of a young woman with estrogen insensitivity syndrome (EIS) (i.e., defective ERα) suggests that the ERα is the specific estrogen receptor that is responsible for increased SHBG production and levels with estrogens (Quaynor et al., 2013). Due to her EIS and lack of negative feedback on the hypothalamus–pituitary–gonadal axis, the woman had estradiol levels of as high as 3,500 pg/mL. In spite of this however, her SHBG levels remained less than 50 nmol/L. During pregnancy, at the point in the second trimester at which estradiol levels reach 3,000 pg/mL, SHBG levels are normally around 300 nmol/L on average (a 6-fold increase from a pre-pregnancy baseline of about 50 nmol/L).

    References

    • Ben-Rafael, Z., Mastroianni, L., Meloni, F., Strauss, J. F., & Flickinger, G. L. (1986). Changes in serum sex hormone-binding globulin, free estradiol, and testosterone during gonadotropin treatment. Fertility and Sterility, 46(4), 593–598. [DOI:10.1016/s0015-0282(16)49633-0]
    • Carlström, K., Pschera, H., & Lunell, N. (1988). Serum levels of oestrogens, progesterone, follicle-stimulating hormone and sex-hormone-binding globulin during simultaneous vaginal administration of 17β-oestradiol and progesterone in the pre- and post-menopause. Maturitas, 10(4), 307–316. [DOI:10.1016/0378-5122(88)90066-7]
    • Elaut, E., De Cuypere, G., De Sutter, P., Gijs, L., Van Trotsenburg, M., Heylens, G., Kaufman, J., Rubens, R., & T’Sjoen, G. (2008). Hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels. European Journal of Endocrinology, 158(3), 393–399. [DOI:10.1530/eje-07-0511]
    • Jasonni, V., Bulletti, C., Naldi, S., Ciotti, P., Di Cosmo, D., Lazzaretto, R., & Flamigni, C. (1988). Biological and endocrine aspects of transdermal 17β-oestradiol administration in post-menopausal women. Maturitas, 10(4), 263–270. [DOI:10.1016/0378-5122(88)90062-x]
    • Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., Toye, K., Kaufman, J., & T’Sjoen, G. G. (2008). Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone, 43(6), 1016–1021. [DOI:10.1016/j.bone.2008.09.001]
    • Mazer, N. A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: With illustrative examples from male and female populations. Steroids, 74(6), 512–519. [DOI:10.1016/j.steroids.2009.01.008]
    • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016]
    • Odlind, V., Elamsson, K., Englund, D. E., Victor, A., & Johansson, E. D. (1982). Effects of oestradiol on sex hormone binding globulin. Acta Endocrinologica, 101(2), 248–253. [DOI:10.1530/acta.0.1010248] [PDF]
    • Quaynor, S. D., Stradtman, E. W., Kim, H., Shen, Y., Chorich, L. P., Schreihofer, D. A., & Layman, L. C. (2013). Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor α Variant. New England Journal of Medicine, 369(2), 164–171. [DOI:10.1056/nejmoa1303611]
    • Rinaldi, S., Geay, A., Déchaud, H., Biessy, C., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R. E., Riboli, E., Toniolo, P., & Kaaks, R. (2002). Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiology and Prevention Biomarkers, 11(10), 1065–1071. [Google Scholar] [PubMed] [URL]
    • Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3666–3672. [DOI:10.1210/jcem.84.10.6079]
    \ No newline at end of file diff --git a/transfemscience.org/articles/shbg-unimportant/index.html b/transfemscience.org/articles/shbg-unimportant/index.html index 4ed546c3..abd15964 100644 --- a/transfemscience.org/articles/shbg-unimportant/index.html +++ b/transfemscience.org/articles/shbg-unimportant/index.html @@ -1 +1 @@ -The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy - Transfeminine Science Link

    The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy

    By Aly | First published July 10, 2020 | Last modified March 25, 2023

    Abstract / TL;DR

    Sex hormones such as testosterone and estradiol bind to blood proteins like albumin and SHBG. This limits their biological activity by reducing their free fractions. Androgens decrease SHBG production while estrogens increase SHBG production. Hence, testosterone and estradiol can influence their own free fractions. Due to robust inactivation in the liver, testosterone and estradiol have relatively small influences on SHBG levels under normal physiological circumstances. At very high levels however, they can considerably influence SHBG levels. During pregnancy, when there are massive increases in estradiol levels (e.g., 100-fold), a maximal 5- to 10-fold elevation in SHBG levels occurs. Although large increases in SHBG levels can strongly limit the biological activity of testosterone, the situation with estradiol is different. In late pregnancy, the percentage of estradiol that is free appears to be decreased only to around 60% of that of non-pregnancy. Earlier in pregnancy, when estradiol levels are lower, the free fractions of estradiol are reduced to a lesser extent. At typical therapeutic levels of estradiol in transfeminine hormone therapy (<200 pg/mL), the limiting influence of SHBG on free estradiol is minimal. Oral estradiol has a greater influence on SHBG production than non-oral estradiol and may be a different case however. In any case, consequent lesser activity of oral estradiol is only theoretical, and available clinical studies so far haven’t reported important therapeutic differences relative to non-oral estradiol. Although SHBG may reduce free estradiol fractions in some contexts, only relatively low estradiol levels (<50 pg/mL) appear to be needed for maximal feminization and breast development in cisgender females and transfeminine people. In conclusion, the influence of SHBG on the effectiveness of estradiol isn’t something that should be a major source of concern in transfeminine hormone therapy.

    Binding of Sex Hormones to Blood Proteins

    Sex hormones bind to proteins in the blood called plasma proteins. This is a phenomenon known as plasma protein binding. In the case of androgens and estrogens, the plasma proteins they bind to are mainly albumin and sex hormone-binding globulin (SHBG). Plasma protein binding serves to prevent sex hormones from interacting with their target cells and hence from binding to and activating their receptors (Hammond, 2016). This is because plasma proteins are too large and lipid-insoluble to cross the lipid-rich cell membrane. As a result, they’re unable to diffuse through capillaries to exit the circulation and enter into tissues or to be taken up into cells. When the sex hormone is bound to plasma protein, it can’t reach target cells either. Hence, plasma protein binding limits the biological activity of sex hormones (Hammond, 2016). Binding to plasma proteins also serves to extend the biological half-lives of sex hormones. This is because protein-bound sex hormone is likewise unavailable for metabolism and elimination, processes that depend on cellular uptake.

    There is only a single sex hormone binding site per molecule of SHBG (Moore & Bulbrook, 1988), whereas albumin has six binding sites for different substrates (Pardridge, 1988). Androgens and estradiol have high affinity for SHBG (nM) and low affinity for albumin (μM) (Moore & Bulbrook, 1988; Hammond, 2016). However, albumin levels are several orders of magnitude higher than SHBG levels (μM vs. nM), so this serves to balance out the fractions of sex hormone bound to each protein (Hammond, 2016). Androgens have higher affinities for SHBG than do estradiol or other estrogens. Estradiol has only about 10 to 20% of the affinity of dihydrotestosterone (DHT) and 33 to 50% of the affinity of testosterone for SHBG (Anderson, 1974; Ojasoo & Raynaud, 1978; Pugeat, Dunn, Nisula, 1981). As such, testosterone and DHT bind more strongly to SHBG than does estradiol.

    The vast majority of sex hormone content in the blood is bound to plasma proteins; at any given time more than 97% of the testosterone, estradiol, and progesterone in the blood is plasma protein-bound (Strauss & FitzGerald, 2019). The fraction of sex hormone that isn’t bound to plasma proteins is known as the free or unbound fraction. This is the fraction that is available for diffusion into cells and hence is considered to be biologically active (Hammond, 2016). Total levels refer to both free/unbound and bound hormone. Bioavailable levels include both albumin-bound and free hormone levels. Due to their relatively weak affinity for albumin, sex hormones bound to albumin may to some extent be biologically active—hence the “bioavailable” descriptor (Nguyen et al., 2008). However, more research is needed to fully elucidate the biological activity of albumin-bound sex hormone fractions.

    The relative calculated free and bound percentages of estradiol, testosterone, and DHT to albumin, SHBG, and another plasma protein known as corticosteroid-binding globulin (CBG) (only binds small fractions of the androgens and has no binding to estradiol) are shown in the table below.

    Table 1: Calculated plasma protein binding of sex hormones (Dunn, Nisula, & Rodbard, 1981):

    HormoneGroupAlbumin (%)SHBG (%)CBG (%)Free (%)
    EstradiolWomen (follicular)60.837.3<0.11.81
     Women (luteal)61.137.0<0.11.82
     Women (pregnant)11.787.8<0.10.49
     Men78.019.6<0.12.32
    TestosteroneWomen (follicular)30.466.02.261.36
     Women (luteal)30.765.72.201.37
     Women (pregnant)3.6095.40.820.23
     Men49.944.33.562.23
    DHTWomen (follicular)21.078.40.120.47
     Women (luteal)21.378.10.120.48
     Women (pregnant)2.1597.80.040.07
     Men39.259.70.220.88

    Free sex hormone levels and percentages are often calculated from levels of total sex hormone, albumin, SHBG, and CBG with validated mathematical models constructed from data of published studies. This is because free sex hormone levels are usually very low (pM range) and are difficult to measure with routine blood testing methods. While generally in the vicinity of the true values, calculated results may not always be fully accurate (Rosner, 2015; Goldman et al., 2017; Handelsman, 2017; Keevil & Adaway, 2019). As such, measured levels, when feasible, are preferable.

    Effects of Sex Hormones on SHBG Production

    Plasma proteins like albumin and SHBG are synthesized in the liver and are then secreted into the blood. In addition to binding to SHBG, sex hormones modulate the liver production of SHBG and hence influence their own plasma protein binding. Androgens decrease SHBG production while estrogens increase SHBG production (Anderson, 1974; Moore & Bulbrook, 1988). Administration of the anabolic steroid stanozolol (a synthetic DHT derivative) for just a few days suppresses SHBG levels by 63% (Krause et al., 2004). Continuous therapy with extreme doses of testosterone and other anabolic steroids decrease SHBG levels by 90% (Ruokonen et al., 1985; Moore & Bulbrook, 1988). Similarly, weakly androgenic progestins like medroxyprogesterone acetate (MPA), norethisterone (NET), and levonorgestrel (LNG) decrease SHBG production (Kuhl, 2005), and very high doses of medroxyprogesterone acetate and megestrol acetate (MGA) have been reported to decrease SHBG levels by up to around 50 to 90% (Heubner et al., 1987; Lundgren et al., 1990; Lundgren & Lønning, 1990). Conversely, combined birth control pills containing the synthetic estrogen ethinylestradiol (EE) (and a minimally androgenic or an antiandrogenic progestin) increase SHBG levels by about 4-fold (Odlind et al., 2002). High doses of oral synthetic estrogens, like EE and diethylstilbestrol (DES), increase SHBG levels by up to 5- to 10-fold (von Schoultz et al., 1989).

    Testosterone, DHT, and estradiol are strongly inactivated by the liver and have relatively weak effects in this part of the body under normal circumstances. As a result, they have much less relative impact on SHBG production than do synthetic hormonal agents. Accordingly, SHBG levels change only slightly over the course of the menstrual cycle in women despite substantial fluctuations in estradiol levels (Freymann et al., 1977b; Plymate et al., 1985; Schijf et al., 1993; Braunstein et al., 2011; Rothman et al., 2011; Fanelli et al., 2013; Rezaii et al., 2017). In one study, SHBG levels increased by about 6 to 13% (+2.9–5.3 nmol/L) going from the follicular phase to the luteal phase of the cycle (Braunstein et al., 2011). There is additionally only a small decrease in SHBG levels attributable to the sharp decline in estradiol with menopause (Burger et al., 2000; Guthrie et al., 2004). Nonetheless, estradiol therapy can more considerably influence the production of SHBG and other liver proteins as well under specific conditions (Kuhl, 1998). This is due to 1) use of oral estradiol, which because of the first pass through the liver has a greater impact on estrogen-sensitive liver synthesis than non-oral routes (Kuhl, 2005); and 2) use of high estradiol doses, for instance typical injectable doses. The table below shows SHBG increases from various studies with different estrogen routes, doses, and types.

    Table 2: Relative increases in SHBG levels with some different estrogenic exposures:

    EstrogenTypical E2 levels aSHBG increaseSource
    Oral E2 1 mg/day~25 pg/mL1.6×Kuhl (1998)
    Oral E2 2 mg/day~50 pg/mL2.2×Kuhl (1998)
    Oral E2 4 mg/day~100 pg/mL1.9–3.2×Fåhraeus & Larsson-Cohn (1982); Gibney
    et al. (2005)    ; Ropponen et al. (2005)
    Oral EV 6 mg/dayb~112.5 pg/mL2.5–3.0×Dittrich et al. (2005); Mueller et al. (2005);
    Mueller et al. (2006)
    E2 patch 50 μg/day~50 pg/mL1.1×Kuhl (2005)
    E2 patch 100 μg/day~100 pg/mL1.2×Shifren et al. (2008)
    E2 patches 200 μg/day~200 pg/mL~1.5×Smith et al. (2020)
    E2 patches 300 μg/day~300 pg/mL~1.7×Smith et al. (2020)
    E2 patches 600 μg/day~600 pg/mL2.3×Bland et al. (2005)
    EU 100 mg/month~550 pg/mL2.0×Derra (1981)
    PEP 320 mg/month~700 pg/mL1.7×Stege et al. (1988)
    EV 10 mg/10 daysVariable (high)3.2×Mueller et al. (2011) [Table]
    EV 10 mg/14 daysVariable (high)~3.2×Kronawitter et al. (2009) [Table]
    Oral EE 10 μg/day–3.0×Kuhl (1998)
    Oral EE 50 μg/day–4.0×Kuhl (1997)
    High-dose synthetic E–5–10×von Schoultz et al. (1989)

    a Estimated typical estradiol levels from various sources (e.g., Aly, 2020; Wiki). b Due to differences in molecular weight, EV has about 75% of the amount of estradiol as regular estradiol. Hence, 6 mg/day EV is approximately equivalent to 4.5 mg/day E2.

    The influence of estradiol on SHBG levels is most relevant to pregnancy, when estradiol levels increase to far higher levels than usual. In late pregnancy, estradiol levels are generally around 15,000 to 25,000 pg/mL on average (Graphs; Troisi et al., 2003; Adamcová et al., 2018). These estradiol levels are on the order of 100-fold higher than normal menstrual cycle levels. In parallel with the massive increases in estradiol levels, SHBG levels increase by about 5- to 10-fold by late pregnancy (Anderson, 1974; Hammond, 2017). The dose–response curve of estrogens on SHBG production shows saturation, with most of the increase in SHBG levels happening at lower estradiol levels as well as limits to how much SHBG levels can be increased (Mean, Pellaton, & Magrini, 1977; O’Leary et al., 1991; Kerlan et al., 1994; Kuhl, 1999). The graphs below show SHBG levels throughout pregnancy.

    Figure 1: SHBG and total estradiol levels during pregnancy in women (O’Leary et al., 1991). The lines are the mean and/or 95th percentile levels while the points are individual measurements.
    Figure 2: Total sex hormone and SHBG levels during pregnancy in women (Kerlan et al., 1994).

    Effects of SHBG Increase on Free Sex Hormone Levels

    Changes in SHBG levels result in changes in SHBG-bound and free sex hormone levels. Aside from DHT, estradiol and testosterone are the hormones of the greatest interest in this regard.

    SHBG Increase and Free Testosterone

    EE-containing birth control pills, with their 4-fold increase in SHBG levels, substantially decrease the free percentage of testosterone (Graham et al., 2007; Zimmerman et al., 2014). In one study, an EE-containing birth control pill decreased the free testosterone fraction from 2.45% to 0.78% (a 3.2-fold decrease or to 32% of baseline) (Graham et al., 2007). Due to concomitant suppression of testosterone production and hence reduced total testosterone levels, free testosterone levels decreased from 0.89 pg/mL to 0.18 pg/mL (a 5-fold decrease, to 20% of baseline) (Graham et al., 2007). The influence of EE on SHBG levels contributes significantly to the antiandrogenic effects of EE-containing birth control pills, which are taken advantage of therapeutically to treat acne and hirsutism in women.

    During pregnancy, testosterone levels increase to as much as 150 ng/dL (around 5-fold higher than non-pregnancy levels) (McClamrock, 2007). The increase in SHBG production during pregnancy serves an important function in that the higher SHBG levels neutralize the biological activity of the increased testosterone levels (Hammond, 2017). In one study, the free testosterone fraction was 6-fold lower in late pregnancy than in non-pregnant women (0.23% vs. 1.36%—or to 17% of non-pregnancy) (Dunn, Nisula, & Rodbard, 1981). Hence, despite substantial increases in total testosterone levels during pregnancy, free testosterone levels and by extension androgenic action in the body change minimally (Barini, Liberale, & Menini, 1993; Schuijt et al., 2019). A case report of marked hyperandrogenism due to severe SHBG deficiency in a pregnant woman evidences the role of SHBG in limiting the androgenic actions of testosterone during this time (Hogeveen et al., 2002; Hammond, 2017).

    SHBG Increase and Free Estradiol

    Endogenous and Non-Oral Estradiol

    The research indicates that increases in SHBG levels and by extension decreases in the free estradiol fraction are minimal with physiological levels of estradiol (e.g., <200 pg/mL). This is the case whether the estradiol is endogenous or exogenous in origin—so long as it is taken non-orally. Such conclusions are based on both calculated and measured studies of free estradiol (e.g., Freymann et al., 1977b).

    Increases in SHBG levels and decreases in the free estradiol fraction become more significant with supraphysiological levels of estradiol however, for instance during pregnancy and with very-high-dose estradiol therapy. Studies on changes in free estradiol with high doses of estradiol are few. This is especially true in the case of measured as opposed to calculated free estradiol. In any case, one can look at pregnancy to gain insight on the question of free estradiol with high estradiol levels. Moreover, due to the very high estradiol levels in pregnancy, free estradiol is more amenable to measurement during this time. Accordingly, multiple studies of measured free estradiol in pregnancy are available.

    Although free estradiol percentages during pregnancy certainly decrease, the increases in estradiol are far from neutralized by SHBG. Hence, the situation with free estradiol in pregnancy is very different from that of testosterone. This is illustrated in the following excerpt (Rubinow et al., 2002):

    Pregnancy is accompanied by a slow but sustained rise in the plasma levels of many steroid and peptide hormones and is followed by a precipitous drop in their levels over the first few days after delivery. By the third trimester of pregnancy, plasma progesterone levels average approximately 150 ng/ml and estradiol levels range from 10 to 15 ng/ml. These amounts represent a 10- and 50-fold increase, respectively, of maximum menstrual cycle levels (Tulchinsky et al., 1972). Although only a small fraction of these steroids are unbound, the amount of “free” (and thus biologically active) progesterone and estrogen also undergo similarly large increases during pregnancy (Heidrich et al., 1994).

    In the study by Heidrich and colleagues cited in the excerpt, total estradiol levels at the time of delivery were 21,500 pg/mL and measured free estradiol levels were 232 pg/mL, with a resultant free estradiol fraction of 1.08% (Heidrich et al., 1994). For context, the free estradiol percentage in non-pregnant women ranges from 1.5 to 2.1% with RIA, while actual free estradiol levels are 0.30 to 4.1 pg/mL with RIA and 0.40 to 5.9 pg/mL with LC–MS/MS (Nakamoto, 2016). Hence, in this study free estradiol levels in late pregnancy were around 50-fold higher than maximal non-pregnancy levels.

    Due to variable methodology, the findings of a single study may not be representative. As such, the table below provides measured free estradiol percentages in late pregnancy from several studies.

    Table 3: Measured free estradiol percentages in late pregnancy (mean ± SD) (Perry et al., 1987):

    StudyMethodnFree E2 (%)
    Perry et al. (1987)Centrifugal ultrafiltration251.27 ± 0.23
    Hammond et al. (1980)Centrifugal ultrafiltration50.96 ± 0.12
    Heidrich et al. (1994)Centrifugal ultrafiltration261.08
    Tulchinsky et al. (1973)Equilibrium dialysis50.67 ± 0.18
    Freymann et al. (1977a)Equilibrium dialysis171.15
    Anderson et al. (1985)Steady-state gel filtration121.48 ± 0.55

    As can be seen in the table, the free estradiol fraction in late pregnancy ranges from about 0.7 to 1.5%. Results for the free estradiol fraction from studies using calculated free estradiol levels in late pregnancy rather than measured levels are similar to measured findings, although sometimes a bit lower in comparison (e.g., 0.5%) (Dunn, Nisula, & Rodbard, 1981; Campino et al., 2001). The measured free estradiol percentage in late pregnancy can be cautiously compared to the fraction of 1.5 to 2.1% in non-pregnant women. Using middle values from these ranges, the free estradiol fraction in late pregnancy may be somewhere around 60% of that of non-pregnancy. This estimate is quite close to the actual findings of a study, which observed a decrease in the measured free estradiol percentage to 55% of that of non-pregnancy (Freymann et al., 1977a; Freymann et al., 1977b).

    In contrast to estradiol, the free percentages of estrone and estriol are not different in late pregnancy when compared to non-pregnancy (Tulchinsky & Chopra, 1973; Steingold et al., 1987). This is attributable to the much lower affinities of estrone and estriol for SHBG relative to estradiol (Kuhl, 2005).

    Studies have also assessed free estradiol fractions earlier in pregnancy, which might in theory differ from late pregnancy. The results of a study that measured free estradiol throughout pregnancy are shown in the table below (Freymann et al., 1977a; Freymann et al., 1977b).

    Table 4: Total and free estradiol in pregnancy (mean ± SD) (Freymann et al., 1977a; Freymann et al., 1977b):

    ContextnE2 (ng/mL)ChangeFree E2 (%)ChangeFree E2 (pg/mL)Change
    Non-pregnant350.16 ± 0.101.0×2.2 ± 0.4–0%3.5 ± 2.01.0×
    Pregnancy       
    6–20 weeks92.0 ± 1.113×1.6 ± 0.4–27%32 ± 219.1×
    12–20 weeks105.5 ± 2.234×1.3 ± 0.3–41%72 ± 3921×
    20–30 weeks1210.8 ± 4.668×1.2 ± 0.3–45%130 ± 7437×
    30–38 weeks1716.0 ± 7.0100×1.2 ± 0.2–45%184 ± 10353×

    In similar studies by another group of researchers, free estradiol fractions were measured in earlier pregnancy (weeks 7–16) and were found to be lower than those obtained by Freymann and colleagues (Bernstein et al., 1986; Depue et al., 1987; Bernstein et al., 1988). The free estradiol percentage was about 0.9 or 1.0% at 10 weeks and about 0.7% at 12 weeks (Bernstein et al., 1986; Depue et al., 1987; Bernstein et al., 1988). Hence, as with the results of Freymann and colleagues, the free estradiol fraction decreased as pregnancy progressed. The figure below provides a visualization of the findings.

    Figure 3: Changes in total and free estradiol levels (pg/mL), free estradiol fraction (%), and SHBG binding capacity (μg/dL) during weeks 7 to 16 of pregnancy in women (Bernstein et al., 1986).

    Free estradiol during pregnancy can also be calculated using total estradiol levels and SHBG levels. I roughly calculated the free estradiol fraction during pregnancy using the data from O’Leary et al. (1991) and a published calculator spreadsheet by Mazer (2009) (Aly, 2020). The results are shown below.

    Figure 4: Average measured total estradiol and SHBG levels (O’Leary et al., 1991) and calculated free estradiol percentage (Mazer, 2009) throughout pregnancy in women. Another version of this graph scaled to only the first trimester of pregnancy (when estradiol levels are typically ≤2,000 pg/mL) is also provided (Graph).

    The free estradiol fractions in the figure are merely rough estimations and hence should be given conservative consideration. In any case, they are similar to the findings of the available studies on measured free estradiol in earlier pregnancy just discussed—for instance in magnitude (relative to Bernstein et al.) and pattern of change throughout pregnancy (relative to both Bernstein et al. and Freymann et al.). As such, these calculated values offer a plausible and interesting model.

    To summarize, there are profound increases in total estradiol levels and proportionally lower but still substantial increases in SHBG levels during pregnancy. In accordance with the marked increase in SHBG levels, the free estradiol fraction progressively decreases over the course of pregnancy. Studies are conflicting on the exact degrees to which free estradiol percentages decrease. In any case, the possibilities for the free estradiol fraction by late pregnancy range from about 0.5 to 1.5%. These figures can be compared to non-pregnancy free estradiol percentages of 1.5 to 2.1%. This may correspond to a maximal decrease in the free estradiol fraction in late pregnancy to around 60% of non-pregnancy. At the greatest extreme, the decrease may be to around 25% of non-pregnancy. Conversely, in earlier pregnancy, when estradiol levels are lower, free estradiol percentages are higher.

    Despite the decreases in the free estradiol fraction during pregnancy, there are profound increases in free estradiol levels that parallel the massive increases in total estradiol. As such, the increase in estradiol levels during pregnancy markedly exceeds the limiting influences of the simultaneously elevated SHBG levels. For this reason, pregnancy is a profoundly hyperestrogenic state.

    SHBG doesn’t impact estradiol like it does testosterone during pregnancy because the proportional increases in estradiol levels relative to SHBG levels are far greater in comparison and because of the relatively lower affinity of estradiol for SHBG. In general, it’s not possible for SHBG to limit the activity of estradiol in the way that it can with testosterone due to the inherent requirement for substantially increased SHBG production of much more highly increased estradiol levels.

    Oral Estradiol

    Oral estradiol may differ from non-oral estradiol when it comes to the issue of free estradiol. This is because oral estradiol undergoes a first pass that results in greater estradiol levels in the liver relative to the circulation. As a result, oral estradiol has disproportionate liver effects and increases SHBG levels to a proportionally greater extent than non-oral estradiol. Hence, the greater SHBG increases with oral estradiol may result in lower free estradiol fractions than with non-oral estradiol.

    While this is probable, it is more difficult to determine the precise magnitudes of the differences between oral and non-oral estradiol in terms of free estradiol. Some data are available however. Clinical studies of low-dose oral estradiol in menopausal cisgender women have reported the limiting influence of the SHBG increase on calculated free estradiol to be modest (Nilsson, Holst, & von Schoultz, 1984; Nachtigall et al., 2000). Likewise, oral estradiol appears to have similar effectiveness for menopausal symptoms when compared to non-oral estradiol (Wiki; 2nd paragraph). Studies of higher doses of oral estradiol that provide data on SHBG or free estradiol levels are rare. In any case, a few studies by one group found that 6 mg/day oral estradiol valerate (a dose equivalent to approximately 4.5 mg/day oral estradiol) increased SHBG levels by about 2.5- to 3.0-fold in transgender women (Dittrich et al., 2005; Mueller et al., 2005; Mueller et al., 2006). Using the numbers from one of the studies for total estradiol and SHBG levels, it can be roughly calculated (Mazer, 2009) that the free estradiol fraction may have decreased from around 2.1% to 1.2% (a 43% reduction). Analogously, a study using oral conjugated estrogens (CEEs; Premarin) at a dose that increased SHBG levels by 2.3-fold reported that the calculated free estradiol percentage was 40% lower relative to an equivalent dose of transdermal estradiol (in terms of total estradiol levels) (Shifren et al., 2007). These findings suggest a non-trivial reduction in the free estradiol fraction with typical doses of oral estradiol in transfeminine people. Consequently, it’s possible that oral estradiol could be to a certain degree less potent at the same total estradiol levels relative to non-oral estradiol.

    It’s important to be clear that it’s also not a certainty however. Levels of estrone are much higher with oral estradiol than with non-oral estradiol (~5-fold) (Kuhl, 2005), and estrone, although far less potent than estradiol, has significant intrinsic estrogenic activity similarly to estradiol (Kuhl, 2005). The degree to which estrone might add to the estrogenic activity of estradiol, if at all, is uncertain. In any case, it’s within the realm of possibility that estrone could contribute significantly to the estrogenic activity of oral estradiol (Pande et al., 2019). This additional estrogenic exposure could potentially serve to offset the impact of the higher SHBG levels and reduced free estradiol fractions that occur with oral estradiol. Further research is needed to evaluate such a possibility however. As another consideration, the higher SHBG levels with oral estradiol can be expected to reduce the free testosterone fraction in addition to that of estradiol (and to an even greater extent in comparison). This is important as testosterone suppression is a key therapeutic effect of estradiol in transfeminine people and the main justified reason for use of higher estradiol levels. Due to possibilities like these and the fact that free levels of hormones only theoretically represent their biological activity, it shouldn’t necessarily be assumed that oral estradiol is less potent or efficacious than non-oral estradiol. Only further clinical studies comparing oral estradiol to non-oral estradiol will be able to clarify this question.

    Relevance for Transfeminine Hormone Therapy

    Some have concerns that SHBG may substantially limit the effectiveness of estradiol and thereby hinder feminization and/or breast development. Some have even claimed that high levels of estradiol may be less effective than lower levels as a result of SHBG increases at higher levels. Before even touching on SHBG however, such notions are likely to be misguided. This is because low estradiol levels (<50 pg/mL) are known to be fully effective in terms of feminization and breast development. This is evidenced by normal and induced puberty in cisgender girls (Aly, 2020), as well as by the excellent secondary sexual development of women with complete androgen insensitivity syndrome (CAIS) (Aly, 2020; Wiki). No evidence exists at this time to indicate that higher estradiol levels are necessary or beneficial in terms of feminization or breast development (Nolan & Cheung, 2020). Available studies in fact suggest no relationship between estradiol levels and breast development in transfeminine people at typical therapeutic levels of estradiol (e.g., 50–200 pg/mL) (de Blok et al., 2017; Meyer et al., 2020; de Blok et al., 2020). This is in accordance with the concept of the maximal effect of estradiol on feminization and breast development being established at lower estradiol levels. Hence, besides the use of higher estradiol levels for testosterone suppression in transfeminine people, concerns about incomplete feminizing efficacy of estradiol consequent to inadequate estrogenic exposure have little basis.

    If SHBG is nonetheless explored however, the research indicates that the role of SHBG in restricting free estradiol, and hence presumably the biological activity of estradiol, is only so considerable. Within physiological non-pregnancy ranges for estradiol (e.g., <200 pg/mL), changes in SHBG levels and free estradiol fractions due to endogenous or non-oral estradiol are minimal. Very high estradiol levels have greater influence on SHBG production than normal physiological levels however. During pregnancy, with the massive increases in estradiol and resultant 5- to 10-fold maximal elevation in SHBG levels, the free estradiol percentage may be decreased to around 60% of that of non-pregnancy. But actual free estradiol levels are nonetheless profoundly increased in pregnancy. Moreover, increases in SHBG levels and decreases in free estradiol fraction earlier in pregnancy are lower than in late pregnancy. Even with among the highest estradiol levels that would normally be encountered with non-oral estradiol therapy, the decreases in the free estradiol fraction due to SHBG are likely to be modest. The impact of such a reduction could easily be negated by a slightly greater estradiol dose.

    While the preceding is applicable to non-oral estradiol, oral estradiol has a greater influence on SHBG production in comparison and hence the higher SHBG levels with oral estradiol could result in more significant limitation of free estradiol than with non-oral estradiol. The notion that this reduction in free estradiol corresponds to a decrease in the activity or potency of oral estradiol is only a theoretical possibility however. Therapeutically, oral estradiol has shown itself to be very effective. The decreases in free estradiol percentage with low-dose oral estradiol seem to be small. In addition, while no direct comparisons exist this time, higher doses of oral estradiol seem to show similar testosterone suppression as non-oral estradiol (Wiki; Graphs). Besides testosterone suppression, available studies have found no differences between oral and non-oral estradiol in terms of outcomes like breast development or feminization (Sam, 2020). As such, the differences between oral and non-oral estradiol in terms SHBG levels and free estradiol fraction may be of little therapeutic importance.

    Aside from decreasing free estradiol fractions, increased SHBG levels also decrease free testosterone fractions to an even greater extent. This is advantageous in the case of transfeminine people.

    Taken together, lower free estradiol due to increased SHBG levels, whether with non-oral or oral estradiol, isn’t something that should be a major source of concern in transfeminine hormone therapy.

    Supplementary Material

    See here for supplementary material for this article, including a spreadsheet and other calculators that can be used to estimate free hormone levels (e.g., Mazer, 2009).

    References

    • Adamcová, K., Kolátorová, L., Škodová, T., Šimková, M., Pařízek, A., Stárka, L., & Dušková, M. (2018). Steroid hormone levels in the peripartum period – differences caused by fetal sex and delivery type. Physiological Research, 67(Suppl 3), S489–S497. [DOI:10.33549/physiolres.934019]
    • Anderson, D. C. (1974). Sex-Hormone-Binding Globulin. Clinical Endocrinology, 3(1), 69–96. [DOI:10.1111/j.1365-2265.1974.tb03298.x]
    • Anderson, P. J., Hancock, K. W., & Oakey, R. E. (1985). Non-protein-bound oestradiol and progesterone in human peripheral plasma before labour and delivery. Journal of Endocrinology, 104(1), 7–15. [DOI:10.1677/joe.0.1040007]
    • Barini, A., Liberale, I., & Menini, E. (1993). Simultaneous Determination of Free Testosterone and Testosterone Bound to Non-Sex-Hormone-Binding Globulin by Equilibrium Dialysis. Clinical Chemistry, 39(6), 936–941. [DOI:10.1093/clinchem/39.6.936]
    • Bernstein, L., Depue, R. H., Ross, R. K., Judd, H. L., Pike, M. C., & Henderson, B. E. (1986). Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. Journal of the National Cancer Institute, 76(6), 1035–1039. [DOI:10.1093/jnci/76.6.1035]
    • Bernstein, L., Pike, M., Depue, R., Ross, R., Moore, J., & Henderson, B. (1988). Maternal hormone levels in early gestation of cryptorchid males: a case-control study. British Journal of Cancer, 58(3), 379–381. [DOI:10.1038/bjc.1988.223]
    • Bland, L. B., Garzotto, M., DeLoughery, T. G., Ryan, C. W., Schuff, K. G., Wersinger, E. M., Lemmon, D., & Beer, T. M. (2005). Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer, 103(4), 717–723. [DOI:10.1002/cncr.20857]
    • Braunstein, G. D., Reitz, R. E., Buch, A., Schnell, D., & Caulfield, M. P. (2011). Testosterone Reference Ranges in Normally Cycling Healthy Premenopausal Women. The Journal of Sexual Medicine, 8(10), 2924–2934. [DOI:10.1111/j.1743-6109.2011.02380.x]
    • Burger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000). A Prospective Longitudinal Study of Serum Testosterone, Dehydroepiandrosterone Sulfate, and Sex Hormone-Binding Globulin Levels through the Menopause Transition. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2832–2838. [DOI:10.1210/jcem.85.8.6740]
    • Campino, C., Torres, C., Rioseco, A., Poblete, A., Pugin, E., Valdés, V., Catalán, S., Belmar, C., & Serón-Ferré, M. (2001). Plasma prolactin/oestradiol ratio at 38 weeks gestation predicts the duration of lactational amenorrhoea. Human Reproduction, 16(12), 2540–2545. [DOI:10.1093/humrep/16.12.2540]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de Blok, C. J., Dijkman, B. A., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K. M., & den Heijer, M. (2020). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • Depue, R. H., Bernstein, L., Ross, R. K., Judd, H. L., & Henderson, B. E. (1987). Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: A seroepidemiologic study. American Journal of Obstetrics and Gynecology, 156(5), 1137–1141. [DOI:10.1016/0002-9378(87)90126-8]
    • Derra, C. (1981). Hormonprofile unter Östrogen- und Antiandrogentherapie bei Patienten mit Prostatakarzinom: Östradiolundecylat versus Cyproteronacetat. [Hormone Profiles under Estrogen and Antiandrogen Therapy in Patients with Prostate Cancer: Estradiol Undecylate versus Cyproterone Acetate.] (Doctoral dissertation, University of Mainz.) [Google Scholar] [WorldCat] [PDF] [Translation]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Dunn, J. F., Nisula, B. C., & Rodbard, D. (1981). Transport of Steroid Hormones: Binding of 21 Endogenous Steroids to Both Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma. The Journal of Clinical Endocrinology & Metabolism, 53(1), 58–68. [DOI:10.1210/jcem-53-1-58]
    • Fåhraeus, L., & Larsson-Cohn, U. (1982). Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17β to menopausal women. Acta Endocrinologica, 101(4), 592–596. [DOI:10.1530/acta.0.1010592]
    • Fanelli, F., Gambineri, A., Belluomo, I., Repaci, A., Di Lallo, V. D., Di Dalmazi, G., Mezzullo, M., Prontera, O., Cuomo, G., Zanotti, L., Paccapelo, A., Morselli-Labate, A. M., Pagotto, U., & Pasquali, R. (2013). Androgen Profiling by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women. The Journal of Clinical Endocrinology & Metabolism, 98(7), 3058–3067. [DOI:10.1210/jc.2013-1381]
    • Freymann, E., Hubl, W., Büchner, M., & Belleée, H. (1977). Eine spezifische, radioimmunologische Bestimmung des Plasmaöstradiols ohne Chromatographie im Zyklus und in der Schwangerschaft und die Bestimmung des freien, nichtproteingebundenen Anteils mittels Dialyse. [A specific radioimmunologi determination of plasma estradiol without chromatography during the cycle and in pregnancy and determination of the free non-protein-bound fraction using dialysis.] Zentralblatt für Gynäkologie, 99(6), 321–329. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF]
    • Freymann, E., Hubl, W., Büchner, M., & Rohde, W. (1977). Plasma levels of apparent free estradiol during pregnancy. Endokrinologie, 69(2), 269–271. [Google Scholar] [PubMed] [PDF]
    • Gibney, J., Johannsson, G., Leung, K., & Ho, K. K. (2005). Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women. The Journal of Clinical Endocrinology & Metabolism, 90(7), 3897–3903. [DOI:10.1210/jc.2005-0173]
    • Goldman, A. L., Bhasin, S., Wu, F. C., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017). A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications. Endocrine Reviews, 38(4), 302–324. [DOI:10.1210/er.2017-00025]
    • Graham, C. A., Bancroft, J., Doll, H. A., Greco, T., & Tanner, A. (2007). Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology, 32(3), 246–255. [DOI:10.1016/j.psyneuen.2006.12.011]
    • Guthrie, J., Dennerstein, L., Taffe, J., Lehert, P., & Burger, H. (2004). The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric, 7(4), 375–389. [DOI:10.1080/13697130400012163]
    • Hammond, G. L., Nisker, J. A., Jones, L. A., & Siiteri, P. K. (1980). Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. Journal of Biological Chemistry, 255(11), 5023–5026. [DOI:10.1016/s0021-9258(19)70742-x]
    • Hammond, G. L. (2016). Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. Journal of Endocrinology, 230(1), R13–R25. [DOI:10.1530/joe-16-0070]
    • Hammond, G. L. (2017). Sex Hormone-Binding Globulin and the Metabolic Syndrome. In Winters, S. J., & Huhtaniemi, I. T. (Eds.). Male Hypogonadism: Basic, Clinical and Therapeutic Principles (pp. 305–324). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-53298-1_15]
    • Handelsman, D. J. (2017). Free Testosterone: Pumping up the Tires or Ending the Free Ride? Endocrine Reviews, 38(4), 297–301. [DOI:10.1210/er.2017-00171]
    • Heidrich, A., Schleyer, M., Spingler, H., Albert, P., Knoche, M., Fritze, J., & Lanczik, M. (1994). Postpartum blues: Relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. Journal of Affective Disorders, 30(2), 93–98. [DOI:10.1016/0165-0327(94)90036-1]
    • Heubner, A., Brockerhoff, P., Kreienberg, R., Grill, H., Rathgen, G., & Pollow, K. (1987). The influence of various dosages of megestrol acetate on SHBG, CBG and lipoprotein patterns. Journal of Steroid Biochemistry, 28(Suppl 1), 214S–214S (abstract no. 6). [DOI:10.1016/0022-4731(87)91680-3]
    • Hogeveen, K. N., Cousin, P., Pugeat, M., Dewailly, D., Soudan, B., & Hammond, G. L. (2002). Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. The Journal of Clinical Investigation, 109(7), 973–981. [DOI:10.1172/JCI14060]
    • Keevil, B. G., & Adaway, J. (2019). Assessment of free testosterone concentration. The Journal of Steroid Biochemistry and Molecular Biology, 190, 207–211. [DOI:10.1016/j.jsbmb.2019.04.008]
    • Kerlan, V., Nahoul, K., Martelot, M., & Bercovici, J. (1994). Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clinical Endocrinology, 40(2), 263–267. [DOI:10.1111/j.1365-2265.1994.tb02478.x]
    • Krause, A., Sinnecker, G., Hiort, O., Thamm, B., & Hoepffner, W. (2004). Applicability of the SHBG Androgen Sensitivity Test in the Differential Diagnosis of 46,XY Gonadal Dysgenesis, True Hermaphroditism, and Androgen Insensitivity Syndrome. Experimental and Clinical Endocrinology & Diabetes, 112(5), 236–240. [DOI:10.1055/s-2004-817969]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265] [Table]
    • Kuhl, H. (1997). Metabolische Effekte der Östrogene und Gestagene. [Metabolic Effects of Estrogens and Progestogens.] Der Gynäkologe, 30(4), 357–369. [DOI:10.1007/pl00003042]
    • Kuhl, H. (1998). Adverse effects of estrogen treatment: natural vs. synthetic estrogens. In Lippert, T. H., Mueck, A. O., & Ginsburg, J. (Eds.). Sex Steroids and the Cardiovascular System: The Proceedings of the 1st Interdisciplinary Workshop, Tuebingen, Germany, October 1996. Parthenon Publishing Group, New York, London (pp. 201–210). London/New York: Parthenon. [Google Scholar] [Google Books] [PDF]
    • Kuhl, H. (1999). Hormonal contraception. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 363–407). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_18] [PDF]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Lundgren, S., Lønning, P., Utaaker, E., Aakvaag, A., & Kvinnsland, S. (1990). Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer—I. General findings. Journal of Steroid Biochemistry, 36(1–2), 99–104. [DOI:10.1016/0022-4731(90)90118-c]
    • Lundgren, S., & Lønning, P. (1990). Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer—II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin. Journal of Steroid Biochemistry, 36(1–2), 105–109. [DOI:10.1016/0022-4731(90)90119-d]
    • Mazer, N. A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: With illustrative examples from male and female populations. Steroids, 74(6), 512–519. [DOI:10.1016/j.steroids.2009.01.008] [Spreadsheet]
    • McClamrock, H. D. (2007). Pregnancy-Related Androgen Excess. In Azziz, R., Nestler, J. E., & Dewailly, D. (Eds.). Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders, 2nd Edition (Contemporary Endocrinology) (pp. 107–119). Totowa, New Jersey: Humana Press. [Google Books] [DOI:10.1007/978-1-59745-179-6_9]
    • Mean, F., Pellaton, M., & Magrini, G. (1977). Study on the binding of dihydrotestosterone, testosterone and oestradiol with sex hormone binding globulin. Clinica Chimica Acta, 80(1), 171–180. [DOI:10.1016/0009-8981(77)90276-5]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463] [PDF]
    • Moore, J. W., & Bulbrook, R. D. (1988). The epidemiology and function of sex hormone-binding globulin. Oxford Reviews of Reproductive Biology, 10, 180–236. [Google Scholar] [PubMed] [PDF]
    • Mueller, A., Dittrich, R., Binder, H., Kuehnel, W., Maltaris, T., Hoffmann, I., & Beckmann, M. W. (2005). High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. European Journal of Endocrinology, 153(1), 107–113. [DOI:10.1530/eje.1.01943]
    • Mueller, A., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Dittrich, R. (2006). Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female Transsexuals. Hormone and Metabolic Research, 38(3), 183–187. [DOI:10.1055/s-2006-925198]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • Nachtigall, L. E., Raju, U., Banerjee, S., Wan, L., & Levitz, M. (2000). Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies. Menopause, 7(4), 243–250. [DOI:10.1097/00042192-200007040-00006]
    • Nakamoto, J. (2016). Endocrine Testing. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition (pp. 2655–2688.e1). Philadelphia: Saunders/Elsevier. [Google Books] [DOI:10.1016/B978-0-323-18907-1.00154-2]
    • Nguyen, T. D. T., Dolomie-Fagour, L., Georges, A., & Corcuff, J. B. (2008). Dosage des stéroïdes sexuels sériques: quelle place pour l’estradiol biodisponible? [What about bioavailable estradiol?] Annales de Biologie Clinique, 66(5), 493–497. [DOI:10.1684/abc.2008.0259]
    • Nilsson, B., Holst, J., & Schoultz, B. (1984). Serum levels of unbound 17β-oestradiol during oral and percutaneous postmenopausal replacement therapy. British Journal of Obstetrics and Gynaecology, 91(10), 1031–1036. [DOI:10.1111/j.1471-0528.1984.tb03683.x]
    • Nolan, B. J., & Cheung, A. S. (2021). Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review. Transgender Health, 6(3), 125–131. [DOI:10.1089/trgh.2020.0077]
    • O’Leary, P., Boyne, P., Flett, P., Beilby, J., & James, I. (1991). Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clinical Chemistry, 37(5), 667–672. [DOI:10.1093/clinchem/37.5.667]
    • Odlind, V., Milsom, I., Persson, I., & Victor, A. (2002). Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstetricia et Gynecologica Scandinavica, 81(6), 482–490. [DOI:10.1034/j.1600-0412.2002.810603.x]
    • Ojasoo, T., & Raynaud, J. P. (1978). Unique steroid congeners for receptor studies. Cancer Research, 38(11 Part 2), 4186–4198. [Google Scholar] [PubMed] [URL]
    • Pande, P., Fleck, S. C., Twaddle, N. C., Churchwell, M. I., Doerge, D. R., & Teeguarden, J. G. (2019). Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: Total estrogenicity calculations accounting for competitive protein and receptor binding and potency. Food and Chemical Toxicology, 125, 341–353. [DOI:10.1016/j.fct.2018.12.013]
    • Pardridge, W. M. (1988). Selective delivery of sex steroid hormones to tissues by albumin and by sex hormone-binding globulin. Oxford Reviews of Reproductive Biology, 10, 237–292. [Google Scholar] [PubMed] [PDF]
    • Perry, L., Wathen, N., & Chard, T. (1987). Saliva Levels of Oestradiol and Progesterone in Relation to Non-Protein-Bound Concentrations in Blood During Late Pregnancy. Hormone and Metabolic Research, 19(9), 444–447. [DOI:10.1055/s-2007-1011848]
    • Plymate, S. R., Moore, D. E., Cheng, C. Y., Bardin, C. W., Southworth, M. B., & Levinski, M. J. (1985). Sex Hormone-Binding Globulin Changes during the Menstrual Cycle. The Journal of Clinical Endocrinology & Metabolism, 61(5), 993–996. [DOI:10.1210/jcem-61-5-993]
    • Pugeat, M. M., Dunn, J. F., & Nisula, B. C. (1981). Transport of Steroid Hormones: Interaction of 70 Drugs with Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma. The Journal of Clinical Endocrinology & Metabolism, 53(1), 69–75. [DOI:10.1210/jcem-53-1-69]
    • Rezaii, T., Gustafsson, T. P., Axelson, M., Zamani, L., Ernberg, M., Hirschberg, A. L., & Carlström, K. A. (2017). Circulating androgens and SHBG during the normal menstrual cycle in two ethnic populations. Scandinavian Journal of Clinical and Laboratory Investigation, 77(3), 184–189. [DOI:10.1080/00365513.2017.1286685]
    • Ropponen, A., Aittomäki, K., Vihma, V., Tikkanen, M. J., & Ylikorkala, O. (2005). Effects of Oral and Transdermal Estradiol Administration on Levels of Sex Hormone-Binding Globulin in Postmenopausal Women with and without a History of Intrahepatic Cholestasis of Pregnancy. The Journal of Clinical Endocrinology & Metabolism, 90(6), 3431–3434. [DOI:10.1210/jc.2005-0352]
    • Rosner, W. (2015). Free estradiol and sex hormone-binding globulin. Steroids, 99, 113–116. [DOI:10.1016/j.steroids.2014.08.005]
    • Rothman, M. S., Carlson, N. E., Xu, M., Wang, C., Swerdloff, R., Lee, P., Goh, V. H., Ridgway, E. C., & Wierman, M. E. (2011). Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometry. Steroids, 76(1–2), 177–182. [DOI:10.1016/j.steroids.2010.10.010]
    • Rubinow, D. R., Schmidt, P. J., Roca, C. A., & Daly, R. C. (2002). Gonadal Hormones and Behavior in Women: Concentrations versus Context. In Pfaff, D. W., Arnold, A. P., Etgen, A. M., Fahrbach, S. E., & Rubin, R. T. (Eds.). Hormones, Brain and Behavior, Volume 5 (pp. 37–73). Amsterdam: Academic Press. [Google Books] [DOI:10.1016/B978-012532104-4/50086-X]
    • Ruokonen, A., Alén, M., Bolton, N., & Vihko, R. (1985). Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. Journal of Steroid Biochemistry, 23(1), 33–38. [DOI:10.1016/0022-4731(85)90257-2]
    • Schijf, C. P., van der Mooren, M. J., Doesburg, W. H., Thomas, C. M., & Rolland, R. (1993). Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle. Acta Endocrinologica, 129(2), 130–133. [DOI:10.1530/acta.0.1290130]
    • Schuijt, M. P., Sweep, C. G., van der Steen, R., Olthaar, A. J., Stikkelbroeck, N. M., Ross, H. A., & van Herwaarden, A. E. (2019). Validity of free testosterone calculation in pregnant women. Endocrine Connections, 8(6), 672–679. [DOI:10.1530/ec-19-0110]
    • Shifren, J. L., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2007). A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause, 14(6), 985–994. [DOI:10.1097/gme.0b013e31803867a]
    • Shifren, J. L., Rifai, N., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2008). A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1702–1710. [DOI:10.1210/jc.2007-2193]
    • Smith, K., Galazi, M., Openshaw, M. R., Wilson, P., Sarker, S. J., O’Brien, N., Alifrangis, C., Stebbing, J., & Shamash, J. (2020). The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. Clinical Genitourinary Cancer, 18(3), e217–e223. [DOI:10.1016/j.clgc.2019.09.019]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., & Pousette, A. (1988). Single drug polyestradiol phosphate therapy in prostatic cancer. American Journal of Clinical Oncology, 11(Suppl 2), S101–S103. [DOI:10.1097/00000421-198801102-00024] [PDF]
    • Steingold, K. A., Pardridge, W. M., Judd, H. L., & Chaudhuri, G. (1987). The effects of membrane permeability and binding by human serum proteins on steroid influx into the rabbit uterus. American Journal of Obstetrics and Gynecology, 157(6), 1543–1549. [DOI:10.1016/s0002-9378(87)80260-0]
    • Strauss, J. F., & FitzGerald, G. A. (2019). Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 75–114.e7). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/b978-0-323-47912-7.00004-4]
    • Troisi, R., Potischman, N., Roberts, J. M., Harger, G., Markovic, N., Cole, B., Lykins, D., Siiteri, P., & Hoover, R. N. (2003). Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiology, Biomarkers & Prevention, 12(5), 452–456. [Google Scholar] [PubMed] [URL]
    • Tulchinsky, D., & Chopra, I. J. (1973). Competitive Ligand-Binding Assay for Measurement of Sex Hormone-Binding Globulin (SHBG). The Journal of Clinical Endocrinology & Metabolism, 37(6), 873–881. [DOI:10.1210/jcem-37-6-873]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Zimmerman, Y., Eijkemans, M. J., Coelingh Bennink, H. J., Blankenstein, M. A., & Fauser, B. C. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. [DOI:10.1093/humupd/dmt038]
    \ No newline at end of file +The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy - Transfeminine Science Link

    The Interactions of Sex Hormones with Sex Hormone-Binding Globulin and Relevance for Transfeminine Hormone Therapy

    By Aly | First published July 10, 2020 | Last modified March 25, 2023

    Abstract / TL;DR

    Sex hormones such as testosterone and estradiol bind to blood proteins like albumin and SHBG. This limits their biological activity by reducing their free fractions. Androgens decrease SHBG production while estrogens increase SHBG production. Hence, testosterone and estradiol can influence their own free fractions. Due to robust inactivation in the liver, testosterone and estradiol have relatively small influences on SHBG levels under normal physiological circumstances. At very high levels however, they can considerably influence SHBG levels. During pregnancy, when there are massive increases in estradiol levels (e.g., 100-fold), a maximal 5- to 10-fold elevation in SHBG levels occurs. Although large increases in SHBG levels can strongly limit the biological activity of testosterone, the situation with estradiol is different. In late pregnancy, the percentage of estradiol that is free appears to be decreased only to around 60% of that of non-pregnancy. Earlier in pregnancy, when estradiol levels are lower, the free fractions of estradiol are reduced to a lesser extent. At typical therapeutic levels of estradiol in transfeminine hormone therapy (<200 pg/mL), the limiting influence of SHBG on free estradiol is minimal. Oral estradiol has a greater influence on SHBG production than non-oral estradiol and may be a different case however. In any case, consequent lesser activity of oral estradiol is only theoretical, and available clinical studies so far haven’t reported important therapeutic differences relative to non-oral estradiol. Although SHBG may reduce free estradiol fractions in some contexts, only relatively low estradiol levels (<50 pg/mL) appear to be needed for maximal feminization and breast development in cisgender females and transfeminine people. In conclusion, the influence of SHBG on the effectiveness of estradiol isn’t something that should be a major source of concern in transfeminine hormone therapy.

    Binding of Sex Hormones to Blood Proteins

    Sex hormones bind to proteins in the blood called plasma proteins. This is a phenomenon known as plasma protein binding. In the case of androgens and estrogens, the plasma proteins they bind to are mainly albumin and sex hormone-binding globulin (SHBG). Plasma protein binding serves to prevent sex hormones from interacting with their target cells and hence from binding to and activating their receptors (Hammond, 2016). This is because plasma proteins are too large and lipid-insoluble to cross the lipid-rich cell membrane. As a result, they’re unable to diffuse through capillaries to exit the circulation and enter into tissues or to be taken up into cells. When the sex hormone is bound to plasma protein, it can’t reach target cells either. Hence, plasma protein binding limits the biological activity of sex hormones (Hammond, 2016). Binding to plasma proteins also serves to extend the biological half-lives of sex hormones. This is because protein-bound sex hormone is likewise unavailable for metabolism and elimination, processes that depend on cellular uptake.

    There is only a single sex hormone binding site per molecule of SHBG (Moore & Bulbrook, 1988), whereas albumin has six binding sites for different substrates (Pardridge, 1988). Androgens and estradiol have high affinity for SHBG (nM) and low affinity for albumin (μM) (Moore & Bulbrook, 1988; Hammond, 2016). However, albumin levels are several orders of magnitude higher than SHBG levels (μM vs. nM), so this serves to balance out the fractions of sex hormone bound to each protein (Hammond, 2016). Androgens have higher affinities for SHBG than do estradiol or other estrogens. Estradiol has only about 10 to 20% of the affinity of dihydrotestosterone (DHT) and 33 to 50% of the affinity of testosterone for SHBG (Anderson, 1974; Ojasoo & Raynaud, 1978; Pugeat, Dunn, Nisula, 1981). As such, testosterone and DHT bind more strongly to SHBG than does estradiol.

    The vast majority of sex hormone content in the blood is bound to plasma proteins; at any given time more than 97% of the testosterone, estradiol, and progesterone in the blood is plasma protein-bound (Strauss & FitzGerald, 2019). The fraction of sex hormone that isn’t bound to plasma proteins is known as the free or unbound fraction. This is the fraction that is available for diffusion into cells and hence is considered to be biologically active (Hammond, 2016). Total levels refer to both free/unbound and bound hormone. Bioavailable levels include both albumin-bound and free hormone levels. Due to their relatively weak affinity for albumin, sex hormones bound to albumin may to some extent be biologically active—hence the “bioavailable” descriptor (Nguyen et al., 2008). However, more research is needed to fully elucidate the biological activity of albumin-bound sex hormone fractions.

    The relative calculated free and bound percentages of estradiol, testosterone, and DHT to albumin, SHBG, and another plasma protein known as corticosteroid-binding globulin (CBG) (only binds small fractions of the androgens and has no binding to estradiol) are shown in the table below.

    Table 1: Calculated plasma protein binding of sex hormones (Dunn, Nisula, & Rodbard, 1981):

    HormoneGroupAlbumin (%)SHBG (%)CBG (%)Free (%)
    EstradiolWomen (follicular)60.837.3<0.11.81
     Women (luteal)61.137.0<0.11.82
     Women (pregnant)11.787.8<0.10.49
     Men78.019.6<0.12.32
    TestosteroneWomen (follicular)30.466.02.261.36
     Women (luteal)30.765.72.201.37
     Women (pregnant)3.6095.40.820.23
     Men49.944.33.562.23
    DHTWomen (follicular)21.078.40.120.47
     Women (luteal)21.378.10.120.48
     Women (pregnant)2.1597.80.040.07
     Men39.259.70.220.88

    Free sex hormone levels and percentages are often calculated from levels of total sex hormone, albumin, SHBG, and CBG with validated mathematical models constructed from data of published studies. This is because free sex hormone levels are usually very low (pM range) and are difficult to measure with routine blood testing methods. While generally in the vicinity of the true values, calculated results may not always be fully accurate (Rosner, 2015; Goldman et al., 2017; Handelsman, 2017; Keevil & Adaway, 2019). As such, measured levels, when feasible, are preferable.

    Effects of Sex Hormones on SHBG Production

    Plasma proteins like albumin and SHBG are synthesized in the liver and are then secreted into the blood. In addition to binding to SHBG, sex hormones modulate the liver production of SHBG and hence influence their own plasma protein binding. Androgens decrease SHBG production while estrogens increase SHBG production (Anderson, 1974; Moore & Bulbrook, 1988). Administration of the anabolic steroid stanozolol (a synthetic DHT derivative) for just a few days suppresses SHBG levels by 63% (Krause et al., 2004). Continuous therapy with extreme doses of testosterone and other anabolic steroids decrease SHBG levels by 90% (Ruokonen et al., 1985; Moore & Bulbrook, 1988). Similarly, weakly androgenic progestins like medroxyprogesterone acetate (MPA), norethisterone (NET), and levonorgestrel (LNG) decrease SHBG production (Kuhl, 2005), and very high doses of medroxyprogesterone acetate and megestrol acetate (MGA) have been reported to decrease SHBG levels by up to around 50 to 90% (Heubner et al., 1987; Lundgren et al., 1990; Lundgren & Lønning, 1990). Conversely, combined birth control pills containing the synthetic estrogen ethinylestradiol (EE) (and a minimally androgenic or an antiandrogenic progestin) increase SHBG levels by about 4-fold (Odlind et al., 2002). High doses of oral synthetic estrogens, like EE and diethylstilbestrol (DES), increase SHBG levels by up to 5- to 10-fold (von Schoultz et al., 1989).

    Testosterone, DHT, and estradiol are strongly inactivated by the liver and have relatively weak effects in this part of the body under normal circumstances. As a result, they have much less relative impact on SHBG production than do synthetic hormonal agents. Accordingly, SHBG levels change only slightly over the course of the menstrual cycle in women despite substantial fluctuations in estradiol levels (Freymann et al., 1977b; Plymate et al., 1985; Schijf et al., 1993; Braunstein et al., 2011; Rothman et al., 2011; Fanelli et al., 2013; Rezaii et al., 2017). In one study, SHBG levels increased by about 6 to 13% (+2.9–5.3 nmol/L) going from the follicular phase to the luteal phase of the cycle (Braunstein et al., 2011). There is additionally only a small decrease in SHBG levels attributable to the sharp decline in estradiol with menopause (Burger et al., 2000; Guthrie et al., 2004). Nonetheless, estradiol therapy can more considerably influence the production of SHBG and other liver proteins as well under specific conditions (Kuhl, 1998). This is due to 1) use of oral estradiol, which because of the first pass through the liver has a greater impact on estrogen-sensitive liver synthesis than non-oral routes (Kuhl, 2005); and 2) use of high estradiol doses, for instance typical injectable doses. The table below shows SHBG increases from various studies with different estrogen routes, doses, and types.

    Table 2: Relative increases in SHBG levels with some different estrogenic exposures:

    EstrogenTypical E2 levels aSHBG increaseSource
    Oral E2 1 mg/day~25 pg/mL1.6×Kuhl (1998)
    Oral E2 2 mg/day~50 pg/mL2.2×Kuhl (1998)
    Oral E2 4 mg/day~100 pg/mL1.9–3.2×Fåhraeus & Larsson-Cohn (1982); Gibney
    et al. (2005)    ; Ropponen et al. (2005)
    Oral EV 6 mg/dayb~112.5 pg/mL2.5–3.0×Dittrich et al. (2005); Mueller et al. (2005);
    Mueller et al. (2006)
    E2 patch 50 μg/day~50 pg/mL1.1×Kuhl (2005)
    E2 patch 100 μg/day~100 pg/mL1.2×Shifren et al. (2008)
    E2 patches 200 μg/day~200 pg/mL~1.5×Smith et al. (2020)
    E2 patches 300 μg/day~300 pg/mL~1.7×Smith et al. (2020)
    E2 patches 600 μg/day~600 pg/mL2.3×Bland et al. (2005)
    EU 100 mg/month~550 pg/mL2.0×Derra (1981)
    PEP 320 mg/month~700 pg/mL1.7×Stege et al. (1988)
    EV 10 mg/10 daysVariable (high)3.2×Mueller et al. (2011) [Table]
    EV 10 mg/14 daysVariable (high)~3.2×Kronawitter et al. (2009) [Table]
    Oral EE 10 μg/day–3.0×Kuhl (1998)
    Oral EE 50 μg/day–4.0×Kuhl (1997)
    High-dose synthetic E–5–10×von Schoultz et al. (1989)

    a Estimated typical estradiol levels from various sources (e.g., Aly, 2020; Wiki). b Due to differences in molecular weight, EV has about 75% of the amount of estradiol as regular estradiol. Hence, 6 mg/day EV is approximately equivalent to 4.5 mg/day E2.

    The influence of estradiol on SHBG levels is most relevant to pregnancy, when estradiol levels increase to far higher levels than usual. In late pregnancy, estradiol levels are generally around 15,000 to 25,000 pg/mL on average (Graphs; Troisi et al., 2003; Adamcová et al., 2018). These estradiol levels are on the order of 100-fold higher than normal menstrual cycle levels. In parallel with the massive increases in estradiol levels, SHBG levels increase by about 5- to 10-fold by late pregnancy (Anderson, 1974; Hammond, 2017). The dose–response curve of estrogens on SHBG production shows saturation, with most of the increase in SHBG levels happening at lower estradiol levels as well as limits to how much SHBG levels can be increased (Mean, Pellaton, & Magrini, 1977; O’Leary et al., 1991; Kerlan et al., 1994; Kuhl, 1999). The graphs below show SHBG levels throughout pregnancy.

    Figure 1: SHBG and total estradiol levels during pregnancy in women (O’Leary et al., 1991). The lines are the mean and/or 95th percentile levels while the points are individual measurements.
    Figure 2: Total sex hormone and SHBG levels during pregnancy in women (Kerlan et al., 1994).

    Effects of SHBG Increase on Free Sex Hormone Levels

    Changes in SHBG levels result in changes in SHBG-bound and free sex hormone levels. Aside from DHT, estradiol and testosterone are the hormones of the greatest interest in this regard.

    SHBG Increase and Free Testosterone

    EE-containing birth control pills, with their 4-fold increase in SHBG levels, substantially decrease the free percentage of testosterone (Graham et al., 2007; Zimmerman et al., 2014). In one study, an EE-containing birth control pill decreased the free testosterone fraction from 2.45% to 0.78% (a 3.2-fold decrease or to 32% of baseline) (Graham et al., 2007). Due to concomitant suppression of testosterone production and hence reduced total testosterone levels, free testosterone levels decreased from 0.89 pg/mL to 0.18 pg/mL (a 5-fold decrease, to 20% of baseline) (Graham et al., 2007). The influence of EE on SHBG levels contributes significantly to the antiandrogenic effects of EE-containing birth control pills, which are taken advantage of therapeutically to treat acne and hirsutism in women.

    During pregnancy, testosterone levels increase to as much as 150 ng/dL (around 5-fold higher than non-pregnancy levels) (McClamrock, 2007). The increase in SHBG production during pregnancy serves an important function in that the higher SHBG levels neutralize the biological activity of the increased testosterone levels (Hammond, 2017). In one study, the free testosterone fraction was 6-fold lower in late pregnancy than in non-pregnant women (0.23% vs. 1.36%—or to 17% of non-pregnancy) (Dunn, Nisula, & Rodbard, 1981). Hence, despite substantial increases in total testosterone levels during pregnancy, free testosterone levels and by extension androgenic action in the body change minimally (Barini, Liberale, & Menini, 1993; Schuijt et al., 2019). A case report of marked hyperandrogenism due to severe SHBG deficiency in a pregnant woman evidences the role of SHBG in limiting the androgenic actions of testosterone during this time (Hogeveen et al., 2002; Hammond, 2017).

    SHBG Increase and Free Estradiol

    Endogenous and Non-Oral Estradiol

    The research indicates that increases in SHBG levels and by extension decreases in the free estradiol fraction are minimal with physiological levels of estradiol (e.g., <200 pg/mL). This is the case whether the estradiol is endogenous or exogenous in origin—so long as it is taken non-orally. Such conclusions are based on both calculated and measured studies of free estradiol (e.g., Freymann et al., 1977b).

    Increases in SHBG levels and decreases in the free estradiol fraction become more significant with supraphysiological levels of estradiol however, for instance during pregnancy and with very-high-dose estradiol therapy. Studies on changes in free estradiol with high doses of estradiol are few. This is especially true in the case of measured as opposed to calculated free estradiol. In any case, one can look at pregnancy to gain insight on the question of free estradiol with high estradiol levels. Moreover, due to the very high estradiol levels in pregnancy, free estradiol is more amenable to measurement during this time. Accordingly, multiple studies of measured free estradiol in pregnancy are available.

    Although free estradiol percentages during pregnancy certainly decrease, the increases in estradiol are far from neutralized by SHBG. Hence, the situation with free estradiol in pregnancy is very different from that of testosterone. This is illustrated in the following excerpt (Rubinow et al., 2002):

    Pregnancy is accompanied by a slow but sustained rise in the plasma levels of many steroid and peptide hormones and is followed by a precipitous drop in their levels over the first few days after delivery. By the third trimester of pregnancy, plasma progesterone levels average approximately 150 ng/ml and estradiol levels range from 10 to 15 ng/ml. These amounts represent a 10- and 50-fold increase, respectively, of maximum menstrual cycle levels (Tulchinsky et al., 1972). Although only a small fraction of these steroids are unbound, the amount of “free” (and thus biologically active) progesterone and estrogen also undergo similarly large increases during pregnancy (Heidrich et al., 1994).

    In the study by Heidrich and colleagues cited in the excerpt, total estradiol levels at the time of delivery were 21,500 pg/mL and measured free estradiol levels were 232 pg/mL, with a resultant free estradiol fraction of 1.08% (Heidrich et al., 1994). For context, the free estradiol percentage in non-pregnant women ranges from 1.5 to 2.1% with RIA, while actual free estradiol levels are 0.30 to 4.1 pg/mL with RIA and 0.40 to 5.9 pg/mL with LC–MS/MS (Nakamoto, 2016). Hence, in this study free estradiol levels in late pregnancy were around 50-fold higher than maximal non-pregnancy levels.

    Due to variable methodology, the findings of a single study may not be representative. As such, the table below provides measured free estradiol percentages in late pregnancy from several studies.

    Table 3: Measured free estradiol percentages in late pregnancy (mean ± SD) (Perry et al., 1987):

    StudyMethodnFree E2 (%)
    Perry et al. (1987)Centrifugal ultrafiltration251.27 ± 0.23
    Hammond et al. (1980)Centrifugal ultrafiltration50.96 ± 0.12
    Heidrich et al. (1994)Centrifugal ultrafiltration261.08
    Tulchinsky et al. (1973)Equilibrium dialysis50.67 ± 0.18
    Freymann et al. (1977a)Equilibrium dialysis171.15
    Anderson et al. (1985)Steady-state gel filtration121.48 ± 0.55

    As can be seen in the table, the free estradiol fraction in late pregnancy ranges from about 0.7 to 1.5%. Results for the free estradiol fraction from studies using calculated free estradiol levels in late pregnancy rather than measured levels are similar to measured findings, although sometimes a bit lower in comparison (e.g., 0.5%) (Dunn, Nisula, & Rodbard, 1981; Campino et al., 2001). The measured free estradiol percentage in late pregnancy can be cautiously compared to the fraction of 1.5 to 2.1% in non-pregnant women. Using middle values from these ranges, the free estradiol fraction in late pregnancy may be somewhere around 60% of that of non-pregnancy. This estimate is quite close to the actual findings of a study, which observed a decrease in the measured free estradiol percentage to 55% of that of non-pregnancy (Freymann et al., 1977a; Freymann et al., 1977b).

    In contrast to estradiol, the free percentages of estrone and estriol are not different in late pregnancy when compared to non-pregnancy (Tulchinsky & Chopra, 1973; Steingold et al., 1987). This is attributable to the much lower affinities of estrone and estriol for SHBG relative to estradiol (Kuhl, 2005).

    Studies have also assessed free estradiol fractions earlier in pregnancy, which might in theory differ from late pregnancy. The results of a study that measured free estradiol throughout pregnancy are shown in the table below (Freymann et al., 1977a; Freymann et al., 1977b).

    Table 4: Total and free estradiol in pregnancy (mean ± SD) (Freymann et al., 1977a; Freymann et al., 1977b):

    ContextnE2 (ng/mL)ChangeFree E2 (%)ChangeFree E2 (pg/mL)Change
    Non-pregnant350.16 ± 0.101.0×2.2 ± 0.4–0%3.5 ± 2.01.0×
    Pregnancy       
    6–20 weeks92.0 ± 1.113×1.6 ± 0.4–27%32 ± 219.1×
    12–20 weeks105.5 ± 2.234×1.3 ± 0.3–41%72 ± 3921×
    20–30 weeks1210.8 ± 4.668×1.2 ± 0.3–45%130 ± 7437×
    30–38 weeks1716.0 ± 7.0100×1.2 ± 0.2–45%184 ± 10353×

    In similar studies by another group of researchers, free estradiol fractions were measured in earlier pregnancy (weeks 7–16) and were found to be lower than those obtained by Freymann and colleagues (Bernstein et al., 1986; Depue et al., 1987; Bernstein et al., 1988). The free estradiol percentage was about 0.9 or 1.0% at 10 weeks and about 0.7% at 12 weeks (Bernstein et al., 1986; Depue et al., 1987; Bernstein et al., 1988). Hence, as with the results of Freymann and colleagues, the free estradiol fraction decreased as pregnancy progressed. The figure below provides a visualization of the findings.

    Figure 3: Changes in total and free estradiol levels (pg/mL), free estradiol fraction (%), and SHBG binding capacity (μg/dL) during weeks 7 to 16 of pregnancy in women (Bernstein et al., 1986).

    Free estradiol during pregnancy can also be calculated using total estradiol levels and SHBG levels. I roughly calculated the free estradiol fraction during pregnancy using the data from O’Leary et al. (1991) and a published calculator spreadsheet by Mazer (2009) (Aly, 2020). The results are shown below.

    Figure 4: Average measured total estradiol and SHBG levels (O’Leary et al., 1991) and calculated free estradiol percentage (Mazer, 2009) throughout pregnancy in women. Another version of this graph scaled to only the first trimester of pregnancy (when estradiol levels are typically ≤2,000 pg/mL) is also provided (Graph).

    The free estradiol fractions in the figure are merely rough estimations and hence should be given conservative consideration. In any case, they are similar to the findings of the available studies on measured free estradiol in earlier pregnancy just discussed—for instance in magnitude (relative to Bernstein et al.) and pattern of change throughout pregnancy (relative to both Bernstein et al. and Freymann et al.). As such, these calculated values offer a plausible and interesting model.

    To summarize, there are profound increases in total estradiol levels and proportionally lower but still substantial increases in SHBG levels during pregnancy. In accordance with the marked increase in SHBG levels, the free estradiol fraction progressively decreases over the course of pregnancy. Studies are conflicting on the exact degrees to which free estradiol percentages decrease. In any case, the possibilities for the free estradiol fraction by late pregnancy range from about 0.5 to 1.5%. These figures can be compared to non-pregnancy free estradiol percentages of 1.5 to 2.1%. This may correspond to a maximal decrease in the free estradiol fraction in late pregnancy to around 60% of non-pregnancy. At the greatest extreme, the decrease may be to around 25% of non-pregnancy. Conversely, in earlier pregnancy, when estradiol levels are lower, free estradiol percentages are higher.

    Despite the decreases in the free estradiol fraction during pregnancy, there are profound increases in free estradiol levels that parallel the massive increases in total estradiol. As such, the increase in estradiol levels during pregnancy markedly exceeds the limiting influences of the simultaneously elevated SHBG levels. For this reason, pregnancy is a profoundly hyperestrogenic state.

    SHBG doesn’t impact estradiol like it does testosterone during pregnancy because the proportional increases in estradiol levels relative to SHBG levels are far greater in comparison and because of the relatively lower affinity of estradiol for SHBG. In general, it’s not possible for SHBG to limit the activity of estradiol in the way that it can with testosterone due to the inherent requirement for substantially increased SHBG production of much more highly increased estradiol levels.

    Oral Estradiol

    Oral estradiol may differ from non-oral estradiol when it comes to the issue of free estradiol. This is because oral estradiol undergoes a first pass that results in greater estradiol levels in the liver relative to the circulation. As a result, oral estradiol has disproportionate liver effects and increases SHBG levels to a proportionally greater extent than non-oral estradiol. Hence, the greater SHBG increases with oral estradiol may result in lower free estradiol fractions than with non-oral estradiol.

    While this is probable, it is more difficult to determine the precise magnitudes of the differences between oral and non-oral estradiol in terms of free estradiol. Some data are available however. Clinical studies of low-dose oral estradiol in menopausal cisgender women have reported the limiting influence of the SHBG increase on calculated free estradiol to be modest (Nilsson, Holst, & von Schoultz, 1984; Nachtigall et al., 2000). Likewise, oral estradiol appears to have similar effectiveness for menopausal symptoms when compared to non-oral estradiol (Wiki; 2nd paragraph). Studies of higher doses of oral estradiol that provide data on SHBG or free estradiol levels are rare. In any case, a few studies by one group found that 6 mg/day oral estradiol valerate (a dose equivalent to approximately 4.5 mg/day oral estradiol) increased SHBG levels by about 2.5- to 3.0-fold in transgender women (Dittrich et al., 2005; Mueller et al., 2005; Mueller et al., 2006). Using the numbers from one of the studies for total estradiol and SHBG levels, it can be roughly calculated (Mazer, 2009) that the free estradiol fraction may have decreased from around 2.1% to 1.2% (a 43% reduction). Analogously, a study using oral conjugated estrogens (CEEs; Premarin) at a dose that increased SHBG levels by 2.3-fold reported that the calculated free estradiol percentage was 40% lower relative to an equivalent dose of transdermal estradiol (in terms of total estradiol levels) (Shifren et al., 2007). These findings suggest a non-trivial reduction in the free estradiol fraction with typical doses of oral estradiol in transfeminine people. Consequently, it’s possible that oral estradiol could be to a certain degree less potent at the same total estradiol levels relative to non-oral estradiol.

    It’s important to be clear that it’s also not a certainty however. Levels of estrone are much higher with oral estradiol than with non-oral estradiol (~5-fold) (Kuhl, 2005), and estrone, although far less potent than estradiol, has significant intrinsic estrogenic activity similarly to estradiol (Kuhl, 2005). The degree to which estrone might add to the estrogenic activity of estradiol, if at all, is uncertain. In any case, it’s within the realm of possibility that estrone could contribute significantly to the estrogenic activity of oral estradiol (Pande et al., 2019). This additional estrogenic exposure could potentially serve to offset the impact of the higher SHBG levels and reduced free estradiol fractions that occur with oral estradiol. Further research is needed to evaluate such a possibility however. As another consideration, the higher SHBG levels with oral estradiol can be expected to reduce the free testosterone fraction in addition to that of estradiol (and to an even greater extent in comparison). This is important as testosterone suppression is a key therapeutic effect of estradiol in transfeminine people and the main justified reason for use of higher estradiol levels. Due to possibilities like these and the fact that free levels of hormones only theoretically represent their biological activity, it shouldn’t necessarily be assumed that oral estradiol is less potent or efficacious than non-oral estradiol. Only further clinical studies comparing oral estradiol to non-oral estradiol will be able to clarify this question.

    Relevance for Transfeminine Hormone Therapy

    Some have concerns that SHBG may substantially limit the effectiveness of estradiol and thereby hinder feminization and/or breast development. Some have even claimed that high levels of estradiol may be less effective than lower levels as a result of SHBG increases at higher levels. Before even touching on SHBG however, such notions are likely to be misguided. This is because low estradiol levels (<50 pg/mL) are known to be fully effective in terms of feminization and breast development. This is evidenced by normal and induced puberty in cisgender girls (Aly, 2020), as well as by the excellent secondary sexual development of women with complete androgen insensitivity syndrome (CAIS) (Aly, 2020; Wiki). No evidence exists at this time to indicate that higher estradiol levels are necessary or beneficial in terms of feminization or breast development (Nolan & Cheung, 2020). Available studies in fact suggest no relationship between estradiol levels and breast development in transfeminine people at typical therapeutic levels of estradiol (e.g., 50–200 pg/mL) (de Blok et al., 2017; Meyer et al., 2020; de Blok et al., 2020). This is in accordance with the concept of the maximal effect of estradiol on feminization and breast development being established at lower estradiol levels. Hence, besides the use of higher estradiol levels for testosterone suppression in transfeminine people, concerns about incomplete feminizing efficacy of estradiol consequent to inadequate estrogenic exposure have little basis.

    If SHBG is nonetheless explored however, the research indicates that the role of SHBG in restricting free estradiol, and hence presumably the biological activity of estradiol, is only so considerable. Within physiological non-pregnancy ranges for estradiol (e.g., <200 pg/mL), changes in SHBG levels and free estradiol fractions due to endogenous or non-oral estradiol are minimal. Very high estradiol levels have greater influence on SHBG production than normal physiological levels however. During pregnancy, with the massive increases in estradiol and resultant 5- to 10-fold maximal elevation in SHBG levels, the free estradiol percentage may be decreased to around 60% of that of non-pregnancy. But actual free estradiol levels are nonetheless profoundly increased in pregnancy. Moreover, increases in SHBG levels and decreases in free estradiol fraction earlier in pregnancy are lower than in late pregnancy. Even with among the highest estradiol levels that would normally be encountered with non-oral estradiol therapy, the decreases in the free estradiol fraction due to SHBG are likely to be modest. The impact of such a reduction could easily be negated by a slightly greater estradiol dose.

    While the preceding is applicable to non-oral estradiol, oral estradiol has a greater influence on SHBG production in comparison and hence the higher SHBG levels with oral estradiol could result in more significant limitation of free estradiol than with non-oral estradiol. The notion that this reduction in free estradiol corresponds to a decrease in the activity or potency of oral estradiol is only a theoretical possibility however. Therapeutically, oral estradiol has shown itself to be very effective. The decreases in free estradiol percentage with low-dose oral estradiol seem to be small. In addition, while no direct comparisons exist this time, higher doses of oral estradiol seem to show similar testosterone suppression as non-oral estradiol (Wiki; Graphs). Besides testosterone suppression, available studies have found no differences between oral and non-oral estradiol in terms of outcomes like breast development or feminization (Sam, 2020). As such, the differences between oral and non-oral estradiol in terms SHBG levels and free estradiol fraction may be of little therapeutic importance.

    Aside from decreasing free estradiol fractions, increased SHBG levels also decrease free testosterone fractions to an even greater extent. This is advantageous in the case of transfeminine people.

    Taken together, lower free estradiol due to increased SHBG levels, whether with non-oral or oral estradiol, isn’t something that should be a major source of concern in transfeminine hormone therapy.

    Supplementary Material

    See here for supplementary material for this article, including a spreadsheet and other calculators that can be used to estimate free hormone levels (e.g., Mazer, 2009).

    References

    • Adamcová, K., Kolátorová, L., Škodová, T., Šimková, M., Pařízek, A., Stárka, L., & Dušková, M. (2018). Steroid hormone levels in the peripartum period – differences caused by fetal sex and delivery type. Physiological Research, 67(Suppl 3), S489–S497. [DOI:10.33549/physiolres.934019]
    • Anderson, D. C. (1974). Sex-Hormone-Binding Globulin. Clinical Endocrinology, 3(1), 69–96. [DOI:10.1111/j.1365-2265.1974.tb03298.x]
    • Anderson, P. J., Hancock, K. W., & Oakey, R. E. (1985). Non-protein-bound oestradiol and progesterone in human peripheral plasma before labour and delivery. Journal of Endocrinology, 104(1), 7–15. [DOI:10.1677/joe.0.1040007]
    • Barini, A., Liberale, I., & Menini, E. (1993). Simultaneous Determination of Free Testosterone and Testosterone Bound to Non-Sex-Hormone-Binding Globulin by Equilibrium Dialysis. Clinical Chemistry, 39(6), 936–941. [DOI:10.1093/clinchem/39.6.936]
    • Bernstein, L., Depue, R. H., Ross, R. K., Judd, H. L., Pike, M. C., & Henderson, B. E. (1986). Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. Journal of the National Cancer Institute, 76(6), 1035–1039. [DOI:10.1093/jnci/76.6.1035]
    • Bernstein, L., Pike, M., Depue, R., Ross, R., Moore, J., & Henderson, B. (1988). Maternal hormone levels in early gestation of cryptorchid males: a case-control study. British Journal of Cancer, 58(3), 379–381. [DOI:10.1038/bjc.1988.223]
    • Bland, L. B., Garzotto, M., DeLoughery, T. G., Ryan, C. W., Schuff, K. G., Wersinger, E. M., Lemmon, D., & Beer, T. M. (2005). Phase II study of transdermal estradiol in androgen-independent prostate carcinoma. Cancer, 103(4), 717–723. [DOI:10.1002/cncr.20857]
    • Braunstein, G. D., Reitz, R. E., Buch, A., Schnell, D., & Caulfield, M. P. (2011). Testosterone Reference Ranges in Normally Cycling Healthy Premenopausal Women. The Journal of Sexual Medicine, 8(10), 2924–2934. [DOI:10.1111/j.1743-6109.2011.02380.x]
    • Burger, H. G., Dudley, E. C., Cui, J., Dennerstein, L., & Hopper, J. L. (2000). A Prospective Longitudinal Study of Serum Testosterone, Dehydroepiandrosterone Sulfate, and Sex Hormone-Binding Globulin Levels through the Menopause Transition. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2832–2838. [DOI:10.1210/jcem.85.8.6740]
    • Campino, C., Torres, C., Rioseco, A., Poblete, A., Pugin, E., Valdés, V., Catalán, S., Belmar, C., & Serón-Ferré, M. (2001). Plasma prolactin/oestradiol ratio at 38 weeks gestation predicts the duration of lactational amenorrhoea. Human Reproduction, 16(12), 2540–2545. [DOI:10.1093/humrep/16.12.2540]
    • de Blok, C. J., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., Schreiner, T., T’Sjoen, G., & den Heijer, M. (2017). Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532–538. [DOI:10.1210/jc.2017-01927]
    • de Blok, C. J., Dijkman, B. A., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K. M., & den Heijer, M. (2020). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • Depue, R. H., Bernstein, L., Ross, R. K., Judd, H. L., & Henderson, B. E. (1987). Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: A seroepidemiologic study. American Journal of Obstetrics and Gynecology, 156(5), 1137–1141. [DOI:10.1016/0002-9378(87)90126-8]
    • Derra, C. (1981). Hormonprofile unter Östrogen- und Antiandrogentherapie bei Patienten mit Prostatakarzinom: Östradiolundecylat versus Cyproteronacetat. [Hormone Profiles under Estrogen and Antiandrogen Therapy in Patients with Prostate Cancer: Estradiol Undecylate versus Cyproterone Acetate.] (Doctoral dissertation, University of Mainz.) [Google Scholar] [WorldCat] [PDF] [Translation]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Dunn, J. F., Nisula, B. C., & Rodbard, D. (1981). Transport of Steroid Hormones: Binding of 21 Endogenous Steroids to Both Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma. The Journal of Clinical Endocrinology & Metabolism, 53(1), 58–68. [DOI:10.1210/jcem-53-1-58]
    • Fåhraeus, L., & Larsson-Cohn, U. (1982). Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17β to menopausal women. Acta Endocrinologica, 101(4), 592–596. [DOI:10.1530/acta.0.1010592]
    • Fanelli, F., Gambineri, A., Belluomo, I., Repaci, A., Di Lallo, V. D., Di Dalmazi, G., Mezzullo, M., Prontera, O., Cuomo, G., Zanotti, L., Paccapelo, A., Morselli-Labate, A. M., Pagotto, U., & Pasquali, R. (2013). Androgen Profiling by Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) in Healthy Normal-Weight Ovulatory and Anovulatory Late Adolescent and Young Women. The Journal of Clinical Endocrinology & Metabolism, 98(7), 3058–3067. [DOI:10.1210/jc.2013-1381]
    • Freymann, E., Hubl, W., Büchner, M., & Belleée, H. (1977). Eine spezifische, radioimmunologische Bestimmung des Plasmaöstradiols ohne Chromatographie im Zyklus und in der Schwangerschaft und die Bestimmung des freien, nichtproteingebundenen Anteils mittels Dialyse. [A specific radioimmunologi determination of plasma estradiol without chromatography during the cycle and in pregnancy and determination of the free non-protein-bound fraction using dialysis.] Zentralblatt für Gynäkologie, 99(6), 321–329. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF]
    • Freymann, E., Hubl, W., Büchner, M., & Rohde, W. (1977). Plasma levels of apparent free estradiol during pregnancy. Endokrinologie, 69(2), 269–271. [Google Scholar] [PubMed] [PDF]
    • Gibney, J., Johannsson, G., Leung, K., & Ho, K. K. (2005). Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women. The Journal of Clinical Endocrinology & Metabolism, 90(7), 3897–3903. [DOI:10.1210/jc.2005-0173]
    • Goldman, A. L., Bhasin, S., Wu, F. C., Krishna, M., Matsumoto, A. M., & Jasuja, R. (2017). A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications. Endocrine Reviews, 38(4), 302–324. [DOI:10.1210/er.2017-00025]
    • Graham, C. A., Bancroft, J., Doll, H. A., Greco, T., & Tanner, A. (2007). Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology, 32(3), 246–255. [DOI:10.1016/j.psyneuen.2006.12.011]
    • Guthrie, J., Dennerstein, L., Taffe, J., Lehert, P., & Burger, H. (2004). The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric, 7(4), 375–389. [DOI:10.1080/13697130400012163]
    • Hammond, G. L., Nisker, J. A., Jones, L. A., & Siiteri, P. K. (1980). Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. Journal of Biological Chemistry, 255(11), 5023–5026. [DOI:10.1016/s0021-9258(19)70742-x]
    • Hammond, G. L. (2016). Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. Journal of Endocrinology, 230(1), R13–R25. [DOI:10.1530/joe-16-0070]
    • Hammond, G. L. (2017). Sex Hormone-Binding Globulin and the Metabolic Syndrome. In Winters, S. J., & Huhtaniemi, I. T. (Eds.). Male Hypogonadism: Basic, Clinical and Therapeutic Principles (pp. 305–324). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-53298-1_15]
    • Handelsman, D. J. (2017). Free Testosterone: Pumping up the Tires or Ending the Free Ride? Endocrine Reviews, 38(4), 297–301. [DOI:10.1210/er.2017-00171]
    • Heidrich, A., Schleyer, M., Spingler, H., Albert, P., Knoche, M., Fritze, J., & Lanczik, M. (1994). Postpartum blues: Relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. Journal of Affective Disorders, 30(2), 93–98. [DOI:10.1016/0165-0327(94)90036-1]
    • Heubner, A., Brockerhoff, P., Kreienberg, R., Grill, H., Rathgen, G., & Pollow, K. (1987). The influence of various dosages of megestrol acetate on SHBG, CBG and lipoprotein patterns. Journal of Steroid Biochemistry, 28(Suppl 1), 214S–214S (abstract no. 6). [DOI:10.1016/0022-4731(87)91680-3]
    • Hogeveen, K. N., Cousin, P., Pugeat, M., Dewailly, D., Soudan, B., & Hammond, G. L. (2002). Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. The Journal of Clinical Investigation, 109(7), 973–981. [DOI:10.1172/JCI14060]
    • Keevil, B. G., & Adaway, J. (2019). Assessment of free testosterone concentration. The Journal of Steroid Biochemistry and Molecular Biology, 190, 207–211. [DOI:10.1016/j.jsbmb.2019.04.008]
    • Kerlan, V., Nahoul, K., Martelot, M., & Bercovici, J. (1994). Longitudinal study of maternal plasma bioavailable testosterone and androstanediol glucuronide levels during pregnancy. Clinical Endocrinology, 40(2), 263–267. [DOI:10.1111/j.1365-2265.1994.tb02478.x]
    • Krause, A., Sinnecker, G., Hiort, O., Thamm, B., & Hoepffner, W. (2004). Applicability of the SHBG Androgen Sensitivity Test in the Differential Diagnosis of 46,XY Gonadal Dysgenesis, True Hermaphroditism, and Androgen Insensitivity Syndrome. Experimental and Clinical Endocrinology & Diabetes, 112(5), 236–240. [DOI:10.1055/s-2004-817969]
    • Kronawitter, D., Gooren, L. J., Zollver, H., Oppelt, P. G., Beckmann, M. W., Dittrich, R., & Mueller, A. (2009). Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. European Journal of Endocrinology, 161(2), 363–368. [DOI:10.1530/eje-09-0265] [Table]
    • Kuhl, H. (1997). Metabolische Effekte der Östrogene und Gestagene. [Metabolic Effects of Estrogens and Progestogens.] Der Gynäkologe, 30(4), 357–369. [DOI:10.1007/pl00003042]
    • Kuhl, H. (1998). Adverse effects of estrogen treatment: natural vs. synthetic estrogens. In Lippert, T. H., Mueck, A. O., & Ginsburg, J. (Eds.). Sex Steroids and the Cardiovascular System: The Proceedings of the 1st Interdisciplinary Workshop, Tuebingen, Germany, October 1996. Parthenon Publishing Group, New York, London (pp. 201–210). London/New York: Parthenon. [Google Scholar] [Google Books] [PDF]
    • Kuhl, H. (1999). Hormonal contraception. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 363–407). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_18] [PDF]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Lundgren, S., Lønning, P., Utaaker, E., Aakvaag, A., & Kvinnsland, S. (1990). Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer—I. General findings. Journal of Steroid Biochemistry, 36(1–2), 99–104. [DOI:10.1016/0022-4731(90)90118-c]
    • Lundgren, S., & Lønning, P. (1990). Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer—II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin. Journal of Steroid Biochemistry, 36(1–2), 105–109. [DOI:10.1016/0022-4731(90)90119-d]
    • Mazer, N. A. (2009). A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: With illustrative examples from male and female populations. Steroids, 74(6), 512–519. [DOI:10.1016/j.steroids.2009.01.008] [Spreadsheet]
    • McClamrock, H. D. (2007). Pregnancy-Related Androgen Excess. In Azziz, R., Nestler, J. E., & Dewailly, D. (Eds.). Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders, 2nd Edition (Contemporary Endocrinology) (pp. 107–119). Totowa, New Jersey: Humana Press. [Google Books] [DOI:10.1007/978-1-59745-179-6_9]
    • Mean, F., Pellaton, M., & Magrini, G. (1977). Study on the binding of dihydrotestosterone, testosterone and oestradiol with sex hormone binding globulin. Clinica Chimica Acta, 80(1), 171–180. [DOI:10.1016/0009-8981(77)90276-5]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463] [PDF]
    • Moore, J. W., & Bulbrook, R. D. (1988). The epidemiology and function of sex hormone-binding globulin. Oxford Reviews of Reproductive Biology, 10, 180–236. [Google Scholar] [PubMed] [PDF]
    • Mueller, A., Dittrich, R., Binder, H., Kuehnel, W., Maltaris, T., Hoffmann, I., & Beckmann, M. W. (2005). High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. European Journal of Endocrinology, 153(1), 107–113. [DOI:10.1530/eje.1.01943]
    • Mueller, A., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Dittrich, R. (2006). Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female Transsexuals. Hormone and Metabolic Research, 38(3), 183–187. [DOI:10.1055/s-2006-925198]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • Nachtigall, L. E., Raju, U., Banerjee, S., Wan, L., & Levitz, M. (2000). Serum Estradiol-Binding Profiles in Postmenopausal Women Undergoing Three Common Estrogen Replacement Therapies. Menopause, 7(4), 243–250. [DOI:10.1097/00042192-200007040-00006]
    • Nakamoto, J. (2016). Endocrine Testing. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition (pp. 2655–2688.e1). Philadelphia: Saunders/Elsevier. [Google Books] [DOI:10.1016/B978-0-323-18907-1.00154-2]
    • Nguyen, T. D. T., Dolomie-Fagour, L., Georges, A., & Corcuff, J. B. (2008). Dosage des stéroïdes sexuels sériques: quelle place pour l’estradiol biodisponible? [What about bioavailable estradiol?] Annales de Biologie Clinique, 66(5), 493–497. [DOI:10.1684/abc.2008.0259]
    • Nilsson, B., Holst, J., & Schoultz, B. (1984). Serum levels of unbound 17β-oestradiol during oral and percutaneous postmenopausal replacement therapy. British Journal of Obstetrics and Gynaecology, 91(10), 1031–1036. [DOI:10.1111/j.1471-0528.1984.tb03683.x]
    • Nolan, B. J., & Cheung, A. S. (2021). Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review. Transgender Health, 6(3), 125–131. [DOI:10.1089/trgh.2020.0077]
    • O’Leary, P., Boyne, P., Flett, P., Beilby, J., & James, I. (1991). Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clinical Chemistry, 37(5), 667–672. [DOI:10.1093/clinchem/37.5.667]
    • Odlind, V., Milsom, I., Persson, I., & Victor, A. (2002). Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills? Acta Obstetricia et Gynecologica Scandinavica, 81(6), 482–490. [DOI:10.1034/j.1600-0412.2002.810603.x]
    • Ojasoo, T., & Raynaud, J. P. (1978). Unique steroid congeners for receptor studies. Cancer Research, 38(11 Part 2), 4186–4198. [Google Scholar] [PubMed] [URL]
    • Pande, P., Fleck, S. C., Twaddle, N. C., Churchwell, M. I., Doerge, D. R., & Teeguarden, J. G. (2019). Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: Total estrogenicity calculations accounting for competitive protein and receptor binding and potency. Food and Chemical Toxicology, 125, 341–353. [DOI:10.1016/j.fct.2018.12.013]
    • Pardridge, W. M. (1988). Selective delivery of sex steroid hormones to tissues by albumin and by sex hormone-binding globulin. Oxford Reviews of Reproductive Biology, 10, 237–292. [Google Scholar] [PubMed] [PDF]
    • Perry, L., Wathen, N., & Chard, T. (1987). Saliva Levels of Oestradiol and Progesterone in Relation to Non-Protein-Bound Concentrations in Blood During Late Pregnancy. Hormone and Metabolic Research, 19(9), 444–447. [DOI:10.1055/s-2007-1011848]
    • Plymate, S. R., Moore, D. E., Cheng, C. Y., Bardin, C. W., Southworth, M. B., & Levinski, M. J. (1985). Sex Hormone-Binding Globulin Changes during the Menstrual Cycle. The Journal of Clinical Endocrinology & Metabolism, 61(5), 993–996. [DOI:10.1210/jcem-61-5-993]
    • Pugeat, M. M., Dunn, J. F., & Nisula, B. C. (1981). Transport of Steroid Hormones: Interaction of 70 Drugs with Testosterone-Binding Globulin and Corticosteroid-Binding Globulin in Human Plasma. The Journal of Clinical Endocrinology & Metabolism, 53(1), 69–75. [DOI:10.1210/jcem-53-1-69]
    • Rezaii, T., Gustafsson, T. P., Axelson, M., Zamani, L., Ernberg, M., Hirschberg, A. L., & Carlström, K. A. (2017). Circulating androgens and SHBG during the normal menstrual cycle in two ethnic populations. Scandinavian Journal of Clinical and Laboratory Investigation, 77(3), 184–189. [DOI:10.1080/00365513.2017.1286685]
    • Ropponen, A., Aittomäki, K., Vihma, V., Tikkanen, M. J., & Ylikorkala, O. (2005). Effects of Oral and Transdermal Estradiol Administration on Levels of Sex Hormone-Binding Globulin in Postmenopausal Women with and without a History of Intrahepatic Cholestasis of Pregnancy. The Journal of Clinical Endocrinology & Metabolism, 90(6), 3431–3434. [DOI:10.1210/jc.2005-0352]
    • Rosner, W. (2015). Free estradiol and sex hormone-binding globulin. Steroids, 99, 113–116. [DOI:10.1016/j.steroids.2014.08.005]
    • Rothman, M. S., Carlson, N. E., Xu, M., Wang, C., Swerdloff, R., Lee, P., Goh, V. H., Ridgway, E. C., & Wierman, M. E. (2011). Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometry. Steroids, 76(1–2), 177–182. [DOI:10.1016/j.steroids.2010.10.010]
    • Rubinow, D. R., Schmidt, P. J., Roca, C. A., & Daly, R. C. (2002). Gonadal Hormones and Behavior in Women: Concentrations versus Context. In Pfaff, D. W., Arnold, A. P., Etgen, A. M., Fahrbach, S. E., & Rubin, R. T. (Eds.). Hormones, Brain and Behavior, Volume 5 (pp. 37–73). Amsterdam: Academic Press. [Google Books] [DOI:10.1016/B978-012532104-4/50086-X]
    • Ruokonen, A., Alén, M., Bolton, N., & Vihko, R. (1985). Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. Journal of Steroid Biochemistry, 23(1), 33–38. [DOI:10.1016/0022-4731(85)90257-2]
    • Schijf, C. P., van der Mooren, M. J., Doesburg, W. H., Thomas, C. M., & Rolland, R. (1993). Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle. Acta Endocrinologica, 129(2), 130–133. [DOI:10.1530/acta.0.1290130]
    • Schuijt, M. P., Sweep, C. G., van der Steen, R., Olthaar, A. J., Stikkelbroeck, N. M., Ross, H. A., & van Herwaarden, A. E. (2019). Validity of free testosterone calculation in pregnant women. Endocrine Connections, 8(6), 672–679. [DOI:10.1530/ec-19-0110]
    • Shifren, J. L., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2007). A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause, 14(6), 985–994. [DOI:10.1097/gme.0b013e31803867a]
    • Shifren, J. L., Rifai, N., Desindes, S., McIlwain, M., Doros, G., & Mazer, N. A. (2008). A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women. The Journal of Clinical Endocrinology & Metabolism, 93(5), 1702–1710. [DOI:10.1210/jc.2007-2193]
    • Smith, K., Galazi, M., Openshaw, M. R., Wilson, P., Sarker, S. J., O’Brien, N., Alifrangis, C., Stebbing, J., & Shamash, J. (2020). The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. Clinical Genitourinary Cancer, 18(3), e217–e223. [DOI:10.1016/j.clgc.2019.09.019]
    • Stege, R., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., & Pousette, A. (1988). Single drug polyestradiol phosphate therapy in prostatic cancer. American Journal of Clinical Oncology, 11(Suppl 2), S101–S103. [DOI:10.1097/00000421-198801102-00024] [PDF]
    • Steingold, K. A., Pardridge, W. M., Judd, H. L., & Chaudhuri, G. (1987). The effects of membrane permeability and binding by human serum proteins on steroid influx into the rabbit uterus. American Journal of Obstetrics and Gynecology, 157(6), 1543–1549. [DOI:10.1016/s0002-9378(87)80260-0]
    • Strauss, J. F., & FitzGerald, G. A. (2019). Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 75–114.e7). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/b978-0-323-47912-7.00004-4]
    • Troisi, R., Potischman, N., Roberts, J. M., Harger, G., Markovic, N., Cole, B., Lykins, D., Siiteri, P., & Hoover, R. N. (2003). Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiology, Biomarkers & Prevention, 12(5), 452–456. [Google Scholar] [PubMed] [URL]
    • Tulchinsky, D., & Chopra, I. J. (1973). Competitive Ligand-Binding Assay for Measurement of Sex Hormone-Binding Globulin (SHBG). The Journal of Clinical Endocrinology & Metabolism, 37(6), 873–881. [DOI:10.1210/jcem-37-6-873]
    • von Schoultz, B., Carlström, K., Collste, L., Eriksson, A., Henriksson, P., Pousette, Å., & Stege, R. (1989). Estrogen therapy and liver function—metabolic effects of oral and parenteral administration. The Prostate, 14(4), 389–395. [DOI:10.1002/pros.2990140410]
    • Zimmerman, Y., Eijkemans, M. J., Coelingh Bennink, H. J., Blankenstein, M. A., & Fauser, B. C. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. [DOI:10.1093/humupd/dmt038]
    \ No newline at end of file diff --git a/transfemscience.org/articles/spiro-testosterone/index.html b/transfemscience.org/articles/spiro-testosterone/index.html index d3afbb1d..f333efd2 100644 --- a/transfemscience.org/articles/spiro-testosterone/index.html +++ b/transfemscience.org/articles/spiro-testosterone/index.html @@ -1 +1 @@ -A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People - Transfeminine Science Link

    A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People

    By Aly | First published December 19, 2018 | Last modified April 21, 2023

    Abstract / TL;DR

    Spironolactone is an antiandrogen used in transfeminine hormone therapy which is especially employed in the United States. It is widely considered to act as an androgen receptor antagonist and as an androgen synthesis inhibitor, both blocking the actions of testosterone and lowering testosterone levels in transfeminine people. A literature search was conducted to review studies assessing the influence of spironolactone on testosterone levels in cisgender men, cisgender women, and transfeminine people. The results of these studies were mixed, but in most studies spironolactone showed no apparent influence on testosterone levels. These findings suggest that spironolactone has inconsistent and limited effects on testosterone levels. Moreover, these data, as well as studies of estradiol alone, indicate that estradiol is mainly responsible for lowered testosterone levels when the combination of estradiol and spironolactone is used for hormone therapy in transfeminine people. Besides testosterone suppression, spironolactone also acts as a direct antagonist of the androgen receptor, and this importantly contributes to its antiandrogenic efficacy as well. However, studies in cisgender women suggest that spironolactone is a relatively weak androgen receptor antagonist, and is likely best-suited for blocking relatively low testosterone levels. Taken together, the antiandrogenic effectiveness of spironolactone in transfeminine people appears to be limited. Other antiandrogenic approaches may be more effective in transfeminine people, and may be considered instead or as alternatives to spironolactone in those in whom testosterone levels with estradiol plus spironolactone remain inadequately suppressed.

    Introduction

    Spironolactone, also known by its major brand name Aldactone, is an antiandrogen which is commonly used in transfeminine hormone therapy. It is used in combination with estrogen in transfeminine people to help reduce the effects of testosterone. Spironolactone is used in transfeminine hormone therapy particularly in the United States, where another antiandrogen, cyproterone acetate (CPA; brand name Androcur), is unavailable. Conversely, CPA is the main antiandrogen used in transfeminine people in Europe and most of the rest of the world. Another type of medication, gonadotropin-releasing hormone (GnRH) agonists, are the major antiandrogens used in certain places like the United Kingdom. The combination of estradiol with CPA or a GnRH agonist in transfeminine people consistently suppresses testosterone levels into the normal female range (<50 ng/dL or <1.8 nmol/L) (Aly, 2018; Aly, 2019). Hence, both CPA and GnRH agonists are very effective antiandrogens in transfeminine people.

    Spironolactone acts as an androgen receptor antagonist, but is also known to function as an androgen synthesis inhibitor. As an example, spironolactone has been shown in preclinical research to inhibit several enzymes involved in gonadal and adrenal androgen production, including CYP17A1 (17α-hydroxylase/17,20-lyase) among others, and to substantially decrease concentrations of androgens in these studies (Loriaux et al., 1976; Callan, 1988; McMullen & Van Herle, 1993). However, the steroid synthesis inhibition of spironolactone appears to only occur at very high doses and concentrations of spironolactone (Loriaux et al., 1976; McMullen & Van Herle, 1993). For example, spironolactone is used at 10- to 20-fold smaller doses by body weight in humans than in animal studies that have demonstrated substantial steroid synthesis inhibition with the agent (McMullen & Van Herle, 1993).

    A widespread notion in the transgender community, as well as in the transgender health community and in the medical literature, is that spironolactone decreases testosterone levels and that this is a major part of how it works as an antiandrogen in transfeminine people. In actuality however, the clinical evidence to support this notion appears to be limited, and available data from studies appear to be highly conflicting. The purpose of this article is to review the available clinical studies on spironolactone and testosterone levels in cisgender men, cisgender women, and transfeminine people in order to help elucidate whether and to what extent spironolactone lowers testosterone levels in humans. In addition, the role of androgen receptor blockade in the antiandrogenic effects of spironolactone is briefly reviewed.

    Spironolactone and Testosterone Levels

    A literature search was performed to identify studies assessing the influence of spironolactone on levels of testosterone as well as other relevant sex hormones in cisgender men and transfeminine people. Other sex hormones besides testosterone included dihydrotestosterone (DHT), androstenedione (A4), estradiol, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin, among others. Search engines included PubMed/MEDLINE and Google Scholar and relevant keywords were employed (e.g., “spironolactone”, “aldactone”, “testosterone”). Both observational studies (e.g., retrospective and prospective cohort and case–control studies) as well as randomized controlled trials (RCTs) where available were included. Studies are discussed separately based on whether they used spironolactone alone in cisgender men, spironolactone in cisgender women, spironolactone alone in transfeminine people, or spironolactone combined with estrogen in transfeminine people.

    Spironolactone Alone in Cisgender Males

    A total of 22 studies of spironolactone and sex hormone levels in cisgender males were identified (Table 1). These studies assessed pre-treatment versus post-treatment hormone levels with spironolactone, hormone levels with spironolactone versus a comparator group, or both. Within the identified studies, testosterone levels were not significantly changed in 12 of 22 studies (55%), decreased in 4 of 22 (18%) studies, increased in 1 of 22 (4.5%) studies, and mixed or unknown (e.g. divergences in changes of total versus free testosterone levels or didn’t actually report testosterone levels) in 4 of 22 (18%) studies. Most of the studies were very small (fewer than 10 people), with several exceptions. The studies were of highly variable lengths, with some being several days and others lasting for weeks or months. Few of the studies were RCTs. Most of the studies were very old, with a majority published in the 1970s and the rest published in the 1980s and 1990s. In relation to the preceding, the quality of data was limited.

    Table 1: Studies of sex hormone levels with spironolactone alone in cisgender males:

    Treatment and subjectsFindingsSource(s)
    100 mg/day for 2 weeks in 7 healthy men (23–34 years)T significantly decreased and LH significantly increased. No significant change in E1, E2, or E3. No change urinary total T excretion but significantly increased urinary total E excretion (including of E1 (7.72 to 10.54 µg/24 hrs), E2 (2.60 to 3.34 ug/24 hours), E3 (7.69 to 11.75 µg/24 hrs)). Slightly but significantly decreased excretion of 17-KS in urine.Pentikäinen et al. (1974)
    400 mg/day for 5 days in 6 healthy men (21–33 years)Significant increase in P4 and 17α-OHP (approximately doubled) for whole duration. Small and transient increases in LH (+20%) and FSH on the 2nd but not on the 3rd or 5th days (only other days measured). No significant changes in T, E2, or PRL. E2 and PRL non-significantly increased (+56% and +34% on the 5th day, respectively).Stripp et al. (1975)
    100 or 400 mg/day spironolactone for 8 weeks in 7 orchiectomized men (46–78 years) with metastatic prostate cancerT, A4, and DHEA significantly decreased with both doses of spironolactone and of similar magnitude between doses. Influence more apparent after 2–3 weeks of treatment.Walsh & Siiteri (1975)
    5 mg/kg/day for 1 week (275 mg/day for a 55 kg person) in 7 boys with delayed puberty (14–16 years)Significant increase in LH (+60%) and non-significant increase in FSH (+60%); individual responses for FSH variable. Increased P4 and 17α-OHP. T and E2 not actually reported.Santen et al. (1976)
    Initially 400 mg/day for 12 weeks; dosage later decreased in some due to hypotension (range 150–400 mg/day) in 5 men and 5 women (3 premenopausal, 2 postmenopausal) with normal or low renin hypertensionP4 and 17α-OHP increased by 2 to 4 times compared to pre-treatment and post-treatment. T, E2, LH, FSH, PRL, and 17-KS all unchanged.Taylor et al. (1976)
    100 mg/day for 4 weeks, then 0 mg/day for 4 weeks, then 400 mg/day for 4 weeks in 9 healthy men (18–39 years; mean 25 years)Dialyzable fraction of T increased significantly (+20%). LH, FSH, T, and E2 unchanged. LH and FSH responses to GnRH agonist unchanged.Caminos-Torres, Ma, & Snyder (1977)
    400 mg/day for 24 weeks in 9 healthy men (21–28 years)No changes in LH, FSH, T, or E2.Caminos-Torres, Ma, & Snyder (1977)
    200–400 mg/day for 4–13 months (mean 7 months) in 6 men with hypertension (35–61 years; mean 47 years) vs. 10 untreated male controls with hypertension (mean age 45 years)Significantly greater LH and E2 (30 pg/mL vs. 13 pg/mL; +130%), significantly lower T (440 ng/dL vs. 270 ng/dL; –38%), no difference in FSH. Also, significantly greater metabolic clearance rate of T, significantly greater rate of peripheral conversion (conversion ratio and transfer constant) of T into E2, non-significantly greater metabolic clearance rate of E2, no difference in blood production rate of T, and significantly greater blood production rate of E2.Rose et al. (1977)
    200–400 mg/day (mean 330 mg/day) for 20–27 days in 5 gonadally intact men (50–76 years) with prostate cancerP4 increased significantly from 0.25 ± 0.10 ng/mL (mean ± SD) to maximum of 1.3 ± 0.31 ng/mL by 20 days (increase of 5.2-fold or 420%). T decreased significantly from 427 ± 74.3 ng/dL to 200 ± 80.3 ng/dL (–53.2%). No significant change in E2, LH, or FSH.Baba (1977); Baba et al. (1978)
    200 mg/day for 21 days in 4 healthy men (26–35 years)No change in total T or E2. Unbound T and E2 slightly but significantly increased. Thought to be due to a direct interaction of spironolactone metabolites with the plasma protein binding of T and E2. But not due to binding to SHBG as T binding to SHBG was not significantly altered.Horth et al. (1977); Horth et al. (1979)
    200 mg/day for 1 week in 6 normal men (23–40 years) (RCT)No changes in T, LH, or P4.Huffman et al. (1978)
    100 mg/day for 10 months in 10 normal men (23–40 years) (RCT)No changes in T, E2, E3, LH, FSH, P4, or PRL. No change in metabolic clearance of A4 or T.Huffman et al. (1978)
    100 mg/day for 2 months, then 200 mg/day for 8 months in 8 normal men (23–40 years) (RCT)No changes in T, E2, E3, LH, FSH, P4, or PRL. No change in metabolic clearance of A4 or T.Huffman et al. (1978)
    75–150 mg/day for 12 weeks in 6 men with essential hypertension (28–64 years; mean 48 years)E1 significantly increased. E2 small, gradual, non-significant increase. T, LH, and PRL not significantly changed. PRL responses to TRH normal/not significantly changed.Miyatake et al. (1978)
    150–300 mg/day for 40 weeks in 2 men with idiopathic hyperaldosteronism (23 and 44 years)E1 increased. E2 fluctuated. E2 increased by 10-fold in one person by 16 weeks and this was associated with gynecomastia. T, LH, and PRL not altered significantly.Miyatake et al. (1978)
    200 mg/day for 10 days (n=5) vs. placebo (n=5) in 10 healthy men (18–31 years) (RCT)Significantly greater urinary A4, urinary EC, and urinary total E excretion. Differences in T, E2, LH, and FSH as well as urinary DHEA, LH, and FSH not significant. Examination of interaction between treatment and time showed significant changes in T, LH, and urinary DHEA. Concluded that there was a transient rise in T and urine DHEA for 2–4 days followed by increase in LH and normalization of T and DHEA excretion after 4–10 days.Tidd et al. (1978)
    300 mg/day for 7 days (n=5) vs. 200 mg/day triamterene (n=5) in 10 normal young men with diet-induced hyperaldosteronism (14 days of a diet modifying electrolyte intake)P4, 17α-OHP, unchanged. T near-but-non-significantly decreased (704.6 ± 55.5 ng/dL (mean ± SEM) to 508.4 ± 45.9 ng/dL on day 6; p < 0.10). Also assessed endogenous corticosteroids.Abshagen et al. (1978); Spörl (1978/1979)
    100 mg/day for 3 months in treatment group of 47 men (age 60–80 years) with BPH; control group of 58 healthy men without BPH (also age 60–80 years)In spiro/BPH group, T decreased from 650 ng/dL to 290 ng/dL and DHT decreased from 450 ng/dL to 150 ng/dL. In control/non-BPH group, T was 280 ng/dL and DHT was 90 ng/dL. P4, E2, and LH increased in spiro/BPH group. FSH also assessed. The authors stated that prostate gland can be a source of androgen production, implying that BPH can produce elevated androgen levels and that spironolactone can normalize elevated androgen levels in the condition.Zgliczynski, Baranowska, & Szymanowski (1981)
    150 mg/m2/day for 5 days in 6 boys with irregular puberty (11–13 years)No significant changes in T or urinary 17-KS excretion, elevated LH (by 600%—likely typo of “60%” (?)), and slightly increased FSH (from 0.75 ng/mL to 0.86 ng/mL).Skorodok, Savchenko, & Liss (1983)
    50–200 mg/day for 3 months in 17 males and 19 females (36 people total; 18–38 years, mean 24 years) with severe acneMales no significant changes in T, SHBG, DHT, or FAI.Goodfellow et al. (1984)
    50 mg/day for 4 weeks in 13 males (28–60 years, mean 47 years) with rosaceaNo changes in T, A4, DHT, or DHEA-S. 17α-OHP significantly increased (from 1.0 ± 0.65 ng/mL (mean ± SD) to 1.7 ± 0.98 ng/mL; +70%). E2 non-significantly increased (from 61 ± 29 pg/mL to 77 ± 45 pg/mL; +26%).Aizawa & Niimura (1992)
    25–400 mg/day (median 100 mg/day) for 12 months in 32 males (59%) of a group of 54 males (17–64 years; mean 44 years) with non-alcoholic liver disease requiring liver transplantation vs. 469 healthy male controls (mean 31 years) with normal liver functionSignificantly decreased T with spironolactone in men with moderate-severity liver disease but not with low- or high-severity liver disease. SHBG not influenced by spironolactone dosage. No influence on gonadotropin responses to GnRH stimulation.Handelsman et al. (1995)

    Abbreviations: T = testosterone; E2 = estradiol; E1 = estrone; E3 = estriol; E = estrogen(s); P4 = progesterone; 17α-OHP = 17α-hydroxyprogesterone; A4 = androstenedione; EC = etiocholanolone; DHT = dihydrotestosterone; DHEA = dehydroepiandrosterone; DHEA-S = dehydroepiandrosterone sulfate; 17-KS = 17-ketosteroids; LH = luteinizing hormone; FSH = follicle-stimulating hormone; GnRH = gonadotropin-releasing hormone; PRL = prolactin; TRH = thyrotropin-releasing hormone; FAI = free androgen index; SHBG = sex hormone-binding globulin; BPH = benign prostatic hyperplasia; RCT = randomized controlled trial.

    A few additional studies with the spironolactone-related drugs canrenone or potassium canrenoate (a prodrug of canrenone) (e.g., Soldactona) were also identified (Dymling, Nilsson, & Hökfelt, 1972; Dymling & Hökfelt, 1973; Erbler, 1974; Corvol et al., 1976; Dymling, 1978). These studies are notable as canrenone is a known active metabolite of spironolactone and as the studies consistently found decreased androgen levels with drugs delivering canrenone. In any case, the studies are excluded from the present review as they did not actually employ spironolactone.

    Although the quality of these studies is limited, the findings of the studies, which are mixed but are overall more suggestive against spironolactone reducing testosterone levels than it doing so, are in notable contrast to similar studies of CPA and testosterone suppression in cisgender men that were published in the 1970s and 1980s. These studies consistently found that CPA suppressed testosterone levels by 40 to 70% on average (Aly, 2019). Subsequently, the findings were replicated in several more modern studies of CPA in cisgender men and transfeminine people, which likewise found that the drug given alone consistently suppressed testosterone levels by about 45 to 65% on average (Aly, 2019).

    Spironolactone in Cisgender Women

    Spironolactone has a long history of use in cisgender women in the treatment of androgen-dependent skin and hair conditions like acne, hirsutism, scalp hair loss, and hyperandrogenism (due to e.g. polycystic ovary syndrome (PCOS)). It has been used at similar doses for androgen-dependent conditions in cisgender women as it has in transfeminine people (e.g., 50–200 mg/day most typically). There are many dozens of studies of spironolactone as an antiandrogen in cisgender women (e.g., PubMed). Instead of attempting to individually review all of these studies, the present article will discuss the findings of several papers that have themselves reviewed substantial numbers of these studies and have summarized available findings on testosterone levels with spironolactone.

    Callan (1988) reviewed the literature on spironolactone for treatment of acne and hirsutism in cisgender women and found that some clinical studies reported decreased levels of testosterone and/or other androgens with spironolactone (4 studies cited) whereas other studies reported no change in androgen levels (4 studies cited). The author cited several studies to support the claim that androgen receptor antagonism with spironolactone is more clinically important than any influence it has on androgen production (5 studies cited). For instance, clinical benefits against acne and hirsutism occurred with spironolactone both before androgen levels decrease as well as when androgen levels do not decrease.

    McMullen & Van Herle (1993) reviewed 19 studies of spironolactone for treatment of androgen-dependent conditions in cisgender women, with a majority of these studies reporting long-term hormone levels. Most of the studies were open-label and uncontrolled, with only five studies having a control group and only two studies being double-blind placebo-controlled trials. Changes in hormone levels across studies were very heterogenous, with the majority of changes not reaching statistical significance. Only 1 of 7 (14%) studies found a decrease in DHEA-S levels. The review concluded that a clinically significant change in adrenal androgen levels with spironolactone in cisgender women was not supported. Conversely, testosterone levels were decreased with spironolactone in 13 of 16 (81%) of studies. However, in the only two RCTs, there were no differences in testosterone levels with spironolactone versus in the placebo control groups. As such, the review concluded that the decreased testosterone levels with spironolactone in cisgender women reported in many of the non-RCT studies may not actually be a real phenomenon. As with Callan (1988), the review noted that the major mechanism of action of spironolactone as an antiandrogen is likely to be androgen receptor blockade.

    Bradstreet et al. (2007) cited and discussed a Cochrane review of spironolactone for treatment of acne and/or hirsutism in cisgender women (Farquhar et al., 2003). Cochrane reviews are rigorous high-quality systematic reviews of all of the available RCTs for a given medical intervention. The Cochrane review identified 19 RCTs, with 9 included in the review, 8 excluded due to methodological issues (e.g., with randomization), and two others which were described as “awaiting assessment” (Farquhar et al., 2003). Bradstreet and colleagues noted per the Cochrane review that spironolactone at a dosage of 100 mg/day had little influence on levels of DHEA, DHEA-S, or testosterone in the trials evaluated and said that this is because its mechanism of action as an antiandrogen is androgen receptor antagonism (Bradstreet et al., 2007). The Cochrane review itself did not discuss changes in androgen or testosterone levels with spironolactone in aggregate. An update of the Cochrane review was published in 2009, but with no new studies found and with the findings unchanged (Brown et al., 2009).

    Layton et al. (2017) was a hybrid systematic review of spironolactone for acne in cisgender women. In a table discussing the mechanism of action of spironolactone and other antiandrogens for acne, the authors stated that “Data from over 50 articles reporting effects [of spironolactone] on serum androgens are equivocal” (i.e., ambiguous, uncertain, questionable) (Layton et al., 2017). The review further noted that inhibition of androgen synthesis by spironolactone in humans may be unlikely at therapeutic doses and may occur instead only at supraphysiological doses (with Menard et al. (1979) cited in support of these claims, presumably related to the very high doses required) (Layton et al., 2017).

    Rozner et al. (2019) reviewed clinical studies of the endocrine effects of spironolactone in cisgender women to assess whether it is safe to use in women with past or present breast cancer receiving endocrine therapy. The review included 18 studies with 465 women (mostly having androgen-dependent conditions) assessing the influence of spironolactone on sex hormone levels. The assessed studies included retrospective cohort studies, case–control studies, and RCTs. Of the included studies, 10 (56%) studies (with 179 women) found no change in testosterone levels with spironolactone, 8 (44%) studies (with 253 women) found a decrease, and 1 (6%) study (with 33 women) found an increase in free but not total testosterone levels. Changes in levels of DHEA-S, androstenedione, and estrogen were also assessed and findings were similar, with no changes observed in majorities of studies for these hormones. The review concluded that there is no significant change in levels of androgens, estrogen, or gonadotropins with spironolactone in cisgender women.

    Almalki et al. (2020) conducted a systematic review and network meta-analysis of RCTs on the comparative efficacy of several types of medications (statins, metformin, spironolactone, and combined birth control pills) on reducing testosterone levels in cisgender women specifically with PCOS. Nine RCTs including 613 women were included for all of the medications. The meta-analysis concluded that the statin atorvastatin was more effective than the other included medications in reducing testosterone levels. Only two of the included RCTs employed spironolactone, one of which was with spironolactone alone (n=34) versus metformin (n=35) (Ganie et al., 2004) and the other of which was with spironolactone plus metformin (n=62) versus spironolactone alone (n=51) versus metformin alone (n=56) (Ganie et al., 2013). Both of the included trials found that spironolactone alone significantly decreased testosterone levels in pre-treatment versus post-treatment comparisons (Ganie et al., 2004; Ganie et al., 2013). No trials of spironolactone versus placebo controls were included.

    Taken together, the available studies of spironolactone and testosterone levels in cisgender women with androgen-dependent conditions are highly inconsistent and mixed, but with numerous studies finding no significant changes in testosterone levels. The reasons for the findings being so mixed are unclear, but may relate to study methodology and quality. Findings in this population seem particularly notable as regulation of the hypothalamic–pituitary–gonadal (HPG) axis by androgens in women is minimal to negligible, in turn making it such that androgen receptor antagonists will have little effect of upregulating gonadal sex hormone production as they can in cisgender men and transfeminine people. As a result, there is less homeostatic interference that could influence findings in evaluating the steroid synthesis inhibition of spironolactone in this sex, and hence these studies may provide a clearer picture of steroid synthesis inhibition as a possible clinical effect of spironolactone. However, as the findings are still so mixed, the results seem inconclusive. In any case, only a limited effect at best seems clear.

    Spironolactone Alone in Transfeminine People

    Only one study of spironolactone alone (without estrogen) and sex hormone levels in transfeminine people was identified (Table 2). It was conducted by Louis Gooren and colleagues of the Dutch Center of Expertise on Gender Dysphoria (CEGD) at the Vrije Universiteit Medical Center (VUMC) in Amsterdam, Netherlands in the 1980s. The study compared levels of testosterone, DHT, estradiol, LH, FSH, and prolactin before and after treatment with 200 mg/day spironolactone for 6 weeks in 6 young pre-hormone-therapy transfeminine people. It found slightly but significantly increased testosterone levels, increased prolactin levels, and no change in levels of estradiol, DHT, LH, or FSH.

    Table 2: Studies of sex hormone levels with spironolactone alone in transfeminine people:

    Treatment and subjectsFindingsSource(s)
    200 mg/day for 6 weeks in 6 pre-hormone therapy transfeminine people (21–39 years)T increased significantly from 17.2 ± 0.8 nmol/L (mean ± SEM) to 20.6 ± 1.7 nmol/L (+19.8%). No change in E2 (0.09 ± 0.02 nmol/L vs. 0.10 ± 0.03 nmol/L or 0.08 ± 0.02 nmol/L) or DHT (1.7 ± 0.8 nmol/L vs. 1.8 ± 0.9 nmol/L). LH, FSH, and GnRH-stimulated LH and FSH unchanged. PRL and TRH-stimulated PRL increased.Gooren et al. (1984a); Gooren et al. (1984b)

    Abbreviations: T = testosterone; E2 = estradiol; DHT = dihydrotestosterone; LH = luteinizing hormone; FSH = follicle-stimulating hormone; GnRH = gonadotropin-releasing hormone; PRL = prolactin; TRH = thyrotropin-releasing hormone.

    The fact that this study was done by the CEGD is notable as this institute is among the most prolific research centers on transgender hormone therapy in the world (Bakker, 2021), and, while they evaluated spironolactone as well as nilutamide as antiandrogens in studies in transfeminine people in the 1980s and 1990s (Wiki), the group ultimately settled on using only CPA instead. This was probably related to the lack of testosterone suppression with spironolactone and pure androgen receptor antagonists like nilutamide, as the researchers have touched on in other publications (e.g., Gooren, 1999).

    Estrogen Plus Spironolactone in Transfeminine People

    Eleven studies of the combination of estrogen and spironolactone and sex hormone levels in transfeminine people were identified (Table 3). The first study was conducted by Jerilynn Prior and colleagues in Canada in the 1980s. Subsequent studies were conducted over 25 years later by groups in the United States, Australia, Israel, and Thailand. All of the studies were retrospective chart reviews or prospective non-randomized studies, with the exception of a single RCT.

    Table 3: Studies of testosterone levels with estrogen plus spironolactone in transfeminine people:

    Treatment and subjectsFindingsSource(s)
    Oral CEEs (0.625–5 mg/day cyclically—3 of 4 weeks per month), oral MPA (10–20 mg/day cyclically—3 of 4 weeks per month—or continuously—”if gonadotrophins increased or to aid in T reduction or breast development”), and spironolactone (100–600 mg/day continuously) for 12 months in 27 transfeminine people who had been on “high-dose” E alone for an extended duration (Group 1) and 23 transfeminine people who were pre-hormone-therapy (Group 2) at Vancouver General Hospital.T decreased in Group 1 from 169 ng/dL to 87.4 ng/dL (–48.2%) and in Group 2 from 642 ng/dL to 49.2 ng/dL (–92.3%). Per authors, spironolactone was intended to help reduce T and facilitate feminization while MPA was intended to help suppress gonadotropins and T and improve breast development. However, authors emphasized the decrease in T as being due to spironolactone despite inclusion of MPA, without data provided to substantiate this.Prior, Vigna, & Watson (1989); Prior et al. (1986)
    Sublingual estradiol (4 mg/day—2 mg b.i.d.) (n=14), transdermal estradiol patch (100 μg/day) (n=1), or injectable estradiol valerate (20 mg/2 weeks) (n=1) with spironolactone (100–200 mg/day) for 6 months in 16 transfeminine people at an LGBT community health center in Los Angeles, California.T was median 405 ng/dL at baseline and 42 ng/dL after 6 months (–89.6%). Free T was median 11.4 ng/dL at baseline and 0.8 ng/dL at 6 months (–93.0%). 10 of 15 (66.7%) had total T in female range and 14 of 15 (93.3%) had free T in female range.Deutsch, Bhakri, & Kubicek (2015)
    Oral E2 (1–8 mg/day) with or without spironolactone (200 mg/day) (n=61), finasteride (5 mg/day) (n=49), and/or MPA (2.5–10 mg/day) (n=38) for 0.3 to 10.5 years (mean 4.3 ± 3.1 years) in 156 transfeminine people at Albany Medical Center.Oral E2 dose-dependently and substantially but incompletely suppressed T. E2 with spironolactone had no significant influence on T (+10.6 ± 16 ng/dL (mean ± SE); p = 0.5) and no greater likelihood of achieving better T suppression (<100 ng/dL) (OR = 0.75; 95% CI = 0.44–1.29) relative to E2 alone (at equivalent E2 levels). Finasteride associated with greater T levels. MPA helped with T suppression in some (71% of subjects). More discussion including graphs (Aly, 2019).Leinung, Feustel, & Joseph (2018); Leinung (2014)
    Oral E2 (0.5–10 mg/day) (n=67) or oral CEEs (0.625–5 mg/day) (n=12) and spironolactone (25–400 mg/day; mean/median 145 mg/day) for 12 months in 98 transfeminine people at Boston Medical Center.Combined E and spironolactone decreased T from median 385 ng/dL to 130 ng/dL (–66.2%). E alone vs. E and spironolactone not reported. No significant influence of spironolactone dosage on T. Incomplete suppression of T (>50 ng/dL) in all but the lowest quartile (25%) of individuals.Liang et al. (2018); Bonzagni (2014)
    Oral EV (4–6 mg/day; median 5–6 mg/day) (88.3%) or transdermal E2 (11.7%) alone or in combination with CPA (25–50 mg/day; median 50 mg/day) or spironolactone (87.5–200 mg/day; median 100 mg/day) for 0.9 to 2.6 years (median 1.5 years) in 80 transfeminine people at two gender clinics in Melbourne, Australia.T was 10.5 nmol/L (303 ng/dL) with E2 only, 2.0 nmol/L (58 ng/dL) with E2 plus spironolactone, and 0.8 nmol/L (23 ng/dL) with E2 plus CPA. 90% of those on E2 plus CPA and 40% of those on E2 plus spironolactone had T of <2 nmol/L (<58 ng/dL). T significantly lower with E2 plus CPA compared to E2 plus spironolactone and E2 alone. T with E2 plus spironolactone lower than with E2 alone but non-significantly. No significant differences between groups in age, hormone therapy duration, or E2 dosage or levels. Graph that visually summarizes the results.Angus et al. (2019); Cheung et al. (2018)
    Sublingual estradiol (2–12 mg/day) and spironolactone (100–200 mg/day) with or without sublingual MPA (5–10 mg/day) or injectable MPA (150 mg/3 months) for 3.4 ± 1.7 years in 92 transfeminine people at Rhode Island Hospital.T was 215 ± 29 ng/dL (mean ± SD) with E2 plus spironolactone and 79 ± 18 ng/dL with E2 plus spironolactone and MPA.Jain, Kwan, & Forcier (2019)
    Oral E2 (2–8 mg/day) (84.2%) or other E forms (15.8%) with spironolactone (80.4%; n=107) or without spironolactone (19.6%) for more than 6 months in 133 transfeminine people at three clinics in Dallas, Texas.T decreased from median 367 ng/dL (95% range 175–731 ng/dL) (n=70) at baseline to median 55 ng/dL (95% range 3–709 ng/dL) (n=131) in whole group (80.4% taking spironolactone). 65 of 133 (49%) had adequate T suppression (presumably <50 or <60 ng/dL) in whole group. T with spironolactone at 25–75 mg/day (n=15) was mean 129.4 ng/dL (range <3—611 ng/dL), at 100–175 mg/day (n=61) was mean 180.4 ng/dL (range <3–1137 ng/dL), and at 200–300 mg/day (n=31) was mean 170.1 ng/dL (range <3–798 ng/dL).SoRelle et al. (2019); Allen et al. (2021)
    Oral E2 (2–8 mg/day), transdermal E2 gel (2.5–5 mg/day), or transdermal E2 patches (50–200 μg/day) plus spironolactone (50–200 mg/day) (n=16), CPA (10–100 mg/day) (n=41), or a GnRH agonist (n=10) for 12 months in 67 transfeminine people at Tel Aviv-Sourasky Medical Center in Israel.With spironolactone, T decreased from 15.2 ± 8.1 (mean ± SD) nmol/L at baseline to 10.2 ± 5.7 ng/dL at 3 months (–32.9%), 3.5 ± 1.2 ng/dL at 6 months (–77.0%), and 4 ± 7.1 ng/dL at 12 months (–73.7%). T was in the female range (<1.8 nmol/L) at all follow-ups after baseline for both CPA and GnRH agonist (–92.0% to –96.4%).Sofer et al. (2020)
    Oral EV 4 mg/day plus spironolactone (100 mg/day) (n=26) or CPA (25 mg/day) (n=26) for 12 weeks in 52 transfeminine people at two clinics in Bangkok, Thailand (RCT).With intention-to-treat analysis, T decreased with E2 plus spironolactone from median 645.0 ng/dL (IQR 466.7−1027.7 ng/dL) to 468.3 ng/dL (IQR 287.0−765.4 ng/dL) (–27.4%) and with E2 plus CPA from 655.5 ng/dL (402.6−872.7 ng/dL) to 9.3 ng/dL (IQR 5.5−310.4 ng/dL) (–98.6%). Adequate suppression of testosterone (<50 ng/dL) was achieved by 4 of 26 (15%) in the E2 plus spironolactone group and by 18 of 26 (69%) in the E2 plus CPA group. Study also assessed and reported E2, SHBG, and PRL levels.Burinkul et al. (2021)
    E2 (sublingual, transdermal, or injectable) with spironolactone (n=39) or without spironolactone (n=37) for 12 months in 93 transfeminine people at two LGBTQ-oriented clinics in Seattle, Washington and Iowa City, Iowa.T was median 11 to 18 ng/dL in different estradiol groups without spironolactone and median 10 to 12 ng/dL in different estradiol groups with spironolactone. T was significantly lower with spironolactone only for sublingual E2 group (median 11 ng/dL (IQR 6–35 ng/dL) [n=27] vs. median 18 ng/dL (IQR 13–205 ng/dL) [n=16]) and not for transdermal or injectable E2 groups.Cirrincione et al. (2021)
    Oral E2 (4–12 mg/day, median 6 mg/day) (n=27) or injectable EV (2–5 mg/week, median 4 mg/week) (n=6) with spironolactone (n=31) or without spironolactone (n=2) for median 6.2 months (range 0.6–28.2 months) (time on optimized E2 dose specifically) in 33 transfeminine people at Maine Medical Center.T was median 13.0 ng/dL (range 2.7–559 ng/dL) for whole group (93.9% taking spironolactone). 28 of 33 (84.8%) of whole group had female-range T (<50 ng/dL). However, in earlier studies by the same group, similar T suppression with E2 alone was reported (Reardon et al., 2013; Spratt et al., 2014).Pappas et al. (2021); Pappas et al. (2020); Stewart et al. (2018)

    Abbreviations: E = estrogen; E2 = estradiol; EV = estradiol valerate; CEEs = conjugated [equine] estrogens; CPA = cyproterone acetate; MPA = medroxyprogesterone acetate; GnRH = gonadotropin-releasing hormone; T = testosterone; DHEA-S = dehydroepiandrosterone sulfate; LH = luteinizing hormone; FSH = follicle-stimulating hormone; PRL = prolactin.

    Findings of the above studies include inadequate testosterone suppression with estradiol plus spironolactone in most transfeminine people (Leinung et al., 2018; Liang et al., 2018; Jain, Kwan, & Forcier, 2019; Sofer et al., 2020; Burinkul et al., 2021), no difference in testosterone suppression with spironolactone versus without spironolactone (Leinung et al., 2018), lack of notable influence of spironolactone dosage on testosterone suppression (Liang et al., 2018; SoRelle et al., 2019), and inferior testosterone suppression with estradiol plus spironolactone compared to estradiol plus CPA or a GnRH agonist in transfeminine people (Angus et al., 2019; Sofer et al., 2020; Burinkul et al., 2021). Conversely, some studies have found adequate or near-adequate testosterone suppression with estradiol plus spironolactone in most or almost all transfeminine people (Deutsch, Bhakri, & Kubicek, 2015; Angus et al., 2019; SoRelle et al., 2019; Cirrincione et al., 2021; Pappas et al., 2021), and some studies have found indications of greater testosterone suppression with spironolactone versus without spironolactone (Angus et al., 2019; Cirrincione et al., 2021). On the other hand, some studies using estradiol alone without any antiandrogen at physiological estradiol levels (<200 pg/mL) have reported adequate testosterone suppression similarly to the preceding estradiol plus spironolactone studies (Reardon et al., 2013; Spratt et al., 2014; Cirrincione et al., 2021). One study was confounded by the concomitant use of the progestogen medroxyprogesterone acetate (MPA), which is known to suppress testosterone levels on its own, and hence reliable conclusions could not be drawn from it (Prior, Vigna, & Watson, 1989; Prior et al., 1986). A couple of studies found that testosterone levels progressively decline with time (particularly over the first 12 months) with estradiol plus spironolactone in most transfeminine people (Liang et al., 2018; Sofer et al., 2020). Whether the decreases in testosterone levels with time were more related to estradiol or to spironolactone is unclear, though estradiol seems more likely (e.g., Wiki).

    Taken together, the findings of available studies on estradiol plus spironolactone and testosterone suppression in transfeminine people are highly variable and mixed, although overall more studies support spironolactone having poor or no testosterone-suppressing effectiveness. The reasons underlying the differences in findings on testosterone suppression between studies are unclear, but contributing factors may include varying estradiol doses, routes, and levels, durations of hormone therapy, differing laboratory assays of testosterone levels, and other differences in study methodologies, as well as limitations in study and evidence quality. In any case, the conflicting nature of the findings is in major contrast to the almost invariably strong to maximal testosterone suppression in studies of estradiol plus CPA and estradiol plus GnRH agonists in transfeminine people.

    Spironolactone, Androgen Receptor Antagonism, and Clinical Antiandrogenic Effectiveness

    The clinical antiandrogenic effectiveness of spironolactone in cisgender women with androgen-dependent skin and hair conditions, like acne, hirsutism, and scalp hair loss, is well-established (Brown et al., 2009; van Zuuren & Fedorowicz, 2016; Layton et al., 2017; Barrionuevo et al., 2018; James, Jamerson, & Aguh, 2022; Wang et al., 2023). Conversely, the clinical antiandrogenic efficacy of spironolactone in transfeminine people has been very limitedly assessed to date and is largely unknown (Angus et al., 2021). Spironolactone does not appear to be very effective for decreasing testosterone levels in either cisgender women or transfeminine people based on the findings of the present review. However, spironolactone is a competitive antagonist of the androgen receptor in addition to its actions a weak androgen synthesis inhibitor, and hence it also directly blocks androgens from mediating their effects in the body (Loriaux et al., 1976; McMullen & Van Herle, 1993). Based on studies in populations besides transfeminine people, for instance cisgender women (discussed above) and cisgender boys with gonadotropin-independent precocious puberty (e.g., Holland, 1991), in which spironolactone has not decreased testosterone levels but has nonetheless been effective as an antiandrogen, the androgen receptor blockade of spironolactone is likely to be its main mechanism of action as an antiandrogen and may account for most or all of its therapeutic antiandrogenic effectiveness.

    However, while spironolactone is clearly effective as an androgen receptor antagonist, it appears to be a relatively weak androgen receptor blocker at typical doses used in cisgender women and transfeminine people. Numerous publications in the literature describe spironolactone as being only a weak androgen receptor antagonist (Wiki; Wiki). In relation to this, animal studies have found that spironolactone is a far less potent androgen receptor antagonist than other antiandrogens like CPA, flutamide, and bicalutamide (Bonne & Raynaud, 1974; Hecker, Hasan, & Neumann, 1980; Sivelle, Underwood, & Jelly, 1982; Weissmann et al., 1985; Labrie et al., 1987; Snyder, Winneker, & Batzold, 1989 [Table]; Yamasaki et al., 2004 [Graph]). Moreover, in cisgender women, the population in which spironolactone is most widely used as an antiandrogen, testosterone levels are relatively low, on average about 20-fold lower than in cisgender men (around 30 ng/dL on average compared to about 600 ng/dL on average, respectively) (Aly, 2018). However, many cisgender women with androgen-dependent conditions have PCOS, which is associated with limitedly elevated testosterone levels (e.g., perhaps around 60 ng/dL on average) (Aly, 2018). The typical therapeutic dose range of spironolactone in cisgender women with androgen-dependent conditions is 50 to 200 mg/day, in which its effectiveness may be assumed to be dose-dependent, and this is roughly the same general dosage range used in transfeminine people (though up to 300–400 mg/day may be used and are allowed for by guidelines) (Aly, 2018; Aly, 2020).

    A relatively small amount of dose-ranging data on spironolactone in cisgender women with androgen-dependent conditions exists, but in any case substantiates its dose-dependent effectiveness across its clinically used dose range (partially reviewed in Hammerstein (1990) and Shaw (1996)). Spironolactone has been reported to be effective in the treatment of hirsutism in cisgender women at a dosage of as low as 50 mg/day (Diamanti-Kandarakis, Tolis, & Duleba, 1995). However, even a dosage of 100 mg/day did not appear to be maximally effective for hirsutism in a study that compared different doses of spironolactone; effectiveness was near-significantly greater at a dosage of 100 mg/day relative to a dosage of 200 mg/day (19% ± 8% and 30% ± 3% (mean ± SEM) reduction in hair shaft diameter, respectively; p = 0.07) (Lobo et al., 1985). Levels of free testosterone in this study were unchanged, suggesting that the effects of spironolactone was purely due to androgen receptor blockade. In addition, a study found that 100 mg/day spironolactone was significantly inferior to flutamide in improving androgen-dependent skin and hair symptoms in cisgender women (Cusan et al., 1994). However, in other studies, there were no significant differences between 100 mg/day spironolactone and flutamide for hirsutism (Erenus et al., 1994; Moghetti et al., 2000; Inal, Yildirim, & Taner, 2005; Karakurt et al., 2008). Spironolactone and flutamide were variably taken together with an ethinylestradiol-containing combined birth control pill in the preceding studies. This is likely to have limited detection of differences in effectiveness, as these birth control pills considerably suppress total and free testosterone levels and hence have substantial antiandrogenic effects themselves (Zimmerman et al., 2014; Amiri et al., 2018).

    In a biochemical study, 100 mg/day spironolactone was numerically inferior to flutamide in reducing levels of prostate-specific antigen (PSA) in cisgender women (Negri et al., 2000). This is notable as PSA is a systemic biomarker of androgen action (Negri et al., 2000). However, the study had small sample sizes, and the differences between groups were not statistically significant (Negri et al., 2000). One study compared spironolactone at doses of 50 to 200 mg/day with placebo for treatment of acne in cisgender women and reported progressive increases in effectiveness with spironolactone up to the 200 mg/day dosage (Goodfellow et al., 1984). Similarly, another study found that progressively increasing the dosage of spironolactone from 100 mg/day, to 150 mg/day, and up to 200 mg/day, resulted in increased effectiveness in the treatment of acne in cisgender women (Charny, Choi, & James, 2017). Finally, a 2022 systematic review of spironolactone for treatment of androgen-related scalp hair loss in cisgender women reported that the drug was “largely ineffective” at doses of less than 100 mg/day, whereas doses of 100 to 200 mg/day were effective (James, Jamerson, & Aguh, 2022).

    The preceding findings suggest that the clinical antiandrogenic effectiveness of spironolactone in cisgender women is not maximal at a dosage of below at least 200 mg/day despite the relatively low testosterone levels in these individuals. Put another way, spironolactone at typical doses seems best-suited for blocking female-range levels of testosterone. As many transfeminine people do not achieve female-range testosterone levels with estradiol plus spironolactone therapy, and in fact often have testosterone levels well above the normal female range or even in the male range, spironolactone may not be fully effective as an antiandrogen at the typical doses used in transfeminine hormone therapy. Higher doses of spironolactone, like 300 to 400 mg/day, may be to some degree more effective.

    Summary, Discussion, and Conclusions

    Numerous studies have assessed the influence of spironolactone on testosterone levels in cisgender men, cisgender women, and transfeminine people. Although the quality of these studies has often been limited, the studies have revealed highly inconsistent influences of spironolactone on testosterone levels in these populations, with many studies finding no changes, some studies finding decreases, and a small number of studies finding increases. The findings of studies of spironolactone and testosterone levels are in notable contrast to those of studies with estrogens, progestogens like CPA, and GnRH agonists, which consistently show substantial decreases in testosterone levels. This has been the case even in studies of similarly low quality to those of some of the included spironolactone studies (e.g., many of those in cisgender men). The fact that in the available studies testosterone levels with spironolactone have usually been unchanged, but have sometimes been decreased and have rarely been decreased, seems to suggest that spironolactone may be a clinically significant inhibitor of steroid hormone synthesis, but that it is only a weakly efficacious one, and that its effects may be variable depending on the individual and other clinical circumstances. In any case, the conflicting findings warrant more research with higher-quality study designs, particularly RCTs that have with spironolactone versus without comparison groups.

    The notion that spironolactone decreases testosterone levels in transfeminine people, and the use of spironolactone in transfeminine hormone therapy in general, appear to have originated from the papers on spironolactone in transfeminine people published by Dr. Jerilynn Prior and colleagues in the 1980s (Prior, Vigna, & Watson, 1989; Prior et al., 1986). In their study, transfeminine people who were either already on high-dose estrogen therapy with inadequate testosterone suppression or had not yet started hormone therapy were put on physiological-dose estrogen therapy in combination with 200 to 600 mg/day spironolactone. Cyclic or continuous administration of the progestogen MPA at an oral dose of 10 mg/day was also given to all of the individuals. The authors reported that despite the lower estrogen dosage, testosterone levels decreased, from 169 ng/dL to 87 ng/dL (–49%) in those who had already been on hormone therapy and to 49 ng/dL in those who were pre-hormone therapy. Prior and her colleagues concluded that spironolactone helps to decrease testosterone levels in transfeminine people and that it can be used as a safer alternative to high doses of estrogen for this purpose.

    However, the concomitant use of MPA in the study is a major confounding factor in terms of their results. This is because MPA is a progestogen, and progestogens, like estrogens, are antigonadotropins which are able to robustly suppress testosterone levels on their own (Aly, 2018; Aly, 2019). Indeed, MPA alone has been shown to dose-dependently lower testosterone levels in cisgender men (Wiki), and at a dosage of 10 mg/day, has been shown to considerably suppress testosterone levels in transfeminine people when added to estradiol and spironolactone therapy (Jain, Kwan, & Forcier, 2019). Hence, MPA may have been, and likely was, responsible for the decreases in testosterone levels seen in the study, rather than spironolactone. This point was also notably raised by other researchers, who were unable to replicate Prior and colleagues’ results on spironolactone and testosterone levels in transfeminine people (Leinung et al., 2018). Strangely, Prior and colleagues concluded that spironolactone was responsible for the decreased testosterone levels in their study even though they noted in their papers that MPA was also given to help suppress testosterone levels (as well as to help improve breast development). The work of Prior and colleagues likely resulted in the prominent and long-standing, but poorly supported, notion that spironolactone decreases testosterone levels in transfeminine people. Subsequent studies assessing the hypothesis that spironolactone decreases testosterone levels in transfeminine people were not published until 25 years after Prior and colleagues’ studies, with several of these studies, though not all of them, failing to replicate the earlier findings of Prior and colleagues.

    Many people do not realize the capacity of estradiol to substantially and even completely suppress testosterone, and many mistakenly assume that it is the antiandrogen—which is often spironolactone—that is mostly or fully responsible for the decrease in testosterone levels seen with estradiol and antiandrogen therapy in transfeminine people. It is certainly true that antiandrogens like CPA and GnRH agonists play an important role in testosterone suppression in transfeminine people. However, as evidenced by the present review of studies of testosterone suppression with spironolactone, it is not necessarily always the case that the antiandrogen plays a major role—or potentially even any role—in reducing testosterone levels. This is notably also not the case with certain other antiandrogens besides spironolactone, for instance pure androgen receptor antagonists like bicalutamide, which likewise do not decrease testosterone levels but instead can actually increase them (Aly, 2019; Wiki). Clinicians and transfeminine people attributing observations of testosterone decreases to spironolactone rather than to estradiol with estradiol and spironolactone therapy may also have played a role in the perception that spironolactone considerably decreases testosterone levels in transfeminine people.

    Due to its relatively weak strength as an androgen receptor antagonist and its limited efficacy in lowering testosterone levels, spironolactone is likely to be a limitedly effective antiandrogen in transfeminine people. Additionally, spironolactone is likely to be less effective than other antiandrogenic approaches used in transfeminine hormone therapy which either more robustly block androgens or more substantially reduce testosterone levels, for instance CPA, other progestogens (e.g., MPA, non-oral progesterone), GnRH agonists (and antagonists), bicalutamide, and high-dose parenteral estradiol monotherapy. These approaches can be used in transfeminine people instead of or in addition to spironolactone, or could be considered when testosterone suppression is inadequate with estradiol and spironolactone.

    More studies are needed to evaluate the influence of spironolactone on testosterone levels, especially RCTs that compare estradiol alone versus estradiol plus spironolactone in transfeminine people. More research is also needed to clarify why some studies find highly inadequate testosterone suppression with estradiol alone or estradiol plus spironolactone while other studies find excellent or satisfactory testosterone suppression with these regimens. In any case, available data overall suggest that spironolactone does not consistently suppress testosterone levels, and that estradiol plus spironolactone produces inadequate testosterone suppression in many transfeminine people. Moreover, available data suggest that spironolactone is a relatively weak androgen receptor antagonist at the typical clinical doses used in cisgender women and transfeminine people, and is able to block only relatively low or female-range testosterone levels. Hence, spironolactone may not be fully effective in blocking the testosterone it fails to suppress, and may be particularly unsuitable for transfeminine people with testosterone levels that are well above the normal female range. In any case, more research is similarly needed to assess the androgen receptor antagonism and clinical antiandrogenic effectiveness of spironolactone.

    References

    • Abshagen, U., Spörl, S., Schöneshöfer, M., L’age, M., & Oelkers, W. (1978). Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism. [Zum Einfluß einer Spironolaktonbehandlung auf den adrenalen Steroidstoffwechsel bei sekundärem Hyperaldosteronismus.] Klinische Wochenschrift, 56(7), 341–349. [DOI:10.1007/bf01477394]
    • Aizawa, H., & Niimura, M. (1992). Oral Spironolactone Therapy in Male Patients with Rosacea. The Journal of Dermatology, 19(5), 293–297. [DOI:10.1111/j.1346-8138.1992.tb03227.x]
    • Allen, A. N., Jiao, R., Day, P., Pagels, P., Gimpel, N., & SoRelle, J. A. (2020). Dynamic Impact of Hormone Therapy on Laboratory Values in Transgender Patients over Time. The Journal of Applied Laboratory Medicine, 6(1), 27–40. [DOI:10.1093/jalm/jfaa192]
    • Almalki, H. H., Alshibani, T. M., Alhifany, A. A., & Almohammed, O. A. (2020). Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials. BMC Women’s Health, 20(1), 68. [DOI:10.1186/s12905-020-00919-5]
    • Amiri, M., Kabir, A., Nahidi, F., Shekofteh, M., & Ramezani Tehrani, F. (2018). Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. The European Journal of Contraception & Reproductive Health Care, 23(1), 64–77. [DOI:10.1080/13625187.2018.1435779]
    • Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., Zajac, J. D., & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine Connections, 8(7), 935–940. [DOI:10.1530/ec-19-0272]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (2021). A systematic review of antiandrogens and feminization in transgender women. Clinical Endocrinology, 94(5), 743–752. [DOI:10.1111/cen.14329]
    • Baba, S. (1977). Antiandrogenic effect of spironolactone. The Japanese Journal of Urology, 68(12), 1184–1192. [DOI:10.5980/jpnjurol1928.68.12_1184]
    • Baba, S., Murai, M., Jitsukawa, S., Hata, M., & Tazaki, H. (1978). Antiandrogenic Effects of Spironolactone: Hormonal and Ultrastructural Studies in Dogs and Men. Journal of Urology, 119(3), 375–380. [DOI:10.1016/s0022-5347(17)57495-9]
    • Bakker, A. (2021). Een halve eeuw transgenderzorg aan de VU [Half a Century of Transgender Care at the VU]. Amsterdam: Boom. [Google Books] [WorldCat] [URL]
    • Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1258–1264. [DOI:10.1210/jc.2017-02052]
    • Bonne, C., & Raynaud, J. (1974). Mode of spironolactone anti-androgenic action: Inhibition of androstanolone binding to rat prostate androgen receptor. Molecular and Cellular Endocrinology, 2(1), 59–67. [DOI:10.1016/0303-7207(74)90012-4]
    • Bonzagni, A. F. (2014). Understanding the effects of long-term hormone therapy in transgender individuals being provided care at Boston Medical Center Endocrinology Clinic: a quality assurance project. (Doctoral dissertation, Boston University.) [Google Scholar] [URL] [PDF]
    • Bradstreet, J. J., Smith, S., Granpeesheh, D., El-Dahr, J. M., & Rossignol, D. (2007). Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Medical Hypotheses, 68(5), 979–987. [DOI:10.1016/j.mehy.2006.10.015]
    • Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2003). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, 2003(4), CD000194. [DOI:10.1002/14651858.cd000194]
    • Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, 2009(2), CD000194. [DOI:10.1002/14651858.cd000194.pub2]
    • Burinkul, S., Panyakhamlerd, K., Suwan, A., Tuntiviriyapun, P., & Wainipitapong, S. (2021). Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial. The Journal of Sexual Medicine, 18(7), 1299–1307. [DOI:10.1016/j.jsxm.2021.05.003] [PDF]
    • Callan, A. W. (1988). Spironolactone therapy in hirsutism and acne. Australasian Journal of Dermatology, 29(3), 135–139. [DOI:10.1111/j.1440-0960.1988.tb00385.x]
    • Caminos-Torres, R., MA, L., & Snyder, P. J. (1977). Gynecomastia and Semen Abnormalities Induced by Spironolactone in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 45(2), 255–260. [DOI:10.1210/jcem-45-2-255]
    • Charny, J., Choi, J., & James, W. (2017). Spironolactone for the treatment of acne in women, a retrospective study of 110 patients. International Journal of Women’s Dermatology, 3(2), 111–115. [DOI:10.1016/j.ijwd.2016.12.002]
    • Cheung, A. S., Ooi, O., Davidoff, D., Leemaqz, S. Y., Cundill, P., Silberstein, N., Bretherton, I., Grossmann, M., & Zajac, J. D. (2018). Cyproterone vs spironolactone as anti-androgen therapy for transgender females receiving oestradiol therapy. Clinical Endocrinology, 89(S1) [Abstracts of the Endocrine Society of Australia’s Annual Scientific Meeting 2017], 14–14 (abstract no. 62). [Google Scholar] [DOI:10.1111/cen.13727] [URL 1] [URL 2] [PDF]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249]
    • Corvol, P., Mahoudeau, J. A., Valcke, J. C., Ménard, J., & Bricaire, H. (1976). Effets sexuels secondaires des spirolactones. Mécanismes possibles de l’action antiandrogène. [Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action]. La Nouvelle Presse Medicale, 5(11), 691–694. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF]
    • Cusan, L., Dupont, A., Gomez, J., Tremblay, R. R., & Labrie, F. (1994). Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertility and Sterility, 61(2), 281–287. [DOI:10.1016/s0015-0282(16)56518-2]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of Cross-Sex Hormone Treatment on Transgender Women and Men. Obstetrics & Gynecology, 125(3), 605–610. [DOI:10.1097/aog.0000000000000692]
    • Diamanti-Kandarakis, E., Tolis, G., & Duleba, A. J. (1995). Androgens and Therapeutic Aspects of Antiandrogens in Women. Journal of the Society for Gynecologic Investigation, 2(4), 577–592. [DOI:10.1177/107155769500200401]
    • Dymling, J., Nilsson, K. O., & Hökfelt, B. (1972). The effect of Soldactona® (canrenoate potassium) on plasma testosterone and androstenedione and urinary 17-ketosteroids and 17-hydroxycorticosteroids. Acta Endocrinologica, 70(1), 104–112. [DOI:10.1530/acta.0.0700104]
    • Dymling, J. F., & Hökfelt, B. (1973). Reduced plasma testosterone following spirolactone in man. Acta Endocrinologica, 73(Suppl 177) [9th Acta Endocrinologica Congress], 53–53 (abstract no. 53). [Google Scholar] [PDF 1] [PDF 2]
    • Dymling, J. F. (1978). The effect of spirolactone and spironolactone on plasma testosterone in man. In Addison, G. M., Asmussen, N. W., Corvol, P., Kloppernborg, P. W. C., Norman, N., Schroder, R., & Robertson, J. I. C. (Eds.). Aldosterone Antagonists in Clinical Medicine: Proceedings of the Searle Symposium, Nice, April 13–15, 1978 (pp. 297–302). Amsterdam: Excerpta Medica. [Google Scholar] [Google Books] [WorldCat] [PDF 1] [PDF 2]
    • Erbler, H. C. (1974). Suppression by the spironolactone metabolite canrenone of plasma testosterone in man. Naunyn-Schmiedeberg’s Archives of Pharmacology, 285(4), 403–406. [DOI:10.1007/bf00501468]
    • Erenus, M., Gürbüz, O., Durmuşoğlu, F., Demirçay, Z., & Pekin, S. (1994). Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertility and Sterility, 61(4), 613–616. [DOI:10.1016/s0015-0282(16)56634-5]
    • Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004). Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2756–2762. [DOI:10.1210/jc.2003-031780]
    • Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshrestha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., Mir, F. A., & Taing, S. (2013). Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study. The Journal of Clinical Endocrinology & Metabolism, 98(9), 3599–3607. [DOI:10.1210/jc.2013-1040]
    • Goodfellow, A., Alaghband-Zadeh, J., Carter, G., Cream, J., Holland, S., Scully, J., & Wise, P. (1984). Oral spironolactone improves acne vulgaris and reduces sebum excretion. British Journal of Dermatology, 111(2), 209–214. [DOI:10.1111/j.1365-2133.1984.tb04045.x]
    • Gooren, L. J., Veen, E. A., Kessel, H., Harmsen-Louman, W., & Wiegel, A. R. (1984). Prolactin secretion in the human male is increased by endogenous oestrogens and decreased by exogenous/endogenous androgens. International Journal of Andrology, 7(1), 53–60. [DOI:10.1111/j.1365-2605.1984.tb00759.x]
    • Gooren, L., Veen, E., Kessel, H., Harmsen-Louman, W., & Wiegel, A. (1984). Androgens in the Feedback Regulation of Gonadotropin Secretion in Men: Effects of Administration of Dihydrotestosterone to Eugonadal and Agonadal Subjects and of Spironolactone to Eugonadal Subjects. Andrologia, 16(4), 289–298. [DOI:10.1111/j.1439-0272.1984.tb00286.x]
    • Gooren, L. J. G. (1999). Hormonal Sex Reassignment. International Journal of Transgenderism, 3(3), 1–7. [Google Scholar] [URL 1] [URL 2]
    • Hammerstein, J. (1990). Antiandrogens: Clinical Aspects. In Orfanos, C. E., & Happle, R. (Eds.). Hair and Hair Diseases (pp. 827–886). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-74612-3_35]
    • Handelsman, D. J., Strasser, S., McDonald, J. A., Conway, A. J., & McCaughan, G. W. (1995). Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clinical Endocrinology, 43(3), 331–337. [DOI:10.1111/j.1365-2265.1995.tb02040.x]
    • Hecker, A., Hasan, S. H., & Neumann, F. (1980). Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinologica, 95(4), 540–545. [DOI:10.1530/acta.0.0950540]
    • Holland, F. J. (1991). Gonadotropin-lndependent Precocious Puberty. Endocrinology and Metabolism Clinics of North America, 20(1), 191–210. [DOI:10.1016/s0889-8529(18)30288-3]
    • Horth, C., Lobo, P., Shelton, J., Asbury, M., Clarke, J., & Venning, G. (1977). Effects of spironolaetone on the plasma binding and unbound levels of testosterone and oestradiol in healthy men. Journal of Steroid Biochemistry, 8(12), xx–xx. [DOI:10.1016/0022-4731(77)90178-9]
    • Horth, C. E., Lobo, P. J., Shelton, J. R., Asbury, M. J., Clarke, J. M., & Venning, G. R. (1979). Effects of spironolactone on the plasma binding and unbound levels of testosterone and oestradiol in healthy men. In Klopper, A., Lerner, L., van der Molen, H. J., & Sciarra, F. (Eds.). Research on Steroids: Proceedings of the International Study Group for Steroid Hormones, Volume 8 / Research on Steroids Transactions of the Eighth Meeting of the International Study Group for Steroid Hormones (Proceedings of the Serono Symposia, Volume 21) (pp. 313–315). London/New York/San Francisco: Academic Press. [Google Scholar]
    • Huffman, D. H., Kampmann, J. P., Hignite, C. E., & Azarnoff, D. L. (1978). Gynecomastia induced in normal males by spironolactone. Clinical Pharmacology & Therapeutics, 24(4), 465–473. [DOI:10.1002/cpt1978244465]
    • Inal, M. M., Yildirim, Y., & Taner, C. E. (2005). Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study. Fertility and Sterility, 84(6), 1693–1697. [DOI:10.1016/j.fertnstert.2005.05.051]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • James, J. F., Jamerson, T. A., & Aguh, C. (2022). Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review. Journal of the American Academy of Dermatology, 86(2), 425–429. [DOI:10.1016/j.jaad.2021.07.048]
    • Karakurt, F., Sahin, I., Güler, S., Demirbas, B., Culha, C., Serter, R., Aral, Y., & Bavbek, N. (2008). Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: A randomised controlled study. Advances in Therapy, 25(4), 321–328. [DOI:10.1007/s12325-008-0039-5]
    • Labrie, C., Cusan, L., Plante, M., Lapointe, S., & Labrie, F. (1987). Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancer. Journal of Steroid Biochemistry, 28(4), 379–384. [DOI:10.1016/0022-4731(87)91054-5]
    • Layton, A. M., Eady, E. A., Whitehouse, H., Del Rosso, J. Q., Fedorowicz, Z., & van Zuuren, E. J. (2017). Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review. American Journal of Clinical Dermatology, 18(2), 169–191. [DOI:10.1007/s40257-016-0245-x]
    • Leinung, M. C. (2014). Variable Response to Oral Estradiol Therapy in Male to Female Transgender Patients. Endocrine Reviews, 35(Suppl 1) [Endocrine Society’s 96th Annual Meeting and Expo, June 21–24, 2014 – Chicago], ?–? (abstract no. OR42-1). [Google Scholar] [DOI:10.1093/edrv/35.supp.1] [DOI:10.1210/endo-meetings.2014.RE.2.OR42-1] [URL] [MedPage Today]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Liang, J. J., Jolly, D., Chan, K. J., & Safer, J. D. (2018). Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort. Endocrine Practice, 24(2), 135–142. [DOI:10.4158/ep-2017-0116]
    • Lobo, R. A., Shoupe, D., Serafini, P., Brinton, D., & Horton, R. (1985). The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertility and Sterility, 43(2), 200–205. [DOI:10.1016/s0015-0282(16)48373-1]
    • Loriaux, D. L. (1976). Spironolactone and Endocrine Dysfunction. Annals of Internal Medicine, 85(5), 630–630. [DOI:10.7326/0003-4819-85-5-630]
    • McMullen, G. R., & Van Herle, A. J. (1993). Hirsutism and the effectiveness of spironolactone in its management. Journal of Endocrinological Investigation, 16(11), 925–932. [DOI:10.1007/bf03348960]
    • Menard, R., Guenthner, T., Kon, H., & Gillette, J. (1979). Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. Requirement for the 7α-thio group and evidence for the loss of the heme and apoproteins of cytochrome P-450. Journal of Biological Chemistry, 254(5), 1726–1733. [DOI:10.1016/s0021-9258(17)37833-x]
    • Miyatake, A., Noma, K., Nakao, K., Morimoto, Y., & Yamamura, Y. (1978). Increased serum oestrone and oestradiol following spironolactone administration in hypertensive men. Clinical Endocrinology, 9(6), 523–533. [DOI:10.1111/j.1365-2265.1978.tb01510.x]
    • Moghetti, P., Tosi, F., Tosti, A., Negri, C., Misciali, C., Perrone, F., Caputo, M., Muggeo, M., & Castello, R. (2000). Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism, 85(1), 89–94. [DOI:10.1210/jcem.85.1.6245]
    • Negri, C., Tosi, F., Dorizzi, R., Fortunato, A., Spiazzi, G. G., Muggeo, M., Castello, R., & Moghetti, P. (2000). Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women. The Journal of Clinical Endocrinology & Metabolism, 85(1), 81–84. [DOI:10.1210/jcem.85.1.6230]
    • Pappas, I. I., Craig, W. Y., Spratt, L. V., & Spratt, D. I. (2020). Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients. The Journal of Clinical Endocrinology & Metabolism, 106(3), e1290–e1300. [DOI:10.1210/clinem/dgaa884]
    • Pappas, I. I., Craig, W., Spratt, L. V., & Spratt, D. I. (2020). Testosterone (T) and estradiol (E2) therapy alone can suppress gonadal function in transgender patients. Costas T. Lambrew Research Retreat 2020, 47. [Google Scholar] [URL] [PDF]
    • Pentikäinen, P. J., Pentikäinen, L. A., Huffman, D. H., & Azarnoff, D. L. (1974). The effect of spironolactone on plasma levels and excretion of testosterone and oestrogens in the urine in males. (A preliminary report). The Journal of International Medical Research, 2(6), 439–443. [Google Scholar] [PubMed] [PDF]
    • Prior, J. C., Vigna, Y. M., Watson, D., Diewold, P., & Robinow, O. (1986). Spironolactone in the presurgical therapy of male to female transsexuals: Philosophy and experience of the Vancouver Gender Dysphoria Clinic. Journal of Sex Information & Education Council of Canada, 1(1), 1–7. [Google Scholar] [PDF]
    • Prior, J. C., Vigna, Y. M., & Watson, D. (1989). Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Archives of Sexual Behavior, 18(1), 49–57. [DOI:10.1007/bf01579291]
    • Reardon, E., Farnell, P., Langzettel, J., & Spratt, D. (2013). Efficacy of single agent hormonal therapy in transgender patients to suppress endogenous hypothalamic-pituitary-gonadal (HPG) activity. Fertility and Sterility, 100(3 Suppl) [Scientific Program Supplement: Oral and Poster Session Abstracts 12 October 2013 - 17 October 2013], S333–S333 (abstract no. P-640). [Google Scholar] [DOI:10.1016/j.fertnstert.2013.07.914]
    • Rose, L. I. (1977). Pathophysiology of Spironolactone-Induced Gynecomastia. Annals of Internal Medicine, 87(4), 398–403. [DOI:10.7326/0003-4819-87-4-398]
    • Rozner, R. N., Freites-Martinez, A., Shapiro, J., Geer, E. B., Goldfarb, S., & Lacouture, M. E. (2018). Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies. Breast Cancer Research and Treatment, 174(1), 15–26. [DOI:10.1007/s10549-018-4996-3]
    • Santen, R. J., Kulin, H. E., Loriaux, D. L., & Friend, J. (1976). Spironolactone Stimulation of Gonadotropin Secretion in Boys with Delayed Adolescence. The Journal of Clinical Endocrinology & Metabolism, 43(6), 1386–1390. [DOI:10.1210/jcem-43-6-1386]
    • Shaw, J. C. (1996). Antiandrogen and hormonal treatment of acne. Dermatologic Clinics, 14(4), 803–811. [DOI:10.1016/s0733-8635(05)70405-8]
    • Sivelle, P. C., Underwood, A. H., & Jelly, J. A. (1982). The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro. Biochemical Pharmacology, 31(5), 677–684. [DOI:10.1016/0006-2952(82)90449-x]
    • Skorodok, L. M., Savchenko, O. N., & Liss, V. L. (1983). Hypothalamo-hypophyseal-gonadal function in boys with irregular puberty. Neuroscience and Behavioral Physiology, 13(2), 141–145. [DOI:10.1007/bf01190800]
    • Snyder, B. W., Winneker, R. C., & Batzold, F. H. (1989). Endocrine profile of win 49596 in the rat: A novel androgen receptor antagonist. Journal of Steroid Biochemistry, 33(6), 1127–1132. [DOI:10.1016/0022-4731(89)90419-6]
    • Sofer, Y., Yaish, I., Yaron, M., Bach, M. Y., Stern, N., & Greenman, Y. (2020). Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocrine Practice, 26(8), 883–890. [DOI:10.4158/ep-2020-0032]
    • SoRelle, J. A., Jiao, R., Gao, E., Veazey, J., Frame, I., Quinn, A. M., Day, P., Pagels, P., Gimpel, N., & Patel, K. (2019). Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clinical Chemistry, 65(1), 170–179. [DOI:10.1373/clinchem.2018.292730]
    • Spörl, S. (1978/1979). Über den Einfluß von Spironolacton (Aldactone®) auf den Stoffwechsel von Nebennierenrindenhormonen und von Testosteron bei Gesunden mit diätinduziertem Hyperaldosterismus. [On the influence of spironolactone (Aldactone®) on the metabolism of adrenocortical hormones and testosterone in healthy individuals with diet-induced hyperaldosteronism.] (Doctoral dissertation, Freie Universität, Berlin.) [Google Scholar] [Google Books] [WorldCat] [PDF]
    • Spratt, L. V., Reardon, E., Olshan, J. S., & Eimicke, T. (2014). Efficacy of Testosterone (T) or Estradiol (E2) Therapy without a GnRH Agonist or Progestin to Suppress Endogenous Gonadal Activity in Transsexual Patients. Endocrine Reviews, 35(Suppl 1) [Endocrine Society’s 96th Annual Meeting and Expo, June 21–24, 2014 – Chicago], ?–? (abstract no. OR42-2). [DOI:10.1093/edrv/35.supp.1] [URL]
    • Stewart, I., Spratt, L., Craig, W., Olshan, J., & Spratt, D. (2018). The efficacy of testosterone or estradiol therapy without a GnRH agonist or progestin to suppress endogenous gonadal activity in transgender patients. Fertility and Sterility, 110(4 Suppl) [Scientific Congress Supplement: Oral and Poster Session Abstracts 06 October 2018 - 10 October 2018], e21–e21 (abstract no. O-44). [Google Scholar] [DOI:10.1016/j.fertnstert.2018.07.075]
    • Stripp, B., Taylor, A. A., Bartter, F. C., Gillette, J. R., Loriaux, D. L., Easley, R., & Menard, R. H. (1975). Effect of Spironolactone on Sex Hormones in Man. The Journal of Clinical Endocrinology & Metabolism, 41(4), 777–781. [DOI:10.1210/jcem-41-4-777]
    • Taylor, A. A., Rollins, D., Snodgrass, W., & Bartter, F. (1976). Effect of spironolactone (S) on adrenal and gonadal steroids in man. Clinical Research, 24(3), A279–A279. [Google Scholar] [PDF]
    • Tidd, M. J., Horth, C. E., Ramsay, L. E., Shelton, J. R., & Palmer, R. F. (1978). Endocrine effects of spironolactone in man. Clinical Endocrinology, 9(5), 389–399. [DOI:10.1111/j.1365-2265.1978.tb03578.x]
    • van Zuuren, E., & Fedorowicz, Z. (2016). Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments. British Journal of Dermatology, 175(1), 45–61. [DOI:10.1111/bjd.14486]
    • Walsh, P. C., & Siiteri, P. K. (1975). Suppression of Plasma Androgens by Spironolactone in Castrated Men with Carcinoma of the Prostate. Journal of Urology, 114(2), 254–256. [DOI:10.1016/s0022-5347(17)67001-0]
    • Wang, C., Du, Y., Bi, L., Lin, X., Zhao, M., & Fan, W. (2023). The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review. Clinical, Cosmetic and Investigational Dermatology, 16, 603–612. [DOI:10.2147/ccid.s398950]
    • Weissmann, A. (1985). Antiandrogenic Effects of Topically Applied Spironolactone on the Hamster Flank Organ. Archives of Dermatology, 121(1), 57–62. [DOI:10.1001/archderm.1985.01660010061019]
    • Yamasaki, K., Sawaki, M., Noda, S., Muroi, T., Takakura, S., Mitoma, H., Sakamoto, S., Nakai, M., & Yakabe, Y. (2004). Comparison of the Hershberger assay and androgen receptor binding assay of twelve chemicals. Toxicology, 195(2–3), 177–186. [DOI:10.1016/j.tox.2003.09.012]
    • Zgliczynski, S., Baranowska, B., & Szymanowski, J. (1981). L’influence du spironolactone sur la concentration des gonatrophines et des hormones gonadiques dans l’hypertrophie prostatique. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy]. Journal d’Urologie, 87(9), 635–638. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
    • Zimmerman, Y., Eijkemans, M. J., Coelingh Bennink, H. J., Blankenstein, M. A., & Fauser, B. C. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. [DOI:10.1093/humupd/dmt038]
    \ No newline at end of file +A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People - Transfeminine Science Link

    A Review of Studies on Spironolactone and Testosterone Suppression in Cisgender Men, Cisgender Women, and Transfeminine People

    By Aly | First published December 19, 2018 | Last modified April 5, 2024

    Abstract / TL;DR

    Spironolactone is an antiandrogen used in transfeminine hormone therapy which is especially employed in the United States. It is widely considered to act as an androgen receptor antagonist and as an androgen synthesis inhibitor, both blocking the actions of testosterone and lowering testosterone levels in transfeminine people. A literature search was conducted to review studies assessing the influence of spironolactone on testosterone levels in cisgender men, cisgender women, and transfeminine people. The results of these studies were mixed, but in most studies spironolactone showed no apparent influence on testosterone levels. These findings suggest that spironolactone has inconsistent and limited effects on testosterone levels. Moreover, these data, as well as studies of estradiol alone, indicate that estradiol is mainly responsible for lowered testosterone levels when the combination of estradiol and spironolactone is used for hormone therapy in transfeminine people. Besides testosterone suppression, spironolactone also acts as a direct antagonist of the androgen receptor, and this importantly contributes to its antiandrogenic efficacy as well. However, studies in cisgender women suggest that spironolactone is a relatively weak androgen receptor antagonist, and is likely best-suited for blocking relatively low testosterone levels. Taken together, the antiandrogenic effectiveness of spironolactone in transfeminine people appears to be limited. Other antiandrogenic approaches may be more effective in transfeminine people, and may be considered instead or as alternatives to spironolactone in those in whom testosterone levels with estradiol plus spironolactone remain inadequately suppressed.

    Introduction

    Spironolactone, also known by its major brand name Aldactone, is an antiandrogen which is commonly used in transfeminine hormone therapy. It is used in combination with estrogen in transfeminine people to help reduce the effects of testosterone. Spironolactone is used in transfeminine hormone therapy particularly in the United States, where another antiandrogen, cyproterone acetate (CPA; brand name Androcur), is unavailable. Conversely, CPA is the main antiandrogen used in transfeminine people in Europe and most of the rest of the world. Another type of medication, gonadotropin-releasing hormone (GnRH) agonists, are the major antiandrogens used in certain places like the United Kingdom. The combination of estradiol with CPA or a GnRH agonist in transfeminine people consistently suppresses testosterone levels into the normal female range (<50 ng/dL or <1.8 nmol/L) (Aly, 2018; Aly, 2019). Hence, both CPA and GnRH agonists are very effective antiandrogens in transfeminine people.

    Spironolactone acts as an androgen receptor antagonist, but is also known to function as an androgen synthesis inhibitor. As an example, spironolactone has been shown in preclinical research to inhibit several enzymes involved in gonadal and adrenal androgen production, including CYP17A1 (17α-hydroxylase/17,20-lyase) among others, and to substantially decrease concentrations of androgens in these studies (Loriaux et al., 1976; Callan, 1988; McMullen & Van Herle, 1993). However, the steroid synthesis inhibition of spironolactone appears to only occur at very high doses and concentrations of spironolactone (Loriaux et al., 1976; McMullen & Van Herle, 1993). For example, spironolactone is used at 10- to 20-fold smaller doses by body weight in humans than in animal studies that have demonstrated substantial steroid synthesis inhibition with the agent (McMullen & Van Herle, 1993).

    A widespread notion in the transgender community, as well as in the transgender health community and in the medical literature, is that spironolactone decreases testosterone levels and that this is a major part of how it works as an antiandrogen in transfeminine people. In actuality however, the clinical evidence to support this notion appears to be limited, and available data from studies appear to be highly conflicting. The purpose of this article is to review the available clinical studies on spironolactone and testosterone levels in cisgender men, cisgender women, and transfeminine people in order to help elucidate whether and to what extent spironolactone lowers testosterone levels in humans. In addition, the role of androgen receptor blockade in the antiandrogenic effects of spironolactone is briefly reviewed.

    Spironolactone and Testosterone Levels

    A literature search was performed to identify studies assessing the influence of spironolactone on levels of testosterone as well as other relevant sex hormones in cisgender men and transfeminine people. Other sex hormones besides testosterone included dihydrotestosterone (DHT), androstenedione (A4), estradiol, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and prolactin, among others. Search engines included PubMed/MEDLINE and Google Scholar and relevant keywords were employed (e.g., “spironolactone”, “aldactone”, “testosterone”). Both observational studies (e.g., retrospective and prospective cohort and case–control studies) as well as randomized controlled trials (RCTs) where available were included. Studies are discussed separately based on whether they used spironolactone alone in cisgender men, spironolactone in cisgender women, spironolactone alone in transfeminine people, or spironolactone combined with estrogen in transfeminine people.

    Spironolactone Alone in Cisgender Males

    A total of 22 studies of spironolactone and sex hormone levels in cisgender males were identified (Table 1). These studies assessed pre-treatment versus post-treatment hormone levels with spironolactone, hormone levels with spironolactone versus a comparator group, or both. Within the identified studies, testosterone levels were not significantly changed in 12 of 22 studies (55%), decreased in 4 of 22 (18%) studies, increased in 1 of 22 (4.5%) studies, and mixed or unknown (e.g. divergences in changes of total versus free testosterone levels or didn’t actually report testosterone levels) in 4 of 22 (18%) studies. Most of the studies were very small (fewer than 10 people), with several exceptions. The studies were of highly variable lengths, with some being several days and others lasting for weeks or months. Few of the studies were RCTs. Most of the studies were very old, with a majority published in the 1970s and the rest published in the 1980s and 1990s. In relation to the preceding, the quality of data was limited.

    Table 1: Studies of sex hormone levels with spironolactone alone in cisgender males:

    Treatment and subjectsFindingsSource(s)
    100 mg/day for 2 weeks in 7 healthy men (23–34 years)T significantly decreased and LH significantly increased. No significant change in E1, E2, or E3. No change urinary total T excretion but significantly increased urinary total E excretion (including of E1 (7.72 to 10.54 µg/24 hrs), E2 (2.60 to 3.34 ug/24 hours), E3 (7.69 to 11.75 µg/24 hrs)). Slightly but significantly decreased excretion of 17-KS in urine.Pentikäinen et al. (1974)
    400 mg/day for 5 days in 6 healthy men (21–33 years)Significant increase in P4 and 17α-OHP (approximately doubled) for whole duration. Small and transient increases in LH (+20%) and FSH on the 2nd but not on the 3rd or 5th days (only other days measured). No significant changes in T, E2, or PRL. E2 and PRL non-significantly increased (+56% and +34% on the 5th day, respectively).Stripp et al. (1975)
    100 or 400 mg/day spironolactone for 8 weeks in 7 orchiectomized men (46–78 years) with metastatic prostate cancerT, A4, and DHEA significantly decreased with both doses of spironolactone and of similar magnitude between doses. Influence more apparent after 2–3 weeks of treatment.Walsh & Siiteri (1975)
    5 mg/kg/day for 1 week (275 mg/day for a 55 kg person) in 7 boys with delayed puberty (14–16 years)Significant increase in LH (+60%) and non-significant increase in FSH (+60%); individual responses for FSH variable. Increased P4 and 17α-OHP. T and E2 not actually reported.Santen et al. (1976)
    Initially 400 mg/day for 12 weeks; dosage later decreased in some due to hypotension (range 150–400 mg/day) in 5 men and 5 women (3 premenopausal, 2 postmenopausal) with normal or low renin hypertensionP4 and 17α-OHP increased by 2 to 4 times compared to pre-treatment and post-treatment. T, E2, LH, FSH, PRL, and 17-KS all unchanged.Taylor et al. (1976)
    100 mg/day for 4 weeks, then 0 mg/day for 4 weeks, then 400 mg/day for 4 weeks in 9 healthy men (18–39 years; mean 25 years)Dialyzable fraction of T increased significantly (+20%). LH, FSH, T, and E2 unchanged. LH and FSH responses to GnRH agonist unchanged.Caminos-Torres, Ma, & Snyder (1977)
    400 mg/day for 24 weeks in 9 healthy men (21–28 years)No changes in LH, FSH, T, or E2.Caminos-Torres, Ma, & Snyder (1977)
    200–400 mg/day for 4–13 months (mean 7 months) in 6 men with hypertension (35–61 years; mean 47 years) vs. 10 untreated male controls with hypertension (mean age 45 years)Significantly greater LH and E2 (30 pg/mL vs. 13 pg/mL; +130%), significantly lower T (440 ng/dL vs. 270 ng/dL; –38%), no difference in FSH. Also, significantly greater metabolic clearance rate of T, significantly greater rate of peripheral conversion (conversion ratio and transfer constant) of T into E2, non-significantly greater metabolic clearance rate of E2, no difference in blood production rate of T, and significantly greater blood production rate of E2.Rose et al. (1977)
    200–400 mg/day (mean 330 mg/day) for 20–27 days in 5 gonadally intact men (50–76 years) with prostate cancerP4 increased significantly from 0.25 ± 0.10 ng/mL (mean ± SD) to maximum of 1.3 ± 0.31 ng/mL by 20 days (increase of 5.2-fold or 420%). T decreased significantly from 427 ± 74.3 ng/dL to 200 ± 80.3 ng/dL (–53.2%). No significant change in E2, LH, or FSH.Baba (1977); Baba et al. (1978)
    200 mg/day for 21 days in 4 healthy men (26–35 years)No change in total T or E2. Unbound T and E2 slightly but significantly increased. Thought to be due to a direct interaction of spironolactone metabolites with the plasma protein binding of T and E2. But not due to binding to SHBG as T binding to SHBG was not significantly altered.Horth et al. (1977); Horth et al. (1979)
    200 mg/day for 1 week in 6 normal men (23–40 years) (RCT)No changes in T, LH, or P4.Huffman et al. (1978)
    100 mg/day for 10 months in 10 normal men (23–40 years) (RCT)No changes in T, E2, E3, LH, FSH, P4, or PRL. No change in metabolic clearance of A4 or T.Huffman et al. (1978)
    100 mg/day for 2 months, then 200 mg/day for 8 months in 8 normal men (23–40 years) (RCT)No changes in T, E2, E3, LH, FSH, P4, or PRL. No change in metabolic clearance of A4 or T.Huffman et al. (1978)
    75–150 mg/day for 12 weeks in 6 men with essential hypertension (28–64 years; mean 48 years)E1 significantly increased. E2 small, gradual, non-significant increase. T, LH, and PRL not significantly changed. PRL responses to TRH normal/not significantly changed.Miyatake et al. (1978)
    150–300 mg/day for 40 weeks in 2 men with idiopathic hyperaldosteronism (23 and 44 years)E1 increased. E2 fluctuated. E2 increased by 10-fold in one person by 16 weeks and this was associated with gynecomastia. T, LH, and PRL not altered significantly.Miyatake et al. (1978)
    200 mg/day for 10 days (n=5) vs. placebo (n=5) in 10 healthy men (18–31 years) (RCT)Significantly greater urinary A4, urinary EC, and urinary total E excretion. Differences in T, E2, LH, and FSH as well as urinary DHEA, LH, and FSH not significant. Examination of interaction between treatment and time showed significant changes in T, LH, and urinary DHEA. Concluded that there was a transient rise in T and urine DHEA for 2–4 days followed by increase in LH and normalization of T and DHEA excretion after 4–10 days.Tidd et al. (1978)
    300 mg/day for 7 days (n=5) vs. 200 mg/day triamterene (n=5) in 10 normal young men with diet-induced hyperaldosteronism (14 days of a diet modifying electrolyte intake)P4, 17α-OHP, unchanged. T near-but-non-significantly decreased (704.6 ± 55.5 ng/dL (mean ± SEM) to 508.4 ± 45.9 ng/dL on day 6; p < 0.10). Also assessed endogenous corticosteroids.Abshagen et al. (1978); Spörl (1978/1979)
    100 mg/day for 3 months in treatment group of 47 men (age 60–80 years) with BPH; control group of 58 healthy men without BPH (also age 60–80 years)In spiro/BPH group, T decreased from 650 ng/dL to 290 ng/dL and DHT decreased from 450 ng/dL to 150 ng/dL. In control/non-BPH group, T was 280 ng/dL and DHT was 90 ng/dL. P4, E2, and LH increased in spiro/BPH group. FSH also assessed. The authors stated that prostate gland can be a source of androgen production, implying that BPH can produce elevated androgen levels and that spironolactone can normalize elevated androgen levels in the condition.Zgliczynski, Baranowska, & Szymanowski (1981)
    150 mg/m2/day for 5 days in 6 boys with irregular puberty (11–13 years)No significant changes in T or urinary 17-KS excretion, elevated LH (by 600%—likely typo of “60%” (?)), and slightly increased FSH (from 0.75 ng/mL to 0.86 ng/mL).Skorodok, Savchenko, & Liss (1983)
    50–200 mg/day for 3 months in 17 males and 19 females (36 people total; 18–38 years, mean 24 years) with severe acneMales no significant changes in T, SHBG, DHT, or FAI.Goodfellow et al. (1984)
    50 mg/day for 4 weeks in 13 males (28–60 years, mean 47 years) with rosaceaNo changes in T, A4, DHT, or DHEA-S. 17α-OHP significantly increased (from 1.0 ± 0.65 ng/mL (mean ± SD) to 1.7 ± 0.98 ng/mL; +70%). E2 non-significantly increased (from 61 ± 29 pg/mL to 77 ± 45 pg/mL; +26%).Aizawa & Niimura (1992)
    25–400 mg/day (median 100 mg/day) for 12 months in 32 males (59%) of a group of 54 males (17–64 years; mean 44 years) with non-alcoholic liver disease requiring liver transplantation vs. 469 healthy male controls (mean 31 years) with normal liver functionSignificantly decreased T with spironolactone in men with moderate-severity liver disease but not with low- or high-severity liver disease. SHBG not influenced by spironolactone dosage. No influence on gonadotropin responses to GnRH stimulation.Handelsman et al. (1995)

    Abbreviations: T = testosterone; E2 = estradiol; E1 = estrone; E3 = estriol; E = estrogen(s); P4 = progesterone; 17α-OHP = 17α-hydroxyprogesterone; A4 = androstenedione; EC = etiocholanolone; DHT = dihydrotestosterone; DHEA = dehydroepiandrosterone; DHEA-S = dehydroepiandrosterone sulfate; 17-KS = 17-ketosteroids; LH = luteinizing hormone; FSH = follicle-stimulating hormone; GnRH = gonadotropin-releasing hormone; PRL = prolactin; TRH = thyrotropin-releasing hormone; FAI = free androgen index; SHBG = sex hormone-binding globulin; BPH = benign prostatic hyperplasia; RCT = randomized controlled trial.

    A few additional studies with the spironolactone-related drugs canrenone or potassium canrenoate (a prodrug of canrenone) (e.g., Soldactona) were also identified (Dymling, Nilsson, & Hökfelt, 1972; Dymling & Hökfelt, 1973; Erbler, 1974; Corvol et al., 1976; Dymling, 1978). These studies are notable as canrenone is a known active metabolite of spironolactone and as the studies consistently found decreased androgen levels with drugs delivering canrenone. In any case, the studies are excluded from the present review as they did not actually employ spironolactone.

    Although the quality of these studies is limited, the findings of the studies, which are mixed but are overall more suggestive against spironolactone reducing testosterone levels than it doing so, are in notable contrast to similar studies of CPA and testosterone suppression in cisgender men that were published in the 1970s and 1980s. These studies consistently found that CPA suppressed testosterone levels by 40 to 70% on average (Aly, 2019). Subsequently, the findings were replicated in several more modern studies of CPA in cisgender men and transfeminine people, which likewise found that the drug given alone consistently suppressed testosterone levels by about 45 to 65% on average (Aly, 2019).

    Spironolactone in Cisgender Women

    Spironolactone has a long history of use in cisgender women in the treatment of androgen-dependent skin and hair conditions like acne, hirsutism, scalp hair loss, and hyperandrogenism (due to e.g. polycystic ovary syndrome (PCOS)). It has been used at similar doses for androgen-dependent conditions in cisgender women as it has in transfeminine people (e.g., 50–200 mg/day most typically). There are many dozens of studies of spironolactone as an antiandrogen in cisgender women (e.g., PubMed). Instead of attempting to individually review all of these studies, the present article will discuss the findings of several papers that have themselves reviewed substantial numbers of these studies and have summarized available findings on testosterone levels with spironolactone.

    Callan (1988) reviewed the literature on spironolactone for treatment of acne and hirsutism in cisgender women and found that some clinical studies reported decreased levels of testosterone and/or other androgens with spironolactone (4 studies cited) whereas other studies reported no change in androgen levels (4 studies cited). The author cited several studies to support the claim that androgen receptor antagonism with spironolactone is more clinically important than any influence it has on androgen production (5 studies cited). For instance, clinical benefits against acne and hirsutism occurred with spironolactone both before androgen levels decrease as well as when androgen levels do not decrease.

    McMullen & Van Herle (1993) reviewed 19 studies of spironolactone for treatment of androgen-dependent conditions in cisgender women, with a majority of these studies reporting long-term hormone levels. Most of the studies were open-label and uncontrolled, with only five studies having a control group and only two studies being double-blind placebo-controlled trials. Changes in hormone levels across studies were very heterogenous, with the majority of changes not reaching statistical significance. Only 1 of 7 (14%) studies found a decrease in DHEA-S levels. The review concluded that a clinically significant change in adrenal androgen levels with spironolactone in cisgender women was not supported. Conversely, testosterone levels were decreased with spironolactone in 13 of 16 (81%) of studies. However, in the only two RCTs, there were no differences in testosterone levels with spironolactone versus in the placebo control groups. As such, the review concluded that the decreased testosterone levels with spironolactone in cisgender women reported in many of the non-RCT studies may not actually be a real phenomenon. As with Callan (1988), the review noted that the major mechanism of action of spironolactone as an antiandrogen is likely to be androgen receptor blockade.

    Bradstreet et al. (2007) cited and discussed a Cochrane review of spironolactone for treatment of acne and/or hirsutism in cisgender women (Farquhar et al., 2003). Cochrane reviews are rigorous high-quality systematic reviews of all of the available RCTs for a given medical intervention. The Cochrane review identified 19 RCTs, with 9 included in the review, 8 excluded due to methodological issues (e.g., with randomization), and two others which were described as “awaiting assessment” (Farquhar et al., 2003). Bradstreet and colleagues noted per the Cochrane review that spironolactone at a dosage of 100 mg/day had little influence on levels of DHEA, DHEA-S, or testosterone in the trials evaluated and said that this is because its mechanism of action as an antiandrogen is androgen receptor antagonism (Bradstreet et al., 2007). The Cochrane review itself did not discuss changes in androgen or testosterone levels with spironolactone in aggregate. An update of the Cochrane review was published in 2009, but with no new studies found and with the findings unchanged (Brown et al., 2009).

    Layton et al. (2017) was a hybrid systematic review of spironolactone for acne in cisgender women. In a table discussing the mechanism of action of spironolactone and other antiandrogens for acne, the authors stated that “Data from over 50 articles reporting effects [of spironolactone] on serum androgens are equivocal” (i.e., ambiguous, uncertain, questionable) (Layton et al., 2017). The review further noted that inhibition of androgen synthesis by spironolactone in humans may be unlikely at therapeutic doses and may occur instead only at supraphysiological doses (with Menard et al. (1979) cited in support of these claims, presumably related to the very high doses required) (Layton et al., 2017).

    Rozner et al. (2019) reviewed clinical studies of the endocrine effects of spironolactone in cisgender women to assess whether it is safe to use in women with past or present breast cancer receiving endocrine therapy. The review included 18 studies with 465 women (mostly having androgen-dependent conditions) assessing the influence of spironolactone on sex hormone levels. The assessed studies included retrospective cohort studies, case–control studies, and RCTs. Of the included studies, 10 (56%) studies (with 179 women) found no change in testosterone levels with spironolactone, 8 (44%) studies (with 253 women) found a decrease, and 1 (6%) study (with 33 women) found an increase in free but not total testosterone levels. Changes in levels of DHEA-S, androstenedione, and estrogen were also assessed and findings were similar, with no changes observed in majorities of studies for these hormones. The review concluded that there is no significant change in levels of androgens, estrogen, or gonadotropins with spironolactone in cisgender women.

    Almalki et al. (2020) conducted a systematic review and network meta-analysis of RCTs on the comparative efficacy of several types of medications (statins, metformin, spironolactone, and combined birth control pills) on reducing testosterone levels in cisgender women specifically with PCOS. Nine RCTs including 613 women were included for all of the medications. The meta-analysis concluded that the statin atorvastatin was more effective than the other included medications in reducing testosterone levels. Only two of the included RCTs employed spironolactone, one of which was with spironolactone alone (n=34) versus metformin (n=35) (Ganie et al., 2004) and the other of which was with spironolactone plus metformin (n=62) versus spironolactone alone (n=51) versus metformin alone (n=56) (Ganie et al., 2013). Both of the included trials found that spironolactone alone significantly decreased testosterone levels in pre-treatment versus post-treatment comparisons (Ganie et al., 2004; Ganie et al., 2013). No trials of spironolactone versus placebo controls were included.

    Taken together, the available studies of spironolactone and testosterone levels in cisgender women with androgen-dependent conditions are highly inconsistent and mixed, but with numerous studies finding no significant changes in testosterone levels. The reasons for the findings being so mixed are unclear, but may relate to study methodology and quality. Findings in this population seem particularly notable as regulation of the hypothalamic–pituitary–gonadal (HPG) axis by androgens in women is minimal to negligible, in turn making it such that androgen receptor antagonists will have little effect of upregulating gonadal sex hormone production as they can in cisgender men and transfeminine people. As a result, there is less homeostatic interference that could influence findings in evaluating the steroid synthesis inhibition of spironolactone in this sex, and hence these studies may provide a clearer picture of steroid synthesis inhibition as a possible clinical effect of spironolactone. However, as the findings are still so mixed, the results seem inconclusive. In any case, only a limited effect at best seems clear.

    Spironolactone Alone in Transfeminine People

    Only one study of spironolactone alone (without estrogen) and sex hormone levels in transfeminine people was identified (Table 2). It was conducted by Louis Gooren and colleagues of the Dutch Center of Expertise on Gender Dysphoria (CEGD) at the Vrije Universiteit Medical Center (VUMC) in Amsterdam, Netherlands in the 1980s. The study compared levels of testosterone, DHT, estradiol, LH, FSH, and prolactin before and after treatment with 200 mg/day spironolactone for 6 weeks in 6 young pre-hormone-therapy transfeminine people. It found slightly but significantly increased testosterone levels, increased prolactin levels, and no change in levels of estradiol, DHT, LH, or FSH.

    Table 2: Studies of sex hormone levels with spironolactone alone in transfeminine people:

    Treatment and subjectsFindingsSource(s)
    200 mg/day for 6 weeks in 6 pre-hormone therapy transfeminine people (21–39 years)T (mean ± SEM) increased significantly from 17.2 ± 0.8 nmol/L (496 ± 20 ng/dL) to 20.6 ± 1.7 nmol/L (594 ± 50 ng/dL) (+19.8%). No change in E2 (90 ± 20 pmol/L [25 ± 5.0 pg/mL] vs. 100 ± 30 pmol/L [27 ± 8.2 pg/mL] or 80 ± 20 pmol/L [22 ± 5.4 pg/mL]) or DHT (1.7 ± 0.8 nmol/L [49 ± 20 ng/dL] vs. 1.8 ± 0.9 nmol/L [52 ± 30 ng/dL]). LH, FSH, and GnRH-stimulated LH and FSH unchanged. PRL and TRH-stimulated PRL increased.Gooren et al. (1984a); Gooren et al. (1984b)

    Abbreviations: T = testosterone; E2 = estradiol; DHT = dihydrotestosterone; LH = luteinizing hormone; FSH = follicle-stimulating hormone; GnRH = gonadotropin-releasing hormone; PRL = prolactin; TRH = thyrotropin-releasing hormone.

    The fact that this study was done by the CEGD is notable as this institute is among the most prolific research centers on transgender hormone therapy in the world (Bakker, 2021), and, while they evaluated spironolactone as well as nilutamide as antiandrogens in studies in transfeminine people in the 1980s and 1990s (Wiki), the group ultimately settled on using only CPA instead. This was probably related to the lack of testosterone suppression with spironolactone and pure androgen receptor antagonists like nilutamide, as the researchers have touched on in other publications (e.g., Gooren, 1999).

    Estrogen Plus Spironolactone in Transfeminine People

    Eleven studies of the combination of estrogen and spironolactone and sex hormone levels in transfeminine people were identified (Table 3). The first study was conducted by Jerilynn Prior and colleagues in Canada in the 1980s. Subsequent studies were conducted over 25 years later by groups in the United States, Australia, Israel, and Thailand. All of the studies were retrospective chart reviews or prospective non-randomized studies, with the exception of a single RCT.

    Table 3: Studies of testosterone levels with estrogen plus spironolactone in transfeminine people:

    Treatment and subjectsFindingsSource(s)
    Oral CEEs (0.625–5 mg/day cyclically—3 of 4 weeks per month), oral MPA (10–20 mg/day cyclically—3 of 4 weeks per month—or continuously—”if gonadotrophins increased or to aid in T reduction or breast development”), and spironolactone (100–600 mg/day continuously) for 12 months in 27 transfeminine people who had been on “high-dose” E alone for an extended duration (Group 1) and 23 transfeminine people who were pre-hormone-therapy (Group 2), or 50 transfeminine people total, at Vancouver General Hospital.T decreased in Group 1 from mean 169 ng/dL to 87.4 ng/dL (–48.2%) and in Group 2 from mean 642 ng/dL to 49.2 ng/dL (–92.3%). In the whole group, T after treatment would be mean 69.8 ng/dL. Per authors, spironolactone was intended to help reduce T and facilitate feminization while MPA was intended to help suppress gonadotropins and T and improve breast development. However, authors emphasized the decrease in T as being due to spironolactone despite inclusion of MPA, without data provided to substantiate this.Prior, Vigna, & Watson (1989); Prior et al. (1986)
    Sublingual estradiol (4 mg/day—2 mg b.i.d.) (n=14), transdermal estradiol patch (100 μg/day) (n=1), or injectable estradiol valerate (20 mg/2 weeks) (n=1) with spironolactone (100–200 mg/day) for 6 months in 16 transfeminine people at an LGBT community health center in Los Angeles, California.T was median 405 ng/dL at baseline and 42 ng/dL after 6 months (–89.6%). Free T was median 11.4 ng/dL at baseline and 0.8 ng/dL at 6 months (–93.0%). 10 of 15 (66.7%) had total T in female range and 14 of 15 (93.3%) had free T in female range.Deutsch, Bhakri, & Kubicek (2015)
    Oral E2 (1–8 mg/day) with or without spironolactone (200 mg/day) (n=61), finasteride (5 mg/day) (n=49), and/or MPA (2.5–10 mg/day) (n=38) for 0.3 to 10.5 years (mean 4.3 ± 3.1 years) in 156 transfeminine people at Albany Medical Center.Oral E2 dose-dependently and substantially but incompletely suppressed T. Relative to E2 alone (at equivalent E2 levels), E2 plus spironolactone had no significant influence on T (+10.6 ± 16 ng/dL (mean ± SE); p = 0.5) and no greater likelihood of achieving better T suppression (<100 ng/dL) (OR = 0.75; 95% CI = 0.44–1.29). T levels with E2 alone were mean ~80 ng/dL and with E2 plus spironolactone were mean ~95 ng/dL. Finasteride was also associated with greater T levels. MPA helped with T suppression in some (71% of subjects). More discussion and analysis including graphs (Aly, 2019).Leinung, Feustel, & Joseph (2018); Leinung (2014)
    Oral E2 (0.5–10 mg/day) (n=67) or oral CEEs (0.625–5 mg/day) (n=12) and spironolactone (25–400 mg/day; mean/median 145 mg/day) for 12 months in 98 transfeminine people at Boston Medical Center.Combined E and spironolactone decreased T from median 385 ng/dL to 130 ng/dL (–66.2%). E alone vs. E and spironolactone not reported. No significant influence of spironolactone dosage on T. Incomplete suppression of T (>50 ng/dL) in all but the lowest quartile (25%) of individuals.Liang et al. (2018); Bonzagni (2014)
    Oral EV (4–6 mg/day; median 5–6 mg/day) (88.3%) or transdermal E2 (11.7%) alone or in combination with CPA (25–50 mg/day; median 50 mg/day) or spironolactone (87.5–200 mg/day; median 100 mg/day) for 0.9 to 2.6 years (median 1.5 years) in 80 transfeminine people at two gender clinics in Melbourne, Australia.T was median 10.5 nmol/L (303 ng/dL) with E2 only, 2.0 nmol/L (58 ng/dL) with E2 plus spironolactone, and 0.8 nmol/L (23 ng/dL) with E2 plus CPA. 90% of those on E2 plus CPA and 40% of those on E2 plus spironolactone had T of <2 nmol/L (<58 ng/dL). T significantly lower with E2 plus CPA compared to E2 plus spironolactone and E2 alone. T with E2 plus spironolactone lower than with E2 alone but non-significantly. No significant differences between groups in age, hormone therapy duration, or E2 dosage or levels. Graph that visually summarizes the results.Angus et al. (2019); Cheung et al. (2018)
    Sublingual estradiol (2–12 mg/day) and spironolactone (100–200 mg/day) with or without sublingual MPA (5–10 mg/day) or injectable MPA (150 mg/3 months) for 3.4 ± 1.7 years in 92 transfeminine people at Rhode Island Hospital.T (mean ± SD) was 215 ± 29 ng/dL with E2 plus spironolactone and 79 ± 18 ng/dL with E2 plus spironolactone and MPA.Jain, Kwan, & Forcier (2019)
    Oral E2 (2–8 mg/day) (84.2%) or other E forms (15.8%) with spironolactone (80.4%; n=107) or without spironolactone (19.6%) for more than 6 months in 133 transfeminine people at three clinics in Dallas, Texas.T decreased from median 367 ng/dL (95% range 175–731 ng/dL) (n=70) at baseline to median 55 ng/dL (95% range 3–709 ng/dL) (n=131) in whole group (80.4% taking spironolactone). 65 of 133 (49%) had adequate T suppression (presumably <50 or <60 ng/dL) in whole group. T with E2 plus spironolactone at 25–75 mg/day (n=15) was mean 129.4 ng/dL (range <3—611 ng/dL), at 100–175 mg/day (n=61) was mean 180.4 ng/dL (range <3–1137 ng/dL), and at 200–300 mg/day (n=31) was mean 170.1 ng/dL (range <3–798 ng/dL). In the whole E2 plus spironolactone group (n=107), T would be mean 170.3 ng/dL.SoRelle et al. (2019); Allen et al. (2021)
    Oral E2 (2–8 mg/day), transdermal E2 gel (2.5–5 mg/day), or transdermal E2 patches (50–200 μg/day) plus spironolactone (50–200 mg/day) (n=16), CPA (10–100 mg/day) (n=41), or a GnRH agonist (n=10) for 12 months in 67 transfeminine people at Tel Aviv-Sourasky Medical Center in Israel.With spironolactone, T (mean ± SD) decreased from 15.2 ± 8.1 nmol/L (438 ± 230 ng/dL) at baseline to 10.2 ± 5.7 nmol/L (294 ± 164 ng/dL) at 3 months (–32.9%), 3.5 ± 1.2 nmol/L (100 ± 35 ng/dL) at 6 months (–77.0%), and 4 ± 7.1 nmol/L (120 ± 200 ng/dL) at 12 months (–73.7%). T was in the female range (<1.8 nmol/L [52 ng/dL]) at all follow-ups after baseline for both CPA and GnRH agonist (–92.0% to –96.4%).Sofer et al. (2020)
    Oral EV 4 mg/day plus spironolactone (100 mg/day) (n=26) or CPA (25 mg/day) (n=26) for 12 weeks in 52 transfeminine people at two clinics in Bangkok, Thailand (RCT).With intention-to-treat analysis, T decreased with E2 plus spironolactone from median 645.0 ng/dL (IQR 466.7−1027.7 ng/dL) to 468.3 ng/dL (IQR 287.0−765.4 ng/dL) (–27.4%) and with E2 plus CPA from 655.5 ng/dL (402.6−872.7 ng/dL) to 9.3 ng/dL (IQR 5.5−310.4 ng/dL) (–98.6%). Adequate suppression of testosterone (<50 ng/dL) was achieved by 4 of 26 (15%) in the E2 plus spironolactone group and by 18 of 26 (69%) in the E2 plus CPA group. Study also assessed and reported E2, SHBG, and PRL levels.Burinkul et al. (2021)
    E2 (sublingual, transdermal, or injectable) with spironolactone (n=39) or without spironolactone (n=37) for 12 months in 93 transfeminine people at two LGBTQ-oriented clinics in Seattle, Washington and Iowa City, Iowa.T was median 11 to 18 ng/dL in different estradiol groups without spironolactone and median 10 to 12 ng/dL in different estradiol groups with spironolactone. T was significantly lower with spironolactone only for sublingual E2 group (median 11 ng/dL (IQR 6–35 ng/dL) [n=27] vs. median 18 ng/dL (IQR 13–205 ng/dL) [n=16]) and not for transdermal or injectable E2 groups.Cirrincione et al. (2021)
    Oral E2 (4–12 mg/day, median 6 mg/day) (n=27) or injectable EV (2–5 mg/week, median 4 mg/week) (n=6) with spironolactone (n=31) or without spironolactone (n=2) for median 6.2 months (range 0.6–28.2 months) (time on optimized E2 dose specifically) in 33 transfeminine people at Maine Medical Center.T was median 13.0 ng/dL (range 2.7–559 ng/dL) for whole group (93.9% taking spironolactone). 28 of 33 (84.8%) of whole group had female-range T (<50 ng/dL). However, in earlier studies by the same group, similar T suppression with E2 alone was reported (Reardon et al., 2013; Spratt et al., 2014).Pappas et al. (2021); Pappas et al. (2020); Stewart et al. (2018)

    Abbreviations: E = estrogen; E2 = estradiol; EV = estradiol valerate; CEEs = conjugated [equine] estrogens; CPA = cyproterone acetate; MPA = medroxyprogesterone acetate; GnRH = gonadotropin-releasing hormone; T = testosterone; DHEA-S = dehydroepiandrosterone sulfate; LH = luteinizing hormone; FSH = follicle-stimulating hormone; PRL = prolactin.

    Findings of the above studies include inadequate testosterone suppression with estradiol plus spironolactone in most transfeminine people (Leinung et al., 2018; Liang et al., 2018; Jain, Kwan, & Forcier, 2019; Sofer et al., 2020; Burinkul et al., 2021), no difference in testosterone suppression with spironolactone versus without spironolactone (Leinung et al., 2018), lack of notable influence of spironolactone dosage on testosterone suppression (Liang et al., 2018; SoRelle et al., 2019), and inferior testosterone suppression with estradiol plus spironolactone compared to estradiol plus CPA or a GnRH agonist in transfeminine people (Angus et al., 2019; Sofer et al., 2020; Burinkul et al., 2021). Conversely, some studies have found adequate or near-adequate testosterone suppression with estradiol plus spironolactone in most or almost all transfeminine people (Deutsch, Bhakri, & Kubicek, 2015; Angus et al., 2019; SoRelle et al., 2019; Cirrincione et al., 2021; Pappas et al., 2021), and some studies have found indications of greater testosterone suppression with spironolactone versus without spironolactone (Angus et al., 2019; Cirrincione et al., 2021). On the other hand, some studies using estradiol alone without any antiandrogen at physiological estradiol levels (<200 pg/mL) have reported adequate testosterone suppression similarly to the preceding estradiol plus spironolactone studies (Reardon et al., 2013; Spratt et al., 2014; Cirrincione et al., 2021). One study was confounded by the concomitant use of the progestogen medroxyprogesterone acetate (MPA), which is known to suppress testosterone levels on its own, and hence reliable conclusions could not be drawn from it (Prior, Vigna, & Watson, 1989; Prior et al., 1986). A couple of studies found that testosterone levels progressively decline with time (particularly over the first 12 months) with estradiol plus spironolactone in most transfeminine people (Liang et al., 2018; Sofer et al., 2020). Whether the decreases in testosterone levels with time were more related to estradiol or to spironolactone is unclear, though estradiol seems more likely (e.g., Wiki).

    Taken together, the findings of available studies on estradiol plus spironolactone and testosterone suppression in transfeminine people are highly variable and mixed, although overall more studies support spironolactone having poor or no testosterone-suppressing effectiveness. The reasons underlying the differences in findings on testosterone suppression between studies are unclear, but contributing factors may include varying estradiol doses, routes, and levels, durations of hormone therapy, differing laboratory assays of testosterone levels, and other differences in study methodologies, as well as limitations in study and evidence quality. In any case, the conflicting nature of the findings is in major contrast to the almost invariably strong to maximal testosterone suppression in studies of estradiol plus CPA and estradiol plus GnRH agonists in transfeminine people.

    Spironolactone, Androgen Receptor Antagonism, and Clinical Antiandrogenic Effectiveness

    The clinical antiandrogenic effectiveness of spironolactone in cisgender women with androgen-dependent skin and hair conditions, like acne, hirsutism, and scalp hair loss, is well-established (Brown et al., 2009; van Zuuren & Fedorowicz, 2016; Layton et al., 2017; Barrionuevo et al., 2018; James, Jamerson, & Aguh, 2022; Wang et al., 2023). Conversely, the clinical antiandrogenic efficacy of spironolactone in transfeminine people has been very limitedly assessed to date and is largely unknown (Angus et al., 2021). Spironolactone does not appear to be very effective for decreasing testosterone levels in either cisgender women or transfeminine people based on the findings of the present review. However, spironolactone is a competitive antagonist of the androgen receptor in addition to its actions a weak androgen synthesis inhibitor, and hence it also directly blocks androgens from mediating their effects in the body (Loriaux et al., 1976; McMullen & Van Herle, 1993). Based on studies in populations besides transfeminine people, for instance cisgender women (discussed above) and cisgender boys with gonadotropin-independent precocious puberty (e.g., Holland, 1991), in which spironolactone has not decreased testosterone levels but has nonetheless been effective as an antiandrogen, the androgen receptor blockade of spironolactone is likely to be its main mechanism of action as an antiandrogen and may account for most or all of its therapeutic antiandrogenic effectiveness.

    However, while spironolactone is clearly effective as an androgen receptor antagonist, it appears to be a relatively weak androgen receptor blocker at typical doses used in cisgender women and transfeminine people. Numerous publications in the literature describe spironolactone as being only a weak androgen receptor antagonist (Wiki; Wiki). In relation to this, animal studies have found that spironolactone is a far less potent androgen receptor antagonist than other antiandrogens like CPA, flutamide, and bicalutamide (Bonne & Raynaud, 1974; Hecker, Hasan, & Neumann, 1980; Sivelle, Underwood, & Jelly, 1982; Weissmann et al., 1985; Labrie et al., 1987; Snyder, Winneker, & Batzold, 1989 [Table]; Yamasaki et al., 2004 [Graph]). Moreover, in cisgender women, the population in which spironolactone is most widely used as an antiandrogen, testosterone levels are relatively low, on average about 20-fold lower than in cisgender men (around 30 ng/dL on average compared to about 600 ng/dL on average, respectively) (Aly, 2018). However, many cisgender women with androgen-dependent conditions have PCOS, which is associated with limitedly elevated testosterone levels (e.g., perhaps around 60 ng/dL on average) (Aly, 2018). The typical therapeutic dose range of spironolactone in cisgender women with androgen-dependent conditions is 50 to 200 mg/day, in which its effectiveness may be assumed to be dose-dependent, and this is roughly the same general dosage range used in transfeminine people (though up to 300–400 mg/day may be used and are allowed for by guidelines) (Aly, 2018; Aly, 2020).

    A relatively small amount of dose-ranging data on spironolactone in cisgender women with androgen-dependent conditions exists, but in any case substantiates its dose-dependent effectiveness across its clinically used dose range (partially reviewed in Hammerstein (1990) and Shaw (1996)). Spironolactone has been reported to be effective in the treatment of hirsutism in cisgender women at a dosage of as low as 50 mg/day (Diamanti-Kandarakis, Tolis, & Duleba, 1995). However, even a dosage of 100 mg/day did not appear to be maximally effective for hirsutism in a study that compared different doses of spironolactone; effectiveness was near-significantly greater at a dosage of 100 mg/day relative to a dosage of 200 mg/day (19% ± 8% and 30% ± 3% (mean ± SEM) reduction in hair shaft diameter, respectively; p = 0.07) (Lobo et al., 1985). Levels of free testosterone in this study were unchanged, suggesting that the effects of spironolactone was purely due to androgen receptor blockade. In addition, a study found that 100 mg/day spironolactone was significantly inferior to flutamide in improving androgen-dependent skin and hair symptoms in cisgender women (Cusan et al., 1994). However, in other studies, there were no significant differences between 100 mg/day spironolactone and flutamide for hirsutism (Erenus et al., 1994; Moghetti et al., 2000; Inal, Yildirim, & Taner, 2005; Karakurt et al., 2008). Spironolactone and flutamide were variably taken together with an ethinylestradiol-containing combined birth control pill in the preceding studies. This is likely to have limited detection of differences in effectiveness, as these birth control pills considerably suppress total and free testosterone levels and hence have substantial antiandrogenic effects themselves (Zimmerman et al., 2014; Amiri et al., 2018). Finally, a case report of a cisgender woman with female pattern hair loss and normal androgen levels found that treatment with spironolactone 200 mg/day for 5 years failed to improve her hair loss, in spite of almost complete loss of secondary sexual hair, but switching to flutamide resulted in a considerable improvement in hair loss after 12 months of treatment (Yazdabadi & Sinclair, 2011).

    In a biochemical study, 100 mg/day spironolactone was numerically inferior to flutamide in reducing levels of prostate-specific antigen (PSA) in cisgender women (Negri et al., 2000). This is notable as PSA is a systemic biomarker of androgen action (Negri et al., 2000). However, the study had small sample sizes, and the differences between groups were not statistically significant (Negri et al., 2000). One study compared spironolactone at doses of 50 to 200 mg/day with placebo for treatment of acne in cisgender women and reported progressive increases in effectiveness with spironolactone up to the 200 mg/day dosage (Goodfellow et al., 1984). Similarly, another study found that progressively increasing the dosage of spironolactone from 100 mg/day, to 150 mg/day, and up to 200 mg/day, resulted in increased effectiveness in the treatment of acne in cisgender women (Charny, Choi, & James, 2017). Finally, a 2022 systematic review of spironolactone for treatment of androgen-related scalp hair loss in cisgender women reported that the drug was “largely ineffective” at doses of less than 100 mg/day, whereas doses of 100 to 200 mg/day were effective (James, Jamerson, & Aguh, 2022).

    The preceding findings suggest that the clinical antiandrogenic effectiveness of spironolactone in cisgender women is not maximal at a dosage of below at least 200 mg/day despite the relatively low testosterone levels in these individuals. Put another way, spironolactone at typical doses seems best-suited for blocking female-range levels of testosterone. As many transfeminine people do not achieve female-range testosterone levels with estradiol plus spironolactone therapy, and in fact often have testosterone levels well above the normal female range or even in the male range, spironolactone may not be fully effective as an antiandrogen at the typical doses used in transfeminine hormone therapy. Higher doses of spironolactone, like 300 to 400 mg/day, may be to some degree more effective.

    Summary, Discussion, and Conclusions

    Numerous studies have assessed the influence of spironolactone on testosterone levels in cisgender men, cisgender women, and transfeminine people. Although the quality of these studies has often been limited, the studies have revealed highly inconsistent influences of spironolactone on testosterone levels in these populations, with many studies finding no changes, some studies finding decreases, and a small number of studies finding increases. The findings of studies of spironolactone and testosterone levels are in notable contrast to those of studies with estrogens, progestogens like CPA, and GnRH agonists, which consistently show substantial decreases in testosterone levels. This has been the case even in studies of similarly low quality to those of some of the included spironolactone studies (e.g., many of those in cisgender men). The fact that in the available studies testosterone levels with spironolactone have usually been unchanged, but have sometimes been decreased and have rarely been decreased, seems to suggest that spironolactone may be a clinically significant inhibitor of steroid hormone synthesis, but that it is only a weakly efficacious one, and that its effects may be variable depending on the individual and other clinical circumstances. In any case, the conflicting findings warrant more research with higher-quality study designs, particularly RCTs that have with spironolactone versus without comparison groups.

    The notion that spironolactone decreases testosterone levels in transfeminine people, and the use of spironolactone in transfeminine hormone therapy in general, appear to have originated from the papers on spironolactone in transfeminine people published by Dr. Jerilynn Prior and colleagues in the 1980s (Prior, Vigna, & Watson, 1989; Prior et al., 1986). In their study, transfeminine people who were either already on high-dose estrogen therapy with inadequate testosterone suppression or had not yet started hormone therapy were put on physiological-dose estrogen therapy in combination with 200 to 600 mg/day spironolactone. Cyclic or continuous administration of the progestogen MPA at an oral dose of 10 mg/day was also given to all of the individuals. The authors reported that despite the lower estrogen dosage, testosterone levels decreased, from 169 ng/dL to 87 ng/dL (–49%) in those who had already been on hormone therapy and to 49 ng/dL in those who were pre-hormone therapy. Prior and her colleagues concluded that spironolactone helps to decrease testosterone levels in transfeminine people and that it can be used as a safer alternative to high doses of estrogen for this purpose.

    However, the concomitant use of MPA in the study is a major confounding factor in terms of their results. This is because MPA is a progestogen, and progestogens, like estrogens, are antigonadotropins which are able to robustly suppress testosterone levels on their own (Aly, 2018; Aly, 2019). Indeed, MPA alone has been shown to dose-dependently lower testosterone levels in cisgender men (Wiki), and at a dosage of 10 mg/day, has been shown to considerably suppress testosterone levels in transfeminine people when added to estradiol and spironolactone therapy (Jain, Kwan, & Forcier, 2019). Hence, MPA may have been, and likely was, responsible for the decreases in testosterone levels seen in the study, rather than spironolactone. This point was also notably raised by other researchers, who were unable to replicate Prior and colleagues’ results on spironolactone and testosterone levels in transfeminine people (Leinung et al., 2018). Strangely, Prior and colleagues concluded that spironolactone was responsible for the decreased testosterone levels in their study even though they noted in their papers that MPA was also given to help suppress testosterone levels (as well as to help improve breast development). The work of Prior and colleagues likely resulted in the prominent and long-standing, but poorly supported, notion that spironolactone decreases testosterone levels in transfeminine people. Subsequent studies assessing the hypothesis that spironolactone decreases testosterone levels in transfeminine people were not published until 25 years after Prior and colleagues’ studies, with several of these studies, though not all of them, failing to replicate the earlier findings of Prior and colleagues.

    Many people do not realize the capacity of estradiol to substantially and even completely suppress testosterone, and many mistakenly assume that it is the antiandrogen—which is often spironolactone—that is mostly or fully responsible for the decrease in testosterone levels seen with estradiol and antiandrogen therapy in transfeminine people. It is certainly true that antiandrogens like CPA and GnRH agonists play an important role in testosterone suppression in transfeminine people. However, as evidenced by the present review of studies of testosterone suppression with spironolactone, it is not necessarily always the case that the antiandrogen plays a major role—or potentially even any role—in reducing testosterone levels. This is notably also not the case with certain other antiandrogens besides spironolactone, for instance pure androgen receptor antagonists like bicalutamide, which likewise do not decrease testosterone levels but instead can actually increase them (Aly, 2019; Wiki). Clinicians and transfeminine people attributing observations of testosterone decreases to spironolactone rather than to estradiol with estradiol and spironolactone therapy may also have played a role in the perception that spironolactone considerably decreases testosterone levels in transfeminine people.

    Due to its relatively weak strength as an androgen receptor antagonist and its limited efficacy in lowering testosterone levels, spironolactone is likely to be a limitedly effective antiandrogen in transfeminine people. Additionally, spironolactone is likely to be less effective than other antiandrogenic approaches used in transfeminine hormone therapy which either more robustly block androgens or more substantially reduce testosterone levels, for instance CPA, other progestogens (e.g., MPA, non-oral progesterone), GnRH agonists (and antagonists), bicalutamide, and high-dose parenteral estradiol monotherapy. These approaches can be used in transfeminine people instead of or in addition to spironolactone, or could be considered when testosterone suppression is inadequate with estradiol and spironolactone.

    More studies are needed to evaluate the influence of spironolactone on testosterone levels, especially RCTs that compare estradiol alone versus estradiol plus spironolactone in transfeminine people. More research is also needed to clarify why some studies find highly inadequate testosterone suppression with estradiol alone or estradiol plus spironolactone while other studies find excellent or satisfactory testosterone suppression with these regimens. In any case, available data overall suggest that spironolactone does not consistently suppress testosterone levels, and that estradiol plus spironolactone produces inadequate testosterone suppression in many transfeminine people. Moreover, available data suggest that spironolactone is a relatively weak androgen receptor antagonist at the typical clinical doses used in cisgender women and transfeminine people, and is able to block only relatively low or female-range testosterone levels. Hence, spironolactone may not be fully effective in blocking the testosterone it fails to suppress, and may be particularly unsuitable for transfeminine people with testosterone levels that are well above the normal female range. In any case, more research is similarly needed to assess the androgen receptor antagonism and clinical antiandrogenic effectiveness of spironolactone.

    Updates

    Update 1: Spironolactone for Adult Female Acne (SAFA) Trial

    A large new phase 3 RCT, the Spironolactone for Adult Female Acne (SAFA) trial, was published in May 2023 and assessed the effectiveness of spironolactone in the treatment of acne in cisgender women:

    • Santer, M., Lawrence, M., Renz, S., Eminton, Z., Stuart, B., Sach, T. H., Pyne, S., Ridd, M. J., Francis, N., Soulsby, I., Thomas, K., Permyakova, N., Little, P., Muller, I., Nuttall, J., Griffiths, G., Thomas, K. S., & Layton, A. M. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ, 381, e074349. [DOI:10.1136/bmj-2022-074349]

    The trial included a total of 342 women, including 176 treated with spironolactone and 166 in the placebo control group. The dose of spironolactone employed was 50 mg/day for the first 6 weeks and then 100 mg/day thereafter. The trial was 24 weeks (5.5 months) in duration. Women who might become pregnant were required to use a hormonal or barrier method of contraception.

    Spironolactone significantly outperformed placebo in terms of improvement in mean Acne-QoL symptom scores (higher is better). Significant improvement was apparent within 12 weeks of treatment (+45% in scores with spironolactone, +38% with placebo) and was highest at 24 weeks (+61% in scores with spironolactone, +35% with placebo). There was no difference in the rates of women who reported improvement in acne scores at 12 weeks (72% with spironolactone, 68% with placebo), but there was a significant difference at 24 weeks (82% with spironolactone, 63% with placebo). In terms of the Investigator’s Global Assessment (IGA), treatment success at 12 weeks was 19% with spironolactone and 6% with placebo. Rates of hormonal contraceptive use in the spironolactone and placebo groups were not reported. Testosterone levels were also not reported. A small subset of the women had PCOS (15% in the spironolactone group, 23% in the placebo group).

    Adverse effects occurred only slightly more often with spironolactone than with placebo (64% vs. 51%, p = 0.01). The only side effect that occurred significantly more often with spironolactone than with placebo was headache (20% vs. 12%; p = 0.02). However, a few other side effects trended towards occurring significantly more frequently with spironolactone than with placebo: “other” (17% vs. 11%; p = 0.06), dizziness/vertigo/lightheadness (19% vs. 12%; p = 0.07), vomiting/being sick (2% vs. 1%; p = 0.16), and polyuria (urinary frequency) (31% vs. 25%; p = 0.18). Rates of other potentially relevant side effects, like abdominal pain, breast enlargement, breast tenderness, drowsiness/sleepiness, fatigue/tiredness, menstrual irregularity, and reduced libido, were all not different between spironolactone and placebo. There were no serious adverse reactions in the trial. Rates of compliance were similar between the spironolactone and placebo groups, suggesting that spironolactone was well-tolerated.

    This trial is the largest and most rigorous RCT of spironolactone in the treatment of androgen-dependent skin and hair conditions in cisgender women that has been conducted to date. Although spironolactone was found to be effective in this study and was about twice as effective as placebo in terms of Acne-QoL symptom scores and three times as effective as placebo in terms of IGA treatment success rates, the effectiveness of spironolactone was seemingly less than in previous clinical studies of spironolactone for acne. This may be related to the relatively low doses of spironolactone used in this study (50–100 mg/day), to the more rigorous and less-risk-of-bias design of the study (large phase 3 RCT), to a possibly too-short treatment duration (24 weeks/5.5 months), and to concomitant hormonal contraceptive use possibly blunting the degree of potential improvement. The latter is relevant as hormonal contraceptives containing ethinylestradiol provide a considerable improvement in acne via functional antiandrogenic effects all on their own. A final possibility however is that spironolactone is simply a less effective antiandrogen even in cisgender women than has been previously thought. On the other hand, similarly to findings in previous clinical studies, spironolactone was well-tolerated and produced few side effects.

    Update 2: New Spironolactone and Testosterone Suppression Studies

    The following new studies have additionally assessed and found inadequate testosterone suppression in transfeminine people treated with estradiol and spironolactone:

    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (November 2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (November 2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]
    • Miro, E., Rizzone, K., Ho, T., Mark, B., Sullivan, E., & Cushman, D. (2024). 2024 AMSSM Research Podium Presentations: Testosterone Levels Among Transgender Women on Gender-affirming Hormone Therapy. Clinical Journal of Sports Medicine, 34(2), 152–152. [DOI:10.1097/JSM.0000000000001212]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]

    Angus et al. (2023) and Yang et al. (2024) compared estradiol plus spironolactone to estradiol plus CPA and are described in-depth in a section of a different article located here. Yang et al. (2024) found that in addition to spironolactone resulting in much less testosterone suppression than CPA, it was also less effective than CPA as an antiandrogen on multiple clinical measures of demasculinization.

    References

    • Abshagen, U., Spörl, S., Schöneshöfer, M., L’age, M., & Oelkers, W. (1978). Interference of spironolactone therapy with adrenal steroid metabolism in secondary hyperaldosteronism. [Zum Einfluß einer Spironolaktonbehandlung auf den adrenalen Steroidstoffwechsel bei sekundärem Hyperaldosteronismus.] Klinische Wochenschrift, 56(7), 341–349. [DOI:10.1007/bf01477394]
    • Aizawa, H., & Niimura, M. (1992). Oral Spironolactone Therapy in Male Patients with Rosacea. The Journal of Dermatology, 19(5), 293–297. [DOI:10.1111/j.1346-8138.1992.tb03227.x]
    • Allen, A. N., Jiao, R., Day, P., Pagels, P., Gimpel, N., & SoRelle, J. A. (2020). Dynamic Impact of Hormone Therapy on Laboratory Values in Transgender Patients over Time. The Journal of Applied Laboratory Medicine, 6(1), 27–40. [DOI:10.1093/jalm/jfaa192]
    • Almalki, H. H., Alshibani, T. M., Alhifany, A. A., & Almohammed, O. A. (2020). Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials. BMC Women’s Health, 20(1), 68. [DOI:10.1186/s12905-020-00919-5]
    • Amiri, M., Kabir, A., Nahidi, F., Shekofteh, M., & Ramezani Tehrani, F. (2018). Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. The European Journal of Contraception & Reproductive Health Care, 23(1), 64–77. [DOI:10.1080/13625187.2018.1435779]
    • Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., Zajac, J. D., & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine Connections, 8(7), 935–940. [DOI:10.1530/ec-19-0272]
    • Angus, L. M., Leemaqz, S., Zajac, J. D., & Cheung, A. S. (2023). A randomised controlled trial of spironolactone versus cyproterone in trans people commencing estradiol. AusPATH 2023 Symposium. [URL] [PDF] [Trans Health Research Blog Post]
    • Angus, L. M., Leemaqz, S. Y., Zajac, J. D., & Cheung, A. S. (2023). The effect of cyproterone and spironolactone on breast development in transgender women: a randomised controlled trial. ESA/SRB/ENSA 2023 ASM 26-29 November, Brisbane, 54–55 (abstract no. 132). [URL] [PDF] [Full Abstract Book] [Trans Health Research Blog Post]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (2021). A systematic review of antiandrogens and feminization in transgender women. Clinical Endocrinology, 94(5), 743–752. [DOI:10.1111/cen.14329]
    • Baba, S. (1977). Antiandrogenic effect of spironolactone. The Japanese Journal of Urology, 68(12), 1184–1192. [DOI:10.5980/jpnjurol1928.68.12_1184]
    • Baba, S., Murai, M., Jitsukawa, S., Hata, M., & Tazaki, H. (1978). Antiandrogenic Effects of Spironolactone: Hormonal and Ultrastructural Studies in Dogs and Men. Journal of Urology, 119(3), 375–380. [DOI:10.1016/s0022-5347(17)57495-9]
    • Bakker, A. (2021). Een halve eeuw transgenderzorg aan de VU [Half a Century of Transgender Care at the VU]. Amsterdam: Boom. [Google Books] [WorldCat] [URL]
    • Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1258–1264. [DOI:10.1210/jc.2017-02052]
    • Bonne, C., & Raynaud, J. (1974). Mode of spironolactone anti-androgenic action: Inhibition of androstanolone binding to rat prostate androgen receptor. Molecular and Cellular Endocrinology, 2(1), 59–67. [DOI:10.1016/0303-7207(74)90012-4]
    • Bonzagni, A. F. (2014). Understanding the effects of long-term hormone therapy in transgender individuals being provided care at Boston Medical Center Endocrinology Clinic: a quality assurance project. (Doctoral dissertation, Boston University.) [Google Scholar] [URL] [PDF]
    • Bradstreet, J. J., Smith, S., Granpeesheh, D., El-Dahr, J. M., & Rossignol, D. (2007). Spironolactone might be a desirable immunologic and hormonal intervention in autism spectrum disorders. Medical Hypotheses, 68(5), 979–987. [DOI:10.1016/j.mehy.2006.10.015]
    • Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2003). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, 2003(4), CD000194. [DOI:10.1002/14651858.cd000194]
    • Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, 2009(2), CD000194. [DOI:10.1002/14651858.cd000194.pub2]
    • Burinkul, S., Panyakhamlerd, K., Suwan, A., Tuntiviriyapun, P., & Wainipitapong, S. (2021). Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial. The Journal of Sexual Medicine, 18(7), 1299–1307. [DOI:10.1016/j.jsxm.2021.05.003] [PDF]
    • Callan, A. W. (1988). Spironolactone therapy in hirsutism and acne. Australasian Journal of Dermatology, 29(3), 135–139. [DOI:10.1111/j.1440-0960.1988.tb00385.x]
    • Caminos-Torres, R., MA, L., & Snyder, P. J. (1977). Gynecomastia and Semen Abnormalities Induced by Spironolactone in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 45(2), 255–260. [DOI:10.1210/jcem-45-2-255]
    • Charny, J., Choi, J., & James, W. (2017). Spironolactone for the treatment of acne in women, a retrospective study of 110 patients. International Journal of Women’s Dermatology, 3(2), 111–115. [DOI:10.1016/j.ijwd.2016.12.002]
    • Cheung, A. S., Ooi, O., Davidoff, D., Leemaqz, S. Y., Cundill, P., Silberstein, N., Bretherton, I., Grossmann, M., & Zajac, J. D. (2018). Cyproterone vs spironolactone as anti-androgen therapy for transgender females receiving oestradiol therapy. Clinical Endocrinology, 89(S1) [Abstracts of the Endocrine Society of Australia’s Annual Scientific Meeting 2017], 14–14 (abstract no. 62). [Google Scholar] [DOI:10.1111/cen.13727] [URL 1] [URL 2] [PDF]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249]
    • Corvol, P., Mahoudeau, J. A., Valcke, J. C., Ménard, J., & Bricaire, H. (1976). Effets sexuels secondaires des spirolactones. Mécanismes possibles de l’action antiandrogène. [Sexual side-effects of spironolactones. Possible mechanisms of their anti-androgen action]. La Nouvelle Presse Medicale, 5(11), 691–694. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF]
    • Cusan, L., Dupont, A., Gomez, J., Tremblay, R. R., & Labrie, F. (1994). Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertility and Sterility, 61(2), 281–287. [DOI:10.1016/s0015-0282(16)56518-2]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of Cross-Sex Hormone Treatment on Transgender Women and Men. Obstetrics & Gynecology, 125(3), 605–610. [DOI:10.1097/aog.0000000000000692]
    • Diamanti-Kandarakis, E., Tolis, G., & Duleba, A. J. (1995). Androgens and Therapeutic Aspects of Antiandrogens in Women. Journal of the Society for Gynecologic Investigation, 2(4), 577–592. [DOI:10.1177/107155769500200401]
    • Dymling, J., Nilsson, K. O., & Hökfelt, B. (1972). The effect of Soldactona® (canrenoate potassium) on plasma testosterone and androstenedione and urinary 17-ketosteroids and 17-hydroxycorticosteroids. Acta Endocrinologica, 70(1), 104–112. [DOI:10.1530/acta.0.0700104]
    • Dymling, J. F., & Hökfelt, B. (1973). Reduced plasma testosterone following spirolactone in man. Acta Endocrinologica, 73(Suppl 177) [9th Acta Endocrinologica Congress], 53–53 (abstract no. 53). [Google Scholar] [PDF 1] [PDF 2]
    • Dymling, J. F. (1978). The effect of spirolactone and spironolactone on plasma testosterone in man. In Addison, G. M., Asmussen, N. W., Corvol, P., Kloppernborg, P. W. C., Norman, N., Schroder, R., & Robertson, J. I. C. (Eds.). Aldosterone Antagonists in Clinical Medicine: Proceedings of the Searle Symposium, Nice, April 13–15, 1978 (pp. 297–302). Amsterdam: Excerpta Medica. [Google Scholar] [Google Books] [WorldCat] [PDF 1] [PDF 2]
    • Erbler, H. C. (1974). Suppression by the spironolactone metabolite canrenone of plasma testosterone in man. Naunyn-Schmiedeberg’s Archives of Pharmacology, 285(4), 403–406. [DOI:10.1007/bf00501468]
    • Erenus, M., Gürbüz, O., Durmuşoğlu, F., Demirçay, Z., & Pekin, S. (1994). Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertility and Sterility, 61(4), 613–616. [DOI:10.1016/s0015-0282(16)56634-5]
    • Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004). Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2756–2762. [DOI:10.1210/jc.2003-031780]
    • Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshrestha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., Mir, F. A., & Taing, S. (2013). Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study. The Journal of Clinical Endocrinology & Metabolism, 98(9), 3599–3607. [DOI:10.1210/jc.2013-1040]
    • Goodfellow, A., Alaghband-Zadeh, J., Carter, G., Cream, J., Holland, S., Scully, J., & Wise, P. (1984). Oral spironolactone improves acne vulgaris and reduces sebum excretion. British Journal of Dermatology, 111(2), 209–214. [DOI:10.1111/j.1365-2133.1984.tb04045.x]
    • Gooren, L. J., Veen, E. A., Kessel, H., Harmsen-Louman, W., & Wiegel, A. R. (1984). Prolactin secretion in the human male is increased by endogenous oestrogens and decreased by exogenous/endogenous androgens. International Journal of Andrology, 7(1), 53–60. [DOI:10.1111/j.1365-2605.1984.tb00759.x]
    • Gooren, L., Veen, E., Kessel, H., Harmsen-Louman, W., & Wiegel, A. (1984). Androgens in the Feedback Regulation of Gonadotropin Secretion in Men: Effects of Administration of Dihydrotestosterone to Eugonadal and Agonadal Subjects and of Spironolactone to Eugonadal Subjects. Andrologia, 16(4), 289–298. [DOI:10.1111/j.1439-0272.1984.tb00286.x]
    • Gooren, L. J. G. (1999). Hormonal Sex Reassignment. International Journal of Transgenderism, 3(3), 1–7. [Google Scholar] [URL 1] [URL 2]
    • Hammerstein, J. (1990). Antiandrogens: Clinical Aspects. In Orfanos, C. E., & Happle, R. (Eds.). Hair and Hair Diseases (pp. 827–886). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-74612-3_35]
    • Handelsman, D. J., Strasser, S., McDonald, J. A., Conway, A. J., & McCaughan, G. W. (1995). Hypothalamic-pituitary-testicular function in end-stage non-alcoholic liver disease before and after liver transplantation. Clinical Endocrinology, 43(3), 331–337. [DOI:10.1111/j.1365-2265.1995.tb02040.x]
    • Hecker, A., Hasan, S. H., & Neumann, F. (1980). Disturbances in sexual differentiation of rat foetuses following spironolactone treatment. Acta Endocrinologica, 95(4), 540–545. [DOI:10.1530/acta.0.0950540]
    • Holland, F. J. (1991). Gonadotropin-lndependent Precocious Puberty. Endocrinology and Metabolism Clinics of North America, 20(1), 191–210. [DOI:10.1016/s0889-8529(18)30288-3]
    • Horth, C., Lobo, P., Shelton, J., Asbury, M., Clarke, J., & Venning, G. (1977). Effects of spironolaetone on the plasma binding and unbound levels of testosterone and oestradiol in healthy men. Journal of Steroid Biochemistry, 8(12), xx–xx. [DOI:10.1016/0022-4731(77)90178-9]
    • Horth, C. E., Lobo, P. J., Shelton, J. R., Asbury, M. J., Clarke, J. M., & Venning, G. R. (1979). Effects of spironolactone on the plasma binding and unbound levels of testosterone and oestradiol in healthy men. In Klopper, A., Lerner, L., van der Molen, H. J., & Sciarra, F. (Eds.). Research on Steroids: Proceedings of the International Study Group for Steroid Hormones, Volume 8 / Research on Steroids Transactions of the Eighth Meeting of the International Study Group for Steroid Hormones (Proceedings of the Serono Symposia, Volume 21) (pp. 313–315). London/New York/San Francisco: Academic Press. [Google Scholar]
    • Huffman, D. H., Kampmann, J. P., Hignite, C. E., & Azarnoff, D. L. (1978). Gynecomastia induced in normal males by spironolactone. Clinical Pharmacology & Therapeutics, 24(4), 465–473. [DOI:10.1002/cpt1978244465]
    • Inal, M. M., Yildirim, Y., & Taner, C. E. (2005). Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study. Fertility and Sterility, 84(6), 1693–1697. [DOI:10.1016/j.fertnstert.2005.05.051]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • James, J. F., Jamerson, T. A., & Aguh, C. (2022). Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review. Journal of the American Academy of Dermatology, 86(2), 425–429. [DOI:10.1016/j.jaad.2021.07.048]
    • Karakurt, F., Sahin, I., Güler, S., Demirbas, B., Culha, C., Serter, R., Aral, Y., & Bavbek, N. (2008). Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: A randomised controlled study. Advances in Therapy, 25(4), 321–328. [DOI:10.1007/s12325-008-0039-5]
    • Labrie, C., Cusan, L., Plante, M., Lapointe, S., & Labrie, F. (1987). Analysis of the androgenic activity of synthetic “progestins” currently used for the treatment of prostate cancer. Journal of Steroid Biochemistry, 28(4), 379–384. [DOI:10.1016/0022-4731(87)91054-5]
    • Layton, A. M., Eady, E. A., Whitehouse, H., Del Rosso, J. Q., Fedorowicz, Z., & van Zuuren, E. J. (2017). Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review. American Journal of Clinical Dermatology, 18(2), 169–191. [DOI:10.1007/s40257-016-0245-x]
    • Leinung, M. C. (2014). Variable Response to Oral Estradiol Therapy in Male to Female Transgender Patients. Endocrine Reviews, 35(Suppl 1) [Endocrine Society’s 96th Annual Meeting and Expo, June 21–24, 2014 – Chicago], ?–? (abstract no. OR42-1). [Google Scholar] [DOI:10.1093/edrv/35.supp.1] [DOI:10.1210/endo-meetings.2014.RE.2.OR42-1] [URL] [MedPage Today]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Liang, J. J., Jolly, D., Chan, K. J., & Safer, J. D. (2018). Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort. Endocrine Practice, 24(2), 135–142. [DOI:10.4158/ep-2017-0116]
    • Lobo, R. A., Shoupe, D., Serafini, P., Brinton, D., & Horton, R. (1985). The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertility and Sterility, 43(2), 200–205. [DOI:10.1016/s0015-0282(16)48373-1]
    • Loriaux, D. L. (1976). Spironolactone and Endocrine Dysfunction. Annals of Internal Medicine, 85(5), 630–630. [DOI:10.7326/0003-4819-85-5-630]
    • McMullen, G. R., & Van Herle, A. J. (1993). Hirsutism and the effectiveness of spironolactone in its management. Journal of Endocrinological Investigation, 16(11), 925–932. [DOI:10.1007/bf03348960]
    • Menard, R., Guenthner, T., Kon, H., & Gillette, J. (1979). Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. Requirement for the 7α-thio group and evidence for the loss of the heme and apoproteins of cytochrome P-450. Journal of Biological Chemistry, 254(5), 1726–1733. [DOI:10.1016/s0021-9258(17)37833-x]
    • Miro, E., Rizzone, K., Ho, T., Mark, B., Sullivan, E., & Cushman, D. (2024). 2024 AMSSM Research Podium Presentations: Testosterone Levels Among Transgender Women on Gender-affirming Hormone Therapy. Clinical Journal of Sports Medicine, 34(2), 152–152. [DOI:10.1097/JSM.0000000000001212]
    • Miyatake, A., Noma, K., Nakao, K., Morimoto, Y., & Yamamura, Y. (1978). Increased serum oestrone and oestradiol following spironolactone administration in hypertensive men. Clinical Endocrinology, 9(6), 523–533. [DOI:10.1111/j.1365-2265.1978.tb01510.x]
    • Moghetti, P., Tosi, F., Tosti, A., Negri, C., Misciali, C., Perrone, F., Caputo, M., Muggeo, M., & Castello, R. (2000). Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism, 85(1), 89–94. [DOI:10.1210/jcem.85.1.6245]
    • Negri, C., Tosi, F., Dorizzi, R., Fortunato, A., Spiazzi, G. G., Muggeo, M., Castello, R., & Moghetti, P. (2000). Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women. The Journal of Clinical Endocrinology & Metabolism, 85(1), 81–84. [DOI:10.1210/jcem.85.1.6230]
    • Pappas, I. I., Craig, W. Y., Spratt, L. V., & Spratt, D. I. (2020). Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients. The Journal of Clinical Endocrinology & Metabolism, 106(3), e1290–e1300. [DOI:10.1210/clinem/dgaa884]
    • Pappas, I. I., Craig, W., Spratt, L. V., & Spratt, D. I. (2020). Testosterone (T) and estradiol (E2) therapy alone can suppress gonadal function in transgender patients. Costas T. Lambrew Research Retreat 2020, 47. [Google Scholar] [URL] [PDF]
    • Pentikäinen, P. J., Pentikäinen, L. A., Huffman, D. H., & Azarnoff, D. L. (1974). The effect of spironolactone on plasma levels and excretion of testosterone and oestrogens in the urine in males. (A preliminary report). The Journal of International Medical Research, 2(6), 439–443. [Google Scholar] [PubMed] [PDF]
    • Prior, J. C., Vigna, Y. M., Watson, D., Diewold, P., & Robinow, O. (1986). Spironolactone in the presurgical therapy of male to female transsexuals: Philosophy and experience of the Vancouver Gender Dysphoria Clinic. Journal of Sex Information & Education Council of Canada, 1(1), 1–7. [Google Scholar] [PDF]
    • Prior, J. C., Vigna, Y. M., & Watson, D. (1989). Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism. Archives of Sexual Behavior, 18(1), 49–57. [DOI:10.1007/bf01579291]
    • Reardon, E., Farnell, P., Langzettel, J., & Spratt, D. (2013). Efficacy of single agent hormonal therapy in transgender patients to suppress endogenous hypothalamic-pituitary-gonadal (HPG) activity. Fertility and Sterility, 100(3 Suppl) [Scientific Program Supplement: Oral and Poster Session Abstracts 12 October 2013 - 17 October 2013], S333–S333 (abstract no. P-640). [Google Scholar] [DOI:10.1016/j.fertnstert.2013.07.914]
    • Rose, L. I. (1977). Pathophysiology of Spironolactone-Induced Gynecomastia. Annals of Internal Medicine, 87(4), 398–403. [DOI:10.7326/0003-4819-87-4-398]
    • Rozner, R. N., Freites-Martinez, A., Shapiro, J., Geer, E. B., Goldfarb, S., & Lacouture, M. E. (2018). Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies. Breast Cancer Research and Treatment, 174(1), 15–26. [DOI:10.1007/s10549-018-4996-3]
    • Santen, R. J., Kulin, H. E., Loriaux, D. L., & Friend, J. (1976). Spironolactone Stimulation of Gonadotropin Secretion in Boys with Delayed Adolescence. The Journal of Clinical Endocrinology & Metabolism, 43(6), 1386–1390. [DOI:10.1210/jcem-43-6-1386]
    • Santer, M., Lawrence, M., Renz, S., Eminton, Z., Stuart, B., Sach, T. H., Pyne, S., Ridd, M. J., Francis, N., Soulsby, I., Thomas, K., Permyakova, N., Little, P., Muller, I., Nuttall, J., Griffiths, G., Thomas, K. S., & Layton, A. M. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ, 381, e074349. [DOI:10.1136/bmj-2022-074349]
    • Shaw, J. C. (1996). Antiandrogen and hormonal treatment of acne. Dermatologic Clinics, 14(4), 803–811. [DOI:10.1016/s0733-8635(05)70405-8]
    • Sivelle, P. C., Underwood, A. H., & Jelly, J. A. (1982). The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro. Biochemical Pharmacology, 31(5), 677–684. [DOI:10.1016/0006-2952(82)90449-x]
    • Skorodok, L. M., Savchenko, O. N., & Liss, V. L. (1983). Hypothalamo-hypophyseal-gonadal function in boys with irregular puberty. Neuroscience and Behavioral Physiology, 13(2), 141–145. [DOI:10.1007/bf01190800]
    • Snyder, B. W., Winneker, R. C., & Batzold, F. H. (1989). Endocrine profile of win 49596 in the rat: A novel androgen receptor antagonist. Journal of Steroid Biochemistry, 33(6), 1127–1132. [DOI:10.1016/0022-4731(89)90419-6]
    • Sofer, Y., Yaish, I., Yaron, M., Bach, M. Y., Stern, N., & Greenman, Y. (2020). Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocrine Practice, 26(8), 883–890. [DOI:10.4158/ep-2020-0032]
    • SoRelle, J. A., Jiao, R., Gao, E., Veazey, J., Frame, I., Quinn, A. M., Day, P., Pagels, P., Gimpel, N., & Patel, K. (2019). Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clinical Chemistry, 65(1), 170–179. [DOI:10.1373/clinchem.2018.292730]
    • Spörl, S. (1978/1979). Über den Einfluß von Spironolacton (Aldactone®) auf den Stoffwechsel von Nebennierenrindenhormonen und von Testosteron bei Gesunden mit diätinduziertem Hyperaldosterismus. [On the influence of spironolactone (Aldactone®) on the metabolism of adrenocortical hormones and testosterone in healthy individuals with diet-induced hyperaldosteronism.] (Doctoral dissertation, Freie Universität, Berlin.) [Google Scholar] [Google Books] [WorldCat] [PDF]
    • Spratt, L. V., Reardon, E., Olshan, J. S., & Eimicke, T. (2014). Efficacy of Testosterone (T) or Estradiol (E2) Therapy without a GnRH Agonist or Progestin to Suppress Endogenous Gonadal Activity in Transsexual Patients. Endocrine Reviews, 35(Suppl 1) [Endocrine Society’s 96th Annual Meeting and Expo, June 21–24, 2014 – Chicago], ?–? (abstract no. OR42-2). [DOI:10.1093/edrv/35.supp.1] [URL]
    • Stewart, I., Spratt, L., Craig, W., Olshan, J., & Spratt, D. (2018). The efficacy of testosterone or estradiol therapy without a GnRH agonist or progestin to suppress endogenous gonadal activity in transgender patients. Fertility and Sterility, 110(4 Suppl) [Scientific Congress Supplement: Oral and Poster Session Abstracts 06 October 2018 - 10 October 2018], e21–e21 (abstract no. O-44). [Google Scholar] [DOI:10.1016/j.fertnstert.2018.07.075]
    • Stripp, B., Taylor, A. A., Bartter, F. C., Gillette, J. R., Loriaux, D. L., Easley, R., & Menard, R. H. (1975). Effect of Spironolactone on Sex Hormones in Man. The Journal of Clinical Endocrinology & Metabolism, 41(4), 777–781. [DOI:10.1210/jcem-41-4-777]
    • Taylor, A. A., Rollins, D., Snodgrass, W., & Bartter, F. (1976). Effect of spironolactone (S) on adrenal and gonadal steroids in man. Clinical Research, 24(3), A279–A279. [Google Scholar] [PDF]
    • Tidd, M. J., Horth, C. E., Ramsay, L. E., Shelton, J. R., & Palmer, R. F. (1978). Endocrine effects of spironolactone in man. Clinical Endocrinology, 9(5), 389–399. [DOI:10.1111/j.1365-2265.1978.tb03578.x]
    • van Zuuren, E., & Fedorowicz, Z. (2016). Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments. British Journal of Dermatology, 175(1), 45–61. [DOI:10.1111/bjd.14486]
    • Walsh, P. C., & Siiteri, P. K. (1975). Suppression of Plasma Androgens by Spironolactone in Castrated Men with Carcinoma of the Prostate. Journal of Urology, 114(2), 254–256. [DOI:10.1016/s0022-5347(17)67001-0]
    • Wang, C., Du, Y., Bi, L., Lin, X., Zhao, M., & Fan, W. (2023). The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review. Clinical, Cosmetic and Investigational Dermatology, 16, 603–612. [DOI:10.2147/ccid.s398950]
    • Weissmann, A. (1985). Antiandrogenic Effects of Topically Applied Spironolactone on the Hamster Flank Organ. Archives of Dermatology, 121(1), 57–62. [DOI:10.1001/archderm.1985.01660010061019]
    • Yamasaki, K., Sawaki, M., Noda, S., Muroi, T., Takakura, S., Mitoma, H., Sakamoto, S., Nakai, M., & Yakabe, Y. (2004). Comparison of the Hershberger assay and androgen receptor binding assay of twelve chemicals. Toxicology, 195(2–3), 177–186. [DOI:10.1016/j.tox.2003.09.012]
    • Yang, W., Hong, T., Chang, X., Han, M., Gao, H., Pan, B., Zhao, Z., & Liu, Y. (2024). The efficacy of and user satisfaction with different antiandrogens in Chinese transgender women. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2024.2323514]
    • Yazdabadi, A., & Sinclair, R. (2011). Treatment of female pattern hair loss with the androgen receptor antagonist flutamide. The Australasian Journal of Dermatology, 52(2), 132–134. [DOI:10.1111/j.1440-0960.2010.00735.x]
    • Zgliczynski, S., Baranowska, B., & Szymanowski, J. (1981). L’influence du spironolactone sur la concentration des gonatrophines et des hormones gonadiques dans l’hypertrophie prostatique. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy]. Journal d’Urologie, 87(9), 635–638. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
    • Zimmerman, Y., Eijkemans, M. J., Coelingh Bennink, H. J., Blankenstein, M. A., & Fauser, B. C. (2013). The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. [DOI:10.1093/humupd/dmt038]
    \ No newline at end of file diff --git a/transfemscience.org/articles/spiro-visceral-fat/index.html b/transfemscience.org/articles/spiro-visceral-fat/index.html index 23fff72a..99218381 100644 --- a/transfemscience.org/articles/spiro-visceral-fat/index.html +++ b/transfemscience.org/articles/spiro-visceral-fat/index.html @@ -1 +1 @@ -Spironolactone and Claims About Increased Visceral Fat in Transfeminine People - Transfeminine Science Link

    Spironolactone and Claims About Increased Visceral Fat in Transfeminine People

    By Aly | First published October 25, 2020 | Last modified October 2, 2022

    A claim has been originated by some in the online transgender community that the antiandrogen spironolactone increases visceral fat in transfeminine people and that this effect is irreversible. Visceral fat is a type of adipose tissue located in the intra-abdominal region which surrounds the internal organs (viscera) in that area. In excess, visceral fat causes the abdomen to look bloated and unattractive. The supposed phenomenon of visceral fat accumulation with spironolactone has sometimes been referred to by people in the transgender community as “spiro belly”. The claim is based on theory—specifically that spironolactone has been found to increase levels of the corticosteroid hormone cortisol due to its antimineralocorticoid activity and cortisol is known to increase visceral fat, which together imply that spironolactone might likewise be able to increase visceral fat. It is also based on claimed anecdotal observations of transfeminine people taking spironolactone, which are said to corroborate the hypothesis. Despite these claims owever, there is no actual direct scientific or medical literature to support the idea that spironolactone increases visceral fat, and there is considerable evidence contradicting it.

    The influence of spironolactone on cortisol levels in clinical studies is variable and the magnitude of effect is limited. Hence, the clinical significance of increased cortisol levels with spironolactone is uncertain. Moreover, cortisol is an agonist of the glucocorticoid receptor (thereby producing glucocorticoid effects) and of the mineralocorticoid receptor (thereby producing mineralocorticoid effects). As already touched on, spironolactone has potent antimineralocorticoid activity (that is, mineralocorticoid receptor antagonism). Hence, even if spironolactone did increase cortisol levels enough to potentially increase visceral fat, its antimineralocorticoid activity could modify the capacity of cortisol to produce this effect. In relation to this, there is accumulating research to suggest that spironolactone may actually decrease visceral fat via its antimineralocorticoid activity. Antimineralocorticoids like spironolactone show antiadipogenic (anti-fat-accumulation) effects in vitro (Caprio et al., 2007; Caprio et al., 2011) and have been shown to decrease visceral fat in animals (Karakurt, 2008; Armani et al., 2014; Mammi et al., 2016; Olatunji et al., 2018). It is possible that they may also be able to do so in humans. Here are some notable literature excerpts relevant to this topic (Infante et al., 2019; Giordano, Frontini, & Cinti, 2016):

    A possible explanation for [MR antagonists reducing cardiovascular morbidity and mortality more in patients with abdominal obesity] may be that patients with heart failure and abdominal obesity have higher aldosterone concentrations due to excessive secretion of specific aldosterone-releasing factors from [visceral adipose tissue]. […] Several studies on murine models of genetic and diet-induced obesity have widely reported beneficial effects of MR antagonism in terms of metabolic outcomes, such as body weight, fat mass, adipose tissue inflammation, insulin sensitivity, and lipid metabolism (Armani, Cinti, et al., 2014; Armani, Marzolla, et al., 2014; Garg & Adler, 2012; Guo et al., 2008; Hirata et al., 2009). Nevertheless, data on the outcomes of MR pharmacological blockade for prevention and treatment of obesity and metabolic syndrome are still scarce in humans (Tirosh et al., 2010). Of note, Tanko et al. demonstrated that the powerful MR antagonist drospirenone, in combination with estradiol, leads to a significant reduction of central fat mass and central fat mass/peripheral fat mass ratio in healthy post-menopausal women (Tankó & Christiansen, 2005). Moreover, another study has reported that MR antagonists significantly reduce body mass index and visceral fat area in patients with primary aldosteronism after a 1-year treatment period (Karashima et al., 2016). […] In light of these data, MR antagonism may be a useful therapeutic tool for prevention and treatment of cardiometabolic derangements observed in metabolic syndrome, even though additional studies are deemed necessary to confirm its impact on larger clinical settings.

    An anti-obesity drug whose primary mode of action is to induce browning should act predominantly on visceral fat, thereby directly counteracting the major cause of obesity-associated metabolic disorders. Accumulation of abdominal visceral fat is, to some extent, linked to increased local levels and/or activity of androgen and glucocorticoid steroid hormones145,146. These hormones are also ligands of the mineralocorticoid receptors, which are found on white and brown adipocytes and could have a role in abdominal visceral fat accumulation and BAT to WAT conversion147–151.** […] **In this context, mineralocorticoid receptor antagonism has been shown to protect mice from the adverse obesogenic and metabolic effects of a high-fat diet via conversion of a substantial amount of visceral and subcutaneous WAT into BAT153. Given that mineralocorticoid receptor antagonists are widely prescribed diuretics, used to manage chronic heart failure, hyperaldosteronism and female hirsutism154, patients receiving such drugs should also be assessed for weight loss and metabolic parameters to establish whether these compounds have anti-obesity properties.

    A number of studies have assessed the influence of antimineralocorticoids like spironolactone and eplerenone (another antimineralocorticoid) on visceral fat in humans. Spironolactone (12.5–100 mg/day) and eplerenone (25–100 mg/day) decreased visceral fat in people with pathologically high levels of aldosterone (a major endogenous mineralocorticoid hormone) (Karashima et al., 2016). A study of cisgender girls with polycystic ovary syndrome (PCOS) found that a combination of spironolactone (50 mg/day), pioglitazone, and metformin decreased visceral fat (Diaz et al., 2018). However, this study was of course confounded by the other medications. In addition to the preceding studies, many other clinical studies (at least 10) have assessed and similarly found no indication of increased visceral or abdominal fat with spironolactone (25–200 mg/day) (as measured by visceral fat directly or by indirect related measures like waist circumference or waist–hip ratio) (Wild et al., 1991; Lovejoy et al., 1996; Ganie et al., 2004; Meyer, McGrath, & Teede, 2007; Karakurt et al., 2008; Vieira et al., 2012; Ganie et al., 2013; Harmanci et al., 2013; Leelaphiwat et al., 2015; Alpañés et al., 2017). I was not able to identify any studies assessing visceral fat with higher doses of spironolactone (>200 mg/day). Additional studies are also underway to assess the possibility that spironolactone could decrease visceral fat.

    With regard to the anecdotal claims of spironolactone increasing visceral fat in transfeminine people, it’s important to note that anecdotes are unreliable and are considered to be the lowest form of evidence in medicine. This is for well-founded reasons—succinctly, anecdotes very often don’t hold up when rigorous studies are conducted. It’s probable that excess abdominal fat—a problem which afflicts many—has been misattributed to spironolactone rather than to the real causes in transfeminine people. It’s notable in this regard that androgens are known to increase visceral fat and that men have twice as much visceral fat as women on average (Blouin, Boivin, & Tchernof, 2008; Zerradi et al., 2014). It’s possible that many transfeminine people may have excess visceral fat due to prior androgen exposure and that this visceral fat may not fully reverse with hormone therapy. As we know, hormone therapy unfortunately isn’t able to reverse all established bodily sexual dimorphism.

    Besides increased visceral fat, many other serious adverse effects with spironolactone have been claimed. However, these claimed adverse effects are likewise based on anecdotes and theory, and there is a lack of direct clinical evidence to support such side effects. In actuality, spironolactone even at high doses appears to be well-tolerated per studies and systematic reviews. The claimed side effects of spironolactone may actually largely be due to phenomena like nocebo and misattribution—which can be controlled for in systematic studies but not in the case of anecdotal observations.

    To summarize, no research, animal or clinical, has found increased visceral fat with spironolactone, and there is accumulating evidence that spironolactone may cause the very opposite effect. More studies are needed to further characterize this possible benefit of spironolactone in humans however.

    References

    • Alpañés, M., Álvarez-Blasco, F., Fernández-Durán, E., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2017). Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial. European Journal of Endocrinology, 177(5), 399–408. [DOI:10.1530/eje-17-0516]
    • Armani, A., Cinti, F., Marzolla, V., Morgan, J., Cranston, G. A., Antelmi, A., Carpinelli, G., Canese, R., Pagotto, U., Quarta, C., Malorni, W., Matarrese, P., Marconi, M., Fabbri, A., Rosano, G., Cinti, S., Young, M. J., & Caprio, M. (2014). Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high‐fat‐diet‐fed mice. The FASEB Journal, 28(8), 3745–3757. [DOI:10.1096/fj.13-245415]
    • Blouin, K., Boivin, A., & Tchernof, A. (2008). Androgens and body fat distribution. The Journal of Steroid Biochemistry and Molecular Biology, 108(3–5), 272–280. [DOI:10.1016/j.jsbmb.2007.09.001]
    • Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M. (2007). Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis. The FASEB Journal, 21(9), 2185–2194. [DOI:10.1096/fj.06-7970com]
    • Caprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M., & Fève, B. (2011). Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome. Endocrinology, 152(1), 113–125. [DOI:10.1210/en.2010-0674]
    • Díaz, M., Gallego-Escuredo, J. M., López-Bermejo, A., de Zegher, F., Villarroya, F., & Ibáñez, L. (2018). Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome. International Journal of Endocrinology, 2018, 4192940. [DOI:10.1155/2018/4192940]
    • Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004). Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2756–2762. [DOI:10.1210/jc.2003-031780]
    • Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshrestha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., Mir, F. A., & Taing, S. (2013). Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study. The Journal of Clinical Endocrinology & Metabolism, 98(9), 3599–3607. [DOI:10.1210/jc.2013-1040]
    • Giordano, A., Frontini, A., & Cinti, S. (2016). Convertible visceral fat as a therapeutic target to curb obesity. Nature Reviews Drug Discovery, 15(6), 405–424. [DOI:10.1038/nrd.2016.31]
    • Harmanci, A., Cinar, N., Bayraktar, M., & Yildiz, B. O. (2012). Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clinical Endocrinology, 78(1), 120–125. [DOI:10.1111/j.1365-2265.2012.04466.x]
    • Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2019). Adipocyte Mineralocorticoid Receptor. In Litwack, G. (Ed.). Aldosterone (Vitamins and Hormones, Volume 109) (pp. 189–209). Amsterdam: Elsevier Academic Press. [DOI:10.1016/bs.vh.2018.10.005]
    • Karakurt, F., Sahin, I., Güler, S., Demirbas, B., Culha, C., Serter, R., Aral, Y., & Bavbek, N. (2008). Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: A randomised controlled study. Advances in Therapy, 25(4), 321–328. [DOI:10.1007/s12325-008-0039-5]
    • Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Seta, T., Yamagishi, M., & Takeda, Y. (2015). Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism. Hypertension Research, 39(3), 133–137. [DOI:10.1038/hr.2015.129]
    • Leelaphiwat, S., Jongwutiwes, T., Lertvikool, S., Tabcharoen, C., Sukprasert, M., Rattanasiri, S., & Weerakiet, S. (2014). Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A randomized controlled trial. Journal of Obstetrics and Gynaecology Research, 41(3), 402–410. [DOI:10.1111/jog.12543]
    • Lovejoy, J. C., Bray, G. A., Bourgeois, M. O., Macchiavelli, R., Rood, J. C., Greeson, C., & Partington, C. (1996). Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women–a clinical research center study. The Journal of Clinical Endocrinology & Metabolism, 81(6), 2198–2203. [DOI:10.1210/jcem.81.6.8964851]
    • Mammi, C., Marzolla, V., Armani, A., Feraco, A., Antelmi, A., Maslak, E., Chlopicki, S., Cinti, F., Hunt, H., Fabbri, A., & Caprio, M. (2016). A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet. International Journal of Obesity, 40(6), 964–972. [DOI:10.1038/ijo.2016.13]
    • Meyer, C., McGrath, B. P., & Teede, H. J. (2007). Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome. Diabetes Care, 30(3), 471–478. [DOI:10.2337/dc06-0618]
    • Olatunji, L. A., Adeyanju, O. A., Michael, O. S., Usman, T. O., Tostes, R. C., & Soladoye, A. O. (2019). Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats. Canadian Journal of Physiology and Pharmacology, 97(1), 65–74. [DOI:10.1139/cjpp-2018-0416]
    • Vieira, C. S., Martins, W. P., Fernandes, J. B., Soares, G. M., dos Reis, R. M., de Sá, M. F., & Ferriani, R. A. (2012). The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, 86(3), 268–275. [DOI:10.1016/j.contraception.2011.12.011]
    • Wild, R. A., Demers, L. M., Applebaum-Bowden, D., & Lenker, R. (1991). Hirsutism: Metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception, 44(2), 113–124. [DOI:10.1016/0010-7824(91)90112-s]
    • Zerradi, M., Dereumetz, J., Boulet, M., & Tchernof, A. (2014). Androgens, body fat Distribution and Adipogenesis. Current Obesity Reports, 3(4), 396–403. [DOI:10.1007/s13679-014-0119-6]
    \ No newline at end of file +Spironolactone and Claims About Increased Visceral Fat in Transfeminine People - Transfeminine Science Link

    Spironolactone and Claims About Increased Visceral Fat in Transfeminine People

    By Aly | First published October 25, 2020 | Last modified October 2, 2022

    A claim has been originated by some in the online transgender community that the antiandrogen spironolactone increases visceral fat in transfeminine people and that this effect is irreversible. Visceral fat is a type of adipose tissue located in the intra-abdominal region which surrounds the internal organs (viscera) in that area. In excess, visceral fat causes the abdomen to look bloated and unattractive. The supposed phenomenon of visceral fat accumulation with spironolactone has sometimes been referred to by people in the transgender community as “spiro belly”. The claim is based on theory—specifically that spironolactone has been found to increase levels of the corticosteroid hormone cortisol due to its antimineralocorticoid activity and cortisol is known to increase visceral fat, which together imply that spironolactone might likewise be able to increase visceral fat. It is also based on claimed anecdotal observations of transfeminine people taking spironolactone, which are said to corroborate the hypothesis. Despite these claims owever, there is no actual direct scientific or medical literature to support the idea that spironolactone increases visceral fat, and there is considerable evidence contradicting it.

    The influence of spironolactone on cortisol levels in clinical studies is variable and the magnitude of effect is limited. Hence, the clinical significance of increased cortisol levels with spironolactone is uncertain. Moreover, cortisol is an agonist of the glucocorticoid receptor (thereby producing glucocorticoid effects) and of the mineralocorticoid receptor (thereby producing mineralocorticoid effects). As already touched on, spironolactone has potent antimineralocorticoid activity (that is, mineralocorticoid receptor antagonism). Hence, even if spironolactone did increase cortisol levels enough to potentially increase visceral fat, its antimineralocorticoid activity could modify the capacity of cortisol to produce this effect. In relation to this, there is accumulating research to suggest that spironolactone may actually decrease visceral fat via its antimineralocorticoid activity. Antimineralocorticoids like spironolactone show antiadipogenic (anti-fat-accumulation) effects in vitro (Caprio et al., 2007; Caprio et al., 2011) and have been shown to decrease visceral fat in animals (Karakurt, 2008; Armani et al., 2014; Mammi et al., 2016; Olatunji et al., 2018). It is possible that they may also be able to do so in humans. Here are some notable literature excerpts relevant to this topic (Infante et al., 2019; Giordano, Frontini, & Cinti, 2016):

    A possible explanation for [MR antagonists reducing cardiovascular morbidity and mortality more in patients with abdominal obesity] may be that patients with heart failure and abdominal obesity have higher aldosterone concentrations due to excessive secretion of specific aldosterone-releasing factors from [visceral adipose tissue]. […] Several studies on murine models of genetic and diet-induced obesity have widely reported beneficial effects of MR antagonism in terms of metabolic outcomes, such as body weight, fat mass, adipose tissue inflammation, insulin sensitivity, and lipid metabolism (Armani, Cinti, et al., 2014; Armani, Marzolla, et al., 2014; Garg & Adler, 2012; Guo et al., 2008; Hirata et al., 2009). Nevertheless, data on the outcomes of MR pharmacological blockade for prevention and treatment of obesity and metabolic syndrome are still scarce in humans (Tirosh et al., 2010). Of note, Tanko et al. demonstrated that the powerful MR antagonist drospirenone, in combination with estradiol, leads to a significant reduction of central fat mass and central fat mass/peripheral fat mass ratio in healthy post-menopausal women (Tankó & Christiansen, 2005). Moreover, another study has reported that MR antagonists significantly reduce body mass index and visceral fat area in patients with primary aldosteronism after a 1-year treatment period (Karashima et al., 2016). […] In light of these data, MR antagonism may be a useful therapeutic tool for prevention and treatment of cardiometabolic derangements observed in metabolic syndrome, even though additional studies are deemed necessary to confirm its impact on larger clinical settings.

    An anti-obesity drug whose primary mode of action is to induce browning should act predominantly on visceral fat, thereby directly counteracting the major cause of obesity-associated metabolic disorders. Accumulation of abdominal visceral fat is, to some extent, linked to increased local levels and/or activity of androgen and glucocorticoid steroid hormones145,146. These hormones are also ligands of the mineralocorticoid receptors, which are found on white and brown adipocytes and could have a role in abdominal visceral fat accumulation and BAT to WAT conversion147–151.** […] **In this context, mineralocorticoid receptor antagonism has been shown to protect mice from the adverse obesogenic and metabolic effects of a high-fat diet via conversion of a substantial amount of visceral and subcutaneous WAT into BAT153. Given that mineralocorticoid receptor antagonists are widely prescribed diuretics, used to manage chronic heart failure, hyperaldosteronism and female hirsutism154, patients receiving such drugs should also be assessed for weight loss and metabolic parameters to establish whether these compounds have anti-obesity properties.

    A number of studies have assessed the influence of antimineralocorticoids like spironolactone and eplerenone (another antimineralocorticoid) on visceral fat in humans. Spironolactone (12.5–100 mg/day) and eplerenone (25–100 mg/day) decreased visceral fat in people with pathologically high levels of aldosterone (a major endogenous mineralocorticoid hormone) (Karashima et al., 2016). A study of cisgender girls with polycystic ovary syndrome (PCOS) found that a combination of spironolactone (50 mg/day), pioglitazone, and metformin decreased visceral fat (Diaz et al., 2018). However, this study was of course confounded by the other medications. In addition to the preceding studies, many other clinical studies (at least 10) have assessed and similarly found no indication of increased visceral or abdominal fat with spironolactone (25–200 mg/day) (as measured by visceral fat directly or by indirect related measures like waist circumference or waist–hip ratio) (Wild et al., 1991; Lovejoy et al., 1996; Ganie et al., 2004; Meyer, McGrath, & Teede, 2007; Karakurt et al., 2008; Vieira et al., 2012; Ganie et al., 2013; Harmanci et al., 2013; Leelaphiwat et al., 2015; Alpañés et al., 2017). I was not able to identify any studies assessing visceral fat with higher doses of spironolactone (>200 mg/day). Additional studies are also underway to assess the possibility that spironolactone could decrease visceral fat.

    With regard to the anecdotal claims of spironolactone increasing visceral fat in transfeminine people, it’s important to note that anecdotes are unreliable and are considered to be the lowest form of evidence in medicine. This is for well-founded reasons—succinctly, anecdotes very often don’t hold up when rigorous studies are conducted. It’s probable that excess abdominal fat—a problem which afflicts many—has been misattributed to spironolactone rather than to the real causes in transfeminine people. It’s notable in this regard that androgens are known to increase visceral fat and that men have twice as much visceral fat as women on average (Blouin, Boivin, & Tchernof, 2008; Zerradi et al., 2014). It’s possible that many transfeminine people may have excess visceral fat due to prior androgen exposure and that this visceral fat may not fully reverse with hormone therapy. As we know, hormone therapy unfortunately isn’t able to reverse all established bodily sexual dimorphism.

    Besides increased visceral fat, many other serious adverse effects with spironolactone have been claimed. However, these claimed adverse effects are likewise based on anecdotes and theory, and there is a lack of direct clinical evidence to support such side effects. In actuality, spironolactone even at high doses appears to be well-tolerated per studies and systematic reviews. The claimed side effects of spironolactone may actually largely be due to phenomena like nocebo and misattribution—which can be controlled for in systematic studies but not in the case of anecdotal observations.

    To summarize, no research, animal or clinical, has found increased visceral fat with spironolactone, and there is accumulating evidence that spironolactone may cause the very opposite effect. More studies are needed to further characterize this possible benefit of spironolactone in humans however.

    References

    • Alpañés, M., Álvarez-Blasco, F., Fernández-Durán, E., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2017). Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial. European Journal of Endocrinology, 177(5), 399–408. [DOI:10.1530/eje-17-0516]
    • Armani, A., Cinti, F., Marzolla, V., Morgan, J., Cranston, G. A., Antelmi, A., Carpinelli, G., Canese, R., Pagotto, U., Quarta, C., Malorni, W., Matarrese, P., Marconi, M., Fabbri, A., Rosano, G., Cinti, S., Young, M. J., & Caprio, M. (2014). Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high‐fat‐diet‐fed mice. The FASEB Journal, 28(8), 3745–3757. [DOI:10.1096/fj.13-245415]
    • Blouin, K., Boivin, A., & Tchernof, A. (2008). Androgens and body fat distribution. The Journal of Steroid Biochemistry and Molecular Biology, 108(3–5), 272–280. [DOI:10.1016/j.jsbmb.2007.09.001]
    • Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M. (2007). Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis. The FASEB Journal, 21(9), 2185–2194. [DOI:10.1096/fj.06-7970com]
    • Caprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M., & Fève, B. (2011). Antiadipogenic Effects of the Mineralocorticoid Receptor Antagonist Drospirenone: Potential Implications for the Treatment of Metabolic Syndrome. Endocrinology, 152(1), 113–125. [DOI:10.1210/en.2010-0674]
    • Díaz, M., Gallego-Escuredo, J. M., López-Bermejo, A., de Zegher, F., Villarroya, F., & Ibáñez, L. (2018). Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome. International Journal of Endocrinology, 2018, 4192940. [DOI:10.1155/2018/4192940]
    • Ganie, M. A., Khurana, M. L., Eunice, M., Gulati, M., Dwivedi, S. N., & Ammini, A. C. (2004). Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study. The Journal of Clinical Endocrinology & Metabolism, 89(6), 2756–2762. [DOI:10.1210/jc.2003-031780]
    • Ganie, M. A., Khurana, M. L., Nisar, S., Shah, P. A., Shah, Z. A., Kulshrestha, B., Gupta, N., Zargar, M. A., Wani, T. A., Mudasir, S., Mir, F. A., & Taing, S. (2013). Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study. The Journal of Clinical Endocrinology & Metabolism, 98(9), 3599–3607. [DOI:10.1210/jc.2013-1040]
    • Giordano, A., Frontini, A., & Cinti, S. (2016). Convertible visceral fat as a therapeutic target to curb obesity. Nature Reviews Drug Discovery, 15(6), 405–424. [DOI:10.1038/nrd.2016.31]
    • Harmanci, A., Cinar, N., Bayraktar, M., & Yildiz, B. O. (2012). Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome. Clinical Endocrinology, 78(1), 120–125. [DOI:10.1111/j.1365-2265.2012.04466.x]
    • Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2019). Adipocyte Mineralocorticoid Receptor. In Litwack, G. (Ed.). Aldosterone (Vitamins and Hormones, Volume 109) (pp. 189–209). Amsterdam: Elsevier Academic Press. [DOI:10.1016/bs.vh.2018.10.005]
    • Karakurt, F., Sahin, I., Güler, S., Demirbas, B., Culha, C., Serter, R., Aral, Y., & Bavbek, N. (2008). Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: A randomised controlled study. Advances in Therapy, 25(4), 321–328. [DOI:10.1007/s12325-008-0039-5]
    • Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Seta, T., Yamagishi, M., & Takeda, Y. (2015). Comparison of eplerenone and spironolactone for the treatment of primary aldosteronism. Hypertension Research, 39(3), 133–137. [DOI:10.1038/hr.2015.129]
    • Leelaphiwat, S., Jongwutiwes, T., Lertvikool, S., Tabcharoen, C., Sukprasert, M., Rattanasiri, S., & Weerakiet, S. (2014). Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A randomized controlled trial. Journal of Obstetrics and Gynaecology Research, 41(3), 402–410. [DOI:10.1111/jog.12543]
    • Lovejoy, J. C., Bray, G. A., Bourgeois, M. O., Macchiavelli, R., Rood, J. C., Greeson, C., & Partington, C. (1996). Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women–a clinical research center study. The Journal of Clinical Endocrinology & Metabolism, 81(6), 2198–2203. [DOI:10.1210/jcem.81.6.8964851]
    • Mammi, C., Marzolla, V., Armani, A., Feraco, A., Antelmi, A., Maslak, E., Chlopicki, S., Cinti, F., Hunt, H., Fabbri, A., & Caprio, M. (2016). A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet. International Journal of Obesity, 40(6), 964–972. [DOI:10.1038/ijo.2016.13]
    • Meyer, C., McGrath, B. P., & Teede, H. J. (2007). Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome. Diabetes Care, 30(3), 471–478. [DOI:10.2337/dc06-0618]
    • Olatunji, L. A., Adeyanju, O. A., Michael, O. S., Usman, T. O., Tostes, R. C., & Soladoye, A. O. (2019). Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats. Canadian Journal of Physiology and Pharmacology, 97(1), 65–74. [DOI:10.1139/cjpp-2018-0416]
    • Vieira, C. S., Martins, W. P., Fernandes, J. B., Soares, G. M., dos Reis, R. M., de Sá, M. F., & Ferriani, R. A. (2012). The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, 86(3), 268–275. [DOI:10.1016/j.contraception.2011.12.011]
    • Wild, R. A., Demers, L. M., Applebaum-Bowden, D., & Lenker, R. (1991). Hirsutism: Metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception, 44(2), 113–124. [DOI:10.1016/0010-7824(91)90112-s]
    • Zerradi, M., Dereumetz, J., Boulet, M., & Tchernof, A. (2014). Androgens, body fat Distribution and Adipogenesis. Current Obesity Reports, 3(4), 396–403. [DOI:10.1007/s13679-014-0119-6]
    \ No newline at end of file diff --git a/transfemscience.org/articles/sublingual-e2-transfem/index.html b/transfemscience.org/articles/sublingual-e2-transfem/index.html index 3a73124e..23f27471 100644 --- a/transfemscience.org/articles/sublingual-e2-transfem/index.html +++ b/transfemscience.org/articles/sublingual-e2-transfem/index.html @@ -1 +1 @@ -An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People - Transfeminine Science Link

    An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People

    By Sam | First published June 11, 2021 | Last modified September 6, 2021

    Abstract / TL;DR

    Despite being less well characterised in the medical literature than other formulations, sublingually administered estradiol has been used successfully by several gender clinics around the world. While there may be practical shortcomings associated with the sublingual route, clinical experience and best judgement would suggest it to be effective and affordable when dosed correctly. Sublingual administration of estradiol may be a useful alternative to oral administration for some transfeminine people and can be used for feminising hormone therapy instead.

    Introduction

    Although the most common way to administer medication in the form of pills or tablets is by the oral route, oral estradiol formulations can otherwise be taken sublingually or buccally (Kuhl, 2005). Sublingual administration refers to the placing of the pill or tablet under the tongue to dissolve and be absorbed into the bloodstream. Buccal administration is similar and refers to placing the medication between the cheek and gums, where it also quickly dissolves and is absorbed (Gass et al., 2004; Bartlett & Maarschalk, 2012).

    Many transfeminine people wonder or ask questions on online forums about the sublingual route of administration for estradiol. Some of the most common queries are “What doses of sublingual estradiol should I take?”, “How often should I take sublingual estradiol?”, “Is sublingual estradiol better than oral estradiol?” and so on.

    Previously, I reviewed the literature in a comparison of oral and transdermal estradiol (Sam, 2020a). Although many transfeminine people experiment with sublingual estradiol and its use appears to be commonplace among those who self-medicate with estrogens, I did not discuss sublingual or buccal routes of administration in this review. In part, the reason for this was because few studies exist concerning the use of sublingual estradiol compared to conventional and more widely used routes. This is likely also the reason that sublingual estradiol is not discussed in many clinical practice guidelines (Aly, 2020a). Moreover, I wanted to focus specifically on oral estradiol. Since the time of publication of that article, however, several new studies of sublingual estradiol in transfeminine people have been published. In light of this new information, and on account of the many questions asked by transfeminine people online, I believe an in-depth look at this route of administration is warranted. So this is intended to be an overview of the published medical literature regarding sublingual estradiol, with a specific focus on its use in transgender care, aiming to answer some of these questions.

    It is of note that, although the sublingual and buccal administration are distinct routes of administration, they are very similar to each other in how they are performed and in their pharmacology (Perloff, 1950; Chandrasekhara et al., 2002). As such, although I have ostensibly chosen to make use of the term “sublingual” in this literature review, much of the content here is applicable to buccal administration of estradiol as well.

    Pharmacology of Sublingual Estradiol

    While sublingual estradiol has not been as widely used in clinical practice as oral estradiol and other formulations, a number of studies have examined its pharmacology. These studies include both samples of postmenopausal cisgender women and transfeminine people as well as other patient populations (Casper & Yen, 1981; Serhal & Craft, 1989; Deutsch, Bhakri, & Kubicek, 2015; Cirrincione et al., 2021). Both oral estradiol and oral estradiol valerate tablets can be taken sublingually (Serhal, 1990).

    After the administration of a dose of oral estradiol, the medication is heavily metabolised and inactivated into estrogen conjugates by the liver (Kuhl, 2005). In turn, these metabolites are gradually converted back into estradiol, which serves to prolong its half life (to approximately 13–20 hours) (Stanczyk, Archer, & Bhavnani, 2013). In contrast to oral estradiol, sublingual estradiol does not pass extensively through the liver and is not significantly deactivated by hepatic metabolism into estrogen metabolites. Instead, sublingually administered estradiol is rapidly absorbed into the bloodstream and directly enters circulation. Consequently, sublingual estradiol has greater bioavailability than oral estradiol, meaning that lower doses are needed to achieve similar AUC estradiol levels (Kuhl, 2005) (Figures 1 and 2). This is an advantage of sublingual estradiol over oral estradiol, as it allows for lower doses to be used and for reduced medication costs.

    Figures 1 and 2: Pharmacokinetics in different studies of a single 0.25 to 2 mg dose of micronised estradiol with oral administration (left) and sublingual or buccal administration (right). Sources: Burnier et al. (1981); Casper & Yen (1981); Fiet et al. (1982); Kuhnz, Gansau, & Mahler (1993); Price et al. (1997); Wiegratz et al. (2001); Wren et al. (2003); and Pickar et al. (2015). Dotted black lines represent approximately average integrated estradiol levels in premenopausal women (Verdonk et al., 2019).

    Because accidental swallowing of some of the estradiol seems probable, the sublingual route is, most likely, actually a combination of sublingual and oral delivery of estradiol (Lobo, 1987; Kuhl, 2005). A preliminary report from an ongoing study of transfeminine people reported that a single 1 mg dose of sublingual estradiol caused an average rise in the level of estradiol up to a maximum of at least 179 pg/mL (657 pmol/L) within one to two hours of administration. In contrast, a peak concentration of just 36 pg/mL (130 pmol/L) was found with the same 1 mg dose administered orally (Doll et al., 2020). Thereafter, estradiol levels decreased rapidly. This response has also been found in other studies of postmenopausal women where a wide range of peak concentrations have been observed (Burnier et al., 1981; Price et al., 1997; Wren et al., 2003). Estradiol levels are found to rapidly rise on the order of ten times that of the peak of oral estradiol, then rapidly decline with an elimination half-life of a few hours (Kuhl, 2005). Sublingual estradiol is somewhat analogous in this respect to intravenously administered estradiol, which also is associated with a rapid increase in estradiol levels and a very short elimination half-life following a dose (Kuhnz, Gansau, & Mahler, 1993). Another route of administration that is similar in this regard is intranasal administration (Devissaguet et al., 1999). Owing to the spikiness and short duration of sublingual estradiol, sublingual estradiol does not achieve as stable of concentrations as other formulations do. As such, this is a marked difference to other formulations of estradiol, such as oral estradiol, that produce much more stable hormone levels that do not fluctuate as much over the course of the day.

    A range of estimates have been reported for the relative bioavailability of sublingual estradiol. One small randomised study of postmenopausal women found approximately 2.5-fold higher area-under-the-curve (AUC) levels of estradiol with sublingual estradiol than with the same doses of oral estradiol (Price et al., 1997). Other studies have reported relative bioavailability estimates for sublingual estradiol of up to five times that of oral estradiol (Pines et al., 1999). A study in marmoset monkeys found that the absolute bioavailability of sublingual estradiol was 10%; approximately twice that of conventional absolute bioavailability estimates of oral estradiol (5%, though with a wide range of 0.1 to 12%) (Kuhnz, Blode, & Zimmermann, 1993). Therefore, with respect to AUC levels of estradiol, the sublingual route appears to have between approximately two and five times higher estradiol levels compared to oral estradiol when given at the same doses. Based on these findings, approximate doses of sublingual estradiol for use in transfeminine hormone therapy can be derived (Table 1). It is of note that, at this time, the comparative potency of sublingual estradiol remains to be properly characterised due to a lack of research.

    Table 1: Approximately comparable doses of estradiol (E2) and estradiol valerate (EV) administered by the oral and sublingual routes in terms of total estradiol exposure (Price et al., 1997; Pines et al., 1999):

     Low DoseModerate DoseHigh DoseVery-High Dose
    Oral E22 mg/day4 mg/day8 mg/day10 mg/day
    Sublingual E2a0.5–1 mg/day1–2 mg/day2–4 mg/day2.5–5 mg/day
    Oral EV3 mg/day6 mg/day10 mg/day12 mg/day
    Sublingual EVa0.75–1.5 mg/day1.5–3 mg/day2.5–5 mg/day3–6 mg/day

    a Range calculated by dividing oral doses by two and four to reflect differences in absolute bioavailability and rounding to the nearest 0.25 mg. * Bioidentical estradiol has wide interindividual variation in its pharmacology and the effects of doses may vary significantly between individuals. EV has greater molecular weight and therefore contains less medication for the same amount/dose by weight. It should be noted that estimates for the relative bioavailability of EV are extrapolated from formulations with no valeric ester attached (i.e., E2).

    Sublingually Administered Estradiol and Feminisation

    The very short half-life of sublingually and buccally administered estradiol relative to other forms raises a few questions for its potential use of sublingual estradiol in feminising hormone therapy. One of the most commonly asked questions on online forums is regarding which gender-affirming hormone therapy regimens might be most “effective” with respect to the feminising effects of estrogens. These include, but are not limited to, outcomes such as breast development and fat distribution.

    In contrast to oral and trandermal estradiol, no data exist describing the extent of feminisation with sublingual estradiol (Sam, 2020a). However, as discussed previously, oral and non-oral estradiol have not been found to differ in their effects on breast development or other feminising outcomes in transfeminine people or cisgender hypogondal girls (Rosenfield et al., 2005; Shah et al., 2014; Klaver et al., 2018; de Blok et al., 2021). In consideration of this, differences in efficacy might not be expected for sublingual estradiol either. The fact that several gender clinics have employed sublingual estradiol is also encouraging and suggests that sublingual estradiol is effective for inducing feminization (Deutsch, Bhakri, & Kubicek, 2015; Lim et al., 2019; Cirrincione et al., 2021). Nevertheless, as no studies have been conducted comparing the feminising efficacy of sublingual estradiol with objective measures, it is not possible to say for certain whether or not there is any difference in feminisation outcomes between oral and sublingual estradiol. Hopefully, studies in the future will shed more light on this.

    Testosterone Suppressing Efficacy of Sublingually Administered Estradiol

    Another question that might be raised by the short half-life of sublingual estradiol is how it might compare to more conventional routes of administration in terms of its ability to suppress testosterone and other androgens.

    Estrogens were first characterised for their use as antigonadotrophic antiandrogens in the 1940s, in the form of oral synthetic estrogens, namely diethylstilbestrol (DES), to treat men with prostate cancer (Huggins & Hodges, 1941). Estrogens given in the form of oral ethinylestradiol (EE), long-acting estradiol esters, such as polyestradiol phosphate, and transdermal estradiol patches have been studied. Their efficacy for this indication is well established (Stege et al., 1996; Kohli, 2006; Sciarra et al., 2015). As data are more limited for testosterone suppression with estrogens in transfeminine people, these data are valuable for informing transfeminine hormone therapy. Sublingual estradiol, on the other hand, has never been used as therapy for prostatic cancer and, consequently, no such data exist on the same scale to show the ability of sublingual estradiol in this capacity.

    Recent data from some studies have found that physiologic levels of estradiol (i.e., 100–200 pg/mL [367–734 pmol/L]) from non-sublingual estradiol alone result in rapid and near complete, if not complete, suppression of testosterone levels to the female range in many transfeminine people (Leinung, Feustel, & Joseph, 2018; Pappas et al., 2020). Additionally, new data from around 900 men enrolled in the ongoing Prostate Adenocarcinoma TransCutaneous Hormones (PATCH) study, a multicentre randomised controlled trial in the United Kingdom, show that sustained median estradiol levels of between 215 to 250 pg/mL (789–918 pmol/L) from transdermal patches were similarly effective (~95%) to GnRH analogues in reducing testosterone levels to the castrate range (<50 ng/dL [<1.7 nmol/L]) (Langley et al., 2021). However, because of the markedly different pharmacokinetics of sublingual estradiol, it is plausible that estradiol administered in this way might result in sub-par suppression at doses with similar AUC levels of estradiol. Put another way, sustained estradiol levels may be more efficacious with respect to testosterone suppression than the frequent and short-lived “spikes” in estradiol levels that occur with the sublingual route.

    There is some weak evidence from pharmacological studies of estradiol that support this possibility. One line of evidence is that some studies of both sublingual and intravenous administration have reported rapid but limited suppression of the gonadotropins (follicle-stimulating hormone and luteinising hormone) in women despite sufficiently elevated estradiol levels for several hours (Tsai & Yen, 1971; Burnier et al., 1981; Casper & Yen, 1981; Hoon et al., 1993). These studies are low quality and indirect since testosterone suppression itself was not measured and they were performed in cisgender women. Another problem is that all were single dose studies and their findings may not translate to multiple dosing. It may be the case that full gonadotropin suppression becomes apparent with repeated physiologic doses of sublingual estradiol. Nevertheless, these studies might suggest a limited effect of sublingual estradiol to fully suppress gonadal function in transfeminine people without the use of excessive doses that would lead to greater health risks or the additional use of other antiandrogens.

    It could be the case that monotherapy with sublingual estradiol may not be as effective at comparable doses to the typically employed doses in studies of prostatic cancer (e.g., two to four 100 μg/24 hours transdermal patches). Transdermal patches, gels and parenteral estradiol esters, such as estradiol valerate, injected intramuscularly or subcutaneously might therefore be more reliable choices for monotherapy regimens. On the other hand, sublingual estradiol has been studied in transfeminine people in combination with and without the low-dose use of the progestin medroxyprogesterone acetate (MPA) (Jain, Kwan, & Forcier, 2019). In this study, at least reasonably high rates of testosterone levels within the female range (<50 ng/dL [<1.7 nmol/L]) were achieved by the transfeminine people who took sublingual estradiol together with medroxyprogesterone acetate, showing that sublingual estradiol taken together with other antiandrogens (e.g., 10 mg/day cyproterone acetate) is very likely to be viable for achieving effective testosterone suppression (Aly, 2019).

    Monitoring of Estradiol Levels with Sublingual Administration

    A further consideration regarding the rapid changes in estradiol levels that occur with the use of sublingual estradiol is the relevance of monitoring of estradiol levels through bloodwork. Currently, consensus guidelines do not recommend a specific time for monitoring of the blood relative to the time of a last dose (Deutsch, 2016; Cheung et al., 2019; T’Sjoen et al., 2020). This may be in part due to practical reasons, or because there is currently no robust data from randomised controlled trials to guide the specifics of dosing in transgender hormone therapy (Haupt et al., 2020). Nevertheless, because estradiol levels vary so significantly with sublingual estradiol, knowledge of how long after the last dose blood was drawn is important to ensure proper interpretation of laboratory results.

    For instance, measuring hormone levels just after a dose of sublingual estradiol has been taken might lead to the misinterpretation that levels of estradiol are excessively high and that one’s dosage should be reduced to achieve a more sensible concentration of estradiol in the blood. In reality, this would be a misunderstanding caused by the pharmacology of sublingual estradiol as the point of measurement would be right around the time when estradiol levels are most likely to be at their highest. These estradiol levels would not be indicative of the average amount of exposure, which is the more accurate measure of overall estrogenicity. Similarly, on the opposite end of the scale, drawing blood just before the administration of a new dose might lead to the belief that estrogen levels are too low and, consequently, lead to the use of excessive doses of estrogens. The latter misinterpretation may be more common among people unfamiliar with the pharmacology of sublingual estradiol as levels of estradiol only remain very high in the first few hours after a dose of sublingual estradiol has been taken before falling rapidly.

    This oversight may also have implications in studies of sublingual estradiol. For instance, in the previously mentioned respective analysis of the use of sublingual estradiol for gender-affirming hormone therapy, the frequency of administration and time of measurement relative to the last dose were not specified in their results (Jain, Kwan, & Forcier, 2019). Although this data is much needed and is valuable to ongoing research to characterise sublingual estradiol in in transfeminine people, a significant problem is not knowing at what time estradiol levels were measured after the medication was administered. It is difficult to say much about the estradiol levels recorded in this study. Moreover, it is impossible to use this data to help derive equivalent doses of sublingual and oral estradiol.

    A possible solution to the problem of rapidly changing hormone levels associated with the sublingual route might simply be to measure when estradiol levels are most likely to be closest to their average. In the case of sublingual estradiol, studies generally find this to be approximately four hours after the administration of a dose, although there is likely to be considerable variation between individuals (Kuhl, 2005). Nevertheless, this approach may give the most representative “snapshot” of overall estrogenic exposure and might help to avoid misleading laboratory data in users of sublingual estradiol.

    Administration of Multiple Sublingual Doses Per Day

    In order to compensate for the short half-life of sublingually administered estradiol, multiple doses of estrogens can be administered in smaller quantities per day to maintain hormone levels that are somewhat more consistent (Ahokas, Kaukoranta, & Aito, 1999).

    In one study of premenopausal women with high-dose estrogen therapy, 2 mg of sublingual estradiol was administered three or four times per day (a total of 6–8 mg/day), resulting in significantly more stable hormone levels than would be expected with a single dose per day (Serhal & Craft, 1989). This was replicated in another study where estradiol was administered three to eight times per day (Ahokas et al., 2001). Conversely, a third study investigating low-dose buccal estradiol found little difference between the “steady-state” estradiol concentrations with a once-daily and twice-daily 0.25 mg dose of buccal estradiol over a 12 hour observation period (Wren et al., 2003). These findings may indicate that sublingual and buccal estradiol needs to be taken at least thrice per day in order to achieve concentrations of estradiol that are more stable.

    For the reasons outlined in the subsections above, it would seem advantageous that transfeminine people using sublingual estradiol employ this approach and take sublingual estradiol in divided doses throughout the day; perhaps ideally at least three or four times per day. For instance, instead of taking a 2 mg dose every 24 hours, it would be better to take four 0.5 mg doses in the space of 24 hours (as evenly spaced as practical). Administering sublingual estradiol multiple times throughout the day might be less convenient, but is likely to provide at least somewhat more balanced estradiol levels and potentially better testosterone suppression. The administration of multiple doses every day could be regarded as optimal for the use of sublingually administered estradiol.

    Safety and Tolerability

    Unfortunately, as with the pharmacokinetics of sublingually and buccally estradiol, the published medical literature concerning the safety and tolerability of this route of administration leaves much to be desired. No long term safety data exist for sublingually administered estradiol in the same way that both oral and transdermal estradiol have been rigorously studied in menopausal women (Rovinski et al., 2018; CGHFBC, 2019).

    Adverse Health Effects of Estrogens

    With sufficient exposure, owing to their effects in the liver, estrogens are associated with an increased risk of blood clots (Kuhl, 2005; Aly, 2020b). Additionally, under certain circumstances, estrogens can be associated with other cardiovascular complications (Anderson et al., 2004; Mikkola et al., 2005). Although the absolute risk is low in the short-term, these are the most significant health concerns associated with gender-affirming hormone therapy.

    A limited number of studies have assessed the effects of sublingually administered estradiol on the liver (Pines et al., 1999; Lim et al., 2019). These data found similar effects on lipids and cholesterol to other estrogens. One line of evidence that indicates sublingual estradiol has greater hepatic impact than other non-oral forms such as trandermal estradiol is the significantly greater quantities of estrone and estrone sulphate that are generated by this route; a marker of estrogenic exposure in the liver (Burnier et al., 1981; Cirrincione et al., 2021). Intense estrogenic activation in the liver is the mechanism by which non-oral estradiol induces a hypercoagulable state at high doses (Sam, 2020b; Sam, 2020c).

    While a large body of research does exist concerning the short and long term health effects of estrogens, none of these studies have investigated sublingual or buccal estradiol (Oliver-Williams et al., 2019; Mishra et al., 2021). Given that oral estradiol has greater risks than non-oral estradiol, and that sublingual administration partially but not fully avoids first-pass metabolism, it may be the case that its own risk would be no higher than the risk observed with oral estradiol but no lower than the risk observed with non-oral routes. A retrospective cohort study in the United States found that the incidence of thromboembolism in transfeminine people with an average dose of 4 mg/day oral estradiol was approximately twice that of cisgender controls not taking hormone therapy after adjusting for confounders (HR 2.0, 95% CI 1.4–2.8 versus reference women) (Getahun et al., 2018). These increases in risks are much lower compared to regimens in transfeminine people in the past that included high doses of synthetic estrogens, but it’s important to remember that even such increases can significantly increase morbidity and mortality (Morimont, Dogné, & Douxfils, 2020). It would be advisable to limit doses of sublingual and buccal estradiol so that they are not excessive (i.e., <6 mg/day) in the interest of harm reduction and the balancing of the risks and benefits of gender-affirming hormone therapy.

    Non-compliance

    A practical obstacle to the use of sublingual estradiol in transfeminine people is that it may be highly inconvenient to have to administer doses thrice, four times or perhaps even more often throughout the duration of a single day. It has been found in observational studies that, in general, the number of prescribed medications and doses per day are positively associated with patient non-compliance and the number of missed doses (Jin et al., 2008; Toh et al., 2014). These findings are especially of relevance to transfeminine people as, in most cases, we require decades of hormone therapy. While missing one dose from time to time may be of little consequence, missing doses repeatedly could be more problematic.

    In contrast to sublingual estradiol, the half-life of oral estradiol and transdermal gel is long enough to enable once-daily administration (Wiegratz et al., 2001; Potts & Lobo, 2005). In the case of transdermal patches and parenteral estradiol, these forms only have to be replenished every few days or after even longer intervals of time (Thurman et al., 2013; Wisner et al., 2015). Therefore, when considering the use of sublingual estradiol versus other forms, whether or not it would be practical or convenient to consistently take medication several times a day should probably also be an important consideration for transfeminine people. If not, then another formulation may be preferable for the person in question. This may be especially true for long term use.

    Summary and Conclusions

    There is much less research investigating sublingual and buccal estradiol than other forms of estrogen. These forms, namely oral and transdermal estrogens, are used in the alleviation of the menopause and for other indications that have historically been more widely used. As a result, they have received much more attention and characterisation than sublingual estradiol has for transfeminine hormone therapy. However, several recent studies have added to our knowledge of sublingual estradiol. Clinical practice guidelines for transgender care that have historically not discussed the use of sublingual estradiol may be adjusted accordingly if more information becomes available.

    Sublingual estradiol is different in its pharmacology to other formulations. The main difference is that it is associated with a rapid rise and fall in estradiol levels. It has between two and four times the bioavailability of oral estradiol and hence provides the same total estradiol exposure at doses that are two to four times lower. This is a particular advantage because sublingual estradiol, therefore, is cheaper than oral estradiol, and the higher estradiol levels at the same dose may be helpful for testosterone suppression.

    While no evidence exists to show or suggest that sublingual estradiol results in better or inferior feminisation to that experienced with other routes of administration, it is plausible that sublingual estradiol may to some degree result in less testosterone suppression at the same total estradiol exposure. Sublingual estradiol has, nonetheless, been shown to be effective with respect to testosterone suppression when paired with other antiandrogens. Care should be taken with sublingual estradiol when monitoring estradiol levels to ensure correct interpretation. In order to help minimise these potential problems, sublingual estradiol can be taken in multiple doses divided throughout the day.

    The health risks of sublingual estradiol have not been quantified in large observational or randomised studies. Therefore, although the partial bypassing of the first pass through the liver is reassuring in this respect, its cardiovascular risk profile is unknown. Sublingual estradiol may be inconvenient and other formulations can be used instead if preferred, particularly for more long-term therapy.

    Taken together, although much more research is clearly needed to properly characterise the route, sublingual estradiol may have a number of advantageous properties and may be a useful alternative to oral estradiol in transfeminine hormone therapy.

    References

    • Ahokas, A., Kaukoranta, J., & Aito, M. (1999). Effect of oestradiol on postpartum depression. Psychopharmacology, 146(1), 108–110. [DOI:10.1007/s002130051095]
    • Ahokas, A., Kaukoranta, J., Wahlbeck, K., & Aito, M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol: a preliminary study. Journal of Clinical Psychiatry, 62(5), 332–336. [DOI:10.4088/jcp.v62n0504] [PDF]
    • Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., … & Women’s Health Initiative Steering Committee. (2004). Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial. JAMA, 291(14), 1701–1712. [DOI:10.1001/jama.291.14.1701]
    • Bartlett, J. A., & van der Voort Maarschalk, K. (2012). Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine. AAPS Pharmscitech, 13(4), 1110–1115. [DOI:10.1208/s12249-012-9839-7]
    • Burnier, A. M., Martin, P. L., Yen, S. S., & Brooks, P. (1981). Sublingual absorption of micronized 17β-estradiol. American Journal of Obstetrics and Gynecology, 140(2), 146–150. [DOI:10.1016/0002-9378(81)90101-0]
    • Casper, R. F., & Yen, S. S. (1981). Rapid absorption of micronized estradiol-17β following sublingual administration. Obstetrics and Gynecology, 57(1), 62–64. [Google Scholar] [PubMed] [URL] [PDF]
    • Chandrasekhara, D. S., Ali, V., Prost, H. M., & Nader-Estekhari, S. (2002). Buccal estrogen in toothpaste study: systemic absorption of estradiol in postmenopausal or surgically menopausal women when administered as a component in toothpaste. Fertility and Sterility, 78(Suppl 1), S98–S98 (O-258). [DOI:10.1016/S0015-0282(02)03639-7]
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/S0140-6736(19)31709-X]
    • de Blok, C., Dijkman, B., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K., & den Heijer, M. (2021). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of cross-sex hormone treatment on transgender women and men. Obstetrics and Gynecology, 125(3), 605–610. [DOI:10.1097/AOG.0000000000000692]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Devissaguet, J. P., Brion, N., Lhote, O., & Deloffre, P. (1999). Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. European Journal of Drug Metabolism and Pharmacokinetics, 24(3), 265–271. [DOI:10.1007/BF03190030]
    • Doll, E. E., Gunsolus, I., Lamberton, N., Tangpricha, V., & Sarvaideo, J. L. (2020). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Journal of the Endocrine Society, 4(Suppl 1), A1128–A1128 (SUN-LB9). [DOI:10.1210/jendso/bvaa046.2237]
    • Fiet, J., Hermano, M., Witte, J., Villette, J. M., Haimart, M., Gourmel, B., Tabuteau, F., Rouffy, J., & Dreux, C. (1982). Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17β. Acta Endocrinologica, 101(1), 93–97. [DOI:10.1530/acta.0.1010093]
    • Gass, M. S., Rebar, R. W., Cuffie-Jackson, C., Cedars, M. I., Lobo, R. A., Shoupe, D., Judd, H. L., Buyalos, R. P., & Clisham, P. R. (2004). A short study in the treatment of hot flashes with buccal administration of 17-β estradiol. Maturitas, 49(2), 140–147. [DOI:10.1016/j.maturitas.2003.12.004]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/M17-2785]
    • Haupt, C., Henke, M., Kutschmar, A., Hauser, B., Baldinger, S., Saenz, S. R., & Schreiber, G. (2020). Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. Cochrane Database of Systematic Reviews, 11(11), CD013138. [DOI:10.1002/14651858.CD013138.pub2]
    • Hoon, T. J., Dawood, M. Y., Khan‐Dawood, F. S., Ramos, J., & Batenhorst, R. L. (1993). Bioequivalence of a 17β‐Estradiol Hydroxypropyl‐β‐Cyclodextrin Complex in Postmenopausal Women. The Journal of Clinical Pharmacology, 33(11), 1116–1121. [DOI:10.1002/j.1552-4604.1993.tb01949.x]
    • Huggins, C., & Hodges, C. V. (1941). Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293–297. [DOI:10.3322/canjclin.22.4.232]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone acetate in Gender-Affirming therapy for Transwomen: results from a retrospective study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Jin, J., Sklar, G. E., Oh, V. M. S., & Li, S. C. (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and Clinical Risk Management, 4(1), 269–286. [DOI:10.2147/TCRM.S1458]
    • Klaver, M., de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/EJE-17-0496]
    • Kohli, M. (2006). Phase II study of transdermal estradiol in androgen‐independent prostate carcinoma. Cancer, 106(1), 234–235. [DOI:10.1002/cncr.21528]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhnz, W., Blode, H., & Zimmermann, H. (1993). Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 261–322). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_15]
    • Kuhnz, W., Gansau, C., & Mahler, M. (1993). Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43(9), 966–973. [Google Scholar] [PubMed] [PDF]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., … & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/S0140-6736(21)00100-8]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal treatment of transgender women with oral estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Lim, H. H., Jang, Y. H., Choi, G. Y., Lee, J. J., & Lee, E. S. (2019). Gender affirmative care of transgender people: a single center’s experience in Korea. Obstetrics & Gynecology Science, 62(1), 46–55. [DOI:10.5468/ogs.2019.62.1.46]
    • Lobo, R. A. (1987). Absorption and metabolic effects of different types of estrogens and progestogens. Obstetrics and Gynecology Clinics of North America, 14(1), 143–167. [PubMed] [DOI:10.1016/S0889-8545(21)00577-5] [URL] [PDF]
    • Mikkola, A., Aro, J., Rannikko, S., Oksanen, H., Ruutu, M., & Finnprostate Group. (2005). Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate. Scandinavian Journal of Urology and Nephrology, 39(4), 294–300. [DOI:10.1080/00365590510031228]
    • Mishra, S. R., Chung, H. F., Waller, M., & Mishra, G. D. (2021). Duration of estrogen exposure during reproductive years, age at menarche and age at Menopause, and risk of cardiovascular disease events, all‐cause and cardiovascular mortality: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 128(5), 809–821. [DOI:10.1111/1471-0528.16524]
    • Morimont, L., Dogné, J. M., & Douxfils, J. (2020). Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40–51). Thrombosis Research, 193, 221–223. [DOI:10.1016/j.thromres.2020.08.006]
    • Oliver-Williams, C., Glisic, M., Shahzad, S., Brown, E., Pellegrino Baena, C., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2019). The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update, 25(2), 257–271. [DOI:10.1093/humupd/dmy039]
    • Pappas, I. I., Craig, W. Y., Spratt, L. V., & Spratt, D. I. (2021). Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients. The Journal of Clinical Endocrinology & Metabolism, 106(3), e1290–e1300. [DOI:10.1210/clinem/dgaa884]
    • Perloff, W. H. (1950). Estradiol buccal tablets in the treatment of the menopause. American Journal of Obstetrics and Gynecology, 59(1), 223–225. [DOI:10.1016/0002-9378(50)90390-5]
    • Pickar, J. H., Bon, C., Amadio, J. M., Mirkin, S., & Bernick, B. (2015). Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. Menopause, 22(12), 1308–1316. [DOI:10.1097/GME.0000000000000467]
    • Pines, A., Averbuch, M., Fisman, E. Z., & Rosano, G. M. (1999). The acute effects of sublingual 17β-estradiol on the cardiovascular system. Maturitas, 33(1), 81–85. [DOI:10.1016/S0378-5122(99)00036-5]
    • Potts, R. O., & Lobo, R. A. (2005). Transdermal drug delivery: clinical considerations for the obstetrician–gynecologist. Obstetrics & Gynecology, 105(5), 953–961. [DOI:10.1097/01.AOG.0000161958.70059.db]
    • Price, T. M., Blauer, K. L., Hansen, M., Stanczyk, F., Lobo, R., & Bates, G. W. (1997). Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17β-estradiol. Obstetrics & Gynecology, 89(3), 340–345. [DOI:10.1016/S0029-7844(96)00513-3]
    • Rosenfield, R. L., Devine, N., Hunold, J. J., Mauras, N., Moshang Jr, T., & Root, A. W. (2005). Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6424–6430. [DOI:10.1210/jc.2005-1081]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
    • Sciarra, A., Gentile, V., Cattarino, S., Gentilucci, A., Alfarone, A., D’Eramo, G., & Salciccia, S. (2015). Oral ethinylestradiol in castration‐resistant prostate cancer: a 10‐year experience. International Journal of Urology, 22(1), 98–103. [DOI:10.1111/iju.12613]
    • Serhal, P., & Craft, I. (1989). Oocyte donation in 61 patients. The Lancet, 333(8648), 1185–1187. [DOI:10.1016/S0140-6736(89)92762-1]
    • Serhal, P. (1990). Oocyte donation and surrogacy. British Medical Bulletin, 46(3), 796–812. [DOI:10.1093/oxfordjournals.bmb.a072432]
    • Shah, S., Forghani, N., Durham, E., & Neely, E. K. (2014). A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. International Journal of Pediatric Endocrinology, 2014(1), 12. [DOI:10.1186/1687-9856-2014-12]
    • Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013). Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception, 87(6), 706–727. [DOI:10.1016/j.contraception.2012.12.011]
    • Stege, R., Gunnarsson, P. O., Johansson, C. J., Olsson, P., Pousette, Å., & Carlström, K. (1996). Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients. The Prostate, 28(5), 307–310. [DOI:10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine position statement “assessment and hormonal management in adolescent and adult trans people, with attention for sexual function and satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • Thurman, A., Kimble, T., Hall, P., Schwartz, J. L., & Archer, D. F. (2013). Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics. Contraception, 87(6), 738–743. [DOI:10.1016/j.contraception.2012.11.010]
    • Toh, M. R., Teo, V., Kwan, Y. H., Raaj, S., Tan, S. Y. D., & Tan, J. Z. Y. (2014). Association between number of doses per day, number of medications and patient’s non-compliance, and frequency of readmissions in a multi-ethnic Asian population. Preventive Medicine Reports, 1, 43–47. [DOI:10.1016/j.pmedr.2014.10.001]
    • Tsai, C. C., & Yen, S. S. C. (1971). Acute effects of intravenous infusion of 17β-estradiol on gonadotropin release in pre-and post-menopausal women. The Journal of Clinical Endocrinology & Metabolism, 32(6), 766–771. [DOI:10.1210/jcem-32-6-766]
    • Verdonk, S. J., Vesper, H. W., Martens, F., Sluss, P. M., Hillebrand, J. J., & Heijboer, A. C. (2019). Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS method. Clinica Chimica Acta, 495, 198–204. [DOI:10.1016/j.cca.2019.04.062]
    • Wiegratz, I., Fink, T., Rohr, U. D., Lang, E., Leukel, P., & Kuhl, H. (2001). Überkreuz-Vergleich der Pharmakokinetik von Estradiol unter der Hormonsubstitution mit Estradiolvalerat oder mikronisiertem Estradiol. [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol.] Zentralblatt für Gynäkologie, 123(9), 505–512. [PubMed] [DOI:10.1055/s-2001-18223]
    • Wisner, K. L., Sit, D. K., Moses-Kolko, E. L., Driscoll, K. E., Prairie, B. A., Stika, C. S., Eng, H. F., Dills, J. L., Luther, J. F., & Wisniewski, S. R. (2015). Transdermal estradiol treatment for postpartum depression: a pilot randomized trial. Journal of Clinical Psychopharmacology, 35(4), 389–395. [DOI:10.1097/JCP.0000000000000351]
    • Wren, B. G., Day, R. O., McLachlan, A. J., & Williams, K. M. (2003). Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women. Climacteric, 6(2), 104–111. [DOI:10.1080/cmt.6.2.104.111]
    \ No newline at end of file +An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People - Transfeminine Science Link

    An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People

    By Sam | First published June 11, 2021 | Last modified March 30, 2024

    Abstract / TL;DR

    Despite being less well characterised in the medical literature than other formulations, sublingually administered estradiol has been used successfully by several gender clinics around the world. While there may be practical shortcomings associated with the sublingual route, clinical experience and best judgement would suggest it to be effective and affordable when dosed correctly. Sublingual administration of estradiol may be a useful alternative to oral administration for some transfeminine people and can be used for feminising hormone therapy instead.

    Introduction

    Although the most common way to administer medication in the form of pills or tablets is by the oral route, oral estradiol formulations can otherwise be taken sublingually or buccally (Kuhl, 2005). Sublingual administration refers to the placing of the pill or tablet under the tongue to dissolve and be absorbed into the bloodstream. Buccal administration is similar and refers to placing the medication between the cheek and gums, where it also quickly dissolves and is absorbed (Gass et al., 2004; Bartlett & Maarschalk, 2012).

    Many transfeminine people wonder or ask questions on online forums about the sublingual route of administration for estradiol. Some of the most common queries are “What doses of sublingual estradiol should I take?”, “How often should I take sublingual estradiol?”, “Is sublingual estradiol better than oral estradiol?” and so on.

    Previously, I reviewed the literature in a comparison of oral and transdermal estradiol (Sam, 2020a). Although many transfeminine people experiment with sublingual estradiol and its use appears to be commonplace among those who self-medicate with estrogens, I did not discuss sublingual or buccal routes of administration in this review. In part, the reason for this was because few studies exist concerning the use of sublingual estradiol compared to conventional and more widely used routes. This is likely also the reason that sublingual estradiol is not discussed in many clinical practice guidelines (Aly, 2020a). Moreover, I wanted to focus specifically on oral estradiol. Since the time of publication of that article, however, several new studies of sublingual estradiol in transfeminine people have been published. In light of this new information, and on account of the many questions asked by transfeminine people online, I believe an in-depth look at this route of administration is warranted. So this is intended to be an overview of the published medical literature regarding sublingual estradiol, with a specific focus on its use in transgender care, aiming to answer some of these questions.

    It is of note that, although the sublingual and buccal administration are distinct routes of administration, they are very similar to each other in how they are performed and in their pharmacology (Perloff, 1950; Chandrasekhara et al., 2002). As such, although I have ostensibly chosen to make use of the term “sublingual” in this literature review, much of the content here is applicable to buccal administration of estradiol as well.

    Pharmacology of Sublingual Estradiol

    While sublingual estradiol has not been as widely used in clinical practice as oral estradiol and other formulations, a number of studies have examined its pharmacology. These studies include both samples of postmenopausal cisgender women and transfeminine people as well as other patient populations (Casper & Yen, 1981; Serhal & Craft, 1989; Deutsch, Bhakri, & Kubicek, 2015; Cirrincione et al., 2021). Both oral estradiol and oral estradiol valerate tablets can be taken sublingually (Serhal, 1990).

    After the administration of a dose of oral estradiol, the medication is heavily metabolised and inactivated into estrogen conjugates by the liver (Kuhl, 2005). In turn, these metabolites are gradually converted back into estradiol, which serves to prolong its half life (to approximately 13–20 hours) (Stanczyk, Archer, & Bhavnani, 2013). In contrast to oral estradiol, sublingual estradiol does not pass extensively through the liver and is not significantly deactivated by hepatic metabolism into estrogen metabolites. Instead, sublingually administered estradiol is rapidly absorbed into the bloodstream and directly enters circulation. Consequently, sublingual estradiol has greater bioavailability than oral estradiol, meaning that lower doses are needed to achieve similar AUC estradiol levels (Kuhl, 2005) (Figures 1 and 2). This is an advantage of sublingual estradiol over oral estradiol, as it allows for lower doses to be used and for reduced medication costs.

    Figures 1 and 2: Pharmacokinetics in different studies of a single 0.25 to 2 mg dose of micronised estradiol with oral administration (left) and sublingual or buccal administration (right). Sources: Burnier et al. (1981); Casper & Yen (1981); Fiet et al. (1982); Kuhnz, Gansau, & Mahler (1993); Price et al. (1997); Wiegratz et al. (2001); Wren et al. (2003); and Pickar et al. (2015). Dotted black lines represent approximately average integrated estradiol levels in premenopausal women (Verdonk et al., 2019).

    Because accidental swallowing of some of the estradiol seems probable, the sublingual route is, most likely, actually a combination of sublingual and oral delivery of estradiol (Lobo, 1987; Kuhl, 2005). A preliminary report from an ongoing study of transfeminine people reported that a single 1 mg dose of sublingual estradiol caused an average rise in the level of estradiol up to a maximum of at least 179 pg/mL (657 pmol/L) within one to two hours of administration. In contrast, a peak concentration of just 36 pg/mL (130 pmol/L) was found with the same 1 mg dose administered orally (Doll et al., 2020). Thereafter, estradiol levels decreased rapidly. This response has also been found in other studies of postmenopausal women where a wide range of peak concentrations have been observed (Burnier et al., 1981; Price et al., 1997; Wren et al., 2003). Estradiol levels are found to rapidly rise on the order of ten times that of the peak of oral estradiol, then rapidly decline with an elimination half-life of a few hours (Kuhl, 2005). Sublingual estradiol is somewhat analogous in this respect to intravenously administered estradiol, which also is associated with a rapid increase in estradiol levels and a very short elimination half-life following a dose (Kuhnz, Gansau, & Mahler, 1993). Another route of administration that is similar in this regard is intranasal administration (Devissaguet et al., 1999). Owing to the spikiness and short duration of sublingual estradiol, sublingual estradiol does not achieve as stable of concentrations as other formulations do. As such, this is a marked difference to other formulations of estradiol, such as oral estradiol, that produce much more stable hormone levels that do not fluctuate as much over the course of the day.

    A range of estimates have been reported for the relative bioavailability of sublingual estradiol. One small randomised study of postmenopausal women found approximately 2.5-fold higher area-under-the-curve (AUC) levels of estradiol with sublingual estradiol than with the same doses of oral estradiol (Price et al., 1997). Other studies have reported relative bioavailability estimates for sublingual estradiol of up to five times that of oral estradiol (Pines et al., 1999). A study in marmoset monkeys found that the absolute bioavailability of sublingual estradiol was 10%; approximately twice that of conventional absolute bioavailability estimates of oral estradiol (5%, though with a wide range of 0.1 to 12%) (Kuhnz, Blode, & Zimmermann, 1993). Therefore, with respect to AUC levels of estradiol, the sublingual route appears to have between approximately two and five times higher estradiol levels compared to oral estradiol when given at the same doses. Based on these findings, approximate doses of sublingual estradiol for use in transfeminine hormone therapy can be derived (Table 1). It is of note that, at this time, the comparative potency of sublingual estradiol remains to be properly characterised due to a lack of research.

    Table 1: Approximately comparable doses of estradiol (E2) and estradiol valerate (EV) administered by the oral and sublingual routes in terms of total estradiol exposure (Price et al., 1997; Pines et al., 1999):

     Low DoseModerate DoseHigh DoseVery-High Dose
    Oral E22 mg/day4 mg/day8 mg/day10 mg/day
    Sublingual E2a0.5–1 mg/day1–2 mg/day2–4 mg/day2.5–5 mg/day
    Oral EV3 mg/day6 mg/day10 mg/day12 mg/day
    Sublingual EVa0.75–1.5 mg/day1.5–3 mg/day2.5–5 mg/day3–6 mg/day

    a Range calculated by dividing oral doses by two and four to reflect differences in absolute bioavailability and rounding to the nearest 0.25 mg. * Bioidentical estradiol has wide interindividual variation in its pharmacology and the effects of doses may vary significantly between individuals. EV has greater molecular weight and therefore contains less medication for the same amount/dose by weight. It should be noted that estimates for the relative bioavailability of EV are extrapolated from formulations with no valeric ester attached (i.e., E2).

    Sublingually Administered Estradiol and Feminisation

    The very short half-life of sublingually and buccally administered estradiol relative to other forms raises a few questions for its potential use of sublingual estradiol in feminising hormone therapy. One of the most commonly asked questions on online forums is regarding which gender-affirming hormone therapy regimens might be most “effective” with respect to the feminising effects of estrogens. These include, but are not limited to, outcomes such as breast development and fat distribution.

    In contrast to oral and trandermal estradiol, no data exist describing the extent of feminisation with sublingual estradiol (Sam, 2020a). However, as discussed previously, oral and non-oral estradiol have not been found to differ in their effects on breast development or other feminising outcomes in transfeminine people or cisgender hypogondal girls (Rosenfield et al., 2005; Shah et al., 2014; Klaver et al., 2018; de Blok et al., 2021). In consideration of this, differences in efficacy might not be expected for sublingual estradiol either. The fact that several gender clinics have employed sublingual estradiol is also encouraging and suggests that sublingual estradiol is effective for inducing feminization (Deutsch, Bhakri, & Kubicek, 2015; Lim et al., 2019; Cirrincione et al., 2021). Nevertheless, as no studies have been conducted comparing the feminising efficacy of sublingual estradiol with objective measures, it is not possible to say for certain whether or not there is any difference in feminisation outcomes between oral and sublingual estradiol. Hopefully, studies in the future will shed more light on this.

    Testosterone Suppressing Efficacy of Sublingually Administered Estradiol

    Another question that might be raised by the short half-life of sublingual estradiol is how it might compare to more conventional routes of administration in terms of its ability to suppress testosterone and other androgens.

    Estrogens were first characterised for their use as antigonadotrophic antiandrogens in the 1940s, in the form of oral synthetic estrogens, namely diethylstilbestrol (DES), to treat men with prostate cancer (Huggins & Hodges, 1941). Estrogens given in the form of oral ethinylestradiol (EE), long-acting estradiol esters, such as polyestradiol phosphate, and transdermal estradiol patches have been studied. Their efficacy for this indication is well established (Stege et al., 1996; Kohli, 2006; Sciarra et al., 2015). As data are more limited for testosterone suppression with estrogens in transfeminine people, these data are valuable for informing transfeminine hormone therapy. Sublingual estradiol, on the other hand, has never been used as therapy for prostatic cancer and, consequently, no such data exist on the same scale to show the ability of sublingual estradiol in this capacity.

    Recent data from some studies have found that physiologic levels of estradiol (i.e., 100–200 pg/mL [367–734 pmol/L]) from non-sublingual estradiol alone result in rapid and near complete, if not complete, suppression of testosterone levels to the female range in many transfeminine people (Leinung, Feustel, & Joseph, 2018; Pappas et al., 2020). Additionally, new data from around 900 men enrolled in the ongoing Prostate Adenocarcinoma TransCutaneous Hormones (PATCH) study, a multicentre randomised controlled trial in the United Kingdom, show that sustained median estradiol levels of between 215 to 250 pg/mL (789–918 pmol/L) from transdermal patches were similarly effective (~95%) to GnRH analogues in reducing testosterone levels to the castrate range (<50 ng/dL [<1.7 nmol/L]) (Langley et al., 2021). However, because of the markedly different pharmacokinetics of sublingual estradiol, it is plausible that estradiol administered in this way might result in sub-par suppression at doses with similar AUC levels of estradiol. Put another way, sustained estradiol levels may be more efficacious with respect to testosterone suppression than the frequent and short-lived “spikes” in estradiol levels that occur with the sublingual route.

    There is some weak evidence from pharmacological studies of estradiol that support this possibility. One line of evidence is that some studies of both sublingual and intravenous administration have reported rapid but limited suppression of the gonadotropins (follicle-stimulating hormone and luteinising hormone) in women despite sufficiently elevated estradiol levels for several hours (Tsai & Yen, 1971; Burnier et al., 1981; Casper & Yen, 1981; Hoon et al., 1993). These studies are low quality and indirect since testosterone suppression itself was not measured and they were performed in cisgender women. Another problem is that all were single dose studies and their findings may not translate to multiple dosing. It may be the case that full gonadotropin suppression becomes apparent with repeated physiologic doses of sublingual estradiol. Nevertheless, these studies might suggest a limited effect of sublingual estradiol to fully suppress gonadal function in transfeminine people without the use of excessive doses that would lead to greater health risks or the additional use of other antiandrogens.

    It could be the case that monotherapy with sublingual estradiol may not be as effective at comparable doses to the typically employed doses in studies of prostatic cancer (e.g., two to four 100 μg/24 hours transdermal patches). Transdermal patches, gels and parenteral estradiol esters, such as estradiol valerate, injected intramuscularly or subcutaneously might therefore be more reliable choices for monotherapy regimens. On the other hand, sublingual estradiol has been studied in transfeminine people in combination with and without the low-dose use of the progestin medroxyprogesterone acetate (MPA) (Jain, Kwan, & Forcier, 2019). In this study, at least reasonably high rates of testosterone levels within the female range (<50 ng/dL [<1.7 nmol/L]) were achieved by the transfeminine people who took sublingual estradiol together with medroxyprogesterone acetate, showing that sublingual estradiol taken together with other antiandrogens (e.g., 10 mg/day cyproterone acetate) is very likely to be viable for achieving effective testosterone suppression (Aly, 2019).

    Monitoring of Estradiol Levels with Sublingual Administration

    A further consideration regarding the rapid changes in estradiol levels that occur with the use of sublingual estradiol is the relevance of monitoring of estradiol levels through bloodwork. Currently, consensus guidelines do not recommend a specific time for monitoring of the blood relative to the time of a last dose (Deutsch, 2016; Cheung et al., 2019; T’Sjoen et al., 2020). This may be in part due to practical reasons, or because there is currently no robust data from randomised controlled trials to guide the specifics of dosing in transgender hormone therapy (Haupt et al., 2020). Nevertheless, because estradiol levels vary so significantly with sublingual estradiol, knowledge of how long after the last dose blood was drawn is important to ensure proper interpretation of laboratory results.

    For instance, measuring hormone levels just after a dose of sublingual estradiol has been taken might lead to the misinterpretation that levels of estradiol are excessively high and that one’s dosage should be reduced to achieve a more sensible concentration of estradiol in the blood. In reality, this would be a misunderstanding caused by the pharmacology of sublingual estradiol as the point of measurement would be right around the time when estradiol levels are most likely to be at their highest. These estradiol levels would not be indicative of the average amount of exposure, which is the more accurate measure of overall estrogenicity. Similarly, on the opposite end of the scale, drawing blood just before the administration of a new dose might lead to the belief that estrogen levels are too low and, consequently, lead to the use of excessive doses of estrogens. The latter misinterpretation may be more common among people unfamiliar with the pharmacology of sublingual estradiol as levels of estradiol only remain very high in the first few hours after a dose of sublingual estradiol has been taken before falling rapidly.

    This oversight may also have implications in studies of sublingual estradiol. For instance, in the previously mentioned respective analysis of the use of sublingual estradiol for gender-affirming hormone therapy, the frequency of administration and time of measurement relative to the last dose were not specified in their results (Jain, Kwan, & Forcier, 2019). Although this data is much needed and is valuable to ongoing research to characterise sublingual estradiol in in transfeminine people, a significant problem is not knowing at what time estradiol levels were measured after the medication was administered. It is difficult to say much about the estradiol levels recorded in this study. Moreover, it is impossible to use this data to help derive equivalent doses of sublingual and oral estradiol.

    A possible solution to the problem of rapidly changing hormone levels associated with the sublingual route might simply be to measure when estradiol levels are most likely to be closest to their average. In the case of sublingual estradiol, studies generally find this to be approximately four hours after the administration of a dose, although there is likely to be considerable variation between individuals (Kuhl, 2005). Nevertheless, this approach may give the most representative “snapshot” of overall estrogenic exposure and might help to avoid misleading laboratory data in users of sublingual estradiol.

    Administration of Multiple Sublingual Doses Per Day

    In order to compensate for the short half-life of sublingually administered estradiol, multiple doses of estrogens can be administered in smaller quantities per day to maintain hormone levels that are somewhat more consistent (Ahokas, Kaukoranta, & Aito, 1999).

    In one study of premenopausal women with high-dose estrogen therapy, 2 mg of sublingual estradiol was administered three or four times per day (a total of 6–8 mg/day), resulting in significantly more stable hormone levels than would be expected with a single dose per day (Serhal & Craft, 1989). This was replicated in another study where estradiol was administered three to eight times per day (Ahokas et al., 2001). Conversely, a third study investigating low-dose buccal estradiol found little difference between the “steady-state” estradiol concentrations with a once-daily and twice-daily 0.25 mg dose of buccal estradiol over a 12 hour observation period (Wren et al., 2003). These findings may indicate that sublingual and buccal estradiol needs to be taken at least thrice per day in order to achieve concentrations of estradiol that are more stable.

    For the reasons outlined in the subsections above, it would seem advantageous that transfeminine people using sublingual estradiol employ this approach and take sublingual estradiol in divided doses throughout the day; perhaps ideally at least three or four times per day. For instance, instead of taking a 2 mg dose every 24 hours, it would be better to take four 0.5 mg doses in the space of 24 hours (as evenly spaced as practical). Administering sublingual estradiol multiple times throughout the day might be less convenient, but is likely to provide at least somewhat more balanced estradiol levels and potentially better testosterone suppression. The administration of multiple doses every day could be regarded as optimal for the use of sublingually administered estradiol.

    Safety and Tolerability

    Unfortunately, as with the pharmacokinetics of sublingually and buccally estradiol, the published medical literature concerning the safety and tolerability of this route of administration leaves much to be desired. No long term safety data exist for sublingually administered estradiol in the same way that both oral and transdermal estradiol have been rigorously studied in menopausal women (Rovinski et al., 2018; CGHFBC, 2019).

    Adverse Health Effects of Estrogens

    With sufficient exposure, owing to their effects in the liver, estrogens are associated with an increased risk of blood clots (Kuhl, 2005; Aly, 2020b). Additionally, under certain circumstances, estrogens can be associated with other cardiovascular complications (Anderson et al., 2004; Mikkola et al., 2005). Although the absolute risk is low in the short-term, these are the most significant health concerns associated with gender-affirming hormone therapy.

    A limited number of studies have assessed the effects of sublingually administered estradiol on the liver (Pines et al., 1999; Lim et al., 2019). These data found similar effects on lipids and cholesterol to other estrogens. One line of evidence that indicates sublingual estradiol has greater hepatic impact than other non-oral forms such as trandermal estradiol is the significantly greater quantities of estrone and estrone sulphate that are generated by this route; a marker of estrogenic exposure in the liver (Burnier et al., 1981; Cirrincione et al., 2021). Intense estrogenic activation in the liver is the mechanism by which non-oral estradiol induces a hypercoagulable state at high doses (Sam, 2020b; Sam, 2020c).

    While a large body of research does exist concerning the short and long term health effects of estrogens, none of these studies have investigated sublingual or buccal estradiol (Oliver-Williams et al., 2019; Mishra et al., 2021). Given that oral estradiol has greater risks than non-oral estradiol, and that sublingual administration partially but not fully avoids first-pass metabolism, it may be the case that its own risk would be no higher than the risk observed with oral estradiol but no lower than the risk observed with non-oral routes. A retrospective cohort study in the United States found that the incidence of thromboembolism in transfeminine people with an average dose of 4 mg/day oral estradiol was approximately twice that of cisgender controls not taking hormone therapy after adjusting for confounders (HR 2.0, 95% CI 1.4–2.8 versus reference women) (Getahun et al., 2018). These increases in risks are much lower compared to regimens in transfeminine people in the past that included high doses of synthetic estrogens, but it’s important to remember that even such increases can significantly increase morbidity and mortality (Morimont, Dogné, & Douxfils, 2020). It would be advisable to limit doses of sublingual and buccal estradiol so that they are not excessive (i.e., <6 mg/day) in the interest of harm reduction and the balancing of the risks and benefits of gender-affirming hormone therapy.

    Non-compliance

    A practical obstacle to the use of sublingual estradiol in transfeminine people is that it may be highly inconvenient to have to administer doses thrice, four times or perhaps even more often throughout the duration of a single day. It has been found in observational studies that, in general, the number of prescribed medications and doses per day are positively associated with patient non-compliance and the number of missed doses (Jin et al., 2008; Toh et al., 2014). These findings are especially of relevance to transfeminine people as, in most cases, we require decades of hormone therapy. While missing one dose from time to time may be of little consequence, missing doses repeatedly could be more problematic.

    In contrast to sublingual estradiol, the half-life of oral estradiol and transdermal gel is long enough to enable once-daily administration (Wiegratz et al., 2001; Potts & Lobo, 2005). In the case of transdermal patches and parenteral estradiol, these forms only have to be replenished every few days or after even longer intervals of time (Thurman et al., 2013; Wisner et al., 2015). Therefore, when considering the use of sublingual estradiol versus other forms, whether or not it would be practical or convenient to consistently take medication several times a day should probably also be an important consideration for transfeminine people. If not, then another formulation may be preferable for the person in question. This may be especially true for long term use.

    Summary and Conclusions

    There is much less research investigating sublingual and buccal estradiol than other forms of estrogen. These forms, namely oral and transdermal estrogens, are used in the alleviation of the menopause and for other indications that have historically been more widely used. As a result, they have received much more attention and characterisation than sublingual estradiol has for transfeminine hormone therapy. However, several recent studies have added to our knowledge of sublingual estradiol. Clinical practice guidelines for transgender care that have historically not discussed the use of sublingual estradiol may be adjusted accordingly if more information becomes available.

    Sublingual estradiol is different in its pharmacology to other formulations. The main difference is that it is associated with a rapid rise and fall in estradiol levels. It has between two and four times the bioavailability of oral estradiol and hence provides the same total estradiol exposure at doses that are two to four times lower. This is a particular advantage because sublingual estradiol, therefore, is cheaper than oral estradiol, and the higher estradiol levels at the same dose may be helpful for testosterone suppression.

    While no evidence exists to show or suggest that sublingual estradiol results in better or inferior feminisation to that experienced with other routes of administration, it is plausible that sublingual estradiol may to some degree result in less testosterone suppression at the same total estradiol exposure. Sublingual estradiol has, nonetheless, been shown to be effective with respect to testosterone suppression when paired with other antiandrogens. Care should be taken with sublingual estradiol when monitoring estradiol levels to ensure correct interpretation. In order to help minimise these potential problems, sublingual estradiol can be taken in multiple doses divided throughout the day.

    The health risks of sublingual estradiol have not been quantified in large observational or randomised studies. Therefore, although the partial bypassing of the first pass through the liver is reassuring in this respect, its cardiovascular risk profile is unknown. Sublingual estradiol may be inconvenient and other formulations can be used instead if preferred, particularly for more long-term therapy.

    Taken together, although much more research is clearly needed to properly characterise the route, sublingual estradiol may have a number of advantageous properties and may be a useful alternative to oral estradiol in transfeminine hormone therapy.

    Updates

    Update 1: New Sublingual Estradiol Studies (Added By Aly)

    Since this article was first published, the following new relevant studies and papers on sublingual estradiol in transfeminine people have been published:

    • Doll, E., Gunsolus, I., Thorgerson, A., Tangpricha, V., Lamberton, N., & Sarvaideo, J. L. (2022). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Endocrine Practice, 28(3), 237–242. [DOI:10.1016/j.eprac.2021.11.081]
      • Safer, J. D. (2022). Are the Pharmacokinetics of Sublingual Estradiol Superior or Inferior to Those of Oral Estradiol? Endocrine Practice, 28(3), 351–352. [DOI:10.1016/j.eprac.2021.12.018]
      • Sarvaideo, J., Doll, E., & Tangpricha, V. (2022). More Studies Are Needed to Establish the Safety and Efficacy of Sublingual Estradiol in Transgender Women. Endocrine Practice, 28(3), 353–354. [DOI:10.1016/j.eprac.2022.01.004]
    • Cortez, S., Moog, D., Lewis, C., Williams, K., Herrick, C., Fields, M., Gray, T., Guo, Z., Nicol, G., & Baranski, T. (2023). Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 12, e53092. [DOI:10.2196/53092]
    • Jalal, E., & Baldwin, C. (2023). Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1095–A1096 (abstract no. SAT391/bvad114.2062). [DOI:10.1210/jendso/bvad114.2062] [PDF]
    • Yaish, I., Gindis, G., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (2023). Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study. Transgender Health, 8(6), 485–493. [DOI:10.1089/trgh.2023.0022]
      • Gindis, G., Yaish, I., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (May 2023). Sublingual estradiol only, offers no apparent advantage over combined oral estradiol and cyproterone acetate, for Gender Affirming Hormone Therapy (GAHT) of treatment-naive transwomen: Results of a prospective pilot study. Endocrine Abstracts, 90 [25th European Congress of Endocrinology 2023, 13–16 May 2023, Istanbul, Turkey], 274–274 (abstract no. P182). [DOI:10.1530/endoabs.90.p182] [PDF]
      • Yaish, I., Gindis, G., Greenman, Y., Shefer, G., Buch, A., Arbiv, M., Moshe, Y., Sofer, Y., & Tordjman, K. M. (October 2023). Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1104–A1105 (abstract no. SAT409/bvad114.2080). [DOI:10.1210/jendso/bvad114.2080] [PDF]
    • Kariyawasam, N. M., Ahmad, T., Sarma, S., & Fung, R. (2024). Comparison of Estrone/Estradiol Ratio and Levels in Transfeminine Individuals on Different Routes of Estradiol. Transgender Health, online ahead of print. [DOI:10.1089/trgh.2023.0138]

    References

    • Ahokas, A., Kaukoranta, J., & Aito, M. (1999). Effect of oestradiol on postpartum depression. Psychopharmacology, 146(1), 108–110. [DOI:10.1007/s002130051095]
    • Ahokas, A., Kaukoranta, J., Wahlbeck, K., & Aito, M. (2001). Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol: a preliminary study. Journal of Clinical Psychiatry, 62(5), 332–336. [DOI:10.4088/jcp.v62n0504] [PDF]
    • Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., … & Women’s Health Initiative Steering Committee. (2004). Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy: The Women’s Health Initiative Randomized Controlled Trial. JAMA, 291(14), 1701–1712. [DOI:10.1001/jama.291.14.1701]
    • Bartlett, J. A., & van der Voort Maarschalk, K. (2012). Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine. AAPS Pharmscitech, 13(4), 1110–1115. [DOI:10.1208/s12249-012-9839-7]
    • Burnier, A. M., Martin, P. L., Yen, S. S., & Brooks, P. (1981). Sublingual absorption of micronized 17β-estradiol. American Journal of Obstetrics and Gynecology, 140(2), 146–150. [DOI:10.1016/0002-9378(81)90101-0]
    • Casper, R. F., & Yen, S. S. (1981). Rapid absorption of micronized estradiol-17β following sublingual administration. Obstetrics and Gynecology, 57(1), 62–64. [Google Scholar] [PubMed] [URL] [PDF]
    • Chandrasekhara, D. S., Ali, V., Prost, H. M., & Nader-Estekhari, S. (2002). Buccal estrogen in toothpaste study: systemic absorption of estradiol in postmenopausal or surgically menopausal women when administered as a component in toothpaste. Fertility and Sterility, 78(Suppl 1), S98–S98 (O-258). [DOI:10.1016/S0015-0282(02)03639-7]
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/S0140-6736(19)31709-X]
    • Cortez, S., Moog, D., Lewis, C., Williams, K., Herrick, C., Fields, M., Gray, T., Guo, Z., Nicol, G., & Baranski, T. (2023). Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 12, e53092. [DOI:10.2196/53092]
    • de Blok, C., Dijkman, B., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K., & den Heijer, M. (2021). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of cross-sex hormone treatment on transgender women and men. Obstetrics and Gynecology, 125(3), 605–610. [DOI:10.1097/AOG.0000000000000692]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Devissaguet, J. P., Brion, N., Lhote, O., & Deloffre, P. (1999). Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. European Journal of Drug Metabolism and Pharmacokinetics, 24(3), 265–271. [DOI:10.1007/BF03190030]
    • Doll, E. E., Gunsolus, I., Lamberton, N., Tangpricha, V., & Sarvaideo, J. L. (2020). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Journal of the Endocrine Society, 4(Suppl 1), A1128–A1128 (SUN-LB9). [DOI:10.1210/jendso/bvaa046.2237]
    • Doll, E., Gunsolus, I., Thorgerson, A., Tangpricha, V., Lamberton, N., & Sarvaideo, J. L. (2022). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Endocrine Practice, 28(3), 237–242. [DOI:10.1016/j.eprac.2021.11.081]
    • Fiet, J., Hermano, M., Witte, J., Villette, J. M., Haimart, M., Gourmel, B., Tabuteau, F., Rouffy, J., & Dreux, C. (1982). Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17β. Acta Endocrinologica, 101(1), 93–97. [DOI:10.1530/acta.0.1010093]
    • Gass, M. S., Rebar, R. W., Cuffie-Jackson, C., Cedars, M. I., Lobo, R. A., Shoupe, D., Judd, H. L., Buyalos, R. P., & Clisham, P. R. (2004). A short study in the treatment of hot flashes with buccal administration of 17-β estradiol. Maturitas, 49(2), 140–147. [DOI:10.1016/j.maturitas.2003.12.004]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/M17-2785]
    • Gindis, G., Yaish, I., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (May 2023). Sublingual estradiol only, offers no apparent advantage over combined oral estradiol and cyproterone acetate, for Gender Affirming Hormone Therapy (GAHT) of treatment-naive transwomen: Results of a prospective pilot study. Endocrine Abstracts, 90 [25th European Congress of Endocrinology 2023, 13–16 May 2023, Istanbul, Turkey], 274–274 (abstract no. P182). [DOI:10.1530/endoabs.90.p182] [PDF]
    • Haupt, C., Henke, M., Kutschmar, A., Hauser, B., Baldinger, S., Saenz, S. R., & Schreiber, G. (2020). Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. Cochrane Database of Systematic Reviews, 11(11), CD013138. [DOI:10.1002/14651858.CD013138.pub2]
    • Hoon, T. J., Dawood, M. Y., Khan‐Dawood, F. S., Ramos, J., & Batenhorst, R. L. (1993). Bioequivalence of a 17β‐Estradiol Hydroxypropyl‐β‐Cyclodextrin Complex in Postmenopausal Women. The Journal of Clinical Pharmacology, 33(11), 1116–1121. [DOI:10.1002/j.1552-4604.1993.tb01949.x]
    • Huggins, C., & Hodges, C. V. (1941). Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293–297. [DOI:10.3322/canjclin.22.4.232]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone acetate in Gender-Affirming therapy for Transwomen: results from a retrospective study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • Jalal, E., & Baldwin, C. (2023). Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1095–A1096 (abstract no. SAT391/bvad114.2062). [DOI:10.1210/jendso/bvad114.2062] [PDF]
    • Jin, J., Sklar, G. E., Oh, V. M. S., & Li, S. C. (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and Clinical Risk Management, 4(1), 269–286. [DOI:10.2147/TCRM.S1458]
    • Kariyawasam, N. M., Ahmad, T., Sarma, S., & Fung, R. (2024). Comparison of Estrone/Estradiol Ratio and Levels in Transfeminine Individuals on Different Routes of Estradiol. Transgender Health, online ahead of print. [DOI:10.1089/trgh.2023.0138]
    • Klaver, M., de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/EJE-17-0496]
    • Kohli, M. (2006). Phase II study of transdermal estradiol in androgen‐independent prostate carcinoma. Cancer, 106(1), 234–235. [DOI:10.1002/cncr.21528]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhnz, W., Blode, H., & Zimmermann, H. (1993). Pharmacokinetics of exogenous natural and synthetic estrogens and antiestrogens. In Oettel, M., & Schillinger, E. (Eds.). Estrogens and Antiestrogens II: Pharmacology and Clinical Application of Estrogens and Antiestrogen (Handbook of Experimental Pharmacology, Volume 135, Part 2) (pp. 261–322). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-60107-1_15]
    • Kuhnz, W., Gansau, C., & Mahler, M. (1993). Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17β-estradiol. Arzneimittelforschung, 43(9), 966–973. [Google Scholar] [PubMed] [PDF]
    • Langley, R. E., Gilbert, D. C., Duong, T., Clarke, N. W., Nankivell, M., Rosen, S. D., Mangar, S., Macnair, A., Sundaram, S. K., Laniado, M. E., Dixit, S., Madaan, S., Manetta, C., Pope, A., Scrase, C. D., Mckay, S., Muazzam, I. A., Collins, G. N., Worlding, J., Williams, S. T., … & Parmar, M. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. The Lancet, 397(10274), 581–591. [DOI:10.1016/S0140-6736(21)00100-8]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal treatment of transgender women with oral estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Lim, H. H., Jang, Y. H., Choi, G. Y., Lee, J. J., & Lee, E. S. (2019). Gender affirmative care of transgender people: a single center’s experience in Korea. Obstetrics & Gynecology Science, 62(1), 46–55. [DOI:10.5468/ogs.2019.62.1.46]
    • Lobo, R. A. (1987). Absorption and metabolic effects of different types of estrogens and progestogens. Obstetrics and Gynecology Clinics of North America, 14(1), 143–167. [PubMed] [DOI:10.1016/S0889-8545(21)00577-5] [URL] [PDF]
    • Mikkola, A., Aro, J., Rannikko, S., Oksanen, H., Ruutu, M., & Finnprostate Group. (2005). Cardiovascular complications in patients with advanced prostatic cancer treated by means of orchiectomy or polyestradiol phosphate. Scandinavian Journal of Urology and Nephrology, 39(4), 294–300. [DOI:10.1080/00365590510031228]
    • Mishra, S. R., Chung, H. F., Waller, M., & Mishra, G. D. (2021). Duration of estrogen exposure during reproductive years, age at menarche and age at Menopause, and risk of cardiovascular disease events, all‐cause and cardiovascular mortality: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology, 128(5), 809–821. [DOI:10.1111/1471-0528.16524]
    • Morimont, L., Dogné, J. M., & Douxfils, J. (2020). Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled “Estrogen and thrombosis: A bench to bedside review” (Thrombosis Research 192 (2020) 40–51). Thrombosis Research, 193, 221–223. [DOI:10.1016/j.thromres.2020.08.006]
    • Oliver-Williams, C., Glisic, M., Shahzad, S., Brown, E., Pellegrino Baena, C., Chadni, M., Chowdhury, R., Franco, O. H., & Muka, T. (2019). The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review. Human Reproduction Update, 25(2), 257–271. [DOI:10.1093/humupd/dmy039]
    • Pappas, I. I., Craig, W. Y., Spratt, L. V., & Spratt, D. I. (2021). Efficacy of Sex Steroid Therapy Without Progestin or GnRH Agonist for Gonadal Suppression in Adult Transgender Patients. The Journal of Clinical Endocrinology & Metabolism, 106(3), e1290–e1300. [DOI:10.1210/clinem/dgaa884]
    • Perloff, W. H. (1950). Estradiol buccal tablets in the treatment of the menopause. American Journal of Obstetrics and Gynecology, 59(1), 223–225. [DOI:10.1016/0002-9378(50)90390-5]
    • Pickar, J. H., Bon, C., Amadio, J. M., Mirkin, S., & Bernick, B. (2015). Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. Menopause, 22(12), 1308–1316. [DOI:10.1097/GME.0000000000000467]
    • Pines, A., Averbuch, M., Fisman, E. Z., & Rosano, G. M. (1999). The acute effects of sublingual 17β-estradiol on the cardiovascular system. Maturitas, 33(1), 81–85. [DOI:10.1016/S0378-5122(99)00036-5]
    • Potts, R. O., & Lobo, R. A. (2005). Transdermal drug delivery: clinical considerations for the obstetrician–gynecologist. Obstetrics & Gynecology, 105(5), 953–961. [DOI:10.1097/01.AOG.0000161958.70059.db]
    • Price, T. M., Blauer, K. L., Hansen, M., Stanczyk, F., Lobo, R., & Bates, G. W. (1997). Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17β-estradiol. Obstetrics & Gynecology, 89(3), 340–345. [DOI:10.1016/S0029-7844(96)00513-3]
    • Rosenfield, R. L., Devine, N., Hunold, J. J., Mauras, N., Moshang Jr, T., & Root, A. W. (2005). Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6424–6430. [DOI:10.1210/jc.2005-1081]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
    • Safer, J. D. (2022). Are the Pharmacokinetics of Sublingual Estradiol Superior or Inferior to Those of Oral Estradiol? Endocrine Practice, 28(3), 351–352. [DOI:10.1016/j.eprac.2021.12.018]
    • Sarvaideo, J., Doll, E., & Tangpricha, V. (2022). More Studies Are Needed to Establish the Safety and Efficacy of Sublingual Estradiol in Transgender Women. Endocrine Practice, 28(3), 353–354. [DOI:10.1016/j.eprac.2022.01.004]
    • Sciarra, A., Gentile, V., Cattarino, S., Gentilucci, A., Alfarone, A., D’Eramo, G., & Salciccia, S. (2015). Oral ethinylestradiol in castration‐resistant prostate cancer: a 10‐year experience. International Journal of Urology, 22(1), 98–103. [DOI:10.1111/iju.12613]
    • Serhal, P., & Craft, I. (1989). Oocyte donation in 61 patients. The Lancet, 333(8648), 1185–1187. [DOI:10.1016/S0140-6736(89)92762-1]
    • Serhal, P. (1990). Oocyte donation and surrogacy. British Medical Bulletin, 46(3), 796–812. [DOI:10.1093/oxfordjournals.bmb.a072432]
    • Shah, S., Forghani, N., Durham, E., & Neely, E. K. (2014). A randomized trial of transdermal and oral estrogen therapy in adolescent girls with hypogonadism. International Journal of Pediatric Endocrinology, 2014(1), 12. [DOI:10.1186/1687-9856-2014-12]
    • Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013). Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment. Contraception, 87(6), 706–727. [DOI:10.1016/j.contraception.2012.12.011]
    • Stege, R., Gunnarsson, P. O., Johansson, C. J., Olsson, P., Pousette, Å., & Carlström, K. (1996). Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients. The Prostate, 28(5), 307–310. [DOI:10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine position statement “assessment and hormonal management in adolescent and adult trans people, with attention for sexual function and satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • Thurman, A., Kimble, T., Hall, P., Schwartz, J. L., & Archer, D. F. (2013). Medroxyprogesterone acetate and estradiol cypionate injectable suspension (Cyclofem) monthly contraceptive injection: steady-state pharmacokinetics. Contraception, 87(6), 738–743. [DOI:10.1016/j.contraception.2012.11.010]
    • Toh, M. R., Teo, V., Kwan, Y. H., Raaj, S., Tan, S. Y. D., & Tan, J. Z. Y. (2014). Association between number of doses per day, number of medications and patient’s non-compliance, and frequency of readmissions in a multi-ethnic Asian population. Preventive Medicine Reports, 1, 43–47. [DOI:10.1016/j.pmedr.2014.10.001]
    • Tsai, C. C., & Yen, S. S. C. (1971). Acute effects of intravenous infusion of 17β-estradiol on gonadotropin release in pre-and post-menopausal women. The Journal of Clinical Endocrinology & Metabolism, 32(6), 766–771. [DOI:10.1210/jcem-32-6-766]
    • Verdonk, S. J., Vesper, H. W., Martens, F., Sluss, P. M., Hillebrand, J. J., & Heijboer, A. C. (2019). Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS method. Clinica Chimica Acta, 495, 198–204. [DOI:10.1016/j.cca.2019.04.062]
    • Wiegratz, I., Fink, T., Rohr, U. D., Lang, E., Leukel, P., & Kuhl, H. (2001). Überkreuz-Vergleich der Pharmakokinetik von Estradiol unter der Hormonsubstitution mit Estradiolvalerat oder mikronisiertem Estradiol. [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol.] Zentralblatt für Gynäkologie, 123(9), 505–512. [PubMed] [DOI:10.1055/s-2001-18223]
    • Wisner, K. L., Sit, D. K., Moses-Kolko, E. L., Driscoll, K. E., Prairie, B. A., Stika, C. S., Eng, H. F., Dills, J. L., Luther, J. F., & Wisniewski, S. R. (2015). Transdermal estradiol treatment for postpartum depression: a pilot randomized trial. Journal of Clinical Psychopharmacology, 35(4), 389–395. [DOI:10.1097/JCP.0000000000000351]
    • Wren, B. G., Day, R. O., McLachlan, A. J., & Williams, K. M. (2003). Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women. Climacteric, 6(2), 104–111. [DOI:10.1080/cmt.6.2.104.111]
    • Yaish, I., Gindis, G., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (2023). Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study. Transgender Health, 8(6), 485–493. [DOI:10.1089/trgh.2023.0022]
    • Yaish, I., Gindis, G., Greenman, Y., Shefer, G., Buch, A., Arbiv, M., Moshe, Y., Sofer, Y., & Tordjman, K. M. (2023). Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1104–A1105 (abstract no. SAT409/bvad114.2080). [DOI:10.1210/jendso/bvad114.2080] [PDF]
    \ No newline at end of file diff --git a/transfemscience.org/articles/sublingual-ev/index.html b/transfemscience.org/articles/sublingual-ev/index.html index 4bfa1f14..f5088ebc 100644 --- a/transfemscience.org/articles/sublingual-ev/index.html +++ b/transfemscience.org/articles/sublingual-ev/index.html @@ -1 +1 @@ -Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People - Transfeminine Science Link

    Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People

    By Aly | First published January 5, 2019 | Last modified November 28, 2022

    Abstract / TL;DR

    Oral estradiol tablets can be taken sublingually instead of orally and this allows for greater bioavailability and higher estradiol levels than with oral use. For this reason, sublingual estradiol is frequently used in transfeminine people. Oral estradiol valerate tablets also exist in some parts of the world and it’s often inquired by transfeminine people whether this form of estradiol is likewise effective sublingually. Research in this area is limited and no direct comparisons exist, but at least one study in cisgender women has shown that oral estradiol valerate tablets taken sublingually can result in high estradiol levels and gonadal suppression analogously to sublingual estradiol. In addition, at least one gender-affirming hormone therapy clinic has reported use of sublingual estradiol valerate in transfeminine people. Hence, sublingual estradiol valerate appears to be an effective means of estradiol delivery similarly to sublingual estradiol. One difference between these forms of estradiol is that estradiol valerate contains less estradiol than estradiol by weight and hence should be taken at slightly higher doses. While they can be effective, oral estradiol tablets and oral estradiol valerate tablets were not intended or designed for sublingual use, and formulations of these tablets vary. The implications of this in terms of clinical properties, if any, are unknown. However, it does seem apparent that different tablet formulations may require substantially different amounts of time to dissolve when used sublingually. As a result, some formulations of oral estradiol and oral estradiol valerate may be better-suited for sublingual use than others. Additional characteristics of these formulations like micronization and lipophilicity could also differentially influence their pharmacokinetics in ways that have not been studied. It may be advisable to choose sublingual estradiol over sublingual estradiol valerate where possible simply because sublingual estradiol is much better-characterized in comparison and there are fewer unknowns with it. However, sublingual estradiol valerate can be a clearly effective form of estradiol for transfeminine people as well if needed.

    Introduction

    Oral estradiol tablets (e.g., Estrace and Estrofem among other brand names) are indicated for oral administration (i.e., taken by mouth/swallowed) and this is how they are normally taken. As an alternative to the standard oral route however, these tablets can be taken sublingually (held under the tongue) or buccally (held in the cheek or lips/gums). Sublingual or buccal administration of oral estradiol tablets allows for much greater bioavailability and estradiol levels in comparison to oral administration (Sam, 2021; Wiki; Graphs; Wiki). Transfeminine people often use sublingual estradiol as the estrogen component of hormone therapy. In various countries, for instance many European countries, estradiol is also provided in oral form as estradiol valerate (EV) tablets (e.g., Progynova among other brand names). It is frequently inquired by transfeminine people whether estradiol valerate tablets can be taken sublingually similarly to estradiol tablets and whether there are any differences between these two estradiol forms for this route. This article is intended to explore and shed some light on these questions.

    Effectiveness of Sublingual Estradiol Valerate

    Estradiol valerate is an estradiol ester and a prodrug of estradiol. Estradiol esters themselves are pharmacologically inactive prior to conversion into estradiol. Estradiol valerate and other related estradiol esters are cleaved into estradiol by various esterase enzymes. These esterases are widely expressed throughout the body, and the metabolism of estradiol esters into estradiol occurs not only in the liver but has also been shown to take place rapidly in blood and other tissues (Wiki). Hence, estradiol esters like estradiol valerate do not require the first pass through the liver that occurs with oral administration to become pharmacologically active as estrogens. As such, transformation of estradiol valerate into estradiol should not be an impediment in terms of non-oral administration of estradiol valerate, for instance via sublingual administration (as well as in the form of depot injectables of course).

    Studies of estradiol tablets administered sublingually instead of orally are limited, and studies on estradiol valerate tablets used sublingually are extremely scarce. No direct comparisons have been made between sublingual use of estradiol tablets versus sublingual use of estradiol valerate tablets. Hence, we currently don’t have reliable data on how sublingual estradiol valerate compares to sublingual estradiol in terms of pharmacokinetics (e.g., bioavailability, estradiol levels, concentration–time curve, etc.).

    Only one study seems to have researched and characterized sublingual administration of oral estradiol valerate tablets. This study assessed the use of oral estradiol valerate tablets (brand name Progynova [Schering]) administered sublingually 3 to 4 times per day in a group of premenopausal cisgender women. The researchers reported the findings of their study in the following two publications:

    The results in terms of hormone levels with sublingual estradiol valerate were as follows (top plot is a control menstrual cycle in untreated women, bottom plot is a cycle with sublingual estradiol valerate):

    Figure 1: Levels of estradiol (E2), progesterone (P4), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) with 2 mg oral micronized estradiol valerate tablets (Progynova) administered sublingually (SL) 3 or 4 times per day in a group of premenopausal women (bottom). The normal menstrual cycle in a control group of premenopausal women is also shown (top). The time of blood collection following administration was not specified.

    As can be seen in the figure, estradiol levels with sublingual estradiol valerate were much higher than in normally cycling control women. In addition, levels of other hormones were suppressed, which is in accordance with the high estradiol levels exhibiting negative feedback on the hypothalamic–pituitary–gonadal axis and suppressing hormone production. These findings indicate that sublingual estradiol valerate is well-absorbed and is able to achieve high estradiol levels analogously to sublingual estradiol. In other words, although we still don’t have direct comparisons between the two, sublingual estradiol valerate appears to be a highly effective means of estradiol delivery similarly to sublingual estradiol.

    It’s notable that at least one gender-affirming hormone therapy clinic, located in South Korea, uses sublingual estradiol valerate in transfeminine people. These clinicians have briefly described their experience with sublingual estradiol valerate and their rationale for using it over oral estradiol in a recent publication (Lim et al., 2019). While they don’t provide actual pharmacokinetic data on sublingual estradiol valerate (e.g., estradiol levels), it seems apparent based on their clinical experience that sublingual use is a therapeutically effective route of administration for this form of estradiol.

    Formulation of Estradiol and Estradiol Valerate Tablets and Implications for Sublingual Use

    Micronization of Oral Estradiol Valerate Tablets

    Micronization is a manufacturing process in which solid particles of a substance are reduced to smaller sizes. Micronization can modify the pharmacokinetics of medications by altering their rate and extent of absorption. Oral estradiol tablets were originally non-micronized and had lower estrogenic potency than those used today, but in the 1970s micronized oral estradiol tablets were introduced and replaced the previous formulations (Wiki; Wiki). It appears that micronization of estradiol crystals to a defined particle size range improves the absorption and bioavailability of oral estradiol tablets by several-fold (Wiki). All modern oral estradiol tablets available today are assumed to be micronized.

    Questions arise as to what influence micronization has on sublingual administration (rather than oral administration) of hormonal agents like estradiol and estradiol valerate and whether oral estradiol valerate tablets are micronized similarly to oral estradiol tablets. The influence of micronization on the sublingual absorption and pharmacokinetic characteristics of estradiol and its esters, as well as other hormonal agents like progesterone and testosterone, does not seem to have been studied and hence is unknown. It could be assumed that micronization might improve the rate and extent of absorption with sublingual administration similarly to oral administration and hence may be important however, as touched on by the following literature excerpt (Sayeed & Ashraf, 2014):

    The drugs that are administered sublingually generally have low solubility. Therefore, to enhance dissolution, it is crucial to reduce and control the particle size of the [active pharmaceutical ingredient]. This attribute is important in the case of all drugs with low solubility. However, a tighter control on particle size of [active pharmaceutical ingredient] is desirable in sublingual drug products to maintain the reproducible quality and performance of the drug product in view of the limited window of dissolution and absorption time.

    As to whether oral estradiol valerate tablets are micronized, some formulations of oral estradiol valerate clearly indicate that they are micronized in their packaging or manufacturer information (Photo), whereas other formulations of oral estradiol valerate do not. The oral estradiol valerate tablets used in the study by Serhal and Craft (Progynova [Schering]) as well as certain other publications (e.g., Devroey & Pados, 1998) have been explicitly noted to be micronized. Considering the similar doses and apparently comparable clinical properties of all oral estradiol valerate tablets used today, it may be the case that all oral estradiol valerate formulations are micronized but that this simply isn’t always explicitly stated. Indeed, the original form of oral estradiol valerate introduced in the late 1960s is said to have been micronized (Wiki). An alternative but perhaps less likely possibility is that micronization might not influence the properties of oral estradiol valerate similarly to how it does with oral estradiol.

    The University of California, San Francisco (UCSF) transgender care guidelines state that only micronized oral estradiol tablets can be used sublingually and imply that not all oral estradiol tablets are micronized (Deutsch, 2016). These statements may be assumed to also apply to oral estradiol valerate tablets. However, as discussed in this article, support for these notions is lacking at present.

    Physicochemical Properties of Estradiol versus Estradiol Valerate

    Estradiol valerate is more lipophilic (fat-soluble) than estradiol due to its fatty acid ester moiety (i.e., valeric acid). Lipophilicity is known to modify the sublingual and buccal absorption of medications (Smart, 2005; Batheja, Thakur, & Michniak, 2006). How the differing lipophilicities of estradiol versus estradiol valerate may influence their pharmacokinetics when used sublingually has not been studied. Hence, the therapeutic implications of this physicochemical difference for this route are unknown. It’s also known however that esterases are present in the oral mucosa and saliva and can cleave carboxylic acid esters like estradiol valerate into their unesterified forms (Yamahara & Lee, 1993; Rathbone, Drummond, & Tucker, 1994). This might serve to reduce the importance of the physicochemical differences between estradiol valerate and estradiol in terms of sublingual and buccal administration.

    Another difference between estradiol and estradiol valerate is that estradiol valerate has a higher molecular weight than estradiol due to its ester component and hence estradiol valerate contains less estradiol than estradiol for the same dose of substance. The molecular weight of estradiol valerate is about 131% of that of estradiol and hence estradiol valerate contains 76% of the estradiol as an equal amount of estradiol (Table). This difference has been shown to translate to pharmacokinetic studies of oral estradiol versus oral estradiol valerate, with estradiol levels being around 25% lower with oral estradiol valerate compared to oral estradiol at equal doses (Wiki). This is likely also the case for other routes of administration of these forms of estradiol, including sublingual administration. Hence, slightly higher doses (e.g., 2 mg versus 1.5 mg) are likely needed and should be used for estradiol valerate relative to estradiol for equivalent estradiol levels and therapeutic estrogenic effect (Sam, 2021).

    Formulation and Dissolution of Oral Estradiol Valerate Tablets

    Oral estradiol and estradiol valerate tablets were intended and designed for oral administration and not specifically for sublingual administration. Although many of these tablets do clearly work quite well when used sublingually, different tablet formulations vary in their coating and their compositions and excipients. It is possible that differences between formulations of these tablets may influence their properties when used sublingually, as touched on in the following literature excerpt (Sayeed & Ashraf, 2014):

    The conditions prevailing in the oral cavity for disintegration and dissolution of sublingual tablets are markedly different from the tablets that are orally ingested. […] Other specialized [oral] tablets, such as modified-release or enteric-coated tablets, may also partly release the drug in the stomach. In contrast, sublingual tablets are designed to completely disintegrate and dissolve in the oral cavity under the tongue.

    One particular issue is that different oral tablets of estradiol and estradiol valerate may dissolve at very different rates. One study of oral estradiol tablets used sublingually reported that they dissolved within 1 or 2 minutes (Burnier, 1981). Anecdotally this has been the case similarly with one brand of generic sugar-coated oral estradiol tablets in the United States (Photo), which dissolve and disappear sublingually within a few minutes at most. Some transfeminine people on social media sites like Reddit however have reported their tablets taking much longer to dissolve, for instance about an hour, when used sublingually or buccally. In any case, dissolution rates of oral estradiol and estradiol valerate tablets may vary depending on the formulation, and some forms of oral estradiol and oral estradiol valerate may be better-suited for sublingual use than others. If tablets take a long time to dissolve when used sublingually, switching to another brand may be considered.

    Estradiol or Estradiol Valerate for Sublingual Use?

    Sublingual administration of oral estradiol tablets has been much better researched and characterized than sublingual administration of oral estradiol valerate tablets. Because of this, it may be advisable to select oral estradiol tablets with the intention of sublingual use over oral estradiol valerate tablets simply because there are fewer unknowns with them. However, oral estradiol tablets may not always be available in a given market, a person may be prescribed oral estradiol valerate tablets instead of oral estradiol tablets, or other considerations may make oral estradiol tablets a less feasible option. In this regard, it is clear based on available literature that sublingual estradiol valerate can be a highly effective means of delivering estradiol similarly to sublingual estradiol and can be used instead if needed.

    References

    • Batheja, P., Thakur, R., & Michniak, B. (2006). Basic Biopharmaceutics of Buccal and Sublingual Absorption. In Touitou, E., & Barry, B. W. (Eds.). Enhancement in Drug Delivery (pp. 175–202). Boca Raton/London/New York: CRC Press. [Google Scholar] [Google Books] [DOI:10.1201/9781420004816-17] [PDF]
    • Burnier, A. M., Martin, P. L., Yen, S. S., & Brooks, P. (1981). Sublingual absorption of micronized 17β-estradiol. American Journal of Obstetrics and Gynecology, 140(2), 146–150. [DOI:10.1016/0002-9378(81)90101-0]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [Google Scholar] [URL] [PDF]
    • Devroey, P., & Pados, G. (1998). Preparation of endometrium for egg donation. Human Reproduction Update, 4(6), 856–861. [DOI:10.1093/humupd/4.6.856]
    • Lim, H. H., Jang, Y. H., Choi, G. Y., Lee, J. J., & Lee, E. S. (2019). Gender affirmative care of transgender people: a single center’s experience in Korea. Obstetrics & Gynecology Science, 62(1), 46–55. [DOI:10.5468/ogs.2019.62.1.46]
    • Rathbone, M. J., Drummond, B. K., & Tucker, I. G. (1994). The oral cavity as a site for systemic drug delivery. Advanced Drug Delivery Reviews, 13(1–2), 1–22. [DOI:10.1016/0169-409X(94)90024-8]
    • Sayeed, V. A., & Ashraf, M. (2014). Considerations in Developing Sublingual Tablets—An Overview. Pharmaceutical Technology, 38(11), 34–72. [Google Scholar] [URL] [PDF]
    • Serhal, P., & Craft, I. (1989). Oocyte donation in 61 patients. The Lancet, 333(8648), 1185–1187. [DOI:10.1016/S0140-6736(89)92762-1]
    • Serhal, P. (1990). Oocyte donation and surrogacy. British Medical Bulletin, 46(3), 796–812. [DOI:10.1093/oxfordjournals.bmb.a072432]
    • Smart, J. D. (2005). Buccal drug delivery. Expert Opinion on Drug Delivery, 2(3), 507–517. [DOI:10.1517/17425247.2.3.507]
    • Yamahara, H., & Lee, V. H. (1993). Drug metabolism in the oral cavity. Advanced Drug Delivery Reviews, 12(1–2), 25–39. [DOI:10.1016/0169-409X(93)90039-7]
    \ No newline at end of file +Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People - Transfeminine Science Link

    Sublingual Administration of Oral Estradiol Valerate Tablets for Transfeminine People

    By Aly | First published January 5, 2019 | Last modified November 28, 2022

    Abstract / TL;DR

    Oral estradiol tablets can be taken sublingually instead of orally and this allows for greater bioavailability and higher estradiol levels than with oral use. For this reason, sublingual estradiol is frequently used in transfeminine people. Oral estradiol valerate tablets also exist in some parts of the world and it’s often inquired by transfeminine people whether this form of estradiol is likewise effective sublingually. Research in this area is limited and no direct comparisons exist, but at least one study in cisgender women has shown that oral estradiol valerate tablets taken sublingually can result in high estradiol levels and gonadal suppression analogously to sublingual estradiol. In addition, at least one gender-affirming hormone therapy clinic has reported use of sublingual estradiol valerate in transfeminine people. Hence, sublingual estradiol valerate appears to be an effective means of estradiol delivery similarly to sublingual estradiol. One difference between these forms of estradiol is that estradiol valerate contains less estradiol than estradiol by weight and hence should be taken at slightly higher doses. While they can be effective, oral estradiol tablets and oral estradiol valerate tablets were not intended or designed for sublingual use, and formulations of these tablets vary. The implications of this in terms of clinical properties, if any, are unknown. However, it does seem apparent that different tablet formulations may require substantially different amounts of time to dissolve when used sublingually. As a result, some formulations of oral estradiol and oral estradiol valerate may be better-suited for sublingual use than others. Additional characteristics of these formulations like micronization and lipophilicity could also differentially influence their pharmacokinetics in ways that have not been studied. It may be advisable to choose sublingual estradiol over sublingual estradiol valerate where possible simply because sublingual estradiol is much better-characterized in comparison and there are fewer unknowns with it. However, sublingual estradiol valerate can be a clearly effective form of estradiol for transfeminine people as well if needed.

    Introduction

    Oral estradiol tablets (e.g., Estrace and Estrofem among other brand names) are indicated for oral administration (i.e., taken by mouth/swallowed) and this is how they are normally taken. As an alternative to the standard oral route however, these tablets can be taken sublingually (held under the tongue) or buccally (held in the cheek or lips/gums). Sublingual or buccal administration of oral estradiol tablets allows for much greater bioavailability and estradiol levels in comparison to oral administration (Sam, 2021; Wiki; Graphs; Wiki). Transfeminine people often use sublingual estradiol as the estrogen component of hormone therapy. In various countries, for instance many European countries, estradiol is also provided in oral form as estradiol valerate (EV) tablets (e.g., Progynova among other brand names). It is frequently inquired by transfeminine people whether estradiol valerate tablets can be taken sublingually similarly to estradiol tablets and whether there are any differences between these two estradiol forms for this route. This article is intended to explore and shed some light on these questions.

    Effectiveness of Sublingual Estradiol Valerate

    Estradiol valerate is an estradiol ester and a prodrug of estradiol. Estradiol esters themselves are pharmacologically inactive prior to conversion into estradiol. Estradiol valerate and other related estradiol esters are cleaved into estradiol by various esterase enzymes. These esterases are widely expressed throughout the body, and the metabolism of estradiol esters into estradiol occurs not only in the liver but has also been shown to take place rapidly in blood and other tissues (Wiki). Hence, estradiol esters like estradiol valerate do not require the first pass through the liver that occurs with oral administration to become pharmacologically active as estrogens. As such, transformation of estradiol valerate into estradiol should not be an impediment in terms of non-oral administration of estradiol valerate, for instance via sublingual administration (as well as in the form of depot injectables of course).

    Studies of estradiol tablets administered sublingually instead of orally are limited, and studies on estradiol valerate tablets used sublingually are extremely scarce. No direct comparisons have been made between sublingual use of estradiol tablets versus sublingual use of estradiol valerate tablets. Hence, we currently don’t have reliable data on how sublingual estradiol valerate compares to sublingual estradiol in terms of pharmacokinetics (e.g., bioavailability, estradiol levels, concentration–time curve, etc.).

    Only one study seems to have researched and characterized sublingual administration of oral estradiol valerate tablets. This study assessed the use of oral estradiol valerate tablets (brand name Progynova [Schering]) administered sublingually 3 to 4 times per day in a group of premenopausal cisgender women. The researchers reported the findings of their study in the following two publications:

    The results in terms of hormone levels with sublingual estradiol valerate were as follows (top plot is a control menstrual cycle in untreated women, bottom plot is a cycle with sublingual estradiol valerate):

    Figure 1: Levels of estradiol (E2), progesterone (P4), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) with 2 mg oral micronized estradiol valerate tablets (Progynova) administered sublingually (SL) 3 or 4 times per day in a group of premenopausal women (bottom). The normal menstrual cycle in a control group of premenopausal women is also shown (top). The time of blood collection following administration was not specified.

    As can be seen in the figure, estradiol levels with sublingual estradiol valerate were much higher than in normally cycling control women. In addition, levels of other hormones were suppressed, which is in accordance with the high estradiol levels exhibiting negative feedback on the hypothalamic–pituitary–gonadal axis and suppressing hormone production. These findings indicate that sublingual estradiol valerate is well-absorbed and is able to achieve high estradiol levels analogously to sublingual estradiol. In other words, although we still don’t have direct comparisons between the two, sublingual estradiol valerate appears to be a highly effective means of estradiol delivery similarly to sublingual estradiol.

    It’s notable that at least one gender-affirming hormone therapy clinic, located in South Korea, uses sublingual estradiol valerate in transfeminine people. These clinicians have briefly described their experience with sublingual estradiol valerate and their rationale for using it over oral estradiol in a recent publication (Lim et al., 2019). While they don’t provide actual pharmacokinetic data on sublingual estradiol valerate (e.g., estradiol levels), it seems apparent based on their clinical experience that sublingual use is a therapeutically effective route of administration for this form of estradiol.

    Formulation of Estradiol and Estradiol Valerate Tablets and Implications for Sublingual Use

    Micronization of Oral Estradiol Valerate Tablets

    Micronization is a manufacturing process in which solid particles of a substance are reduced to smaller sizes. Micronization can modify the pharmacokinetics of medications by altering their rate and extent of absorption. Oral estradiol tablets were originally non-micronized and had lower estrogenic potency than those used today, but in the 1970s micronized oral estradiol tablets were introduced and replaced the previous formulations (Wiki; Wiki). It appears that micronization of estradiol crystals to a defined particle size range improves the absorption and bioavailability of oral estradiol tablets by several-fold (Wiki). All modern oral estradiol tablets available today are assumed to be micronized.

    Questions arise as to what influence micronization has on sublingual administration (rather than oral administration) of hormonal agents like estradiol and estradiol valerate and whether oral estradiol valerate tablets are micronized similarly to oral estradiol tablets. The influence of micronization on the sublingual absorption and pharmacokinetic characteristics of estradiol and its esters, as well as other hormonal agents like progesterone and testosterone, does not seem to have been studied and hence is unknown. It could be assumed that micronization might improve the rate and extent of absorption with sublingual administration similarly to oral administration and hence may be important however, as touched on by the following literature excerpt (Sayeed & Ashraf, 2014):

    The drugs that are administered sublingually generally have low solubility. Therefore, to enhance dissolution, it is crucial to reduce and control the particle size of the [active pharmaceutical ingredient]. This attribute is important in the case of all drugs with low solubility. However, a tighter control on particle size of [active pharmaceutical ingredient] is desirable in sublingual drug products to maintain the reproducible quality and performance of the drug product in view of the limited window of dissolution and absorption time.

    As to whether oral estradiol valerate tablets are micronized, some formulations of oral estradiol valerate clearly indicate that they are micronized in their packaging or manufacturer information (Photo), whereas other formulations of oral estradiol valerate do not. The oral estradiol valerate tablets used in the study by Serhal and Craft (Progynova [Schering]) as well as certain other publications (e.g., Devroey & Pados, 1998) have been explicitly noted to be micronized. Considering the similar doses and apparently comparable clinical properties of all oral estradiol valerate tablets used today, it may be the case that all oral estradiol valerate formulations are micronized but that this simply isn’t always explicitly stated. Indeed, the original form of oral estradiol valerate introduced in the late 1960s is said to have been micronized (Wiki). An alternative but perhaps less likely possibility is that micronization might not influence the properties of oral estradiol valerate similarly to how it does with oral estradiol.

    The University of California, San Francisco (UCSF) transgender care guidelines state that only micronized oral estradiol tablets can be used sublingually and imply that not all oral estradiol tablets are micronized (Deutsch, 2016). These statements may be assumed to also apply to oral estradiol valerate tablets. However, as discussed in this article, support for these notions is lacking at present.

    Physicochemical Properties of Estradiol versus Estradiol Valerate

    Estradiol valerate is more lipophilic (fat-soluble) than estradiol due to its fatty acid ester moiety (i.e., valeric acid). Lipophilicity is known to modify the sublingual and buccal absorption of medications (Smart, 2005; Batheja, Thakur, & Michniak, 2006). How the differing lipophilicities of estradiol versus estradiol valerate may influence their pharmacokinetics when used sublingually has not been studied. Hence, the therapeutic implications of this physicochemical difference for this route are unknown. It’s also known however that esterases are present in the oral mucosa and saliva and can cleave carboxylic acid esters like estradiol valerate into their unesterified forms (Yamahara & Lee, 1993; Rathbone, Drummond, & Tucker, 1994). This might serve to reduce the importance of the physicochemical differences between estradiol valerate and estradiol in terms of sublingual and buccal administration.

    Another difference between estradiol and estradiol valerate is that estradiol valerate has a higher molecular weight than estradiol due to its ester component and hence estradiol valerate contains less estradiol than estradiol for the same dose of substance. The molecular weight of estradiol valerate is about 131% of that of estradiol and hence estradiol valerate contains 76% of the estradiol as an equal amount of estradiol (Table). This difference has been shown to translate to pharmacokinetic studies of oral estradiol versus oral estradiol valerate, with estradiol levels being around 25% lower with oral estradiol valerate compared to oral estradiol at equal doses (Wiki). This is likely also the case for other routes of administration of these forms of estradiol, including sublingual administration. Hence, slightly higher doses (e.g., 2 mg versus 1.5 mg) are likely needed and should be used for estradiol valerate relative to estradiol for equivalent estradiol levels and therapeutic estrogenic effect (Sam, 2021).

    Formulation and Dissolution of Oral Estradiol Valerate Tablets

    Oral estradiol and estradiol valerate tablets were intended and designed for oral administration and not specifically for sublingual administration. Although many of these tablets do clearly work quite well when used sublingually, different tablet formulations vary in their coating and their compositions and excipients. It is possible that differences between formulations of these tablets may influence their properties when used sublingually, as touched on in the following literature excerpt (Sayeed & Ashraf, 2014):

    The conditions prevailing in the oral cavity for disintegration and dissolution of sublingual tablets are markedly different from the tablets that are orally ingested. […] Other specialized [oral] tablets, such as modified-release or enteric-coated tablets, may also partly release the drug in the stomach. In contrast, sublingual tablets are designed to completely disintegrate and dissolve in the oral cavity under the tongue.

    One particular issue is that different oral tablets of estradiol and estradiol valerate may dissolve at very different rates. One study of oral estradiol tablets used sublingually reported that they dissolved within 1 or 2 minutes (Burnier, 1981). Anecdotally this has been the case similarly with one brand of generic sugar-coated oral estradiol tablets in the United States (Photo), which dissolve and disappear sublingually within a few minutes at most. Some transfeminine people on social media sites like Reddit however have reported their tablets taking much longer to dissolve, for instance about an hour, when used sublingually or buccally. In any case, dissolution rates of oral estradiol and estradiol valerate tablets may vary depending on the formulation, and some forms of oral estradiol and oral estradiol valerate may be better-suited for sublingual use than others. If tablets take a long time to dissolve when used sublingually, switching to another brand may be considered.

    Estradiol or Estradiol Valerate for Sublingual Use?

    Sublingual administration of oral estradiol tablets has been much better researched and characterized than sublingual administration of oral estradiol valerate tablets. Because of this, it may be advisable to select oral estradiol tablets with the intention of sublingual use over oral estradiol valerate tablets simply because there are fewer unknowns with them. However, oral estradiol tablets may not always be available in a given market, a person may be prescribed oral estradiol valerate tablets instead of oral estradiol tablets, or other considerations may make oral estradiol tablets a less feasible option. In this regard, it is clear based on available literature that sublingual estradiol valerate can be a highly effective means of delivering estradiol similarly to sublingual estradiol and can be used instead if needed.

    References

    • Batheja, P., Thakur, R., & Michniak, B. (2006). Basic Biopharmaceutics of Buccal and Sublingual Absorption. In Touitou, E., & Barry, B. W. (Eds.). Enhancement in Drug Delivery (pp. 175–202). Boca Raton/London/New York: CRC Press. [Google Scholar] [Google Books] [DOI:10.1201/9781420004816-17] [PDF]
    • Burnier, A. M., Martin, P. L., Yen, S. S., & Brooks, P. (1981). Sublingual absorption of micronized 17β-estradiol. American Journal of Obstetrics and Gynecology, 140(2), 146–150. [DOI:10.1016/0002-9378(81)90101-0]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [Google Scholar] [URL] [PDF]
    • Devroey, P., & Pados, G. (1998). Preparation of endometrium for egg donation. Human Reproduction Update, 4(6), 856–861. [DOI:10.1093/humupd/4.6.856]
    • Lim, H. H., Jang, Y. H., Choi, G. Y., Lee, J. J., & Lee, E. S. (2019). Gender affirmative care of transgender people: a single center’s experience in Korea. Obstetrics & Gynecology Science, 62(1), 46–55. [DOI:10.5468/ogs.2019.62.1.46]
    • Rathbone, M. J., Drummond, B. K., & Tucker, I. G. (1994). The oral cavity as a site for systemic drug delivery. Advanced Drug Delivery Reviews, 13(1–2), 1–22. [DOI:10.1016/0169-409X(94)90024-8]
    • Sayeed, V. A., & Ashraf, M. (2014). Considerations in Developing Sublingual Tablets—An Overview. Pharmaceutical Technology, 38(11), 34–72. [Google Scholar] [URL] [PDF]
    • Serhal, P., & Craft, I. (1989). Oocyte donation in 61 patients. The Lancet, 333(8648), 1185–1187. [DOI:10.1016/S0140-6736(89)92762-1]
    • Serhal, P. (1990). Oocyte donation and surrogacy. British Medical Bulletin, 46(3), 796–812. [DOI:10.1093/oxfordjournals.bmb.a072432]
    • Smart, J. D. (2005). Buccal drug delivery. Expert Opinion on Drug Delivery, 2(3), 507–517. [DOI:10.1517/17425247.2.3.507]
    • Yamahara, H., & Lee, V. H. (1993). Drug metabolism in the oral cavity. Advanced Drug Delivery Reviews, 12(1–2), 25–39. [DOI:10.1016/0169-409X(93)90039-7]
    \ No newline at end of file diff --git a/transfemscience.org/articles/transfem-hormone-guidelines/index.html b/transfemscience.org/articles/transfem-hormone-guidelines/index.html index 35abb8d4..a024faeb 100644 --- a/transfemscience.org/articles/transfem-hormone-guidelines/index.html +++ b/transfemscience.org/articles/transfem-hormone-guidelines/index.html @@ -1 +1 @@ -Clinical Guidelines with Information on Transfeminine Hormone Therapy - Transfeminine Science Link

    Clinical Guidelines with Information on Transfeminine Hormone Therapy

    By Aly | First published November 20, 2020 | Last modified March 21, 2024

    Abstract / TL;DR

    This article is a collection of clinical practice guidelines throughout the world with information on transfeminine hormone therapy. Examples of these clinical guidelines include the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People, the Endocrine Society guidelines, and the University of California, San Francisco (UCSF) Center of Excellence for Transgender Health guidelines, among many others.

    Introduction

    Clinicians use clinical practice guidelines (CPGs) to learn about and guide themselves in administering medical care for different indications. Clinical practice guidelines review and summarize the available scientific literature and research in a given medical area. They allow clinicians to competently administer care without necessarily having to delve into and develop their understanding via the primary scientific literature. Literature reviews can serve a similar function. However, clinical practice guidelines are generally more substantial and are more founded in evidence-based medicine. They are also regularly updated. Clinical practice guidelines are developed and maintained by clinical organizations and societies, universities, government agencies, and sometimes even large medical clinics. They may be international/locationless or oftentimes region-specific.

    There are many clinical practice guidelines for transgender medicine (for review, Deutsch, Radix, & Reisner, 2016; Radix, 2019; Radix, 2019; UpToDate; Bewley et al., 2021; Dahlen et al., 2021; Ziegler, Carroll, & Charnish, 2021). These guidelines discuss topics such as psychotherapy, hormone therapy, voice therapy, and surgical management of transgender people, among others. In addition to educating and guiding clinicians, transgender clinical practice guidelines are useful materials for transgender people as they can help to inform them about their care.

    This page is a maintained list of known English clinical guidelines throughout the world that include information specifically on the subject of transfeminine hormone therapy. The most major guidelines on transgender hormone therapy are the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People (SOC) (Coleman et al., 2022), the Endocrine Society guidelines (Hembree et al., 2017), and the University of California, San Francisco (UCSF) guidelines (Deutsch, 2016). The WPATH SOC and the Endocrine Society guidelines are international, while the UCSF guidelines are based in the United States.

    International

    TitleAuthor / OrganizationYearForm
    Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline [PDF] [See also: 1st/2009 edition]Hembree et al. / Endocrine Society2017Published article
    Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 (Alt; PDF) [See also: Version 7/2012 edition ([PDF])]Coleman et al. / World Professional Association for Transgender Health (WPATH)2022Published article
    Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of CareFeldman & Safer2009Published article
    International Medical Advisory Panel (IMAP) Statement on Hormone Therapy for Transgender People [PDF]International Planned Parenthood Federation (IPPF)2015Online document
    Transgender Women: Evaluation and Management [PDF]Tangpricha & Safer / UpToDate2020Online web page

    United States

    TitleAuthor / Organization [Place]YearForm
    Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People [PDF] [See also: 1st/2011 edition [PDF]]Deutsch / Center of Excellence for Transgender Health, University of California, San Francisco (UCSF) [San Francisco, California]2016Online document
    Medical Care of Trans and Gender Diverse Adults [PDF]Thompson, et al. / Fenway Health [Boston, Massachusetts]2021Online document
    Protocols for the Provision of Hormone Therapy [PDF]Callen-Lorde Community Health Center [New York City, New York]2018Online document
    Protocols for Hormonal Reassignment of GenderDavidson et al. / Tom Waddell Health Center / San Francisco Department of Public Health [San Francisco, California]2013Online document
    TransLine Gender Affirming Hormone Therapy Prescriber Guidelines [PDF]Gorton et al. / TransLine / Lyon-Martin Health Services [San Francisco, California]2019Online document

    Canada

    TitleAuthor / OrganizationYearForm
    Gender-Affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care ToolkitTrans Care BC [Vancouver, British Columbia, Canada]2021Online document
    Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines: Physical Aspects of Transgender Endocrine TherapyDahl et al. / Vancouver Coastal Health [Vancouver, British Columbia, Canada]2015Online document
    Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients [PDF]Bourns / Sherbourne Health / Rainbow Health Ontario [Toronto, Ontario, Canada]2019Online document

    Europe

    TitleAuthor / OrganizationYearForm
    European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”T’Sjoen et al. / European Society for Sexual Medicine2020Published article

    United Kingdom

    TitleAuthor / OrganizationYearForm
    Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria [PDF]Wylie et al. / Royal College of Psychiatrists2014Published article
    Various [PDF] [PDF] [PDF] [PDF] [PDF] [PDF]Various / National Health Service (NHS) TrustsVariousOnline documents

    Italy

    TitleAuthor / OrganizationYearForm
    SIGIS–SIAMS–SIE Position Statement of Gender Affirming Hormonal Treatment in Transgender and Non‑Binary PeopleFisher et al. / Italian Society of Gender, Identity and Health (SIGIS) / Italian Society of Andrology and Sexual Medicine (SIAMS) / Italian Society of Endocrinology (SIE)2021Published article
    SIAMS-ONIG Consensus on Hormonal Treatment in Gender Identity DisordersGodano et al. / Società Italiana di Andrologia e Medicina della Sessualità (SIAMS) [Italian Society of Andrology and Sexual Medicine] / Osservatorio Nazionale sull’Identità di Genere (ONIG) [National Observatory of Gender Identity]2009Published article

    Australia

    TitleAuthor / OrganizationYearForm
    Position Statement on the Hormonal Management of Adult Transgender and Gender Diverse IndividualsCheung et al.2019Published article
    Australian Standards of Care and Treatment Guidelines: For Trans and Gender Diverse Children and Adolescents [PDF]Telfer et al. / Royal Children’s Hospital2020Online document
    Hormone Therapy Prescribing Guide for General Practitioners working with Trans, Gender Diverse and Non-Binary Patients [PDF]Cundill et al. / Equinox Gender Diverse Health Centre / Thorne Harbour Health2020Online document
    Australian Informed Consent Standards of Care for Gender Affirming Hormone Therapy [PDF]AusPATH2022Online document

    New Zealand

    TitleAuthor / OrganizationYearForm
    Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa, New Zealand [PDF]Oliphant et al. / Transgender Health Research Lab, University of Waikato2018Published article

    South Africa

    TitleAuthor / OrganizationYearForm
    Southern African HIV Clinicians’ Society Gender-Affirming Healthcare Guideline for South Africa [PDF]Tomson et al. / Southern African HIV Clinicians Society (SAHCS)2021Published article

    Elsewhere

    TitleAuthor / Organization [Place]YearForm
    Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities in Asia and the Pacific [PDF]Health Policy Project / Asia Pacific Transgender Network / United Nations Development Programme [Asia and the Pacific]2015Online document
    Blueprint for the Provision of Comprehensive Care for Trans Persons and their Communities in the Caribbean and Other Anglophone Countries [PDF]John Snow, Inc. / Pan American Health Organization / World Health Organization [Latin America and the Caribbean]2014Online document
    A Good Practice Guide to Gender-Affirmative CareSappho for Equality [India]2019Online document
    IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Reaffirmation as FemaleMajumder et al. / Integrated Diabetes and Endocrine Academy (IDEA) [India]2020Published article
    The Thai Handbook of Transgender Healthcare Services [PDF]Vacharathit et al. / Center of Excellence in Transgender Health / Chulalongkorn University [Thailand]2021Online document

    References

    • AusPATH. (2022). Australian Informed Consent Standards of Care for Gender Affirming Hormone Therapy. Australia: Australian Professional Association for Trans Health. [URL] [PDF]
    • Belzer, M. E., Burnett, J., Deutsch, M., Franicevich, J., Gorton, R. N., Hastings, J., Karasic, D., Kohler, L., Vanderleest, J., Van Maasdam, J., Olson, J., Green, J., & DeVries, C. (April 2011). Primary Care Protocol for Transgender Patient Care, 1st Edition. Center of Excellence for Transgender Health, University of California, San Francisco, Department of Family and Community Medicine. [URL] [PDF]
    • Bewley, S., Dahlen, S., Connolly, D., Arif, I., Junejo, M., & Catherine, M. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review & Quality Assessment. How Does the Endocrine Society Fare? Journal of the Endocrine Society, 5(Suppl 1), A791–A791. [DOI:10.1210/jendso/bvab048.1609]
    • Bourns, A. (2019). Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition. Toronto: Rainbow Health Ontario/Sherbourne Health. [URL] [PDF]
    • Callen-Lorde Community Health Center. (2018). Protocols for the Provision of Hormone Therapy. New York City: Callen-Lorde Community Health Center. [URL] [PDF]
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position Statement on the Hormonal Management of Adult Transgender and Gender Diverse Individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., … & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism, 13(4), 165–232. [DOI:10.1080/15532739.2011.700873] [URL] [PDF]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Cundill, P., Wong, P., Cheung, A., & Brownhill, A. (2020). Hormone Therapy Prescribing Guide for General Practitioners working with Trans, Gender Diverse and Non-Binary Patients [Version 3.0]. Australia: Equinox Gender Diverse Health Centre/Thorne Harbour Health. [URL] [PDF]
    • Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2015). Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy. Vancouver: Vancouver Coastal Health. [Google Scholar] [PDF]
    • Dahlen, S., Connolly, D., Arif, I., Junejo, M. H., Bewley, S., & Meads, C. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review and Quality Assessment. BMJ Open, 11(4), e048943. [DOI:10.1136/bmjopen-2021-048943]
    • Davidson, A., Franicevich, J., Freeman, M., Lin, R., Martinez, L., Monihan, M., Porch, M., Samuel, L., Stukalin, R., Vormohr, J., & Zevin, B. (2013). Protocols for Hormonal Reassignment of Gender. San Francisco: San Francisco Department of Public Health/Tom Waddell Health Center. [Google Scholar] [PDF]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Deutsch, M. B., Radix, A., & Reisner, S. (2016). What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care. AMA Journal of Ethics, 18(11), 1098–1106. [DOI:10.1001/journalofethics.2016.18.11.stas1-1611]
    • Feldman, J., & Safer, J. (2009). Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care. International Journal of Transgenderism, 11(3), 146–182. [DOI:10.1080/15532730903383757]
    • Fisher, A. D., Senofonte, G., Cocchetti, C., Guercio, G., Lingiardi, V., Meriggiola, M. C., Mosconi, M., Motta, G., Ristori, J., Speranza, A. M., Pierdominici, M., Maggi, M., Corona, G., & Lombardo, F. (2021). SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. Journal of Endocrinological Investigation, 45(3), 657–673. [DOI:10.1007/s40618-021-01694-2]
    • Godano, A., Maggi, M., Jannini, E., Meriggiola, M. C., Ghigo, E., Todarello, O., Lenzi, A., & Manieri, C. (2009). SIAMS-ONIG Consensus on Hormonal Treatment in Gender Identity Disorders. Journal of Endocrinological Investigation, 32(10), 857–864. [DOI:10.1007/BF03345758]
    • Gorton, N., Jaffe, J. M., Thompson, J., Menkin, D., Nesteby, A., Dunn, D., Baker, K. K., Harbatkin, D., Do, T., Radix, A., Meacher, P., Goldstein, Z., Carpenter, W., Caine, M., Henn, S., Murayama, R., Feldmann, J., & Zayas, S. (2019). TransLine Gender Affirming Hormone Therapy Prescriber Guidelines. San Francisco: Lyon-Martin Health Services/TransLine. [URL] [PDF]
    • Health Policy Project, Asia Pacific Transgender Network, United Nations Development Programme. (2015). Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities. Washington, DC: Futures Group, Health Policy Project. [PDF]
    • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • International Planned Parenthood Federation (IPPF). (2015). IMAP Statement on Hormone Therapy for Transgender People. International Medical Advisory Panel/International Planned Parenthood Federation. [URL] [PDF]
    • Latkin, S., & Coakley, G. (2017). [Transgender Women] Prescribing Guidelines. Doncaster/Bassetlaw: Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust. [PDF]
    • Majumder, A., Chatterjee, S., Maji, D., Roychaudhuri, S., Ghosh, S., Selvan, C., George, B., Kalra, P., Maisnam, I., & Sanyal, D. (2020). IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Reaffirmation as Female. Indian Journal of Endocrinology and Metabolism, 24(2), 128–135. [DOI:10.4103/ijem.IJEM_593_19]
    • Oliphant, J., Veale, J., Macdonald, J., Carroll, R., Johnson, R., Harte, M., Stephenson, C. & Bullock, J. (2018). Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa New Zealand. Waikato: Transgender Health Research Lab/University of Waikato. [URL] [PDF]
    • Pan American Health Organization, John Snow, Inc., World Professional Association for Transgender Health, et al. (2014). Blueprint for the Provision of Comprehensive Care for Trans Persons and Their Communities in the Caribbean and Other Anglophone Countries. Arlington: John Snow, Inc. [Alt] [PDF]
    • Radix, A. (2019). Hormone Therapy for Transgender Adults. The Urologic Clinics of North America, 46(4), 467–473. [DOI:10.1016/j.ucl.2019.07.001]
    • Radix, A. (2019). Primary Care of Transgender Adults. In Poretsky, L., & Hembree, W. C. (Eds.). Transgender Medicine: A Multidisciplinary Approach (Contemporary Endocrinology) (pp. 51–67). Cham: Humana Press. [DOI:10.1007/978-3-030-05683-4_4]
    • Sappho for Equality. (2019). A Good Practice Guide to Gender-Affirmative Care. Kolkata: Sappho for Equality. [PDF]
    • Seal, L. J. (2016). Information About Hormonal Treatment for Trans Women. London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
    • Seal, L., & Barrett, J. (2017). Shared Care Prescribing Guidance for Treatment of Gender Dysphoria in Transwomen (Male to Female Transsexuals). London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
    • Sullivan, C., & Dean, J. (2015). Prescribing Guideline. Pharmacological Treatment of Gender Dysphoria. Devon: Devon Partnership NHS Trust. [PDF]
    • Tangpricha, V., & Safer, J. D. (2020). Transgender Women: Evaluation and Management. UpToDate. [URL] [PDF]
    • Telfer, M. M., Tollit, M. A., Pace, C. C., & Pang, K. C. (2020). Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents Version 1.2. Melbourne: The Royal Children’s Hospital. [PDF]
    • Thomas, C. (2015). Guidelines for the Use of Feminising Hormone Therapy. Information for Primary Care. Sunderland: City Hospitals Sunderland NHS Trust. [PDF]
    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]
    • Trans Care BC. (2021). Gender-affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care Toolkit. Vancouver: Provincial Health Services Authority/Trans Care BC. [URL] [PDF]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • UpToDate. (2021). Society Guideline Links: Transgender Health. UpToDate. [URL]
    • Vacharathit, V., Ratanalert, W., & Samitpol, K. (2021). The Thai Handbook of Transgender Healthcare Services. Thailand: Center of Excellence in Transgender Health/Chulalongkorn University. [URL] [PDF]
    • Wilczynski, C., & Emanuele, M. A. (2014). Treating a transgender patient: overview of the guidelines. Postgraduate Medicine, 126(7), 121–128. [DOI:10.3810/pgm.2014.11.2840]
    • Wylie, K., Barrett, J., Besser, M., Bouman, W. P., Bridgman, M., Clayton, A., Green, R., Hamilton, M., Hines, M., Ivbijaro, G., Khoosal, D., Lawrence, A., Lenihan, P., Loewenthal, D., Ralph, D., Reed, T., Stevens, J., Terry, T., Thom, B., Thornton, J., Walsh, D., & Ward, D. (2014). Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria. Sexual and Relationship Therapy, 29(2), 154–214. [DOI:10.1080/14681994.2014.883353]
    • Ziegler, E., Carroll, B., & Charnish, E. (2021). Review and Analysis of International Transgender Adult Primary Care Guidelines. Transgender Health, 6(3), 139–147. [DOI:10.1089/trgh.2020.0043]
    \ No newline at end of file +Clinical Guidelines with Information on Transfeminine Hormone Therapy - Transfeminine Science Link

    Clinical Guidelines with Information on Transfeminine Hormone Therapy

    By Aly | First published November 20, 2020 | Last modified March 21, 2024

    Abstract / TL;DR

    This article is a collection of clinical practice guidelines throughout the world with information on transfeminine hormone therapy. Examples of these clinical guidelines include the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People, the Endocrine Society guidelines, and the University of California, San Francisco (UCSF) Center of Excellence for Transgender Health guidelines, among many others.

    Introduction

    Clinicians use clinical practice guidelines (CPGs) to learn about and guide themselves in administering medical care for different indications. Clinical practice guidelines review and summarize the available scientific literature and research in a given medical area. They allow clinicians to competently administer care without necessarily having to delve into and develop their understanding via the primary scientific literature. Literature reviews can serve a similar function. However, clinical practice guidelines are generally more substantial and are more founded in evidence-based medicine. They are also regularly updated. Clinical practice guidelines are developed and maintained by clinical organizations and societies, universities, government agencies, and sometimes even large medical clinics. They may be international/locationless or oftentimes region-specific.

    There are many clinical practice guidelines for transgender medicine (for review, Deutsch, Radix, & Reisner, 2016; Radix, 2019; Radix, 2019; UpToDate; Bewley et al., 2021; Dahlen et al., 2021; Ziegler, Carroll, & Charnish, 2021). These guidelines discuss topics such as psychotherapy, hormone therapy, voice therapy, and surgical management of transgender people, among others. In addition to educating and guiding clinicians, transgender clinical practice guidelines are useful materials for transgender people as they can help to inform them about their care.

    This page is a maintained list of known English clinical guidelines throughout the world that include information specifically on the subject of transfeminine hormone therapy. The most major guidelines on transgender hormone therapy are the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People (SOC) (Coleman et al., 2022), the Endocrine Society guidelines (Hembree et al., 2017), and the University of California, San Francisco (UCSF) guidelines (Deutsch, 2016). The WPATH SOC and the Endocrine Society guidelines are international, while the UCSF guidelines are based in the United States.

    International

    TitleAuthor / OrganizationYearForm
    Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline [PDF] [See also: 1st/2009 edition]Hembree et al. / Endocrine Society2017Published article
    Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 (Alt; PDF) [See also: Version 7/2012 edition ([PDF])]Coleman et al. / World Professional Association for Transgender Health (WPATH)2022Published article
    Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of CareFeldman & Safer2009Published article
    International Medical Advisory Panel (IMAP) Statement on Hormone Therapy for Transgender People [PDF]International Planned Parenthood Federation (IPPF)2015Online document
    Transgender Women: Evaluation and Management [PDF]Tangpricha & Safer / UpToDate2020Online web page

    United States

    TitleAuthor / Organization [Place]YearForm
    Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People [PDF] [See also: 1st/2011 edition [PDF]]Deutsch / Center of Excellence for Transgender Health, University of California, San Francisco (UCSF) [San Francisco, California]2016Online document
    Medical Care of Trans and Gender Diverse Adults [PDF]Thompson, et al. / Fenway Health [Boston, Massachusetts]2021Online document
    Protocols for the Provision of Hormone Therapy [PDF]Callen-Lorde Community Health Center [New York City, New York]2018Online document
    Protocols for Hormonal Reassignment of GenderDavidson et al. / Tom Waddell Health Center / San Francisco Department of Public Health [San Francisco, California]2013Online document
    TransLine Gender Affirming Hormone Therapy Prescriber Guidelines [PDF]Gorton et al. / TransLine / Lyon-Martin Health Services [San Francisco, California]2019Online document

    Canada

    TitleAuthor / OrganizationYearForm
    Gender-Affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care ToolkitTrans Care BC [Vancouver, British Columbia, Canada]2021Online document
    Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines: Physical Aspects of Transgender Endocrine TherapyDahl et al. / Vancouver Coastal Health [Vancouver, British Columbia, Canada]2015Online document
    Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients [PDF]Bourns / Sherbourne Health / Rainbow Health Ontario [Toronto, Ontario, Canada]2019Online document

    Europe

    TitleAuthor / OrganizationYearForm
    European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”T’Sjoen et al. / European Society for Sexual Medicine2020Published article

    United Kingdom

    TitleAuthor / OrganizationYearForm
    Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria [PDF]Wylie et al. / Royal College of Psychiatrists2014Published article
    Various [PDF] [PDF] [PDF] [PDF] [PDF] [PDF]Various / National Health Service (NHS) TrustsVariousOnline documents

    Italy

    TitleAuthor / OrganizationYearForm
    SIGIS–SIAMS–SIE Position Statement of Gender Affirming Hormonal Treatment in Transgender and Non‑Binary PeopleFisher et al. / Italian Society of Gender, Identity and Health (SIGIS) / Italian Society of Andrology and Sexual Medicine (SIAMS) / Italian Society of Endocrinology (SIE)2021Published article
    SIAMS-ONIG Consensus on Hormonal Treatment in Gender Identity DisordersGodano et al. / Società Italiana di Andrologia e Medicina della Sessualità (SIAMS) [Italian Society of Andrology and Sexual Medicine] / Osservatorio Nazionale sull’Identità di Genere (ONIG) [National Observatory of Gender Identity]2009Published article

    Australia

    TitleAuthor / OrganizationYearForm
    Position Statement on the Hormonal Management of Adult Transgender and Gender Diverse IndividualsCheung et al.2019Published article
    Australian Standards of Care and Treatment Guidelines: For Trans and Gender Diverse Children and Adolescents [PDF]Telfer et al. / Royal Children’s Hospital2020Online document
    Hormone Therapy Prescribing Guide for General Practitioners working with Trans, Gender Diverse and Non-Binary Patients [PDF]Cundill et al. / Equinox Gender Diverse Health Centre / Thorne Harbour Health2020Online document
    Australian Informed Consent Standards of Care for Gender Affirming Hormone Therapy [PDF]AusPATH2022Online document

    New Zealand

    TitleAuthor / OrganizationYearForm
    Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa, New Zealand [PDF]Oliphant et al. / Transgender Health Research Lab, University of Waikato2018Published article

    South Africa

    TitleAuthor / OrganizationYearForm
    Southern African HIV Clinicians’ Society Gender-Affirming Healthcare Guideline for South Africa [PDF]Tomson et al. / Southern African HIV Clinicians Society (SAHCS)2021Published article

    Elsewhere

    TitleAuthor / Organization [Place]YearForm
    Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities in Asia and the Pacific [PDF]Health Policy Project / Asia Pacific Transgender Network / United Nations Development Programme [Asia and the Pacific]2015Online document
    Blueprint for the Provision of Comprehensive Care for Trans Persons and their Communities in the Caribbean and Other Anglophone Countries [PDF]John Snow, Inc. / Pan American Health Organization / World Health Organization [Latin America and the Caribbean]2014Online document
    A Good Practice Guide to Gender-Affirmative CareSappho for Equality [India]2019Online document
    IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Reaffirmation as FemaleMajumder et al. / Integrated Diabetes and Endocrine Academy (IDEA) [India]2020Published article
    The Thai Handbook of Transgender Healthcare Services [PDF]Vacharathit et al. / Center of Excellence in Transgender Health / Chulalongkorn University [Thailand]2021Online document

    References

    • AusPATH. (2022). Australian Informed Consent Standards of Care for Gender Affirming Hormone Therapy. Australia: Australian Professional Association for Trans Health. [URL] [PDF]
    • Belzer, M. E., Burnett, J., Deutsch, M., Franicevich, J., Gorton, R. N., Hastings, J., Karasic, D., Kohler, L., Vanderleest, J., Van Maasdam, J., Olson, J., Green, J., & DeVries, C. (April 2011). Primary Care Protocol for Transgender Patient Care, 1st Edition. Center of Excellence for Transgender Health, University of California, San Francisco, Department of Family and Community Medicine. [URL] [PDF]
    • Bewley, S., Dahlen, S., Connolly, D., Arif, I., Junejo, M., & Catherine, M. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review & Quality Assessment. How Does the Endocrine Society Fare? Journal of the Endocrine Society, 5(Suppl 1), A791–A791. [DOI:10.1210/jendso/bvab048.1609]
    • Bourns, A. (2019). Guidelines for Gender-Affirming Primary Care with Trans and Non-Binary Patients, 4th Edition. Toronto: Rainbow Health Ontario/Sherbourne Health. [URL] [PDF]
    • Callen-Lorde Community Health Center. (2018). Protocols for the Provision of Hormone Therapy. New York City: Callen-Lorde Community Health Center. [URL] [PDF]
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position Statement on the Hormonal Management of Adult Transgender and Gender Diverse Individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • Coleman, E., Bockting, W., Botzer, M., Cohen-Kettenis, P., DeCuypere, G., Feldman, J., Fraser, L., Green, J., Knudson, G., Meyer, W. J., Monstrey, S., Adler, R. K., Brown, G. R., Devor, A. H., Ehrbar, R., Ettner, R., Eyler, E., Garofalo, R., Karasic, D. H., … & Zucker, K. (2012). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism, 13(4), 165–232. [DOI:10.1080/15532739.2011.700873] [URL] [PDF]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Cundill, P., Wong, P., Cheung, A., & Brownhill, A. (2020). Hormone Therapy Prescribing Guide for General Practitioners working with Trans, Gender Diverse and Non-Binary Patients [Version 3.0]. Australia: Equinox Gender Diverse Health Centre/Thorne Harbour Health. [URL] [PDF]
    • Dahl, M., Feldman, J. L., Goldberg, J., & Jaberi, A. (2015). Endocrine Therapy for Transgender Adults in British Columbia: Suggested Guidelines. Physical Aspects of Transgender Endocrine Therapy. Vancouver: Vancouver Coastal Health. [Google Scholar] [PDF]
    • Dahlen, S., Connolly, D., Arif, I., Junejo, M. H., Bewley, S., & Meads, C. (2021). International Clinical Practice Guidelines for Gender Minority/Trans People: Systematic Review and Quality Assessment. BMJ Open, 11(4), e048943. [DOI:10.1136/bmjopen-2021-048943]
    • Davidson, A., Franicevich, J., Freeman, M., Lin, R., Martinez, L., Monihan, M., Porch, M., Samuel, L., Stukalin, R., Vormohr, J., & Zevin, B. (2013). Protocols for Hormonal Reassignment of Gender. San Francisco: San Francisco Department of Public Health/Tom Waddell Health Center. [Google Scholar] [PDF]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Deutsch, M. B., Radix, A., & Reisner, S. (2016). What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care. AMA Journal of Ethics, 18(11), 1098–1106. [DOI:10.1001/journalofethics.2016.18.11.stas1-1611]
    • Feldman, J., & Safer, J. (2009). Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care. International Journal of Transgenderism, 11(3), 146–182. [DOI:10.1080/15532730903383757]
    • Fisher, A. D., Senofonte, G., Cocchetti, C., Guercio, G., Lingiardi, V., Meriggiola, M. C., Mosconi, M., Motta, G., Ristori, J., Speranza, A. M., Pierdominici, M., Maggi, M., Corona, G., & Lombardo, F. (2021). SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. Journal of Endocrinological Investigation, 45(3), 657–673. [DOI:10.1007/s40618-021-01694-2]
    • Godano, A., Maggi, M., Jannini, E., Meriggiola, M. C., Ghigo, E., Todarello, O., Lenzi, A., & Manieri, C. (2009). SIAMS-ONIG Consensus on Hormonal Treatment in Gender Identity Disorders. Journal of Endocrinological Investigation, 32(10), 857–864. [DOI:10.1007/BF03345758]
    • Gorton, N., Jaffe, J. M., Thompson, J., Menkin, D., Nesteby, A., Dunn, D., Baker, K. K., Harbatkin, D., Do, T., Radix, A., Meacher, P., Goldstein, Z., Carpenter, W., Caine, M., Henn, S., Murayama, R., Feldmann, J., & Zayas, S. (2019). TransLine Gender Affirming Hormone Therapy Prescriber Guidelines. San Francisco: Lyon-Martin Health Services/TransLine. [URL] [PDF]
    • Health Policy Project, Asia Pacific Transgender Network, United Nations Development Programme. (2015). Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities. Washington, DC: Futures Group, Health Policy Project. [URL] [PDF]
    • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • International Planned Parenthood Federation (IPPF). (2015). IMAP Statement on Hormone Therapy for Transgender People. International Medical Advisory Panel/International Planned Parenthood Federation. [URL] [PDF]
    • Latkin, S., & Coakley, G. (2017). [Transgender Women] Prescribing Guidelines. Doncaster/Bassetlaw: Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust. [PDF]
    • Majumder, A., Chatterjee, S., Maji, D., Roychaudhuri, S., Ghosh, S., Selvan, C., George, B., Kalra, P., Maisnam, I., & Sanyal, D. (2020). IDEA Group Consensus Statement on Medical Management of Adult Gender Incongruent Individuals Seeking Gender Reaffirmation as Female. Indian Journal of Endocrinology and Metabolism, 24(2), 128–135. [DOI:10.4103/ijem.IJEM_593_19]
    • Oliphant, J., Veale, J., Macdonald, J., Carroll, R., Johnson, R., Harte, M., Stephenson, C. & Bullock, J. (2018). Guidelines for Gender Affirming Healthcare for Gender Diverse and Transgender Children, Young People and Adults in Aotearoa New Zealand. Waikato: Transgender Health Research Lab/University of Waikato. [URL] [PDF]
    • Pan American Health Organization, John Snow, Inc., World Professional Association for Transgender Health, et al. (2014). Blueprint for the Provision of Comprehensive Care for Trans Persons and Their Communities in the Caribbean and Other Anglophone Countries. Arlington: John Snow, Inc. [Alt] [PDF]
    • Radix, A. (2019). Hormone Therapy for Transgender Adults. The Urologic Clinics of North America, 46(4), 467–473. [DOI:10.1016/j.ucl.2019.07.001]
    • Radix, A. (2019). Primary Care of Transgender Adults. In Poretsky, L., & Hembree, W. C. (Eds.). Transgender Medicine: A Multidisciplinary Approach (Contemporary Endocrinology) (pp. 51–67). Cham: Humana Press. [DOI:10.1007/978-3-030-05683-4_4]
    • Sappho for Equality. (2019). A Good Practice Guide to Gender-Affirmative Care. Kolkata: Sappho for Equality. [PDF]
    • Seal, L. J. (2016). Information About Hormonal Treatment for Trans Women. London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
    • Seal, L., & Barrett, J. (2017). Shared Care Prescribing Guidance for Treatment of Gender Dysphoria in Transwomen (Male to Female Transsexuals). London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
    • Sullivan, C., & Dean, J. (2015). Prescribing Guideline. Pharmacological Treatment of Gender Dysphoria. Devon: Devon Partnership NHS Trust. [PDF]
    • Tangpricha, V., & Safer, J. D. (2020). Transgender Women: Evaluation and Management. UpToDate. [URL] [PDF]
    • Telfer, M. M., Tollit, M. A., Pace, C. C., & Pang, K. C. (2020). Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents Version 1.2. Melbourne: The Royal Children’s Hospital. [PDF]
    • Thomas, C. (2015). Guidelines for the Use of Feminising Hormone Therapy. Information for Primary Care. Sunderland: City Hospitals Sunderland NHS Trust. [PDF]
    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]
    • Trans Care BC. (2021). Gender-affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care Toolkit. Vancouver: Provincial Health Services Authority/Trans Care BC. [URL] [PDF]
    • T’Sjoen, G., Arcelus, J., De Vries, A. L., Fisher, A. D., Nieder, T. O., Özer, M., & Motmans, J. (2020). European Society for Sexual Medicine Position Statement “Assessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction”. The Journal of Sexual Medicine, 17(4), 570–584. [DOI:10.1016/j.jsxm.2020.01.012]
    • UpToDate. (2021). Society Guideline Links: Transgender Health. UpToDate. [URL]
    • Vacharathit, V., Ratanalert, W., & Samitpol, K. (2021). The Thai Handbook of Transgender Healthcare Services. Thailand: Center of Excellence in Transgender Health/Chulalongkorn University. [URL] [PDF]
    • Wilczynski, C., & Emanuele, M. A. (2014). Treating a transgender patient: overview of the guidelines. Postgraduate Medicine, 126(7), 121–128. [DOI:10.3810/pgm.2014.11.2840]
    • Wylie, K., Barrett, J., Besser, M., Bouman, W. P., Bridgman, M., Clayton, A., Green, R., Hamilton, M., Hines, M., Ivbijaro, G., Khoosal, D., Lawrence, A., Lenihan, P., Loewenthal, D., Ralph, D., Reed, T., Stevens, J., Terry, T., Thom, B., Thornton, J., Walsh, D., & Ward, D. (2014). Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria. Sexual and Relationship Therapy, 29(2), 154–214. [DOI:10.1080/14681994.2014.883353]
    • Ziegler, E., Carroll, B., & Charnish, E. (2021). Review and Analysis of International Transgender Adult Primary Care Guidelines. Transgender Health, 6(3), 139–147. [DOI:10.1089/trgh.2020.0043]
    \ No newline at end of file diff --git a/transfemscience.org/articles/transfem-intro/index.html b/transfemscience.org/articles/transfem-intro/index.html index 2a3c1ce9..65436652 100644 --- a/transfemscience.org/articles/transfem-intro/index.html +++ b/transfemscience.org/articles/transfem-intro/index.html @@ -1 +1 @@ -An Introduction to Hormone Therapy for Transfeminine People - Transfeminine Science Link

    An Introduction to Hormone Therapy for Transfeminine People

    By Aly | First published August 4, 2018 | Last modified June 17, 2023

    Abstract / TL;DR

    Sex hormones such as estrogen, testosterone, and progesterone are produced by the gonads. The sex hormones mediate the development of the secondary sexual characteristics. Testosterone causes masculinization, while estradiol causes feminization and breast development. Males have high amounts of testosterone, while females have low testosterone but high amounts of estradiol. These hormonal differences are responsible for the physical differences between males and females. Sex hormones and other hormonal medications are used in transfeminine people to shift the hormonal profile from a male-typical one to a female-typical profile. This causes feminization and demasculinization and allows for alleviation of gender dysphoria. The changes caused by transfeminine hormone therapy occur over a period of months to years. There are many different types and forms of hormonal medications, and these medications can be administered by a variety of different routes. Examples include as pills taken by mouth, as patches or gel applied to the skin, and as injections, among others. Different hormonal medications, routes, and doses have differences in efficacy, side effects, risks, costs, convenience, and availability. Hormone therapy should ideally be regularly monitored in transfeminine people with blood tests to ensure effectiveness and safety and to allow for adjustment as necessary.

    The Sex Hormones

    Types and Effects

    The sex hormones include the estrogens (E), progestogens (P), and androgens. A person’s hormonal profile is a product of the type of gonads that they are born with. Natal males have testes while natal females have ovaries. Testes produce large amounts of androgens and small amounts of estrogens whereas ovaries produce high amounts of estrogens and progesterone and low amounts of androgens.

    The major estrogen in the body is estradiol (E2), the main progestogen is progesterone (P4), and the major androgens are testosterone (T) and dihydrotestosterone (DHT). The sex hormones are responsible for and determine the secondary sex characteristics. They mediate their effects by acting as agonists (or activators) of receptors inside of cells. These receptors include the androgen receptor (AR), the estrogen receptors (ERs), and the progesterone receptors (PRs). Following their activation, these receptors modulate gene expression to influence cells and tissues.

    Estrogens cause feminization. This includes breast development, softening of the skin, a feminine pattern of fat distribution (concentrated in the breasts, hips, thighs, and buttocks), widening of the hips (in those who are still of pubertal age), and other physical changes (Wiki).

    Progestogens have essentially no known role in feminization or pubertal breast development. Rather than acting as mediators of feminization, progestogens have important effects in the female reproductive system and are essential hormones during pregnancy (Wiki). They also oppose the actions of estrogens in certain parts of the body, such as the uterus, vagina, and breasts (Wiki).

    Androgens cause masculinization. This includes growth of the penis, broadening of the shoulders, expansion of the rib cage, muscle growth, voice deepening, a masculine pattern of fat distribution (concentrated in the stomach and waist), masculine changes in other soft tissues, and facial/body hair growth (Wiki). Androgens also cause a variety of generally undesirable skin and hair effects, including oily skin, acne, seborrhea, scalp hair loss, and body odor. They additionally oppose breast development and probably other aspects of feminization mediated by estrogens as well.

    In addition to their effects on the body, sex hormones have actions in the brain. These actions influence cognition, emotions, and behavior. For instance, androgens produce pronounced sexual desire and arousal (including spontaneous erections) in men, while estrogens appear to be the major hormones responsible for sexual desire in women (Cappelletti & Wallen, 2016). Sex hormones also have important effects on health, which can be both positive and negative. For instance, estrogens maintain bone strength and likely protect against heart disease in cisgender women (NAMS, 2022), but also increase the risk of breast cancer (Aly, 2020) and can increase the risk of blood clots (Aly, 2020).

    Estrogens, progestogens, and androgens also have antigonadotropic effects. That is, they inhibit the gonadotropin-releasing hormone (GnRH)-induced secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from the pituitary gland in the brain. The gonadotropins signal the gonads to make sex hormones and to supply the sperm and egg cells necessary for fertility. Hence, lower levels of the gonadotropins will result in reduced gonadal sex hormone production and diminished fertility. If gonadotropin levels are sufficiently suppressed, the gonads will no longer make sex hormones at all and fertility will cease. The vast majorities of the quantities of estradiol, testosterone, and progesterone in the body are produced by the gonads. Most of the small remaining amounts of these hormones are produced via the adrenal glands of the kidneys.

    Normal Hormone Levels

    In cisgender females, the sex hormones are largely absent during childhood, gradually ramp up in production in late childhood and adolescence, are present in a cyclical manner during adulthood, and then largely stop being produced following the menopause. Hormone levels vary substantially but in a predictable manner during the normal menstrual cycle in adult premenopausal women. The menstrual cycle lasts about 28 days on average and consists of the following parts:

    1. Follicular phase—first half of the cycle or days 1–14
    2. Mid-cycle—middle of the cycle or days 12–16 or so
    3. Luteal phase—latter half of the cycle or days 14–28

    Hormone levels during the menstrual cycle are shown in the following graph:

    Figure 1: Median estradiol and progesterone levels throughout the menstrual cycle in premenopausal cisgender women (Stricker et al., 2006; Abbott, 2009). The horizontal dashed lines are the average levels over the spanned periods. Other figures available elsewhere show variation between individuals (Graph; Graph; Graph).

    As can be seen in the graph, estradiol levels are relatively low and progesterone levels are very low during the follicular phase; estradiol but not progesterone levels briefly surge to very high levels and trigger ovulation during mid-cycle; and estradiol and progesterone levels both undergo a bump and are relatively high during the luteal phase (though estradiol is not as high as during the mid-cycle peak).

    The table below shows the circulating levels and production rates of estradiol, progesterone, and testosterone in women and men and allows for comparison between them.

    Table 1: Ranges for circulating levelsa and estimated production ratesb of the major sex hormones:

    HormoneGroupTimeLevels (mass/vol)cLevels (mol/vol)cProduction rates
    EstradiolWomendFollicular phase5–180 pg/mL20–660 pmol/L30–170 μg/daye
      Mid-cycle45–750 pg/mL170–2,750 pmol/L320–950 μg/daye
      Luteal phase20–300 pg/mL73–1100 pmol/L250–300 μg/daye
     Men–8–35 pg/mL30–130 pmol/L10–60 μg/day
    ProgesteroneWomendFollicular phase≤0.3 ng/mL≤1.0 nmol/L0.75–5 mg/day
      Mid-cycle0.1–1.5 ng/mL0.3–4.8 nmol/L4 mg/day
      Luteal phase3.5–38 ng/mL11–120 nmol/L15–50 mg/dayf
     Men–≤0.5 ng/mL≤1.6 nmol/L0.75–3 mg/day
    TestosteroneWomendMenstrual cycle5–55 ng/dL0.2–1.9 nmol/L190–260 μg/day
     Men–250–1100 ng/dL8.7–38 nmol/L5–7 mg/day

    a Sources for hormone levels: Zhang & Stanczyk (2013); Nakamoto (2016); Styne (2016); LabCorp (2020). b Sources for production rates: Aufrère & Benson (1976); Powers et al. (1985); Lauritzen (1988); Carr (1993); O’Connell (1995); Kuhl (2003); Norman & Henry (2015a); Norman & Henry (2015b); Strauss & FitzGerald (2019). c With liquid chromatography–mass spectrometry (LC–MS) (state-of-the-art blood tests). d During the menstrual cycle in the adult premenopause (age ~18–50 years). e Average production rate of estradiol over the whole menstrual cycle is roughly 200 μg/day or 6 mg/month (Rosenfield, Cooke, & Radovich, 2021). f Average production rate of progesterone during the luteal phase of the menstrual cycle is about 25 mg/day (Carr, 1993).

    Mean integrated estradiol levels are around 100 pg/mL (367 pmol/L) in premenopausal women and around 25 pg/mL (92 pmol/L) in men. The 95% range for mean estradiol levels in women is around 50 to 250 pg/mL (180–918 pmol/L) (e.g., Abbott, 2009 (Graph); Verdonk et al., 2019 (Graph)). The average production of estradiol by the ovaries in premenopausal women is about 6 mg over the course of one menstrual cycle (i.e., one month) (Rosenfield et al., 2008). This corresponds to a mean rate of about 200 μg/day. Estradiol levels increase slowly during normal female puberty, when breast development and feminization take place. Mean estradiol levels during the different stages of female puberty are quite low—less than about 50 to 60 pg/mL (180–220 pmol/L) until late puberty (Aly, 2020). In postmenopausal women, whose ovaries no longer produce considerable quantities of estrogens, estradiol levels are generally less than 10 to 20 pg/mL (37–73 pmol/L) (Nakamoto, 2016). Estradiol levels below 50 pg/mL (184 pmol/L) in adults are concentration-dependently associated with menopausal symptoms, including hot flashes, depressive mood changes, defeminization (e.g., breast atrophy, loss of feminine fat distribution), accelerated skin aging, and bone density loss with increased risk of bone fracture.

    Mean testosterone levels are around 30 ng/dL (1.0 nmol/L) in women and 600 ng/dL (21 nmol/L) in men. Based on these values, testosterone levels are on average about 20-fold higher in men than in women. In men who have undergone gonadectomy (castration or surgical gonadal removal), testosterone levels are similar to those in women (<50 ng/dL [1.7 nmol/L]) (Nishiyama, 2014; Itty & Getzenberg, 2020). The mean or median levels of testosterone in women with polycystic ovary syndrome (PCOS), who often have clinically significant symptoms of androgen excess (e.g., excessive facial/body hair growth), range from 41 to 75 ng/dL (1.4–2.6 nmol/L) per different studies (Balen et al., 1995; Steinberger et al., 1998; Legro et al., 2010; Loh et al., 2020). Hence, it appears that even testosterone levels that are marginally elevated relative to normal female levels may produce undesirable androgenic effects.

    It is important to be aware that measurement of hormone levels is subject to methodological limitations, and hormone levels vary significantly when quantified by different methods and laboratories on account of varying assay accuracy (Shackleton, 2010; Stanczyk & Clarke, 2010; Deutsch, 2016; Carmina, Stanczyk, & Lobo, 2019). Mass spectrometry (MS)-based assays, such as liquid chromatography–mass spectrometry (LC–MS), are regarded as more accurate and reliable than immunoassay (IA)-based assays, such as radioimmunoassays (RIA) and direct immunoassays like enzyme-linked immunosorbent assays (ELISA) (Stanczyk & Clarke, 2010; Carmina, Stanczyk, & Lobo, 2019). In relation to this, MS-based tests are gradually becoming the standard for laboratory testing of sex hormone levels. However, hormone levels vary between laboratories even with LC–MS, for instance due to differences in calibration of LC–MS instruments between laboratories (Carmina, Stanczyk, & Lobo, 2019). Whereas an accurate range for testosterone levels in cisgender women is 20 to 50 ng/dL (0.69–1.7 nmol/L), for instance with assays like RIA and LC–MS, the normal upper limit for direct immunoassays like ELISA may be 70 to 80 ng/dL (2.4–2.8 nmol/L) (Carmina, Stanczyk, & Lobo, 2019). When interpreting blood tests, care should be taken to compare sex hormone levels to same-laboratory reference ranges (Deutsch, 2016).

    Overview of Hormone Therapy

    The goal of hormone therapy for transfeminine people, otherwise known as feminizing hormone therapy (FHT) or (more in the past) as male-to-female (MtF) hormone replacement therapy (HRT), is to produce feminization and demasculinization of the body as well as alleviation of gender dysphoria. Medication therapy with sex hormones and other sex-hormonal medications is used to mediate these changes. Transfeminine people are given estrogens, progestogens, and antiandrogens (AAs) to supersede gonadal sex hormone production and shift the hormonal profile from male-typical to female-typical.

    Transfeminine hormone therapy aims to achieve estradiol and testosterone levels within the normal female range. Commonly recommended ranges for transfeminine people in the literature are 100 to 200 pg/mL (367–734 pmol/L) for estradiol levels and less than 50 ng/dL (1.7 nmol/L) for testosterone levels (Table). However, higher estradiol levels of more than 200 pg/mL (734 pmol/L) can be useful in transfeminine hormone therapy to help suppress testosterone levels. Lower estradiol levels (≤50–60 pg/mL [≤180–220 pmol/L]) are recommended and more appropriate for pubertal and adolescent transfeminine individuals. Sex hormone levels in the blood can be measured with blood tests, in which blood is drawn from a vein using a needle and then analyzed in a laboratory. This is useful in transfeminine people to ensure that the hormonal profile has been satisfactorily altered in line with therapeutic goals—specifically that hormone levels are within female ranges.

    Gonadal Suppression

    At sufficiently high exposure, estrogens and androgens are able to completely suppress gonadal sex hormone production, while progestogens by themselves are able to partially but substantially suppress gonadal sex hormone production. More specifically, studies in cisgender men and transfeminine people have found that estradiol levels of around 200 pg/mL (734 pmol/L) generally suppress testosterone levels by about 90% (to ~50 ng/dL [1.7 nmol/L]), while estradiol levels of around 500 pg/mL (1,840 pmol/L) suppress testosterone levels by about 95% on average (to ~20–30 ng/dL [0.7–1.0 nmol/L]) (Wiki; Graphs). Estradiol levels of below 200 pg/mL (734 pmol/L) also suppress testosterone levels, although to a reduced extent compared to higher levels (Aly, 2019).

    Figure 2: Estradiol and testosterone levels after a single injection of 320 mg polyestradiol phosphate (PEP) (a long-acting prodrug of estradiol) in men with prostate cancer (Stege et al., 1996). The maximal decrease in testosterone levels occurred with estradiol levels of greater than 200 pg/mL (734 pmol/L) and was about 90% (to roughly 50 ng/dL [1.7 nmol/L]). This figure demonstrates the ability of estradiol to concentration-dependently suppress gonadal testosterone production and circulating testosterone levels in people with testes.

    Progestogens on their own are able to maximally suppress testosterone levels by about 50 to 70% (to ~150–300 ng/dL [5.2–10.4 nmol/L] on average) (Aly, 2019; Wiki). In combination with relatively small amounts of estrogen however, there is synergism in the antigonadotropic effect—the suppression of gonadal testosterone production with maximally effective doses of progestogens becomes complete, and testosterone levels are reduced by about 95% (to ~20–30 ng/dL [0.7–1.0 nmol/L]) (Aly, 2019). Hence, the combination of an estrogen and a progestogen can be used to achieve maximal testosterone suppression at lower doses than would be necessary if an estrogen or progestogen were used alone.

    The antigonadotropic effects of estrogens and progestogens are taken advantage of in transfeminine hormone therapy to suppress gonadal testosterone production and attain testosterone levels that are more consistent with those in cisgender women. It should be noted that the preceding numbers on testosterone suppression with estrogens and progestogens are averages and there is significant variation between individuals in terms of testosterone suppression. In other words, some may need more or less in terms of hormonal dosages to achieve the same decrease in testosterone levels.

    Timeline of Effects

    During normal puberty in both males and females, sex hormone exposure increases slowly over a period of several years (Aly, 2020). In relation to this, sexual maturation occurs gradually during normal puberty. In non-adolescent transgender people, adult or higher amounts of hormones are generally administered right away, and this can result in changes in secondary sex characteristics happening more quickly. The table below is reproduced from literature sources with slight modification and is commonly cited as a timeline for the effects of hormone therapy in transfeminine people (Table). It is based on a mixture of anecdotal clinical experience, expert opinion, and available clinical studies of hormone therapy in transfeminine people. Due to limited research characterizing the effects of transfeminine hormone therapy at present, the table may or may not be completely accurate.

    Table 2: Effects of hormone therapy at typical doses in adult transfeminine people (Wiki):

    EffectOnsetaCompletionaPermanency
    Breast development2–6 months2–3 yearsPermanent
    Reduced and slowed growth of facial and body hair3–12 months>3 yearsbReversible
    Cessation and reversal of scalp hair loss1–3 months1–2 yearsReversible
    Softening of skin and decreased skin oiliness and acne3–6 monthsUnknownReversible
    Redistribution of body fat in a feminine pattern3–6 months2–5 yearsReversible
    Decreased muscle mass and strength3–6 months1–2 yearscReversible
    Widening and rounding of the pelvisdUnknownUnknownPermanent
    Changes in mood, emotionality, and behaviorImmediateUnknownReversible
    Decreased sex drive and spontaneous erections1–3 months3–6 monthsReversible
    Erectile dysfunction and decreased ejaculate volume1–3 monthsVariableReversible
    Decreased sperm production and infertilityUnknown>3 yearsMixede
    Decreased testicular volume3–6 months2–3 yearsUnknown
    Voice changes (e.g., decreased pitch/resonance)NonefN/AN/A

    a May vary significantly between individuals due to factors like genetics, diet/nutrition, hormone levels, etc. b Hormone therapy usually has little influence on facial hair density in transfeminine people. Complete removal of facial and body hair can be achieved with laser hair removal and electrolysis. Temporary hair removal can be achieved with shaving, epilating, waxing, and other methods. c May vary significantly depending on amount of physical exercise. d Occurs only in young individuals who have not yet completed growth plate closure (may not occur at all in post-adolescent people). e Only estrogens, particularly at high doses, seem to have the potential for long-lasting or irreversible infertility; impaired fertility caused by antiandrogens is usually readily reversible with discontinuation. f Voice training can be an effective means of feminizing the voice.

    To see real-life photographic timelines of breast development and feminization with transfeminine hormone therapy, see the r/TransBreastTimelines community on the social media website Reddit.

    Specific Hormonal Medications

    The medications that are used in transfeminine hormone therapy include estrogens, progestogens, and antiandrogens. Estrogens produce feminization and testosterone suppression. Progestogens and antiandrogens do not mediate feminization themselves but further suppress and/or block testosterone. Testosterone suppression causes demasculinization and disinhibition of estrogen-mediated feminization. Androgens are sometimes used at low doses in transfeminine people who have low testosterone levels, although they are not required and benefits are uncertain. There are many different types of these hormonal medications available for transfeminine hormone therapy, with different benefits and risks.

    Estrogens, progestogens, and antiandrogens are available in a variety of different formulations and for use by many different routes of administration in transfeminine people. The route of administration influences the absorption, distribution, metabolism, and elimination of the hormone in the body, resulting in significant differences between routes in terms of bioavailability, hormone levels in blood and specific tissues, and patterns of metabolites. These differences can have important therapeutic consequences.

    Table 3: Major routes of administration of hormonal medications for transfeminine people:

    RouteAbbr.DescriptionTypical forms
    Oral administrationPOSwallowedTablet, capsule
    Sublingual administrationSLHeld and absorbed under tongueTablet
    Buccal administrationBUCHeld and absorbed in cheek or under lipsTablet
    Transdermal administrationTDApplied to and absorbed through the skinPatch, gel, cream
    Rectal administrationRECInserted into and absorbed by rectumSuppository
    Intramuscular injectionIMInjected into muscle (e.g., buttocks, thigh, arm)Solution (vial/amp.)
    Subcutaneous injectionSCInjected into fat under skinSolution (vial/amp.)
    Subcutaneous implantSCiInsertion via surgical incision into fat under skinPellet

    Vaginal administration is a major additional route of administration of hormonal medications in cisgender women. While vaginal administration via a natal vagina is of course not possible in transfeminine people, neovaginal administration is a possiblility in those who have undergone vaginoplasty. However, the lining of the neovagina is not the vaginal epithelium of natal females but instead is usually skin or colon—depending on the type of vaginoplasty performed (penile inversion or sigmoid colon vaginoplasty, respectively). For this reason, neovaginal administration in transfeminine people is likely more similar in its properties to transdermal and rectal administration—depending on the type of neovagina—than to vaginal administration in cisgender women. It is noteworthy that the vaginal and rectal routes are said to be similar in their properties for hormonal medications however (Goletiani, Keith, & Gorsky, 2007; Wiki). Moreover, absorption of estradiol via neovaginas constructed from peritoneum (internal abdominal lining)—a less commonly employed vaginoplasty approach in transfeminine people—was reported in one study to be similar to that with vaginal administration of estradiol in cisgender women (Willemsen et al., 1985). As such, neovaginal administration may be an additional possible route for certain transfeminine people depending on the circumstances. However, this route still remains to be more adequately characterized.

    Estrogens

    Estradiol, the primary bioidentical form normally found in the human body, is the main estrogen that is used in transfeminine hormone therapy. Estradiol hemihydrate (EH) is another form that is essentially identical to and interchangeable with estradiol. Estradiol esters are also sometimes used in place of estradiol. They are prodrugs of estradiol (i.e., are converted into estradiol in the body) and have essentially identical biological activity to estradiol. However, they have longer durations when used by injection due to slower absorption from the injection site, and this allows them to be administered less often. Some examples of major estradiol esters include estradiol valerate (EV; Progynova, Progynon Depot, Delestrogen) and estradiol cypionate (EC; Depo-Estradiol). Polyestradiol phosphate (PEP; Estradurin) is an injectable estradiol prodrug in the form of a polymer (i.e., linked chain of estradiol molecules) which is metabolized slowly and has a very long duration.

    Non-bioidentical estrogens such as ethinylestradiol (EE; found in birth control pills), conjugated estrogens (CEEs; Premarin; used in menopausal hormone therapy), and diethylstilbestrol (DES; widely used previously but now abandoned) are resistant to metabolism in the liver and have disproportionate effects on estrogen-modulated liver synthesis when compared to bioidentical estrogens like estradiol (Aly, 2020). As a result, they have stronger influence on coagulation and greater risk of certain health problems like blood clots and associated cardiovascular issues (Aly, 2020). For this reason, as well as the fact that relatively high doses of estrogens may be needed for testosterone suppression, non-bioidentical estrogens should ideally never be used in transfeminine hormone therapy.

    Physiological levels of estradiol are usually not sufficient to suppress testosterone levels into the female range in gonadally intact transfeminine people. As a result, estradiol is generally used in combination with an antiandrogen or progestogen in transfeminine hormone therapy. This results in partial suppression of testosterone levels by estradiol and further suppression or blockade of the remaining testosterone by the antiandrogen or progestogen. The addition of an antiandrogen or progestogen to estradiol therapy however also adds the side effects, risks, and costs of these medications. An alternative to the combination of estradiol with an antiandrogen or progestogen which may be used in transfeminine people is high-dose estradiol monotherapy. This is an approach in which estradiol is used alone at supraphysiological doses. These high doses can allow for greater testosterone suppression and reduction of testosterone levels into the female range with estradiol alone.

    The feminizing effects of estradiol appear to be maximal at low levels in the absence of androgens. Higher doses of estradiol, aside from allowing for greater testosterone suppression, are not known to result in better feminization in transfeminine people (Deutsch, 2016; Nolan & Cheung, 2021). In fact, there is indication that higher estrogen doses early into hormone therapy could actually result in worse breast development. Hence, the therapeutic emphasis in transfeminine hormone therapy is more on testosterone suppression than on achieving a certain estradiol level. Higher doses of estrogens, including estradiol, also have a greater risk of adverse health effects such as blood clots and cardiovascular problems (Aly, 2020). As such, the use of physiological doses of estradiol is optimal. At the same time however, high estrogen doses can be useful for testosterone suppression. Moreover, the absolute risks in the case of non-oral bioidentical estradiol are low and are more important in people with specific risk factors. Examples of such risk factors include older age, physical inactivity, obesity, concomitant progestogen use, smoking, surgery, and rare thrombophilic abnormalities. In healthy young people without relevant risk factors, limitedly supraphysiological doses of non-oral estradiol for purposes of adequate testosterone suppression may be more acceptably safe (Aly, 2020).

    Estradiol and estradiol esters are usually used orally, sublingually, transdermally, by injection (intramuscularly or subcutaneously), or by implant in transfeminine hormone therapy (Wiki).

    Oral Estradiol

    Estradiol is used orally in the form of tablets of estradiol (Wiki; Graphs). Alternatively, oral estradiol valerate tablets are used in some countries, for instance in many European countries. The only real differences between these oral estradiol forms is that estradiol valerate contains slightly less estradiol by weight (~76%) due to its ester component and hence requires somewhat higher doses (~1.3-fold) in comparison for equivalent estradiol levels (Wiki; Table). Oral estradiol has a duration suitable for once-daily administration. Oral administration of estradiol is a very convenient and inexpensive route, which makes it the most popular and widely used form of estradiol in transfeminine people. Oral estradiol has relatively low bioavailability (~5%), and there is substantial variability between people in terms of estradiol levels achieved with the same dose. Hence, in some transfeminine people estradiol levels may be low with oral estradiol, and testosterone suppression may be inadequate depending on the antiandrogen.

    A major drawback of oral estradiol is that it results in excessive levels of estradiol in the liver due to the first pass that occurs with oral administration and has a disproportionate impact on estrogen-modulated liver synthesis (Aly, 2020). This in turn increases coagulation and the risk of associated health complications like blood clots and cardiovascular problems (Aly, 2020). These particular health concerns are largely allayed if estradiol is taken non-orally at reasonable and non-excessive doses. Hence non-oral forms of estradiol, like transdermal estradiol, although less convenient and often more expensive than oral estradiol, are preferable in transfeminine hormone therapy. It is recommended that all transfeminine people who are over 40 to 45 years of age use non-oral routes due to the greater risk of blood clots and cardiovascular problems that occurs with age (Aly, 2020; Coleman et al., 2022). Oral estradiol is not a good choice for high-dose estradiol monotherapy in transfeminine people due to the high estradiol levels required and the greater risks than with non-oral routes. In addition to its disproportionate liver impact, oral estradiol results in unphysiological levels of estradiol metabolites like estrone and estrone sulfate when compared to non-oral forms. The clinical implications of this, if any, are unknown. Oral and non-oral estradiol have in any case been found to have similar effectiveness in terms of feminization and breast development in transfeminine people in available studies (Sam, 2020).

    Sublingual Estradiol

    Oral estradiol tablets can be taken sublingually instead of orally. Sublingual use of estradiol tablets has several-fold higher bioavailability relative to oral administration and hence achieves much higher overall estradiol levels in comparison (Sam, 2021; Wiki; Graphs). Sublingual use of oral estradiol tablets can be employed instead of oral administration to reduce doses and hence medication costs or to produce higher estradiol levels for the purpose of achieving better testosterone suppression when needed. However, sublingual estradiol is very spiky in terms of estradiol levels when compared to oral estradiol and has a short duration of highly elevated estradiol levels. As such, it may be advisable for sublingual estradiol to be used in divided doses multiple times throughout the day in order to maintain at least somewhat steadier estradiol levels. The therapeutic implications for transfeminine people of the spikiness of sublingual estradiol, for instance in terms of testosterone suppression and health risks, have been little-studied and are mostly unknown. Oral estradiol valerate tablets can be taken sublingually instead of orally similarly to estradiol and are likewise highly effective when used in this way (Aly, 2019; Wiki). Due to partial swallowing of tablets, sublingual estradiol may in practice be a mixture of sublingual and oral administration and may have some of the same health risks of oral estradiol (Wiki). Buccal administration of estradiol appears to have similar properties as sublingual administration but is much less researched in comparison and is not used as often in transfeminine people (Wiki).

    Transdermal Estradiol

    Transdermal estradiol is available in the form of patches, gel, emulsions, and sprays (Wiki). These forms are usually applied to skin areas such as the arms, abdomen, or buttocks. Gel, emulsions, and sprays are applied and left to dry for a short period, whereas patches are applied and remain adhesed to the skin for a specified amount of time. Due to rate-limited absorption through the skin, there is a depot effect with transdermal estradiol and this route has a long duration with very steady estradiol levels. As a result, estradiol gel, emulsions, and sprays are all suitable for once-daily use. Patches stay applied and continuously deliver estradiol for either 3–4 days or 7 days depending on the patch brand (Table). Transdermal estradiol is more expensive than oral estradiol. Gel, emulsions, and sprays may be less convenient than oral administration, but patches can be more convenient due to their infrequent application. However, patches can sometimes cause application site problems like redness and irritation and can occasionally come off prematurely due to adhesive failure. As with oral estradiol, there is substantial variability in estradiol levels with transdermal estradiol, and some transfeminine people may have poor absorption, low estradiol levels, and inadequate testosterone suppression with this route. Estradiol sprays, such as Lenzetto, have been found to achieve very low estradiol levels that are probably not therapeutically adequate for use in transfeminine hormone therapy (Aly, 2020; Graph).

    Transdermal estradiol is the form of estradiol most commonly used in transfeminine people who are over 40 years of age due to its lower health risks relative to oral estradiol. Transdermal estradiol gel is not a favorable option for high-dose estradiol monotherapy as it has difficulty achieving the high estradiol levels needed for adequate testosterone suppression (Aly, 2019). On the other hand, transdermal estradiol patches can be an effective option for high-dose estradiol monotherapy if multiple 100 μg/day patches are used (Wiki). Different skin sites absorb transdermal estradiol to different extents (Wiki). Genital application of transdermal estradiol, specifically to the scrotum or neolabia, is particularly better-absorbed than conventional skin sites and can result in much higher estradiol levels than usual (Aly, 2019). This can be useful for reducing doses and hence medication costs or for achieving higher estradiol levels for better testosterone suppression when needed. Transdermal estradiol should not be applied to the breasts as this is not known to result in improved breast development and the potential health consequences of doing so are unknown (e.g., influence on breast cancer risk).

    Injectable Estradiol

    Injectable estradiol preparations can be administered via either intramuscular or subcutaneous injection (Wiki; Wiki; Graphs). There is a depot effect with injection of estradiol esters such that they are slowly absorbed from the injection site and have a prolonged duration. This ranges from days to months depending on the ester. Commonly used injectable estradiol esters, which all have short to moderate durations, include estradiol valerate (EV), estradiol cypionate (EC), estradiol enanthate (EEn), and estradiol benzoate (EB). Longer-acting injectable estradiol esters, such as estradiol undecylate (EU) and polyestradiol phosphate (PEP), have been discontinued and are no longer pharmaceutically available. In the case of intramuscular injection, common injection sites include the deltoid muscle (upper arm), vastus lateralis and rectus femoris muscles (thigh), and ventrogluteal muscle (buttocks). Subcutaneous injection of estradiol injectables, while less commonly used, has comparable pharmacokinetics to intramuscular injection, and is easier, less painful, and more convenient in comparison (Wiki). However, the maximum volume that can be safely and comfortably injected subcutaneously is less than that which can be injected intramuscularly (depending on the site up to 1.5–3 mL and up to 2–5 mL, respectively) (Hopkins, & Arias, 2013; Usach et al., 2019). Injectable estradiol tends to be fairly inexpensive, but may be less convenient than other routes due to the need for regular injections. There may also be a risk of internal scar tissue build-up long-term. Estradiol injectables have been discontinued in many parts of the world (e.g., most of Europe), and their availability is limited. In recent years, many transfeminine people have turned to black market homebrewed injectable estradiol preparations to use this route.

    Injectable estradiol preparations are typically used at higher doses than other forms of estradiol, and can easily achieve very high levels of estradiol. This can be useful for testosterone suppression, making this form of estradiol likely the best choice for high-dose estradiol monotherapy in transfeminine people. However, the high doses that are possible with injectable estradiol preparations can also easily lead to overdosage and unnecessarily increased risks (e.g., Aly, 2020). Resources are available on this site for guiding selection of appropriate doses and intervals of injectable estradiol esters in transfeminine people. This includes a simulator and informal meta-analysis of estradiol levels with these preparations (Aly, 2021; Aly, 2021) and a table providing approximate equivalent doses between injectable estradiol esters and other estradiol routes and forms (Aly, 2020). It is notable and unfortunate that currently recommended doses and intervals for injectable estradiol esters by transgender care guidelines (e.g., 10–40 mg/2 weeks estradiol valerate) appear to be highly excessive and too widely spaced, and are likely to be therapeutically inadvisable (Aly, 2021). Doses and intervals of injectable estradiol esters recommended by the present author for use as a means of high-dose estradiol monotherapy, targeting mean estradiol levels of around 300 pg/mL (1,100 pmol/L), are provided below (Table 4).

    Table 4: Recommended doses and intervals of injectable estradiol esters for high-dose estradiol monotherapy (targeting estradiol levels of around 300 pg/mL [1,100 pmol/L]):

    Estradiol EsterShortMediumLongSimulation
    Estradiol benzoate0.67 mg/1 day1.33 mg/2 days2 mg/3 daysGraph
    Estradiol valerate2 mg/3 days3.5 mg/5 days5 mg/7 daysGraph
    Estradiol cypionate (in oil)5 mg/7 days7 mg/10 days10 mg/14 daysGraph
    Estradiol cypionate (suspension)2 mg/3 days3.5 mg/5 days5 mg/7 daysGraph
    Estradiol enanthate5 mg/7 days7 mg/10 days10 mg/14 daysGraph
    Estradiol undecylatea10 mg/14 days20 mg/28 days30 mg/42 daysGraph
    Polyestradiol phosphate160 mg/30 days240 mg/45 days320 mg/60 daysGraph

    a Doses and intervals for estradiol undecylate are extrapolated and hypothetical (Aly, 2021).

    These doses and intervals should be considered a starting point, and should be fine-tuned as necessary based on blood tests. In terms of injection intervals, the shorter interval, the more stable the estradiol levels, but the more often that injections need to be done. Doses may be increased if estradiol levels are too low and testosterone suppression is inadequate, and doses may be decreased if estradiol levels are too high so long as adequate testosterone suppression is maintained. Doses should be lower (targeting mean estradiol levels of 100–200 pg/mL [367–734 pmol/L]) if combined with an antiandrogen or progestogen as these agents will help with testosterone suppression. Similarly, doses should be lower following surgical gonadal removal as testosterone suppression will no longer be necessary.

    Estradiol Pellets

    Estradiol implants are pellets of pure crystalline hormone and are surgically placed into subcutaneous fat by a physician (Wiki). They are slowly absorbed by the body following implantation, and new implants are given once every 4 to 6 months. Due to the need for minor surgery, their high cost, and limited availability, estradiol implants are not as commonly used as other estradiol routes. Notably, almost all pharmaceutical estradiol implants throughout the world have been discontinued, and the implants that remain available are almost exclusively compounded products provided by compounding pharmacies. Dosage adjustment with estradiol implants is also more difficult than with other estradiol routes. Despite their various practical limitations however, estradiol implants allow for very steady estradiol levels, and their very long duration can allow for unusual convenience among available estradiol forms.

    Additional Notes

    Table 5: Available forms and recommended doses of estradiol for adulta transfeminine people:

    MedicationRouteFormDosage
    EstradiolOralTablets2–8 mg/day
     Sublingual or buccalTablets0.5–6 mg/dayb
     TransdermalPatches50–400 μg/day
      Gel1.5–6 mg/day
      SpraysNot recommendedc
     SC implantPellet25–150 mg/6 months
    Estradiol valerateOralTablets3–10 mg/dayd
     Sublingual or buccalTablets1–8 mg/dayb,d
     IM or SC injectionOil solution0.75–4 mg/5 days; or
    1–6 mg/7 days; or
    1.5–9 mg/10 days
    Estradiol cypionateIM or SC injectionOil solution1–6 mg/7 days; or
    1.5–9 mg/10 days; or
    2–12 mg/14 days
      Aqueous suspension0.75–4 mg/5 days; or
    1–6 mg/7 days; or
    1.5–9 mg/10 days
    Estradiol enanthateIM or SC injectionOil solution1–6 mg/7 days; or
    1.5–9 mg/10 days; or
    2–12 mg/14 days
    Estradiol benzoateIM or SC injectionOil solution0.15–0.75 mg/day; or
    0.3–1.5 mg/2 days; or
    0.45–2.25 mg/3 days
    Estradiol undecylateeIM or SC injectionOil solution2–12 mg/14 days; or
    4–24 mg/28 days; or
    6–36 mg/42 days
    Polyestradiol phosphateIM injectionWater solution40–160 mg/monthf

    a Estradiol doses in pubertal adolescent transfeminine people should be lower to mimic estradiol exposure during normal female puberty (Aly, 2020). b May be advisable to use divided doses 2 to 4 times per day (i.e., once every 6 to 12 hours) instead of once per day (Sam, 2021). c This estradiol form achieves very low estradiol levels at typical doses that don’t appear to be well-suited for transfeminine hormone therapy (Aly, 2020; Graph). d Estradiol valerate contains about 75% of the same amount of estradiol as estradiol so doses are about 1.3-fold higher for the same estradiol levels (Aly, 2019; Sam, 2021). e Doses and intervals for estradiol undecylate are extrapolated and hypothetical (Aly, 2021). f A higher initial loading dose of e.g., 240 or 320 mg polyestradiol phosphate can be used for the first one or two injections to reach steady-state estradiol levels more quickly. However, this preparation has recently been discontinued and appears to no longer be available.

    Additional informational resources are available in terms of estradiol levels (Wiki; Table) and approximate equivalent doses (Aly, 2020) with different forms, routes, and doses of estradiol.

    There is high variability between individuals in the levels of estradiol achieved during estradiol therapy. That is, estradiol levels during treatment with the same dosage of estradiol can differ substantially between individuals. This variability is greatest with oral and transdermal estradiol but is also considerable even with injectable estradiol preparations and other estradiol forms. As such, estradiol doses are not absolute and should be individualized on a case-by-case basis in conjunction with blood work as a guide. It should also be noted that due to fluctuations in estradiol concentrations with certain routes, levels of estradiol can vary considerably from one blood test to another. This is most notable with sublingual estradiol and injectable estradiol. The fluctuations in estradiol levels with these routes are predictable and must be understood when interpreting blood work results. Differences in blood test results can be minimized with informed and consistent timing of blood draws.

    If or when the gonads are surgically removed, testosterone suppression is no longer needed in transfeminine people. As a result, estradiol doses, if they are high or supraphysiological, can be lowered to more closely approximate normal physiological levels in cisgender women.

    Progestogens

    Progestogens include progesterone and progestins. Progestins are synthetic progestogens derived from structural modification of progesterone or testosterone. There are dozens of different progestins and these progestins can be divided into a variety of different structural classes with varying properties (Table). Examples of some major progestins of different classes include the 17α-hydroxyprogesterone derivative medroxyprogesterone acetate (MPA; Provera, Depo-Provera), the 19-nortestosterone derivative norethisterone (NET; many brand names), the retroprogesterone derivative dydrogesterone (Duphaston), and the 17α-spirolactone derivative drospirenone (Slynd, Yasmin). Progestins were developed because they have a more favorable disposition in the body than progesterone for use as medications. Only a few clinically used progestins have been used in transfeminine hormone therapy. However, progestogens largely produce the same progestogenic effects, with a few exceptions, and theoretically almost any progestogen could be employed.

    Progestogens have antigonadotropic effects via their progestogenic activity and dose-dependently suppress the secretion of the gonadotropins from the pituitary gland. This in turn results in a reduction of gonadotropin-mediated gonadal stimulation and a decrease in sex hormone production as well as fertility. The dose-dependent testosterone-suppressing effects of a variety of different progestogens have been characterized in clinical studies in cisgender men and transfeminine people (Nieschlag, Zitzmann, & Kamischke, 2003; Nieschlag, 2010; Nieschlag & Behre, 2012; Zitzmann et al., 2017; Aly, 2019). Some notable examples of this include cyproterone acetate (CPA) (Aly, 2019; Wiki), MPA (Wiki), NET (Wiki) and its ester norethisterone acetate (NETA) (Wiki), levonorgestrel (LNG) (Zitzmann et al., 2017; Wiki), desogestrel (DSG) (Wu et al., 1999; Wiki), dienogest (DNG) (Meriggiola et al., 2002; Wiki), and progesterone (Wiki), among others. High doses of progestogens by themselves are able to maximally suppress testosterone levels by about 50 to 70% on average (Aly, 2019; Zitzmann et al., 2017 (Graph)). In combination with estrogen however, this increases to about 95%, with testosterone levels suppressed into the normal female range (Aly, 2019). Progestogens seem to usually achieve their maximal testosterone-suppressing capacity at a dose of around 5 to 10 times their ovulation-inhibiting dosage in cisgender women (Aly, 2019). Due to low potency or atypicality, oral progesterone and dydrogesterone are exceptions among progestogens which do not have significant antigonadotropic effects and which would not be expected to suppress testosterone levels (Aly, 2018; Wiki; Wiki).

    Besides helping with testosterone suppression, progestogens are of no clear or known benefit for feminization or breast development in transfeminine people. While some transfeminine people anecdotally claim to experience improved breast development with progestogens, an involvement of progestogens in improving breast size or shape is controversial and is not supported by theory nor evidence at present (Wiki; Aly, 2020). It is possible that premature introduction of progestogens, particularly at high doses, could actually have an unfavorable influence on breast development (Aly, 2020). Many transfeminine people have also anecdotally claimed that progestogens have a beneficial effect on their sexual desire. However, a review of the literature by the present author found that neither progesterone nor progestins positively influence sexual desire in humans (Aly, 2020). Instead, the available evidence suggests either a neutral influence or an inhibitory effect of progestogens on sexual desire, although the latter may be specific only to high doses of progestogens (Aly, 2020). Claims have been made that progesterone may have beneficial effects on mood in transfeminine people as well, but clinical support for such notions is likewise lacking at this time (Coleman et al., 2022; Nolan et al., 2022). It is notable that progesterone at luteal-phase levels, due to its neurosteroid metabolites like allopregnanolone, actually appears to worsen mood in around 30% of cisgender women, and produces more overt negative reactions, which constitute the diagnoses of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), in around 2 to 10% of women (Bäckström et al., 2011; Edler Schiller, Schmidt, & Rubinow, 2014; Sundström-Poromaa et al., 2020). More research is needed to evaluate the possible beneficial effects of progestogens in transfeminine people.

    Most clinically used progestogens have off-target activities in addition to their progestogenic activity, and these activities may be desirable or undesirable depending on the action in question (Kuhl, 2005; Stanczyk et al., 2013; Wiki; Table). Progesterone has a variety of neurosteroid as well as other activities that can result in central nervous system effects among others which are not shared by progestins. MPA as well as NET and its derivatives have weak androgenic activity, which is unfavorable in the context of transfeminine hormone therapy. NET and certain related progestins produce ethinylestradiol as a metabolite at high doses and hence can produce ethinylestradiol-like estrogenic effects, including increased risk of blood clots and associated cardiovascular problems. Other off-target actions of progestogens include antiandrogenic, glucocorticoid, and antimineralocorticoid activities. These actions can result in differences in therapeutic effectiveness (e.g., androgen suppression or blockade) as well as side effects and health risks. Some notable progestins without undesirable off-target activities (i.e., androgenic or glucocorticoid activity) include low-dose CPA, drospirenone (DRSP), dienogest, nomegestrol acetate (NOMAC), dydrogesterone, and hydroxyprogesterone caproate (OHPC). However, of these progestins, only CPA has been considerably used and studied in transfeminine people.

    The addition of progestogens to estrogen therapy has been associated with a number of unfavorable health effects. These include increased risk of blood clots (Wiki; Aly, 2020), coronary heart disease (Wiki), and breast cancer (Wiki; Aly, 2020). High doses of progestogens are also associated with increased risk of certain non-cancerous brain tumors including meningiomas and prolactinomas (Wiki; Aly, 2020). The coronary heart disease risk may be due to changes in blood lipids caused by the weak androgenic activity of certain progestogens, but the rest of the aforementioned risks are probably due to their progestogenic activity (Stanczyk et al., 2013; Jiang & Tian, 2017). Aside from health risks, progestogens have also been associated with adverse mood changes (Wiki; Wiki). However, besides the case of progesterone and its neurosteroid metabolites, these effects of progestogens are controversial and are not well-supported by evidence (Wiki; Wiki). Progestogens are otherwise generally well-tolerated and are regarded as producing little in the way of side effects.

    In contrast to certain progestins, progesterone has no unfavorable off-target activities. Due to its lack of androgenic activity, progesterone has no adverse influence on blood lipids and is not expected to raise the risk of coronary heart disease. The addition of oral progesterone to estrogen therapy notably has not been associated with increased risk of blood clots (Wiki). In addition, oral progesterone seems to have less risk of breast cancer than progestins with short-term therapy, although this is notably not the case with longer-term exposure (Wiki; Aly, 2020). Consequently, it has been suggested that progesterone, for reasons that have yet to be fully elucidated, may be a safer progestogen than progestins and that it should be the preferred progestogen for hormone therapy in cisgender women and transfeminine people. However, there are also theoretical arguments against such notions. Oral progesterone is known to produce very low progesterone levels and to have only weak progestogenic effects at typical doses (Aly, 2018; Wiki). The seemingly better safety of oral progesterone may simply be an artifact of the low progesterone levels that occur with it, and hence of progestogenic dosage. Non-oral progesterone, at doses resulting in physiological and full progestogenic strength, has never been properly evaluated in terms of health outcomes, and may have similar risks as progestins (Aly, 2018; Wiki).

    Due to their lack of known influence on feminization and breast development and their known and possible adverse effects and risks, progestogens are not routinely used in transfeminine hormone therapy at present. Major transgender health guidelines note the limitations of the available evidence on progestogens for transfeminine people and have mixed attitudes on their use, either explictly recommending against their use (Coleman et al., 2022—WPATH SOC8), taking a more neutral stance (Hembree et al., 2017—Endocrine Society guidelines), or being permissive of their use (Deutsch, 2016—UCSF guidelines). There is however a very major exception to the preceding in the form of CPA, an antiandrogen which is widely used in transfeminine hormone therapy to suppress testosterone production and which happens to be a powerful progestogen at the typical doses used in transfeminine people. CPA will be described below in the section on antiandrogens. Although progestogens have various health risks, cisgender women of course have progesterone, and the absolute risks of progestogens are very low in healthy young people. Risks like breast cancer also are exposure-dependent and take many years to develop. The testosterone suppression provided by progestogens can furthermore be very useful in transfeminine people, as is widely taken advantage of with CPA. Given these considerations, a limited duration of progestogen therapy in transfeminine people, for instance a few years to help suppress testosterone levels before surgical gonadal removal, may be considered quite acceptable.

    Progesterone can be used in transfeminine people by oral administration, sublingual administration, rectal administration, or by intramuscular or subcutaneous injection (Wiki). Progestins are usually used via oral administration, but certain progestins are also available in injectable formulations (Wiki).

    Oral Progesterone

    Progesterone is most commonly taken orally. It is used by this route in the form of oil-filled capsules containing 100 or 200 mg micronized progesterone under brand names such as Prometrium, Utrogestan, and Microgest (Wiki). Despite its widespread use, levels of progesterone via oral administration have been found using state-of-the-art assays (LC–MS) to be very low (<2 ng/mL [<6.4 nmol/L] at 100 mg/day) and inadequate for satisfactory progestogenic effects in various areas (Aly, 2018; Wiki). In relation to this, even high doses of oral progesterone (400 mg/day) showed no antigonadotropic effect or testosterone suppression in cisgender men (Aly, 2018; Wiki). This is in major contrast to non-oral forms of progesterone and to progestins, which produce dose-dependent and robust testosterone suppression (Aly, 2019; Wiki). In addition to its low progestogenic potency, oral progesterone is excessively converted into neurosteroid metabolites like allopregnanolone and pregnanolone. These metabolites act as potent GABAA receptor positive allosteric modulators, and can produce undesirable alcohol-like side effects such as sedation, cognitive, memory, and motor impairment, and mood changes (Wiki; Wiki). As such, while inconvenient, non-oral routes are greatly preferable for progesterone.

    Sublingual Progesterone

    Sublingual progesterone tablets exist and are marketed under the brand name Luteina but today are only available in Poland and Ukraine (Wiki). Oral progesterone could theoretically be taken sublingually, analogously to sublingual use of oral estradiol. However, because oral progesterone is formulated as oil-filled capsules, this makes it difficult and unpleasant to use by sublingual administration. Buccal progesterone, which would be expected to have similar characteristics to those of sublingual progesterone, has been used in medicine in the past, but is no longer marketed today (Wiki).

    Rectal Progesterone

    Progesterone is approved for use by rectal administration in the form of suppositories under the brand name Cyclogest (Wiki). This product is marketed in only a limited number of countries however, although it is available in the United Kingdom (Wiki). While not approved for use by rectal administration, oral progesterone capsules can be taken rectally instead of orally, and using them in this way may allow for much higher progesterone levels than would be achieved by oral administration due to avoidance of most first-pass metabolism. Rectal administration of oral progesterone capsules has not been formally studied, but oral progesterone capsules have been administered vaginally in cisgender women with success (Miles et al., 1994; Wang et al., 2019), and the vaginal and rectal routes are said to have similar pharmacokinetics in general (Goletiani, Keith, & Gorsky, 2007; Wiki). Hence, there is good theoretical basis for rectal administration of oral progesterone capsules being an effective route of administration of progesterone. Whereas oral progesterone achieves very low levels of progesterone, rectal progesterone can readily achieve normal luteal-phase levels of progesterone (Wiki). Although inconvenient, rectal administration may be the overall best route of administration of progesterone for transfeminine people.

    Injectable Progesterone

    Progesterone by injection is available as an oil solution for intramuscular injection under brand names such as Proluton, Progestaject, and Gestone (Wiki) and as an aqueous solution for subcutaneous injection under the brand name Prolutex (Wiki). Oil solutions of progesterone for intramuscular injection are widely available, whereas the aqueous solution of progesterone for subcutaneous injection is available only in some European countries (Wiki). Injectable progesterone, regardless of route, has a relatively short duration and must be injected once every one to three days (Wiki; Wiki). This makes it too inconvenient to use for most people. Unlike with estradiol, progesterone esters with longer durations than progesterone itself by injection are not chemically possible as progesterone has no hydroxyl groups available for esterification (Wiki). Injectable aqueous suspensions of microcrystalline progesterone were previously marketed and had a duration of 1 to 2 weeks, but these preparations were associated with pain at the injection site and were eventually discontinued (Aly, 2019; Wiki).

    Other Progesterone Routes

    Other progesterone routes, such as transdermal progesterone and subcutaneous progesterone pellets, are also known, but are not available as pharmaceutical drugs and are little-used medically (Wiki). This is related to the low potency of progesterone and difficulty achieving progesterone levels high enough for adequate therapeutic effects with these routes (Wiki; Wiki). In addition, progesterone pellets tend to be extruded at high rates (Wiki). In any case, certain compounding pharmacies may make forms of progesterone that could be used by these routes.

    Oral and Injectable Progestins

    Most progestins are taken orally in the form of solid tablets (Wiki). In contrast to progesterone, progestins, owing to their synthetic nature, are resistant to metabolism in the intestines and liver and have high oral bioavailability. In addition, unlike the case of the estrogen receptors, the progesterone receptors are expressed minimally or not at all in the liver, and there is no known first pass influence of progestogenic activity on liver synthesis (Lax, 1987; Stanczyk, Mathews, & Cortessis, 2017). As a result, there are no apparent problems with oral administration in the case of purely progestogenic progestins. However, some progestins have liver-impacting off-target hormonal actions, such as androgenic, estrogenic, and/or glucocorticoid activity, and this can result in adverse effects like unfavorable lipid changes or procoagulation—which may be augmented by the first pass with oral administration.

    A selection of progestins are available in injectable formulations, including for intramuscular or subcutaneous injection (Wiki). Some of the more notable ones include medroxyprogesterone acetate (MPA), norethisterone enanthate (NETE), hydroxyprogesterone caproate (OHPC), and algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA) (Wiki). In addition to being used alone, injectable progestins are used together with estradiol esters in combined injectable contraceptives (Wiki). These preparations are often used as a means of hormone therapy by transfeminine people in Latin America. Whereas injectable progesterone has a duration measured in days, injectable progestins have durations ranging from weeks to months, and can be injected much less often in comparison (Table).

    Additional Notes

    Table 6: Available forms and recommended doses of progestogens for transfeminine people:

    MedicationRouteFormDosage
    ProgesteroneOralOil-filled capsules100–300 mg 1–2x/day
     RectalSuppositories; Oil-filled capsules100–200 mg 1–2x/day
     IM injectionOil solution25–75 mg/1–3 days
     SC injectionWater solution25 mg/day
    ProgestinsOral; IM or SC injectionTablets; Oil solution; Water solutionVarious

    For progesterone levels with different forms, routes, and doses of progesterone, see the table here (only LC–MS and IA + CS assays for oral progesterone) and the graphs here.

    As with estradiol, there is high variability between individuals in progesterone levels. Conversely, there is less variability between individuals in the case of progestins.

    After removal of the gonads, progestogen doses can be lowered or adjusted to approximate normal female physiological exposure or they can be discontinued entirely.

    Antiandrogens

    Aside from estrogens and progestogens, there is another class of hormonal medications used in transfeminine hormone therapy known as antiandrogens (AAs). These medications reduce the effects of androgens in the body by either decreasing androgen production and thereby lowering androgen levels or by directly blocking the actions of androgens. They work via a variety of different mechanisms of action, and include androgen receptor antagonists, antigonadotropins, and androgen synthesis inhibitors.

    Androgen receptor antagonists act by directly blocking the effects of androgens, including testosterone, DHT, and other androgens, at the level of their biological target. They bind to the androgen receptor without activating it, thereby displacing androgens from the receptor. Due to the nature of their mechanism of action as competitive blockers of androgens, the antiandrogenic efficacy of androgen receptor antagonists is both highly dose-dependent and fundamentally dependent on testosterone levels. They do not act by lowering testosterone levels, although some androgen receptor antagonists may have additional antiandrogenic actions that result in decreased testosterone levels. Because androgen receptor antagonists do not work by lowering testosterone levels, blood work can be less informative for them compared to antiandrogens that suppress testosterone levels. Androgen receptor antagonists include steroidal antiandrogens (SAAs) like spironolactone (Aldactone) and cyproterone acetate (CPA; Androcur) and nonsteroidal antiandrogens (NSAAs) like bicalutamide (Casodex).

    Antigonadotropins suppress the gonadal production of androgens by inhibiting the GnRH-mediated secretion of gonadotropins from the pituitary gland. They include estrogens and progestogens. In addition, GnRH agonists such as leuprorelin (Lupron) and GnRH antagonists such as elagolix (Orilissa) act similarly and could likewise be described as antigonadotropins.

    Androgen synthesis inhibitors inhibit the enzyme-mediated synthesis of androgens. They include 5α-reductase inhibitors (5α-RIs) like finasteride (Propecia) and dutasteride (Avodart). There are also other types of androgen synthesis inhibitors, for instance potent 17α-hydroxylase/17,20-lyase inhibitors like ketoconazole (Nizoral) and abiraterone acetate (Zytiga). However, these agents have limitations (e.g., toxicity, high cost, and lack of experience) and have not been used in transfeminine hormone therapy.

    Although antigonadotropins and androgen synthesis inhibitors have antiandrogenic effects secondary to decreased androgen levels, they are not usually referred to as “antiandrogens”. Instead, this term is most commonly reserved to refer specifically to androgen receptor antagonists. However, antigonadotropins and androgen synthesis inhibitors may nonetheless be described as antiandrogens as well.

    After removal of the gonads, antiandrogens can be discontinued. If unwanted androgen-dependent symptoms, such as acne, seborrhea, or scalp hair loss, persist despite full suppression or ablation of gonadal testosterone, then a lower dose of an androgen receptor antagonist, such as 100 to 200 mg/day spironolactone or 12.5 to 25 mg/day bicalutamide, can be continued to treat these symptoms.

    Table 7: Available forms and recommended doses of antiandrogens for transfeminine people:

    MedicationTypeRouteFormDosage
    Cyproterone acetateProgestogen; Androgen receptor antagonistOralTablets2.5–12.5 mg/daya
    SpironolactoneAndrogen receptor antagonist; Weak androgen synthesis inhibitorOralTablets100–400 mg/dayb,c
    BicalutamideAndrogen receptor antagonistOralTablets12.5–50 mg/dayb

    a For CPA, this dose range is specifically one-quarter of a 10-mg tablet to one full 10-mg tablet per day (2.5–10 mg/day) or a quarter of a 50-mg tablet every other day or every 2 to 3 days (4.2–12.5 mg/day). A dosage of 5–10 mg/day or 6.25–12.5 mg/day is likely to ensure maximal testosterone suppression, while lower doses may be less effective (Aly, 2019). b For spironolactone and bicalutamide, it is assumed that testosterone levels are substantially suppressed (≤200 ng/dL [<6.9 nmol/L]). If testosterone levels are not suppressed to this range, then higher doses may be warranted. c Spironolactone and its metabolites have relatively short half-lives, and twice-daily administration in divided doses (e.g., 100–200 mg twice per day) is recommended.

    Figure 3: Suppression of gonadal testosterone production and circulating testosterone levels (ng/dL) with estradiol in combination with different antiandrogens over one year of hormone therapy in transfeminine people (Sofer et al., 2020). The estradiol forms included oral tablets 2–8 mg/day, transdermal gel 2.5–5 mg/day, and transdermal patches 50–200 μg/day. The antiandrogens included spironolactone 50–200 mg/day (n=16), cyproterone acetate (n=41), and GnRH agonists (specifically triptorelin 3.75 mg/month or goserelin 3.6 mg/month by injection) (n=10) (Sofer et al., 2020). It should be noted that lower doses of cyproterone acetate (10–12.5 mg/day) show equal testosterone suppression to higher doses (25–100 mg/day) and higher doses should no longer be used (Aly, 2019). The dashed horizontal line corresponds to the upper limit of the normal female range for testosterone levels.

    Cyproterone Acetate

    Cyproterone acetate (CPA; Androcur) is a progestogen and antiandrogen. It is widely used as a progestogen in cisgender women, including in hormonal birth control and menopausal hormone therapy. CPA is also widely used as an antiandrogen in the treatment of androgen-dependent conditions in cisgender women and cisgender men. In cisgender women, it is used to treat acne, hirsutism (excessive facial/body hair growth), scalp hair loss, and hyperandrogenism (high androgen levels) due to polycystic ovary syndrome (PCOS). In cisgender men, it is used to treat prostate cancer and to lower sex drive in the management of sexual problems such as paraphilias, hypersexuality, and sex offenses. Besides cisgender people, CPA is widely used as a component of hormone therapy—specifically as an antiandrogen—in transfeminine people. The medication is notably not marketed in the United States, where spironolactone is most commonly used instead. However, CPA is widely available throughout the rest of the world, and is the most frequently used antiandrogen in transfeminine people in Europe and probably the whole world overall (T’Sjoen et al., 2019; Glintborg et al., 2021; Coleman et al., 2022).

    As an antiandrogen, CPA has a dual mechanism of action of suppressing testosterone levels via its progestogenic and hence antigonadotropic activity and of acting as an androgen receptor antagonist (Aly, 2019). The progestogenic activity of CPA is of far greater potency than its androgen receptor antagonism however (Aly, 2019). The dose of CPA used as a progestogen in cisgender women is about 2 mg per day, which produces similar progestogenic effects to those of physiological luteal-phase levels of progesterone (e.g., suppression of gonadotropin secretion, ovulation inhibition, and endometrial transformation and protection) (Aly, 2019). Conversely, much higher doses of CPA of 50 to 300 mg/day have typically been used for androgen-dependent indications (Aly, 2019). These high doses of CPA result in profound progestogenic overdosage and associated side effects and risks (Aly, 2019). In transfeminine people, CPA has historically been used at doses of 50 to 150 mg/day (Aly, 2019). However, CPA doses have dramatically fallen in recent years, and today doses of no more than 10 to 12.5 mg/day are recommended (Aly, 2019; Coleman et al., 2022—WPATH SOC8). These lower doses of CPA still produce strong progestogenic effects, and in combination with estradiol, are equally effective as higher doses in suppressing testosterone levels (Aly, 2019; Meyer et al., 2020; Even Zohar et al., 2021; Kuijpers et al., 2021; Coleman et al., 2022). Even lower doses of CPA, for instance 5 to 6.25 mg/day, are currently being studied, and may still be fully effective (Aly, 2019).

    Given by itself without estrogen, CPA typically suppresses testosterone levels in people with testes by about 50 to 70%, down to about 150 to 300 ng/dL (5.2–10.4 nmol/L) (Meriggiola et al., 2002; Toorians et al., 2003; Giltay et al., 2004; T’Sjoen et al., 2005; Tack et al., 2017; Zitzmann et al., 2017; Aly, 2019). Lower doses of CPA alone (e.g., 10 mg/day) show the same degree of testosterone suppression as higher doses of CPA alone (e.g., 50–100 mg/day), indicating that the antigonadotropic effects of CPA are maximal at relatively low therapeutic doses of this medication (Aly, 2019). This is on the order of about 5 to 10 times the ovulation-inhibiting dosage of CPA in cisgender women, a dose–response relationship that has also been observed with a number of other progestogens (Aly, 2019). Per the preceding, CPA alone, regardless of dosage, is unable to reduce testosterone levels into the normal female range (<50 ng/dL [<1.7 nmol/L]). But when CPA is combined with estradiol, even at relatively small doses of estradiol, it consistently suppresses testosterone levels into the normal female range (Aly, 2019; Angus et al., 2019; Gava et al., 2020; Sofer et al., 2020; Collet et al., 2022). However, it appears that a certain minimum level of estradiol, perhaps around 60 pg/mL (220 pmol/L) on average, is required for this to occur (Aly, 2019). Estradiol levels lower than this threshold in those taking CPA, which can occasionally be encountered in transfeminine people due to estradiol being dosed too low, have the potential to compromise full testosterone suppression (Aly, 2019).

    In addition to testosterone suppression, CPA can dose-dependently block the androgen receptor (Aly, 2019). However, relatively high doses of CPA are needed to considerably antagonize the androgen receptor (e.g., 50–300 mg/day), and lower doses (e.g., ≤12.5 mg/day) may not be able to do this to a meaningful degree (Aly, 2019). As such, lower doses of CPA may essentially be purely progestogenic, with minimal or no androgen receptor antagonism. In this regard, referring to CPA at such doses as an “antiandrogen”—rather than as a “progestogen”—may be considered somewhat of a misnomer. Higher doses of CPA (>12.5 mg/day) can no longer be considered safe due to the massive progestogenic overdosage that occurs with them, and should no longer be used in transfeminine people. Moreover, as testosterone levels are usually suppressed into the normal female range in transfeminine people taking estradiol plus CPA, there is no actual need for any additional androgen receptor blockade (Aly, 2019).

    CPA has been reported to produce various side effects. Some of these side effects include fatigue and a degree of weight gain (Belisle & Love, 1986; Hammerstein, 1990; Martinez-Martin et al., 2022). CPA might be able to produce a magnitude of sexual dysfunction (e.g., reduced sexual desire) beyond that expected with testosterone suppression alone (Wiki; Aly, 2019). It may also have a small risk of depressive mood changes (Wiki). In transfeminine people, CPA has been documented to produce pregnancy-like breast changes (i.e., lobuloalveolar development of the mammary glands) (Kanhai et al., 2000). In relation to this, CPA sometimes causes lactation as a side effect (Gooren, Harmsen-Louman, & van Kessel, 1985; Schlatterer et al., 1998; Bazarra-Castro, 2009). Concerns have been raised about premature introduction of progestogens—particularly at high doses like with CPA—and possible adverse influence on breast development (Aly, 2020). However, little data exists in humans to substantiate such concerns at present. The side effects of CPA are assumed to be dose-dependent, and using the lowest effective doses is expected to minimize its side effects.

    As CPA is a progestogen, it is associated with increased risks of breast cancer (Fournier, Berrino, & Clavel-Chapelon, 2008; CGHFBC, 2019; de Blok et al., 2019; Aly, 2020; Wiki) and blood clots (Seaman et al., 2007; Connors & Middeldorp, 2019; Aly, 2020; Wiki) even at very low doses (e.g., 2 mg/day). Higher doses of CPA, likewise presumed to be due to its progestogenic activity, are additionally associated with elevated prolactin levels (Sofer et al., 2020; Wilson et al., 2020; Wiki) as well as with certain generally non-cancerous brain tumors including prolactinomas (McFarlane, Zajac, & Cheung, 2018; Nota et al., 2018; Wiki) and meningiomas (McFarlane, Zajac, & Cheung, 2018; Nota et al., 2018; Millward et al., 2021; Weill et al., 2021; Aly, 2020; Wiki). These risks appear to be dose-dependent, and thus are likely to be minimized with lower doses of CPA. Besides risks related to its progestogenic activity, CPA at high doses has shown weak but significant androgenic effects in the liver and has been associated with an unfavorable influence on lipid profile, for instance decreased HDL (“good”) cholesterol levels (Coleman et al., 2022; Wiki). Long-term, this could result in an increase in the risk of coronary heart disease. Other potential adverse effects of CPA at high doses with unclear mechanisms may include increased blood pressure and heightened insulin resistance (Martinez-Martin et al., 2022). Additionally, CPA has been associated with abnormal liver function tests and rare cases of liver toxicity, including at doses used in transfeminine people of 25 to 50 mg/day (Heinemann et al., 1997; Bessone et al., 2016; Kumar et al., 2021; Wiki; Table). The likelihood of abnormal liver function tests with CPA, and probably of liver toxicity, appears to be much lower at doses of less than 20 mg/day (Wiki). More than 100 cases of clinically significant liver toxicity have been reported with CPA, but only two cases have been reported with CPA at doses of 50 mg/day or less (Wiki; Table). Monitoring of prolactin levels to detect prolactinomas, and monitoring of liver function to detect liver toxicity, may both be advisable in people taking CPA. Regular magnetic resonance imaging (MRI) scans have also been recommended to monitor for meningiomas in people taking CPA (at ≥10 mg/day) (Aly, 2020).

    CPA is usually taken orally in the form of tablets (e.g., 10, 50, and 100 mg) (Wiki). Under the brand name Androcur Depot, it is also available as a long-lasting 300 mg depot injectable in some countries (Wiki). However, this formulation is not commonly used in transfeminine people, and happens to correspond to very high doses in terms of CPA exposure. A pill cutter (Amazon) can be used to split CPA tablets and achieve lower doses (e.g., 12.5 mg doses with 50-mg tablets). CPA has a relatively long elimination half-life of about 1.6 to 4.3 days (Wiki; Aly, 2019). As such, it can be taken once daily, or even as infrequently as once every 2 or 3 days, if needed (Aly, 2019). In addition to splitting of CPA tablets, dosing CPA once every 2 or 3 days can also be useful for achieving lower doses (Aly, 2019).

    As already described, CPA is a powerful progestogen even at the relatively low doses now used in transfeminine people (e.g., 5–12.5 mg/day). As such, there is no need, nor point, in adding another progestogen, for instance progesterone, in those who are taking CPA—at least if the goal of doing so is to produce progestogenic effects. This is something that is often overlooked in people taking CPA, and can result in increased costs, side effects, and inconvenience without any expected benefit.

    Spironolactone

    Spironolactone (Aldactone) is an antiandrogen and antimineralocorticoid. It is widely used as an antiandrogen in cisgender women for treatment of androgen-dependent hair and skin conditions like acne, hirsutism (excessive facial/body hair growth), and scalp hair loss, in cisgender women for treatment of hyperandrogenism (high androgen levels) due to polycystic ovary syndrome (PCOS), and in transfeminine people as a component of hormone therapy. Spironolactone is particularly widely used in transfeminine people in the United States, where it is the most commonly used antiandrogen in this population. As an antimineralocorticoid, the original and primary use of spironolactone in medicine, it is used to treat heart failure, high blood pressure, high mineralocorticoid levels, low potassium levels, and conditions of excess fluid retention like nephrotic syndrome and ascites, among others (Wiki). In terms of its antiandrogenic actions, spironolactone is a relatively weak androgen receptor antagonist as well as a weak androgen synthesis inhibitor (Wiki). The androgen synthesis inhibition of spironolactone is mediated specifically via inhibition of 17α-hydroxylase and 17,20-lyase (Wiki). Spironolactone does not appear to have meaningful progestogenic activity, 5α-reductase inhibition, or direct estrogenic activity (Wiki). However, indirect estrogenic effects secondary to its antiandrogenic activity (e.g., breast development and feminization) can occur with it at sufficiently high doses (Wiki).

    Spironolactone shows limited and highly inconsistent effects on testosterone levels in clinical studies in cisgender men, cisgender women, and transfeminine people, with most studies finding no change in levels, some studies finding a decrease in levels, and a small number even finding an increase in levels (Aly, 2018). In spite of this, studies commonly find that spironolactone still produces antiandrogenic effects even when androgen levels remain unchanged. Hence, the primary mechanism of action of spironolactone as an antiandrogen appears to be androgen receptor blockade. In relation to this, in transfeminine people taking spironolactone as an antiandrogen, the estrogen component of the regimen is likely to be the main or possibly sole agent suppressing testosterone production. This is in part based on studies in transfeminine people comparing estradiol plus spironolactone to estradiol alone (e.g., Leinung, 2014; Leinung, Feustel, & Joseph, 2018; Angus et al., 2019) and on studies comparing testosterone levels with different doses of spironolactone (e.g., Liang et al., 2018; SoRelle et al., 2019; Allen et al., 2021). Due to the minimal influence of spironolactone on testosterone production, testosterone levels are not usually suppressed into the female range in transfeminine people taking estradiol plus spironolactone, with testosterone levels often remaining well above this range (e.g., 50–450 ng/dL [1.7–15.6 nmol/L] on average) (Leinung, 2014; Leinung, Feustel, & Joseph, 2018; Liang et al., 2018; Angus et al., 2019; Jain, Kwan, & Forcier, 2019; SoRelle et al., 2019; Sofer et al., 2020; Burinkul et al., 2021). However, testosterone levels do tend to decline gradually over time in transfeminine people on this regimen (e.g., Liang et al., 2018; Sofer et al., 2020 (Graph); Allen et al., 2021).

    Due to its relatively weak androgen receptor antagonism, spironolactone is likely best-suited for blocking female-range or somewhat-higher testosterone levels (e.g., <100 ng/dL [<3.5 nmol/L]) (Aly, 2018). This is based on clinical dose-ranging studies of spironolactone (typically using 50–200 mg/day) in healthy cisgender women and cisgender women with PCOS (Goodfellow et al., 1984; Lobo et al., 1985; Hammerstein, 1990; James, Jamerson, & Aguh, 2022) as well as comparative studies of spironolactone against the more-potent antiandrogen flutamide (Cusan et al., 1994; Erenus et al., 1994; Shaw, 1996). The clinical antiandrogenic efficacy of spironolactone has been very limitedly assessed in transfeminine people to date, and is largely unknown (Angus et al., 2021). In any case, the antiandrogenic efficacy of spironolactone in cisgender women with androgen-dependent hair and skin conditions is well-established, and the medication thus does appear to be effective so long as testosterone levels are not too high (Brown et al., 2009; van Zuuren & Fedorowicz, 2016; Layton et al., 2017; Barrionuevo et al., 2018; James, Jamerson, & Aguh, 2022). In addition, higher doses of spironolactone (e.g., 300–400 mg/day) may be more useful for blocking higher testosterone levels in transfeminine people, and are allowed for by transgender care guidelines (Aly, 2020).

    Consequent to spironolactone’s limited and inconsistent influence on testosterone levels and its relatively weak androgen receptor antagonism, estradiol plus spironolactone regimens will likely not be fully effective in terms of testosterone suppression for many transfeminine people. This is liable to result in suboptimal demasculinization, feminization, and breast development in these individuals. Other antiandrogenic approaches, such as bicalutamide, CPA, GnRH modulators, and high-dose estradiol monotherapy, will likely be more effective in these cases owing either to their ability to more potently block androgens or their capacity to reliably reduce testosterone levels into the female range. If testosterone levels are still too high with estradiol plus spironolactone, a switch to a different antiandrogen, increasing to a higher dosage of estradiol, or addition of a clinically antigonadotropic progestogen (e.g., non-oral progesterone or a progestin) should be considered.

    Spironolactone is a strong antimineralocorticoid, or antagonist of the mineralocorticoid receptor, the biological target of the mineralocorticoid steroid hormones aldosterone and 11-deoxycorticosterone. This is an action that spironolactone shares with progesterone, although spironolactone is a much more potent antimineralocorticoid than progesterone. The mineralocorticoid receptor is involved in regulating electrolyte and fluid balances, among other roles. Spironolactone is associated with modestly lowered blood pressure, which may be considered a beneficial effect of its antimineralocorticoid activity (Martinez-Martin et al., 2022). Although spironolactone is usually well-tolerated, it can sometimes produce antimineralocorticoid side effects such as excessively lowered blood pressure, dizziness, fatigue, urinary frequency, and increased cortisol levels, among others (Kellner & Wiedemann, 2008; Kim & Del Rosso, 2012; Zaenglein et al., 2016; Layton et al., 2017; James, Jamerson, & Aguh, 2022). It has been argued by some in the online transgender community that spironolactone, via its antimineralocorticoid activity and increased cortisol levels, may increase visceral fat in transfeminine people (Aly, 2020). However, evidence does not support this hypothetical side effect at present (Aly, 2020). Available data also do not support spironolactone stunting breast development in transfeminine people or producing serious neuropsychiatric side effects, such as prominent depressive mood changes.

    The most important risk of spironolactone, which is consequent to its antimineralocorticoid activity, is hyperkalemia (high potassium levels) (Wiki). This complication is rare and is mostly limited to those who have specific risk factors for it, but is serious and can result in hospitalization or death. Monitoring of blood potassium levels during spironolactone therapy is advisable in those with risk factors for hyperkalemia, but does not appear to be necessary in people without such risk factors (Plovanich, Weng, & Mostaghimi, 2015; Zaenglein et al., 2016; Layton et al., 2017; Millington, Liu, & Chan, 2019; Wang & Lipner, 2020; Gupta et al., 2022; Hayes et al., 2022). Risk factors for hyperkalemia include older age (>45 years), reduced kidney function, concomitant use of other potassium-elevating drugs, and intake of potassium supplements or potassium-containing salt substitutes. Other notable potassium-elevating drugs include other potassium-sparing diuretics (e.g., amiloride (Midamor), triamterene (Dyrenium), other antimineralocorticoids), ACE inhibitors, angiotensin II receptor blockers, and the antibiotic trimethoprim (Bactrim), among others (Kim & Rosso, 2012; Salem et al., 2014). As an example drug interaction, serious hyperkalemia and sudden death can occur in elderly people (>65 years of age) concomitantly taking spironolactone and trimethoprim (Antoniou et al., 2011; Antoniou et al., 2015).

    In people who are at-risk for hyperkalemia, dietary restriction to limit intake of potassium-rich foods is often recommended (Roscioni et al., 2012; Cupisti et al., 2018). This is often encountered in transgender health as transfeminine people being told “not to eat bananas”, which are said to be high in potassium. However, limiting dietary potassium with spironolactone to avoid hyperkalemia is theoretical and not actually evidence-based, with data so far contradicting its efficacy (St-Jules, Goldfarb, & Sevick, 2016; St-Jules & Fouque, 2021; Babich, Kalantar-Zadeh, & Joshi, 2022; St-Jules & Fouque, 2022). As such, routine restriction of dietary potassium with spironolactone is probably not warranted.

    Aside from its antimineralocorticoid activity, spironolactone has been reported to increase levels of LDL (“bad”) cholesterol levels and to decrease levels of HDL (“good”) cholesterol in women with PCOS (Nakhjavani et al., 2009). However, findings appear to be conflicting, with other studies not finding unfavorable influences on cholesterol levels with spironolactone (Polyzos et al., 2011). Long-term, adverse effects on cholesterol levels could result in an increase in the risk of coronary heart disease.

    Spironolactone is taken orally in the form of tablets (e.g., 25, 50, and 100 mg) (Wiki). It is a prodrug of several active metabolites, including 7α-thiomethylspironolactone, 6β-hydroxy-7α-thiomethylspironolactone, and canrenone (7α-desthioacetyl-δ6-spironolactone) (Wiki). Spironolactone and these active metabolites have elimination half-lives of 1.4 hours, 13.8 hours, 15.0 hours, and 16.5 hours, respectively (Wiki). Due to the relatively short duration of elevated drug levels with spironolactone and its active metabolites (Graph), twice-daily administration of spironolactone in divided doses may be more optimal than once-daily intake and is advised (Reiter et al., 2010).

    Bicalutamide

    Bicalutamide (Casodex) is a nonsteroidal antiandrogen (NSAA) which acts as a potent and highly selective androgen receptor antagonist (Wiki). It is primarily used in the treatment of prostate cancer in cisgender men. Prostate cancer is an androgen-dependent cancer which antiandrogens can help to slow the progression of, and this use constitutes the vast majority of prescriptions for bicalutamide (Wiki). In addition to prostate cancer, although to a much lesser extent, bicalutamide has been used in the treatment of hirsutism (excessive facial/body hair growth), scalp hair loss, and polycystic ovary syndrome (PCOS) in cisgender women, peripheral or gonadotropin-independent precocious puberty (a rare form of precocious puberty in which antigonadotropins such as GnRH agonists are not effective) in cisgender boys, and priapism in cisgender men (Wiki). Bicalutamide is also becoming increasingly adopted for use as an antiandrogen in transfeminine people (Aly, 2020; Wiki). However, its use in transgender health is still very limited, and well-regarded transgender care guidelines either recommend against its use (Deutsch, 2016—UCSF guidelines; Coleman et al., 2022—WPATH SOC8) or are only cautiously permissive of its use (Thompson et al., 2021—Fenway Health guidelines). This is due to a lack of studies of bicalutamide in transfeminine people and its potential risks. Nonetheless, a small but growing number of clinicians are using bicalutamide in transfeminine people or are willing to prescribe it, with these clinicians located particularly in the United States. A single small clinical study has assessed bicalutamide in transfeminine people so far, specifically as a puberty blocker in 13 transfeminine adolescents who were denied insurance coverage for GnRH agonists (Neyman, Fuqua, & Eugster, 2019).

    Bicalutamide is a much more potent androgen receptor antagonist than either spironolactone or CPA (Wiki; Neyman, Fuqua, & Eugster, 2019). It is typically used in transfeminine people at a dosage of 25 to 50 mg/day, although this dosage has been arbitrarily selected and is not based on clinical data. Nonetheless, due to its relatively high potency as an androgen receptor antagonist and concomitant suppression of testosterone levels by estradiol, these doses may be adequate for testosterone blockade for many transfeminine people. At higher doses (>50 mg/day), bicalutamide is able to substantially block male-range testosterone levels (>300 ng/dL [>10.4 nmol/L]) based on studies of bicalutamide monotherapy in cisgender men with prostate cancer (Wiki). This is something that spironolactone and CPA are not capable of in the same way. Owing to its selectivity for the androgen receptor, bicalutamide has no off-target hormonal activity and produces almost no side effects in women (Wiki; Erem, 2013; Moretti et al., 2018). The only apparent side effect of bicalutamide in a rigorous clinical trial of the drug for hirsutism in cisgender women was significantly increased total and LDL (“bad”) cholesterol levels (Moretti et al., 2018). Hence, bicalutamide tends to be very well-tolerated. The relative lack of side effects with bicalutamide is contrast to other antiandrogens like spironolactone and CPA, which are not pure androgen receptor antagonists and have off-target hormonal actions like antimineralocorticoid activity or strong progestogenic activity with consequent side effects and risks.

    As a selective androgen receptor antagonist, bicalutamide taken by itself does not decrease testosterone production or levels but rather increases them (Wiki). This is due to a loss of androgen receptor-mediated negative feedback on gonadotropin secretion and a consequent compensatory upregulation of gonadal testosterone production (Wiki). Bicalutamide more than blocks the effects of any increase in testosterone it causes, and in fact fundamentally cannot increase testosterone levels more than it can block them (Wiki). In addition, increases in testosterone levels with bicalutamide will be blunted or abolished if it is combined with an adequate dose of an antigonadotropin such as estradiol (Wiki; Wiki). Since estradiol is made from testosterone in the body, bicalutamide taken alone also preserves and increases estradiol production and levels (Wiki). Because of this, although bicalutamide has no other important intrinsic hormonal activity besides its antiandrogenic activity, it produces robust indirect estrogenic effects including feminization and breast development even when it is not combined with estrogen (Wiki; Wiki; Neyman, Fuqua, & Eugster, 2019). This has important implications for the use of bicalutamide as a puberty blocker in transfeminine adolescents, as bicalutamide does not actually block puberty like conventional puberty blockers (GnRH agonists) but instead has the effect of dose-dependently converting male puberty into female puberty (Wiki; Neyman, Fuqua, & Eugster, 2019).

    Bicalutamide has certain health risks, which has been a major reason that it has not been more readily adopted in transfeminine hormone therapy (Aly, 2020). It has a small risk of liver toxicity (Wiki; Aly, 2020) and of lung toxicity (Wiki). Abnormal liver function tests (LFTs), such as elevated liver enzymes and elevated bilirubin, occurred in about 3.4% of men with bicalutamide monotherapy plus standard care versus 1.9% of men with placebo plus standard care in the Early Prostate Trial (EPC) clinical programme after 3.0 years of follow-up (Wiki). In clinical trials, treatment with bicalutamide had to be discontinued in about 0.3 to 1.5% of men due to LFTs that became too highly elevated and could have progressed to serious liver toxicity (Wiki). To date, there are around 10 published case reports of serious liver toxicity, including cases of death, with bicalutamide, all of which have been in men with prostate cancer (Wiki; Table; Aly, 2020). There have also been a few unpublished reports of serious liver toxicity including deaths with bicalutamide in transfeminine people (Aly, 2020). However, these reports have not been confirmed, and they may or may not be reliable. In addition to the preceding reports, hundreds of additional instances of liver complications in people taking bicalutamide exist in the United States FDA Adverse Event Reporting System (FAERS) database (Wiki; FDA). Abnormal LFTs with bicalutamide usually occur within the first 3 to 6 months of treatment (Kolvenbag & Blackledge, 1996; Casodex FDA Label), and all case reports of liver toxicity with bicalutamide have had an onset of less than 6 months (Table). The liver toxicity of bicalutamide is not known to be dose-dependent across its clinically used dose range (Wiki). Abnormal LFTs have occurred with bicalutamide (at rates of 2.9% to 11.4%) even at relatively low doses in cisgender women (e.g., 10–50 mg/day) (de Melo Carvalho, 2022). Due to its risk of liver toxicity, periodic liver monitoring is strongly advised with bicalutamide, especially within the first 6 months of treatment. Possible signs of liver toxicity include nausea, vomiting, abdominal pain, fatigue, appetite loss, flu-like symptoms, dark urine, and jaundice (yellowing of the skin/eyes) (Wiki).

    In terms of its lung toxicity risk, bicalutamide has been associated rarely with interstitial pneumonitis, which can lead to pulmonary fibrosis and can be fatal, and also less often with eosinophilic lung disease (Wiki; Table). As of writing, 15 published case reports of interstitial pneumonitis and 2 case reports of eosinophilic lung disease in association with bicalutamide therapy exist, likewise all in men with prostate cancer (Table). As with liver toxicity, hundreds of additional cases of interstitial pneumonitis in people taking bicalutamide exist in the United States FAERS database (Wiki; FDA). It has been estimated that interstitial pneumonitis with bicalutamide occurs at a rate of around 1 in 10,000 people, although this may be an underestimate due to under-reporting (Wiki; Ahmad & Graham, 2003). Asian people may be especially likely to experience lung toxicity with bicalutamide and other NSAAs, as much higher incidences have been observed in this population (Mahler et al., 1996; Wu et al., 2022). There is no laboratory test for routine monitoring of lung changes with bicalutamide. Possible signs of relevant lung toxicity include dyspnea (difficulty breathing or shortness of breath), coughing, and pharyngitis (inflammation of the throat, typically manifesting as sore throat) (Wiki).

    Aside from liver and lung toxicity, bicalutamide monotherapy has been found in cisgender men with prostate cancer to increase the risk of death due to causes other than prostate cancer (Iversen et al., 2004; Iversen et al., 2006; Wellington & Keam, 2006; Jia & Spratt, 2022; Wiki). This led to marketing authorization of bicalutamide for treatment of the earliest stage of prostate cancer being revoked and to the drug being abandoned for this use (Wiki). Bicalutamide remains approved and used for treatment of later stages of prostate cancer, as the antiandrogenic benefits of bicalutamide against prostate cancer outweigh any adverse influence it has on non-prostate-cancer mortality in these more severe stages. The mechanisms underlying the increase in risk of death with bicalutamide in men are unknown (Wiki). It is also unclear whether bicalutamide could likewise increase the risk of death in transfeminine people. Limitations of generalizing these studies to transfeminine people include the men in the trials being relatively old and ill, a relatively high dosage of bicalutamide (150 mg/day) being used in the trials for an extended duration (e.g., 5 years), the question of whether the risks were due to androgen deprivation or to specific drug-related toxicity of bicalutamide, and estradiol levels with bicalutamide monotherapy in men with prostate cancer being only about 30 to 50 pg/mL (110–184 pmol/L) (Wiki). The preceding estradiol levels are well above castrate levels and are sufficient for a substantial degree of estrogenic effect, but are nonetheless below those recommended for transfeminine people and potentially needed for full sex-hormone replacement (which are ≥50 pg/mL [≥184 pmol/L]). In any case, as the specific mechanisms underlying the increased mortality risk with bicalutamide seen in men with prostate cancer are uncertain, and as clinical safety data showing that the risk does not generalize do not exist, it remains a possibility that bicalutamide could also increase the risk of death in transfeminine people.

    Bicalutamide is taken orally in the form of tablets (e.g., 50 and 150 mg) (Wiki). Due to saturation of absorption in the gastrointestinal tract, the oral bioavailability of bicalutamide progressively starts to decrease above a dosage of about 150 mg/day, and there is no further increase in bicalutamide levels above 300 mg/day (Wiki; Graph). Bicalutamide has a very long elimination half-life of about 6 to 10 days (Wiki; Graphs). As a result, it does not necessarily have to be taken daily, and can be dosed less often (in proportionally higher doses)—for instance twice weekly or even once weekly—if this is more convenient or otherwise desired. Due to its long half-life, bicalutamide requires about 4 to 12 weeks to fully reach steady-state levels (Wiki; Graph; Wiki). However, about 50% of steady state is reached within 1 week of administration of bicalutamide, and about 80 to 90% of steady state is reached after 3 to 4 weeks (Wiki; Graph; Wiki). Loading doses of bicalutamide can be taken to reach steady state more quickly if desired. Animal studies originally suggested that bicalutamide did not cross the blood–brain barrier and hence was peripherally selective (i.e., did not block androgen receptors in the brain) (Wiki). However, subsequent clinical studies found that this was not similarly the case in humans, in whom bicalutamide shows clear and robust centrally mediated antiandrogenic effects (Wiki).

    Older NSAAs related to bicalutamide like flutamide (Eulexin) and nilutamide (Anandron, Nilandron) have much greater risks in comparison to bicalutamide and should not be used in transfeminine people. Nilutamide was previously characterized as an antiandrogen in transfeminine people in several studies, but was not further pursued probably due to its very high incidence of lung toxicity and other side effects (Aly, 2020; Wiki; Wiki). Flutamide has been used limitedly as an antiandrogen in transfeminine people in the past, but should no longer be used due to a much higher risk of liver toxicity than bicalutamide as well as other side effects and drawbacks (Aly, 2020; Wiki). Other newer and more-potent NSAAs like enzalutamide (Xtandi), apalutamide (Erleada), and darolutamide (Nubeqa) also have risks and have been studied and used little outside of prostate cancer to date.

    5α-Reductase Inhibitors

    Testosterone is converted into DHT within certain tissues in the body (Swerdloff et al., 2017). DHT is an androgen metabolite of testosterone with several-fold higher activity than testosterone. The transformation of testosterone into DHT is mediated by the enzyme 5α-reductase. The tissues in which 5α-reductase is present and testosterone is converted into DHT are limited but most importantly include the skin, hair follicles, and prostate gland. Although DHT is more potent than testosterone, it is thought to have minimal biological role as a circulating hormone (Horton, 1992; Swerdloff et al., 2017). Instead, testosterone serves as the main circulating androgen, and the role of DHT is thought to be mainly via local metabolism and potentiation of testosterone into DHT within certain tissues.

    5α-Reductase inhibitors (5α-RIs), such as finasteride (Proscar, Propecia) and dutasteride (Avodart), inhibit 5α-reductase and thereby block the conversion of testosterone into DHT. This results in marked decreases in circulating and within-tissue levels of DHT. Due to the primary role of DHT as a mediator in tissues rather than as circulating hormone, the antiandrogenic efficacy of 5α-RIs is limited. This is evidenced by the fact that they are well-tolerated in cisgender men and do not cause notable demasculinization in these individuals (Hirshburg, 2016). The medical use of 5α-RIs is mainly restricted to the treatment of scalp hair loss in men and women, hirsutism (excessive facial/body hair) in women, and prostate enlargement in men. They might also be useful for acne in women, but evidence of this is very limited (Wiki). Due to their specificity, 5α-RIs are inappropriate as general antiandrogens in transfeminine people. Moreover, DHT levels decrease in tandem with testosterone levels with suppression of testosterone production in transfeminine hormone therapy, and routine use of 5α-RIs in transfeminine people with testosterone levels within the female range is of limited usefulness and can be considered unnecessary (Gooren et al., 2016; Irwig, 2020; Prince & Safer, 2020; Glintborg et al., 2021). In any case, 5α-RIs may be useful in transfeminine people on hormone therapy who have persistent body hair growth or scalp hair loss—as they have been shown to be in cisgender women (Barrionuevo et al., 2018; Prince & Safer, 2020). However, it is notable that evidence of effectiveness in cisgender women is better for androgen receptor antagonists for such indications (van Zuuren et al., 2015). This is intuitive as androgen receptor antagonists block both testosterone and DHT whereas 5α-RIs only prevent conversion of testosterone into DHT. Hence, although 5α-RIs strongly reduce or eliminate DHT and their net effect is antiandrogenic, they do not decrease testosterone levels and in fact increase them.

    There are three subtypes of 5α-reductase. Dutasteride inhibits all three subtypes of 5α-reductase whereas finasteride only inhibits two of the subtypes. As a result of this, dutasteride is a more complete 5α-RI than finasteride. Dutasteride decreases DHT levels in the blood by up to 98% while finasteride can only decrease them by around 65 to 70%. As nearly all circulating DHT originates from synthesis in peripheral tissues, these decreases indicate parallel reductions in tissue DHT production (Horton, 1992). In accordance with these findings, dutasteride has been found to be more effective than finasteride in the treatment of scalp hair loss in men (Zhou et al., 2018; Dhurat et al., 2020; Wiki). For these reasons, although both finasteride and dutasteride are effective 5α-RIs, dutasteride may be the preferable choice if a 5α-RI is used (Zhou et al., 2018; Dhurat et al., 2020).

    A potentially undesirable effect of 5α-RIs in transfeminine people is that they may increase circulating testosterone levels to a degree in those in whom testosterone production isn’t fully suppressed (Leinung, Feustel, & Joseph, 2018; Aly, 2019; Traish et al., 2019; Irwig, 2020; Glintborg et al., 2021). It appears that DHT adds significantly to negative feedback on gonadotropin secretion in the pituitary gland in people with testes who have low testosterone levels relative to the normal male range (Traish et al., 2019). The therapeutic implications of this for transfeminine people, if any, are uncertain.

    Another potentially undesirable action of 5α-RIs is that they inhibit not only the production of DHT but also of certain neurosteroids. Neurosteroids are steroids that act on the nervous system—most notably the brain. Examples of neurosteroids that 5α-RIs inhibit the synthesis of include allopregnanolone, which is formed from progesterone, and 3α-androstanediol, which is derived from testosterone and DHT. Research suggests that these neurosteroids have significant biological modulatory roles in mood, anxiety, stress, and other cognitive/emotional processes (King, 2013). Possibly in relation to this, 5α-RIs have been associated with a small risk of depression (Welk et al., 2018; Deng et al., 2020; Dyson, Cantrell, & Lund, 2020; Nguyen et al., 2020; Wiki). Claims of other, more significant and persistent side effects with 5α-RIs, which are termed “post-finasteride syndrome” (PFS) in the case of finasteride, also exist (Traish, 2020). However, they are based on low-quality reports and are controversial (Fertig et al., 2016; Rezende, Dias, & Trüeb, 2018). The nocebo effect is likely to worsen perceptions of side effects with 5α-RIs (Kuhl & Wiegratz, 2017; Maksym et al., 2019).

    Clinical dose-ranging studies have found that lower doses of finasteride and dutasteride than are typically used still provide substantial or near-maximal 5α-reductase inhibition (Gormley et al., 1990; Vermeulen et al., 1991; Sudduth & Koronkowski, 1993; Drake et al., 1999; Roberts et al., 1999; Clark et al., 2004; Frye, 2006; Olsen et al., 2006; Harcha et al., 2014; Kuhl & Wiegratz, 2017). In one study with finasteride for instance, DHT levels decreased by 49.5% at 0.05 mg/day, 68.6% at 0.2 mg/day, 71.4% at 1 mg/day, and 72.2% at 5 mg/day (Drake et al., 1999). Parallel reductions in DHT levels were seen locally in the scalp (Drake et al., 1999). In a study with dutasteride, DHT levels were decreased by 52.9% at 0.05 mg/day, 94.7% at 0.5 mg/day, 97.7% at 2.5 mg/day, and 98.4% at 5 mg/day (Clark et al., 2004). Based on these findings, 5α-RIs can potentially be taken at lower doses to help reduce medication costs if needed. Finasteride tablets can be split to achieve smaller doses. Conversely, dutasteride cannot be split as it is formulated as an oil capsule. However, dutasteride has a long half-life, and instead of dividing pills, it can be taken less frequently (e.g., once every few days) as a means of reducing dosage.

    5α-Reductase inhibitors are taken orally in the form of tablets and capsules. Compounded topical formulations of finasteride also exist (Marks et al., 2020). However, caution is advised with these preparations as they have been found to be excessively dosed and to produce equivalent systemic DHT suppression as oral finasteride formulations (Marks et al., 2020). Lower-concentration formulations of topical finsteride on the other hand may be more locally selective (Marks et al., 2020).

    Table 8: Available forms and recommended doses of 5α-reductase inhibitors for transfeminine people:

    MedicationRouteFormDosage
    DutasterideOralCapsules0.05–2.5 mg/day
    FinasterideOralTablets0.05–5 mg/day

    GnRH Agonists and Antagonists

    GnRH agonists and antagonists (GnRHa), also known as GnRH receptor agonists and antagonists or GnRH modulators, are antiandrogens which work by preventing the effects of GnRH in the pituitary gland and thereby suppressing LH and FSH secretion. Receptor agonists normally activate receptors while receptor antagonists block and thereby inhibit the activation of receptors. Due to a physiological quirk however, GnRH agonists and antagonists have the same effects in the pituitary gland. This is because GnRH is secreted in pulses under normal physiological circumstances, and when the GnRH receptor is unnaturally activated in a continuous manner, as with exogenous GnRH agonists, the GnRH receptor in the pituitary gland is strongly desensitized to the point of becoming inactive. Consequently, both GnRH agonists and GnRH antagonists have the effect of abolishing gonadal sex hormone production. This, in turn, reduces testosterone levels into the castrate or normal female range (both <50 ng/dL or <1.7 nmol/L) in people with testes. GnRHa are like a reversible gonadectomy, and for this reason, are also sometimes referred to as “medical castration”. Provided that an estrogen is taken in combination with a GnRHa to prevent sex hormone deficiency, these medications have essentially no known side effects or risks. For these reasons, GnRHa are the ideal antiandrogens for use in transfeminine people.

    GnRHa are widely used to suppess puberty in adolescent transgender individuals. Unfortunately however, they are very expensive (e.g., ~US$10,000 per year) and medical insurance does not usually cover them for adult transgender people. Consequently, GnRHa are not commonly used in adult transfeminine people at this time. An exception is in the United Kingdom, where GnRH agonists are covered for all adult transgender people by the National Health Service (NHS). Another exception is buserelin (Suprefact), which has become available very inexpensively in its nasal spray form from certain Eastern European online pharmacies in recent years (Aly, 2018).

    GnRH agonists cause a brief flare in testosterone levels at the start of therapy prior to the GnRH receptors in the pituitary gland becoming desensitized (Wiki). Testosterone levels increase by up to about 1.5- to 2-fold for about 1 week and then decrease thereafter (Wiki). Castrate or female-range levels of testosterone are generally reached within 2 to 4 weeks (Wiki). In contrast to GnRH agonists, there is no testosterone flare with GnRH antagonists and testosterone levels start decreasing immediately, reaching castrate levels within a few days (Wiki; Graph). This is because GnRH antagonists work by blocking the GnRH receptor without initially activating it, and hence desensitization of the receptor is not necessary for their action. If desired, the testosterone flare at the initiation of GnRH agonist therapy can be prevented or blunted with the use of antigonadotropins, for instance estrogens and progestogens, as well as with potent androgen receptor antagonists such as bicalutamide (Wiki).

    GnRH agonists must be injected subcutaneously or intramuscularly once per day or once every one to six months depending on the formulation employed (buserelin, goserelin, leuprorelin, triptorelin). Alternatively, they can be surgically implanted once a year (histrelin, leuprorelin) or used as a nasal spray two to three times per day (buserelin, nafarelin). The first GnRH antagonists were developed for use by once-monthly intramuscular or subcutaneous injection (abarelix, degarelix). More recently, orally administered GnRH antagonists such as elagolix and relugolix have been introduced for medical use. They are taken in the form of tablets once or twice daily.

    Table 9: Available forms and recommended doses of GnRH agonists for transfeminine people:

    MedicationBrand nameRouteFormDosage
    BuserelinSuprefact, othersSC injectionSolution200 μg/daya
       Implant6.3 mg/2 months
        9.45 mg/3 months
      IntranasalNasal spray400 µg 3x/dayb,c
    GoserelinZoladexSC injectionImplant3.6 mg/month
        10.8 mg/3 months
    HistrelinSupprelin LA, VantasSC implantImplant50 mg/year
    LeuprorelinLupron, othersIM injectionSolution1 mg/day
     Eligard, Lupron Depot, othersIM/SC injectionSuspension3.75–7.5 mg/month
        11.25–22.5 mg/3 months
        30 mg/4 months
        45 mg/6 months
     ViadurSC implantImplant65 mg/year
    NafarelinSynarelIntranasalNasal spray400–600 μg 2–3x/day
    TriptorelinDecapeptyl, Trelstar Depot/LAIM injectionSuspension3.75 mg/month
        11.25 mg/3 months

    a 500 μg 3x/day for the first week then 200 μg/day. b 800 μg 3x/day for the first week then 400 μg 3x/day. c 500 μg 2x/day can be used instead of 400 μg 3x/day but is less effective (70% decrease in testosterone levels (to ~180 ng/dL [6.2 nmol/L]) instead of 90% decrease (to ~50 ng/dL [1.7 nmol/L]) per available studies of buserelin in men with prostate cancer) (Aly, 2018; Wiki).

    Table 10: Available forms and recommended doses of GnRH antagonists for transfeminine people:

    MedicationBrand nameRouteFormDosage
    AbarelixPlenaxisIM injectionSuspension113 mg/month
    DegarelixFirmagonSC injectionSolution80 mg/montha
    ElagolixOrilissaOralTablets150–200 mg 1–2x/dayb
    RelugolixReluminaOralTablets20–120 mg/dayc

    a First month is 240 mg then 80 mg per month thereafter. b 150 mg 1x/day is less effective than 200 mg 2x/day (which provides full gonadal sex-hormone suppression in cisgender women) (Wiki). c 80–120 mg/day for full gonadal sex-hormone suppression and 20–40 mg/day for substantial but partial gonadal sex-hormone suppression (MacLean et al., 2015; DailyMed).

    Other Hormonal Medications

    Androgens and Anabolic Steroids

    In addition to estrogens, progestogens, and antiandrogens, androgens/anabolic steroids (AAS) are sometimes added to transfeminine hormone therapy. This is when testosterone levels are low (e.g., below the female average of 30 ng/dL [1.0 nmol/L]) and androgen replacement is desired. It has been proposed that adequate levels of testosterone may provide benefits such as increased sexual desire, improved mood and energy, positive effects on skin health and cellulite (Avram, 2004), and increased muscle size and strength (Huang & Basaria, 2017). However, there is insufficient clinical evidence to support such benefits at present, and androgens can produce adverse effects in cisgender women and transfeminine people, for instance acne, hirsutism, scalp hair loss, and masculinization (Wiki). For transfeminine people who nonetheless desire androgen replacement therapy, possible options for androgen medications include testosterone and its esters, dehydroepiandrosterone (DHEA; prasterone), and nandrolone esters such as nandrolone decanoate (ND) (Aly, 2020; Table), among others.

    Monitoring of Therapy

    Transfeminine people on hormone therapy should undergo regular laboratory monitoring in the form of blood work to assess efficacy and monitor for safety. Total estradiol levels and total testosterone levels should be measured to assess the effectiveness of therapy—that is, whether hormone levels are in appropriate ranges for cisgender females—and determine whether medication adjustments may be necessary. Levels of free testosterone, free estradiol, estrone (E1), dihydrotestosterone (DHT), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex hormone-binding globulin (SHBG) can also be measured to provide further information although they’re not absolutely necessary. If progesterone is used as a part of hormone therapy, progesterone levels can be measured to provide insight on the degree of progesterone exposure. In addition to hormone blood tests, transfeminine people can monitor their physical changes with hormone therapy, such as breast development and other aspects of feminization, using various physical and digital measurement methods (e.g., Aly, 2020).

    In transfeminine people taking bicalutamide or high doses of CPA (≥20 mg/day), liver function tests (LFTs), such as aspartate transaminase (AST) and alanine transaminase (ALT) levels, should be regularly performed to monitor for liver toxicity. In those who are taking spironolactone and have relevant risk factors for hyperkalemia (high potassium levels), such as older age, reduced kidney function, or concomitant use of potassium-elevating medications or potassium supplements, potassium levels should be regularly monitored to assess for hyperkalemia. Conversely, in healthy young people without such risk factors who are taking spironolactone, potassium monitoring seems to be of limited usefulness (Plovanich, Weng, & Mostaghimi, 2015; Zaenglein et al., 2016; Layton et al., 2017; Millington, Liu, & Chan, 2019; Wang & Lipner, 2020; Gupta et al., 2022; Hayes et al., 2022). In transfeminine people taking high doses of estrogens or progestogens—particularly CPA—prolactin levels should be regularly measured to monitor for hyperprolactinemia (high prolactin levels) and prolactinoma (Callen-Lorde, 2018; Iwamoto et al., 2019). In people taking high doses of CPA (>12.5 mg/day), periodic magnetic resonance imaging (MRI) exams should be performed to monitor for development of meningiomas (Aly, 2020). If the preceding tests come back abnormal, depending on the situation and its severity, medication doses should be reduced or specific medications should be discontinued or replaced with alternatives.

    Certain therapeutic situations can result in inaccurate lab blood work results. Monitoring of progesterone levels with oral progesterone using immunoassay-based blood tests can result in falsely high readings for progesterone levels due to cross-reactivity with high levels of progesterone metabolites such as allopregnanolone (Aly, 2018; Wiki). Instead of immunoassay-based tests, mass spectrometry-based tests should be used to determine progesterone levels with oral progesterone (Aly, 2018; Wiki). Conversely, either type of test may be used to measure progesterone levels with non-oral progesterone therapy. High-dose biotin (vitamin B7) supplements can interfere with the accuracy of immunoassay-based hormone blood tests, causing falsely low or falsely high readings (Samarasinghe et al., 2017; Avery, 2019; Bowen et al., 2019; FDA, 2019; Luong, Male, & Glennon, 2019). Transdermal estradiol formulations applied to the arm can result in contamination of blood draws taken from the same arm and can result in falsely high readings for estradiol levels (Vihtamäkia, Luukkaala, & Tuimala, 2004).

    Certain cancers are known to be hormone-sensitive and their incidence can be influenced by hormone therapy. Screening for breast and prostate cancer is recommended in transfeminine people (Sterling & Garcia, 2020; Iwamoto et al., 2021). The risk of breast cancer appears to be dramatically increased with transfeminine hormone therapy, perhaps especially with progestogens (Aly, 2020). However, the risk still remains lower than in cisgender women (Aly, 2020). The incidence of prostate cancer is greatly decreased with hormone therapy in transfeminine people as a consequence of androgen deprivation, but the risk is not abolished and prostate cancer can still occur (de Nie et al., 2020). The prostate gland is not removed with vaginoplasty, so transfeminine people who have undergone vaginoplasty will also require monitoring for prostate cancer still. Testicular cancer is not known to be a hormone-dependent cancer and its incidence does not appear to be increased with hormone therapy in transfeminine people (Bensley et al., 2021; de Nie et al., 2021; Jacoby et al., 2021).

    References

    • Abbott Laboratories. (2009). Estradiol. Architect System. Abbott Park, Illinois/Wiesbaden, Germany: Abbott Laboratories. [PDF]
    • Ahmad, S. R., & Graham, D. J. (2003). Pneumonitis with Antiandrogens. Annals of Internal Medicine, 139(6), 528–529. [DOI:10.7326/0003-4819-139-6-200309160-00023]
    • Allen, A. N., Jiao, R., Day, P., Pagels, P., Gimpel, N., & SoRelle, J. A. (2020). Dynamic Impact of Hormone Therapy on Laboratory Values in Transgender Patients over Time. The Journal of Applied Laboratory Medicine, 6(1), 27–40. [DOI:10.1093/jalm/jfaa192]
    • Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., Zajac, J. D., & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine Connections, 8(7), 935–940. [DOI:10.1530/ec-19-0272]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (2020). A systematic review of antiandrogens and feminization in transgender women. Clinical Endocrinology, 94(5), 743–752. [DOI:10.1111/cen.14329]
    • Antoniou, T., Gomes, T., Mamdani, M. M., Yao, Z., Hellings, C., Garg, A. X., Weir, M. A., & Juurlink, D. N. (2011). Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ, 343, d5228. [DOI:10.1136/bmj.d5228]
    • Antoniou, T., Hollands, S., Macdonald, E. M., Gomes, T., Mamdani, M. M., & Juurlink, D. N. (2015). Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone. Canadian Medical Association Journal, 187(4), E138–E143. [DOI:10.1503/cmaj.140816]
    • Aufrère, M. B., & Benson, H. (1976). Progesterone: An overview and recent advances. Journal of Pharmaceutical Sciences, 65(6), 783–800. [DOI:10.1002/jps.2600650602]
    • Avery, G. (2019). Biotin interference in immunoassay: a review for the laboratory scientist. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 56(4), 424–430. [DOI:10.1177/0004563219842231]
    • Avram, M. M. (2004). Cellulite: a review of its physiology and treatment. Journal of Cosmetic and Laser Therapy, 6(4), 181–185. [DOI:10.1080/14764170410003057]
    • Babich, J. S., Kalantar-Zadeh, K., & Joshi, S. (2022). Taking the Kale out of Hyperkalemia: Plant Foods and Serum Potassium in Patients With Kidney Disease. Journal of Renal Nutrition, 32(6), 641–649. [DOI:10.1053/j.jrn.2022.01.013]
    • Bäckström, T., Haage, D., Löfgren, M., Johansson, I., Strömberg, J., Nyberg, S., Andréen, L., Ossewaarde, L., van Wingen, G., Turkmen, S., & Bengtsson, S. (2011). Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience, 191, 46–54. [DOI:10.1016/j.neuroscience.2011.03.061]
    • Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1258–1264. [DOI:10.1210/jc.2017-02052]
    • Bazarra-Castro, M. A. (2009). Etiological aspects, therapy regimes, side effects and treatment satisfaction of transsexual patients. (Doctoral dissertation, Ludwig Maximilian University of Munich.) [DOI:10.5282/edoc.9984] [URN:urn:nbn:de:bvb:19-99840] [PDF]
    • Belisle, S., & Love, E. J. (1986). Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study. Fertility and Sterility, 46(6), 1015–1020. [DOI:10.1016/s0015-0282(16)49873-0]
    • Ben Salem, C., Badreddine, A., Fathallah, N., Slim, R., & Hmouda, H. (2014). Drug-Induced Hyperkalemia. Drug Safety, 37(9), 677–692. [DOI:10.1007/s40264-014-0196-1]
    • Bensley, J. G., Cheung, A. S., Grossmann, M., & Papa, N. (2022). Testicular Cancer in Trans People Using Feminising Hormone Therapy–A Brief Review. Urology, 160, 1–4. [DOI:10.1016/j.urology.2021.11.014]
    • Bessone, F., Lucena, M., Roma, M. G., Stephens, C., Medina-Cáliz, I., Frider, B., Tsariktsian, G., Hernández, N., Bruguera, M., Gualano, G., Fassio, E., Montero, J., Reggiardo, M. V., Ferretti, S., Colombato, L., Tanno, F., Ferrer, J., Zeno, L., Tanno, H., & Andrade, R. J. (2015). Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases. Liver International, 36(2), 302–310. [DOI:10.1111/liv.12899]
    • Bowen, R., Benavides, R., Colón-Franco, J. M., Katzman, B. M., Muthukumar, A., Sadrzadeh, H., Straseski, J., Klause, U., & Tran, N. (2019). Best practices in mitigating the risk of biotin interference with laboratory testing. Clinical Biochemistry, 74, 1–11. [DOI:10.1016/j.clinbiochem.2019.08.012]
    • Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, 2009(2), CD000194. [DOI:10.1002/14651858.cd000194.pub2]
    • Burinkul, S., Panyakhamlerd, K., Suwan, A., Tuntiviriyapun, P., & Wainipitapong, S. (2021). Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial. The Journal of Sexual Medicine, 18(7), 1299–1307. [DOI:10.1016/j.jsxm.2021.05.003] [PDF]
    • Callen-Lorde Community Health Center. (2018). Protocols for the Provision of Hormone Therapy. New York City: Callen-Lorde Community Health Center. [URL] [PDF]
    • Cappelletti, M., & Wallen, K. (2016). Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior, 78, 178–193. [DOI:10.1016/j.yhbeh.2015.11.003]
    • Carmina, E., Stanczyk, F. Z., & Lobo, R. A. (2019). Evaluation of Hormonal Status. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 887–915.e4). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-47912-7.00034-2]
    • Carr, B. R. (1993). The Ovary. In Carr, B. R., & Blackwell, R. E. (Eds.). Textbook of Reproductive Medicine, 1st Edition (pp. 183–207). Norwalk, Connecticut: Appleton & Lange. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org—2nd edition]
    • Carvalho, R. d., Santos, L. D., Ramos, P. M., Machado, C. J., Acioly, P., Frattini, S. C., Barcaui, C. B., Donda, A. L., & Melo, D. F. (2022). Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know. Journal of Cosmetic Dermatology, 21(10), 4171–4175. [DOI:10.1111/jocd.14773]
    • Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2004). Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism, 89(5), 2179–2184. [DOI:10.1210/jc.2003-030330]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Collet, S., Gieles, N. C., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T’Sjoen, G. (2022). Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331–338. [DOI:10.1210/clinem/dgac576]
    • Connors, J. M., & Middeldorp, S. (2019). Transgender patients and the role of the coagulation clinician. Journal of Thrombosis and Haemostasis, 17(11), 1790–1797. [DOI:10.1111/jth.14626]
    • Cupisti, A., Kovesdy, C., D’Alessandro, C., & Kalantar-Zadeh, K. (2018). Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function. Nutrients, 10(3), 261–261. [DOI:10.3390/nu10030261]
    • Cusan, L., Dupont, A., Gomez, J., Tremblay, R. R., & Labrie, F. (1994). Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertility and Sterility, 61(2), 281–287. [DOI:10.1016/s0015-0282(16)56518-2]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, 365, l1652. [DOI:10.1136/bmj.l1652]
    • de Nie, I., de Blok, C. J., van der Sluis, T. M., Barbé, E., Pigot, G. L., Wiepjes, C. M., Nota, N. M., van Mello, N. M., Valkenburg, N. E., Huirne, J., Gooren, L. J., van Moorselaar, R. J., Dreijerink, K. M., & den Heijer, M. (2020). Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 105(9), e3293–e3299. [DOI:10.1210/clinem/dgaa412]
    • Deng, T., Duan, X., He, Z., Zhao, Z., & Zeng, G. (2020). Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis. Urology Journal, 18(2), 144–150. [DOI:10.22037/uj.v16i7.5866]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Dhurat, R., Sharma, A., Rudnicka, L., Kroumpouzos, G., Kassir, M., Galadari, H., Wollina, U., Lotti, T., Golubovic, M., Binic, I., Grabbe, S., & Goldust, M. (2020). 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety. Dermatologic Therapy, 33(3), e13379. [DOI:10.1111/dth.13379]
    • Drake, L., Hordinsky, M., Fiedler, V., Swinehart, J., Unger, W. P., Cotterill, P. C., Thiboutot, D. M., Lowe, N., Jacobson, C., Whiting, D., Stieglitz, S., Kraus, S. J., Griffin, E. I., Weiss, D., Carrington, P., Gencheff, C., Cole, G. W., Pariser, D. M., Epstein, E. S., Tanaka, W., Dallob, A., Vandormael, K., Geissler, L., & Waldsteicher, J. (1999). The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Journal of the American Academy of Dermatology, 41(4), 550–554. [DOI:10.1016/s0190-9622(99)80051-6]
    • Dyson, T. E., Cantrell, M. A., & Lund, B. C. (2020). Lack of Association between 5α-Reductase Inhibitors and Depression. Journal of Urology, 204(4), 793–798. [DOI:10.1097/ju.0000000000001079]
    • Erem, C. (2013). Update on idiopathic hirsutism: diagnosis and treatment. Acta Clinica Belgica, 68(4), 268–274. [DOI:10.2143/acb.3267]
    • Erenus, M., Gürbüz, O., Durmuşoğlu, F., Demirçay, Z., & Pekin, S. (1994). Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertility and Sterility, 61(4), 613–616. [DOI:10.1016/s0015-0282(16)56634-5]
    • Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]
    • Even Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. The Journal of Sexual Medicine, 18(7), 1292–1298. [DOI:10.1016/j.jsxm.2021.04.008]
    • Fertig, R., Shapiro, J., Bergfeld, W., & Tosti, A. (2016). Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome. Skin Appendage Disorders, 2(3–4), 120–129. [DOI:10.1159/000450617]
    • Food and Drug Administration. (2019). UPDATE: The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. Food and Drug Administration. [URL]
    • Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103–111. [DOI:10.1007/s10549-007-9523-x]
    • Frye, S. (2006). Discovery and Clinical Development of Dutasteride, a Potent Dual 5α-Reductase Inhibitor. Current Topics in Medicinal Chemistry, 6(5), 405–421. [DOI:10.2174/156802606776743101]
    • Gava, G., Mancini, I., Alvisi, S., Seracchioli, R., & Meriggiola, M. C. (2020). A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen. European Journal of Endocrinology, 183(6), 561–569. [DOI:10.1530/eje-20-0370]
    • Getzenberg, R., & Itty, S. (2020). How do we define “castration” in men on androgen deprivation therapy? Asian Journal of Andrology, 22(5), 441–446. [DOI:10.4103/aja.aja_139_19]
    • Giltay, E. J., Gooren, L. J., Toorians, A. W., Katan, M. B., & Zock, P. L. (2004). Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. The American Journal of Clinical Nutrition, 80(5), 1167–1174. [DOI:10.1093/ajcn/80.5.1167]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/eje-21-0059]
    • Goletiani, N. V., Keith, D. R., & Gorsky, S. J. (2007). Progesterone: Review of safety for clinical studies. Experimental and Clinical Psychopharmacology, 15(5), 427–444. [DOI:10.1037/1064-1297.15.5.427]
    • Goodfellow, A., Alaghband-Zadeh, J., Carter, G., Cream, J., Holland, S., Scully, J., & Wise, P. (1984). Oral spironolactone improves acne vulgaris and reduces sebum excretion. British Journal of Dermatology, 111(2), 209–214. [DOI:10.1111/j.1365-2133.1984.tb04045.x]
    • Gooren, L. J., Harmsen-Louman, W., & Kessel, H. (1985). Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction. Clinical Endocrinology, 22(2), 201–207. [DOI:10.1111/j.1365-2265.1985.tb01081.x]
    • Gooren, L. J. (2016). The Endocrinology of Sexual Behavior and Gender Identity. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition, Volume 2 (pp. 2163–2176.e4). Philadelphia: Saunders/Elsevier. [Google Books] [DOI:10.1016/B978-0-323-18907-1.00124-4]
    • Gormley, G. J., Stoner, E., Rittmaster, R. S., Gregg, H., Thompson, D. L., Lasseter, K. C., Vlasses, P. H., & Stein, E. A. (1990). Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers. The Journal of Clinical Endocrinology & Metabolism, 70(4), 1136–1141. [DOI:10.1210/jcem-70-4-1136]
    • Gubelin Harcha, W., Barboza Martínez, J., Tsai, T., Katsuoka, K., Kawashima, M., Tsuboi, R., Barnes, A., Ferron-Brady, G., & Chetty, D. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology, 70(3), 489–498.e3. [DOI:10.1016/j.jaad.2013.10.049]
    • Gupta, P., Suppakitjanusant, P., Stevenson, M., Goodman, M., & Tangpricha, V. (2022). Potassium Concentrations in Transgender Women Using Spironolactone: A Retrospective Chart Review. Endocrine Practice, 28(11), 1113–1117. [DOI:10.1016/j.eprac.2022.08.007]
    • Hammerstein, J. (1990). Antiandrogens: Clinical Aspects. In Orfanos, C. E., & Happle, R. (Eds.). Hair and Hair Diseases (pp. 827–886). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-74612-3_35]
    • Hayes, H., Russell, R., Haugen, A., Nagavally, S., & Sarvaideo, J. (2022). The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone. Journal of the Endocrine Society, 6(11), bvac133. [DOI:10.1210/jendso/bvac133]
    • Heinemann, L. A., Will-Shahab, L., van Kesteren, P., Gooren, L. J., & (1997). Safety of Cyproterone Acetate: Report of Active Surveillance. Pharmacoepidemiology and Drug Safety, 6(3), 169–178. [DOI:10.1002/(sici)1099-1557(199705)6:3<169::aid-pds263>3.0.co;2-3]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. The Journal of Clinical and Aesthetic Dermatology, 9(7), 56–62. [PubMed] [PubMed Central]
    • Hopkins, U., & Arias, C. Y. (2013). Large-volume IM injections: a review of best practices. Oncology Nurse Advisor, 4(1), 32–37. [Google Scholar] [URL] [PDF]
    • Horton, R. (1992). Dihydrotestosterone Is a Peripheral Paracrine Hormone. Journal of Andrology, 13(1), 23–27. [DOI:10.1002/j.1939-4640.1992.tb01621.x]
    • Huang, G., & Basaria, S. (2017). The Case for Androgens in Menopausal Women: When and How? In Pal, L., & Sayegh, R. A. (Eds.). Essentials of Menopause Management: A Case-Based Approach (pp. 173–196). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-42451-4_10]
    • Irwig, M. S. (2020). Is there a role for 5α‐reductase inhibitors in transgender individuals? Andrology, 9(6), 1729–1731. [DOI:10.1111/andr.12881]
    • Iversen, P., Johansson, J. E., Lodding, P., Lukkarinen, O., Lundmo, P., Klarskov, P., Tammela, T. L., Tasdemir, I., Morris, T., Carroll, K., & Scandinavian Prostatic Cancer Group. (2004). Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6. The Journal of Urology, 172(5 Part 1), 1871–1876. [DOI:10.1097/01.ju.0000139719.99825.54]
    • Iversen, P., Johansson, J., Lodding, P., Kylmälä, T., Lundmo, P., Klarskov, P., Tammela, T. L., Tasdemir, I., Morris, T., Armstrong, J., & (2006). Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years. Scandinavian Journal of Urology and Nephrology, 40(6), 441–452. [DOI:10.1080/00365590601017329]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Iwamoto, S. J., Grimstad, F., Irwig, M. S., & Rothman, M. S. (2021). Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review. Journal of General Internal Medicine, 36(5), 1380–1389. [DOI:10.1007/s11606-021-06634-7]
    • Jacoby, A., Rifkin, W., Zhao, L. C., & Bluebond-Langner, R. (2020). Incidence of Cancer and Premalignant Lesions in Surgical Specimens of Transgender Patients. Plastic & Reconstructive Surgery, 147(1), 194–198. [DOI:10.1097/prs.0000000000007452]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • James, J. F., Jamerson, T. A., & Aguh, C. (2022). Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review. Journal of the American Academy of Dermatology, 86(2), 425–429. [DOI:10.1016/j.jaad.2021.07.048]
    • Jia, A. Y., & Spratt, D. E. (2022). Bicalutamide Monotherapy With Radiation Therapy for Localized Prostate Cancer: A Non-Evidence-Based Alternative. International Journal of Radiation Oncology*Biology*Physics, 113(2), 316–319. [DOI:10.1016/j.ijrobp.2022.01.037]
    • Jiang, Y., & Tian, W. (2017). The effects of progesterones on blood lipids in hormone replacement therapy. Lipids in Health and Disease, 16(1), 219. [DOI:10.1186/s12944-017-0612-5]
    • Kanhai, R. C., Hage, J. J., van Diest, P. J., Bloemena, E., & Mulder, J. W. (2000). Short-Term and Long-Term Histologic Effects of Castration and Estrogen Treatment on Breast Tissue of 14 Male-to-Female Transsexuals in Comparison With Two Chemically Castrated Men. The American Journal of Surgical Pathology, 24(1), 74–80. [DOI:10.1097/00000478-200001000-00009]
    • Kellner, M., & Wiedemann, K. (2008). Mineralocorticoid receptors in brain, in health and disease: Possibilities for new pharmacotherapy. European Journal of Pharmacology, 583(2–3), 372–378. [DOI:10.1016/j.ejphar.2007.07.072]
    • Kim, G. K., & Del Rosso, J. Q. (2012). Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. The Journal of Clinical and Aesthetic Dermatology, 5(3), 37–50. [PubMed] [PubMed Central]
    • King, S. R. (2012). Neurosteroids and the Nervous System. In King, S. R. Neurosteroids and the Nervous System (pp. 1–122). New York: Springer New York. [DOI:10.1007/978-1-4614-5559-2_1]
    • Kolvenbag, G. J., & Blackledge, G. R. (1996). Worldwide activity and safety of bicalutamide: a summary review. Urology, 47(1), 70–79. [DOI:10.1016/s0090-4295(96)80012-4]
    • Kuhl, H. (2003). Östrogene für den Mann? [Estrogen for men?] Blickpunkt der Mann, 1(3), 6–12. [Google Scholar] [URL] [PDF]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H., & Wiegratz, I. (2017). Das Post-Finasterid-Syndrom. [Post Finasteride Syndrome.] Gynäkologische Endokrinologie, 15(2), 153–163. [DOI:10.1007/s10304-017-0126-2]
    • Kuijpers, S. M., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021). Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. The Journal of Clinical Endocrinology & Metabolism, 106(10), e3936–e3945. [DOI:10.1210/clinem/dgab427]
    • Kumar, P., Reddy, S., Kulkarni, A., Sharma, M., & Rao, P. N. (2021). Cyproterone Acetate–Induced Acute Liver Failure: A Case Report and Review of the Literature. Journal of Clinical and Experimental Hepatology, 11(6), 739–741. [DOI:10.1016/j.jceh.2021.01.003]
    • Lauritzen, C. (1988). Natürliche und synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien. [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles.] In Lauritzen, C., Schneider, H. P. G., & Nieschlag, E. (Eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (pp. 229–306). Berlin: de Gruyter. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [PDF] [Translation]
    • Lax, E. (1987). Mechanisms of physiological and pharmacological sex hormone action on the mammalian liver. Journal of Steroid Biochemistry, 27(4–6), 1119–1128. [DOI:10.1016/0022-4731(87)90198-1]
    • Layton, A. M., Eady, E. A., Whitehouse, H., Del Rosso, J. Q., Fedorowicz, Z., & van Zuuren, E. J. (2017). Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review. American Journal of Clinical Dermatology, 18(2), 169–191. [DOI:10.1007/s40257-016-0245-x]
    • Legro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., Ohl, D., Carson, S. A., Steinkampf, M. P., Carr, B. R., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Myers, E. R., Santoro, N., Eisenberg, E., Zhang, M., & Zhang, H. (2010). Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with Hirsutism. The Journal of Clinical Endocrinology & Metabolism, 95(12), 5305–5313. [DOI:10.1210/jc.2010-1123]
    • Leinung, M. C. (2014). Variable Response to Oral Estradiol Therapy in Male to Female Transgender Patients. Endocrine Reviews, 35(Suppl 1) [Endocrine Society’s 96th Annual Meeting and Expo, June 21–24, 2014 – Chicago], ?–? (abstract no. OR42-1). [Google Scholar] [DOI:10.1093/edrv/35.supp.1] [DOI:10.1210/endo-meetings.2014.RE.2.OR42-1] [URL] [MedPage Today]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Liang, J. J., Jolly, D., Chan, K. J., & Safer, J. D. (2018). Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort. Endocrine Practice, 24(2), 135–142. [DOI:10.4158/ep-2017-0116]
    • Lobo, R. A., Shoupe, D., Serafini, P., Brinton, D., & Horton, R. (1985). The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertility and Sterility, 43(2), 200–205. [DOI:10.1016/s0015-0282(16)48373-1]
    • Loh, H. H., Yee, A., Loh, H. S., Kanagasundram, S., Francis, B., & Lim, L. (2020). Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones, 19(3), 413–423. [DOI:10.1007/s42000-020-00210-0]
    • Luong, J. H., Male, K. B., & Glennon, J. D. (2019). Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat. Biotechnology Advances, 37(5), 634–641. [DOI:10.1016/j.biotechadv.2019.03.007]
    • MacLean, D. B., Shi, H., Faessel, H. M., & Saad, F. (2015). Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males. The Journal of Clinical Endocrinology & Metabolism, 100(12), 4579–4587. [DOI:10.1210/jc.2015-2770]
    • Mahler, C. (1996). A Review of the Clinical Studies with Nilutamide. In Denis, L. (Ed.). Antiandrogens in Prostate Cancer: A Key to Tailored Endocrine Treatment (ESO Monographs) (pp. 105–111). Berlin/Heidelberg: Springer Berlin Heidelberg. [DOI:10.1007/978-3-642-45745-6_10]
    • Maksym, R. B., Kajdy, A., & Rabijewski, M. (2019). Post-finasteride syndrome – does it really exist? The Aging Male, 22(4), 250–259. [DOI:10.1080/13685538.2018.1548589]
    • Marks, D. H., Prasad, S., De Souza, B., Burns, L. J., & Senna, M. M. (2019). Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. American Journal of Clinical Dermatology, 21(2), 245–254. [DOI:10.1007/s40257-019-00493-z]
    • Martinez-Martin, F. J., Kuzior, A., Hernandez-Lazaro, A., de Leon-Durango, R. J., Rios-Gomez, C., Santana-Ojeda, B., Perez-Rivero, J. M., Fernandez-Trujillo-Comenge, P. M., Gonzalez-Diaz, P., Arnas-Leon, C., Acosta-Calero, C., Perdomo-Herrera, E., Tocino-Hernandez, A. L., del Sol Sanchez-Bacaicoa, M., & del Pino Perez-Garcia, M. (2022). Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy. Hypertension Research, 46(1), 219–225. [DOI:10.1038/s41440-022-01067-z]
    • McFarlane, T., Zajac, J. D., & Cheung, A. S. (2018). Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals—A systematic review. Clinical Endocrinology, 89(6), 700–711. [DOI:10.1111/cen.13835]
    • Meriggiola, M. C., Bremner, W. J., Costantino, A., Bertaccini, A., Morselli-Labate, A. M., Huebler, D., Kaufmann, G., Oettel, M., & Flamigni, C. (2002). Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 87(5), 2107–2113. [DOI:10.1210/jcem.87.5.8514]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463]
    • Miles, R. A., Paulson, R. J., Lobo, R. A., Press, M. F., Dahmoush, L., & Sauer, M. V. (1994). Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertility and Sterility, 62(3), 485–490. [DOI:10.1016/s0015-0282(16)56935-0]
    • Millington, K., Liu, E., & Chan, Y. (2019). The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone. Journal of the Endocrine Society, 3(5), 1031–1038. [DOI:10.1210/js.2019-00030]
    • Millward, C. P., Keshwara, S. M., Islim, A. I., Jenkinson, M. D., Alalade, A. F., & Gilkes, C. E. (2022). Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review. Transgender Health, 7(6), 473–483. [DOI:10.1089/trgh.2021.0025]
    • Moretti, C., Guccione, L., Di Giacinto, P., Simonelli, I., Exacoustos, C., Toscano, V., Motta, C., De Leo, V., Petraglia, F., & Lenzi, A. (2017). Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism, 103(3), 824–838. [DOI:10.1210/jc.2017-01186]
    • Nakamoto, J. (2016). Endocrine Testing. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition (pp. 2655–2688.e1). Philadelphia: Saunders/Elsevier. [DOI:10.1016/B978-0-323-18907-1.00154-2]
    • Nakhjavani, M., Hamidi, S., Esteghamati, A., Abbasi, M., Nosratian-Jahromi, S., & Pasalar, P. (2009). Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism. British Journal of Clinical Pharmacology, 68(4), 634–637. [DOI:10.1111/j.1365-2125.2009.03483.x]
    • Neyman, A., Fuqua, J. S., & Eugster, E. A. (2019). Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents. Journal of Adolescent Health, 64(4), 544–546. [DOI:10.1016/j.jadohealth.2018.10.296]
    • Nguyen, D., Marchese, M., Cone, E. B., Paciotti, M., Basaria, S., Bhojani, N., & Trinh, Q. (2021). Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride. JAMA Dermatology, 157(1), 35–42. [DOI:10.1001/jamadermatol.2020.3385]
    • Nie, I., Wiepjes, C. M., Blok, C. J., Moorselaar, R. J., Pigot, G. L., Sluis, T. M., Barbé, E., Voorn, P., Mello, N. M., Huirne, J., & Heijer, M. (2021). Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study. BJU International, 129(4), 491–497. [DOI:10.1111/bju.15575]
    • Nieschlag, E., Zitzmann, M., & Kamischke, A. (2003). Use of progestins in male contraception. Steroids, 68(10–13), 965–972. [DOI:10.1016/s0039-128x(03)00135-1]
    • Nieschlag, E. (2010). Clinical trials in male hormonal contraception. Contraception, 82(5), 457–470. [DOI:10.1016/j.contraception.2010.03.020]
    • Nieschlag, E., & Behre, H. M. (2012). The essential role of testosterone in hormonal male contraception. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 470–493). Cambridge/New York: Cambridge University Press. [DOI:10.1017/cbo9781139003353.023]
    • Nishiyama, T. (2014). Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature. Urologic Oncology: Seminars and Original Investigations, 32(1), 38.e17–38.e28. [DOI:10.1016/j.urolonc.2013.03.007]
    • Nolan, B. J., & Cheung, A. S. (2021). Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review. Transgender Health, 6(3), 125–131. [DOI:10.1089/trgh.2020.0077]
    • Nolan, B. J., Frydman, A. S., Leemaqz, S. Y., Carroll, M., Grossmann, M., Zajac, J. D., & Cheung, A. S. (2022). Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study. Endocrine Connections, 11(5), e220170. [DOI:10.1530/EC-22-0170]
    • Norman, A. W., & Henry, H. L. (2015). Androgens. In Norman, A. W., & Henry, H. L. Hormones, 3rd Edition (pp. 255–273). London: Academic Press/Elsevier. [DOI:10.1016/b978-0-08-091906-5.00012-4]
    • Norman, A. W., & Henry, H. L. (2015). Estrogens and Progestins. In Norman, A. W., & Henry, H. L. Hormones, 3rd Edition (pp. 275–296). London: Academic Press/Elsevier. [DOI:10.1016/b978-0-08-091906-5.00013-6]
    • Nota, N. M., Wiepjes, C. M., de Blok, C. J., Gooren, L. J., Peerdeman, S. M., Kreukels, B. P., & den Heijer, M. (2018). The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain, 141(7), 2047–2054. [DOI:10.1093/brain/awy108]
    • North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. [DOI:10.1097/gme.0000000000002028]
    • O’Connell, M. B. (1995). Pharmacokinetic and Pharmacologic Variation Between Different Estrogen Products. The Journal of Clinical Pharmacology, 35(9S), 18S–24S. [DOI:10.1002/j.1552-4604.1995.tb04143.x]
    • Olsen, E. A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M. L., Wilson, T., & Rittmaster, R. S. (2006). The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology, 55(6), 1014–1023. [DOI:10.1016/j.jaad.2006.05.007]
    • Plovanich, M., Weng, Q. Y., & Mostaghimi, A. (2015). Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatology, 151(9), 941–944. [DOI:10.1001/jamadermatol.2015.34]
    • Polyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2011). Spironolactone Revisited. The Journal of Clinical Hypertension, 13(10), 783–784. [DOI:10.1111/j.1751-7176.2011.00484.x]
    • Powers, M. S., Schenkel, L., Darley, P. E., Good, W. R., Balestra, J. C., & Place, V. A. (1985). Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement. American Journal of Obstetrics and Gynecology, 152(8), 1099–1106. [DOI:10.1016/0002-9378(85)90569-1]
    • Prince, J. C., & Safer, J. D. (2020). Endocrine treatment of transgender individuals: current guidelines and strategies. Expert Review of Endocrinology & Metabolism, 15(6), 395–403. [DOI:10.1080/17446651.2020.1825075]
    • Reiter, E. O., Mauras, N., McCormick, K., Kulshreshtha, B., Amrhein, J., De Luca, F., O’Brien, S., Armstrong, J., & Melezinkova, H. (2010). Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT). Journal of Pediatric Endocrinology and Metabolism, 23(10), 999–1009. [DOI:10.1515/jpem.2010.161]
    • Rezende, H. D., Dias, M. F. R. G., & Trüeb, R. M. (2018). A Comment on the Post-Finasteride Syndrome. International Journal of Trichology, 10(6), 255–261. [PubMed] [PubMed Central] [DOI:10.4103/ijt.ijt_61_18]
    • Roberts, J. L., Fiedler, V., Imperato-McGinley, J., Whiting, D., Olsen, E., Shupack, J., Stough, D., DeVillez, R., Rietschel, R., Savin, R., Bergfeld, W., Swinehart, J., Funicella, T., Hordinsky, M., Lowe, N., Katz, I., Lucky, A., Drake, L., Price, V. H., Weiss, D., Whitmore, E., Millikan, L., Muller, S., Gencheff, C., Carrington, P., Binkowitz, B., Kotey, P., He, W., Bruno, K., Jacobsen, C., Terranella, L., Gormley, G. J., & Kaufman, K. D. (1999). Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. Journal of the American Academy of Dermatology, 41(4), 555–563. [DOI:10.1016/s0190-9622(99)80052-8]
    • Roscioni, S. S., de Zeeuw, D., Bakker, S. J., & Lambers Heerspink, H. J. (2012). Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy. Nature Reviews Nephrology, 8(12), 691–699. [DOI:10.1038/nrneph.2012.217]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2008). Puberty and its disorders in the female. In Sperling, M. A. (Ed.). Pediatric Endocrinology, 3rd Edition (pp. 530–609). Philadelphia: Saunders. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021). Puberty in the Female and Its Disorders. In Sperling, M. A., Majzoub, J. A., Menon, R. K., & Stratakis, C. A. (Eds.). Sperling Pediatric Endocrinology, 5th Edition (pp. 528–626). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-62520-3.00016-6]
    • Samarasinghe, S., Meah, F., Singh, V., Basit, A., Emanuele, N., Emanuele, M. A., Mazhari, A., & Holmes, E. W. (2017). Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks. Endocrine Practice, 23(8), 989–998. [DOI:10.4158/ep171761.ra]
    • Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014). Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology, 231(17), 3557–3567. [DOI:10.1007/s00213-014-3599-x]
    • Schlatterer, K., Yassouridis, A., Werder, K. V., Poland, D., Kemper, J., & Stalla, G. K. (1998). Archives of Sexual Behavior, 27(5), 475–492. [DOI:10.1023/a:1018704630036]
    • Seaman, H. E., Langley, S. E., Farmer, R. D., & de Vries, C. S. (2007). Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database. BJU International, 99(6), 1398–1403. [DOI:10.1111/j.1464-410x.2007.06859.x]
    • Shackleton, C. (2010). Clinical steroid mass spectrometry: A 45-year history culminating in HPLC–MS/MS becoming an essential tool for patient diagnosis. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 481–490. [DOI:10.1016/j.jsbmb.2010.02.017]
    • Shaw, J. C. (1996). Antiandrogen and hormonal treatment of acne. Dermatologic Clinics, 14(4), 803–811. [DOI:10.1016/s0733-8635(05)70405-8]
    • Sofer, Y., Yaish, I., Yaron, M., Bach, M. Y., Stern, N., & Greenman, Y. (2020). Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocrine Practice, 26(8), 883–890. [DOI:10.4158/ep-2020-0032] [PDF]
    • SoRelle, J. A., Jiao, R., Gao, E., Veazey, J., Frame, I., Quinn, A. M., Day, P., Pagels, P., Gimpel, N., & Patel, K. (2019). Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clinical Chemistry, 65(1), 170–179. [DOI:10.1373/clinchem.2018.292730]
    • St-Jules, D. E., Goldfarb, D. S., & Sevick, M. A. (2016). Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients? Journal of Renal Nutrition, 26(5), 282–287. [DOI:10.1053/j.jrn.2016.02.005]
    • St-Jules, D. E., & Fouque, D. (2020). Is it time to abandon the nutrient-based renal diet model? Nephrology Dialysis Transplantation, 36(4), 574–577. [DOI:10.1093/ndt/gfaa257]
    • St-Jules, D. E., & Fouque, D. (2022). Etiology-based dietary approach for managing hyperkalemia in people with chronic kidney disease. Nutrition Reviews, 80(11), 2198–2205. [DOI:10.1093/nutrit/nuac026]
    • Stanczyk, F. Z., & Clarke, N. J. (2010). Advantages and challenges of mass spectrometry assays for steroid hormones. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 491–495. [DOI:10.1016/j.jsbmb.2010.05.001]
    • Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2012). Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. Endocrine Reviews, 34(2), 171–208. [DOI:10.1210/er.2012-1008]
    • Stanczyk, F. Z., Mathews, B. W., & Cortessis, V. K. (2017). Does the type of progestin influence the production of clotting factors? Contraception, 95(2), 113–116. [DOI:10.1016/j.contraception.2016.07.007]
    • Stege, R., Gunnarsson, P. O., Johansson, C., Olsson, P., Pousette, Å., & Carlström, K. (1996). Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients. The Prostate, 28(5), 307–310. [DOI:10.1002/(sici)1097-0045(199605)28:5<307::aid-pros6>3.0.co;2-8]
    • Steinberger, E., Ayala, C., Hsi, B., Smith, K. D., Rodriguez-Rigau, L. J., Weidman, E. R., & Reimondo, G. G. (1998). Utilization of Commercial Laboratory Results in Management of Hyperandrogenism in Women. Endocrine Practice, 4(1), 1–10. [DOI:10.4158/ep.4.1.1]
    • Sterling, J., & Garcia, M. M. (2020). Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Translational Andrology and Urology, 9(6), 2771–2785. [DOI:10.21037/tau-20-954]
    • Strauss, J. F., & FitzGerald, G. A. (2019). Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 75–114.e7). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/b978-0-323-47912-7.00004-4]
    • Stricker, R., Eberhart, R., Chevailler, M., Quinn, F. A., Bischof, P., & Stricker, R. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer. Clinical Chemistry and Laboratory Medicine (CCLM), 44(7), 883–887. [DOI:10.1515/cclm.2006.160]
    • Styne, D. M. (2016). Laboratory Values for Pediatric Endocrinology. In Styne, D. M. Pediatric Endocrinology: A Clinical Handbook (pp. 385–434). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-18371-8_16]
    • Sudduth, S. L., & Koronkowski, M. J. (1993). Finasteride: The First 5α-Reductase Inhibitor. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 13(4), 309–329. [DOI:10.1002/j.1875-9114.1993.tb02739.x]
    • Sundström-Poromaa, I., Comasco, E., Sumner, R., & Luders, E. (2020). Progesterone – Friend or foe? Frontiers in Neuroendocrinology, 59, 100856. [DOI:10.1016/j.yfrne.2020.100856]
    • Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017). Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. Endocrine Reviews, 38(3), 220–254. [DOI:10.1210/er.2016-1067]
    • T’Sjoen, G. G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186(1), 61–67. [DOI:10.1677/joe.1.06112]
    • T’Sjoen, G., Arcelus, J., Gooren, L., Klink, D. T., & Tangpricha, V. (2018). Endocrinology of Transgender Medicine. Endocrine Reviews, 40(1), 97–117. [DOI:10.1210/er.2018-00011]
    • Tack, L. J., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine, 14(5), 747–757. [DOI:10.1016/j.jsxm.2017.03.251]
    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
    • Toorians, A. W., Thomassen, M. C., Zweegman, S., Magdeleyns, E. J., Tans, G., Gooren, L. J., & Rosing, J. (2003). Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5723–5729. [DOI:10.1210/jc.2003-030520]
    • Traish, A. M., Krakowsky, Y., Doros, G., & Morgentaler, A. (2019). Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. Sexual Medicine Reviews, 7(1), 95–114. [DOI:10.1016/j.sxmr.2018.06.002]
    • Traish, A. M. (2020). Post-finasteride syndrome: a surmountable challenge for clinicians. Fertility and Sterility, 113(1), 21–50. [DOI:10.1016/j.fertnstert.2019.11.030]
    • Usach, I., Martinez, R., Festini, T., & Peris, J. (2019). Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Advances in Therapy, 36(11), 2986–2996. [DOI:10.1007/s12325-019-01101-6]
    • van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015). Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews, 2015, CD010334. [DOI:10.1002/14651858.cd010334.pub2]
    • Verdonk, S. J., Vesper, H. W., Martens, F., Sluss, P. M., Hillebrand, J. J., & Heijboer, A. C. (2019). Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS method. Clinica Chimica Acta, 495, 198–204. [DOI:10.1016/j.cca.2019.04.062]
    • Vermeulen, A., Giagulli, V., De Schepper, P., & Buntinx, A. (1991). Hormonal Effects of a 5α-Reductase Inhibitor (Finasteride) onHormonal Levels in Normal Men and in Patients withBenign Prostatic Hyperplasia. European Urology, 20(1), 82–86. [DOI:10.1159/000471752]
    • Vihtamäki, T., Luukkaala, T., & Tuimala, R. (2004). Skin contamination by oestradiol gel—a remarkable source of error in plasma oestradiol measurements during percutaneous hormone replacement therapy. Maturitas, 48(4), 347–353. [DOI:10.1016/s0378-5122(03)00043-4]
    • Wang, H., Liu, M., Fu, Q., & Deng, C. (2019). Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study. Drug Design, Development and Therapy, 13, 2475–2482. [DOI:10.2147/dddt.s204624]
    • Wang, Y., & Lipner, S. R. (2020). Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration. International Journal of Women’s Dermatology, 6(4), 272–276. [DOI:10.1016/j.ijwd.2020.05.002]
    • Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of High Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study. BMJ, 372, n37. [DOI:10.1136/bmj.n37]
    • Welk, B., McArthur, E., Ordon, M., Anderson, K. K., Hayward, J., & Dixon, S. (2017). Association of Suicidality and Depression With 5α-Reductase Inhibitors. JAMA Internal Medicine, 177(5), 683–691. [DOI:10.1001/jamainternmed.2017.0089]
    • Wellington, K., & Keam, S. J. (2006). Bicalutamide 150mg: A Review of its Use in the Treatment of Locally Advanced Prostate Cancer. Drugs, 66(6), 837–850. [DOI:10.2165/00003495-200666060-00007]
    • Willemsen, W. N., Mastboom, J. L., Thomas, C. M., & Rolland, R. (1985). Absorption of 17β-estradiol in a neovagina constructed from the peritoneum. European Journal of Obstetrics & Gynecology and Reproductive Biology, 19(4), 247–253. [DOI:10.1016/0028-2243(85)90036-x]
    • Wilson, L. M., Baker, K. E., Sharma, R., Dukhanin, V., McArthur, K., & Robinson, K. A. (2020). Effects of antiandrogens on prolactin levels among transgender women on estrogen therapy: A systematic review. International Journal of Transgender Health, 21(4), 391–402. [DOI:10.1080/15532739.2020.1819505]
    • Wu, B., Shen, P., Yin, X., Yu, L., Wu, F., Chen, C., Li, J., & Xu, T. (2022). Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System. British Journal of Clinical Pharmacology, 89(2), 440–448. [DOI:10.1111/bcp.15336]
    • Wu, F. C., Balasubramanian, R., Mulders, T. M., & Coelingh-Bennink, H. J. (1999). Oral Progestogen Combined with Testosterone as a Potential Male Contraceptive: Additive Effects between Desogestrel and Testosterone Enanthate in Suppression of Spermatogenesis, Pituitary-Testicular Axis, and Lipid Metabolism. The Journal of Clinical Endocrinology & Metabolism, 84(1), 112–122. [DOI:10.1210/jcem.84.1.5412]
    • Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., Keri, J. E., Leyden, J. J., Reynolds, R. V., Silverberg, N. B., Stein Gold, L. F., Tollefson, M. M., Weiss, J. S., Dolan, N. C., Sagan, A. A., Stern, M., Boyer, K. M., & Bhushan, R. (2016). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 74(5), 945–973.e33. [DOI:10.1016/j.jaad.2015.12.037]
    • Zhang, J., & Stanczyk, F. Z. (2013). LC-MS Bioanalysis of Steroids. In Li, W., Zhang, J., & Tse, F. L. S. (Eds.). Handbook of LC-MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations (pp. 573–590). Hoboken, New Jersey: John Wiley & Sons. [DOI:10.1002/9781118671276.ch45]
    • Zhou, Z., Song, S., Gao, Z., Wu, J., Ma, J., & Cui, Y. (2019). The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging, 14, 399–406. [DOI:10.2147/cia.s192435]
    • Zitzmann, M., Rohayem, J., Raidt, J., Kliesch, S., Kumar, N., Sitruk-Ware, R., & Nieschlag, E. (2017). Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial. Andrology, 5(3), 516–526. [DOI:10.1111/andr.12328]
    • Zuuren, E., & Fedorowicz, Z. (2016). Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments. British Journal of Dermatology, 175(1), 45–61. [DOI:10.1111/bjd.14486]
    \ No newline at end of file +An Introduction to Hormone Therapy for Transfeminine People - Transfeminine Science Link

    An Introduction to Hormone Therapy for Transfeminine People

    By Aly | First published August 4, 2018 | Last modified June 17, 2023

    Abstract / TL;DR

    Sex hormones such as estrogen, testosterone, and progesterone are produced by the gonads. The sex hormones mediate the development of the secondary sexual characteristics. Testosterone causes masculinization, while estradiol causes feminization and breast development. Males have high amounts of testosterone, while females have low testosterone but high amounts of estradiol. These hormonal differences are responsible for the physical differences between males and females. Sex hormones and other hormonal medications are used in transfeminine people to shift the hormonal profile from a male-typical one to a female-typical profile. This causes feminization and demasculinization and allows for alleviation of gender dysphoria. The changes caused by transfeminine hormone therapy occur over a period of months to years. There are many different types and forms of hormonal medications, and these medications can be administered by a variety of different routes. Examples include as pills taken by mouth, as patches or gel applied to the skin, and as injections, among others. Different hormonal medications, routes, and doses have differences in efficacy, side effects, risks, costs, convenience, and availability. Hormone therapy should ideally be regularly monitored in transfeminine people with blood tests to ensure effectiveness and safety and to allow for adjustment as necessary.

    The Sex Hormones

    Types and Effects

    The sex hormones include the estrogens (E), progestogens (P), and androgens. A person’s hormonal profile is a product of the type of gonads that they are born with. Natal males have testes while natal females have ovaries. Testes produce large amounts of androgens and small amounts of estrogens whereas ovaries produce high amounts of estrogens and progesterone and low amounts of androgens.

    The major estrogen in the body is estradiol (E2), the main progestogen is progesterone (P4), and the major androgens are testosterone (T) and dihydrotestosterone (DHT). The sex hormones are responsible for and determine the secondary sex characteristics. They mediate their effects by acting as agonists (or activators) of receptors inside of cells. These receptors include the androgen receptor (AR), the estrogen receptors (ERs), and the progesterone receptors (PRs). Following their activation, these receptors modulate gene expression to influence cells and tissues.

    Estrogens cause feminization. This includes breast development, softening of the skin, a feminine pattern of fat distribution (concentrated in the breasts, hips, thighs, and buttocks), widening of the hips (in those who are still of pubertal age), and other physical changes (Wiki).

    Progestogens have essentially no known role in feminization or pubertal breast development. Rather than acting as mediators of feminization, progestogens have important effects in the female reproductive system and are essential hormones during pregnancy (Wiki). They also oppose the actions of estrogens in certain parts of the body, such as the uterus, vagina, and breasts (Wiki).

    Androgens cause masculinization. This includes growth of the penis, broadening of the shoulders, expansion of the rib cage, muscle growth, voice deepening, a masculine pattern of fat distribution (concentrated in the stomach and waist), masculine changes in other soft tissues, and facial/body hair growth (Wiki). Androgens also cause a variety of generally undesirable skin and hair effects, including oily skin, acne, seborrhea, scalp hair loss, and body odor. They additionally oppose breast development and probably other aspects of feminization mediated by estrogens as well.

    In addition to their effects on the body, sex hormones have actions in the brain. These actions influence cognition, emotions, and behavior. For instance, androgens produce pronounced sexual desire and arousal (including spontaneous erections) in men, while estrogens appear to be the major hormones responsible for sexual desire in women (Cappelletti & Wallen, 2016). Sex hormones also have important effects on health, which can be both positive and negative. For instance, estrogens maintain bone strength and likely protect against heart disease in cisgender women (NAMS, 2022), but also increase the risk of breast cancer (Aly, 2020) and can increase the risk of blood clots (Aly, 2020).

    Estrogens, progestogens, and androgens also have antigonadotropic effects. That is, they inhibit the gonadotropin-releasing hormone (GnRH)-induced secretion of the gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), from the pituitary gland in the brain. The gonadotropins signal the gonads to make sex hormones and to supply the sperm and egg cells necessary for fertility. Hence, lower levels of the gonadotropins will result in reduced gonadal sex hormone production and diminished fertility. If gonadotropin levels are sufficiently suppressed, the gonads will no longer make sex hormones at all and fertility will cease. The vast majorities of the quantities of estradiol, testosterone, and progesterone in the body are produced by the gonads. Most of the small remaining amounts of these hormones are produced via the adrenal glands of the kidneys.

    Normal Hormone Levels

    In cisgender females, the sex hormones are largely absent during childhood, gradually ramp up in production in late childhood and adolescence, are present in a cyclical manner during adulthood, and then largely stop being produced following the menopause. Hormone levels vary substantially but in a predictable manner during the normal menstrual cycle in adult premenopausal women. The menstrual cycle lasts about 28 days on average and consists of the following parts:

    1. Follicular phase—first half of the cycle or days 1–14
    2. Mid-cycle—middle of the cycle or days 12–16 or so
    3. Luteal phase—latter half of the cycle or days 14–28

    Hormone levels during the menstrual cycle are shown in the following graph:

    Figure 1: Median estradiol and progesterone levels throughout the menstrual cycle in premenopausal cisgender women (Stricker et al., 2006; Abbott, 2009). The horizontal dashed lines are the average levels over the spanned periods. Other figures available elsewhere show variation between individuals (Graph; Graph; Graph).

    As can be seen in the graph, estradiol levels are relatively low and progesterone levels are very low during the follicular phase; estradiol but not progesterone levels briefly surge to very high levels and trigger ovulation during mid-cycle; and estradiol and progesterone levels both undergo a bump and are relatively high during the luteal phase (though estradiol is not as high as during the mid-cycle peak).

    The table below shows the circulating levels and production rates of estradiol, progesterone, and testosterone in women and men and allows for comparison between them.

    Table 1: Ranges for circulating levelsa and estimated production ratesb of the major sex hormones:

    HormoneGroupTimeLevels (mass/vol)cLevels (mol/vol)cProduction rates
    EstradiolWomendFollicular phase5–180 pg/mL20–660 pmol/L30–170 μg/daye
      Mid-cycle45–750 pg/mL170–2,750 pmol/L320–950 μg/daye
      Luteal phase20–300 pg/mL73–1100 pmol/L250–300 μg/daye
     Men–8–35 pg/mL30–130 pmol/L10–60 μg/day
    ProgesteroneWomendFollicular phase≤0.3 ng/mL≤1.0 nmol/L0.75–5 mg/day
      Mid-cycle0.1–1.5 ng/mL0.3–4.8 nmol/L4 mg/day
      Luteal phase3.5–38 ng/mL11–120 nmol/L15–50 mg/dayf
     Men–≤0.5 ng/mL≤1.6 nmol/L0.75–3 mg/day
    TestosteroneWomendMenstrual cycle5–55 ng/dL0.2–1.9 nmol/L190–260 μg/day
     Men–250–1100 ng/dL8.7–38 nmol/L5–7 mg/day

    a Sources for hormone levels: Zhang & Stanczyk (2013); Nakamoto (2016); Styne (2016); LabCorp (2020). b Sources for production rates: Aufrère & Benson (1976); Powers et al. (1985); Lauritzen (1988); Carr (1993); O’Connell (1995); Kuhl (2003); Norman & Henry (2015a); Norman & Henry (2015b); Strauss & FitzGerald (2019). c With liquid chromatography–mass spectrometry (LC–MS) (state-of-the-art blood tests). d During the menstrual cycle in the adult premenopause (age ~18–50 years). e Average production rate of estradiol over the whole menstrual cycle is roughly 200 μg/day or 6 mg/month (Rosenfield, Cooke, & Radovich, 2021). f Average production rate of progesterone during the luteal phase of the menstrual cycle is about 25 mg/day (Carr, 1993).

    Mean integrated estradiol levels are around 100 pg/mL (367 pmol/L) in premenopausal women and around 25 pg/mL (92 pmol/L) in men. The 95% range for mean estradiol levels in women is around 50 to 250 pg/mL (180–918 pmol/L) (e.g., Abbott, 2009 (Graph); Verdonk et al., 2019 (Graph)). The average production of estradiol by the ovaries in premenopausal women is about 6 mg over the course of one menstrual cycle (i.e., one month) (Rosenfield et al., 2008). This corresponds to a mean rate of about 200 μg/day. Estradiol levels increase slowly during normal female puberty, when breast development and feminization take place. Mean estradiol levels during the different stages of female puberty are quite low—less than about 50 to 60 pg/mL (180–220 pmol/L) until late puberty (Aly, 2020). In postmenopausal women, whose ovaries no longer produce considerable quantities of estrogens, estradiol levels are generally less than 10 to 20 pg/mL (37–73 pmol/L) (Nakamoto, 2016). Estradiol levels below 50 pg/mL (184 pmol/L) in adults are concentration-dependently associated with menopausal symptoms, including hot flashes, depressive mood changes, defeminization (e.g., breast atrophy, loss of feminine fat distribution), accelerated skin aging, and bone density loss with increased risk of bone fracture.

    Mean testosterone levels are around 30 ng/dL (1.0 nmol/L) in women and 600 ng/dL (21 nmol/L) in men. Based on these values, testosterone levels are on average about 20-fold higher in men than in women. In men who have undergone gonadectomy (castration or surgical gonadal removal), testosterone levels are similar to those in women (<50 ng/dL [1.7 nmol/L]) (Nishiyama, 2014; Itty & Getzenberg, 2020). The mean or median levels of testosterone in women with polycystic ovary syndrome (PCOS), who often have clinically significant symptoms of androgen excess (e.g., excessive facial/body hair growth), range from 41 to 75 ng/dL (1.4–2.6 nmol/L) per different studies (Balen et al., 1995; Steinberger et al., 1998; Legro et al., 2010; Loh et al., 2020). Hence, it appears that even testosterone levels that are marginally elevated relative to normal female levels may produce undesirable androgenic effects.

    It is important to be aware that measurement of hormone levels is subject to methodological limitations, and hormone levels vary significantly when quantified by different methods and laboratories on account of varying assay accuracy (Shackleton, 2010; Stanczyk & Clarke, 2010; Deutsch, 2016; Carmina, Stanczyk, & Lobo, 2019). Mass spectrometry (MS)-based assays, such as liquid chromatography–mass spectrometry (LC–MS), are regarded as more accurate and reliable than immunoassay (IA)-based assays, such as radioimmunoassays (RIA) and direct immunoassays like enzyme-linked immunosorbent assays (ELISA) (Stanczyk & Clarke, 2010; Carmina, Stanczyk, & Lobo, 2019). In relation to this, MS-based tests are gradually becoming the standard for laboratory testing of sex hormone levels. However, hormone levels vary between laboratories even with LC–MS, for instance due to differences in calibration of LC–MS instruments between laboratories (Carmina, Stanczyk, & Lobo, 2019). Whereas an accurate range for testosterone levels in cisgender women is 20 to 50 ng/dL (0.69–1.7 nmol/L), for instance with assays like RIA and LC–MS, the normal upper limit for direct immunoassays like ELISA may be 70 to 80 ng/dL (2.4–2.8 nmol/L) (Carmina, Stanczyk, & Lobo, 2019). When interpreting blood tests, care should be taken to compare sex hormone levels to same-laboratory reference ranges (Deutsch, 2016).

    Overview of Hormone Therapy

    The goal of hormone therapy for transfeminine people, otherwise known as feminizing hormone therapy (FHT) or (more in the past) as male-to-female (MtF) hormone replacement therapy (HRT), is to produce feminization and demasculinization of the body as well as alleviation of gender dysphoria. Medication therapy with sex hormones and other sex-hormonal medications is used to mediate these changes. Transfeminine people are given estrogens, progestogens, and antiandrogens (AAs) to supersede gonadal sex hormone production and shift the hormonal profile from male-typical to female-typical.

    Transfeminine hormone therapy aims to achieve estradiol and testosterone levels within the normal female range. Commonly recommended ranges for transfeminine people in the literature are 100 to 200 pg/mL (367–734 pmol/L) for estradiol levels and less than 50 ng/dL (1.7 nmol/L) for testosterone levels (Table). However, higher estradiol levels of more than 200 pg/mL (734 pmol/L) can be useful in transfeminine hormone therapy to help suppress testosterone levels. Lower estradiol levels (≤50–60 pg/mL [≤180–220 pmol/L]) are recommended and more appropriate for pubertal and adolescent transfeminine individuals. Sex hormone levels in the blood can be measured with blood tests, in which blood is drawn from a vein using a needle and then analyzed in a laboratory. This is useful in transfeminine people to ensure that the hormonal profile has been satisfactorily altered in line with therapeutic goals—specifically that hormone levels are within female ranges.

    Gonadal Suppression

    At sufficiently high exposure, estrogens and androgens are able to completely suppress gonadal sex hormone production, while progestogens by themselves are able to partially but substantially suppress gonadal sex hormone production. More specifically, studies in cisgender men and transfeminine people have found that estradiol levels of around 200 pg/mL (734 pmol/L) generally suppress testosterone levels by about 90% (to ~50 ng/dL [1.7 nmol/L]), while estradiol levels of around 500 pg/mL (1,840 pmol/L) suppress testosterone levels by about 95% on average (to ~20–30 ng/dL [0.7–1.0 nmol/L]) (Wiki; Graphs). Estradiol levels of below 200 pg/mL (734 pmol/L) also suppress testosterone levels, although to a reduced extent compared to higher levels (Aly, 2019).

    Figure 2: Estradiol and testosterone levels after a single injection of 320 mg polyestradiol phosphate (PEP) (a long-acting prodrug of estradiol) in men with prostate cancer (Stege et al., 1996). The maximal decrease in testosterone levels occurred with estradiol levels of greater than 200 pg/mL (734 pmol/L) and was about 90% (to roughly 50 ng/dL [1.7 nmol/L]). This figure demonstrates the ability of estradiol to concentration-dependently suppress gonadal testosterone production and circulating testosterone levels in people with testes.

    Progestogens on their own are able to maximally suppress testosterone levels by about 50 to 70% (to ~150–300 ng/dL [5.2–10.4 nmol/L] on average) (Aly, 2019; Wiki). In combination with relatively small amounts of estrogen however, there is synergism in the antigonadotropic effect—the suppression of gonadal testosterone production with maximally effective doses of progestogens becomes complete, and testosterone levels are reduced by about 95% (to ~20–30 ng/dL [0.7–1.0 nmol/L]) (Aly, 2019). Hence, the combination of an estrogen and a progestogen can be used to achieve maximal testosterone suppression at lower doses than would be necessary if an estrogen or progestogen were used alone.

    The antigonadotropic effects of estrogens and progestogens are taken advantage of in transfeminine hormone therapy to suppress gonadal testosterone production and attain testosterone levels that are more consistent with those in cisgender women. It should be noted that the preceding numbers on testosterone suppression with estrogens and progestogens are averages and there is significant variation between individuals in terms of testosterone suppression. In other words, some may need more or less in terms of hormonal dosages to achieve the same decrease in testosterone levels.

    Timeline of Effects

    During normal puberty in both males and females, sex hormone exposure increases slowly over a period of several years (Aly, 2020). In relation to this, sexual maturation occurs gradually during normal puberty. In non-adolescent transgender people, adult or higher amounts of hormones are generally administered right away, and this can result in changes in secondary sex characteristics happening more quickly. The table below is reproduced from literature sources with slight modification and is commonly cited as a timeline for the effects of hormone therapy in transfeminine people (Table). It is based on a mixture of anecdotal clinical experience, expert opinion, and available clinical studies of hormone therapy in transfeminine people. Due to limited research characterizing the effects of transfeminine hormone therapy at present, the table may or may not be completely accurate.

    Table 2: Effects of hormone therapy at typical doses in adult transfeminine people (Wiki):

    EffectOnsetaCompletionaPermanency
    Breast development2–6 months2–3 yearsPermanent
    Reduced and slowed growth of facial and body hair3–12 months>3 yearsbReversible
    Cessation and reversal of scalp hair loss1–3 months1–2 yearsReversible
    Softening of skin and decreased skin oiliness and acne3–6 monthsUnknownReversible
    Redistribution of body fat in a feminine pattern3–6 months2–5 yearsReversible
    Decreased muscle mass and strength3–6 months1–2 yearscReversible
    Widening and rounding of the pelvisdUnknownUnknownPermanent
    Changes in mood, emotionality, and behaviorImmediateUnknownReversible
    Decreased sex drive and spontaneous erections1–3 months3–6 monthsReversible
    Erectile dysfunction and decreased ejaculate volume1–3 monthsVariableReversible
    Decreased sperm production and infertilityUnknown>3 yearsMixede
    Decreased testicular volume3–6 months2–3 yearsUnknown
    Voice changes (e.g., decreased pitch/resonance)NonefN/AN/A

    a May vary significantly between individuals due to factors like genetics, diet/nutrition, hormone levels, etc. b Hormone therapy usually has little influence on facial hair density in transfeminine people. Complete removal of facial and body hair can be achieved with laser hair removal and electrolysis. Temporary hair removal can be achieved with shaving, epilating, waxing, and other methods. c May vary significantly depending on amount of physical exercise. d Occurs only in young individuals who have not yet completed growth plate closure (may not occur at all in post-adolescent people). e Only estrogens, particularly at high doses, seem to have the potential for long-lasting or irreversible infertility; impaired fertility caused by antiandrogens is usually readily reversible with discontinuation. f Voice training can be an effective means of feminizing the voice.

    To see real-life photographic timelines of breast development and feminization with transfeminine hormone therapy, see the r/TransBreastTimelines community on the social media website Reddit.

    Specific Hormonal Medications

    The medications that are used in transfeminine hormone therapy include estrogens, progestogens, and antiandrogens. Estrogens produce feminization and testosterone suppression. Progestogens and antiandrogens do not mediate feminization themselves but further suppress and/or block testosterone. Testosterone suppression causes demasculinization and disinhibition of estrogen-mediated feminization. Androgens are sometimes used at low doses in transfeminine people who have low testosterone levels, although they are not required and benefits are uncertain. There are many different types of these hormonal medications available for transfeminine hormone therapy, with different benefits and risks.

    Estrogens, progestogens, and antiandrogens are available in a variety of different formulations and for use by many different routes of administration in transfeminine people. The route of administration influences the absorption, distribution, metabolism, and elimination of the hormone in the body, resulting in significant differences between routes in terms of bioavailability, hormone levels in blood and specific tissues, and patterns of metabolites. These differences can have important therapeutic consequences.

    Table 3: Major routes of administration of hormonal medications for transfeminine people:

    RouteAbbr.DescriptionTypical forms
    Oral administrationPOSwallowedTablet, capsule
    Sublingual administrationSLHeld and absorbed under tongueTablet
    Buccal administrationBUCHeld and absorbed in cheek or under lipsTablet
    Transdermal administrationTDApplied to and absorbed through the skinPatch, gel, cream
    Rectal administrationRECInserted into and absorbed by rectumSuppository
    Intramuscular injectionIMInjected into muscle (e.g., buttocks, thigh, arm)Solution (vial/amp.)
    Subcutaneous injectionSCInjected into fat under skinSolution (vial/amp.)
    Subcutaneous implantSCiInsertion via surgical incision into fat under skinPellet

    Vaginal administration is a major additional route of administration of hormonal medications in cisgender women. While vaginal administration via a natal vagina is of course not possible in transfeminine people, neovaginal administration is a possiblility in those who have undergone vaginoplasty. However, the lining of the neovagina is not the vaginal epithelium of natal females but instead is usually skin or colon—depending on the type of vaginoplasty performed (penile inversion or sigmoid colon vaginoplasty, respectively). For this reason, neovaginal administration in transfeminine people is likely more similar in its properties to transdermal and rectal administration—depending on the type of neovagina—than to vaginal administration in cisgender women. It is noteworthy that the vaginal and rectal routes are said to be similar in their properties for hormonal medications however (Goletiani, Keith, & Gorsky, 2007; Wiki). Moreover, absorption of estradiol via neovaginas constructed from peritoneum (internal abdominal lining)—a less commonly employed vaginoplasty approach in transfeminine people—was reported in one study to be similar to that with vaginal administration of estradiol in cisgender women (Willemsen et al., 1985). As such, neovaginal administration may be an additional possible route for certain transfeminine people depending on the circumstances. However, this route still remains to be more adequately characterized.

    Estrogens

    Estradiol, the primary bioidentical form normally found in the human body, is the main estrogen that is used in transfeminine hormone therapy. Estradiol hemihydrate (EH) is another form that is essentially identical to and interchangeable with estradiol. Estradiol esters are also sometimes used in place of estradiol. They are prodrugs of estradiol (i.e., are converted into estradiol in the body) and have essentially identical biological activity to estradiol. However, they have longer durations when used by injection due to slower absorption from the injection site, and this allows them to be administered less often. Some examples of major estradiol esters include estradiol valerate (EV; Progynova, Progynon Depot, Delestrogen) and estradiol cypionate (EC; Depo-Estradiol). Polyestradiol phosphate (PEP; Estradurin) is an injectable estradiol prodrug in the form of a polymer (i.e., linked chain of estradiol molecules) which is metabolized slowly and has a very long duration.

    Non-bioidentical estrogens such as ethinylestradiol (EE; found in birth control pills), conjugated estrogens (CEEs; Premarin; used in menopausal hormone therapy), and diethylstilbestrol (DES; widely used previously but now abandoned) are resistant to metabolism in the liver and have disproportionate effects on estrogen-modulated liver synthesis when compared to bioidentical estrogens like estradiol (Aly, 2020). As a result, they have stronger influence on coagulation and greater risk of certain health problems like blood clots and associated cardiovascular issues (Aly, 2020). For this reason, as well as the fact that relatively high doses of estrogens may be needed for testosterone suppression, non-bioidentical estrogens should ideally never be used in transfeminine hormone therapy.

    Physiological levels of estradiol are usually not sufficient to suppress testosterone levels into the female range in gonadally intact transfeminine people. As a result, estradiol is generally used in combination with an antiandrogen or progestogen in transfeminine hormone therapy. This results in partial suppression of testosterone levels by estradiol and further suppression or blockade of the remaining testosterone by the antiandrogen or progestogen. The addition of an antiandrogen or progestogen to estradiol therapy however also adds the side effects, risks, and costs of these medications. An alternative to the combination of estradiol with an antiandrogen or progestogen which may be used in transfeminine people is high-dose estradiol monotherapy. This is an approach in which estradiol is used alone at supraphysiological doses. These high doses can allow for greater testosterone suppression and reduction of testosterone levels into the female range with estradiol alone.

    The feminizing effects of estradiol appear to be maximal at low levels in the absence of androgens. Higher doses of estradiol, aside from allowing for greater testosterone suppression, are not known to result in better feminization in transfeminine people (Deutsch, 2016; Nolan & Cheung, 2021). In fact, there is indication that higher estrogen doses early into hormone therapy could actually result in worse breast development. Hence, the therapeutic emphasis in transfeminine hormone therapy is more on testosterone suppression than on achieving a certain estradiol level. Higher doses of estrogens, including estradiol, also have a greater risk of adverse health effects such as blood clots and cardiovascular problems (Aly, 2020). As such, the use of physiological doses of estradiol is optimal. At the same time however, high estrogen doses can be useful for testosterone suppression. Moreover, the absolute risks in the case of non-oral bioidentical estradiol are low and are more important in people with specific risk factors. Examples of such risk factors include older age, physical inactivity, obesity, concomitant progestogen use, smoking, surgery, and rare thrombophilic abnormalities. In healthy young people without relevant risk factors, limitedly supraphysiological doses of non-oral estradiol for purposes of adequate testosterone suppression may be more acceptably safe (Aly, 2020).

    Estradiol and estradiol esters are usually used orally, sublingually, transdermally, by injection (intramuscularly or subcutaneously), or by implant in transfeminine hormone therapy (Wiki).

    Oral Estradiol

    Estradiol is used orally in the form of tablets of estradiol (Wiki; Graphs). Alternatively, oral estradiol valerate tablets are used in some countries, for instance in many European countries. The only real differences between these oral estradiol forms is that estradiol valerate contains slightly less estradiol by weight (~76%) due to its ester component and hence requires somewhat higher doses (~1.3-fold) in comparison for equivalent estradiol levels (Wiki; Table). Oral estradiol has a duration suitable for once-daily administration. Oral administration of estradiol is a very convenient and inexpensive route, which makes it the most popular and widely used form of estradiol in transfeminine people. Oral estradiol has relatively low bioavailability (~5%), and there is substantial variability between people in terms of estradiol levels achieved with the same dose. Hence, in some transfeminine people estradiol levels may be low with oral estradiol, and testosterone suppression may be inadequate depending on the antiandrogen.

    A major drawback of oral estradiol is that it results in excessive levels of estradiol in the liver due to the first pass that occurs with oral administration and has a disproportionate impact on estrogen-modulated liver synthesis (Aly, 2020). This in turn increases coagulation and the risk of associated health complications like blood clots and cardiovascular problems (Aly, 2020). These particular health concerns are largely allayed if estradiol is taken non-orally at reasonable and non-excessive doses. Hence non-oral forms of estradiol, like transdermal estradiol, although less convenient and often more expensive than oral estradiol, are preferable in transfeminine hormone therapy. It is recommended that all transfeminine people who are over 40 to 45 years of age use non-oral routes due to the greater risk of blood clots and cardiovascular problems that occurs with age (Aly, 2020; Coleman et al., 2022). Oral estradiol is not a good choice for high-dose estradiol monotherapy in transfeminine people due to the high estradiol levels required and the greater risks than with non-oral routes. In addition to its disproportionate liver impact, oral estradiol results in unphysiological levels of estradiol metabolites like estrone and estrone sulfate when compared to non-oral forms. The clinical implications of this, if any, are unknown. Oral and non-oral estradiol have in any case been found to have similar effectiveness in terms of feminization and breast development in transfeminine people in available studies (Sam, 2020).

    Sublingual Estradiol

    Oral estradiol tablets can be taken sublingually instead of orally. Sublingual use of estradiol tablets has several-fold higher bioavailability relative to oral administration and hence achieves much higher overall estradiol levels in comparison (Sam, 2021; Wiki; Graphs). Sublingual use of oral estradiol tablets can be employed instead of oral administration to reduce doses and hence medication costs or to produce higher estradiol levels for the purpose of achieving better testosterone suppression when needed. However, sublingual estradiol is very spiky in terms of estradiol levels when compared to oral estradiol and has a short duration of highly elevated estradiol levels. As such, it may be advisable for sublingual estradiol to be used in divided doses multiple times throughout the day in order to maintain at least somewhat steadier estradiol levels. The therapeutic implications for transfeminine people of the spikiness of sublingual estradiol, for instance in terms of testosterone suppression and health risks, have been little-studied and are mostly unknown. Oral estradiol valerate tablets can be taken sublingually instead of orally similarly to estradiol and are likewise highly effective when used in this way (Aly, 2019; Wiki). Due to partial swallowing of tablets, sublingual estradiol may in practice be a mixture of sublingual and oral administration and may have some of the same health risks of oral estradiol (Wiki). Buccal administration of estradiol appears to have similar properties as sublingual administration but is much less researched in comparison and is not used as often in transfeminine people (Wiki).

    Transdermal Estradiol

    Transdermal estradiol is available in the form of patches, gel, emulsions, and sprays (Wiki). These forms are usually applied to skin areas such as the arms, abdomen, or buttocks. Gel, emulsions, and sprays are applied and left to dry for a short period, whereas patches are applied and remain adhesed to the skin for a specified amount of time. Due to rate-limited absorption through the skin, there is a depot effect with transdermal estradiol and this route has a long duration with very steady estradiol levels. As a result, estradiol gel, emulsions, and sprays are all suitable for once-daily use. Patches stay applied and continuously deliver estradiol for either 3–4 days or 7 days depending on the patch brand (Table). Transdermal estradiol is more expensive than oral estradiol. Gel, emulsions, and sprays may be less convenient than oral administration, but patches can be more convenient due to their infrequent application. However, patches can sometimes cause application site problems like redness and irritation and can occasionally come off prematurely due to adhesive failure. As with oral estradiol, there is substantial variability in estradiol levels with transdermal estradiol, and some transfeminine people may have poor absorption, low estradiol levels, and inadequate testosterone suppression with this route. Estradiol sprays, such as Lenzetto, have been found to achieve very low estradiol levels that are probably not therapeutically adequate for use in transfeminine hormone therapy (Aly, 2020; Graph).

    Transdermal estradiol is the form of estradiol most commonly used in transfeminine people who are over 40 years of age due to its lower health risks relative to oral estradiol. Transdermal estradiol gel is not a favorable option for high-dose estradiol monotherapy as it has difficulty achieving the high estradiol levels needed for adequate testosterone suppression (Aly, 2019). On the other hand, transdermal estradiol patches can be an effective option for high-dose estradiol monotherapy if multiple 100 μg/day patches are used (Wiki). Different skin sites absorb transdermal estradiol to different extents (Wiki). Genital application of transdermal estradiol, specifically to the scrotum or neolabia, is particularly better-absorbed than conventional skin sites and can result in much higher estradiol levels than usual (Aly, 2019). This can be useful for reducing doses and hence medication costs or for achieving higher estradiol levels for better testosterone suppression when needed. Transdermal estradiol should not be applied to the breasts as this is not known to result in improved breast development and the potential health consequences of doing so are unknown (e.g., influence on breast cancer risk).

    Injectable Estradiol

    Injectable estradiol preparations can be administered via either intramuscular or subcutaneous injection (Wiki; Wiki; Graphs). There is a depot effect with injection of estradiol esters such that they are slowly absorbed from the injection site and have a prolonged duration. This ranges from days to months depending on the ester. Commonly used injectable estradiol esters, which all have short to moderate durations, include estradiol valerate (EV), estradiol cypionate (EC), estradiol enanthate (EEn), and estradiol benzoate (EB). Longer-acting injectable estradiol esters, such as estradiol undecylate (EU) and polyestradiol phosphate (PEP), have been discontinued and are no longer pharmaceutically available. In the case of intramuscular injection, common injection sites include the deltoid muscle (upper arm), vastus lateralis and rectus femoris muscles (thigh), and ventrogluteal muscle (buttocks). Subcutaneous injection of estradiol injectables, while less commonly used, has comparable pharmacokinetics to intramuscular injection, and is easier, less painful, and more convenient in comparison (Wiki). However, the maximum volume that can be safely and comfortably injected subcutaneously is less than that which can be injected intramuscularly (depending on the site up to 1.5–3 mL and up to 2–5 mL, respectively) (Hopkins, & Arias, 2013; Usach et al., 2019). Injectable estradiol tends to be fairly inexpensive, but may be less convenient than other routes due to the need for regular injections. There may also be a risk of internal scar tissue build-up long-term. Estradiol injectables have been discontinued in many parts of the world (e.g., most of Europe), and their availability is limited. In recent years, many transfeminine people have turned to black market homebrewed injectable estradiol preparations to use this route.

    Injectable estradiol preparations are typically used at higher doses than other forms of estradiol, and can easily achieve very high levels of estradiol. This can be useful for testosterone suppression, making this form of estradiol likely the best choice for high-dose estradiol monotherapy in transfeminine people. However, the high doses that are possible with injectable estradiol preparations can also easily lead to overdosage and unnecessarily increased risks (e.g., Aly, 2020). Resources are available on this site for guiding selection of appropriate doses and intervals of injectable estradiol esters in transfeminine people. This includes a simulator and informal meta-analysis of estradiol levels with these preparations (Aly, 2021; Aly, 2021) and a table providing approximate equivalent doses between injectable estradiol esters and other estradiol routes and forms (Aly, 2020). It is notable and unfortunate that currently recommended doses and intervals for injectable estradiol esters by transgender care guidelines (e.g., 10–40 mg/2 weeks estradiol valerate) appear to be highly excessive and too widely spaced, and are likely to be therapeutically inadvisable (Aly, 2021). Doses and intervals of injectable estradiol esters recommended by the present author for use as a means of high-dose estradiol monotherapy, targeting mean estradiol levels of around 300 pg/mL (1,100 pmol/L), are provided below (Table 4).

    Table 4: Recommended doses and intervals of injectable estradiol esters for high-dose estradiol monotherapy (targeting estradiol levels of around 300 pg/mL [1,100 pmol/L]):

    Estradiol EsterShortMediumLongSimulation
    Estradiol benzoate0.67 mg/1 day1.33 mg/2 days2 mg/3 daysGraph
    Estradiol valerate2 mg/3 days3.5 mg/5 days5 mg/7 daysGraph
    Estradiol cypionate (in oil)5 mg/7 days7 mg/10 days10 mg/14 daysGraph
    Estradiol cypionate (suspension)2 mg/3 days3.5 mg/5 days5 mg/7 daysGraph
    Estradiol enanthate5 mg/7 days7 mg/10 days10 mg/14 daysGraph
    Estradiol undecylatea10 mg/14 days20 mg/28 days30 mg/42 daysGraph
    Polyestradiol phosphate160 mg/30 days240 mg/45 days320 mg/60 daysGraph

    a Doses and intervals for estradiol undecylate are extrapolated and hypothetical (Aly, 2021).

    These doses and intervals should be considered a starting point, and should be fine-tuned as necessary based on blood tests. In terms of injection intervals, the shorter interval, the more stable the estradiol levels, but the more often that injections need to be done. Doses may be increased if estradiol levels are too low and testosterone suppression is inadequate, and doses may be decreased if estradiol levels are too high so long as adequate testosterone suppression is maintained. Doses should be lower (targeting mean estradiol levels of 100–200 pg/mL [367–734 pmol/L]) if combined with an antiandrogen or progestogen as these agents will help with testosterone suppression. Similarly, doses should be lower following surgical gonadal removal as testosterone suppression will no longer be necessary.

    Estradiol Pellets

    Estradiol implants are pellets of pure crystalline hormone and are surgically placed into subcutaneous fat by a physician (Wiki). They are slowly absorbed by the body following implantation, and new implants are given once every 4 to 6 months. Due to the need for minor surgery, their high cost, and limited availability, estradiol implants are not as commonly used as other estradiol routes. Notably, almost all pharmaceutical estradiol implants throughout the world have been discontinued, and the implants that remain available are almost exclusively compounded products provided by compounding pharmacies. Dosage adjustment with estradiol implants is also more difficult than with other estradiol routes. Despite their various practical limitations however, estradiol implants allow for very steady estradiol levels, and their very long duration can allow for unusual convenience among available estradiol forms.

    Additional Notes

    Table 5: Available forms and recommended doses of estradiol for adulta transfeminine people:

    MedicationRouteFormDosage
    EstradiolOralTablets2–8 mg/day
     Sublingual or buccalTablets0.5–6 mg/dayb
     TransdermalPatches50–400 μg/day
      Gel1.5–6 mg/day
      SpraysNot recommendedc
     SC implantPellet25–150 mg/6 months
    Estradiol valerateOralTablets3–10 mg/dayd
     Sublingual or buccalTablets1–8 mg/dayb,d
     IM or SC injectionOil solution0.75–4 mg/5 days; or
    1–6 mg/7 days; or
    1.5–9 mg/10 days
    Estradiol cypionateIM or SC injectionOil solution1–6 mg/7 days; or
    1.5–9 mg/10 days; or
    2–12 mg/14 days
      Aqueous suspension0.75–4 mg/5 days; or
    1–6 mg/7 days; or
    1.5–9 mg/10 days
    Estradiol enanthateIM or SC injectionOil solution1–6 mg/7 days; or
    1.5–9 mg/10 days; or
    2–12 mg/14 days
    Estradiol benzoateIM or SC injectionOil solution0.15–0.75 mg/day; or
    0.3–1.5 mg/2 days; or
    0.45–2.25 mg/3 days
    Estradiol undecylateeIM or SC injectionOil solution2–12 mg/14 days; or
    4–24 mg/28 days; or
    6–36 mg/42 days
    Polyestradiol phosphateIM injectionWater solution40–160 mg/monthf

    a Estradiol doses in pubertal adolescent transfeminine people should be lower to mimic estradiol exposure during normal female puberty (Aly, 2020). b May be advisable to use divided doses 2 to 4 times per day (i.e., once every 6 to 12 hours) instead of once per day (Sam, 2021). c This estradiol form achieves very low estradiol levels at typical doses that don’t appear to be well-suited for transfeminine hormone therapy (Aly, 2020; Graph). d Estradiol valerate contains about 75% of the same amount of estradiol as estradiol so doses are about 1.3-fold higher for the same estradiol levels (Aly, 2019; Sam, 2021). e Doses and intervals for estradiol undecylate are extrapolated and hypothetical (Aly, 2021). f A higher initial loading dose of e.g., 240 or 320 mg polyestradiol phosphate can be used for the first one or two injections to reach steady-state estradiol levels more quickly. However, this preparation has recently been discontinued and appears to no longer be available.

    Additional informational resources are available in terms of estradiol levels (Wiki; Table) and approximate equivalent doses (Aly, 2020) with different forms, routes, and doses of estradiol.

    There is high variability between individuals in the levels of estradiol achieved during estradiol therapy. That is, estradiol levels during treatment with the same dosage of estradiol can differ substantially between individuals. This variability is greatest with oral and transdermal estradiol but is also considerable even with injectable estradiol preparations and other estradiol forms. As such, estradiol doses are not absolute and should be individualized on a case-by-case basis in conjunction with blood work as a guide. It should also be noted that due to fluctuations in estradiol concentrations with certain routes, levels of estradiol can vary considerably from one blood test to another. This is most notable with sublingual estradiol and injectable estradiol. The fluctuations in estradiol levels with these routes are predictable and must be understood when interpreting blood work results. Differences in blood test results can be minimized with informed and consistent timing of blood draws.

    If or when the gonads are surgically removed, testosterone suppression is no longer needed in transfeminine people. As a result, estradiol doses, if they are high or supraphysiological, can be lowered to more closely approximate normal physiological levels in cisgender women.

    Progestogens

    Progestogens include progesterone and progestins. Progestins are synthetic progestogens derived from structural modification of progesterone or testosterone. There are dozens of different progestins and these progestins can be divided into a variety of different structural classes with varying properties (Table). Examples of some major progestins of different classes include the 17α-hydroxyprogesterone derivative medroxyprogesterone acetate (MPA; Provera, Depo-Provera), the 19-nortestosterone derivative norethisterone (NET; many brand names), the retroprogesterone derivative dydrogesterone (Duphaston), and the 17α-spirolactone derivative drospirenone (Slynd, Yasmin). Progestins were developed because they have a more favorable disposition in the body than progesterone for use as medications. Only a few clinically used progestins have been used in transfeminine hormone therapy. However, progestogens largely produce the same progestogenic effects, with a few exceptions, and theoretically almost any progestogen could be employed.

    Progestogens have antigonadotropic effects via their progestogenic activity and dose-dependently suppress the secretion of the gonadotropins from the pituitary gland. This in turn results in a reduction of gonadotropin-mediated gonadal stimulation and a decrease in sex hormone production as well as fertility. The dose-dependent testosterone-suppressing effects of a variety of different progestogens have been characterized in clinical studies in cisgender men and transfeminine people (Nieschlag, Zitzmann, & Kamischke, 2003; Nieschlag, 2010; Nieschlag & Behre, 2012; Zitzmann et al., 2017; Aly, 2019). Some notable examples of this include cyproterone acetate (CPA) (Aly, 2019; Wiki), MPA (Wiki), NET (Wiki) and its ester norethisterone acetate (NETA) (Wiki), levonorgestrel (LNG) (Zitzmann et al., 2017; Wiki), desogestrel (DSG) (Wu et al., 1999; Wiki), dienogest (DNG) (Meriggiola et al., 2002; Wiki), and progesterone (Wiki), among others. High doses of progestogens by themselves are able to maximally suppress testosterone levels by about 50 to 70% on average (Aly, 2019; Zitzmann et al., 2017 (Graph)). In combination with estrogen however, this increases to about 95%, with testosterone levels suppressed into the normal female range (Aly, 2019). Progestogens seem to usually achieve their maximal testosterone-suppressing capacity at a dose of around 5 to 10 times their ovulation-inhibiting dosage in cisgender women (Aly, 2019). Due to low potency or atypicality, oral progesterone and dydrogesterone are exceptions among progestogens which do not have significant antigonadotropic effects and which would not be expected to suppress testosterone levels (Aly, 2018; Wiki; Wiki).

    Besides helping with testosterone suppression, progestogens are of no clear or known benefit for feminization or breast development in transfeminine people. While some transfeminine people anecdotally claim to experience improved breast development with progestogens, an involvement of progestogens in improving breast size or shape is controversial and is not supported by theory nor evidence at present (Wiki; Aly, 2020). It is possible that premature introduction of progestogens, particularly at high doses, could actually have an unfavorable influence on breast development (Aly, 2020). Many transfeminine people have also anecdotally claimed that progestogens have a beneficial effect on their sexual desire. However, a review of the literature by the present author found that neither progesterone nor progestins positively influence sexual desire in humans (Aly, 2020). Instead, the available evidence suggests either a neutral influence or an inhibitory effect of progestogens on sexual desire, although the latter may be specific only to high doses of progestogens (Aly, 2020). Claims have been made that progesterone may have beneficial effects on mood in transfeminine people as well, but clinical support for such notions is likewise lacking at this time (Coleman et al., 2022; Nolan et al., 2022). It is notable that progesterone at luteal-phase levels, due to its neurosteroid metabolites like allopregnanolone, actually appears to worsen mood in around 30% of cisgender women, and produces more overt negative reactions, which constitute the diagnoses of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), in around 2 to 10% of women (Bäckström et al., 2011; Edler Schiller, Schmidt, & Rubinow, 2014; Sundström-Poromaa et al., 2020). More research is needed to evaluate the possible beneficial effects of progestogens in transfeminine people.

    Most clinically used progestogens have off-target activities in addition to their progestogenic activity, and these activities may be desirable or undesirable depending on the action in question (Kuhl, 2005; Stanczyk et al., 2013; Wiki; Table). Progesterone has a variety of neurosteroid as well as other activities that can result in central nervous system effects among others which are not shared by progestins. MPA as well as NET and its derivatives have weak androgenic activity, which is unfavorable in the context of transfeminine hormone therapy. NET and certain related progestins produce ethinylestradiol as a metabolite at high doses and hence can produce ethinylestradiol-like estrogenic effects, including increased risk of blood clots and associated cardiovascular problems. Other off-target actions of progestogens include antiandrogenic, glucocorticoid, and antimineralocorticoid activities. These actions can result in differences in therapeutic effectiveness (e.g., androgen suppression or blockade) as well as side effects and health risks. Some notable progestins without undesirable off-target activities (i.e., androgenic or glucocorticoid activity) include low-dose CPA, drospirenone (DRSP), dienogest, nomegestrol acetate (NOMAC), dydrogesterone, and hydroxyprogesterone caproate (OHPC). However, of these progestins, only CPA has been considerably used and studied in transfeminine people.

    The addition of progestogens to estrogen therapy has been associated with a number of unfavorable health effects. These include increased risk of blood clots (Wiki; Aly, 2020), coronary heart disease (Wiki), and breast cancer (Wiki; Aly, 2020). High doses of progestogens are also associated with increased risk of certain non-cancerous brain tumors including meningiomas and prolactinomas (Wiki; Aly, 2020). The coronary heart disease risk may be due to changes in blood lipids caused by the weak androgenic activity of certain progestogens, but the rest of the aforementioned risks are probably due to their progestogenic activity (Stanczyk et al., 2013; Jiang & Tian, 2017). Aside from health risks, progestogens have also been associated with adverse mood changes (Wiki; Wiki). However, besides the case of progesterone and its neurosteroid metabolites, these effects of progestogens are controversial and are not well-supported by evidence (Wiki; Wiki). Progestogens are otherwise generally well-tolerated and are regarded as producing little in the way of side effects.

    In contrast to certain progestins, progesterone has no unfavorable off-target activities. Due to its lack of androgenic activity, progesterone has no adverse influence on blood lipids and is not expected to raise the risk of coronary heart disease. The addition of oral progesterone to estrogen therapy notably has not been associated with increased risk of blood clots (Wiki). In addition, oral progesterone seems to have less risk of breast cancer than progestins with short-term therapy, although this is notably not the case with longer-term exposure (Wiki; Aly, 2020). Consequently, it has been suggested that progesterone, for reasons that have yet to be fully elucidated, may be a safer progestogen than progestins and that it should be the preferred progestogen for hormone therapy in cisgender women and transfeminine people. However, there are also theoretical arguments against such notions. Oral progesterone is known to produce very low progesterone levels and to have only weak progestogenic effects at typical doses (Aly, 2018; Wiki). The seemingly better safety of oral progesterone may simply be an artifact of the low progesterone levels that occur with it, and hence of progestogenic dosage. Non-oral progesterone, at doses resulting in physiological and full progestogenic strength, has never been properly evaluated in terms of health outcomes, and may have similar risks as progestins (Aly, 2018; Wiki).

    Due to their lack of known influence on feminization and breast development and their known and possible adverse effects and risks, progestogens are not routinely used in transfeminine hormone therapy at present. Major transgender health guidelines note the limitations of the available evidence on progestogens for transfeminine people and have mixed attitudes on their use, either explictly recommending against their use (Coleman et al., 2022—WPATH SOC8), taking a more neutral stance (Hembree et al., 2017—Endocrine Society guidelines), or being permissive of their use (Deutsch, 2016—UCSF guidelines). There is however a very major exception to the preceding in the form of CPA, an antiandrogen which is widely used in transfeminine hormone therapy to suppress testosterone production and which happens to be a powerful progestogen at the typical doses used in transfeminine people. CPA will be described below in the section on antiandrogens. Although progestogens have various health risks, cisgender women of course have progesterone, and the absolute risks of progestogens are very low in healthy young people. Risks like breast cancer also are exposure-dependent and take many years to develop. The testosterone suppression provided by progestogens can furthermore be very useful in transfeminine people, as is widely taken advantage of with CPA. Given these considerations, a limited duration of progestogen therapy in transfeminine people, for instance a few years to help suppress testosterone levels before surgical gonadal removal, may be considered quite acceptable.

    Progesterone can be used in transfeminine people by oral administration, sublingual administration, rectal administration, or by intramuscular or subcutaneous injection (Wiki). Progestins are usually used via oral administration, but certain progestins are also available in injectable formulations (Wiki).

    Oral Progesterone

    Progesterone is most commonly taken orally. It is used by this route in the form of oil-filled capsules containing 100 or 200 mg micronized progesterone under brand names such as Prometrium, Utrogestan, and Microgest (Wiki). Despite its widespread use, levels of progesterone via oral administration have been found using state-of-the-art assays (LC–MS) to be very low (<2 ng/mL [<6.4 nmol/L] at 100 mg/day) and inadequate for satisfactory progestogenic effects in various areas (Aly, 2018; Wiki). In relation to this, even high doses of oral progesterone (400 mg/day) showed no antigonadotropic effect or testosterone suppression in cisgender men (Aly, 2018; Wiki). This is in major contrast to non-oral forms of progesterone and to progestins, which produce dose-dependent and robust testosterone suppression (Aly, 2019; Wiki). In addition to its low progestogenic potency, oral progesterone is excessively converted into neurosteroid metabolites like allopregnanolone and pregnanolone. These metabolites act as potent GABAA receptor positive allosteric modulators, and can produce undesirable alcohol-like side effects such as sedation, cognitive, memory, and motor impairment, and mood changes (Wiki; Wiki). As such, while inconvenient, non-oral routes are greatly preferable for progesterone.

    Sublingual Progesterone

    Sublingual progesterone tablets exist and are marketed under the brand name Luteina but today are only available in Poland and Ukraine (Wiki). Oral progesterone could theoretically be taken sublingually, analogously to sublingual use of oral estradiol. However, because oral progesterone is formulated as oil-filled capsules, this makes it difficult and unpleasant to use by sublingual administration. Buccal progesterone, which would be expected to have similar characteristics to those of sublingual progesterone, has been used in medicine in the past, but is no longer marketed today (Wiki).

    Rectal Progesterone

    Progesterone is approved for use by rectal administration in the form of suppositories under the brand name Cyclogest (Wiki). This product is marketed in only a limited number of countries however, although it is available in the United Kingdom (Wiki). While not approved for use by rectal administration, oral progesterone capsules can be taken rectally instead of orally, and using them in this way may allow for much higher progesterone levels than would be achieved by oral administration due to avoidance of most first-pass metabolism. Rectal administration of oral progesterone capsules has not been formally studied, but oral progesterone capsules have been administered vaginally in cisgender women with success (Miles et al., 1994; Wang et al., 2019), and the vaginal and rectal routes are said to have similar pharmacokinetics in general (Goletiani, Keith, & Gorsky, 2007; Wiki). Hence, there is good theoretical basis for rectal administration of oral progesterone capsules being an effective route of administration of progesterone. Whereas oral progesterone achieves very low levels of progesterone, rectal progesterone can readily achieve normal luteal-phase levels of progesterone (Wiki). Although inconvenient, rectal administration may be the overall best route of administration of progesterone for transfeminine people.

    Injectable Progesterone

    Progesterone by injection is available as an oil solution for intramuscular injection under brand names such as Proluton, Progestaject, and Gestone (Wiki) and as an aqueous solution for subcutaneous injection under the brand name Prolutex (Wiki). Oil solutions of progesterone for intramuscular injection are widely available, whereas the aqueous solution of progesterone for subcutaneous injection is available only in some European countries (Wiki). Injectable progesterone, regardless of route, has a relatively short duration and must be injected once every one to three days (Wiki; Wiki). This makes it too inconvenient to use for most people. Unlike with estradiol, progesterone esters with longer durations than progesterone itself by injection are not chemically possible as progesterone has no hydroxyl groups available for esterification (Wiki). Injectable aqueous suspensions of microcrystalline progesterone were previously marketed and had a duration of 1 to 2 weeks, but these preparations were associated with pain at the injection site and were eventually discontinued (Aly, 2019; Wiki).

    Other Progesterone Routes

    Other progesterone routes, such as transdermal progesterone and subcutaneous progesterone pellets, are also known, but are not available as pharmaceutical drugs and are little-used medically (Wiki). This is related to the low potency of progesterone and difficulty achieving progesterone levels high enough for adequate therapeutic effects with these routes (Wiki; Wiki). In addition, progesterone pellets tend to be extruded at high rates (Wiki). In any case, certain compounding pharmacies may make forms of progesterone that could be used by these routes.

    Oral and Injectable Progestins

    Most progestins are taken orally in the form of solid tablets (Wiki). In contrast to progesterone, progestins, owing to their synthetic nature, are resistant to metabolism in the intestines and liver and have high oral bioavailability. In addition, unlike the case of the estrogen receptors, the progesterone receptors are expressed minimally or not at all in the liver, and there is no known first pass influence of progestogenic activity on liver synthesis (Lax, 1987; Stanczyk, Mathews, & Cortessis, 2017). As a result, there are no apparent problems with oral administration in the case of purely progestogenic progestins. However, some progestins have liver-impacting off-target hormonal actions, such as androgenic, estrogenic, and/or glucocorticoid activity, and this can result in adverse effects like unfavorable lipid changes or procoagulation—which may be augmented by the first pass with oral administration.

    A selection of progestins are available in injectable formulations, including for intramuscular or subcutaneous injection (Wiki). Some of the more notable ones include medroxyprogesterone acetate (MPA), norethisterone enanthate (NETE), hydroxyprogesterone caproate (OHPC), and algestone acetophenide (dihydroxyprogesterone acetophenide; DHPA) (Wiki). In addition to being used alone, injectable progestins are used together with estradiol esters in combined injectable contraceptives (Wiki). These preparations are often used as a means of hormone therapy by transfeminine people in Latin America. Whereas injectable progesterone has a duration measured in days, injectable progestins have durations ranging from weeks to months, and can be injected much less often in comparison (Table).

    Additional Notes

    Table 6: Available forms and recommended doses of progestogens for transfeminine people:

    MedicationRouteFormDosage
    ProgesteroneOralOil-filled capsules100–300 mg 1–2x/day
     RectalSuppositories; Oil-filled capsules100–200 mg 1–2x/day
     IM injectionOil solution25–75 mg/1–3 days
     SC injectionWater solution25 mg/day
    ProgestinsOral; IM or SC injectionTablets; Oil solution; Water solutionVarious

    For progesterone levels with different forms, routes, and doses of progesterone, see the table here (only LC–MS and IA + CS assays for oral progesterone) and the graphs here.

    As with estradiol, there is high variability between individuals in progesterone levels. Conversely, there is less variability between individuals in the case of progestins.

    After removal of the gonads, progestogen doses can be lowered or adjusted to approximate normal female physiological exposure or they can be discontinued entirely.

    Antiandrogens

    Aside from estrogens and progestogens, there is another class of hormonal medications used in transfeminine hormone therapy known as antiandrogens (AAs). These medications reduce the effects of androgens in the body by either decreasing androgen production and thereby lowering androgen levels or by directly blocking the actions of androgens. They work via a variety of different mechanisms of action, and include androgen receptor antagonists, antigonadotropins, and androgen synthesis inhibitors.

    Androgen receptor antagonists act by directly blocking the effects of androgens, including testosterone, DHT, and other androgens, at the level of their biological target. They bind to the androgen receptor without activating it, thereby displacing androgens from the receptor. Due to the nature of their mechanism of action as competitive blockers of androgens, the antiandrogenic efficacy of androgen receptor antagonists is both highly dose-dependent and fundamentally dependent on testosterone levels. They do not act by lowering testosterone levels, although some androgen receptor antagonists may have additional antiandrogenic actions that result in decreased testosterone levels. Because androgen receptor antagonists do not work by lowering testosterone levels, blood work can be less informative for them compared to antiandrogens that suppress testosterone levels. Androgen receptor antagonists include steroidal antiandrogens (SAAs) like spironolactone (Aldactone) and cyproterone acetate (CPA; Androcur) and nonsteroidal antiandrogens (NSAAs) like bicalutamide (Casodex).

    Antigonadotropins suppress the gonadal production of androgens by inhibiting the GnRH-mediated secretion of gonadotropins from the pituitary gland. They include estrogens and progestogens. In addition, GnRH agonists such as leuprorelin (Lupron) and GnRH antagonists such as elagolix (Orilissa) act similarly and could likewise be described as antigonadotropins.

    Androgen synthesis inhibitors inhibit the enzyme-mediated synthesis of androgens. They include 5α-reductase inhibitors (5α-RIs) like finasteride (Propecia) and dutasteride (Avodart). There are also other types of androgen synthesis inhibitors, for instance potent 17α-hydroxylase/17,20-lyase inhibitors like ketoconazole (Nizoral) and abiraterone acetate (Zytiga). However, these agents have limitations (e.g., toxicity, high cost, and lack of experience) and have not been used in transfeminine hormone therapy.

    Although antigonadotropins and androgen synthesis inhibitors have antiandrogenic effects secondary to decreased androgen levels, they are not usually referred to as “antiandrogens”. Instead, this term is most commonly reserved to refer specifically to androgen receptor antagonists. However, antigonadotropins and androgen synthesis inhibitors may nonetheless be described as antiandrogens as well.

    After removal of the gonads, antiandrogens can be discontinued. If unwanted androgen-dependent symptoms, such as acne, seborrhea, or scalp hair loss, persist despite full suppression or ablation of gonadal testosterone, then a lower dose of an androgen receptor antagonist, such as 100 to 200 mg/day spironolactone or 12.5 to 25 mg/day bicalutamide, can be continued to treat these symptoms.

    Table 7: Available forms and recommended doses of antiandrogens for transfeminine people:

    MedicationTypeRouteFormDosage
    Cyproterone acetateProgestogen; Androgen receptor antagonistOralTablets2.5–12.5 mg/daya
    SpironolactoneAndrogen receptor antagonist; Weak androgen synthesis inhibitorOralTablets100–400 mg/dayb,c
    BicalutamideAndrogen receptor antagonistOralTablets12.5–50 mg/dayb

    a For CPA, this dose range is specifically one-quarter of a 10-mg tablet to one full 10-mg tablet per day (2.5–10 mg/day) or a quarter of a 50-mg tablet every other day or every 2 to 3 days (4.2–12.5 mg/day). A dosage of 5–10 mg/day or 6.25–12.5 mg/day is likely to ensure maximal testosterone suppression, while lower doses may be less effective (Aly, 2019). b For spironolactone and bicalutamide, it is assumed that testosterone levels are substantially suppressed (≤200 ng/dL [<6.9 nmol/L]). If testosterone levels are not suppressed to this range, then higher doses may be warranted. c Spironolactone and its metabolites have relatively short half-lives, and twice-daily administration in divided doses (e.g., 100–200 mg twice per day) is recommended.

    Figure 3: Suppression of gonadal testosterone production and circulating testosterone levels (ng/dL) with estradiol in combination with different antiandrogens over one year of hormone therapy in transfeminine people (Sofer et al., 2020). The estradiol forms included oral tablets 2–8 mg/day, transdermal gel 2.5–5 mg/day, and transdermal patches 50–200 μg/day. The antiandrogens included spironolactone 50–200 mg/day (n=16), cyproterone acetate (n=41), and GnRH agonists (specifically triptorelin 3.75 mg/month or goserelin 3.6 mg/month by injection) (n=10) (Sofer et al., 2020). It should be noted that lower doses of cyproterone acetate (10–12.5 mg/day) show equal testosterone suppression to higher doses (25–100 mg/day) and higher doses should no longer be used (Aly, 2019). The dashed horizontal line corresponds to the upper limit of the normal female range for testosterone levels.

    Cyproterone Acetate

    Cyproterone acetate (CPA; Androcur) is a progestogen and antiandrogen. It is widely used as a progestogen in cisgender women, including in hormonal birth control and menopausal hormone therapy. CPA is also widely used as an antiandrogen in the treatment of androgen-dependent conditions in cisgender women and cisgender men. In cisgender women, it is used to treat acne, hirsutism (excessive facial/body hair growth), scalp hair loss, and hyperandrogenism (high androgen levels) due to polycystic ovary syndrome (PCOS). In cisgender men, it is used to treat prostate cancer and to lower sex drive in the management of sexual problems such as paraphilias, hypersexuality, and sex offenses. Besides cisgender people, CPA is widely used as a component of hormone therapy—specifically as an antiandrogen—in transfeminine people. The medication is notably not marketed in the United States, where spironolactone is most commonly used instead. However, CPA is widely available throughout the rest of the world, and is the most frequently used antiandrogen in transfeminine people in Europe and probably the whole world overall (T’Sjoen et al., 2019; Glintborg et al., 2021; Coleman et al., 2022).

    As an antiandrogen, CPA has a dual mechanism of action of suppressing testosterone levels via its progestogenic and hence antigonadotropic activity and of acting as an androgen receptor antagonist (Aly, 2019). The progestogenic activity of CPA is of far greater potency than its androgen receptor antagonism however (Aly, 2019). The dose of CPA used as a progestogen in cisgender women is about 2 mg per day, which produces similar progestogenic effects to those of physiological luteal-phase levels of progesterone (e.g., suppression of gonadotropin secretion, ovulation inhibition, and endometrial transformation and protection) (Aly, 2019). Conversely, much higher doses of CPA of 50 to 300 mg/day have typically been used for androgen-dependent indications (Aly, 2019). These high doses of CPA result in profound progestogenic overdosage and associated side effects and risks (Aly, 2019). In transfeminine people, CPA has historically been used at doses of 50 to 150 mg/day (Aly, 2019). However, CPA doses have dramatically fallen in recent years, and today doses of no more than 10 to 12.5 mg/day are recommended (Aly, 2019; Coleman et al., 2022—WPATH SOC8). These lower doses of CPA still produce strong progestogenic effects, and in combination with estradiol, are equally effective as higher doses in suppressing testosterone levels (Aly, 2019; Meyer et al., 2020; Even Zohar et al., 2021; Kuijpers et al., 2021; Coleman et al., 2022). Even lower doses of CPA, for instance 5 to 6.25 mg/day, are currently being studied, and may still be fully effective (Aly, 2019).

    Given by itself without estrogen, CPA typically suppresses testosterone levels in people with testes by about 50 to 70%, down to about 150 to 300 ng/dL (5.2–10.4 nmol/L) (Meriggiola et al., 2002; Toorians et al., 2003; Giltay et al., 2004; T’Sjoen et al., 2005; Tack et al., 2017; Zitzmann et al., 2017; Aly, 2019). Lower doses of CPA alone (e.g., 10 mg/day) show the same degree of testosterone suppression as higher doses of CPA alone (e.g., 50–100 mg/day), indicating that the antigonadotropic effects of CPA are maximal at relatively low therapeutic doses of this medication (Aly, 2019). This is on the order of about 5 to 10 times the ovulation-inhibiting dosage of CPA in cisgender women, a dose–response relationship that has also been observed with a number of other progestogens (Aly, 2019). Per the preceding, CPA alone, regardless of dosage, is unable to reduce testosterone levels into the normal female range (<50 ng/dL [<1.7 nmol/L]). But when CPA is combined with estradiol, even at relatively small doses of estradiol, it consistently suppresses testosterone levels into the normal female range (Aly, 2019; Angus et al., 2019; Gava et al., 2020; Sofer et al., 2020; Collet et al., 2022). However, it appears that a certain minimum level of estradiol, perhaps around 60 pg/mL (220 pmol/L) on average, is required for this to occur (Aly, 2019). Estradiol levels lower than this threshold in those taking CPA, which can occasionally be encountered in transfeminine people due to estradiol being dosed too low, have the potential to compromise full testosterone suppression (Aly, 2019).

    In addition to testosterone suppression, CPA can dose-dependently block the androgen receptor (Aly, 2019). However, relatively high doses of CPA are needed to considerably antagonize the androgen receptor (e.g., 50–300 mg/day), and lower doses (e.g., ≤12.5 mg/day) may not be able to do this to a meaningful degree (Aly, 2019). As such, lower doses of CPA may essentially be purely progestogenic, with minimal or no androgen receptor antagonism. In this regard, referring to CPA at such doses as an “antiandrogen”—rather than as a “progestogen”—may be considered somewhat of a misnomer. Higher doses of CPA (>12.5 mg/day) can no longer be considered safe due to the massive progestogenic overdosage that occurs with them, and should no longer be used in transfeminine people. Moreover, as testosterone levels are usually suppressed into the normal female range in transfeminine people taking estradiol plus CPA, there is no actual need for any additional androgen receptor blockade (Aly, 2019).

    CPA has been reported to produce various side effects. Some of these side effects include fatigue and a degree of weight gain (Belisle & Love, 1986; Hammerstein, 1990; Martinez-Martin et al., 2022). CPA might be able to produce a magnitude of sexual dysfunction (e.g., reduced sexual desire) beyond that expected with testosterone suppression alone (Wiki; Aly, 2019). It may also have a small risk of depressive mood changes (Wiki). In transfeminine people, CPA has been documented to produce pregnancy-like breast changes (i.e., lobuloalveolar development of the mammary glands) (Kanhai et al., 2000). In relation to this, CPA sometimes causes lactation as a side effect (Gooren, Harmsen-Louman, & van Kessel, 1985; Schlatterer et al., 1998; Bazarra-Castro, 2009). Concerns have been raised about premature introduction of progestogens—particularly at high doses like with CPA—and possible adverse influence on breast development (Aly, 2020). However, little data exists in humans to substantiate such concerns at present. The side effects of CPA are assumed to be dose-dependent, and using the lowest effective doses is expected to minimize its side effects.

    As CPA is a progestogen, it is associated with increased risks of breast cancer (Fournier, Berrino, & Clavel-Chapelon, 2008; CGHFBC, 2019; de Blok et al., 2019; Aly, 2020; Wiki) and blood clots (Seaman et al., 2007; Connors & Middeldorp, 2019; Aly, 2020; Wiki) even at very low doses (e.g., 2 mg/day). Higher doses of CPA, likewise presumed to be due to its progestogenic activity, are additionally associated with elevated prolactin levels (Sofer et al., 2020; Wilson et al., 2020; Wiki) as well as with certain generally non-cancerous brain tumors including prolactinomas (McFarlane, Zajac, & Cheung, 2018; Nota et al., 2018; Wiki) and meningiomas (McFarlane, Zajac, & Cheung, 2018; Nota et al., 2018; Millward et al., 2021; Weill et al., 2021; Aly, 2020; Wiki). These risks appear to be dose-dependent, and thus are likely to be minimized with lower doses of CPA. Besides risks related to its progestogenic activity, CPA at high doses has shown weak but significant androgenic effects in the liver and has been associated with an unfavorable influence on lipid profile, for instance decreased HDL (“good”) cholesterol levels (Coleman et al., 2022; Wiki). Long-term, this could result in an increase in the risk of coronary heart disease. Other potential adverse effects of CPA at high doses with unclear mechanisms may include increased blood pressure and heightened insulin resistance (Martinez-Martin et al., 2022). Additionally, CPA has been associated with abnormal liver function tests and rare cases of liver toxicity, including at doses used in transfeminine people of 25 to 50 mg/day (Heinemann et al., 1997; Bessone et al., 2016; Kumar et al., 2021; Wiki; Table). The likelihood of abnormal liver function tests with CPA, and probably of liver toxicity, appears to be much lower at doses of less than 20 mg/day (Wiki). More than 100 cases of clinically significant liver toxicity have been reported with CPA, but only two cases have been reported with CPA at doses of 50 mg/day or less (Wiki; Table). Monitoring of prolactin levels to detect prolactinomas, and monitoring of liver function to detect liver toxicity, may both be advisable in people taking CPA. Regular magnetic resonance imaging (MRI) scans have also been recommended to monitor for meningiomas in people taking CPA (at ≥10 mg/day) (Aly, 2020).

    CPA is usually taken orally in the form of tablets (e.g., 10, 50, and 100 mg) (Wiki). Under the brand name Androcur Depot, it is also available as a long-lasting 300 mg depot injectable in some countries (Wiki). However, this formulation is not commonly used in transfeminine people, and happens to correspond to very high doses in terms of CPA exposure. A pill cutter (Amazon) can be used to split CPA tablets and achieve lower doses (e.g., 12.5 mg doses with 50-mg tablets). CPA has a relatively long elimination half-life of about 1.6 to 4.3 days (Wiki; Aly, 2019). As such, it can be taken once daily, or even as infrequently as once every 2 or 3 days, if needed (Aly, 2019). In addition to splitting of CPA tablets, dosing CPA once every 2 or 3 days can also be useful for achieving lower doses (Aly, 2019).

    As already described, CPA is a powerful progestogen even at the relatively low doses now used in transfeminine people (e.g., 5–12.5 mg/day). As such, there is no need, nor point, in adding another progestogen, for instance progesterone, in those who are taking CPA—at least if the goal of doing so is to produce progestogenic effects. This is something that is often overlooked in people taking CPA, and can result in increased costs, side effects, and inconvenience without any expected benefit.

    Spironolactone

    Spironolactone (Aldactone) is an antiandrogen and antimineralocorticoid. It is widely used as an antiandrogen in cisgender women for treatment of androgen-dependent hair and skin conditions like acne, hirsutism (excessive facial/body hair growth), and scalp hair loss, in cisgender women for treatment of hyperandrogenism (high androgen levels) due to polycystic ovary syndrome (PCOS), and in transfeminine people as a component of hormone therapy. Spironolactone is particularly widely used in transfeminine people in the United States, where it is the most commonly used antiandrogen in this population. As an antimineralocorticoid, the original and primary use of spironolactone in medicine, it is used to treat heart failure, high blood pressure, high mineralocorticoid levels, low potassium levels, and conditions of excess fluid retention like nephrotic syndrome and ascites, among others (Wiki). In terms of its antiandrogenic actions, spironolactone is a relatively weak androgen receptor antagonist as well as a weak androgen synthesis inhibitor (Wiki). The androgen synthesis inhibition of spironolactone is mediated specifically via inhibition of 17α-hydroxylase and 17,20-lyase (Wiki). Spironolactone does not appear to have meaningful progestogenic activity, 5α-reductase inhibition, or direct estrogenic activity (Wiki). However, indirect estrogenic effects secondary to its antiandrogenic activity (e.g., breast development and feminization) can occur with it at sufficiently high doses (Wiki).

    Spironolactone shows limited and highly inconsistent effects on testosterone levels in clinical studies in cisgender men, cisgender women, and transfeminine people, with most studies finding no change in levels, some studies finding a decrease in levels, and a small number even finding an increase in levels (Aly, 2018). In spite of this, studies commonly find that spironolactone still produces antiandrogenic effects even when androgen levels remain unchanged. Hence, the primary mechanism of action of spironolactone as an antiandrogen appears to be androgen receptor blockade. In relation to this, in transfeminine people taking spironolactone as an antiandrogen, the estrogen component of the regimen is likely to be the main or possibly sole agent suppressing testosterone production. This is in part based on studies in transfeminine people comparing estradiol plus spironolactone to estradiol alone (e.g., Leinung, 2014; Leinung, Feustel, & Joseph, 2018; Angus et al., 2019) and on studies comparing testosterone levels with different doses of spironolactone (e.g., Liang et al., 2018; SoRelle et al., 2019; Allen et al., 2021). Due to the minimal influence of spironolactone on testosterone production, testosterone levels are not usually suppressed into the female range in transfeminine people taking estradiol plus spironolactone, with testosterone levels often remaining well above this range (e.g., 50–450 ng/dL [1.7–15.6 nmol/L] on average) (Leinung, 2014; Leinung, Feustel, & Joseph, 2018; Liang et al., 2018; Angus et al., 2019; Jain, Kwan, & Forcier, 2019; SoRelle et al., 2019; Sofer et al., 2020; Burinkul et al., 2021). However, testosterone levels do tend to decline gradually over time in transfeminine people on this regimen (e.g., Liang et al., 2018; Sofer et al., 2020 (Graph); Allen et al., 2021).

    Due to its relatively weak androgen receptor antagonism, spironolactone is likely best-suited for blocking female-range or somewhat-higher testosterone levels (e.g., <100 ng/dL [<3.5 nmol/L]) (Aly, 2018). This is based on clinical dose-ranging studies of spironolactone (typically using 50–200 mg/day) in healthy cisgender women and cisgender women with PCOS (Goodfellow et al., 1984; Lobo et al., 1985; Hammerstein, 1990; James, Jamerson, & Aguh, 2022) as well as comparative studies of spironolactone against the more-potent antiandrogen flutamide (Cusan et al., 1994; Erenus et al., 1994; Shaw, 1996). The clinical antiandrogenic efficacy of spironolactone has been very limitedly assessed in transfeminine people to date, and is largely unknown (Angus et al., 2021). In any case, the antiandrogenic efficacy of spironolactone in cisgender women with androgen-dependent hair and skin conditions is well-established, and the medication thus does appear to be effective so long as testosterone levels are not too high (Brown et al., 2009; van Zuuren & Fedorowicz, 2016; Layton et al., 2017; Barrionuevo et al., 2018; James, Jamerson, & Aguh, 2022). In addition, higher doses of spironolactone (e.g., 300–400 mg/day) may be more useful for blocking higher testosterone levels in transfeminine people, and are allowed for by transgender care guidelines (Aly, 2020).

    Consequent to spironolactone’s limited and inconsistent influence on testosterone levels and its relatively weak androgen receptor antagonism, estradiol plus spironolactone regimens will likely not be fully effective in terms of testosterone suppression for many transfeminine people. This is liable to result in suboptimal demasculinization, feminization, and breast development in these individuals. Other antiandrogenic approaches, such as bicalutamide, CPA, GnRH modulators, and high-dose estradiol monotherapy, will likely be more effective in these cases owing either to their ability to more potently block androgens or their capacity to reliably reduce testosterone levels into the female range. If testosterone levels are still too high with estradiol plus spironolactone, a switch to a different antiandrogen, increasing to a higher dosage of estradiol, or addition of a clinically antigonadotropic progestogen (e.g., non-oral progesterone or a progestin) should be considered.

    Spironolactone is a strong antimineralocorticoid, or antagonist of the mineralocorticoid receptor, the biological target of the mineralocorticoid steroid hormones aldosterone and 11-deoxycorticosterone. This is an action that spironolactone shares with progesterone, although spironolactone is a much more potent antimineralocorticoid than progesterone. The mineralocorticoid receptor is involved in regulating electrolyte and fluid balances, among other roles. Spironolactone is associated with modestly lowered blood pressure, which may be considered a beneficial effect of its antimineralocorticoid activity (Martinez-Martin et al., 2022). Although spironolactone is usually well-tolerated, it can sometimes produce antimineralocorticoid side effects such as excessively lowered blood pressure, dizziness, fatigue, urinary frequency, and increased cortisol levels, among others (Kellner & Wiedemann, 2008; Kim & Del Rosso, 2012; Zaenglein et al., 2016; Layton et al., 2017; James, Jamerson, & Aguh, 2022). It has been argued by some in the online transgender community that spironolactone, via its antimineralocorticoid activity and increased cortisol levels, may increase visceral fat in transfeminine people (Aly, 2020). However, evidence does not support this hypothetical side effect at present (Aly, 2020). Available data also do not support spironolactone stunting breast development in transfeminine people or producing serious neuropsychiatric side effects, such as prominent depressive mood changes.

    The most important risk of spironolactone, which is consequent to its antimineralocorticoid activity, is hyperkalemia (high potassium levels) (Wiki). This complication is rare and is mostly limited to those who have specific risk factors for it, but is serious and can result in hospitalization or death. Monitoring of blood potassium levels during spironolactone therapy is advisable in those with risk factors for hyperkalemia, but does not appear to be necessary in people without such risk factors (Plovanich, Weng, & Mostaghimi, 2015; Zaenglein et al., 2016; Layton et al., 2017; Millington, Liu, & Chan, 2019; Wang & Lipner, 2020; Gupta et al., 2022; Hayes et al., 2022). Risk factors for hyperkalemia include older age (>45 years), reduced kidney function, concomitant use of other potassium-elevating drugs, and intake of potassium supplements or potassium-containing salt substitutes. Other notable potassium-elevating drugs include other potassium-sparing diuretics (e.g., amiloride (Midamor), triamterene (Dyrenium), other antimineralocorticoids), ACE inhibitors, angiotensin II receptor blockers, and the antibiotic trimethoprim (Bactrim), among others (Kim & Rosso, 2012; Salem et al., 2014). As an example drug interaction, serious hyperkalemia and sudden death can occur in elderly people (>65 years of age) concomitantly taking spironolactone and trimethoprim (Antoniou et al., 2011; Antoniou et al., 2015).

    In people who are at-risk for hyperkalemia, dietary restriction to limit intake of potassium-rich foods is often recommended (Roscioni et al., 2012; Cupisti et al., 2018). This is often encountered in transgender health as transfeminine people being told “not to eat bananas”, which are said to be high in potassium. However, limiting dietary potassium with spironolactone to avoid hyperkalemia is theoretical and not actually evidence-based, with data so far contradicting its efficacy (St-Jules, Goldfarb, & Sevick, 2016; St-Jules & Fouque, 2021; Babich, Kalantar-Zadeh, & Joshi, 2022; St-Jules & Fouque, 2022). As such, routine restriction of dietary potassium with spironolactone is probably not warranted.

    Aside from its antimineralocorticoid activity, spironolactone has been reported to increase levels of LDL (“bad”) cholesterol levels and to decrease levels of HDL (“good”) cholesterol in women with PCOS (Nakhjavani et al., 2009). However, findings appear to be conflicting, with other studies not finding unfavorable influences on cholesterol levels with spironolactone (Polyzos et al., 2011). Long-term, adverse effects on cholesterol levels could result in an increase in the risk of coronary heart disease.

    Spironolactone is taken orally in the form of tablets (e.g., 25, 50, and 100 mg) (Wiki). It is a prodrug of several active metabolites, including 7α-thiomethylspironolactone, 6β-hydroxy-7α-thiomethylspironolactone, and canrenone (7α-desthioacetyl-δ6-spironolactone) (Wiki). Spironolactone and these active metabolites have elimination half-lives of 1.4 hours, 13.8 hours, 15.0 hours, and 16.5 hours, respectively (Wiki). Due to the relatively short duration of elevated drug levels with spironolactone and its active metabolites (Graph), twice-daily administration of spironolactone in divided doses may be more optimal than once-daily intake and is advised (Reiter et al., 2010).

    Bicalutamide

    Bicalutamide (Casodex) is a nonsteroidal antiandrogen (NSAA) which acts as a potent and highly selective androgen receptor antagonist (Wiki). It is primarily used in the treatment of prostate cancer in cisgender men. Prostate cancer is an androgen-dependent cancer which antiandrogens can help to slow the progression of, and this use constitutes the vast majority of prescriptions for bicalutamide (Wiki). In addition to prostate cancer, although to a much lesser extent, bicalutamide has been used in the treatment of hirsutism (excessive facial/body hair growth), scalp hair loss, and polycystic ovary syndrome (PCOS) in cisgender women, peripheral or gonadotropin-independent precocious puberty (a rare form of precocious puberty in which antigonadotropins such as GnRH agonists are not effective) in cisgender boys, and priapism in cisgender men (Wiki). Bicalutamide is also becoming increasingly adopted for use as an antiandrogen in transfeminine people (Aly, 2020; Wiki). However, its use in transgender health is still very limited, and well-regarded transgender care guidelines either recommend against its use (Deutsch, 2016—UCSF guidelines; Coleman et al., 2022—WPATH SOC8) or are only cautiously permissive of its use (Thompson et al., 2021—Fenway Health guidelines). This is due to a lack of studies of bicalutamide in transfeminine people and its potential risks. Nonetheless, a small but growing number of clinicians are using bicalutamide in transfeminine people or are willing to prescribe it, with these clinicians located particularly in the United States. A single small clinical study has assessed bicalutamide in transfeminine people so far, specifically as a puberty blocker in 13 transfeminine adolescents who were denied insurance coverage for GnRH agonists (Neyman, Fuqua, & Eugster, 2019).

    Bicalutamide is a much more potent androgen receptor antagonist than either spironolactone or CPA (Wiki; Neyman, Fuqua, & Eugster, 2019). It is typically used in transfeminine people at a dosage of 25 to 50 mg/day, although this dosage has been arbitrarily selected and is not based on clinical data. Nonetheless, due to its relatively high potency as an androgen receptor antagonist and concomitant suppression of testosterone levels by estradiol, these doses may be adequate for testosterone blockade for many transfeminine people. At higher doses (>50 mg/day), bicalutamide is able to substantially block male-range testosterone levels (>300 ng/dL [>10.4 nmol/L]) based on studies of bicalutamide monotherapy in cisgender men with prostate cancer (Wiki). This is something that spironolactone and CPA are not capable of in the same way. Owing to its selectivity for the androgen receptor, bicalutamide has no off-target hormonal activity and produces almost no side effects in women (Wiki; Erem, 2013; Moretti et al., 2018). The only apparent side effect of bicalutamide in a rigorous clinical trial of the drug for hirsutism in cisgender women was significantly increased total and LDL (“bad”) cholesterol levels (Moretti et al., 2018). Hence, bicalutamide tends to be very well-tolerated. The relative lack of side effects with bicalutamide is contrast to other antiandrogens like spironolactone and CPA, which are not pure androgen receptor antagonists and have off-target hormonal actions like antimineralocorticoid activity or strong progestogenic activity with consequent side effects and risks.

    As a selective androgen receptor antagonist, bicalutamide taken by itself does not decrease testosterone production or levels but rather increases them (Wiki). This is due to a loss of androgen receptor-mediated negative feedback on gonadotropin secretion and a consequent compensatory upregulation of gonadal testosterone production (Wiki). Bicalutamide more than blocks the effects of any increase in testosterone it causes, and in fact fundamentally cannot increase testosterone levels more than it can block them (Wiki). In addition, increases in testosterone levels with bicalutamide will be blunted or abolished if it is combined with an adequate dose of an antigonadotropin such as estradiol (Wiki; Wiki). Since estradiol is made from testosterone in the body, bicalutamide taken alone also preserves and increases estradiol production and levels (Wiki). Because of this, although bicalutamide has no other important intrinsic hormonal activity besides its antiandrogenic activity, it produces robust indirect estrogenic effects including feminization and breast development even when it is not combined with estrogen (Wiki; Wiki; Neyman, Fuqua, & Eugster, 2019). This has important implications for the use of bicalutamide as a puberty blocker in transfeminine adolescents, as bicalutamide does not actually block puberty like conventional puberty blockers (GnRH agonists) but instead has the effect of dose-dependently converting male puberty into female puberty (Wiki; Neyman, Fuqua, & Eugster, 2019).

    Bicalutamide has certain health risks, which has been a major reason that it has not been more readily adopted in transfeminine hormone therapy (Aly, 2020). It has a small risk of liver toxicity (Wiki; Aly, 2020) and of lung toxicity (Wiki). Abnormal liver function tests (LFTs), such as elevated liver enzymes and elevated bilirubin, occurred in about 3.4% of men with bicalutamide monotherapy plus standard care versus 1.9% of men with placebo plus standard care in the Early Prostate Trial (EPC) clinical programme after 3.0 years of follow-up (Wiki). In clinical trials, treatment with bicalutamide had to be discontinued in about 0.3 to 1.5% of men due to LFTs that became too highly elevated and could have progressed to serious liver toxicity (Wiki). To date, there are around 10 published case reports of serious liver toxicity, including cases of death, with bicalutamide, all of which have been in men with prostate cancer (Wiki; Table; Aly, 2020). There have also been a few unpublished reports of serious liver toxicity including deaths with bicalutamide in transfeminine people (Aly, 2020). However, these reports have not been confirmed, and they may or may not be reliable. In addition to the preceding reports, hundreds of additional instances of liver complications in people taking bicalutamide exist in the United States FDA Adverse Event Reporting System (FAERS) database (Wiki; FDA). Abnormal LFTs with bicalutamide usually occur within the first 3 to 6 months of treatment (Kolvenbag & Blackledge, 1996; Casodex FDA Label), and all case reports of liver toxicity with bicalutamide have had an onset of less than 6 months (Table). The liver toxicity of bicalutamide is not known to be dose-dependent across its clinically used dose range (Wiki). Abnormal LFTs have occurred with bicalutamide (at rates of 2.9% to 11.4%) even at relatively low doses in cisgender women (e.g., 10–50 mg/day) (de Melo Carvalho, 2022). Due to its risk of liver toxicity, periodic liver monitoring is strongly advised with bicalutamide, especially within the first 6 months of treatment. Possible signs of liver toxicity include nausea, vomiting, abdominal pain, fatigue, appetite loss, flu-like symptoms, dark urine, and jaundice (yellowing of the skin/eyes) (Wiki).

    In terms of its lung toxicity risk, bicalutamide has been associated rarely with interstitial pneumonitis, which can lead to pulmonary fibrosis and can be fatal, and also less often with eosinophilic lung disease (Wiki; Table). As of writing, 15 published case reports of interstitial pneumonitis and 2 case reports of eosinophilic lung disease in association with bicalutamide therapy exist, likewise all in men with prostate cancer (Table). As with liver toxicity, hundreds of additional cases of interstitial pneumonitis in people taking bicalutamide exist in the United States FAERS database (Wiki; FDA). It has been estimated that interstitial pneumonitis with bicalutamide occurs at a rate of around 1 in 10,000 people, although this may be an underestimate due to under-reporting (Wiki; Ahmad & Graham, 2003). Asian people may be especially likely to experience lung toxicity with bicalutamide and other NSAAs, as much higher incidences have been observed in this population (Mahler et al., 1996; Wu et al., 2022). There is no laboratory test for routine monitoring of lung changes with bicalutamide. Possible signs of relevant lung toxicity include dyspnea (difficulty breathing or shortness of breath), coughing, and pharyngitis (inflammation of the throat, typically manifesting as sore throat) (Wiki).

    Aside from liver and lung toxicity, bicalutamide monotherapy has been found in cisgender men with prostate cancer to increase the risk of death due to causes other than prostate cancer (Iversen et al., 2004; Iversen et al., 2006; Wellington & Keam, 2006; Jia & Spratt, 2022; Wiki). This led to marketing authorization of bicalutamide for treatment of the earliest stage of prostate cancer being revoked and to the drug being abandoned for this use (Wiki). Bicalutamide remains approved and used for treatment of later stages of prostate cancer, as the antiandrogenic benefits of bicalutamide against prostate cancer outweigh any adverse influence it has on non-prostate-cancer mortality in these more severe stages. The mechanisms underlying the increase in risk of death with bicalutamide in men are unknown (Wiki). It is also unclear whether bicalutamide could likewise increase the risk of death in transfeminine people. Limitations of generalizing these studies to transfeminine people include the men in the trials being relatively old and ill, a relatively high dosage of bicalutamide (150 mg/day) being used in the trials for an extended duration (e.g., 5 years), the question of whether the risks were due to androgen deprivation or to specific drug-related toxicity of bicalutamide, and estradiol levels with bicalutamide monotherapy in men with prostate cancer being only about 30 to 50 pg/mL (110–184 pmol/L) (Wiki). The preceding estradiol levels are well above castrate levels and are sufficient for a substantial degree of estrogenic effect, but are nonetheless below those recommended for transfeminine people and potentially needed for full sex-hormone replacement (which are ≥50 pg/mL [≥184 pmol/L]). In any case, as the specific mechanisms underlying the increased mortality risk with bicalutamide seen in men with prostate cancer are uncertain, and as clinical safety data showing that the risk does not generalize do not exist, it remains a possibility that bicalutamide could also increase the risk of death in transfeminine people.

    Bicalutamide is taken orally in the form of tablets (e.g., 50 and 150 mg) (Wiki). Due to saturation of absorption in the gastrointestinal tract, the oral bioavailability of bicalutamide progressively starts to decrease above a dosage of about 150 mg/day, and there is no further increase in bicalutamide levels above 300 mg/day (Wiki; Graph). Bicalutamide has a very long elimination half-life of about 6 to 10 days (Wiki; Graphs). As a result, it does not necessarily have to be taken daily, and can be dosed less often (in proportionally higher doses)—for instance twice weekly or even once weekly—if this is more convenient or otherwise desired. Due to its long half-life, bicalutamide requires about 4 to 12 weeks to fully reach steady-state levels (Wiki; Graph; Wiki). However, about 50% of steady state is reached within 1 week of administration of bicalutamide, and about 80 to 90% of steady state is reached after 3 to 4 weeks (Wiki; Graph; Wiki). Loading doses of bicalutamide can be taken to reach steady state more quickly if desired. Animal studies originally suggested that bicalutamide did not cross the blood–brain barrier and hence was peripherally selective (i.e., did not block androgen receptors in the brain) (Wiki). However, subsequent clinical studies found that this was not similarly the case in humans, in whom bicalutamide shows clear and robust centrally mediated antiandrogenic effects (Wiki).

    Older NSAAs related to bicalutamide like flutamide (Eulexin) and nilutamide (Anandron, Nilandron) have much greater risks in comparison to bicalutamide and should not be used in transfeminine people. Nilutamide was previously characterized as an antiandrogen in transfeminine people in several studies, but was not further pursued probably due to its very high incidence of lung toxicity and other side effects (Aly, 2020; Wiki; Wiki). Flutamide has been used limitedly as an antiandrogen in transfeminine people in the past, but should no longer be used due to a much higher risk of liver toxicity than bicalutamide as well as other side effects and drawbacks (Aly, 2020; Wiki). Other newer and more-potent NSAAs like enzalutamide (Xtandi), apalutamide (Erleada), and darolutamide (Nubeqa) also have risks and have been studied and used little outside of prostate cancer to date.

    5α-Reductase Inhibitors

    Testosterone is converted into DHT within certain tissues in the body (Swerdloff et al., 2017). DHT is an androgen metabolite of testosterone with several-fold higher activity than testosterone. The transformation of testosterone into DHT is mediated by the enzyme 5α-reductase. The tissues in which 5α-reductase is present and testosterone is converted into DHT are limited but most importantly include the skin, hair follicles, and prostate gland. Although DHT is more potent than testosterone, it is thought to have minimal biological role as a circulating hormone (Horton, 1992; Swerdloff et al., 2017). Instead, testosterone serves as the main circulating androgen, and the role of DHT is thought to be mainly via local metabolism and potentiation of testosterone into DHT within certain tissues.

    5α-Reductase inhibitors (5α-RIs), such as finasteride (Proscar, Propecia) and dutasteride (Avodart), inhibit 5α-reductase and thereby block the conversion of testosterone into DHT. This results in marked decreases in circulating and within-tissue levels of DHT. Due to the primary role of DHT as a mediator in tissues rather than as circulating hormone, the antiandrogenic efficacy of 5α-RIs is limited. This is evidenced by the fact that they are well-tolerated in cisgender men and do not cause notable demasculinization in these individuals (Hirshburg, 2016). The medical use of 5α-RIs is mainly restricted to the treatment of scalp hair loss in men and women, hirsutism (excessive facial/body hair) in women, and prostate enlargement in men. They might also be useful for acne in women, but evidence of this is very limited (Wiki). Due to their specificity, 5α-RIs are inappropriate as general antiandrogens in transfeminine people. Moreover, DHT levels decrease in tandem with testosterone levels with suppression of testosterone production in transfeminine hormone therapy, and routine use of 5α-RIs in transfeminine people with testosterone levels within the female range is of limited usefulness and can be considered unnecessary (Gooren et al., 2016; Irwig, 2020; Prince & Safer, 2020; Glintborg et al., 2021). In any case, 5α-RIs may be useful in transfeminine people on hormone therapy who have persistent body hair growth or scalp hair loss—as they have been shown to be in cisgender women (Barrionuevo et al., 2018; Prince & Safer, 2020). However, it is notable that evidence of effectiveness in cisgender women is better for androgen receptor antagonists for such indications (van Zuuren et al., 2015). This is intuitive as androgen receptor antagonists block both testosterone and DHT whereas 5α-RIs only prevent conversion of testosterone into DHT. Hence, although 5α-RIs strongly reduce or eliminate DHT and their net effect is antiandrogenic, they do not decrease testosterone levels and in fact increase them.

    There are three subtypes of 5α-reductase. Dutasteride inhibits all three subtypes of 5α-reductase whereas finasteride only inhibits two of the subtypes. As a result of this, dutasteride is a more complete 5α-RI than finasteride. Dutasteride decreases DHT levels in the blood by up to 98% while finasteride can only decrease them by around 65 to 70%. As nearly all circulating DHT originates from synthesis in peripheral tissues, these decreases indicate parallel reductions in tissue DHT production (Horton, 1992). In accordance with these findings, dutasteride has been found to be more effective than finasteride in the treatment of scalp hair loss in men (Zhou et al., 2018; Dhurat et al., 2020; Wiki). For these reasons, although both finasteride and dutasteride are effective 5α-RIs, dutasteride may be the preferable choice if a 5α-RI is used (Zhou et al., 2018; Dhurat et al., 2020).

    A potentially undesirable effect of 5α-RIs in transfeminine people is that they may increase circulating testosterone levels to a degree in those in whom testosterone production isn’t fully suppressed (Leinung, Feustel, & Joseph, 2018; Aly, 2019; Traish et al., 2019; Irwig, 2020; Glintborg et al., 2021). It appears that DHT adds significantly to negative feedback on gonadotropin secretion in the pituitary gland in people with testes who have low testosterone levels relative to the normal male range (Traish et al., 2019). The therapeutic implications of this for transfeminine people, if any, are uncertain.

    Another potentially undesirable action of 5α-RIs is that they inhibit not only the production of DHT but also of certain neurosteroids. Neurosteroids are steroids that act on the nervous system—most notably the brain. Examples of neurosteroids that 5α-RIs inhibit the synthesis of include allopregnanolone, which is formed from progesterone, and 3α-androstanediol, which is derived from testosterone and DHT. Research suggests that these neurosteroids have significant biological modulatory roles in mood, anxiety, stress, and other cognitive/emotional processes (King, 2013). Possibly in relation to this, 5α-RIs have been associated with a small risk of depression (Welk et al., 2018; Deng et al., 2020; Dyson, Cantrell, & Lund, 2020; Nguyen et al., 2020; Wiki). Claims of other, more significant and persistent side effects with 5α-RIs, which are termed “post-finasteride syndrome” (PFS) in the case of finasteride, also exist (Traish, 2020). However, they are based on low-quality reports and are controversial (Fertig et al., 2016; Rezende, Dias, & Trüeb, 2018). The nocebo effect is likely to worsen perceptions of side effects with 5α-RIs (Kuhl & Wiegratz, 2017; Maksym et al., 2019).

    Clinical dose-ranging studies have found that lower doses of finasteride and dutasteride than are typically used still provide substantial or near-maximal 5α-reductase inhibition (Gormley et al., 1990; Vermeulen et al., 1991; Sudduth & Koronkowski, 1993; Drake et al., 1999; Roberts et al., 1999; Clark et al., 2004; Frye, 2006; Olsen et al., 2006; Harcha et al., 2014; Kuhl & Wiegratz, 2017). In one study with finasteride for instance, DHT levels decreased by 49.5% at 0.05 mg/day, 68.6% at 0.2 mg/day, 71.4% at 1 mg/day, and 72.2% at 5 mg/day (Drake et al., 1999). Parallel reductions in DHT levels were seen locally in the scalp (Drake et al., 1999). In a study with dutasteride, DHT levels were decreased by 52.9% at 0.05 mg/day, 94.7% at 0.5 mg/day, 97.7% at 2.5 mg/day, and 98.4% at 5 mg/day (Clark et al., 2004). Based on these findings, 5α-RIs can potentially be taken at lower doses to help reduce medication costs if needed. Finasteride tablets can be split to achieve smaller doses. Conversely, dutasteride cannot be split as it is formulated as an oil capsule. However, dutasteride has a long half-life, and instead of dividing pills, it can be taken less frequently (e.g., once every few days) as a means of reducing dosage.

    5α-Reductase inhibitors are taken orally in the form of tablets and capsules. Compounded topical formulations of finasteride also exist (Marks et al., 2020). However, caution is advised with these preparations as they have been found to be excessively dosed and to produce equivalent systemic DHT suppression as oral finasteride formulations (Marks et al., 2020). Lower-concentration formulations of topical finsteride on the other hand may be more locally selective (Marks et al., 2020).

    Table 8: Available forms and recommended doses of 5α-reductase inhibitors for transfeminine people:

    MedicationRouteFormDosage
    DutasterideOralCapsules0.05–2.5 mg/day
    FinasterideOralTablets0.05–5 mg/day

    GnRH Agonists and Antagonists

    GnRH agonists and antagonists (GnRHa), also known as GnRH receptor agonists and antagonists or GnRH modulators, are antiandrogens which work by preventing the effects of GnRH in the pituitary gland and thereby suppressing LH and FSH secretion. Receptor agonists normally activate receptors while receptor antagonists block and thereby inhibit the activation of receptors. Due to a physiological quirk however, GnRH agonists and antagonists have the same effects in the pituitary gland. This is because GnRH is secreted in pulses under normal physiological circumstances, and when the GnRH receptor is unnaturally activated in a continuous manner, as with exogenous GnRH agonists, the GnRH receptor in the pituitary gland is strongly desensitized to the point of becoming inactive. Consequently, both GnRH agonists and GnRH antagonists have the effect of abolishing gonadal sex hormone production. This, in turn, reduces testosterone levels into the castrate or normal female range (both <50 ng/dL or <1.7 nmol/L) in people with testes. GnRHa are like a reversible gonadectomy, and for this reason, are also sometimes referred to as “medical castration”. Provided that an estrogen is taken in combination with a GnRHa to prevent sex hormone deficiency, these medications have essentially no known side effects or risks. For these reasons, GnRHa are the ideal antiandrogens for use in transfeminine people.

    GnRHa are widely used to suppess puberty in adolescent transgender individuals. Unfortunately however, they are very expensive (e.g., ~US$10,000 per year) and medical insurance does not usually cover them for adult transgender people. Consequently, GnRHa are not commonly used in adult transfeminine people at this time. An exception is in the United Kingdom, where GnRH agonists are covered for all adult transgender people by the National Health Service (NHS). Another exception is buserelin (Suprefact), which has become available very inexpensively in its nasal spray form from certain Eastern European online pharmacies in recent years (Aly, 2018).

    GnRH agonists cause a brief flare in testosterone levels at the start of therapy prior to the GnRH receptors in the pituitary gland becoming desensitized (Wiki). Testosterone levels increase by up to about 1.5- to 2-fold for about 1 week and then decrease thereafter (Wiki). Castrate or female-range levels of testosterone are generally reached within 2 to 4 weeks (Wiki). In contrast to GnRH agonists, there is no testosterone flare with GnRH antagonists and testosterone levels start decreasing immediately, reaching castrate levels within a few days (Wiki; Graph). This is because GnRH antagonists work by blocking the GnRH receptor without initially activating it, and hence desensitization of the receptor is not necessary for their action. If desired, the testosterone flare at the initiation of GnRH agonist therapy can be prevented or blunted with the use of antigonadotropins, for instance estrogens and progestogens, as well as with potent androgen receptor antagonists such as bicalutamide (Wiki).

    GnRH agonists must be injected subcutaneously or intramuscularly once per day or once every one to six months depending on the formulation employed (buserelin, goserelin, leuprorelin, triptorelin). Alternatively, they can be surgically implanted once a year (histrelin, leuprorelin) or used as a nasal spray two to three times per day (buserelin, nafarelin). The first GnRH antagonists were developed for use by once-monthly intramuscular or subcutaneous injection (abarelix, degarelix). More recently, orally administered GnRH antagonists such as elagolix and relugolix have been introduced for medical use. They are taken in the form of tablets once or twice daily.

    Table 9: Available forms and recommended doses of GnRH agonists for transfeminine people:

    MedicationBrand nameRouteFormDosage
    BuserelinSuprefact, othersSC injectionSolution200 μg/daya
       Implant6.3 mg/2 months
        9.45 mg/3 months
      IntranasalNasal spray400 µg 3x/dayb,c
    GoserelinZoladexSC injectionImplant3.6 mg/month
        10.8 mg/3 months
    HistrelinSupprelin LA, VantasSC implantImplant50 mg/year
    LeuprorelinLupron, othersIM injectionSolution1 mg/day
     Eligard, Lupron Depot, othersIM/SC injectionSuspension3.75–7.5 mg/month
        11.25–22.5 mg/3 months
        30 mg/4 months
        45 mg/6 months
     ViadurSC implantImplant65 mg/year
    NafarelinSynarelIntranasalNasal spray400–600 μg 2–3x/day
    TriptorelinDecapeptyl, Trelstar Depot/LAIM injectionSuspension3.75 mg/month
        11.25 mg/3 months

    a 500 μg 3x/day for the first week then 200 μg/day. b 800 μg 3x/day for the first week then 400 μg 3x/day. c 500 μg 2x/day can be used instead of 400 μg 3x/day but is less effective (70% decrease in testosterone levels (to ~180 ng/dL [6.2 nmol/L]) instead of 90% decrease (to ~50 ng/dL [1.7 nmol/L]) per available studies of buserelin in men with prostate cancer) (Aly, 2018; Wiki).

    Table 10: Available forms and recommended doses of GnRH antagonists for transfeminine people:

    MedicationBrand nameRouteFormDosage
    AbarelixPlenaxisIM injectionSuspension113 mg/month
    DegarelixFirmagonSC injectionSolution80 mg/montha
    ElagolixOrilissaOralTablets150–200 mg 1–2x/dayb
    RelugolixReluminaOralTablets20–120 mg/dayc

    a First month is 240 mg then 80 mg per month thereafter. b 150 mg 1x/day is less effective than 200 mg 2x/day (which provides full gonadal sex-hormone suppression in cisgender women) (Wiki). c 80–120 mg/day for full gonadal sex-hormone suppression and 20–40 mg/day for substantial but partial gonadal sex-hormone suppression (MacLean et al., 2015; DailyMed).

    Other Hormonal Medications

    Androgens and Anabolic Steroids

    In addition to estrogens, progestogens, and antiandrogens, androgens/anabolic steroids (AAS) are sometimes added to transfeminine hormone therapy. This is when testosterone levels are low (e.g., below the female average of 30 ng/dL [1.0 nmol/L]) and androgen replacement is desired. It has been proposed that adequate levels of testosterone may provide benefits such as increased sexual desire, improved mood and energy, positive effects on skin health and cellulite (Avram, 2004), and increased muscle size and strength (Huang & Basaria, 2017). However, there is insufficient clinical evidence to support such benefits at present, and androgens can produce adverse effects in cisgender women and transfeminine people, for instance acne, hirsutism, scalp hair loss, and masculinization (Wiki). For transfeminine people who nonetheless desire androgen replacement therapy, possible options for androgen medications include testosterone and its esters, dehydroepiandrosterone (DHEA; prasterone), and nandrolone esters such as nandrolone decanoate (ND) (Aly, 2020; Table), among others.

    Monitoring of Therapy

    Transfeminine people on hormone therapy should undergo regular laboratory monitoring in the form of blood work to assess efficacy and monitor for safety. Total estradiol levels and total testosterone levels should be measured to assess the effectiveness of therapy—that is, whether hormone levels are in appropriate ranges for cisgender females—and determine whether medication adjustments may be necessary. Levels of free testosterone, free estradiol, estrone (E1), dihydrotestosterone (DHT), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and sex hormone-binding globulin (SHBG) can also be measured to provide further information although they’re not absolutely necessary. If progesterone is used as a part of hormone therapy, progesterone levels can be measured to provide insight on the degree of progesterone exposure. In addition to hormone blood tests, transfeminine people can monitor their physical changes with hormone therapy, such as breast development and other aspects of feminization, using various physical and digital measurement methods (e.g., Aly, 2020).

    In transfeminine people taking bicalutamide or high doses of CPA (≥20 mg/day), liver function tests (LFTs), such as aspartate transaminase (AST) and alanine transaminase (ALT) levels, should be regularly performed to monitor for liver toxicity. In those who are taking spironolactone and have relevant risk factors for hyperkalemia (high potassium levels), such as older age, reduced kidney function, or concomitant use of potassium-elevating medications or potassium supplements, potassium levels should be regularly monitored to assess for hyperkalemia. Conversely, in healthy young people without such risk factors who are taking spironolactone, potassium monitoring seems to be of limited usefulness (Plovanich, Weng, & Mostaghimi, 2015; Zaenglein et al., 2016; Layton et al., 2017; Millington, Liu, & Chan, 2019; Wang & Lipner, 2020; Gupta et al., 2022; Hayes et al., 2022). In transfeminine people taking high doses of estrogens or progestogens—particularly CPA—prolactin levels should be regularly measured to monitor for hyperprolactinemia (high prolactin levels) and prolactinoma (Callen-Lorde, 2018; Iwamoto et al., 2019). In people taking high doses of CPA (>12.5 mg/day), periodic magnetic resonance imaging (MRI) exams should be performed to monitor for development of meningiomas (Aly, 2020). If the preceding tests come back abnormal, depending on the situation and its severity, medication doses should be reduced or specific medications should be discontinued or replaced with alternatives.

    Certain therapeutic situations can result in inaccurate lab blood work results. Monitoring of progesterone levels with oral progesterone using immunoassay-based blood tests can result in falsely high readings for progesterone levels due to cross-reactivity with high levels of progesterone metabolites such as allopregnanolone (Aly, 2018; Wiki). Instead of immunoassay-based tests, mass spectrometry-based tests should be used to determine progesterone levels with oral progesterone (Aly, 2018; Wiki). Conversely, either type of test may be used to measure progesterone levels with non-oral progesterone therapy. High-dose biotin (vitamin B7) supplements can interfere with the accuracy of immunoassay-based hormone blood tests, causing falsely low or falsely high readings (Samarasinghe et al., 2017; Avery, 2019; Bowen et al., 2019; FDA, 2019; Luong, Male, & Glennon, 2019). Transdermal estradiol formulations applied to the arm can result in contamination of blood draws taken from the same arm and can result in falsely high readings for estradiol levels (Vihtamäkia, Luukkaala, & Tuimala, 2004).

    Certain cancers are known to be hormone-sensitive and their incidence can be influenced by hormone therapy. Screening for breast and prostate cancer is recommended in transfeminine people (Sterling & Garcia, 2020; Iwamoto et al., 2021). The risk of breast cancer appears to be dramatically increased with transfeminine hormone therapy, perhaps especially with progestogens (Aly, 2020). However, the risk still remains lower than in cisgender women (Aly, 2020). The incidence of prostate cancer is greatly decreased with hormone therapy in transfeminine people as a consequence of androgen deprivation, but the risk is not abolished and prostate cancer can still occur (de Nie et al., 2020). The prostate gland is not removed with vaginoplasty, so transfeminine people who have undergone vaginoplasty will also require monitoring for prostate cancer still. Testicular cancer is not known to be a hormone-dependent cancer and its incidence does not appear to be increased with hormone therapy in transfeminine people (Bensley et al., 2021; de Nie et al., 2021; Jacoby et al., 2021).

    References

    • Abbott Laboratories. (2009). Estradiol. Architect System. Abbott Park, Illinois/Wiesbaden, Germany: Abbott Laboratories. [PDF]
    • Ahmad, S. R., & Graham, D. J. (2003). Pneumonitis with Antiandrogens. Annals of Internal Medicine, 139(6), 528–529. [DOI:10.7326/0003-4819-139-6-200309160-00023]
    • Allen, A. N., Jiao, R., Day, P., Pagels, P., Gimpel, N., & SoRelle, J. A. (2020). Dynamic Impact of Hormone Therapy on Laboratory Values in Transgender Patients over Time. The Journal of Applied Laboratory Medicine, 6(1), 27–40. [DOI:10.1093/jalm/jfaa192]
    • Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., Zajac, J. D., & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine Connections, 8(7), 935–940. [DOI:10.1530/ec-19-0272]
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (2020). A systematic review of antiandrogens and feminization in transgender women. Clinical Endocrinology, 94(5), 743–752. [DOI:10.1111/cen.14329]
    • Antoniou, T., Gomes, T., Mamdani, M. M., Yao, Z., Hellings, C., Garg, A. X., Weir, M. A., & Juurlink, D. N. (2011). Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ, 343, d5228. [DOI:10.1136/bmj.d5228]
    • Antoniou, T., Hollands, S., Macdonald, E. M., Gomes, T., Mamdani, M. M., & Juurlink, D. N. (2015). Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone. Canadian Medical Association Journal, 187(4), E138–E143. [DOI:10.1503/cmaj.140816]
    • Aufrère, M. B., & Benson, H. (1976). Progesterone: An overview and recent advances. Journal of Pharmaceutical Sciences, 65(6), 783–800. [DOI:10.1002/jps.2600650602]
    • Avery, G. (2019). Biotin interference in immunoassay: a review for the laboratory scientist. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 56(4), 424–430. [DOI:10.1177/0004563219842231]
    • Avram, M. M. (2004). Cellulite: a review of its physiology and treatment. Journal of Cosmetic and Laser Therapy, 6(4), 181–185. [DOI:10.1080/14764170410003057]
    • Babich, J. S., Kalantar-Zadeh, K., & Joshi, S. (2022). Taking the Kale out of Hyperkalemia: Plant Foods and Serum Potassium in Patients With Kidney Disease. Journal of Renal Nutrition, 32(6), 641–649. [DOI:10.1053/j.jrn.2022.01.013]
    • Bäckström, T., Haage, D., Löfgren, M., Johansson, I., Strömberg, J., Nyberg, S., Andréen, L., Ossewaarde, L., van Wingen, G., Turkmen, S., & Bengtsson, S. (2011). Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience, 191, 46–54. [DOI:10.1016/j.neuroscience.2011.03.061]
    • Barrionuevo, P., Nabhan, M., Altayar, O., Wang, Z., Erwin, P. J., Asi, N., Martin, K. A., & Murad, M. H. (2018). Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism, 103(4), 1258–1264. [DOI:10.1210/jc.2017-02052]
    • Bazarra-Castro, M. A. (2009). Etiological aspects, therapy regimes, side effects and treatment satisfaction of transsexual patients. (Doctoral dissertation, Ludwig Maximilian University of Munich.) [DOI:10.5282/edoc.9984] [URN:urn:nbn:de:bvb:19-99840] [PDF]
    • Belisle, S., & Love, E. J. (1986). Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study. Fertility and Sterility, 46(6), 1015–1020. [DOI:10.1016/s0015-0282(16)49873-0]
    • Ben Salem, C., Badreddine, A., Fathallah, N., Slim, R., & Hmouda, H. (2014). Drug-Induced Hyperkalemia. Drug Safety, 37(9), 677–692. [DOI:10.1007/s40264-014-0196-1]
    • Bensley, J. G., Cheung, A. S., Grossmann, M., & Papa, N. (2022). Testicular Cancer in Trans People Using Feminising Hormone Therapy–A Brief Review. Urology, 160, 1–4. [DOI:10.1016/j.urology.2021.11.014]
    • Bessone, F., Lucena, M., Roma, M. G., Stephens, C., Medina-Cáliz, I., Frider, B., Tsariktsian, G., Hernández, N., Bruguera, M., Gualano, G., Fassio, E., Montero, J., Reggiardo, M. V., Ferretti, S., Colombato, L., Tanno, F., Ferrer, J., Zeno, L., Tanno, H., & Andrade, R. J. (2015). Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases. Liver International, 36(2), 302–310. [DOI:10.1111/liv.12899]
    • Bowen, R., Benavides, R., Colón-Franco, J. M., Katzman, B. M., Muthukumar, A., Sadrzadeh, H., Straseski, J., Klause, U., & Tran, N. (2019). Best practices in mitigating the risk of biotin interference with laboratory testing. Clinical Biochemistry, 74, 1–11. [DOI:10.1016/j.clinbiochem.2019.08.012]
    • Brown, J., Farquhar, C., Lee, O., Toomath, R., & Jepson, R. G. (2009). Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews, 2009(2), CD000194. [DOI:10.1002/14651858.cd000194.pub2]
    • Burinkul, S., Panyakhamlerd, K., Suwan, A., Tuntiviriyapun, P., & Wainipitapong, S. (2021). Anti-Androgenic Effects Comparison Between Cyproterone Acetate and Spironolactone in Transgender Women: A Randomized Controlled Trial. The Journal of Sexual Medicine, 18(7), 1299–1307. [DOI:10.1016/j.jsxm.2021.05.003] [PDF]
    • Callen-Lorde Community Health Center. (2018). Protocols for the Provision of Hormone Therapy. New York City: Callen-Lorde Community Health Center. [URL] [PDF]
    • Cappelletti, M., & Wallen, K. (2016). Increasing women’s sexual desire: The comparative effectiveness of estrogens and androgens. Hormones and Behavior, 78, 178–193. [DOI:10.1016/j.yhbeh.2015.11.003]
    • Carmina, E., Stanczyk, F. Z., & Lobo, R. A. (2019). Evaluation of Hormonal Status. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 887–915.e4). Philadelphia: Elsevier. [DOI:10.1016/b978-0-323-47912-7.00034-2]
    • Carr, B. R. (1993). The Ovary. In Carr, B. R., & Blackwell, R. E. (Eds.). Textbook of Reproductive Medicine, 1st Edition (pp. 183–207). Norwalk, Connecticut: Appleton & Lange. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org—2nd edition]
    • Carvalho, R. d., Santos, L. D., Ramos, P. M., Machado, C. J., Acioly, P., Frattini, S. C., Barcaui, C. B., Donda, A. L., & Melo, D. F. (2022). Bicalutamide and the new perspectives for female pattern hair loss treatment: What dermatologists should know. Journal of Cosmetic Dermatology, 21(10), 4171–4175. [DOI:10.1111/jocd.14773]
    • Clark, R. V., Hermann, D. J., Cunningham, G. R., Wilson, T. H., Morrill, B. B., & Hobbs, S. (2004). Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor. The Journal of Clinical Endocrinology & Metabolism, 89(5), 2179–2184. [DOI:10.1210/jc.2003-030330]
    • Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F., Monstrey, S. J., Motmans, J., Nahata, L., … & Arcelus, J. (2022). [World Professional Association for Transgender Health (WPATH)] Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(Suppl 1), S1–S259. [DOI:10.1080/26895269.2022.2100644] [URL] [PDF]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/s0140-6736(19)31709-x]
    • Collet, S., Gieles, N. C., Wiepjes, C. M., Heijboer, A. C., Reyns, T., Fiers, T., Lapauw, B., den Heijer, M., & T’Sjoen, G. (2022). Changes in Serum Testosterone and Adrenal Androgen Levels in Transgender Women With and Without Gonadectomy. The Journal of Clinical Endocrinology & Metabolism, 108(2), 331–338. [DOI:10.1210/clinem/dgac576]
    • Connors, J. M., & Middeldorp, S. (2019). Transgender patients and the role of the coagulation clinician. Journal of Thrombosis and Haemostasis, 17(11), 1790–1797. [DOI:10.1111/jth.14626]
    • Cupisti, A., Kovesdy, C., D’Alessandro, C., & Kalantar-Zadeh, K. (2018). Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function. Nutrients, 10(3), 261–261. [DOI:10.3390/nu10030261]
    • Cusan, L., Dupont, A., Gomez, J., Tremblay, R. R., & Labrie, F. (1994). Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertility and Sterility, 61(2), 281–287. [DOI:10.1016/s0015-0282(16)56518-2]
    • de Blok, C. J., Wiepjes, C. M., Nota, N. M., van Engelen, K., Adank, M. A., Dreijerink, K. M., Barbé, E., Konings, I. R., & den Heijer, M. (2019). Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. BMJ, 365, l1652. [DOI:10.1136/bmj.l1652]
    • de Nie, I., de Blok, C. J., van der Sluis, T. M., Barbé, E., Pigot, G. L., Wiepjes, C. M., Nota, N. M., van Mello, N. M., Valkenburg, N. E., Huirne, J., Gooren, L. J., van Moorselaar, R. J., Dreijerink, K. M., & den Heijer, M. (2020). Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 105(9), e3293–e3299. [DOI:10.1210/clinem/dgaa412]
    • Deng, T., Duan, X., He, Z., Zhao, Z., & Zeng, G. (2020). Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis. Urology Journal, 18(2), 144–150. [DOI:10.22037/uj.v16i7.5866]
    • Deutsch, M. B. (2016). Overview of feminizing hormone therapy. In Deutsch, M. B. (Ed.). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition (pp. 26–48). San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Dhurat, R., Sharma, A., Rudnicka, L., Kroumpouzos, G., Kassir, M., Galadari, H., Wollina, U., Lotti, T., Golubovic, M., Binic, I., Grabbe, S., & Goldust, M. (2020). 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety. Dermatologic Therapy, 33(3), e13379. [DOI:10.1111/dth.13379]
    • Drake, L., Hordinsky, M., Fiedler, V., Swinehart, J., Unger, W. P., Cotterill, P. C., Thiboutot, D. M., Lowe, N., Jacobson, C., Whiting, D., Stieglitz, S., Kraus, S. J., Griffin, E. I., Weiss, D., Carrington, P., Gencheff, C., Cole, G. W., Pariser, D. M., Epstein, E. S., Tanaka, W., Dallob, A., Vandormael, K., Geissler, L., & Waldsteicher, J. (1999). The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. Journal of the American Academy of Dermatology, 41(4), 550–554. [DOI:10.1016/s0190-9622(99)80051-6]
    • Dyson, T. E., Cantrell, M. A., & Lund, B. C. (2020). Lack of Association between 5α-Reductase Inhibitors and Depression. Journal of Urology, 204(4), 793–798. [DOI:10.1097/ju.0000000000001079]
    • Erem, C. (2013). Update on idiopathic hirsutism: diagnosis and treatment. Acta Clinica Belgica, 68(4), 268–274. [DOI:10.2143/acb.3267]
    • Erenus, M., Gürbüz, O., Durmuşoğlu, F., Demirçay, Z., & Pekin, S. (1994). Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertility and Sterility, 61(4), 613–616. [DOI:10.1016/s0015-0282(16)56634-5]
    • Esoterix/LabCorp. (2020). Endocrinology Expected Values and S.I. Unit Conversion Tables. LabCorp/Endocrine Sciences. [PDF]
    • Even Zohar, N., Sofer, Y., Yaish, I., Serebro, M., Tordjman, K., & Greenman, Y. (2021). Low-Dose Cyproterone Acetate Treatment for Transgender Women. The Journal of Sexual Medicine, 18(7), 1292–1298. [DOI:10.1016/j.jsxm.2021.04.008]
    • Fertig, R., Shapiro, J., Bergfeld, W., & Tosti, A. (2016). Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome. Skin Appendage Disorders, 2(3–4), 120–129. [DOI:10.1159/000450617]
    • Food and Drug Administration. (2019). UPDATE: The FDA Warns that Biotin May Interfere with Lab Tests: FDA Safety Communication. Food and Drug Administration. [URL]
    • Fournier, A., Berrino, F., & Clavel-Chapelon, F. (2007). Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment, 107(1), 103–111. [DOI:10.1007/s10549-007-9523-x]
    • Frye, S. (2006). Discovery and Clinical Development of Dutasteride, a Potent Dual 5α-Reductase Inhibitor. Current Topics in Medicinal Chemistry, 6(5), 405–421. [DOI:10.2174/156802606776743101]
    • Gava, G., Mancini, I., Alvisi, S., Seracchioli, R., & Meriggiola, M. C. (2020). A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen. European Journal of Endocrinology, 183(6), 561–569. [DOI:10.1530/eje-20-0370]
    • Getzenberg, R., & Itty, S. (2020). How do we define “castration” in men on androgen deprivation therapy? Asian Journal of Andrology, 22(5), 441–446. [DOI:10.4103/aja.aja_139_19]
    • Giltay, E. J., Gooren, L. J., Toorians, A. W., Katan, M. B., & Zock, P. L. (2004). Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. The American Journal of Clinical Nutrition, 80(5), 1167–1174. [DOI:10.1093/ajcn/80.5.1167]
    • Glintborg, D., T’Sjoen, G., Ravn, P., & Andersen, M. S. (2021). MANAGEMENT OF ENDOCRINE DISEASE: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 185(2), R49–R63. [DOI:10.1530/eje-21-0059]
    • Goletiani, N. V., Keith, D. R., & Gorsky, S. J. (2007). Progesterone: Review of safety for clinical studies. Experimental and Clinical Psychopharmacology, 15(5), 427–444. [DOI:10.1037/1064-1297.15.5.427]
    • Goodfellow, A., Alaghband-Zadeh, J., Carter, G., Cream, J., Holland, S., Scully, J., & Wise, P. (1984). Oral spironolactone improves acne vulgaris and reduces sebum excretion. British Journal of Dermatology, 111(2), 209–214. [DOI:10.1111/j.1365-2133.1984.tb04045.x]
    • Gooren, L. J., Harmsen-Louman, W., & Kessel, H. (1985). Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction. Clinical Endocrinology, 22(2), 201–207. [DOI:10.1111/j.1365-2265.1985.tb01081.x]
    • Gooren, L. J. (2016). The Endocrinology of Sexual Behavior and Gender Identity. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition, Volume 2 (pp. 2163–2176.e4). Philadelphia: Saunders/Elsevier. [Google Books] [DOI:10.1016/B978-0-323-18907-1.00124-4]
    • Gormley, G. J., Stoner, E., Rittmaster, R. S., Gregg, H., Thompson, D. L., Lasseter, K. C., Vlasses, P. H., & Stein, E. A. (1990). Effects of Finasteride (MK-906), a 5α-Reductase Inhibitor, on Circulating Androgens in Male Volunteers. The Journal of Clinical Endocrinology & Metabolism, 70(4), 1136–1141. [DOI:10.1210/jcem-70-4-1136]
    • Gubelin Harcha, W., Barboza Martínez, J., Tsai, T., Katsuoka, K., Kawashima, M., Tsuboi, R., Barnes, A., Ferron-Brady, G., & Chetty, D. (2014). A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. Journal of the American Academy of Dermatology, 70(3), 489–498.e3. [DOI:10.1016/j.jaad.2013.10.049]
    • Gupta, P., Suppakitjanusant, P., Stevenson, M., Goodman, M., & Tangpricha, V. (2022). Potassium Concentrations in Transgender Women Using Spironolactone: A Retrospective Chart Review. Endocrine Practice, 28(11), 1113–1117. [DOI:10.1016/j.eprac.2022.08.007]
    • Hammerstein, J. (1990). Antiandrogens: Clinical Aspects. In Orfanos, C. E., & Happle, R. (Eds.). Hair and Hair Diseases (pp. 827–886). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-642-74612-3_35]
    • Hayes, H., Russell, R., Haugen, A., Nagavally, S., & Sarvaideo, J. (2022). The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone. Journal of the Endocrine Society, 6(11), bvac133. [DOI:10.1210/jendso/bvac133]
    • Heinemann, L. A., Will-Shahab, L., van Kesteren, P., Gooren, L. J., & (1997). Safety of Cyproterone Acetate: Report of Active Surveillance. Pharmacoepidemiology and Drug Safety, 6(3), 169–178. [DOI:10.1002/(sici)1099-1557(199705)6:3<169::aid-pds263>3.0.co;2-3]
    • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
    • Hirshburg, J. M., Kelsey, P. A., Therrien, C. A., Gavino, A. C., & Reichenberg, J. S. (2016). Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review. The Journal of Clinical and Aesthetic Dermatology, 9(7), 56–62. [PubMed] [PubMed Central]
    • Hopkins, U., & Arias, C. Y. (2013). Large-volume IM injections: a review of best practices. Oncology Nurse Advisor, 4(1), 32–37. [Google Scholar] [URL] [PDF]
    • Horton, R. (1992). Dihydrotestosterone Is a Peripheral Paracrine Hormone. Journal of Andrology, 13(1), 23–27. [DOI:10.1002/j.1939-4640.1992.tb01621.x]
    • Huang, G., & Basaria, S. (2017). The Case for Androgens in Menopausal Women: When and How? In Pal, L., & Sayegh, R. A. (Eds.). Essentials of Menopause Management: A Case-Based Approach (pp. 173–196). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-42451-4_10]
    • Irwig, M. S. (2020). Is there a role for 5α‐reductase inhibitors in transgender individuals? Andrology, 9(6), 1729–1731. [DOI:10.1111/andr.12881]
    • Iversen, P., Johansson, J. E., Lodding, P., Lukkarinen, O., Lundmo, P., Klarskov, P., Tammela, T. L., Tasdemir, I., Morris, T., Carroll, K., & Scandinavian Prostatic Cancer Group. (2004). Bicalutamide (150 mg) versus placebo as immediate therapy alone or as adjuvant to therapy with curative intent for early nonmetastatic prostate cancer: 5.3-year median followup from the Scandinavian Prostate Cancer Group Study Number 6. The Journal of Urology, 172(5 Part 1), 1871–1876. [DOI:10.1097/01.ju.0000139719.99825.54]
    • Iversen, P., Johansson, J., Lodding, P., Kylmälä, T., Lundmo, P., Klarskov, P., Tammela, T. L., Tasdemir, I., Morris, T., Armstrong, J., & (2006). Bicalutamide 150 mg in addition to standard care for patients with early non-metastatic prostate cancer Updated results from the Scandinavian Prostate Cancer Period Group-6 Study after a median follow-up period of 7.1 years. Scandinavian Journal of Urology and Nephrology, 40(6), 441–452. [DOI:10.1080/00365590601017329]
    • Iwamoto, S. J., Defreyne, J., Rothman, M. S., Van Schuylenbergh, J., Van de Bruaene, L., Motmans, J., & T’Sjoen, G. (2019). Health considerations for transgender women and remaining unknowns: a narrative review. Therapeutic Advances in Endocrinology and Metabolism, 10, 204201881987116. [DOI:10.1177/2042018819871166]
    • Iwamoto, S. J., Grimstad, F., Irwig, M. S., & Rothman, M. S. (2021). Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review. Journal of General Internal Medicine, 36(5), 1380–1389. [DOI:10.1007/s11606-021-06634-7]
    • Jacoby, A., Rifkin, W., Zhao, L. C., & Bluebond-Langner, R. (2020). Incidence of Cancer and Premalignant Lesions in Surgical Specimens of Transgender Patients. Plastic & Reconstructive Surgery, 147(1), 194–198. [DOI:10.1097/prs.0000000000007452]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone Acetate in Gender-Affirming Therapy for Transwomen: Results From a Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
    • James, J. F., Jamerson, T. A., & Aguh, C. (2022). Efficacy and safety profile of oral spironolactone use for androgenic alopecia: A systematic review. Journal of the American Academy of Dermatology, 86(2), 425–429. [DOI:10.1016/j.jaad.2021.07.048]
    • Jia, A. Y., & Spratt, D. E. (2022). Bicalutamide Monotherapy With Radiation Therapy for Localized Prostate Cancer: A Non-Evidence-Based Alternative. International Journal of Radiation Oncology*Biology*Physics, 113(2), 316–319. [DOI:10.1016/j.ijrobp.2022.01.037]
    • Jiang, Y., & Tian, W. (2017). The effects of progesterones on blood lipids in hormone replacement therapy. Lipids in Health and Disease, 16(1), 219. [DOI:10.1186/s12944-017-0612-5]
    • Kanhai, R. C., Hage, J. J., van Diest, P. J., Bloemena, E., & Mulder, J. W. (2000). Short-Term and Long-Term Histologic Effects of Castration and Estrogen Treatment on Breast Tissue of 14 Male-to-Female Transsexuals in Comparison With Two Chemically Castrated Men. The American Journal of Surgical Pathology, 24(1), 74–80. [DOI:10.1097/00000478-200001000-00009]
    • Kellner, M., & Wiedemann, K. (2008). Mineralocorticoid receptors in brain, in health and disease: Possibilities for new pharmacotherapy. European Journal of Pharmacology, 583(2–3), 372–378. [DOI:10.1016/j.ejphar.2007.07.072]
    • Kim, G. K., & Del Rosso, J. Q. (2012). Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. The Journal of Clinical and Aesthetic Dermatology, 5(3), 37–50. [PubMed] [PubMed Central]
    • King, S. R. (2012). Neurosteroids and the Nervous System. In King, S. R. Neurosteroids and the Nervous System (pp. 1–122). New York: Springer New York. [DOI:10.1007/978-1-4614-5559-2_1]
    • Kolvenbag, G. J., & Blackledge, G. R. (1996). Worldwide activity and safety of bicalutamide: a summary review. Urology, 47(1), 70–79. [DOI:10.1016/s0090-4295(96)80012-4]
    • Kuhl, H. (2003). Östrogene für den Mann? [Estrogen for men?] Blickpunkt der Mann, 1(3), 6–12. [Google Scholar] [URL] [PDF]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Kuhl, H., & Wiegratz, I. (2017). Das Post-Finasterid-Syndrom. [Post Finasteride Syndrome.] Gynäkologische Endokrinologie, 15(2), 153–163. [DOI:10.1007/s10304-017-0126-2]
    • Kuijpers, S. M., Wiepjes, C. M., Conemans, E. B., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2021). Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study. The Journal of Clinical Endocrinology & Metabolism, 106(10), e3936–e3945. [DOI:10.1210/clinem/dgab427]
    • Kumar, P., Reddy, S., Kulkarni, A., Sharma, M., & Rao, P. N. (2021). Cyproterone Acetate–Induced Acute Liver Failure: A Case Report and Review of the Literature. Journal of Clinical and Experimental Hepatology, 11(6), 739–741. [DOI:10.1016/j.jceh.2021.01.003]
    • Lauritzen, C. (1988). Natürliche und synthetische Sexualhormone – Biologische Grundlagen und Behandlungsprinzipien. [Natural and Synthetic Sexual Hormones – Biological Basis and Medical Treatment Principles.] In Lauritzen, C., Schneider, H. P. G., & Nieschlag, E. (Eds.). Grundlagen und Klinik der Menschlichen Fortpflanzung [Foundations and Clinic of Human Reproduction] (pp. 229–306). Berlin: de Gruyter. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [URL] [PDF] [Translation]
    • Lax, E. (1987). Mechanisms of physiological and pharmacological sex hormone action on the mammalian liver. Journal of Steroid Biochemistry, 27(4–6), 1119–1128. [DOI:10.1016/0022-4731(87)90198-1]
    • Layton, A. M., Eady, E. A., Whitehouse, H., Del Rosso, J. Q., Fedorowicz, Z., & van Zuuren, E. J. (2017). Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review. American Journal of Clinical Dermatology, 18(2), 169–191. [DOI:10.1007/s40257-016-0245-x]
    • Legro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., Ohl, D., Carson, S. A., Steinkampf, M. P., Carr, B. R., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Myers, E. R., Santoro, N., Eisenberg, E., Zhang, M., & Zhang, H. (2010). Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with Hirsutism. The Journal of Clinical Endocrinology & Metabolism, 95(12), 5305–5313. [DOI:10.1210/jc.2010-1123]
    • Leinung, M. C. (2014). Variable Response to Oral Estradiol Therapy in Male to Female Transgender Patients. Endocrine Reviews, 35(Suppl 1) [Endocrine Society’s 96th Annual Meeting and Expo, June 21–24, 2014 – Chicago], ?–? (abstract no. OR42-1). [Google Scholar] [DOI:10.1093/edrv/35.supp.1] [DOI:10.1210/endo-meetings.2014.RE.2.OR42-1] [URL] [MedPage Today]
    • Leinung, M. C., Feustel, P. J., & Joseph, J. (2018). Hormonal Treatment of Transgender Women with Oral Estradiol. Transgender Health, 3(1), 74–81. [DOI:10.1089/trgh.2017.0035]
    • Liang, J. J., Jolly, D., Chan, K. J., & Safer, J. D. (2018). Testosterone Levels Achieved by Medically Treated Transgender Women in a United States Endocrinology Clinic Cohort. Endocrine Practice, 24(2), 135–142. [DOI:10.4158/ep-2017-0116]
    • Lobo, R. A., Shoupe, D., Serafini, P., Brinton, D., & Horton, R. (1985). The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertility and Sterility, 43(2), 200–205. [DOI:10.1016/s0015-0282(16)48373-1]
    • Loh, H. H., Yee, A., Loh, H. S., Kanagasundram, S., Francis, B., & Lim, L. (2020). Sexual dysfunction in polycystic ovary syndrome: a systematic review and meta-analysis. Hormones, 19(3), 413–423. [DOI:10.1007/s42000-020-00210-0]
    • Luong, J. H., Male, K. B., & Glennon, J. D. (2019). Biotin interference in immunoassays based on biotin-strept(avidin) chemistry: An emerging threat. Biotechnology Advances, 37(5), 634–641. [DOI:10.1016/j.biotechadv.2019.03.007]
    • MacLean, D. B., Shi, H., Faessel, H. M., & Saad, F. (2015). Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males. The Journal of Clinical Endocrinology & Metabolism, 100(12), 4579–4587. [DOI:10.1210/jc.2015-2770]
    • Mahler, C. (1996). A Review of the Clinical Studies with Nilutamide. In Denis, L. (Ed.). Antiandrogens in Prostate Cancer: A Key to Tailored Endocrine Treatment (ESO Monographs) (pp. 105–111). Berlin/Heidelberg: Springer Berlin Heidelberg. [DOI:10.1007/978-3-642-45745-6_10]
    • Maksym, R. B., Kajdy, A., & Rabijewski, M. (2019). Post-finasteride syndrome – does it really exist? The Aging Male, 22(4), 250–259. [DOI:10.1080/13685538.2018.1548589]
    • Marks, D. H., Prasad, S., De Souza, B., Burns, L. J., & Senna, M. M. (2019). Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris. American Journal of Clinical Dermatology, 21(2), 245–254. [DOI:10.1007/s40257-019-00493-z]
    • Martinez-Martin, F. J., Kuzior, A., Hernandez-Lazaro, A., de Leon-Durango, R. J., Rios-Gomez, C., Santana-Ojeda, B., Perez-Rivero, J. M., Fernandez-Trujillo-Comenge, P. M., Gonzalez-Diaz, P., Arnas-Leon, C., Acosta-Calero, C., Perdomo-Herrera, E., Tocino-Hernandez, A. L., del Sol Sanchez-Bacaicoa, M., & del Pino Perez-Garcia, M. (2022). Incidence of hypertension in young transgender people after a 5-year follow-up: association with gender-affirming hormonal therapy. Hypertension Research, 46(1), 219–225. [DOI:10.1038/s41440-022-01067-z]
    • McFarlane, T., Zajac, J. D., & Cheung, A. S. (2018). Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals—A systematic review. Clinical Endocrinology, 89(6), 700–711. [DOI:10.1111/cen.13835]
    • Meriggiola, M. C., Bremner, W. J., Costantino, A., Bertaccini, A., Morselli-Labate, A. M., Huebler, D., Kaufmann, G., Oettel, M., & Flamigni, C. (2002). Twenty-One Day Administration of Dienogest Reversibly Suppresses Gonadotropins and Testosterone in Normal Men. The Journal of Clinical Endocrinology & Metabolism, 87(5), 2107–2113. [DOI:10.1210/jcem.87.5.8514]
    • Meyer, G., Mayer, M., Mondorf, A., Flügel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149–156. [DOI:10.1530/eje-19-0463]
    • Miles, R. A., Paulson, R. J., Lobo, R. A., Press, M. F., Dahmoush, L., & Sauer, M. V. (1994). Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertility and Sterility, 62(3), 485–490. [DOI:10.1016/s0015-0282(16)56935-0]
    • Millington, K., Liu, E., & Chan, Y. (2019). The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone. Journal of the Endocrine Society, 3(5), 1031–1038. [DOI:10.1210/js.2019-00030]
    • Millward, C. P., Keshwara, S. M., Islim, A. I., Jenkinson, M. D., Alalade, A. F., & Gilkes, C. E. (2022). Development and Growth of Intracranial Meningiomas in Transgender Women Taking Cyproterone Acetate as Gender-Affirming Progestogen Therapy: A Systematic Review. Transgender Health, 7(6), 473–483. [DOI:10.1089/trgh.2021.0025]
    • Moretti, C., Guccione, L., Di Giacinto, P., Simonelli, I., Exacoustos, C., Toscano, V., Motta, C., De Leo, V., Petraglia, F., & Lenzi, A. (2017). Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism, 103(3), 824–838. [DOI:10.1210/jc.2017-01186]
    • Nakamoto, J. (2016). Endocrine Testing. In Jameson, J. L., & De Groot, L. J. (Eds.). Endocrinology: Adult and Pediatric, 7th Edition (pp. 2655–2688.e1). Philadelphia: Saunders/Elsevier. [DOI:10.1016/B978-0-323-18907-1.00154-2]
    • Nakhjavani, M., Hamidi, S., Esteghamati, A., Abbasi, M., Nosratian-Jahromi, S., & Pasalar, P. (2009). Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism. British Journal of Clinical Pharmacology, 68(4), 634–637. [DOI:10.1111/j.1365-2125.2009.03483.x]
    • Neyman, A., Fuqua, J. S., & Eugster, E. A. (2019). Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents. Journal of Adolescent Health, 64(4), 544–546. [DOI:10.1016/j.jadohealth.2018.10.296]
    • Nguyen, D., Marchese, M., Cone, E. B., Paciotti, M., Basaria, S., Bhojani, N., & Trinh, Q. (2021). Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride. JAMA Dermatology, 157(1), 35–42. [DOI:10.1001/jamadermatol.2020.3385]
    • Nie, I., Wiepjes, C. M., Blok, C. J., Moorselaar, R. J., Pigot, G. L., Sluis, T. M., Barbé, E., Voorn, P., Mello, N. M., Huirne, J., & Heijer, M. (2021). Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study. BJU International, 129(4), 491–497. [DOI:10.1111/bju.15575]
    • Nieschlag, E., Zitzmann, M., & Kamischke, A. (2003). Use of progestins in male contraception. Steroids, 68(10–13), 965–972. [DOI:10.1016/s0039-128x(03)00135-1]
    • Nieschlag, E. (2010). Clinical trials in male hormonal contraception. Contraception, 82(5), 457–470. [DOI:10.1016/j.contraception.2010.03.020]
    • Nieschlag, E., & Behre, H. M. (2012). The essential role of testosterone in hormonal male contraception. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Testosterone: Action · Deficiency · Substitution, 4th Edition (pp. 470–493). Cambridge/New York: Cambridge University Press. [DOI:10.1017/cbo9781139003353.023]
    • Nishiyama, T. (2014). Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature. Urologic Oncology: Seminars and Original Investigations, 32(1), 38.e17–38.e28. [DOI:10.1016/j.urolonc.2013.03.007]
    • Nolan, B. J., & Cheung, A. S. (2021). Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review. Transgender Health, 6(3), 125–131. [DOI:10.1089/trgh.2020.0077]
    • Nolan, B. J., Frydman, A. S., Leemaqz, S. Y., Carroll, M., Grossmann, M., Zajac, J. D., & Cheung, A. S. (2022). Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study. Endocrine Connections, 11(5), e220170. [DOI:10.1530/EC-22-0170]
    • Norman, A. W., & Henry, H. L. (2015). Androgens. In Norman, A. W., & Henry, H. L. Hormones, 3rd Edition (pp. 255–273). London: Academic Press/Elsevier. [DOI:10.1016/b978-0-08-091906-5.00012-4]
    • Norman, A. W., & Henry, H. L. (2015). Estrogens and Progestins. In Norman, A. W., & Henry, H. L. Hormones, 3rd Edition (pp. 275–296). London: Academic Press/Elsevier. [DOI:10.1016/b978-0-08-091906-5.00013-6]
    • Nota, N. M., Wiepjes, C. M., de Blok, C. J., Gooren, L. J., Peerdeman, S. M., Kreukels, B. P., & den Heijer, M. (2018). The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain, 141(7), 2047–2054. [DOI:10.1093/brain/awy108]
    • North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. [DOI:10.1097/gme.0000000000002028]
    • O’Connell, M. B. (1995). Pharmacokinetic and Pharmacologic Variation Between Different Estrogen Products. The Journal of Clinical Pharmacology, 35(9S), 18S–24S. [DOI:10.1002/j.1552-4604.1995.tb04143.x]
    • Olsen, E. A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M. L., Wilson, T., & Rittmaster, R. S. (2006). The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology, 55(6), 1014–1023. [DOI:10.1016/j.jaad.2006.05.007]
    • Plovanich, M., Weng, Q. Y., & Mostaghimi, A. (2015). Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatology, 151(9), 941–944. [DOI:10.1001/jamadermatol.2015.34]
    • Polyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2011). Spironolactone Revisited. The Journal of Clinical Hypertension, 13(10), 783–784. [DOI:10.1111/j.1751-7176.2011.00484.x]
    • Powers, M. S., Schenkel, L., Darley, P. E., Good, W. R., Balestra, J. C., & Place, V. A. (1985). Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement. American Journal of Obstetrics and Gynecology, 152(8), 1099–1106. [DOI:10.1016/0002-9378(85)90569-1]
    • Prince, J. C., & Safer, J. D. (2020). Endocrine treatment of transgender individuals: current guidelines and strategies. Expert Review of Endocrinology & Metabolism, 15(6), 395–403. [DOI:10.1080/17446651.2020.1825075]
    • Reiter, E. O., Mauras, N., McCormick, K., Kulshreshtha, B., Amrhein, J., De Luca, F., O’Brien, S., Armstrong, J., & Melezinkova, H. (2010). Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT). Journal of Pediatric Endocrinology and Metabolism, 23(10), 999–1009. [DOI:10.1515/jpem.2010.161]
    • Rezende, H. D., Dias, M. F. R. G., & Trüeb, R. M. (2018). A Comment on the Post-Finasteride Syndrome. International Journal of Trichology, 10(6), 255–261. [PubMed] [PubMed Central] [DOI:10.4103/ijt.ijt_61_18]
    • Roberts, J. L., Fiedler, V., Imperato-McGinley, J., Whiting, D., Olsen, E., Shupack, J., Stough, D., DeVillez, R., Rietschel, R., Savin, R., Bergfeld, W., Swinehart, J., Funicella, T., Hordinsky, M., Lowe, N., Katz, I., Lucky, A., Drake, L., Price, V. H., Weiss, D., Whitmore, E., Millikan, L., Muller, S., Gencheff, C., Carrington, P., Binkowitz, B., Kotey, P., He, W., Bruno, K., Jacobsen, C., Terranella, L., Gormley, G. J., & Kaufman, K. D. (1999). Clinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair loss. Journal of the American Academy of Dermatology, 41(4), 555–563. [DOI:10.1016/s0190-9622(99)80052-8]
    • Roscioni, S. S., de Zeeuw, D., Bakker, S. J., & Lambers Heerspink, H. J. (2012). Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy. Nature Reviews Nephrology, 8(12), 691–699. [DOI:10.1038/nrneph.2012.217]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2008). Puberty and its disorders in the female. In Sperling, M. A. (Ed.). Pediatric Endocrinology, 3rd Edition (pp. 530–609). Philadelphia: Saunders. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat]
    • Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2021). Puberty in the Female and Its Disorders. In Sperling, M. A., Majzoub, J. A., Menon, R. K., & Stratakis, C. A. (Eds.). Sperling Pediatric Endocrinology, 5th Edition (pp. 528–626). Philadelphia: Elsevier. [DOI:10.1016/B978-0-323-62520-3.00016-6]
    • Samarasinghe, S., Meah, F., Singh, V., Basit, A., Emanuele, N., Emanuele, M. A., Mazhari, A., & Holmes, E. W. (2017). Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks. Endocrine Practice, 23(8), 989–998. [DOI:10.4158/ep171761.ra]
    • Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014). Allopregnanolone as a mediator of affective switching in reproductive mood disorders. Psychopharmacology, 231(17), 3557–3567. [DOI:10.1007/s00213-014-3599-x]
    • Schlatterer, K., Yassouridis, A., Werder, K. V., Poland, D., Kemper, J., & Stalla, G. K. (1998). Archives of Sexual Behavior, 27(5), 475–492. [DOI:10.1023/a:1018704630036]
    • Seaman, H. E., Langley, S. E., Farmer, R. D., & de Vries, C. S. (2007). Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database. BJU International, 99(6), 1398–1403. [DOI:10.1111/j.1464-410x.2007.06859.x]
    • Shackleton, C. (2010). Clinical steroid mass spectrometry: A 45-year history culminating in HPLC–MS/MS becoming an essential tool for patient diagnosis. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 481–490. [DOI:10.1016/j.jsbmb.2010.02.017]
    • Shaw, J. C. (1996). Antiandrogen and hormonal treatment of acne. Dermatologic Clinics, 14(4), 803–811. [DOI:10.1016/s0733-8635(05)70405-8]
    • Sofer, Y., Yaish, I., Yaron, M., Bach, M. Y., Stern, N., & Greenman, Y. (2020). Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women. Endocrine Practice, 26(8), 883–890. [DOI:10.4158/ep-2020-0032] [PDF]
    • SoRelle, J. A., Jiao, R., Gao, E., Veazey, J., Frame, I., Quinn, A. M., Day, P., Pagels, P., Gimpel, N., & Patel, K. (2019). Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clinical Chemistry, 65(1), 170–179. [DOI:10.1373/clinchem.2018.292730]
    • St-Jules, D. E., Goldfarb, D. S., & Sevick, M. A. (2016). Nutrient Non-equivalence: Does Restricting High-Potassium Plant Foods Help to Prevent Hyperkalemia in Hemodialysis Patients? Journal of Renal Nutrition, 26(5), 282–287. [DOI:10.1053/j.jrn.2016.02.005]
    • St-Jules, D. E., & Fouque, D. (2020). Is it time to abandon the nutrient-based renal diet model? Nephrology Dialysis Transplantation, 36(4), 574–577. [DOI:10.1093/ndt/gfaa257]
    • St-Jules, D. E., & Fouque, D. (2022). Etiology-based dietary approach for managing hyperkalemia in people with chronic kidney disease. Nutrition Reviews, 80(11), 2198–2205. [DOI:10.1093/nutrit/nuac026]
    • Stanczyk, F. Z., & Clarke, N. J. (2010). Advantages and challenges of mass spectrometry assays for steroid hormones. The Journal of Steroid Biochemistry and Molecular Biology, 121(3–5), 491–495. [DOI:10.1016/j.jsbmb.2010.05.001]
    • Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2012). Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects. Endocrine Reviews, 34(2), 171–208. [DOI:10.1210/er.2012-1008]
    • Stanczyk, F. Z., Mathews, B. W., & Cortessis, V. K. (2017). Does the type of progestin influence the production of clotting factors? Contraception, 95(2), 113–116. [DOI:10.1016/j.contraception.2016.07.007]
    • Stege, R., Gunnarsson, P. O., Johansson, C., Olsson, P., Pousette, Å., & Carlström, K. (1996). Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients. The Prostate, 28(5), 307–310. [DOI:10.1002/(sici)1097-0045(199605)28:5<307::aid-pros6>3.0.co;2-8]
    • Steinberger, E., Ayala, C., Hsi, B., Smith, K. D., Rodriguez-Rigau, L. J., Weidman, E. R., & Reimondo, G. G. (1998). Utilization of Commercial Laboratory Results in Management of Hyperandrogenism in Women. Endocrine Practice, 4(1), 1–10. [DOI:10.4158/ep.4.1.1]
    • Sterling, J., & Garcia, M. M. (2020). Cancer screening in the transgender population: a review of current guidelines, best practices, and a proposed care model. Translational Andrology and Urology, 9(6), 2771–2785. [DOI:10.21037/tau-20-954]
    • Strauss, J. F., & FitzGerald, G. A. (2019). Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction. In Strauss, J. F., & Barbieri, R. L. (Eds.). Yen and Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management, 8th Edition (pp. 75–114.e7). Philadelphia: Elsevier. [Google Books] [DOI:10.1016/b978-0-323-47912-7.00004-4]
    • Stricker, R., Eberhart, R., Chevailler, M., Quinn, F. A., Bischof, P., & Stricker, R. (2006). Establishment of detailed reference values for luteinizing hormone, follicle stimulating hormone, estradiol, and progesterone during different phases of the menstrual cycle on the Abbott ARCHITECT® analyzer. Clinical Chemistry and Laboratory Medicine (CCLM), 44(7), 883–887. [DOI:10.1515/cclm.2006.160]
    • Styne, D. M. (2016). Laboratory Values for Pediatric Endocrinology. In Styne, D. M. Pediatric Endocrinology: A Clinical Handbook (pp. 385–434). Cham: Springer International Publishing. [DOI:10.1007/978-3-319-18371-8_16]
    • Sudduth, S. L., & Koronkowski, M. J. (1993). Finasteride: The First 5α-Reductase Inhibitor. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 13(4), 309–329. [DOI:10.1002/j.1875-9114.1993.tb02739.x]
    • Sundström-Poromaa, I., Comasco, E., Sumner, R., & Luders, E. (2020). Progesterone – Friend or foe? Frontiers in Neuroendocrinology, 59, 100856. [DOI:10.1016/j.yfrne.2020.100856]
    • Swerdloff, R. S., Dudley, R. E., Page, S. T., Wang, C., & Salameh, W. A. (2017). Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. Endocrine Reviews, 38(3), 220–254. [DOI:10.1210/er.2016-1067]
    • T’Sjoen, G. G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186(1), 61–67. [DOI:10.1677/joe.1.06112]
    • T’Sjoen, G., Arcelus, J., Gooren, L., Klink, D. T., & Tangpricha, V. (2018). Endocrinology of Transgender Medicine. Endocrine Reviews, 40(1), 97–117. [DOI:10.1210/er.2018-00011]
    • Tack, L. J., Heyse, R., Craen, M., Dhondt, K., Bossche, H. V., Laridaen, J., & Cools, M. (2017). Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents. The Journal of Sexual Medicine, 14(5), 747–757. [DOI:10.1016/j.jsxm.2017.03.251]
    • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
    • Toorians, A. W., Thomassen, M. C., Zweegman, S., Magdeleyns, E. J., Tans, G., Gooren, L. J., & Rosing, J. (2003). Venous Thrombosis and Changes of Hemostatic Variables during Cross-Sex Hormone Treatment in Transsexual People. The Journal of Clinical Endocrinology & Metabolism, 88(12), 5723–5729. [DOI:10.1210/jc.2003-030520]
    • Traish, A. M., Krakowsky, Y., Doros, G., & Morgentaler, A. (2019). Do 5α-Reductase Inhibitors Raise Circulating Serum Testosterone Levels? A Comprehensive Review and Meta-Analysis to Explaining Paradoxical Results. Sexual Medicine Reviews, 7(1), 95–114. [DOI:10.1016/j.sxmr.2018.06.002]
    • Traish, A. M. (2020). Post-finasteride syndrome: a surmountable challenge for clinicians. Fertility and Sterility, 113(1), 21–50. [DOI:10.1016/j.fertnstert.2019.11.030]
    • Usach, I., Martinez, R., Festini, T., & Peris, J. (2019). Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site. Advances in Therapy, 36(11), 2986–2996. [DOI:10.1007/s12325-019-01101-6]
    • van Zuuren, E. J., Fedorowicz, Z., Carter, B., & Pandis, N. (2015). Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews, 2015, CD010334. [DOI:10.1002/14651858.cd010334.pub2]
    • Verdonk, S. J., Vesper, H. W., Martens, F., Sluss, P. M., Hillebrand, J. J., & Heijboer, A. C. (2019). Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS method. Clinica Chimica Acta, 495, 198–204. [DOI:10.1016/j.cca.2019.04.062]
    • Vermeulen, A., Giagulli, V., De Schepper, P., & Buntinx, A. (1991). Hormonal Effects of a 5α-Reductase Inhibitor (Finasteride) onHormonal Levels in Normal Men and in Patients withBenign Prostatic Hyperplasia. European Urology, 20(1), 82–86. [DOI:10.1159/000471752]
    • Vihtamäki, T., Luukkaala, T., & Tuimala, R. (2004). Skin contamination by oestradiol gel—a remarkable source of error in plasma oestradiol measurements during percutaneous hormone replacement therapy. Maturitas, 48(4), 347–353. [DOI:10.1016/s0378-5122(03)00043-4]
    • Wang, H., Liu, M., Fu, Q., & Deng, C. (2019). Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study. Drug Design, Development and Therapy, 13, 2475–2482. [DOI:10.2147/dddt.s204624]
    • Wang, Y., & Lipner, S. R. (2020). Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration. International Journal of Women’s Dermatology, 6(4), 272–276. [DOI:10.1016/j.ijwd.2020.05.002]
    • Weill, A., Nguyen, P., Labidi, M., Cadier, B., Passeri, T., Duranteau, L., Bernat, A., Yoldjian, I., Fontanel, S., Froelich, S., & Coste, J. (2021). Use of High Dose Cyproterone Acetate and Risk of Intracranial Meningioma in Women: Cohort Study. BMJ, 372, n37. [DOI:10.1136/bmj.n37]
    • Welk, B., McArthur, E., Ordon, M., Anderson, K. K., Hayward, J., & Dixon, S. (2017). Association of Suicidality and Depression With 5α-Reductase Inhibitors. JAMA Internal Medicine, 177(5), 683–691. [DOI:10.1001/jamainternmed.2017.0089]
    • Wellington, K., & Keam, S. J. (2006). Bicalutamide 150mg: A Review of its Use in the Treatment of Locally Advanced Prostate Cancer. Drugs, 66(6), 837–850. [DOI:10.2165/00003495-200666060-00007]
    • Willemsen, W. N., Mastboom, J. L., Thomas, C. M., & Rolland, R. (1985). Absorption of 17β-estradiol in a neovagina constructed from the peritoneum. European Journal of Obstetrics & Gynecology and Reproductive Biology, 19(4), 247–253. [DOI:10.1016/0028-2243(85)90036-x]
    • Wilson, L. M., Baker, K. E., Sharma, R., Dukhanin, V., McArthur, K., & Robinson, K. A. (2020). Effects of antiandrogens on prolactin levels among transgender women on estrogen therapy: A systematic review. International Journal of Transgender Health, 21(4), 391–402. [DOI:10.1080/15532739.2020.1819505]
    • Wu, B., Shen, P., Yin, X., Yu, L., Wu, F., Chen, C., Li, J., & Xu, T. (2022). Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System. British Journal of Clinical Pharmacology, 89(2), 440–448. [DOI:10.1111/bcp.15336]
    • Wu, F. C., Balasubramanian, R., Mulders, T. M., & Coelingh-Bennink, H. J. (1999). Oral Progestogen Combined with Testosterone as a Potential Male Contraceptive: Additive Effects between Desogestrel and Testosterone Enanthate in Suppression of Spermatogenesis, Pituitary-Testicular Axis, and Lipid Metabolism. The Journal of Clinical Endocrinology & Metabolism, 84(1), 112–122. [DOI:10.1210/jcem.84.1.5412]
    • Zaenglein, A. L., Pathy, A. L., Schlosser, B. J., Alikhan, A., Baldwin, H. E., Berson, D. S., Bowe, W. P., Graber, E. M., Harper, J. C., Kang, S., Keri, J. E., Leyden, J. J., Reynolds, R. V., Silverberg, N. B., Stein Gold, L. F., Tollefson, M. M., Weiss, J. S., Dolan, N. C., Sagan, A. A., Stern, M., Boyer, K. M., & Bhushan, R. (2016). Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 74(5), 945–973.e33. [DOI:10.1016/j.jaad.2015.12.037]
    • Zhang, J., & Stanczyk, F. Z. (2013). LC-MS Bioanalysis of Steroids. In Li, W., Zhang, J., & Tse, F. L. S. (Eds.). Handbook of LC-MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations (pp. 573–590). Hoboken, New Jersey: John Wiley & Sons. [DOI:10.1002/9781118671276.ch45]
    • Zhou, Z., Song, S., Gao, Z., Wu, J., Ma, J., & Cui, Y. (2019). The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Clinical Interventions in Aging, 14, 399–406. [DOI:10.2147/cia.s192435]
    • Zitzmann, M., Rohayem, J., Raidt, J., Kliesch, S., Kumar, N., Sitruk-Ware, R., & Nieschlag, E. (2017). Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial. Andrology, 5(3), 516–526. [DOI:10.1111/andr.12328]
    • Zuuren, E., & Fedorowicz, Z. (2016). Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments. British Journal of Dermatology, 175(1), 45–61. [DOI:10.1111/bjd.14486]
    \ No newline at end of file diff --git a/transfemscience.org/articles/transfem-lactation-literature/index.html b/transfemscience.org/articles/transfem-lactation-literature/index.html index b20ec11f..bda60276 100644 --- a/transfemscience.org/articles/transfem-lactation-literature/index.html +++ b/transfemscience.org/articles/transfem-lactation-literature/index.html @@ -1 +1 @@ -Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People - Transfeminine Science Link

    Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People

    By Aly | First published March 26, 2019 | Last modified March 20, 2024

    Abstract / TL;DR

    A number of case reports of hormonally induced lactation and breastfeeding in transfeminine people have been published. The earliest report of lactation in a transfeminine person was in the 1950s and the earliest report of breastfeeding was in the 1980s. Starting in 2019, more case reports have been published in the modern scientific literature. Unpublished cases also exist (e.g., that of Dr. Christine McGinn), and lactation has been induced or occurred in cisgender men as well. Lactation may be induced in transfeminine people with the use estrogens, progestogens, and/or prolactin releasers. Reviews discussing lactation induction in transfeminine people have recently been published.

    Introduction

    Last year, a case report of lactation and breastfeeding in a transgender woman was published:

    • Reisman, T., & Goldstein, Z. (2018). Case report: Induced lactation in a transgender woman. Transgender Health, 3(1), 24–26. [DOI:10.1089/trgh.2017.0044]

    In the paper, the authors state the following:

    We believe that this is the first formal report in the medical literature of induced lactation in a transgender woman.

    However, this actually wasn’t the first case report of lactation and/or breastfeeding in a transfeminine person in the literature. There are various previous published cases dating back as far as the 1950s. These instances are provided below in the format of sources and excerpts.

    Published Case Reports

    Foss (1956)

    Foss, G. L. (1956). Abnormalities of form and function of the human breast. Journal of Endocrinology, 14(4 Suppl) [Proceedings of the Society for Endocrinology: Fifty-Fourth Meeting. Symposium on Selected Aspects of the Practice of Hormone Administration in Animals and Man], vi–vii. [Google Scholar] [Google Books] [URL] [PDF]:

    Based on the theories of lactogenesis and stimulated by the success of Lyons, Li, Johnson & Cole [1955], who succeeded in producing lactation in male rats, an attempt was made to initiate lactogenesis in a male transvestist. Six years ago this patient had been given oestrogens. Both testes and penis were then removed and an artificial vagina was constructed by plastic surgery. The patient was implanted with 500 mg oestradiol in September 1954, and 600 mg in July 1955. The breasts were then developed more intensively with daily injections of oestradiol dipropionate and progesterone for 6 weeks. Immediately following withdrawal of this treatment, prolactin 22·9 mg was injected daily for 3 days without effect. After a second month on oestradiol and progesterone daily, combined injections of prolactin and somatotrophin were given for 4 days and suction was applied by a breast pump—four times daily. On the 4th and 5th days a few drops of colostrum were expressed from the right nipple.

    Tindal & McNaught (1958)

    Tindal, J. S., & McNaught, M. L. (1958). Hormonal Factors in Breast Development and Milk Secretion. In Gardiner-Hill, H. (Ed.). Modern Trends in Endocrinology, Volume 1 (pp. 188–211) (Modern Trends). London: Butterworth. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]:

    Recently, an attempt has been made by Foss (1956) to initiate lactation in a castrated male transvestist. He was given an implant of 500 milligrams of oestradiol, and 10 months later, a further 600 milligrams of oestradiol, followed by daily injections of oestradiol dipropionate and progesterone for 6 weeks. Immediately after withdrawal of this treatment, 22·9 milligrams of prolactin were injected daily for 3 days but without effect. After a second month of treatment with oestradiol and progesterone daily, he was given combined injections of prolactin and somatotrophin for 4 days, suction with a breast-pump being employed 4 times daily. On the fourth and fifth days a few drops of colostrum were expressed from the right nipple. There is a possible application here of modern hormone knowledge to man, and further trials would be of interest.

    Foss (1958)

    Foss, G. L. (1958). Disturbances of Lactation. Clinical Obstetrics and Gynecology, 1(1), 245–254. [Google Scholar] [PubMed] [DOI:10.1097/00003081-195803000-00021]:

    Experimentally I have been able to induce lactogenesis in a male transvestite whose testes had been removed some years before and whose breasts had been well developed over a long period with stilbestrol and ethisterone.9 In July, 1955, 600 mg. of estradiol was implanted subcutaneously and weekly injections of 50 mg. of progesterone were given for four months. For the next month daily injections of 10 mg. estradiol dipropionate and 50 mg. progesterone were given. These injections were continued for another month, increasing progesterone to 100 mg. daily. Both hormones were then withdrawn, and daily injections of increasing doses of prolactin and somatotropin were given for four days; at the same time, the patient used a breast pump four times daily for 5 minutes on both sides. During this time the mammary veins were visibly enlarged and on the sixth and seventh days 1 to 2 cc. of milky fluid was collected.

    Flückiger, Del Pozo, & von Werder (1982)

    Flückiger, E., Del Pozo, E., & von Werder, K. (1982). Prolactin: Synthesis, Fate and Actions. In Flückiger, E. W., Del Pozo, E., & von Werder, K. (Eds.). Prolactin: Physiology, Pharmacology, and Clinical Findings (Monographs on Endocrinology, Volume 23) (pp. 1–23). Berlin/Heidelberg: Springer-Verlag. [Google Scholar] [Google Books] [DOI:10.1007/978-3-642-81721-2_1]:

    An observation (Wyss and Del Pozo unpublished) in a male transsexual showed that induction of lactation can be similarly achieved in the human male.

    Flückiger, E., Del Pozo, E., & von Werder, K. (1982). Nontumoral hyperprolactinemia. In Flückiger, E. W., Del Pozo, E., & von Werder, K. (Eds.). Prolactin: Physiology, Pharmacology, and Clinical Findings (Monographs on Endocrinology, Volume 23) (pp. 102–152). Berlin/Heidelberg: Springer-Verlag. [Google Scholar] [Google Books] [DOI:10.1007/978-3-642-81721-2_4]:

    4.3.2 Effect of Hyperprolactinemia in Male Subjects

    Although PRL circulates in male blood in appreciable concentrations its physiologic role has not been clarified. The lack of lactational requirements does not preclude that under adequate priming the male mammary gland will respond to a PRL challenge with milk production. Thus, Wyss and del Pozo (unpublished data) found that PRL stimulation with TRH was able to induce milk secretion in a male individual pretreated with estrogens. Certainly, the chronic ingestion of dopamine antagonists or estrogens may lead to sustained hyperprolactinemia, and the same effect can be expected in male subjects on chronic estrogen therapy of prostatic cancer or transsexualism (Frantz 1973; del Pozo, to be published).

    Certainly, the prolonged intake of estrogens, in male subjects also, as observed in the treatment of prostatic carcinoma and in transsexuals, can lead to hyperprolactinemia (Frantz 1972b; del Pozo, to be published).

    Kozlov, Mel’nichenko, & Golubeva (1985)

    Kozlov, G. I., Mel’nichenko, G. A., & Golubeva, I. V. (1985). Случай лактореи у больного мужского пола с транссексуализмом. [Sluchai laktorei u bol’nogo muzhskogo pola s transseksualizmom. / Case of galactorrhea in a transsexual male patient.] Проблемы Эндокринологии [Problemy Èndokrinologii (Moskva) / Problems of Endocrinology (Moscow)], 31(1), 37–38. [ISSN:0375-9660] [Google Scholar 1] [Google Scholar 2] [PubMed] [DOI:10.14341/probl198531137-38] [PDF] [Translation] [Translated]:

    The appearance of galactorrhea in men is most often a symptom of pituitary prolactinoma. Combined with gynecomastia and atrophy of the testicles, galactorrhea caused by adenomas of the pituitary gland in men is known as O’Connell syndrome (1).

    In recent years, however, cases of galactorrhea have been described in men without radiological or clinical signs of pituitary adenoma (12). Of course, in these cases, the presence of undetected microadenomas of the pituitary gland cannot be excluded, especially since the level of prolactin in these patients is significantly increased (1, 2).

    Some medications, especially antipsychotics and estrogen-containing oral contraceptives (7, 10), increase serum levels of prolactin and can lead to the development of galactorrhea.

    There is information about the influence of psycho-emotional factors on the lactation process: the possibility of the development (induction) of psychogenic lactation during false pregnancy (3) is known, and, conversely, the possibility of the termination of lactation in nursing mothers after mental stress.

    Accumulated clinical observations on the frequent development of depressive states in persistent galactorrhea–amenorrhea syndrome (4), cases of galactorrhea in the mentally ill, even in the absence of neuroleptics (7), as well as experimental observations on the effect of hyperprolactinemia on the behavioral responses of animals (5), require careful study of the relationship of hyperprolactinemia and psycho-emotional factors. In connection with this, we present the following observation.

    The patient (P), was born a normal, full-term boy. He remembers well from 6 years. Early development was unremarkable, he did not differ from peers, but loved to play more with girls. He played with dolls and cars. At 10 years of age, there was a desire to wear women’s clothes. From the age of 12 he swam with girls in a shirt and shorts, as he was embarrassed by the lack of breasts. From the age of 14 he changed clothes in his mother’s dress, and only in such clothes “felt like a person”. From the same age in a woman’s dress he went to get acquainted with young men and got pleasure from it. At the age of 15, he came to the firm conviction that he was a girl, began to urinate like a girl, squatting, use lipstick, and put on powdered makeup. He suffered greatly from the presence of “deformities” – male genital organs. At the age of 17, while working as a “nurse” in a hospital, he began to self-inject himself with folliculin (estrogen) and progesterone, which caused the development of the breasts. With pleasure, he did women’s housework, and loved to tinker with children. Having received a passport, he redid it as female, thus resulting in a female civilian gender.

    Twice he tried to commit suicide (he took sleeping pills), since he could not bear the duality of his existence. Twice he was treated in psychiatric hospitals about transsexualism, unsuccessfully.

    During the examination in IEE and HCG at the age of 20 years, no abnormalities in somatic status were revealed: complex as a man, male genitals, shaved from 17 years of age daily. Erotic dreams were frequent, wherein he played the role of a woman, and denied emissions. The ejaculate was studied (obtained by vibratory massage): volume – 1.4 mL, pH 8.8 (norm 7.6–8.2), sperm count 31 million per 1 mL, mobility 57%, and morphologically normal 69%. Sex chromatin is negative.

    At age 22, a course of treatment with cyproterone acetate was conducted at the Institute of Psychiatry of the Ministry of Health of the USSR. Muscle weakness, reduction of sexual hairiness, and appearance of colostrum excretion was noted.

    When examined in IEE and HCG at 23 years, the breasts corresponded to the age of 15–16 years (on his own initiative he periodically took estrogens), and colostrum was secreted from the nipples (abundant drops when pressed – galactorrhea (++)). He insisted on castration and amputation of the penis, since, being a “woman”, he was ashamed of not having the appropriate genitals for his sex, which he called “deformities”.

    On X-ray of the skull, the shape and size of the sella turcica were normal, but signs of increased intracranial pressure were revealed. On EEG against the background of the general phenomena of irritation, the focus of pathology was recorded in the left parietal lead. Indicators of the functional state of the thyroid gland were in the normal range. In the study of the radioimmunoassay method using standard kits from the Sorin company, some increase in prolactin level of 24 ng/mL was detected in the serum (normal for men is 4–15 ng/mL).

    In connection with the repeated suicidal attempts, failure of psychiatric treatment, and in consideration of the fact that the patient has a female civilian sex and performs a female social role, castration and feminizing plastic surgery of the external genitalia were performed for the purpose of social rehabilitation.

    Some time after the operation, the patient developed a renewed interest in life. After the surgical and hormonal correction, the patient irresistibly developed maternal instincts. Unmarried, the patient obtained permission for the adoption of a child, simulated pregnancy, and was discharged from the maternity hospital with a son. From the first days after the “birth”, galactorrhea sharply increased, and spontaneous outflow of milk appeared, with galactorrhea (+++). The baby was breastfed up to 6 months of age.

    Thus, it can be thought that several factors played a role in the genesis of galactorrhea in this patient:

    1. Increased prolactin levels with estrogen and cyproterone acetate. The hyperprolactic properties of estrogens have long been known; the ability of cyproterone acetate to increase serum prolactin levels was shown by K. Schmidt–Golewizer et al (9).

    2. Increased intracranial pressure, the role of this factor and the genesis of neuroendocrine disorders and, in particular, in the development of galactorrhea was shown by R. Peterson (8).

    Our message is the second in the world literature describing galactorrhea in a male patient with transsexualism. The first description of this kind was made in 1983 by R. Flüskiger et al. (6).

    This observation demonstrates the independence of the mechanism of lactation development from one’s genetic sex and is alarming with regard to the possibility of drug-induced galactorrhea development in men.

    Barber et al. (2004)

    Barber, T., Basu, A., Rizvi, K., & Chapman, J. (2004). Normoprolactinaemic galactorrhoea in a male-to-female transsexual. Endocrine Abstracts, 7 [23rd Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine Societies], 271–271. [Google Scholar] [URL]:

    Hormonal therapies in the form of oestrogens, anti-androgens and progestogens are often used in the treatment of male-to-female transsexuals. We present the case of a 36 year old phenotypic male with karyotype 46XY who presented with normoprolactinaemic galactorrhoea likely to be related to prior oestrogen administration. He had been self-administering oestrogen and progesterone preparations continuously for 7 years (aged 26 - 33 years) in an attempt to develop female phenotypic characteristics in spite of a heterosexual desire. During this time he developed gynaecomastia with galactorrhoea, increased energy and libido, voice change and an attraction towards both men and women. However due to lack of financial resources to secure a complete gender change, he stopped self-medication with these preparations 3 years ago. Instead he embarked on a regime involving self-administered testosterone in an attempt to reverse the biological changes. After discontinuation of oestrogen the gynaecomastia regressed somewhat, although galactorrhoea continued and worsened with testosterone. Prior to referral he had been treated with dopamine agonists with little improvement in galactorrhoea and gynaecomastia.

    Routine biochemistry and haematology are within their reference ranges. Baseline endocrinology is normal: Prolactin 197 milliUnits per litre, LH 2.9 Units per litre, FSH 7.9 Units per litre, free Testosterone 20 nanoMoles per litre, 17 beta-oestradiol less than 110 picoMoles per litre, TSH 0.96 milliUnits per litre and free T4 16.5 picoMoles per litre.

    This case illustrates fascinating effects of exogenous oestrogen in the male. The effects of oestrogenic products of aromatised endogenous and briefly also exogenous testosterone acting on oestrogen-primed breast tissue may account for, at least in part, his continuing symptom of normoprolactinaemic galactorrhoea. However two other features do not have any direct explanations: the development of osteopenia during this period, and complete disappearance of vascular migraine, a condition worsened with oestrogens in the female. He is now on Tamoxifen although an opportunity to use the aromatase inhibitor, Anastrozole still remains.

    Subsequent Case Reports

    Moravek & Pasque (2019)

    Moravek, M. B., & Pasque, K. B. (2019). Lactation Can Be Successfully Induced in Transgender Women While Maintaining Gender-Congruent Serum Hormone Levels. Reproductive Sciences, 26(Suppl 1), 136A–136A (abstract no. T-055). [Google Scholar] [DOI:10.1177/1933719119834079]:

    Introduction: Transgender women may be interested in breastfeeding their children, but there are no established protocols for lactation induction in this population. The only case report of a lactation induction protocol in a transgender woman significantly lowered her estradiol dose, which would likely result in decreased serum estradiol and increased testosterone levels, with resultant increase in gender dysphoria. Our objective was to induce lactation in a transgender woman without interrupting her gendercongruent hormone profile.

    Methods: A 34-year-old transgender woman with a 15-year history of gender-affirming hormone therapy with estradiol and spironolactone presented for lactation induction once her cisgender wife conceived. A modification of the Newman-Goldfarb method for adoptive mothers was used to induce lactation, and serum hormone levels followed.

    Results: Baseline labs were obtained (time point 1), then medroxyprogesterone 1.25mg daily was added to her existing hormone regimen of estradiol 6mg daily and spironolactone 100mg twice daily (time point 2). Domperidone 10mg four times daily was initiated 1 month later. Approximately 5 weeks prior to the due date, the patient stopped medroxyprogesterone, decreased estradiol to 2mg daily, and began breast pumping (time point 3). Just prior to the infant’s birth, the patient was pumping 2-3 ounces of breastmilk every 3 hours (time point 4). Spironolactone was decreased to 50mg twice daily. Her son was born at term, via uncomplicated vaginal delivery. The infant was able to breastfeed from both mothers without difficulty, with both mothers pumping when they weren’t actively breastfeeding to maintain supply (time point 5). When the infant was approximately 2 months old, the patient noticed an increase in facial hair growth. Estradiol was increased to 3mg daily and spironolactone increased to 100mg twice daily, with resolution of hair growth and no decrease in milk supply (time point 6). The patient continued to breastfeed on this regimen for >6 months following her son’s birth. Serum hormone levels on the hormone regimens referenced at each time point throughout the patient’s course are displayed in table 1.

    Conclusion: Lactation can be successfully induced in transgender women, without a significant decrease in estradiol supplementation. This regimen allows transgender women to breastfeed without developing male secondary sex characteristics incongruent with their gender identity

    Table 1 Hormone profile at different time points.

    Time PointEstradiol (pg/mL)Progesterone (ng/mL)Testosterone (ng/mL)Prolactin (ng/mL)
    11141.10.36 
    21301.10.059
    3301.30.06152
    439   
    5291.40.89184
    651 0.1659

    Unnithan, Elson, & Shenker (2020)

    Unnithan, R., Elson, D. F., & Shenker, Y. (2020). Galactorrhea and Hyperprolactinemia in a Transgender Female. Journal of the Endocrine Society, 4(Suppl 1), A899–A899 (abstract no. SUN-043). [Google Scholar] [PubMed Central] [DOI:10.1210/jendso/bvaa046.1781] [PDF]:

    Background: Galactorrhea is a rare manifestation of hyper-prolactinemia in males and post-menopausal females, however the hormonal milieu of the transgender female may increase its incidence

    Clinical Case: A 43 year old transgender female presented with three years of bilateral breast discharge. She had chronic, stable headaches and fatigue, but no vision changes or other symptoms. Notably, she had breast augmentation surgery with saline breast implants placed shortly before the galactorrhea commenced. She was on a stable dose of estradiol tablets 1 mg twice daily for six years. On physical exam she had pronounced bilateral breast discharge of a milky quality with nipple compression. Prolactin levels were checked several times and were 40-50 ng/mL, TSH was 2.36 uIU/mL. An MRI showed a left inferior pituitary lesion measuring 6 mm x 3 mm x 5 mm with no mass effect on adjacent structures. Her breast discharge was not bothersome to her, and her pituitary lesion was small. It was unclear whether there was a relationship between her prolactin levels and the lesion seen on MRI, as we expected more pronounced prolactin elevation with a prolactinoma. Instead, given the timing of her symptoms in relation to her breast augmentation surgery, her galactorrhea and hyper-prolactinemia were thought to be the result of nipple irritation related to her breast implants combined with a hyper-estrogenemic state.

    Clinical Lessons: In the setting of a prolactin secreting micro-adenoma, galactorrhea in a male is highly unusual. This case highlights the importance of recognizing that the unique medical and surgical characteristics of male to female transgender patients can lead to hyper-prolactinemia and galactorrhea.

    Reference: Reisman T, Goldstein Z. Case report: induced lactation in a transgender woman. Transgender Health. 2018;3(1):24-26.

    Wamboldt, Shuster, & Sidhu (2021)

    Wamboldt, R., Shuster, S., & Sidhu, B. S. (2021). Lactation Induction in a Transgender Woman Wanting to Breastfeed: Case Report. The Journal of Clinical Endocrinology & Metabolism, 106(5), e2047–e2052. [DOI:10.1210/clinem/dgaa976]:

    Context: Breastfeeding is known to have many health and wellness benefits to the mother and infant; however, breastfeeding in trans women has been greatly under-researched.

    Objective: To review potential methods of lactation induction in trans women wishing to breastfeed and to review the embryological basis for breastfeeding in trans women.

    Design: This article summarizes a case of successful lactation in a trans woman, in which milk production was achieved in just over 1 month.

    Setting: This patient was followed in an outpatient endocrinology clinic.

    Participant: A single trans woman was followed in our endocrinology clinic for a period of 9 months while she took hormone therapy to help with lactation.

    Interventions: Readily available lactation induction protocols for nonpuerpural mothers were reviewed and used to guide hormone therapy selection. Daily dose of progesterone was increased from 100 mg to 200 mg daily. The galactogogue domperidone was started at 10 mg 3 times daily and titrated up to effect. She was encouraged to use an electric pump and to increase her frequency of pumping.

    Main outcome measure: Lactation induction.

    Results: At one month, she had noticed a significant increase in her breast size and fullness. Her milk supply had increased rapidly, and she was producing up to 3 to 5 ounces of milk per day with manual expression alone.

    Conclusions: We report the second case in the medical literature to demonstrate successful breastfeeding in a trans woman through use of hormonal augmentation.

    Further Case Reports

    • Delgado, D., Stellwagen, L., McCune, S., Sejane, K., & Bode, L. (2023). Experience of Induced Lactation in a Transgender Woman: Analysis of Human Milk and a Suggested Protocol. Breastfeeding Medicine, 18(11), 888–893. [DOI:10.1089/bfm.2023.0197]
    • Weimer, A. K. (2023). Lactation induction in a transgender woman: macronutrient analysis and patient perspectives. Journal of Human Lactation, 39(3), 488–494. [DOI:10.1177/08903344231170559]
    • van Amesfoort, J. E., Van Mello, N. M., & van Genugten, R. (2024). Lactation induction in a transgender woman: case report and recommendations for clinical practice. International Breastfeeding Journal, 19(1), 18. [DOI:10.1186/s13006-024-00624-1]

    Dr. Christine McGinn

    Dr. Christine McGinn is a transgender woman and well-known surgeon in Pennsylvania who performs gender-affirming surgeries for transgender people. When she had children with her cisgender female partner, McGinn induced a hormonal pseudopregnancy in herself and her and her partner breastfed their twins together. This was described in the media, including in books and television. McGinn’s case was never formally published as a case report in the scientific literature however.

    The Oprah Winfrey Show (2010)

    Terry, J. C. (Director), & Winfrey, O. G. (Presenter). (2010 September 29). The Mom Who “Fathered” Her Own Children, Plus the Cast of Modern Family [Television series episode]. The Oprah Winfrey Show (Season 25, Episode 13). Chicago: Harpo Studios. [URL 1] [URL 2] [URL 3]

    Trans (2012)

    Arnold, C. (Director), Schoen, M. (Producer), RoseWorks (Firm), & Sex Smart Films (Firm). (2012). Trans [DVD] (1:21:32–1:21:55). [WorldCat] [IMDB] [Amazon Prime Video]

    Boylan (2014)

    Boylan, J. F. (2014). Dr. Christine McGinn. In Boylan, J. F. Stuck in the Middle with You: A Memoir of Parenting in Three Genders (pp. 223–233). New York: Broadway Books. [Google Scholar] [Google Books 1] [Google Books 2] [WorldCat] [PDF]:

    Dr. Christine McGinn is a surgeon, a mother of two, a backup flight surgeon for the space shuttle progarm, and a transgender woman. As a man, she saved her sperm before transition; ten years later she used that sperm to have children with her partner Lisa. The two of them are both biological mothers of their son and daughter, and each mother was able to breast-feed the twins. I sat down with Christine at her office in New Hope, Pennsylvania, on a hot summer day in 2011.

    CM: […] Then there’s the scientist in me that knows that there is a difference, there is not a binary, but a gender spectrum. There are chemicals that are different in men and women. And when a transgender woman transitions, we are somewhere in the middle. Especialy having gone through a simulated pregnancy, in order to breast-feed, I felt the changes of those hormones. I felt my milk let down when not only my baby would cry, but a baby on TV would cry, and even, ridiculously, when a door would close and make a squeak.

    JFB: You had to induce a false pregnancy in order to breast-feed? Tell me how you did that.

    CM: As a doctor, I knew it was possible. I followed the protocol that involves simulating pregnancy with hormones. It’s estrogen and progesterone. My simulation pregnancy was over a month before Lisa delivered—with twins, we were expecting them to be born earlier. That entire month I was just pumping nonstop, every two hours. We had a whole freezer full of milk. And you know, the first couple of weeks it was no good, because it had all of the hormones in it. So we only saved, like, the last week or so. But still, it was a freezer full of milk.

    Lisa had no idea about the way breast-feeding takes over your life, because this was her first. It was kind of funny that I went through that on my own, first, weeks before she did. And then it took her a couple of days to actually—for her milk to let down.

    The children were so small when they were born. They were only five pounds. At first we had to feed them with a syringe. They were breast-feeding as well, but they weren’t latching that great on either of us.

    JFB: What was it like when they finally muckled on to you?

    CM: Oh, I can’t even put it in words. I really cannot put it in words. It was—I was just—oh.

    JFB: Were you amazed? Were you afraid?

    CM: It was heaven. I was afraid. I don’t know, it was uncharted territory. Like, I knew the milk was good. Lisa was a little concerned that it would be like skimmed milk, or something, you know. [Laughs] Like—she’s like, “Is it the same stuff?”

    JFB: Is it the same milk?

    CM: And she was a little dubious about, like, is this really all right? I think that’s totally natural for a mother, to be concerned.

    I will just say that there are things snobody thinks about when two women are both breast-feeding. Like, technical stuff that you don’t think about. When you have a mother and a father, the mother decides when the kids get fed. Right? The father doesn’t, really. Right?

    But you know, when you have two women who are filled with pregnancy hormones and have that, like, mother-bear attitude about how things should be done… It was really crazy.

    JFB: So did that cause serious conflict between you and Lisa?

    CM: Totally not serious conflict, because the most important thing are the babies.

    Eden finally latched—I breast-fed her more than Luke. Luke was never really good. Lisa hated breast-feeding. Eventually we decided to stop.

    I’m putting on my science hat again—when you decide to stop, there are hormonal issues. The strongest emotion a person can feel in their life comes frm oxytocin, which is the love drug.

    JFB: Oxytocin?

    CM: That’s what’s responsible for babies’ bonding during breastfeeding. So the baby latches on, breast-feeds, your brain just [makes oozing sounds], just like, oozes this gooey love substance, oxytocin. Fathers are proven to have higher oxytocin before the delivery, and just stroking your child’s head. You know, when the baby—when you smell a newborn’s head, it really—that smell, it’s like—

    JFB: I just saw a friend’s newborn on Friday, and I was like, [makes sniffing sound]—

    CM: My niece said it best. She came in and smell them, and she was five years old at the time, and she’s like, “They smell like cupcakes.” [Laughs] And it’s universal. When you ask me what that’s like, I can’t describe it, you know, and I’m a huge fan of food and cupcakes and chocolate, and so that’s the closest I can come to it—it’s like chocolate. [Laughs]

    JFB: So when you stopped breast-feeding, was it a kind of a mourning, a loss?

    CM: Yes. Lisa wanted to stop before I did. The problem is, once a baby gets a nipple, a plastic nipple, it gives more milk. And so they don’t have to work as hard.

    It’s a unique situation that two breast-feeders in a relationship would experience, but a mother and father would not.

    JFB: So did one of you stop breast-feeding before the other?

    CM: Yes, Lisa did.

    JFB: Lisa stopped. And how much longer did you keep it up?

    CM: Not long, because they got the nipple.

    They were both so small. We weren’t all that successful at it. We were so worried about their birth weight, and making sure they got enough with the syringes. There were definitely times where, you know, we both would breast-feed and, man, I will never forget that. Like, three ‘clock in the morning, four o’clock in the morning, in the little cocoon, nursing.

    The heat of their body, their naked body on your chest. The amazing thing is, it really does kind of hurt when they really get going, you know. And you just… I don’t know how else to describe it. You feel like the life force is just coming out through you. It’s so powerful. It relieves that pain that you have in your breast. It releases that oxytocin, and it’s just—it’s even.

    JFB: Did you ever do that thing where you would fall asleep with the children in the bed, and wake up with the children in the bed beside you?

    CM: Yeah.

    JFB: I loved that. It’s one of my stnogest memories of being a father. Having gotten up in the middle of the night. And they are so small, but such an incredibly powerful feeling, the two of you together surrounding the child. With us, we also had a dog at the bottom of the bed. [Laughs]

    CM: And we have two, and that was also very important to me, too. We have miniature pinschers.

    JFB: So how many months along did you stop breast-feeding?

    CM: Three months. It was really emotionally painful, and I cried a lot. I was really sad.

    I was pretty sure we were not going to have any more kids. So I’m like, “This is it.” It was very sad.

    JFB: Is there a moment frm the last year and two months where you think, This is what it’s like to be a mother, this is it?

    CM: Yes, immediately. It was hot as Hades outside. It was, like, a million degrees. We had just had the kids. It was like, May or June, and my mom was over, and it was, like, we had all this help, initially, because Lisa and I were just not getting any sleep and it was, like, round-the-clock feedings and the kids were small, and Lucas had an apnea monitor that he had to wear all the time, and it was just really hard. And there was a big thunderstorm, and the power went out.

    And so, at this point, they weren’t really latching very well, so we both had to pump, and then feed them with the syringes. So Lisa and I are totally, like, engorged with milk. And the power’s out, and the pumps are electric. Right?

    JFB: Right.

    CM: So there’s no electricity, it’s hot as hell, we’re worried for the kids. Lisa and I are in pain. We’re both leaking. And it was the weirdest, funniest situation. And my mom’s there. She runs out to the store to get batteries, and you know, she’s just beng a mom. She’s getting everything, running around like an angel. And Lisa and I are in pain we’re miserable. When she finally came back, the batteries wouldn’t work on the pumps—something else was wrong. Lisa and I are dying.

    And so, here’s the guy part of me… I get the pump that has the backup battery power and the backup car charger. Like, I got all tech on it. [Laughs] I’m out int he car trying to get the car charger to work on the pump in the pouring rain. And it’s ninety-five degrees out. It’s all wet inside, like, the humidity on the windows.

    And I’m just trying to get some kind of relief.

    And this stupid pump didn’t work that way, either. We come back in and my mom has candles lit.

    And then the electricity comes back on. And we all just laugh and pump and breast-feed. And every one of us is in heaven.

    Pfeffer (2017)

    Pfeffer, C. A. (2017). Trans Partnerships and Families: Historical Traces and Contemporary Representations. In Pfeffer, C. A. Queering Families: The Postmodern Partnerships of Cisgender Women and Transgender Men (pp. 1–34). New York: Oxford University Press. [Google Scholar] [Google Books] [WorldCat] [DOI:10.1093/acprof:oso/9780199908059.003.0001]:

    Just 2 years later, Winfrey would feature another interview that elicited many of the same audience reactions. In this 2010 episode, lesbian partners Dr. Christine McGinn and Lisa Bortz beamed with joy as they held their infant twins. Again, audience members’ jaws dropped when it was revealed that beautiful Christine was a male-to-female transsexual who used to be a handsome military officer Chris, and that Lisa had given birth to the couple’s biological children using sperm Chris banked prior to gender confirmation surgeries.10 And it was Winfrey’s chin that nearly hit the floor as she watched video of Christine breastfeeding the couples’ children (the episode is referred to online as “The Mom Who Fathered Her Own Children”).

    Other Instances

    Published

    Estrogen plus cyproterone acetate has been reported to produce pregnancy-like breast changes—specifically, lobuloalveolar development of the breasts—in transfeminine people (Kanhai et al., 2000). Accordingly, galactorrhea (spontaneous or excessive lactation) has been reported as a low-incidence side effect (7–14%) of hormone therapy regimens containing estrogen plus cyproterone acetate in transfeminine people (Gooren, Harmsen-Louman, & van Kessel, 1985; Schlatterer et al., 1998; Bazarra-Castro, 2009). It has also been reported at low incidence (6%) for other hormone therapy regimens (Futterweit, 1980). Sudden cessation of hormone therapy regimens including cyproterone acetate has been reported to result in the onset of lactation as well (Levy, Crown, & Reid, 2003).

    Unpublished

    Many unpublished reports of lactation and breastfeeding in transfeminine people have been described on the web including at the following pages:

    • Richards, A. (2003). Lactation and the Transsexual Woman. Second Type Woman. [Updated August 2018] [URL] [PDF]
    • MacDonald, T. (2013). Trans Women and Breastfeeding: A Personal Interview. Milk Junkies. [URL]
    • MacDonald, T. (2013). Trans Women and Breastfeeding: The Health Care Provider. Milk Junkies. [URL]
    • MacDonald, T. (2017). Jenna’s Breastfeeding Journey: Trans Motherhood. Milk Junkies. [URL]
    • Burns, K. (2018). Yes, Trans Women Can Breastfeed — Here’s How. them. [URL]

    Cisgender Men

    Induction of lactation has been reported in cisgender men and is noteworthy:

    Geschickter (1945)

    Geschickter, C. F. (1945). Endocrine Physiology of the Breast. In Geschickter, C. F. Diseases of the Breast: Diagnosis, Pathology, Treatment, 2nd Edition (pp. 42–81). Philadelphia: J.B. Lippincott. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]:

    The results obtained indicate that a lactogenic substance in anterior pituitary extracts may cause mammary secretion in nonpregnant women when they have been previously stimulated with estrogenic hormone but true lactation does not occur. Secretion was also obtained in two adult men with gynecomastia after injections of lactogenic hormone.

    Huggins (1949)

    Huggins, C. (1949). Endocrine substances in the treatment of cancers. Journal of the American Medical Association, 141(11), 750–754. [DOI:10.1001/jama.1949.02910110002002]:

    The administration of estrogen in effective amounts causes testicular atrophy and mammary hypertrophy. Growth of the breasts can be so extensive that lactation may be induced, as illustrated in the following case.

    W. N., aged 64, had carcinoma of the prostate with osseous metastases, for which he was treated by a permanent suprapubic cystotomy in 1941. Diethylstilbestrol, 20 mg. daily, was given orally for two years beginning September 1942. In September 1944, 25 mg. (500 international units) of prolactin14 was injected daily for five days, and at the end of this time creamy milk could be expressed from both breasts. Orchiectomy and removal of the cystostomy tube were carried out September 6, when administration of estrogen was discontinued; both incisions healed promptly. Since then the patient has been clinically well but has continued to lactate, a large drop of milk being easily expressed from each breast at frequent intervals.

    Huggins & Dao (1954)

    Huggins, C., & Dao, T. L. (1954). Lactation induced by luteotrophin in women with mammary cancer. Growth of the breast of the human male following estrogenic treatment. Cancer Research, 14(4), 303–306. [Google Scholar] [PubMed] [URL]:

    In the observations to be presented luteotrophin [prolactin] was employed as a stimulus for mammary secretion in patients with cancer of the breast, and the results throw new light on the physiology of women bearing this neoplasm. We shall also describe conditions which resulted in the induction of physiologic maturity in the human male, since knowledge of the action of hormones on the human breast is vague.

    The effects of luteotrophin on the breast of women post partum has been extensively investigated, but otherwise few observations have been made in the human. Werner (14) administered a crude pituitary extract containing luteotrophin to eight castrate women 21–35 years of age; lactation was not observed, although in one woman “a few drops of colostrum-like fluid” could be expressed from the breasts. Goldzieher (4) treated menstrual disorders in women with luteotrophin, but mammary secretion was not described by him.

    PROCEDURE

    Luteotrophin,1 dissolved in physiological saline made slight ly alkaline (pH 9) with sodium hydroxide, was injected subcutaneously in daily amounts of 500 International Units; the solutions were freshly prepared, and the injections were continued for 7 days only.

    This series comprised 21 female patients who had dis seminated mammary cancer, and all had been subjected to unilateral mastectomy. There were also three men with advanced prostatic carcinoma who had been treated for thera peutic purposes with oral diethylstilbestrol for 20 months, 2, and 6 years, respectively. There were eight persons without mammary or prostatic cancers who served as controls.

    In each case of mammary cancer a biopsy of the breast was obtained for histological purposes, the material being stained with Sudan III.3

    OBSERVATIONS

    Lactation, when it occurred, was never profuse; it varied from a tiny drop to ca. 0.5 cc. from each breast. Clear colostrum was not observed, and the mammary secretion was always milk, as defined above.

    Mammary growth in the human male.—Estrogenic substances had been administered to three men in the treatment of disseminated prostate cancer for many months; after luteotrophin injection two lactated and one did not lactate.

    W. N. (reported in brief earlier [5]), age 64, had taken diethylstilbestrol, 20 mg/day, orally for 2 years, after which interval sub-areolar button-like masses of mammary tissue could be palpated bilaterally; luteotrophin was then injected for 5 days, and milk was expressed from the breast on the 6th day. Orchiectomy was then performed, and both luteotrophin and estrogenic substances were discontinued. This man continued to lactate for 7 years when the formation of milk gradually ceased.

    In the case of A. W., age 62, diethylstilbestrol (5–15 mg/day) had been ingested for 20 months after bilateral orchiectomy; the breasts became slightly enlarged. Luteotrophin was injected, and lactation occurred on the 7th day. A biopsy of the breast showed moderately well developed mammary ducts and alveoli containing milk. In the case of E. G., age 59, diethylstilbestrol (5 mg/day) was ingested almost continuously for 6 years; this resulted in the development of large pendulous breasts, but no lactation occurred after injections of luteotrophin.

    Lactation in humans without cancer.—Luteotrophin was administered to two normal males, age 51 and 59, and to four normal females, age 84–59, and none lactated.

    DISCUSSION

    It must be emphasized that lactation was not copious in any of the humans when it had been induced by luteotrophin; merely small amounts of milk were obtained. It was apparent, however, from the histological studies of the mammary tissue obtained by biopsy that the secretion of milk in any quantity was a criterion of maturity of mammary epithelium.

    In the goat and guinea pig it is known that estrogenic substances can induce mammary ma turity without the intervention of exogenous synergistic steroids. In the experiments of Lewis and Turner (9) diethylstilbestrol was implanted in two castrate male goats; one of these animals failed to lactate, while the other produced a small quantity of milk without luteotrophin injections. They obtained small amounts of milk from a male kid similarly treated. Nelson (10) found that estrone induced mammary growth with, later, lactation in the male guinea pig. Our observations demonstrate that diethylstilbestrol ingested for prolonged periods of time can induce maturity of the breast in certain elderly human males. However, the human male differs from the animals just described in that spontaneous lactation was not observed; the injection of luteotrophin was necessary for milk formation.

    The duration of lactation induced by luteo trophin was impressive, since milk commonly persisted for many months—and in one male for 7 years. The mechanism whereby this type of lactation is maintained for such long periods of time is at present unknown; we know that milk continues to be secreted both in the presence of the adrenal glands and in the absence of these structures and the gonads as well. Observations (8) have been made on experimental animals which are analogous to the clinical findings; most dogs with spontaneous mammary cancer possess lactation, and this characteristic persists for many months, at least, despite the removal of the adrenal glands and the ovaries.

    SUMMARY

    The breast of the human male can be induced to grow to a functionally mature state by the administration of estrogenic substances without additional exogenous steroid synergists. Spontaneous lactation was not observed in these men, but it was induced by luteotrophin.

    The formation of milk in any amount by the breast is a criterion of functional maturity of the mammary epithelium. Luteotrophin induced the secretion of small amounts of milk in a group of women with mammary cancer and in a number of healthy women as well, and, in addition, in two human males to whom estrogenic substances had been administered for therapeutic purposes. Lactation did not occur in two normal males.

    When lactation was induced in human beings, the secretion often persisted for many months; it lasted for 7 years in one man.

    1. HUGGINS,C. Endocrine Substances in the Treatment of Cancers. J.A.M.A., 141:750–54, 1949.

    Miscellaneous

    There are historical claims of lactation in men and lactation has been reported in men with pituitary tumors and refeeding syndrome (Greenblatt, 1972; Greenblatt & Leng, 1972).

    Additional Literature

    • Brodribb, W., & Academy of Breastfeeding Medicine. (2018). ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting maternal milk production, second revision 2018. Breastfeeding Medicine, 13(5), 307–314. [DOI:10.1089/bfm.2018.29092.wjb]
    • MacDonald, T. K. (2019). Lactation care for transgender and non-binary patients: Empowering clients and avoiding aversives. Journal of Human Lactation, 35(2), 223–226. [DOI:10.1177/0890334419830989]
    • Paynter, M. J. (2019). Medication and Facilitation of Transgender Women’s Lactation. Journal of Human Lactation, 35(2), 239–243. [DOI:10.1177/0890334419829729]
    • Cazorla-Ortiz, G., Obregón-Guitérrez, N., Rozas-Garcia, M. R., & Goberna-Tricas, J. (2020). Methods and Success Factors of Induced Lactation: A Scoping Review. Journal of Human Lactation, 36(4), 739–749. [DOI:10.1177/0890334420950321]
    • Ferri, R. L., Rosen-Carole, C. B., Jackson, J., Carreno-Rijo, E., Greenberg, K. B., & Academy of Breastfeeding Medicine. (2020). ABM Clinical Protocol #33: Lactation Care for Lesbian, Gay, Bisexual, Transgender, Queer, Questioning, Plus Patients. Breastfeeding Medicine, 15(5), 284–293. [DOI:10.1089/bfm.2020.29152.rlf]
    • García-Acosta, J. M., Juan-Valdivia, S., María, R., Fernández-Martínez, A. D., Lorenzo-Rocha, N. D., & Castro-Peraza, M. E. (2020). Trans* Pregnancy and Lactation: A Literature Review from a Nursing Perspective. International Journal of Environmental Research and Public Health, 17(1), 44. [DOI:10.3390/ijerph17010044]
    • LeCain, M., Fraterrigo, G., & Drake, W. M. (2020). Induced Lactation in a Mother Through Surrogacy With Complete Androgen Insensitivity Syndrome (CAIS). Journal of Human Lactation, 36(4), 791–794. [DOI:10.1177/0890334419888752]
    • Trautner, E., McCool-Myers, M., & Joyner, A. B. (2020). Knowledge and practice of induction of lactation in trans women among professionals working in trans health. International Breastfeeding Journal, 15(1), 63. [DOI:10.1186/s13006-020-00308-6]

    References (Inline Citations)

    • Bazarra-Castro, M. A. (2009). Etiological aspects, therapy regimes, side effects and treatment satisfaction of transsexual patients. (Doctoral dissertation, Ludwig Maximilian University of Munich.) [DOI:10.5282/edoc.9984] [URN:urn:nbn:de:bvb:19-99840] [PDF]
    • Delgado, D., Stellwagen, L., McCune, S., Sejane, K., & Bode, L. (2023). Experience of Induced Lactation in a Transgender Woman: Analysis of Human Milk and a Suggested Protocol. Breastfeeding Medicine, 18(11), 888–893. [DOI:10.1089/bfm.2023.0197]
    • Futterweit, W. (1980). Endocrine management of transsexual. Hormonal profiles of serum prolactin, testosterone, and estradiol. New York State Journal of Medicine, 80(8), 1260–1264. [Google Scholar] [PubMed] [Archive.org] [PDF]
    • Gooren, L. J., Harmsen-Louman, W., & Kessel, H. (1985). Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction. Clinical Endocrinology, 22(2), 201–207. [DOI:10.1111/j.1365-2265.1985.tb01081.x]
    • Greenblatt, R. B. (1972). Inappropriate lactation in men and women. Medical Aspects of Human Sexuality, 6(6), 25–33. [Google Scholar] [Google Books]
    • Greenblatt, R. B., & Leng, J. J. (1972). Lactation anormale chez l’homme. [Abnormal lactation in males.] Bordeaux Medical, 5(3), 241–243. [Google Scholar] [PubMed]
    • Kanhai, R. C., Hage, J. J., van Diest, P. J., Bloemena, E., & Mulder, J. W. (2000). Short-Term and Long-Term Histologic Effects of Castration and Estrogen Treatment on Breast Tissue of 14 Male-to-Female Transsexuals in Comparison With Two Chemically Castrated Men. The American Journal of Surgical Pathology, 24(1), 74–80. [DOI:10.1097/00000478-200001000-00009]
    • Levy, A., Crown, A., & Reid, R. (2003). Endocrine intervention for transsexuals. Clinical Endocrinology, 59(4), 409–418. [DOI:10.1046/j.1365-2265.2003.01821.x]
    • Schlatterer, K., Yassouridis, A., Werder, K. V., Poland, D., Kemper, J., & Stalla, G. K. (1998). Archives of Sexual Behavior, 27(5), 475–492. [DOI:10.1023/a:1018704630036]
    • van Amesfoort, J. E., Van Mello, N. M., & van Genugten, R. (2024). Lactation induction in a transgender woman: case report and recommendations for clinical practice. International Breastfeeding Journal, 19(1), 18.[DOI:10.1186/s13006-024-00624-1]
    • Weimer, A. K. (2023). Lactation induction in a transgender woman: macronutrient analysis and patient perspectives. Journal of Human Lactation, 39(3), 488–494. [DOI:10.1177/08903344231170559]
    \ No newline at end of file +Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People - Transfeminine Science Link

    Published Case Reports of Lactation and/or Breastfeeding in Transfeminine People

    By Aly | First published March 26, 2019 | Last modified March 29, 2024

    Abstract / TL;DR

    A number of case reports of hormonally induced lactation and breastfeeding in transfeminine people have been published. The earliest report of lactation in a transfeminine person was in the 1950s and the earliest report of breastfeeding was in the 1980s. Starting in 2019, more case reports have been published in the modern scientific literature. Unpublished cases also exist (e.g., that of Dr. Christine McGinn), and lactation has been induced or occurred in cisgender men as well. Lactation may be induced in transfeminine people with the use estrogens, progestogens, and/or prolactin releasers. Reviews discussing lactation induction in transfeminine people have recently been published.

    Introduction

    Last year, a case report of lactation and breastfeeding in a transgender woman was published:

    • Reisman, T., & Goldstein, Z. (2018). Case report: Induced lactation in a transgender woman. Transgender Health, 3(1), 24–26. [DOI:10.1089/trgh.2017.0044]

    In the paper, the authors state the following:

    We believe that this is the first formal report in the medical literature of induced lactation in a transgender woman.

    However, this actually wasn’t the first case report of lactation and/or breastfeeding in a transfeminine person in the literature. There are various previous published cases dating back as far as the 1950s. These instances are provided below in the format of sources and excerpts.

    Published Case Reports

    Foss (1956)

    Foss, G. L. (1956). Abnormalities of form and function of the human breast. Journal of Endocrinology, 14(4 Suppl) [Proceedings of the Society for Endocrinology: Fifty-Fourth Meeting. Symposium on Selected Aspects of the Practice of Hormone Administration in Animals and Man], vi–vii. [Google Scholar] [Google Books] [URL] [PDF]:

    Based on the theories of lactogenesis and stimulated by the success of Lyons, Li, Johnson & Cole [1955], who succeeded in producing lactation in male rats, an attempt was made to initiate lactogenesis in a male transvestist. Six years ago this patient had been given oestrogens. Both testes and penis were then removed and an artificial vagina was constructed by plastic surgery. The patient was implanted with 500 mg oestradiol in September 1954, and 600 mg in July 1955. The breasts were then developed more intensively with daily injections of oestradiol dipropionate and progesterone for 6 weeks. Immediately following withdrawal of this treatment, prolactin 22·9 mg was injected daily for 3 days without effect. After a second month on oestradiol and progesterone daily, combined injections of prolactin and somatotrophin were given for 4 days and suction was applied by a breast pump—four times daily. On the 4th and 5th days a few drops of colostrum were expressed from the right nipple.

    Tindal & McNaught (1958)

    Tindal, J. S., & McNaught, M. L. (1958). Hormonal Factors in Breast Development and Milk Secretion. In Gardiner-Hill, H. (Ed.). Modern Trends in Endocrinology, Volume 1 (pp. 188–211) (Modern Trends). London: Butterworth. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org]:

    Recently, an attempt has been made by Foss (1956) to initiate lactation in a castrated male transvestist. He was given an implant of 500 milligrams of oestradiol, and 10 months later, a further 600 milligrams of oestradiol, followed by daily injections of oestradiol dipropionate and progesterone for 6 weeks. Immediately after withdrawal of this treatment, 22·9 milligrams of prolactin were injected daily for 3 days but without effect. After a second month of treatment with oestradiol and progesterone daily, he was given combined injections of prolactin and somatotrophin for 4 days, suction with a breast-pump being employed 4 times daily. On the fourth and fifth days a few drops of colostrum were expressed from the right nipple. There is a possible application here of modern hormone knowledge to man, and further trials would be of interest.

    Foss (1958)

    Foss, G. L. (1958). Disturbances of Lactation. Clinical Obstetrics and Gynecology, 1(1), 245–254. [Google Scholar] [PubMed] [DOI:10.1097/00003081-195803000-00021]:

    Experimentally I have been able to induce lactogenesis in a male transvestite whose testes had been removed some years before and whose breasts had been well developed over a long period with stilbestrol and ethisterone.9 In July, 1955, 600 mg. of estradiol was implanted subcutaneously and weekly injections of 50 mg. of progesterone were given for four months. For the next month daily injections of 10 mg. estradiol dipropionate and 50 mg. progesterone were given. These injections were continued for another month, increasing progesterone to 100 mg. daily. Both hormones were then withdrawn, and daily injections of increasing doses of prolactin and somatotropin were given for four days; at the same time, the patient used a breast pump four times daily for 5 minutes on both sides. During this time the mammary veins were visibly enlarged and on the sixth and seventh days 1 to 2 cc. of milky fluid was collected.

    Flückiger, Del Pozo, & von Werder (1982)

    Flückiger, E., Del Pozo, E., & von Werder, K. (1982). Prolactin: Synthesis, Fate and Actions. In Flückiger, E. W., Del Pozo, E., & von Werder, K. (Eds.). Prolactin: Physiology, Pharmacology, and Clinical Findings (Monographs on Endocrinology, Volume 23) (pp. 1–23). Berlin/Heidelberg: Springer-Verlag. [Google Scholar] [Google Books] [DOI:10.1007/978-3-642-81721-2_1]:

    An observation (Wyss and Del Pozo unpublished) in a male transsexual showed that induction of lactation can be similarly achieved in the human male.

    Flückiger, E., Del Pozo, E., & von Werder, K. (1982). Nontumoral hyperprolactinemia. In Flückiger, E. W., Del Pozo, E., & von Werder, K. (Eds.). Prolactin: Physiology, Pharmacology, and Clinical Findings (Monographs on Endocrinology, Volume 23) (pp. 102–152). Berlin/Heidelberg: Springer-Verlag. [Google Scholar] [Google Books] [DOI:10.1007/978-3-642-81721-2_4]:

    4.3.2 Effect of Hyperprolactinemia in Male Subjects

    Although PRL circulates in male blood in appreciable concentrations its physiologic role has not been clarified. The lack of lactational requirements does not preclude that under adequate priming the male mammary gland will respond to a PRL challenge with milk production. Thus, Wyss and del Pozo (unpublished data) found that PRL stimulation with TRH was able to induce milk secretion in a male individual pretreated with estrogens. Certainly, the chronic ingestion of dopamine antagonists or estrogens may lead to sustained hyperprolactinemia, and the same effect can be expected in male subjects on chronic estrogen therapy of prostatic cancer or transsexualism (Frantz 1973; del Pozo, to be published).

    Certainly, the prolonged intake of estrogens, in male subjects also, as observed in the treatment of prostatic carcinoma and in transsexuals, can lead to hyperprolactinemia (Frantz 1972b; del Pozo, to be published).

    Kozlov, Mel’nichenko, & Golubeva (1985)

    Kozlov, G. I., Mel’nichenko, G. A., & Golubeva, I. V. (1985). Случай лактореи у больного мужского пола с транссексуализмом. [Sluchai laktorei u bol’nogo muzhskogo pola s transseksualizmom. / Case of galactorrhea in a transsexual male patient.] Проблемы Эндокринологии [Problemy Èndokrinologii (Moskva) / Problems of Endocrinology (Moscow)], 31(1), 37–38. [ISSN:0375-9660] [Google Scholar 1] [Google Scholar 2] [PubMed] [DOI:10.14341/probl198531137-38] [PDF] [Translation] [Translated]:

    The appearance of galactorrhea in men is most often a symptom of pituitary prolactinoma. Combined with gynecomastia and atrophy of the testicles, galactorrhea caused by adenomas of the pituitary gland in men is known as O’Connell syndrome (1).

    In recent years, however, cases of galactorrhea have been described in men without radiological or clinical signs of pituitary adenoma (12). Of course, in these cases, the presence of undetected microadenomas of the pituitary gland cannot be excluded, especially since the level of prolactin in these patients is significantly increased (1, 2).

    Some medications, especially antipsychotics and estrogen-containing oral contraceptives (7, 10), increase serum levels of prolactin and can lead to the development of galactorrhea.

    There is information about the influence of psycho-emotional factors on the lactation process: the possibility of the development (induction) of psychogenic lactation during false pregnancy (3) is known, and, conversely, the possibility of the termination of lactation in nursing mothers after mental stress.

    Accumulated clinical observations on the frequent development of depressive states in persistent galactorrhea–amenorrhea syndrome (4), cases of galactorrhea in the mentally ill, even in the absence of neuroleptics (7), as well as experimental observations on the effect of hyperprolactinemia on the behavioral responses of animals (5), require careful study of the relationship of hyperprolactinemia and psycho-emotional factors. In connection with this, we present the following observation.

    The patient (P), was born a normal, full-term boy. He remembers well from 6 years. Early development was unremarkable, he did not differ from peers, but loved to play more with girls. He played with dolls and cars. At 10 years of age, there was a desire to wear women’s clothes. From the age of 12 he swam with girls in a shirt and shorts, as he was embarrassed by the lack of breasts. From the age of 14 he changed clothes in his mother’s dress, and only in such clothes “felt like a person”. From the same age in a woman’s dress he went to get acquainted with young men and got pleasure from it. At the age of 15, he came to the firm conviction that he was a girl, began to urinate like a girl, squatting, use lipstick, and put on powdered makeup. He suffered greatly from the presence of “deformities” – male genital organs. At the age of 17, while working as a “nurse” in a hospital, he began to self-inject himself with folliculin (estrogen) and progesterone, which caused the development of the breasts. With pleasure, he did women’s housework, and loved to tinker with children. Having received a passport, he redid it as female, thus resulting in a female civilian gender.

    Twice he tried to commit suicide (he took sleeping pills), since he could not bear the duality of his existence. Twice he was treated in psychiatric hospitals about transsexualism, unsuccessfully.

    During the examination in IEE and HCG at the age of 20 years, no abnormalities in somatic status were revealed: complex as a man, male genitals, shaved from 17 years of age daily. Erotic dreams were frequent, wherein he played the role of a woman, and denied emissions. The ejaculate was studied (obtained by vibratory massage): volume – 1.4 mL, pH 8.8 (norm 7.6–8.2), sperm count 31 million per 1 mL, mobility 57%, and morphologically normal 69%. Sex chromatin is negative.

    At age 22, a course of treatment with cyproterone acetate was conducted at the Institute of Psychiatry of the Ministry of Health of the USSR. Muscle weakness, reduction of sexual hairiness, and appearance of colostrum excretion was noted.

    When examined in IEE and HCG at 23 years, the breasts corresponded to the age of 15–16 years (on his own initiative he periodically took estrogens), and colostrum was secreted from the nipples (abundant drops when pressed – galactorrhea (++)). He insisted on castration and amputation of the penis, since, being a “woman”, he was ashamed of not having the appropriate genitals for his sex, which he called “deformities”.

    On X-ray of the skull, the shape and size of the sella turcica were normal, but signs of increased intracranial pressure were revealed. On EEG against the background of the general phenomena of irritation, the focus of pathology was recorded in the left parietal lead. Indicators of the functional state of the thyroid gland were in the normal range. In the study of the radioimmunoassay method using standard kits from the Sorin company, some increase in prolactin level of 24 ng/mL was detected in the serum (normal for men is 4–15 ng/mL).

    In connection with the repeated suicidal attempts, failure of psychiatric treatment, and in consideration of the fact that the patient has a female civilian sex and performs a female social role, castration and feminizing plastic surgery of the external genitalia were performed for the purpose of social rehabilitation.

    Some time after the operation, the patient developed a renewed interest in life. After the surgical and hormonal correction, the patient irresistibly developed maternal instincts. Unmarried, the patient obtained permission for the adoption of a child, simulated pregnancy, and was discharged from the maternity hospital with a son. From the first days after the “birth”, galactorrhea sharply increased, and spontaneous outflow of milk appeared, with galactorrhea (+++). The baby was breastfed up to 6 months of age.

    Thus, it can be thought that several factors played a role in the genesis of galactorrhea in this patient:

    1. Increased prolactin levels with estrogen and cyproterone acetate. The hyperprolactic properties of estrogens have long been known; the ability of cyproterone acetate to increase serum prolactin levels was shown by K. Schmidt–Golewizer et al (9).

    2. Increased intracranial pressure, the role of this factor and the genesis of neuroendocrine disorders and, in particular, in the development of galactorrhea was shown by R. Peterson (8).

    Our message is the second in the world literature describing galactorrhea in a male patient with transsexualism. The first description of this kind was made in 1983 by R. Flüskiger et al. (6).

    This observation demonstrates the independence of the mechanism of lactation development from one’s genetic sex and is alarming with regard to the possibility of drug-induced galactorrhea development in men.

    Barber et al. (2004)

    Barber, T., Basu, A., Rizvi, K., & Chapman, J. (2004). Normoprolactinaemic galactorrhoea in a male-to-female transsexual. Endocrine Abstracts, 7 [23rd Joint Meeting of the British Endocrine Societies with the European Federation of Endocrine Societies], 271–271. [Google Scholar] [URL]:

    Hormonal therapies in the form of oestrogens, anti-androgens and progestogens are often used in the treatment of male-to-female transsexuals. We present the case of a 36 year old phenotypic male with karyotype 46XY who presented with normoprolactinaemic galactorrhoea likely to be related to prior oestrogen administration. He had been self-administering oestrogen and progesterone preparations continuously for 7 years (aged 26 - 33 years) in an attempt to develop female phenotypic characteristics in spite of a heterosexual desire. During this time he developed gynaecomastia with galactorrhoea, increased energy and libido, voice change and an attraction towards both men and women. However due to lack of financial resources to secure a complete gender change, he stopped self-medication with these preparations 3 years ago. Instead he embarked on a regime involving self-administered testosterone in an attempt to reverse the biological changes. After discontinuation of oestrogen the gynaecomastia regressed somewhat, although galactorrhoea continued and worsened with testosterone. Prior to referral he had been treated with dopamine agonists with little improvement in galactorrhoea and gynaecomastia.

    Routine biochemistry and haematology are within their reference ranges. Baseline endocrinology is normal: Prolactin 197 milliUnits per litre, LH 2.9 Units per litre, FSH 7.9 Units per litre, free Testosterone 20 nanoMoles per litre, 17 beta-oestradiol less than 110 picoMoles per litre, TSH 0.96 milliUnits per litre and free T4 16.5 picoMoles per litre.

    This case illustrates fascinating effects of exogenous oestrogen in the male. The effects of oestrogenic products of aromatised endogenous and briefly also exogenous testosterone acting on oestrogen-primed breast tissue may account for, at least in part, his continuing symptom of normoprolactinaemic galactorrhoea. However two other features do not have any direct explanations: the development of osteopenia during this period, and complete disappearance of vascular migraine, a condition worsened with oestrogens in the female. He is now on Tamoxifen although an opportunity to use the aromatase inhibitor, Anastrozole still remains.

    Subsequent Case Reports

    Moravek & Pasque (2019)

    Moravek, M. B., & Pasque, K. B. (2019). Lactation Can Be Successfully Induced in Transgender Women While Maintaining Gender-Congruent Serum Hormone Levels. Reproductive Sciences, 26(Suppl 1), 136A–136A (abstract no. T-055). [Google Scholar] [DOI:10.1177/1933719119834079]:

    Introduction: Transgender women may be interested in breastfeeding their children, but there are no established protocols for lactation induction in this population. The only case report of a lactation induction protocol in a transgender woman significantly lowered her estradiol dose, which would likely result in decreased serum estradiol and increased testosterone levels, with resultant increase in gender dysphoria. Our objective was to induce lactation in a transgender woman without interrupting her gendercongruent hormone profile.

    Methods: A 34-year-old transgender woman with a 15-year history of gender-affirming hormone therapy with estradiol and spironolactone presented for lactation induction once her cisgender wife conceived. A modification of the Newman-Goldfarb method for adoptive mothers was used to induce lactation, and serum hormone levels followed.

    Results: Baseline labs were obtained (time point 1), then medroxyprogesterone 1.25mg daily was added to her existing hormone regimen of estradiol 6mg daily and spironolactone 100mg twice daily (time point 2). Domperidone 10mg four times daily was initiated 1 month later. Approximately 5 weeks prior to the due date, the patient stopped medroxyprogesterone, decreased estradiol to 2mg daily, and began breast pumping (time point 3). Just prior to the infant’s birth, the patient was pumping 2-3 ounces of breastmilk every 3 hours (time point 4). Spironolactone was decreased to 50mg twice daily. Her son was born at term, via uncomplicated vaginal delivery. The infant was able to breastfeed from both mothers without difficulty, with both mothers pumping when they weren’t actively breastfeeding to maintain supply (time point 5). When the infant was approximately 2 months old, the patient noticed an increase in facial hair growth. Estradiol was increased to 3mg daily and spironolactone increased to 100mg twice daily, with resolution of hair growth and no decrease in milk supply (time point 6). The patient continued to breastfeed on this regimen for >6 months following her son’s birth. Serum hormone levels on the hormone regimens referenced at each time point throughout the patient’s course are displayed in table 1.

    Conclusion: Lactation can be successfully induced in transgender women, without a significant decrease in estradiol supplementation. This regimen allows transgender women to breastfeed without developing male secondary sex characteristics incongruent with their gender identity

    Table 1 Hormone profile at different time points.

    Time PointEstradiol (pg/mL)Progesterone (ng/mL)Testosterone (ng/mL)Prolactin (ng/mL)
    11141.10.36 
    21301.10.059
    3301.30.06152
    439   
    5291.40.89184
    651 0.1659

    Unnithan, Elson, & Shenker (2020)

    Unnithan, R., Elson, D. F., & Shenker, Y. (2020). Galactorrhea and Hyperprolactinemia in a Transgender Female. Journal of the Endocrine Society, 4(Suppl 1), A899–A899 (abstract no. SUN-043). [Google Scholar] [PubMed Central] [DOI:10.1210/jendso/bvaa046.1781] [PDF]:

    Background: Galactorrhea is a rare manifestation of hyper-prolactinemia in males and post-menopausal females, however the hormonal milieu of the transgender female may increase its incidence

    Clinical Case: A 43 year old transgender female presented with three years of bilateral breast discharge. She had chronic, stable headaches and fatigue, but no vision changes or other symptoms. Notably, she had breast augmentation surgery with saline breast implants placed shortly before the galactorrhea commenced. She was on a stable dose of estradiol tablets 1 mg twice daily for six years. On physical exam she had pronounced bilateral breast discharge of a milky quality with nipple compression. Prolactin levels were checked several times and were 40-50 ng/mL, TSH was 2.36 uIU/mL. An MRI showed a left inferior pituitary lesion measuring 6 mm x 3 mm x 5 mm with no mass effect on adjacent structures. Her breast discharge was not bothersome to her, and her pituitary lesion was small. It was unclear whether there was a relationship between her prolactin levels and the lesion seen on MRI, as we expected more pronounced prolactin elevation with a prolactinoma. Instead, given the timing of her symptoms in relation to her breast augmentation surgery, her galactorrhea and hyper-prolactinemia were thought to be the result of nipple irritation related to her breast implants combined with a hyper-estrogenemic state.

    Clinical Lessons: In the setting of a prolactin secreting micro-adenoma, galactorrhea in a male is highly unusual. This case highlights the importance of recognizing that the unique medical and surgical characteristics of male to female transgender patients can lead to hyper-prolactinemia and galactorrhea.

    Reference: Reisman T, Goldstein Z. Case report: induced lactation in a transgender woman. Transgender Health. 2018;3(1):24-26.

    Wamboldt, Shuster, & Sidhu (2021)

    Wamboldt, R., Shuster, S., & Sidhu, B. S. (2021). Lactation Induction in a Transgender Woman Wanting to Breastfeed: Case Report. The Journal of Clinical Endocrinology & Metabolism, 106(5), e2047–e2052. [DOI:10.1210/clinem/dgaa976]:

    Context: Breastfeeding is known to have many health and wellness benefits to the mother and infant; however, breastfeeding in trans women has been greatly under-researched.

    Objective: To review potential methods of lactation induction in trans women wishing to breastfeed and to review the embryological basis for breastfeeding in trans women.

    Design: This article summarizes a case of successful lactation in a trans woman, in which milk production was achieved in just over 1 month.

    Setting: This patient was followed in an outpatient endocrinology clinic.

    Participant: A single trans woman was followed in our endocrinology clinic for a period of 9 months while she took hormone therapy to help with lactation.

    Interventions: Readily available lactation induction protocols for nonpuerpural mothers were reviewed and used to guide hormone therapy selection. Daily dose of progesterone was increased from 100 mg to 200 mg daily. The galactogogue domperidone was started at 10 mg 3 times daily and titrated up to effect. She was encouraged to use an electric pump and to increase her frequency of pumping.

    Main outcome measure: Lactation induction.

    Results: At one month, she had noticed a significant increase in her breast size and fullness. Her milk supply had increased rapidly, and she was producing up to 3 to 5 ounces of milk per day with manual expression alone.

    Conclusions: We report the second case in the medical literature to demonstrate successful breastfeeding in a trans woman through use of hormonal augmentation.

    Further Case Reports

    • Delgado, D., Stellwagen, L., McCune, S., Sejane, K., & Bode, L. (2023). Experience of Induced Lactation in a Transgender Woman: Analysis of Human Milk and a Suggested Protocol. Breastfeeding Medicine, 18(11), 888–893. [DOI:10.1089/bfm.2023.0197]
    • Weimer, A. K. (2023). Lactation induction in a transgender woman: macronutrient analysis and patient perspectives. Journal of Human Lactation, 39(3), 488–494. [DOI:10.1177/08903344231170559]
    • van Amesfoort, J. E., Van Mello, N. M., & van Genugten, R. (2024). Lactation induction in a transgender woman: case report and recommendations for clinical practice. International Breastfeeding Journal, 19(1), 18. [DOI:10.1186/s13006-024-00624-1]
    • Trahair, E. D., Kokosa, S., Weinhold, A., Parnell, H., Dotson, A. B., & Kelley, C. E. (2024). Novel Lactation Induction Protocol for a Transgender Woman Wishing to Breastfeed: A Case Report. Breastfeeding Medicine, online ahead of print. [DOI:10.1089/bfm.2024.0012]

    Dr. Christine McGinn

    Dr. Christine McGinn is a transgender woman and well-known surgeon in Pennsylvania who performs gender-affirming surgeries for transgender people. When she had children with her cisgender female partner, McGinn induced a hormonal pseudopregnancy in herself and her and her partner breastfed their twins together. This was described in the media, including in books and television. McGinn’s case was never formally published as a case report in the scientific literature however.

    The Oprah Winfrey Show (2010)

    Terry, J. C. (Director), & Winfrey, O. G. (Presenter). (2010 September 29). The Mom Who “Fathered” Her Own Children, Plus the Cast of Modern Family [Television series episode]. The Oprah Winfrey Show (Season 25, Episode 13). Chicago: Harpo Studios. [URL 1] [URL 2] [URL 3]

    Trans (2012)

    Arnold, C. (Director), Schoen, M. (Producer), RoseWorks (Firm), & Sex Smart Films (Firm). (2012). Trans [DVD] (1:21:32–1:21:55). [WorldCat] [IMDB] [Amazon Prime Video]

    Boylan (2014)

    Boylan, J. F. (2014). Dr. Christine McGinn. In Boylan, J. F. Stuck in the Middle with You: A Memoir of Parenting in Three Genders (pp. 223–233). New York: Broadway Books. [Google Scholar] [Google Books 1] [Google Books 2] [WorldCat] [PDF]:

    Dr. Christine McGinn is a surgeon, a mother of two, a backup flight surgeon for the space shuttle progarm, and a transgender woman. As a man, she saved her sperm before transition; ten years later she used that sperm to have children with her partner Lisa. The two of them are both biological mothers of their son and daughter, and each mother was able to breast-feed the twins. I sat down with Christine at her office in New Hope, Pennsylvania, on a hot summer day in 2011.

    CM: […] Then there’s the scientist in me that knows that there is a difference, there is not a binary, but a gender spectrum. There are chemicals that are different in men and women. And when a transgender woman transitions, we are somewhere in the middle. Especialy having gone through a simulated pregnancy, in order to breast-feed, I felt the changes of those hormones. I felt my milk let down when not only my baby would cry, but a baby on TV would cry, and even, ridiculously, when a door would close and make a squeak.

    JFB: You had to induce a false pregnancy in order to breast-feed? Tell me how you did that.

    CM: As a doctor, I knew it was possible. I followed the protocol that involves simulating pregnancy with hormones. It’s estrogen and progesterone. My simulation pregnancy was over a month before Lisa delivered—with twins, we were expecting them to be born earlier. That entire month I was just pumping nonstop, every two hours. We had a whole freezer full of milk. And you know, the first couple of weeks it was no good, because it had all of the hormones in it. So we only saved, like, the last week or so. But still, it was a freezer full of milk.

    Lisa had no idea about the way breast-feeding takes over your life, because this was her first. It was kind of funny that I went through that on my own, first, weeks before she did. And then it took her a couple of days to actually—for her milk to let down.

    The children were so small when they were born. They were only five pounds. At first we had to feed them with a syringe. They were breast-feeding as well, but they weren’t latching that great on either of us.

    JFB: What was it like when they finally muckled on to you?

    CM: Oh, I can’t even put it in words. I really cannot put it in words. It was—I was just—oh.

    JFB: Were you amazed? Were you afraid?

    CM: It was heaven. I was afraid. I don’t know, it was uncharted territory. Like, I knew the milk was good. Lisa was a little concerned that it would be like skimmed milk, or something, you know. [Laughs] Like—she’s like, “Is it the same stuff?”

    JFB: Is it the same milk?

    CM: And she was a little dubious about, like, is this really all right? I think that’s totally natural for a mother, to be concerned.

    I will just say that there are things snobody thinks about when two women are both breast-feeding. Like, technical stuff that you don’t think about. When you have a mother and a father, the mother decides when the kids get fed. Right? The father doesn’t, really. Right?

    But you know, when you have two women who are filled with pregnancy hormones and have that, like, mother-bear attitude about how things should be done… It was really crazy.

    JFB: So did that cause serious conflict between you and Lisa?

    CM: Totally not serious conflict, because the most important thing are the babies.

    Eden finally latched—I breast-fed her more than Luke. Luke was never really good. Lisa hated breast-feeding. Eventually we decided to stop.

    I’m putting on my science hat again—when you decide to stop, there are hormonal issues. The strongest emotion a person can feel in their life comes frm oxytocin, which is the love drug.

    JFB: Oxytocin?

    CM: That’s what’s responsible for babies’ bonding during breastfeeding. So the baby latches on, breast-feeds, your brain just [makes oozing sounds], just like, oozes this gooey love substance, oxytocin. Fathers are proven to have higher oxytocin before the delivery, and just stroking your child’s head. You know, when the baby—when you smell a newborn’s head, it really—that smell, it’s like—

    JFB: I just saw a friend’s newborn on Friday, and I was like, [makes sniffing sound]—

    CM: My niece said it best. She came in and smell them, and she was five years old at the time, and she’s like, “They smell like cupcakes.” [Laughs] And it’s universal. When you ask me what that’s like, I can’t describe it, you know, and I’m a huge fan of food and cupcakes and chocolate, and so that’s the closest I can come to it—it’s like chocolate. [Laughs]

    JFB: So when you stopped breast-feeding, was it a kind of a mourning, a loss?

    CM: Yes. Lisa wanted to stop before I did. The problem is, once a baby gets a nipple, a plastic nipple, it gives more milk. And so they don’t have to work as hard.

    It’s a unique situation that two breast-feeders in a relationship would experience, but a mother and father would not.

    JFB: So did one of you stop breast-feeding before the other?

    CM: Yes, Lisa did.

    JFB: Lisa stopped. And how much longer did you keep it up?

    CM: Not long, because they got the nipple.

    They were both so small. We weren’t all that successful at it. We were so worried about their birth weight, and making sure they got enough with the syringes. There were definitely times where, you know, we both would breast-feed and, man, I will never forget that. Like, three ‘clock in the morning, four o’clock in the morning, in the little cocoon, nursing.

    The heat of their body, their naked body on your chest. The amazing thing is, it really does kind of hurt when they really get going, you know. And you just… I don’t know how else to describe it. You feel like the life force is just coming out through you. It’s so powerful. It relieves that pain that you have in your breast. It releases that oxytocin, and it’s just—it’s even.

    JFB: Did you ever do that thing where you would fall asleep with the children in the bed, and wake up with the children in the bed beside you?

    CM: Yeah.

    JFB: I loved that. It’s one of my stnogest memories of being a father. Having gotten up in the middle of the night. And they are so small, but such an incredibly powerful feeling, the two of you together surrounding the child. With us, we also had a dog at the bottom of the bed. [Laughs]

    CM: And we have two, and that was also very important to me, too. We have miniature pinschers.

    JFB: So how many months along did you stop breast-feeding?

    CM: Three months. It was really emotionally painful, and I cried a lot. I was really sad.

    I was pretty sure we were not going to have any more kids. So I’m like, “This is it.” It was very sad.

    JFB: Is there a moment frm the last year and two months where you think, This is what it’s like to be a mother, this is it?

    CM: Yes, immediately. It was hot as Hades outside. It was, like, a million degrees. We had just had the kids. It was like, May or June, and my mom was over, and it was, like, we had all this help, initially, because Lisa and I were just not getting any sleep and it was, like, round-the-clock feedings and the kids were small, and Lucas had an apnea monitor that he had to wear all the time, and it was just really hard. And there was a big thunderstorm, and the power went out.

    And so, at this point, they weren’t really latching very well, so we both had to pump, and then feed them with the syringes. So Lisa and I are totally, like, engorged with milk. And the power’s out, and the pumps are electric. Right?

    JFB: Right.

    CM: So there’s no electricity, it’s hot as hell, we’re worried for the kids. Lisa and I are in pain. We’re both leaking. And it was the weirdest, funniest situation. And my mom’s there. She runs out to the store to get batteries, and you know, she’s just beng a mom. She’s getting everything, running around like an angel. And Lisa and I are in pain we’re miserable. When she finally came back, the batteries wouldn’t work on the pumps—something else was wrong. Lisa and I are dying.

    And so, here’s the guy part of me… I get the pump that has the backup battery power and the backup car charger. Like, I got all tech on it. [Laughs] I’m out int he car trying to get the car charger to work on the pump in the pouring rain. And it’s ninety-five degrees out. It’s all wet inside, like, the humidity on the windows.

    And I’m just trying to get some kind of relief.

    And this stupid pump didn’t work that way, either. We come back in and my mom has candles lit.

    And then the electricity comes back on. And we all just laugh and pump and breast-feed. And every one of us is in heaven.

    Pfeffer (2017)

    Pfeffer, C. A. (2017). Trans Partnerships and Families: Historical Traces and Contemporary Representations. In Pfeffer, C. A. Queering Families: The Postmodern Partnerships of Cisgender Women and Transgender Men (pp. 1–34). New York: Oxford University Press. [Google Scholar] [Google Books] [WorldCat] [DOI:10.1093/acprof:oso/9780199908059.003.0001]:

    Just 2 years later, Winfrey would feature another interview that elicited many of the same audience reactions. In this 2010 episode, lesbian partners Dr. Christine McGinn and Lisa Bortz beamed with joy as they held their infant twins. Again, audience members’ jaws dropped when it was revealed that beautiful Christine was a male-to-female transsexual who used to be a handsome military officer Chris, and that Lisa had given birth to the couple’s biological children using sperm Chris banked prior to gender confirmation surgeries.10 And it was Winfrey’s chin that nearly hit the floor as she watched video of Christine breastfeeding the couples’ children (the episode is referred to online as “The Mom Who Fathered Her Own Children”).

    Other Instances

    Published

    Estrogen plus cyproterone acetate has been reported to produce pregnancy-like breast changes—specifically, lobuloalveolar development of the breasts—in transfeminine people (Kanhai et al., 2000). Accordingly, galactorrhea (spontaneous or excessive lactation) has been reported as a low-incidence side effect (7–14%) of hormone therapy regimens containing estrogen plus cyproterone acetate in transfeminine people (Gooren, Harmsen-Louman, & van Kessel, 1985; Schlatterer et al., 1998; Bazarra-Castro, 2009). It has also been reported at low incidence (6%) for other hormone therapy regimens (Futterweit, 1980). Sudden cessation of hormone therapy regimens including cyproterone acetate has been reported to result in the onset of lactation as well (Levy, Crown, & Reid, 2003).

    Unpublished

    Many unpublished reports of lactation and breastfeeding in transfeminine people have been described on the web including at the following pages:

    • Richards, A. (2003). Lactation and the Transsexual Woman. Second Type Woman. [Updated August 2018] [URL] [PDF]
    • MacDonald, T. (2013). Trans Women and Breastfeeding: A Personal Interview. Milk Junkies. [URL]
    • MacDonald, T. (2013). Trans Women and Breastfeeding: The Health Care Provider. Milk Junkies. [URL]
    • MacDonald, T. (2017). Jenna’s Breastfeeding Journey: Trans Motherhood. Milk Junkies. [URL]
    • Burns, K. (2018). Yes, Trans Women Can Breastfeed — Here’s How. them. [URL]

    Cisgender Men

    Induction of lactation has been reported in cisgender men and is noteworthy:

    Geschickter (1945)

    Geschickter, C. F. (1945). Endocrine Physiology of the Breast. In Geschickter, C. F. Diseases of the Breast: Diagnosis, Pathology, Treatment, 2nd Edition (pp. 42–81). Philadelphia: J.B. Lippincott. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [PDF]:

    The results obtained indicate that a lactogenic substance in anterior pituitary extracts may cause mammary secretion in nonpregnant women when they have been previously stimulated with estrogenic hormone but true lactation does not occur. Secretion was also obtained in two adult men with gynecomastia after injections of lactogenic hormone.

    Huggins (1949)

    Huggins, C. (1949). Endocrine substances in the treatment of cancers. Journal of the American Medical Association, 141(11), 750–754. [DOI:10.1001/jama.1949.02910110002002]:

    The administration of estrogen in effective amounts causes testicular atrophy and mammary hypertrophy. Growth of the breasts can be so extensive that lactation may be induced, as illustrated in the following case.

    W. N., aged 64, had carcinoma of the prostate with osseous metastases, for which he was treated by a permanent suprapubic cystotomy in 1941. Diethylstilbestrol, 20 mg. daily, was given orally for two years beginning September 1942. In September 1944, 25 mg. (500 international units) of prolactin14 was injected daily for five days, and at the end of this time creamy milk could be expressed from both breasts. Orchiectomy and removal of the cystostomy tube were carried out September 6, when administration of estrogen was discontinued; both incisions healed promptly. Since then the patient has been clinically well but has continued to lactate, a large drop of milk being easily expressed from each breast at frequent intervals.

    Huggins & Dao (1954)

    Huggins, C., & Dao, T. L. (1954). Lactation induced by luteotrophin in women with mammary cancer. Growth of the breast of the human male following estrogenic treatment. Cancer Research, 14(4), 303–306. [Google Scholar] [PubMed] [URL]:

    In the observations to be presented luteotrophin [prolactin] was employed as a stimulus for mammary secretion in patients with cancer of the breast, and the results throw new light on the physiology of women bearing this neoplasm. We shall also describe conditions which resulted in the induction of physiologic maturity in the human male, since knowledge of the action of hormones on the human breast is vague.

    The effects of luteotrophin on the breast of women post partum has been extensively investigated, but otherwise few observations have been made in the human. Werner (14) administered a crude pituitary extract containing luteotrophin to eight castrate women 21–35 years of age; lactation was not observed, although in one woman “a few drops of colostrum-like fluid” could be expressed from the breasts. Goldzieher (4) treated menstrual disorders in women with luteotrophin, but mammary secretion was not described by him.

    PROCEDURE

    Luteotrophin,1 dissolved in physiological saline made slight ly alkaline (pH 9) with sodium hydroxide, was injected subcutaneously in daily amounts of 500 International Units; the solutions were freshly prepared, and the injections were continued for 7 days only.

    This series comprised 21 female patients who had dis seminated mammary cancer, and all had been subjected to unilateral mastectomy. There were also three men with advanced prostatic carcinoma who had been treated for thera peutic purposes with oral diethylstilbestrol for 20 months, 2, and 6 years, respectively. There were eight persons without mammary or prostatic cancers who served as controls.

    In each case of mammary cancer a biopsy of the breast was obtained for histological purposes, the material being stained with Sudan III.3

    OBSERVATIONS

    Lactation, when it occurred, was never profuse; it varied from a tiny drop to ca. 0.5 cc. from each breast. Clear colostrum was not observed, and the mammary secretion was always milk, as defined above.

    Mammary growth in the human male.—Estrogenic substances had been administered to three men in the treatment of disseminated prostate cancer for many months; after luteotrophin injection two lactated and one did not lactate.

    W. N. (reported in brief earlier [5]), age 64, had taken diethylstilbestrol, 20 mg/day, orally for 2 years, after which interval sub-areolar button-like masses of mammary tissue could be palpated bilaterally; luteotrophin was then injected for 5 days, and milk was expressed from the breast on the 6th day. Orchiectomy was then performed, and both luteotrophin and estrogenic substances were discontinued. This man continued to lactate for 7 years when the formation of milk gradually ceased.

    In the case of A. W., age 62, diethylstilbestrol (5–15 mg/day) had been ingested for 20 months after bilateral orchiectomy; the breasts became slightly enlarged. Luteotrophin was injected, and lactation occurred on the 7th day. A biopsy of the breast showed moderately well developed mammary ducts and alveoli containing milk. In the case of E. G., age 59, diethylstilbestrol (5 mg/day) was ingested almost continuously for 6 years; this resulted in the development of large pendulous breasts, but no lactation occurred after injections of luteotrophin.

    Lactation in humans without cancer.—Luteotrophin was administered to two normal males, age 51 and 59, and to four normal females, age 84–59, and none lactated.

    DISCUSSION

    It must be emphasized that lactation was not copious in any of the humans when it had been induced by luteotrophin; merely small amounts of milk were obtained. It was apparent, however, from the histological studies of the mammary tissue obtained by biopsy that the secretion of milk in any quantity was a criterion of maturity of mammary epithelium.

    In the goat and guinea pig it is known that estrogenic substances can induce mammary ma turity without the intervention of exogenous synergistic steroids. In the experiments of Lewis and Turner (9) diethylstilbestrol was implanted in two castrate male goats; one of these animals failed to lactate, while the other produced a small quantity of milk without luteotrophin injections. They obtained small amounts of milk from a male kid similarly treated. Nelson (10) found that estrone induced mammary growth with, later, lactation in the male guinea pig. Our observations demonstrate that diethylstilbestrol ingested for prolonged periods of time can induce maturity of the breast in certain elderly human males. However, the human male differs from the animals just described in that spontaneous lactation was not observed; the injection of luteotrophin was necessary for milk formation.

    The duration of lactation induced by luteo trophin was impressive, since milk commonly persisted for many months—and in one male for 7 years. The mechanism whereby this type of lactation is maintained for such long periods of time is at present unknown; we know that milk continues to be secreted both in the presence of the adrenal glands and in the absence of these structures and the gonads as well. Observations (8) have been made on experimental animals which are analogous to the clinical findings; most dogs with spontaneous mammary cancer possess lactation, and this characteristic persists for many months, at least, despite the removal of the adrenal glands and the ovaries.

    SUMMARY

    The breast of the human male can be induced to grow to a functionally mature state by the administration of estrogenic substances without additional exogenous steroid synergists. Spontaneous lactation was not observed in these men, but it was induced by luteotrophin.

    The formation of milk in any amount by the breast is a criterion of functional maturity of the mammary epithelium. Luteotrophin induced the secretion of small amounts of milk in a group of women with mammary cancer and in a number of healthy women as well, and, in addition, in two human males to whom estrogenic substances had been administered for therapeutic purposes. Lactation did not occur in two normal males.

    When lactation was induced in human beings, the secretion often persisted for many months; it lasted for 7 years in one man.

    1. HUGGINS,C. Endocrine Substances in the Treatment of Cancers. J.A.M.A., 141:750–54, 1949.

    Miscellaneous

    There are historical claims of lactation in men and lactation has been reported in men with pituitary tumors and refeeding syndrome (Greenblatt, 1972; Greenblatt & Leng, 1972).

    Additional Literature

    • Brodribb, W., & Academy of Breastfeeding Medicine. (2018). ABM Clinical Protocol #9: Use of galactogogues in initiating or augmenting maternal milk production, second revision 2018. Breastfeeding Medicine, 13(5), 307–314. [DOI:10.1089/bfm.2018.29092.wjb]
    • MacDonald, T. K. (2019). Lactation care for transgender and non-binary patients: Empowering clients and avoiding aversives. Journal of Human Lactation, 35(2), 223–226. [DOI:10.1177/0890334419830989]
    • Paynter, M. J. (2019). Medication and Facilitation of Transgender Women’s Lactation. Journal of Human Lactation, 35(2), 239–243. [DOI:10.1177/0890334419829729]
    • Cazorla-Ortiz, G., Obregón-Guitérrez, N., Rozas-Garcia, M. R., & Goberna-Tricas, J. (2020). Methods and Success Factors of Induced Lactation: A Scoping Review. Journal of Human Lactation, 36(4), 739–749. [DOI:10.1177/0890334420950321]
    • Ferri, R. L., Rosen-Carole, C. B., Jackson, J., Carreno-Rijo, E., Greenberg, K. B., & Academy of Breastfeeding Medicine. (2020). ABM Clinical Protocol #33: Lactation Care for Lesbian, Gay, Bisexual, Transgender, Queer, Questioning, Plus Patients. Breastfeeding Medicine, 15(5), 284–293. [DOI:10.1089/bfm.2020.29152.rlf]
    • García-Acosta, J. M., Juan-Valdivia, S., María, R., Fernández-Martínez, A. D., Lorenzo-Rocha, N. D., & Castro-Peraza, M. E. (2020). Trans* Pregnancy and Lactation: A Literature Review from a Nursing Perspective. International Journal of Environmental Research and Public Health, 17(1), 44. [DOI:10.3390/ijerph17010044]
    • LeCain, M., Fraterrigo, G., & Drake, W. M. (2020). Induced Lactation in a Mother Through Surrogacy With Complete Androgen Insensitivity Syndrome (CAIS). Journal of Human Lactation, 36(4), 791–794. [DOI:10.1177/0890334419888752]
    • Trautner, E., McCool-Myers, M., & Joyner, A. B. (2020). Knowledge and practice of induction of lactation in trans women among professionals working in trans health. International Breastfeeding Journal, 15(1), 63. [DOI:10.1186/s13006-020-00308-6]

    References (Inline Citations)

    • Bazarra-Castro, M. A. (2009). Etiological aspects, therapy regimes, side effects and treatment satisfaction of transsexual patients. (Doctoral dissertation, Ludwig Maximilian University of Munich.) [DOI:10.5282/edoc.9984] [URN:urn:nbn:de:bvb:19-99840] [PDF]
    • Delgado, D., Stellwagen, L., McCune, S., Sejane, K., & Bode, L. (2023). Experience of Induced Lactation in a Transgender Woman: Analysis of Human Milk and a Suggested Protocol. Breastfeeding Medicine, 18(11), 888–893. [DOI:10.1089/bfm.2023.0197]
    • Futterweit, W. (1980). Endocrine management of transsexual. Hormonal profiles of serum prolactin, testosterone, and estradiol. New York State Journal of Medicine, 80(8), 1260–1264. [Google Scholar] [PubMed] [Archive.org] [PDF]
    • Gooren, L. J., Harmsen-Louman, W., & Kessel, H. (1985). Follow-up of prolactin levels in long-term oestrogen-treated male-to-female transsexuals with regard to prolactinoma induction. Clinical Endocrinology, 22(2), 201–207. [DOI:10.1111/j.1365-2265.1985.tb01081.x]
    • Greenblatt, R. B. (1972). Inappropriate lactation in men and women. Medical Aspects of Human Sexuality, 6(6), 25–33. [Google Scholar] [Google Books]
    • Greenblatt, R. B., & Leng, J. J. (1972). Lactation anormale chez l’homme. [Abnormal lactation in males.] Bordeaux Medical, 5(3), 241–243. [Google Scholar] [PubMed]
    • Kanhai, R. C., Hage, J. J., van Diest, P. J., Bloemena, E., & Mulder, J. W. (2000). Short-Term and Long-Term Histologic Effects of Castration and Estrogen Treatment on Breast Tissue of 14 Male-to-Female Transsexuals in Comparison With Two Chemically Castrated Men. The American Journal of Surgical Pathology, 24(1), 74–80. [DOI:10.1097/00000478-200001000-00009]
    • Levy, A., Crown, A., & Reid, R. (2003). Endocrine intervention for transsexuals. Clinical Endocrinology, 59(4), 409–418. [DOI:10.1046/j.1365-2265.2003.01821.x]
    • Schlatterer, K., Yassouridis, A., Werder, K. V., Poland, D., Kemper, J., & Stalla, G. K. (1998). Archives of Sexual Behavior, 27(5), 475–492. [DOI:10.1023/a:1018704630036]
    • Trahair, E. D., Kokosa, S., Weinhold, A., Parnell, H., Dotson, A. B., & Kelley, C. E. (2024). Novel Lactation Induction Protocol for a Transgender Woman Wishing to Breastfeed: A Case Report. Breastfeeding Medicine, online ahead of print. [DOI:10.1089/bfm.2024.0012]
    • van Amesfoort, J. E., Van Mello, N. M., & van Genugten, R. (2024). Lactation induction in a transgender woman: case report and recommendations for clinical practice. International Breastfeeding Journal, 19(1), 18.[DOI:10.1186/s13006-024-00624-1]
    • Weimer, A. K. (2023). Lactation induction in a transgender woman: macronutrient analysis and patient perspectives. Journal of Human Lactation, 39(3), 488–494. [DOI:10.1177/08903344231170559]
    \ No newline at end of file diff --git a/transfemscience.org/articles/vte-transfem-analysis/index.html b/transfemscience.org/articles/vte-transfem-analysis/index.html index a74adefa..7f0c86bd 100644 --- a/transfemscience.org/articles/vte-transfem-analysis/index.html +++ b/transfemscience.org/articles/vte-transfem-analysis/index.html @@ -1 +1 @@ -Analysis of Studies Assessing the Risk of Thromboembolism with Transfeminine Hormone Therapy - Transfeminine Science Link

    Analysis of Studies Assessing the Risk of Thromboembolism with Transfeminine Hormone Therapy

    By Sam | First published May 19, 2020 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on Reddit and has not yet been properly or fully revised since being moved to Transfeminine Science.

    Abstract / TL;DR

    See the Summary of Evidence section at the end of the article.

    Background

    Venous thromboembolism (VTE) is the umbrella term that includes deep vein thrombosis (DVT) and pulmonary embolism (PE) (Tritschler et al., 2018). A thrombosis is a blood clot that forms in a vein; usually within the leg, whereas an embolism is a thrombosis that has broken off from the original site and blocked the flow of blood inside a blood vessel. VTE can cause permanent damage to organs such as the lungs or even lead to death (The Lancet Haematology, 2015). Thankfully, the incidence of thromboembolism is relatively low in the general population. However, age is an important independent risk factor for VTE (Silverstein et al., 1998). Men and women under the age of 50 have less than a 100 cases per 100,000 people per year incidence of VTE. But thereafter, risk increases rapidly with age. By the age of 80, men have an incidence of approximately 1,000 cases per 100,000 people per year.

    Thromboembolism is of significance to the field of gender-affirming hormone therapy (GAHT) as estrogens and some progestogens are associated with an increased incidence of VTE. A 2018 meta-analysis of clinical trials, case-control and cohort studies of menopausal hormone therapy (MHT) found that oral but not non-oral estradiol at low doses is associated with mildly greater risk of VTE (Rovinski et al., 2018). This finding has been attributed to the disproportionate amount of liver exposure that occurs with the oral route of administration (Kuhl, 2005). However, the doses of estrogens used in MHT are usually much lower than those used in GAHT. Moreover, high doses of progestins, such as cyproterone acetate, are commonly used in clinical practice to suppress testosterone levels to the female range. As such, the incidence of VTE that occurs with estrogen therapy in GAHT is, overall, likely to be greater than that observed in studies of postmenopausal women.

    Analysis

    Previously, I investigated thromboembolic and cardiovascular toxicity with high dose parenteral estrogen therapy in the treatment of prostate cancer (Sam, 2020). I thought it would be interesting to perform an investigation into the risk of these side effects in transgender women. Additionally, I wanted to see if any association could be found between different types of regimens.

    Many studies have quantified the risk of VTE in transfeminine people with gender-affirming hormone therapy (Asscheman, Gooren & Eklund, 1989; van Kesteren et al., 1997; Dittrich et al., 2005; De Cuypere et al., 2005; Ott et al., 2010; Mueller et al., 2011; Seal et al., 2012; Wierckx et al., 2013; Wierckx et al., 2014; Gava et al., 2016; Arnold et al., 2016; Getahun et al., 2018; Nota et al., 2019). Unfortunately, a recurring problem in many of these studies is the extremely low number of patient follow-up years. Because studies with small numbers of follow-up years may significantly underestimate or overestimate the prevalence of adverse effects, they have poor statistical precision. Therefore, it makes it difficult to draw conclusions from their findings. In my own analysis, I excluded any study that had fewer than 1,000 patient follow-up years. Consequently, there were seven studies available for analyses.

    Of the seven remaining studies, all but one were retrospective. In four studies, cyproterone acetate was used in all or most patients, while other antiandrogens were used in most or all of the patients in the other three studies. In the first three studies, most or all of the patient follow-up was for therapy with non-bioidentical estrogens. Bioidentical estrogens were used in the latter four studies. For each study, I calculated the crude incidence rate. Using data from a 25-year population study (Silverstein et al., 1998), I was then able to calculate the incidence rate ratio (IRR) with a 95% confidence interval relative to age-matched cisgender men and women for each study and for therapy with and without cyproterone acetate and for the type of estrogen (non-bioidentical or bioidentical) using the method described here.

    In Getahun et al. (2018), a much different methodology and definition of VTE to other studies was used. Therefore, the number of VTE cases reported was much higher than what would have been expected with the methodology in Silverstein et al. (1998). I used the hazard ratios (HR) as reported in the original paper in order to avoid presenting an IRR vastly higher than what was really observed. Therefore, my analysis is limited by this discrepancy.

    A summary of the details for each study can be found here.

    The results of these analysis are presented below.

    Figure 1: Incidence of VTE in studies of GAHT with more than 1,000 follow-up years relative to cisgender women.
    Figure 2: Incidence of VTE in studies of GAHT with more than 1,000 follow-up years relative to cisgender men.
    Figure 3: Incidence of VTE grouped by association with different GAHT regimens.

    Summary of Evidence

    Many retrospective and prospective studies have aimed to quantify the risk of thromboembolism with gender-affirming hormone therapy. In the studies with the best statistical precision, feminising hormone therapy with estrogens and antiandrogens is associated with a modest to strong increase in the risk of thromboembolism relative to age-matched cisgender men and women. However, the most severe increase was observed only with ethinylestradiol; a non-bioidentical estrogen. Non-bioidentical estrogens are known to have a much greater influence on the coagulation system than bioidentical estrogens and ought to be avoided in feminising hormone therapy (Swee et al., 2019).

    Perhaps the most interesting takeaway from this analysis is that the use of cyproterone acetate in gender-affirming hormone therapy seems to be responsible for most of the increased risk that occurs with conventional regimens. This may be both reassuring and concerning at the same time. On the one hand, this indicates only a modest increase in risk when other antiandrogens are used. However, cyproterone acetate is widely used as an antiandrogen in clinical practice and by transfeminine people who self-medicate.

    Cyproterone acetate was used in these studies at doses of 50 to 100 mg/day. However, there is mounting evidence that much lower doses are maximally effective for testosterone suppression, while higher doses have greater risk of harm (Aly, 2019; Aly, 2020). The finding that CPA appears to be the main culprit for pronounced increase in the risk of thromboembolism exemplifies the need for the lowest possible doses to be used. Using lower doses may confer a lower increase in risk. Moreover, it is reasonable that the use of CPA as an antiandrogen in older individuals be avoided (ie: those over the age of 50 and who are at much higher risk of VTE and other serious adverse effects). Other antiandrogens such as bicalutamide, spironolactone or LHRH analogues are very likely much safer and appropriate choices for GAHT in high risk groups of transgender people.

    It should be said that my analysis is limited (as described in the Analysis section of this article). Also, my work has not been peer-reviewed by clinicians and researchers and has not been published professionally in a medical journal.

    References

    • Arnold, J. D., Sarkodie, E. P., Coleman, M. E., & Goldstein, D. A. (2016). Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol. The Journal of Sexual Medicine, 13(11), 1773–1777. [DOI:10.1016/j.jsxm.2016.09.001]
    • Asscheman, H., Gooren, L., & Eklund, P. (1989). Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38(9), 869–873. [DOI:10.1016/0026-0495(89)90233-3]
    • De Cuypere, G., TSjoen, G., Beerten, R., Selvaggi, G., De Sutter, P., Hoebeke, P., Monstrey, S., Vansteenwegen, A., & Rubens, R. (2005). Sexual and Physical Health After Sex Reassignment Surgery. Archives of Sexual Behavior, 34(6), 679–690. [DOI:10.1007/s10508-005-7926-5]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Gava, G., Cerpolini, S., Martelli, V., Battista, G., Seracchioli, R., & Meriggiola, M. C. (2016). Cyproterone acetatevsleuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clinical Endocrinology, 85(2), 239–246. [DOI:10.1111/cen.13050]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/m17-2785]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2010). Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074]
    • Nota, N. M., Wiepjes, C. M., de Blok, C. J., Gooren, L. J., Kreukels, B. P., & den Heijer, M. (2019). Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy. Circulation, 139(11), 1461–1462. [DOI:10.1161/circulationaha.118.038584]
    • Ott, J., Kaufmann, U., Bentz, E., Huber, J. C., & Tempfer, C. B. (2010). Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertility and Sterility, 93(4), 1267–1272. [DOI:10.1016/j.fertnstert.2008.12.017]
    • Pyra, M., Casimiro, I., Rusie, L., Ross, N., Blum, C., Keglovitz Baker, K., Baker, A., & Schneider, J. (2020). An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy. Transgender Health, 5(1), 1–9. [DOI:10.1089/trgh.2019.0061]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
    • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422–4428. [DOI:10.1210/jc.2012-2030]
    • Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (1998). Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine, 158(6), 585–593. [DOI:10.1001/archinte.158.6.585]
    • Swee, D. S., Javaid, U., & Quinton, R. (2019). Estrogen Replacement in Young Hypogonadal Women—Transferrable Lessons From the Literature Related to the Care of Young Women With Premature Ovarian Failure and Transgender Women. Frontiers in Endocrinology, 10, 685. [DOI:10.3389/fendo.2019.00685]
    • The Lancet Haematology. (2015). Thromboembolism: an under appreciated cause of death. The Lancet Haematology, 2(10), e393–e393. [DOI:10.1016/s2352-3026(15)00202-1]
    • Tritschler, T., Kraaijpoel, N., Le Gal, G., & Wells, P. S. (2018). Venous Thromboembolism. JAMA, 320(15), 1583–1594. [DOI:10.1001/jama.2018.14346]
    • van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47(3), 337–343. [DOI:10.1046/j.1365-2265.1997.2601068.x]
    • Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T’Sjoen, G. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study. European Journal of Endocrinology, 169(4), 471–478. [DOI:10.1530/eje-13-0493]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    \ No newline at end of file +Analysis of Studies Assessing the Risk of Thromboembolism with Transfeminine Hormone Therapy - Transfeminine Science Link

    Analysis of Studies Assessing the Risk of Thromboembolism with Transfeminine Hormone Therapy

    By Sam | First published May 19, 2020 | Last modified October 5, 2020

    Notice: This page was originally posted as a thread on social media and has not been properly or fully revised since being moved to Transfeminine Science.

    Abstract / TL;DR

    See the Summary of Evidence section at the end of the article.

    Background

    Venous thromboembolism (VTE) is the umbrella term that includes deep vein thrombosis (DVT) and pulmonary embolism (PE) (Tritschler et al., 2018). A thrombosis is a blood clot that forms in a vein; usually within the leg, whereas an embolism is a thrombosis that has broken off from the original site and blocked the flow of blood inside a blood vessel. VTE can cause permanent damage to organs such as the lungs or even lead to death (The Lancet Haematology, 2015). Thankfully, the incidence of thromboembolism is relatively low in the general population. However, age is an important independent risk factor for VTE (Silverstein et al., 1998). Men and women under the age of 50 have less than a 100 cases per 100,000 people per year incidence of VTE. But thereafter, risk increases rapidly with age. By the age of 80, men have an incidence of approximately 1,000 cases per 100,000 people per year.

    Thromboembolism is of significance to the field of gender-affirming hormone therapy (GAHT) as estrogens and some progestogens are associated with an increased incidence of VTE. A 2018 meta-analysis of clinical trials, case-control and cohort studies of menopausal hormone therapy (MHT) found that oral but not non-oral estradiol at low doses is associated with mildly greater risk of VTE (Rovinski et al., 2018). This finding has been attributed to the disproportionate amount of liver exposure that occurs with the oral route of administration (Kuhl, 2005). However, the doses of estrogens used in MHT are usually much lower than those used in GAHT. Moreover, high doses of progestins, such as cyproterone acetate, are commonly used in clinical practice to suppress testosterone levels to the female range. As such, the incidence of VTE that occurs with estrogen therapy in GAHT is, overall, likely to be greater than that observed in studies of postmenopausal women.

    Analysis

    Previously, I investigated thromboembolic and cardiovascular toxicity with high dose parenteral estrogen therapy in the treatment of prostate cancer (Sam, 2020). I thought it would be interesting to perform an investigation into the risk of these side effects in transgender women. Additionally, I wanted to see if any association could be found between different types of regimens.

    Many studies have quantified the risk of VTE in transfeminine people with gender-affirming hormone therapy (Asscheman, Gooren & Eklund, 1989; van Kesteren et al., 1997; Dittrich et al., 2005; De Cuypere et al., 2005; Ott et al., 2010; Mueller et al., 2011; Seal et al., 2012; Wierckx et al., 2013; Wierckx et al., 2014; Gava et al., 2016; Arnold et al., 2016; Getahun et al., 2018; Nota et al., 2019). Unfortunately, a recurring problem in many of these studies is the extremely low number of patient follow-up years. Because studies with small numbers of follow-up years may significantly underestimate or overestimate the prevalence of adverse effects, they have poor statistical precision. Therefore, it makes it difficult to draw conclusions from their findings. In my own analysis, I excluded any study that had fewer than 1,000 patient follow-up years. Consequently, there were seven studies available for analyses.

    Of the seven remaining studies, all but one were retrospective. In four studies, cyproterone acetate was used in all or most patients, while other antiandrogens were used in most or all of the patients in the other three studies. In the first three studies, most or all of the patient follow-up was for therapy with non-bioidentical estrogens. Bioidentical estrogens were used in the latter four studies. For each study, I calculated the crude incidence rate. Using data from a 25-year population study (Silverstein et al., 1998), I was then able to calculate the incidence rate ratio (IRR) with a 95% confidence interval relative to age-matched cisgender men and women for each study and for therapy with and without cyproterone acetate and for the type of estrogen (non-bioidentical or bioidentical) using the method described here.

    In Getahun et al. (2018), a much different methodology and definition of VTE to other studies was used. Therefore, the number of VTE cases reported was much higher than what would have been expected with the methodology in Silverstein et al. (1998). I used the hazard ratios (HR) as reported in the original paper in order to avoid presenting an IRR vastly higher than what was really observed. Therefore, my analysis is limited by this discrepancy.

    A summary of the details for each study can be found here.

    The results of these analysis are presented below.

    Figure 1: Incidence of VTE in studies of GAHT with more than 1,000 follow-up years relative to cisgender women.
    Figure 2: Incidence of VTE in studies of GAHT with more than 1,000 follow-up years relative to cisgender men.
    Figure 3: Incidence of VTE grouped by association with different GAHT regimens.

    Summary of Evidence

    Many retrospective and prospective studies have aimed to quantify the risk of thromboembolism with gender-affirming hormone therapy. In the studies with the best statistical precision, feminising hormone therapy with estrogens and antiandrogens is associated with a modest to strong increase in the risk of thromboembolism relative to age-matched cisgender men and women. However, the most severe increase was observed only with ethinylestradiol; a non-bioidentical estrogen. Non-bioidentical estrogens are known to have a much greater influence on the coagulation system than bioidentical estrogens and ought to be avoided in feminising hormone therapy (Swee et al., 2019).

    Perhaps the most interesting takeaway from this analysis is that the use of cyproterone acetate in gender-affirming hormone therapy seems to be responsible for most of the increased risk that occurs with conventional regimens. This may be both reassuring and concerning at the same time. On the one hand, this indicates only a modest increase in risk when other antiandrogens are used. However, cyproterone acetate is widely used as an antiandrogen in clinical practice and by transfeminine people who self-medicate.

    Cyproterone acetate was used in these studies at doses of 50 to 100 mg/day. However, there is mounting evidence that much lower doses are maximally effective for testosterone suppression, while higher doses have greater risk of harm (Aly, 2019; Aly, 2020). The finding that CPA appears to be the main culprit for pronounced increase in the risk of thromboembolism exemplifies the need for the lowest possible doses to be used. Using lower doses may confer a lower increase in risk. Moreover, it is reasonable that the use of CPA as an antiandrogen in older individuals be avoided (ie: those over the age of 50 and who are at much higher risk of VTE and other serious adverse effects). Other antiandrogens such as bicalutamide, spironolactone or LHRH analogues are very likely much safer and appropriate choices for GAHT in high risk groups of transgender people.

    It should be said that my analysis is limited (as described in the Analysis section of this article). Also, my work has not been peer-reviewed by clinicians and researchers and has not been published professionally in a medical journal.

    References

    • Arnold, J. D., Sarkodie, E. P., Coleman, M. E., & Goldstein, D. A. (2016). Incidence of Venous Thromboembolism in Transgender Women Receiving Oral Estradiol. The Journal of Sexual Medicine, 13(11), 1773–1777. [DOI:10.1016/j.jsxm.2016.09.001]
    • Asscheman, H., Gooren, L., & Eklund, P. (1989). Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism, 38(9), 869–873. [DOI:10.1016/0026-0495(89)90233-3]
    • De Cuypere, G., TSjoen, G., Beerten, R., Selvaggi, G., De Sutter, P., Hoebeke, P., Monstrey, S., Vansteenwegen, A., & Rubens, R. (2005). Sexual and Physical Health After Sex Reassignment Surgery. Archives of Sexual Behavior, 34(6), 679–690. [DOI:10.1007/s10508-005-7926-5]
    • Dittrich, R., Binder, H., Cupisti, S., Hoffmann, I., Beckmann, M., & Mueller, A. (2005). Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 113(10), 586–592. [DOI:10.1055/s-2005-865900]
    • Gava, G., Cerpolini, S., Martelli, V., Battista, G., Seracchioli, R., & Meriggiola, M. C. (2016). Cyproterone acetatevsleuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clinical Endocrinology, 85(2), 239–246. [DOI:10.1111/cen.13050]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/m17-2785]
    • Kuhl, H. (2005). Pharmacology of Estrogens and Progestogens: Influence of Different Routes of Administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
    • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2010). Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone Agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074]
    • Nota, N. M., Wiepjes, C. M., de Blok, C. J., Gooren, L. J., Kreukels, B. P., & den Heijer, M. (2019). Occurrence of Acute Cardiovascular Events in Transgender Individuals Receiving Hormone Therapy. Circulation, 139(11), 1461–1462. [DOI:10.1161/circulationaha.118.038584]
    • Ott, J., Kaufmann, U., Bentz, E., Huber, J. C., & Tempfer, C. B. (2010). Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Fertility and Sterility, 93(4), 1267–1272. [DOI:10.1016/j.fertnstert.2008.12.017]
    • Pyra, M., Casimiro, I., Rusie, L., Ross, N., Blum, C., Keglovitz Baker, K., Baker, A., & Schneider, J. (2020). An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy. Transgender Health, 5(1), 1–9. [DOI:10.1089/trgh.2019.0061]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
    • Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive Markers for Mammoplasty and a Comparison of Side Effect Profiles in Transwomen Taking Various Hormonal Regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422–4428. [DOI:10.1210/jc.2012-2030]
    • Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O’Fallon, W. M., & Melton, L. J. (1998). Trends in the Incidence of Deep Vein Thrombosis and Pulmonary Embolism. Archives of Internal Medicine, 158(6), 585–593. [DOI:10.1001/archinte.158.6.585]
    • Swee, D. S., Javaid, U., & Quinton, R. (2019). Estrogen Replacement in Young Hypogonadal Women—Transferrable Lessons From the Literature Related to the Care of Young Women With Premature Ovarian Failure and Transgender Women. Frontiers in Endocrinology, 10, 685. [DOI:10.3389/fendo.2019.00685]
    • The Lancet Haematology. (2015). Thromboembolism: an under appreciated cause of death. The Lancet Haematology, 2(10), e393–e393. [DOI:10.1016/s2352-3026(15)00202-1]
    • Tritschler, T., Kraaijpoel, N., Le Gal, G., & Wells, P. S. (2018). Venous Thromboembolism. JAMA, 320(15), 1583–1594. [DOI:10.1001/jama.2018.14346]
    • van Kesteren, P. J., Asscheman, H., Megens, J. A., & Gooren, L. J. (1997). Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clinical Endocrinology, 47(3), 337–343. [DOI:10.1046/j.1365-2265.1997.2601068.x]
    • Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J. M., & T’Sjoen, G. (2013). Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study. European Journal of Endocrinology, 169(4), 471–478. [DOI:10.1530/eje-13-0493]
    • Wierckx, K., Van Caenegem, E., Schreiner, T., Haraldsen, I., Fisher, A., Toye, K., Kaufman, J. M., & T’Sjoen, G. (2014). Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence. The Journal of Sexual Medicine, 11(8), 1999–2011. [DOI:10.1111/jsm.12571]
    \ No newline at end of file diff --git a/transfemscience.org/assets/images/beyer-cruz-martinez-manautou-1970-cma-stunted-mammary-dev.png b/transfemscience.org/assets/images/beyer-cruz-martinez-manautou-1970-cma-stunted-mammary-dev.png new file mode 100644 index 0000000000000000000000000000000000000000..ccc0d9d7dd84bb416fc9e5fa1a3cd14e6218419e GIT binary patch literal 1452383 zcmX7Pc~q0f|FspAq5>kNs4UT9p_U3#${LcWsAxs_wiFQ!prED-$PyqBvZ$!+M5R>r zs3=r{gouDFNko>gCLlrr0RkkDKsF$dg@o|(JMSOQnKRFsbLKhooI7*x{oKj;pRc#U zu7kU_ZQEvW{@m$5w{80tv2B}f!?!!P-qd`<9N22Uf&b}!Y8!!Wv9Q(Ag`K>3a@#f% zZnx(8j;+3a%()==wr#sj{_pu_TT#jWZQC~AoIic?ucQzWIqTnJO$nBEy+8b@-lUFH z6gMP;*siY!dE56j0oL4t9lH)@=#H9qPqe(tO2e+RIa;}5bA!66fNbD5WmwGf>`kqL zy4j*jILs9kmZ|wzEg!q?usKK7V4RglzQ=5?Rzfx~b5pfl&eOKjyVJA4vH$fY$JSHr zs`(|&qxU5AM)bo8#l#J1Q*K^W%Cm_dzDnv%{e1-WNBIaZ>f0aPn=oD&x}&^_Gol~N z=0R?h$sX&n{T$KJ!FM8;O4rWYx*r}YO70*kK!yE-WEo#nD!7Hmo(HIvzNmBS}8 zLb@&XK}csF(2lFJk0ra|<%mb<&>7^Z|Nk|Y=N?n5CfJ)dTvfG}m!&^@kIG6JZs0_; zv%l5OVnO}gu$v%R$ze+B?mr7sA9@>sQ7OzMN0W>pBvQq@auU-^SlYWrFt=0Z<5&(kMmQLs*FpO zneo{Z;nZ<1t4YCogb_L2Rm;tR^kd*n=H`0nW{-yA$Ge$#0u;C&cYsy2-DJ z952z5{!pRlRbR^v5iCueWiK^G?tAa+8JV4Mc>U`Mut{~3-qR|w1S6`o0=H1xz=4#W zO7wAnhhH~JZ3_q|KZ#v0OKLT0!z6yB3c8FwLr2StljxS0RFA7HtiIvgk0s=exjWKF z$ZREZ<+XFXI#b+*OhB%)9B~?pN%3v?#rUwLpM6a zB^Wj}Nbg03w);BVm;`kfF`Hn9WGg+~0MF?IU|n~DEyZtY_?x`l6)eHUWsgf`GQn6Q z`j#j~KI9^2jJSw5ztcQ%Qky2xm7a@9T@m*WqHLCPB=-FNMutgPDq}=;?b34l4HLY? z`_632{k6(*8?2zVp^wH2>~jNsWe{iSnNe`c!RC#Ku<%gP8?kY_2Xjfl|N3(y&~vd|XoS9%jQcZ!JqUPxd-GP~_f~Ir-mm5T4Uc`UFi*L-|RF@NpeQuF?3Q`kQ_! zQtXyz1@F1<87D4SHaQ6q)|kZsENO9uCLN%|+NWKP7x{JD@$#HtTHW0a=l?}B5{$@n zC_zr%P97Z_)1@sZ(Ri}n`8$mJR&HJS(!gh)c{c;e55JKSDysAA3&Pc0*quKHHtJp6u-Ll(!c-84vv%``DTJzC4^5R`fNW zvN7j?Rc*qwfWQWShOc`K|G*{nQsLmR2G#mQa_Aat5gqwoa`Uf`dGFWB`pqGIZnG=| zW9}a>^^uB%4DN(Y=;IVMYHhu9jPQ3~sTn7o9A=0(#Cmpj2th@q?{p!Fd`sg+mj zw@9ctvumVDm;GvM6Q^zmG0kl7+2Z0@f>OYe8w(0I_~VJwm=j0_STUumE<(ZR;5s^` zp4!2O@7|x{cdx$8Ri2>79-@6>rJO+VXOh$Xj$nR}oLof%24NFm9qphFq&RQ#;hKfw zJNZ$Ubm0w9$-FL|)&R2kH|2{dU`L zToV_pBz*^#>NxW#_#c@}(BgP_-gvcHsd5fZOo=_k-1vLbMr2M!Xeue+CLER=Loa#| z4&jtt-nD=(dLjCrpju=bxtr8>w|N}WItyR?!)k4)o=;)?0xK-4n@}}y{lGXe7Sle91 zxqjZBsk$mk`|bWwp<7TTcHY;15Uh!DIt%-f;8!GIH;5tI6_URs&%mn}mhIviU6}QY zjNi;^qtuo`_}Rm4QUiL3uv2fn7FZdYgYm6^RZ6`So=Jq1eG{(jQ1;b|)>ESg+34Ra z;rV*9;e+*4`6igDmnjnfrXS==QAqJ>VsdEB$*yGIgVeegT>LcvkEaabsPJ(eqlrE2 z*k7t$YfMDu=8VE>Kg`UXjXx?BS1-h`0K%2+bLZwK7`(Hk{|1l;F(GY#c?~xaR@kJK zjh_Wq`3GV}M-fDRkrh1Jss{a_Ag|hODB1Qch_BM6FV^u#FgB`y8Ie5s>HvO_u>*`^ zOdK6f?ng@pK7?8#OpEuk;L*uDZ251wvDCgz%OjWMzdrFg;>;Vb#eDu9Q3NS1hy1I* zLMtQ9nU*LQl6sE4-x}p+roI%o(qHWn+nl32Zpy!(a^y_8JePE#bWqIkyL?50Ks;RnLlSZUl% zcz{C$7}%oBWg>^iU(4<$lCFM!=el$91huw2%{E?SY3p%~3QRUrGGM7U&GNtv$2Y$f zbyo2V^Ck(}V0`QM`Zaa34byX&?(+YsPiqKB_^HTc$Ie)Z6?GTh3~$bXtXn)G!n-zM zarvnVcrV}^qB+|-(8r})9}%CU*q?%mWd!X|%$^y846)J{^af=-gW7Js}4ami$lTg}QmYFUWh^+aY-ytJlr; znO7qY3Ih*0U!{1IJd%F!Zb2n8s1E|y*MIq9i}yyRC25VVNC=HLSGy$qTzCp&n#f15 zS7UxuhIS@ZFo{WzWn~xdLWwII-wO2A4OLDNw#~uAu#x0^K4Si9i1r;h$#jEe$$1lq zp@v14Z zY$HIGEn6ye6C1(CSG;MAj>RTrI{y)Z9vH^VL*#wbc;ODr3yAyzx}n z7_RT|YwJfC>z_WpZ+faZDjHxQhx)xZD!(A%nI^`jqA#1JsNc;`vA@5Jk*(vBb#s`imkONFvt$>chmeP{e51e#h9v$VSe3stJ zPN80gOnSrPv>u3AA7@bSZHH5{&D4gq0?J3MWa#J3Jm^w}q*Qa=lp|Xcaq4MHcB6z(U4P>TZt`fPo2dH{xJ%8$&y|7|Z_3+BlJ>y zns_Ta;JZj3rfm@}Ci<%Cge^1Jp>n+jQUkOJ4<-9rVQ4h0ra_ul62)}`iX6gcAJWY> z%cO1%MiW5aZZ!J=`i8}Mkw9&EgKSB_6)3sAp37m}su@dNxp_6mxsk|fs+dMy1z0e+ zmU1SA8@^IlrI?JrTh;1x_v+u|bj8l@{Cl&hN07J&08jwEhd;>hoclAJ973hH5IZrp8s#jk6o&$Yl zCb&c~lL!nLA&2h*#Sh_;k&P=Gdve9g=c8JR z+(M<@DqX%$F#X5yhm2(W?(i0yL}}8$+qt>aKK=m-FZuWN>5zv3!G(Sf$-Z9k71EJ` zJ4P?UAB{$PZt-e$S|HjN^tn!3a&-y(FaQFS+_sWXX~4wTi_GnnvG))<@jj!!0t)G; z+k?(L2-oGPBY~Lt_uro{E49S{*9Tzi8-qPC4rNo=sQNkQT7p_%b>c`myY6DNen$ul~yKg zhU8UQ6|KUVcFYee=712HRjEV=DJf@|2J%x4mjCh*`Zt+srRz_C(e11X8;^ z$T)F|Y1M7AvR=A69C{BPWqu?n>cRf(s~n84Vqb|Xvx57k;fd;~qKDCo$U{{e{10*i zG|S4vvLDJxzTXr)k!XsZ?NYOpumvM$+>Sr*??Msg81Js6n!u_8)H~ zwcL_ZG?!yE{CvtF2cQyU| zgt8ZkYDp`sd*an~pYc4vXb?Wt2L8BHs7p+?s3;hQvLBVn$mkm)HC>uXaQdQc@<_{` zbfVQ;iRR-HEITq8U@snf->Ybd0dn9D*oQKRh*UUs*sGqH!298VFq(8*6Rak753ap; z-t>bs7rosD>}nE(FS{zLg#JKE6~yB~X3EJ4>-qu~!k1Coo91!YG1xrbK1#=`F<1Rh zN_^8<2<+dolqv3G=hQN$h`)<=8-OT?1ksWfFCO6^-B@z}O+IoYL{#F$hcNp&Z}m1z z%vY|=Ar2zm(_A9_E#iE{3!!D|>K0lXW{(Uit*v{h=vpVckiL-cJ+LsuMo=9@C+x*yGd=J!f{4SN{bMZaI zZNQGw-GfPN68#OihnJg94qptNDfp_>QC?j+YOk({TYCEb-!=2B5pca+;rJJT3gDmE%xhV#pUEZ1$q(tb@zbqkf}%Ur1Xo>_OiRZA)MS z*7pL#PQ-`da6lGgSG)(`-{Y|`d;ku#db=Eyn2@(gz*W{4mQqa-+?cyI64BaStk-CZ z9~7vExm}kDnDl1MOxESOl}4YVQy_<3R&VyEUbajNZFa<7QGZu1%XL^UR0PoI2Lm@( z9FVB4Z4Clll;4eG`z)C86hw@b?GZy#iHz{rlyq48j~>axFp<}`mU;B?#x}T0!mIDE zqZ-HQ_mCicmy$dGwd2~&R>2RuY}^z4h)<9D)y8{1oDY$F+n`?^RC(LH?mfHn;ccsy z;QlW1l~Vusq+4RFXmaamPN%KS{6MYNc zsq(=DCXjzk>vC+-`{X{5auhwY$F)l1b?3x3>eG;j%ho&Bf#!961|E;c#!?2tS1wRB zlZT}miQ@|$UdLLd9hshxY3d0fU2Vi?H^HbI2Oi_AlCEJZtLZ}Eb!>}0X*9o!9yUPN_-0!k|Oy1@vy#IA&$Xfx0PVmtu6c zlBbGd+sL2N(P znm$YY{>@!W-|Z8fc0Z1eSpmo|rS(vr^*K#j2lBg&I1GzBYzG3YtqFGF#n&3rDVxkZq8=a!JP2m zvEUjLY#{9NTHX1(9VKD-F14=@dD$vBcATBj5mfqCU;a=NhkMxL0x$Dxoq*r0L7xnJ znIJRxr)ef>M%ONW zv|vALn{c$wP}V<(tfZf?e<{077%ipc4qFiA$`5xnqLnSRqS8}`dyYAB+Ntnlh9{Bzs>^0y)Tt@*ndVuj4m5j>^I4{Pv%ZD;mY_DeRlQ7m7yoQ z6B`h|8y9q#)2;jc)OF?Pi>lvpBR0|%uyJYNQaY7BmV9gA)G_~y_pQo{6XFZfth@n{ zuqCXSI^;h6J4I$GmN{S4Ze8D+6+CIXQQlxOIsdgnjW`u~2~BBX((|CRK+NSj-}%zI zsE@wx9~jN(QwaX^7fI?`t`H zx46!~bhejlo+Adw@`HB!g9jr_>@4R4g&BEJm1J)PLuty2sn3bHXNRx$Yp7j$stOTm z4k^BMnTnPW1qDjaIbO9S<`;hKj{16owHOSMV*Xfu(x}9oJg`Qu8^T;F5sjSY-<2p= zW$-g$^9SG}f3{`G8%faY-acpXo#+ZEygpjEHw|$C504zUO=aJuSx#1{_lu&hgrnc^ zn`?ABJ{XXNWUo(LdEKxRr7`5%fCrffETM`o!G4W(10FDG3?H{b_pKVLhqtOjjaVi1 zW`;GeSWv;E`l2Kbx-j!3Rr<=D8 zX8tlG11Wy77YE|)uif0@AoLF$&+p`u@|Ke73&ExQ?-~=Dnx!2HDEbM4^36`V(p2n_ zB*`Sak$%IG82h;IUpHRzBeyxWq;c}!Rs={dfm};W3XtoDEOtkX1;^Hm$x5D|@?c%b zPC#5^%7K?Cl@_Q+0#$2DWCa=XxFhzL#R9r+eUdcs1Kw^H!5>aO)X}ZT%dQE>0y(U0 zNIUeWT#JK>`~*hu&~l(^TK$_IcYIkI;$9&vt;M3^>HeOVRn84=s zS^z$)(52no3|91D5+(??|GOYSwtioH4(!ShJPNt~ym6zHHzose_F4)%&9s-6L67C%*ll98gSZgw$8tQsAK{}pe%E67GU846 zxFTcVDB-2Lt(B8CaNd5ySFGqRMZU_q7QNJYMd&tq!)UZPy+&N=_H`iW_etaUN@d4d z!ir_$GU9_Y|Cp?4JyQ2hyBW)M6_Xa=L%Us?Tc276$qcWFE4@6@i^l82{{+aD!lX)2 zX4yvd$17AXKI-#giSx4MZ4RA^j*qG)(tY_S`)fTKEv-KoT~^^WXB;>O)UfRSs}P>{ zH9xA6n|pUSVW(PXrECs=jj^`Y-`AG3*A zPOH`ug=Hy1?fvuqR2_@`01F(VM1VTN1IQIl|Yx49w$E^?Hf8$i89CV*}BYvy0 zE9-fSmrjqBQOxCn-#>A2_xRJsNjocGGeHyP8rk*q7kmqwWP~3_yqN~Ep?(Jb152`n zpp2AOA3PjT|4!rw8ixYb`ePDhs?SEj5SXe2AF_4Gl7HUrX|!QE@PNKh7xzl`b5i4E zGWLJC!g-9cj8`&0Q8dXnRcqlpDS%<%LO$o>rI<@UwE7#*`)z3zai{@D3Vwy#0|0p29nzn>?6^veQnP;0f++(|2HYJwG?W(^YiWhFPVx2->Yf+FpnY-uT3^{727;*~^5 zZ;x(F)%n$}V0R=|H6zpu`z-+y9?2usHg;Pu((Gf`zjfb??j9nQO55!zYo|EHRUQY0 zdCb#Hyc9bDcHM3aarn$?8%yl%nH8K;egD|qE5$}sOdQ=VfSgnb)Vfc zr@p3sn)*obU$R_3xDTFr5rqCR^g^xQ5;FZ*>?>T1QN#VwEP&!wxHBtQl?bSC`q`mI=8a6 zemas6f62%FH+pg!`on-VS`PaYWqnv{4eo1^-D)vOtpANyo5fip#t)TK9$R%#(AT(^ z{VkX~QKQviMe@QV)NgGsDFw@hHo4tzAuNK$((wssfsQ#^ati#AsoiI-(#V`B-YOc3% z-ZRhtwQL(3UT^O{*Q+|WMH+Ceh@pWZG2v76HIc<9WPgg`_$Wi6yP;nN{m<2{^0oy~ zO)`AqFPxg`y_+daiUMo|5Nq2j)yBpBe2d>!N53TBv`?ZWB(e~P0C_23K&6sC9K(^_ z%G{9+f75tCs;P-#1a?I8O)R3XP(L?G&snU*`*e{ImU7peaD=U*YORYRJyi{k77y3I zmgk}OEMMSU4-6#^wFG#M9+p2nYD1|3tZQ{q^`S_wkZR`*kiyUoU!^jcNIe=&RE*n8 z?&N5#wKjbS0?CB=|U6=M?vxQh8+7hha`{dw$- zcftjTb2nT?V&Y+;W_K^;G2YJ+4*P2w*xlrp2K7E^jnilb_ef9c_7i8L4rW3rQdl1pbPK23zh)T7?=gfsER z@yW(FB(Gt^n0-!xeAzF&)AZ?sfwDG*#2`@fr{XU*qOGa2Y%=6Mf6^h3;sg1P^;lJk z*Oxx(DG4te#V;1m3oeKd$@?0)elEcXf}MI2Ts!JwLqYK4V7sd(nq5XS&QI`e1H^h^ zX}>iTjv_u{*ojslvavI`2`KyBze|79SvB&hwQXAXWC87uK%_cOl{m@4T|oxM8q|y=?(dL}S8~wv9#-|oaRlyUTk<#jW@h@#4rzEL+hJP6`^_L6gh zG@~KtehB|*mEwg$wM&TfoSP!e__mtnNtK|S`o5QFQTp9=_p$1Au2u)OJuaF&fnWJ= zvg$=H^gxTYf3BtVHRbkOdy zXaTowtu+qNee*eD^auBala& z3q5FM-I-8!<3chgPsdSb`BZ#HmL<~ea_Ahqo}$AZwm3xE%XMd3j;Bc%)IS@ka}1H$ zLG1gvib+hjE8g*GNhr7+hQ9~yX0L(eJ+>vLm$PnB~pHkOKA z!Guxv%>I|*zL;0T%ZJvhHg=9K1a?D@IJ?^jF^ywPUAe!+Zrs&<+`DVF6-}e_jUZj{ zVUG?3ZO&t^UUn0uwIOJd$ne(P2`ALQ|ANPz&<-UWlRpBevv73u0~P(4C%eUTE4^Yq z`YRsVtw$ytl@)qb6rEzLtT-JvBG)mdIMpCol%nRL2V*~B%2Pv7xB9QtEz;_$XT@>) zA$5d^2l6`E?wT#diKjHVlG;bXo@E+ntheGjly8&sTgO?(;MX#UB;9~-E2}_zJM05t z4T~Wga&|P<@6ZK{Ggj{DE!*>aoT7dLf1K4*Pe^B{>o)GKIi0ooQEOSwtvPgyU@I?^ zqS!VIW|l92tF4o;mu4)SvK0QG>N$)PqIrbn5tfpwTdgjv8AXcf-+<2 zhi=Vn?7>-&Mqst*Ssv%;EwhL#aAKWR8&N0$seGTLERKn9QZ<3E6+l+rWQb2Z4k0H? zXBJCBN@-NNyll6;(7EfL_B0I+Re!6*IgBn9Luc(iA8fWG z+%X8M!{=k-*P&^GFZg`%9jkHMByhMS*vWZnCKue?A+MLcFtT+^3jh<`lPn~omgC-> zv>xJ`?`)YMK5Bs<01onoeOXKH{)oo`Q@*OzzTNK5O;g!Vr;8@Dj<1D3X!c#3;iart zQ~b?062vAbJ?X~M*i4bT#=Q#`W18|#{Vt8gLd-+4T~&&PlzqW+x=(Vfp+!}jy-Vt$?jQpcDu?tpGz@_g^QupC$-4YVtds zL}bh5w)zw53sYYWFoq>|;ffq7rVYHGt=&btPlx!xkI%*E@oW21>-(?zPVXr@zTp0S z_)4(qjGid`W>)UnrP^B?)5}MzQ2hZGk;{2y;lm6Ewef9g;EM~bm`YtpXmZ1=Jok8z z3vbN*=7h8EV$zSwz7h97O_JR!1uISa%-LfAmfy9Ss8o(?uItPMA>F9Mtx@i@peKBa zo$r3$ysqBqA(#Vy@pxQ+6lbdJRP?5)rOt8Z%IGxi)(^EDZt@`w@bFW?vG2_GVe`G* z-fkH-31gw6$qN#%RnH3BZvf&xRnoxmXl%@gxtf|9o=AV}ygukGPM5x|$aw48aYGbg zqVBf0QhBL=(9@iLWwIchZ*}-Vfckz_@PTM>GqEZLtq-xcINdwkCrNrBy@1Ed-VtGS-}OP{z$cA21TTyN(MT9z^V=lAffPv^6TbG#r`I&62R@$f z5e-e@n{-4!Eap!j$I?$Vf?V}ZEq-lW&s}Xls3=6AcH>NJF0EY#86j$MlR$AAz-rEE3a}B0dZgITc#f~* zeTCN+;TK-X)Lh&5v_Ai#vZ69KuVhH5@pG#uVVS_WXTskT|3@=Y6s%9I*oTlq!CdfF z>UJ=vX=>6800Xw?PG9L{8Et!if}7_UmKaex z95hya0t@rD=<}}4TyU3n3!hA>QTx>ekyN{2e%+EqJl-Q0pZ{-5Qs@<%3b)*7_qJx# zd@wn*5*oPO%1`BJRwx=mLBK9{ZYw7=2b-R^#=w1zcBFYsq!>pnNdh_yhVyBcCMYfSM6!n3OUFo z9&vjf;0s(D{t&93p9+KK!3`$-ViDjR^mJOt*%d5=vAF{j0mODCk8NhsRlm`7mkD7z zY320VI+*szPR2&QXS=1kR8qB$*@4VkB1HC#>noG~2{5{ZJ_(tX$?iZQ; z>FQT zb>^nI6rxQ%a9$VKX{?YQA{lopKNK8SeM{0Kc2=TcqP2z#8)A;ftuF}%thwH#MQJaj zW2b(`{f>XVPHS!57^d<^n0YsE<2%;Rq0;%704zMfR^4XmJNtnikjvZm5-{k}RO#22 z;0Eg&^0Mg`8`_0den7{qB_FT44Dz!iSK_`Z^3P8aN~bO^`J_pz#z1k%ri z&3)UVxOrm_FVleB4cach9=da*nvZV_Lp@4J%FWxo79Wh7Hs{~MZbcyCk@i0Ddlw&C z?aN9Q!QcG5m&}`VnO5C$rk1O@@ZZaF0sr+RZ%H=Dv*#I9Aj8NRv=0Hx^K=WZbe4NI zC4lJ3@1BPYtM7&I_f?16OxiU3dkr{WWWo{f#@FR7SJ~G=U3OQIB@rED1NwdE(Nb)v zPV;D*Rb5&hnX!XnQ(I|+gD1K{o+M0hze(wOJU)qsE||x@pOWf!AipWipeMX({7kw} z;y*yA9FrlqE-ZuyI+?Yag9h*5_~$O;RnUy&NARon8J1Njo5bd=beK=%50VAL)eO^p zsctPvf$I2tFVRp>!N*cYa7D?o0sR=sgZZ{00EB=KI9XPB-Y;1a?+3P25A|7Am9#kc zLszKn?+`!&ooUJ|j<^v}w?Mf*O#Zt&p|Y{J%`t_nD9;ctRwpvbi^+YhQG?urAPxAv zUe!9{qaN-as0q&-bR_j8z_88C`w4u#D52VpYSXOMZr4hVcN*nUE2yb^9Rhiotg8-+ z^o>K+k2(}ZBtW;8_lvDJL}%!_bg(g4uz$FjSlQvH9w+sEQ$4%|zq{Ri>#ONgoi5?J zZe~r7b7xXCe(>BVo5?51TZiKmEH!v^DX(r{@waOyG>M)XquoS3L{x3B@nnxpHR=F= zxak2^nrHn?Ex*51%7VAKCqTZ-}VS+5MU zXg8|8i9A|(p2PJX8=+dq0y@|JXa}ChJ_&t

    5Pig}Mc%L4Et40NjrGI_UI3lKmHb^Iful444qq9w9+nZzTiVN*HAVRig{Twf7v(lh~AV@ zD^WxJSp2cqlmqe9LuW4;CN~h3Bu&g&3jD)8S`7cdO$UwpWX$(PWyO)=yyadFaZk!; z%2Ho3@mqBV#Th|omUm$B$q$`ZmNcd%pxv^-%Mfy`{Zq|82X&EM_-6l->C1|Mja6mo z$F$Xcaxt%v44xrqjUYZT4Sq^{zPJu=fGo0;-sj~>k7Lzr4#o^qae2<2d|`=3R{d9G z!ftZr#pW~K8P?Sy_Fw@leMsL$c)v6ZW9ExgxASE~j4v5Df7MKKk{-DTHx7tXG`*@o zjL3gly|Gp;R;D{i_ixngh?wxc>}^&$IyuSrSk5G?{Wjyg32rwnB)aE6$GA3ioGuEs z?!U2{)#y84=RTc4>-QuFEfk!8u4Uc2$%*$7rRPN)aZHDgH<~I7&;62ar6_rGLgc;j zcX9S)>ehV;!;K`{mML8tK5hXS=LeF&PTMsw{ZoL7N;2^ev z(`Fo?MI*c*uGd25Z*=XQ(aW8?K{FSA7ih%N1L-|UkHVW=z*RvURnm7TiM;7B%^Ufl z?!5h!lhasf7cFpg;r2Y#iT|L^_*vf~`Mc0kZpUjA_PMY>+J86l4SOUI#|K4N(yk17 zOb{b`enjWS-2KektxloZ} zH*LrNz?~t^p!84)J~3sMh|gPvu6$yE$gZ}XNTj!eB8n+SblY&EV+FBEfgFx#!qd;B z`w@-XRX(Iv%o#Q<@g~mR-H(*BW=7G$T`9 zznvWH=ey(-wN&i(HKoYBLk~SMgfWR8XG{@c3utJp?I_PAWt}wpj#`zVV0sjW)|Bo= zN1}Fm0xWC;@9+*@rQi#ztq(WU$bR3pmTLs5SY;(P3c6j@-v?J6eEFJ z|1TomxIKlDJg)tYrZ8Ejn?N&drWt?v8tsCnz0jhLJe#p^Yck!AQ5{NKf;I3RS4 zuyXqnav66*>MDH--Dt`PVMBB<9-*}EgJG>qPjld`5#+6%%Tq0?0yFFW+-@*xgVzgy z^VZqX)D7_FbE;+zuhsA&o8X-*has0$iG=IUj~gJJ8^@cZ1;%n)=OyZ{yS44NK6?zN zM04yQF^$?$m>&`onA(;baVH~~5X_7RUC(!N^KHMvJcZ7yN%=y$?hLqu4xf^~Jifr* zoD8|Ro_n2B7&@o^DNrj&UMay)^p&;5k)*Ijh@A-j++VO30N&WMx={`tL5$!tlpWC` z>kZVz0KRDXOm?f+zzF|4*|anKogUft@j7xcAtgrx^436GLWkOSR!bdU^g&U-+9V<~ z$W)_v0_7FJgQ2g!(;VH@$j}CsJ_{dJ!}Aq4;!e++P zql=};vk<@7>;M1)rq;a^d$$L){PC2eay$y}C?s|IeSC+_93%OxUdFHN5<9G-Uo;G2 zN)TOD9tEK_X#~gSjOP(px?Vgf>$p)F_HnK__E0W&ZhYg0*w`YPCV~FO- zPxs}E)uW+f1zWfqZzM_{rHs1xM>1}TCZe8`m^R~yoP0KQXa@tw; zk#fVY{kD&EGZ&cb119-}baxOOS~k|)kOGfUx?-1l<-ii^kRgeMpwSORo8yfLh(eKt zUPV*J|BVke`jymI$rQD71ut8&5+0yc2bT*ams4PxNmj*AK2vqSHz0PbyFrfrvEloHMK~V*6E{-D%V^stufzyAYT{UOVK%`YIGDqVM$JP8c{mU4I+LnZ0}vWEb%QO%P8+A63{mQ5 zH@Wrxpf;3!`lUdzts3|$BgY3JKx<3B#GLe}i|mnN=S>2eyW9VN4bPvH7%?1Ufn z=*CPFk4Ar}7xOck{{E$3Z6>+zZMgHoZgPes0F6j_1W_mWf;cKdymS!!l5twQKQiosX*g)bo&Nbh~QGsv66Dqz4 zHF^&j0u|zQNaYr!41@RU@&S398LTiS8vC_Vh$r36KX|wSi3oOVpD= zld)24$6HLslaTqz8N2~Pgqoc3 zqi#8s9N8nijBqOgE@|-3pB(?**BLukJGpU>L=n2JIgLy;Irr2hRQGv#UA!32c14!? z85ArYX0)6fJ&%6{L-*0d@oFGA(S2sLcc8eYj7ZdZ)|wVmE9C^ zqe9th=3XuL(E6f3^)mHsVXMHWQ*R(-#p*vuKZWKGBtC`lc>&D7qh|f#%`^dp`I4My zo-nbm!ytr|f#rYNKWpt_E3G1M6m7A4y{b(G@P2c zw=iiN5&`JPOAP6!E_dqo^}1fiq%EBzv*G0CIUnHzBZhhqIT^~A{7D^7`S5AI+mTK+ z(sc39^ZJ3R6RV!otOYO|8+o~00er=AvBUE6)PiYXpzwtrg;tR=s|slcGjrREqD1X$ zF*!z>hb0%;Tr*IZkDFm&SOde7>}xplGt+bwxWintzUcX%%uq>BFym*ACWPEtIRlmd zRMJuMi4rtW+>yPNtr2)y@+BeAq2&6_w+PY<1^%d^FTV+D-SM9KWH~?7%OK=xj;+$S zLHLMysmb}PTPJm8sHq^&Y0wd|oR~n(ybbY0d>I}s)aVLt=BTUoi)}l0wt#iyW>-ZU zlKD(Z_>D*a8S^`v1sjgQb+o*SSalYyqz06g64xXhe{UrPSz}YO!woF8YQCw*orFoJ z|EBo)52A6*VyIIpjpQ z)!~6vt2>g_7t4iNc==q(rRCI!2iaV#NA%Y$?V`wUdN+r)LbKT9Vl_C<=3Fkc9jlJs z6yvo*>;{pF3pYO>O6mke^glIE{*sj))V{MIy1K3%qf@_Q_J^tBCF15fag!j0UUm2= zIj*Y5S%%Q~x5>QwpMJBU0z1BM`C7MlhCdXG@&iM49II)p_3TQ|{tuF*t+?rYDI;@q zz?t!-*EMF;_aydtF|!2M)Em+HUGy1hrC)bh@B+92+bt=Jn9Fyo z1pPKueh=55Y_X5sY@=!*S`PiF2)sv>Ff1d5%MXRCNv6ZHRcDrqV@98IV)w(SSu;*6 zG@J$vt69%AGTFF21%szW1@nU^h@tma2`PCg$luAfAj3)|`FT@lDdgkIMCp}9v9dro5-w}i>qZa6@Z_yiu3lnNsF$S$(M8WuMDj!sh+{GdgOj=r@h}peW z#5U4iuaaQ@^%Q=yD<-ZzIjyfAc^wK<atUvA<203MhXhnupvYlw5Pxo( zE{hR=xz*$8_hT`*U&R}yZx=p19tIWs&AyE%#(#Ed>iS+ia^O?0wh1S9AA2~gDZ6Qk z^2f1*GljZ8XqK4HvLP(Nb_paRn6>6a*CnS^aUp zzyHtcb zMqB*1LjJ*=N?JuZmnUNcg`s*RHo5~fdaj-4q{)VOM7|K5#Q4j5(kmkYdrDTx^T18o(7c;?(UmC+j)#L- zbjvg!qN>}v_X<^it2VHzv}m>{1`wdAe26oi3cJMNy;6zHm_^I(>>^j~pwS{)w7P5v zs!h&yG|ZLAONZ1S;>6XdPajr~+m0$aWb3O4Y}I_I!jKNI#t46xHdUOS9i=0&8yV0g zKbIZAO|0wjchMg!0E^&(=Rj6T)M)&2W`Ha#8K!RA3}P`E*b_?OeQuV(%Ww7#L3&~B z15eJbK<)@GZ7EJMCiN_A`8aFVRiaxb?a?*J5NDYHN_y-+c4W#dcepz2+s*#DIc5S zPK(jq?um~XIy@xG^F8%`ApZQ;BGlMsGS<`(W&7bL{4Pbu!ryf*L)AX_zRR@1Q)C|- z6pQ2~c_=sR_}4yTh5RCDSy?oX{PN>isLDGI)Yq+5_~;Sev7kLl5)-S`4olUs3Bho~v7!$7w>{re)U!PmiUu6kGBh z;>;Lo>;gS=wUVmvXPG^UgU%%Wkh&nJfED1hwG!S7%g(t&F5Hg~wZAvjORoyWW1qrj zfGaEwF}MX4$wPAbs(p>KwU~HsMi^Z=(C`Rl@E?>=hu;TCjJ|}AUl9j^Rb-UJ;UZ#s zFQcDF?rB~C%iWW6D~NIZu3cX};e#MHTX;sYbc*V|8GV%>Oe}2;60SPiAigHF9hDjX z2Mwhcuyw;THOt*;*Bj-)UHDar6Fuo{WJbJqsxGwIcjQLf*Fo8x(6B7H?7n$2a^cd_ z!;Mj|v%4?6Uk}Kv#caAB$1|oTxX@8}eN9|X*ziAUV%FhOXAox5piTUxyyCHMkJLr`*S>ML0GaJ6WafhA zKJD*)sZP z3wY0boNU&c0=;x)#=2@fi&;iB)szXN#I#QCub%4M@aSzJejueNaqa6kv{ zYAc5nzF7wp+J0Xs%)|pX;4#!K6~z1JLr1BL!o&`&&hL`o0l#YD_XowyCqvFOnA^;c ziDuX}Qpe`%^w|AVS?k}`7AYVP5zA@U%;5rL<~7{mA<`CuLx$e-t5iQNj8PJ(?r_=rDyGcPxFaAxW!zxZ2tt(wA@&-pV`5r@^Ba&-$ ztj`>~<=)V?8Jjm;M2XwC8g&7?N?v?NwME4zQTtG>=_hfArQd%9vxf^zIfJMy+-K&K)-S{WBw$bNm+WZk9BvB9IwD?Vi z{tIqc-M{8-g8#njzmrDJz&EJ=|2n~^_*#3_oFjiP9Ym1)5$n(h$?8uZ&gA55RyG?@9|Owzv`L@!24;xQJM%x7a!@v{{Nvx6CDTEFi%h!iuS;D_!3!x@K(I z!f7Yo9Cge>Ag_AblM>OZmP%wAgXKiyb}r&oww@0wYyP$R;kAV#?2sNs!mqvnox9g^ z=r{X@1C`m8;QlIR@+-ShPxX4a=oTZYzFH|B`Qq$Zn0&b&+4U*nG(DnilP0tB6Y^ya z0fHOP&%MqM2R$B64oXdy@IXT=kz7#CGI$sH{&}-4$?-$};CjZ;bXM#pPD-o|x7uIU zJm=kD)ocggv2c3>G^nCjDUl>QsZu8sqzbpxoP6*D+qxpvp2EflS4*6Env&;A-A#Bn`qrBju->MUnhB&VkRviMGyD>O4c!k2;ka1W|jT)-y#Q!=aJ z={qFjVN=j_FG!^hycYBa+klQpAtm4{JcqS5W_D|sb^Wte7wNH_Z02!b#6 zbd+n;^J?h!xwvGImC&oL)2okjsmevMCyOlTG)MM6gvx}^JYlh;j?6)&Xc#uT$8!Ps zA1)u5`h;_oKcVyI99A_B-FT4K)bSYe>B~`y{;Ua@YaJ215WtGv$Nv6rUted(#Gt}? zlwCh0W5;R{gq?X+LA6@QgF8x#0g4qnlLJmt(b1&d_6*m~#S_oc1%R1$}@>ex(D zF5fv)58K7hn?@GoYp;fJSN`@XFD40`VZvd>$lqm;P&nyC)40=1Hq*Y0m8r5(vfYt% zbIxo$TB}?g-m?=*rg0}P)P~Lk5JUHtr?See@&OEcm|@}DB}QDeICQ^;*vzYFM_^Js z^8R8#M(HE0XAz4{tT@I&4_NK`6x!e|&w8h_Ch&{Iq}*#hbJ@%@um9iygW?e5mK9#B z^YlB+Hb)pIz^nd98Q0qZo3j?WPxeaQf)EyHD?^Ie2fWi!7WfZE^JInpU{0-kuC{Bb zW?-A5_ke5+MLZHe>#zpqs(9Pyr>w&i<=EIN&;i4c_FZWYjdGHMD|`ca8MJFEcwa-^ zXLJ6BV$p#Kw1j3o8;ic1vVdGRANqJK1;Klo-ri$qu8S(@k1j22Mr2}Ob*33h{cF3s zN#rn;mme9cv0giOAIBX~O&+2S0cRgfpN7DgfT)Y=G@RudY;V?u@zv>!Wge6J-F%QT z6`)qh3Mk9RgPTzKh0~uN5(2pv`!-gJ6SatA#uV~vKL9x4V&ZUqzkFZGefVvxiSP^U zvt3#c)5Dt-;aj>;4lfZM&W-6J#?%kV{(o9sIP*Np{(Rr*$lV_jPav`R46w;h7h05E8oWtfUlI!5oFpIHsBKN#RK1iwV@34CoVj1~xA?ot zQX)Jbb|A5OYjsJ|nd}&0%y^gt#B_`jy+GbFeTDoJaARfW#9}C%>}5N84Xmkv>=mBb zF?&A~Kz-Bdo*dY`*)E&zIo>ZjBV!CNbpM?ITh&8{U0;Z8853Af-W#3^E9X7>HltH$ znS-pqccE!D2P(u(HR}H{dNi;D2?2{myFJlGw1K^+6CPac5yvb-b4;df!K_7LE&Mgd z%j-F7wpafL)W+f>UE02dFrAw1#D7<<8b=^6%Nw-$m(C?$sxdoLF8o0mY0EK5wunhd zEje<-ZD!wnetJue?AG5_9oI)p=CkRJxq@K;e6X68&9yIbbOy5sD;scWYmru;?sb_6 zecvnF%#Vpo7>=hE3!@Y0*Krp!0)$(a{7Ux*0awP3W`{Y4BW-4f0Wa}+qD$)lY?k)| zN982i^wAXY7F~6arr<#z#Fz+ANht@!BqyB2MX+ThDS>2*OMQvvHaBlKEcUB(O&m

    quc`_Xh0nFh9I0)p2TY&#(>&5l@o0$sIU^3<^pnPLr_sZB z;Og1iFQ5S64>ut!o}d(*5+up{uJ{;icQnPqef=$kx5s+6{)5uZMo%rg!eesT0- zRbU?LL8a&}#+F?tpmT32ywOTO9riv)^v*mihTj@Z7qh|0W{+KrEyvjdE2rmQDer}! zEh}~tURsa+(}SS_KEsk#yb30uO{d#n>e>%#Iib$aD7|_?W?3=TZ1rlTX%?sP zc|V1)-71>Q7AHUdOBS?C+uAPZF-o}3h945Gxy`Q^lE`aLhMT1^x@D-QmY4Et=9~OO z5vQgOfHHz_Dh@HM8Bqb$sm2ut;n0UxPWym-QVv~tOBT+hkDQ`AtwAw>4|sLoluJ`Y z5fKZ?|3!VA-#OqW4-6#d57azvzMippFT%yX61_0+q(;v6LNB*shsse4+y}hY9zm+H-=m#{t!A#CjvKDX}2tQg_LbT;xee$q`51=&|>Rz>E*C66aYVW7g(tKC5ItSXQjqTAD?2? z=E>hOqF%t<)L|=g@oS;-2h$Ipm~fUZG%2BTEJyvV_p3p_bX;a!>2h||-5U%UF3b=2i)R$4&1My-L|>6kBuk0nD{K@Xgw*L9l8!nT?yY8E^Gn(C{?Kc$AT8 zCA`+>7Hl*ZWmY;ec>7q3UJc)~9*eV%$hHo4*gw@*cV952z83hWY*I!4r^a5{Sn5Bf zHtR!gwaqULR^1HjWt6PFNei;6L7zKDsG8^AfgdW9U&-_7EVwk*c<(Q$cA*f|RJwFD zux2?1AZrJD-Dsy1ct`oLsXgVcB=P*VRk7DCOR9cTY+2!>H}K2>IhDia>TQA?}e z{WSDG?3C2eo!FjZ*HG?}iyz@kcs*)-VR!*r9`5w!DgcR+|Gfr(#=Xv}oUZ|hk25Z3 zch<)_ye6y@gf_YySosIq0;@ah;XQ^j&1=zpjBgILfLr2CAddu}-y%8=9LlCtR71tm z*bhH}nEt6Ee{EaoozTuqWcq1|6vM)E8DqPeSIscxXa53ETBqG}#A9=NZZhZuTRQFX z3!q>nSb}(9p@C!!*7~OxDX&ZF^+WN?leC)vP2(s16)x}^Pd3{nU@7-T%={SZHdi9j zjGY0{z9e2Giipf@y>I-Ccg5%UMUEQ^YZiWV5rY#-azuXrH3B9CN3xHs+2&sDnA|v3 z-+h6!c;B=#=@CHNAVy`wQ>COJVd7byO7BeIoKqg1+9NUo+*DQ(SHHg34?$wW>*Hqi z;mAjS#c{3b9G@Su$L#&){uF3)g>di~s)h65=6mGHa->MxQ_|3?bV}dUc_iDs6Z_4% zR30+t3+XOzku&sqMm=BLn7dxZhf= zUs#?VpD=H=b#(Wv(2(F0VEwsAW!l8-p`I5V_7DeR|5wKtW^Fu0aWu`=RZ3lu?j(2K zUCQzKBZ+ikHciM@H`g-%lKEnp@7G2|cn?Hov zK3{Fo!d+FZtgoDRcmWoeNrc>fXHNLOdX#6&5Sua|rSXW;S9{9wFW`FMWVxwNO*0}#UJhik^z1LL~K5%2SGl&{eeDiTLcy7sl z=R?CKqWSJmfsuc(*`(SV?rT3crcqj7f`;#e!!Zq>6`w3te_N-$xe!7eeI|aU1uYjA zM&Zw1Om7H6W!#lI&C6^8H|}vHkP4O8*S9wbti>M9_Y%JSia$FqlAW5RF#P7cw#Z71 z&OxQ5z^8bh7mHoPeUkfv2AarTvJV~T^7ba`dEA@FrsvZ)K2=F|9(aw|XcJWJStV>e z*dAdp{k)}6{N3v*{`u-}HlFFdg`u6Tv}?Td<7EzOCZ}{I7vj1La*_M%gsIA2xc+D^ zw{b97WNc5Mr)TYZ6HTcTM`6PLhRPJeQ+xOI@Mz%G`8IpW6nG>^b=z&Jaehf6?;R=O>OUaW-34P+pyBPlW~(2~F*i!n!ee@%nN920XtS7!?fB5% z&%BJzV|>@K4N3I@_svorybWEDyQ{K$*1TO#bbEzUPq{(*(->!hc&UbJ%gg5F`-RNZ z$b%^C^cQ%{f%c_OCrTAC;{4rC*-;c{v|ZcPq)&PbMjSp4CH=vQ*3+}Q{A{wEm=0g| zK8|D|{3Ri7BFJs*_)1=Ar{@q4G21(KaVMc+6hAwRUY^LftIbVTL$ILtxF`tue(bq=&$;JHiQ#` z1eatA+DivkiD-rS;83piMB4)W?gcFIpR=z~1*3jXtjm0eTIL+&&buJgD|{v-FujqQ zD^_pDPmK5^Wbo8GQ7}(en-cL+4kBdbWsEUZ9}%EB)Lfh~ml4YSn;pr&>Tb61CN2xU z;&m$?d7Trnt)Anfc9%iQ{SU2-~^LnzQ`)^#}aWiJ3&iKyn zismKf)-8?v{k%+WFB>CI_j@~)4CsE$4h_vp$$%sYL52ZUh&H0SZ*p8vb3V5^=a%xn zox%@GK+_?`%7f1AC1Og%d0nao5^Y-f%(uO8&7TZcc3~Kkr)_}5O}$o+LAB@YTv3;6@o%n z1b>$n=%r1hK6-QZ{mzDz7CG!tLK4b`?MqRD2Ri8ii2usBiGtE!CyaMGXV8?|Tn;r< z4(x0ejDfC4?D16DpKCfF-Zm{SFfiJ2ai?+oH+Kkyh)6xPH~&QZ~60iRM~5 zT(zaC>hkiz(;3~`k-iL+yiRW((|1L=xvaGJo2WIpY=}XsOjE{slW}$S;q~Dhl5wma zHfy(nH_7;F*PK61b^+*~O!JcTZ%&!xu6td{_t}m>90tbl)uAM%llwt>!bQ34uS?G* zIWmStIeMwpoYRL`$dfA{AiDU?Pg}o|<)hdj^u2rthNb#y4sE)PsWU9HZp&z|ZT-^E*`NI!qS@gp%6H1&M_DMVMR?B+fkiM4>4Ysk3`N5P} z>Y!u8nlXMj1A^%Ob=rKqbJjL_Om;?tC|V5H|L%{-(?T!1NEiP!*AXSWOw*;Iefel| zM6$zpSqkb0m|8_k44i=e;bX>}f~ z%QJ~6y|i7)B3=c<#NjiE+kk?yIPRZzf!80XsoWtQ{R-( zc(TD$*5nsI4LV+yZ7Zb_(v)Qxq;h2aA(wX4t)^g_@8~U=YWxDb-@Ep=RJ3o?PXe?y zI;fWFGv zecJzhr2&Ov^+|Jw^gEsL4`e_N`NKo`4&wU)GDuJR+J;~pR(MVHr)NCcqZ6@Z*^k z3;Gk0hQLQdj+;+R?%8YK18L$lIQm4%FLXjA8E7kIs-qMDSJlXTrR6pP7h{AW6LI)S z$<^+c+?Y5{^WC)jYsKKCyV!thr9ud|RX&_VX`0~X_InsTF zne0P=JrUccd33tEHiS#}jYcI<2B}r1Lebv|H@>RPB(_sFsWFdNR=K4oAfL7Ca^2gu z$HAeccu(T_?a6`c3K@zx)L-6@I~-)3f_N?spc%_+KQC~(=T8eq-ILkv^2+o_08Du2 zMtbSprnJ&ud=UNCsriNUi0X=z*Yc3W0TyTo#^hWTAO@lu5;_olKuJ=@bqe#87o52( z2-4aq2ha2hF;N45M590cCK+1;?JiS4M=jpRC-=v!v5L=AFg5gkIq!@=zjYeres9cC zcyCXzuF9C|`1IT|1PRz1G=&{fpIs|brNlPQuEt6ghrJTG-)pPPDVembM$Vr;FtT2` zr5q<^hN!POH=n-zg5Hl1t8v*2j+YP-*l-7s_R4!%3;pmX+@WjW^xA-pK4wnM4!AJn zNq*h`0{kY1gIzU0_0)eFMCI9}#pmgqJz&d2y};6;jgm6WV)e2h<(t!`nUBQ@Wlfij z6?Y!%8RsZN`NCC5&>PQwF?|=jpcTeUQ5)Wbto+&oo8E;9A0jIU#GKP~#do!EWa$#& zW57mRN}W)3qqOE%{k6zFU~mbOhT~0yk?%TRDZOS&p@edpLzADB)y^-u15N4 zp2?4|0ft=V5-P&qFUt2WA=bIq0BGJ33iYsKAK3TewKx@RgAZ998$kMLa~`H--7P z4>X~_M)k7F;NvB>TdB>^=oWt< zdHNf2TRz!uqNv`Bojddtc5S|#D?oFR+HV{JXdIS*iHYB=!)!G2OM^|z5tT@SEvFir z{K%00j)QH<))yX0&C11w1m3q(lSX<Oebk!r_G-1f%TaG37}3fh36%b zf<&mj6lgdYQiG?uqE3%q1$FD^-v(-M|3XuPJeD^35L!Z3ie{_s`3ADpR=&xyb#>^e zjhI3^8*Ck~fg9APG-lIXdu$SJ%ja!QNJlOj9Cy133u|n!TJzP3Vjtaqa&degGR+T2J|U}h z;=`E2BgUV6I>CWtgkoc+=TR1N9zd+wMpuPwt-KCBQAa`d2#E0I<-KrQZ2qS%P<*5j z=Ys45YH+N7U+K^(h+YKI8O`v9!RjI&(rKz6*9^Tn-+N}tM0_0eaL5 zY*#bvWJxIxAB+Q-Ghk?;+X!~qKp~@m#Gb9yo#`oopBr}J?ZU6F?PXc1kKbbw z{A)qkk&PA_TB6yQiP&cwX0jQ%%E#2WxMVJnEwzSWj|Pr$1~-K;Fosd6REiYLi|~6acmjQPn9v>4D5u;E8izi zncOUt3AwndmMmQJV8;5esT22%`cwBbwdS}Q9>+W*-mUMHKJ>5IVy)t$@lT48Z}PSyd!H{GZy^~%sUu_{n|U$^dRszPqc`$ z%0A|C|MTXsFxGXxWb|2(OkALXB<}yL9DjWua0NrQ{btOj(6Wxdd|_< zPKyKD_%a$()bR9=Lotp(f9%#G{zA@zcObQwoKG|&N%k2rkeZqsw^O1}x=Iyi+Q(Qp z2gDLl%f`Is?s9laDHeZs#c{ME&0=V5?hjq*Y#@M=BrwF=4V!D{t7SDW3_GTaerTsX z^`pw6@sFtAGZ^We1 z9Y9k-DU6aZ0+HjUu=94PUOu_g1sNP(^w6ijq*L}_9Fm&Q6E678Pxc?FemMlnkqP`|w@&E)9#=iP0{hl)3)4e;G88h_UxL?j@p|lzMqDPp zs80UKF3QJfygZ_hRke95Bg9QK>{-_YH5xPiRO25=H{Qn{t^UK0pw?iYZ}N=)pfghM<}@ zUGiWEGNFWGGJ=0e2?d+w0LF&`Ji1Bp_95H`u`NMM-yC~dyS-?1;3PQ*4p!|2^#1X_ z!wfSM9TCTk$(giaY?u}|g~3#V8DSMGx4AHI?V1Sg3(XSJMgT)rt`e;oCVsQlbZJ4W z?6!s_<%G|Bt9_UV3MpG}WLP*o_2u3=ivh`oQVG;swhr=q!jT&j$P#TuLvX^OC&&TF@S9RG1t&(XYXg`oM8l9ZMp?ZLqxjbN)F!|9}Ab}-kH z2=7-zHz+~Sa3qDY=|ufEutM|WC~|L*_fpnLLL)!lMM@jVz6ri%<}})P=r@*Yt^iD% z%F_kLm98vgl&32bU{uvUz(R~we@q?Ag)BD$mB;-Xj3^1%a{9e67X4uyRd;Ci0{s=X zboH@W?SH}la~_EEfk>^ zveRN;6bsMv2oV!2Id*}xU2n*wO4Kidy2i7Z%~7X?GelqNiiY{MJ$R`%nuAjmy}n){o?&8po<{kM)np=d)F3sfj_A zqC}Em-zfeXvgNzYgTkj6lVCWAF8uS%+m#)r!dIoy?#kxnn>Oe^78g`Be~{YID8O$H zral&vlVNheCgB&fZ(x_3nI!R!`9_6&_e3l3CCgiGn$c2oTT*2^LFE#&H@)V(fZkcD zyUO#L{b*twQ2QKf&&my;&SU;!SWY-6HtX!V8Xv07jZ)PP_er7Zq^a z>F68MX&Yd9L1koIdEUL{w4lHk{Nh3K%dL`(Cw`vzu07}2ZJi89B zYf3ttZ|HQ}F4APMARL2jnd%PuFGeE{`V^!GUZ4Ml_yX)0E}rk!*;mdVY6oR#cSIZ` zqm1_5f6D-`OvvkH&FB3!{62XmqCot+9X54?aU^+dCDSf3KMmSDWNqt#m zNKBneaI@1zZ6UpCkh>a$-NpLgqDuJ>i@5NGooa$hMbBT_i*i07P~abYvocdTK5^7~ z%tY#M)NjsN`lZ6FD;P;(BHsrGNi0B$jAPg0m*KAkcC$SC?$*Tp-u)4l;k%&JG^;jq zV1Rpu`8!9Lc($|@!Sh%jCP5m38Bg5}_VJ1}WxX+K_Ja3+(U&!9iczogTme0y%9)fE zuoWnJvA~t-i8v6GpCG~9=s6$0#Y5z09lMTEfilK=((aHFk|e5sC;3yPn^Yit_cOF^ z!i@M`7;(d-6Q z;#bqyptuD$e`M}t_#IIY-B+808}b9}BlvP#N1nX_b~|2kPCVEwMGW9hCs&&e`EkI} zja#)_hkU64>Q%Z}q|M3qA+KM{HL787A#gY}lMuSZrwh!k23_W$jfp&=u2OKS!?eI^IsE8;R&wXQqHm$n~(DYaLs0FC;OB+&c`w|LPEmVZ4eU12?vFh4VzWHaZHE5%E`^UO|MwWgL$1T-HxT_OO!9Y7? zL7J`)obN#qQKR5(YV1SwK#CIU%X5k)#82(YZ|HD6p+1u^b<_k7u&Xy8yy!ZIbep3t zKa8JeLy}|_s=NHXeI`up`H0>nYv8Q~UC!3@WD z_!1-!U4eJzRI^fl| z1GuH$YK>iU=w4Y1uc64dBc=~YeZTL+ZyXrSD18>rrh462gw%L+Hy4MIUvfncW8xYs z50o#`H_Gx^x!nUCi^|y3?Un9e{AFLsMWYwUvv1;?Fftok3l-K{Z>U?aUmcGt1(PL~ zyORQZj8K2QXC2>IUTj?ilpdt{m7TtAey;t;>Kfpy?M6KN{Ow*-yOQbeC9Nsf-CWxq z0p?M}onT?i2|&|50OhlKr2Zy9K(bi$DR1uNZ>(w*Q~7VJi|$YSgf$0OC>gs%CN7@F zg68pfKjehny6{+!Wo zVgxRzcdTA*YONi1Ue$S(cOsG-XGJqUNe=2SN@F%u4KO5xQ1&~>-m)`8K|zX2S>pU} zE$|ND#4l$SAG^d}G7k?5Cl+*;Rfo4wRZKeU48q9Sqm!~&2UK|m;GHhHt+p6?Aaz$#;qqc=B)Qye z`A@r7f;-bEZI&mk9ZDR$*$?$+cBmAaK+)lCtrVjeoYCz%;=+lJ-I<*9_(@4zPUeE8 zEy~0|(Txam)|9BHsxV_$GZ%I)msFkt0*Esnt3#VT-xD6II&eN_b;71XCH{c`B#b1l zZyu6lSb@c*6GVZNYBjmi0>AnITxTTM4+SL>-vC!gp_l97z~7SfZmqdPli&2)%F)Mr z>0jIo;oZ?e))`&{H3vO{WjVBmag8^-aA(IjVK@;p(!WI8eV}LQ{tI3b5Nh&htAB#|zT6+ax2636tytMAoZORHYRoa?$j>g9?J0#z z=nVwPsm&Xu)O3=b`25_QarNsSk}DTQjSEWZziG ztYTX>LZuxAZc{^{!wFen$jCjlQ(*Ld_Pd~bJt?WxDkWmqm4}JpV5R;mMAa)-ZL0yj zDOaPM_p&@>1QBTEs&pz{2h%TtQ{9~9> zyL%*Tep81j`7^Gl-Z;He$5$mpl$uLjui-oUU5!DWa1&i!g4Vc~$~11fh%%UkF7{GF z+oB!#b#LmrT=|KQ^Z|kbTe;C2a_JlHJr6c0(}I|0iH55MAZ??!z0*ZtJI5J6b%@M< zhb$Ets>u0J>0GC?3!MBIY3v8GRzd|93}eVRsP^s=0^&ZD718UB(pc?g(Wp`30|*di zq)h$*;$g)9M`d9tNS3c%D8rF-bKzcaw-&^%u529AdI{9zjmNpum zetV{J1NOm2X?{x6-US^j5iV?48XKCpN=2KuKHrv!m?u3F%tbRUv2EZ`E7Q7E?}3N~yY(GhXq<=Pk5 zd_V?fFdypv1fv?F)YUgVBs`E`SS%8NkCR#}YSiaAfpJN>%hw&ACVu-$;3J+} zeveQ0WH-tg+gDbs-cgwdh1ac%bSJ<-xoyOOY{Y7ZT-{Y)3LGs^FMH*-Z1RySFHEAn2HIH zI5iL2rMi|K2l+u*_muE;rs9h#8|05Z=W^^GZSacgoYCyXyd?Zl`=wN?TpQRQ@dpS0 zqrurb(UXiJG^3sIo0?DxCz!#v+&B`$-1`@z^ps)fjaUW=CA}a(f+&am)qXu!<}RnX zBtl))X!o3EEjHzv(FZ@KANKGEN3r{wKA?hqrb9+da6uUa=eInk5zR)-BD+k9LSjQZwU^==EIgap?Qz4VvF%F9kwg!~2BG)He6s*%d`fPHH|CbQ>y4 zp>85OC6&Zd?m&ni`WJ`}w5YF%euMAUSDSLm^dUz5<=-ZKVw_bP{qU;3x^KO3Ow1k? zh$a9{W~Jg#yTg#Y;6V7l@@I-dsfE#3t2J%Qq+9QUALswY zvIusGXlvA2L!n#zk>t-H&iF?mHA=`8-f*0ahT1$Fs<3IAHT>qo+2iB!zCWXX?9Cw; zd1XWrG8e_x+lKWgQkhkr7X8CCUzTF^nO|&R+F&{7SGrUozJMnAq@L)7Jh2GnUuX`O zdC|#-Xfml|;&^_OMbf8-a)N)lpL8{RAxG~i8Tk5>k&375nQ8JHNxhBx7@?bdBioQF zC5zbuhGT=I!7JX!=L7S1WiCK{>3&0o(MK3S%1p`BdJa-p8>a>|gK>7cy(PlW&8 zj(&Vcx+~I%8ZfF85t9wp)O0+`zqa{9ys(EBq!kXql1{7USJ$53U57P2zh^x3v$t*9 z>l6$iLW%Hpq)b~*eKQ0uyNX!#oi?-Ud%lYW04R}d# zKJe{lJiA(O4O$}YJ|caEy>(;%5;Yq8;}jF0bZOu;nTRAWP#jP5M0@5BdLVCn*xoB2 z0kQ4&K%6u5Fg&$jMx;Sf3$xIw-^CUgI`uNjl4U?$5Cz38t zc+XUQeJFgkGWd|QB^~%YCCoxlX}p!y&l_uEAQd;n{jduOGztrP6 zYh7SN?y%ShLhN=n;a+c+9v1I{GI|r&Xd_DJrEKC8u!K|ZbWy#cJ8Hs)vlMz~0Bf#r zXl6b!DJNd6<+*|(*SY9uw$_V|42l&V@6JRP54PUqRTCG^R<1@8v2SEuG?@s|tbK$NHIEnv z?7re!(~JW#^latcJwY0fO=}9!h0*%@A;g=e@yV|6$r#t(gGvv0(^R3!_CwWH7IhoM zCmeobG{OvMcH-i74aBSNl}k=9^Tr4H5PAesaxAxY={SAFq_{d!Q)hnaP^K;5N! z`X0p!du;~LSiuXJK;M=(O$8D`mCGS*#m1=gR;M+mSoD{$HR@kRqO*!Nv>+yVldpbF zDPWu`PkHyv{RCw4-!l7G_wLC~K#5D`4E;g^o&)%Y|5}nscH6D0G0~%5dHd>4kN(-~ zY*(7_q?QUl5oA^gvWsB@@Oh0!bbGFlh<(gX{u!JQp&PJ!k}$Y;g9mKL!7Eku<5)ec zkG8JXU%OcGN#%cW6sTU3Xss57c{@Mjz2HRa)VZxRqhSKk6>77)h zi8f?~99r&f+g4Y@KG6fO) z(>9L2kAlpjSr=R!3poSIaq~mhOqYuJCUfY)asynurCKolVfiy=xnu7H{#Zs*{DP%m!mf_?c=Usjl*0=B1#I_6XuF|u6nJ`eX);ll9Ir5qfS7=yvfm$g z4*&9Yt>C=0*{Zx!SvFVN<1!1=o(gX^k6YV8VQ6n%j<}>QY)PP?qWmQp6Ue=RN!wu= zoj`9VFn9X0@A66p#w(~jj+-p0AYPq$0SOd8g1Mf+TLZiexuAy0KxbG(jx7oD$AsLk zl}mrb_QSP^W^4er zJ@vgnPrRi5b#SifmHuO{9NtAc$SO#vGOr@xZ{)0VjT5?cmu}>k#7a2+oXv(0gNeT4 z>yOMlK6}HSuzut)5hoFSXS1CoI_ps&fD)3xM|pL>DVqQ41)dc~?`KKZeoydIfDqE^ zg_S3?N<;!RYNMieW#}c>$Qj;CCVrmY0~VLV6x&Y;ovT0l-3nYia~rNH8kuZzz*6@m z!(5H45GlH%!Ec2bHSI{gKW&Jh^}}D{d@|aVllNIP;-D)myY96s-tmqs}h)n4Un7&|7F95V3|vO`B+ zugFLaGbW)SHWHiDhG7^RW(S+u@A>{-et*F(yIl5s?D4$cZ@24}oFHf^3~U;#8ZFbm z3LbK-$V$O{X7WqmZnvjdIfrjlXHc(;HNk{K7;r<~a?L#N1lTi~qqXX?+1F?=Z{!pH zM#zGIW~Q~WRERz*Qe^}Dxkc0i|3=MPf$KF5Fv?3U_`TxpiL|5g?ONW}VXIWqd9#+- zv5uVj^#{e&w&UbLnv?$Fx67kUt-ZT~RMRh9uHnNw3fDob)_Xvm?DS)q(7xl4BygLUtNHI2xyz1HJ`FzP@!MePnI3gc#jHP{#+V&WNDGco6+H0D%UA49)m0 zLf>rs%I_iL!`?ACTAj(8w5Sf`!(>@nI5PcARq>2ZWk_6naEqj~l;?Zr<3$U#1<(0I z^kJ@6N;30~D9kPevUM1;I{G$jvR_Sm&@_+UTvb0~XUqSQZe4X$wvB7b;!E@vELYW2 zBWo#(E{^ERQda<*UgO0Z!3o+hEOM^DBI-2RO#<59lpm$<8V}6D_u<_1XQej&SKDe) zKTjH-PV})*v&OwOC7^_-tlYraE1?svk}QxGNrHNcCNJ7k<8=VfeF7<^rjrRMVexya z&fhDR9giRTP}ena#_>qOsUgui6LOxx1dhui` zh&6jFvY^h40YljhiRX)vhOtjmFe0}|$K?o6X*@H1B*7oQ}f0Ncd}hQeapeiu=>Ztn2>9M?bnLLX zYTPZE2?F*!&7AE*6xSanzmF0C z(zLkREo$u|9}VX)I?+4k4_yv7@t_aZ0<-cvS8wG!o9?7lo2*4_{Tn~MHSRZ4T!op- zY!T-cNv@g4yKeNY>~fcsyuPc*KLc`{b35;-G=B+sewW)@fB+q!Ja8l0=tAo06$7=S zTIi&cNfikeDFf(!B=qCaaIULz(z*IN&0S7a8Fzq|-AJOM;?IsO45QU>r7RD~_mBUn zdT%Hqq78X-4m^&F&4;Rj%SA#1dfHO^(loCjO zbj@2ecmr`XB%L)}=aJ-BvC#5Hl`@vTzGRASr+bR=Oi9q15);0*d!HlA@Qb{k1nHqj z*Nbl61g``fgU*ivL2ZSZA`AX_H~cxl6stL8LEIsTxaLl`Yux3%q&m7VUl;Yws&L)8 zpv-BC-lZ|{boMTfTSilc5Z|=d({6L+RBb`ZO@A`wFA&?V6Z!xNt(q(~^EJF)he@&~fc<^c)&sa^luWDJlv_}v7@<#Uy6-;$M z^0R{wtTmd-uxuk8K%}4CJaxC8*Z#_KB5DsJmTr1cuKiuV4OAaG|4t1fqR7A_PS5Zo zbXVUo{z~+nS$lO1ldiaO$i4<6vLoFiD8qx$)5;F`trCS9@&he(*j$!QeuB~~T5`h% zqW)54Rco~c57~;0Ucq0)pP%V`rDCBk8Eqt#TV36_I+gW|9C^^=NbETklQyZkp4o<#=im z>-6+Jqp&X27iw$*p`u1*bQtUK1uB9+B{!O0#esYpttwU%F`X|KL5Vove#MzU42yf! z)7;w6sN7_sCl)EP2B+O|tP|RW4^GqeHC^$PIrD#fW_3U>G^-X4=zq{0^i&6))Ad45 ztz8E08&$!oi|3JsL1KgOGJm}6FwkXo%JIN&p+2g$>t-ar3wv$ITQ!UK&ROG@R%T37 zvk=bC%#8e#ZCaau4EBB-U-md33}jahQto*(eYtsb^&xpX9lif*ZA;Z@@FM?{X-~dQ zTs-!m4}DQMzZo zjT^v#J^>2r206;M4Dty}zt-xChC(*32R+%N`K}#%b&WWw$XYH!%^2k!`t0IrWc7*8 z`cxGZK`=a}+YdU$%11(%#ku}8MUHggq$<<+RAO+RX-wmNQCEpn#pQUcey{#F1h^s{ zDjuLN5{z3N%C1=^CbXn`S7&N3Xa1B}R=CJUW~sWp!9#E65bI?e*L`7K$M-hF9c#&} zxzU5Jj`6e>hE^XFns^5ZHa@O^=iB9$}vyA2n~;G&$;( zQk!g$ei3~orkhB}Rn9TG2E(7HU$*&@IST)vYmz29C*G#&m&|H0?rNI%{rF0K{I4No z9nxU93bPcyWuf|$6~iieD|TBGslmH|!YYz-EB_me-*^Jb%C&n+_jVOxI zkmicb22Ui4)C-L?AIf99JIVHC+z&T&ldmG2mqqs`VA76H&#l(naz_wt38X<S+_9a1|iLFd1(YXwi`ZK#F)vQ&J59y`eSTimajYi3$9I1JEjODX9hY0{NBDE-^t_ zCmGc@`xdAxj(vjgJbL+AYo1nshI$meuE6H@CR3)ymasdCmZ622M6u6V_UWqksxBR1dxNQ=i=nDs zhZ1S2YX7($-_F0?>w|Bwukj_j9ufm{hD52rusCCAPkVUw^>Ve zwCO&GrtoQDXSpyAAidpeYPq+RPqkzk4xL+{DroF%k~|FtQg$iXyNaSWp(`RvY?E!- z9Q@^S&ah!@kVg!-s%YaqB6K?XBAOCUbiYI|dy%5NW@Gy#)n^^ff}N7n{6%4(Ez0N9 z_jo#QU!Q6a-V|^!@!*4SQ;_DHaS?BT+G^WfQBj#$x03w(!rT^iTV`dmp6m-I^W^5) z5wI}1^cCBIhAE!K042fBc6JUD`9DShMcWf;#@~^AMAmns|Auhm@$C0+(0*IQ%PYYx zn2D^dGjUIEfVtvg?_oh^w;FUf1=0;S*I2Qs-*& zHcA31Qebr7?WJVJ?(w1@!OEzbMZ5`iu6N{&Y{y}uwuI+lmy*5+Wi3uZJ>*wVJor=( zh55NGCYvrg!U}}0C7iUx?hzcBx`zW~GvzU)A4U}`D-CKprpqMCfBMYY>2B!@O!Gd0 zsgZoB&=&)BG94k$Oxs7Cb{x88Ox>*2WlI0~Wlf&DnTLpP*^pLsp zBc3jMz|^mIhV_|KK@t2|!Pi5)%i<{=juQ@#ScCQ0!pU;K3SXo6fGb?LZ^?{4N?;%0 zNTTmi*7nrM8N%f>7PoqKVUl=5lYOuRHRDY!69+2-TvIlj?y&d$(+crA5 zoP&zHdD0%1Eg5wFgdazqk1vPeUP*hVG(@L@tkP@fJz1qLg+is}*r_?nU#3=M3zf6l zarM-|r_cnQ#eU4WiYHGOZ+yIHsP^?HzrxBFk3a-~8W~RNhvCDAKw*QODo8G9n!7GK ze(sOmE3K-RZ0gFn$hA3*r|F6@_OFU1_XNWTpDDeHg#cH~&8AF063HhUyQxNGKoh(U zJCY;GvGKIb)%d8N4^9L$!I{B(>}jGb)E?^O1+72i9s}6AZ2VjJ^=U!yMF#BWVxk&0 z4!X189CK2S9`kAR=Da&YEZ?LyPt%Xk-y{ObPn4L5>c5w6XSb+>h8dLIpfRcJy`1$0 z96;Bf^CGowaJ$_2l&@CGZuq{nE;Iu!waODb5VW#9JKVkiVLc!86qr0EIoO+ukbg;_ zAeSy#%M1=9yU{9%`uD_`?NEEqcyImEWkh*|cxoq8YgvV|#4r6brX9q9Ng^m;{$vas zydL|V?6JNvA1Ga*t%#Zuc}K-)8F`{?MtXuCC&nr4m+VYB#YG3MzvlBW0UxosFH5Cy1-skM~`OSRTJZVK&1LN zyNp|t7Q1)@$_vWQ02~9?dQ{^Pw~Ii7&aC=f#;+U2uwa|{A_0-RzF~v7l_xQ^Rp;(9 zdNBT3XJ*Uy!(mOvwJjc@DDeNzNMmOY;X~Q&j?!X#QB|*Z*GPJr%PrDK4D(SAX7O8V>y-Y53WnG=ML!ioy&rFes(!n4Sk*y7;0M5 zG~?+V4jl!trjj>ePV#}6;MHUw5_FShP|Q#4~SJ3*wkJ+ALeBP_H^`d|=O zjnzM4e!5M86G@Ba;bXXmHfLAUkVhL?CsUf^w@p?tL8ox-f0FqR{d8YDez0X@6OZwJ ze3rk{e~sU&yge6KuG^P7Hf(joa^gyZ{pWB@1mZ`<4tWdp~%c+ z8^0E=UgOzT&o~P|?vG0_?zSta2R`4sQmoAgk;Z)4AnbB}9Fz?#JVL+fVjMW_b!t~~ zue?PG1d@ABcvqClzB>FnCfGSf->z&SNOsV~CoDPgouP}e-Q|4w9rT4puD}_$6#kl* zK#7awwa7aAz;4klTq}QRB;%9K4-S=Dfzacn=UIWS4@fUH;Rp9(;*N^mLvBuM&RDBL z$!!TCKpA|Y@w`04EpcsO&|;r?6-^f$Hf17Gru_?^bx93-JP43TbI{(C+b20C!dI{? z@l36dl|i%3MYUB;wu-N*+@yF&hYnuwBw;+*~}lK;eBdJ2g0F;g^{+Y)%@(YH7}Bubjy1Y`JV*$}xnn zT@fows4RKzwqm*{X2Bx7t&ROVS(9?J!&S#suv<}|;pG_tH?5+KJ1f5=wOc#9bT{d( z9hJK!PGPns_#2YTu8n2}HR-S3%Yb!!gZMPuVcgz$%eAQWUALf{qaRnq-T%dq5juuc zuSJm42VhI)F(l?d&BLrY53*%H*!xMaijU3UQ}2R20oIV6g`&RmJ@JXV_HauD8hMfKP(d*icC8*#Pzaobl+5l|Jb zK|6rMQyPXW0qHmAIoHh0!2}T)0vJV8efrm8SvCA;w4!x-F0;LSo-ku31d_(N-?}_z zO6^$*Cj*K}18#YPi?OO?ttqcxx$RWgN%oj?hf9N5?T?v5<*7a+NTQo}M{*2-=2Y=& zW}v|gO!aS|D~M=**f#a)3XHU|aSJ0MD93r`&6TKG!p!dkk(Y=MaVWKSu}Boxc9)mL*8E1vyex$e;nhK%Ih#ArHlmwcwm^2Rh18P@6GPa z6vFnXdmV^~8`iOJAjCWa&M+n2XYdK4{pS&oGceq200UXNGn@~Tgu%)!rfo;OE8298 z!vS=?ZGsOEUpc2#XAWl@gp`5kUr<`UCnugA08^F^SD7}4e3Z=tGSnX#tS72bY`T1> zXqA~@0TE0e3V9ZyI&xJWdU2)r9_p9}du*AeRU$=U3fvhJl6#X(lkE&If}e?1bCVpO zTc7?cycwQEIWjIdn#2D)Ph5JasCa(C$wFxf`mA~DIIV9HG!v@-3MPAoM*jw&7yrt& z;#D{BI*YL`;=Dtz-A&QN$;#42Lt4zfYJf0cI<*zw7I3rq=CtZrp@K9Y=S6JY3a(fg zNBdNkihLlSegW0RU6E@^Bl|EzA$Uq5vUhJfCdSrewgoc3s-~xTE}vvKj8+2 zikk+}0@P*<_t}qI+GXfUz&l_d<1b%OWrHV!ms~SlsTZ_DVr~}{Ub>{YipsTDhBq7c zude%n2{sE?m7UMXjvZDnA=CZIjvS6dm}u^bXv_wk+uCMrT^<*GU4$}m6*Q*0lxMR1 zPJ$29ke0IpKeKWQaHL~b8EqSHgY{{@$S$Bg6uSZM$zKp(Yu{gm6Rz;7-?FksN?Bz2 zt!-HGKG&@s_}CbTlD7SmZir8dM~D|os*ax-6ZR7VTl2jp%@9@5Ux^yOb#3ub2KajI zoPAte)a*!hEc?bk>1(szs{QE@O{_-+=MipZdn)B8YP~J5=touA@xy8BOUsIzJyd>5 z!xmJ;gpqkEa@L!FDS~^M+}`$0_nTF06w?+Ic=-vpjR;Fg!u{#3`k7-m6~&vCS}7w# z5Vsg_d7(})J?2zKzV6FXg#Vh-ySEu#_4F;iyK2MZs8k6;oG1e?GDlr!3I7PvRFw#5 zuKYK!hnNllXEKS6AiUcbQ6ngBzYp&mG`ad~Fs4AQoCsT98zNesEtR_A72VStZzk+s zZ96T4X@yge!NZOlDNgGVUz#3)Yahy*a;Izu4mO5N#lk4V?46-W5y=mUP3#hBZ&T7k zPJam9*IPYf0=(rw6ZCWwW1T!8glBY_iTNssKbxfMf4!%saAA22GjA7n0SPP}#p~uT? z57kz@lKRGn;!_l_uM2tpnN;H)6PcxlCGE6SrI^n8TMbtP42?j(bLv=rnJsq;pp zYQ7tCzvs^_ZpbCXv9wE*AL95nG4~aNn^rR0?yxg&nED0?Uu+3<-?%u}4CL@fEU65_y1DzVgbue&s0{a2RLP zzTFI+-xRpk6R7G5dw<}7_0E9kX_^)?NHX$!&zEpCKfu+nSca!(J3R*e# zXDn?4@jTO%1N|ZYC;kjuSTyD7t?%6x7zR(+zZ<(mPRa@>mYv=gwBinX?;6e-w{yBW z4t7D@n>8}hoix-8K_YrP^X(p-44)O>d&oq+%M4~TY-#$I9~)DF7+3vq2`o##xT?;g znyeqAFcaFxumq)NHnErtYl|Vhn0;rlFoLV-ciQ_V%)Y+?BP-fdyIfe!samvrYZ8W; z^sMq6tRAc#mvnO0KCC-bfk47+$ixdHGW;;o#5?XuWT=xa-dGOE2drELk;eDjKRzzJ zYt6BFSzwn>kBJ`38fzXG#29GeDNk7jpEPGjX|^4Q31#eDj~Q>eWqI71jl1G0*C43iz^vRblYWtCLvnxCXWmw{zC4iZfEZg0k~&&1L1cvw&eAA zUv;nr(2 z(D0jGc*RsseOdKc@4!8D*RNgdhqw}sp7F{IeUYFQZb^4%j}JfTGy*##D4%12ROPdB zvtA`)rSc>=sNc%D=P98AfCC}-{WGyO!W(X8Dle7n2w)um!E?!BQvu`EsI;)Lxs(Ko za-#A4YI$*$N>5!DSP|--;~rxAN|=0H0r&B~9E=eD-War}?3!zH8Ho0syh1{@1PT$x zCjEvHy-(W^*!?p_bF62YziSN7^C&T!^A?W$H}mo)Jr?Ebgm;AGNl#F2_&sM#$~pFd z(`o24mNvHhE!Zxmrb4t35@9;VP)v85wT-lcrhjYzWHppylb~O6UW^i3jKK<#-{HUo zY+)Z zhR9~pZ2`=We}<<@(XqenrhdR}d~H4X4A1CQE&0`Vxi%$VWLkpv6@yl7F1nV^(FME1 zXBW4+ZR~cz3J?!iqxmmc)t`-GEti9(hek2A77&?XM-i+*HMXv8EYPc%TwIxNfO5E- z8^sHyjM4`bi*S0}{)lfc0(wGH#OW2y$;X0Qi!vVi@y00S7d5M}lk0UMB2}6o2el9( zbY|7HS-L3PH;1oxcVM;>5$6b>sW)vZ6MWhNF^L~bOT;$?;i1!|=b{IE zGK&T+?>^C=2ok8~?3UkLqHmb6#Am%PSE%7;n5B*O=x^pK0Ju&*=BbYFp8c=fIMidq zD%PYlN6;0*8-d8XFP5qz&#}P(qJy6w82cK2p7FHaf>*uqAMlkdD)9RBsZ#bIrtpj- z18X_7r6SAcZt>JNqg*(#OqJv}av8rd5h6NrWHsbjA39j}0doAz@lXgS#Nc8#=T*NF zn+B#Smt1pJNb>D?gAwC z-&Ro7Ne9j=!&u#6#0@5D>&ETq5ofGjd(kXt&Lth7G;*As3-anMYSU?5)AOTSfq3Z) z5<+yUr)A0!UY6AJr_bbv75@)oDWeOpdFnFNo)%bA^RJ_CAh~JpVWF3rI9WqB?u&I} zEJ-@ntx2)m0P?+Evk4FjGQfTCYbwLGnc%Y7RL{2kxPI3zIyC+%^Ef{r-*z+@$YYce z?%T@>lPp{m@QNajg7smB?%6f6K5n-pY6eDx@`9cDR0G$!?GJ zyO}9D56eCFy^$L>wH1ew&g(4uG&0QCOvRUBJ`5ZegcY#AAYvRkfM(G1yAt)0~H2MzxeH@_%u}H zfxT*cnr>RNt#|sQt14*_E9}aUaboAyk^{bA%O$%T z<3;f1B=5d&AWU{}#5#OZyV2bhHlLyS_qWL;G8A=qvK4EDU+cDwZmyKz9;osQ%YvQB z%vR@k(1$CaA6u9EYyIiHmK)T zpt)*fzV9TBM|CO92ib~ysb0qlTs_tBU_vr5&0$w|^|+WJ*P^!+T@kMtx^*YyYdOVO z#-88zPVt2C{D1T+Px^Jb={DUY$P~eF>-zYG%HoJwX}-qo6gKJCe(de27irmbt;rX< z|J8-FAG^%HYX^~z#WVF+cg?-%G<&&a5VdVeZEz`C^F*<}kTgKj#F&z56(HhXZTRmhQ^5r1DlyE5x)z#}&m0FTsYJ4+jkNCMSvtm9^?GdPH;hcqSc zQOF09_=^YOU7i>Ob!na~(qt1F4J9H#?&zf|2K4Ajnu@mOzW|Ttu9<6!z@hX-gcEdS zqG2<6?I4XW3JsnP&E4`b^;+{z#JzQ$|HI1%S1xIq>hvJG&#a6z_^!)~qGi7jAF216 zx#%fMamf@>J7+2Ohh*a7XWIeOrKtP8|%Rj_*>(;6T0fciU)BP6e|w-b7qmE?Kt!+ zYcG#L%c;U37e=pMFdee}VCP{((w-NCAKr~RikxlWmZ%ysFJirfvAEwyhBmrjgXVc& zH^6YNk8tbiA7ptL<8R-YlH}^|ulBd9KP49Ub^Fl+u7kEj3PwxZ`f7UKH)ki;XjxrN z_Ic?lJt}`z=H?PCgc%zHoVc}U@_lPr&Uz_##D_A%4IBucGreW`a9j&T_@!bI z^W2Bp)dGFuHS)@C?fM*jr@(o!WvlA+G^!vUU(qk`XE|6!6!?Q#X2OalsVXqZ_^SOa z@B^>VrR-20V?g2dB2UqlZVd(yt@@SZKK#iqFCtGv)K))@vBy=xscrFI#;!Mtt->OP zO_ucjiO%2RiG86@H16MkFRs^@>bBIT*aF0~zMAq$N7{i^5dC@yrYTQ+0sYC8iFF4x zIm|gM`w#%Qe^0ttR8++q8$N+uDyqVB>Z9{CccU^MnGRm1%GQ7J?KUn|j^T5tmmuM0 zEaHSP*dJHt^{^%`T|QoAVV5^F0u5)x!763-|^i|mXT`UBBUJb(~pM=QHHZ^>wn zDL1Lf6t>2O)64F)6|JKDcwN|cxGrn)4Gpv^6u)pooh^=;u5<33-YIrvnGlrNi^Tpw z^dfrX&i8K(3CfKha_tSO%?&aPkE1%kMUI+%=I}WPOZW>%A1^fM%yYtQPptRJu6cp8 z?@Y)SpOEJ%J0Pk9qpTg^*M{k)5&jGd$?9|J{SEW+QvTVmqbRQORYF{X&s9ikQJK^u zmfI8c6zwgU7g)d58nTnwL*>(3*JFdG`PUK?ihP?qoI3~9vv7l}&Y=ZTSpmYliL^1D z{lETf+Uer22D$fj%eUC-WHn7#E!9||+ux`63P%~1Hl(u~+23C6DbITYZ*m`*CLJJ_ zg@F!<^A#_Tv9YnwERpz`1#FVouGR%fL~2=j8FEVOKX@Aqczc;H z_Mwhzx2>@jAs+;2?^yz3%>j$OQQ$FXaag!d6J@-qn7DYa2k5X%M}xfQt8{Ejv5y8H z1(7&Y4a0&q8hpEj6T1Whh`!H99A#=_RNI(1F}>~K3T+W10ws=O3~SD^o&#Vlju0&-~;$M!5K$YgvLwGf175;b6)YN`7H2S zIBDj5!RTA^I}_2riz1kv?Rm!Xwe{mRB;xia8ewKAzA>NNZ9e|uJ_#0eO}EGgpI8O0 z^;+${y&x{jXiaw`0^pUJ2zUjfVsRr!irU zbKJ!e(9m>o0^8vnZ`NAj8216VtN`V6*cJZtiiCwQch|e%L=tUbt4OZaNefEX^N98q@A{J#&WWQjebP z&XbIBbg3WWq48kEBCw1ap!T?6I@W^L;+V7kj$!LD+avpHU$GxZ(yccS644I9*XL|a zalYPGiLo~e!e$B)Jx}39^ysas&08-?3z?&S(k@ccxxAp`q+ z-#rdA?=EF3&TV$4Mj?gH0HIUI6~s7a106{+3ObfkoiJ+1jAfiEZz=`|jdY1qPo{v0 zI@C$(%M64rBRJv=kM&wFk$7Q?4C)Y!f67-90tcKXNHZ@~We|}9|HQGrzpx}z=a>C! zJ4l_HG_i-Q7zA6Op6Wr3eG=t!fEu@OseGx?v*DS6x;z>Ern@{RUmywsq}yCko~H$WCQXk>=)1QPbFvCkSCg zmLt9xCNZ$vd@d)sVZgFT*}c z36Bn0Sg0>227d7A^?{V>(LF$4hy*V|%^jK>Ei=zDZpBusHC>~82H+>HI z43Idq(Z$4#431~w-17UniakpcYx&VJxP5rcJI6d5B+x%epgh4oJVa#-g3;W>3#`P0 zt~UI&Su@eOhm9}tdE-W#8x-Na;&p`W?1*vV#_nY0?wkTlJaLMbu$5%5;wOK?4ni>x zf`$G7WEAVAn!*|ie~xqd5Iex`SUIX-@Orz>PiWd!^a|YU6E{Nv=}Vp354fmuV1n?e@x5MB-E9<%;K6SD#?jlM{K&gb*Vpj9S$((wy$1A z0cJXr%}v3}U0~OUkutk@4hNZ*q|cz!QFn;#sz#}^EMAdCZ~_ud~qe5?(|Y}7!T zpLN>Q{MJ$AROYt1D$&UjpOQpk8LgZkq{bTI#{}Ke=(bvj)@Dq#`e&Ok<=w-Koy4$8 z@hmFjb#n%y>tAc-?zFTwz7Pok4^03BO3n*>3Im&CRL!Ly?8>oa8C`;`y1QzMwLvmhilgO0Q6bDxZg%O-2{Yp|WC0eVssCg`7O- zL{l`s=BrG|rrW6QA}H$-{0%p-3Lg|-@6hcfMOvTYv2ToZvd!a7{xzF~SywWHC7vxO z9P`#-aY3=u@b~;PhC+DF*p%xh9eJ5u;(4Su51{2>n>_G?heLt7kHnbQ*I5(hs^h|J ze|e=*@v*sfWNo55)Rep~MT*-+k_Sxg?92RQ!ykSvKz%L3Pc7KWJ4_J@>^pZl$doYhiEdt7 z+x+cs*IQ2kLxM>=po7U^Z6s=5kF32^MPw5hTa!I)5rDhbxYkUjH!>A?%`)6gQ^X+i zv|H$JQb`!QMDOnDjQ=Z;8Xq$A~o_=*v#)5i{e06NF^y9yg3U>w`io4HR&=3JgLNw@52)k zD)gB=dYDjUQdhA&d_h2c4WJypGWt@uNeEx)ro zlbbS_f`hXIJ1NA~@qvW8=3lJg{V!N&$pu-|=<7TmtYtZ3AT1bS{R-o?@j4Y)8(N2} zy{o}Z5vH{PO%jU*Ez|CV-Ls1Hf<|u3iL|qkuEzbKF7^B9Q$0a_m@}j+8+s7a0D1>U4p@^W83}A%i_T@4TQN9ASm9qO_ zFr)+G0)r06Ng2j+@>Hnbtr?%=y7K%$1KnjU6D>wo8ztfUsTZ?PC%EtsZT3$;6dsS1 z;vJ_%32jq>M=ckaSAmpx8|%Tearu1Evqs6nLJY>2*!ISoJ&(>oxYP62mkzK*rs`&w zaD@N#N_TLW>K`?A_?{X0@e^V-3 zaV0AF_cvoEkISU6BRp4heiM&~`ybWUoV7Y;q9-?xeL7RRI?1(U^D~qz~oq2^Jwgf>0c#V>X3Vn2%oim5{Z^pzGV*1`73T4xp??Sa5}w zB6mW04faU&P+c*2*5^e~cQCChVTA{uvYk7`-XCWgyJ+UJTBW)D(k-*k!|~-e+COZs z8Gy!lU}gH=h`tJTd6YS^GmchFCX>sm<<{QeyZ^Njq__k{ufKgvNY8?*U*4HtRDDkV z2nt)dsCgT`%ti*)LEz(Ua&yl$Pk;PIBDXKy2`6;PmX>h6ow%I{yjAX&W#w>9EH450 z8}|jp5T>T+PEZ#4^uU-CZ?N-_(AVZQi;IkUE$JAj>bbXJ;MD9_kqw!nQTm9?rp2q$ z3$X9P@JepkX9zt{^XINgc180|FjSz~VH^hhPxpmeQWLsIQOraWaXcC#l|Ec`+vkmb zJtEyYawwj*AFv$>Zgf4WZUwpY@upj@Ed=e7^~%k_9nk}6ZI+HPU_$uW=oQDlDjGh} zRg;eswhvOh>nr|uvdvYYW`_YqG?RSD*p<(0-v~}okI3U6@3ucmE!`dgudxZ$gJl>m zX$SBZoGb3CfU&_Oqar-ixUyQE9i(IVG8$3}j>xlZk}DnpN!ImYT;WVrJ2wnzGCcD) z^X5^PJQEmx*%;pMkRq)H|+3RnLnxYzE|%EQ@xh;E1}6}RWtWA zmQ_w$ri=@Bk)k_Vr~vKm`*Fd*Az@Il7}X;^AnyCSAUvdftm-@Q-nY>+x-{i(@at5r zH{_F-vfZG=CRe`0;j1i1bwfQjRColqMRfnot{#{CKmdfai-NbLlEnqp&@cd=YlhD? zT9}rt-N4E0tFG0F{Rqasdv-Ya)OWE1=a58LUwjbOCxL`0n)LFwT$T_g{Ib))#DceBqM7Gh^a)1X^5uaCF(Hc^;l1Y&5#Tku>Hsh+Vn3PS3O zJ*qQ}OA1@U;z^yiyZB=@EpK9%$Yo(tI1pe3MZXT?Q3ZnHKr$c(B9vb?zgAJH^VEMW zEjy)fwDeqXSff4z0S2-89y_;8v@*i4`1=|^ z!qPv{a7!QIhXv(^-5gztVfV_tD2wqes9A+&E#);pU`0Q4X1c|1^vW*fA-0iQH{3+r zmxgmS6z`Q|a@I>!%?MsUv;h7&fU{OCOQ+tAWc=I;pPJJAC$h-D2Y0aonc$a+x>;0T zZKL))TDErQ1?q7H9-iVUp+a846TIB`r0^$C4=h}jMTVnBmPzMIg*t-(>4(nK-ph(@ zJ%i|alc=vKTBnk@&~ICvkKVCw4mGrND#*`)Y-Xm|g#sA;UvQ!TiA(Z*wwuFZYo){7 z!rFLrfC!s=cNX}QKwVedvy79VRi~rGb?uV3JodXP3+)qQ z1N}m~dCm2iZwYgzO~QMAaVeiy{wFXmV0wCV;_c(vPj0`fVsMtpTN#{A zZC@POEEX8!@jj$2%pN+Khri5v;GGl?xjK$u_%$J%)7SnphgZ8Iq-qeM^k2d4D83 zDYuAj`H~;`>sxcb;EYZag}+e#nfR}$%^Sll-k~)Xj+afm>DVB~)af8U8`eB|1w@0K zf4fijj{9<%*hWB;zHSnv9bi8>)9ppK(1wCrFbtAyrDbE<1NN3$L<_T)hKA&7@J)5; z1GTQ-l#UN;L$jve{BnEq*G*f(UY^f!y6@oikN(JZ?X17-r+CkLcTQf~xiY~s#T&FizcXN!kB;k$^d?{ zh#JvCi$SAIbyah3kN048oke>E7k4!VH}@Y5fWvt*BXubP7qzlZ1Vy%`{*Dh!r&(?U z)ARVyYG8j~7ma`_HDhed+xgVE{ar z9KZ*-oa+B{=nkdIQ8nIkzi{6vKX(1jyPEI^<-J$fr9T#7v8KvD&-Ik4oipF#6d~!U z>hedOqC5s zzNr6n*%vd`6d}bO8?63X4)tSEE^>Flp4sD+ zVD1U;>@{b(7ZjgrEHqm-ylp%OaY;UzeC;L4o7tu&E{=3MS$&bb8}|5@rX};aXaK)$ zBXNsA4V5hnC1ri+4QHsS@gVqH!FY3S_V1SLc9vbq5y6{rOZD^t)IE!%m`yGs*97>l zEct!>s-JfES2X(TRdqNY#gdQdEzM!a>d3DDBK9wM{WBQ$$-AJ->c3gmX-2H@A!YT& zTxW#+Uyb?`O%tQXRo|MjFQv&{T@0hhe|a{1iF`OhjlXqLVSv?{WAm!b#s%p@=utOE zR_xaZ;v>8s{>^M?E*a@ARv%hHZo}jD4`mwY1>hU& z>=GBLW_!i@OTOA*C(4E9pA&=DE*zj)WF$Kbp=`^pNUV=ycA#lbn7DT~%Tyh<>0D%c z_|~uQoo}FzlYfV`M?JD;uTtQ$raUB4Cm{^6C;46APH`EdsJ-ng`M(A$b|?|-*C0gP zej+7{Js0^($oePRcuZ2=WfxvJmnGWtwUfOVXcP|>USKUgT{MP4~1Y=wBeB4UQwsWUl^Bq_FvUd~&1Im}^m z-ki1wbDqN(hS`SMW_*2qzsvLA=jHjw`*Cii2Fw>AE!1rfc4p!f(gO$2BCp zNt?n`Z9}4JpNn8y@hs!!x6UzUDg=0alqFgfr_C{|qqzOw8c?k;iIk$Pu?m@XF z&r3kDD7p0?dvvQiVEAS*aZQNFZJ4a?-uAu-JDv}>opjc{F`Mu_{8e0vcZ(Ya_cUz( zg}Zr_jq|0ydcTpYVaEoQ*)Mv@;X6x!WJayk_HxfccbZk6Q$=t#xOiIHM;(!9V>!m9 zidtrlb&pi9iT5bE?tUO7aHP+2t|mG*6lc}r{M+RHY+g_K;Ly)=w=GPoF`@n{D9p50 z*Rmyr;Fyl5{{+&!M5>ZM3+9Ji4r({(I5C6jS&1E z6-<`hbXzzK<9BGu#rE3>ZFsWHubJ5~teY&ddtTUpt$L*h*lxm`eNax=)Q-56h-B@m zp5tr@wR1Y;2kS|3>EkAfePOo#36qwy4{PIA=A`=`xnMI>EuypsDXiKE@VFS5UbS?P zp^S^;mjETEbB_ehfT;`iT zt6K78xXA{hRNkVQfw){_$TJ++sz?7cTRqs~XK`N8d5ziDR9BlkpPwkfe#o4=d1>oM z-(uiCbTrlzjQ?eRr z#@p$0hy3xJoI2rUMW`fK@)xgE#4$7=j4E0)$ zKy#prVc9svl^)^VS*^xNAh#Un<2}4)MlHBQbLBC$*II>{)~boFKnl|%YQL3)uSsx9 zOXtiGRX5)KYV*cRsWhdvv-D(v6J2TrP+u2EBB)lKmTljxlN#sp*M^l(_eV*w){P|Yj$m{tlf6V7PW?+cdHnJ zLDmM|qnTF)50~Z@gL)>f5tr{C>$fk}SgTcDm)f2Pv`lr7={8h{Jk*DEk!$@Y0%ypL z5<>k<*MSOgVV$8ry@;IT zL$Mr#fi;jejhGH5YP98Be?n?C`*UF*+@mXA_DhX%Yr;9j@z=u(iJx4MRf3Tk5PNzY zgtY1TfIEM%+fs%F`GgZ0w0bauyihUXyFS_SVPyFev9t&Z56EGeoe1!G+V3K?+&A~# zkz}H?cA0&NO@~c)JkZAIcx$unaM4#s&IK+a+i|3Geq(XnEnh;k$ya6;5U!mwStP;S zjymgzk_ztal+c&VX^s56h35BYuXK1)AC*y8+xRDE>a%Cxahu7S?Q~Z0Szp1|Pf?lO zwMpE$P?7H3W`-54*#wWo0OgzXfy)k+fhEEwXh z)H%~2epOttWLwb-acV#vFF@|B6(n@Lw%PG9l_ZxSQ)IWLx4hrbUjHG$z8vm)GU~Op zkIkk?@YXJ19yi``?Gs!F<5fjGmqXM`-uCA?Qd_yRlmf>`UAiTZ>Y)ou!i|kR9y{nM zxRqKc*eTB(s{=&O89h&s`OW9(-3$O(La+qH$cJGTmEDPVu>Fw_0 z)qMeQzf9$+rs+}@_YTl~zngrQpxnRP4OogG+Gt7=9db>U;k*d&Iiaq}!T1?hyJxP< z$(mbD;8%HL;AP%9`hRT8O|?lNax^7$XNd^CJ9?>5bZbAwp!XQZ!hR;j>LY~CQX8Bm z{K9Gz|M)3) z1n!vJ<<>%Ywh=+C+1;gOfGcQG^c-Na?)R~}$9`8Sss5lj^>?DtW+@HDxJAGoeqox_ z+@-BEdUy|Gti`v6FlCj&KSR9_rT#qfpVReehl^R>J=3r+cbf|*djetz#eYfl>5m-q z+*+2U=S*2S@q7vbamo`FdD=TEfNLhMtBy4K&z(!O(St=}r&6=S8G3m2Z22h|;P8&E zLrbo?ar!7xw#v%#qLt4(cZlpT0go44p`JIHK1*A<`8hY6o=%c9gxVbEw5K;&%B-qS zjRjQZGpdaElUBV8n?MMQ7n=t1N1pEC%MkX=q&bA%*Z6EzHufn z*3anm}<%}{oJ(0Zs{tIK|A2TJNk2!fM zZC%c^HZXp|ED?DuQZ#k-LIG*CltpN4li9U1NlUf{l6ZbtxKPphpf7K*zx z``k;e6BS>rOA6nc%Psyb|`HrH@?!me<3kMNf=N!T^P{d zJN<&z1h_bh8u3t(KD`l6d()0zG5WL*U-o>mD=e~hQ{9kL#=FVG1umG)P9m2eGF}A; zbWiXov64HU+3n;La4tLAO_Gm3c@@h|57=#Lt;B?c3xy^du}+m@I9`RXVFnIVfsDwEE6^X;~H_LU4Mmqr)txA*r==ddvSFM}6aa51+Lu``2 z;+CAnE{)?KlD|E(J2dLzo^8|aKkrrfcqf{HqWqO2nO~#9GJ>Bvy^h?q#wFMYC4E{v zn}3%FX7gGTJmy?|liBQ-T4rEHz0rqURc?Xr%q^3n0yJ-Id3#4oB4tR*pRJ5Kw{+fB zH?m6FFmzH_?-D%&Naz&admi@Otn^5MxQPGg#h`p>t4@hf$^d=?(I z^uyJAJr=J&xKHOzX&oO57ak% zFWT5gerOV0Xqjd*>5k07@|x%cl5>q5TV-@U@1G`U80Lic;0@Zx7{d@cxiEUC)#%2a z!5e5Wus7YM_N|s$X7Z2J)L8N zfUULlQGC}^b9zoXJ3@Yjx>5DG)PU~sIGf^Z47uHj?q6p;pT{S0-KJ+1Z@ELkZ91MU zu23tP)-^`idv&bdF&P;ynWzrFBr?0_5M=%D58eB!0hwlPLmMCAiDYz@@9?PNG7$BP zF4FS*nw6XUvPA;tvfdAbW{K$elilpNI}Nrb`Y0QI-%sY0*{t?|`2RTWOSFRvcc9vZ zikn4ga%D_THcDkwsbHf`!tY1CXq_$AAQ8j2`d|9O(M=+Ni2PYzLP)LpNlD9DxAjvaQOu%Zl z!v4H&*keY(Yr-!OLOS%4u%IM{kwUfht5{+eIH@8>0hF_&WfQXm>3>`DZ4wUbkr+Fv zMvU6jNM@tg-LAU^A!pq-M?m-%(DromwnRY#f*he>3k{Y~zH02dth;prteFFYE1TUnHrppgE>$#J@ zK{^wrqCex#SUvYC?l*f8-PWymbQZ4BBN>ZgU5+Tzt|25|u52&NZVzexlL!eN0$Uhox=xXRZ@t&NUwbGg8=o1Rb`HXTg*y83=C*O+SP_Qa6=W_oC(0aeVz6bC8 z48SpK{-0>MB!d(8pFL40d-a_v%iAUJgB9uvtdVscYEbZ{(D$3_Rnyoh;j)c5^nPwdb+X{DJf-VSH8eHg4WsvSBA7*bn^pU2#j3HhCx91;DXU(8d<1q>yaV9<;J zc%*NaU)N@m+2d1$;aFz+-I8=Bp-OKAMv%*oPq4gC=mdqYly7@ZJAV2yZ)_VeCXo#{ ziyU*K-|w5O@wRwRrL2W69fMR1qPAr@DRp*5LAa53@L1*IWjeh7gCyQs?B!zmLug&n z5LvFfq;WpIJ(m&HC;kOQ2&_g_tse68R6^v;l*PN?~ON-LZ;v;Zt zT{@M3r5`&WfTeNP-J+eBltXejQ4|JBYmRD!YW2eF-ET7Goxs@Ua!lj!doC_`M2(P+ z=hnl+53dcDD=-kyS*ySs5RV{8BN$4n_fXh8p5LA2om! z$+qUqk@r-4cfZGP=xI>`%P>b{GvZ##W!D{wmP-2adi~wfuVsw~hmDm0w4Ix}?j@(1 z-Erj{%2HSZlZRjV)l&xuD5mB4gtXBgfA>|bJ_k>u{;>R&n?&GWa?RYyaRsmSNbjhu z92b-ygvJob+=ak>Ui{h3%f8SZR#tDzHvG{GKOhTE2U7wSs%H;ND0KuTY$su2c8R%pLdd zx@LX`b?vxals5?;DU^fCmXdWSZiw8QCN8Uv&mAVLKz-kSc*``h;#1mk1YNP7sRd|hLAy7652}NJ49W>4nA%*M~ky)6l;`5wxKIz z0!9^f5v3QUZ%pj`6I%3QC?L$!)8JLxz4Ys7YB)Dex7~C)Z$* zy;wN5HBQ&`om%MA51@-LKCE|1##Vm%hOSWmcukAToElP`^irOzvVn7Rff62D$F*pm zPjXDsdOy%coLNx&Kd`Hldp(TQmj~rkre7|x0kqu7DoDY)N>hHGiM#>^CM7#gk(7+{hi0^a!hew&wRkeTyzhKrTo`$>oa!Qp%mgXY%3=gXSm1%?6b=GkJi=&i$+Y zZoc>tlY+#$YX4xp9+n$(z{nH2hkU&+{T$}6TWLYh#-ed}5*zB~^EQ{4_3L1|qaX!1 z@7~9P=pq?h0+#z~U3~tbNiFqwpXw3TA&QcBHTI{4j!uwqBCpT>Dl=^)p!PH@6;hFc zLMT(6NZlxWLo{E*htaLQ{CoZq!tYhFtkA2G=k{Mfa?&8WMISXynH?d*_2%kf^9O$V z%AxJl1Rt+MqT?Dg|3A5_KV!*#ZUux^^qh)6CDs@_#;WVtg+5VzB-p7_WyZ{y4J6z*IpNMU>dtJshx|=K2S#AA z7t=-Zq6xX(S980gp08G^_(1VLI9V<(THd8218XU^9K{^&YErP3`!>%hP_d&1kwoE_900#ZuMr4anB~M_20uiPKZn$rnFLMi_f- zDxHSg-D7A1V)rT-K4HZUdC7(>YQJK(rLoThU4V32w*z{fkuI|XbyC2v#Jq586Q-H_ z-~-QTt0sg$;vwhNFbXZv&*~#|t-ac)N}}%!dutq8sO#D}3Hx>WLVMvoNbC2)@R1N1 z%X|Xe>p8f7*W6@6vioB?tyj&J3US__25YV0J|oQ_9M9>E*lit+EjAN<3l+5y4`!{* zMQ6JE4y4#Z)Y)(cPg;a0fQ{_$jHc}0uCDw9Z>hZ|(XUlV)LJV zpQ50hsV1P<>!euoYTJ$rD#mjNoF7I3JSkGNy98c6DZMU4gTNN~NuLg=vc;LBPC z9|nA;DiZjds6Gv!r=$j6I5Sf|WzD~#^Co;b1Lce}z4|vPZbxVFI0DGM39GRr#522D z_gdc9elCR17_Am=xYs)hN9difnaG@o3j#cAXS=aib$B^5<(VVsmx}`#AkT(vVxmwgJ zIMg?@ia`D<$QNl?HZEHJ8*-VwYKI{_!|3bX75lYRH2FHjcDEEP4~!Yfc6l%9SzGMv zp=ASMIF3?quCT1$B6PG8|GR45{2}h$F8!Wwc0MvKADC2V>SLex%K8xd`n6oz^WlGC zbhvGp*AL}ftxs2U$5@6Y6T&ZA{NprNOjv0C6I^EYrLyABr}xT9YIuwI7o=sV`(IZa z--wcFJ24tDmfk^+YA?Ey)S>AP{h|NVMzUjz%V%s-UZN`B8f!$Czbd#mX-PeDh-2&O zI6M2HXe}(qU25|y0;maN$No%YUBb4*}H>`0sNSA4h46N}#3fF>f}&E~R|+v?MM zu>$t*_2!E48`k*Y!SgfhB8W^4s>&M$rC0)EZtW_;-+DnA*#Bk8QM%2D6q~9#hnWclm-koLWj5J+gqSqG`D*yH zU@DpYh8OppxDM0-EGgOOTvw-KzPeA8A3Sz2INoIX^aCaWL4Yv3L+A45#~K-tkTlOE zO6T3aOYw%4k2-}E$AE|DKJd|(WgnzA$9$%3jMr>3NDT912-y7>F6Dt`(jBKQh^$Df z$hN<20+6ze6pVAroQzw?ytkO) zV+Je9jQyw0Bxc5Y0=P`LFs)V8YSXio0<(mZz2fSC)jGT-2%n6~z$7nk9&wXXlsKuI znL=UOI%*D$;;i+)<~aTUeyWqkxo#gT^;Zq1x&oiC{nU$esKnI^Pyr8dQWj6DjpC*Z zmR<8*pe=bcY)G0e;<7J*M?dP*hH9|UX4&|Ct%$G^s{Og7t z#saM*oB)0A&DqH3Ov64cm#QsDMcEKf&WPVUt4urfz;+gJ96xs90>eU!SM6~$Ri&ir z%VEH~^zmP~Tyu*rFOr6HM~}D#MeU-K}U0=N0HA}C(KdUp0>JkMBO`9gJxfZ38n>gzAm;( zKxFO86q`HeYvuH*XzvBLIp~W7erMRxu1J*6ZmElce_WMCX9>*;bA8_1GL2gGCoT21 zpoRVQ;_giP1Mi~};1kpY6>S{~)2rLZxl~xuBi6E$kft`@d@_ZsF@uPLI)k;I)zE&` zE+eqc9S!hc_QA4EX>HgV**yG*Z}5!d?0H8GcVzKO%c279;8Z#L>&0L`>uI}zuXh(J z*+c?Sxrb^g6y@FR`p1ryil{NhYYQIzq_9Gle7C`? zKYNY3DKoY1df!Kt1@^-1?6FVt0k&VX-^Qg_qVuRnW;M_85WbFmCZXh0t8%* zUj)kQ8+$}qDdjV(u^BkDvr^I8t&4lsDa)$|fU4Oa^ggL`d@fX`^=)=Wv1`Tj zJ|*kTS_|s-RRW)jn%Hry-V_`2u%cvd9tX2W=2HBN-`N>pyHev(n&%BWl-QT$w8SI2!Pc@4Mb)2dQ)#iO8wkH6L-;b5aV7Vrl~; zaho-E28z%{?8{bh^{+bMYVZDcVq_wLE|D%|EL&yJO)5kNHe)7T^%ZfI`^uGdfW#}z z&w)6cnQdsD!BU91l9JpRd^n`nNc2T@5Z~!gVjU6_+A^$GCN^UDUg!OFz!L%{GthN_ z0wR({X{W`dq8vA8^Xu{W(51jTErqv(PWg%n`QmS(tkH(uoO(ogj9r~LbYr4}EbREO zvbxbQhPWPyN8yaD4Nl-hX{ZM~#Y?=i@0@0oT=4~7BQwUg2^6Py06{*&F)70c@pmR% z+G8Hbw4}aF3Rcz<2WB~xrYF3>h8)*viE49zhKYO9sVhjB7H)~c3ud)_i6?&EQAA9w zQ{zI=4bGtDrtZ~}?v(XDmMe1f1o-K#hy3WqKz&JXcX>1F_UhlN*BPTV^{*27 z*)dx$kG^f@i{KL%357SjpJeqK(3t%Q!x2X;1h{8cgxW};{t1I$F~R|GLe+D=S=W7qI5g=FFb-kKl1(9ppif67QN`=WM}_@9M1F& z?N&DoOHwH0&s=`Kt7Ueta4rP!3ZRMhW_1$TRdTBV@e zjwXIH@rnG=mXF2I@N8_#SVmN5K@1^=&CFzX0kJ)tJ(4>U;`S!o?a1>=ree$y-59YK z{hZ)L%cG?uX#vipR{1q%}o*9cI@E5+?k278@O5c;UQLE)fCpq zPEwL8wbZN83@(K4En#GdNv~^jzZDYc-|1u;EF1$dt+q6JLOkRtaL_jbEZw)M8Sy`( z`(#Pp#(PEYNwKcrCYzQ;t~5zBf%zumVm*Hf5=2Tb$Jdiek-SSBqbs7HEU>r1v#_@W@hu=cbR!C4~5Q=UuAP}%F* z*c2k~J<>|IF#98*4^sOd{Md|LiP>&!mh*3>A^~t6d3~DAZjdugA74{9kYu8zpdE=5 zsmQ^}z{4gFyv%PaZJI?&oLlnhTk(C=)sNRAmw@3sXpDSS+cJXUGBvJfNSDB(nChYv z{?VStL6nA@by>H15<|We4q}X0ovslwsi*X24nEe{Vv<7QeHM4-i>E;hd>~P6L)TW& zvH|#F{;%SzYUJzSEtqpc9B2MaG77JDWtLghx`AT`t->iCtRf{9Z1s>^+r};g>i!!Ka)a_@Hv=f!w&J z=o0@%{$Nv_ja3?n$DKq99`uoZiq}c0=Cjr)!Dqomqi`fJ!}I$5lf}|kb*nB_WLMlj zFY;8@n7Shx{5hLOG9DOg0#w6$v`lZZP2w#f{!#|)40Rvzq^-bf-*HYc`Jx0Y35Pl%Rta-4#^ zRlf1ynX@Anur~`8G<`vSKjt>b2;ejLE9GI*NqRYf9NkwKOqHN$m7VT&JtOYu7Wa`2 zF>aGZOkfIm%-{OYux|o&758K617yT!Sp71j{bb-5@d)`J6P-GhWiUzj@pEYSI^G}k? zfrlU=VQ^bLVf1ylS${z7neeVqmLh%AEq}fP#a6gY9g0DuM5$`>XT$8RNi(YpCu2Gv zZl8&k>=Iqk7R0b&eMWXv<|(#M;GZia!LB=3^$1Q6@7Qm*rZ?bDa;qHGHR|%wO!(*t z`6Je8!iyh3%z-jXGi%Pd(tXmO+fdIxWAE&(o7rS-7#&;w=v_c@EwIcC5vHLSlAv~d z#!)2eR5q}i77YpuVRW^9W!)DBd>YqUZ@RC}9t}$c9qv_o)IQ}Lb-TOLaqak}#VdQO zoVLECl^iUTUsyfGb$-JiRl1w{4nj~tJAqEQEp>R>AqFX{mEH@LRcl>jg1h|<;s zcq4{~0`V2?O2(Py$>lZB|zuU9!UDLhTXkj%40zXHu&0Nn+NTaT;kHxd^>`jjBGhp|j*Id6M zVeZa03H83@tGZb(XCTdUD>Xv1F99omz=zxOun^%+VHN49v`F-gP*xA)r3#$|>sQVO zW=Kgtpzp^E-*#hZr(AU)lHT`YQDCF|aOS@vioXB+Nu7Hk_eUWWz;vIuBHCo`-8fLtj^jFIP&-oi`D<_4u=PgpEbm6BQd9-Rr`=g&)enJ<~+9!Nv zRIg{5)|Kbh>;pU#5v=CkResuL%8p;XYc)k*s8;JD^m%`f(IEjUj%5H`3boMQ>__W3}YB9dXRo68o}6g@vAOZV^KVsbRKY7>RBb3$%rh(%a>-lQ z4GOaiM1L>?@W$00=;1}G9oia#`^_9(TBUlbZDaV$(>t9@U)hudgcej^I*bck8nXp!%)LO` zvjg$8kG5agcW&Sq{m_n?6sOW2<$eqKLg4Xkv@U)e^;^c5s&xM&wn$mvUf)K#`#j}T z!H#^=tL?n&`xwJtz<`u!S7_Vcq$c>EnhkZyzhYI)h^V$&@8+OUyODd8GQGc_^&U;i z%q@Ci2TI~i2DP;TFM&Tu9~Lt_zYeX>+benR-O3~U@mlxEqOU!>=8;(`0Ig$*d+)5u zd`dW}Qy9HHH48~t>%%k%p1nJ0WL3zGF4>)Zl*Ee&P0tso3-ucuM2LFqX?_Q0!YM&mUf`9b$DRK^r#jQB5<P5VRi0>&0{p-F^jDk&c-JLz2OH6 zmoltDwqB#y&-KtoY?(w?ar8|p`^VhB;V$ALO>X&%Vi}M6-Fa(0S&3%mn<@6PXwyI8 z6lSBgmO_65d>);)PA%RbHy1}!KL+xM=I_5VV_OGQn_KYLtojI-UxpiwY=`CidoG;y zspfM>R<+?Ts~_$qI}0w^Fa!QF{m5UowgxEC3aK@^IxT`1?UJ)}kInVwts~rHa&=F( zcQ@=oJo!;^fMPCr6gr&KPAjyRvIbIz<2EzQi4EOoJ9(>Q-(QKq(W4Qbnv0L2N`gb= zbol(MP8hq-tZVwC-xUejeoG0tM4#@(L-bXMQOzKb2!4))DZb_Ow)T4}0LfYOj`%uUsR(zFDgDpL>S9W~CY z@_Wsne1ZC8?GagbAOe_bYc8Mw6TXcXezd)?bv9eq#bs)&($x!BxR{VZPP@zPZ5vZK zFD~ZPD3M;xqqg}pL(`in>t+n1efmjX${*<>M$=bMTb**IL}&C;G=~ zf(WAI!8`O6iK`}FPrzPYWE&gJ0t5kDRhz9ARN>6u63-Hj|!+Z!4Eo!p}_VO)rflh1_NLFH!f3A zORe-+=dHn>tH{$ZZOCa~u7(^!!2YLd*e$&Zg|c?xg5xa*xKY<1($od&w|SVa?P3xI5A=SnVck6#KJ+69 z1m^5JMu1<0U1U$4UTV@DjAbr?uIx9ni#9TsX}Mv!O>BKc^}th|&}0=>Mpc3o7{1L1 zfTbW^Lk<1Qz2eVNP)-5WI?aWToN%*GdZSO6S%aAYlhxLD3`0v*9@%DQ^0~$t(9LW4+f`c|X;`|Vg^fN`6G>$;pRQqF%);)J& z-q6KpL(MO`R%L|7zaQ@e`s-#RQXTs(-h8QVJ{7d?+${9{JE=y3=?rOdon>wN2+JQR12zA!ZNicUI^8fr>GmzyIN|U zT(+k}c_*558R9sv0Fq`$AaC|#>M`sHk)ul50W_F^-V*X6%uVt)>D6>Nq_TpHo;C`Z7J~%h;Az)wnOl6yb82zBJ$+P>pKP+xXi_V! z+*;#|ZLH(B*1IflVhgaQ;;NX>k(U9lO~&!%eGcvc^O##9JLX|+?YvP zP_ofly&2ROTBi-0JIGSfST?N-I9lfv{v&e4eIHeS6I^{GvxwCenETOzj6 z6zYcF-l)Xb)G02X2fBE2@hN;VF9QE*a{Z|J{73kkap=GfsT&Yn+S-pTo|l`ccz6Vc z>u@Xrrlb$O8bHi}*}t3~qTKxiyLh18D{DoYJ!TrY9lj>nwPtQmrB4&->#6$LvB=bkW1c0XLE4j#Glpcee1D~>CgqC$1_#QCkx+6{ug-q zK@_}8DeVVP)wB)sGSf_AHaN+K3&*5Y+olfaKmg<5d3r6?$k-!$7JBx}e1nHHs6`wZ zD!TVaYf3=%3-V37&rJl5!^7d#%4+&&F+9B3PGSx>w%6b&V%sYk7ripOGe4UgTKYv) zg#Nvfq%u3NvEFMEu#>G_h?yJrlrhYgqcj2b48-Z+j(Z6^t%GNhtM|%+%XUfEc;Ds^ ztY4Z$wZ?_aI~^SODR&G@OjcokGX3eRQg<_bWM{dwn;l@M;ro*3Hn`2LyBwJ{bvtn{ zEJTo6HpyZi&d=Mh9dg6ktv$bISU_1(&4^+1Xn!cJrM!eSiV~KZL$~y-P`RSi?SY#( z$m2B2>NVW8*=Ao?pZb62hHn z^Hj4ubQe0XxNx;q1BIJWT4wL%njZ)>AB#1^=zQz=)?VCUK_BF$Ih~qo{c=xFqt!iG zS8ykaH7Rhtkfb7eD`&hXL_~Xj0k}F@Z9%3=bCb(H8!!?If;qNH8=-&%v>D#9kFCx) zw25o$}r za|9ASFfZtejNz6?eyeUBneNwuGslA;9V?EPT*h>IjTk>R;wl4-n?vn?{B%A;m?Urh zNj&K{de%u zU@!Dq7|G`yZ>5ryZhVNO&im&|JahMr4{*C<6=E~niwuusgGtqM_N&UbPSoua?2t*n z>-LSCT1E~Z6m45IPP|VVLlNQD#?){Z9gle8j)>p&?5sMw;eFdKOlaRpE6%zfX!V2A zWY-Pw^O8p-Usu7~DC$ZTU+itlp9>m$fR|IN0t>VmPP3LB>2kjaa_4b74Z6phvPt@2 z!IlP2sKMHLI#I!OTh&9bex+GOaK*2*rB}FGQDBAz>MK0wBkV!1(lTQ1Xv^xooj{HT zDGl%Q-LcxhD+>SObGlbe5HxF3Cy;)a*lvDF1 z2!?T;z8|4 zhXV9V-bo=L3Nsse80bE+dFrw?z76qLOFgN_sfWOC&*j~oTX>*PFPnXYI z_`m;ct=M0?;=-wddW+Bb6&)Pp)L}MP3}>MMr9W-!)ppFd4GxVI>}FjNkBnne-9x`4 zp0)dP3$r`E9a^>yCt*eY=UdnhR(6OqfbOP)v$^1; zlRUT2v>THk{VY(RK6*r0yWz!M)&Kn3`78(St;0Ox9Z(MC7^r5D1ik4BF}1qryDO~` zQ+3MYP9>?pj2*^}+*L`G4rtjTmc0rHPMWAfTz%wfXRY%23du9EVda8t`Irt$#-q4M z_q6Z;2ikJg!Wj?WshUDcjFvOjR@nNyaO$g~D{G(`-rO)xn+?x$+GxMsSFe|>P9&PhzM53`wW(H} zS(Bhyk`c5t9VhLI#7QD)pCf-CO5d!`3Hbxr;W-v29%571W@@PXnqaJC`-V4cr?0A* zzc)fQyJ$%H302uw)n{lX56x8OZY!p;kg=^z3Akhg(qEj(dbyFJSs49Cdu3cl^`7E4 z_d7A)vceUbKi`bkHP6;{7_RGsP72&+-fnG4?&vnYTHA(&DEp`fS49rHw4@;3A3QIy)!@EE*ze_F=7_&rk6* zmf$3P3Bp@@dSI_uJ)h5_l-;lUE37YwP*-SkYGQ8|(+9uR>73`^$GGQTSHM~vsn~Js2O{a291+S0 zF+wf6X-a8+UdJ~JzS9)e!d2?wIF>0~IIwM5z=w`?+_0)EJI;P74Aym9ad~mW`%QGS z!sCtYs0S`rb#z@bDk%NnsH~)d0sZdIflNkuarYQudky-*b3t>9MfCb;moSbH)zqd{ z@c&pk_i!fo|NnQV($Pu>$zcg8LXsS}rD94q9UPKVA?r?vk;7~YmC9iu$!V)3XLHEe zCOID$VmZ!v7{-ov;y0h~??2b&x?GowYw!2_^?W=ZFZPjKDizuuoKNf>$+UzV+?0*h z$q0g=Z4o!fMap@|$_VOvFzFW(xJDT;V9@-W6;I7%lvgc1qHiqBgVRrruea!f4M$!R zy~EKTHaWhV9O^8Aj-(ep%@S~;dnL_ks_WPEH(C6BauHqPT~)c3*v2@vHFNY$3m#jJHglcCPF#gkooa5CwZ7pe8W zEWbP=Ip>)YO-+M4Jy zy0BCxsi3Pc2F&eme(58RMY~lU-npuu_KRA3?d8Z(GyXEQ|149~r zvG@AmE@c}2Hb}#*x2fl4VEe4;#ssBft?#s~e}}35IUgD3WcLM%I4M=#0dTcUDnF_0 zk1AJO%0pUht~Q9?gF&rFPRfK$sNws$%7V4=Q`ak9@@;6%M(T=C45_XOpYde>r?l&> zkG0ld7F6_{HoLiN?%X|zFZb_+jX5ZzMI*nkpc$R{!&5VXl7>~6U7~LQ-sH-Iv_lg` zvb?|1)Z`5i0G(m>Ntu3V{+o}CW6T`q4v&G%Ba4lT(y_`hw$-`Xc^KkumeG&|(&K{w^N$*^n-3pDBa37A^u|0#k7M-See0kB;R>3=) zilDbt<@P|i@K{`Jy4kGbcB5=5{7wb@e>S)g+fd~Z%gZKicS!q5z02A=k&>jc4&Gxc zMay(sS3YPjqW#PBJ$Ty;@k;F|!45b4UT!QTJ76qafeM=}uL^)Ge@I@u+$Q@lEJ?iJ zBv=vFKWni8riXORoHGF=gVqV#XF9=Fc2BAaG^6I*zsj!I?QVT$}$s}L(uKeD4Vrm6!zC)Nzzy;enJ-BBOi zm3xmJbk+nL8caFPUWupOT_$DwAy=kcOrq7f0=s?Oa&)muGj0LF`2=YcrD!eizf^}E z&il*HyYDZ}GC>U$l@}2n0DZ1+?0`%+IrxS1S#_eN!~N(m`X~l{a4Cnh?Pc&4e~)js&RCgumi(Q zhqEK$$%O$(gDGabpmQ9_6K13WUXPya;>|5wy7S0*_)U_HP3Zc^06m3rhzGKf}HO$crlH~;A9V*5@ZBj21!QoYp!D^^dgV6OUwK-}DaKK3|vP1vt5u z@|T!(cRs-YjGKpvYO*k?zmR;rrwv}qt92^>UH$jZRE+TSf_)o|sI?9V?PHGzV;w)Y zT0r?ha+~KRf2EV{+ST($;3qLn)KT*@Sn62sEOk1gO7RR4|0S9#xne!VtDziqq9DH; z44C-u`jZ}rGcB)B)OIf#`~Y@RJcX?feUB)R4yf2&yeYzdcxq~>qU)N}y_;-bbcLw9 zS%;}k{%7QnxK57JMDw%iND?(Y1^T&w%xVu?OnUnW-npU)`-OiO`=|zeOQy{Cxy8Ng zvO)D+V)a#u(H-QQtCaaK5JddE#4$(O;;m8j*At}T;`#u2(c82_%EUI-FjrTnnJyZq zgA5T$;}VtqWq+47Y~c2l&(K=yJzg#nH2~vz(xg~BZ)<{5q-TNs)J%OVcA|B*z( zyRA1_))Zj_P}oo?Ox|R;UYcE?B|p}l)0G>#(K4A%m||MoStxjOci?=P?BvF3wHrS5 za9A)Ya0dArbI5BKSi>CNGl(4x%0ZN)-mhTw4E7b8uE;T-t(6=q@G7rZ@wGMj1PArp z{RB55S!tQgC0D;qT2H}8=S&4eY={@yK5dr}XQka{BQU%g8m53BgfS9Q`{RijhmchbXy74_53u0I3-OiDt z-&_X(PT4ABRnIoH6dV=rDbG_BJ))mJvT-z%X@x%^_8A{`Ij5}v+ZU7(ji(NlJBOp} z1MS?gks~!WHt^BPjC8ZPx+_^w7Y3DQD}F~ghD|j#o07btRU3J+7PU7%*IFI2{a0CC z)cffrOx&^eKUn?zvrc!3eVYQs@#pta)m?s{-%ZvOS^G%0;&4XL9n-e*!0CUD`-TEO z*Ef4=zcY<<$`0samDU@P*sFTsPtGZQr-B=qEM}Z-J=sImx0Orjl2RDdB-6nOdbh83 z>~+ws7;QZ(yj5rGVf-r)TCk|B5zNEVF9OFI2DB!%c zd>tbRKdOo2hTwvj-V~0vb=??90}*5fd(|6dY)2gX;$E?_)Swv{fF6E{o}ZIdVZ|yQ zbrfGjnE{(_EHwufhUqXeZ(TM|^1eI{O-t@i~Nb74qW;1+^v~6wPf7*0?&o8(DJ2@_ zOqa5KdNKEMqlKd~I`V^_`&dfe1gSlQ#cRRXnT~3VC4>81`lp&s<*nI0Gf^*aL7x+m z(hiXU2eUh3or)iYy%yv=9o43aCF_k)nvZuVHZwGeE*miEr$Br^{i0$9VXsYbf9i!Al+MGJs`_{;A1)A$kx>k zm%cpRh0H|19E>_3rYeev?5`&hmj?j_9vd6uOfeQhTGr{UbbFsY7zKOTQiCogM?Jj& z<44U1T-#%Mqk`hj^XKAZ2Z*3)>+s#k#MU9;>ZdON&j1>K>(Srt(49sR&T+0nGJWYe zd_15kfP(refKvYUe(|OM|DjyGz=B&qVd(Cl_p1lDm@opS@Mb2Fs!Mw~W|a^{X%`^9 zKX=TFpmD^t8dRE5yOP#Q4Ows}w_&(1;_9I@C$1xB-xSLj2Kj-mPw6;&2K%HWuiTxQ zWj=W=xM9v~x0?QIA3F0nOnT8G_kp~t#bAf7rT@R?)xP0Io}Vkf3flTf%VSyHKM&lF zmkX%)555v}0NQnX^j&-`^`#;pGwjT4UC!ba>r)rZ&BXWU>3}LM?Kw>+5Be2t(RUm4 z`_Lz#p9fZwYnR9F6MIr<1A5x~o8%XK!xgWaXxBgYyHG^EN>oq`0{lmA_6L!)A0_=* zSR#ODp5`5wzFkP(jko*-PE?V#T(ADD)?o^tnLcHrNIiRM`k(2uUm1FdQge4)``Fim z3uk8Au*y^g7rCyb(eLj79r4sN@43g`M8!OCfo{-MNDl`wQbQ%DSuhnxY*twaEV^h_ z-ji^+NPFlV7dmr0SkZYu`Jtwv^&OdoRYZQY_C+;Q8Aj^8dH2LArWO|7p{n$Hr5#ja z0_{QGoC#5b4oyuLd~$qH_=>ZA9c=NC^7Nk(F~p@9URN&psxzg|iWAC2-pq5OWdSgw0M5YOTA=_pP8-TiMj2j{#jVL!uBG=@2HBvk+@D*=&Y9<6I(p64 zk@^wCN7J~|JZ#)(RnbXKir^M-^*3Ms(V)a}?qh&WO%Yz6 zBRmIDhMxk=JYA*fh1T7u=vz+F1Z!l(JNE?oT^w9KONYA9Kw4ANR(!${S$jbO?mvy| z9}xD|dt-#&506|u=uRiiBialG^rqH>_cBAfVaT{YHf+lc=>SjK9&8zP;g@{DI)Sw0 z92r+6xhP8)IaN$tQjA30bC-V=mwMRIeUHD@8uI6-MyHlP_w=xj6~ptg^Q)E*LEcic z;rLkLp}|vT(`Ug!r&AJjQxPBk4#Nxk_YTYH&Wqk@g&E1c?$(V6arJ2NtWX{mBQtgl zjX%viuJ!}_boyn7?3Q{dPws{TWm+`+MNryxd}55PPO776$b#7u0Fk7cuTL53;+G98 zFMgWbLJ{=pcCq|apnn&&$(Iq}CA zrnX>;zfyS$E}h{+lu}K?r*!MB)m@vbxl(xyj5SKyP+vEi%8cZz-UrryeB(p+a7mH^ zGv>uDjc6^ss%?mpR8r>DBX2Bp7+>7#ne>EUqS!Z@$GP=7itXEwXSy4DEUH zFZUW^d zMO@&!jjz7eH!(!4={{hYZWCRPB~*iUn3LWBP^*#FJw2wt)xX=lXr&S0^9_=5!7Vl3 z?1w7vmnl4BbT(2dZsS}WcvQ*Rw5}IdAwJj5AOHJ-ls3-#uBHqk#?7b)6f8a~mVme_ zA^kJ_($&9XX6vRmpgIq1wb#}aF{7i|r0jL9#To^|Uzhy`toMXCN#kEJQ=B4i*U8g3 zpH~ezO*da4;sfW4;`efs11i8S*YC{I{g_T)VMX=|13u^ZW4KXX^bCZf8^|kv4k^FPzSmM_jf zVX{qzC1-C<8rsRftsTH)s&|w6kzc0~E~Qsy0i$$9bJ_u0r{l8~lJrC6)t}3LJsH<> zoM#-Lr3M=0>jf^g*Z0{gmJw!1teDya39-X7vL|GWK`ydFw>-=Ae7ML(yE% zouO53WeM=CM&_?xJ;dW9L6#`xygFU`B2~Uw%svFTbrhWIU)1tui2a|66mdYCV?woP zLCrJ=h!jfLqz_NO4C^YJ*DOV^q-hHs_tl_hP~BcGy2}Ry#aHp&Th-`clw|}z7ZCpq zfR#<9Z8W%2UaxJ@`IXe_I9u&X)}^6RsClrPI zPnLaASyp}fA;(EhUD4haVC#o5;D5DAjbPV;Kh z}a!iHeua#Ul3&t+q%81gO!qWWoCjH#$D22tTI8t8Rr>L#T3Ad(9XlYeegtk zrYz2G*d7!51^ zx%gGy!2ouIs*|OB2ahywSlaiKURk|ry%}&_y+9|hLWD~>S zR6hYD54(bbav7^AH>!I?$q$0|E&GnE4_SaV;X;%kVnt6h4Noc~UXO&iu)7sXc_V0n zFJ+~9)IE;Qbh3=?tOvgk>wu1lQVyW(=*N+WR>U|HJCaHD+aqR?QS|m9aM*!Ai4NTn zsp^E4G~@9NP9>#IJnKjF>RZp(oCwN;z~Pt501sje+#K1(f@e`1^1U7K>tHD57~|j? z*m=6zi5=qQgmoX)P`>WG#7n$YqsJ z@~?B=mnXV*xNN=+`-g~ce~Og$SFx^iWh;f@9+4iF%ap1T$1zI{UJTI7^zIvYPtni~ zYO9wFthsjAP^(jZ!2y3HF9`Tql4S~Qc8l@7|8Tzo$Mxvp)$rZT9}hs)0(XXFuM5n{ z_E>3j{R&fx3A<_{)DT=18r&7LN*UupAzCvzCqXzPfeoI(gg2%pb6W{PrnCD{Wj>rjnyllS^s)=4w;x6-jTGw{3bRvBp4pj6F^;PPwIuS_e zm~YBn!+UuJzZWj7z*FF`+6V!KrYtxEaderkoG`TGdEQ*S!aX6lqa#F-*r}6-_IKi$ z8Q2Lzcw;%WPTlPY;M?>sMZfC`*{O|1k;3$@`oy@d%nsKs;cn6x($0Seg_~a<;;cM+ zdS}&hT$21l)z^*4`|Zf^RN?4O13bf8l!RO$JVUQoUU97kN5^Z=u_86{=J zPz|esfz@-c4>w4yM&oO7L8D=;OyHO%kkN~yjBvBz1P|^1D9uZ5@2QHDiqoLC2KTLrr)#&7 z`#^HSQ;L?YpkUwhE+FC1%-z{vH30?du3z3|(w;yrCk4e-AJFL|IRq>IVjc|9v`L;e z48W*$B31JP3of7I-K@t((QMDV@D2?GuS9$O1li3R zxIJ>NnAiyTgEcm8i75mf_xp|)TrO(XBWFdXs|>*7$OmtCdlj6BDu}=5_-V{>iRpED z!*Qzc@2zQ7j)~V9*}{QiZT%R8|7Jkyg(tsVs8FTsu1>jkXCQGJRpV{u@Z2iP zbJhv>(PrvP0rXSaB+>j*7fg}Ya5(I9w1RuOF_wFKl$-}4v+ERE6zU!9-S?m5oPW^O|5?};k_XV>87bbK@G|oZCMGvAWt=s+DeCoQ{@ihuf$MSx(nlrc*isU(vFyda4ax$IW+MZt z=RS1~f=|tqCU>Z9ABw6quYS~>q8otxw>T(we(p_wbN^^OjyiZ+ywAqcGPGj zYWzB9w1I-0LT}PHk^ch?Ig!d40q0$Zyl!5|T$DpHN_ru}=jibro*>daUGthh$~BPI zF97oZv{v(GSj#yz4wzRfoD{<<-2%$yhFYrjoL4=^%hzS?o&9Lo3Kg}&{7SPYGLlH0 z_Gq>}q!*Snc8=I;naKTZkp!9{Z6DTHyg=$CqGtbqX9j0 z9r-!ZT6psMQN&T!jHCEfdza;l=mta7oO`^Vkp>03hy*Q9OK%=Bx+%D2S)bnpdQ zd`pN=(FF#1wyTOX-AL9AR5ynsCU_Sj<=aOb*nYcgF$P@sz?JhWQ;(fJN!qcQ(+_A7 zz~tH{ub$xss&l=Y<-d-IiBL!HaM40}TNFib!d=_asq!#6(32Ot__Oj8&v3h+)3s!> z;>=;RmMmO*B{CB~slIM{@9taDzA=)5i+l41<@vaTjX`}=_8xhHsYXodj#NA8U-E!I6+lU z2t17P`4~QldkpIv1f=SaRj{8RF4{ltRcG0#&+0#)ff2&uijdva#o0fjB4U*_d2{Mcz zf7&P|8Cl2287Rx}wd+sfmbzD{>mM>hOpf?#u4uptB@yAs_o$)h&)CN|5$_02>;tEuH_Tu2`n_v5mo{QT@G?u$P z6nia3sQUNCNP;6DSE5S1T37fWs<@}%i*8;6?Zbq-$MibU5u42)O3%Y_?XH`XJ1 zhP}|pwS9ysmI?l-*O zytz}T{sZ7?1iQ;_7W;!HlMf3cPSJXFS}LamUY#h%FCBg=ijb^6VEf+rtOI1NIBen@ zdhQ3Wk`rZlkB-utU4XDm0B9A!e!KCoPH;NrsQ6yT9qsr(fT&jn+1o9Kh>|I&-_wy| zPVWnQ+22Jp7pEMvq0;G)^STWD;Wtv(lKn7kG;yrbr7b%k9vASiZ)0Vwb)}e%_?t{F-+0Fq26~ocPb`_mFqCwaaC_G#eU`u2z-$) zZn3f(L^J6pFKwR>;=Sp4{yJ>k$bJHDqaEy%w4_R#3jF|B`=hG{zmXCyRRWUn03-pE zHJ_HWA9sA3L3pl^S-wg>ifKnKAoK!XhQYPR^gjrYP~=rJCi%Fo%ocI}sn-bkUlG4FnXtsu%N>kQHKd%0Lx+G zUF&R6VKJb3(-5lO*V3Bj)$$ULESEGghRBr3L%*RJ572fVVa|6u6;pZ__`!PhM?*ic zRmbsO&wdmgDu7oGDzF@%V}XS04zpeNE1T4OI7*1dYC+MC0Agu&dI#Wl5M!)Qdr%$u zqLnFs$B4m8EK&K}e;7x5ugEv@Um=5As^Z49Z;iE3_Iq{txoRno20ha7%PY~WqTKi$ zz7({=166Il8#*vPc<@vee1bhO=Q0diGGJjbyssij}ZMK}S}MWlT5D zB3AGBygyp87|G(LL;@#NlYoP9SOq0yKnUF-st{xl;nw{vLe#BjZ6w(0uZN0>Qr2V) zXkKD3Z~0)&pd@IkUkluTa@AqH0;0DHWPcyq`ZvTSO%&+F1Bxys+M>1&&h{Z4bKq!v z0OAT4YM+n3`+CGO3{a!8aWj}(OF=S~Aq-`GvDMeucXkT^@&QxfVCtM@JW~9Qh31iD^bG$PC3u)+UkM2* zI+|o%*!j`GiW5Q86mkA`WJQ90$hbXi*KCl)TfQgndH!d3kC)%sd8H``*KjeOdzN{# z+RH@jGJ5ei4z9**1rR-BSgVdalRn*{QqPo4)p@rVHw68Vzv3RSalOJgg%vNNR>=rM zV{}(dV5JeXEW$OfzAxnmGx;3ITl%)6OMutHJTFL)=f0&hPSNdHOuA)}1|aVx=zRoA ztuOq?PIAy4$|H@92Y=NOh6!|++M{_j{xM$HNPwP@*Uwx)_Hmcx+i&+U%94jpxcFxP z9iU#HsesLUO#rECFj1fG@7jIRSF9o>4cCFo%(=#2JJ<>74%0{|dx7UP(3y^P~bkEXX~LTssg{?h@S`iK>)%F|R^I{X&A-YZ)8=s+g~B}ffUi|FXh?jWRCrKByc z#7X*4*_zTC6cwF5SyB5(!8SbiY#mu{lDX(^pU>Cj|9*`>N`Od&-MJgpDn9=B4Wzg4 zM5A!hn2?9tnPLjugVYN{0T~y$>GxHadOy5_&0;wl zPiNmOE9;S$W(Ug?eS+$3V#1g;Z>`2LnWM#pJA}eij~=WH{n2rzd@a|YNFsB5clV?H zEREV29R?CtO%Kti@48KZxz5lZBSl!do+3Zd!jD7JVu;6XM#3g^qcceKAiVg{%S&-j zc?~c1eWmAAH(vL&O8b8Z-rr>EyAScy&H|T0yZU93d92tL5{BE2JKWSqoNP0!N!KM+ ztr|Av&KVEw6Z~h3Rkgtn*5^^UyR^?IVW(*`9EBC%nIMhzHA2Vu(ad`Y#!pXAYN#~3 z6*oCPy`&##lkfn8*~?x2t(^U?M25sWS8v;Mw8{MMVQKMF8^RjcP89KE+}#vb|IR-} zT*?Yp=Sq?Pjkj)AH1+uffA|!Tv}}hi0P$eXS{hZL(qA|Blh;s(qeLC!-CnFaYFT|F z5&kL=|L48waaVMN4)@-+20_R_rxo6g47@u35y@qyRFPPbOFPlKXUYwR^JQhN-$!-s zoqvQr&b?ogTC=8myf6hK5qHWJD)L@N_Oah@oSIReq}sn-HGDhrrGGNiMS_|+JbG+l zwfe`x4x4_}zl+H(Rr8GsnZ5?W;$AL40zFR}P7u3yfXD{PD+%IiU95EvN0(m_e+~Go zE!8+L#F>U7&P5sjslN?4%;*u?3OZdk7~%l=8l~fFAPW%(M^=3kT>dG3(+li4Lcc9>JVVH0lh;EQHVQpwA1u>HGQE#|7?5%xB%U-WC8uqMi z9sO*_0TWk?&7!;4&Ent~i<5ZFdz5{fk<$)d)@2vtBCbKb#>UQ;thItSs- zPLW*PTq2VU@-XAsw`wuY(MfEC#X8C&_jgt31oG2R!5!Y@F#YYJnUA!W-l~ZAo1>U@ ze_X0q>^|Y~nSe6Gv`*k(8{V-uSYNeMGVx&X@E=sM z^`u!#v$x$&bZFcSlh@x$9lrE)H;nU%{XR!AG%$ys-!>k5%L%=!`tksP|KU!&&T+>t z48#0x_v=Tz%9t}`<(a3sr z+gduM^EPC>%QSbK!a*l17cMQY@<(ku^^Asjp?2hoZ)Ol2nwS&q>s z@Ddf-)<2^Y{p40;PdS-$&X2i;+>C5n#1>yu1N~wF*r{I^9@@@F`ov+^>5ud_*+`|NY-wKN`0-TYVtt3Z6-&jRC3UFS7M*`4fZJsL50b=`vfbS>mM(UlQ+P5#Nm=tHXrZLah6MV0lmlDx`}8!H*R zduF5RK8-{yg*e|pa3WvwNh^&mZIQ?{vSEwi)aSbk*QH~#w5HSX6P%2UL8{W%(7J4e zC3g=%Q@nWQ{x&+1to-A3n_V2IW%+IZi3W2eS^uhYwP&`){9&^bJhWl7sw^%yX-N{X z-;X#cM|`+Wby$B9MQon_pP0c_`3w5uU}d0?P|xN1V3fCJ<@FCT?AO9_AFehV2R&FchzhQ z3$i$ogPTmqCe!ug|12`%rY)HMmZP>N&wdzx8%UgWB+lA_w=598nZC5(F`5e*)&FwP z33zJz$}6j$7P8yXdhK;t;#EVc;H=2uV-e=QHTz(xXJHz#{n5)%%qq6~Re5;KBomy? zjDKo&X(mMkGa-R`2CLTZy{b}#w99+yd}=M~piuKdvdgSTDS0s*_MwVVFDcqdfdlRp zIU!hT-FdA#YDul+!&Oyhtr&Z_V@~K4v0X2#bVLHxXFvGdu5K@0e|q~`J~-eTX^~fJ zwt9E@a1)g~K~!n_u)Ch)7X>!WLgbc@z9WnKxcQ-X;t_isvKDD}HX7R*_J#Er%RErt znrsr@>e`%rIO*lu6Q7sdW_Mq)AdEMh;DA{K{- zaIh1^0)}(0QlOo8O>mNdLq3%DGrJ^8Ho z@i*_G>78qp2Qf~^2J;+sTgeu*@8ZB@N0=*r!!b6*^>2;-!hoHzPAR-T$!ehAsZA-?1yPtF{r|PBH~(=+*sSV; zoVTPN#RoSR&dWDgG5(Kc8~4q_%}QgH=DS=F;>u_}njd?N|Gu#jMXMa=+!Eb!-5jLw z9rZUCT}Ama!iA4}MU7>fkpgvRD-Cfs11N7$L-Ek(NBM4;j!hqoc5j`JR9d7iRtCi! z7Y!*O&qHavYMh|D@+;tZ%*Mr5EZcDsx6zO0&lH#gFY`*Z1*KHxAN}V6ly9fTITe)| zj4xQh&GJffq;OV@qRSNGLvsL6yNTsjou)u%)n%mb@wX$Yl#NHp*zF}tK57yXU@Dl zz`ak>nHF_Sp%;ImJuGWF#I{1YV$t5ir+5)zJr0`|M1-ju$_W{mXB`dG=W)S!dwQ0W za*-^}%{d~|uZ?}5hkZ5Zz^&cH#S8nc&?ZQ)ZHpVCUW#IDkYCZMV%@i+f0mC7j>(gU z{=_5ePI)&M_~39n$X;GnFz^mOvJP5qTQ!zv5Ry?avw}E|W_@;>>CEMb)NKpn=2r1x zd7^xp=B?z`W-+xCWl}L{dB7sdE!6qVL~^MVTr9gE*`47YEh?Z!ga~Ws^8L3b?DgV= z(`upx`49O;fga<2f+KSpZ90C&Zt-{DwX}CKul+VH&R@kU#RT?=X;GzRXtgo6vS%lG zp+9%-!f9%Lb(h=9s}tPfgrLD(!nD}*q>tW{x8YfYXy9VOzPV`Mn7tS%@Ir-aEvlnG zhJHxoAhiis6z;*)PR)w(wr+8?A45?jnFF=fw?K1o88j5w0#BGeX18HtfvRoAin0Lr z0)S4vlDk<-iKC5e`Y?S5^%y0OjD+GeFe15M|$JYB3cyXMq<}We;7!1U<#hp^SJ10Xh#FuyjPd2 zsvXka-RZ(9O{-_vZ*(xBv1=whbep2TNcaG|} z1}tx9H9mTk;?e^HJLZTN9T=MlQs8QMV-Jd$dO_H!1$>7}~y%-q4IgV>+Ew zYxJui(&R(7!VaHZCsIY#Vu$tWS3$KT(TG3l`4c_M)Aw!wf z{6^&os-Knuog~(fH$9{jk~G~7i94rA9y@*Ha~RGIv@6$=>{Vx!9xh1--%KvFx%B6p z(Bumwf2|kFDV5HbFb=EIj&t+_TIsJWEx%g%Zv~0fc_ZWn^YK%D^at6>Hi1_>VfPqQZD_6`P^7a4B8INAGG41)l)kPl!l zH!ikYi~d-TVPSxxS5rlGE5Q&Iw=7JA9yDFtS*6!4H!9lkDYFKhAm$P01Bjndq3sCh zY}5Vus|p+cV8kZUEK)uG`Mqc-x#O|+pK0YaRXysZjV)%+;-t9AtDn-9hx3=n>4`Se zQhsj-ZjT){DeKE_bSg?-9Zl?tGFW#Xhd;0?#uLCz@dpsyq6u|HU1Cd zs?(X}_KjBJWPV15lzF(J*IV7>bm(qc#&nxY>3ErNTyNv)s!`o|yiIu!cQj@IoIta1 z(q0pqW%Up3tqg+Xi_6zRI>^{-+1&S^cgeIOQsF<#w8+~HqdT+_>0}fk`@>^wSZ*hJ zE}SLt_X6(xO5kB=%#xD~GFwjO9kg)IrN8ihZ$hX>vi0IkjQ7G)8_Q2zYLsi)6+cfG zTKw>Pe7ab?@J?j1+;ypM$SFUYxS=}~K??#gu`c;|#84?YtLzRbz6J#Jzt5(Ire|*x z8?;`sHgElglOFAS5_qVTnhMJ!LHxM^UXxrolcKRk&k9sf2{B*CnLcb-RC>Sjwpe4J zlu158nERc7#D!9YN?kSDS$=xpuX0dSJ*m(IZKjVRuVXC_A($UUk8#+sXi&&v<8l6r zR#~7^@U$Eyn7Q>J%SPSX!8)MK>z0q3V`By!HpQW~&Wz-_bX~B?1%CfIw6GN&#@tFJ zwf`d0Vc5^O$@~-SWrZ=xi{_7)QB!Itw*^vqfT5xD=Ika#REw?@NGO&jipBw#M)mDN z9U3H^DmENWEMt0I3Vz=|#oalZP=Ad~zsLS}tDzQ$0x0#UF5W;x-KxBAG!IfFRvzjl z>rMnw#}ExsKX0J_ru|71u;O6=PS`sNAYrkZ^8+3WBi+6Sg!05Qv^%^qHGkJtY{_EA zNWgYRCfVg1vpQnr6r=vse2~ZZ*As9Pz)w$)$_PQvaVf#;6AwL@ZI33)Q+%TmS5b** znv8~k@t->hxh72X8$4IfGrt3R1`D_pBS?2!ox2GYy>9@V=yP|dyUB)dj!CAH|BdGv%*c1TSXXl3)B&P5Lj!b(hg! z8^bsTSZ>x~z-;3el{>ZZO0dW;{?%pW_o|isH$;(Mb3j7VPYPZuZWZ(|$ZNAQ=mI=Ddf`jdyVA06knP zNL@`7G~+8Xm6@!9Xy>Vx~qy|{w)Ob9=7 zYu2?HTm-<&KjLINY$a25^A1rSt|mblFv8}Pt1vnZC@29sZuA@bii_=+kOnYL*C}A! z(jF{;|6HaS(P}*IXI$SA6xJFv`ac}07`XJ=x8UrBU+g>Ftx=gb#6>Vn2Fot=ZuCb5 zZCyw~vW5W8=Y6DYGtxHP>v1~clRRvE*@$JZ^9KXs_nG91-PIwepC;}_j(a#-y1$JZ z$-6@vQfKu%6ccpc0}J~L6iKnPCS;Wbnd>>YxV?0`jimmv3EyhoUepR`^V2Hn)*wLegJzHVi?R%8sG3%Rphh;VpsD=D>0@YRXKp@IsL*-U6ftLk!xWJAvf$;}e@e5z-=MhTXKpnsfXKg- zd^ra>19|9S)kA4Y32O)N%iXXfIycRW$#P zibBz}S+~bg{{*!63s&Q&wiD@#X4^zRG8Hc==r~2e0}heA_mvWk%$UX98qm5!->)^< zKQv4ytb?aaxC8zBy@K1zN3WElF<%84qWf@bT z4CwHaZ!R)zpEPVXJg+D!|2{fn=7Y-UEBRV>gTD}FPfl{VvOJ!dLVst~+6roM?i;J` zNHV-W_<_KHFPuUQxkYQWb~X2wM@MFi_)fkdutX_JCZs2^FKH*=QeR%yQybdu*Kb9} z%KUPY>13;WWP-iFyeo^KruZMo`()S>JaBlqT2SkMmo-JngE z!;IW(za>aXC1nU*W%z_%PDkXLmEv~Wp1c%S4-4tRWvx}@-7f%zc?rc$QT--&WU~y- z!mMo0;Dm`I0Dv%ilZErC=S2d*GsCuI!%M$h9ibG)t?onAeZ+}L?7QGaJC=}Hx4FgLReG@xP*x9En?qjlzXxt?*?lO&p8(-chW_QJNKN1u-{V`O zu+TIp*IU^aEg12I{8`(w|5Q=|2UZA9S68BjK$D?KMc{eHR;Z=Fxk1?!q@j7*o3n|% z)?Yx`8ylF-H3+ueo?8dZf0DCmBAOR_kPtDqZ^q_Jed|*gvJVDh`%~U0T1tk@m+#DV zaojd`2>K+^w^A*euwm|j_9S$Sny(WL-}#^Nd6(0&gZ*tC^?a0b^FoiqEdW)y6zbS~ z`<$z5sA1=qQ^=rospXO!QtxWOADa&Bs?=d^RQR>JQPM9TSCDnmA z4#eZ77oK!;SZRjIdz%;9!clX;bBNT4EL7NKvlhU;3&3?!5Drq{Cn0y zVcb#@bi14Mfbc5Jw*HTjHYVvjRLbboTfrLB3Zf))?E!UTTm7H2>Y&@r(Bxp^^YxZE zI6a>gVjZr{+Ib1w;&MWipt;5$wZ9_Ok>4S?nq6HWXYzg3$iR)pu^naY#AdI;Cv{AT z7wwv5Cy8s}kEIS3)ow@G7pJ?tN-L4#yhVOG0*=C@e+1lQHK}WY5DrEK>D}X*{{R2~cSn_1ywpo_TqWs6@si}Yt&&zLUdkaktWbJIPP3RD6qOPdl87y* z$YBdFhdFGO!<^?lhuNHG#%9K5=J4I?^ZWhlpI!X%cs`$x`~7yiUa1Zs`VYU(ir~6@ z?fQfgxE}E=cU)p_-i672ok54Q^%E88zy%t$cY`KPf#u zeNj=9!c2ywP@befBeK|B9d0Pam38{j{I4gtp)gFw4PSfk+Mva8d<6CiWsmrW7Aq}B z+D(GmRuz8R>E?fO;b5>&wOZ9dfCNNL=3m5%+iK56ZNb)1`WDx)RKy3*inb4!|} z|BeQ+fh!wokut>L#tb?0ypm=hbdq#yPegX#XUVm0-;#4gLSR7oPCsZ*JTY7RIErCx zZ>E+Xwbdb_-o$SCB&fL@EED>^FAyoW&WEJjKikF?( zT84O9e&|NEZaA#H!iTu6lvD9(0)an>so%OGYVJagC&pOwTtx?V_9idgTq>3Rx&bP@ zj?9D+`}nU)y49KQpT4MrkfirQ!+}Zl6%3Vv<9@w@L`dV5=i14w-&9+*#rObw;cvx0 zhN%(!S!79D)giMoU%?Df9g9jjTkiwyZg2$%7AbLu0$8oXxlm^LjY?j=UoccyLn~f5 z-YEbLtwJs+kC`^U83+s-zL8Rdm4s(+PD`1xtlHTR+?!h8I5HGeF*mNmjqN5Qeka=B z29COiZ;@~fo2&ma{h0C;8S-uE450~^K3p{vLP?NO*M530bp-iv`FWeDY4M1oB>d^0 zSjNHPKJ$DTY%k@k$9WCCwaXtLUwGg|>;`K0hKqL<`8TiGW za8MGrgjjJ|=*qsQ(&El5#A;hn9Rm8V)f@N*eZ(Ia_$Y}OE6P<&q$fz3YVzNcAEV6< zZ2zHGraZ$7d|Y>=dC!(%X(R-MP&nl&yyjlj;Fmg=S|i!$xoZ1%WI}=dnM(NAeIMyPqWOL)DxF@gkV&`vt9gT#rB1 ztL+#QSULZoP+cozLxgL=U2%xL9=Na#(DZUz zZo!}wQFGRS8bp)6XRz=gRP^xw&xXWAuEhk(8s>^t#N=s#=bhrrvPU~^3cfCT9!3zo5!=%a>)m&<$g_uhGU^B^A05ohY2|9o^h zV`{4Hu=%gkk3fbt`7BAn7d(?yNX;=XJ*P+*m30&&269R+;|r~vLmDvL5n{0-JibMv z^itX24ZT{YUWL&o#Zio_1y%YH#?G)2+jai*Z|`NdK%)%!J1DVw;)`PlAft0 z4cvaR%LYrOz?j}e@1wpFH*;hnENF6ohx0NIm8(e(se88=7pjMcELmAnaQ05pw7IPv zlm78lbUVhD>k(Pl|1J4h?6#jr*Bbany{j6nS!rn1IgR5Y#6`1m&-V#~kE(dM(}QcQ z^txBAKKQEiB_329bb8Y_lU$8sH&}qxW-<0j7T{f#+fq1L?Lk!PqHw+i`(~ zv0`(r8AK2s+tbt&KD##{d8?Y|f0$F!$dT2Cq6UlZm6t!jUls-L;dz(J$gd?PWxhJ) z?nSE${!6W&xEvJ!UJJ_^3ADB{9Zt4qQ|aUTcmSCM)Y@*Y^#Y5yp9YvSk@3jotYQoR zJ;U;}WSB_%*$Osi7IEvS1UFGy&$@W4d_ze_d@S%H(QGG3F6PhKw>xPCPtpb;8XUw; z598P2M8Ri>F17kp0`+jC5>I6~mfCvv2l|+Wrc4!>=?X%^KUK82f)iBZQ3K$K-APSGF@HBFDG^#N_{0tfv2!NhQ%5%mo5(5yB{DWeK+%X%7O=vb5C0=y~*gpilmn0oua)DC0FQS1g13fAR-D8=Bs zZ3aIXS&94Mg`R77XD3LK40?H#R0(JJmvblFMU71G6T z#MfyvDWKM?lVD^U4tC51V6RCLjfC>(Zo#8^ubbzhn}=W)=MpkrY%EATN~iqptiHZi zSw?-dM{>FS{lSsnZe!1md;IiSJ&oaRPU&E-`Ph!}`un(U{uPL_PUFhkDW<@}C zw-4dYZt)Gg7Qbz@)I;QBWgYAZKjb$P0&4mD)Pre@t>-)O(AGZqxg%d1qWx!uy}#o# zoR=MLMcnDTG*%}Nn7&Z}9t%)bhbniFPL8eReR=Kbk$SmaRKbZ@F8;BOeWF!@UFf&p ze7^R7K_kUD&~l45-FwD-Uc5esq41YRj3%?_Yb|3-@5S*Hd{Pj8ZOviMURM(${6V3( zbcsX6s>_f@SHF;dTFMW9F(CHQxrq>-HgxS3G+ekWBk;Bkyps_4>x9uj;kEx`%ss1< z-jDfj^t3j;u=Nu-KZluh1i%jqXPrS6YppOW0Rx{Y+B#Hle2gd?e%8K4Fxg0NZQOdBA;x%}z~>@mD)vZ4_a7g3>YZ^QVJFQja03Fs6bUTsWeC&etPQB1ago zm+Y57WbDZhoFt4aZr(jG2eOde>gxZ@{S3SzEuI2>$r#4AVKr29bjwlomARjjX^EP} zbNgiUwPyg2v%QxN$-2q36RS6po&`)*dn)S(OZE09eSbFnDYR7JG|;G(s=(&Ctq-l4 zn@_ss@(<7ju#H^%L^`e!-;mcfG6t#GsvnSLB zPY8@v2p(YcbzN$K%j!)11)z!RHQ}wR>+@7Prs}C_8e2p|@pv zQHW|HyiFG~MiHxQXFeTql2ku^XxbpW?j|mR)hn`=%WD=G+xxsYEs}k-0T@}{*{}be zM6J+nrfb^?9L;o;Hho*C4n4Lzttifig|u&`lCL8E$~W40eDhbiHEh8!Ge0t`G%k7E zwwhKSy4o$%eoK~1oGC=6<1Vz9k8l=FL`g>T-Xfb`z1)Mvf1m#jArjv zU8MZB*Fe>_)-A|Ov4s`XYBq?f_ts7Wpj}{Gdn5(=f^tLee1hTiu<~F2Tc`ES|F;_0 zy8rXp@B3ehOS%83SWjK^G=BE7jsAG?75&)DNsOz=@#+UY_jB$r#o@>^VYE`-opV};#S*7pknN| z3VPME|1X^hP|KW|f*Fq~#n$gMy8T66Ww?Cd=bJ(nhc!G|dxCG>1d&yi4i#a(%;(*= zVpkLVodp{;X1;w*OKSrgc`fkU3q9y0g!9g^qtpyb^~i%)L`-8`U<%9>C%ZW*4-?Zm zhRRZN-^n7Y4A$w7H0)exVep3M&Pk`F>3jcdyF?}6byKzz+P2806}Z}BPRE)r{kG)9 z-pj<{{0NqA4=@T?vmfdBMf(9GuZ;3X|K+Fe>Bu=0;GyW|$T~x9ChVIU!6sE~itaNV z!$eclHe@e?etFR|opJgCLIn`h|Lsbs-(Y;nWKG-IiLE_EeL+T=F2%_;FSa74B-o{= zJ~og>j7{+#a;gd2vszqc62?K&!kLo0ZNqV1u?COwEMyw2ax zUSHZ#DN|~FFe|FBKjI_{2Hmcb#r@VARnS&91|nl5XOj?_iTP6%Fjz{+^@?l3-n5-)o zRgflzk=2|%XP^E7<3~vDdGnK2*D`W4tnBx%k`{CpUABUag^qUg*J~OnRfF%fdlOCm zh7D#0-hUMua`vL%VlKrmhf&|9T8=9BJia}wyh3GcMHe^5l=xLNi9H%XUGSZ} zREJv#n$?vL6j1dkMs)$~3hRZg)%e_Z2E@&5w#hl-OebeYV zd8x&-&aaa9t;DbX0GGa+glw2`{mI|6U#4M2WR_pZVOHZ$Qs>H9hKF#FL!oat?C}er zd|2lTYQfP?9nYKuX3>FVJI;^o4!-K|el}W%a!^GPq3C!F_*REVpmkS$kctN`W!J7e zKJ>@!w|C+@TcRwSLk+IGluuctWY~b-z%z{s$u$YI+Q-&;Yt^F%>c5AhXgj*8SFd4J zQVO*iHzjKa8vA;T zsvpgC^dIu9mVL99^&Jlt^%46-d0vEOc>URD%9)Ewc;goHhl);k7wT^Bfs9Wxx|X6p zk*GZ!cuf)LBI)Uv^?rEJAIskqL+7luG^#efU_Lki2QmmGd>z1GMblhfqLqcpF!r|W zPg@%*mNQSK>%WJj$bYA4h{iwOO?~7TO*ikgOm+=)Mpn(JV85(hlC|)(ubP(wPHI6X zVef@@%$UC=t`CW0dTt`;!BQPVuTViaf$)WCEk4uCinaIOy`@)Ry6KEw0*&dO(`C^N zzTcCJ(3h>679%KfP#2@NgJW@cI!!MJ)Lq5H++p?X7zEoO4XOXz*2?dNe~ukS#nAs+ zE}e%)wCK65VkiAh&0R_ee6c}WhCACc=q>o!p?sNQ1R5e_ipgS;o0Vw!tL&a3vM-e} z3yFwxx0CBn*hfAxKDFU#@h%NK>+u7o3(X&qM=UxTiIT_`_#7D)7$F0daAp}@Giv^C zwLL^%_$1ruHmwPONJ(_Pd8O{;chjokTM!g`&C^kl7}(EcckB=<2Y@e2mTSd!1@>%h zXYZXD9mL`}?_6p%8)qKSiBzV&6C2#~j;T(IUYJ8ubwY3xh~tQO_jJD|)!VfUItcuwC3ZoetmomTfb%uR`4*Mu}-?1yM5FZ3+R2A>4SK%qW_-X8ga7TjcQxh=EB zGlg^k6=^@wmUCo0JCF1||s5W9dUSfT?op!g|fZWU{M988^ zZbHQE66Fiu40GR+{l%AwMMtyechpS3-p5I{A1ptxW%X=!g07_=ibHcm4$X&BnCRoM z_Kot7B`rAm%1gG}3HANbyB1CqeYZq&w#nbzk3gc;5c{%d4Z0eQuE^H|INiJiCGpmG zFa!M?I|9!0G0ur#@t=UT;7E&nz_7}&OKG3@jk}yC@Dv)l%9h;k8_wavoxG!hBLmOi zEpTrq!w+KY4w}C%zWkebYP@Lq^D~b2(_Zo}3djDh*M;j}#-W*JXh z$t@2%M_vi(^eryd4%Z?PU*Q)2Q>O&bz_M8uqi%bXPXQ8Tgv7Ok(W(E?OrQU=P}Bfj zv^)&7O8V!VHo_O=kUkAH}~a57CY94&RcN%@+uCPq2tubecm zx;zr(x%%8JmJ|GHrPbjt>c&3K((@mRi0eaN4mn6xj8+D2s!g_r)NKPgiedTqMCw%u9_$0c*+wbT-|Ap_SG%T#(FfV<^6)y!*9fuLQhui}cu zzW48fC~+@Fi!bstJ>4b|&#C#KrS#BZ6jy`7VLd%>`c5$gOxwe#ipI^3eT~(zswxbm z|Kf_$&DdH&z~wv@X1=>^LIyIj&~zHND?$wx+%4rNFqV(fR)Qi<=_HhC%rg_HU))HAbrh(jH}`u$fsA= z?aSom!XO;&?xv%hX_J~Y(MSbRZ?g`nSMTKfWayWtGP!Rdg*7er*2Lm!-SE__X!T97% z={N)V^X@BJ9$$4{KREP*A%P<;q;yz^igMK8q0k>kO`MUFr*RDjrpwxnP~Q5FfzS^P ziVzc~oBNxWnv9Up;ed&P&9q|C!5T(+n3r>YsM1g4cK+e6J_^e(-4>Vy!)t#WooCSL zkq{jQG)nQ(nQ?~S@sFcU|94i2Y4)6DA z;CR^L6bAHb^He6b>*~4_j-$JXX43Lv2zdF`n>BN_%rl-zMq@-`JXd1QZRzpJ9$45m2|akC z1p@2v>#%9ryJPkxR=!H8J#A8|UxyDcEql@98H)D^d=np#LRHNLPrlLnIGX~i3M>mC zn53G-mUGi4R?VFPP6%H+FgZXtnbDrAMVEkh+c%PRD!|z|I zm?vT-8Z^7<)2iZsejux2BU)dGl$FmJ$fHk7iAxrR>9}XrF|{Kk-9sFqXLY$4 z9^n%opt&23?`wbF|3}-K}E7q0W^ndF5Vm9vUH;tKT$c49zYvO_|pDHqi! z3O%_i8X*&D4JPcO(?^mVr`qJrqo^gj3yPAoJ0=~&F_|qN={s9vp}J6OM(Vo)FM0a) z-ml3A@U|Y5u5=v`c39#(%545PAZjX3#!*Eq3v6^)74lYicgM5ZagCVAaR*tAAAX}RS60vk4jb;HfW0*&7||5qt^;Ooq+!vzKE+0 zbp+Aw&%$i$N=We1dd0EL%0u$?${v&cW93>6I;}vIMc3hJMm|Uu2CU08fY9w_a#XT7pS;s&A@v zzK-UWbkzsjA71fS99q6Og_=zUIcI~kLCqv;hgn?7b8vnQVdWg}K#JkUwYdjQE;#HJ zaCQFLhLRqD?0i}18U1c)9gg!`6qfyTaXM^qO~#L}vNcamW4VV>pVsHU-@M^o6;*wL zp7o2`W4r0lal_@;QTk2~x>&24AWK_Ry#3cUxKQHc`qQt?Lbmtt{Tnur-|_SUII2Ed z(eu0S7h!v8c99~>Nn>Km)>4(;FWBwOLp_TgiR)`2=U;2lwN%dYVcNs7 z?D`XKpN5S<%eIk@>gYq5?c${R`Duf!uO$`m7Rca7y0U($uSNe~hnA3>Glgc_diC>6 z+w;w!RiH)o@-AGMZr$r3z{S~5&oW!E%<>7MkPrWAwYzTi4=99+oM#U?RkLDtS2%^= za`Nz{-ynKijSE2*gm+?y$C)ZJD51yOyPRb4zY$tyYkT~!bm`0;lIIjW`L+Tibd?9T z==~EjZn`N?)V29irR;U>k2|48yKBZpAO&8uOp(F%tp?9c=7Z_5F%2;(R!^=+lEv(g z36Mpx-cWxBL9DQg>^JOrvIa+@1WwV|fef*XE+!^xYg9m+rZR?ePD&?(;a$SFehGxI zLENVaqdkbfa6;vk5PL$|PtQq8ZHGCn^A!sj4t>RazR~TXvJ`&k63G2sn^<*?T!2D$ zrRjzT{7IiKt|k$7Qkc8=dp55-FPo?HmCBB!8qdws%$#l#Tp~V=8={{rtn#Oaj^KyZ z(R(qNKb<2MXgilzd{Y|PJ1C7o!##s9owmw81;c2yl?4Sf$-ne}fmhOG!P4o^>+ zBbWg(38SGQ_=07a`Dfd;W|xZBT^kBRZ&gx4{v1N-n~F?6nQR-3?>+*-9wNUfXJF_p1e@q&#Q0MD4Iew~`fa`_#v_+r}doq;Bl+l3x@D>_h?QZFs^ z`qvI?wR}EXnxCXC&MnxGtZ6ypU95z-kJ4djcy6TlmA0R8AzFr8MuY~&OH@%ms)(Jg;_g^HkQ?;0k{~$}5;>PnHmd5S{)d9mnuen8zZ{Hx>VG>MX)0T18w`We=cA-0A zAR#!1RqkzyOI`xu$N+Sep9tw1@59NmT$GJQU65b{yfC+Kqam)@Wl2Wn=?j6)Jfive z&djowpARMRof%cErT!ARgB97et1qJM$2Gt;9|N1bGK~!}KToK4mG&s%HG3~znde$i zhrAo3`i17Yix#<4iYr}Lrv}_-c@_wq=pQb^Q9PK3>CuTK6Ysi+b|VrgTfxpJESpha zI61VVMt0d8mB|Y=zPUwY=qp|#>~!NC+qvC8wRTicc{!uwKc^Sb>yBdF#yR!{PTy*1 zX#EWpy+{!LaTh)GN`9)}Olc8HBZNDv?-Omd{NjIXM(T4<8K-W!=8nrXx_81cgDsN1 z9wq$_Qw#d6aVi6O1GFKTGABhg!~3g29a%Y^E?XP4?TuOct!euJkf;m|-|N*hdo(-p;K?3N7fV=Hu^&gMe}<6Qel8(%(R zc5^(pUg`_>YBxi#SPfBnSMM&f`A#+|SoQ=gBcD7~=}LQ}?7<1oya+9HuR6Bjn*h{L0l{N#P76W_b=Y?=gjF$U^H$h66Q({^>F*mxc*K7mGJWQ&W2FlCn( zyX;ljwllIemTziSHu#U*fFcvWP}QtI>foswmiIc&q3PyySW{Rw^JETs7C5(jLgj6! zm0^|Y%&6q`aGi1Nozf<;){;H;QMFx#XSSR1ir^;=+4fTyhR0jP7CTINjBR8X_BKRjC06z{rt0yPwCu%p)8)Ex z8^YTuKjSuU<&dLIH!Ekq9Ch1}_gafM;DKcQfv>;a)MIv{m-quO-Lq0ZtJJ7E5nL&< zaYQ%=djvY>6fD#Sx(UKFrVP=&yW+znPmj|JmpR@To`f?;whEM8oxuLxDY$v>;DRi37&rJ$UnrtId1@550@TlfSd6rpMa3H2P!u@@`dy4=k~tF?92NBQ&#Yo zvO?xtZoL18IZu*)ft&+YY5t~WbK@YRocFKTujv>zt`jly&O6{5#m=&^wfY472OM&{ zDLA+M^7>D3hB7<-Z|lL^@edaj=>KSkzka?k_aJ(0SB%!zHO6V@k$o%OGoD33(zH-V z#M`!*T(1j?p6Zv;hXD3?knRhfyNpQ(jVjfU!wVT6Nv>KD)tTA@=FW)qjCaRGiEB=@ zLz7P78;Q6n1QHm9I^T>YDu!GO#jPhuJs!LZm_)>d+~|g@(;A?MO`wZ@v@}F(ffhFP zK0D+etFF_h5H6(rgBF+t|71OUTJgL^+B>${XIOAJfBH7ZNs@8PCF~Wuswv<#Y8qI6 zIaRSt4z)h=W+iP4sFF#WPI9aW?956RqeogDYT(>vmxASm##L7&6`q*;xhVA26XAL< zlV~|??S#M2%73F**(fN@Kz@9XiLS4OhXrqJM%%s`JcBkGOk8(6rZSKVEn8Mx@hop# zeM$Aw@@RfE88_Q?ijP&G%@i}KNb3k0V9fhvM6=SiJACES`c5mHzADZT8mU}j?eYG8 z$i*>&r!wcNbJ@fNmQs9srnK#eJAfZbIEeV3I#)6@inYx`SNUd^@i8=wOXMX8%Z#{$ zJTM$hFPEF_Z7&~8!#M8LU&YRf#s$5ml2Xh@ZDx=M_$%-)wooy%zM|WOulSgv$?55+ ztdrjTl%uW%PO%CxEfD(`+7>rGHhu>TrgaHU=dANA-H>3f71R>?hkWyq7T5>B8Da5= z=yIoT@@5Mcs8RZG(FK)}SoEdp&#J6@+Xt5-_og}(vdh5~ z{E@n^#mbc{i)#KJwlVOBPnA4`S&DDztQVT(qe8(4h!*J&edIIwuu>=~^0pR2W*qq0 z!)~71#3YuJNK$6UfF?`8|3m%oOfj__WTGG8%Gtw1Rx1r)s`bv(x0>_!`$9wlJedjWZcqO`JbHUHg)>>mk7PQ^D$8X+@}M zvkMG$3%M0DFMRbuc0hToKT5IleIO+t2$f~0IN3A@L8xaF9N_8#F=53E?s<&myqT() zH5@Q*KEukOS8TKsnYJ>C$M4oOWAaaH3!Dp1dmO!26qr=m+han_RXfZZh1W%9o(%;Z zrA1scs(a)qkGct3issibV;6vm8*jUG&5fV~-;88CbnivEi4X*jT@j) zowd17o%|PShln|aZ;h%-Rz8Vwmj6s`q44sZJ$@UK`V3N#$BapXx4({%H}}MsA;w8p zM#iX#5r-weprQwkcq(t+w);*-+^bt7dUAvHg(~Py4g<;Q7(9xcFn^o@dd!%52x1!2 z)U9ITW{i?ud2dDXf2)WOOTz1lr$)kAWrIB#p9X%`B@pyc=n$E<*504PJwlO9me#+b zTHfY}=?~m1Wl1aPw7X=td*Wrs#@x!>su=-V>Tj4_$8fMYh{@;d`Kg4^7MF0tR^@{I9*M#l5hBY7 zMIyfk^Y7$Mjazz~c~-q=6=K9Q7sz(M*twtA3Hnz_B;4TNm~P($ch|6u!E9L4&VX8K1C*V#vU`cBFih4mv9#mqtS-a1Lcd+a4Uk9nZ8Gh*V|Wi~E3 znY5E=+~KD{$qdx=V4*ENwX5y1eUc@!FQo)i88?4u{tbFYu3jmPc)xg_cvmobd~_Hi zyPDmZnHM6?_P$P6bpbS<;jeJlSCX{n(2v(2dTzPXzs*{VC3Mh(p%M+{8bA@~5t>lm z3#J1Gq6u8fvQBf_*{2YUUM^8hatGrJt1{!zLT-;Jm4=cWs1^0UM_qS5Uua8D(ji4}+WgO$lSE(uE%Z@|YypHZ(@DflFs*{P zVw2#4oEdRM5XzcF*EAA=T8Y8c^l_0)Hxj)ClPx&2?F+N!_U@i3Fb7yC-Q0b?%YB4o zNI#qj&TsQ>*81Ftc0|aW^<0#n!g@@00_v{dB7gFIDga1V<%RjQU-bdOuGi|(m3qbX z8QrOgcGQpVa}{4aiLR64%;m}LGvxErP2k6Gif@t1D5zU?3KQ(>>$|J6R0c>9lPt!L zbhoi~5I*?$X3!$?rJ{|wyS}|B<<4Sh$|eLw`<7kQM^jd;Uq~C(-U;lkhDMJD{gFbT zdR*F?a~g2F8j!POc2` z)vJ!X(C9Qy5&a#%%YMY)^|Mlc$lm1~_mdG@wny1+XJ2}q7&p=Aq#{o*rPeRreQOBa z!d@?%XgHe!L}zu)r?qE@v!lo)oK$^=Xg-qxwAh83|76mwqEc$AQuWitCLiKH^EP1? zy?NE>s?lNbuEy6lAjQobnO~8$mP+Y?6?xf~C} zE@9A-v3B;SpNZ~1E-u@(P;_*RG#X?OO2{Y=ENk+FEUyTZc=Clt*rFU%7?A%StLlWO zy_Wt&P6yWq_6qCJonu;c_8dqqxuDr%sr=UwirafA3JJ;}77Gt}Y%y(F{5W4bO#K0q z2n9qYUvA^GWlQ@Mw}5$V4dDtZ#5|y3ejS0P{tzAm{goelU9|H9o<~e1Dn!ywvsT`i ztugwdI|k4`(7f98@*k$4jaBDv<6}5(XiL~?#%jcpHia2>(UjX}b(n+Hm{>QL>wit~ zTCYFxCO(`gqbbsYEGGkBWlXnk2IGv*DbQu+lN>8wqr;tfVA0X3h2wnKj4@2LhcoFy zeZoJm+z`Vq%*h=s0(IS0@zo#Lobo3{K99I~!Qcm(|Kun2Mu%#-#o?xtAmB09%Zh;> zY0BS4S8BFycAHyh1ERtYWqGH#?1^YQ{&WdKd~>{BdAkT9FFtFr4N6%2O)Ou&;Y)IH zl-W=9!UiR0{_r*lTTWX&A-wuLoRE6KZYCO7sS`#|F_bI;b*d>Ev%c_M>pVKmhOJK( z-oyM(1Hzsa`bPW1L4~cWuc)(XtO4Q0`$Tgwwfr6YkGUZ79`RX*A{z&mEr%wqscfKj zN8olr2H$F!L08eIrgi>c5jWk7r&G5GPIpvv{q8<6@uiR6&L4DN4@gEAbyxdK((Kta zG1b^{iAUUR_IK;nWA3t&+OVv!F=Ozg$GUybhnPWi(xZS_@fm9(M_eJ@ZW){8c5cR) zEyPIwHEgk*ai!u*d=rrkVhCLrU`A4z#x5O!$0 zCe*XagP-&`{v?@wv}ig}*y`J=gB+6(MCqcP;42KebbcQO`*1PUJvugy(stTj(otWr z6GU{~K2R9rd&=+insKu4>0ZvbabDSKFu}4nAXj?Lo<}iW4~L3Hs%sc;VhCk!Bgx0U zoQCNfa$O?NBti_DDrAw3zzj6ezX|`Rlj3>jdggJfn5!1X2_VyRxR9QhtZ=}NH8F~~ zr?jQVhUEA-!MC={vJRKX>}x@Pb3y7yR?bGqbEXV1v~wrKBk0jUX6=pJx^9pGaFkwpz1x_0Kar0&6IkBvJm9=_aHw$8MfD;Zd(LJ|!>K9G3nUjV}g3L~acO>GB)7^gh9nqqjtHq=* z5t#*IGO=dJm|-C7cOOg*_KDV%(l^&Kv?(LrD}Q53;Zmo#G92 ze{Zi2nDCRzNo4Ozb7{7-dfl}-!fD1PanBakbp67QHnzfFIdt~IEF)rWv8hyFzhp;= zqxZ7qvPUNz^MmWfcxpy3U9M1Gy&zl}dN1heiVjyDB?3P-SLat$4YShOBY59|E&C<= zxJKcjOy+MP0`yr_2K-xS-PJ@3?G18nOaLu|{t-@`1hqIlt}A>hzb3rL0HD<-D!11E z*PjUwKl@91XTZk51N4o>L1=7b*}98o{LZ$x)m*b_rd2Bwk}<92YAV`pEn0}D{R1-> zE(_kIA=XUlAI5E~zW9{hN2^Gu-xV>@Ivz}8Wc>A(c%$QP>)Gxvo6i&L6EvrKAL7r& z7zUvsvRZRgoy8mNGVFd>Tgu4p)$m)F$vSg+fkcGuE#-0x-*AA%AKI&L+N;5%{q_+z zpml+oD~Y)KmM7T5VcJWPN2bp*OyRWm@uTsw9Y)HwK}<@;Uh(HGjoIq$%r5GIGLOzM zd-S-UuC$o=%ddw7brH9{DZWFVj;?Eg$b7>Q?icaqn&#pWz0oV?W-Gd|Bh#Z2I5ef? z2Y8OL$ze?8yi+jWC-R=T^L`gizIi5^oq9h3p;@b@pNn6e)K7#qg`xTC;TsMHTGZ8Z z7|$HbW%LJv+}}+fZ>1I$Jn1)*x~_&co^iR`QxtNX-^OIW3U#-Kfhd>PUuv|QDXXPY zhE2m5vNBkcF!J4vtAYDY_a~3LLjq6!ee?x9R9d1@0SJB#6$_#sjUrU2aDzQYb=Wj4 zw|Mp>;LXy(5?JEaIi3RpTA@wY?q`gWVq?C!5tdn#hCYnnR}<^lreHF^9Ma85^ZhJcM(DnB<4Q`4ULr zTFhl0G%C_~VNQD?G%)mMRK82ZY~H)TY2Um?r<<_5zD6i~2UuMQSHSs_(~c0_1{x5` za*UXjHJwl085jrW`UeomHN}aMEI9-q7jS&E&{wQF@ZN78xI_-Jv&T+uHc+U+sE);u zgL>Tp#qZPVJy$NI;qNrr`0D7skC%%4G+Vvj*?$^-jPot!2Zp?#J7|Se1CG%!kuJfX zU`wqe08mBD#%$E}d3V5*S9WE_FE4LZ#~a6zcA88;fsgRd%q_>Nmo|i|Gq7K<=N*@1 zO)VHf7qDC+O@O_(n=Os39KZM&wVe}@D5=e;$T`R9IZax%Dy znil$`;`iL4)s^2iNF`>f?Od$^-THr1K)n-NwOV23j%0m+T2XVUW~aH67H{DZ9%kRJNS3WF+gycnj^>2vMGGc4o;bvRp>-{! zvu+S5;9!4H65dJ)v%Zd`MDd$K&k00LpqNwHZ{7y<>ljjA{tR#VXqJinSNlTc(7VF0 z?A}&23$O)S4S0QkUkD1qCvewDvZ5|t$phE_5&%~5gzyehK1RNj?Yr`Q-x3}Y@vb^+ zNptoe+pl^bqRHW9&G8mLhhe`sjn>0J$=?c>X_sFR06I8g!diohY>x1*<5<2@|A`HB z<8L!;zHkk4a6hTtlzaM|?5LUqP;ZnZ(9iaQ*e-&51NMXW3Ov`ZE;@}(m)%YlcMFc% zC1@_zjv`AygijtgyN8y$C@I?=5BTZMvd><*@tUHFEM2z+ow$x z1u_d%EK=Xra*-WZ%(*V|?7eVCLPwx}+b%~HbD#L>(WV<<1z4PK=C93je2d1bSh{wk zR_-mjEIj)n)FkzSCP8jR={pUykFOp#i3m{LRja4#JH5S6E9^rwyKt%{;A2rln)GQq zxBl-A2XX>6eb|whoX~7S^BhD~g*o3hY<<)eprc^k1!4#`48D$cO=wGdqDrr?w5KFa zU%j`3W#DmhRx8bT{;)W<9i88%ikJ?u`ryf;Z)~{E(oDgCv7*$;UcdR(6XJM>Me3Z6|0Ayy0q7 z75*Z6j(<9=Q(!f>LU7$hTFN-ILP=I49XZ6~{x|;X*_;rI+ko2NU$i}HqM0lqk@8He z@e_e~pB1!g8NIjoA416#aK+chms;+)egAp2W;I$@oM$gX+^@jJpkp1^3H!}$3vt?5 z*(?KhvrWeO!j+Aj|U;4UpRNuRT0d~g_pZ}$nGDM!X|bIkxm z%>(|avG5qtEph%kx0OdI7KHh(*jp{u-$5@d#*ke=izGI# zcC-A90psz&LF!dO=Py!1O1!CUcmsom9$!G!>FSdQ)U|N>E%}2TXzY5C`R1-e?DCA< z=#KY>SJvb&@^*Y`V%?Y_A}2oe%v_j%<^PFJlFrS$VAdi3H%>kNs9CqFqmNi0w!Y(} zP=(xubf|lhdH&S)82;f78lW&k57?bSV^=Iy2r!R|2`<}UWaQ!U(J=bzlietyda@%-{bQil*WHd?w-qic+zC~{NI9aO&iv3US|&b8z~(x7>%yHyftQEgV71JnBu&hnsmS=tATdt6?rd5@e6h$guaR_8QFHi1c1|Ncd<6269TpF zVPW(!Iq)zbzEAjs_s6s%o}+GcH9xuKYu~EC&VEXZPAvV#n^`&NVW7MwI?739A2bRz zjAjA!TVmMr^jPlBZ;JnqqjT|Rvj6}1UG8p`B9$bkBq@sImc}-uP>SS~99B`f5i!S| zbds|83pu+4_wzP~?Vk3Fu>b-h3D*X#K#Q1h-|7drbe zga57yQ3VbY-jOh_uGy7+I&lA6UL#2XLx$Ui1(r99+g>ZEmlsM%hk#GSX~EmERLd-P zW7mqxTS>T}RHFE9_)Li=^O)<6t;)pW*OiTa-CMVcJ2wz^MHQ>A@N{B+@BNt??k{17 zy%D5+PV9q<%KV~lEed+|;JAm(R{j}*hsMS8Z|Kf;ZZaaxCm%^XhxI^XDTp8o1P0o5 zl)w9jx`y~Sg}hf{oBU5DM?<8u?YD5+g?rtFdta{n9cT*FVrMN}!N7H0>K37I8cD9) zFTC_{Q4(sIF~Ta09_$xGWyTRHaXQ*q&NSr*r*ndSI>>r`q+V_~ScaP=Jm7Aty zo6$f=sU+8It8|nKOu`LxkyA`e9Xev=6}oj8W%iHrL}{X0@3LCbt$dvN%rkvl*s54e zTTuyJLRqcPNpf%%?5wcfOCCLH+eJj z-75qdsZ?Rh@R~FJWjCk62=xuh;#>7ul`tTsNu|bahn`k=FFAACck^?$ zT;G8!`~1n+@29O8IfM;tPTgfSZr$zey?3_`qu~|)Oi7*f1+N$iTki9jne-VL`D96li51G_y_Fdx zO(|?4h#iYcS3~a;+Zd zl4cLt z$*odQ*TqBl(aAqe_pqnE6~GYI?Al&}b^XMw5gz%lQ0N>&agp?{Ouv1ocGIATt<-wi z4Dm)y@DPeS{)uxjgf0zO^YV8Op>x$V< zIRkWp#5XibL9L_L9wlr&?cI(_3_Tt1N3>0SWP&iq7JhcTWRhL6HRrhQe+4J;(8%}x z*Kjvcex!Vwof8#TvGuLGc5Lp_cNmEgmjV@|#CiIdj31%mcX`ix&$f-inWOIoBBH$^es!k9QJ@eMd!1cJC zY8i6=PhHQBqPld;;=svF(t@{c5j2oKyL0mhSJd782u} zCpo|iX}$zi{qz)!?D>?~{i#m)(R11>WVq z4uR`py7k}?gWq&v4n9i<3|hlGL*Dh=q<~qKtGZz`zjz0ZX};mE)5<&!wcl#;DTXeL zSEjU$y$Gnz7Obp@iJ4&{*e5d^<>|*XX2Ypvi5p~qz_%dSbm}vYL+QD+lLNjUOzuZc zP4{zx9>u@tuJ1cLiQ*T|Riln&WNu~CXtRrvYAhYEL z)APV5hH6x2wWKJ{O7YPo_>JP{TlPRVdCcwc2+z5j61*7v05 zoork&b%gC;H&~s^_rs z7p82q6dMz@#OC&Nz02V$p2sUqX-72v+5CCOdcA@@C7&wcb;WVgddJsZQ46M>c_I^%)1EW$_-l4iz(4lc8E_(Y8#_c1X8Bk5?gK!nMAEqk;k`ru2t2H?`c#fJfov zQXG|S^jGi-lljMFNSu_E2Pikck>Y#~-sM|!FIjb4c4@LziDWemIziR(rP?5m$|@?QAa7fC)Oq4hW6BZo8tza*R^jv38ne7Pa5N1W{3MG}c`zhi28@ z{!Xb_-3hw#twofFw6ZP&MXKTCdMQt_nio*Jj2tM}WnosfSZ}R8gmQ+SPSfsAb%18u zih+aBJe#xUKj>aHZB~c6^2UywV%#Q0PA`|2ZE}=t9;8dO(w$xlh-rMUxpgmd`|Kx} zRWkhT(A6hoo}Iy(lq@fdLqWD%2#+vbG+BS{+Om7HL2nSZp^`TI_&$5T25M2 z+4lIcXKZXDxsGJzaw{m^FQDUWAelgv5w*q;+Nk`8TB42-FT1M7!-K**{!K=D8|7K8 zv?I~hjK8T=1Tbt!)ZeSXI$-YcKtYW^?<3W(LZxf+Ie$+PAY41 zo@nRMfUZ{m^nxq?Cz}pR*p8J^|A3#}k@!i?A=Z_xn|~B{hy_P|RDRx>k66!srSfff zpf5}S8wgS@!(XO@nNTy%KgWb?xK3YI@O{Pp zQ(W^4i1i7|NQ<`C}xn>pc(qS{EaZEBD_u>O-z>$9P@J z;w1Ie&L1YAWDVXjKN~y{=Hk_AWhh4I%k`rX(%bpi#9q@CT4xt;Wka`g^TG-0(IzEV ziCt9adx{Z;Gcz_MzCfHo_iCjzIb&tP)6WC&l5>B#4QwmmG>kJ4$Z2Rn&0?4_dtcXA8}E+91-^_9urL|H+kMpj*_?vZ z{nxn6^5VhK<1Ns`N)RXSpTd%jsror@NmTjC3A!l16)!41j@nSQ;QURXw^FX+DEs*A zxm=Flvmn(qrgLbf)b`m#=5ylHZRfxwXJ}4d=)YD7Rp_}DOZ@?>ITg@sH()FDZwC2h z#|(343-e%KiJo7^eo1BkOMP2Z!&BSC*O-F6W`|WB4D~6iO-n_O`Ga|#LIszQ>sA*N zdL*Z%SH5f5ad5GJ6Vr&vqbY+i>v6XrF}RPhjdb|)!qlzLWdD!9$AD52(|zaO)yzgV zC`)eImC}>28cSr-qeKEfGWj$Xv_*a%vf5bOFjtl`!2|t#S<#pZzDNvQiiL*s0)!t^ zWJgmNuAi4Y{qC+5g!L^mU8ts?8HZLs=0z1XGMo?5yFHnKY$hv6Zm9?U@zO-1vrEX` z6_&~10uf~Y-h)-Z7^#zBMttZiKd2{|zrdBdyzAd|sz-(BJ%<;>@@mZQ9o(7DtIFPW zE?s|O?+AWe%?!Rgaz-^vFGTjj>p&|tJr5``26VCb2Xde*Sy6iZBk`#K)%XwYKF1kw z+!!oP(au)Z2g6)E(#N*ygXz`zAx&Z7%&mP|zUZd9*P5TXtgW-}{ITv)9iRG=m5Zn0 ztTPdQTZiyylQfi?fW*|_nF03Gf-&VWT;EcrPLnJAdv!gCgjPNNl$?-cssF4 z*$w$R3Fj_|wlFL@Re2l{|!Qv)aGnb4{uax2mdVhk< zW$Ied0ScDWa<4qh0>(*drHFsugfYWNr?Gx^VgCh11-$=lC|73>DHA5&x>1q#ZZhgs zl5zL`dX=)f9uYpp4WVt;4|~)O&eaqD)ED+NYlPSNZtkwZKMT@mI=G(v>TMf8*ViXd ztp}Yi!?!PRlObq4!wxDc69}?mwd-QZOQFQbk5}MGIrSJBI11| zUB1zCWlCb$4mbMCKs?8+wl8@{9cn;NWkAuz!4;ls;?V?z#w`%K6f`YqF(XjBh;;8* zd$fdR+)0MNP)`{tPbEaGNXm;Cy6{$U;twy$9i>tMC8v)@Vn{Qo41BE1ib9Z`&Wm*Tz4+}j7Xj~{m-;V zd3{FTu4{-D(xt}g1o)Q~b|BF2HN_rITZdS4#u0OIoK<&&JVjQl1gq*U3DvP=e6*uY z7(`$D$_0PzN?#jwWr`v&f|aIE2kXC$b=$fnd{gn#?gEd}!0w8em5Bol$YbcISN#3TFFCt}w<0|TZ z25$~|&|Yg6$>Ds7Q1IsE+2UU}eG-v4PX!2a8mjb#&il)BwLdJ{69rhhXhO-q!tiX~ z=th0gA6LNIF&IoQN7p*~x9%9YH68>T)apOB9F=j=WI(zTxLJSML=*m2c+E6mJodBL z{{~yr0W^5BKi@W{vLYa(cZW&zhnirYruxeIW1k(T35Nd!GMNdKT2Ta?Ujb#|Rbg{K zqs^mhhoR|&9o`dCu{5L}J58>r<;h3OrnzL1x0f~8{TI;^#*G2jdob}wg=3dzMORQ0yjAl1(^P@{^@XV*sgUsD9Q1%zju3~@U@3%|2*)p6AIk1ktY&>6Yp4h>`qZ3LL< zu#7TNGn$-3@rv>=Guy>&!-l+5oH6z`QsmdoLx`r^)%=Ouq&J9C6&llvroZ)7F_LA= z!!Q*e4b(i?eT#ML=+2WZkzO)rb{^fPjuamJh-Y6=id&#}*988(`9@&)RDqHPQxq_n1m*dNy9wCLe!3NRb$xE31T*j?&5 zRGiQlCAjMpjJOH18j|*zksBa-vrW(s60&HIZZQGN;!>bBw0N3dv3%@1%opH9@Vkkm zF>(8cVJEF`39nvRXUAba>Nh>QArKzXfha6Ue})|&z3!VKEW$w04@CLuNEIvIg!bP$ z$fx7;v>3__b?CTeaCA0`b@?QBfG%7Q?PqEo2!%W{6e;U+|&Gh*5~u zlydyq?{JjWX{+wqam#q--a>Hv!v1ermC&iG1G8nC=VgfPYz19A_c zS3H$bdtf9W%{h)$rTcGj<2--Qj8PPXp?5(qj6M+wEbYtoW?HR?n=7CbDvggG$?cg> z%g?jz_`MTZvH?A8J&Yu)O^6Zoo$aQy+mYJ=2>LIcdV5r_ui#9> zZpw&!P1yI7^EKeH1IQ)N?1WkP615tqujwg~UdTK!Op|5%Y%$N>ON*Dr>rSnfH(P(1y zp{(Y%L?uL)|IM*ult4qjg3axf3SWO!L@m~aGf!*^8qmJw3FIRe){}Hx&Gt^x2O#m! z)#|w#E565VV&VT-8Te4dHui!BG4z~zcX6rWBcjE(tj1-4&^G5ea<-|4gMh1+5_VW`sHLqu%6E^JtGNr3F0h>|?1WoEd)WjVvv^6a88~_yzOhR8 zrZ=)+$B*(ROnQAiB{|(87zk6DwOrd){I{p-=4ibB0{+O{?gF}0TX*y&uEMY)oM<3wbaAVoDBcp&qel~ zCEYUk^|zPlz4z^9F=d}aBwUr2$=!8_0$cGEnNSyTVh)BmzSh`^L{Iw^Xofs-`C$dP z70Ya8zNKEb!?-dom0mm0L+_FnI!&^yc$!}pJ3$GMAxwBKoqE28QC%q(y=CS`F^%w> zr?*ei!wJq|8MbOM0RzT7Fw+F(r2${x0oGBLFyUUP*s6O-Ml4KaQzgec)u{Z|+NTzF zXkJo@|K#Kx!{`rnv&im3Uc?16ZSNBb&Y<#|v5khFeG8A05XlJq`0ys{n_4UXRi_}Z znAeakKJ9~+ThhY)Qma=f`hHit>f8G4={WsNOD{{R6lZKVE3#tuc`U3bm_}_95pvj4;S1WI7p~4~rak%XO%oS3*&HL#i#_sGo2Qt0Yj{Lu>jZkC2QwhVD0#XLGo z=hO09=xt+f)?HrpkcrH&7ag*C6|%a3eJFpdIH)p`(7Mgd@d2LMckQw@+4`3Gk<-xu zF8bWlaoUqhO+6>SahYgfCM#6MRJSWcb;*WBJhO6B4!*MvzY)H%?lx|Ck`1BNqi6 zTacrAu}hNtv|a~ZZ!*yR>5Qva4_hQYq?n-B%l~-P=RmT9Hf-D(o+Qey4W+_g5=(rq zWu%%)W97X4`tH(^q!KZemR(?W&(?0WWmscUe0L1;MWu(%MKg{R^#| zF2sA`o>QRr(QWJpIDrDUU~AlUV~xJIW-a`iU>7B*?M9G&fHwRM61u&$*@FG=&w3!+ z#JvlFxlsDCv>DF$Iav|b16gzXXw<6CPYJE1YHclqf*`)CA7835QB8mH3{?9S1#eOv zPi!vnT$~zL{MCyk^7urtk1SX&*O$f|w<}Wr-y=wqouNvIl_9c&h7f7==&WXG{r7rt zHFoLR zP(;=|7^+MzgCTm?Og!6fC~r4Zd`7%S?>FdQgFg4_SpNM>Z2jtit@pcGA>m^_knsQNB&z?+E(5W5uCFEBt=IP6ORZ zXB3WO-KnPAAXsP1|amfyN-}k@Pvpb-d!nPk)=${<9%>>+9yVo$P&4@4?D?2GT9*#TG_ zX)U0r2;JEM5odLFU^AGXN=K=0qo}_KuV8DwK>U!}qbbZ3dGvS#aXzL)w|NGw+BnlKG2boAKcZ9Nqw zB9K;AddK}$hm1bdK;6ko+54+v*e^uwcB%df*#@DyO@E-{!rh!QO*o~GEm@pto|Xmp z?DIqixZYt&8ALAcU4(M>6KrN2`Pe0E)rT)}4E&n|>h3@B=!X~y27FKOj4u2Wd!dXu zzcQ}pz2OnFs;j(kskAZ`baz)1HwKcbkEn+f6!zrf0NRRaU=VXJt9bt(NM|%I<|US# zO-FS>octHPvx3Ab@uVrBx9-yQiqd9i=FM4udsVLC-Hcb4;1BxV;mU9N^j`PvIHJ6b znxYt{>T|{bqLBSRO*vEL*wq%%i<|55APn8`>p#1{*xfZ2@OJ$Vq10!^ThHsuFco4J~(&?4}jPBin6#4}(yAKH0j+*x@FDJA?+X+mlE zCYam_m)dUYQ@JB&K1sdhol`6_&2?xx7*aS~`p9n(B@dv~E=LNaI9cqE>XO+3uE3Y( zjhPdu$EqD6<0&n*u+w?RXJlZ zAi3%?qkpIb;C8Z&PTA3CZ^;`A?NQY4{^cW1INoLjU!WfU-;A zQxbg8mEV$hmpBw^$LOl6zDiMQ|Li9}a-Ktg1@OIE-RjVy%H~!{KER8jjD)aKg1ps^lWz>|{ z1v`Xe-_Ep=eDO2d|zlMdgxUZ9B2G$yM8r@Qq z#=?x4{w)nfiEgvUeOf`O{CcBS- z`mS+_SIswaOxd#rJe88C+o{2u^}nHrrlki-HW0zjOJ=Tz6PkI}_yUZ@z~*YP8FD*f z{c?1(zA~}r0S6n6!0i?3Uw}KUON}~5)6}tnN$b8Le$`LEq^R7 zdkQ6bk`Y$^#z{jUWNN*oN%ONlj9}@ne>lUdX`1!zpt$4LRhh~@jr$ovqYdtzeF#?L zRdItGuE0Zb2_y|E7F>#Pq^mXhx`>4@kKUK77%_EU75!eqeTV)b;-p7@KaEflvO@RfURWA$i12(=K1ag`+i`g{A|SF9TZ2MBAsDM? zWT`YB2^9iOW^0ab)_dfZ)930Ry(95&EIoIIkL2;+9BtvvB8H?z{{Ye*)XIcfIYEpD zDyL_6G!djQ3~1-5dlrf^mtpyS3mxJ0qLE68Yfi~c zyC0ophX#itb;9 znuKw?=}a`$G1Dd11JeUhLtgl$(x0}tm`O;I=b?qNbLpY%xjf*-u zg#yNA?nSduZI5N^S5it9?XsD1=Kx8t{xp7?Xs$yyB!yktv_yHRzht>~T!KhAaGa7B z*GEa)6?q!;#&rb`-aW0kx z)b^>AHXu|@x64-Eanl0U2-4g;^4jpCsC7BM8Z&Ft+g!~V3}B}7REH)cERv}5dAD?7 z5fSAs)zn<^z{xg-YMg%VmXzpf$eGSs_LR%|pxFsgI^p5jzM!sc8L()SGO=BAR;&yb zvTuEj5A``Kal?RJw9FlWZsbP1&+3%hbGbTAyAHB{$U2P&Wbfo>B?VlNHhVFKo{rPA z?g({44`}-@00e}0#RR*dV+7h6s&3$bZ3VgQ0oa>X-%tL#s~H|oacm{8X(n? zhxFe~s#%9t#dJW+A7mctlr|C97p+znaw|JjHqHWZv)!=D)Vr|_$ zq1e*mxPUv-Yd2sc(?OZrj_>DV(L%slb!>y2p6*YkLg%$$HyIMO$BgXD0zh#8q;lN} z_&;sScZOgBwPj5_HvdrZ;AL-!v_ zE)~+3&&vfmt5eP4y{?4DG<<9D%Z zxGVs#{#4ZK>LZp{BC$`trgr6jo;G2b2E$p$-$ij8i#Zn+Mp$pb$4SnbjU$PoSEKc= zPLk59HPM6-aacpONxjhu)BNHsrn1tMcU)bp<6q$K_3dC2=P&hy5&)y>W~aPP!QRpP zWgc;PVGmK4VLA2;jnb;Zw?l42Qd{L(q;le@WqkWCNHOG|ShjriKHU}qG zHhytkpK0tq;t7+fX&B)I#_k9Cctkl7e!bMQSLf66{SY&9J4Pdj&M*1Ta|^y!hICl} zt`E{)%g22yDl6%hvl6Ce1c;S5p$15r2urWWA&Q99_tbn!!(fm=TyL5GuM zuMhB@V6Q;$u=d~~@1d|I`piHDyBh}g%7LcC&9|WXoshN7&=@@;!od`9I@}o>`gL1t zU>0*qe{_zx&* zA5S%DHU8c?@w7FyOf)R@BDyeP@2tnvZ%#m0X#Lp&qo?OK^P!n9H?C4lzPK*gT*i#*ifyYE6=srC&8ThnB$?}a zpfCRB#$?OcaAsccyfQ19G3TfSrV1~mL)+g;?}p#nd8~N2xNUyxYS7h)*ZdIuZcDy! z7y(>Av!b5pw?C3>=*j~AGt~I5!39HsuhfE=Q0Cy4SL?>^VX2aPOUFW%LK-e2)YYDg z1x(o%HEcUT2d#Ohi|_Q+b+odLJ)J@{-q_SAXpsIAW&vrzDy`v+t2|p`K|*llXn^A~Mop5zw)zG)+0Yt@muRo45KHh~ZwZ z$DDRuyuYcc@xedTIm6Edi52$xE>X(Bi}!=jnTFiA3w_(WzqP%=!P;vQC!R?383fC` zX5*bH2#c?KkcD#%_3LsEwX`9g5B{^f|KazlR}l%fOjBLZHOsOODNmIXpA3}XUG4Or z;K?5UlJ8^}cW8||Zo~(1f~Ggihabscil@8kM61BgyeNud^~KQJ`fMIl_!FGjna%P3 z^Qi2HVy*n7chd4P?rFh;%ll`p11$zgoYx50S{O&m1*R6$(9_;9Is{rZ8RAp6@C$!Cx2=3Z94+_ech&d{BI z656E(yogaJ7`!2vx{-$K8=5pTU%q163`MtFiRHRRY{Y5@2b%vWlFs+NG22^9iITkx z%i3OLI$dlbg`PAP&&^?t<{S&@Cg@#&zX++u)Y2YNd!)1FM!p7CAdRljWIG5?X*0NS z6`vP!On0^a#g!kzQ%t*G-nFPdI9ovY9yt7NMNjT?hfb$OswLHsQHIc^*)t7GR!i?V z%T|93R0U*vP1NP`?#%5@cBPz4)uWrZZZD(vQ>;2Z7Mgj>M29~p^!^ac&D_m;uZztp zFppMP-vL_2uR7TH?h2@51nV^fePFxKr!`U2YCocw?vE!#fI_x0-T5qfs_N^vrONKB z)WLQKgAql~hP|O-y--TwhWKw5LxuRSUe_@^^9r+08L|tWA|awvEMR(?I+7VI!~=A1 z(IihPP?~5r1QdA8heaj!f_PbAxP4@@dq~;zJm75fPF3L`>ZGio;W%}0hx%l~m<~n^ zlT&GmkkCb=${Dd3{@u`ZXIW>+zo&wm?#kWitK8X?1C<7?HvTm;x@H#aj@a-jMOZQt zRZUFz%=6$bxI%l^$mK1XHq&qb{Stkh#B2zkFPWxGZ?5LixfbW5GVMB!P!iV7 zjRW@SqWEA9<%Pqo=wsHDW@1mRRFh`I>jb|E=t*C7_r70G?!B?UI_o?0JYu@nq0H%y(?RO;1;VhGFT^oEjW-pRzjjC_x^=o3Uub z6<5i!2+`yky<|;um1`eHvgFJpTQw*!I}Moym9FP9!QY|%vjz!?YW_Mp?yBE6_bA1h zc}GO5EGi25Dw!D^Q^w&~P@Mw$3@w%+ID5;ZPoo9OqwM1(hFU{Whb24EIFMy{=iUMg z=>$Yv${ExIEwLR?Z5FYG{1B0-nBJNOBqW0N$C zzmy^kLGpc?<{?YH&9NdS2bL~|WPw1;ME}d&x@`g^Wu^@NdhzA)!L*g{;L7fOA?DxG z;rC;7npB|J2~CdkbXXBar2S73q^U!Z?!I!zQ!E?u2iUC0fA-_l!+(gk+e+me7O5wZ zQRqYHzF>dU06pho#;Dh+H$|oUf!2!Xj4GNjRbf1`gKJ>MIT?m$*pTym&n10q>>+d= zEmZq-DaSZWM02@d)v@N!w{NHj{?(KLPLmfv` z#cm&urlk(&mp`)2>g*prJm;J0yGzKPo17Kkn7s62t88PoW4vLh(xj#X=YXe7L8604 zz?F^6dyYu*r%KSmior#g7ybY50GOE$=nhOJA zf60Rx=_&)htrN$ZX*@}jM($t?*gtfGjX-y^+P2Q#RiIA z$^&74Nyn9rY_Hkx$Dj>OddwFHD}d)gN^HIu(V^zK2f1E#_%q|A?qdjkcfc?8Y0(d8 zDE?94DcPt?SvR##_@|}%r+bft@64)nd^)M>#k5HeB$FJ!r8df=JcnFH^Yd^-P*m!6 z?;DZkibrXb!LO3_ds!K)sjDSTbJiht7h1xAuM=yg54o%&_J1Dro}ujyrFFEg(Bhch zcFdkd9npekOsLM7qu|B=bUqt&`{<2de96lS^1~(HH(1siV9f22RG}1eyUp$y`qSR` z`62oqoaewwll7mNgxK{pG-~E`N3TD6Bjp6@6T4iby8!iqxwd5;jk28Q3qq+Ew^D#@ z%Zp}lH)wS!f+I;X(*kuXmG<%9>JJVT&&L!-orK<+$a%>aFMbNg7W$@teXdh{WyKNg z5w9CJ73G}`o4cJic0T)JKKrwg`wqyAg^H(ZZK3{c5;N0sKKwk>+V5w-DAT%`Fdfy~ z@X2fs2!}{Gw;4JDY1!Q4839!-{aE(Ckhh4u_HQw)CVHmaSToGWEWyo75E7lj>;jO! z29G-fDMP?~J4iX15Y(aMh@!z|k!xGmec9jxo_g6u>@2>8lhFB_yXg4#1ie)ISVm{v zNqWd4fJ>2ooD`)R6?mYgl(PB#oDFp|B*+C1X}`;|XUu?g4v*2{`w$izz4el`97vP5 zJRag;x1Ms za3~Xoc_~^wT3r&-DhI0%pG2h~vwYV;lDL7RwQ&7tuhzK0CC(nGx~cNh(#mQ5+J?(E zqQcY)tb50JlyHvOHa1Vy2%P4ZrK9C)rqRk@mtCa+LuUtmYYN!?!F1(5kEl}DnofwiNa+Xsa!ca{o!q7>>N zi<1rq;I(SAb-DVmd3ObAcU5G;52T2INFr+QLANqLp?A>BE4arM(K$}UM@iGIrx`j0 za>$VK7ZFb@{KIE%5NqdIXZed@Qoi2c#5dT^iZ4*i0>Z{pzf91tLmvH zwK(eEEP8sy452PWmYBUNTk2OUWBmJiyfgeYUj-7!sHc@yIa{q^runqf#$0;Cca;1e zwM!4S)#G8k6NrAdQTuFN_C^{c;kzH(zD6W|J(f6u9E%=gxxh;E6RI?QPf z3H&?n)WcoWzB@TDA(b}i-X-WulGZ2NwR)$z)4^@2nbIb|{Vt@GBHrZCJLph8bg7jT zV}?J(*IXgi%b7)35$&HNj#uu2T#*1-Y_8*`vUK9MBZcl9vPVz8Y##l2dcd%2H!BRq ze_Gl^ezO(0$g^qUWqWs@;s1yFX0bjNb{m&m8c50b{Zl#qGiKJ%1^$Z_g-G?nVUIU; zKhhOEHG?A_rNmPrrX#&_?Eh!?`{nkL8)MG6!@6!#4KAo5ri;&3NcI)&r_l~5_zF<} z`Sed|#f})XHm1@?VH~>~^hO|Xe8;|NtXJJZv!0NHO~2!yZVy;nXVblaTP`Nbi@Hq^ z`DEr>+ks?GyU4xkOz0LDW;Krv@T@yT&9i87EB@+z&PDv+1Ybea+l+3b<`{e?^Or`I zR)2IE;Gp8&pH(Gy0`}-B1J*hJ@Jw^6@wBODw5jJFk?Xr+K>@Mn4du#eSiZw7JGC%z zYhR%zPgP*2%I{JM3&+bLHtt9^?>{xAvlFh9!r~WK%7nJljY|(iz=5e+ig|?dB)>i& zL?4dAFy9_UF)mE#~aMD{u1K<$g$=SxSzsxyq{SXRuX`Pgh$4@zJO334zFVJ+fDArfi;DXC6C8saKCtsmKc9|A~b*1c1 zyZGUkWDRt6V{{C=H{=Jil=F4Wa<-LpI|LOouSR;~9RstQbaTJ9QS!=nca^VGy_(@e zxtVX-Spv=NKqm1~_1-nYrKQ9uNO6LjScl?Q-YvP$(}hbMG(XlrLmqDALuq*o$!bSzfwQw)MppiLjh!!EDKM z^KTmqgk99{l2Q9oV{w+ zvUspv9?T>frf@TDAl3`In_m^$N^eIZ0ormLH?V0@8ASEU(h2xNy~IlJCV zEf=5-?)>MwLT9{+PUoIZY2|jNwCT(V`=0bIi>cm~>K+g|v^<|@s`+fy8q0<559KhNV$cikZn zO3!AM-uN*#kmoTz`DcTrOY-ICA}W?heiX^BO3yn@o6@XIwQ~n<|&wz>~J+Zxr>vv42Pz33(pO#z&wIrM9+%mr#1JNJZU{7;i zn{>NfL4seyudwKrwGcfPBH^p5r(@xK#upbZmi-YLzaW1PNZDbg@}8IWIK?BZw?XSN z4AGFWOK78v+B<)h;`3`rlUNDFAH*$xxsL4f382Lxif;C z9BLZJS}~N{!^3HNNUvaQvWbKWhLGsSs;+Bf%3ds&!keYMz_*ZM7?HR`)HE>R5zrClM$UAP%S$}3jBO4^0V}) zbVp}1@95gTaXrQMKESqDdX-f@d@dk9XGL{mM}N|PGasRhhG-%xfF zWl15I6ohu$7%>qZawF(cb`re0R5B8k`nRSaLdH#FOBLs!YKg0@!pW*w(Fn_W{{C87kJ=~{= zfzR)*V-B7zJu;}c_KQ9EefG+*FC?EYUC9-@&H&dE#8l{02 z?(6h0(TG6eHI79moDQ0$#MZu&yID|U^@4d&B)hWm3PbQXMv==IH};&U;bl4l>y&Wc zKSZAkSnQGn-oJ#P^I_ZNH1-yN+FY}GJCu+V0?aC2EjQ6#h;f83V*3=}qCQY7CKIpE zKrWO_`%ksddgAzh20VH&^Xr$qX@>w!FJO6-6?Ny`v821-Nw3%5#P%{P%^xh3+rTZ9iwr{OO^hwkOmo~7E#m^(IxD=(^E55i?znps~_&#HgOzr&jZJU z%At~kJb063Ke^42J@+lQRPK25C(16)#pa3R=F9bvi)u-T2q;2hYA#6(z~mLKtmZrh z`!D-PUn1zUp7H=Ak35Ly&o3F=u4{P`!%y_E``8_Cv^0M(N2dN5e`^O=cX9~}!r&`j zHa?g(4m0_(CNK{|l98e`!C;@f`m>uU=;Nr4u!h&by%PHOtM%NPm>39o9k{mLs@%;l@a@%Jzl58WgAsY z3qyl{Dh+ASBuxHo_u$Eco@hiNldv1Yk(VT=J$sX&hljvgZ&HSSbGjZ5_TZ>O6_*qV zm(2pT^b#s*dIXI3pl>qV*Dxloe2k^~Ax^=c(G0qWOfu{42PlRu0lxNW2o9+5wtJ7w z-cs`EitY-EF0VIis@t9fDV-1@axHhKa0 zhKYfbm=}!sobV)D$a-4{e5qov;_2jEQIkW(`CrXg5$M?Lm-MoCW^=mwAnWS&zm+#W zL0M%H<)nSoYtaO?C1sFmGv(?=IP(8UI`?>{`~UxcN-jzzN|IBO6lIrOa@^K=l_EJ+ zW~&rMIgK24iVkwxNRk{@QRJ9hVi-Bjc_c>0oQGj-*vYov`}+R;wVVC5+irWkpRecR z`MlpTr&HOjxwA9I6q6qT(0;O*7rq?c-P>nM{c&B$H@)4JR{~7Er_Zh)VD;&E;hsO* zwY~*+kLG=(_T6p|4-a_7NYwE7FiK9!(4Py+``I$-+{)Tpht^Xr>8C|z@J1b~GWtrM zn|D$EZV2Jl#Eu9L)ec`&SLrNU&oX2!$mx0Tfvc1Bqf+?D+O5e3{=I2UMs&A1m33wP z)J0fG_+tP>zS&fJ`s&rCK2P5a^1lkgJds6y{b{!|$A}#&t`ckGld;*>Rn|5&#HRYx z0Zn`-&>aX%=dwI>gtAvUT+k1p{(a2k+%i&iURkA9!&Y+NCCp009n(3(+mdTo`|(MhDg zw<=ByvR!JjA}O9xqYhQkl&t{$oysHBAx;MpJs zXkBgaUYCx8v$cLz*ceWwSUZRxk&(2hau4od2Y{VTW>qA~%LLfi4VHb%`4n2xV&mnc5_k5MD+#Q7Bv@Zxbo5%Fm|X6)0IPd^uCnUEej_6BV2M6NG?TnK=;zjtiBbMVj`F(PgY zc3TAxJg7T8^ENQAjar%{`!^LL{8aYhGIP>8-i;T(wZ)rUnLsK@6nU6LaqJI_Y@p6Z z)e?q~3)aIb0y{?T-7q*{SXoJH45gzV{i1K1VpT#hKJkKhVGZzq9LnCgbcDYxlQJ22 z9od7V%juq_c{)q2t!)zAaBw6GZmbOK)U_((w@BZiFn;p$S*Ib^5%5J#K=+mvVOHby z^M@vKjiPWjVuuUdr-&O`1@EhC6356iipyM(fg8eX6fI8c+uRJmvV-Pr#S%7a6Jn^F zge_2%i?o5KG8?!8Asu2$6QqKzyn)H^>Tld5{UyfJwgw|GE)5xk1ZQd>RFvH6%4&isc% z;tK+p4Yc#-ESeF?ZTs}6@a8OO*|DYBmdV#jpntxYp9xN=Ir6~sATg3k?|PPzUgUcN zeDB9ZdDgt|i((?VM1=}yycW5mD2D)0_)dW3;jXhTb%?n5TCEObo%#oDfw)v&QF6y& zbSaKS3bpWAeYD0h{$z@O$U)p&bJe}4F1c*ekU(tz%o0e&yw~y#;0%!-sw{nIPwiwW^NmlIYc`e zGvUINX;lJvOpjPl?j~WH@=ZjKG~9(R83tG`@E5xoXu{uq-$G2 zfAP_yFKBq(>e3x+BjTYXk`o$YR*fC6<>G)CRaCoT8H^5Kj~4C&C!5r(m@_K1Y^j(L zFHb4>X9!`UlpjFl`Y$bS4$h+Eo~K->B8b7$3fly4Kt3wQ!eHm}$1AYMh*ar`%}_u$ zKWetKYP91~av#W&u5KM+njhy|f@H;qir<*>cjz=qwq+WFv^7!*1MPgr=}@&H@14Lc z96O_{Ntl}XVf{sS^&M~Y;m*i*g|N}hlx_=fQyq<%2pYI2FLd)uV{YdY!R1fIE*XV- zzR5-1E0N%cGgy`U-VpCZ_f$FIGd6kWnqs#b>VF%RB}vLb(ecB=mB8G%^7q73bRs#c zfmV$HriYAVutT-w{~$Sck^Z7O-eoc z7^XnNoh5q(<3lsy;)tB9YPyV3Y~ffSBg?Z}DZv!d-my}{Fcj4ECD^1uTdg*P{Hs*{ zx!2@M|E|Z2G0Wx2lt&>=>Yit+RM&S_9VBw23lG$}ueLq>>>3ngOW;2Z9J;v7f#jU6 zZCKkPRi%Foii)46w%eoPi6TAiji<#)Mb6>Y9>ni2SM^tP+U>0sKe$ICx~nOqxOQf1 zZ5(#b?;TAYHRPGukbuJVslvTox&D!Oepfhz&aig|Fir4R(9iB+ti(?LaLT5DdcgPpxXoP=e;3RCIZ zJpe#UTQ9Z)=7OKFHWqCLH|u@5wiA#-wtC0uYm4g5&0S8$Cu~G^8<4%Hhk1PQxri+B zcA6n7+oS~8e|5jdIiDKpqOg|B+$mgUX@@N|q4WsU`3curBiGeE`t*qBtV6PVjpb?D z<+;jJ11<1!$j&EeCBuP*^Y0f;hpsEk?%y=0cSZz(MrnQ1PLk{!O7tAah>u7NF^q+> z?@;pyMxj2i)XGuzzjp}Xr@J+FTYJ!9xx7*};v5Unf%xvq2mSc{^l_@X@2@pqwK@N< zl!&DO#7Bmg)urf&ro1d8w;_VhG9t+g7t*;;he_N02z;`X;mtZb**SN_ojx5-0MQjl z)ql;x21sPF)ybc5(XuZfYeV)9S^f&7IBG?+FOy8?1Q=03RV8F}5mkpb%51M#x?fR! zXsWOO7`OI1XO@{qB#5bpsTZt*!%W(aR2aQwqd3mt;?mg2qQ?DY-S26f7!3Ypdqran zo2)E(i5Jq>)UmzlV6m?D3zh{VJarIIm%BLMFz|`$02DC5%j|pW*G|Ext3>5PL$8U! z{izGewdGbR3PC2VH(^aH?7}oS7)t+&(I*U#nVtV;5;eJ(fi%!|>E4{~0*w(jy+x>& zsZu8|A6RqkMO;x4=q^%CfYj?~1Gah!`!uY`EdQNqwCJ39o%~woWMvo<3m23Vk?)Px zk6QH(ANQSkK-o?6J~W06hrP+|G+;7)?*RRmKTTc#sVt;!wCUlOUxqY6B zCP`?4gsB)j(KIg9J|82Acu^!$g9$9v``?F5W!b*SUYDn=0WHSRnF)yTX~U1ic@@^R zAs2{!B<%|&v5d82q%wO@2mb{*PWrl;WTHJaOLl#d=Jr_*LXSzLrJ(f}&zb*-qR*S( zS9VLvlo?DNA;qU9Hnuv5mc?F&&B9zu4CoA^)YG;RBeMbCEN`moJSj z62d)mmC}Rg{vVVLN3j z^`_AVABb69XEiip46L$x=ZC$TVC=}Uf_2Hj*$=GsF$hD4p)9CPDlXZi9I+1Icbz@6 z3Rs)wZ1gHJ8j)&!ZCOE!lZ1`WVUMPb|Jm8@C~Zy2&ht@)EQK5BD0q1S1JtXes;2~9 z6^yH>{~b_zKWE!y%A98J7QHqPfZy~Sk05L$rVr;b7pO^+w$V!HI=R)h&*WyCUC0Ct z`EDZofbMTQ-9zzxhBSF?1rP1r!3AXMA>a4oLYmKt|l>(8R{L)uZH7+ie^U|sH4_{R1}1syz+oAM9%InncdTY}{+;gA1T$)F zKW1j!>ULxK&s@Sr_^B{|Tfd1~*F@09{bGQuTLp=N8n%VoA-Di8!Af9`R%PJ5L9W~} z+Nd^HPmi!~F0_&|i^)Mm54%y4bc57?wMjeYFY2OO-}MO3k;12MOkV;kCUP!!|N6-E zo0I}2T+E~8q5iTIA5vIGtP%gWo8SHpt^09`oOGw=UEDeFjq`yut{h#dWdzP_YPUy) zdjHznjNKbWC-NiV|2OlBw4>wK<$&Z$oWXaim57f7*A~kob%PAO=ezdjq=po~mexeK zXU_uzvxDA?=(fRZxHF(lgJO3{Gj%Z1U!4)w^XVnRPTDp!=7>~9;`FE_WsR4Sj|fw? zZ2wE8-2tT~FO9UCc>xeYUWC(mh%qGEz5(iBl2t~Q5e-83xNn3vu79|Z@^|Q^Jo!8N zmo9ur*W{?~>YJ>FYo_T2O+IXtvRlPs27ldAoZn98FAi8PQL*~yL0|s&kF<7s*NYN> zv7q>d>N))_gvqRgtkw+ZE^jDA_amyBZj}+;rtTjECSb2tC>P&(JebQGEhyty!vec; zqT0KQnC;|$Qg760qWpXVZ0C>C2n(ReepE9_?jehB1bi}u3s$(vmIQSbDTR)^5&Tr+%hCnZC*Y|9$@($aW|% zjb#^)Yv`f^!hlEWa-x!YVF>rvP38!2~9xjR$OlmvgO+oSCU9gAr!-##MNDS z+&jmx2|sIj_-#x6$~To^0~pZv#h^wI{}U=0Z{+M=zCLw=J@>X|InICR@+^qg)MOzH zH^~sc69>Urdwy|LoXuV0?|PGdK3>j5$Kx*L^i7XFX}VK{0h{O2cJXs%yfZLtu|O-J z*mK4$iPZR?iEA(naw-cz9J)AUrqo=gPKK<{28S!kjzMD`Yj&1IqeR9S#AGY^c7kp6 zJv(gfYxG~Or+KTMc1R#{VEaHmu@G_mzv%+!s{Q+Pn|m_&|DekZ=te}J?aR5@IlnTS zpZ~kKP=)yi(jL-unebatr(iz~&Zu=SIX+hR-C(cj^VJiENf9ab<};Pp=2)y~pRn_m zrGsVyEl7@Thqw0Gt|8ejH>~z8sqg@kJX-cH#h=a(?=~kvuva2f*8}HWgCUY5%R6wR zj&p^Bo5=TZQ`e`DzKYZ#sr%_;x(2IXJ=1+|Dr~lBeM{mTXu9LUXz?7^e23ERZj;x< z*o5!c??8IZX#9ztIw|NbO)Jr#ttIUq#@Bwa;_R3th~GO7Da{)wY&k)U{mqQyfR@)< z%N>sqQzdFynt#767MU7oQ)uYCC=qWsC? z*=3HMVDepfLf%02_x^V?1_j~Sq(^NfXL0>b8IEplS$<7IKha4oqNn^LCsE#7V2`63z2o4RG9OuPow5a=VAn z@r`AvHmh=BCqZL3dVv19VjH_Pe7Yl<7iHXoE`BEqB`5}E2`~ScS0ZlB#)bPwM!(z} zx5EIhI&+E_dx@5lys|G8H(`jISn}XR&>Q=Of>-rI_r=_TLV8Q&#@Ohjj5c@}t{#Hp>&TpWLHd*aKobS^_G<;$c@4rDn}nIUQM-)NDTI)ZA~ee2ejiu|$ckyPwZ zDmcE|aXZIOf$UYwTz|}bLh3u37d?M}V&#NMxZUr9o3aANdGohnh4-34Pcn&3kKMS# z?O!1j9q6_!sz;^<`m-)!p}?Dv*Ye}q+UNYM7gND*Lk3GQQTB~~Tbf*t?TR@;v7!hQ zvubDrL>HlgGTs9(@;xG)q;r2UBb&sIO`tc!MWOGKp^G=Q4gSC)!p}xIbg`T73_a*% zsm@h$w%AN3TWxJAAZs8%t;&;G={;nhf@ND`4i8q6pY`ynD=#nNS|mcPL{5`9E|Cuc zSB1uuIJ)uQiUgqVX z#VYk8eQmC})BbjkE6FsvZ*D-yGuOpAGgLN5Y7pW zK{0$c;4DCh5zjhzAl=#PoOU7h;T!!#_m-}V(nan-ph0L*gMFnxpE*6C2VQ$xm)xXF zGZQw}i4W_pW;)_u&^OIxXXls9cOdc#+8wWzP&MX=7oi{aQ|t#6zpcF6Kb+iH{t;`5 zCO4wLyvKqH51{#hCi(l~6DC;JqL5;8nYYA^_Z8FemrAX7ff)B3YW8DHT<^Qgi#74@ z*;lJF-HK9ycxx=&R6H=4Km(mINS*I}d^}5sgO`apNY!v&Iuj#%U9SKY)O+(?4A4Ds zO8s%#sS{91t}K|J$rNUW`iC`YF8LNA7Iw|QK%5C5VIxBMU?vY7O4^t*?9d5t&~p#4 znfk46qqQV-s;9-46tY@&M1#(&VuzAuG3?adCdonW(Oz;7?zhg2QVhqpOIXSAV0Pf7 z2Ty@BAKmwAyrmUca{LGcd6GZHL2nKmbl0I%y@Do1w@Vg=Ko$tUd~^gGT!N*dW{z^| z3(=p~j|;H3*5Bs));l`oqYoHL$hJYv& zj8tGcDj1SKC6Yglo%1|yM~N}0q{sruI=IpB$V85z30 zBcYJ2*Ur{Q&GM`4>pi=<2Y#@gLP#2_bzX>1w4HQRuPp%nUw;uGGd@#z`L!SXfvxZV z)-G6ul0u~F+rBCkgEm3c)3Rw|%ZSXUB;6vxCuRhtS#y<$FDXGKrdFGSvc%SAC ztj#Xf=v-Q&T;9Ohi7%g1$E%gp-&f;?wclG@*g;5bK+WD;!`Z0+NzeT`dY>d7R2fS} zUvf63$(L3|T;NHsa49Tyw=JNjh0rrYRX2~WlFNE+F)|Hg}9w}~lue_3y3&V0;01GI$pW2@{)Y;nq_;#j1VT z@7*q<7r)lLUEZkP(-hMBwUPeqmij{4SvMHYICAQZd1FORV~F)!-b@}kB}t}sLo;=o z2z;yTcxBxiyAL`nov#tSZLez>{{)mZ58v2%^Y*kRyrrD7zF@uI3ICH8Gq-Ni z&oKC)d(?dyV~jKlPYPq%FvIzy{969FPv@h|we%A>aRpvHK7ZnyPX0IyHw9aw@t0#9 zFcV8QwUahW$OtP{4&5puTO^Ug{R@dw{%1^S^X7#Rbt)BZXdv0PuJYP5g+%$@ke|h} zYz%>&T=h0rIQ@9=vfz5Bm9^Q|F|%ZvgSQu(mqj9$Y+Hdz{o6UR`-;(?K0f#2Y@bf#ao^w5nB!p{tlPhp zyQ>jd$tXJZA69p0KmK!WX_B)qevd}M+0t^FtpZJHg<{D|=$ftZoN{wU`6Z)_a~2o& zb0gIF6$c;cbJL30MU~K2^ZeldjX2%gQd*$pHp_i-o$Bd&9qVOn)e|2ehpQowcT;#bxZzq+I(6 zYXMjxw|MSVinWdXP33_;tl*szignw6QU8R@>3N8E=Ai|%buF4g4Eyt;_(}hiPNG%_ zMU8K8!fk`a&pTeaoK}0jg(@>L4iC0YQ%Y10`OE$k9&(O`=v({!5oqF;3sukd+gWKbtw~A4w~86f8TK_e_T;2Ldw{ox-tQkw75y9 z#stl$enw#Cf;??~+o}?MKeX%fu8_A#uM}?C*m(WzOTe7;kOxLLbQ4x@MfZ&hrD(=4 zLjjqNnnYe0Qn$@LW&Jw4jnX7}!|#7p?3TJP-qC8c-k8vl#DC8OS;G)d1f8frSJ9MY zVN3o#^d%-*L-@GnJ+%A9clqj8`kN!>3rg zDD80nRd|QAsu$Jmy`PP51CQ|`EDJwIm{sLEjb%5J%PO8AKMLQ=(<=H&KT2C4=8<34 zGDIk=-zaJ=b4g=B_>1qNmJI(9;)Vz0W_@6c@6qH2P6y(3OXZmnLN;4D)o^8Jhp<%6yk)@b$iOWGW8L48na zl=4PG)0*|@T5%{iBa?vmDM%v;)4bWt#b-VYUU3iv*w|Cyasu1pP!elfU{$+&%3~`; zg<68z`K>XPkjRfzx=s4~r9%w;nRXPRiCS@O+G;o0AK;`k@iae%&s%N28)2VjOzKCk zytkF@SuYrH48!2-8_@-U=jgxBUg@4@0-)E{%S8{%QjJKc3ChcwC7)#bQKVWKu5&@2 zodB9Ml6phMLr;hw*el+FM!!D z-~cO&-)R%UlWoUB`Hk4bh|I@PSxcyHx2g9U({rd!*1n15PK}s-!hnCM-cL!@4;T`0 z#Is<*&cjKW+2KuVT=7xsrkC-C@KjXAT4~Y;UTP%x;mRTF ze}`Y%uz60jbFKFWfW#8_!S}o4Cps}pZDx8cSANpYBW!M=Xo0@PgEM6Y_x~}xlVG!A zZIEJr`A=Bp8SAG667f)5g!R1+%88E93!m+nESlw6T+kYqeQ*9E!eQgTD{oU>3Vj)3n-sTC=-A{MymhcW%KS_#r0NQaaf6B#8F{SG$fdWrfM<;E!8A3 znS?I3_(Rkml}Y(b)>lyD#`#Zitj%fJXNzILFbwq!nr z{`T5wSyTpsglpgBwj`%9? z4<$Pubq&+g2D$ah3Sm0LfupF&KUA+H5b_aaTw)WeTnRf-)yR7{?bM%Jnl^GYql06x zTwAvDXxjtjqMx@4SBpBv8F?)?Gk=eXeO;6JE)5ib%(cb5DvZ(^pKmhs8CvWXINWU_ zPQO0%u+#U#_0&pRX7A~e*a~?ekG69oipa{?*Q`Bs+9EfQb7|i6?WBGcd?cF23N#*k z+!koey-GS{pAt%#i#VJ}*Jt43GG_-;ZrS9Axxh(=t_Jqz$muA~Dk*qUE%upoZ?*nM z9YfTa!MIm6mu0Kz+vu)NE)VA%EXiAj5SBx@*xA3c4%&JXFcq+UEX=uSP4uHQdZ}pC z{#d;wN}oY|&i1J*njpt7-%`nI$%~#;oWI$7b^Xud7myGNH$0+u&hG{IP4J|4E#zA+ zKP92N?Q^=rtYd%mWy1fE8oN(;pDP!dzm6~&GqqAkSd>Q|ZSWKd_5#~#R3AQ6)o1ST4&{8VVzOb<=}wDink8W z#I{H?ruI9PE$PPKL8|Xzt{(~gx8V5xFPqWa)cB3ZF)ujBE3d9gjxhY&6@xn7V-``x zyaLKN3h2cpLNO(U4&=$I9NWa@z!?AA!c(WLs}7r{#vf(y2@-sdtwD2{~I}GAtU$<&k zw;Hf^d35!Q#Yo-Ycu2>L0&YxU2`2=+7k8#oW)0$*q9Udds{h?URXcSBaeB>xiTUr% zGWAr~X)11knzd-I9f`>w)b|p(V+{Ok=H2AO1MvqsH}N0MU&8o-%E}>|r(s%`APOqM zZtRZ^qscC|#hkJvU8319_E`8u_(F&YBbSs-`tWSj=;1S&(aXt`E>||HUa2u*V1=B=&(i$DMBuDa062NW zZ!-KD$)-3iOk(_@&d3;tMdn-!B|M`~l;)dmtaxwYAJ3^a@Xx!eEpN3+IB$87*Bc(< zA6~RNfZhzxMm>DRzMjB(@A|=}0jbI_)j#Og)BW%lt-l^*rSpQmnCQ^_z|XkJ6)QMjqh3phcM*v0fzmuj=UTM+=XG8) zCS#3*I|FB2m-negvmLJj^3IGh2*$(<;(}Ys)#o#eG~xu1CG5H|$vI4-<(6pjsdnX2 z@;Bu}RXV+ED&m{croF}Kq9$OG-T%>PS6}Fhlzl^Hv?K0qR?9?My}DUcg~(>>w~XMqJhG&i*x4#M-|u@26qnB>hn(_;)DP{SN z@kM?!>X8d)L$iTD=1;&gqMG~2{-pB~Aa*^j*$gioiDUi9g$ztG*xyr0qOYX=(!YpB zbvMt*v^tn#G@dg)|NWbNHh%uzs;2e-br&hq$Nj@ABMe}&w+ZvjJ59w2M)W3{bb&T1 z=~0&SjQApW@4dNy=(X!h|JAq46}gy+-K0u1@EU;k0>7xx65Lt=sf~`8(3wQeV)^<{ zf9Z_>sH6-zZTu+`zw6w(SdWd@Ys2=A(MQl ztg1AW{Lcc3+BpulZH^#Rxh*#$7>(r+cfvXBnc}3B4cDN$0g-(@TK`T7@46hRBT)oc zgR+M-m27;ze3?gh6L>1CU4i0l_-<}zUY4eNmZ9L>x5nrusy}?^`m^Vf2A$yGOmXQi zv`U^2m-0SO*(7ygtCf)AGA$Sk!w-7vlY@2rF*`X{zSn@EYFppyCZ}q-%PLa?^^ftpcC*L!cX}Z0MP@vld*J3Nj_7kX3KxGkeMjkBB3Pmw@daaOHRh^lo;5M6KSpd|Hd)1R#lsPMiWKW9K`#c z4o%_2xj(oOI(DS7-}nwu`#jxn`kR4$F>P9re|)xY9uP-N-3qp< z!uTkdO-V94uY?`(vMJ8aR6n>3~@`@}^?A~C2Pf+S=XXzPlZm-*p+ zx$09_m!jai@>-sYFQz#PpP7sr>7z*nGujb{HB5O<^_|$F2A<3UW$^Ic#f!;Q-u%rl&5U@lnPT7T}6gSKPqEqA%@NFr$K}x zsXiV*&ge}14!L&xRo1ljd!Eo~;&mNeZ++lfN<6VgL04`**DI5EzmZD2I@9ksSM=w4 zT*p@d1Qi&3l~4w+u3-#FNY~|R1t$NrE4AL)Vt(;Dll7yu^@nE;)mm@r=p~yal_Zpj z_8=_{au+7myFSWz1> zAAJ|Yr48}S{jQSfH0Ut71;RSCwKUmJ>mPivwAEt8iWQ-Re$+G?rtgaRRCXRXV4pl; z7n#n@C`*mKgkrv8Fv`KOsj)cj`0^ZX59<7hlGW*mhtWDA0mv%K>Moc_O;G%3**H*} z-Vt~X=bgwywC<>UE4Wqt=yQJ8%{1N9StggJv-9mDYQ0^r)vTIj_mTSFUo)<)QAkVO zQq%J0oRuE>Vztpr)=U_q(BSb#L{5cz&{r=i;OgKF|cCUm>+zkWiOnx|0mDBYDHh8IW%8-U`b!zsCrNDkW%pa zYZ~c|M%r%Qqiq?}pvk#g6SEq}#N6HIWP7z^?mx}_>C`D~NyzR+GT0Rd4@EfEBfs5f z)-_5Ao`wAGI23!d*G@-QG7IBCxJg6?g$3q>_snZhzJ0j08ZZe`OTvs51+@dKNjGTP z6x)>_6_mwspB*^QmxwR>Bu>ZGL`4VsmCi;{KA4LM90B2T>Q$|2?tk%!vYSIPbx@A= zp}K;1OQ5cbJCN%;Gusx|lbRb9Q8Ze%cNM`7ok#sjQpS2?`U?|G;RTcrSK%@nkQJqsh8MtHm3! z3;qZQG0vcf${uC#a7Y)5L|(h}{`4#bC%ys&EqDxc(Fwk(zIT1?i{pwq5={Gf*PJI)Mqi~! zIg*`6m?Nx|jqu_WSw5uHf^S_MTK7`m$DV8M>D5&;C=WYFx1CkKeJ( z%hojtqng^Z9e73l+HLLD=Fi#rZr>G(B1`NHQaDbNPb%w*b=_sxwQQO5r21X5Dbhx= z7%#fN1?Ot;_(Elt9gMEj|I<$WI}2x5r}|$k_I9EMNSP`4JLCO8#YVw2yJ4Cs4>r{C zE9%J7x2^F@R;8EM(*JSo@gMK8(?KUbo}ftF@ofLa(Z>1d*vG|-R^vBkSa4daq{5uz zr+gGwLF4|J{9@U^4*(J$87S19eWd5Pd=>%m{Ltb1oc$SVNZ39nWo0}!av=J z8AdI6!jjAZ*ZM|cZ2U)kF)k&(vGz`8;_tJBv5QFeWox)I$ElHjW?*v4{A3iRZ&8<2 zvdXpQwGPJ6PuXjmA$5%VH$edJu# zc;-7Ht|2Ded(n?8{(S~6gS>L4`Q?6J3(R@Oa1CyQfr!qa%m?upgP6P1*lkmU<1DMU z4H-?omY0ogIH@ZPJNiLbz#Y9H%-(~bR%i!Hi4*sS|8XPlrZy+lMkI~p=6ipx&Ed)c zj?wa|h|_;&UnQ`|JwZBDiQD&vy(1dGmlA!yo15Smsl-czcJR1($L3&Qf{XG2wXR54 z)2WDCgzUnwHD)JU%TMo!VyLtt4!G}|V|goV7GBBcUU8rK&JXuU3VB_97trE#d$9!w zKysU*pC3cYzD7Dk{n4|g!!$X#cHzNeCpxcqi#0eQ&c{B-BYLLhts|l8!oKP~E;!hj zdD!;USfB34K?F4JIo}yP1N7v$EzQuFU-$=y9tTT(&Ae@Wi@@lEXCK2PRdbGl=9 z>>4(xv#orfvnO}=-Z**pkA0{*Adf3aglz0zc~5&W@s#xJWCnM+iy9F!VeSm+9lk6& zAJk<~j5K{e+)%hv(y~MHpT|D;}gSO+z=LWdZy}rgTx+tmGUB zITfe3Dnv><@Zo%*lr7-1)R6oTWGKH6D(Ry&|GMQ@&vBoEFK^#nCV8Kj3iUTSO~bkc zez(sm6&8lf(!OqXA&h1hcAc(M?QKTMVB@7gT_CWoat>qWYgK0q`Kor?T#%Y0re`8> zSKJTHweTlO;TI_KG~um}I;X*K=-#O*^49f8jzX65L$lXg@V5TTTSvlv33X3v6X>j9 z@$ryShd^$GdFU!!C$6xo#BJ)LHD1GMLflru5BP0;n*>aDMml1;$b~0<6$Rx5P|{2m z+WOlp0nEMxcQLX9-DvE3WdDYINu zUi?)IZAedtwolzr$h*PX)5^~N2{Ly%(}kWygLY34&m}%j?Q7gDXK(B9=l#$Z-2fI|E<_Lp>m~-ftw_jc zmb@>y6kG(S`cY`7*EX`+_8N)pGyLF!(PB|!ncvjevBvreyLDjgx3nsZb(m+H(yhC8 zzsoAC5@8PYyqD}dL60{m)3T-83*gJ9xj-D#=Bt2D@xR^8!gf-V(+Dg?%Scxxu zPjR$`kW^dpwrV6<|4ukWmTl5aOBF{95TnVg!!I%dx>YXzPJXefA5>Uve_h%6#+rOl zqoniP)fMQ6>c6u-Ss5+{;Xv8@iKp=4UH%3ad;O1ub@?Jt{QtX%|KDZ0cD|r?9uZt@ z+I5M;*~qLzaXRQP)9?Lj&&n&hrI7PU)4_G^LXVQ)Ihq}4n*cdzDC!7YP+?8#%EE-h zTC2l`t3lNG)ry8Z!}mN}E1G5hJKWhOL&!=@bOCF8notzHQmt;|+S{?yAID4YVEULw zi6@J{dqUSe`6n7lG+VSpx`H8maW@S5hljv z_dK)wb((p8(&Q;Isc;OkTX+Dr6=!BavjB`}9{V|FVR%<`$Um!>dO(~se(Y%VsXs;6 zn&tSU(u^eHac96R!T)9eD^ap~(SPezGBq|^te@BaIZE6{8et$AvZLA_TJy16x-hzxS%2iLDqa9e?4q7#ZQ+d- zq;O3qB>c&wwudyzibTb?v;`iTyKCT=4&h%upW=`U#;L(o3AbCn2k}}O=_KM2g(8~Xa z2t(C^eNtnql-0>vlpl!ualcoOKBwcA5p5oG{wLj8z)+mKpRfd#gl(@k#~D@oW$?73 zi%U|9e>#}cz~lU9`-Uvr^*Eo?60&s!Wj~vH&1-v8XaBH%`90_NHlrs#kqN7gTdlst zw?<6m9+U{n&*6Toddbg6#h-n&dOh?|HpUq5UY`}R7P2ILG!f5z_HSyK)}avBWt}<3 zCA=V~0*AQt8rAe!+P%cMCbshIvl%b7Jv@1IH8=ZKcFkU#3EYrn3lZq_kvWf(PIi*J zU;V4TpqwBqqv(4YIb3AY75Ut+J%%~?>A21<;>)&wkv_ZF7Rk$;wPoDtQDDpHlvh46(t9cZE;ZQF$x@=9J z=+qmhF%q|rxq6kk8sN$ssHiO;aq^GoOV{ZJmgK0?N&E(J(eA`8kfepMv*;_rUgM*8 zA^z!{o#rG_o_tY|aZzw>9s0a-AyV8nz5j!{b{5NgngTpQP>yRb`X94SQ&I$sW&S5O zb+$R-J)G~`#HV_4cFQ&bdM%+hZZEVX_~wecOVyW%*<*;yH$VScqd~SpZOhYOrtGhQE!U&*6H|R8>FWRIg!G!TRPjS+*WJ_Bo-$60Fj)cJ z*cXMrrmLH&30Cgw@@z`;U+aG|+kLuW_$;`w3pDHtAc@AJHC)$4pO;RMvhp zgyskI!ZP_ZlHJj6GRevPjxsU=)DyknaD7d5{{@ZQ4|ZOxLj^YNZyO~Q2yD;$)xf{8 zj3cRGe|hiJrqx~zZhz!M_zFAFw4&*G$hejNHaaOlR%SWtr*cD^ZV+yfYy9@~7B1oPO+7buGJkNfu7*^mpWuetNvS-PmCm9k5HF@DWt>@3{^{Rx z22iEGqfxj^(!{6JRYWlCEwwY2^@pp=ufp)FS5`kMfY1*R4O#o93vrf1 z#`Tn+6hr(J(SP-Gqb#9S5bjHd_nJ=ZPWqS+9{Ki$dp?nOAj`2 zmoYte{GSaIbAA;q2d>8-dhD@<9KlI)`Q_IBDk+O~)3jY>__9fTo{9ID3Jc_dmlPB; z(1BXP&V*MHm}Wgi`jZeMDMzzp8Dnj0A~K!;S8iEt)@Y`~Q!K9WTsJgQd^4o$0?xkv zpgl|JYv)zxS-d-k)DX|8S24x!9lWgPl(B>;%J}B~cX{(yv>k`6v!ZY78Vcs79^`AC zQ@0cK*Q$7AeP6Mh|H}SEihxu!?DaVC*N>@FI+?V8cc|%O z(+vN=&k3W`Nr1&zHOcA(HQ_~;(~vmaAa}y_eCn{3W&TTQ6Fuq{cmM1fS}kT(7^WM%SDLIT#dhB(>K+Vg+DW>cYSah=VKdT{>og2jBsP=u$0GDZP6| zc`hvsV5R>*md?eW>Hh!!pN`UjkfgALtK!O%OAOlzSyEI^l~Y%AxG0*D(+){RPIE}> zfECKwQkS!Bl`}CEBZoPRInQjf%}(EU*YEcqu-)G8y`Hb<{c(SES+9EzUbY>BH-&*_ z{ZmrcpUpG`wLBJVBs+d#nMXpt-+Qv(z3p{cK&h(q_;p}7EgE=%aexXUVB;(vo330jA^gkMFPaHm4$L@Ihuqf% zaYN6sqUyob4xTYO4}>e!ai7yw>Intd1yelr;_aQB1`C+MiQA;sxv0Mm-LuD(lxO_( z+~9rV78;cCu^ZBosNL}W(zDQ>X8a0lwqgD~OYb!8%v6rrNBa9lnX~7+yt}6E31~;< z1Bxd4u;mcrVy!e6h=JfLERw8&4iEGw+aPY@OZKD3=5BM6aM%w!54^)$42gJK$-R+6^~GEV5RuTId%xCu!W1`oDyM#fN$=9Rax(Ni5D3cd*y zUU!8#@zzSUu*LqqZ&>bNla3)I`5Xh&ePxN0b_Bk5R)biZMY|RQ zTe(g1LI?=3YMVd(GXwB$qEMN1M9f;tq@DvKvtO0lLUZ2SMJ0Pky;WC#0Ov72lJ2*7 zdG`-NOHpl2w)ln@63teP#xLq}9j>%C35bm^@e5w-i%%RcO`p&c&mqe2Q>ge1=*tOF zU5^!;NQ=dXZOo+QaUx799|NvWp7|b{-C^!$Tq4}HAh%aL&KE4>0^>p^JbKTyRf<_xu&al0t3$qhD4I4h_(;%N*+$^T z>1?is70>g$B~}=R6D|)^rNf|dr&jJh>5LNjf1Dfuomg%J$yQ8z`LpJpZA95Wno$@# zn$a!lE5FCGql5tM>kIIyAN-5pm%<&8Z_y<3SJ|vAQgdA4U)4o)u=jzS!;lZ#mXt9; z(;7Oh3r|o>C1t4!d<)r-_q(XoxMZKH&WG$LN}*nsKNm8|$PQWBQd^E0+@K{1wGJ~c z35?v%T8;jTwH*6$$pi566i4d-M{Ze`9fBok?$W98O;aN3l_#2V%^DY2g_UWvfMhSZ zD-%KfDY%D4{ZFPc&tErFD&N#`05^W}Vt;{&#zCTbPxg@i&bQs_mLSjT$`h?9cb$1X z4C}Rtg_*(%MVG!63NN0~<5Z@9w2y=@T!Yh8WQ2pF&)UA5x<#KW?7$J|c^6{T+5zb1 ziuiYVVx)Z8F;_fr3A(>ANBnCc6pG{6J)(#a4bJL6Pf@acp4?5<*b-$nKcr(wgbkFr z^iTa%NovQlU#a)>_uec4wQ|=+1U62lRm}S8s_m<`#U`6q*MH3oAl((BSNHdPUe@Y~ zE!Tkf&Ls^7hxeN;R6*XvazDF5Ym}f1l zzw9(DSznG$v>4sjn&o+V$1>=eDr4L7=V7f`4=&S9(f8%<JgfEz{-Tc1YOKoZ`jtqE!#AS9FtPFM(9YX2jx;-qWb%qky7YDyir^{u$|w}9|~MF znN+RsY@C{Ogou1?AVt0oea$e{sJUE8^{JdZG`XdCpa~O3sW%x=jW7FU5nj~tl@#_p zLYrB2rtQtkrm*~s^|vOoXkiVlogjVy9F%_2kA0Ne%|LIM!FgWvR&+yNU)lQAiIYYZ zw~qL%m8zb$9=Lj(CIysz94*_;Q-cn(&F9M%1MCXlA0SSHv)xu|HE7M4f4n1#fDUSy z!0e-}IL$9JqXlT4c!vF~@U2r#cxW%|M|JtlDH!u}M~txPXX1gVBB1PpC`So^Cp#`& z{+j_2bLCR1Tp+zfZwR#s%4P)IRTiET59Rb)rwg+ZU6KKJ#3qnx&JNGTulGh+I=*@% zpy+*QZ7)@#UvPfXERWfFhP%ud`f)(wD$`ol=$-o~%lchsL5afEn`gpHg4ar2l9R7o z-4SYud|tiYWEsIWw1j8N_A>RP5!U=?d4eQS{sG^wbhl6HH`veERi;BWH^Go6#qd() zh3WLbaQ&uP3y%>MH=H#h&e;=D{%rjhsLJTo4Q&<4)p)r)3x z9vj`hCjcJ6ff#tV(bY4Qeh)d;$y(58dI%%t4-7^Z0lSsE-kY&~Cokcc!Og7rOV*z-n|)&|Bp2zF9Ga702%yx17Fz$U%Bt*!vByC6w>?37e?Xh2>EO+Ln&8AmM#TT z;iOdfTsT;Nc3LUwGXF1B#@%M$<-uRLY4YJ)2>u&CJHB&c5B@nxHc!I#L>SC6F-IZk zE(5kTW#awM7G@$nrh3EhQSBpRFEcUIC0tq*G1iSy>X5JkesPF}zy6bym8Ubg@KW^k zTuOOHg|$7a#FMV>pC~ljU7ZMR6!(etE~?F7Xm^rCZq~s!EQA?txB?P)2o%up2V6r) zYC&xD{=QkRiMZ&po*vYqmO}!0H2JxioUThq^gc7~IC_q zJ@3%cPX#L7&^mnb<5ne^q5Nq1rq#Iru^`K-w7u5L@kxy7v`UMl@XES)p6Ti?o>}`# zErT)BmLAQDO8PVTZWF(dY(KqOd}0PY`fp-nO5|v}**K;!NylkBH0xdn zmE*nXEXn(wxL^zI4SG3gvAvO#^^(MU+wrEN zLn8^j5$k1Wk8&a;if@BO`wpR%Rm{^vt>R4R zaAyE4+JdFC(54gisYB(Ifg5^y5CplGxbmSDShOV0aW9OD=7vb!6 zS-Fm*xf;2LdE~hQYaRO?~8%Yetqy|7Gm_C|fV`bCH1Vvx|unW?P^VvW5Si{k> z=ZB-=KZ1IyxL$Diof-3Qz1KJ_qG=Hh5 zx_>O0hbey@hhEmXN{e?HFa|*2Mb|Z<7XQGY6=7bGxHH;|meZ?z0WE8}$su<`rv+|i zCvPn558_~!3YFGhg?Xcrnez~r*p#TE(_lLxoOq~r9~gQ+S!nGSWYk-U&h6|}Qy+5a zz8SkRMDlw?nQ3=G@;xnim*ZrA76R3iYyp=Z9vj!g1Tu8S ztmr|Ib=(1{b)IlU6IqnwF5ZSVX2&`nPju`0F%@|0rWB+$aA2r@=96tugVxAEls2_> zH|Nl(IbmHXX4E`tGn#h)p zvB_czTTGdt9xIK$%%uWT7fJw7iH-ul_G;_`00qpLks_TalSY)u<^Q&Dp^{OmIGp|e z?s9#^zvwT(KBYe!9{DUr2mspVKHoZOXcBna;!uK7hICX}&(FHR31|su<8bE9T^?fN z2{gFmT*TS~q&rgXsY`I#H^f~{V-@DO3bK6<_iOnLx?2_uR4GJtte0;)nM0zR79*AQ zaIhIs=-u}AsY8$)!S}O(V%tcga8=9U2}3V4rL{EVf647SIHA{9>E!UzP_^Z}@~v%C zPU}dt(z|6Rryno#<#XAx+&CSk$x?cjU{H_g>l!6=J*HLEsY~61cCnp|I{Qdz zvL>76VlJvX&Z@y_6t>uz8>5vjfH*Wb%z@Wbg9H8S4z7+i( z9#qv*H18ebQ)C`xA4c|kqH``~Rt+ywWhD(GaSMmk2P2izJA5XQ zVaGypWT@|v?MG`s68DJnr|%&if}{E;qLgZN9d4rbc%N?tf(*!LNf@kRNfP=1e|koN znZsRdJO^CU*sF7YU80DrHw;+PwaGu>nd-iT!PxmTX9mt2*T(G=KnQ`S!`vZZ3*(iy zl`nU1;8?{p>~%{?Pw7DTuw$ajayy(i0uixQo_L76d>3DMugP6r?!3!K%^zp6F8$*b ze`kJmvDG7MmFaGp6E_J;?Z^{ub^FwlW~e%E#ZBi%>37$MR+ay$*7bCrdQmm zXJu#9!F$p=Rf^;g4A9wJGrHuI`+7mY9ZA1A5`C3_@}7Q2GH763nQ7!5L+gOwY52uf zlG)7*!?s8GFtZ{_mzz(k3NCzK1fgy?>Wm{j;4~h-G4Ni%?&o#lFr0Mp{Ja6>EIfCA^q=Lrac*^9 zWCm6#)BC-7teGRu+b6d#47txwIp@(l7qnkdTeAS0(llVU5lbO-klF%Q$0e6{hnvm3 z7`a8cs-dgxvw!@|PM@c#v&3T)@3&4EOsb6N4bVH1K9^Uj<42wz=BtY-F(s zoo4cE_-0VjT>L#&-T`_q=e1U~;~R2>vNsxUrQ^ZsU=-bTUl}x3_Y9z6^+s#_jWRD} zMyuzQR5V7LCYbmIj8qfAaDhFf4MV*Z1?iT*Le0E^cAgn>T-)Csm!3F7 zQtZFjUO5?9ZQ$Wc=r{X9ZCz1_#qJXodywacUZT0NyR&zM8qn=Boij_Ywhn?DaXzy> ziQ0LLr^vtHTvIqoFa?)Qh0A$F*^hc4UPumSaI_gn`S1k_aB7wfNzJbT*hX{Af2UZB z0~ye3&D>6{l8WuszLgICKgwSD3|`?w=HIVqd0=$TR1&0}M@09DL8k>)A%BgL)E)ks z0iJbBcmCrWg~4ZMrs#ktIf#`mL|x^210x4INWY{8=kTkZc247^^QdH^&Q>~VIqAq< z^rhd{(H1mT;=>}a@n{`~%)Govd{^a4g^E$-gYn_1*|SdDE;yG7~2U+D?;eTZA`o6lfXqeB6KAXOPR02}mT{k{2_x-R8DSi6~=@NA`H4q(k zok}Rzkt}nds|8UJ$eW45tIvf{8=NM+Vx#uvkSs`ufwP@S#8Dft?Mg_TPumKvh0_lZZfoJ&){-Ox*$AI9=Pr+6dO3Ewna}oKyi^u8!J2-&tppLg;YnDhH2~ zT-~KQt>-xxO;q=ty*33SKmxpK(+Eu@DXMIh@K(>t&M$sA{1H)8Q-KP5fsHrelEywh z&HdyEDyOP5;H7wyUyBnu$9m;x==rNR_h?iBgwekqn=2!edER&DGD)Wu781VvsYGcP zAGO81uZR6}C2lB6zcvT|H2~gQ@5;td9eHS%V5sslobmVTn3VZi$z5-5p#S^uf-n0M zmapa`HLCx{pt3&;=B)UqqcW*V^z3JVyySd}dilb7wovd2+T*B*(O6vqOiREim}@E6 zr-R6s`NZpv5OIjf$V2fZzh>W+bM$mQ$}@tjbziiOY(%;<_so8Uyj{zCH&e=(LUv0Z z-T6-62ofSe>it?(%ZU~0gC&a|+D77_k+~4sK4#lKdYd7QF=Sq@bdq;A$XbUrPh~Xe zG=hX966fUqvKMlm;}f4nAzi-iTTR_C=_UD{#*GNYqbvV5@~2jf~F{_<{9;MArJNmRTJwfI$3 zmqUFA{toDNTv%~{4t7g_1?$wIU2caZcLwQtr{oS_Qz)|pL zG4rU6ciRAfTrbBSW0;>>kK)*Xp|e}IJ(Hoo1kd*DQ27sflehOV#AHT2bs$mYHN8_S z>X{Ar?24y#XxEOt4G-Ue_N{(u+{WLn(gE^BPZBgt^^+X&km)}-1js%Y@4k{1p}Hvc z4Br|2qDSn8&c5}wx)`^ewI<)AxfI8|InU_GVPYq9PN(=cGX})mmgEEGK%O(FH9Dt# zz2U1nLwQsK2Z4&cqK0~JfAFaxFj)lxXDFG^X|`D?5^tWMoR-i`t1IEzVj}jwEpmCq z_VM;=t0#Ks|3QG7g3ZziWfdj5d=ftKb6UL)=7^5fWaoEq_l#7pNS{xZE*h{){G07v zE4=NNBM*mdfrPSPTX{A>;q2iY+nLL~B94WgN`Kv@SlY7=1Q0t8XXrR1zStv{p;QH< zm!7Wwud%S{~C`{#du}w@6>xSsqki&3YY?sm%Kqj1E5NIU8cVaaD84kAH!N z#h$egpP!X%15J&Dq3`M=V&JP6Br<_zk=uA)hU4XCdgtzj=kEw0-i=n^DUdG=b?#Qh zE^I-qo9@kx^qJ`i*Ao3O!CA~QaMrMI=!8YHf;{xO(BvaIk0CxQ7cZ!in{+1(_Gm|H z+R5ZiM4?)^FYk;mZ$#%7^eY#+FV9~42|F<$`1;{@N+96L%fct}l8?9cK4~bfgpP!!^lsB^!8&Kpb%r7)kX=T-11 zQgYk6S46RIa1Y>CXwEKIko6HP)&eG|nA{{9V0E}R1naYVpLoUNfR`n^DN;QLq+aYb(rN4Ql^O9(iRB~q|d`u8&N2Af6 z2+p&PenVYMLAZ$WAK;h#U}Kz-pf3+|4ZCZ<;-5yPbX2d}!e4fNC`ew=dnWFw{e9=x zyPjMaGL*;~nV$PTfrPX zE>ANl(BKv~IBPZr@5m!q%tqq`<76iIpU1#?1$n}__N)YKuYI>c$FAo9zWL>jHsY{V zIqNJzQgsm5QL@^p#WhwG)kSE-wgMEF*y8)lkZsciSA^_|H!IM{6Vr=VUz=&G3k#f0 z=X$P~T^P9y6q7lIfDC|@y2LM0NmK|D5eCK(D-HIa6ox8@(jnUvrb7^O`auwzE_qUW zA15q4t4;Mub38@;tdOL*`nR`1p7p45;6ohxkJk({xML6D39JkS+Mq%A+S}RDO%G0^hc7@n}@OiHI8+8v1kJT*I>`I#1!g29X+ zu!?tb>Us*G)c9KM-?(Fs7ORePos~)=L!;NUQazSgdgHJ% z{~aB1(XYl_Vcu0A>E++(zfd_2i1~=}ysS~DNhnimU$}}-;!3UC$G?4RkEe7e=)*ij zh`0MUCBMh>VucZ{cd?tR=JZHseDE(tzig&~!~$<9utX?hT2s|R1#R1^+5V3O|8rPl zW`g1x{8>u>tRW&?{3La+Au?3qby2v&`3?i0iEr6 z2N>;fJ#_36eGIec2dbCzE7S34rk>zinE4-b!dAHu#E@@&BIm$mt)stPQe*#d;4dM& zq+631!emB7O_YxGf9zd=3uiRYSNw~`1THYTMger#S|{UpzwmJMwi~{@5{B!+i`0M!>wtTC>EPb3V^6v41uyEh+Ouw}Kvd zVl5)4S}H$JqsCva+y)EYcV`6LRhMUl_Of(YgfD)+CxT8yEm!O{vc9#;IeGENCGzkm zAH5aSWAN>M_C2t-@~EZI_o6ubND6|Tt$xB|+9oG`{_5ca*dwv7H6$`a{bro?$q~QN zb@%V94~U+a#8+i&djj9`cdvJ;M}3W9+|cE1eC(3|M51H|z!98S!l}Rh7~M{@1p|o5 z{3fwh?+%TIJKua>jc)48XtS>!w`F|_CnhZvLf#RqBwO&nSl}jr-!H#t%sj8mnTiYjv1T_^dewb!b4OVT#%5tC;LAczxf)9) z{0L1#trlDrk1V&)obo~j@fM}BNd3=n^Rb#gS+ep6hEYz|YdNDGD63)l$1fikQF=46 zKbnhLtYv1Yk*;Pd3Yeze20>6|Ig}p_7X*F#FO2nHK2O|<^444L zcKO}g<{p@NjMv+OgG1#F?UzcK&z#0crT2sX-wP!KVut5!FqGrs)fV^P1Q)h*g1-Z2a=Wgb$!zUjIk>|D3@>QzjYRUdMw z4<5j?#GIFopAEJM2l~@m9`2hRZ{oXfYFVz$Fpyj~$rS(b*CgGHgKc!>!5W>WC)4MlXlP>b?|Z8&#;X^X8F z1^lUN{&L#DoAk9=s^6i@x?TIsSc#=BTtaukn%hkTakPM)9}m-&sxQD_#S#mQfxN6D zo7mIax|{0L99H42vVuCyH*{s6SNLRZ?aONz_nIV!s(6>4^H^cIlE>d_fFxezy$MHq z+;&32p~j)*1pSCtj{+qCZTEsjl+2^vync*c-T1UM)}BF;_9yszKF zDOI(!XVp4ukz%Bi(X>FKL#_$B-q(A_KwY|9)i2lR@0c13FEM&XS*P)gAB-K9ih@u# zavm<6+Z@(bZ0P&`TCq z_YWI8(;1gD;0O8;Td+lXf8+mGcT@-e(#hPXc`ZxdQe!z5GSj;OV4HT#twl};Zar!A zz-N=IAL~Q0Z)&35!ZO`+HfnMT5^fwKxAdaTADGUX!WvWabgYC9xV|Y^Y5r8!TC0$CbA!Qf^0B(^+-g3GUG-lU#9uW6Hz*X>MME zHXFgX<_|1> zxjbXU%3>n^wWy_)G^FGwWJFF|lmAC*e*aCHba18^R-^rm`#f+$B(ew<9scY zB%S@V-!`-^iDeD_ff{aRD*`b;cABPJP)Vp1^16TD(2wGi$wk5IJN8ADnM5Vc)_r1} z8~d!zL%OoYV7EcmFLp$^b>%@OxO(JcsRRKY#b*8afqukF?r7L;c6fxa_HYX8m32v{ zKMPl&W_b<~jVB}x5&@a=6rPv4m=_pbd2 zr2HN41w9yPR|rb}G@lsr(;HapDVd4N&qb^^Mcyz<71NBabcUmB0r zkLFMw;dMRdzqb6HjV_a*1CtUAm%rbhxhUG*KWON-l)GOI=97)WID9hCDxt#Yio)8q zg#_NErRdNeZeUAR(8w$Py6VD5L5_u)`65~2GuEJFT@O0&&rG1%KzybJenVuMr;n{q zc#X8UYdb=?uvXSm%Yq2l9^Y%@Gtrcu*m)P67fC#5^iA@T;Y6!9)DK2zsNF@;U}zO_eSQ0C#AiT=wTw zT(Wg+`>6OO^gSZ8baFjYs)F%qp6VWt{A4&6?O3WZpG?XFm~>sE9$bFj>jTZbzzm7# z8K6 zUCTVROwi{)xqJBwt@>25@u8_29K9qUHch$J@AHFF5b_}AXwXgiwEjmyw8x`e4=mGT zyL(Zd)gZ-j&)uDV!iGEx5$oWy)Ft;~Edy=l$#fLbiD8tq?%H223Lx)uh70cxB@BmQ z_m!;eh`uOLwmdpmzm4<^xqOBmR{IC~SeD*uC}aNJ3hYi2VN=A_hu9L_{sIDJtM)AS z#AED_$LN6bcbr#;D|j|r5j|$2bP#7tv?gddQNy|~N0?LHZT0~|J~9Dzyx--xCtmQ( zQr!_8JbNYuF1{^aB+nA(nZ%nD<`FB8;#TwQr^g}fAf%}5psKVg6}YCG5&$ne*6YL0 zd=JEYMw_|G9$N3<*;Cj-1!m#CB!^jIN@gm)@k)x-tHjtcmhLOj;>xf3mwNG@4hqP% zCeLO}IMO`?y0IC4#%|efLga`BC#5=zrmmje$#7O(tLV1+*ov6>tMlfQG!V%5S?0R& zGr`7UOYhcJgXmPSAO;5tNAF4nx|C0x3^g%59B|g20)8Thd`xOAeDR9tvZ7^qi>uA_ zc?MV8Jr{_H{IJb8+`s8hTDP)U9fn`}T$^UK8VUtz{Csjh`%Y;`pxrd<>vOUQ0 z-7WvkCxJb8x4f8iEOqLIS9M>%Y3`4k4IM**(!u?voPEZJq^iIqAn=X>3(Cahjr`Om z_EghC*N6lt3nJim-1Rc7Lzi#J*`=DJUdy`vzNPd>tHCvpept4#Q})n?i&+ZYOoSpe zzM(XX5mDOq;$ynhU7cS@4`>v#p{vKtE(G_3WIGj@Gl;^&oMNYV3u^d3` z4ztCzTgZD>|64r=oX1i^7v~mq-W&+L(l8uF$v!79R!Bn z!IX>60K42DOxqz=FQh%usuI?k+-GqW1D>2uKOTlifZzE z8mjX=4Xd6XD$#QvS>%%wm{qT$M3i=9nl0FQ#YO>aI_q@^7loX1mIKCd0ZTSQtk)oq zPXIf;k>?q!TyZZ-Euqu#!1_Jy^)hXV%WP+okp z<+Fx)kUj+wx0~L9q`55*w6c_)!n|MQp1wUH67c`nv2k(GRxw9 z^B&V;RacYt9Tx1CEvTb}@it0wKw-I259(D+cfvBH2j0lp^Ooql{@yoA0AOvM0`UI3 zKqS2p7a<6iFHtegiQ2-YCgQ!iu~;#Z(YBMpLM%m+XLDhc|5kBxy^aT?G?`-H^8wih zw3VqA%zxdBT-{&CX_A)zvWUJ5c!=B4hF5Qvz>*g0%%BR)G*Myj`ssfe88F`otiDei z{c`_%6ADx0>n@B~N4{Lh-^4ikgx*xyh-#&I_XxP^@mC$z5$+2{-}2 z%k<*~ahw$>29 zS6L`iP`OoJha#GxpI2L8Pp{V!)IwdMW3~j1g*MFWq@O91cJId@t)_&uQ`6zftCyfg zRi}*Iocae1-Wk(^^&e&nd;~_UhQj|PaW#0d6Pp+rBR+>t1i{q)Dqvg5PQ>XiZT6e3 z(V1Fp-k~je6gQK)9c|$QV*M=B13MqLA1ywEdaD-Ohjb%v?r#MxPDX}8Sc?J#L82b}gH zJaVI+gCHAOKbH^v#olO18+qJfh`IfjLQdoMRYVzcJi^Qr7lR~fom0qt$)P{`KTe03lw)E{ZD+E1CCe|_| zojdW`N+BU{q`s!#VqI~eb3d_eV7cT`OD(lG;~f~dG4Uo`$p5MbR}ASi2GX_m4 zY4Oqi58oFY$7`dzzj2pCt5SE=CA6+-NhEzqH$GRX^6b}B>&~*2XBP^qfgRYQcV0r$ zdx_f27aD0-$Qb~-z%KkfgT8Z&*D&#}Mm=OpHtsi)GRl^8vqz+{xE1APn$d4&gDo>i zRmKS$ml74PIb&;{d~^=Wsc6SJYExL*0gLIgX9&OjY4wEpo0??dJC0mJlygVl0J5pL zUbBXi-I&rttkITML}(pknVv=SH~OV#e9*Ta<)1kOm}`7b2W_KVwydG?4emVm>*FgH zg{+$NHalWkr#>8~rBPh+WE&q^8YE2YrnmNn&E40&amcBq@DzfNT7KkYPMkb$k24VA zo_x@zA1#SsSeN4zo$blpvPr$@(Takn$MV^k7C-B+HSP?#NVK}5P+@Kycsw@R_7Dc{ z+{U_W|s2BI@V!=Ukg65df*Rbu(%8NQFEEY5D%=+Hq*cu%M zsd@mj-3J7O%|F8%BeuH9iY?!D#F&5xWcJ_sf-3!XuhHt(8|Q_!H)8Rz!+HtNW-XE4 zg}kccpXt`3gLNNnCmHldr1VA)JTvP}QHpjV;Wdl>KeYUQQ~)(F)Pxe~exS z3Ns$=#eTyj#5&LNbT*NOrz>inYFVz858sh*>niYS9JAQM&eRX&BB>9MZ+;GUv^h-) zi6*NtK#=l=Vl`5ms&Ls74V!X%OEdjfEc=Se)HB%}$<=i7HeH$8_}PRI5CrxC*}!Yu z@j|aFPjtdAoAga(WmPc`jRg6_Uk^LB@D|csL#Gb0!Ek}BB4<&m5=3=d8|N3~vquUL zlNIp?$>x9EDyd5VM^8l7L;c24>N>Gmsx9vq)-^jdyY2y@ z!qi08X!extxApDQN1=+4PExC98LIM@0BRE{ly?2vaRbSdoJOL_DRz{iyu{N^%;}Rk zB_xHKU3ZcyCoPvA;}?#!n{`FT;JShOZHsUmfhh&V-J^hyN*U?}rIF<8q-r@cd5Z5E z7HW24c`XG`3mvH@hClem`lz|Y;Z2{+_8#!6n0DMDGo->ka7PM8xQmXLmT&<@H@2-7 zuP&sL(C#*2%YL6YUNwI>_cxQxHfggVe!?kJb1_Q>2?zc&#Tf%0gP)PaqJQHSucF#n zv~71EqYpibvdDE*e!`kKPTdF_Jlym@^xP2+@Y?nwn%pgX64?Ef#xeB^Q{Eohdsum3 z&xW~*9LscE^L*VDj=5uH4zsD56L=8&Ydf5D_sL?zRz|Rm;3%$p4kq9eqAd@3UbGgu zmZQTDZIu=7vd8T9E;F@%AY{*Tvzh~x=A1DvhdMs|;8>4VN5uyN%{kf_TKs(EJOz`* z-_#XZ+Js5sWw}AmGP1<`1pgD=Nf8BjK|5fI)pIN2WBk?qxJM|EixM_CRn5dp!@d?$ z5~bJR{3=mm~3o7Y&zW>q28?7x0XQr*Pjd8ykJcsY=CqYJHW9sc5bls(D077F_HpfDIojfrAO61U za%sukh>E9_v`sR%yn$_u)zd!XbfHR49?_%C9@|$v>F{`FWhu%M5vL~%%en1TT5sz^ zumdQpnQ#2}sKpgNC+pLTV!0dnpzk%%*U$ECt>4QVmn2#Tw2N9fFHPmDt6gL!Qhzp_ zsr5iubQcxGWTbh!iFa0W_)9I$%?p>h>y{_`c3g*|(Lag2V?E9c`q_b#CF=Ilzk`0Z zF76VTSPs@Dch}M`D~H?@dHI|nd~MyIfaK8JYO2vmBh zuWV1}6r>4gx%I~&axMBh~`NGll?ULBe=d zjb;41sX1#pD>ZOk1NO&>>MZ95g&X9&uYv}7~@hxs;L;_^y5D{f=<)dC^KFzo92Kp$OoKRRn zW`~OpEpdNoc4c=AU}qHw+Uuw1+>3?91lIX6&sh%}UxQDa1tq$sgUxv=vG&&aQenu5 z1}v-B>qNqP*^0G*RhJ?$D8yQHnNdC|;U{Wqx6#$Ct*qj|t{W-07^-+LCY-BQy)-?~ zb;_jg#K-M+VQHzHm1C33B`a~vb1zv6#^1QUK>jerEDVi(x=MOm^_b)IGZ9Fk@#~ST ztu9r$IrriBjhQ7K(dq&KJ>Gh?+E*NLX2xyK-Ou_*11#B1?6fv=n1}aCNd=+bJ5NNq zK`dW8YqwOzA0(aobeQ!>R=X0%IM=3aZ62c0;dy*!-oBo%R*=c=#Uh=1S65pq)gAqN%l0 z=Ye94t>m+BsUPW==uvYvxJViVtbgQ%B;Qw*cT(CMBm3q{rq}ME_I~sIxk42ZaFd+T zOV<;x8}(+9DjyFfDNZ{CTZel)#vgr0`e{^n3Hb4S;`6b`QT^w+yHSo_6M=_%dN27E zzmjn$H%o70Y6coYo;w3!e#o}9hizGpX|d&Vh;GGdg}cuaqgc5n>wk;@G?iX1_AP=o zJFLU}G1a}<^|L_Z>ibWBL%Wk(oix*Gy$yXYmiBuYjhs9KXrwB}zK1g@K!(-o+sj0J zxTPNFN-Ev-vIjj!P;3EMddt>5UoLH#k=9P<-oE&$l7`<9_8xdIBy`39>+B070t6r4 z3UvH6YQ!11yX0K0R6s|UcKi0L0k!DFo^T-2idfy}3SsV>a_aYNVmZA_+yx^>eRrEo zYFX<@f}T{uyl)lV%@j72dn3LH)&sl{H?03~Bksn~*!p1}ZBZi0BD%-(RBLp04am1Z z-F;vxo`#<1djT2=qpDfg^yBVb&u;gBy7Jds(<@&!!ryZ)&gIk{WPUnhY3SXq<1`nH z$jrc-EOXzYEjgkx*9z63TZ)k(N}3=j{Z)kUY8|753%ZUB_?^P!?f>k1 zzx>)QWX(WtGY6SdW>lHb;rl7~$2(!iKb@a5BQh;O>pgMHzj@*@^2Dy-nrMc2EF8=R z1dePh-vh@#?bi)d!vtGrLGf6>I9c$&nnQt2oZHFtOG6HpeF_^Rk9m>Q5S*)|5l6tZ zIp_TC<@N9F)~2`1KexhK2@U9Fy;OQCBxa$5UHcZy{0f13Z;=)&0QHJG*1pfCWYDqg z%PzQx>+G|IyZ*N3gx!Fb_KB<&nu^w$s7DQj_46B8@iV$CeJ3+UyCHAPU=Hn37yX4K zxY2Y8`GlUa5bqj6Ehg*wzgb`l5>w)*WcoU-UxTMRS;on%WqK<8#&hs`5DVB5L+fDb z_@(1cNtqFYu0VlkSWJMDF5x+poCZ(Hswd-7BMEHZFC_6=U|ZlpIK0k6kD4jFH2!AY zdvm1QBo|HXh)kmup+BU?+D%1OJjAWrQs3LKEYC$uoC5D%>Dw|1-m+sygG?E1^M8cpMEFH^8f;3I7c73u`Wi_>U) zh6%L%u}QZX3w)->^lPHpJejmXw0%-nsF2*7sIqz(Ijk?;K0OIJH>;Nlmbs{g-mbx? zVc$9uezPda~FEI{ylyqW^H@g9r-YA-Yg6@EzXs%8;|(2|Q5I>ArCD zdn@K{$(K7$uH5v5bEFK-lBg1z(qMX{`xQrmMkb0EyfyIHyK2}A|CDT>Gv$nt^wbu=W4Hd5%Hv(&e5Xk zM+@*Oi%7Bp|DxFETln1;M95M1sar&+Oz8LZ6UB|K7DOoC(jKYRANh=3?51NRy7%|Y zLaCe1)wcK7H{{${c2-;S!>Qs?+JEsosUs+A$nPhKXDUK) zJn)FmQ!_38JaPhjUivC!^@24; z+3>@Ro0@zv0o@70@-}Y4uEfa8gkzm!?Y`4LTCdtp7nn@bI<*(m7E40x_mxaqZ!KV^ zEnugjYM6DQf*&e1?4${nXbVAgVvsyyUKEg6(Ap%6PbG_nS zbT0mr$WFTSwE<`qg7^%dUpx8v8%m$`eYiCw2yBFnPb?46sGIR(qOqF0`z|q7;<~np zGQgPj@z-O1c;^)LehWVz#QIixnAAAudQkr7Eh41DU-q)&^NN8#`$y8Eu;h8a%tb+= z&X<;ZH)D^jWubP#j9)eL$jh8lti0Phkoq}#kCeMB4v5Zw9Y7MD)*M{vSl6AuE2QqG z!MV3(-$(xo)W~;}CIQvMxK!DII&pw9@i!ASdoxu)l}p2cVwzzcd!KfOY#1j7bf(dO z5S8n%qt5&j?XAs^)0rN78w4daC;*k_a7Kc7Fp)LwDt7ie)augXaN?;;*F-EV+9?Uu z_42-N5`Lxx0#e(LuxqhLYk8-n3~w7szD}tlZN}P}u`1r~7gT5|pw$Wzr-5?JDx0uA z+jo)ui*!ptbh=6CW|pPuCT-$Ew^1EZ0j@eZKP$FjeODZCzoTOv{4TH>1+>MbR6q}n zXhbZ-5U{iBsk05MwU5Ni!HWLskZYB?58ku=elE0L+Sw&yZK|7#Ln+>0egHUF7_D1m zA00d=*3>`m$LJKH9{_XgoJC(a@Ik{jkpG>UMH+ca=Cby0z+A$_eQ^@1Y!H;>(Zcej zN5>rzAr8p=IH8#kQbYQwk>pkdbMLasi*z3r<$l-TUY2 z+T}L`fYNIFZWT2(Kg6Av2Y1Ch-C(=v!1kDJH*+}!mwGl?-Ar>X>f08OyV1Vl$%D;S z2Y1D5|9k#t&*kWiGc$E9YvDfKo3;{!*m>p$R_-tck} z{@St9T8);5zrM=Xm;$+sAzw?>qMZGkL9kvm*o_gL*yb0AFmAZ}WrylEFsKG0_--9_ zs#|EFguV03`8!(l?L}nh&(^)5>mXf_ua2(H?l**g+G4{NuL_Qe(wfZIeEQSM%$n{uz+NHAY z{yM38)x1laX^_o`Oerroz3Hp8Oh(->AWZ==gu-BdSBl><8>SHJV_2367 zYVp}Vns-S-y4l$fShLwIY84e`^X3_k4$JUy(PCU)sG57($DJvL-W!8=$I`Q?Z}jJ< zeZC-RWo;1`T6UAVvb}%QE^c1cQ4?zuL|H$AI)XDlQ!3rwVo3LoErp|cxaUmgMr{4B zIXXn`{NZJqeQEdtE2GY61L+m(dZq_z4+HIzW3&FzfbOk*Mw?X-{eMJ#XIzqt`~K-P z>||wTX6C9iJ!WcZ4jj-{b5MEGoRn5%IF2GIDp*;WBWLCYE7Q|)pt-^USuPylMsZLM zP*G7?0-}G;_xIxe_IU-L&-2{ly076}uo>;D!@F;aoozsk>#`NWfZ(MkbvYF0^fHYB zKcNj#V!IT4^TrF%A;tc+Blm6hbZPvFj2JwrqwJ#b6bO2e+!;Yre-^x+-V-?IS5i&$ zBoBrMBx=m^@mmOa5Fw3rgYOrP(36F4(^F0n=LPt^zPcOG;8BFbg^Jem`ArH408e0fsA=p+l?n_2p%O5 zlcN3tZmp$gpf7ja-hh1BERl)?rjAPv;tkKq(580YFW^A)@6Ldp4+tG@i4xW2@3Ug^=GZE~+$C@9BPypwUnACk^V-wNISvVIk->So$!5U52B#j5Fb zcx&3xxr!IuBz##LsCwPVse5mPJr5pqHvo$_3W2jtvzBF{zc1^66lTv)x(S6$_0$O! z3Hc?StRybGY$EY_z4chmHtL5NX%zkLOpXGQm4_5D4p!7|Yw;e`ven$7*^dvjcV(|Q zX(aDxUT6xRMNW6zS*XT8pxA~vJsnLbWNw*s+;$#{jSI@qh;e-g85#~xURHqIG$bMV z>+B0WPt+kRq906+VNM1PR0w|L3f?g4Cs+D zdMJwHBlh@d*<=Z43CEdm8@LIPn^GbE0Gf*}K<7?W3++3ek+!d(UFX=yyW|=q<2go} ze@3~=9*piWxtGj3*g3gL8nk&xE{g(|Jve(e$tH#=_I*YlZK;Q!>u5lu-v9pV!S6l| zCp3H>|2)0FaEkF70&!fO+togTeP{ICz|bSrB$BZDv-`;GQ^BzZ6O8=J<6zwQ zl3>nBb@2lOV*HEfZ!j5+R_><*g84*6JHlv7gFZ6K`L6nk@=0LiEO!AMBQlbqBsWb( zb9&<_Xnu7HJ^%UCeSE~14_Uq*80qYZ+i^4H$$GW#zo-o10DDv1;N*(t4T^pu z67&hU)HUuTJSnr7b5W}K*T^85_xbcn0Q1)CkxR{A!OSYBsE$9(7T~`B?nFz|vk(X9 z{y3kC?y*RgCeK7^K03X?0M-TX6VsoqWZE#8nNJq`iqR=0uoJAmYt>sR$LcmtQnmtK zl1VmPAMMpf&)_~Re*)lmU%z7LWrQBek6{T%Zk-$cfcOn0`hp-XXYrEhejZ|bMvEmH z9@Nnl-U0kEmaW&UyA_5yzo}{)qeP@IlOPMUi40w+-<(G~n|B-S;`C&#HALL@q=B55 zT#DtEXl$*>vz-t{fjqj=y5q7*%2XJ59_K!{L#^5f^Uq8^p#@I@PczR)z9wG&WEio@ zIGA6jm7MZC;i6)ToSy_?9FL6HOZ&}i)VYROV-+hr$sLDC8x~6oI`XKRJ(U~^DaZL% zFg|hY?2l#mb+}PQMOsL|_ms8;P}01g=<4Mmd&@n3pmSP*Pb8V_N0wZ^lU`~K%=QWq~XN(GbNc6d%+`c z#f-}iMl)1lOQ0*g?Si&9Qd$JlB{8BB4Z?qJ7Ulg($TB|sFDMAUIYE*Xms?^=PXV&( zJ`Xy=Tmt5e^7}&|YOn#*?f87R;M^ZL!e{+|vdn4*5nAO|@11cP!>5;zP=?LMhR?Kl z46dw%gt=dig9P|j^_*$MaFUfE?9oU@CHlU)!3pafvR`1T9)Jmb1u{o$v7aA_qmKWefnH8WGCY^o=T> zQuwf*01_2V(Omd3;Xe!xVJj@e5hDGGxeg)Tkxr4(yVqSRzI^fSO%yWFsayDdptXXA zSw){lA=`q|<9ZBwwtbLd)J~qu#h=41ryna z_%sy%R99xn9{U&!x|f8-fIbAyYqo;{mstf>;DUmc$LddDf7cK+DZgn$%BxSY%6rKg zumnd@VQ_%r+Hn|-nq%>Y<-S94Uy~cX(;`2!Frh#J;)NjHOw@U-(0N}G@DlJfHf~vF z2%#@tP??7&)=BLhx1EsnHWcWc)0CUa&u-0)3oe zq7(xBgjjioUlb>7PXfnNqMjy`MhUaE`J6FuD3FuO4F~r0AMM%MceCdJez#;%Cuh^y zkMkF3ZeQRG`re!&B7G#-lPWKeTKr7@ilpK0qB7a7v*PPPP(a?`k>IQ!io^uLBeEI^ z9&-8}%w;9sbb)rxXV^hw0mc-+-txL^9DEV%1-=EMh8kQARV!|C0rgWKdq<+oN3iK| zTUGDUbtJLs%dgFyD_5smN@jPjeOdV4%-|p&2Y$UP{B#SM30tmR;0bfH60!2gqd3Z( z(4xVdE=^PdZT=T|p-v2(QQu_6NN^gEV@PLmGyzNQR;zUvD7kJghj~a@ zsGx)LZL=e)75io%+&Zan+qn@9nQfNj8X7d2Px%X4yMH>q@rV=s&SAGw)Lvk1y7ZeA z1Y4(&B~)mGfh(wbb1YwfTJ`{;^=G2$R!_Tz932^Q5wy5^;BeE^)f`GRW6e`5LVm}u z(}y;HT@FbC`B<#B?R}vnf5_+hYTK?CS&AEb_7Pt`-(J@Io*i6tW21NwWzRL>_kP1400coEck5nb0m6j<=;S#Gd^enHq~fH{U(V>vEDtStU1%f z@NcSMDk%v8gG_>F)IsC+G1e*`s6%N7?F0bbFj98?PJ+(eHlSMMOWsaFW#Rr6VnPVTFryVU!0n6YlKc9zg`b6- zBCKK~&%1zD?^nbcB8Js#`H!b_j}_yK{62$(U|I!drE06;V6VZ$ACgD;HF?otK*8*v zPrf&N(L`7VGdLo5;dKoK=;HzYXE5CwbDi-o(Q}if(q`X%Kt|7K@c^$bZOFUF2$RpYU7Z zN{dwI*Y8`uP5RrACb%{{HQWsyR@Ngh@VeMKq3WXm`GB5EeIbB}9-%t7Zdz0Qg*|cT z)Vmr5+yZWsS!H9L3c}cR@l*3xOgT!jU~(E~do}W`4OF$CxsTEpx%79zNd8N}>4mCC zjUM#0kR|r638wtW4)4GWejchY<_NTbU&O3-&bVKe+%0PE%)X2A@Pf(n8upB>1Z336 zbm;4m=j|9q{do1Xkd*c85!Jzm`YwhX5-TPPDzb+pS1n_`7gEqPX6#=%6)~dGGvu+U zQ&wJV{=RmSq_JL0uxtJTxgRpu$7z?=c}ddF!6v{TFgvX2qhRZfR0;F@M4?~(th#bF zSa3B@jw=mzRrQ06-gUld8>Qa*kuqxf0s#N59i8#wE7>NUdH}`HCMoGGiKkx}x?1q( zc8F-}zB{%^rZeN=awF1BQ5+^!)5ga@@=p}glYcqv-`CI{jvKnsZw@%5@$0kum>pp1x;DX&``O3Lv}h$I-^1Xw3?h?&eXjRIhrl&qStUZmzwpX1s&Pvv1V0+1%8S^|MH&}ns(j+t8lA*?H8FmP z1nl9N*L>8GL{rXEw9c1n8CuJFR2?f%+%uAonnf4yHTP36GnvMGaZFhUhJHv{Jfl#t z5VdYKRzF!2lvuWjxu`M5HaeuqW}BFL^b=a|q{2$`zr?)Kol@3lCT}clSzQx#39Gj* zG;(WyFDNAhHnKO)>NR=;@n&P{!jB-KoxQ4HQ*j`?3l2AH|BLPKT)bIuxn@%MXu!uk z#8u9V?L{*am(pWgt5%!WGs_q{L!X*`WuP&j4e6d2Hyd2#PM@{)&`k`PyFhsk-tM&8 znKvUhV)8Qs^eCJF$6eaLt4s!XE1hH;`=&O3a~$f^oHQ5`OxocZxePW2-N3;w7B^)i z+YH~eU3{RfW(ZG9I<00RDUv$Pz>}J{@4Vf9^j7555m5OHeTZu%;2X8!Pd~{Jxdp0l zTI5hKqFg5YFe>mxFvrDt5qbciVkfCF$1XvGz|W4gb}++i$~(QnXVn7+gOew#&0O|N zz0-G#H&q`5BKD}|*=)ChH(O^mGNkd)KctSY+iO*zwSFmgyGoK6vt|fH@3a$JUS?{J z=A{rOY*$V%_g@uxT++BjC6uovA@uY#7$-gtf;gSJ@Ts}h$gX7WAW+$gi7+gP!oh4e z2}iN9TsEOu`)OpPeqVSwFX&nG^dKxL?l98TU2pm$op-&bJHHaFG4d|^n+2=j$s1TY zKHD?4cUF%{Gjy!_^0Fcp%PFvBxo3ELc?fJ_%@@Si^0Ycc7=~+6kk}_pJlWP2iKh&O zr{LXCU#X;braaf$E(=j=jXkk_$9NADzd$*)ZvX2zsj1AcXz~oSqq$z`&6?X+dbJ}H z8`kvM^@2u=M)?yL19CavSoo4ViB>kjQGo2N#=nRQDyts@Y3AhjgIJJTr|JoDJ3S3K zOJ7_vM?J&;n<2O`0!H3EHNwMGe*fOqW?$mxt3Rw z$X9!fD(@Yz4i;m;{HhKxIgO|vbxDUAig_0u55}sFY7!!J+mx&iv6!{#(EUCA^~v$D zK9=b6H&s%wt!PLZAV8KW2EZ$whOkRMdj^4&3tRaYpW~+Btj@pk@;TPKK?{j@7|sSR zzys9Zsh?^EoJ*il9J%dSUr0^8;<}q_5k#E478fXfFahr~&Fu?cG4<;Ms}-?NhFNRC zcZrj67aTzj^D5M13*w{O;I`cJP#h7LdymNqAjGjE>|Sp2dScT;qj ziG3PGAE%XIm)NTq#m8^MHa{ZP&CLiVDP@?N9fg3^!S(JslT9|77IJqP0S?4$$<>c1Q(wnM}3LpQS4Z<{`FEXQugvy zzfHv@CBV+88+X?y;du6n6&d!ps|`Qw^8~%%$HebL?G`nO*|#Lc!QXIL9e?8Q1)G~W zDe#9(F>#`Kek_h3Sg|;3lgg~2T^2i#XPa{=`L7EEq0Ib${0KSWG^sz^NDNhb z=F2-jm=lY~_<`Ex4SD>Njy^UM8@EWf^7QYiy}%7f#p;J0hHC#M%b}x{Ta@G@EU-_S zCe~!Oe`-YM&shFylS4FtU*`Z~k&V|X0M0u?T~}GWb^y|KwsULveH*4}jh%Rg>yLc@ z+;rP%zjwgu^7ht)$f{W0gdZbeHYY+_HZCVi%SE>7qGPlC(wc*{K(;4MZaeDu;}u!6 zz4%lG{7((yhR#95r$4*%%i>M_mN4_4pxxeoL&`J{ztXhQ;M(?V88v3Y$V}izCRpjPvon4Qh=K6QtIxo=_77I zROd0Si_AjQUNynv_JXLH*X85AQf9kAPLIe@;w^E7wUb5{Be%Jxum69&$m|&wyUmNo8fglg)@#Ku z4@=Mpw{)ss-3wB1ug^(dQSx=d#Lrsm*kl$Q(`t9nP^nCP>sZ~OFe@k8gN@w+Oq z6a#;i_AbSB&Y>zS2=-I(zlg(a+f$n-7YrTG3^oX>UlKFVMojOy6{-L*9Q0z+Em57i zLoG<|qdfnhOIUtjHL>dxsn!e2NT1xip9L>vJrx3fWa3)aimcKi0|)txT)<$khJt?{ zKOTJ~c$NfZrl#Mxti>FMjC)CN`tYan}PQSTZ?w5pygN^7=I_CD(}|1>O5 zQgT66OHjzxeT8%qn(C?fVLl;rqTmR$B`&{u8PU3?90Z6fU~{uTe+DXqr4gKm9VGdU zr=fO@-( zXj0W&oFxR#J@SdP?x#-L^g%i(_#wdI&>rhrFqwgg9I+0mVCooWkrS(J8dmxW_}XMZ z@HjAeSLan@9jZ=`>;Ro4K$PP1xW=~6Mf2EURqIchA+!k&ooa z@^M-E|2=XzrZE1_t4B^_s4KEsY1+llXXxkdKUya&WZ=Iqtuh_dN1h42K4PP;Y2oy5 zq)29uqfg@$!n`<3haS&Ix8F|&qN|3Lj*VwOKR{S!xgCSWfoJz_E;z(2=%7v}yM&*f zPw-=gE>9g|oplQX;3nMIlo9yLVPJpv=yLa+Z@IPL$Vo!^2MqO$KBx7@m8gKX*9zK& zK47fd1rX~lNOGSpX711N6ZN2(PF9nK7c?ZpQ}3x-5=W6T7};Mojp=>a?3L!}F1#BJ zTdv7j3dc_!W<8kRB40-beXBT%W<(q`=D{l#O#K$e35D2!q9Bo-cH@I;xf|IDe1!9A*>o!#sqt*feyXIgATEp9am~e-5S_6~dB69P(L0&2^@| zXw~G_6dL~n)Fh4bvoq;uz8Ljgay(ChsFqAMM3;QVh!E%9FesBLIgeud#L|tynaS^swi(( zGAVda|FdB|e`yn{*4YS;E5ioTih`z_o}BBo7rQU~*?V4RK@T3Jf+~?#0e4qI-~*=L zzvd#T81kI?7~){FfyjwIzc^^NTul@$jomBb=B>S-aXJ;qLf=YPHy2@i3qJYPP+qLv zbe1N=9m)2sa~=>Sj~n22T$#tMJKN+iiX`82V6aU1^W^Dcx9UAR@pVpjuqzo!3pV=! zSV0gO3NpIZp60)@cN*&WO%64aofx(1l?+tz%DWQT^do;E6WO z52q0NE@Ek`={s2?N-fFyZXPR+=-?8Q_QUz_Y$AgIN;?;deuNG?@V-09J8>8w$v z>}hPkSsaYy7dj`y<*X`i4(Qz1DBFGCnsNcuB@bPX+E);}Ry;wT)mwb1|HAZ>APbhj zQ7D($$e(^jb*>0Mn8Xpuu%YA|Ufu8qEsbc-ggwTtN%$X5a56w>t&e4si*;=*Ht?7>mt3uo*zt-N@UI0WwOg-s@mK2jLlP> z;;R#e<%dqXGt=cgue#%S2d>=z)D+E#tJv(h8 zKzkzxnV#?(;IrQAsxW!lPI6g70HPj;l?hO9oyW%OS6F-;DQRD=Vk-{nJw zfbo81lawG{s@pO&nsGG`juS?2dU1lER$~i>M&OWP-ak_UO9jcq4{D+|JSI&D5z35F zC)yXo<;i2>4tNRMK@He+C8AJ@C?musEXmFolxLy^3X(J@{QbY#9;wGicgZStSIM|1=ET!7PhKzGc@buhS{FCzY=Zc)jK}gxS>3Ad-gM4=wA5LbS--7O&NJo$fVVqHlHTL=eW7y=4fEkYf6o^1%=+!=rP2>O%x@CgnZmB<>SRGEp=7nE}9GCzI= zw@^xTS6YX^;$x&CN}{>}>f(`t|;1bE$`S6z;+?^KtIk+7gl+%$6@EjU4!lV6HO7nEqXe1ZdNTfe2BX{lPLSS z6tsM&gbjS8$nbWPfeby*UH$%>K0%)Uqk&L)@?8`s1~6kDUJ2eDv{f>Gg|sM6Zt{A6 zh@PeNx`2~|1sqPyZo2csJbXj{)a=7IBu&9<$jkt9P9CyU$a`>*X#WCHAqO$*k27?; zqal#xlls33efPlkS&CYm*Bp7f=YN(W-h4DNfPH_nA40!)JH4HJ|UaWmGZgGS^*`hpLrPuu=Z zJ?t~fF0NaBY;ky7j@V-;uyTCvIajjmMTT5eS@!HC5k@II?-ji}@JXAE#_Mdot7Yzq zu(9vlYRJN|9w)Q-nIIkG;GFdka`R=zuv9SsJ(pZ0Cw3{zIshnN4`sW@E`bCD^2pXv znjoh+e-cWaPYS-M!yY!FF7=BNhQRpeB7fWMk?J30>w%Ja&k%B5U@_k0j-ckj!BDg? zROX){j-b$7PW#nYV44~9287NRpLkK*^mm4RjIC7S+0s``Tq=b+2Ht{RYA$s|_ul*7 zluPIf>SgX@qzOmO<0@>*Lg8qdMp1Bf^p7;Gl;epWj3Li$+Te%T%8g{KO}O_nn)85J zO@`s$Q|P*%s9fM%ZU)Lu!=9E0BjZLF09hPHJ_>~Mmj{j4_C`Mq8H^k|la8|Up3l8V zK}bHKu)h+V7M+pKcj0E&d`j|TqmIC^TglOlgzkC?fK0HUa;(TB*J@SW5ZZ5O^yqCTZenA*jTGJ zidX8~OrGX%I@6CS>n(g07TU(tOvSv3T)duKjguR%aWmvut-Ouh7#p>O`f3kOG@p=Z zMag$Jec~*J3~*NDUCjjAe%C2Z$T=^Z09wVW$!M-*MAiYYgu4R{_NvTW{jDSR;w4;m z#cqFkpWiRhrNd!XGVRx=1a<>6x-0i*y!gGn(QhXj8w!IU3Vl%lLmj}=lD=T#xBQ0o zhi7T{idpORQzt>J-O5EXf|(CpX`Z2smiX zm03nDT!hT88$UO^c;bVc-#*LHPrxWYImWkW+D=qu&|-1Sldz>M>@|`}bW}`($*q{TuoOs7`m(2^5Jl)1J7+vF|gq#xX+WIc14$kSU9U@tiE4%z`+kNi6`DLfnXOz|B-=R#T zTy5uza@IkO;hz@pn)I@8^+n|wyL1d?t>1b8rWXpS|4HyX+<_$4J2OUMsdd*)gkcrS zp-cIWYbSZyV*i8lGZ{8oWEGsJU5s4@ygV=60=i^>Mp zFehWPxQyVaa;GK)XQ)~B7<rEO+_Hc(y%&P^a1Eoc&Y2xCoa_(DS)qDFpzcyyO zfp+z`U0YrD$<*RRoDpfGuZzeVd~Zq<<$0hex(gUo+h!054**f0<-0_xX{A)sWTUOv?vJTS2hQD3M_!5JFe?2yOi+U_;_L_IoTT(sV@ni@Luxo1;Fww zicQG|6va{1Ka7l>2aqj~gL1K*7PNxe%$my$ucW)j)h}|%B_7|>n(tx-H$~l)+Ui<6 zZ$z=`IQ<1@UVT9YHV4~{7Q^q`#t`}*qWNk+-ey@29xrPC2Re={d4uu{JO(Bxz;EUH zuk3S)Ml~=fCWQ>r8QiR6GBm97B(L*97YLW=k7|4S!@$t*7}%H+pvX0`y%HJNppgw$ zW4caTrskQF(2HXrhs8l^$*~TWU4MmOK3eP@&(eE+I)i`?HGn()69xRbi0GI%%>bPX zYL6Ql9{Do90fzqE5X}*zoO}JvTN_Q?(J$me7K|a&V+7>=2W7IR(ELCuf8;1Wm zvb(ZPL)=ng7)3DU` zL-jQr#wO4QG-SVt})rrq}$iD*ZdLtrb03!Ok1pwD_j7CO+ZON-;h>Zq^)%0SeYS~|hY zK`kdbekRkIQcv)s-eOK2GU2$V0b0_W*t?&I@AP)pU;y{6aVA%U3^jYMyCHk6zpNpq2U!@C-JdH#XW45_nz>G6Fm zbg>F}ho{5>Gg|Ich(#+_WaLw#*nmzL`PkSKFL(yC3)c1)%+x9sRs;M%3l&Rm%-d`d zkh3Q4%dqJlAD0f`va;t5LBfHuuyOkJ;5J1R0yh-qo2fU`WUwUW+#SgBu{s6Pdy9#k z>sHg|dEGy(P;l1o0o44x+`Sa^DDqIVK$igQgAKv*gLll>GwwA_v5z#`qvqF?EAht# zXI+58A38U~Ei>Xtat))}dg5!IJbzDPoEEH|Hhlb{*FwniZQYcDH)UbT)2Hh5hryc^GE~b48l=S1bWSt6=s)S- zn_4&W1}Gzr1?7CrOwL%l!#Nw&Yul)K3l~VbW3UcEp6^esU&+1eQO;}ir^1-dn|tBID3yAp`J$Ys5R(x zf!WuoNZUf(0Ycd`F?=enxP2#_4EW|O<_613`#ddgxu+p#k2nL&7^Vh` zz!JU=UuQC&#Gm5&G;1f>!a!_g#xYIc73MFz-0E`myY1qSZ$cJkWYxkXj9sj*<0$Sw z=65^t4IiJ#`N*HWPna*HKL-a&1Uf#O-!Mq{d2Rh^Otyo@B4AH@0)O<9wBzZ-_&of1 zdRG7`F-tol=kl+)gN(7nc@x1)5M;El&73(ayns=RB;0QqRqY+O5fNYA>`VcKel%b_ zH=GuJctw|zjxF{gh|p@0~FXuDXnlDMc_cCs>c2EWw@lA*X>7OTEdc zR6O{0@n3$uVB#n8ii*a^s$fAqj@Pdm z-L#Xj4Sks@dAxNt@Q2T4Asm7a7GTZA#4}f96*i2JTAm$8k7q*${mqrjH;O=Y*b&!Xrpj0=R|2kk+X4cxm|O$ z8R?94G529NH(&&CpOTCi#-Zp>#5((N{}ud+YaI)Kj&i|YmhG)a8aqqS0#^rbz9L~+sftNBaG3q{GGAQ4?&zy z2q{G64^jB+7h{Uv=Tg32J&q;1oMjf*#uvz)bY-^QNlUgVzbN)yKI%TEp4KoDavOXz zrWX1wu3S`6g5gedvG41Z>3$ht+c-0Ssu!CwhTadm@$-hG)6p*oA+Jl%mzCI9TA#Iw z74dm9l40>KP}DbM^eEVy1Q6+y9r*04R0Dy2507c8zwP?NTCQz@lWO%6@Ob6&^)N-I zjei0e6hGxfp9F5@)_rC(_6Oy3LTpkq7$Tz*WpYayP__GWjv|r2U zsPE)IdWJebQzlUU--DMgWOrxX+!ZBwaYJ@iCwL&| z5&cWXMl`eo(hd#i29_xpy`kiDXh;Gk4)M1EGb$jDlZu-DS$eSp>AC!ccXq+b5a66= z;<&XEzeQ>PJ7ome4<7k0ywa>K`TP+R*x>{kGne7~jBa@c7}?zKLaF;C*ylo!diy`z zqVXFfLsh$ZUT)bC?;lo4Sp#JwQ9d~%+OC`dpvQfw5$%H3g>hz(&1r<^-Guke1XWl@ zLpr?q-E1TSd87mIcbOB77O6kyAsP+23Z}bRur&H^H)*H$T(k+9;0!cWj;DY)Lsc>D zW;vl_{m3)+jNJ^xwRQEUUgN#6@XQ)g6E6#0g4)4aECP{uo_&P5*Q7n}w^&|1H-6U!gr>^7fUg_J?51mdCN>kFp~53gSncLY;^ihSa4-8Cnm; zqilTvW+>Jha$jIX%4YjbiIdKi-9KjAN3z^xAlfr0@$-(HV*bq#WFjZD=T4g=S zIp#Ix_?!}Wd_y`=JBqrbV}r3PAkXb@cY9LgJn}dpui*`>6k*?NpROwde-U&V^#CLR zP^k!rVWC=J!as@2@N~dMMh|2hRW7P1t1v^P3-zDm!?hR%=VFdZ z&W{+gN-&cA*x|3tyh)l(UrYzyG)QE%{yw=jK%y!BBXE_;JXZeQLPC(J>`L7FJ@4nA zIq8o}rZ;PVy^{$_A3|UGLymTWHq-65F;Sx-4^Ma*zHWUdhA<5}bSepVVMP~euYxPk<4eiEN_sdNDqT1W%@PO_Us23s z+&sf#eiI$&{if_GLPH3cH5uO`Df8|IrscL;cI{QOk1{UsFs{{TMOY%+UneJvNAHqBO)PDiHs&hQ+$mfUZoWHhhmB zpUgFP1k9;F8h(F!*CY@Y;BlP6y-Z|1RIOko$w&z=>YSWGN0HsiMKw>q@Pmx-x1N0I zIx4CqYL=-y5dx&Tqx!A~whV^*iDl+dy5T;ldQDv;~xID{(+wohv_3sv?ZH4sm$VX zSYe9EKjCc*-TV93dpAi{tT_{*X7Qx_Dw!K@dS^_FR*zL}l%rwdGK1};0Pz@~zV5Q}nQjzSX5dIziN~7{ zdZmkhO?6W4wHYDB!e7Tlt&AN2l*Ui-siy*!)iFx@yRGn0QVpFFpx-YIfco`3Ab8 zZ_iA_GpAk}alS{;Y{yN@*kJ?AG~E4KCO>WzGFIa#ZtBX}EbN$nl*d!z`B%%eSF&rT zn^5ml0)1q!e@v;7j?+&_k8MzYI#Cv2>p5^+H1?7hsA*3bgY<&GQfsP+)v-Rokk@c8 zO$DEii%@zMGS zgKm}}mOY6NnTGbn{OWQ({vgVy*U1i{qyNagPbiS8Qla?Ec#t0awKjP3s4UO3FVh z@aD{7ET^L2qPJ)CCux!&K3dOhJvwM2MNE+(Fi9?V-BRkXH+06|dOjLo5~zPd+-;!T z&vkGOneFuPqEctWm1Le6iJ;cUK3*Mw@Q3{j9@tiBEKFV6%4@sQA;6TdeInTjEOfgz za8(;P9UH!B0+z;Dq|CqPKx1?(w*EGf z+Kz1XQeY-6s2>uftbTt1P@zw(r6C_()&PkfYUnmKt*H>#RD!7oM@=~B#@&&3t!FC3 z8J+Q2mjC5R*zBWA2avLpPlF|*1IM_W@w12Cg9$aW@1Tj5hM^ZeW0!94a$Y%-_Oe=$wzC8uG|^KT{;VU zd7eg#8)9wQ6p>(&r{6>&h$E*3nhTnK_M*rBHQ13>&dZ_h>^{G+0?tHsw{ZBYI2FZl zj!Z_=&IPI1soj7MIJs`Q7Q&MKZ8u3ue$?c78?Tp5=}oV4F(x3?qmrq`$R5m)+b<)x@eylYg?%+&s7f6!FbskQTPsPHlKM%qf41~Z3q03 zW!#8VQEpSOS~a)~E1o-xq5LIv*yD@j86E5ru9^;!?I%@FNdad^ja|ORmVY;^T_68( zUZzy2SRf6Ai+1$C`KaxB;;*hqqlizCjBWzDyh6(>R4J#~p z-B81K7x=u=1=)eVS>Qf3xn^X7ZemB!j6W*yL4?;R5BP74O3H>LCxd0PXU2)^F^)OO zi7T+NOc4J?9~E72rbr=~7kLT-G*vP2q%~;fFH&ZnIU11vt^0B&9$^C>XzX3tCs}Uwc z_aVbBrnaLj<99t&XY*p??&39hJXLORkAXKcV&p5<-zSO(k}ak!93TYM&}k(^{zkwA*7hd@ zvsp7TM;lnXSQjH7v)fJk=O`x?4WqlK^&ZPM*#8%8*M{kp5amnm4eX=RpAL|CKNlZj zA)+@es4Elj%eQuQ!8L`uW!LPt{fjO+`t4Ke$6qF!ga1SUEaMd0igeIdFHfB=Q$+r! z=xtbdBB&?l;e4{upLn(6mw2q(avVfjvP0UKdC~-hvdY#sZ`aFL3LerOcjfI>HMH?L ze~3S(5kLnmAh(w7@84+N|Hy_GYj`_9#<(s}mCr1VrBB750L_;U#fYX?*$w}I@b5JX%8TyP z1sP9@JhAiVB=+4SYfrYetC2`*ziwv)xfHsgPZONyPfm!nIzV58^;y}jHwwcJ8^|59 zJb9!yN^Eqr`E63SnGGKX$X~Jr!Y1nH*_Vl%#GEPl+wUJy(WKI+SPnNMfHes+ zyxQc_=P^9wQ)Ux-mYp?xnSIlOuRQYwo2z&LNO2P1*@xvigd}u_6*S~U?$sG?Ty2RV ztaZ0b2>NYb5Y!Up&8~-gYF4OZ z3tT!(J+;@!Pwf%Vi;=H?xvmS*>JE4Eha zNZHriCaH_C0|iS5x>Q8=GF14f!{e)X7g; zh!q0F#i6OPz0=>4rJSA84`O}cXBe+jnD0H=!J*!@ra<7 z$%QkG1dK*Qjp?tJyF$U55y_v5?|umqsWVFoDb2p7pKh?p(}x3$rmB|stCNTah?m-E zX1@9)^=Li{%C(Hx1_&a+?{e>NgM$xrH7fs*x=!`e(EfqrI9*V^OHE@&{0Gn`#9I1h z*&Nos!qgS0(z!!45oH1>!~S?P4VgH+6G*jLE#$al5wWbHXn-8m&**1jwfiTnQLY?I zxNz_CHnCBVe~GmsUw{X!93&h1&kAb6zqjo8W&S--3ty0H5W3>M3Ef!^`kic8#*7E~ z|G5a^|1vL~*n(H^j}vnlhh??CzaQ*)y#DJX!1Lk%k&0rw-IJGhJ^5kPnV3GV@m6`! zFVzMU99=OP^)}gnkW!A`+BmPim$R2s2_VLne!9ajm;Kx-6IU9VoDKH)vH&(Bg49@L zh%Fd)PWp%+O~kHXgoU-V|0D1qV^1bq|y(T}7y=zh@8qRDEM=Kmp^ zJHz*J-apsvlwJB^es5C8Ezbc5(OUvZv;WwN1>dJNn#llR|1*^Y0NGNP#A&;WIWrOG z=u}ULos4>EUJ1As-#I#I(UcTOhP)6akw(W4*W4M&CD~VYhoU+z@E20ZO4H#S11j*V z%TyAz+(YWomp$X28L87vIuYqSdnJ^7F= zJ_GaK?r#!2*%~c zYy_<0^G-SF%Zf|z)_{GDp8GYev#D-(`}l{}d7RV|pj)_XN@eFqU^n5wq{cZX@;S*% z`zKd8pMi618n>(bV563a{Bjjh^|gPU^QN^gKh%VN>(}C~*RQ-=ypKFolW;;5a+Yx@ zV%OYG9j}fLr9(Y&?tG1;7Gk7mi$$-#9{nydT&ju{%9kWZk)PmY$4lhg`~ce z!aSro3-w0ylcMT1Vay}DbirBYAIZ47U@u)>No3<>>*&a5fL6Yk_7rpz8Zk6kDgUTh zFj1>|bYAs-dzx&#F8?$5vw;+>=<|U$DR}@}&*!`e-t)coNRk)l8%dK|YkO4oxG|`a zL6Zz9V~f{MObliRtf7_QvoBmv_x`;c6DecgOXzGW$0GMJQ(1sY+TjZ%r1Y96i>L?S zx3n0+R60dpH_AK5l}nb>?)$5h{XA^-OWw0IMoOV;OS&)3pY?$=?6y|l8#BGUQhTv0 zh*RH>J=%}fV!lE?w~`%iQh?5DO_-D~*#8+vDz4&I`VvrY>(hg160xcCO)viQprcxE z-ROqm49ofqZSYUin4^;y^d}qJfMdkEnx5m6_em&`PI&`?GDu8!;mFPwQz<~~50azYDi+k-9*57}M+89v3`1uZlt(H8bM z4Q~qdgXe_@Y2%n?TjB4F4Ru@A4w`Q@V?D7y2jy7VEc1!SSO>X^P<0g>;H#e*hzqQ0 z+G?>(#AU?fZ~TUMc}mAuBa8pvQ@9N+lrO#JB+Uc|aCA^_xR|C#7Q(_FCbcZOI>t3S z?J)eLjd^!rMpEyG7AXHKz%MlpW9(igR60e02 z_b6wkv-~NP=ED}*;R^LkAQlnigkxmP&F5!hbNNRC7JQ~CiYQ9sCB=fqdfviEczF5? zDbZZ)XioHDhNf6d>&beC@QM}OaE$rV7K1QhOn%nh?@WXOvA8S+O$e?vAze=%BaICH zlTqxOG2>l`llCs zQ;2*%iz3&?3%i|V9hFGD^Gy=Ns-{jlGXtmtA&Yz61QN$M}X~PClsHlZI$~l&(1wqzwL`2}3H@8}gFcGDY;D zW8g@}l>NxBe~yX-8iVt%Ms|vOGH{GWv+lN1eAovg$py}P6YRoBVgmU5R^i?3BRPPS zrN>sHOr+eNbj?C>homu>C$Q6qwEbA1gry^5Cx=7wF%BkgXu896Q)C~>n;TJ{=e{4A zB<{)QP@X1;eRdxJwd&4T!7|FihD;QfPo#atk+7v;y=tf1eR@F2Q` zp3^$~)roHrPsz2;X+g|S@S|3=)^`Ci(}nh7`B6*vE0{mmNy_$9^Ih_-<2VS6!dfyu_@K0Z(4FwQZvPx~Kn&TA}NP3AZX#L1DW-N9$j5 zrxPw~sE&sMe>ZIO{QFP(`8}Th{fR8TWWW3fh=z}8&{7bi%!K5>{_oO78@lL# zL&O-|P1z|a28SbNs~IyLU9eaXB{|=O`d@`k@=*->l|lGX+EA3itYuIm z@eOyDHlW)H#WwCRVQbUAfBFt#?D_5AHQ|q`i$;n>LBtDQv+1vkHq|^g9LFUJli+HI z2WW$M!@}1n9a66!wh2_5$46Y4{kWY1c+fQI!&P^8WCS-2D%=ptS)+OR{?4U0llf)T zaV|C3i!&esZ>lOeD3c1Lw()1h&VurL?(9C}jK%D`?Gi~69~8vL@P^Zc!^Stv0g9~K z;C6o(Mop9nu_}wcH?M+||2GI0$%WfAnJp>%^_;b5fwEMxfIqgj2yE92sxH+K=q~3u zYC2d1Wa$AdH_}(}3*wO*Tgc!%W?+IAlhF0V#s9Leou3&=BGeicN)ZoVpl{YteUYH@%}=vc)Nv#{5D5Y%KL zw?aO*Ibs(T(h}VGfGpS`a{OUgobY|#@|%G|^Q7zbzZbV{?F8A>ikp(Llr}iP!M!Mb zpVg$-9U6D6s#JT31UAn;Ka~;6J4&25DEtC=V4D2MpayrDS59fPbUHtC0>nD|1Zb$c z;K$bPIyB487_(Szk6`CP`pixSbau#cY%Qi4VJ%em;upfc<6?p-YXsKhm*VWKF_G5= zu?P1so|~k?d}wp)e<`3am~qNSYW@?q86c z;4T`^sC|*2nk`-UK(GgAD1;Mx5=Mu!%@JCPlU!U1jVD#Yu6fA2c|l9*SSA7-5QUR% zelozF$9cEAO3MLB3}y$Yd2I)>c`$}YRhEL?MfZ&WcMk&3tGlUV4LP&eqv@e*U_hhY zVZLdDt8|a^-K1XCrFZT@H5%Miwfqs2HuL=`1GF4A2cIK*9DX?MpJ^n*LaQ_#Y!r~Y}`&GB|K)mC(?UgG( zY7G#3)=hB}rdnXx0D~r<)0}*!Vi<+Jm*-o98u+<>a<}1O?dtZ6`qiCv>pG1=2NvBf zm(&5i>rUK)kEh3!9yRGq+i!CASpX4votX~)33{B3X^S!Wbv34PZ-SMNvKmRWo!g-& zC?1tP4gAE~>mOy7TeYd?y|$2Al+FnqgL*8#H4F86YwovRltR}Nycqh@&p6~4Sp(q~ zFB~534b!^qJP>>p*3cS=bmF<0`sjfa>xYm7HkHh4gJSbd(~GDLpwVdqmQkZ`+sa>n zTh1HVy-{EIr<-u})A^-V;hqYRh@TteH5;bV8G0>}1`XZMOC_xxzIo9tdi)A%(_;t$i%K^^X#MI!~IBxrQd$noI(!tke+k2O9CPz;N| z2M;^dW{&LOr>59l9}nlMvQ?bG_m`5TNgaC?($7~g2rI)byLhB;k+Ry?$7n@WuEy>6{>F*v4H^iWuV)%v>^4vVvVk!fHdkD2JEPOD8b2Jq_NDGpC zdcBjL^|bCOeQ!qbI8U(Yf$-nQ`|0Jf;4S|aa61rO_=_@_m{&c=n;oc{$eY%FaGa}4 z_yUqz0Bg#9m$1(l%^x!A0#z2-Y}>)Czi0d8mEeJV`k+WdmLQr7+Y%uu?kcnw(?v&o zPTI;nbFv$a!&080;{)j;$u_K9IK=*d(a@qJVY68QiG6JP)^^h=P+jeE{d;wm%J+|a4#!Fn`(^hBVIN`TdFj|E z-3D32tljq1O|<@;^>Z)i!h!d}0?#=!yO}R|cn!(tBW9bz1jH@~2uJ-ZRmvXX58H%zKs9 z$-A}2dXBGTs<`MrG5ToYnJg|m=|Hy8-iMYLcZ^(3Qp z4#^&nel160pZ)QEVQ}m2{_pte-cN7q|HmFQeO$e3ibu{?@>GM@g}G4%$iFb@+X@UY zS^8_uu{HY>XxwMvhd6-_o_g(3++EVk!cRbox|o}Wr5iJx)R~J5Bbts0@o*eI$&WtN z(})GpB}{1Wh|{oki7h*{o7(zMx|Y&J{>-m|8Y@-K@cF5R>L*?be^f*nvm4zj$pzrU z_{<^kzi&EnT_m^4-7+c7le*mL^5)iZ0na@2ETvw2N)fkjgv{e*PXCkWE>UdPPU9k)lWd{#tY;jwDiyL&F*JC*u_QeSO;!izPfR)~w zU7_&_7($0#4b$|hqT4i>HvpCOAs+&ZXeh!dO}Fn}9i#_E5N|HYcnf>IHS|MMSLp}E ztd_!gPzvrKoD?~i*?^06c=L2U`6ttvY=2`8 z&ujjt`0}uJmFMWEd586UiVlDCKq7+SX0-gpfnIO{3b7FORpL9SE)qIQ%IyW#h{F{&_DbpIQfWH;CIhnH|3|!#YjGR#Cs1E@`@GZ zyLL+YbP>G7WPN{HuwC{JTsR){c7>s|nu2zY&j#icYp& z^`iXQt@*#&MCqRgUg8G{ODDaSP9}`@M|si|ug4dOk$5QfMT+U$gyrhe#k6U*&+7%; zMy1YTTEZXxwh3b#GgryaIqockJiJ{#tP{_ueSa$A2NcEn}fIW9z zldvCga4yzJ^2`s)yCG$CyiZVEXXzpX?wm6FPzl4>U#`4MdMdZ=Za3~Y@*-CL^{G_z zi%94E0&{TSq#6WKp-XrjoWVdYpSNB6#DsU007W|K8O0ub^(&pYz`FkC1Bkc}GCNss zRNv}eznlOC>brXIJl>wvWJ|u!@==t4t48QicdUJwL0oy~hp&jwSxFr%A!fKhy8TLQ zZ8f0q8t?X%7|*PDrQG0`pZfknr}YyLj>AgjhWd!*uDIe`@!S#}X$ z3YVP_>1Lz2Lw2NNSsvuM&FLD}YZi5qB*aW))^$%PQ6A-l&{XOpatI z`Tvjh{gDx={G?rIAxXanS=*iR)7qQkn9@Wk0DLRG7!#8PcIUo`hek?!5&$>V1etxx zRPZb2AxOVbQ}kV}pPXoCPIqHQ24dHWH=}pjp5WS^dw+N2Q|Q#`#wcN3hH>WAc?Rf3 zp?D@o9w(T8T{=RNl8d3_V$55`7#KC?kVgjmAvinVS80x^IhIiXYce<3{O7h(fb=I3 zu%?&`{3E?Fa>qmkvN^zL0?wGk4GVm@P$S(&kY5iv2>3uz&Prp`)l*m z9M+KvVxmIjE9;+$H9uvGN7pR(@P!PfG5phsq)1T+n1%3+WSf1|$N^j%9f&EjBN#o= z((5+;ObDRpb;J6E7`|EdNzVIn@aisOq7Nl_?jZ9-6In*J7}i!m$*;lWBEg5X=`YFD zf)vd8G6%ec*Icik>pJLMQ*oga2#VxIoc2o>oNu^h<&A{2R4%h?S~PO16H=CX*78a5 zXeLK%NShq$7deSQW+%}q^Gfl35qec8DCOwx;85!K?6(PsOQZ4~K6B0{ppj4WcjS4# z^pHFQKUsVoM!cVE1jLp?{D8YF<;&Nkv!ptUZgOy-d06;To2G^R>4wWc!kbgy%uk!y zxcAkn+7w0%Bbwcv&24!l1#mW!A3?HZo3xh$y8`z;`S9F$@V(Al1h#v$3zTsT;iwZr zlcAv3WVaYbelEXV`E#=&xI0PJCQdl=c@O3D4Yx_4!8`ghVPA_c)#_DcK)M558NqbQ zznhpxQ-uh9StB*VV^~R$S;}A#@sMGl1sm6(Mu=^pgScpH!#h%}W$nWUwM*sQqlO-k zvDL{uQ3Sxoq%-*7ee9C9#KM7h!$cbBQs_E3@Z(=->;LQ&Qrmacl!&=Q-D~j>CSsk_ zgOe8LF52J!nk=Zv4&WTm4SMalj?a+ymP6hJFNSTVomZJ2Jz}**&~dnmF``gHF>cg7 zJgFx%p0S4~X_>FxM_ye%GkyB4jJWoZ-BA3&*7s<+#%GG3Yj{L1;y$^~3~jj8 zQE~&Q*uN5tbOoDSLoV$TW#hU-ceC>D*;)FeSr^BhY}e}~S&s}R~~4-dh>Q?XukH-+98s+e9ymQruW_|LW4({tcuyFWKae7+m=hC5gSZa z{wUg*qoOOA>4sQg?=cgFHKn#78ie^aF>n_yPP>Hpm%mdB@0a`G5+OgC6@B)5wtkt^ z#^!LIb-<(4{qpo2#Iy^raT|ZSE2q?eH(&!n5`wCpqo&SKfzyYR82Rri3lLj{3A4_E z?dV6gwd02`a?jY%T%RBAZOu6HL^RBw%TuhRaXKYl1$JbLFsH`qAofUtVQJzi0Ef=` zY!$GKP$3r8>Peo=wuE*oNqd|4woc%ur3bivdjn?p7F#0nZ%DVWF0TKG7}4hCeeo<4 zpPZwAk2^M(ASx>idi~u-M&5{>MJVjSmwCXMP+IxZ1U--~@oZKCp_aT8OW6_}5I0Ce z$G?FcPa++3e)9XjH8mkfGSc8PN0ek4U`YyT(tucv(g~KY$Ohl1Bd&QV;9*Su<(jg{ z9V-WYGGdb=6y7DJrm_*nOcmBvX1GGpcI&@8mbFi!Ko0R0| zy6(TZTXpe+FiB!x7~;^aT!2n0_nNHh+ zXJZJiRGCBR{Yx~hcW)^0N{vVLhuz;FT5{262-Xx};nGfLtcV!uJ7kn-(%TnYmKbr0 zp5tJr2>E*Lm|T;&AHhDILlm_d3*ZEW=2-aYL|()-zSk9*(5T@F9eA|6GCqfjH=45Q z7~UE3hifm6s)+NkRsSlOEu3}?o*&6tm@glChWxie_x=(Vp09)LIkLYU9)~;tkzbd& zNtz`y5pVO|c%2aKmJ$<5xq^8EPjW-LBQi&L#hA3D)maB~dRC8b`~lYH(WJu~nPYzD@z z`A1dn3+O$@nQYV0J&!j}(&x{gk{7I!&yDP0p(z&KIg*Sw#ce>sdtXI8%EuE;HK8wr zlnrPeit?toq~^G=DwL{k#R6;ej6+ES9C^QDfhrI2dW~p)E^c(iZnYOAB6y&M6vTHC zaKwFiBiR7)r$fDZ=(iGQCdv#K{w;1g1_j)d$AzSI+9ccsXF4+&w=vQmYDIx1{n2y( zI49Yy!YIm33w8K<7Wlnpu(Xfl$7_K z)3!nK^P;$*_MVLcrwP1AynTi9+uQ)4Sn1T@bAbOUZfi;`^`9axGE?&`?HHf;`r0Ingn(c7r$wWW`1OE|DMxuEXlvz5|| zvwV`J=rv^aa1P$2T`xY$Sb$U!wrHTegLs{;aM#AS;IQ%1u#fF<8~%epHGtJ~D;-|> z@QF8~M}&622k7S#^5hP+b$|WFl=1QC8twfy=+K(4Eht7#gQVSAG1GiOrD@Ga6`GS3 zUwC3$=}Y5=;PPLHU8(g4OZ?n0dbaecvZal@EZiU)qEy-csENvBzCAEl?%*|oxP}K^ zDL&K<<(_*dwQ=tn{zNh=8h>O3$_smL=oomhickYfuC%aSb$J1x%xKSqD?Yj)pV}`A zvF(rj%XX$HQPuZT%3?qV9N+KfIDWFSS18829_J{V{6H&?Ar zO}?Is7#xmS_?YG{k&K|N;IQ~&X~#bkZrBV5MM7{_ms}@CBVf;zd%7=pge$^2Xp?WwglcX87ZT z@229GG&CZzgm|#1O(B3Xmt7#m3~obUYddqm)7e>MbLbWbXUcB#$^)%$uUW~g6c#|n z;D10-Ot+}>Y&`sWnohVtSCu3#2LHw=CKUU&8eBZ56$vgDUVZ5wDpsSq%tcfry>c5XfH zg*+Fk*_?{qquyfvu;cBFxo=8YEDd7k<_IJ^i}N zM3tn91)?&CoYC@5i_a?wWUl9v-pBT>;@!y6^ar{wjEtb__1m|DiuSVnOCiUR-I0Su zAIFDY|H^ojdx!H5b&^`v?dN3dM_>8(yt3@nc9cD0e;%rte_B3JJ_XF4Ucd}T3rSdS zJ@1jcjN7Uq8EdXiYoYf{KS5>VtM4)%6y3O$lgc4?t|5kC6V)YPg-6G@rxMYlcD}qj zjMii`E3{BX-Y$o~mx}{x<=6S7scGQf-J>p}yi`CpYI(#_HCUw=v5St}spu56$xL4h z$)K%L35aQh5h1U~Fv{wtv{?A&UQ*Snh?QFMp1QM6t9*Cc^zU|7v zn9aATzgjzrfT>ta92KS-g$eg!kAeNK2$Q}+`L4WaqmwhipGm#PobTyR9Pe#Z?w9P_ z1jtZB>r7Yb0#}Vlr5h;6Snn*M4XA*<=OE9GjvwM)c|A6|@^-DrfIeWVKUU9=GV!T! z_W!n<_Vnb2*^BMIrQTt?Yd0@Kgo$J<^N! z3fZyee+yZ-EmNBDR&@Ctx?A#=I7*4~A@6JwCtt{u`!M1>oq`3E{<#j=k>1 z1n;a1_`PV6ByK_HFu(7 z`CXZx67N(Vs0D>3ev;>(Q?yo7bC?|(Z!BiYhT~dleRmy=6e3i5+lp_6=7(4oS-6s# zGY<6k*=pXOU2`Lcynd7KKWsPe*KO5`3e&eqoa8=dHLAeTALFUTRpW@y6IqZDG4~^~ z7)f+`H|wZ=t#*K9=Bhdlt!zKmW0js*L2`#%F^3@)9~DS1xtz$iVJT36`CI-MZ1!SK z?av)FoP!ED(+f*f6^1w@MjVhV7;qk$%NM5zTx9tjPl6RGOZr7T0({J~ar2X$o!PeQ zp9A8|bL}GI&J?FsF8t_XB zW}F{D`Zw92EDx?y=35Th@NMjamyGgQPlMMqHi&LJ%`%T5iwU!cku?XhyWTWxFnsqd zQ#pFH>j?ayWBP~nYYXG@njyVo@CqyXDmS7LB&x}K? zc)i>&2J)|?#nb#9sn$E6csh4B#kDLS(3MYe`}R_kJ@m`T1^trazBv)Z=>r{{4Vox%Y8-8_?pq5*+4k0?@y} z;K}Y3hFmS-P%T?Kl>%CNN=nvzl{>92%r(oIjxj-c)F-o)49r*dZ5ND71h+Se3U%Dk znSeP>H@Ns}K8O4OrIfvcYw z)D`LlxJNwH5|jQ~Vh(eN-&jk}%hNo|7w#3D`zYQa*ap7fB}x6fkgxf(`lnePtOp_O ze`n~F7@_By5Rv^xp5gY+yo`B^z7mz|U_oE;4=ikvPkPQ;%&!t+iqY^<@iBn{u5z2x z(WydTX#WtzX}8lnDJUK7hGR#6>vn}j&#TOp^hJu_%@8|8@m5nCc|3Suc3=-pm#~?X z32AJ!9VA~==qO*pwT*%uW9M%Tu)=EGuyN)dn%M)7)3WE%4!U#yh>NvZ5DqLt2g9=iNXAo&5flcZgh0u!__3OyV`uEI7|eK<=!4JsQIx-(Du97e=hbj&@%Ha3cu z1s_gG(52vFNTFLap$5K<+DZO5z4F!n@JdHO$Z&XWkJOeII_gwd)~h9XCTdEBJ%4jr z@7m;*L{O<>HXr`3AlzfY3hTjM2HskEd)Ynmj^TpaQgxr08NRSNaKM@E8&HAwd|@t$ zZUw%)N7R#ebEgHOE00Z-83z}W_fF=^;k57+ax8ju0V>&*x^{8e^D$}YXCQ<;C4INn z_9G*dTJx9Z3k?N4yrjW;K|;v~xX9@R=^BkvLdTa_)1Q$egEC4dU>1N()X}&KT`k^t zOiVR+r6c+9BQ@Ecek&JMAWdiTIk>EPL!GHAMqEt7`Y*Ob2LW{!{w$mp_D%^>YV1jE z)0qpzlAf}QP3D&tzT988+@l-$E9lST1n@u3ou5hrS9BK+(0?XtVVg5|d*UwxEgbO`?0S7Z6PBGytCXPmiZ`DKvw0+A3Sb0rv5_Kzi-RUhaw zi0xdSdeg2dw9_Y6Ek}9dumyY7BWW6!EM2|YGaH|R(SO#8@x-&#d(lAuJ@BW*!$JwIsj!img@Q+H!n)kicu65N+jbG6^#2j(^5$d3I@HDBHD z!+hFLiCx+~fEg}Q#2ZPqvmN2`IYnM8|%yQSJOnmqz_^+_F zh4Io24D8Q4FHt~|^vSBGn9-rAy8kweMeyfLo)Qgp2f3Mo;8{Y?iEA_kYd>Vj`q*3CVeIFnCpEXIKdmBv??=8u@J|?PKZ+gNFLy}fGdrZ& z#M%p7jqZp`UJzTJ#-~78pgWW>RPUIAiAFSjLgLL)+3i(j6OTNcBIJ_f2pCpZ8dVae zQk3A3;HYz(w0cFId9XQ{9&H$+BAklgqXg zy@>f}Ir$If)(_=U$ZU(yxBCd}JbjWYKf=F>yHS8O2c244$|8ywVapn%EC}E> zVpNJ}vUfmpi&6c^k*<9^4WS`Qh~uL}7Tz8fVK=?*cUX2iKs>F-Qa8Z2$;9SGTEv6W ze3%N=^tnbN9cr5`Dn4&GbBs)gs>$z+k$wEIkP%c{W!5rK{UE2-+yK#%!A^j;>%BE` zwuNkGrNHMPEO+N79R8xmBlP8(V&C}fa-E(Gp=dKfxAO?P^^*uO3_7ay6ASQD8ks1O zKJto3V1HWm>t_4Ro!6gT{gh|#Tdn=7XIV*{32d5kl%Hr4BLd4Q+JB5BAw)~J+raZQ z{xy17Eq|iAjDB+F%fNuLJOrH{97UV(hrJuVB#Ma&Y9A|pI+E6-9~ zTMA`&R@F}r(1r@HlT(@90RE2HrxRSA<+s>ix;xQ=qCJ`?y5l)HDq}Y&bRi`Hz)TXM z_Mo57=wTEV8Q-qW?HBlBWo@$fdb{4V@5ApiN?B zC-SL>eTu(MHY4Nx3B zp3XUTCfHAWjHM5hi4b$A9pjDc4QHSewkKq;YchYtTJG$suLc~(ca1dBv1%;iCJwts z2jaj}1GK+h4R<3qaRORWON%8u)so<$>GH2F7$;ib1663Kp+Xm21DMS*8-v}S?UyyRq0&-hu3AOB} z8Q5OvXZYgP(j5)bsrmSx?PVSsZ1}pTLUmtiX zq=3jjK;5FP(-qFZJ=&>NGTTwk?v>wB{*ZGl%0zyWV7^PEk8mLdiM*{Exw6&m*z!vd z<9Q5s2lr>1%vg*1TUDJoZNVV6bXXm|hnrVZxUJHC6z1IRt2-)Zyws(Qik7E(*DPWI z?T5Sw(ooEdSu0$AfcH;jnJzBYAzOCtkaX|DegFLx55SBmB`E$sLt-SIl>mex;Lom3 z>ll;e7X|!wG&cLY&Wbi3x3TtB>BZ{Eu0pNp?+PQp4$ww4XKG8WC^}hfsbS~pig%2` zkttK;ca_Ni{IAQ+ZHzq#!?Ly1CKU)L5I%A$zsps(G0x}lddaj>0kT+sn*SOk1gU#H zZb|ldA0GpNZ&0&a&wS%EP1Pbbqls49%UFm?rWYSx^}&vUO6|=PwI9Grd^KE8v;^uB@DQX)&Iu z^aVy>UKX27=eB|6YTaUa@yWR#g@_VqFxgN3K3=;Zde+<5qt9=^aOReBqa$uCJS~h~ z?Jut?LSd-&UT1Dj0@R!9uPNH@4))Keo{!aM@7TEk<{gJhM~|;%Ffa$sg$_bKXh)`6 zC&4FSSPRyN8sl4uT6R)*$re_E@TgBN+IPadEDzp;qi?TVJ4R6`z}Wr&<-92&%iVrB ztzVONFQ32~Jiy)X8omAnz?@C*x&HLy;h*8j3BGb?Uk7S}!kn$pTdcz-zMFP|1Ds{^ zX49t<<-*~za}B{NHFs|4RvAs(MOryT0AY`6w=X|Ophk&%d6^jHC;gvq-#j14!DcFvD zoW7B#Waco4nSh`}eJB$8_S?1aN^e&?_3^2io@I@37--)?BF`1+H< z|12M?0o3;S!~-$61^E`=UOU90{Oq*Yon@I{v=S>+u{!O?G*yS9VPmf~GjjXF9N2Ap9)fuPqADcmjIi`+Bu6`Hw_Qra7aA2PEeYchtUcOl4F zD9+uEh!XF8@_j1pQ+9Rcg|ng;U;{+8!X1NN8B>O=C{nus5lRv@^h5p@P_|+O#_d_Y zZ`HngNQs|nWH_A%m>-sP)(pDtUvOdVVGXH|YsK5~iSm#8T$z>t%;3LnC+1@esL+v49u39H8=e0FV7eA=0gw(9*2sn>=}{D7%mjW;fm zRz3rm3dXoIFa|t3p*Ju9Umn_Hqp)$q6lsZ%C2ip_xx7C?-d}I9zGMJd{aPzb)>@k% zl~)1Q{{YwOVB%-HqSxf zI;|U>H&6ZHGr+9VOQCw*m~?qGnWofEzeq9hveqoy3V*5$;qiH@w%oyjg-zLRr&@DGEKH%?>5|a z%DVCShU^@EobjbMc{W{lno(1^z*$}u1I=n1faY7r6VAD=Ur17kTT}6uT-n{p@XAUY zx|d{ler<1(CgK{WL}AqH7*ee;X}J5zYRx;a6TVw>!gaN* zu)mSeuD`)y75GSqb^MkA;$qmAWmYM18nc?Q(O+urG8OB#l${^w69uxWceT{W>SvthLOwz~jxSs=Lr*%kOYTBV>ARGOhb+ zRkaSONZDIaIBfVsBV-;#4x3O1w4e0Z8R4jb@b&RpIAn^1&R zXDWMGeS!?K%@4q{(RQOqufX0bB{xX0=DTXjkwO`4=Q!}0!fl`i!CF)HYGdnKiIVm! zy`v4An9j7IE0HBhK|UOImg(aA)$@%9&o3Bd5e*4~h|SCjlWOp7RZy#QjWF3{ZhweX zz_BJy16D^;Y}KU`SJ%y|D#;i zNMOD=+R;_(To1Haxz0d5`RL4Z!?)2`t=o|^$+(&N7_jhD3}v;If>|jtkQFt>h*zCg zCfle-XWtZ}H?aI(1QR!!(b?9-ov7D{lEzI^<~wX*)9A{Z(eQk=(h1-lVL=@t!&>YGkD z<8gYYyR~8dgY+D);Kpvy7lOC&0B6xTMp9r?V10k4PS50K4mVLWa64d3#}L|v+LpG>TF%M13ajRldCpTUV!h1~xxwn$e&lWQ1a(`tPC@3{jR~xbg$@{HRX&AdMpCxr&#j7+5Al zSu~2{`^EW~E48v3fTFdTNl5{Y9Xnyp)Z$k9@he+0@w;loLb8|*aBeEoGHZ{(|l2&p4F_y@bBR? z_L~R!A+yxJSx4GGnYaD1o>I1TdIbXTB*G@9U&Q=1YtTY}Dlu79r-WkeFqeblN0}F! zPF6L8e{+5+CJubvTiRZN$)7O}@Wi1gn(&)KRXNsGb)u>YC2tzLHHfA>FsbseXGPZ} z-M@&XnTN)Z5F*IDAa;8?8B-%#&!aU1B0Bm1p8E-A z)bEE&szg@=%pKRQ%}e;xJiz@!kQjO(w3 zR4+8RimML%AFvMigcYA5JvMxn!0m)9)8v#FHxl;-RlXB%kpLF0Ns+aryY=R_jU@ow zcpSh{PI+zm_T=oXZb)W@XYn#%&HT>#QaEfW7LN{|+}tv^LPT7eb$D5!pBvh>7;qkVH16e)gPrF-8>hHGE2ehxR<>W6V85w=;{kp$jywD;DGi&DWGFkdXTAR6TFow(oF$$iEd0MCNWfdwwmYzk}(T1>sWbPT#!D}mH zIA+&_eg122W6-}+Wm9<<=+j^{_9pcRVc`5ywhymMwz2rmpDgFW8P9%HR)SNSz$$U;f9fNbBud0cK|MfF z-%y2Js)Aulq(aPQev+1cDr48AachO?lV+3ob=|)ka9C)PDo)J8i72+9Amif!hM|(z zmb^Ok&->%l1Kk7Oed$lGu8<@Mc-GVsS+oR{6fEN6Ktc6np1pW+J>p;Jc8h38a``Ob zgsjD^S>?`j^iQ=d({Z{4anRZhePpevMAySvVwN)WsqkBgmwk+SNrvnXO11@UMT}hR zlGV4I=ZDZ*;@E!z2%5RPt<{sFJ7_FSTR)U3Kz$bm1US?6wq6vx^-Bjs&Qpw8sQ zvsUY7F5nHEU#GlIapvs@syNZUF6bXQ+RAOF5xWTQU)>{XX%hJBV^P3|$_y{QD&gp| zw*@nM?!t&-(}#StLv~y;c@P_FO_U5vG?^uNdb3z!P;h3O@BoJVMJy?l9SA!=QW@f! zlf({ozY|{v(5SPQTU~8ajvfS0v_D!Mb0DYZqb_%r#cjq^$Bo&<$^A%<%`X@#bjhAk zYRkVywXNH>tLdkQPLGuby=L(LH`YIksM=ctS=jujRbyUMco(h_LxYwVA(C8jVh9fK zYZ-61zZUV**$UmxdYm9~bAqx)zauPGg>=@@I&+LK)ogjd12Je*yB;bhvrFpLDt-bB#Kj;2@+!s z1{a5D4I>0Ov6eI^Um`n6ThL*TprbgBx?PVZY2> zTo0^Il>&?~-wrLOOE*IPz7ZC`g6pM7*|D0t6;WP`QY&Fm?dDF~YShzHzBg>(g6ttUr~J&!tL+D*YE`RH?8SFNg;or)v&Kt<9TbkNwr3!bWf%Xe=gb! zvle%V7NIi^!oK~g-OU@Z`0*=J|BEuU`&5l|>w|6Ea`Vk(+QqA)OcjjS|Beeko__{D zTHte_=idxk0>9brA1KSy>M%+6j}(snHhr6ejAeC7gm>C|x0y*q5Ys0h_Y&a;1W=>2Ht1a3myHk@U<8qJh*C`+DA|Lf>%lD=h|bDUr- zDLQ$&BItE!k}q>*{-OlBHL@VphA{MGoOTVk0R< zHrEO7C&HF*cFL66(G3fG6N@Wv#!~utoE5a=0{5+EiAK3Wv6Jv0nI)ZsrG0_0U$s0G zvHS8Pk5Th%#vJVk;(XNxV*Uik(T+3 z?^i1gWBr^J(oIr@j58iZL&CdP&f=>7M!6U>lwDaLgAYus3c=3+%(>OpNdF;ovHM8C zYtp6$7}|Efdo~~lw-{E&{3gLYUHPF)Wfz0OQ+Y7Rh8%G*Y4U+nFWw~vVqF4c|F0ksi+t2 z4X(<&_}U7cGETfKX$)0Xcuz)oXe0fVjc_AIhU>GhGv~I+TGM*~Y4ahoSqF#k6c)e_ zAm{&zPIgkU*=`_}#&KjPh_#?IK+2$^v4^sVzw0nMIIeuV3y4#QMEGo#H7&K*_J-b| z+K^2%XxFJF#qyY$RFg9($UejU+dM=o6!BHOy>mI0$S>Um0zZ(U{ZwA)ul=a0-&*HY z7<1Q8*r(f_DrY)5fg@!$Z7pHE3!`pZ%_L@QEet)xM76+rZ4yiL@+ReHhEsBVE zZV2`0Vz2VbR1NqY1@fV6tQ1tdj=p*rreV)Q4c3IJxBVRG$6N zzVS-e2W0a@Toi82&<;Mw&T8}pfeE2tf;JrU@L$@wqo~U$2s~X>PY~Vw8_Ot>pc?~R zjqcg|4j-+_J4esX?DC0#^Z^ptjpr;^*B9}{RK`K(`|bPL?DQ>2Ql6nt_+%Z-ZtIcA z%crj`M1g((jiNmbQ8vPkbvYD7Dr&YYA8*SKx=c@gMAGe2g9V?D5Aq&mjd0Lc`w&qg z4M%%nrGF7EbV8pGE6WdTv0SZKiJLvRaI_D?ARIvN5ZqxGZKYGsAa-KaF9;pdSw?o1 zntgtYL0P5P^LKb&(Me*?H*CixHXdobaGBSLqq{@;6@So3gbz7o*e-n@?{iV?O7UG# zU_cSAap|{6VNEZKNb254lV3sh(!TSd$Z@*pV^KCXVFJkhC&y;9O--Du@7gSC*bPwg zvF(}KSpWzSp4dkZdDbcA8G)h+S`It0ErB}&7;bL?b|#tuH{_jwBKLmO0szxm`^T2N z{dUjL6is?sB+uE0as8j0(z@ra>Bm}yIcRfZRa)nr&f<0C4>OwKc}O&U=ik!?7qm5~ z+Q=@GGHCZZqK;qIcW|w#vqwK&VZX;2I~a7+1U-|Hv{mwWpU2k~ueN>!g{AEmxLIh^ zmRX2nnw_5MZvh4k45sc3`Dfp{+TQxOign1qL}+~eRc4faDU6xyEGrBm6}UwfRSvwU z{WEz=Wz)eN*r~(*qD{d^nIGIR`(XfIMY_Hzy)K4RRi%#JMw{%;4NCd z8J2XDJsvrIiY<+Xk7M*M8wjhJ@Egr}HonVm(NU*3G1muP)uQp#msDZT2+fZVHK$7V z6>nCzZJn3zt@@3IM`4?gO#_u6<-pq?hF8rC`tyK|o6)SLkGjp-hOEdaEe`2{=bGH;1F>{{rkm9!kmM)^yzim(@s>4E%WBtg3yaM^HQGW`e zcqXGkj=J)0ytl?`mhq91GEK?O!-}S4#@-WJU>%7iM;WaR6`dW}5e3cbn|UMz%C911 zdFm5UnsU0tdwi3vnC3xK3U&SIZ0L6rr`4Q!H!pp|yCzggDkxEy z+BN80N-_ffc02{;8+9+5M4W$vWXGBeUi4VGHvVXXR(^-KT#^4s@WHtQ+pTZY=2=0= zNqcc;vBHW2)?46$mw{CJoN?d7V&z>zZo1Arkmb1GVkg(qvBh6+f$q$7Ywx9av4h^U zQLfR;SXni965-p5U&Jm4X-?3lrTx8+pQtgCoh*S#Kt>mZ#HvZ*!M`|kN&4~W*G9J! zXp6VHVaQdxqGfTx#5>~_V-3`;!>H{-mV;heWoS01@p_}8-kE-3d! z0?8x7|Fg|MEs-fvfDfqo4)aH@Z`Ry&4d?q?Qv93uxUcOPjQnQVYz5`+I9UR-q+enx zp#|KYkJ6>2v0gDceNaX@3f;ytv_5GBhfxhE2S=|dnWdgu*EVeOOZwzlKO>W)EIzi{XqV>EyJ4ju`U_KP zMx?Or8jHjxu9i#;T*U}JnO_v7BW2J(sL|s&{OdnF4^J|~sltjPZf$c-z&LN?Fp?Q* z+?If;W0LRQg}{GqeLz5_a2789h#dg5>JENpXC-yK3vsg`Gd3UT#F4S`V2y?dPY zgXgXk@1dSlUA%xdVSQFYIv`!2m#E`Y(H{fw^BC)(?mLEHMjapT;-pRvglr0giU;ZB&4(}6wUv>k15JJjy?Q6$4`j1u?g8u8ao=Wj)b?{?qsW) zkmQ>Yb``D0nHgTASp`?hNap;MiE!li@E5c@goF)Wc<^NF|Kw*+ly28|$Xftt;$?!c z3?MnwVu;=(7qlH<2kZ@`%%dN3 z!NGHQ^1C35n(tLdS=Y}%Y4!z+p8;2F4a{f+CEX@%ibN5ME`t)Qs!MyFblzP5=f4FM zWsW@_CI7=9ekRy`1<#V4-4QTWKpXIj5vt3l0K)#hknVagu1Cy-cNF?>eiw_Ho=#H< zfrYq7xZBZs5ArPqk?OOHCfO#_P<+)a^fB=kJF}+eF>JeweZS+U3OS{$nw?4{=d;@o z6H0ZX-RaU{`vAgw0&W7%z*CG5yg3O8xmNG@;?J)NK$sjIHNV98JKg}`fimq1w^H`v zmA;UyWU{rUMdR{odM_fo7L1_C=(;ZHfOUnHA_Nq@5fc{zgF@?G}jm@J;2X143+^Bbu z1*B;J!W?kON5FD?*0-EPog32g@sZG6!G%125q5uv#o(x16)pTc(eW}-{yH?PG$as zdc$fcG)J~brJDez?j%#&PH}4<9&Udv!Jr@4B=j5C6fupS7tYy+{3|q4c=Ge#RRmUk zY2f!(`tPy#FCJJt^LqxenT8+T)lUpQfmr{ThorMEQVs?2?7O$-528x`*yFbBfv&oL zJi|}8Ub~_S`Ut?xoBMT0=GCc?141Pj?YvDy>LuPw%!a-zOCJDb=|Nd*AW;)Jgde;uQdjvT$qKAVGM8*A8~P^v!q=ta)hg z&;N}%DJkfAd+eOO^4z>)Fs?^354aY#9`a&uEzp zxv7r3Nx!0&et8(_lPaxh0nN-CGRjpwE%$}NGPdJ#-4*=8)sXAOF5kVezL`_Xj5k{Tqj5rS-?ND4*XVl527@AFA@TzWPeS6-hFE#T8q>2URMgx zZ6X~_H{dSnRHBII=m(m6u}5Zpm*aPR$7#}&XG7k_j2%VJ8#B8kUhwMy#R7YMhNE>r zol#zAn__Su+o5kJ-+6rje{8$Md{+x3YE#+%qjP^GOM4|Xg`%%aqBBm?}>xuxw>yrYUuzj>&2jSvB-Y=Ky9Or^h`z$s;{)! z+yS=ODsL1o>8ykYI`T;m>P2B`@5u$Xr^AYV0!x_gc;-taPL41tn(C%2K3xKH-6Qq4=T5n9{-AU3Nh3zU zHX>7NDlILF_8HS?n9aZv@ngYEJ>kQdQZIW0+ zX68{E105;vAzY`U%~2)ikfoO#fB}trp_!31P4-a?ee<^BMh{54_)}!}EmNbLqpCaE zFVB64Uu5k@#A8|#A;#|&my&d>Al;?yZrABjmGIV+yqi$^l)lX*!d_|1^}eA+0Nc>t z^;Wlw%F-iowAD#6vK0}u$IzRC&3!N+<W9fkHTx(oo?P@@_?rUj2K^((jZehT`g$=cg5SE|5QF`=ml60uH%kLPcUzoZ zqLBynLvxIJ*8fK7U8PsaN#eHy!^72YLK4;@ou&otE&27sV*%tl5|b#wz8IRkjgxUU z;#sCYSn(@0rg1-kAukelXz}wD0mn%tGSJN76Qq)-#6D#nYL@WIl z+bdfWw6N}1Kq|A1{r>mj8SebUq%e{9@=DrR{`NPITF!|-H$j;^)(&J%0-L;AQyOAlV>DdNno&)gHYJ-C$ zSpSUb7q!;(DlEIfZr#jCXXB#o-Yb_$9@~$JKH~`jIJHHO|Dq%%`^CaE;Bcstdb(`=G zJMXcCs!l19+q!4pyVqC>krvoVJaXE<^VD6{V$0++{ zJl1}U#>zV9kz3x~=!*kS3MJ85u(5QKAIoWuI}lcG<83G%v2@SvAh=s%X}7CsPw1MZ z)u@hkYO(If756{VhrC0l4Aul@`Cqd(PHm#16eHjD z>_e01Sm97kIKY*g?8>bSYqAe(YLFy4; zL5PnSNo+6(lRRL)I66g;-hvVx_Al0Y2wg31%+w{9yAG=@@~d7{eqODkE*H;JUTbc` z`R^=N)!pv>2A+%B4=**D@VE2({X6$X1bAb-QaK(spvrkdlz&@cm9X6Lw{$1_`gN%1 zE8#?Fc44aw<~Vy|d0RtMsrY37>wioWmlRn*rLTxD0SRy}ZG&;NG6sm;Fr%0#M zkFb+|Ly*O>39-o%QCv{>_%0EvQ`Q6jOR+d=^FeoaaM8eL|87GEJ|0JGE_cYs=%GO=!vmC!|s8gDMIjzOt-HFb6>{Z>3@6%jRz}$W{`22!$8CH z3Q*zswkOJlL5tSB{oucT`uFR^PMfZ}hQex+?{~+O^z3dIFM$}cZKBu$S~>xmG>O-f zXOB;Zj+)WS5+7|OiH@qQOLy+We-zngNJE)tBT zR$=N=XI|lY%vbFeDY)`Ae*IYF03@nA^55AgahT=H$WHA07bR_b++yWV4$SS@i_Gh$ z`*yuGyXfwyNk0SabGBJdHu1QvJP;>;oO9!}$n1Vecb2W> zJepJe2K$cvW6SPHnAwEt_xB->C1eob%h-IIp1r_wcVA~QZ}(H;_7&A9i4~uN3bHLO zYRe0DvIeA-ns_%y)TyOQ>8zWHC3?~;UZ?4uKd+y5TG6Xy6{+=)y+vT4KR^Y&xSZ&(CV9PA-Ipg8rSg&1)HOIbI5Ta|;n9eT(Cle3Q-wk0`FR2wite$CkBItLYqQZLS; zsFBV!2C>g2a^H+^|D{UoP2Pbl_R)q3|7{@Fn_?Gm4y^S!oM1|_fHVS%+FiMtaWi8S zD9=JXKNTnHh4R)Kpn?Y1XLfZ1zXboqRG?wgM+qT_ZDVIXZlzdQ(UN-Q$Eu%`il0E7 z0Nt=qX34@XOyP9W{|_?-AaC9#Z&q7(9ix1qywQi`aZu0x=V3{{3SCM*n_ok!Tv^@l zhU#|x8imT)-`MwZW%Y`qt6T41+YSyT9c~vgk)pdFpTpFKfVh*twYZ_NRrtZ`Od52U>kbt)yx=9W--$N#Zjh5!(H?^C^@|u~O;`JwM~4c+ zg@f>^Euray~{BqSuy>EjKDt%C6jg3 z)nEU{b_QnV^9|eo!QB%1{FsT3<+t-*61XGzN!oN)10}vue__&+i%ODkQd&1MAstp!HfmBy;#*q~;QuE_Pwqv%Q)>Eez8Ihvy51F6NX ztwsGs?h`*I3_2ip<*3JzNq*|mc$pMk7qm>=uItt?Mi8bjnI`fg1EH6oDLY(E*gDj`dq24)(;Ejt_n4(Z&8hP&9w0+pIF zJ2e+D7ra5h z+vazb7DuA$m<58<^@4(WZg!FTaciT zyj7*l8g>DIUg`0TGA6B8VQ2x-9+Z}+?XnEExCHn7-C%E55LPH49Si`9>bn3((iVf> zY!?185*Ey!FOS=1gf3ap-k^i;jM;=Mdl9rNE6d;Vd{pr=iMVTL?6p_BG4fE4EV*B_ z|NUg-vZpu&iY28bdl*DzU$v$4Fz7otIBQ9v?*_1nlQ4$lmtN8Wy<)_22Ws_K-j^`4 zHva7myb%Pp@nFP0HxpWZOBL6fxmMp0dcYQ()r9)Z8(Y=5dzh~+OZa%Ku#^U&NS>W&M>iy0mU ztYvA}ApSVS7X!vHSGqp}vN2v6ppdn*FVH$~AZrT^2+9brhvHB1L|o!jrj#>V9HjzT z5xXcC5zVIJYE7o24ty&orpz z)&rpXP}Z_Q%v0}mcwOfq^wI*pbx@zxrBjQ#L_L4qHHvo9r+J`i>t5?oukorae~HR= z51IFOY{`-4?qSEH9u8>1u24D!7M-x3#tw_|A?rjQ3%kQ*dI6JG{tgC|UQWtvVo`z4 z>lOXItL^s9uc_%z>$%=qmc$RvqrKcLm6?Js>!Djb*2lntP0mebTf2e&G;DmoA@h6< zJht(sx1so0dcZlc{B`=-er%}Kge}t|^ZTGeG$9dkQp1Qm66L`#Y(74=TD}^Mq^{l< zHh#3KF+RRg0-;}?8=g6CyaP`f-X(F4#6S!DXDGnt@A|RHuYOq&a)KVR0E%TdZa5sDz3vXNWoEg?RxA;FtoZ?04fa_KuVXiE zhXk8%LfP+jNm%euc-`$H@dKK6AqS}{xT>fEC24O z_{hL3;e30tP$>bNnXIatm*Oq78?j)d(>~5PO9!5ThBGbcZ#iIA}T9r$= zN2jqF`~{(JuNVj|irt*X0y(JBi$fxR_ilUVCcX7_*b z83FeCCr9UH?m;{8HF36rNGm)PJb;$92Jq3@H3LoCQ2)|7?^ zF!T2loJbjYOzHt^qRC)dsKq(!C!oLIxesK!c1Ym>X#Wp9;2+c<@L+Su@_*{Ha)yc# z=;j%LI8?Y-dh`2!?nw##GpY;fb(Zv{-nb?WfZ`}z*GdRmv+fL=Kg`LCyTqa|q8^Pq ztKwicRQyD#GIRpy&|gFGary?(AJ%V?i)c)>yenj_Y2U`D>qDwRnX3HHm#9zvbvRIA z{$t#vUR{1;ZO>lHhq{6?gp0veg$_cUf2X61_h~Q| z#l+dXhJe$cg`#zjLoOB)?5T-1#2x!~sq4e4!jBH;m%O*M*2C12`}M4w{OIKM0ZXvN z6(s!#*e8!T5KrKD>LYIlm^7KpUQuJ*^JA3FeSdx@@1$0u@QumK%glbF1j(7`?HdVa za4mU$IETpOeU(JQCV2QlRgXx8aqk>bY6kA3TRdp29URdqrF#RrS0jDt8hs!jWuS}F zlj1!wR(k!x(U$L%Ua8-3k7Py&#|1mJ_#dC&8z8^i?t#R1TN>RoK}?}es?J446VW=K zU2mj?v6VNlsKdGP=R!=oCuQHF1^?xVsGX~&=(b&<1m3-mgH^t>RjE6K3vD)!7WA@?d~YWVeC)jRkVySS!p4QZj1QM!%G0*nNfCC; z7;IZG`~B@cey=juT@68fP&_WZAV~~e6P@K-|Dwo$U1$A+%Bv@4CK|WEat%jt23Y1c zK47)g_5n9Uj^?^LH69X_DAB+be>wr0X01$!y7<(xBi#IJ=^Nw(*Ci?!Hv zWvm`Kj~Ch-0#w0H%$abSZr~>V>VA(Lt19YMADMU+WK%*oM|+W}fx53lEQ|GZ01W%LeV0tZL(WIE~M5HiANh_nuqV7qq(ad{8NpV0!nGBwBB5yeXCA&E6 zLgDb}eAp+X-^Mb_=^x474D0ETv!66br(suU%5#!7RO+N?QsvGw3KO<_x-*D&geLyK zu>Xp)xI^+!3XsJ4BPShAEbzdM0ZO)N?vhs%vT;&JloG#RRiN8TzH4k>Vs{d-Fm?ud zGj~kz;#V%t@`+1tT%yh<``AdZSSQ=cDpZr7M_=L+lADJHAZ^Ikoiz?!6 zaP)TZ*ws-5Xd8G-&zE0)T%hOzpeF`2njnv1io)2T?d6x?+eudX^#qy|6?vR>!dGIj z?PKFRoox-@5aMF==M7&#;?Fmq)9kZ9a2Z9eE$+;3qHqTyGtGO5w-_lN(D33uZZOQG zJB@y(CWX~?A;k(F0i~lSyDKtxq8D=^GfwH-4V*=Xydp@lQ*Y2luYP%vh3-onZL8ue z`^%k?T#nJ+yOiU+f#Px-%y@X`>9xt{uyU@$r*kXvBXP46_ktc-JumbhwOMZzNbc#2 zis$t)D|CCr9qQ&^>|<q3~8>ZpfkXA3?e5i&?!U`Bmn?Mw7D$gTa4X z;Yh~?u%DJ!vSPnYN%yTp)?%M-E&;F;^=$-Dg?ZSDCu;nFPejHv!=pit!qeu2^PQUW z3XzlHVRH52-i_)C}6SDn4G5XUwuJqVCMd#Z-uNLbaMWTRj4zIjHyABe+h}3 z)egg(W6ztv=ftps+O@0#GXh>16V5X~L}H`LHX>tI4h!>B!6W4BA3JkAm^UTtF88n2 zOXj0Le7j16d^(Id=v|3oudF@>fut7L`5pOl4=ZvT(TTTx)Xv6#SuMg*>nMM+u2R|e zRaiBNsqklU$Q~Pfu;k+?K48-o$zQS>*LwrceRO!+HYjjeU*c;m;KoZ&sVM($fGS_u zI5QaeJqjev`DyQdQ3AfZat#VR*Eel3Sr_(4W*=Afl!VLp{rDDL=j@K(Lw;BZ zyacwR&2O#VdR^t;Ka*ntliYi+QN0o%WbmQZ!O+k7c>WJ{2LQidCyKj+MlcdX(W^(w zMpIHei^WwP*`NNscvx;BP1a+N(GBfSS~D-rZ{I#zfKS=^?v2@=f6wTg>UlkM@9-|A zJ?pYgrq`cdIC(VmxX($aU1rwzD{lV~i($Z}kum-RF?2EzPwL?m6xGpnmZ zVkon@xfU(|K+lo(`;@nouJ1QwX&mPHj>~V;E3^UAcjnFeU`N814b@LLT6$48bEUgLy25&H;rYIA9R^^q@1t~T%a;T_w&GkVzYFN->&xNQ)lIyVwj zz*M1KSHSepG#ZT`O@bXgW0d*;+Sn+_z!__I9a#M3Yt35Os^Go6zF6IQNaNVM5Ausc zlPV1R%Sn^vSDVi`LVVJ28>SnHgnEE}R!^wr>EctlyezXtubC4@zj+P@>?iEF_@KUt z`;Q>`f<(gZ5%IaI&r02$n#ixdG20%OhL*;z@kqxk79lO&qNHHc>r6&zH* zVcO&iz7q1QUPSiP$wGyQqp;c5nWJR!I#kpWiQVNQ`r0a|%iK>5+6s^^neI4sb1j#% z6Ew26bd35B(DKj{H?1}(dLUkYcSw!LF7nM1-rQ05zfX|uLkjo(An@%*h>xD{5wA(^ z=T~Hu9d27zt}>=9loxs@j;j>canMe#0}$~p z%AbGhOjpOlU`W@i*eRnj82fc#mtj9$lnR>}k1#HR6|;PPJXX{M!`44Jy)0_U#k3eN zv$AUd-I$%>k@=8oR^sNQ7Bs~8^}HS>=793EC!>)Yve>ZnT?$W4=XX;4j33UK{Z$C~ zg8KeK-e|+MtbQg!3ivTJ_8Q**73b|8f~*e5bXX8`$N{Nm7w}>A{hnwQWZr!{Ob9iJ zby?@5J-(&4gj!#h6!vS^Rr%3I>FiZQ;}b)bB2K5P?JooH9~m-J?a5VUmS*A7NA6jR zg1e*cT4$(gY&r78l%t9brc1&7&?%n(ctS}TFOVBa(QhBb7$gMvu+L{tmfaOyZ(^T~uQ66H&cO(44nFDM^!@!)zgTZAZ2{@% z9*D*K)4Byd9m%N4bt=iHFm#oj?AJ8O8=4gKs-hL>#3uP+HdGkUviS9N<3D#y4rA$X z>|;R{=!GAZ+m)xx% zoc5<+TFFm_g`eAr>oJl_HU;h1vUpwjm(1}RgWbY$Q1DvhzM|CKxi}Zqkc8R!CUucX zr_pg+CD+{(rDb_t61?nS_<+=Wl<&?6_nFz$-!413zoi#ILi&x(4#%UPE{_ajUOKCI z7`-z{C_O(}YY}*cny*7>Qpm8iQdoWGXdUktE>LgR_kHq5mC+yEuXQCq(z$u(9rV#B zH6H>Ci2Dl&2rn{ilNwh1JH)<3-L3@R(G95Tu+v_)K`J2SRwPLZCO?Qnp2E3_m8ye76U>#3GnnS+$EUDeQ z@!ZF>{rpm`C-IzbDgDYywjaLcjck}O&zjd(6D>Vte*^sKX?yqw@UGG<0A~7DdGYqB zAb0n6lJo6ZuW{%AC@`zaMa3t)d+wqgBysiB#OZX+)=YKBotTA^o>+e~Wd=BCQUXPUTA5_dr>@As{)T>UtwOoiuG4Cy|Afsdmlq#8 zThiO=00GHg34kvste7WE~I_6Yq@P_LTFN(0K4isE{Y5uWwv#+SN=5e`Y z^Mb$Wc-wnwj3B6*d?=3@5iyrCHT z*HX@~WtVpLxi(wl_8_GVoJ)lIFr;FoFHoLORC?-5(6;+npn z{>Vf@byYcc)&H9!I6igh)&vu`$bA2#Kq?HgW5)79xRNe*@l$NzgPme!O>c9d`qSH{ z#B)AZcM#7X=Db3!^ijZ{#K$KgUg9%b1L^xFEiG=2?={}=hp;}*#>H>Vh2XafA-*Nz z0d1_uF+IHHTjLNbtL2BT{R@I# ziIauU=E0zuDE38-`hGqS|MY-C)&lBVdPk;?W+_U=(Oyb&BOsn!waZP$k};#Iu>wR7vP}FZQaB}q%SsMGp zBVm6>sS1(qi6GqxXgbSu_N#f%Wh9i$HP5Ud+Q%ejms#tXr;MJ zvwvVtXo`=HAFX04&7^S>AFPi{x1lxaF=GST#hpZC)@G3Dgv^Df+^@GsQND?G>xJ>9 z+dg{Ie9MiaJe!|KqlsIt>bl#<)pUapx^sGMFUyBRH*9l3UM~a7Q`l#HUTvn6obs}t zc6ipAVpWA^npOm2VXAN(-gn`I_Hbj$-ztFvQt7zQbHQK2=zh@uN78wRv$?o$yeOes zX*p&QYSqy;MeT^yR@G|x)+%BaMU_}VVztGwX^R@6wCdPu)J(02JsZ2W*dswmh+les z|M|z|%5}Z+KF@RC_vf}ZDsC#Xa|Yy4neVQKymv2+JA0?X7rOf435IQL_i`CdQq^d< z@}6Y2`4xUlr9c2SrzwYPs^JUv^LANCc6ftcn?=96?0(tjGn)rpX)1!()&Pd7S=FjL zk~h(+GPB&FQF>9bwBK$&x}b{|iwvKE>7uZz+(8{ZT;@T}lDI>~?nwrZ^U$`h83?b=2>DVhi zUlXeFLm?rW#a<4FT0y_(`)1OYBqBoQ^-uejA{Dnq*)!x7A@63UrvfhbZC)BlKt)GJ zP4Tls?6Qj-cbGRA=R(dNT&7IiGa{Sp=#yC$E7*ab6`Q}d{ScjRC^CjMR+mZntQ}v? z;S(kLfvN|O@(n2zX9J_Fv=}Bi$<-CTJ@Mr@V^>&@fR?2gt|k)K&&y@4rgdk}^H)AN zi)ljgVaVtP@SAb02Bm{7BlRQ?2(#J#>Uq;o6iamDn$W~5M8pAGZok*OvzY=7r?#u6 z@T%hKSyq`C&ct?qe}2F#q6@)UC=o8eS2KL7ag)5bo11)cz>}hKSnjJ$7nqvinxf&O z$=b^N`-Aqqg7V|shKkFPTjfJRvo8|rBK#hw6vEh?&TmZ}IVRVR_!D(5nlWKijL*w-1o(y7RSQcFR#p$*`?Izx>F}V7*c8d~)-uLsc# zwIt>6PcD~>mA?w|5l|5j^A(ksZOc;IuHbXE%&PXpKN;vrqU%HVBv z0AGNCw9@(o$3BI6&Vbb*Gp{d>9ILXOGLp#3MGcl>icPqp|NR}60YCJkdU@O@-}tf# z6?RYUvdw`g>MpCN4(RCm-jv4KJB99sk|C%lK7TtUbxz+6$;x&zBJ#{F8c z4@prB>5k-8JN?BRD$yD>F);w?&pe)e4ter6P`RgEI)p|DrL~`@d_8;sJojXk!&wok z+2}ZD$fCp@(%VEKTkD}5U~qie#4plY?!YNY$)&agV0gI7Np2c~6gDq!jEqS<{GVCo zRn=9GmZ^7qjbP55YYWOJczwpcr+^UWKFBvLx&hyH=43+;eZW3d)E32p$=t||Z10~g z!ok|eB{456)*S!nc8fO(JUB<7&0=c9M~Xg-t0LYwF}8&5HUt)ABDpe?%1^quDoVOP zXmyS0_I^WRNi*V_1~U58(s5G+OaheYt~!-61POn~M=PhN#g)fcTk+%^CM7++D8aDchA5Nxdd*z2?*qbGB&wIwt)ujwYP)TyBO-*hb z7VO*EosV650M(}j8k50NVLvAI4Of+i-+cFpDe*okwMXa~8UU?X=qP@VbV13RsUm$HFJ`<=0TT*qYIpN_6m z=Z&E&$>4y31jQ6iJisEVK!}d4LGA2yCeYC|Ucpe+#3SQA8!pQEA%@P>Ibnfn?8g{4 z-LCaI`RIi>B59nHyzoJ7JFxc#cXJBF0#CD&Ju5&`p_awm>E9Fd=%=}X3v-QWnm+1Z z)-66tZmn|a`unH*zN)EdZ&!uvV#J1HYZ)^)f8z{8fiv#m-z96~gRy4HKpI+Th0ay3wb5bTgP?LNbT zH!pd42@Ost_g4Grcr&pyOTR!c7w!J>(eoZyYiW>+-38>mBw*3BDHveM^?cINR7sDlK0hWhic`p(pTQv{^`M15@O z9|YVk%YWDubc2PeM-Hov(|Jja%Z8WQ09aAljWSQ?u;$Pref&<{{hsGCju{>XRXtKZM%mm0xF%CO&)-+-o3QQ>3CL=yt)#LS z{7%~G%wY)1E97(u6naE|vd)8!{!miV*8eMkUZbN{0O;pb^`^gTW)@@>o_Uc)0uIYT zoG8WYR!8>?%4m7OUKKND!hRYD+g7GlG}>PtEq9Mjh_`~N5}sGhEdA&fIAA`?aWa&hSV><-!|Ryjiq)Ga&L4su0!{@NWE*5kj{0}z z+V7R&i~>IlW*CQ?dZ{mWe_}k;BlW}_*xu!6QPvBYl;d#xNMy3H(-E2)Lnqa~fvgLQ z+;NN)EZ6Kyl3UH#pV;O5)!#&K`C9)?A1FQlad~SUCG#3wa!@#v7ngRddL&k|Y*TDq zC%Gc$zs|a?2$GHlpEz-|0HMZ23XpGG-+z1udC87)+iP1 zuS_v44=JQ&hdO=DGKG@c{)v9-P%}0+ngph>+8RPL7zU?L83~WUsYRfp;00 zPGV*b2ObfY9427NPD2f=OWiC*bH7U{OI#|4NBV&qVk?IM>q08X;S2bSd#3E zlBPl9n8hn1T_ZK*T8dkhL4@7%v!Mx^F<@MZQD7d9QK z60-80ZErjbtj;L+KUkn>$4UJxyn|=BzMNF+PZv_L4v;ISPo$7fL!)Jf5(xacA@~V_ zbTC1(g%q4aoOzoa*Bw-psGfWKrl{8^oi2QfY%K)2_&zRgf#NFfDfKP8GWMhXS)Zlc zLy8EJUPnsG1%FY0zQ!{zQ&s8{kzk)_4lr$lK^Rqe`3*MR9TxYQ;|&r#i4QrgJJ*9K~>$8qLsU3}GUw>DOq z3I>Hr!*>40%ixsrtP{m$JI5g>G6l^t>8FnzI_JVeLO1DLriIRHwl@}FdV5|Hr{kRT z@Gs^_Q|6o0KJg#%@=a+r2R}pko%d%wbSfZWrmme=+`qop1!H7)$1zEO%PZ;^rhPt~ zwvh)_rF5$*q{A_czH(9YQ-mXR@h9x8IP`GxkM4`nqgU#}jx@We?4b)_NE%8lP;(F* zdEr!#U*`xE`KRtY=s#=Kpsp9-oK^rk9V!JmO8 z*M(B+Ft;_jHi$y2?R3?csa#8lnszI$emi1zh9h-g^6;toNk?*7jX}`mgj0$43aFxC z622ouNQcWmMB4M72HT8@n5UakYhe9mu=jxSZm!={LaSw_?jz9gUsD9l-uiAZ+?F+_ zx>38Q#7XM+Q%|$KH>sMiU`_sM={fF-)LPB1Ks=8K%cJU7Q_bA;e4Skb}#Gnt(4kn^8*?vqO{KD)G`Ifuy)h2;EAKAr1MM_Olx} z%aOTNyPny6kbfs%FwnDlt!!=8YG%XOu9*ColeE5T=IXMtd%59vyilSd{fSUmkGryb z|LDPVQd4ExiDAK&p(E3WuDt?<9Q6J7ZS4apHjU2M{3U$vZR+DmF`jE(9}6+NlnGP+q}%+*}IAAQ66_(V=bN-F*9}O0*uzf|LsrU zT<@Yi_Ge!D(2<;tcURS(R=>V`Nf#ww`#$ruw(r_V8E`vyCcirqD(}iw1ed8!)L3FH zbLXPxQeP)BB0R&_Y*@9Pd0Si ztf(iNLb*%rKBsb$EUXs#zTW_^bCieV-}Q~Ai~9@#p^_SHL26wV^a_s%sLup^&O`ZY)tmlcy! zkxHn_LsS`{cFPn1I}LLYE(0jWv1K9zD`;CFas-vZB*B7DtbO7KJV)jD>d_crug@5% zIUB8K5wMwGLP@F>-FC7Tp+?BopD@PWuDYtIi4}YAmdTYgEd1Ubfq#cPdtg(My7}QK z$&+zI#5gv=eZ7IrcSfncP}FG@*S;_ zKYzizG+;4pyec`UDBJHS<9@jsET@!wG%8tX;OBhDPk=wFg>O@hP_Fs>^U~`qUt`yD z7LafQP{&1o6cNO{`VAO1l-Qr!T{_K&74 zfd=XNgRwE=uCwy0i42vyM-#noY90mM3MzFi4M!3r1v_(ZuU|GXqZX%$|D?OFy6bQO z2D&KBITdq0sY_=@x||=-y;QpAoDXQ9E}%%}%A8F}+A~~z3Y&KqTxn9FL@6{mhvQT( zS|REye3xG1U4I}zbO5;D3*TkYI2+YC`xqLPLPbQNudNp%%PPLBiH^IFWp06qyiayw z@*A9KE_*jND`GvTx?GOBF5!zj#X|$OmiHNawrpSB+npLfGTV z$rSgNU1Wcy5A0h_EY!we-J7tnOkMWEo5okph8bU7V0iVnw__KE!?7f8?`sM{U{D9K zQxC}L+3CGVnBs26j<&L|74tTh@4ploWX=Iv=np*T4~;L>!mF%jC*+3^1!vK3W4;si zKA?Hurfp;FA>}3p<(w1dw$~+XI{!B}GhS=5>vGV1w3O$I%DFK}ejKy;5Y(qlllTDy z=W$PYE#3^!;EGNL3?^Yd{%rT7-H5@wAZj&&h4xYy?xSZ)e*MKxLrh5Ty#=z)Eq}z6 z%|}`tdVDEkrb`4(RUJ%oO>xtL{hev-BF^)}6z$ea#}lPmpUIc}ky>r(;vrlh+TFc=XgtA?1kX9Jg+!x zf6IUR-c~H;IChTclf0ZWR<7b?Go!Y{KLt5T7rT=vkKIwn)qHj~dTi-z!U2_=$_OiY z6Bo2|W!Nz{XMb(bTI6^ysgdzWXD5+6x;IcFWP!v=d0kq)qM~`d9=J}Jx^xhj*Oqo` z#L%HUl1Wrc7h?K5zKq`vI+$0Mukxs; zJeO8&RL7W^6Isz~v4KFC4+Srq`C4;TtbG%Vb+gQOw&4=$f(rTE&H#M6y_nyHHpAG&$ne;*8I_#@8Gx()}_b#eF(t0<1 z7UNXUi)#fCM^BPTalY*SVE?@v{Zi2V7#A4X4@S-+4Rpq$inMwLBY9(HD?@lr8-`-< z3(859NyU(w_EkLhW8GA-X#K zR_jqBQRMKD;63cV5VE6=5ZM+7%}X6}-j?&hVpN^6N+|Pg`BCUH!Ifs_L_4sFO@O}*#*Q9Ztz>!gKPP<}xS)YD ze|}A_thBP#%Ru%K9?xTE3_=+nl-G!sG4Fp721=ZiZM5s%^wgVbyR&rhNE2(1TAMc= zNf`eZuZ^%;oxh%szH%b+ftQ^q8pH{lLhS8;|2|Hd6{HFh4rPJr@?YgEpjh<9Z>7+} zDMp{((~y&JJTIH7E=+E3B|Kyg0sfIw7G4vzm*G7%XtCZ-USVDIn@uNti9UUH8QzM* zGv&}cDnB?LihF1s!+~oc#O`1ctSr0h3S`r5PIX>?diB%hf}rD48|clI=$6`9K$t9b zPJO*Skb-qC!4@}l#j9u{XC&O1GPTe5+(eyffYQc>CD-mMo^JA<#0`_KcBHEyYiy!} z8jbo3`vWBcr&MFdTJHo8sx!vHK1<>njn!+Dql|5*?(-t7#*>w~HeQtd4B2B!tZd=m zoI{*0wri~A`kh&+oAH>Blhx;ojvs zz2g4xwu$>kS_zd>E5}7cs1fr-u58mKR~qYvk~+^+uAi3yq2{@LKXJlfIgnU5uwj1p z!ntt4wq)OzZIX}nx&CEr(~~^{Z3f+VI)o(3cE-=HuO$EK6_IhWT_=aq2G0>`X{H17 zu+!Mk{Z#=yAztdgh>=V5bfHE~NM$6iYG9>UsPvZwTfA}C8sY8u&#SnJl;gKoZ56`< zPY607%FuW4*$5bUR0E^d0D~AOA@45Gpw!7h=z)~4@VYtCI(tk`%|O-79k2-45YK9i z_*I^MQ2B$=dn>_k+~VqYcSdIpoU>sr+uj+6o(8hS_db@9k5CgjxTK?6b-QBN|DqzT zymaYG>ca%501IaLua8yLrcd{@L{kq+&xMU$5yq@Z@YJ*Ck1W{X46BoHX)zz+Azj`A zP!gPNMXm*}&g7VE%e}0sT{r(RDC@!aZRyHIiT4>!Aa-)+q(D&CAa@5n!O(MY`AFSKfAq+W2lF|(4-hM_W1QVj6`ZuTn$uZ81cU;ICSn@0rpjk z=dRO(-jbUO6A*cgiV-H2fOi8o9Njoatw%1UdYFD*8mxp2E!BQF8r;(&jd}@psiAIo z4y&S%u6vFG{(%lf(%p$3L0q`A<)gljGHs$0x;?)-u52d%ZesAy*%JT$npaf`T4OGQhvkN!Pp} zhkx0}^fRv_Lnc!|%j`@C{h2?KM$Pb7a8dMUH!&RIpmb;3DGvM4xF;>exa@T{k*Im!}-5*-WYLKpcTT#S`%t7R8}c=Tp4Q* zFxe1gQXwcW(5hOhO&HaeHjd+L>=G@eS#S+Zl(HD_>hgnR;#6M$#9P@<@LsO`+KKCI zt0m=BEocKJ;5Tf2PXb8UkvMvG9-)gb)@s33XDNi0#QHqJ>!lZZPYo+)lzj1FNOjkOz>aBhNFDJcIEkXSJiJUwLDS zX^piqSs%E}SKcbjt%FuRD2^BHWdA+z zBQvo4RWua}XDLntTmU=2zI|e`Mf+mlNM`K4w3=Fjx`vq&rNF*lm=>$fs{c>w`HrCm zobSMQp0~ydHMu6c=i6!vyVF}SUU3%b8))n?Y3ylkW&Q^xnJ2Mx(*AivQx*0gw)J0X z44w4x^7Sx({mkoM8AX3^fC1Q(4?Z$nepsL}U2vZiJhZ(%&(KcC8Y7XkN30Clp?Rb=ecw)?Bx_JX^r~8(9(G~jag`i>DMleWvn;V+Xhb;IOYpO^K*zk5UKtF;wKsO{ z=x~%)T@=r4Vmuim3DT{QEDiWIz+bKIfO_eKED0cf50zoq^kY|$%n+CD*UDXD8jvu# zvm({v%Tl-Y18OL9eR=7`c}2(O(R0DZtT{wQSGy`MD#G4N*^7<@Mo1tKR6)e=|< z#HJ7Kn&{mKs4ICvK@)`T&o${P$FBW1C*k`@|(6K4UpXTrX}9fa)Xl?ypA zcXYKsp;4}XHoGvrrqd)cUsH{6Xm@|PxuRq0pvyvhaG_g3!dboFn2O_yEr234e=2M% z=r@M#_wd$kNmaZxWWDQUfbZayA-=r?tC)9=3SsNu6}9F)9_tLLo_nv*5s)Cd_|ujX zIsy1o=7K(J)i?%#tU|bes`$C4qAS!?K-W&xx~PgA9pH1i7zq=%KewN=`T>)}3O;uq z@3nHrB(hxqujI~z3KNn-7ATE?>in#r2?ONvkSNUIV;JohJj<>Gv>GluWD+{w=7-~p z=W0ttXk-8N%DsKWb^A!&ESjP1E7j2Q8L$BeWb?nFY|v7_cH!DmF8GeOV-@pq zx3IXeUEfvzZvfKibsik7I=3I01xEfz3_r}v_W81dXB_hKLHd;TCsNYY3PA8aRc)b2 zh9ojHpG$^k)o^wE8wZzxd3wDqS>ZnkZaq#B zj?53bXF@9(xa7I{PcuHxd3#n$1yF@4wi!@CBP*tjRg7M`!mAvGiwZq<8t+f(VEOW@ zm7Z=yeDLU9QC`0!nSFrp5}fRZsFroSdZj)6!C(0k%)UxvU%--=s;gSJ_=o>h3vAV( z7aiO>Cx-T{tij6nilWMoFFt6Q(YjKo`obE4!qu~th`OtU z^EwAsF0s~|4Q&Yih$QF?#y6(0NkMsKB-$aaUQD^mNYCR#Vj|3oca2hOV4)VIowYzHx$FH22| zot+Pk(Pe12sEcNhxRfa7o*z!Qlk3>|0Mx*grZuL()46&zk z%X_x}vr%3Mt|IFg1jUaBa(lnfe6fQ#}uQAxHQs9|^RXNxw zjb&syxHbPF=MsxziJIIR-NH+|J~lk{k31C(Nho_T@{ZWSu)@xMP^56%sVNB@xg0B8 z66p>Q)h#Pwdp`tLs41IxQ^Dqp>}ON!*-%@`O-!JD15sN63$;72L|%~i^XrR|(Q`;# zulUXbq%7bX*X!nnvX017p}p;f;9H0phcwx{cQzlg1MS)!uVr&@&$sBSv4!vzi720;JOiSunZn?{|ei z?-1x)tk6vHD6PJ0e?pl)+nbro@{#V)vcU<@rH7CF70qxH0o84ZwxXc{?Qg{1-_lJ=-#ZyPNsjz^iVxwH$n~TortfN z%x3Ueg|>;OR;i=M_TH$`9eKS}>oA4wQ}aWM?a1m;Ummx{?YW4qj+FF-_}QGyie70r zG{voCxjYvhiJQ#SMO_&3fyZRV%=~YeeKWF5da4f{^CU5lRW|0L8|JoT;mOYe3+ zj&XysSzx|qHF9sWJJFp%<`v*m!R~Z5d`@Z*NAQjcVbJa$FW!K~xXX`Js6*9CnVhRP zooOi+lNVBR3TEY>6edIES*YEn7*E40V`gOGxlFnP(xC5z-`>D9jy^WOk;Vo`AXAn9 zDRRtHheKvE6J9@j(bl6|Hhy1bYjt2zSdlZsk$?a?*_eq}0aX>*s^huY4$Umq?^R+l zFOqKfy?VQU%s-8;IZ;`xl)*T<^F4>sYfXUJ$RC7uBaqL&-B48I$&;}(?X~toU?O0u zdT+QLNQ=LoE;Ih&#Ew%t0TCAJ*qtsyitvA=auCCYJe|+noJAqRHh+tQ{*~Va-~K6O zyJe{qroMWrz(SciY%Luh?Qn{>xy}kDmB|vvVp|+zqFQ!%S1(W|+H3v%Z7~ro;wg1v zju)qleqSWS_4)-|DUrXJ_-Tcme=m6fTQv978njxOq0oi~V%;hWuSEN0;QVe3#DSeF z@;#R?__?T0p10iXZ1+h_gGdg^3KQ)xdnQ*gfBip7h$hxeS0vYf7M_7WTIJNPSN)YB zHi%~;C7S6m?e>t_RE2-a6EnmjIq)cpAzdn9CG1ED9bQ!|@TIgG?dw(IV7brWch$wQ z>S)AtLE1y(!7NvEt*(LzRGM7rIS~H6#{88;@$8oIJyFl{E%t3ETRqAXqhPl=71t5< z*lNUm`eYpZ%UgkF9Vuk;LaI2cBk0oNC#Y#&mv(4;H}88~U>@dZoHo@C4lJ2x7Y<$W zI*qS8W4wULIn>cO&>3v`BlIkotNG7Mq#R}Ya=X~>%}a2UwTJsDFUdH5KFdI#WJJ;4 z{Bb7mZ(d$5+%1^J#4Ut}Z2o4%yBs=P0-m0ap(&<=EsHWOi=GEjv>{MXYRhRa=5#U* zIhm$T9ieZ(07}|95eBW>Goy!kPI0d6pMDDL*zO(g(8 zB~?l)YcL+x)O;T&sT*aU*xXl;W|02IBHqHB=1kV)9Jm*R==ihGUvlrpkd8Aq%m(7K#?7ZMbk1UrJ zvq#9an_%P5J>{?Ql1NYO+iAXU#Ijepo(rE}RZ{s8PKbYHg`F9*N7oqUp>$AOxWFnF z%P6c9`^$osv+wWM>Jv@r_bSils!B_(5&@BNp1#^+5!qgmxV8?W|M=Y6e3i)&Br@UK zJ78yHNFeGqog#u5BIsy9nKyi+bX)JkoUFzW7#dhe^bBFYkbFA zt%g(|0##n#l09mzbC0#f2x`yyX@9ihQYuv(lVZV6C;_9JJ&@nZy8vBpy3!Ps0z9e) z1H&WJ)N=ncrUJnML)t{rT)R`*LCkDc9LR}-Unay#v#En+Whze$(HBJ1LbteQzUE+D z_OKCbH2;>`QVP632Ty3&c!aygexirPdyAF}As5tOFYOX|CLs@16}Rcu?a*V$xEwCy=slTu`w^?!Hwe#Z}? z;O{|}%yx;pAhyKoH-|T6hdD+=%3Jxf4%41M2LW^YLUa2eN89tqXG8RO<44%Se>Eao z<>!YO)P}iQ!Vtokt|ckwI3*6z)~G7bVQyc@sEcxX{oul9@#afEtm5R;iJQ!Oy|u8r zD;nHigRT?qkp;^4Z!AEUdzq9JT)za{PwjS3XNQ>@y(~Fa`{r1N5_z3+I5TgU-&E0{ z6sHsPG%!wM+`Z<-4KnA!4N~x9>q+)4sdZZ%1=eaBif`uHdo>wp%tmG{4GyUDs``2$ zG#!+)2G`ng)I;4M{PM~OV8>zB6>@mSl*xPt4YYEW(-szqGStV)1p3y=0J@KkDujl8 z1xkz=s@TrVhu?(QZp?%GjzP_T;L_;keeCtYKgY$ElTjLOJ$TA=8CxR>oCp!g9%tXE z&Y2JSmiRtz_hbZ6Xcu54#Z!hrydKce5H7%+pY4VQ(#x>g{e)R>IQBsd9za1yRK^Qc z(D&q42&Qemm#HI6$RjuM%7J|7hP^e8kxpCLn6hGT&Dz{zSElt|#mhP~_S?T`!+#%28NZy@XHNqDYXiolS-|NQ>4BNo@8@fTZu%vACrn9Ny1;Aj5f;&z z3it7TQBp(ueBs|}z&Z%QN{)nNh8;FX38U_;`6aH;EPHZNT|Fhy>7>A31u+iX(%YG& zw^e3D8(mfu1$UMOodJv~yMIvFmyl)Ucbd)LIe(|ZUniSl%!nNS=y=g54$RgXIppBYPZj3iw={A{**KVj1Nph2C-G$f|aUWzP$&cq@2jV3_m2_SfH zlX9)Pi@{GCHzx9{miJbFU1aG585Ytpo+T z?q0DKXgzB7UQJUo!TPB*LL+!@nStr`7q-^xss!6dkMEj=zFmiXU!Hnwi$M&80R~Rh z64I{Nj?|B1p4vAj+VUW-y*9MHNR*FiuBH#pbo6d7JyfqT1D^l#LxbvazSWPJ@HQ?P za5PWqYL9I@ci(ShK9C3`hHJeT^5CP!2+v*e)G=3d=|WvZ9>47a%jD$BaoA@kyq4rx zGHk1bor+`Y6|qC!ck7rC>CeZ1365fy^OK1O-(QTpdB#D$PtZHRS;l6*T-5rH8A;8l zNoI=vCSff}^j`fWp&`4^$^X4n)mFJ-F4gCbG{FSw_y}c+Z5$bf@>Yp>%^!G+&jhcs zcW35auBE=y!`kJ@6lma1CPVEYM%T^L5URBKgM`nsrY9fSB zeTD{dT!w4MKDWvf`Q1PHeL)ja^d6!T5|7oU?3K{<;(ffnLMcBpl&vJYx-raHQ8W6u z!BdnbUd5BUq-Q_@b9J<$95F9Eo`l{xYH8vf$*D1DVBS#2Vy_KMY%7Z=)!aL0D^(jl zP>~Vb?5bH7%>t&mA?9}j8;ZK2IKT+>%@_v;->NUvGT+)O)U=mZ0;Gj}dj!%T?vGQi zKpUWIhxX-4wlz_}QynO)nQ-u`kJ9H^!gA#S#z&D1CqCzlq?m{}AhWQ80S;B{PL zq4*oM3ExKT?|!NcQ*s3%A?j1c#N|>yoijp2h_T2$H#D95ZhP$BUqUx%UnVgI70}2bj@nG{m zcgMf7K*+J^>*h&BN;*#cVQ*mDQ_pEhAoiS2nE^&&=DnFGDC6f8m_|r~C2z>2v9K?5 zW7>`Ty=#Pj%Ga6M_vz>Aen+G^O7iy|;Q18}I*`ENUbg84Z~%n4&%UN^pe_AmC0!o8 zx%JbQI!xcO3Hfu8)XfLsQ;jTj_|<=Nf*(`pL;w^?_VgF*?AKs$*IgrW+nfA)C_qq@ ztVl~;Hr(dV`p~Zo`n>*=zxVrjx?#HFt@qX1QtcK!`=xfGKC%K?Nf6dgWBn)hSCv+N z^s32DR=%^;rMe^^Rh7?jCv779B%8a9O^5-HKrYg<{rUqgg7rD|c$eI=qm-!tiXkVL z@j({#_2&*JckL}BupAD`bx-aq0Z#@8*e;4Hp(8%HXb5-v+V$0ozCDmGhwg;W*8 z86Vm1$dDP+eMeXCf#ckzNbf5+*ftgVg+vdhj1tTtCu&*A^?)G5AY@j6v3S`soZBTa zKDg}+`t-($Wn}Pp+Z6dzm^91X6XWY@nZ*+UA?va~qT6Kwxak*BEKLZ7g&E7EiYt)jqKV1g0zE_`D+0b`w8)7saPs z=hy&qun;g?Df%sqn)*@TH8gCd{U{^A19m+=0j=x_zY{LBv}chdfP0J+?rt=W(~0mB zT+3i@D!J_whFFX&;X1c@*DymT!DKF@VC_?Q|r2;<3u>&p`w( z72AF(v_;AVSvCY);PR@uuzPpou{QTAD=M}w3 zVsdp#M#UoC8{$!rEzE>4bfBmA5o9}Jkw&!|$D6K64*pEkK?d|7)-YiS0*l$vPt@9U z$;$1LxvBK);IbTO{c;%vk%1FX`K@*GQEh~&RB2MrfJ9s-JxS+<_=lc_@|+5^W6tSQ z_QKr1%igcSuRZI7Mdw{(VUk)cO}w8?fF zCSv#O_wMY@gCUiFo~g&XJuqfY1W+9ap`CLJtvV=aPTi&FubtWp)Y<6&A~OCB1L{~> zEaRa*qo6WsfeG&(0hoL<3lOZScR{K~-7h=2R5a%+BX{2P!_dj2@%TceovBZ}NJ{~M z*Kaj(G1TDI&%gtK^|-h_Bo!8j<;WQPyRd+*pByoNNs?OsFdMX1vqdSvTh!Yam3v>_ z*laM^oP~_9T>gD!lNc0w1|^30FxO+m^Gau-V^Z%4EO+;X*&Q1IW-993Wye)tj~);~ zvB6Ufj7XpM=T(ZR-^)4rf}Pa=sW^KGrFtu#-%2E&fW2f09nr$Ee>OKO?LE_`8F#wT`*t@2&5v2LwVzWmC-5DCfWx=*6g3%=t>Mw|6H*l(9lzN1CRA7w={ zgWsMp4UzyCH4@ogwgy$EL2N}f+99v|1vAUN`PeHnQswsI1_dSWV%n2w9BV;w$xI6S zZ+QphJGQ;qaRGJY!M29kc0A#4+y8A(fb`Uq=cpa~e~~Pw8Ltb&W$a?rgFAODoj8Pp z8<)T&Xo?tkKx@d-E_G=PetD>{z;G*Ids(3>O$crRB&f=xN z&y>+9FRd;Vw`taL7NT_H!huF-Yx?2$xuL|P!4XS(@cHsrzKS__I?0HU^0jT$ zSFuVF*=#_oZvLM;KF3}{UETUlG?@~o5q}ehk?dv9094pf3TMyX=X_6$%jG2>FC()3 zQy6-rWds9^OcQn#^kCik)y?wh4jK{O;xSvXdS&*su|m?C`!1W?9R3r-_OWJ?B8cN9 z2(kJ2Rvcoj^U8f;aec^v4hO&QIw|)S=qr_Xam~deZsq&#p8hS!{JX%lZFa#p#1IyO zivCbpzb7)xs~*DeCRAY&Y;yeCLK`StHGzFNK(#ZOuEzHYB+GcGf`Ru-nIYYPuGLZ@ zj|<0rredMt;R2=_$75K^nm*B9{I-9EA(YM>Eiy)KGf7r>g&&jTk`vONT zmclb5!m_9)!u}Nu^Rhq&cutZ+L{j#nHDiQhT{#4TLs)fNjf@vQN&9#V2hXc{%DBid zxX)7@S2NB#Ee!xIIwVC1Zek4?B6T1v8APo!sC&YcF3}DY;^#8N&I2nA;f9>ej>~fn{jCOJ4k!Xrdgh%i}UL_G~BbJ zzoco@(DPm3`38g4!hhg9;i~gLI9QNyb?Bc)2vSBJlSbX@h-xD&$f7^5w>%~*9P>%G z6{h4JFX{V=KiGkMH7D)faZ5p>HTY&Zo5=oq%#^*bE@7UnDD^Il9;5O?9{raErpD0T z(3{utf#C4dKRJs`IZLK)fnnb6(92T~6GrFWJS$yBmpbd5uZ7Z~dMoYw?1o);=<+O# zIn0nX-}<1=n-G3x^uKJI3O52PPM|Q|!zK9vwOjBlvH6h*Ny}>l&@rCA%-QE|I-$g) zby>Q1YMD|JBGkVd_Nr_6ZjL;C*!uLs0}tLFN_!Ku5wTUcb?v=+@o0@^;%TrKBeuKu zN6pd?`es0+=-*HbL5zy7RH1{F#vj&8W8QeLiFxrj#Z4?^G0nqAu?X_DQl+ePcuu9< zL@Te-|H8V$l|1=^ze^lSj9#040~Pg3Gb$H6v;^b=2%Z{aZf>dJQhrCLry9B80@SWC_GYm zt#H&Og7g!t6Cp9hZD)QblwO4M$0C=@J3c5T9K1Koez=-1NNrVT7)hjp)L#+v9XXzC zOd6kUf$Vt$+WlOqGIO44U8%6mi*jAqWekE#@_fU2vt+H)yt}S{m0pqtJKc+5qjdDt+}amQgdWAj0zT2I7-T<1s#x(R zZAJ>#cC*bLEfhxyQJ}bjU&6$Ll~i``$&^%uftvq;)WeOP#g~5aY_64S*ri#eDuqfP z(8!qcJTrW_pvCo#H#rJS_;kt*Iv}cr+?rVPvz#h?_5XN!4}Z4z_y6BkHPY6xYL`-P z)fhEG1l1Nb(o^TyqZJxTD5;$orB$^@g&IMX(_<5>G$@T2jaegRYmXQ)lc3+6&+m5o z{R^***YkN@kH`I9zIS!;a%!hA2ks~S3UxrJeYfr?BC^PXFOj{#8}=pbPr#k5GxIs} z>%5qmrko~qa`4%nQ38P8=G2{_MPT_eoIo&_tO4pM{KMd8;_JA7i8$K{{=)gvC$zQf zOzs1V3Q? zK>t~Bp7)Xj456j#YijS)a^y83?0y!dRq?@45g}R)bMG|?r?Lc8wd!7~8xzr|M!mrx zr5LXkF<&?ak=LlWHTZXyh}uqw5deZFiCvMF-}Z$;l`0}m{W|Itv*^aPh?Vc z0*5(QlpG4f^@TYrDokHn?f3)Q@5D*Ja(?}BIbb@`+U43IB|QJe&^}moie>jB&*X~h zr87$VSrZmH_x3l{^}N4}S1u!B<#`ZPI~6)zu49WTgnG1DaeslPrAa7?W+Y&d1=8!v z3~oG=5O=)eFFV{77z)f{K9LGBB=sI4kkgABJ)wZGkE!6yc5CI#NjZ~L;a_M+b`&)oJfsy6u>s9qQE+DD7(bE=t?X)ka?5^|@RxLGYU80? zT_lHxqWC)eCF5aEZT;_Ss^8k)_MChd`={FKsJhUbhn&24kWUelQD#L%lRhz& za-U0Cgx#6DeQb4q)x)<+$rP`$7V*gKZw8N&-c)}!M_U#j9 zscTXh;sU}8=Apc-kdvsPROCzY?jPhI{9SnXqeW;#8^o=v-P32~N=P2k5+pYO(*ZS4 zlGb*7T%sX1f!gzT87|*O{GVc-2FlXT*UWhk!z-b^Y7;4tg_sc22mLX&QWuZA3@Ath zkzH46BTWw`-S%KW0|U7G6J}z+_@`BP_kF%gz#AuZY=G-OFN@Uf)&L9|Cl}u5?3@y5 zFE7UOOaIUPCJQ9gZGt<)UM^nE5L%~z8~9)%T_=16jJlk1s0E~-a1+z5$9Y`4llXsq zcooNY_xuug!ZMf09>`LwUg|L?F&y(oaBV^aX1H=;YgNZFOa*u#~QU_rvSt92lQ#$LK9IrBsqoQ4Sam9U?h2V_Cu^ zV>SopsLe(NVTB2nXfcx`J%s}qx;_a)U9);FPz;$HVkgTSZz9HglhBk)7*rOukb9b8%z=d3QoI1P1w;U}e14k3)%TvLB?6 zB!IzQac6NVM>1faJ1ngyR_cJqZIcQjE6hfRr%xj&t^no@H&_!8=`&UG-iL7!!e3+XJ?gLR7%;%T*+UYx=rh^2%%2y4iHOmGn5yYk) z9kspW$9#srE&GQ2a^!FW543xf6eXtA3_8e6@-sC^MNozPk*n_4G$*=ci&On; zExnZ&US?Y*)BkgU$aGo)+Bph-*%ojYy#+$jvM9rrMSTj&gg>@=V%E#uW~J zBgp}%NRfZ0@uN?>K*wHWi!b>}M@=z}dy9uj^pot<+kVT{v^D$kzfYC%9V?M^rpY5( z0ks+&vD$Tb#Nngp{4Go{$JmdhCJOOnQO@0kt#1L2c5wk0!{E*ONoBd#}<_{qaM@^3lA zq){uk^f(NaT*|3zpm$^bb9sc@znu?+oq7-NJ$XyJAw^XcIsDNJd7hMVW4MuAYTDwM zhNqOZgQbG~$qzmq`x>nR)K}#fKx4H;|H1rk_WDaDLV3AMrFnwH@OrQsrQC72(N^_5 zA6#ou`;p{s@};z!v+8^6R=t-{y--C4ank$_92AXR#eA3M7Kv-?vufCsg!Iv9s`M*jLa zvk>!@IVJ^}NZUI|2~(A?UOK8>kMVNpixLgj=NnoylG8mGzjzp*bJF`QZh9@PdQXh^ zvA_s~?gC#Faiq$6SE_V6jTG=*4)Bpg zyF^z@l=wg%_hjUN(Krh>bfEb+Sa^VaA$Mk>byYox7@DF;An@V1fe6Lyj5mL~bV)=} z<7Xvgw1)RLDh|lnk0ot%lgzB<9=JvpBCX4M1jjT}co1+nz+!*0kuU%~H2bX|3|%mB zEf0Leg;$3U*O9S4?xZBMh+odp^hWyxj{Wq-Zk($FmqnXg$-JD?VN3b(-)pNkY*zOW z2FJ5$=hiYXw!G>j;G%zCPe)E*yAV07;=5P=&%-?k&1~*g@`3-M1nVQ|S*54`gd_Xk zD#4oD%FP%`FA3(e^Nc?X5#;GeEJyww%%&B@@LqPMk*?E}^d!YoC*EDkcC)dWbu6q> ziJ&7(VHQq%mHZcSPZQo7(3$G4`pDy*^Vu%Vo&SnD`j^fOPUC*><~9aHB2JkC)1ULW z+e6F&-0vgpGtKm-`bdt=yWZ^xJ;)-rc!m>sa_R}`u+Jv3eI_k|KWs)o3@RTsW6JPt z%tzf}wr5}Bk=Af9nONK~n_0FqnSkgab1O$?Y{_%yX*Z6wD2_ZGfAT7MpKk!jW3gDZ z`G+;3!pZGl>;C2DWyM@W2(>BQj@JCPH!jn&0CxP0dX*ZE@8OxKWu4Czo|%kl=Al@o z=IxiNqiIublRNh<($xt!qg@j6`oRm!wfPIiZM5X;2r(>5RdUs2FX2ZsEh)?KvJBTR z64|QmAsh4CELf>mbk^rx;nU#T4VOHgAzO!nin+PCc=qU)C{v!$Pp@ah<^uM%r@OxsVY1at+$fO6^mT` zI;kn7q+!I^Fy0C;I#0_NstFfX@di%~?njllY>W=p*1`R48ewxr_CAh_PSf2v{`;{= z%WDk&O{L0TdNJc>tsR=fWvLi+PfF(>(5COLFB8)uc7E`j^lnxjR9j6K4{E}w%}Sfb zIu6nt40X=~U^^_sX$Vnnn{4)V|PmU{uxqc%qHi1u-8nxyHSs zTP@4%e}xR>7{Jhv0Xg#MR6v9$XM>s)+Gt$;*V`ED5U)~njzL|U2UmLNNA%r zv4)oz|Cf0p@J((Ul55@jUy%|%v4C3O((Hf=`DD zz|*h5HnX;^z5m895zW5m|0NP3O$R|JY6cc{gl6i*m?(>H|JM~@y!JbJt&L{>g`|TL zD&W(7d-l>*>?KxJog@Kd-&5sACNK&X?bNqD6yODC+i#f~`F+>=CLAU>$@*!c(d*D_ zkDL=kl$O|G}zwKI9p1QC39Q}T(2_Hln7VD~+LT%Tp)I|<*Wl<#(KINM_Axf3H758FJPei}%^iJW27-kt?XWco!<2g) z&y+(y!Ce{Yrf0Y(k-uiyUX&r>#f$HEvqghU=b4_c+N@8!W7r!hA7|vqc2j>$vP||a znnF}QOJ$@YO+2y5h{MsN1NJ;*Wl{!htYOFQ;AF1(+xg#;-q^5%RxX)PeN0WkxY)r7 z9~lp6nBSM75wDX@Z0EUoWTtWc1Q)lr$9!Z1@9|Zi$6JrC^^kMcTqbGIH4N>v4$od^ zR!n=iE#&pGMFWdgl9q|jbCvZ_V6&dBrcMYt9{P1-g-u67GaAA z8{{fc4%M11T(6iVj^N1SVCf4GU6$6Z78LOlKgAOpDy2aG%A$({XO?;h6sY5Gvvl^n zp6DTb3#@B-{(%E@UVO@nXGU&aHbMrOgzKTNFai6jw3e#UZ&HlmY;Z(sOt!Y|QVW4l z4Qw$C%xsV;HjPW)+3Q;Z1#YSO-+M&xSGCT~epXV!wCut)=Y3C*twpU7AAzVNqFM-UEYc;*xkm4;M1Z zEBA?Rqu}p6%`V;dr6pJ5#oD*w2v&qzR%#l66)}2e$+D_S40)-s(rfeLs?QJh#0Gdd z)4;aLC(R~iaFqBBmDYs^u@DHqCYy2hls^FvV0>QU1z~-k{BDhq-V5s%_H+eV7|n3``biwoXVnEyIH)%=*0OFcZp;mBBfBG@%m4QsiUMZeWqx6 z4H_7g7iXjXu;=2=g$)IX)jV|1ow=Mz+swy#jaOT4t>gw!e++_-@{q-Wwx%sShu<7s4Z9+t#I+DZ1OnFKuk2EBnCx9Vf}E{^D9n~+(yvHPK&rXDZkTJg(V zXWoD7#nnDVO(w8n*TV}nH&y2$v6lq8 zXtD4Z=$+1u-OOskyuviN{-Y5{ea+3ZQ(NpdPj&KZ`{MV;rTtF-{~RKOF#w0`XPy7w z29q&X202tvivx$vi2mdi>8U${wg{AG=k7r4DMEXhwN^4xC~}zd1%H*kh7S`TAbdyB5)0r# zcK!Ia+7AVvo#LKu6N}0rfRD5WewQmzYx^%>w|8{L7$0eeIXe;t70uo|#K7c*ktsdqETEJm%XkJ0cc)Qz~fI`N0F<>GoZpl5I(mYpp%C zJj8E#GrS;Z(u~O%OMrnI_dkLSFyKSIXW8w^tQBIFd%qNsZu!gzxWi5+#tAvWBPA0z z2V6l|vEdmG0XyRDK#i6`T=XsUQBtAQdM@b2(06^M`E2n4W9MA?L1}s{3yOGXkzf80 zcs!vJM3h5%l~|(ROXD+QH$Ne~{{5u&kwdpisS=H{Ha=Ei48fw*_NBNJ!~N>{sDOs}?z{TZyqmBjDfS8Px*wZ|*^`wq=XE%xKQOaOideqVz$$hNtS_X$f9i7T7@onmitO!!|_{l1>W zl--lE45U*1Xy~&gxcj5QP!(i~_sg<71=7B=j<%hjfA(uy(49K}Qw1|^0`tGm=6`RQ z**xDPYA2*6-hz4Akt%xvgyoTwTP1rtf7Py zyw4xZz zbBu~$JQH>7`)Bktyo>&(=S1CR;<}fIZNA(U^7|Dh$26qgL2YJ`4gTuDV=q-rrkWQ#*}MDpnF_9vofpQa1AxDTrViAg9VKoePsQA14;* zCQ=wJiVJdjMd-K85zSsXOnUk#pPjjYiM5c5{M2LT9?5y23r9?`A=a(gTuh$pug7Rq znV_F%G0*!y2OU@tp_XrNQFoi44#Y)5bTWHH^#+!^?w*WY&`X{8=JY$@OJW5T?7oE2 z{m)8)r`25m^w!28VEe3cu#@qm+D)U}i7y-Jf^?TiM*zZ3@J(~gAh^&kd0>>A9z7s< zjce0LVEm$LN~Co5Xq@^=ES_B5K%6|-?B_gjPjq%4_$~rqp4LC`Q{p8Qe_t5q3_!4) zv*5Q@+lFj6GJ^ZBVfM#j@rT!3C!)u>Rn{H#$2-qhrN463t*zUJuGDa5XB=2cgUm$P z83me!ft3R$U%6EL{ZCIG=0UWQIMMWNm5`MuPJ~Pu8y-(~eT3n`J2iNe{)=6+gaXtl zs{>=4;Iv%UmWnAsdo05yK9A^*W2tP@=|nXu{VP{2!XY()dH_@#Z}N{Ckfo@VdblvA zO3{eU)zhz{ZURgu!Jxj>4nFoNxbIW7fm>7nV7N3nT-Z&@{zxf+$pOj;zj2%y(C23S zTMSB#R=b_qHO_J1Ln(7!aO#VafnU+I2aBZZfSGBE_y?aXw6 zfx%0!^b+!Uv5Vc^xlt0yQHVQpBn%NGXqwx~TRe_fGD38cO*Xx(C5t47gQC!<1x94M zVe31Lb@-~@e&kIBN9XzO|CREL>RM)_qLMA~jR7-^XSQ<3ivna9BZI!-4QbDLwKcph zsNi{Kf}w#&Lki!jtgrj?4@u&_r`I3mhQnz}Yw{;{Mu2?iVK*IA0MLiD+Gihaql|AtYE9^lkDTFDp^05f{~$l zr&^hD{i5U2m#PwhwI^6%eIJ>OiHfMeRq`-*0uHQtP$b(pBi`2;cffNwW1{us0Z2-V zTFu5xc!}tt7LxdmYK;?d<1B7`HE{j~v#%i3=mT>9AkxrxH%cwL72jaipBK6zBIRDW zR?fZLU;v}MT`Dr?8@pHo!AE7(7Io=F-s6A}Luz17MDu}qW^C=+aizZ^kB^)(>x675 zj*6(v4;$8oR1Mg| zd7VH3x961iwgy55s?19Hr3Wj%=OT$7hLiTM=%$9h9EZe8WU8Nxq=4@1UT2lICv&uA zdf%v~@Q^4(yQH6Qn9F?6;8%I((o{*f!6!A^qg#$|0vmyKz|3_}&&fdG$Su>HyVGof zz_h(meOfP!&j5CrsI)1uxRtOKgY$@dHj012tAOq)53_hUFI)(~$(HVqU&akLc6UQ* z1?C4cKPKy}Msfm$K55IYPH+FP^ZQ0h=~3A8P`Q$*4{+)HYg&>SCSfcMwJgC)9=G*r zBNSL)Jn~Bqzv&h10PHcNmZ2PM9*qmn^#~o_MKKzyKF*6h5^kgQ zOGZ5|@dC@Pl0&YoDuhd2&~s&T^cuu}ww5sQUujF=Xt9qCpmqKTFu`*mm2$IvwtVz8 z)osY7$^3I)p1UifM|bSPP`nD_RCP!w?$KBO9V{*lnIAq4!<&hbXE2G@(o;O2fT3N{ z5X8m?rde_1wPMjx0-yF!NKs4%#9*1R4vnNopW3@dQgg&bL+dTu6Zg5m=q*;ljLa}_ z4}NRq>3oQ+k*jO+7uiLpuQSWu{r-K`A<4skOY2~$*OssJV%=@RSPWW2AA=*5-d*X9 z`+Wae54~ZVr67I(nuHCPXp}7v5_+Fp(kItvW1EB_& zG|l>2GHYM$nk#3UXE&|U2+TyE>KqTnxW$JOe0t0gg!D697atmYuLq1@(Sx@KzKVE- zhULf@90nOiPz{oz8J}S6O4XL`RHw{rH=lyVrDL^nsE35M&FO2ccUZdeqx%+ZiF&l- zZn0J|<8kdYZwytrVry$iYrRZzb=JD&9A1Rpw_o2V_h0fJ@e=*bai)ts>(xf~+6ud) zlYep19i020bZ!2D(11edMDC}dUwUKem!6n>%~DTX?-~^VpKYdyo?X94ZYv!ak4u^y ziv!9TPTuE2`|J&+iRk^8i}*sT*1#e7wk3<4S3IxxDEX1Z0HCM(UaaU}YTOPC7QMA} zK;Snn(BlamuOEluu{0f^=m*{kX~>()4CY;;QdDE`nDf_=R;pFbvl6vB>zePF! zsc{D+b}(=HN&4_>)9?dXSe%JP6gXNF$^VI0g|_Mt1Ua}~h}Sd`DL5Ciwr$Tf>W)!) zR*gUmmlY7WN18N0`fV0GPGJC@Je?Jz5T>HQS~L8M=)9n4O*JUb0!AmEQ&dpRk^KVt zg5zX#s;2AVaIfwidYx29+fdA)o$KUn0TzH>-}TN>u1a@`r^fw|K9=cNHJIQ?J2*As zotfkfv=M>r&tRr$EeZ!a8<2D(W&h~ndKf3{N*z%|9f>W4iifX7Co)y<2mH18JD{yK z6Mgq7Zv4zod~d{d*_r)2*W!k3xv!Jc!&9m1o@7-XwMkV|`d`Of4))v5+S-T0n@A~^P%F=Y%H!P$c z8`2L9&aUV@Jh^~y>WHJu{1N(is>+9z5*S&wDWUVe>7kci+8&$x(B*;37q9mFwilSk zK^2{Uc^CSh_QhxJfE8#O9j}A7j7PbwT0RNsTWzgys4K17%?*pbn5Pdt0C8>AuTR!k zTHrl%v5UAxr@l$}nPkFP{;!OYf=vtv)B}2xD~QibYoF}Q4t>$A)|q7Li+c=k9Pqbh z$7`=00I`q&;$lYLj5UFCn45ZK(ootHmfkDu={V(UOB4;N8@PTQDsh<6)Ma&RGb0MP ztm9Fu9Gzt;GrF0fevs3j8%YlOULsTqLhDR0=Ln-N&t4=in8NRnLFMfkxxd)-@(c9R z1Lw}~cFQh@DddUh&znv&R}|)i?4zH-rkv&bUi`A1SOd-AKB2 zXwz~dqt0IBC#u@E->!%I(?RQ)z z>L)9i^^uJwUE<*2oe;eT&TD*+juMmA%gNcR&muUPA2oTcw&y}B#*|jl)(Fe%XrD-* zJbIt1M#Wv4NOTIP59NA4aHs-aCqQnDa>YU&&Xl;t$q)IAJB*%N&;MPT=9*F+C=!M4@#hxq8e@sBV=F}YuC!8 z(Z$AKFrSAM8`&r&%)u{Y%}siwsYNYL1;I-(N{(*PW%lYH$4s7)Sn?L>m!%-6RNjR!?zPCVLRS zTj)T&ouk30dW4?8s<&Y5I0N^ZvYRT6hZ+7g)$$vBDS4CThO|TsEwP^=rsQp4_62Ov zS%$bG0WauE(**p)_h{`GWV|Z^#N$*(q#n<-b^BT|)_WodMM?RULN(e`evXM6k;@JR zTI)A!7SBaa-ZS6OdYD62FUMA8@ea^(P+j3_eW`K@f~T=sKb3MWE7PU%nz(=5Yj`fyNA^cOUer8m&wqgD4RsSYz*2LY$>HP%QaJffKn_A zA@YOz0?Td8GmihA+{f3su{(SJ7p;KL)AHwOPo>ZQ(?1$u!t@~LdnpFQvy+tHC-v?y4G2AKB{%Ao(F zJJYFVb8LZ*?b;m|#isklIhM!1Ya#GAU+|5;|9l&?diu9J$!uJ)CnEIqSVNX=AwNYz zb~$*gMr!=iW>@p7#QdW{rDR<6_t=K|hz)qYMnUZUM$n8P>x-)cd$Q#a?Q6}lKa))S z?wik@8Va~c6%R^i3)7YXZ(LbJ|HD*8NXELd?k!(tjwF~rwP1+MYGr?{94K_u$xRzW zw9{~TPPo5W?U^og&`KD20O?V_)XvD%C-SQhbD!?!O7S8jrXFBT>VUkhy5Uy4lfHSq zX4CW>lx0xzvz0b=oR}X8io3J=@0WVJDXr4(Tgl3*W$)0_RqbbH#}~(-57xBNuHSM3 zJ=-6TWMFEo{1tW2>uEQFZO(7{*20r>HoMK;w*=!GGnk+WE<~BvtE{PBCdAFRFO-o~ zC5eqRoIA+T*;8Qp2Bs7YV8S3E^8z(kcxXG8?UtiD^)h*(MW$M=IpTmmLJ$AGuK8i2 zz$KXeoFA`#C2U~WR#@tss4`)z3czYrd&{~l$;tuWJg;BmZQtdUj;Lh+y>UaMQUHC1uJk4Dc7h=UmkN}qaY+R@$*v5^ z20sQ*c5%r616W3m&o`J`fexS4~x?kaX#BQ5VrXC>A{ z%+`4w2}TJ9K3CXPf^Z*QQ+1=x$`OV9NMT~G@pM1ztAC%xQ1TcU70g%Yt-NqK_zKue zpD{TO$y7a;4}nLcd8Wtf7h`$~U`*!!$*!5D?06i~oatwpw3j~S-wP9XIfO~^J6o47 z=m4k&q1?0)9}&lZ#-tqlUSYKgkITw0(XR?UHz6pmct|Def|%Q|AKAO)OnL39fiO9| z;=7!9&Sqx)z7qGAYy2R&nrN4D!2(RV&Abn9wPwA-*wJ)j62F~aW<^`wev+OM7IBAU zF4YwOcN( zHUY{Obb+u>{BD*X~^+Z8}B9d2JwRGd85|}X2*&jM-*qkk+ z@o#6It|8k26taz6U_(x7*_YV5%8WHs7z&6w_#llgjAWLUDD_PL~6zAA0?Q z%4lQkQPoInl}TUSKLg@%2*Dao<^xgG=d@`tMWt~TgbY-t?RosRapyDX?lj6J(j=2t zjHVyte-hTi861ofsv2gC1P*Z_SKjH8UuEW}BI(1g&or{P zESlZK^&VZLJ*rZXw}Cu*9nt53%D|(D^gENipIc2Hl^!ZuoW3JB_-Xf$Xac}s0?dDx29|G~qL)q6_wi$i;+pEIGwHQmM#lJ;M8Mq)}oq4)ki7!r+~ zN;h7a4Qvsb^m3$gPR&258&wS|JS~|x*W)5oDSalv`NcExGo25k!@L%W1=%5$6WOPV zl&C7)*R-Viwd?@!9@7#)7(i_w3g!8Q_6UN2yX!Pw)%#XDJ97?6ln>sKcL*0U&1pDH zZ65{`#9XG|Fi6W@d2dK)y|cM|)ji2J``{neiFnA^hj&!+n7386a=eJMVS-9X-w+#` z`ZyKCBZFcTrh}sRtKqV!g^9SA-7!+SmhFE`yURXj=$DNI3l)G4Ib zF3gL{{QAqrfc7xU^^%$ZB^w*~O&c90pk@yxxb$}#OS@Z;8=n$CR_y(Xo2-E+M%98{ zqzeC*ZY3C2=6rZ{daKxSxz5jrt#v*8r9ZFx=>4N;$dLJLCeq5@J9EAjRm7exQg;yj zIj1ZNaFBx7@crWRDF+s4=XW~txknN{(-SO|Cj@9ZCfB088znO`*myzRnaYf&c-#McJJAO>RA2G-qI;G%|C}@b2DxZ>P?%d%-8ih(zst<#+-5XY&`j?tl6<(aKHQVs?;NV+U54Fvh73_UopvS#^ z`g?co7roX)Sn4@Ce)VCL&BpgLt2=}*A8dK@9=d#MzU$kKNpk8c3FdWq;XC@iZZ5Pg z?BgACr*F{&N?py-0ZE!fg7EH(1i; z2m0XZjzCTOsSl`rBDo4#yZ>)Tn><9@l>_|SeCKw>_|e7fCyO^rb>|(9XMojvj7=T1 z8W&Zk5hZG2ezv9e)Dm^6N1{7M%hZ1B_B`l?ES>tU=ulUf`U-x`I?)04TzVxC(b?s? zchWYBn)og5F(ph|C=c-+}_XXBt+w-?vcloC|ohmQ*I;TCQKkV2?8Sou=dyDuyXwDKSu>XL$G ztu_0~cD(aV9&doX<3y2%J^VO5{14{h$9+bw06qgG1-6ZSLq_f0NZ~(LWu)%M87j~& zt^Sn)dIMUN72aa?P792lNni=xGRiY=i7a*wDd?9$YW4_?h~SY>Vx*9vQ@VfUjb#q+ z(apT)kafP19{n`h%&!l~!W}%c!Uy~Px7y>R4(sly?MnIvgz(!N%rAwsh#G7EL4Xab z$$w#*wuDO0w1!(b(fp~Pu%rd}kie(oze2>YAnYdAuRQSMEf=hLVo~{X%P#_P6^tMB zcIKpxjXghVapsiz{_c^ulKG}lM%%WY?`;DQiniq%Z7cZCvTIQ0yZ2AG_i+VR@=X~1 zqN$cI=Qp{?_kR)R?F-AQ&K#8x7TN9&jr&)KAnkQ%n01o8_m`{M@muUDQ`;hvmF;h9 z)SCaue#tV=K(7Bx2vJ0@jkVMA(o#z_!Id?Poz!l1K)9$9u`XAQKLYJt)e8ukT$DByG1`cXpWX!_&fgYk?mUcRkCT$f##om?hz!*LvxF8b9;xCk9mHr zjY&e%%$rC_yHF{;;4p)6|MS(wi(;*3LY8*lbE+$e5?7KNRzuQ-%CoO-@%a7qaxC|m zp3y89)n%#W_{s*w2iuwHy+6RIijfC^wX)<&pj4>q_&-V>b%S|`z6aNO`l4N2Q}@5N zWSUpJP_SolmAtXf)X@EPXBOx04#k=Ttkm}DPlx}s@PWI>28@xz`VC^_XtNHhd1^z? zls&T9Ns7^V?JxgEd6|fXu4^wd32Vx~m0$1)Uau>)MsuQReL7rDW&ZhVF)b(-f~GvW zN_oE@MgKYJzSW?j#VkSj_k#gHQ8K=51IF~P05nQ{MOIP;OeyTwd=B~R_!|dh1Y_94 z^)ullzMp%-MSRo5dCBt?-e>q@3Ita5qc*yLqXOFy?Z>~QC{~T^YvoFAfJ)=F@;^Yj z?-m>+VeHPN45eGi&jsvX;GUr6mqxNqIn-p>qrK+re)zG02-1e!SNho8Gi?>TM`7NH zZ6M2|@Aq7B#5>!H?PbezFIkTM(OhzA^7#JFjIrimu<}MIl29DE_z^I`>-q&_XZ_1s zy2KTc3s`b7{URR)-74{;lVGl5n}s*Qj23dLT<*yDeK*0hTd9y7{0!DW`htQ@OiK5gn7ErlI>nUeYqiSTjY+ zhIie&wsAp3gR#a88RT zJ$&#&g`Bc@Gz_a5L9CU_&bMUs)8wP74=`x=Fe#kmKQs^|rUK5$E%Zr8IWjuHq$_(v zS|bXN!IY0YVi{+1CMiXPZgYz;(Du2Iu63(p;o0j`d78{(EtFD!p0xB4Pi@&I=_$H` z()QD{Lz2ACpH=FOCjxL^dRGO!g75X23Wh~oZ~FS2l$*A$*p)dfn$=7; z4fXoEg#0SzSV(D@yW2PQUV~^OmWpCV7q!+_L%5fNsLZ0ruzx!*{n4)nw+a#E*opX5 zSSqA`zDNEccS#bi;o4T<+ydY~W#8{`r&HcUrA&d_99ui4vpgB#F(f>#?o;@WWYc`5 zl)rtyxBr^9E5g;6FMdhedx{lJj2YJ{V_&zKDfX5)F6N^ z9&?`DeVbd7vY!WSS)rUfWcCr0W@j!Z2F7V@8a!zz^NmM-?GrftF_UTjk_Hy22R58} zQJSevwHdqbU*h%c2&mbS_&VQ-3cD>z0bVQsi#hg#lAYO<$O8J?zfA`Xiov8_M15u zt?uQf@-9!O$zTXEZXA_!{Qmvs69TyoOY1es!cPpHToXnNu^q60(~e{eQOQY3!Vf?l z%z=4mzqOQG@+2`W>@r48P!N$^S-e{v%3P^;i|;CuH9vtkd4(bA-R-#$A) z&(Tk7>mwNznBg3Occ`e^&pQi6#7L{VdJM#Q{<@=o>?WGh*h3k+{^lsF1|o_Zrm_u*bJ>IkqoDvNg1~yfSJV z1rs%-5Q42Ls=~|h02#mnPY8$$G|qJ-bE>+XCkn3uX&D?{WOUQjtNFa|osQpIF9wxF=QbZx-F;kjQ`@ z#m9|<1rzJJRLaf{zBx_jMETrdTtisYH6A4?A2MOH$2c9Ban3s*>biEIm6*W`u0BiZ zckf946>EjX=U7Rj{294xlw%3I%K4>M%0HOTIsF$uVLt2OwjMx#x8~)RQ8Y?UFXp$` zNs4&pT7He#5B6jpZX&K7Up^ywu~A39q&C_#4xaq=G=27azR|{ueA1-1*y7~6`UGC0 z$u~J;o?fA0DwbBK9G+s-!=_N6w*43-={TM1epLw;X`)wRaa``hGFc>i<0-G@#FzE?2r8n1v##1_yINtt6dMxKA_sgrZKj-ekL>0C zSdXD69*;}YO4+J@UZU|$bKPn0OS-;eOt=iJ20E>_G*g1)mHNQQWR|PMz5ASpZO3D5 z+$2eB7bz7l0-WEiH$1%=njvFgXGk|w_w6x6BSr?rZ_kYFmo{pj?D9T|5m#Ym3;Ay->(jaT|f|N)$5YM9LgM$+nQ`e&m?I#VwCc4`isfV^ZTUVux!dpXv zn*Y`QMk#pUSblzaQj zsN?jzuKiu|=Xk@^aI9AZ^~=B9STiR@dQIx)5URGz-(aj?i}F#T=bwr9;D!C`>`OVv zy6-SL&0H(4+#_+#x2)z*eqHU|w5jrtCD3RuDQ#H~3?^R^1tZ8&j|THbw9p=&U$Ty5 zl^Peyy$6WiwszP9_LNEa>RD?Nxm4w}1iHdn`=_6D)zgT?cnoNtWrJKClL&|$DUT z4*$NM`44RULoEg=eyesr5Gyi4-wpzR~0~uWZC5; z*QJ@*ck_3t@32IjRua6n4+)nGbg=qOU{8Lgq~ILQPdSjt4tY$S4f6b0uJd8y$U5Sq zcOvuoI;9??CYS=pCU;TX|iZt20!Hr9is`inhjaWq-y?pmw zxn)Ij7#1aYb`>M95J6H@kK;lr>(}JAzEmRBH-_^&RQI%^f;*CXXnlk~63&Cssh>0Q zXEH1YK-iFJV6gm)5z^J((Vy~)k4l%*F%iM0;u~f8JaC`t1I2UuIk6BHbKu4Dka*el zU74nSN>F<`5Kh|y`Nsev@K9HdOBci8!gNrSgK8jRAU2h1cSs$B!Cnxy@BdMhYC_- z#4jvsUH!Q^m;71j#gujSFG6q3*IHpi%t{9+Mne}dzpqf3?~_*>&PlK3QfBMk{9IMI zbukA?9~evwmsuo+9AcQ+fBj%CXF;DO{CgjGds^N2EZHI`eaZRWrUlH4+uLY5kkt!* zt?1mH9p}^ag&gz>r8J>@xTF~nalQV|rj}+<+jxI%Tld?@SX>J;jF9}PI(uCCkb1hK zd9AzQ6EhNgHxp%dvE~&%NYs0N^G_d*LH64YQU|o56wnbM!0DKJt!L+yv;$5B28JLk zBw8kRF#z^y1Js+^h&McrWO)&f+IxwY&=fnSfQd5D>+Kancyi8s0bbB`IrGi{ouzC0 zUo+t&%W$7eat-K}IfqUzh0W{y%q>&F|LDAhXHjE0S&F+EJ1dW#5?S#(+l>RR9X(g(u+ zA4TUL&t(7q@uX6zR=Eo~-$ErV#LQtMmE^F>9deo)A*Y-T8xoT9p^(E!QD4V7%y|mU zd5#%#j4`J=v6>8d|--bXi!=P3*K-mExYZRFZ49Y`pV zI0Ap90jR`yZ>k#1KRF@k(6m`|yx&Uhxiz9Yq#8I|1<3~NO>gWUv%}BATi6#fIMJFX z=Lm`Sw8!+%K}SvKA@leno%{&I^nPKJrYL_<62wL3bpe!3JjEW(vKllXeE#BelkF@m zD8rvN7`3g-n`lO99+f~HaW}?!d!+Pam^(L;SAwpA;`^l;=4myNYw$?6;?xg$r3rSi zrd7eahGCmB!+t*G`f3`6pquj%#s_s&SW%l9JPl6Yl27Zh$x}R#Q)VR>m7wLXhNcW! z5XLOWJ?#km=A{EXo^su{1jA(kYps?awQW~Pnoe_&4~}a6lb4n}TL(2YTB^KGASK`2 z^mMYwi5baS%p{f za5;&0m>H`8inunSbQjfmRe1$MXwOSQn);`-H)}SlF=y2Cwb5d!rMSO!tRIaZt|vDL zRVcHTn<~+UKTuW}?COY!Y;N3v8sH|RYf`S0lrEL=k`K&0VMe!-U%vSsO8X2ee}U7={?TzMxbrGaH%H-+E^j?$iiA1qV21;w zq-EvAgWU=MCLI4(hpPOX2lSnI;K}oiBao*S&6FRhX#p2Kn&ss5f^b@O>q;}+a=w7pA?Opg#d#Z=tiqLL#?l_d+8}qun^ip`0pP6KJ z{JkEDUt^J)?$o%_jxdo)_@0V9%BWbU?rl(fHCTq~?=AEc=U%c#3F*%6x=^xan&Gf8 zz7jwO0uv>ec)&*8D@wyZZ~JS0P$E=(>m+He!r^fpLMo8is&ZJENg15=Ct+rPY6is% z3#JP=CR4-bEJi6+NdjD)@C)q@7Ec%#=E-x2T61k;J zkjg7Bap!q=hs#ddTIHdvxK@qtv>hhJaGNDB7Ekt1GEP0sMf#{qI{s}eL{n2Yje0u= zJ_n@mqC!xIDT9ly_qB0^Gn+D^jlsul9dr6^!s>PJ!r8I{+Y}8ZS1;bB6cmCyuf7!t z(3J{q4NR(fwU<_O){#%Wa}Zw|atg}i^RJFk+FP>pp{-__4?!yY&ix#g(w_fxB!s2{ z!#4+vwB>qDSb-L8(z&u1))fPxVQ>M)!O`F&VuTZatq(YT~g8& z^7$Q=oV&765oeSg&L;6~Y8RG%3<)dIWb=)KLXq^y?XYa!o~wo6K!WsIIi*o8AP9Z-Kp*62k_pAANaTagIuXt}Qmg>VSgDn%@rlp)( z-tMm5sh;y=;X<|A3r9E-@leb~k;BUqTN|QZg)@^;Vcd7w@GcuY@{-6ARE$p?y)<3Z z!0URJCQyig*;;$qD7U^d$QFWKg@cjcPw5X2?m+VwEPJXNV*W^mZBQ?DiU{=?c-EFD z>1>Mz3X*~Tg?kg|en)s#m!~mnonnzOw{dyJuj{hCKuS8bYA3&0!UX?QYHzFq!dz@| z{B;c_5iE1pRch#am_iD``OXsSYQl;|mDeH2&MfDkcliTaf7PVU^d`ci97fo0#R_DU+yVcYdod7StmWEF=O^ z_K}Uw(j1$AK-}>bxDB%MY}YU_?jF9OD4tdO`0`T_%cZ~m(o+wE+E#Ikt4TeVDcVb) z{d41rf{aI!YUvofKemu~%=am*8p5G;Ufwp0(f0Q)L+#el99^M)6t&OLW%*g5DpW^z zQRpvmZC5!4#LyX5ZM?E*lMru`8xr`mm6cX=Nh1Ar$24i~8ir?yyJ2wV>B>+v#Rzta zKAo&0q=Nr=MpxeFXeOtcsD%Nit1Ike)3tKm;h)-}NVl)cY;=++ZT(J3AvD8fpJ!F4 zTzCfCM0b(z~T5*5GG8+PhnF*HZvH2V@y zhj)OZ`AzcvfEU9}N4yGPYv)m?kd9bKsC)3ftKAM`gP~fgY!7lh3XlkNX%on_iAM0I z%k$)%&yNACN8-}ivjSQxqN-_Xt$1Lxew>UWHq~`)H`*rHUXnl*`B$DA50jLZ>Z+&c zbzd;zN75Xn21tb=w5z|2bn<|XovD*93opc+p`>^)YC$_>r3mJJ8;4)_WS7*;Oog#5 zUD9KEzMmg#CY;d;BgFV191kt6i&9IAsD(87oDN!?y53c;OM-guq-IM+OIz2UCG zWBL8;NMzW~aUjBS@cGx0gR=H4FLn8eyUm6z9WNaL=rXC!X6bMbJ@WDEGd@mvkTm7+ z>a$NjWi0%t8rJ!s+`NF3JXrJAD3i7J`3~CD=>(H-OCi73RR-xdW#is?|Q(A z^?+pM+a&F9)2IBonoFQ>rB%*3JH_Oy{(|$=!wuh(54%@d5?yEks~d!F6UG(Hg#E@FAsJ8J08c{O zb0p9V_O=5*#~&u-oA(xeR{!Q*E>VUL^U$!>S1z+kHEbAzKTcjQOn)A#i+IsUw z>4a;OL^EVKs5H=|eCtl$me&7@cF~2|f26QGKQB zHWCe2O%_3P1idiI0Qnb=NgpuY9-{fcs}T~UVa?Tu%Mjqz$5L>-UP3+BSVrMwV-kv- z&i7LF!F4^idh_$zNx|8pR&|GI;pz5g-*v#s6qUa_P1OJ_g-LzQJY@6kohA0avFGqu zflMhBQw%ld(-(&QhFa5IH`^YBDCyem$0_|12UE3CuBVsbZw=h5`!mS(lB3G*DT&y@ zyCcWCLll-2XcFNfWh++)R4w}b)^)n(iNX<^r!4im)L!=M>i9#wfO@%z_ddr|vY{oS zKhw9~tP_1M?)*Q#7_AXKBEcJX=Kr_W^^^RUmS|wbq>0e42Jq;FY`=7$Q4JFsSelr6IW$auWYYg=9={O@B_o< zY-`)cIE?I9Jj%@(Zi9`rTLo2s7UZSgrmMt{7|vQx--;>lBVLx6|0WxNay>1vhLM3*1E7IEJ=*+!|Eo%^7vp1H)A|HK>89 zZCO(1LBb-u!!I!)Cu=Sqjg;rt&_A3cQpP^QYJ2c zZ>f|uZ%Box3?%oRGINt=3B}z{5r}hgCFQeFOi7HP6-tUEpcwd`4uJhPiY?6<+V6+Zu#s% zDlwfIS>_su78*sQoAKYP=(N9Mn;OnpIA*>gR-dE& zFHyp6;38D1USlTcJocz#S2~$odoHsGslTL0SklZZ00hR>^aau1WTG#s)W2F+erVk( zQm({w$ut;cCh`KSlvmL?AFGfWnAIgnO#o2JkXyp z@MH!Vp1`g*C7{ zY8!qtWC8piq=66#-HoQc98FM0g*fTFk1;=A8{!+d+$P-GtH^Nofyu#_-mM)}G?9Va{zg^0@=r^`BF%%ZJJSwc@+XpV>9%Q|oPIG(+?dYe#4dbu-h z_7?eLP}^5kxPz{3E^qyXVe!V)n(dOa$iPniw6jY;iXhf0*s;m1hhHJ~JPhEwrUd_7 z^L<=F?`bktvKxl#;4SPncF`L%^MW5TE-oD{yZ{P+c<>0&ZF2og?&U1<(Ks!2_fwos zN12q+6Qv5?+P{Y~<{oyFOJ7d>F3IVTp1&|`siBa#7pJ_C($e~9_vDhL7NZfvY!aPC z|EKO3hFpLcYjrl1%lYv*JTcW(`s6k=A#+4GSLo4tt;Ex5tR_>Ub|zPteDQ~V7S;>F zPmhXe?-8Bc)RzQ%+MWNf3hi8zLjt%oxm_CqjJ4E z1u^jhFa*F=J1K(ukp-xui#n1rj6!hI_Bdu%`zz$J0(BvLZRSIDGS*2^MBi3R8aUq~ zK<*dibbsJ6dK=$zqPfy}(|>HrJ6H8DD)KgWLa81?(j?oa>&42phU69kA2r3>$Bj$?wc*tib$Ixi)0QHna_tDJHmOxHI z>OFGJj5e`YwBsK6tK-cfI1`&mGADG3z~kVDG3BE!2wX zOwEJKVsU!ZXr1{XVU_kMrOu7uB)koLB}R(Z#|b;)-+Ol86>;xwV$GJEV5fNeRFgFO zi0v8=vP9u4)pmUc4`D(Efau<={bNXovYoZVJ4UO5f28v5=uk$yzNODDzFrKfgrHFP zt;589bfN5r5=Wq?Zo@F6_#}b%QySzG?rb#+tFW`aQ^1j&PikS*2I+bB?G177xF15= zRt{UyQo91HC;A~iqq-9F(FP%e?-HXqaORsC{)L)I2}8T?fq*lVtO5kXB{Kq}`FI_9 zZTBRK*Zk4WZyM2^RzpaNX=S83^U`g2Z_|cL5)tkbzHXB%Cisb0M$pJP4bArE&I0# zx#|lsBc4+aIJM?bjE{unDFGT}f+jQ2Us?l+e>#E_dk+ z-qKogXq<(? z?}nJkI#d@ejI8*0uDx;U`iIctPCHutlSUH!-stt5e4H#8FuC!C@zDt4oW+AB22FL3 zO@6-k|5cfvqFFi^4+D!!X-`sW5-t{B~#mGNlMrl(w^x0p#6%8NTrmc^&Cn7+i zM=B?;{*{*o71VF7_XQkQCL%qp-fM%8dRA;%+~FQ$h;|?q6EB@mKj$uLP;bH>-J|PX>j%aslfG2q8|D83EaToiCMO=&Pfs3 zJQ{aE75$Jy&YJbg!3{Fl4L*?->FQX$xc1cuv%?xb08D0a(&wo4*kZT>ev>a`?DPwM zYsmNCK+VqJ=7ik#G40K0Pbmu96}7X)$Lrt~Q0v z7d3Z`?cbNGTpWpPsNeYhWA$F23_A(zuTv2%L6Y#DT5`(nye=3j;A`voo_BDP!Bs0% z7~V=^9>*dCLKo-8EV~L^oo{tp!d4$(tW?aQ3&+?JK;3gg=A&N6>AM=8b<(~xt*G~X zYM#cc?El`lCwO0#oO|mX8l3G@HY*Ha1w7@h${k7wb?9uD0o0r;7T3QuVUjq*Y9B3y z-7km*wQOs(Y`=m1RmHG+vv!4NyQp^j9SO{?`*o1k{ba8r+$#~mipk2R_asNjO;cK< z(#Z8l;Towcz@81A7yD%t?^t5-yX8rLpmE3TK;w9smr*ITZO`j@AeOPx!Bs}E+Fz%C zF&4;PExQ~6yLq+s$UpUemzqNF99AZG5MwnzaYIl=t(vsgzb7*{RAAwtL#0@05zxPp zyD#m0?-u`@Rh0GC?qf6woBs@)JkwoV^?_fyjcdviPvP8uiDHz1l>m7Zvf5C0<~*E2 ziCC+}6hDL->Ou)}Eq}S^z!(TI&o6SHQlB`I&j@pE8HeS~Pa9=7SB&))LoYDDU236P z)EGi^sb@xvW|(qG%z@-1KGPv#9r4FJzk2ik66>tql<{rKj0AX2zcDk1m&AbNnl9)S zyDu&)Mti#DZ+?5{R<2ukrD9Ii*zZ3+38^sSQ;X{t zhVSWs@>z=Yr(8$}_b5(+{w&{iF>ua7sf1TH`X)YNxg`&g z9xXwZJ;AY$xyO2KS2tFsb4UEvsQmjO_K_w8yI3|o4DeUF3`nE;l`tzmg+c7s)V{w1 z&i@Vi@3~u$gpo1X2q{I(r?zRje+4*bL>*^$>W=XUtvsRvl=CS)t5lHAHvgopa(Qia zMuZ2*o5iqsde3Y7_V$pMQZGwF zbS`h+hlh^kp|cI>oa;fE26uy(Tn&ycO2<9RS`keQ(iPQ%ZX5lCA=iFZJp)`zSFhx4 zL6JfV?`-!vGhmB`Qjm9XEJje{Vy_?t3$v9Yu+5_~#?q5q^#xTfGhE_93(uW8cCb{Z zQ^m$FKs$&!Ut!HdzS218KuCjnggk-E8aM9wJm0gC` z)q!QN*7{3QJCjNkrUWX_;+`3y5+zZcPpb;j0wZ{aj=Tl`jJe6>+?wFy?F04Vtjxu~ z^$(bdud!LH8RAY&kv*BP=N^srceTsOGy z{y#k$<{vM%Gi@d>0|0Zn$K*eQx=P+S1mErUQ{wIDciT(-|7aDsCKUS&ztdLlx38@K z;6+DOpIiERW_~g~CWiDd^Amiz4fg0Z4rkc?L%)~M$34AriXn%sOy-UZ29R&d&t`8| zFaCRq?IPejv$|D1pMBshsm-;%484|_=QqrZ&hK_<2QNI8yk?+vJP*KnIOa#_{ieW~d18EPm>eZdimou^rG%x)5=-d0cfdmGzcT;DFN!b&R^ zikSP4XnlrpVm?k^7+KZ17QPmnP(VHIJ;n?)xlMYPVBCS+rW%b3S_X{&DusB1LAj^gZ(CK45~&$M)Suue`)w$asc$0esY ziQ!|88Vc8`)UUY8#HNwQQm;Er)? zq0yN!X?fRKk-TV$wYwu?Vn44at3w=IL=l2nkjKQDpCFa)V*WV5K!9oYo*cpjGBRLF z_zZcfK>N4+Onp9o|9se|EAj=B^sL|f} zcbB0{7ldXmZHKpbT@h%vo7-DYzg2zwJ>P9pOj7V*2%r0CB$)DD_8pK>atWm?CFx*- zrD98Iaa|B4unSKDVg-ATbadnM!O@2y_HiZ-OA~ir4!yYfO&js@1Yub_WVE&BDGBl} z)YlS@p6aL}A})MQV9M;2rXm-v48smx6lu2~TwdAl7ROPr%&`jp`ZB{Kw%7J2u0Sir zRV6{y>!{aB%wxGKt8rig!fi_`5(LRNml#@Aptg-)nq=)3D1 zaXidtm^HGLzw61iV0xJp^j`B^p*jMYWl`=nSEki3A;29Llq-legYspR5 zp^GWdagB%qvRuNNSldTS`lMF;aKgULcAC-A&O0#i`0$`*qu0C}T%tVHuG=9r<+#uW zR-+OL!0c9TiD=o**h%rVl>1fAC|^_L#eV76hyCT(98?G&b&$)#x2MNXTpy+<1mhE@ z3bc8pP<6`i4Z$Etvd?hHmsM;^x+f&{CW3}luLq{lR*ebgAL4zcgb&Mwx9BdC=>u@~vRkr4zwLh+3)-?VH8%#yT-G$)`k2B)a*@8~LaxkS2M<7r#k3>dg8B z`LAD0{QSd-T+I8(QQnmN&HN(n@Jl2Fw4VWjB;hU!m1BpRg}=wHZdWEe+wD@~%&Xby z)H#)}PmCA^Wxjz81(j$sAbp6Za9g2%!vwMG9FeaQhBL^7MuE<(kW$9E>k3o+Y}_ka&e#gl zi~)CD`S7Xj6T+b{%d%6ad^u(?gHPos%I&#h+92FzE$dVXSUw7^KWzzCrP*)W!$&tu@idGe~A1p;n&-2Pox3F&NKUtch@lT z@9ghTH5&koA5y!IyIT>r^w0!nMUjGyo}0vi0#x7+Kz19jVKiz~So5mGh``9NjS`Ac zkI2ii7kxHDoKve=Z={aUtbYIa59WYq=Kr%i#(5CXTqpQmBz$iZ=#o*S-f1219*Yy1H#jedHEciK-!R@?%lc;-=SzCGlx#sVkyG1HoNkxL7MKqtK)6Wrs-A6wpf|LYiRy7P+vdXe3&B<+e1 z9jtpR-6QrR;IxiftaZ{7p6@}W3+-`SYGvx7Hb%U7-nZ>s+yUB(B z;aS1JS~$$uLN>kA>x^}6nM5V?{^~@lf;tgAeeZ9S0O;;j&m`$+)9#fXEax4+X zVY@baS*l->{PlGJ|ry9}#amW+7smFh!oxa4Bc z84*|hVoi5EPLOvt!}@@?+m)@H~(p3WUi#4 zeTAMf0X^R(Eo2Zr3U8c{Ba`rK;FUFU}UThRK5_W zh&+X;1#*qM`gIqlYS;Ttc#obPfT5Ctn16b#1R3`etZ|4F2F!${hT7Q@;QS*br<#!L zJ@hWOf2*C}tc37f$PnuNR^r}GKJ7~`S6McqK>kQ+Grb^nZ)dmO5CwdhW|H(P zBd+~BEmww*_OD)iY$t^aYd+&;vchlN745U++E!PQ-0`;K1wqe4JCMS6HHgw1;X$o8Yr48KeH3K-* z7)jZY1SG+FWglmfs{wp&X8KkGTN+VE)Juw)Nq)AQ?j|yX^H{^qtSp|M2p5xTc?4I% zk8}$@^Kk5bv_{1@?V1Y7>h|z5@Ib4+0d#Dr3_q*t*}Pc*^ojO_jI=j7htqWrfkCv&d@HXa2xM9hL z^A(9_wkVK_PuZ)PPNrI9o;Jv3Lj8^8K=gp$&8G&}fNKin*w0yRu*V*9(BJlJNq&{K z;q}!YD|PU~0QIDygv)zi$ zrNTguEte7(SQax2R3puC-#uxu@at-px{BlgGZVu^{p+_@6mLBM(Pdl8>~B!~>z5TED?Zx* z%7@T)kcCrKJa(EUrOr?OJO4Mgl}DXBR~DM)dzGzSEE1#BwTARGKbFh<{B3aMVdiM2 z_}h=@9c}{UOzach|dUlwPwJ!2#22eNRh^Dbt0d3#-U%)3R{>wi41)it>#jwNh z2!>Q_b&Ec`M|%W>lMQ-Q4Sf0OSV;dL#fzzBc^fv}cajjHydro15teMufw4}jXja~8 zzG-cIS`JZGnj`J*4@FA5zfVJycN=A1dMbSM2MIl9b{F}pF7e|r#PtqBQ|k?jQ_=-C zn2F@Bx>=K8HQIP?I9kY^db#necc+z$;(k`qF?kFThJ_zjzxpD(Pkw4_VlW~aD5B&QX5_AtKT zCTb6)`_**8R&FZPCgm{$l7Ls!!=E)j0J9+)>6n194CytVnP=r9qXFa{#X>p|W52+~NlNiGk5lqQf64^8B^ zGaa~f4}aeO>Rf@x=oE78OKOdSv1`J}z@SwWJ0QTes74k=nVHG~zFQL)*r@O@=Pi(0v{a3U`$51 zJ79ll4qoAZhdL?h@F$>IdYe}nA4;gK4jUcoj2vx}=JGj+OhoS(3ci549;uFza9^3R zyf-1VS^Z+F#5T91Ch;bl{m(M&FoqeMb4tk|Wc+PRde{s-VOZUA+)|I_5suZTbYz!q z+dD>#Lh>-|-M8q^2}vqWys(ZAuQ!umz$pvg9xptXL<(_#pDXYq_+F~^8&rV9%}g_% zz!>WaTu_*b5ugkgqGmJdW2_Famg8*}wL%NoORVC$XP(D-4-uxO>Zf!c14hsdW2Pqq zykL)aH$$iT9Bo$Jx)u;coLxieAQpXQv{T5t-M1>WcA5~-iDC4x181qKAN}&Tr}2R~ zQ~rDCDDkuw%IdnFPHMWh(u8-deK*6rv9s(Nc0M*&0b+QKe?d(S!6f;L=L2C=vaiSE z^a91d!WQl`Bk85{mhfd&KWU%iT^m^Ml~~>r#8|ic?a}x*FFc{F6W63P1Zsw}Q`<*i zqE@snA-Xi;+2|yZH;WUf9xVph;lj{~!wIPTCQSo```4W87SIqhP3(V$#y%-L{+=)G zr-QIVyu4@!Gd2C^gKbeWeog`nlRpv}M*{du138Ae)^~%?vW6$$**WFG2C3(h_De2k zQ=0WsKqTqI?ijE`^8AUj-aFU@6SYn;jqcUxtP9*54@t_1trI6gIwr?933;GcZOr#{ zblAK^nr%LHB6?}78p5>Lv2?(@l&=o>q##KDlJ5DI{Fr!bnrW!+c#m^LCpRy*(m+$9 z=UsI&F2Hgjg_Z!|eOe0WUHKY68Sr?b8~hMCQN?Qv_=V_7c9djLs*}AOdbWr*i?wg5 zctac`X>~hUSABkqeN+^wgvc6LypwKk*Nxq`&d;e9=yjSC@>v}3)SMC;xwr&UH2+xH!rv_rI@{PoxE~3p%A8+iE z$m-Uj7&azdQtaBUnN;t#fkEka9lgb!3E`%oc(MZXxAI+fyr6P{Ehu`bg_|A=*3n!@ zLUW$Fvm)qEoJcrieU+1I%L;0Qb98C@w4N6oj{nZ3m?bPGnff!pkV8f$ZPW}Ezn~cE zQw?6w3SC=T8}FNm;Z5{vR{2*tBm#Yx=#iBl1!lfmsekfA_^3Y_W38xNUd^6))9s(L zu}PUf1=?rCm()V-Z6-z)rW|5@Buw|SrhfReDT)cl89w7 zuY7Kq)1md7>=xH8NZGNB{8u@tYa{>xbUwT%M}HXJP!Ew=J^*H1-XgAj>fl=0z&-25?Xu$bALBWhN`z8Pyjtb4TbTx!`>b9BtbzSg8Q&7_VZ%$p(lcC z*TA^zu)o;|ym$1_xA}Z>ExxiJgmKsd{l|HJ7=M}8ZwS+%h4u}^5|@Nl#(7O1H2rX- z$727`j(eRpv-@SWZ!Cnwp4^N6X%T$5ZpFQ!exQ^-cWK*zaKQUAic8}DeP7`GxpXg` z{DXsoC@mZe^yr}cTQmn56cLmR)-g69AlUMLAJRp8GSPu^_I&ArwRVA=*4y#%xOpyO8dR|!Zw$7 zpOY-fBAov128S%?V?#{W#+Pg#)LRB9F+AGFYM$l7noEi7j9eSC5hkC#7$>$c!Mbgb z!^iz;QQs2)9j2I{rDb~kSe+Z47h(*FD0wtN9d2`*|m;oDcc3&ZejwnrDS57#^o7CjG|qxr@JRsPvL)3mxMK^*-a z{YB^!|FSw@Yj9aByIy?=sIIvh6m1QVhJuiqe<>Jxi1yYCzfZH=u(+8$RV*@$B{@*~ zS19{n`tM>WD!YE9_)oYkFm%5tf>;-fPX(ghDm07DNIl@v`49|d-n1sN8l|T&cS$Sj zq|~xgy{>FFI<|(pFWUlq&Xfxm7Jy`Jc5YH;7xaOeOveYv!9jr_ySUll=TAcB?X>

    !=|vy9rZowYA4B(@85BR>{U6jyWY_hJC(UAO+Lx)Pl?g z*FaF1AP1*&tY}KtW`S+!C3wyCgR}5HM^tHF5xUcEL1?sp*^||X;i_*q%COw~XJq!> z{I$0`gakXkjJ}|<9>7?BWdq&xs-{23WhGB93l|?`6iJzbazK$Ux!{XgjL~Y0~QED7&5gm(FA6z%IpRoI^ zVB|@XX*Tm;OeU_>no62Z-1qMbKOmQwYLLob{{PP!*E}E7M>C`fr6DjnrI@AECex;F z-dVJHb&&)5>pwb6m@f}9Ejf7Zvzrs#?}B0~=ui%XlC4v-^l>ZaQ%k7JJ5RhCTE6jw zo2Z(lzr!P=3NNaMHOZ5eL_+=_k=4Vsb# zrF3DWu)T*9JkD3kp|HwPG+e!ML2xUa)HKODjxNSdP86Wz&o^p=LJw9B*Q1j?zaOH0 zkaHdS;rrNI31BJO>f-U`X8_FBgxKv*M$Ycqj^mNU>7$6io*{-i}gW-1|%*#a`KCHk&12B zxh9}?Wvefs87Zq>?}4G~k4~PX{{XUZw**#`-1eOkTf2J)>DvhRTT+jM86EuFsg;Vb zu?&g>n}4MSM4)-G#)PQF{a*>(K}4H@gKgZ&r7C@H8bGAJkK!sMCTht606^{M^nx@6ue4(Emzw7Vz#pi6iJrV8q zWiPxu$#jgd@@qwDdMiNNZ~j^6>Prv-(AU3p&mY916LXtdwcrY!xo)3k*LVonN?~?D z6~F;T7d!k|KDQx~L*1OTzGhL~04gcTu8hA+QZ6ysE)vPNEQYUhSm%edu)M$2`V&Ee z-P`=d+XgbOIt0@C~_l>qaVS4nS~06;1V0D3LaF3!HazlZcYG3H05_o z7tzWeH4NR?mf5dT070G3t%g#=(IE%1Sggl(ypU&b1Uh-2-f{@Nt!o?ikI3}3`TM3_ zP`xeF_C$K@KNV7Le|M@XJ%44kX-&?xbcdr+2ZMXlWY0j0{+KEpZDFW(whJfjSw9^J za`OOLO@+CXDpzxLO zvUKt0_A!m0Fd%4PG5r?YZaR>UavTnP+2g}V&bo*Xs!xHZO`#9|QOI7cP&VBZ{*$_N zY&sRs=>Ms-t6FPq%X^$MtP|4%3U+dn5@AoI{>J$g2suf4?A@a}z1Y45K=`(mng&+7 zz*0mR)vMo>HJ>CXH0vLDP!Do20SEAL^d*MV{>K2drNPp3(w@DGm*~j5T<=rRN@7wA zWB*3fXJP{`s&7~5pMd3dHkyu^B754!?t#YVo|%T8Y3i9TF(|JDci8V!K;vv=WDr?2 zX7|}7bMKQ=Q`TDh53$G`OkidG-?Y%*%uA3hpOu@aqd^lKW|htqV=m_Kp8y6-Y-_jY zJO1|eHxKBUH!UQ=A1^0YcEIrs>2Z^Yb*BstA%4E)CzC(=z-aA#oGJ9FuG_-XHN0cLBo-MZsbArqj(}m3~jugPox* zc=m3n(6Df$?@IjV#~e3!!HNz?(W7P#+ec`^^GR&^{}+p7xQDXrXDrcz{!gye3YG5_ zt?h_@!o*7!u$vK_xsIFYYxz`%RcrT^QHB3^gOwMXwUCdNT`n=cuyeMgbUl3;Z7 z&3hOR4NevHICdkBG5@c+gZCYHw+Cs5ys^@7!B%5c@iki>*86)Mw}n>%F6Cg7l5icQXIs&-n|iXxpu79#sgQu1U14oDI7D07Kq0I z{_{-VhQ(&7KgbQ!@|L)X{Dj%OMWq?~ezEZc12@w4^Pg}_zqyt+d=iF^^WNM;BWWa; z?KF%1gK4`N-aCTbi)}m2Ef-Ax_I{V>;f3>5+tP}fXT!w}DW0Bo%WZvBtt{AMNzkDl z04Lm6u<;A1Rc|;c{SfeM%FXR4^+Bnd*F5StjJc3#8sgg2+{H%B1qYA*VyD^V+u-Fe z7T9UqC1095s7*Jte@;v4O)7>Z5!XGTf%#NrB%xBNb@>ZZ+=JhG(p zKk6w(5d5^0d)Go^P&nS^X9S*nG|TR!2t#DW38+;`#U$!Z3u)9qXHB`~IH~vV59_N1PTQ1%+Z&YaN{?^=*FZqjj_|N0M!QJ)M zaz19>{>mAHEzQGP*Tv;CTr01|!*eu7Vry<@`69jadlYOX(C?f_rSq07hjH3_**N#z zOmn)LHbeTrY+BKP!y@iZuj(*XqPRJog;&0CMfJG&xV!khh9|q|3%2u_7OuP#@lbXN zIhkWHf^q@-dd6)2?x*e^h zGuH}Oxd<$zi**lm_IJ!>dR(sb?#gRV2BGPR=NF=c&SNvGTfg;pBHd#Oc?@n`Zh~?T zC639!iRn`N+~08SZy>cb2=U?B#{5(sU{0^5(`#29suj&``1B_tFA*38DhLLgj_XnFi`+8>&*W=(wUfB z3t&3zR_!&mNZX+{xTJZZkUZjX_=AJH=(au>&fC|H{r3SSTH^5ksl|<w(+e z_g%5JCbTwV%Rtv1D&{@IwZ=4w&MB6}5PRg=_aAD9de$=j91L zF`A?#lLjKR)%D)rR3B1}MboHJS?WU@OaN!xthY?Tfyg|z|C>CyBW%65Dv(xc8Ku!35V*_3o zB*`5=WQ87J4$+6RVm_6`D{@vtFWhUBQs7d3(BH$+<9)Cu!fWt$Q1se|{Vw?dMGu5O z>-k8P7~St_WvOBbad&n{kOf(evhedG{tMYDJjjM@|H)J>tWpPAQK<3}fxqiyCQ>~D zzggURlL~^e*1F5B|5v1H+DE&W1P0(eb7tzN@U{Jx!A5^3YH=cl>tX9?3_W!K?wz+42qRW(w{4Z0Yn-Xvs{#HFHS7 z{ykU_=>Ir66R#xG_l-}hl@-%iT4~xc6E&txfy*Hs!3*MAm}LvNVm z3G2LO%m2}zv;IL;Q#vvt`@xltpmudwE?j#FNL&IkxBB7RMh^b1|9xXnZ3kX8d)BCd z56Pu1<$0tea<^?nnKOg|;{-&hZ%=&g$~9kb5=h$oOK+srIAO|j=(Qgf%%Rl*PEePy zx(srCmU10AGR(6J@uAz2CE8R!Xj^3LV4LHV&8`;@AWD715_XiIc{+yX{Z%* z*06!hJ5i3L@ov}9!LmqF#e7-o4Vx8~%GXnA=_{rfK6DIg{$LX@7CH;>YkvH2Ods+w zMlzHeEH0J7aN#3sv~NxGid5{nKYJ{3sinA2Te0Xl?=|zu3!SQ;Yqs;(U7Ei#bSgb%95n#Hx8c zPPer$S)EPq6R`Kwqk|2XqQgX{gUoG^sn{AHn=O;~{LhVHcP~6lQykRq2P|Pb-?@0X zKDDXMEUwA9u0D}D?7S!GJpe&clum`oyo85iXMmFd>seRIO(Ei?|J5b(3?IV?+8R$m z8fgNSOMZ+Rq`7tWg}ndrXomqwW6%Cplw!`myW~LJ=Uw04O^K`3clOz)Bqn8LxbcG# zOf{^}&gn16p#prQfXIC^S#-2gz zv88Y~)oyRao5Y=&*jC$Iv&03`6hHH`uw2(|lCK>}n!U#-sXK>r$-x)p<5y`Nd)=bC zP>b)zPLd{`&M`kVIz-LSZRq69Zc)Cj#J|Y(4y#4hKmKPhNCaHx98|l{{#RaLTI}F| z#v#4xwkil?^i9#-?q9E*-+oiLW-1+8E6ua}mDkML&bz3i9&HTYQ~wN#k5u(gRqCVP z_m6c_%In$V)06)6o66UO7F!;aHZhmT%uNVYE_yJ4zGLcB@imyc6W#?2?LVfRn*tJ_ zCMYKEPElUGAcwUwpv_s4F0yrGuCTLa>{rx!fnX+U{wl>K2BvvaDGTT*x9S}xMzyfD zud}rIq{QDen;waR0zQ_QyQ%%awrNLX*C=Bu;pcRU%k=<5dvXC1u*8lAbOr!?=>sEc z+O>8KgHRK_*r2BCD-ih6Dwh?4^#vAQ*g(#3L}Z+<=YU;{}M9{(a{q zYo>v1^z?D@IAx;qODBkuusISRpf7XL#oJ49?I(DN#Ik^RAW`T#$HeX8)ih0-NgjOe z9Fc$PdO51N)tJ^`HG9Z0KMv--7y!?|Ky4OBdJ6en!-;Eun%&cUC1&pOGMdFUxXac} ziJcRCACOnu3h)qmyq5t0xhE~$0)o`{@t}PV*PsxmdSsu0(g`HOBLGqNYN_+1R@~Rs z(peHP%YdX>+|8nR(#QK#90q~SPwrxKWB!0lmRiM!*c_=J0sKL%+goJu;}shk$bDnB z5UDZ4-OigYM``-NpeJ)5@R2UMOUZ5{BVSfEMT}T{49jhH{M&khbOv6A*yZW+<#ij1 z@-ks4#VI<2@BgF8MTd9vZMYZWp7~=7iBlwGu|g;Bumv9i$80_C6BLGXtnOTN<20EG z#JR>vW1hf|vq?*<8`C$9ict+7dzL4_2G{+il6GsqgU$=iXnisPx&(El`sD z3NCVEgyys#>7C+6_$!Mc>1n92Pu-4c?K3Hc|Jf{0{{rYIYl)bfrMZZR{!I5D34omb zl$n5|_yS2{>@J*}E$BbDqyPYAEPY4CDDg(t_?C)I=O_&ei>K|=`pmCKlJyVBMv8af zR-dwID`Z6|{%^<%(V$kWQi#R82Jk2R)u{483l7}j;vhrPXlkp0N1QtNC=vJ#h8uDX zgvjS=A>Ko-5O#(3urwyPCxkctaB%CV?npl3Q-C-X!&tZn+@{H^c%1Y;1R0{gZ2M{A=^?0cD|3{vx@+NGdBTOjBlUxM%C=Y?+>o3@+NIR_2u04!3FKzK8Al2i?lTSX5per+pYbRHIrMYxi zaB+{bsGH=~tEaxVt=w&9RaZ_px1=47rx?ivBu^N}Y^HfQ>uDYS)j*m8YkzkH+;VkA zc)~;{AQqP!)|f7Et+0+hv!POzkN<4fK5X{{5)xh!;rkj>gHCZ^+qJWoHwm0uA#=WY z{FK<7od_=v*8}G$2S=~n_6M+`E;^#oz{6zx5<$-akc~~WTfSY+GZa6A?#!%qmEFd^ z?sFTBpsfQt1B%~b@j^`a@=17D+X=y9p4DOW$F3X;r$O;{WkmC5HCP_7T7vbwi2I92 zybIMK6NXcSiDwxPo^^9tv^>`Pa3dX7KEmlAa}$v0Hq^7QNb1jc>qDKAvCmPx~q4c zVck&eBSrsd4hxR!`ed+!4rbRiK1RD%-(|i!NQzxLWs=H6U)?c~bq#fgX-b{gIfQna zuz#G(`h~Pq93B%Mkuj4NqK_zw9txfzVIF)-i4`JUmlq_7+~&QvD*D}*VW25xqaoo6 z28~l9uPa*8s&94Ze=2tH$pJqL@Wws(k($-5Soy6Gz{pLAPhU#63{!q-cHAKojsyjUZ@ER)J=<0@GG5he^i)<1;VaG z25TPahkxQO=JCX+#5c;W!7k!V<}C+(IVAxqI}Y}pLOsru2c4RP*8sn*6`2sl=51GK zXT&i(oXkrzq6Fb4f~3RsQgN<%#Wk>;;_aT&r&t>vMk67YLB_~<<7YWGo)rky4-s9z zxL>_2&|`l?Tri8*->GOtOA{sqN`LHe=S#BR6LjmRdFKV}KC3c_jNPf$L{bOm?J{E| zbPH7nul-?)8Z)-NJ_Gok;!Hcp$y`n!+2f+Qf-9*}O)KsUq@<(U(|FA~`%D;(!ul|9 zu$*hgjYg+LK=WzD8^d6go9>;7-Nf~>T^bm?WCXikjExdPW^uQ>WA>MNoT(A{itCQ@ z&mbaoDv7)5C#IFt)P=}L2!}38K4QG|-96oKB|4H;aia$P3i6xw9p4nQ!2R*mL9^EF zi*r)0&!axHSJF>jhsY`T2AGKxb^T9H@Rf;=CocbVExp<5KB+X%^t#U1SRf{S0@<8CNN5S45uCgzppPRgf<+-V8uYRypd|Aaq)w)UFyzt1JSeME zNVq1u11|9+@YI$jmIA^weTAG4h;yRX4MHYPVN-Qj4M~T+LnWFM?t5}rS;sMx@E(f~ zhB>;9!qXWQr1#_?FL8B|s%(^UvUs!`wJ&p?(zdu~)vsQ^n$vd?IGTuJ>we@u&$`8j{*fZn znbGL4B*99=qIx-x-t(QI?by!CeMYnyN4 zY-iGGR{;H}T-#tDkCTM}I@t(Mi0-i32U;(G9f$kout&UY)-(>`GI^a&LC(1jgZP#> z4liiNkn`K~7{B~AHURnhA;)_Px6|ISD`2mQa}0OvS?8p?%%zF;66?5EiZ4s=&tZBw zp1NwpHACc1&}x#(AwJ|xMcp$+FRhLodlQ6-*I+}TsI{$Q!M93Z3`qn)T^~{vNi3Fm znb5Ur*ef1(ZkwrUHbQ#0b)o{xpN`@1-WwK4`aaO>cyQa!5jr5TZNdi-vZvfKMz<=C zICvPjyT7I4CT=B?OS&*eUqu?C|~T5{!}q2~KwtqtL!2RMDUM*f=jgZy9w8L_x7 z#I}O@^`H9qPUrs!DMe=C$}jD9f&dqh{&&18*InWD=3vTi_(M=E`56Oni^G;%X=2e^6jRePYm`>}RlVpXcey|&?8 zhj!_4ZvOWITymoHc-kd0w>*L7Nsz`ZHx$fwn}Zt1pGH*S7q6lVwN9)l@_hNAyZtVoq~#Kc-(qBGxG`9|$6$=2l$;l!Rk0(V`a$K`XNEE>6fukUbO0%^ppI z_9XFp-B-tLFcljUj+F@&ZI=ygbh-NC7n*Jip0g+76rRr*%vg$Toz4R2#apa*K-?B4 zS3uk@1mJ*6Yx$O|!2G)}ELU)oHbFEF<)hG%`v~e4-mp*HK*HpF7yu@Kw4GP`AdgQvbkGvIAVVKX=9q`(9a86(tJ6>DMu}s>JtKmG^!7htc>| zZh0c|(AJ78z31~`V-$xql;$Vg%6iqEzP+BmwhNB~os`od-rj9asCPEj79N{(%F zRmSUDy%!^28tfHjjrP!pQ(;$#*sCgc`soh~3Hm#_ChYK-I;tF+Hw`3;jW2mEu4Zqz zHJzFg%eDy=gkPq_O`arue+#pN4W0~-Vdl;ln~^u=BoL{NbaMMaBGpyG+Ek%Yp8!qlRN$Z+$6S{2%6*&4PQEM3_y6 z{$&4zNn*8SFzi~{SWKk25cB2fb4$$Qp%tF4!&=NoNugEd#xwp`aO#C0#2vqkFjiHi z7h4>l9^mEzBHEO@U#7gnKE*6>%Yb@O_a5U} z>*hVd4tU(tSX^9-bwEj9G{UDtNW6toz?5Qu8K+mDrJ6PPVrB+lJ^_OLJj9N;ZF8EJtE7+M%=EY)kj^9r#SLmankTCIwh2yZzt;`5;=6_BeLo z6gM!4qVTkvj08Rs?XD*{}o$`HS*bShM*QRTNBzjuBbt1pL4t8=f*x7JwXMZBY( z%?%bgybgneKoku&iLY(TSy2YzznTEC5Tg0ka7ZPfh+OH|j!*XkBDF`gi{^<7v)O&^ z?JWAib<(Fc*0>pU2Vrn$we$Vv=9`&bttjftEYDOxG{3?_dXxrUEDgtBE<}g9?HnAq zJNM~T((ohHPn={*Wb$HY_@1%y8H7gf=e}#=M8lfW~wuFwQNp*Xo+OOIXV!}4V z2Nd=asPL8SSX#H}>%v>YZWXYx&_yy~Z|94be?jKR9l&;SxC~^c^)rFWG%RS(W z09F^ugx0@7$aMddO!ftM!>tvtSOPv#JSGB(Vj+EcefA>SEYs)yIIL960qRI0#;=!(%5XLq8@3${9$j9eui9C<&hnmtgAh1m5A5k zv>AQF6~pM;O@JWGr&~WbiM_pyu28%w6OgeJflk_X4sYCO8?+2a4E0WcFZG9b)%L{w z-&ftTh}HQsIvD1D-f`#5gl+d4zZNM%=UUCPxb2F6kL1I}H*uX7R4&* z*Pz4LFito*c;7)n+pH$)t8qw)!)py#nJ~|7J6g2U@8H=~EA$vq`2eS55R?*hXeKG0Cjs0lSQ&Ap4I%H3@PHMjak!%Z- zyc4m41nibfS{*Qnc7{H%rTUY*E`e19MhG>%$5Ox|6q2Nu3bmxuNi9@Z;4Aq zyLkNVUlT$gs#=5wgzC55hi8Q^rmGtfUqQXziu+Wn$Br~~m@4I(w>sI4UeE~(LEN3%1gx7_bNSRg=3%#jgLNfE;M$CYqiz^D6c@D{ z8>R*3S4Wo%w6SxATHcy^iDFroXW$nGv)CC|t{S-S>Qi+(8!ot~R2n zndu{Pg{9tmrWb#1j(0EV1MZZde*+i*)>*kgGP`~o{s1whY&Se}k-5k;byKR1l$r%g z+C4IzW7yt{M#s^Nq=kFq+D!J1!EtY=M}#Y3?1Y6pP&`h!c$nfQ!l;~k+;P(=oW!Hc z+|DUJ-uV)y2wJ6SD<6{FC=t94pmi9t9NWB2|0MK$<2Y<(>lYIge~iS|=hSUj$RXYk zmX^EpKA0fYHe4>zTX(@QFBLzyX~w>`_f;u!xZ88g1?6{Nw&}hzsKcyo3egN%cIA3J zZ%TL=-W)CDqe1I%ahQD(x;-2x>dT4O-m}B+^6Y*y=q4u>s_#u%lo!UF9s80cb~|R78(k8b0KQZcFq(6(Z6+}7wv~cK7?v% zKiS_K-W1{C)OHGl)(c^(qg5k$G_3t<-F*GI(D znO%TXP6rv2@6%${&$p$&L@W^xDIZc!r>>a)572PR%4d;-0igT%A z%oC*W+rc55Ui%Z2!mNI56IQKog(ZPm`4;$&*54}V@`HKp!Y=3huwsjLpxdV}>L6Zs zO?WV;@54fW((MS{A(15x6bbHZ|$;sUahk>RPG|Hqx1Wk%NUIhf(e54Vio`Ge17qqiq8+qxS)yHzoNvT`Gs^^5Yp8 zAy97{y)h3&jBZ|ljhW($2m)B+N^LTsD(-Y_i@f7;-@&3d?IX*0#T zT>p)roXl8HT=S=PT{U$)+jGZQ0QfUJ5xSG7tx?tPZ6viOO3^iTDHT1ln#HKl%M~;C z(&g`=xEl*cLANh0BLIHW?9&{!B3c~NN+uIX1@{v=J0`bq* zXeZO=rEZqvX6O9yp=WKnb$qub#=0t>#Ev5hTLC&1R`-Da@Lmzxj(ouYW(ggG`TgPO13* z6uj-pNKoJOl?@cnwH4RYo3W`;EsBX9v?mPqg8k|cDb<$=&TkGOHA+Iu=8UpE;|=%%@_fPs>5?m(BwvxZ%P|?w`FP(_US6bhplMf7(!jzx`RDuW z_74jaq`@OARcqLn7@EiX>9vh-oYFP8f(`S#d zwI4FSlCi_&`Gd1@6+x$BuB^mL%N*AkSy~KwLbyYm8^O;R)m@)5^()c@8gAbO9oAU< z{AAl{eHUZ`^2F?KHuYy%xa)_6c86SY{`Lixx15PTriLGA1)d4Ox57M&^%L!3gI4n6 zH;RU5`z9@V&0xMvZx)m-jYQqN4%vA~_wpt^x;s~}#c;mRjl(g6%vS=NOm?P7T_5m1 zCg2(i^@kd-Xi_E;a!#vq8M}A99K;K=@UxF!ECxY@HK#Kl#py?yZh}BzD`Rt58{?e# zw-EV?RwJzq;M4bQEMO+6Kd$CITkqPJ$0F{3+2VySe8EUdfBcWyeRox1pbAk?(BcZT zAP1fxEZHIjak|YW)$f?X6ZK(HGsjdT`A6{1^yz4kc=2eR{x|DmUpQIr!kT8BM@)5w z#gD_Ko(>Cr0x03*UjyKNq-xa#b>dNQk zRh#4WTc!jLb<_@&46@Q`?_Yz6sbFGUJpP;G+rDQ;u#o#mQk)3=*}vQ?)}80v>g-ji z_Z`8`f2e{Y$U1UhliUOfW~>E2fHBG3c~GM~l;8P?W#PhFQwvug4V^4-6?;SwUJX!a z7v(M8hE9x>(y_M*dOh;P!k|+5{i`j>*}(fn62cYLJo5=hS=*cgL{>eyJ20EnfV0Q0 z;*9Rgm-*}MF3{y3D%g%s-kJH)`8h7>ZgfYcT(wPgC!H#* zM6UEyC8f%KcjBmAu}tV_qQq~$a4TX#UKT~VAye)LiSb+A-NVB&oN|-qQM=CT42D_D z{0&;t7T&jHL>Oriudk%OGzVeY_qDsq5Y8XqqLtX;E zOnQE+@sf-sqHh z*RAtaHx;~7o5!>`hkS+odzZChV<8HJKE<^^M3B>*fw0thR0EBwt(8 zwvXiSAGS5urCn<=2sooianW6P9o~Tzq44cZh0R_3(pj@&%+;vL0zYJ3B*~&+87)8k zMoATsh!=&|;g>h6XB|!%3>3p0LBloZ=>`eC=l`)8Iz40d{%_tSOI$oZOu6{(%Qb(b zmoKpy#>vhza3*uOIc0(QS(8TBG|@F&!V2?1lLEgvVca_92MDOit_Gt?`c@rQSIPWW}#|Q1#_QHB5PuI zk8P8gmC_xQ>1Z|FUFQSX&bdVKocD5kO;M-^tkFLmkDVxRyTsLwKQ6+i$Zk0VDVo5& z$@aHpqxpdiiDHjf%*pXjma1L1QmzAd1Pz6tX)-L?7$!lG13xA=>@ogoX}KMOx-;XY z#m4lGDIq(qiYSP|VdH9|ujsQFPju%}u7)8U~@d&NbWzIKsY>MrnA9$q3E=P992&xWI3_dOa9cJ(KM@ z-ror?ooK7L=P<4O{+}T=!7?vER`yn5Cv3X^GHf_-9PL#?&K8=*sq4) zeVf=&*KtC4X+j`RurGzW8uH1=RSC!6VJ5O+B;DEtCF*?b6{20JPcq zMlEa#xwLUgdJ1qkv$T`HE62?f`HYcCy7rcF52V_*2YZ5ay{@Lt2LIPh@vUb|{N-i6 zw^@mNtDrq@ZRN%d_qO3WR~yTsI1e{J8x99Fm=h>}ZNu!3iJPn=$-A(k(S|_w+@AMi zi>;e^4L>tvzy4|AvytMKn*KF8=_dT(GLki&^X^k);J{Gb0Q&L>cxQFe?XPLe+U~{N zxps?hQayDDXbn4KD7ke?E4718!o9uXg@DA#|_yYs!^R6C3C zm6i^$#yq`{E@OkuQSc)&SE+imtHZ)0rxF5JPXp8M|$;mdW?ofe6`3+zpagsq#TZ8)fK@5ccD2`f2Trn&i3${$|#Y2SQ#Yi|LY?cEWg% zd>8LrB99qa!GwEm%Cvy0DCk#A~jvwz&&&^OhM}U11&OHb* zz9{L5HQX~&-!I!y#72DjhagJ--l=>C1J9D;Ri+iO(B|s9>;+$4K#vI6lt)T$`iRg; zgLDCCRi1YSb1TL=t3aQCZ^>Fukh$q<;lr}+k>GP1*(E0AjjwAOE26P?$<00cVXw`Y z@`?RWm%+44UKp!3p6jzcIz(RV6T%DSZb&+5s35vNoqu~LfsveEBeQJuV$)UA%|r5G zv7^m-$p<$9Z>}w!(AP9xdtLud$GT~K7ZzD47n)QT#~JN&k(i4WJLwv9pOwDJ05d;U z=sNt5iFC$$H!1JR!Qc17wbAR!p!kl+Tfph7G1lxD{hg7_gXikZ&{n{=ZM#I z!G9tc(It9*oMXBUGBksj__1f>)R!FugOXri5FE#k-!t5PWk~wWXt8eY#$1rJg}Oe? zHM#D2)H6Gq!Kr!UN7x;>L%#T}Y_ybrc<;R->U!CqN31`3Q;)=Qr2gD?>~ux&S4K+* zDx0+=KLnWyZMEPH`D_s}w;0RKgrzAx9wU}NoJnR3AAwmOaGS>h=_M_}C2Zcx=+_>0 zD5jZ_rZ+KzjZfwdnS24toEKJ%ZUvRn7EZ3FyvPC`6`>wujRtSYBV64|d?d|@ZL=JS zFDtZSc?6g!942b7-l_Yn>=fC4qzHgGdVI>qzThZi@+1||uJa9j``6;bt0ULL5*tef_76mgKPM7-?+y`MMBc72F6=mtyxX98) z>E-mBHY${{26Rw-x^Amx0)gWHo>LXr)(I8eBq55e|41DHOYSp8>)a}|E+zxN&cibo zoypRns^D}#_yyW#rt3)3V4z1BH5(WdPEC<6D~fZgC~kDmWCL3(oEjCCgzH~u>L`=< z2&sU<5fz*y{d4GChW16#MC?WesZ_+8!oO0}mUTuo>g?Hf6Pk=fnJlg}C+E^KzdJ2_Lk zXHOy@GdVVs{!Hh5DRv%yCxlcD#J(`y)+MpaS;+b@i+e>s_^Iy3Z7d|_`@5Vh!aQr1 zz@K3&>Gwm2SemIMJ(eFzlEOspS^L6Sz33e}JuLHq2IZcPj=28%K7m;8L09qHsYa{_6n!qmQ8WE)W52xPvWl+NEN` zS{n2#CDH1z@%?02dQ&9L^XqC{bjAge<*Oe^!#q#dM4($dMvJHqQf?OH%m?#5)WbLHUR<0FR_ThpWi+E!pvlg)Vlh|W}$a1l3lzicDIH0g%u3ptQG zH*lNT)dSS{2+k2?{HNYk(q)V1i;`B(j_!;HbS$#Kx1wYVJ>vfzRa2MAHZh9?$~S{N z1#S4-#PZTuvg>W@)=rOy%IHl~$wn90Q~#9<@7-hfesefy!<*t?*i1m&n5fw_Xley& z_$oRJLjCL+Pxa`}yJAFq>Xmr_$N#@}wOWxTs4zmip%SLQrDO-tGq)p_)l6s{9ksg}b>V0?@ zBTh9CQ)6mrdbz3D=)|adXO0vvo~9wir1Xiy2U+2wuah1?PJsX=fCloA`KZIL+5X`4 zYeCp2JTqTdRNC=4 zt2wCj?wSySrNj&I=_*Ch%~(a8uB7>Ll%cu-)362eyf5EE(Uf466EGh7Ico!V-u3f4 z*jG!#j-_scdM2W!o7Ls3V#n9$)T_YYEQ#`0D*e?!x_MkCXI&)Uvvo#JdOB>3) zna(}B8fS0)BU2!Oimpg(PcJk9zp~~~0om!j+aGc%>VKQ*-Pm(bJtN)z_Z&=sl1ZwPuHi~T09P41WCs&Nm49( zy_aLHN$jTkA<&}OhclxV;Rjp)B`2j>E~AH*BQ|H+JQ5AhHXwVEqnG&<&rz4!MNU)Q72f65C6lVwHDUh+eY(%6vmxp`ISh9`SY;ESeAMRll* zj@DxO8U(Rzj5?&g6ZN=K6o1sc2u$C*F144>|qy5Wds<$d0sb)E0Z7)t%_K8@7nzfgZD!)Kh549 zC_}tVnd=lD(wQ!`1#z#$0Bi|&^RQvYfS3f_G#mxzM|Yk7!a(Y7`_m?e$u*djB0yPW z*opeZJ$|$_K6gUwx~99S9{hW^6!greL)@zkWXw= zNoYYLIYB0WCn1CHKy{;)g1Lt=6Sh&`sGR($(%IucUrt6h{dQluTsme{Xu=8ZtWA|i zHL6(YIZ#s{i*n(*%;u}|z#WHq*X1K+KzPg*>f*YR7`1)9d^*Y)VFIs!2ckcyFx4q_ ztCD~PT6TIj>VJemrNSMd8v%ou_>@FUJ2c;k^nE`o;e_(69qIeSpz9S{;WFa{Cz2FM zvnfys zMHhcZkm=$%Sar;LvTmCum|~O8yPY1OO++@EmC(}QZP*+r!YXQHLbgMVn$r3PzO+4fsYPryXDLjJ(txY-|Dt@yH zt%}HGYAGr1Pxdsza+jjBeZpJ4fpT|B)-1#kKSWPk z0A_X%3U(KeY1AXMivnJ1^gc3n-UI7H8?UXSwYkr(Y{Hgh%7%kS7W>l2#!o^Bz)0|9 z8K42*W^#ttg#r_`MBS~}^x~M`+wI0E6N^=%JOg?AO}taZB5jL2RAA}Q3OgStx`>_Z z6MVFdNT20JEY0g9s~W=zYL`Kvu#NaQf~}ZF%6(NqJmm$P=eT*;+zU(6QqrSl`EqFf z5}Ru}uLBCfWuO&Jgw`vDxa;vW#d${w{!i}x3VB0^;pF1biv%0tSdFGjpZ!5!;7N zl0KG?_1Zx_oNQYv0)#@mCE*iNwKL`f2pxV<@io@>ee!&}G2Xx9#vw`YjEoUsZqUBQJx0tG-;i%*`}O zn^3U5?K~;E%sd-)1vPLOxUNa5a@pmDeiPG|eC>`N6^M=JuoT&4&&qvBFse;dx|9Ss zgX8}U36hHY?K8l~*#++uZ?`|PK4W2XfqKwd? ze?Xg$W+Owi?ICmp?**6_`*oq`fgBd8V(P7WC#D=B@*`^F?gKUH4ebB9+I6!(>>&GwTgvTw z9$4T;VWCY01moEC@CoSlksw9Z}KUTfN1YsNaMVJ_6-+WmU zbTIGQ{{Q06<^|%O+e6jrph!O}$Lu^;&nQ1krS3svLdwKMfNeu#eWWznys0@gC}STr z9puY0*Bq55EuXlQ+?s1L47xo?u^s^R<9ir@+wC8{RXLjU&+VSLZw%HEywpqnr?B}| zgs2EV9_RG)^YDLoi$4oD+3X}u`!OR_9SPybHew5-QxzubXEy`i1B=i5!lUZF3jzio z=Bu@VUAYZdckk1V9V~|r*iDuVhtWBf*#WLb2IhsVrdd%(%zqTnAV}t28yzEu9qW8G zk+S$|;u7-uDL9rCr2DXk6wB|!{L&9_|8bPIllL>>GXEwS!OUcx(u9pYe@}=#eE~$j zf`bJB9zD-$L!nwD=@0oF4^8x4?R1QMdmiY=j3_96VTs~AM|I#?{pPUyLW|RTNW0YN zQBJFi`Jb$42`D{Hz3Gpv!bjHnG0es|pR=@L|6-tXX=WZ%VHSU^;#$xpoC0nq~O@8iPJ)OVxZfsu45_B_D9uQU24Sb(jW>J#RWhAvKB7~a?Y7&fJ zsnKDDlVTMG&2rp)LL+nmN^Se!@$>b6$IsZ1^C;F{QgU$C`%|-wf-!YAIFD^;Q=Kui z4ns~SA=*l|XT^c~hVLinLxNSt7rbniuQ3xNTgdz1PR=7T$!0Nfe?IsLs%&~60T$rK zOU0J4Zm8=skfZ0j4(7{FY`CHmubFOwm+}^KJ~KxUE^^;e!ah_-{9FR9ek3oCxy=Nd zK~hpJHJFcjf1A7!W(|FT_-KCk<8XmKN4V#F{$ZgE=u7s3W9-WO3`?4eyI9(T|Uz#t5yO^`dww0Q@waI46y4Fu?4 z#ciqS^)Usts0ZC2vf-hN%ai{BjHo(D&-_lk-U|Y1izj*7Jc5kDcmjtfcAjA7Kv(h+ zkR^B21>u9ZxaElGl5)5-NEuBH#yqc54D7VFtOXUG*0DnYiXwdmb%H zh15R1+sDfoF>#6cNfv7nZW10dk$pKW^S#X$^61B*BwT@_BzMj|LSpm;A<=CkvRZ8c zFi6u8$=}O+Fo*s3l01`-u^0KIMw(^osjCh?<2%u@a)%Zt$~AXoZJ9DN zQnRvB!Lo)*4VBbffXducN)vZTMG#OCkbUv@`h2h7fBeaH!FA5_oO9ogo7vB@I)!t^ zJN7O*9wj7}R`$z|xS_6P&g$b1lA* zAfvG*K@O{_6|@u{QT;fqpFMndB%Dihur^m8Cl|$J0MnPxE@XJI_%Lkg6zUkbx6Zro zFs!gSvafO+!+#mn7?qrMb~G|FY()8+$AW&Pgc|o^i-&Da=UK}3vxa}d64s?l#icgl z2-waa3y?;6*L7Ax@^LF&Sb2ixcQK8=*{{rM6T&gnI>h5G)%MU-BfqfZIYE$NSijRF^ zJV~F+Z>w4!cuzVfPG|se3bG+HWm2=3&JV%_n>}j`(uWt2O79c?m^H)Cn{FWL zG_Rqmr@%k4lOKq!(4HV!(lVN3X}cz%PifGe{2|64qN0%1kocBD<}<8&7}8^>uaVui zR-W!J3zfXyOhJhGeXWltOUZA>C>Go|njIr3Ir`GdzX-SKPE*H;t%*xs1V1IUP_i+I zTQd|g0X(hm!Oo6+Q|3{PM>!dDGX1px;3F&@Zk~qQ2Rb47b2@Kz3x%N>D*)d4uL!?4 zzbde-N74t3Pcrbtz*^{iuD)k!6S>>{oYA7ASqd;lm^28FJkzsO>=90G`+;!wpqsnV zz8jD89wX`P=@*Ncw4C?-1BeEsWMd}Xn8XmK6LH_+8Gj>N=GG0<1Q&5jn$3c;7*EZB zJ@l0aF*Jl&hEl z=)_D;2o2JI3;*fIoSdsokj^VRzYLn5fJKII8MizhkHjh#{{;1h(g(h5!UPjEq6 zgoQzj1Ejh|?ID9NHWxlHMBN%!P*%w&{7+vuySi_oSsVH`lr*5t;dsHiU56WT@NScZ zu#s^fvd^b=Sh-32{q5@H?$tr&_U9c?de!0!cbFxv(Fey^$T5|~X*QD|8x4=qIrz-7 zmE6gpC@b$A{i9{kxcWP#XIc#vo{>fPDTDlz=0_0MC;EUq4t$k0xzrJ+`gmGGpZm-y z!^9q=dY3&j!=~TwHIZWYZ2Et?PfI>JT{e3Ig*D*9{jB`xlUa#btZ~_K#sqyu8 F z>-r;2cPC!$H_~kZwC@*J!NCQtzaEkC7xQi2fK~o$S9hOTZ7RWeOuB%kI+jYBJwx=w zurhwE!sbgf^N~1*kqP-Y+rCup!Bko_jKqzqr&qQGA#_YkL9gNqv*SPp?T}VFt2alYsVftx|2SScT&8k|`R9C860ZqS$z5KBc`f?tK1I|fMK3gm ze`Su#VJE&6TztheX#&8mEGbp-(Xewl3P~_5@0fJ0H7BW=ncj0+7nq|ins69-SoPa^ z39JSD=k=F4DpLShdXOjJPQ%=ia9UU1UgMY?IHfDf4ExeIOiwb^WT3?_G7U|D?96&P z{p56@>AQr{oImHb%Bv=Z$py_Rt|iQrvz z0c?~CWmADg30s@-yh_~u0O*Hsovfm-Yd13v01`nT*`YPRb)wet)un0c5aaVXkc;Tg z#boRpWMa-YO&e^iYD#l3sYL7>i~`i>_j1c~iBUE2QU4mS)f zEjU*jh$j&&+a1d#5@L#o98TxYZyP|jUto%#b;#UD)*Cxr_+94;E~0$NvyC;{7f7BJs4W=PBP*G*`n-mx5!9nigF@3s2>jiFC> z&G=y*C`+zaJdizQAXVWK*vGMA2{Jo$+780A@gVbrp9DkaW1#(2Riks)yHKt>TOsSb zp}Qg&k&x*kf$2j#RoRrPRAA3NS}k)7Xw+n_j??^DYt`5t(mS+?=q3xG9GpM4MGWcg zpu6ng#WR2CzfQ%Hf=dMJS;wCf9s_(X?~hxdmMkaS@Jy965uSGK-47l&INAF>ztVh6Z|HyEpm7NWkulco;U!3fD8R7b3y#?t>-F;I(UF3%W72P-xcUE?+k+P(sR^4P;kkTa`2h`Opr4PaZOBbM zaJC$G^JRvv_P~hkl=AD5e0^-zpjX=vk%=B&**jnZtgd6826+}b9o)h3d{d-x^j;I4?|7&6Z3+dkbcyl&a3)@@f`u@e* zswR2ql4ETmq~2!{sj+LFvtlb(=ymN?;kGa#6qt>7BBudJZIlD2*vQ5V#c+s(fp=xB z`32!-O+}U#b8Usa>U5v^S<}zod&E;;mR|Kttj)xczo6EIyOYv>zO5^G{>F>c%(E{n zp*i=yV*KO}?VbJLl+-}hhXJcLTVzLkOm!-V;egZrf zym@{KT77IZ=fGT)9e5!4EjPOr($|%LX@U1nHnVE%vi_;`l4i%xf51`21LqP?FOp+5 zy6;BuevdVK3xdit3AdZD$&4iL@CjZvT-zu4S|R^bjm;5wdk@!sm3(-SHp54~L*>|<}O0tjKtKw!-33;c}kC+$8>De|yV z!pyDp6zcGpl|`xL1G3@r0t?rV)QdI;^w74ql}R=2H206Efb1mW6_r z8%wBISGeR$Oj*7Cl;tY>>iIg&zoi^X_ie5s&9dbEtK^Z+7X*LLCYybcWORP%_Ym#6 zu^p8cXRqBWm%-06+gm+9D8@K~Ru`LrvO!|u2)>_&macvb?QI$Jv1oGgC$ zE$_7|eqpGxn9Ap+7DeUUvy8~($%LHZ0X8ym*f)2Q{-#dDZ^ZZ#bhDhHg3ZCmef-@0 zSK(UHO0^Ht$@zu1| zkNI#0t5Bi5!pk28M$8)hmc$WPl`d ze#G}9dS8Kd_>s4zvlolai#yGwJ*K~~Im`MmOiYfY-tKSp`SX68`m)almtH5jx?@BP z&_(p&Rq*`>nO5U+?Ulhq!b%0oAN3?-hguZORX$u5}Iwyy&U|0hy}+Dc^yBnYn!Z@#wVk`>2OqX##Lwj`3iX z=aVx&A&N$3Yu6$bJHK6ZohP=u)=&dIt9W~%$;~#R@rWn?DESd33_0)miz)v(ZHSX! z5|hrq@RYj~Sar(a)rf4AyfV0qc!GTDAH_HG3)n=&=~*l&2qr+Mxju2}3bg_Ju}+*& zaFFIjljhOd@&RBfJtA4o8(_VCC~v+Fj}M<*K}rX#Ds0-FsKKiii^Dt8aP}}oQc4mU z_MIiL6B%^n$Zj{G-+8xOUL0o*#*8`A`%_fzu>maZrn5#8_LX;eCsFlp!&SDu&-A^8 zO(Bu|86var`tTw#WF!>~u(^^189kbP$sjF05#9omJoUM1oIZk9{t*3j=^R8O-nWR;B zP{jn@wmL!jYvvnaS(}Ud+o&rPZ}u+>-eod{rBfpTbAOla*(p4UKIdu#3e$Sd)yZ7t zpXq~9hGCDoHhX$njO=1>#S_x`&)P3}aU1`VTo?J|`AjablTVqk?W+?~k`MwOzJoR)c0_x5R}6v0JlVX}e}NoR1SAvv!j6f4K+n00Os_%}A?|{H>s&Rr^deB` z*i&hHoBFfl1Mp^Fe2eQCFxi>PI2JnB6AM+EjiQ|5nJ%V34a zKpYIQRhHd4Z?B>Pcu`VH$;&xw_J)_M*M~8FvPILc$uNW_V#3mCpe&Lp1FQea67N4! zKfle5TF#_hO(&(p@j31NO1_{IW8!9iSv~iI#LW%hy2wt8H%+vg3I7}N0Fao5egu-= zy~7K}1b$)w9<>G%hht+ahc|iUW@*~|ji0skOA-~oPP{TJ;pz@IepdcXPOe{sA!JLe zNq1%SsRd3y>Bv_^4F;*yXM)Dd_Ji4HGT_8-sL_?Y^p5A5UumAAz(d>zi^{~bUrRof zQlgn!ApqXyf#O#gpCj)buxe^kRyF7P?=z;gRPxbC=2(dxGWqVs6zda|2 z4p2|1(BjNn^p<0ZJB7YWUIz~ z8_K)wr%G2vXbatS;_8Wn%~bu*#Ymuzv~e}xwQ~F0JA1NPHYT4Xg~uEPdlVe0??1gY zSqRFTxtHd!8u$G6`Hc35m=^a*we;qC4e*Q<0PqA78lLq}U{CS^1%BPl45cMBPyQ!V zIJvQr6S@Jttpk?vwbRtHGDiz{D{o)^E2}8zEG~v;`ofWOTT%;!c0BCbJVBs2<(ldO z<#@K%Ya|~_QZRuAZ{4m%l&0=go&U#uABk0 z)b8{&eD8ELHCa9&aN>VU#kTjj?1vcT_jKR%?88Cu{}up{muo(kOmoww6BgE1ny?UT zEyP1#F$*?MgYhar2TjmVtr`fc0BmPfzN&{YbrVd(1lJ%~)sqRD%f66I)%w3dPxF0p z%NLV?uxEq8nEHH^hMbD3L!q=g(C$Ijb{hIq5S_v?G3z(8)b&uOv zdYG?kBQkEHeB!`*{Kli-CoiHUh*br`P*3n4tBBvQi6=OchFmK&*jz!ykN0O63+UJ>*pJt%k z5d96)Zia0rubODqguX>oBI)OlkHs2{!4Qej`p|oo7>wL!eiAx8QaGEewrWMfM9EtF z1FX+R+%-dVn-ssn7@Sg}+orlW1!`4!zQA~^&I&Kab!P^xKHIt|=Nv`( zA!)`hAu!^`n*im<7eji?p|G~IaIXd5@*>_D(8#tCyB0+Q2C`1A|Bo=x%I8!vslcUaPCn~h$=7FgvKp{`TW_xZ z8y8E9EhtQ@Wfjj2@U3}Fk6z}Z;IH`-fc5$&qr2H=%~)u8RbYTkck_%YlaUlm8}Fkj z%tU7mQ;d6N@5SiwCk2CqZzEdVkK2udeODsB2ySiV8f){E(Rj#!A(?ygp7#R^oWptX z4mE~&t{nZ*Lznc-KzmJM6u@M$?S@rl>qKTX!*I{Gi*g ziLhKN`^vgef2}5Eak<#FKsLJ%ePHEp7HExjkO^L+e)k?gXu%A|4lXH1+3$<*Pi}T) zy^;$34b>@$qQfAX4N#No2st0DUeK)MTO$B`k@U>F{B;nEvV0z&{>S5dCTPSbLEckf z@k6)ic93$|PIcI0536bXivvL?g{;aT%)*?y`A;RZpB5HEK^otn>;zGMoA@;SlwDSX z>>;dvmyJg{Ubr5bbjTeCJ$dq0>TiR?Vub8DXqr|a+f+jocxwG;wkKmU_}A|@ooYg# zdJ0}NeHsc$z;<_uylp3jy3AzOqY+_!{2bA{7iN1VuruU~q@)A58k{)nF2bS2tZHpM zn8d~=L6XpYQHHGU%ojf4oJ2anOIUu|YD9*dHy)SBh~n9EvyUQH?N2r~x|hzhJ?W5T zVqKBnp^oLpF@)8CAGABu;4LIK19&xnR{2kD&cZwzzMbCgG?MMUqf8%V;d*+|DW94|}`UIrrdZ^7{U{)e<0u21*;WImB#6y-x ze+dv6JCGkHya$C0(`E}t_cYb5ZXXnKUqqJVC|sYK$vwZs*?e=@5EJi^)TmxiyrqBS z``-?@txZji?*)@|olA5TW8-IEnE*UzM;QK80GYg+l*BvORFo*2*-`THT{l7XX83hR z&u4FIMQl_xF(gsveTLjyv}N85`ZBW{Zq&GZYn@qc(#Q_plIlW<{})|eL-Kcv4+Gs& z{0!?{v>uO^-(y(q4u6RK5)%~X99g`rD!Q6h5Gh9j^@qmU@tOa+{?vf|Ct@!2dNJY0@;k2SUfZY(k{}oyTF*)l>@@PB<4@%bb%Oz=*tlRydx`4%aXk$rd|HRRP ze&u6S((#}%b}4oPw(Us0=m<(L`u)h;ET7Fneu+0s^B25&rINRcB8y~dI_*cy$R}_~ zhW|swON{+YjXQI>yF=o6NVz-8fC6a_*Noi{t1DTaFvENTIY;;1Af))ESlY$6j5T!K z_+Oc*kRbV;7d)V(<%pvgpGfPp2lv~&rzL&deshh`-aUCz>!&?x(*ZmHdt9 z5RzexsgPRQ=7eLq_qR+j4~mDlOZ{guWI3WTht6@oOk!2m-!h;GMFo{hs8^0b-37%# zTykgcs#&=wb@_y4jz3zk<4**!-(OEW&1lmv?#Lf`^u2N6|3thhNzA{xw{Jie{in@( zw(f(0?N0)v)n;ei3K{Ek%^n|aEZ*`pY}NjNCH+l}U4zeX(^0O;LAgVYPkxrabWrGP zcZC;dOP}lV*G!l^7+xzL=0e?nVO=NX&fq^x2drfyzSE|xBZ19U{4Xg4`lTI9&(?G2 z1~(pQN&lg6Vs`(dAGqDWc%8);nqZpIr@yS?{s#+oR<12TIMnr^a;jM~XpiYFJn6Q><3yFGhbv zmfkz^rVfaHLto>0k=lZnPQAX3TIhJF*$Xd9JsQa#}cyq60aE2#&qlc%k6SrR88JC)%L7L5Q=dt}$7sneJ(%~#GGS)IV zoKB$u;WKvukc>$6uu1p8`gg*5PXG*Y--A|eD zBzyS!WLCyhI&;L(fa&BfS?m5LLJ3PgEs%Ib`CIO*xwg6*IStAC%+*D!E@LUVO^p8G zcSzOk^sN(%+hUGyd2CZR2KiIoka0a>#v_w=w*_pXbi}`c)t+hd`llj zz|1{-N-D9l*8N9Se)i7M4A1KQe3H1DP4UH0L`IcAqP#A3_gR#A6?B(eW=lm$MZPk% z{*u0T$KV=GVI|3K_#U3_VDZ7GTNIe)dU!$OPAQ%u)fN8FMt>X$rPU2U{<2s@(od8o zj4fLiSTUOowf6%sxi76DcdP2Kq7!bm&7)`LQ*cY)-{`xZh>6;=c+B;us`j0unKio_ z@kc*pKyu&iCuqhMy?yV(6U<+Nd%>~@_+U?N-A}{cXyU8gHJ5oEar@j4nY`c%?jh76 zCNCkpbT9juRnaE`t`CAQ%*VOh$9R@f+SD^9_i~%nbDM=b$40Vh?-v-RimdYXsyMCc z>Z<$NkXH^y*{KofrTxb(?n3D5_>u72q8GntF(<1l*}{$}W?yKaAOV-(VEFh80zc#a ze!v}}*-u)iP$+lqWNy>*y^yVp#liHKcvx*uNMPYH+d z6*!H4W@;cd{;bS?H{l6jeR*mL>E7#EwAjCN!CJBs#SBZ{J9fKt$dP_qSCL&|9Xwi@AuEfm8h*+75}y_?**anN;tkvq)r$UpV1Zm!E(aP4zH zYezbfd=RnhP#V_QlO#=g?Ma?-Y>Co&m3cVbDL04a72)X#bo@t6B;t(}$nTS{wAwvr zTABnvU~4q*`@sp(dUhw)7ZRfl`Pbr&jg_=tO7B)Ie~(#G9~~JD{LnAA+8PBuxpDM3 zYm?Te`y8D4=q9AmTQ?H$ajpQZMq=#9TS;4abGBpoHxR%4?9yc~s2oL)=DT8{qv#i( z1MgvbtbK9oJnmZlU21VUt_}n^zrTzIPBcu}Y_E(gboIf{MIc4K4E5=e8>}raO%+!j zB3rU~4!8q`9b3z5z%x6B#MhKRA|RNXQ8t~$clz8DZo|xG7=AKqILD8p5Wapfpw6dp zVuq;P8nS-h;9hbzMG`yxOS0ts3;7o6N?7KTN2eE|c{%N^lWR8~SQT?)m)wf2L} z!Y(fjfcZIq%&W1`J^T?-4mmIfaJe2ex$$*nu*C`Rk8^|iZM@bN3cjrv+Tm4dZyXB{ zX9F3tQfmP2kyon!_>X}hw;-*kmn6=STwBiH`sE-Sw@%Tb)~q_IxzaKzWiTQKLuSa90TH-*#Go z60v8cQet*UJ)f99SHy~2g5D#w&ClHPnnG_IhpUvzPM0gqHVKId)r$`WB~y;gH@F7Z zm_s)6O(PoDZ>O}6oUSZ*ItEV?laE_QB8h5#h}gyEMxI}))QwD<@?_1KV24nYpjc~P zLv>^N&1<5q9|8ru&oxv{B<9qJ$3dZqjEJNw+XN>o%km#{73C5wxuAcW8#A`_YV(^j zH=Z?h9F|2y30_$(%TFv7xnA*Eo6vGZ{Wx^XnE+*E(8}006Dnzk*vVRa=D*?u-0>0Z zl~minlIrlSV}ECA)}&z>A6y{r8C6`=2?f=rzDUf`*#c{aMzw_^=H!w+{f zmq@=GKyEHS@%*HiA2*Jl$=H4$<#c^i`M1&diz4VyjLZ&s6Lo8VbQ1i4>itD$SzjWK zkc^*j`8r~f$re(Yyu0DpO!T$-F_P=KV)BtukLS;9%IX^kcM>6lbwI2|IC}6W$!m`s zbgF3I{ne*w{wX%G-txx!BX`csYdE1!d)Nxfdzim{9bZa(*m;L}*tr;Rb!Lt9&8nu$I z>5qc2HvqwJQOW7EPV1G5-JTf}ZDthCW;iw_Y1BI@dk@k$giox=XUBusHiJHs63_;; z?+thmw>=Jm{qSGF5mtLcor%$=wvQ4`)J}n~cgCi}TV?+aua|zfLyeyMdYNfqArc-A zVw?tRrN#Hixr?~)Eo}5R2_4Uq=?7*UeIRb=o-=ffJN4uT6k~2OzXU&env<_Umo0Ac zP7&QJB9eMaKy=@UTu}kLphYpzZToS5Vjp6h?nc;ge zMLnpBu-n5?P?(wI%+FjY@7;jAYNbf~i2U3_@ejtIDSu!f4&nkdp1AA%wmD}H$T7KL zTF2JQWydnfA25D(>e2B^>Ou0?h1tJ7QN&pC?kNSPGM!=ne|llM970Zg33gu&HM-M@ zX>9es4HpnrE9o0b0DC|yEU1s6E2lbIktcnp-qs% zNmyn<|CSS8=HLwL_a5*7$mGx>jt1EnW^xktX=|%mVe>hI{08}la?kHO%9ox+$piM6 zENI_d#e7M<@eO(N#Kv2~ef1{-8uCvM90}@X0A@~}rnAJoJY6Rn$A2+3@7-hhcD4x; zTh$QV-SO@0fCd4``J*abeWdk!`J%{DOEIBMz0$jBTLIE;Y;#ZjUh;sCXvY@V*tmIR zTkRGV`>`-bGm zak#i^sp`RE(}DB}APlz=8w@?jDd);w;-Q*Z)ru|LI}Mv5aJR;yOH~MYlp|7DN4t(S zF9pfj2N~wcv&$5l%Is{cEjf(z(2#F!sP%{Q{K5>-R@{AE!Re1 zcU9U`YsV74|B~^2YDb`n+6g*Nsy&RJ#A3!CtR5NFY(^0~V1lZwaX{imJtJ?^Boi#y z3p?%TH`tQAu=Hh#N;Vj`wTr#2{bBhytt6|}~`AxB{ zljC6pj$#O8z z8^7IAZdh1dM_EeTjFqUjkVQC9QqB^p)%oSCp>sKo6Z#RjzC3q`n>WR>937i@76$ZO zCw%alWVU7}=OSZuKq@lqXf#bTenE+E)?7?6Y@f-CToAqBdy zKR;BxN=3E0Zm-G?wt~D-ceBP%ra?B2cFAYp$DV8FU)1s0Y#vCq$Nfg9m) zlhsWOpOF~|&wiFxw7#_Gm&2ZmfR;^Fg}U z8Lz68H3X4f*)00({kAe%b~=b+ti%HM?@zO#OFo281?2M2=%Ot^1vFM!Zi9d~^0H-p zJCeoDC(Z6~wMVl?d_rT%)Tocy3-|pz{9A$z&kZF66n7_b;q5PFDK8=AsgWcFKXU)v za0~tFnX<+SvzEnHkDTAVjhPG8yS&lpCC>|z^0nUUI-s^Tzk-h2^yCwHdCM9xdh3u? z!L20SC3QFGL5bN+yC=+{IppKi$PCRf4BN7iiCr0duo*Civi8hWlFpS9?9SxM?j^-5 zg}c2S!s5@?&EyTc$bhXDQZHM2Ovt!VZKJl5(64yd=wyRYEuEI9>`j48c8=&P^Z$Ncn0CUdiI3V2@T z*CKKubweXGJ8Axyei0q_0;L%+S>BpyL((>wLnad#7O1w`x;u-cvdmTlIv1Y)b;Z)K zQNNL(mBkV6lzUpL?)z&o|5=oe3@ruhUIk8Xl{7F@bGy(R@Ph+ZcY6DaC|Gja;kHEy z@oQObIkz^`9osQNao`s-UHCQb?w=+&`$=bT0RM9$`jYYQQS2;LzpdUwQId6=xg9|5 zoq*iJ4O9-SK4G@HgDHkE;jIQj+9`pMr1=2PN(_41nyHKE%QQS45lngUhmeDEZiT4tBHXVCbljs_{LHhdHst?E zP-PKRriMkXaZzGy2PjEQosPMxLmC@4fu`sWE>lP+;vv5(PpeOkD6^2i)k=SCS+z9N zM9AC!GvV6cw;F#;*uqzjts!VDOz7W7?>2=u*y^vj61KvG$~&eJBNle=Ax6>TgH&w2 zS*6c24FBml$mX`6Woz>hqlXBF5rRQy@hAO<*I-2;YpYE?%6_?fUiz6J9Ws3~a1H{I zZR71*)t*BxU?8{|aeo9iSq;Eg-Sz)liI@;jr6V_GZI7AFMjH;ai}3Txg$p5i2SmDm z#$mDUE^Zq&Ax!xfzCF|l_U)OI7=o(gzACq~3a59i)YT}{g&$ZisXk)H(sqn5i8wiB z*Bq8A`FAp45#-hFX-P?ruV3mIM2c)0puVa+oNoj2Qzm?rPR1xZ7OT_AW4PTj@gw2@ zntlX%RPyx5Tl=#n=b=Rh`-!15hAk zxo^x$T_3Gh4vwRgQ6VcK)oQ5DkrE0&LM3}OT{ndqmE*x zMhORlx%m-H&2Mfd#@@MG^tS@}$C~(dmqHQ-5ukll@RmU5mbvA+ERDwofPh2Jw-e_R z#es(BFpN#pYAmK-6;ZhVM#>ZV{P=kMn$i5LALaHVaU82h`Q_yrnO_SwX^C$tOD|FX zj{nYej7nqayQg++WzwGHR@e{JX4wHRl2v^mp+bIQ3ns`;s-)dM1{;5FaVEc&we+0! zh+tf}r(WEa8nf6CjcY}YDQ3+_o@cZK5A^BGJAUPSOQlJ-Xh(7m@kQedPT?&EX$aX` zA%J^iZt;xbUIBWVadVZ5CN;0Zg@{`pCHv?$uiD|+q{dvzs=bkN9=V8Hp>B>lG@!O8 z`$`I#mWCInSu7&HCR>YHrk;l5H>~t=36-(f?=OD|N?S9~jTslH~oIIdBvs`yv-JC+m*? zkn8*vGB_6d5l%1UTqwrZmH5evnc?K=Tg}QN3W>f)wOQl6Rq`T>kFkZw^6HW0{Y}Iz z{DgW~9V4u(Jpxqi)7Hq*yqZnK8gH&{=>YWAW5X7Vkh(dxX_w8>5WFZaHwg3vP!zUPplfz#$6Zl8P z`AvfBF=8;0sy#+nOlnhZYDk{`f^0pkw4WFMDGz%y1{o#aJvQ4roz9*%lA43af&%-G79mF4>_!F&NJF* z(AmAYa~@X(5ivIjl^uv7N)Rx2%ZEEoVpag|r~!ruv*gu2qFqul8`3fre-7ZRJkz~hGM!r6(j|6jeRK=E)~GD3Zh6~= z8C@duk9{f%fFVLEZN5QHQR{tW8)s+%bDw+?+=3H>3usla^Rs+v%V-$YN(7gukDImJ zV9iv{l&rOO<0~Iq$-r~q&-X0wn6so+CEMG_z_y70dbMmbuW7tSQ$xN%7CGJ5%Zn17 zi5ruBVT`&_y{%#XmKUhiedX~RY&Xg<=kh*4(-jCSZP=Xpq%{rw1MKIL*2zmrn7hf+ zMGy|Xk#&?w6Kh_gd@x<0?@9w5C~4mDRVJx#`?4^lx64)-EMhADW>gtg-i)$u9RT8r zNTvCkvBJYXFE-$VHE#CtPA2kKAaDGL>Q7BK3_N`Q`|d}SVw(ufII|m%PWmORDr-|W zp>Wp64>wmr&&J+QGYT6(+3A{X{sn!3SS)LaG-2oh)9pqlH7^AEBL}IRhLSN_Ll#{i zUAs;3oamEd?1ORjkInk3OtLk-CM54@i?PD;1B=1U32;q!!Gp&LI|rrq8P&b0EO?|Q zMRx?8xbO*^bIQ7bFaBbxF@}sDfIDB_r{Vtq(TK{$X4F_oZ6;SVivr%Np`sFKIR+yfu!E-a%i<%Ye%8;V zezdeJA}rUXbiJj%26WH`p1ASLYWTi~l~c>NzhN@x zL`JY9?I9M*nIy(myitfgaHN0MU%IlZ)p!)hBrW*y7XADSla61Lasm)1kLQ-K*z}L{ z&sx=Ib{nd4C$d0lM16MiVBew$Fk#Z1>%($=ifI<>=OoXFu7n$sY%I+Qd=>)aOa5v9 zYuCVrDPqZLcR}pSv#ijZ2@_oUc4EJD?#}+7CaTO*3ob2&Nl%onkQV??AsYTEFVa8b zlIBGiILMf1Z`@2xZ=%}23nfZvuo2j|sof~eANcjaMjlgtek7g?a6;}4ywGhL6o~KP z>fDT8*hhgWC5Y2=6k-Z1L;gw6BX=90c8uj?cUs^W|1t3hMcVAE{>_x7K}XHZy*7Oj zx{!JL-6LpDW<0aafmZ^nWFDL5gCMb%)VBKtnIHfa%g-Qf%_OEXLJamUyF_ zp3W6mWwFlRTDIkmdD>5z03^bj?`}`}#HnuGh~7Mf46}^thUlLE^p=5`wLqnT#y%w` zeJRkcO%+h;@a7a~BC@(eQ0e2$mgujP<&Saxpi*iZe(Ljp@nRKbNc>y{g}=aS%<=Qt zAV>Fr%0=c~Xn|rkIK5=h)z7(ULz{lMSo@gZbM;~IutlT(Q({e{-nOkDG-{5*J(k_@ z(|k)mn7c1WGv69=OW(Wso<#)acCVQB17DP~d`WKjNCK=M=}$90kQJBedjzo6?;t-PttegI2T0@=2>vF z{k7?S_|c!KBNO(xWY{n$6e@cLLuswL}pT8y7()rdCl+X=}#Ve(nt zgnIwLc=?KxdOI){({Y-0C>&}4?y--+I(uM*o1bM&%IP(I#~J{s0UC)L6MmNLip!rG z|HHn(PmFG?KdkymXos(~oS`Cce{GlL06EPg-TyJgg#*MZn$D=^I>e!PO#66yGmx{& zC@q1@%rt!}PA;!XGg!<7qRCjB$4b&rc7T)2elp?a8cV^ZQW(HA?J6|dub7h;%$}-V z81sm$uPiLZd5Gz98>14VGwt!BQlNT3uAE=?><0T{4yD~C&;BWM6yy=kw4Y%P=3FBV z&0o!wZewaLVVU)Cl<-f&+>uX?uR)J>x!-1f02Ex1Q`+~8It$b1B`)*I!8MDg^K+}= zkIId!+0MZ1x(~WzLQeNG>)4m&ASiCaj-q9Gyb8h` z*YsQE%F8{tyGV5E;`9NMD+ZeX&cp+1iAJ1XA?z6p+ya`6O?QWa5ht_9u4vboqy{O; z>yD(a#B4buyD)(Ia+Lrp{6qj5)dwlK-%&_%y=46wu))Gp^G@7B%*gl$Le;(t!->DI zh-q?HbfeEc$iF(joG1DR^B6*ZFcp6j;av1nf0d=EU1_&m*Cz6jejr=}2++-S{dmDe z_BU0bpqa-*zf2uDnzdEJ%e_~#^!KP|Wi1+JIkR2jm;&pufW=v}p@k#)4wjgWVhN^D z;xeG^gw>Jv0C`lvQZ1@1>wsZOPsT?<$V3)#Awxf9FL%qSO~G?u!iLPIQvuf?$(Ymvv3{H zl9rm&{82Cx4#i5Rjm}6l_IU?=1)4us>0R;Dkwf+~rUgl=nyJ43Kv*{uvG!dTI}rg} zcH{53YSTP9TzP*H&X7GOte_ja_v5-ZYy&?m&WnN+*UbfjHLps>ehM+3PCEl1prF2Y zK1i-Opjgw`^*p@PONTx9J6iu7gBi5ol!Jheearm_tAZ-<{n+GJiLD^GQH0qu7K6E%4uc^mZcE&WJ-p5wv~PaaEfETK5SzB)J)?t z!Ue4v-K%_flVN)$;x*(gXzEp+c95}cE%QN7_0WrwU@P>P&*%5rFDAwi3?1EZSRh!3 zYd$a=Lpj2z&&66wKPnt-VxSYunF{o6bdtOM*(hp}qVpR~39ZiMe9$ihauoj4bgnfZ zTU}N6>3$UaXY_OSYbXlHzQN^FzUOUJrwYewuZx2HeXi(h$f1Hmj7N~0s06akG7lYa zRb=@j%w}%T8|YVn+q=)Wjni{EXr(elvT`AfAkwkA_aI?|f~F_h5W@|Vp7*k>f79(o z8JSM)#U$xuesLCGb2Er1&fD%z2s|x7cJw2|$M~82=J3*I7ia11Vd?E*XR+HTs}ou) zq+)ZD;DR)kAOhHyfToLB)b?JqpLY@u_teC1K^+r%_gD!3UFcQaD;QFKV6PQ;kF)Lu z+f0{{m7THF1Qm9H3kvr+An)BzPuoZ4*Sfi*{eGWyV%_5ctD5Aaf)^I>iZDDMzVh87 zcW@jxvsUE6v#;e^F|RCqJ=dCon11cE*xh77m3b>j^Py!x{L$tpR;W=rKsr)Lo`cZe zA4``1mC5mnq)tf)lXab+a{YSa*ST}TF47!-X_GPa_T^?(6gCZUAcw5Ry?3Gx5poXY zFO0xv$ICETy>I<_qM9wTgA@K2KwpT6-*<(L;EC9y12X*p1F_$PR#!EGS5nJCqH@>V;jZgZ5zHS zo1aE<;w0-g{YsD$(ZO`ZO?-~($u35TiD9I0Mf~Si2=~**6@anx;s4|4Ox%)8-@iSr zPK!B>m6axy70t9bjpHs*Sy^8vv2jK$7b+_%O>#x{%*rj(va%AP(z0^FB{fB$a!XCH zR1h~z1yn=?WZzzX?|;DY@ErGZ-PiTG&XbXwu8~}9-Nf8{Gor6u6~-=;iL>q(GA4aT zvoPoOBDBXWoHw$DI^TIo;fHXxava(!dAyB?+arfg~sV$;B#AbPpr{lyyYqx&q_)!#3z zliK3`Gw=C=P|k`@9T&}xctWZ`7(zfE1x-HF>59O+qME(xjkL29W+)ofqr=nM%D zmbIjn3kq{!gcwa`xA3~^Cy;XL4$x%Fc*jgusyDhx<03${A3OM3+ZeA_m;Hr}v|T9v zM8rFUjXL1Io@I)X&iT@qe^!4>!zCcMup0Yj!43L9;?);52_ zY`0{_M*PmeN^o7F<;lAN!a(pFhpAkc(-zMp=^*HL)8Ikv8AQ%}O^UFs612@fVzp`V z;>i*$qKNby;e>sg^zVou&_OY7FMGK#a8UFdF=W`4Pr;R+N__0n;GkeKO0)SyO&U=% zV(I$vP2`p%Gm8=Fbo?J|8^GD{XjgR0v;I{H80 z|3q5LQQibGYC#3-tEg3$KC7Zkx|eTz~Fc zK;i;5>BA*jMdl}_D{*$Kxpn2$Om5h#r zKJpXDk4wxiD&a(-1onwvufzQ}kx>$_TZ-Y4G=1%*_^YNBa$hDvP+}x>D%THKQ2Tj! z9x1@6Z1__V>Jvf-7E;IjG$9WGO#gFScWwQ+urzG5q=cQ`_G-Q>$2-8+W7Vqe32Jl| zW9)>@gYs_4FLu;a-J~J|(Bi2OAB&Q)pdR=`T9EdO@T=fbuNQByOmg15(E^oU`_zi* zSWIs^=y)8PQsrztP|RPIj=z3ujpb-DJ~VqCjzsSp0K$pm+qE4HcIVJDC1c zoK1fOPLuDg%Lg|7a%l4W)LV^w{^ctGYGHBsobgE;2JW!|8iV;)+PR);MQl(#XWAH* z+sB=@IA6})9O#DI#=zb`+r44Ng&4ONZqTi49rq>a^4Rj-;7t*tMJbN+QPE5#)iHB~ z@z8$gd^G!JQ?IrB==8g0!+W|6+&b7_3iLWPj4S41@D^q5SN29I=A7tyuT4of2&C-# z@z_t%RvTKj&u1E+39E|nh$p56iM|59pB{;KtTj0%gj;5t``SZC3T%A@i3(KnTlJ(f zNtTkMjE_*Hj6~?OlG|$LKtr<3hDP@bs3KHd?wmE$aP+{a_PCToONhaLz|Y;0SY)?s zVLySCAlDC7$ty7(!6jPZMpj~o{<@H;$ND;cy4QN9P}$(Mjdva`p2+yFU&&F~_TW1s z#ikuxKsJy`BPMjl`+2p6-m{R^sfN`BM3u zQ)xZ6Q*cQAce+RKF2H#vR12?Du63u&Nc^D0am8I;PgI zzm#BVJu~iIpmOUh@$|%MJNus?w?>_`>jV)9;)cy-ttGGkoCPJ?3Wvuv!wM9U&UbNr zUG|nK*!yFxBOs5cN@`(O`7$VYH{APJT$UGw^-u9~T#|fu1Y#ZF+w?HkCC<|eh))VZ zMz~k{j#s)siHZ$NAd~Flb-Hav4K~SbIb-9oTr7U>tG8J2dxYmBJIJvkuiY^-kTX0) zJiU}JSp-<{hG>r{mvnC7yf*$pU5>^=zuS0+QIiX?jIU0=i0;OQ774pjZl12C4h_Y*JlK@?s4F`-xXd1ZlR8D%Gb(s54}wzarS63& z%@LviE;AOz&gnCf_w?E&S9c+fGe<{1?(&)b*mf!2!V(cyPT1B}piIa{8Q5~dUMoC4 z*A4BQYw2V>Vl0cIF(SUfa!q^mj|#oY>r0dvtRvmaeUft4NIzWVmIKWF=7&$ZSpNmO z6zWh>+rz2O0DkRxRdrGxoze&Dajq}rM;oSGS>oF5qVT;EgW=tRI}jucw{iM zD#~&O4GxcmrOkZkKoX!BuT)xq5ln>q8EeB z@6D7R#tl{A%(5jj=csl+U!dQpWWm$Q@MmUqb!oHeKk_6FNhi60Xy>0W=@ym@=2#U8 zppd^#{VZHN<@D!!yHhr=d9`-aZU|?VHuqX~=lUOFXZg({PXb{&G4Ce-XF1Q#T8m^) zJ@_W0CeAVk)@B^4xBHv5bf&doEgT?rf5}8Ydpqv|$yaH#o$aqBBU z_+$}%`r;-^p(pwU=FKr}7tPU0H>(+g=PbOkJ8BS8h8+?e>(ttHtEPjTiON&6af>6h zU7tuko90&;77>i6$1FUNgmIBNs3+%hUe5T2sMtZ0S2@yWz#(9y&^e&c{xMVMK0Grz zN>)*Ex1kB->si`0p}wGSjQnVwQ!%#dM+bk9Xd|b4ew0JC6+gl#$qx!$Lm>UiPIHE` z7xBebjx9aM6>9%dKdo}>pvY}_&sjKw1xdIk7rB4BedvsvRJjFe9;XfuAVl)5l=2t& zFU}+iO^m$AfgV9#LA#@I|6Y4BoU~UO9n6fc^gxF?M;rR1PMRM|eI_l(WPl#E0P+y~ z#J0V&;gy5_PyHPJm3lTlWn5xveu|8H^LofpYQP2#E187)A; zX?nbY>LO$}BtiSNqaK`&Kz01ITUtc}rVj*Hzt@!Z($9{y8zbRsw!3!LV;X_3R)o#G z{L(7VH*fX$y310_T`&pRN%h4Rl>_W7x0*R^^?nZegO%j-dN8S zwAPz8*gT?n2+}pt6l{{9DBjL;0#dS)r!89D^EZ=e?KCT4azY;*^6ph_)fq3b?)2Q% zPo)H7wW#%BK51~tzoW{0hEKNSxAc=%5{J9}_4uDcjb3sg~B$M<>24p4{_LA zoky+lZR&_^#D$qf(S+7-Q1&cQ2_q`IE{|;L_5GKsbv*-vX{S#p0`JBhoPCzcwu8)F zAI+W#%-6l6AjQcy;2@za+h2(m1TsRiK3rxWVH71NX#Q|(_nY3Tq~dp6LjUK7KbPuP z66N~T)APMu=)|wHx)WBN-aA4qg;*%5yM8nDOQ_UWr*%RyLJFbxP2Mz20|tu5t=DD* z}sOl4`OorZEL zQ~jQqmKGPQ(~V<`e_6y%F>?@(h?o+~r#hH08Rv@`f%tXwnCFRI)yv5DhzB&pElr;Z zPf~V}pDpR~w_8s|PkgtA|0vyJK}(_K%iMV#dqhW-FEGe5WJe!i@G&sFrNZh@o485s zak4Z$CcZkt5k1|%>bqkl_K$FY;|F$r>G{t3v^vM(gVt{_+jsMilWu!`2erpNNG0|E zxP2Tyu+c(FAuKyERayR8_m(A$MtVNPHaP}%WadRwbx&{VXjxZk$U+noOP_vC_hSLR z>$8!7>2I>@62BFut__oL>HN#Lc3TBbcL>|j)6|-CCrct^eE;1Cv}@a+*}P%4N|&ul zzqmh*aQ*wLKX7s!_EfKpmu9+V(brPSUhU^+&Yq>drZ&}jS&5B&8tyi|%z<*uSl+rgsdka7df^4gPrBsKzcHuzhL+H$XX-cLC`CqmC0KAyWO!bJZfTo} zM?;!nR?DiV!kjNgI!=!8Zwh>?Z4LjLbrFtzwvib3Gd{@eUe(zc>&{Fb;${L4dNdJPj&_3xgi}0^y*)R>v0k> zaoIPZCAd(h1DFl@`nF;irMv$LF`h9QNDYh)Oj>AUsT!7QN-q)0v@G+350>tdFbm2p z+5D5ucPheLZMfJ?4T+x0lPXG^<}=a4OJu;(?xKaPCC7^W3Jb3OfwWo3b__+oP%&J1 z$}~Rat#NUc=9pl+Syf4{MYY9UaAL~W+PqVcmViu}Zj@63I2WypI}PdXYN)+Wh%)|3 zjnHA2_n*oMH&2%`>6d5?!melcL`mlS8hyo2-vs_Xi14ymO|Jh^!QU37eTr_j8}hWt zm@QZTZ_D^R?B2|xs0-2uH8z~_A|da2ASfI6M8RwLrAG0fBI5miD-7?4l}{9d_m=J> zf3z3v6Nk~=nis>2OPvM>7XyCIe9C{*=q5d?%7)n2dvv)tOI<`4z8Dq~Eva6emonhA zynqRvFHZt?F6+gLM`GoYAuathmugna}zBgN1<(*X-~mqVM=T1@Z*Rdudy`^ z(}f{ueA73eN0h#A&UT(|3T@Z#;LJ!}bu0UcGXl|4I?&>3S%}fO_h3tCvAVE`(JRbq zA%cX8g?B{!xCG>H1x&_Y_*4OAX3}f-afByIKA2u_kZySd1s4EQ`&T6wq&3h(9eYac zqL}e#^Y<0xj`E-$k)U(&aK5{~Kh*n65_;N47NA>4nF4D~eMwkGyoYfVqg<(!-YK9C zDXV2Kw0UrkD9yTYiYz8XtJ-U#fivOl~zgGk^4itC38TKi~NO{zG@ z`!maZAe-qS`1Ql|?NG%}$UMd=4{jxrcUz@x6C((uVwdF>ci-QeB$x; zFT23AO+J|4ZeuRPL6xJ9A^G;z0VQEywbgeL#7MWF1JH?wFa@cG4)*{|fA+k#8>+hM z&f((Uv_-;lzR2i*DaM))_y$MnqgK2z8Z z!Nt3$wy;jc-tFujhyctB|6gj+MA?-UfK6!lpbL-1?@cDS+p^o5*GzI z^tZkz{}=kgp#{OAG#f(Kh=Ush%zK`E18@j^P`9nnGT?C``DlL>9;mVC#D4aMh_jN6 zD>$m4g4QcF1eWa1LXq@Sz2<~@+95ZQ@Qw8Xbh|>z5_(&tdMkMk{VadWw7#$5R5dhL zS}_urBJ}6~8W}q{-w>j0yVY&O_Igj8c4HHr{({=Y)V)yJzEZ60=rZ;ZtKlOnZ77rWVA}gVwcoDsk-5@2{hpOk@!RQJn728>`;;EMoEF{Q zOY2w|7@>299hAe!>@In7T_=qnYq^r+1sG{3EjVq>AD=}ZDJcDhf2QB5K52w0<_^hd z#JNq+ML&&|GW|!qT{mQzg|y{_k(@+x27468{kbJJ=kl#um&bd?UU83K+7HnQc||v* zqdi81y5U$-;OKZ&UY>qn?uxp-_kz|B2V=M0nsYg&Q`UgTGIC~Dlyz?p)pj+Xp$l?+ z;@_l#*7ZI+`H;fc%LW?HD@H&>HUE4%jH$3mzPeSkhp9~YJEpKXj_+08@y=?HYPln} zE|2_o4G4Agd@$5FzC;Ggx!dZp9akq{)uGuK?Jb-T7SZ}UBAsb01z!E)KDI4RC#cuX zsN4Ec@d&O*)Y!IrO#EqP$rclIMCA?o0|xhzkN1fm zb-+QaujOP`WoE7NGurMz72BE%Rf3Jd3)v%8p5TW?z(B26B~eIYcZa z-3LRSkN!(>g)6%lFVDYc%kG}v;oin3g54i)&YsRiP-3(fV64{55#6n;4bd^mW>QQG z$8^-N)1SXF6TZeh_Yu|5JXm355jU`s{p0qrF$@pow+xt92@~ZZVcvw!&R#jd8cw1s zFz=U^#`|hXXpqHt(&N?G+Kh_GzPgG-&1Ekn(bt_p-kqR8e4IkpAZ zq#IUU-c{8lTHx+9xsTtN;xTYm_m%_myyk-#;t#k4d)7sq_E2P#HFh%bNI8u9F(&dFsW)Fa z7u%SH5?3-P37^}})r)~U+zC5_zg&t;By134<3lY$cXQA%?$haf!>njDi=@{h%qqTV z2u>JY>(TM8p`lXVy6=9n{lmL_!}D6}gn3v}Z)k*RLn~Oxa^TEuu#(p-?@s^HeY@X;l;s|HjVo9rg;>SJ{29;uLXkRYUudI>Wnc!tr{~;?RIM4Qmg@TdLh? zuAkkkZVx;pG>%?jrq3U=RD+T%K%gcz&2B4U_?y2!fkPd{b`(>Dej)`TJ`-_m5T&A>&06uI}#u-_9}VZ%Pc0D2<(kh56QPaer(lV5&~7xg6!& znm)Nc!-<>^raSDlG@au{>;PKV!;Jj;th^vAwcyBGn4c`O6#D>(w~Z_qC34?E ze5ELwPfK6ha+M9q7Jsb;V(%0^g8X=|eK__=+P`X{=8BJU9!i5=&r+`}=<@ChO}2|v zTy_Mth8nMTNf++(XF0<6;bmL?f$KQbXuE`FU6vaq8R*6toI@|ibWiX({x5tUiw1v| zag$aAn~!+8(+Zn8_8eguwmt7L@#QlCzO&}^&FGjA`muELdM` zBDEH*TQ3?;h3S9o{4}-tC}dTEI-}x|Jc&I?uF>zhFk%#d+sA0sn^$8YBFDGS8uJ&M z*gl#gBm9?fornqDdLY~oQ+D}Uz7=o2_t|hr;ZB`@T@x{9mRkJr>pxK#iamPsc@?lF% z&~=LnHv?ee1PFE*;Y)t!qAF>_c|{p9*LuGG!1kzIU#cy;rB3X)Yc?c5kes}fx_Por1O*@5mG(0;EL(B{oyj%Ho!tnYn|-kxJ6ah}?fmz@ z*jO3a=Xpe8AI-c`;WJhLy7$Y5YXAHu^0Vf_!?D@QgW<}RiITAn*UIL2H=PZPWYcI6 zuOb%u(hmm`Pl0yV%cIs6;Rb0Kzci$%D9S%H3-$o$*X8%ywJ5Y}|8h*5jHO!&jcko2oI}<`^8deEycl!ewH z7KTGhtqK&@0%ImQaCWMt+wOlTwvq>bL)J`JjP9GufF_(Z#(dp!&gcraK%wjD=*9G@ zEdhLlqx5>4hxqOpcW}SBjQP2H|4NI=%UU{Vu?6jG-#x|^p$L~Q z@XOd^Bv>Bb+zk%>IOG$++qdg8oSwUSGk0$NHAi?A?OY^9`G0d(s1Fa9#azfPw66^A zC2wjPNrOG75o-eGYp@@pLTK@~9#K4uxSRA#0R?&W;?S~5f8b-{%o8g7IKsk=;z)I1 zaoqBl_ik$1g4ymj$TH9S`)R;gfEmU(n+PSLEeU-J|GZ&v>`-9LDVsZ>7WLFa^G z(k3q+b^dFh$3?hAhUL&?S^wo=4z$_vXJ5o~7@ko>-r}h%Z0yrh;1uu~z%=;{9JA98 zG!Gw7J{QRVJr^xIB~qyZjmDdLf!Hgg5B{Lf674{($k7%lV@U0jl$WZ#!)hV z9Jf;i_?0r-iqs@dT(R+vCzi#dgp-@K+;o(2gk47LPVP@bfo4dIUj3;l7yTADYTS_4 zyXpJMq?uWrxoea;H(b4!i>~-7;>O>Z)zieqS4@?C0kaM9=dnSvFv>O+ zc^k-GNqRr^)U<`OrX-n;Y#pkhqhq`CC-(d?b_J;UJK9mbdWGI0I%17X zb$5Wad}MKsiy~~$`;c@!sC2o((7Ltfblzx&#&ulmX(!*Q8UL%Zf8$h_o%*RgOTLy; zLEJ6H@Ap0%%5FUn+@3MR8=NQAjwQs9>-9^vOOrS=i@+Y$67&e^q_!rnUj2~85Z?$G z=?~)vtPs>GpO)D4KS}_7vBVAHD(;mJH6?WXc_md6T0oQ3if}S&_(YBR<%t3T_*U4;>AqB5_kyx zn!;sRM*rX6`Im)UD^#=^h*f`3Rh|>C#Q?CZe5b z?4qOUJ%6Ge<9@ zRpLQA7YgU|q-1Dpo1susVh(-0HSqR2kC6?}%B)wYZdBOBnzB^TN&cvuLYj_65_n|* zx^sflkkDOkpM;c5gj@)<{xMm9sn`ESV(mkx>DF>Pb_5u^trqS`f3Hg0Vhrge)xv8!(-=->I_P zUHD9y>4}`nkiQ}QsN~hH?fHPFJ^41vDxjT!u zNmd2NxrMSL^0q;$bX9LOt@j|s(3U*_gJs(ZQ3ddqRQV4m?4Wn!fU?DmtD|UeC4;tR z7Bx)gFY{~%xUqu1x>$CNzG|-+YUUq8E6oT|W*MVfF zeXD0=bc|#Zv-{QN&(i==9K{WqEHCHML@s>e?t+4k4Qu*8o6A;ZCKgasG?vA^;+rII z<6{&td`psBRH@%F;)%pBhW*MRG*CPO%8Yp=3q<~sdW}fEDr4vk@kiOd6il2jad1B> zeZqdP$d*M{o-nN*PA)}FRE*37n^*EG*s4SkmYF)sY|}eb~^bZYL*{VhBDQ`)eh;epC?O_N6_79t@9FT-?JI z6c3@6>M`&5S9?SCtHLlm*B~hL6FgcwCIzII$9`FoCel<`mI$u?NAY>UVn*Hg!gU0E zZ+Oz>8=%Q}GRmF)2(E<1C)(N7H)S22SpwElHP$!!><6NjGZUwpyh^T4g-H@C`p;b} z%h7c9U+%Wk*y3b^)PQ(Ql{?|Vn$0gjxN={#JKrF_AOF04TaJ8NE~sE>iAQKq?Z0Ws z;;0Lu0o}e{;9?I!aY_FrHYq*ad>sEWhfi|6yPyqKq{gMH(vw+FDm)T)0FsoSLjDH# zf38dB4fWb@KPID%X6Qae7^e+iW#hj&zHm|%#tui%YYhv$5%v*>=fWg~m`w(nt3KA&zY zh>j7K51IdKiH$3)>MT!OEOKP3)Lz~DBL>h8?v}Y-XroL1v1$k6igfc1YTy|t^L?SlPHa#~6_x;A3!KmM}G$GL(B^ep(rzt{&822l#C|uT*-A^ zO9U&T>cd1n=w3Vy8iwdRYn%s7=mdumbYpJ=! zF(_u&aMO)z_%d=$2~T3U6HQjVU>|f7C_3FKHGHupYYKxua8zp>qMacVwu9ah$RlGJ zFchXQ8CXR$#QIs`Uf#SLI`!G~V87?Obzqqd&mwG$+{?WuU#*?A;>~XCbkdLbb3?+* z^Tn6+D^=cQ@|jn!@?9gHW7{Ge@(6$Y=fovrplr!^VOdi z7sM`^ix`!e+z0IB$8Ft_wPj;qa~%EYykS3 zCjpb~oYU)pL{~3=?j6@Ec1hy~)pQr))e~VfYcNlDc)-G+5$v?uj&SOuVe$a;Z*#(j zIQ<`kk-=`19gN(7Ep3uhMNhym%$4Fj6`qjoNFNWjX`sY=S?4FO{foWRa4{h?_@{ks zPkk+TF;znZt5^CSe;Y`KAM!!$XJ(mKgvaw+I!qm+q@-NqzDuHMjAgtL7jhwTZ+!uO z<}0*dsDVElu}wd>3_r(8B#AWpIK;^4G8Iz(9@WgF6hNJ3eJp3$QZ4eUeI4tT%@sQS zvh#(S2jIWVJ1n+rg}3bYoRQK|*y2!k9{F%m3Hu7dItn#D36dn4OOi9KWk4*RG*O={ zr%iW#8{Om{9yOpne+^my!@p6x7YNSGvDEAvJ~&A9a3y*(C?6d>bGp0=0f}dyBKz}B zt5;t(PY!J^$GZ8KVK?}2#a60vY=BtbGaO&5-ZuWUTy)(0$AHUzY`V**sC6)$>wS5O z%F77(e3hIp?>>OsrR$nZ2(K znZG%^UA<{|z}kpv;M#!=r72T>QiG;-opXf65?@M|CdC511E&a?_Iz&Ze*TBsoa5N<=Bt0fhgjd!Z90(+l1IPkvhfo4%ySQc_DwAap7QtQyx|v7M|~p2@;4A|&!H%%0Q>=d&HG(L z6WNG>#tql0A1ipd3QROPB$eL7dz@7@9Q>}tQAe@`6*oV4bvXk>{wP^+2d!ozoRy~%6#(ao1?QbzYR0lCaqZC0mwes1B!86+qGwZ!

    0>4Lf7Uyxbv@P zp|i{hYocgPmBYnSw`xRK%n8N|v=0=Ul^3P$wGs%$nm({sOe% zAS{vjAa5 zz5(V5Y!`s>)|Cd-3x4MpBdp^}0aG2|{IY$9USfk2P;t=jdu_y#)rE^&|OHD476R7I&q zo%5Xo3Gyju|Bvvys;)xZM9mjSCAK}WS>7J|zYh}Q{^@5< z((@A2XJx!;e155C4C)VGx8V8SwYu-rBQ>8YoC zOqAU+ShT%K?hlt7Fz?96>DCN9>EbFKzB_*}#0sf#TK~xSa#kCvx^@P(Skio@Uc8I~ zEHhrQ<7X=@kj0APw0MKdDZ`_MY>}bxW9g`~YH(_FH4t7o8i7v*vI1Fc1t+x^xh_HM zYS6@5EC&QFXPnU%lCDNUsxEcaA24>acN4v$iV!D@q>*f-X&YbRglETq*wv*3Cr1C% zR7@w(K2j(D;Wt$-_HB?mk(~s2Azi=~xSv_)ABQHDXKM>=RoD$4Q(aCyj}Q$N;Za5L zyOI@>@WcB|XFq#iW{b5}@!YJa+f(py(7nOcMq+x=Z28C0U{AY-lb2%u?x8VOurEiETF2wofF;Pl0UVmVrD6t zi||78P!&tO=UqkWAV4#*4 z<72NsXZuHWcHg@(khlXoZqDVo_Nn=TAmk~&fItd*yHX0nQD;L z*iq@ar5s$=$mk$%4`qROhIX$pxOI_!Zczo$@R7s#wkavQW_{$VGZI0R<(0im`7J6@ zzQ_428%oKn=VB48OMZWBu(vUdXZ3E@Bvxo>uV?(Q_P`KoA7J=ag@^ZJ`+u$Gy8#3D zlhcQlWsvCJW;zsjb*Eqh!h;*=*m{+4uiO03Zs-I#t*MV7#J${1o;_n{#SuMJp_+d5 zkJ|Rxa)|MvmD^Zk>EKf!^%uYR0iUzi4mTFO=WEMa@WOu6o-+28p@;)y4Ou6vfC9Xf1yw1vq*fkw|xGCE`RDKJFy^-G%1opmDbL@-x4yx+K2lwG* z-kjPg+JdoRtkEjx>f4e?xnCjfZ(yrW_W{G-wiWF-ogZswWD6S6Xj50r# zZXY`8pnZ#EkC%)QCwNNXs5-7XN$B3tuULuO%H$~j>_M@9aHRbsJ7yiu*bz?|uggih z31Ih(iT6Xw!H;uF9m^S5$f?iVSxYJt>k6*)$9r zS51?Zlm>^;l7mrk*L)^;>WHsR#pTJdVnMm3(8YZ3O8C5s5?wtZvT-(?Yd6LEHPIK= z!Z&aVT-G2&%gP~h^Pi8kb5?0gu~t~06Yi@c6}rmB=fN*PhSuHW`(v?d&bLH$b3Zsw z^M1lRzdYuwQEB^uO6{k!6AR-2=V+Vh?=_HR)#u>Xj+Dvk_`XYes_L1DpsJ zz<#&F_P8Ih*M3ocU*?tqJsUr_9$365z$6cZ;U{|&ZK))$NYH`$oFc&4I!^gcCfMFE zTa&mYk3ga#icMoqf>r$wDtspDcImY)gQ*qP7E?SHacT{g6S(@hbA8+Z?yQJ14g~YZ z@5TzZyjyQUXO88Qk~5Xo;~^D-VXd^S?G~lwowFFLnz`GX_@S|)y#&mkFHRfr7Ewro z2Eyl(B=fJQm?MZYD2fla|8zORhB%mNc&y*Tv0{a7kX@pwLC^X6(Q8aP>a6 z8(We}=&xA{*Jt;b+|#9ZGz@`ZDU>vA{s)2O3>o^&F>lll6~iyIbNDPMe)9StnR5EM z(+k9oF)8C1w~T5LIQ9GHPEv&5NDrx<8hc z8ts$R`VtNo&vwBkXbF8TtUHc^Kzcqo3v+VfVwVDB2C*qhh zGcJc3mTDyTX3MMCb!d?LyNr*jasrr~<>9UzUuWQyrqosoIwDI6P15MR`2u9+lydh17{L&A=cO}Cs zSf)c@g0f0H`*V!g<9K2}KRaVdbuFqhqo1!5giA|bM7(`5x}FwQE~eJv&U&&?5DYgV z@qv7TD_TTxypgEtZyF0)gL5O+Sw!xt;%Dzx4REvCdc4AMEfLD6S*J~H3QK||9k(!e zIlJarS*aEAKx;kVv8`(LKxYcQim;;#G5gG2$aM^@lDkqV%8#x{GJ~`jkc(87jrG@G z{cM{LP5{^^k$xF)93C;EDpMw$O6}LLC#S zVE#23$_k7r5Cc6VXCSfs9kYg(QaaEl78$e3?E;mDTx-cb*YKrV(+tfWC&_UjJpV@r zV`Hng?8-@ZnxH9`e|@l3_CIjzbd4AW3TYZ-n+v-$l>RrhK}g7_4)ne26U4+hvHn&z zdi*V!!M$;^TKuts-L|Pj`4-+Zs9)jc?h!w-Hbw@ufG?qLALstF`4pk|W}Z_oJZlko zAh2=fcnNhGN#x-U?l<*?CBLirjrQO4s zzPeLtul!xs3^$JOjUxba{a*d2H1HoKjJ0kD#nCn1OP-0iqaCq%t!*K^g0I_&Zs$aZ zvRSt4m&B^NZ2I#Hp*GFJsQ1!~rFO2)b;bE^kQ7$i7mx83%7 zc~<_DE@pC+y?Z!%VSI0XZjN1`b8+;$P-cHIVy4%h9t3r+p?{En+6i!~+(Q|kdlugC zrAo2h58hR9GAUNXetl+Ici`r~kg7Xz@C;v@{+ToPeHmE#X~o)AQ_r70%a_h*-RhmW z1kI-t^`5q|G?m`ri!ECPi7??N|Caw|KCk=n36L~vUinLosSiow#HMQhr_7hOp&kop ziT(D&t)-6>WU2QnyzHR`mGLshCmrK+wpthpKw=Y=I~YQx#jFjzK$#DHk(Fv#*JWYg zj&O{$3$Ycc7)sBm&dvFbIGSr&)NlR3Yo39cRd;n9(Zq_`U{(a=N3Zb_aYYYx4qlG@ zm1RKLkY~J%0ma0N@#pblUoU=oZM^#Kk_Ew@&(s1v8caJUhQjoQDL+a{4K%9PlJyv` z$kvt)kNcpRt@5UcJm_~F>PL8VGNRW4E3$sa!@qns5yFB>A2FB62SN~k>qVlW_+A3i z9!vgH^|zpb72%LAoAl@E7p)m^_*xItpZq^f8ZdLV*``9|8D= z>;#Q%($!s<=VeH9PGFsoP#=yBm_5w|Sg@ru2Tc zsn3PGc1yvGz;E(mb{4X(hfu}qqsVKPy9p>1#V5pG{;dFq?};%FkxZ+esxIchg0QvJ z(df=MEgsr2_8WM>rQI6WU$W+(a3$Mu5)PR?g#K$Va?k!rKpESo3o?hB;!Q4*bKJk< zuShdwnQ#fP`t)evY;+P+`_^1j*>F&7Tk2eo19vFiH^lD1V0wwaLq3svzk*?}Xd+Y2Q>u;QdEkU>vfcA^KX+_EsS+gaWj$MCl_|Y2D#1=w4CUP{XVmGEfr(Mf&Xd>(Y=*PK^`q z0SFpG_&DNv3d}!`f7X7qW%xsR>j=H}Gz&El0wk+46KA-pB+3A(CY;h{Kd$*LV9tWs z|E8?85c7Wgw`EllwOAtzlx_$w;*l;(>nJg5miD*n!u0_|leQONpzOfzY#Q?K>NJR{ zYYVtVWVLLnx7_hi^{rz`u@ZvYwvp~j?fu9#=MshP1$h=#+eUBZp^8e^U8;AlHnv`g z&M`ACD}SBybAWtR7UkJ}Pz~pnPfOhE5e)Z>irJr8#fe1H*?UFe=ke6nJ%e9ZQ#;E6 z51PtkN~b=e4r-pZnYQ}vAJELl8u;!kUGSP!v39&`k|TF@=b0P(+ZdZCPm!|Q{Z8IG zNhrKOdLP4Pbul9}i<%v*AhEuQ&7OzRiG6!yW^Z9#InS1|W8+!ROya=xUcKAPl6rwiC5eyeK+ZAvGekkEa_<*)vvz~vW$N_dRXJ*q#1)S6SMS#57!LsBylfHa6gNAOCudC-C88I~YzI-+By}f0#f9^d z5FJ)IDxFzK0MSxFV)6urC4HI+uRAxfQCodw*r?HjUGF&aD*XG zQuU|!LDEsjjB_MyH7cn;D~sW9w=k4xH{cu$792i|iTu8~x?H+2zVo^HNLfWgjk||L zay+NV6Tl4-9pR88;9erI?SetD%Lct!E68$(AI>jC<6D9l#hbf(CnocA4qTv&hA>#I zn>u*U7?>2g>u%=~$A2O%wF{3wkmB42q({xpDpskwO2Lo(6Cdj{`k!Xq zXMIov?)#vu(6{#jNIUx-VLsXCxV)s8Pq>S*UCNfhCf~Xew#8@2jGH+Oja}DOHCLjmFt=3*E0a>@7I;Hi3thNYJa-l-QQ&Qr+X-5*pP3Q!%Z6J@L%H1x0ge9 zEZFFT3Dd^QXBWng>wcUg{(R=sw3)EX3^6oA487*{{to)Z7VWg4aCX(6HR!SR6H>ED zYR)z5%_gR~`~Sv~V=03G4gRszgc=G+?)=?aNuP*it@i~xi zeOtsX{E7RN=XMF&4j8^LPs{lj93#KFw;h=66S&I~Y&+;qCIC zAXm+yAeLYxhg6Yj9Osj0vC-!1)of9Cw!94dD`l-_BG#B-%?+wLi;O4)QQ}Sk0LqQD zx|-ko99q@Q&8iQ8!mWURnl5Ocdj%xaEk!DxbNllN`m0p(o7P5l%9A13WhwkmmLu+_ zL`gkJG`TKJF?Zpx9P{RHiOT%OI^EyphWc9=Gi}b+ym`!I4q!AmGOCREcPmmWG71dw zkqWI;L!5XEtbnsG8#PD3bT{m-{{=8B6ksRmSVLFMGsK_gN8``1Ir`xlW2bknC_0LL z9VF@~!E{nMreU%vOf2F5|pAN;CeH*TQuxtS+BsS5MTYKv3m zpvtiutfN2GQu_9=r<8BZYY$4dp05f27bW%i7}L-c#fjH-Q}&S(n@icR!Cu~o^q_lJ zZ(w@7Zw>#dW7WEVsV=gat_+ua){)t6tWhSmo{sif@&_>PTqLu~K{9cGBWgvv#V&8? z7b9;J5q5DFu7a`uI;Xo_wRDKvk>3*kf!?hgF1*Iw6}zv;mvV@k6V<+X7G}xQARdnJ znpLqodBN(H=GpvG1<#nQxo8WeTYN6?L(-Y%!`A5$gzKA2eO8lH%hY%^1yGnUE%DrQQL;r}o%_&^p_ z6o_ZoIql$!4mN2bVJ)S&_FD=j4! zZdw=4Eiv!{#opQ#nndSO=}YsOKxAV?x>R+YTu3KlS*U-mXD=r~vF7q3GU{Z%KFAd6 z%T6-?)3d4J9=xzaLa0~3k8)3F%Y1&I!XQK?z+|CGLRKcYjjbju$MyeIXVCxS^1U2y zDo!)*&yBVfdz3c|3vVe~(TbtX(1N47?6v0KDx0?P$2W&36V~l8MkY8H(Jxn5?GjFB zPj^dxbhlaiL?{IAa`AGe=YPJ4Mg74h$A6mUbx}CTVa&N#?WaMO+ef+cL;RHr?)hM+ zaA!uii~f%mSon~))BKg_80WV@p`rUk60W+|COj|hd}z4xUclUJ20*h=WL_xF$Nm#g zOn#OoT*#hT-V_HE%Jb}|(-y1B#q0HPMO|%!PhnWdOWsfz@9lv#@rkrMWy%+d$%21Z z734B--GaOe1>|hNab@0uZw6lWTsOJ1gw;$?wji>59U+zxZ}hAMi9~!NSS9FiTjW#h zF`eSr^1@j~P%TtCcBNF->_<`##B1{r_~9pl*zwo;74Obf4U0ytXX|sOH=jssn&^_+ zTBvz5oBtn4Z~m8L`oDiq%VbWIPFY&HRaVqkF}_W416n4{X_U%Jb0e*ZDHV5-z1`B( z%E~DfYHG4_K{Iy&OL0ksazk7|K|}>bKtMp?=JUP(fa`~Ad7S6Xdq7?})h&fg)2j+f@OA3#hsl4nm z(+hPuZ#@%86Mh2H2gvTtWuqtGG6^xf{N|9*O{A4_+j}l&Si6 z@vO2f=~ji*TlebGt@iP$Te`x2R$!RLuFmnxi5tK-lUl7DbNGM?!?%uShrLeFqv@66 zZzrZF-vg4)-{Riu$_NncVQaU+Mcn#{e@kkX6%#yaPLJww1Us>EmY68qeSRY%JR)oH zzJ6*1@f**@h-s@GVtiuP;U8m_&23S1w(XO3n?ReK?)4#F{?i3B8x(H#V>c}^YgjI{ zvivyD@$=9!Xr0{4&i*+ZOXt`Qx;>6v-KP}OA$#O3P_+r7xjV~MhS z*wOgb|ANOrqn7wK{9qZQH7^(4#JCpdmkhR5rqUdOPl|_cD$%<&aic}Y$hlM`tQ4sS4F(KO zN!rcb8Sy5XA^_wwCouj_*vu!iBv(O`p_TRS=abp}voCnd+#MF`;cv=Sh~;S9SI1`} zy8?3h@JSd~__1d4?f{UTtv#&o*@!UdCy!FLBJ97Z0 zMenJp7N^Eg2lB1S0s}A7AqnMGdTXZaLF&ze1rnP%Y935>f9`7X)R6y|i<&C{ zywZ4b6SViqg(8P(t8p8chV0|(E{FV;yd*F_+b!?-QV-eieIqjZcR}Ncn(J+EZlkF8 zq)*3Y@_Lwxefi1@Ix7%fC5rSss!M4NsLD773IX0A{5?y5doi#U*d*y;Q^26PDHR`p zoJxP7|Lxnlsigd{y~LY&5=i=v#n-;Tn1MQAHRD{Kr-RK)pw%yQhatuBn>NAh0N{05 z7YGh{wGK;hJCog$xJ8VhHCui#d1obJEVTr{FgO}Aj1%P6b!CpY4^IQm*a?`jYKp}} zlqTK>*p3;<($HR3b!B`L#K7za4#F_*ntZE9zB*yNv{Zb&UVbO~S&805_h>i%VoU_C zdanAv+z1=ZE!XYkE}p4-zz-`Joi+&c)38L&Fpz0jxcJG@ai4nm^N?L;mAhQ5ct@7I z_X;crabHjVnVkBxz|(g5WsPe_GWBn1Q2m6zakWYrzgyCPR^FL2I!}`0!b?UJf2zHI zVavBcd-P$FRQ>(sT^W7t+M+^z9Mwy6JH?qCJxAoz)8%2@r$mdU%~p9O$cfnh*x8q4<0KJ?ij~Bu$I!u2tmrAt=%f7?zDGB6UY^&wCYO zJ{cxixGd(pLwx4~eS**q)vTJ~6Rd!?)kD?fPwu4p#n@p?^8Y~Rk4e{JNbyaYt)OQO zgWRgUvY#c-Q^-=r`zyUVYf^NpBU$9j>eVOu8UMcO2$z*0&>Jfp7p#^s-DV31g0YK5 zMX00DLof2Z`<)5CK44e1!_`tc<5boQO#Jpi)zJOZtp4FD6g4l*?YuV<(>uDioojW^ zX%s7f*^BiYb;edC|`t52a<#Ri8hA`KZOs-jGRbB`+v3|7rz{ z;|NMU{)|ESG-v(DwP`PB`f=TDiXIdGXEHScj&#kGMrGIXviq1d4vD@70^ifVC9Dnb#N8cDW)0u#Hyh5WY z5-8$6S-V1(AHw!dwSn8GCc;~0)aI=QYYomSBd%9#E+P@iq_unDg1o||LxVl@ZGP=F zVsL~&dp72yGOxl=;qKgJPfBqvM?a3kiI&%3g+<1l##qur`+8Yn2sVj-HNGA`cgI!@ zN*5YGq56mgW;)bH$c&mlInD#Sm8%A?JTh37mZ9a18${%-PW#nyhWS4S5mMXb7v%r5 z=|jMAf}iHd3Uah(=G8b-?9VZ*9Xi7#-9t)$GVQqwtL6&Fumz$GSiB$aA*E6S+kvcH z#avWEOZ7Rz?}of5iej|FJn^<^Rcynyg%{)z{r)Bh^d<)W%CR6MIa(U0;iXXO=D?hZ zwId4qtW@v3!{q&P`W#gd7E9{s5^vhel^>!Iv*p{tpxt8KfFr8Z=}E_X%f*##$vF#| ziYx5MI$`=BL&}`V*q=YuY6sn_!RT1WDo%bCUY6XFTBS6zA4@PFGb~K*u|ohe784hH z@38~w?Yd_YH-OZ!0@w4f)OY5?(j(9A9icb?5qg_nF)o+s!0M^l4F!`Y7v8_#_Cu}> z;-Q)MCC|@O$UkR6F2#8ipRZ)gS5_m12MCqo74YWcbckGf6Z`je5t| zv_+@pw)fAXzmXIBHqaO+wKtB0D+sqAI$PjDA2(Bg({CdGQMg{ocx^Wj8km$2h`E^4 zLeee?Z?PSC>Eg2bM~?T+66)SQ&|e(1T&dsE3~x$zKd*d98r&yuB-q`mFTy}H#k5Z&bJu?sErcTDn|fEe zm28(Jn5j2OE4Ant_pbbT)Og!5fJ&OVAsjT}^V*7G@OKb8A`L0UP2N>ji1nN;f}dim z;IwM}?}1_I!On%IbL$FE5OH@_GM;~)=S&V>2IPYqo?6w0aLVv$ZIkv$Ss?CwnDdbipvyH7yOG8tzoJ&cbK_uEfU*O^`QD;@hf%q<@f5bAoBi6M882 z{L1jwNN~qn>T>WP=}C}h-*dK_B%00*0>{>v87p@;U>FMZ?oR|Lp8ju&()lNF9rXJdwD)J<)C~X*Uzc{9*^^6 z{MCA(ZPuLrbUQ7zexWO)S&Q0}xbVoYrui<3xkZ|^r9|<&Djol}(a}o%cJ`7@sbZh{ zsr)wtV!zGbM9<*hdC+@OkagEOnY$Tesz4g>Vdje3oF76SL~z%+iwtFhu!V!{bpIM# zzk{dNW5JWCog|kWbMu2v#bt>fL%d zuQ@ySpgs~#!F_2ICssB&&uk0+u)Bj%6)<3tUYw>NKkH!ud?nf&levwmU5{ITPL}Hb`&1mkyH;qIHdkz4R z{SE(MKeC|;AWaxPK&Ap{sAWxg#Hg*{0XzNcOx3^8@&fJUSQ7DXn%CcRFLr}ntLH;4 z=*#f=6M=hZUfSGC}9;VrB}wsZ1F);bInSwEo_ zSb)O#xjx#@_bZ_AP5wa5Z7R6e^D$p|i3-~7nR+A^KHA+QUN?E^viQgDlcCTn7e=gt z_a{#N*Jg;>l~j}4x309Z>0Vv>1If##uP#qUrv8ajDGxhLC4I1Y6FPa6nZJ&9Bf`t4 z`8*A$KP<5HGEBuArpT9xx8ITEVUia`9_CvZ`-#dYwOntr=!22$ExKz%1=n35vdnl1 z<}Wkh50b{IuZ#|N>H-Xw+Vj0Dyg3EjYIO?+v$7+ zyj*CZ*~JKt&32XyjOM24L&BhJi`Ia{f!c4DPQr7@?P;=!QOgo&Tqwn2vc^LVT|t&N zGU|3T!eV(*G0lK{p~2o|yiL(~>9!&~GU^hsp#7@xy%CVc87;3=rIE(aq?i%TylA3T z+w=wCPP}@yD}c0cO=`|t(B}+ENU`q`GwSs`Tza7K%XG zEpaD%#5aM)*2k#d!-m35z@d1w(R1O~;t?*Vc+mSXCL!nZaQ#O-CaoibncAP+o-H;_ z7Sd>Cj{?j83&Cm}kG3j>x`&i#qGE6Mfl9)OqP2>}>CS#IqA3(mGdd+JK>0{sO{8jf@wcBi2+_;g~7u0T1nspy@_Z9W&4q13LnbR@TFZNl=5-A7ntxLMfbWAA8 ze-dBa&tkSUjAqMZZt(}8XUb18yRl3B zA7~swPCl*5)c2VtcWz%CIEwfbm|)$vt#pQyX8E79rIURn`AtbM{;lkr%&9IjV3r!G zEqy%yoh$3nNgm^@M{Wsg-S0*}cFic>usAllMb5YcTYouDZie}n2Cn@j*sZ^X0Fcmr zm$VF;0_X+oyw&c8;iHPdiSDhvWpl%0=}foF>g*?KPzdpz>DGZ2#A-`Q66YU^B=9m; zm7=5Jr$fO}(5t4%yU5<;v-w}cnh|&ed(RkPseiuJnO+4K{?pU~aOd$+iG(giULB6W zSI;X}C$_Ty^tQe!)C7yKKRJGGeQk0GR#DBV*8DWOG~LUCNI~R<9{t4Tz?}5XDYoLC z$Wr>J;av+Is73h_C!;88hXhN-*odpsmPXN?V7F%`;tLJHhU6VakIE<1SLwAxa`YvN zG+Pu76=H`!_o&|L)-ceFAP5XSmcpBSYRneh?PGdfr3#8Y(AF?zDXT|nPL}VcJPcr$ zyIkNw4Rx0s`$6|nX6GL=%70u}7Z_GIYW(D%~@dH9=bv$o@S}KF}H1t*W{qFDG5Q zcKh1<^1)c#3dzX?0>ir4CKSHkaPN3rb1m?pWWY9;kYAiSitj9Zy#A9r68M}zH}H` zK1AP9E`Q*xOV3u_^zqJ*eax=}0`?-#6s>NJd}D@XBop4SDwd1-vWuJi$sqg%eCjRD z;0a!&A_7EvT%l~9KY*l_f!Kh8;K%lbdhnce(ZJ2I5}e7>Ny@fTZQBXGPnLpy5smy) zJeKFE{|e|(mHvfRH4K94270Wu`zLF|{rApqHMY(uyemgRJ`Ah~_3tn-xCuaupo?QV z5T1EfwbX+7yC}^h-KYFD?Ap?%E^1TlmIBt-fP4v;8Ehs3@4cLC+NR{6>kXS=mCvMC z6bIXX9O*NR;CP%77-4hbeqLu7cwkWP65B)Cx&&$)prxw2Q$%aMGa|^EJ0=EJCte#` zQY=z)UupeZy;yHzH$ujAS!|3ly2f%Q8-eG<(!kjH$mD5F_w@7LLym(-*Fb4A5-H= zy9(q#G%VsKOSy&#SY+!csiCmeahFbDp={sb;LTzToM_7bK3C;40RTzgVD)E<_2o{= zw6-@sI?AnkN8C~1xt}xFci8|s?&CG7dWqYBr?->ODLY8nzzFos*NnhrVJXf2l}{F1 zV@0_3IXJs$!;@8ze{-|1mDPaF3?53Es@dGPmoy zS48s8jB@*!OP&`{fkhehp^eX`Ii2)jmHuHl)uVH&rcxk{s8sBnQr0ywI&vU}=<(ay z#__Pxo+y!rpn6{Wn^__wDu{3jA7O(hb(yzMA@+-AQTQ2!YNen4C4441mZpA~v^RL? z`F}0(fx6Pi1nFz>wuvxcW8h(ZVmr?+jfx)6%niT~x!pU*8aDGX9eQ9Ym^Az)c64Fl z(;)Of2?jQcMw~#}og$3n#SZ8Bo#1in4Xb0qOi1;3f-U_Ks!p>jOz`ypD!o^vZbjwA zZ=c_4YgQ!lDWTF#?P9z<7??#U?ShkOKz*x2pCLS;oXIG1rJ75>dFf#rGo#zJ_ zG*~rt{im;`>Rj0FvNeU{K0BUScC6~-E9aDrsC<#@KGnut6 zHXtwwrt3kq`a46uz{GV1LX*ZUm#K%>a6$hZ8?}UfRRZ6FG#{0XHi2))%=d^-b z$vbe^#LKr@UeIh)fPeXd;&uG3GfU6<24A(AsDL)S6CccmR396GO^JC)R#i~R%S(Cj zkT*jY5AaNiFQ@2C`IMwvY=02E5e^US%67b9@$VX1kF8a`DTuSeU>d!Tv>Q$IW+1U! z$6EYg1z5PTRA8evkNt4WPy~e#uDK!YsO2@1$xusm>B5zufY=8;Gs5SVF8LXcR^zVc z!q|6HH(GjRO-cMU{ctCTq~W7YN&m&{Du!U2&y`*S=F|-!yUmt58o6*L+LuTi6CaS+Cpta$ez4{r?`1-AcxHfeZSq zr)f`7L*jR%u+eL1Q;eqq3y2rP1eIZ$%^l9>5yphJt29$ez(@12&pp<{`*FHqrUT9U+fh5G8%v{a`RT zR6!EFP8(I)beAjhy{3<8%P$7G&#yzhZ1 z<#%)rHTm=@bME;4d(-H(oX&aXz-*`>1U(={DZ~L^3kPt zen2d&+!vi8%m>~d3E96>%{*H=`ztbBZhg$*6uiM=c7smEk>|ZuRQQp>DTBfziwmDt z7(BYJ#vDpZ!>VL#gwuu$hp$hGc8o{I?7CX$G0A9usxu|YN&dkxY}Gy+!hJUhB!rSJ z>nH10_YXct9+cPk$xmAjIgR7O$>ro`gywNmlry3qyTq}1?kGllXocr=IMDCc^K?}7UEyx!zFT8BxTwQ5%UFPyOFGju}J*% z?AVz|trfjKa-&WeAD6bPuJs-?;^N7dKG(~`1K+r|QPbruESkRhs^JiAWdXo62tEzd z96-8pE5gZNrC+A%ng&t^o8P)x48p1*GWv&!$-qpi_$k9g_nfkcoI8MYzZR(n_()Gd zOg=^15!ga2$~zBiERLDnOp4a8E(oe0ZIf^(K4m$5V!wj|21R-Q+3W!;7z+|-Y`dl8fh#G(3_?4~xgs|XiS{zZ!a3kBOY}e(9zLNYfv?m49%RCmX zM0ZeCbf8W38OO%^%_A19_WOC@p%WN>{g@SL7a7)E{?C-iH7oH)Qr%2Ew!~YlxNus$ zPyRm$Cl=XR-ol*tv|eWFUnUAsS*r#?p7p)JK?1uOnp0$!rp53--Aadj*NsUFPc&3C zl^}E}v>5eCqtGJcEq#|3H%|L@neh_@Demc7KkUui3P9}nOb$s|W+t+0{S#ILMXIPj zs6UqYDa~utO zfs_1`-*VR&{xLnOC3Cbg2A9J3uf5ZOnjTu3O|i4XOrLh&kf@J$9RC#Q#= zP#VNG^d8#=&F}ch<)7Q1UT^w9XN?(#K2?8tE=|J!OZ<_lwT4yN#%p2U zICq4jE`>EQ!K^^N)EBXug3$y>;+d0^`kF!V;$?+c3s@{3t?+yttTGt@M-*0Fm4!Ob z<&zWVc~)PO75ID|Ww6EtRt|yj`hQ3~z+=K_1^5%SIj6qG9bEU3RfK)_Z@)g!!Bzx?6R}5(pd2tMSNF`aL zWW10<`fd#OPuriNQrBUShlb4v=?S)p-;|L%3B(8A6mdAr1;@Vo!QG^DVwbC9jT;t< zVQl630DsMf`u@fwr|mV+=^^OsqrAE!)MagZY;twmxg2FzNW_#!1f0t12$*M7wDsv6 zWPbnSr_z!xzGm)n*cnLue9{J(gS#l0g^B2*{Uq>3$6)*@PI5%E2~PEoae1IUO?Q(nMI?p99*osA}(nNfLS)zOK^2e({NhrKE7{UHe z?0>M1{|-Vu6GS~J!X&M~VJC(j6h#y*ZYNNkOp57zQ)1&D*+|zQy7Cbl-In-8wQ6<; zd2Yui_KDt>sh@>TzF&NqM3HyPdJm_f$E;n&rBy=Q_6)w!sh=lP zT|#ZJIu2(;%)i8<-B`lv+AVe6GV4_z_i;^mo~2>ejOa}AK|;(Kr0kO=XTM}1x7@S0 z`drSnUKqHvICi6MfJ#7+c73|y#C{lGBl39z8wBn%H2S11uYtqbs4`BiX8+w0dNEwM}Fqj&BKStg;~|=`Spe$?{p6U5m~Y z)TKpj4+>2%L*kPD_)?t6<9s6Kz?ODR(N`Cu2OFz$K?`8)*f4H)6F+|ip2&jrpMhFwL|o^hF?(j}U$Rc~+D)HpZ~@uV=Cvrhg52^=(YkLLN%cqt6<8G< z8%L=|w4G_~uv2t*-%-)pSmZLy1%@~9P7n$N^MDysgUI<>_hQ2!&lYJg`3Wyj=IvR0 zd$w~$AB)USi%WqB6Q+8(vnKUXNpf2rFly-riqX%p&Z;;^5PqowLDh|m?ABZ7B&k3FKrlV9_052owB+>)0NRU2hu3b<(?DsXbrY!!83)lEmOR**y3KIGGk z5pxR#5tWv0%pk)+RB5|vGVY+LnO%SX`}5vMW&ZKX21nOfG;n;`pD;qk^h5qx#Va%C zci6ymssvl1GXeT@f6$o&T>--*kDdg-UNRs5H8MIPP#nyi$vpYh32*rJj?4UppeKKF zgzW_WYgTj;8ft~U66R1*9|xJ}r$7Eh1nMB7&!a|&KYBjYR;M%A+@4~R{`p?QyBsTF zRShK}Nur%h4<&AknTyoKTHxDy$FAMY^S-(s2QyY*r7bPS!bkub)D|Hv<(YIHm|TA~ zTQk5b=R7U0B4jL^02!_Tp$35{%17Ff?g zL!uNuSiMEj@tOhrEK9a|Nm;tEEB!$hV15x`_DG5@I;O+v3RSUr%}h?0ck7WaJw|hi zBn=pAxA0(6Gnji$f9cm5{Jq8f&!yRlO^~8w#hlZ4rDb+=q+=fUG{#qfJltfpnDN6D z)oEeHGV`zc$0So(b$v)T-bPZ?+(972OR|X4U#X4gXO}OT)Xh^SAHIjqEG98CQI$1a zU#YKtUqhml<=vr5HpV<8+j%8RyMbL+MhZWJVv+m`gjg{k`V+h)?rTG4--=LsM`sg{(>Eq=o2%X+r&m6U@)^n60{L25q37f!c<$uU*{h!a^ohx0 zEOxXBA_}t?e)^jdUTUMfO;87t3r1DrouEVTF_`RtUws+8A<3|s`BQtbe7zbpG#Y$S zfWlWpD0vU#J80+=bRA>u49wf*d@Yu8%246PH3@ugq1ZIOWZkzSxdlajGue3GwGsB? zEHBcm`1vQfXcf{}aaxC7rw^B4H!x(q+@PTIgQP>qGlYEQ0kcCBW0L8iw{6 zGaDaBP0F*)ytJvSj(jOyeuqZ>>WRLy^i{minv}G&+?lnF1OpdnUt1Wt(_@{A3{i42 z3m_SYYP~w|T`%e-5hWS?(j2&nn(Iyv15dnNC*pQiIqf5x46gAeC`IuIp-|7!?BrR^ zfZ6~_|AxZebj8mxT}lmw0HwOpnn>_ zz;4Z|{94kA^U zv%nc!^^b-0M|j!fsX)S~xm@oP`gb%}OWM@8e#phG#Qa z#p2%ZG2e@@k0M)GbLFMVFf+*PT$5K<(yiqa^@|t8g{A)N3vOgnx$${snOrCP^Hg2-bkTU6? z^YnwK2r-SaC=vZ;bSsRBJsUD&d!DEu-pRwpWWef~Qh}8;JIsK(#JIO>3y>OgRZW!?qTBCXT=NDYBA|AEHVpD)A{(R(4U4|m8I`&W>u2E zbHU!M%+-$6N0G~hSINe@Rf~Z@Y97Cp%HNtwR^AVvUTYk44)(kcN0#~PD%|J7s&0^; z3a6Tc$G+YoL*BQqox+THAFCY7M-aa~TC`*CY2=R&co$NQq26IGlCH)rb^IX*hFQ|D z@pc1o-EDR-HVN&%8o;S)+e%5ryEL@PDUr0xY=%wl`27-;WwQP^{$;jf+7j-CsL>OU zv{Io;+*~sB#!GqHve8|5lC|exg*(MvTvkFr&=qyp!5f^$PlpkQCe(IhM=#F-zvlOW z$}M7BYGsVy&k!XY9X`;fj77F)-p>605NE*0%9%q%IEl_T1tV7a;%`PT`h|>{wc6YoqQHB)vO;VXD-w@Y2Un%C|Il<6 zi_hk&9fEoiky8GJN?@)wB-T_Dc86}q-+SevnQ&d#fWh3wJ4@T&RJBK0P9uTi;x1d- zR@q6O*1C+O2n+x3^uErjP6jgGmIj})$O`KwPoB=!Gz6yE_Zm6B94obLcx$QvLj+P5 z5djN-)MCAX?a_sHFzrPi*V*t8qI+s8+zDQ2bu>{4&(jzn2#3ILnUWxq%KJW>_~47{ zi;;7aPYOGbLi4#I6NIEBot`PgF^p&1-&39y_)I(yN6IFRpOA#43&mJvJro^yW7)sK zcF-&hubr4BU6pKYaea>n;#1#?a=8V!BA@2#N)Z2%3VculU9;TfU?vIC=v3$~GI7CF zi&wdO$vsye&DW^Sk&v)ULtB(_yGdbE!_S2-rYNRu8fBR^3VpONBbo>rN1G*nY!oj3 zgbg^*UOb(=ZK(~>^f@vqTJ2t&fLIO~ibi%)zc~0@C{F>EvepBn#TUCkM*I<1lw$Fw zbZUk{UV8M}xX$|j;qi#e+rL>p2GxDO8~N>lZLJ&nCP6U!UyLxX>Y^xm#_RyF%O7N< z{qWK4s7)9U36srUy#(bh{x5vaKdn<0#Xbdz+%B9kdI^bIvZ0u$s3q!ZjZ-|m$-dog znX*Xh#$5Q(qUc%Dc-GaC8gR?}Jnc6n%ng1Iy5 zmJPz~VPpfW|0JYynEs)Jv?5H#j-+^DUq_y_t#LjSdbJz$zrw(?#ivP0rRq1y^*bB|Ok>RNZ0SC_m9|!X8xl#}Sia9_;9QQ|-Q*>{>0 zJHU;~2ZM-mQSIbgX9L7)(1uk7?n4hsG*zfQQu{U%4_v%5(nn~PSX8*Q#Q!axC+h9E zVjQ}72aKml?)zx%&Q_7;9Wm)s^F=kr#G9y4X(g4Vl|AI@4%*rcC}tG^^=ygtLqF+C z%z8<`n*D#0;XIacb&jz8VZ%~;p4OR_Qi)>DjbissGw$iu(RLE5N7mi2{nfO`w-R)dN1hFWY z{R1R?aNw_4I^>R0$acUR?x!nDbO~qRBfP@wEdGu3qM5kmHMqscjx*tpgYj$7so*=x z^##xna>I7O#!NU+oR@s4m`%UUbm(XiwYaencO{6-o(r#2wW_p(YUb?w9Ft>k_YBH0 zfy{1(uSC#Et+YAS`_VgmoT?_fU7z z&&K9xB_s}bidDznByNfX^tPXUs7I9gJP}36XniZy6`~ z>AlCWwfbycQ!23kdcHNPUpbo-z#p|2Z^#us% z3-tF+);bFZ%bYR09`#?Np^(UbFfJ<7uSq{sd2?~4SoqY^K4*65pU;JHz^nS->iB-- zY+KOyfie~)QWt;%GX)O zzapWu@p5;?n>yb!rP?Q~FOVTC7J;yfmLxsS@uCU$0@z0inXJ7iw`tJn0)o2bglMD# zo}0<3zQFo=#0PT3A|gn&mJUWa8SD5RKyPi*=Yk*XD_#luQrAq~_u%usxkXBqd1_;15_s1RU3zT|Ryx^QkLrq2vk6LAdMz?-(jTViyn7VrU;`#@qf_2=MI2Y`=^qr?N^{xpqf3WaMw`C()8dHx6XjW~9&(LT%+4n{P1DS!Ak@__^nnl8n~e+EM;m zWrq}mt<4;UuTC2d7@HvmK8@90_B>5kc zv#vqqiJe>Nk7x~v@18GWS5udT^8`ljlT~44EWM|W{k+SGc!t0~B!3$07GkAf`i@dn zy?NSW4fzd$;f^y^tCFh)6!II=7ArC43KMaJeZrlxtmtB=n-+RGVpSXSch=YY-^8x^ z`e2LYU^p*Z)dRBjR2=jR(VM3^XC(tYHxOOi2LsfNrz5fU%_TV65gcRRV0o~0ZF&)J zU$N9`upDhyr^DR^%!ieWZO)^z;&x%=w*m83F?p;R>=ZSm5fE!~n8!9vK{qU2EiVv! z4M61yYY3^-#})M%WAH*datHsM{zgxq=#EMFB+uVfj$zw4PU(!~mSHk2k;}g!duoKq zJ`nwfJexxEQM~&DtFjZ4ei+*qh3`SdzbZ#{)Gmh>sBx3}bmQ1jFxXN{Tf=hl&_+s$ z568Fi)Sld)YR^ZAk38{q%aypB`sFBf@8UI@FuOOF5Rk^X*ma%5IQn3)1c;%|*#iGz8@ z1zxV|An5afIAy!N2y^=3ZsTg0it#H+=CgFYB{Z?jbSstomprhdZaY!d^?4}!dq7`L zGJHt~FIjZz<^DZ(QGNUo^k5;Qidk#(#o}9bN&Y+hKB@3mTQ4y((|7u0*0-?sp7xVV zhKGVXb&eZKdt|DAn_PZ?;ZG;S4-Ft3XKhC?F_v_XNG6_>ex%sS+2ow}Y9`dTo($Gc zEh<0N4gL;k^U%DbY#S&A{!YMrlno8!RRK@=)SNrdZj=ZUwA3o!kItZ=2Ul$!$E)2nGJs$9nQcv)IOg1PVjgKZ`5u zWRCktsgY>Z$JQ6&YxtdJt-N}w$E#E?pCz38hl2IrQTpBzW@r7DGV$)P%8QqdViVt* ziS2D>zE*1hAv8HABiM7aqJA1QvN}>zK33*9u{qez`Bi&I?5{@Dzy)8IcS zeFpD%)^i{u86Pd>Nn@kpy6Lj_sKd3X8j^%$%*=;9?#Xdp7qd*!8Z3k{XHT-Cz_&DJ zuB?kx1Uk)&T+kG=7+YJv*mS}tYz4fA|9r&NnogKczL>Uz$(i5E+51dySkWZ<9NpBN;#A29K2Mo3i@(6Ul*b8tEMCtXVp$#HIjOG5iAvep?IBV(LseP`y2 zcaJBEw_~EhE8biGeegVW2E3Jyzv&0>ztY<0nkch`&cZ8Y~W`12)>L|2eDp;cZEGD&)|cexh@9Y zUss#%TO+hZ+4)z35cQ0xKnyB?4(4ig;pfQWy9qF%RI65H|9cYy4C z@dltVMd&+w8UdRv9#TGEUj%0V=*>Q%;_z>`VQdy(){VeDxB9zl%Beo?&#DvW@-2sK z%pQzn#by^VX2n+=BP>bRT1<%N#VZTLrGvlZx_Ca~ z^%z^73xot4k#(|i$Jl%Law|f1SzS(g2(|5PU@ge|#+Xa{G5~t3%zU!w7nU5sB`RX^6nXY=g>#lSsLJ;A(tjVgqSA z8RZd&bm?W(LrT1bt#g=+6j5~=(>No!TNf&ke3GIeN5}a%v@LWXV)lMirit zaDJ%)m8+_HfEFG3Lw#Au9OOM@4(B^|M(X#`P}h<*MjPE4W;+%x8{hw|o{H=kG{p^P z7##r(iSUk(PO=(ym-QCLOH?xI80waK)p>E`m)4ib0-G)jd=L}~o?X}0;Ptg7^q}&I z1tlbU@g@z*m02>@Po)SSeL_U$UN2kHpV$uH3BMSoj|QZe7o394o>TT4wSiyDnylx_ z9AnoX1_sxwcaJp;3C~6%*5jY+WWDg%dB@(fW>HyHg2AfW{Y>wM*T+^DnZf!q{UNBs}%c#DuTqa&GEpk$7$FJb8PLkR~f1 zTR->Ic2vSzmY_(Ss?LM@`^8@IHGoLYs9a}`)WikgpOt_PfwVtwi=9~FmN*Y$ll$UweW-&sZ~BHn`GNfLLYU~U<59D-;fCscW(tvybNw$;!Pl)P%) zu6#zV3XsXG^Qf=#r$fk-pGoghE45R_r4eF4$6ru5Ctol-;)-0~NZubxu`Emz8KUFF zoioH$%w0Hs`<|=#=+vp`>D~TjjCm4=npmkhB6jr^bgoZHZ*=e7J;MsA&{Ukhg-uXL zsV7O6CgT;~k%`G^nZT}w7S#2xQ}xVXkpF8R14F&-ZZksylNNsdyNvus^c(Bi4!9TV z+ElA6Y4m*NqwFQHqS|kok)5&l=d~vVJ||e2|9@zGhta?@>Y(yJU_JsHzc`P{Ta?jR zm`OVE{Fc9}5p%iKe=_<2@tp&9Mk0{dwWd)q;*Ci|xCc!Dj?{!lk*zOQd;XBq3}XqbZOrJ| z0`T#G!KBhXHL{NYoWNy|=3!D$i9vEMt4Rcb>e&?3ax1Ze0BSKqqXtOdetM=n&Mf9-Colj6+<^a4w-2=jCAE+GFZXLkN6QfBN*8n3VN=$^ z3JpM6M|hLp7~UtNbDrme2x9*J2GK%P{C;2R4d!q5P~MIyPTM(4*%PwQ0&pm853a}` zHz+&wW%gd3F9g(|cRU8`yv|)5+%!crFHDUMgw@UU4Tw|%_wroyMpZ)x1!AgbCmvO0 zDdU*FO+p_5P>y}f2vFY^hLD5kXIP#0iye;AD8ERxqx{<*!M#AHkGA{!SZs^-ws08j zp&>ON)NGRCOn^6DtGPH?YjYBKL|Wy7j4$o%)7+L=gU0^V2fObmsDg=JjJ*#VovmXK zGyPz*9FvWa{$0Bni3a-J)2*qA;fc0=7;6Y8SJ-uNa6c}j#&bmvxvMbkGtUo8NEhxQ zHigr2@wHg%#nH*ex-A1=YC~s#)N@;ynwtmdlXsI@O{_m(w%Euon0OM58THpR@j6al zD(!My;1CgYz-MBg`xCfmbxb@hCM1HDHSqBERI$M-w$KDNQI;%oC(?=}&zsTf<0*mt zEa8o?z{W^yQWss{)(7P%{FD z>&{^@vmit*AILfnQWKhHg)jcmt^9i|3!a$pvQ+#o^V34t zL+u;l3n%Z&O9|j|p8RDOeOT@1qm@65Y3PYL-Sn-{lIM!p_;IdKQVF8a3s6)hZFHsn z5B;Es(0mqn`t^%BD<4Et62)<;+t%MxaF6u@N@~SmTlNG(x(2p<{TxDG3t!;KpF11N zZsCu@ZIM}+FTRCyjDI1Apq09b zD>jox^GHTh)Eq>4VL?-5hk%agZmX|g6=3XD_-M8G#f?6wPf=$czQXu*>KPA~&=nsu z>-rO{`i(Rcn13yV-czLy?r0OS5cW1QPJHe?XZGO2CUtOPlK%N9? z5W1gY6Sh`KUxY>sr7GgZ%TH;C6Ir9k^ryxHmby-jreR`?8^8oVJgFI#Ajyh&*?U%r z;(~?eXHflqHGmL1I6sv<+nQkX5?5Ra19ll(<+A%3rfx%VTXOs(L$~E1i@@>&+mzQq zvAMHEH(qiO>uCBA8aeBk_sL9>AJnY`n7S}H!uA|I>!NK2`B51@*;8c@X->~`R}JvJ zuaH-~^1)hXd)w1V{<3>B^%cgCw-IP5f}4-YxMebO{FpFQvAJ! zG^+Kjf4}JizGK%-zI>~VE*s>!u7KK46k99L)xMY>h=Gdz7+J4>g}>|vQ4!yH|v=Fdn`4_Ty{X5 z@YIjibi1lmx@+gLY#2Ko?FmX0enboQ`;N+NONhE=$Nn`DmjdZ(iO|f!XPk^@>YbSyZsgD=%TC zryC%he`qRZE}VgkbDXsyzD{jeF4LU#p6PB3Y)Dg8-FHHUzX^XZn9i?0uTy;s#r={& z(H$X9PBWBA7i=P{DkAKR!@z*%hsHMHouvmLliP40 zvYGmLzST5qSISUa&0}V|8deIOTnExw6&-=t8lObtzvwIgta8xQeR%|rcraFilEv2_ zqt!wFKa$S;A<6Xr`qOGnlU7byY1&SWrQm(VMc|VK|zNEie z1?_73X>|xaiJoYxG3B3}MlTr;&PQ~uja;BT%*v;)j2%NjimZaERdZuaHJV21+ZD>p zD;ryV-8#I_1r$v&c{#^0E%`BS`GIaTe<{P6?lZ_0k@RjFcP`n^J9PqTN z`f6hnS{s+RyfM$&mMz|gARnKo3`O7*y2%Blo7h@opW(Zq^q`{qdadE-KSix8V@sWH zmq+?K_~~x*IiRaT>AV=qvSC1azR`HV2*(J|RfYL==^gv9G5--1)?JM5)Syu4=jup# zALdIdDzP<&gaqWruM-{V)Mu3O8^C3#sAFJm(af=hRlF#dvTheLbeJgc)-SBYIpNX) zS2*;B$DLlJ_W(L-?s9E%3P)Y&!d4+M{}`w)@4-Ky<91~+?2<-C2$*D)R^1GTEG4B< z)8Xin)?%Y(^M4l^^B9dSVLH(jN-u>?ZoEWzn z`T#T@rfXtQvtJu+`o=;@#<;&>aT6CQyM$atXKo1(xQlX4KX;w47c%Z6Hv{y0* z#e2lTG}h&u3(H#7E2+pfoTcMq&mU?HR_e)9Bh7_o)4USho|o)deO@p64jr1a}*?a@f)zbHkRNE!1b(oYxlW>4H40uiFZ{{YOg`|AHE}RKO8t5eP4Na|z=8T04}#<4Cd+BtpYxbLEyd4* z)vZ+M&(cT-`ub`<>4h7n{CDb;S?&|r^OebNDn*Z9tW90=wpU?ox#2~Rj_6BVuIpb` zXL@v=g=GbhXY>iJdrU3!!cmZ^AzO#f0mn4_XI)3iY!HaC<-ZHMG#e1gH)vT=?4G{x z(ruEloSck^g549MA7G1$@cUB%4Eb5?JF8D`ePRK|Q)zdn8Y0L8P{d*Cod9H$K36He zxHU?rW1!2Lcu0mBosPLt&NBS7M)SNBziRfi(iYk2nXp)M2}XF$yIvZ95}q2A?>&Av z$*P(h`{|zkYANXhXKh!E{r#A^l`U1#yd^LUw|&+}TIoCYSs3OMM|D2rBhmWX?g-4# z?bl+}R*L=$=XaZyQ=@}u#MUw9J>u>Ql)ki5pC1D~w*vB&Pmj2_29A{AUq`xK8zRL!>8b?0>J&lEUse&` zKUKzb8F^u4oBpIXVwq?#md#~3T#el){S3W_j@;m`JXrONPOr@lkAjcv_40OCO=f15 z1X5rmzmXtzFvA1iw-KxQrDmpkbp+l~ypt;Dte;IR{nP?OMhm z_tUHwM+jV-8l7cizR=qCqu>=W^z)TsF=G$i+zs4uR||L~-gEP|H@p;8gVQBJ16pa9WO7X5 z1bjziY6?>&!YvH^upA01(jdwzEf*aETSonL6vpGtRPiiZEr5#r@h z>tEoupi0v!+}7kgk>2QKkfc0(l$!jXKXtoaBuNKasZDWhXIgULpAb;;UR_m5?O_*D znZ=Axax>E0v?RP^%b*n>P!8`9=X$QP#_x)f{HLx&Q6TmzoWlZ^UAFe_bITB;Pp#%D z5`h1WE~QNsLXAjgMve}?C34A^MGD69h9~v%?aPIW~Gixr$cBy;Ts> zQd916)q(dbY=wM$IU+*31FvK?gg~b&yE>31T!d3FA?}6G-E(19s+H>U!Zq(qvkd^@ zDgu;lI0>EZR&m;mPYv3Ba_g_gv7gS>mF{@8M|bkEXj8%aCoIRZrt{{aQu$STg6Dcg z=?%jv+D5#fVJzR9UAc*T@a4UOZQfI+ic>{2o9nhYA$Q}-TEmp!{6+)lv3c(g6XN?6 zXHhn&qtHns+A12Y68iLQ$u6jSqIv7n)f@cHl8}0zb`6r-x@qZ^mfLl##>(+C`EXOW zqS{piXe==>q95`T9NrzwaHBGBi}KP-`+AVQUcsN*@g)8ylrfi zp*^it-OzYv*cvd2*Mr!c`@@Y4|9zNjDTR& z)v%QbI=CEt!MDyc3zXiAyTN70Z6jQF=7K)P)NZ0FIFi&}CO%yg+7MBzpvXZbm_TD@ z@zBziBksamgITTJ-P@QI=`kaC9gi$YFy`2vv56pAjZHZar`DLm@a%|si9w} zdIb82*e!mbkFxFR-p5S-f*Bq z(4@-!AI}dzU zeB+eAL(q8m%ChuBD8M_Bvd&B8f^!$>TZpX@z=h7PaqsN@)EuygZWI zSk(uOsGILYv(dRa@8yTDP-)qF?$qcD^dF%biYSif3$>GFg<(AV*pHC9M^3Zp%iQas|JQ_X~DGfY9nKE zr>^H)74qph;oPq%U6-|x{}Ins=VjF1uYx(?{RTTvrej>_GJM4t5YPjRO%dW5;7MW&D+l2RA6Hse7OW}Nk zSAbIP>zyq1`z7RAp_KWC$Rc%9@08~oXEEs^pUa_qi1_51u~X~v~r z;k;&R_^R&;=_^V?I0-v#C}aHzn#M6@?-P;tk5x_UqwDNGyjU;G3a}hs&u~-5UuAe~ z62?wFOsGkZ*fuvoq?kZ$dCJ`qc&x!44tI~~(u+PWQ;{%Y^UeO?i7SHiA7q!_5o!=Z zbuP6fVy`oFX(WSGw?I6#n_C-`IQz)BLF7{vGq*5Fqpl!`a%;iqdDc{#9U;(uQw^3p zvXrhJ7&;Bd)_uX$PvO4IHB0)}6#=FPM|QHli}#jXFtu}l^Q$oSw%A>WS=kp(SS9_I zGegs`gzC!VRuiOIorx(&uI0I=V4DmkEopllyH}w{Q6tA|gtbb{C}#3z2v_>NJUgrJ z%6!Akx!llC4q>V<-cCETnZ>$G>ZRZkOum#p__$YMN=SldI1Yd&I)yX&NYx+tK)mrV zBx=AgQaBJ*&lR4hB&r>`jgjU?TyG>E5Cs&?$jJ02VD-m#i)fO7v1do&r6hV~3`QQ` zYt?z&Ic+FjosgTL9)Cl3XiD1&PKqz2plUC~B&pg<8Gv~uU_rHIjIMowy_d~%BATSt zNl3*w&obG8d&j^DAuA5)@4HH`Y}1!8X)$RhahW);Nsfqfa#uWT$qHu~`)b2-71%1_ zH8$D#cU%7HsFzj+)_=o4ct+$PptO;y=c^6ZLby6X9uf@PuQ3HM}& zQ=1lzXV@pJ%bd+ulJT_U@Er1!LIK`OJDu`8s4|nWnz!SUs<1r>vK6M*#w78>A8>EY z_&fy0B9P@5CbnT-n${!OTJSQm%%Lb_eOGjt_(8@QsOH@R8hK^p4iHxJ&Q88)9-b5S zC{TSL0d)kE+~HH+lXs+d%PTbchHRzZAr$1yO6h(Ks0%8C_W|X6_1P9-`cKgmfAd&G zAKb0h7q1_Xgf^9wlj1AJ4WuS(zNrs$OZ=C1L4t4*ZlJ-R&rUTEKOHk~jdb8@=z{^| zaPq1oOYTO`ICWNxcy$jf;%@}5qJ`BKHV9;u=K^OMwnx!`5|aRYu$)iYRTfHF6bg;2 z?;(>`2zL(U;hWI@{{7%{!sOXTsK5_;ez?L4Dm<^SiL`J76^YQm*JIm`)?5WmJdS9?!-Kn9)pG#t|WPL`Hf@gQ%8mI7kQ^;$^Cet1zD2@ zI@7KEb+dos^sHZ6MSXUQZaLdTUs#0M-dIml%Qt*byYF-RDZAz|0K1F5y8^LgkU^(M z8OKlgcKM7B|JOh8Pb%;Zspi&)rP4lH84gxMKjCqIfhxOH;IqESCy=l6W<0%dAaPL4 z*hM!IZy~x5b8ogN)9!IoAJiMa&}Ja*DDors_9MFI;AcVN`QLLkWFBb^WlA{TP|+`f z79!IIZPU{ZQ(9S)8NPJ{7I*I}KazL2&H7X6b?1`*aYl34Y#JnpA#**_vERmKFapTU z#$&bmpq9d!bNz`wG|#ewx_e>@{4Mn$5tvN6=~UYIxse1H9ALR@7x5jRFVMz`&=ql& zQq??{>k!TKnYLg-f$m}&glC0>yvxn~kApt75ZJOF613N0RP;=QK8)+V6 z*F3o2J)h7#EN zD~JC=Dfo^!%E#N|SxDAH_*ZBHgY+XU5uQ>u*I?6C0O|K(k}s6vCDht|kY!+e5Lp6u znS$ZM{M=)+9Llb-)+FKE{}r5xF$%BZD7QEP1Jdp_>hCeSub?2~%w1cxf>5xe-1?>B%VELKfN|XmO?@jKcOnuF1u*pf>@=fp+MjrbuDy~<}c?r_C*nW7`CB8hK4i67S z?Z-DBfCLdcDe)@`dvM=0!@h3c=shEsN8m9mcA1*G5A1*$<=;s8X0y(DTx{wzoOFKuWftl`0OyzceH0w@yKxUt5y zF3^QM=|n$g;%Ylh@VKdpuxl~gb8|_io4LjUT*{qNxr8%%^qVYxvoPj9uT|IhuRTD} z03(BHN~+73x0D0T&!ebXkchq1DdInNAJe0T8Sxc#O@v#9r_a~`F7mQ|gMff39R>{s zvt}P}k=a`n_+sj=Q`7v%!{P#;d-<5RqPMZYDZDY5i#)UtXV*^&&YkFOl#o4J`+NO( zl!h=~Fw5eJlKs=wq0aQ~74i%llE1R*op0!sQHMWeBcG_S74D{1;cTk|p>L?_q+O{v zBzkr-<+0|sbvE-{I4=bha;kh&MleouGaCn0sXhzzBwU}TZCqPS@#s#HNWu5u0Eb_ly zg0xX=Yn+Yqknf@SxKy=8>buUM;`_96&y4h@(H;(u=WzUYYv#|MFp5>;kPLcAC|xmA z6&B(vxmg#P=fFjSS~)v;hAm`|i5F-&^bZTYAb;#P@ll(=ID^l+P&wMoLR)#&s>Tq# z+x{|nxl4LDa+&-{SH>I5iq6m|OhVkcxP(ib`irQMdUvxp);+wF8kK#Y?P5RZ&~R;P zi8qhD+ndDwjcT{V)_60$zAoCBtUw*pwT4_)J4C zyy_Nupzm`^W7?e>EL@%JF?>JRGLAOE*J&xUF<)u;Vp26N04vJ(4WcAxxK`=U1ls zfPa5^y5hz$W<}xGywlre9lvbPdiKnMx zxsvd=O^0GGD* z?X2W=pOMGzan`k7j^7l1JvFfhKKj|NAxF@aczKtNs>eb-bJm&bRuho?a?S(T1Z)t@ zr#x$6rn;rac(!c0ChmIjt(D4>)L3|@$1iWuSSQecTq^}goGPldgO4MVC?g9rPY}|} zM@2`h#>CJ z(W1Et&F`#5hYtgZYM<`8J7%WmDPH@TA=TXy0oq;bf5u0HQWVw82ruWbMdI=_-XYO? zYu=TCSF?M>p>m*J3&=GfHm9-|+ub^{70ECc=8&IMBG~;_Zfkb+ew;I&b*j`~Z4J=>?UUoi&T6Ql37R3gK}aKXtZ?}>R8kczlV zftK2l^R16J$etZ;YqHX>(|?f&*=x`BRf=1~?uM`Tw#M8KjrZXsv55-;BKt;xnJ+&d@HY}T;p->?RDSKRM6Xvvr46W-IaA&xkwu|T}Groy-@+HOZObWV_y z2G)80aa!|k_YY+yYda^8$O9(b_x}2hEmeO{fmiwP<7~5*MqP(=^?jf}^Ytt_5eP-^ z@PBAOlksgJBfajYrc!lhB|&v}>5t-%fyJCPbWcc$V-B0b48tsRr&`Z+aUw&880t{r z)_W!DscY@hfJbsiVF02J1TzwYBa>usTaQ%KJA~f5i95BwYPS;P5;io_m*#&VkVe?v zOjX&E<{XujK`NdyEqyG|5Pxj)?edD3=;#JL}p_OXYRy1Hy}xJ$-qB zC5RBAp8Oy!OeWk8P$dwTrhfzcFaWb0<1nfnzuOrO1YuJa!g*2qon?UBbt&B;r_y8T z9KTAHUBeu-KwslN#3jDwT`KMCoL)LZs&X?wTJTsZN#-YqM^GY23*oFKLdm)$OMpC2 zX!MLuGW|gv=hu}2oESy_?(}x)(kQ-pI?~yDcqjU@a%s0aEN-mKnIa(yTg>P~%dam% z&n~VL8E=ZO;D_sE9Tmr=eBra{aLM*gD;s=6Z2NelOp;g9BHiz@UR+Uq3z8Olu7usl zZOtwszAd$J8I<2Dc33&n938(LTkUbTMbNr7_EB%6UsuwCe1vNH*wM%@?u3ZMA8Jro z+uWanZ+It=W=n-Wg!hud!KwEhcsFuj|#c4W z@R4LSO!Y@24CF3_PeDsf6wx>B_o07b?i1F4lE-9m1;9C2cRiTYnHR77I1Q$N#>t-V zt+KN~wCT8xdI^)~Su{Zsj+hVa&&#WFf&6}Ct)eSpn(jd$l2lZ4}&rHGG4~th}(MMUT zS7gt@LF6gl@@AozZP(ckp63IWch2K%S7i2|S+C~2B4E9&(%eS>b^Df2v162SY0s9j zx%;EV4fyzgoRt*p_iLf43~+NWX&_LJ@nqDWzk4IQ_U;_@zADJuy3HXe!99F$2>Rp^ zNKPH;ZdCgattmWa_lq9u+AIGxVvx=w5VVWFzt(R3> z-`eET=JbyiQM%v0GZcN(q4wwu#*8M_xX&S`bY{&fd~alEE4859u1J+v7$gySD5vJv zcK?*^MkNl`=P5F$wx={-dx8uo?iLkIq($6~xV0N%ror^YLFf`rZXOSJClyUOAb;;IRS?e--$Owt;0cAXceLv5(jZTp(OyFb;v`wViy)bn8> zwlpcKOy2XG!Zz^v`q<$u3Sv`MjuXmDP2=P3-qtRtnN6bW-y_1*d7ZM0YH`m>;LZ3hCJqEH@#e{L*HQ*Y zs>Gip$sA0&2w+PEnDN(Pi~$Bk$t9G|d8VRLdI)zk7wS~xD1U5((Q)Q)e|Kij@K=c~ zJ4VHY zCtabml>O=j^k&Llf1CrRV)W^wY0_hwM`HrEK{d6}{Uv*|!D|#HLcNW8j`efnJ8M;{ zELU9Z)|&Euhkx#NQj^&UcROu){C5_`Ds2SSVIp=IH-$+rKO>y^00&Z@Ymfi(i+S2_ z|K3y6pKUHe!rN^gg~U!g{ryJh+~k)l(+l>)KCH1udfv?5FkPso9l8%YwP0S7M(8Og zgh#_Sr1d)NPDm2pewBhG98P^8TIqswZ+MYzcwv#&mblaYbId~4xYrrf4u`5IOsKka zvCkDQEd>CH$0t&xR51SUzqG?CbDtvpr$WEJiL4KS^3#UZgYi#*Rm|kz;?n7V>_d-; zNxT1cg8uBRACYXK6Z?N94Ldfp`y?y|HTC#xsw0jnml{N!O6!)rrvn}EtHJlCQbo?` zlymf-kQ*0H+@+d!g@9hnqEgokH-6)r3{M!_Kmx}Lwhjc(f$7GnF-FMun@%-Q>qfP@ z)JywghQ5fXqgDYS4ln|zUks8OD6^5q_c<(Wfost*(l@XNF6LqX(+JG@#3&x7rxjZJ z0X9(X5`*hWpH0FC)B9p46o&5@g@1{nW{tnGJz2+Nfl9pNe^qS*_f5;lSX3-wUR4zI zY7?XgbNXCzV~PLZ$glEb!>3fMTF$Sstj@VI>BhErqVzEA)JkO-`6)jq`W13ZA_yY5 z_OlxK-c<4mSq=PXplZ!;eB%;a^;UcuF9A(=+KhDPXb)}3HdXrCVP?Be2bOnQ;U=4$ z3@39s$5PvB{=q<`#4N`{eN$lFZ+=2g(VuOayO%#YQAegk@2$uaB~aHfELFTpH3Rryp#`wv4+}_ z`$?kq2dx$rw|e)k?V_oA-FA&GlC>YnIgZig-FFJ-k$Ovq)2oCkDIPen+?g<;jTssEOz zHSj#!q&YmVVEK&y>qzs*QYRsCmw!KcHvwJ$Emic*yg_)6%YR2`TsZlpE-S9L?(@2m z8jjb`r<}Q^X3-_WaBA}q$c1o+(je;_e4h@x7E+;Xnd_i}NSI>P*E+p5(38Z~ESH)J zYk6^dne*vW07UVCU1MNXe@WF^I87W(4vY&^-D=kcPaatlp0K+sUXhq{dt&vE6f{W= zx{%DE9$ACq`U|HXJ9Mx2zc&?jA-`C4$)*BCITsC6<F$zZ=6x;KFS}9Kkz$jo$b+PxOrsdu1lY!p(7HSw>4imr%M-+x`deKbBD^BMuzjBUdaLJGpnjk(Nn4`8 z$GyPl!Qc&O zFOwT=+SaLF2SYcbFoxZTEr{~>4`4MA>kOEa_R0=3yK9C~zqd=m+~O%OVR}{o{KaE3 zX5`O&AJwg>Q@JGZ@S%&Fd0Zw*^f(6Do7kD?`@QCNoOgWO=tu+EA?#Jq>#*Mic1>Zf zs`u~ZdC|4gozYfBau)~ORY=`yygR(e+Z*PuANpEb+kL90JV^Z0{^t$a%J`F^+_x4R zjpK5NQzWv(>U5*1@C^yFT>Jd@j(+v*v zomJ2iHjvb-J=8aYEzjd9_sy*nnZ^xL`pa61Xx!BNGSO`hU>I*J@yyWAp zB1XNq?xBEC9AQ4u#@Jx%_HfKqYbRfaH!Ckse(0_?fBE+RaMd|g4w~ujHfkgZy^ea=HXHk0kRS+~+Qle^Z3BgIc@9>-lKGDyHq-)4G3!3PbeOHx5 zb!W5SO?{)tHt4iQe0jSFD$aoze51J)}-b7$GuM9_JRap(A*w_EzcNX6ZW*)rG$jN!`F=^q&pxZFzHZ_879TytzHk`JbW zy%r4LVQGZ=%oM`)6a=SiO~mjMZvmRM$=)ad4>a~;M1@RkAnF{@P%<#|UD*(Aeq4Ws zCu3@r;rQ$5nS)=rHt~?VVuuYzGZH+R*)-GeVzDsdf60>%1Lj(*RlGkvwBBcFSV*!8T(P`KJU(DXM+>FOFA#K;nw{xyRx*CR>zqQaDer_aU!F6JEJt!`dIcuz6 z;az%H)>q;OyOY*kvAEQa^{dAclL5(X{Ljj;`45XNC~d3(z(;0SF?-tfVpUXk7ytLaY%$?W6e;jG6q;mVeQ9!;T>7M~J# zTGRRNV1)igDMZy-TY48K^Oh>k_+Z7y8YYewd$*@$`qCQ346C%AR;=#$Ps=p#)LUd= z8+pQUO6NZ#9py(yXMj>j{XW5puf!j+2WcJe0`VPV_><(6RizDqF>P)iZsTo63_+ zHZa{|d&&u8LwrGbjSRmU3YR8!RC{D&a{g)3%E*sfxp3?&LfLYq)&|-7iQviAco!9u zM+FKz$A6ZcV>H!W>zDM*ewVlVAiB$SnXLo4?jX&FH`4VUk-+5XA&9h6C@bev;axs{ z+Jfbw?gdLvL|~@p=s7;H?ghN#NTzF_Iy*%Y?*1f1 z*8`BWa~pYMTf`S(ETq5BT)vlRENAUx>9;!M0X4a_^N_Uar(MIwX|m>jm9(ZDbLVO8 zOvlyWU7kVhK&Qq`wx(=g^t_9>bguPnBDP@Dq;4X&p!@{8J1_^!d57Tcqls3?O{z6W zwdv1;IP8nk%Gm-Caq24iPj}E*0!za^h1fX3^7nRLMOiyGzMdZufqRQ=I_Qtib9fKy zeiRu0r%*Lg+^E<)i&>oM<}f=JyPfvRWOJ3f6jstS)PEqSt0&L_Ks}w?Z54rYY0Eq0 zrN%z*8SeD~x~9b&L9FdjBj3rVn5EFQ;`8PacV^BjpHa>SA*((!9jR#Ey)s5KQ+&;8 zknby}?d*$sQ8_*ZZd@mnM1}RGvDpX95;dtx*QHwDI8phbXT!fx0t8_!nq{H}b2IXA zHfMMGYo9`^Iya~;V`4#g6?pvVY2j0w{(msIgP})o+D_hLUY0@*7{DZH@c8t*Hjn$)q@jv#SbkS!Gh- zTYmCHNQOGC{CRpMrKGAa#ortlvMj^{5cYb#4|&WL=}DEcH7&24!2^JQIx|XeXf_4- zYXk#X0c2gAt@XRQYdCbhfv&9a!C$Y`t@jvSr!!2P<)R*-sy?{Ef)MJ7O_A{HT_uKg zCql>z7DT6+r*2g&l`jCk^_x>STq%@|(5W%?29%+76F^{IsoP(E5k$R@*V(`g$zQ34 zZ;iXDX$ko4L*H#hk$92B8dZHRM_C-m`Sw=dbIVXy0diO73Z-Ks*jrejYcaJ510Aip zp5nA^V5t$jSV(0VwP!5Y-K#UKhr@gKJH;Ol(&mM;V-X3Hx zb$fJ-btb|59f+rX8bJ3|0)U+<7SMFs7;G;ckSvGgKYNwO zKON@r!}bZ5JKjTuvzF}6AySDt{*9*A{=Q=ZAIzYT^JQ_@q)k&;>DNXZ-ZAfPhqmWk znuVZA8>U_E)b^?Ou`M%o1Tw0ZVH*kF`ue~i8=LXrKksbgcI(1He63d<&08MT zu(4!|>^E;KO$WvPc1Oi4h&y)5hB{MljN(}JwY2N__|)N^Wz4x)8e(X~6IU4Vpw)1S zp$~{b3|+Ers!EnzKzx^Eg%V?8dYa^Y7Q zT7F>!rp8>P=%IA6+ObpsFaO3chxsF3sThDe@}QK9<upMTWO|71%-^5CfdQ{9$;ozqiIi{@DG;jU;4b4_v z+d`LJ7`{+Q@Q}OxJi-=#p@wAJN|$OUM>nh_D8#nTm&0N{P{~6N3nLFJ(tgyunpMRR zLep6hWVceseC(&%Idqv*j&`4V17kRsz`7qHSXHu;D(BSNGfELrA+7E0(G((+?^rIk z#Z>L_+|CKvAp0J>7jiR2QF=?e(Xv)d4ApPzJk-2kG;TY`nO0>dW6r>70LAx`c}TRZj`JM?n|hnXKTu?aB}fEED2YhC8;V`xhE<51SwNtjUJg zJb}y7gr;5(skX0|wUb(V6h5_CI!BM;=puzt*ZVWIRV(NRowBmJ$?w%u`@cXFj)fD3RMxx|3Z_PZT1Oo`b_%~0A&(F2Q z$FC%&&_+XFN%IFRx^)G$Lf&hSf+HAPhh!4jn9ZM-kdbM;HFRX4-KCGp6x=%WQxs=30N0fx^e_fNNK1}nG1 z%lv}UgVDCi+nV(FxjX9LHUH+8r-}}Kj5NL|?`rh}!@+bEs(-LZL3MQRuHSJl(WT9% zux}Kzsc}fswd^?fANNmeoSi5JiiR2=G@OTF(nedJ+c5d!pUW;{UiXOFC@AfZ9r@@o zgu~(TVeM334kkfcc1zM&Og{nbytJ?)J8IOrYTRb6f9jy$7(}SJMqW{+t(#U4`@%|4 zbkP@tr9^z`SWE%;S*wJ&;Xynhv>V{jKMc&lrMA2=(__^5t;Lp}naEvaXorU?eIQQ=`^0wl56eg4Ek(J!e(PH>+WAyf5rIA{DrSPiSfulma84X}^?pk(Qb zdubP@eNV%>K!$G>KHk16!}(ng2>P#y@mE`i+!21}o5>hMEceE2{nQhs{W~IeVCQjI zSR5H3#C@AL%~anE1;Z5nY~dmoE*Uxm@~li+6O4!`liQ*o(S7>OlnuG}Vco8qK_~;L z7hb~lWcT`YqdaTnEsY_9XLhwBgxMip-VgD$Pa=5UD4e z3iM=LP_OI2^6vC;fo=q-)+HK}`TMXRTCq}>S{$Ln>zRBfKlfT)s+l%=|__J zp&^EwPQr0jn+<)Ab^6Yc=P9#o!L}`jmZ#mwKb4D5rj5Z;r;>4xk?wJ_Na^AP&KOpq zx=d*}ahG-PnlQ}f2fk`>V`rc}=OZfY=ymE@ccymO#pVbKcd11ny)z9hvP%2!_bhW` zHidp-+|a{nW$n9r#qkhyptT^uF9HZm(}n6hWw23ZXjx7P5ZzzmgAXJEXUbdm@c6NFN7qEw0i7_KjXw&o#cBi@jkvbq+f(Vf;niWP3j8giLZ-V6 zr3$N{C;Dy8?(XKr*vH=Y#Le41ODh0VDOUT;O(_4x^#2h&vbw$pZIw4Y_fIYr{W{b4 z%bkB;L?#<{g(((cTUbE7Y922dR_c%(3EmAZK|RMUP4NrupV$iqgDVb{ugfYem0`|I zweeem!Of5hcu9DMBOW}{3c|3bI}eQ`iN{pT#hdd@^Lp&VPMTO7a}_-P*MXqE@cI7b z4^4;n0ayBU(fkb)*1gtc+E#U;RkyE(pU%BXCcp;T1lEyea}PdcV`RMz0_XTRjI^0z z=Lt;FpYhYuO7WTMJ3`d&JY+QOsbGgH(4AQE>tO$Bsfh$24bDY6$j4gIrX>A(1>-MB06Vx6M2EA)AfneDH5aU z$uMHIw`kPy*%Q~1kr6yI%OT})R(ox&&lbb*b;4{DVK!pG;j)=(o~D>ml1?$7Ey3U= z(~wtGP$fs_a|ZJ1cJxaJ@$VIfjuX->72ToBHA{*F{;dPo&NAxdyBPVwkRIp*?3g2& zEXykB0%0@eX0K*fAI6N2w)i<`cWa;}CJnDIaqze4po#Eq<@%(11J^>ExGR_}^u*aM znvW#^C?6FucWU`8&$I{9V^Ybz9y-gOJ#?;_;hcgiH3=S*iDBa}o*4G-i84w(9~x>u z{enh2l3^%RVMw^Dla33D)8gPNWpU8=< zuR-(bTYs*$Nhx*#*xz(3L3TtNX!S|gCRS50Bfxq*!E~aZzWaUG8_3|_gYEc_+vNg; z5C5c+Bau0lVyV@(97-+etBlr6eB4zn_VgOPGh-M`nA=)8s5=TJsXS9Mwv8CdQ>BPH z<{qdaS!~6+Mhqx<`UA}Me*#AaiaX$Jp~J;)7LbxG#6+Q<&{0rm9d z(BM&2>Mt-cdqc(Q;xFm}V-1&}WoczPx1^p;BGENR7oV?Z*PC%#_a2UG#EBqNW90`` zaKoO|PucFNA=HWE6v4p(gWC?^dmQ6aP`kRsT?_ZEgt zFwx&EvnS?t-1o=AJKV+)WeHdF&{0zJE3nzkc>h?jtUjHw8qsrBhyVU}w>h0OeT5Q- z_)qEH4cxcFjN_d@_0LekDb+&T1v=4NDEB679snFwIIHn#LHhH^{Y5;Z8sZ1LNG`T; z!H<&xam?`U(M~^IX*N}_Ho<*rR-Ip;hN>TrT=g{80p-OJZoZxab8KJoiO?t5+^B7N zBdL*l7VjMG2}PE1k~6!*;l1l4$}bE(kD``a+aNKtCpn)1KiJp8YbPFy@3=^dc;;lb zjRQb?J4h&L-?_8>@Mz;)OtI(pPIyl25fq@s2*FP*=lirqg5Bz}JD!Yl&TqFZChGIN znQ+Eto%HtbQ`tsRWZXkGL$d!k;c|PXR#6C6dg2T?)|Fn`aYsI!2`XeQ^u|Mg)xO2to!G}^)v!6&X(LZxtW=ACT9^Y%LR=E1{Nq@JrXBFXYUR?yX&sdL)HtHxEF zPj}iW<(~SN+V?SwbsECP+t}&1=O>E7?eA4{$Cb}fhXh+lD2Q$R%`%pF+puDBTW{3m z@0y0DR(;nlOvAB{5@}U@S1kK1jkOZuI<$1m+ef0qaTKz7xK`j=8FFd)_w-S5UR*yw z<#goUf1-TwYQtwUe_|h5^dXb_47|h9cx|e1Thd+CVrb}uwJO&Up8!p$R&(lKrN+~~ z7EkPAUnh@cAa|#>SDgxP7(LW=+HEwOJ>sMYz(ei&ss-QG0hRRB#8G=`CvU_N^GjsZ zO<#1e!5^R(-oYhJ2VRw$88df8v}by8yrGfvNBcl-R_s*pB@mepjt-qbC0zuJ&(XCZbx9%cp)#ut!8RKMkxTNc zdXB2;6GFE0-PF}iJ8y>o6;@=F7gc5x23_oY7RYiej32z}PfUZiuv*}%28VHkv%Ehm z!J|0Qjr63JcM^3z-6$!zRp0<+sf(QlQI$g_rR@dw`PLY#wb}jcNfs@}HipYT^%GPB z{p*?(?p+F}&DOK7NW%xLzkMP$Yu>Xm?!;J{96{_(pvAv*#Q0#R^UN1Nb6$Ci9z-!~ zwxGV6B8202nyUR|RmSWRaRnqkIVN*d;~!%JE=0yUlH^2x4s z%F2?BnxQg1$Kcr3C#k$T`sy0v++ee1&vvekW3kA70}R9{0;!Lyu-KvtLy5g zQFR{&iq&U=XRgWywl)`Qb=Smi!_{_1dy4pc%@ZAV+7}~!&JaFeJNkiHy+vC&CTVaJO|AwzHzx*}b!tiO>A7tTHyVBtdK2BebzW>n9rVG)7_BHE& zffSyAbZ5EJ_I%8a0Ec6u+y*zjA^(SO;Od{tLs%zVeU)j)4zO%iBpZMh&Wr$KR+GY_ zta#1%si~mCM~u7NC&zfrU5YYkL}B`y=`95l3-@bwukwM>D`nuprpPPCK!#+~)4^*g zLBT#H>!l5~z=t}7AkGs^C}mH%Ucv3heS76;U)t;m{~`IdvuA;5#x=mH|5~e!dtS}E zZy%ONJIe@Wmb{`&gm)^=&2vMetd>8pgtr-*_S;997t^;Z%HFvu*#E4Q;77a(rB7$B zMPBLmPFJWx4X1u=@~n*l=O|l`V@ZoezPmZAn-GoOTRl{%QOWU3EdPeViB9>vhaI2MnAye6 zPR6y%Z|Vlm$loM%RXguCBd(`DlM%PquuRq&?N~+r+8X1`Xm!N;M>*F-Zwf;?+h0P( zjQQWxp(b@JqUna8s)L}OaMSmSlvYMToQvp3-?0$F`+rzsqcy6?S>x#;ua1S(b6=-+ zwnuq&`9cE9j{UK`c#t`<-Xy!AQMM|&jPWNwcK*@drxSL7(Ub3t&I7nxOc5&5jN~o? ziy80_`+a8M?hz<{1>!yDS{c5GDdzjgV>WyZ3wXk(w*coUoFqM9L*7AuB4cQgeYI1U z!GzHn(3J-@2Y0Dp96<&U1%Iz1$jI*;`{i%6}T+Y&|h3 z{glO-torY@w2P&c6TP5iZ_{j~O`x~)P>j`r^tH8g=h7mFDGm>;hjacx46wi9&!v}h zs7{~hF?NH=f%*6cFLRNJAXq={U$2QO`-N7D7ZYVzQVOT{(}ycNmyF&kJ3nHtgoipB zr*>n-BRNIAp%V%Zr{Ri;h=mQRa!PUqysH`;?SF&A;W#;}&YYmepzJh?TSU!1x-KNd zl5g>}WE)Meo$&)PJy&No(vIl_@zDsm*Szc=R{XeXWnEc0*mjn4*@DuUiQim>{^dQ> zrd1dCfFk{7jwfMVh#dO;Xz&6w0}#(YHsRy>yF?4PIRHk75_HJIf0@XVGCC1 zcKkBP78o&s#KMw!CRgwZ=MwzN;uU8_Fnaol*3cxlIa7D>2@zFYB2t_dvB3p|#XJw= zDPoyti{Lh^cu?Xp3cNW_K>j$~`u1QPpX^U)_64d9Z_|%CUHb?zMgwsv0># z%VgT|^WwhI0P9=Mr9xGeWxQ^!P<^P6VDS!^bW#1ME2Ds-n*B^( z#U|9m?c76nJPEAD*uVE61$nqKxN8WKQ-&hv$Wm0W2UT<#x*|)4K4!(AikvqfAf?Jv zL2iaFu@Yzy44vNdMBfn{PHO?~ki%`;tMCQRmZFS2=&mB$4Ljt8=n&o+$jmWjAb;UC zLG$z7e_zeoEWG6|2`!JpXA}o`P6wU)M>XrBYK2?s<{DiGC`;VCIo$D6;aqohq^1+L zG^D=o|F{6C@x0srp);udi0dKHi^cbib-JCjrgt|~SXa@Tew`23w2|&Cb=1twjP*8( zMkp;4YWG8+LsgmEQNGkWiq!^bN)=DCe$-s$TQ9X3l?cB8l_`mx(D#^;b>ylJy`qjx z)2-pcwz+LUh}^M@kT7SvSU%&znjA;{GEO=IOO>sIhT8=^f=|yKQD3_^Iqcg*A)Q=TFw{{N|R>WJ_4Tx00KzH99OcpO_N?kH zzB=}UZN)bUz^AD<|2FXF@zn4z+GIN4D(N^`pkr>6@|oN15Ce*Bxq>!Ka6` z9SNb-9KFgV&45buEc`mf6Du0L+H2ARR7)#;T2}Y71fQZ8S}V-Z#d@Z(>>iXkRQs#L z5$s-hC3(Shx?o%DMz-ffou|q+Y1#ttS@M2SegUxjqn)yP>lq?SGFxC)KIKdpIWNX8 zB;$81v=<<{%Wndil7Z$*)Jge+l@Yzt`6dedkzj0vmY>#tM6*;8GnoVpqKfoJfw2ic zHLtS8KRJnvilJYr)sn5RW%9|auz;x8*(U6Z@PuF6vS~T&_prI(-m7OMXPm^Uokhx& zmj$~oDp8B#y)GHf%9}^Qc-;*`m3$d?F}{ATLVdi_1vC`yG?}Lu5(P{=HrBrPzXV{h zr$eHl?{J2qokOjDvfcFW+#GB5Z#lx`s)*6d195HoOwxFC80}cPQAj84d#mkJmd^Wn zA$3-s)P#O3E83J}(M=KX0e7$)M*XCeEK#Wf!!ZhLJ2p6UA<(uD(^CUvSv2>$QK*w z#9aA*P5!a^XMqhy$rfgR1JhGWWpT2<68ghB;KDt?qCqfMEpWWfinv%Y2b{e=;jmnO zt0OiMY&$dOp>bEOe5S-h-E@=D->56_?!({~)~0A~#{zR#in~KWU9bardgbSk$|MI* z%FyN?D|O0G8!vy0ywm$ob&#MhmB-ykf>Xs+_Wa!l`Pq+Y1M`cGMc{Ou%5L4x6SR`D z<@d;C@4r%6ldbr8R3W!#)ogAKvbsw-9h~a4=nf0x0}|%c5&9#5Yq!R~aVI~N|79;b znU*dZ#UA#4d;jy`f3Q6LQ1w^dls9!gu9}Seas`k$q#Na?P ztoAeiz^*Aue`u%Mfd^Lnhn((?|Eq}wtGy0T&O&D;hV0~{Y7O|t>SVIdlD|n&2j=hq z$SG#6T1<*bAg&<>vj+CidVWn@iIEwjD_S`xR+X@Edu5fjRpU9@ zoXtdAiBLWc!rR4DW4*cuG4@o&oYrWx<3?z%Jd>I52fcm)oKwlMX9*iDVj*dyuS+kO zW$|o-Fv#_C$%zEGCJY~TXwWl06ztZ(B%ZU!zG>FY|B@o@0{9N29-vVX%i;N%{wPH% z{{KHMA7(F6*RjZ}1l?Jwv6vVx92+}kT4~$l0SN5`^*s4rgZ~b407>1J4cUodD1~gY zGK(jhBZQLXx_!66U~~D(12v_BE4V@K#OW#wrACqH#3br@Wq;_Xha{&u4ruQGD?8)B zK9c6>%TkWjD6KZPUe+)Ss+((AB6G7E$G6pI|B*Qf?~XxA1@8WrWdrGVk(#1b_BW=F z`~^nl8o+`Nl}=G<`+^;CgYO3ME2erk&Re?KPhBn8^yD&devdsj6Z*#3HoNnrwM5-> z>jFdh9QinF_w#Suu+I%CqP)Ys! znltWCt?IF!Xsv3lKkSF?XUa-j3`Vd2)<4a^F19@FaKRrU&-OpeK?lNH7o_s7b#Z)V ze1yAIvNwZB5Qk(~o0vyx78AFKYW`{n7r9)r%r+Y5PS|y9DfIcrdMSP(WRE1ISiTv+ z4Tm^9G0ToDzZoTcp%tB!>qnGRddolMOrvewFcHfsCFC0cwf-ye{~I8K@=$5qbbGwD z%XI6R-!CCtL|?aq;~}5W?8-y0gy#@$@<9_#>a!i}4M9IW%)M2jK@g{Yh;wK(@%4z#3^Oq1ID~1f8&+4< z)yf2ONxuMY3__Y{GH=18nig1JCAjGF!eXVky)%D9lt3@a{IQ4OLKtZvx)$BDUKDB7 zg_4l_k_s5G9+`fREGxlbx&Hd~LB&o)8#aqFT)gR&;q~?8`Gm}CyLPRYe=ez$h+m~oYk$IM<7@S^V8p;wbG0MSuQl0 zk+3^=RY*Vl7z2bi;pb1uiwFiPGwdF8LILokeP;ZvU4H5^HmELS?as)vubl1(d7E@| ziyZ^lXT9~ZJvIqvo$Yr>J~QT@K;x{q7jVa>Wy{pCO9J6j-5ftF5!j~V^CEsH zi#;#r-?-l(W8TZmGL~ufG#!L-t)71vg_<+CQKe;rWX9XidM!iIl^4~vOJ*mW0uAL< z&h@mptx#(4fwrL4_$Ke84+*Iy7pahHQ`}LZut{8;PgozJOiP_@2K&+ zW(JZ>=CN;FuN!@X2i+RS#iz- z3jb2_sw>{@imj<#6m$5fU?U|>7EswZBx#a_&8vT*P|ra3z|Px_dTQ2=;#?p4f?+S< zvPAayba8sN>NMU>cZT^CH18;!iOC8{?NlB_pbyIKp!1jBi2fJuo3_|?6?v+(Wt=&5 zwf907&CyF1cZsmYG#0x;Y=Vu*0^TZZ8IE?o=xZ#$+R-c2Rr%IDtrBv*j^$Aa@In}ergHs8Cmc}jW-{} zhCo768mo%Il9QIV24@#n9=x)s{OzS~xsW4t&os?(edYg|$r#4T>0E~KhT#g+or@i760ndw{`lG<_dXtc9K zGXG=?HR3QWIifrq9H6u;<&-DAoCc=k0 z@i9U9hKgLX1odXr$}gt}Aa~pWO-;DFGV`-hfKV&tSBr)sCVMydPwiaBg|F1~Ch^H# zEk(V;1E0Wu2M(K*gYhpykvDO|cSt<9KMTM4vu&K@i#rmtri7h`JHZ~!ascZE=!CSu z+L?I!?xYUmZF;R;w+OTn`aibtzvAYY4f}_9@7Xgjmk&VyoFFD9lL=)+%>%g#dFxxdp@d)#80kJ6Mpb( zATI@fn7)8JRR}M$xEo(PwDulJ!ge27N)=@ZM7P{tfxVD(LHz(__iL+t?mmxqqetp$?9l97QGCOF7s z?oE&qJ>x!@2o8E@wC4HjDvz=;EO|%o-g-3%gJ)=N7DO^ckJI87DPv%sXOC zQ{6C`=P4n!Xg`VH1FsNt|L^hI5z=glnBNFoQ%Vvc@%d=V;%@Tt`>GhyUp)ROKJEDd z8FV=<4VCIv(w=p#k|aTy#+rrEOa?e<9ey14J(85OZKAcyE7i76wCG!>_JOt50Zs*@ z57N|W*Q3KDwNk*$(xq`v_Onf2;EOFka{tR63iiA(H}3qb?mx$?N>)u90?Ke+P3s0E z4v7BMpG_t&P3{3fg)QTfG5!Ep1bH9Ve{;!fBl~ut{#OF}hvH0HtuciuN#2W&m%Dns z2VwKiYn7V!6A2cS>%O6Kt2U$3!)}n7-fNxHxj~;04xMXEWI<4_xv5yux9eMHfi0p| zUj8UyLy#aXt>Hbhl)K)<$wvBbF)r(Pa~>dChWQ0E6Plj#m5T4PWfUnpn;t>`v@Mws z_q^VVYIh}9F{o`XePd*h(|ATQ6@r5f?TLTq?>ddHTy5xW#;dGFS0@Z0`ML!w0+ZFz zLAs!5*%ixF;$McZ>&R*@uKwx*@9#s*0X`tp3&oADQHQFa^;n*jBhJ#2QEpzmW#}eV z8||**oAf0&i7aGsdr;8S^C9J~8H9KV?9#l<#7QLb@V07;325ILqqz0u`73R5UY2JLNhUcCsTerJoJGoklfW_z<*u&$~ZoL4RpfR3p1oqA(rXUdW`>c z-$xUiM}UnWgT(kqknSVSCih#r67^nmD5~W(Qy%n4md{%+VpcDbmgxpdT=evVAsc^a zDMC1X)It06Q&gLIf->H)b? zJ=D~6FIDmz9N#g>u}|lo7ri`*A4LB(BzG(%n+~FRA6An=8o_#k1V7kuzqTmrduP3L z;U;=ymhenBCZ?oA09EB%mTOssh;@UyC}#Yv?K^GoPd6!!6CQ$y*=mdMdA}iNV}AM; z<=3V5tfVlftpG{=ZwLj>{l4Lq&E7v0N5jPf>`)&_3&;d;8kvB-ExNnt`Ue)!X+ux? z{IeG9JIBcl_l458wq=F_*w}9OC|tg=L~r4fyWn%~o7K(di&`5p!ePH$#q3@6d&^W5 zOep#obDoG_$uuW=3A-n`kEZCvzo*#La=QU%ZM80tPppKOv}2c@YQFs6UHE^fuJoE6 zkL`gOikK^lp3d|s!>~CGg5h>=w-v6qW6lE`bRKSovTTIO0wpB>G3>)R zN~n#A_?+z|_@Ot1HF^)eW7iI37<@4hW}5N=F{>?Ma!;2&5aif%@xG+8b_$AkC>V9J9A%VHnAVs$mUHa z7RG|GoI07EQ-3-7B<3f*SKTvq)@9JQb^H^oWNBjf^^aG0G&EMKJv`Ejq_h%#^nq}^h?x588t%GiPJY~6&=e*mhR?qb- zT9mmwT*{L!KN3C0zKx#-qh z9s0^6fS%95CdO!1s_2&iCHx=ku4_v{EuQqvNWSV53@2rOQPv;4*LiPM{@xn_Me|*4 zT;gA}&v{Vc-Rni`nSsNn;wynon}PGC*00DBe0O~7?Dhqs7!khkvd-SW%XmH$+t3$) zJ2O0~{HGrtEOjYuOn$rDR`6>|V17-h!>ZK?b&luibKTQYB!+bg>6NhMI~#f)R&?li zZGHL;Fkt6(QOAADokVEWK;vGP!?zaKKFzjv3|7utB73L3yVtIGrsJw?u>ZiJDD z?1Kt1YXSX~phGr0Mlp;6H2-t1J$+#AF|bcrRC+CSMLw6u7|aW51^Q>Er#^#@=KJtm zTLiXVN@OY=S70>H3VDUnTu6mO;qR+z+1tV#ba^u!&;Xaf;=dN!&E0Hh*QA)cDgvV=dKGhy+LLYrOIfXD!;VMy z^Gqj{HMAn7TM>yq8n)P!p*1SdD_Wp#(ws}qBsA57DbaiA9?XQPFIV^1E#yGGsR$=b zMEi%`yWlxi2*0SY2(f%Cg$!HEmYyqoN$>HVRi4w%!X%27^4RvICj)Lw_@pC%|zff&NYZ0pfD_5;`L;JV254%}iw=a*e6?5?K&+-kx?u(1kM+R!r#Dq~&Q zugo3uFG@Fc$X$swr1iw|gtXOCR_7OBN$P;KeGGtX@liKIqHdYJOpZ8*pqA7o!n_dT z{&dpv-za&3%#xKrv{+O%EKo<@{--NJi42Ab&gAK_UT(GgtJr>Z>q-^C4|4`}JN^VZ z$|nbs6f&r9*K7;4RZY;H_`=UqH^mmKB>*1vzaos~sf6=iKXR_nn$9?Y29VJt5bsuu z8-2cVgU~jq|LV1)uu%_vH$*L}V}TvzSM;&*(;&@CD={wWv=3K5c*#+&xaSxJXD?0P z6d!T_VN&E{2DvZ&{b4`h;VhMV4LE1ZS{#MVEU~{k0Bw;(;y?-1O>=HIJE>v~&m=vS zG#4DaJT_M627T`87jT^Eev3#RMICA>9s62cBmE}?I5u8;L<0F{x-kaGC(Q%O)I)Pi zTgkA5#+TlLEwq8A$ang2iUIl&`cifiBRIobzqWr*=Um>ars$`wo$6vj_1vIoxggAc zYS6qQcX7tnSg$o3!o)uQhKkuk^9SqR0lF4P4B*0sAU?vIcu_0*v|X$zB{5$n=NjJ9 z${+T+)+U^H^`Vzi+1Hk$H}5owp9&AnAIgoo1_5=7{RDRzq{WG4K-^-EnCr|wOI5uo z=Xn1PxyV$+5{5*d^!X3vORg+rCv91>P51<)?aUU`;01?R{PNYv!!58*=f_3;L@PEw@^tmD{RC*3VrewO;c?sR9eiqbhbd+cc(MQ<8Y;jwz&# z5cDaGD{zftg*OL=h{`jYJZaybHQnd>0${FIUCQ?9)5kGBXOXZDd3*z4H;KZ8@=cIx zq@FTmC=&{DmlO&_6~%_)*;Mx4o14v9Cz7yyN5|yFKL5hv)uuqjJ#IWX{F2+n6x9NF z+Mx9aE{rVeaSjEUd`U7DQB(h}DG+uo(2FXuli5VB-?mMEk^uuMzf+l z%~}>L32fWY_NL)3)8zAQx^$T4hp>>PHF zI8Mm^^pPtLH~~&%JhP(Ag>zen&entA+5osYa$WeXk}dqvo%M2pXqWro?Y>(Z*Kg$O?haySgO77-ta z@g~o}7eGTe9NYZ$vDL#v(T}!QAuQZ*(6H5mSz;CA`)i>0b#0seaFLB_npuW?U$^y# zqqp25tfsPadxe|+m2i2o_k}wHUwCnKh~LPf*^>Cekce_$C!sMsVgQY;?FbinR5G%` zf`NKap{bK@BcQjiRc4fpObj~oQPEYqouZkGpHcrdrfLmnEx+Yz$0vz`>7qj#QnJ5g zkMDctR>EEm1@+1Csq&e9I- zj}@(o1Jg?N%?8HzrjBbnorE&RgSK=x7FY`0xnK@CAh3M2ycT*Xx$eN)nzw=14YA8? zLXBnde^SG#I&nqTSCDs2@@t^EX~cX9I~_+j{S*DP=;05oKVHjA>PJ|vtbBcgdjJUf zV^Gtlo?b*1YWa!6!I=k zhXM2|05)s`l<7x|qLd>!zBu>6RzZ%aF+6^oD`15ZUn6R)w8n{`daIGs-cAnE!P+SO zRjjvXecNXWLCjOO|GYRA$6tI-IL|R|EaQItW?QO*NCd^I>xd}XtF$i?-^iS z(78uhMWwqP%ljVz+gv9SdZSo5c$<|U@=sMR46e6>K#KKt=8}zVT+uDT-C*%qr_17#AGPUpM z_o2q}wq|Zlj71MJ;h}dr32MxFqpSDw&Qzw_j{94Nj*}-Z8-Dc^HT4pL%@bbMH;r^n zg6t$^>OOpF<@qTe@>!`H0Qxf#L|mn)D$^z_sa5pcB>*_+4vPWQ0OOf8 zRSMFA;UY^t<|mvdl6AGc)CoTqG-m)KGa8*YO==l>dVgrD^#H_XI>8o`E`_w!ZJxj6 z9Dv@4pWWlaD(D#Q3l|JzNbCukLMx{qa@<|!_1%7>Lf zhDX=G=2(Q$`cu56Mh)h;o|+`na?7TXa+!@E3CgQ9=)g(Pjx-|Q3$hn|Gl>+(UX}n@6T;CXHOBF~EfD}pnkltUS z64}K?{l5dizvLw`!B_LaJw4w>!@X-7-doxp;mEqTU(?vfX zr-QD5e=#>RU8mUR2`-tIo;oAV&w7(ZDYeE)N>QGj^tUGEzK+(V9-ivlE~Nbc$o`e_ zA9_>6nbIO{!hQAiF3U?G?c7=N8>-v74o7d%;^OCKFU#OTMhLZ0FJj(YepJY!X-Exj zmW|0R4j^JbeqB#HHxE@93)xns=HxkTnJm?F;wd~+gVI_yYdU`_Hi@RnNiB`?fda`^H6&cY z)W=?N)gT+cqz$U`>&oiB0LyEU0#lP3$Cz|9S#;loxCDO;4rD-*S?VHXVa?AGdfRx< zc)Jgv4kbK8#dxtYMddR0{rIRaR=IUWcAAoDI6=`Hj)viF$f8L-g{9y7di@>3G=yClx|Aj`F z$e$en@^g2kOyAX2!^$5NZh>WVsh2#$5`vgN7GC6a`H~wWQ6P|giPiKPR>*wY;h^-{ zZnSt=#lAZei_+ZU{YBMpk~UpCsso?a)5dsfN?M^o;q;`%DtqQd74{Po^$wb0vXGw+ zGsjeTGOOLy*6)mjtB*i*PrFbumL^iVG3A*66=--C%l0k~v=mCD!$P3*3tznOio9Xm%x+Qqny&C1;>%~_n? zJ-QyrBjEU*nF3xD%g3g<>BF7g;1uqRf{+xFE!d%B=kYj{xNWjA=7F1_fPg3}VJakL=PakW2H<>mcjC?ttxg6gKFW%{Pd`OWhnDl(|Ua$`!)13xIt9 z&}<^_PoUcsZ_tVgO_YL0&Zul`^h``H!vKS zzmjKG7@g29y4`_*1{FX{G8Jiy;|8Bs=e)U;*)@j%u(t!Nkce|wR znlIrlrw7t64@i%^PN-x>Z-L4Oz9wavw;7KYr6M3ffRQT60e$FGoqRHUq+SZuUJpf3 zGZ3dSHw)2)#YG>C@fGE8n07B~Hu8kze45Kvc+qIyt(eVbNR@4sR&o+q30j$N(L1Sh zACulgK;3B%y*M?OY@u4m@E7{OMgB?H&&XLk))RFJKKpe-2QM}!Ln_)nym3b{?D+S` z+72Lw7&afvZO(&8t5YvKj?|gVqU#lyGay}v&c%U39#vH$t_}OgxD8WobxqFY(Ko^A zw8U{z_Ht+Q>*fyq9CFoin>Lf$c$=I`3xixMf$(|tASwB}`uO%Jc@=aL)?XeqUrrJmnMCbC5aI*VTL)!4p{UpJcBL8dW^F1&Dys_q9gKGw-K zEiJU^-{)>D1+4^Cw4btq(t0T|7<RqevJSa%prv_kcBz-%Lhse(<-1tBl;-J6 zAC}HXD@g~oo1za*Qk7TGe>w%oPDuUHNk@PWIEa4wD5Stgd}Dl^CO9|VJ~Wq38h-9`)R7v{I0t6GE|k? zI+ik*oW7XiU(UknAs?Fp`4#1Uuqv|Z^FzAVEHSzBoXmHRj-436JBRxet9T5QEPqSG zk!|foy1?!UHi9Gx-#9xcxA7!*5`0Q?n73I-ZX4gNwprJ1PJ|l*tuO(cw zdR!gED`>2NI-5d(-xz6=O z!bOU?RmDpQW(x&0C8T{yr{ZW6&H%IB(tu_VW}WEF!#GcNLLjB4Q+F=Q-P>;)jbi zE!Sb*j2(J}E=G4xj4Qx(vaokuNir{i)4BzA*fhP8NN&qsKtgCCmOkyGmz?v z65d1~A@sCqf1ixIw4!omB*GZ4+H||`m5Z^_4X36l1}cnU_hrm}0{Z?0Z_8C>pE%$f z75|Kaey4iZt@z@N*zagvjaXO*EEvTTtB1cUAkE92 z(u3);{aLbt333Y@2T>O@6P{xw_@~~q^~0iTS?6hz2;DLzwL%_$P$T{SeA?(g)z)a%Cr$DnGHYo11=^SZ|5FJa=p3q@aBcsQR=vCz+JNSKGnY@u?Rxi zH4BDAeuQ&AYQ8QxWBiyyq{;KNgzKqmhtpaMF+cOvR=%O!)(uZPG&$zAoQW%$r5ZlX zEC;*J#bJ7$7}Y;)!#yYIz90FVfC(b>{b>wkZ+{tu9~vou9?L&=R{ynU6$6FVV?~~b zod0o#Xi{@moH9a)*%$x9LnmE-$@FQny62M6xKYFyevn-_!3L8H#1DE0;maPQx^!`H zXi6+y4A0jTj}MD=;M~iA`$G+EI--5 z`Q(gldr-pjz)N3;D0jL!+QDWV;V>lU@ksW-k^2Lvw2aPuh?ygfGmZ|Wa*OfRJ@~!^ zwque9T9P$+8|Mr)hS$o^F?gBZ=hTNu*l!Ees4L`D-SenizCeEf1VE-0tO6d!~@&cC$v z4?k)NgxzH>rBW@%(@K+dK8UH}xl?(pFwxAZw>}jXDdGJr`R6x@h_9D(uOU zz02^dUaRS41G?yK_NLcn`QA(UxO@=tLZxWwSb+`MTe3BebRs~?J&phIU1sdlyJ){2w3MLw-uxcn1_aK8M}qMTFrMw#-T*wc-j`Ua$j z=U!N6JFfFY=?AuE6aG#fRrF;BU>=jAD_?;MeZ?QTv1->P+Kg%>WmBoEjQgLE;1YgH}~y2QH9vjuJ!Iw6lc zz}o$Ws!7%FkMF6fmTR^KdoFhDW!Y*4{!6HNqZ}c6EGO0wl59)%o>(9<+z1)IGZ*wf zKg%J^`Yv4^)x~C?%T)153iy$%iy^+d`{{)$w4+(wL=wGz^*R_Vid?{NAs5^GR&H7D zaOoUBrUag^hPUKml1EbdJwo#ABoBV?2g=`U`6y`vH3N`-c_a$|^uq-?;go zX3GYWs2E0W36Grw@)Z_@moi>K*N+FacP1!z_MGIihN(pGw23F@iqZS3tpr!;d5X&P zDVz|R&5@bfAf%v^nv1Alb}FcC>YN~Rw{bAjo=8rlVDE-3e0j)JClOYYv{Uu98*gsD zMm2OTNr11q*mheCFQ!D=0S|85K4N#aYbb}7^gQWh5)x^5%>;8cAtTo;XhHh$cwMS@ z+WC@zn8bLbf8Vs;SpAOHtlz2ndB*yp#y`0S9?ZvO>_aA`{y&PqXl@#AZ@xz>`L zEi+9jThuI>b822tSz2pJeyzNr)S^7+iQJWynwpxG6#|(RmItY+c|m2~ig|#yqh-2Ir)+laEb3XaK4=cTzoB=RKDg%mgHtUC0z zx;Ge`{pEICyH}&EIPnCHVAI|?v4i8_r22|O=d8FCBXtCp3eC@of*aIz;W?f`BIe}_>fA<$fw$FWkvD$eprQ!y6)UN!ZBJ;SZ$Xzy_YhYTm2f;Am|M9 z`zBO^G6SK{QSI08vmD0~Mug4<5fFWG@OdruCJN6KLGH*qRz6uHXqja$PgL0|zScXn zZ39oE|?$qZ)BQ+e%$_f|AF0QrI&rfuF z7q=O^%)KD2OnwI}>kx>yB!^gG;c(u=UEfQ?2FwK5Ogx;#dP|W8*J5iX+wY9Gv&?3z zuo%q)>uF@$!XI8u|Fl{P+BhwaA-*xZ=KG99tYG{I(0JD%VfE8psD^IHVW8f7u5~)D z7CmmSC+yZkPjR+_jtg*JkWqpZhKsM;(I*4_0jvqkZ^Rnq^zD(1So04HukGr~7 zIsR&q#&u6U`FE{i>(Kat+J*dl&6~Cxy=?-+1)=Q0(th7mJJ^0yof(!QJk@IYt|!$S zJPlqlFvsmPg4g9#cnY=`70i%Is+yuGP%AjTFfZ$w3vt0dz%#fYrqLH?Sw=HT^0hpyzEs_!&&q#$1*;uyAyee4|0y;-aNbRRzqJ+hgW2I|HpTc zgQ9wb(_sU+Hghjx0t_C}>pL4fqH4!~cKIMAH)S^cmG#v=(1ADG#qBnG$CbV*b)9dWl*+h+c1L?Nx?|_T;Ngp^9H2OLeVQ1J)I9Yi;qd zdqwr83Bp8xgJ*aNC*)W~=1;_U#db#$&NBmL>yXVCMpDj27CnQN5>Ld0k|n6M+oY9# zYgfT|GP{Jc6phi}_63hv8OboW$>A)RUsLtwmgLW)e{;uWYR9|512Nqq0#D$q+w`pOH7?Q!$&fLWwBX>Q9B_JFj-z@BSJM2z-91~Hq~F3nWATjeY7 z%;FzQpg&Tmx+4~Z!H-U zP;`Va}ih(SSJP(H7N#7DDdx&_bO0>tqc1i?$;0Op8@hxTz3^Yv+v9+ zEcXKDzJEGqpm2MtvqsfyfZmvI;{(Ve+yQ}==$wB=6{L< zEjf{06}>ML=g!)AJLN6@J|UY-%bveI?RgGyjJdYy5%Y+w+_fxAY>QZ}6MZ(bBXf?q zI++*l9BlUZSLI`Q4zRE*cw<86Ci?ht1hUd?yU#?zKtyz;QG#3k>;qjK*bsRcI;6-$ zHsW3^-$AR33BK4tv+yQDfO$%Q-0nOCf@S3-IxMK@Iw@28I_4}>`?gH-6yoO4s!j9C z&M-^lZyo#T%b#@Wu~OwlSGN)U$ZYb*$2O%pTo+>3LbZ^y)CJ___j<(2OYI#4Bw5Gn zwgX4OidPXVLv4t>hSG7yh8^%rU0yyj5mW5uL+`EElZ!G!?*nkNU!Ri zXomnfQEx zW>juf{dKOnVQ`|j;f$6YFxf(fC$Z1rv|XRle3`>lJ>_x-Y;21Ttm84&Qp$b+Ci1!Q z0)Verepb6A>oM8MiE|p~d>)1qwAmg1|5At_2ZxoX~vq z{lymhX*VHLRMxaKcoz|gv;AV{p{zs~$!?bBZ{G)w#?t}Q`Q~o(caYG=dG(IVh~b4T z(kC~k3O!Wl zhMPvKwGuodvL^@rj?r>t`M9$6RnO&I+#Kk4iDDLn==kOU17Ys?5Jo9t=&uw5_Rq*A z%<5oj7(J(FKoQIZO}tZl_AwG&tbst&rA9b-7*zd{hy}}KuF(lAIey1^4^`zkmkUH+9YBq{jYd>|nm8rZ@G}d|h<5J-`x#JWy znA?}B&Uaae-k$q=FXzB(>~ky)_+0J&wjqFPcyv;H1#zDj7WE#qHd4sJ&1G1=+XJ$T zo)C}uEe>hyskjRz>T{^Cd`;m73Z`iJkvH*PF!O;K&xiRyVr_)rB{@Kd@(s(cf^yvUIrwesSvGCrBEgpB2a4_+|c4V*lZvn z(8^Lz#?O>(Ii}lj_%$x8WyoM(Tk&MADXtdQA)3yw+UcA!y+NP&Z#V7BH`m1F+Kui= zsLJ|sTYUfRZ>3$ePulB)r286h?KCI7avo}0<)?_gy~OVQa@?#2Z>e*bNDpyojhTMKMOa z3hiou3pAWY?XD9nwSy6BxM)YHa_u5;YSEKvnhbYDa_4HQ0=2vw>j&@d6lZ)n0|%~q zXZK!LbpX-zWw}o}W-Y4`xQ9TU`nQb3w;)z{el8k+(4nAugWes>b@Oj>@SIM%$n&F+ znQ@t1%OdrjUiU$}z;g1Vwb|2Gdl*Qgw{wC3Q0S(;Wa}4t4Oq7f&Lv%F~9OQ@i@nG;7YUYyM7GItpE1fc9Z`P95|}%kNoekLNao z^)zKD8T}|9^~we;g5VHyZJ#c*=!HV?mh;eFvl_HU223waUdTb z`9@`Alg~ufI8X)I=Oql0o*!$ac`_~5(h=vW3o~Ugk>jR~Z4+}7i?d%*c5#>tPMrU& z4`GZ>y`d36XNjTXYkAxR>ih{e!c3GdO02U8zz=5v2cJ z*R*Wrn_J&%1r;bABM*HT`8%81gJyKuFIn_o(dQ>;^aJgyFHD@A4DRaZ=4q2IE^+2N z9SAip9);DZ#^UD-o<)4iwT@oEr3(AXiqwZeUl))AxC*yft64+3=^eLQ$(A2l88?nq zc*`tVnoEPGwz%_K0#Shfst2Z^*cwGncB*sm;2D}>qlMVJfG@oV$4@Hn7206bqg41+ z{N-+#G@3}tI0h?^+i1HkZ1KU5`5y4J`hys!uk(U0>CIokBM=%quD$1Nq+m)nbsNC# zcLol@+!nJf*S4SqU3u_WWu;AwHmjwztq74Bx52fVKA!wyrG{Cpd`_8lmAue9vz^<)G~|pjf#j;Uzo~(MM=o14LGQzQ>2MwDPGJI^SZqs_2SNqgPH*`aG zo$f<~vMru?{!#)`2owo+$2)k)UoMpIFRE@Z-sY>BI3qzWSzg_un9Bd=W!$ z)l=xwf4a5o+lr|%a=H9aPKRC;0x!VxOI0BA*ep&$381~R>w`>TV}q7Tca^JXP86XR zXBp;3_nm&%wt0*mSM}P*HD0SYG11a9@B>&Uuf2J=^yz?hgQIj-7!#u{3zX^o{?LILOikvi8RE)m+sn za7aF)MsZ_-<=`LpP4793!WTrq?;3FE&$=0?;tYQKI^MWjW$X8dbP(12Y@{ z0^E+I2|4OVSR`3Ey^)aOx_(=oS9N*J@-6LI`__l?`hTz03=?^$_i4avOAMpyQE+uv z(HxvwC#$oZJQqa*thN#D%PrCaZ5A#@AWgFm6B@6na$&vxy+Jc825cJ?`HjBv$&EPa+HT`7XC9TIESSMoR4HtGN}AyA!#%2^Ug(i94*${@kkE z$gaeHKjTAQ9DCX%m{2lKZP$kkW~xnFNy6l~E~4V&{hq2=Mm`|y8vZCI?N9)@mN>qr z!#u8%#rV{-GV4!mw4;$41ClJKrGGADT!jA5%ovRyN&P26vNN1)^d&X?h$M~css~K; zxpU@kK7%8YF0y3FgVz$ow@UQ#Rt-v6Bn6TapADWHLPM0q57Hkrk6xt=dbI{wU*6g zS;(xB+p{^P$vNOg!thde!uA{Yod*RL2@W}RM{a@%BXjO$2e?wKgjS0_=0rgsLTH~pG8Z9<0i%`K!~oOCTva5=U3AYjJQP}}sH=A|!%q?&$@7fTL$skn>6FOJ%1 z?0dhbXfgYYq3~r3;qm3f^|Z;$i5&hKzWJ~=Z-sUswa2=kF$BLeepwY+y8M)>I1D(F zXiCd&<RViOc-8<(9;im>~|XpGrq?AssVodX2)ZXA0-F z5mSskjg6arb2sLrXTo&1>Fg3~W>R3uPo-(;2i38Ll!npCtnrL`N8!X9=gUH`)~4o; zEXXeHv#vV?hs%p2_)v^C(%@>bNk$aZY`BoEk{=IXxj7i zTzJ!qhzWveUZWpB67Qizq*N}VQpD}q74^~W$i%;|HXHWa+0Oo!?WH`IY4_S0dspfd z%C+no`=I*Y1fElgjDX3<4-eb(X*+%QgF;;uNh>n7psWJZ(OFCJEjiMXS36f&Ab)zs z3)+O~tD=8MmfqSGX0Qa`(}X)(t@Zr2eKVM$?zGM6NR)1OoJ=2>ONZe;%IG*sWQ;9! zEr#)oi}~J>gi5sWQrWRsy+^1o?COtT0>axdspeA$u9Nsh_x#Z zGZS;al@#MjO+6Py&rx$y|5Kg@DfB-k@SWlIt$#rX$xu$_m`u269bNhm4op>TY($xxa>X!tLS?8y0 zdsXOP!F6A=ZV1nL_3-|&LCqEn=V^?8n;LjjvLn(3x(G9Bsh)IFB`7Mk+cBkpvcq+7 zGkr#-Jzq3VQ>J^u%UCy_ZRN7koX|}(+|gn96Z3{AH-iL^e2edfJ3OFkIVK&*#ov5f ztJn9`c0DfWEWtUpDGk|cKl9M;TGTIHE^jPfrVf5kn{*&}CeZ}=2v7dV3(fb9s#RXn zjL(8r5iNwzd0ZZSDL9K(T2%{qMrHI!XTJC}vi82nqm$ib)_^$4Q}n$JEkDuudO6@t z-ULlX4Z)LbA4nU|>15BPzmj&jH=>R}xnD7wGM0EMQ+1oPwB1E{;Xt|QAXEg=F9?UC z9X{)Mc>0g`4leS4$-b~*1#NwhpIJ3`I+_)GgzE$I0}9tVV%9b-OvprUs5yvGYHv$t z47H@C$8y!HK{{42nU@_ReELRSLafqk$DIImCQjWSm>AeKp@+!AT4Y4(e6&ZKT@Ixo z*Z7UR5&OnCoxAIe>Y1&XM!gnojFgrXR%mkz6DDl&FcH4RZ431*H)dzo)6(%yPb2oo zXxj4%H^ST| z+nUm{A7vs(;c5~TJ(g20F#OOA%|bBs+Zl#9ftJKv(GB^t66UQcx{8kA#E*cQ1w)qX zVl>Y$xP=91|1=_S`6Kv?r&DLTP94zo8$e1P9M-Z`V%t_&tE1UA0L!)I-yw^e-Z9=y zll9{CQi0I22E5dMY*}=p?AdG=<47_5I_viUC z&OM*$F6NpgmOGb3$}%sK0tWjSj}Qcbhy)=>lPsO{aZ#+C!@uUoyjQt{xM~hJ!I8$t z*7O@#AvU|#_Y6F8>CARr$nuUB42aO@;x(VGN-oAO`Vza@K-5~@n;*{yeM`k}W7%^@ zwsSGPmzxfv9C`*EZ{gS@l1k0D6u7F-ugn8GpP4whxO@RkoVhhV;{KncX%VG`w3O`p;^!P&^vvViDqozdcVl>@K!Y@_vp+X?bRREI^7#>X(aQM%knt|6*= zb?RQC28=pUsOU&77{4|7->6F@>~z_?xW zuC#0vmyZ0jv-U@)3%=$LET6Q+gjvz!K7~^0mi69>SBu9weF1|DU|m|7a~0Tg-}Vq6 zuJThAxHOE{esM_~4iHs=pM@VVjX-QK0l>Ue&6lKm^mHo5h&;}=O;1YfY6bfEkp{}Z zyRTNa`NUNJUSfLbiwO<*`xoKw2R)U7>HJjS-ky=8)$UCl+b_O0Tt11VdlFoib@yIP zIzgAC&@o&1X}SXtvh09ctg%-4yB%QmRPb4#lt&$9AS;E2}Qgi^RNlC_d>$$|K(v;yI$32aSrI4s0XqAJV$O%S8d{R zeO52b2l!liTAzzDo1*Gb(z7FztNQ}AXF<$9;7wnG?`tpVrr9ab!___5oSIeca z6^Nf#yjCu)Jk@snq%AJexjbGWV*%q0muxeW)fe;o$n8xXjSUHLGQ|~O#fXdBB%ch> zyqt?}eGR0p-XO{a?ec<^#E{A}^3pQPTkDQ#U_hMg9BV45>Soz#BlZiULHxi(U1L}C zFy2=k;wSlJlpTqGnvv&5#mn=E_zs7Ou!+7bQE3LubZW>GBkkWYHSinF6;Bldnlxa= z9z@(y!&{-JVk;4^?^{MG%ml~k9>Z`BAuV%Ngar7gdtGh^7CVk=i#xhrj8XUzJq}#V z@s&OTIBUdx6i$Bl?ygqX|INv2;kR5%XAD$~{Cq3C?LGgXYF}zB_J5FKM#_^LF_Syr z>Nd>^mRt+s5=##Er^I;%nhsWB81@e%YSc3WC4k~l0mrA^^AZeB8S}-cI}OUpj9a+l zk8i|On+2w_^XN@oG>h36NNL-%%yMVV&0u>g^+~s1n~8;n6(W~=mg&Ak!TB@o+gY|@ zK9S;LjZdCE@f2JT{mVI;-L#@gctX!xvzk9mJv^&v{*fxgApT9_U05zI$ZsdP*Yyv@ zpc7Wsml|isTnWyO)Z)2KPg28Q8H9%|?g}!>VjHjrKe!#qjS<_`^0RV!c@sHam@H(Y zNta`P46tfTNv$O29RxA*fGmm`4)Ve;K1$82T_pWNiSrM3K9j+-r`Y!TwLU8IY6n;5 z_n6M@lvTwlafV7{L154kd`$PXJ~YBr0WXNtZ*9`E&4rJiqoO!gNyOK}!{UkXBy0>v8j*A6ft{?F`yxgylqLf#{nX>-}GOyA%=z$R)F6q~B= zT%a$y5GUw((-9Q0F5R6e#GZp61+0FViP81+JnNnQ`UY@`0!WMbHwK*%24XtH3NWCH zlLhnvZXR`=9Y5+otJUhm-~T^-g1?v5@PYRO%yu=8>`bnke~4^Q2aeCu4l!?1q|2`O zdnAI>DhW69tfU$vSdUEP=#c;{`^bVvBu}xxsnVIKg6Y;^x=`@MW}_k#T9Ju$C^34~ z0TNm8D^&AbPv%(v)O>*Px$0yXUa*`|2M*F~*Z_~KY-I%5znI=lN~@{qN%yiZV{wvi zl?GJ`r!0TZ?nFdSKlHJJetfL2^s;@<9_7}9U#j;m5)L&Z5z*|{Ho~!pwf>`Pg4JF< znb}}5yaJ>tJdQo5501fi!1uT7o)zgr(u@_K=s->5M`h7X_;C+WZa}7@*5O{p7x(pZ zYIvFlL{!>wvurZ`0$dZD3O}I?iv$#o*C3Sx**|z7YjsQSfPc!fUE6Dkh0682t#Lob zeJQtv#%<*$FBCU7_WC-opTs0~8nl1mSm6aw|5Dm+BRr$qo7xu^G7EDHDGdLiz9rgn z0X%5fh%w+8=TzH(oWzU2q|uF3We)9n2@=$DsV$#yJA`~HwM;SkWG3SZ!*+I4#DL#n zp2)K(+1xad!g8(Q^n!L*({NNzuxAs)Q zclX{uDNN1NZz$kUl$E_M=Yu3T(|GySsLx_AOlpDyb6|x`75`9Q*5vqE=}0qm+XKx& z)!jxhh=6F}<8%KO;m0hZm5y*~+Y-u>O=7io_Ak2@<^(@Ch#;{>KV5GS`q!@<>M)o1 zpH=)0)E?1nwZkb~?O42)b_2Pd? zOl_M9q-ZXuj+e<@vQL+xaGphxg6m6LxjO@n)gcbF`FElvG6}H7TLed+eJ+dpLMsKRhA&bmOZiQ zzL4;}^dxaYS%#<0{s(zd{xK@_Wz2NOF=RS9sAVh3=r8a^)s;j08M#f94>Cs3N7bvx z;P*WU!=~Vg>76B}clc`xH}B}4p_+nYmfrS{L!I@Gcg4=mjAi8(-dF$Ufo>x+GiKP< zZzVk++^V9%#x7fj6t{Yc2r}}hGgI(2yK_tD1}6TWn9JlX*xNKqbQd)W`6FUQHe`04 zY3zSKN+CD*VhYv|-#HAF9xHD#bQpP|Ua5C7pShmDWg0kmdwzE{x#_*HTQU;zDk z;4UMlPvj+aF*1j&kNTx$J>&UA^TtOT?J6s_whsjX1oQZ&aY-SVe7asB@u#*tSVVg~ z%g;-+f75#nmNBN7bp(zacbWowQ4|~uiMkEm5xv#CzX~GRQ?fGurM1gf#8}-tEm*5LucY>a-^%VEiQ?SSDw( z8rR@1)m}+i&r3z2TjHpwzSIvuZ1?m^*R zv_vhBdng<{$k$KsORbz}*`*r*tH&A7n$1AKGhcsVYGOSBsV0k&-nY2l)+$cl{&iBc z5sGh*Zja{KyEbqZWY6n0t9ji8(Tz*%=|{UQpIck=S%T=OTC}poJtHizji2F3OBptJ zL}c8AD~`ri0z~uoE|(#dSKhObj852i)^%cchcOl+=Pg_qMZC6 z1Bt)fz)cCWU6o>CwsU6Ff0?;@N=8jwsi{W<&i=VFAd3Tk2#;*)UcG^5v^SoRdv3xg z;O33tx5eRfmG`cv@*)g0d@p`cziVPeRsRsHQoo1Ik0Ty}Pf$vY1!rVr6J=mgV&b#_ zp&BH@N8nSmZ0A%DMt*yt#jwXwn@O3~!v>39X-C&%y1Jvo?jc0)H&^%iIo5lBIarcr)QH&z!&(w9T8y+f&!Hc6mw74x( zBbz%VwFDSZkB{~tOv^iUR-(0n^yxdwYS$xDd6jvR)`<9U<%OCMPCOp-!u;Nam^H?5 zWOpsI-4UY1S>($9DYD=LbdWKzx@AWoi8pCCEWd1Di1bt zL`av@pWBJoGUv%;?Ut|*veSFQ6>Ns}{)grd-Ld5EiTx#sh4+2mg6m%hHuFTv~} zZDhT{MWUn_(?!O|Kg_NIj&MvRac?cr{zc&{hHi47_fWBd5CZ=tNqs&r-tDbNQd(AH z$q%#pO_hB1?V4VJfl9XFZB?@DGqJiEnEW2R?8(jQZpiOKFCLID|M1zQBxuwC_h;%X zXW1>zCNpF(-nPZ=^Q2~^t5C5*udqzZ_bQH2?~TBmSV;% z&GeNvqU@Ya@|r61Lbkf9=RRO-23*luVc}eLieMZG+gYe|Uu1=ZDmq``G8Iulf!K)b zo;_q~F661EoPjGm3JTa2q3z6t#%b4PA9fuK#KkK^YUen`K?cFaZI`yW2i23}PnnK} zx_&VlW`{m^uZ^#pds#nxsL!{S`*RLv!5TU@@~tSSbFt>`TGsAK4$0=TkMCc9a_#GS zZ^ciWy`R%>mH7q7Jq*^el1UkasKW_*JlnZb+r@ozXY_dIvaWc=u|tDS_ofHzzlS0t z6U8G!EAP5(B$G4GU)V<>ST zD;e5hrGE_<@OkyC-U#txX(a~O>?`3HRa>| z1~qDa(N3A>den*CzD*k#>)GQ)^D{9PN<1nK=$-du_L}?&kbC%?yj#72tZX*?TymFl zM!>VmA-4l2mL5+|z4o!3>ga7fJ=ZM?8p?Rb=v9=%{{PYE+LA`>5|zpyBICuTj%Y%R z)>l`f-AJP(&JE*cJh9~hDf&(zg?`lX6PnWXyUrz*C~w>K`*0(`y3}Wz!xRtf1^v}; z0_TBzFd`l>aHgKoiyx~0dLa};_JdSk#QogVo%keN)ZyuErmouzv{`R$pUi+uGr$y! zFQ#C;I&QQ+bA&&X+|T(mr@TDo`W6&-jBsf27^1XnOZLC8)zS=aH+^q5vm8hoJWXvh z#XgL-TK^7R_)dCU^g}GdhOsIaFI*V`SR|D4+L_PPyNA#RJQcg+>&aE{&!jH#&9l|| z&Fnf^8;Fyjuur!Kt=0(4Bt^Q>E}$zB;TIq57V^H%VcY<3ci77w@)9 zRhwn(v2m;8mjoC)5k&elv;crudjrHBcOV-x*mc#%op#GSL@03ArizU3zz>1cb1Ng_ zA;k#rf#979B8re!$&LF2c08Xsy?qfhJZ?ZVjwI_B1>Ux77M zm$M+H)pIIW36UsobIRd|507%=>Fy3NH)zyF&{JC|{hhNu1yyN6omc;JerC(E%KB$@ zB+U0JLsh4Tr%d@wpa_mbEg&tkqxJ~0F}?}XlSjq9%=Z?@-(D+9j%Zk%eJ6tLJu|6) z9Y(VB*2rFxIR{~XXo`+sBrSp3wfs5Xb!cBzv?{nD3w59V---cg8J6(EVs=~qgciD| zDe{FK6%-kCX%YTC?+)lkMr{0wmbbzKxQx522=7pA&O}75jasZfYu@W$)RRqUL8X#v zb!3&}J$F8f4gGOtS6+A1xygy(9yaYq{Y(5`RCJ=1a)pRBeCVmj@Ua;IWv4pG^I#~= z%ZR46wq;bMVL-PuW=wI4WDG4P5lKL9$c`} zx9~{F)oHjo8FRL6uFY&oXL*fDuc3!56>OP>a>d6lWwm!HN;@bSrv5H2Eq_I8lwSbE zuRpbfcN?nKDtYvEJm>8vZG~+O4Ucf3wHcDdd88-gEf|6LG@M&QkX^Dd+~-*_@(AV@ z=9voEZJMILGa7_ykC9fWH#3tLeWI(xsPUAgIUw6;;pw-?-+)(0(2u?i&Y6niVeBCM zPo25I*fnc}%ogt)CO)<_N>wjV@$_umc^6gq?djCGS9)JIBBK+ukN!Apt)OHAQFlxI zy-WQmR;03wR`v8Sx#x$L?A2(iC#jf}L2T#X<&BkPTiTb>dw&m)5&wP_vN|s-_$S62 z7doh&>rE~}RiG!=T&U#SWLa9Yb|)|WZ4u?WKtIxQ?&Q6hL-NUE(-#75VS#D-0c~?d zT5UqJK(}lCAWQGZ!jd9%e-l$laC9VuHtA^V6^8Af4uTd!902_Gx>3n{XV?c`ygP>c zXh2T6uFsWNcL8w^gs^wE+gn_&1Qyk2{v>>vK!Wy}R8F85-z}1Gx#~x(+HYsJNRPp$ z_w)i!Svuq&C}@n=+-5VUx{nd4>sx4UOUj4Gv_&MNNF(n2-wO@$n<#|v^JG&P=r9wt z6<^aDDdA$j?4WC<h#IANwbwo&@O;mN^nKFNBQ`6hw6)$_3rlG%5OkC?V; z$ADn2;(N82H5rt}@pjs+plyyA7;a<;e(QIv(I3;2;D3BX67pI~?!y1#CwEAYk&^){ znEre$LZY)1^<$G7!=B0T=t7+3mV1IN~hf#nPgclOs4ftDpl3u@T z8ab|>N!)ZjX6+PFSxJS9q#HyN@Hc3@IJN%W!`j&1-^{J{>Qj21mKUhD8nH1^ej_tW z&HILPj^X$5ePM44{Vp-qj1+#ud1|`4=CP`S*@Ax%Q||b)<49J26p+!<;OxLTtHpjR z*v6#XGiD~9LP-=4D^pnK7kv-xkHifVX3AEkGkqcl8LuQS8pZLy!zNM_7nYZ{^Ep|3PU=$rj z9EWdZ!uhpyRI>m!9%6u2JXa^95=|53C9y=$6~PBo=r=03yv;kf(?}|y$?{R}8 zJwUi$6DO<36r@{XyQsLEAuZ#*hbK9{^h*--4|?jU_2fa5+TpBsD)Ac&nB1 z&HS%8{Byhg(^b76WU9oDX4Qrd6ku6NV#ul*X%veCaJ>ut)RC20RGi$e` z{teO>NDhRzzyn-G22@yOi}Kny?tu%S!=UNFOKNn|ysPgS*b#i7W0KK;KY}I7L#X3U zBco<$1DJ!lzJ*Wv$EkB<*XB%W&Vb1x?Zh)jo0c(G%nkGr*~gV*PtV@z^AyNJz7;v` zT|71b_%qq3&LuQx0~Mv?bRjM}jQ-Q4(%jIbZ@dnY}XIRcLy~RRRxC zcyi#b3G3g+%vOtnp#R2b#J`!&rp$J8#;@!p%x!!WVIP=Z6{LCc2UV7`<$OdUAFCRx zJGq>ShOQ*qK7f+q{E1)vmg1beA?GYP9)9NW+BLf6)h?pj&wOb=`tMpOeuNwEy`)aE z?6qt04C|o;H`%`k>#_q+I+c$%2F*T~Yd$RMO}>uftZT?~;~4MWMek5s=mzum_IoAa z-3Z*q*~^Jukr3gm3-JdGIW_NrXP3(D!$?d4cTxAnhyIvp8>8gzMzAXx)YWjPRAT}( zk2&a{e6QLWR`dTI26x+tJo?mw#*v23FuJP8xTa9&e*ttR?;{&t6#9{5g~zMUFw~ z1)^j!{s04e3H==ej$2${WKD0g3XH!kgbN4{J=(LjVf>&wKhB=s`_rr!@NKY>SfpttE`Qej@B(`OPbK(gCE*2h zB2ZAWVV#!^-aWKgIa1ev9D_$u;ts*uhZYK+TV+o_XC3F#z8GNnuJsvX1{Le}6wQJC z4CD3lCdBEd8L#e_8CERX?S{{NL_QZHPc7+bL5Q2oxW7DjV<FR5uw2JtpW(I0!cT~q%Uq4H7rCW%V{#+vXu>w5XK4)@j+(g!vi))G>r#;Y>d zS(lOfAlAB2eDE>qR1wleT%ItrtQumN`_fcf<6r?KX^Byw$>>hS6d5QVSnhLsDTNf)ZnUD1&k*F}d4JC3? z;T%d#S%Oq>k7OzFV&Cnfi@aAP!d&O*`p+W;M?ycA47YS}7hYG@_vEFncNsW9KoJp> zJGC;ZPC?bRK`cIA9t*p)E3DBW$4mSUV~x-x-^_B&NxfBJ*nkFf9&T@6k?ppXzgxSs z(Dqn!>?&ewOV)aMt~!75sU7-MDRCb{OMRqgvMXcCDz)_Yg#K0l*vTa#)D0 zMdIGWq{i#N(&}&g0v$<@ys38v6gf!Q!Uktv!)~zGMh~3Zb=^{l{nO-P%wSt>eE9ud zhTHZw*T4gwuJ|lZmMOFEsjsNe=?_!vC782IWPyNnl{oJ0MdB)dS?~DVX*zvU;ZKAS zR(T`1sQ+K?Xld2Yf%{jW2%V3oi(s)`_9`h#%(!E>`=Zqj1xDX-=l7+@DIb1Y;_0pS zEkfM3xzqH~HPB08e2!~puK-L!tr>-=x6yQQcf*i24TO`(@S zBvAD1Q)?1+J%!SIhL_4x&p7I4?NE81py@|v;;-qdCVJJBv+esQUg>|q9n$^vJzQQP zeWGqWUYRnleZD8obOBx?JOQb9obj9pT%AZir(9nNU&;&{GmSqI;lIoNNta24ym3`zw4%?EVE?34?A!3DEIhNDd zF`dX+Dit=RnsQhOIc%$($(#?vw!(}#%r@KX{M+~T`ybx7*ZcK)J|B`<3n zw81iMm_7QkKv^@gm_X1HcCY!gX2|d%&eXnJ6e9U=QSTCr;2_QJvvv)!P?wQ~+ghG_ zbDVTnKT#LfqWG)-8+HwLXTJJfTc7IeVwO<9=!`m^sp8ivKTtmhY-W3qUC4j63CeY2 zJd_(W@P0Jgj39W5sOxhMTOq-9jAiuqwF$zbz#boXv7&SwR!mq7r3kt=u=4`y))<24 z2K8&`wwbf-@9R@@fkK6;qot|2_6h0ymj0rZr#B**%mFLkHs_%|aoxHpwUx$2f{_PY zMpa^EUHSqSMh=8B(d>4L@6^Cic*3-PyZa}22Xq-FTZ5TzoGc0ff{o`VmoIONT8bXv zoI5VPJq?dOUfzdAwyrQol?=sNf^@3OXOX?vNe~A9&gIu>0Obx+qH!rxJneF)oZ50* zjZ%cE1qm`g)e-q7?r(8Fo<);q7*hF$!51e)*^x007vVIb!Z3`%J0*G7(vdTALE<%D zM$@M+DxP3d2r?g~86ac=TbgnA2A_F-5z?1bop9Q&-A>kwi+d9rD{9oq>*89pgP&{* zZQyMjM7>A+BiS+7@Luv$mDgqmA8{x?DVuuL*U*CYRIx`K93VqfWL~W$-e~H8)Y}ln zvr1TylO!g9K(V`jL%Jcsq8JEc=4m!e%igf5f%%Ng{#`|mD}$1~ae@7MCHdLDD?6!I zrK5697~jvvgVgaho_+m{lMY$Cd7Nx{&_1j^;QC^}wM9YuhB%$!`7Ih|ARJs-R{mLd z7VA!RNK&|%;bWS*XEx0(t)BVbnC~5->v>W*VXaAxRQf}tknHZaXz|wf(XEfr`Pkhh z7yV~iHnX>-XZa5zT~`;W6Th8n-Q|BA=l%V#>g)64lPs6!$X^%HUjVm+;069%<>H&Q zt8>L&&K(baICnIC1RTsZa5610`NnR;Nq<>W({Ig>?#m(S&Lq;f95e8LQ{4O{n`OhE zTZ}D%LBm!>25bE5`i2~o8Xk|y7ZF)CJf(=RSlP~+?ES6XGcoGczNH0%M1Ai)&O@J> zyuU|~(fDVh$11n&D|X{Qtw2C%(u3oeHR6zP*%T+>7_J;Jc?;jRGV
    LY>lW7vx3SAQ@*jWOuLvB+egwo3B!( ztDvllbt7G}W~y)DzU3E_haw*qILpk24HgtDdY$td#EVXpVUFg!d}v1KQtw16{_?VZ z7roTdUE@gUULPQeskloJs6h$qD1CG@FakHQrR86yOuw}IcCBR`_CDhRp6X&hR8u*7 zIqeSD7Se-5jmw(#A&of%^SHPM@a^dI0QxbSh!`)3?LV3iUv8dzK)V1`^&bQnZn1N) z4UU{x)qD&E3U7_n(~5Jd#)mx6MvU)QKOyPY+7GiXPPEQ4WKVv5%;l%|y>)Qn2$}^c z2rfSXoU@z$C(M}trqPQ=bkK=nEdXj7Af}Fz-lc;r9=cJsR)@z=GM?0%4n0^J4$CR#`GJ1#?5m4!fY7wto-qyqF8fH z4tu67efoPnW{FZ;FNm)AIL_&wRYtHsPOI6<#rk`>ovh}>3q}Bc;$!cQ0add?pch|u z?BteV3h_yo3uM)KM(WE78Dsk8>=il(5Tv(Z(*t`ybb-MywJ_k>c34I*Thm`({CBzp z6VeUdL3KHx~O&Ns`EsUo*5zD>^%Wycgbon zdL2FSWk;NQ02sMrXo`EgoY+wm)-FBW;&?my9MN&g$-ZNp5VCZYhrb+JTst=xj$O6p z+7XhmD7P1wglgtV_MWFC#z8>uITF~}-Vg|*_dYKgn@(E^mPZXIE|~ghN=9<-RvyQ& z?+CT*2`gT)w4a3y#0I4R9K0pCo z{q+dU6I@{!=MIYv9qDB}v0i7(C>^?+COWG4o7a+)DPZ>8`sTWbm@;c$`cskKr@@h! zEmxf!fo|t~NUc2s^sU?XLU)zAxut{Sz_Mi^YzWupABZD@7G%x02>}XPo~58XSxmlP zpZjKJDRk*?em%-GI!=*t9QQw-$#q8pJkN~Fm}n@?cNVo9ToHPMTxx>T_eby>s4V!{GIB6ijJ}2w<{<=CHcod^rm!! zVV#b-R?WSm0O@Ai3?+gehG>L<)g`%}*huVY#dF&plL8<51(T=3SNJ+*DBeA4R60DZ zAYqZ}kq$NV-sY9-Ozl)%tfL@C)(dQ(O?VlGS4 zX|s}3442bbL|Btn9_W-Nm=F<1#OjvC6G>SRil}Mh3SEl={saX$o*X)Fkp0HwTknIh zWZLR*$f3}1=5^sOm*G1lb|By;7*}@SI6f8#aSQ_Pdgz_r0!kz-9M)wYya|aC-!JvL z#GKzka^w#kQhmW-o*>ze_W`wx^FMJB?QSmNdX#vAot_@ zJwuCE_tiq__R&KjOngf!pj2|~)fE3I-Un}heQ7P;`rRzo+ist*gRmtdI%vW1jQ_o9 zS4hL`E(lyaS#EH@AXwf$4Br@})A0}pMsdfIiFp#dxtR5Lua zil?5TDr?nZTeXs^matl>@&>AWQT^i41n6@3!b&+NIps#FcGv_FgGiC#he0S*O`SDs zPXpL#_pb3q?0C;2Od>X$HA{dK$)Nzs8kn@h%;Z_5ovDzbKkF>_f?kVm8$ck#=HXxD z*B?$gD~~~AWfuy04h82`(hy#A@Kl&X19E~BBrFPIaAuy-bsg{ioI52l9hD6PCDq{L z&D3WS4phj~?1A81teWqa#Y#fEbbR{mLy79oEbcj7H&V;cr-rXym1_MpE!9$pjW0Ih zomTa*CxYPpJ|HuhCPU)4bPiD2gP^nv_ufF53d{z1jN0N=bBOtD5NILameeL9@2ed) zWOfj~9aab4*O)R@F85y7;u^dc-2W_r##A2Hp_f!CH>1yZ^w?98n-&c~{7%305CQCq zvJ0jXjB}bfMZTuU0#D73%FKyRHk6UO)w^EyBy-Z?26fn4I9%Bgfs!?=)qJ(Z$}5{6 zxIsLEVq??n@O!}p_c!IqSz^yL^bWQL3L7V?kBzF({Y7fvHOVGXo&DS(`Hj^skZ2DT zaecA_W>z@cK=u+ckNhe|U#sOs&wKZJCoC9m z6oDO`sQI~K#->SbC@6D8rr}XdV-{81hRLVAbTXCPMQ&n$gR7Ug@<$2stxH>i)iRP= zHjY1t*ebc>IEXvX!W1c|5yI!Nn8|UaY-l?K`A9HQOY{Y|5G~bJQ<9Zm#8p$&Fg*GI z6KsIJp-^kCVb>=TP8wo5BMd7Pn;mp{V@E!pPWOumy*p*9YrGS7+~g08bT%>5(Hw0z zmskaSY(g<#<~d!uI^TLNeXy^oR`&FHXacF5t~*+tU7myq6%J`|jq_FwQNREQc=f*< z3tcBb)#9jdf98xdagtMOpa*lYUgX2-qP1@0vCnXz|R}FD^>*_IoNT^M+t{ zOJJygc3$aa&<-=2=ROWNGfdxKY@-oR#wSx6<0g!j2mk5`cpTrM_XQ9&dw)NXR z#}(w?@SZcK%bMr@NbZc(??;zcrVSu8_GD^nNKmbiYxf;~P8VqJsp9~{$X_)2u1>73 z?1o1W!N($R5SiQ9UID3#-Q8;aPY0+jahg@|%(-f!Tcb^xaX!hBY{pL8jijPY6zqo*YSVPO$f@3p`xh+)g zZu{(_j1+YS^FnR)>&5&P$#8Auum;27L(bDtyUp!1_$is_n{&Ub>HT-cnWStYhKUCB zqeW8$p9-eN?Z2*_i zYMNVg6{9`DyRfooN?oLWon)XZuA@?)upsSn((BcX!#As+AN98p*GK;uP;IXpJmkyj zx&juh?L6|z)3MookzdAs*e=y`)0vFRaJJ)Q0*V^9C;MXqV{J-HYLRJyDSaj=on(?2 z>6B{{2vea`dVrU-Fu?`x)w0qK*N9;BbI9bD$d5+SQcaQoGA&Gz@#~mp>4HN^fe&8B zbQ+GC1&J=FDmn&%H2ejz-xe(AABb|z<^bs*RInCiw*~_~Q<|!~-Ea}#UR{+U**rcn zqxfi*lDR*@Jgz#c!)Y7HuQti$T@t?}Xw#q;JYYE8_8BaJSX(y+dm|ig(mKE;r zM*0lSV+Hbsv|7>ahI&EQO{tsNBzeH@Mt7I=aaF5#LgeBiU2M|so^L6r*h!1^VdUID zS?iNtf}+*B4%IZaL6+j9HkYLz9sd)G`jR+xd~_sUS377l7HRSa+RI1RQg`QcY8kMl zT{oi}^YJa`_tc}`zk?V}rB}O(>X&P6hdlgEeAuUflSPV=k+Ie-Gjsb;-$)m}SRTMy zidtqr3kPz8q?2$MnSNs)y+0J&a>QkxlF#p;o}2;gX*RDhNCw!8bsZY7&I+s7tx9(h zbGH-Dr3FXr56ys?Bva6X|3&EGU&bi*|JS|H;S||EwbwS28?lo*8sE*HN&2Lm$`Jf= zyUHJL5P!2<)FxoR&AHyES%R*OV_)DbSGTr2EIY(_FMbFLA)m`_>W(xVG7lO6Ml zB>&)r4UXIrZ70vnJs9;+x$&XMN#LUb>Vte*^kxx4T5QC6<9l6sFG1zUTisR@nP&(y zgddS|2{pJsZHAu&=aKfgPef@R3+N9T)M(E{gnUJ3Ub2hU)3XE6@j$vntgdP}_kuZw zyT9N$|5>OgS64sTJqPArzcJ5oNsZn{#7kR|ot(#J>d)ZFcn$9|Ed%%8+3;VXN^ELl$Nmp4T~iY{-Pa^<6!?1R3T}2R{rfikZml zbkM|)5&H)xe3J{_cwKGG$Db z^nA5`(p8RJwR{nj5FWuX;@^Hp#gypOwUcpoEOG@KrOwwmDiuH@p7ZGoV=0f`bDT+%;RY~gr*6MMm~lB-WUDnljKXVoy zU({U;h*@#~plr5l=(-kurt*y>vgK1@Zja)d>=+4Jh<9lYfR2@LFOW{gyrorGLc&Vt za)nEW#>Nu;<(@i<8d7)akg6XD`&DJ+VZQ~9)VxfUJBj77E1Om(KSV13$_;zrJ`sPX z%8zj|V|oW8zDw7E`bPLA9$ppSe>_v*yVI&*2C9jX+esS&>P0i94l3?LGn3`$`QNtj zf^FUD(290<0JI&eEI%#hs3R=Qvju& zyxn59hweUpr|D!K*cdD%0KV~*k4mMdqk3v2S9#zmX2R^5z(T|JE;~%ZaVqoE8wXCp zNHiiQDTbA+J!qKlBFJ*uR0nVAf9a|v*B^CJ?O|OOUUzd``NpJh(zXY%ysL#6{UDwg zf!%*)RNBoMdz@1XZq`*?-tw+iM)>ssM!?IqkCtPUr|1zqy~DLN*D<9_+e(BVFPx0N zGTvH69aj%g40(x&LZCFhM z+J?TSH7jowuTkbJ*OqrIzaP~!jC+(TXDPX7b@g;Ld*-d^g1Xa=rVCmd(&pN8Nv%!L@GubkVWhmBKF4maGURY$Chg16C6vr;( zDo|@$;qZl|zeEGyVeMyuz2y$$vfa5s6FIacIvU0H`t}FldABljrPn( zy6H?~4zq7uFjL2rnSL9m40jG~LitAaf^Kx5MRo`oaP3zFz`VT!HZ6MUtWr zd#0?Zn|HC4&6zU#-e{fo9JAI&6YDdpL_oo|Z7sES8WAka9Xjf}UrFnHGA#{zcrngd zKx1E2c!R;;bCh(#`n){F!dbXMgp`uPUuUE7|J~tordl=1O%CVo+{1jx8^Z`yM0{=& zQBy=`1-#(2K0#>2oBf%!^YN+3`|b=PQ(GuJ77!j7fk?eaSXhZ23;XH4 zdWpA5ZV`(0qyA`(h)C0r7-TT1Ktf-`!BbC*f`zyJf1gK8eQ2_c;@u(L)m{Xc$VqWu zGwXSEMbB{31nrr~8!bQy^Ld!pNWJ}c`Dv5=0d|LhhoeT$zkt<*(Bn1E0xKXmDrsJ~ zN?LBlXlaOk-+*Xc!iJ?YtRK8wXy6FP3rLF2j<0skp%o=$%P3uj{BIM?c1-~tDa?#e zr3?CX>ku|+!y1awF74G)nm9V>K%H!9)&wY7U1_-^mPI^l)BFMd2u*0ssof)Lk+|Xp z`_vcGt-*QKQ+`|Ji-6vioeirEkwZU*Uy`vaAgjGt57H?2xhs4lNm(`11g}u@|6##W z3nDqk0WE3XP|^2%+$9Q{e*_-;%2Z@(Ib;+bX1aW+X3ykWyWS2LMO3-AGU8h4V~^v~ z6Ej`O+*o-~kL*G*FLdakJp?Vfvdeo(x`+<(Jg_l|8cZ_pzR~o$Vg4ylF~!WFDB%PWUN$Wrrf1lX2qxS1 z4B^1SZs1EGReFBQyns5_ewilzgpE^;m#n02TGZb|k5P>Z;LtK*n>U8?`{!{+{E(+k zR=QD*yKs1DjVQMi^vyYj-=XR1;AoA4I-8cCut5{zK>Kd?#kBa2$a9G3&KfCh-E^XR zGEi;R_PG%ng-PjKrD@kO-}z-i|H;7a!lMhU3+5O0$x9#kLERl&S~KsF3=hE|nkD70 zj+y2;&aPEoYD2)W$XNU&`mGj`)mqJW+{okpwImy}Ugpz!p!-{8py-o&xZ6^m0R6Op zLTR}jEeqL6g~!ih0QcxKROFHr*c0;1GzI2Qybv3M zvwVwA9-uncpJ(=tmHjbPWPUiCPH0Y=J=G%u(K69<@|^vT`(VL=2Rz^wi|NqYBQ zh~K5iNRSS{YEy$dgvotGbWABgi+(~`d7+I3toUyc;r|ER1kc`I_=;{{-L$?l;VWOT z$*@**1eoh$p1Xj0xgVHBnU&q`(9)`q^e%sX4-cQneVh%^eX4xBchUKST|>yI-t*|_ zYYoZ?srVC9^gq8V--7&lnmu)QkXBET8q>L!{pTSNc91bCHyJE$%L3F3!7lX(GXJVAOi^BHvYjoBrQrk1&>z3{ z?%Sv7P1Lv4^>wnhbI;nRuH<4-YIISdt3!aizd30q(sZzq+r6Yj|QJByV+?8FG^|*tOZz6U2JYZ)-5(qTF zmmC95YD;!JE9e6qs+=i8?W=6Hn6txO8lavj++9}=4xteoTb#vi|5iwE;byN)jYEU(ws*Q6`_l}Y zuT~wkJD0XVAH>N#@@4wK&7!|43Gy2B{{&Y+bG?z7X_LRlp>l2}TSlrIo0plh0(TMj zEj!N-r7ou%ss|GboMRX0OK5F=N;eQweL0BmNc^?}pX;VfNuv3F$~*Q9sL~g#Uzyjw zWNNG`II85?>PI(%5sGKt|I5t9J%eD|yFCRPpZXbSeX8E$Ilu5`6{BxoPzXCek@1C*_H-GOF<%$KQtHY zgk+88+Xbg`7t7iXV5g4uKKaq0GLT=^&~LH(4v@ia>HOa$+(ci}i(emC!?(Yybrc#F zv=7f-zm_&>d(gh5Hkq@g&-sVe54Rs%egG0yidzWr2^j;hK@k|D*f)&ATHPUw_ z(2%!&SAR)XIX4cKJciyCqVBU!L40?r^KtiwaL=Jg zmPcHonoVMw`CusdRyuTr5miQ@k8~C9F^41@ zE1!48Qe8XpsMzg)b91sYx#i*+>CMcAM1U>EOsUyOt!VV9tJL5*>d%AtQ4Rx!nWO^< zYt)Z=RbL;J`a~rLu6<>7I)l3<_`#T~bOdStfa=Hs3Pq z(-g=JD^q3GSKfheCzBEOPMX@Mfrr=nl^`5R> zt4DfdeRW+BT>7aO8TOrrU@;nHAezSZnBczcdc1YWwecIo{~1grbJer9*IM+nLGvhk zilUScXPL8SWRv$#PCh^{l=K8lM|%TmlFVUU4}$p-^TqYu2gqlUf(7*KjbQ5Bg2}Re zy9Y-jK?CPuZra<%(5lwezAoJN2Tt+~L)o5}2QckTAAz&*D=0UDEr%MtiB6&x7<$T+ zy-Abo$k@3@RkRgfVgvGCW-jeKZs)2+t`+eV(LSOsECcN*O?b56pnXSpxiqR{>G5=l z<|TV9IYID4_JldqfC)uE5-Hu)g9)973NA`6mo5JzKC=3?&o;gvA|1ks50KLtoJ#Pq zxPtC-O2$EpECYZ*o^KMn1&!^=f4!;=w#u|H&AyCY+oj%c#CuOLA=wTO;N z|6`FH`k?kG--U250Nk@jdNOoV$3VDJhsZD+HPX=ZU{eMrSC zLC1dm&n>W1zRPuiROA_S7(1>T)7sPgkT=MB6yjw{cqLNgeg}t7p5qKv^rH zkWBj8y!17}dKmCnUey19xdOUg-w~5Q!^@mu9ok!Rg&D16V%jO-xQnXFv&!n6?KFU! z&|}k6ZSmh?0&+YPIo8NA`2mF_nAbGU?SvGBP`VR)BC`oO5%H5r(+)0WPW}#fB;TN8 z_lkR-Xuv4^Ct+o-Sr$q;DP;#oUcb?8Xvp&0BRh+ZS2{?4cSuTJ&d;wj*!|6cv)Bj7foFMH z{wKo;c*!)oLiT%QOTn(G3)q7MBJXn@AMqa#hwwn;saF4p)xAKJx5%Cm9Wp)3P)Xwx zctKeA&Bf`%v`%Se^BO_a31aSrgd()XXw1loo=8cv;&TxPKZMxTi0+R~68RVNoR{u< zY>iVT4g)qT*cuxKLhX~f`Ux>pjBj_#7n}+SX(qN&2bqnxMqYRxaD-&h(W0_ z7W9*NbzjwQGY3mdO@HK=lDoUn!VMLkER2k@HAW)bBSIzZK@YWY=_dE{JEThux8cuC z+KKtuSnm=?uHBe@Avt4pqS~?3^=h$p{Gt=p?vgfrNAj*w;YI9Blue{RC=UT%JqG); zR`AXlu#aDPUc0ngx|^!L@d@)6b1B^pwKK*0SS513Ld@tb{(yIC6->G^^nN|B(pxlH zL@Qr*wHZB%dRUz(+sch$%7Aez^d_LoGhI{Py?;~bZwhZJK3A>>)!CbYy!Ry*khxcP z8c^*3AwxLSqSXNN3vYVytneDSZY@*%#z(a4k-*YrJIM~fT~6TH4MZ1mF2MH_Y{yO# zP2?aJ@^QPst!?ADc00V-d#JH`iXi=i2}qB+wKdNzAuQr(QWbufWWHRXpt)fC?Silm zsvS6=E1XZXAKpw@_7dxql<n6Peu0Z`>Q)x zsBvUAZab?!zi~X}d1O#b`P{xa4Ib+66esOZz`xtH>o=~Pg^51sWm@2vJPJ+>+Laz2`}`eQCr)GkP_a}~5Y-e+{k2GUYkmhwxNSqp2>R~S4QfjPI5(GRhac4X z(WJ2w!Qwo1&5!f1RtP zvk%nxfUe4a3^(nX{s2G@rv5P$szQ!_Dk#G)0745_nuGE#z$WBwPW4KkCIisj%5V+M z@hb93d#2+`peAF}J%{l8Hs!W-4u6VjmDO0cXYP?GvHyx;g11%yEi-{kbc17lC+2Ve z;u>|S*0*2|YZP*+&K89;EFv#;5itvkc_ZPPMk#H0;{;sfAq#S-aA4)RMq4S)g9 zrv}&oXkGZKg*h*%s;jLXhSJE_IsAbEUd~vy2I283CV75jw^vz}4bTWpr zpQ558umx~bM*XR5o=L?f(c=vC=of%AvwuBhvSiI67|7frU+|ofH4#tqOL|WI(J8Fj zIqk#n&>eU})z~+Yeu#P^>yA*ZzbyPn5@hL5EYS9Ou{5S?_3oC&78(oBNBA^EB88iV zZI`K*UaBWO7n4W>ZT+^Zm((8+t&MY+B*QrIJtK+q^M1N3O z@lv{rlu+I0#0V|SPc*SJG^IG?$YWLPQ_PJkt9RQ@Gt`2`C5}83a&Q^;WLEwzUNlUm z;nq*WRBV`PM&s-fMutkjAOvw8rr1DK0M0$ciD+em1|IKso(dNS6ckom>6W3KXJ#3k@FrY+W{vxxUV?!WyLJ$Z7Vs0Yrf z9t@z)`$^w~H4jId^SCy?BdH*Vz~epjzUixq{t62KD^K>*$J@18hfOuocp1d5s$$>Q zxkt%S8cR}65E>~3+U!+w@2$+uz2dwFSwRVn_}U)xy?&tUriXXxPBX2DWPaVL)uC&_ zP^vvlPfcGFKz`I}_PNBx9MS8B8jEzsw2|VrXNF@v>JG7Dl_z6=yoywv7SjHOJM%;p z(H%5+{e+FHMu7zYHI;RoI#!Ro{~Gwo?DG*$Hwg8tRIyUYxn*Z#JIn*a+nEb5Gs7y! zEhp8bS~!f0qQju?qe<+sN#|IXamX{OzO6=Nwd#P+a+Zs4XAFG}QoI)#_UyH>=)WSn z-0p4JRW$LV)gKJf5VSc+{y!s%h4t^EJMl3^(B(4K(R>O``Ph%f+Rx%;1@QCK%+)L^ z$SNJBQky4VZuB0Vh|`I>dVdI&6d5Zy=6GH10x>iVCLBw!{^Bx+!n#W581!iRL_;r% z#L@dlw~iF=D#o;pHRJ~Hu1*`TnL+1N*h)z#4%cakAML;_g%E>xKLgKj6lJSBkHhgkT@F*f48YO`b}<2o-2HKzHM=NO*^g;|1dfU_+|{BNRE7E!*t@|MsC z<3k2Nm|WSqhS2fBn$ut1n>Bq7YGL|?_?)V zuKDd&mU~A1HFEKHc3FaIn%=awZ|?iQyK#o`Gfq&nqp<9^k?@tWf0Ml}`F+g6?Lo1f zAMHQomf}VC!bIs5X9RBRgAk6N?wrWrz6Q7ic`FL+pk}96>_c7|bxxRz zK7p2x>+WMS4MHIAJ|E3Jmw~>A565v$19rC4Sr!{bt&S+i`u0ZOxiSnW$jtj1G~$wQ z*cT&eHtFAlE(|$P6>+BJp}(z{b}6v%B4%EDwpW`&d^uHkGc*CCV<%SA|Wnm6DV{WGLBc%I8>Bn*65e?f~ zocY)ATm`E!k(Y&|Y&X1{LeTwek>qkBc-y?gC8*GtbzuCEd9FD&NTV=vlvjl|vxe7o ztlSapjyLN+{~~;Tl5i5E4#-dVRtCQ04z(*?;^sj#ciAdjk_IIDqOgZf{5AiPVh9#t zxCM7@dc46My|024IVsVtrblPa6BZ07rsvz>@9kF5qwuCz2Jh4lMbe|$tN|Qm3^X<| zauc=BOO@e{6MgX6A{gID2Lh)#hyDJ9!Q8HMuA{1D@NF9Kvg7XpULHDusQ5rCKL@7q z*G96|v-TTaS`bD*ZA6`!ztgpMwpYD#K6*aA^L;$qjKx&DNU}BOF62*B7D)^!t52%@ zeKCB=fl-jMtp!M2y37H&Sj2~pH%`1ssB?|tT0Hvn=wBM0m)tJxgjuGuO`(Eo0e}=e zH0N%nQWGL=psEfeQhKvo_5tP`5M8Y6+93LP5JhUUGr*BR=F0 zav=;KEHWuYG$!^a5@YXvOYR&2H?Sm(3f_H8(k0y}?;4x_^Ox9+ebz6dqLLN&ck0z;+=-@)yf`iq!kg zu(m8Dz)9Fb+BU!>+gY`$T>dMd{+l)o6Or|`<$$Y)@hUQyQb@E2!dTP}4-t;zWs6sW zk5d(2AZ2X5=i2{~8V&Pufjb)BM~t?=}|)>TMx!^l;7)O^Um`r`HVJ`tae&u2D-(xVJN z;m?qt@cXXnRY>fPcyGIQe|owxCpA^iK``A~EwUhpPjNQ;UO5AKCft!9bgQvu`$Rm| zdU#}R;A>;#SAGxr_u*R6zu4G;zQgjrUO-PFj!f5zB9{)A05j6n`H@%s+|2}r---5S z5siTzGuyhu<^QNkzS2R_tL0RUc*pWqr1h4L!?-3|RcuC;`XgaTy^fXb52!W_6&{u7 z@PbE7xKeukPOULvjOd#DfC*?2^@+3hXH^?;HfJ9EPUD>&Xa$-CMKfByF!RhI!3WgU z^b;E@R#bK@xG&FGanCNdM5P90AcKMe8hPbH%M#_-=hcR)dLVvnPwS-{Gu1oTVdmSAZEa_6W|tj+ z?Ui93iHyljW+$YzP})g%*q9Y9=EZPiV>Pa-!Jc#~V#LfpMtFAjbNHxg>>M+?aDC+p zPV#^5MXKVfme-MkK3k4h`~>!I<2aTYD;EgoT-L0F_Hi$5pT4vFboRkzSpBb8y0V2e zn52gX6YDm6spdX-k2{_i?ze`emGsP5G@tJx!BAt3eZvsu@t!DaShvy7kVmrpox87S z&vPBn4xdHYb&8yihXxE>$sYEf9ln&foq>jtHL0fLZ(E%5SIL)<-}le++;&DS6abUC zm-2YSDLQ}a#wTNeFQ1n%%XXop0~}oFE9y#rIFP@lwSnYk))=rvcS^4^u-3`TQw_g; zq3Ha5Ab}8-hz2ieY9a}u`*wAjnnQ;HMC_)%T!0Dc=`(|s=LOXjtrCB}ZEP;e#LLQp z<{xW!a~eRm3w*VOQI+CJvj)DebL?Mnn7Czn1)<=Eo}B&eMuTjZ?%EU5Q`6E%;qy7J zEgBN#zc<4PQ)8rSqU-XOo$hq+uVs3FdD~gElXOa%=YRXBg`IB9;}M>S$mZoU)$oPX z=fEUHyG^iPIZ1I!C>_U6MTh_B7GJP%>}Jm!AE$lot7Edhk2xy}@zR0FYP;L~<|M<& za6xT-%SEHq>8E9&iW3mSP=ve|6w_5S`V=#UGV?Wz8RqR8Hkd#&;@{MnLFl+j&(f7p zXM1AA30u0KQ7Gq&=;1&HzgzqS8a%z=pZ04|&vfs~<**DosONjIyPOx;6S1i8UMG5Q zJrjC9tr&F)3W?~r56YW)5lEyq(ogc(fs9{ww%;q zc(tz(6LBW$W~zGlN>?O!Mc8BO=Q~yXq;$QSe*EU8i0W@ZId|dJYphei#R_0}Eli?n>I72OdY7WUbjaXq?}GNUKuZtiFupKzzI z2ajj(y9C3Q1`+rUT1cHP0N-;VT?hcGj%Vo4!GlJOZn&mr+kdLFG0B?p4g(QdL&{b7 z}Hyk867flcQ*H*dS zzh`x!5KGg`PLnm)KfL}PXis+%ParT*d?z$015L>Bqh-Kp;a zFBi>jh*)qj^7i%oZUIW5=WYn~A-H8_w%Yz(izH&t-Mj(2&W;e+%HQmJ19Ee49as!w z2xD*bQsnN2G7o^r;`H1B%U@*?HRPibWk^IcEH4-Zb?FcV%uyEpy*n&gx=Z5XpS)&? z9h1`L;7!VfFYjYfTaIEZXR9R#NsjRhltPl*{6Zj$_!UgQ@TD2_0|wSxv7L&DXQ)ZR2Inj@OzNZ8VVFJZWffU;2s`9 z_Y6MiHoYIcb>WWyWNK?m7IoUwX7|jmGulBW0Z9k*a5)d3bI_2Cg+y5zm?e?L`&M@AXvT95T*w^8s4_-Fz#oT=t z+b&uAH!Q7Xi!5-vH|*Q$=`*1d`TWjXe)9Nl286(!eidFx9=HU*Htri%*ZbGS??E?6 zAB}xMQHmwEl<=qqYFxqGy$ZCfa(BnYr5I`1S^6lp*;rl?R5=I zCRh~2%t!i{<|^4c0$D5Tv#kHrg$IOqt3(Zs5d|Kx#s2q$y>x28{A#|mnuG33S^XOb zNhk}ryE|z9$ykG%QZu@|CiDQJx`czi_w2yi8_-Xl{A_({Y*QUPyAvlpMB3Kv94<^J zWHH9j-{>1oK(BG$eU4j!Hgu3!Im65=NiCh(( zQ>A=Ur7-gp)}0WQyt~XajP_YBd)K1LAMDkiXf@+?a5OROmN8#LSxK!jkK_%0JrJSZ zRWr=vQfdT=rGQuL7M{*i+E|DMopg`(1QXZo3a#k`>u?N|2d{L7olZK7u{lq9nG@=6hzsA1vrO&)eQbEvkcma) z1>RE_K&!746DVI+;St$#Z?w&R4clJkJ&Qifwc1!0D0-ly4on)>1=W-IAK4@Rk)h9x zqXmI&{{6}U`?FC%95_{X_TViYekyllLr}7}|EJuOL+{3tFDo!6(Zoy{`tiz8anB!~ z1Uq`j@szoh@T(Y)`L4Lo?~$QSx=u3qg)}MG&NH;6AB#W7WxE}c zpHOMeJ=KawC!Tq z<3vUvl*;GsD=LHCeXjc#UVI_w*Wq+TzcuN)NRL zt$bpxwBYjz4PnC9S92DbQEF*qq~=|Hsj}$1~mkZ~QKmx)qh8a!RKuvAenv zV@oRCx3b(SWmut<4LKinN+*ZqlpRz7$aeGS`IUZ&1`J!V1E1l{@g$N zV~@}Kwa@!{UDxy4_4YNf4v+&)uf^;ct7~5Xog9ZL%6vmyX)C_yfo9^3pwm$y*Qz`3 z{h}3Nc{7Lmm4qr!zv$<4|8yWc^h0Fm7+!bJoPy~kW=m~<#w<)d9f(1Z#N&p@ddvf! z!?@AuF>)^f4aQQH0lhR z*-GD7@x!kl>oG01AdVH#t?mcSYCr^jD~Xl|(w0Gzo3}hB-}zG?yC1S|JtHewuNpm+ z_I(Cv((=N2{5_*1)%roin3WH#^?OJ2f1h1x!K9QzuUB;TgWhA=!<4$?Wr3AcqVnif zXT%S%oy63@;Y4eh&!qx5ZfM)KUs*%jk&v!UgYZ0S7MyR0jEDU&9@)4&`=%ejyA*Lx zeu?{9fBsxn{JkbrJ$%H@bYdHZ|vX`W$V=V{f>ILOBT=d>g&I8_2vl z^+$iyUvE=BW?LLNcYMOA0{ub@j6y9>mc>k|kw~bFG{e}IxY2k*l_Px ze1q(DwY{ytG3P;SBI#=WnpU2Ut3hD$BFx#$I_Owe2{@4uIo)g|U5gPj+CO0HYj$+& z2B-$d9W+X4k`G$w0a$OV>VfZ3VB>A8KWZe5hf}{_fQEX{(5zAM^9%25Y=)PRJ!`7d6g}(lI3u(vreP#{iW4R z$zAwc`E>11l+Eg&#U86P>B#i(j8U87odGzh!O1#9kTA1d8o(BMHt)kS=W((=PREc z{B&`qD|QSrwsUQEzz+CW_kn+ta|NG8nb9VKcJNYJed7$F#`=e1^O(*nh3&?c!YbT0 zh7L%1|6Ga&{FL#>Owe%ygfn`0cZvI|!Vu9?Z{;+0m>1|Z$1V0QnoIc>b9gEh?#Ws4dI49(KyJ^sC3tpbHb2t-b{hTPjGM zVy+WGj=Wsp9|var+7qzf_IaAOKDrv95z$d)^2^b!k^zl;RdZ{Kisox++)cz zs^}(|v3X+p9Q)_hT>fQezwnaGWf;7Yx#qGfx&a3I?hv|3d5)av;J7 zEpU}3ZYO&xQbd`6eShMKw|+qv~y8!RU8jq58iJAJuD(@i%mS6v_mvQHRs zWa`px)|aZ)ou8Pws|L@i8KDDT7%zUb4bKOwp7aD`LTih z{bZXlwmJ}1Hr21TcgL7y%$B|$Ub-UG7uSXVh-7v@oA!RkbD%Q z*jMo0y)`}@`#Oj2PWeSCfGX@81;@{*T}6m?hh z|E(x=bkb`fex0b$$?81tSAUjPQB&f|Mj|vc@ncMp;{hD7Kk&-M-hB_$rvP7nL#Szt zX$>aiC%Q&i>--v+!RyBx7R30Ey}&)st8FcBjgF%fO5$fK!9QLAY5vQFS9$sn|DR`@ zWFb1Hev)z=KS!AkRDIPRwltG^pt=n|`P9Eb|7d*?jFmlYJLXU!s~{8tAGd_qFLUFW zsdj8s;7@)3z{mw&oM z`xOnZjBkDu{k;;|t#2T6>pIyS_|yzgYQ9roaOjvRsy`?GlJ z(84Cye2mb#N+2HP6Bq7{JJyo10D3fJhA?Kt$!|1CRfOKB0qQ}HONn#qJAE5i3aQykDY4E97Z$uF+N|(mm5JYL?Z!(^S6Hu)xOM!2a`T3;{H?uZc*<461@m z-s>>_^HR5H%RWE+m0TkJXTwep$snuoPwsQ9wd)SeymHL?V#OwlEDszaQtiri_cx$y zDAE5NvbmdiX7)M+H_CUOE(yLiA~qccOq5A?Cf^Dw73Ax5G=pw+Dn~O#=6|9?(1Y+# zoy>Don|jj8(+f7$l;{Ua&>);q9K*ckBeSGt>Q&_h?_K&gibrK~z{1bv5tB=$GukmD zw-!Z178%T~G5(ag!LHp1l>h~17w|e?f_Iq1*!N18Ql}i;__E_1#iI)t;bEblMcv5V zvDcYC$D2@kKjTL%2Kdhe!C`Wy6wIUeT54lrFY{*7A>o$@%k0Myo$}e9gRqW8N(#G6 z*r{%@X$t!XAPc+iyD@CwTBBYX(wgPZ3Bb=Vf{!;XI*FcTz@oMp?<0$zLwt^J40KYQ z$3J_Inj!k_xN0*rF(Vw>4$`U}m})GxhpO(bKJnK_@T}>}jhY8Y-fgN?Qzi(?lu3)Tz^6>ZK4`6cvNJO6RXc$<8jX{+!?Eh^mnI{q_QvKhHOT_8 zaKP-VycMxt_Kt|&1PBS%aZGqnt^8D9-6T4){kqhymSvVDxdPYnjKVw8o#ej5bhU_{NuVh?;b{~o!S9n^LG}M_qBIxMgw(M zC_Jqrzp|TR_`+L%aI!rn0d@+8MPF4heu>7R`$sEA-}w5WVGM7JY>FAGxW@<{(5(4 z_8P}ZUYl2&LzIv>*$%ukd?L7nM+1H z!l`Ydq|>1z{#`+H?gv&&Q{$1LHl?d4?vZh7!hfk?COwEV?#%f%QwmwG#KtQ#JDaL0 z8&g8$(?Phq+khr+_JO4JYd&Iwi9e#;e(LJWjI@AOcmZ#s8)WOZa^_*P{i!7vV7i5@kz zZwVQntikUV)|}zrG7l_0=CIVTsQ9GI)uo15vS+rvAl4hw6u-F*yiLSo=_bL8wwg6n zBA)Rqd~W{wJIFg)*&5o6`opEAI&xe2u2yH{JR>z$&B%4=$Sw;CN=k%l5rF(>x<&NZ_e7~33%>Z2(4mnk$uFn6QNDl>IrKaEy3Hf zYhtWxGCfQ#3q);>Kjyf@%o2St2gyqqE+H?s6d;kt4h4OE0jCw~%OY6G-?`3=$1Ml(HxL7c9I@oWV%e^bPN7|`#4N%~4H&d#X@-8f0-dM! z|I~90qc9RRjU;~)R|^5V(EI43*|{)=k;HH>wz74E{|pL{QQ+qFQuSQWYcLT1)J||{gwLVH83N)3u2Q&kM?QCA^ zo7-WU;4qQXf_hTB!tW=1GM^|@QPY(Jp2na%w}PXBV{BF*DSxenbth#8)LI3Qq(TfQ>6&JdP$(}FO?FHH~myCVy5)(-dYy9yCAsFm8 za~?nYp*2D2Nf$ri>*?ex*Qy4zQz#MQ$Il>=8KBP86S=?ZF!WB4W2}|QRo*#7^YYH0 z*SpfbqAB)%7i_QyeFqtCj1=t@dZ*u6j38shDa0{QWJve`|FN76dx`geE8gjJRF!#X zj#`Yau^lITWUMZ8Do(BZ8P?E7SD(;S=4&xc)pPy9Gv|p6&ANxceZ;!SH`SjXe+TgH zwYo-8TH?q5Xwx=He`@>7w9v|OQg7zn*<+D6Ku3+fyDVd3JPBE~)jkg-9c0*$Z|Rf7 zPuG^6_hNz5ViMkZ(pU8Je%Ozy*l}&7{>ICgB6SC31Igt{AFCEyK1rvHJ6XuLB>=Z7 z+l>^bofMZ^G@iEazS2H(#TY5-*6a)P$Kc&88QZ%X5X{TbC3$W&i4N8KvI{J|Fx`_C zmxtR9K6n33vO<*FGiwbHgE-ogUP~e}WQeQT2g7L2{o_pBPb4R{8)GYgy=noM3#g<9qt_^@MtUaySu zhdvl!q%2*@vyM`>sV1Y<<5D=k^ZH&KEI0ZX_D?Fj#9;_6Fot`Z zaf17#J4fw8TwXUlvIy_6NQU{)r~zO^NKomJ82Wd%l6{(r_Y(x+%EQY1gMWioM@EMo z=NCnB%%%4P6T>giYTbkGn!mN7RONXmWdkJOaN(_GW{G{{x_7cqB<{Aa8^~>R9c{&XH=v5?lpnY9?h+PDGg73 zHOtd%bf(gbLHzQEji*QKKJS!0{Y-RV#4o}$&zQ{rsM7TGC_L9R_OA|6xE_nx+A zk=*Fni+bN-Ns*qh6=RMO10IP!VP=14F()f4BDi{@eB57f$Zu}AKu;HZS?e9M z-t#IHEfyc9FH-Qxz6aRFO~Eys_@S!D{Cu!FTC<9v4LAupg(rV;V(7_~ZCp|{`LPFB zP&|l6(Em4daSiUsP|nJD3)!Tn9!q)ib&hJF|K;?t5oH zm>WsJ+{?spL(1zpH~ogft83yzc||m$A_(U+rI?#bPkdUv!m%48k3K!e2W2jW@0bti zT=-|iI|GAVyvYnTyXqGX3b7mmwwa_i^t4?;*FlOLsf;7H(G|RbgF5IZzJH}H7n>Z^ zEw7t3C7gEeI!g$`Qrc8=M}`5qIbF;We5ty4D~{DG4| z;kmqh`R`AW0<61Mxy?q_9=RABPwl?$yNic+eWi8#YFPDa%=|uLS-WhOk1hlM&W38< z@QbRbLl-_qPI3(G#@jYv6ZT*ebi@9-i@N*4dF1B6+vi$GY%Hp^XIAe0is#P@&$32q zk0bq^Y4+g8xqCx-)_Q(-2X;-+eMVnw2^X4GmpCeQd9_qK3&`(i?MLp1-q9DJD^QWEvloeZ zzbX_`k|Ua{mWpS<@vd z0AA6igDgc<9cbvt=jvfXrtg$D9ZR^^_Bpl(gek$GzM%ezHWHa)mi~qObqZ77UuU+0 zjId$Z{&vB_c&E;x#piBd6%5T~?AFn=_?5ypplrSB6VRFf@W3bn`Qbo`-IMGS6=!Dy{yvi zD^P@7*7k37;|wIaUqJD8ge={Wwm8k^7_JRM#O>S7k}b#Z7Y<`F)U~)%1bDTchV45b zc3n)#PK6nc;rb!+AGk%^Fz-K67x%;4Ukb+{hQeEnIhP#p`V}w-avIRsis9kxPaMne13nNe=!!j5E%rxN`!vdf zQi)?@v~Y4jW8SXJ1WNU92>p^lRPAvWQJ~r?A$jJe_Bw8!HUzof ziibBrn^jS+7_*DEluZ)SJ7-2dhf9jREs!|Dxl!wc8$n+?9|yj1!1R@NisL({c~3l! zBmB7HIu(?qSzN#wsc|F_f4^V?kcRj0bXBX4h-Eju6PyD%j4fAQup^f1%53POM}y1H z+oP;qf0tZfv0R7qd(vEO#|?fC#>N30Iy4tth`;}dinYn<{FfEWD<=P{o(Y~M=QH=n z3u)NnO)Hq&Ji9cuy8$m$7|c8I5{MJe{e_f78;9p}&vU{@7MQ_P!}g`pym7NNu5*X*-7>e;wvfP1b{e~FmY;gola{{ zcy{uqe`Igx&~sj%aUi%)MqXvE7ANqC9_qAx9l6B)b&p)^ZrR&r4=PE^3Th0dD)PQZ z#l4P-={*MO!e0N3_b}*;1UZ5~VFed8t^2|{`{iB=Q#QXWZSt)yK=?dF^%TXUdRM!X zLTlU#anyU05o>iQI+?LQLASD88{zrs=y1|%Q`x;-k_SzC8ZBtb@(Q>Z)xrWzTbYzX z=DM8UZ; z1ReQD)N%S-+K`Yq0w~ zz`&*mTWHn8j8@L6UG@Ak)L!7Ft_s1QwKiKxT1fSeg!y zW&f79zG?L8b;nu~N;Z*<+bk+wg zH(iOa#|e0W|7s>@q*8a`4Jsw=k=(aq-m+Y;aouV3gIw%2xJyU=7ZFxZymF+fq<`$` zY}L~f^W8r8$KsM#Cxpv-z(F=Hn;biysYjxxtQfTnj}1#F)TkWh5Mgm4v{M+v3#kxZ zI!f{hcq9jS)jhFkLwzr{BLZLNnxYk054=7)}dwZ=rryC0jx zB)%W|l~@wC4IXVBHmt#pV$LM+hkJ`a7@4ShwePXz%cbl036e0)IpZJN1`N7wqO&36 z2O;hm6mG7aUgmkX*n?UzX!j61?%$m{29n|X0azMPNo;N9a7#oGhYp=CtIr&epJ@2x= zGqb>#L0@%ghCOiGUvY2wMViMuv60te(S?1JjZC`Tgp;L%O(CxwNN@nm{JA(iQ0xE- zMAX;3MLGrDarN>odb}v>%1Q%6lu6FHn=y^I<>v{BNRboRG-vE%r__m8BIz!wmQbqh zYm)D#-o4mIn(|(q7SsBo3`3dCImXx3-I^6y)3?o! z`|Lm{gWMKI^WZrr^uJ~nN4lXDwE+j~`rOc$f;tV0-Uk$5?!ST=8~FuE$@;8+0k#XC z615tDT*=jns7RrQv-{Og4&Ng!#UROi#?b6T%S%Y8X4F&!;qrnq$NXyS8~)xKAwh(# z@CxB)st?->X|%_K$jDKUr20_1<-|1Qo>@-BGab^8-HMKL=cOOWi;vua_96}&hCZ_N z2#sm(oMGvFwiPH#o{*Ti=)d|^@|< z9nl#O6?u~J17G%=<*7e_p;ng`weJ@fc_sDlG+Z8LtU*=a9MkLj-XqYiVKs^wm|UBi1v zRNgQ;uSGS}2;;~Djv| zzZY(#9JT>zw&Upw0bU>yCr(eRD`~!scJj1cvDS2K@bru`UG=4*;q?69@||5}f;EM8 zYjAhFuN`-D%ndh-XxY0Gb|3jx>{4HEy)Sb``8aH^GXzyUem~-l^le+36RE*|b#X7e z$?aG+5T?!0_Q5XS`%5^QVt1+|`bL0GB{v@et`t3k|7(*U7P@@SsEeQUUT3apo5A9* z2CZ-3Ql#|Dei~xG+FIllyr%(bwgCsPd|Urlk!x?Z&#xNZ{=dN=2c~+=Z6x!jXC4P& zxkbgbVnk~FiX*W!t}mH?W$bdC-1F%^|xkI$NOB1W1olPc4zD4 zEKVH=@X=z&OYbR8dX6+TTdxFGNf68(AaABN$UANkrlCHH)~9M2IVCBN`PWw?)F7Q= zXF^`z7u$-a$*gBijC!U$81CPjwc5AlW0EyN?+W1cAX;)pYS3mW8?(sr1wQHE?3%dY zWo*iZe%nwpnq)H4k$^t1`f-H$by~5hSJL=#DJ?NStxrE$aJb3i3!^mnK7;LTx+whg%_9iAo|Cd<)N=M7tUrJCPu5Iz%=hWlRwif_1YbR@FBHyc z6rzp<@?9L3#B)<4ipl8;x8On^oi;>RAK%$@r}N9gki%<*9ypgjN+VUbD>z4L+7&;X zI?>VgU&Hmo^xrt8UaV)$TGlV^6vyN;o8XY$cQ*6MflFvt`XD>JI4VGF5ODo2k4{?wBlzZxj(WD#8 zssk_6ZUFO#@g*p~@_n_wH&9Fef<;fcM<%fc{D$lZ2pIoH5Nn$g^ScBLQGTrTR`00$_ScW4`|T&XQOa(4 zT&!Sjc$=%Dex)CyGlEzD&dTN8fD{Y$e~H!58@r8V12YAE2Ug{mw3g%Z;w;O(QzWKz z^bVbW4=LonQ}*5a>`F{lOBSXF^E^M6tpvhjvIc2=e+FsG#jl%7^;l#ZyVb^a`b$YK zZBOPmL`X%_#FY!Q52DKSquyr3nM_V#Lv~yuKBWA0UyqlVe;akz&9J0_P59Cgph4AX z3Pc!5uYWyJC7aeaQHUzJ1y3A6iz$vACA)%j7THVEKbX6UF1m#Z>2L6&oMB}DXiAR4 zCDmnd3Jsq*8Nk3@O`ls#27ApovezE2i|pXkQqf(Tmk&uY-HD!fiDc(cMDmKReQVvA z^Q_{q)W1O*67wox)f?jqCyw>7;G-ZcZbRp;kZOBI*4*83T^VOByRJkMjUkh3h*P*D z`f-!fJE|7e?jfrC%pymhYZ)**Tv_0}amGi*VLOy5hF1tWv!n%?S^l4jH5*Vnx2I4+ zP`sgnOlT-egJ^;m38{V|YMtE1eIV;;YJNH^JtR=oxwWNt_I>kXt zliRby;K<%;r(aM{#H zGOT=1t;-&?U2)g1s167DsFHe|D@vNjbWt3}-JWF-b_$ta#aY-1MQz7MeU}#ZUMHK? z_9VCm@bvtX1;1qLru%uC6c0&e_nc~d?fX+{owCghLX|k1uB2%`R{w`?o!Bbyx_rOI zsY&~%aI4e38B51_9vS;6TSo^2e7A6E6Qg)oBhv5Ulc2LdCqYAt9wYc~@kxgM6XIO^ z@BPn&>#wM9Tc|Ma-HrY7>4s`sG41Ota4;8fjeev4YCYSuU?-{&EfQ9p5no!hR z!SGsj^n`>kZV}3Asf#GMu!eBFdmn0`M_TOgGiR)BDEr93T*mMTnp1VatNk2B?h1N$ zfIA0OA7c~3GMta@%zp#ASTjw7e<_myuS9t0^01o@oU@NZ-qLBbv^kD!dqZpM(@M5@ zYhc0x>esXk7lYnYQTw~h_3bN$Z6$b(kHokozokBgXW~P6&C1q?^=kBjGD7vbfM(1Y zXexOh)7Wj&%P6IOHHKk-f6FqgnZ3*SelFU{|0!G`Dc<=`gKv6FFk*hrzplcB=!*Jl zkbQRImn$C(Z!2I;uKXKlVf{D&sY1(19s{(ZodKmdyOky4{c&&I zM`cX}D@7H?T-{Ao@+wRBh)?;vxgN#B*j~bzRcu9z3MkiW2hffEmdW%l6R?gpw+my} zw(HFN*a40F(Kpb`GjX(duGnI}^yoxc*mv@VzJh?S^2${kxWD034TXb81jS9#+yCsL zZ(;@0#K`|?8Y$||(tdE;Ik8)q0A_)y@YRF10Koe+7*A(15r)rzsevy{E@RT;$PbD1 zKyUOU`I~XQ?7j|32z7)QNT8nlYxFqBdi;qz_0?+N

    9S~ydUGo`8|is)akNdRi! z%CMhX3w(!ASN+a=B7+ID#KVv=fZ=5uA0;tKYEi=#cP_bad4?mc{wa)j#Zyq}U7PH< zwE^cU2KZ`+XttiP37@M1q>q<+1QaiM5OtLu@9DG{dTg0s#m&X|mW~z2R;Twb%u45| zB<07$SfR1dh-YUMmN<;WbG*(oQAcdS$sbu{cjVWrLYt_G0q;IpmWM^;?2zHY2!9+h4INShf}i; z^VhcZr!u-s&tz?h0^Qh$mi}y~WN|T^wC@xW*iPIZ(UPR73r}kGiNL=XX-bw$uqVt^6^W%o?lVo%q!;)<3|q?es&P8q$@SvC*jek+yOX3%rtwRg(LJ9@Co>xz2_ z)i+oE=b0b~JVHxno8YVNYLB9Mj)5!NC|Z>#Qi~eDlUDb)Op>Ur!x7Tz9!NiLQ<<`~ z>?}1G{-A6blA*><2^G2w^!tBIe@D!gIm;R z)#_1*+;>gtuvBY_!=<1frj*fwUCA0dVVF3x9UfgksV}}6s?cEXS7usxESRw|S&dgL z7&mI==+=~{UKv*Dd)iFTmlJ@0!M;Gn>(zC~&Y64EK~m<&2a@h*JaqsjpDz@vi5vg38`idN~O@a}WJIH3xq(W-gOmBE9B!%C)14)76V zs2?eK#(I^_lki$r%%uv+=!ab8_5&#KO$9!eKQ;-;v+KMh)E8O`k4ML?+P!9Oo|8?+ znRMSmF(>%85KwmO(NS7eOvo;j=3Ug1ZNF^aL*~^bUDW5LeW1b zl5{gnIX*h_5&gOosOU3qL|}7yciV$&@f=^)wYOudU*6J<@`H@xk)wTR` zt~@bFGHQO^4;|ZPQlkC9_hE+x?mm&&)LlI{2t7ogg0bg=WADvaJa*TNQt9SV3&MlT zMOU3JJGc(;ERU!5+utDvm4e^FI9|2+T1~Q(p)-7+m;@zwv@(+~->+K|vcMPu+edCg59mzs#7#RJft*3dqkzVcF z{|r8GQhMo>5|pTh(ufQI`t*|-4ec+V){>b3pD->f-UG?V@WP(Ldq50YKWGk6a#lTS za-A%W6N4$=@twQUPs-E3z>QDI2h?3Yr|*5oiP=B^xbiWdeZC&xcsxnZ)% zeY0{Sga!3c$-1JBC5s!%jyX)UpQlRKUa6&Q{Bkp{$6&mvNK_s-uk8qh7YZ#zpvtDKH+#l><(+HCN&d!8M< zdnM-@eGr29TyE+4P(6XmRkJpoIKOK-X4qpPeCcUs3#hAga?YYfwePxGUeg43KZJ5` ztf<*18eLyry^g4I5S+ak+YZlDrrcc#Sv6lIi;M_jO-B#Sa2H6B7l7;mlI#(5wvKLUh7W*P8!`mlp8l)v! ze|(a)u0|=V?WPC6vC_+oeO(nfQSjw$SpTd21$`aY$x;-mkkZ9_NXVPG<^pd&XBC9= z0K^SkvZ$PBb8}5JhAF8kn&#AeM&7Qz<{WbMSimw7sidp}-FHkfyt?J%JuZz8@MhSKRQaEAkHbueR4*&*BJkEO^UeN0Qo@P`C3|!Ag=iqt==@Ilt9= zUB}tpN5Urd8!aVC6Zry#GE>X~vEdM1_7D|~k6#VU9s&*dLwdKsUnF?gb=-wz{?E*_ ziG|rG0o~FQE&~V?`jgiBE3jZ2P+8!75-0P!xyr*0+&wT=4dU$~o*ch^fOsK{q|8($ zLAk#Vq42m+JQPw#-Y}?EHfIuXKgT9G{v)Oklq<+7|05V6X%T&gNB7g!xy{10x|?*7$;fy%m8CdL}Dd-ZC}9rdFcsd+5NUt6-#?49ac8Xm)`3zhCo0w43w*44)NZl zH6L_N*T4Sh+z}bmBlxxjeN^OeLAF7~I;H&_ySGdKCfjGeA(i@a8vhS}q64*@>8#wR z>0WLL&r9zx($}IjP4ujkr%zQt}ax(*%6%1&tFrGZ!rWAYUtZgn;dRHQ#N_DB76ase>KP`vE>I|2GG zZGg<($nPFKF(|X1r0+Uyf7wXF{`8?qpcOPbaBZ`L^UUMB4OEJo`wIG&vk9|S)#o#~{?NaiyqCYq_FUDWE_@6Mxift_ z_Jzx_ogU@l5QxP5y7eoUD2b!t*kSAXedy=H-V-K2*1#Blh8;=m&}=yq;mUD4ZV;{B zVcZ5Za3*uK*M>6=SD{}*X36#ze-7H{#2^LraS8l$aJB4ZWB}2ajaCr*M$gz2pY$>sH8z)cW|O z;@KgLYM8UqAE2UlV{9*LGp^QRZccgL4g|ElfEVXMUD&PNkP$4Fg(-MnJ3%RUJn#O}vK@l)#J5Dh&8Ppi0>_ zvTB@QoU44*|Lh}yeTtjQe4Q#_`1Ujx&-s3Jn&4i(C^Mr=83P@uCtKSu;#-o7cdMm*bKE=c_{?js; zrQS&8|EF*|>gyyx)S$DRtlk9}w@xpvX{}5fKuiwmIOuS1Tbit4qM1)*zH`-G!LBg| z`|19TU(ZQ=27Ql2nQgFNL04SKO`B->T~*q|Xv9S{y+24_Jn_|4M5NkySlvr4{HG*x zI>(H6O23;7Z;hH9`*`el-z0f}+)fyB&_saPo)q(7$tSpvr?eu-Xdw;$iGe7=S1)+w zef0_DnkyLjMC7D%F49cu4~;FKagIsUerK+S`jdi7)@hkqs8SMBa)-qae7nGmuA%>w z3|nl%3m{?MfA&S%qz@bO-JEtq^^P1&v9a$^XWoXF%1P{kZ>p;1Y@eOI zOMkwU-bC)RnHh{;BOxO#IIH1)u_uj_bH+Aa(*@A zF65y@Do0Tee%&H{3BEFcvYc15H9T;$qiH$;)U2n`DbY}sv{ud9iOOG)FD94J{;esz zmYk5^lNIe8O~cU7-q$yY0vrEghQu}v?n%}Sdb-%EU!1iiyfyx$qTFUXonl5G>jj>} zbTQ#OAO|$eJ=D27OiK-w^a;MSL3F!0&eUpzvOmP+XNSJxlq*5}mRCB2HFu6`J7$s_ zfNeB8L;(gL=<7%@+#P2Ml02;6^*!^)_LgJF)h7|1(#BTYGg!Lq^plzEpFFL+yMl}= z+;PnmGuiq<^{MpPA>29A(J(!$o9o8(w=1TFxv^@gbgQA5td`0{>8tteokEqopRS^H zTr~S;{MYi?sZ~t+50^rxj|pofYla$T{t&*gk?xh4Hfx+s)3Ls(F@Qa`9_)Zd`qND| zE1STXkTkTpLv*Uab1?)dM-4V8IllRj@9&*K4S(?;@I-V&1r6h-E_PLlhed;>%^@pOP z82=#$vo#0yTs;woW&x#bvT?OYg{`@Rc%Rl;FO%PE+iB9G3&i#A$|0vY0LNxx-4^;b z{!DA>g44gfBm#WNc?)m6)wUd(EXDkR*fcEweoZq7D2vdrwT6+K3MG84a;foJtKUq! zqO+6^9oPVWqAJb<5+*CT2;`V?Ci}4Rz0pzm$4cC086Mc;Z6+-*pXw#Wqbu$=(_hvs z?+B6Zg)QP8afcx(@t?kc%;PU&li$4Lc7)t`h(%-wlsf=Z&CWMUWdf(D*LqiPXQ=M- z8awmtK$^T|oJK&0tG(!_juo(8x7egFIJ|78A`IVa zD9#~4UH<6jbQuY9|Ox~lK_OuKI#_U5uSu%Oq#47y()VG#Po~@vGvoq@-E>_Z{ zqh9?cBFX;c94wg<;X6zJA|fE|M{jFj-}SXd-L~?Hdz>rOWnWj=EV@d;!eF+yp+xo+ zDnw!`nvfsp!pPdQHOp@D&lX|PQ-=GhFpZGi(c00L3&=72usS@v@iZNBUIfpZXg{0k zKk*O8i%RKzg0YjckEBgjws^_PJ+N$HX?sF+Q1ss|!4|Z!D$A7{XMb?ljYae?uv<*z zY|E=riwq6r4qb&m>&T=(Yk{47u_RP-$wTs!C)B|$Hvl128)o*hd~2}A>ll!cDX|4a~(-~@N(})`cG!vLxop3Ak4O^*Pxw( z{u(c?-7Pzt_BiT4k3+IMkOk?)x~}Cum_xLbkwlU_2& z^7YU!P1IUx9i_T7INJXJp(|6_o)nMf6aV4jqNl68dLFr^U`O7 zq>y?ox!aS+#}_)F+enFG@1z31miJ4=jSpkpKs35wcn3XAhy%UVj|X+c$JcWG59odJ zOm^TjWRLV^?Z&UA$F>tP^ATr1*f;;YJA`U3>;rG{N_DQZ!WueIqB(znkFAZU(SejT ziFLxiPcNQ!dM<8H-kJQxbtkCxcyo^Rd#83Y0LFM<^2h42`$tSvMi*UdboF|Q8Kr>z zs)2w<5T%yvsi0VN-zv8Kt=2E2+2!|;(h$;4>O1_QTYwv<)QpYmJbRB&iI$y>bH9_0 zqQ~Q=>VBPHMHk-}H96pmzEng%M2Y5^6{)J}Y0}`=T(dl+%~d@`>vg11uuTQ}4eJON zRIyVJ^G`oapm`9MKXm$9Tg8{X-#um|7$`vv>|b;v=l#8WQ=h1jsg8D6WI?x^f@-Zo zo~NJ}Y0_h5R#c{ZA}2BvqJL{5eHygO*z<0YU6)kywCfBewx>jjuOv!Xu;#}hGD`(lWeod0E*ea=yy_Yp4Kaf(V&nUIYN#SUSS)&)M)?JP3 z6EQl7Gs38N#vlU|nmptI@oNDt~#n$R-T>3FJE3PO_nIhc#v% z4!IO4Ayx5^=GThfsVa3&iOZ5IO=GH>S9^hPVmP0BIf{NM?av3kF%JKu2xki>?hH7$ ztW-OTFrYbCYsTcxM8JK==qdE!cjb2Vi-{y|RMyXZ_1&bU!QOp~V=WfO^YfUGBb0x8 zgV+WgMdX)?Q2o8}?AiHNOrzxIz?s#HUi9fai)ph(K~t{K_qza zjv@Z$O#U$kJr_IgCBkQfuSSx4nHp_#qIHjXtX!#ZBZ%7?9j7FaZe;5z1Jx$x1xaQ?JCrd>kN+8caV)}1MLC!`^nW^ zyNf>Wzt$(ex2iJ#Xxy#7>p_lkZZ)M_HL$V?R0CgmwXS?7l_b8IS?qf0zJ=+ zv}*q%9z@3N_JL(2&Rm&dy$f`p37%T;XHBi=9u4AOEU{r~YrcP&^SV53dyBW@&x{!c}zo7};%UE|bu$Mj`PNs9_;-Cwr|HUC%a1fUKO9_m)%YDw}o5P z%?4}9L+&th_1C)d`nZ!qPB^jIl&2c5Y zI~~aGnxOOPwxC7IuMfTfEnadfWMikrXrjN(a8-({46?H473A=OFNy=a#~fN?oLSoq z8zy9v?OPzRV72O7n@UT4k_+7!jbG-}xDx&Ydr}E10(w zBX*5GW(oiNCsI9ZWz`HfX)Sltjk511h72VxMji!4WhC$}HipUWAadRL3;n~2?x`;- zo7hV~nD$4Wkn$*xkkxN2z0}9Mm3cmTvtX^K@V=|K#{wzN2tpu!UiZLra|ZObsaT%4 z9min7{%dXlm@o*pd{5@gJ+kU=z3GzdVYxQ!R&a_m&o>aR|JoXG_DuemK1-U;i!fNu zLz))_9Q7vkM6L^!Kl$~8u6yesE2kv*h~_t`vwKTxs;LR?G0v%TW0T{Lw_Le$p(uR! zi+a02vR%8DQck(?Y3IjDQ=`3;#S8x??v!p2K~JqR)|CwCx?N`QfiUO6cxxg{>!r3P~ zFz#zCm`%#eDMPN{5Tl#_wo<~@sIb|8|7Ta}AZHK#l}59~+g&pP`j_;nVBo$yETcwV z1=LbdLDQ%2tWIDNHdPbY-@x+=(2S(RRRP27Io=yPWU6TrDR^c)H!~y6YCYPG+2rb8 zPx`bY(@g9@7)!Q$4~A+(Z8I03HF^)kvE({k1Kd+|oqck(YCXb-BPV zAmyhlt$PtdInK5?vqlXCy^58TKP=Ktxg6B$_ha&2;vjbLNSpklYb(wXtwfy>m_`*X zyT!7f5@6>$wNgGFAH-8)m|1v|C#cc1rRQ@ZZXsL?6T1fcr47c>PHKIc%k5Tcc#0j+ z%!yOv?iT{uT3Ak1*oHaCe}_c#dSi&kg*esFa2Ji+-}F_fp2valYYq$N zkhoUzF;Q6R?{hG?(fX1KnN^Tzx1vRP9%Mc*5F~y=wRr62OJ8kQ=Tiq$>jz9zphVSH zwyb~D;#GcO*SW&vfu^+2i%SmzR*Ykoa+kfd5PO@96H8aRyP+#-{}$cQhl-@J&VBFz zz$vW;Q7psMOlxHuaSq5hV^6;qXb*}(G=LkXYM>EsCv%9XrE;HUxoJa7$!#n}IUQ@< zUyYrdQ0JImH9Em?me4bD0dFy9(BUCB)Og{wX41ys&W!Je9u58*Qk!?+RA)4>-S3aa<{ zL;-8#RrE2Lx+9~J*BNhP$DkbNXfU-UC+eI`{8HGbR^6UxRonCSzRy}6YF^-!_dap3 zdee3${tg=c=3qeJjHx~T`EsqM0=an%RZZQ_Z}070DcI|5eGwjs6h0yv?9xe-^$h!F z7n)B3${=$Q_>`OCT;df{A$*d)K@t8556ZTdu3SCfv&KF(*J*%OjQ~4=a4nLa*jqw> zsh3bE)2o?s2)Aa#`Ew3uE>;S0sEtF;rSG9w$^A4IGP)|6x{baV!&26tB)dKFHh=hh zNUV*%2jK<(($or0T_RF2G@Qe+qo!!+qZ%xO?+r!}@ZY;kHfp zw_d#Kk{G6VGchjxzO_H~G!J_irRf~~ve(lAdQbet={LmIevO)Zjc_Wp=>9w7XSWQG zp>7xxyI#ZtP9!B(v1i7Q)}gX(`1O7Z_C>24wTBx)DHyzl8`EZA)J#U-i8qm(4F6JR zdj>y|qmSTRzm#cGc)K5j3|vVI)DDrID?C)}cxUVQnQjBL5EeqMmB8*N3 z9g}%Q&mR~;d}drWW^@4SmXER@%zU$)-tI>1dk$xW#+mCKlUWsobbCeESpgzyqp?f1 z&K|%5r-jyl7T|Dfss&<4hUGe^)XzSPg$ED@`KD9ik`$Fa}*VmSh{$)+NTI89JVNs zI6P}}4jB6?C$phs=@p;PGnh@~I7S~|zV_}AKR$AFx>e}t(l%4X;N@PpR$>c$6`-Y_ zS>#&>r?)q-J0VM27QnR{dlQJrTQo5b8vU;J*p8CRM;sUEiIIKGwxLz}2Lkj$apF%p z-|^wed1kT%U0i`h&xHq7l)bmw!eiUWDZ%@ zXNWT8!7ImBRo4GgG{3-wxCzF4XKG%O2OYE;i0AZ3^L%DiVl6F}9$;o^#1=4NX+jcn z3Smd}n7nvQ-;*@|WC(U~?EWesaAEQQBf8sb?grWQ+?n%K-5fnb?hXA2HDKQg{88koHWNwqn~jnwZvYan&DQ!%9OM|UKX}IWl+7Y6 zb2Z1eL6@SAG2NB%%Yei3NeNMU*EQ-{+y1=~j>t@2X;9z%jtn)|Z*+?lMhh9)`mi ztbJpb@K&Z@t9nfk|k5jV4=HUzLv&+z813k*+UN zzn5!!9j&^7e`BIL1VwkBL-@ML#nKCBt@3-dgS);urq(23&6;bBizXK$N$_A`(-Jh z{bh9}?1>9V#X12_q3^*$KrKLOnXs@W?jE;Fi@Ap|JosNG4mA;heNYHm9Q64(+ZD|w_usSO7 zK58|}*cxZbj!t|#>9utzEhJ-i>F7CNx6HOEWY|>(UgK$P%uL9gSs73H%Vn7SW8ua| z$#*R%V*J(IFLv6l+Ktn{PP>|WM;#zQU9|Ml&OzTTefu_L;TUi5mzHjtd)nuuYC4>n z-l3O%U2%P);w67^;A?<-=9iTl$$p-!>wi$B2hj|%Hmxi3tjmB>TwV`>aIy!{_qn+q z@XMpTn`C!=T^}?t;_)K_YIhpi`$v9CiW`NqyuaJ3$|KJ(<&E`;CY|xzyP1ZoX6}?d z9eEJala9x4$r!1_4?F+_1fMx3ouxt zbX|LH{jveu)CWC&IVd3Cm`YpyPl+fnRlV0<>h_C_{$;-swzApoKVQ)3uOG73nNai$ zWw9mMQyl#3@CWMciRZ!u=_qyau>C{e*5ybdUNHNguWWcyZ%TOqgT^hEit;h)v3U!* zeBJ6$SSn>mk6%LV!o<(vKC}HsKh=b)Xr;rxIhL`VJA$ck?oyL{_P^n)9IUVp%SL6djl!_r!?9~irC^o(yEX``IbD;*($b#|ESQ6y zpNVIT$OOGZduDQOKS3mW^0STK*LtlE-P9`!P`GQM*OrW5FByNXMb7X8Txj^3D;0c2 z(c8}pKW5;&&?u5gKp-OhYl10Rd&bk}EYt!Q($nDq9}TSj0y*&E5lXx)Yli)4+|l{c z3nOm5(ZWm%Y*_t)zwjbZalX*35e_w&)0;f#Vee14*mcLC=X>On2pgTn?hUe{`tFmU zCH7UbELp*I% zcK^z}IG5zxO7nmRHS33x+Ryw>rCPTV9z+kXN!)N=%^dYE+Wjc&Tcdz;DYc!oC91>o z2`M^g2ydxscah!k*!=0-H829KXxdCN&6jC_@LQ@uO-M1`Fjy7s5=y@*OMmb5vNXR7 z!Sppd7GmKQpJ4~ehOfW#IJAxht})ack{z=Ikvvn6r!s4w=Ul~=j>RbdV+Ixaia*py z{(W*isa~e7tQ1LYw zSmm5TyWbZ(ou?=n`If?`$M1-`3%Raw$XoNb*S0{MWB__WHML2cl9dc=Fph_=7%ghe zxn4oWIuq`qr^2ItC3J`HDynHw{4L#C)DV8_Ng>zvOvr3gBJt-rK)c!68^88jO%~Z% zc?AiV6JE@hrNEX)XIk#gx+m!XGc+eNHl@37XWBo_OQ~?FKP2ZYc0a=*xIi<|r0Wbi zBRPSq7x1Pn)o#9KLj(Sm{V}~0)k>HJr+K<8E$+`;Ig-M-8e#?A>CnLX&0jwZ-{`Dk zta@bF9E1%yL?96|^ynHma5etmyR0{#Gl+@aXMGj@FzX@UkD48G3ZHC-UIFH{H3K5Z zbw?E5Le4!EQfJzZH~yNO0ya6Xm%S*D;qprcq2ARFYavNfi?Myq>g($t%aTu~wXIuj z3&xgR_@GHOW}$P6g`N-A%6BbJ_WkP7=+)qSpV#;gM3&uaay>41^xgEE@tAokclP?` zv_kiPl61H>|Gpk1h|v2FJWRQmldO0s%FRi0CSj{MXgu`p*-Z&>RfUJS}Oy`5TYhwGYL$go7)%dU;B2|_YgHKhUijWcZ}o>wTz z3ni3((0hPPv$6f9Wh>G}$ZGe4Zlh8ONrTNKdQE81phx!=(2x8+k?d&EWLFK)qi%`u z`W|SjgL)4~b8t~(uVjCe7DX*(ed%JzQ+3-|o|$!C4z{O^q~8)^k%N0cMA?BFxx=ec zyZaF3L*F%c@BG&haM##E>-ttQeBybqO^I*Zf1@6y!(AAA@abydj4$X%3rB&wmq}W* zN;T1M*%-hqPe4s2PL9lBemW->_k1Uav=G6I3^eGs;dwJ@Uq73VxC59|=`t zIb6ihJ4Cp(85}0P3-%p#nkJaWdUs30vJ9*ENK^cL_QOm{%A zgL9g;f;LZRX6tquK7aW{^t6XzJ0*}a$hJ1W$uJ!&0v~wDYO;&046Oc+S>{qeFC&H1mjKdU`FCqQc{CETw_d$l zVB92SNU}1BjV&ju$4(?utv5&5=Z~#zK{Lg1@^<#pYO z;`-BU1fZZ+$qaBN;Vs^UHp^kD#2CnNH0quJa|8f0n%!yVyRB5X^fu8AVuVFlf>Voz zmaneYDuNJ?2~}b}_jVeGvz88A+fiEBmvEL}J7U|zF%?}DZBNh^S)oP8!qlw%Mn7!# zE$N^=0|vumV1m7Hl#??AHldyNc_;gkSIT}v(T<2`>+@UBD*auKan~1d>&i|A)wv?& zrbypj-JAn2-Vm-Gz=TrVdefJ|8$E#^BY&#*#!pJ93`zn4bAdE%MO_B4t-a2(ZC;6 zX39Q@isptky~N(NGP)%@!+VCisGRxkhzyD}@l~}W(8#}1-IME+)X!wR`!PX6JO^&cNilL_n+1|Q%j+n6-IDWV~M&hcuNk5R-Q;6{6E+#eFm$^IYR;kSoP zy9uw;eN~dH`8%S`!PExh|FO;UlIMo@IX z(~%eIc))P*;_dBSCz5FbQ}W4%-GtXKU~@rU%!r(^qTJaZ0Hck~A$MtFH>g=s4|)?NJN2u85id=6EWPSm3UpfDd21l`7TL9b zPq)}2duUH5eCA|tf+m6!Jfgt8(s`PwWz;ztp4R4|o;e9SMly$kmPjKP z=#BSpv46rCDJ3aqq^*6%FE7S;FW;Hxi+Wi{7N9$ zXxiiO#W*6qrL#jf3smn;YEBcD{D zdyUQwyl(HJaK!&dWz93-c~J^#bBKQIb}a?BJUHZ9N#efT-n`sBdH(sizH4kh;~az8 zQVUji*<~#2!_?_H@c(9@)|u8G_AJe@kX=5{&Wm3XK+3X&HE%lve(70coN_+)z9FigbLhL#0po=U5~%$(RvWLC;$}UP>ABrM84ja(lv|3V+XE1@ z!MP-OZTZj+%ET|U4_fC5Do%MzN28v{#4$;vIb~Hh|9EaCLeP@5`cCRzR zfRNFgXviV1@l_4kRlNh`rOC@!7kw!qaDg`%)7SWJ2-PSLd&}AhbrBA*4mgu|>94J) zIH!{ZD}f^0`K$l4haQDPpWyrE`&LUM(G2x`D`=ePMzJa`y+_(9KZ62 z!Qt|O{|ny7-6>lA#zI6*;2Bhlb#@kVHEdqnzkpczV;1%Ibp?s1fRsW&8!;dnewCPWo$lPXui z8tfhV?mAbb{aZ>$pX5n@*ko*;d6scnf&2G&}Om*|~`XGgsa!ZL7{p>@p($x|kw%8#q9 zg)PzJ#)Z}N+bdR=%18YZmPT)cc{k`eY*o^%H-mVWv|2oQkE~(8FG+m2Q!jVbs?Cp@ zWut%mNPk`!yVEGhiN0c_mzQ!1ulPTAuL3GM!FyfwvOF@rBfa@W5PAA?{cIwuZ4jkE z-B|9b&%0>Tcf+{#gBYV*Y5%3--RJJEP#&8u}8L=1_3rrka$Ni5ijURKDssUx0yX(^Y+C!})OZsW=e?Rh_}l=kiD)3=H;4b3>%>u}@)s*1hs5$M(IH7yD{5I;S?_zx(yZG&lV_YT1qd zf+L~^?^yVGwI!Dl(<^Z&*6Cfjc}|Omw=^PNhAnGrCgGD>i);$&b_N8b{LZZ2z0Zs! zVxN0xmEw=V;#WIz1su?FMix5H7(T4`#b3$F3jPx61J8PHrjuodkC$g+FKpj6D#4Og zyDkIbrrDY{{m=@)Vr)i0g%FO9!tCq`EwN*%Rj+62xn9y@{-SCkX8s{RvVr{5bqYyT zA*zg9zWH+fQtJ0LyUXWl#PiSfPcU|(X4h|O7A@s!GfMrMzQju%_@cqlFTzS6k2>8&=Q%nDFz}=y_e89H&=0@5tiZ}KlqtW!0EF@=bS0W+mv{b zbi!hU-!nVheBVXO8$ zc801!;Ox;}#nrdg$=L}B2|Mkj1s#BVxs1R^ST|Era0$MBAKZ(KEjv7HfCD3M6~BcI z?CCuRpbT<7=w@F+>m5IyVQys6(gnKOvtAROM^kI(0X)b&#pXg~UyPF1X zY|x0e#v><5)TisSWV_;A0?HxnH?U(oontHgn@B%>UhT>=#;C5RImb9|RE1bv!7u-K zF*vPLu2fzps;Xncs4t(8<0q`sCZC>0ycfO!L3+92>$fE%_hmr4UNn7;de58p%za4)EsA2~^0 zU8q>}DdM+k#SUq*BgceAJAE3;x9D?fv@RO(RR7sBMAue&IL@m1)!ltrt-m480ORL< z{FP?||K%vGGD`eEq3ax^Qfh*-Qb-$8cPh-lc|&s+P4V7}=FcU-VSe?4-BYVK*FR_y zLhj^y`GLJVcMX&GIqx2B%j|Qu7pn zymCPlVlS2ixwL%W8QgkCtcx9_i=pR7Mn-g(R0~avEu%2%D}epuyT*0p=WM2@pvuv% zk-W~*l~~7;(R{ADk}Ty*AaS7qe)mWEE5r&Qe)`ud50nRYS3traBH7x+?>LLrBLH*0 zd4ZI(jhWAg?&H?H($Z0M%=!9U^Kp?rNX#tuH(Lyut~_}r^Vef^K%?_mAQ|$~0hkx| zbBmfR)cnP3k@Ft-vP93d80JxwjY!V-Xnx-ZY5o^$lfSFLQq3}VgbgQuyO0p^T^%3- zaav-BwCT4T2>*6Gl#}q9AN&5lZ#o4K|IqahPNJ)U>mDO>O?7vk`<$t0d{Dy-IJ3rG zSl{wnM78*Z@zy%c2KP;}D9v@5MR!K-1;EWZYLzBJ%!HM=|F&A{Yk*DkpS&nuFk3U& zm?%44700*Gagc?0xFMkia$XQhkf#?wCA9{tLQe9s0RHx6hkJP2bW@f)w8pO*+w3+D zTBLGJA0y*=Hwz!<`VMfvGZGYU^LB#SH)~uT z{}F`T+PGF@>Sf>h+RG*njxt9^OrZJ?O>C+qIsid+Si84b8Km9swZV_zH)e6w(Pd;4 zEymltTXyzV@pb+hmm=5`KEg6Ha#Fv`v}n)L5HOrPr-dk4*#LO z;CLN|#_Kg=a+&+1J!el*_UuOyzu?ha;jlJxvD`OxrnS6*5E9YymN4$@_WdT3cHzhy!o-QHG?2P}C7xZT9%$fwW2POP0fl+On#V3khLV|7H@Fc~wU1-4UCTR(Z687Q!2_9!9msfOJxl*?!Jl0V|`u z>aB&rFXT^jz)>L~gk=?B`4rMtFnBScVN^9b6Dv_8LF{}5@>Onh>MSM~;2}P-9Lka}auG`oW<=YTlDDJHd1MoFEVE}V#@)B#25O|N9tzGN#+C8oCd$yrvmJv8kd+{-yZ{Yq8HKe7A>JIbt)_~1UGEBf;3GxM{czur z3>(gr3pZwhZ-MS#tV(&Sx~OEHg$96A?i#I0yma889t#hX`WuZ^0tfU zi&q_pltd#P7Z%!26e>j~`c$8;iVYRk{cCb9mPdQ4Wj|OoPOut3-2`#Sij6nAlAsRu zI2avWuPxrB0;2sIsJTMm5pe%vi|l)cn~;0C0=g++`mq_}==HW`$jH*$Y>HZ`N47t_ zVp;gA`-X@=YTO+$btHi2i!I10%$+q7ezu!Ee@2GXa>6=Kq~Lzri~cW?oDkgK@({Ez z5o7{P`kd0fgPwjNs>&CXNMrZCfG)Ccl&oA8H6ost`f4T4==dc3PMX&m12{kJtOV(! ze6jkH%>ENvql{5pcxa%?O9z_pnZu1x*$-?Al5nlT==h(ydh2IVA+sY!vZKE=jppsS z2Yt!@jvG_t(YKACl5Pt0=2*kW3q$_0T4B{E?yBmlTy5pG0b}pt1qaQLwJDk%8g-D= zwqlje)2{(*7Q;(5O*-u+HY5LH7Y#cABdEH(c&%ThdOtlkBW-Rh8eVaLisKCmV$2bUervOD!pQ@-=m+pE0>2}Uo`27^^zR*;(F5>+9 zb)pYQv6tSJRQ>Trv;JDR!?at13NDMeC9VD@`o;VSt4T8y!z%qcJ%>(Q^D?&9(Z4ia zGblIw{gx_!$VnXxGVu+{a2Vr8e>_8_Ux~ASq6vG<&hW7A(0Vo5TIz+!NVu^$fRZEh zu?#F;Z)-5=X6jVW>r-qTPmLL@2mh^=G|8KB(+d!1 z=XJia?HL%@@AyL7QBEgBM#D9isHYC)Gj9p=b4xJGGdIQ_JPK~4UNVNJ{6h+O>+_g1 zxjNp2S$m9aSvHw^PpCuRHT9Cj)-XMFe%;vCziV)$A%u|-Rw*xssRTrKqzX&tL?Xfl zfmyQy)o|#bv9!77Q)iIgeoWtWALG`apa|$pUeQ3LRI}G%uXMRVLrH4#a%G zXLt40#cju}qMx$S8p0gXdVre?u#niiQ3fm^rIYXb#GeV0LpCKI`8n5Zu&peS8T_AVpLJJJHnvD<*UV*pg4Vm>LIXe1=0(t|3NJC!g)ghi=Bx%i)avqLf}7zDZ53HbKWlGsF*aQb{Gw1gEMzWmlHtmpQNgAoE&~Tkv+_ zjktet+!}@re~@q{HiP2Vv8h3O-w<$i%y8G>vs~-BY;qu$Xz+H{fS4vfdio4vq@_vJ z@g6mOcXt*p`tM3iG}9JwUNXDaJQAPS$`3Zsg~jzW_L)tD{8>u+(|HyNAK~?bbRBe{ z%ltNwC}l?&GAGD>nQ1WjwDM&@{VZUTYJSCKk$D0f>tT%qv7SWL`N#Bs{=Aw4h4;!Q zA!L4808Uf#Y6m94I{a>nl6ZokyrZQEX*2U|`%H=uig&&XMMmg=FHt}ul1Ka7=Xm=> z{&d~wO!WibCt>?-eoJ}O;_pa|XmQEo6j3GbAUEl#R<9`W1&9Inlb6r~2V1d?xU?3_ z*jJTRk!!Oq+$A~txQWap?{l*^t9uha)&6iO@wT_X#EQ)0HAuc6UiXihyIiU4q#Df& z%4ib4yA|FdSjv9btqC8@Dr0R%SBJNZ=YwPU8~M~*PwU~`SQh8tYFn_Zbz7Nr=^jiVID;k(xM2V<_BNtw^&`#$+`?%(<6A}*b_ z*F#8K*otd!K1p7zuU+(RHa;zNw|8ZTie>@~AS!B~(GQ03aZ+`hhU(3jqBChE>tU02 z#d+9K|Aov}Vc_yn-Jz=`(obq+F|jU&;~dSHBIO_5yGZ+}q<$8e)+S`l@Axv$`YS-7 z2fW%ia=qJmNB*P0hLa8VStugDaQ@tER~F|=WCT$cGIa@Ml2@@xU(y;`iA_eB{`En< zx600nntOr1B;;s58vSPlTvwI=XYY&8JAr;NZCe5gp1VKzCIH=;5V3y|ugQg4jW|Bl z1t1E$9K7N~=SELcocJqsFulp|(&8xcVwSqjph_7VSqs{~2J!zNNQQGWoEEEev#obu zx^R;CY~W{UJ58SM<=3YVF2K->QpO)HpCcz1pPsO7Tb(ILE_U5}_w|~Z!Er6o@R!iN z7VzA?eEsj%50a{tH}5Hb@jtsaxk<1Y8kP&}Gt_rulws3{s1iZdVVu$5CLW-x#EIv= zXgSOq?jGgAD?K>$!G=He4s{6YbZWm#ond(Jp5ShU+DKk8MBW%MSq6!)5x*L~n#H8f zoh}|T(5G@df7|OD8O=OqX#Zm2{=Q3CX{OCy`*IJvUE37?p~uXjAy!uC7(vo?r*UV2 zbAMMZDRR<#6u~P;wQdf{gdEx!rL!%Ye&u5%a#3rQ)^(f8;r(&BhFO}xI;IxTGbqt# z5p>C`u~_(tqS*GtnUq&j-likn%uuX=e2E$~A_0i+8aL_#YAF@h<##c}%MLb`>xgQc z*0F96MRt~zTl-#iu(rqA^!shXzLD==R%oVH%jQP1D$hKl9;!uTiruW^t}I&vQl4*G z5V86_G&9rN#-4BxAUOiD$?y%(I-6O7cP$&8`6@rLDofeekZ^56JNa9aj1VG>pagb+ z@8M>^`TxqVA|C(S!K%9n)`$CS7pA>0ROrl{kh$;{YBhbOA2cB-bAC}tpXSK)mh!eM zc5iBA1$CW=*VKnmh`N~l=yZE|;`q7w-$yfFr+mABVLa^#RPujXAkp%!2R_!u%v5;( z5AD|j)iGEHge4Y+wtI*;5d-`gpaQZN4y^wzvWTHMGy`y` zy~&pAhl|{#wKbpV1AO?zgTA7qNfo9WuflJ03=^Q6F6=y`g5hEg@}*q9LBx0^OgEKRz7sRD{$}c51BN;ihp9^aW90Zh!mz3f@^y!Nmgn z#gFC~scVY_@Vpyhw?*o#chE-k1iyVktS8JPW21`4 zjxyF;#BJu)VQxL6Ou_jR>(c+pxpLoC0P&Cq#2|#l_r0(>X!kr4&S{k7xY{j`+!3A1 zz#Fi`O84>d!Jz$;FE=s6T~wIb?ip52>h*B7<#NzxJivzJ0F7(+ai|x*Nqu91Z%9*V zN4Y8Jj3(F6QG<|eL?-5hiM*CCYUQagpy-<@{@z33>c^`E3FKMiC^tk4Fi%b_vPU2v= zsWKO9U*gl=pJN6*J&30l2$5bqxXecG za0Zt3(cbS4V>Ye+C_x85ReQj6jGt~>4cV2ey6bO-*+o(6eV-qBzdT?&;8(y)FT1SB zMo74y*1T;FWwmy&Siu%j#KwFHS(v}cn5sWLvZ}5@Z@mitqOI;4bVluu;lA+cSwE1M zuxL7j>-e54u=H&XP%e8f3mqf7)C@()WNt6Nd~HiqQOuA7<##q5#mQXPDh>XUweLHv z>e0&oj0f5N6)OD)g14(flwV8(ovFk1%H`#ZD>s)}QmK2jG%WrN1{SPty&Zbakakc# z+XAOaC+dLH3swm;x7h#UH4BhC08NpUl^ok1hE_ zE^Yr9=Q&VV?2>zWnHpe~KfwC$LbUQ;B6Y&n{}ReuCTP4Bpx=%e1ZCqZ<+~2#pN~-| zo<{W#Hc5cs4v%Mnb+4_9NHxb}w$TgY+}J?@773F4fLGL9!?Ww<{h+H0xrEsb>Ui_y z!Gs#hEi0UP&__x%kb^thELB5Bm!a#+V{ymMe%v&WJed44IoqY*2nlFR!xd;o0RHfU zeW^>M-XBt5)EXk)6x8KVYW)y%VeFTeRSK^a3>8cQ?2G}^>AHaF9tW!zr=v|}lSe*B zfl9dJx!a@1O_pt}kOw^M624pk#@mky$F3o7=O95?;_e^7ddD}ba#jem84p>;gJ$B- z!qOs+35sh#hUBmrBI8W_Pm3bbg)>KU94{`C4a7Gp^fL6erOqr>j|Sc`jt1*T`j}K8XCnCyn_nd%Q(Igk= zSiyxPSkX)vfCXqJxSqgFA)^x=w#ouWxzC^l;)lL<-=u8%i{(LeXKIV2P|2?B&c%G5 z84XF+^$==XdO6e7ZmA7ppsfT%QCzYcDtWG ztei%NB?t!~v>3x5c*HS>R%q(4bDB?irK)U3pTkkWPxWzVV0Z_+IAL~{fa8nzA0N{H z8RTCO@7(7*-|yNc`Zss%Wdia>-nwm-)T^nhc(f(+I=q&Miw0h~LXmGQ9O9(K4$z9k zbdc;}SUpAkO{VtQe#Gz2lTwR~*M{^3*)oI?z_xh867mDfumtVe!j_9}ZKM zXjqWop=eB#)MW+mcB=orbnMITAWCQxjw)n9XySx1&HzZ^Zn(s;Y!>4yChR znS`#Jsc!4WfjsG-X^Q?#)u`rKXhY1CKz?O7{ky516fPXRsTP51gUV?SOTESRd139zNy;Y?|3q zYL@m9oo(=s{)B%N5%R)|-0uqxjz^01AaON%@(r){y`DXcA%DSI zWQZ=|hOodueEy5f)8y6xqoa&jW|14~eIpE7Sc}L#m)1h|yvEp*K7va5y@L>^H;{=; zp@wB)$B^?R_WV`)aZLT~Yin5X8B(7YWZf_UB+yoqlnPcCyEaMT@we8Q$` zrf&p^rn;a(--Wxdmb}u~_8EI6vYC7I3c2j^GG9|{W}hs@DiDgzxa}<=N5JMlywhdt zwQN69S4|68@RwEA``OnKDoz#I9pgPmjy`*y33h73=i56Gl|E-ug*RdpYE>gKA5bt6 z8>tk`jQv|_2S2Wql39^D^lz$H=`7~;BQLJP3v zK>xeb^QKvkU9+{U01auG!ytt2d$-KH5rA#rdw-MDbeDH#Z!xqF%dw%LPxNm%e`vqP z!R-Rc(0zcvrU$k6=~vH(>Ko?&ada+@O!xo$zq?iL?uw+SoGM8r_EEPplT_+fR<}Y< zD|D|Ii#gk-ZiUP-Ma4`<)!H2AY^#`K%xPnDSPgUB*le>SzkPrI!|VNiJzvl3x*nI_ zXWcKD&iYqSjbmd{wB&?NW2mur!gqR{{LIESvpOkM5t5m=uNo9+#$isEj<jgL*)junFXMOZPh?~cvZUf2MGvTi7Zj4LcgWbau(;OpA9V$EfJOxk+vk=C zD3_`qO0Lw}qqP9e7qNyw4Er&C7pBujF4Rg2!7YFCbL!045^hnHv#%4jlTLCPKTipC z;cn1h^bs~SF^-IsgusK%bV^l-Ve;lB20(ngX!edaxnbcfNv4w$N!?xpocXWR>qkgN z%f37bZKRskh_gb))>+5rw&;1RUm@7$NkP%TnQy(EH_S)gg5{-ByplP&Ue?JnBileV zhs&vdX?*HPo%u-at~(_`V)WKI-e1PJu`7H3~k9+(4pvpz}@w3 z)~4Rmq#?*zy9Y^IZ{qcDvEI)d0g0R5{zPXjO`j8-xphKI+M z3MtnzC$`Ij=*lZ&5JTiN;pWNN1M@vNtG|w#8rdT{)xjsH+hCI|c}7tZQvITvmEcfa z7)g}bVO?>EPF8YZ8zU+>{2F-O=LA-S#S78o10Ae}_%qp99)2QHdS)UCcf(rXr?_}| zar@lBG6CBn-ujRB;)IGGR>u6-6@fUj{%ySdW@b7n$&<_fQT;v}dCA;*SDeTtS3!RS zIvAY1C%MuT1{j|n^Jbe}fV0B_GDWnqm;v?#Vh~?KA!JpVVHdVB*|-P_{RPr$I>%hV zzUD0VG#VT_E2C5sufs*R-J$cZqpMs&Jc@sSuO=c`pfXg_)Dt>i8^z7779o=^x(AZ- ze1|4pL7nFJsDIDbMZu#YkiYAN)WHJ7PG&1!3*4;}NL51!`yfIs{|AH&{BP+($YGxb zrYtCrY;TWq^b=TP4fiYQ-`8)jvbGaHY|8oZDUC|9uPd+7(hCA?RfcZDYb7sSEcs%c z$gUn)?Xa+0zcza<={k8|95y5_Y=?}Vg-p7tM>I+TjzWs?g3hCQU3FNRW_hD`j$-KX z!h7Y-cu3f+$R@Rjm$l}1OL-j|C;6+^llNTtJbd|};@BLPXzae6y1M^znb>pB2BW02 z11EZn8Cz$9jm*@>Hm-$)A%{yMAL%Wh6IbmmNG?iKa3Eu{SvaB^KJ^&hXFDm|);`O) zKms-k)TKVoW8cNAkxZo32iQq^=YFmt)_ESDa(Zvg$J37Mvb|}LZFq#};K<9drv23V z)duRH(1GB$r%U|pAE?-{D)l-}3mAlx2APb=+b8ZW@0gy)xosTwjw4UPfG|;j-OWm_ zJZ$xgp|CRvTty+FtV~_KpdaJA$?M@0i>mk5j+WKTq~urNme7b4ezEJNSjbz(fB+NcfltGCh^BDoD~Y7V z*>laJmgew>m^fRw&)Dqv&gBsLq}dTT2Z?jFW-;Cu`G>7vgiC zzV&-h$Y|<9?t=UKKg!kh_t$M3h^y#xA~v0j9usg{g=O|#s@`rrn@*J z;URM?kI%3TFKd>k(d*Us#T>kTq_QgIz}tmAnb#WL=ZvaQxT9*153=;q_O0IVC`0g{ znK2Pr;D;(b#Ar~1%X93wG`vlv= zbnyXpxKFR#0*`UElYUIXsI%(6u*iE^en!El&yVA8-C^G z6|y6-chwBAI(@aF%)QT%!9KT3^F6tCg%MgDfPZxuaKjup!5$oB=nKr!#O_m3Wn+b# z0|%v$a;JZk^FLRwos4cgCydJJPSNP6!ieD;M3DH)Nsh>TQsCiiH^nyFnt%_q`V5rx zHy0SlKh-y$A&xASDW0H{twNjsN1}W=ACLDI{o`JEG*uHJ2^jxF6c|K(Sr}&)FlqJHrX=mVO#s!;Vh37_% znu8IH`^DnK?A`DQp{robIUK28HrX2|$;invbE*aDIp{8snVw|^7d00Efd2E0N3txC zGh}T2QMAruv}lqMZLD#xW6sfuxg6*;lc5#DHzXeIRx^LWC$I zcY1sT)goV%SPQZz?e>fwBTP4GzFP#AdL?O|%FeX0>8I*01ZwYZDvaJZ=vf40TKTe& z^MksUy#0FWP3wQmq8oU2&@xx7K{L-mF=P@N~b#L1V z)^PgCJ|7noQz9`7LN~8{#uvrs#`x zZm;4=3Lv2(&j~2GOgiwi&c?-Jfy@tOP}~$h(M^qEd|y{_ZX+(4F8~xQ-1`A+VN+T3 z{d)l?K>XT``6ut4K7x{0p;?l@v6GkZnkTk8!lS2asmJ7;Fyj~o5^&VIw{n}*tbE}& z=EAn9;~mh4{uxdcgVNR!q72-Y)RfoA}$PJJiyX=*)UG}l`T`E@5u6LQVf=zUry-eu7rA??=OS7aQ<{qjUq>Xr&hdI(VZJ|hSH@RIr%!9#jo z?X^(h0>-`a-+-(V%kaoOdJ~Fs&>BM1g?7P7miS~SAmd?Hi5k)}{W;Jf^xULj_UN0O zANlXAZ|Nb`%Z0H7$3j8Ul#5ao56UgC_F#S6zh+mPtr$PX2+^UP_=`?BIidH(O&0xq zKg(e{Z0zp02tJK`d$x9?``=R)NS~MQqe#8xnJ|%E@HU(E-hYLU7M?kUhs`&TA0ns> zQ{aPu*(b60L<>`^ElIU@KTR)=u+UMzV57TKlh|&eBWJ2{hH5gL*lvl z^SP{#{=H>|<)MQ~<+buuhYa9LA?49$*JU6id3jG&JmN)J4nQ+XcI+j+EbfV=Q{0SD zHL-vfPhZ4-8vUyb$RYlbb7lE}wDYl(SV|y;j|S)u_x9aNsU=T{_v{2H^Z2mH+;~+YVXISB2O(n?J+`%cpZPyaQ14fP;)oyYcaLr zpsm*5{6%KjzRifY(JK^Y;v3$PA_qHho_|5kZ(uU>ti3d4dcoK-PYpjlT<2H>O4Zn4 z3|i|xb(@(uU3OlaxX1aXrLkG&D8u;AG1Kbksq-Moxvi@0j;U1eBo^Ts>)YX( ztXu$?d&qI>IM0oHCkrO>B})p~l*aaxSJ8_ut3O3|2A`%`E}VG>bFFo$5!o>w*x7gx zQvO@Eerf%Zcxcl*kVmn*^oL>Y+L?lSQkw1)h~|HPULc%Tr7Nb)GqNtrC{F}0p>~IA z^Jl?h>N@;8et~BS%++)0^^%N2L+k_1>9304jViH#DOye}!TuoXnmvId2Oc{U zZaC-TEI%>!N6qwNei+p!IceLB^9iqyTY#%(Tdl$Y2V*WklMMCieSxEor+vxL8gfRp z&r0VF*IH&%JLBWgdE?SFZ$nD?c@D1HJ|uY6nu^*36TxD;LVG}y@uI@!lSJ;Uj88KI z=T1aXby-1$t-SsHuV%3mOOUtBnD&p6s0;}C{{M7zlbB0;rsx$YAX5*6Zs+EIjIX}e zy!r=ARmJ;`!Wu>AL!X78isH^pm<$1j#F;am`jGI~F;oj?eJkftTiFM>+fHPmqMfUD z9W_&dsv|d>DA;EXwx2HK=%@%4s%2VN`(f7IupMSatWvUFN#ym_8LU0)+r8zz9?3FD zajy#;bgGGCgYkq_+Lx({5dVxwu@+yM;e*z+W51oTC7voFoY$hdmJfRzrr~eR*O<)DD^zep&K=k-~D5S zYnOjZ+6r6qP*pQs=|ldOcYeaCQxp-$8nwJTQfR#~ac>F+r97%LpH>?kSw5hX3u=i~$h33(kc(FFr@278Zo8`i9~ZHnII z$A0c9dNcIGz@Cfd@q4XuMhxFzk+rlON96*{oNKOJ!rkP52?Pq%IiH^w01tytMoWg( zt!X=Nn%dQRS83v!V#B&t0nX+Q6xR=sn*{0B#*nK?AD2t3D6v*5?mU``T7NzJ43U(| zUHCnE$oYx+xsJfy+Hd?cx;|f8@5aB%1z5!Bs2jd<+xisO?wj-)p5e4Br!oC8ewtP= zj_P}F47{Z$xfd`Tv^X$YTtAv!>owhjlq&Xu?DoW2-2yu+g>Qt19mT{&(2g;1Zc0e0 zf|%zs{6@*z|I{gVxIP|_mkbw71Pu~2c01TnBg0(Wc8+E`!h97$d-8!r=}uq62npd< z0h8ITmFO!cp?vdMnXkC*eZaG@hI?@>&8KBcWO=`SKxIW&POXoNV@M|sPSw_vU%s)u zbWCP3niY6EMg-f8uGgiKUAUw8K4izvX@Izra#XbyT zwGwm{`b%FuHYs}q5_z^cCZ%m>yrO61c#-4&=`ZK`Z|Po1B~}kT*56c+4gdt65u$t;@NaS~a!aLcHD;ub z|3~?nIkJ(`vVJXLD(@2P4rX<_2GiRoRn;EAYvZU|YI+QM4*0U9U#c~b>n^ZSv2+uW*6Y;)c4Ww)uQK;TfIOtOw(OL`JUmEt0wckB` zPp|H#E#O`_e0ocW{>z-wR`>1G^G_Jx7D|1J?rO8F|I>J9et8{j;>U^DJT2;~q#b&Y z@zVSh0~Dco#0ZtKO>z{ZLk7@BDZyniL#8PJjl_ydo4}O;{fW^0Ww?c00-5CSyS08i zF*AtugF7~G@+T9d$27!Or=tFS>*`(<2tR23jM};H=}^Y|LUb)MTZj%A=giPw)s*1D zd`^d>kz}U7STaXkr<~hb<+(od$Beg!*;{jsRobQly4omNFFN586j*F*^?7+_?(pLS zYu}#@)iOAq+ZTh^_Fpd#+5@(W{#CU#z@rKu>tqx?3JvH=ENS};M(C-pc0 z0XlMay_3JwYyX*4U!!6DCfXmLh_*Ep(slgTW}pMK3Xm$cI7QH5hW<(UZD}Pz1`8|- zw7i>FKTIPJ4kXZIo#su9zJFslreFt-8duRrE1x7X(yFlr@$c6*pR!TPXn%N#&nYk< zpkGC8QK74ka``6)Wp%WS!wfo0fisW)`#;?~!If2@i;$RA^4IFEbq#u*D(2GMUOLL! zqwyCez-P?nMN`*Oyc`6a8uTEHLu_(y{%$`{guNlw!TZO7;0p0~=4B(Vh*=M$ ztq6wF;V>N_OZON41u&cY8c$+YZ*yVEG2SRSDBcv#^oQ<1gB0KI$)A^NcinS<)l?91 z;zKQZufno)%d+4~k0Z%4@Vh!$SJ@PjG)tQ_KZrU7oo`aB*Q>9NPNR=J)h4gi)UKVp zyV|76SXmNFzAh0EY=+v!QF0bS^10SLU($!voxQI zctIs39eP$I`#otwd;WSpFC?0=>uqv_F*Y3l^wW!_Oc?y5$m;ES4Y>Vk#731w&E*=N zILdEIky@tKOJD}*+gv?drB0(M`?)umUX`UD^crB@mYj6SpT_V(tk<0k8FdR%HC&G+ z%Z9M10KdE7bfX)qcvC+a0?Pugq#^jsWGnjmZ{ow&(_gImOpT_S#>#MnAWMMe=6T=b z8enG_MYBjvNn|N+PS7@s8Zve^;yN^%5SyDnj(6jbH=(5_rdzE%-L1I(XJ}>0wt^Rq zdMfWgHML|PW6vyaO0@`vsz5FMv)=kh-5dH#`8^;3CsgV*GOo|Y#r#NB(Ft%DHi5^X zj5?<{A?>%9HU&A6*wb0nZWnf5jiH?GfB~fgWgP`hS|)DovKn$$?<$T6Tc}o}rBTJj z`+QB|P;b*yzCXQt{fwdnsy`%~?xktYP#7aoj6V85wKX9gc9sWo{gl-^Lqc)qk^FQD zkXVa>(cafreZ6cgHg+KPFDWQ8*FPh=B=Ps{bW!%WT z%2QP5<7HQSds>L+<&&;r!v$sJSQ^DYGZz^tS{lx1K%Ud+Hdpp~8@=*7QVnOE+{*nF z*1U?Vp3)0c^+!`gZ*9574H(HVEVhP*$iobQr#M6rO?OMx-4Wov<;1^|We$v z0xrbG9&O_Pa_cj!VulFjzx>k0qe`(X;*-8+b{h1K?#xJz@h{e^)q}1fvMi74sZExiWWCyY#qPX9Xxuz>GauYD|+Wqf6oem@H zyB20wYXh%3BQ0+>wY*hT0)M>n%&GDmRtKCLp0yVp* zn!?VEqCox`zS|k>4h)@0y)Klv6B3`g(RPwiq_c_rh_F3B(B^g@BgEIlF7C-;c}`K% zPGA$wu=3O7LbFw!29q;iGy554sj6u!-rx*|?dUqo|0dAw`T|u(u^QdVjDn+>Ch%{z z(Bw)1x(ES$V7Os(1kSWY?gu=UF&C~~`3`XA-5v7#so`W)iagHV$XeXK`#S5_9oNyn zgwQ`iZfA{M4SyC6pFBF+d$si2S@EV@Hdb$1-O@IXeGRPqtx3KsNy2!7b-Gn;8~0Y% zXfQ2HFO>0b9GXD3uG(hsh8gupbUt|%R1laBN>wbl@*gIA9kbsHw;pt!l~`P5L4 z-wX?^@zO>dNejBIm!T&KKBLanjf-@J^a6% z;WFh3FQwo@z?|%%Tf+M$`Ibxy;e5#AkfnEDUi0VUc93&m|0mmEqHY)Pj*z*7e9DyG z4foBIl$=o<3i`R+Nz2ZGtEWJenU?jM&rRJJSvYD9r|d4TuRc_Om|x8rzI4*vuTb2{ zGl^~T564J8Y@azpM})Bg=iGpdn{QfmJ{!9C(!eB1_f0g}`fP*aA&2OvIMlD_sLnoZ z`q756dX?N2;yN~dsp9|c3xafkh#Y-U1b(LWR}TGx55x2wyw(q!+cM+y>x2A~WB+>3 zh3nZi4p`=g>zVv>puE#IRR1$_way3B z65UUbcH%HhW%Ln$t4)qT=60s|KJ|CQ!|pjihxD9@d|&bCS%I}h4q`+{1<=_>EW6y9d_{*tk`f{_ z%3rG(_GD*w{)c;ph~_@j2?n6O)UR;FiT}%XtFA zV-b$}0q#vcaJ`V(hnP)TTk8w0l}@vozN~HYo77_bSZ{v~E@tvBnyI%3ec~Fplp%!j z%mv(38%}aBF3sr_;DL8pYm%=8uMWkI ze)OQ|mp9jWIbX&R30+(kPQ+E$=I8nF;``d3V^!Qp- zZ+Sxa+V)eNT@1uC8&&hmVw2gTH#zh-nMAe9i*Ee{KMTY^PTY^Hb~;vg(L!XSbE~eH zU1{PSJB)H}-5+P@lZLcFr(IF8tRdCH4Hk2mdv{=m)^msaoT13EW>XI2(-9DG&xL)vxcxs~(VzSmvq^vbk;OR81>gX@2O zJR~dbH1U7aW;MN;tgXxUHy2s%*2W-U->-?KDT>e`(QoP7p0_USYi-|`^Fy}i@~&Ki zaqgf|+NCtD1nU|0H?xAMLpkd?Mja2 zJ_kn$$~{7gY>vLAk{usp`#i`*78_L#mLHY6*Gg6xSBF#^OUm}nMB(9%YU?wF;r68X zYHP|3pp%;PZuSOZ?+Bq>su6TcZ4>f(_-MG3L_653)4TBj1Q>v~Y!C_=ZXwf;+tOER zS`bOs#Agd!6Y^*}aSd}Rq=ZgW@cawi!p60yr>wEdbOK@>#^!~O)S5SRTm3`YWbF}u zW^*kdx1ueEbYl0d{Fj=Q(hp+t_1KR@V0-b)e|3*v2WgpT5NlnR-Frbq)?Z{pLHk;zLv`v&*-rM5k+8~@{lD)@LvNGDqxR2G?)h%dADUp2)`KKsQC zd%0OlKLVQy+r|GNqHXBW&3ldpE?olL@|2J=3 z+d{J<#il5?H!9aAdA{!7lPnqd&?I|1!y*l}d%>Bq6<;0>$F2lmq5}4~H@F}Q*V>gT zrz-q*!kkIP$Q3xcu7NfpxQ$Jp4T22#0(o$h{8zhd^J-nKLe%hP7Ku$0+I$c?E#s5i z7yzHxaeWVK2^u%M&bjTB9Q4;wDgHfcl~n)qR@PEdPTXT4EIxU~V!$Ca?$58@>p^RM z#wamc6v*z;TRzf`C`j{RtUjUU9Ik0^NyhovQy#ecx7Wv(Q(i#{l+WdXSIK}|(>)d* zi_o^SIWMN%#u^>xs#o7;uhTRdUie+p6)Uu?hH7DS_FondY4=$Dcw)z%4N{mF8Zof9 ziTaQ5V#5((8-y%b4B$s;$+!VA-?$3d`u7}L`yoz#UsFB5Vx(K$bRTX;2H!fm2WOj< z^WL<8;Dm(JhskTKzRkdNG)cmTfYPp5d24gm>$eu#&YUTI_47N!VV!ef)WVI(b3_}d zA72Z-lNE5w^n>89_LqRC8{$99d^TYf62b>ctIp`hEck~$zc71f>8ss*PT?f|Ibe}J zeqa#L&NeF)WH&jsz3%n43}a+uIS=kD6cJuZYH|T@jM7F$XunMHhvlOgs&fz+!%aLz zg~=CQ%`x${Ge-=Mfz7ovSu>^OlwP;Uqlh?^gXuZLrB2zXzJvNUo{V-Zd-In~q;S{7 zZ;AithvIZ-=bct8Yz%{u{0zuyp*lnV4}(=zk@6&>MmLFCCuZX>AFI7cKR)SpG_>@s2!T zS`oa+9*a2^H;O{!_7*+jCV!Vb?5W#L=%xOAqM3;^`r@%(Lu=t{Q-kc-%~5M%iDCD}JcCQNHEECRW7itEtb)qN<%&pc!j<3CZzO495b7JG$_`*{4 z>x6K5jpbfkf#FyQ-f4(3eEO}VYVqcfJOlE|(jsP@+6RP59L`Xo{*TAj;&>S&YfJ24e!$iakjGX27t68_lA530&#|eFJAxqLggY@f% z8^}h{sehmvXVT>K^M>yvy{?fXI;LP>6e6%78FI||T=JcULoF3b)AR<}GdKQoPnFC3 z2I7!m82=M~74xxy4z!i~V)Msx2q_QJK&a3An`gXs+>g2cLjKue-oIr*X|OHG(&9r! zBL%T)5jbjn^Ia2a@Lmp`!vyeNS$+#p5gXEE&>un-DW~-V)8FPJX~#Sn!JpDl|5~gz zu<1-ttM`vEgMN*BaOP9MFZ0x&UtcANeQW9Zr*uou{rj-3V_7NFpiGnT^Sit?Yu+Vr z+y7iD%2BIfaQ6wCNUM~%gy%U$=prARa|zcsfWyB^-8*)+q-9#pvsv3&>nomDBwJST zt_|8qQhLlk7M!^@Kq_ab>jR>$q}L=Dm>skmqUoR5q@xM$d+58T(B5b9XlhzX0`WLq zI3J2O4u~iT7j;vzYl|+bL@qbVb53#Rr48d zJ!WT2ER6s!B2-$zgFMMRx4zSsydD>R#Y`cOmn3`C0w@*XVh(p~rqYQ>(1ElCkAoN) zuE__3RuB;E#*2WWu)0;yBJ1Ic(q=t?cVybK?D)~$%WsHIDOp672eb}8_FXVcPb;&X ztkC}@nBbctI(VEK{=cr>ryXZ#C4m)j;n&v|3}90$I;{)M^JzHu*@Xa)_@S1m-rIJu zJi_Cda`H%P!1f*nlaOXZhQVQuzc{kC>bp*pW$?Vd+AfM8v~cPYY__DHb@k+>hBL^7 zyt3*FS-)c8WC@3K*8dRzA1`QH1OxV z%<7yWeFHJ__5Q*a-KQ;&M$7)&Mz-tEz^#q3Y3BR{zlXHG{zn05ph$#${FAWi?i zmu`Z|V$K!PoR@ZZmKa?h_&v|7A<&n4a77(WO<9C!TDak_%TM| zpF+^aCx$L|oY!U1hxcVtZeMQeaBE30|3a?6QMfR6AN)&weahx+uQ|x|k5R)n1($S|Qannp8Y-x;{jN6oEw{)Kuh%r;=c* zn0b791N+EuK$G_CcW`4EmfL5O+B4$VEcN|@>g4sVcWwQ_B621lX$~fgRY&>V@+|WI zi!2&aO_dx;(pmf4!IDRkHI-p?BzdrGu=k6z$j0_sH8TP*M`}p?Gxo6N z?eZ5~PbXc6y4js2(evr%lT1PU?lqmK0Symh(zm}FdIdTt4;dM{iSYG%SKWMY>&V+A z7I4-HlvtZjz%a8a5#!*doT>8IXkizSHJ3ndnvE-O2bAy@Ba2LfDhnp*QNaU)zrfq| zs%=B1;Tso4SGQYTQ>Pw)*R%T|)M8{wSBDB%giQ4sla-8>P$QpMIUv|4j+W-bnrU72 zFNm~~01=&SLTBpkhUh=3lnCe5N}{qnw+n~ONPRnvC@H45n@CCJmsYrp?NT9XbT$l0 zgaLHfpgw znTU4RgC0^Q#A>;vB)(2)=i}aJIOkPekJ+|zcds8qmF#`rEK0Jff|Eo!Elw;PsRQV7F1t zqriruY z?^6;G5sB=%Oom%AKl|%Pp2iUduMipOiHO4G3DXi}}gQEM-)RtiqViJnb_f zqZNdVp|mOov^0-HkPV;90eSKu82RU0?NJx$>Nl|ba%Qg@R(d-)a2=C{Gu0u!1A8#v zB@nqwFM@*&+xn45l9aYT9@32;A0esg3sH}HOf4jur4kMObqvC1oP33VHfiu`0?hBFkz~M4uAS+NZkF!Q|=`qVipwOPmO{gL^1_LP{r0@~W-sn}0!qwnyGc z3RY;)y_(zL$1N5En&NVVaXV~M9Rl^jWWGT8RT4FRu<199u=%ZmpOdUO^#8Sk8fCrl zye6_GxRUao3R}KRDdh&FXm*-@0!E{6`cGEZY#(m{>472hvLHIZZE@bGr=YXN-rFca zONKFrWG~r`HSe~n0ZfFg3k6+NyTj+cS74>tTB1ihq0F&Z8vL-mXcix zI>@q}d3VJbOF3!^Y)sAM|2#>so!%1l)7zi13%Od~gA424XR5c}s2NfO5-lF!HxTJ1 zZN$ooL)(KB=;dPCQ*bz>mG}il^1TjgxDNAQYHO1FI$7(6QQlu!xko9(J`(CQK`>fx zw)*80Z@9&(-Z6pvu4^PcnE8aQq%C-3B6#Wi+5qo8?Seb#vh1qCMd_dkn(a~b=|em_ z!`Qj~o4r%4_-Zx}MgoW_~Q?f&fGjOmFoYggO>JK}NM9A@igbL|_+Kabej zEQ?Eh7G_hj8_@VI`yfp+n6i8&U_v-4gcZXiFGov4zf-&QBAT%ZU*koPk#Cq`38Ida z$Z{E%qPoN7+$28ovBXuW=RECx`Bg@2HuXL{6x(%ei@FgPOQFLo8obO zWj4HaUYZm2$BjC+F|Rk2t|Y}}^BB>i^rt1D`nKC1?un=wob9C%Kg1==yJOYSME=y= z%fDCDFoN%ga!P)+4EeP7OrHL*taOT#-FBlw*6-_hF8{vpu+{!y(4}r=b`MVGH6^2z zy{8fyO-dg3ooNo*rR`ytF;Z_Yj`+Q2zvS>OgZr=E;=KC&mQO)@^r`?`2O-;*wb;iB zdd>6HuS5RBF;`8p+4QrsHAr4S!#G37kK}#UKBUqv&?gKTd^*ixBWV7|t}s2_iUAwg zM15mTT)IX+11`fIPf}O z*DPdBXCr@EIM`wxw*$BFh>m?X+BRUQ;E|Pe8)9|6Nll0JUYppV!x|4<-yGZZOHcg9 zxX7_%OKDcmriXu)-?%T1HmHfHF^EVs_!)7)Hwb9a&(YNFV^4Q9+l?!PF2h?WeOow3 zZ}~S1tBnI5O#Icz;J96GSD_qUIXWJZUHuL)aGZ!1pPlXSIY}$mDML5f=Zf&4L6cl6 zeaJFryX085_KZ{#W>J&CF}=hwOo@s#~Fcms1o^fruyJT}Xo587HQ zIHuk>Gu8{b{4SDs3{~5=y(CLdau_5!X7T${@4fkIc!`uI7-=rR=yX$G?OS~g=Kgs% z(znplx}WqBJbM}1=A(2%IPF1Jn1=R~em)kMbsX$dn6N(-EtPRkP4hk%>*#>fib@Dv@ zol|=F0e!Tw*l?^MQB~bG3)7m73mJGp-t1Mr&Rn+NN2Z7$(WpmRdaZpl*5beA^Gr02 zTBai~D0n-%JIvd;#;`=lzVvFW);6CLdZ|&@#wNTLZ7SDu>ojH94<@l2d|G_PXah9E zO3!x@wJEY)9j4qxmHiDMm^Ptl4c1w>Az;~$9=y}x=ok zC!E57J<@Aw)Fc_Q6ST|}v=#_|h<2>`YjWl?zUlrEjk^@{3APSg?E3!lqC{Z$3;8|i zJSl&nYCI^<8*4Q8b0wi~BjSDB9x;@W?$=Wm_nb6+DEj`??N&qY<)+Qfe)d84K%c`a zS6ti-Tav6nb!(^n6=%cv_aa|`)Z31c*agPx3uf({?rmvn-${~RU`IOTYBF~QFdKRi zU^x4y_v{Il?fp+#35_i|-KNQ^$S=@Sn4<4b`3J38PLw3gn#^2R4(*H|P60Qpm{SG+ zEd*jRS33#}hs&w;Y|46QnyS3Mb#-%V-01O4^nLz6?;J=|E&(hxdUw|;D{nfq>d3#{_R4K#+N5%pN{&H=J%@i zcTp#`S0KiL$SON@mu#g*Nkfp589)Qfh8m?Z^i%nbngY=x2Rat-eDgrx6;FjcP2 z1tA_0eO?zoY(Yl0^J6CVpb?R#l*!5TtmvKhE=AhvwauP`&rm)nnZ8d7e-gwqWKjhv z^2zZh)qL&PfPkv7Wqb9B^4OeSKZqytbK1Tpos2pkKA~J(qM4Mtua3-EDK!6f)8LPm z_-!=>*H`!Q8FisP#k6n!NEybmfyfGQYv;`K>%JCgel<11+jn|nq$dI^O(NTacPtH~ zZF}CyD4+*BKWXTJnx}W-jDAe4#t$IEm_2HsT98l45l24hHn(8$5)bt|_|nDX0ZA>l z+A^CnRzw41o)gEU^|z-~3#gq8x^H=}n+)%Ch_|IrPtPI|wt6dEK5vah+B@jJlK+Xz zFP~wweAe(*FMz~|0@pV01{%)z5?n`ro8VfB`|24PcQl1DD4 zFLy03&>NG*{*i#C)7aT2`J1FKF@pB+ai>A2fU(uG#7$Uwcm5S>bNGD4?Ve@2zmX7c zHFDa`S!=sTXL*4zvp?3E&|CLvYf-OZ`%34WhbvJ+5sD&{yWHf zh%qosI&C%?bb?wGCo=!=D5r#Co4>?A+5)mwlbV6W@wFvEi!c4hh2QE6EGn$p%QPu0 zxPf}VnNh!B8AEG&LuG^>wNOY~O;QDFj?y+)GO2*zIQ=CDhr9=q{N-)VcF*|M97}1e zwSN?~1(oI9eQ1+Eo1<=Yyug>FL)j$F3mYM?b@i3C*nlJ_HNLh)eonKKdnre+yZy6% zgb;L`Fl~kyd?Nq5GBBZa=v6~hy``!!z;{>cdC1H{D#te`2{~?CL{5~c7D5W%|Dnv+ ze{zP&!vo1(GaTCOici+M1-mXy-6Etgd#5geTp}I_FP64WHo9_48~#{(FjO|u`ggNv zEWUK?Xbc~n=MmI*o_lyr-NVQ$GctO0x=7VQbPlVbRc7boJQLJgZ~v(h?J+@t?TDu6 z0e+1XC*}%Nz87|kOIQ~Ey{Ce6sq(QfbjW;NkspzX%q42fc=47FC8?H6x&|`&u1*U= zyK;&H71CLcE}F-->%@{=Ff|Gg@k|-w{>p8Z4P>6iw$aet5 zF|;!~Yaf2-N_Vd#W9^?s&iw)R;Rx1%WK&}O^yOE^GakiRL3;{|R|I?OnrV4LLWibd zRu-ZYtXEL*TSyg>`8Sn%XVE*4Q!f94r$krVmgtZuY{ zoaFh{bX}xugIxZtkeP>=8)`X5lJ(pyZl}2**aySHjBwTTME&S0(EY(KopOI#MOarc z!saNye(S{~qI3W=~ zloxfWOY>;J*uqxfA4P~?2m5d4x)KL$KyjKtMUORmacJ6+hUhcoGWG_6(IP}=0A{N#>+v*>ao}VM`^k1YiHx#*?&+09G6$PC{ zl4uLKjVZ47RKp+mSovxmmroR*jNohcd!cwWnZh*`4u0+z4*ySi1@#Xe55@y~Y9a3Fv!Kw(!m z`m|K>u0;87+#$VK3^MWve_0k+Sv%vCY}b|b%OQPg=i=#USoq?|zi+ce*m|A9)oq}~ zo|`RR)Wi{^26?5-8#3~J%+W#ejy!@)oX~!%N<@xSDLpQ~_NnPD?~|p`y=J%dG>t}z zIgL4De+I;Txl+t2$vWA4clb?AU*{2*dWRUw zBb4-VrZs^Cy=Z0T)=Vpouj>S~xkRhy09xFClFO_EVsCd5`5jp_(juAvCmuo za6OQ6{fD3N)A9uzKvx{i_~;@J#$b`484&tyfl6%A>3NPxJ}a+BR^GKS0@^nbr6y=e zsUvY=80dhV6k)t)Yfhg@>!&7L?k$Y3!947{8dLM(0wrBj_&Tx8(|JjTDI-gG`X@)U zt8OMKpL3=M_r+#$^EaS$i@(UfhvlEFi?nCj7~wZ~Hb|yZ>v+^ zpA5E;UhUSMK%SW~GAfEMqJr&yF8_YYdz=$+EQtH&(x<&~9unAqcQT%`Z~6H-gPF3>wrr2uCW5)f;aYKA0(NtE8Y%%- zczQ@zZ9*<&%#_cA< z-T7f74JOL^R`d<$m5Pq0a$h*1g?=%N$Q}kvh8i$6kD)A8g!NuOzlr-q-RLPodn79Heq1uJy&S6y{z)2c4b4pS%5f%)$O`4}qS zRfZ+ZUJ}b(itDVgD>|;n`pShrn}E71eOyNhDBnC8l;9exTR7Wfg&0i8aE@mEIU_&4 z?o4@HR{gZZI^lbtGiA^=8zF>RdN+^NdiiZQ99xGTn4*Es=sTGfm3i;rw3PL0)j=!> zB~+pKX80G7?iZ0iC@n{kSf`rr4pFq{@PBov|1wVQ-D`9lHBNzGawa23UyZF@U;b+n zBzc2wb=Zx(HHAr!@3=`0T7YY0Pr@@SNt0@#*NTT%`0=n4y7poY3ix#jc|G%;QjLGz z)N%p+81S9snB*PouDTEaMjZBD)1P1QIzi&V(Hw`l74txU+jJ_XEx}lEqv)I=aOC6j z7kp7GJ6W!(XU>TmAdPE-X3w2`*L*QjV5~9NR8HDgWlH;k9QvGfAUsgAB8kH68~1N z)QKC3j%DXLtBN2RD{pwNJIsoDb=}wJ^KE|&>{Pt;93wD7t70YgXzue$QPiMUlVVhj zwI&5`tV>lesexG16H$=q(&%gv)V!?=G@>G>M;uXjgBPJqhTTSW1rPXr^JU;2ml`*J zj^V>5M%*e4tDgTqlHNNm>HUrSZ+kkHR+dx_>NKpcgX3Lpg|>MtsZ)u$C_QC~Bizc$ ztV~VKtSlE7s{}v0%ZzGNO9nK5tc-WuaWeZ`gf`=!LgC^NMDKl}^ z{uw3!*8$uEJgEe4l^)5d^lFgf7me#TFkYDQJWKg zS`U*$Ka;K&m9GR?aZPk{PSht=NytVqcz&QKx?Hu-WY`3TNkj$a(RLq~-J2g`JH)?v z=(a+lz;_g=Vq!&9oM;FM$gYdueG5GOs*h4sT#ZGeC3&FPpq2x5L0lEt$#y9*?SrL( zbjfK$(3gVk8M4fG>hjfi{&O55fj1X@-!?E>Ik(zjH0r#>Lcp`a#U7Z=iy+&8)XhOa@!8Q0H;J;%*{vD{gMNzybZd-5e5-ead7nO-6GS87Mg4nD$RlT`weAY zvV0-&h}-0g9W?9*UrrT}+Uuz@sbSQ9R*rB!5;a%YDA$Z{9@I2nvEEi!;@or5!GGSY z=mAK#2>ITp=GjN~F!e>^jMh~N^olBWOp>PVH8R3CVq?B{ozYX5a< zNQX9fJxTj;r&rkWklI;$+v(Gm0w0Y*Yr4V!nH+Pdq*eZUtqrv^z9HbgGTCj8 zYqeBAY>K$KdUSnuieqVn71dvIAlLAwfwc<&bQ_$*J+uqO*$ zwH`Svt$W>G=^GQBl~Umacl^FFef>f~*?9Y5e|fE4;uEFtl`YU@twG2c>pR~1s$a2v zSGSxTzB|kQ-VeA|dH&5oR*IKq5B$(l(7E)(w@ve!mx-A)x1OH*NlZ=|feUWk==k%8 zYpb4v4jy;a%=+tDz4MSWDPNSLcMqT%vreVdDuCC;5xaa+R;9> z)HQB?27Q2|^)RMCyPUh2pUU@v5Jr?I>#CF)f=I0*(BN+@kNhYEN#5h8#eWe9Om^4T zZJQaNR?p<=C4LIffmhns4h52>4j}&w*7=YeDv9?;9^$%gizSpQyj2$dMd)V5U-1M* zyDY$UV1&HPe{sJ)p?Kl8P;$8qzdEZd;o8zWa#!5a;4kHjO|f82@qC^xDUnBH$6-0g zX^!Qpz})@jOY1P772o8vl=1?cbk?Y~hPe@$aKR@9&#{R3Bvel|uCuVDJfAbH(_@S;|*%$UjjZJf_}p%EDp%D%^c4yo^cLs%AoVhUpw^*IuEFVJUhzD z&gVS?R8S}|oT~fkW#H7gir>@zm)m^rF<(|Xw$58AI+`G@(??Qdp+DcdRdaRh{c{*j zX(iesi0m}JzcVfM5dmXc#~{Y7ubmrz4KwH}^j5PjQXAR}Y=(kz{R-J7b*|SqpIhiS zyEg^j*LFl&D-NJT6(0;{EWPB5?e9=#1r5TK#wBK2JngFmx6<#BVCF&7?Amy{qY=eN zLy9Q&DjwWcPc|^uh$QXHtSNsmvspPnZWFkU@Xep+2R`2Bz;R41|nZ$<5Z$_Gm^y#knSfL*6O*4awsl*OrL zK8&a?*+tUs0DuFS2wK1QNrG~$m4ey{nO`p7@sV8>!rvSpfE!;cOL)rOQ{283;O{3i zanLzCM=YMT6wFJ)oBq|*cl{SjYtq~ELY_3f4><+OhhP2A58|&u)GwDxf6Q-OEdRmF zoD`@w$bVSODgCVLp>4%hzLwcdZLDTw!(^$9xBP6Dv~Rh8{|K;A+oXdiaqQ<3CNmxc zM8(1&{t$dr(#dAY^i@{PJJh~u^FpoiCoQ4x_~yQQS<2sYqoa0tRUaSnvvd~(8&~8n zJI3kP0SYTad(}78mXbp)aJHo4tlf*7 z<`QoZUP=PO_;L7=jdR*9&4OBiESGmJgW0tDaO4&vm&V2Ab0FJ#WE!Ud^M@m^cQB=O z_sH^6sV! z85Hiza5x-&%|>Ie=D+%X?+o(Sj7OYEt~_}Pg8bb&0Qd*va}7$jk`d zn)x7zdp0#8^3RdS6&%4nZA4|jPT7yZKj=58SlQuhbv`qX6q>19wq4MZJxcxM>A+Ro zdVI-dP`5Buimwda&sygDkMc9{;n#3O>|TJ&_7=Hfwk6u|9)o{v7;t~FW<+^Yq+g6J z-2<|%#l60{v5KDp9&39wrh^?vg+xN;PRH)mCFq_-+I|)?D#CHsWPqj+Wg2;hf^??7 z87$rw$GS|Y#pLv9Bf-f0c8Ahjpj6Q3KRO)({mgeCp`YkkpQMfx=y+$vT^n3Gp$l9iHPSTFW+*aIzG)3|r_~jAO5|O$cqL^_Wf7i!8E9{e>Hsf7k2aCru%!?i} z9C)M+)SE5ai5M`_$iM9T`4&5SisrTr+5;v*shPn9e^UK z*JG)(0Po4$2Kl&ee7~1Njy==L<~V4zYYEB0OxjMGoYn2ekuAz|HkF-0LeOY~-0A_; zwMrZ5>XtI#og3p?(-ZDyredMPH4avs2jr2JnEvmH`0V1gCY+m}+Yyu@3kqy4NZ{;Y zr~g1R6F+ptY-{`v&*9xNU&v4CY)g_dC`P~kT<*w`foz(eWF=7A7O67O8ovx!6UT1n))KFyY@y(vpp&FbzQ8IEU7M^yzwOAgJ#oaOZH zX4xnt6Pd9W&K652-Qvm9KXYulf*dU7HE)rkRQ7_{qxD>04FzUGKx!55Bdxtqt!>yB zytS?Wb}8px`?u1x{8JTM4;iePxrEppNeYAWD$b~_-Q!q)rsw)Z!tZz=(MUdc72O8s zH=)C7?*xC(9?ZCs=@2n1Mo3EzC_=c6I#OOMcQQcYfRj2vDgmf>aZyHi?{jmlW6{q+ zJ5}83Eg>L$>7YQ*UE8Srf_-sP6=B0=c?2w$$0F|Ad>vAZ>$lzoM#jDcfT(EJxB2A$ zYfQbSN=~aOZc*C4LHAP{JKoKfe{K~2$g1@BcOOWOwTm*B@6OrxyG9hVNdJZ(ZhhqG zTG=gcbpCLDc0cVtrU%=q&tmxY_?RN_{;HYof#igz{76mL4Vu4B!4O(u&tQ1~`+GqK z!K902U6l#a-eM9^{#tcCT(t$B_-#IOw+K7zFI>Me(nO-ys_1b`PF}&^0JNAz@j`$X z{eKSC?M%`~Z~i~|y}M^!3c|{rwCeo@m%e3L!L+U2jo5!}X4ihQ{;+qU`c|{`K>msq zmhpaP&44_uOkpt)+pq2vI+m&)@|#Q<@xT_dljAOic^vZerhw$36U{F1)uzb-k{#ZY zN^KVAERJ~H1e4lpsnMEXx!EcS10qnWEeq3Fxb?G0Mz3BAmW2E ztYU7E9-t~!ZLl90Ndm>$6ba%84FLAI_RscL$5cr2PluHO{)6K1Vh^-ouky9#Onr+ZU$ zMIJvO{S-X&i;|+9&QVw2?s7(vW1t@hUUHZLA8%+Mdd_vzfMZSA^332tgkRyZVy1bE zyo!@bo(XIIa>=zl0Ikbcqm_4i8(-k6m-@AmOHYQne;#;;LDuc;X10^#XFJl4m90{b_P!C;a-!Jy}Jl zZ@tPvf@{gJP2pfN|#T^A+z{LOj)ZZm{_98t77L034l93>Xu+9AeMYP2xYm4W4AG693ji(Cj1oWsdjk zqM=ggS)%_MO!XEi+b!E0WEQR-Vz2xOZFFJB8}>=gCxPu@`lRB5*63KS!yOrVQN2{z z=Vo6N1=SHoH@_@D$a=7FV^cfD^=`(mw((uisaJXkLJgho^uam=!9XX%4p3IC>*MD} z_uWYV4C2Tsi{RF-ra$~J*mO^L0KqSVSU7;HpOO9}`*s7Qyl!i5%G03-(7H1kgmOyE z%LOcmiqgyn2A?_DXzy6eO&p8l#tyu|eamyAW+LZxJ$6~e8TyHz$qlM@%X z&6+(8Lm~g3<7d%^2kH#y-@MTDiUSGKcbT;Qv*UzJa?k-xrOwJZl-*JvaY2`Y*L=`r z2{rDgMsSr}x0D10@?hWH2)i|=txm7GyS`omej57+#ln2ux%`DY@bxrtFa%}-{B@&O z_8%3~p6$O_^A6f~x7D-fNL#!ja%2r~S+)9%{RRJ`%^_r^-&>2D(Lz$cBw$z$q%|zp z)QRouyaN{VdSB97O?`;Z3mO)un@KUBP6lQEKA-pN!Qi#cpKgqIC9BRZS=K38!l<6r zPM@CVfAq9_-DaGMiJ^VtIvqq&rvW%QuZPHH75L=U#|Be{&)uTUcI1lZUpZITFq_&4 z_3n!cJ>zdNpX5AaNRH=HyE2ncP+i=RbT-!7@s+=fVK80R35GRhtlc$o?9K|8%S zNk3l@A^oLO9(^g8H~KsvkHWh5P!jS}>J=I7gb`nh_)Rl+CXLxfuY=*joH$OJ!l4rW zHEKk9M_gBD%3TjHI;nGh7c7WNRY#YuxN>f`4bjM?oAVz7Gp7T9NWytdXtj^#Ilq#N z`G#2yn{1_oh|;cs!&d&n4dILqy_k5DbURWQL96z*8ChxM&SN;uv$}stJNrc%2ODb_ z`G{wEiJj81iO8GEkE~QhRDZUZXBH<5HWmbV0CrCTruZ#KZXci>!&mymGyN>H1@{!Z zb5oZ=hipD0ir$Sr|Cw>w9n~}WC$-hDqv3_0S3_;_n6H{;oW3=_TCN^)!XT^Y7ds!3 zqdwYS%fd(fAlCVNIG6gPEPmyc8$*5v0aKB#g2ye4AnM?6Ub(t=FRKtsy42QQL{>Kfn1i!II>Rv9_q8pWqHj?M)HB?IuRkNw7u0h(QZQYyz6B$j>jRrF^WYO>3 z4wZ2=Ef94JP+gT0vuaDza%0t{!0|QRqN@50Z1Ky~#chCY#FVYxH6C~kX{!tvqM0@7$dWHiAD7 zm+a;<8%@eJVO-wxld9H9!Oj~9lD55isBSF{;)OYTf*eL zlE-!#AvnwpGWQhom7d}vM;-rrCF-Bwf=!${h0dN;x^y|i?b3iNUGWd$c}pcHl3J&Q=>o6O6u(9EV#gf0U+Nn+ zH#M)yu!|num;{=^JSdL8-pKzW;YCaSi}Own+-PSwgZ>Rj3tOnpe!KMGORj)p6y^WaHNC-R$(k_@LF;zV1Y}fSAO)Vlf={$>d|*h0LF+ zmD(=pgFHjj%|e5ZHN zCCQHboqM_vu*|aR;;j;M^7jef<$t&sQjR&K<;`DxGv8|d4DgGN*M$qpvznMC!@^|E zHh1yM*|~84Cs~;HAtSy|ZT$L4k|}kbeib6SBV->y9BCC~IVl;%)-`-8upL!Tx?66r z)=DOcyML3;JTCCVOzCy%ZM@fC!KY)Z_Y+tz5OmZ9O?TDjSW0YX8)$t?V39+bJo>F4vEe$lk&WvJ%K8vlaH zNRcW`j{Q?$^xH^JHO~+I0Jlb2{H?d#%61`QUbjUaf~W=KMn)4B5lkDV?@~ha;y{j^ zqP#V}!;@?ec${%E<4BRxa<;wEG5sB-iUFia?3wZQl6#@U&8F=&bUArzjqpL}67~}E{3CNxsQ20s~iFNc*rWca;zpkLobKW>E z?i0Z5UoHEm{%6pnx=!Brjj@S+R=XP%XGINt18;8MC#nS6$pb~w7c{=ea7IR18cG@A z$oI}OSlfs?zvf`t@$=hA$gBthdcj?Ld`1B6`x({248qDxKdn7_DYQB%^CT*9>x#(> zglvXJ&jl+k>o1RRS2WxeIVgVldG^|C<4+Jns|as~Q_kme-&AvM!XZCi49C_PRM>lc zPA#OKoLV?A;z)>1c8=i(QBuy`14G<)4!>S(szN*dW6{MxM4CeeGLE|jtXkKxHI8Q) z;UBZi+D(k8la(jy59!gVcX{}5yA+!q!rDspT0H;X0-Sv^LAJv*rtww$$w|;e2qrWm zhvG;|lXdNXM9=I8E1oWjwDTgYDww3ntCc8)}#t8T_8Uf9$2~|9Z|gb>$TNe zwFBe(=kCbhe_shkU5D10V?Oo-j%5QvP&QoNEePv@uF(W3n5%%5T{HOEl9Z(8wG{;v z&YYSkeICMbFTDF!L#7tI#h;I+TLP@jW51sMNtQm@eA_f6Y0f2nCZo)Mjx@ZSVSyrf z>)jjL?c!uHb4NISjcYEojFUP}r7U-xtj==}DtuJ5865n<`>tm*S^}-N)pY5KI;Q>> z@~R^`!|^dmZm!R#kB&C!dw=QTx&LBb4-ay9R%e{%0n&{t;wyk40-{BSONGz+Rbt(YD#plHINuGp=(Xg(1Y1U1}j@CBC=~7TvxzGe2su%N3*M~Yf zKP=QZ4=1z?(ynugc|Moh1k;cKi1V@Sr4}~K z6`rp9kkDEK{P|V2%8iNmmZuY~c>wjg)JI_unsT&kYMZ=u_hneHNM9*vb?+~8x4^3+ z>i%X_i)`sBCp&+xP6d5b^3GYK9K;}l#RF;1i^vn(4oCF@HA7=?V)7P2LAd7KtsDX&NO-%2K;3+nM`NhFYUwzvU> z-`Ad&^1;?1$SO~kR?mzo%3*)cLP|^69uU(H^FpJMMWbMJ07!_Nd|5R3dl(r13lw6? zD`9$_?{i1TNH)iOS{)Fl?kVwmT$=x1d~{@{4eHBv!&a-nzv7VFk`iDin%A-OUh?$g;jQ zz=S2!f+6Vu){YB)>Dd8_bjo!M6<3&58POW(w~NiUnv6K!DKFUlo;kX^DXQD}$glAf z0)mR54OWA&nxHvni;;R|;ZBHIBj3B=*H)a<7TKU1h+3*T8)APO2V*mwsSPA`z<-_& z14q^{)>+&>r#Ep4gIw=?p|j5u67a}#SQ0jj{XXP4O29AMcd<{1d8@I)jnlic%9|C3 z-JJvUV>-I`p$N~j6Qdn@gSI2;m&`zY$szM_@qugB120L64>aj9niCooSf1+t$Y(~n zKI|mPFs6e9;L=$uS5y{F__3s3jX@iGZ!`V$Qd8mLXbiy!^(wH@gqf?+eZm!abiTvC zDAW3AJlWWx%#4HMQ5zb&YO%8@SonkIGq>rT{}1 z_sHl5B7*k7dYRq)isapSA`jn*-ZT;!PR!j=YeH!bQ}>+ng8J zI^Svw^;YNEa%Jei_DjfP(#+$uzb*HqMBo<>?$?;J9@>tky^r=%c!!M9v+ZNVhjSJ5 zJdw@L;H1`hru zUXV~%acRxNh_3(%iu-}GS`hY`Sf#`Gw*kCR;|Jp*^olEh=)f?v2Veh_c7YiWzx${N zx5aZC1ef5t{n5@l2^Vu97xfE$3svt5C^N}r4@XQ{sM+7H)c|I3Mr(uexT^nUmXklr zZtP?;YnS0rS9x82TISB0cW^X)H<6?spL@I|N!GbGAg)N~;^ld@J_l!A*t9rMeg#ze zg+X2X3*o={q^iokRKxOKs|bOg(^V;+cw$L=x}s7-cXX5mQw#6Rlml?A^uR>l5Wmg5 zj}IBT4?qNa0vC!jm1g2P_xslHCYX}`+BzaQJUZyS!{LLrahNTf!n~Z&JRAnQ(dKXF zLpSihR_wc4B@=u*bCoIp#L09UX@Hf#-5km}1`9W0f3(4!6$K z0M$PZa7aoJ+8OZ#8m*w(R&<5~rbz-Tt9)GgJIB}L@QiA51EOKVMVcp9T3k!DO`NoyG`qWyj5l}$f|ROJ&>r4GM7N8P zhLDRyGaONJfcq>ZWvnsQ8X#3$)%T;IQ<^;nPja!bhvI_kMmZ|OJ_p29N&ZRaz%d%2d6cswJ9yUVBH`JgV7KOK>Og=u+wM(*D+$L|zBf-ovhf zu;GHAS{^-n&@0?_o3rFYICeeY_aq=R88W55eDaqu06Xg|RUC152cIe~&jUHjzhKS@ z`zoAQ7pw#MY32{_r#*puHvQGVTZh*r7Ebk-%jy2qc550mX?oCbm^Z;}R7Cyi8A&?8 z|DHKnb@dp{YVh%X@;OUN_(I0PhJky@DAgA{AP>90*>GZ z*p=`qx>Luwt=Y0XC^PA;eBk)`d_HPh1A4JZel7N-(pTZbWCpdxG-a*zlL^7CM3v#; zhwX~{4wRt5M*lf~Q$buY<`$L%a(685%&xlN*q_g9JY3GwomEeF!#N|)tXT$859H)M?58PpIG?@KTY`!vzLDlatswzt< z*ghE)%+YIv9$FdX5xJxH(R_#-C%9UnqKGWino~oDuF4M9Oqw$ z_A5g_1cCv#0#K#9TQiSn1uZPhNqNKWR9#a!tDa=0`$qaM_WL-_No`9p*P@oKoDrIi zc4lsGin}5Fe@D#n^;A$L`c}+Vn#Y}<>RJ=7%dOsKJw|%-GgR48X#DItp%Zf86*FAdo|13xQUNs~D9>iMWlk<#{_&*{!`7hHuowF+6s%tu_m^A%#x1*y@TjJ|11pr3p zbIZPOgATYv?1pyhGycNP%C9nM-ZG{}^Rq2$mP?-C32JG!nh z*i>V-s1DGc6VRBa3Sswt1PQvj1~Dh4_uWP#gT8^Exw zYv=JoUuy4c;M)U~rA70yNb2Mb(f@djOZ(J!nb9>Nj@1H+UJ^rK5<2~=eiW5TMlVtS z^Eww)b<^L~twzDhADYB`76rLL?}*<5A%Vz`9-@Dj30pNY7JAp<9ZEK(ETL=(+oN*1 z-s0}`ds=gIsYR6uHbV-4^+<5%G|F(C=HCe`7f@Of@dq#l$;w{%Sz)B? zZy*%0tn4_|m+v(znKLT{BKY5p(|@>5wR;+9f6r&X8I->+tQA_1WgCLaQFfp0dOYYs=>2^IzW$HgyJq$TPDUWs zNd8#^$s9N2AB+p>q&=N(GgHAaJ=17$$ckdt>e1UHV@-b&d=wMe6K#pGw_QG1!t*08 z+Mh5k_BZK&I5^a1|UFzdltxrs9reK532Mtx+`&pXi2;UW#aVBI0US{Zs6 zsua-A!ioxQd4)4q4n{H-b zTl$}whCWy-HLHj)5*2b!=lRqgu2XnxR- zW_ql{WGQQ`ZlP&q5wGplEhonDD+)XgoyhGzWUf#>mL#(G87nYhl*+(mu~_|f@*rkvG&;N?CZS=+z(YYz`_1nfM$tM|x5`35{y z-P(Kgr~SmzUqxZ9DWI3*O^r`A#O6`5(FRv)NCoc$-W~pZz6E`Jgwda`l zTf-OoKOFBV)C_>EJ2Fc2tPHAO){HvA{OWX=gJV<{+^@OS(Z;qfE^gvbvAWiwq5h0| zTkw}%dWT_XR#!vb!>9mr@Uov531mEe->vEaZ=H@OS50kC1={voSZ77uL-Y4V%nCCp zHwt|A36I;hT_064KH~AbpQHWg>fig6$gQM*IuHdRQ0}hYNOHY)X%C4O71>Z9ibRr4*?=&(A#Wg^svh#GW$+VJKK~}tXiZrCBnPqdPhVXe3LQ>MsXCw-%LHc z9{{73=*LV{*hERl4J!vSmOTG0N}}~+`s4Td54;4qlY(LA|5%xsa4T!(vm2PE)C<#w zbF4K`@{_2|^qbUv2jj+RVgO>0XXGim88i;_B>H|Z!^WM0q`A{}k3G@5ovpBqbSnzW z9Pk#MDnhj#HP)j9-DdWE*$MdFJGpkMdP(oR=v~6y&3>lH=WnsnzoSH}*c>l_3bBOyYXW=Q9}gTuDcVuwTDc$Grd z3}pm)w4MS$;H*>a*+*`O(rSqO_WZ`Yklkx;{W{0*@rO|ZXBI!njiLS zbl7HVRbQ>>+NkRKh}}|;w7vx^Q>J+c8==N;?QBOW2U#@DUk&u`V(%0=D6QAkBh{xI z-Yi(Sl8g3fH(#W;y36KvF}z&)wCXURdvK#~b!a_pyzYO`3KhK`)&r>@u4SgPQ zTcc(mx2t9*4CAmWo!-~l-(=i^9G59VUo$Fhh->z#v>3f3{8j{qL?T#AKa04?ewidx zJ3nO6S{*kqKX`9ciM}VBX+Y~PWU5_{M2v*!6o!kQ3G+F9NX?s>Yna96i0%Y$j6ath z16rdlwNs85ed>;~>S(KJP`Y4$P6o+jxk0+CPanH^s1){cVRm9^D{ zoD}tl4~*0x7ZnImnYwX_w`VyiVkatlI*}L1bt}Xx6$7S=12xqV9l&X~e}{bhs5&e0 zTJ0U#rX$dwMl+K{r9;GdH1Bds=3bLT@$pX&6zH2YY8@~>JkIf~-DftqwI19qWk0M; z{0^i(p{@H_7GkZHH&P;T8M)z!wPjzE#P{sI2zJiOum06-yFdYCF)Vz_LcgxF{Q-2c z_v#1}BtW8Q`i%CEBh8wST%-&} zUS>OJGIJ{PH$*C=4Usmliv7B~$mUF<=>SL^Zn3+u~G3B_! zFX6qg;>{TA;w_Uqn(wxs))%-uE^XPRHzmE=vENG*G_zq^5JE^qT3jbjIZl+O!W~}n z%Ig;CS0A_M7zQ``83m(Qd4J9r;|pFkkfsHZi8^d!(Ds@Fur0J_2eWI;QZ8?4C}0W} z?+Zx0U!M<~Yk2F$A8!~Qbl3^E-xWz%j#&D=ePkwm&pUuoJ2osTTM&6Ia`8 zzpnk}1l!8eBVA<;tu|ebccHPR`$h+&5`U&p*{;)blOnKL_&;azU4 zSUvvavF*|RLfyQ!V(w>fa68y1Ro;aDRBwCTLJuswL`4j&rIaT04;cNGeVYb?*lZS>MVy8RlW^vhbIC=?6=tJEAEXlu@1s4PA0KD^9+E4 zj((^DPQJ>Zr~JkcwQVWDW;rXOc`OUSjx&P{kju2;HRUTCl(1_;?m}s>se8E32%=2e z8E$3C?p5@SMz0~M_cwX37)g*h#OFnzV)cH4L)Qjx(O+i$S_>;~uGPG{51 z3r%3R!V`<5s8fTgb+f8-!lHKRc`Hg;-)Q_FU{{kRO4`e%iqeesmsLmdtXHOa3+L?H z;+dgOBbhPGC=oCNb8tMQ7ZuCP&eB|bmEdp|9XK6u&D0fwVdJB*3q9c#M1xc3PeA_~d?N&5Cx7NhDlqngyHnMHs9QMc zTdva>&6M=y{2CMZmP^h-{}V7+P4QON<`@DJ5i{_LnP&?W9{7qdcQ&Ex`>lWxGINg( zKhVR_i>_Nj$T0>L=mADmEnh7tKyw-!ta!qKMxH6#g+fucnyz833O_9Decjj6##(wZVNRG5v?DP|b zZP7@q+vX1lHU^R|wuJuhDqh}3){PMYEN73PVlUP=0ZlHE{3C7^9!ty((!E&CrW;wK zZV|(#7a;`yh1^VLgA!KL@ChU1B9UwS&_!j0aQi`}fOTX5^^U~bV*;bG*Su(3+=9E#v=R#0KBH*prMPkgwq|JMKFVg0xxlEl2RNp4lO*L0rvLx7qj5LFG6XPGgWW?836uOCgR4{kr{6*j%I{VVDx zCVo4Iadr`9tm}-S9{%pgW-A#%1|7XWRv7O)i7)&9DlT368_aJ;opbfnxdR=Fc9Fo3fGum&{8>G+v;rhK$X%EN4m;s!tu2c5zPWOKv^S zH2ru`@I#4+T<(?}z={S($pLx{-Q13Ol77+3_g0s4t6}E@_E{3IZ0DzUY&6GcYo2b} zLyKI-zVV?D$1EMf?R2}B@;F~{q(O{_oh=l)xoDR{g-iviRpnsWV* zDc7vT_j8PY1Rgc}GtS_3%hVR<|I7|~jVA+Ft7&n{k)3y*Ef{~KlFnb)6mfYAF7>l( z#|`3v0Y6VrQB-=9BHcaRWuE;hEoJ_%sWbTV;w{0{$7E^!T0c{HH((Fd=Kvbf`O$1X;)~;pGDL~Vk$`)!VPD0=sNa6( z$Mk-_i#`r3R5Lu2R=u?7T7COms#|hs2N1~6{RPwwUNXy((fo4mt8|M>-!GOMhL>yk z?9oUX50e&Sg$b@BI*(JD%2-cwEezYg@*<(n zV~x(1C4k}xaY6*hTW@h7zR2bU;IUh;s|(6}>G7p~%p=TmOlEPB8)RU<<|PHoWX-ST z{R-)g-WKod7LR--9hOIw$gtf_5385>%EfWkhUz52QlLmPn7vEQ*{eb95MW*%v#@nn zj;*CdS>MD^Ddk4s#|ZjfnB78P5AdT0WTwIH12E0>72O}<2D<3k`8#?0xPm0TeMMUjadoi2z>luFR#AnDDh zOk?RFU$+n|KWn>?u{KXS7v^_K-){P`g`i@5Dk(Pv#U)+Y%t}O1zC{)a@xEgf5lZ3P zgn?u-1#X<;^u|E&^I}2FD8gtwhUIAx1cKko1FF7fH}rSswXrW&2;UlmFm>~%=a7;g zdYVw8y~mQbR2=qraNWYz;PA7lc*(Q+!m}#(#RAx@5T;MAB5t6cmcY@Bm?=j0tB)gK zvwJkhA$)>SG=2XW@RxiyBx5dB`H`4-NN{2J^*dN+IzB7Wm0_aO#opjLaq1Zl1IbmE z4pP<`%e>GasI!Bwv!p^^>X_Tf^5wiC2hDcuLJ)d)l7T)$9a3u?Ym+N|N@V!s)PA=gr3rkd&d0L)USA5N$1wxnZ@|$j9_#scUe4mYcxDDx!tanJ|-IMqPj#(4t4Y+gJ z5+e<*73md+pQ5QyOWtv5laJ~`N<;qWDt1@0Ykvqf23b3N1K`n1ug(skelaGU!sf7` zx_R4#^s<+0wCZrov3Bat+G_^15S&)B4;rVOB{s@8{g2rRp|NL9HpeJr42iYvF#w+V)jz6D z{XlXq@}kvrM$yjt_tsvIKvx4bj3L~K=9o~{Db#pBqD3vzN^x2yM9Vi=A)2SYT^rUd zm`}b{Z2QLGf$i<0&E~0A)G*%a==Fw*mep)Ty{?1Tpvz6&75*azbpR}@w=UK$i+TGE zD)dg#kCeST`C6Tx*_w0SDME{G-{rjN2?#Bie!@G*VENGc2e$ql5)k3X3F?5_#-(s9 z_^?2Rl5b-GwwLqDi#u^^y3n^udGfH{`Ipn zXBZTv+LLiIV7PgCT7QC?z;*_r%VXijF>i%8Gd%rh(F5im;$wAtQJmce9mg3qJhDtG zbz{O&|Ayarf)#0Ho8>^Gt4lBii7h0B+gb_d*)5e$LGEgkBcsG;JAgqIcjzwns-3pY_bmD zKMp!$ee^wSo)p$U=#B~BR%Q>(U>nE(UyjZ+Aj!0C!<9`=)1;Lpjcc1)W6Jn8?h2Ka z`Bu_osku?w3?(Wd?krYTZmE@(l>#|hmI}Cp8v>Q06>e#OqJo0rE+GPfq95<~mp|}_ z=YFp1KF{O$6@vPJlfBXBo(A=ih6BGY!ye9c-=VC~kwZz7q!?`wHB68_tE2nPw3zBw z3XDXWQl6%d@!b&rWsD4FHNg&aVMyJOZb+`_$qcsLv$eBS;y8PXLH4C@X=V- z+OtG0q<;w59?*~ihOhCCGH`7Zh4X{WCc{T!;l43;Q-?dEmunB^u8{7Q1rm==^eJMi z-9}?Q)Q%G`6+??db1&x9?6%q(V9aOS&F(IF-GuYiL2dc+F^7lY3q|iwS?b$Q;_pxh z!=4d7-2rvs<80J$NH?Z>-mq->+kN1+2iSK#fF!M~5@=efveIJ+ervr0fI-*Q?3GNh z1MCGn&Iyc0;P?Ga;%4a|*Jjr9C1a3sBTz`vgO4Vyx1r{oCzj&7OkIBL!a1XZ_j3RU zvui5<9MONe?qd~w<)aE8a4KJv=MEkJwwtIBu`ZeE07?8aSX4zjuk9;rg4hpS?!SCL z>gcbmtK=hRT95Wu1Bo;n%>V$sGETZr?{fS z9A2!v=OVV%FT$@!MMi)%x(evnK7SZ3F^Q^b3}E{YT@$Z|V}ejy{R_#LP-MSlh^Bd; zu^AqQ{F?2e_Ye}IyFZQ&CqV4pm$@K~VDGfuye{X0(z2((uJD|6g5!nN*nJwwqPu?E z?6b1vpK({pP7Mz(j^9i7++Lu0@63tp4zAu^QSWKJ)FB=@5(=vM$#trr;pgNk;yfW{pgz;(me`PTD`h&Sr5uZ7# zS-A!~w-tPKE?a#_xww!#PFwnIn0Rui{$A%)Ko=+Rw#rCFCd~&p5xL;2lypc{SSX{H zHDwYHow^*J8>%Xwua{w2zu``)MD7WyC`zZ|obv#G(uVftQo;BQ0>QES1oph8?sdjd zYT_wOnV9rEGt(G|=U`lydW?<0Q`>Z?@B`)>xWg3nSUapyfYn636~br)R$`vK4+U** zJAdxgv+me+^6~Yoz^Ii8)W=g~^_9Nbph}kaM4=q^e4hD0qmq}SGt%`S)ii{Ubnj{A#4zUp^4LK5LKs6r-tIly&=R3qKjOw$Zz#)C^$ zDs(FCJ(sGd{@q5qU>_3=E0gOdWgrzZL9un?^R-um?B^}F^UR5NAvlp8=InZpfe`6a>gKfpyj1caOGk7I4v&SmzLdr2DK2FDQzC_|M;P?yxk6?;D z2n9uE29~eCUh&rk*(1rcbL!uU)?Mj!I9)6j@(Q}#`V_zVl_KH;C%VAnH>)+p*jwxh zJ7C~2YdZAukONsd9p*s-@@xh$Et02#e_eZVLb_7|*HnLKMy_M^y|WrX6jjAjET>`2 zCP-|fu*xYBGfw;8u+StQw@#Jdj$y&mJ8w|)t zdP=jnAy?otSaQVxXevttJz%rko}{H@mIZz-^PJVPQ=EcQHq*MGx-NJEck+d;G$$C^ zIh)rVhY$Wh-QY6znv8xno*hh3pXmTlhTOmlGlzpJ!uXN?!=h5QeGD?%oOMa-|F!s~ z$fu(nFwr&D*Ro~&ajw(aT)iqf`Nzq!rOjh{mGOebk5rL|YJm4V)oFUzaFYhuQKXm- z37K>L;%q>bn*7Oamj-cO)_adzSyo$hB@*}EOpgrCE{w~Iv~2yWa_L7LJ#JHL7sagJ zY2e0GWmJ*oKqyWvTuJ~=!=2wKpyVjdSH@EA@y;T{gT_wEcb0v%6J;;Qpo5C^zOWwK zM8&HBb4B*07#5kNW25d#xPbL9A10+bZJZ$ePbOW5eCIXsdih`f7`_64Sakwa`R3uM z4&?iIsN+T3UNFdf0VhrVN^=cJ54dUq)H;3CnI<2?S$)+3i+PU zLVyFAIA(jz+qf-mVC1kgJd+l*lbuTgT=Ta4N-+*7^3m1h_TY&h$A|t`bsOePJs48o zQ^&np`iMzpjxI3Nk+|`H8@YpNJ(%8*xi*^I7Aa6u#%N2q^W!U#L#q#ijsDc8&Tz6O z$qJ)}OhKf5oBVGYgFeEo6yyU(R?8TzBu|PPz_8_84lH$@g=I zSUu?Xbwd^IBX4+S_@2PvR33QmYEXvF4SRt^Fm3dJV(|GYDor%pKq^Buj^413`3$<< z`H`_pfBTGdb<}cobWJWc&`-ZDl3K%Oj-1+g)we(HgWKDnl-AL1SLE)d-H3flcO1rm zM1|NXpi*>@+|a>8;1pEMxIPRJTWume_s!#wcLE^EM<-C3rX>d+vA(4TlYN5)4}S=1 zZp9>Mxa`cM%Ehk;_)EK}=#2kg5yKgdc3L>CU&iPBQ_@)wm|1w*Fm`QC$hcVph#SW+ z$NbzU`09lHv+24XYl$Vg3Yq^NI6LbQ<9r0COgERDHr$7ld$*piFcAG-KTW!XF#OrM zL-{Yi=LWcP^c^>Rzj{03!mqJ)VZSccwri~ci-XyidDpN*O3W-bgDZ6m2 zq{-Qk7348Bs%s_P*FIeSG>|BIIFAy5_tRZ1PxP)jn{SjSvmH~Tf&^|;s; z071zl@=q&+L4ic#SisFWLR;qzFeljx@BGABU8=gTBMHJAqp?l4o`pfdvzS<9{2pkP z>Z+E&DoxaLNc!h7;dMiQQZAaI`c-K$WO>aqRW|aI!k##rFW7vuy13m?=5c_arOr|X zo+gRlSyv&zT2PIaI(aWnZ3Bri^T&cQ=gnA8^CFE5@e8&Aj^`m#o9PSD^}2EGj&WYf za#2s7(f2n&;`OcpUN}BY@!~Ba)gwTH|L;xNF(}QkFG$+)IQDm@Xt1%>#qubia#UwbZKM|$P?8q(Bo78$EoZ+Q zz|f+zG|=*|tT*V4<@9bIp0k7;gIH3K@iY9Lh1&TPo;0Yeoon%a;x18XL2*r4na5SN z1OMqQdj9_I)>X3M1<#v0_lXSFZHbR1*;y2|ZEQW6b#J#gZ9Jna>3je4z=#siTu#$K z;q1Tda+=v>#5~?qHX6TckJg)i{h5(v%u6K z)U1zUra2CB*jXESDLVV7ydv=?RH=6FRQZ{SdhH&(OzGyEfU$DvsPEFpPrsp8kIYoc zkIg=!lAn%SA^+z9Z`{DmE_U&0yj53wV3TA2jI(_LfX3Bu_l*3ftkXGl9C5aCm-ig^ zjrMac=tt<`AhD?7LM1C83Y<-C)UtU)_;jUyP-^cP{kpZga6|~fhdS7J4cUHE3!d^Q zZi0W&R1k-jR{2X=a-0AjwIDUFAupSth_-_5PJxl>e$%j zuCD^PdQxyqX|i^gM(7MkxGKIgJKv04xT~m7L1?O~1*lfvEs4b2Iz`Qf0r0o=Cf;_5=sP zr}q(7?Z4A19C1DxHqg0RS@~z(rp3u^$_DNm*ky-{Wg6;0-+l!Nkm!aCbS@*=D^HP{ zA+yUDrLXDmo`Il$DhxH9H`qRA_~IP+-}1c*L{}+BZrZV4D6$9W_FLZ4Q(X1-eEKfv za>!X9sx2a9;ZNAvoAA!sbj6IPRtIsEBT|V&%yYeeq1?0|T09sZba~!>e>0ZfR$ACt zJ+c?rO^&z25?wLgV)>rxfIZK2xVNu~Ls!VS(}s1VHS-=;{^5j>wL|w`t&I&fYx~H! zY9}E-dUX1*K(g2JsJGb({71g-PND^@J#MxWP<|r+^u9Y9r!RZU&oPg4CT<$0-j3Uw z=m*DFt~LDkdlRk+p5IN?LqV$MxBY`^96s#v=TS^}{PqLE-!b_HRZhss;e#PXq3eP^ zgIhPVFGcytj>(Mm-`iZVnBY5Yn#(D`QumIR*)cStp7OsuqNptST^-As=PzvqE$wJw zzLH7Tw9GY~ED!wt52@Mh=c+T-in(l?2^z3g`)a?BP*A0>Zg?jfm9QXd8y{7h7MX@7 zSCnDA6#4Dk`@0iyDSI6N-+|h$Lf7-ALks(2&$dF!-3yhr8MXX{zh))xIiSq65v!H2 zIeE&0xdmqcIF1I%ph?eduhyFPC}`UUtfz zapepQo+7(e*m+V;8eaXETGqgww_SNKZv#ah=1qgA=9V%|2~jxX0j!no;eB&LxcEuJ zb@g#$yK}=vlJY;0(YMqt`MS@qAt$DJF&2paK;n-t#+9kB0KrWKXzEkI4CJ$<(_0~EqWJQl4a&ro&`Rc@%B*+3 zdHDhCt*U6=RW}&$2y{WZN}EVz5waVKE_eT++l%^D>$QuUdpN2NL82W-(%PDrqG(pd zNU(#;RG>j~gvz1^ZA6Pa`>I(DC&5sR_b#oyL-S9$A=1Mfa#1UPdBggq*^J#kUgW2B zA6)qG4d6icX1y@K7+?oh-p18|>X#nu&^JGCWERd(+_fW}K0n;`Jno;PhdFxQ4i{^u zy$x&58K%Or43q69_?IgXf|L*X_#@LJGXcjaSPM3*VvMF_D zZeDSjjT%-(xBelJ7TxwEq$h1W6u0X0uuQEHMKRTm|FG-ho2O!OI`TR4a` za#t`mh4pvH*1qA{|tQOv!kw@7$xxv?|p+oWF z(tKu612HDLe3v%TJK*s2ddz5j`gsA%&VIrtl$JV2C4_FXw46TsV6$(CixKKPPQkhx z@L=u?55~KSXn%KVtE&E*w(@HYv};C}rddUdc1jaP$yu}_cR(p)*f4Xa&!pcbcJq)ANW z6WB%Q>Npg)(on*@{5Wd4>kadUXhgR-b0&^^1?^unavjjymwqo~F8$@>#iscVs&40S z#@yXfT|*8Xv&^C!_Zz211mbn2*t_Pu37D+Z=s~9LxHc3W=CU|xvx)XYYKWFZaaj9b zJeD~$8gLxc`gGEB_w8yb{cZH&(u$n2eLHU@82&ds?I>m@agO%z0sKo_T!g*xhh0!7 zH5?=m{n=d~Nc*x4<+6~;E_Rw1{Rc)W%rwlEIB`XthC&U}NUpnlGmyP79PmPKkbIT? zva>?@4$=?sZmgyFa;!jrh9dUdX4Wk@iW`vFJbb$Od{Xs~wCuGXma8pHwJ!cQXbE*` zT>ni^5#NH!Zor+!@SZebei7JDi&Q9vDoC{A=saPaxV4_oG4RJ;r^p{_uWk zAtmXD)p+YEVviJbG5CQ?jylf2GJoMeuuvkI+VvFm%<~Dc&di5u40m-Ql4}`<;}R+? z(M6mLtmU4cce-EIscM#tIYh)Ki!z+!+h?y>o5K$>r=OMTB~~)`QR4i+-tG=RWD$KG zG;#-zKAwO%JYQ6e&88UZWN!tApn;3El0>Xxk=QWWDcM}l9l!;QX z`k2Ml@L_q_kmp*b_*H%Pe9pZwzr$0vkd2iY(eSf|OWSmOWoFb@JG9$?%;q2H9Zk`Q zAxRU*8KnJJdRc8f8#(B89xA;YwY;M&(fmqUFnzH&@F-J7oi1?{gyb(AHuxjJF2k`d zymh}#^&`Rf1}yU3UYhckdRLDIUE86w1R=ySrhkpQPs;B!%6b=M40Ml>f6@-}sf2zES;X z!PxQ}0zuLvP!Wb=O4wZk1BZMPG=7R^377PeloG|UoUiZXe)BVZO;`#cvpVH6(2}&` zk*40K&V!i6WgYsM4@QpV=LJzSZTk~7L3LHGt@Pzhrg=Cw*?YiB0-@-nY6~`Hw!f#d z&Ewsh#IqC+itnc~lfKOo8uvYq8*+iX`T3yQW_G3Rd1wA`7nrJO!J~UeX`bIV$}CTTUhZuh*|@EpYxs!5U$XhU`6Pz74@XMwo| zWBe&Iht-VwhQ6N+W0?eZ|Kg;Z-N}a0)z@{Mp3Py=u<8abk35sceV*%b%lwd~t}W=& z*L^?CiA7JDeIJ)a(Ol=;-;HMer@s21Lgt)T^>{i0&0U?NT~}C%`gB4D`9?#mmaEn& z>LBA6np>MaQdChnc2NQs_rxHnGiU-~&VG6h{mhdrI4LiC?e~Bs#xMVW1);f2IX`Dk z4OF0E2gW;Lt`mcS=)K(Ock`twg%lhfCSJKdHPyaeqzVfy5(R<}garY9k( zOqQd0l*Y)>WYPlP(A3*tIF^MO?mv_XiKGU2vn^ zoLK$5d@C*Hni45*KKM*|0c<%Ol~M2unEd19eapl}<~5|>*JnWI)>ZJum(8Nm}xw>}twRx`N#m+&sQ%`~s08I`2+OuBrnX zP)TA*+BwI(GTdrKt=#{?tKr>04=O|1Fh#vTK{nFx8E&OSjDD1~ai2OT;7rHg^$n|8qhA98@frvU zz>Y12=I?40e>`MZ!>wNn4Iw|3irh6sZg4hC_c_81 z!1=^zDO?TimkBKHGLem2-sMUrSQubTQ()>lg=q3@xrK zrdwIIbtXIM6$yXTU7Rq9u%!?!Xln`bio=03-^Mi>AdWf!F|A(h_%eo{wJ z-eT_4i)C2g?*SWPBlGCqk=X?xa3?@lhku%PWNdcnSB`oVCf_Hi85qLrx$dMmI=q;X z`@`ojx{T&y?#A$OsYYJBr1nKOm67#`{YVfC=gjQj5 z(^18hV3Ml#s`N7pII+MkYjO=Z5dwlII-Oqo&k68+!}6zsAlaqP%Jn!mNdm*8^<<^Y zP}JfVt*P9Tz%UWNW`hbNYxn67aotq5k_sT9)$D4YrQ_^ga%6iQ=-so$&k9b;P}JD5 zF_^Txz~5IgW}7Ha;@hA_>E>iW@&-C%`Lsxcn4`{q?KH8BQ(qfg4VpRoWDDpZARPRX z5}n6!ya*ez4IkESby){PzW}G84NmipO`H@Ctyb+fk7lr;wm|B*w@@IfV1lS|-(S-y zgdo`l-=?|vHGa-gljW$bVT1!|-P%Tq_H)2;1P--Mwu@HhDjTbRX+5qVgc>O8d!9P+ zS^E+DY2Z7A=jPzw-j>;TVkJq<+YvY%YrVK(kgLwx(&1d@2(>88GZxX^M#*cxI3;9E zK2R6=aOSG6@5=Cp<{8Clhi=bvY}vw^-*`73E| z+T$ZX$KkLcUU_7gON??Rl)BFO;fNB^EjB*a34ha7nj+@VoO-aZ$_q^R z&eGz!P}JOB?7x*j_TwUP#mLWNtC@HF`79_8+y-fv9}aRn^EPV z(tl5Qs(bvQ(zI1;=&abu2yVAk1lp>&{BcjcwNo4T+Eg04uO^KH8nUD z(^KVezQ+97$=vO(X0L>A5*rfo&3y}nw}-AY{o$YIiz8j?_q@U`wiCotEg~?CvMn7 z>vu}m{X4uY`W6EF9qH#N3__>tL!r;E4}VZky@{b?Sk_!ofcJ*r#8;61m%?~$n?h&7 z+LD|l)cXKvkDX+%htCyzOo<^2lst-h_Ku4&_j^Xz#CNmR*gcY7oko!Vw(zBL56oNS zll8auR&wv$9XAw^pj8FY4(~D9?U9aV}6&NNg zJjgag#nr$c)SH#RVr&&-KrDg7E8maH5Ub~L81&{oVNr*o=6vo4rc2Q< zqh~thB3M?{!c(+bP+WAUO_zlsBetY~^fIGGQNAmCx3k5SbO4w!zqQkflY@(oBIBC4 z$2@E?(6w%j@kcy_(+t$F5S z(aS9FkcC%}GSz0rWDP*_%7d$z2fU2l?kudB^~JGmZ>3F>KoZ53CTw)kH3qyofP%sv@9Ub-sEarVs! zMlUax@49FTpFYkv6}fHCQ!BkJTMrVtj`Acz?XXbm5{#Xv8g`j|lh#&YmU0c5)k(5v zOxJ^}{OQ-MzXo4?sY3^-4$Vm1A%hFL+onUVmw>WACB$6U-Vo%@0Ec%!d9G~6KK7hy z;v@gHR!KZ5odTW_2=O9)7m+4CZ>t5FUiOZ2{GN?It(GQpFZflg7tk z#tXwgFr4(&YA~*2V(_=Wj_k8{yiSM{yyq4Qsh9-DQPYBuDbvCL;xx=aH>d*;E93fu z&+?w77UcwQ;fjBnNjz3oqA5+8OdlUe zz785v*l5XDuX|d$3t!ezHKFyH%MyOm>Ub~qAN3XaP_oXX5)azj72K{NQT{Yk1EG!f zy|h4b6^d2Dy1X_u`y5hUf~r&fql(9((BOYi#9drju)hKHn3-Wm~OJVe#eV-Lf zeb2fjHw;_zYF%ey9e_+_mLZJH^mI!LAFns@9~6z$(`UhV&pQh@FXF<^_3hekF4gSG z6}5UT=7&Q|Z473ptS|Z*ba{wvcW2p(x_q^i-cAy}`0TtsgyyY4R-HSprTMn5pTZn> z(rr`*Z6BU-C=&)nAJm~!koPLKAjGk223aK`e0RBS3zfFSGcfzlf34QJu5?bWZ98$C z|0lM|sW|(c9^Bs7O}%c;BDRTd&^;|L?Cir7zF+k(xaHbJd&ghsZNqQ9=H)hWR5%I+ zb2h$*fGYmN`4d04G#N9qtAHUxX2aK-wkI4J3lL%=WZSj&_MpMC@ZLITYhVcHo?Q%% zm2cU+c=LS$M<4RmsT7IiEcCfp#&|5mi-o{~N!iq?sTIvt{i$?AXMoo=p`y=a!j$7}5aX@vmEq%YBmD{e&i_vZl-(%h!f}tMTP~D@%`5-9aU1 z?@guU0@s5&^KX?jzsK(#5r$b|Mt0O18$vl7I@$vW?^5tgnmH{)K{i>VlF~t`9Ea6p~ySI%fOjTqI)Fl)WGTOiZ6D16d?zce{Rkk@~7n z@J}%DM_TY1%8?e}+KH{1>ZGY@ITV+~{_AYm%@vmt{y<5TY+=yx&DH_7cQAhG&_C5X z6CHaYOSeQ~+K~&)+JB>q{*<_9+EyEk8*tp#ZZndbHr6D!Oy2=n*bVA{-kPgga%aAM z>$$J6xjhUQwrbiK5&LMBKg1^uPg6Q6BYqy)ZHQGu(s6jbf$f$QG`DvuB^tbEFz)ee zP+EQe$DkdAHc0em!=3HjBMZOTu;UdQ@Se^CF-(~sCb7uAmF_Xdzf0BH*9;^iPfy6n zUZ}*m8>?N9>M@|(!>m}`r+h(vPGgz2u?`V9xCkEj#^m*A&Io?IQGMAY5LHTld+94b zQR!JbhDVC!wEQ_vAr{hnT{CJy!Yfe% z^wtrZqh-&RDxP5*OBvxlS&kXED}ALW1;deO*jLLh_8?R^$Di4CVrF);XD=HM!j zph>t|+Pt*>4E2d$5v|*$b4u>Fm9<{9q3%?yT zdAR^ZonO&Gz2wyJ+@muMS)p5U#xHrkA9%7Qn9~!7-wz<>sXC6z zMmq!4@q&dH1{qZUD7>jdMM*LV!=KU2{pFS;o5&Wf7&%Z%_lI2}f*Bcs9Tj?7Ws`^e z9%4DEo_yl4`tNK#fF=GU+L{?#;lIbiL-`SRfKm9the%&8H7;9z1AJU@2!u3-s0)E> zk)ilwLs3g#b;-(}m`ceNl|J;dJ&|)Xc$PbP7`z?f_~Z=cE;F(KF~@yksHW=3I1t6U z6{R2q*LfKbfcr{Pcinjwid%Xb>{th`w^swDD^)hZhMB zEaJ2?Bl2=ooI2iqXuqbbGO5X;*TGsrMZd{Hh`-!_B5wP+jdORmSMtl2WuJwu;|-`F z`9~M^Z_QKAluoGzy#arq&^EiQ@yDNQrO>lfNCMZ*HivS}8_~`A?^|M5F!p7iHGaK3 zU@csQu1?Uf(B18Y9wcUQ{Lo%)jyU$uF8{(+Dzk129NCa-0`ptt+={AH--@zt-)9hr zAHOXD=7END%9cSsFzIbmM1x~+SDUSKu1%%EDm7T=s&m7>y@xj(uqPy$q=y1iFXZr3 zRo(OSVJOwznv)c7q(XFWke(WrC#Eh^k(b-QVTJMr)kDF_4jZ*?UXnPz6 z;c#%vC0!-@B2cTOsYdzSxvOIS^vm57Y)$7eEX^0q{Jl$H7Yylt=dCvCPyF+LE#gEe zgT3uYuxuv)WHuKsLf^uTjMh$Qk?D1As#UlF1UXB1|132+{?@|p&Jhk9+_8!S)A-Ma z=p=}m6)ap=cBfTtmzPK_|`=8 z2khu}ca?b$<)7Iat?mMtX`y2NEqnc9%bsS}&|}wI5{%p)n17~iNB#sipU?W_Pb6$j z*Wqe(KcdGW#scuM&=*u|Lwh$h1_U*-&U}SzF{nzL*(P4+!P(dWBLZuj&6*@Xc6leS z!#NvU5ncNUu{r$L`s4f4nE>>(6#VPabMLcl-xFzbrRMojX=G$yiS-}=;Z8mU`bHZ@HTD}a#QUcFiPMi)86IP`4G(4jXIyE%MMn&87{Z|cW}bX7 z;6D>iA7`gs0cwWR43pns=v% z^o;^qL+1vGAL?DJ8|*V3hD9RF)a1;QF~O;t*j`EkCr-X^{0d{`m5X}L~8{H5aWRCR{JHGQ2-xLrbpFp?8cZ#(C{nWSQhyFNm{4k_J ziNO45J(fC=Q=lVB&^B=ng^=&b!r)WnPS$vmR|;{FMDkE$YoLXx=PHT2mM-!jaAsB+ ze>Of=oEFtP0H-ukXAU23XO&S;;{3tj()b@MJAzf~?Vishf2VuV!pY4)o~5~p3A!O@ zoNt2WX0^EA0eUri!O@A;r))e$zYSxW!xu3M!3dsVnXnD|ED0b7jfC#|D=$jnBVVqZ zH{Y;Ci$C4Ek=0MTtJ)&9jh#M{#z;pvL$3*&tjt6TU$o*@YB!3EM8Oa_WMl78$o=gtwpM z6*)7O)>~#~uPG0DI>iMApyDTgEk#9_?_F!-_*KS5BITEDpRGjW4p?$RwqV{O8xwGq z0HZFKEXW!E3GQ)tYDap*+@rdcTNbnib+Hh~tt->s%2|sHC*;Vu|HkjAuTw{!o;0;_ znUZ2p2!Gq2&wcT&%=;yUpvh4WyZnqNTSbGYQ@pY>55C+vmkipB-q3b+xd%s?qwH~y zZ*5$zYF4MsK|=;3QIv!UQ-E1e`vRQitu}|GGO#|z= zjk5p;T@XyQb)mJS6Sh1QNRwgijq8iY5ts==RTJ@AwOBWx&ry(yeK|CWe+!+*tv_W# zD|0RrVg>Z(Wx7e9-Ls@0DgN8Kja4}5TZO9en0GKHi7$>lqPnPxT4+qJYJukhkwz&E z3)>NjGeP>v+;+Qvnh${7;4pjL9l)UafpcKCeqyvddqoL4s!W!89v^fMlKzo2_Lr99 zZO^gQu}}WP!(B?JG4?5y`%O_R0hY2v5f@5_fBM9hI zXX4efLW?kqC7C!Eyr%wN-z}Gs@o&}FpFiJoY&E!h&Ox9zb!&cal>GGizr6qpu)_{1 zYUeP)j&_?(VyCYufD8xpP=Q_tfH(a&!ro#o>0c7n5Cvp6tBL z6m8?%D7ZSlgw+my4q5oC^Xp}%JVOsr#0oTP>sfU>)7r4&U+z^c9ucnU4k+l?_XQY# zKTXn1fT5ctC@r?n*v9iM$>{_c|8e?KktV8jKPVbTUJ>6EP6n0Vm)zt%=9UNZ*1M;0 zzdp)~{7$(*+K%k6#ceAgy@?tR{B@Ci*;iHuDTg`!9o$i>%}MjE&d84gJ&x=KOxD|s zdv}L8DQMP(W!)B8mb!N<_cv&seb$6enLL=BNKdYLr7C5L+2$rNU|k%?6CdQZ`Fg?r z+kBl9;#$2M&9Xj$3V^TOS0o}MZYiQWmktr&FtU6zw*mok&yBm%z1Y>#7Z%n`a!w3R z>SZ#(x3M*1R`-wfS{vVg4Y*%OeKugWKEyGsw2)FklOt{Z2Zl4i0Lj|Hp+qD$^&azn zH}PWtNNIwu7^jxC%uk*D^Nmz96I4!L0cS&$rZ%44<_B|IU(PTme)`k;wxBJ#6BW&R zIdQO2Y7uq%GuTtwjmsEeyI{Njk;{@|5JT+CW()Ez1$ec6ZE0@H<5d?S;6R*5n##3O zVemMxg?A)~Nq=gY+O`5PdO~xx+g`7FB`9eId?8_OiYEMY=Z#>$0d_UfP)<|#9kMRM zuFBF?xS{n)l>n4jbAmMJEaxkab!>J=ahGg`;XCsh%Bg0Zk0POhyY_<^CGNg3r0$_F zb&R+B$4K1-9SvW;oyV|TdrS4WY2}jPHga_anlNkre#oia)GxkRuVIlIw^UlzZ48Mw zY;(EEfqB7Zi1wAtg#pJ;Le7!0u&$S8b5=Nz4~QB`l8_-VK6UyCMb5!h^Ip!-n_QOC zA~&(T^1yD9`;1?maRYN(3!m2pY$?LSi;8PMo;q6?oSaQ}-ABHAu9-DHJFkfB%FA6M zwINwFP(CK0_Ab_AA=a2yAhWe`{Gxxgo#|NvZWvC@NcNZ>(B7jr&V$cmZ&urABvU)i zcTXeipk0|qUJ;{}<9EI2OO$8Brq60;ZsjJsjYH}K*E!!HE?f#WBYCYN;q1J(Mycwz zcI0q&*~R6#Ia0#GslMHe>GE6o#gHX%?Db@T)*wMb|0DP2rOg$7h#4 ze+F!3;U-MsGwc%CQ&A8!TS6^e=|4=6)NVzHqvkbTI_W!V3UQ{6QBj~>_`qNLeIfs@ zdm``X;d%HxgjI&{wP@9z0u5Vsgg%i<%7$0N#VMacv$Kig|CJi?_AwzfGmt>@g9Z_f z-?Atsj*#*^hTG%$x#1RCeczm*Qc*OCBMVJ*Nz1UXZUYsz+gK#eOWfYQ+l>9Er**LC|*qeWyXTk!nips9Bg zpKM+uJ(O8Jk!n{s{lE!ZGdihr||Qa0-;XfPR_ zYko-Df=^n!9g}MKT`8bf->8U?U34b8(zBOW4iN-uQh`_eKfI*mubI~hp#6cL+q?nq z$Hy=|)rkwp=qZ>NW^5A#T0 zSY39on*QCCF3vFZ=0r@F?!VF(Gu*45Yd1H5GJn7G_|20vi80M}%B=%^y0fpg+Q;dq zT>&1Ufs&thCys7QN&4Y>^mezCEnU=>UDCfWP+So>1%Sw23LTw`E&hygV>Jv-rH9w~ z0=%8=u+BT|uIAWU9gprv3D8jUX8pRskWOB-$2qLTlUA8a9US}-Fpeq(cf!K zFF|$2ju_Bv@yjgOoY+_2BrQIfLT?_MKPEkOm0$r?ccmsje3;t!#OV2vdFz6urvhoJ zE(@is*EbBUe(GH<%0}s^N~c0XO>daI;>JsL}!!zRTOkoMjR`!}taW*_uVn1H;} zC(7NB39@u%Tn9WkEw~8=8NGQ#O}yv>>V@TaxGrLJ=ECOxY$St0<%^E&(+ER01GM zq(jG}N58MKR$b4LaRJe_2BxM?}uKiGN77i4e+7?Rt=i;Ae3x^j{ z^@)qw-L?0^x?Qh#Vj-AT%`~h}+u9J{trI~Ls_CYS>87Zt6kN6A8|iPesH`=58qiC_ z+k{MVDywyvDbz1&Mc+~VmfEoP|4HX1F9s}HswULy${C9)e80RQ@sYqa1vuqO63SnE zPJ=dnKkm5AeJZp>m7~K#7=xJt)_agH%$w)-xL@ zglP*6M+1CW=h@!khSt^z?w0r5$vESq57Zg#1~+jPKo%%P83%9Ra(Y&m(_Tvty)OlJ zbiAt$WZkLXo$u1zq9UAHIMyFo?_WAoqMjX#fR2?J#<2vKAtr-)(@{_bXgBL0`3V@j#41RYT|y9lI!z>P_N*RD+iH*?skj6ShFi|Zvjo)0;UIM;)r=3E`!8H4 zX*AhZAJQ?AP2SyUqZ+bW?DwYx$ub^gG=_9kSxX)k%A_elf`@fC17_JRC!A)MRAp{v#NNJ1e z^h7>C^I?UAXd>M(x-uxgnjAT^X0?!)AYUO1 zO&!ft`I%*N#LmJ_c)<4q4*u>ns0y!JzEqwvq{rG5LLC@^cO7}n#6BV%QMtadv+fby z4w^KvM_lNbni3yyk(U^H>U)BzF4R^N!rgPo-{8nE=V-`m){EBxMVh(ppG>QKfx&l- z5|bw>pw*y#^D8>W>@|VA-jwIAfM#0W472E{5QDw&fS*$k=60(k1e8G)0b`K6pjuH~ zm-ht36pDLQG&NDc=w8=FMDYa2T#q>o0Mev?XqHn_D;CLT05Rn8H2uZRWXV_!qqZeN zkWz#kh_Lf?psd%@sWC8DS+amcm96EJ3 z$L9Z7dJn&(_xJz*lyy9vPEuJ?IcQtQlzN+6q4IRhV@Xp=R7xvK9N|{hX_}c@S!oW? zqh*PJ3%6n=TAE-Q;3fy)MntBdKR(~v?~iyrU)OkC_xlfl{W?v!)W5{s&!#4_CYHI` z4!uHAzXCz$dcpsgHLP!O`g$&L&ARa~IR>Z7mqsR5N?iU}yLpOE~<_;$R}~SlQ!q=5?#?^;a5x?S#^JeKp7T&0_5iq&^6ZHqgDo+1L~9ig{d1 zm$H|DK9wwO&$%&;DuoL(HX}awZR1cNh4-y zt8xyB+FXuiRxu+NU!>f|KML%5G3BMYK|TuaK;?-34Zw)gk2Q29e6pFFnL@1BAV7gM zEqBN%n7Pn+z-W0Uzj4~jF-Xfw{2V{&dZUe=7^nQ-@|eBN->CcEe3-Q7uA;;~323T}Sv`w~r1?Np8a(aAvN*Zibex73y)zsBOY zo3l`Y1axUkX@h6<4?&i7mKE>1IviUz4YPOAe;U6qOY25%&+X2opmPq{r}D_brK@Ka zCu{7x6S=pcJxF45P5B0L$ndi>5OSA>eh2B7DjB~zM{Syni4h!A{^u4~zrW%NG~BLN zt#GKfTpnUNu#ZXF;r2)>aV?}cO#v1z*|djCU+Hm&S7opKox-s3%R4qE%C4No{a|ul zE>34F|FDfobxr;zf6CpTTjA>zFPU{`@*;U=-e2H3i&{)unzOd%vp9YER)fS3bKNu{ zMj=d$-A?w>gD2f0lNzwqU0?_Nv|BRfXR*NLAH2-hUbQ(0$1T&%>P{H_g|zWi_gL8v z1}X{9$O|{T94tPi{$f78h8|7$QQ8l*HEjsaJ5!tjXYG z`)vdbQ_o1U|MD9>H5yTcYvOjdtqN2c1~X=`PnNkx*yJGPS;{c?UB&k+civ4P90bn! z$j%r*ajklRVZ&rsLo(?%s?9pTruj>#Tti}2M@7&^+kF`Dm!%;hK^MKuO{F0s5* zgAWQ+4n+Bd3rl(L6fFQ$F&HuJkLB7KNm*H)nX@}cn_6`|ZgT@jYs za-cf4sS80>GysX-uocmy4$9^%{5jnGuHqy3wxow&o*3m2HWvI_$hcvwU;*Z9Y@iDn z4F)*(ESgZ^kwKvxoAW~$Uk)JO3f%46u#O!fh%|1XGWSYR{fdHU}Ccp{6&e_i=$d``XJS zUSG;WOX%RHg#C20nN-mpZ#eoH~Yh~L1 zkpVG*dlzh5uRUe@nO58eztHPeoHDI$+M7n|Mt^gQHIA7M3c7VBtdSm_8*0INqNnkN zL;LE0MOE?lIx<5n`h;GmTSz|?v~(~=K|4{r>2lkv(yy^7n(}`~ZrwF1r0>f$E+@ko z5RM|?DHC7kbjbi;$2F<4@8tS)@OnRdZJI7C+G8n!N6ZZU8FoJ4U%K{5Et!ufZxLYH3c30$6$?tAJf{d6fH^Vsi~o+1`h7)<6{^Ju(Zl z(gj5qNB=w&(ri|F+vpVD+39+Lo#Yp%F3s99`%-O(yQPu6(T1?Y9HMKSOV0AEhekI6 zPaOuXQcv9CS2?YAXj)0E$9BB3_DYSk-ic^Fzv-;yzRg=G2bwO$zTMpSs36=OdhO1) z$6L{;{Rhnq%*I5(NKjC~Zl7`X?^!9me56immj-wEEhcOS{eh%yEysaK#;t!-|B>g|A@^^t>*rCHW!O+2_pQknDUX8z*YgO&M!T-wa zqTg4|$hioCg)a=5eH58ee4$QwmTGz*6KG!fmv(f{sg6*|+7Q*3z7Z5!#kz^GVRa`4 znpCTU|I&PVVh&Zra~@)rf$FhjJo0yANT)mMzeHdYtH=ZDUsffWjP@A~hJ3tBBviCz zWG18h)T2etNuT$-KvY%|IX`m?ESpd_xpAYH-)?e>zfu3(rp1!)W7X(nsNK=wxI9kU zYwMppyGA}u9d{E1c3q^{BGm6DucOpD{tK!h-g-P)5XcKCT+g8Y z8%tLY=L-q{V>KTz?q2e0x_+7MZ$ZC)ts%$8UeWI2heS>y1+aLi zXRnieeOsryJpP39E~FeeVnys{Fq;A}nwMf@p5owgYELLlPD%H3olF#wW=tG-qptv1 z4l*Zhl2i4Tthv}@gxYY8$Um%Ak zeC*At(v}!=crCU)Zf{XH181COYNysSbOkA>5QrPUzYA=|RAXJZib~5@m^Wuezb7J^X||yo}B0-u!+)?sm%LEy{k@x_!h>+L zV&W1nAlCog9;3Oy_ZQR)+<4plxmHUfE`>Ua+vr?oe~l?TyrHAhl_tGZaDCbnJRo8S zFNFm+1NwZ|n%!Xys3(&zM+Q2k&z_SHB5i4ZH_rCBp6`x^cv(sk9Kb@N;&?f7# zKkA+*EON!m_l=IiwUd3uWpY_K)t=mX^^aC91M2I?WvS0owxTB&5@Fc6lG`cL(!YDZ zQ1Dj;@sb4EuTlRJgQ&G@BvXIo<&e&@3vR54k5Zl2eGQv79`zU&kiH!vV8-okS6A&dE3Mn_kdu1HpA{+#=nY)^QMs1E7JSJ{DkmS800fsYN~t%zcuU0R9J1n z%IRsLaLGD4FLwDWz@oE{Lrsq#qfZ6t+ARJru{Wf51TCJ-0$jE~bl;$o+f`}s2me}}Yyk%ZwnLFK-#$)Bv)x)QA+!tie(JLT zKz-N_^_H|SOy|}D+h4eQ5%|!$nFaSd6ThCx$|!Jr06^oL7X!OGR!Ivsj1kthL$l*r z$utmW!U5($>$u>>$x4_>!9h<6veEdnz{4I-)&+;s8ZRhCCu$9I7LM;IGFHliQjeO@ zFKbk$)8LF&HE*H9j==_lW==&HAwUz`#fdG)K~DgS#<(B#hAx}Z!As(jsF9 zE2}{IC>DMRaj~k&2Buk<2ByO57^5RCK-%IUHieR=-AM}ROX_)Jja=QY*oActVTf4# z@W$FWVLisW^hoOZpZ|<@I&`HV_pj+rC`dwA(!f5J&<1GejkIpxfvZL-IzQteVND`6xA-QYu~Q=3O~#y6Hub5hw|q` z8i9$A!+-|8J|$@oI7waB46Eml8cO3%$P;cXZEZr=*D?3+4{-~2;KVLdXPvY*_M(0y zl0LQkJNZtn)36E#$pVYl5@{Xe5zUtAb&Dh|vz+N#fzNQkwTlG?Qm-b2fCzKtZVVgJgs4ZQPblD129wP*!fl1cls8aa!RgCk@s|k`E>XY;`b|aCN2b zf+a?LjCQhTEiS==uVBvrRJ!#WT2`DZQMal}&6=H|ZfVu~8d34ymXMVylF_7WzRAm{ zAQ(Bf1`yc@EPZt!qs$DMD9(4Cc!EkLD^4<<4F;m5FHsHuf}QiICcbv8ht{TbalL>g z&qd=h;STt+D$rxJIHiqu4}figbm*CTH67o5#oyjwd|HZvh<5}az{|)ZV|~M$j(js@ zppiddOy4fy1!_A0{36^eW%4^8h?v#i{M`JU=2xAneo5x!`(K#+?m0TVtz}=_qxyh> zhB#asyktnmYe}}83%qEoZyIPxqKOaWc)QuGecVj{_|kKcit*MVEvt=z-H5TNBX{}Z z6}Z0p3q6|&r=&J_4yHk>$LO!_M+^4Mm*M2exyP_;c+(vp29tc>1Mae6_999J?#F6? z-A1e|pUiO+%&4Q;3c#M7sPkqU*SCMHxy;&=ZDn3NnX!k=y(q{syR*wNv*M9eKIe5> z%E|DP4T=*2v*p6b9;dE_li*G1AvQuj#J-9amg{a!mTtBU=)2uvU~gXr_BWLNOb^dd zAAsurnE|-W#HpbGXJ%4lso5gS7|~dL^DHEVvex1+s1er#`Vr50pU@X+AEFk5U}iZR z0vnb%X>pkM7N!o~3r|pWasktO`pGCgU{RjFV%&c>rJk-6kMU7=3N48d59%b4~aL7`xPYednuMRN) z|KgG0scdGYsIg-a-|I4Ns@*gvP62HCgzCyxy$p3v;I(CBZ2X|nNJZe+1pZ^+Xb z)#Zcy(Pv#vvgz%)WXEZs(e*fZs(?LOx$aM;b*|}D)QhE;h&IshQzWlyAmW^mwn+#58ra?`X7s9)mn-j6#u$; zgXMpmzqP~Ri+u~IkYTefIzgU%CJWGag|h5>0KClIJE`k&Mkbl5D*lGeO)h{y)`-Zn zxy5=F^6Po?VsjAp(YP&QtRJomWqy*cr{iw_|8M*&a%YA8b@v~)#V72vLdnXqWM%aJ zF=Uj}gHW5c-|362NAD}gf%m!gL}=Z)sO0|(!^CyI!)sKS5{^&ZRx<$*rqE+eZy?Ke5e?ZhdLXfoM+?l#0W5ECH z%7>#@@!{fs$jm99#s#KK-L*gJ-!w-)2OguoFS-{$Z3Qk49n~fa;ou~&*W*S%a_-iu(Hmm{{lG($;q1v# zFZjTEfSc=tkLfZ61>redG>p_xr-9kTJieN4Pcz;9H-GD<`lk5vR24WQpnoxWJ4k=N zx_Q8@UETmT(E|-bOwsAV-|>2gT>d`Cs0|BzU2%UQa%M&~m2vLMG32mF0C{q} zq;2bb7cl6gA9@yBxAPrgwYvT=4CDivLQmdi?TP4aUnPmylZ>l?#Wd(z`R|(4qB-AQ zf)*Z&5&OU_VD=rmLOPp1F?4I7K?eM=>2vji;ZJ9>1$h1T;0o~$e#n<_X@Eg&2ZW`f zdsIW(dtj7%wm{DOqG(NYsTLP6xBeRfo@+qM`cEvwS6*>S3Bk;A^_4@+4jpudgBWht zYZj2N+aPCD^T@k(ise8tEA76?;ySlHuWqTUY;Y!iZu^glAH5ZsaYa(vjCv3h@=fXb zhq_YK*q`R2kw$57XmwFqw)m;I9F>YHY7*Zjdn_UE+|rF?TGV$ko$FJva|z;p)OG=* zF=LZd|KLN6q^0kKiA2bczbr8C-}xTqq}kz{emLZ+UKbP~ znyC-37rs_G1||?Ub0BZT?gQ$d?tgr$g6O8atCer%(|=U1_(p1F1)biZxfR307Gbqy zf6m?IJug*b&50&$!v)GW$PN97CEpE<$x=^;6?NC>L*``!C4&2!&dYjz*)pVZ$^2nM zr}TjR{VlKus2Bf*+rOmd`O2WV!~Qb_Xl#5Kjpc*|fht{C=T zKwy{NCQ`8qlXKAQMatJlZZ6{5CC{ZF0b?+zzxJ`yk#_4!UV@WD20{JWgHf_Cq~2uy z8ktu2jK&eZ6)G3{dbPlTELUN&RqaxMKfmphpSoN=7^&#L&$eiMmR2)zB8H|`yz5^B znGE)<-K0su-rN|EC44}jC@4fzUlMu{C#5FcZZvE53&jpI3RxT+_6oU@GkZLKY{2d( z#QTmw_RqrhYQ>55-2XLc7B`OtUx8-pkEVG$v(d_63zDemUS_qzp*590lc3Xwl31`;G>Lb6g{r2K!{< z{s8swFncS^^K9F_Kvc2#BFA43!aj~NQjG-dD=qWRuoh^gUfXsM#%WBpx?ti$-MK@++&@HOFwfXLVBMctp1|zu9_4q(dZOAmd{#CQ3 z|0fbLXL6g;Mr=-#Rn~TYCBFt)yVO1KwmTp0JbDa`IfSHUMTb?!UAeDCPnx6?msM}k z~Ku)LQqPoCVKc=&tzkFoYVJRLQ9(!X@M!M ze2F4(99jgI@6z9-^V$}6O2aHjaejrSI|Pb*lIzD;a$8_a9nj@5=<-0COGDJO*WNo# zz~Iq4Sz|4`MxM=a5nU;zkRO)n-&%2WqBSAu{@7uK9bz;E&|t z-;uu4QTYjnKp55`6oj$Uq>IyP2IaQMFNW3~L=+e-bl4DEckXBALlAN+lj}$u&1mTn z4;7V64-|4-^-?cZNQ2bVp49<6!eHIge!rbId7B~?COC0TtjPV?*6x(`D}k)(e~zec z2`U?ZOc=N|Ih%GFJf~p~CIMDy*hsCPL+*3hnI`Gmi(J)|d=&o?M|V?ivo*)>1LVj`~ zy&%Fartr;%4{Y9QtbDKbwy*;w!}aVDt`P>zE`WU)Nx)1&4!8t7@ebKJWgrNt6t&-t zYBk19Y}q4F2Sd#D<}u9b0l+k9Q3jy09A1tw{I@w+W)$fySS$UMl{L=jrKC>IXzPKP zKsWPK;4kuizg*b!A^EOlbMTz%-YoYD@!Hs2g6u1`ZJ|e!u=Ip)RRTT`CL3U4vY2Jr z$ij3$`BI-I7Dq5-sZ$R<1sAOxXqk2XobI_wzF|lWj>& z;zAUx+m`Jr4QSw?sLEHQvcO+faHg`Lp{3f`o8*t>Ux}{rp>(VwZg^2EJtUtS2dIg< zX(Um*^CRePNpiK_K})lQWyPT$!L~wig?x0AB&rjgtz_rT_I>kkS}PR>oS9HG=udTQ zL8>E`J`D>3i;J9y3h!{)ZXVZt{XnaOzuh7|;0r_BS0%=TkV_bFQ7m#r`aX>7j`!1NnWm66 zBNYvkAKt2)noHhkpLi8Tq7Mz4pqU$*pPnEbQK& zh-CT>A7EtMMXMMbwFQdrjz4caO874oOJcBs1(ov7u|q2hyE@3JaedKMeMR6EA(yZX zyn@?wi}drjz1VS{p|)?m+cgl$=HZlA#2#e4l-jn5e$sg%&vJimTujwd7A1hSZ*f`- z_}2EE&L;Dm&ce`(FZ8EaSH&$8%d%qcMMf)c{8aH){S-Sjlb>Z=AJ>vOe}TBmGT1^zT)7?GsGbl_AO5FTw@&nlJ>amMvndaimhX5c$RsG5R9aSk#>A!C zxfA~o7UhsQRi>@rz=NFObnWN<_xp6g^@rKs*%DE=gGqrST4n^BMz1`Gqa79K&Uiln zWc;ehr8*v1hw2ZG0VC=8e+ncNE7QTrmzsiuIAXR$nCMd_nxi z3h|dFX6Bw!MYT;oX}e48LvZNyoJp&ppC& z1+`T)|1x_=LK^Qy%G<3_roIN_G&td#?qg&#?awdT+Lg?S)WMRxTDI$mv1+U!R!H5I z9XRsiG7@3Elbm!JUv<{lesS!IZenr!>&G3{u{Dn0_i=NHRoD&LpTYhI68o=5V|Mpt zB1`rSPK&->6 zNMB6($Bz8Y0G#wm$2%~nH|flx=QBg3uX^qB(~6$(r$E6HvPI|;_H4r(26OGr=b^RJ zySHS+oG2Mp$vITJ&9R#S(^1Dm7e25~T4-6Dz8RYpkIbQ@6TrkY#R)dy$N!^yKy|Z% z<=Hgw^PyW4K3=OMSh46fxRZ$Q>LxvoAcahR*yR?}(tlF#5x1bdr4@zYMD>$N9B8Rs z(Y`=5aPskYf@R8BKG?gd%0lf8>pK8d`>Q!bspnX5pSC}%nr6b7?d-o{kU|L> zV+Zh6#^T_-t$S8Ft6y`p^0!IgeJw`}9lI?xi&%Y(+l?V(Te^vPwX4yX{ZaEG<2$?b zNx@7Eos$YR8wDX{ylg(d*kQ6?;?*)mADTw-PvJV;o2K>>6Kbx2Nf<)Q)QyihX1%vM z63=YxXfPRVHC)!GnI?{F6nk9=okeZ1&EJx(+nNJNv>ViDDxSu1D3K^q-I_2VXUL&1 z(j0#sE0o>~(*(W(&%Y6zbw#zjDMJm>%Z1?7>-c+^oDy)62!2ABdtWZ-&$Vi^B!0{+ zWjMg5VFW$Acx^6ssYS&9FB3lA7ZBxd^DU9FwEenrJg6<>vpLdL8lQ!jsUxgr)kkV* zYjt$TMt6uiCQCq&o{#}M>0!FuXO#VGIgQ04BsMffG7fIhd} z`wyc>n~G+eV0>E-grIS^)Njfyud2yT6DTj4#`DaGq!Ear{LPn4f90M8Rv^$pvZ2vI zeZ*r0Yq(-%!tvoCsvJ0?-nI{evPS#~x^ma-Kk7x=uw&`0?JKk5#-^%mg|11?@BJ}q z%ho7&&FuQ&z*cubP7RMC1Wt*`nKC+A+riX!q(KiTJrbN*{hSlR)uI`q#M<|OWcbEJ z&p^d_o7N6}hNxmV-s;zDVCAr7?nAbFJP?7;0oko4$c=-X3+wjIOkNE7=|T$mxb!DU zIGklRIV!1$60E(f4C@CyQsVjID|Jfe5%3BtH0&<9Ch#I6wDwk#Q`MqsZ=W#38&VF> z2!1P4{ClxOQC-)U?pDOgA7ET3DET|w{Mz@BCZkC|lHR|mjW|UH>q359_LnCEi)Qk) zW2?A<;@;`(9)WA|+Pl;nsFFzi1cgJWylK?CcdDf-E-=)lgVIp(A;lnjYAcBUb(q+` zp_l4*x!wtBG3zoC+lEUDhxJa3g`V-B$3O!!AV#>28xu1VwWuHh=NLB74?4W_Z>Qj7 z18r$OWp1h9KM2}4?ZVZJV-2(@$(br2^*A}qE>Bz%XFo;B9+c-6K&syqfs1N}oI~e2 z`f}`z{u$*!!tbwkY0FDXxT5Eg~OH>E%^k$9qAF_7FEnI zA{P~n(0p)9>0u4zsQb0kW2x><&X&2y547$^V#9`a`Ok9kcEH70 zt&xD6vNGE5(29w_$>66hTY4-unIv>IUZ0ML zCnh2^^cwsqIw(M=ZB^2sosFL~HR@{euH5;Tj#x4=8n%x%sVnXMkOCSaznkE-gg2?L!;OLnI;zh4Ij3{{v z-`DP|!~4ki(hG+2oq=!KsQufq60h#DY*Itcdd*IsrEkRO44C*KtT_ms@UXF}Vg9=% zT>1MC!V^Y)L(?ahTzOf7iyoi9uVePoN(NC=MARhTA3a&W^5;9&%dMNY@ZK?`8uQ)R z&uH?ffikq2~KkF&c_@%%Fj5^H!?Nv^kCt0N>~+Z=S*kx#{A^N zVZP0|sQ}^mX(!z^u*R@g<0I+(zO6ED^Yq>oiq~Q`An-l2#{WS!Wsq-!;K$mOMby=VS%TiPAM{KJaS-KXDm5g77h^0ru#OOJYE z5jg$Mo`})JEr4-TKyAz(eVg6BJp;!;4%m1cw%339A{D}@D<>LLju_uF?ojr3KllX! z{Xo*p&V1Q+fgGTj^+fqHWn42O>6d_+;B^{B7$`2PQkobjOV2c>`#xU?$`CZUjxY!N z_KPOFJ*#bR^`9b<$Dr-w zifi<-wS5S2`1Br_+NWomubq)I*YDDGr4bfF__eyqDj!ofi$J}XN8Kkx>nHpu z{Kr(fz+At=pI%QAnNZQ`mNU3AM$58G2bpAbRowp-I1%0`A4sE}R6Q8mP1q%1vFGXu zANybB0d0xJ^ut@ayaMzgAHb9fp^eyshR})na{k zfFy7ix52RxZmcC;n%zfcNe_K566bcxQsOL3>0zUFNoi%#ga!xo=QQHAPidR< zL8P8OXFcH5d2%bgfiXFy{8r$uaO!n#xe#!*Ge>En7BaJLB{LW$F(S;O#qM`8az@`F zhMx0nT)sDk4Gnl%l$XRwdyd_)}_PlO1IA;y3-SYzsoRI6l!>#rdZ{&g8y1 zGkA5Me2%9s3p-=o8xQ^XL1{b|>;VKfO&%JB8yy3e0dON1m$_?HU}&fl)go2Y*rU$r zXC62Rs#}mYp;J0;AYyUu?y3IY|O*6J0alkue?1AR?Y4=YR#c=;GGk{8YY)Ovz?(8*$tpeY~(>Oy($9Uw{XJ)53Pc+`Zl*(nE=JLo-*S zKRS{YbD?5dWUm{|?W))OH=xaRr}ps3XbT1Q-opELxUw?>Qgqk?g)#TX6-$I|s1&Sf zLwZeAd$jnvRtA?%OUJOawYl4qMEf}TF zcS3!dk|q5u)2)Nj2xJMnozAjsBJr5r%r743eyZWN*w9K|e3gnK;F24$OIQ6M`O%TQYznCSLb!67 zWZ<^G-?TTgG{{b0q{>YtPV82*D?_amFOulD5*_b&GJJR1kbVQE|T-mcDTi6OF_H{b|aN~)o z4b(RC^08Q@K2&5mpMnTwY;|BpT!c%ua2<%Oq;v+p?O*DiWnZbj$PA1D@786Sf+TLi zoF-iFT1AaLQ-Vb>uC$cY6fwxJ6i zj&8;bxI2dk|5>=u(GkPljV^HE zf{i+q5Xsqp1r%$2cSdH&i-Byr9}O`c>pT~hyCJeAGc{{JJ2NrS7lG7Y*_cu=>H%B3 zxod0UlJdQ0Z3k4XCkIGVZ5t+N5{rOrXragaZr0n5YV5ti$|1@xhUdfn(njo|phD%l z*lU1C^4a3&%(4*cz*rauI-$_?|=MUR=^r==e1j{l@N zg<4|Tkw#1Ou4nVl3Ze;rC9tiUHebjjQ~?H%u9HJfads<}E9@_^U5wIY^%qX--0-u2 z%egG}5Sp!De4G%|^~{ z&MsNh!Uuq=dEqwI-iY;QO!Q{{wkk;9n`ymxn=~{WH1V8a5cKI$NC*a-aflu=u{b4yeti&mLkdI1%1){A zg?y}Y#ez@wqZ4x1OZF`^gA5@QQ?m4bhP-uMyRI537a3f**S}=9Hts#V-OUR|aoB2E z0OgW_f}N~f#tXO({L5s}GRq1agg?SsZJh*f5LQMv!}PuX-N2WK)vWw%B*EDjYtviF zi4aIdH>tK~dQZe(^eSuFR}*cM^I@upCi)GzGpx4E$|#>7eX(isiTSso9mh1Y?#pUx zx=2r6>(2f`arQZc{lM4^MVlW46XsQly*mX6U@{!~suBmnFso9bU zx_1HVJs)gSwla6SP?ra^yca2p`cbrG`FI_#XV+PR>X?}U9xWR6Mh0->-fAv&ETn?G z_ZrO}m!E2D9B^xp1g3BeMn5^&Oj+IJH(;D6Uws};4WH|y;~vI33pF3Ws-vP<+#{iE zE03tNRR1oCf|eyN_S4OwAM132NStsI*RY^G$XltGD(J@sU#Ahu^UyZ>l`k>+U@K!l z+KTPQf12VFUt}B3XadD#9zVk_NcqaQTjv3)i>-~VDf(rAx_)VTX{#@`n}~{)=Eh0A zz;oA@relv=y3J}j-Z@^=221J{!;A4jO(uTk|VEyTJvpz{P?%VVn_B1@z?;HA60+?4o`Qa`3~sgCny zj$`eY&3xjOQRd*s zU8!oYkJC#iF`3t4?8B5#RcNT;r#Fv=ZRq_{y}rshT_X}6D1wZ4b1Ygm0?YS(Oo(p< zq|NlsOYT=XZ!UY9VH!17mNuK>X3uYWd?~vUsR`LJU4J~f$Bq^=s`*!tat3XLY^bhk z1{tYaj*vzdI@rUPz>%|wwNnB9JB%U4H)_M!QeL9=fu_I4uf>wM_XiU)&}KE7$o@-g ze?!xA>X^W{!BhVJ?^Y4Tip)w&yZp>tz_K02eXQxF0<)p~ zw8-((%C%RdV_miXqDJoGNt58bO{=%KTXz=@v88F*1jG`bK;oqP>i znFHZ#sRB1_P*_0rdg4_#8&Ti$(ea`ktw~{uzLLp@$s#mnU*85s-3+)E%5P&)7_s*BXPtA* zDm@W?3i_2K>)gI0Q7f=j8mae$R7KAg%KSsLmNs3$czdC-Hb94PCNqK}#cr_VLQUBgrZ0%@!(|>mE1BIwb4VoXe_}s~d_) zMBEi6dl0bMHRIbWIOl}MQ>&u>?ORG(nQ5o{sjKvds}4+zEx+EAFcn^M)$fp^dX8&- zgbX5JK?`ByZcnYRPpkcnc$>?b>vklNly9mzjZJ>L^`U(3aY3YD2eeT#QsvBB=N}n$ zXEsfO_x_Y*KEm1l*mOA$vbYZM!uqlG-(t%Vz=9wLf>_4fK;T*3MHl8GuA+u^;HO(3 zfd2!aIW_`)7>m5`sW1rIh)~W6mggW9WobAr4+zU?*;ZoLdUAv2+Xp0?+ED&^gE;W6 zeAE|hgVcT*FmrKA$as}ll{4T~8*Q;TIo|<-XrqUny^a+nh?t!Ht-&YrvRWwpZ6`b6 z48Q9LHe!A0uT<-zh#&OVrdEPN+rMXEc(qAI<9G3A*K0@{q5p>FgdB#ajG;~T$TCg@ z)jkVuM3wt7W^ar+-o|WD({Hl=OzQ*(OpTb$r~}*nZb-2fX}nu*AX7DqPX?T(4rTGX z*RcvJ1n#VlIMgP9*)i=-n=*+U^Cx_aeJ=;IZzln_?s^6^sBH4meUW+tq98cnP@QjN zVVpYUvx2$_A8oZiY@yd}yuNqxvhs94C?>PwSE2ipgQ@-1$Y#rrhylO2DW>m=b=R=l zNc!cz9{dY-QLnM;$@Rs~8bTuf zobrdxw}WhwEs?MY=}}^v>c>0c+N%E}4rNcg8@zVh_lWtiY##8$-rxS~&8fVy=_)zR zK0&%?-prX=%N3?aeGEDO(Ja5mu(_sdI&kq}zCkb0-#?1yeE5O+MC`fZb@esh9Xy;H zjKWr;3c$6MxMMl#j>bRr>biOpx`tb!Ud(gK@#!AJMji&gOHM8 zO!&W$Xs94BekrK4p*C-8T^gs)~ughPEo84sq8Ayev+AHo^5U)M}b!9injvQY2p6dgD5WL1cJ z0vnIq7QNv(TTREzuHC@HTL0>EBG>XQIl$+tlQBvqXNJ46`T7 z2f&ZZ78`qDo}4?~EAO=4hFqs%buVms?T#(5*X`=m&jirx!k1N#K_8RoXQ398)@ivg ziKyZ7N|%OB*KvNfUY_@=BGBj2j<_c(*AcF^GrW!YTGo#Yb0NUTlI0j_@a%2E7;|-i z9y=vr-)Pd?ay(I%f)@GwK~>EcN$VBYz6N)vL>EFLyo?m5TiJvZ)?ynIG*DQ@bBIMi|_n6s> zK(~;}_vn2URcmG*)(9;Co5S&bS;oxXJPtX2`4>qDALyT#I6z9){@j_Uct8*7-lM_4 zK1UuVrl_mD7yCq(MyzCn>*U*lv}AM%G;2<2hBd$BvN5e?>l47Jui>&MwhdrW)A82L zP}Up}P)Jz5gJ#Z;Rvht%ByrZ|Zjc*)PAHqd0faV;p0IBV-Ubbok5~BenV-_k>b!F= zmHkFz{lWTF7D+$TLfbzxz6z6Sc-bMCcGzwy78I^&Q?%lpcRjuspLC-+Tpu&uDVc9qAQlVba@Vs zmf6RTclH|0E) z0l1;pQaGAEpSIu&r(eKUYunG!7Gg!X*7x*B$H?HO0igB#^JdMj%ajkYoE3#-0K&M` z8{{*67krHYv~Idy@nOXXZdp&CfnK4r zstIGA#3iOyxw0%+>AuEzvp?TpsI&I-X^&kYW?yS}8$u>-O@@s8rnArRmzn?Z1r=!i zBzr|0eX9GjF|t-IzM}zW`1xh8A7B6NRdw>Ij@E`6?!(g0RKRs3=KYy>o7xuMr-a+( zSF5k|RC~81YJ0<%-3+ z$KTbr!B5_9r3{84$f*QK3@MG~enk3lg9iiFQsE6f7$faZrdji^V}nu}{a8~wVD=V` z)a;yr>d{N4c?0pi4SfsN7C*n^cOyfNeH*n0@4wYkakF9Roa@F5%-T3(d(m%=$M`!Q z8z)}iFFMhOs*Lu)RevcY;~oP)w&LL1jsjZRX>`B3g}vWm5qwT z$VoM`gQT%nE=<(e)Q>q`p1qD<>Re3@v7pEfz8;vZ_9o#Zez+`sZ~Ks;yJ!-tMdWGS zkG%feelK*%tUKP>mTzId+*23HKvA#?c11^8&D=nLNaeaA_DlpH#_x}ihRC$@GZWiK z`*ssJ+c;ZfE%nDa$g;<%qhvQLI&+wdnTY2=#_6aKt?H4ZWmJ1oX&dm)2s8GTrVw>x zsAhEEoMsQOrqt4Lk^Pab1d(GKu$z#1DmZ9mJ`t+TEc)D(wYg0F)$%zoSM|N)Z^WFV zM22_j`S3QmAoh~kQ?;DXMN%|f<&=zhI*_DtZF%H5U+H9F^UQ=A-_!D##>iN zvC#hf1ife(>6@S`A2B4ePcNOUR(2~oTwl5~zQG1RZp(Qq&)<4K>{ECQP^7=KXo62&Z0J@y~cY&kf4OaQ4jN&XBh0odb!hWy~Vrgi!mI>iz?#f=_0 zeQWlcru>ssO;x`pEem(c^hkuWrxZu4yASYjn{uSLFk zgpHw57^zZVE;KG&Przz;U>Si9V_Ia12lz@qwyP2}MJ-WE0bjj;6# zp}(C?!HrSeLEAyyAbtqtAR#R=iIv_Qh`fO=sNZ*+6vinKc15n50lllMx7ChkwvbZm>lz*`uzW~^yYm@p#A^$l$FzEX=R1w)^1&0r1$gKthmJCnG*%<+L8)Xm z#^R(NH;8B(bWa7sokLNiO@9D75;i#ub?)^qF%+G871XxPn>fRc9adb z-Hl&me6&VQ0aDl*pK~`Z*?*m%_V!gjvoALeRnJL6zt`P}uzOAQoVZ!H?rqbjVD%QM zy3_vc7iXBLgzrwjLNnalyboIxeAhS3EooPUWl^(YYiXe(h{GUAazsorVz^P zyQ}n?suXUpV&^D43XXh6#+2BN99pP>o>ya1iHTA1> z`}8d*4tZwUj-IJdi{RMyPIUx*Sg1tl9?qB4x!J@P3bSGGCfDh2GcU}hC&cGw76!i6 z5@`91ch&H9f;~7+c}hH-iue)Wkc<&*-}4Y| zlftt00QXTt_q~`()12oy>TtkdlwB#MK@>YZTz4%jK+=7gvQCr(Y3zM!Bn1q$9q|I; z((0AhXOlrj)U5F_M#@gX2KAp%Kk=@tiS0|i+cPaEFW=&?P77|$gktgku2`1Qp|mLb%-Nxh8Wa*S5aiyk z0r5%nqqIu}^ua}9XhQ_Pa+!dk3lnP;OKfEhHhn2g3TjI4Ue=uCXl*dn{3R1A zhMMiId)u(qW1xBH@;+Jr_7b!Hm%VzA1+ThQ{zXoMr@A2sc#Sxz?+F1V+pQ7%GT-PP zw==mvH@P^6j+xC?EDt@29n_DZDeNWx*%QOS?e?JIXuEiXnp2PspFJDxARb0PLA_Y^ zKcTn$;YTx#(KHZI{Wyx!pPQ1K8kiM&e>*G``P8`WVuVH8Ps0>thvX)y60{}9>d*R1el)mEtSio>^vGHPK)qU`lir*gS9+YYMUW^pLjrV0Mi=Dp-iw>@e~5%}8z^rCdNz5keunM-*nCB*;^529O0<-T$f>=39yby>;%RlDjCn}<`-G7zDe3QHk zuaABOCcaHzlx6OnXsU1u2@G4>cL`m)bfY<+vb#9qciz&=!?&{L4qZ}*4^aSb2k%lX zwuEVgmxAJlYVdvMB{`NAz4S$FBwJ#Xetm`YG3G_Fe`r@PJV=se9R?oXCu*m=GQuN; zc^+AU{q37n36rL;>WX$7Gmu`NE>`|U#ZX9qH;7Qg=EpgTU}IN?(F*A*=Usrnmrr|2 zPzY{7GrQeD+Vu0_1&=`4Ktbt&@ThV{g|IlK81gC!XE=XFwXa1bs@1<6w39GB|M_&2 zczxDb=W^X&Zn*ud>#{!$7rYyqS|_(lZ7&p}aQJo6r@?DS6YAgye2nJ5Oemszy7k=FH@jyN^ zIL2;IQH@klJ?!*#nf)|G$lh6}Dz4-0ct%JLSS|XY9#Mz~CspOao`}$LyI{NGNh8tu z>64g+33K6;da_{#W-Fat6*_mecp*pO8xJar3?k3Wcqg&$|MCiahJ4~9=~v5e-xBxC zYz(~yB=ac0LhOV)fvMKkT1|w0k+^sm9U>&s7YBVf4-pTF9e5G$j-ko^i{H~s@uU}~ z=57hVK-|Z(=*`8d=Pmok!F6*OG77vi3toj%8@Y)W%Rz|;GdG+_g zpjKpp`FP8-NY5wbwYbjeZz;yXfFB_(6D8(`jnW+Y;-7g)MDN%{=zI#^!~zLB)4z?s zO8VsE5kpSW@&G3#p&+9~zdq4Y(3F0*JT@BObBZ72wwh>*S+z8Ic9d;wc$1`HbppVl z)WOD=<_J>U_gka+KbR*rXxc~rOv}(jEsLXYm_*6H&Uqvp%^XgIv`_$dbz>)xE`exn z-l@^pR5zp~PW56Cxb%cZb8~_kSpZeaQtVl|@+0D5EI1&_>&Ji5cKEh}2CbofJ2}mR z?wiE;eW=`%WGJh9IBl?`2m=)>por73kYZABj?smZ$+G=J7XX^cejfLGxc4WYn_exr z`BCuvsh-&#H6b`H!{O&W1m$1{yCo>7?Z5GEPw#a3G<24L)*;DLz`2~I5y7l>-B8@cG?q8c1f{sf>b`A;TaWw3NzQM4wKIH(oqqc9P%QorxTRsx z;HOH9@&0V1;{Rzh6JC+B&nGd+k76I+16?jw-YeUfUmZ0K3{3S|Zp$L(+OI^XBXFMs zgxZRzHaLlI^#{&dQ!VW=UU0?Q~x~9(%ue)1lxs;$h{F)dwApgCqS+z!pJ&=a< zGlvLyjNgZmE?Fa#x2p7n09&HC_XS)g7=UN+GMi9}{psoio@c3H-;=0Nkb{YKTo@V> zp;R+@Tw2ap7@;_5s=8Tbu$ox+xb$=TJ4hAD`HaPrY7_-*oqicP)cfPgT1Do z;^2lw9{+A%>})7F(9-VIFslkc8%NB2VH6Ao-1lDc^9k(J7TUV}G|C2NxSB39PLGDG zpBmx9&sfAL+3uqO=R%@~1~pfTmb26o|7@a^@_CVuBcN?9+2iD&QG^g#^|y4Gg`!{V z^4zu}Id=Xf5hR>^5fM3&?*bnQQm>QE<#mWxGlGfY@dfQ|T4T!d81O`u)bY?N#Hj6f z-HOO(E}k%Qp7K^ow7O825Q*I>DUtuqs$CZGxSHN|P&-&}hEG@Z;u*V|2ar^1LknQE zuik87Ab5QQ+wg*61J$MUb*;PL7J0f5z2;lCb>P3*CKC~x9M=E5bU1qb2XAKEEP_%@g6^F&Vfnx7wE!E``aLnjg%!-D*qVd*}NX&H>V4V3BD(OcEeUt zI33BqnJ0dI?S5}ibPl_CJu2wbQ5to5Q1CFvUF~_IZEHqW)6lQLB5f_Fe(YqBHOrH) z9qV=uIb$69GK0vyXyB}fPBpB_W{s`K0K%kogX%lUf(HxbWGD_Ww2$$-I)TAT;KXaY ziOUNm^uZtL*UsJDT37#{$-5p2?c#}>wxQG9`-$d}=T*NA7&J0iN2OfM*x>Gn4UBuP zW8g4aW9*;?-OT(XkxTxS(7G-u5_1{l# z6ndlDWGb9Ig&8y(Uf0?PxlXz*34N6veG1ltVVNv=cm%Y9mwgeU(?!7z@~1?x z@Z88`z_21Owr{Ayju!37*g{-sw$C_at@-vlo^?g~$P_Q7duA3IG_syx5lZq>YO`sM zv9+t5&wt?h|b zYvrsmv!RR03X|}%lq)M9MUuoIN@`0rQ2X`MuZ$>Fy z*6j0yHlzmonkDBNWIng&`o6*cQz_W0hmWejC-ouSqd~B8JXpZg{o~iEA_FpP3x*HgzOOQ(4Y}hm5#fWw7xP z?2E{*wR*mXb_Ly9p@bnM`=?UYrSHXz80{xGU` z6p%A>ZxlKTY|P{NcaO1jdMEuA>C0)`QCNn8?hv0{XOh>=4e@HZ1mYN$WjZNN`;>~C zhZ6{BpM3C~YvqG6goO6QTF`n>^iam@b=+Qu5Ej(vPG=TT^bA7}n5m*Ss z$w?$XwM(Am*!kk&?)g{5(HGi*-V~gL0%@4AkVOdDZUXU^vTd7WRJ3 z%RYdjq_uj{B1o0+jsqTu2rj~NuJ#09aRmhC&hKG?hPO$zKa1$|)!XNT2@iCH9qPq@ zPCOpEV4{cY0Z^|@>68Ds!&rRWCI?{$J7}cqIH(DJ$$MZ4P6WJ)sYM4wisgu4eF^Dd zJk{+)|4W}Rp8h^^Tq^TJNq|gEXZh@6-v4O*D@tM3SIKYjd$+lK%%A)6ZDs$F?P>@9 z>xQIl_J@zy@&AGZ1zEhWp9I+0U$H_J&hEOI+3TH>Q88w2B4rplUl~cd|Hafq2O6<| zEV`)c0oVq9jgqCW(x^`k>@G~nokJEiJAmIB^;q=1Z4Ma9h`dU`0d8A&X|Aw0KK=?t z*asugn{HEJ!A)ryBg@^J0S!*}v*GzUp7r6!Aih(Uk zifv2O@|-A{-jQEu$*}D_;bVIVQ~}|_b}G$xEi;I80v<9 z$f8!x%P$z6;X_YGAfpXTiTn!;FHRaZ? zu<4cMNGU}u7i~~Ip8JQREStg+{cW(z^1}`@ZoeYX&eWCJ>c%BL0jp`rjfzHJQibF} zm)V@? zcYGI>7R=e)P)0jNdQIdg!x0yYUsazqu9x5Q9>Ki)Qs)Ft!p|`-p^3AazO}l9*4pW0 zf2B|PG0zyxg8h1J#Zy}<=AQbPrJS`?>bWI`-8Q0ssN@qDCKMrU&?@)0uB49h_Q#0$ z)!J{q0VUloKg7vXJIQv>D0pxVer1I7wTUQP{s$wm6%_0eG#5 z-n}zV(RsGuIsdZF+OEDiU4lxmV0G-YzH3Tosq!qGe@}}p*K~NB0Jf) z&K6UK0Va@tA5EUa_AuN=rvwKH+$XO6AN9vv4eP+lYs_LepXHArfG(u4IJ~A(SPTME zmF?31xtpeddBtb3)~dqy0^<9QbDVe>KnC6|w!F-=QCHcTI56u7)XgVPHYm8-iE3N> zkGu%ImLSb@U?b~c+Yaa-2V}6w;tWwk^hwHI_C$KHara(+FQYTR7#C+Vvu(MwH$2tG z8aIBt(U4)ZD6r|<=Xa*3jW_KUVKU91!AcHRykq*&8>XX{5SvucO<{=`0J(l5^L1F=h<*Yp&nYugfng_GV60R^ma{Xy?>ntIbIi#^0@Xu!hc}1Zjn=C9$O%O9A~nk245-B%Fx zj*yJnj@2L5ty!lfo_^DKCl`KPD*=XR$#%2jEmZG~tp;v)xZyLtYILf{aCz>dGjFNM zV2hmb(>i;q^r?TWJ9;wcv{GK|RQbDZ*MU_ywUC3p;bkF>(PvyTPbo#$XpKkQqW-BM z7)N+{_R7|>KTV)2Fq43ekv?x7s#WY`xvbW^=z-2BHX{R!*PPk<@S^AODQ{e%nQQgS z;Ja%No|HOMlDp^$+q|v?;&n%YhT5t_&B*pE_3hJ zkN!yqPn;NFv>IOR&dcuw4qnPzWJB7*qiT9d#+x&c;5yPeQA8R4A#~%XjaNHtt^vIS zNA39m6eNh)8#ji?IGf4XJs&d@)U&jEVCT*55^%rorx!81z^MkL>hGLfL{ZYF=O)%u z!ZTX#+U7M~mF{K|V5Ce;2HAO~ma5yQ)b~T*@m+t}rlGK_ho;@j@OvT?pIX8ZhrN)v zDiclL>4BHGtnYdymY(8JqB%!nCQS`VI{B4bD<>sd!bJq*(2c|z7jv@X<)D~Y;l<{f z*tyNs>dA_*gOP5}<^vsokwwC5nM`fEt&gN3WeT^R?N$N>+hXRMO$I|5M3C2msIWmz zn_XXk11qHPZu3p1yAfvR_t};6{EXzdWkI6q1NW$I(zLBSQbf^XqHI&NrZN2mxskNp zAoTkvB-8ycTt0Mjh!xda#O+F)EpBtQnv^^wfwFUQiGrTK)d$HXwiTr$>jJ8rZkR6nf!j~thC2nz zAkodJaDY-8s^CTUNG4<1jVtjG=l6A-hG_kr4K*T|U=mI&bnFnQE10K}j`7_`2{y51 z+xYs`=2xnN*!$oAm6&=Ir8k6*1~5(kU^?3~$OnRL?k1~jJp+>Uv0}Wcf|dYc7QBH) zwED=xyEC5qIQ`g8ZGJWkmi7vRdfBjsf;V~D^W4SK((IJ@#EyqqG`HopnZz0V$B*k4 zlKAp>mu5GMa%YPTEQY;Wq3U#aw!5u(?h0@_vHnHWY}b@Lrx^tf`u}FNC0@(2Y%kn% z0XF`j->iGYFX+b7G@R#m-=1kVUx;;H!adJVx7=#17uYsl3%C9Gnk#l*;W@4=wDC#z zija{|U~N41Y{`Ly)VwU5`Zuroy1F%-@b|s%wY`PWEb~+6B1oHI&rW)aq4O>=^Rr_7Z<>ns+TQmpfEaZdp`nW4S!OLkPu@ z#`tn|GWktw{4n;dNZHt0E57?Nn}{u(o3?`8Lvm@T!2s;TWP@50zz){)_t zlRMjo;$B8o7LjHQig(2HZJuzv3b(ahxGj8Ba1rlT0L0;Xp?eb}bfqa2Wvge~MbB1P zlj5qde=RNjsn=4$&wnOMVNQ>|og@f`_ITqaXq;+@3u1u`qSXD0l_#@!#)W^B-7tLO z&0f@jGARmQx2|3Jczl-k-S&h|TxbM|A?_*fw4Ezn5y`fd^C_jos5@~v?RmoT6`sCh zF1w8BQgy2SmE|Do5$G&lr)V*7k8$YDv0D0e2(D*ZYYCfr$xFfn6hf0A79p~F#LWH~ zmzkl_x?pmB{OtI00m*3q>xEwoPE3jDj=03{28OTAM0*9 zM6o7#5qxIUps>#Y%>Oc17EUhRq*ka^gUG}E7FaIBA-=X>dx7lAkm+tecHyzECh#i>1mA6{se z8l3s5E~u*$(^%-$_VPl`++Ex||MAkD`5m7<;4A3DWtX>0-i1@bx8MXy z3Q6PzLOj6fY-1?^^JaFaB%#F>_?q!S~FD%CNRf_HB?t9XI;l#Ey zFf91szP4)cAsE>5rchDR?68_Ivxkxf!}*zeqUWd|RQLP9MD>1+Krs67aYikUvabbN zJK0ulLC&6BrCDIZ;qQ_hb06Wt{JV=rvMRg0zCD&#h<&XXq%MO}ij~ZkPX}RJ>~Nx?A^+hi z&ka8srSA($P3QKj`Vu$~9HK!V0D77!x`XHzJr#}69NTcT#H{$sHc6#nH{rDN;WAkXnvJKMVRD}ZziC;L35U!0PKzPG(c5=bjX#_1FGJ7$ZZd6_U+PqX9#Le^cG z(xBzKSj=S=;)-OU=49m+^-ifv$kn}mmA6Is*@w{^Fo3)@m``uwZbnM=__8$hB-`yD zz>468dD%-&$YGcrRe4>W{$(Zyj>7+*YH-#T#{Ec)#^@VS(IfP5Ww7koyMN1hGE?qz(}T$N7)&e;eua^XlQaK z)WXvfqbJ(!0_|X;^6Alab%M>hDZ!iGTEvBs$-jMQ&F9PP9M(DQZ;tu_r#iiZ1%(zx z;xZV|Px;Penfly&H zJAEVOa-DVY+OQ%+ZgKClBJ;8}*YFSe zO}of|)$QS-E7bToh8O-ynXzlRNmH)*RSu0Gb2ivLO5Ekso!$6BPBQ6tgdWzgc0~}> zr@Mx=txaYLpNv1Cy<{I7YV)ffb!71SDDDdUN zsrxj|g)iYXXy008z|lI*7Rm>E?WbX!0({@$8v4| z*a~b#0mEa4W_GsU(}`ORBMw&~<}VsnRyo4S+`6{JD^QTBQhdMR3|<00PFXY-C>;|R z)aChGG^Y==vGNr{Lc06{9qN>6+u+VomCA}?7?E&Wh)id9*C6^v+pQ5UDinSyB-m(o z^X(1*Rq3cmxGrzIhuQK)*M{xGegiR^4M(g;Y#TXI8wOoT+aOE&yvp{82dGB0$v!Bm zW1;{paSXDW>svVw>oG#0A%T9QUxpH`64oskUVpZ6;qedUKh^N!i#YXFA&$mecw4{8 z2C1{T=Yeb0teO`8J)_CGDv9*^`qUpyp^IJkglq!cml!ich3FKeqH5IYf0eu)=^|

    wB(}|dwg#HiMZ$Hm2CL7`{$dQI8W|8oc!X+G1Iu2YCC5_m?Nn}hQ6nwbke zhW^X>##c%Cw)6B6mu1^B-b3}15FO;n#x!Vj0qjqXHp>@``z7tL-1hm#{{Kjm^Fy~h zRQT*kss8dz?tDu6+mm$vBfV~a45f8IQpk&1Ly9q=Wap*NLv42`i+ z;}&2Sw;0Q7KdE3?LgX^3W7VKs`0sf8W#m8}$Fz%Fn_%1k8aKET8j<<4&ZSQoQ#m5r z1&Lvq<{Da#kS{nMwfSXKv>- zQbWz|cl*8?&kCU~otY6q1jhyss1Kt;@r4MGm3pw?Pt+1Cd(M`iEPqFTMNRd(Sju5Oziq<_PILa3hedWB? zbw;u3&U^)eIF8(S&sx^@lb;X7o(qau^XcB=8A37Z&dl!8X+oXqU?WDB>|Obox{_bw zoySy$>vE%-!4%x{zQ%TT=sVdwJ2YF}f1gZ3qXK`b4W5 zuW&;47n={@p15Kkk{1Z=!l=EOl$SsWo|yC!+!%aWk!u`-R?0OrX5)vmsUVBA9cjY2iE2 zr}B4m&B94sy6t;4CP0{yO|mn~OL30ml5Qb`c4tMncqO^22-mF)HEZfxh;DYp^QmyD zs9;9JMb+`v>JVn^XleIW%-pbws{@|mJxr;M1_QGfX8<1F7%}%TW_Hk(N zad~A-f>}qkXWh)Sntkb1N%d>SYfvW)_lrp&D~oV3L(W-HPj%@dt~Ok@O0G^#!Tu~{ zimpToU7#VMOL;R~^Eg}PWFQgtFOh`3$y_i6-}hJl9Tj#tCj}J$UJwDczw2Qxd0--6 z?2ij}v*97TQ890sm%Q+W*{-o%qcCK{7G1>e`KPu|!W{=e%|H5V0PCnZEdE%8w$Vg^{Y$bd zlB>*qZf*&$L1(d(5|JB=%{`U4uyTu&PXA|vlCoZ&=Iq1=R5|?~eHdJEXm%mv+mP>L z?E4sCywca=N2N~USdj)Gc01fMPPvm=lB9g&7Wei`b^`u?I5`aPv8h#Pp3l-7NRM|I z;sM?cE8kV_ucYdtyh^VQngKjkYG@SvvyAYV>v6&x%ch4@w4ae<%AEFYVLASONfG}l zHt$Q9DM2i+#(bwD$n7mRIx;-0J5a4Bme4;5`wz1FNXChA>xkNiD7P{kxEv?#n`HjH zs13D&92DP)Ay4wgc|PNpQQ5NuzT*tr33dgkX3aMKLv}WU4fktb7{zd+POh*tYnx-G zbPv=1k#fc@WAm@^8#66LhVl1%s8g9PntGH(?wws$Kuf5w~^PfIXD`fJTyTIf6S$u0PNUt@-MStfby7J2vf>_J#8Rf3m5HIWw zMJYw+d-_hO^KGq~?_}gTZkxR`zbuyDn0=}pb=F>o*Im*FucdgOT`DFHgYj^Ng4=!Kmqu(G0@sa@>>9y;0>J1BN3oEmsj4aim7AB=Yu-WoYF z;`L9ib?|c1%T44sL_*uz1@+APk>mW&<-N@N_;WDhfD{dESp>sPWdNOPmi~GnvC?Qq zxNQwG_Mc#O_q&E*XwIFJpN2FCPt*$jS{72A!-MSS53U?vKDiVl@kX5S{7Q~S3oK#{ zs^H5FeC(3~U{s7?PH1#L`~yLJsVC#Sz6I&UNU4{o(v#+3MT-)bLq600dAs+0yo%_D zxQ+attjNi#j90JKE#8k;`O#NCl>xH!A<-#yts$fTQenAFP%-^E4L(xZtgG$AV=?o= zqg3lHoIu#u%iSg04JDW80Y6(%4UNpj`6h>A?k*FDAW8J05Qj$R9&%PP#R#0CQ3s2&`M&ZV=_P z*$Dox)nC~}?M0NlnAF#+Ih?{>7zS2y_5P+)WeMG!Aj}}3yD1l^rKqOb3J(LuAG;Hk zosNb1CARkHFHKq6$&%HhMN#{{USQccB`TA)4ilW^;cnyn3SNS0#Oh$#SQsF z{JXv~9x1yJ7WN_jo*%jy{5?@X9ZY;S+V?-6Aegixf-27tb7loEdKsk+`=)}>l^-Gl z>3V=IMZG4L9BYj;R7Jm{Hym~kltPI0P_%tL5h3LdV#IrkBdB~+<|D!^!3{(ou)*Y$ znRQ%MkaVcu@ik^XIRz(=K!ZDmcaAX|rSEorJ3W87k4u4j_W<5#yEfkLxOggiV{8_M zBq95sIovO(+GG6jQD}xKWO;}p9{mrK3;sS9JTf`3^xND;(x=mL4)D{b(e~A02CSB9 zH2+I#BJTDK7LYdyNH^3f>~Hgd9(&oE$94xo7C+o`4Nbl5=~n&DJ1<*#96X&Dlm`Bs z1|g{@Eq^p8A$xbx{~}}WvB&G^#id$S-HCA?HnrL*wJ`COx4`C6(qdD#5q6KUHCuRu zTwjdDF=p^#AC!}3)~VJWt@c)8bjNqDDYACg2@R=)e7Y`(8x@8biW-fMy)>BYormPU-N@uDB<{% zLBdyd>!_0*da%*B)Y}a#y6^EEFMl1-FC;tPYA&h~2#*4Qa42Z*PZ*JqAKE?Kyn6yX zK&$of4O4s^)lF}hvvx^^ss@#vm?YNjz{D;C_)%+AE8t$}&Gmucd1&*e-Aj}Hr1Z+@ zA{3wDz9Rl^o2T8LqGv&f=-|o|gC8z7Y(am+M^9K(owu>Tm^1{HRc?lkdXUBXs#|&V z@BsF6&_F}o>|4Y=yVOae|iAq|~g*;F_iBIa?hXE#XoG#lNF?TnW?vX}@Rw2;E{K3uM-l>#6!0CH@I z`hl1j8&aHR^Cv723_$yRQnbn$;DlNkZ~of%GyUid2MN8LB=l*nMM=)>MW-=iRh! z6Q1%U`LAIre=A>Me+r97loIhsXI8w*sD`mA8&r`KBULkjDjG|kjU!W}a2 zOnLOjS)6dRgn9Vb>0~p^!g5z#W&Xk-iZq^)eBP5A<~;wZ5Moy`5uBm-UYcYzn~Ld; z7aT+F3rR*;Ptvw(?#~3~{(fMICKL)MjyBN|zOypSlhB;@gs%_16f?z~CGm=uxFYvi z!OaW@%|TPQhO~ES=Z{^DTN&-5I4+j{D~mdfHwUYbswI;8?OJPcIxcX zRywuaiw|nLL@d|E*fqRw1T^;b4CxV^0+VQm4io&S^#T>J=~W)+V|-thw8g;QesZv3 z3solOH5|g>hEeKx>j8dBr0Sgj1>8Lf8$l??4%sYguHP_;v4ho*N>{m54l-=~RG0(p zp_e%a+F2Dz9}4rA9$KQ^0|w2+W3_ko-T6Rne*!$$n-ly6_}QiSNk~k9?DxUEh>2B} zoS&SZl#2cI)`0Z-6f7aCe{h1DNdZDOJOi~;PgdFJ4V%}Oeap(d?=^z8I+~V zUSplKhH#xR2d84~9J6U=l~6Uisi>1SAS5k5GR{7o9#4*dnp~Q#RlHv2(pqiYr7Liy z4Q7jxbI8pp48I^~G`IuBY-M;1Lu6elfoU=Eb4lXoC?{2o{v`sJ;NP>oGWtmQuAZ_$ zaNmxJmp{QY0gZn-h}s^JG*e#erou5F^Bj{dz30cggCFv!91)Jrf(nx&RY7x82W^zm zsbL5`Fov`4DqX#)k#MV!j$6%gy5>_Cluno3&%fe_Bh)pUJe}vFjO8K&%>$rp{$sX5 zC(%p~w21M?g_jY{0`m+msCdxK=zH@>AmhJazlGnIr>ck25N)kjb z@ZcdaS@k!v2#p%gt`$`0y)nCU&}4a49!6Z3z$&Vtx4@RH;dYiqtcyn6-b@pnGG&g% zJEAsqNX3m%rY+4eXvniua9dtP#vxz~Th4^d#w*+0D|WMml{%%*KTaxZ+XU#WZew;| zO?_xpa$jn0NMoSeS7`;X zi4UBee+9J{cNMl}BeBR(THLwfMOHlhta(+D#v(GvK2)6XGmsAYSG7<5ftcw~uKX9i zn(iuidx;h?i@u7f9tN$F%LW5t35s4D*Fi4{tvSMLw`D(1R=RxL4WDjf4VV>xuDVrR zzBRLc;wuQ_LWE_A*1P1PzQ$wqtCp5Qe6M7M>{G3|&_h9w*O#c%CB$B6!aOQk*F3N5 z>#(^3aSqX;9CBuiep(4a1j`b_n`xQ=HwG4gkMxKP9>W;auj_K9T=J~`mnty=R~W8z1ajgVaJ0R(|HOL@ru9GnC%H%@GzM68j@_d=F_VA zz7AJ4UHoty;A5;Pgay}5LaEV$Xd#>Keh(aMsA6MP1ZSkyt*UkE|{vj}KTKFj2 zhpN7u#`C`n<;6Jdx^n>lu6oBuV`+mOtGc|+AFK7)wypT?@fE93t8w`kxNvG=y%obY zzVS}KbGa4lYTSZ3UyX$AUJ8%K>Q}9$6>?wnQa5o$E1?gX8P*=%a(pVqK$mdW&wOZ= zk@170@lUo6tcp6nHpXo5sj-{&=5vdfag?k3R`IEp0|OKN&f9Zn?ELZs#(mdIYqqRt zrBVMFu3Jec@hQnmPl&J(B!}a*7qT&tx=-G#F=<0Q*OBSt)_?d~|K_Xx^%#O<*Con6 zb&Id}1&j;^?8OdF393#EMtB918rsij>ly0{It&URHhA-}IKdS=%dnIDm%mBX(-v-y zZ*?_LWtmz1H))Ve--UVYOj)#<+-?((`N7UMYy+A1M;RB8d%<{hM;znwXuX0sg_`-u zcOCQkxj(8%_0Nm*wX$?09O(DP@}TZuCL?_>4C7t2i>Q1O%n6La)Nw|`dMbt1i|wPh zMy0lL1h7*F2m}3f7pY`8+v8N^`N=W*CYR;OHasUlerJDh>D%girzj5vd`v0O_$_)% zR_r}`$Td%+#*WzbBUyTI+qb;GG|g)cbIJ`i*%(i0^B%M(%p~?l(kTHA0j2B8k6Q@M z;j-5|$+OxEE|2F_`FttI87|=$D+_iW)gLa|njY-W{xG zAlqq&!9ehjOjvZ=-e7dFc>uZw*?7!YR@%Ipdnd8AG_f9$SqFaWp9vegMREhvTPgZo zj3KUi^66g)sL9Th`G*VSJ^_oXfjG~KphjwRxbzEG?;(Xo=^o7UwEVHOQ=FS8eU|nO z?H|kf!V7fh5`u}E(EUnMuu;c|aAz-)xr|x@u58vXcN&C5HM@nYwn8sWJi)$b7F4!sLK#RcfAmSK)(VvqdUr*6}m?q5knX zzJFE8;#O$cqCIML=)mi4=Uc(l%0Zi}I=d1vr#(R3SqdN4q)>+3mboULlyK;%aFsYI z679FtGc6B>Ju9fQ>TsQwbDCV$;VW%xi_nHYp3Ub0mUw695mO--N74NK+DmnP$7sKM zD4V0^1H18|LBZ+|#@Aw6vLRZu^={EFlq3x|K(*!VBQ~3UBFABCi$C5mz&@L;zgs&( z8JdYZmw7wStFJkx+Z+5OTe~T~*a;is`t$T$Uv0gZ`)0DE#L1#fW%&R#P0MI0b-XR@ zB)ip4-&#V1z>M1i!k!TlrYS`k3}DtG*C1$px%R*U7ZK08TMoKTwjSSFD!*7Pe0%!W zKXbqpz21ghz5DLo5N`Nr(9*4cs=mcL_jG^MwU<_()BVzW7_)7*mdJ1Q0G@kGQh4*Q zLv{1;up%tD?I0nj*NIq8%e8u4GOFw2H6=hK*E=+m6-(P^Ux-7d_qLtJcs5F6v#Spn z7X1$6P7WtdyE{U8cMZ&gs9?dGSkqeV1tV}x!c+0MjOx&vcd8)@dzYu_54lA+tr(bR zslOEap-*B=?n7!9^z!9y(9cgN<3XZq(xjuvN&S)97mV-C3PEeWvM8>mSXG ztX)C-(Vi({bfl1zD_!IxN^Yk9h?D*^lJ^(CfZbfSRGXXSq#1uk~++uk?U+Ss(dZ&X_CSZhKsAgm|6CK!RKQ%g60c7z-O z*C>0IFGH#2DT_f?N;>>D^KZ|S`lU3M`C`?LEZ6gWo2?^+5kYjO$+3`T$MKx-O(`Pd z(A?SMh-0|YZb%H}wZ!?W9#niHk~H2~>6xb=aTqL;?OkkYIe=7yq0Rn%6XQ|Zg!hK* zj6C|(5ki6syx8s=95N}-p^JxXhK{Bn!wWU8pR65_OG*K~(?59iLINQ#lPRA#$g6R{noTd%&= zyuBni@N#5@HZU-F{{P?N-+Fwi!$K3VRslS2rrMu&-}aS&vbld%h1&UPY`S2;oI3M!`W zs$kvyfIywVz}({}=|(u;@V|zmYqNZc#<#hQk-s#>FiiDCL3y6_D{>T}f5^NrPNTh9 z9c(4?kND6x{e}{NV6A)1s%ZW{A_Q4`RZ>$23qr;)BIq7eagmE85B%Clb2mi;^`=Z* zg_M;VZ7s|`7O4Po!iW9&`udsd-GhZLC1tc z+82vYLN6AY4>#P&t?A7vXY>Jv*^6h4DsOY^Da{G{W?m!++iJ~3(>yXP$boSdSPN>R z)?GA`QddN9leX66Okkm~pZ0A2P>I+yrll@vtmIOCyk)$d;7K+&^I{Q${bKI*!-eXz zfSVxtG$r7s$ludbP(^EdI2lpQU(C*HV?bw{-Di(hWS-?mn+Ce!1155f~jRPq$ zlvm^o+gG@d2EV}c9gx449M@M1c1bs$=(9a2W-L&H{!%QnaN%Fa)VBy!Zs@fs9R zj_KcKK;(@j<$VBOQ*9~}!mL20!d9{aXo-W~6)d069KKU|;?u*CQoQ2RqxR-gH@iRQ z%lNxDiw`!Z*Y08PkiiaxC!gJgKMAtj8{d@jo&y!i$G0e?h|s>d7ClAV^$S#noECd!tV6TyXM0K@rm< z4ra_sj;s|A1Y068TjV0&R^?SrhDk5p2h2bzWcMjlrQWlb1N=bN9m7R6bxm(8dYFI> zH!!!krQKHUr>t)}>Tb&?Npf&YRZjY@QY~Z|-_C~)x~iKiUBsCX)Vrn4f5t;b&;@Qw zLR!D$z#`9j(v(JPoiqh|7`A7WE?KILf2A*Rc|kmNkA1Pts11JJ52ac&l>)yD{}-OD ziV#?`EcE1=4k{kSggnmpe=MDORMP4Dzo)Em97`)pD;Fv&YfKqGj=N%IWlkkEEx1!U zGnBZ5yRv0gX68~(YPry2X({4{yO6n-p{4<@kSHReqU^grzUTb@^i{Sv_lMs~fxvxg==4>qeD}V2L=={0j z`_c!Ysw5AL*jRP22eV-q5u!T@S5s(w?dL zJYdnA<(CQN)EBDQMHXC(ekR74Wr<@?`+qj^l>dpts#Tm!3pd^-Ad*Ik_mo)pc_@?@ zIdNf|Fyq4DjyBvj9Cp&X^`e^MU)jrUA!caXDkc;g++CPWJScN?4sqFLf zVF$Wuu@ktyYPh~?a$k7*As|K+W)Q1Bkta%R&HP8_h+q1b)Wv~vgXa!CoHtuF&kEfuU=7|V=^De^cD}{niYb?IN9vMp6u*(`0!G1>}7q4oH z$nqks>2rWzOY5T;}U;3-+-zf7)+?%;jl zjgkwlTu2(tr?wyyWP5$f{P#4xrb90mRc^@Zdx40}#oAy~(a2kbYhT^GmQ6ws-vmHr zlwkR)GOzpD1<9s@fU|}oxqfJ5@c1(*>e^fy|4+E6KGQ3}wz@S9s_z6dO01re zo3BRGlj*2fk6)gy=!&|ZoI?o+%)PG$3i2OLwqL87f6A+emyXdx=I727VCe8d(pIf-CM>S!fdt(4dmGbZg4y)&ks%Mt&wSjVIkDAVh+nPLr*m zm6H?HNx4iMpNzfuYC3Vvn<0kN> zX47dOIEko(<0pyw-1d_R$g!RZzcwWjmznrX z5CA`G;yuM36+Q;?leE8i-PVZJa<8V{-6_d}`@nBb+6U?*7u&P;d2d|E6 z9z{OZ?Zcq%SlScZl0+9~p94nG2HwYBtUk4@)NH~rsFPkKS-;~-8ENWe5T%K;MkK7w zGgC%1^*IH_-8!Ia1z7jBf730C!h4K4vJ4+jCF*&((MWov51djEJLYhcKbamrx_e>v z&N=t7cr=`C+gBYKiT+gTyC$Ep@amjnbRDQ0+99#`ZI{CEXRb2?<-eu(cbI3`Vz;S zwFI%-@pXySKQh2tiJN^p^F~-iF=1N{IC(w4pP$uX$LxV6^8Kg1r;t<1*7bNG0=!UK zC*2;Y#+_)STX@G7&E_$TMwF+Vc5+Il6IC8u&@!F2LM=@?oRlLjElDEOdPgkl*8;_D zWF2#KWbMnbr0tq+q1ge(W?rUuI;gEYg~%u*pi)X*0-KdnKcITKd7M&bHjDz(=g;8l z&&iCeRwn)q^SnW)U4!BW^uAWU;)L=is8<3#0f=9zZ4SdvW1a*m{X!0w4m8z&OR2ra zk<30gC%=Vb1PUgR&s1YCv_=738=<3~Z4YH#dz1BqAX~laQG6eiR(KAqUQPoHOPdN* z8$HZEXjj@xxZ;JxtXxUsM8D;XRTR6H^D^;bEcFpa{98820%7;gD(OHcv|B0+L>Lydq0Re=>VZ*_|e#J3^F{b9i3Nge3d6ta5h7sP6a_#m;)N4 zujHpF`lpfsX;#5;%^e0cQZ?IWKK)fy)0K5@yE5$waA#}(uAmLETYkOS<$95Hd?Baq z?(o&yML+}P^uGIOK`rY}oO6V+X`}h3-}y5?J_dE)9r4K=AA+W@DAjs6K&g@ z%k*PbF3!w&o0G=4IWLhPe+jnf23oM*x22yo0V^-U2Rm)a6djX(D=gI$>#@7-h~V-T zUYY%?T|kWdt2WR1b%X8N2DO0UXpVOc?&zgm8~M!Goil#}O`8~yROZ*bePcNNRR9Ev zFXx1hheTYM$ZR%gL#P(0b-b^KcsW~VoN$}gleAsP?{%rfft>t@wMtlZ;rQ`bQT4C_|yHJ!KGgygy zhkw7{RQeC1fjXmjgmW1wy<*>psQfqL?C+33vZ5k5zPq3SLeqnm6iFtXeb)|^ymH=F zYb+WYwnX^QQ{ZL7tIPON>wLS2D%4VQJYM~zNj(loa5jl+2sBk>h(k|KvFI*bGZ@5{ zy-U^x%9>dm@t6O~{I+#1!^;n<7d1g$HpASd2IAx$7+WB+rQcDR*bfHLfxDZSPJ@DD zG$Z;F1jaV1AuHz3s%u=wgKjMw4bNf;=11lg(`E&uMpafO@?Yflv)2D){b?&ev)yE; zu%k4UFS;?5qOFhe6qFUW>+63SgW&^Wy`+>Ll6}t zO>%G5GG8O;1ZOoYEj)xw$*zuyWbYk2fUILyyzmtduPu#oYOj}hr9ZLXX@&a?+!#kO zQojTwf+m>^yPmE-PAC&1B3mC)_jeUH0@GbRwdJfom%?B7*x9b7NsbqVOnJ5I1f$R^ zQja@)tJ^S3Opvl}%&aK<7WliK6a7LY-XUCzms<~(nbpkFe4$4-Y^R(e`0n#1du2;+8FVt zJUjxyURtV1gbfGL!OAz$zMdgVYY)LT%9qgw0hcW!Q2`t<`h&;zbPYSQyV}dGbX}(TJd<544C>-#OfL#OVRu}}-wpF{9mvM4E z%JNE_LvOxnHPPvQr!V>3-q5AxKh(tgT7Ahu(=dCqApiHL!OX6TuF`D7{ZSR7*1uHgWQuMONA8m6-G08hBFyf|n6dm=Fsqi^a zc+WS*?J!qYBODDdd&v9JoMK8JG9KG&#m;4-On8#n7lnjn^nSgicF1;E#)`riFvQ4d zkieLMU+!yYXCq=2JuJg9SD0kVf2^ati`JGQr88~_bpw*)&U`Tp(iaWr0UFm{)8#8w zJ(W}3dMV>`ItYY#iL3c+>pPIXbwlhp+)bxB3V9eBF+`F5u!gP8mO{1VVpck2=T!49}6@)sm#%DHXzx5ry+W`5=WRI_}5 zdtKD^3*2M(%e1JkjoAHZ!Rdj;tjJ3Z_?e?*(e3Cg=Y~+Ob#aoj^ki);C9y^cOwjxv zaj|~`ur=~m^cqWB^xZLux#{EdTac*Isz`Dl`jOHuwl)3)cKU6ElD2cym8<_YAQsgP zG_`vgPDgQ0nR-|Jd{Bdk2Dz!10xe@ANF7Nd1SaSkm7ehKg=NfjP6P~Y4o-fbYLB-? z+j)OD7r$>@X!3ZH6aJP7+9t#khdvqzG9U+>RFnc3akIKtZ+e~uBw-Y}QJOp&F~YH2 z)k}#lZ9Wq|?G^;64jZ}PubwojmHl=Nk&0CoKD??S9)woHg0kA^@mmW=qp=J1UEjo6 zZJ<&WBqzK^-5Wlc{C<#n_T1O2o@OFFv<)<_+uCaC`&MB5RZkm|hhI@;<8)5!$`ad4F4~%CTLrPg_v?R?W5Ko5Kd0-lEXl82Ql@qj+N5ql z(E%lG79r!Cc|K>o+Z2_tk=1IePxGbV9gm*eqb8?Yb?_RA;cq_Yn65#_(=s5 z{>*lUpmg@6tTjcZ+z{6Ef(*E`9FO;~>iCqU{ByPSLrt(O=|hIj*f1qgJ0z+!@))`( z>99}Xb4wn3N}YKgv#p$4lz2j9wr7G&WDsr+T~nT)L+g0E3wm@L46j!=U!4AcXerDq zLS@t@r;J~rJM$pQrQ44S#zZ5Aa!V23h<{jc)eS9)WB>L*79pERG{LJn+!jpUIIoSP zWPUfAHacf?In@G_-di~vk-)3y`+Q(OCh=QA9kpCBbI)s5fjH!R)dW2}LOBx{;#_b} z+u#1N6nkMkraY+oQzW+V0Ki>7CJp~M1QG?GSGE^xDLvkMg)L%Uz~w-Ahg;>_*5~!T zuw;Qr0`5y~@)X?7GRvp`Ff;rtSv_bB4&y1a2{~4nxXj9bgQE|6(k6`}QL^BmYFf`( zU=a-h87Lio64=@^pV{wkAbIGU+yqnzjyUzhK#%i+!QKN{be$tLIqdmRqQjr&=t^1g=aR z42<8AiKT0y{HcHx!9Mmk2Di@++FPP_hUlyI0YqXUljPC47yBw`+@wj}=WVfqM;`ug z0mT{%=m&mxEU3na38a$k8oq_+4Anh~Kr5{=W6qctSp65ReX0OiMWduo#8fRTHuCpD ziQ5$ROk$*M4*w2rE}I{uwmOzxndi|GR73!jhAVwa2wooA`yc$6qy|}cm*-&`L^=B zVtM>~GV7dHHa@oxh!ABYCWL~}l1+wq*(tMHB5UBSLj@q`ltsi@hke7UU`tBmU~i3` zj{3BCQl_Am2XVUt2ibTER z$R9rFA3~=7w2*teFU2Jvf;%Vw&5DP%8cjS(J>4SpW$21(e$vcTYj}Jfjj#1< zeoCTW%+uQ2zu5X!Ua)o4Sp7(&SYu7NH`m}nQ>uo9KC-H5UBc9`yv^5nSTzBwEO1lR zwgS&cHj^m9GpDxivPCqz7RrAN?f;PmaLuWTM$@Qk*uy{KLZP2+8kMgm`pE z(D*kW$;bYtt^p@NbDMLxoOkA*sjNS%yFuc8!i&7r3k5$qqhSXOnxKKD&d;rfWIHN` z`Y1hq`ijZB7*{Tg5E(SRoJ#B!*LUt$;|Zwme_oIjd{}&K5%j=&oi4EQ z4Yi$A_2_AXa|CkfhX8b(`aD?4yz_ggF=B``~{bACy*k^Jp0@#Mz4Z$_D zMnkrfCa|xeTaHL$u0h)88l`XITIr6_LFf-@&cU1>t$}n0Vk{HDk(8(Od`>~PKb@~G zL4Z_L~r#LB^0E9KYt~&Lz$6T7+toguN}Z zs65ij2$ID$OW0#+a7J)Q+bgH-sMSdjgUS>VZabp$^g>NiKZ@n*CQLvxoMDP`g zd%;5zBd%h+#Z><*9mLf>c~ZKz>LXoSF_-Hr5F1k>WC3JF8L@P~sE7___N=r#6}i;H zem74j1(Y83;7|wlc8><|w<|5~>SIgU=xcV6={o*%wt4`oo+dxNnLQ;vo51e2@b<$p zIEoy-_StWpra01%(Y}9#6^8ibJ?|6BT!$;G1@)eak_<`uA43HWXm?l3Wq*9L2ey8L zP=OkW#C?aFYgerK(Nova;nc>x-LH!4>gSgp$>q0$`}Rq6_xB=hGU` z!9O{hqg&Y_nfe=ItqZ`e^N1lwMD z3QIkfLtg$Yd*0*=Ip4CU-kz3I@7Qu3yLoO0;kv=KCKPYV(+%(0_eyqeD?soU z7I|r!jU3YRL?nHRNp^)oXG%y!@%qum!#B{KV&#|hQI#0IHmAHS-&t9?{vSW_wm2(q z^$*Rj+-@LX?y7m9A(ZO2q=p}YDstC@*H3K(&H1F?6ESXxp>jQnmgGyosNKBD$S;hv zRx5G!rfFp>e`;)T9<-5y{*|=jVV?xTDNzNW7U6UVSu<#p5G8g+#w=S@65ol>ulml9 z&$~1+$@5`2-1KN$j%ick{AZA%50X(oZ2x^s6;p4~gpO)jpWjb*mQ+y^*Z-FeD@x{b zJ52IK4`rw_I9~W$e)Hdi>8u?1C&Nh*&7dLTrS|GjPDqFoC!!;(-s-cyq}zH@ak!Y} zjv@ne%a<1EPp&cB%4MkIE}OI-vnsqH_3ANg&3rCG)Y8v*VQq*Xi>RXvDJnN(q)U6! z7oTMX@nPE>eu7mEMKCVQtotTpSFA&W828Ml7q4a!*Q!bEuNqQXeva|NGsDTnZeZuz z7ZE7c9n8~c#8^#yR)roqHhh?w@%>a}3U<~Mm#gi#kmY!!*#MY+I_b<*g31UNrrMl1z0fyOqM&YwPH{>jnS>p;@! ztH+AGKkiT1KbG`5dhh`|FS3ZLdlcU_+&c%}(%M77k+6HbCJ)!0bJDE!Uj6F$!lHpY zKR)^@Csr~(ZynOJ{JXsFTaK%?XyOZXOmH4w+dz#`E>3S?>IY5UA6Lzv^)4dGBPQrk z|C3h}Ar`~Sfq=7Z&)4z@+MaOjYPDnUsp`dX)Q+lxwq(uN38Y_JLe_XAkRbV^v&*8a zJeZk*nwXSWl_ZGL=?Miv!XqQ>$9UK>xur4B6yS*&I9Vk#OZ=Pl>3 zE<1B9m}SmXe0(d>$1#rj7G5mM1dW(*tC`hL;u675#@PzCPxnY~EyjWSxR>IGW>4s} z@zSvPj>w_0ILvAnwJ^GNqH@t&_B-z3c0&-mG5&Lbm?gPAKu&&n8AHu5)XHLM5br9< zT@vzYib@!~b=4^y>^R*wR@eu0LtnJgj5Q=8D!_Ho;5sKj08oktW-s2#IXm<`e3#6K zV8208W41W(*431-YFQq0aG*mTH&;ctniIngY!^JuX_+4%^HPouT!I~B-qU8ofawxK z!0O<-^x4zqG`+t7uP39UKl8s*(^WY#w5sst3vFAO+VU@-PTMn>4!o= zlt~30&B849l=^i`B)wX3Gcd4Zg4RXbm9TY1VU-jgog|2#?OgnfE8|!!T1>{KF4d2@ zE}=J$C0^iULKS)dId=~~gu(GZ*R63A$zVtk&e_;2Vko~f(BraXoZs?t`T4xdce6oM zCcXZx-{N6T%v>Hm@u?bOiu8S28jpei8x^W2sviT495=0^B;-$U1YfTCWyRc!gqq94 zhV_>R+$@3v-1r`0LLfLYLH?4!+~f0jQlC_5xawbG}Y1{fj z=W`6E2h-y1_Dws_ghn3nj2lmLfy;_GOpxfGn031^w3^tRvg?5!vwyia$G<58t)e*# z@ibR2_z+g?03)mhtOUoR9`Rr7kNGz&%h|K!O~=pUJx4JJ2df0SrLEwKWv$W#tZMe! zn)xaR>hMpRAx3er*g4|s{O1@03d9ig^;uf$=iu|Pabt<|+}!5>VDi*Pbya?E8|OM| zGi%2Sa>_-9ctCGKOI~Wg#*Ns6VPWsc@E!^bw6N;mLHYIy7+qmJm=+N4$gQB$Y#Ga! zYUN)VTj%K$zp9DcQg9P(qW9R!Yoha0$V(GZB@9G;8*t6?N4-1iy>E&2NJj?oHu|KPof8PO@*Idx5Qzrs|b8qmVLL)t(BuVbH3^{3A(=x zj8Y$?G4uFLSBoikPzEAia3X|SD_*_Y;gx_iD1u`+QR|nN+1ny47Ah&G(M&-*53-sFB}-NKfZKN%ms~gwo!u7QxYLQn!ScKbyw(1Sl^uEyN*B z{LFjV$OiOU%WF;rvI*Ie$X?-kkSETq$!s6Mwys4Cr({c1T$iqQE?QTDmmg=^a z*&ni4k=xPu!FW!zT~!|XjBb0%nL|sgCvyY`)%VvhvsJi_yLfyT=TmX~UwG;%yq073 zhAC{5$2_35(Y|;d?HwidLxOsK`!{8RO;V`F2h^x=Xr2Z4)cex32HLVf@=B7m>v&2>iUs0=rlgr{3EAS1xc=l~&}j^6zH2N5q5?-sMwo5a@PB4kBT^`NR|3y^&~F+R}5~ zn7h4**$)7JG|~#U+RB5bMf;e;0WAb_TtK~UB4ETau7PTl2zzbz z6M3-S^(s!R--Eg9%zkMD#Y})htAdLZ8A;k0X#tCHK|R4TK^`*yQ50p@FdiS4Q|aOt z6&#(xdjqe6)5NnAypWeG_i)2$W%hN+_b5e?Pb1BiwZC@5$)W1aXkeB0P_+jz_2qr* zf7o^zHOk#4!vsowQ!Iberf6P0*S!sBj$w5HJQr_Pw^#0e1t~Tc?pY7tr;X|GK>u!` zA#x2pTvdYfzO2&=+lLb#OnBe4XjuDjbyPCw7nmjDu6;JFM*J4_QI`dUhM;m|9=k!= zd3?$4ky=^`KIK2dj?g+vsdh)4QElizC?%psD4yEMY9KP z=h-^ZhjAmmItuQ#ZW~px{(jl0RMn}7z(sGVixt&ncEyZ~_2DHter>lo0^uB={zEEI z8ie9Exl|4Wk1|pi6U4^WOt`d6XTDKlDs9R=9cvoRH|!omHz<>a+(PjwEf~c8-U&*q zdal4z%J1%&w6Ev9Z!8q$(eO{^<-t*<0FSnZut$iYo$eX6uw0m-X>3jHZD9}x8u_6l zUv$i#l+J5z=MgKytMqSNYBL|X}g63h9HKH2k*->K5JXM?1RA~DgIV=^;AI~ zG0si*9?AGoUw)Qc@>iRy+&0_AaiHF=M6`4oS0ewEzRtk2cFXFZFNqd_Fx81F)wk_K zNy*=JQ^xb+D)j))Pb7y*Y2$ejdNo#=v<7Npqe`{`{nyrocuiwM1oyoTpjV>vVSDvp zA|EVoFjQ7s{X91m-`QA%tD_V1@Dp01`hpB1vb7hvPnMw^)2>L46RX#%J4Q#7=!E@7Pau97kvbJ^5L*W{1dD z%KZ{cm1A$Ycy%r(WMe?`a)4$nalZJ_NVDscmYFBJ{#v2fadv-SrK4^y4 zY;WuMo)GCoV^uMekLWhaa$|g*j)LowMmUCjv>SBs?B=)+>BSAlqlcsi$otJ5LSg1P z;XKA=d{3S6hs{f>yX1R=S?j@7WbJNwd2^fdcA}H-3ozrA7@mjYB`U|&7XAEDIr3!j z0vy86ZpzN=P1NXt8~;xJ$ku+^_O3-Jb9h2xiv5+o5%(D)JEdz&=&8Q1qE$~@E1eS! zhj&PytQekJZe_;tD@#u>&E6l*44syL)F{#t9kn(w<)7NOB8Wawt7zT>9Zs%T2x2OYP!5!%~TT={6^EH4)yZk@dZ` zzuuwd3Rl$z6=nor*qBQYwLO5?2r{PL_vLI(Cz*^8Y&QuIlbO!y{B71`u!e%~2X@Sd zh(G`TXc5#_bjSz#N5s>%wT%(m&_%S(p^P(bh28UUT~;VI?#hDr2_OYA`^HO?CR-=^ zw@sfig_)muWnR2d^I*z6Ho?6M|5%R%nAJXN!5CiqQ#~u5w z6;T!&)4Q7;emFrxbr?No0p#$pJrM8KgVe#WKe%$Aq}Arlq~{D~rzCn5HHByjs>F zSXGachU$35sJV84ENtNUByaGrODrABlX#>4BIO!9d{R2mVv9N=*iwrNob*5jB&<~( zW*-;WTq8B8_g8Xuk(d3652Hgpzqjz-U|TBeefDLu3p|sk>-cTyn^)G_c8J#YhyMgm zY-zlv&s`4s-8aF^ab*y=f-2Vf!SEftM6(dNa+8)4?HplH+2(qi<5XU0N^=^%Jn9Dc zAXOkAU0MSOqXBd96&FBS)8A} z>|fNg=k)QW`2g8S^B^K+3@G*Cf8>N7GbAZb)tZP*NMU~4F?3nFTKcLi@omx{ zE90Sq6O>Nj8)+M6-^}y-z#sF^e~kawbE6|jHsco3k(aTj`=~8|wKnQ@5F6SJ3tJXm zc1L7+=%5)|#7aj&z#A)w`}eaE!`FCah13Y?rB!2s`g&Nz z^j@-PhwxzbS_m#;?ikjg;Y^~mYtKz4WGPTy?W^ipFbjZ_Utvz-Y&_Y$29Lh&d1utr zi?~Z6PUX!9&{^7KWsecl&t_38;|-@i|5i{b9?Znp3HAen+J5E=&Xvn11}i~<38)l~ zV5P@9AvMI|$YFq_;0G)#a{WY3Vv9J<(l>6*4G?3gkh9Z+#kASv@i0P_DH=v(KFiuo_0Wyalfm z4jsgC4-QXg{|3bqL0PF=qhhQ*@v1Klc8<6|pg|fcGk#GaAk4;P{ga241|>wahPdi0 z^a6v3aRWZqhXG|Nh0w|QxP%)K5H6~GSvJ&tKj_pTJK>)j?I{$hrs`gE=ivIW5P6aVb58}?W=V^~ zY?*6woE8x*mdvJ6<{l+4EM}RK8(pz>I)i>bI zn5S$cb801#eJ=N=Pn?*1@5QS4p%to))$0^QR=Od;TGQ32YR7S-)PPNC&u7t2Pe_Og| zs;DzX%U*E`I_^#{;$<(zGoBAR%~|1wcYl4KEWJys#^7a}0Cqhq(ChJr|Lc9D*x+d` zzpQ^`@IVRkSAxoc4Es$FUP=D{wS(q8lh^Tv2OS;mKYppx(?Zhuey-{Db540$7uY0| z_Vd+K6*$i#95@J-I)mFH-jE?9od4>T{^j3<{)mwDOq}EG*i^L@s_l{=jCWk|bZEV8 zoZLEd-Onocm|)??{Eugr0QM80Mm(Dv;&AiLhs}20<@#v&*!{7+w$lfzIBhA3Ywzfr zJ8Ef(BZbf%xU$v(IwNr{A$5Cfj1$xs^@zYUYk;8Al4B7%>HyMYlZsfH)9i1_nyEvb ztr)TZYiRka<3Yq7xC^d#?3E%S9G#C383msR%%J~)pS%wLD@iCM<6>q#ZF|v@q|GMYEiK3lN0n*%O<&IiGwtAs} zK(yG=T~HPwq7cAn@ypA;F&X4*7hJuM1DS{eh>fj_e_2CG#or_w$D~ic;*fR9t?z%9 z|C0uod4s%KVJu>q={l;e=xQo2xg1Aj5@S&bC5Z;qU(#b~l<`Ai#9&MFhTqveuKM`8Cj0)@q@ued)Qo!sb>` zNY8+Fz702e>0PdT*9hB3RyhG6J0^7F6C6u+(bGMC$E`2!*CmN2FV}>acS*3oo$J;= z0u5>s3OMsbEgWo@ZY!7RM_4Tb`qF7e3nSkc&R`A3CaM?`pTvrZ>>AYq1Uf2}mmh}< zwS>ut>Sb~H`m_Ht1P}cPE@tlKv-~at=z;VQh1e*CiV_!*U2D{vr>)vwkY%TG2J=FS z8$6&Xw#@~OE1C|TDjxf@!!Z5Dkkw5iVd*W<<(9;@bR=QHqYGUeGIR|Wxer@_`v&~?m5NI?ti4p3P-ZrAAN5?DYRYXQ=cGCPcfqV@(FQn%(f z-_nCF?=gP}Zm+bd*`8i#-%AwEd3^C_r7@l1S>v@gGT%7-m5tW{A$YDkbex3Mdd#$& z><9xH%?ed(<^1{m-lDEfF8<6@fw8^gkrr}VqpxR)h;^Qz{m#Lw*8+E7k6;^7FPt2i zn5Y3r*hi}>TR_p}x&#IBC1^3y*9^4JvqVSwIQ&VCCH0Rs#X2B9@vgOheh}xy@vP$q zDj)5AfBe!N=imdCWk=hkn?)x1=lj%(th0ZOY~0dT|L^l<^j;}%kDlrf^)yt~E34mL ziJo=xoamkq43m#IVT2bJywHCcu=k`ZRQ&pPvU>p4B#ap>A-6Rae9WFptLe%t;UV~1 z5~qjx$5>vUhBmFDjicg|PP&!_tTtf+D=o^VD4#!jeB1qHzX6KvrSJS1N!XCE_L(4j z7isv*WK7Bz{O;kDmgNb424B{bp_y3nL$)x)nKT^jhc*{i1U(IkD&{F~0dVsl+l8#E z1^ym}Gck?^5o$x#@cJY{pr>!!ne`P;46uM=837RJi8G%KF-;N8Q?>y}*6rnLLd18y zR$!~=&1uVz9o_0XaTg$g+QNYL;+AO+OjjLTFO@~L7eS_GN(ki+v56!XJ69ZKQeT?L zYGIeu4izMcT0SwqwGT+9ey1lsmpo*Ggv<2=X&90z1RAiStLHmOnf08sIE%9h0WMd( zMqIjHakh^mTotIff__4whh>IL>l*1VcOZS(jy7up_@xViYtmwV^9Jn&7Bu@?W%c+% z&%5kEn^E|nAEZ$H6ze)@rMJv19B~$^_3R-`%j@|YJrRG2qB<5`k#0$y-MKj9ct#45~!L|3dL1b+%(18lcnrCdlF2UyL3`Wb=BRpkJ-I z4%JcC>}0KIv0eN*J$WO(h+x2egTsa1@7 zHb4D0F*vPEy%F!cynQw24f2ZNL5CcqYWDqwpS)o>3r251=nCoVd_jl0kE;KEs+F88 zX-^57@jCVp!np~*ZtI!!2q&6#ly-K|xYw+-^I04IabWdu=^<3Y`jC?**Zfwr;PO<~ z1=gv8D>{A#L?6WLy#ah*b|C#<$oacny?Sna??5xaTAC~NqWO+laYxOW4<|HVuUd{g zzvxB(6~PFyRuIK*PNzBw(gSh_|5w=8>Cm4q3-h&;^+VeC;fT4|u#;qX8=MSyJZJUe zqKEOk2LCb94p%0w)M0O-nY1;cn_Eo=kBbNLvow&#Oe%HA8w4yxMSq?Alt-~1?ofbZ zorc;B<|oo~LtH}qhtYzzvoLWrPFsIa`hG=9`m3D`+!$kWEd{d^x#wBm$$$Q?xe26=N zfQ!)V2yMGm!Z;&BK3K7TmX!UZG%QKrZ<85ZC2)KfSlavY0p82iIn{wQnXWqC+Hv`r z*U+s-nigbW(j6(yjYfPAgnumudZOmVfIlkkyTD6~#0S{`!s%FutTWXdacwRetGv{q zS1P)_lOU`BudcM;LM(Mq1GWVQrC5)%-oDL?QYYo*dJNa=CP{m?uf%M$`%c-DujQQ5 zCej3tnwmqMIr2uUYRk2Sab4#9)e8lb5bzy9A%wSRetTORa1_xGaUfO?6?nu%iZ<`T z_S_2#e+;HLw9Ec~Nn?aUiYckfeC$83E}^h7Q<6RP-D8TvJWuN#(_h(`KSiJa| z#Ozv=UzR+_3$fp0N5M;Gz+cBAH>&!L7It+7IV`A%`3xFt`2?og3Ogq_#>)x*m~PMA zyNEgQ;T8HH-s6SDUir?n()_}vp#T)icVPpR>z<0s^=*_o2g z<5aJ25nO7w!m$o(EBV#aL5&GK{?P=jiP*GUEN+Ua1%W<{1ZA0_~Tsc&<22zxm9lymnW^embUItglwTtCR-sgt7G!@pd5v zlSb=3Z4S+v5eI?<4u`r|O6>2F&~=8&!JAtGl=Bu*WS$IKFm6Y^XMMSK>S=a*WbWEhvc{&L+eR1golrfr^TwY&d$&A;I}ba_Db=r6)W)*t+>*vEyI3 zu~V)N%!A!=%1@an-4{%|FZM2y9t6?Ho-5|p){Np<>B-rI3XQFpIdQi6rA{jgNV>~BuUI{OknmBsraAXBx}i)O?cULn^8~Gfop+c(j>Y zkm$14%jK}#ekgm+bM?}4gVrwkRsS<-p98_6oVHBd-LqXM8ZlRS=6a+w({RWIn5LMo zVi!cUr(xt75cAcXu&LYppmcE)W+od~BQe1fNwfTi?JuuYcPc(jl(Z$)y+0(e_VhtM zXM~DJT5c{+gp|e3HYIQ{#&qxYN9Iw*xQsyC+q0Pa1Dsu@gS~FYa1)7ju1)K|{p-r@ zELV{}4Jk4P*!iB396&x&0j8gX^N%~3M>b}vA|BuFTMP0pLET>-{fGR!?tF%l=n^^9 zfHsyq4s=6L3BhCkGVMp|>uaU&NI_@81G=9}gQY99r_E2BjjqqSuv<<__S}IFZ)2btZAU?l|RCx}u*hIr*o}L?H z48IS#7Zv&yV4i%ObjQ%0wcBZmFtk{M{0ow|S!%9INp)+FREXDXd3UQLtSJS>4Nv z-;FOHquX&^W&(_{PcEosK}QYM`tGclwX*el)IhA*hm+g=4@dCoLVzXtt`&2Rb`bQ6 z2q7ZVtp??OWYJ?!iru6rYnC2hGkor3E41xssy*O)n>zo1WWYDn9lV3%ldTcTbJIasK$@ z#fw?Rdm>XPJVFP?Wwp})8d^Qo*(x7oNsu9Xr2ciPdc2_`^qVDZ)fjq^Hqin%Tn{Dc`sNM{m?;~h<{k-~_xxUd!EMHb3mx(AO9KYWRo7R$ z2&wJ{cLE(c)4^*&%o0Q_8d%E-nM?uQ;j18?e&%K=CcTDEvCH>C+Mz4!aJ0iJ`V4mV zVP40bEGXvSALYURe~?@$TB*cY&cssTe-QQjC?5UPQ>8_wj*=rT-n9H`ec<%PLdQze zYufPa#)x|t-n0A8#9f!oRyNO9edA|lk}igaap$~oP*;y_0h~as*v__0CHaY!Uh2-C z&AFv+?z*v%12=f2YE9iRiP~l--;bY(s5%n}Jdg-qx+X}4xa`hU?hJg42L~-w1N&ih z*M)xoXt1E~Z|e71#fnys6vRYs9b%Qif+N4qfa~;WBlv`SIVyi$d=k=jw(oEi=yN#+ zqg|=87WpnO=@xNmU#nGu$l@gn1}Pp?XJUP;lq|TlwMzIZxP;~i>Vzzb_15xZL36?8 zT%q?DLdT`bT~5@AxCI#G*p3|9V`_fVhJ%`4j*F1T6Ex%T2|FHE2JzDD0;NB*Fr7F@ zTZ9$T^Pv?q{PTl2<0<%y`VehkZ;SRo2@b|*WL|DmC9OTPXVQ9(IkpY9peRj;qhOgO z7#C9^fWD%I#_ZJPG_L_5BjSDO9pFY?#C{dqJ}QeiaKSWj_V37%E~lOPoVd|}g5-^~ z%;0v^2OlL8a+iWljJ-9o19b`r*7-jrj-z$WTA5t&fR z`WbG0W4WZ(obd1&CQ^NSwmeq+WARfSgTK{I64WV)Mz8E?pDow0XepBrhoncfvrDB* zltbe|9<$0V@4>F?+-4{eb5I%dCoO@_MV9j2`m?3=xwRZq03z2*(||mK@9W?-6xTz} z4Q-NYwD}g@dF{z(Z8_bXtd>kN)nWoxJqhSpeK{~_?{n^pTXh!OYi_#jX?$`GeTUhO zp$bM{3Q6+y5F3KlWA^^`E&r#sJC;%CC$Dk*K%Ir@`#-`jkay3! zn#?af!4hZxua2Apd@yGQZ4^m8CIgVWvBNuf%X?l0PFJE^{sR-6LO{-mAx3cOnPanp z588G>y6oA|X_tpZ7h3gfsZIIS9v|C)-()|zN{)AY7@sh0^6u@a^bO#6dvss446|c@ z0UedAt}n(ambw`ehY;U6X?T^SK8M)c?*$sDMA3o$`z`(-M`s$AWcv2u%F1yn zt*orntgNUpWgJIbff}dGv82XE%#G5@68BwMY&SKvbkb6R94$*l+`tvE60J-zO;B7Y z2wV{X0YT80|9c#K36bDZ<%VjO^x>6~smZOOg+PS+eny$li#^&j-QUeu*PRm~e8n!Vx zb~1%v2;2^)OrpTg*^#0}mrX3G&b2y{$l^Wg6B>Vhsm~bX83@`{$R29ktL$awst+()rbppi{&G8eHLM>+3w@zyUHoh@_4GF8aVC0}m8$qL`ivxOTt;VluOmJQ_xX(U@2N@s zim-?|pq`s*B&ox$2Z$O+nm1-$vv$$O`a;M;p7&WbVnpzS-z_v)I!w%kC-xDnoS*>Q2>LJ=m3lkSJ$3&f1zL)b_Tfz5Gx4a^}>J zbDh(i8TC8!CILOc8%SAtZMuq4Fv^yr3FOuz)lFSSX=pL+w*B9|I>>RE&+1Ri$rTRSOx9^en=cw`KWkmJAQ3C-XvR z+Wvum-1E5eCag1cyeR4{+*GXD347H0vgm`mXL>(iD9E&s2Viuu{bol)3G}(@o$0%q zXplkjX_lCEw2d_YoQy?UEZ#P3(+J}Ddm7$&iRgA+2uN?ro@qgNLeqple<@=FV^%}% zgCJI(4L012tL(K{ElrT1t_0JW&8)`719+<>nuNYHNQLb#O?^j>iV)SH@6ViVN{nC( zgNMl+xbHm7cRAS2mL^>_ghB92{~~Ub#N+bN7zQ!~;BdN@Qp*~v8OK6cY^#3QI|bn} zm$dlp<0^b9XP(L1SwS3UiSzB2JgDD|U7Q_+44p=Bb`IyQEw2MLZcL(1rc-E>4WU`6 z6y~l088K;VgxI_s%2T=@5qk@jmw=}`xQYDO)L7ByBGP%Yg$@*DU&Cu^ue8mfU_v%6K(TS&fv#y!X$2nUhKZ)&k z;Hrfb6-(-Gt=;N|85z(i)$-yED`9aOldLV~2{-8KEACGIJ#_Gwy|Qi47pBqgh;h+e zT<=XK)s6ZSL6elof1Q9Ou3e3n1pJ<^mr;l;!-ip_4L!y3peNJ5R|ap5d`Vwj}Jj92`G zSnAS&8n*L$GH$g9$+(dJn1JfQmJgc{=y6kASRhWA>~R zbcZsxMx-2B&`HjiZlO1sPoDL_IS~(T~6q~SOWV4o~;40Ul98K z8mx)7256To%yg-j~E5!oM}bxo-pE5<4$i+KwFUdh0;-+vHgZL?_d`l86H$P|-jO1evV32V$yQbNEN9$I=!1w=bg2;-srJYF?CNFIX{(rkZvbp4c-4<0`Q?@Bsq`RgZI6`v&H0`x~ z6FaCc^UDMg`nr$R1BK3!doSgpIN z$LA2FoT3NnDgrD{4&ODzGw3CWk~S3hYb!JpSCpH>-1v)?|HQCzTp2KZA9^AiAxX0* z=my5}5qsq^-oHkos--J@t^XC}eym{AXcX8$4p)YDFv;Q~>(g4mc*QVbrg@b!$eK0Q zVpxmSujOXbxDGIN(sOp4k5Zl?DUCviPMFs4pAab44|4}1rs}jLA_948YhM`}G z-N2pnX2}9J4q7I6TbGJ6eZ5OCCfiAf=k0>Y*@NIUxCUEHKHx3 z5Bo^XC&xrpsh#(+a#sDDjlw*so^?%p^lvqSCQK#5dKzwLyLeaL2g2A2u13v0MN(u} zxE!GKJs3!}y~*yg#ltj4YU0v2a%iyfr6z1>8&@}+wIRMVG1*FLQA?U{VA%@~Ju!Fe z@Ho-Dg>bryimITsDE8m<`kc(G8At1+TGiGjL~XxKB0d6L08c&d$`1y?!)3VJGh6ll zXD;k_gsR%>>(;rfWYtBi8*!5@?kDK56-Z$NfZZg!NdmKrLipIi-J{T1-Td&6QTt)+ zA;&}0KHjvvr9mXv97z_G2Nw4SBm|p?!%jf4OPMCCLYZD~_sxW#xa)brV|Hb$zmWG{ zH|ajLtT$aw2nb(k+67bVgaRy+>L9b}0BYgVAmsZh>#^Z%Kt_p#>yGl^HuS z0@2IPiw)Zsnbut!C;y*)fLO7T!~Zv+yaDtven0T8`O{CgSga)Rn1-_%9yR9YF(w5NC ziIXx9-Ou9xm03ovq54h`*}{-+|Myqx;^y{N(NjeYe%uo5vOjoXo%2vp&_ffj`f+x0 zmH%-WNBH#+R`Mya<+ds;z`DwFO1A#(OYMBPNd>z7y)p&hPfU2{wHeEaLN6ZRUM6bD ze+D{x$^)T&d8|vn!FyGKRNQEZJU?t>%%Paq*vG__Rx(c8moir18T{E0lsGmsxXmhl zX>3g+&pm#@)(8*s(8MkRm+u02Z~$RF{IV7AHM~{*W0g1_`MA+BnC~oAMcM zN{o(qH+J&u`8>_O)DZoE;)?;q7_aQMHA_?L4yiXp<{KQpa4I4kx4O8rW_EjGzgZ>Z zLvh93V&KoqB<=F{b@VyLcQ|x4_~~p=ttR0y#mCRgdC7d=)WNA+8KE|{fH}qElSoaJ zma^--xvW6~dX=D1eOmprZ~xyxnuTfJ0m0MkC3Mn}Pu#uZ8k^5g?X=SWDoCt8*yQUt zpW|^?W%?2JM-!drX7d*fzykrZj@#{rHPZ|5z9k<$+go0e#zo`St4?2{=nKF|vjsbf z*XOm%Jn0uKqX9i)3J{!y+7hB7WZ;W_J#e$V{wBrQPP4+%DrtAcSkk`AvLeMb;P>}t zSM-7(j+lI;p3eX##)O?DU}7q_Kn2Iy`@Arv9Z4y5Z$rchU48*LgW&8)`w#+C^TsH{ z*wm;l)e?*YS#PLMo(BxhUKR2O zCI-GxSgpg1ctf1!vK7c&p~-}4@~?p%MjJHiio-69Pk%fxFA*0-;ie`{8b1b4iaAN= zt$m8p<-{l~e_oyRB8bg|)BIo#7AA!#^+(1yuo)zh-~d;azu%nSDb4lVPFejlS+#`n zB0R={Quf}(284-I`RX>TEcHHlWaS`&u+;WJxAX{N+(|;xO*(yV_g+A*;2D7Gaq;bJ z_-A+>$tH!jy<4{{nD5E{_-?Pk;>U?@RAGM-kolmw8wHy(zbdbnnT6wP8~W(J(Q%fd zO=BekA_z$yK27Z!P8I)2?O8he3O0jW&LdeQ9S6SNrTLC9CyL{aym{aUGO*BO3F5AZ zLseq1H>UE6Jlh|2-dwR~SoV(v-~&{fEXJHQ<#~~c)FhbteSvQ{&(wm?3F|b0Y7*$5 zbG&Rh?@zfd{R`E`))uVcil`Q`-~L*3F=AC+kZ*IaL4g)sm^{52M@7z)hg7F;XQuo; zc|WUJdTpm#<2jRx&b?_aOo$^A!zBYK|;w`*uyQ`r6o z4FdC4<&8L^Nkhxbp7gFOPGm|d%OhYf-z*9}^pevEo2w%3l0JPHQu8dnD#VFgVDqeL z!s#pTZ}TdPw-wquHQq5xx22WLq>$zSDJrBP<z+K|8j46BTHix ze*ETt-HFMnmlgC>)~tAM+WI1Wr~j&D@;0>UA&58;vy z&AVo8O9avdd)Tzi`GIiGBVkrccIq$=l}P=^4R-XPTb|4mSdYa(_&3jG>D3ji#3Gqz zAX$Y7Y{`}s)!cTFIJVTidvXw>jDJ9-Z%d7t3x5b?2?mGv?jGdILdKlzxPCMlNfZt$ zycc|@op&j~`dH{}GXsnZFDOiE(6--Crzk;`4ioMH1gCTNfUaZIt<=MGb;62kMdn{} zUD^S>D|nztJ#^%fy{SSiQ(zlV?G#Cfoi!k$!uA@U(AIt=Ycx9+NYmL9>UR0r$#*TLia~T$kqW4n2*n zts$KoexljhUwKmgKFQ&#!>9Z3n%<`f@{ODwdY|93EV<>IXeygnNc~#m_*PvKYGBLV z-&sQA+{leXC9esNER|Jya1k5SeZ)6})Yn(YYIelg>MXr$m$LlVu|@)dIEy+8bKXp& z15gn!ilfO3nZh@^R!j|9z%$D#wYLenb2o)nWpFHqEVTo4#a3DaTRCcBR$TjZ)S5M` ziynWTym+lfe-lI~wMZ|oqhQTm#MF@@^Uft4mge6@6C2*H1<0dAk}UQsKDr_VLFSd) zei(rgQ)J(118#pIgTm3NweeABOM2$*o8Lh9S)$Kq5Y^M&zezA`z_5#I-Jk;FOlzBR6aq0&U^&hOm*V-92 zHx=skbxrrmp0C(P18qE7)j~R~Zpp_xA<0mE+kN?EV(_}QCFuyhm}H%l7a5Rc5VICE zWF1%=StFnGHz5rNZ*UG9lKYw^GH#YE9H5ZqPG+KPmb$MAl@0xh?etr&ZJ#l=|E=q=ZebSF&gYp) zVN(~|cqaMlTT30MA8Wp^%`W!d6i}6`W7Y6Yy2l+N<2`0i5X4>TFrl-;RT41$yguc~0caab9RXzk)TH3ApFGnxFj>2ZPrHdj z%sZs4=EftZ*Y%S6n8BFwL_Rey3t+xIQB#vxrTjXd`hi>3uxl@rDCS6eCPnERRw5!U9n32EU?6Rnd3;qzG%$&~-M_pIUZCWH~!oz2q3Pu8NidHv_nK`5r82K3a z7$-8EEJsi6`4Tj0HI?%3;&T%75KA@xJoXyFI!ovf6{i}UU;Zy{aCt{$d1x7VeOgTE zSiRg;d3>Or|32=GruQk-Lh@VpM00!5B#N0Ri2|QMQg^EyNOV5nd&8_}U}M+JU{T8Q ze>%*9(*0eoqvVHWhMTLDfDJaQAisHV%X@ng266yZ@_8EWDZ0a5oGvi_KG>@6CXQ9Q zCmgj1&Y{Y~o&D8}!y@E2m;UbO)`8a3=C73>`?}QuTzQoCljVvjO4i_mo!f8G;kDT{ zdIrkdPc0@tNK@71&Xi||#%;9-7ze0x9=^86QeF7RU+t9#W-N6;`rm@zUR&OeZU3PI zNtzbN4LD8#31M*wd0DFh#Qd2Zp5J#grpbfp(Fc~Vkk46$kN#_T{7WVfN~itis&O?~z?^W8p6GWf!V5RjkIKKuSAmaB!8<|8@AK4a6|#vyTV_-4+b z@GS=jr4o+QvwKn2od&II@*@v+`UPhjMXa2#icE>ZaFX)Qjm_LGh*VGSPI|C3f5c5% z1*;(A*t^{6RNZ9Sla9Vs(}KQb8z`R^Rz`WvDO}&aS&9es2@QKj{p`iBd;^GT{~q1J zd@dUK%;Hyom*fB>o|AUa$4u1}MC0_`Qpxqz3~owYhDu8A%Pjz|WR<=wj%XQip)ejc z_@#V|wdhxDeH5Y|*{E$E5+DE4ZB(d9V7{48miNaHqE|#vy!xJDn&eRI4`aC2F;7uH zd!{E>Q_9f^2+}GKTL?bER~C48|Fr{0)QR_QE5p2{riUsy3TrO|{}0@*FS(;N_9P|* zA^k+q!Q0a>hH7Iv?^*W!1+7QypfXFMCX%g11Lr+Kf>ttgqw)O$WfB? zj18-1WhN3ed4e$B2JTaEFn1PfR;-qVF)iq7q6YOJct=y}Ni%K?3eL^~ECUvvN4B%( zak*{R+s)(|%h9r4FxWfK-&nDT9DlD=VKDNMdtP37mt zanEUP!!Hu_0ahoE>yoD|+gT!+PB~Q+(hdC%#mD|CEMA=W((qg4d72+(sLa_<_ULyO z0#A+8P2R=Wr8@hJtahpiqbJpVt2ZGKB&fIUFEbJ@$=r!F*E;B8&&`${%x8uk7E4c! zz_hF_!r^QF1iIq2nizGb&?0k1#Y|g~kZxPUZ7bI<|A`T$OdfcnU|0%vAR;EMZ8{w% zE*t(h0)dK7u2f!0xSCIO0!`m=3&kj1Ekw{&VTYr|^h-Uz5J{!UxTAj+-Y*7a1T<>Z zm9m&1!^P-plQ>fHVxrSfoY6;z_u!NlZoPl zf23b4D_d@?Kub`w*RwC`_vf0RRJAt=qkP^a#9C|fm@~E>%a3c4CHpmhjQOX%>nf)o z-1sCE6%_t=^~_ERVKw+h!=)fyhYO6RJD19X|cynDnG{c%^4F)V5F<#^w znbqe;Az$<&LXLt~(O=i$&{wPM`)H6$sA1cD1NAYC+2Y$0|Vk z!@E3dl-y$yWOXud;3LR9WcK`W!v|$BpW%dwRYrcV;-fV6u^pCp+jyCKt3@KPQAauCi1DrV ztq?*m!kiCZhuqY=%H1gc**_ogmWb0;x>kt0P_&L_C*tx8?M%w;3hf+9MqiPWpq)mO zRJUCX=)HjD@R8>JfDih`_i|F0wfNrh&z$lX{9j zfeImvI5(j4iGVj2Q4ayf(s_fPfKrpCqpQirngvNqKWdL8=Rut7)Ko*LckhX@K;%So zYkyRlVtEh7X{srzc?sXCH1f0O^-SET+Vt=r8^2k9U_||kwsr9{Y4-v2q?$x6BC@Bg zMV+-O>Nd}O^-NpKr>`nkSDIF5KD7tKFSeSmf4hF%?W^D0Bt7`SD82AJx3#KG(~eVy zdBA@^&=wmGqr3DbbwH6XMNM9h1Yb`c)UyASo~zD}+&n_$+N?*D1^u^a>4b}Vv2VMp z5|ADtM}2gv*C;PdLb(bXE_WnVYzk*sWPG405FE5-lUeKHR#| zaFIA@-DFN0u22+s)itVu5tzN~?n@Es--xpNmUKaNgqYaV5K!f2JN>Y91Ckey%}Bi| zhWyAPsy}#)X?#PCJ1_Ykt>^`0L^%iMcX_1zdp8lev8$Qrg=9Q(gMR+zKes4$I;s!S zp83yc6}*OM-5q9@D}3v?Iy8_fpUmRc>_lpY#q&n82>PpBGJ!{itLaxFF(UWV$XH~7G#`|O%@9n$^CO!p9bwlbAP3xQcSF()Xh=*)G_6SH7PA0B3imV0#aixt;WK0`%3Mx zDE&o<>O%GzCp98Xtfn+@D#Ku$?JqT*ut#@$_5@%UwD%Wvu9{ zEby(0Wb79P9ne<2hfg|l%b(4I=M&~rz@dXZw6S6s3FaM0dga@o?b~Eou9&g;-R``0|lP0tBI=jd6FTEsL5g zw2(N-sU-tBd3kJW`YP|vGf5r(T<~#yreSNJH}jerM~_D#4leJrd=T0%MBt|6eg8ru z0tWa!CAJoh2{pZp1KRs7!YJxxHj!M@8`a)Q^XV>e1*OGJhmG8IY@W=|=4=&fm!2qI zwaUZU1*nqj9xJ-!el{8Xb-W~DvWDqwvMBhI&LrTFF+Fc+DIl~-*)vx3ulkFEPeI(G zh7-*861g$th5EIgd5FfPYyzb=8*(b8AG|IjGddjJ{!fil910Rj-*!2^-2f%rUdFC- zkC}F}|CWV`Ar=F3e8x_J6du|!OAbjmd8tzD!*CrTD)84fu zU|H}RG_v1VQTH{KzILc(Ny0bWFtzbj^vVqtbfsHY$I@G2r)k-`*8*{E&FjT&Yfd_{ ziyFEB8EgJbHrVU(8THtMmN+=gX$)G_+SO{kYt4VRp6+_*9AlT|Ov zn7|*19{pqZz2VuN9`t}La?3if=7su%?2t`3anjP}#k?qLrNcSWqkXBC)r@ZBF@WO= zPfc*v2>HY!{{$cdicn>vB*d%+r#!MHLtlZK$ZYuAMm-CoBZ*FV1azQ{M_rR}h+5(t zC7dpZk}SpBxb8?zzGSrzH%IPy1N6zKofk$S*U!CJ68O>-edGX}7`}c5TGtHjYgu-K zEpClT3(k9{XFGS>1%5y*kM8N>+Ib=;QZ*u6p#{^E35!r(ePKf9?2P*} zJjAu3>M+s40x$fA>vcg_7IOiZI0p6|Kn8Ob4O-QtCzU_KL^zpYtj`u*` z8Y?SW;738lPldF*ZAui>CyI38IvpSwc{fxOrkW45FZMGVIM9(>L^MjBHO-uj zI|;qKALBFZ)UwrSSK4gEm|u)XJ8xri|6w&zX57RA6Q~Y~v3aehnR)^W77I%I{JsGp zYQ_0|j?cTBiXOhvCF)yehW8~J68X1^lP(e7YOBmUQTOc?@k3{=sa7c1yt}z%-W5)2 zo@?e@1ke~=dXFR^IHcd@!haiC(=y{nJ-Eg`Bg61N$PEB0v$!mZCf*-y%cS|L-dpCV za_&+Rke%&Ct&o$mX2}*62%LySJ;+<*HP=(6Oj+r?5*kGgv|Fml4)}m~v7Jte$Z}`5 zJ`=p;Uiyf~s~~OQRC6dnvJz#q?d&VWHG}2H}@v9h5RatACQjLTOBC^jCAx>04Q~o zXDV)Td~}wDc5&+B-NmV^{^*DABRt55f=3a&fUlEQZRDZVpQrU{3hbI-es~|a2Q$?0 z5@n)&Tmzc(ZPR8|v=C0}wqfCTakN~gR)ej4PRoqfrEv^at&(t>pKCCDm^O0d1>|bo z82t~Y!~aA6@IFEeVXigYBxlj8`hoa|@*Z+EgN_DEE;SY~<=VcQE{tQpw?ZXLC58wh5YhsBK+-^llr91It@IjeKHfz*mNuHsIyr{lqxh`jii#Xrm|GUk{rDbF<6KLHTvtH$xj)z2rEQ=;}y&Cyg4FnVU zwE+GCMrt4e_0f%oaOEw%mN(ILvpiA`gf5g=c5RB29*q6FP&&4^_PzDT!Xm|ZQdLIKj*H?POW-+`g*>8YY4y`=^GXBba3;;jAY_g{-}Z#gkjU z9`4*!A+7Nm${kDHscYs5hZ75my0b4@-f>uQbf5%j^H}_0d&`YBj*7@vQ4yFUnna<0 z6|IZ$+s2gfR=7;z0gY@Q zQfR5s=>d2?XB@sqc4QR)bANvX?Z2&mh9|H6#kY1kbIUf{BjcA{I?T5_NBnxsmgqau zANMWdb#_AkLnrK%tRbEJ?yX?#K*02Q`3ANwr4WOqfQER&Ov~vz<(|=*h_R}Z^((}k z@Z!K!70+R$_ymd#d2Sa}ER-_RQmV3B<87uE1n&wfu(s8LGR_lWmVWTR=}wTPzqS97E9Y z=OiB;9zLJL>z>%i)Es{>|K}22v!> zpKO;4m-7m*!XbW&#l@Ik056y|sbVTc-q~K#27u>N@r-Ry)8W=am?YcySHenPF(2px z`BC~$Zg~vy7Cd0ds%r+>%g6WIc6X&Ne}p@IYQuumk}G8*tnTh;(_upx%4d#NwiK*^ zs(v{_<2mJOkJil&I6r(_C~HFeJHl4fbDko!R`ER;`An17{&92CRqj&g6OsI_!u2-T%}puZ~{6QA@A z>cVQ#T9G57$>P(KF*1UYPY(_}o?9U=)=L>!21jdmAwyU;7O`KPII>3eOvQ%+!om)J zPhj;p2Pz-GOO~^9euq~J3*C^9X{a#d$c|9LwQ=AsQz&=jMz3Dmyp|`g4$aTSyG!1{ zGCdu*co(oyubb2EP~}*i!qtj7g!keV^A3#-%~;W+cT~n_y^Eqt5go+fi=}dRUGp0XO!? zoSyp5%7uNFaKm`h?)(~E0b=T+EH)ybJ$}SkE;2Vsx`Wc) z`AmOM)LqlOYdOq`rlnsh96QM+`@I&6nLq??!z^zr1~T+)u@4Zci0L1=mg}(6wOC@2 zi0QVZG!OZD5-fi_mg~rI{|4NjUa!8)$L4=5xzGApV2LMOrXc+yFPnu8lmV9?YCivg3uJ* zk?25l8ZL-*N<^GtH!nx5UbqvwKk(tIwEgc#_aMhsg{3Q;>Is(sf6#a1(Z!MXWK|9G zRBMxt%x3eMc&-JbUzN6;4V6Fd{bc-^8}RL;BFD|XMMgUBDpCObxOThtIyBLI#2>}R z^@#88rj%7f24der*jNHZSzl#3kPsDTF%N!%n@#05wf0@X44muG{3UzbOOc!OLW$Ns zV%(a2;{?+t#XV%2*7sI9+?C6+vUF8t-*Z1S+TVq;R2Y9yR$c@WqG zu?rI*yyhAP0m0!^vSdc<{&{KO3X|kpu8|f}F$*mf^wl{mv9_VhVKjK)Fmbx)OVBPm z9Qyk|IU=WiSa*BUK7y=mGQn$jr?JWMEtrJ=$BaL$+w2KlqJzHGuPs^VIPkW2A0=0C zdr%sCZn33iw#;rP)H)mo>b?h!NNlb;H~GdQ@mUW(+sCyokg0w3)(jf2;%FbHtF9t1 zS}bxus+(&GwaD-VR@ar5q7BiU}W%t9!|JW-$dDs{T)OW=+OAJxd&*lq0WQ^VJacZ>I$TGIo6ePL*j zBYj5%PVqPlPk>8_n{6j$qhxIOs_LKRa9&=TL^o4azZdSvS`cXxLu|X1ED!qL{F&k%4YDKqT$azV(jZfVYazGH zQMEp1GRB!lrLIcOQOH-JOO9@4Nu|l$9XI56*E~r z`!-o6@pwdROH6IvJvg-8Su=0d~(daO~Yxszf$9FFZG@`J0%r%B*TBdMJTf1JS% zdYvM}do~&Pxwwt}LloL=f$h1UL-8AU8H&dTRASVs-)s8f2ifzk<7i|X>B%V-#i;KV zCK|7@kHoV1&sMXa&ZQ)Rnyx!m_Rt=0!x}pWhg)z3L^8{DisT!Gt#d{PdaQCVCdjDO z%Ua;4! zvWq0Zm?IkijkTNDyMq6~b)l1_R~i&zG+5P~syd@c<+K1AvHaf=^h9}3Ok3h@Z2hkk zgbRTnH<5nX6Il`z;XL1<=BN*uztGP%88@0qpMQ@ctb;7YaoI%<@KH48!!9WEL64i6 zGu{Qi6A$hhNwHaMFY~9zNIt|`)~1}K@cM~~k8{nt-Avj2j&0%Dj1KD3$d`<=)En${ zkVSTB`&&DQwwW~=g+_iB)Q5+FLlW;X@ol%gWSF2ujbh)3%ON^g7Bh{j8&>Iu{H+Q8 za$h({ZJuxeG3CAK_Nli_gC^ooN#98ts((HN_?)ZB3UpoJx3-ULRlnf6nvZe3^StaY z7g|3|C$)yT@E2t#Ke=GY7gqb8?iLZ$hlgsPp}(7SgH5(Vk=e3K=Zfu)NNZ{wDX{4- z+qeFPCkk=k8Qg_%Rn~=Y`GN4>FCUM%=vLB!{^JZ-=V8I$IHg&B-zF^U$C*NynrF{6 zO5^S7-YphvYl?kW*6NoYk)_&)lA3jsXh{aJ4eW!H3}1O3qa`Sz_2 z+l?qg_XE{()5)ybV@JS99Nn?VQZ-T#K|t1!I-kw0+|$_vC7p?px+DU)`FR$cOspxN zy%oeh<&<#&18UN2P4$CxCgv2EbyG?nI$%m7(2o<|I$&cL+Du2R=h3VzAuM-s$`u-PZhRfL*|g0;(_-6 zUmDmz>fc_=hs#P^o}S`Iknq@&9_7rC4utLuFEVm58nPN8pGrio{-umFs5C4E$HO&w1&&9)u+c3+MDO0G}H21l5 z^E6ct0;|cc3$+TAUd$IXFn>W#KSw@-Gw(Ey*$tN1UHc4Ni4lPtlfF!B=*-spXi>*% zNaF^=Ns}P3+Ocab??QWT73ZQ=9C_qD>-vU*P5p;wuGA#^$(FiWz%1PocdCgy%QgFu z0h|^7m`$088-why0MU~VWi#L*2|p~{(HzrdF{V_BT{MrV_d9gmIuu{0kon(HplPy5YCHzIb@WfDwAPlzc~o+9 z13U4|$eFk1@+6LSo9&G|5uwpv6C-VWQ$8Hd^eB?wbk?a+j z!}_{y;UKU3CG@pCJ;=JwN3`&!=5Z9(~P zXFp4>?aSpk0(prKDqAS_sWoyAs}h#-kI7Mo2-Li5GrfhGfE`f?Qc}9#wgybkzyI_M zHhaRMX5L+svNTs{%$k0a;L7hpgnk_Rc{Da0y0k`O0JcUv_DcAr$*~cSkg=-Vmg|=D z0{@fZ|K`Y6Kt3^|& zGE(2y;BIvjr8aT;@eo%o-j7hdSq+2|ZZQR_Urq;nO;x#$(4>-`!1*w}YmnAN~6taVo1(o{n+&S7u3m=rOy^qHyx7ERjN zQ{mVaB7?VqCzCF98| zaf?1XNj9QaJcFb;vSONqmqgn0^w#bt`>ynOnM==A41c>M(*3Eyo?F2fT*# z^+PbJ<;k&IdzMd%0lWpe*aW=|>q2kaJ_s~M~@^lv+3rq4ILH-O3gnYfv3@auD$Jda&u(C_|4jKsCQD9W(k&wCR z2P~V9Gg7NZ8a^Ug6))rbw9!es=24dZ&cUk9osqNey-d4>4~urV1PzUb9$U$Sz%NxD z3Empl9GRmj@RvIn3FxjIEB@k%)t& z&x-|Rw3LXtMpK7*$tY;5VcRGqf%^C{#Qy~;w?}$_7xB5{m29*njMl(g8GK%9(s|h% za|?&XUS7T;_e&cX9ZST-`TiTVy&k~8kZDq@W{9o ze9D{$r`(U#{AU675o&vK$$-D|2tu|FqQUL(5n!JQzthb+x4TYnF^b7ae$@b9fUpa8%EKAQ2Aq|Yyq~!R+rG3prmg;4;VpYwP2YdMvztiCQ|V~L>ZZ8W9{O16PoV!S5|-}c zitDyiHE(G6o)#yCW|djrfOt3`I`}8uZRqVmb^P=XW9QexsgcbwE-!?BI?dr+>;6Xb zLjxx}9U>*=`V7Rg23l|qrX*l1=D_5_O)YzQMY-88ZZXq+#w0}b=A~Kd<<=XDcctz; zLjeOpGp#7>tI6+;P;Etj^+uY3Ru!cf4-ljd@2eLet)f$E$Lh%wsw-K9)_B>gT+-f4 z;sC&G+Gks~WZVS0kwv{(mG{`vAsriM@E=_Tt04*qf?D5JWR;U1 z_*X1;v?sKCAZCgXS9*?k-Eup)BHUR7sEx?WDfmDL80FpF1*i{ow{iz5Dv(F|SX1Tt ztjH2{g+HRlu&M7viM-c(p&Ygl-<5i$o+SL*WR|%W?PNqX+nF1Gdhcx3)7-xQWQ9AJ zt!Bn!l>0NAN9i|+9P8@95f$NWMItQaL|s0C;WFx#=Q+@1F!Gjo6%|Cd)yo-Q z$!EgVfzYd}aDO^_La-C`U?sm-{Xk7xq`%82F_=r5^}%2U>b{_k(zLpsVpZEZ%Qq0k zgr;imkzDc2k8LjrI3%I$o=jEnC23_KnVX& zBT&t*F+OpUEBmjx*WTt;=-p75j_0{4kCc239>9FfyG!N>Js?ZJ6M~#)KEUPHh9jw0 z3%NtHfrtAff+&o#{WJVm8^dM1lKkhRiKkyb>7d0agdxGnrTekpy-SvMnkw-lR8NK1 zX(lRMT#J!hf%vDY4k!DTHI#gMnY6(+75Z3@j-fq*n$o7fr~6MnSc6HV^@}jYz}O2D zF^5lrOP_J>1)**pH*#&1qqw#O#@McVTkz<3n+3ZH`;Cbsb9>g9EgYP7GE#S>J6GP{ zjau37U!P){^##4||44cpf2J4z|NoS8ayp7iS> z+OBkQ3JI0MNwbuWm~AeaYg@%AR}*IDYS}Q%%*@!e?>@iZ?Y4j6wdd>gd_ErcJMQ0U zwq^?IWniFuYHv5b_;CYu3OMWOtd@ebcJ|uzG{x(??hHG~T~V3Am1Zi?a**bO1` zhHUxMyIWh=^9jbr{S+1ON+)y-QJK{Hz^%9oQe}Vmp0Pm;QlNdG^d-q>j}lCM+qzuA zbV6!J=5%rbeknp@SuuWjJ;S44>lT$Ndy@pvlg-8QDCpWQQZJECw*Ud;zHB+iSZ09_ zCVyMHF>0dDB;b2XO@6pE-Vv;o=cx{lA0tJt={S!RL9{C#2l-cqq6uW<$G52nRJUK3 z(!NkIx>$#q(&gW};xORr>O(kpV&g;{``-x2Sch9Fk~)tvyXU55>zf2RPpI7h>U&qg zYR9D}G4HrD@bhb_n_-4i*e&G+P2j(CBeKTx{-ed9X9woWkj7nG)|BO1t`90O5geU~AkpVyqS-kI>cSpmqF zq`b_=ldc~_YADx)o?#GtG&a4;1d*QKfWDf9qUY4q^M{cMH}b)M;xTsnW;VM8q$lwg zGJ9@0!S{oIp1MBHw^ogM1n0Q)w!jlX?5m|Ax84C6U01hQDT8rEdskB){P@@`Gjh?7 zT{ucOQdCFndYGfqGIna@J)GUF)!jf7#Qz{rlh=b^`JE+WhaHVWeik#b>#Pm&pW1RV?Mx`_+wAuM7*Ve9L`e4Qjy3+- zxG&x2JlfMk@jM&y_XPcG47KS_tVQ-18@lsKIYlUSu)bdzbBZGt}V?iqaK$VxRGPjoNViM>5$NMwuD61_t+jUyy4thbqRCs%jN3 zMgV)GX0A9eKq=(BzEh_ER5*~#e}DivFydKj(65J6UU?N&N=9=4DI*eQgSt`^+%X!q z7GYJ;qyY@&YL9oBP-loOSgb3)L{sgib%ydYpXHdQDHhJI=`WY0bWxR z{v)(jR^>o?C_PPEyE~C~HXWjQ9`Pk?<7gPbCWIPrH)rBurycI4)VF7V&Xf?t{8oo} z=kRx>3lur)TK+$b3FE=EWSStQi)w;Q`P@5_D~63WLNr4hWiX zrmdEtQZtFDKi3|2%#(YWF#M=N53%`icogq2BzYMjBsD)) zqV{pP|3K{`v0~EUVBBB5qTiaACHfF*(6=x3$xTDA6XAU(Y}7AvMFa>-{RZ`PwMdUw zDY4uSy2CQ+A!{s>r(?u{_@!Ra(2@e%`CT@2=Vp~86GP^jGR?QMj2T z-Vg6m4BMwNkq#jEB^0G6Aki7$tpBnw`Uc}yt0&^RQ(d(p>mQ%5q5n2bPucd4Vc+r~ zUvDSP4#~WA{V0i{jF){iFzYp#ARS7@vpODRkInX70EZJBGpg{r+9+pqWi=CgI!LEl z2gzOSB^M#gQU6Kl`QQw9De2MOG|K$nKzutw`|fXP0HUvs>wpxpe{DP(V>yf~^c`W_ z!vv?mo3kW9S*T&Bi+U)r*(&9vv%t7}{r@zN#_xCQXQfh4U8>ms;D=d&{<(VhUmtgb z>B54)%@@`fMQ&=cpEmo;KJdIBc4XK(`?u4jn(?VvFAGrpw$PMHbH%|aKs6&97*b>v zq@U3`(T0QjU3adg8IzHwq{2~#E{w3_7%wngl(-ggkNKP zOR*2z&X?8+f^8VRqgfF0 ztAp*#gH5r1O(8zC03Q3_f%XQ>e%XiX`~!1iQ6`Q5m}1e~QlTD(@jB>!dh*JCtlwAQ z*UfDa)+My`fw$-%ieDj#qNjMGP5{^uME}cUjpWv&J}OIjZsAH~*>sHS?HEaeHeeq{ zR>M*r299byZAxnM3Xfz}sx4>kC~60&U~ab;J&T3__}S(!Nh{AIr22%KT2BdJVbSa_ z?ZQX`39VnFL49xvcrGINaXeVe14Lt;D zn0;`~ti@#qDx?S|+DI*!Zwcna+_|aE(Sjrf@mbStsSUF3KY#+v%$RF64{8$DMmw{| zgJ{>tMy1ZY6I^fDliOP`l5sP@J6>*-6F;#T7(3idi46{=eT?j;^onK<1u1Xow;hVi z3^n1j?Uq^PIjWotl$zRvshZsi%Zpma`w8glcp3L{#qzJovfj!65BfF~RF;;4?FV>7 zGkplx<^-9gL8~=29knAJ6f9PD=dkQ+e!?gJ3uw|vT&B42t6p~vEz+P9ndx1(A&Vdf0nIvt*&$SUa|ap zT$`uuY7an<=zb*~E8XOHqM?o!7(Yl|wMEJ-&AiZHGw(5yaE zmp2E^OyU0$G1b|`R=r~kA8~zqeNsef$9fvfARU*K5)J+a!r~-Sr zem|^9`YwxC>Z2q-T}+xX#W&UR1pFXq4{Yk4U1`D`#*imkRstZeTH&XmO7Xls-bx*6!Uj!i_qInzcd#fDu zp0LZk83_J9EDqNmKRk-Equ>!$hxseR>FkMqtq&xs{H5LBy$6Ffa|Gb%1s4nXSir11 zzxdb(E8VX#pkHbAGq6#;SD^92wR2BX5ht6!n7S)}8G^p@-%ai*4bE+T@H+au4@fGJ zmaOaJ=K%s2#l@mP<4hHs(at$-Ux!I!vatc*-2CT=y_S6!Qq|zec3AVsy2VaOCyBYf z2OR-Dx_mV&IAO>>T=Ukg-j*cfD*Rh4QikS<%0r__ccS6DIVdkE#+FE(qDtI!F6Wn#@bWPe=whaoV^Xq0sh*{A!_hK3tQn zMjo2K;9)xTBgHCb-h84cV?4Dl&p%Ej9m_K`u0J`(=`yPl36=`5TzqtDIwaoKEFpTn}em%~>DE zudDb#wHukKvy?@{HVoK#$P)F@`tx3={LV6RO=9_2^=I^iFN zM758Y#|aGr#a++9*cC)4X9zv2(4%&lM;~XIu-zt6@F(urxt$i)TAu&8QS~Qu0I!Rs zAX+>A^&jEzx7Y!Pu%ksjI6&z0802aiQC3z46DJdmq)-obPN(R6mC3 zTENXBIv_?c@gNvxE5_?jXq5G}N6tt0+LZcRNGB9?Nd_@nqg&K(TGwNrsHSaF<>JK!c77DH$fkXP zh$12FSE;|!57*(7Hvnf%owHUEU96bV2~3HxV!w(J4V2CFhO93?94avNj=b~4@F*b6(M;%@*lRpG z;k8`6Y5Ep%ZFZp?MR}_&dC%GaT$^EyMlGnOP2xAL)MkWzj)l6ukeAuEp?trolbCLx z?>JBjr}`~fQk|WF5x!gOgvU&;rx}I=R|*06^;2f2fCl|0*2zxrhzvZnAzrpiCvDLM z{k5UxdTFobj0jgPpU(yU9bjdO2E>0M-GmB_hQ7|Argsfbtm>G@?)?|p9=0a0DsnmRsD(z9{5E|F>npBYEiw)X-bGPk=>bX zOjk_APS$a;9d6I4$e}_T-PYL9+tIE zQGAsqWn@%qH`mq*E=B1 zqOo6akc+RAH2o=uDz$B>^&1E^`r*oQ%_^&-y%_;uby#j@aY!(=pCXA=V_X#3$PqMI zliLn$Sj`&n9apS0ItX&zQj6vB$ZKI<$p3EF?6UaFBVVn!eZIMHL1`GikTQ7eh~}bq zj{sW3l?MD_4G!6k`9XH=@&a$5c4Yz?U=b{Yeq=m~Om25GtkYM__#5i1sa-p+T|iH) zbg%aQo|F6)Ov-R_R?N|T$Ebht@ZJfcF2lD$LwU#4pMWoPIV+TDCZD-31FrLOsH!)~ z6X21s+Iua|GW4L!*3XBi^@oKv#X8~vEyAtRL=4DWpC?niVOA)Q9DsP@@?wY)420@! zBU!HuOM`Z?dMoYkIda{>(TE80;Den_=(%0MJLw+7uN)0y|JU(I9rQq4_y4h4~_UoBg#^^>pA^iO=zvj**B{ETjam^2Y5$j>q5Q zgbNt>=Ypa*7G}R@wQOwqQpHHfZCq&Wc)rVJ+*<6-LbuzJs@J2TjV`bYuexBb*%Sx` z=inT=v`!i&Xq|r)U-WbNq$n#^ z@mq4mgk_=Z%c{*||LkwvBkl7-q{P3JDSQQ2>5Jl*Q*M4wmNflY$2y%Jwx+*khZ?Q`Dk znqCZOoqcyG?n@1Yzj29(2MxoNQC29#=7O3tuI6WXGtL&hPr}aeJC32%aAMMbPX>DQ zxz}8IvacN}7qrAk?rw`A;&doJw^A|lkr3lnV40Iek4`xbBLA#-3hA4nIZKH46L^%( ztorF+VWzXtcgvSzsO2~NU2U_?l@ndfaf1%9ty&(15Le>-gVUs!I#Z#nnB20qb~$cn zZnEE(J(jsEC#0H?xG?zP*cEL2$$)O&yJ;YI%tasUxEp%RiTi{m+7pn9=qS#!X(U~e zugcGvp%2Ap2I9K5+t||6=7Zg6$+xrEOS#(qjbj8e@)unRli{N;9)QeF>a_cdR(p_D zOA+`_%4B@#a8jNU>QTsg+yel=iP48dNt)`e^E)2|1cEl>DZ-8~eo>8ev_Cc4Ol3yh zhP$8kvVFcqWX=8I1K5LUBZ?<~S}N~L_x3bXoI0c=wXAi2C$&}b2hb|pKMZgMKrvZSZbaC$ z&;N}6*Bm|A->@-c7gYV2Y^TM-Ts`&`_Q5*v>bVsjf6Zx!`zL4yDhmEejJC=-(^8;bl!;ygHKAdIrSIe*vD#`~iRB zQ9CzfL0T9Epx#71L7^b!Q7Va!f^txQuEOAXAT{0jBTP!sGBh%CWc-};4nXC%G$)J_ zm-?1*I91#O328A|jg0X&CQu^E@SND|14yA_%L*?6wD0Xr)t$%4LGnL3pecJ{FmUUfWg%X?=T4LATBlGO=nGy;RF6Bi zl3;<-pZSq+EmsJnSo5~zMxe#hO}P=ug6|3UHr^E>SC{&Gpwrkem&Q;Aa$fk zJ#j9J+Xbr<0#Q{vsAsWrf-qxph&yknyUxh|jPxL}Z1bg<``%$hnv!pWjom3;5ALKlX~Dlc9*@=HRJ%9`TmJnYnVI z`iQ9L9X)bO&p?M=^eJteUDQYI->Og@wb)@`w*oqgB(qqn)Hiu5q{p!Hzr32=s_mgE z1(^?0YD<(~YE|L%eZ4nC2iY5F8cidG-&!QC+o!IdoN#$)dp)$J95s@@6Nu*X-s^naWei0%!)SC3OjYY1OkTRQFahoH6(F^zS9(m!vVS%ztES_UDY43d z|EhK|#!%@%A!#G?KdKYDb8I=xyH<+`FK7Po{B!(2l?(qW4!1qw z7_>V!y%15$?D7)?gIxMb@w+>~E%C3q`19L++yXxKSYa!ah_s$u*XqNTS27Y?dFMYn z|M@s?tJ{ff+?=4ax=+vEcW?|guG1JpvIF($pVtq6%ck1y%*je#IGff{T+^UF_BZy& zV0l=%*d*b;-rz~j?B2G;V*#asNor_ukI?z8`S_))~0=)j*c3eN$U z!hx3q_c^O~uZ%{#DuCl`4w$XWDWvzU|22k7_6(ld>iTQBJ8(x&7hb<25ag*$Pa9q- zhf1r=EN)v*M9S|uW}J9TU<93S{J=TU1Il_z0*6ygI z?S4G40d;mD10ILrqHPDV$e_OWh8@$J<9X%64R3m9WDmH^8Akpo+y-ev%T<1mQ8~Qd zcao6D7$W@gRj;%3)ztwKVD0Cz=}(XFT1ddL%3K)hZmlcZ=-Af`V2YzfEVl-EC64+l zC?Y*qH^BfdSsCdVx1lcU;&N6GjjuK!BWcbNqq;<-1=BaHOENQo#_l(rJukKxS_Bw3 zBA_|3_41!aleGp|uOZRu8pyZ#6A9f9pqX^O!&3GmjJnWv?_+Q<=b;QIfGR zd(!4&ySO7MRA}bM3lrQl$@d%9SbWu(2FaC+D(F)_J(nCiMxofHV$@qo$=d2f*eB7h z4wM!8x7GZC?7H=%4@|Vrs9FU+rYuyW&axCLp#5L;m&|L#>uW$&jC_kofoJ5D{TwKE9;AOGF4!VQpt_5!nR_)T zirZtHa2wxw=rh}7%6&^i9kk5^&+RwN{Sgo~f>$N#ceXhHOSUgGC=dm_G;f(9d?W4Q zwF68gT1yPC1)khy5e-=WaAt0KKh=l%Zuc84111VF0_S@WBYLcK5qE)AZ5y0>Vf-u@ zyhPGZ9d(IHAc5r10dwfP$;;aR~ERz;_{m7-Fh{=A-Iw7kpyuijf^ zz2FY2-=5akG_)>=_m06?-X&O`a`&<+=1ufBw8f~Ob03aE)?AX`)0}i#;_D2^3enRX zd{v7Nn5-H{2VIwvAVLNDOOq6`kZOdVsgrdcCi#WwO|UC8+?QGMz|gwtxMFw=pPC7+ zg-x$^E{2;y`dccLJH{8cmM9;}hq7`rr+vVjgD^yA%<|^yhe9&m(pYji00`)r9(CK< zO%M$D-uAvQ80glRb4~D6A668#sGbOIA#WE&w?Ltx$eD_@*SjQ(Wkxn?ZjC5l*3fx~ z`)@R6Rk>x(jl5MYu|;+Ls|!o^G2`cCN1|0`dlTJy!NL|<$Xv-pNNy`9v;_J`Sx-!66O&kpv7kJmeintDw* zy*~JdJxQ9`&J7mp5&PG*$xPL+7)kuppv&n1dFNq}u&4bUgXFvo+hgdwB6-$kNsTC{ zf_U?V=JHPs0?4AuNiTVggrCTC}^aQ<6s)d%;^rfK8EmD>^WgZ0av z9rq?%b9B%?Gc{w^4UWf6M`zKj|5=`UdwT-34Wn48-6SuER0y42tZ3+PW<~)FT6N&H~&`NY7= z>#%XDu_SQIeFql}rO-W5VCf%)&bI)@az!(zWRES%AV9zuNE|MFM@Rf*><`Xf)3@HI zaD!*P0(8`WKDyGnk|7`{$}z6bW6$OReq1(&s9tyVR@Y1^MAuKHk?U74UP)73@!B{t zf6@ljBOZA0RwaL8gF-LZde^VK(+9gsrjrcbWsS4{glYWZ(BeIuuE2m$`NpPIQ&H^9 zfDa87&{&D>5f_TGj4Q+*GTUe@=2>r4TziI-J>pxKNw7Mc0A=mBUEI_6@9nMCyW*k< zSEDGf3`^WRpd)0;fZyYRihJ7uG!A3xnN0LdHdMWy?EN=IpqjF|ryz#wG-a*~w1B>G zvs(!%$#tvxWLXgUC4nLkggL68WYt5hxvWF=;>Y*VW=C+w7tQw^Ftw z(_LQuFyuLR(uX!2*~M}k^*agZ%%8Q8YnM7pW!F5h&8;c7;L{g{gw*DfRJr8*|B>mb zSmu~Zu!i}2s=p;DJxPE8tYzy72*_`B;Q4;L+9A|2aqnP5h+)je`F|WxqE9kjYi|=V zDFC)NqbF59=bkW~k4s7EyJW18N&js=)(XU;3AR6`z_Uy12Q^w`rpCw^U_1PkzPrs5 zh!`w?b=AXU#AEEE(B?`UKJH^A`$`9hkm)OAKh}$vGZXa*I+xNSp5&;ADDpJ9rR>@Y z;vBv*#%#nxGIO>n!?k;kkmV@WLI^B-(T29)up~cD@&lFd7d*3lce&mRV@%b)Ui#F) zD<@m#-QM}SB5PdzJnt|mAd_R(my_gdDLho{-_vbDr0)TQj+Ji>KN@5!|67N0$KWEl zxAGMQz+QrP=d^If%5T2@31~MgY8(zHRxx6zZ3#wCdi-G;d2cl45c_Dqfoe*y3Sb(O z+ZVK{am-t7))1CI$2_*Sj21vb)+;U4&^&+caTRh^8Dsor%d*i&q29wuL>rpD><`xv> z<3;i=eywz}Ha9`qusdS4zuQkPB&^mNt(h?`Fsn*`L!?BZ1ilvuX(qt>G zA}0&4`aWLMyfH98D|Hk7uz;Td@zK97^&fbZlyk@6Ja^oVgYg1$EXRSLl0Q47jx3&@ zoX-n;{Sm60xTxKl=Kg~+@B>4B*Crw$aeCCv#%p0~Db67~S;H!-OUb)Dv8_kjBpE?P zVYU9=Yj_CNbCrI0&S*f>-yjjj{H@QfSUI|co^?9mr&A>{5Fc=R*UvHn%ziyhT@EF@ z=cf$1(1s*W!03CXO4AtAHuIsR3#0XZ=^aUo^Pz9*>?#7wur9aAhuAv-^ME)!Q)~08 zBHKqW!#0K8QvXZNjyyq=S`zt%G|*+K@2Q1)b{fcLZ@xLKi#)>ZV^8YN_ItGjk0R}K zu!GM(ToQNdz_hxN6Urm@E@5Si$(f3TO^AzLqILC84JbQLM1GZvuAY7XMu;ctkdbcmQva>9b-D+>aKW~2g<(ezt@3iub z16A3MFk*QAPB*J58sg7eUVr?ov_k$!l|$ntrmp>y+2q~wgZ7PjqjUBO^3hg}&A`t$h`dlo! z&v$<$*9S&OT=i6ihzTvMU6@s-KP@qC#7LI$F7A;5ZEm~LJ?%x4y+$EtQ)bvUtTxy6 zi!FD~a<2#*5zmJ*>f1?r{eG&)&Z*uDmO+(Gm24 zJe!u~+vlg|U-4rk-*PaANYDV)2Xk+;v&oYSN55Mrmgn}y;JJhU`WpWUb$ey8+N(uo z(zFj#ovl{rIU_PVTFuMBTbPvybfL|SkLL3Yr)==XV70W%VyC~_b(ZOGS{F_4wlBU+ zq7&`g5y43b=}vI*sN>XC?|7Fc+3Mdn&G?bRm&ax*C^=}KfgxB%5**^Ae#4jvNq_>E z&<~;ZoX?76z91aa@GmU@CP$`0BBNis8GOqHqG+}8i<&RYlr)NeL6hrH%&=6@;fTc< zH=Lw?Y;$cn=$b{#L`M>fVtw1--yNx=F;>`75*m=NQz5Eky_feSD2awt=$qAfcX;2J z%M|Zrv}RGBW78ZlH|L<=E+8}zbbG=Hu(&1~1RJ4)BQXwQsGITfs3`SL-IW2Y9|Zw# zFWOvmwP;UKT${_oT7CdyYk(`fEeJN_W{j+xGi@K<+oG-J5BF$6nQ79Vt9S?kT|2M# zbJe&?Tt!ocHumUn)Gg$M)V1ae*NDueVCB;WTxLyuN+Md!ZqnIY)VjhRxSZs4B{dGQ z0ZD)C6^AZ!XC#^oFF)`=jk&x_iTfEG+?uztI1T_cS;%+hM}yD(S6Uk{UvN7WaKOlA zIAFLk3NrmkS4qA7**DV88d7@~qU<2KeV{W^AD&*pT|m~EwaK;ZSe2G1ziCXzxL)0R9t)4;)GBc=r&w;@XTA7t1_ zj}v0Z3lS9Z!sr1hT{(SLQ25Gm@c2a>FC3U9b+?~pIfYwIMC@3bzYJ1be4_gBtY(yI zEJ}F{H)*RjP>8!>AzA5yZo+95Hx$Q6zN%xwEyS<7;HTMZ!3x#$$mIsx`zae`tknC` z`AZkxIHCvUDz=A)w6uJ-U7T6E!Fhp1%1(C(qZ%mvI{&5S7!S*WuF5S0wmzd+z) zLAxcMsRF}(hKKO6<8;S0j_VEM?ik$ih8cowbRby~pLxASeKu!7`AzW~{f`MQQ&swj zfMi)OV|WWH7gxDffrt;0yNWleA>2Mskz$ai=)L<%%@9rr-$`zEPHEhkb%K+B=ysiA`+(2m*9 zEx_+yb@sT-nQ9KAYPm)nqhEQQL(*dcac)Yaeu~*ArumTUY-znb z+|=HnibyHSG1UQ6hCXsdZY_;OQbQ3jzCSMLY#h#1xa|KT353*-LjSItBIsz1`@nz} zd0>L-!=PTW;TBr}R5xYL&EZBA*tb&|FgmI0-{-TwxOGG5=b5^{4 zk4xH&YzLz`52I)caJmJN@%>=|0Z5P87|6(Y7rKghs}BFmY}CJC2aU3N zv2ZI+_E<3H=-&G`z76($RWk@*UgBii%mb71sj<38h>@Vp4K~+h`pSJRUhQVWb?xO`TyKBd! ztk}tBws7a{!y!OeXzMEf$cU`H!qR!hxnE zyg%1xi0FFfJ^%<*brtWm;@$vhWaT#N^s)(JLRCUs6Sj5egU<^6+ZkFjSId8qKEqF& z4wfRzp}5mn=@S-5D$f~S;0PB@!yy0Y&Mb@lXp?^>>7jqriAE%{J(WdFEx27!Y{cMB&D zhd8g-&vhj6$VJo?*T?T{7GH+c=^o4uzMwW_WeDEEufVd7Z>d6L!fc0ZK6@=9t|`?A z>Qb<>7v>n-Hh=HrpQ_=JrqVS`$x`?a~{~4nl!F&jDd7cth*qNvUx&4 zeOWCt8~T_99lk;cNje-8Egp>4&zjrbHv?78oRwO7Q}bwmV(fW$FfMtPZ+YY}kQqh> zR6EsqSMwY=^iG;Iq6hFX8^*5%CKc3}t&U|J!3M~@pAh^7QX+2?+}&tep?&5qE)sIr zQ*Dm?hi)BE;FS8*(90Lfm8ap%o+4PFL6Hr4>(%>%ZsiM z%%{Nhovb>|(A?!p&%H^Qm@QEoi9{i^zLDh+*&Ux`n%FFnlQlR`XUhH-7aHa^ntw0q z18kvvA=(s(a0aZHueQw4*EmQ0}H@fH|Rc)ig}An-sPb`#~(#Y+2|I_jQ!VAD@yr$ ztaP!2UFr~mf6B_(Q4i;ceMwg79lc1cfmGPA+0C5ik+!mU)pApD2Vjs-YmCvTmKsp{ z3Ks|xn3d`JI2;Fw!!+>J7mwO5mw}jdNmt{TnFjXp(~vqwld*AL0yaVA*oAEcCbpT-lCK`qhzF1i@w@C)RY$6-Neg0yfG3)!?+<8h{|ptSXqfu2 zi<4Hjuu@S|F#k0eyRH#we;Qc_SaX}0ktO;Ki)QO$#Z#?KyMeLC^75Ub?sk15ldAXT z9$5CQZd`Ks=m5Hqud5qHt^Vvulibbs6LfiUoF`+{*HS|TikY_ONlpcVEz>z$*XtuP z={C0ogbkAnvugnC^gHq`W_o4TnxZA8&1LbQb@ZfZ-F!s$KMVIvy`R#O{md`o@vEhA z8)py%eb3jAzv-?=R3@-iAHtQD37NV}EG$@lgS>TUj^}Oz>aui;o92K%TFjG)3=0JC z%fpG^VAtho$#DEov1;kkJEE6hvzv1~ao|{vFx)|%b73R+*)GdB%Obn?TLFRkvyzQN;%eyYo=QFFH=<@dSmrYmz-%@f9zdyTQ; zg@r3|$Zv}tn#V0-E$a^U(6QdSh%2gB1U5k`?P1fh-xh+z^2e8JS4en85~yN*6jm9f z#_cSv(VxK;5=OBdmZM1%!l1lBiZ zAT}=AqHHSu8#it&E%3*;3sDmBhlfI4MP!W*vM$>=W;>u7^953^dF*jg@$|wlR(ToL z^IAO8R?x=|d*H|{cSf<6HOIAugQzbKZHV_K_I1(?;&XXTd6=pZwA^r8P^Bc$K_bT@bt6?bV5h zDs~c{`yD&`qy$r zf}0w?3&!tfC#af%9hWO2F5|fF!F*3wY0a+7&6-<-{4;n5-ub1+4(Y{3ElRk&WHfc< zQyOD({<@WMf-vqBdfpJJl3zNt9_xY6?Ezf2`c>US9Qn~G&9ezNAY_61Y!AN~$ILy+ zFwEh0d>(FQoCYa7+_cU7J*gVz1>);nRc+gCH1+M5ImkHi!(~6u{JZurO0mz}qnUCK zb=0?C)>CEtR1IHS)BbSw@My(Bi(q1A&Z1GLqw;aN!Aw@6`OMDm`>)(^Xb&36w9p*h zxbSH&cqF7%$Pc~#B+lXMxDO^Sc^jtjZmMo1ZE60%22jA8z}w@p(bv=dL5k@EXRK%u zb8qKE67NN1MxD)4`7)c(qVfE+o2b3Oj zGqDXcih3PWo6j{=&n%4>EdMBtyXe*S5#WjX8^isV?B*b^@Rn^yHh~v<;BzrSk>aNh z8dsP8mn~StSGlrJP)`QTMK__{K^a)|{vh^M2^UHmTE39FR@^YO`Nq3lu)=@Z>nCr< zqzm4{-@^wB%<%L&sN)o&> zM`Nm15F;(aw#Jw*c$qxU0f?TfgCJPZSp=Q+%prgrVINj+mI`QDFB7W%u=&2iQ=K0KHh-?~v#rO+wbENzb`nZ_cdTdlOA}K5g z%Z=%GH2XGl>nMK0m>zuDbqqvE#E#~JYc>a=s{rtXC5S)9-O7@QL zR?ldn2G7HqZseGwq)RDfZa0iAtgMGdz#r^a~o!0TFlgZ2Vg&veHPFH`XJo^Qo|3%*|-W{+$~^GqpOORGI~!pLf0=xvx>%7!BQPa zBMTe}E~Eq&YW1tq#n5qsCfLE%DDwKkecScTW6ACCQar74buzGfq$v+Ch`|t>-B;zY zQ0|G5^?7~73*9Aho?ipWKt2DoM8^+1 z_%`X@gac}AK~m`Vj5|a2tG@XlGleo|A}G{xm6x57`LM28HX`Z{Cn=I|XNE3}Hz)Cu z^Su(Tw*tTzBQ5#UF&+~nY%;dWPX2)>4Plo`^|j`6@(}00F=Iu};fl-?9n=xkG7B#ouf5waq!UsDV~s$Myp#{)^nD&$#^% z+p8H#zn6tDg9=LhU8CaKHZ>-<9k>&xFGr-CTI*&wUJ3lEeg+Q)gaZmQeU91!;-@!< z@O3_(vTFLZsUGp^G;P=zOqJVS^SJMUsq%-cf2&m=W?ryl3>kM_U5xfqXtSvA@LTm4 zxaL7A+wA5dBMKj=3J9BUE)vzGuPQn(`J;iqLpmOzx(kyY4ha|jay{oVx@{X7@%NSw zG%h`z%7#28ilqNX(wT-O zx%F>*H(J}$%AHmY)V8u7Qy-slR;aAZZAxu-VGdAQS>g~mpfXt7O3l>D%5s1#%M=lZ za6&*!v@*psa0UfuKtu#&(wG17e&^r|H}_hXlM?wI(j_{fk)B@irnx#vej-J3eNU<61FWEEKoyFtyuD4of@nSq zt>$}_I*T2W6#L2!1`W%@bz<21Gc|oDfoGe^vc4EIu7&{)LJNewHj24(zecG|CcBau z-n<4)W|?D2@&V%br!d*$cg_vt7oj3A$E8f4Qdzg}Gdr7*=`m;u1qn&uMigTxjk!~O z6v2c)`mNeLg|r-ePqb9VN)?{JgAc z7?43UI5fRiyL+Lid5@<(Qv27()o7Y(yW)OVnKE-qtZKiBmDN22i-uAqs*I$7(Y)+C|32C3gW<}kix(KOjDrBqaz*RI;(KM6^%D< z-%H1N<6s;B=9Nstb?uQHnJp@+4F4UZY%5hfYPqCQd1NjPzMRGYGfE%eQunLbgPElp zXL*MV-DmqUrWbWnR{3U({r7q%PU(|}C&pZXVXqWHWs-_{>1Flnt=v=ed|iwJe|rjV zNLzNWolxewNEulF$0JfoS+Mh0Z2jwrvu#&Yc(7Y6{yo5Zs1 zZnAPYx-Ikm6f%eR9rl@?yt9;TR-6+=Q$GH}z8|-;G5~ZVVgdm~z^?YoI!~Zt&;B48WT2V}?~IWGRTm$+ zbyG2}1(+p;X9LpKl*I%b`gbgdfO(xmMTRJToq z_S1VYdUcQl?Dmc*w?2}vGRLY4A|37180%O3B&`0$-k4xpG|FdJc3YiQ%)tyuRSB}e zIYKM4B|5g@W^{iqjK+rio6p$FW+%-9r?7nM}0%heAZ==(V zn}t}cC$Q3PtvIfJw04Brgj^&3O?&(ua_kyc|70*~USaVxM^hufJj)6cQHNbYlT}0| z&PGT^M|APukj$+rld>@z-ZjP2x$m-HNNl9t;E%%7sID<$gu_+}!*a#ge)7W%Od+wIixAwMsb zrVL3n=PIoh@^J3CJtHC0hI%#CZF>#Cn$2!uX`lDa{U*Dj6W?vJ zbxv#Vx=w$!U7yz%P$=wji17;+3>n1l0NYf6&(o=wZ+2aTL?x4nWxkG(rp@mQpiYNv zitB5DS>&m+@h_!pDz)svT=)p10vN|jP0PGQk%iYgjH)h^4zN;U4rM6G)*ph)^-(*x zL{bC0hGY!{qIDx2+8~j~P^%#w5{dATx2)g$} zQ=MIj>k0RN9bDyKXu@^hJ+m6lxcRd@gDM%b?h9XN9v`^7+wnG$n6(8Zs0Y$i&k;=@ zgk3zazODV<-Br^*0S+X1$*&cgRwxhJ^WH70vFF3&jX~B$y-t!CQDeeoxmFR!PIu8>} zA}hyoTXFUQK=24Iv=^1<1s`155(6Ayebxnm^RA$$$No>PjEH)qCVXYKH`sSdZ)yJ$ zkY(f9CK^hq`{YH9h~A5Opu;yUv#d-l@dA{(<>0Cyrkby5LhkP(YKM-^7m8GJ{w2zx zjoWKch}b#0bhKl1b+nVbm#w<$RY6*6zP;+yokHv5>pcoTa)x;%3V&K78Jw=*T<8o5 zN&XNQvrn=p6jD!W*tL2IgP!hk=tUpWo&YP{b@kvqzs5(*?tC-(XkJdliQ6BBV;z9# zpBtn?<>Ht790Kc+4ORZWsl&o&(;ysBHS0z?dHp%E$C3aBfAeQ}#I_WiaC}`SK|4tcH#VXBT z#=QYRXM$kR#Va~{GQ?2QlE^%@(%SfWG{@^x#FcDYkMsJ~&GnsS4d{;>pg=)wm}QC? zB^&V`{QU*<&H+a5QIO`K^J`tn55~?oQ62)E-5x(*`;N9}TQchr0QI2MWrPUV`5wST z{&y3)fT9ht_o`b-oT?xC<7herQ@*n*m1P(0%6hja{>-9@6Zz7+o8Bw@o$7=^Gr>iC;2DD6pkRp(3;lR&i&E9RE+)}6l9Uncq)>{poeZ{ zF3(BTRr$~%t5*p zZE?3rRMKzraP@a4A=s7AsyAM|_!xQC>6_lM`rsgXHSk0eBqi*#PVymcS|P8lk916X zgFj|4tFux~&I^VHEETV*9k029L7I-QHVTE2+RuY1?ULmByz@U!t7M)SxxgAzeI@D& z|2n}Dh55&ld0o6_MG&`|A5+7PeZ~=pwZj9=3cY0IB4D?Ur?p}QO^{nY^~CO@4<)9u z%|II64|^d$lSzKCJHR3?S4%yR8XY?(*@KE1T)i7EO82D;g40sI3 zmyoT#rjdroPfHtm&^1k)OHw5Kl+Mpr8HbAh{bwnJFw^39wa=={=)sx4eyaA4?NwY) zUmfbmJ4tJp#h-{DW9$`>d>O$x}E8 zy3eEejoGtMcorgJ9m2t6rgi91-fzC#S)LS}W0s{!XlehB)kr-!9T&9BPu>)JqUj-zqs(%;oD!FgRSVrkp2U$$Lzal|I;R#~ z_N9*oE$Yl1i#C|atWQ{u)XK>1tW5kUN?myX74sV{FSVK+apH02g`$WIGSM8PgrtUk z&H4o9y@r95hmfv;;fJt6xeb$+Wwz{8?2b9Ogc>j^-kaSiHSbNevKUv{uNZXv{}qGm zlJf7|-v*GtRItDRo>C2`;JGK{%I_U@GRh6(!4Mtm`y{Zki#Z{^uZesNu}|4aLbtb) z^$7Khx-SPTnmUo3z@WRf zXI{h8<2p@hj`mB-!*@qJ^G2oH413)WV#egQ`sFFgOGD}8?`YJj#8y;0xN_(o){(5V z1%IZq15s>XL6}eY&j8eEAgiQd@;cS^vUO#ha|Xh`Li*F~X-dr}?!7k&b{L&p)rD3z|pyqsa_WwRPu261=;fTY97zD)N);8o@&&Z1Kq zWMuIh1So){*xZ|2FKkOKTK!!JWLS@a`PIx0dGVeJxa>PzX5vP|Yw*9V6nybm*G2za zIV*;eV!npk(^5N+f{MvHrgtw@)v4uuo6-Siq~L%ReSR0RKW6@l_C*Em=sCH?bEqP{ z@~U=!(Hj6A8LuDrHJ2ppVu53-6DXJHyL66Fe5CPwipku>?lIhex^z|a+bl&ygU!Dl zf6W6nn=P@1v_&9Sp|-(ui!?I%5?L?trHLC*$M_VS%9fMDpSsYRKn3uwf!I_X77xAM zvODyX$#Ov2RBL`xXm%X-lg7z7EUE217WnA>d(wkDl?REb2y!IztaxrtfAL*^ZB5{g zFsX|5G0EnSquuS_-eUHRw;wi%!W^QvKQS1u1y)$Bq6w+7?7_GGQQzkC9B2`O+)31X znJyvESlAr_|3e(NN4%$7Zaoe&6BK2{b@6}3zvDt#`L#K~a9;0pWN)~ewCE^p^Maw$ zQW9I&HaR>EkuUG;)3#`@t{V43pP)_poay&%VQivJTDM)*drMmW6UZUEHyz=$djOYh z4&Gkfbgg_iNBrLj7PqHKJnoxjTd=sf;gZt`Q3_t7GUqzC{y3mag*3kAl12Ozi~dyj zm${IPj=vni%U?j+K9F`9;kDtQtROAkVmI6oR{Z-l8xO|FpRQjGkg$!)nsLCY1dx)x z8rohM57;&IkNfiWjt|=yPI+x618tL`(|M)Fw?nu=sZ%Wv@5VcNH)&j6VfGyWV@&=V zWIw@wQ%wLb5v3u1=V8Oi65H^wP-12Yn%KVs{fX7e(Bag9V_Xx+khZ2wKNairpJeY? z%-A*lS{|j~@(9moqS(MTSjtL&Ug`p$n)6g9mfx4QYnr|_x;%-1`MO#SMc1J( zuS2&skwd>_zB0;LscUg`bDVo)%ldIy0xNAa{?(L^eEFl+`_~haW}`MMDgHaT@NV{= z_}q#*Rvx_|ElGU=Cjf&?{}x6P>*=Dcv##}E8Djih@TQ5Q7A2;%w0x5>?AX<8&g9pJ zt9PKSnSKb7LlTeMxWD^i_!a*M`#MrvhQBQZN-mD#+LW^o>qS%2$ zMQ>lRN)Z93zywif|B`7f>a(>rMIYUvu%>}$A|-T({R@B8yF_VAF`ahqh`>?&iG^kCe= ze-bc>tTdsMpYGw7bBWU=_1|F)+VxHSF%%vS+%IeHKXw_$>lIy|^0>DYDQ=9WPGhlc zYiJ(&$$rE{zr-^OKi!^PIznTBXP*0rue6^B4s|^(!WK^a2Z~NU!ytmTCDqRw3Naf? z>J<;VI`*W$-`Kh4HX$plP$?|>uC7DQt(;Dmf1n23@+-hE9)nSP*T7->iZtK+J3H<~ zixZ;YnJC)rC$+VF^N)6kLNc}Dp#0O&!oG)!lQM0 ziS@R#yv$JNi39uFTTH0(!hcd56r9c&aR8d?c)#GHck`1G@My({{QH_`I+T;MDQt_h08_W_A}4gCoe%oIqU|kVDQ^Go8)}ocWsx|w!8+r`ox{F{9Ams zGDELz6y11B>eXuk_6-RV0amB(8HQ-mwZU6S&{C>(%eDTR|)gMvL)81pgTL$V! z>cw9-{k87DKf3d;I!@k{t!$hO0dC7FQva@LK8bkdR?i2A0tYw9gHl<9GlUdLgs7;C`P(W(2YHW0wd?dk z6rB0O>*KVF(se}{&PNiq_I}e52@U=b8&x%~?1h;ibUjn{5QmIxNMH=^LRKn!mS6bU ze;W0|A(0mxOi~lipk8_mPh|LCp}4fTQA>j_K~mz4-Rj{=zZR9eUw(3H`IiT-@gx=}8x5e)`*MUJYzd*^#f4S3k z+yg(PHhQ}AyN&kC*K=d+rQzA6_L6Evs5o;fi@}Ns=1xZ?7lEq3Q?!Rt;0>>9IqHi( z6IXw9yK3hmX?yYwHAx%GEsG+KGtHoJpRPdh(ZJa+s%RqSA+DaK-_;)tnlS2^>bgjX z$PHmGPo0NF5BE;z#pwzRHffVDz(5r=g7)(M+>3=$$2Mhc3L`Vm8T~WIOYO6G+VGRm zHLV-Mtt~nVmzcbBzYD-bh1nO{Ff(Z3pA{6|nw16x^~Kk;s@8&)cHzikC)989@952H z=js>hF60Ry1<$R1lA;;KU%<$R_G44sxn9g&!y;+!D)CmeYgz;UvMAFh4J2r(Op3Ku zvUhyk>gJb2m+7;r9Y@*lK^vU#bIfY}ktpL0B|E)`%~GG~3`~Eq^G`OK&3>v(p9%R>TO%w==5AvSFOrp*5(p=yc zfy%^J+L?Fay)Sans?S`{0B+Ne1QJz@sLqGeqX85BSO1;s83=qkuRVTRHC_p*oH*|n z$2#F>TPFOZ&;vD*Bh#hlw<2B`&9?zRp3Zxc{IL_0KKXhp0R1iRD|6S(MQQibA-Gbs zgYSk+;LSCR})(f4Ew>UDMh8+&Pfd9t4Rzq}OM z4#eFevtyoxr>xvwKIDGups(_o6n6KXM&a&iMi**vRIxvmmc4fH4zIm8HZmb!Q zgy=H{6V=T}_P}$IU&F-*_)|3^;QmoX2BiyCimjWQsqCLGI=jdqDIi?K<_@{}-_{53 zaR4nOMGLK7u5Fx*sSlsI57SFc|QA9SrmyXh(YZntl3dzv z=sC~}QG`xF^c(iX_~@p+k@*9l?rnZ@j&x6ot7zR}z!*WxKG`(6g?%=7Q&5e={E>-F z3~(>?iDB>1U&qco|m`}f&kyA)cR$o6v>Twn8{@8|{(OT@cA z%mv%K>tJyTvv}~Uck6`G3(cV~Va;UL9mSaforRIDotW>0ZkcAe*j>8PdC()u?9(E_ z_C6q)apVkb!V2QB*Mq(uxUxoQ=BX?iHKyK5R$k-hTW=+V>rtQc%R{bYEYq;0&N#wVB21^7R;!)xho z^Nq=X}bD~&VCZHJaFozam@_1l@ z!L7)x-wF9AW#up1WrG*tt|jq@Dw~!2XFb)|v5m7PsTIIKNaRpKss2)KJL5l4mx-L` zsdd`nm$p?QFwLvZaP(qlW$l$1egzT0YXW-cb>qXoKt<4LJh18jg;|`K=p0mZV!Bfi zK2pIbGuxBK&NuRM*R=Ut)35)ABX+iW{6r1{#eCa`0ds$VY3{3oF}9KA7vs|sCGVre z2{D40Xhy}kk7wK&(39i(kG< zv>Obm+4-A^Vcu4eSNAfp`6OeXBxXyN@>5x;jL~*tFMDS2reSIDZANaC5^nw{Jnrkt zGV8>%%(M!?KNI_*dPshqUf^e%dJr^igPt!+sh99ea|77Wy0R z8^wKj~yZahv(@EybkMZ$+kl4R{Nhx(KlE)ZiOCci?k6;;d^J#3&P8F*$uq?=d z2}87u%zKd|D?P@%^qm*{J%-bCP!3x?#N@shmpp&_N1g2!im(c*{3L%k`71kE5Q%sM zcOX1uu>O4|Jj*24<(0n#+n297{ID<~7?a^Kubc&LH#HGV{?$g3qsgWEj)?>SzWe2_ zB5(Mlm&x*2jFNba4xg-j<`@2F$a(&pna(8nEM-Ts(>72ud|1zc7o)fkt$Aev<~Hs5 z=yV}h{@OR{BnZU%eOXXhtypiU_BS7xasvqp0y<8BX8OA7JcKxr-#%qmJtCI0H*bB7 zA#y7l2``q^U1P4hh34D5R9hDzm$w&)f1`uXXHQCBRCK*K?Ld>ZqFt}TRR(ZH1~3>1 zS4{BzZC5v;(>nY|1#l9HqQ`A@8x9S*&|g|>oS^x25Pi%fkN{X1u@4@#HgQAtXEDy& z;?R!S!y)v5)i&*V_%x?xs#~n}8LMD1GU9PT{aq>c!(~vysV7M*fwyj~5*gnjje|UB7%DIVsFBMN3FbSi`=gj}n zESDb(YAcyEjPZvwr%G07owmggKMBVQGEBz)>8dDufxLmQS68M&$U<{{%>s92(b71Z zl~?4_#Jg2bj}^jZ7k;itvewzk$dh&oGVC&5$+}e9P)83W&sIDE>OV*%=V6>?gIx&P zedN`+h)|AldrrxPu})>yJs^} zbEi+?0a*Td12)D&TJ&PsBDAt;zw!o*+9~VS5p-(!0{{xQ;{#73S)7?Wk zpdbEi0G*yz=a6(U*6i^xz_q=_k1AJQ;U@j4Gjp7uvPl>NU2e|rtdqrk50B3$7-ki( z@Bzr2{3+G=-FbGiqwbBN%ewrg zy|ckpI1rOfgy^65LfwW%>il>50L|;#mwu?K8b?MXm>BNgJe*)LaNOZ1Z|}7HfGy6l z4o6f?&92eK$ig_u=wdTM2&OvI2X9_Eq`mMiX+&88MA!g69+d18B{6YF_W?aV>#g38 zc?Omvwy1BWe0HiP`|WKMgGT zD@Cy}nhI*onX$_3ob;X!AM-+EJ3hFxKhWe}ywwYTDB8K? zbMr?x;TFgAetmld-sb6E_-$qUH-n{gAgyQmY1}W*Blc?GT&xp?cObD!AT46=TK4`< z-zAcYq@|-+0dFVWgH^{yBPO2v(S|ZJd26(qA!+2~Rc_&KV*YaBy<7)WUsF<80@~SU zWz*Z$zo98J#W%VQXqu{TI6D`~K9g{aV)Kw2+ygw7?=)@pM}IR_=J7J6nXo$@f-3?y z1r}EPjQ`+ndS?+fe<-iJ$XT<<*EoCWDiG9LcphCHfakE+lW-=XS-4l4^c*hkH2Gp} zL>?^o*E-Ou=bqRirzZ4LWUZyh2%t(t8s2jAVlN?sN93>nF@%>mpMRVc;&WVQ`ux>u z7Swpr3KL62zAXQ?_;>hp!Gcc(iWn$R{6!++LTB51R%gjr_$;%%J}@cvc{Y0X zNq4NvErL~Rv0ElRk+C5Gu-ucAX66BzuP+Jj(v>_ALSbfq?Rm~#TQ0*EFfh{Mijfl; z9;TY6pat0xRtKTEm+9nobH(VIdh;X7&1SgFj?PN@JO`Sc*K{G``^r{xj-x*nbj(9y z@qdP_xWe~w&p)=Jf?FIn7Z{GnNZab4;H@ge$mDUiU^aIs7$AeJX80t)hht0SH~}YP z-Y|Z~V0gMeU^r1r{Q_wsrp(1iyo8@~wf^RvfL~cl-3iQczy;=M#ler$?X_oWd}nmn zL64tQIKFMv4G5zK)xgd4B>Wzz!X;9C+g11|*HD1DVHr6~0Dpcde$oA$O(7^8)I7z? zM9wkxOCwth`!IKJ_O5MdcWhFyXBFA;@Zn0E@xEPFhq#Hxc?%b|j1+GF7p{f}TMW$= z>b}1$ef<)fsS9m_l%PQ5Fd4sM-tXFbyu3K9&0p02vYm~ z(AgWmR^D?jBmq5@KW5Zd=`J(sA16!Q5hIv@?o8hJHP}9Fgr7V~EgRS_swuZ9ShR+BO|1e z{i}A!h|H`EG;*CPzu+#D!kgpUkFK$)WY@%m*q+LsJoT$S?*w4%S3b@;(#h_le0B}D zIPrY5yvpM`eqp*}lY5{KY-G-wR`@3VGtOo{61BT6=Lks4&bRAdWIa0Y0pW=5sBZ{# zY4^edSCvP*SMT)RNc9XamfrPjO!xftF+g)~mn1qnYWl}fPTFG+AXB& zWXRtS8@#D(ylK9an~2uau}S{rTFryjAy#Y^y4MVNaVPB^N^)(OlcI-jhtgB-i*;E{ zQy8p3LD)r1sRy2K-Z?ORbet|5s!9gKul6Icu_H+hd`JKl;y7xV844{Bh$~?un4ah( z7{w5+bBQ9&qNuxMm94ww20z$M$R@Vi!lE zhlS?YX*4m}cT1B5i!Hjd;B-BYKWWSzz+n}(KPBr6;LZ~6PgPrr{XHBqkLi-QxJDx$ zl<6#DZ){IxE%?+Ucla$G$B)JMhO`NFXN6&ShV&`Gr8+kSb;Y1L4HZ)W{-p;1R@g;j z_(i+=ei}}lrL~oYovXM`Ue(`WUw#V}N@VtTAIBF}bWFzl z-x*fQ*okGkjec_-PHJGPjEc{RIE-8w;K7N>b)cm-hu#Lx zy0|uqIryae=uazF!Pct0qp-mE7{D_Wa8rovts!q37D;TlYdt!*Nd^Af#wa$FY$%!Z z4~m|eJny?Ogjg}H^?ls;%>Wj=oc_WkZNh%oh9O!QT4v@b61UN>=Yv3c!eO)~yu zGb4*ShLn0E!|Zz1>)~|AelM++HV*P8yt>-$Tdj!JGn7e1mU}ZX&$Ns_O}oxEDMN!; z3!CBUoxLGitKm}V*_g)dvbhkJhhY9XUBlWnpj#P2@&?xRs)K_-1wq|1uqGB}1TTF5 zuqR}Va{tss7ZMc&E7*!>b)XT?rUID;yuVaiwkt+apQ8n5+d?LWHKRcT9$c)1*XxoR zu@5TCPGe&o=!FAM=2-cT09lYvTkr~ERC}x92FqrCG>B-b+X{hV17n@Peo2a#7jm)c z1(yh>rS=ZN_PhbQ&Uh%OFh2+KZ@tID4;64Y#^cWC7)(1}R~*T^^T8AMM3>KxveN}{ z!v%T~zp0$!WcG`+?&9iSeDe ze%G#M_MdKrF-kg+s?2386L@Xo3CE~NyXOY!b#_ShBepa zZR%HJtENCbJ5GtrcAaRdr}bduWDjtgNfxyy&@MXZN#gg-9o;|fd;}PpJ&SubcO^>E z0Pva1yxhFs*3FA+mZIU?=7f&_L5k2(WBD0AXjd!Y^1-g3M4L1Aon7vS{bb-D5@OW3 zn#{i6tGrA1JX|W@9;tJ`d&>nzyyuu|{>-@s5`|uri_^bSa16RoFhV{JUmEiHZ;A_Cx|y~26Wg`wTfg-L zV2+fN$ueXp*MoQz4EnQM%J|NDuuEF#=qpY0GX_M!Wmtnc!K=9e1gW>LiI6iGDMX@_ zn-_O-OB+nZ;co(zA*)E*ivMUmU_O`+slyAqbSxqBN1g*Amn-JqA{49;`d4vOYBj16 z)l8|ZQxrPRVvaZYpu8?yQo}Qlmsg!V)3y#T8}Ze+KRMH!4V;~-c}P>@5=^jg8P3hq zNWGoDePCWsJfer$0WwQ=Qu>X@w*Q}@f(wjYs$3j>XU9?RzQ4qo^wP+Ew%~nOYfUi3 z7PlGgk0iJfbJ6irPW6km?APq}tts$Rei1|A zH|)zVx|s6UM|xukl%_%dx3=^CQR+TU)%Db)c*ddZr1*0t<*D+`OT_J3=f$UhsPN)F zmonov6%C;$I|ej!*E;fQuNXX*;;+GJuOtsuSquV^o79k)pMww3iFy2O+}5#1EM#T_ z^u>(6`89Y|k&Alz$IrulF3-AK*cr!_#D%`27otULmLA91t_yjVv;1#j(NFer4}02f zcJ~u}cnNp&CtMyb(-~4FWd?oV5M6qB4q*y*-o@x5HMuG&syGhP~?W1`Oo?%?<%CFZ{a~RZQ>+yC}P1&k$dOfm8b(ImxR-KdGR!-T~N)-hg1tHav zXGVxCsz_VvLW%TnB^HaTYFaKuMeX6%t{4a`3$pYm00E`ZIFgz~t_n z>N?~}@umc};|)x8fzLvVNlrv6Sb5z#;Si}LIMp8W`DIS1ot|Ts6MgB@;^}1tFgu)V zXNV#aX_2THV^5)wZ|A3R0%%Lfr;gyu+U5%9kQ?6=o)t^vmDILOkSif4w>mz#-f#A% zTgrK;HOm`7zox)Gz&i3W-o;eDYFIMwMtXAXi%!Vqw-_}orbcw6y^OJeLOOzz9NL|Z z$qR?|c&NzmH?BV|7bgjqaDnj2-x=kAB|;;$r=~N-{#j_1KLNcqT24QD-n{&%Ixz6>5ube)W!h#$*LJ*9Cf@X>5xmJaqpru2@c856or}9` z)O{)Hm{pNNr}!Id4t45yvgTj&W#|^$T57{L zg)a8XyjsugNvgr^RqSMu+gGA*35mS#n%x$y!QE8;*lQTT{ESQ7;hU@hsjXJ%?##;!#L{`&^ex4}cT-1n;@Zmr_FzM%2F?=a6P^zi(TYiWp)P@h_5O7!3Z&nt&p~P}{ z;UKbmcsMkm-#9JNAiefog761CBWWf129G^>xbo%mF!isHd#LbZu=Tt~hmRl7yb73h zbCHU-z=#1#<1u-((Q>nDs#wt>Wp(KWSD+U$HVc|TFwg~!Cri?wj5PtMjL zmrFj=#b&Hyhr{Ea0{g9MCw@~=)`e4 zN?_luO8bP3@%?iJB%!9bFq z1FM&02aR3tdxtyoKl%;N=dC39cB^?73gjo@V47+23o7atKF*F6|5nej%_ExdhO^%l3 z%%JBnUGuc*3I*^z7*aU*#TM0sFzTPqq={$w8UCT&c`+lKanvu5xZ%GqnD?capNvw( z{s$PhgP+I`v!$VV(*UAo&GD3xdpQA-1WVJ#?KD+nv4QR%^J-SQ4{5LZaRX?PSrp?N zxk3(Yv+|qztol?hG90^Mt|Kp&8(!^e9^%gj&kmEc(T6UfY%CBjg&EWf1yi!jeKgmF zR{EtaYvn!I#V>XFNcrHfo%?bpXkIlnVTxQmZJcs`e_D4aYM-8l%<{s;Wie`)-LF6a zPw}+Gy%v6qu;Co<_M&%l-05&GNryh_DNQp)1rJ7`>hN>0tqVQkEnj`kg<%IIt(VN| z?zDPm2NwR|e|7|BG^Mw8BV(IbTlJ)92YUEfi;}?OE`5E^h>($Qi%)!3CfewYQ?;$E z#wU>Q^-kDY5e0+`HMR!DbrGzBfKtNL;>+0S60z41?^1t>^EIWhb(zIA_}dMb^Imsc zo=w&EJ)>C6?3&J9Pa_h6RhL0aEoK~<-d=&YYLYOZ{REHWV^ih1)x)&-_wqXK*ugchSIl`se@mlQC3A8gjS z)P%&lZd6K8lt>L`PfmlbfoDX!l0RJ4>QwaDG#ObEAtl4BVy#Un_Hm#_(^0_ufohLV zTnO`jAxvi0>-*+n_YuSlG~KYdeA*g7ni`x=?S6r5sJ`dxE!DGb zQ`$>{)0^`9a;!%0i{6g(uZHqjrPHz1;y4e1_cU13Afc~XSSfbW>iq)iriO-x=0bpR zirU0#6m}DI%9Z5CtefuIGiJ76^u_Ec$e_E7>!hkTZWJkA${n(WpW1>Q9%Px61A6+z zuh%#xqM+)c68ASpSr-4`+t4R-fUSl<>}KvS@w#C4x^}og*Cu!QIQ|#YgQH4#&7Bn2?NS}){$7z!&1im|@xcA5dMH>xUqy5n z_rFEl&v$wmtcPFz%mw|fFq9fRb-;Y~`x$wBH52i+XX=Ud?){eEE7uLCvWr_>IL;@4 zb6wP38*k^~Zq9ugZE1DJfMt2t?CeSJ2X4(49=M(wI<} z7LM~D7$rwlR z(O79~!hsnvG~ymfUOe3?r2s5uFWH5^Gs|qn*#>EO?Ot1&hxvDY+9kO2-uUK3*`zGT zwUe)kii%5Wzw2$!Y@;XNbc00#XDkkgL#h^js?)G6*i+ zIrH*M4)3D76o0!ol@j=6s(Nh$+mM2lM64K1ATjPriYu&GgLQn_VGVRkVfx5P?cji- zC7cRkn-HybepVzXJhF&_Qxa}>JQ2w=_4}<#@{ZNpM5ah4)VL^2jkN25c|UACrK7dz zMpsBZ5+?o&Bff_+sj=7L61#qam&MR7zhP9B9f7m1ojp0IrZJ@)eTl&QHFJJaQwx6N zm4^e4gSY%`FdO*gbZ~RB*Hg|_;U_A5ABXy7xeGMTMg9Qx%M8mH!JI2lDEb&vFJwe> zB5n0f8fg83%h|^fzQ6D(64jS=+*k&ABjEVF{zWSUrG=n6&>*JWpISD;gJYe? zefxvSC3z{KTNqDcR|dbn(+ZBh^%!9WFAYAL&N2QKo^pI{gnzo;RrLCoNt$7u_UWc! zkK9whhF3sK?MaB0R=(8AK%~Kyk7jn z;hgii@Aq}R`~1~w26=k-^-vPF*TRT}(+BNc0RgSW`S5wkTaErCWFQ;09?*;UWA=vC zk~kF=o2CaMi$5^*HrcyrBYt!YxSGajmb=oB^nqq-Q{Nfv&$9)ouT4X*dXrbmkAcw7 z^Y$90JdY$dO2V#V+K6N6DHY_EHcrY3=|>U$Sgt+bqk4!ARSmJ)hsXV_2RXaGD*E7Q z8pKrG;umzbA#uT!PRMLT*wIk)^12k}(X0hALl+05xc!MZ60&aDhFv~(CQz)Yj#xGe zhSd~KpR12RiwE&J;vhmyum1GfkLuh=8@aj4UH}w0{MVU(v1n`yJ1y!z@5cBYMPQ(_ zIVIT3KcLg$>ZA{0Vo9se1w%?vu# z-W?~mydwO^FH8EK@=f(Nw(K6y{`!QZpmL&}e4wa^(rCZz+kpfIUsqMCTzq9ULggjw;Fsf2Jx)Iaj}6C zV38|Va>Dy4^%KN(t284Q!6CrNi}7s_yoG}gh>5dhYE~5d@AOt+o9NX}8n9Lt;cqfV zZu|bMao3ILLop{7f4;?DWEaEAF_7rh$gx8E-~wyh;w5UDx;?nGJ1dK|Z&~hVELu1I znUJcDsi)Sq-IDE}XtRM>g}OKRe+Y^@`MB@EM}e|nqSmmZFDm*0wQ<(KT9jFk0fyBJ z-(YgT)YfCNqeB37%F89Es{^zXJ~TKfq5{>kSJ>|4ve=hML8?3jB^2((LCZNoWP0SP9D7^Y3YcwT;K|CeV$;nH11qlE@0hFnPX{XEvA&n) ztem&}=c(o9VJ-g_Q|cd8y%9Qp?2O1NMLr$pKMK9D$#YEB{|Z)iX6=KQ!F@aJ%4Bm~ z%JG0W{wHfUqTOwFyxuj}47PushxK0SS-nna!>ux?4_ds9KX&W3bzS@7>4T6|3qUbe z`oX#-O#VN{qn8XYDqvjsL>z=|dzL&R&5P>99^D`M_s;~til$)HULDhR4Q>icn5(rV z#i19ex8>umlkM|`odxgR?RKQ}?{+V+u9s8pm&6vYWpF@3fHIyc8pqX1Ub6DC6GaXU2J z--T`vkh#hJOiRWAuw*3(V>}=CF7e2`Kk3LR8p3!#Aw)F0?=BZJH1`meC3Kt|2&%|h zchAD|s{P?@52B85g#NwYUcZQteM@)xR&U&Jq%`pt&3!`FckEFDwfrHLIs)w%hB@&< zd?VlYo(U)#&Cc{($p}KfXLR7neW#;CIK>mM9C9ht+V7Y;^gIugrd72HscDM00}Rze zN=HUBLJx3RZ&ion*$%k7JQ_#z$8c-62=)tu-Mu?LpCf2cPpIYBZLb2uScb zoj0^+!bS)H14nmX)ft`)!4B5(Inhr*3v=tYSMTVp|2cyy6xOS|cVRkq8-Nqit^;Pu zXDjmckJ94pAYMQHvktkD9SA|1KxA_FKp=rE>J998w+RHl?%RhdV zl(iq9cnGs618El`K<({p@SiGM3LV4AZ2=1hg3-$X$KzIhe9j1NmQJ!Z&vaE?F`27@ z7ezAe;)bdx%qpkOK!avppHUSbii^zyRV~cU_K0!cC0}6j_N%mLUv%JzgED|*UGK~r zXl&)9g(ioOxQOVtE(HoO+SkmEKsmJ}EBW?lAznFo#=}C_hAU*18gr^IdUNu@=yGrJ zkw!5CX7@Rh*u+YI1*(@<_>?+^)Zy#Q$xmn@dn1oq{x470=$nRC`S7A3LDe2ZmV?cEcOAJubwzR`PQ_3!4z9L4*SU(Wm)nBMWOdANIN zm;6UIQgo7*|J2-S0Wqh?bOv!7aygOXiqMADJ5(nkf)`+Hv(lXt>^lErhXa+UAC2Cr z!0RDjP5kEiRU_@^c3{r7Xp_0}DTia$k}&yQ)0Kg@C2#X8^)^$GpB*QZ<*)WGL7n_G zB{!TqORxj9s6*E~q|;R$yMqz7(AN7+M&^N^(!t^K<&Pr-$(kq)m% z_^p@PlB4G<0meJY{Dv51s#DZzIow9miKysJp~f~Zy4SA`hbE6)_OOd2jKFRO{i&97 za|j$?o$%=4Wb)0Y!aj(xbMj568iP?}nd2t~6=wB%LVY_A_Jx%YNZ~q{tzX3^;G_Wwz~VQb)6Ya#MrM?cASPE5aIJ3F3|>y9wJiV>7f^b1yEz9uin<`{(Cn=nfC`#qjAb<`@`!boJ!i zSJq=+0=L}zHa2=NyTJHy&T7%*LgA$M++-0JTemXri&Hs9^jIh>L6(5NTQUu|C;&WM zdnj#-9sxwh@T6b!5<`0j4GidC!02lELFI^^1-CP7h*b%c1>FtxNT zjntB>#L%siow+As`Gqp&qtL4wF3+oL(D2xm?X{8&7n{MBcnYJPz87#&tzh5c{$3Ee znXJ?DHzqL*I@Jk&UoReS4c9Br#Ehw~IMh382Pji?gfAc`X)huD=)84is>+y6{CGvy}j|?J!#$sE)ipzA_I7cfD zh1ox-Eg9FE|6908h!7@?Z;6?&i=fK(0ySLq)fT!V7BPhUYi5*p&8C&WI^*ihozAhu z#lQ;&%XG-Z%NF+6*#1)H+mV~F<2a#&XcD|8H=bEfVw{fo*#)3#Yu7`@3gQ7P)y|nawCC%P;ddAucebgv;mlC@wv0Pf45Qgu zm*>KZ(tMiq#V!=153jE-&jjt9>Q1;U12#;)VX3AbE2K_I*4uTgsdp{$jtH(tK$Ygo z_Z&37(9!4o)Clm=Y1I{ux-vKLnTE;BVGLk!B;coalxu`mz7NS5F&QxGI=@gE$TTGRr7GzUBSpw^r>QkHbGVLIL{ok=6CLigT(gpu zwzhdq1j1}g7xz_Rpa+=8K?|HVn9cN0`L`<;9Z~FrMYe%_c~i*bpNmN6{lV3v(Pv4H zMeYeq18X1AH(h)4o%E_K{)v@ow0skEIHqa=p&H*JMGMpUJ@v{F+ZxHNE~n!<4|;$t z_0;uuy4sBkTp@n2oNqdc9GfwunegD%(J^h(@lPpWO_*>m=gK*19^fY_Sh2!>g_8DE z6S+)+Uou-8Bd;Tb&G9J}i{ZS@^z#5&^u`to`4s&(QdCC8UKWR*mrxANTJ4OQ(UXaF z+gb8a+qtFP8QH6~^`EG=qKfl)@OvM}6U}f**EqUmRkBI(VB?f}MJ(&Gt|TGtU8o`h zffi33q4xY@LUT`Ww;vX+c`WBYG)S~OM;mPl)E&hQDciJ>@P3U5N3NUv| zpRsy4YfSR$p4+fud*hA7YdxfDx3<@4&nXtosrXRD-3RZ}<^Ocgz zmf|VNiek*R8#raV#C(JH?9Yo_Z=`LF0gedW^pY^Bl5NbtDWaakv%PU0OmB+35)sX)=_K?BDBp|4fb7z9{}8Bl-U@Ohk51xq7RmNj=o5H<~Z`{x@&uhYkCmP z-^oZN9caDcnz-Fu9*#f%II2ZcBn)L!>J{XoSIg^4+=ixig!H@D_W5sSzhxf&Hw*7R zpm$9*r`ZZQpL!aoxSnxh1Wo7kC(V$o`RNN@rxDKY!#JJLf}>3#uk{=2@cijj*m`y5gRO*i?ujCh>{t_MFFA5KEeTb0d|V zy$$8*>t$1MXD3dzGCbl^gYx)!;jz_D0eyu3Li>4uD(X@Jf8f>+!{El$OGR?#5zTl3 zD$-Po_U|6Fy>dMESYBVHytmDiGaUSdYdq7hI??6XeI*Rr?1!rN#I}Wz=zsl7A=@4) zBDH4x4xJ4)SqrVAl1rm&BuctY&lEYZ;!@lQ_xHZ|T=OasHzlGPbtSXH)9JDnkt}`? zRfFsEmSyvjmOWF5BS>Ci@OpKt-eSN+CIwNxsneWNYP<^XC4=RGCQh3+`ic!FgDmF< zu6MtS_O%R1;Xe!S=Rt~?DLB#EjRK6l*scTF(*1g@Hi=(y*sX&C7-^@}KQo;lrtd@E zhuUz;ErlZ)F%#ESOdhx|3St3!i;P1>0tx}}_R?lc>(%si@t8Vl?bnKi7M%TB+q!-j zFat71{rW2MS#P+({3B+og5*eZ$6nc!$3xCU;Zm5l0w}7Hn;6_~fkIc#zuF@l*Ll5q zmykpm9|?z)smTE};rX7MPIqRj)m2sXtITB9#_ud%`w_uL)k7C>*Zh}2I6J^)90?Y7 zjh|d@E76lDj;DV)v=)mZOA5m?4=H;9h|+kY6nfUZt}Q zFIYrlo=)Vh9WVX2buTu)b zfQjj~s$7nNM@F8Lw9nC}U7EBF+OEONuNsuN4L8U1{SIApv*N$DYV54u_@{KNT;EZv z&j+R%FtOTqaM=6)V_(FQFFp1}%1?~Vl-h9vj+3VCo7B_VdN4v!{Cof} zPj_DVK8fWQ)OM}mn%9WY(Y&x4uOFUzGbW%|=|Z_}aA|Yg6=}<|*`7_!;>lXKp~P3D zToksZx*pi}2j{zmMra8soC~mc)Zz@-32WP)64`*w*m(7N_k!;pGWX77V>r4 zdd)wu&`v3&wU{f94`c--E3OrqP#0;Ate?!__n`0Qvu`Hw3#Ro@PX;mY7m%pXh5Rf> zvkKeaihuiS`Kx+21`H!%zMLE`w7p*RNUvbgu6vY%vubK)TT(0xBOf(%Kdw+{C+_;qC`iEf*znk{MXI= zd^Ch&)Q_%|Mih!vk%uLmTp@SA!Z1+qg|l&r*5u6vz>PQ=zhm24xzvcpcrd;VV_%*7 zaoVd#xsOtYBCzr&Y!C0TVzuVfwQ~>P5D$vXOqz*sP&b0YZZ=^k^4JS%?=f1g*UOm`eWbP!D|A5(GoY7B=^m@`V@^bsHH^43z zioZ-C?`$M*CwO4?JX)Ab&m^&2hu8S;ek-y>YW%?Mc1uFTy1pP@5<$Av1BeKCnzGk3 z!Rm3ZwIK;hY|;QAGgSEUISL$Ahx3J;1v$E4zDIoTO)uVpHfz zko}lR$Y=Q_zqTWP1Xk|`;yGa#Odh1`aAG{;&N~0X#WdNBduvN~|K~M$O*6`!G=nyA zB3qg{E3<=BdC`HnG^ap1X=(Nj-p6Pwm+1FgSI=ZatSthX`!VFnt4Fdk2P1cNNiFCA$exXT|$G!Zk+5`xL_uU|DT~aocawtuM_(Ixd`B zY`-5;mlBeYMPBrfb=TAV0lq&D50|^6jy>{wt^6{(d+4NMI56PH7&mwk1%rFSMw~)H zi(3P*;;X8enrUSj6zi5FN;sTR)`au}5xUHucqNbm0fe=ivIk)@*Gf{zmnzZ&hz)f! zfW%1&!9a31AbxK3$&tz( zy4g`?hkS#gGOm$Z%ltKeh6yymU~NTCVN9;Y7$7}zqS67+BLiEI^wbVkv1_eE-gC%B zS7UPM`ON*MZ9Iyf0_|VI(8iLPWsELCUe<`8%;Y2?Q&^4Z7-O7}*2oNwIiQ&(`OA^I z)^@i_GRw$e<+sLqlUex*M1+&RB&s_lHo9H;trNBdRCRm)ox$C$%)J`53+x-fa`~1O z6|NV5vQVU{sFjF#8mYSs)W|Eau4ca9@X{nH3R6#ZwaJ{7J+ZnRi+9y>w*dOM=#CrK zzn<=z2EI*gt=z4p4Rm%F39?;!0$|{V+Wj=F`RDH~xslk641*#p^gHARoS8c}O!n!+!)wBO_$!!(qUzY@G*ud-L#$oL7zSnS%D>~EdTxfm?D5#AkC5D^|yc+UxY zS5he*zEoklnD?@1xA8C;)PC*Hwe8qh7I3~nPwwNO_C&7|pN92zxSLdDBgj*fAt_<5 z<1o>m7Iv=0FzP!lBIHdv=#-;*OIS z*=dH`;i74446oo8Q-dT>0KTU-qRg4?o!rjK)AOzDN{b%C~#zrCtS=js967XjQP^E6Z(xR z-!0;&Nbd(x=fkm~CtC(v23qu13pA!g?$5tolh|Zsm8ngceNr&CVqewlMM^>>+$4@| z422WI3R!i`cBiO+F|7H=J77J5j7_T3(lB_hD7&CZP}0;_Ycszu1cLb;&rRPVYkCG< zAB63?Q6E;{F50jB6@JLHyDZmtAZo_wu_U0+-)^eg=~K>v>6572ghB%+IwekU5aRS> z_3Gn|6;5p-`JRr?c5U_A0V77UG1_#sAW8L%uv$7YeJ@&WnJ4w}9t%>=%hvr=Kq2Ss zJ;KOrN;EtQo^3d7%BSUP9!<1op$Ds6g$f~V?7;9ds~zp!)TYOCNB@StQyu*`d6zS& z-Tn>dZnX%3l1K?_$X`f*k^G$p5(c14L!mh)dhozH^`(A%4qUiy%` z&X|rUy8|Bosx2rE3OK4)Uwq3PCcCk2DO5bbtd2$Z*cXL*h`lrsQ&=PbW$IiuyA_@A zYW0no>Z7p-FfFkBYSW8o^>UgSiWj;b#UAst52iAv`ized`O0OlV1 zLN0DAx7nb(E`P>GGYB^S+hgII{X)7qvf8y{1Wy*1XX?y5{R9)NHD4Oh0{QqTI&tx> zTC6(@Sz^^K<`{lxK-TI7wpOfXK%5twFkR5qfpQbKCcm;lc_ZqqIez$tj~ExbXWmu* z!(9H4LuIe@YwL|K{1Z|^N$bylX;?fOo!%;#WY$Ja2i;Ncu2M5w6Uf-n3_%4D)O}S2 znPCSp$LEmHCf?Y?ktJ)HY0<|(N<**6E3YUQhb*FCL5w(A3WL zyEp|S?5&Vre9+;psEJgIESvsrZJQ%XUvtC^tkv*UZF?D+6Xq@coYiNdg$g{IP;oN$ zsCNI4jtSXs&h5&?$b^(|qT=|;E=y2pKK)fzv$W(yf>^k3*jZx%W@OvDZ4Sw;aEjX+ zq|Qg`rsD1{_V`ug{tBx8Tf$wtR$@N_ESbDxVjx{SEfr;XO{%b1t>^+dE#V8<%E#NDuQw%k8#F{lA}}v74LSti?NE z5|{zho_X9Yn%)S@Ch&`@M)>gQ0qSmZ^^xg$i?ehPF;G;6>%nvLB-zpKz5sL7ILCTsneT= zmm5%8MLA1*89PKB0r>Ayl;l6=7bpBN#C*EO3iO6*XK5<(^w%R!ldReoPb!EX2)4C? zU(+)K!kzXdW9^Qa!_lJ#va3MRe#F6;ij#@lnG)+GFT1U)x*dkJQ5@Zx2K0T$kd;7# z$WhL&23fA;ptc=TAmXc0%FIysX@CShcJ%x9X*) zPocw+PHMqzk)Dfii^%*1q#(^~g#%b;A_^oHmAw`V`B-J7Y2Lu4-l>ZCd|9=3;WHSvq!*3IX{{0)Q?Ukq^L4&xT;xYuH< zR9_nXO5OUOi7i2~=kt z)|g@Q_Sxa#Z|28zH$rE|)>}@Zr9(n!Kt~7>@CA&z5ooor-cuRrhHLAO1O|r=HoZtD z#k?MPUG%NM%tnSD0watV|>@Fh}4(DGM=h%Gm~$T zq}kPvV5r1!)k#VdT_33^x)2f(og6h^>*5>z_h6H-_Ik^lpO*2@6TOtLir_3A+9_J} z`EbNz2rtP`OTN;gF}9F1&|mpiNZeNu4u+vTj@>8z2*hfjiS&}+hM z7iY&|i$W*8+i7ChKw8McrrN4+XqAAb7JyWmK^YCV0bNz9gt!eAj%`-;MhjQ4AYLez zPqpE6SqA4fbPigIzCOJlv%k0y5q)$B^_OJe;c)V&;2zxvg|m^~Ju5P=vniHS$!?#6 zh-=Tvv?`DA!}<)}Y+`^V?9dQnn9~#1&y+fXV&(N%s-h0$ z_~C{^d@lSK9%?!9|r141Ge|)|TULshp7wG{tngkFXShvy6 zs=1n`HNH~weFXfY_T-3J;Ml$;){G?6hDNw~M5#a-FJT(gKb2WxmK4 zO3L6);XkrmR_m>-2pMlYVE;R$H`2NlV_kC@qFJAKJ+Lwo{wn-K_?TKyDhN862M9!a z%w-!$+2iZ2g%Q+y?u3nJ@!Jd6$3GiHggNWaYI7zpWzrv;-_)$RAQR(&-rA`G6(;41 z&QX9pI^*-BEdMsJ_sa7f=K zGXOl){m_~d{j~PPN&pPXo_U~;>xCGo{oSHuR=s{LB4`B7_t-^2kr~Kdo0H&plksTjGCY)5sCG6nV z^=VxoiHLg5@aW4$G^Lw6sEfzyG;R>RV+I#BTM*0EsO@GzuA%$teog?dW8de`SL?xx z+W_4M=DJ@;57eGs^M+RKr}`<=QuNbqs7Ep!1r4Ul{Nc+GJ63Kq_2*UtV8+!Qz7wniqcN$*_z{TVwdF~g=l#_i`^n~3?Mcwg%KI1>_Ksvwn$sT z8ipqY+l@9YxI333CZRxP?5!K-Xqed`|I!k8)xUsg-N)b26mRdY6J{T(BbzW#p z_a2SEu%zS`w6@5ulDW2*$X`j4dR{6$hk%|fQ*F-+Rs`fo4}ClkL;iFIv$I|v=0=H% z2F_^G;3RvtHO4*?^qP0x3cZ4Q=?}3M%-o~q7J?eEgCV8)4G+BZ8gZEQiXwR&l z0GieYaB}O7S<<&NFZXwx{Hx(6(d7yC*R{6zW(7BPd2%0#PiY!K-d0;N9b+)*3`TSsv_+( zt_!|B?AS8>z&MX-r+qdnf@!sSKbW7VS8kONv(*%+Z0rDq_{V7u4=?l zPS2x`^qVOSC2wze-Lsm(Ee>o76d8B`SGE$yjp%Nv6s$C6ZDIIl9583;51X#bUTfQv z7x4Ag@}5X)y0&t$*>wyxzeM%zKp$!pH2|;6?Wsdf&5(TP$EOvA4J2J@PW(jthNFuN zpvMHMr1uHRJ4iQG-+n+5=u@QNV+*wNU;%g*kd!I;57qxE^dSWCx{(ZaCM}z=0jF)S zzWB*Mt>!v$tE5E=SxPdr`oUybUtxGf3qMNlsvc@yLXt%gM5TEKralfGJK(8Tzj3VQ z!x^ZksS&<9sEKNV5Wu=63*==&B>Sqr5U(=!$io$KF4HJM(8?7ueT1rW5AV{y{sq+! z`wG+&u6r0G&4Fyjc=i%3I$qdXNZ&?3-WNqA>Tc}|sl93g$qFmi1GPp=A|JaS6|W=D2;d0Aq=(cuOn+)q+$g&9dxL^{-D;ipOerAT0BAK;S3x&_cP+ z6auP7{?;N?q!K+bnk?t*7wliqwuhx|X>XAOV!5Jasj0-%X6EHK+GB1#i^@HRtVJ?9euYo0ck_vO_W)Jd9( zOLCRljn`i5vG$3{H8N?M&neJS@qOmP`p`xlWoYr&Ts>a$oH>O+4|Gkh-rSu-T#H&p z%N}>9U=mB$=;O6-Z$uV3!GgO}BwxV^ZMUMC(5I-xJZrjppvKVE`tgj6dsTPkrw;O> zWiPxt!{=gVEp3dMHdocn5?wfl3G_sBXjtavt}XU?rA=XNmr+O`nm1>lsS6(g zY~bGO=4K;t#;42mKNn>$NVbS{=2Kf0Y+L?&;n>go+A9%q;qcFAtl`xv7`O)PfWiKa zQRD1Jv=&*g^))s|{wkhV`;svC6Zf!pD^uK!J3XGjo(_eo=D1#eCR)T~5PUebyRiy#3_Vs`_UaQgpV#3pQ5ATv zXMyg}>O_ZTwR`QrhOoR}A_81KUB!+>G0kTS^`=)Ujtw(9#xq%4M;8P+nV$4aNZft` zK23TtLafne*u#o~?U|j8NDdHs-pAinKGvkEz111ji`mmY%Z?xAUv#zXhh$4{$zZXw zm#{?^;p8E7+sxPCVTv?^R1E!d(p`<=M*qvK_V1#(o$bkZdy8Qep$SZe9z0@-XHaRk z*IRClBin!|c02`io&Z&94$E;7a{fY_Mt^yhDlhgJ(YaXk4XES+`28<>?hXh`!VFEkb zs&3I#;nNLk12knfO?mmCr#7v0=ljT@q}}D5IuR?Cs&&is$;VCGKbW3B{oi+_Zz|}= zmF&~p)Y#KAfVy_ajsk!&+4PKFo^=WJ7x|7e69#YWj}%$`PPDF4-Oc%Ej*Ur=*7I;p zXLP6$DK;uh{AOMLd!L2bp|9h5HBperkfN0v-}x~~u|p>`wvr{&2k}BRj4~}gID76f zdG^f6bW~b{s=CUQ|0atcX1&7v=KOx^@(ZYa%(Kt{Y`gToR^$d&d{F5nx2}ms)zb{O zXCATDxkUfHkh0SV2|>k*SA{Y!tE2uSi}K%a*aJjtcgRZ9pqd9FSm^=V(rf~#ocwLo z?OB;_cL194_CU(HrWY2=9|-vR_}9j5e?f!Nc~^TM>0&V9A?M1qTa|Vj4`wfqw|5RS zVtRP>jkgX>dwL(Tt7RZX+W=i(dY?Jo~7So*YUdFHDU_YEQZ4# zMZHA^BJO_vF8i=_TNdXk?>7I~Z6AS&`wM2N3NXM#Bhms0PA!A?g5&xzR^!wS`nQJs zk7*7z*1^VU$WY)A#H(I@FXYZ=P1=1NL`h-(?L`+CozIeg-cmNJd0wRGt$#h!9Rc^r z|5^b4D}vEIfKMg76i~t^BHNPr#V^d3x3={-&^)EZ+&Lf-RE34_69YWp&HQK0Riwi2*ov^QbAU#23#4Df&jH)lMHxeT^Gc5p2Bk;tks=gl- z-_U^O2%>lNu?^^ktq*W8kFdhw0)2or`~(DzSg5Uz1rF~-1?sZu&v3<1HG1EGzBvjg zVt`{qzzsHd`Ajx_VBZL=%(=$ew3D#9B2#|O?D)-t=ZztUK9=0KM%OJ2cc##5d8xV+ zte^WML~pu1L}b3ZwW`l2F%OA3y2nL>#xAJaPC|9s+6^Ke7f-~?=y;)eIWLu%yS5$C zCUVIXj;QRpO}@6+Ht)HeSb+nr8SyAS-P-gi$W#n2-^4aY37F5qeubmdXG7pj?^C3k?Hy{*0gysbz6>^NMl zvV#CT>glk+cRE{VpoCs9JA9 zwYu&8s#*wQqS7bfMVJIlfQ*Xld$~+|k99n}o~1P{UZ}kybbhw&yF=bM)eHq@F>)vG zHtli%qV4<6WQE?=o4ul{<5rxs^DK+*A5T^f)b2J%Oz-pf0fbBwU2X!PUmjVNLXZD& z3=6b7t6j#wfP09~&6Lbivg;*v1g+&AW~Nl51*`!ww)~`>9Ro}b+*r)PCN4hB)oXUs zp|?1;X0itwXFt`2rxe@kHo4 zbVr*5=+H7Oj0hM?{M0-B0MvSIVX_kpt@urK8so7O#I1$XO;Ms4DT{mxAXq? z#LKc$3<_5ahA&bMS7ITzpy^%y^{wOn6Qj*?|~(+L(kbOvR3Ui>hU~CHHxQA|@^VRd!$X zD)*FBXtR2(t+xY&@$~Hf(Jq?$1CyYCag$Ft{p(&y#5*N&m%R;YI(@99uifU9D`N}( z@?=abVL7_#7dQLRb0;d)(xeS8f^EwQ7Aq^5EQ<+)S(BMVz$M4+s~Ub*&3>VJdJ>uG zI(G{xX>X`k4ci)cgtvSK(vR6J9lrvXD4$8&`~`hsWA+V>HJ;8Mch|x2c-la~^NPfi ziM`}1`^9isBH$k;P46sgPRmr@Zy1@$WDfcBl3OM3Be5E{4a?(%*#;G6 z57r(ZVvqd-5eSz{;=pS!>=I_zkI6{wMvjfQQcV~wS{}MLtcAb8) zfb!8@m|?mW#YcpP$}O%4uhhr)KaCXbdSi+>EWfA^FO~TSiuIUm%BakR;6D9WN3|Ar zMalH74aQ!Wj{#|!ff*~*6Ou-OwM=0mop3vbwY zJ(eHd-yuGlmH0|ed`CFcy@B6?7+&BVN)R)tR}Ab9DZn^7SC2+`DpdOLae zWl;zEWrfe|7bxt5lXLf5XQPJS6ih2OV7-*?2pC@8;SfFCQ4+5Z_3yMV9h(ix(7}nc zfLj3}>5<;!p|5tCVXr;TbFD0Bz!R2KBdodmj_6-Nv%iQ^QH(aWi*wBId=63jcE;BE zEpUp1Gzeamn0^5JCYL+xC>Y;@@1zQRbK>WO>fN=`uf1zBN*u*iSWZO;tIq%UV|n$N zvh{}xk{*KHkLdH~;(lHGLbg5N@nheA%U-xkPyI_ZONwLsr$*b zg7NPSSGJu1cwh@HfR#a1{U;_JBu%@qq}FhEpf9A*zx(VK^wYa zvKmX5X%c(KgP;)Mr5GU2UVVG<3%6Oq)<`V;Cx$3XRK!MHhqN#;V%4Fq{k{uzE!6FJ z19k497ozqeWE80vx}J7Rk=lsNg#MdJy5RM+h^PWjCPNwNmF#8 z?24ibiEs~SH-N4Mi5}5-uU%S!w2+yyAyF6Le;$SzuWxC1wJ+MxQY3YZ`Npw*JcaH; za(+v|5ZqD?pDjG&(ur}0f<;pnJ4$%P%K5GjBa8Se8+}{n3N#T_-L>1oo&oa!hy-Cl zb*jIq(hih-2Oc_ayg6n?vO`<+ZF6>LJp9$mLFWzX`ZtYsbGdEG1$1cQRNw5=(n!;; zj(n=4C&3}Lku`gnNM>#TOOyss!SRL2ISg_sFki4xZ;jSWQ@uTv6&tK1fJlSnos`0p z17Pl>(f#-*3&W2T=pD+txh_rUuZj;~mfkmO!1>mqO{-PXHu|MLnf$VZU&Z47e3+^7 z$8uhz>?L!{iMiCZ1eIrnjR%bTP5 zUrGnx^$V}xw?7E@b~e~%q;O$qQok(S#9{7Z-I+X$hG2q^^+p;y^N)ea7Y3tz2rrWt9;a3NYbwIkeOZ|E$wd@c z`Pgi#`!xR-TZ`XPkAdqC7?g!-T5Nx_DF z?$<@3<2Xo%-?X~F%|beRSHx7b@v$9C7GuqHi>AK@6Pg5kv2VfMRid3Htn~z=(L$2g z79dgcSsL${r|ix)f9n)3=w!2h3yX@qxR40}`AtYKRT5^aFDheL@8q+-geuhggz2S& zNMAuOYGa{@$un*i-4#C7P_{1Bs2vfJQx_7p2cX zUNftCg(W}3CFsMFB5lNsc3v~~-l8qu4x2jGGA%!!60;oJuK0Y4xPI=JD7wko)K^2@ zcySV?@l-e_i!a#`5Gap%G+H4&vcYWdAI?Efm)m0q=G>W+c{D1`$z0WV1XjIuBF2Tn z^zw4X#ke3J=-F+CSx_;$GZ`i(#^`!mFS~bbs%uL# zD|$jrNZ3UP(wvu2E#$WyNZx+~fB}&`zePGNYlT&&72)?74tQE8IUZuZ&c(zjZVpPv z^7AN?siqaH<*=pUUXQ|DM%H}HZ#8Lvz5oxEloc4r`CYyhtwEe9_m>CNzJPw%fH5I- zsplzP&=jR*Bil1U!$?}o-Sw+dw2Jm-0=03ma=y+x) zskPjmNK*fks3XxFdM8KrXyG}fv~ZP_dnbEAghXJ7pm;;v!C5k<-@N-ppT$h%jtS8H z*$3TOv}Al=1GfXr0{X}klXEGSB7AG8@L*H8Zq7(GClSZ_n^Zfkbt<@U0Q7) z6l=0Wa=AD&emctp(j&(5R?Lp>4I%dJh35r_yk&NC2eYCh%wZe z0=;^UtVtXEjkMQ-TfS{BN4Z@%6}7a!S@Xj_7+J}lR|Hr*(+daI0Rv?0f7j7V>rle; zg4J*dCR!_Y*loO;IyQ=m<_C=``S(PuI>VjHG^gz)j^yDh6YZ?F?FDN;hSq*#SKYmo>-TGsHt6Pi7 zmAc0Hq#|0JwJAc*u39w5XDIE`al5KL|Bs_HjY~Rx-}aQ1HBDMsS#IRCSYyigYjPJV zo6NDKrbf(-)QS?7a6@IWvT{qU%(Ps{$;lEGO>q}mM9U4+5W$5)0Tl%SMRp(l&nsT> zf)DWdUe|q}=W#GneOtR|ue(nZua9`@Xd4`$cjJ$psoF_WNcVjRcuDuNyR^cE!hdJh z=fkMpPu*snekL#MvG+o8NA_@E`AgC_w}q{-D(M#;*Sxb<-eudA1NmJYYiENrv*1<1 zs)kw7KVZGv>*vd^MxpC3rW+k^RXyRGu*nH~H`u`T4g9L!|NJ#!qjS z_xfQR7U$mW(=(HTb>8uV2eED%<+w+)yfa9@&|e+77|((Wb~M0r4hp=hERea(SuUr=fSFPibxoCs_$5mq($*(U~?ra|aMZ9M?=(nm+2 zZp45Z^W&8U4NMOZS#5QAcxU3Sc%VFaDMfj0e9w-GME=Y_o&u+ieiBZ(juB-Ie5YNC zHXllhJOd{R82(fl+lu&4JU5V1gc%BO@xy#ZW44Or=c|kVe8MT}cEdtfp=)!YK|N}( zm(SW#Y$46=2~`~l&{fMJZB9QL6}}(cpERbVwW;3E!2o0Ya9l8zq@Pipm#}&T$^FFs zjsRoyf+a{o{=0Pc24P94C(-U~rhuw_=$*p>pW!P;<83*F09TQ_{y1sp(wsPW6!WsJ zzt{nl8!tA&D{Vw0WF{Or*=n{DEz~}?0>@4CPtqu#BQS)^K**tkgnQr>edwZCyj3&# zVrxR6lg0SgNmOLLxNQ($Ita`aCCM2lEZR*Zo$ofp3{-$%lE)YhgeN|Fm(BBhD9@^K zd1M3Fgp1XP)q!Wlw_=;8{!+Znd2cu-PybvO@80?TRdOb?wGp?=XFQ^1`Pmc}xwzMSW`589L2S|yq{Y;ry94ZOLO{~E>dE|c zDHY2{tKXZ7mbhgHSfAL(I02L%m+$uoN`>S@w97j9MpKu7PapQ6`6W2PfUc3Cyv%X| zWqx)4J_L$8See?o9p3T+ID*ExE^G$aEFDT@8nDr#JRMdsb2s11SdonZV>vJXf!qTe{UGOkhRed>6r)(UX>T4-{b->eQ_EEzBwr<^bzk zY8X*feU|}eG4xDlzWSk9hDYd=5S|?k8b_)H`Ce&~T}F4~?6o`~!raU12grC1N&jF` zM{y;WqhBW=4*N;Im3}WjIB#vW0DP8OU^a*<6@r&}^Z01)U(icm~z!w#AoEIyyD;zmj>@91%(&Fvx zDOC}YMec{Pv}R9M!Pc~%#Hr|z*`A65bBAtI5M%%D?usDZ#GP*mTitG`jHa#5rh7?n zdq~F&oss8mRUY8BU3DGD+RQ#Z3Xs(BdCbe7pOuocq1j4=y*iHe^&stl8)3RabDNr| zFL&;)fcnlN7CZ$PqU1lC3_Fum0kPPVE!)R4y_?wgR6J`ze!pE|TPy90@!Qj3+uf&v zCK(6uG4o+h^XkY;FUOM;I_oIp-*O~fYoZ)j{9I>%M{22!sm*L!yjDA9r24|II%aCP z)i~3#B5HV3wZv=5`;b++;k+MVNh8941Ikrx-&2inEzzQ)RZ+@XTDnb1b=!*s!kbw1 zU*O0wlVr(xrl?YMSgWuz9demaGB`n*uTKBpim{QEtD8TgTo5fR~=vxVNs+Pn~-cVWQw}rUx0#vXUYdMi9!v|F$K&>3;Q zYF{aS8)%Dnp%BN|BPooKAgcNyDO;CkOkV>)#9ot>xA}wg4~QBdzJ`=9Ju4{D=~)zE z;bA{O#50Qr{8n<%8OJOn3m$dkfK}}City^) z6yrtOfSJTf6#O?{vv`6^M`E8s9mwToau=d_3z0e{1i>L}$NZyPs=T0HtNa}TJlqtvtyrCg!@P$q*N#m7 zRJzdQXQ7*Uw@r^QIql^GY@1AFJo#1;sFRNypH{;x#$Tjw;?bILk8?Y$yKWnIL>%-L z&QF)X)PJ(uBEC#o7&U(_fQe&2!k7O5+B7!zWUR`2g2sumpVNb*Y3GS^*Fx+yORH^J zgybJLfQt8d^e~qu9WcCM|GNsohr5_ZQqV>pFnpIf>m96MxS_r=iP#<|HVg~B-1 z2EW6RTLhqUimh>ofwX!)CP7a|`IUQeil1=yHdVE7$GIFg-th;3+mCKBfj^i|wFG#i zb=8tH(pofYIoNokrT$r`?p>X+c=sm#C*lm8YRS)PIX|&CIC)bF<1uGR7zh_!KA_JC zR@KGg=L>K?tp-k}--k!p?4_XN4ybB;f2s>UIfu;OSokS}+Ixp{O6SpiKFAK|Fv>Tj zW2*;!1b{Uf?l0NmpcyPpVhK%%*gCpKpV|!W%U&;B4emo2@-y?##fCByK<>(o3u3gS zhhst!u6iljKgDRD#wPx!_Hw}&bhqJJDKjFi*Zca}c{Jp`EkP_*+polNlnu}H<3vfn ziQHv_+}mFr!OPjF8ca?IAcS@pejCS}@9%E|4joNPWutSYEO;(ub2E{(U-FY9Hi6KV z%2EVX(G6h>@hkbw9aG8R?#B&{A0PNLhn&QgAH2lJ3Bl=ROC3n2s=shIG4EIuVUHp| z&>{0;;JLu8Kp}RzK=JTOj(^i@eJAso{GGwp(fdE4GGPxvFD9y7G#oW`UpC~VP^T;m8 zTcohQ7+7$W&RfSad1*XSc^F^9nlK*%)qZk-(MYHFf+iH{q2rTizK7`oCOvml@~d)t z?395o&qUEVhIJn^f9Fb@!#?l!Jo_Y<-HH2XW3C#ZeHp+yerFwpx;ru+;2ln+Bz?8k zeAQFWkH`O!mZz@atSio!Kj0`*pV4j4ujUW@HAr`AkXNKA3sRH_!@g^8cGq70EeLnj zc6VSJ+{vaEh^pSwSf?-I82&@Rr3LgNDcQD-yNiMxs!t%o7N2t>z1#O%b*Xq(Ub1Fk zYEn38ba^WM+(P$RN2Yx#Dt!#}UAwwVyvn%k@pd4i&h^XNAnssprO}IB)R;1i@#%0% zr|5Rpk4NTHZOentJV9o|HtO#I!-mJccrAZG&@9qfiGecjI&1rNePil%rhhM(2Yv#+ z-Ehj%Ot3F7%7WYads=M!om~3~?5_G3vMuu~7TaPWA6NO=MU8mOkn*c*EPv{JNS9us zcsn%vQaB1Fv)HPUUeHgz%d=M@x2p0D2?4rkIvV_w`mr}+{<09;ospY(koJ^>UHUST za)5%psr-B}vi(ZCe^GB*gKwWKAGG5YWw}eaRw>?-g{BBi3!d5l<`uUiYHB8;mKkHs zZsw+V<+~=#GwyYql1zg3)lUs4(luQ(p!uL^tG&Ap`&n3nYp77~FCIfe)Ic8$8^Gb_dhx6UUkXoLSjJcf8}kl*U=_PFb@9G2SoDk=n@Y7GLOWvnWT+%#AY$P!509uH7cyfKsYt~yY zeCG#xYoqIS3gcgYR+n8{zZW*?l8r-hmj@90<^uUwtTX&WA$WYDt+n^sl=Mr}C~suX zeZJc#{Yy8*wyQs_)@egfrDX0|6UDvrFkvuAs9@O8#{6j&hR)nE*%446`BEC?D7&Z{ z@zGQt)O>gBSb>#2kDSy9NL+dtA5u-)GGDxlyC&u*c-7Ij070b0Aii#7GO&A7+T`ZB zt2x2(`Qa@G_)P%CAJ8LFf=c*_vC#m`rbwdAwxX1iXxstTaOkHHs$qYMR)<-t8G6UrC#*dd5^4Uu^X4t5FM_1ZeZ`>*wci#fuCSXxy!R)mwbS|G6$oX8_qX4TvN#U z31-W^sc*A;gHy0$#)84i%a)$m{lEh5uC`(~(=OVTK#TXO5C@G>?P}>+k~1o^4ZoG} zW@oLB83|x_wW)n}D5D_Jyx#E#aWrQ775&+j8unng0e5%3sZ9!hv@>fl*k1kchz;Hm z7B-+9VsCC&O;m9VJGrUgt;U_Olq*IF?a8Jj=LHQxrzEWE#o^FZTfn^oK_`w@-rD*j z^TdwO|88#|I$c_gG9R{HSghr_QJq;YjX;>Y!|MaT1O9qORX}SUTkyu-vGYsbL4nMX z?lCj9l`9Ux|H7-s6=NiyS9E)C_G6D-NS*tMwry;U@X@lDW!DI|`hIUJ*rC_}H6K;H zB&jmG2S{kMiJMvZbmU7Z60?zUge7~Opfrp^1cd+ldW`!o;dndubdQq*(>2Goq(%Bh z-l<|o7=XG^zfl#^z=x&Q>Lb3G=O7I z9pbk5UuELXqnxGsFHS|$nhobM^bavUghguI%#GeC+6%K?E26h%XwviHTw`@nfkVb- z!u(J2N{;SYQ0*=5ur*B0TLf;pchnoY^u#MF3M$(o>d zOr(zgFQjvzTeT1wspY+S4J*U4^HvM)a73FQBaWR7;e{^jtl?nCQHMsjbMJ>O+?5*Y zeYAV2H0Wt}H4L%XGpS)O*5Ne&jb4D5X2mZKh9Ic76n||LVC;?r3*S*d7yVo!B{V8Pa)UO_nyr4;bXWwK&K;vYFZuA1j z?cK_+6CxBU15|@ud44Gi$w^iDHXOS~JnbCO9|(kV+rlZTUjjwgnI@*@jWvEyeR50< zE|FF{4!Y>eRgI+$f~ER378^mGY|*v9C#2`Ty#!om_53rStM%+(VpMn7%$;}NnnvIe zfjNZ>7nd9DUuz`y2B?K$Z&IDvrJL+7Agha|f%9|WTe{^>fGu_Fg@d{%ZPf&5rk9Kz zg9#ai^!<|~tj{H%$DU8(YJGui&d&>=LOmd=&87s<*h~XvcuF#o92ps;Ia|=0I+=lx zq^*%hgm-B4qi94nV0WM(?YqEb_OgRbPNMQHWT_X5of>HZ`l!pJw6t+dI$$^hH55vj zJ@?}rhcir5icHraVrDNh*^pS;H);Ln6s-4Dc7A%Ad4>>_i?H?kH9@B=FQSUnSi6b{ z2ooEIk8L#MMFKJ_9%vFA+v`Oxo15cy(dtk4l+~Y{8SHjSNvx~CJ`g~57@#&{?>ek< z(^(NCrE?-Rg3QRpddTAO!q{5@V zGe0&fzni~UWi`7K%9Edz(4z%1L*@$f5c82(r5tUnh*9j@vq>gqqTh>czT)BfE-=xJ>ktYAc@x_*tt&Je7_Z0N6xJD@xQjjx( zB^WkTOUTRm+#dfuR_&=^ys+T~MbAFch@ExHsN8Qv+z`?}n(cf-lJ&)j9W)#ZOMkWdiwVCe-N2$S~1#pv1)M5(WUwdY!spuT>ev98F5 zH(*$V9j@C&o!gi=$n47EEDiUk?FsMnJIPEbr+5v`&CzvfG=EF`?|Z-@@ak2Af#u^ z>__0k=3Vd=FK~vNd8@p>!$z|+%{g`ennXsU{-f8txY>j(iFV28h`K>iii$a-l7Wbcr@8rRxZ}D=i}YB^#+*oUQ7jH$Y!HPf z$4TiF^wU_I)0oi70zx^O&pS~$HQDWar03{|v_WCg*@q?Jf>yWIdSBQP_a5-TGW7dR zib{H74owgTRgcbdeH{T&WM(wStel{?uI9f96nykAeH1gU)LyH`x0%9RXO3*=V3%(!4!^_rFcWLzp z(TH(x)XUv%v$E^esM6l*<~gHskzcLUqEdc#Z;AU5wg^Cx2@a`0gzWi{yL*0hBF_V_4>>dZu`!s(K z=)LG;=Sk873wD5#lEgpKirih9id{vp)~>y~2&{-ZIVidZxOp~D?yq@C2e$2um7LA2 z#~Ahljd3l+_1fyUWR0mguzjJz&#vlglT9gr{zO(mb^J~ur>#?P=qn_^@OR@Yxu zm!keHu*cM8c}rPl8LwR5cn7US-did@kc@piaIZ0_^Jr6&ds*_GMvA}lBj-$?WUD^& zKm!M$Vci`g?ZV30rxzv948IpX^`SpkAxdt>hONz+gbb{6*yY4w3?w$8hvmc+*aTEU#>YvxsP{(isg>uzRIE=st2HMEq9zXCzSy}WGuJ5 zA{P>$RRPkK+}G2PLzbp;V%6)Fo8l;`kmcEodiOc7_Z!G6yAz{Kxl5#*a+bYu=Yfv4 zp)Pjav^iKH+|pHFQVD-Kyr&*I?beKi{kYh1en7m)aNU9CnQ%z&L6KlAQ!EWo{tQJ% zW#AgzH^Dx(mbuAZxRf|b}qVi84Exx9Uijb=!&TV1;Tz|S+j z4DOqi<}&r(lv-*{XK2sew)aN5OjocGq1qytJ~7U*av7F;nIlot4RsB@f2ORkbt8Iq zLg8vyywyhP{I~wm`usxEeOAp9%t}+xY}ZAj_Z4nKDP?kwrYJ==HgOmPcvMrDXsr*< znK3iH>|YGO>yR&2tSSJjQ?OOt3U$>);+bjKN_C&zn?LBmp_3ou+$A=V` zKZk!iYwl;wM8azNB_&UPiH^Ffn>&2tu4nOaaBa3Ht->_r*j^Q1F#t)n?e9KZV>^2f z`)(6&8(Pa}81_&LPJ%bajZQu47kT~*;(r^PR8Os~_9^S2Z9yLUJ1db(18FIXA|JNd z5BSPYHd?GnPCGujheneZ+8oN7md`;a89srQ(u?50L!i2@fft|#zv8gU z=dN#y1SG&w^_4tA^EbZf2)g);T+sy3o+pES{Y{M7K2az|jhw;R6U%>Cl4egT-5FGA z@HTpRDrjQwWXV|A0XL2rZmUmexyAGWa8hs6i!M@PBx=afYi55WWo^f1P@eg#f}h&- z_Q}>~pM!Bk2M4OVvbp7X7Spn#+c>3vr&G!)!n%Z*3-nUsCrC%hJa*jCGHR=5WGwIf z>IiA~apZvkUe^Phz}H-GRlu4ikRozqDsk#PH)iZ{o5=tbqgKba%gu^lm#~hSuf)_{ zFO3^05_np;Y^~##9A9R+yg^nsCg1SzN*uIhVmr4PCq0T8+AbX9n{qD`kjsAywdY4L zpItdl1=u5%pGdbAwpqQj<`==izf}hwm#f49ed`M9KiP|GnbcJ@JL)|pO5g7j^+gLEwlC`g&ynn^ zIP0Ws=!>2xj-56Rdu?lT2>Le`RJqf^ z227wU=8cPRx_?q9lNfoBE9NOd9jUY?`)BNJSY-u?*PVRq*ZyrSL@)8qe<2WCu!D&M zhR%I^kjw3Nq>Rjd71$QqTq*S>9DR2`?&VR>+|F&-U2h&}?=-gzTs-!+<`hg6QJzg0 z34)*M<1aHj4zF@|Lx(kp4`u`Jk>GomF18GcgEaq#WI$4V6ab6w2F^S3I3Pe>C}NAT zI<%&Jw#mv%Sl;gHd5==auQD0;FvowMb#EXkuNB}0X@q-7yMYBCm#sqmo-zo^ns{!i z|9X2@`Fpr|5Zy+RX6cvbsZx6PGWx?aV+-X)^Vo>LGSA%(sk@@Qzf_cU@mNqNB+xQ@ zEF~P@xx>)OqCupOD~+G9h>w4udN|?oquW)FHhQ`mfgpVglhykn?5rkea(}z*6^}YS z8aSZB3q~lcs8=~BgHjbEKOr^5i}3%=?kNlJ2qNDDV*9EKZO)4xRXe88&cof?d=?)_ zXWjFQJg##tXp=Lc~as_0zd=8G=sIJ~72Gm!E+hqBz4C+eMm(ATjr z^KFT6*>45VcI$x?V4QY(XL8dZOH-!%dC9$5h*`NQZbNIUahe9kg{-Vbl^i6qqzAJE zS^0e2E@{iS{>EVCEMh{i4v5OU=4-K1w|k!Ub;ad*vuw8Rv5zu|seJh7vHAQR}9& z{0+5i{l+h;&jPQ@<#_ZNuw`oZuqdHoBAqA z$#Sd0ydF_T2HQG<+0&(a95T~j@K-O)0+DCw&R;4p105NuE-K|fu0xf_oodNNqT`qK zmJV}iV68euPyA))Mi|}w)n~lx%-@4QLw4s)>Q#7yiUe zH3cZ|J@J;>lse{gT|GgKM`gH=J$mG;v(#9<83Cq61`JOsr=|ac8l8{AyuF0fTKTFJ zZsiI$jnNB=3qm8Q1DHLre;>9R(~|iqC$iWo-98R6FXfcZuDm*fYD~Dp*`K0f%iWE} zo{S8K8g}WQz#@FaWJB0JW?t8T4jI_zKH48Ug9OB1SexcgOe z5&G}(<7roWNxNy=>angc9@_%bvJKv98VWxVgy3h?hvo#kJo8Z&Ud)XIqQlqr*AHKB z5-K9yT^>cSF7J;ZS;bsfbHKbgs^l^{IoN%flOanGaq9?5FF}o79{L?EnHbuko z(5Osh1~wBwRkHTuMLS=#+hrqBV3_4N4xcDXv+T^h$ye~}vBv|W_eKXz5Jlf8 zTUYKggU8Td6<2OQ7aX3$kxmqMGX0E`rL!G0NYWnJwE=Y%U}Xk25I{NMF1|w%eBV4W zM$$JXKp~p_n{}0;4y^B?IsT*(c3kIt@DW0Dfg9zXaX2P0=U(nh!a!*~Z?FBDaL2g^ zpGGd|82eJzdBviBx7k1lTZC5~)QehPI^vj@F!F_{mU=rshta8?Nxag!QyI@!*@tFl z*Z=4~w0i6-zUciLs{BFec(S8h`OT>U=y>UqG`*sc{)6$X^w>E0yr$ILU2bvpRaAdz z(Wh7bDh=0vLZ!K$<6Czdi2oKTjLre*W=K!Xp91|2C{v}tSjOhuB}E2CBfD8*ymsN7 z&dk%1Ju(Ng{M{5LLk%K>^w4#weQwP5+)H3`oJfO8I~rYsxp!{mBHa7oOHql--`R`R zHTPBrc03i%#WA_{D|^0HWT7!WJ%5(SJW0u9NQtop&x9Hg=({9ABFWzLoKUs10 z=*A-(Sd@54W($4ohkE!6UnS`tZxmGPaFBNRdQ!s%XUW@VC7T2vjz&iUs=kKr%ZdG} z?P03!a0k1Mt9ogrl?Bfh&p|2J);2L_U1b#hML3c2@>qo(=)+g%#X8JgwBY1|@;y=Z z-|~3e>9+d*c>M4_zSI;cq1AQSf0+y@ZusDgvGY(RRsm#j*5DuVJn{F7+U3=Z+wG1k z{eUW@dU|S;<`Po_W-;`3!Df~6&6Y?x*6!VU!Juq-Lb+r?kuBG6tsoo#XNuX>AsoA2 zd|RvXcUMOE7L_!11i?gL^@L0~-)!D$D{r|Eb+@1SPi@Z;0w>&7cQ7p`ZTn#?Oo9N$ zS{BVsikm3f`RH>#)BqVHHp2c+fU9b0JYVE5ej)0c^bjp}cy-9+T6j*i$2)ich0JFH z-8ctWO5XsV`J-``l0+opVuU~Qo?*|+LO%q2W{;9T}$o6hZsxIWuJWY9m{D@4bb*S=;`kq&~a+w7} zC%F2|kz2VBu!yW+AJZxup6@g04Lzdy>G#k+0^1EDxBXs^@g~VW6}&Jdw&wdRH~5ld zll7scr3nk2hp!9jU4&r^AqemIy^-$(ZSAc8QnTP&3c`jLT4r2?RQA`7kEZ3M>J8*| zFA$}6U+K|I$tM$=__@AL^UA}Y9~0g?1-GzZD}SN0R$Wi0Jc6_mU30rsv}vL`BkuYc z^8O{ZfsCzqHaxdA+<~^zZRxxVD&mzvsMw~E{(lNe^Z{n}J$?gstN$2So3^?L(6Mt* z;%dDb)BFavJgV!zdGS|D^8C!!w1>{4XZ(rPXJ%zApZ?HJTQHX7v5h(U0x#n~WSu}n zT{kaZ>|Arj^QC(P>Paf9t_O3iuJsnvdi9DWEPi{h!Q783tBCM{-4F>TJ^3@a4Xqh$ zYT5+rG$Swyc6Z-j^h`dJK{4xU^2mZyvdO_Qfn)t+nqf-(w%37#2H&Onw;<<83W}9H zU$|sVjAdRM{qyiHkMO$18HVNv+LHw?zk~KI4k8|xe`yAz4Qnm5Ykm=^dP5hZ|V@Fs^1g&x48Per52?w)k zPLS+!yTjIe8rjkLn>=_ke=0Z|3bg?49`CgQWxGMjTTQ}~X)qE0Oe@d(oe#k-n)N1^ zoNZpfj^w=>hzKg_H5sCNZ6`_VjOG>5rO`n`C^#yq!q)G5*7xD(kH$)oLjE(^T^Jmz zEHKW&bl*LC&B!Je;n~M2lw=jSy#*$AE|Og9r;B^I>=}gYU)&YW@t8!aHAA*Jb$Gq2MECrVO=G25(-T1wMyt&|_E2P!Bh**!G`?LV|ZVqpr zs%;f3bQcyobXiG(qdK(pX@SjR0iBPw?{rYF8{)X_t?Ca>9my-@h<=FJljh{5p#u{q zChEsp0f7*kHTX<{D4}A--Yy{=Cm9u)2Bl2@@SUa>E2^_&5sb}F=m=OQ&S)0nsUbc` zXQf>22IeR(L&x^xwE7$rVGCHh=9Ji8>}HXzbbN*gD)7=ZbfoZ(w;Oko2LKqn>g-yU zlvO%i6g9KqqsO<@eG1pM%A7keS3mXqzUc*|K0VKTDos!@s?GZ(JC(o z#Hoc$=Va}U*;$mH3Q0nSv{C!J$%2i*lNId6JfJM*^(Vqe;>xf17_#5P^Ao6i;yBx> z-MUohb%cJyg7#r^0COmfyH&ya*5X8?Gup117%=nzn!3FSpo8e4wCidPf= zy0?0H;-V1Bh6(p$suiko?akGnni78?0m7+f%HELqmnt%o@7-e3$nB~K8cKDJZVwy! zLfWlZsNae_c75zJkn^4rG#erD&HUgso;`aFkpt0`Y(baQm&F4b0KA@q_){qtax_!r z_ocVG*l^shj=rUBd=jplr@Zgd6i86ClxV=$>wk(S&42CAZ0~*a(bEn^)g;0N}d9UV&mnme2uF z>Lj{+X`0LS z(XYY&PSD8h5WCAIJN;KBSx6UoPH<84ADrgGbq&}hSit-Qkq6bqHBPc5E7K+cNc#zX z1e4@oAI80%+wpJULdpHP_cgMwmoLN068U3D(Dtpvm*ZYzK%+kq9)Z-{1KF%ME*RYt z={w(<0tlA14M#4Z(yOpPj%R)v(EfPtQ}wl_r5i>?*?p)Wuj_*ax_mdGmco?z<{nA4 z%j3vj7GqIdF}z zHun7Lghfhojgdy)ZK-Yk9uxQb*w*sh)_?A9TGJJmJsWlWLtmazK-zC=21)$W%EwO? z0QcX1_K+_d=%;bo{n2}2mxrB5qdN({=6gBV-p%kRAi%wE`O$&M#iP01e;FqQ^%^W? z97~?fw0@l!Xn5Dl!u4umZ$*2!w`~<> z>35D&UjjP+fGF4=S0Dw``)=ZdN3H|Xi)YIA-1@Oiz!R^(-Dt0wmeQtDWeJ_c;6QrEQR(~D~fd4nHygGLI z4Lv2?KS!F$87VV+60`qL!?se`iiF{bD=w06^A}uiwwsDiK-yj4P zt`SrJLE0a-&lEefdXLM>cEv^e2B5O2ns0{&qaag{NYejEl+ynuEmaXgImbz(0fY7s z)LQ!zVi?>U{pK})COX7h$+(Nx3|%gofS@MgoeTAvW(hKz0J^l8m#cYh;GXUpZ{L>M ziq-)C5u%;qb1(_tTHUg8Fr@aE9{VC58XCoA0!%f>QyxcaV+QF+_0??q(vrqs z|Gk!Awbzdkqi0OCi^syB3#w#2^#z&$`*FC5u%5z9NphE{?+I> zIZ3eB7jwVjZ%FXl3v%2{1u^d@{Bt&a&#@U3F(zpfW#>g81GSeNEQ>f<|9cm{ej}l@PKIw zh4qhJd+wamCsE>~kSv-9Wh7luVlLAhQJgjH*<6gHWTURNxw{HfgRZ!LVZP_hd#u5a zwtNfNw=`XbJcpZ?=xn+(>ivU>9yyUsR_9K+0ihx6<^OINg zMSqJQd4=82zw?4z+5(1@{Rc63)zX6trsgLrH0I2;6t^5`-P|X3mnpN9Jb9GQ^80kp z?q)8#Ld6Ss==_tpjCXwtdL>A3XUXGJ%jZ(g97~-EKHnx4o*gvdfTZCBj37aeN1{wq ztBWgbX3!&!X>)&L&!k;4R}H#fO-l(gB8l`SpXXKmT{Uz%FQU(w!zjZXV~p7()h zdh3oB?I^H(>ubyTfL@}$G6%Q3BW~es8CzY)ctoAv=_tQgy!`kGg?qgt)^z@wptAl{ zsfPL~M%5$tUeT9BR?m(*!+zw8&~zGlafj@tQCi|RxkYQr?O-|y$3*i#suV`t*s;wr zQk?!5);>KP%paJYyj;Q;m#pKyTS>}DEKvAPAAL!`s}%_>2h|5x=SQK`QgK)+K1m+A zT;tsuyK*#rrKIjylupU=FwicMJAhxKoH@_DD6{WEyFKR(#dMiCLYElFL~=bKF$7dGu<762avl41dSwhjC~TT zl$=d;Ts%yPuj{=`Vbz;Bd4&7xglQ$afU&dNY7;J0r~BgujzVsOKN2*R;qZUXP4oMd z2H0vkUkf7)mJzS3%FUikRE!M&7;7c(&j~=yUJDPlXPScbw00~739O%ec%1y3xZGvb z<;`le??h&uVi>$C1Fte@XH?b(C#JXA9=g?);ZlT{DniunEA=&O_Z&|BscV_+u{Bs> zblvbb!aOP0=n4Wgb9;NZd(>p~?dhZ6fQ!-?0%KKw?FSr?=@!0!#T z9T~9>_38OE-dIigoaNj-$4fQ1@X3B@XELMN6@iLt zjOO}8b4}e#*|cw6WeV{9_Q?#r<9yx83kyd;w%eHOVH03i@(v@Y>a9Yuh9|Qgi(`LO&2s@I~j^@l%%w84a-i)|Dpsf-6{33FyR9pdn**5IISz>K1n%lZm zavA*?=&lP*jXcMw!x9njVqdz?xTFg>u+CV{;vYQ%dD#}#68TUXovRRD&dZabl9;@K!;q{)f_YCu(IaO{yByu|t%_?N}l(`LQ zC*X9^0FO+^6Sk=K2`9lC8ACwS#L@W`WKWzL ziseZQmpFo*spCB>0QQ7yx!H%VkKJa2B;d24Te2W-L;M=mTvv+z4DAxkQSwzvf97ml zy{4#ZHgBmvq(Q`0vW{yr!9+pun!RlINweM`+w#!4>- zAE!EJxWov{*9Uozb0^!e2}i`5>E6pjPy^KHG=LfL3GXsuOxuTjB66y`v-Eq+zLTSw{HW1ty%^N_O4p~)=X_|j%O z^?Tq`&qGc9b!J;zUf3{lqVZ2+zIEG#@E8G~kqHYl=~2I|mCNV8py6DLpcL0=Z6k$v{Q za{JlKdz~gLnwK#L3dY>78i?nIl=dU5Hu`ExNpa~Tj-tvvR3NO#^%;_(#op?3u0_^u zfD@8WIl?R^t`5=rPun|mCJ4oBhUf7!P~vx!h;mFzvSObh!OnY?e;oS^4d)kSkCwr& zg8@e#(gyWU5^*684SWkL!sF*s@p=V!cL6io8s@UBo42$9A9~Qtn!~_VIfL+Hx>+(I zB9BfnAR8}0#p~aF_F6mVx6p}P-BhFe)>uI1m&&um6Il@mkow9%fbb=rb;0N zWWQcN_7Y}+tByxi-ih@O>0%toK>Cm!#BdOCA2`50IfUDjrr89TUpaapFgdVk zer8w}^!!!t1}U)v7jzq6=j}3wFxiR_zRpKej%zbtAv^re>EWsEn^H8Fx-}+K<)aKJ zHFm5SuX!l@k5K(=NqhTys4P2k;?{D?JfhRev!%e>$GzW1_MbKBi~o*e0| zj?->Edga=u3-7+1JqU}f!tPD&*T-?}r4?0oEskB3EncacKDq9l+m+BY7y|B6{}Fe* zY6`HbFa_V61#a+ImtOF@S9#3Z?QgQJ`B8)H{IiDEyrSS=A0+Lzx@&dPaQ&`oMfN7O z$CZ&!+g~M_oi@(%%ZYmGqEjXv3R>$Clz883l*Sqdon0o6=%K!)JHU41ztir8LNbvh zb~Tm*MnnB6NsL^yZf+2tHXIt=e}^F|+gUMcD|r>kJ@8twsjaya>NCx0RxO0o1iS+6 zU;flN5DO^%Ml!4X(-fy>_#^0O&S9OTQjS^k271gE`fFNDSvi*YxRqa@0PVTBMJDi~ z}w@rSwa%K|8j5XrLh1( zo%a7xbS_>=-~S)qcWrZB%$23)b#%X6gSznV}9MCz_nF&xh_=wCRSiI&@h-_Es{ashK?PR40#sn1?5Z9jChY2N(!rNhva z%*bMpyXxk@%YW*Ut?34R{3%SHmPlkRiI5V;W*1KVd-s|-ct*Z8e8vmn%6@Ip9Z=-! zwAy_}DNK{J*@07{JNVX9;>_{X-fT~!rdkx4z_NlWsB&Rm(oeCAgs!=Q&*RIbhX|M( z6|q*3#95<(1I1h6WVdA5e``7zmQYfdgx!Af6rZuJsrQVG?gt{IOE&AwZ0L-1 z1hN()-(}%u0Ey%K_iDu%aN47Eo#{V7_Bk!PHHVSN(f@;XMMneKec>=$z{X*2nxd7H zt=(pztho%EPTRCEj&6w4rgX}@f0y>Qw5MF!nq&8sUx{?URgKxv-RV|`wQfo&85^SM zr2vUA5#0-pLXbRva{U;HIhC>eDA2yQC*+N+uZEW}xzX^Q3LN>juhY@F%62{A5D2nQ zN*Ybk$E{x>#t;7cxUu&*YpRKsbbh#|V+&;$l%6#esIO>G^%JjlIGLHrT&qFReh)-c zSyxMz8C01*7NldF(R6N;?Lwd#oGYE50VldrK<=;$$RSHeEgo~el{MrBA$143fC0=f zlZlsUZ|0vMu$%1Yk$|pQTuG76jXnZcu=DS_?WCY_3*?Uh6s%sWx4=p4ZZ;?V1U4XA zLkbe0vpOx?gXC`iEqZ(`{?JX;;XAw2w`e|ILw7uw_pte|(kA5s%?_l#CSh-$2GU)rZDjmj`7a!yBo#dA^bU zCBN#mbhi|HMuHPrQ-y1+ch9!MVRdn%n(OrMiW%7BwS{k546H;6*FZe6)aF^-1AT#3 zcJlu4^~nzrvd~J!Y+;-8z7*E|cD3j4d~k=vTEBg@1)d>pq;&Naqts{W-lGE?hO6f8 zQJu!27dY)?@&FUIA#;dWv{mmjpb?S>ifqO zEX-54Of22=VbOlpVUK5kJL@_->&4r+aGg8eO@DrR`q@S6FI%?v<*!SgYOnnRD{c(; zZC?4UCF!&E1cSo5vzA$1y$W7=mos_uGN#?R_F}=Bs`IN4c18Q+HizGrG&ro$`at4~en7}?p1X7WeuP1%nWw*ux9 zhJiTPG`ogs93=4Wi&&xAt~&y#DO6bR(({b_h&>Xcu?kIXx-LSsk{G)7AQxo&1%=XL7lt?gqOPJw*D z)inwEMAp^yvx-sTw0qkEGb@O@Q0(K;_fwnRg3_N%#Qs{hj=M2>)hJ(Zm8SmXLL|uz zX|;d$b3m7P;^hL9zx9c?yuI-!aE1eSWjfMMP8q=TwMst~*t&14FZh>IZus_2#9pjM zMwiAYxOP4c9~73zAK5>2+^^t8hX@6FW>c-40vx`PtuTwa+VIIL|CnEtzZd>wecg=D z3J$7L3Yd=wK+lOJeqLSwEeuAk`0Vy@`1r9Js9&%=U#+8M zkq1v9{VP9mrl)a4qTQF)^yvfj$*=f+pS?KGeQrl262NC)vix`TfArUA4(uz9&d4&} zhh2W0;q;Q(@QFRY}gTuQ+U2_`i->-o`LDU4u$cjjG+%Sy#P@O2;WwO zdQpB4kDaRQntgLuH7(2-zf+L9vhk|h>{WWK;2jUwEp?(0Ha~I4w7<{;&1-?-Z}O7Y zuIfWQKR!yB0K@sa_le!P8}A0Jjhf~z#9z_9YQ3s>)pjO)P4WcXmjhh9>iZEixooNh z9u<1o4dr-}!dg2wh)%G)LwBD=R>)@VDw>wu2oc1B_Ey0DlkrIp$D^O#9CwYPRrh2Z ztu$DEpK7&}KwxIbpB6$eQ};sMhFa2J{aXRCJpVE4h93>xDtuoCF9kZe0Kc#^Lrv~? zG_F5Kqz4r_8i8$VA<{bM*?_4(GT<@xE&L)8;C6l4URZzdXPY_ya&aKcc6*^X07gEQ zyQ`sv5HqHv^F!x*?#*DnqIM1bNlVGAL1H>1@&e`2v=I6)Ma0B^yOUBcCASw570fIX z-t71$czi5l1=>Ay=VCf11RQdH?t3qX0W*7{iskR%RWK@{92)i6V5`ngi7ym{0_%m= zwy>{#JO_`4yuf3eLA}GtHzt!y%aZW}pw9G?9l^QY5qmD`*N*wokc3F4omm31=fpaX zNpPh@Z>Y^b?Jfc2JS}&N8T*mx5(o8^Pi##((!Qp8@ZVP=7qhcsuqy|ExkgD)CW}vQ zrFO^<3-cY(3+ut}J$V_`e?sP0OkOz2loUR&QXL#AG2cLfWF4nX1aIpX{|dsD(VSZi zg98edZ=&fTE3I;bx;iEf*{?I^8nn}>yuFidDccriI7P=YI}O6w`c4~umtCZl%t_PW z$p+r;3{|0}6)5#~mb-P?-E?QgJJAnY3jY_Z9EGRRrj&R&-FvqB%Gh}+q(gh+s$3>Qlv6G>^*&Y zc0DFlfDPK9=v(Q#vJpM!+{RsFVm@YhQ^Ml&1c471h{wA|^T?t-kt8R{3~KiFLhqhP zq;BH!3n!rdj%qpyBfjMn6qnAE$IOfB1V@rz=rMhaw_HPyi@{FCqRjx)PXwBpN>ghb zoNc#2Qugj8JJ=t)Y{Ez1utOs3Hexmb*Y-zYC~s`6&MT6C?$gVtYA=kzNaC;Ep8@N5 zBL!a-i0(FNJt#D10*CT%%@#xKRbijgYi^&OI}nr_XMAvM`HxTj2nUG0J|=}lf8i>K z41E~-HFo_!DYW_aN%wxv`urv6gXmzp^&Gd5Qy*FMI5UoJqEy#_9Wx{A%h&NPBShEA zz+U%>B6hRH|1V$MQEbvVLqetJhDY^*D-F?;eKW`5Hu4#2USz!?VYx8W>3P3Lrv6L4 zELTrL>ob1K4}R%?o&+%igU@uQycFO$~HO06Xk3j3DZkG_b-2wJ>lOm@oci$ z#j;28qhAb?UOBR~sQ=yjfj`SW1=@}rF33+3uilX^Bk}-9OJ=SPUv|k>h)-k&|ANP$ zYsbr=WQr{1NP*%h(IR0IY>w{L84J0}JZKVXOp67)BsdNJbUq|nd|K1xe2K0J(@wI)o^*6tR{u6Pi!w65Zv`i4R}v0*uY?H{aT` z%~`hhYo0ILdB0Jyl2GMQUq3Ad39Pb>#uAl>U~84}tRD5^Thtb~!D;a!Qa>$2IsJLR z$diS!>T$QWGELG+)w;d-foD0ggo=Be$j^?N_B=O2Z!5j_xzE}z1HM|T6O#JIvWFcY zLyUJrNma*oSo5`G4V~9@@CGen_LTcURN|(UrmXnq#ZUC_c&v0G2*dlwoJzL}bI9qD z|B6)sNs3LOImDGGVdVzbFZ9~hJ3R}PK354M@M^oiX-+A0y*5t^bZ+owVVMFPl6$&N zcLhMbgjt!BrMmJ~EQ4aUSpB_CYp$wzx;?60Mi{$SUQ=%Aj210g!RV!@?%%~PHk$n- z|JP(}PY@u$5LNHbjYZ@Cs zdm2gCq(J_6 ze3f}*v`1&|_;>Gty^j-5Jbaczme$@xo@~%|F|{VejLI&-?MBP4q=FKi!&wbI3<$Ng zlzcL`34lBOfLMWEuPD*srr1KsS

    cE$3eFND!nVy(m{32%qkGH`>-x8#j8&-9PmE zofKKf&9Wb_AN{2E*wmo$gwAK5i+$n3V71=P2I8VN zDkCjx_=a!mLYisI$iw8Dt$&zC|8z!vB`M!>I^lsnd#X~3sGgcTK6hCmrT?{NgRwAL z+f#Zh7MZzo*hT^JqgVgU*EY`777y+4=zMx>n5vwKUH+rg;327 zs6$ibA>D(5$wLluw|8lJMr$qYsDK`;nwNO1*>TrlR&-8}x(3yWMNRXPM6=!UW+y%j zB2VHUsoCDX?6dP+kBd%=`wZj5K6UR<`)W-IgTWFh1@7RTkF zTvmbEIKp>ZXmj)LLHo?~xsxlZ6G3(c_v3nh{Y(pzWw>JDTSt>}=Qt6()z@i)2|q{#htV z{4Yu;P^Zd`QsQxZ&)T|wG6V7RG+2SCYjJ$Zy0(OSauF^r)O9zS&DM)4qKt$my6L%l z#FPp?f4wZI&ypwfK6#bv?Qbgh0c3liVsEXg-&%e6>cYp@OFtz4@5@2y#lp<&GH zL1hZdC6*H2I@&h$9jdDqw0K&3h}$kr5P4tLH+F)W{G6`;Jn?4U7Rxu}V1~FB z;98OcT*wo$niwA-LC?nU zn4O*<>~D%|%^{dxyou%@J+4~W)zT?@&T9F5A%|_s$Z2+Al)c*9f;F@klfysv{U;c` zDT&kvIz*xGCw*{ao3xD`**uJNU*U{il4jcaB@t9~vPG=4dNe0wm@p@XbhRc;-JV=u z3huqk-KwTh#C;cS+C`2@uLAZ(^l;|N=IX+j@7yE39z3x|Tvg=}_lD+V7ws@!v`a7i zTHHK8zI_)l4DcdI7_4vZ~rTNFG z$J8l+sGoSONVkc{!fd3tVW*&#l5ED#I2LZB_kJLI0>FL*l9Wt7$!GBni_16d@d%de zN{AYHqe+k2k^hO2I$)Vf7yG;!iA?Q&mH}FS2_zrG5rypF;0N)ng@}oIJjF?#=}PKA zrR7WSy5fzdy+kKhX7X0}Gki7O{S|tpSl?;Q?~pIz>3UnYn{$?Rxf0#tVrgcOVgv)u zpHUR*97jS#-&hzW&f+G!FW{cUk!5aYLWhl9%uMOlv9nhsyo$UPTpVrq^|2DTQm+jg zNlHSb7d%xrBz%E_}%3%&}YzQ!|OhAPC2WAT`= z6|D+1kq8j9e4TISTr#KH7fAYulIePQdJ)AMqTwl{Ls@H=58Yft8e@Q;v%w74OJa_T zKaV>XdsrZCu9G1H5;lB1c*Jk%m(Gp;Logl~F9vhl__Kq^4p>r?dv@$DqgA;sw4`bLPOQ*gu9~4s3%J7Yf5GCN@$xX8RbTW6<_6D)QBA z+oC~+h1z{;B}qanhNl0@uEjf&^^SMtf5$!l5&Y*_z#c$O?A-)0Vgt`21*j3^uRk zS)fFuohUp`r?(r3eMwR5`ZsNf|C2=FNi{wO;?Aq*N(VE9iUI=XqqzRi{PMVAM-$*N z`te40g7C4C`n=PRaCK#+0>7jZZk}H$%S1V`o18bfoFSII)q~$Nh&gg^K~a8@jSeipvutGaI$YqpzR!EJ@K

      b?Nu93$j34hYSUUT|Uxy?A$9=cIKKsq{ z)z@?8sqJWgi4yTV;AzZ$+lNJsN5zBA?mzjJ{9$b1)%p)UWGOZ7GvR&SLK6%6{;o9==B(*2uUD?{k$6>XfH zT7*(?UoztRS(dWUm|OZb!oCNbNA0-qZeIwL7k)3&GlTrDjfK|8(jO1G%rA$ARhHJ` z!MB)Wf~Br6yX>W_b%Bv2hn?1E?__|(4HWSB@&VYOAKcWhIK=B1WO#khBwKdX2rFJj z)!%Z!9rr7?DOG%4+yx31LKdN1-s?8M-Rax?)7`t~e8Qt!me>^|DCgXUP{Fu|I^yGR z0`q~uhiry-`7vHXWBqXrGdvXb3Y+w@wfr^q-MNuC6LR?NQQc%@4G`zUkuz8y-u*++{`9r77oj@U=#80gxf zUFU+=Hsy%^@e7X$28a)!4;&5?fb6-d^o&}`*%s~8KPscbX)g~E(evW|qa~z~ zfU^5a%VA=}u^mwDL+B&I6s<^PO5mG&j=iN%8ych+kt-K_(yh89?7GMuP3IhNvsmO< z``vEZbT?*n)pTw9-jKeJJbbO1_btx1e?dQA)Y-WELSp(@mEbNOi`rH_!B4ezi2A#& z!wYdKw=wAhw-1somPsa~FVtTf_ENh6W^6oH%F7ld*y*&93Y z^fu#DQSN-H8=n!uY8C){_tB7URf5MGF8V&O`^$?ud)uOoU|9A$MmQ>&Z8(6dZ~YGc z1~=G*9(rPO!LUbCXP+I6s+m+HZYe6?y?gD> zj6~y?8OiMvLPmVJW8O9CGu=ODv8FsiWbkqKuLvpdbo)Yx+wI~jW310l79d>l^5A%C z%E9SdTTf)3c`ej-)K@}D1tr~sD!OgBKO{-)2JHSaoNRS`42 z12V}7Ey_pgI>?|Ra^e6l81V)-n zsGXn%-zQQ6mDQ2O(q6uC5q~JbxWH9SY7^|Z9p~u!lvk}m{}7ILd3gO z9AUeR%E}?HIS#f}|TTymr5 z73oTUsCiyY)%rmHhUo1_U;8KRd+GeH{QG4V=-Ko)%$96tJMqt2?He2PUk*2zefW}D zP-a*?!&v?26^7%L3`yKH!kL+xDF;B9t_Rd=J?gXE@Q2z@TEH7bT5)KklRi$**LQY) z7tKQoTDK5bSgHj-J&#_{athRDCXNNjgi-Ki?-3V}by2&!1@qr^vR_#Vg6_g|ySm}O zi)o@g#F9~SbwP@J zTc4CzLJJXI=4d9=JmwAoW4cxvo|-e8F#AB%`O)2X_)1n0u7_-`Ae_uS*XmhtY&&Xm zmbiPLOr{sKn495n-`=8}Dll-7m9@Bb#C=*0`%vtDF}Fr$G=!Gs5w>u0Qu@I&$U(aC z9j?a=riM;-;L3LUNspzx2{oDcr`0ZOr5%KlZdASNep$q9>8>}8|9RgO^NO{6T@jc+ znof4${~H$rKYOitGFOX6ar|vJAEE1-a&T8!$lWdnA@kC(!!|Nq+9@j`u*(UU=Sq1}?aHq3G1>k;K- z(OkE#oVE6(#~di0_!yd+tA?)yW@TMqIV;=>ep6m6bu==vXP4(qR!{O8JL)1cT zQ~C-1#^*3*GM~_2+TPyx+G?NiRL*7XDf#|vuDrDIoSR@*HUkJD_1nNaHfrcp!$WY% z`yikJ4rX^}5d-Y|3t}2SEI;yF-FC_g=wFb#Ez(%1;KgwW3T&4U1f8z6&LOy=e}1rh zexd@eC!}cegff^zr0`?WemerOVVqh~$&C zR~EnOxr%t4_uN)T61Y_)KVg^fSslX9ME0HDl--ea9|uHh8QCXgG9_8KDP@OG>t-F> zF_~%OPHIZ!uqy=th^^7UWbmMK>2k2mmaIDQB6merbE>AJ`w`wl@YHNKwREc5T%e;r zP@X9>=f>l-hSJLtj3uhggpC5x7 zw$WpUV=>I^PbFSl;kas(d~zI3dK7O|(9W{RbFV;FAW1P}U+C$e-m4BEh*!=|gO!n- z0gUhIDzL<#q`j!@tiMVWO>U36*l$#mU{QwITa;+5^Q^S{X*pX;ryk_)vl==lG8O_tf zlm6Rg=Xy9qH12?%atWBB8iyL2?#%W7zf_h1Hz{(y;t=y}uHO97_t*aS25_qtnH=L^ zGMN<`5($_!YzXS7Kkr97=b;ksC&?1}#-_kM6I~-K2j4v#pR{0CKiAo9dZyTwstUDZ zer48Ft&9jGWzqGArn0r+5HsbJrGBAVvmzlFf(NgK*I}6!fH~ofe45)qsK4;-Mtw3` zF~7f}xCE;#)WWZ}A~5mGTGzH3Z61IV!H=QvxxTzaWfXGK5_t<)dt;IRZIMXw-%VzN z1D@4JfsY&BFtQIhw^?`D0XIYgWIoAI%EQOo4Ue%Yz)Apg1wMW%CldBra|pqnZ?QdF zSpUAWz?Es|K^#CMPI#~BjnGVHSC8|)o@Fa&Qr$}?(=ffa$ZHl-_H$FY^W>>6b?+*c zJchVdTk=d=b$TYvbZ~2sL2ttvqeAw=9Ef{&6mBa+EslFz?0+qfF%G}1U=eGYrqh!< zGp>R2X;>_ym8>A=a~b%CuCp;Io-h@<_O6?o5c{QcHW!5zco&=1E!XJb@OjQgPK+{= z{Xeo`6JZC2vLh&5CsX`Iji=1Y)<_osA|=lT-kYO!;5%K&*0ENkIgz1L_xt81&0)K3dXKSZlOLu z5o}$l`Hs4%$^(JN2<@^528%5{su?SH{JoZyh3R}zFlxP4O&GIIPbMEik;o#_`ZOeJ ziifirz8$mN_ut7VREjjAEr*GzkE>62qVaBs&i5d~pO|ONi_SZ%aOCvs!#wvrz>Y8V zCoJs5M=`9W?uLBORN)-oR;;-uu@8=fMVjjjvg z6?Z&xMZ5=hweQa31jNG~QH|5H#yk2JfNxx6?H})GRC2)H-g{$OH!LS~799jA ztI(eU{8r3##ANLMxTx^NO3Y_RHlS@H)xU2v;%UTveMYpD_+0|S_hE!|v&35KYQj5^ zE+^&5^@^FTJ^9cT#t4C-{8C4;CoQ&g-B+$Mf8U#Z-^$+U9pAu{KtEgFo*T8_ZxIC7 zpbNf3%n@QjOWQ9mS|BLk^UiwPoJNhk^N?9}D(7413OWiBKvaeQu;see5$_VC-ST_^ zyb|&u`kz;J`O+FJXMI`2hbq_zeS&-DT$HZ1fkqmvTh#~d3&}kYlpbK>ZeNZspOk$# zHKK1C;^v}nVHbr}A#Z|c-FIL*tJ&(`ATe!rv$GTFKliARcHgm8Ed4eO%wl7{!6NYC zP`Z;H(|$UliY4HOU7nBTdJMZ3%xyII&Gy@e-P6VkAcz=vIK5$$^n`n&?zX&15oJ)~ z-c&R_1wtNOtyUm4Q(rYZ4?ofTr^_15ip{K$XG^%w!BkLcm{~Ixzm$6_mCLI`*UcX}(TtcY3#ry1Ws;JFi9x=%ag?&Q-Nx!IH|u2T^LBfL#M@}W7pk8U#e;3i zV4%1zxMoMvX*1IlMxgUSYVW0Q3CiveD9`{bAGq7&Hb|mXopSdcpkG!LNJv@2pLc~RYGONXKCzSSKbNp0>!<%}HdVYV&8dUf> z-yLx^n=}&mC8_T0!udb^*|*rOk4`4*a(_!!t~XryRdoy5UhW^CJ1I2%9u{w>v=bN6@DKiU+O8<&1 z8~1M4`AjlLUK7)|u=fwRo4QJWWFX-cV?A1B$!}jZGGfJFB)S3Rt2L(>ugh=0XAVG1 zJe{(3Q&lZ}9TH=xzX=#LzP!BplA4WZd&oMqD4d;prh`Jxy~+kx$ZFe#N6aLwymMsH zFDO0cu*Y%nU%=dRQ|m+vs(tv=7A@I#e$oa8LzQwH%W;vgxcuuK*DK6)BFZh4h>|$U z?T)J1MIXV7qGiYk^9l{4U0_fG^Uect(`_^1W357%+6)yU42Axxntw>bbPXN9gXAir zkUt4%NzoVB^O;bO`LOavb;UhV?sAuMazjYFmY^feJXXK?B}&2h2IkEC&1S1)fOF{} z%;T){NN};4@CZDvj(!7vvDV85-5ED`gH&n=XZw>S112&TzK9YL^I+rH?ECfMCLEBI z+D?)@0;)>~X=#PjmUGgYB;_HhXY>Ul$b8AG)jD1D+(T$b3Ew~^j*e4>9JK5Vne@t8 zd7}77B}7SCc6wB%H3}2CwmCQ&0GPa4MP6MgAapfg(j?#x3UTdwL?^Zc)YQT~g}KrT zy^|`p>!4V#_EjKx+oPVd(6<)+9k2T#1<}lDAu-1=#x^b#kLF}|mz=%I7QpJ=2Nnm!kI~1OPoVkKw)V5?Q`bv^NzC0eEu!y-;*hv2~3dLVaO;u`-&;js^;@#MJ6w1^(Kn zaI3TQU11^pAFX{(ph|C*N=dU?J~Y+qAYIId?Wi08-8uy0!1bcAEt!Prxt}#E!qyMB z;4HSTcgWvH9((NFLq6J>?Qu8$Iy-LhPaEelofyr8aqq)!aGQ>2TiJm`*%j?s-0lX2 z;(%*w_bbr8vES4Gb}1Rn0dO}gnCzacww20fPL@GVL_ejj(=V`#9@`7g;_^1`aGy5j z?{ydhU2uAL(+uU*Ef$YA-29_1o_;6Xv!rp=d+ZzcLD0U=#Mz~Jy|IyEgbg74eSE8o zH#1W2YW2Rib^o}slRRU1pq-p>+v3yb)h9%y>&NRMo>MFCJ`C5JG+SQYkWk|#kKoP` zfgMpJLu1(G;tE3$Y~JlD+SL7K&S`;SE1n^Q}yvekCi6tVUIcoRYdB9}vQpUWC^LG`Qa!u|bZ3`$(lCd0>_JB^qMy-O2n&|G{!w&yG|nZ zTT0~AqIQKmooP6f0WRlkSO|*q$jr@iUBoJidjskMiY#r{pk-=~8{w~}gEeFsYjIUX ztfqrSpW3buwdsUqHeXa8jDfEZj)VDLX=A~A+ceI9D5;!T_=>;;`3bcTl-$?NUsVs! z?~}4G40+9hhI!BPW@l^icM?{I1MzbMgzeGe2;yYKCGwpH`kx-j5ZH?ZjJ{v_!Dp&lF zJTfp)_IJS)BXDzb(9%Xc_<9X89Wdj*$=M5V9e`@z-|U=MNN(t~E&i8QHOGKl{9N7v zFp|07;KS4=j$XBZ_8cAj;FGJ7=0yq>_-V>vmy*JJK(>>nEdBpE_I}Ov44JeDud@j{ zVF}CGqFW%&!p}9enaP=Nk;n`hNBmrYCwhdweMItIaW)pdp^(((*O@^+n#F`Of8b-(*Jf_q=piG{Dcg8|>LnYn6gA)CudJ*pm$La` z#fgiLU+pfS^h7_j$B!mnHS%&_VF=B&;mEo8OnYvG)JCtZC*_-+(GpAxO!lt4rsG*) z!^Tm~JG@MXEq)M)|F>gaTF-`Q$nD$fGhsLNyRHl`B3rJCS=i zbRr!dGn%-I_Uv<;mZ#6=2wY#+XOBx=qr^O($x3ADYm);Y(q3{Wy>EKN-SpROVNz3X z&BZ)+v3@=C>oePPr=YS)0LtTq*b zOpICBU{;Wab#%bxdE&PHUeK5qad|5y3r$aJlF~zr5Wej3|ZdSTJ#*LIxhC)z#^#9)O$r-i?~}22|Vzb$ZYD4`5(D=_TE$M10Kjyb2TcQpKBH>aizp=H~A`4BBU#N1GP? z>%hlc&i4e7xRWXu^tnJ=Q=B_81 zT9#m1=YbxyV$jQDyX@QE29=CgZ^}OCbjyo;%m~)hMLE8HZrZTrkq_*sAGJPzy!_5` zWL!1C2(uDVxoK6m;H)FY-NmO~m6^t-u+|HRuIw-D@QmLw&AdL8eYB~5L|No?wP;2J z=2}wbaG_#h-bVlLMuoaV}*4`;Ok$;|Gwr?4UYV%eF{7Uo9ic5BPoI2<w}42FxXI zh4|*)21kMNWrEA(5na#)L+5>p^;T&K-wA-MiodVW6jWx6KgN)X)75%$m}%cm{e_r?!VTJd2zcB>_<&YQ{O|lUyPxJ<@+)=ZEQ@5p!;bmqg@~AWNL-!`UUkTs zI#LC@YXj|4`DN=njp^%4g^nj@#^O-?iDH_^Z13%$k2xTK@TkzyhJN5ojBLmxyC;Bg zH;>b3t+m}6g4y}B=$GK4LGNyIEu{+R&Pv9XlLq`OaQt{6Ejd0l!Z zqhYGbiofwPsC3kHwe%spO`;jy5fU*>*s7&~_xM6YfgXbco0Mal5ufB5A!z52^PMAd zR}0d=83!pt)|kiCmzpJbWDHg{kg+*HbN$V0XH(La(a{%v|5Bwr()Rbt5%ZCjkqigK zOK;X0>x0lOgz|__i28)mnGlg}66^nnzV@U4R5-X{jBi-C0k;iP#pCQL*<*bxuOswz z3^q6l@ci=OWaMCKm6KxA^LA*0DPZ~e%IQ|#w^z4ir}2emqKRxX{X4$ZzEwE-p8>G~ zoH^4)hp2iwNnpOwv8&BVj$!`wX_t=OFd9q*D6i;Kl!xy&vJO*gv!#%mz}cas0%HxQ864H ziO?tcw%k6ZyzJB!$XM8z!4)4)CxFL^4&-qn7$Zjx1M5}~s(-+ee_W+HPFpwj{$T$A zaBDpVxZ8*Vp<-@c`?rq}Qf*x37#)U6GVzTDXH;;dCEsT>z$3cZYYxhOY>Eqj#(TR!Qubik6)-_gr zqvOW4m;Wu{=`1t9iGvZIw!3DO`IMHy6Ir;|09!0FZ`_(xK#)qS=Bh?<$#@*D*tzGR zPnuk*f(B0ub+?a&Rm#p&fX(O+AXi{-`TBF9Mki-)o!y-%w=r$_Ra5lGQ8)Pq0P#DP z=iNM)$y0r98 zd3IXgUB21V6)s_89@uB^wKey_waqTfpi+U1Yv8uX1{cHmk(=Q@eAw!w$iyrCRkoMi zTt7W!vKYG3%_YG{2FjKLJdkUfl(72N_7%&4jjC?@90l^H_?G8Vv1NE~+;BDnR~X50 zW9F9t%+{7RPH4J`BJyf(lG{4+*^Ig%P0Gl8 zK4LjauhC--5<3D#m5B*gVx@x1p3?LlPaRG6=yUM+hrB*JsO`=uGQBE`S+w3@C*YXA zsz85WXf}#`E% z9Od>NJ@twjQWLV#cd-t_M?@)^FByoHaarPIk=cO)J;K&6ewuN;k5A)1w71Np>d?|k zXdI8}d-$j1w;MaAIhNfAMLy0An)#PBA7&+XoBU<>N@%KJr_#D1dZTjf4N)cLlX1#G zHG(CYeB8iDeX>|E4O=qlP%sILgrq6;YMN{$=7Ox!*uEIlv6{FX9Oea>2^9q`doFF& zN*_w8^_qzhn5TqSBf_MJ2obNIvszhJRWWsbj%CLj-J()$W4+=iLE5wlSU_08abI#&V;{7e6;DVR=XWTTusN47sNWnq@FaQ zaQpq&nIqp7xxb!yw-vs+`Z_Ck)Ag0DepCNg9Q?EbSCt1fR(E6;>9r&t3)*hqk+spb z;1`n7bGG@7HC@U%|GaY99#ayl3@AnEMd8N>%QPbZ;yct*@_PKFp0~%r{j>=~uY)d6 z3o+Ah(tvP}QM2qElH5MNT+mBd6z(uS%$*~>4%>X9ARJRmAv;2ST!Zpt&(@I1{;-Vc zS$hNXH_tDgoZLKk>95=gL)*(SnB^a?xPJS06Y{6G&ch3Rdm6rhbAJSPi^a9yB@*sp?+JvqwVMq(FPW= z@y1hO3!Lo_L-dc?&$s?0>Ui1d%QkOKE6K&{#Jw|GFN%@po9$g}jaSgpb1^bHYoWv} zPbZup3#4%hmS35Ecc=JSBAZCWB-VHeO}Gr?IZ|ecZ3(9m316SOp%rf`48$dno{A+8h9Q9vJ>w+tCc&?{X9P@k6wK_ZLXT_0(1`?gzwNv%d-P#$ene zolx#Ob|JR}{O_X1rBnmw?K8Ftb*Q&jyyJ^}yru%=*q;eBvLExZ^BsJ$F#fw zEAQ8tjDFkZ8kO$fm2iA0)7B1Y5l{5o?Kmp7vhzwLFEl@wB9G5fihB1>KJE74LQw4P zu~^UAw~W2Ttwn}wofHMQqk5iqaTHCC3?Th%Czh1=HNhU)zJ8Ki{{>XU)m&dsOcs5H zx&cgmA`;EYcP>WYb@C<$RRzKV23)Rrymov)&0&u*Pmy9tF}}@e)8H;u_}0N`v^_)S zk_~D$SYF@xyA>)>`IWz2DA^edg{%@>;XvdH7F=FPbM{IuZzHZkM= z&>15wY{dNULvD3E$igZ8*+Qt>CyjLUIW&{jq=dxD`VFZFVS#f-GN&D653Z9@Q9tv< zR$;cg9jE_~qBD<5GV$N`ccz(fno286Ef=QD9COQ`xhqanlbI!%C59-e6)L!(DH@11 zEvBSSo4ZoumLlQ?E-07^mK&*o0xF7u<%UY2sMyPU4*x&raGt|CeD3SMZVAt!hV5rS zbxdmrRo$8GtcbCfIyP09F$Rf_pJsQ&Z7n`%mv^0vzjx3Z99pd1rp$V>OTFUsisf`EgLJQ%QvKXdn@k#yFOcS zP|L4P`K_gqrk#NK3qPGoDt4KfJ7#2I=M#;-fPT((<7nL?!jhbtHttA|TDCPF?#^>F zNS3V*AI@pWo@!FvVP8+Wob-XyisKtSZ$|4Zd)~N4D1J5v35aCAE>(GE%zOlX8WsJ; z>lkr}#>Q2gB@R<#n)|WB?ZR zrTSRWi2xR|k8N_~6H1o3P=6*ciJzMFE%1Ya2yEPFtI}5O6YZ`>R%ad4k`+W#;OQV>Y6oX=CS7P8v4hpxo?w?=d$kQ<5ck=fQ zax`JB4YWC~eVn)1;r7;&@ru=F{3;q9geEDA5Js9yA)>$V8Wo2Vgy`=&<|&b(mP66W zabd;j<{)V)F#4ux!WjRKYUXq!ZIsJ=v@@Wc)6NF|WTeSyb3O$x@}D6XQn<7e?h!#5 zziKX~IxCDmCD_k=uwE*~@|#{Fi;vY1V?1%#Um4BoyN9GQZ21?LZ#dSCCOb>}gH4X& zSQEjtSoih=FT>s!2Cp=CEie=%xFA+rJAK_k#Dp*{2EY34Q)DsVCfBaMc6ReLZ#Bs`KZb*bqQY#Odm^*(iQ< z5wUcA@TpXvlNs3NW*V}8om*s@Jnn~ocg`TP@ChznHXepL31ZFy9ycGzj;C&IEY)0# z!$e#RuB{LUATk=g@gvP+r=m*jpCb8MhrQbdD8c~a&9Uoc5r1{x%kwuM9JDsI&wzd4 z!vuq;cyjfu{q*uWtp2jQ^e75%=&lv40Q2fslI8;9i z;w9W`J-Io1b3>fnHv)kTcZ<5ffK2=CW%J{a4@i9;0Ij5mfl5=C+`!|^-?H3Yt{6?1 z4>-kaO;1_sI(>M+0z^>)4Au=LnpSkH{{tiz{?PipEI`*+>z+MwTQcRRbz!w~5lLBF zSijmQp+>R9(a@;H)3O-lRZMTz9srhCnU#FQ+`D(%j3vdb(HO-!gJJW1US0#wVoe6> zj1d6@i=ejfr2X-w3cOHCppW-I^0m6@RF$Tq=>kj) z%b0#P*XGporv3e3?rMd4?hKIWWWRcJ(dpv;gq6mJpg8fzz6(|yPeESr2))2|X?I7s z(IEY8zb*~R*S8z?3$>isascC2wOuqtFJiwuP0+dtrf+pks!p*Eo@?FWb>5f-c9;~t ztldW*BTCEywqqv%7ayBt7fORhBAV4(Ea4yu6G4DftTa5fz5g=}A^=oHYij*yp4pdW znBsVncQD{$!ip9`g_wC`Np|c!5^T?If;=&c4#_NX!ptStN!{UPv%2Nk$-glmFC^&< z*RX_AU`i4%6nzy|n&H5nu!gR5f)V8I;GWbw{C3t)pobhupQo43hU-GD7Uimog?PjV^C70^0jRx>J7g z8d%ooLRfv%jIJP0Eqc#;j~mEQ6PQQcggLdUGDtd0*U-zcp4{B=NYqd^Q7LKUoC0DT z@`O-1^Psgw1k^yPBh7861^XE*!!pvgGlDZ~Nypc(>Nayaa>q&(7X{X!Ytba4Kh)FQqB zkn&B4x$4agZ>f-UYWF$Yjq;8yj4cFpac?6?^lTllu$2;m58V@;yNKB4M}Vsbb=2Rr z#^#U2yLHn$&P0A{X%nQNzAeVXAMs)EBT*;EL_=#!D&3FWp*=wsxsY)|)?BA#DXHal zDE+RlEClbHJT}B7XDCljrQvm71)y)RnZ@7N4;8?BCJpw%4BGng!j$Rn$UsZsMsupK zckC1NmG+o4n94A^TKup?uQAS;`x_A3xE1WGsT4+Gug7 zp9h@Mz)eB`sz1P!kP~D6(qe&g-~Ha}hWODfen-_g&ba^g6Wb@(3a=rbL6Z3q zBoRa{04eJlf_5Xi6W9Jut~oyc{o#uxBj3>0To$VRu=M7p^nz2eWYcX7TLZIGp7&IN z6`(5_urxXP&PoPZy+cHhs#E*Vw&UVp0ON#oLBoWi{wsq8KA-!Z*Xv8eK3zLhrL!96 zu~77<4*76f0RH8ZF0CkZUdz%o0&g?x>gG)5c5RodeCgKw#8u72c#VbR31}NLnMt_h zga-TVLXAxspe^hCE=Cr1-r7}?pKh)*rvs@HBxkHz&hxOqo=Q`8FzH3!c5 zLlSx429NO^gy{6`pLa?VWRr^b?vi(C$BZE_4=0qjwp*};&8YV{q8 zgENMT;JANPs>%V>E?vMw{2q2(XiWY=XFZA08qvxTL0 z2mcIqM1~1nzVWQs5orvk;h-=9d-b-*G+gbfTUzsl#IN<7Qk1wo`g>jUx}#e$5~i=V*xsQek;SXbC_z4`Uvt|jQ!|GV|gaf6s3ci{3QdWx<{$` z%za_KDP^-M+S={I@5AS=e*53ilH}ozVB~)g#DKX`NJ!#aXvAjE&dLV@lhhptD>VK~ z-GMV0n;Ot6#}7|`ABe`uEVE%T*XK2CHLtfsgzN6qOw0k>q+hCzEH>Pq+^Okp$GPIl ztUEXLkZ8g&e{{$%k+?j(zEY{!XxveFx4GztoV>pG_@=)8HxgQs4xyVCpNL(KY|mdV zYrd8fdwbN07;U+LobyEl?;T@u$gIYOel{fD%x_cLe|fe$Z>Z_GaBIfE;Xg_c?5X-_ zGt3n+av_D)*EF!=+n|Mdsu6lBtD7BSxJY%&{ z(W`E>m}j6D`EAe1tH&ZV8HK`UOi^f?or#+DXv3@2yCVmY34_B+*6Ox4cxwFcmhb@f z`Qi)1J{3_3YdeV0O%azQ&NX352$3XNezVtD3w(TNE!k_rl-pX6?f{j=pY5~w!*!^C@Ju*t16q1pqPzy)dh1y0I}`E2+G4KZ0wHTL(!K3%=E{)hxu}DX zB|VKhxxiSJO}vLk5wvdjBqut)^@57DLGp@-S4HtFF;yV@Xn80>Naa>#IOmqM3pO=N zD7ve^x#P|Pbaqz>a{=3!+izP$V^YVN{njTc=87`52Ly+OTVuyKOjqQ}${U{4nMsDc z0xNTyGMk(X7Mj`@bN)BD2R9uxIQO;TCBfv|LRt&FwNRjsqAYZtswv)BG@}Gr&g46L zaL>ovX{LfOPeCU@PEHzbS`c`%G?KF3(vuOZv%aF)F1Z=_Qw|iOwzjJ(xG7~)NxlOtxjb@I9Wx*cnaPArlCKF1bT_H zG%AgL3OWovDvUi5B>!pv1uT+I@AtE-wr*M##32po&~(eFSq*pUoW#OqB%&;vd!zH$ z0QZ_LqDP@%X7DDi@0!;K)>})rRiF;~CbO?Mb?uuMW)iih?wWPV+>Kb^rFf2iPhNL4T+$AzMHDtC;h{AfC> zF>b1XCZ}8DO`7Oh&M#uKF)dT|Eguyg!o!6TTwe8U6te(n*)K2p(~^Q!l)-|(yfSo|_sPSu#JE~A@IpC$5^ z+?P0~8Fh}#;Z?Kj!$`}4dDDSKqXQ%UyK@EQ%z;dR$;n_Jbuvzx{&#<*t3KoTR!v5} zeD}X^wcKnm&ms`4YGCkfuQx$zsgx@P+sqV1ToXC8Ku+#J+(TacxY*9 zDl`1urkdh#V32FNgx6NMC2BUP%7f~^uUda!CB;|DV{diY@BXpGpT@nf)$ribQ{p}* zc!@)6=dc8hm@94rvQY4z1~ZRNdi-WJX=wp}q&yxoVtu+O2X`{v9B@Li`j1b)=$Yc_ z^7YNn+?SuvtiE}83BxTzkXsW;kxN_MH9!fKdMZjmYWSt1uiEu(Je5-|tB9V&%@P5+ zxQ&zf#+;B*c_oF#%_pkqlBl!aFXVpZ`vH>f=$@KPhLI9h%NORGjKEHf@VVi>H@Xky zbJvoGS9|s~6{A+B;2zx;0Ju(yO3_3er(oCdk(Rspu1gU9Av`?N?iI%FwcE@}d98A2 z`H$WH8DQd`f{=HW)(+!p+HprD^h(^yXAslM6tb`?XeLR6Zb$EdQHyp&{+K$zI*|~E z+#h!q>QAd+J>l;iG}>3zL0 z6G)58coE{ty!%}2G36#!U9k5C2KdHCPBL*O(-R5~&W(8!gCJN5rTg@nej$IxguF`u z7sq1vyAGqp9~7($4IEIR+v>x(HPeDf-I0dqg<_OO3n5xSBUv|y^hcLe)#($Ntf0RskKWJL!6fY zOPnJKk%rcA6%w&lU)#N>nPjxZpt8%tFA2e^$xkP^x$14ieCy)m8!N*r`J4CeZD537 zQndc@WFwcmnn%H_e^mwftuQG9N;ht#Ec36 z5#M>w6>W!014fbG@Vb7%u5Eu1x9a*Uc|pUE-uj# zp9$V4t8`i%)Ry0esT#!;$5Kf3shSDruT80L#*lf@lR%?I!|5)+MSfN?@Ye-JmeuUK zU%)&k9~4KU^P%xotPlLlg@rkacIW`Jz->tMXJ>W_JG=eMcvUKmb*Pp*Df8?KBTw~s zAZM!^!Y-10I>C`Kq6$(?>EX+DE1iGOKTQD6bbxpHjz_$T+C9S+09soRm*f>-t4kacUu=17x_K3x`c^bGT&=Eq}LrN5(wP%Aqm)YivP>EJ0siVZ)(3v zhM_2Cr5J=it@Q639BXUlTwr8VVP9V?@G1Arqh+fBEtFm}_O=wAXY;x~J*CL*_U6cUyd^bHSk`ahC4Va$g0sx^4zsxYbFKe0*grY;2v1%t&c9SnmpF z82Do*OeAEe3gw~IlFDk`(W~p-$#CxWn!mi(5so*b+gTPmO6ej^P)giM(7Mh@Ay!~* zDTuhHF6wj9*qoBtaWYJYrBY6|+k?MKyA;g>aN*;b<@93D1GY{_+luid(7L?%&yVqMs8!sO%G zZNYFa-c>-PdTJYo4YNOs$Rsyt*CfTQPc^&h&)hD|K;=e!%zHf%&w0C!Wj=brK&|*S ze5i3NJ&8(Xtldq<_#;3gikkN4aY>vjGKf91XD4VgmsKRu2%wAm-P=Tw)v*(Wyk{}| zo{7H1Lj}=VZ(aI%C^84Ek68FDujybY#P{G(UbnB+Aj74~nw#wZImgoKs*wIkw;})9 z8tKezReQDlsT4ZOI3&AgpeGlU6nH;wzSh6dAFbu7+`Cxw41di%31Yeti>o&gy&PeY z7t6^_#PE;hkAv)s)KNu-DT?C-P%Hb zq5z(h4$8fkYUYaTsdYDoHqz?+UovPkwpntJJoAAT?QX{nYdVb~b?5n984OR-c@fw~ zIf?aC6kUMEJ%rhZd~@n(p1mM2%C4XvzPvI}H{G<>%1yMHX^#K2MC0Ka*`>05-te;Q z&ilN)>rvSAb!O85t%x8)?Bo~QwDynI*7g`3W}vH6y6$5?)%2a>MsC=q2>Pw4DN+3E zi!fiuM%1Q%du5Wktvve&V2pEFlk*?HFGFwb=_y7pd3*KkB6Mgq93~o?ZChCFy3XM5 zb9LQRsac1LsoKTs^G;U+*tXXK99LiMdPj2(BaMiA>G6E0k5}~gt3IjX0SEoa_*2w# zQyYR%oCTBvFWjn{4_eb*mf$|2hw%sci+_CKgy1iU_?N{YhV)4kJoy+j#zos=j zznO@e+pnJUN&0re;%BwX&qI?~6kAqiH@gsswBZYjDanJ_rPpq{lBFP~*6pM#&`;`d z=EH<$MKv>e1r^EY&Wf`vAd$vGo=3d4e2j`a<=%?uOPi9vbRpS0vb@|GcV@<$&?ZwF5>!pWfEh;}B;+G~mn`DHZG9Wh6~bKz0f7BN)4|{-dh*fR zA>P=ve_Xh;&D)8u(UFYNkJ9Ts6*M2%Q;~o4c%XV@jWFT0-{JYC(yEA5FIQ#u4ok-BP}Cr{o4l>Q;sGol zMHlPjv||Oc>%Hws_DC~EgwLK4$D~w@Lj;H83I!g}lK->A*m6<=+jD*sX<;M?As5B@ zU9|L0Ow8HX`r`7pa398c_1*QpY<4m2j_^z)t}e~SObgN1W3aR;Y_0MNg|v^Yl8!5L z95fTv1Ov;%3|J$tVA#X*o{s4K)G9BEIwf`3~_Pc_-S%^*D6-a7L<9?{xzqo01yP} zIu_L*dyHd{4ZmKq4reF06P<;F7&vfp?p|DCb9YZ}XH*UCM|a%G?r_5NUc^s;qq>N# zu(9=M6=m`Cyhzvj(Jr!EruFXm&GFj=s&$&&oX3UvG~5w?SJx}&vRwY%psq7AelFj5 zzv#GsK-k!mi*@!GckG(P;hJBOk(^iNDHf2jcy=F867FdjOU;n&$rmtnIdzf7AX;*d0`PlUJo;_9>@Ohd8_dH@JeX%`- z!uNpDJ?0rH&8rCsOFKRgmRdvtT-BqN2p<(u7b!cXsjMth*)~x|(+>r0 zRxfHfJ|!mrp+HDnEgm#ea;dj2F;K7XXLnLQmD}ZN@lPLIIm}Ei z;a8D@agE-N}I zr-|!oVUWRmd@uoiB9lwge;e<_G7O3z!^zb~&$Twl+Wtr8_6PBXn~jI}junMsZZkHH zxXP=WDg+AeX>i7`R*i+>agJB&GB80iV?o^xgyrxyUewdrN7voV3Ph{XDHK-3xlRrw zC&xf6wMbmMwoA6Cwa?f@yjcoPpxe`5zVD$sZ!TE?@{3ZG(|C==!i7U`I6t}D)K3#F zg|Sz3Wt^vm2K0@W6p}Le~rB+#dGa4T5~6!7{of9YF$xZiZ&?hqF5`D)?{V!<52+iDz8{S4kbj`*6V&S;;4Fek5;Ot@)+m3BK zw0^3{Fm&HCqhTp`l+l`e)zhP<2|p=94mH(G&~^M~<~kj0Qa!e!_q0cI@QMd6$(wJD zu*zi<$M~A69O_-F7FSLr<7PYQm+QL28B9;=;4<;&Gz?`p|Ap@E{7e6UwvV~U5wN$e zZir-dHJwvKZ5RSh*xTte88oh5L)*QH_}9-CD?2!HohQ8_YIrnrXg+10pYq3FoSZ$C z_WbpZKfK#K<0GoG=cZi#lK*oi_~TZNx@$069Ed|s`N|d7FPg(JuNPCn$gc4*r9&p( z30h^kSWPi5Pmiw^HqO4wcfMvjqxgArFrm$ihEyj?X6KYh?>l8E1lqzX(!#p% zbD*K~ny6_s@d@!b=Se%}GQvA(Io)%r+iB9QlIlo`-a4j8r9xKf+IfkY;V%8PVW%|n9;Yhb%$97f^H-}-oMQ)=wPovCxWF7L9elO6%e zo$MLe2i9I87uJ)r4usA`e)qIjklw-R;NnDBKPyHq`GUaQ?7&TR}<- zGVG|Eei1s9?Zf`B&W?SStr*x`6|78bX2qI$|C5TL66};YE?fU_XR9V#CKwZF$JUVz z*Lx+oMD>9oeZujXyI5DJKthWiAnm74&?b^j#vD@<(n74F7Q=pff2%z-tZoJ{x%z)g zz;U+O(mA`MiS?K4Q_r}T6wSjcRN0r6RB8A1l)Q4X6oEnRB^QScN zZ(ubM!)r%2KclL50Yz5y}epn{J5}WL(3t@I0 z9tDjCD!09Mwv zrf&ra3;j{rsequ`Fbwk2Bv(7G(Y0$oXt&}lEy3}!4d-!(Wwz6}sJ|w^(!p+UR^hq$ z3OP^is8~5qS4Ce(R;5thSu5SnKMQF){OjWH_P1f*`Br|9q8c#o1>+kB|3WqNnYvmI zuz!$xt!?LcsrEj0zHE5>KQYZ!bl57g4dt?B-=@*^!yC;94~D1z3x47QlvLN1fma2t z!TDYT%u0Xe!0ksx{)w%wn_Zfl(xVOES5Ih!`fu46yRF8|Y1{BRNjjU$Z*>Eb1P_c@ z5uh$pr0+^W9|LfFY9CwFQ{)fNBGU29>wjcLyxg-#08OB*sEw@y=W4_?WcvdZ5qML& zyh;3mniE|6^?Avl5rH(c8*^*@NSOZj1$^Lcl)7Y@fNVUuETo0PT*Z1l>!kzlY&B`JF!JInw_(0Z99Q|Q z`5O94V7HZr!L;`5f3h035aM(zp!g2r06eaF>hGyLnrpzWONB@|FCLeX(~z&DbvvXT z+BGuk_34-61>8Pc!B#L4?_YEa5VP?H!59xiX7GLawwb0u$7+^ya_n!>C}VH~w&Q-x z4-CkG3TUHxKqTvVL@%s{h^lD5pC&IajIa0(!CWMy@0&~OJXb} zGht5^_1Mk{z6Ge$I~imDdE7QELnl6yTnS}y(}J>c!%0Ml(|-(&0D{&LXRJA^&N2hMp7)LCmnce9&z!BuStE`}JV8pylUd~#<^(YwU1#z7D0dXXJp zhFg2oF=dv#|XF37$DS278sFLRK}jo&qGyU(FndUMT7#=z*j8aig{q zbfVAN4a_4DT}}*^tyV9!TYp)7n!~>`k5R1kU!gZ1_9M^bGpK6yI_;hw{zbjOV5ScU z7|vBd)Axi*87xxYnXM%%aM!+hPG0hJ0vB^`QY^%1q(=GqpV++WT`5;v88Q_Gej`|n7TRz15`Ir#GkxvN znz@B+eL1x<+G>gOG&=M!d6Kjc+(2QK$K|K!AxGxq$3}m_&Hk)Y!=3h{B>u}KW zo(DzEoOiC%+T_9OaKjWCrwNh+o;4|mAzs_O&1iIdHB+40T$8_fUM(l*UN`>!L7|kDNk)NK8&vpA^!Qf3RHF!@ z5hzG86Q7L#^I$$>;5`g;5J+P&tBu@h=SJUf6VCIIRUl8tmv_ciKV%{^F;7G4HNqpbQDp3-Pl9_~-d6PL{sC>3XMrTL|`FIXg#lOlTak}3PN)MNIY(X6%3 zqE%H8cO8t6_@w;T10yWXhHZJqA49eBA+e+9?d}l?_4|x%teRdQR52^S#!*#G~aFfiv?b9R;O@%`W6A|o-gd(fCeMf2YlF3 z7}GKfEjAmanaV$aYjZZW$t?ZUFHK;+>B{a!r=t!*mbVZSMbA2y+C@u>rIHDA<#Kcz z`n>GsV(XfG;_szE#;@f|LFoFVwE~xP7?cZk9skv3X6gJ|z}j6QqE$$9pnb2`ZF0E+ zgSNEhOngv{+Ngf7WfPXd3%j*U7h+GQ+Pbv7g|{iYJTk>=kGrPMnpE*LH_l0TAv5$%t}l#wP^T2UEY)d&0X zKBj^`yJTj%~v{UDvF1EHSLxnfQ75^FRI3kkC`=3mGE**p=tqE81LO=D>6#->55|U8pVXeI6QO`RXeDY-7;91|0)i*z>C-k z*j_%belubkIUleJ@paAMI$aw3S&_$f(RCGfIj~sY*t-&yP-M(^67>*(J5yFx!mOR= z<%{yz0dKna37J2oo}q$~fZ;MRtQgcrA~z~71b0_LUOvcGnEJTbfm8T_w;1a^x5TSQ zko5<(YEW@SCUmeTWyCLl6t8aHh9VkWn}WWvCLB)=T-${i&x@4GH+g?<>NG(TGvvIq z)E9TF033&=!ba3+6vH6Q$+vEpyWRm>1m8u4Czj^F^pY`+NgwK3IpqO4l#c~^z1h&}A$TWpK?)OSN!CGvraq+ai+`4_b?ddT9$P;wWeIrv(|(otx* zE6Fke+KAeV&qDtu&$}|;@OMiCC;f<@0h-)vOtJDKRMs1B95Wh)J)OiX;$dSwBy=#r zr_(ZX;|sd@2Di5|`O%w8#84+N+^G@GT_=Ks$Vjh0wP_5{}-7ViTK6}5-12?dqtRrQSyCjgSJY8w~i=Qi7V%=%zNy*^m^phGk>;(-&y(C++8)I{=f{NjIlK` zI&5Em?NOiCfAU|x_W|mU=Sql#4y!kfEk*2#qgQOeGbM?dXf+s~8oojQbJ(cW{vSXP z-Yg-qFnymxIyklawu^z`m!Q3dn!Qw<{JepY);%|Me6jdmq8F`h0-}?A9H$SV(+>F> z7>4Cg-O%@)J9yU7%_zT|vlnM#XUsJVt!z-=1_T;O%Yx)zEBH@{M%XK3ZdXyFGjitC zi~6iMN=eAUxcMJmK%=nQs0iZDj9oBQ^Q8T?7pqn0_!}hfh)53+e3dY8ZDEyYe@w_K zKA4j^d(--hn-^y3?F#pqyFo6uk>=gCt6=H^@yLfv_W-&Zu{|sdI(Cyi3bE9kFoe+{gE7WKjygGXsU>^*dTz!r0`v9Q~rw3o!2I+}klODf}v`MJZ<6N*(cxAk` z4HXuCy(Yup{=m4JspCAqhPkWAwr{A;_QQ7UbA1)g;1|o*TuCK?N_9m{UvY%UL@x`l zE{w@XkoX%ORSdmTX2OgT5I$#uA4dA{Lrwn67b-OUOYtKnCjl@$iMzh5q2Vv4p#3H} z{y5(O8|IWyPL0$Wdv%72ww#DN&FknJH3%ggNI3FRvU zD44v&=S!VioR$vTL|N}w6cJ86rHt0p1_!ve+mNdx=bkQOz`|GLvE%F5zsJBOY*F&T zg3oFh8)#+uJb|kmDsGoVjNF`cEeN;yHetLZ1u_aui%j<4Rx243-0y%7JjlSjFPe8b zzZN5X(=O=TU1Brd4iI0;P|{4-g3xP}!61R^iPzeHNo!%~dO-2|51Min$gsLHL&p>s z{56$)Ej8kTa_>A6+>||i3cROv7NeVQ%6lg1_WCv;yZ<63p7P5BQMr-0G-043O(_qw z^w5hv!nwa}E2O3AjbuDCtey;B9Q_T7;`xRqC;+Ldw$T1_Zi|&twCdkMBd0a)T@Uc4 zg3i7NWE`#t02eZQ@_I+0ojRFu$LZ2MRc(z<6YvagZE_{#Dsk>8LE%S}-+;MNp8%`dsC%;^@}FlM_JvgeC5yt?sS=o1XUQ}v1^#+v z;Afrb2WNy6pUzE8`<)5-PV#~BI=G!ZKQuY^jNZlYZFN8h4m7|BLQnKt6QmEx9*4>> zTB5yho0;3~a8}_;g#B{g4ss&6B*LF|G3UHQi$8bP{+IDKI=pn*@u8)AD|%V{(ZxY1>b*9| z`ERX2{<289z zwaRO&YAUR{rld^L{M*Bn!{S<{4xyv8wwt8bkW58R3@mPiOmSQOuy2Q+H!!=NS(?Zk zqEaoH9uv!og|PzF#A}pY;P?O&_{j?Bo!Cc=BV-3CwpKdcNYmW9BmvU4tD%LxfF*8y zzK=qQf9Af^!(3zbKU*J*3o(yP35`SyCJ zx|Kf?eX$Ek$E_?sG?ps<2bisNdF%3_4f3eVV`8kgE2%OYx%{<|G8^l~dA0$p%9i{( z={TewktkBDAhR?U=3Z@mV}IXbr<|q(mXdP!34by80rg?z?iao-pFS1dh6{*BInodqwYIpl>xxt&HOdyUvU;69UlxP97o<@)@`u7yaGlQ zUhMWTe#Lw$F>ym&bI^h5mS(CSa>>$FyZ9N-=_Bt1I~EQi$*YHo%@83sg>i3h>7J`Y zJv$R&0H+p3>ovMP@F2mxy6q>OwqyF-!lPym&>SPC2QTY7u|gNq?sod7Y>vpdJOqQk zIngK9IZpBukL8gvk=pN3Z>0Lm%y9$VL$)$=j3|I6Hz9PODi0L{mauuKY?xlO~=&2=D6dKEbREaMqN zZ}mN6EQ34F+Zp|Ln_Q!e zWQ~&WR(P^1sqPRpVj8aNSLki5BGYOd_Sf^SH#Z=C;- zq5PhXeYHkBEL`DM%!bYXeK#BYK^s>uQ}npiZ=UUrt7xwHgXe#8EJ9|-ethTqsoU_( z*63u`9Nuto;xle;&^YljS}+-n+6lwD_QwmuNzwF;l~H?-by`-tbaUDh_C7;xDn%>f zE21nM6aB!J6PrcJz&@XX{fdxPIj@PmnXI$dl*Tf9I>8qISkf}*Z`E#o*ZO(PuYl0Q z?2}JP^L<*GI6D~3^$C4T^cbu{uH5T#2h6hyGzPeNCv+p>|BxY-_uJ*|>Ndy#^N}Gm zIZn|gtqb1@I|@QM3z#IolS;)BdeS+L<>;@gZgnvT_dg$F#~O2jTlUIG)6;QU!fP_r z)iXbuYEDD6wa>Z#G_N~kW{`lb(r31--thJ#!kzkF0Cvw#23^ySTR5*w&w;^zE_S*w zmY_Kk(%(}^EtKtQa$HcZXqoFr&d+_eElA;LwLGSp|b=`LV~uCN(=hI)2kIZXbg{S4=Gu{tsI zjPD3&Q~Wcb2-kzq2f8}ylJOXMu>RV?c{5m~EcW5S+w(CuZhJ7FKiD8*W^bv66-Rfk zHcmR4S-tws4Rqr)%PJO~h>D+df7C7ZZ+2kVMX)P#=W6z3u}r;@)%Xlu*KP3uTr&v~ zj!ApLzs4X1x2;AJD9j`JeXdcJ>TBW3qzozW3T?GJDmIXY>{F4_3cumiHMU+dkg4*F z=}r>?Kv&wBRlwNyY$$5VQo_&6(hvZSEO%C`E^>=S@{&^LwimD!HEsZEOF0|3;=e!+ znJn}J2TjxK)r)|}5%LQ+QmwUAOLpvoE66+6*Q8R?=8H%<9^brlb*+^R0(OP2NNFZyX1#@$E(oOREp%hjK?5^MEstqy zNr|QF6RL?aY&FGOhjzHPWR1jbRu!M|8W2=$b(w=9u6(}4#5*LjV`rAzWYGugqTMxV zM3A>KLR)31ZSQy|VK}yl>e@g828+sBgXbtUl%OS1_&oVk%`X&BF95oV&qa)v*<9AiMXf4IrC?2ul}K z`p>q5bYo@BS>itTWJ2GjVXG_CM$6@uHKjbN80H?ZobtaRzC)7eBC{tPp?=yNERYi7 zw+j)VO|h#G3ymIw2V<(vNPmR4qR+yA0PCH_UbvBc#wMoT3T<}Q3PFM}GLh%I2O)oK$Q4(WuYAJ1AeyR>f15Ve0Gf+tfYM8>O0fc|_-+f8nX`m@m#@F(ka2 z`Y=5Hl)G$h-Kp!HI;w@=uwHeIF$~L(jQ_W3ef^sHY^Fx|h#QmqsG61TiNF5?jZGZ> z)=6GG0=*Wh;Jk7tu_P2$$kgM|9D+_Xw%7924ji{(8dgMhyHwq95WrUaKFGO_Pl;1h z6bcBjrDBg@{E;Tb+h#Mf?~qPE;3~f_z^!-Wa2wt%C30ImX*;gSRfL3gRm4;09%aQ< z*xe2#=|R*HeYI!^x&G+-LQMMg!Bd!j0>*jvlba=dW3EX0O4(Tfy%AjGrW{fvtqtF8 z%h9(irn-*pUvZJ0{MNPW0bnv>w(P&aJvqzMUWI4idvA}gSZO4P*|+2V59A3IzmBHI z6&zmMeN|gFeafn5fUJh=q6p(=8=tUnIC~dN&#{bEnw>k_R2R4eY|R zCQ>j>d8RA#7l#L{TTTWqTtDSO40H_+bk#c*aKfGM_%vot>iRUWBty-p9Yo7}2S=l- z)#=0U^B!};>~7fwJsN$xG5HeOlBX=)W_rKiA{=^NVRasWWFS|;3w4b{`LE=;i+8c) z{Oo7Lq(>_$Ud!HOq~W$pqIJ$GO@(6UD^xPM;mD%k!~18dIF24Fw` zgOPr6L}w-B=ya)SGW1g-UF(f0Cl!Iy4NqJMj~R7;7}P6MJwE^Mg`qxnxyQq*(&m!r zSKGGrt{Z}U$Yn<{ZL9JBQFJc;Oz8g~Kj(B#>Qq!Ja;?)vj#$2qJKHJeBnd^i%w?fk z%xJ`D7dev4Tq>b*Sr-yBbDK-p%C!tDY|L$J&3$8Lo3ZiR?@!p{v3>UWyx*_a^SR)( z@)Yl>N9O(0HZ=&Iy#Tv1($P%65DClT1Ok=_`t|Fomk=XSOl*6@MJXoVU-qs4Fr`xv z_9A%C;O1n24Xlo?Q$;hqQhm2N@T|#gFaLD_QmGMdHUO6gbX`|1%$L8at*k5>-jY^g z0Ov@z6SK6C;fUlLd+k<|;V#A-mE8actZw$It_406E3#y2b?2X+DNmB!Vw9C$TXg8XK4EPhJ7HI@VH|{%NI3NOGc3!4L@)9=Q&z9HHD5@M$f0;fR6e;Z0^(5lKebP zhTGmPaPa2fY$4H%K{~=oYPJsV4|(k(LIjaW@Ya&l*xk8 z_61@qW=r@SiE33a%Uv*F;IB|c*9z(R*kv8Y=dC&~d$X0aj6DaCLhdyaVLN2(Wyp9y z#q}&n$tzEQWc`U145u>YV-fD^>)-Y~zxkK&5%2(|mJXE;f~_SjUx<_!=h8}YR~Yrn zD3oW%v2)z7z-CS^OeQe%B~VyGKFUzFc;nV`R4i&#&u0;th;gAyI;ra#|M`2#&{ znVcx+yxWJ%E#0b2{aG7;c?Oq0Mvy;biit25r^gdwycB2teYyDzWyQ%_L;J|yP+&OY zyT8Epp1C=xq;L9sn?D>_7C&1w<9Xi)d;$TDd+d8TU8r1CbgCX|?1Z#w1|YQNV! zVKC_hwNV>DKJ6;htALxa2J6o?icW@^jyc##WJE~j^#G>=WZ^ULTlz&i z%nRNitzu;9Uf^)tfEs;-@=a17Wekdv3{YaiiO4%QweuWXIMD5^Ti~ z?Vhrz7W0#6+wR7Jd$!5orZ0V3`oXd)x_mc8}!~ ztARJvg6plgV=4u}ANPSunu6S@lRaXK2UUc6R7`@HvVjE;B7%|YF?*^Aozdx@*Z6Fu zZNaYQ)RM%HK@tSMKM6Sq4GMrbEBn6R4Homp5zpZ3*Y#j*wEK3w*Q&2=++d(KKRm&$p7Kvn?9Xly#2|41+KK5j*KI>D7uSzD(Z1 zrKsZ^?)^{MN{zeYpbd$q4B0Q_DHLATk#pF?RA_ce5_DM!?IBi|aITt8$b=(tL>Zcv zm|{esYqtV8iBZz~AJ=~c8t%N^JzQYJQbQ$d3-++rlQc-2TMn|@`bWaJ$}u)4w8G^2 zWY=ienS`;pa|YY;-fM`SLScSa(f`wJ;DvzlgOHVPlha`R2ee?fd?Nn$ ztSUBGS$4M=q8u9gX!8N5B|Gs#kRmZoU+*Z3dV_7ef4Z$?0YX(|Dd$$TT^GkG)YSYV z%8*Jh`;s}tC zqSvao7OxXSN${ZYt&Z=0<6H=ae+`6M2?(JwrGJ)DEl#5Uc<)C@&MiO1e>rFqkG;sG zLzaHlS4xRTJzFHAnKSjW=N-|qdi`GoH|m$__{Wo2=z?;Ln8@B5;MCITRw2rhbw76V z3Rx*?t!QnAIyv8bHdCkFU~|K=>43$|oS5O3L1S5&x=oR>)}D?*mEarQ+V36|!}2k) zkOOuxS%Jmpocz)d(NV{dio8oL&vYZUyTFwjIN{5)%pj94353COsy$_^w%nhcF(|+B zf;hbD3&)CwpKIg7O{o7^0O-WcDrvE`cqM(U_b^Iq7N{QKK4$;D^?av5xy|v!^e@zU zQuj>PA|*jfVAGBzmhwh9%P64RZB^ZfSF|4+#;-04ZW^iJRa#0zI}=#`W3AZ`Ol)WR zSQ^55AO}bdna|katF03EO=4-Xlokj$lW-y#NXXT8mDM$biQA1O<!ZIzCTY6C!?yxizN06SaRY=oXB75i#V&L-^QN2?{!~q3}4iA zZkJya|3rS)suB?7R?PuCZk$nm)|Qm>%7)?qawhENX->-6@?WSJ?u6N{cgx^=w!Ucc zke_v(s&jfD)jn}>(kDB+xjvrka8|_6_zU4n4<3Q^=p~XiR7vi-T>D63~rLMY#-9c3pPtSP`o^wJ4nm{aA*^OV}B0>!Rw@pc#P5_?~Ih}VXe|faCI#)M8jF9B* z-@6gUEnL}c`_yrEKzFq1?oya^&!MO=b-!LRmGe0hkT7fah~_y_-hhps(vOEWZg>8R zs(Ad@7P{SKI?YjoU0fnS2PQ)la29$e(b(0|{(C&s(4 zRCqkHe2ZD$4J=*wg{1Wopw>ox(BZG$z%#J85wF>hp}j=3oY3sNLsIRm?x))c1lt0o z;?-T$U*Tt?fjGgKkGz{fXYNFrs|VwMwpbFjxw+J<( z5i$lbvSr5d@--m=~rXoQI4ZPZVi3`Gr(H`hqLG)Dz0 zi$f2PkFZhAu1;9Nm8jPIjkCP1`G8s_vW*L80&r*QEl zXRx`aaGqLouXF*K9HXS6_a9J!#Ge_Bzn#$>4f{tm)KDL&l!uIU8d+AC8|%xOxs3bl z!@PoU|F)z9F)$+cF?aQYzBH`jJFn0MZ@mP=+oJ_@6PX(Q3#pbFj!MJQ*(?Hcp|%== zfza?%gSM_=rYo=e%1WdkK?^J0x|CsUukJ<()?A5Os;0-j7);ZR5Dwj5yj*aA!env2 z9pxHO7gFQv3!NqQ@k~r+E8TfE#UC45tj4xMOJdFY8x;JCyS|Wci4?2$=%||5y#eTW zly($rQ8h*I-%Nq>$;;ZIcea>+R;(jWFZs;kQUGe27&ic3sq0ckL~)L_6FLKt(}bif?&?w)%fncC z)2?59=O1>t&KLT7;;Y)zJEMUG>WB|w`K9Xi>3l5`M$uKL^?43G*M2H21tBqP?y&N$ zi79JD3?{SmMm=VWZLe#S3=Y6VA4ny>Mv5Q{c7gp3c7Fl0wHmcoW1ENr>cHe5S}#xg zo?wMcf4bzP6v@5+m{N;!H{RXyNQqik`c}T_*uDad!<~df=V?^bH#1Jt&?o?|Sn8NY zHYF)T@r?`^?1g=^cuc4Lt3X1?vwr4g{x#ErX|fZ3HYV<|vU&^0$tu4zkMG`Q*h)_> zQdghSrC-#CN41@eJp&NvXSf`{^e#)!&6VQf7~WxO{<4uv&G7rLM)++L9~0{Jn|xFa zG#0;yzT0pZ87Wzsob}R1A|AMX941fjfXQM&jO07iU7`>(QZUH8;$Fpd$lKPO?FTD_=n?D1x+(<)8+;yO05+)%6fXq zOu&}+vE}00N-Kn~UwsILNeDKzQNM27Th^*z;dgXBJ!tw7((cx|AJ)wyH_bPwbdBYy zLlCRieC<|~LRt%YFu}#s%+h9P;NVQ{8`;(M)pz~Zp(Wt!v%b>x>7NoiT7}uq=`(qC z?@O3S5XaC}R%=$TH@nm~yMxeFXGK)jo8HAR%qN5Vn$K~M>cg$h74!kA^ZBHtGD+Y8 z)KGxChz(sW}iGzl7=;bDc&S9a>1oP>;IwJUan z5Y!3aZMDHk0>Kl#E+^g)Erf?lLBORvGndi!8&ST48%RM&QP{Zu=6qJXoD0!;xRs;= z`nBfe!O2f)?={nI1+3ON9JVriDBP#17jnYpultr|Vt)3<^xeMc*I(crUG)^ikKu&N zwqY9V^_ied%);~=8Px0SM@iRGXY{v)+2O}uZ>xc|H2&1vH@Fp@uy(KAQ*0Y1=VgfNJQ;i%s*~;_&`bH4|V; z_2SQ+jEy30>zTgVvLmrm>HzW|K{*Dti~h&ZG0Vbi_Dp_;Y-tp~YL=U2x0Wh*imB5K z6X>n^eZl1t>?=&1Mjk~Rd~cE2s8I{{9v&W8=VeoKG2^3vQN8cyc2oPyJas69X`wSA zL9+@sxW^qv!R6bZ3d&PEFsA2D_gXmX0kDRc)U|%&BT?f=?~pA zL8VIIE5D)E-Id93NLSA9F7@FY%JugW5#k9j9FyW5mOi+83*R?W7k7J*@?AOI%P$Qo z>3nl8kTHDF0&&{bQ=5L8Z+)ZIN+K^mERdN*n7>^QMGP5OE$OwR%iAM=_iAoBJ;Nw% z9MZXBYJ&%+i*behrFNVX7T8V`K&*JTwq%9j=u)6f1TeSCEY=GR>mS9VJ`mZI&jd>2 z=cTygv0B;d(>qmSHm}I)+(xTDXc}Jm)1pk3zr#?qh!e)|thjSBAj2!5ucV3~9IY=J zVq5>$-81?buESoSyqcS>RWP5e#vg7*gCVvs?RKz2jx=VU8x~xK>9Z+8Ftrbb=cJlxb0c%PXnZZ#MWWO9Nj)l6?H@;~br zf^Dez;4LF*p2&J#{b&K8FX>|X`(2 zy{r%6rp6{T8#qc;){j-;WMFgCcLBusaPm|TrLpl_YlCNn*yQG5bLV(}JGtJDqx+cd zfvFGOPM4+890NA>5)Qa3y3jXqFX5EynKKN>!X+OOdQ=S_+r`f@MJ+=>_k^kv)g+DZ zWnc@zQaLK;_+*_(FkW8T2rJ_ys$|ODw`NvFvSP(uH-fz>iHX6Mpj4Hkl5qKSL+R4p zXjg4@$s-I9ytu)5Z686BO)r|cY#$=h-D6jH29^@5@>ce5BlOagQt&{1I3E%xLS4_x4|6VcA zD5DQ*jm7)n^ff2c%vg}l3Xq^iYfA2Z97ZYVwm88yI8cn>9VI7Fts2Xip4>8=V z5>UDl?{e$JZ$rwWTZjS0l`Ist0G~DW$x4WdUfW!NjMeHpj;F?kRW!jW4&%QJLXUx9 zw-eO@o&%=Y_BZy%nKPlw6K^Mw2mb%=pkW7`nf{nJPGh!l^Xt|6M3%#w!?PC32o>_g zR!UQIinkl>p1kYm5!?#f96^fWp&C~%F(N~aJ*9Z9isR^ zmN?627DeA{-gN%H99o^{fCsGZA&vCqP%%#deDn*LT7##2pc8#cRtpFZ4#L2-K*9rT zt>(YB49CtDafse@Jy!+u$Bl5NtvZWzHmm=@UU9X)AOX8`0NVIm_X=e+lG}_r{W#77 z<+)oMk;XgwVlYOH>^j}nqyJuWhLf`|ASlHC-9}L`oytW158XBwur@CCC+L)EN#Y*2 z88@s>jYYvSPqR|K>wgd7feY^nKU6mcRlT|QW4Dro*zQs!6d%xb|_;WUDbpr z2@97b6t4c#dv?^Z>tl&fI$e{$dB zfnOy({7c{1G_NqOp4l;QBpK|>b66)7qU~ZA_*47@a8sQ4x9e0DZD6xij+@5wSY~fX zo_@8S0URQ+@$O4@Ug$PZ!t7RX09Q^|iKxp{m3KgTeP3@<12nV7(7>Gnw&wU}hA{zf_K)Go;x0z< zEK;;jsw5S(AZVY#AB<~=@2^qrciU-wEJ1rkwangz?+*ECgA{jbavrZ?^L7S319n!hU{vj? zV0;nzDTptZ``^xV5cPuKg>|v+7VDqh@ziQ5M^5VmT}f}R+^QR|>#vC=9(WNHO?uxS zy4i}J>-v`KD0CuEdD+{kht3>bxjm)?>D+CcHaAi6mJ^Jzfu8Y1)34Mh)$Rw@IG>_5 zigp>o`cn?oG+pv`!_%v}oJ4-q$M{i3R`Eu{v ztOv~al!jS4n(xf@cUyoI7`ZJLzF`>k5iEB@F_qXZp3}PGAnOH=(Gp|5wJSuw;WVjO z^k9=_nAF5IlAY%7`-(-33<~_|lzLNbIHtb8Fk0EOwu8Qpa_DUuYk4>BjQx3`bsSZ` z`SK77q@JvvEI3{xTnkL|*h1XTif;JKuS^`Acu(%nZQIq1%6tU?g18Ikn=L!PlP=y` zR3_tbYfk1v?*n0k+XW()*2x)|@1R6L6o|_x<159F_JL5$*$W>xp}N#i1AL^pTU~Sf zJsMP0%rHQ`Xx;pwXNi!tU+ytPo5vK%KaHUpqxQQQ_XbUW_QGDDWXh^f-7BlTh$&t5 zaTtTTELPcgS!sJgvFNqkORL=_m_@U=dil!OtDN@Lh=?<(W*~mhU)}XUe#;kwvy%1H z5I6bvDZM3&t7M|qKt}}>m}^g<9vb94+F z){l%D2EWrbYZhozHTT!Xe|AusB(?K8=Q9aMA_vpFTt=lqN!|LMKv@LPsbIHu&wEdk ziLboYkp+rrNB3`}C35FfK4?M)M$B_UCtfZD`sv9#&t$D9eU9mt9nSiZY};yXtPx5Y z32i@P;Sy89)7FQ}tfIQYI5#2oUUlGC4X$av@bvbQ45SGe0`?B7A@%{rm-_O}lpNd# z9jR+r0qP%_P|3V7Am;vRF(y8cw~x59&idnk=6j4;*R@`76d$pvmA78P_|=koYdN*w z3B`;{H9{MY5zZ~*@Zo;qO46yN>C=l56pIX;EYhg-FKXi}RGYb@Q*ga)3c$1+C&8X?Obi$hjR zl7twQtB8-dw4B1`#OFq+rVTkaYQMH*VmWM1oD2)dNb@n7X;x1qqeal*B2se`9X;VZ z{rSyIPjaQcSYLPDr&>o+*bBf~X)5jY%)7zv{m-YS{X;+-;YtK-chahc3O1BdkYZti zRu)3}ql>(&RI8IHaBCoJP`7rlQorxw6_`XXV75=kU+D`~s`~zfDn~{=BWU3CA=1d^ zQBcc2ARZmKH5@*+zEm_-a{Gkpcg|(s2>e~^Zu>y>l-ECW6ytnQ*&^#C(Mw z%ch{#1BT+3UUnLrfZg>FDe*+j&TRd&FEGo$H^>^7Mjn_OnN%}Bnp;b)i|yy5d_bkU z67hBuxT02y@7d**wsSMI$Hv=&>*W8ODm;Q4wUf(t=v@zBSwiqstLYD^R;+0QDNz({dcG5}`nI%I@fbqxlazK^1(<$H((9KS?|bNi4dJmx1rtjI@8(>(53Ybr{48j?DKB4)?EGXoOi1Jzo3NP1kbLeI$BQH z-lnS~v0=KLhwt|M_ff7TO-Rw_PglbCU5xJd8fWUMVYxo zT%GO4>-2>q+e;SMs6(DjG}MjWt)DI}g&w9$N-#=w=ih~Uf@fKP+Sa`&LmPJ3$F;Et ztCbY3=gu&OhcY2#KI7ZmbfbC8*~Z$N#4HwFK(y&YHZ{Fu-oXw%RK>tRq&E;ePJYyi zeGui(gS4h&@@hO zufOo6gyG5{;RK#Pe+bGImPA%HOayNf(pS%%p0s!D_l&z6_>A}179IDQe>U|-Va+~A z=L*rgC0X0+a}OM=xDfPz`W05?JG86I4Fb-!C5nrgs9f2r#iI`$fB3Zu&*-^~__@?? zSDx(>Q$=}>e2?wJ%Rj!(I<@V}s&vDUFEf+9-^u>kKFPExwd~5ty60JwSUtO$Q^#!b z-uA*SNBYQ8+HfdRyV;G{`F0fE_qS4KF;al;8zkw_3o8D*xE zXF{EjK6njD_?)7cAJsKkvNV-8EfC7ypyEV_vL4g$X;4)Puwv!zvZmC#@%dClMh#;% z31ER8?YvTBnw4i;V>_f^75WfAAeJ8s?#ER9I5x@rW+&g6nQl)_B*#AXaOo>S2TGgz zH?Q?QfP9mH^VLuw`5F#}-zNjBX9K>vDG3p*950KRQA=;0r+m_~E3h1j`e&s53*@Y9 zbvMl~TA*SUsz#E&#%^|JasK6gQ8gG(3k={7wL^Q^@)=7uxW_H?+?WxixPUPf^{}~M zG55K73o8D?M9 z0WJr2E^a=yKb+6;+}HkgsCA3a)migDBc-uRF9b_Tho{#Uhv5c7$RSEQXAO11kF z?c@$MHFs>}cd*C1pp?=XrKPyy#&%VYDV!)?C{<>H46M5`(lZsYrB$o2h}|eyYpvXC z8XPPwe{qZMAnVGR*gE^^<$tt(z2eX(@okkYp^O7q;X2RPembPxD1M842ph$_yq>b7 zwD!PhxT*@6?->}@Y_5TugVx6V81xebL9`nSllnrWW_zQ$)_rOC(|rf{Gq3oeF=FZ; zjN?tFUz9~9?ELS|3z5UXY+oFoG~Q&e>Dz7)*O_I%ZD80HDq8Nz=6i*bs|SB|-Hb|_ zAZW$Er`9XqKKgvOI7#o*B0|x%CV|;T=J*T5ac0N6Adlsvc6~>QZh-0kG^|ke>NB)MeP*(JOeaWb*iIa?*kToh`jK; zx|y2e>tO;;u5T>wBH=eU#2xyFK5U5SL_e7?pIW z>4s_p@{;`Khdu>Y^;Ol=Qm{KBeLBp)K1NQCT(&*tLz($8ECn}_^&34Ft9GLYT0VBX ziTi^j>GvbQuA&w8MOx+^^1zj%5xMblLZTnk)&1JE(v%^jnT zC%jOSu!rLn!x5nLzx#JSv3PX(;7`v~9WdZ)mu{6&WO9$F(VT<*^pC$RB!?8<|C`gz z936$H%hzK+DDo^L`6}l3EmK_7pxXQIymjMVz-b_1_H#3<$Hn;uooDhwCjdpLCqy1~ zARx6#yc@~=kgf80$B;(2u;N+*JFuBSC`@p@IZB|*}k8~XCxtnbpC zw8Lfj$!~z<*c+Dc+4Nksy`y_xJJ-epPc@**T%2MU4t9U)|50Ss?8V4Vi}tk}kT{R| zpg4}4+gR=+7vfP%mEmNBse7<~q&?(N7ANh7{TMA$n($|IE;-;ab5x_;LXJ>w7GCV3 znq3eXva1e8DVyuj&I%8d;_7o3a^if&Rj73*XmTTn!%ARm_>%6XAOw0p)Cbz{`OOPEY9Eyv~?KoIF!l-JQs_P<& zJoO!yQ(K|Cs9^L;B{2Z;yV+T|oj4FFU~wwUp{+tet0p7oOG4endLn*loFLAD;pZZ* z3?h7^rf88&GW52N5t%2FlDH{HO+ z2Idx79slU8Ya@=j7(1y01|)k$Hw|nwYXJ=<*>y+gzjj3~vfh8y&8ACEY=Y_L(JFk= za{pZA(qtRSHbbj@elp|4=T1vsaniR_Ps)Etg{=*O^jja z1ZKB-GxRbwyO?WA7l(O2c6mf_Re^2~_YZH?Pmx|;*8a0J)M-7}GQJ?Ssc}IA%CI|& zx(Cu%#P?44R)&2=RKR{-`o*aXe@I->b=mjrmx~1=<0-&MOnSk~s2fjxcUo~~G@`OJ zP5&3=as=nBGM6a#q=E#msj{l}61lC$0=TdIhUuDYIzJ_wzR>O##cwwCpH04n0~N0Q zjY~%6(cf)u{l$(mQKJAL<~w4R5bt0_odT%%T0Rig4l2ufkm@pI4H55vFkZjt@Qc2DZ*lKQs}W!H$~%Wu zA0yRpUa+2qytjJV!9)PnQIOvi~dS_!{rGJD||X7&N*N4*7A- z|DnqRhAL;ldZGCb*0LXS_rxb8%00dDFhTQgP-=eelyA{!N8@k{w5jUl^8Oj*@>5^zEN;`G;y_z^Nsk;^k7XqM%Oe%}{S` z$(0z&E|BbY7O9}Hr0C!1;fRRyw8v^Oydb}`qF?V(#G!>@y1UrBi>2HwTXdi>SygES z)Q>xJ&-K8GFItWV%YHxoxAv~CQ$Nk*h28B{`RC8-u80m%va{N=`o!}icAfCB6LJH0 z#ks-leJWU;ejYoBMhl*p_+6L$E;p z%0c|p#kE1B_dq@SA9{k;lLI)FROb!f?33)#P!Ic|zpB+14tB38O^eR}pn({lmV4?fCI+GF$S_j6|O=`Z2~5?~Q&e-n@3*&)siibkx$iS-(I9a=Jiew(V${8?Gx1L{aRE8(Tg3Of~$$%j4ef!S!dwR5l4kcgnfpv$2uO6e$G@;Sl>xyEj4-WDN z4#FqLnJ{`-6YZ&9U<0u8nsZzo(jMnT|Ksbg9_acoPP^MJf_cnK)^hBG44_p-74ZNJnFdpH@2x}#J=N&4633E^T~Mk zaJMd?vR{3@OJ{f#`fjOK=D0s0jG?Lo$N%n&1hF<)Yp#NzY$j;L2F907idZM z{OirDGytB#E}RNDjiGqA%2TIx3sTqCam+-7cl|9sUB;KxBQ zz!8x?Xso&^xGOc9M5u+$dD4JUA8O5)mnW?`OPjx`QOXVStp-!0UTYvfY)wKiYAdWu z@gT@A_{Nfl-QzXtfBxG>?7ronITxMO{J2($rMt5mgiO z+9lTkdc;xLNJ9p!iGmCFP1vjOp!T{z#wYOX3rgJhk{A8C<^miz<(LNu8po0y*S7re#VYHc6>foajm{nX$cO!g<5u&Jd272X;rzZu!*ICH zf&q~&No8ld+~qSi3}SgvO%>Y)Eb_nNjXz1`<|xu5sxGzNzy?3Xd=wi~mtV?^$|+XQ z8byAA)U#eL7k)G2X7ZaKF(=UM(uvZrj~;I}Kij7oh1fT98dUpoP9P?^vz5z=t4qYE zrmaO!V@n9epvBKRC}B%&s{=+LFvI)p(q7iI`$*#+J6#B@eL1*#e#7q@^p_1`1?Chw z#DRPqeZh~J*EAy?e~~EG#m_A6*sOvfzF0sOd%Vo&i}xG>e+i}12KK? zI5!0rFh*GfRbFpA9CgaGAkD>~>J)Ce7BD(Zr*1Vi{Q*|$E zcjozpRXVtv@CpO+$J&QZ1!ZJ5Hi{T;%qsgg(6Fy>*A?4uBD{97T6CRX%Mg0gm0s)6muov z3y$fEGo6nEYE0ML^c|JiFGN=oRMpKQlvxxb`1D{l@m4#a%$0G>7APh?#QZ2VD}fYd zh~I$2^7Z`~f^$8Bk=AN`yB!I2V*8Pm{vW6)=$o-;)XAy?rQV!;T11>i zA{;Sjcn5SDnIPS98xG07pKopVfn4j{yr0Dw2%*GBT++XM>SO+7@eStj=6Fr3) zOfVu;)UA99@=i%3J#axGPEB{5U(G_~k>f|!Y*Avww43iR3TnVz@} z1k66w&9tLJb;eUk=m$-_u?Nf$xra#d=*o{=RQTM__P;c~h{)9SS4bXBY0yJGO=72f zCxv-?zTF<4$X^SKsl+uXql&E8(pczE(CP-y(a0Z(nvmTa=pj<8!d9xhTp}vRW&g%~ zX?mpznZ%LMz`nzY@j-pD!&>c<9r}w?+Syip>cH7ao8+S}NuhjnO?jS{m(3PmUGKigNh1klpu3H4rsilFbM8 zN=BOZI~6&Zx>gR8{)wM>liGAu$CQz}Fa9P3FdN1=%btWNs$ux;O;rXe7~Y#r;f~ZU zTrn_-WFap{?*xvWkYFfF{tFYA=g1L}y!OU8>s1FE5FeylFmf_9$+@81ALY*f@wF%= zaNPQxx(0BKh|Ae$f|-1tZ5j}^^fYQo5kl&#ehSjIp33r_)rBBBTz`VLIa)Jn7RP;{ z>TXR>mSo{qNYUlj4o-?m? zI_IyD)%s)Ef$NnQZw1ek#=e~0)W8L<9pFxMcpDjsXiQa4$}f&iEXv zTh=>Fg{_-#E4yo7;YfPF0w@Wt%P7h{Q$e#TNIq+XB^_h_eyfz%-AtihiG6Y(#{2U4 zMLSKWEC9E5to44c0jGIC`2WtPWQy6rZC0K}L)g+ME#yeg7nnRCT} zQr;mvkdVrfS+Ye_tduMr*6IzKTHVF}tYzPw0F<@$E9JknV&12c`=iA{5&K?QnmAh9 z?pU}}nR_d5d10z{VbVeVeoWeh&ARFZOsLe_zzR0gUVU{!OCQ;GH=Ui`a=Bh4*Pw$< z85SMqGkJJdS}Jbv&>~$PX6`sfabO-dSK(dE$^dsig}9r{N2kb+*;{SI z#(fiySz>+LgF(BVJD|m#>Qrzps4Swj^%n{HGxJ@0Xr@d3o*3Z}$Iu{deZ@hpVVk1= z>0W6&a%=bXX322CL1>Booh5=<%ARK8ZET;fSE78ysVC_WKoBN#&ec~=A+{Hs%UysC z#P{el587im!0xph=WWTJPDXg|uem7s&nnnAnmm7Op8>k3dNxHf`>G!A-%;EsA63N7 zs}w~x9YKlIRW!skq$1RS^H57G6Y7j#aZK~6VD{wvb((Ps!=K4r`$dR8Z9mA#(ZC0N z#M_LeHWSqT_JwT-zjjL!Hw+L&H#g^3&6o=$tvbpki-uSXbj`1zFF^Dp|6=V8x`R>8w5462vU)e*GI-AFE7Na^m{{p%7vH~mS!ly zXugnoqzOt?grr-sq_3e681S2A|NB}&(>*|^*?gQSTjOrjgqh&5DH=Ox-y*#ujYRI# zZyjrPpaHbWLs=)LJz)NOgd7#Az{Rw0@HZGIT3X{v?fiZL^%And{9#B18bz00Kvvmt zO3dk*Tg)z-A_lUg5lmif{W^=qZ(}s(Y#$bUq|yA@wom?o82?B~L^`m4zK7EfFEnde z?ekh50Or5sYK#JmQS}TLe0YqNC>16<0y1IjnqBb41Fzd+%cE@yOZrozqrfdAIbKcI zoz3S_P4T@JUCI8|w-O1 ze)gXL>J&$N9F5#1*Dl1I{Y|3hJXISv5Rpz+ANINZq7@8MC*r{ zw>kkxU8*s3HPz@V@i6}6UD2o_k_}o&b?xRgpxnbSdN=YOd=(zfMGqsz(Avn^zY8+R zjTS4HrAAds{NCX-@#O&@y*v-DK{H&#Ey`{EIsolX5|_mX|KNTdUKplIsHd=d*re5a z7cU`?nJ!m0Ne2v~_s!Qhe?pr&nKnD;IZ8`_o0!w0h<^XSS7$59MXu8Kx%Rp+B|HE+ zjGEkhgKVWAXZ@r&hBek5nAjt{Lx|4WTp9;iNg}iqz+rp0d-EcQ_!n3!K&C<8Y@2n& zuAh5f>pi*t-0g!N?|R<@jrs2OO^eNih{9WLqz7}L&O{o`P9Qsl4kZ}eqF>ZG=U5X` z5YB%ay~##x9L|N^)OKrO^q}(Bl;6;T52q;du!5O1I<$I?LDpRT6MBJe_4V}7@Ihc5 z;vOX}pIX$dv~bDFqvLu?&1O*ucHj^8mT^Z%;TM%2+s|*HS78OJnXylb_Mq1Z7WexO zD44IAXy9T5rt=WZro-6(1GevmukdEHte0AkH6N&P(MRfRY`t??dE4z;0o0bHThJ#J z3@UW777EMS(C-VW z&@88u{pkfGL94+T8Q^tS4l;AWBcs3wJ5)ZaDebp~$g`~iuwl0Pj7!dQ47Z!G>UEwn zVfWeLm*0N;U6o_J_uy63o^-o^&W3^PloIWrKa1Kn5<1l`75_r}Y!e{w&`;m3AMjB@ zIy18BHFi8l1H`+T{o{7O!vN0LFXonYqu<8CFZj_Z5C5LzrQ7@If4iZR-?dL9z(w;F zD>>e!jw?{ddsE#Bi$7_po6dcsL+cS`eU`e_X+{R-VafqIT=5BHxQ(_@nHgbFTh_Rz z03goC6!iW-W`6i6a5wD!BbnV?mW18!PrV9?1hOR1d`9<(+8YB;t0&T5LQ$f9UOEccNJyz=5vcx$!_w?B57ryuo zY)Yv)lb)+KRj80MfBHnYdDm08!f zqxF90h=PTtrCz6r^VIzK&emi{-VMcKegqNiMETnFK3k6+hAYfC@@n{qM>9ET?ad2j zT9b~%?uLr_sI8xN7FuLLv9DL+BF3wtGsp2A6Rf84Em=Zny*Wkye#gyWV2y@tVQ6)b z3Hy;t+-mTZEC{er+VL^&wMRvfQ`8cIYpY6QTfc$oc1&o+;n&jb-)Mz2kdEM(5U1Hc z#)bdJjK!N{lQTLm?yJObZPi%pXpxuT=)MeJSnnO*Z;-+Y!Zm1`*{Z^fYL7Tk%&c-^81GV+$KFchW(`<5h=uj8v--Wko1tBJwRAxv5vD zYE`qW8qyn&-0#y54psSG`bTbBCj>pxea$zV@zT|A zWx+LIOIG5c1Dkn0`UDLg9JoC=yFd6INdQ$Q8+Qbs^Ws;eo`(?UUgCmZ=hwZzxKPjj zxg6g-)|vqwnCP#x`P+O+^lUj}6gVucd|i6vs=tgA73}G_Av?WF+KHaQVgHY!GmT0D z{o8PpQ;y@Lm6cO2R8~%7O8y&nh04ktOWG+>DXl1R2{my6tgPHpD<^H-XmQd+L{r=a zOVCUO(*QRlA;1*`6ahhB-p`!lIh=#f_Pg)v(hDyy9*Qe|J^d}%z}hJMNf;~8S;JmC zO1@8o+QX+OTFBtXQd5^7yHY9Co1s}Ij7C9_fB1a5`2;WF8~=h%HC1ajAuZ{ScNq^< z^p)j(A60xb$1Cy4yq|RNrVPF4cJUPf-o`(ixGl3V*l}{cud^}cJaLll1+y%+bJ`m| zd4$})9gXrO8)?VJjyySIVqvj>+Q=DJR=zj5jh7eWhza)iFz-8qm&|Y~2q4OB4!u>w z9_}w|NRT#-3~9sCHP2^{9B{@ABkbWS{yuAfQA^mC3YTt3>z&Oh{h?jSDCPDwjy>l+ zi74_T_X?Dh{b8lCI#x_Rzs(qeTwY?HpH!Es#o-;n6Jx(0B`4Z^ZO;z&e;0( z5Al4mdC&a=K+2D|l(`fX6S2HGr&C$QTrVv4O0!$({DRM;6vSEYK;|Q5AHH%P;K&<8 zV~E=VmWRhHk`OJwzqTwKbQa~4w7LA-gOGugg*cN8bM_K*_h?oF&a5dG^hAG~Hv7^M z=#(_Dye0q8HzxIv?BT+-W!Ow+894;|DE>j*4e@k`rgde|WwkB}&mX~twIo8Cz$;!JPZkf{0XNw;AiX5peV8aE&wY#phJg>3d5>ylgu)rHH4 zy_!91_i7IF0;H8$Jol-{IQ&wTIaRu@Gdv^z;bIR2m-~Hu`cR(KQTJN2VtR?YsJAgY zaK-6z7`~D4%o6J?1t624pYfo`5nIXVJ3Z^P=p`_C@gT%ySP?z5>4V)(WGCh`AUQ%> z6{HtIt@Zz5l~EhG6W6G`a!;xS{@B7c4f4e9`@{w1QVxxnW07iBo}YRih%3r~Vy9k4 z0W_9>GclADSuqm6S-`*Lu}W6wn1Aj-m^Ha|$Om0G!!0Q9g!H~-F>F+fWCkNBL$u!k zND-@5vAd*6xzQa@M*W!+fK;yGziUfW4=WH=^|)8w9BsY&V0QlR!tJTb#vNDQ+93wS zE5x6`;hF{pPW;`^Gl?bLuY6)};rOwUsa(iEv|GU8(qwD`k!L%IvthpAIf~xLjt8LC~_@&h6L8GxH zP5KnwA9pA#H@*SL-sMF(nfelLm>u8VS7^8X0HR(*?s-A+Tq^qPhcubL@9OMe3UV=x z2@ou(ox3_c8P;zCv_k&w$&?)9?#q;*5M!Jms}?)^gbQB#;Y8Q=pBz~P!~En27FNy0 zTd|H`4DRd)d~n*yT0>zbHdtxoOXMfw)7#24^CVp=$`Ha6XHyihv>gKli z+dpNvyZ10Il=h}W-%4V^u)&e@dfh6@%{$>~p9dgzs%}YGa5~{DN3_g#G8#5>r2F&x z8%Mr1EKOh1V)lq=UA&iBErSWN5)?vd8nXO4Be=!@JlzR(nhXkzm=DP@d*))nH1QJX z|A%m}%w>}5m?oIE&JDM0tVg>&B*7}soBg83K@qNj0nc&Qr*5OkA z1u^k-dd3HS3#Ma27Mbt9XW!AIJVo;;0=o~>V z|Ljf*Nq&&kHrJUc@B-=`rO5*Ha|zEF1(}E47Xc$9IMC2H4pZct46DI5vQ!~igFdR9 zLIeNpN~eyWc?`s$mNY?Az_*SZG`~l zU*`r>?(@Q~74tCP3T&>0)(TcT+eZV5Zp1*}gd?)PVXCqpb2Q(y1{Ic^vDLI$i!RCV zxyL0BTb?YsA9?p0EW5KiO8 z4;K_4-&ra_`)_J9x}x-n%YNmR9(SyADcrm(J`|ai*})LEuDEj1+xbaZO(1BJc%ufi z`V=X6;TfIMD{xNI8jb+JYe{7AZ z#yb%d(Q6aF8S3j3jJrokF+6dp_CcNrLtY1w%dvq~Sg<4k#!G)0atno~V0p8Z%fVO2 z(1_g**25NE$AjFZ^fBzIt^lV~asxKuqLN6;z8fK{T4Uu|N57QI?j=k0r_;KchG5pt z7D`HzQqcwWATPqYaH%ekuBfw;Uk7UQtQ^$NhT**yU5-Y>&s4Y7Xy>9$sN#GO=fnP` zkk4-e**TY4$EXDt%-eImJLENnY{ID!;-dFi`i8hiYQ1!*RLA5*ODmxbM2}Ti?(|mD z!;-ioBrUn`W6o-{;lN6!)#@UAb@A=Rw5LA}e1;9$YLeoA-gazl#4) z>lWsf27bwI-kROxne`ji;f4g$51s?tD3$-}5uzJw`Ov?V;m)9%VNqsJ&NgTh|J7;L z)PuRhG?|`A`q1Qr&LkCeu9%(bw%gRX6kFqCa@EiQ%=TV}*(l{t1o3^ zt_&h_pyYRhpvr&npptNRgnWKY!qbz0hdW@Tn;SV?3(Q<nRe6WrzKi8||3>1)=kF8CfhazQc%%+`MW z$&qh}iB+&XF^r~bkIjwoZ#f1<6xuV${dKyiYvY9<^UeRNk%-vDc{u+30KjX zk7BlY5YX48MsWeo!xE1-ZU~Ook%d0PnFV^NAFY|^HSny~gKi}-ew{RwygqlbFh<&M z2O1R~%eY}RzZ)af-O47>iaf`nB;4)@!jt5=x@?ficv2S<~G6jS&D0{;M9|R8>?p3 zMAR6l&`?thDY~;0W~#~5pPVh==YFf7Lw$1j&JXOi!Oq10h~jid|JUP!%KL>EatVBu zLos8%WqTGbDE6*@e<@3F&)h#i5Z`r#=b048D&MxisR~?>?VI|?2f53uUNzbI%}UB*e{S zuD0z@G!e!8huwH6FL{igN^nE6a&XF!^tU+nmm18_Z5Mnj85NamHq>?y%2gXg$is@j zAiW9RH<8Gy0?W5nF+6mnr$F+r)5qEiK-sU!cLZXEvV+is|Cr0wPy?@VI5EJf|Fu?@-C@V$(MdHM@NBy(yEBYy%-w+&Gx%SrNpavKt+)*(VbAs3kDqG++B6n& z*;cr06xm9~Rv3MimT=wT^oGPX>TCCb8LRd5Y3rE$p5ypn$HgSzEyZbOVqm3Helm8Y z%}##WC9+c=4N3$VDsw9AM9bO_=osbb=9LkEblqgk9`LxC$hTRwQ8&H55B@UKM-aUY zdO9h!s|5|{jv6~M>q>;Xx2KZz9+c>^mU=bu5q~bhKkk(HZ{*HPH5O48e7|oWtyPtf zSt4^a0Et=d?MH01%mrntW<$7vt+WFUfGIg^>4BEkF!D^;JD%{40D%Y9i98MVP(=hc zFuC|AaaBzJih1e*J^6!2#dIx5V|6)3T2tNf(hw+gQ{YgPL&(KsB02g&kB8N(T(I8$ z-Y8yQ+2iJ=7Fno1+m>=b5942Qp0fqq0DUiw|25%!lKn(#)eb@wZ(?!oy;Cc8sV++L zE9I#8uq7pID!e2qc)@5PJilcdNwROL2&I1E65bZ+m+{q2s_n4@VZu*+N_G0w`EN8^ zLwdfM87TIH;UijEy|tBlg$19FhnGLn-;JB?+93%phScRjJ<6wN)xKv{4PF)d*zFps zKYDBLD-scSkZ+Pj+w;cB;oy~|wVT?0WZCpqb(Hl7-3;32>`$%vUCl;70;E13xbS+X z8rnnGFkf@OIA<4Yy6y1yin+sjzdZjsFQy z(r8X{Yn{#U;^wE~mPJSV%W}+k#W6ZYP9CN9BL#pWTubm~o=PIVumPZM=yBdq*auKg zmn%5zKZkTz_M|8`3xy~xcwrW6ov}{+M-)!cXN!#}8cBY0LVf5G?9ENDeA-xNU&Bic zoz>ZpcbQOyN_U|d0|synsiiIS?FUI&FztsyL&wkT6Bfy#NYw6)Qspc0|G)u)lKTuS z_-BvIk=YC%zVDASTq6BhP(3|G<>cesbzJsJH5^+tVx}MO6d7@YI1u@Z)fXWR`Eys2 z264!~yW47Q2nO`E3O$J55gfkDK`pYSijHay!;8Xa2*;Q8!=Tf=E4Q-yMEg(RDmz36 z{1NYJe*`YB)cfcBz#mqZqnO8}$0iTZ^=XqgPU}}xIWbPi4XFS+eDUtZdQ-4~5KWO6_Gas3Jet$Ec%w@MA0Hwsp7@lgLNYaR%2b6(myzmMMP zoS$0@`)y8`*mYRy`$-9(=)PpJG!56XobvnRNF9gY4G|P4XWX4RE-n#EzwnG%vM*-5 z1$;I0S6Ct!m9#CB<25M$O}eCO{c2TLFDk5MK$dD+uDVrS_inbMPZfWxN*ZY6n@A2t zL@d=@rrXYRw4y?+zjYL++W-PW6~v{LlTl#r%Y=QU%jbH-f04}2FAcxMM@yD>jE1Dc z!grT=va$wXNxquZwuA(Skh_jqyH-C#Bq2&naiic*c}z_C#|NOA z`d3g2Yr~ysYWP44w>i|BQpf0wPDlR%DZezLVY31bpoR-=hSUC?MI>3u zUu2Ecxu9+z@E31@xAM1rnDFaCgA}3u;mzt+_n)~Rj=_8 zE6Bl*8%X5+U}S9H-EnfGIJdONu(}&KX|Otb5>I%(D5$*9P+IT>3OfKIT*Te^R?y&( z_cHd$eJ^lv-?$MfJc@7V`qWjJ@|ldi7r)hX645XeNc&VIGd4OdCRw+~*qW{zl`hP_SJO{1$O@0t(IDF2oy zi(eAph8)^alZQ z^j+J8yai$crP=&w9G-t0P%yd!Nq4|SELoe(_O?(3=Bw-iM6D-LjOL{qUANmu4TzDk zTp+2XQmb9o;PL&_zn6_W&bGc?q7Kwh7nN-fNLlM-YzbnYc5`#Muk^cik?|Q2thI&Q zviHEoWzl~$s5HJYVFrzBJz~gn>6qDW7EE7}HM~`nr74As46?!W&UTw*jV$amyhM4i zn5=xZ02j|De|`-C0K^=GMp+Z+4#u8{2-b$ABdZD)ublAf?P_T2-;qL&{tI!y!2^Xg zoolIa{E-t>j~b8zlLgUZt#u(!K`v_CFuHdIZ=p$zi@`4ab3P$VZD&|i;k%aZ$7yxG zFMnkm%P(k)pMGN+PT2dbc3WzArbQ*8d(iUQ=vcI$d^@R~p=d)eUjpLdN4=e9dEdW1 zHFf81(mywcyok}MI?opVo}Y;V_2rvh?lOzQRtIMv1GkWcrn5dwA6~jg8LMq5r28xS zXsF&eSOi26dBHSbDmMl<#wy{pwXj+O>t^{)TKtGDm))oEEl2^Z3Qdfbx~x`atTsQ+ zXs{O)8^l;y>d9AtH20J1ZZ;eaH)3)2ooUU;s@*+0SePN3=0de=-|O4&QB$JT2iz&i#|8>e0(0ESq- zTXbq3OQ+l>8U&+kgg*(7)4rQe!gBFrlZ7eD*LRU4m|Fyo{*E$0La?wu|F)QD>d~pY zT3fG%OI|lIUc`LOd;>Tm2=s5H)##5+o|K|oMgZb)(JN*Z_DPJ>#nkD)p;S}^QmscM zD!LksAD8FWkQWqYXlL2ZsmCGdXDt(l^^P{KJgXL^C;1`?InD2z*o}(KK36;NmnvO5 z@iZjtdnmFoDHG}_7);IUB)o+?s0X&?hHoIdK9Bb%|F6OAS#bF*Ih-s?KO}YAnZygQ zi_(Jw?K#m0A*npfP1qQQ#)|(>&96K#*@@?QN$I2F`W@A^lyiX*MTdL!#U|uZ09>Mx zJpqSXt2=#Ro}lNf4i7+SBKpLDY3#O6O!$h@JE-0o^*7}72eY@0BeCjo9ID?%>OUVm zl^KdI7{cU1P@g*Gz56;Bh7=cPSq(0-?=Y(7*6Tp^b8n||Ym`(Xjq%YFbgDdQ6V%J1 zw7UZZI3-3gTwEO7TrDV52iYuHJ}gs{O=qMb;t?Mw3T_AWd1hJDnIif$(6suU1RsL! z0-Hnk+V8m_j3kD z(Q9N^mj0hZ1(g2J(rDG9wjTRwgAe`)R;dVT7cc2*-X5xTN^9ActX^7qpWSZAGfHMX zq$&x{*=$;tIe3Jzvu&$qh3SQ^@xJ0sbDd#ST5Z+d;f|8+_E_Avw6y#APL@i=?d3Bd z;hXitFLLtkC7}5E^MeJTI&<};+exV9?#Sh{LGsr(ys5aru(|iH@>8j6ij^4b!~h~H zG-55r4H#A`#N(CEc(kIxsmQ9ZE0Oa5L9Mk4b97v3!pef;_`U4AifBE=Q*6u;`pNAa zsw192{)lr!3hEt)(+QUf&o9Qfd=-!^>x7@nw5ssn%4l{Z&a1F^0}@l+ot@LjZCy~; z@B$Lggs;?{3H*+@mUV%n8nmUqCsHvVJ~nCc47&l>3rX5K6V*##YM;?$UMe{ZQ0YQV z5ZX{#Lpy?;e;y#@AQ8JLQ;PFik(z}N&o&y?%?gr{XBe}nb1mauTvYrv+w5?~3p{3m z{%*$$g**%5`K0GakLebs<&T`|E7uL^<)$-!c9#UI_eW-YhgR%LYn7;+uEo_o!+!<; zl?^`Ig}w|P{z!xfs^jo)EX_I6H$%f?+bAEXuUZlwh3tVeDqJLHIpJ({bd8dj^FSU_Gu}0AM>3Dt z`;1~kx2Th~;o-l4P``GD(evx2evKmYFK!8+7-i7bXcx8%2P2pr%?~#!&u{w&n$&zX zswzPlUz?juj>v*XOa{`t64p^FjOYKOlK+>VR<@qi%rsTjOSQ*%fl2q05dVYIe?~^z zMac#aaT1viG>f{ORMbq&NhiaaCz;*0U=VO|_YDMZ6f9`{v8nm*j`*-+u#^em*4w__7253Y+2Zqm?eZ&nouQw|I~ zV%L*N%iIrAq}nWsd3-6gwbI^aBd{fmnDtigDZ^#XV5X47ZsXLlk-y3wiBjVC(2PG! zRigFqDff7qF`T&@B;1Xr-gbrQ&ZdrB4m}S-eY_85R`XtIU+3wkqkZVbjfJ#?Wpbgk zYVUpKkJWn7krRUK!L=uaj4Y>e3#pfgL;Mygih*)n{|iso=vV zXDo)VT@F8Y=IFvT(*r@+b=^zd5f$+&f!M(SCKVzp za|(Zl8QS0O7#7;%MMIYmYiEgyGjC(?8vSXDt>E=8Z;>J{wcxyMXws zmJM2qLIl%4=*|`FIYyQ@MZE_T7dc>8qMq*Wd0L+Clo(DMb}tk#6UTNsGXMk%dSv>S%t92F4TK2-XKoOcrP^2%@h!$F$PI-&v6cCoC;(aJKXiNehi#RtztbCLzsUMC@?o*F$GMZP=^31W)n1Xi+oSxjh*zX;TQArKQmb>XN?oEfdgkoMH$z z<}$hswo|8*Ca*$P<-k>Wk9%RrE#IWIEw-Q(%`6YFsy{+$Wcj8RPrX0c@^ou5Gl%#e zE~Zc{HZEVc9_sW)7L`+9Hr5cFOzHklWS?_XJDtI8gdST9`^#{Xxg#@+MgUAV@lbaj zm~0#NHNp8^3RM~q{gDtbKRmqO)DrcF=|P{NEx8-8i7w!o=^G}Tu<|I%?+Yg#cSLQN zkKWc-Ll2THe8jkIbj-8@YBX6>cjLaLw*@R7_>q~7`jB*5l?&bNuT}4vtuRZ9m|@Gk z?^QXKi(*IgC9cF73q*fGs39xQ1Tbuoe;((2GwBiRE~%bX_VRVY^Hs^iV$OhYv}w}q zYXJ#F-m_X-v>;1|juDI|QeGO=U(;=LrzAY*er zJg3%_-XnMKW74`HE9zTd)tGLRF(S>-BVjF%beZU zf?%-jo4XkF>3w{-3EWq`wuP~B-g-(hVyEAn9)zPE{-P-0_Z@mI8pW4?3Way~nn%}g#5+_GoT(_N~KdJKkgG52vG z;eX_uX@8BiU$2?v;9Sw&?2)&wBaot#x{|LTfZG52feYS9VG*;@5P3L<$%t?g+VMmg zP0sD6tE@Gu2R$zUp35oO)RjdNIAAr7AkA^d_(*vu+2kp6(~Oi8W?MveA6`*5%HDftnL#2_QCPCf2Ae_9W<+Y=WP=AMH?NrAaZc{4winaB(i< z%WmFJwjg!fIAe{2SB&J+Qf2eJ zfpVZ}ns>hk{+oMvj|~>tI6uYPt%qDwgb)`jG4Ko76RFOtNPxK~j-#IUo-y`sk8au7MFQx^CaT&IAq zGP;9KT}1>JIdrsbA-4lBxpwPPon0_>LfN1gVsAJ+(veDND? z8rJ3N-`^G%208Wm`(*ysLyqH4&zbV?e!XF}dIrtV3v=B=AZ~N3I$G%~ zT}u>~BHn86;pLmlniYed*g!gO$4qSl1C5V5NeS<#eZiQa-%R4 z??^YG2Z)Q3Q!}&bieS*-bdRAqy3zy0kkCP93Ns*X{(T7s#zUW@G>)Jojp|qw7pxI*NOE%0LOEeTh~OtGM%$>gwQsdQ5!S6AM;ky%9;B@){bK4 zT(hw^=MEjm+*_SJTs2IB<32=yhxlnOQYtL1bB2u-_|1#FO*nEZgdjK`Z?9OuwXE{+}GMAhpB0`royCgv`g^3v#CS z#Ep%l%Fp9**Qc+P-^A#>()`y^C0o2582Qca4O&>HN1=Q;pn$U(bH|4DQ?DWwjE`T$ z2+N8%k4ta~ulN0I5%&AVB*ppXz zmRzOneyHa_mjQx!sA>7WaZT`e77K{)tNloD3_oxV+uP8&FH#mobRKi0#XMWJ)rsop ziO-*|S{PJ;ipfEx`S{L!Z=`vPNj|gcztJLP`fAACnc5~dtPrv2ATMNCQ9n&%pL-+9 zQSz;lMAVnnVpqW-0ZfD+8jrN5gk>Lfd{L(98@ z8s|J(2f7NkFx{stBQPPB(74#%7E+-LV$7=hU7NFWRQ5xD)%C6uenU!!+Q?Ih%*An3 zS%d9}Bym1iR{U7Cfw!E<%g1;-qMn%pls9?iB7rgepz=z)m;p*sj-Lh>W*Lx4hZ{yJ z@ev$E^GI0PO`>2dX{43ufO^F6X`XANG$}_~nxzQ+07#u~UK&aPRT~Wl^yK|x_E&xm zd->GON*D#340FaVki@D-!#TTdNlce9bd%iPl#) z*mb{&7wD5_@7!s{><6bZyo2kg*P&vC{97EQ;-_NC=A(f5&7-|Jl%*5^5__t%+k? zy?b!|3c(iKIoIUqfO*k?QPbahwSF>LFvq}JGsdPDY9_10uH|G>)Ux2X^R z_x{dy>4`h7hQ~f_p3$pKCJQYOYvn`QT)F3;81ewqyu4T)Hg;dKi<}2JXLW~^J!kuSEnkqZ!L&D^vlVbiGs*Z8Jgg$4YVUO5+Sgv<2#ncWu@MyoQ&KyF#(VsFl z4%7zsF2tQi24Y%~Gr7tKv5%4I?leDS#M0Ay3A=5VubH;Mvdm_RvG(|o>PN&0QEd?m z7#S}s1gxF2N*5@PP(9Jsy%RKQ{bl;?U}S4eodw|ADXLdF4^*EzSA%P^$W<~dlhw1H z8K>Q$@%B7nkpG#}dMw5kYMVdULgPyow6sO63O-r0Z!Z0lHtJp|F=r;Pe0dw#n|Y)+ zeGn%+ZG^5eTA8PQpI$zEMc3#wZ>i+0&!ZYXv_0UHgQ#gl{f zkxPiULhokoZHX)2B*sOoC+OQ~|MD3tYn!1F8G5sy`bZ1kAcvCxaiSKuG7nlDV!*zQs--)tY55O!-e2ZX+zTnKC!tVt| z#LSg#V={c}U*#l;%fvZcO=m+B8Ca!WsJQJm*H}O*X`J3hZD%JCF7e;Nu!1){S01vb zbNCKtk@7tym>Jh3_=iffoaedolA^Ykl~KiZ66G$2$SlU!J^eDP@}&h7u-b;0>Vl1h z*)5f9a=K!@0IYDqwpMK4Pi>swheIJc6*uu#N~7@Ckc~+XNr-mW64nvG&=u(ubcruz z@-nZMq8L%uS$^A$ZfyX``hu|mZ#gTp+8zJpW;GW3QSSLC3>fzb9srWr-I}&@zv
      mEsz-AT#0pOY5(2}IqoC?Kgc#HT#7x3DA7Dc(38?w; zyqx#4G%Y1t%gwv)a|FUGlTa2BGFQo}Ime(Fry&B-C!8MM^Dxe1KqCkaWdcL*d|@c4 zfI+oXh2~TNCO>FJY6S*|IL^~FD%R&6rRuw37{)$YQzCNGwAFooeqPJBi*37tD%@Uc zx!u0Crj&~g4=04-;UQ$te}8>_G8CSL6SE5qmU@L`8N`fQH7^>cfxYk{_4?{=GzA%v ziP>=@3H@-tcI(?Ct8G7kvl-zqGG+jk0Afd$I~%eM!s4J>i|@>3gVq(L!24;6cE z02T$(<^1j2*E5(0mdMyMuIxmT2sBf*RzW_nc6uDbF!&z12ne<69OrrV0#@;!e6Ja+ zUe^OxsASD4Z(D`#3gmGBU~A3$24JtHPtD5)4Wj}e_U?+@P*nyL-qHW<;n(SZ{Czd# z5E6=Aubd*ME$s|InTW`SFlP|<vM6I_RX_+eugmxC`x&@gww$GH>-qchW+bkniYYkEKz=$8 z!DHF2=3Rks`qQru_k$G$7|g@Oa6vB5`(A^OaquEAtJ;lsG;hyO-@i03x$Ail46s8l zp{XiZ*b`bix}E^MK+9H(qEx^XVFE}x2Y1E(bpiDJWAPUQ&freJ;up*|bp#ZDU zblM+Qun3CttT;04y2b3m7Fwm{@x zJEXtDaU4Im(kS}LwqqJb%|H!&6e=%cyra;#g&I3llVA4us(v~|dtV84zKVMWhIL&v zTup?oYyXcGnrn2}Ec9jHj@+FAg33$SyXGN%FRrz#>TG|(tJq>kH}`Eoy!z0iv31ut zIDorqFKI1@FB5@@u4V39p|In+au>w8e*D`DbA!PW;It!Kjsf8j`CS83@3-O@)*mX? zt-lLb91p?3>aJk*V=W*yLM^2Ry`N&`A;R9>-G8{7S(?5U0A-LP_|~)JF5r&VT5Cox zvA*>?Yv%iFWJxIjDkE=Kx-+>t_nLRZRvhsa_xY!y!lEQCVkrK2*IqD zn)1sbc~B6~u!3z78UU1H6{^d&FH6zwb_s_otG`zg4sZey2_zs(yOh=n3B}=IcK&dH+;K44|T2Mg@A4ZuT-f_jNkBqE9&D8_Rvu8NFUu(5yRgsCCf-I%ABK(vm z*_sjqq+}p5ILG{YzR)?WFSaJYn|_O<27nE%c|ucY?Y>y8^k~Ii7^+NAgT!G6OpC3` ze3=6OIe3N^a}pHL?fLWL*Rul5!TZs{Jepc%MU0LOrkc71s8YO3mx}@#&J` zdl;{gFuX68vR=Sgl%d(^bpPuwA5LRXs@j?FIn?-MZeRwNx8OR7+i-A0MAC zL2iOT9W+#GRwGk23PY66$fgdeapVPcueBRSg9@}tS8u5RmdsJHefeJC3GAGIJDcfG zF!lPz0BZhzzn>}yQSau5hlde^8~vW58e{wIX_>*l#F52j8oa;z?c28PpCj(_V1#C^ z9S9WV(7kT1;>>jW>$t~{z~`ug3w!O;9E{rSO>n@KWYAoLH3#a{i|*4y&e0#V-G1EO z#693}wXEoHe>%R8AL|2mvsvhvm*)EC_q{bcB3?U+xPD$mS$pyeK3-t2;5YpnbfEUC zh3E*{#~u#k_&V(CmV5?Rw4nj4AV=g5cL&@AQ{F_rcFk$GCm09d{tA01&QoOY{yry6@RBv|)2S$@fqD$9oUrQTY8d#=rvA{Y7oY5nOj?vZz4l zPC&^yzWL%(4_!{cMsNd$_f*s4qlZ@F5Ih)pH(d>YxK_<%PwDc@!{DP4elHc-^=X~D z=0J_bdy%{b0kV~BrFY^zgPF+-P|?n< z7BvszIQo4U3dFN#5(!cj;N&YjpneEcb8}5ORcKXs7?@ZJ)XJ``T>;p;z*=@KIV&V( zOqu0?Sv75WFMF=#`T26rd#SxGE{;=$gRlT0?6nj~O|%UK90I-RRE{noAqfCw4@cY# z&$U^twLyvk4tgn7?leuGIk4JuAY%{_F`Z?*%+i(|vjR+n0+n^T6JZo>u_SM1T&C9IWbI z45>694qQZtLJq77vfc(|_Trh91Q16}*`$-b*bzDMhEmt_ylyQE> zL$1OjwDsKY`T4vpnZZ6pgeu}oL9MNnoOks39*uu~`jVb-&+8h3Xg+V3=kxlMS}_6& zV(=2g3A9|c0uWHP3Hki^`M1ZN1Qpdl7&)BE8U0Mx>ZKNopMLod_oMd$)!I_6$)Hth z`R(z%V;I+5YD;MQ$`M?0UY@^w|GKIlV(^_|WdOsFpU->94T!@7*mo?ZkP^W$dz6$q zYMV(|6T=H@E0!~M49M6^##sP354x2Vufv7!sxZx*jMEeZ9wnUKpXPCfr&*r14LXPN zTlsRrq%sB~Pwd0}{oP;7@}2qNG&gI|>f|Uhm=C9$o1^j%T~9hD+)BMscD09dMsKyt z93NN~MLUE#ZzFRedW9B!JzDE!^vj6ib=*_s&bPCMP68*mgNN7u_vTsbkPs_iP;<>S z1A(noePNBma4oP%8-Uidxf|Z(Z53$%sJ;E+tMMSiF0Isx_qNFrk>dIz*~7$9I_C*z0j z(i+GO=qw}6eWT{!p2>`65 zRJTTh#7J;7#jb)0pcq8J5-B>7NMJ3gH^a>!s;W8d2;1O!2qBU;BuG8($#;;XU2?gg zD!6)&c}J~4E!l?J$O9am*Svr=DRWFa)^;7yHZ5gO`Pou_-j;38hsm|$NU75$1n{vs z0JSz;OyRe|?d$S#0GdE$zj20f-;q$cG+>xW08rV~pw+q;cJSEFYcWEoe>CX@!GsJT zVt#X*_g+Jv^_CoQe^o`#P)i-dINs0WGzC^Ot+|$rd9n() zNDvXO|MjWN^LsrDFAg%W06dSUy9vqnV>Bc95!=(Qbzd+qxQpOY6hPhf^Y`;sMjt$g zJW#hS2N6!&s#otb4u9tDujh33C7(hmd0o#X?cV{Rca>qV42kw#)|9{zBM`4n^;0D^OhH;mT>I#|v z)>aPt`M0|V8eIEB1KU3NY}5q~9KFTG{A(NcHUbl4Rt2~Z+Xvos4REAbnXl?N0hk3@ow!MYduf7U$QUC+I0MLqktL#G` zpx?FzOTFl&A=b{bxspaD#@iy^AwkE<)E&Czg1qm?QORNA(l?LRN)-qnEF`HwcOk;d z14P{`JwvK?exbgcMAN2C>z1`_spI?m2OUSmfdo!on#^lb@G!b_!|DOMHD`^W%?d7c;*uO31{ z*}q%O3qH%2^M~Q~)ReqzDUVr4Al|h zMH&N0$`J7$THLxU=jDgTcdRP_GaxByQo?W=p)l3FE#>Qz2drv(Slzx||p_?bplEjxOc@?_00IEb{qU%ucjOx;|6U|0l}K1*h`8d|8xZKwbtyhm;gh&DQ;JyW2rOM231_a zr=|=uBB;q#rt^?RJ`9ZBoZd@GgWIRM21f^U#Q-=*<^*O}Q!3{mumsJ@>=Z-I45tO%VVQvN`TSp#e#0{H$$_g721TZASp9q*HLoJ zL;#0-F7G(tX`0UCJVjxcHF(>r55+UNuJGMzQ$lpw`Cib0gBOBTWmYs01c0{MQ4lJ` z_qDD7vF5Fo^liB;4$vK?79$5)_uWI32M?ztQEI{womy(9W>yabYt|yCu{MU}CAGamP*LkH#ql6sYAcxG#to3Yo-xi-03I*j6rQm@Whx&}nQC4& z1J5bWgE0Hn*fVUXL`6Yn(|hE6`GBVC;5d%t2+R&-Z4`qX4&zn5 zR(!5AO%B>@gI3jQG?*pZwWzharIZw~;#&onTtHD!AYs3is&}XTvMa#9)#r)RdR~*@ z{B+I;^XL;`S^_dKgb=535SDw`zUNX?+frW7TQ2b6DZaaRWn(HA_MS}PAx_sqo}3fz z558*41EUiJq@FShhj?&1QlU_{_p8T0kQ7O-yZ++eY_8n)}-Z9!9$#J z5y~jKr@gH6dH??P>+VkXRQr=fW$@&?jUJb12H5=MU?7QN_n7!c1yS zKDC-JkCri}g6-R1-w!;FB#sg6^4IS-;0zRnW>y>>kv@sX)9 zUYyDm2V&4cuaiRHaEf!ca6}+8be}@Ja`$_Y#WWo3@0Y;RZG`ky0ZK+U&=jsx60RK` zm`1QJ2+FNrsAJCrw$|sY*N-E(R&O7S9`^*djDq;bE-&8VVET@mfv&>Qtr@!bhf_1{ z(@JMn)iyX`_nU#SCn+>AfmV7?9IOoKmy%VvwMwu-5RV} ztJ+k%V=Ni07{HJ|s3icz0;h5C7-Brrom_EzqN=sE#(^Cv)H+gmU`+)E5Sw_v;OawomO(?%n9IZ z%X?D5dFqcs@g45X+6p|t!V1j_<`n%HJxVT@=cjL%#Ip;?-@i$Wf@-N^16YUz{_!+_ ze8)>-NT4WCmp=b>MoLTGw_1A^R8=d)gM1_ufX9&MS}fNK9(>xeo|nyt2dqzPWJpC# zDOccvhvnV~#KVBr01vcO85lmu`PrnWi84~4>zuABxE)>dT8{}m8La=_I&|T6cl38p zMZfbKM62zoDv8w@_@`ecJg2X9<#C*bftZ58sseD$($oK_+i8l>lAbT$&r87lB zv-tp3WDse}BBw9~!IsNb6MFzM;xT{yUzMSjmcReEf7<5{cN20gNRW6x2Yp(fj|u-X z@O?ig#CN~`@-W|%FwC?84psBMuUQESdAJ`#%OE({8Ks0)iUA=`fBs)i{CJ7u{r_d) z{QYs6r+I^EN;$(nJsZ4*Umu6VFdPOj6_^=u$3Acu#u9)3@v?p2vwfOlnzUKbI;Z7v zdn(L#NI?4QyN7!}K$wB;mp?zI&GNR-z5Zz6)&t))?7dpr`{b{;IDgmDI$lBjw{M?~ z27uhn*qhP1b=(i7;H@##+>Hn44rIf%?jeK2&+42bG&H>83bc0E@>~%jSIx`z@}t{S z?E3dBb;zGR*RQu%IHT*R&^qd^9S}(|fUH}(_aIFKZBVv$9TAc>C_4rb%s{0l6ZP_xVuRwr^nX|YfYP#nrbofP&3sAsMhYJ*>SQ8slX^cuqqbi?`3;@e%`lK$pgU& zI(A23&UIU77}d&k77EB(x?M9XEI|t#Ab~y85C`8ejybhb;W-8$6?Li*CO>fGl-A|> zT-9p7yyCm*Ya@An7DVzaf&rzJ1S3>e3Q%(@dWP;>DYaHNpemYLMTHX*4^}@TGpkfW z0$E<9F5A|eX@RfJoslk2Pg?`#8!83y@U%Rait~+-EhI$)) zTdS%KtVGuEbJD8y7Xqw~oFnVBcVYvWSbQ%778pp`!)gV)W@@c=ir)sLS_7JE=f|gu zmqLMtfa*sN@dHN&Ylw015}D!1`-lc$sd?Y`3_?Q8RaH$>Zav8a>R~l)O)C+jmbB#0 z-+uPwK(lCVJ_y&A; zBrYHWunm`#=9ns=bvv8*Y%B)}BuHNi7qAZ_>I~i2eO@;S12pftd$7ph37G%%{@ydOgy~-Q_VDpxK=Fn>XI->ZBY;WbI0OJ{ zno>%WG_BYG#mPsHwmq-weu0PSvTb`62(vDUE-w>^uQ_8H-+%l#kK&jG_R@wVfHMZZ zi$lvu>WC!}Q`1_C6^fO{(}z#*<^HJ(ORc#S9s)VTZYl32!TAED?P+xDt^e-rRY~>Yjmthm(jy zGljP9Es!1e3fS6Bu+1It(i;`;&30V(rp@VFK*CGlvzK!eM!znu!S!ouukoY1Dl3g+ z9CdSn2*wt{{~y}^rOS~dNfX6B6%kc60~`pCM`l${SI;!b8FEGb|DVClUGUs{?mW7u zsHp$30MMozOAv~#*E5)K&545}(BBHx4A2WFwx#(9arB)Z38kKQwc zh`b}+e?S3i?SR%MXnC~a)>2xkt)UyNN$Xm*!8kbR(?5Sc|B_mpfufn7mD{?hwvtL} zb*f_)pdsu2z*%0%?q@IqB_#z)diu7mTW&il#|w{oF2&xhjx+Zr_0t{H8Z6f`suV+T zp1{FRUL-^sUfXD;?Hn2w(pehBMLEEA-ImW^p7QgB@btW?x)$a**Wd&U)RkLwV8D5l zEf2Am@jK5ExipvoJs}z}1AazqMUyI8hA!2olv0!Gqas%R*Gpd4)d0fz04?h@*h9`S z@FMx+{9&)qk~mt+O*)>u4FCF@{WJihti5CSJsQ~$%uWVW+eXuQjE5UglmJmvkpcjp zpHAyGM-f+6#G80O3*aNStVOMI`u64FdN&DToF-Hp4jhC@Jckn8G=<1QU=A}xfdbR* znsNiCKGhCQtm|fu{b*+Ho7b+mdhw|1)7SNX{wpwzUg<|I>*adctN|VHM?QbLKc5OF z1qYv`pjCr`G|T1gdJ&s^SudBTYg?D#-KU=pW7Bv$gn0y4q9W{@uArxx-R0q-w7Mu5o{=U9fF&is zO@5xI1Ah6-ySqsm`}yvlE{gZReDDTsMN8VYT$BUgJjdgCwC!u}wIXJqwQkE*m)h=W z`R(!PdTn_*BBgW%q9>$OG@PGr^`bn*)BF4LkzUGsx21*!K$t(B897}xH_dVOL8z6S z6f9AWAAkPy&!K$1ZVkEu;Q4p})bdiQ0_;)I*I)0E?)_v!=)H9_7{-tHs*vUUxt8Tp zuWh*&q?15#XxI0bf@Fq30BSCU$q@nJ-Jf~UGoj_q1Q>xkx^pbUk8W_?nCbf<@cdsl zp|8EF1~StB)e8T+wpU}_~j0W2>P<#0l=0b0|y`GGOnGBjD(n( zWq8ZeAWjH_{jiVorWHUKmd4N_IRWLa4z)s&Tgo}5Qr5I>+GND<)~&SGEWiocw{JLZ zTdC(jmMF|_f9%$@m6USY^5F>Vo$(#=FVVbbMqvdo3tCAfEk(DM)@$CXq1UlHATL7V z;UE)6h%(cLyZ5S#ptfub>O1~U9HO5>oTe~r@1R;nhRH0B!M%A1OPrANa{cYg!*xUg zb_m78iK2l~lf>TUX^xTEN`hvB*V-BRvQ{uFn7v1fQyByc0HeEhWQjAHC7ha~ibvHY z=hC!^b+9%;s?8<{b!18UJO>N~CmsJUBf_xn7^PRqM)y z*Kq7(8@^-goAL}w+B3||QfWC~A0MyD7lgZJ(Anxh!%fq*COSRTj za$UCw$X0=lHb`xtrxWAy@GZBZ6_YTP4QB#U`j(21{@qV^hm-vI=Q#>G`}y>LQRcf@ zum$D5mF<#pwSxr2uE+DoJ27VR&XJ3P-c&WqT9f9LuYdo1S)Ow139U92k;tlPDR-}y z9iHa%yW=Fp$~-9LP3i_ziar^$Ihf6}Tz zGEWecvaJ&hL0+DJk|#YMP!gCOsE<%U>OnBot{^Zm8C!$E6wvXu+o6N(@RH%GBgO0B z(G^g(*AimSOY-a3rO)}^tpfS-=MexL$Y^-Sd|!n$43794n52<8e(vUs^9>NtuElag z+tUqn2)v?<{Sb2bDyV-~=Nu|7JFd|%0FnjbN%Hcub_S1IRx!c*E_+; zdcPsafqv5tcFf=3|4WziyKO^%dnY%XC*02V8(q)u@3YsMgy$*D!D)vntQ$m}cxGbm z!>*W|1M`hq0K)LFcl?~C+3?O{SkGqAme#eXm6W$!q5P7gS-0kTlbmx4NHza_67BVV zf0WMkT5Bpf4O2IuJ#P#+Od%k8@Gf#2CT(d+*F|-!ZA-NqdGwCrdIUKV$6%mgqvyvH zVk?Yp+7QuAh60=u_Qx2f*@HZwXgb1yR@KJUMwaH78_Ih5{M+UFG+FNe1Wh~|>KK{C z?5Dfa-H{b-)h#(eIHVMiAC|1MN416mWnOHLdQKSNX`YTgK((P)Kp$Y5N@?19^=cqR zArkQ}f>~xKXrWqn-3Y{tK2Tc#7>=KEYmM1;E7cLi7$Dv|?%J)<7^Mw$_v3<+ahbtKZS`p} zBIvrb{P=KL(}ZxB0p}>Z|K(C_F>-S}Oo716<@56NZCiGK+MF+#6$J<^D0!<}0;VU2 zr|V_W03HP(I~LcKr}%*-%G7g7qNsUUm#vNkk|vx!d^*Km z<2=u~@g(M;tr4*Tb(Qt;VND6pNU(+&Jh9eoP4a@5o5K0-)BVx+_Nv0yF|3Z6d01f8 z{`I&2cA3wL7*tS8scH~lKF`xU6IouM8#sjdbjSc|%>WRoX+^sHb-Up1e6&E;>be1N z)1+qV$gy@c138)Pd_Q{!ps7$`h7yAj9=|1F0J>h6$sGVNI3E3)W1wCkp1?x^rJDy} z+RYT^0XWhQ6&oqi>q4jP+Q-j<$Utv+*mkRP+Uq3o`5&)yyM6<3kP&u$k^Q)7ojK|} zDC%#yL;D%&_ujXC#N}P9VRQ~}XTHTk*GIYUj}0b%c)ZH@2z#10Dupj6+5ywg7pbgZ z#m%)~&!ouR)TvpSiKsj1o5lmi;oGJt_DlpxW;OIDz5N`~C=d$EUiR2+)4A z+%UPxvy;$^nb!X5mxD~Be>X14_8tF?j@dhguU#K0f(?<|+|bLquBF^`B`Gj@5bRbN zwBA}P*-fofZ3oR8c;xv+mNb{7ttn8R@1LcGV@dD&c9@6wpa*-@ZMi(HNsYAB3J%_9 zRT$u0^W@nxNGf7PH4qW8Hr+!S2;Oyby#m7iG|zG7U{+mG)mn#;WXbFS9b#6jRoi;` z^7n5~Pc<|%0~iprK2SgK#K*hyr~7vYJZdQ`vqa46fdzTFWSj#!fC`j^%>W_+laImA zhw~f*+P<@ET$Y?t?yySMK+eE-2MN*7>=nLN!!{w^qA}2Ql-o2ZtlGY^AO1no?@229LfjS7)S{ zrYU$~cBsUABnLTjP&M|4G=VkMmeLh2$~1fCi7&pz`#*g=#d{AxtwQaC&vCs?;FhkB zK$cc>_Y6zz3jgKLr7{Lsw3V_velGEF#B%vO#Rlm1$m#R9HF>E80I~BY{KHl@70CM# z@6MBu^XbdBEKBVJ2hf*j7t;zqdxy0yda2OE7D=^SFw~q8QgQ)YssRc)|M@RJ9}g78 zp*Ki4`Z>-Al=Vw*rEX8lw{4$e-gS5W>HR4{&v{dhIYwu#j8;{8#KwC0mb5o+hyeH$ zDQHb8SG*`!+@DW}`_qi9GVL4kp>oBIV+agX^osoTpZ~VaI2@XRprz#800C<2oq5hv zKq}_X=hG?DaTj-uAgK*a7o-L6bA`Iz%Hub{#WbCYkL;wmVQtr)OsDh5UpM&qILEtb z63bpB#>3y-lK?Wy*v23`g2zR74D5B(F-rTt12th6gCEs0`$XF=vB;l6+o;v zz{I})jNMp{&+i*ADZsMpMnBK7=eIfLKP22bc>6&(us+KC14=``i;Nhl6j}fAZT;c# z!*Z?-AyUI@jcmaWvd0$?36TRDK=39I2Xdk|5aqX253e5T(3|-FeEXlB=q_Tje+%$7 zn|pzN-d^6zv2W|kgq&;8DhAh~MKgf#Y!?4o!b+{HY8@zC8dyZf=vDzHtxSNLYFk!t z$!kdlxCr0j5QsshE$Dds*1DNd`PR(z6Y?rX7qT zp?b~ac_Q-j`FuVd;xiN#IDA7wemf6*Jovj9;n0<*;2jxiA9qTIPUHCs7|??5Sb$W$ z?6a$NH}G+-)scjcjVQ^esW-SEwJ>&c5xQD$+N$>Mv>5=$tR~Eo#~8Gf=(25R*Gr2L z0zjhnH7^@5bC~X=osU!c_@Sxl0-%1G&d_ybe>{qV2sj z5j@2hJrQ;{6Vld=QPI;{5bj#=oOlE3hS=|9I^Ru4_w7OFU;cEOD0+B6bJO-SEt}-g zU2%Y}#5oc$p`yUFE|<$?+M&bHeEIFK|ElN1bolTf;b2$6C1ZWqUeEmqk5*I95`Si% zfL2>tmMzuM7Udw&r>u)A_{fZsils8_8ko^~Gqk2CTY{8O6cO?M&;R%z|NMRq?uHHb zhZqjW3D>ngJzX!Cua8>>hUQm&-`;YVK?7dm?9;^hs5UQOE!J1v4JYWC%>$0aAZx*d``Ffh;VPHwN>W_3fiX5RE zfH<)NK>@T4|Mi;1gEi+bzXC2E4oi$j?>&*34FL(_`TUpZ!bcyOSVBh+@eutS9xX%9MJ~y`^WdfUWcI%B>x^04P<=>j{L8V*G)h7>cx(| zK{@)JeZWt!hZ!2zi0*cHW$)JUEH5fUQUl^f89})l$T`4>q}%VVi$Q+`t=lzL-L38V z((1$QdIkw_1U?(0aYI+<)%%=Bek$`CfWX}}w_(|8&b^e26&)P{Q>`Tfz0jz7DhR4o z4N7Pt?9{AjUf}vxOVJ*|cZ#lP5U@7%B1S@O)QmkBRUE>s`qX5A%2^v!0hz~>69-|3 zYTEcCz~X~e9Z=-0Tpk}TDQgF+br%o!pN=iBPf5wo^X!>X`xy-oeqAhwQB2Y-z>p%IE3=0ZV%U|r2*|(=t!!ynmgb@%s!4n zk*JoMAscH}uqrC>NFMOw9V*mJ!Eur^Gf#)(d^kSq6f&Hb#RK-bDv#Y34p7HaoTIan zo3aP708nCsfdwoL1m)HovI5==AX6vG=-Rre?mSWJ&e33cHl^Nw)O@#o^IS7+wW)Sd z>mU#_^}fSp+Hp&1!Pbx?d;_63!z7xok83I3PsiyLu-$)Jf0~{ipOy*`e?GjE_Hd0Yp~ktmaFnyy?82UDP=;G z>HYir`5b@qcKnBrcV5|%2Q?}6?h~$0o)LV6ivU_pS?^?)0HlooyL^3r44%PIv-0@s z|NMJ;YYyIi8H-G?^e@zFZ&H$EVhUKS*m} z;^X-=&%)wmI;SoFk6(Q#OaT0yc+yh0(kYT-79S~m!ga~jL}+@2*z(gHCNi~N4Qx>C z00BoNaZ+Ubs{Hi%3#MrbQJ7^PucZR`Y~kR!t2kfkGFOSwr-N?6gTj#u5Kxq1+op7i zjkj%X%51SZi;|zM*c&Y|4)VGqH5iFAkLn>KmW_OUeL?>6h&dmN=)t` zXwQn(R?1dLI zy=Pnt2o4VR`}t?&$PvBBpp6V~7{N`uN~PPQoLYy`^J^eDb)y*jZ`C?q;aXn5`24vW zy!D1^yAkj9f6%T&_R77QobSjLo}C}-jUyLsAQJ+}y6eNn{ifmJeymMHfb9}xXVN=LWc$xT`vIyI_u)Dekzb)>I8Wdf@=; zs*Y4u8$d|jd)Ir{RxV&@R&9-rJ`yaI0s$KL7SuZ?6d_P#s!93hI{}_H=E%Xb1JE6q z0c{;{!j2ifqeZS(;bZn?jH_~4pVqY1Hhu^v^M_wPP`P~FlFISUS7Of$4@`&V)!;eG z)yT7gh|vOt2-D$-HqFPt(iRN>m9ps1r?pzOTr00l3lQcufBCC!dCjTq!+`{hW;N&1 zfku&Gc}nxWLyYu~e@3=gr z4dN|buRdQN_`D(#9FcPb*Smw}r^kmyYg0!Nz;TXRF4KEC1n(sbbQ?Jb>e{WXJ?G21 z4*nKA0L!^n576=a@#A!iKsmjCAIJa+a6;s9&Ue#P&HJf=gn+t96gT^>wQOC0a=9Gm zAOwTeb^ZI-FFDeu>7d}iNab2vZa|!42qF%EC-D1E?=GIFDXDIJ+0On!n>IKQxj02< zDQ}P2h(Z*!tjgpkh@blL2%xDldd-?#D}lUB|F2IU{(K+BDZo%w<4!OZQPSmd{qnf1 zTO-6ne1szo;W!^A?v**7Qnkm=>}2YIi+998t%f0mF7p(8_*lzQTMKaxFT!}G8u`H1 zScf(T%xrX;95WN3PuXaFSdPcT@gQEDqXBcX2DDb_?l^OY04=fl=)E10VgOHvc&Y67 z+-Q~S)7kr)($iA{FwMvLFlme;FzasA^yKjA@YhR8TUsK+vm>X@wDTop0%~5LqM@tv z9^l{wrXVI72@{KRc5{yf%o=FG7i@$vejE07I~*{v;Rh4rxheR&zbN{5)xUw-A0Hz; zXP>vY*U@3$v&aXv%RnGULw|D5j)t07@77-{=-%AL2kLSNm+hUuZXI2p1ub7`^1ig! zUbDd68&nD@%x-ng@2(F3z`DESDPDylM-DU~L>e8tt{vT2r8xp#lObIPk0|CGpt!Lh zZ&$j5scv>duH#kMdnPIl+>OG}M7u#v4UioW^YVLm$7ngNzKfxEs5VFwb52RYy`t6H zTQhjynsqfrZA9ci+M2JeRILDEtI@dE)N0BgSgU||KTkpOvgCob9aDnQ(S(@1Lr?iq z8nhIT!iVN}q^@H?P~k)nK#(S`vZo_F7^+P$ajL1+YVB4kc5(jj(-F&WUzZ&HIXqwr zEC^5^rL_(hMRJh})`9MI-U%wG03ysB00p-p*a;s(8^%LVs0GT)xn3V^Yq^#V(ry@8 zpQ%}IjmQ~{w3V`}~K%uB=c?|F;IAPCIU}+U#b`q!ANAS!;Z$$Q4In^h+`J+A0 zk-7pNMpe5Xoupy0+KmVf*nR6rggsO%dIO-&axgQtLNeTpZzFDOLETJrS{3XkVc~%(BkB(5R&x4Q9xvC1a5yX#uvB)| zrwe{QP4O7A*7-aIstV^Em`x?dgBNckLNpTfK{=PkLD)r*<~3JU1G;H@x;!pvx%>5? zYf|Na(o=4L$bbXGlpP~X=Z~M6Sxe0ol9nm;ZrwoSgr|AtT9+*=xRrpOOZS4NwZlaQ zOgkFTnyM8)ALaPd|NVSCL`JI`p{gAapbc(PUY6@)&aE3UMMk&aXCE9fsB>(w*~#lJ zmpM%g1veT6aS~=9qOVYEpu4j!zz$}-%>Jn6sRLzK8a5j%byqF5=2Vu#nlQbekH^Cl zm>ob6CTWJPhF|ZGbHgAHYt2zf;&hkcL-etzX9skYoF3kvV%1i*MNP3x+kE~Rrc-z5 zicwtg@f-tCE~n|}nV1|iOdI}w0V=fATyKj0AdfcG>X;mn3_xnHAdnkE(j67F;|EEB zH!cCjv~!%ETTXA5{a1o4KRjN&^@jg@J~iRyR0!!HUrRM{y~9TLZ)7)sp*IDavLlBO zRIS4iTkEw0hEZwR&peVF0$^<{qs&Y@{h*D;;&Z+9#ui|7*b7}@9Ek!1H*zpATpV7< zJV(II+?@zeRjVl%geVRm@IV!2Rd_J63Sop0-G!ir*0zlpJ4(t9KsWRTa_j(pt@Q{v z9xt1<{kKTWgD;?_FPS#0qFe7U>OFgXRefg=m-ieW%h&$y;0*p4;&NGY9Natru(Up0 z7Lb>EBFD#2p6Z4$X<(>fMJ=ffKQZ>8b^G#g&CsL@gxUW;?@+U*MRVI~c`907B+7Y? zKEgwA@pbcivM-TGqlf`T2@*Z5w6=PY{N>jRrT_p>kGQj+fmx21e3EvN|h^&A^OFl3l0EdYPNdbuXQnV_jX3w$f<=e0S`_}|4-Tme7e@Bz^r!yc9 zySjtZ-plpj%fod;1Kwfs6EiT~efn@bc!|~;vH0k;H3ilB_}72_-wgmUvquGr8r~iA zzrYFV#Xp71G5&On6LFVIC!m+KEjed|I|TxoGX zfaa_G3IFB@#CNV@t+vj_RVxR>mXqQ=~CAWEMI;D6ARY# zB}&8e>Eq8>3AT&T$c2$H)v@&QFuz}Y6x@S!wKYTDHqF+ z_Ama^FF(!Ja+AX}i#X=!(OX%*{_Fqv^)WbX|3{xc{pbJu=fnNG!|c#C8^8Nc^QX_3 z^5xO{zkN8~b9nbpm(}Cp|NX!H-ATY^90JEM;pd0P&k0Mwt`1J!T5EZ| ztW6B@6oi?fX!!{&!t4ZN$#x7PhIKPVZ!e2KkKH7_2?(!?aCU36y?R3jZp86d?SI<) zqSkkXSp$?tReX0#GuR6#nSj0e_nbX-BkZmZ|AsE813+vY=>4s;y6$Itref|_Y{PEp zl~JzkzVF}N@vDR2hO!Dd5R8;TN&vbI10h0pLrSJIc7n$9XWy`dZ+~#lu-PBqp95$} zW4o7EZtMp4UA1|*;leq`Bfx6*!=;$kX5^#SI5%(xP>Zy!wyfQnkTnRi_aagnJ+dLk z*u*mnRI#@M;i@*T4DCbqR$EELoH?+#uDO)fMWR+ix#4|SVgwzgw4}0AUqQs>sA{>F zoi%O-5Xb{&!~l?o0P>CoyXS@CX)mmzKWOv=#1#Z$@*>QrYG4PFz#@2T zgHd2r947{ORQqc{heJSU09csF#$MAgkbqW=;_-Z%m?U!T(X>H0j7_Oy=ZJu&d0n>BdIOUX zlYW`c(3!0CvbHM~) zQU;s?Ij@(et*$20;O38i`G-GE$2qe0)<8U!5AdPX)%ERZnI;!Qa4guiYeqQm#9QBl z!)!Qwe22(DMN3P~+T=LFQbJ&PDs@)0!#+Z}lXLX*X?y6XPc!vky#vfXzHTVj4?u9;f^LQJJ%f1}nj#nY# z&FW1+H|d>!H?zb&GvIC?AbqhKa63H@-Ow0hjE*bNal7d+oa4fIx{H8wI)x9Z}4vfoSoVYhn z1h?dn%((%t`K~SdCNwMHhRA@7kZV9|h@&}3L34~NT4o>60V4JxI|Cf6Lw#B=%hL)8 zB`Uh>+IkaaF1r$(*7fV-3h$%=K)GBmXK&BW2wNy5= zEr5^l4ot4L?s}^Yh~!I#0O;CVZ;TRF0V|`l7 z&`{y%fmVh<))JFF>bTMMyA1RSmkd!hi=j%5;?av|gIT;Z40^2-})&%flf`U3Tth>#cWC zht;%xwsqUY-yJ0!hg2{*GOOk3>(|GnBY+$cN5>#PACJew6r^>t(o_}VC`<()#*uZ^ zs#-aAH(Z6(07MGs^La`a5XLmoylA+Kt!4G8HdRNX7*m$V%a&@!1UcS){KtRz(?^-a zL#;Iuv)K@*j9if}%aP!m7r=m2FbRd|9Zx39)Pzl1p64-E&qm2;DC6*KQH9ZU*6G`ob+y8|G-;f zgh&FoI~_eYXU{Mc(2i?-)1y-irN1{>BoSb{svC42Sh^zqj1a*R`sgZYDyc-w2jh!??tIH!E)^c@)8)HMFiuc0nFE8Nkmj_qLX#HoF~kFe;iDJNgho-~S(Q;@hJcTse*Wph9GG?iR;bpJzJ7jq ze8M#O`(NH4Sn&vb(5K|17(t{vQ|aW`y77(#0f+PX=wiT7b)xDorK*R7IWknM5ex;| z$kbHJaw!V1kmI50jIpv~qCgS;aQbj}H;pz5LBfZBvVZxXzcLg1>2R7$op1&prvsCC znP!%Ohc>`Z-kk+amy);SL?VR93!h^t4@(o_>5%i5JDgCrTID(&r)jYFism+0rvOTM z`s@1exbfkqKiz%MfdC*_Z`<DS%u{r^)wFhnpkcOhP5{8V zq+B5`Mq(&x>&?iEKcDW-bIgTriV6u^Md(j?wQ!hE^F*uwJCyY8*Go#JW0KRyfBY}M zd_1vdQr6zd1;9^-bCz;R`nV<*$dEW~r52*$VpHHr;e};3U8|CxQ1lYdTD=4yUB6iZ8+$Z~}KzopTP3 zUlGE-TVlt|P~3DmzYjIzgYNrC^25W1J-GjUxOyE4?H2Z4%|&4*3OIAOPUUmk@#Sm) zjEvlkQ8KQXZwcTZY&48*2)+Ei^7{K%2!Lal1$BKY&zy0mkCxjR;0AOwK%>iPW4l|4ZFARs+x9NCX zwxkbBhk|AD(vUY(v<5CVzXPC84dv-_1;_2s7fM5$1lrp3@bL4Dt!!<{4T2z!l`b7J z6qf<N2|0Mi_2?*JzRv?e!8!wSnlgaE?Q2m)qCJTxETvQ@yps6W;YxL^cCow@?k zQg-9n-mS!WKF+=Zr3SRx-~xz&UM&nYZ4kScN#j@srhpv*I;JV%ZL|1gm=Nz?V1IZp zoLB2`{`r#4M4bWgaDRZGBm{?@+Nca*Em3C%z&L~$nOp~4INeJVjq~^SpqNK z*oTwH?jO43=Bf#1lgF#z2$mtJ7ILF|>M3Y0cR{TP}bbZ8F{m;{ae1`4~flN)&09 zTdQchzL|oYV-e5f9RNSY5Q1m0XUPjfq=_*0d8+6}-S^7A9$En}#_hJQ$Mfm#AnmGb z9-6N)96+RIKpX3oW7=6R&N-G2*I7n47}`ZhoHNr7H+mdqHs-eL1ZLc?kO_(_XrffovU?d^VM?arWKOOHUIZOZ? zfn9g+F2_fN(;TBB5O6-nY4Tw_26hN{F5Vwv zE{k5$w-8qa^SQ%GjPN^cyThy_9`4Cz@B9W$X`>@e$Kwn`3#DAvMw1ur4y{$k9kF=> z$N6vwO+4#1Mcz8RpW{p!MK7PP$>Uh-av5k0hhEd=>u--2lP1&P>5frJ%ut8=WqbH~ zfq(z*bS)5zXa(uLy`Q4yYxi zhb?anU_3UKNf8dw2RD>FSoG2^508Z=VdSCjuMjW#uGVcUwLXQ*HkgtIGVi?){3`D8 zt)6E)O7l6SIS}4(s)Q;>%EB;-JWRx-!~&)y$QSW%YL4L`MyOHGT?2#w=Y*+cik`ocO!;+ zO!d2awEY9G9@6bGjPmjrvA8LaI&`KV7jlP(TDNYaa0lK?vOhxlFy7p&une&tK~z0< z@fC0eG7t?rgM#WK+~5BN#WElj7cRA$mAYICpbF-I10H|fQtF!<2?TK|bX&F9nM zcnB^!W?|O}O{0 zGL~h>EM9yg)03hF5>089QmL)00g9z)2@KCc=hZVw8wmw^g^@JC$i=%!Y0Xum!iTO9 zUz)7GP&;sF!hUP%X;CB8R>}?pCPdU78e|=C;-)aMGK+_#ma*-KE)Rp7=HQw3`T;Wy z_PGQfHr5!Q1yekFEzWfa;QZ7JOv~gN_Awm}heK>gi$YUb0WW9UN31mfyzdmdp~D3@ z1~~$`4l@%t=cuC>#{v8Pf5CAM(#n=g zCI!b>XQ2974#6?RPa$}AaOC0ub3ly0bgvwdC$Hgr|KY>C<0LPGbc|y5G7)?XvruH# z52Y5eDZmH`g(?;v$q zQyO2LA*u?AA;u~2xH8(|4>S`$efj*bK7w#Z;A7s7T{(i?0Od5-YEyT|Ck5KJE^E%( z8vObGfYlPxmKtItSnI8$JD4#8#K+^i$twb@_Z+h_Pjhgn)vozzZB@35e{k&m`1R6u zdAO`fy2FW?TTpvGQ+fl(t3_`C4 z?-2TZZ9rI^gXZE1Zt&H8px5?3BULD z?>Ph@IOjT%4qLl@uY8LLuR1g22BzhYZ6RofMOyE@kC@)~1nCC~%>dkJ`6=EcgESx} z{pGB{YutIEU5i^ccJk=w+Bngecx^WQD%y9rCsq% zT-;}RH~X%2dQ)k!4l-7R{RdVEBlPY#1JalPClCZh1~veH`!+7E0m@)0u&YKjtqtO4 z1f**+G{x@mLh%0X0}7Z!3@%KLnMlA8u(C95xG(GD;VYSHEe66gM}k?~ers(8@{$N`7DQ&f*qt91$1f{z47kN4Foe5+;gEpBMrlEA8^YQ;3%YNpKx z>lqMxdMtZA(^Z)+poWjY~_$iahP6c6*<0V3}t z1{4Gzkz373fDW=;L!4vuU{y~5LYQ1YLqHSuoF>BTA`3vX)Pg1gQtcGlA;%mhDy(2f zWF;Nh^X7f2rDj}KMW0677^VQ(UZhh)>!2V*+M8fHIHit(UK^Cr8BptE*Xu@|^L7lb z0=~=l7>;asXLgtkaZ>9B%T>Gkk9?RN>Nfzb96272PVlk9!wExWj!`_LGsI5~F=8cH zIDLF~o}>6t;6Zl=c0?{5-v`T>rrHeb{d=(gocKckSRyl_D=_>`!gTzYrsMJMbhrx? z1<>Bm4W39QgGdZ>LmyZtFP??qdz(&Ruy`+6Jl3sZFh_f{dT$LW;IQGJO`j?E6WBy2c+EczI$&>MO`mt zjDn;!SMVIqAMf8E`RHeCm&b=?iSK^;$@Rc; zM-dIpM@DPak%MWgb?MG~563j$YYVs+RB#M}R%>1q%yQ1^H&kpW=>jeFzVZ~Npg_4S zl{iX6@o1dVvgOza4%CTAu7AHgZqT_D(E}V6t&pxg9N{B>eyGQQqLmy&0H#1}uausd z(QWu@-O{7yC6)l_tHv7L(mXR7b;38ZVXrBUhWP7q{OB;kch+(H@wzZh*qvPQD$b4p z;y`e&k23U&&i)@AHzYUJpd8oulFy}=IIzjgoPpy7l8GKS}Fy^c)=M|3BX**wYf+_&80f3e^S8&xGfP=@`OLM63}_Q*AASXPk~x zuNabj7QBDLJo|br+xBfmgUBJxbJ!;MIpFTzCu}GwLnbsI2l8A#q+CGI4X71fM!Gb;GlI`Qd-tz@!{+Gr}JGnkPi;6MPRok=yi-C2T&#F;Pmy#>81v6fYrWR7CQWq zOyR4;kz)*zTQk53qpRAGuEssh5n54}twkW-onnAPN2`MiF3irs0nUd5g$WF3xPSL< zj?6$KQa9EiCYcWJaMrR;Xj=*ae3p3lxVG~gIL5$!0C1Wa!O3*@F^Ip5(_!*1uyr)3 zDm>5OILvsb)^|LB^UTZ+Js#e{OZ47F{HASPHX0D1g4_x)zk7eH^*nZ2%v%6x33Icn%kA-^#9`+gFPIa5^5DH6ix~ zaWnttp96IL_J6jg2yeJ}$q-cb|^9;6X9_DMSP{k>+h@C@n_)7@oclp2 z8*$ML`Z{FO@6C0MHP8P zVx*gE`mUleUUTjb3Z1X8t3-fjMXi8m;tug}(vTCF3Ee18y)|9Sn)Q-zjc+gqObb%Y zE!JErh${muJfUbWJ5V^r$pfkt8cKNfA5z2}sE|=@p zmUS)R+OYj1IIw3j8w3?&1$u*XLu$E$$U(V|5y0vID-d)6T6v}nUDBrxk{ z-osaJ0D(PwW`}NZX7RK4Oh{WkOiPClcFmR$uvN#lFIfZB*QvW&*CmzG9S-jy@q9eQ zzzG9@;h?IegI(l|vRt07TLvRFWhO9cS+a#`7S3sH>d3(X8zF!^dtI)!wI(tP{qh$^ zzLXhhy-FI?x}vv)-AqzTsknoW$4{Sr zzCXYnrodX(kLw42I!#I1;lc+#ct1)9Eb#Mu2nfGO5Jp;3c}TZD3}S15X{~J%kKXe7 zbh%bc#>~cG@pr6IG8)*UsWmM)O?Ls}kA^P*5{|(XsVQW3#0-MtyVISLW9`tcTd8By z?i{gs0cy=G717{e)}5hx(Bppf3N9q++k$s zFD83$!5M^CpZ{MUHe%Zk_a^Ht#*Qo7*s|KSJ%wS=sQUi)m*T3!5E(UtVh8|rvE30_p1<3p_dv@$_dESmYt!ZZ!+PBiWoUw9D QGu0*rX_z|L33~u63D>%&{|t-;0YWgDNb#FvIu|+&?TscX;oNFO$VekmC|xa6}Rj3k3`m0Qrhkw#y3d8x(R-Fp2jp0@ukSPV@O3-nZV$Xbkl!W#k6JP9Y|N zlj#^@)@?1p2`jhy6b^?t1%m6UVblv5K&?$%qt&5W>WVOX-Y#ZnGBR%~c{`kOy!^M6 zbL~DYmyZoY;Jh0^7=~c|#jwM>R+M)+cryhcW?dvu*H++RUA^)cXE&e8A@}6oxUY}7 z;RIxzVMF_0&2g^`t%lG+(CzYV-LOpSdSFk2rmbGrwcC-s7+W4?&1fK@=nOtVx$v=)~d;3dPtmsD%$xmEc1VKMc6canOB>&D03p zC>Y1Jv=ZITJ2HL%d+)>na)+Y0Y};nrZAGe@$acGRN9c~>oFWRe@#H7@bU*v~xLv+gifCcFdw+jF_YlJ8_h&wOT(>RlQ@)##_(}ZWvw%Ch`FNb( ze`u=Y{dCrE9cCV=xccSm6aqYOu0`Qz)Pf2)Z`x3zmh{w6mSsu8!aylxfkSM|Wht2M z?*H`5Pv_&rAQ57V^GScE$z!VmT^^5Nj-oyH^QBhE;T{M4S-gj?X^!#x4#dqjG^*%I000VLa03wJP!CvAS zes}Dqe?uhyc59Ac-F35u0a>rznz7!Z8bQf`u0vgMIQ(`~9Vj7nqcKB9O`EpX$x%S6 z{^-c^1%YNC$k5ln{MY~O@rnCHP%S`3kZ^k8dHyJh|;!{|4rW04Pad$RYluPyZbp zy+0q0gCoG=)NIgV34~jw-U0IYsq{J!M@fVR6O@LtA~|#$ zDt%+fGeD5%_5lFvMA|CDvcfsmye`|*)*OYyNg>*D-o8Ct*9F$9FL1TC?>G5$}EZ%VIIK=rd z%lIupfK2zNcw}tLb-^8EyC_hd_pPNNe>;WaKefvR^D(YZnz9R^Yz^77<%m>P?Qn5I zDNWn)G*4@JSh~AA{_>yy!-qLwz@0$kXWSE`nn$bk*LQw)ku{d!wH#=EhhzN3dk@>z z%cfu3->;dxgPaB8x6em+pR+YhPutVBZk!Q4v-3t0$xw5cA3o0aynVC!?Z5wpJO@>P z^{FD#4AfM~^jmGYXT{+--%Y^e&$=W`^XYs(5;_??6AlMLYpOCu*2FAct%cwK1N-CQ zL)q5cl4nsksD;K^NY{DL$jM> z(0AVsg1P_Ymph65tq;(@*gq#kIcGzFq>c-toc0PD?Kt6NP=$_C)f z7(o5sH=ddO{AN#;3u{lW^~>HMl31$136l>%9OJTNStjy@(f)L_qVxIVr@Mpv&~WnQ z=(m%1;F)xDJN9-n@!OL;d$0i3Zqpb57%A+K#)m&@gv>c|UvCA9G==4l4t=i`BZ znjw=9zGbv)7Vo4zuhJwcG7K&6Cd?l{eY!h@XF&h+FAid1@uO+hT50uisQ|#uZQQLg=%Z-pQ0_yAYj+}|0HVo_O zwdOXnVwba0^j-Dj)x9|y)yX&CG?oGD!`_7f$5AJiy~_DxYg>Bm!M%Jv?E~}G^>*NY zfiJlIWnAIw(a??dZ2TFs>vo*38$xN%b+7)aq)kJ_t=F74OIyDD?Q^()&*I5Zi^q5G z?m@xzvQ-DvmU6BD;6ZL;kc%Qsytl{>U;)fp+v>8Q&&Ql4djmi+qm3n&D|9-Z-<_Wp z01)vE!W6|%(=>V30#1qS+Gyt$_Ez0vRb@WT=MeLC{d(D21FmX0mzKL#gEugFMXLVT zc41|OwT`U5E+DhK&76m*Gjb<70m}>66jO9JUl!; z9Qk;-JAb(UI0-w@SPKj=2$6%2@h}(II*YctmCu(3K>RH1MLc(c2|VqN40d%QwtPmK z-rc40xL&TQ@YyrER&NeEVk;{S>h$CJ%U0;=pF?DT$+_eEye+_lFry&X(sDOz`@#Ud5Q^H}?3;cfH_E2mnjBAp5g=ogBJOFjl(d zl0QsHpk z|I4p(`VS#ao{Z$YeA)=ChLQxZrrH2d1cVvFj)elO;RJLvGeho@@^vEymmFI4Fwp2) z2(yDKTs(jJe7tHUYONX>I7XSnL=4>oT2K~yrF_w^xi%2_=z~w`GH9(^E-hId_tXGl zW^7B;dgLK+t=b#VQ426^f2lRAaNP#@*3?R?4iGOyTC7#3J*0_epf+ozDMIwfIcEd_ z)`Z}?nWE(D`-1v{@CcyFC+Juj@4x$l;D}=1V|#U^p;0 z5oLj6%%{849?lwaGN9?1!}Je9W)}fPJOxkU2=W%Tb~~B@UJP63;CDDNpt9>tO@_)Ttvh(&`TfJ zwL=4q!Z`EZaxs8{2(vb{(BYWOY$T_S`~cVqh}c>0X4bpu;Iods=aAU|cbI8Pr9y9M zGefBBx18XnAg}U0cppYq1P(r;e!Fa2U5>LmU`;uetu1iuK~14g0FS`^7-!% z*PM;~l)=3LlK~{mhr^t^lQ@UMW=*C$kF-4HYs;!|eijcfIYA@%c>)klKYe%~r_(eu z)VhJ3V8DaO!8w_ZN3E@uQgTVl*93uQiouI`;SNY6dmG}ppD==*V#kvXJPFx=vV7NPG~C3q-)55C zKpoJ1GQKI%l4JB62-0ZBX+Pi4aD0Cu6FlE9VYeku+&6Lt@SeJFpN)96Hw1>r^V>0YQVtIQck1p}B%fS(d`=2b>1Lf|k`l-pgz$RRejKp*5Qk?Rg3Z zU(r_sFaZiwv|@mv4dXFz#8*`sYC$6{H$!zGgCCD(8@Nm~cm`B!t}QFkG=X(fW*7{O zRbW+N3kMv}iNR#3fI5K5OGAp2_(-VW`FK3~22)h6*hE!T?T& z8krk}FdaUAhAOI}p=*IaFu|XW@i3vaoa5{R)3}0{Qp2mb2RLFcU`lX19X&vV$cPw@ zMVQ#}>kX{~byfhTiUu8>O1lBZUL9mklvvmWtlO`Df7k#A$1J=%n`zgrq?FpP8=VdZ z?I6`L$;tZg=#2WtbW?|Cnxn>D$U3Y-omhvdnpuZJAYdN;l4jb?ToodHX52a+l^IPX z?K=l{?7fGyv|d((H+51$2tLLb8@z<*YuTRGYWDuf1=nSbYpPp}6BBY*4B=TYJ7J@n zI9zXy0Y-186RN@=?gDVx#B#&>?dd1$(~?tqo4*DZ+&i3Fw&T0MLB?)1Th656oRv zn}I{WZHED73DaDXT4t1WTXJ&~vw~xA%*^T>39NR39LXR8hlq+&xAk&;sPG&rHhwys z&WCuMNx^^*^w&$X^u^Doqi1%VMWBkv5qWQHcz_t%l+=gFC`Wc=poWOPZta z`EQ(gk9xm*{YT7@9|XR!A-GAm{q8gTqr3iYZ~k)gyYlxS4jEwbPO#P{04^J!KOQG> zjzT8Fmf6R{VO-TKVc6yYKi|FE^buA$ zNoxR$p96rJx7e^~+7y1Y_Z@(wIctHC^Czp>05*b^nmfE_fa6|JENMI&RUCowtD8)> zrU{ib z9Oroo+H0;ANDU%$LB4!@YVQ8Hjb}5A4l0-k&n@}8UuzX@ISnzU z#DKO!X19W2m6#4csRiHD>PfLqJ(x#8vvQcUIzq3@$Q}YJ02oN^t{q8>(?)j z4{J74f_MGGE=qN-idT2)}4k7MUFw(GsOnpXqM@f_HnnwFa^RnN)b&!Irq;`Mb>D~{!xfcBY^B_F86veuksv32(X9UdNS#tpDkZXs*y5Xkj{N`lr z$dP;H_-Fgfy_Hgb-~M|(1Yk!F{Y@d)u;-tzE2_^>*Z!P-yJzD2+or#D0`w+lGoS&_ zr?-Lk*;gFa9p9?le|(XB-#$BmyD=f$NPNdauE5RjkbxH$rLN-!$qY7<)SGjIb?t!j zAu3!TpxO1;Q(#PkEf7mgVnKodf1#2&319I;jMh~m+UH3cFz+;%AhYgy2m zTAZ4xK@>o<+LVbjk_2d1!1c|TFoS?YIGqm>bt|X4!zofN%s@>`2Kf}KU$43Pn(_*V zUDu`=gaz6wT+bQZF(iC!rL0)cx}V`ayAY0N&+Hs1Hk=O-8FsC&N8arw=K)ZItHT2^puu72s<8rH4UV}z>xh?XaH9~#22*CwPSs%6(7Gu|UtBVu zApoWdunV{6BOWCg0(hRHe*sW+kZ_#O>bhsoNDZNSVEY^jE3hnu(MtuMu8+%7D*%+d zL`|rvvUC7yl{f-UcyhI*-uM9Y3v#n=Kz^_^ZNPZw3_u!7ItqX=!KW~->hIp4u@Ez>w$x^(;NcF@lQ(T; zS)R77#q;^y0R%(k?#AAs)|Bf6nau*7&nH?hlNUknt>mYt<;&-%Cex?Cyo-ETmoMKG z;6vRmUoX|2KYcuXT`px&%*RFSTx;QyF28+U5&}>gn5E7% zPhs1hSHFbK(7N`kfMfK*OE7ZKS}fIua{bIXa?UwU6F^Kv@XpsM_uC-u?K^RgA27$C znE+j(Mh?RS{_Q)*dfEB)E5AR8aN|C_J;rvXW5f+dV0I2L5_B`w+HXlEjkovFCVT#t zZhPQyZ>AqWZluEWyt&7&L%r`(X@oU>eNoT4*Ut={*SgbV@{IKI)u%cdKm@V@5Ca1= z1ThG&iRptAXsowXkKTk`f_1WPJ3aAL#O&^ODc{TQpfWZE``4kHBjOwO=GBkeMH)wIF#^ocwgzAdQ+&!= zwZj>8t5&*E>yAuY0|UX&bMOQ$wJD(1Q)>EH@@0U9gI z-GqcR>YP}@&6GCxrVC1KAaA4%-oT@;WU^uV1|&Ep(bgIX2@^QZ=TAr9iqChS4#78L zRn?N#&B)J_QOON}w%Wi<#4HY(*a^^JUGoZcQJdW7l8}?4$pn!Qr}Oz3qYx+<+aV0+ zyti}hRo|-XUT|dAt_0^8k=-qY-J1&i%`Vb0@|3BRk?Sy&}r%{sFq+V;4Hm1fPk8iBat}qfwd^u1j5rC zKAkzBBq(^&*5MdxIi;L)H4qngLIIqQ-T?x&f~sW$6pHB-xFr-!V<|(Nrz86T@2a^~ zh4;(>y_4CteEs_Q+XeHV|K!Mz^aC{Vj*_Pa1Vz9J@6TTHHqfO;L268q!vB4%jYlGHmN^-n4iL9s%l!E(qz3mkU`1ubpCjkFdQLP@3zN>zyIq+ zIkJ`#z$`A_pYGOc+G_%OK`oG4OJL!6j7Px1dQI!LDg;Ph>cvHE-OqD69n}#Tv$3&N zDD+krd^IBYZ5rs9_+|}fqo!v3dsKaY{_DSuZlPxy?DL_cVNL)IvbgJR=mWx}qpP;I z=THM<(gzmT5nu}0l{p7)@w<8pk4Zu=79;yT)9ucQ*uBo@0T{Xt2glp}bl^qdvUfap z3toT9cKitS(ernX==MZk$1B&L(Vcwjj=sXS414$f(goc+utw+(zf1bM>xK@*0sm1N zV1sdb?l5{|umilPx9E85z7=+~gXYHFD1f@I+t!}etpH_v`1|>EoVk-kL_v(cdhx7v zYem7(dV$(DT!%z~Qnl1>4URdAwA||2(lVDe=$u~A70vg3FwMcVj577;oi-R1#9pm|L4G>==$W^=Str1XwU);YpefMt)KtN( zP0b5hAF!MbFr2!ENCwsB=KEP0Z6~+Ghy<~B5Htg=bvSSN#pBS_d?xqpS43^O4dbKi zr8WW2=exW2-d6DW-V1XFN~tBMTwQ=EYl9a-5dcKOo)|DdES0_9`djDGbfrv;9HzzdiLlT%t8_>bb;TwIY*U?RWxqR_1-ZMEgk4xsrS0iR|o7oMrJt%R@DY!X0H`7ik}a| zqVf4w03YVc8c>#6!E=n0AU)AXj{J9o;~{Xh^liCpsbpYlHS5Y8gTnwFYIcs4IKWF2 zt;h-v+DhHmwSwf&ciso~s6z$_KF%?|zh@wm0XS+Z2Jg{IDY@1P2Q-3*bV!^gH2^ge ztSq&nPnG8Y)(xtdDmW7S%#e40<*KdaQsF~{)260n{rb1R{rY90yN#zQMvxT`>$SF; zYb^jrFv2I?pIce`DIU-p+WPeEUq4?jTRtBD{L6;}9*wuBZYEI>2q0lP9@a>pSIzNSaE?SU|PaN zvpdw&AeOe8A1;>)4=#F{5LnQ{;Zw>}WOfHuF)}g%j7|0X^yv9tjsV9j#Ng3AGeALm z$^TWL=(Y#G*8~5@$KdSsA7p%^Q|E{s8FzQf90k3bwmu-GFfy`Hj-%T}KDQTa2a!A* ztw9ZXVBj5j1CT+6guqM(XDq3T+8h}Z-G0bz>dN5*o!&0pMmK4t6%MLY)}9C{?>sI zAIpg8ekW$2x~A=^}~NW|Yz!ZZs>%BWL2ikup zeg0XTBe^3EP^&Gg8x5tbth-kckgH__%?)O5RPafV0Z=G#h%{uJ{Crl{+;WGap-X56 z=goD?V}G!d+`2W<+y)@sG!t2K3H03pa{yfvrv;HWCC&A&#OUISF3ZG5hDurz*%Pi5o=LI1YngX z7;r`{#T2q*0Ci1unO=VVx6dyZnQ?e`*aw1pAwY|kwkt>?4)uWNw64XbWqt%~UC)2} z>z8#}5DxF3-|c*co?l+Art|sbDoTPRID}ASQss zZ%9gj)p@FDWewVD66mgOJptO9pGn{O+lhn0P}v)|pB)f#wT7f*?~U33uy>Lw!TX~1 zYX;e3w{h0jOhW*Bnh_B8R{caRPzVqL#2c*t=JrY5I0TqdB!at|`l7;J9J|Q_Fqp&* zh8j!^eQ??pR(u=A7TESDWngbA(^^@m-+GiAL{AT=a)quN0b@WS6d*7$3dsL zh9QH#G7e8jDUjR37hu?>)brpW)PV7j>)(D05BZP(ri!xErBoeast5Otj@j}H%`r_#jZ z45%ry47)siTK@^_Ji*kk)X9ws5aHhq6l#KTJ&9u5i^gc0$pgtuuq2= z^)&;#G-8p(C;2e0^QZs0oK%nx?>?@jtSF~B{!Jz48Ll;CwHgHSuKw*e-6a`8IX|O5 z9C9oZW(@K0@ejZJbVv~*B!QXkSOBin6nls^y&fSF*#pD~EUoV)-#T>ZCQJsvV6Ff& z3k5ivD_olpr+c+KjKvoT%rIN3HiX5OOO?H<0Eg%F;XPUjW#;1s7S#2m;cZIaT$gK?+zbc{_S*H@knDF_IdsFSA0T> zI3DY9`fvXmR$vG*<5Jf%hR2^Chn$et(>yItsgw{SN?DM@&a1s%kbn6)pD&Z~_;A?& z*97Q!Dz!|vF`sGokYe^SV220OWjTK_UgjC$fVJq37Y8yh6~N}1(>W$62Fyo{dlVof z1dfvG>9_L&$cWE5kNc3^=TYhpAG|}z<@Lk z0d;v?FQ1QVcoHn9az1~3d6^cB>6iV7pMQ=h*uQ(XA6~J1rPnW$B0fC5d&p6q!^4*^ zr}-XPO9aUNm;W-A)&UWLBe2P1$-j^e~pl09cJquD)IC3e1ALxaRiLu0IC8#k2j9 zD?>m|tlZ3AV_r1+OQ#OGc7zsg-i#y(nQGt=gL(<5U{fHs)!hWx31*%mbq!>lZQjh?wmwZ{Oh7@cGF10^?5(z~Spny=$I*wY_byk$D z6^R0J)KdC=*Xk(d1(7I@sSX-~_rBQy!khz^V2Wj4mNlWQ3UCCD*OzH47)UY4F%koa z8N}r}HQg9NP|FF==ku~GO9j+QOUDLy6WZqlk*wCrM+~4~=I(1>N}RDUNz7^7k0}N$ zs?rDw>J^ei%lcd3fSB{cUQl6H!!%U^2~=tos2B@{P*+J=0tLwdn)Pu$uSgi4e);(i z?;m@e35x)Cee3!-8gWUK03jB=#&$nau(6kgb23cyrrFu}Wf}mGlL}beye`y4 zeye$v81o+K@H8HFeQGL}GL?e3AMn%rhyBAi1QD2XaZnN=5eX7{iL7}f0UNO)5Sol; zC*WM$Br#eiAutg$8+$`CtTqg#dYM7l957b%rD@_w1=Qf`4%X_m28&xsmIEv1>9=41 zdK%wh93zUrlovPz3N3n$G7O8ZFPFbw0LmN#<9sX&X6*JkuaP)F*Lg6wc-3jGKEd?z z<>kw=0ItL5xQRL^SklkF=r-qn5vpqK-AXD>tP%~kq8JmAIi$lA3r|r z0&2me(ZGqJ)8+i~*RSUl7>E7-`7ojoNs42L1-__6WBdti|n2iRr*%0RfUp8@}jU-n5p+*ouFeJP5{{0yY0D^Ic*o&Y*OnE*D!+3Q*hjB zw)yUJZ_LRCP&Q_gg0B6KzG)kGf0pf_u28+)yBDVAGOcDrECeW)W|o20BNcTO zRhAIaZilkG0wf4|2&@M33N!WUhU#um_p&mCV{Ryb)s~B|T)YCyQp{~BRROko*XqIn zV`AYTtOpa2P-n6~~A`qq^gar;s`zP$nu>1Mv zpPu$ZAZ9R=1l+T}TLOXJuAG0^`09W(W|C zD97^*khG?J^HL0czMOLic_%r!_$nwDU+Pkq`d4_FzI=K4vYG+p1hcw^y3VV5?Q-NH z#Wa+tR)eRV&4vmqs#;Oqz=0U#4uCmi*s4540AkSUsDLEXGO1!@sag$E0BHOfk_C+S z_^^*D2%DOX3}{t1MPOl}K-~5`9}b$+&xfBsJPeFlFE$Q4l@QdIb(z*>ofXedX_rG2 zyg=TK0{~=awwNRb5dt28cv%iZiYYKtqW}Vd^H3@h5p5T4qVugboZIhV?BuuPo}sV%yA$1VdUuApbt-EoW??Ywt|HFBu1)_& z$q_(z-P{{$>S_*xFgMyR3m|$UX$q4txrqZU2fq=+1+L=F6L7_?w^HvyWFYSxQK!JV zIypevh%_C?RPQzFqCMDiAUaEA1C$_Ovs#Oa0OlK4hnjVW0TM9nhk#R|X!-bWczOR* z!YD!>dfx}TR*1E|c1gQS+{^kU|3%#rIOeER3%DS#Wj?5!J+Q8lqF&a12|SUpgORob%9D?!#ppg8nnfGH}Qw| z_Blmj=##HxWtnqZD!o3{96ZB8>s060d0i^Nyyd;{(9WU&$J!eE@)nQ-h6xk`Vib6m z{o})7w@Uyp0U;_LNl?3(N{Hh_#KXJHtCh7@1XrzP%I8gy^$8g-1JwPj%X$F)c|M~sNK(pcZ3AfPw7Bt~iHqE@kLXt=1E zt!j>hn07THK0b`?5rH8n^E6usyM26mNV}Y38}Cw!1`d$|NSIiNp_D~nH@Ql3V{(;# zH@72b8~{!^k~cji^Rm`3IKfw}bCSO1FXgf*Ac54j&B?SBH3e#k0_{a)7xmQuD^z4i z*ryzURcE_Iz!Z{eIS!cTWd>zV6hu*0tKhOs7r`^4U{*5dd^s-*f-HZns`_$zy(|Kf zSedXaXDw@4N`0eWYo#mlc`W?(NmoS>~g zP(*DDR3hR>6d=T$<-^DzFIHD%^IEmc^D>NCpk6_uy#-Kwd|$`Ieh6%40qf(k##DW| zEa%s0nb(5xeH@0&ur)}`hrR~5CjJ@>CVW9EwtVgTo&j&n( z_aDEW%gjM{AI51}7vSMxH|(Fh;PvCN*ckv+R8>ozK{;xjzx?@SK|vH2h{ANyrC_1f4;Xp4bw13t0HLb;l_Au5yX#H z7R?(!k*4106xsTT_fOn$-;0iaGEyN56F@wEfybh<wOUIAu2RE&&typeF_tg;*TL4PzFa=7Uw(c-1_w4mGyp~dkXYOK0;QUV zCG4;~zFZoeD93coSTKM(UtXWfmRp1^Dh+So+$?DUA_7txcQ%bId!Ve^3vLvyZg!LW zH7fx;(6H!IthfPKX+aHDtCv~|)JipgOu`Mw=h#b$ds&oK)y6atkOPitFqkopWi3mw zVhF*ZW^kvSSa+9f?RMd=Z5^XPyv^T%^5fzCF2#sa+M;^1B4Qq&P-S@9LF5)%%Nkfvy+jlSCqdVc!lA_&8N7qRY#%-}fy1u)pW zEXx$p%oV2yK?T4GF*ce|e4xB2sLsc~{raN$>G7_V7(ufIioo(I`npyvrou3A1WZ#d zYY2ek^@3zo3xIWAYXA>1z5)OdO8}-gBBdtyY71bs&JiezSjP5vq)quyZ9%931av|i zV6N_}RUIh{(D_OLIP5s>k@Aq4%`gw^ybBe!=vgmaLjCbWXd-?9Nq&4k+1hAwX3P2W zBR?@XM;XSlOEJVZiW*@!oL^R*iox{9c7t>${c2UWzqZ(_ zbE6u%_3af1AU59|W)N}jQ14I($fZU1)VQNpgW514fI$s0@Lq7?*7JdA`xAH9)Y0n- zVW0qYh5I%=goK#f2=I1&=GG6!3#3U=qGMXyquQQ1!+Kr@=~>5^?zW^}I@CMx6;oPBel82}7bA;0{Kl3LsG8j1UkL*8TnfbU=&0@~}>`LS#@w zQ$nX;(CN3IP6q`jR0-8ks{!B))F2=zXaIol{D=uF4w%>JJQW1WcUv8ilnxx%kOtIw zS&Fv)I13}JFe|250k2j72K;9CTE%`LH-ze@?4^VB8=H>>;w2E~>eW{@K&y8Kv{$yS zYSgN{85B?h0%`zISET*|@-QCWKkY;SAz!x|7DZ_NABOUAcu+})eL2k>lK}zi$#aOp zkg$hvBnbj!Y5mFBYKT$dgBQ>^JnTYnRi|zC-mg$LCSouM+NSAs{`YzRgM;q>#xVD$ zcG7d`tROZtdNrd>akK(Php3yXma1qf$N`Ushw;uQdl!%Xc~xe@F2oS2br$8IAclMB zRYb0>KJ(2WoBdRxdr2Jt21x-RAvb|D+;yoAhCtO6pd4eXQzgj~h@@6>*EyW~jwoCvt*D_j{*)9WU|vH4h2gMIiDgJbh-n4A zyngw&fBWjYrS1}}>Y%kS11wG~jIW{v#nvtD5=UL6gGKQogB31!ZIOP(rjxh(MJysP6%6hpthB6Pi1`03-TUnQBnk#^Dm!i$nI?FX& zkQll&F1M#Ag^Sub)755H0-iK%Nln7^2c{kr%(Ui|1m+3 z09C_`by=)qjk?71>-iX}SmR&FFf+i?5^-+Ux~IRTfovKIw=LAI0%CXEuk9BO2fR_e z`d;px*a80DHzRKd;(eTU|F7;=-rGIi%-ox)4t8T|#SI|aFc)t>Fjfc@>~7bp1YGxp z?qR}U2-va)ci>6S>a$(xtZP|C_m zutKaPL`=d=U}Hsp&@KE_Q+3oIM5+w181+U#yfM!e5{L=T-n+Mp^LNaKP@@e=2qLJL zmt%Pd41sxVZH}24(CC$GyNPk-Ie=o2M8*;`>Mobp*UM>9K=u+tt3(z7>iP5G@R$Q} zNH+JJ8U;kKkkn;GViXO-{s1{YLUA;dWkt&O`*}jSspt(c;XHqx&*t8$0|Lyn+|cVj zVQ%l1*r>wR3-YDOy%ej`+9Ngyq-s!(yk2bE@85`X)u!^N#XuYaaY3k|b4o%5V3iB7 zkNfvek2|0u%gPEM2nkf+6+o8VLs*1KYltxg zHizUmMBXybyd@a#?vplzrU8R*Va|Ja;{IE2XGHhUyT+x1z{*f|HfCw1K&^2nz?^Ee zT8kQs6u3&*?ZzEdm{(LNhJeek!psqRvnm558Y%>48g2;y0A^0Nfr_CQZN6!M3+vi| zXqBvHrr#L#oKl9n1$S2ov84>D$*;1Ac&&M?;iu?>qQG# zTCtAM@M^qhBmhAI#RM(YYM?OecQL>~LX?c1eERa~(@9s!O(|ATYpfo}uK2dF6|^~} zs0bDCbxt$;5`bD}Xo8kvb*Z}P3TH?lW~kKSfbId&;I+?GV*n8`#9b1Ju@nPiS}vD@ z^Xo3nhY*Gc6t87jE=3V4^0P`ke;p%~m-jk3_Xfa4n9=}10&pL7 z-@AFYdS^GLR_Er%jU@Q?xYhs~ZdK9E!faVJ`BwLg&};d&4o-c=vy&w z%$xqC7{myz+d=pFdaEdI!fQsn<$z47HHBvY3SvP3QbrXLw&ireA5W!%89XK+#3-U} z0n`e6n*Q<9Ur~~nv#crVyUY30JT?Y7PLP3mNLT-|coICY3{Ztrz2z za$rEEh6+g|DiESjeP^%pSs@%&-tBS_hR6tErbq-c2D31c)ewdt3_v1)pLrQoEs7U*@gvN}jTB}p23=0M$0r8EE0+h2+V?tx-6zv3X3F>w(t~6Q;G6il}A2>=Ka1 zVPK5Ahv#<>Au_^K9=M+CJkQUMLD=-XR;_R=&6x=W1TDvyW&m(WEb(!hFQO!&af9zz zU?h6g?s7PR-S0M#JKZg>%?Oag&3gc_aW2}2TUqP5@MIvjQVl z)Z_8AECfKnwPEa(m{XR(nNf$PJRB0L1mS4Ye15eUfEd6AS=hjH3twXvKn@3p>WUV> z7s7&4t2vQH5PM6Je)E26^;(LvIRu0<>8`@>lw7G+=8A6*>LIdgZopkNxQ@2 z(_xnw5=k7u@c7fu&w!rQ&g=F<1CT}4fMvbBUI0LIxHU3!$SO=M4BXS{`v~9e6pL#OLGzq5PNau@s-GBvP@wni{_8ZO+EeJzl)?Nm%`w~}=N z`4&NWXQuql;Jw=gcvBi~uBKm=%sL24J*Mg??}iYYf#I&yl=|434@wTFruF;QX1A|u zVpngABqo7j>@C^DCQwmtF|v`j zl1)O0#Vj#W9(M-V<-^~Dyv{~Uy-7OuwaOL;BroI zgEzb#wJP9Fnu6PA@b8bx(6w}?D>K$bBCq#OkQ@A4Mic-J!mYPyL(<|nra_=~TG4ZT z+))|yHh>IN#ekR+Qi?G(aW4Wm<%JmLB&T{y$)Z0hJ+*{&0(G$(ui^1PMZILe%1+5(xtVZq*bakhlm! zj6nh$EU48|&w9KpAs;@x+q=74ugwu=SV2)XaH#A+$6x^Tgs=oh$ac9b0N`sm%Ni=CX`Yu92N_TpsQhbM;x z4$8wgjtOXS9_BUFw(MZ$=B6tYSz0G5g%#LZDk2h~F<)UkibIY$T7h5xo9qvV{WR|69o%Zw^{hwCazQ*^MzU0Y>JoR%__2N7M0N$FRJ73P0^~lJ)VRE9O_N zYc*g3pkVRG59MKv=QJMnkNYHSg#kl&`WYXe73WeGos0nrUE(5|aXWmz<`KL^4_*^=s0v<<747Exb27*oM>+fY(*jM&#E8 z=0GRH_Z%Tp%P11Dfxp*{_ATE61CccP4ukthjNuBXnwiifT(m`1JIM!(M_!udAsV zm_j5#wO9lclpv)D<#C=~PA^|yOU#4J>yi*^U65&9m(%LRUhACCWt9T0InnHZE*WT#d(JpL7LuEv4GpL}k~dmZenp88tz2s1?a@rw(cb$V<5#FDrts>jjwCxx`=UWh&q(a_B-N62e(8bBQSH z{Oeyh4g2>$y|3Y2@Zq7L$Xb9}T}7hI3$rC85&|@j56>^>b^q|k|N6&A{alauEmC?I zf~3$lV*+56gaZMLf6dV6U+Q=W6w>p;7sFb|T9%3whAaTbM+=9kOi-1W5;??OtEQ)a z+CA+6Ii9A)4Cdr94*>xRg;$_18~joOF%t>2sT$bkqyk%|oP{k0vgSyV3w8Wv%V0Nr zvzaVcL+e|9*PH}=Z%&(X3AUmKx)Ld=RpB|ojro=)3?w1zMIrH?3*zRcOvKV$HYR2^ zt6c&`S|Sn#&S()J`L#Td7(_-;H{Vz&N^oKlZpi7D!0+&5-yzx>F>ae-3z5-X7GGV( zjcj9+_8V^25db*A%nfqqZQB-5s4GZ-(1S975n=&a(E&A4F&Alx#n94$%vzx8Y6x8> z4ZWV)gov-nR=WKKeA_LpKRpH;3&_o@?zY+`jgL?TGC%y&>+AWSUXGS_>HR+syDV(P zY>qs1EgC}@BES?wj8Whuyl@5sm(SCu6_*7PYrtF=MFlP&|I>dO(ipI!OvDI+0%d)H zE1N_1i0diS`1JDIfB*Mizg+O}^u*`a^L{|Rlt}wO;rx0!ueK~!5d?C1o$CRoRRO4l zL=k2V*SV#GC~(6eSqPv2)9%JdPD2bBVt)6!{E*;CDfrb!!X28~wouTW^Dtudk}Cq3 zBV{aF44lV({LdfLF2|g6OnKNJN(E(%gD^pBDflC~0TLwCN)iZa>WQrY5`u8wCK%8* z=|ObY`s5mq+RZ})mXNshKWX)`w*_fX2N5%o{~nza<_!+_)*0xY#03Uw^XaV3W$7U% zX`x7gZ7uWb=Nk4|U(1j)Bn>Hx7N*FF1Hu>;L*I6;{$KB`_VoZmpr~Plg{`HGIAIhiSUM3*!k4vdz*sn2<&(D|n z{0ZeX5DtOM8OWMK3IP>X4)d(>6nNgffNUXPPmvEy--=Uv(bI8usv|Jw^D~LcyfvZ*^5KEu2#@q_oyai=F7s!7nzt?)`88-__@^_lfZpR%w>V7BV z{CAIUQznf;*n-p_i$?sPIvj9&+X|{33;;nPXk|97g38{G+3ph_|F;f`Z)*Rf#r6Qe z0c@=i-DAx;ABG_|*QEuJ8#%B;)$L1LxrKq#@N|h#R4rP88URHY(h!7LLS#lr?NPM6 zJ<$Dw$ee>4E z9grdJ#$m`+^BC$Pp$&|6^B+Tw1i-Xo z;%=p15D3sS08@i93e#_<=ZDA8(qgwqg$UWp^SdCT%ev0iItiJ3>+~pq07HrW3Ki_} zJ0?Q(8W5aAE55OnfEq#oVg*oUL`e}k)lzK(t1e4xWCAsVDeUu-hbQ~Ew{sneM5(~Lm{nN;0N3H zH+FAJuW#z=qFr;c)pKuUh`rM2?QxeoM9bK@zC}-4B($XuukgFCm4a6K~>gZu$Q+i`;d&00KBC*vvz&Z!06`CjjYU12&hXjETS|;+IfOET% z_6)!2gV>CmpwVB0fu-qu3z!WmWj{Pk8nTSLm_mS|JKIbkhBOj71R^YLBdXQGsUASj zU%nPV&8=!mAdGR~#xP|eNu#={u4pPu>S)^9B}8B@=v2jW5rPYo0~PViF$1-#IYq1| z$ob3hR2PlCdG~tNFK-)4*TFHs)nEZ|2QwRnl=qJh55oW;*G13mp~w))%VYp34;w~se2@;?I?}lN2*b7^0%!D}Z#{A18#TZkFBm=6dfdX<M9& zQN)SetgLHURHciZ8lVeEbU}4fjRDEkjAKBzrk;3>I^p%g5DqD17pD-8n}hFP^#e9~tb z##|j5EI3;=VD~Ux9MzUGjZCnGxR%)Q7MoFZ)ujR~!It^!@$li}!>$``uVqzaQ3-jB z?+*g<`Sq183Vgx&a(rD7V|l`=1v09tdNugOwIq0{wW$b#nL<|T6u1zp8Zf(73}enL zS}P`rDaEkVP@%1TpqDbus{$}A#cXj!bsVd&Kq~8u-LlTWQZ9I1=2FVByu6+-lmkdw zA`||Y^Mfrr$@~3o7^L-&V`;^~#Gv8buI6|9B;xt;=Vh*8hjKa$iEsrLnFFD@3k0`@ zWj&1Q%PE(18S=hAHSt(~`Ghe62F;?R}RG6?vgrR~! z0lJ>n<7vToczT%D-NDA4w7r)qYs-a!nkv>7L0MyZ_IeQ65C*jQ+%i}UK$NI8K5yES zTQcdMY-|lwRhTyPuB$#Ng6o!w?gE?b$-K3D^oIS?_WTWNBD73<8#A_g;@ffiM@6@L z^D@&k7voi>?65Lz<}1f%<+3bw8SdIzW8-+E^SeAjxgLSb;aN=yNp1!RQV zs9Qp?vtPRkTX6zptH$D61wU`k>j!t=h3xGOKS+duEdfi;#1f<`sFy^Umb|VI=9uW( zu12W6XaOsS)~qeCfL&3W5&?D`$0eR%Doh-}76MX)ElVvGAYl$wy+RafwL%TnzC5R< zH*tu=yi}hNDTg%L%D{q8`{V0nEec~m7x?LTytHRD?5@b3*kpM+cb%^^4T$6bP; z&7RJCBK+QY05};pU+d0cyk|h00@?)|&@vpc^(eG;p4JNJY~0(h6lDYy)8e2=JgVvf zY4U>gy3EasK-Fs00I-6H9P!H5`Tl+dU?@x*Ok|3#GeY2yECd!3XkE?@EHk(ob3D!S zgk@I(I3h4m;Lu26SG`O+uae?`b1C)pcpe`gD;BLeCj^**$HOVrQc%?*10aH^HKwc;obAo`z*u(5=ZkjbK0etp61l9yEWi2J- zJO($L-#zUE8|@{qEdmH+;ebH8Ue3oaUnV?ERbSTy!kL(O1+kfRo&*zGshXPtDke9I zN?UkcfQ-$U9G%2yE#3nIt%H1@nQwzQ1$xtDzT;x`4Y$$48YiV&fIGX#%^J~-hYdiSCD$UQtk|ng4y6zzX2Zrx-Zfv+%0-@7&Af0Yl|oO?fH2N%c!MUzT>#G zF!NhcY_!~q#4G=x*Ebn$${Wn9#+C8HDD_c<&IwO~b?z`== zVw)KaBGTHh_rN#hsvY*0jtK?nQfCZwDL;lZ9)_taz$7t_yJCOEB}nZ|}5Hk_6k+YbYTgy@NHUZf}-@fl>S9j~aXP|sL zp}@eV33M~oO&4%eZ3oEdcTZ#lr#PHVnVG&4EKs+09xnc=E<4{1aFV4!$4Ih5%Ul8YTAeru)Q}3|VYF6Pgu2d)q_}&097aBj4CriST~AXGT+YW&=fg(~ zdBmDR2^CXO12bwMuBfV8^F1c!B#o*9lxh_YsHq^VgCMF`w^C8C&TAU3&us=|KvBRj zZ&F65)?P#*InJvA>jmratg!QPURRHK|NQ<>fBeI{ArWzFZ?;MZF){ZpbZ+h%oE1c} zrxe|CW>9=Yewtn{NKn&4otW3?B5lHR!X|n%$5)-_+2yf-h#JRB4PiZfdRgY5 z_M*#jam^oc7zoPmp7v3Y_773k%gT}lo!7~MaxQgxd6}^&Y&PC05QK4YfNEdt)FWpl z7#yT;#F>e=z~k1eHT3=3#9E&1$^{{O56Ec4P=d5N(Q8hgm9`-7F4+2Ue(zotd;91{ zT>Sfx?EjgA-ULkj_+F{zyW__`^glwA`F6EUZL0n814H@Eh*-Ku(Bwg>%S`^g?`@)P zw;$XE+iwm6n260K={7bPxUqoy2zxhrCIR1J+sqE-iM5XYxq-W}?=_^aW6EN+0L7=us~qy_+r8A_7^ zl0z2w>f4QlR^afq)iUMC^sRnFI~u|{8@R~lTh(kg#2W$<^lO~oF{1!YC0!WC6V&}ZIp_=jyjbR8- zzVjuGy}?hdG4VG~K>!H^w-xL8%LRvkq{%bza?4q)W~i#YFYt8U5X*6{rf-smw)}`sn;Ta8Awb?1nR3!XCMOv zL~%tJAStOc!w`3}`!HQjuVGAR0w8T@(o1&{yHu(M*{ zxEfe*<7j~Ew<>G`NQ)8LgK04ZQzi1P3;nml1K4aMeB4G?3E~F!)}8PgXSN;N!6tVb z3p*g1Hw+Qo@CgDrhzTxSi8urZ6!rOEeW}Ybl||(oMe=Sx$YTvY7UCFluoYIp zoh^%E9K5JID4C)q;G%?KltvAZ5cA5FVVsyL%cus9Im!;jBrMBfh(j9w(_Zo}?NXMX ze&)!j!5+da(lfNgLImG3uK;Zd0U(&SN)zp%expV<$j@ARkv(@K-6hBff?l-nBirR$ zAa{2#y`ApHcc1uuoO7EXTU%+ru8Z5TwX^D_KHM5@nX8t9h_F=fI1FH36|gGc!68Fn zR+y21K$75~5TeAJ%niep!33cuK+Zx0_RxmWR|C)r|7>d=jm=$9fCMI{GC+%I?glb*%JWoaF^77|!!Fs8?1q_D*f#s&~!4mT@ z#{jZGXRnmy3R=AXJ(G$!~Ul~{qwck6+i??VhJ!^ruDZ42+Mc!o z9d=clydcNj9zN`U{$-qoFL?g&h|9|hbegMXtqS;jTpkX5nRbhqp(sGql%HVC@Qqj5 zG%c^86sUXhE!S;;6H{kZwnofo**_Qhp2h)={YS#GVZzpRQ(HmDX5HFzHU5^@(pH8v zwkHEDtrvV>EgP@1p|bXdck%}5W8xm8+>MSIOq=1mZz^>C1hG@=-p;t`eBB*ahx%r~ zzWL2Jw?p0p;euQ@GwR6~v=D?rJrmQ^3hk!C#$dkI%3sYMgWVNyyP=zJ0QmNV=zfRP zu9V$?ST|N!=wG+~osNk~gHXXiWE-uu9(tiEwn=AuG&xRcwY*wOS(j>Z2}yDqg5;+- zM1qRKU0VbxwnNKr8^Dl2k%$$`a{TbWeV!km|K&eDjQY4}I71>x@^E-J`iv03AYRo1 zB^Y+mB#+}j_2LCi2*MnjAcmP6AY&;8d3<~t20-GtkHX!t8R8Cy6BCm++|muQts(c;%#MVix)~r7(JhX4n76Kr z-nC}imfkInY?VLXxmE3`n>W@iDw?Bq{k>z8umyK^c(_Mps&!!2WO6ExgsFN6fm%#%i+1qRZq)Q zs(88lieoH>f*gd{AoW@R0|#>+9`^gZ+aITSnIIwUIi)_th{*Bb-Qnwdv_epG>Psh^^0HPuT=Xpvw$C1J`FLMD82pNFeVqUgzk2r*)wb)Wifk@D_3K9i^ zt*($mQb5mVD1ZwnXhAMWdl};Z_<~TsWSAC!f`pU^Ud?781ck29v{#)Ml~x?YZ#-(CfIuBFz>stAE42$PyRhyzILP|PWaLB)Gjw2Z=~D6 zyX{rjpb&1Wvmp<(us{F{c0V-W zZ8q|4b0ZU66L?}`;J30@9sm2`1>gSc4x?@IGsG~u*WKN0lGY~wiKYNUTW9!9jpkZ% z+5By6{VKSTR{W+EaOXe>xF^Q%&|+O8yL3z3HWb2k=FJ^3c=JctAkuZdTeRsWXbLe7 zA?6lx6N?bJ6P``ImRi)(${~wHP~3IX2~c1XCO~;;bX;|SAVN`sD13dNv3q^@@t^-V zW*g>J1s^AXhTY?Sub?1^DGz=r41ux?z_8m7m{AQTK|+qLgHJz(hk0H+JRd$D9<{EB zv>RgtnWonog46{e4-X%n4+CDO^D2jTANLROa=t8hco-ia0!5O@OgRA{2mx%h0uBkN z%wa3dX%Er>B2qwv>6SU$l6G$a?bfTxx~>AX!0qZR{t%G?l$8V!5W%l8;w{U&naeGo zVE6KUZw`k+e4DIpaC_73m9J;HCQrNB@3TyTz>xEp09XT&iK9d!n6Fw3023yGgJO(9 zLQf(}OQaOuG$*W;3mdKugfVJBZ5-WR3BenY+0e8i6);X-l(A07^U(|=5W{FJ$g<9L zDj*I9%U}#4M?|cL%QMc$FR&*Uva3ro&+jWnI?= z5g|sP>ddfPe?DSayw+MvsX$~w21^LA)n~()4rSI^3qYAy<06QX5Fg^O+k;BQ=m%Mf z%?hC$#zC;!GM$BBtvRHmfN96^u_^GmR)Qp42_J53b$va4`E>%u$7QYS00Ij$3rM`E zLXrr%XIC$PDwG5UkdP?apSPJ88Py%}8Gf)&5#@FGpZM1cg#f6UKdrWY!CK~{Jw|zW z|MUi;%5zCS5>s(b*rhqz^rB3rw4mlAH7ORLUw>~A>l1f+Z zSd++W#1S^yq{_@I5Ug=Y2E%fVjbAa{De)50)U~@J$|E?oKJM^kx&1hTU8@kSa^v?fr z(zDiHFm$^#dEaFffNQt;H>zmgl;|yTd;O)kdZURFT7F-PT6H!~A`}1~z|y)}=TEV_Hv_{O;%X`!TCMJsna0SgRrr!+y{iQ4l2#m1c)QBr-7U_VL=M zk7FJ};)6gS5s=-(<#bm0>FLAc1D44YV+;}mNP9?3Qz?{(=YRUAcLUC+&oe#0|9Llt zWu6Om!w?5T%inGMR)&C_UGL1p4gKz^yf)FL_3goT&yK+8Eu*gA?EkUjzj9ld8G03izYa_q$J=zdEF4$CLj{E546H-9Ah*RCGX!oKY!T8TWVM5T-J3B08ZBNhCv`Jrn)5tAqcyg2kf4vOVP3{7wFb-xzA}cEA#Qo z%LQ1fGSs6)=Bp`F2fzYCfGS(TKR85CiDZYd#@A6`<#HU4Ye*GjUVZ<;mi=@&oefA2 z&(DY5E`-V06c{8XjN=gZOL*Le3f&D*T`F=wCa-0#K9_ZQ<`8KZ{{Be%iu=*tY|`$Z z4QAG4_O^Hr_Fb7}Z z#~V&QXGJv?p(ZfgJPyBJ^Gdjlbc^7x2~Kko@3oT#<0d%ktv!XADWg*(4ZBSas2K`@ zgG~cVWP+ns5@x_m;naF20eh|VA^mF&>HRZXiSg!#+ zvMNH{gK*~r4|;l@$r{G{^{v4*6H)7Pp`+x1OvkU5r18P{N?=o$M++!e?Ls1ECPjE zwW8HQdwAXnE|=4P54JA84q-?Um)9BNIF5o*>aq@ykYn*$ z6!20)BA<_+|HoeeozK7RUp_n@kkXJC3Ri_E5XdS>2q7f1QmOG0*$AczFg8C=0Js`u z509%Ny?;FXx39i?h%H1kwHVhu_{(RTcz_JUE<`df#L(q@d|84pUjA^9pF%7ygIx9~ z{D7QyyF?2V449oI#g)I#`(19?Dkl)2)s0j{pl+_awzQnOx!`UA0*HzInwVn*z*`x% zDR+6WX8#-pr>1!9P~Rw-+>|-dtbzif0y3m4uf=-Rl_EHp=w7wNJ7s%2np4?Uz|BA!dKWKtRUQFz z=@pT02@&Q13571k&@KOUDB>{b53hry+ivRSepN}8yULNakHP`2kk(wl2;55M)!amw z80MfLEc*)Z!`_r3`B40)YY*AHhncH+#bgXy>-ptUvD@uZJ$?Fo9LA|&|NQeGpLf!p z3o*Ci0U1*YY+6b+CV?)8WyX-lJT*Sc5Hl5Zbr6Zf+wc{{n~l33Zs-O1xO=L#x;ocu&f?gV+eHEf-I4c(}Z0ke74SQ;EocYHLJ~TFO~_ z#eo7y(3YfDYO4`-;Wg=zo1UklG1D+15C&j{V;})kIHF7INpIh6Y@%14FsOl(q~b_YSN$~QC~9a%Qrc`@Um>vq zEW&_+$f3Hq=BzifLxVn@HVnrYN>}{OZ#X9#LD319 zw=m=_ClNn5egHYad*1PGBLVCdy|pd9OC?=-0C%Uqedz}m-=s;u;mX}UN}YNj$~TmY znEDLiyL0^rM!Lf}-}38vLXJ1(0Dzj5@DI*H-wm*rM_TI)55B%^TyfSLwDmSxH?$ld zZqfE;sr{+<=xua{{lsKHLVb=g5np_i`?%yD^rnae)g8c}Ll!2t-70R_rdk)Z1| zovZOcWNP3T6VGJ0%&G<1FC`-GhZz&K+SEEpYB5wH3J8!Pk7>}CM^1s*wZ@S#95f6` z&S5`BuIpti<;Xbu!eoP%#X+J45(BhM>@H~!`T2`TDvbNfF-4zk^sKUWm(l#2q4K4h+#H= zL75Kw93n_|&p-X;QrCzu9AtvkVPuq2AmBejH+Qe^$slO$YfQwza2Vewwhg!gakk@{ zeUk3L!sPp9`_|x~=Z$&`@m2za*sSTTC{zKsJIwzhiH_~~y$sk75*@bz@eMWnzQw}t zd}%x3w;%t}^*bSk!rdrXNIDkw;{pFDN%O;-BZ2qW3-}KwGOs6dG;YMEh0R;wym2Ca zc*1TmzYR>c_DtS)IuU^9``(eJE6J)5)O|M=fmTn5(2ULQr$Hy_=u_d~++`sve`)7Q&npc3dZ13)?9>zPA_9KW1qoQHi1SahBM1m*y=(i%iS zw5*qx*Qp{Pi}{Lx$TXD+%Q~4=URJ~~K42U$)umQorm#ms6xggx0C51Y{QFO`r=ajP z=D>T`loOp~hyk?>3*=K4oUmG9Q?CfhO+H|mu$&2LEfokcLYH+qzPub)Sxc#i;P^N& zU}hUy^~=YPAKveFh_wIdU;c7FIuQ5IycaNsYA2wTo!?K`hMKXJh6vKV2+gfD z;cgw=19NwtEVo8D--tK=|6Irv?bdS2F?pd}syZ4*cN(A`5hzsE^C2DUz*Tx1`N52tbW@;T|%)k5SH;C#r z?qcQM@qw-%V}|k8kqr%WdxKc^tclQFp-CSD0Hdz8(>D3gJNvaT^7eEcXm;`X)SBr7 zUwtS5*xFWUi?QCg=OoPoAeDe7)zM;oVnXnSk#G-yn_ahdPf`=#?A~{EMbsbJ7VzEwYMV3e8?Uqj zQG`}|gAQ}P#Zd?iy69P9s+1O8d!VIjgmA58SyWn~VyXIo#(}B|*%XE-hy;;qTk31Y z-gN>|b11fE@W7iWRICXoG|Dr)tdGz5^0ET8mMP(a6(i-lq3gmGjEssbo@C@G`V z-ScZ@W2{)4J*z;S=fnG_-Eo?h3P~_wNy7k$EYo>z^=e8-lxb;IR1$`97pLjduP(|o)$~0zeL?6-fB3>6$ zHB>N~lePUm$l^Wty}<8II|Co3xucmRv8my_%dByMGma0(bwjzk=pK|b&Y-e;(- zfEj8vtN_v=u=RBXFb#{>5W|q*mzUrE^0g?$CIe&GJ&unD;n->B#bHdc6}4@RvlxIf zpxWSp?`HhQi5Yg!Q^jl1%Tk)~Aqfk#9;VA#zuJ60UCudBA~2_697;vi1*g-BAjTAS zAO7_Dbtw?p?FWr%f1c|yJ7Nf_Q6a4L_6kH0L@Q!yEo0U8N;iJ9GNi`+F_?-5s!3;eCsxX-Z>*qlhbwL=vNy%~vc6sVH` z-V(Ol9R}BHct)Z^*g$9bu7vY8dPjGw?q9jwM2GI|!G?^Gw{WnPUE;@4)ZdpN>!#$#IA%$1g8mE)Dr?Ps}+RIfMS)RVo*^) zr`O}@R70dV4%@xXudb^bfWiS`c=yxKu}u4^oTuZoOisJQqvG&&s+d99)NMY;=civB zFe_&i1yU;jCL<*Wg?-#(ski`$fUjN2Xs9#lNsGP40;K#n4}zCp|NQF_aU20gh-tUm z?Vqk-#JVUHA`<9UWo>Oey8+q~-EWuJ25B$=A0D5p<8rQ-Ra;EK3>mDf(*^4Uy}a&n zA|xTikc7fYC|2<0;b{R;2>yq!pH9kwK`Er&)1UuR>uOB<@g1sbZK}O3<-$g+mBd9t z+t ztog=r*+Uhm@>B6nA{AhsD51Gszbf9JTSSg`H+{mXaXB8P(5SgtuWyoHdz zKfb*xHTEc5-|TJ%`92RxziT>)40mk#>tMH@59a8Bv9WDD2q@S$g3Ol1BwS0lwvlgB zn*g+q4n-&uepgVL%>h?Pi!NYoW91&+tF|72=wjq8?7nWN&C}m*lmIrcZx3G}=E1t3 z;U-;u!Hrt5<{eFf!64oqZI3XV%;DPjC~c?TF4OZ8-vIqY(#^!ZL|>;$HkX7!z52%R zjWyZ?gSaslfAFBNnQHG(zxz&`Xv*!1=r!^!lSbdntL=mBG+RRWc33l`jIPqz!aZw! zGR^5Ou)X^dgTTfCN(7h}qDFkl{r7I{E&nqFiV;8#fyJc)fP`j8-Mh5E!2>ht^_K8W zB9iWkXz%V%`qMUmTx(h8WhvVEBCSt(0%9ra@wiWy>A~GiRTxD%Kw_!W68EzKH7o!S zB;=|SY&Ka%D;O+U!8xXVS)r~9WL?dH;_ve zpC6Ua%W_(lJO>mj9N{5V6oNOK6M*t{I#08kAW%r)2*Bk_sR{(P>NVxv^G_c_T}E5h z*W=eC*YV-$3G(T;qpy=i^$L|RjF-7ut?TRg9Duw}45tc`Rv|o&QY&y&;91X%71e4n z6#&zEF0TS0?U&sy;kUp2`O_l1kaz^-aCqGB$498DS^=i>QddaMIn*Fkm;|WvHj`1D zq~-YUTgPm_CTEJnQz?ak^ZC%Ijtmy$-C5Ep_vTA;Ks^xQ9V4TPI?@6nw8$%_K5WvA3ARn!X?zd&}CVSIR9EBMvihM! z#t$*6+b4f`8SgLU+h1wi~@>a~#`cetgdFitd=a*|v7-EpYc1 zv^QplH|>#Ls0lPNY_(RLe0$moH&=6j0*iDVso#xc-ZV3BmiJb zP3HdYAvYMbnMZQE2eQAJj(=~o|M1d|Tj}3F?p5~9g*UFfyE1^5nzh0+X^1I` za$q6}_wq5+TpbRm*9H4cT*}`SN?pI~t!W7W)XVG3-~RS8mF9elbH(6f3BVh+tNc7}iSF>uH*t2TIte{(|dP+6}#HKMj>Zvu~5fw z&2XRHlkc|PO`(zA>>0#OXi*noCpWhuu|Ez{wkD|@TI{E0+6-{pti-P1r#fJ8bGN0q zffHvprwC@)n`zzv1T%9s))sMat7>GaLhb!obwf)tn_KU11$`UX-kg>ep57nQpwU*c zXm51=+v{)#^&OWs#^w#bd#iT$X3lM!@tX`E^;oc%Ja%xs>#Op$PKDXQu(CH-E>!Mb_U$!L zXD7n|onL?b_22(`(OCr{SVhqzB9J6S5vWefGABkcRuBtBFUP<9^$1815&?w5PWDeT z&Z_2!GA8Dxfy9!AonuCUKnGNSwY5!-G3NcdhkbeV&*$n84jBd*kNc?WT(N%`_J_wY z)saP3N7JCGzK9tr`Qi`B7GJa&%Ccwy7`}v{Nyb5-*i|g_kU*Dlm!E(B<^3a99;*7o zL*Av+^ZTa*^M}U-6VBsq90nlm6V|ED=XrYds4O6?f!Pp9h$ToG57six%j0K#sjE6r zfdSKeT0#Jzs%weibY20VuD|RT@NPfk7){sH`S?1mTBpl#QaKzBW05@Uf&g_nVn`w9 z5FjGm-Tw9{XlNA2QJ1Qym!(u`D&7D>-WQkS{{+f(B=~XwamZs9#Jwuy@bkyRPQ+^n z>EY-9Wq!c~#qO}*hy3Y(O)m>{Eo%l`y*HTavn^>gMU7FT02?BA9hh}A=^J^a>!Prp z4eVRh^;`CR^}9ma&%N!)ZD(sL(4E)P#P+D^$atp~GH~CR!BqO*_hVO&F+kT3BU( zT3w7@D+=##x?4T(Amq0p>D6m``wMP{&)_w%n_JP%{V<@FWrDyiP*inuXb)Q1TjAz* z`vx_4)3um_EL{^`gf}@wV1z0ZYbL+-tNPaL z`48UB{n;B9)z8YXhP0yoK9me>6;L zWGeu!oru#io7Qw{oQSv;l}Ctjh$4ukWp>f|(@pe-x*i75(|f*wuh*+zQ`>k`T|s?i zF<|BOumAh6pA2(t_-6%yQ8XF?9c_`J&j zh+}{kUFKR>P%_n80#YBd2y+divawLT@Nzr`xE3Hpfz?`S*fI<$UbdX({@n_sT?j;4 zm-FBL_UUw~3Dfah!|{3AeZ{y-85QfY#$h*(yBv97Z`zXgN6Y6sszE>$;%?rp$F)O} zfI=7&#;W@SU_HkRtD&h#0CE5@9-f|ZW;QmG;o+x0{I6?0*Zqa^Zuj`4^Qt0#Pn)#?sFed>7W_93)^ZxxCegR+)n`$ zbuLKr<@_zqp>ka;Z%*I-Bhs=(e-|rl_GL(|~BadgjfT(5KYr!>Uv`XS((;)#v_(=JHYhd=^#HsWi-@-8lT za{}Jj64(NEQ&$H_MJfPQt9sRv?yfNh~w(}=C zi58vL)FNm$YI}yL+~vf+wcB9ooq+u=#%+x%3`EK%je)@C#W&6hn{ws2?_@G9nnR&5&=lX#4&5U%_3@>h7Jx?p}LKHC{^!t|jHhO)zPDmv^(X<#xXh z$ABx5pc|w1@#_o+!9lh)Ww8yoWrA4mNzzMh+F96|4%6F7=wQheut?p(Foj3}V#qai zqm`Ya0N_N4doi%#uAl*CmHUYL!??rr-#oJGv$bo}Y=RTRmgASB*;&2o5Und#gc7yH zvqmjzSwfSoXeoSOrpvKtW2cybAYmAVK_&o8!r=^+9N6Y@zmrmyi~@aZ$6sEnY{X$=g6Fx2LvrTTd|&Cgv9r21Du!6ndO912*1a+SAtiw>vK~MG?cYBgCyO%A zGq~!y`M3HfKc>gd)i*?6WkG|J38MKKe7+ffjmdvnqxeSSfw(X5cL=;6a z0BQ;riNo#y5rqtoPw$4jO_`7$<67$!o?n0R-H7S9+A@DBIY?FjFjsO=YG0#3bPBEF3=#xl3HpO!+@nQ(V+dIQR9F)@YXkB(`>8aEXW~HZMz&!p(Dg_} z2)&4_i*W<3(I_ffwTHG_So<@o5Fy!^J)NVkm9_^Sh#Mjb1JvLIy3b6tLx|kDg)CN` zgjk?vU0KV#s@blly9AZd8m`ke}^$KRw+B#)& zs1Zce8_`0|)dXrzF2cP>cGFtr*6BvcTN^=#y0{aFnm}B~ZSU08?n1K`8*VOD%b(h2 z!L0w!0g?>z+604v%0ydCcDHRRgo()=+M*40b3ntk1p-dxWSdkhWD%bpA5>IHJ6U>eD5`sdEZ)~HusYOK-GlN*-sRF_wJ`pU%z}=YfbF2 z70pZ);bD;D7YvXzzDCxZw@s+Mg?X;?`NCMrVytx`o7bjZAiF~v&kG*@@Ra_K@#F6D zx8L;n2`dm8rdlIv1zd~yIP5Z@WuD>H4JuEt9 z0NL?w7}x&^;2q_daM8Gv9bsPb%lUl#bW|j~d=&(+pJtS~;`xt<<=20wk7WkNU;gEn z!{73Fc-##E;TeT7gD7Z|kp>ob+W4z3;NLt;y?b6_!X0b5rdymS$sv zJp+A9bERus_}0Pfhnw3KF>WPi`fX{Fw;SSy4++rwoZkAAcW<^U4-<&tdS4vawxrf8 z*nw8L)}3Q-36ZxOk#*0y@&C-P{xq(4au46Mz4#tVyTxsg=9Jtw2fW)v8+3L5<@=Ek zwvscFAI80Rv1PdK=XX_7_XjuJ$oTHX-hPQx#lR`V05pjS1G}2u4B6Xbt9BrUwcg-O z`E7gCzk~i=5w17E_#45u_K^7&-)x_BvLE)4dh#?jH{~^zZu;8NP*XZx%yOY~B8SH#@nno^JHEeCBtzdY>j|Tyd1`nk`!Eo@~E% zdkPK!OyVFfZF}fraR``+i70N|FTy6QiLCmIyPK3F`=Gux;<49OVM;LbL@i9?&*yq4dqKF`XR#1p=uX#K?l*yzQ!rL-W z1s8DnGMxi<2ssZarqCPP1^{f)4OW25d0A>;VYX>HFHM65HX{knCnTmE)6h@{^_AI| z<@j=%)@^fX?=#k_(-+kVd1zdrx=aCZv%8J8{n_{7Exl`HT~ycUvM&7p)2oO8H~`LZ!s6}(lKyx;Cmj{GT=_D0$tfKM;Ms~#b4+p~0(Zl3JlCbn zwTv&1bFXy#G%m}Gm;B}ZxetX6S2(}y&l6>P;X33P=T`rdHtTGPtjOia8pi+`4aziTW#m&-+_fh?yk>6 zNFqh_!5j?S4f45-w&U3@$X#L0#$~-7t)X57TgxGtRz4DJI`tNKuJNrCGCmMj?f{?> zk}JR~Hn6*>yCbzY;r0Zu?b94oI@^1S{N74v#SW4PrYqFjh%Fnzs$B6G(1CthW*MG`HnS zH_DTMG8>$*9)5jJ-;aj)(yI#O%{2>ab))kmHb`~|G91Y4jvB6VW86p%g^(nXz%w1X z+1@yfw?n%Tx4n4x$QqrF!g{{VUpBioQqS+!{K-U-gn4{$H#tAJbn2(<)vnU0Gj)XRA2_T zsg_9uz~$+pxI(92U$hgX+z&$@SOjo$6$n(| zfEKUIREi~$1f9ogt<wxFK}R)u6(^FHkHGp zlrmRamRgis0ND-a3d@UDsIIU#i>*HTfuLRz`vNh@0ynJJ0aN|cb^Z;u>(42cBEOclbyrJ;4vA`&4TTn$iw8655AYwd(F8qL}7 z55k=+>Z`#3Y;CgMqLcP)=x%nm(~57>LB@eL-}Bx?85H@e_XOa^%krA^azFN#iZ!Mz z5gIp)uam8XgKua!x1)F{U*9#?V*hh&Amp@718Ng=m9g{{z{G0c?(PQnOZPRq#(EF& z-{xec{TgvaE0%3k?_wq(W=_P+289!hEv6;F<`xpt9uI<7HM5louT5lcB}a`KHrg@U zYBT02nd9#GvpjyizI?u1$^_1Rt^lgrJeSEZOpCg!Rzd{ zA9COIJ+zhtK?M>MnN>vMEF)OCJTbT;EsYf8i8hxw`n9abShB`~_S7djf91wphB01M@SQm#*W z>WII}NeAY1=-&O0oi4N2@+8k+2%_m&`Kn$qjiWY}I7WAn`qQ$!6wH^e`CTvaD0IEP z%r6+eygTRIWFP>y3N?iaSSf98^4^1S?+w8DLj*p{{kngFJ?^ZrJy)V6%U9EmwtEXg@)kx>RIkLJWt|vo-b!g(m&#iZo5!uLu64^IWG5z$*QO9)*67B&0Wkj>SQ-_E(7X?w>6dGnaf ze=xwmYq})~FRDdDZ-4!EPrE(>0-SAY@!aU=0`Gg{NQNyj^4(+FL#0MrC1hCZ03U)m z-hs_hw`sn=8;Am}D0BTw%XaUoO~k_jIf!?Cw_c&i!Ih13bO&=6{5f4>kw!k}3RtVB zCZ>hmqr4$#Pa>m@*MMw5*Q-7E7LQxd{{MiNTWV&p4Flepwd50^u(A7?3j3Jbgp|E`I`Y>X_$r{ruMpW4TsE_-?ZL zLT>j{MQ_y?2XzHi4Qap(h0hm{eH|Z$L+(TuII`sdo^ujZfIF~AdZ;?jWsWsV z$KmiGY(sxK^&PahbSaA%h>%$XP-YDgnc?*A+5Vb$3qWFnFw%{O;DKurl#77#+V4|L~z0Ua7cnn8Xxr_(&OVlcgssZ%~QU7 zI|zE@2a|8Q%(c6WOHIsxazZclr)7D%==Agtd>kH6eV3=})AUrP%k^?B0v1?H-zhkN@%1K+&=o2^b>`~UEz!tDLG zj$1JIZyL6rt>4=gTFKu2$oTF@M0)%qqxbq0E#UhiS+X`n=s?>iV;2t{*07?iQw;Qu=wCW`lmi*L=*>Q^yR{=fD5;x6+ZzNxN=Q1*cO-;Q;@^b71e;`3REpt07|Jl0q;P%l72HKMuW+qwjN< zAn-1=5?HpifVS28aPAMsCHKHmlOl^w5ahhd%YsC|aXsts%fI)ppgyIZyIwj- z9+eOanG!%<Zl5lo=^SI{cwG3$hi!UpRO6W zj2G$!*Zy6pHuS>XM|?hf1uArU61?ltbwyxR$8jvTo33II%4q~%(gN*?i@-D~kND}x(nvaMaqQA@X;e$8HPZhPEIb2MaYzB1RfC?}$I zCx-?xNlPIb+}+_0No-JQF(1j!G_NVT?*~B`+~AG?P1f(Nd~p)~N`(fGvav#JhkDa1 z`0|I_oZro<`_ZB$IGV^WZJ={(q}vVn>Ok!*7Bx5Sm4{)CH1GSq&ajgdK=Iv0-QlF` zM?vraNg^X>>uguyXzV z8i>Y^JJk{gn2}n!$+|blim?EI7zuzJ+ieYptZ8oqg5iqPlqVI$Dsa$>wr`KQg{j=K zLJbMB9rn~V2bQQHVieLYH8+eECoR@gHAd{rJVkLQ88350|E7Zh-^ zbX{M}YN|ECii#Z1hXG3{O?J)yFb7dYTQwY0&gXwxj{lexK<-edXYa(86g$h(G4=h> z3rZBDTS3OWgl_JVU0A z#`98bvabn@rJITZI9PXH&WBi<<5g%#+53xXT`E6aYso}#H-m%wV=qaqPM7O+0%v;n z%k%X!9#046oKupu`T-09gjt$6?rUN!tb4J6tKPaVc(;mf%gpX*Y}HmALEW1jksdE(Ex#AI z*H*?#fEfYGAP5xd3bvNeH*9S>POVJnkH_!3{ws@3JoJ@j)!Wp3eGCf-k8e*Ck%QVF zv5|DYJ`>##|2t;~ujbDB2L_0vQz7OwI5a5Mm)Tsg`?D}Pw|#=%0z$Vkp2l$UUE_K~ z!D+Wh+SS|_xDs0GA`J8^M`8bEk9K_uxjd+w+lu0CO(keovL=-J@}K_qzyCVs&L*>2x&lmfR(Ayn_r0*{ z+@9yltnQ%dwfve>m!v(E%x0(vi7PGBr68Ai1|TU*LS;1oI%p7{b^D(DBz&TiD zPJz)euT%DxS~3HXx)u}uErGNkV^UE|^ zcRop_MUt!c9D6ROVdw-pN3KqRacdu5fgM+%;?m{BLpuNTmyag^(T$aobX|tMA~R_{ zzRhn-hw?EUzRfRoy#T<{jRgYEOnrA45>k>3y>`=q1gfUB@VLyX5HeGTy5}q*&Jxy5 zaQN`={Z~DI7!IAJl#{!Y$7W;@Vh%TKHD}wkIf8kwExkMPO2UtnDQ|19#bV%i`@w_2 z;j@`n3#|WDT}w122ZOc}T%&a=Vm?U}Z&}wwx7)fxqXT1g@7F?_pk%B-R4-x^$wl+` zg>Jq2>$1GF{u-?QK|tR&GH%3>dv4;j+7Z$6 z7xmvQCBq6OUQgfl-E9-`?V?+zH^N$1H>T*%S5!?RfO<7C_DGJXnyVFcK*Xb@fXzX| zfC@Q?6B04`zTo@zwwo)Y>IBIK)rv&It4#%iz+4e<7^8XX#4!D?fZ}&XvjBG{Y=0pw zAlhQAP}AA|wlim|5MYQ|uG5}~fj@)9u0k7|?fbEOqc=OkxUtplYQOFNo9o=qi z6?(j~SKi7?o$pNIEg&+E3G&J?e}{$>(5jjIRff&?-(4rO5OH)rx|%wKB=mq#MM0~2 zM-nFT$R|sZjThbEu87(YXk|C{sQzURHV^RT4UxDt9?=ppvqfI$hD0z3$&12CRC9mmB_#)_hiLU;wxA>|<1{VkmZA_) z&Yhyd%&hjEh7-a0^mslTQX-fu>Wn^jt@n^5NJ|uedT8u4LFSGa6QXY?<>ULuM;&@x z^Px|0RVBDWI3)qh;kBshF+U8))4RvNeZ_b>cL(57G1mmnsM@ElA5JH>`8wrJp#@Oj zG{LRHt4eI&)eX<5JPd_Dy!&`Qf>?sHNF-%}xylV9tZVKACSXSDPdJLna=lzCfRYwK zkZF)^NWvs3A5z6Q8yNKpuLbk9IGAD89o3h+2@ON)Pao?4P|pwV9*#NXE~x_r!laep zl)9A3V>cka&&qAR?Q3pkt4C$fj_V($?yoX>fK%IJNDv5^q>$IETFdXodx3_nS=e*W`|R%=G$>-&?(BS25xj1*z4fgdfunG2cVLs23)i-P(;Z3U zx`8r?8~pmCma(@2)BT?tetP#lT;U#c&ASItb}7BLT^T|Wd6N`me{gdlAVFa@t&adO zSkU$FJG)gvD8li>SMqNkv6=pNJKX=@$G<6?*b4q%+r2+N1%N-ydjD6B6$Vwa;M!+m z+Gbn}hnr`x{<5ilzT$UzD8M#_{R-=n+{wr+TF`(y$gmkv6Wx#1Pr3|@Sk zz&VMpeYPfU_zfzD`r%rig}twh3XOotTL3s2T26 zXdNMZJRTtWY@F9swo7mLAg3XZFYB9OB!K!ZT6c9>seDz}-jw@Y zb54&ZnexNqaS&uqA;SR4LSWsyxCXfswPfj>hh8&K3t&s4r^DlE>UdZ`BnjBfnYH8< z1V9bdzu&qfA0B@mkB^6(M1&GF5@i(e4H5nM{P%z5Xjzbbaluybm_Q^_Jf?S);9)GMw}ji;ywJji6x%Eaq}%3Kqg>k6tZ{-TMAKi(cX8`9GA3KUMG1zrOLm)3U1O-^ zG%EmCCiR=wPAv>8+wQK_&2rWB&G2CY?>R4V~U+@4b;pbTKR7tE3b1g{NbUZFtTarX6%2ESMK$pn?XBAZ-(}QoJMwL8N$5?fa?J+D|E%nT>)qb4 zRBrrbD_&dIkF`a4%LUwS(h(mFYJ!yrmpF-ewMZGkwQfzc87z{B*{zG5&PrR0HQh%9 zn0c)vkuPBEP}w!($=-^R6{SEp${~2Qcjm!+;|bloxTLP@0emVDNef%5g-HnY<>e*y zB4&!*5spW|7Lmtm8M|dfDiaN&?XG21>HDQS4HF#4^zZ)p;iqF3 zSIoclDZ^~)q+?S>2D(TbK+RO05`e19Wq3CwRHUvW*Syp{K{|@HAeAkEg?b{Exp@=yH5_?3OG2WjLQ7dVHGwa;-~Q6b9&!&zP36 zOb>$=OjU~k{G}c~9Dh2f3z(QA1sVG}HQ|lcT>}^^5qKdLK#u*n^M8D)a!BKJNt%{r zF10e4j~`B7=3zni;e7t-Br3=Er_|G9dj8wPiCdEwff+hpFJLP#zaFY9lpp(X>4(Qt z-!Ta#NGUo`4swyqIf*d9P}DWzKntYn99d8km2Gu4vTD7p%NkRVB<)h|u}K;jtZffs zGxTD<%+*@v6e;ptHA*Yna^z^cwGFe}mZ1TrtH`OWgbmx;_J*ScXsK2_g)yR*-D^9R z1q7)L>}rid23K!>K|9~Zo4t9j%^2O1d9Gn1ylp10ya<8>iF3=*P{4=G5ONRoa^t{+ z8%OgNy|la@+UbN=3M@D9?V@Zoy={*QW57&aK`KfNG`O-kr_GyKX6YLIX|g%bY^n|t zVS_@!Zp?tTR}q{8%wb65fry)l!cAR^GO-Yo?6&H~0A_-*me>WOi)I}O?GbtS;gZ%CT*0!A> zr>zVDIh$c&2}8CT{hKcy#@caHBBrMC9xQR}ZYeeg7_SKi0Er|^*yfCwqS_d$+6f{c zYU)x!^V04hUdaaRDih$URUN8gw@AtXSZR5_j6}qghyFMm-=o4{21!hvaq{bLsl$)~ za5r#;z)e_AzrD;)7p|xm3@J-Kcc()pB*6%zKJ|SjCoQN+dU+Uf>89yWBzIYQ0I5ca z*4?CFg1Z&7iX=4wTFX3lITtAvK%q`#=ut1Bv!}};B@7+L+0tUzdd1;@ zxt7wQkq?W7&#txwK&Ew`IsjPE<&04d8PzH0kHR_SE}<$hfhii7MBJ8=xDRldL^5!> zemeKZ+@4O9u`!BT1A>s{qUjBvCLv2 z1j~!HH9-vGy6y^2tOhsS{=- zP11FqMSTa%_E3c=gCuQw31G-7YZ`k}Bxn>Sj5>N^iGcGizqkA8#(#2Kw^cx{Zng`O z>#j%rPa{Xh28r0Q=?Jy2JMb#KVc5Iluf}T(iQ2V??P;5_w?yQM4B6eKZoHefptku$ z;U3?Cz5YsrhXA-J-%8e3-vDH6jqFBRB9a9SS~P)@z&VMC00MpkDcFr4_16W1=xrro5fuHXnnof{6)7WAa+gzi79pX)Q27I=Hda>-hXEK}!;Oh*s!*ct5I^Is*>s z(?O6jGC>s;@RD*)*5?eS#8egYGEFQDQ&xyqttHm^?xM945y;J;V35ycsRu$3_gaGF zt{+l@%>q-S#JM{ik4P8b@L{M@-CUt|7;?g>D22t%R>`=P@Ja}*uC*-7I4v_6B%-e4 z_4-r}8P78rl7p$stpX415T?`_Ct<+rGCn^)O_2V09PmGXssAzpb)IA@b`cDZ55k5A zeV#8?A>094O6KkWSrm|@me4clba^_L_M!mz=9hjqTJ1hIKVF8@y9sh3Ag2zv3>}uk z(UFE!QO9Mes%o{&B{5VB#_JdbG;ZdQ!~0*xTm}ZZ#LY)dV7L`{Gq%KC^C2ZkT3yQx z<5^QaNgBw*x61_sZr|a|ZTw)X1DhLkMPDQv*7EST^LyI1qPs)7SCHQz()E)__-&E{BS?{!%<^HHTbL7Z)-XE8%2ttO!tHG#n%ZNipu@{haF^0O}NIm zarzSzn|K4cL;*@d5|Hxm-`}5jP`9CIWgkD#VvI;%z3%Tsq0tl6Z*+(d%Rr(K#^Y8eb`RR?e1)7`}~ zgqUy?Xf-+gEa#_-F4HtEhBQo~#`g5DC4;+0QgCzQAO6EPV47+%9dm!QJXEWZ%qmvX zB7NU`KK3XGnVxx^3ldPdfMD}&KiaiFRnghW7XVg^=r~8aS56pE^`5)8*SZUdmQ`w$PUz^RXk$-~)&z5G#__43EJk18LWtt{^?$AA)26)vZ%QFCUQE*q#_wzDABzJw)I-ugh z!{xhK#Pk}XU&q}9KE9uUrv<=i$O3(qF~3h0-Qnc$X_=Q&#cNq&XQ=k{<@v+y>;3VU zf?sDR^p9K1V1fYEbs-N{29nG(z$}zR-kk9Y2s7aa7VZaQD?;3VEwVqVu23Y@EjxoB z*gXqWNbf&j?YipTm)A;yWV=%P-&w)?BZ;|LBjmU>S2Z5u{U1D0 zj)NFr6dedHVq@G9MLJLb7ISlm5jBU~9PS#Ev;}YRA3>|LzrQ*1=xk@*a*`gXIvH5t z0L8||Bt&ikYXY$VuqkD%vHATjvm#h~v%1evuTolf7p0mV{-Z58tRB=W?jOfmv?y2$ zGTj(ZV!#qYxwZlvv>o?-E4-;!wT?p*eft6!LIjBJd&MlGo-HD??N+HpuEf##wjm#{ zYfNsq+0HK?89|Qs{tzR!HTED-h=$eXrb^8j#%z2f4XfIgQ34occ zf{G06v!B5%&m{0(QOwbw`(Y~M<%wxd>5$S~lTDvTLVqH#qp@hH8RINj=ZrGj{2~XW zQVy`vRX`MyW==Vy?|VgM_Jy%jwT$Xm62!}m2!eJ~(h6Y-uNkgvIvZN?BPAS;!|9Mw z>QYN3)asm)eJ!;cFGY&Mb!Jp(1ys{Cjn&~Dfw@svN1rp01UAnvPtQ-6sXCC57-d2F zM;(QMl=EX%WMoIHzXc=%NwcwtsFusOr_WDMW2vWiA5~7jEdQ^U0xJuas?#{7eC)V( z$hbaTfZ^OnKi$WSnt6TUwB;fn)bDNRo1VIAeGH5X?9Vn-q zMQ0%Ae3Iee{ka0mwA50QYOOUV05wHfEsRagG@WXthw-8~9(tijNel%kXwaM`5g~b} z#fU^?SFLwj4AFHE-F`O&Z1Y&$z`k2Lw|iP)(mU6dVplfPu^dxIB_aBrpYwJU-;UtB zNGoIzUOhiA$$@kWgZ`AqyZgRvbpc_C$?uM^_Q1amz6cSot@Kapb;btch&J2+gB!>E z?G{@DBD`5^6Q@wwHiv;2O_V71(q{V@4zhje#Y)LYvbJ}@0X0@)1Ct3TB0c~l#6~a) zIn-^JY)GzwS6FcyEd^(+yT`tF-VAHn^3RW$Q?I_H>nw>?KroIf?ob{UgSpzu=*&&? zcz+>SpD|jhP=3&s&|dFdpSRxFNoDN;Y^@3r$lNk_E%WGa^)I}6LdUJL_BBr^ulYf? z=z4}Lk4EMj^t(Lcrz;A0)tPx*hd3*KM{lB7J_0AjS+l1Juc8~}M)VIY75GK^n_$y{wySx}ye}q!K zZF;s+V!>5XRb3%H9)RP!!_WcN$Y0zIwT|Pvv0I*uk-4J<1$CM62rSdLXDxFbdg_{c zapNM8TBqlyuV0_0F`fm?N(BQ?xhPJ@{`%g5p{ogIC|=1l0}J^n*>crIjt>b{p_Pxv{#^U62j*p7o?gCi?K9&!6U$noHeBRv= zZ`qXQb+2wa5IP9HdI;?c((>QigLA+F=M+Z+LmlSit=wV#&}#O!^xf{t99ycVWdotm zCg3W7!&ar+?cT%TkBxIRXbK>B2KIOAAsue}*0#G1znQ(eI43$Z_{Z3=`c|6s{jeL? zPE=vG`V@2Xy2bRyx=;N0E#_2-zI?uuu-KnqWsbP}<@OV8ye(}bUKa)%-{cqE_YqOE z1NXn&oj4k4zQ5P_u)tw#4mXGg&+7ft*=*bWyEneGV)x(q{&ZVf;f+UcM1X9)?%%`d zaRh2}{syfeI6KzV|Lvo^U0l>Otd(UR0PRgltR@FHjO5h~w6dvoDJr|jac5x}1Y*@>-w!D@P7MRV?4t4=O0`X);Kfj@B`Kz7t>b&_5|{qV4SIP{r9xiuL%3ZlZXQwFiIfVrvp+yIystGjxOshJ5) zbt{a{n&W$YAGhi1xQ~t;Zf$%0`o9hDK7IU<68ZN$W&2wTWbb=bIDP#k%C~~LKi#Xu z97P_l`7{5U##UGU-9?8`cza|wvq5m^j~?W`48#7{`{Qp_cDqjil@Vo#fw6`?+}$eq zN_yIuRY~B+`Xd~E-{kklBNGI|%=GrHDbzy3>FuYlVZw<+^*L%u6I5 z`U8J=d{>3A4n`EB{kRo3H*3}(ZB#6lO+*i8FVgTU&G#n4-v(DG)a+xb=5Cy!J3trs%y1T-GT#PVuPwEq)Q1%T+jpE@!a*NG-RXkiZ2F{#0(CNYnCCM&c}7XGPMkV z2V}$fkk<H4NJV$lwiw z`ObMIMo1V0YGTwdJo9baT@|VCsu_TNfsAe*%NDj-$bYc05*c6$R|6ZXn7g^jT9aq2 zrd|PZQg`CL0!N%qz`!lex*uU}UiXVL6Eid62SB5nRX1VYTiHnJ2_gVx2S`_l-N3d= z)i<+$qvmhNRIJm~3E^M~u zmf@p)&6GEQ{1so?s(W;IPIcROHf>EpzB%*T9AVIof^+8_w4@%B08Q56)pOzYF@z)U zo6)Cc_ySOPb{d9QjoUb+P(D38H10 zXB>kftumIeAE(R9!@$Qrh%Oa^u$5d-_wfu(a|d_0zqRnqa)t#;1=RgtD7bvL09ci|2J6RWF}kR(Z* zeX8K|aDIPE$DEHypPq|ehCYcfNuLBF=nnaOewSj76*G4;H&1<%;h3bcLopkHWrvoS zdb1WyD(42m$2FC&&`A zNd;C%Ffls?wSkJ=*LVc;Tbnh(|M|n#3oQUuYlXyiKn5!!YTV zc_jM229wq=Z~4WByWb7|fkBJI`t1~Nrv-N>3o$N&-+ACsU_wOX&flden)PohAedj# z^klF`GEE-v_DXe4K3iK{vPL|%LH+9`OoIsRH;jOy-6@%>#3@3s$eUurZov>7W<|}G zA}oV?RW0zW2Vj{e#UP?1V3U0LTm4X^Qm{=K01{^s7GXwyeE9U~u}gJ9EmcjIvS_X5 z)fA=9O5PU+^{IKeX2uD^(xw~$Amv0Lmc$Foc9(&hNghr={qinD^Ekc~2=@aOf>q2p zlcXdVPUiubo?gCv`8GNp9tTWC&Um`!u+*zwvN53Z`1JY9w-*JdX9z}}FX@z+7%cE{ zs>$l~bP|ySMixdo%u6K+b!hWakq5^6pC)^F91{Ba?rEANF|iN|J{J_usYC8EP>N1- zy>d}i#iFV2v%?LC-V4AfiQM|W7E^&|R(yvgc>`UDSOHTC4^UE_kq+n%=To1!>zP0N zc77^d&MAwF^c_Ib4c+;%UoEP;ikEp->H7mqBEW*nxY47nj*_`ML12}k+;)>)hR@AJ zxCwbOR?@z0d$SF;0PeP!fJ4m`TOb{RK?-)^_kFScVPGq@X?UmhHN~C4LA0E$k8fRn z$^iHlM@#fttk-lKwmPZnNADAoXohNy+1%J$C}F^k8+TJ~2fz^FrfQ99I z<8Z-x8(tnEKDci#Z1EqxmA`DYS}~Jvy+90W9oX$-sn!Iv>Z`lMtU+nJ|6qpj$O>&A zVuQPBRa+`aCon52oPdHfN{;#6j{tP~0@M7_*ICGk8L97%IWhC;@bGwk>@e#5qQ&N= zs9N>KPz0u0fow=JWSOSim31*OAbDLi#7wCPKJ(_>u_U&V(I3w5J{`JQO1X^SoD;QG zR&zcLL#jBO4qR+m#_Kp5u7F{#sd|%RZ(DfF(A#o-`t~%dE5Mzgpw7jC)OWy=imR78 z_WY8v0G&z}>EDm@%)UW-lIWDXUgqU^ejKW$B;27(NGUBSK$c_1;mAYENU|6w$r&iM zTxX;q8BBFx8^RUhc#A6l;$})rD#ivks5B+KZ9j_)MsBzO9A?Oe{-I+COV^!-UUTBa z$#P0m(BpW1`1H{48NiAvB=v^@423#C5Cs7uU{fJP6d>S6oX3AX92zYS(XW7|hM#OKL>z^*!fth1UB-^Y) z)u=5Hk|YqQwr$5PhiF7hwrxi3VtWqQ)qP#Dw@kdP#s>*2FU)q|5nWUJN!+x7+OH$8 zbyuX@&nuse2UQuH{E(`fS_B$}QEfi#Z)HDX9toK_h*t+S}+y{eS-_M(%SroS-vapi3IZ#TelJ^msb``{nb$eEBlQ#8U$jI;+uj zj1heFTFkg{V={Fhwx{&?;g|p6pMQFvbzWXBb4?GA?``__beZ`vOX>j(gJdiQT}nkd zOgNlQ;z-Az|HJ?M(~waoWJagzsu1QfJ^kaaFWgUMO#S(jeV$5%Jso)v=r~T-vbce1 z$iu@SUtV4mr;iXMCr8)!P#(^7#Ly*C^vBM>z5MI{`T)M*kUG+ru(V1aTsmW|*`T~!T|NsL1MfVu<#r+@$Q z^6QtO$MmHi9+8KXp_?5kLMF0i3moZ;*b;2cR436iz#=x zlLcyEkxqO9;2;rHCt_jV>4OCIA@>H`sDv31u5JK&+SQX*g(L!qVQE#EG6R!96l%su zkk+A-P@#}`xmv0T)_TtG-EvE0SHM*@6et)=nA&7|zO_B+1+)&5N|2m`?vDlVQ$)e-f}T(y_^-VReb}0h>b-kL*${nj1a++XHFG9VZ!<8D(azRP~$36 zlD>itU6zXSe0_Qr>dQe@FjiG8at* zD5Wk73Z^f=K3!)`tq0t|#GJE8$}#}BPUB^+#*&bUdw@QC`sv*{_0dti!;XBOp2pd# zmQrUu;3)^D3@DZ|Pi4^%J~2E1oKOg;<7D1)0nU0<1h? zf>oR)gSiJ1@@T~_NL5RjdjddW3}XRtOOQuR`j1stxXJIVsC(`X?;rYJDo|#1Fbm9z zrQxU43B%2i`op<9oj;t9{Yp4WESjQ&SwxaR)M2bkuB9$c9Yo-P3o}DOOiUbROwWz; z`2LotMMnFL&%mT`K-+HP2BM8MW9tfxeEIgw8PLG5VPF-TRERJ?13i4uG<-pa2pg;`UvuR%f`IngP`3)RqAtY@Cx)1sG*U z@u{kzqIUo8p(5I=tI~GO zEVHll@!yZlH)OcBo^~dHb$Iynu}l@1momG-O?6Q^{QSNi#B_m6|L&K=@OV0;=qz@? zL*>yckfakaW`$}^i%sKoPLD2P1tOqCf?^D&*99AdEqC0qC%Xa-i`_OF%7gIddok+W z{Y8UZY?Ql%Ad7Cs=a1~(+vDb)?tRp^QXRYGO8ZQcd|1Oj3wCP)OYEg!O*gy4yDtUU z^h3k9{hFIyCV~ecika@?>6^ zcF8-e%&9?-s**jbm0%K`9m!N3o|vJMqUFUkl)uPD)!D&j261Abs2Nc_X(BL%MW*Q4 z0#{Mg>L73!(`a;B>)jYDN@fj1ZKYnQ?2T4xE!ssmLV=)?!ReNZ4do4O5N(tBZc{jM zM2C0J{1$*w(3|PXEgswY&gqC~b*m}__}=cYVN*wqW3RDZ_$9Y%+zo&AkGoEKyzxo? zBR)C6b`z|5RJ=}p-`U^qzqn=?Zb!P^OJv?wRFi^T0ZkG1)rG!QPvnG1l7gB@E)wAC ziNFN_!^zmGX$9NVcXtP17^k(|39D%}t5aP7WWW?iEO}q(DRM|d*F)#!iV~UZ2{rwv zev<-}e&SU`$}{fUbxkh22dRYFNCEFaNmYk0pyQ$ZVNKTIu-fmBeVRUD5o-PSMkf z$n7_*L*aa@1AY7MATTy|^BPh9y6o@DE&uE6UK_6#@msZMx7*r(kG}sSGfBij3i-Y5 zM6h7Gm_K#*QimlNtTKBKCBtq9iFbs z5=trN0J_FaX^YL%IL?V{jT}9`biK|`g-vk!a#@bVwx|Hqb&wUL<$Qeq&sP*(O0kOc zlTOQ278_BD9*)BR5;{){>I9ue2y-uD&5u!`KUf&s>x>sjQNIysUSb>`f4<^B!^^dQ zdKr(IODPr7Ju*!R1(`axzaU93yK->OSd(ll+2NcNKD*X$fB%M=;qH2 z$17_EzbVK6{z7b@iB#7cpyeOhz28|@es^}>YOMF8A;1lkX?q~t#0eB6NumIRh_J~L z#I7kYzI~}tUC58(z1?qHfj5I|6z{p3Ca|r1$hQYU0U)>ax>_AlZ@qK-(K2bl*M=aJ zRBgCpYBW0uB+LZ&&4*_qn0@Ca5WygI3vRtSX%H7i)b@0>tw`s}+Vg7cVAi#; z^7oqIV-sCD%zoG0M6%G((EZ`D66W2*$<09e z>JGXy5iyr3nR;9*aqD0B{t++$lW0-DMYLAS_4(`gaySl;o+*;mO&mgu897T95b8V( zDW~hSbX6`ozkE3y6*+e>p!)dq^le;3ILrKNetP=+>+-U&irUgK<{4~;BGUK$>HOjS zhb{?lJVEMZTAXK^;)zNMlIhl%Oo5o)=nJT49fPQ&4Jtixfd1=LYaB7$XF zFt4txV;K73-7o)ieqa%hut4Z_ITM4CvZPD`FjG>vR-NZrS7Ax>`8g+yFGUv6@!M}7 z4hJjCA_5T*7&^`cS$cy!4_d}$T1-!W!7`1PaV!StWnQYK#E<=i`ix~90bOj?<1pkg zl8R?W6{p;#5jmVk8O{(&jRw?U zEJzF}t3{zp0BZ|SpT7S3k8hZ`2PQrkC<&7&MXkBK;-I~?BCnF=28c<}U9kZqwj~Aq zhnDZ2SA&?q)~Nk%g(H7t_ukwG2(OJE00_)q(G~B)k1bXOVBk5Q<E2DXP4*7b{CP!}YJ3R6A zx7xp(aiiPpr5kb2?NZjC-UQy;anSDE$(`05UfAIM?%`W)%KgRLT?-pya^tLqF+@mEDLhvk1a;^$KvylfT+#&B zWuE5hP9(15zA8itMDg|Mx3A?|Sj-tq!fZ%paImlphx7TE0ZCm#e>@Ejnt9Ud z;6xo#ZKOObB%Fa|d$YSZqgLhA!}xeObVnVZ`=ugrN&+k>W2r_!3N?Wt_owrx52u8c zBKCd`<>P6nKn9&34@s|=YQPMr*{lvwYNd!a!%eMPD%17z-`;n`b-8vqF$tjVWhumv z&ffphsg|)6tLOiKGGAYwo-Qi6;|Ln~n5j&ulyP<&yJhnE!Ar^!c{Fw5wrjpM;aBfb z0ba@4^}RJHaFd?hax@?k1xJ3#V6;jl?!u7uOYMf~MB4QHB$wIf`bhaE`d!r_%6vg z6znPh7Gk&-IEQ*{0@Tc^86QIUx0nw=?3LPd8_X3NxShKrp=vEltrcDuubFb_`2vI- zgfvyPD#8_mxzAU%3Z#t89)(2$)U_9dT%ZyJ%^X!X2D7F=&LHu~Al`4$%^dOi6g44~ zM*#_~j2hRpo3j=RkSNG(B6itVa&8}u-l_FP`~b8JGJy66hj9edY%Rmz(w%ROKY&bH zc0Eqo$U}dGNurS>f?N521Y~|Y%!&fs?(WUw+) z$~6&)SUT-wsf(#)PF>rOzRy>1vz@%kb}#_1)0e;ffBp3Z2|SLl`T6PTsZ;=DO9zKivaF7r6ZiRaI^^uN z4|bJ&ny?78RHQ5n;w4<>%$%8gu3i&B9U*AeUA1ID9ufwXhj-`GsT_us4G^i|MX`+Y zl6tK0#RGTU@o*SSbx90(l6{f893LMa0GQ;zd_2o?y-b>L0oaMWOzg4vJHwAI+G@!SuS{|GeoPb0eoY-yfo0rzM? z+n?^cEB?bn7bw)#6xkfxv;4jte8oCf-z9!qk)j9Df+e0pP#ad4c_}rWa_$9Ir}7~J z8PllpP?(n6qEjWPmFf;uU#5bZQxbKr0I#fLs@1mW$e*XX$^+Hvrwih%=jlq@Dmw` zt#J@EipoDTb$)mJPA>+~IKlBli0OC7kG?@|<+yIx&c7u|^7hc6LS=?khf|Ui4kf*L z8G(+jx8DRatc+j(@vn-Dg0j#m=T13OCBSM@0y=nQVi~40QvK3*EV1n4b*WLSuwAIf@zxOcZWDkf}B)RH)O)1R#SId%`td5KD=j$_VYje zCEpzU4fljF|&walUAwL4D zm-G9tPdMbq17NPwkq%FQnok7042zmRmIw5C5clOqqlWwHq`Mco)=h`FHe6W%kVt?2 zZJMg(FMrE=hERtxSy=$-GP(J-&E1|ul4ziA1Qdj{I{T2Mxcv1?HyjHe5549eTu;>& z^L^jUzCG*cUHBt1u-n-9Dc)GK|CRZ@AVjo#DrGjXz9K0T;>zl#&TA>z?kYl#V)N0_ zSle{IR+W1-4{Wt`YCKgW#sM)M}jw6S=9DS-r#@6K?YHZ0Z7lh{?4*Uqu2p z0M{I9%~6Yq$;u59-M07$9&f85Yg@e}s*!oo`!ux&B+Sr;xJCt}+dca?tfIA%#bf>c zd+GO78cg+$1VdO_}x>uU`?gJd4J*e4gqJ8GlWc}&8b@e;PjG4Df zX;_Q7sFl9GK8~-d7rWuKR!ad;fTHKdbt&-1OlEL>?cE@XK;a;Pwvx{PU3I=bzu-_R zm~&fMLL!tZ0IL?ANR-+2l=2axX_>Eb!oQx&^2>DU6F-mR^>UdY-8@yDmdka%CyVD! zYFUUgn?gtk)i|TnaWNT0byx}@eX@lu1t)EvC}A#I3{bYNFpvu7qbh)OL^n=~)1k|q z=8h9XqG7K3G);vM>&fM`glx_-B_v;yFWbA4$79&dKQ4L#->(p+K3ddW*gLKJOVQ^lm=U&(aF4i1QE2bG0a?H9R23T z28%WVZuNn_v1!Hm3;;`@d}|mNw^JiEs^%45ORY6J8XVcIQ>l^maD!B8%yQP`fD8cG zD43!NOvI+OUSH5jW`Ss(r|Ef`XF&h)aJB)<^n5wi#L+XrOpp)|QY+|EhRq8DW@@e| zqs=N>0V^RkW-M6+$_dQIWKi>^=rS7&i3lj38hqNqDc(ZlU_c`Pc2j^9Vv)hkU2VOm zfP*RwDTJSN&FOA$Q=}O?bKfg`v{FxJ^T4{{02{eAtEae|2d`-*ck`98<;0tnVT=Ex zaH}{3FK#k_SncGRyZg@Q-9W_%ffzxx5)~!19fYZDy+-iHYHMibF}_L!q#OLSBA<8G zj{(qD673rl`ewEjNNX+5hQK-?jZwOB+U^bvAR;_#uZTn%{t-4W(VFb#TUOlxXn=&~ z@ES=NB-EOS)A8fKU%Jb=!)zY;2PYylz@a*jvrzD|v!oMXz~N~`=`eq-&yR;8KYe++ zR#){I6<(&0noL3zpuv$*6r2QxS`?hpfYBqsNP+=XWG<*ERZA^qAWW15+Jq5|+|0Pz zT$ksk^IzT{<+zNO1(H#<7PVR{k_~`YtDrn`%2}eZ7Gl5lPko(e7#LZ=?NJVU`*#2c@-n9dN7E7R4>A zKr5GYa+v92l=fki2X(wg7nC|kl65H{LvD!~R=`${Y6mK@fR&)q&dw4v=mZ$mx$i|N zn6?NoH*M;4ECMHkhqbter6XXLZSfjRL2OK5EN@wT@hCwNV{=tNg^5=xGfK5FFgqG8 z_=cgyUYDK4LCmd!z}#UoF)`G%09vMbQBVfdkV~h1_4YPn`xBy;SZdPi&8k!>fDpTC zndX-XOYTxmit*|B>Dx29$6TLkDMys?dHly9$XS?JqVL$%aa|U4r!(s1Ym<lGa%^$gRo>xmiKbnA@RVA0T{jloexT{Q%;M1(n+ z)j4WMgVSZ5#Kx|~EmP>`wN_InS_5DQ6#IJ4l^@2~lp*0nfGti94B!rf=ur+*+&(dbi_nE@*Js^Mx ziNR`h54U z4s6z)&QDLz*Pme5>E-$Okgs2!G!g0q3<68a3`h^AB+QihWhp8tcV6MkWhsZQM;%i_ zuP2};k-mGL=UGdsr5eDD3kw5Q8qB3!*;p5U&QBlZ+#Qc|m#@YGsGBZJsVJzZsiG?A zG7iU+NJfDQ=FeX_3r@ph`6$T{Xiseq?Q|^D<+qIPv1c0|9`gKTk6;R!FP({cbWj}L zNfr##%jH|@AO7;`v5sBei-<6>NXI4v7emJn2^CKH&?RA5t*IN-MwOIumolYj(;g^(_Ns)g#qnzKLhRg(H zxr^4?Y+skQ><~z|wQ(p?+)#mSRpbH(M8P)(L=x-}%$5FZg@bHm6LK>Cx8(P>hA7jO zy?y75|Ka#yQerjmzW(zE*lN3o-%J1fsnIl9`FkuV&R_^@yCPKXuZmRNO?3jM9#I;3 zKeqI%8CZp4lHLBU%s`pOXpYUD?6V+h?mU4FL(~%)t4FeWrNwGD(%y(kR0zdw zzKOK=5nFq$%ZLif^+(Nr#tPynrZ!VD*pKCKe@q|-+)Q3W1HV^A+>bxee*PzigRsjg z{hu`$Ejjn!=V-6dl^+h;uXzRlj-EIGAg1V;CMIHq9AF%@kHi^B8AE2XI-b9d|9Apm z6GO^;JARi0xH4H~FcLFUVnF&_SHw=oYsLcPl#siAIE~j{mwtg(m&y`-46?$!&F)nx zp0yZ&>N+iw01W85US!_i`RrOuF=AGTWDGb06<8L<^#Og~Tm2q8lzf`$`q=w2FFRf) zAad}YPkrC@Cy@jZ&NClQ@6Lw^^`btT@-AT%ehlX}<%tBO@R}%f+r>)ix}iRvA$oW? zOP;RR%W*PazFnWbctLku5jws-h(9-mZs-{BXpwR*oXcAJW@w+;{cVPW3wpt`9|2dVt7W7q@|oy>ZRoLijcFtDjP zz|3q;3R907PS%*FYOc$4t%@UqC8=83y|*C}Uusq-up~*ulv{YAUMqQlPuI(JEDA{f zaLnDyZ^6UHDZba$1h0nyjlYxZyAC#@J*|n{ zPtee$+qQ=d?&Lc{wV3Po0`G`!i4+7sKe(vvyH58O{dJq`_ah1eXazkTu^51v&sgt!|vLOkZRgIy`3S7&aW1 z>t_St2{3{N53D=5WMIv7xz21Q9!#Fc@d+K$5$Vu(RF>Rsmj_#XDz#L+cxUK%I3)gr zvCP-YGNM1dXzKHc!9~q^bF?^v)44p#JYL7Kq+TP6pG^$+^H;5A?lx0kr`osI5F#Pf%r+PRaf%4fL%V6`D z=YRbM>E1tryVUyCHfD|2lYE+iiwa(L%UHYPOH~=(&YIPwbipZpK zd#>%VYNoA8NnkKl2Xzm1!BZLDA9~KG(~)6yl})`}NeCbQ{;07p$SNDVAB;PNlHHHH zCFif|wf?~ZTZ-$eAQiHcAoD2|m&?270jTOFUMH-FpsGaI#* zh_z}CZoGGREKj?ns8y`t0w5OB{!m*BcoUjQ;TYlwSz6BTs{Q%hYYK!GPVBnDgBpYwmJ{*sOGBgs>&4&_X$bhW1mZ?HIi=~umxV!!F z!$1E||CIitNDs`*d_CmD8rvf%-25U z#|4yA0&xW-3IcddKZT%>TX0n=yE_3ebvMx9u6)w&-1kX_uIm_9(`En|(GN1|jxJenbD$G9!jJH3pY?^y-ee>x}>aWD$aEsq=3N$+;W49D9|PqIH3KxjudUaw&N%1;g|EbN|;% zS-=M^$jQg2r>DzkVChch^Y}QV+Lg8iEi z5($VLD*)7a{Pyj6(L?SNi2|B(k|eF1y;T_bUc1ztm`zpTAaV;~_}1hFYbgWbT~U-T z0s&aSlHsc6S~2YB!`(~uCS(?LZ*H0b`7y?poY*3_-+$#`(3=P+dow=(5uBnUqfP9% zrr4jOE#2NYQ!5{Ftk!pJR&ANv@6X!A;o}2AmC~M23(Nj!0`K(r)~rmsmLPlBSbW>r z{OxA_-x*E-gyn7b(HM=2o6xB8Z=Yl^u}M0(eagqjL!XieIXQuec~#PiqCTdz^-q{B zqvG_j^wR}EmyaUg;i(^I2SgwV1nL=?dXj`fr^CTsFct{vOD)6G0GzvrLxOA73?Qq{ zb;_83SOnj=z-xxta=m19eLnQLLqd4D(mk9(1v> z$COl^Hog&sd8@Y8qL2)ogWfg)=e{66oPYkOkNqV{f-H3$`;LYox&{Ei5bx=MTj@P41PYNBE%kxygPRr-dFJDJ8d;|y}QSnAm6`Pygtw3UD z1DJ@S{?0&jIDh)-*Ga8lzG5mBsn2FvtDDO3*mXmf z5hP(zxaqWV3mBH*lCz@iojVmcC~-WF0)$LW$Q*`$p^zlRB$Qiq%dC1JGLK`t@xH(w zFKz85GBk#TrlUfyros<~1qr?FCSaJg&3f`(0&sP*w5>q`h#T(ky5m>N3xBWjY-{{PbeOG)WJn+V}l%Ivl#A)moNunntabPEXhIn8+7n zS?TAYRUHc0G%i5uG0(-k7!jF zro^NYe7{jxln~Qe2{4lGB;7KhKKG)kPuFkY=>_@n`Pb(c>lXm(Rx$)CmSEi6w7Ypk zq5=k3#GTs1ODA1^`7&W@^EDlZu4^(BoLSK1R~&2QLu(V?4GpaeW-t|%KIH*IOo_65Z*6vex~_%9Eqa%nk#_C~#TsoT;`$v_ z>rn^x!5zP?<>qL3`WSid|i z5Qt$+-BAkwEOP2I)7OpUGGgb z#}p33<$C@4kH0@X6%6oc0#bz^5WxdAs?qgPm?_j9YOL&DR1FMi;s&iuMWGS9I~lfa zRD-fI$jvPxn#dWDLxFTJvCP265%c?_RbBtlOOF6i?&+UtlMP?*Zx<925K_B;FgQND zbLfaw&_r(N_oKJhfBXHio9&E0Jft__dN;hv^#5S#{9srswcW5I`91Gq-yqxY9|4m5 z6LnqJWntct6mGz@MrAa&0&pc5q}N~S@-CDd64cB1^6h!NJONO2-5`&HpyQl`@qD*K z`Ha@-U3E@Xm%2Uq;Ae=@lL(+>uR>sES*L1>0BXKoX9b4y!>6AH)!7sfACK?fKOT-< z!gaY`rnswGVRI>ka>3etMxvPKIy-=6Mn07a;0l;S6VMGA-G}!N3H%PsC^U-HQm9qc z=Fl$&kYfF5RTPQ(mFQ!1TI0O-juZf;PLivQWx{;h+~#E(XC&!zFDT2(1^XSn(l(?O zO*cVi0YnEqfB5u-7lkkVaC$f%x;_Ww(U3Ml)UfOi1Z5D1e)NhwFj5{eh$VNyZT6!% zO>Ey$T)y?OAN>05FaF+|{8M&M!o4AnUP2QIW-ksKB_Ifq0#JWtVc=$s)P%5CAIA$$f-MI zlzCoCR*2SwenCa*63PfJ*@tw=-SGAL>({R{I1jTj=3;n2S7e#y=jZXVOsb~@nZAB~ z8X?{Ao_jYWf|n6& zR=j73A{N5x0!CtQRz~&Q8iZ<`+V9BW^6~+Tf|gSpY4r)ptV0l>07q0yq*8%naA3 zr?DU(A3y%|Ax))-O2@Js-+lP$eC)AYm+QDJU z5GAM^Y6dTp3?F{_^#0W4F1ouW=sW}IP?1G4g-%+iBBDxrdL+XW({ppkw%4|mhL|dsFo7-#T%NpM^D>0lD0zr3t|CcLrfzavw z&p(|{$381W5@@CQ*49zuY5+Syzy@YvViZ#i@<-+l6%6Szh&Z(K_Q@>rb)RkmAoGucK2Ve{8@q-i^Q&w3pu;ELaG;%r z9<2t@SJ2UI=RNN$BDRg}22lRM>}|?3VQ`JrY*){@rb3v&jrGvB7%)Z?Xr!iRpC9}Do67ykv`F3&2&0VcJA@y@DHpd^mJ{bwoX<$o4oDZf54u%E#(vu9n>m zs%nygNV=-F&=^<)Ap_789Hq?DJWc(fAA~urBDa$6rY$!&CSDoZq1q>WD~bq|(x^$u zy)kyM_>ILb5*N+ET2JSDwg$XqQ_XlnN4D38ULjc5}+zi-yVf*Xz?Z}ZdY|J=V zC)pp2{ps%y>&EUd4}ze(k}U`Qo}|Rx*a)(ljpNAdeDYATgwgUu*O7vye6(WTvPSy*zPMZ!B%Xw}PDs)5tt5^VfN~6oUv;5@A4Hp~#2^T_pAS+pkZ{gyGod1GtnbN#Wt^T+%Rf zfpaEuW3AA7y#O>nq`tGR?UvSJDOaB{ca@k)-H_lOOduWBOkbpw*%G{iq+uMd8Msm> zxd4DX_NT{#XkDr%MDrV4^bFlz?D}>C9~CFdY90*OQosx|Qz5T&+Xf~jet-cD`+`Ibax-DJOC4*|f9r)>A@O`vOcDST%; znof(Y^>)1asykVj?P%svv;aeVftSj!3URW_t_@Y)7W`Qq60bH;I(lLQNhT< zt+HR2>1Ox-`rBbC=K-Qx?K(YyOF6w9yT^AA3BopODa$x3G7Mer60Xyf0U%GRDnQS< z7lwfgjFlO}ChVj|~-~RUZFX+<)j$>5^!Qi^gvwi#5 zFMt2_#Tdi#<;$0EFV>%49?p*y6y$2%_6!YhudZ$|Hv^lSnyZ*Xt+tvBcdf-DGG1qz z85GjNyy*1u?egp2AAkAq?v%1XqAeiNe%c1+8B?I4CbaIdXp_1XaHCm_A7Gs^w>;j> zdNjKI4R=3U`>?IH4l!e>iIx253^$V;JNw$t2Dq|J+ri?*I6!Aj^PGv{%f&%;mOK<J~$ zPMvV(Ky2zZH9(w1_{M;-__U16T&qL6;~{m!X%xu0>z3|(9t2Q-o|aOoatF>sM3Dj3 zc?+IQ$LY(LmxA+jexC`a%Y+*HzMEh5bj-(x$3vGgj2!Oj*9*YtYpqElf@o;9tLhB6 zYI0*UWr3SDA(9{jF^*KR2!KAp>1DnM)cDj1AOtz(Q=j35q$CEIK^!dr)?B`}E3S!% zMoiG&DyOa+9Lk0krjSZY6Qb6twV-p})ccQXMnD@ci znk5Vy`2$yQ^I{pqZ&h;;??3jcnc!}}ShsltfJ6>Z2cSTZAW#&fz#Dya1mx~$0N}Mr zx$??==m13%E2*{($g8roZ+i$kH!!OcCz-j>sUd8Npq=0IXSg zH-{Gj8$%dSD4LuB?mpRy7+dr&!hoq(Ee=W~L|qj1qe6jx|9yoU=VWa2^!)Vlyv%Tv zu`J7^nEDU@{{QyzIREwk`}G$9HVZ^Q;OXiAVB~zr|J;r-E%_IG`CNbsOq7NW089j> z*cE)lTuf&$#x_@DairPvy8t!|90sVmv04! z2VjAl6;&V|C%~38vvfMWJk4^r^e>dsQ(1>u(`e_0HP#SM+SuRls_R9!jhkef8k>_9Eo%k>K?y>H6$i6z@gz{V zIICTBm6Z}@{WY4#2;YmbHI@zl8@Q38B7+_74kx0uh-CXx-)6J#IAXjas1rh!DsulG zK{zu}6b`g=1q5k(Ud^@H!RwZ5p+J@mT8%&J0X_~dOn?g z{`uqKmqYH@mglE({J#Tr#I^7Hrz@N|^@mK;wnKXG2TJOtX8_Z06lYw1=LN|beX^XfBv6O z)*oJu`u_1S+UNT6)d3>X>zE&U9FB(!)P>2R%k|r5JOHT^y_Q4Qhoz|VGA`Hgd1~R9 zEk4((@_@)P5u`kvG%wbkBTEVVFFQZ;qbb zq)8}q+Bi1bXK4M`2Ke0tbnb?xC)eh*)2%WkQhcp|bMFc>ZZYWwd9Igtdz=ucGeFF* z9!2|V^I8mGwP}Pl<;Qrz$ou0Fi|8>v;L{<#|?-G-SC<%lLembzacn z<+_xj3bR_(9FTl`>I?;jah~TnIqNvC9UIXNs&$z!+Dlg%T9+~_1jbUS)~edqgcLM$ z06?Z@FzTvl-LONbsOotA?Qeg*B#AB%l{KZN3W2(@vP3;ii(1?a?N#2pF_CE6&6IWe z-0a({$#Hwl_kU$n zTZiNRpIaFYz52xKKsba!8uJSQNQUIrSuj1+vMj}pAJ?L7PuJyoRX{pj(DldnAK#z* z!;pH|()G`lfI8#pAe;n1PKRU9Dk%vtCnt6|C}rsnsH!u7<#}0@GOEs3lRhQQy#Ulb zO1@0vQo2*_dVxsBhs#t`27uw+$Dcl&PlJf{kS?fH%~(+CXhukya;}|(pmN9 z^f{WHNo~G-{f3+}RL7diJ9GfSs@77=T#Kn-PG(u5waN?;u%wj>Ptpa8eQ-Ap@{YF6fl8(ky!YW@>cTl$0ObZ?V!wt zi|xx4wp}^S2}Ct^09(GMY5}d)-D%4|ZoL!a3Q%%~*QDFQ!lhm=*P0ls^7`ocU7OabM2 zdctqx^)f4XI2<}mFXMEbXHx=tQ`Mq|;#E}@3OSxitaV6V^=K8kvT zRm|A}uW3&)R1mjW@`K@oRkwD7uGT-rD{;KGb^sdrxRVEAc?&>RnB{KVcJ0^>xNQ|4 z)pg%_m@DjizlQjBtVSxonyJmvy{nGg{{EfE>)VySI`18PDXvl1vfjiS58*DYW2+MF zch>fmVnys5H}3rJWuzLjsqtN$zI}P$Hye-Q)jN{rBp3i!SFN?;cwK|YO5<`}3aFPp zBjxmXJ`P!uBw!wn4{BgrXnFbVI=}$wy2F6;CZF82?q< zxlalC^e~Q3FV`V=$1bDydRUInNNEP}?)^`n&c~r6rh!C4k(|d^=uU^@Tt}pjb;*fgwK8*J*i{uhQh$t&nhCiRqJX|U9?|{@ z2i*kJiq<5U=j${tz}S!1F?YTIV5mSPv91x75QR97!Nv~kDroS!iy7-1IAc|gq@0T|>Cri*e&zcY}?u`(wJ=?UK`EU2D?v2ZL zf27rYPFvumSQU=gc9e=+z9rPV;~%$PH*PECPFjr;nme)|4OnLiX015uuD37>U|8N< z=)X6N0rIFn3shq}yRBN?`z%=!045nU7CE=S8t*yI>f+Y}m=7>1i>_q=W!YZrmC7V(Cnr$>Eo1OUr*DV2@^8raSj4kOfd^|7=|+%Fq=(N zvZeq{1es1~Vvsoo9H)RThR8y#d4}p}+&Y0NlyHWeP7kLu@8A5l{{GOI&I%C)%u=O( ziGjdZhb~(vr_*MsULDEC#x+#)@-nwhW8eJqyg5}!0sx2#d-CGay74V+#9lF>%mN^l z3&t2uPF@#V5vlO9wbvzYi)qHo`q{{7zg9CB_~N=%sp+?$6}_Ek3->6OJdq-TULriY zWJQpd(q6XA;N}U&R?Wl;pHQ8NQgsH7Z7lWWJs23qxBLAX*r}gXymmXN)xajWtC=af z^@Olc>I-nBT@QrN^qq(?3A{<&e$Ih0H~8|`(>@r$vF$o0NY=?Ln+Ft2#O7$GP-K?y z|4H{#&+zjXoW|u@LR~yePYuvCZ4*NS)u<0hrBd|$PahBaCI|zOxnzQ>ftvffzL|XL z08BgqhykUF5Fs}G?tUMIfXLZ>e){zEXh%ued2~CRK6k38$ z=T;#lBetX)Y1--y0+6!pY$s7)K>Tbh(_@4RzTKTb{DZ^%aq4fLIu>#dB`*ESAZ+A~;*3;x4znIy(5; z9KPxZ({m}jw8FR~G{5?b?`z9;eXX&96|R}F!paJTtEvKg>7!ynfHQMR2~v7CXE|xQ z#ODWL%;!fueExKNn$+PFW#c?$K*EGC9wl_KWwFydWd&b~eTv3;nm82JP44F$iXwI% zCo|33cQs*RcBfOC5-5O0pif_q1He)!E_FV40f41aMkpfB^MEwuIHyu1(g5THup)V4 zAdOF_F#|x#L!R@;76LF3hA(KPm4;gU^4Q95-?l+wVgH+a#Jw?zfWHl zZXlg2NYiPw*$n$u5nlk{+Y3e|&=n#-+#EY9q$2_5hbZr1!msAebX;KKJJM7zO6G6nG$AT(I zY}#d%0P=V`K0H3r-XwK69`(aLhe84Jrgs23KTR6XZFAp+R*;6ij{s;5WpuZ#%@x*C zLX)fObee}uO`c9o*TksZGQ~yD9B>PuXdbr28=wG*U8CF}a;(UqRxa1gYpqe* zfVr6G)wbXoS-RXFMP)6r@5M&UFvB*U^GY49QI*$g`(he?*9lPE1(h8;c+KHwL19%; z;;Yk#6(~N9RlIq|)v;p$)8_bbsnK|}*&3BC?MCcve^BXvq2kk1Dm}<(E!`OVOlFM{ujB=<@l350O;wix?cZ%UUQbnF(Ha zD~T8W4G{>TLH@_-@P9nanh~Un0co64dKwhG%P1;~Po)~J!N;esPh)CB0$EakL-X|T@axyFqZ3+b8VRlr(@1d3({P&FgM_f#chii(Vwz?HH-~l9Z5z{k zYK)DEbxvtIjnk04i8{~6C;zt{0wM+AzZ~+I6M%VqICnfWySAl#oH#oz*3OIYwLm1q zC@Lz_XvrL(&tJP;11v%dp1iBrk zT@yg8n@6&hUG28YuxIYX8Zf`JR&*X$C^2m(9UkF`jiSHff_m_l1Lj9Pw-AnPhyY8$;t(=PXb~v3+=>p93seV%B^}S_@pL?5)&%5$ z<_trr!!ja@pyi04PjTPx`}VvFm#Gl6dy&FFe3SDTYIfhpMh z!njJ{x+~W1Rn+B@7Eqlc7a!W{idxu<@lDDQt0qF7Cx;78bpoDg<1Ts}~=`?NN1W^DQEIi*uIXI72~#s#d^K`k+8l z2uft(E~pxbF$_imVTQK%zmp%DKaF!z;XVqEG@@o{*mp6oK&0vJ`nDvQr+j|+_1A~f#I5lDzHf<2bry2d@qBt1?xjP#fA?u(gaFm7 zDxs?jO@ZcK=7%QlBa3m?d7KrR~Qz|9_cDyjU#{3K6pzw29llwhdr|#>f zU82VRw(4kx)x~H_8j4%lNsPt2=h!Y6TL?U^s{<6jFLAv1PL|FIG=LOP3nk3^a$JUZ z@6pDuwd@H)8tD8u9KSrxIe?09D0`X}a0s_O1rZ?S>Ezh~nVGr-K}4E$62+VWW<;c% z07S+B*k}_*?HeX0pRyVN(~R*r<-1b`2e3%w*mgnYW5zkgLx11L07ssNDIr?hPCZ2> zZn={*PYDc5gXWZ`(`lSP{fw*`Ew%iqQD9!n?J-0IzfL@MLqGJf%Pl#k>3p8s7CcEn zAUqjE5CP;zn_VFx;#hn%cWoOxX_`hz05iry_rf5Qz?YZom=Z==sxMphkC9idS%*O` zukux$X-(I20J;b$ljl)XTn~6u4wqa!^9A^*dfN-3SM{LxB^9xniCnU?DwgNVQe`YD zwYco0tBt-)!J0HhmBzRD)z@E=RQqzf8=v*8FyI?%^8H1=KZ9U5b})e!4|ff(q{X^k z)n$XzN}aZ}C5PmyD;Hb*MyFYfK3Z+TjT0w0IfR5fqiVJlZF8U$&7#n~Z$I`wO>-I$ znjquxlaE7SMGyg;CpAsMVqk+=1g3LN6z=gUcP+ZZPrpAL-iMZ$I;DGXY=dY{(DN{j zQ*Pp2_u=FI&8`b2BhV~Qr>C!vbEj?W4~H?JC164ZXuk){kQM0neEjF*yEk_s_JMpH zAu)tGpJ{F|TRxpiRr;p;bcc|WG@Z$5RG``SyPoD=>xo8O%KlzaeH9`qY5V)TcaRQg z9)~>TtnhI-HaLf95K$<%p41S6kOU?PFldQCWN;}t%>W4lU;#1IH{qMiW>B!o=9Ok( zfiFw(GJ5c>m>sE zc?*TJ5{Q0<=s>!Jy*_?gKNv?04eu&qQ~CEcgL=Qrx#tAUK+EPMGIWO8rLElM>7EPY#q#37f z-!zAM%aU(p0Ebe!1nbZVB)h{0LHzx08NO=u=^RjgnQuqf59C%x5eC?hvO2Vituo6Mk4HTNYfIKNm)W70n=#G1Y z!`=br03dG_*tby)lV?~`Bm=vd>4XG>=7f;5Wd*#@qfiTku*V4}r4SB>B+wXQRsGZRlbYReX79X6Yx01c=V_oX|9cW)A8k4I*sLU}D#Kn#a@mJgPoDWd##B zhH+HKwA#eQ?~>J(ffQwqeQbbfn5Jo}PG1-}#GI$|Y3MsW1GpEWr!NnmQhe7ODE2Hd z7MSXa$+cJx+gy7azxU;OFJk zzdHY)i^nY(!io!s2&^ij-41p!#5Q9q79&@N#f`JUAX<~xi#2J$CL;R+a`I(m)B5@K z)S39rMd~n!l`I7E)h4TjD~jz&o3Q|ZRNBOs-plo80&!cNC`-30xfEmLh5|@y&jhQL zV1OB@0i(A9j|hghU4tym$s;omlu#wEG};Z-4*pr?+k22J);5*8m&4rorQ0h1#Y~2m#5}6N0=0bVgFeJ`JZC-RXC} zZ)0rX((UIqloWCcVV?5@0E{oXyW63Kge*XsF->!GH~^qpgQrZ8Z1;$(K?EXg_cnG- z+ho(c!w6Scn&s2E?av~rxoyfEa$tA~X~g9uE8v_u0463X?67VICj?^xaiu}u3O>zT z02@Ov)78vpR}fwN_gujaT(O{+w`vvcH#fMN1%`oD&8})x8w4l?z}FToV&-+H-sMr? z60^!cm3vuB9X1vs80j`Uh(vEHTNe1eI7wcCQ@y;PCDsU7JoE;s$BrJkbJk0=6WJs+x zm&O6ywB%Y6{51P%Ow%-v!=z6Fg{GWxJ|^DLK8EJbxD?z(fJDRWh(Wr2OsW{Ip1_7F z>hxA7&Jpl1pT}tqA!bh;vVt8F`ZfiQyKvVb6_Uef$VgR={%&_V8}KA5Ci~ekoLq}%@jRhFK&R=S|8jbq`qaPMDM^e{FypeHOG#fY zZ(s{@msslpRnvxkw#4b1F)TYOU&ITG@M7SXRk9q@cKP;2Ewnf#mbm;haU$nMm^q2oQ;KfZ~zW7O&#~0+6gs8a3ma2Sy z$#A@E9lO2zDw7Kr3ju|5^did{Ap>66mKW=A8Gfa{T!lK;M=0~fn78F_mmkzQMm?u$ zw8HX!$+i3sZQ|7oC0&hxlG0LKE+tNph`3#13PqcSF{`U3%mK(2l28bO&_>MzVB_rE zMZ){Z30>EAu?clW0@;{J(@0^0v?=s&{`e2?KE8=<;2K9SYJQM*Qt1Pl`;Qn>*X$4b z7W{)hswl9*sND{ScoJnv&anfA{GxpPqE;PWU=E=LS&B%_O01_hdN`(M2ti`ZkwW z!ElulI4YHI0!)!*m6CkfKU~7Sp#n3&NfF!xYNifiXi}K*5`saST5^{qS^N&Q2TTl7 zBEeMz3#|YTU$%+LhQ!{08eh7ucU}5fKQngJ0>s6Os1usL5fC#$uT#(&M2t|<=KowZ1 zLknq(m{T#NVUDJTph#m1M@A{I=LSfS$k~A6m17%|#~4VHPUpuX!r{L497qItPUEkG z>2!K{I39Hm9c?(Bp3-Epm%iPBn~n{N>_8V}grRNQyI4H+una-wQpm2QaHf_U(EMkG z?B8|y>oH&&6v&}(eH`bu-`~gMNmY|0K>T5@p)^P{#TdH7{w_X+uGx#uI#12{>xj1> zS{jdEA5RKQ8PjKp`!+xwHudB5aDU$rROj*Wm@**yX-;ky_wUAmp_65|bZXyr!1>dI z1M%&+XG{}5zj^!PA=-2r9{RyXplg~|r+Ge~Pvexd`83Lhk2^ek{(pWMCk(bfNcT~! zxC7LUFPf|nSj{d$6aYX0rF>(FH8!X#34|P3L0H0yUqm1;-Xvjng`(y_xq}OR*5ZYd z8fsZRAa`Ly;DkaFTc5dt}#{L6B{^NW@aY0g*hhqE;u2Lo8aHg2Eh8fy@b2U9 ze>mLlBnCoeK%mlcvwLrWG>!hg{li)B8wzb~Iu>b>JjWH z9iin0o#-h|odHdZ{r+%xe;4woXH=apAps@Ee9;labn_NUg|`Ikc0V20<@5f>U;g!f z&nL_&O_I+rO|bmG_aENB*L$|qHpS~nE)}FIZ*JLkIR|9`+yHPehbYomCOAR}USbb! z>L66$MFDZutXd**Mt}nY?oi^@3tTfptAb@fseL1$>hQk_fPs)N@uJm7?ttrd(3Bpd0h~z5ZJvhlc=DVcAHEz<5Jbc!BR)@Q;yKMTuk*_k zVW_;V%Vz=bi0r_W19PMnv=lVrwqfI-0J5c=(I5zXWK*O$uf&T0$8r{0&fw+`A`NCe zJx!L!l$y`)aK`C8p2sPBhGs6@w+Wi3^RYYJ?RKrEVK}9f0T6S{Q2;!ivQ8;aZU&#e zMt!_Vtjyz=xlx^MK2CXt%=_#cdb~k1^eNytCAAqm4fA=Nv_T*^Fe*btNH%-!mAAGA zLW9=YwOV-){sVkW|MzZn{NLez+%yOLWi$E3NBq{dWV(h>|F3Txq3Q7czujh}}c9bU#n?G@%W| zjf94o0Bm#0J3Hv zHbJhuYKSkrjs5ze=;8gxxuXyXoq#0arPYd|uC zYGTf;-~<4%iLem{Lx$@}IU`0Uj5EV9XU(bxkQk(Gx)@S2O&PNPBf$p@DGg4RasJeg zF=IYHo`zF05y_!_d+_Qn+IjN+zyc zJ`R9GQTWX*un@svYNf>2#@2YXRhQti@|$#l6L}M5Q%m;VE-So(r(U;;99)${xe#1l zyldavzWqe15P#90FYY<4o%f28T>0vkK=a?4JYTB$Z3lGqY_Em)wtkh>39>lhUMd6e zg1qL-)GxUozo`bV{7eOq-h^RCc2kwZ$KzjrwKNr8TEJu2-*vn57!GgV?fbq7VF^dX zHZ~$!AQnc8xBpAdj&A?{zUfwe$yjR91O=o;R##Pn6H}B@PY-75niTN4kQ7O=zH^?Y zX-Z3+o9Q&C1T<~awq4gpjF51bXFYuSth=apW)H43@KD>50{Hn9oQa3T#tA2nV3%1O$LtN_M?NA-8+G#BniE6@gVI znHczLGx&?T0GG;wd_@#?T@HJBkX8zLV#PXJ#nI-*wq~ysXrHeugRajn(^s5{S3j^t zF@=IIG;f!hPej#=RKVME`#>>r#{Bg2m&fBd_LEO7ViNf2@!|Z%*O;=WzUvSfo=ri+ zV>=JyIDk3EOf3-V$_hRMrWs&_7BL4TOLjIkb^I*lPOoiJt12#>QgoXo+NmE8_b)O@wBy=FVSN7B9?N?9Lb=z=Y zm&E$Q&2{lSdHLM%vPSn}Tgt+-Ewvr5+!S8@Qm@|d@3CE}o&gTjYwK_RSy8|NN))bQKk?ejMNZ?)_okH&HH&V;fpzObkS4`KRoPrrr0l z+@3`MsZkdc5xk7rj9I8g#ksj!t0gD57!sM8;hJ(z8OR3DP~<5q5SkD=ZiFoghoAaW zBXa_{KGu@7d84SKIL%7sSUn2!5fA8YKWyG-9o#Q>q#( zF_PKz^`AeVj*9&}zlm*V1N?aW^u#?H2yE0-PLd*ux5iSM229g*1_iUSQeqG`ObJ6k zhEo8{5%vLj$|);H1QCRsfhNR8V}MK{Ghn7;)3zO^aW)oR-K?gjw=GZ6aTTQG%eQw^yyHy|&X7zKjO zp}t3jf-(?+(I>KqSo~^E|H7Z(I(#^038lr!nHQu zO4{DwwG&_ipz!MRzx?{;$FHD|6E8)cH}-11&TYG`^;;sZK9HXIIF_C+mRX6AC}d6s zVDZBkTP+H~#r5*SZT#BYyeJ~&=9QagJJ4+_gx`y8Zkx%YU=0v=Z_fVvU(a72zI;sv z`#M|u;rIXTN6ep|-u}b8`@V@`6QpsK%~Zk9&~z|El%`>|Qc0qi70Zta3p`eK zilb8KV#5#<;F{IVJ(r+;qot~pNBL%C+oL!Ovcbh=aG32lg7%fjrT?GJ}M>3A~88-)Nlv|Y$JJ*A8^GOZxwz_S7FfetnSw^-E`)J_jZzJcmm+9gJ$Oy<&t`QB!I!(jZ_Wn>< z12yc4Vh{IB&0EdNGZ>xf@{crm>;@%jJG<}WSPztySy zcR%)p)&Dnm%wM^fo`FD{_S&4?WVwE4D~H;5wyn8$(})_0?QXV@<9s|GA5y~nugBc} z_`m+~UC2LtzW?Fvn?431tHBT0j-=FtF@crZ;w%z~axq}HiQ7=cb3QjSY^wzcyu?Wf z0Whsh_*!fhRRbh&35zlcQNw;ZohJpPefNIX3J6@IDXFMpYym2EmEd-nwuq)5yS^XB zQ#+kbfHWOWfG~%!g-5=%;`uVxLiZGI-pvM5@k(jEz?@*&;u_!b{(i%Q@ZuJ~B*BsB z^X*+wz0IerSV^@4dp+mYufuCGC`()$0cM3mV~gRuc#TrUs;*lFA+LNVZg3@D4apT> zF>qm)+FU^ny$)m{_{RFP8WMUv0Ar^m8qA7P>8xy0U~q=1+Y+oqfU_{eO^2sBX-SN`&SD`lWlY?ny*u+-)fGGkKkl4n_T46BUysld!G?8FP00<;4Nz+h? z(BYIk_h>!r7drD(NZQDk1i&8_cxDu>k@dOp#Ab{0e0Wwo_g@cfd z1u!iRl0p}a*PzZ#BY@~?b6F)};?=8*s`gc=ld+Jxd`s!NJbnw9+_0#i-l#w(FYlIX zrH_ljw>ghryh<;9w2K3#%;W{&d~WUHxjepLWmw}(sQ^6J2NQ$X*l0<}TFYMgqNl)t zT5PZIUh&oC6_~klMvyUTNh$`6e)F`nMUgMmW#-t@D-xR^Y71a~e?FZQqJQ~1;p6Y$ z-?I&GoBMqigH%g#33XVzSG_DkPQ|lU?LT0{U+DF9JFN$eD+FYUl|dF#Q!ag_oFo^+ z3e;r05M;lXvIwN)9+t3EV+(9h*}kx)3B#z5O`9^_pT9g!Ds7uo zn!~&MKE6`0;OgZtF<7bODrW$wOe!}82X1UDuGGft%Ag|m$QR4+CeQA=X*G+N^p{&7 z)`b$ymKR^vSQR5CFWmY{6tcj?uyD_o(`KPo^70P0R40Y2kfq$&j5p{&_h-3&5dGpjqjF@!ld{=Yuw6BC=7gYG7?jf{wTas zHB6^0KDX*#s=Ll$I!}*?bMTy8hvD&Vcj$3EjpMJ39R)xY(Q}@BL=!MBj0zmrEk0#2 z2$1r*bwbDy!mK$+2PknvXc46oiD(mgK@A2LFd^h1P(@nOp1~qP-fAc;T0SL1hJ^ zatMXRvCM7g`dWz00c!XAgB(@0lz30z=(CPMl#7~~Lf7y11T`?K|Hunt*Tq@E0F!u4 zWOqxhZcgl^g_OV-cuPg;dw34$cDVpvD$)8)PJ^Nbb0 z;>#lJ3iPWH3>!S=<&JDD%r!)lc#)bb$O+sWI~AAOcnUVbIG10`^C8p@V)4_hT#UXH zRkAvS)q(oL9i9_9RmVo{f)RkTG>j$T zvGph{U+~RK1h__r0AL{o=Oxp7nK~{@uEZ@c(?xY!>wFsOmL;&6tNHS%-)vfR!6IXp zwiu{aa+6I;BBou8z0$RHy8W`(%%L!s%ljgLP4uF>KUZ(-Nl={GWJ>`Et3I7VMzwl0 zil500meMpgniR-$P7hz6?uK5{IF7%<8pt#rkExyVIGQ3Nt3e2mRu^E-kV8A|0nOvY zIXDW_c?wxXFo!7zQUMYmAHO7xv6SWu)>4ql7jH=QJqC`{Qu{XLtZXoyPJ!G0{&3ef z-GsA_r!!Q#hasmBW|S&P+#oWwA%s9Fi#|=%#I}z}DKD%Tz@%nwa7st0N77*$5fLH- zvqBnFy%rSi-tHTnPY^bM`@{Y~$GH%dib9%JgDMQI=a^z3ia_l5cP+A}3!{fINNXx> zai3Izu)2;tm-XfXwUTD*%T`r-1qHckFSCb~RPeHy3V2bDF6iPKz zFGk5WYkBD~p^~F6hhOO>p(t$2B3y+#R!`vq@|G|yHo(+HxpHw;*#bbwsmMK4gH;ir z?qG?v$b}a8gP1|2Tz2Y4Gg&6@GIWJ#2!e2b>bfrzq?KlW_x|0X6)22VK*aRSyKvK1 zOt&1BC3SQ|lXhJhR=FO+1ubI|DA#iDv}~_enl3f>q=tCdH43YjXXzsIwqiu|Wd-RH zvnUJ%w@S-(r7D*f_bgDd?x^h~m#{InZx{NqYJU~_{NHNK`ET;CsCnM1DP?AVd#5-Q zhHt*_t7fj6GCDvl0XCnX65uiCtdFiO+Ua5=3rR5!PTS?(F9Fqe;PO0Vm zyaP7Fvr1Iy4tkme$eI;s03iuzHJ5u;{G0-{;Xcn(iN#H`_SE0q?E?DNkC@JnqtpKB zB8Vu@i%P`~JH{OW)!dsNgxgJrx?eG5|Hv_&!OZZ}A5aBms zOaF%F8(jZqcrkywT{+%rc?_@u#1tg7xt-Cp0nQO3oBH48zv1bsQBN;@W1HNGOWqZ+ zp%$cpTCu-ep>Eyg^{gI>MahNFrP^vH>N6N5fvG~rwUPz|VwF9PjTXc#)@XXo zn$1RvA}j>BF+r!V564ks?4Q0Ihf${(q2oN~F=d_SzSGmwgfCBDClll$os43GbjpB) z95UPjaz6j*vtXJ>OkvmcE!&Vz7$5z_fb7u;#-~yDcf;p+_-Pl8a6HWc##3<3pQ(!x zX`JW&05CkI6F%9LGD6G3#If5S4)?om93DP@c|4D5`yY3Y7T%)*_7$&*fcWIa`vcVR7R#Ubo06I);*?}0y60&BTokJV@*h>h9pZ@T%nICq?FSCe5 zJ)VGJglfvk44prL-!*ROcXIqP&OyISKmJ302=hLo5!aN?^PDs25WA)c!nUv~h|$9O zzy1r^5;K#692CMDlY&_*KyVc_Sb?hYw~@mOHJku2vrybZWF9wQS?9x{H_p@eT_#yVYUDrsNeO*AfdMp-d zApijqYC%jBB$PnU@|sGt>SC@E*AfaS6&K16iK-b7Vt{$|5rd6x*q#-aEz~XxA5`L~ z7*ORZFigmo*)bqkyF(f30?+Z?3fkj;cW^#&FWjwg<||;fv20 zge5zsFi@4EDaEs)H5bS$?cTcS8E~iS#Va3*5Zt7i&^cHXDaRI(>2!WN4-*(70h%BT z&rmhf!Eq*}JOSrHAv~w2*;1oIs0^c1#Xy5l3 z!u?(#5CrfJHcrFi>1hy{hGazd$#j>r4Lc8nl?z$*r-vnd` zH)53?4p2qP(>x_>?`H!-=g>pPIFH7d=SKu~-9-S?#vKq38is3%-s!F)m?6v^fob^x4x>Yr>yyE zbh%E-!YidY?Nv0wgt!2tAi#L*R9wogIk1!jx|V%(b<>SldZAsQ!1|Y67(cIPKx{d& zN?+DA2&w{Lz0t+_Q09Y;fQq5j6UeHg^m5T9+L39Mm9==SmEZ;vz4qBH4!81uHIQPN zjAFd0mP^5kwOo;?keA5~27{pDiA7UbpHL8CE1nSMjhJ5C6^!bJvBG(HZF11^o^0XX zuhH{s|0<*6Cep!fhE$pgSQf*K39>2&1=42o3#GtqE7K$(CMbo_n5uh+AWaj6iI)mN zmv_kEwbnO5h>K!pur)hVz$JHV@umwgG{ZbEGOpU!>y+GrfeaXxdJDeH=+dM<+t|HQ zk^%6-T~RXGY~2C^fg9V!#9fNyF^R73Zp)w|_y|Ia9UK6Y%FhXa>qHVN*@?NjUb{F} zPYM$k1#eRs{o;hHqN^NDFB-aQ`CW3nl+(bMA1x$j8`pga>8ak~wU(Z1nG^$ft)aMW z8}or-RP*1tMj!vofC4&X+PzISV9wJv z2TS(toBMZ%HctuD=`>Af+xGro5qH0Pi}`rCbEIrgq^D^<4iBfN82|;c`GhpT0Z@#D z&rg*eX)(3957HFw2;v5fNVnVH@AnP9#Q7nS4^KJ9k|YtLs7+~{rYTt;TmeW3yl=uDHExArWrNH2o&#yLH|7&G&6E8&`*L7PC zftArpwc`H^i#U(0n$!5MB4OOGw=Sny(tfekF%*?zax` zs(0%$BH*e>dF|w4U2Hr1jXVZg_O_B1v&C?8#VQH7)(qJ&LR?hJ&2FervXzxihO*Vm zr{QW~%L_1rnVb2u-j=m5ULzo19);^V^ZyZTBlXJdQH{g$_=VFJ&wKkq*8tE`ZG~!n zB+2Eq)Eo*HDBNJsG!Bo)$A|K$F8c(aRHl(^W?)N}sGF8v3WwM=Es551zl%}EAy1fX zA@T(v5|I1}Xz$Tt-($cyjHkX0(jEgZRG5ajZo<&85zQZdIz3soDJ5&yVRdcy_J_AS z=p*p>>C=~y<;~&UPPF;(4~LLX`;hZA4e6x#WjsEfPbmRGfR=TzS>H+pJ>>Km4sZZh z5;$t^?`eeP^1Ayrws*V3{jPyRKdog4hcP2`5CC~PpHj-!`7|T!Le~}aEwpWqfBtdz z(M^3;(dl%0O6bct)!b*}#vw4cnU>t9Z~+#cFSiT0}hg?c4{%wuKK~4cC0hL0fd{c1f z@@M&1$=JBW^uC(VDp)Rk?bXurE5ES{n52k0FZO6P?OthrUvB7C3n(XWskjR;$WW|! z-B!Ov0hYOttP`;n;A8RT@>&4}i<^R${D_xFS}fyY7e0@iTM_SK(lH>ky?recQxzP7 zU1-YIT_fRz_hx{=T??4b%Qy=9To~R|BnW}C1CBh8r>CdWI2*dI4_T90k|~IYP8l=Y z)N=4NF#?AfLE5(Ida&6DQ0R7tz8Q|=2p!FG;f$9EraYx&oI;cC+D_*@Pbb!NH%`N2 zGtaribZ3PDEN#1w)=tB_H=N!)cFO}`e zpGzlR*{c`F8@wKARs@T?UIyba1oKyWv4F*q(dGB4_11&(>~)&(o^{+EF- zj^=F>r&=%$Al4eYdG!;1*2kCoeHo;%yRp{Tk2T8sh0(1*4sCa|l!#NiGLhDwvRlcS zx{x~s5EF~R-HIGq3J>|Mye^<)G4N^Lt&*SHZFP|sbo3wZDa@f6p z-y=Ddc(0tt`RnQQG^jLD-u*5@G))umh$#cob&=l}EmZ=(9><3S1cZk32s0ochNkZ2 zaImN0>wtLQbUKe|Mg;KFESg6#kRa(~J~Y!fK21-P$$X)8QA>fin=m3^{#8O7kaMyS zc4=Ol$P`V&oZ~Z6yQ1FCQT{ZN;=!UHL}v zSq;cvVmnHp{}ueukGjT9@ss%I3oUR5r*ufGQ(i$2qGv zhJkI8HhJM7y?I3GNSQN7sSkr%=4WX)XX!KcB)|Fka*|%fpWe=L(SkNeQ%&%y5WpqW zesjfhM+`5HLA+|7d0i3)E5U%WO}}7cVglQ>azuE(bPUzQbS3#%XsO0pFz^L5^s2YN z&yF0WYxhaz5Syj)f`UGLP2>ZN2j9OkUaZ zUa^a}OlIY?g4IXB>sMAt-U?#??m!X0R`DLz<*}i%z0qpL zpj4xa${AF-4H<|VxjbHVP6iybZYsGHW1G=EcT(T2NcE@siTWF^p$dyrjS-)jG zRtVy@C<94Jx?w}5g)yn;#PU{H1r`io&&-BGFRLjlntnKG-o*pvVE_zCG_;&ylUd3D zW^n9xA?B%V+rH~N0cLW5;(m9(n}9J;P;b!hcCisvODSb{CT?SAnluB%6xxWam0^W} z0E8Uc-QE4W#?CU!>G*UShMcxj7CW)0r#v6i^yi23Nn>Vi@87AkcYTvAPkGL#^XYif z)0k8ZvFW-W{_!qg`1E=3>73@|6xy!qKL8XU4BUVDlFt@_Oos$D1>zF8og(6W`sBkS zn%vDet2r^Kd8?R*F(D!V*(^;*pPzD8nWQiw6tWl~70+=37zd3SwIic&{w)FBx=h1Y5`zf3rPPd2crFS|{EwYTmUc z&NgOKDb)9pUuvxbVOOB%#d_sivG;-+O}{Dl%D-(PIR@s6e$-H)Vf_Yl4V_jaZ+lc;!B{#qCSH;q3yu zU2pU%=&%_b!`zC2dUYl1?M|1)6YIugY-_0@uJssLT;VFHRh>(p7`Dj@0R-^!D^z9= zQzuzgB`qFptKqozdin-qo#OJtYdvn&4XRLeHeZ<>Rz1U&kYT(Q{9N2A0$4x|S6Oc< zD0D`p;-;1;sY17G1Tz8%LN3N^I+qj;*Q`L?9Zb^`_;BDOqhz;1LPR_9xP)?3ySs0v zG_`%Vzw7n_Xs@d1+x>kTH9v;HBEar`zwcz6pH4#}=5~MB-SyLi5iA|`cZa5J0Zpcw z12eZ^YPI8EtkO0#j(>_>TvrEYqYHHSoP6WWi*oHHP8Xqp)NuI+k~ z-MIlgtLcE05!?Q*-?tOPAsrxyjVGL^@mJ_H8H@tA9n#|$70sF5s6!eaPM`m!IlQ~O z4+2aKAP|CthFpOVW1}NtVTl^CMLzrQ-07y3vWvj6Q7qPd>fXi;Ece3X_z8y0y z2TYN5mw1s^k^pVMSm{-jB>u{YD?0^tmFzX3B8=+R#DE1~jcRkYL*Dp!|; zf*ZmI2bEk3w<0b18s{{5F7Ew>Dqz?5^deBJ&)EFhhP)o#qVH`$-38~=t2N9u=%Xwa zcSjB4t@hDPCzeHaYltmRL76vq*O#|Sm9*bqq2blGgnz%tbabN_-d2dX?h=Dtr4;!# z)Og#Pf1>Nn*_`2?YwCyrju3Zmk;gp7W>4MamZ5E@W&y2cYGSwV!Z5`y#BRR>8+Ow? zA~GS=t_J3K-*$U}4&#`Bw%Hxt9`-l^ir5C}-@OxV6ibP&C?T}mblu^w3+D)&zC0bD zh8mW#HXWZ%gMp)jw%ybI!yo_ghr4cqAm!s<|Ly-g8Z*X;$JbXP* zIRr?XU^?3q-UI*~+O`Qce!}BB!35n)^gR9PUw(f4rFr-ES1aJtYm26~YvBTre{V)Ey$Y3WI$sc! zYqr}>^YwTCztetu^mKKye|NtHFwpnZby@X;YbBAaG$fU$3AVt?0|G zzYhoZD>jGg?>2wis;c~UdwIgXdD&}^-;RMGFTcC$_F>|i4`1ILzojqoZGT?@U6!^a z0m*{I{+4B1+jqU2*IJ3^tng-q538N~te?bM7lRSOV5V6XZHzB^+LAhI@Mkjha;4 zSfZ$#0u=TM^YJOPO^1d7I5HzpY`T-B3_AmeA0R_Hi+aLBgc5*&GJbazetekgw z1aeJbpAxs+y?guaZf7SBP7<1T?_$_ByQU+cjWIOIpauzXf4A%R;oo`RBs#URd&7g})8S7I0R5qDWjg-#pa13Y+>V0*hZZ+Xcefs({aaUfI81Z{>g^pm0mlnmGQO&1$FD!)wK6Z=QYA!Ik~) zW?;|HEb^LcWpZWG(0ah&a+lkPnzbv$rOf6_fZBqB5__F*BCJqR@dDOBJ$t^|UTww( z$$V8qs^GS`SzW%l^Y+shCS!#du?+Omuh$|bh+#`oNbSv9vvl*b3K`le6bt-7)i*%2 z9<^(siJRqKD&3je64&y)FKf5Ix2;HiMPeB@%GEl$f>h9T#_bDx3;>lHSnzennbw~M zz+A0vm_n>51@&IQ6lH=J_!n>^Sup&?$w9 zEs`Z0R)N9`fx@`4EJ#PK*kwSFPMRi4KuQJyBw;#AnjVg)j0o!b z!@gwgGi6TBbkfXVe zI8DP~LD25O&FolYp9%{xd^t~7$h6SeY&-RQrVJ<{#TQJx zhO$tJQm&1G3mG#OdWY3r2Y}pZjajD4MdfX{uc06y5Ep`viXGRtaMQ}sy1e{FkS)~H z>~J$9n5jd!mai#}+#(eUbKM0)ha1}xzweueTqb9$SFO`)6(7FxWtXtejhoar6N+Ux z1agRRDV_^AGu0_H01)7L7>nD~krj{t(ZW4LV4auQ3k`~8!_37;=s>8f_HODz;8N1u z@(QYJsTjj7rdE`?GCWrTSTh!+T}qJ9b)tBPP;4sy6*mP zclhu)J#-=D(|9`Xx;Ifr4R5H8`v$X~2I~Zh)9IK0H=yG%q6^j1h{iyT^TQC>P7$6rq>^56eJ4z)C8;MboY@_s*l9a2ULhyEUq;~&%0 z@zn0`f=o|S8nVV9eAmY|U>c6e7_pVEZ(EFKi8y}#{P_r^X&N3*7!3CHJUDg_f4Tb+ z^GOX+x^dip{N4MzHURHi1_BeP-$AI5j1@;`AzuZUpxNAvQE0`gv*og=P^zW6C9n_) zq12NG>RHQt(cT>ZGm+QBTCdd5#R@6-LJgCs@y1J?o3dkxa8Y5egn$$bwrc2Qw~3*Y zJ2yb6(kU#Iz>adZ7BFN2L#Wz}&W4)kd~F$)gTR+Z2O?rK%aEFhOIHjYT(Wu?C~7ba z1X~5!iv@73K7{HSScYeI8OQjC%W(m(qc?GDwM% zRl7+!rXaQUj2jB^FazKQR!SLf>?&0dyHtjc)HGowv(!hbx1cBvTBK}Bf zfP@w%HeR)+)u1V_t-9@+nt)Yu#F(I}E>cLZ4V$$0O_A6PRE*A1DAB-`1Q~`BU9seb zF$2)`AvI`1&6n_p0;+A-$?91%EMc3qx_ohGmRDe|PSBiHNS10V1)g(Q1{?@PzIAE3 zflE~fa$O9jjrM`M1lKoM4PEjQhamzX7!*)wVZ*;{22ryF2~^A;s-rh^h!jaY&*{rg z9aO%jgv);OE)M2RQ_X3b@^l^)$eapnSBU6D zV!T|57zLP-h8%zsMAI-hxRi=>P#DH~Y8_h!&f_>w1^`+txSBbWEsX#gL=l{{Yx>=; z??Y?_AnbGpxuCby%nq2%41haGeE-uw{J4|0-S6+)1{w1_oS%-TR5V~|8p8X-p-0x~ zJUom!Ph*J-6)ESF!`0lFm62o9wm<&kKfLd|J#)DG@|b}SUCz@yrj&uxY;Xce3{J?y z1RyPPL9+oZBT9(xc8o9sm7o5)mF0^(W{iqFC(R*^A^ZzcMsAv@<4Lm++UH{fr(4NBPGOW%EmBjok=Tr_@fTd&%pG!81Y zqyIg9`oFBLei5?;m-r0`oXep#u=xu8nb? z=bVvMlefY-WlTeE;i@nl%s@U{R-e#`=8O>F`laavrzwvq2l(8GrmPLxmf^EyJ4tN1 zrs*2YDoydFNh{<*pcXF z6z`jHIRE-MXJdSMnkED^ZOen(IGp0B^PDq$PQW}FNtAutHg6kf!faWMk%PcoG5dVR zFdK^jHcdi4n%b0-xeUl7k|9dh=i%!NK;Oico>FWOI0nKbnPHlf#x1*oD_rNCBrt`l z`7K&DZ~nQg$;AzL31@iCiSlZ@F7Z*}`vt!$jKcIiLa@-s$ig^ZKP>;zZIZ;ziM%{w z+jU!Vv9|qOzIA%t_r7VHnuyn5yfhY9Fu=y^CcJU6Kfm18gzu~0UFAP5N73zPWdaa`YXIPK&8BbbRh!2z@7ovj z_SLPnx(V5q#LVK3lI8GT4r{Nxst|;VaI*tsm4S6r11UR5=qPnvTEz<>$}C7}}=o`@J+#xbGT0KYn?5 zdN|hkWVCJnrsFh>r=)-~1pyF0{_&4Lez@y`2utY4DJAWB9Dn`!%L#~h7)FJI`<7)! z8U|IJhwKhmvN5s9es_1b@7`gWj+3fe7KXX!Oc*}zMjXG4MnA0>WMdpTMP=OQ6@*S$@=4xrIc+0W|{cowy zQ@skj29g%-X%T!@&H~@CO?=~KRW0=Dd0EqOH#P3AIuD>GKNruy#UJy07_=&=)fe${ z_@rZ{X4z=9SWugncbLOAW(KYKh|k;Q9Q5UwznYqIxU3XX#Y6XOD4V}m|JCcQ z4ws9(=5jjOlKjqBDdxO%yGrE}b6?KF0I-Es^VJYbuRpF*Zv`p=z+J_tM#8h#7@?|hT_4%&aqOGN zug*+gK+tQw;F+@)u$weZE&lP%;x;&pwpoeBbr+j^5e$X8xupAAKq=arFp(SpZ zJPQfpm)_bm1H{~Sai~ESZGYHz^5LKU@L|sY@|?yr<>~n8)2CmD32*M3_jiZB=00d1 zAHE!iG7zkVLUjC`6i zn9=Tg9AVR7(Bm|lnJ3KiB>VmT?fdt4yLLJQ?m10xV>2alJdB;_@z<~C1c|Vu=F{Q@ z$$W-o1O`GAkxpnuSdkGsX&ej^gF-Erqj7100Eem0IZ#Z|RD=*v0>F56q*YfjHZF$k z^6{I^_^r06(u+(W7@$l`)zT6q@v0bDAM2Zn3soswJG3~n=(0H%jU2WHtFG2wiA=bD zVlk2Ga$g;UFLcBN3pGnQgk?R$uK#;=5wMiDD4ZX^SroALuNo6qbT0K(tPJ0HVSCq+ z(ZZ2)oqhP?JeOc}dw#THxl?)gD=JTkBEnK2qsC6ucf7f}Jb$ST;+uajKXJfIM8#!D zHFvQ<+Ca@|yo`fyM!(cRSZ`m{jOrt+>{;bqTxm;1k&$Z~?y7M?@@ndRv5L0e>$Y+q zN%5jx5Q@z?eo=uoAFTtSdWqpBb*>K6fCBKBKwY}9)l^3+FLsmxOSS4M999WaazcH{ zWHR8HfA4mwZs%q-jpBJ_UaLvj0?`w2fO&9;Vqp)>+`*NeIhAlw}i(9z1 zOU&!^^z@g9958Fqj154z;#iN=Er2>Ew=_*TDIh8#Ahz0!lftZ|o)H1ayZznAogNxI zJPbfWre}$cO(T`cStPWfA&yK==)A-3pxxBW2om>3;8_9g+Wp)69lyKlqa~zt8lFyP zw2u#;J|AZV{qFa>ce{NHLpmipPrv;7G>q9G;20vcyZ!!f7owiZYUj4O@7v$~{trLC zz3;>^O)%GaPV;oHU%!0*{CNTxq?QwND{b2i82~hob54NGNV77y?f1J~3%B#>={(Kb zK|UQh%){|1J33)_N|sfaQQhR+g1O(_AG!g+G@klh-ts7f^`%`t<-i6NW;-%4I7W>5uQZ+^H6 zHmb-kZ6%$*95J$C%>A3+muu`|q zilWpHQM2=ah1j*QL)9-g@THI!wfdW{&~^FQhTZRFjd9fyx1W{D=0W9~%ca!0VL+t< zNmcz?7GB|-Qn&g1czhf?84)@pQ9u|?gaT=5=YZJvfT3Xnk|j&20H4%`e&02srxTxH znVC4Yp=D%1cDuJ|@-Yn)GLQ%k2^^%HWD=Stiq1n0;yDBm1!58no~iM6KYtAoV3s>H zLQw(Pb>014PogPhosY*~KR=vReth`y@O2EKZ$JJ+f4A!hDW{aqU!HzBO&&N<6Wg{6 zO>@6*_BKyrwzz{K^zYss4!?i@!~31ETbjPO={!!;m`d{8-*)_d^wiNNbRcIC=?nK@=5 z$KdtR*L^P(BDR$6ruAwEFJM4GLaU$;^xv?P|_;<3*itjjv6pj;^6 z`ZcCNY}N3gnwql!Dlgk6^-FbIBK+6%iS@1vQc_+(0X7-@QiXJ1@$8$&7dufmX5ve| zSy2yE1eYtH42dszW+eq%x4$$NNJSCVV(`wPQ-R|ATeJAJh z)1MoFbKFbUGQ%>4-aw)4yBG<`C0bc0F2)RlyM3ft=W`CbrVSDzQy^g|iGZ4Z>W5Jw zM4d3g#PY!OZ7$(m}qQhOg(-pa60pF-PVcct+;NC5Ai9s^-}MY4>f1DU2G+ z(oeH=?+`*O0MK{b!e)VH@_C+8-mFxB!7!wpvI_*ToQ3#o${YY#E}&02ig-CVXgyWk z=oM1M-)sz!FP^iq*V*8TOW_w|dhxKkTIa>j4l=&D3fBsC&Suq#NR@Eg)`~o9Q23=S zT#T0%swk@@WmQXfakv*svdgB#B3`%T8=L#HmGSZdV0=seyr6mjXnPvia>MQaZ-?hg zAS$mv*gWl(d8RA1pA50wVkR66(}d61)oU`fs?(4d7Zq=$cL%fH_@-YCG)pcuudjC2jYg z7Ved+<+OcWOaO%?%ge3Ca2c==IH1s;0$_!!s{5EScTr_ub4I#GPf#oI^82<=fZ-wJ zjAUBghk(NF-5)+2_Lxo&{0Stf?Lrqr_E~*69p5IOhB4)U3?LXw!ptEGO9Z+mV)D~* z==bp;5*$oWsJkk>ZQ3TZ3J%fEU1gkDrg3W2VQaN9C@2`!UYc z3Uq!rKOWCtAD&K*fR1AfecLx(^ES-q^YLjorPu=D?!*7~Pwx+t^bJ(=JfFtLub)0W zjff)icp4S3WD)_lQ9?7Sa<|`ir!gZHqP%1(u#`{vB=~fiPigQqYe{(5hDM-sW~Mxh=fME}uyS;BCIa#}pL6KS`clB! zyW&go_1LSS3nimXF4j~zQ2pi{{bpO7>>CXiuGbLJrj)^Nv}MCxtep!c#l?!FbwB!r z6@Qcaygcp2@?O3OKGdS&^2#``%fNsDHqa9Ab1jkTkIKQrL>J@h75@DdpjzE!FSN_C ze=GJ@Gj@?ew-0%FOv^#GwTRZg)nQM612!wLR>8L5~#R*?^NoAxV{=aVOkuPwt#!r z_2{^AMy&E1C?ejTz3zp7EA#1<&J=s5CSVf7>kRQFw?`qy6?OI%c)UP4 z#cZWtEpH8PL^mAZXq4*PFpbG#_Uyi5! z+(4QZuQic4_l77PBodI*3_T!y`Ss!C5jvcPq%Gq88$4=InIC_BIOpNvIE+EiprtnS z-M*3LfSiwyPbby51KKyg|Ka@)yC-x6wP~7X_~X~Vd_|C$#%vP+SlKnnynwsZ?|}`* zU3Qhu2IS8}8Z3e1w)b!Qc^py#$md}U6(A1n{=P%RR3fj`4D;bFQlZL5yDMpq0QodL zJ`DzNEnN#BOw0tG&*StaDhwIwdfFS%3e>oHbuw?-e@yC~KNmfJbK_Ei${!%X2E`4Ep^(=OMA2 zKvGqlPV(vS@yFl)7zJR=>2&<%anA84iO|sRo4r8Otf%qtA^78bKIrI;AOr1xEWfA3h!i(fQ|z8#ID0=D<;qvu1}ND^i*f z?x1dlz&)^gCu|t){JFu*pqTOI$F7gij1VVo1B_*Vc(=RjkurdA8o+JaU>qhreR+78 zAWi)BzVEw8IV*Mq3CQT$j-;GhVfuPLJ?-~x6Ih6lg@900LWject4v`EUIF1AX7p2&N8s6u`!YB}& zn!B-pc!{MhRR3d;!4_7K0OTVJ5h% zt&Ez5=(Qfh+f$w|e^}|ZEzVhG+f)j=YE%Zee!YE51~auHcsKZM<@;uoG6ID^3ji%O z0ZUGnqh{}cR}Y>5^*aSZ;0ruO_3dw9P$|jIOyz}a4nej}^nk%lg{4Nvk$6e{^8^-w z!qti+tNMzW;HHaNLlGZalFi2Nu zQ`msKl0)+fh!Y@%l*Wo3w&Vs?%pF&vyv`B>5U|0jeY`jqm$%1|l5qfY5<-MQT_t#7 z_+n^rPpB5y#_P&+RR@HvP)~Aoz?s8rEp|^-1B0__Rw=A%0U%~ow&hJYRSF0x_I--OJ`zX1}GOE>#|o(VV=j~@p1U&0lSC<>;ctzFb=7QVAk?3 z2gDv32_Xt3*j$z%GPT250R-vxhkd{Q^e{#N)H4`JM|2|l4mJRDv%7!W&uI27Tb|SI zA0di~(9FlA3fX6ez%8fq@t2>Eq3sVg4^zAUaM*VOou1lrf53Sjr*TM-@OaAAvI>#; z@czf&y$^Xho&WNuzkYc#j-hWTAOkHlr`aaQQ^==>T3#jZf2gOp1ML(`lU40Zj8~;I?J%-u&*Tw}Po@2Bj7NI7H)soZXUfGxrIq4n+zL1{!~SjuKB`{t~rt=x76m_W9X zJ4oBP@cS0O%74f`WvsGDsHCKMmuDw1obK$q^+bH~;RunqJ{ z*MAi#Re@_#i`C2L)eU()CR+tJ+od#3tthn!3_)@G+xD{Mz7>iqT`UO^bhAhb`o>@( zHp3dRzj9%0=F3!+CBgNiEoVK}Ot9xEi7N#t6ChfZw?(!rniT*F?rX7h zA+WnbfEzoA^>YYyJGTm9QZb-Iltld9q%tz!#o)bza%(nxK_5 z?OO9#ewXLz^!R1`^1#cAjdRmPr`Ux&ssd=bc4vuZIARF7#l(iW2Jqx``tl~;qp?Wc z0sZg)$1i~DFhc-@*fk-~V`7PD=enpPn+p+xNRh$dgXT;RUKLu`I*g<(zmHpK=RBh<40jPYqg+e&EfQ_juX|Nhf10ydo=K7Tr%thX#p%MgH5 zPI(-YK?UQKj6rdCcR1`DE}SzU%lUjdKKWeMAv{g$*<2x0P5^{Oc5m+Q8_{{1XIlNR5&B=w=*6BJGxP13o8uCkL^pcSG9qHcdL#orH ze&*Z%T>lU#%+L!B_H*(7%%yib+0RAVB09FWu`9E@PRQ#(TNP=S8aG9wxBx=yhnxPa znAF<$SNgq>m2)|FOKa~oM$GN4SePngwl$00mQq<>`+bXz7PD?ywM&Pqwo&NC zx6=GIWZaj^hkpk?y1o1L^snoD<83Q1;U)&;Qg6iy11eR#e9_@-DLn6&$C$I@DqZ~2 z4Z8*xiVEzj@)Zj4ib46CSTip`%}YnZclkp$eJ+hk*))F5|GjBNdb8b>f>btfRsU|N zd|7;pKi^(h36_VaufP8J{HHIFuGahE(9Oj^Gy{Od-EM!H0i*3S>alA_LMF_@{06`*(-k9Uk-uAW9QBG@ar+CZGlUG*8nsD9m66 z_k{ah6mO;P@5wL>eUIVk%ctYx!(&EhTA#IVOWoNiMT+1Mxhbf)x^XK2CNc}A5Cjq? zgv&{{*lGNYRO{Co)dT52$6LJ-5~0+W*b3-P`&(QqOB^%T}z_J+6xke^WkRF9iXyZTUn3P)aG4GBnGx%bx=C4cJ0UzW1i< zRlBHl+6{QQBGY!r*SaUwsLJbcP*Lq}aD>7%FDpLG$QD#GO!F(@D!%0TR0YEp$6-zA zGQw59VZCTRKmGdWpHDwO#a8zK5)im)R65}~K_QKB6Gv!<8CploVJufqs<2W1s>fZp zfAir@Bk_&>a6F#UIH6@eHEp+J%=6?CO^k<+KYr*NV47N-0nG|(ng~IAQYUHqHnLhi z|ML0aF{z9tYbFQ><>c&GR(dlZD;=;lszb_rfu>F;WZ9^Xbc%Psj5#QWGJu z-%A6W(l|VhlR9!Qfg`ou-Tm9QZ|{5Yah$*sl25<>^64}|AVM)%%JVekjDpC3+q?Ti z|M928uF-TFhC#DmFOg~(v>c@+LEwG2@0)nWJkBZQ5WBr#oO3AvfEhN8^Oz>5xZFi{ zZ2%zz31Lo;bF&jYJ^l6ccs$QRVxu$qj!A%gZV?O;q6A^UTvaW=%w~6uQwy+!CdgL8 zX8>vp{nuq69!$Fbx%EOf5d@k%v<`;t$vCb7Fg zh{5EywK2&{I^1P8^kwC4z30`{ya~&`bYq3zFRc)u61Z?>Um)1uiV8KZNN4?x8MM0M z>+Ky5yE*MF&*QIu{`p_Whp{UK?+k+hU4md9M*x}k$a&Ve0kU*JOw~WkVag8AkLe+% z{m0+^^!C1GZo47o?BKSwrfWDPRYwom_isP`aM!n@)70WTsSF4m#YPCSa|2V;1Q1N; z`8+DdCSsb+02{*act+D&n+BccX-sKWaC86TAAkS5L(fxef|$1x~U?iNV^7LY1%G? zO>Ak!Q2<;*p#MJG?F!7p5+$(x(3jk4T=`g@wUtU@^$i&Vv~WX~2+x9nQl0awO6523 z;4{%jUM1f*4T-gjzBydMcvc^t%5K7S((8Y%`0nktCxD0?OQi8_ zvr95~nX&5e-`>AEKI^|K(8h%yvYy*F-M`#^sX|3=uC4%G*&HP+tB`ui^IC~Si|na& zh>1b0C3~6#>cm>ok2e=B{?~=2ZTWKBNru5+K9a9KTo=|$zkK=A?Q5uN$<@?vnc+(0 z%O+p`RwqEs^)@a7PN=xftJE{Q4X#}s3)j%|tqp~$fKl<_md6GZ1d)k}SI2d=*$9hE z*5PnBCc;e#_~J!jl}h|w%Fe#rtoGr$N42xhkb1se+O|{{s}ArY)E5oxWgF8_vXH4J zkixW(gI<#S41n7fH8-<7Jw82r`8tggbs`L8q%Uu48Lj!GxCQww#!Zt}Etg zATV>&FrbD3nA5DBrmu2-I)mfm4k-=C)0}eF*xvv6U;pW+k9~_%Xc%^yPRHr-%csYj z+mM^x?%mrT-Xc$Vd_0}cLo%?m{hJ+TbU*$6!>$tsa?(6-nDX(@KmU9(v~AyFoGCvI zI#@C=5QJm<_VDgQe-}k{J|Bnki~z1VvnE}PKvs=0^!vm6yF;_vr}^>mbUZy-i!|hn zoU;vZMM^eVoP129I!GFc0wBh&iKKaW$Ws(N9*^_XrZgN)vuc)1&A{P!+_g@gHW7DL zf}1QSz)Cd?nHi9-*`wQ54XJHKJ8lldZ?(#5v4nOlpKhw%-K|b01eLXN>MF%)9n$5)a*P#xu~48a4A9S9Nt} zvesXX<&w%)snIv54zVo-0hvn|*Q&)P1U6PGhw$dErPgfX*-WE7};KYycbtyVHjF9m+ddTcE=diAGuLPSpic3VU2>qdhgrg{{>;N zl=dN6?L8u55+}K_$zPZ#twoDoTv^}t?_CEGZ7;=ZsqVK=u*G@2w6)XU4PV#J*R0Ia zt=ordPUGWnaswoG5|N-sQ7v5O$&dldIu9qEQ*1<}(Nn!PHoeYi$dl($r`bK7AKx9q z<7{XXH@idMiD0xTfnq29;qBc%25=~#Nc)JUR;VU$!18jb>Gp>?VaAw7jHeT1njbNb zdDfEIcAC>TPMUYS!w)~cKlE+Djs!NIzx?{^@bq{bagP{U+<*A^p_$K^k6*_5l)y2z zAKtxv2Tl8*etO>$G#5?@o9*kL{^hR|c;EH=4yO^rJZPTW!H_0O-@iY+eY5K^;r#UL z@#~Zr6k>=J0-XA`1*QbVwtM&X1l$JzKnt_)a9`V(eH;TP|(WF?EnN2F$)l+a?cc6mnG7xC=|uIFXzHy zZ(a3T#g^`~`72V$%>lWdnp;26rPt-SzkKS-;8N$^Z>{RzSQdrysfZG{;>&~xVS&%x z?FPJX*F4V?z|?hJzmJx5PJlwyfHA8pvZXO57!71e zseL@2N50c|=$nHko90o`_dDM0+9-e;L?Z-Yhpy}QeY1e&OaMfK_m-jQG>?N~IFCSc zLIlTf9*+iK@_EjhK}}@QG+Dz8%j458KmYt`9H(KDegFQ@e0}rbaF53{9nX(bN;$-R zbN^p|{O}H%+YfJALSjeCh=b|$r~mU`pSrH^yZt>wkW7;$bC4n2#df!Q`|e%e;GFIJ zcp5dia12ei?_&d%{jNo_Nype9-oAZv-$&v}Pd`6=%?J~+NXSUZz%fXhCpMWhWiZDe z+Uy(5==QsYkRCt(X=;v7JRHY}038!c5CMfo0QWhK6Fj|@*aB`TCU+I&@%%K2<}^y2woV)Mc(r7Jl2T}`WYa&?&5!biB(ApIK>^%@J=L>875S6aP=UWum) zE>xx3Dv|IzACU-x_X_i0AKUAx@Y#wjdAhHyxN0689wEdHo zc&P=Be(5dUYQ~qQ5Divw#O3;p?Q!`KsIQ{9gqHlTm96p>H;$K^6WBxrH=Y_>r$w+Z zy=*Tp=PIp56PE-$FWJq8TCVg;?YEUa$Cue!h=U3;AON}R);YD|c;04~td76_R>GfYJQI)oki82by6Min$BN!9t`t1frk{kPV*UK8Zwa8HP`8w#{rSMd*tE#>(BrEmxtM=EaCo- zfB49M>E7Ho^Ne|X9Mfz-+#T-!@el9s;VSz(B-beePLVC2KK=RAq+QqS`$J3^<7}2{ z`Vif?*zX#srZk|xe{+AhZvv+2^vkagBeg*% z35+>U33s6lF{E+S>}n2b+K$Gqi(vHqzIDvUFAoEaW7Gjr7-^han_`=&i7^3roCcVR zw1HUFea>o)W1fc7*kPO}1;F#93Ut>ob4;RaFtBsMvdmx8-Ck_f;l;c;&==Y$dx4ar zlz#l}LuE|_sOAu=T3S35URj9wBEPO>+h&U`QgM4eTu!-f4vwn`uP=SMr>{2O_Ls{a zyh5v@SLUYU1}$8~-fOdQr3x%3$EGlzUHy_TML1t<+x(Go`O2CFJhN4n$ssmhXYa<2 z+WdHn)3V|wIC!P7t9-?`m4nGkC}tKQw%?7BFEKJWc+@1?D0_Okk}e(~aE^`O{@DZWTP z;x#$%g{Ql1bN&{*_F7ifzpFMPp=rCh)%fn?+XgtRCIDddoU^N{0TV()n1VrA>O3e^ zclT$E-3eLIazh-EdLO?i1YN(6eGi5z(Ck|m0838Rf`~LmM!>&MgfGr*)=l9V2|gV z4FZs~0w5p;=$Icqe>sjpb7SCkY@p!QCq)EDra(Y8jK-=tr)ZgwGQddF^pqm9YS9lj zNN6Dvq0PQ3Tftzi{!Ed&U0EfeXesqfAi6rsDjN%cQn>Q=2)Wo!zCE~JXpBYqH(%<8 zuu~0lVY{3;bpq@pLIN%Ntq$nvP@-lPXs%r1u+pPPg&qM$JKlEeUu|Brz zRISUrWoASw#4F&AegH^Oiin&!tE%n5maUl~i6969aQETv!F2f6*McOVQZLk(L|V}iC{UeEkPo#+8?U@ zyOZwUxBDuEpS!PPFs`aGj%Q4hsDfZ^{Z6{4QFwoUkANyu?wtS(!|ACT=k(XQYAx*X z&VTMAtgEXxhh_k(Ex}TY8!87g@BB;#+3v;W<2$VEjtUM8Gv!VIm+iW!ulNq z=fr#S_4LoeRU={)hWU=3yNB$1k5hb-~_;8U9cI?O%=>I_NN_&wu~x zKfVTM9oL8b@z~tqX}G^Tm^7XK)=&Q3{n5$v)6buN{4};y>%$X&IN<5i&tHRrkYLD} z`j5vq@9IkCry*cIou|orgH} zk|Yx`u?2BHdQIjN%U2gnkN}0^;x8voP?J{sq||y_8!t01iWLgjh{{-)cu~SDlO_=b zydgukB2_n&mbuxI0my)iSz~Y6BuxN^KzP4M60;Ctib%HuJpHCqj}i1O->{ z-Z6aTy|0|*s*HOXR1%Ib-jE}9OfsuX{Zl`K+ZnJ#0PJUnY62=$wR1*Nq!9=%grSD^ zoqT;7Kc54m<{H@j>CbQLF@%$`ET6yj6Ue)|dUH6o$HpT88fofI59e`LHC2j}+f{@l z;)cfU9Lq3_Q-IT;pvt*c1I*4LaCLqdLjnw2+Dr7ca}{`e{N>Z=`rgL=6WY_R0YZHI z+tZi9qS@aaFj)Yw5ott>je}!BJ2zo5TZq{5ozoQfPreRD?d(k zL#XSSzmyMei z=f%c{ve4g^Iz)!DWoTY9qqaR>dbs_rTz8G=r4q6ByvrQe{gN5*EEbK-w}7$V(&NqQ zZu*`^C0v2C`lDEgF*Tq2B>^xy%5FWBON`u=bL1rl%LeW>0AaD?*EjYJr_6$;7O?rb zT|sIHYRpT$+z`A{;p;XR9b6ejJ4Z@4U|nvvb7{7pn#+gA+(-mNCA;flz~H52tGXpr zTW?EL#&1Ce$v|ik3JJ0Vb7*mhEuqOPY?o1piwU@x-6@0rbXC&lTZAP`NxA&$a&=fN zD1lz$$gZLAWnCD#xH(HP1n{DsSiG>YZW}?1Akh^%04>=L3yE2-$aw3n{l;cV$rMkg zxiMF7fB1?CnSH$mrOerjKcS?glzFE}Gc8trrpqu;EM3i!FMuIqckEH`+KM&Rb<-%Z zKtfP4b%F{sTAdkZf6vB0CXY0I<1oHV`KRsyG-LrH*!!=cnQNsC`FoEmC z-Ca9OAhJ;rH3T-U0O$ASVM>bB#V|TOe?AR@l=T5lF|e>O*R71>IQyn* z*#%4yEhA1HM7Xg)lBfWJN`xh6oihNFNMHeA$T>iW7BXR&jH$fL+j7~W1uZMc=!%qP z;>diwrR{Yu!9{D`nD3Sp!Q{yk@RLM)TaQY zrRLHLEo+B{7R2*1fuJOGv%FSpei_AbqH4B(G}#Qo60q8P1}|;&36JT(&&r z^a#BOsLNw)bkZC52#{G|H7UqkDX%xQvU(%-$|}nSopS!fXi~k67SKF`go5QW3OrFV zGEA0rsmxCXtx`e)IZrL@u42;E9NsAeA|cE(yp5OuAR@pyW(NjX1ML3oKfS+m@C|ba zg1PdRQaFu0cMK4741IWvlEt2@Q61X4a+P%qO-VJch?HWAL9n-ETqalT!s+SD(PoIC4Fokgn0>7)9 zx9{H_o5oftV)jq*^DqDYqoA$c`XD1Lm>f*)_wSE8ou7t&Qfq@U?CyAXsGFv79>xM= zh=7H)jyc5c>kb%x`PZ)<)d0(Q79K#D<1~J;#Le!_p=~Wd4mOHR6Ufw2kL}Lm;qzk$ zTi5hSL_r#+4yo_DoHIC)Bbp4sSjY9jW9mC;E4BzThTvewT@qpjtYVfJ1PD<8Ypu6% z2%t10aZnJ~KB+Sf01*SpAZej;r|VUerB_~%o1?z`H~*1TK}u#@#~o|3=(UrLD0^zY zVQ;+H6bjX)#Jr}m;@3j2dihUoDQ7Pg6f_%o8Ml3YHkL$=^tvvbfV67Q<%8`Mpdet& zU(d^itKoEUg%#IE@yBTfjadM@_DIU#!~)##oT*#nE`Q(FAPcm$l8Z0OyyCrW0uss5uopK zo;A<}U{nBz4pq$z2r7v2#}DuS_=Z)+-M*^-;U_i#MhU~ZF#_hNfSSoQb!E9~eC;ah zECU&(Pm=fj973oa7)SygyYBSm=YEDo*<=jH5JdK_CfHf3Y`~}JFr9zxE6Duw-<>}+ z?cMvk`a?BGhcJEl`5#}WIZiVG_G z9}c9U>xO{F8lA|ucW>|a$Gd}vjKkDl=5ZdoA#mu>{q3>Ogry-&LI7l%LI}zGrmY?3 z2w01N7^V<`S#1kyA|pmYoO}qHu~%RYQwV_35DnO+q$4GVYPUxk`nhreI?UrJ(Xu=4 zJ{;id${?2>0j3i4%xoK7PCVh9&!x-Dd@Z}c^R$iRj`2e`8 zO=i{&bfvTx7OLOP43m;xv(cJWd;VSBy!!FCke6k@z1~d9LF2FX^4t_lW+C>tP4svL zE=p@f1anJgx!&ZP?Q$$#Y}n1$7oXJTNegyY(j6|`FZ9iszo-L?wz1`^HYSIDCfNqL zn_JfA*V@Lu_`VBn+WPR%*u}~?u$Xy#NtjS7tK|2TsN5d#`H^23#jEW(cQju|Nt>7c zd9n90#=K}MK*?h;oHo+z`IybxVfGblQ`{G0b%E(LVH3H1VHbRsX^;R(EJy-~xppXC z7Gq%(O1e=AmfM#*EsBzqg!*e2hvuTkB?R1%$@K+kfgdu5K*}Krn)QSj#%UDJsf|Qw z7vToTY3L%rKz6`dIoKDK)QeZ>(4)VUt)7SAdo<3pd0dm$=2pKK{ z6B%yVH+6+D*b!tLBGMct1rj@7%OIaWojT!uXP=UmXk?YSu&W|0uY1OhoAzL%g9CIr zjpIBd>DeFd{9FH~F`xj6>tbNT#uC(M5U|5z0BqeHyx*Y)L1mj2#?P1(7IR?}pI>&x ziePO~iOVW{jq5u5!+)p3x7CYF_~NSaz2d7{`29<0Tuu*rMcS@Cym%PAVw>jkq+DT= zSxe78AJC=zM26|oZ=dj5(7b0ODz=6xR^s;j$nO4IU^$_@mZY~J*>$sv0lUIrWQtv9 zV6x*V!?SOP+A{Sv_s=yZgrLgQ?E66YObX6`Z ztGc9yQ%;;p+eCwH&Bmpm(po<^=vqx%IiM0R-AV+uZaDxlT$+ za}d^YqSBfVxVb}|hNp)i`qm~@2WDp~_hvjvoFlxbN`wV$Z4lyQ=c?WL=AA|3cD2`$ z5@5J)n_V5t^b0JQ9ZQ&HI5Ev=y!VzthLBX1BP2}Y&<#Pxwmnn?_Lj1uDRY=%ngfW2 zIVf2HV5;i)KHBPs4+oxx&Usfy0%{v!0Ksm*J66s6AKtaCXYR)CACD8Hi&Q&6!Z1z| zQ8e@s^Emt>yf>b(gq4ldfBN!N-@pH-53L8D1aa<%094J}83INn!%ubVcsf6HBR801 z=00sal8(+GvN2>WWbU2>u%2wDnl+5M%KE;mgdt1y%qfnfbBYoW0uZgswbO|Jr-G0d zk9D?!0$f#91N33~(oIk2ryv13kiee?CFWp53Nb`5O9T*8K$JM02LTw}Da=4s@BO>+ zgS1@2vL zH%fid#Z!|V@hLBmJY2%%$D}2`;;Jg&c7Petp%*0WRkd2+LTJAo2#m=^AU1Un%;oYd zRC4atqMR20(2d~R=&?&&z?J&&@?o}`^C`0hZ?mPfqIxUPUn(u7o;ZMk;W^$c!}WFeq%e6OD> zpaeEoMr2tYDNBsypDX{$rYcA&%6aEqtFb!iFhK!SRZRmz1bOUucl6%ZhA<;o zCJiBqh6#kY#2_#L$S_TIIKr^EuFO-?lmszM!>Q}0zB|6f(Gx0h)>Rf!U0|w}UG=E* zOviy{)cfQ6!}}ENo4dwZsVr5lHt@B3iU7FXzu&vRH2dSOas&{j$G-iWJ5MemlW>&Flr!h0juB*>O zM5>XKwi26Lio}vXSG-C~yTCpRX))GKdwb?6E@|pCf!;fvJ9jGfKBe;>$xUF%s7u znUy8Ez(~;b<^C2s>sp^}Q~pU~jPrK}OI7TL6(%&O~pVb3PEcrU^6P>fP~fzq7t>D(0l>Ec#*c)sZdj zcAondLzK}}9B@9Jhp%|UeTFY5*oqOlbNA-%MRl-ZThZKc)y^csvn@M%V*U0+bwMcWlP5mK_Khld+DGLKxK8 zRI&9MA|e>pF(>63F*-2;k=R*Vd5M-X_dqxG-Eiv8)2IN<&JZM=o;tH<0yIW|Y6(R{ ziec{iUV+Mu(hWlbjPKyu3Pi>w1%cS$YCRg0kjw=|&)H-PkVjaHeOz39SD|#-k(cxW zU*JU~^n02??q!o%9v3Rdbz7Jhj!wdYMP1hYbGJ%{0l!fbP+yX1w^GlVe!dnl+1+ zm4)85wvaZxtj3H2$zV-kUoWS`rX-^+^qU524e<+0Hp3G6fdT0Bx7y0#>FnpXFvYyV71d zx|1eDfQYKU_EeeGdR#w9Yu9PH%NlW{YbD4P!MA{6D}}0=*r0edgH6$lAZ$&4MIK>$ND$Mfux1T13tKQTYzaqN1Vwoou zWdQ7|iVet;1_8i~G=BNFzn>+@y{jt-Kq)aBiOG@$RA!FjN!o^M;oXO~$G!K_?%z~E zI<^K}3v=byZV4iqOwPoO|?N`xz*y&SXb#tHYs2XJA9$%?UvG31CmwAckS;PMrXr=1e7E zEXnE1!HiT@I|9Tg2&xOJWsJ!Qo+c+ymu+_mrPo5uj72Vk z$twu9z;3Gsu8;+HdPcm23%~X%FgAC}XQwXCfh{1qFm>gVsKh9!!9q!!eZZQrtPPZy zR$W1XC4_^QNb=%gTV+-@z&8<%*^feM3p|=XWdRf%`SRKFIBC6HQIgdRK@;&sS|tO9 z0*TxbC}~n$m8DX;w{Uk6K}lA?GXZRJ6k(Q*`TR}p@*06eii8bkM`2*eu<%0gM#dPZ zrVI5T0Kk!9GKC%36j0mnCAr6BGa*+Ed)9lTVYcWTxKq}i=Z3{Y5|Z_BsL(!dG~CRAj#f} z){7pKkV)!^~0`J_H zlimGb`k#OP)PL=!WWX4oB!C>MMyAY2$ugWm7%c-5VPnv$M(iKH=mfHdR^~auLmd>v zWSNOA!NS4nj4{T!YQ61#{nvjz+xkHJokvWDk_wW<5!S0pfOpQ<>`KRtf>{8cOGEhe9YfgrG$%pSy;ei?u8j0x?3|KHxk_kVai z4G54YrZG$j#?^1%9K*wTARo2bzyJ8g@wi~@ZYSC)C8Ur5TY2jV1gjvIg`NT6NevX( zyTkpl<^ei9jXDnqL#O%dGp4qf#I<+#drTVKI8NgLVEPfw!CMz&n&Ui7!wA$|RzJJS zNqFKj*R3XNwIq-g!hGej;ml^UW<70jmgF$vqUT~`{j5>oYxTP#wDJMH1e&}I@@yOzc1SFmgzE+9uS#){9P1ei(C;^FWu#>2c=DEg8VU;a!MPE2+NbpZ%&%=s7r!{u7_1I%qWkT z7OXixf^Kmr+p@|CNA>DxEa z%_d0-Ljr;+=JAr)|3WhW({0MjLSC#k3#;h=ySRV^*2_r_-tL5a76~o7&sT5EE2Y zTw|w%J_0y$dwl!$*jP&nX0{Y#7{_T803stgwojiPzb0GTd5#ibDl|3gzmH>^jXh!7;2y@3kcN&J#3)ilyQB~u)_4R&_+Tws+dwA-H0CY2u5vt>x<8cg~ z!tdT5-u>zQPA2q6=W7H>rfM3H145Xks;u{pF=b;5-Y|d)RW36e@Au8IMmIcl;^Q=S zkZv5iDTJ886L!u!Mwmot9EN@bfC)TR01#!43TA)-4qySXs~U$X;^}GZ?`tB%y1~EX z1*YF(DlD=vudKywvq*(Y-C0^{C|>K2Yx_;Nz}Bk>V1r;?SVQu$sh1O^c%LqI<;}g9 zKbP7tw8+pK7hYQamxIPkvDebYQeAg-GRb6>;6)I3^@AFH@dwGEB-gK~Pr5*GS(nb> z=X%VU6_{FV$IV`-5>oBF&Xvsu)emkgL!kKq4c(^8t_W?Yv#%alqP ztJ@Jizi91qLx7@JOCW8th6+gXYB$%d~M@YijSSi?+9$b`k^tJ|1?*G=-=T4#-W^ZBW$#v>Xo4kFQm{rPnXtwinNmmrum+QB9X$ zF21tgfKh)7WktHkl!ElWK8o~eFw1wfWLBGTZ30TmnUX)b)}0IGa-roYcD5-z6tCro zeAg%wz9sqiyM(|Rig;c7rFgzxnMeV!iG(lJa7s_F1p;Ox@uCpmcU97Q#U8o9q#0Q- zidWX_i&uTCDM3rPyMFr;GQVTpe{ZwMuyAG$(C1FnP213MW*1vp;1>mqM5qM}8L;MX z(W}IeC7E@rOmFiXmQ8BX;uus~%cAFzz3Oi#vt`)eGLMu5BuEJ<8Fu9vR`5R41jfGW zLI5h6rmp+)bnYkl{B=?whVe0Ur&)j)^gSEm3T!~_1VjWG%Dt=O{hNIwY54pVsJwS} z7cuoS9LUu*qUPf}iK{&AI%+EES-_a2PXm-J2K4A>G>W>eDs})FhKNq5PY=AB?DhxmYDoryBmxgVRWSf~_tqZ|ZSfugq#F9i$A^a*6^IdMIgj1Lxf4tr z1aQ{3Oca?v$ub4%`&`)#b{^AtIKrCVCqD;|p80<8RF@cU%Er)$Y z#v#otI*nlt<2=I}@(kNH_X58ApZnv1!`JZ?J%^zm$0NsXr5k6mHC0mLo@MGaEcTwb z8Q`j}+NN?GG4bdJW>sY}tPAp|+p{L?ZV79I1}&eiwhXfBrzMjuDGZfh>UH7YxV2td z(VL$v2;%zd)rY@=oR34dWR|m)aS55vR=~C%iHg zEpL~QcWPdxWYYQ#0N7<0rG%W#sV`)Ntb@9K9%^n0=0E>IP3_qKR<%1dOCuE`79u+>bBtt z)^e_`!QSZ|DoltY3}(!u0#p+a!pyA$m@Sb33llWp{P@d1lG*t zSz$>LVVmRKyTH_t*`m zE~pWYC<6Dc^5FK5zVR3=hFN4dou9_cKdcef5E-}khqrI{jj^%shf{}A$buOxh;#}f zVf;Er7z;$iFitVV9MxhF4RHm;{)ER*l%M2u#^Od{TW$|*<7mzTvwHI-dY5v zrVgErb8Q``>>_^YU`h$;c>>N#GyOtSg7PNvF4+&(S-86}kJ68T`%<&qbk1OSv*OX?PhBU4-@ ztMY(yRHqG>H8w7|WL8({dWvt9gzqx!N_5W^Kni>_suhM`VaZsAM+r&^NogDAQf~NL zqGKx}iuf~&VM-cfjLd+yOj3N>l48Voe)#3FpWqy-))VIO zYlL+OMC8ad`$OCE+|41tSPwx&bN}w$ThDb{TR^A2??kLeg29-p<&pCk*7xu4@Ar3Y z1iT&7)PMQ>>C@BrwI9xdfa}N-=jp@SyB6$fXOUzY&L_y}^J$)83Bgo(<=Fb*-@LuM z+mVgo>4bUEi0r~;XoUU<05PaV)4(Fk^Au24j3XpyilQNO^2?|0G)`*krm+o}v;tz^ zgM9@T04rcdz4NZ&%6n%}y=liYTOWL7E#ox`qpYHdMZ%_RkFFBIWHqpqoi(&@ITrEt ze0#mP;V$>i*JZS9xyR~a%)cNk(rpDK)7C5Z+#ymzGgdY7Vn!?v@zQf&{(mJYNyQ#c zd7pkqDt<}Z%;Ua3z>+B}7?efwYA6F&pl#ZCSo6bdAS6!a`}qLO65W3_jI9CvQp-Ah zy3V550F#BvW3lcDSC*ZUfs#UBk6Bp3gj@i1!`Qh@2*GT@(+eZN;XHZI%+-_r!Nf^5A=+*f%&%ay}%vUBa7=V<80kA1FGrH&}dULBycT2)ij?K{( z98uDB-yqkWT_nzLwhPbvi*D-3@9XM3eo39;P&tTM>F?v7646q`t&#?=c*N+*;T8NmeE$=)A_;H@1bo1jwcOC*bCXALxRsq8K zRJDNP!unp4d88BKG8?6RNy6_$?IOH~sE!V~T&$z%Y z7ylNc;WqH(rH)ou?Dq{|@%F8Ezc6F!a~tG$w*(}!J!7+2N~QnhKa#)N{_axFcQeDU z&Cz!lT;{hXm|iWfef_K4;nkZ^fOHXQFAtBhkH6q_bWy^#!RRmEZprt5US07w#`tn8 zc7BHT=$qc%-`if+_w@STuUe1)Dc^1O?}@5_kTXzThdEd1Azh|^k-jNA@UoCiNH| zg=f)7Ch8Q>cx%!uX8-<=|819MnM7i$cTY{zP4KRgnLF6AAEx=2c|^kk#;$#Plqt-! zSX9Tmrt>{>i>V*ySw?nY4pWM7)&cjscW?KkAx<&OaPSiXS<9SJp9q=H-H2L-`P6qY zz(7Te^OdhGt4a_y@q8Xso}?=ke=+rfCoHkzw1B#pzDUw?fZt+lmQGhjiEYfsQA-L>s; zS2@eT4m}~p06=--3Uizi92sx8hIK7w9s%Tct1&^NPN=7$tH)vJy1o-YCNgn0&H+Fi z1DtoxMqpypU|%<`X*@xvV8Yl(pzC}yx(4jrYy8E!$skySUIMVB){t2hWCG%1mgEEE zR`9)i`rQy{E!uYuanA{OtG8pbJ(je>HI-{?lH5RHi(}z(mzP@h{Hei``vokON)@=c zW~2zd#Tm6;f7{_kYMSeF?)th++`{GalpdGh;iX7sKqc zi|JbefpdAD*IF_PN(~8>lQaUT2)J%D2nqCH%nvRB$A{>H8)= zbZIY*ARAt^R2v|eQk?k)4}Q7vOWbWYcf7dZ3SU{7Y${&K)v8qj4CTMlS|SrS{=Mg} zuZ-7g`9HHTG_Qlo8f_9lU*nD644AGwau?Jl0h^tgG?(Pnv`t*kg6SJt)UqFFgGAEm zI5eC2dSPVS*OxV&tSlHHQ<)WHgw&8C6{4BY^}{#~^U$Gdo4Pd)@K2v((j?O`Msuu? zLUQd7|NMsvfl-tBhizdlF^ zV1kb0lwj)!i`|E}2MTisnFqj`Im|8Fobo}cDq)_5fq4vL3;-+yu+BNlgd`yVu{-q= z`w-yBVUi(W7j2`KAm?9)p+9$U;I^qeL-1fL9Pa&e;^T3D@aVhGB4Hc`a;WZxp}G5b z-?nVwDrTcV2xA05u#hx|S-_Rw-`_i>`}aTWQ@K#?$-peTHcTMyMuQ(%K$K5r}QMINPH)p06e z?`d)RZN|@7F4`Qo#+X->ijBN@aU8|l^t$BBlHn?v?)seH7Hm>nQ``wyVUi|IF9Hgt zSbH#%Jvpp}Iz$ryv5VNd4Sp(V9t(x`i<0LBEAaUzbdj*jZ}@_R|5p39kpisC!yq$t zrgd1xT>hO>L@AYl$MD8Nwx zYh7j80zinOnzvv1;#*$D=cVv(5mJ7y!W72qck7#rS%6_rv`=nB(0WFHP+$0kf+NQm}~g zBX>{xJy)lQlLAfrB2Sx;!gSaN@iX8FC7xE?7*Cn z^nxjOT@+v;-b+X;R(pGwXJ^x^@r$ebFbg-qEhLlDDhw~tGaKo7>pb86Dch9aP_?h_b>(T>{w%!^D5zjD zNSYKIkoa<20t_1fd||*OKobd6Z9Z0$f$HirPDSc1xgO<(-AJ!|gA(1b01qZ@yv|E# zN&e5pqTRraH}iBg`m4Whezct8myc;x9m@sJyrqT|YedF{THrg{`omJ&{bm;IA~;io z&1)-(mJ%C^#23MpQ~i=$-8u(HG7KQOAJO0(loCwteQ7bj%mfgXptyvbcw*p`#emF` z>7O!%i%i-0kx4VXG6+V*5TGLcR9V1+ks{eSDx4ve9FuCu5L?pd9_EKgf@ z3s%JV_1|O|#%vaxLzuXN#(5bqYwE_j`9pKRKLW04ET-Y1d-!#J?4N>T06VvbY1;X* z7l5)o^}%;vzWn?dHPK%x{n0h9X&N^5{h!16@$sp9P_%8+w)@?=|EE8`yZ6E}{(t^; z9^?4M6W`zM0c-3yjF6|VKYhi~v3v-!u|U9|MhR3yMO;rzOwASCucDKVVo!HtbyIVJ?Qjl#=AFv71SdtoY3Cy z_uewI12HC@PNx9?EK7{%X*dh-k01Z||M-{thS)jJ3U_p_P!y!leSJI)^B{B%Q+0Uv z!@vB?$9Eoq(LeNkKRo=nugP(Q^N07x{e1cwj(6|xZA>PpOz2a6Xf5KYm-hVQzdZ>M zM(2SLD___4pPOMG;rzZa^J$g@+xS{UWf;#-QAzxca;*F`fl?ypz5fHor*x=+4u1g4 z0|SD8^3z!+^ufLVOARrZUeqCCnuf2H|MKSDJ0y#w)|HKTrT+^P89;!rdZsC3PzDAi z;W`!{hPh*0ZFP!QX!K%C=50%5i#%5i>SxdSxJ;5 z7nEX>1V9oIm{bvoj9EiFmu4>#zwn3@&~LTFZ#mE|%^K1zp)%z>deUw8(3B+8tP-B* zIV_+VA!B7FvvDzF-1?h<%@Z%3utCPA!Fe_{B^ZZ=>t%#9#2=6Cp{X&V6MXqPa@)Rt_r`g{o~p1sQRkPNXj(6|h-L>KIQ@^|4AtFL0GIrRtJJQ5Jd^(-G zNyvKRp&;M1dv{;Cj>|T10IX@6wwpmwowdP{cMc&=L(F*!mGf1Fc@$fZ?HF7I6pxx^ zAWQ-|I=Do7z#^yYTuKeNQj z{g?!seyeHSV#AT7?8(n}fc^;O%+HcJ(^tdyj5W2~7>61Gf?DqRdOrDQZ0l-tw^ zUx$Sv;nMd;ykYwUM3^ELiw=xt+rz;oh4nqQoK6Zm%htI&pz4?@a7h{kslci z)l!#h?cst1D{@J}q>Bw}4M4;enRe75AtmKk6a)sZox1k#>=rx?TBtxc6 zNR&dgR7PK&kOk+~b=8;JAGsc3QZ<=TG~4-c8b=eoLlQ(O_W?uVI8I5TsKo4YWkV`q z>^`5qJfxvNpU%@P{sOf-M1VY7eE6Yicl-NYb0Tx>|!6Jz8@$Tb?R>%8&mBMg(`0^BDsVRP9>su>2hKX&R zK=spUW($KBQ<`x1?(NRm0%=BHG<1a)>dtE3fY4~1m83+&hyld6Ek3{ zrm20LrxXQn+j#7Nc|3Qsg65{K=FgwL28;e_p85bp3m(rEp>~DBcs-<+wO)>b?UAhX z+#Q%fBr5;Ht7gd3Z`n=>7mwkU=v_9<&7ElTv+W%Wkd%b6atmg_Hsy-g1f_2zqJ2-> z)OcM-zYbJO(ypNwJxjpCOJtJKi$@-WlKV>wHfEkxk6v4O4e6S(Pv`i={`Gzoy=*>&u__? zG+P6SF7=rcG^e;^dyg4_YBVAPXFMH&_t5px{?AV36mx4Umh zrr4dH9(wife%QBf`_tnm0a7BHpjGrO!reS7_8))vLrYp!Ec4f2fBp3|YZ2Bd@S&{$ z2?Aq4H2*oHGqHm^V?%>bH#B@5~g_;sg9>Ko+l+^|MX`D;xP2nJX3RQj(5$@ z83Gw*7?QzBC9u{RMx4HW{&Z45k5biOk#QEo-dZNduz(C0{c!JXjA1;7oFaniShqZf_Tzv50lx8Z zS4ls1KZ6;KW5V4VUo%8Hp1=I~>2&6Xz2OQ9+Z>O_>R@9nApjUGm_4ZWwTuRH1Tphl z$5#6B=^PRP#7*;NS49E9j;m@T_l7W>ANqL!PT^SLd>Q~9p5}R+fmUIAt1;|%zQk@W zoYHx1Ue24V$T@QnSS6%^*3%HFIOKBFn$EH&@T)w=EI zn+Nk!tKiCbOsjWrGe8DI2+Qc7KXU$6TE}I~#d}C#1I|b6&0)Xtux$rba{h~xjTA68 zs(|T=jzgFCw5gB9S9R%3IZGuQZ%Lu6Rg&dl2?Dx|$&}Yr*3)HC8M?`p`~LjBRSmfQ zG~Yn!Hq7)JZS^^RW52BG+`?)jnsAkSOPWZLYg!~thDfP6?F=!l4cD@9=?2Bs=L_MY zsu5h@9HFZR(PY6j6;7)iBVymO@bk&$c8Oo{1Mhl3`iCb zFd#B?r_<^4c^noy2~;;VsR~yP0BpT$jyvlB1f=Qgj`hwWPVr&F@}%5U4gtAJVRLL7 z5+6VRV|W;yZ{B=p-;6t#o-S*KJ^ARRpK$;75ASvilj3;(^wZye88k`+I8t;F5hYUr zuwyhac`+8$*Bo`o!4zyZ6IHyT*l6*uA@Z8_5}B!snkKKcTAXw)Hzy zt+%8KNcjBY=W|~*exJ)Sxc1HQP#wL57~&AZW;unk&2FWN-&jcM&*v^$4^ZXnU0a_U zmi^uPCi?#JE_w_Pr}H#JM>ii?P-AzG^El4}wnXtM4x^-%&i^_i=kmwz*~hS%`ev+GE6?^2{>2lwJsa@K}jJkAs zeRySK*nG$P`bNQ7-4tBBq;`G_Lk1~GFh`KBZxYjC05WDx`=jS??Ip zWDI#$GW8C&LNH^9Y>+g9OqwIAy8b#3LpO;MY~AdSJD!N#I?nSbj96)k!>r6U z!x3!2D^RzMD>JK~XX9DeuJt^3Kt>d=1KOUq;+cPKr<=4W>6gu%F4|+M`n>AYX5&uV zQU;=+aLZuKf8v~@O*P#z3R5x-lgZ`MzTs56j469G7k^I)Ayv8@43t){+l}?8w+G0} zcgTj#wGLojd-y9y;Wt}(_k||p>I%9P0?Hg=IjSh*YPpskmLM70bQcjoCh~S*YuKN` zY76I>lV!BaW9CU;GCa%eb$!(va}NuAP>M7zy)Bwbx_tKCtt{San6sb{`g%^~3+*?5 zskoTgc?Dczh|1c|*{5kGYSlt;VlRG5Bq)()T4%+xU{#ZllBBf^Er8`1-2m6?t|P!a z3v4Mvll1WV|2?;<1CMi-e_sRoB1rbA1c_9Nt1L(Z< zVV;v22~hot+7ps(-c6r?7)8mMx<0-;Hg>RZu5J$zmTKy|GDpA{z;R^>7&_Fb01=R5 z0+8uZF!z>7F^e!CkHGLFMI&Ql06Rv8MDdF=as8ZATw&8~4iv%~}>>=kU; zSmFdgr{VF-FMs>_G$do2raiI@9a}m5^5cWw?V4ljD`-^GvHnW6hsG&R{ZBvt^5dg; zFSZ4>&QemHyQha=zx?>+JQJw0qyX5l<;ol9YLiAwV!)7~QQvo1s^33^Epsf^7?)YY+8<*>ky6wuet^#@y%1W zbdx(>kX^m_$%<8Rd&DP{dh3OZt2m}|D&NvmaR=w0yu4J(eFus&n98?Pe0WNo0d_mzRJ#fUCSO^GVj50ge*XL<>_EbRttwYp)({jDLz-EpuJ2~l zw!VM={@wA;y=&MasRogGJe|%%a8+|W9u9!pw|jRQV}xrMxci@P-o9x(mk@&lKp+yr z+(!YR!%zSIb!;2QBQT4E5XU(6G>j6(*knaQ=)0#=KN~=T2H09BRl)4)O80BEVgM3{ z)0cnz?bB&Yrmpsl^Ky#uZ0BEp{JH=0j$PgQN>UU??JMyNNOw9tefs6g;~4^%Q0>}X zC5qIYzWnmj!f&p zlyu2oCm55yCGfV5%wlaU8*FVkBn3Bpnai!S!wCy3v01`AO%A}s>gCe)R+2Z~?^Eip zhI<9{m5|Y;B&#kD@!IiqIZI@r63xe^F1B`D!VUu`$GKZeNKh$z`Uzev=)m z3I%vcKG9;HEdJYzD0@+KC6iJC2`;X@%@2!3vr@g#Z%3Id24%WtVauab6p`2F21e;Qca6!rx+-#Idp$SRMja3Y2E_!}JHu&PR z(C^+o7nSR>MhThfj7{eC0cdL#7tS##lITltzOCTNnM?&AhNi0hTUc)Q?~Z%#B*8X^5%Xz=#s0p+uC1bR))4~}Fr2^q^!bdcA|#DKRXIlN zPZS(NgaPL9>zC7r5B2efk3ZZWTI<*V8bh3A>>fY$Gx&IX`&RD(ID>#1@Dr@F`#)5> zUA1wI3nYoi{M1cD0H*#QKZkaAtY%>er#K}5=?TYiYBHyHj6>I-hE4&f#0X%RQdCsV z`~ATZSJ{EAnugP_KmGjWd=_$kcYIR;=w}y(PmibJ&sD{M4l!!jRgO&Jb~lc4`uY4c zDWECB)Xn{UO{2j)eEIy-=P!?agsW<#r)WV5-0Xsl7PfM;iGTny^#P90abb2qm%=bb z1prAva3Z5cP#P`Im>(|dr5{Hr!U7VUM!`G*0B6=t%cwlG$0Q94`y2zd*$gi%^&~ma z%Mj%G*XjFeJ1=e75HFwNm+lv(91Dp(V76x%8De8dHw0Rns2i3+mL@;sb`YwRLfw&JX> z07yjYzkYo@jjm=U|3UQQ`?zMO-u6mYdc(n_brgO;M7nN(}SZJ@j)#IQ?>};16sgBaBl}u%E{&geZ~3 zKqN}+`*{`%$UFy$>3p6eV4J2vNL5afOolX0!`Fw0X%ZnD8JV{Me00XFe-8g3Ul}GHE z*aFd9Fd9=lB@3{%=8Gx7nrkjUuh(7JIez14UNg&a9YT891t#H&e~XcdK2M9_*zQmR z15*l}E_yqbAc_3fZ-}nnYB_AZ@adcF6Q;$={I1$NEBlBkmU4;VPJogzDZ5ZEi0ayk z97^Ul&f4Xu*_>*$*rVG}pG&!iSK<>EXW;^CZCbXvNEn99M*F!0Q(mab(@Vq6aik3J zrfkl##uQlPX{k~mm&*X6cEtKOP##1hv4>57QKDa!2bL&oT|s zG{YpWvBFh73j)}&7&~hs!$6$Ly1I(PD1pAtE#4kI`muiq-3-2e_h#R;yQZz3g90jX z?D~Eb5fSVTY8y|+5&%g^AqGq^jX4HI1j46dKTJDJ^K@t&PM?21&D#Fu!`lzX z#@CJ^NGVECAW2kk-5w8(kJB_o0hp|{zH*i4ssb%0xF!%J4gD}llr*15)ZF~gx+*+X zc8C7!DcY*FEUmm&iyI6#ygKWOcQ&XLOg%^@ux56kWx~_ zu{#C$y4k;ff46rb#RO8W>S><4X_|rx6e)PF(ajMd3^9l?ra&OGYDh5x6uOqDWGoY) zkk8{BBw8kR2&X#C2xo=05vc0QFte|mwaicun^b_hocwy(MX(M_FPd7|3Z+NwgG`S@;tdIlGa9X7zw&QAGe5lUB!P_FZb$)ybrC z4giWmv9ge=Fc!CyUaYrmr6L1xQXpx{7!rtd$%I&vw<&YVk-16x+gM5YCiI-7y2L2O zA~UE|GA!=7thI0G!dD$5nQdV|Dx%u3C}kd(kg$YJtm|Zv^;rbT8WO>4NMfOPMuINN z5*74xT?wEZxQ)$QSc{qG?=z^J3Usiz%t(MpNGv%T@p>Y#Iue)Hpg>HbN!JpVC2S@k z2eWSCn#-$LoLweo-DkpXJ} znI?E+5uqjPWKDob3Zq0&O(`OQO@ay{*f4=W2?j(8N+QB+2!>=q>et6h$ov>r?#={( zu?7sutJ+v%g9Oo}q&biEVqa_01VLs<7AaYr1j9%WjbjQS#3@c_hNoX*`@s_|9GtH##j`9W>c-={Lv?RYK>$<$!$&g%wgs^!$8zmyJ|DN!~o1L5=JKBA` zAm; zW@{niD5x1VDv|jY=>%N0{!cYjnAsq9j}M>!_K(NF)Vw3OI6gQIACI$y$AA3#HA@r!kiPI)PoS7#+^)4NHET(kTp1gtC(f}8m4#q z@zMFp18LUJy(XAMWSyC0B(RL*u|mt#z*w*)!)!fcLmoU55hsYMwd;Yg`p>gp7(xcC zBaxP^dDTpk#pCeoTT`IQ<;vAm+IsaiNQ!|;`H)9i$e9blMp~Wknvhbd)T2~H20@Xz zZ??yNIcbf_?4+EzrE&m06{)Q&CJ7{{UV6xa)u;6?Z8Bs+1)HFm$2OBp`_<7&1xB zGU?VDC~f!je@W9MNpv;fFMDch`K7{1kD_q^#4y`b!y8y+i?+T3zQ;$T5G0mWQXLO_ zEAi?4>C*!$RB|MWK*RgHW9z-QKp3V|w?)2Eh$7Ldl$XqW%z+>fEDEOuh}p4SG>a%9 zAWjM(MJuAyIJp=d02YPB80L&lRLA|nAy@z@%(KMEcz8Goz|2+v#3l4)oMi%17`q|H zWhqERU;>75b}=t$yPg-$=2J3-slzmcC?M#TqA?60a`wg{GfRo&5+4 z=SI$NwWTESYnK_)*J`=`E+6psuaEzbvoVXSRMaEl*ON7`+|9q)DJ^A1OrqEKk0F#| z3`^|EtErE_`$gxS&64$nZ(qM`@il*5Gf5;ADOcQ-EMkj^k<$#6lR{PyBCQ8S1|3Y+ zIMsrP@&QAJ3+kL7R*cY5M8&!@~&<)eMGA z_K3S5-g;L#$ap@Temsw30AQJbq33z%1&G6h2;(8r2F#;QBI6X;I&7pT8&eLavUf|#CTkoxN-doEi zM|zbvB?_IV?%{J&!A<@7gj4;&xA4F`&)n2N-84s3hy9_kNys{pG>t(N4iLl)dEQq; z3<|cssS(4(fN&ZgzkWV<0rdnpZ!1F#ZsvIuaJ!?goeY3wC&Q-+Fan*YfBgN|6Y3NI zjKsh^bR(*1>K{%DYaIY`7REWEPUpvdm?8jEnWqVGmNCUJz&dA; zfH}iv-g-{63WDh{k2A-V3`-Kxl$TDN9^tIFu@TI$lSgoX1S5wi32dBYGC8O;gC&Of zKO*grvHk)vzC?nRaWa!&QUZ)@(422<%Zm`uO!|{K|#M4|nQ_r3ui`Zl?09GLl$tN3$0k0?C)#MUDv2bnX3iHM=83K46 z@Xb`b)UGH0=C@na7gyq_aG*V-(2?687ED;6*`vf*Jg9%i}ra@kS={1pLM5Qhxi zri8o^iaev+Um6gMNs{YM<dwf?rXFX` zqDZ+iSb|95WH(gk>GOf1snuVG_`Q00-2`~LmvTXv{7Q{cOfPPfno~tJWYdw zQ6D~hczdkUNKxbTbo%n^=W}%&&mDYSSB@N1<1{H?b@VVuW9)34kJYg{9_|j_SlwIBI&cMWT4^;keIJA{xXPskX2vQK2grpjf=Hc||Aym-5@6O5e0?%md*D0PN zdsw*2?~cb^#ma1%RbmWLG82#W6F@jL)fo}(VSoJ7ozMGRr_--LeLl@F#v`){=*+ba zr#_-V)sA6t@J~4T510;mp^Z*RJbe0_!2{p4A7)pI3g#NFGW>7X%#8+h37s^dG3ohs5myMIHr<$8N~#OIDVPEtmfC>Od?rCDq>@!_a=v8-ANf*;KsUZPv%MBY=%$j>xK@)W(Ts~6 z)SHVg!@m`KsB#h&BzukXhr47yk8|PJ!Z9#kXq)tW!u{q$loL} zwtV(dubGo=0ruDH^UnzcLyNPw6ydV~h)JP2G9*0IQ`bFp0sF|9WrY=^gfPl< z{`~Oor!b?oh>(e_t*Z(e0%GXKh{~sEUES_#c-tKB{^`S;eMJh#t}>$2a5{-ZfXP{x zps4qI>u~PiTHXG{JWTW1Yh zASsEkK$3uiM}lTdf?lg_`cgAFkfr4M<>ECr=R@YZUi=|9C*G!~?H`w%ydtb#;gv)t zaeVnCz7>GW-o6B<6opnxMtrVFt^)8?tj2e=je5>Yo)>|$PjUf-GRjjp>|wISy-ZCB zI7x{X`3p|Ql&VFWH&RmAjApl3j`%Q3Xv@~7;+N;;h3CovLJU9>l=4ZK&$dM#XKXGT z1GhL@Dv%vZab>2(v><@9oF|hC6SaA15T>ZV3L+&?DYRgc!BX9Hd3DbpBPoFmJ=ate z*MbL7O-YtS=~5(4)}WG0pBn^W;jLMVOWd@)gx1xaU4xQJjPVs`!^WJxV(2#;Bv(1fld+hDFRqqVBf_`BVmE8D zVEXA*e~6M&LQ*7p6Ji%be0m&fjDV`nVS=q^fGb8kg^7-Bb7)u)LwEZ1@1IT+d6eQ# z6Z*#;H9(l9lNx{{I8r-V%hSw<8pbkJ;N$+Vw>VDGdg%bn!AgLe?ZrO{LzFd>7(xO$ z_Wb_sU29e6^XF(IdH@K6+qX?s6ClNz#;`36fXt>H6vvN8d#QpLb4gACWDa4N4v?%JJYGKSf1m$`_Jvm{`W5Jh^RKb@5vBt?$Xu(_WT4ZNfiNP5jg@WCQ(gLp-70{TL`|Tep z*2QHrGC*of5*W}ew31AzpOU%c%|;_g+2|!9g{DMVzFSz619_D)7EfZ>5DAu0o&^A= zZInu;u1_c_3AxcF>Np8B6Z(i0(&VHd5|dO!6o?Y1^XXw8c!sNw6sJ=cg&D-6z4l%0 z-c?M{Fg-m!{PNJjH#!BSriS+2jOM5^&qD3VP zAOd_~M1o_+VSi|xWipG}NxPjzb${47HzUMHsXW;ER$!X@cRSB>7`oFiz_bG97M1{u z#0hnEynDODj1Zzg0y3qILZ)GuzD}nh=mU?gk^=R zDri4HJdD-x-N%D>fK1aAg}p&#tKG4!E2cQ9sgfj_`aZycJpx>FIQaU2H`A2d{^0%I zz_A4-oriu90oeJNqlXQUrg@BjP9ti-z`J(0`{BO>I-S3K{d$56YGIqUM$7fF*)@*w zkXNO5QMrA4R|BY<;}83HZx0nE5oYV4&XOar^DMS$Yd?(A-hDjw_f1dETZRG8F#*PV zW@7~&CJB_CsVE^zh_j>w6Ite}GS))kjEq%S2GBIlTkk6(N&zs$(43s0f|-aNTjy-% z5&7OG%Wq9)NW$|hKV1mMzPl~8-hq_XdJtF6m-Uxs<50U?{#sjqMrQe;7H$3F@+wNX zzFc|b8?9syECFyi2ytV7$Lduvd7fqU_=0# z!*4g}EG@F|`fX+xE8XJF=@K-SluSMeS3jOv96h*vw&_-snE{C8MWB>ml9;7#o+)#a z6ei#L1+s2}$x$I#U;hRcFJ|YZZQ?;P{7W!qOI(wwN?^9@F^Nb};U$i9`}j()*e;id z#+Ua+8EsldiGo0CF(|Lw0u!5Z)eCeG`5OaLh$gdfo99<*7QHPcSqm#<^MPc+ATP0@ z>z&msd2@LI(9&m#VAZAONZAUPm>*r%+>+O{(ZneGo^q|Dq}l60NSc>JnV__AFtI99 z4$GI6l$ij@*CZ&C#&evW9#41I*K9J|L64O%pcVE_dt;}C-a92=JEPf-Oy5#e^;6LwQV4VF+bzz#czSh(8PyJJ&V zmZ{JHz%=II$=$W=iuc7idr$k35~Co=zdc!&+-=2x5w4QN!+zcl##J@mx2S zO7>3zWFAhB-82ltFe(s^AC7O|?sp7Q$#Fs@Tr5GtIE;@^YTJfP^KM`ar^mCYe)y+9 z-QTq`Ip0h?*|q_<_dk4iQ!ylr6IGQ+iV_1HR}~UaAAIX-Q%7M}dG?K@BuXkFm*IsI zOPL~U(W)${t|`JX;M(23`S52QPW}1u;S^jw4uGxi@0yQQb?_B1V+;Y6jAV%0w{QRK zr-=4={LtJTYDdwqVQ1lE-PH9^k3r#^``xcVtedv2yu3vz3}Pikq+Cgh2+0RENOqT_ zwWk;~B_Jgsf-}|UDqNi(^d%&b+VzF3}Q2`6VMoQ(kbZ@9TO! zMT@U)bF^o`Yh|D^i_lGm3JADV{3FGJ+a}Ff!CRkJE*7;i=&O~DKG4DQl=I9&HqOzr9-it?N={BB*73;N@A!$U%8~WDVHt>bvclq^9s-s za2)6a3 z#ROcL1q=!Yd0O&1bFS#3`Yf7{$zD>Eq!7bt60qjEE{K1Tdu1I`(ge-L)N`GCEiac8 zDW&0Gr>XDHr(wp7fbOyK&h|4SyUq63CCmG?D{lfKl><>EEEQ5 z8qW{Eo@5T)I0LZt$HU#5+OOJ{k`%2|B@E~8#}jtSmGkW}=-hoBo%{GNAKtVs#Qj~* z;pE>Qf#V;4c<;dobKhe(Dfte+xg>%*-o+VyAa=1r#O*o?>-)kx1P+34 z4VWAQIum?O)Ms}`Y+wx;M9GCo$gnU$F`gbL;r4ic+_%a74isqFLV0^Hg74YS5=?Ra zt>GlM?Q&6$aLZzE3Exn>Ov18Qm)~chF1b<`Fi0u;_w{n#Q}J>szKGKFvQ~EP3TwHCO^Vx1&;B ze#(Xnpqk`mO)!~cU>9Chy?qIJajrI~0J-#V zK5NUbWf?PRN{A5XEBbZ#e+P}3iAtx0q3`F@r!P-AuFqJDDvoxJNFw9(`03LbyM41e zh#gP~fN7d$R)F0qJPekw7z@|L5GIQ`z_MXOmH`jsL`b&L&s8m8X6H*5!O|G)toOc5 zzCEzF7zq$Q-ru(eBnOPM0OZ?a%j(#+ zwYS)&b(Wo=aT?BFKD$^8jN3JsLKr9K4#&HrXY$S6yql+#h%ZQk(}!U9VmF zU9f$O(@?SZjO=d|q&Pb(aqN`svffmo2nwimT-P-*XPSMmC0n(vogL;$fTo?h3E*9` zKRU%EE3`qvL*!jj0*E3Vwv@OCcaUNR(yzB6k!Ac*Q zW+1=A5*ij<1;|vG*wPuwk*8*HtA&5fBWRD034?1SCzK5ocBF0BDGF-#>l% z6hwrpc3=OmN08Ccv3rAQh_iwu4z{^J{&0v-75|@q{rRU(xN6(oK^k~G{q?Uue;I_W z+f{SdqcSx7qvB&N)A>=VgNtck>8Ba7+WW(?3gP@qU){GI?{>`aAKro=Fw9EMQiv)s z(>k+3>>p)hBQE+<1qHUzhgW8Vlh?k zenfq!-TVLkKaLop5pny+hwlCH&HH0>XlkK`B!2z(&o~^9GNIa6fSdjmu^b_%x5xW8 zRb`;@1k*Tc(E7G+-RHUGv36g>oZOzmFc90iu302Zw!Ob=%DRX=3M$<%-#mLUin&#tBpRbpHAMhqrHAdtVu%?A6GL>Na>6nyTJNbsOBsVDXkV!CMHz68fhSFx3};&? z0ZS6kC45Xv`d$XBV!j}oM|oxibW!YcE=KWb(Z!Wm%tAIWuo?RXbGFv1_2?=SwM-Tj zR^puOk|a;zd#3ML>KOE!-q&q}EPp6^Elh%pHu!zRh%r7WWm zO(h~TFQ-L@rj_a~&yFO{+>aVBGFD+LLu^VyNP?jZr4TPb!J@;cNJuQjmM^$1tuqlX zPCPb6glSnsl+(NkNPOCW)>X}}0!$6i`O7)L*{VV4PZP*?r^lvd zVD3VNM*Ep1bi(BPt}@VR=m$(u1PlaNhH%v!gKKuX75K_aLgo{Kd)n>yO@%m30T@)G z@L_joYLn)1nj$+ypt*nl?r=PY{do|;^RaPtWgtliBcQ2<5r(9(AG>LqqpehCZr=Uj z&ND-iqR6GxWtyQ$rfwJ`JTOgyh?%H5Vt02yua2Q}&^QlA=Y4b6)C|K&^YHi?6FdpL zSb(Pi2!JAD1a>KN2n1)?Kr|U!Tj#)SRaZ~kPecwQASQ}HL{Q(q|L9-1~?Dr!T+ zn3Rl{Q-me&_lL@j7~h=1 zd!qRm%FL%As8K_jh4uxrdp3u(c2&5sj9IwUt}SaVxvXZRl58imIR9Ak*g3zoi`cxi z9Fxftx`|j=ep&d%cp0Knu_OvD2$#=G z%zvgl-sA)nKa;^_X_!1?ETvpxekxtWXF+zKN9kYYgs{z9$Ti5#I?>5oAo8nXL<<~k z%;Kv|m)oszfw&lkiypEHt1R}kWCW6K-LPimWK&)ie#s=x@tjuD7EpLLl{amX(CgIY zEZoJ(TVDLlwOgxRRt@DcSMvX3?@zZR$&oZs?1KoPP*q!ejfl+3s_vfQ+%r$W_kRWc znp2^74?VQyFe%x!BC`n2Iq86%Y7`y&3Fhdm5fu%OEESN;XkQT@GV}}sH#Meie|UmdH}zwOG4!2Gc}RU^K}b~{T}la@!W5$OK>+kTz#>h#bzHTLubJ2u z%Dt487}K~bftiiX}Ejd`ov9uj->$b}9Z%S;7I6#PJZqAW1}0juTMTu<+Q!d+P|Hdp?YD ziUP9MvNaho^j#0y-x2`kLQoksK_IX(i4?7}GNc+M#2m+Q*NHP5SxNnM7b6rF30)ej zV|G7$y#GKk$@p03{g=;QI#e}RyuNO)Z|^qi%0iIixO+Z`^bcbK*;VTt&<^m-NdY1< z*<_W}ch6rQx+oDTPtYVF8iz2!HoyUteZ9W^u~gCoCM!H%OxAkwo`dUbJHc_ z@VqH0&&9{zlXFYh!r8)l@1Dzgzx0^oV?nqR$;-0Tbe2A3-UR9$i+C>2gJXXEg&*qT z`QICj%2(0i`$vP^vqeg*toARrEfl+6KE;Fi_R7anKRU$2Js{V)u2?iJ4UIz zlTmT1caM43!|%uIpUK#)i&mfUI;sS?2!=U^dQd4|PZw2nF8z^ne*f9edW3&Z-FQ{4 zHzUIo9;{-MEp)DzS0paL{CVM~^UJ;idVUiJy^J+II<`;Noi%5V%ORYv&QevC<)tgv)^Nn{}Jb1JWmBA7ufcKg2N2@|4Bz+665Bn~Of`a&=st@oJH z5N+MS*4u5{c)&VM)7U3ty{}??dfxXIHGr7Le&}}t_dfJp4FCd465(v@`yMc`5TqOv z6sT^hrtuC<c@C zXAE+lLg;oO0KS?!Z#@(lVH&2O*tU&LQ?>p0p`A;7A4&gIA>nx%yDkI(B4HZ3Nk*yu z^J*1=^z;N<`O1d=Wk1HQ1+4R)7^1`ex$8mriD4XrmSjK?iObkhiJg-i!Z<`qyXPlv z{Kn(<-(7ksf=VO|#<#1w`pZvO*BD-2UUqrEe|g#ouQsiqy}A9cUN@BmkRcA<;NP|S)v|9v8PS&p1F zCiBLHUN)EujI%Ibzuq5;UyA^+5K6U$^B%bDkH0A%;>{w&k-f;WFhxiVQp#?0Ko-T0WmnCnhCc z$|{)OmuluzWN2XvIQ;LY4R=YUc}ohwrhF;g~sK{fK`S++2<c8vzz0@<+;l1;gu@*qjLQk{g!il3ej>lY3tVk{?2!FY?q-l?u zvXM9*y4`a>c`#!_jHoL>q`-10H9delMgTzS_6ew&wl|w~V~d!OEU_ZC7~<0*kgGTM z*PDhAUS6I?8r?XK#=!!t2 zt!{7Jaau2bNS5KT+kHLsO`bf~rsU1Rs<1q!ecBqFrD+Whos(}-f&$2j%- zXGsl!$hO_Cx4yE56p-og`F}oyjA;aXy=}cC4Z&E)NOr*wQ@{J|Z@)ZEN@+Z+s)D51 z0LHGtbz84$z_uNb1)10aA_BOk^+?cg=IvM(e~xpE0M`-&1jGK}`EfwCYPVY=$!wwI zG;55*IE~`~O{kyQroA-FZvQ)TepxJ+E92dD^6ka=9zyqb#3{VT3Hlu^e}A#~Q#-}(Ta9N-x|`Q50L_9Mnz5mrkacJdUNUt2e-3#Qf997I8H6=J=< zy4uu~M3ANkCgW-zq}z{JudYA-`S!*;6Q7=50!0pC0NdIDuo2k0G>oGN18_)VzZ=15 zt>1Xds7!Gb14cx-YN{qo_011|`Dts#*Q1xnE+Pd^8uo`#scpH!^-mve*GIk;W<$_q zF(Hk8A16@L+loD^+QJe{GpOIzEsOP6^`Z(BmAEh!Npa|QUw(O-c(qA(8V|c6C;``% z$w~Tt*Qs^hvB(es%f6~AOAs0MFVBhjSg1W&!3wcSPyz0)x3#szj0%!t*gfqYySwUP zCw1L48-wSSB?VQJ1qkf@_5F6cYO09o>2r^2*p0~oAV*T-6u@qphum1TvgBC}5~+ zJV6S~d7A1_n+2j-639|cX~MK`s+X@1Pl4;ESvS_%x~enh2$dLPHw@#5Z0)Y9s^nt= zg;Jv8{l&7(<5`_P?k{hlKyv~f&u0GdQh)cxd(rerA&5NJS=A*X5P7kXUU80*(X*I} zId@KH0QFV&;T!{S;R!l-FD@wI(bCbyWdky#h9&FrV>z%q{F}Y&^l{dNbv7Y%-kU&p zm11_ZHL*B_UJ27Y+vDY4S}cRh8+Qc1}Ke!%7dJdXD>&k}*eP>D-^CI3lcy3=pd=ZpazdqgSH;T&SBf zpK`If&qqX$ZzP|l5-r}j^3~#8{{1!!0P|{CO62|d(pjL9a)Oq(mb2)k-}by+EYo+| zX_#hO_2Uo43Rt8bU7oZ!C5@dWnp~nVv)Eh4CZEyaLi3W&0T^VJB!HPS?xjdmrnc`! z0P|&;)<}wpgGj{crK-GRVOv%0$9v>rO8F$dHQ*m-oj{*d^3bN{D5U3ru9{^4O5 z4P4d~s0M(M-H7cL-4rr+p2-0aiOF`7UQfm{Tk0EBa{s4~pKe>8y50+{7n5@@kbc++ zsya`VyScr)YAXf|oZ}M7L6hZz=8bSlHdz4y#KzXC6~AsP7Ux<&dqHMhkpSp4jS_~T zi$)lvVK+pj%G_L46vF_CLt;BvYmfo1BDP-C`5AeR3gKCqF6INJ8^|q}yjb&yK zA*qDj#$ay*z$9q?hNFF1Er`^-bE;_#ozo4nxt)J(pN(y7w2OwY?hhe}Du-00Z z3%ZHp++Qkr6M%R8dFPRz$4%%Ps_z91`VX`d$;M*(;DkM$1m6V$X8_FZrFq+16x`Rl zy(v)TjMx>V>-=%eEcmdbkj85OXoOmo#7t z!ROg`M>Rh$QV;J8HWgRkx%-vOx8z>dC4OWXhY|og7tDTtgIz`rF!Q6nj{7zEc9z5} zw$6UcuZ)nH{aBG@;ZQzmWb@-60XJnFx9#$l&W!5Q>dCn9sLoGt8hZtnx=hD$n8SKz znTL`s@;&5c+2~sa9SB}!kSbp%*zOrN^Y6t5{y>`U}vhY66sqUl#ACeE5P1WqzqG4VgT4`6@9fU=@ZO= zixnU;4A_qu;w9GePiHl7{@MIfBoU(pYANDFzudpFWEEz z5C}j@0K#6=d%6b-7WH(sDe!Sb>tStf~0kv_%u!|8c^rJBM zsOr_#cC%_23E)xzfR-0&tM;&CT@nDrIO72@R?Vt58P+nE1f7M6JEv(1?3>CZi%wX^ zF~c^i)jxkQd4#uYI7z7wWvy9lH>=t*sfzT6=TNn6i;6f)9{^jeVU1uM6XW_xpY)wK0>TgEPn zq}aW@?7Lh!c;m0O>xOD3S|Rv~Qdwi8xUZS+-RL2U{!1)^7Vz$7up% zl&Y#IYl0ec@XoO_)&ogGh+zrTx6b5wQ)ex%WCKhIqu|hWhmfjB`LDZXdmXL;GOCiM zu^+~9A=-{TEZ{3=z=jrV_1QDkNbnGt`;Sc962C zd>g@>_b9U*I)7>2bWdlKZDwqqnL^ID&r&Ns17dU@s#oUVu}_Q0EN`+zBfhs|FNPK! z9awA#N@U*f6`U-hlKB8OluuR2&yS=TTF7PGUdiu8k2(47kmXDy6m~O3VZbWc)~C)N ziL@0<0o~Ju=eW)LL1uB0 zNpmg{OXvKYvz_(#psRY+m)`5uS^ebq8-t9QC-?gqp;|1#W$maQll#xE;(c8iNF7pR zlk}Dwk;>Vy8wnL0DsCzlH9X}J0K&n_3Xs?WuHCdvU0H*;?-6;cQCke-K3QARwev9S z_J2L}6Dq)13sp%-2q{FtRK(241mjXwML5W=N};uub1vgNkE!>5Ww&k9)+7Q=fVW~N zecGWamq{Z~uiLtEdNv?OK3KP&c`GYld0=QFvO!X+SB;01fa+yzjyg*m#jnCAeiC4W z#0Xp8-Cuv&N=giHlkF1SVQjN%3bmT3jQb(2Zmt@50m9e`aP@&rUHQrxYS<97VFJxA zEdi!UXuDo}jMJB2o&v~w@Cbi(|LKR@P0I*Tzy9*`^8w>ClJz(L{L|gGsjaJQS$8TD zV+dog0N3PK&N_CLL7kQm4MFUl$1l6XT>7H8NNwdk0M|HXphUvjWT~|t7Lbgba{zIp z0wAO`1(}D-*vcK1K;vMzP?ST5VMvvR7y(2R4)tyT*E2Gx(=^3XU<{D5NQ^dp3jo4E zJ-lq(RNO=FSvGHhK80j`_sNbG4b&KXb1yFKmFc{w zEjXp)=cB&z<~H~p-0%NjyU;oQf%9obM)XvU_I#vL`S99p006MF*ptgedx>7YZs!2< zQb6e#o-&hpnr}){!pw|jj5!;5pfFqmm;EeM)Hs^MM_;kE)>g>O);f!6;>wd&7QPFX zg_%9!&g3{uqk*WMdXqXgQ-@gZ9a~n!T@UaU`(P0IAvJ6z<&;u*`tA8Cgail6Xn;~M zJjNlq2AlvuCJzhr^#sS#KXaDKHj+eHp;--JEc>f7*ndEiU`=cA|4xGd5<_0wty(?Dr-vu2$Mjypcci4BO=+$MiPc7A{vr) ztDBEEALfQbUokTQIi)lOahr7m!$>mp0cb3H-&VDCCAgDk$itMNDmRL7 zwOzBM;pg9W5zbbCA-lf$>HfO%CW^+#-@YD_4ISIs-F*7^v0b|($|9;M#-KUFvbEM% zm18nQ*4ad}Nr-Xm4*Okz@i`fi(?*ObeYwO|=5EDREUA5e%QlU7DM%IdS03xC$ z1-Q8S9XljSlnUTNY>BO5P2(^GizFZb5_WasrrpN6OjJoR`H z=hg|7vN8(0#w9}eJ0VS3jS?u6GO~gU5$Cz4+Ql<1#HR&`Rs~9kb{0VRbx%uC?s)(d z=7K)#(mbCTuFuak1))B(s*m%5@+&D}GC*2th#P|o(#_LzpX~Yzqx(4eB*!;$JPZaW ztoOSaakSvkO29E$oB*{Du)TN_$4eTTi6nHET1w}_?pR6FEZx^qU=s#FnW|+Woru-u zOw76ODC55@t6V1e+?hGXbRlp@c>uEv?pdCW0;LLj$*Y<>4*;Y&s}jR-6WgY?h*0Ld zpY}tu@eK#hVb=i>sNvk!hJHZG3UY)zB3UOrx$Ac24I4=RbO_rfS!|FGeHUSE`$OyE zOFDf1ZTGwv>l*KvU==YTYn+mX9zI(H0M+0a?G&pODolGx&fg&CyaW*Bl#TVPhK+;f zFePC?HI75Xf=vorvfev`B;YdNr7#940K+*>0t>*B3Up`!~ymLAtCR8xF)HF-HYP=&rMYD3XCQH^ChTrJ;yaSqH z?KgGB%!Q@!G`q-FO`I@tT_Nl_9lq{TnZ~x}o4@?apKmLH4wCxcKJSx20$aDe+H9M; zK7oQNW50Xq5(FzwxaT%{t^)>6I3vKypu84NFKj^FI2fYv_ z3+_E{pvpLt2q%dor*H&5+w{v_=55YoXnsG?@iLpwTwMBg>)0Dy(!t=lW`*VHw=hpjG@S&Hki=(-!+I9Y5EeWtB=&u;cXnyz3Yg9RP9Gq5Jw7*Pqr%N`SF|QU+U#IF3(43L%LA``<7; z|ME5X`wo&;szDMl3lETz7y;Frgf{NF%DMh;mLX4(YK?KM>#NN_|8M_vUu)NO{kZ$>^XE}w z0M(mMfBM)Wpm8v4G6dNThrj;!zwX32*VZ?G`sx09QvvKOLNZl@A$Mcn?e=~A`n-FZ zl&Vz|e(`m?su{q?Pk!4tizMMO)BDHoTCNoW#W$y;mwEU}vT#OrFd1D1<3Xsg6!8 zGkuE@JsN9AMZ+u(VZoAsp;^ulA2L{ImgKa)&;9<3m3G$BavX$85uHWM7PJ0TLuM{5 zWE43Cf?*|)Y6e*OOghd)hjgqrIzI@T!e2o&=aC|3C@-bZbl#sX+$}|apWnt29lZ1; z0yyWN24JD45W(0=vnar(cpwacNYaI0r;G^6Qu!S`vlVcOlu=}{#3kkW=v1TmJucxY zX~C#73?r8XXNuF$Fvu)^LuQi;&7+y4i41T|Bh?~K=Vv@go?M*SDDJzQvmv7M6#cot zIxk!plFn4OQ=A5!`;Uv#q`J)8;x!b*%k}1|a+-^VD7Qry)7xzu=-0SF>Mj42@|+c@}kRb$Y;+Z}d?A*oKi z1*+P?BOoi-+7w}I?VLiAtKFt?o9ljxfJN1|-q)40g}K>)s#@3~PMONm&0*~0)Q4%B zL}EmOa{&12wy{eK+(Ok~Ga~ARjsJXaOeYWvMBQ{Qx+( zVgS}#}>v~nH*;ZBKD}SnP3!S=`r`;|AaK71YH`|SO zb_n1!hA|V8hS2r{o1W3PSPHZ`O;`sS5&}1 z7$!p|7gg!iWll%u!psNF0-d!y1qxzvJ|q^%Fk~nbX-+Bj`^Uq6ICLS{X$f;y0=V21N<;pkBsya;l?&bM#=p_UkBu(48 zs%|>Ol-c@LqTBd&R1ybfkjMa(l^KZrt`kA+D(4cw6&jCj_q6+S3+tQp9Fwa?NJTY+ zGveXvf$m|e%GPzW+EP>Bt=r17A;VbTe4GXzr%}=fOU-rTon=Cdp?mJ1_Y+Jzk|rw? z{0dd$tRV&r8@DWRQiO})AOu(BLt2)}*VKRk6~fHtf3 zYP)IMx~c#aCs3Bd%j0jqbRiS_&DG7_?e(g**!Pj+^EicMQ|b@T&(Hf#o`;m#)vL`G zHLqIF5(2D9C?p}gk`yGvFk(N->}fh_d=*wVcblZ0EgKnGOF#xHL*CaOA%!u97!}2L zKvePec5~l&q$B{+xPSQib&zU%bN^x6IME!5!IiIk34@pwgQGL7=y8R+oz&orQsN}; z2&YiXvc`_T8XT7<6)<#JHz$m5zCy-H*FS#0xLe-YS`00)9%W-PooXzo5Gx6;`Uj=@j9XRiX`kJB!XUAN8%=Cxx6zO;(AM@VN zFTs~r*4G}}W1n(9;gK15CrA9f_HARK1W2;#0z97PPnlw;f>BC1_qCpUr^}RBiYYDa z+=o}9aNaXQ6sM@4H^1uJk2C80j#Kru#42tAf3#(fBa?FjYBu2Bzgi;rg73~to?(g6vinQJ31Do)qI#>kh&oK!~cBjJoeZ< z4`^1~RpS`c4Tt@2`)(RA$mkSi#aky&8V4o6-B|EyJAns$y}h~H_|@&kSwNsdC3lIkf#H&)kh+n;RC#9; zVz$n<9&x}g9<=%BYAxioIV+gR5L@Y{hp){YoU5DE+}<^fb?Z$`x-tipXlr_FQ{rdA`nBd&%>gMCeyDMLD z<`^+{0hvh0{p0h~(>Q1!GT5(g?zh!PG&Q52CUKIYjRXt7&S@HxDl~z;ZxqIvNX}a4 zfJE-Yv;{|PaDw5*-bM)z2;JB?zB$IR`?Eu$MHXNB+A*gn}LOh%VZSd3p$-u z0JE~a&HnUv>SI%JHIoHJIUw5|~oP>>FGI=cgBvVy zM7&E0_7DXWefRk5U!NpShZI9ha?AqMoFdZ15Y?15!&(k;6a`>i79dakQ~&(eFHeCE zYoy+Z;Dln?1 z-L#E&hD#=pD7dCHO`{~#o64q`Vu*+e^4v%f66@=>uCAOd3qPv@wBXXlaOEs8k3@z= z*gIy|Y$3dh6W!OVtOR0J7|LWF$Ot;fpo0ZhHSRxtys3b?wonyV7_Qrm1qKFy`ufw4 z+qxoToyMVi*gyAzs`Gj8y^pB2tGeaZSw<;ScTA@oy8Z64i>|WH_i-nq2vF5Gcek5O zQ(2hWTZnYS{_ArXLR1j7AJ_LEZ#PZtxvUWqWZ8ZB{P3KO@wobMeYah;m4$GODI@?< z((w53_4zO+iGcC#%?}?|Z3V}Y+P=?5BwA(*=2ecanuajJ)~ih*2lDjQI`5nX7`^JKKaFutM%0aD7%=!lI?vKsxTjK7UHXXEML1g2#Y7{T+!Ea zLYa&L$S6Q_jaC*qvOyLT^E@5zReZpSXiLsF)Ke?g$4S(_dbT1EGb!;|5paf~ z%U_FC^Q!4A$`%om&-bTGJgSgjFM_~i^BNj^b8RWQFJN>Kugx!C;`L_|PdK#6mQYO!^S7k~gI zkb>nM=GoVsH<-%@p2y|BX&2uX<2WnM;*Mn|Xf~MH=`t>pNs2gE07&yRG<+hvIWMqV zjB5pzxhMi-m<{sDzh~$j%ZIrT{Zu=C!6fUH?G&HYbd8ZhO? z$tYk4*B1Q5U)j28eB~;l900ZkD(?J&iL2GseeX~K6IZa@4H3M)OE++so&+BR&}APr zWSfd~nk)nIymH`e_2W+;ubn7C1Cp&u*<@FooYvaAzx?^`dc_C`hyBZLKP8D6cBr44 z)f%X(&8ETDTL7i3Oiq$TH0_3$mwiX>G;x^gb$kEA)wQpT(a1oW#(uw70FD6Xe)uoV z_WEYkSmtFmtE4gP4hgnVe|>#-wQVZ~G9mQ=U|`(szkYojxuuQxw@ykB_-XL1~U zD|;ZNU@XAKxSSJ^1J;<(4B!f5_Vuc&fP`ktr&uh<)>y#8+N$=}@vOg}rrqlH#~*J! zTYD@)3;?Le;RzMXfEeNpjH@bZiSyeX>ec*x{e?NVtG=WC(P}c;;O}teoWcjb;fVYX zY_m`1-MjuySKdL;fd60zDJ_vW|3_QSZ{0k} zz5VO|WNkq<0UYHXfzMxS0YympLSM=kSNOd<PZRZMHP9Cs27AnB*PHF6#YtP zVAj|pu0aH7lrT-AnqVDt8lE4&J`Ty+1cW%nBm^5>RaqASTiGSR6kyRP5r(W^Z`UTJ zAqENikQ5<#g1@@D+ipxs(S|X0U0?DHjBjs#{L@c2o3vf8Ut)cIyZ-SGQ`nm@)WaGM zV+S~kW`ZEi-6Vl%lr$l$#6CL+;{s4h(;Pr zgTk$N<+hs-cUP@5SwqY@$r*V|TlL7G}7f{pDuU;?wm@fm$f zh`3|tE5~yU4l?ExEisX@Q9 zcj^)!dhzAyjG1ul5)VFgZW)wfrK$N2Jp!{=6^1e+zjyqC)y;v67v>%v`(*MA*PUuS ze3NPH{K{{`o|a4jKnr|Y?lRXgra4_iF>7!qkYOGYQ|LjDj^DSY8=bxSGDv6d*&IU; zFHTuX=FXgLr&NmhoMrxA-YhSi(#J36X`Nwo*$OYLFHwfasC>peCLQ#H@X*MnD9W*&;aR zXF^rNFpgu6(KRcpvF~@gp-VNuDW@^cDrB|lMnu##&0#SN$SA6Sbxn11+p>mX04#ZA z7)zdRKHP1*wXl{UlSnE=A?$B|{Lg>>xUH~S-Sx@(w%N9D7D%GifXdg9DLGpwE0SYU zs3CzQi7~~jGKG`?U_!F&oNG{0#n_NXKq%AW@evNc>TGL9irb> z8{V#+pn+NWB)b71AR&)~aI{Eq$|-hFUmm&?Ut~))-F>*dwn&hv4+^-e*2S?80mDw* z>h|MLKVGdHNEpL@*9ECc-y!(gkZVvi+imSu&N5U%>-rj9B~Q#bVE%~m2@)oiOj{a{^P)sD{{@o1aYS?gCTY+Gj;qH&7*-RECM zx2+NS=iTGJ6Efab)ZE?QeY{$=h-8UDOuFllm_xI?hYpUf*si*-a8co6%MdwgK$TsD#4~;dxrQ#==(4 z%>lf8)a_;r2TNiqohJV5ZqWkH7|c7TzL737db4DE=U0v^gAAjk?w`p9$ob4@qara) zHpr#Y*E!CakA-B-qWzmQWOb3G$B>}c&aJb}?;T9?NVIv@+jH6xb5;WW)e|3!C)A<6=c>g8;l z^(|5=YFfUesGB3Ei~-X5gDiA$ub=HGAoCkhIiuZFKt3@>7gyd)dwpztlzSOiDsIl+ zw(<%Lzcu3x3|;Wz>AQdaj>1%G=xWiGbWZkoFRU!*nV5_%vtbiU#=CH4hUOUuGFc@} z{ca30Xaz?(g%F1^Afp2MBt^i$x6>-xWb2xIxq$_`K>>h$yZZQ{Q;{hql?Z`Knx-jg zk}!&Z;h@97e%00tOKdH(vDTuPdVT!-aF}k5Z;Gs+2PrH$1XZig&r>%w_jSEu#-JhF zcE$3vV>Tv>ghMxR<#>vkLih6d*WaGUfXr3By}jP7Nx(Yo4to*);i|=M=qKzt*WCW; zrw{k5suCIZ&xbAuw-!+_%7{MJkt^TSb=@@H0)S>oY3lcn4=?-O;Js^%8)Bc@A%Is` zAFo?kZPv8~k_->7Vwt*r(z_-CRl8pM>pPIEEF0uvj%abcXl`2c61$-r;eB1ZdUbzydv)bqjsO`{Y?DLA#1+6g0h-e^?EB}(DTWL{Wo?@6 z#yf?CAp5b~KX*ZiY~>tF5?||dR$6pFq9#@ zicfoQw_eURr3-}PHb%$0EM%G&U%qOW8|K@s;N*9FWpR>XrbaxK<2~!}xA&Jf$pFjl zx`4&sv_XNB%X3x*F2?HJ$WEepe9n^pUv1MRF)uHkhWD^R0>Bzt-sK;A&YT*k?McM4hZjI;%1g|w9K$q$oUy8|L*2b3UgLpuC${J zdgtjbUReP`N=Qrj&*fPQt@(0>EZ5P?r^LLNN+$ZOqmlBw#QvfDy*G5|f7p!qKBt3W z%YY#*-rqOMo{XXELKsq8ZvjaXwUh(0XYLoaRb3;w^{VQCd2SEoH|u<}UR6LAklSuy zQ-WEoSNEG1rEK3ttJ=G}o2ymD45{Y)%LIVyE!S5GDbAT7Yy%KPRX74!reU0fW$Zh^ zGJKwrFo~%uVrFJrN-h8@sq2S_&xaA$x33;IF$^js)m@Kq#008aFJb}!aJ#+vS{VQ` zO}poj+uG#Or0(grufOdMA;V7q`?{%$o2+}-4-p~>yM3S04eZvp+fCaz2GZ_%Hv!xt zx~Z^kLShXtv-gfqMO-9yFOR<-x~aOk27oxYDFW8rTyNXhw%(CKG(5YSk%9o*O@eLe z)vBr+5cBKx(pH;o$E&76QB-v5cf->!|NghQ9vTeRjX?m|rm0r#cC)D~S6(C6u-D_*i|k9n!pP?1K(}7*H?9S*mu6R z5gxFWhw+l86esc3)F%LT-4vl$jHSg{U;dNzau=Qn{NCGc^cyKb|Nr*?(e_6;XaT4- z>uF#AhA^9R<{|L<&z7L&R z!-XX^hFNkcWtJ@fRW9)_`BbPZo6AMLyk)aw_a7nqVpD<(u3-Uao-bsGFc-f#v6+`i z!yHSQ_Q(VQW~v^DA(W}a(sx~d=s)jvyC>Q9O&%Zq_x^F$4~`5c^YP|~o2JAZRxK)F zzi#~=4v0fHj2fpH6M?M1_vuU6zwAVI2?ATKRyV7^+^n{>ks;&>NGV1ovd*nf${g8=)Gz~j9Rb&7ehh3l8Fzhg3Q;$O*V9{jB%4{oU3oxt1 z*zKNn-GA?F+c+dwS(^nQXq*NOzIJ4Y@7K$g0DkQ&x7}Rdd4wr+pAn+1 z)o?yc=HQsvqTNEKZajoORsIm*6rNVstw%SGheOE1T{ob$SIszv3CtGzkf;S&+b0XM z%&g#&LRU;TXXgAUQYqo{x&+D*&IR8*zYB-oY5nsY=VnM}qQfjDX8YZibB3}(7NE?Z zd5<~PHXxksE@xLMWvLfccHSr#bSa->p3l%QaS^d%eP4iZx;+~x$Jw2LY@g`OP-C=QcHvk7dub^3oiccqDaj1 z;v`uYGjJYcD(}cLVW~T7U<`4dW!DU;Wavc^45ECj33>EVVxCYJ{L)!VB77Mm&5}j4 zVGt3ZoXycKzWhUgD01PSHfL~hvIVvlNa()oh7fjN_Pgh4xF1}2{@Qgz0vU+#dg~bz z(h#Rf9niL$#%@5+-i0^~NfL;Sf#lGSLqBwr^hND=tI9d=D`x;1;xwk93g;U5tJ~|Q z@xC&AD&@fiU3Q|W*HPHyNmHTw9~`ZnAwZ`6aENH@3d26jdKgkJ#w-ZNGFyWTLrKQ{ z)8lUcB%AfNVPfZuuo6S2K17VE@zALs&^G4&c3WEr15~-qs-b!d1tKU7QNYecq=&Ch zUmqr=%GdSXpMLuDedBG;P?^Svrm@fH11vkBxoNgH+s4<{W=!34Zy71MFbP_Z30z;_ zerVYGy5eO?>+bpR_}jy7Hz}z0zG=|#1aQ?ft+$Sxg=Fn_Umt${3QKiW`HHVLt5xeA z190*t9W->ei zh?!%=;74ag5|lY{3}G4q$fT8NHrLl17cor3GZ3<%wh0kASqDoHks)@Yq`03BA(5w* zYg$V=#xW^0CBXMmRbEF)VCRyxEi4#}X&R<%ON2ZG83KhO7sm`1=k$#1&1>dtk3E)O z;a4?#6bj57P79s&@2JJIZ$DpB2Ob+;I7(haby-g4<{5aIah?=)u|Hh`j*B01+2v2p zpL`N9$A>L0Co>DX1U&lS3FuS$n;&(fb=;HokSUz_9;z+}@04J0PCj$@| z0xgWaxv+2*WSrE1jJc@zrc^wASmKqId(dK@6gA>B6U?!w16WYfD5;PyD;0*-cSvRo z=G4E!#4Cl-`zj(r;7lGy~>c0bK=HgiuzOba}^s^#MR?Wyd3&*41`Bkmv zBe&X_3s3-CqrUVv3;3Bg6?j4T+j+RgYOh#|_&wjf0K~K&`c|7Nj6Un1&R! zQgCHc{ACq2Oyi_7B>OTx^29-jKb1la*iXC zLB==?6Fj$9+nS7FfL)8KvX&GgDNPbyg4lLlC1)U_J}Y_K{N?V?A8y*(86ZwWpAuW7 z31Cdj0JhEb?d_&vqDiw%QwA^%-4KXYjH0F|QRwcBp$wyCTh72ny&nNk@0u}=Z;jkDg8cZMWNic{Ymx&d$_ zP>p+!Skw0Qy0x&z&6PA&GbXSEk(iJqi&4&oWWlQ$wyx{-?e)f+ltLW3QDRI;mMX4{ zbWioQ*)}7{@qh=)(6W;^E&>60$KU(2a}I5!FSy9?Q<-0uOv2_Ov{5{ zzWg5n!=gC>1b!bvE@Cg|??IT~dxk8;faWCo=ZBwrVM((E9AgF#U2^SuO*o|RA{bb@ zp+g1KEdXGp5h3)u{h?1Vjw=sLf2}1VqZn0+3%&gu*808nyB*GRIEuNH<_syM zGjt}YnBTjW6dsT)7bAE4K>Rjh=#Pi+ADeH-;ZfvEar1Xx=gf-y{dRih<;WuUaz<8j z%xIaxOj16<0N?7JF8ShT24?Ze%`T0(%B@n?nV#ur;$Cx#0+pnK{ zsxeN&4h}IysqzTF-flS_q}Lpu5XUk2+IWFa09z>f{?Hw|F&pbVdxK%PbSx(x4aWx) zV#DL})AQ4=i*U|w@7H(t>z}UL3PNWEi!FnotOCRkrph=w+G&U(Ax#t!Y?ykWYFlp| zX&U++rsmpjZ*FRaz&guhN+4Jm4lhq%9u8e?+tsSBEZef>5C|IfDRtY1y4?=d_V%W2 zodpw=Ylq5OB?7!eYaPL_HjPeU`0JN2im(Oh`|E96v4J9VFQ32c(L(zH04A~yo2%;& zcbmpqQkmkI6&*%sKd##At+^cz*SDLRV5r2j%&)n&wiyPQkS15Ru3p!*QxLJUOoRl< zQKpx#4iL zqy}dMj8uZ)4VQcZn*9g_2pz#m%(H(9o?8@m%72tEz4+Ye5BH(d&x&Hx6?`aX%s!3d z@3X1#t$Qz&CwWoS-vLSI3zZPog-!!+I(f8z^67Ln^WSFvV+KwOB4sWM$uD0*mrpPz z^VwC)eTtilF8f!E#bY&edZlg5dfKZ@zsqsViG9HYR6-%NV!I_}pW5#bwKgA&kHM+poV#wPG0s9*ocdwXyK)o3%1zlrR#8 zaZ=}fq&nunCd<@yhg}y0fU)ci18KCyDGKdaJtEOU8_9ScBGGYcB_OgNpTA7I$~+ZCg9as$rU@2#_igoNu?=I)&@iZR?;QI-6H3h)iRQ zA;lL|Ro&Ee>oSaCwuTIBmPCl5n?@L)T)SDVRz#Wr%^|B4QWVY5&_DnCzkU_2wz#rY z+jyu#axws{_4kRawwsN~L0%GY?R>=+DNp0rcLJ_zPn!CtgM`pcJi(%Z1M9edejXBx zx6NvMzujzDQtV&8J`TG>oHEe3)m1~ycC~F>#87uH2`OkspBToFv(^+}zrvzwtL^sc zrlAC+NsJ-(DI7FR01B%9aWunPr#SC3@o}sIYG!|75$LZk zJ@b@Z-n>B1#dl#&jAzFq=*_-*_Gx)}b4U~PRTjz2WC2r9F@h-oF1;R%;(t4Tu6*|4 zvVg80ZHJ{EFJsPp6zD79)|5SX4mdLOYL*a;QGge1t9X@h6zQ`Vc)wjL0N>gEXi~ju zudjUid}L(!w#Y5|%9-}I2s8@-Sp{>Jcs^6v49oI*GVnb}<e)q88FmT7S{U8WJ2f+ zEZi_oGGG`JY?9z?bOOs2>g)Tf>y7tFQA$WsR+TvP&tHD~{AC>B5Z4NUtZ9Q%Ss+Nm;q$-!^%3i>w2gO_=Td1+nW$Um?q;*~lEUF>8mA%JQIJ}!83wy2x!_Ik7Rh=P91 zoRtlS$J9rl*;u%0Nq#*Gb9fE!&AZq!reJPoG@Ssak zhJqCO#u8&gOSg52FEz{XodPPBTU|c=Oni)7%>LtLGf?R9=M=`b?c{$vO_V=Gm`@Qb zzkeLwNQl=z70CD7%HBK`%rS`+K%U>_;@?~By-V-jcO>1B9QV6-?pprJXGPh|-IpI< z-{8&gvLUEUyDu-F9}gXrMFz_Z#srUQ8&5)35Tv}f#F8Wp$&P8-fBkwGGPo{3fLwWI zYXA!*n^L*!BubceV-yhAo9iEb{HeXYaaB{l4YJntX>_Vce}1Vj>$C4m4H2xoBBT8l0MKy}-;GbJ=j z0)uT)OmjA5n+hrdq~Yb4U(}MX+tq68KUmKMAWp+LJpHnBRn_+g0QGvaU3tFWI)Y@F ztmD`NuCCyidu(pDZIvhZnsM@Oml@+S(q#Jyk^tvdbw$XM4YFZapi)V39EO;3bawmW z54XOu-H-to>nxHls&$fK|M+wmGQjR;-8x$C!epy@y4&2Xn>y8XjcMw1&}ujI##fm3 zhsTGny8+w&C+`8s^n6HTus+1l5`gsh^OqMSz^|_F?{3!~Nc-o9hv)q`2wyHNa^u*Snda zv*WR^R#e%YUl*hKwsicChy0JJIQLFFzB-*V#ozE{rup%H-_Utendtmu*225WP||l| zEMK2UcpED64xfyiV7Z(j(0Q$!HywDt{$VhkxedtY@@BX*_eDgYvjG1;7_2^M&mcHM4D0*{oVNVav;%-5De zUlt;)a|}Vxm?lYR$ko@^_xIa&T{-WpBV0^oF<^kR;YLJV1sKF#(^M@O5^P-qED#w6 za^BY0Xg8nked7#Ztd#tmER%E(hhKmGb)U2{ahg($iL)V+C}c^kuiL>*0LarVSESL9 zBAb|gHzKwC2VG zc~TH$oPt#Ts=?6MF*n=Ba|U_GNK$Gz6o{atlq8Mam#5zQx^60KCWsmsVz5ET)A01$ z&tG?4fZhK1(}#6!uzw6YL9^bjY*H8|Xp(OCvhU&Cc6;-osR|ORmciD#4Yw)CVdxEs zMEDqzf7&(4)EM_K4__Y+BL>_>IM2+72MNjgl&5WF8S(kohY0~}>&?~mrnOz@cF$j* zyG{aNn$6Aqr~BRFqMPQYIVJB9AXIZFeTeKq?iD( zZ8!JV8}AC|-^GSUvqnFIPh~bQPN&nMC-aaN+p7?e5!f))e81pBL2C%#p>!Vu2WfVX z@vCjl9=rE0v&F(PW)^mpB_qEOqQIPL5Sfy3KxPq!mt8C0C={?ID`f^7^Vz+0xh2g( zBb?9R$ob1fw*Y}m)+N66*k*T;x!iY_a;R^p*_Ls7XHU%+zw61Pqa}Letc)5d6bTv1 zmgZ6ri;;Ly@>EZmfB;H-YI!<9p;-*FApsqestK6OF)U!+JQxBx*8HI&jzJ8Ng6P~p z$qEvN8W>d+=9y)HNHr@RQGs^_%aK~oWPzbSh{{}^38{vtqvO{QeITL+Dfub2l;XEZBJ28FInrU}xG@eoor*0N0+6=JGw z$a|}W6N|I)~cYKOQ=FsM>s-4j-8KO8AyzdJy%Gv z4-*;-(=x8tcN<$Q8e=k)kyA>sf8ISj9!3B*#grr^62o3%Ld}MK?VSNY7Or6;O@&i2 z<)W8JwSb}^5sflMfbZSv>h5;CZXDTF<83J)rqeLe82WD9GS|&&TesXgi4p}M4P%0B zn-;d-bjfdON69cTX_PawLkd3ib+pcPFcSGOp`z}Zjfc*CM?*7i* z-nfQz$}XlT5ljt;Ix!$hNPtZuFd5A3YVRu_fIRe5@>@xwuv(#B-`(D{N0{?$($Dh8 zEC`r@K)J+s$Z2iQC!C!13l}FT88&|`z;K}eXPEDGN1XPkvcfNG&76v;ePc6|67yn6 zmm<+832`J9oih>4GIf6E5%hE?GXqTu#xaxk9EHlIgBK%nwv*7}-+Kf7E<9!L4MfIC z>$vFI_rZ5X2%)%f&hLn!WYEOwfnxU_}xO4C3DRfdj&)|;|^$CW_Wxda4 z=R!45$g`=4_~rkX1Eg71E~@J4f;1Pou9BvS+18nnr{Fsl4s201Y+)0Uz&Ztl!Pa7w z6ec$Uf-#OE2prf}LxNPk*>2ZffRrPqs*PRWOGF9PFJjO(TyO91@7Jr=+k$)1Ims#| zaLL;=);l623C68_WgP&x+OxOGM#%|-1)OWvo7Ouv3<0>{sv7%gx7$5+Lttwhr0;_& zkR{0!Wb#aaW#0pE+|(>cvo~Yn*$2(Xxmnb;oY7pz?e#z1ZrjQ^=(@HHV&d5El1yXY z1yr_T!>+EabI_QkY*@xVOh}2GZ`vwWO~q_zrdrN4#}tqOnJhW`ji>GU_}R?5;|Y1f z$@sY3KF-`ri(R3wetzeyW0T^0nw?>n0NQK?;>34+@{e6|zL@-4#^_urp{U}E(KZ(} zMUk)P{>uz$!B@8-9Zecj7uudvw)u^ zJ+Mf2oLzXf;%2drQ|RQZ)f~mQd5bWVOIgh&tIDt>5Ue5a!o0JbGdpJU>49k(g_O^h zk0E2SWS#w>Y8G8^uJBuo@-rNB>8^^rsFQr}9LHV1@6#bLY`_G? zeZ9T^_~B+-S7b`GhRi5Q`H&zGf+28gEo7YP)t^5B7O;McaYEQlA;$#teYM$KU9DUN z>y5+&Hn8jvr~a4U_T$6T^9xq>)y)$Qzx{x^$s%Fwch8Ay@4F6F6T{Fn*9}CbIK}|q zR+THe*%2cs;UZyzzjOb$`qTe*=LulT&T;Yl{qleR4M;m-%Z3X|=R@BQ zJlWgpx&jPa%QXiPzu=&yb7KW6j z0Sr8b-_|uI4Ka-owE36&JBOGASZ{lE+q*3yWQWGVp*!4s*nIr)!NpKe#Yswk&vczN3GpLe?e2UzyH@Vw^UF^dE?SM@Z-z%~PTrgpPI_qZPi zU46LPZk=;^TOrX&+!RZQ=2B}j|JbEQdNikKhM-Q1a&CfbP5@diS1LF(r5<#7U#pVyOiCW%}f)e#m(_eoC{)f0#3D;ma0a}m6y%EEX*Q) z`0V^*6doft*=P3Knlk~jWw#8SsW1vaY=~&7g$ohMN2o2IL}v+`%OYUbqig`P0Vza53nJ%$ zqXH!mn9MMiO42pJCEz#bjHHDl?KrRiuo$0(?B`s#m7cJYX5mvt;gYUrKnw#017eaW zorKC+3EFgwH#xH4$m^BFb3_D8QP1uC%JLFDeG*{hgo0}yfl;Dtfm1k>0WI3u+>tYd zu=MTiS}^7qS$n1e=LKMR2QVegri8|vu^iBmaa$meaOlPWi6W9UWJ!Qe7VNzDHVy!! zf}|9qLIhc$F)$%&+{G@$0618WrrI`ltJYgvS<8?dH%=AV$0~uia!kzZv081{YhN>y zuMAscRe@j7=Hl!xJ#@qtf^-FZfitk|89qoVuPOn^gAX068c`y^7zd`Dro;2o*RL3BFWDk}-r7#HWVX${YuOg8Dfdz*w_w8xlzw z#yAgTl`!;OFR)xW0F%O<$dpthB*@Fd{yA{fwj(oFWT0(_H^_|4&;BnRd^;WPq$AuC|^b7`y$hA9wp*Ortc_ zOXX`W`#&*q%(46OLPH2+o>D>q%8@l-oRk!{0ahF(M@RyaL?KC$Q${y6u8Y>LR?YV2 zcDsT~+CS`vFlK-(n$4=RRud#yHh>KM!!Oezq?8dc#A0eBLw)ZPoqtby9Q|`I?OeO2SQ)eVrAg8_O<{`cd9oH(qhtfHT46aK z)JtQI3N~PlcbVe{kJ|Uyq31?eUQT+ifE>LOsc0@QaNdiP>2>aoI-5L(az6Sc&9}ke zZ~XN7IgV!esW;y|yo8L*s@ZAi&yj_tvfpt?&aX1l(~!o`e_)09$HAQ&(=mETfy zK=Oi7lBNh4VFfgfW#dUNYO`H=JCXMllV)WrHW>rt87{`t$# zKmYa^672O~{^ifN+vwUYNtlLy9}5vkp0e?%1#EQeG)Wgi9Fp(0M9hUcJZqjyJ}Mz= z%CJ}4hGmQqU@ss*($M!4$k%lvBZi6qGDKtyB!#gLY5M%U+f9|NT5`7J2CAM3z8QCu zEZV<3|BrwDd2iOPZe;|7S^C{)2t<%FKBxZhIAL>*kN;`&p(WL!`?8y+Ok`c#uCF}h zF?WaE^L}^O^Z$oh7>Z5W!w8)IQ|8lJvBB%Oe$Q;t)H zDv+}%K~q)-E)-=Fy8S3|oTu{jYQ1V|=lOM!o+JFRfSDHt&OCt({(zw*pS#Sn$#3Yb zjtS%ERqoEupF4BDksWvIKO%-I-JU}eGtSD|zT1x3PKB5En}?q6`FmF@SA6?n-lOJW zEu!Wk*?t)j^XlZ|Hhp4^DjC`|m$@w)^U>@*Z~6G+`8Bm{wX+>uc34tXok7KtFQ*x* zF;0Exhl#F@HEboT&SH~r9>J;^Y7{_LbF_<=-%ihW7BYN%#Q>CM&f{6zqB$T(PluG~ zl#4pzZ#<-V4lJAzQ*&|qcN#5b956$)uiEcr1Z1U?a+tAjd7ioA^z4Z)u3FB>XI(fB zYRkxyRV2wY4t+PmyT+k{Q(RZ=s;Mi>Y%Kw50G-|UL^u|XM+Oryz&=SM zfUVbURWbV19d7^XI?)``6D;VBXyR<)44p`ef~j;}E*1 zFV?ar%L$fYkwxPqf;0_7nEKSz0jR7s%u*QaL9BqPN&@(9+agZ=4(xACB@C4~1)xH^ zt)@vkcrXzeqO3WE{cf20pZDDX-nBbal{L&3NrV|EjMEU1LJTjTzxgURh{Cnrr<78^-}RV= zE&{Hqudkccs%{+73;@x|T0%bRn-}H}vH+Y3DET8tPR-L2I{vvVAOU@{D@-6}$%?vKghQ-M$m^rZMTNgcUKWD^`e<**; zz78yDX2r8}!GnKssn;UfoJ+1;q8YL-Lr04VRTy{Q?9z*e<8{32EcVzSLo}jHqQCVkbz3s zoh*yUii01CDq>#BXp=IaSyG51%pbP3 z#NE>a_@pBez;uj8P=_S0W(JgmuSnnJ(d9RjL)dv(3t ztnw7b-P6NEpQb5 zZ7U!um>#^n^NiWlig;c;FL~ZdmrS*z|F1~KS2T*h(@2UV$S@=$C&>y-F+~6d z6S68|2CPl&VhJuE#u#hI$S_WvB}{ql7R~)v0GAf*yyee6F@wbb1&&(P^811VFQ`JE zvDrD$#gL(;wnsVVy?T#%{@*Tk73$6X zRn35BqLe}$1KL%yZk-X~0RS|F@wuOX6j1_q;xLYNBW2-P1r!n`glS5EUp0*J@bH9Y zT`?Ilu4?nm_1qs&wQ8GHTiLRTWE}U0-83cuuJWfxmwd5%5FlaLKkRk^Hy-W!=B7#A z^I&hhbWexLEmJ8*0Dg77-Nt9D&g3K+Lx@0AZ&$VB6o<#h=jWZw9P;eEV{gf_0knJC zbpbWpHbwvrL~!eyX*Yxk0InUt!hmvB8vwRR+Wg%clupzu)xc6 ziymLr3NS~1pq{k1@18xsGxEQ~F01t3Tf8{p`y>(Rnfow*7uU62xQZ4yYqn%&srr5n ze(_C|vKeOxH7OZIshLr#t00&4s+<+Y)+1;kZzyw3O(|M6J0|B^L`oo$6sDo;hZrOR zCH%X9L=3jZ5umCHc6Gvp`|-eqb=8wjiV1UY4}i(pvAcq0CWsUfCvhBhzhLNx-EK^X z0f0g71ZX`N&M<}K#1-AL=pq0anXUf}L^1-2Q;hZlt(w|f$FLAc3=Em3n5GfzFb$JL zXAEgpC`{F?n`ZD0nwz_unvGW05(|M{?VG~G2@NS5q;Pn6Is|}GIWWk!Hjh&%1}L)0 zIU$X4n7VF4m3(Do?8d&1mW#D*Yux?`Qy2RR+-$G!Z@0B$A}B;tjQun^hU3-k)%B`z zY{ZI|uy2~D1OpPs{p05caNEK+&U*~czdgA9hWqDGReoEuAi;@C_WEYyZU4j(BC_A@ z_C2`u+w1kl>C``d`E54|tR17;Z0qLk&Q0<1X=c8(o? zy9kx?jK{xX#d-tUVU7wd-mEufU zd4VIJ)n%AxHpdW%rN~H((=dvuQY~Yd5d@IaT#2dz3k1XvZqOvnNwu`9_T)DO2-kJ)YnG-6p_N z_SGCKo1f5ZEP&Cu{5l!%<$&1}Rw{StdGdQ+?BUlA+xc_@olE5s&WbCS$D;;#l(eWAQ_>%o|7fzmh^k!S0@1ZJi;MOa-=*QW8B= z`*Y5v-b)7i&D{@&0c&2}-?WV*%ycKl+bUZR(VUW|z?jDV>1Edq;8g?HI8^K_rdgin*?zD08%-PY-d?dodNAR@X|1y^ma9a88pB@OAz z&%bn|W#gN5Q`r=DkAHiZxUwyhaIkK>`S9nvD`$`)S-PRO?2!d4a<&1gw%Ohet$*5$ zDPz?@X##+1TYG06IgcNI>kd&+4k(Raomy zMH>5;ug@dWG;t?TP1$-twCIbqWn@=b>8peor%8Z*3Si%Ex7)UGSDzRak5LZG`djMy z7z0ds;j~jP7K6S$ z_f5Y^O>yv1iH}hjlS7#LA(Ho5pW&Ig+%l_Zio2)X*mc9raGkuf1;sYS&nd(Nkg%Gi zgbm@8nqA)VscIz@d>oR(p0U(bovEp@oW&62BNG{2>R6hyUWWS43GQ^Z&!2Ap?kiOQ z*}&MmNT3tfDFBl9h&|^uQr>1M2S`$IdqROam&>23K%N<64eP%A+TL^`Y`qsN}!twI?GMl3KB}<|CW0~8_M_$5^&++?GIyGrk745)K zd0vq?^!t#wzU%rVvWh}B60*Rfs+eU8c0^7=xweTgKGe1w60ousIsmY6l(HgcoyPrY z2yw#H52kIl6$^+NaB#I;Df&(@VCu#JL$kdG$XIQdfdt8_0c?$B3q!obsFoDC%)(f~ zuq9>%EN5Y)9EUz8i44cS#ON!)f(UZhPM>z;0IpV>ZCh6?M38>q9pD;+W0B9@2FERo(w;#6K zt5wZpuv8}Ti5mykZnoE(s;%ehDMWk{dsbr_x-Y*zJfT`|w-t@MZnuB<@;vU_rp9{P zUa!225Zr^QsaqSQ8!(9O!oU5uUv@EDc5UMwb^GTppPzVJZ7Y!N!P~2wo4>49o&m{f zyq`p39J<}dT4F@y+h)BT95Z)QgeZBpbq>t%P3^4*@ad=i!9`6Fco^%PZ&udV2TMjRu&;0;ri}5Hie@~Va0dyw! z@U2MmH?35p$;bPe+1}Hl-XE`&j}Xxu6hP)wmf}_We(3jtsnek7+$vZ+HyJwnKhG)> z5xqAWi)-&(egMc>U_nc~>yoo|bdN2qASPMP?_>awl-*cn6@n4^upff;UeXSguf0}` zlmyeTe|Y%3Pqv;WNz&GhVP}~%3r3J7C8o>*$|$tbvWN>JEa+$9Bw4D{&kymodc-BV zS-?vJ&@p0T-qRP&{cNCQ4(U7<2r#GHzuU@NxAR{m@#0n4taql|$qGCAnhVXryP~z| zBxh5{T=cyNEW%v!U|y3YmW2wp*Sn_KTmPQwso796KKVFGH0Fki`{Dh40oIK?T6j)z_6Z}Y|*Q;GLL4M2eZr;KoM zIt(Ka#kOtmYPdFl z1LP}beb0)L+?OWA6s8m>R3;9)-EKFAIKco_(=@e11R-mrc>^NEzTd|%M4T0tq1Mxs zlCLaVW2)Md40d9sRnvHT?w7J`(OTy=?e(T{o{)1wA;~&61|;>v*p1y5s2mWUo~CXb z$8l_~c-?MRtyM&JsC;F)LQ26V^xSv<_Seq^r?$)vF@#+g0oPW5l4~|so10Bt%>i?6 zD-sYf>~=r;#5Jm>@v9awjH8HPMCH&n8)s8TuCksPSYOwk06~I>vA(VxKnCOfm*1XW zrqnoF*W2y&bgq9Fu<%%{C`<1Kqg)ZrvKA4vs7k$NAg(| zqgzal(He$f7~~95JIHj<|6#9PXCLoRzxu%I@>S5qzj5%P%M1*QW8lIoOK8=EgHruC> zayH)jb=)fyD&(#k49_9$U-sh)7V4<7X@jy|PPp3w=!O_=>c(!|zwGa>ysfMw1RZwW z9_(DxHkAX<7PEV8|UJneN4^G4NJ%t$Px|@T{^s=+BgnFmf>YT zV7uPZ16%Lw$~!yuXm4~JVh47v^41!_I04vQZ*q&ociFg`fBu(S({=ye z@A+oy*W1R!-&5oL$~PRGX^y-a149IR{bMwtl#YV zI`EL8++J^Ln_l|BRqd@M1=66&OUlXCuBz`7;G1T9wOLsMRT3srfd!e95w_SEOVZu! z!T=T%EFamnW<~z!#9KC3F-DP3RaTDf_odC{yqFh?=;cgZ4m4*f|LLc4UpZga^L@{e zzPb7o%~tRcV#`KJ=&WG;MTe9Cp8fg?EG*G_{siTNWCe%{gEVy68H6&BNzZnbtXQZN z&CweKLvzBqqHHkv+z)eM;vPSjcuz7YVQxG}G7w%VA?LnDvka{=)YuYkrwT3UjdOGi zM3PbsfyqdHnyRJmI(8w9Lsk1Bq?96T>s^|t$_l9F2x7|?D3nX0xvK+Gl^QW!nc z+DK7A!fXss_!k$jR)K8GZ50YV!T`D0$OMy-#ZY0oJb{!E$Ebo?k7BdvI|}49=PS=& z9O3>sHni~nWC%o#v*i@ew9E(#%B4pl0!O9@t-_9%kHw?Pv(B~^9ZgrdsKPLJ;8-r0 zU{%lJrSyWEGaD$7vcxDb7AUO$8JdxiB!n=AZl8zP4P6XC=tF(wsxggw04~I7*h+S` zA|Ok6`1yW@0#t3iQ&Sud-!ik?dJC82C#x90Vx-+KM_H>RNf*ZDhjS_-A;gqcTHW{?Yga~ z6fz~KrZkNi+^)A3cE)>`k+YgAMW|2684eB>4iM*f>e9_W|I44Zja7*BU%J?Gv%;vA zGZLrnWlWDdyD=W)i-w1<12(Rya|dhdX2nEfz~)|_LjsIpriBV#Qnc3ARm+ChmXt-% zj3^mi{N@rIDN^VowjZ{wr;x+$(TxhIq{+w-U#?JBK=os7;>+&vByGFiwDINelvmeR zqgnm=FCSNF_uKzYw))Xk-dW>K-T2B?TvbFUNnzgGX}7Cef}gx!ts7sFnf6nNF^nbA2g)o0}k7>fWmbLyD+RvosPCm29BhL>K<65)LBe~ly;aJ0x_0zuUhm{hX}!H|)h zH7BAB&1n+j3E(7xF~As?D1kKWz6^ldzKnaBVzR5&yEO6Sj6ib+5tpi(3Ja5?fJvbs zk`p3m2rxF!DecHd8FuQiF~($LmaV?vhs;9DOjsU@j{fFL12bbz#?!N}PGb_0<^M(9 zpKUpkBw2#sWhP!^0idd8=H~7ZnHgEtvz$INFa7_2Fn=&Tr)w%RBf{MlHK+oRg%={8 z2NuDis^;#IRsAp=C(O+Nfd~t4M0APh64e0AviOLr-)hNYG%M-bnH{W1EoQqE@>}%` zpj46_rEArAXl0gnDp=6$g=vc z2|b6G8oUTiE>|zix0+B5J5^U2()SS!S)BscL1^l-hnC;26MKaMOLcp2n!|A#V@@F^ z1`1+`@Ji-+o*FBydHVm(&BF)35lzVFBY^7!3jlE88t_?TS&GbKGP-eF=beJL z##EC)0Ik`$Mlp{*1De2GiU~44VdQBzz_B)tlh%q; zPCSi=(b`}T7k*3c48e2GSzrKhemBj;ppRW+4e3ft66ax>V1bUvIAe_>qpBEZf?fnW z5Jpqx=lxT**!5dyL^3C!VR#s`X*?1NbmO&e8)Cd0XVJO>!VYMEMruAjAWny;QSUm} zIpyJv@!nczj3G@5T!c9!X?Mn36LG)Uv|DctR3Vx6U%m_}gPb*mbJl>d##sX>>UX=% zAqaA27}wvo4;{t)^mLjST6wd5Xk5+=iq2V^3Xousa~OvCxgZ2>+oE9Zx7)sJq-ogb zJckehLxT*U2qY;2Q9!Qkn#OuXMw8X6N&Fp}617BGE9gZsie9VfEX(r-i228HyLzij zB-tNouOG8oQ07YaiSX!-x-|WT80(uqVuJkz|LSMa1eV_Bq7D;zI z&Z59j-!DJ92#MOewbalu6-r-`BfjXg#!__kOuM6TiTO}^IVd$&UA4ywAWlmV9b zJx2s79qJx?V*W&2W8GRnTtV<2y@8uQ=y_wk=-P-?>2nv=ol>@a@}v91*$t zR_0-j7<8FKNC24Uu_K4J=?ED4_-z=5kPz7(WEdGBM`n4kN<{!pI35mrb`jvhmLd?w zQJ~xF0bnp@ZJo_?DWbt#c>M2k^EBCAl**fXK4s)~!<=;tmKY~An-6!51xx1~kz%RN zOJ%)vz<>_W27m}lDGD%7Wk%&>tyKOkZQsG(_q%Rmw1`9?4NQ{&kpabd4(a$bj)aD3 z#55*2-+BTR(!_q3cbx#Hec!>j54*Op1V}>8)A4XRp=RwFLqO&HEZu+SPY%sF%JmVsf4jX_@pLZ+8Eii^*ynp7x)QEw;OjCYJk# zv^T~mGFAbFQwk|C{ASY;kLBmC_pQ@)LQa4GM_wP3yv}-a@ zPI(T@*Gh4oQZBI8cYWJ*Efi6W#QGzPzb*>B09N1Q^7=p7TlL2u^yc@M7kzO;$nO;C zeB<`=;u)2(^dI*{iWXf1rT^IAtw*5f1%vv%>u;a-TRnj?HX(%LXWjItsqMT)$>V99 zF|2_U91dV`Ky(D98<0j3W(Hk+mrSeRds}4uCTZMtTLx56u1{SJh*GOg`^Q=>&GLr| zW8J{o|07L7Ly>+Voh~;nSm>y44&bwmDi?c?Ud^-tpf&X3o)VI?rMxl-T)Lqu4~|wh zh3>!8&h$nr^0_8vE^1yi*!7uup&qylDIgtk8lS#>dI~^H9EE`pLx!DX4vP!82Z$ahOwL1E6nQ^a*hkc(fTnWxnPNovcVq zk&CdY81OiVY98OU4O}hZxMJ7U_#XWR)Tf(qJuObkQ0m zCIoovEg%33)%cu336etrBD7IWOIDlrjq{CG1rqwv@_^^VmQKV>c^twt?wKhZnK;J? zW4g|g$wbiGZ?~I0|%wZg!zC9(ygn_+Tb|#(mB#pv3GXr5j7!JJa zy6#=)D?^U8&Uel#AR?!T1n<3qw;nX_c2iw#)HUw@;U}Bs5XRHv{xGzz-R%qt?=~7n zkx`mR6_GT}r&MCnTkn1F`C;pQqqRuZ9KL?~^$6FP#v@0YgHoz(8cU>=*1p~B8j}H# z-F^7yKRYnbpZ-2i5ni>v{qdod>F{+#8vwHu3kk=k$FEPPp#X}uy`5nChn)jptrI!r zS(4OPcbLjDE@6U4ububS8W7AV}ptLDP0|B<6YE&EN* z`|3(T{+-*_bK>lsu`BcFrN#ur+`D#W~m5XwAjxLAdayaVqFJuY#X3?1iU=GLQ z;a8%*9d_H+H7Uj8Q$T?MY^_f`0g|DatR`Dk-o&gL$p8yjFWJo1oY4yd{k7R$`R88D zLa7!5^uqI5yIX5Iy`Y=M67O+6Q362M8jMA~7PploL$CHYVeNs!tvyz|wWMjho(5oH$dYv@Wz|&Gjb~ez7jc~i02Iku61u1x=fmqg zbHS6pZ~N8y#q0iCcC=owf%6zu$WJK{*MNYvHkJ@`9QTiZ|NDU*n5B~L=gc};goOV5 zr0KJ5d#@q+5T;sTBbymP`|LLFw>un=cvPsQV*rY9&Y+`K$k7#Jy=&%m@N;6$wQ4Q2 zrYo*}fE*D|`_6IK)T2SGnr}}4V5}%zO&pd*k;=i_wredkij<-?h!unZrGb>!*hJ@ObBVw48MwhSNAja-?H677^&sw-%w~ z>3A9eg3R-H9JASWeb-q-T2h|k;c43MPfUe)-}Txg1%ja!J%B36G2{q@v4lhFHn#V@ z(}kHqcI(@1XKjgNJPeUwy>B!$DNW9JBw{h>KA^kXSw+O*>3N?R#<#oP=~V7oU2%+x zoR>78o&q7m`<-b`zUyscj3nqhA0EH$CymBvfP*$3FvfXfwbHD~T4!vAW4(F*&;Rlh zPE!bvkCGXtX`6oABJBU;(*f-eT-&q;l=1xd>C=9g0$_Z1|Dly^{7xapn1GN&$R$I2 zhN|0ykyRckBf=ADZJ`(Pr>kB60xPSgoziE&yQtSBUJK5-kbC~)7SH*9i}&PZ_}cH7 zqf6`xpo&^uMi(6RI~KuBFE7{BP5(VBLIIb`4z>8kS*`(ej`_JpffqXcYryf%-rQzk z>znTupJ(MD^oH*MeAmPjNMxR_$Vg=6BByml4~_jmymc(FQkdC6;{Yd)C1nc6Fy zU5l2w)D~~*i>6m4>D9`p)UB&cd~H@PW!S3vv6?bk>Z5L#^jebR%$ar@P^lK{=lr8v z#C4S~^^fY`yYWy~LjIRsUy1~l#YL=eGdSzYx~$tJo>MCn(4tiFswApg2w1IU*=wAZ zycn9>Ruk~Ayz5F``^i^)@RH_Vbu6jA0*=Gs^QXrX+NGM0Le3?VWGbR}HL$)ghU`*w z4LD5#*aZ(Su-5k5j}JRMI)I{RBAx+2`DTF8DV_}2TMxjblv`C&RlTZr&Kl=751m;J zd~!d|##+SjIl`|Dgtbg@y~OakPjVzI;D@>WATX|x$DmkByhtn_{xVHDs5}nHr z5{MKyjbj9C1Ji7qwpLfIK}X)Z&LMv7%?#5AEyH-6lk**bB(MNE*R`Hw8pg;O@o4hl zFpYvu1wd;y-eLayZ9E<#`o#HLf*}o))KZ~iQQY%1PZ3Btgk+kw?Z_6%B__C?vCX#k z6cuxt<_6vwql%yiOJR{YbmW^J-Cdt@4#U&8Cx-94ZP#{ITeMEE^RESkS<*Ba3JK7C z*3!1tlPZ#h5BvQv1rM@dFqsT(tZ~kh79cYh78uQ5|NNK#^3yKNamIdB05zMY?`26&E7!J<>{5Zr9Q5k4L z$iCC$oA&Nu*Ei0a8j6^*L5V4iAxCtM8DQ46(5ccZ9jm-dHB2uYOi<9_Vh4SU=Exi-1q|U;N zj+{l?<#A`amev1!D{L#?ay4dWUg}G$!}5CN%9;=OpUfkA%Qk;=cd|}lI(&QHpJvX` z&@ZzL$rz(hvdA!GfEi%Xo)+0*R1eqhet!S1&AVM=nvp?G1_0WYfXd*RMxA%9@%_Ub zN9J_hP21dUfBf@LU9U+Kh{$gK%S50D2TpZ8>V<`PO`J0TFgkRbzH`t3&!_$Im#?FQ#mdeMNM;mxTpi+h z9uFhHWuD0PyG9{p1C<1uyoI#}C?(_YgvJ`u;LKt$9rpV%E7UGFr-^{J($QKc5)h*zTu4{rKLG0GT*G zeH!O5J)Lr`ae2McIiyj+r7(pN9RmhX`fLk)UsjzdsH>5oUX+-=zVeUIME`^Ba>GCF z&RKtOyI&aRtQhW&z~L-F%2gOOa>Xa7TxY}$`I|F?e6FI+s>Q&RsdlnMvyRsAq3!u z2bMJ#svfgd@bH^wt-{+P4Y+(EO1;tJ%d5Pe$`@9Q{s;VjS2tNYT&`SgztdjFwX9#L zq9Alzd9nbjCUXAc_3z7d!0PKUGytxs2nrxY3KcBY$<7k$rP$>K0dm zwG8!@Qm|%0sDgr`G;0lBnbD<)a7k$zPKW&|XD(1=YAJJ*jMhdejldcntP+w0=GMvDVq2C%|mCyWTrME2C5ud^NB^BXSNgCjdiooE;>ZG&+1+e|z?k8}4g zz0Zeyg7pPW*D4cAe*VSiriC++rVOI)!@GBzjn)u}9Dn`w^9YXbP2U2#F(}F! z0_@hAt|hHBnOe$zb%KikO1F?44nW&`gSvD$r}^-=uMtMK{idH8$QH_YZ^>xQ98!4t z^7s9eh~PK>%b(u0W!yh~;iSm*}b4k--C{R$M>yc)FNOKAtb&7E~-22jcT~H}Ma4vUtvjsF{jhk1fkp)^v z1LZ|Z_}L=?rHU&0x2s;hYI@;fI`80u7YtOd+ckIEingetutJ@{!VD_c2hpVt-^;^n zsoS>b=D&3!FF2=O5(=&_tr6(w+tnLm)$KLo!rpamv=aLA_s&;2o4^GNe7WSEuw0{~ zHxp9vSkZE8S`+|6XGtjFAajU`;o%X!{q?WU0f@0=Xs9N{$X7Q2{k{6Gd|T>5>*8H_@f3iv zmZ2=PE~|1?9Ys-*B_w0{t*N5zW^Bvi)WwS-t7)1bR-{G!p`fB#!U?*1I@g-BXS;7* z--M->L;<)+32_(>LkgTTOaXMZAgzlgBBS$Y0R>Y;Bx%m934qr?^#lUG`QiRgKi>B) zdMy(U378{5wkcq@Wj-PUnV85DqSbp^k{MV4BJX$aKfHU_8bexvh*O4pG4lIGJhFnftM^C_Ok!_?K#ezvZv;u|M{P{JrE}#kH_QFu}GRqbyO7q(5AYm zBZp*Tj&U44x4nWgMc3mRZ+J_pm%E-0t6ytT;&1J!i_H9<9{GE1jc8eJb948%?Sd;z za20zCaoT!j7SxR6oAd8`b=UQ+Z}NLDaqf#&6;i$N>!^#S{i@Ha7XM1{K||M~ao>67 z(x27#P*P(f3JS^%eeRWAd_#}C1j*}5`tjNR!#N+WPM1bCxT*`_NFV7JaT$au4OUo?|d2J1=^`B)) zv!k13wc^)r4%iJOceQkiTGfXY*{I?{FV3o4jJdMhEhGKv5sOc7o&T5psF@f5q_URE ztye&4MlHU!_~JAwB)m*A)eLYcbQv`brRBzaHLF^nR!7Cf#(UA{_0{B@^rE2UJfgp; zqb^fXx0G7o+tsOjy)#81B01-f)|aWB%&-wk!(@w0MT$a}j7opyzzk|?L?!`lcmJm! zKeP=QE%OJV0pJM0z}Swqm=;)*taGG|q!R&x5M$0z*fPa~#a;H^T5F$A6;KRr)GO#-{1CKOAA4Z`+--km+!m zo=!mk=)S=?&Y!+M4n`HxaQ*$mkMCO-6Cjfv52uhgrz^lI8$khb<{}wD&S@Gbb$2dX zIT!c*ep||ZE`BYof7=6g-c1W43asu!+#;#x&8gLQ#7u$0cRW1TO{m_jsO4N+JwG)J z>UatRM(;$FYz2!2!xyQAUDl7fT z%}>g!XGtm5M3ftOP@vWs$tfJC0OKihj?;J&PeDp9%H{&3m;_`AfN_1-_nkKe&;%t! zu4MnN5MYmiBjhdP#>qJ(I<8~F48^^-!U@irT zUU_oMO;pHbe5&zy1%Q|HpJ#cYph~&bm`V-1`F^Xxm`jq%byL^9INN(`JSS?v=D~ zD~|K{w{M?*o$&ttaA-fcICsugH$Q=MDKTRjo+n1@vDe zfBxUz)8W^zDK#2^@!bwT-vR1=`{x2RM`TVpf!;^gDfr%6^)0mzcfGX+2|$sOr^B}) zTZcp1|K;KS$If}9O6HoGSEE!@3K7i?fk%AUy?@Wo%;qqWYd5}W;Plh;*AWJoo)0}) zKxpH>K0kl{^@NA6`}p(6kJ}Dm9LGb5(=poj4*pM2Fctu`7O6`IqLqWy$PBojrxu{r zgG(UI^8D$ubIk|nht00Dzx?&F**70~Hkt#If#{P5!gv~kLPefs6s=NX#QLhq^^ z0X%tC<{=C*2<|O4IB4E9_G8m}gOVLmQBdZL=byLkx{edH#sYU}r4&GGW%6ogorS}d zlQ}_GF$q$oK%`X3APe1vuBxh9%W^IhfJK$+VObAxIZG@JzPQb63=^8BvAedjMv>8)V^P*^wZZ@E#Pidfo4@?!&pr*&Dw3RG zEO82AoCZ)B2B53KtDGEKVX3jIRrMKUkvgJh;iKw2=^H)b&1!?UxOknO>x=mMQnkQ? zvJifhTEM0LJuU)!U4>=oZxK=;x)Qsp~T1B89QUg`a7X z04Z0?{fx0hz=(zsl*0L3D84@EO2obv%4Mxe^18@`UJ>7G(|q0kuN4NpI{KDrDIlh* z`)SiS>jPu9<=y#i4;|%EM-OhxJ?79bs?Yq0SDFx)Lu`SsI za%30UwG_tF+*s3ej-jYPTi*q6j42kt+}+*n?su(s3uMg9ft|OTu5BC{WF!GJ5!HB4 ztreh|PtUXJppX+_pp11r6f(4P*lcYL?qnYKk6)u}Tr2ng^r5r5M)a_VsZB1WE&VXee0d7 z!D1;*)09vvm1KadQ8hdB5?#zd&M}6RGP4j_rx=;DX^m}-@s=>2j;FZ+0N>wzxNj6B z$9bHx?R2->zWZs{dR367LkJw8c^Tv(=lfz+B-c-_z^99fsupskmv_3p=XcDeYwy*WElr<)w0!c0a=w%h zyz0am8Gd2Sy|(WbAAfbyEa2rDF1Lop(^&&P^KHm0kI>C%oIg|-sPO!Tb%~wNtb*0J zxjeOY?KWZT_KnN+bF?T3co<-vEsEOBu0fs<0d0KKc3qixnj(y`{lDzqy}xfgX|0Gw zLu=$9oMIf%P~%CJvg8FQXk=Z~xgVwQT5aNNUMN)^c~wVHU=%4(qOMNw8kBlfMCwZ2 zxox-5_;+4^8HA+*!d1H}#l6_68VV@#Vj!!KS;I}wgS!6rdg)$ZW&qcE)CGS4mPx%l zUaiYq;T5)v>!~w`Nc`gXVTdb=6NPu$<_n$DWsecXCboAj=`+nDaodo4z6aZPK@nr6oU zJcsdgU~zDb4vGj2>-$4WOA-U!KfK?z);PDgnM)2Scx#P!mPm1s$bd4&c%!T)Re+2V zrsI>|!5}hJ3+w$Bk$EE5ZdBj5YfXj{hbf`))O`H&X6GzH3z$TKMM}v-hy|Sk@NU;Q zr;!B`^K^Lp^7wU_?jG7O=J6C}>zo0zw#M{bC5vJ}Wl5ZU;7knXJ%IzLSgo}JiX@R3 zo}VVM7GS`;MSCt%w7xzS<~)tlaGVk<;tJ+Th@AD_6X|p~9LH>7Y~0}e&%54A8ivCV z%uaQiZTGNi4GM?xa4ejiwx;u@CjeSQLxWh+a&i(1b7E%GB5{tVJx@@k(ct;%^F9Fp zb09m%x+aXX%c^8aMfZKoszum;nhqoSo*MVzz4s;)k1UVH-fQc(o8E=FFcf87$ZE3A z_pLLr%+v8{KMV|I_`DyDx32FRW0HWZKojl>MqB4>*IW+A3s2(99kfJ>tlMWv?bhsH=$bS!tcf#c2ql>&-lwc@C&U_9UH&7=F~Lw)lfU@Z)|=wIK9Yxs>;YFx_ioFgyp zrWBMaTBxi?q0|!AFMd#IimTu8%J{kR%H7;uUn>af1#tah?mTv~+- z102Tz4~^sPt|Jb)KpDT;?sl6IfH5%E_W!!+ciYAqt%!{%1xaB9c$$J1B1=$`l`ViW zq(vz*WC5v^nFL+V>X2Tsg&M)4wFcg1Unu}95U&8eKtjJ&mTuwW?=`79*>8n&-V~6y zxncE3R*T`X%2zn@8all}lmRS>k#DtYUE>x-J%5PmfxC#>Yq6&;McC`5rW7es_%@yW z&4*tuV0~q*mUHsw8nkk*p}P=tLe9R&%LD4j@MRaHKtl|SP=+?vbq9O>a+I|I*+@aV z>vuaXVUAt0UDtUSYdd2~K!SCfJMVh~6oyvH8RthZh*GlI8srQ_M$C--Y^>2Ds)31d z@#>g|U1Nv}9(<@$~eCVrF876-~Zl6~-Z1 zw5EHv_12I8S|f7;b@vV*Klaj8ddQ?<)9~&2S7vIro88v; zEg8jOJU;KOfo)pXHPjLSr3{oJXcR3K5Em&aO(}Sfkf-pN4;}PQv<=h#uTKhq(KBgG zsq$qSZ?WV@rkLAyM*)W7(_iBp>EV9&t~Epq1XyQb&0V)^U8Be67*l~Z0&A#k`?hnG zr}*^rbw8yHP|>EI+hlBO`>yM0&VXrcN`gC;1esxsGse&vF}nWqdJC0mBAfvar8HEz z6?&`Lc5})s)?=wr&nspl=ZmXz6a^4_{zTro)61LIU3(?%ZXwCD#x6G@9Dk(o`3(84 z>*l4eroz0n%$r&azFPG`YV`A^4-2sv1nL@fd-I(tv~;NqzkGj@>UvER_(ud^!E(|G zEk9&nrWU`s7ZL1_?V>D<@g*Z$9womQ4t<)pm83_fP zlW|_SMXPaN*JlB)vjSJWW(}RX(pjqQ^Id23RY7J#kpf=KDW%SjQ1!Am7k@cROI>jV z1E7e=>%i65?Lv2U9l7-zE2jWz4RLFt|0-KOt7LS}vPbFhnmO(5+T9|W5Cx9BV*1!Wi13ATMKTXHyuTL2u#3y3xI>6USF-_O`bu^(;;mGV# zv5Sd2*EOX9loZA|52vRgqpM-G{fGPB19j0{c<@u^=V?4W4O0TpwcFlwXU-u8Te_+#Gy2P})B~WBZ>svK5jhjehy&~-* z`$Yh1JGX+PqC6T$bLZ>syjSaJer7f0v3q3R7RQgS>U_WSNWs0-tD|bDGQWT>vM66>2R8!=V2CTYqz_N1163~b^sF> z9;T2`tw!oR3iI&%?eoEPe)I0W>xc{^PsguM-wq&Zyl-1)7J@_4S}~+>spy(;9LHgr zk|B^L8AF8IMdec*4&w-T18ANR&DQk)^xjd;-O&KYd7PjfFH5uC-T!pA?c8`u$HSLz z!#wBhyAK~exOf~-Urs4AOab7nZyIYcqI@|%eLV$%)-X9ikrAbxA*GR%N%M@>SwcuK z({K>We$GadR#fCto$lhU11`rw6(Q9=csmDqx%f5arh!U(bOtxy4350f;nzF8Eq*Q{ zj^278mI|xu<1b$PYAOAmO#4Gv=-K0ToujXLEpdZ_QbeC4JFA1U01&NFy?)n+-sPFU zd#Kl!C;-$#{q+wWo~7Cu5ERys!a3%c0z2Oi7IA6*X z|FioTp~>jQJH{w6f#9rA(^yj^a)4J(7e%zj($sRy3q4v{qdlvOZQ+jrpcx`kgKw{W zmTS+~*a;@l-+Aeqm0OqVcX5Li%Bz196ue-+TwqvPGBz(Co~1&0Veyo!U%vYA+NrJ8 zQo#s-R`p+6R);{P_rC51uspWhIET#}kNbU{ZN)$oc&(kGRzbf27fZiah977!t}{Rx z3CDU^lzXebaQla5z0r^Kn8m31+kamKqYqXhqt2Uqe8JQABL>&UHV$+xh~a zz{mPahxdTT7U} z43D3lp64R^%5ixmV~Yt6jgsDcGo z`Yi8>?s zdxSX{NIZPqjd0!?teuD^^Aj$5M7hM4uA%7lk}G$?vga2- z8d9BD3eZ)9l`IK40;HLk0C35fa~7E-rND{PjI-R+E>`bs$?2%O){#NTWH`j*3}E=m z!~XH4DCF_Uxg5TI8Ro_kr-^OvaEK62P{uYEWL)?4aX&<&UBBx$t%2^400)pIgP3y4 z%NFGv#&JqaeN2Fa>1qFYe-gTzho?=~5%Ku#%b`r8*vs1KTWt{0?;dOpM;?Yf zcAH%Bi?TwM)nyOBl@jx`KaE*!Q<97{9)=9npa~_i6?-u6e|X8HUp91ETiO3qQ z6+r+^O6izc1b|T*A)F5TAplBZ7J$9tSJfCJ8iArs(@-xOLY;HSJmRqb=}_H zvUM9Sl^t=FH+nWUWxZ;R$b8HCxsE2mBKWQY0m?adPXN7ST&*N6zb|V_si(;ATv->| zN-0xTi7jgum;l%5UDX$Ktrh&fm8Jl^3d@v>;&AEkA8!Q!3L{rPCg&KYG)xJ;S5{`3 zkB5mlHk%Oa_U^|Y-)$POf1shC=Ms=+Y>p3{xrPTrgA^fB(@@eMI#+TSh7sf%1F0rW z0aMN7An39LVu%1x0xeQQUh4QPVo&I14P9(nRYw4qzvXnLSOPvFSL9bT-WxZaMvxW9^VY9t>aP^WYf90;b-HhuWHJ{EvK`FY4 z6#ZU1Z>80&{M}aSg`)8~x{7m*ED5AF8O6|GP9e@53XoD^iSumVx@$hr!6~Mg^S$Qj zxF02h<2(#gbZB=5KpwvQ+rUn@$-$s$2w#_%Fg9tl)OgH8I$~&cyIs>+v{W$^GM#Q4 z>%H|g0#i80L(s6+Sz98~;V>Ld;sFdp*Fwj`-##AzWp~|aJXe^kO1Ew)BX^5(y_Hy`@Fph_q78)Y;iz*0^{;2VJa4q0ZF7}fUS zU;gV)_w>5~(91fwjWi(O`$ba!!KT)*?NV?0$2^YbU#~X6`IGbM@Sk*^{L!e1a*dfT z@YXAaJFj{fHi^mQ-5-~y2t;~b|MaPU63eAqu8;JxZnXxrU~ z_ZzPPZ*e?mWE9oyc3uO8YvopGt+fU^{}8b8$e4!xkgRQ6z*tqFIG>dW1277+2p3dN z5)@{ECTNuJ@x3ZwW!bFS(M!AQe`p}SGxpWe`JX@XwJi}U|AQ`b7(i>S2Al7D#5P)0D#GxNVU)OMZkK(YF*pp6P}uB8&@X*ii2 zm{Z5D^XRfofVDev?Y3!J>nqKigqY&C-|p@kRRD0DLK2wSq!i+au>bbyq?^8JU@%9x z>b~TVz{V07~TE5 z`+Kh?6k~jnVLwjOB=aZ*lCfg@q@|X}fi99$n8#t54r5@Jl)`j0w&@*l6xHY{o4)al zDhVrgu}pN~G>4@&g|=<$8)smhH}?;2YZY5fdV)=z*96SWJRNO{@Z5Muq)`|gr_C+sPDUW1WVd2a^_sb3#jXmiv~ir_dovl{#{#>ch#~TZf(7*CJ;Ka*;hV?B9L-(u>Y1LM@3LI^yQ=PWG|cy}!AhT1BYtw#1Zuqg zGE9(CmZvRgAN8jq3XsD5I|9C1dT$?%WeKwT&m5dZ0O5i};F5EUA!NX+0y6pU`==+> z!*pz^ZQIs+Bx%rej*yYtKmYLV-G)#YMLFNb#0LdUHhI9HeSFUVndE-tR)y zs+5*xb?SQEa;?5L;IMwRvY-8qz~pl%NvYLPsw23Z>Gi(TYEgyd0b(u=7q!&6S7(e~ zS5mrb{~hYT6)JVk*}yU;JHI!x;+cpiX0gEIM;+R5)gV|c!_q*1TKmg_#4yVCv{QaFF_N*s9927v! z2I&wR3Hxv3$kKN$I;)@Coo(K?$ehzqvH-($Fke28$2o%f)&%dfb;-;l2hM=%Oy{(% z)odk?v+G*V*Gl0~!4&|_EsU%83$*3vvZ?H`ZX zuzNb}I!E2Z%qV*IPe1qsX5%#^!|N7*`7ifmy@Aqn;hpuZOajxq|6yl#jZqwiPyhX| z-=7l%TD z6ll?lv$5VupFN;g@ZtHdq{^!kW&w?s2!Ewjy%H!du`EE#8p?2$^tV!`(ej}65o@97 z=zVH!9xwtK*q{JB@a1EkJ!+4rNzG?2p!!ahP65!zd_U=PxYqBsL zS%QZ4oyr3NXtW{_Qa#UxD%KulwBI{nPvO`23V+03xNN2xN^G2SlSGIOW4c&eG}Y z)TTMXSRDRi+o|BQ>L@?=V8FMV-DVod@9w?l5yj6?b4Y0V8QL{YYvhRIVT!3Sux;b} zZQ~R(fsw;>Jk0TVYkO~Cyzfjm3=({Q|K5d>kB!o{0?plhO9^CZB2kgTn8)Gs^N}|9J$;*xhhc=C?B~PuqwBn<{bAVs<^#As!t%h+5MVSmhE8(L1XfmklcRS@&N#Xg+U;p~cK29kKg6LQVAjch%^>gM3 z(oLgt4q@PwO9FVDy|xaLRW_2vx_T-QR1^i<-{1GslqRB<@Zo(A1{tFjp93Ioq>{Sm zo%;L-ps8|wLIX3FluAHuZ7*8S`9(%mCR36106xpbdeE#^nxbmO)vp;sN@;bWz_<>2 zxpJIbYxOJb*-bb(>)V6r@&z>1T1Tb&ZI)oeT0;+)c*FGv=MfPUu);Ymyqc{{OAsgN z%45n}autE1Sm}kgOc}1LU9T$ja(Y+$S3!eN-<)}sy&428bj~#+4h0JUU%3?Oovu>i z0h9&V(h302Q;NoT9kp>_NO*b<#lG9^w9iLSgCXVIG`l}{eGArFYXxlprH!>SkH;$8>Sf6+R&7CHh}Nod zM;1ZV8&)rHDOc%u1VbnSQ4DC5a|mLoN|G!|CKuOWy~#OVsVss>1cp#o@3kwo$|R<% z^6XgWNY0a0eSDRugew5B>;=(^R3+_#R<*B%L87asV%Cm;v@B*A)L9nG^?Iwoms(dD zphdLN`eh!2=GB$GKqCJLNLyCH|401Jx&UNMF2ZzeC1(b4Hh?7~<{Au=5K?65WaB7` z2o6A=rpa*RIVBxaKndX>u8W9i7;AzX05HcI3haGl1O$MbnZx-K01^|ZyT89P#@C!b z2Ipx!&VX$!Qb^Dq?L&T^G5fow1CYy<29D_awrRciez&hWYffis5x~ZTk~sn3=OM+o zJ9T|05^CS|A3wTV50Vr~ z(>OdIl7WLo3Sb}{vqcye`zp$X4bi1Q3UZonGj9R zg&(dWKl$}9UiVb}ermxVXy>3bd4;I{XWEi*{zsd7!;|-qG!0SZHzq-?m#yv1EA<~6 z$Pz=)qk|!Uj4=j4p2F;5TsPFp*1B!GzVZI%y)tle4n7CwthjI-p1ypWri0}SfXU<% z(->1QJOD0~szE@63lv0y&XgekDUA02&zpjVDoX$UzIZDn^Qx^iS^+4cygCaNpq0us z2Z*6A)U(&ZRAJGVG%n>Ga*Z~srs;Ks-Lw99-eG_USvF23fU7C1ktItAff1c2+ce5H zm&KEFh;w2Z6QVNisU!!!;< z(1t-40C5}#xZTe`?0TcgRyNw4=I6)HUnbYwwdpZxv=5!LdJ1|}o8DtA(-`Bxpog|? zx&}@Eu1toIIZyM%1ah$AV9bam(eQx7_So$l2yvK$*==B5-x{w9YvlPkZp9;ISW-k9 zn;%Z;_(*;K!@IsUMrp9j(|CA3asToChyTZqU5&q4s4f!=hcKNEW8PX%Xek~CmN8mY zQWl*BnoOe#i~*EZ8meFkjn)NRgQ9E~>0v$*v8bap7Cs?Q!Na#DB8Gy46&U>dcXO1CEU!MnhY;gjJiFpP!CdaPzWaQ)K z-Mfvngx!DpHH*M(?zjGK*Yys}1qv)B=kd7T?@wvwq7RQ0HJ4<=w{Ks^DRYsWMWA=> z?*3had6=K$oB{*t7y!vd1SYSGj3b~5IJ#(|LoTu80*hv|*)^5i=Di7wyNBKzBSq9L z_V;Q7t{daR(|iuw)JADiXO`)8V=Pz`pwyK&?u~=4lxik1e)}M}lDG?9{HuV3^B$v@ zbc#29{@#PCk}u2cWsTszK6Sq9CIV{yBMP`0H}aCJ>V@A_FCf?Yp;Az#ns0h_cdn3g zVNvGN4>=>pYX)FNahK$st8?C#i&lGyU%<~K{tN) z;eFRO-UE!HK(-lD&hgQ@o!NFX6_gl`hcAD7{5sAC)OrJF3?mBzIZwzituIi73}%5U zieR)RfI-YyxGd|DtN^H@)rvG+K?3V?D>pN+7Hqf?4QHByN-^?k%FgRt0a`Tp>M&oY zb3s(UR})ID#^v?x0K9TJmZHiM9a97ann`J;U*7o5VoH~}J8#XKrD&_VX#gmtQ~@g^ zE17Ot3P{(N(<_!xhqz)PE8ee{@)x3c!BFIt+wwf_mnE#J2-#AiC?-Zp1<1@?#$n(c zWwg%1U0X79sz;VqNJ+>#f<<)68tdRJLAwY?fW#2zC;_mhmPrJ7CL&ErH{K9ulQ{=o ztYzoOD1ez6cK5@_O=ZAhK<6|czI^`WD7tBEIv!!)bs*ZjJLa!&lnSQPILE|jI12#M zT5MDVE@7U=Owh{Mtif5cNDcrFn1-=?^2S2uC=J)Vc4JTg;XEXOi5W%{d1JM_%i&(P z-Ce(N78;!6czS+%dP?2H?#Dm>(3wikUPYfSVBrEoWV@z;&&Rz6(kV0GbyFCy)|gfG zStE^5ttg;~)=H7FzHho-!GblBF$674WPmKpspeRsn(c;w1k%PhiSw7|r?KGiQ~zPJ zHON!mIzB;!tu}PGtpzv=EE${9935ueHqPV-#tgvu&8|~hzukED%Cr{q9E$Dl-ZyvM zrZM1Dpiq!G4u>J8lmW=R$I+#*Gx5u(r_(Snr@9P%*WbO<6Q54UIVCPgb-^ipR>@TL z)SYFJM&`^?ic)B|T~C1I1h0`{wQ$L29&vSHvcC3*6fC9ekoBdm!3xSK(n_g%IOnBy ziC*^A;-Fa()KV7aksC%6slw&^1=_2!s;*=8uO#2qbr%I$ujkz>VXog6iOYAuRo|A= z;0ohBtIgM)Tfm`fv9@4o<>q1fWkKyT$@N+jp<;gJ<^*2di`VMEsP&*+a*k_J*;U)W zW<@#wNUzBjsL?iQcs@?}zus$amW$$;U_sDbzt8n|um zNlF?IPoF=3o2INQq-8xBn!Rf=q)?t2-4qj>OV^1BT0s@11%+YO3^^ezpJMg;s&#BG zvv?yf7I*CG>;<4u)CxI+&hvKNE+w%9)gro;r5Z~$i*q;hYXUHZHS%i3R&On*lEw@DMH%n(R(5^e8>*`!o{`zRW#^S6UDb=hbEQJL1QZPcDH|P2z zED3r5kO)xf+R1+9*sl*4D5Wh6Lv&#IDmm9y4~$| z8&#My6p_lq^yTv}pAKwHr!yEu`OyhJ^79zxj8It2T1Atd# z41|r$A%ek4N|6wH=M*xu?RS0GSW5&Zg(4A?1%V9=OyisZBpGUa>l>pLBjnTZ`Sauc zgzn={A0IZpVrEN9iy;Pc>S55dz11#_&x1!g4h-s@O&LZTv!t#pJimI?ky#Zfq6oDh zo>o9&79w3~1z|`EOHLsNMHXo9KFsX|-#VE_Z&2dXr+@$T#6*W@e0X?hwal4N4mqXF z;O?i7L>>j=w}@lHgb3EQ>$HrRIr5xMho(23Z9O3=YH6Il9z^%McU|9k4~~Ptg1{W- zVMq)Z1(I!oO@3r`vf{bh9<3=)7!3P0~s7qAyx;f2Kc$Fpda_lT|2nDhf z!#lf6F1pEe6Ma*t;ij!2GYiMPy6nNCK-X5PqQ#Y1-a7AqN^NqLg!Q7Smx2#+^RM5+ zF$*s73RS&_Do}KDc-5yb0VefWzv%SU`nZrG=%wn;#jUqG{}x>yOZU7#JEF3(+Yq z#@m&xevu88xTLInFZKKLke?l0FSMVsenkZW5)EGJ4ybBjUY0f%(%lzLucevKrlzdU z?;F1Av#U&$BiD_i{>@o-yTNENmC_q0Ao>s&fkS7cdi=kEdN z8ggCBV+pEwY4G8#J)=-d1Rx`)SON+%^YHCk`e6gOE>d@szE?^qOI?L?orbP4!FN3} zbOaYDZ(56KnnO{>xZat}h$*t1GvG-BTxy=OYn$C>=ge|L-R^d~&PxI(fhHY}!}H_* zkf2P1z=veb53|z(;~b}yT1>+{L&0Mno;p83KBk-jv-DnD(k z&p+ZLz8pXKp;7u4&T0fIUKm_fB5l-&e*!j7WKx}$Sl)xLgSr6 z+qJ#d04E?_@!wScGhRfk7Zj9I3QEZ-rid6*zMag>DaJ6z)N(^xn0}Z55Dt{a4&#^q z{@3SZnugJA9zOO2&dFwf0))0wQb+s~x!!~kq-tW^a9 z6aVy-QiSii`?hTi=joZzXs1wONU#>UWI-M$(@bNh)BbS^r<2lNS>=@WMgttDIiy-L zOmYE}hSqCb^rBn>N;~Vx0M(!+X!4CSkZBsm;Xjap-SPCkdH2p5O}O2#|3Le_?7x@i z&Od(t^L=hUEmwx<%Ll&Q)=Pi)RsVoX^7~Emszto~;?+Q%Ym8o=tY1;Uy*NmVEIi69 zz$q{534W(rSmW{*AsG)}r%zU!MDy@;JdD#oU5x5`csHY|%!+eR01pj?vCPNErvYTC z|JTm9?Y3{6)e@VIh@a?lES#p8LNTtsl~(71gGHDVl_jg|ZU64&vo|~Sc2_TDn0{yB zsVdj50d{>^Q0h17TyKMAuB7gZ!aJAQt-0vmx!v#hk$-DF8fdPyFol-{hQg%)q^g#+ zrX)a$(km(YLh@EiwDZM^CMYd}B3EK}LC-IpIKQq|T6<_nisKyTVogb5o~AHH_T5hA zrhAh@To z;rQimUwh)AA0n^<`XUm;I1eGC_1;@-@83;vp2q1op7x#R!_%jyhz3NP?Y8YVP76wU zIvz$D52w^-=M4k~%+3s4al`@t9D8o(v4u^)JUEexuP07!{ z2DPKEQ7DZ5$2-X!hcwRt{X97EFw87~R?cg!j4_CN-cNHDK*Mrncp~dHX36k1z)u9C z8sE1T!c|!Uigv#DIWiyi`*FwxX!;NDo4*iQ1899+uDr!f_?+e~!sDke<1mLd18JJZ(-eRl#=~K@NoS*=C_{IooOaFd z)f)mInTT*iZ=k!b`(HeavX)3eQig98roA_WFdZ;!*Gd7%8qosH3MFSwkqpi@MxB7_ z4by;@*98U?-N^Vgrw)3F-P8aGD>7Yk2-FMlxXhla|5G)-QYr!ng-W-(EE1{Z5%kO7 zFQ)aXv|QxC&5~1PEhAC0bL;xj0wslSI#p91Uf}$4V};?BaLkqs08`z28d6H-1}au^EyeVS@88u3-z}oMD>o;lq8qZG69Nywysv2DESi?At_TqiHD2(@{lCrX9Za^uBFf6$ckc=f=@cD%4qEu+*)o z$fR1u-Xa)H6_13PJyd-jucA+I8x*SOGJkKj8fc(j?fY{o@wv~H5eov)TUBezZ#?AO zv3l?>IdgiA1JR58U6iZq`&3n07q$9ms)!O`#)%U)hCS^rPm!dmLugmjA6TSG|G(_uel zC{yOcnLeEPXSVqp^Kn#gz6r#B3~ z-{YQ3PJlI!p}PMnl}1g1RYZ#ibaDG8U}b-Mu?<$7Q$uM*1w|mY?5AsG`!m>H>KZQs zgThF0cp6W<<4ygR0RoJF_YG`ggDJ{`U>wb>t^GHmQ;Mq~m5ISfxf z5ZUBIKTXrW&nW}Gf7onWSd`51m`9l4NRcK2z>F}Ca!(BF7)$;|v-$90*KU2=x1PY6 zOA^fm0_7hNxaKj$TyoAvDTvZq6>tjW`0e>`|MvG|hB4&Gtd!JPmL(vrGdeG41*~e;%xOLz{{GA3F*@WS<{~0Y0w6O_^AK~+?GKJf@ywoW zCZ6Y{(o8nN7*MnGIU?lDg$yj^G;%@;A)8;`-!;xyGMbEQcZD*BVGKhAi2mizw(a_D z)7pxlvj~bdUak%}zU)Zo>ZdG)9zdgaPE&{q~hJr`@*X{lj( zHU482zz{)^B9(uZ&)UaA!d(Yk-H3wg-kvvCEe1rc-8`I_r|AiChzE%o4KyLA!`IW4 zVIVW?p#ddjl!34z3j-+h)-{HBj*N|Oecv^mv-gNo;RI+o{rbzW>uj8c_dD+pF{2;@ zw&`}MGro3$Q%($#f_fmy1%0cwS{2~y@Dzo&1D~oC;e9{gYK-YhG$h2tbe`g|G8oWZ6E~54wtp(yx^`NXZ_! z&EKnqQlu27ic>Bg;~N)cS^vD;a`DDPX;NT1OYa4pkc%7oOhkmGQZc9qC8TjU>^Ug{ zX9k$hjO%&PQ!+ynYk>wivfeagz}WBS+=Phz^GI5m%GVy?jrMIrfN3lXr6XAbB$%nS z5wTKEd%!iOGbYR^sfFs=&XYo(j?>{-6a%L*0}hxYl4!|{Fpcbi-0(Qf^WT{PW!ud| zcMst_Pk>CYleY%OGZTOuV+wr>z_c*hK4`#f-{0N&wrM->z)^BmU`Q!aOjjtx>TyiL zGv}o^v<6sG8V*li9*-v|m0^vk6QIg6O}eI&FsPmoEDW+u$+qos45I*muoOm3J5?GA zCB9f5C57Se_3?OucM?-bmbGSpkut|Qq%3Iej8;flfzuR1Oi@F-re=jW*Nid65Tj$G zNJ-)ZAT!UyfZdz~ z05vGR&k6ZigM}$GN+^OJ76^gEtU?nRIiy^D=r#*PtZf>fi=Hd-vq*GQTlw;Tpa5!CC~XNxW4l%;IUky z3l>}R8eDu;uITdjA{E^(dW{rcLBbn(^`=ws`eoO&@T)6tB<$Nck4#JW=cSxDDg=7A zR@V4GSu3Yr#9jeZwJz3&ioObBt+j&|MGv@=$+cxbFId^-C|pnOwL>BRGYCYs?Kb0a z=9tnPaxPE}HH0|CIaHF{fN4^0HZ~i8vo%iZk`b+IoaQ8PZa36!cU#vO^2{W05MVz3 z$G@d%)9v@;&zr`Ar_4MbK(4zFJGQD}0Gx8nqS94*#+d|1U1sYosQT*d>dJUApI86* z4U_4DRbGAeN^n&X`MMYCMlLQ7JCio(vWBv}>Qez&=>@BP%gTG}uL|piIBSq7S)|6b zNGZaylqJmy0Fl*zT+^Lup>oBST^0jWX~??luGC2C04&9WYed;)6f^*E0cS4IDA2}Q zjK6$JHk};!>!cbCd(O{?=yu^--~RYv`1I{CIDotbv_fQbw4?q1{xt!ZpMfYsC>aD8 zG+H31(6+t&AAkDz0s9l+a0nq%cl?+-hY|pIMSe$W$)CEvS7^FTV^N;re|lF!n4XVQ zLgZSAokQ5qn0I%>XkDjEALsD55$ONv<5s6IAHSv4Ik*f?DR`qAtDmuC3sApnw__Lu zO#ihdW82<0#(ComB+p?S3pp(@3=BYfQxhr1<5%)++j*;!BXGuHV<7hAGUY*+tv}_f9QVPfByB8 zY0C7>Xdmu#TG*iSw10|?wS1aG^X|vL{A3&JTn*ILQoz#~!t>!UOa>sG0|DmY=Xf}b zkI560lVHrW|Jz@`j^-gB0U(DoiQCvF#KTEIpC1>8x?})G`xYASJ&?!KX-I&!wgcxN z&inBBAme@W{mKi>rL9YQtWgVhi+f`xvd%b$p3ljZwYWX3K3WfK;EL6htq%Qs>C|McA5)OJ{Xe z0i1KpqKQ<6_BB;CoC!sMAt|G*B2}&LI_h?X^+*XsIA_iUy5>5Sf`LDk+U+kN!^^l?JdZyH^AMGabK>t=D@I0A0niyBnGC~E*sWqpyes#wm(Y^@Z#+;}B^U;25yy30!R zus%uOW_F;m&z}r1jHiHP(}fUT+`ao zAmuuEwX%n1T^-z90FzR5n`}JV)`G{tL&WU8C3f(D)}W>ZlH>x_bS=<$OG>GR400YZ zhMc52zKIh`G90`!j z;ka)(!*saFrVn6{8bo7J2{nqyJU zn2hRyyo$IJi0I{isHED2GbUAG(juHWCqNgZoZ>VD7bR=M2H7TWFp$NJm@I&3$g;rR z)b`~3Kq=)iM&)XIED?sw3e~ttu~kJES;sOlGZEz>7HP;4qt_;l!(k4of7tCD(Pq7-N)m-eLgp%%EW&jUnyGYC&5KwuMnJL^9?P7WxRh8jB0@~T z0bnRttCUvOS!WGFqzE{TkB{HjwuZQb)b5Z&2sQ0M<_S#R-~F$_MIvZgSn&YKXlqW9 z)J&YJ3Il*5q%=q7bR32;0O&Mig0+on?yU0OXuW{{XT$wGkXoaV>H1)mR$c)yje$rj zaGFzy1z;e925WWE04H%-65P%)e)8@1?!MnTlY8wOZw!%gr8q)5?T-MI(wdY8OAhmV znnRK&%nUM3-#bgBYB6c8N=frH9H!H^$3ueeTIURy=W!fahX20Xz3WVlQ+&ey>6kLC zS*?rKqwPG0kN{;=O;j;3xxgrGy|&QG2$4^Dh6Ra+HDt&*h02l9&H||3H9kIZ9Ohw~ zSq2WF0NS|5SzYQObG;Q8z3%4NC`(@TMUAYVt|NZgx&kd{KIymiomN0mMcty7Z??A` zYjuX-`0(sV@WWl_6=|nX3LDWm9zXrZr!dY?UioY+TxT@r zG|iI*r%)vExb<#xkkesw?e@XeaKajrtrw&mWv!(ys{p%9^lvF3=fS@?o#nz?eKj|z zQ*r&HDqU_$CEiTUB17xMT$8u!rB_RdIzdHu)+c^%1Du;$uC313?*Ox}KbAG$<;_Ha z`r^L@^Pa`pg=I;fe+Qhi^`#c1*L;@FmCZ#8446ctq>{L>Z*qXiXqpDpc8KHiY1AY2 zz4OG4+vI&N0m_l5elsJ-j2-CLr*iHNbans;A>;yN;S5+s#&<1-?0Et(J*vDTzqM8| zXX8aMCpeA93fH2=v}2AEIK?;va5Y1Eh%nmuyAL0I3O%$gq|kF8-KHU5t`blj13bYf z6Q`&PFr^_PYGaiLK#sigzA=ixS_AR)^y%LpQ`0v@0NMu*MwNh+P39O=1StHk)f=iC zisOnGQD?zfSgK-EYjOa9W|a9b1q$QwG)4d$n*syYHM={~n*3^pENtdj=Q_# zL#s;UF%SF0EGWnV4Op!$TA$}32w<(LTOb>lY{*#ejfeNFG;_)d78%*V?lg$J!7Ngs z+bnQhZ}f0T(;Nbe=sASMq^$AVjZ=6jewN+53cC8QC3s>Ld#ZXe-joofh=PVL^gYp0 z0~N}(Y`D>L)#a)6$uCVZRTRn_g0JQyV{yKh)u+EyUx6++hfz(ZUJ)VyYj}FWTgS~G zZm-X0z5q~{^Y{vItH+IKER`b!fTUWV)f6yuPGf>k7RHnc!%pqZ8Xn<^XTOVM8hCsC%)bv{<@^VQPnYn)$h(9yVRqVSL_W z^TGUNZDp5X(i+f8YapY>o$0mQ5O8Dfy%J%sTTPg$dJms#AY6W~UjDj~dYP3fF?4!*9dMAL!hdbvQN2-wD=K_#H+w4BJ zV3sPap|n7$Wz2INzCPy7JdMW)XqY}E27I&aI?{UK_(z>CDKKTxU{DZkB?^V=g>YasmY zWs6f~o%=VS>zgLH>QlXv7l`Bk%yyQb7d!q+?k(Xjf&$`~n-X}j8x)}Nvi8Elrltv` z6x3?v$@1kIlByJR5hGxrRA{NT)`8iUs zlpqJ24@T?Oy2inO&0v_;w>y=Fo{Dk?BFHe&9w6I}1w0#4|_f|oXW2VK4(xBv^@X#WXoeWCKFc=SH0}$sq z7)rYaLW}iVeJ44P`W3hR#W~nt)#yP=m?C#<2 zeXla108#{+YhIHSRhYx@?eArZAxXqKODyloj|s?{f7@bN2=q>$fk5DGBwi+5F4m5lpw@hJckoBr@Uq?2V74A8kiE9|hbtDQzT}Oz$Y?Z33 z)-QYA>dZpRcSt)Gsp zI>-5Ncsk4xjtnr)!))#NJn+yaAya0KQ-tlhuJMguyv2MPk;2FWOtbs>hx?5;MGO=X z=Quuw;px|JGi$@6f|d-Bwi+o|`_tN;IvB@a}3iGm9ZT(fSMf2vCV$u)=K z;&84wkJ6%)W-Y`e$7#QRJPq8~ged|6E@+wNRFrjQh$Hdv^gPZmjDlPMc^;F}hr@H2kN|SsmUi3JWNP|N>+RJlk|n4q2hK@^$ZCSt2GG{JACd+n4I#up zHV1?-9wT%M-!@*m&e4)`!psh~+dbU1+F0wMP$Y3ov*-;vKr0P0u5WyXLQZM67>}pJ zVIQN`7Swde{rkI(s|!|y3(u#gU%u`WlJB6qhaW!l&S)m>w)6YL9xN%QkgS0(Wa^fs zyQbarEysZ+%~OPGH?EmAO94b{0*qz^lL1o{K;)wFD1h7DzyIJ4QD#WV!U;+PS&L4h zm99kYIy;8iM(9jjBYS!|W>E?nUsGRS;fpxAP9Ig64ZW zb16M~8_V+I1gY`WFYwuyqG~OjcKe{qRi);fFL2b)ZcV{iC&90UgqqKA6x}EFT%B!k66+oYf0cWG-g>)`b`0(tAH#T(5ln}@4Kxs zx`vV6--fJUzh?iUENO*~X>>&S5%@rZrCKr+IpMngSelJHXUbxQDK5 zN`T*zb0SG33xl0Ehz#c_YcpZ%kotL?PH~)KLLA@{kmi{Q762pW(izuPPl~pZr^Dm7 z15EEBiLA>?0t#E3ngXV#ZCYy#G@)cpDM$J8`7om0{qs-v+dD&g^=;M(VgN-_I-Q;l zL(G8jeSg34_YL>|KkELpNs=VV62zVe%b|yvy7?86Sy|KFLo^o4@WWiq^pJyD@Ilqg&Ev?->h1v%go-LX%uH`lVdlq=A8YNr_jE#y*2T3j zGV)PD)NJA?vP}bJ9c8DWNU;v0^8s{mXQBBiTTe1~Y$uVYI4--JPX|FaFGYwI@>IrBmEL?DM31M+Pv+oS_Zi&2@Ko*HHgBOyxL6*44JDRW8fgrnE7Dh$H~; z#y}X_02UVY_U3vAiUXhM9NKDYL@;LCdhdY@V<%O}*L7RhR)fD_QmZwJe#>lorHfp6 z92#ZqZGB!7og`OL-GRo`;szjlWoAOHojCvIeI`3D62GW!2L7 zhRpD3^Ode};>G+s%$}$<*1sf#o6~tMuT1$ux2E8{st5`g1q@CssQ?DrAm=m<3{nTH zn`8kgpp}m&$csCifT9&pGN3?uUE_oZQsVgX_-VYpjpOk6GEbSu*1=n(HmS;%$UKh+ zY%#v{<6OB-x2Y=wXzQ^XW19LY<&3Snet)~GRYvAqiUD&9|N6`+#R#jc(T=nMfFuFa zF!4%vhpAoDcybxKu5NZsR#-aaXcWcJi&M+hlhO13B zHlebL=fRkS*w1s8QAq~!Jd0l+N*<+J%$`6rNt*W0J*q7N1Jj(?nHolEa+&~Rd}Yky z{Ny;zhjES{evOg3AOG~@)n<8k`sA;am9;2o8eaMdnBa_U@2}gcHA)j1W3(z?!WRPO z#~}nJe+6qV+`NUi5cd1HSwBetVCwFwtBf-x&%(2yswM!?##Xi{0wjkiO#Se*PxkK^ zZL725lz_UL0}%VZs4|SlapXj*X|B7?7Vz8F0)>IXDf9E;^T!VZI(vQhj=b|t<4Kb$ zg&gJ2Esi$lsqeduM|kOz-lDaxyZ!0D;m7pzA&+AO`Ay|{bqWlWAuwXeU;z1b@>{L0 zx~_H`J@T-AWURLeNTozW&9z6E@-`|Rop%*g*5WH(%jJvl$2fFvcd){r`Zvf2f9v@D zG~+rH08shrlGd(v|B>hPw~Q0?hTrA-ot0T|(M~wVsekKs08~3?7)yX~CfF@%Wr4ijiRDHx1O_lT z^CdMzt#r>nG!4HPXRGv^64L-y8lAcfA-@-uYbfxyVom-oxAK3&c(p+n$2{XFiw*rP z(ABgX|N99ls^Y1XWXd7k?In1B#77^d1(^aPW#vi0`P z3OEtCARBfHl2Z93g-WfQmgX7!- zu&N;)m4+8c$T`Mo;M8=B1L&-!#@42QRe~^@X1i4}CI#kr`1EujS8uLbZBT%vRYHb0 ziU|;Fc|Oiuf&qXK(ur@zF{KbQ7lD9{28ZD=!4cxjOhb$g8_k}`Is#ek%%WQ&g~M_G z)IY@iA)#~I-PO)7l^rW4#Xx2-3^42a?SxT#v5Z3v=YwqF!hi7PY+x> zU+GFKa88+=)nsyvlSbwuK@wm*+IG7IY-Nlp0u4?%rkBT0zdVRV-R$n+$a!y+f+j;o zPmPyB`_QB~jXuR`%0_LjyE?zWzpqnvDU9=!Ve6{Bn8=0*kdi~mrAiq~U6|aE0T7;1^*5vCl*v# zD=lxdrl4h&D_uw@>$-Az`lp*&AVo?BuM3z4kiz)<`QzgRGCP+`DMel@Ap}^urU(E_ zAfRx06EkQ5Bp>?c@rcaAoB5C%|Om6i79Z_Dy<+X8i^t>#GPaqLL6I$u8RYVFkq5iqx-TJ(=M9g zqRs$>V$f3G{|9frK227EUV1?){$gsM@7nn@1wcb7wMt2U%j^|EjKV@1f2DgYiAX83 zq+HdK<6FP_ZRV0HU-iEF))k#>{;PWEt4M@du7nF9Y9;k4&8Hixu*B3S0k{RtkOEN( zMG7;@l44S8x)FfT@*1D)`?y2eegap8QYlxsUVcP%vmtUfDmHU6>WHl*} zuqaR3Xwk|zXVzl%3J3*U2-etUvo#_0u`G26r)IHajFr&Op=4uY+_)u~)D}o}{r^QAQ=Xovyjj4Zp`t`5Vz*uh7)*4M@=t3qE0*%Ev zR)!_LeA#K;|&cnXciwSvI%Vty|M9 zaT9{d$99X9jb!7nL=_$4q5oyUGrT*pRc`}u2 zyKbZ0+9X$trXtYo{jN?4x=Q`P1i&+q?>gMH&M<&HN7Q=LUDZf)Uf){n4Q9?`5KU=9 z1dx-Ewry2eD=~&?972Zi3f@+YH#uuLCb!*ob)11vxCrKh@Nxl_7tu`|Tq@HF2fOU{3;3(SI^@@sPNyjUo`7{0gM#|4}b;IiQS z9NeqdkM-$4MwC8@_A7o(9IDGxJI$(Bj8jhc`|_MF2d#Tiiyrbq7%*$@L|ra=dXX!A z9cNtaa>#N^rHC*fCC{l4A!nXmKL7l&M^$TUXp!Jws`-ng9OXHHL0XeRvP6)=Cm(>8 z0s*Boc_I~FT%G4W4HGLi$2ahdmr3}lcyLGX?W5AcB%=-M<~)3_0_H+ zVS&UbCK-uPkeqW)Ar^?QDi0)>6o|%gF21UP1XS%^S2flG-q_l!lsP4MwHP~I)Cxp{ z7Re}ah&5lmNJ6OB z$9+;9FY83oR9F$6La6mk&?hO-wW#2fqr5zq^HX0`(HGtKbME#$NehEW%+lzRh1HoY zZZ5(*E-VEEtIiq4MXG&8ZlM;X<$|SKY&n%foGI{&)K%ei8%651u>G?7XDPlgDB7v; z_?W=+e0!%|<-E5hL$YZtIXsZpP1B&8#)*4pYPj3?cX!tyXN}Vukv<~8V0=!vHNatD zxER97RC(C?Una3}c80O?p@@i?lkFe>di`I2+-Rk>5(4n)6F`U$4-5wenwWv>tIQ!P zBwmDhV2Mn6{`tTE(+g?{|6lVA?+ql(LdIfIK-Od}*$P0N@;nQ)$98jl|89eRln4Nd z48aru)w`G<6TeKEK@LR6zHzWsWxUc$##fiJ2yH_9nm+Eg+aLe*u0dkA$XW2>X>ojb zOtu0J4?q9))8icd`viOQiZvd6%v5N;n;sZeE7$ypOJo{(EIC3 z36J|e+S`Ghr)mG`ss%u=A4(vmg0OI z>HUA3_aoc7#ml~K+m44ck5hMF6Hmh!b=$|LuIqMV9gY^+9TT+m75u&o4C{G3O-Hh~ zx1Bl6Dd%x|KD-3fH82?fx)Os_ZSSs}nL?Oyj#Gvn_toR4&7a=g-70Oq)q8Ex;8G|> zSh;nnIGKmjk5=|)IW0uyQW$C>qiMCcrsa!zVJt8}(Sldf9x3QWB5h#_tXad?_pZo_ z4O}t?)cTsgy@sUFgn9qVF9X`EyK6MHvxWe(cmsJn^wY0n z0jj2H8#5X52zlw$X|>WIr~;7hZpQh@fBn1r&b;Iy=z$)H7%jQj!(Eg8c{t3ntM9sg z0-haJ+eSMgz;9a~pC*E-YQ&0i$IhS0N0T@K2w17#Kr5n#BeQmj!D`tFxLtoeAqO~mA zO?>*{+Y)0Cc}!@!Lr7JqqEV#0@cVI4cfau-(GE3)l0y2!%+*ZiKj$!3Xl*c#)3z6 z%bnyjq5;Uk5+M>&7%6RaYMj;two6MZU{Of{PysMdRx|SDsY98If6rmv?4%3N+EU3) zm#OXhDB2`2K*oT1nv4o%T}^y=O6#R+0RTX%Fu9tUC1ive#@eOj z(Chjo9EPXoRD~8X0no~M=X}?gB`W;wvF)Y^9*-#l*>b|+Fpkj%CX=T$CFBf+`i2df z-EQj_ zzyKM~W}Irv<1mbm`-r;UHcQe2bOJxPa2Wd|cB;zNO$S2VZGE5_o34g%!Zc;T)nra} z1!O!YMjCXkU|kzfSJnVapF?M?H2`=rIPU zUrLJo2aSJo>DB4wS_~hR-~90(8|76qc=dq)y{W#xDeZJ(f#VIbwSZ#6tMtn91s7%( ziA($u5B)ekKS!Wywhg+iQ2zUA}Z2fwdy|GK~Ielv8sf#kRTm zk;idwT@D7|6i4D52pUFoWH=-^PZetrI@`VbyPLK`$y^v2&0U=5>~IhfNaSIN2r=ZM z$T;WfAKN6GstG{b0Y<};mJt~Gfgi&Dr$1F~?UdGF=Mw;)d9BNK+F09EIk9oG1Q0|N z6wzr?i$*?7#sgX;uj_#(hE&FGc6WV0jE8{~0PRuIaIBf8DZ~4vc@RWvqn$I>TJj}p zXln`KfGNhJt=EJF_W>2wrUt;F5c#I5Ntd)d696bodF+4w%SSZ37Sj+w4r0CTZdynB zJFDm_>?u;P*-d>Myyy|ll(rS7=ci$|RFui1%z_Abs+_-vX|CJKX`sX~kCWKus+GBA z*EXI2RZ!;P^M`+VU=raHV;Gyv9P&I*VMfiU@-a?_`JlV))*_J|7Q%rgU?1zcCLZ?v zapXkp)$L7Vbb%&OP+CKzgfR8}p8wnq?7B8pn{Lz8Lk22mIU>vPcuc0U+M1obCC)sj3w}x3@d8*yOK-a&Wf#Fi1{o|^3`EZNw_Z{Ahp0q3X3eucT_LF9^bnRDG<>5<*8Ai zh+ZKk{0)b=JWZ^Onco`%=(YcuKI5k+UqebB&-ZU(#&ZlQmzcFdoc0fo{j?9*G+npT zZCxA1l9<^!D$K*->0ycqt+?7&MuAhv3w1$s0YpO?aY(zq>tl4;^s}jonx+Kfyn?7I zbKof+hd6nFBV4;}TW1&TLRk2AyQ!ie6ChBga6bGp1dlf7B-e<8(hx*#+s(Bjh$bDU z{&CXn`~Upoy(BKmJF76vheMn*C{4q2tZQerUT8TAfQT-osHNRtIf=UIFYe?rH1MUi z<>fHvhJ%;OhSFLCX1Vig)2KIw@vA@9W1ZUl%6bm6R0oP?ElckxtyU#iEKO$>lorut zDfak-E|y-kFyH3Vm#)QYPy(zuIQ#*-SI$K>rwfwH>-`e`xXeg@m-{SSKt*Y#h_!34 zo6*EHr-E#FB5)`ijU=N?PL|oiIG?jYmN)`n0R!RyXDjCj*+&x?oR?OK z*4Wkd375lBdq-+*he%pM8_C5<-R}CK-~S6{Z2+q964KZwn-Zw0yj_S1OdztpCL(PW zV8~hI9@7}eH{#UdB`K{~ppBQ*c;&XcU27>VdJG1D6ww^^AO83M1+=XASGu&${qLkhwivS`z8 zHfU$2x^=2Z;V>N^KmYR3QwxBN~`>nR8oba*QRw zG_GlfshFxpE{KvDEcs}@NS<}j921lo`y1A@{e z4FLs)%G^JE`lU}1-febW=d5)GIn61TR1ESsJpKAGrHqKSF|GwmP6DW z)U{nd^pTit3z?wFYLqD25gQ;$$vJ3ZpsKIBT3cEkCBgc(Yv(9SqD285AOCqo=Vk@w z4Q9fEO8U+9owb+&nUBxMT;2Zk<9*9HCMcy$4%563{RHx%-}lY7t_>Jm&WQ^^lqy9u zL%wa(6v{$?yPz?BJywCzvdZb5KV2wBr;H%ujfr{n?k+9D+EY=Ml7^K>x3EY^Gy_Wr zMe1brv=pF-W~Esfta6!`N$PLTX00K*X!)YxQ0by^E(=mxmN%o|dv@=2-j+2wJ8@fq zf>Jc}QZn+kt^#XPb8WZsU1zQoR;&Jh&M5=1WCMUy(u!Xo8)T#$JV41340L5_b9Z}P zRk|nz&cem-;y4m9q-gIjkK+s%Su28aj_kV<*w&uC*ELp~&#vb*&tsbQ`|$3kcRNbM z%X6$#c9Do686cS2duK_MhGb^soRbw8GMda%ilJs}-e;;BCL04&)i4pUDAuC>S^=W3^Xv~}fdTDEfacDt$IXko!>?R>NCCY9`s*IH4L zIDG!gTuFUpkaGhEpk!#&&Gn8HdPa_YKltkX5BIH3d5#FaDbsZ54>Mr6;eLOJ`|HF? z%Ia7ZuvV*5xU7l06CQAWCTsMs%92_A-ttT!*1V=nUvImDK5MuZ`7$9)=YM_kZIF|) zYQgI0iC%;@)^6=D-#iK0G}>ec=8Xlyl)x-x zSBt&_v#T7}EvnPa%VZ`1KnNj!KKA!MPW!#H%EB5Kc?MuBZ`Y=->zJBg82W9Y^0Q+U zc9z~C)CwA8taBA<4+8l{Klk8)8;#bswOe?Pd|qid5|LeUU*Eb*;92XX2x8jR-3Bqs zJY&18ggMM5{`%kl*S{RlNcgqGsZ}`KrmYFzU;9o-Cjg`rB@eU3G!GToi$&Iw+g^2z zvyKX&$kI~sqD>Q2)wRx%7}myV5q>`GpFV$j7-%W^BV*gP@lI<1wn5Xt#W5yE-EDSP zU1JkfTZC{-0pxXF*(SEqQgxfQF@%ybuR7{da*ERw#(>y^Amh9~p6R&A9bSA=H~~-B?c=NMY=UQ0A?{^zoNpA4fnLa8Cig zm2a+wN*mwalyQiXU^TJ6Yws!~iF3Nuy0~4MW;Ipb5m2?;ZQCpjj{vQTa_#LQQmWqF zI;8*%pa1$P*Y1`xasXh7stiKi?RE+=1n_V;Lf^i-ZfO{YzK5ynWaF5ug{Zn)R z3KylnUJ+$6c>ngq?pf{STVKAGGnC(*XeZnF{Yku-y*CGc{qt|j@SV24G}bHkclqd& zhx0w0^L#{J?Vi$5Yw>E4lW|k3TxKs$$!dL})%N|@R1sW1&r~ zdk#5{Q{B=8z_B-a8w_&hIdMUVFlY!8F;^AOB}cdj4Nb%`2GKCKb}$xhsp}C4^P#ep z37O0M@_{FZaUAa)u__4>^9w+m+F5HP#u!6P8TnWnWtBDpwNTVDvJCrac)GdnoOQs- z4JxHb&S4rOYnur0-r34QBB-uh(=?ulWKmNq0^~Rh&XO})G6MwPY%5wA@vCrPo)k(P zpFcky8*65jATbj_iV*X3ocI6qzy6<(Qs;={B5sQmA;vii(efRjbDbev@;o1>IdkC% z<{X1*D+jLy(6)BIxvsm`J0d`9T4aTwJQPK0oPjo3E2EWgdVG5P_{;MQ>o@|0`ug^I z*LZ?=b(~2+Isi?{;IC6_Z1@yzQ;-nV1Llm;IwA%G!kkk`(2j?8 zNhVu&+w#eA;_3MDafmPmIfsHOR8%+D4dw1SS7!U}{SP%Ohi&sb!Z1n6Sro$<0w)ki zc?}4HQUD~AV4AsvB5)3yAPjQtZdarG@qOp@+SleAW9c05y|qDoGN$M4W{6ov%H^s}=aarLDpr9zmE4yJm*cWX+zj>646J3#`KajgQcgSKC z2t=d^VhpS5`7j-y`T@6hnwEDb3sHm0=@<_E3~h|ByRNphP+DR<^!*5W(Q^3f&!1md zS7a*Uz8`UWQyUMWMVL}_krVW5{GG}2{J_}~fp<0WSZpo=0=7i9+m8oo5TdKwx~bM^ zK?5N2^)9;T?lz4j%DMmL(*y%BO9-*#M5HZ5v~!lc)nJY>`1bm~rSd#Hf7}P^Hrp5` z?J%RCh=z&CYY0S<(kpjTw9wKy z-9X1B&qr1HN)Hpxea(mswf^%cwvPq1Ll#Q2*!w_3fiNT3=}CT zZkv|C(~JtS2Wf}}fgCYF(E{YQjn~8z&x_V(89c#|wIWbjS(8yDPfvJucYjWI765n= z_T$VlhcJwJ5C{mGtgR~sGvKz{$~sa2GZ%p{mpt~z8%Hf^8NujK@22#~Ng+;A zBu@SF$B#qS`A~aj$y8Y8ay&jg{pJ7je}0_3HjvqghGd=+X7W}8*~oVmA_cXG&CQ2? zoKKKFM-(RSYh=LKYU?()uC6K~1Ax@>?2E3*)>#<`wpv4JaN*d0{`}9M4$v(i8OCg` zZ|=Lc(%`Dz5i=T48o1ir{pqURRL;Ov%v3Tmv%@$=z-S9kx6Y8u#2}`sG5{+;I3><7 zjSYcX3LqgYir02(n392fzX&;j^;g0*@TFT1p$uRDGFbGi8cRW52VnwReXZ@O7H->35X zApIPgUvg$si*hd2aA<;*+{kNX3m>12jh1j$jGt+iP~-?Q^@w!PX`X7Sid9EbjC z!qQUc&IW=9xcjLX+D`LWG<}PYzm)zW2-l$rMIIGa^xA(h@rOc24m3e-7+BcPd=V)MH zA(q=S#tz9L&ZS=ze7reM$H%6-fq^n0g=rq(e2wiW@EBHRuOVkNQUE@XuHif>?J5Wu zMM|mby6HMHhapv{5On3N^2UI)QHBB-pvD_xBc~MR6c`vR!BABtf!2lqWZ@+IsQPTW zTCFOpEFv7nVHl^0nL}m(T9LCF0IH_(&T3kCF-#EQkfteEudT6(!Bo5J?)s{>$RKFN z;PEi!oTlgJhnGFa2&$XA>rLHiGNg*6@#Qc7+t0rq;jMAt$R0V)DPdxz>HA7R`dlC^ zV?WI^?7}Ez7LaS&mN~k>F)K&>uaXO5m&Eo^X*;+ice7e>2{D zvn_th+PxM6TtKPi#DXWF21sLmW8Z*L%aWV=ieBMsLYqG z^u9Tk@7EPeq%eyhO)pQ+fo{4@3gh%N=w@UL6F{n{qEI=FG7YgJL~84d|MJ_0Z)JbH zeR9itzB*QCuIQzk_l=Qp63AR=H|q>zEr3=8CZz%4RRs3SO1Ooib@uyyYw(HLgHuvc zy;cCCC@4S)or)9xgSF8vRKb6Hoby@?q!cRDxAmb)=Z30wT`O3bjLZqMCNh|9$kWDk z3D$XQVGtK%N!B%Rc`Y$GT~h%5Lb@}pSAeohzd{ClQ?*RaZT4I*>x*lA2FO`MR-3>X z#u@@RWDbjT?L0bXjp4To3J)Vv^?tru{)Hlmm89YM>5$%v0j}sW+3I3>VTholkRo7> zUA}PJrfX}b08s=5@cewJ=4t=w`FWl&9iZyF=DOas>jrr`e*WdtA$XFx^zEkGlF`tbzyT#3kIxKx=nbq*ttMQXVa!>e3qs1k;xsOjRn+)^wyUzK+W2S(QB)vWf|h{LZW|soU~!& zck2{S7b8G{6c!Oin)_crjeY_taEieM2Br}J!Fb~;gM>5#jv_TpV*v$c+_W`{(8g@jVdD~joW}{CtNVJl#SCpoS0cPCh|z(J{(|JA zt@lh#WvvDvhnIZ5dF9AU}`-Qx?RC~B4a zx+qAoho9=n{XCUa^ZP(#PlhZKG z$>8cw^*noP%+eMLz#_L!3R(&SilG4x$A{0q?E6VMi=2a{w!XUGRn8lv{bTO_ZdVa0 z``Z6zg`quI6%drxykuUA+3fm9_$~u`>tUSh>dM)Y4YV%fev0#^Gw**oic?yf${1CW z#Boe$+BwE30I0sXzq$5Xe_bAa{*>O|ZroMv2?)njhr{C-iXZ34hlfqm)py;lageOG zoDR(Y8r+}nQU=V+N8_93`rUn3iLqXi!`;sjf4SQ~JWtcS2h@IUJ5kDMB}%l`=0ClY__&{H5)sf+ zR4ys!G<^Cr?S8zj>c*QKUV3~Uc6H-P;OwW#)_2$Kw0}0fw%~Al>Qlt7`RNDKkJSHl z7MY!mTz-zT=YUx?DAf{Xv!?Mn! zWx8s}BESa?p>jt0<YE2}mturF|AbQAI7Xds;(_tcD9Fn=_B~WcLantDu_J3aYGf z-mgNZuf3%ge#_+=xLmuOs*QxzLZlUxFU0juS;AAQQ&&wh8%&S-7&$TL4CG8q0Ov3- z_lZ``6ar9E<^*U*m2-f#okPsld+n$-XnSfM$00EYOL;&XjZ$vW3k4vO#9haMk|L0< ztwT(c0J(5d z=YpUN$UEubK10a8+!v0#>faF|#m zYhg*E(QK~n?<=>qdYTQaQ;Ia<)TLy7mc&Xkou|JPfwFDu$S@%!w5YcCw;NBIDI-qf z@o7X;x2>7S3`0sQqclqnhd6~WNgTjN`ReBW{q3&u-f(M)HaCrJJdq$B4p-^%(}BUy z`{%vwud!{f+KNgt`}4 z*Y`vgF|j{TU2xiyoQ&J@dY#RL{&EAQWlc1^KBuA-ihf(gC+AJxm@BnZ7i%G`t}g(* zX-K0MnR&d)Aim

      iq8|oKxx>P1F`^{>F;G;l3{yfc9;abEJU&p~!f52o!4vkVW10cka{f6T-C!-iT#EDmba*>m4syxp@3=7Iqid_WEISx-BW!G%2B|@GK zW0|MUwv7QPm$P`k+lJJWwIFD1DZ_2A@9Q)`9s0m9P9QNNBujG$K+dq7Gm~}1h#Xr8+h4CiITND;J@Rg%=L66jD2k&&y71vnawo{y4M4#G1>V?g- z+MGg*vZ%%q*RPZFBrmGYlU}W|1x2m8G>gXLV!FR5q+MR-0;aOoUr6}^7W`rqfST*; zL@qw_99crj46}HKX=USUCrB31Mx$hCZPEmzMDtvsvE3GVL<3Vb#shAwD{xA2mdpeo zDVK98h1Xb`3&$uW)kXBskQI_)9n^2MQyBw^BZr-Ec_@s%?`D= z5UOwnEqq*UY}0jnYfiJH*}eZ^OByLbSXbMch%PEMgo=WK0nZ1K z3|F<^y?^)PZB0cI`1tto=OcGF-L@rHi6*CrphcK@ACI3O_I*r%tz371f4|%MqBvxK zSH0UhG77?B8hRa`e?D@Or+$c)rMmXckSW$t4$}}h0gRY3;M(flpa1^dRZYq;hk2S4 z867@<`0(`N1!p;>7*|^ zT5r0Mc(0vDoHB4sAxV}DgN#K0Lre-)Ol0cXS_5c+P~HHAZ<2anf)H3!#{~esrR#P1 zz;r1^p_HXZq{jNcZ~peH_&DEE+te0ydlf5}GZ6E190mq5ronit zOi?hZWDaqd!4j9#w1y1Wl%?0HF3PjlCL_&5bTu*q4CX)`G9wPtY@IFsDgx#(Z<^TW zgz3pU)7e@9$m9I->BGPkrt`gdE#T%f(`YJy3`}OuDISI~!;o`TwRIZ8b5(gdcajuI zDa|a93_y7pt$})Twd?$vShGzRj)|jt|L0wUK0yNDx~`>*N;GxymYCLD8Dpv6BU`n* zu4$4codCG*&wsu*oYR59*|@9PUd~d{Wi4`EJoQ)q5=sO0c8i<<_~xej(@*bqt)Y?< zPoMwtKYoGhHf`IQoQtx2@-I1joSq+E_A>z6wwt?m_jlXY%pB(6+iurTA&pWvj*}ig z|J*aD{t&<$w404{Yu+Ia)65PraRL-7eg9wn+n=u+mK4eyrb8d%xW}h|{ICypj>jD4 zI2S+}kc2R3>m7h<)0l_>oDEeT^O%IHsMUpk1`3P*=50H_SIX5_?=eo#{j*mY8Gu(FKtcvQ zN-%~Dkhz4_Xd7!mwsjz8_^N4-^K*~t#@X6Rvw?Ln0VR$7{%J%;1Zigl$`Ul^={S7O z1cWJ0K&^-fM7bW25VYu`P%8j2G>F`TGj;XlxFX&HD|}Fq@^}Zat0I` z?UbpuZM$u2yAXk>xY`><u1+itV#DracPBrByY_Ak@SO`k0O^4Py5 z)D9qTNNKI#lFUyk?gRxCCcv1cyXkuaWzw8CKm6w(Zd}aacpNiK?G2Tr7dT$CKApbO zV0C)XYa#{!EO{~-RO@PYecf#xa>{cWe);eJ_?ZomU(>`y&=BMtUY?)(ArqXv|Do<~ zy2cx=ONxP9TN~sE4N_Ef_EU-rKMBZG?XEgY%=_bbcsV5F$PJw4S$WmAuKn|W`P0^L zkQ9dgasMm>ikyU*ssU${j?|nR#DzdW4EfsoL*dgUJuSOmj>SW{Ob~~)RIzE zr}mk@Jx;CDAf>)s`wiEtGww$s3#E;C%w;_!<^AE zyFcA`6%_@L4tbb@HC1D+w=OmXXl*V-ABQN~#Spmw+0<9}_wRQNk}y?GTUSOASZS?F z{!Lh|;0?Ns<*|Rc#rJk`YQ(WhRlHsDzrB%Oxg95YbiJI#%9dG7o@n(w-)~`>ta@v& zft+$m%P9bQC3lr|dD5>?u3!!K6bhhDGt{hiV&wrXbyy2_y7ZhaP@r4l5*R-w8xwivKRQay1u)rjaCaWPy-_4 zFApD+#oR#t`6Wd50B3klOS9RfjagBEz`XJSSy+Lf$acfsSb>NKx_S50t~N3B56?ZL z-GEY%Y%IhqW%LC}0Ifj;(Ms?N#6hIYQP!~>iepNApe zZtw4|q2iEpp0sTn6X)Zn2xB&ftJ@Z>t9~zP)9On}lCq>dejn`nTQYz}ExvDAA1jt9 zbUnn$OZ@VdClX*zG<)P z)@fogZMQv)3CARoO;cCRrlIlqQ=ja$EkF(HpmpYOczQTQ;Q0kG*1C;%ZAc*}o(D&w zVODt%C|7x;qirXyR{B0TPRY7WOVGmep&zl)sNZ#!)2VQVq-^@Gp=Q%{wY5yhX#9AX zr~MqobScFQKw)!#|NebfDHLpsv845?M@C}#&0V~NJPYKjq!q0~(Z4^%6jn77b@Hix zM>tQfTP>zeaIX4ZEmb*B15x<>PD2+-^@9u9~C;8C-)6X+AsHz<}O|!sX z|K0Wdb-S$yc^dYQpMH5f!sIaKgoV^BU;#jytT!+PP__43lFZbscjA(qbtt}N~p1^t5{m?dO?zYYXX`Xna z3DYniGn+bP&VT`^scOH-4(_yG7UB#jD1y>&dW61_gI^O^7tcaz(Pa^3`J0n(-y0X4 z%r8RzKbWMuJiiqR__w9^zCB*^ZTghoJK^}Jh;BuTS04roj-rb|E3H&vk|m;B`?|lL zu#_UIsB{mb{sWdl{zMrrWNoaCmxr?$PEpf&ooND?-)= z9!N<*wy6Q*+nU_{ozDU-C4~`JhO@K{u(S^{uF@C=9ws=qx$ds6JeWya<+g3DdIp?3 z0?RCnaHy4UYHNtJw}h0(m#2>(`iDNLs=dCw_10Q)nlu^6Nfr>IVO-0^|N4|>maZ+#OoT$@nl3br zuP}G_RM|B3KmYQpo#t$&DKLs@x)#b3pjq;qnSt7qXjX;SUNO)Bc$%`kiqrxohrt7J zc%v%9;#zN$S%EgFV2z{ok~4M5IzKmK@q-;veCAv2F$oL6BO`iXtpIGx66 z{^y^6eUz%wCROI${Z(t?^z`dPpF#pmr76WMz~=pr@2?d);RmWCzB)k+~MJivtMlF>K>IvyZ?(*(hIb7 zv7yGfN`e$LeSw9&DG@t&ZTt3`cCL%&q6jQG=lS{b{-L+qLP+^^naCl8Fds2Z+>)Wj zS58L;!x@B}lC`!@+t%_h^DrkcIm>A3?WSoRnUpjc3)6(W2jyVu?)F`!%CR5z183dW zjxAuw5T`UB#%Zn`e2F5aZk9WglHzH%;Y8f%81g(>wxOii9-q^HamaC=LoS#kEEUj*V><;;4AFrU zX`Q)bKp7CA^+gPFfj*Wq*XZ(rkrs$5a;dR@S)X+INS2OISP?w^#kX$=ysshQdKv|y zmQ=)KL#J0J1?%rG3MVhKh)Br{+M<2#k<$W{ zGypNkb9ZZ|`;W?xX zQ?*^U-B?{j$ZD%BxXKv>Stv2hRn~yL)hKazdi?mYf0=TX>h0CL8d{Mu%gtMB z4GjRLOvT8XJQ*N^f>hhhrm|qso)i=ysXvebBOx8qPSx+<-(GDLoF}VSow~fD0jdO+ zB+z8Y>XZRiU>NILSG6tXt81;e#N)%`ev?C*hcua-D1#i6kY<4MqMvfTC>U~PSghnw zNikE~lFtz(j4cpeUJehDXPA1k-F8=-#w(zJ7I1-!2s&iw`tIEiT~`r-In7fNZM{R7 zK0gKWp(md9!|?q4_>7S2Ec*KPs`Yvb&%aFIG-tpV?IklzySu*H)ubhd!{e`?o?i}! zQp2OD8p0BZ7do$Y*7-`Mx@xyTW*%hfrxal{UUHhBF$~XfnvnezF-;>hG>ic_J>SfY zd|?B=n&;(9)r-H$p8erbUO}T%CVzQtR}-cMD2sP;a`Ml~z&ERlocD2(-TcPUz8T61 zu(bJ9i|VUh!S%~u7FqAW+4=t3zRLoGE<7EHso(FP2THo~TmYtp6T@6MO<1T_@>4X@dK)cl~zh|0d47~bvixlfBql; z+@tO8c9qkFBAgP-984G@8{gE9N}3P*>Cc)arH~6CQu6Y|(m_`n0uJ22it~|9fcuwr zZ9SAyyhMBQ=4GpDe5a@LDckRKeO&Ynha~WSCPQ zhtr!yYlv9XYopAv=r8Ek(n4Y?>atAYqJ8~(o<&$->J$K%iD7IKP+c1fn=HAe=B+ab z)8o_AAw$)hyZc?^Qq(~#hiRH)n2$Y^BSMOkwJ69;9F9YOD1b64XCPw+3(vhr;5lZ) zSW5yM02wKRJQ6q}#$>&M-2v`?lLF?FrztWO7$2O~3J_XSof=4zp&3wMk<6ti4OOK? zjN%RU84Qro=o+`#)U`K873+{v|LMbDANygNA+X-J9)Q+F%M9QQMFi1|!lG^6j7}q$ z02A2Nm7_IkP$*JB&MMC-N#H`eKmEg>u4_+F)*2113QFdjpbc3Kj%i3tt}(SK1tlAS zDynMO8X__f%;Tq@A12J4p?Nrh*}3{eP|V>t%rgiG9sq|BS=q(gDI&v!&AeVhoL)SS zFAv9$Ot6*N-QV2o8c(E6;9O83%yI7f3{%aJUltc1}U4Wu04H0(!e)X4^_VEO!qh8 zHw#6xoWixYE5!m?msiWX(o0{H9j75nT>&ktk~+PL<%|5@V!QwpEJes);hm>-@8pZ? zvsqoD0sXqiMa=AS4~yA5byhna?_$?WZe}^I0N^yg9HtOcvN42l1}RGdVcO>VVIJm; z`Iow_w*+e3%y0`Y+CX`yEv6CU%vpfcgS*<-ZKENqtyWsWXv;qU19at_Z)9E^GDd=} zH&tUaa*mQRgUFMM)gk8b*%*qEBQu=!SUn9^TnsEx?ECqhxe}%XMoC$dH>3j6&5|E>t4<3^20Y+<7vvDPi>uydTmxAXNJqUJk9_GifE}UTo~%4 zGBhcml$aUN%MJ*D6h70lwK7_txTz>I!Yq<&MFB+>Ive7}Y|{DMG5{?)WlrpFn!fM% z$N86swnCo8z59EhuAz)0-!}2^^y|l8pZdvEH|^j5-49(A=X^Zol2eEou|G_rZM$(e zmbo>SfN`4lFVD}TK>rkmBYOjaWAuFn;Pp*K-jg=4w?Bq)IxxsXLB_u4i8ET#`sN>u zvKWUj9b-bXbyH?)HkH$-E3s8~f6x=6Og*K@JL9AX3JkROj?j0_hbe_@e7$uy8*3WZ z7^{hp=fnPA|LK1`m}<&Ux&m0F2&^V+IcY6+Zo$Ys)p9(6@ZlOqTq zIp_B8!~a$%P7~nu5C50{+kd(8M9yeo5EO9<9G-ri>UVc!;o|V?$I;)sYo&rB#Y{x| z;&yW>!O-w%Fns=h|2)^-FS*?`RnMfGUA1j0N4ju0KK;v6XgWiDL<5BV{)I)ib>$G_ z973-C{_gO6oCcTFexmT$zw~>(soJjn^MCvC-4!$$&-C(a3E(h3|N6_rBdGCLcN;2_ z=6*OP)Rk$GU&j9F^V1}noFxo#D*u#B?OR_vy7|+cmoPv6`r#u?7JzdQt?S+H{ZDth z&|6L^amp_r{&|3Jls9H)Ks;cKDP+zJjH>dk0O{qWAVx01P=|O-xn`cBVXg61QC02n z>G|atyAnhPb$9i{Pk*}Kt-RavO5s}GjWzwUl5OPz@7GYIps+T$Ih(B2vb{w}$}1CO z{m=3uEpe2BLMbeTUQO8&4MCtxIpz4zn!N--nZ@#z3x>h#dGl({$|)7`7L3vWDTT6d z9RLN$vVyG4y2Y5D+Irv&9<4)BS+tVBEML$k>{J7~aABjFi%6NDKa7dV0zB@Y?2M}I zoI<|3zIp#&KR^BTv7i41fZJZ*-rfBC*j{Zm##RbPBC?kJcG?d^-%nE>=I878TUcwd zu)UYa4DwFbH}~%6nQT=#!Q8Y}#CFrRH-CE9)dtLo6O02k)ox4Smw)^)L}+K6=Y4!& zvw=3&5pscOO9ATlQg%_$4#oSf#TzkYZggZF73dsX|D3g)g%F8$B4x$ESB z;qyV?HaFgy<5S2~(KD>|o2u>1$dnHhydn$1tjTI<(yA2Z#aYh6O4F+qQ-Cg~nt?-0C^gZLxA?C zZEx?cYl9p<1I$PXdEZY{GByGHp=mc;XH|j3vG2!G06C<7jG-VgvH_N!>z07vwN*_G zKp6&r8Ka=0&F${$MnMyl*6^$$$N+Pv!Q^fB2Dh(HA}Ci^jmdL%-&ktqUj-nSiGbJL#s_7stHWQ`d1zkc}iJW%Jm zM)Md38jt(2*bEhboI=WRf)_;a6s8PgEotLg(m90`Qyd2Ypp7yJp!eImAMdXk!(l%p zCZ(&}zvB-K4`URNCz??Vh=_`eg@-C716}`V zj|>4L)elEK6}Y-_z@h;&Y@KxRJGp^^ra)!JBqnG>K1zNx)^<9v{H-a5yy z8i3#29Vdr4nkk4da7iawHX~n87lt7XhjB*cA`-rc`$66}005rn1L}q}A{PL@^>qJv zGJb0SpsL!NU9+Dp(#Xjg^q!2?0O=L9V|u&q|1e6`cj&g~@di>j{jpF$Lv zguJg_aNGD0$HRqRMk9`jC;8ez+UAMie4S<6A za2Q7b_%%+$lrk`9uKlKUO9wb)Xlv_w3vy*~$3qxrs@vP2x~@Cp!sMb=8Zj5NTmq+J z^ionzL{-zoX%0!j%`S3=R*Hy8ixC)uT60YbDItx~S=QDmBC8=1hW*Ef<5ZxiZd*Sc z&?kYWsuU&z;S{+j5V&v_rL^gI>f3~DUyVP{oBcPjZ+j)OoZ5r>E*g;C> zU`yu786Zymr?E387)^?t*pd{dsftW8B>)kQsO_%coBNwhMSxNwoZ`z7NW=4ofBp4X zny&7)YU;DeQ-2JoyXYp=%L=k|IhxaPm?M)0G?8;vOd*u<_&iOdp(_|wl>hs?Kizhf z%*Wxm1hj3VuKv!vBp4_|(0M3x2rLX3NU1m7t|jJ~hbdY_YR&hh4NkFubs{C&xf-yCO6#T8a9EK*n(W=H|_7$cXQ=2`Dm&rPa~ zF~)-c7}xFaPXO|qrLPXNjT20@sliM1>uRT%a-63mqGL=kWh^`mS{lG<=R6Q81LRQo zwzBZ`5-li#mSUW58o)LV&I0_*n3#B&L(Va>S`;jcKp6!^#@4lW$Sgo%J?x(z5<-kL zPjh6g0R;&KS}R+%TLQoZ2Mk#OY96OVrP(HQ*Ms&~m6ec;Za24`+sAS2scn57ymbv3 zvyuT&ka3EUSZORVp9a9EYBv2Yx^-s-GbunRZ^i!X`Rpa@RowPFqX1wLhEjw|8j#KR#M4vTq1(85K0FTa zvsXU9JUsVv_Kj-q{_}tSaZ4$LPyYuB6pSUBWU+uU$v@e)yLJ{pLYyT7M$6|Yp-AR} zS>W5d+NQ{LP8l%uO;Z`xs)m3O#!-yFdVjy$Y!<311TIITAe;t=5~mbxcYfy9)eUkE zOgYX}v&dR1BU}oyQrcFvA*>P~-n&wuh%|DZpB_Fw4l~31_O|vo%)TXK8fc|pAROmN zQk*J93P5akh+)X80F^U9DJ2siML5oBOrR0wsRInK^GHq0Xg8nva(bw|cuUu~QzqJbh|>;;&oPyh09Kf$8us(JdQ2M@yx z+s4>F+N-ViP1{?04NjbL3`yyzRTU}#ISk~-r~Nor;!xSvdENcP_1&(*EaB;46x{v* z?{D~OhKA@2fmkbOZ{NLdAT!M}1y~S3AWhnmy)woayYSI8G1hRfBxJazYb*2Z zwd7)~q%eJ^f}F%8zNEXnc`;tM{d#XJ(Q-}gLP3i@XZz1q?-gZ~H#SmUE1i~4Uv1v& zAB#NZ0@MDHMP}*sAOOBq*Yw3DXwjlB3xQYDEYJn2D4;;N5T^w~F?NNxIO1V^2@Q9x zwwgp6Qv=42ZPo(FF}!5w0U>f88!1Jywp$=u$TX*zG4nW2RFNWJ5t##EthE4y*VxV) z7-s-zt+j>*k#8E4n}(?JzHL4|5A#5rV$OMvsc>OBcR5j->NdIxB8*ZvzI^`p38=2D ziQ|+ClqLYo1scw+@ty=^#}05)ND0YUWqeyDU)3~lik3~?h5h`}Cv-QP#y9l_4oVY< zfg&gc7Jz8cYcIQn=$Hjqbhp0!Xw*0Ux*Qs!rIb~nNwl1>^R-Fw>sGJO^`ga7q@2hk zC)HSeO3*Bwl+&Nq2G`D19zf&s>(yakTvQ>vNUGuUp!fRvj73R^7XQ`0>t{F^`YGK%h}o#@2PpfTy72(PfSf%$OMfwPb*OHUJEBPEzWt zcUvtXx;P_M&9>`Ytbl|RGsfebU44CjbJbK@%F>*I*&38QPUC!x4=GmrVw?jkOA3#gLLY%~KdcC^<6&zH4?@TW<-O9q^U^Wrvh zj`lM-t(EKEhuyAj>&j|Xpb5bOu%Z!0PUza&U3Z(#D%)-=yYf16iu)uO$A^B3840eU za`^BVWe%*XiFu9|zJ(=J%{`{^h!|#7f-V9*PX>r1O#kuuB^p7s+itq8-MqiLYAg$e z&%g8$J!1pd>mC3vx(9%=frPVz=P9~|=-5ki1?&QO5T-uUgkb(JHN831Egn3zlP z7Hm^_@0F(CFb%KPXno(+g=P4j+54{LP^Uef%>w`}PPL9mkMiLrOV>6xHm&(~zaQ77o+H$H$26(@odSEi9h` z>>`4EiaNe%f3wg@)R{7bx8$fZXJnZWUw{AVo~=M0)S|e(x^S;e=w7E8F9ifeiqMHU zqqHnkmXkS=)8S5K^(PziX1-8?EEd$Bzx*5GJ#|w0Ty&+hD9tA)@r*^k`h|Lx8@q^Z zaXR8R4A^O_Zy)&ret9zr=T*|ID6&wtY^)k=LjZV+QwV^0CQv`XY`VMaUERIAX>~-J zh9nU%!XE#17v~t6Fh#c}-V*O;eJTRaf=X}GJkKaicYAxKArX0MquX3{t&ZA5BLf^+ z09#j;vu>$9DL{fNz9LA7|2q%Q=-f0qX8|o_Tr<~>Nx(CqukCbnDyxEFmXuj^O9E)m zMSwUuwmv2i(adp9Npb<;o9?#a5#v*}!A4beZNcCa4^ODCuwAQ+75Qqjy}<u=2J5sAE=UykA-$0wu*bOewh>d;8SX*6QYm9h|k!t-k=UicApZNpx4=Zg0D~ zC8eFW=5+>@i7}1>Q<+%-IUgP#KQdB;5tA6*X4^KpsomA~9w8h){o?%mm>`1Dr3{0B z-0z2+Gob6u`36vlpv$C5bT=@d-MOQQzR4xz-DIYE+``jM&|Eo3>HNGUshkRaZF}pi1J?rN)6)P+Fi+AX1bj1&;m92^Mat%uvwA+BVz_ zI%EVF*bK&6-%&s#DMjSg12ovfMV$d)#CXm%eLA$2jwM{^bGb&d%-dj@` zkn!bXY!B@!@ky#^Z?-!f;q28-S1*l!5px)a{y0rB9G@Q_W{4e~X^aL#Wh&sz1P;f; zFpZI48Xq+zXiY7p*rQt!!JWu^ywtjonHINuH$azDH<{oqA>18-fVv!LJ z!(cq9+8WYoO|h4p#$h^+qrkcuDOF~Be|6hd6#!%O#Znt1BPLjjT-9cL;!husQM43f z1His(yf?)DX1lq?96M*L>ew%Ey=~i80b}U<2>{?+x9v8SuL+66;puruDNM(Ju_@C6 zF2#iGTUf3*A!E)^+ncQw9{VXQmOq8emdUH__04~3eB)J4(?~S+ahbgWa^yVm98z{D z-_N+8xXfqFaf#S2Km5ixfANKpJN2y;oI8~hR^EX+W#!KNZWQPfa`ZKrRlfY9yuoA^ zulkQ_d7Sq97WMk>4_7k!#lBx-jy2vWoLJW8SzhGNSLrZL14rh$0G3M52r{P`zS4eIeQRV*WWti2D znx=M+NVG_ZA%n=Z-gt7ADLg&aqw;JFmpFXFc1~RbWg$tGloAYTr*g_hI332o03;yn zpO2wHpJaeU5M!KOWsOe)h_%)LU=I3#x!)g-hlD(YA(is7{fG|_FUP=uu~l1nt5I08 zS~*4flG?}wwZe#n*OJObo$M=`%ECp1KrJ0>;;a7vX$=yRd0Xr<+~tj0hJ zL<*#o(<`b0E$6z!*BzbklQRqY#MM4w^yeR~CF=z!=O2H0l8X}8QiovxjU4)yV2IN& zMZgF!t2rCn-M#ziYF8CwJaURT;yNDn(q6=ZT&g6_jEXAf!C*!<#ALpFmABA!q3A)$O(S4pOkHCn!K^&4-K>0*JV-a2&^neGu&cXlpdl zrX~&mjAndM)uQ+iSKL2uLp2q{S;f+l&%!yOV zf)+%qtpK)U(=`qp`j4@|LI6x$Ag0*v?x%OPZz?s%s#fqg5?Fu?O}^dG*td=MzYPYy zO8%`NrC!X|YMK5p-|j*UXGNIQ8&CW#sji&g!LI>GrOJZ8Xb8@7N~44ICf$ITA~8Ws>v9Ouk1${WcHlr$`>6i4QM zoU`bqix>(Qku)9;rsFm-GvMml5djQIbBb{eoCEhMvqqVE8it@e>g)IKZtr#77>K0v z^V2JFWeGzTBd8XuCA73m!MS_L#l63L3@0MiTZpe<(Wg93IdyX1zN^TtSu0YD!pZu* zR$BC$jb3a;DJ#}lPC2tBo_afB3$L?pZ3gjg2>sTsc}py(ExE^XwrZzqTNx(MP+CZ9pnyT8$fA>_FC9q9IWIH42rqpNb9#ArWLu}H@00OZ zNSLL$z54T?-(59^p^s(w@@#W|eb%?uu9ma1;LuCoNS+upyw)oEz= zxvs9d%GQ-pj-@QuAp~M1QpgT8BTsSm#;+AE3c|u74B>P%zJ339?-vz4XcRKGx|t{i z4ie1p!ayVr7quCsIJF;PStL=tG#EyzT33Bu5lU+ z&79`_^MK)h8Lb9LYb^p@HO|=DxT>n0$xH@mj>rD-d5i$Zn4*Dp&S;1f(Z&EdCm;>| zBLE)I!=|MY!2N%j`_mptk|bLcJ1U}!E$$X;X4clzb2nVvM-uP<{{sU2_DFzyAaSSX zPIp!17U5y;w&)_N{GjF@5t&)l)%OhnDo~Y~zL=Stsj7$^IdViZ@EE#1v}Oj^0vg*U zc<-ZD&N!o`@VPUE6l9bXLmUr}r(|2DK@L*}%wVizNh$acBX~VLy#KUBG}IaZ=!WZE z*BG6%AZJKTyt8%lAtA^r0{cDUxQyczsq0r?RMWI=-@?ZXSmmIg6l>Sd_^t)q{_UTC zyuz>W2y+AslQza_XDk;#pB^4QJ&jnOo=!;0Fp!hPurA3LESpaZ>>xb!I?t!4Pe|OT zf}Ga~rO7qdcWl45O^zEJ995;W6esYBmhJ&Ww&14 zd;o=V?WA7LX5q3?*EVMxMp-j)o3z08u%CUR=N6s9wQdfX&-4!{RWDIJt2X4#K%YUs z^WR_1Hpv;pXN{GO?C^J{*sCE@&rfQr>^PrZ=TdU{2ic+D9wp-}$?}|~{LM^$u29M| zQdIo-ILe^IG{sbVZ9&%3@NoO)de`WXks#5>V%{7jBWY*Mr;7w8fXIS1_z35$Ya3?K z``vJTWupV5)r})!t#uJ7l#*ogi|cYX34p92C84v-H*$KuZg>BucW;OGoDpS3svF`s zEdX+gadJQ&$K}5OKwgUT(TE0^jmZJXVd-Xu@+m{_yH+dLx2*=)WW2kzZL10OIial6 z1O$P5am$R+jdQBAdJ`2dIeNdIW{9mB4Yu8$0igQK8KnrqI-ly2T420qYqmm-FebEJ zlqxR`Xl^2;x-UeeP_+t*RI~w-MdEroRc51!7G9RvdPSBYVVRb7#^A@pI0i7_GyrJl z8pE0?2`=<11=9W)YvmN|UHrTp4y%XhThd9jO=A?`=P8<|E3KfE`n0Y)fNy^K@$FUm z{H;lw*V8Y5`#c8bb($tp1u#4Vkd#yLu$K~;o&gPrpT`Ld)uafdU>smvyW6|oIZKpv zuF7QFP_F9<6P7jQod0;#_Wu_{6;S?4JZ&?3U)@fHKT-wuyyE|Ts`!eWK~_@iV3M5? zmq`aO+hMPfqwGwHS^>cHITlwb7HK(-OLPJSQ5q}?5{!aH?)Jx34npgiHlv=F$D{5b znxI=CqzQy@>Y}Z(>&eM~%uk@W+>$NB<5(Q!Y7$Ae$)cS)q># zG9X~HCG*NzuNIpM44{yofAGfTBuEWt^En}MPCO8ooD%>-5fCG15oMTiE+MY*;n%}q ziGgJeM-bTt8F2dM&p+LER-oZ-#FQ+jZ2R>Zw`=(_|F@@9g_y~8Uv2QpQ1#pI<;twA`PN^t;9G7f& zZ~p1cy(vclcLWg9JRjF_mI%|vumBmp9iY0lQ9x&%$}vfn=p$eKi2j$Ujr!?*XIe%S zMOvW<3tK=zOFn)6cvvyq-R{<-d@t)X!w^AYmgVu+W46uD;W(o~2ti^T8g$o`!5RXv zl&DZk3U&Y8f5WHuC!hDjaLscV$5mXT?{CJ3B~f$#{q0Yf*RdqybW1TDPvdc+P8znu z_3c#yv~atQ)>EAP9C&~1oU96;{^c(pg?SC{KQFoXr_Q<^^?iJbN1vclT75y&v`$uu zA)$f0w;?XcGr%|Ex~3ia@9*3UWkgab8TsM={cnevDJMg^-4FM7H}>vLr%CY{(yui> zbe{2asc5Pyh%e1TdCv2_8s$Qu+kjAo&3Uh~67q~o0*X-UqwqyZ(<{2l7u*$672_(wSkph`cAO1G-ZtmE@AbWWlLqE<(Pwnk@ZwF>37V*pcSE$=}t!u2& zO$N$xd^|-Obg_ zmCNhXr^5)_q&QB2`%XX3EcRvqhHf^yJ3N&#FR;--ay&iG)HK7pKfk$dQkI-0WDqMN zw%V{_s-^yl)z%BQoW(Rt1_Nim=9LZ0P*6%0S_XIu1~cPmL% z8TKl@QG+<7ikg<3wLWJHONG)@m6tvz_i7eSJ-5LG0CiR~lNTAd=XbZ&Qnr|~PWKJi zJXda1Sr;K_C3{;BwaNzec zZ&h<*XB8!&)(c9mPD$|7DKB3C1PpbbMUV!&qmKqW6Xs zLBywZnMN;Yhnq0(?(eSp*3!A>2eEEk+u6n?2B}o*o|~3OoiuDi&e~S9urNEc;@HB^ z^BV7lo>w2taDD#sU%!)_HvRhz^E9vS?))fMJC= zPg737g|nnA)6fjs+c+oWLOt^r*Guv84LnJpey2m)-w zITuDzP%Mf}-PqFdbPSo>>o@zg#haNUyWPHF0dg3BIoNyi*@uuB5>t%B&@0_RLao42 zsxHA&vVi;Rx8akY(f0S(k|aa9W@x`Rm^{$$-rU|RAFkH|#U{?vQ^j+m>8`J@cP^=w zp*2FUvq<9Rc(Ac$sK5U2|GG9ivo7!5e2|F7Wk34_Xl-N-0d`O@H^a0X zP6=Amo7K48{^sVo#ZmxE!OtGkzy0f{1lLAU?Aqb}r#FLsyVrbPn3qB%MYY8B_4?fY zUCIlj>6JOUfR8U~f@|I1ix4X3SE(2E%uOkmbL8hEtMUx1UcOW5TJ);@_L&kv>Ny?B zil38(w9y-iqBDM@&bIdgm7a6|&p)ZAZ4{ttk9mbH*5t2kel>fw`iY6Nrp?6{pOBIy zFqy?STI-aR(MyU^RA->WVGgH5Kg1hChpzo_$jj{5X2H5fWh(cY39@?4ed~xy%Iopr z!!M(m!+wBW}mOMxc{{>u>JvZ?5k;UQUmXvoJ`X9v@fR-;pue+PyG( zmvlRXw0a*=6edZYpS)|#{%*J)Y)l~p?-M`-?QGLl2Dik5TGB^U&O3RXdS~b83lk=1 zQ4*>Z%jHt-Rsek6r2X||I?o^4G+Jr`Owpyv`~0BG*7UCmuT(dXV;Qb>Mv!=6qkI?4_xXFU%tQb zw=O^ZcQ~mRqgYDb5SHy36h*3(9Fw0OALfsvK(YWx3=srt;gEsawY-8cDM>~cC1hU$ zGUgn5b_VExH$!_`mWT$PH2}@fKBpKsuQ9Ye|6RESPYNbipW@j@rCh+E|gqciWWA1LQ->8&I${x^;v?}8Lk{1mZiWS>B zZC%?mTHB4gf&%0m!*rS=*cw;eWdJGp#RIl0TC{0&0TI|3ZLA?!AcX`bh+h%c1P&=7 zmn>Nu2Kpp^whj@&D?5#yj)Hk+wos&)4P|Xe{2VP{?|MfXg;m~E6PculU`-h!(1wUx zjlFed<-T`@QIaH}cxPo^=V|o-H~ns}VRM{4psQ8`0U1SN2=TNmAq&S40x~yZO*3=` z!3P1H?mBiW+XTQLs!nGF49IqkQ7O$Q=oF)X8M>qqYo`sGzkQxofr)FPQXnGBp|Z}2 zm2MD{q@o~6V#-j)I?;)&7=sMbGXRLpl!8r?oC?e1ypDf8K{sG>*)@HC_wLPLch3Nj zs*;%*MHso%#;w1#9KJEmk>NL9e_{3tRC%4E`CT0A#X@_2Enf`O-&e^cnXPSa^Z&6d)w{wdIz31i zp_K?YFVN7&vIe|ev(C{kZ7Kj*^GhFwnZLepS(;jk7M6J&pJr|W*z2q7U85B-%9&TI z1>o+6g&Vv4HHYmE#ZfHG(7e5W^ERcpt{zLe>45}<`IHd7^Jq-lbbH;|&N;)BNo~%) ztn>KzX-ux)x6d;##SkZH61p@uZQn9OL2F~JwI)Ivh*4LqL76a5VqsS$WsL$DXm-#k zB#{V&!p4|rET+ls6QGE-Xh0~Zh+tsuZ#NnTL`X4dQWDoBVOo)@teZB_*U|S;wM}aw zl4^ms2e3RY5in%0?gv$T7-Q42<1=oFu!4Iu?a*TZq`>a`u2Zbp z2FZE+c>Mh7^SGpl`xf2MYj}Tp0K<<0*JNNljGvL9?>>Kg3L%~OIEW)9Z;^D$0FZp# zm?e2x(|O_PCJ!7k0By8248+r{t?L-`^m%z)r>vVjjJ6|bb9;Yxf934+8hTN(aHd-S zZezaxnep$Q;P^*}0*Jm~d*XMvEWelQdzm)eK3A#sFYekVIZ0to^JzIo-I<`q&rPGN zhCbj-(^yZvV24dT^+!P3qJYZ$^t7>`{iOa`NA3lvhfA{uHYjRjm4?ll+STrn+ zq8kVR8^={ZU4MUj)oB7CAxtwMX(`GGa?wP98PGfD;6VKWt96L;sp7B#Wg7v2Fe)I; z$5Z8VVu9C<&Y+w7``hd5!DK%^d=}HbGdP)=ksD3wTW)vSbV7iv>lzCHA`Jkx+uwix z_NHQ4IUNt)Lmc~n?xxVTt38X1Q0=)_IVHbK2Pwb*tj?d>Dgs`0ms98Zi9gbs_K%L| z5bKX?Cy++Qww!By&&#P)GkA*6e+8=DBcIfz1q>~1*EXHeNFD*JMv74<-$UtFmX4rUNW}=Y)&QFz=E4R9h=gf; z`c#xSXshpbtu@S5v0(cFO`8IGn86+n0%1r7S^IhEvG+cuPmFEp+V9LZEF@tf6GO2L13d`aNk*2zXb$8*`;ix2!A zy5$$;SOA`trvJ|MZD)PXO8_9+LeNXk_TQ}X%lH;oZj1I_!ADZg5yZAn*G&qFvXlg3 zy-bH`jL6fH^;2WDAzsTiyDZ|Nn!+r3ngS=IQ}jIn;SH<2gjL_uq?-UWi|moKrsg3;r{;adg#iseE!>`>-IM;=*beiUL!@A zzU_C$04Yqt#|$E88|#!q(_X!Mcimf7MZBL5k8?n3F|FAhm2$A{%9R2RCWY%`FVb>DV3_gB3UKR-@wtNp_`F3_OecR%dY`~Pvu zqB7h4aBZD!EJe&G!04{)I@bV5G0CzSUa3--=M)MlKtTgZVurSju3@_*oAZ{C&uKlL zgaI)P^*d*39LQDq2W(u2Yy;YT#J0^301R8JGfCmg8)WtpgfNW7Nr+6jnda>*@j5?^~VI^6?yj${`ql{obgu^#LfVMj0EPU9(>0YY~?^YF+Mg9(XG!_?ioPkz&qU zw;%v#Q&Ts@&6oL&$nWCZeEHf}r+N|Z{k`dWo?1j_1hu@%$dytRVR245J~txKfP!Lv zMaX*TC4SSTdv2Fi51*fjU*EX2QWMwpi}~_^aR zD0%w%FMs_H*ET);G9_d;{P16XxR%@ec?8G~ceghUTg!;C+W~IRu6Iturxb&D0bn&! zlw5M=qF!|dE)tVZj;#S8SvDQq%`q;r25mJf+wENK!&A<8Rs-$e*hRFR!xf9Kk+u~8 zb{M+tbF5jJ3$-~yrpXT1uH!7po@YyCJ>-(&^y%{`F#UeNZyT2KZ|geQdByw%Y4cNMJWrkbsl2Q!9 zPVdm|ou(MQ&ndtPG$Hu$;h~oKnV9D+Fvb-?*AAYlq;-zTgk?eWa2ib3w!{h&mjDac zwrr`rWj=iT_~~gHCy&Za;ge}iw`&c<4Ys|vcR$_qT58adWkrX12?2-@A2OJY29P7N zz_c1E$tr8`rK-fHq+v3^0+kcw|2dx-7v$Gi$UgAfmD?J{n7qxh!h0V9EJ* zS;i2;2|xlg*k%L(Un8DMBh&1v<8doP8TS$3@A}3&>N9NU0jtH+xsh5B^Su^D_f@S zqQLcfY+DuA{|KOhB4y)X{nqDSzHll0dp#lOAAmGpUia$d>T6wV(_6vtlYE? zd0lf=i9UN-`u#EQR{64&MU{%Jzbw{P}Md+Fw=28|f?aRMM|GQ@~Z z6+e!Ppn)BBC=sRs;vrRxTS{8z`FIL!O9Ehp-68*Bwi@F2467qel5 zQ}SLZoe`aKSW1#DGA96e(vkffYRgQ+u4x*>R}6h~cM~Vb!lXf_R#<7kpB~4<2qGY7 zKo3J7mt_U|LF)#PQZhfccG)zEs_M|cS0e6Jy!h{Q&_8bWz8){u?uC%~+oCh&cY8U! zG~h3~@+O4>iD6C3Xk6#U0umhZ0-`Faom9#RWGj*qrC zF(yXzv%|?Ws%IG=T&;~OlEV7*@$oQuwC78ZFi%s4*5oPyT+~Kvlrc*L8r!h|5C(Lu zYGs#);Q?UVb?`HA*K)1;OL4*kpkWID4b1r`8n&jf7JeQ-e|kg%#MUa?;lt0xe1F8Ijo=d+H1#R?Pd!yGoVNb zXZn38ya-+QLCZ$mdIg$XK%L7nFZpF3-d9H|IhTqt)@;9$3-Zr^5Nq4)cU?kh+8v9a zNKsC6GYq|(lWvWb^>iHn^09StoIEi6r`uka6cZWU_q*Y$?~OwuB*oe`?(LN}T1l97 zOj70&4YWlPNil2zFC&9hMiKGLDG$2yBZ zykH+1gTw$|x1ZTsr^GK%DaWKNWfcVl8qTjG5o=`19uBTayp`4{$`bv2_-hjP#tpZ< zHk!{CxMN5%;1!j2VZ=F8)^Qv?gZsX#w^NJ6xM{OP{5qYcMO$$RItiHB6*8{xTN4BN zVc7SrH3TJbc{)s9G;1c!Op?O*VEJI_wOH1Q7ag*0l0ayyScx%C^294RU_XRLTyS+ zx|t($ZIo4FT9;L_X_00GUYQ%n0F)%z29)Rwml#WO06}T0^g$vUb9P3XDr(R+7y|6g z_1-rklQr2QLsobfD36~WPsaryGDHLmjU1L_+F=0q_pPf9me1uyrJ%+@d8@z6>L0dL z6)SzY#7K(N9jQh`=Q@RL={(a(zdg?Uwl7}XPWCca|E*oFoMG1d{Gm;>SG~N@--`FX zErd~2sowMpu4j7X>gVF)Iz=)KrRlhk?j#BCu8$`tYXl0o-*s;4zWW_{IDwI6jt(USf5rOWm7OnDT$Bcvkl=Uvx1_~Ya07_tD2UUxIBSP>v12%xoN!|Q1o zA14p*{bCz;y}tc8&5{z>jmJewnCCJ2!t4zC>!1GlP45^o&CBe0zc%SFA3r{MxW2!h zV*wGuXH328aFI>Px&WL(!cZ)~ZOXRFGJcKmm2c=3kRk%*OMy2~;hU5}B+LLqD18+l zogZus5b-kdEL#U;Qm@eP=c)5|Z0R%jpEC;N+#T-)lLVJ8Oy!l?+xqVj=oQep^=`h%N_x|jB)cOWS(Z;sJ4Un3)=QToNYPspVU8ngF&{^an zDSv#}w^(9kwC`FS<8+##+u`P>Z(Gxt3_!8w#x?uFFjZahCazV;#H1p=%~>|HuSgZB zA|(dzLpD})f@Z08=7a)}M%%dd1SAbGkW0Nu=d@0S1A<$9j0(=OR*($7>5$0~(i$o? zNW%aL5I`|ED^d;sB#2SFU|6AKhAO#8^2_M}a&5QooH6H}71St5LIi}ZMhtUoS+gIH za}u`3I2dRIcr2MrE&a$T#4vieU<;H++2G@*?Tt1D?J(?Hr&%dL=EE;zu=`dqGqZw( z<6n=)?4hlea(p@*BLhja&N4sFPff?%6}Vd5zwSun+UN3uGOrZ>??0Hr8cMIcp-F)m~j+qR^1(>A?z_!EPN-mEN-L4X8FB9E{QuhXZ; z;|c|v;mCr5ho2&L_xCB2-rx3?l_I6K1o}m&NCQfpTbcaBSm(FCkk5IUvH>+OM@4yl zFNpgB===vnLC@#k&Qv$T7hB$$=I|RwJXcA7fg^3#LND--6mdb&kRjgB(+VdXj}Ir^ z7B2~Ae>HjWYl6T|r(=5}Ym7=aA29uI?|yPk&nm}0%Nq8FWyF) zdW#U!5>rT-fQ<(!VOrK?0M|IDQBo$20!13fRRk7m4?c$vq>2bMGaD8W>RN>5)A(qI z>w*2#r!gW$z!-M@3azWh;ujz$C{`*>r}4B#L?2FVw(9DB_#`m`w2a3!2Jh!(O_^Mi zVt;e@=1p%I3+LnG3CD1i{`=uHtI8+S55+J@+G1q@dU-3Nu1FFCz$D9*f~2aoqP1@Nt2QlAd5udD1EX01D8gVE7p$xRvJWvO2VUkaowDN~J2z1k0Q)@tih7M3nO0hyLIU#`zV2}`V0=OUS zU^P-fzaRRpaYQI7gz52+I@c6XHMWvIJa#+oQd~r)DMDF7PARSHx-R(ibLV;}n-%5C zMp&{;tM`EGu1#DJgCv!>jn=ic7BS>paw#SGP^IXMH5M%GPs4uS>YPHbmNjce1~H(B zi{WsJewmjw6#+Y>7$O1Wd{u=q(KZWo;}mP3`%arB6|2|)iWt@)vT+6`o1UF&+oo@A zgCBcVjfGE(|Hxu3!ZO7%6X|t*Jk7}wK*lu<83_oY&2aw?Nu%94tzW9m=4XcEwx}~b z3+a~Uo#YQ#omcG5-y3Ihw$VHlGAO?^L$C5E=L@Ov+3R5JxqI~QH;z>obN<}+A%o5W z*yZ_iFV6j}zFE|EqH-YzUVd=~h;oLM6hk=8rB#ij(+R04Fq-{+h?pY`p+r9~NnnX~ z!>)Py1=sJ4Gb$TUH0#~!+Wnr}DkBbf=`)e-`{B`84&ESU)<#(?mo&Y|vcv$*)b^ca zpwt%91xRBSz;a_OZP6|jm2(CP*mkY8ti5PwKk^lv=?eO-;H~WSO9*FZOtETvQS(Dbye&05L2C^)$ zM!<}sC_@mnYZQ@yg}@n5`CM`Ea#o5VXXs_i@NZnA`Yz?9OA!z#8$<~yfe4w%8rKeQ z#-Bfh@vqZb^0uYKlf>}p2zkH9`%maN=IDm&KmF;4tN8FgehnH&0PDlLcqt0QC zXbL37QaFpG7?*ik7Ed90XZN@J1{pA18!a&BBJ21#o1aYIefTV3Zil|ppRDUTQ%ZU| zjHj|ZiXDdG=Jt9pX~|${Qcxt2L>XX|!(m19_-VoZ`p18MbECUqJpM&I@TS@8ol!;d z0@WCC@W2WKJf!QJ{l0B<@r4yibOstQjCjC->~OQ&x8Aw7Yisi!*X*vx;q!<2r#I^w zV*-%gPiqjkZrAO0Rh_8UoECt!ZJKt;uzP)_t>ZyY^W!p(tC;Wa-tORIGL3EaH~UTl zMdo=8fYyLtqmH%!z^Bi5yQ`t6DC;2W6HXasLWIF!(X+hfq3ossh`}WUw-TZ&e5|fhxm10~{=Kbxp{l5v& z4GE$VV!VJCUo7GCcjRn7%GvnU2JvcJN(`lI;sAi0yR&SKJBtD& zC)x@JH)TbIs+O{mCNCZ50U=degk@G6)T2~7)9W^ztDNhMm4bQ(M^(nQL1t8q(|UxQ zH_8ibs8*##f?1(lwx%LyT)!6W>6|MAktjhxNCxGr93!U!J%s1}4+0MV8oNN035jH3rjURxk`(ScCqThy3mxk_RTGjkaK2y(S(j_+>=W#5mdPzC70(tyB4m26lD}C&+TRFWZ?6xM#{?CYBvK{ zVz+akk9C$s(@wf2~pGOIX`O?DdZyH8lAmx_s+JK zOQ@ea6H!rwYYTTg2QT?0i1PQG&9eEIFJ4j`)_-oK`^E32T!_>r3q#K_CPstV?smiQ_IhU^fD}J3>$=QS0T9;^8Ze`? zyQ}NYWJ#g3tv){`Mmmn;DJ5!n*mW&p8k}>wc8tp<`jDwL>^P%{Lh{SJ&eOUU)$f`= z-C9Osonkbr@^KFI-kZB2?XTTL~v^vx2b7+!-5E=wr_|1-s!%v zR#7ocKj@s7A`uxP-its9sa?CfySpFu%o5^~L0#8TOew8xEC5Q*;7gmW-y7$OhnH*O zrSJMpwazb=&-R!K@RdsMmrLzzUbkG@w}DVnYHN%3^?M3Xgsh4xwd#j}Z+-4^Z7*aD zUtY&0OQc?efCWH4x1f<~86^Wk3MmRuB#aOkjr}pq1wc;GFCk^atdULt<{nxBFv!a^ zdl9V^DHhX$obzTch}t6npO^k%kb@AfFwkCuO?QWB&5@Fy1jK%hfNA>uo7>xAZ#5DT zDJ`t+?uMJTe|vv@Z4IRuDt<}E5f^6DE!WDaB4n4r22Gg}y?|g9L%_A!F~l`wFfM6l zHI=x|a{x8N{ngGkP)u&OA09nx1Rqvc){p>dlBM0d+nq&Przt&sUO%5!2n2AZ@2n+= zX_0dx2GLUeR&9X19yR(_F?20xsNHkE+_Epv?EGxcsfF#Ox*P!jnV#p|7lg*wLEHA| z2?SClWqP(#-xwFR>E-+C`FM(QA>?wtxJ&Z!?9pxCy@YYw_-0Q)14#DZOUGypRABv* zq0aOwI#t!_%k(KX6TcTNrK3llIlA{IoW!8wyHpZOGH5u$t5O9OolX|BrXDOw5rvX zH6OZV8boRvr9~s!4xGf0GR|t}Y=cGpV+Ct=5DhQF1&UPxEn{ zJly`>)&J5W#XN^pVi0IETz6@HLq%}&)0@62|L5`3hhI~MRSrHTpfQ3w)waE(3?Eh) zZo0eO;5utHxHS84z4J?%V+JUQl$5>BnrP#Ygf+8=Ql^beC`|$VuPk$xtN!tnCh8U9?9!0#O0$(eZ};9iHv^5WBX=Z z7UfqJd~`m|?=c7^=ltTPNfrsIKmn36NXOOtn4m1(_>35M1^he2vQSpM1t?k=C{XP5pPgu71gB$q|ek0+bnk*xy}U zcdcglq)35H@9+O3sOxTSZ+fdskahCVR&(1cVr2#U$eMvJtg#nh9XSwSp>%y_EPxoe z-f-(pe0!~P4)fz88tv`%e%~;d72EyIhl#1g`CwJE_$;tcZF~Dq*Nw`4c^c!>%=3{Ri80v9&bIW}tM@4v!bR8;Qp)+JF@pfzh&nw2 zYr+%(UD>;DMB$9Xwx<>b=?B%S}SQ9=ck!(Qxh3{zJ7ze z*REZc&k|v7-`rofCALt_T7dcFP_h`}iXm1bOR!Bl+*}P^+pw)w1Psnm{CM~+&Gt!W2h6yZ!+5t|m-I*o+DC~5VJ=@33I?b@5TFva+InmwhbC!_8dVCmV zFnh&RAW7nScp4uM(=627e*f-Ax6Y^I9FVebBRAi_+d&3sg`4l*G*)(p9&;>c%)la1 zM38aaw1c%em3W8%(6)E`R$Hq9an1Fcw~uA=3qTYDP;!FG?z?w?`VVghgP3wmk^m54 z&G2#>f|PttQvH@@$@8mK)Ba`9^YzHT{pOjKU0(IxJSQq%Za(MyTRHPtO4U&;iZ{jk z=WE&w@v}w!`n1@TGzmaauU7l{&2vcuy}S$bI>g-gAlt4YC|SB|o&?UC z)h~00#Kw|{JkBw6?B{IT!R-flBw3H|+iV&XDTwp*c$ivEte`Y8i;G1yQN%Auqm1$C z19n)Z6(a*(Xu+CqHL`qKv8DvpSfXaT`@vlg`_@{80#<}#T`%7Q&Ry@i&T`2z{qh;c z*lxJh+z@NyZk164iED{j(y76;FdEctlegfb9frM$>Sn#)vBYV78dqa(-rU^uR)JWt zX|IL}NPc8OH-{C}nEq zdx&R45P&Q|3QHtX5FesHEdr2M%s|8f?3;_rEu1CAtzB;1{+|}^5IIT#Y3H0bo1$m& zvV8bF*?`+9P>P`n3oC%NY1j283(UUnEnlG3XBv-!<;{aIY|*sCe%KGKv#fcWRg%Io zeg632Gy*X7o7!s4T7w|Vv`ik7{4DS&wN#;Tp6xON!6)dZ)g^Fj8yuHP9bjl;)~qP_ z=w2Y%WSN_$tBYiVxRq{`V=kv;n#Sehr;joES=e3=d-x7{etMkH2&lOku5b6v-8D)| zabBi)dKiBh!}*6NdGX`5Q3NID6n8-m$Is)KwSgVpz8zY4PgWC9qWA0R>3H(dHMj5H?o~nx1!z@)qwoIdU8kU9Qj8fW zB`Z~XTK^^l`0qZ->wmlu3EswUSImDcR8`sI&o=5+xvjf^OHU(%tlv+}vP%KPFP+2RL9&5ozki zX%2}QL}1Yg5HJ_%Cx%RG99dcumy8wQ0RU@t?Mm=?oJvek4JLsZhTd6gwN?zpN+~Ed zU24yf5pgQ>!@v9-$@VvI#c0wX4r9wv3VI1IZdS9uyS?dkX_wUYh{x&S z(**AC-`w`Csi`Q_?T0aW#1p%=ddFtCe|vL#+qEp~>BFb&r|~!i6wN*Nu4x@0{&e!o zS`xsLAt8nW5EJ4UPSBQXjtpObk+rJt%gJzlbX2?1<^KtQqxR|x^j{?az zkNo1&6y>UYyHO|eGe*80shrRI@&K2=y-MB5`uLZp{tfo^-_`Dw+F-AS!p|Lysyn$Q ztzWFE%$3#on@;MM6WH?elxt8*n;bwz--L51U?Kp;WHYQ?XZuDUQL&8r%UcEjd$p7Q z(@%GAJ1fiM`0*D%10kcu{axECf6R@gat?~&CsLFph+j`3LK|ZprIa)h(C>t6Mgf^p zNKr(Ucy1uJ09Z{j?cNeWv1V;_K#XBE@o@Mw^}|(&Msz84+aO}m#<@MC0Ln5+Tx6Y> z6+jZ7v;sP!TxX!}0tB}2JJ%SiSpm6%tdf@L>GS)~r)Lf}n3;7Al24x>KZe%fcr=Kq z+G*1$T_7<}A0r$L(6mM)0~(lN ztkJ9$wsbWLa`eY>@fo1z=K8ANwP+$Vk&+abasK$PPk)^lcQ;mgk}PRGd|sw`1&nE& zv$KS05!JEP+=%_|r<;x;fjijR5?H&o>xKJn=n~4LO^9h_AP}JKFeP)bTZWvqu8T{p-$3y>0s+N)`NT-xEPYj-;YTwi0kJ}j`94~?gF z4gyG=dDgd-7XdxRlFEb#^levFT`E<_)UA&> zrhvJ?Smf-N!_#9TyMozKa;jt^WwnMXsQ@BYvzT7?GcO*=2@80*xx2gBJDqz;+RE|a z<6qxH_wBBCh6zO}DC63p4<%#-zZd{$&F=2I+pAqerT8Uea5EvS;KuOKHhp8^#XlU@ zkdg(hY`B)mgUPiPf(e@+FS)J4!EfMlF#G;_<`(=kqlb5tzW`^5qgth$H_b8@lKKh&WpaO$=C)%1t4{?`nw7JL8O&FP z>3@CG^`4}xl$az$iOccn)90r#8$iHI6BMXI?h07PfBiY!-&sj8DGRb; zWatF2Li8O(N+Ggr44R>M*BRajxm4FMB^X28JKH$NP@S`!DWgDg4(AxHEWaKDc6*tA zc|V7ow8q5LwmY-3L@_OJ_1(Mc>sD)>Wj&1_pAKUl#}GkX2f%hi#{>rA!s}|SR^X~o z1VN6c<7v)XE9ZVjXz z`h8;%Ex1(JvgC}`_S`vZk(Sj*Nm!*9*6?9HuDb7c!_H`ERtidKQT-bSA90KV+YMLg zfhN=5?yV+(3d1!5NeU$b+G*bR{72Gy&#MKOtod&(mP?_*x4)mCIb+*6XA`P(TCLt@ z2dixB*$kdF`7T$o{VfxUx`;=Ab#bruD)p^TT;AFKcJ`WIzl;~`762vZEFuz^H6v%) zl1^MQ5a#$~Zg|cBB&Muw+wXIUlQnv8ouoH|_U&OVYEEG!EaNKB48)W->`raoFQh3+ zfEk~1TqlBUpqaI@MiVi(y^c|smb9Ip&mBmzDo}6A_)SjLYZ=Vm$6e{0p)d0JE6atSz-dq7z!RCM*lvMV)L z`HG2FtJpU&>+St5t*LL@@I294g_+Pv}RNa;evXsT0^5{g7W&&N3c zq!Fc4hA9`xsgTpw&DmP3bIwu(3PpnV>oKJmkEdl?3IG8|Z%J}4W!o~>r}yZtbxq#K zOo%oJ10p4dAStF8*s=ynGoa|M)jDZreXc;sB5VzJ?XK$$fxD(w)Jl>Rml%>12(UgL zMrrn#9}lyz)@?tuO~30Kb7a5{8h3ARZ#&1JupU3Y|M_VQ7#BeAh`9mmu1~m62MK$&dL!C z@n9eX7_d@?S;3M(SffY?(-KV&I0n*bK2A{pj};tb4Kb+Q-Mb&&Ty>^4bu6S9?S039 zHscI?^TUtxo{hWu?#bRAuJQJ zZF^Qg^ES0X6BZfMay_(r%O;;614BV6&HMTAAty#4#S+=x{q)`5RT4&)lYjc#zkM1l z2^d9UM#5LjFDL@^XF% zpsJMPCI+2BDC$dkKY>xc=(eB=kiVQ@8Q2u>^mceKOr5!T^Yv8u!ce}%NpUglF)TB> zU2C@a@%Qt4e|S{wrq_Yt>rntm5s`99sh3L+c}F>DCBcU%73XYsO=AJKyScj=nw?`H zMnBKX;mUxFzJB}TbxV01XGFmsC^1Zjah+#D6(K4!HJh|%IAk~md{|qNm;?aD^QkKD z1U^DyT%w&8Zy+&AmK*|@fzIhJTi4mM>~JnQ0SuPf5KNIqVVyM_AjM@8v<3liP0mGf z5x|LS9?v|afLc0#T<7JlfjR^cAgzGPJQ=5Jy+1Mm)&QV(=bZVf=M`M6>Uq z&D*WZACm}>(=t8${K?*T`@u27JiBylSX<2+Xv7FGVH|4Z#X7A6&p-%C2ueFigp&OH zu$&fD#3#(-<5PrIFXlL1-TlY^^!RZ^BWp14Yo9;i4(I?D+gACEaB@K?J zFwRSeFmBiO_W9_!oDDdmC*7=h;T22Kn$X*!>$KJYBH(%fczn=J6G>Pbw{M)ahHD~J zatd)?Jp&Mtk~36u>u%NpRsJ7`<@8~9cYC{UDRDm6fHBY-+xzZRwqhhixVyKvJDqca zVu=W!e*SRq2m%yuRY5uj9mJ%Awp}}bLIY#1(X1=$?<%|A%csX?1psTTF$IVojRAMV z_y6>EXR;S)XRR(4H+Mf{{m}9)bxv6zzkV?J>zJy#rmEh&&As{uAPwO8Bn1%gm(@1U z{&u3J}MzQ2*oGG!EzR5m^DlJmI*GeJ`(l(p^pwJMow*9?w;rrTd#?;C?6 zl9Ci)bxi|j+MAo!Qpo-R#UvV`OK;aHYjtpST?kY(0N`%zoX2tG!mQVIfql0?Y> z5@4W_5CB2U^BQ7AmLS=$YXl6SHFw!@Ycwkcia?N*1}PTODQZ?4V8PlHr!@e<5}={F zwIytfKn>FcfDzWpbP-vP$J6|8YrorQCILX9Ca#F30~+Y+nq}5NbN%PL zyB(A18k3!|((V)5&RVNb$~--Oc>j6KL~Ck{>92>@(TSaH6a%6=-I!Wj8BrK0;^)K1 zc}63E;hTL!ki-NQB#CjF50CHO4L4T?;c;9ZY~N~Q8YdbS5FiM;Ry)ko_&7e<8J)Z9 zR6(nl3yMTPeO%(4r~y#o{CGGe)j9*)Sa4v@yXL1KzrVkBe2%g*mCTOzDNN&WjqTm{ z-zRyB-TimBU2n8zvw6!XDFh#l?%UoP5;96v>e}Dk9?ntP?~Bg=X1MpFrr@WVh?EED^AcQ7MGrn2h`LavaA=mXnKUon{a~Z4UF(7}>z=+RiFKvdXz2 zXFvenN~V-MUPXiA5sdA+zH^Nxq7b3DNy#TI(zghiiCu49>ujZ*CzKRJn3qn{CgsS+ z==M4RkiX5RF+QFmvog@a5U$-$2~4^vT{w#rB;|J9u7e1KH5IJ$>ExqH03-w@Bqe7^ z1~&^UGJW4VAg-dF)`p=96gNdRtzYgxPniH1c19;oF}Ul5wtw@dA8-2-)|ja=+7v-M zbhMm44P#@#v_b6WEjeHQUZ0t|Jl$G#aIr5+ih41Rz8)_vf}m99Xpt(_`CE-ZwyF3V z6``;42l=HtR{P%OZ9U4inraKA7qR0D->;sD6u_Jm?@j;aX2<9JUM`ZV({cWC#qlcj zRe(Z;E-%*)RJG)Mu331lldb2=wacC;5N*(De!-q4MGyfbr}BK6wWv=!Vz$Vj?)rxx z?wk*>w>LLE69Fap@xy=r>xY97G4;dMux|=Eis3l;aNPx%S z3;>yaJ>KaQi$D{@ViVKTI|95%oLRi9H(GM`K7?^$D65~*IY*e_cQCefuJU8D zz3G4YX`iRQALG14(-I>Y0Ei-9W@6UXu#rMK6Kh+$gqAb0fh)4dZ#o89Z474x$+8|F zAAAo$Vixe>gg4Y!6PIa6!@IX{hQYG72L0Rr%e$jylz41PU?8m1G6$alSnGB-ckgby zhDU(OXw3{o&KgZ9iLwMAmuX%n&p*Cf4l5cvXxCaz60=AO%XB!TH{JI?+}|{qLymEJ zG-$aS9zPxyfEgkyuy0(T*{_0v9Olmk;H<4mKCV9Tz@vW}11zsNg`~CK_5C9Nwmn0J zH^bX~qibK$nmA)dW+E=8|8V%{|NQ-3(e~a9Z~LZcm>>eGxfuZJ+U@pTa}j%}Q~<8g z(`);8hB5H$3qB9^D&tXQziQn>jwj)9-^Q?)!K$~`S=D)m1ko4wl8dYFlDRUTaTZAzJ7C~ zYFHM_R!+>f62i~%xElP-S3M&MHE;G3j)%v?xE$Gj#^eAf*1gPO&0bdS2GS@ZTelxT zP$UvF8P-m8^B$5LvRFaQ&6}ZV2sVQ>T_4hiUyl%m<>Bt?>Ru5;E@c=cj_-dS5dxSk zGbz%pHl_}L-hcY^ej2+w*-EAWuFMezjNsNWWQq`&-OxF$YWMh@*W=TnG#UNvr@>+F7~mvLWFwOcGUODNlm87NAj)~Ro^hq5k$b9LU9#rvZ5 zV!jA4e?_Azs4{6($sC#Ja*Lm{!3C%ZLXvaPuAUhdpo{Fx#SObG28D~ZWc?ABssTD< z^*Nz^x6j;ONbMS>HoD4Hu1Mk1JuF|YeIvSG47AdyYw^-W7Rbn#7J|g3cGIJ*>HLH0 zJIIQ`QXnNkipsQ=Orl86lCoq$uaoBMAO88rH!3XRhT9#B7)bHQhrj;ym&2@`YuWDh zed7w6){ci5RA)^N>*J^QXaN&!!@x?$7x94Ldnf>D9I-mdAZ{#-Ejp)6rm=S>=Wv2w zQb_JB!YW~%mnB$$Qvy=-4oDH&umY8AkUa!UqzoXcC@_po{JPS1xmNZa&K z+9CiVNf5mc!DuQ4%%rvE+Tx`?6Ee-PP&B~cAfk+6MI{&SpB_H`>i-)_iP49I)7zGtrMb;F!$PrPoE>2rpFjH^nSQ80k-YBZf9J7OU@y&CKi){|g>TDyaVV3xinGiW%5?p>34ubN?S=5+#753zf1|sEE`HD+K_; z3QDPrQa1I%v!_(AqI}cWFHof#zVp(q7IITWGncPJ)mD5&C|LvrvVQ*8|NV!=nhk0A z1k_p{jwlHqrjwmAN?FX;0CMHr@Z^| zryG?fEk&S9^g>PsYKFi4+piBl_uXD9CDK%*Q=UPB4S~p)C$;@wYDcY%OOtj2N=7M4 zL9rxkt=(Tv2f0j1;xmcyIUp>XP6)Cfm(1H~%jF{(wYfpsFxXtAPSx7b9htJ`+SR9C zFK<{aJ!hHgd$RFaa;Xp{DS$%C&RxCCU{}{Qm%5677u0|0_vP|J1DA3E=-D03xn7|n z#Z?NXl5iBMl1q^++W`ttDFfByQW9C`brlV#+uQqnub7;;u2GUgQ6M#-sU@>z25U8&%l*ZuroE5U|sRWoDybb*%)TKe-pYj&*N$8 z7N4XP#gvMO!hG^NN5Brln;-7?0xAG8iXuuyqMug}(%kL))>*AIDayGZ_k_t|TK<9` zZ?k$4+SYg~rR3*%U6V#T?0BPga0LX6j#gRC7OrU=q+}=qodbY~lnl}lYoN;Hh(I}g ze(QF)|ioO8n+RQc8n{%RndmF>ImPFEHJ6!FGv= zPiohjW#jB&nrwjIPLu$0S&`F2Q1S7(hW)h$Y`q*L9tef6vQv54}baj zF{1fye^V!e7v!i@S*GLoFdvuL?b|m^+d9^0cEZbJ@spJpJn{l)!+=5SoFUup0Lw^# z_)!TM48_a>zt$Zm#c1;Cqp||~cBkF0X`G`Ra}s!F-n6pRrb>{xDar-YbQ(x$E^=fr zS!bC{R0<_S8EuW$L|;}76_nbH>mRmve{gI&!Eczq-{OgW$;bSyA!o6U-^)~faqize z@aw%KClq8>$RY_ysbnDfHOAV@`FudKO+VZRtODCPtF;1H!<4L>uD|sk{}pA)GAF@J zue9y*x&W&Pz{pJ_P8YLnyMA4h-uG9mbo0hde*PfqdK_0Dt$|WHN=ot5K{Pwpx5Mq5 z`@2RicZ`q$N%OKU+;G3!4|`{|*)U@%Y+Pfol%GXk0~c0%M)iUv`FWYvfTa7oz5QyB zS8e00QJu4P0}l-sN-3rA6KoJ=|6dL5flZ`w6P{ohYTq%cLp;QcBJO;vB*} zP5~Oazxn?5W@rsmfz>E}9aUI9zW@BVs{OvG0&w3s1FdZt?v7)Q?~nU^gH`XS+iPRA z29S=>6(IuybG;Zn0#GiZ1CVNCp&}kYk_fN?lJ{}d64qGt-b-W?pg~PnIu?`+<~C|F28)O?RHj$7~PB-{W1Y}4qHOlKOc8H$0z%xu%V;&AX7?)L3+oCAnpjnyJp1K2sv z1yEKqGl5hkZ)I7JAAbJZQ^9Uny=c}aK}sny!u0U;;eRYE_@{OlcG_7@y4hvYk0AkV zd0K+6?X_T9y=&VpbnPC+xC8*+PpK6EMbau^S*CeiMFN-R$mfho;e*h$t3-PN zykF;WT9ei0?z_RMbI?M>qygouWuvrlRYkwv#mXX;h`cVr^3XX((vY+~9UguOQikvt zW22%+YrEa9HCn?Ohk|f=`1D!8uvL^WX+pTYEcz9uW`FZttx!JzN-KJJD9{}Z1}5!Dhj3Iid&BE zWq`ZY@0~e51StAlSy^DC)|`Rj$^up8+%6?wzOHKPgJ)UN^3rrtE~+Svy!AcK$Z6)x%wgFB$zi{5v@xnk zUiSiQ4lN|b34nGBB1|g`6ciDi0F)=qki4uuL=$uHt0^(0biQX15`=BvwJ)}Zya;Jh zC5u>)xLO9Tm|cd_lC;a(16sMd9y1|V1?&g|2$1LT+izL`eb402*>gKIG4h|LV2-apW9gpP$*TPD5GRZ1`3PH zMG7PX+Ciqy0uH&TI!hE=bbwZbiOuFWfn;lIuPjj3*-yu#iy6kYxrK;HKo~*TuUYn{ zaySTief(g3w|4}+%g9|CA4Ywg=Gi8li4njo}MSQ|fv}wE)n*I@3a;wBwfGWr(RWwc&%9PJQjjo0qvZdM-=r?)D&o9e`l&vUN z=rnH)we$1cD$jPVHY}`uPgST+8PjTVs&dP-2$j<40b8 z{q=LeuDNORLxj1#z3Pm$hFHSn=J`>A9b2WLwb4#HB&4FHUMjOrAy3N+ZanLR5ECS} zsw9C11fL_5PH|o*;keFYuag81G<_&g0E?_c*I&1dsqMD_AODHU?e|R@Q_kEw)sPhanV1`5==6Urc z11Y6{i%r*Fy}iF`O-9P4qIMZMiU6dz5>G+7h{WKh@#Epsqn;*j73*BW^6>ES!x$Kn zSVIFP%LzIu0Hj*hhM6+THd9GMF^hybc%VbfFd_o6Sx`A>(8vH0Fhhkdi?PDAl>+QoP5?A2GEYX+n;{8X{^=SFp*-5QZ^w6C{|SUzH&Hy`r9ub9>afq zr&+^~?>{|;7z1oKJhfK0?anz!rpQ_{t4((IYx_YL+wyYB{5>m}OU~!G?xo7gbM4ZW z{eK3_Yp7Q)1k7{VMU{)MvE?&L?KgWC&Q;&Kny)$K&ud*huW3Rhuf4R(l}PXk;jJ1& z<%P0hsf(~=$pFZ-gMuFw0G&~)L@|q2Z0be3=Yu6-4P+?lTnS-b=E=(=_P0(F5-%$R zG9mk}2sdDZEX7(2gfK780&Ez#y1jiLr*YhMh7F*#%2C=D!``s>{y4bI;96Uj3rb00 zT?DZ0?)J^DYnf0=CXukr>nJI?VY1y#Cs7d#P$b4};pO9a9M=T9ySsUF+d9sd2wO2T zfsu1G0@gMFr6zkS9y&;P`s=H!-a0NP2d6-`3#w_T6yfI?v6Y(^)Y{E&nUO8|R=%=}8;$8zp6ombS)tm2 zmoI*66hOBAB(J_sxsYr`i3{6h%k=&6#?9x5Pf_NVMG>_j;N_p2e=Y^`50$Y0A>>!o zvk}d5xy@THOqE>JR%r)9PX0I^C$M#JEd$V2lcW$lr{lw+i&+3|`nH(?9^SsWcG|jn zObak%2?yI)*tlVpewlp%pd4#PK$s#(nic?ZoH?oHa;;BCV=M<>#e%}@D-YCK+hzd9 z1_8S3E2oUs%$4zs;6tn#<h@rqJInBq1kB4zVO8l_v zx&~oAe)!v`Coo%p3itLd)aHodbd1Ad-| zYZ%wIoo(1MWIetA<!J6AKyWD){KAsbP^z;3Cm;~+qe6@1B%ku#tQQn=~_j(f-qm=KJ|C}BdPOm-9Vs1 zFke*Ap5OjIn1mtlc`y9E@kRFXRqL16wOUYkMvMwxBty4PantmGUo`-GRuy0vFtf^e zInDK(86YH_@nhX&8{6PRl-uGOmc;I6jbT2n2s0Je2x#l?(q2pFTMnm|0nJKx!?gzd zyv)XcwbHI_b7$I4v-dto$7PSpPAyr&8UQVBxVyRP-Ifj#@ylsCO^Q`_9j1Qg3ZSaW znqPAkiBZb&cv?K*-oAVH-QMUg7$EfoA@l`Q=?yOpjN}x+?e1o1G=k#gIIZZqKAd7o z;sk)+r^S!QIY8#5as2S}_;)jtnQ{l-K3B%qa`lY8V|LYh0l+t{U+v0kFEqxm$=2P!{Y^ z79g+l+J1~BECqGGGL4fQBu;%Xf~vZ zaIShaDJH;(wN^ zD~?wn;yn>pQM8Z}*gzq82V!Q49uRKYp*K{jrcqW(D*w2yYQHSUDH^^Ru5XP_q5P&L(_U4a$ewiO`w!BBkiJKcqV#Y44fHJWWKlww4g3QI@%+l+#jpJRA-Q&CT7P_q$$!>OIp6q!ft2i-U%a46PvyEg~YS zO2Y(B)bwwLZ9|+n9u9|Wu-2XVrr8Xe7UA*3Z%+$5Yn{jA=g*71+jrhtO9U1n6xN`I zdImZAYKCc1rAk3PKj!Oq)JqY(K(hs?X+N#bXv2%%3FrR9*9ZEJ9g#~9y_Z9;RL)iN zOGKWt2EW_6Q|r2{o$mys3Q1*ImMi01L) zC7+(|zhsZ$FfR))da*#1-jvhnaZZvMUc(rr0S*xwy6NWxWFY%mvPhf(ZM`SJv7L|+ zQzlOEr5%8nV6BU2HeE|>$dV$k0%?RVzxD*QoHJEg_&~!NRzdI5MSKj zx`}WG*)4H~a3W!V6WTw%z3D7qjMbu{QIG-A;4mE?AC|+M<|P8qVu$_Re(RJZjaBAU zubAc>z!t0xTdj0`L}4!QK^Y)T%QD;X@!_{mPiX_&I_<3kijQPB!)@O-TC0TBFywSJ zWGql};mp)T0LUF64CW+&qptN4$x5L>z>nAdrN#93(_nE625Oy1pNps(ybujL5C={ibc43W3wZ=Z6EVndg)^ z!ez?Y4)1<`|7PoaSNWa_TA+!b$Y>2{T{Q^vcshLg`1llx9FKxcia0GxAa5;l;oO9I zj%|-5dPml^T#xk3w+4#Ra!$ah3*d-EPHv2d4Zv1li{FlETv+MgbGau%J{lC1OGJuk`KzY)D_SPemm9KpL z=qmxEF3|6c^7o=FbvAo1Upogt*DpRF@a543FN#su^mS21%d;+ZDQDmD>f-f@07W`RN{d=P>M+J!J=l&4uIxGdES7cSRtQd+E2tz9^TC-l8 z8A9~A@wx&eh3Rx)E0(}aA!HFtqL9Xf7+9g}VaYW}%WRvjZ=GR53a9&zze(4-CW2E^ zh=c*qay&i;FasWBl?kXzyNI)EHAU(Q6ah>b9=>ZWA(WV`AWP6-V(Xifh(Mi0c5UlT zc0{BVbRjW@r%w-ylf@>q!!}(%OHJUEVOD`qXoC!ZU%;Kz2^J|)z!};mzzu!l2_QpI zHTS~|!;ES8NQ)FRABz=>W-DjNyzFgmWxdA~@N{eqp`>uFky+RRQsZy`{>t;rsRqdchofok)2l zV1H$%{&AtiGpp|Jsdc^>)$CnbGo1S(J)iR%U*szr`JBrCnlV$?Go;oC8KqUFs^(bZRSS5^nIbdGaz_zy3C1>o{fP6xnWWZ;zZ7XCaWLS43Lr)jQMb+K$O{=Irta zzco<>sNAjdWqsp4S06q5SZ5~ki`MBc*jUe#y~vqNb$P2QYuc~80PxpCLslH&?^&mE zM%^nFW+jX9>s-76lrj#Xte*n(i-mZ-lV3E|GqeU+p|U9|QXwek9!ymK4k?#rlv1?= z3j+wE2@1lJmGMS{(;VT#U;g7G_szd*x8LnM!%3k1_6M{1bj+PMXy3ce=MR7V^{+Q? z{`7ONpiPeB)5l-`^6O!4|9A9#$dMNYKL5f1h-g^E-~8dGM>re<`q%*0&DP$z$2m0{ zpdFe9yc}bht!;>)iuFkt2&!pPf!n$*r-aV$=%#bcrXkWbS4Y_KXlc`0iqXaUmP8wG zGKdt4D8F;#7*ykYh_)dRnWaWJ)+*n1jnj)pTzXhec>klBjB$0yLY$4wo$~0XIg}$!^5v%j%9v44F6lVTf)$IqZ2dj>~Q~hifIYH zy?H<27ytmA4z2#V_Z#x|P@p1cRx9@2B{OgC*9_9i-avpPL z4)fv5{m1{?;}S7-dFbE11?+bJZnNFEUov@XgO=P%c75mZrxvqa{L0=eqn<1FH$b-6M;m!Sb@XjO~it1!q~ z+@!RCO1WgxYNT0k4mZoHCiP-5E0lVL*BghbT|uDCxlmaEDXJ!)E?WHb&D};7z48c3 z!E*=gb$6xnY3skK=nfDzP3n1k{P5`k9i?PyTG-W{liD}w=7|PR8p=DH3#!Zr$erU@ zl&H0{Ekg>ILe!n6j9;eUiL_mJYvrUM-hUZ(-f40DyM9dfhtF?*eB1Ap6w}xgasVIx z`s=9qqk(S-9EuPDd3pT!>xXeR@F+7|>l-aOEaP!R?>;;?uh8dJC=aE9Od^cn61pzVJOoU{l)(6ap_F}_%U)3DjJmH>&< z@$uIY5BrV&;kdYFGjs@F_}7nr{d@|_MxH;%!(q;P{-tmGAjsaL%#m8hq;;*y0s#zT z>*g*}<$s_Iy|4t&KRTdPR?D@qyO18076{g^>6QFK3YOPuKci5%RDQ}T0H$z7d@2B) z(_p%w2((hyu2oi~H4202*&se&$(f3C@s?f_F$?6Om*4*N!vV<}+L9ZB zHhqX%!Sw?hlM2<=2J?K#GYl#spB)IJRit-0dBk zu%(!I0mz2gx-KFN!<(Vsb{@I0)0|B;%F1{yO9pZxeh$uGuYw9^H!qYv>BFhmyJZm=4Kjc7s1aX!sc z6rdq4AxtsFssUx0fu?U7XB2_>SvV-i#nn8wrbVG6tewjoDcVpv3J)9%`#^N^JADHfQ) z`l=VJz~B@YCO@Qpx9tos(_sN|h|2*8h>v4h5OZCP$SgUHPhURWe||XT1gkr@|I<$e z%6X?HB_J;un{Ifk5aEOkP~viUjE*$8WI&N_+qNI}yUr-d0R!o(qA8q!+W%PBO+7BB z<1|ml3Q{4z;)&a3IGsSW2m10R*$yEFS=YVPriv!U0$dyBUS)YtvlU|bACP4 znHBT(duoAG?M@~I8mZLYPZnBb8F_@cWhg}^a{-7|^^0vQt|2YZa6f&vf$Wu13gL1eWDwY9te zoD~cJN+E>&>?b7EDEj;uP<8^1~iU$*ROD3rbW+l8O?(hex-EAEGSUFTia*5zMS!IhVZzi-Z@ z7Z;}hMc;16{(8K;rmL?|@ZM zb{nf?kuOi@@)AmhK_nVYx4qd9CSySFojt^aG~5^lK-MhayiDWcVG2xd3E&hmU`>Yh0GKu# zZ`UUFb#~Wtq{q((AfS#)cFWqDN+XfNT%^F=S?O;# zCg;P$T8&^8Zh!ckmeaV5VHQy(1?!+}yKSp-nO^s+-?=s~sX%%4`m1p%Nf4|X)=R(h z<&IK=*7EJExW;u>TeyDy@6}jco7n5h#5JAy>bh&M^>155S<9HN80ZC}pcTQAjx$dO z)^li;(%_VosY-`2X34IhlCa)3ITvr$ZDtkxtM#G~L!=Zqj^j8|Lr9)fnV|||oaV6P zWdyR(4tL8Olg-l!O>cxWB+rL0AAb4plq{UxMPEciD^lQmJe)>Y+jiabx9A8H7i~F3SQ;+6qJIwG}QxCaV+8%fTcYU?4_`hf+$P67sg~6dS0%zq#ogf-E0DoIZZ| zFfWY!!JDQ#e%sC}$Zf{}x&hnQprx740 zsZ5C-c*!sZD2Wvn#A8YG@#+5l^I;y7D5tvjKmGVda!f@8yoi=yhHcZz2gZ0rjAlrhPLE$k96x`0%%<6G zeS7zA?-35C<4&gI;menYQ-l?cDLP|^ZR^%zDD{0N_SfTU|9KVaRc8Xo`s%u{>h!v> zMK8&M>mlo6T)oa$*5?I+bz$GEoV)L(9@R5D?aU3(s|>|uv%FMCosaZf19r8Z>o!*N zjL%z`=mOC~BnE`#!2TEtkwytq(xjatm12kmif2_6WoT06oa(8b-B~ieR9$eb$XVng z;xRMAIP{+C&COw+!^|_7x2|#RU6@W2$CKf9YXzzx9uB|!^2_H#HVJ&QIB!4tk{S{rqo564hu05;U7p4wZg_E{Jlau&`p zgjm?vX73<4e#&Tk*OC@t4mpLo!H@Fr@UGWT#t7hGotDgC1_zvU{E#!OKtdRewi?1Y ziRCztL)$>pJC*5~Hc~{F+7Mx#LND^ZMQWYpYs2#QgfL45`Cd3Yl8Y39mMfyBT8psi zWUhYViztq3HQ?Fk37|^F4_<@*SCi~pbGJO7=$k`IIg?P=8*!F^RQk%M{zF|htu9rK z`g~PNv{KNbzmWn}1)%dM)_Rv07s(~hPZ17w7j;{-QBVr#APs+63@xkbf>&33=< zok1Sw!_&iu-|nZJfnr-!jgaaJ*2d({^xMAIq)i`tZ=E|}0chJ9G=1M_M?`BVn&%AT zHU^$cEu}k4TuO@2Xl{1BH{ZLt#F6dcxPS3tn3oBC0bogMRiq~Nft(U7wF68gy(DKa zx7hCQ`mP1lr46bX_32?@?!4_Tr*_#Q!M^RcZhdO&exLwwcsQPvHzqyA1ZSP0TB%JY z`?f{zFd@ce{(M*pd^7Ct_I=~MQN+l;1J>Ea3=I)UX*qUa3e&^=iI?fL0O)r&KKOPw zS=;*C!6>V=CY^r@#t*%>1ZY8y%RGlH@Lp>&2IHp>51_rtGZv%-sG^)|J3?W~IWHk| zSf&^yhnU4t|Nf^x>^-vMoKUbp3TzKx`o;Ftd*T%CKm7LbhzyO>A))o#;mw=v?a+IV zG=BR0@bTTxz5@Xqma?$Wrqmt)JWYo$pW=3j5oq4M-|aTTO>Ypl^Y|k#)5E|1g+o=b z5vZZx-}K&SRiH@yeyevie!qgJtl5H>B$Iz`=&OH!_lf_>@%!(CLbc@@ATbt*X_{+} z8F?I&_TE@6OU`+obIyHJW1;I~oTqsKgjoQs;b6cPNA+2M0hFU7J)& zK>USTdt=h^w}%7(5_PDUJsEqB8aRX{prmP%?PeW#u?)KeN*A@(XzfVa_zwL z@}%nG`dl$rzWMQMnBi;+uZRAYbM?=RTHahP2HpTw!3t~1@b~Se!j&YMI-9o(f{Y@h zpdiFrpWCjlx^OGfvPz}tA{ysb2GB){6wYw{#_G*Rl{iZpk@Rdh4V`N=ks{0qQ`dlr zY`Yu0)hRE>OfsHM;{qsWRns{{8#D~8B_a!u^WIqnSoY2sV=NqoyM1r9Ydz(vHJVb$ zVLnW-1DTFQor}pWa=lRuYCG?Yu4N^wQ(lUsRS?23kV59{UfwiqtH%^m5jLrgTyV>InIMY}(p%Qf8Q1s?*&yzINg~Z*Aw>8$f#3Y$hj%wyXRX!BL#zQ878XW8fff#NoB|P2JU*Qs zC@sguG_0EbChz7X+BVKQfGW`bXAn%|Eg;|+=jk|)0c4C<1v!r&9@!3Wx_ok<=duL& z#@l}TZmT3!{j#b~L|SK%al3av|KUvw7{jiJAT0v2TGBEehVJIZ>oh(6`rF@rOPUs& zrrB8EynXlPrrGw^=(J1^e|tjQ-mdOxS;na-E^s6$F~`WDwjXA~{-^i5e%tjeAsXLm ziPIi&nUR5Pf%f+8@V0A6K~?_w@6evVtdVntP&s3s7dp(}A1|Kl)#=U~!#UD>-Mr{K z$6dMRe<$FpB?=d*LFlz+;oOB=UA~W8WiRW&ulJ;ts3Xud7jR+J3IQNvy(LD@iHj-< z;W+1Q;~L8$q;!86?%utl&RXJ&gMS7zl!icZj9H)+8<2KwJ3J^^?oXfFrg!aK*tGegaG0WxuvMvXxl}+{P%+E9b zTVd4&eU$G^{E|%(jTJH%eaY{snno{L{tig`EJ;=`MPp49)|JeqoW)>P;&KIh&r7#r z&Kg?NTGw#-K1I0LA?DN$JuhKWe)>dpj7DvpIi2QiyX13}8OOYo`Ngbb#sl+ih#< z92hGNPe>^|49uqxX|be1i+DKSwbnG-MxR|ubqTyRbmJFe43IKhJ5Sr1{v}lu3HqgP zi6P9^02pVZr>s27~)b`Vq#_yC~Aiv z{>{&C_6}7BlnZQeBFs1~`+ikm%T8!d`x9@j-=ZK0x>ECPf zF3;xK>^)P_UawN7Ri#9rq0ivJDqHySjAdOsdL@^B_i|Q<^pZWP#kPOf@Bvbb`fI_4 zIxB~+wp*REg|$@h8OD5Zd9~a03LR)Djr!$EQ5r(F+wBj85JOWGH1d&=yOI#XJU#yQ z;W0KhWQ|S*XR}*lMWum~!#u`RptSL=(Xh>C|8bUSB5i%sKDEPcI~Zf&^pZ0;EWmu6 z=2_Sh5=&tLxpuefM4>dsU~M8y*xZTjM-T4{ATMc6%k}27EmPx7GiknKo8TB zrw`p5;^`0pW?q<+2tcHqwJQY|9L7iJ9FB9$%$ZY@r$Yn~`#S*OG#?IAVj@P_?Kc!g zgwtuvT;W2bmA?ak9EjOCvuI^}v#|u`G*}{XUDx@>8q%iHjf#Tki$OXIPG3K#Dm(C+ z#!)8&KToP_Yjw%WePhnOB$=EAxgl72CHhL!sIaQ4cW0AXprA=mzHe~9J7f(-zEgQ9 zYZ;SV`mJk*US);Pl|SF{7N4bA3eGc;&c3WFe3rL+!7ZylC;&=j03b~wx-vr6H;72i z<_5&=uAQgPMgwWd@t#_nlk<5z97m2ZA-6~#yRGA-Qk9D1AOfZQZujiUMh^kpa7XdwbIov?Wz#;-sX^JRcuWsqC0oe4ORuazo z)Bvo4gSELHxuG>0&%{_z)4ko;-Jm6#3 z|F1vpJ7fjDX5?c4yaQtQzjSZ64Y7=0?mvGyRr^o2`QhEWx4X7e#u0KxIvgI`IdPGq zpvY(*51_^>V+#bPy|wObxcwo(H-mT1c_PtDlV(XF29VbTXzjPR@ArLUNhz!>?%z9B zv!|YM&g-rS*B&;1EKXj)?xvkAPNH3tXSg zZk^*f%!lI`m=sYncw+Y3A3w}XiVWSlW*#COoNquBm%zy5gkL_N9;R&I0F=Z znE4oULXq(=rll^;NpyOAIIZZUJ39+b&x4k=4cOI+sDxMTwt1zJl^)8VwlYJK{lLpr3>co>;seB;2; zHNd%R0~nxeOiRXCO+6gY69DJ7TiX#?(rbRNK-H`&fN#Y^Qtv5!HMx|kRN=25ZCM+m zzbX*btY5ipS2UFGoTko1b$Qo$DSUr7(9cY5{f%I?po_`2TVO)%Ar$zaham++JfA)%V1Ah6 zjuP5k3rPi__B2lk@Lt=^4|hNR+jp%^OH3ebk>({%3_{Lqpmgnwm>BKm?QT=S0PPJK zWHO`yS(fO=1SGE7C!P#QE99Il-gHKz2>83Mh#PKq-OCh?zwtxgT8zjpLxVZze4M5^ zE+C-W-R!n48Uj(w-FCn6g%cNMC~HXDdP`k-tPP*MRQcg$7s< zfz0V#iShEuXg#<$?~H1?&9?Kl(U&kJbC{0DF+?y?fJ1-;X0L5zU*sAKu<-MVuZFzm9gB zd72(SKb$6KhadmlfB5-r=Yg|4C?B6<8M;mpnLRm=k^+~*A+74NG~B*@_x?@qEled9 zza{j3r~qzIxba*pjcNZsjRLX{hhirT=q7X;N1$70=I3f3NJleDwox zu1tTqzWzT{>HK;aT=*FdIL3&W1(|bHAZy41knCdtoH3e3 zmBKjhqR*0s2AQeZb{*+!i63p@&@?I%BWVy)NHN3|;{pKG4#RfaLJ6yh$v4gsbDT;p zAZNTjyFQ6gX`BEM7sN!?H@*g-HO$kOOsgWZy=x^@VHlP*7(Dlvs&ii(3-|7=rlxJ$ zw%+ghu%zS|j*q8##;}VKl9u_zp3LeNNrr(T3G+C^Y9a`#-K+DUmL`IMd>ZdRemG_0 zTcVtn`FI!?G2RWEzAdDN&D2ELcDKLT0t}8%9}n&zn5Kuvhbbt(dH?hKU2h4ticaL5 z9zU^d$vcbY2VqFcq8g-JGRTsqz8iK!-#P=Bl|&|Rj!;mP79uhz^Auv;WRz8go4({+ z3kX?CR;px?G#(!Q_TTG<wqNI~F;8|S=ysG8lXv0q<2!>MOT^>U<_l!WUGy!>xPn4y8f z0?mX1ZM$6x-sG9HA>&<>jR7E>bEeJ7AjIg;W%Ht+eY@(Sj-T%5WG&K=an7$kWH0A}C9Ay|= zCFlVWUUQ5JkOJTL4HaINF~>+tYyp5%m}b=j8K(AJW~#`n1Q_BJGecsUF`niE1BNw5 zBXe3JgUB%QNGpV7z-w9W%;bQ^Ie40uc|PVvpwUWXav6JTYz8ADMnzy`4THdkDaZI>XDm6%A$+_a(E!b6 z)8F0FzS+lvoD9;@SCo`&(`a#7 zMZntj{jS$245-2iD^wIx(S1(?FwJeh-3`50q6H*?wkt(IGshf)uhylc$B97}j!e^U z8%Jnz6k~0FxABzo_@D}l_I=kmt!;<0Y#+&j;cxtMIIP_pG?A%29z^T)5!5Hz^=${~ zd~-zVVi5HHi#>B`?$C!{eOZ6u6uYAHN*1G-QoK zWF&2fsX;ijBa9_dS{b^estQ+ONMSjB86OW*HeKIn=9K4ooC5WPeD)W#?djdme|o?5 z;IKS=`i#NZIfZeWW5)LFAOFMu{KtJ`!JGhaIE@egkEixMv~gs7!<=(o#uchg!jAh0Z_FJI=0X>b656hc;gbJsUcYfY+v0~0}+pg84P@uXptjQ{cR{;!|! zm#CnvfT)61Sy1Vp`5?sQ@C-HO*3)Q5t8wyo#tOt?E8;E^x12$|W0r zZQV+hzB>P=USde+lgousx2klbNk3-7nG#nWi-@~fLstD+=YZ|W%_k+_Y9O7wA1b|as2!KOmFcX0YcHiDLU?PBk zd0NIOnyk6$60+A0K;JCmlCX4zp-CA!o4VCcQ|0Thqkd zHb^w2=ykHQDmBWv8qc1pB?Sn~d5)sC`O{~mh%+kxlAgFOto7RYdL4qW=6$^yX z;&?dxcEHBMH$&UC`_5_O;E|aWf!i=JX-&?73CtjYZK;vLLqJekDGgEunoKkNsiF3B zbm8dUH5OA4)odlJf`xCCq=zv;M)s!L_Rd)24QY*{ z1z`rlgAC}NJ?q=9{XN}R2OaVnoE-6hj50tZ2Br4wjALH^g2Qh|LUpPw^XI5WN z&b=3&o#%C;E1>qgdtUZf*}q`XLPd!#sEt|AH%{srBwW}m&kH?2pWs>dy2ep!YOkK| zIpbKjI|Zn-5vvzluHhzCRi{uGD;}~Qv8*R57aOjwz6dTG#`?>Z2d@>BmQspPt^X_# zoV5#!7!6Yx1p?yC=B~Y;KkPT-UMQI%4G;@1UV*Z5$y| z;&k}@c)w&j%W2_^>$jU9b{PUND8I!)apHC6kWv}~I@=x%ND&6K(pQxy z1`w=ukn3a8tGO#h%Gxka@Di1%uoABJ9MM=OZ=I&A4}6B9s)r{^NhN?l)zqI`k8MDz z@R~sifKsMLB?5tbO%#JtO(C+EdgsqM&p9~LR(ErOHoC;TI*&|XVQN+zPq0O zHBacD9EvQ$rG)UtBBq=H@ca^ST%>S3e0e-BfCKW3`IJCz*bdtsiUsXF9!3U$ ze4;M15Y#hBa%ssSaY=yR26zKNSt)~eF#}UR-kS~P!$ZR0-n{M4E!z8i*ft#F;mep| zt@+>n{KMXpNXaqI%an2W?U#@J+aGR+#(DtYKp($Vn=7R_P2&_9WZ}2N?Oo?DnM%$q z@ZFx`{^vV~AW?LN?R&VcZ^_c7D2Q{8VVc7%NWLgt@_hVs80R@eK!cQr-3(i2zfS+x zXL$MkH4^-8mEM0>mf|XkJI~k`-mhAtNBznv{vSTHQs)rh+e23SUch*2p}&HoNhW#2teKAs~cEC;-XeIX&tstLLPC- zIkQ}Mr8DPvz;$is0ZjRj6bu29LRgfuWCS47G=}mDe2Qe44g>74Z9DRy!x*8#6;g~j zpPQOeV{7LbQoblZ+}yz*;CH*OHiCP;M|8c1r4fL&spQPWIZFm-0ieCz4tJY3dmtl* z7?F@+Tels$-VxP!7WIx)+?@DatakN4z6WLgLzwe-jrE(9@6U+;;p2jH*4q2mY>jX6 zXY|!C&-Y~gQu>8MaGp_u7tqUBUX8p;q+nVdpN5H{7Sk^=(^z$wL;;RvBK zo&RYIQ0M!;!O7qBj*JKtDbiYuF#uH!HqlZ`X4SbfkJ7rb=1PGgXzSW;m;ejT1 zbo2JjZqpE{l1m{-4te2}p`9JJZDW;IwANV_4mpOHQ(O*DpHC4DXr50vJO;Sob{K{R z&O2Y`2ZLDv$UVGkJhVdP=4u6{vW9|in2v`4kO$?EdIRm1@g++rhtJbfN7M9K^ltyd zkAu@d0l6W?-cQHl!(j}nZ?^xJA2&ChK?!*oPai);gr_g~mp{GzVZZ6>{goW1@#*t4 z3pR~y-`wqQHf=)&P)c#ik>TF73GaV+*Xulv0Zl`_^`^B}QPrz20?tb~J{{-Cn7U>M zPk%+MmPXY{+f+f}6QE9<2cfJ+I~S4+H{cNc|~rFmw#eJ5XEUM!ny#73_m zVtHO-XE+N*u9aWTy#=c4^vyL_&xL2-`8!7a>b;lo+D%^9mIi>rFMB~~u9s6p6+x*j z8FS3Sg=}~D-0wT50dl=2q7%^4?L3`Ee!73N?*=BjwmKFAXvsOmkg45+4w1tWmcxBN zw1W)*i~*cQ z7%e$W#{~pfE+Ffip%s0WMW#$|piN_}1q|bOn8lftOV-PA45m>iucZ{JcJKAKc};oMa>hO? znqTyVf%Z*?q=IjXHE6_ zS(q8kes9d%&EN}5$S7o*#v7;BB${Mq4q^QA@$ywrO-e_c7JkQorkc@bnb?sV$* zy*JQ=&NyoN3=Pod_%P-Br|s^i9oh5o3N)mIWjRjSbRoq!&!NmvO~2W-qc%mLZR;@h zl%^0}h7o{B86vvps2Tj$9TU6>gw zT?Bxtnk~=Mo! zP%e$u%PWj^osOyi`lZ3DYi}i(ps1Q-Q>8kKN~1{ahNGq8oM*dt(c-+!RJ>TfQZ7?} zE%V3v9rRaSy6QP!tZG?CfrMq!9)%?ZW57A5 zaRT(4t+%?u-WpIEqFEX19l%i#Q=FzLBo>0IK#LZT79m3}5qHFrvTGB&nCk5(XABV$ zG+AUQqXABHvfz?)t{a)6;+k#PLFYqaYMQRw?Qd$Ql5>Xn1zr)C5W^CeaWZpaVPS@Z zptUL-mnbD=SljG&ttX=Z0SOA{WgH)$4%6q4yfBmNy`Gme@f6uN?PlAwtt!rWp7``g zOm1+em^tSnri##@wmB#a4yUJwhx>=RupE#HTnQRP4$J2eRtlo&21a>GAO}GMavWcf0F5gTA#? zpp@2JnBl!|+HKpI%zm4+v%YT}>D7P;rxfD!bolUJ|9Y5BV_ms%0#EImwlWUX>+Yol>c)@mXGW z3$03trRt+7yu9Lzj7GUS|F@wSrCzuH#4F!buREgFXA;7TKP#mfMYQO%)TT&IG1ZPZ z)3Q76qchO3WXQLifVOp~&&zlk`#T48&n2@0NqHF$CuH)LQV2y-#56Bq!vf`?+O|h@ zJwjM~DeF#0hJ0si!hCp0%hN}*-Fl-?ScHwUjX2vo?~RjgdpiSViK6@7TgBt!mj@=3 zgSL%F?U+D9LJGoyW_#1sMz2ccbl80Y!U8~#r>6#uBBj7N3o#7PSOaP{JHH(o4Zx7m zA}r9pj|_rCABlj)0!U$jryNGgQ`aUS3nv7t0Kb2Gx4-dZfn+m-oPzP)(07f|y4t*T zHmpfu;-Z$PmV^j@MI85`jFkpwf_wV*wZwRd=EzqQu z%>dAByQXcdQeHd=;ti43kirGbAyL7oNKC=`aJ@`=&7#fBH$8 z?f$lP=6A@#|K9QUprX|%{S(y^TFO7UHtYCZby2@Vs!^%$Uh2hAzuc&DWaN~=ah{jV z23iwY+XP7fk~=;;AVBgKHlB|l0^t-x8jt48fNwJpAvwSUP{y`HPc6_OrFBmg0<>?o zOa@09!Sg4-8#-rDSO8ep!nVWE`OZtB%s5@dP$yui-+0M`yCto=9uu}K5Q zwC%=|7HFNxw~n+R0F=kWXD5yJx=1`8#{dANp*tcAD7UeYs&^#-tZ%~t0Ip?50+zb8 zHGq;14nsg3g0Q;vGrt3)3vR)`k$Spe|IYW?kV`+G0Hb4;9A-(8h=L_ z`@7>ijlT36CGsVo_p0Ced5C7EU%hy7REtvQ1`L;c$4lY0>h@m4!fUu!W4^1KS&E1T zjKgg@pMU`u;%K)hm5p@Y5fkOl_t_;Ex15s6C?la#5sJ@+i^Hwegbn& zFilY?9j6h&q$mO88~_;Db{KjKq}o~35;1EHMa^)V4S=apSUxv*x50~+k_DiKsqZ$s zp>I69rX|V+u6y%tWUW@3jIv-DR@wjv0nk_uz0VDaR_XBg zcsP*p*4Wu5;*s3I%7R6y+E&8p(8Umm96AY%Gz&Bl3|V8qynrLHdc_TxDW`e%k^qq+ zjVe768Sh-x3@ofbXOR}Yg5KY8jI=_9sjGmdW?4y!BIo{QRRLH%r?jf=|3{wIB~W@{ z!7kw*GnB4a`x!=5`aD(7XMqA;6OmWZFntEQaQ$YbfSTqO&1-R$ob#InQuy4_(P&XM zO1i#Yk#z~bSPEx6RzX3bwo-qFeqU2U>*9azJF%YdYu~X5pbZ8Q#GFeOGy|5Rd=Rvo zVZXssT!1Xdkis#U#x!kj5f0&?G_4ZB)je8O;3}-9v;cDH-v!aCfMG5;Oi7v`X?ptn zFdmn~!x#nNPayC(@!VQt$}}-RCP(4|rL@wbp=;*}ZT&uPr{lcLD9iDoYYaSTQAz+2 zEmDdwv;hiqAy<^~I9d&8yX`uol%TA6P^C1(dTX7@fV18>ON7E9B9JOzrAgT z&KoU7>NGfSE9+RsIiq3th~-PhJa`X;tUy$0rX_>C@4CjQ6$sY(xWr|e1GH@%G7N~w z%nWaZ78uE#OTEi^Iz2rs*6-i8)^&~`OhwVBGkZ+Qto$8O`pG@A|#T%RHh4 zW~R-%<4C;Sy?b}N?X0bk1fWdD^7+8F-@p6mkGC7YLe(NdH#d8~`C9yZ5_&XK{A}IM?~JAFW@Rk(E7NF7V9DIbNTyda*!P9Q<2m@3NabcXNJmG^p~j z$XN7>MSjgeIhSO8MaPk=H&v2>{$7GlpF_5Cl~d&FKd&_tmqgJ^82GGUF8~z*2|)}r zI3Ui)6Z)0ctf63vwe{GP1@!Th<*7O5bIJzHImcqK--2^vsh!6N#scQ`ez~Uao2@VN zLG5$~8dX*`Vh8Fr`~A>2rjp{IO!MZ)KMWR+wBUPfna3uPqm$TRl0sP|k%3beOP zI}t$}w1R*|Y7Wf>90$tdw_@d}q>jDPo zrQ~y+${Np;M=KO2(U9jf?KXIw37V9f# z>@1#gO|Ll<#}uGyN1z&ADXfWsb@fTrmBiX_T@mXSUqcw@4ua2%?rgUds?&-y7pC5p zucdAZZ^#%@3c~UDbWg4!1(&y*o1yKzQ)^3YtzP@$DI_rf#UzLaGw!xsLt}zb z#yCw_f`FWN#-6t^5k4GK4iRWg+X(~K8X!TpZE^P?4ok{aZ6J-057T1(Fm%q4BQ3(p zRf<~?l$;KK`;WhJ|EAg60~UMphd=zV>5-SYQOJy9HZqMa4{zSR9XwSBq9{NYzdBQZ5VX`e5~$K+AQJ@6}Lvk?<&@i-H#77vhMoA*2_-ox6(u zo=k*7(emmmUD1c71_DY!L_dRi~+dR(HGx@dya>GLdUnMw`+K<>HhwGw8z< z=W&V!x_Yu4QeqIj5n-PC?NS~e;ZRaM#3ix@HO@Aje;X8_v>`G8D`;hGJH*Ul6nVdd z(-an#QXnkkJbc%6L+_0(24EQ2{hRl9y{%ZfwOxx%>zmfEB1u}qK)h}m!<Yk3OddQ;xC<}a{TyTKF{>dSc?qKah@!_d&huegCfi@K-W44V~7Zx8Jv(k``#Gq z5%R(n*wp}>!@@iQ2t6%xHr>$Jc0&pvK*W^l_0uX^dA1571z@^*=6V&En>!B$9A`cR_5wts)ED}7m9NP_hAd8jr2f*^45nzKk%l00hoCGp7QeDLKY$ylv=w zkDiGDniOf14HHo@d1p|H2snp?w%;xal4EJs3+A)q zMzF}fX`C?%`dq>fK#{p<1&VMu&0sN2VGc2*#FS2l-~RUD^EfAg)mjS!#zDdoI`rIb z_HW+p2WQ|s0R4B8d*^VZV*LeQAthIDT;sBTvc1{!c~-;u(t%#LqW@p!V!k)NanA3y z>eix5rGym?Afzw{>g|=bm9EZ!meLK&c#INrx=K{!6f#Ir3y#s|P02U#)|Py7kEjK5 z#t``yO^E<1!9%nV$hq^iYNQ-Ok*f$-JKuWep6fGRyW0*`rZ58J4ceXcjqygG`!W$x zu^Ql<$pFHTk|RoH0f}(oh&e>Z*1FND{>gyD4!Pn|8|NP(@ zlqr0td(i(MhXG(pQB=-oL;;|+UUg{BHX8u5!dhBhWEI^9gOq`m63?@$E`6m8M6}SQ z$1GoEJ+x>sU=lzfYY2Hi13)PZs6E=Yn;4+3-FSJ-IkB}y0md7jtVTTWkmq4{7pVR@aKa<3dhHfpa12LH@zYc4X_jg4dk$dObW;xmO}`w zZ8u@crfnNb%8)`Wc+w~-+aW$7qaC`PQzC*Kj*o{39HTe>z42rfL^8mc0jjMIm0rs( zK-m6q7(P9Iei&y6;JkCz*mN|m!sPzvXc&wWdcem znVCZp7$4>-|9pFU(>bc$jk79HN|bOmdp`@MbY!qVJ3`JOPfuU&@9(Ewo}TWqF?yVb-@+}6j}M&2w#GL6&=-8 zu%$d-{FO<#>Lmt1N&#an*IiwYmA+a~s$||d;$4lHg07oIB_C(7KpE%x;c-4N!Fgv4 zorO;Ut&ubQZFBSXmk+=Gy3@-vYgi&f;BXAtH?7gG5pYg7J;!C49}m+)JSQaVy4%5N z<$}U;VrSqDkt#0Tg%B}$Xzh_d`uHzzht6ulk2Xh^+%=8U;r`dZPMb01C8B8>!WiK2 zkixsIZ}NgxkwF1zg2c$m;qb-0eM2A)tkQJ&{PB>&Y{Y19`%TxX;Nsyp&Z+!Ai5h^H znCu^ipa0DpEo3#Ih?qsVG~0APe~x`WC_51rK*P2<%@DW-7GYvC`@1*o4pW>%=7$55 zvqx8rgHWn&q!hY^*ODw zmM>`yZBT_@&XY|8s+77>>N75UO-!a0{aDLBg`_Zq6|zEY7J4;dS4>1JC@FGQ6k=AS zfWp_nVofxI87ua$_1YFsE3HjgnTZwW)S8&CVj~T8uJ@O#%f0-$tkwj8D5_1JYV*Cb z6!m(GG$~w@PSyIa7R|ceIHsE4<5ImXitu3HSpc^08nvKA=5#~WA&%Q|hAD}_*=S65 z;36VsWwAgsBQrmvM~c9Ja1kLCPVfMV0*C3-{n!jC(0n+~pq`xsP}B6APB9En5-Ec9 z1|0dsZqv8U)D&+KXr&Y>Z8DFhZN?-qXB_UE{LVRAp>T$v@G_3UHwq=hX*wnt(|8}y zZJi;jDr~1TAe=&AFoTqD8mmx*<9IqHv^#CRH-;>%2G_bP;=)`j^8uV2JDHBi_#9&f z$QtXt0c=O!8ATef-V>oDW`GOFyd+LQo=yiQ*97=sXr+t@yZvA~r%foTK}OO_Ys}MO znK8$(_$nk{cQ-ljq!JFN(6ob!#oBGRe>Zs20;Nm?flJtSl-v;Dx1P>EC=^PbjwjW* z-EP0}w$7PSxHbqS-^bZ&t*O>wiZJJ#Vip*3cDU<1Lj+k3idFzagj`V>i665-n?_0= z7hb0OPk;U8<2)dZQz!s=>O7Lc=7%?c9k#=;>1^((akll=z$;U`;flsuDcF14uF z#1Eh-=-SnXu3sx_BJ7*a^lH-9q`CTLTiRL+@tjT57bO3MbyL-r=}W!owO%^bqTXi> z>hJsZt4h@B1na6ZcIFY+Q>oQq1(oOQ$K_N2lx7iR4FJSS3zQ|q`M>~36X{y3fj=_Yr_F~xCS&{>X2KuyWD(WvB{0F6AG zaY(A;co7NM!&YgTzW`qV{_iuLZdsDsg^$F+9AZsHp+Bz634TH$0 zgd_s(EFp*@)%0)f+EysqahYRc8eow#Lqln$>ohz+=(0Yd7Y-3F1=r_?R2LK~npn!S zB=hABIFq0*N3OPlfwjmTIA^xym9~PcSlDqe4x?$U{t&Izr7MWdRiFKD?J54opEkMaJB(Yn6 zv)$fwMk5>1C@5STZ#dr+?<^@&TA>K%9AlivIicI?+rIbyg7U4Xs}v}csl>!okVUf3 z1{u@x^yTp|&VrajQO5YD8yw;z`Zssm)^^RdYrM%xYwL_X!<(zWt8_IbuXA$hdW~Ip zC$Fu^$}@Pi6Mbde)+4F!LD>M#)yLneH~P-F_F%tp%I{jfvNBcIgQyzFeftAv%;#c9 z*W4#(&hSMUXwfLdq=|^YaBFr?tMdhFsXlb^8}WWgOo{N+E=i(SmaF6{S{yB{In2_^`wo0H=_W7E#J|8eP{ps@s2p>zOv& z#wkh1)6+E1n5XUuf#8!yW?0FHIV*zk*?==NCzkok{V~E@7~k}p!8xUg$PlbalFbaX zwr$*-yVfITtxRojM}=89Fsu`#Lv7mbEIAjW1|qbz#HQWC?)P_FE6kiYa$*K7X;UkH z&VyDLMb;fk38CiCHD2!QS0PHBm$mQR%gppT)zot&v8L0?IigzWTos?z&&QNk$NAPc z=kr!jRX-;Vi+WLDFZD04jw4EyZys6|y;?reP#0@_nfI^d;nq+6gVj`4`t$d=&)*tX zhg49|LQp!dTt-sRMod;p+n51p??K9w(adq0XTv|dYg(l7v!=s{RG1ks3yw?F)%wZWHK8*dN^OznUp*90JDYV0;>wpQc$|J_D4KYRn zX)M!2x9$1mcUo2ccp0@d<V>{@C=+7(j!WLke?T5)y!vmpRS?=*BWk+qG7&YFVJd zB`t@?$HT+Hz(bSK1|`qa@o5BgH)M=+L`F*igDnw(GA_t8&SJ=a$U94 zLzB-wdQ~-+AA5z9Fyz6u}!}I7?b=DhdRn&J1PY7#23S7;b&j z5?B@3!ZD;=0MdXq&(tds4k?5pEwQHfo&}vScP>`@8+!hJZM)0(6876kY<*LY9=!Xuvt@TNjy^ zn4sH+n8~@W>pE@b%sD4!t~jG{ubLn~w;WdHY|=M1RSNs&UL941(3=z^Ta$NOLB76!=74Gr6T(gx(Z&g9cFgIw3n0yjkl z$PYj`P2jY0W$Jxm>d*w*Y$q$ zbhOs_)*8Z1n@a)%#3OVk(D{*&kH@D4{bu8Hn8taDNO^eM-wwS>{mpVa^joKMX_Cx5 zr>Q!pecx__M?8%KFH<&K&v7VIXqM)@>#Ka&{pvJBn z+d7Fjh55K-GPK_sQV2kiF2`w186an;aa@{dwlD?^PGJs9oDQR)ANI|@s|5<0QC7Ke z0ZS1nDTZ;LLpX*AI5R!!M$5R2(+G&Bo| z`JF2}?t4(@resOtvi$b1pB_TrwzF@x`+aX)G|ri93;~Flv&ZoMr`@efOPNy! zTpgvza${gS-8Nl|JC13F=^Qb#xXH0Q|H~LdErHD5Yz%@4ETWN(+=y`*U3wGPO_ETCei*cnVsV7v1~{l)UWParNf& z43jhM=5l!jUj=faU(eESHCYz`nrkvjpG{s-kQc|R{TO(~`n42jQQwL8lwK#~H5GPU z={5K`r|(`}Mt$eCTYD}(1OZe_@JMB1(nV4V02!qT5J(u0BW!=WaUQ~X8V_>@BbXk9 zX4rbAEfJAuNGZaBLx|%PU^>6;e5K?hUPgs>f z<-pX;K0|kf;i&6$gwe0R7*(WGX#!W36OQs*OKmQN1SRLVOmkoWq2v^%m;sokX_YpO zt*QLg!zei%A3y#2Fk0?l3@MGo%k<^TBZ%_Jc+quZIoB&{WmJI}sneBNV1!taA+S+s zwnrFC%4v>C!_h=D1ADyrc}*3^&`hb6OFgD^W_- zav)|&9H!%VTt0{CG%-NLOK%-|OTqzAKCyAGZM{voi_Th*(w3l6#8=~^fTCFo3^b|w ziaHnhTrZC2C4sZ4D@vgMae43aq1H5AJl$7%@V!?4) zra6cdDUclF^!V_2n!WDdydBDB=skgjT?{!ek)h?G8<(5dI#YI(KYV^la5tTA zhnu_J6W|*nV_mIYBADjp{oA|F%s2(&(zJ>!P`Gfa(~|(3HXQ@5ZM`?|IL89z3@MO7 z7$1+1JYY^CE-4gPXzyBM>Dx#IuRH*fa}nJ)&7NLcg6r2)sgjops#Vfhn{b`u9Ccyy zU(JJ6E%rIs$3JN2zGn7N&dI*>t6v3OuV1;O$*;Q~RFVi}wVZnG1*^|ot2zvTmFc5^ zq6I~tZPXQItA3&NOP}wZ0-)4N;Zazt#$Q$!l{35N`i|#kY9~Rj(%}WQqxLeV1!MtJ z0psy-h-lvaq4i3Z@$hh%mjGs1z|!`nGg_ovXe~KT>FHs9e2m!ayYSAcBH$F`_yk^_ zW{dV5n35ri5RHDg+u9B1ejceG_8mN=A9-8|O)3C2uIpU}hE<90a$gD{N@?mEuPqrO z%iyQ`_AUtoML5N@BnDAHP9fI(ELrchB5P1;Dql2&Imhwoa2O*yfQ$x2!gxGAPH-lD zXE5BU|v;&dbs= zJzrKqsRS3TH4Q1znPobo7^0YVOF%*z7Y2j&J=A5fCO5?2&=qC4Uv)}H#B+|^Kh?J*> z84G)D$g!fsyuebJj*n9THQjz_huy9Raxs?3SfVOG-!yk`Ztn&UPRL`3ZD*}_rq-?l zFd*`r-?ae9H;uElWEN;L3ItBHq{k1b%_)Q>h7z^FP}{!jjqkt<&uGB6kcg+s_1ho`mZlmv#K#){X#WXsl2W#S5OORU#+T3 zzW=I2pIj`e@&M|^RrqRrI*duQZ6s-d0Q`9Wl7{c*4y#>Y?hbK;V6LIzpV9?X>| zC>r1tr{nbDm(%A%())PlQ_@V5mvOrPg7i3!yG`Zd*zEf4E;3xxzIlJUZFMkAlfHX@ z*B}qO&C_9w44aa*9lG5%0DjnSS53>6WW)+6aK78NZS5#Qgyr#W$s$?`7vY!_;0c_- z8P+Ov)>?P&%_xA*1`tlmJjVnO$aqUAS%+yn9H$xCEiR#KAXQcYv zDzH)D3N>v70t7&gDJCXp7|@CA1j{u5X9dThix+gCZJQF@!@1 z$H%8n$4U5U!dx`IlMs}uhvw@a%_)6R7@TrIV7^~ZB`^=-RWKUAfYzA>&obaq3_3o(qB z7p~Mtdy4vPn9(ceZ55LMe^DD6e)z4MWqI>&rnbQ_npWJ?f#CE{cn$F{6npL zXa>MJ&d1}Ihhws?Lnee0q2=@A2>0fXKMq(zK8+F9j}jPSxF9ZJ%mz(Ptt|?|aXO6m zPlt!O*!t~+Si*FC{PGFY(;;fE6G9n3+-70gbZ_3??ix?|rrQU-eYb5C$K`PN^x-~^ z08}g3Y&+6zchhhBYp`=omTKR1o1qdQti=){RxoFMpEdscqw)l(OUu(Lp-=$kl#>9i z=f%|Kx6IRNTo_2nW|M2P%ZjvVQYg%GwR#$;J!;R7gTa7-b&ygd*Xr+i6j%>5B_l7( z9MTd^Z-?#BH9muE2l7L+8)_C2&x8ugZvCO_dILC@QkgJ6l;k?&ERh04(lRb%dUNx` z+kInDSZU-O!gQRMtvP>PLCOWK))3}!ygwX3#+$fA@G>WaY@j8K^OX1L^fXcL*Q+2+ z08UAh0DW&?aH_=zD`4GV&BNdZrF<{-<}l-W#n*>k46|!jN!C!KNIU?wxlqw(a`9Yp4u! z@6s`yMtrsl&_n=ao<2`iiF2Oy1ONogVTl2pGjSTzG)GFO0O44cjHQJI2=hZ~`Ee20 zrYKLg?RP_OGNF*N=Ph5m?#=u6x4m0`pOyr?-w%S?Sl49+&~CQWYmuUiGcVA~RKhX` z_&z1c%u*zm3_u(Es^Y!Y@ha$5eVK`&s;*(7uK@Zw&JR?-z&bDKsPBw#;ul}%eeo5R z|NZg2V15@B=66rTS6`y?TFz>nP}Sj5FRSh@V~uT+cpLM*)yMs$_{_ zW!- z)g?Fs7l0)5WS4OPr%_HCtNpx_tV}KR;w@o58YnS8s>D@Apm1#Z7O9))W9ac!nQ$hQq9avp3x~ zW>d~YLb^sY=#1w;trY+2gg^Uco0CHutK>_EO!3yuH!R0_r@n23zgoZdA8jw)&C9=D zE(5Bdf@r=G=X{mY!P%|b`0-vZa<$jZ;i$fEB_|~^?1D%%Is4-z-83F+crbfAAD0j; zD-Bh#KpQqefpdY;j4)3A_WK*7m#4efH3!bgvq)G41G}UT?+0g`!?R<-0$Hc~0Glv- zfz{5#wTE|b#<5uPoe9&Fq6SomkO;c{II|caPpOF!%!%@Goo5f>S>VTo_iK~qDKUy) zpraI}3@e$Jh%qos3wE~ccWu)t)*?nLQp{jo&M1zQlPY9q$(U-GW?ptagJ!;dZe(5q#&Y!TJldXcqTV>#xw1~b%TsDbzB7^GL>vo!mBT&iOg0%Xf;NC6F)n^m*vL99re_lS?53Z#vES>sXlIO#rqb z`zyHRi=%X{+9=5UGK=}SBUkgIfC7Zh!H#pGNWF!ZzdSzx^`fJkHPcHArrXi`eSE@n|JT7cg`>uf(_{U)&P*!xz;@#Lf=4QQb=&7 z>077iW!$+|VKn_=K8*mFt?MkbMJ}QMq$C*(BqgN)I%(GCu(K6Ryp=##769?blb24X z*$sQcBG@Qyfb5a3po}%f8p=ehDHln}rv$AHo=XZV417ZkQU-)d6qDCw^{E00jRKIo z50c=9H`n`?iL!NVQN|kEwiPRpB@dbxLM}yRKTp5@^w(Q)-Jz4T9*?K{ad|qO*#zkc zEA;;G{{4>)teB-uX;LOCl(5c)JLkIYRceD&fzp&&vPep@F0&ZT#$LBw+wS-M-nGtY zmb|~Y`Cwzo1jxEZSf@}lj_y+P zHNS|FY`c}$@9^d7@Y3Vt*J6t=uIv2kOJ06k&+7S0xzJ-5TufLwkHT&3dLG*^JXYGe zeI>X;$f{f-sL$H6IFm5E3V;%`ad{P43*tOJ7BfCPEofp~Pf4HdTEj+b+Lj^($|wRw z1&XzC21|S}w{IJp;-s@*CSijpVNK|pH|U0&o5mPb>Izpci>a)~6Sd3i!&C*KE#Cy) zXArdO5A(FFF(o7&v(ZMLW-sC+gq&`SAp)|j57Q(JOG(Et!%G{Es{xsqgtLHAP$WzO zFs2Bnn_h|O_DwDxY^}JOy)HgM1A*G6X`CeyQN)nw zQ%nWMTAkuLP7kxUU3vllut8Cdp^R&srcB$oU_?@=G3^)5+vUaPm)dsQ7ULOs@_FFo z4Bf0&pypaMwUbXaxP~Rw&`0|kj(aHCdxo51yTf@ z8KqKhs|_HY6e&RFG0ZC?d06Y_B|Hj5R*@yHN%i0T!w(0i1!ey9%k5e+$Qa!oZmzGH z@?8Y*k%mA0@n(m3|1bY^3(O}p?fXA`f7l}zkhWOR{?jeL9U9F}6%pnJ>mxUZ@4tUL zSgnA9oe@}V6e}2KyZz02T>a^E9G72K{>SfJW~~`gL~-4eQV{_g;tW8%2lrRk?H=#6 zq@+P=iZN!0B=}QIULU)auMOYDKlpA4}bY2yhD~&Ij3^W8M?*F$=T48B4jSO537}YW7<~8&`D; zC?kZ^ZU3a#*+-~m$FA?&TDGT=M6sqUumD6-^debs*mWI3+TUDX86vl9 zm^HH`*X?$u1aYP@%e-U|yMEV9c(C@(a5MBytD>|m3eb6@E>)t4s|#~p9Y|fw+Szhk z@^kr&bfcQ;%jb0gc~jfGWVz34zo~=~9cU&WvZ<>r}A(=_FE9gp+reu>=QIRERz9q3`b{qW!ZQClEO28bw8Mg}2kveF+0j(2PRSJ&*? zzQ;WN{Ls~q5!hZk=lZs{R^{hMD*#*DsQF<;0}Cw2N!|k(JvWY$fUmS|`@i0rxO%Ta ztxjWZ-8=)hZkxA%e=v~b*ZBBh#Je7O?u<3D%=7W~;oV_x5g>9-hDlhaKl1JPAZ|Cb z`1tnv+Abkw>Reop$2rAmZFctR-Ie3A0uj!21~UD#Ieh;Q-wizg<_=`{hKq%OHJ4?c z$9eMJUA-GRz~BA!$+zDhEJ_RlrdB;o1H&GM&asFpiWEaBVOFeA1YaqV%rCX)@@2e9 zMXTpjvU`cpI+F&aiyf2A+bPvdRk+0GrnD4nuTWJv;#?FFaxUdL3#^{=*fF2=6lK%7 zt;xwPwpgu7F34HyiiA`O&}GAczVcy7DHN2K1sRG-5%R`;0KC@Udv2F)-|wc+{T;u{ zbiVu~=T-Uw4P}Lrs_FtULYX&M(G2*YrN zWk9jE{XU%Hs!zs_)7ox5x&1rbTs4)Aw#c@X5mp4sj>rTv9X-M_31qZw-x+MN6xsj) z%s?~0cR7opjAmFgUt(ahm4s-Ii2sP1|0-xjFRO zs1#)ekQed^3Qc3$zG;n7kX+WBM7vsJR2wmvcrV!PR1r5^^%}}HmI*n9hY$b!FCV51 z*WC1a(wLCpi5Tk}V1&fEbIww}g#W+RwwT^CkHxoJdF3$vm$XZ)^}n*yueKT}!hc{b zc-5+<&$$2=Ndn?>8kc1OqwAONS*Ml}#xX>>M7CZSAj72X z0BCE@@e`tYIAxUL{XDHAJzDN}(IWyW__(Fr*%{;PTNzsqU>O^d5Cq&g({+dI-XN{h z7?T9}C?4J)$7mv!CCttUBH-5u097_~l!wWKMUowyQluLeI6{i67jAj~=I!2DRs|w4 zuE}S>8in;yqbSXa$>`29B%y!^5Py6~-UDS~na9VUKONBm>d!HF0q-0Ac;DU(`^LVu zZ|W5;>Hoq_Z83k)2Bna5iU|Mtfq#b10&3flZYL{e;0~$R0utr&{fp>Lsn8600q}Ws zMS0t+qACEPNG?*+<`Gtg@j}eHctT7`+YV1rq-v=K4|Yv!YsHyQDU}>SSwlNF91a|g z4-a#KX%}$@>hAv2v=EjAW1Z8C48??Y_h$La8e~1;!}o6*MIaPycX0i%vrNdyMYuj; z1+XHJGQ!L&)-hzzExN0{r9^~ENtan5QBu@O*(+Fo>K~VB5!j*I&kQE=B9cM^3N%9i z<(zhg&LYdCD%5}##Ct#2Dt1!^q?N{q!j1*|ah>K#?-D>1 zL?E&Pz3p1v?)t;9>$E22XPKuJZPRs)VN&P)O-kCFa0AD3vnHG#wQ@$T;S z?v&7A{FflpX<1_eX;Ba;O@QgHzWcjBygzgl43HoY|DXUk-LD^MQmN$_1~HCVO)W@WH&9V*mn2!aMd*3PDA26&GQry7V9MV+mqOcWm>FdivTPk z3d1y=wE-X3(ih~XUF0KmGvesjYoFU#YKW?4pKMSuMC={T`U zN$b{GLm41qRfc#s`;;fdpTD~qntC(3C)f6!QL5DP7Nr3cNt%>`rYJkfR>JC`X<4Ru z?W^43Hm-o2))kG@R_P{8NB3bGpW-#Bvk=P^Q}iiCAVHIYf_AQPmZ@f4YWZ{B$)vCx zgMn7iPEb4|CyWnao)chsc;EG1YbvXmDkZ0NnxB6CaJ%en+i~6RDNL+@;@OcoLGDG9WIk#m&19`AnrWejM|Q60s1rYf4Be{vs)+ z)z_LWAR|XsjoZEX$3Or0W^bW&E`miMkF1T+{oXciM~WbRnU>oJsQ0Dn%TiG&AciX< z-ZTbTxN!`E2$$@qyI=l4|Mb_V)H3aU`2G;qqmGaW787-o1!zt|-f&RK0A zDG4cK}dbOlndi|y`eZiHj%BB1kz&9*#Ih*uNmhF7z zOFXvP&H99EPUMT5`s{-$%p@s<7{wS-E7CHZA~Kolw>KufooD~_%Nlm$v1@Rl0=)p% zg<1Dk??=IuwKj~nhLC`!F(QC;(NyBi0%3qSs~obB#FVmbdZ6jLonzMiDVGF^(`?}g zY-2wh*Ml?QQ5cfaGDWfd+dmG6hO{$;xUN2gh}8#_alV~kgs0W7BYJq?w2P%EvVCU+ zkB{DG<{*Air%~^Tm`RrsPRA2^?*9JW&7o_Q5b`=tkGFSAglThH!!o@qeTSy$TPrDu z0L(;j9Y6hKOv@>RBR<}SC7N#7xBXQLE~$Ojx4S)CZO_2Z&CF0yRU`0QfXFXinz}@K zzU|fjjV)V#t+@EvF;&(lSN_#1+3}TMe$@unJ?u6VGUcqxRsr?JIQ!z?U%8-?QO=2O z4Jt$|l?VIG*OEb(RKSb-d+xaA$X|S!&wNbJxyX7hlrvZcs9V1*sCE`isy-1m0#!U> ziisNqSt4?U;ky3t_TX}$;+Hi*D*`b^upO>$u9b^F$MuNl{qjo(bNkEVQ((%(rfZC5 zfE4Roy3k5VFjM;Ymv?`3K*=RRw~cc~Gjh#La6v9PQ-Nkcu`w?*O%XGos3tWe zuBQ|F(rImNYFqY?VR_OP9U*p1Ih7(Q0UBP?l2Jsl(MAzAx_+v7qJnikt--L-V3%WB z0p&10hBd&V=QnRm>l)Ss2o-_M)A8xy;qhTw->s>}0!S%C3Uw2+g)NDt#MAvJ7#3wT zN)8jGNU2rj-fP`hV~o*&Rs`f6whasmE1AdBl7R52i@5>-7!<(l4*SM6nzbfIK^&KH zl4jVqjV3^lB&4*aCHM>gaVAR3>Bf*GA@`k`~q7y#l=PY>h2-=Rg1D*j4a?g}Bts@7EWfa)Afb z&q@{_*AOLNQOeB(NJ*O7;qdOA$-(>Sr*WEZKi%y6dPrS<&mffo-SpRgh>-{k zj!a`43k_d+C`ty2Rt!ohq@qd=#SA|jB9voiG?ZyqcwjnCj#xWIC9HFC%%K|^xz6ic43`_36c zmUVjc+_|ei4u`AO09naA-QRw^4+6O8C%6bwaBSO-eejdOStd%$z;*ghA<+nZ-4f=HorWVxBaDclsqoP4aW#t^w0mNQDG`Sr$OM4yuzWApiwS5NK-p zrh9i~v^zhpTqOC^IF9GTwV{k}vnHo`A|oY5g(A}lX}jHVOaZX_o$Ify-Rk5dP!=X+ z0hGAP&exHd?UfCVm z;jnX2q^FZ6oENyuDK4k_+fed+`OntGFVh?n z&^f@k{ndnE(f{~|cL!5aj3;>**Dy`fUV%YWm4 zgcN7PcrlT4@iP=<^m>;8ks=W(%YYFA_{mwTp)8tyNXInC46EV%w8mum!!TSiGC-=h zet2;k%Mvs;Dy8R70o^ov3;1|mLzfTy*Wrin-|q^$oRSy74cBk_UE?_CL`eSe<4+@C z98g3=?Lz3-7|p;s-cQo*;@*a7UTT0#(zN25soU>&eS;;10w${Y!AmgliW1EZ1h8~_v(bOfNArhmWt{^rmrzlu+%`$TBwN3aJ3f0tDlY!x+ThSS|S>-ykHT` z1)wY>3Y3$`>SN}1C(Jz?q?mFRMg|v!EaIp8`+J~mbWzMql>Iz`;$)50$mF`LSQkJ+ z*GZwAZL42J7u0ykMRJT8WZJH0b{@&2<|Y`XZLW6hp=Hgy;k$G3aaq=r*A56vLLt)i z#w(DiZn=w!8=f7|NUMSd;Ey;L(XFFDu4wk}ZU$}(F%=+7QUIjnoUFG7`NG{S zFN~gIKt%lX_~b=nj{@!!x@pm{Kfb%(GeU_bjVIwa&8t3#j5IddoB{=6(+-EnS-`y` zWFO+&uG>4vagG_$PdbZb#f&1zsQ>}WC}!J%DTZlIUXmQFMz9(sMJb9|b$*F=V@@Iv zq-BlJyWy~NnuS3i#l~IktD+2b(=yQXT?azfHk1oPcWq~cn4p~140(##-p&9FP+{E0 zv`ynQE7FM-(){W12<}Qs0uTcUHUHtK`(Hm!{na1dciDSb>kI=RGc@c>t4&%~0Bnq9 zdS)2gB5>Q|%ajSSi6#Gywqg15wlZ(zCtn{1U;O#ZW%*f>`T3`+1_5ggM6GeaODFV2 zr@t{h6v}4!F46T@SM;hU!dc(-b^kf13tUCl>m$_Lf95Hx;8A(CXSi^VRkc0ZAltQm z^>T+_09&f3w%4N@<3a5V&Tz zMJUE3NqmXpBS+otcdcP{#;EXl7+xIISG93KXaS+8X29 z{q=X>y*V`5dlrC`s(EbMD5+oW{p$4lOpEVKh52g9QQLIRiQ^ze4qaM4-o`0gPE#3c$tBSS!nP-*6~q72hC&N8EE2kQXAzH<&?ozrBIrWp2v zw3>B|uoq|xC?W+$!(OGd0^mbyaAX3csY|HX<8Q30@U=a1y-8U@B-`_1hiNFd=@*1#B+q;Gs zh0XBmX*GX-cj)4N*EETRt#KAf;wEY-NzC=z=ymcAxNB^OG~fOF;L<>f!3b$9Yv+G&B<=VfY^tVwj9G0tRaffYCRL z6Yk$!?VLPkfrLb%6fa2tgSKlrZ48B`nlTIJ-F|yn?r-0C!E2z-Lz;dmOS;$XV@P6k%4u7d zyOc18r@uVn$_ga=5<-#)WI+xEa0Ie2{bB#+hj%wSXH=0iACWWIu?4%PZ;fGqph#(} zZFgO=pzoYUCDud=!N+x+PT96Nh42emzP}w8a>w=NFx)r>Age#7I0dk&I11+s-&|e) z`29`GWlkl5IWh^(X5-oHscIIg?DJ;>exsv*ITN>^Dg5r7z-L{4nIhbPQD6J&`8S`3 zBo!{Cq2D~sD+|dl&tA^i!Lp_J@wL=t-fEWBwnh|*)8ofqgsr_1=bUl-oF#ypePbzu ziHA2ohS6ld+PazwwoE|IS+szdSsOO6-G1L|3y{$|(c(|H1BU>+%8j*JBWEcBwudaT z#rc#1pi45?ud)C}14#hQN;jQvAAx0wQ;KMv>94Ol129P@QOSF6oUyRBRdCG;*YAd8 ztQq=FJi4LR0%$SLFj@t;rfC|Nnx~i^CJ!J;fU|(X7VjbEL<;M&p5TyBGAZX;t4(ip z32}P5`|#_LU0nZRh&*(fSwkm_u4hP^9v(;hFGJ`0-Z*}Nx!usc+bf_9NRec|mHOD; zl|a#!wtYoi{$+bqXd0JK#EY+`^=pJO>+ z|5YW)zS2a>rh@SG`n?xp{WlsZM&{pz&?XQ-0?K|0$B=bjay|zVlu{-E$SYuoSx3#r zb=PlfXDC3H+a3bsSODDb-vBv2 z{&d%NXiQ@m03$&J3|3ra@c=AiD!Ky-rZGtZP@>x#uE?aEPSYGXtur(_1`)ce8N*ah z34jVSSpj2jZR5G`cO8cpd1YagoJx)W6tp(l7$cUe&>LHJyRPqAXSVey=Td38BLIYD zIpO~9(UzWTkXC?F&i6l5tPemULWPqVP;T5FNB$}!E;cz?GrIuvXlY&V4fTY?|y`C`c4BdEU`esI*tGo*eDHVL$>W&(c1Jo z1B13{YHx}Fvt-n@`oV?%QV{lE|7-*xB%RD|lJUva&x*uA= z9;)$nR6AK8fBEI!{dZ{BHpbxDnR<1C8gVO<#Qf)9+kdeAMnv^L-M*+CxOi;;>Di=! zjjttVkWeXLrBF&PA~lGqps*G1s*ME^tZKG^QA#dVk7SFRfc|pMQPY`l3~24S~`XSuidINdrp9SsxC6{O^Cd z<^s-cms0`3l*uQw{nO%z^zzeuOrWBjBIHzHy1%2-+_e3hH<~4~-QNs%KmXc0g~(<^JZ~o4E8lXh@hIe*NSj^E^4N8O%^S z>V80bnidPgkeEdqA!G=(ozYfn0W%~QFccUHd0nRYxITH^ULE$1Df{E2H!YIK?#;Wt zwYo8?Y^4(=`9&m#6>jhBGMOrTD_(!{Z49w>IeM{^KKd`pV{%7pOi-j8LQ%l*BBnWKwST z-P<32yy_cGah*^14@JPP?;5LFYp!|p3L{g_x+EP~A&SJJAZZ!zK0W=9zwQp-G2-H- zIXym&OQzla?SQoGTBOsbfBp2dBtT^Wp@sqD5_9vWZD3g`HX1$-10EdCN#Kh zbx2iije<>9sJeqMqtZo{>WsbWtf-CAKGQj9TYz#VTq>yG(Na03%IE&#D==$OT=CnL zDW5>5kvBf#E@S=qy)g`d)!lebpk>5ND}jgaBmeYPWEHTH z1be{3;r8JAX^BbJ35RYV1SE|lY>ev~M=2uewmURU(+$H_$6=Z8{`r6Y%k5N*Q~gTn{?Ow0_dVPA5b-Gk2-R7fT&40HD&Di6=umy!yP7U%&U*xX{*(mg(gh_YQzbtj zpwdKc?nZ$E*BXQx>)C{pw?NPtKAMSeCaQj}!N@2|LDFeGJ$`)hJH6|3EE`e-@ihMW z)BUPqXCK!!!!-hUuO(?BYkRw-H3?YjB;Db^|NWm1tp+k!n||IWXbB=U9&Zie9PQgf zUqR?uLWt5`1L^J1x5gktyJ63#+cBgfLu)yMvR|Sm4U#P_sNipZqW1^Qae8YT%nuJE zcx{qqf=HNGFN}EXItw7PA_s1NIDTAXhEd1@D6NWQWN7QGRs^w?>PHkQ268F>c>jbY zpluqqa*q0Nj}9*PJw1Q$ebc z8?B6OyQZ<4P~vI4{}epj6?JTlsw`9$n^+1Im`i=hF{GG562?z|{ntb(U(R^~ZOnD&9d3F4>eW0}AXURi7cS6eVayGL@#;FN z_5I2gxf9VaaS*1Wd+Jliz6c+fGV$? zFo2XTkj4)gy-6WPn6!%77uK4gk;x#0W%02jAj=X{Of0GZavDE<99sbrrun)x{nZ}J z2!0a^}vwxQu;^&jE;Z@rM>)myW@dWr~1zcklauOCmk+Q~^j6|86ea}p$ zZ4CT!|I5Gs{4jytZpUF{nt$^4+BFF&+$A^zZf*u^wIZs!qf5fLh@wnDkxUGcj4Z$u zT~nbeMb&-Mx&9;@o^d@ zM@gxq>{HXCeS0%>m$ibxiU>l;Io^BWZct%8!EWgefe9M$fM8kHm=cvDu)IEko%j$Z zG1rA?KF$kMewbFTqy5vnUF(1n2?{yql0r&pyni~inhWAek0f#Lobq8Er(=i_tAa)X zWnhI-*9R>j%;PwV)_|uBIK6AubzMs$DJmC0nL5-%n3u)@Ip?^JAM%QUcflGcVip3a z7eeMD0^}HdT2`?5hmZgM)8ic0b$ak+9LJc=-stZ7&GmQRdB88^eLBrKY{Q?J&|^Qm z8Fr1OwRjk9Z&Cr2R>->2zo}=iNQKLuH7hUE>UXyd+xAT`=BpWdHi55ABrewOH_r7t zLzLw;6tgDt)LC^6C6}TKN>!!#dYSRpn^MdM$N`fW*E_ZhTNO@o1|Z_s+4~shUxqN0 z;@DKyVHC-^B;@R;aSA|yYi(l~(1cPH+uhaOZHnMHkCSCch_OHcYt`b)1s)B?4}bZv za{nF9g$CJ+^;YLh6r;}|8?s>HO!jF%M4cEpWm)|^pXP@-6v=?Sx;8l=fZRq3Tg1DZ zq-1c@U!yDz@Bn08mjD}%M?Ni#kTbD%+SDaMP^7>xvnD1Y#AsZ~&`H+QF~IeccKiL% z#Tb?tX73^E>KA`(8;{+=c0)h3M2xLg^)tg%kf9h!Vw5SD0%47_+jYsV(FRM*z_$0Q z&W*~?BkCLB?JfR58N@=Fp235kw|prL$Xl%c0*Nj)P?C5r5onSlq0-xE=QPiuz z$v4~UsrBMMYx^v}S1v&j^WGt*AP_xf&cefn<0^)wyy?uAHYm_7?fUN8z0y6{Prk4>_NfHuv0Fs3H`1I*x zfiX}T^8lof=hJZtNKcLNPi;d9gy^GLQ@*KJ%NqOd9#0RPg?H3BnIR!K4JWbUVcB-G zz>f;a`O4i%8v7x{XzcbJGi8@9aASVGz0fELKuR+Lpfy6yYkYh>31AA0voCYMMZ&uH zhff7TJOq-my^-sG_(hX%kB=5e?mx`tC+m&Y~44KutM zmX3CR_nni;k3Y?iD>Q%zklhd6d@^-nRB|0s3_@B*`{b-q$Z;J%{R_YWyWWx|s@a|m zMlHDjUVtQF4dM6+8tMM$pMIG}gyXH8(m0(GT;DW@w{O~^Ssst`qK|i{@d$zjG-+nn z0Ef3X!+vK#fEaBKCFfZ6wU}uuSpToeVwB%scvqQ(&baCS%QXUPYn_I~r5T>W`VFm!G##zG^Rt04a-`{=$vY(#r z2P{ZP(3&*Xl9Hs5B9d+}{`}Xwq^CERwN6IOtQi^PCl3%C6dK8A?)Uq~0J%tv{y5%- z^|*>N3E1uS>}McAAGUrH637?@-QPI)xs?nL$bDQB*2mW7qgX^qmRV87?39$|$-`a+ z1Fcb|Hd6s}ipRU#35^CF4sQpnr*U1T)1z%;P=@L3<+U9hSMC9h+`OM%yTt*&XU$?dAJp%5`lya z`?mY;kKbQ8E;V>SifE(cmlT(2BGF9BX$B;fFaugUKOrPvVoDW|Bw`V!xQ0;6)FX7e zjK@0|Oiyd(R z8>@jVirHF7sW1uBnu+U%xvpLrrCd_^Xa60)(=1m1>BR@nN9FCCSIbb@oUSjY`8TWg zesgtsae`c`89vi{oSAxy+RXDsbK<+T9&(`)z-D`zU})~GYg#_ z<1{{ee0W&n(>VL2$+%h!oO3QqF1!^0e-tmvFGjvz?2xWw%TNm&raPfb+Nnw?gb z2}KE{#05zMJ_!KQ=KNGVz{)Vi#9e3_c950e2*V zrK>v35)cZsVJ36c=D6H1^U6S6kbvYz8v?bMe9)qhz$KL!*7!8escDBj6iT=2D;vK? zT8_t4K!c>(>q8gj@wj50N9$5pN3Auy$bK01jkX(y1t|q8B~vb2{gOxmz<`9~?TJ-r zQ|q)AuISvHORm+ZT%+5n5_D}tfu3{HF94CRjUrL4bJ`NvgsgM^I<7@PDxaC9Fa6{V z47v@{O?v9(*-EuPTsGUb1ru`-WMX8lg$*xbtFPLH6Z$d;Rjo}|m)}-mXi%=iMoP9T zd>-1Hf(nYN>4+Nc-*&(1lG@ntH5bLb3!CRltanYk=XqH|MwsTtSy`rpe$NV~?VC15 zq~wu7IV~(69s)U%Z;0?r zxk!p(o*ptF5jjD-Zn$~({@R(%nnDp2RT&QNlU9g6!BA60);zo7cTND%Lj4-ez zP6^?a@nsIn60I}WKfd2L1poNq-|sz{vaS)N-L7w2 z8~R;ifa}3o;)=Ip<_1NOL<(5*#(;WW7pmE-FEalJ&E7Wip5ObI3HaCjlp2!yqWxES ze>LV>5i955YsuB4E($0W+fs`9PnbObifubY;q}TuMj!+3>iXTg>(;T!>j&>2A0Hl0 zKGOua-Zf1{GnWEMQc{>6K8yj7z{FZJ3B@ETXA<6KS(@*i*KFH8Oye|L5gT++swCY) zg%eA&e}k|tfCl6Uz`=$TXAjeZT}-JU`_p*z!6t@eky0d|R`0<_`KI3#MOK;wI zAhx9WWox*VGXhZ09BY>xr_zW5Ag*(3onKB-K^s;BuHMGHNpTF2nn|5_isC(ADm@W)-3P6NQ?rBVSPwZ;6L3> zsW8fliM7V6BN&JwC2s(W0>GhoHHssH0$5{P^liU)m9mT&MI zO1o8Z$wf*MBn4|Tof>^DOQXG@w38oe*^$T0NPp0#JPsYGf?Z3vLNOpB4E0D z|K{yg=V~Ng0mMKiWbq*^aquA(P@@oqwOS!M6ew#O=RFcEKx`Z&h)7Bzp>nnc$puML z1wv$z=~K6F>rhE+iu3e%_wi{Orxhd;bujH3pAyz}9ker@V;_zS6$PfYZ!G@)-EJU1 z-hX%;*91Tt?qLyt2%n_}bBVPBYYnH{zHggwv@G!B8bq;e+P-DLSYl$ubzq4sr_(Va zc|T7}oB$1NtOnZ&Cx@K!vifYbah>6u!_&Y1+pqUt+Y(phOyBKxePfrg>3g7W898Z4 zT~J6B&MY~LV^&1`oQS9uBlI%C_iB6hw_AChpPwJF4UMm%Px5O}ihBO_|7iobtv_|k zi*nBMZPIxcltCtJ*wz0?SgZg__ct&HzfY$}OfoGI{N~S-9N@IcqYv{c&?U7D|L|t& zM4p+Q06=^Q0ayiKR>&oaOxZLx`cNTb`NafUf(pVk-_0k`D)?g4IpRn}u= z-b*E>q?9dl4B*}x=R@)<2qGz_5_L5yrX?RkMht6Ax@9!ZG9(4fnh7PQBxC(%rvs8#?l9&oOLA(z!060l(J7XGyn&uO_Y>yQ-zi1mk zMP*P?Rgy+g1yL6Dc|h@nCsody`21q;_6q2PXJ_o9OY-WwF9r09RL$W^E~M&y{*qW{ zE*n?Fi`vxB{JnA!i9dg@>Q?Ro+4?-cx7p%4DW5@Izo)&xd7U>BUlb-51;FmCu~vY* z9+itr3|5i^eb5C$WAdr8KqNj{kXV*rAUTM6gPVB*(7fGaU7vpXmk+alZ=I=$!y?NP zVg~l_-raNxu5BEEQn^5hf#eaw8iIrgF~BqmD82wjBZ+`5hJD8oq>?HH;0ABepAvwi z0X-Q0?z@}8Ry;P4qF-YKVA<}6LlMA1_i<3LEI^{1a`8prfhJhZ`FRY{IXY~N>i{2* zlyG{SO~Z^B5;|?I{vvj6b|E1`Rsrwa)!VE7xk{&|p>oNRmiZWW%bbuiEGQdAgunoF z>99(U*)X740|_hOiU#|r8rY`q8(6!8Nr3@CZm(BgRWObxS*P*S-Q&Ch05cH08p2cY z&@JGG;ijWF+2gR&O*gcM*4Y1cZJXeyySp)L18=zQO}snF$jh2wbON+CjTW$V?Xd59 zgXKvk6&8>7;QE_)H~Y>gXGv>aOF=Ub=g0epnM0iBc?HmD*tSJG40B?=B|)GGm@p>^ zzyAEo-2{UiV%s*m-J$K7^sXQJ2m?tgv`RsMy6iJJmrSfQQS~s-Fw3vln*T_SWZOu8 zgHYr1IY;>RZ~qJ1Zz5p+QwBDJoG3H+)cX;Jg(Xh&X`136@)a}nHrZ~zoM0HjcW4t@fxMv^H+f0VM7+EuPTZTItVzKbL7<-3Y9)NWU4|m8kAed zTXApgd&A?$$~YzxV*O`{KBLu)w3IB3&8({=2cOBf@N6H>Zp-g|p#UmSzTk6I%B%Jq z*xW2w-C_N0lTxI_0on1UOvKn@o%ZRso-Wm4Ap8(N*{|)P>`t1-sDu+PR%J5MTx|V6yUbw z)Sw8Uhkc4E2<+j?x#Q{KVf-2Tx-*&-WG!KyLzq1d@7}#@xWHMb>m?}N4FSj}tl3Mq zGYuSIt{)!riVRAu*qPm6_5SA2tQjCxL^7Ll1;cYJY0*a8-gZB}yXlQH3Q7^hWnPyR zS!0y;O(bQQwJU8KVHD>aC`TzV3#Nj`G>NzAp)P>L0w&vfKpq!a^gIV+TP(9k@NBf& zFjoZ%P^@jJFQ?TwG;iMyj+Z_#3sMXWpu`k&EQ%f;(|kNVKF$*c7z{nbFHXzDkutmC zaJ|18_9}H+{}7w*aOkcY>xRw{Fh4#-n3NJsfBpWTd|VzN`4n`UHNeg_#s}+m!}ZWR zKFTpXY6P)w#qF-I_SdfA#xOClQi>EIML&JIdnANqic%>*`rd^)nfyR60bz_z;DWA(Ga0 z%Pw*&;V}Nw{P7}cUL=C z@wEU{DM=HGh(ss>aty143_>m|_B%->r4=XzHd&>s&Eu^iWh3$}8{hy`D*Gg;R=;go z!&kCYXP>B|IOWAhUuhLIbFqw6!{#XJdGys{g_n{hQeqUqZARz}JgHSJte7&D^Z0yu zCOmif!koXjlJmGOXQ`hpM2W2uk+)+iWbu5r^b*GXx_t&2{mNhT91hLOw0#q!2t>l% zssgJSB8?`=F#>Bs1;>_z2sJ&nh&p94ZSNS80y^hdC}+tJ{N_i=1%Slp=Q(;W=xz>! z(;1pweZWj?yB-h^50U-eI*2y=H^0u|{J^yyhJ$O{o4yHZ%jaY$ZgPqt#T>xU?a<#G zc8#`*g`iaOB3Y1=2~(3z>zosn_A5g|(ut^1m?l}4$+OGK z^urD(e|^(m@AfS+eB+EsB5CQOX>AEf=bSy8qCn>qJ}xHUoMo@C<}xR~#pwHbI^=V# zMHTfGFu>RL!mkYN|1aB%B8`{VQ(hJmZsmNx-}B1?D8r@^EJ+)*n%|A?A*UyRLDIIl zNJ^4RjLYK~kbKYztZT-kXeFs1j*swQKynW8IH~n`7mdl|!)i>V1wbI(wO!Xb$BGmv zE0dK%QC26)Y_wI*BBe#AXf+bX2Jj2WbR8q~OWrM0kjAKb%~0Cy(p6h>AcBa9A`mg_ zP5x7roFsXSwzbA)DLIQz2|by%>0FC2&&*^XIboWj(N1Y*WSK;IX?DY&F$nq=z7--yRO+hsH$RCGD=A)LJ<(t8p68Kg-{2t6Dm8YTCCEU zNddZ+eP(P-B5&zRz>h=MKvA5#{`w45&)Kf9~rH zR@q{quaIb$C7LdkAB2Pr%zsJnv1xB6Mpz;yn4<;*lDsrdTi14dVCYL{3T1t;Mn^xF z2F`U%SztAC?0bux!+4s=hGkh73EK_qhu*aeKyyX`6gSSdZJKj}LlR?MqbT?5wf!&! zU7#8Vy=%MOzU%u2s}w-1lA(x=Z5)?HJOIml=sHcTG%BjX#{>qD^GUed?`lZZwMfX4 zBPGdMlBD8;2}w!?=K&yOm5Wqhr)dI`g->Gg+Bl;@K+bTVZ>(9{+{4eZF%TJBVTO$I z@>Es0ifNkmur~=Xh9Sc;c-Qp3 zUgvdPyxVItZKEZ`B?6|EmU}nshNiKs4Ak%A+t#9u2+OFoI4OYS4CpGf zNI4U4v*WT;r46U{!f*S!QOalT-pdPm37GsWc)5W@)r)C+hEjgfE{nzHgsH9W=x+tB zE|>6m&@`7<-+yrvpI_w*DCvugKD`2%7Myk22+SoT!t~PhEZ6NgEpfVSot7K7p=z?E zd4KQG$&&h}Km!`07%nx=0R`Yn5K$z}$A=XL)2TFM8XI!bAlEd;Ff$Yi3SER{NEuSb zfir8QxWqv70z7yfmsmsnVt{@bBHr9I8bXB?bYq*&1wvkZj0ubweGm`<;!(BKWcHDF z89*-LL)JjXV7sA}840okSp|@FhO;KS&RIsznLF26gDwKLgK;{{tB(L;0FX3N2E(=7 zTSf|Ncm%(>*88q?yb)(r2V5u@ky05cbCT%e3IJdOY^6jZ5d=<=6w|gmXOs(8KUX_Y zg%w{Q62CeEN(PmxPy7`>k8mdVda;L-^WT?L-`RjvpYt-{3y>w}stuIuI3pBwMwwLa zsl39Y;8lwI0!l`86Q8H&#oq&v&vDLDFSeF>oax0tsO06x9K8sMJMHvnM`EdKM-|09vU{FCk-K{|D zJOD^u__iO`9aPCpBWXRZ>*`rq0CDl*T-8xUh=5!Ya#4&z+I3jn?#(aDXl!e*TBHnv zzH>Uwj+vg_1=Qbj>q+wPagyHf=a!9*$EugBvYPi|;z z*9_OQtI|*R3xX!w7=|p8@%E2{o^DUI$E!V(PKQJMS09j^1>D{&CQ931UH9SveRVK0 zX+F$&b93EaH%)7pS@#jHYpq7kVr2gK@Bi<=oKk+8z)oZOW$Lk_N`e7`fRVR}_gJA6DOjIw|N8HbvwizV^YdQ-gJmi|Le_@z zx`Z({JsQyvf19TeVg?lEH-Gov|Nb4~v6Mq8)cyLYl2k0z(PyEpCXw9_UZ2 zBII(Zh@=<$KH8*Rb1C(&3)H0I0$$98Z4XJ?#4KkZbir4b4z=xip#DaE`15W&m!eqJ zq>U;?N`WdHXBEy?Rsrfv)QrzQC45FdMtHU8oe{`XYK-gxVo+NKpP;}cUzn&Al`W$p zV5K*G8%9EB0T`{{|HJ*SKmCI7R{P$;sT!W=H2)|i&bJTO@B6+nEGW=ODB=MH`s4rY zPuHzrQ2+Cn@nM`2SX=eocm4QpcSudwIaWY^#{3WgIR^n*UF(6ChhJ_VVocd8cWaHs zh<@%`0GU8$zr?UMhnr!yw+d-x4q01nyOnQzUPmo%0aKno{qsLP(zR)^9$`$|S$q1Q zxB4I7xy}kJIjz_s-s1hRA9NY9hM%4o*6sQp$4{o;BTt7nO8epc4_%`PKo)5lZP*{5 z=G(j5dG!UWYFf90AU5CGuEqH9@peS_`03`IZI#c@`TSf2ISW8Gp6}U(6%BwXMn7ZU zwvGkMDpL7bxTZEr)kdfRM0w%=V1s8UjVgj#StwIQQmPGLd1e5hGw7uTOBFN4_#6^Z z41%ipEk#sKA_0&J5zZwSDAM&a6yyTQUYu^;`5*dfFPS0Q_#6W zb85V`nuC}5y|3-^erH7GCCc^L9ex=o`N}b*t#h4KB~J*8i?I`SSf;S}80X`-oP6H4 z!VE%*vk&tc#dbq$3zPz7M$-*%?^}drG%PVDXcz@33(mQQY0pwWify+K6JRuxutu6x zCL+E2dq+R7P0y=oxM}xIqY+Cgf|9^Y3`I(7YmMF>KE23mlWPWs5NvN{1oJdLHX23) z8pbqh0w7Y>W%dC!q*B#UF2wc(R0f}1Qi{+3JF`JqTKoRs3~@~zl?=+IR!^ohpB|r9 zVYH29LfMkr+j|foXQeyX>13>h)m#uMh1Jg?z;NGpt}@~CL?gk%w8MVaJ8PJsNU6HRm9(CYYXY^1 zF&Scu#AyL)B@;L^7>p95LyZeTwTB=6@BiD6S83jz0OhnX4V39(2_YmTNR9w=DLE$2 zSqOM8%~9u#=^4hnc{-bQs#z0NUcsur(!Noa@cahp<)1Hq`BgB@(5N>Mdmbfg6>_uNO5EdbBu-bem_B`E!YC*(r$OOz1B>i zWZPaLRK#dR5*Rc|!!)*GKr3TloHb5Ijm597FrxPn+Q0%nWXWlx>_FuTWoS2?z^rLs;Y9Tx&G5KMMi9ZHN#~j4Wl$f0w-3A6ga62K)ankT9%ju5Qc|$ zy0NrB^zQpdLS9eMcHei7QkJ-2ng+1Z3Q%l}YrAZK1gV6um0L$K?^npwn*E`}7$?m4 zZEIkdAx5mxx&Tsqn2$j?lw2Qk^~6cA@tC3H?B|n@uxvY9#Rk;=>fM`8Z(@L(?o@%I zl4L&K{`DRX{jjg~tNG4QjNh*^)F* zr;ne;m}*HnB*)cKp4ZAs!xS^vHrBdyu*zY5{P^L6w+hb020C61{oZLNRA?r$gcQQO zK76{HVHjx^+jK5UoFcOHRwponndKa^tbt*5`0s!IfBgBKlVv(i!iF>}VrdX9o0NgT zu82rdM1iBxe-o`%cO*6BQ_K0j2~~TA45)Qa-}o6WX@}1~1wNl?&#RQ$uHd}1oR3iD z>&9x^RhCW8_L8zVo8*`IyXQ+ifB3Su^O--t5klEOaOHA8#H17xE6T>2W;jIzEL~Ox z4B?`P3ug*VBO{m2Fe{H;QnBY?GQDL8J4Q?)B#EZv>EX(;SnDq1Nf87ogdmxv4QM6~MTym|4T$Q<%cYu*1Hw%&H20w^u)e ze;L=+JOPL%X%GwySk_Ecq=vZi#FFdR{m}*l?-G#Wh_)Suw%xn-<~}Y*%AUHmZykcj zGW%eEglz#((Y9%KOHn9@-bku7feOU7>5tKiw7bJj@9*PjLBH#5)v=A*xHN+$`FR}! z`sAaW-^{iakpg9wl2Te1Nz|g*xxG^W-2U+P&}!ObwM6P8E|ev#_rH9Ya7Feo^p+J$ zmKOoBB!VJfXNzk)n86{>l9tC&;C6ODG+l2obFx^BbuEyx+*l%3tN~?>P7%omfW?8@ zhS?=lA_zGXk7=V>H$&eUqW}%;;H29%ydj1)8RM80N|KO1-kpB_uR^R=vfB)wn_C_2tCnz?=P?`~qn{^OG2EfeF;#o^B--dA1 z2vA1Z7}LtERvAY!lrNJILop=QwqL$J-Ij^>Ed*)BNFdItAVJZGncbw}^}sa>;}Y zDoFL&7cUTS0+@AYZP!@?BsXYhDX!zE<7xJ|UcykQHJVu|NbsknHSO?jlsH)pIAg7L z=K4qIH&y}6Xa}#4asp#fV1x+%u2;|rB_`u6D-hUP?I<39ji;T_(>$L*Z~I~>EFq*^ z04S~7Vebrd0+3=@*O(Oi(_O2%Z`zLN9A-y`#AWtt92%uHsbX>y$r%F?TL!}bB(dIv z88QeZU!eP{fGVa%YE-yZ^_^dO4JVe%e_jrU&+>b!F72W!7nlMFB&w1}laf*yzG?+H zYE{6?;Y?f7uT+0ek<#?JGp5RG3snHc8T1NP^Vz_y-=BAX&tHB+fA4pJ?G&YamOfvr-=lA~Y$ z?WgH>JS9LY9k*2p0JC9cYy3U2Zu-^%2xUFq-rkKTe+94xH821~A{E8Zx}>-sAMdAM z|EGjixJd&dc=+z7^Rg@<06@bGW@`T`D&bT}(! z#aa<7D^1^bcjeKqoTQWuBdP(i#-)b{C~7LT16j@k32yrRhjb^> z55q3m?WVE-SUrF$Bh933-|xp&=8Uw7;`I&Je>vT-CsSe8GN8FuAMD_up%OE8HVC-8R<=*_sn`TdkQEL#_1G@i~zO1M;ogZiYo`5Q6yE? zujk#VMTx z5jvIi;jr(tFsDpb=gfwp_c_73mVpofiLejetx*7FfU-`j)&^wSuJt(u0Q3BGJK1Q5 zSPI#;pZwG9*gDA~1u4vrw?7}##8+3k2Dpte#!89-tKD4ycFLs2b+UK~^CRTr!^4af z*0hz&7^S3`&ZC)K+d0EPR&;qsb6vdC@gZC>! zM(YfJu~b@0(a*6GTo|PtE#n>XJVio(xISDrt<{P1k}y*PrCG7=EC6L#F$018XcjJP@$pi3&hMBc9ZFCU59uQYRlQrL2Na5;sBQFDj9Pt{-%9ZPW_Ivpr`t}pE@+OaIl$6xLib|ra#n#Sv)$Fc$_$;SkMwbmN2eSiJ-&^hSE!=xOc zP3sygfFK848CzYkOr@lhV(^Ri-loK*up(w-v|=&PCY2;PQ+1y|YgLx$bsXRl7AP4Y zM*cD~aYjIW<#h|o7BnY76-GuWN&)Jb*%H`RzE^!-E};UnSez2$ zP0Yb^n5pejX4cADQi?Q@Dj8*6AIGH_uk*^Q)ey`+EFPeS^nNk(yi5W!F>}@>tYMmy zFE9WK5|Payr9sG9{Bpb>KRybQX2T6z10>ztyc-10w5$N^Ph-HYK|DQvc!0#X7H%_8 zVrpQ!u7f0xsE`0HAx!u8caIZbT00Ew-fFg2H+vV>xJ-hivqUS-wVg$0xL&R%W4VlK)Sb6#Sf?kTk##nh__WEXf@xsfClAo{6 z7*sNd--M)`?c8|@$pDqhU*+7}S-F$&%Ayu1AXA0VoiA>SP`wVbei3n1=bv4Q5jUpo z7tg5_CPnHZZJ6Wx<4K;!U zz;^C>V5S%sH?zeW@Bfc~{Up{%%DyBtmXHn57=%;M?cCIz*D&mNheM;ma1ueLEl66Y zv;a<#of{}!G73axIVbleFu3GY04UO|bODm2ASnUhi$3QoO1%sCXzQh@{0u1BV$=%s z0yvVN$;&?5p=D6!a^8`hg}XA9N_9f0^?VfrO0TAjY-3MV#g~mU?A5#@yv9k_0jbpI zywvXm$YLE6C= zrL{&`j~^eJ;kq%}IcLJ!3uAn^JNi7HmL+5|#Za2o6vO!G+9gcW_%KcC)kJDm02^G9T#XOYT{w-OlCU<6k|Y5s#(5kk!0O}x^ux_=u#W39kc-fY zQUyfXG#65T7C4&~k{^YwF54^6)mM(QOphml0U@oq5*hLCc#L9-1BHv8kl zooQhE;m!M-UFV$BOoWtkd0xr-e)`i2$T_#+>JQ1AtkM+hr7GcLpx&|b_B6ewZpr2SIk;B#E513 zyW^Z%EAz+OpB@200=e^8=5Ftp0THAm*_If6g6UEN+qe6@bJ}Ti`_Af{w0x8`WI%+8 zjooRq-Dx#3CurApcIWaKXOytU43XkXfN&p=%Q$BM+-l>TZY-JBIwl2_vx@!eR)o$9 z)_8#o`D)wDp4w!{ffr@MuRGlUAg{c~=e_Xjd`Laz%UPLe^V*)_b$FHVdpR$^wC0;? z?k3*;;-}9iRamYJ>7+SB_icHgm4IU4Omm-+6W|6d>0-JThK718S+8OF4x zMVh=t6Y3`S?J)F*wjn?>k~S^aB$PF+3D!Atj35R>G9eWKjBbsCEP;_Ji`3F%Rghwg zAtoq>R-CK1^Qz>WstQqtAt<2a=Zf@F>lkWK>g9O6khpx_%9%=KE9=o2QXN3r7`~u3 z$nfXeu$tHeAq(dVKKkY0#I_-PdA@3XUu`5m_fM5V&a5uJ?Pl}!hPL|V_VSre`l~zI zug5qqmqGE>kMsF%G-XXW7WoTdkqG55E^Xh$@bKu%0buTT{m>5wmgpA%%^m>DNMUdE zae>|8bo+5itM}}5|7J+=@Hs?jr_~I?uCeT7e*F1E_a4_p8OK15it%uFnh@4`nIo9c zS=T6y3AYEGa5^qe^R%SX_?Pd|8NND&57(C6DJfKrU>yvpVZIm$pgBz@UwCR z#C4g*`(x*lX`o#vH`iU)8GYX63-22J(y(_3_Vn(K%V+i5t zaYnOC&?QL801=p9?8n0VbobZ4Jb?SQi_wT*#=FN3P5l*_GA$7>7EMm=c$_Aikw()w`1#~Nj-a-`e*0$MJS4zf zy}M4WQ7E!5)5FI*fo^PLdnTQ7BQm_bd3R+EvsEaewD~l7xcTwJhhIlPX$>Z&k%}hM z@4LaNh8PjZk3HqN>KFK_?VBuSF23u2$C8gUX4Ns4v%%$ak^F682E7jO9c zc!dZ6fk5`|!C^ysy1S~9dV~`rs)h&mNK#cj1or?YE!CNk9`5GuYNqVdPo1}LrrOY0 zTS|PN$9dVBUb}7=&>p6kN(D@}Ypo~5NKk-ctVv?ZxwKQ7=1~v;-?9zCc}G43Z#R;_ zZwkJsrIl)TvrT?&1wE_1SL^0mYEsX5GxJj2)USTnh5^iL3g>lK(`~IjSJ|(>y};V7 z=wKy0F)5t2XjLe_sp`)M!N8E3YU(o@@XH$!sRDrIjB8QA)b#oD$1I*`|); zGEdd^`_=2zM%y@X1=ZizfCC&4K4$4d_2Ys?Apr@hh~}QDvJ!mNh!>i{(vNy zZP)w2sI@A0t9uB@>?)|FDb7Icpbaq@<4f0*)MA_6zH1t`gzVTBULOANfBTogmX67m zRG(+Hwg}}4 zY@rSMPOn<@eM9n91O$edTEI|)dM?a6AMwrH_Znz;dCJ$B#3v`wfOP8^WPty1T+6q| zU&+LSh?u19`?irX1E^K+2kyPb`IwUrfN7fEJ0GNNECA!KAPXRqg~vF+B@DN>%bGv4 zzH8G2ATkV2V~hS6lT_6*-rw~8BC&gZdE>GGK#8S*7){r8t%WQPw>w8mDOD<@#Od~O zslS?u0YJ5{+U)}3;{b;D4NDwwAwVu^S>`DK0J8n#n#4lB8UsREEUFj!_5 z3$|;;t*IoaHK%2s3yilQ$d-{Z=B1IdjE|r1Zbt5LPWz{2GCkVE)#2bB<0+|FGS7XS zVNK1lVa`#aF7s*LPF*Dlm?2Bb87NBdLF1AW3}N;UNXtCekArvJEY@NEeJt>A3s4(} z8dF;4VL%|?htR?S#0=keeH%PE3n&*o5TBq(!$VX6Ql1!lh}kyb0AAsfh)S^5hQ8PX ztaFZ-Kq|&rf(`xE0?ALMH^y@CAr2ydZ+ERTC>jN9JYtk6G0j;s<~$~>3_sSfb(V-$ zW|&`n`4CoPl+K}`^-cWx;eXqB?lJv5{%XYYKWuCoRBQcpz4x~btyQ64>~}yu{rRDn z-h0agV~tfvDOjQrB6`*6S{6y(0)moL%4oqH&MW8%FkS>%mvKJ$?l1z#aUKI3k6LA! zhud^B@MTc|EYoBQV$o9EZk;56qVsYb##|9UN*mUPEiulht}VmWZ`!_Xz@DFQH6a<) zTmT@$u!yAOcSp8o213i$G5~f>aK=~zR4)cO-u`^Mxb|sJWDX~UE?DFoxwX!DVKBO` zZNiJq!m;!iWHx{lfkd07LKU^FU42|NHAsy`IMhbOp7-56O@zhy8g0reR)^Q)s)KuHW$m2*3Tzen!>?g`qng48Ej+Va#DFl2P|O^HBT ziuySruwCs8Euw9jN(P45RB-pk?J)fO^G##}h~Q*Uv#qWPAlmi5 zY17T|X2`Hq^B|%?BS^mFA>kGx&Nch_u{zUUT@APQKi!wcH}fJhZrZCu?+pVr$zkd( z@$OwhoKteYy-N2(IsWLSe=C9gyZ;J&ew^_*-@XsW+dup=7jT^)hvV^NJ;@S_;RNzF zV7iMb?|3B+u|=J8B*)g}5hWRa%XxB(QZOjtSm3?ICDlwzSpbtb#HgPu1)g0dS_` zh+#l?(O!VsEIZuyjVcne9`YD~_J<*3a2`0QF1m`d5(g?ME>HRX}AeKm}feZeE5Q4bG(# z&nzr-rhfwI6Ej+^cseU!V4f?MS2Vj>e>8O?v-m>w(rWq%&haFr3ZqYCW$R8#(5CiQ8+XXfZZVdT3@}fubZ70xWNpYH&8MrCO>vt@9IW0>n zNV(*N1QpDdE3E6=g`M^CproON7Npb8qLRk()4%_Gzu@ku?d4%%XwAbo0f=cz!fSPK zh9dN0d74Gh9xl3=KH&0GB+5tR|4{EI;Xjt#A@B z8<&JWXQS81*Ev^wroL7nfX;T!mtK=$ykO0Iq3vYD!mI|H3UnosUn}%LwQMU;;MR&g z`$ERo8E&+nTN8*XFl30fSs6L&;Vn9{s=pTr?em`q&?yl(l0{H$akj9%i@7`P;K&ShA2(ZA` zl;>lVbDkm>sc_9zE{_?-|5wD@f4(_Ihl{uSzH=8)ixj;%PGPI0M#&;3WjSt4^0pjATK@MbgivmXKbLgmW;v7cH>jVd1I^wGN}oH zy=X24MldbJnje4q{eyjnlXjx1g29Xw?{Dsg89&`<0({sVuC6;;Yj9;XNT2|YLqzvB z6$|fKa+)SI?+(}Rez?Bgb)MEXiYaBq;k&@gkXnaUi>-B&w*2tvuE1Kft!sN{9q{w) zn!~QMC}`hZcVW7(@BgRYnKInp45g%^Fy5lfGYjUdpsTw*XAHmm;g27cd=u4{ntZzK zg0za#w!!(}6iIVRvYa%_{BV0aS4XO#(6+(ew1@W}ez@4T&Uam4iN+i2)dnJzEPl7G z3&NT;7p?3{o>I<^o9=LV*zY|lYOQhke1xCk?(t6mfWRI%gDf$o0NhOcaJ)J#P1EIA_>d8{)XcIqN07LmcO2nnwX-kZF47YtChvqe#gq zOEOi3eefXLv`tgUJIoTgt~Y5$ng)vs#QUHA>5q@0c^qx?rnl8QFq&DVzJ4?&M{>Nsj&hC z-yOsr@7mDLVz~)sWvY-kK1`qgJfPRm0F9tA?c2+J+W?wt60r~j_B|ko2!{)YsgAIK zcyyuht&AU==EDyi$A~6yrCQT*>iWjmDD&yK?>x#BbE!wu6cHGptC8*D5M&YWyxaDE zRx&`9y3w$xZlQ4kjHL);LFYHV8Ann9R;p0;P}S8K+UnG+0HnNT>CU_V`d8I$<*dy- zUZsue6LjTeoZJFWnY-6xU54`N_ibe26-J}RRtW0aQQ~}H5jJEhM6m_-zlgn^^8rt* zaa&%-ti;mw>7#FqmvGp%)c<8pP^s!xwWzE2YdF*%$a-_10qe@T_7r7hWG<6Rl17k| zYH5ru03ZeTk^%C47g`S-#0z70w^bB3I)A zO{WJAg>7^BU78}s1sKQsV+MqP6?MXM+laA0SNnGC($s;a~&hAp5XCBsw&X-0~37G!h*y09oarIO>r?WZAQ zP-@`XtKH#p=e@P=TphK=Bhpw97?ypxLopuI^*CHy?RMw%Vuiw3XPeGLP78*87q}{5 zDnpF1uAQw9?ZLBW>kRDWZ~fuW2Zn$z`c8h6hu?m<4zg@pajrtN#?=H2@r-W*!Tz6*Zs zj9QI#){+_+=+hENN@O6Zq&c`w(D?qUzdp2$sadA^^wTs=*|gaSda zJ2-CGl7ke4rfvO74zs0UpCuU8)YmC~^EEuAZs}j3Zm6|YAJ+92P}g0C&Isoh>+Tgu z#cVLiCyn%S-E9hWOInYxM?D~!@lz_Fxzr< z;yFgltoD`#VB!LZheJ)mD9AZR5ki_1Jhl5nAG{;coKnHg1uHK4;JmX2f)bb0G$-W- zwdtF_1sd+JF83{qM5}_XAcCz0gP?uytrG^gEfB$ky2K>`Wl7$5Xe}gJku}`OSer;G zd+Q3rv{olp=L{4ffQjIfaLEiMg)^ka)LL;ScqZuP*ce`W_-s4$d7LAi3Xqt(LZSJU zRIQqB>uR(%i&eA1Ma_n#sr8k-{Y3~gzA*E?eTZ&keA^n`gwa&cw~t3v)fLzBA2wc0 zQ&v8y*NX4O*o;C(bJ4c@>rWqV?-v_vjU-T@Y&K-lB7g^q#%gU*lm(3C0R^sYc3rpM zH>NI$K3oU;-4CBLnu|RziQ2x~x52uc&zX0y4;N-%;OqxCHPbLJalW~%F2FVyzqNU} z8<#lpG|Ygr4xaPr<6Ya@G7q<>@gE^tl2^#M%cU?NeD)_(S_*(HBV=h>oi92MbZ8%h z#Z|z8tz~NrnU{&zyi9{Ij3Z4;PFRcEN5pB4!a(RbCgO&yp_(2){=YvCzzn!>dGYpb zzuULg^An~J01Ti4XDr)bhfe^!zXaoA-|hBWkCiiCiuWlzwG4l@@n7x?B)eN1P4LMN^NtvI^YyT{P^#G{AExI zE)xJ)z=T~09j@B8@s>p56EY9NNo1FmgVP!^8ic0Cvz}90qI+I`PW_g8&BiZvbYHV*u3b zcER%oEcr@&zo{tbSB@~N&-bG0N3_azm%jq(e08Q5u<0)@d{#GS670VzCbRj4&6`sZdA#M@%Xjgeaj+x=k!&MSasuXQI3_q@0U*OiFA=FgA-w8R zO)=U_%d15$7StRrFGE0#C^AE0?2uG)Tr>fb#G6m=-|zh}r8Ih%=earvM#-l|oG`<= z7GZbT_kpt`;BXxs13D`G>^wINXeu=(znb2q#yO_!7!wOz*Ir*8d}pC~8b?9s8B$kv z24*16kN0;|oC@`9oBg5dYzw=)x;j`Eq{M951hEBsYXKWflH@z@$iRd(r`{Bxius1C^Xk>sDr>{lF9nXVnL5I?u0`12 zhGwk`=iF0U1b|^fFG2(_kNpoCUx7G({ZLV@P>;*b;+0f-QEw zIkbmE-$5ewy>G97^ATuw2fi`3@vU>rlu}F!=9Fzw3WpFY4Bl|(j-Q5-$4@AI7p&VU zk7Ih63J|B_T;CzW#Jl1<>yU@jAc7cy1VUVL76Au^0JR3ol(H#Sh4P3r=O_T0&cu|_6EUah?$3X?8NrrpxcuG>V$%MvO)OBC6c6WJk*uOnoZao+bvk{477G`f8n<`aK zM`A$=6zM(4X;@mI9k8X%%)r%|!N+x|v}Z4S_z$yS{o1B3K`#)q!;sKnM&E+N&N9H4LtiD1_Ti$uDl zg@aZhQ7J`S_UjfLLWyHFeZOah%OHYr@NCbWUCw^Gt}nHcg1`a=sUcC&nX__>+tZfM zT3@e06$RB--C{REIpZr8AQ-JuVZe;F58am;?iZHdH<6Gp0ux_JBR1&rnokg8Xv;sW z3hYaG^;)WmmGKd;mH&2!1c26Rhv$2)fZ6(Q{;J}8G2w5u$gHX_LcHrvU7JR_w(FYE zO(iY!9H%H^Z8%&9mY8H&VRp9E5^Dxru~8RTApvm+q3fL%1n>3DZ;w5?;4~@uU?3_I zr(sISaiLVe?Mg|sXOB0R4tkOimwnTc>+Snt__@r0DD4hcJ;sDOqlZh7^z@1(IW#4m zTQhBlU8XH>r+Gnkm{D_Q-O8_30>DygT|GoprMhi9nwR5jVc|?%=EXFg1Z6~>X90kw zDe+-Q7iF(#7+XU`9(_CD>xjwW_u!ansVG0VWV$d9FkqXI}GZd~n9C{zt-mlN^ zqE?7$;Vnu{E4kNJzf~39AN=Lpoy+-HtZ(<-)fKz7v6B?zZSiff!8;|GqFPQ-m~D|v za2M}>_|0_(d7OqR=D709Yf%7TYkDtI&~<$XBx$<;k2? zAp~ZYoJ)l3xTdn^Uj`yJ%H>YgQiyhS_P;Hj{fClRnJY_d5p=*!hqJu&AOU><*2TR8){L zq0AX*yaiCT7?F~vXgev>91Ajo!~SsCyT}-g&Nybd&99TmhS>oO^F?g3A8oKc!9 zZXHHB0daJ2fCJjV%*@s@FZ0^Uv+3IiFiRl^*rGGodw%Vx2fy#z#uFftma!OSK|0;v zKtk97n#NB*eoP>-eFJWrUB@CD#Z=7eyK&Y6);3)q95t@77DB|ql4Q;W1(wGhQGtP}>kh)zD6M_Y zah4ndevvY(Taf*g?CAOE7k1EA%xA!0$obpflAP!9!dH4B!{3aJtSfXiO1G@Rc1vHL zU3KLKRcyr!uk_xk-PiiXwE*$Otv$=S!QaNV_N809@_>`U(+VPh)fHxA{hPU@Wf<=L z5^K|5fB)Xgbiy$KP;hI@qev+z%1>=eRU~F%B1YpJcHh-Eutla}fs`~)OQ@&e;qKIq z^IWYnF0dg2I>XZMTO?%Vx1EQF=j(SLJ*pD7?jJ7S_;f#%WZJd8SZ^5)C;}k!$|-by z7*yGZu5D*M_npf30x8nL*)U-$Q;a*83Jk(J@5-Pxke>5tB=!hqo{zIB!7gz*+A=HH zcC9xOhmWUw3(@1_{ZOPpg+hP0-1UtkfU!b3U*MlwXfD$dm-!e$@YEi<#xYw9pva0_ zs8Uj?7Qy=<-gCpmhEP!@C6NZ*+p7aDb4lFoul9#aVkUzMEnsGA%bH@NWTY^+gU2hMEePdU|ih1f$clP(r!u-<1IcGCoETJvk zTA$K#3RY5;C~<8BT5B~zVgcwA2?f1UC%XMdn+DbA^FJN&;$qLgeRFJT??u`kYl!p} z)Zo{?YY69Ao?X&&dGc4^*3EPRKuWrrU_imzijCnM0|AJ2c({AFvz`>>q!DE>8-SbI zW(Z2jIi@@=fPi5GfVg-_5{W#9Scb=G-CEnW?;B5$P~(_^<;`UX?bRDy06|fdWt_*} z_cG3@0PU{p0v4o#1dqfJKt!}EtPOS^#sWfnaoL_pt{r+e&9R`z%Mt_f2(Aeh!nv9{ zFGZ}yi1GgC8{{s$5g;Ca{{0}n=Mcc&Ti^Ktz(Nwnky`76vuxPArrR~ao7OreVZ*_C zi;|-)fcFqioH7RoQ7mPiXX=Wsj4e{)j55rH;X6!7c@hZ+N2HoSrs+5FpmW%wRwx5? zYgDin2tOlP%(oUsX+_m@Y3qMre(yD?6M*6+=oI=gDe?3v!J>n8@1~OH;o<6jScKoa|IM{e%MDGr zR217Z2WKDaq9A7j8Gs?9r!r;bhN}lNdbQUm(}P$5^YFL}+T4A<9p*X=zLVPa-UlMU zqWZ3LD1v(Xdq&zfmixoO6WH~1{eL<%xR<${9}ki1&{g;(FP|5I3t)_MyQ{b35e!({ z_6}GEKI@<(CTNvzo}9X^jK%Sp8iP?LxW*`zxSVVWE{`kyAM}J%+}^QGmn6)w|1G(1kdH*?K_;fw|wo zgqK!ZG1K_?`OiN-OfRemz_n}sD@)o$D90q#$oT2sKP`>_UFSSxy8Gk5{lEUr^=&|$ z$80Ra`mmD#NG))&loZD}9&bPX@-VHL7T>Mu(~c#7z8eU;%kSS_H4KymNbKAFp}FXr zV88b1UXIs)P~Zi9(uP#2*Z^{?{;Nt=YK~*hQelkq){$UsMpSiU7kgd%tt-s#nOx(n zXug1&#IM;4Unv4>Rx z;9P(M875PkJrsawTGFyi({b>^q4O>?QY;$5p~M0C_S5)cR%YcV%O^nom_IbT?{OHh z43-mzUElT{1v8FEz%pRHMei-ktj028P0O&P>;d)#rNTJ7zxvSS0!U&H*YA9Z3DyCI zn3=(B+a0VkD2pa%?K#ymVj715`>0ufboa+U;i+6^9LEDB1=NI#=*+qSh3>}l8b zK6uM#hmsf$CA86IVBhBM=5bs}=Sr$eno@qby{6M?9L7G_;C%3$>#+oM*3}5*z;^Sz ze>D}nzQ;mXyEE`>d3>>Vkgjd@zQxq=M8ip6xPIrEzGOW6A05Az)BcJ;?W+UmD?H~W z$SWe|73%cwn+6$0m6ztEKGS;BQ#}L$N{r5VjWMU;;&S&m2*3H=hf7vAk7AVIQY#OD6)=6)>A1G*_+c-X)zj@uaK z5-rN#_*z?PgDk`;Ns+wY)kDrgZfgoiiwqU{reR2d=1j&XPe@k(^`B;*1YnWDB;hsHZt_+BJCiM+66OM)^F$Ec(afByZw zHi!G3t)_=R|3CiwpO3zjjAdLBED(a)F(BnRXEnj*`SUzH+&?@_qp&l?*6%we*v8bQ z32xA)JzO3FkYUII?f!5Xt~$2REzez1VJe|+Ku+_e(yQlu)_L%YK&Wgn5=Av?kmGn9 z1pu*^07{0fA!t?dSUs{=>d2^81?ftvvX%^*SN7t$bn3j|ehoA5ge!lV@;NULA&|G-r*6ZSk6y7t&{wVJ+}bfT6XROyKjgA!^=tQxq@LV+qPk#srXu0j(`|06=O= zb56(Q_;{b;x(?#&td<3?ix}d=aI+*p3d**jTV#<^pg-HgWoO$rf}j2zYO&4b#oK)! zic7;#OiMS{V3E9XTT-@2snEkP_bgy%LK~fDZu{=a&qK}y&7r$GxM_kE6%O#;LpX$H z2N+n>Eoc67tFqdwu^NtM?wcFTD<^ujW!tg z=YH)3-S}XQp(?9R;uY?HR=#U0=S7hytu-m;Rd#Pp3m5~i;LJO1Ow|fCYhU*b=E%=7 z{92lyrS<8g-;%_a2asrmfjP6o*L9V!F;!ou61V)GZj*ee_sq)-rdjiQPw>@OGyJv| zG++KARrL88Z$N?bh1bcP1(qFRD#5gLs~qbh{_y(X2j<1_F-Jm3^q>_E-JGl(xirn0A!eW69pj0-0U5P z@a8wW-~EFv!^tzj%ILtX2{5)sJOjVXT8{b2p z-e9egH5I{9vE(>U(wyG!pa5m2j^DdwDEjkOU)z>ROi zN)rmLx)!3TmN*^%B{W@-C3)k(Nu5UnV>K?qt84al7 zDF^p#$eo=leYG6uY2!avhi^s+N|_%XVSvB_15PBu1eLYP+?SX%V^L+z2wMeK4&4`) zx=lTCltsl(!_!mpRRab-&G`roI+|GPt~<86y+3yb&h*GKMc3SV_x?eKx?g{ zr2?f0W*if@O?L_4*urtQJ6!fVhj2RF&26u@=`GqkFLMMT*-}ar+#jc86~wr_sI!O( zp1XGgZWF9f=r3e{nimhigs|#8*R_B`mkQYa5I|1Jz;gE9A1-!#WN13xAH%^~w{IOw zPO%tUG>-F>=KJ=FcbzS%py$w7CL&V>R25(*BC@vk1=t;`OQ#tCq{N(K$^c|7IS>^) z4UfM(GF4b|U0mW=5<17G#*%xHQY0?|5ZFSWV&_{;wbD6vCEJ@MHEWW`;7m!jwJ;}T zVSv8|>l?Eo<8a3N>6-CVTFdxg*r0qVFn{0pHiq;`^jA;xFGVy6AiR#-efg7;l37i} zCy<(M7}Xca!!PB3J+OXLTd&_C;pdxH7={JgVo{4&pK$2+JGRp797F3 z9Uf;Hmj!hZ%vNydFYQ4p3^O6Nfh~*FNH>J;evDP2X)4~P0y4y4)T*%F7b&&?pTfTH zEx5h9s7-VA{B*mXVRFb5CY1KN zdYl2`s8Ui+QlcW4Ic<+uo_n$DiuWW?7RfP=D=k8|zqr^l0m7n1q?A&WuvM^uoU@jn zVv#F|y+Y!6`}@AXY)l!C(`l@r*!9LDr?@0QB*$@{V~$Q0?%-SX+#tpuA?Vt+arW-> z@M%=AWhghTcZ>pNE69>1Vh&nNK7IP*FEb$bcaK7Rd^~bf#)lt&xy=_gcmr4>Re*A- zDTb7mC^7;5)5kn6OB4_V7YsN4&<6|lEJ1UW0feembWKQbSPS>o7xPTT@GC254N<;I zVV|=KPYJFy=DGD7FUvF>*@4(-v89Sy5iH?IE~YB%%y-sK&{!b zZT#9+>|EhOR;@BK!&$VAmcI8%W8|1uymyJEWJU#urKE@3$?dbTPMr;GAUWkk5LxNq zQk*hC)UR;PttZww3$15K*g`bQ>sqI}Ca_;9l(nnE2B3VFoil&?tN6ke6tCM}w_&WF zx zH^Bp{DWXTY`RRVKj(xy%zr<|E1ld2vqoM&Ax65IVG@(0Oyn$gN)slyYk>AWf3b-BP ziWE5j=^-sm(^-_`GECvawPXL#^_Gp!0KCV;$D7RkVZOe)svTRvqLgVGVgfo+iE|We zc>*Tqor4r2&sCHpPRE|+NNBHrcz1o#nKV{zEmE2@Y-iox0@n6G-+BOG%jZpN zm8|i{Kim(N+%S$0%jae27jS>ox?iAqN)m_R$NPuJQ&eg%E*t;mH=WJL&;L5yObcE9 zmp48QKR-Y+1&)z_W7#n~WMGgiD`VLd_76uL%eali( z>Ry25Apn?og9t-JMFHbBfLw*HZt?Ahp+X~}FWyQ7! ztW5X@Agy0#|0>LxMg|+S_30Wbjr!|tV~ZM90FY8*hGUqDEP{^NSQe8_{~JJbNlRHi zOTR<4#D-;K>o2fG229LBH0|2<{y0B^A+Z{Cp>@}XcONeDZhykt>o*jg3&)&+II$xF=aMdD-Sd{GM!G`^t+z5ig7@&C>hSxf;5~;yW6*< z5WdDR4E}$PQ^LOW<4LEh!*0(wbeBKon?Kyv9lECPXsV}V-v*cSaV@fnQN+?6la;&Gq!EjR=g_z*Y@G-a1Xw!;4`mO{kiODC3Po2ZDF>~J59Ap zE*j_glmQ|TBxl>fUUdN{sK3s$!p(vjj@?iv|s{?NRG^DWhZ1TFe1xHZ+l>^ol(`QCX@oh#&D<}Qi@I9&S{De zYq`labg6g%M8>m+2%`@!ra8ODN)Z?$gK9v=vW+MxB1=put``nIIF;;I3(XjXN;*A! z{^j;w<^_fetTj+kMS;%Kv2BQnbul=RVD9lKU z02r4jY%OBGz1Rob{roTrJX2k!xmb4{N)a}}TRbl08In_K9D~+X-V6qDqQS!J}E=zk5SZSYJ)@hvpV>xvAi63Z;sua`vz2Ur+GR+~1E-h;pg>v-fU?{$E*r~i*av`FlT~5o;JCzSz29lkL+_y_w1v$%Tt)z( zrAQ&wvXoN592^6ZWtt$s zWXmScBOj8W^+6IzEpTiBgunp71*Wvj<8V3x!Jfni>jNWcEIFfb&a;29YgZ#{-gO0a zoM9=34C<3OoZF6n9X@>JzI{DjTV3XS$tO`+tuE4+D3C4Jc9x`Vu20d$m;6ZjYSjRn zD%;lYH^uo$$Gzm|{MOLTB0Oi$#eksJ5Hr-!IYajifAues+1ImgeJ(yzfWXxiA8kgA z3#-nz_n(I1J=9sigkYMcVadzqKkGCN%NzjmOE+Ff7+@&S{X1cqbc|JDv4H*-)Po>V&G8X`hu)91oBmzU0 z$&gg3%lPo~A3oiQ%q!kgY86#O)@VB2-VG(evP4sEXA$341?q}75C##nu9nhr4_mOr zY0f4D?@7vRi??|=mFe#1VHh*FgwQtl-FG2i8gKvnX-rF|jFZie56OqdfKjYt0L%yo z&Npk3TNq~RZOQOh#>FDEwm|38(BkfXlpGE{p$K5`+aJi`1qh8bM23ir0EP_X6}b7lFrVW#Ta>Aue-YTKRPb~&Yo|_Op>yZ+^9)z( zvsQTluB%mXCLaBp#q%S}GHu#{b_rBn@UY9(R>>`+VAOhB9(sleJY z4!~yBE6)3x6(3sIA|)#dN~zI4ELa{+)dbh>uP$5Y`Y?$ZfJ8l+=H^ptyNXzg37*-r zSqWg`0$8g{k&?4&Sxb7E4Kxps>FvQ$*CHXxz{|m>g*|vViVc+;Ky5=H!^TQj-4rMU zRwSndrY><=rwvF+OUmS zvCd!7XBM_?x-Sko8!W$;3apBkq%~p)Vk(0T!BpLR#c!anSvTMCS7!F4`JQZ4g1Bs5 zD7j9Q=Q!T}cr#SrhX{hgHQaWMne*_c|0j@DV};8KS+ESBd-3GK1cW`&(uUm-Edv>F zhc_R->-)B8-4l?FJKq$kvWy@5PgA~?rF9m~n-7fX{&=--Xn)P`IfSeNFge62XQ)F& zOu1M_XG1pCR2cT;=7UF^(R$lC4*>`$nM+>dy)>tSd6Bo=G|<9qL;>=Eb+FFc4kS6{ zgwzxAGB=f-_aRsSk44~J2t8b|ZK4j7ckb}!?XC-rwQN8+1Fn`fmXst;X^!9qZPQ<0 zU98*>6>JPdB%L09`saTeW{ae2%m=DqkT+6JpFR%OIc7{*e@dW3DG)JsYd;Ahu)sjI zq(`tI$CNefxc7`av2T&nG!8cpOHs9LV}f=3?t&$qKL7ah-7L9KPWPN+gisSKpc}-D zZFo)*Sp3{@AeR-KhQhWDwg5T~jodC-jl1%u!U4YdZ~r+z-VQS|#(~_@wCos{7l32$ zJBExi4hQ!n@5D`I0TYNVEbpyteXy2R9NJTtg;nvr+}T%!p+GI=$>1z&4Jj+?3ShO& zP^m>qu7av5ra2}s?3%$L!zxNt8P<@zj)`pE*mKH?w@a?|eS(!nl{SPNR6%0CszKj0 zU9GAwtm`dz`8TV*uZB4@I6aMTEpcM0InLu8%he95wZvu4y~WmRsHxCwH9N*6om8M| zUAHtcSRn?=F7Q-+n zq%4(r+tMS@^>Z3iIXBZ}Sj(PLTBh-B^}+8BP6o&+Q+r)R8gP1?x?Oh8H6j)OQ^)|Y zUQY_ZB^egZ%QBS!SZ7tD&Qp4rCA2<3b1peMYG{uphy5f46@BNNtu+bhaDug)=f-@GfVl^G#pE+qbRWPsh7o9&@8s1~}VTBU4f0 zhF#wVM|^&Nq-)KP5|matjV&zjEJJ6_wh0j7WkX7OLR|fdusr=#VOG=dCCrlCW{1_y zuUpFmpRT!vDc9&ZpViP`PACIglh-HIPNkRfs^_`>)%v~q+TW`Rs%w_v3r+cjU0mtQ z1OEE3HB=GF$PY74kGCHm7MQEN(TT8ij#W?hKmHL+##$3l1dy`af3#yCdLa;T%P_J; zNCJAy3jk+BxAWmi?SbKd3dEC>aT>-nw(y7`40z}Y!2ZzS3_vk#%e{=T^ngsqImf^# zO`B+IEM!Z6eQ6={H1_1I^vi3C0RnQyoB{ao{IJL~TMuSyj2$zhEP94J8S4UhPcRIO z)_d0k0K(C>2mlUmuiDmat=9D%zRpw1d5#5uKfLb_heH>-q3r4Q{-8O9JKSE(@Kz$I2mC83~}w4_{MfZ*+U!3kh^EjoKu z!1#Kcb04ohBmLqtrK%*`a$7BE!RAV?IS|6R$Y4{gf6YLzzrK3^77(ZbB#q-K7JGmJ zG!3Wuy>Bf8#xNTQb4kr)C8knz!+*ZKeAy_dls(9Ytch%mImH5yorn7)tZUx>XN1-Q zFr?CV(vJ@$rujOV@R~e)V-U9aGt)!#RW0IFuz$E;Xw*)Pk)lMPYr5_RU+Q$3Ndb z4!H!Oa?c0AA`S~K+4#N}*d5*0AJ?`H2dN&-YG5At% zeoOB7DYg9nmC3f|-Chp6Ug_^tQoL$!ya4aKx_R@LPp8{ITSd~-f+VYrRG3rF({z0J z{20~ldPx(orro8KX}q}|;9Lm7w(!%UC}sIHz3DG^*SYuJutkv^ABLRWfssY>93uzE zTUx^a1Pg+x7E{1+!Q8r~@zXtWFey^9+rW6|TW<-+9l~F);)z zmhGCWg7s~iyDsf_jrWe(7*s7YP*a?z(>Uim3pn)d!|#08H?6f6Oe`=EiKow>{`jZQ zLw2kHg}&mK+#@e+qdX9`El@b1oo4F)-+Nm*4;9{Z(t~e4o;i#1h%l%`(m^sn3)_**f|%NNb8o8{uV*O6X+^llU}V>l+xC>QY(tAEI%+fyWG#_EJ)AQ;Z>fo;{>2W3@M;h1lW`!DF8nE zR8NcW8>0fRTP(f2e}2Wq`xi!yrxZr=1ORznW@FiK1&jqyeG@zJs3|8hq$}B9-3mZf zd*2vPwP5Fq&XpylwE*dKyq%TWzV`=M>nz9^L)7$#t{V)AjQ%5)Y0rQB6V%O9N^g2H zaNXPYQtbQpEuj{{7VKm7*5#zBE^u9E!ewGe#$$rCzHuG^vXtzsg{Eoc1$EZ415~P1 zI235EMW>XFM<8cWPPn_DPDAou0Ho=}&^0zd*7+DSi?a+EGL{|ka{tRC5&#v>C6%00 z7BGc1ujHHkW#?R+i(BU8@-!n%b96SRm@HezZ{F|i{L??pb5vmTSlnDtu*|pqUE6hy zwN->RWQo>uL-S3R2q2cP6^r5=gZP?#awW9j z@%H|HS|X^qrjte~HrfpMe7b*ljK(-__I=OyWJUn__Woo4_RVx-~-$f!kfZ zd3R{p!EPy=$`+C}&d14lx1-WU+WBA|6Dm~F2`K3_+>JvlX@TQ#Xx_bN=e@O-xA3?r zc^>}w@sA(J3>boU&F;|mj+hxtFveMkto0391-`x5H=cpD?sF??sgl!jdK}l-goQ=x zO;~qu{W#a6@WwJCfC7|?|E{_$^Bkq3I?GVNh5gn0|MFko^?_w-=i~H%Vl(10&x^zr zX2nu!lbQSe(7JpY;r(IfY~rR5!8P!QHy#@!<^BuWI&b&pme?}jD;1En%J%7hg^+A zjK_K5y|o0*c}WS91rDL@8#WfUJzTuM%O#=A!-K@r06q@3xE!Yifaj~X`*QkpTNbG{ z=LB(@GwJkjf3VIu=YR~$PcQx{6ScykK=O)Dg`WK+A!DFl1^Ld|w{MHl%lIN00!T^C za|Hk8k-CNm^_6p`XBAeTC;V4Oec?%MENm~Ysd#Qm@#}?tTfY9hxHhV5C53@hc@YkJ z4d-0>v43@Ly1@sk(pdpkrFA-F4w}nw|1bkUvuoWb03t9?LGSK{YP@Uv{hNz}528!8 zD5p~J>HYoN-Q}Bi9YZ7^hhfZai1(+N_z+8dQuX{qJ%=hO4L1+T!XIM@yp%>n)4jxi z?%jbs*fLublr|tONlTiR3?yKRD-LO`aJ0MYe>i$Hy+;DL3$AS#xd;GDWEEz z(RuqaOrR<=ykXS-%+M3p^Pl!~NUr5d)@dv6i^M(=%=d4SIeva{p!B)0@q%_&YZ z*eSWnF#asl=T)nMdCpT2z*~mP)(M+nSXD{|MAp<_t}yP4wQSbKV?Y9xB48_943ONq zwpKlOUTj}1-IYc7MeKA#k8SI*s!>u}8EAfeg+4R#KdK+EQ-+}%?~jTd^cBXk29PLJu`RT^LyI_dwucd_Q%J0iKq%R$i7Tjv(o4r zHynCr4Td{tl-b3;qVXIMMQX0c;qJZyP3O80bg8A}0ysDTIZ6SL8O}rEoNqr4b7=Zd zSO}w$l1kfb)KyYaw6$gvP(*^MC1ydtd$Vg;HO{jV1kA>J?>s5kcUSLEumY6vHqZAX z&o^$mY#=2g7U>V2n{V!x4QG-WkQk+o<7A5%VuFgubEbvXKInoCkpM%l+GCxQ#8{CX zB>YNbR;SEx{aTT|mWMTIM_92-x>f+zt?T>hifnAL1b(`vKC3XrQ*`mKjr#P@GaC)D zZlS8PBl%bJd(XXy)?aDW?p1**@>jErfBO(vB3QsupC@1=pW{P|W&|+LnL|^D+ZnxU zcW>Xkf4g&-@)X%(85fOtdGK%lk&JzMb@|`&@gaA81_5f!YWC9Vy9jEYj<-L3I+msZ zWQu|MeqZJ>-QNRmaX7$PYuSL697A#j5a+@vfeQe7^88JE`P(DI+agQyJzUpyq|f|; zy}4>puxklnO$sVkQ^C+@sxiQ+g`nH*4{th4hSW+^O94GXbDr;SK929-px<-ToFV{J zC~1~B#?$Fx9@2ufqmVru4lN`JoDacSt3cH}PxpTqGpr3w;{=Dp(Iq$5D^W} zzpu&3FDCfXs$L^W-)M%i4zp@LrT@Tn`>l!wR4@}E5BB(nAKH$%)e1zPEf`YQg-G0x z6k9QhRKpvTV71TdxyDxvVT~rU*ARAK0oKe%XoJJCI#|0FG#c&>Z-xc*0E04XSty#u zLUo+7WY4ZcNIoFT;mwCPKYe~!wiU``kg5W@Je1+T1@W9OcaAU_n=>5RZjS{qwHWUH z{7KkfqO+aP3%1fQw55KLsLk{7{&q~c;ciI)5ykf*dSlIdkRSbz1KcNZ;- z%;N+Pz_4q(rXeWUHWxprZ_*45Zj_s2GcIX&(*3ag!AdDWi0a!md1hdi zsk#>PoYDGze|dFv+4^BOSXc{5V=TbvQaJP-6S4Q~kUx!6RL(B6UY^(tiPY4B3Y2Ml zxH(1%YlBEMy+IxSuprG?cCiFwh}oc;>Me2+S(`GfE$r6P!nNd=Y))~ZF;UhUKPaC<*wVAXpZd=p&CDHhvz(l%NZsJV>8jViU&y4Gd1Z5O<{)LlsL18GbPHAxl`FquF| z>-R1C-3|+y?>_tpGKR^Znnq)5kpb*O>*tUG>;4O=fc<_S`p%YOaIob@sIOGOQNM)YJc`jD0 z7Z!(DEWoS|2B>A3r{p;^+7;mxqDB* z##h#j7|?3Nd`s`Wl#%CeF`z7)KXsN|WpnNb`6byx1=c{l`Br}M+tOFD-p!eX&43`U zYBaVuC$Y*IW%GKX=gjxn%A_sJU@91^YxT4}RIIuFidx950MRsz6~ zP4hF+70E+qQ4KLctZy5cZx8cy5@s3Q4&C9+`?ptp;Nd2FPc{`Lk9-1B974+lw(FXd z%a{=C^>^Q2?=7HO4KYlW=csJDzj=t(7+E0Tg55qG?uW;R+1d02+NmP(=HurK=76_; zX31#!G7qi+3manyjl3%~r|3Ib`m4*!5DfUkbe{&e!md5^ok4Bd&XJOWje((6suWcn z(lAE5t8;!l?0w%lBLIqsawpMt>>W4`7Hq1B3wsW7>DjRbiDUq7*OfFbEX!kEq`lh9 zazBi65OPc7wL;=>^ZCyumSThJuXna<4~GlS5HJj?lwvytP~f@q=07zT?=HH)&@H&O z1=%&9hR+Yl29By#q}XUUMnQ0vuh2V-1Yup9tU42{7%jB|v?_)IyZ`VHe(v(TcqXVH zr%xXTVSy(!%@wy@*ZpIfAEaw{!J^I&AOCc_5HP}V&J;XyJRG`mH+=r_A=*QKwc8&q z4|F{pAD7$H{lhV4Egp@iz>?Or#=k;qtyQI##{0ev!9KICK=oM#y=d7}<*85!sI}y@ z#H=7<1JMkBcJ~0|m=swRT49a%P1|t>voA0VL0t`}t(Z(GEPyp&!$ei_gp)yqHe-z-8G|)}03y(t$rE}GiB`p#g~7Z)raf0otdIk&o5yp7 zuAcK3=ci+yj(=YM>*oa2S}XULk3SE0J#~f}H>%B3f>iaJ9wv*uJuXvK-xdpiRC7rR zGQ?~|z!tSADTrJ&fUIR1@SlGr7hSs-k(nZ{J++TT_<% zyQ#K7G3@qT7d%!F@17L#{Wva|XCy<28ONr-PW^m42v8-oZAF0vLxkb8K#(QFLf4E#9?~$3)wGA+<^4 zr+>T0e!m=-xdK2+%uR)Fdp@9F`*>npM8Mp%A)Ek(5dd(6rHJh>-*r=&hqeo>h|}Gl zeuiUUOu&Bk_PdKiXvbSu`a|z9e!BbpzkNEv%|`+Vu4iIN?$G5w|8$p}xbOedb>rH7 z=ibJ+)aCvU|Mz3efP$Eq9oK@aBn47SsQ`-Xo3?GdWsuog%vD`CNB}r4?d#)dU(C8YqwOu~SmM2iF;EL&4iBZzoq z>(ZKY5m;kbi&SD$BK!+f-Ba^wTG`Uf+L58I1yx!F${+(KKvkB^HG1JGpgrylz8lS}A!>HCEYKO{JPHgupEE zxX7_<3d4YMnU2ehzHhy)lJN$m6c7i)gc`>o3Bc}co->m8AW}vTb_R|Mto7#M=KlL} zLd>9+L2ypQJ4Qny#MWEG7R6hp<`D7oX#us(g65sYGQ^1m|J402m(I6WJPxcCSlj~* zy%SDpN{b?)Z<R|uYtw+rn_i@g_I(2fpb2-Y5V(SE*K7Zwssx-llvlrm zR?*p-H>`_9%-WPl@zP*4L1HJ&C$a4~79e+#x-hbTKm>&M>IXPVYaFWN01erKaOBNmGWfX7_ z0T8;@AeNYbVoL#dt;W7ilIl#8*$5|oQCRhw}Vt!!^ z7#K!q)q_z)01Js@pfd<)+kI>YgQii3#=A6GYI|ZRa*_maAV5o6#=DyVcDHNZe)!$@ z`_?fzZyk|&YR-ooLEP^9!_J4s+l`w~Us^yi&r#qLjHR(;~2SbS`WP&xk1~tT^qb~3GKdN%*$~Yh7ryFX$}hZ zZLozyfY#ZX*X6;GEQYLc>%0Ck*z;^P|Ju+myR!WM zargt5qrnwA+C$=uxWpy;nkzinssi731u2)+-?Tym!tRc7Sou zaV+y>kF2&gW70B@_^xlgF&i_i0T~K#A|=hsq^`jPq}X@fu1blFF^1TKyT%0T=j0oh zmXUF~xw+-TZ@`wIc{$#H{^{ove1CZRyYDUz!ILqLtYIQHsH&ybG9S64=5T%4dvDnq z1H0NwPwy z5DG5Zz@+IIap>KFW4b#w9QupP!!7_~5!wcYhlfu$_cK>#*aFBk!|J zYDxrVrp?uRVJokgOc7O3HS`>9B7LecR#d54I&2TX9>Fhd}5lz1Gb;!+a8z(ORKq9DgF zx5AY=8da6fq-8HDo4<)$p>J971TrvHRsW76^K)M$eTh$A9ZzgUeOrM$Z;I%(;fbfn z=Znv2`_q$@zL?IFfwQ&j`%1^wZ~XWof@)Tv%bF=5IpesW!>cdPWzKoVbEfp$)DHyP zTpHi)Kc4Pp%xQkei`2(dVQgsogZCdkynAEDB_0K9zQi`9MNk&#(zG+8!~*u%#afWY z?;9Y;If@h*JC3g9?vQ=xIj53MSq(=zsBNMR#Z@(9XN*a%!{`AYk$h*Vu ze)rp}rZtWY7#0S^P-rPJN*=wp-QjT2TlWl)kf#@}HJu)AZe}>DVQ~cjYJq5hTLi`f z0?8n5AS)oVYX<;*QUUkBB@1Bx-BpL2Ya5(}LQMAtol~T=nBMIU`-|2o;9(mpklUM^ zhhq#rH|uLFfJNH{hU)--**1+Q6%psPD$w;8S2N=3-^*I7Syil1g;GU;pbKpM7QftV zHTt&WWHxcF6-jbgmYnm;<3vhUOJ7o{Wt7Kk?} zv<4CziY1A07NigbsRE*DB=|sU)OF2^pUvXu{bJ>rdg46UvghY&g{sgkmuIl5%`Now zqMt&2TCZDR<^@0SYb9ALR*K-)Bv9+>I>)5Q7^3dG`@7q8LTDUY0ZIxESn4vDuq<=a z2M%2`%%{FnHU{jx&sb8F&|X~jE;?csO*zfO^6)T>f?^4-=Rme7?QAf_YvqS=Spa+W zXp2(-WEnE&*>==;TeK9AuV6$33jo8Q!-wyOyBZ7N_7|-! ztHE39TRt3iZD$z}vOxeyi9m&w05>s!6w{&*z}f!lyZ3MLk<*x`6LM_3)_E4Gz=WpV zbq$IvQc^{+OnSQieD`n!IvWnolP<-JU#omHrdsAXR|UwMtKZx!@`6-a->^S;RQADv zop-Gzj6j)68gtrSD?uQ+EV(i{dwzM_OIO-WVvd6beUJCmw z-^`q+i!(HbtMcpXes$kZG*BCI?xidI@~iC0h7k6*-3?@%qe>|XV?%d&aee92hj(u~ z)Ny@FVA#f>rc_Fa%i`qLu`dV(V9Ex0KHV1Qa!X9+JXMsc^W+)6 zJviUVJTNM)nSJWnHG{YcYaF~FSj$!wR5$C$FguGhjX)AV9)zsPVBbN5H(=`-{d+w@$-PN2+o}0!W+Q8N_3sAw51x%JI)iPHckQbbWsrnXn^OqG!4^difkb&WG zjJYn4pC)|z@t48$x5rECDaYgOr;qnzvZx50Yr4L5t1fsl z{??Z*IgYotHwhjyHFCBCwIUaZDcd3pa`BVn{(aJS1bLcVp~lg71gDrw4_vCB?yXU5m?I#6lPSFf9?&T*Y@n7Ia?f3YICfq5hb#7>!90%rjzF+goHylo99;VYIh)0L)Dn;5JTIpyLm&xop=(%5b}drI!B^60xd<(yI*0HW}Wxl7HvZiQF!{}OB%Uo&&bGLu% zk(c6|c6ZgHKp`lQD>_{6n&5y6TFK|vb)Xyo@LK_Q0bRcvtL6R0Z-4vlAUA0ijWK7v zyUuM1QgXrU(008or5@)LfmVR#@qTzX4$PD7tg|MIaXVn<52t=fS+CErN9_MgPA>bKm%Zx1pRTF(&U^9i;bdnM4h5y*$h+Efa^o>Sk|}VLDo5z32SeL#pIzq z^bYI+ffmRz_3S7Vk=DP8wDP6jPr|a?e)|2Vd9eUuS{!`um~awE1FZE`9kVraDefDy zJr6Cpj7#%`jldEk;J^+5k>xM6?hA1VAV{eL*f(wPY=AXQCP~1aok)xV5AZTeM0b%l zrN^~Gr;j;z384%R_YW~@DYEpqzZpiq45!I>j;F`F+d%>A4%ZjE)(V_`%JyoNm|}`6 zO2M>^w`|QC-+Uc4mt`96?#GSal$&j*Bqaxw#fwPJMS(!JY<^<-B{%-^&AUVEOqydt zx9dC0F6)M-?2VljQK!e^Lwj}T8pos@3W&7K!`A5t0ELQem)USuKD39{8Ayr++Q)g$ zk`#`u1*~z*c8%AlCPNAa88(byiRtzG_zME7sG_CDxWpLiGwc$;3hm$x!?xxOw#c;t zXAV~;VdNB3j1vHfCFACf0Na^1s+(Pz$6GWAEi(vd2+buK1{rof0P|_-{UJHc9c+om zySo@6u5(C|L3R&j)WQyD5K=V&()>8C(XavpMm`RMx-gD|MV{u&p=jfpRc5VHaL^@g zeh!)#q9F$<#Q+T7mA-AV>ke0k06{4g1-i5Q5Vnng*_9$dDV6~^3$*)~c-I!rf?{`X z-v8#i%f9}X(_<#&q&y!B%G28C)tWs1m=?H$qIBatO9o`Jv3S%psNWEh%Q#LY<`uip zwoMm8*KK}VIP5zH;JPcYB{;^W;n~CThc}0{F;b4>G|UpNoh7ioc5VLN@pq)){-*Km zV!G$+{GD0qO_M!2hR?V9+*Wq;y~voCRju-^rB-#VVBG4!*X0BPq^|j{%@8DdnHZAi znHxN9r@!*l$r>2mH~!O4OJ?gA1GY`m^bQH3EFLnS<|!++P0tJ&A5vN3>Khkz-nAeg z0kzaLjiwu?d7nxT!_Qu(J^0YWVYz%`ccUCq{v98#a!zMY{G z3v6KTGKnns|1kHbO>!hzwjg%&UR`W)w}=1&KxI{RSHCxlj0ia*G7vA!L`MCi*OL#rc%Q|NtwaT^>t?@ z$F-XBWj>u%(=x^cvY^oRUE|0CDg{hR1Y))f>vkTdx?d}dq3;W-Q~*_^h{QR~i-Np; zwJrq2#LgOmig49jGMMX@*H;CBp-dHdPU{i{;1W@?Mgic0paRwrpE<8t0D^3dc&LJ! z1OSTJ9>^|Wc1g|P*{|IwRxeNETn|p3{kBckJ>uiyJ1@OFtdt1PVuLall zJm*)p>*Dl2mqCp43UqHHDJ@UcN9)O2-%G_}HIEt>JUyWb0_HFFMjEoPVw?7m9gya8 zYbsZVvfO|9l+d*u%fsDM5>XE{71kI)62ZV$7|rwNpH6kOUO51kP~x<}LgukH>-@Ob z_7J-s#HLmd!6Kg@Gn@*=;L*045iqTjb52Ss3U@H=`ybv8J!_4nq=M413uJ6X+3-tP zkbuM-$ORZrOGMKs-bSSM&ASgD-W&sdKacni3o&^bv$Wa+KyWNYB(Cv%CkY-+2o}z} zMgUFoh@j_>8bV_U$m`?7f&~D)Yi`=E1DM(jCf|0)w+1PwoUo$hW@{F(Lx-Keye}_R818lrJ{K{gyBqeqq zPc6tl1j@-Zr%_pStYgJ8paP5?^Uiymo9~;hXnfp8W)RSt+Cy zyJ9ZPFW9>`8e1>EJ_v9QD%bHZC2dtLD@!0o`-P%anwlQG1N=A)}LM5-YSl2iH z`uz|bLAX{35YIpV_^%6G!__!OJ4i-y04ejCIDN3Usa{66{spDXGuB56=?W1pR^J;&Js{-tx(lkE0k2h zy5TgfZiyO6>#71U+k&bh5>c6@05*hR&mf&f@+nVeBmnP7c)gW>Jl zx3@!U8L^vgykQ_O0J{tTUCX6Rn&Yx-&ah<;eNHnchRkP{I(|ym*8>|;q{knVTL3uQ z48zd-m?K=n4SVam79|6=dkaaWE-GMW;f!UVdvkLPtR1%J9K(9Wp`zBv^XLQT4@po^i zQZ;13fpWSz16>(WDv&je0N=EC1IqdCVP4^e_s0;&(UmAg6r?Bx&iR0vXwA87;X#5V zp47MCms`W^a)m`h^v(^T85eluymgYvQ+8iw*L!DRl>yI4vyaFn6>!YiDWHs64NzsB zAMVG5=5Q6dwlRq1{7Ew4yx|Zm$=)LKayKss*$TueC9S8~!aCa z0m^vql1z~DOCrsMUjNuy!UVL!+-a?w+*Fb98WWvoeNC8?GtTSazX^9E|O*`~$;|w7rSK+*cFe+13QpqVz=fxU#V^cp|_l>1mMWs|N z%j2K^+m9KI5n(dicE!VG0a$XhIVJ|Dne_4D)8en)c>no?*6Zh|m;~1OrfV+f*o*>& zC1aV{>`CWZh0G=c_N!?d1t221q*7umu;lDl_+#I?0L`_CDygbmgkcGaQXp(MCDL_` z5sbh-L#0SeMX}+3jsk(HhQOpsFvbELQEeb^7*#9EvP^4sA`J<6Xj%TWhGU4|mA}7EJwN7>;IL zl6r90`Ng*l76`1hSn?bpvD|tK?wqr>xo!`Ew9M!GxZHiZm!TUDp{-_%_x8T@oe=dh zvGlK4uJ5MFtCDa9U8vLlrXkowe!j{zntc`lpyv|!_s0cY^HqrYyqX0U4GME1ZMoz* zU-c;LIWBX_bX~@`{TTXH0pSG|W-g)QH{VV1(!u|7y6Dnr_84wl8yxZ!AMXGTC>{V*s{q#Q z1O)pXy+EmQtZ_Lli%X^1n9TO%bA0^iC;xEMHr^kdvliABfLKb7sHiFs5!{4m+h7&+ z);fcl)0&3g4cWc_?YoY!rWCU>5AE;&F?5Y*t_rPMt3=TvOO|<^7Xi0Q9#UekfNn&# z>wN!5IBUIS3rW+G!3CRtz}Az+ism>lQaVRyv1HeFt2*apjR0WeZ41;b-_cB zQL7TFsvs(DeuF~5dzP}43NWm*Mj=I{mK-G)1+~_AKB*1P8ATPa@b-wL!mvY?1TmXd zgV_<^df61X!ffv3*U3lS;=4=jQ7Vk78xZX|V14EDzPj$cDpD`VnP<#F{W|gUeOE!B z|5pXaW(`kY=J~hFMi#i;R@X_Wz;c2F2GwyLLo1uXcTFDVoLc0?pvHK5cpMWNgyRuw zYmqcd5(R>YDvDSpk7`Ps?!F|umG5i;Oz_3I+uNZvxtz}DN36bceI)hUO^l~0Mo~6? zOXF}u-Yt1PTNIohrUdx@aBLf6n^G96tM0TmMO6qJ4p0h!DpEIrSS`6!i7{UH*TbO= z-Z3%K;c##k1g$Cnic-^YD$po`L(S-p*F)bxOPTYMfpqF@IW1`s7(&%JFDWq**tbp7 zHgQ=J;M;ESC2aG;uu}ni)Lg`M;1HU|S=YCLNlScs)Ht6e!TCHi8fw^Z1Gbki)$%aiR^}9{wf^YPD>YU-WQ;b z?%;y2E@$hOQow`{$D4op>EjsD_iH+rb&Xo^IfUM##5F14LqPfR?>|4}xCq#H4#uzh zk=A96C{_RtQqfsJif1VTuw`a%q#9yFr<0fY3jo6CxOnvaZGM{4ALqv(Zm$~RxIR6` z04x^V2{=E-2XxN0Ve{mle*EYE?GyUj+dp(MBJ%p_=cmzgPnc&dKS*aAhA@%VD$Ha= zAcl!ha!xtUPoI|74L(2E0%oqFMWlioJe|Mj@$GGBffWFJ-Zf3Iik7%v$N6+h zMFD>t8jjQ56Sc!(IChRy$+^(HL-Y3P-4MKGhH5n|Ig6AyO`ofjTF|yYn&&THx(`3R z>4MV=&F9n8kN=AZ7+q+6ka;|#X&Rqaz{5M|@sztB(>Ntt&Tuv~EO(EGPM`9+nqd8P z9{?>1#6Lccwcjb4Lofv4>di6qg~+})*|x)>VL)V#aUMT?{MSEzu^(`O8Q);}G%lez z4)~7`zr7w@Ueo&JJU=}=%;mIltOXb!r@7e9w*7E>?XXVCTLdoe`VPV<`Xxp}8+!Hlg@(Xa_1A}*?uOP-98TJoBp$}H_{nzuw|xM}R)`9wZG~z-fQWJ|i8{8-W}}kAW(5IvK~Itv zkl9ve0ugQA!}dB65L1n{k_(QL16lL6Gi$bbB-Ne#LIKdTp7wTUE;4_--8X%W8r|Gv z0-y;1YP|pR1Fo85f0VxA$48S<7K<#V*EU>NNupoI8Xxm%JSX|D5hgn_><@+P6@ocW zBRzfk(@N}t_V&i5DSx^zq^nFgq#hAnViIzq5;JhSnFCN1$my`TWm6wZ5|sZ+?bv0@8BtY9j0WP)f?b zlX+Pp5bSi{2Vi>4+4;0gV|Vk$drpxv5CEiEid=TwaQ#2trJojZ$M?Uz=4DjC^TlZ9 zu{~a0cYQ-SuQ=G7yhsA#{qhCJw;ef@xZ?QsF-`b~|1{K3k6)w(@`~ZAW5|uKF*II8 zz;Qf{8O`9k!|~=AP*TbhEL(ETHPR~T6Jr@o?+q+eA)T$8b61s_XzM+H)t|R%7uAha z`@)g3fw-z+#y5m00@bhj7=$*||K|5>Z3wRcnJ+a4-kNL;f1P6>umFNu4Xi``a%(H^dhUbU(0tB8s=rLzYJ9Y?bg;9`U>7j zukd8g*0ho_M4LxRuikkXmQW!TS^$@7Tw{cy5*I=#X|>3uiY)UqNiMPoey>@Q0d%ir5?QtkNx6Y63EXoC>@?#HYeR4rwWJK7Bnj3QAeO~8LvwUn z|EJWF1k}I14Uibgrg<4vSTshNl6^C0{-SAoc{xVZ^Bd-h~i6i4U%GyV=V%&#`*$uHN;>z=qjW zQq)q`C>rPcaRj!#%vgtci3ZPlM962vwcBE)KYoImC(-Kb)fBw@?PuU8X zm>CXpynB2?ZG6|!_0TqKa$fGo`Ds$)EW2Ki^0E{KGke!N$*V3R-m_r{JL{~o&lD;6 zs{H`_ZmfI&irX^*pVEx9DEwU%5;hIj!H0}Pi}17xS*CO8X7 zo*&b?Oew>`18G?kz}|Hz0JNe2kh%#}d164b2Y!1afwSQu*Cvwv3yy_wrh*Pv3DqC$?!*ZrOe5;w{|L_^$xXwK@1q3 zvuk_yj(Px*5RU;Sw9dj6TV&14dP*Ezo-4S_bAh)&(iH2ylD3CaN@W{-AOZ}x!)@=D z5;HubsDLb~pol;+;M>r!79=n{ER-cl${C>zOhhpDc$$~Q!<(DDj2VoQL9RR4vH&IW z26Dr6dYsW6ZrZjvw!s#eCvjlQfb&hNAolF7)bg4WU8|HWpFw7KV7{u|Zr;{ztzK+e zeFZ#0eL;PEogS=TX9w%I%EcSU%Z18gGX}5i4($vL1Z+}%MwK@9@=JB?IsLy~0-FLu zS~nsux|9w#x?1x>%yT)L0nB%#Ouj*wnpgjSx#*3b)a>(Lf34Z^h4|Z4T*}YC7~31z zAKq3#rnKg@WL1#qLvI~4q5@?;p`7Mij4{T5iO4$S`!ZmwgB8F^N|7Z)vJ}Z~J2=%X zY!(%Mp>!t+lG3PWjs#DmPJKHq#}lm=~G1bL9ap!gIcSz{nah}^)N`B zW^@}cT0~~7Y0amHX>Q5jl0T>I;-3Mw>$1jmPQt!9EbAH!ixg(C^MM%LcuZe1x?pRI z1b|%#&Kp39tT84TW4b6n3=|c0?aYOIpq`>pFhE-*6gS zV6zbbaUE^3%nV7>yh<E}=LnktyV>_iH~u!X2VGaR}&LkbYO&Sn>%K0Z91JhVy6DjAf~h7v2L=_xdS z0DExH66d(0shn#{=!Qg1QltWGo#_maDV)$qvTa(kjE!%baP6vs#n>u9UQTC_MPU=x zR1_7q7C1=Fn-r~Zp63iTVGd!VQRL7uBu!7<4KU9H2cSSCq831MSz&-!R8z^hB*`cM zvo&N4*>IRU0PFyAU1~!F0I)UICTNZZHP(_(<6LZi`=%d=Oq}QGX(>ne-~eL-Qp$jJ zY;7@AvB}Cvg{ai}Yb#=V(57C{QZTyj(7-Qgd%hiY13|nP&pom5?b|k3s3CkCZ0-Cg zyl-B+E-{GZHCbHULP;fn3^A(yqN%)YZH2qtd#?AH3sl7+F9_3F|WT0c17?56A@{E5N$W^J!TZSd&W;gf;;V%e0~$hG6PO(vg8Z zsFu7SF6ec83heuLxp&vYFy1e-M+bm`B%(2|#a(^A4)9w7cb6{N08d&KFnNkGYg*wF zolm{1Ml`qHfSax@#Set#E|nY4Y>*|B4}IIPRROVsaPi?d$0C?&ndbuGW7`CaT53+^ zY0l{Sx9^6Y3z>Zum1%m4YhE7y{N;nUo*{zlEP#U1$a#CVMFqHtEHUb`ca2-;MQH%C zBv})Z-O@qag@m>b1dW)!Ai{eEP$B@$Ybj}6BIlD4fFWdnDiy6(0oX7^tr3wluj{{@ z(|A5DXf}|7LWJ?-3GkuqhyLvkF!i*~<3q|o*CDi>zy8Dd-YpYM!HD8?S zx|j0y!Kb_oN?d|mJPsy1E?Dt+_fCD|o$d3yZ( z^OxD?H8#q@xM7V}W6A4sYVEPN*4e7nG-VEiltn0=akkyjGJ6hMl}czHKaUZB13Y4k zu)Yhv#$uyn>l}a1ODyo+z(>-%FXNgkp_G`mmd|UBF)JvzaN}*?vnQFO%;+K-OpCPa zZ^rQ{F4e*lK+Fh0jglA74a>4*g+KZqL=+oAvk)YnAJV2?7UDc>$PG%HAvu~_N>P-& zOy>eCl{t_RPh^`zgP72?ciByeTR=r5)&;sMJfk@=0I4y?6f1J_4vp*EV3`qAk5A1L zdIMwIn=%9e0BfDCI0>X!6qWh3jLG+J-o5KvEz4=Vznf?G*0jAaTVG!E9woymh#0J> zC?Zu9f2l+Hwf2sI?nEbFbuoN@$c1Z&%4VGOo5u5Psj;c`8M^r`o|s`@QZf})_k!T| z8{ND$l?uQZA~4iI`0I+dY_EQgm-<47{r8N^k?A`Y@>ho0uH`Qef-%fs_<35k-#C9f z3>_&WmS8bGF8OJRForC{g%CocMdREJt@jX(6*_G=O`7M~AuvD!RlvfqsajRn`8+Mt zvcjSi$*2@WnHQ|W{egkBiKlPFLXdSm*CAtz+Swo8V&Jyz$CQf$;FtxPOD=J()7_7Q zH?Rh*<%RA;&9(`_1;G0A90i(|kuymtYvZei>-W7dCs}ero1ATO%C2jJx3tv_hz$d- zUHg=C<#>*Ba;|M#08o^?Mlg%*yAXKGvZ7X~#Cck>tn-}GHrWeg`(`rb*>;;@_H2F2 z5lAHhfMwe_p!gQ>A~`Juc5ClaO78(AeI$%=>BIB!Gm99Ai5jk8o-S?1u{5V$$ggmqeD zgT^&|+dE(`tB)-}48zP!wEJ{_8E*ExzBH#2=hM@?F5EQE?$jJb_I&y7zNn@wrm#sV zF5jsRWGUuo0LW>48pqFzDqur!$QldKc;N?W)7p4}cz_|LE>XH#0>EHsahKHW3u53k zc3^+BzhDHe8-e|0cM=1TnBAMGTNXm=-mJS7>v6$}{%wo-dFvOE=T9l!=A6z>T+=VY-I;1E4C88%f*DtTU0*=TvJk;Sql*E*nfK7KP=Ddm&Q9#x#1?}dp29QH8b(&*4*8}2I(D~H1DXz8I#abPl6vPah zc|u&KxV1aI4C@^OSOG!kB&Jt|t;Hm7V~n(ftnpC&=NssJ$>@HEFZN}T%8JUe~{qFasbuZ?f=oBv;Rz5jB&Kq9|4>$XtgRYjR< zCD5;Y1yYcLtI}6V)$I%xq-IwS*?z+YJ4MY`G2k!qo_j@M%bdLGNZVP<_SDJu9f8*v zoV^qdNvRYSa>pF;+b|+h&a-QEWP|Za6v%DYhW5bD{v)hM`py z#;6gb8dHv0s)6&!4wiu;kqexalolR50Ot^V>JYe=d1J$MEdWXI4mtT1s}KO^9Ncx7 zVLg!YLZg<}d3G$gef$1>Z|g~xQ#BS+MkZ^rvCQ7EWw$w;8wN!4Iz2u-KK}b!YH^|I zyX#|odKhyAkd-Zn*z)qJC*qcBUtT)y`;`z(dDWcluy6szU_bEhV$O6tXUm6(x zYC^)G)~ZF*nwHaeS~HXL&Kn;DOooY=nfE-4O3G_B1hbx}4Bmu{>z48p5zWG=%?caG zyK$LLt15^~@`$`>r7j!tqzWqQCgoXCWos+iG#lu$;=g}GE{PvfT>AIES=pCAdAk4j(q1;cFSVwp3m2+3>dydihBh3deB}$`zmL#GpShGYXFz@ zrMP*Ijr^NLkcE)~dS^M&~AsJ{XmR4r@tj+qHnv`(ML zF#%vm1UNLo@rFMt>w}Ny0dY!OR3m7O1;J<{KxIdh`<@c4<^DRv&^5Jd+fizYrBp&) z?%J;L4ybF+=ok! zln7gX-oO}Q!#Rhkp4}AG{$yZ@ujW#9N*uL%_snCLjl5XBcQha|8B3icPyb*~SmPYYqNzI38Th45Y`d zH|11dotZc^K^i8@fT=24G!;p49Pd9q&Zo7&T6c5Xy}z12vpiM+!PsB{Nl`um&U9Vh z(QRwM1O?VFpFe(loYfiIf9U(p18IhJj>)kFn4iUhs{Wc=`Dz-9YOe7dm#2Bn@UF4e zn$!R$81l@+RT1Y5cs7=4E25=Rw5pT>iI7sy<7tgjYK1CLHJ1uU0L-dU zQkntHj=e>k&kqS6ML}#TV~bZWO)i^H3leCBQdN4@Dr8N@#d>L*wi7Vw%q>C}IM@t`79jMQH7)ER2x#Yy!Kg^`oMjos>mMN5J8(j8mpID=gSK=K;Ll&9HN6^10N zn9k=_L9TZQFrf{OSw(Wr=nmmv0dq8Pt~(?tY#}A*9E$*88?$S=w^xodKYsfB~_YjH3Gn4Bi>LY(wwHn!iT^RDeL3i>AY?QxQUylZQH)Zs=`6! zLB@~&NE#vD1CmU8d?j>i7B>4$h+JbP{kP8UFPS-NlJ>UDtRMy*esl?vh1bD%c2(p2vq}8 z-m8PZa0@QM;8t7Q^kKfUcWtG{{h>}+mY9`|aRIe3iiL}0A|hl5n~K#@~g zl8yDIYmnxr$9ZX+LWg1KmrQRpn<~q)OleI3m|f$C!|l)wYaGq($o|1xvQStrKQ@uR-EfraJuWMuNuYZ*z+VBPY z^%9ePMS=MO(;|RC`W3)Nl?a4anzCEm_MBP7Gw~H~5+o`F(#^ou?@ZF~>dqQ`JLCW6 z@pn}QFPo13`t~CXVX}>r;yeUCk!u0hTs8ITO_V<_Y0F>0kQK1AO~b>XpmR$jZ;Z+EceHuZ%|U4KR?V7)BuRW-SutTK_$)tf~@Nof_27vw%|De-m~+K zJGLD`iv^*=IIxnzK~sctImU(m;Q zgeYmR#4V>8x(Z-{bjJDM+TK|dky8T;0#G(wE^z^*Zc{-D5}e%|Y&aX?vdLI*H%OaSCEEqw?+cpym|U_opzbErUSHP(8|Iiyk) zpyBxLP45F&=sHjHJWmaf$1$5$y3l^$78F=XMb>3LttprDdHQ@Bmr7pI^v9c&Ll8cPU=;luF$`p_Spkrd_V8|MPQ%*|Ts z-=GeriXtVJd0OWsk?Xt07`6~N@}`0|&C|;1hW7(&Et9bDIM2bvJZek;-t)*&;)-|f2bEW+^?~o08pjm@~o<= z!W9BR-PE<2xGGGAUXFKx&6&TY^-0`1FQ6DXH5FIf;o$$)&P zW{D7VSXYeJJI7D~+95&OL+>&GoqYw2b4@Rbnqr1Ml+)A0tCQy(K^t5VIcv)6QYui3 z0O@>&xdL;uEhUx}ZX9eJrwx&G;hF{@S)jzBXaQ*Gk5|D0rKZ#46652~cZ)g?42Omb z04Z}3Oi7lS{1M!D033TS*vK;!sxi*6UHA6Gn}aQcuG^eYNpX#Q-Sk86EDG|7TuG_1 ze(egF4HHAsd>ZHCy@>#f_ZHL~O9UV}pR%mW0w9n(bRUKxV4mcsPj}-v7EFNcIuE4j z{^@i&KO}D7|L)DP@w**W2*kgC71R0`}JBVV1# z2nkT7s^8KrUkk18$<@ozNcMIz^PJkGX9H|5MZ1@8_x$Z&lhM+pQh2$9zaW6SuPTFI ztkLb$msKZ*gkZ@IsMFmb4vqz`YkJdm%ezNqs34G!q6E+0HE_u`)xamR*Zyju`ur{zWWU37o zMeK&^tqcL9LG&QQ-MN*j09)Vlx|U_0*IdhTKMEr-P?nkYx*CxoBWyRmWQIUe&g30I z=DRZ_ZH(A?#T47n1{UNrRbP!UsKOW01T7^BoDz^V`s{>Zi60+*2dW@I0F}6mpU3&( zJo)=(d0FF?>Ft(ONyi_ z{u=sv%a)XqbDZLoghFUHl?o3cM;j21XosJvYANXi1j*pwtfgJ)PS$6qVLpdrRIN&; zT?tVE6zc(4-?Z%xbbugd2D@BJic`r`$)z-&$bul2N#Q^MlX)(TD?l5e@Ro4d|05-> zwE|T{hyhYmsiFiS1z2H>p^ZbnZqyz1`QzWQdzbb7>)Yg3rLZnE-INe3auOFB$DSpZ zlyiY;5tm%7Yi$v>hHNMm!Xh5BrscyA*%%_WZRuA?+c}>dASESmaO^x2N=gZ~FGuez z$a)m1aaot88nERipcFwqnV2DYU4cB!*>NNA4z=W!V+1XUWnHpDP*f^FP90Dr1C?4- zfXG?44Iq$pejGoZPhTd59i%^W-iiYE+Kw4j0$SSP6JNIhQz9b>*^IrrOQxznv8^r6I zM#Al{=f3qlU$5At78HQWUOe10v(H}&7Z~fs?3tIua0RNlSiVb@o3;;Jz-S7n5=hAC zCiSl7`HB>Kz(U3tF{nyPAnnO&L3dgK$yqAch4#0Lj}t1$8x4>OL*P}K)}o{_=L~V1 zTqGQnkYh-8?Ms2ibUuIjdC76%dAxu8x?c^P+5PtzG)ieqUMSv&RU^`3D(!VKDxa~-57EQ~%oX7Kc9{u3@6={9qgB;#lV+brcO{Y)y zA4edM;~KM)4N}1EFmPTTihKVajtxth`^O?p|Ms^Z`r+7ytyB@?>Gb(eKRrxM18#1w z-{1JazVQ~Ys%(RIOfYl-LSA?PUl!4;HMjknv{aE&a#H5T!ghzwd1o0gp10d&cRE`l zIChrFJ8SI#STQhyijs1i89<3KN|J|ld00gR1>jHsOE6NbX%2^`2@y4K9(V$I08A|D z%u>=Z1gn6Gg9>_Bh5r(XNdmmiRVp&|H(P}OWBXQsRnx?q3F-e|dX(B?K3-bDKM7)~{ zSp|6)g0)2z1r?SYTa3%JoD~J!bJ9_Du|=)30x2A{co5aqG3z|#0y1D5I!4BDFg1%1 zS4f)X(;uhvv?6rMzOyJ`MoJk3NLf#-1^S-Yb>1U`;k`2qf=c0GaTtasz}pg#4~{sc zH3m@g_IGbOHUN)rA8$u3w%GgZWHh#kGi#Yn_jjv%-!N_m2BV59Xy;7cSW>>$BF6K6 zehJ6aJg*~geYOsl>hD%()8|0zRja|C5G5$f#*Fr@nY~z&uS#G1^5bs*44Zl(f!WAg z_Ah*)$%I(57r^&IB!DU?QVqdw1y0=}y{Z?rz#RmJx*@}~%I?R}S8Y151ki={rS7t~ z%+FV|eTPle4Fm%MqiBT+84K)bZODcrg`)0IdKevTOV8){`BMBva+6^TJEfC ze!w9;oP??K?M+9^-2yf|(6Ov>5~=HH{QTK1iwYWn>uhrc=!(7x?!FKMRjkssW1tFz1KSdl zHSGYF43Vs^!SLHR9o8?OAIBt$5@Z?|?z-U`#KtfP%-(emXOQ&(;7tDWb*mS;Y96x>h^7b}# zLogD>)RLCz;r`(%Mu86)*>3>NDpdvC2WL$MY$xmuz`oV-$Golr2cYZH8ev1@Txj|R z=N#9$@N^fN;nqoZY`ea(fRd4zO2ryUAiAz=n&h9yyXMJPTd4@7;K7IP* zzkR%04*j?+D@^dNnV|0aO&iCD)AhSItu4zG&*y{^;r`+O`qnkaLoijd}&W| zWe7p!pypshaHwmJ>Oe+oUSd4M8sz0PXXJ5O=BKQ&2nZC2U}}j)LVt4;(11{~v~bAa zL<--+1*{@juC3LYsg|17d~2-t`<7+4I;5y?$Qm}JyIXppy&wb8QZx%7)k2jvKSxTI z&{$SWfYqeLT$T1@%_dj$+UtG>g!2v^;A+ecAZ5d5Q?rKxhRo2sE93az{y&KEVf~kX z`JewOcI*I@actYnWHpY6-hzo?Y~%j?c=zWYPf3yg*siJ7ajvih#IcON@va;~*G%Qh zkLNX20GM)V^L#37H7!rqx~6eDAeIUfEVjY`Obg|HXx(^vI%Naf9NNxz_tRMu=(dOC z6wnmv^E$;Ca~j6^oWU*k!2*nM^FHL|v2;Ntou*i)aamxDZ~DF~3yTlax;!Bq8t6Pu zM2^vh-X2FS(r|Zu-8Ysc3mt#3pC@)G!L=G^{EnA3c*|pBrr{6oTS;pDn{{3&*y;W* zILO^JM>(~wt`C3y@u5e1-GQ5~Wm(2$`uJ&X5lYVDhkjgf{onoW{dF+u(|`Tf2kCiT z*EHn<|1fFq^zRIn25yS%<4!z92EU$9p872NZZ)u2m2YAg_|7>DIWu7h5{|b#+cL=fqD%pl#sqg)tXPB?PU+8W!{CRu;M71izb?tFDm1ekYF?76! zd-OwBhU*R@QmO;ku%%6xWFIO;49NG_351kRcMq|yF`)xGTljGMhxga55ue>!B{ac> zhZT+Q`%Ser0$8(A@de)*uL5!2{Ts$`gX`bDKbmz*&j8rFg{tJd((4cH*UA7di>zxA zIM;pn{qL^Mw^8J>vkbypMTQ4q;*}-%d$wp)&8*K0PM*r%3?V<`6skVHOhfK-Q#F2KZo)eG{B?opp<%?}t8cO7r;mIH7ND`rurE z__Coh!U1l@&>Aup!gOq#HIwN4Fakh2TP$s<<>~2RN??oJy3hefhzBC=!z}%`D#1^n4kG-{_6PdM)QoX{vNjAb%wqrU9Ff-5ST=z+I`rqU%&=e+26jMxn4ccc zb6l2cGWuh{4PU)~d-RY-+zLqQhwIb2SRZ`rSP;)pU|G8mlq_I2QsX__W2)KQqgsl1 z$ll5I`w#BTn=6-fI?YRl0G7mglvI{LwOE!do4j|&2j5x)n-Qm3t#em@_)otdN{qn4 zv&1;xKaOjJTT3M}RMI@osh%ExymQWVp#@SdRwqbFEBa{(-FiM80#QkIUFHn3*GEQR zZ!8-hnqW;ff@-dHYLgFd|K4nYG9r3`eXkaj}3-P z1gV;?`gWge%e6)foCeDC}BQtb6rgXwWRcSA>* zKHq&=9pCtCKHLP?TBAToseJlWH1dsWZS$7dTJN?nTs8_7gl%5YS9^1P&d>p0k&a79%M zRoLws1Sr*EW08U-(B53Mc`N3tfbZ2kQhF`~8G!4Sma5P1s*>hY=3o!+XPkK{h~vXU zIQEvyIHx&QWTY~8e06O4J_IIW0Bc$W70XAIE{%@@9tCLH&>ve1Neh4o4{NJ6c}Wv@ z^Laea5y1IgB*$WfA$E9sGnjc!-^Z!tRbJ%vit}M!NQQ{ z>HdHHe||aR@bnLFTmQagnI3chZfG5HjH`e%;100ytPyE`WIryMeea#s9A~4Jc1SSx zVsa@+Zy5BSPtyqsTOCLw+G^3HL&nca(2E@=hm)qJgh z(GAVETe_`(Y;T*;4U|f{<#i2xb?I9<+iY!s=J_}O2gasPi?1q|*fc0eFGv}MQQ8CS zdU2<1(_hWammxrsx5S~ww@-0C{O)!Lt*52GPNDIzoRg?xYfr+@s-yPl;0 zgcPUo;qh^i3el>n3|*ITjIutQ&wemnXi!R&5SKgwpmvf7$?4n?a)F4Lw#Azp15eJd zHI7|l5GiZkw_Yyp2FD>-HLwww0a)A6lD#qniag2^mqjxS0ZiQZ&~$?>xv1=n8?vUg z0)XUYKFvwEX|N*AQGxc~Ey zcf;-BXd}YAo~epJV_EaV2{weL3&A&T(+LJjmY7p2!ZvJ+gvh)iRC;c{F}Tcr;H4<7 zWnC9|OAZVJ$Ib_TNx*+S_ob>9so;PffP$@5096=ZQ-A^#DJiXwaZSsVR;`X0Fh)SC zg^7Z1e7Qw|N=`tMyi5gb8^^%j9Z!Z0HiWWfa5ivc0IeVr)LI0l$|XNUdl0t$xqy0P zYf#^&C=rPyDb-qrp}miJcL@x>ZB2jKNQ~}Gj?XUk&dOG|beNQMeyokPeEk6}mR0if zl-(+wEnrv9*jianI34@LaO_%7#<#BbLAVQbxf7Ogm7QMKvpY7XaLxrb!EW?5GEHau zxQyepW-#Ii;j2)prs|H(P}KStp!we&gs+*+Uqc~ZnZ2(+u@Ce7(q%zD<8C%VWqSEM!BhpR z$`)%`0K0HF3~427iTz&zls@<7neV;&z3X~0)UUq$j)PJ2b>H3vgSHna>JD(Zh@ud& z^}b!{=g^_#A}ZYUZ)U9hZ?2BMu?XB{-*^jMab`dZY;^*Z*D0zK1Tdbu%H`oyo*q{P zY5`1p9C~Yf*Vzr@7TADmAImBysiL_=)Td853D7pZ`-3qJv9WkY@W3$G8bBqdh#~;m zrZ>aTA3BtE{CMX8z`BhVsg$J{1SxJ;uPrG-VTD516!B1nySe`GkMD=jTT>NPXr3QF zJ)~92W-Dt|Eh)|mQWBB%Kux0+0+R830(aM4ZviBf*`mNQTFZoY1MO5MOyn#oLnIfh z7AUAVhQ1G`IyP=WNikVV1B*&71qEvIG{p!6zu~{xv9Sa#Q>if4H6kf3YXP7V=Xstp zsAEQ2*HX;z;dj4#(*=VnC9i2dPjid~?&dJOZJiB2SYtJx;=|p;`p{ytdpydb47`?@D!h6`D}O)f9++;Hz&V{=JMQRCYl&Ay*G-*z|N&R^~xu(I`GocE-;TF%Qoj7@pa0{j z06=s7{@rz8bXSS`jwGe|Y2D1NZ?Q}e(W^tidYTYc&F(y(&evC=zcs{G+@{2`Pwh(! z%WKg7uZ#+VooO1l^veA$QR1sX-}XWL?R_%@v&&7sIwk4WU25uA8nn-Xy7g7Ox5*&B zNSOSsr~Mn!sV`g2>!a?>qklCf{`wvoLu`y|=|2Gk&DmPR?eNYPI}EK4TYtC>4OO9f z?)yW0(p;ijgW;S0`8cPPL3eab1Kj+7XILM*yv zkl2RMzy0m)`wdzF&4v@o^e_V0!3i7F^>%J|j9=Zr(<7P={%zjVPzA6)v`y<8v<-s| z!y2$*qJk2``1x`uyzfHqNW9_kyo`_c8mPfl++#mz6z0LpdKm739>jOhX*X8_h{}2VR?aliS@A_a3U0aL%6z@OX zo$CXa6Yf5r*PHhrK6p);%<{987%K|!?r1>FKwT19N05?ooR=>T8SV9fy=VT#O#Ah9 zt##w<+A99Wh74Hmt-X+&e&g_!RI{jnn#%#1ea^rpN)rJ_JBOaGQ6w`&Q% z>3b2R)dobsx|`eU>o__7yaACFRG+QQH~Yc{ zkhy$K+8}Lz{Q8aK)HZPX=20M>zgmxk-Z0$5)Hn%mnpI8rdAkf?x(*pOPO zg;SYziRZ`V?n@~E#gv;=Dv0-(R_o?qZ5 zHo>CAF)sPb)2PjdW7`GqETE9r^deh=Z1ZAX1A)c(5}T zA?b#_BLoPgJw>Zzz*$PI9u>Ni9hw~?jh#Woz--ywy{E}Q0mB{@#i+8a$<{qD!@$dLRH&GSz;6ATwHqO+w>VBw!*Dni#VYtL4PgW$rAf>W#nqPbp6rfZoxsv6s%vg1W zvz-r;m-9TzxlFTbi$cPTv`jexb%7weqeVLmt+Q;64;Jms4fn3ii?CvT06+ftX@PAE zDg5Eh)o~cIwI`T9qeBHJ_`XF^&GRYe<@D*aCid!r<%XFJkWyX&vpHhMl5cz)tTUw5 z5R*z=KaNZCtxrpm2*5T4(8K!=AKX#|!2P@`MY$i>@V2?RzWwm~x5pmrh>g?6tHpfU z@|-<0RD`{>{hJQFL{(XfR1>mnq>BKQWao4+c%@wRH<%PPdr?d;)!o0O*8Xeb??zHR ze@;r;lH@T%lzbrEHQHx}~c&v3oWk z)LPRzr7RFPFozJV74Y#l!`mdd?!1HYcKEYi*bdikKYaMju_dYMEu@S;|MV1`}05#sbz)@ZO1Y$lj0=Ef5j{<^s4uk?K(SQKsK-p#4QaUZkc}sm;9>x(pccH5(c6aOPJfEY>Rb}yvCFca7 zESh|BL(k37cH1RV$H(-ZEy{wNR;TG9-TgGGJvgxihnwr0uDzgjJwyO&L0qh^5W{Oe zkN0CPuH6V$!f`m9k;ffw;GtD48sCP-v1Q~8ft2<1=a19c-E`&Sm%9k>;EJ_!`~G@h zZP{U6i@UqFPC_%-cfbA3oA##jT(GecSf@$j!~Mcuz@fynCh_nIz4HQFV5AgOo26_` zs8v84i@E{Gyrld8s#wl$TC^$(?RMkuFk*XI@Y_#($EdubC91D~`^x#Ob<4LJCaBqR zpI_NvMXePmo7A!e>ZV6Y1ghqB{PuO~<=byW#(e7!erNpJT_CyW!GG`KwkvstxNIyi zb(75`m_9ISLAH_^4nCD6GFS0ZHm0RY%x(XMyCtKbmV)x?*eNAJ8=9cx{Biifo-!P- z(!9OytyA{AHGg4;G%!4CA*tQ2m2D9~0DM(e9 zr@J$J$q9((c{LV{2=*DRV}h2Hr};FAe-B%v1OVhfFl4qE1VT_P_9$>bIEK)*)^imI z^k#W;?`!|&!*Aam!o)aI>N0O2iAj=XFD-1d7)yBM@=Ty)R0I;MrCJTnD*s8Ghf-ntM$yujm zoZNY9_XKjxunO-`Vg?EMcJ(kytKUo-{v!40}Y;kts6ZWeMQzOiVzq%FA}P;-GREBtDB?m z0zr~ZhiiWZx$N6;UstJ96XqRwiq`7+TJm~^} zK+Z8Bs9B)}%`!fXeUR1!C-cK&xe3>9pd4*_O7r=gtU}b?cGN?Dg>F0eRD)&d~G(jpAorqkoJC@SDW=zKq1 z4Wj7`pjL>2vr>0OIpRI(|?kcDM1@_7;nB#@*rXPAJ80mq~BcPsJ=hIRdLGcX%KNucJUcW?nH zz3gd!%h*+}Uf8<+=CPmjCBXRxx3Z02`K4~59Pe?5R=~n+HNJ1Y;018H`zik?@88>e z+RG2B3I?oA*>M3-l|Z4;Dw5C8sv9Ac0)XoZcupd+ri{|Q98)BLPi?9d@88C5?#@lBP!!WyV9)svQ zt&1xKZtyqPL)UfL!aIg71pv2QMnnte01-_!pB|q^gp$?)m@&K7Z=Hh;yajShc^s!{ zO<}HJ8{I~F1qN?Z?=tgv$e{?ghhQCBW?{p|A8)R&mU6uP@aC#5rgRN}oDH$%3n8_b zv_435{Q<3mgos6Aj9<+^=M=Ei3~z6Su5YcUBJ1gX{J2a@5)&+LhGW|X3s3=|dAvJC zYk?BQ1@uS6i1_*6|J%pBp1=Wo{q|;fe5?|uho9~q&ua!}7v~fK1?fJOhNM3^-(g z_%~@~b|sCY05E=NheKn1dpxWQCNu%Clwk{;vzD33kR>YsG|l5UP1!6y-QUN-0*z-8 z8Q3Du=P`qNSO*)d<~zB4_ts_95{1}p56J-KMJjY%BFNeDWq8j$n|{I_NYPx~3^)Dd znaN*^?EdP|OWg8*6yyI_#&^?(U!A@}>#w}}ow4-;*+y7})sS9zWUyVrv+<{WEpLv1 zp*;;L`W4byE96!0;#cUNt)X8b)l|u%u)L`#T>6i;5Yj$_NjFWTE$XD*$ZZ)GDeV)FoAJO%}TGzwA zSrnUc?3>0}L$%bBm@N}bg+RyIRUAxiW9qn56W?6;1hAUbR$00PHou$H6)Lq-w{rK>x*KjQt!1&O1ZPx||G7N!D zbDZX7&V`|2c+=-;E^~>G^Ty)e#UvTd=O%SL&WVSsz~^b2Pe9|wlK=JHHODDj-yV6d z|5T$ERZ14P{^%s7F|M=6xnzB9gZ*O_NJ3Tzj)A%s1i>kF4A5JUCcQ+ia zKm7KGx4jEYWLQ-|gk5?ZJAT{j6Lm{-ilT^ARiahwp&Cyx24wdMZ!QbN)WRD*y`q2| z02IkhiK>ZVkdttGgkONuF*s3ae%F!CUmhP%WJ@hd)>ub|LTj4-kY_<7=QSdDq$wfQ z0)*zOIXsOcI)3~1!!gt>38_d}dH@DRvtwa`#;lnB#ShoV5Ih?NIqPlRXxsp>l30UM z)|9epVkQHTjH}idPAimP7y@UkB}&XtRc8LG5$a{oe&1f!sv*eM*H+X0EYg5N2}&iv66xF&9Qs) z#)8*#Ihg9YKD3!7NC2CFDN2buOxvAH@$sMW?!#}Lr^e|zS@4a^F?loxxLzg*H@@q-#vmb$qi};&MAxJ%#Qu~7 zp=lh;v|M#JU2Dm;hvRTO{+B;Z5bvd!5~W61+YG)93@x_ArPTTSFivSXuPROvAjxG0 z!0TgbWd)y?g2UVY{QH4QMDN0OxKTcbo9oUp)m-7;{xFUzeSc_?mnlta%;E9Be7fy( zet3E;2*=<4)9>CKuCAUFYJ^J*&+|sDRW@AxRxFdP=KUIwVYm7k=#p~4Gtk5UW-GqE zj^H*9O08M}L#FP9vkHEOl+=WaXc28OkD@*^t^-odOXt|05!_ubQt(!vt^jmT*=`ve z-h4rlzPnKQ7?7>o3Vx~cUruxR$JgH6#i104(8kAkk&snrY2o2Ztiy)>DN_g**cu z$okN+V?on(t*t32*;-9SBF-Fw5hjP=eB&*%HBhM9p78XDBx1b*R4lwRP*E~upnye@ zyqxAmfCMmNkrb7<vd1 z^)@eS&|npzxSkg(!qc2xEdmml#+5OuDXtApw)O~@WKFa$^19k$P*Tig{N$E-IJChN zz}{AIN|4Q?G)gciIWH**pt(Xt1pQ91Sbzi-7|Wh3c^DOi;lGHs)90IHwtY+iDiY`M z>Ep*y{F~0RwcNn;R|kS&t^$Gz6EQ?p9GJMdw-0GasfcvJ68v?19OIe`ToSEXssbD| z7BH%$(~6#4XhO>#S|C6{krHzTj5TGek{jUuw1S(+vWz2$ZQl=F@IFOU1QIAp0O>PV z76gKhm!DCZ>!vEmTAR^^pgB&*bpikp$6eO4^lgv0g$ebYi*i0zy00&>(GD0 zEwtYRwU=n;>wUcHr3-Z5h@a&i&8|dTpEDynMhvf*(>L%K_8roYd1WSEnbQJT*~5my5+ zTozARC^!!-#wvN(QZszD!Lw!BzTkd&d!)H>7Oux^wGH9;b>zlWS&N^xgDkP_6HI`lL(S#T|Ny*C`!8zMC zpL*8hr&Ugm51&4cOCg1Eu%U6S%4&sDoHM0qPGCY7f=W4m$y0yrmXw68$66UWaq$ih z(>k8!wE}Kv4g~iF)~KTe}R|NTkG(3Yk6K{Y|Ny zuu&aVK(zw00uEr5noCJBr>c?>!E;yvcLR2ZgI4YOyq#DN?!AQ@G(*jl9)%|$Y> zx?r7kE|aWNBZz=^$e5SKpdky!)+1WhG{=}RgY()r({T}3J+Sq&sjXF^rc@CrqHvH> zbay?8jLQ}%C=q~jEWBYhcfyFjvL2sr;q%?8c^U6!I7dAI7!!hT$a0mMt6>V;jW- zoXcuTiFwUA3kC+VMa_UifwkWGrVstWZBkTHifN*+IbJ|UmR z^9r(7V945|b&Ry;wfN8utu1gNwAVvx4T?zL*)lD88prX0$H(8iIrhO?7;XHZm&akJuYsriZUttD7 z7ZFuH0OsKy8CjKehoqiU6`t;901T#3Q4#qTtx$#6Y4IaWqFL)5C+ny1qWE~$Wa#!HdH^MikPT%tf9;9ayHShG~bnASB( zWq6O_yZ+-!!*Dnr-(4Mp)!$sTzxm5o{Q-eA*+7XTf9G9w3#a?;retl51t7AHL98%c|$q`)j5l@Hf9g0!S59 zDRGV~dGv?t>kcbo0%Ok?^26i5|Hl&yZ}zc<;Vi=M0g3VSyd(E`3qhA}pDD{2&1piZvzb|8Rz)@Onow;9x{@15^`Dw?mwhOAO zYCyFwn)d2jhuGh~<*nNi{uUp)7oFaqM8Ey%2o0(!s?bU_fLhXWG9c%TQiilK#wgOL zWNJk<@j3uCp;eR=Ey%g9)1|Q1&RFPb;hF*|t(DTKYQMtT_Wx-hu8%)IO-cEXiih^& z&AY3?$?5rV=}WDq)&h_rU8>f|r|C4$Wpm8~h=S3oNlwx-Yh#TTDaC-40aMitRcQcZ zZ3sihT>xV(aO4orrNhv{fS^Gx%6gvJ5CWkrXzO`#)%BeR<-#HWg6~3~GLG-RKbTeG zCx8ik-w(L$g7;m2=sdmL-3(^R6E} zMNWwa@&=qz%HH_Uduonz0v?x#ERHlX2Q<`gadcFjvhhmZhcJByO5K>G&6+$w2%_3;*r5bQAA96Go6+V?N=WvG2QW@cqHJR36Blc6r?&Jw=d((U+}OVv=C1C%nF*T+oM1?Nmz=lpndD)bw29#uHU zluA0G0M?PSe$1f0DGfw4CMH$nG8W2>*{rdt#}k{ z2Jj->3hB>Xe^{nyZ38%+>)OsR+GrSt)Vi6c>Y}xG-WrDF90f4e5*8$nRNR1=83@KI z&s>X!R-OnMN<#=4C>e-PRT~QvIs+vjZ&+>Ld%GzcpCm$=Tv#|ugA4>%YhtuVFpTZS z(H$_l&Dj(zoKI_RFkN>Xj{!*QDN`;YwMpan@aexMSO*b-v4FLvdykmoI#1^edtlHQ z;OOIZ9|&AZzF#ZiI?boFu0@&tuYdZ#{pmdstiN)89Q;~0*KKD_zpUt#)!HyqPsodE z9*WFs0O$7AwoT{t3!iN-Uw$J*ZUj=Lu*I`iAm1;4-lhcfPJ*iqx>aa=Rb#yzk@h7A z>Ov3vhK_UHA3*#aC`(nB3h6gqvZz29`U|-5eTRQjZB3~6p zx6iG%z^4em9@76oFxUH6usPmWG*sawVV%51V{a&QR#~ldHQSDRy#8=^Lah;-f{M}3 zkZuLVvh}2il&M=o7g~Y#3#glr?*@KdriZ7gzz4D=!Gv)<9*m^EFcOZ!WK&~z=5B{!be#4tesvcZQC^muegIZmhNbnR|NPhz}S7rgfbt&}Cs=Q$Z{ zHspyXh}=)>eCDRCt4)m7);f#zX9LdbG|h$W;bychbPa})P>>D&njk<3fV)Pg(B@@{ z0+GU{R)+cbhwpC{;0(Fp(0K!F;(K2ToExI>rJ8bC&|AfBRM{$^Yn57BC4yKDG;G_U zFI$DGt8Qp4t)aD?05ZJieGukNl|^-h3y_%1Itx(p_RNzuS}Uy$DZTl&2S77vr>%i? zD}Y)nC5^KYXrP=ULasntQ;y4%+h}H}9;h61V$M@dWn1OHD^*(gB^jcBwr*dbiGS}Zp7 z)@u|zmdp37y$`?Y-_<58D6J?+gc6I-V~w}icy(A0qa zHocTlHQofYSE-wNX>0DTpKnf7X$zrSRrc?VO4~uUFGNFXttAs$T<%NiUGRf)O_S29 z!2ngdtM5L~Euto+0f_UBr83D$dmo&)w0-dHaVE%RW3w$0Tx!MX^WC&EY;Z%4f?=>u zC0fsSf0+o#N0bT}?+uGW%;(4Z$0=8a1B{|DcvnR@O>I;_G2p^Y07^&%tWZX6dfmqM z19cq|8eq_v%dAf{G;GCqLdzKl6 z-T}RUJ#CD(uWqbXpa!MY_O}9T)lLXO&`OT004Xj@q0m;2IAKu&W`>(kxiRLAT0 zKiu|~$OZ46u_S0x(mKsC7mz?{h{PPr(^A#~=mw+!ZHW*ebCwuW%86Tt0n|xxY>Pro zfZ(BOasv&d-~RxD$hw{i0M$^ql$`(Nhu;kZ7^{u*&S>mW@AZRqnRx0eN?Jp$t%@|D zHMH6oRiKsL=qz9LovW^BEYg5lQm$Hy0F?=qcZ(NtPJ$RNFhgG3+-hwV8vGS+1?0hG z3kn0qX_O38&``9|vq_?rsc8iOb~dFbbzuOg;#Gi1$}w_Tm%PRX<&F7S;10~3Ra;S^ zsYxTr98*dFD5e}4!csYNPI)iWmSs6F5rCH_Rs~%YLAM>#_e~bnt8wWCRt8)b#3+=M zgk<5-9-V5ctxEwE+?H6ER>_LepiTwzzpOd6yjm*|R1>bpe#opfp=c%sP~zzXS8?dq z6`7e+E!Dci=nSJIL~Iyx8>}bem9AA~Ua|m^^D=^bW;}AcQ4-r1>1F-n4y4B z)&^@KB3W@PFqLv#PpdHSAuu!{Rwh6>XTS+-7o3NitqHea7~dU_P8q`4ft;hlB^A-b z&4+j6!C7j?S;tH)TtzOaGC^u;aAH7k*09#r7_ChKw03Sl3B4sz%qh!s*OCZGD_2UX zT6dqGZc1SRF=+$ONDUU&>#i)Os0QaAQ>i&~8*gvkhZ@Y5J-n*sX>28~JwMyN+868A zw`0RyYJBPKDFE&3PWT0z2>?o0)pj`NH-@fKTWwUS?FnCdqi4BeIonoC`Fmk+ZvuYv z1$(}CN%wyB7{6is#saVc)o-3jcE-YQFC=TAY5~wnK>#qz`s8u-UG_Zy4ZSh<$=`hU zEOA~U8kbCk(i}9z*9|4oc9Kgz%rJ>+$zZrCHW_8;r7Yf$p zix1<+k3Uc;^8x@}59GDXG4Fe5>qBrKR5&^hv7zgSb;BpGnurg@Ff_6j}(l!RanX;fa9$H!@nxzw$tQsGVt85Sp?K9i)wnLLvGmw9JlE`eDAp?w;eVN?hiNI&LbeL6q8nG4wKZUH z(M>f}X25n}w2No8_TlD6qrQ4rKtNiq;CuL6j;GVIWLY7hClVm8F(qRG7;})ew-DV( zgX@4wLIRX@!f-_IP|7+luw#hld3q`Zc8iW%n}&=Hih!C{i(VhPbq)sr=)!R@1c)K> z-WtwXfX@EzUq6Ih$lZlY2@z5O*A)Pz06+%-8Vf2Y3}WTVo-7n-uWnMgP3v(d)6}IWH`^ze`|zbs;Yro~;7i&0}IK5Zg0 z>g&H&0MJUwKklXP5Z3*D4XB)O1F10zfbUxAhprM7blV(0j~}W%e||bMz=aS2*LQL2uok{rZ^G^8EDtByoC-L~iK%egS2avSQ_RUQ;U0Ar=PE_Xi6! ztjpum6jN&0$&4aGnvCzYNMaFjD6K{`B$O)XIzvR7v=ZxmuR9Bg$`GRpf(3}QB?Vo# zO^OQde*f`%UCOj{Zdv-HEK`|t1Tu)o+RnT2DAto|m9^Wrw-L&@v(`0zNd#wsAA8?0|oUUz{!)*q*7S|j{m|MmUvzkeTWjfIW11WBi- zhac~r9%E%hC?AGiZyLf@cgg@@ps{HQB_fp)1yxg^Ztz5dYF&;wYpqBCWbq*M;i?;~ zCJW@An-GyDL1~Q0841uT$;CGnI z%1Nr(BC1FPX>tKT0g#;XM&k4RXs-e{PlPE91{>1$)z@!0M=T&h*PjBN)c@LvK() z(ZGjbmr@u3+KKOcxg(-@SW(FyOYJ zHAqT;Aq`=pVZDbD^ucZL&$!l9*z~I8$S}%aU6utfL=^n{_r9zTYc^wpGlt}C^|Eb9 zGNUgz&IX{;RtS0<`E=d!?|Zse0jD=8Fnv?$XD^Fx?X=g$mM=4_3Fju_p){JRzkt-J z4NcZ6y`1w`_GInt^n5*bJg3@$*uObz+phLo*qj|Lu#c}>mkO#W{ms;}Rp_dJdlcXG zceS845sXsSQetA}-loEPLuXsy{aEA#;ThZV5#g5`qcP9Ziu*s1Q&#O>x>`fOzHX6q z`uzER6^WqWeCT=@ai9i3}8Z`1+huuBf_l zZAdL6iQrsFYZEL{(~7jU1S!sKbQS{;DbiX)c1IaAjN|o{E~`?2_q|=)a-Q==T$M;^ zvIl`7T}heHcXs=(MU@4fcQ=~L*jw9ezp=F?E+<*QAx|nix}yGyvX`0?frJt`aAaWcw)6l%&U#~c|XL;zV^0py$)2f#1dKsVLsHyW#H zD703U4)3AQQ-rLTr>B|F`Ga;O%uxzA=dG^g{Q2_)`~K$o`WU?Ki^cg?>wD5Ld8VU7T__5Mf)Usk8vvOtOhc~cPM zycR}f5Sh_Vyjk|B(RQ{&Rv9EkT1pV=$ACQj^{;2RzK`qaJk28X1P7-{Of$+D=bSdW zMjyoXo_#_G0lYKDG+>kRH6$VoM>n@uM{8OuwLqE1%nfL0WnLMOvOJ!9WA>>gCpe

      (~(tO4gt-n18vEd5PO| z#NS%){^~~Sue4W^eSgE@>;nVqQX3d1rRdhB^eZ>uE{k!s`dW(4DoQP-)`~edY=lPn ze)M^r0Pn-*HX5YnS{cB)Ho)Y0B3y60W)+Bnw)!Azm(3n|K$@EQeA&nf0p3GhLlXod zAXI}DE}k~h;w@1W0?K9K$wx)SdOXiKxz;Gf;V^~@=cNH{^=tsB1Asop*oBxV@YU11 zckQ&F{S>)W3uQGh*I&GP@3 zy+6y2B-yqEv3<@F(Z0G*QdCYF!X*n z4nrRR?+$`wjCHUQstW#bJZU&$Y&Khn0P^kOalroV)wZG>vK5B$L$IuekH-PBH>Rx( z02~f(2!OPZQJg`Bx zZwvrbv}reiY#3Fe)T~JLcDw@~`()aG$qD2u)_o<^UF<5Gqh8_|U-Y0nsAXt<`7Mzl zp02zcHJHA9<$_dPR_W{}%1LdO;H6+mnIbfXWroYC0B$nxV6weE4G$`QKTEE;yk^1n zQh}zVQ579vWfqbJ7mbJ%l7va7>TbXJ^H6X1ays3gu6C%}?w3z^^u_zM(z*f}MDGWO zs%kI_s;a6&aEy~wcC-Xj)wQ*@0VIs4$ItyeFnR@BTOsr~vhl1b6?71;dl`oj<7h&V z>#E!Ct4%Ek4|k`Jj{~HsZoYYUd(&CVK1P5|5awvx-R&qntb~)-5mBQ$U^uxLMPbCk zLc0CinfwfIs#w=Vll!D9TbO8o1F!J{P2sb zYlX2R(0CUx9E^o4SpkB23vpisVo# zS~&DE_^BrFb*=Ptv4^4oOsg%cje+@NVj!{*n2e23sENHWnC>A|~At|MFlBPInJzBj8PP z1M8iN7*kyt)1PcAu0ZaSRQI1wApk>+0EsfA*|Zo#)mHNO`0(h!Vg=mX{^q;g$sYSh z#OR$r`TpdYY`bYJhp}=NR?OgrR{Y^naqM#{)oy!pz1zt6@Y9dKd~n`0{mF;AvQ-_% zF#zhlvwN<#o7xH@S4IHirR~{Z;3Nf`01dW}DVoDkl;&gcBL!X3DzcI zDFmI)^S_p7rbKsVhU8TEXstXIdY<;`%E8nCAfjRqNwDoRLsz6)vCkm*1OnodJsY1U z9^-U5N{Y^iRbuD#5dk3O9I}AqaB_Ys6nLId0~bbm;Y^h$6LDO4djb%O0Fh~~zq=o+ z*2a?`T(jfd?fp*tA^L=sibX>(GWcO|gIdE@1lCxA8ysM)a1$WiW>Ys6!x;F3F?RrZ z=V0o#lW_1Fv;r&;dKjjPs}R*|@FDPTH=DQJrY6DZ&VLvlPo`>`_wU|Zbxq2b&VY}q z!EwDudp~$!^n>8h`3S&h1QB!1kVb&b)w_4*Vc6e^6A?BZ09)JI>o=RLmO{KA?~!(n zh`}gQ8w4NK?01_=!f^NTkN=;C#W2P=IC9iv)~D7#IUb_<*W!#RrWbSZD~R(YOGBDV415 z*%_)4eeZjfw(V}NHXE?9X0zRNt*ukJzjWf6DKjh1XG<@gyDw;SPZz%~Mx43(GZ9-O zV$9NgR0csRN!F)IO@tzreFyKyapPP7LhpL-BTmtc{RmUH){XAu96-kI+x=d^4}fEL z5cH7!{x?U9d${9c71)e{T7>)lpMR;0b%Wna2>qcyq^xpmH+9q4PQo8Kf>=TdgCt-~H}C{9q0b=slo34$hr=a8+-+woP=)D13CT zLwNjnl<^b*HVt<-`)xD&Pk;HxzkGPqAc9DywpDA7r=-4x-rh>J-)t%i<=}_o5$FTh zfFcDzsZtLuSx8dmh2kg}fmLz0*@pJzs$Wc)(0UUTt_Qlf4>JBTGuyLo=L1uiUh;2S z{0^i74@@bCPx5QgoPY0y_6#P;N>3?Exps+OBx47GK%Rhz7*_Odk;z+|Yd z#OVpk5zih&nWbgEUR;6JCZqXQ26Sznm6R2@?%w)P8$8glZmLd9*xBQK)rSZ&YQ;!n zAb`d&dI%fTO)o6X0qzh%Vsp55&j7(|(7<+Vf_l%v zRlT#n+3fc>l@;It_c+}TwdL++f7LaXgY%BrAOsDAtL?tt$8iYZAsi|=4vwHeVLbTbXGqE{V=7pxO@+~`6I<5?;rR0(|M4$_ zD%ilEngh%xW)%-9nGhGFUJNjlGuJGo8wDii(_vyEife1FO5Qcek}d0{T?L;^`;}1Q z;TOAMapiOSTA?7bx%nk{1UJF}wXsInc_@rR33?ta%hm$q5kg|$CZYzh7$c0qApodc z@BZJ>d(^Ce!Wz_WtVA9WB4D9&MefzRh&6&7@ysmn!Zy_`x9W|nySg!E5Cq*CYal$L zav`#vuIU0WD8r8jjOe=UMtTY3 zCu@Bp8&a_{s{8YXt!=4(FX7=n+@BsCfZfJiZ*SVBviCnR*|xWQeSNwMP5*ds087%b zt*L7xbzNz_>uP@*KxQKW)wjR@Prtjy;P3AS02&FIYugF|Vol}Y+~A1)>0@n! z0}Lu^_cxuTpHF}O=YRU}m^iS=4$?I3-N8i`h8vodbV{$D!Hq4Q5XMV5PUrSE+ekN&$f zF4pK*=SmX{isyW7UT(24I?i69IUFK;u_OvPd!R~O1hlIH1_{>^8ZYg|QQd|8omT8i>w5XK;6MS~08*OqDobv|rP6~_LQa}tUeTbqgi(;&2)ZaW^&=Cs}Hnr>IO z1`3=G^B2a7sfzC{8^Aw&{^>76q9^_Y48e2_NaX1ziy2_qpuu}TFs|*sZF=|~Y`aa@#q zePIkRk$@P3#;DAk6_dzGWMZ~ZP9as^pN_-W1+NYe1CL_}egF_h*xly-{xAT5j&N4& z20(B}2jezPXd*-~-~eEw+fCcXzk1Qrql?75UHAU&^-d~pD{95)P+!0O!)Lhh5EMY= zHGt}>NeZ-ut&D*JrhR__@U|UreE5_TZfo@5%39M_0FZpf;eE=q5F;Zzj<5Q z_n0+=l9>ktAOy;Iebkr(9F*pC3<^rJCp59$7JCOrmowz z0md=7<7t4{<}n-&e2tCmZomDPKmL4#m6$v#+))jB??*Rw?{D9?UAJNN8t;7oZ-x_x7)~EQ{(N`6wGAMfedpeM`~$`T706aC`fwT`)o^z&vTx(?h^E=@ zPlElvbH*dML({&$zCwKL@BZZ<|M>8^4^Ek3xV{F!xDm+z_BVSue!l;w|NJjMD!4YA z8uxv0Xb*KI63`TwB8iBz0hOU731|<9U=;>IlM#+ta$(8EE+ArpMDW6(K0^&L%#<%% z7gmPwm;v?}V!_~(({x&7o=n34L)kXFH#@vBhlf}je>}yjQB4TF>op)E)x(a><7n7Vo#$KW-vaIFlA zKDd(}ajKxOw%UI4p|5dmDLM~^6(a=H-uJE#&PNAG({)YL9{=6-{>^T`Zz~oC#0ZHH zLw$mqB-Vc}`R?w+=>YlW_IhtN-+lPyaDS+V0kzbv z?8jkyID}6){cs(f$L>4x(D!52ab^7IAOG>w-DekLPB?V^yEnE!=s^2+Li(oA_R1+xL54ySD!diA6DF(v6_7KXYJ4j#r> z7&N21Z}!{j(?h@W&Vyity8R(Yw`;4~`qA~L$@& zeDD~tyZ(OPY?>Hgt={Lg()br9RM4+l3&RIMrrUR{6p*FXK`{qL=upad`$Z~fX2}G2Ve*X7rbFmWU9G^^BRZ2XF?aHsw-o+Pjl)9vdwxBclin`YN`U2DWB6fjK0oWxHE zMW`TBw!+7?cY$iD9GjDIadt@X8OkbZTOo+?NjNSg##iW0Vqb)KPIK0A&PlyXGSz~x zC3#z8D!|JDQJF=eBCxenV&5)|?;Z|!pC3Ga*KNA`+wpMd|M?GnKLAZlFlcX2!RdXt z;^5SCv-LO(f~FD-xcl*VcXS>g76#h=wW;Fc+tb*OEu=!V9h_-w|MO1+gDMfjfMMt4 zc5~Ar9tV$2-Cl3o&6{p(RZovcckdZ?3=qRqU){EV+1~7`F+4DA=T46^?z$##rd7Js z6wEmmca`=(duf0WN}%WLjWn0;1BewgAN>n1CR7+^N^m%1oLo9lMvRdttzk$^no&X+ z@+H}Z{2cJ~r49tEm&fHG^2DxUelT?DyfA_F(}&5?fiFlCpv48#Z!ZieG0XX#Y4Rjo z-O0(f@WT778xz;NH}@?Az|gzF0jdEAfa?JU)hwvSMD+sTybmx!Ew^?Hv)k`#BaGmV zkEdh6@ezR8+3RoKzw1mKKHU$!nL@>)mjIEbd;9+8jjcow`iH-M{HH&WLk+XL-Xpj$ zs;c(^e!Tzm*FXH}?s)UI?rLdj2G=(p_U6+m!rQjGzJG9SW8pKB8X?Wz09k4r;M-6jw|p%%}j2ty%73 zaO%ARgG$9*+q$a4VH`9P3(SdRfFNpc-YK9dLc+j@F)AR

      tZbJOi_C3Kw}Hut^Z zifXRJR-tbmt5X%+uGwF|d9$PF)R?-i+scSZ`FKSnMR=$v&V1HlnHFTNE>WHwVOMC{ za~Ypv#(}6;qi13DVdaP<={>Z#@O20C?GWLKz$}B(br;G&_lTT22-m4uk0jBD<-^yT&02p1Wp`I-5 z`jMLkb<q+zu0-@d=S?rdeChrj$!fB45wT~o_Y?^_G^SheaDU>$z`>7V}a@$=FB9@W0C zxME;a*{gS-fBAGAL%rRMcYp0+TOdHL_7%Xju$cPeFCY5P#sV^xXfU}@3;-rE26w2e zpuO2|aPa-zhoA2KOj$BNQ!9~5iOi*i~#C- z)3KttdH=S)MvH1=#{TntN?c$VdyM^fI=CV3{^9ET_cu+=fLAfb7(>Y`j94fWl3CP# zcB)^kI`v<%#YvEXB*-lYF(@z~2@|CVsFJPy*lI+GFxHBpIC$6X@BjMK{kW;B_UKW) zZH~u296tkLINU$npX#P-tGY6P-SMpP`t*1L1IBI| z(*g*?>9G#|{XwLKVPi$myN`eR&wqJ5fqER;7%>iG4+7l% zN&3_2?r<0bxUHJqw*aT2oEiX)aN}oxJGlP-_-?;7kna75;K+C!(0c&J7$_REd3SA6 zzC|j&f&ZqBCadCWEtg)vqL5ESIteL`Asy?52t~8u`paKarw%Squ<29H*hd~mL?8hX zLl)H;DM~gC3J{a*$dk5LLIl?Yk(D(eT1m@@3BJ#)KBaA7n$*&TQL$8m&V^7en`wyv zmS*qj0c=AsCYdK488D3ZjfHKxszPx72tYtQ27v0W*>A45Mw(r--PAA$!^giq_OO7o zoBg=^{&(MW4Z`ltw~sFLfPldQ1R*rroA2Mf-PlSHhR2`(=YM%X)yhyIoPN1|u;{!W z#t3}+)4%-X<3j+%wB5#nC~#fZ+w0@|`}>E`?)TyG&p&x|dpOwr{`$IVY7wzG>iyk= zsT|R!sfyaC-Rs;g>`2CG$ojcDLVcHce&iGHD*q zqQw%BJeyXAOzwDjk+TDHw(CT!R%2dtp23ger}Qd|jFijO1%R1r5n~(ly$>-!z!by47VtS$G7ue+K%;seK_bSo zqOL3JrDJSrLAX5uFco0%9$tr&J88K6U3=SY>zV+EDU^|bY+ONsCYLK(W^5sTlVsDz zbO-eLEXJ{{`D={|hP`Sty!v!dC<1B(VlE^@SqLE!ji8tyG*L*b8`Z=ciA5+>E>@d| z&F06`zPoNc?9F!faC|)40VezTcW*Y^U26g0Hr!h>X1l$*eOqn2hK+3wVxXZ903Mxb z_wP5&r=RK*0I)Q>MxY@K549VQsDSav0`H*x;p6}OmlKR;j|hbt^#L$qD)tFSY~Ny{iNAf=H-K2%hQ95YlRu&5(@A^qF>rI35z2^oEJ7F@dJ`mJw{_F(Z`y5JZJMsG zYauJ>?;k%Yho;?cYlQaw`>O^qP`%q)0YR8%clQ0&)$LVnM1nhh{_)3;_I7`R``90F zfEy1T-09)o4Ih8}aPJ^>z29xxR)R*21~#@$)3$rmSFIkJ&4~6r0NFHcV{5}!aH@vm zr`~#R0FX!xBNC3MBR(oyZVbnvKf=R~rvN;Bynp<7e>e>#*&R36)%*ADRf=X_xFk#p z+$9jX%y%xJOzCn;{3gx63X~^=;z^77zU+aeU&iELU7r>361)$X zY-QJ%``7dgRNsf;c4S^+@b z7$2f@0rAbZ($>}zcu@!_nN=8qDI@W!>6|7m7kt(^cxuKupQRJYhWbU`plO$!Tll7N zUg}~6Ct=DrNd+M1;xaB^AWNNy1jC?6QL36v`_OLN>fTfa{&={%Z)>nM*eK+O>s{M6 z3}_?f{x~?he|!56S7x`VDr1`(-VKMt34p@ecC*LLZu_VJP&eIP#sFY^kmC{E==%Qn z_*1)k>rVH-{P}>+oHQT@bJ({*^cbjTTbVYPt?lrfS$Hs-m zvlagJRyw;R$gK2DTEKP@07XpBam1Xx*pg6FV#PJ60EUyA#=P*xnxLoEYrLZQ#p#k2 z))mXRBM1nHAv_65(3I09!4Rn*1~f(}O(yT;Au~PT>DFdt#Uz(bE?={GFaL-rWpfw9 zod4#9DSh!Kks`?GMylR}dplfReR@=l0m_k#@zzvT1q{A-K55p*0T5%W&A!>Tb-QgF zD+FW7yMyy>vwOFHQwz*~zcFqc4}-T7P=mxE=l?hLX18hT8VI59?@tlCf7tF%c<6_R zx;ov}d+Q%Re7bu$9*&+j-M)K!v#qPBs=){er~%m0rfY)<)MNiG1F)455fY$jFh2G} zDW1l*LJ;xqPWSjz5UGvP5xoaYb2uJb`S|DIaDN&jqS^qk+26k1et+9-H&rd`O(~Nb zUg9%PvMDezPgyuQSBOo1NDM`g&~}Ot0Zs5LV>VnA$ceuvCK&>P_^)Ap{>2J5gvvt8oM>shKrsQP@Nz2JcN( z+vE;8f*2AU5Mx|P)lq{x!J9(_0R{}becwO!gFl{5eDDz|o+A6%v1KxjZ2*KOjf@$H z8W0ddaIV^HDl$^@uGNSDDENjoAgTiUw-8DW0ZDJoqoKkvE|Ry|>n)*)feScR4)DvY z?~B>qBpyBU<)X_=8zOxlkV89*o?5(YGTp3H2#Qn^nIU2z-9g&Q2yDeVp7uSq5RCiH z!}0X{tESpi4CuJ2Mi}2*fA{wL&No+0Z5i8C$>}%%brT)fbo;BjCV<(RX1|v{90b0{ z;og{V=$(h5_Ba02A5Pj3J|7}fHF&VF5x@sOjzi7HY*4*D{r|jo!x#dAM1XNTJwA?3 zBh*OU?%%$N{b|s_sYg8+uZ$4Fs6N(%^WpS^wY&Y*r-M_5AH0vSL5Gv&0Aq|ykbm+j z%nJWg=M#R0O-z!=7cjmF?YY>K5>o0EEu3@-Q%-a|WnfUANrEOD7m)>?_iOn=`{P-A z#&dE(x}vHF&5V!p?md5Ac0l17BYUbxygrF@qU=bzVCKK3MFPlxOdWvs5WfHE?s%W6 zrhs?t)vf~``>`LvcC)n#)BucaYFm-1Htog;SdFm;KzpQ!|r$f^y8L;>H5fCFb*D&+Y82q47nmfVa@o@A28CI`AtFG*CH-<1qfJ|%!1P|1UBgoH4(_uV` zKgj?9#t2*7{%{XJ93iJ9B?m(h0XFY8HAw1ezll*3 zxVoF>d9z7x45ULe(}U!Krbv?adbCe~N6oNQQqBL~hT5-hoNXk^tEy%T{|E)9ycyGe zPM3<=a2vqP7RCTN-h^Pltl@a-``>m_Rl=&#w_S7lr?Gnbez$A9={AiaxOUu}07MN2 zK8!A)x%vFD1g}WfrQ%Ab<4MB(@va|6p!t}--E3iM^&yPWN2=>a0J!6EJZ{>$;*Ep~ z7=}XtB=5-JoEtO(0+zPhG$;S?;q$$7;D!K%03YEa)NX$4!oEYj*}(Nd5c)897$a`5 zzIq&Bt16d>Dp2(EaOU5sJ-=6yN5~w$x!Rc*M=~R#3WOBymT=Cc;GC{3ve{R>NC5HE z8JVyPCI+I$7^0c?T*}54BNcQjNAn2+hlF#bR5m5oN>(eM7y=kNB@A3lLsr~MIvPy^ zdm&yWu@a|orjR{KIG7fzV1B!d>IqkXdJb3bettYC96+^jecf#Kl{wx&Ivrs*+g*1E zDTcHX5hKK$J-%!uR;20PUjOF%tIi?>R5Bhv{_~HI$Ag1utgRaKqjkd~@kJPphhDee ze|x>FgAE?c^f?A|JXEK}I>W-d^o1j^ptJ2@HyG&IOQRjS6F%Mv`$O`jn1- z>_?Y01Veyi`;qtk;l46l!K?3`XTaf+!r{YTAC1U%fFB$S#B8p<`S!Zo+R9jBEHibm zPP8sw+Dek0c8g>;32+&)R1T7Xx{EF2oaKp&$GzBy7=b3}eahe&lMrS^tfKW|D_fh| z2kYBGp-bTn#6}f03o{Em#9$cQ;Cz4>#_8eks7#e*HHfNSbpYT{lN+2v+(0SMklRTTiWblc8+b{e1x4`X;#0AgTe zw>2Ky+qbuP_kL?5sI509MJI-cj*tshi=;CY*LLmI58iCLx@M0}TM5v;Yd0o<$$Nnw?jJU&_E#HLZvYmym4mVYeE)ek z9v|JH;87s8G0X;C9g;$)XdBx|2muGO07ir`j__d^0+SVErg0})M1x=3F>gSIVhP5065iAPc`J$r#Y?{;JG%T-mkR? zonras{&NciaLS&%K<;uGp`3{>#|CGnQs{gD5EKz=3b9{5x9otg%Q#djiJrfIVtp0> zV(@V(B+gd5spx1#vim47M}s7T>U7hK_U~oMH99{7A=6-DoF!Swcg-$7>%~pe$|e#+ z1>@D5o6oXagqG}8peM=Na7fsVuiBgp`h0YBD!dx{Kj0g}sC=Bj+_vv#5GO3gbS}5FOaJ~KH z8?nN%hcaO5_V&%2-KLhBgt4YtNxDvY`(z+ke$A6%Z?z+0w%(NJmzT5Vaape~$o`WT z5h*1aLnTtm=~Fy@MOcih8g*=KT~+Yj-`g17+TFOZ>cPekX@Hjy;KL9G9nn7m{oybO z8!L72(9!w9IS&ljw80HNZSXoB1KU;+8hoz2tU9HTT(qbIMgpv1%eAR0*yHKsorkex z;5i`r;30sq_4aDt!ux<2d{ju#5J9$LR98De=-%GG!<(DEQE+2wR;X4%Bg~w5s?-Aq zFqt26(UeqgG%eo6rI{CE$`77Jn%7|HFVzSM6z7af(}%C#Rk(S423=TuNXg}4A^1iZ zseq8U{xn)*joy2=sY!&Ph}PMvyA3Rrm>5u1Rv7xWtpTxi7y)(nch{Ba_8rC?hhJ@j zcd&#I{(3wOqgSwCU<3nbkJfnS``+~tb<>CmA>goW1i)}|hhqu>Rm+Wik_bqIp{Gwj z|Mci=(^S?o5F8s{8L;iPt?^?38573f*!bX_^D$-pF!%RPtksD&Ymo|8EnYau%c;L? zntFZ>o}Pi+G+99cO_?h*<(?j%jm+7cNMMjpJ|93tNarm1bCN`wM6C-$oP?sJ1I8ue zRw}8#W^b5;PU&RdS@eT7?MpkcV4BD}*aU#h0@rdhIetDH;7R~2CVYM_K*7mdegW!< zM-HJRrZ}s$<^A&fv9exRMOFq3BFA?B?swsny5uszwe70fI)OiKYS~@Cy#YpaAvh;N zA=Vme(kuztdhc-co15EhZAAf!VLaS_xa)o8K~|DI52yg>a5^4MZHCjacib9#IEGI@ z-Ft`;HvmV2Q6twd)>u;++fW?*@$e973=}bV1+WPNT+03tKp_UN%9{ou`q9Busf>ak zI6p9JaQ)qfyV_WYgIAxX$q}?VfE$rqGl=Wm+c$4^o7Uud^G~LWBC)Ph=}li|wst08 z#Jn8DughGNcgS*|tqV=1V(pXJA$wR%6n64nM>r22fMAPRTD$BG*-g zQ_6bm0U3-(aDEJ4$#Rfk3|@%2HY8DT3Q>Ik0*o144nr6RYYB!eQ}jbW`XM}z#H%BP zM%ts1x-qted%Pcl8W?FJ;KlpkKn5&zyW8GWqYKXaRL}|r-f(SA-EMEBviomtukHS- zWdM~i6k}8sjWF4*YeK#Yz&k6%vt2Y>4rkxn#iRp8WG$#m(yQW{7R2=}a~_s6yZVzB zFHO^$>OQk~NPwsp;-gmJ_nZu4_U6@G;XC_&mYV=pm>ARwNrIJ##MVB7h$)7Y;>L!Z zt);DQ?oa*bd~L%}+3uU4s+0G|AShau5mgvP`p02#3WgzHu^5I9xW4W&o=yjGDyC{1 zt_OkH2r!)PA0H0=Fpe=&RaZ6DY`lnAoMJYV0IJ8&_mA3ISb+n?damD@s-oI9^+o^| zK?n*5uik5bhw{*SmrP~I+W2L|8%+}!lhgFHQYCnMWwkrsG>K!B<$to`3n%KBhQX1R zTchkknoY=zQa7?_^{jK}24J;dH;%E?GX}=w6GnwkPpMxBU?T4m>mY&xfg>$B3lI`o z5;ca28WxT(Vi#p^^Q#0XtOB_kCMXn=1Ip-p7mv$7a=kePQlXm&Wszy7Sg~Fx$p}oD z_>@Q-)1)IA<0TfoH06j$MXn+vrMt4bSiSpCH~-5oAMYGjo2%v?ZMy*u4}E=e`_22U z!Nd2X{pHVh52kN7SMP5s19&C?Qojqok^S54b~7A6*1#X{?#BlG;F}wZkn4g;R{^;H z7x(jibL|H20eJuL(|`HH=drTkPE8Bo@sap8)gnD<^Zq>!cm4Qy|7jen+x_17Up^0} zI&}h&;MChqg>d-v5bL^YHx`H|w8js9kQx{dR*YD*2FE+tx@!P%-a=B>b^RDHFcgp) zo9l1?{eSr8`daFgE=1^@-0(E#c;d0ZlJtnxF3(BdQxVd%GDO9~cZqpUreKs)6+`Y~ zhDfy(M@j`EVw_LMq&I}9(u7A7aDBD8`|+nowA%)~JNDQD&L1Dk_-)-+bnSThc=TXfk%5XfgPwcn zxPTaeQx~i2>qY|Ze;H4x0c+$?cc%XY2dY4}+iW_E@V$Qg=nq4HgcCKJZo6r_8oa;0 zd9&}@#_o|8OH#^}R53M9m0xrvi)4nxC8$#XL5UB}Qa2eyO!6o&sf;tp%FHbj0tI+o z^l~P9OMN0gWwrdtY4vPBEMO!_O6D4X2ml}n>ftkmFHwmL999tmAVOqvZ!1cdfp&vQ z3jn|nG)esSX|^I&;@jT(&%s>2c|BC}q zZET`Y1_sUUt;O;2r=LH20Q(-~OL18#5x7!2-k8Wh&FzyEh{HxGaKi1s({T8uzdi^l+u3Jw8I1>N=A4P|fTWtyY4 zm7JztvD z2UrYYL=}NtZ#~)F^yyYv=v%z_q+p1&gv4Kz&gXvO8dME==)An_9QeAdFHGY)$Jg>* zaq-xNd>5#^#Nr&Lrjd}fO-Av)FPZ($9!pj0<@e~IhiKx!byaOz>~BV9xDeF(T^)c^ zkE+{mHnuWWARtJn+wRuc?yB902>>*Be|qfueh7nc(xTbaa4KQ+Kp0Q=MG@a8uO-24x@w0U!+!$yAjw{os%N@!@zJ4FZh&{7Y{wHb6x+NW|2}-~Z(So9p+D z`f=>lw#M;DGP!N31|7#SDg+q97!+)c)WmTJ{sb7QuN|4VBvW5Wck3$Z!h|`Ocg3GwYl3#`_D(~JVXC<4M8dk^lcMhs8q7kx(OH@!m$8b z%xn-z9dvMK0=8}|Q&)A{b~Wr^+lV?yr9HJ>cXPdOYqrg<>o#p=Byqj@ zSkS6E=Q`(C;R!2FxSqK(<236>FSd&Z{bIX}olRu%HDq*scNtan^ukwrNCa4)>2Y;O z0{D}#murV}Y&A5l8=Z5`2LPt2tTFxYcp8DK?)IiOTuVUpr_V-2LBwpWHO5d>1kVr+ z9*U;zHr9x(M?*PtI)sUYNo;KyFiyh|9SpN=udm;~y{?V}jIrR7J|@6Od$Yf80$W%U zypei;)7C*1V3s;UeQ5XZzkA=A<%?#s*jYwYNmN)<(q+a)v@FdSoin{>r@a7r3g&_z zW=Gz+3`CxCoiIbX;Axs|2PT*VOR~v?Al2wi8szfM%u)rpP&1HdP+~VcAr4Oy&=BZS zx`wlz8mGZ8h8n4WpI_NHJvPm3KB`I7U)#Ky76T!m)V|J|!y-BAqD^lY34pO1nBUgd z!oQ4)h_-8_MspqH5n<>zXexxk-{QV`dwacaML3mNArqTzRM~86!y*A1e1EwA_{(94 z0lueesp=Ni!He48F{&4E$IF8l$ z*Uvq=y9#KyB_jw`J>32IAaCAnZv)2DDWGjf*L&DXQj&3mph2TL4g-7$V`S#4GmKFq zpb@sZ6*1eJw{LE?O)WGXh4leh{L0zTvo=2Hg?YZv(rTV<9a^l$`G-%`NSb`QB4SkN z6VgjyC|8xmc#jcm2nYxYwAaxePGjYh^BoHlu@W479HSyeZvdDe3MLqm%JOw%o2mg0 z!LfSZ4}$=sB88+z*xEL2*IK}x0$5VP3}QqKYT0a@8GW1(crq}`b+g^w+;kM(5a6>@ zt*O{YMP2RQ+=^JKDk})6_SGnrt#GjI_0838(@7XUm05gKM2`X_b3AfW=tX(p0uWe-$|@$H7lyqAF_i zA$rxI4uCb5rSX0U4geb#YvC$Wzxl&4o`Maw+teFs>lPZ|#aIDg$e8Q>Oq%WbFB<6l2~Q@;R}f*UZn$ zn^Mo5k>+2)HZ$X&gXPabn3!~9W(X>9#rx~FYCm`nv>O&iwb%MjE)33N(^dFI>djc) zyu0oiV^aQE2FTWc)EgrRCPW`jkDveg*UyjMdF=!D4FC%T;3MD=4h?>>`?ka3bboTa zuQ&T^{4$IQ7)r!x)Tpk%|7?yS98ZVS!3~Iq`)d60-lOq=v0_Cm4pq}1KKSNv{6RzL zk4IOvW*84W+NMtXR)ZfMpinRHs!^4in?2(+3^3v$-PPO8wyif^x82kxgVVXT`h`{U zU`-Iy6F;Lb^1)2Ig;UBKGNq%j05O}YY2?jKRW%hbh692dlRPn|!V^G5S9RU>c3%OX zPJq;bMXIJ?u51!>)x43}7-3Mi+g;sUw+P`h0vbGmgtj6Vz_P#nhwlNv8+e48_mFDS z)(E!U?%J-Z#J~_6A(o7@C`ZI8chkIRj9e@shGa*0UVL9n_C%*%TFU3zWK26_UzZ(F zW*l>|)GKh5vaG}FuXC!VMNjd`j?GC&d3E2HW|qud5T;1Sw1&)zSS7Jh6#-&IXcN>W zQXHKaMyTuE`0qkvwu7&lZo8AFsxgdxcz0a^6+18Z=IVBr$`DZiM)152|&mmPuc33Jw9GY^_W=)(ZfI}Z0X z{HgDUL5Dbuy>%b%9ov&5W2_ZpFw{IAj;Ps21Oy+@Hr?SUi+pxz1}vGnsX=j!YP;KS z-rB?c$I%#|x&G$6_xoKV)>c(5Qn4N7 z%s7Jv0Z9;(Rk3H{))$410DvJS^ZHU$<_U()S1oQYpvn0dFOHd3%qP1j=<{mp^Nq9b z(JXhya}O~f)n+KXn#!Yd>Y4&{64n)P7VI+;NLaM0DzV-BpN2s?m_%^w+p*eTzu9-2 z8eO$<;I?Uv5ur4xI))G!P#*=ZKMdh;_v4@c{K*dy0Nn7{TpbS9jgQW=!ovq2-N!D1 zB@8~m)Ysqt?#3aEpQ5JSjo}bHc*Jo0)JkyP4?Uvmp~m0e2QrVIxfZD`lL7qbP@_U% zz*KwNY%C)<;b9mZ0uWK{uMeiJw;lS=*9YIc{o!}-ar*d|4_yW9ufD&1v#TqC6-#Co zjMpH*)1|-Q$M8i)o*7@bY-3t|c)?_tUCQE_tk1KJC_yd6)$W^*!>8Z^)iA&?4j%pC z)IUD-Cl9hhl(TOq7a2Gk9jgbJS;+u~s=B+`fB)Xr#sV(XO;DCFxvm&+i0jRM zcfDy1aQe`m>cImBjq%1RB6vIiQ3~Vb+SazV_3rv+vk~YJT<_c%JpdsQm=^8LH`mE2 zH#*?$rtUUfQ&mDNrWRuilctpZYd=Z~z{-~!3|eBEnkVN~HSRKTTP(#3E6rI+z!M_5 z!15QJPKv~HeWr37>kX67_sTG}eA>eD#PhesaP>8fCRjMjgfTnPGl5cw4&_axP^f|} zK!{>I{{8#@{?L2Vn0hb5gfI?aUjrKYzCXe=yVeS-x&;^-`{V8D_(_923V&#aWoO2y7MpU#~PK*!2B*e0LcRx6PN|%KS7S;83 z-&ICXNd#Gwiji=lFPb4`4I1?H@X+`7KmGB){M-X%gF=VnCID9Z#{&!?!8z|;@WXIw zVH(3#^WC@KUU`g%(FY$jFx2-@s8ZBpCm{wO0(2aEWBkE6)NZs)6-KZ%0uN=dMX*$D zZUk-Xy&C{G`aWnf8r;4Qx4X@@#_)K5A8x+;=G`@hH*Y>Rm63h7-*t_#3?V70sLP_P z<+bI9k)Bv>XKMFiqcdE6)s_@F?b{3er6A{(gf`L5LYi11cJs~Q81B`>2m+i&a5$X$ z!MP~Vnh8dj03kMFpg>gRNX8ST)5%jc5=yM4E* z4d8FS35V0kc@G!@gaHoG34zH(2QY+*Y;C*!ep4X~F1%+Tv84=Pa$=^e>3&LbH%`$eN zq=u82`1X1nhf$f0RLlaz;9^|`#1NeKKG>=f*5F5wfOT|zpYm=BRcxtor_-m0yHAI3 zM^}4m^mu%{AE00(QiI@q0HhJqA2Ia37h~(DHb!>7eLpmz-CcFNrWGS%MCf_1!nuVh z5kO*fJf*}*MKqs9s~NM7r0Fz1HD#=CTG?XDWl3W>%idX95_dRpEe7TIJq9zIg<8re zE(%PTBD1nMl$ZlANK6uCmdVF5m0wDU*@a;}iCLaHPrVSQA79a;0x8^d_CT3@qgP#D zh`Y?+kwhSB!FlNHYZPreF>w|KxV;*^4xcfM-U9|gRoAtZkqBeJB1V`ADc2-4mRtZH z7#=^}J)S=P`42yyK(!3))Q6GkzJc$DQNgh4Mi)n6#HhAvAWi%IH&@reKOP@O^}+jq zkj0lcP)h!x>Vcr@#YeADFtH)2YN}gS4@EHI0}Lb7!BnTwio?)9(v1Q_(!Kj_{rl^t zGw{cUM|rcq>00>fcMsN>s%h%lisZc^D~fjU*J(qXGs7gezeZN39PG5dy^yZOa?+*E z6X$=I3t!k?%!d;Un9c2}AA1*JB?RY(5D`Zo#z+>R3Y1cQF-%l7Lx=(FjS9fkhzcOK zO?Pv<+gmFFR2ttOkB^@eh}!J0-o1T$EeN5i>!xD%7_YvMhvV_ScOwur1XWdq3fYQS zQ=xZM#@M>)+D#RX!{<+jyU*S^1!~Yp+saz$u6LD31wswNZoql zBGyD&^Um>vtSHq6_z9Pq+r;(=DVtBania(( z5dcF=Vjx8Uk5@B3*`J@WVi1c-yIK-EO9YdMMLB1WU32$bb>vkp^u=6i1!feSWpw;%m}b)taBnKZ%Cmr4%pNdK-IO@n(FQKuGa46@Ymiu z9gX*F8w3d1+L!@Y_}=CwWUQ_0x;9+V03V|7d*@M+K(Z%(2y!^t003;-{rB~Mys{gH z_WjZB+Q!!K-IW7NRhe9jCh@bZGUaKTsmMH!3meI6;{T;aSu3a4*XA`hnOQ4+azH2o z9PRe@aQEo|R4a3~i58amv=}wj?Coj9($2$xXOkEHA+v^{` zd$(n%!k8N5#L3q9)9J3dKfuESJ^&G@q}{Yu5OD0L{Ha|94CDQWkEhS0_YqV9I59eO zve^h3G{#m98@{O}8D3Mh5EL3*)?zvNmu4(Z*ZvwS-&dO_)>PrurjaiBG`-y7t9$4r zcK!7x7e)33Om`-=Agea3A&{(M4#MgrGmOX6;89ukxZP~VlYjFcet+H7LSi->a2-V| zV?+qC7%^U*XP=d%r!eN<&=&gOGBEU4bX5FuVqvoeU?pNE7Qs{*IRinM{LbUFF(-A8 zr)*+R;Mf8egr_nRt!>Fk76^z-DXXBIFF_ekT88eK=;>`4zbtzb5 z?50?u;>ls&+2b zkz?o_9-amKf>vB;Q#qlvPXRr5{duG544nJoVZzVnYvTp_Rchpv9WbGrgsd3k9m3V- z>U#gdBN3wrfVM^?f|?dTYOx##Z^Sy*FfPi&8iq0%QzvChEC6o4>xa)x)BN%5FJ~7H(0{DwoqO=_G z%XCFezIM-%2f9c(;%aPkiIMSBf7CQ*;j8!_Pd*ABNNHX;S#;7iHk!9{sywO?%{9#u z+(v;&C;|vl3R*Blg#-wqNhx(ANis6T7&KOiTt}d)Lp2()Ro9aQ31bgqs@jhMyLa#2 zbmE7hKMfG$f84hLF8uHh@As84q=r~XgBTKFq8QRNPYEcWZ84-s#Uv;(C=xi#C1Rgj z)H(dAWY=9@U6jFMVU0lKIs4&qmC`7lUy$Tn5j9ll(gKhvga`phiMr-t&cB6e=OnaG zS<6~+?kX4kQ_k@b8mAm;kO&ZX=~|FaT!LIyZxIvoEy|_>Fr0ZIBITljF~tz42@60< z^g_9?=wkF44q0lItAy-OAWk^|0t1KwUU?KHGLTADmTbHE#RTL7u{0qlLs5xk6>nlC zG$#R74noXOMI;h+rw{*h_u=mTbbmmF5eP<_hR30P`~I8j!yg}yIkQ+q+!MBZLjD{extM=c$YgmX8G?E1gA&O~0*|Qy_AaKg#9m;|(fTy*`K$`j@MNRm4 zD&EV}V#PewJfTkc{|Hc6Q`ACS($k=6dtv35Px+~wF6Ed*XJ~m;C@TX5qUh`P<~#Sf z@5XTK4?|Fp1Zu=I)?ysoFv4(hjrEzllGL?C*Av$cY)tp=+c)ppWbQLsccZ($d3*cI zr}66T?#+H(AN+XihrubN-ZHjVZ{KZ=cdoe`PcevT+Rn438t9#o zUIEmbO(&sy_x`4}^`;?9wlTIML2X2sVlJb@gs7S=X(?Yc5F_U!oQZul=4Vn<=4U!g zOXhfP&wsMu^U9wQOf5Yue^1;sOC|<+Kk0lW(lRD6g5Z;nd(6-cb4-h@=b*tsx<-kpN;Xg6I~vj*=|2+R)#`t5(j)%#u3 zP$FxD4RQ&`6dkTmkob_b9ZZxjzfjsP7PLq{5|QZr)YPNgnW8qzm57LxL-Ht{Unu5m zl~iUOB{^l*n@iMb(z_UtAaOAd5yVu!4;mR95P}AY8lkx!LsXDZL#ZkpReSImpjND5<(tn3*UN zH0HBCUP(*Rd*zrVUa;L%0zHG&M&7}>LQySC9#*A@Zhs@{*l zXdD1j^B4ix+H9ah&pn*S76TY91WZl0Z8{M%d~kqtwygniqu~~<^P~F=-y7Ji#2CSB zHaj#7f{=Yi*5g%h|OZ*H&ZGh+Cia#KkyHj44Kd^cieAF6USChJAM11f)Rri7BP7i%LRNLX{#- z^$S7}VnhvjJbATZ3>qnguwq?H=y_l_J#MK%W!^?HD}svU30Yk^g^yl(Jw++0pvd`e z8ChYBLC#{qR9=o9WN1o%%}N?TqD$tTE?H}v0%Ar~UiEtk=TM|9o=m!wxC{skl8gao zxs;No2qDj@uF(Afr^Bfa3IiX#QLiDmrrN)~YR1lz1;Ixo2wMH=aBtDWKthaObv%vz z=)C$6-2jl7x@k-c&td=xnK3Io_Pg%(?bW81@PK=&`(V0#`=+Ukhy;nj)SIhA*nj`c zRo8N5gb+og_zgURatHuMq!?bB|1wkaFHf(2>UuZr!R0q!0DDIyIzA)YaWaEn!s`}j zUlyNOny#&Z8o`Y~1lrEPiWMM?J}OMzZW{{-Ar8(1pr&hm#@(oHs@gyV2vcbVw)F=6 zwp)X`Yj?I1L5L(QoQk(gQ3G`GvWZ*F)qFF2F-xWN1=IY*iUa&Q+Y5u%MunnCtkw0W zO-fjJ5}Phu5f_@m)K|h6Uf--Qj9AZk;1{<(9}oT_L+ORPT; zb`T_0o`^mGF{K_d#&Dv}Y2IT9U=}fUJyXbHAQXzTw0?2*q>D|NvLvI^WwiMD)h&x@ z3rPOyCZ%(W$KtExkHArx7>tZZ{!Lrq*EC%sR2Lhc{mz6Gr6GtEnD{jZ24I?_BwbDW z<-)FAlfo?izi8(}z9tr*0|Qk7ML__i+*oO@Q@Jv`0#MTp&y3qgc2QKDjQH; zzqz(!ahTU!sSd+%_~4FJU8PVSH-0`Gf*YKMJc!C}n#MK(4pJdur0_rlqSjR7REt+#J}*YM46zT59NEJ93CpNs9BXYJSSV&MD${MX)q&ou?u zwA=kBdjbHK8bG&C3?hW_)DHu|b<^1%Kpd^Lh^~gQ7NZ2^+P3@ax;DlD2-y{mO$F11 z;d%!mCKy6BPe6qCZPQ)7J01?lV~}cpyQ`?%@0yC#1*Yf&z?K9?tdJj1j@d^ALn<%tGQ(TB(3)Q12dYJfsoi*9q>HO$7a4ONU0AR^My9ufLS zX>ZX5ujBpU=TCib-VfeK=TULhv|S@Xo%cgfuE0s5_kii%{^qy)4TsS7{&X5qwOjLT zS5;ye09t)l-PGONn@wYhi_s+O?Q1b=nv$Gv=6vQaZWukg@^b2XEKXNUxOs|jiAedR zz94uyKP!PmgoXdcWYFWpvU%!0bsH%{BXJeGZrdD=$9_-{1Z@k15Q1X3Kluo>+;nh2 zph|3w$LM;m)>Iw_vbp~4H`i5VO#~1G5v+!#YNLj2oyS11%dHjFwY#fhKRQ3an5Nx` z*tV{ieSl1*1Q^0Xh{355O}^vI5D^0gR0SYPnL^6$Q_Ub$s;pHEYrcq*i3e$flICN( zhH;ko8H%toVbl|O{uPah2n$cU+;5y8wSN9;OtIXfJi8^87L^exp0WH`e73))&DT#D z)URu^!wyqaR%l$}$>#@x2%wNG4UDWP0&BXTifCUtfH`1{l_*Grki-?p4FS>Pv%*e=o;&Ekyqo+q3OIz;8omtl}4zvHTfByx!|Cs!W;h?(!LE-uh^KnMX4Hktu{tcD06MrAiZ-9b9gz6L#h{Pfe|r0RWePyklCrtKQ} z)c1#B@POfz)n~66s<} z2oqa*WiRU!SZ8I?TP|MS)0tG4+UpsyeEBKmS@~q<^(z=^I&zVUjfki2%L5}JMk2Az zc7OHosSf}I6>Jj_01e*tP61HWw0Z!fj`e7w4wdU$mP(t}H2b%|{r0x8B2gug4N6HO zBB3@BDL*5sl}Ht<+Haf>At;zDQwfPN38-4WwGe|<>tIZVpa3EkA|O&OtIElupBg8* zsr&^XQlzM0m5jVi#P?}cI^c}(bEaI=x?qmax~O_xJa373JfVV@9)EF6Tx916ih9vx zpO$?&dl50}bDGWhfERGu@%%D4 zPpL#!re7RsQBEELQ^;bBx$5n?5TdKzxhy^-&-+vTaM3PKU_R>$g!%mYY< zJPa}Ts1C{%*Y&n(x(crEk0%G>SU1yrU0+{!O;f`YZZ$@bkfkbx{~!{xsl6JzX-uhW zpGl>JvlJRDwue$2eKGSFmpsv+wViEoh~wh(V&h??vx0L2b%V22kJc++c z?QiZrsgik*n5x}fKmM5fVc44e#s|0&!9;*Tb<^x_4@V&MXaa~;y?55~ruwGY-rQVW zcWouC5>s6=lj#dV44@hVbgAzFV68%(^7I2@gqV<`{}$F&MY3v{7{thIU6u@Kf-)?^ zM6*$Iu{LQ+*Vfd0LSmkwqHtYmMdhHZyi5|sq@jIjE0&AtQPb%}77nLB*ZXbNV)ihb zTrL)0DQ8carw@K@VCyN+LQoS#fHTJT6|MLv^7Q9(6FoVkD}yLmG7CES#Yk<0!pB1D zB%QyYLNhZ<<4N}2QudpYG80RM9ZeYLi^VL~gU=gQGoek7Vw4!U_$p7h_%f4OWa@oY?3e}ursRB* zKYJCbc&6l6p`{nTI{%9a5vIhM5Q0RU?S08FZv zmxfD#)d&%5xrotIH_s)vndXVU#MJtvt!|p1w-Dj}?&cq?S+e-VCMnCU&qMhulxBMGuTWq3Zvgy&i=li8 z8e6yL#-pr-sa+_Y{#+|)`B`7UJWskVQTDIYGLA)YA(dR5O)kUzD!sD2OvIVPnF1Uj zIyu9nQ>O8moIJ5;6byd#J_L-;kE1(%!k_;6Ll5sl zP_F=~wXA?4uwZ-~t-E_ToQ9yl7y)oow{6>07}3dN0HLXxwxYJ`Hk+=&e|%qUYa@VB zNi|}NaGiX$grXu+;$r)ZDVUH8=N2o&*KTOV$dS+3_u_drSRrR;AAUKbCtuMl6{-Y zoF-cZ2#hd=NwIohSLkLL{DmV?5R>KKw7@ix)km7bZA$_*5KU2Y3qdRUKxQ=i zS&pz6f5B0;tY@JVEBf)=?H4*sKa%EJ%xLEl&kGwt2^v*{_aSJB--}2I5E3W*ayk1< zPme`?m%>50vDq)Oy~+NQ{++YpTuhtuVk;Spbkh9N(Of37f131aF}`{4 zC|}qdu@LSBlOrvL`=>hAm+USAA-Maig=1tP|m5vL2W}ZOH4Sb#pXWj@| z@+jDk=BT6dZl^yu-^A;$i-5Hrl=9PIX3qD@IWERS#WJ&UN_@jWAQXRA&6_>ZV_^l8 zhGB^9uCXG<1FBIYqDFW>+`C_Xy6Z=iQPJsb6<~u9Mi+t$$dG$K&1aIw$))U z&3>!Ls@r!r-KNExeK9eClgA$jS(~OPiTtEDjv+G+*4gFnqKv1>TJa?~=edM*v5aT_ zaGJ}Q-}x(=;&L!&BFZuA7KzWs3s>YOmGaJq07zwwW*M6)bU~HtrfVu!0f@m3qnA&9 ztlqr)_I5*~h%tna6I3uy=8BT9#?d*RDYDI32y$7zq&~2PiZyg!Tl-ym({ko?eMC zint)Y=Z-ZC&M`eP>2F0?PvnIO>tuIv`e#||<{~*%2FiYUI;{LmO(c4~I2n1=LReJJ zdeNt|lgGRMa8ap8xSVPx$(1iqvWZbjJONgo8|9~5kr2l%pOQ`v;jSnG&^BDP@Vj0Q>u{UeH~+@#7vU)EFfhvc`^)uSv5XA z8f7!&fyVrbYm_5(kamBZB;4}Nq&(hv9fbbyq*nIQ>wb|~w`kPbEq=oC>o7%QbWrVlE zojmHgt4+hknp#At%Wq;Ps+vKLk|Qp2(E#<#lGO2qkd|m7$*M#zCFitq(if!k3C&5W zqm-UvnS2z?Y@W2_bG)h#OLppYN+khiMTn6Il#-pzT6=P!oE9%m2odYF36i%-DXx_d zex`kU+a5TWk}7tl7_x{@mKIWraUB_M`5LMqD<1WejT zG&Mqsw2zsKMFJTu17*adS}#xqM8uHU&y?B`5ayH)PY znGQe<&=^uV7v&gZWC-PY_Dt!No-_E=NkEJN3e7NOo}Z+BFOy9b7ngJ=NrbNBY7ON? zg^`L2R8owUXfZVj%AE`zlu>{TT$X7q9vO>+k!OhKEh)6h`o7-lx~2pP|3Or!2fvht zM5Giopa6!_#5#2GlOOv{A8js2}O8BLop=e zF9Jc717zlIIp{v|maxdNtNB<@f>^mBD`L=ji^akT$^}thR5S9+=b~6Kq&;Tmjldc- zKoURDs9=(({UruNL<|GYcdrDbnHlinv-w3PO0_W06TlP1HY47I42wH)vZV(mpLl3pbct3Mv@ z55IhH!R{Ks;zt00*xDF)IIn@B#*URABR6J~KrATBKoNwtd%NFkkEi>?$piS!?@-m& zHkH91>Ht$!rm`#~!b~arW)ao38rpeiGm)H)f13Se;bjibpiGRjbzMKMxc?Q|>N1I4 z-FFzC8z4N|M#=5giFB^72W`bELis%Gv*imIs0`mGO}X#36c^sxne+!cT^j z1c@nZf(v;7v@oM2>*xAx5h*BPIyjeJ^1=iY&-5g>Z2v09{KD{F!8Mi_7L8DODN{2+ z0)9E7th~ zzogB95Xm?5`73EbF`v6+@iXsJrQ&#y1*)XgLBDLES?^7$Kqz8L*Fll9yzDxK(+|1tcB04 zQr6g4tS8fh`Ie*(0LWV8`R&tnOFDSDP3iuVi0l)T@vQI^HPwHjWwP378)F*MrDvwW zBtdGPYdyOnk7@Dw>hrs~1 z%31nmdA>KryzqI=|~CvT+HF+wuIH5koad>Tr7J2Ws&b=?sDZ( z$R;vETuSJ(%{l!d8HlY!gPN4V{tJe)c$WmH=^3DVsbK2Yw#(!rPBZ?iTP8Z85KLsR z8v&G(RF3Q_kf- zeRV!T<#~)VDs{R4_1$sOwEjj%Xq~hT03fENnUrJk(mYugR7nhH;U$hi! zSgwpj=nM9t0{fQQMG?qZ3J7PF)fcT`a+#&_>Wd2~Yk5ks4$(@Fc`~>q<13BN_s02c zS^7;DnBX7pfBxeycPH6yHU>T(y2og^wrx{Y9tsU!$UvkepsE}EoIsFzTaBS^x8J`1 z{$^J_ct3gvD`tNMVZ(+Dw%K=Hi04?=QU`23Uxn>ms{N9&wc?49Cu((nCfEF2epFii zcIlEuLX||3r;B1->GKP~X?gclZ1UpcS2zOY$IXI!jQQ<~D-4RoGc^In49o_e`j}@i zOgo+tLL`_A$jVENO1#}#dgLXe{*rc4#=0bPU^U|}x5eb04<$}Qs-)9G1WuYS7?ZPN zezBKm$eFEO&jx<>_!#H2JC|HZ8jgPPj7?A`lEGvV*2JNxOKOt$W&wa0gk%>2tGqgU z7jR>wv`#c}6M9I4+YEns;u<9gYFi582L6{R$&13kYvA(hazNnPe zm&&#af1)^Iiaxv8vb70?PnJEjVtZezEzDOxHzb@X$v7_`pD(7E1EquO55N5U<6YQo zZm(LL9uGhb=DKb>8v&?~fPsUe5w<2*WNtRyb#rh{_rrJZ-)%Q$?=>hO)>;c8fq|f& zLDdBEzpx0;&wWfzs71J4`7uzCIKig@aZU4sew6IT6c2JpoS}uCd zK}sc`QawX}Fja`kW(aH*DDoLNsip+wN{|s=J5XyKmmzUbj|4R0UYX zWEW}TGXp||CVl3T1Q{>QdRD7r)O-Sx%N}3G&FAHPxn0yU6eW?E<_XGDUqn0)lDW`k z>E`mlR_f-mO_eL-YIhJ>HkW#;F~S;3x*&!5iztnMi|`<~>{ zzp@jaf0guO!s#gK+m~ucPKwTy4)nEFCTa0FTHD;76ByHL@ifBu(=wDyT3%nUzX9@0 z@uAaPB=T5hnsU{y>AQ@{O>y>dHRLaN+MGM>B1HV;6FTdj@^v$0w7Q?EsHsATlYOsD zvQ7#3kYD;mL(B4O%>`?DKE?}d63S6yu0XZeIV*VhX`5^~Ja_!+a>rQ0rV6c%fi%dv z%HPEs^VX)g$m|&>=w{I<|CspiVo+J+eH!nbLW{`+21J_i_S?D^xYOq!KlG@YrmeCU zU>p#csSjwRCLj)G)4loT`es*~j}N-8@ zbzwIbH>f61XXR~u<{kdpww|XXrI@}TM9qoB@~}&?YmJwV{8Cs~UHcon@c1)0w1EDY z#uO9Ox(eV?BvIu#bCQn)_%25zt0^&lfa~` zysBDWNDrnGL9dMHJSD=jx1{*03|&kMUP#}UA~)xnBRz5Y&N{=Ck+VcI6qz^{8^}De zvwQQe`GzOsN;%M9+O>sjro(!18Dfd2({o|xZ?o*JJDH=HXUjlAq6>dp7`l?eU;c_; z3D)ysaV}2jvR%Lt(mevpvPfnC5V4qoUI3I5$z4G9&)Tfc&Erjc zmFICQ70`7udM(I{^7PkpT3ANnr-V!qFt~tn@{^l@;(r)ZoEfQ}RTt8w{a`L-6=~_} z7uUzFJd7}h`7Z^4tSPNOO#7J-p*Gl1Rh#|Tz1a()f4u*2_ZU>`wzF`~17QeYGGb6| zIs-igY;M2(_rKq7EwDdsZZ^A(F?^O|9hi42MQEx{q?6{9M1eEctHthKwiuuano_k= z%>IDOllIE?SS@IlIG)gTovWD68K)vN#>J(}o~Gd!H|;L~(~EYOZ%@AmaMAZJVZoso zOjN6K)bmv-ndQ9CBVr~|U%~gdKvOXf@oOdId8B1GuG+Ib>G^_R()SiNaG6&;O`gV3 zkgzFEDMAr>F_V;K#pg@A(31~Cl2m7jV0vs^IJA_JQLd?;DcnoEWbweu)4~%*lzTDL zJ)9ZXSFG)nVo}%CfhKuBquMKJI{#6!K=89vKM(kP-%A?q8l?SIe2@xAtrJ>}xtwds z>RDiuEOzjWbn|@KS3mn%5$4kD&zp2k_@*&Op%icE95P=@;g$q}Cco<6p%tJoNSmy;$JgMbX0&_${w-X=7wfBxW-T zfGH)*${v`g#0$)Cg{H-47kLqCLeqUwpTYcQr~r`|U*;~uQ(1@fPX<)hFRw(4Ax7p2 zMLmbP704+rNI5&prp~{DIwUaq8DR4~itUwlp_i9N^6W!jdCY|7=4wu}K?5lSn!a`t z&f8PQr-+DQT7s-gB#>pk_>1u2EDi&hJvYijax3sqoJmAnY=T4_zLW=_lLXBPEBth+i&q&*o=DBrUUQ-L^T~}7%0x2x zQ)IhxSZNq@%K%r=ZO<-IRluyKX~t1tA~TEa2mi~D09r$4?8Ssbd@#U}N|VBNZQH)t zT<@$7_Xpg5`~A(vijuWzL`d?gmXw3@6qJg+3kZb~JTf;d`z8A~C>Qsw#a>O82`TVS zD$$ec4;JUxg2g0gya)}cr}WQKHJjaH&Sz7XzZPI3i9>6pAuj&_AR!~>JRzux7)xCA zIa0QIXx^F0ejO)hX>}Ks{IPs~9FXfRmuZ_`bY&pRkt4CN@sdU{B6%3cOw*Sqef3*e z)G0^M6N->Nm{Vy?9KA4NS{}(Wbn~2q>8h;Q-5|=Dn0cI@$ z4<)nNl5a(QIxY{6>4;9fls}RPUrbhH(y`OD_c`s{$>3IQjtkv3eL_i@nHhHsDT7Hd z+)?QeQR7-n&2C2#KLFCML-+C~_VHU?o~PN=^iRDTJ{ia4h*KCB@`x zz(haG@u8^Mpqd<&cv=-s>0pZw+3J+@d|J5}c(8uF1}xo1BQl>55QxFTrrr*bKSJt8 z4!hy5JLugVOS3WDo{aTocl-AG?X}%jHNl1Yx^8UBuvbm$8}jJmIZ4#j##1P~axR&? zxMpF6P6r7Qk?n-dXPg)jQJ?@t#7L0}tc4j8TAY6%<5G*@n8miv|H{*O!-SeqWTho( zWlT|?=}-_5Q~oC|)Hpp_=N!&YS8V=AfRF&;7!@*&Ct^X2OCL`$p6Rj`zh803pq!{y zRHkI0TF{N8GOa$k&@!%pOi@;{aLnc{ic^wmn)Wzi5njM$ORo_yo+1ZxQvS$kmrO8E zn%dQ?bL7m}QeI;&ww@#>rIca}5LnZnnhX2op-%}?=Q&&G5d}keN;cCZ%=ya#3IkOE zG=;)ZFHAT zUMr_$giSY81(xqL8_qsJf^+3)6@eBupvE z!9<+)YSg&WY*#r#)(S^rdBx@S88Ji8e>H%WW~6>+>5k*7VGD$5q{?#Fm!@sxFIovrp?QZNBDp z@Pn~{-&rDRz54eGYvq8`_~1QI)oo|nw&@-0{=3`jcURI_!*G#WYwH)X`@K5Q6yv|X z|0{aS^5fTFZ~tq{!qrq*;BUbHF0=^Hh1lo6Q%n5zzo|gBzZJm4q&Uvv*UHIwI>IyT z@D)RQjQ|k9ueu7p+@>&s+~L<7xc_xp{F|_C0Fx^7gv2D<&{u5oIWj30VdK)^On#i6 z`Lt=;9txC70)WOOy?qUQdtPL_be}b;m0NuTO`ZZpc}_bjMx=^4scJT(s3%FpjFViv zeh4EJAW9*aYvLg*nIxA^wm~WW@#=&>x7-X$1D-!g)o(H_6p(1Nn-EEOYq|O>0My&f zepg%Vl{YtUuiLj9F(L^fFeEk=BsqIeemSLUYC@A3y#BB_%5mw5ac<{{Q(3fvk529D zar{+#&dd>^=k~1$nnA|O%1fVBHkc^T7g=GRJbr$;*E}f}P~6fb7%5Vbz@-d&fo+!B z2PTC0g$-7Ex=4X@!Rh0PgRYhQ#j<&Dh&&n6R1+OUEpIj`%| z&hnakGHY53Ts?UssA2_ONw(zb#TfME3N4>0Ktu>ZWhz0V)9xx4rtI2)rt~!D-BOI% zIHE5W#Co(0Z4TEEkJd1bG_eL8$C?B z+c(Xw;>?*-nF2m1^Am+%V2T%qEoA`bwKPiI>J_iZ37RG_b>T&hsg`#vg!>}t<{3qO zsg;yI)9~pc$I06yQ7)R`i!?7Q;~f<~y*!D}jpX@^UC(B@nMwD2!HmyM!&@Yer4mO( ziRv!j>D3nLIZ;}9&aZmW1U>ih%%{aFheco!C1|u5E!I<)thAb)#THv+*)moVCtoX? zUSu_%Wn#LQ@ZKq)=yDNAU>Ze4Im4yAVJ^t@QhVxcrFu?XR!5n}z_` zYGWH?E!HVmIIqFkE`Meq%S#gJSnn%gMAoP?Gff=7IC|uEw!2~>fccM$Tb`Z`_C5!x zCmYfHeSC7^{G==#&0FxvNx`&zUv9<1c;=>+Xz&8^TJ?0f+jLXDrzAunqO|8S12~7c z(lSzfqF>L?imzHQ4SFnTrZY058;HnXrH}k?11wbonvou6vlr{A34bgmRsVJN3R;c=yLlv*s~;}q|3eJ8MpW(0ASPn{u)wu+g)2%1dvpf$+ZQO zUt=z{`)d(>nhDH*`z;Bz|JLoYN8_()zs~ycN`yukoPsB&@#|n`P1Rf02kI%)0}x~Q z(wCWToLqhX71wknoIGnpdrAuu+aMy~jA_xo}0Z*Bo;+NQ2qQvFboT);DM%6B*;4^gI^Fkd!K%<)!nCGJICR6Zy@ zEnvd4&Ci68$z+iVoRjQHFHk>zE&r?F5D1#%#4H7jUHfw5j;9f}x?1XohInkSoJ# z8u(<_V@kRBcn$<5Rzmh_iHY7Zs93h9cX)-tFJ@x>o~bHhNTJ`^;gqpbB4z?YV%u*# z09!RyOma;oPX6gJ$OQHxg`}sj+WExbOZFOTEN65YL4>X{VGsbymVxwtF~kDMHc!^{ zWeOoUlP&Qe8qAEjFoY0 zn(FE8&ihd1*YUkF*{fjNCvQ=B-kcw!uTFIQnZzs0>z=B1G?`=44~c{Vb8_)(iK;$48`7Ye z7O)C`QEj28ZH*gfR8`I9s?-=ErGLU?GY2rmn$Tog3^|HLh!fY+I3N5M39t(UFVGBi#1CBh^c+05fCFaNlF|*lb8V% zMgt*En`55LCsz1phnfwJi^m7VIERs@o(MT7R}qf@KvS8<%TIc;Azm^xooQEz#jf?e z=Qr5=&8!8TYowY9>WevmUKn1QTz$qjn-^CuZ#pZ;R5G*!N%{d~O6GNb_teW`ytAV6 zl95KIivfI@AJO7r%kwDNb14G|m|~CDvzubdmTr=Sv+M$C3*~oV%&C|XWxFs>udpWu zQB?hMJ51&(jLV#F!KI&hG(R(_!uFozJObDQ)vF+wW^Ls83)7eqhs?rAk!O;vkC~?& zDlvODTo`ENm$>5jBWbCOE^YnGb9rg1JeM4)%l681FS{qFhsa6>QpDn4a(V5iF)il7 z$K(nk6ockCg(>7a5l_N@`|*4EojET&5R!N$y2vZ@Vq6T*OEWu#=RN$)5>3MJm-D^X zH<^M};LUD#47GpXmX&{g-ofVLO}Q-vy(w;e5wb9qOaJN?b8Z3Xa|O)|6zWe$PqhFsq@C`W zCArN{F%}FdWUtgPQj~HA1W0sDOcbLQFEL_Z43IJcfH;Lq2uX5?MnP3HdszYjY!dJs zLJr2r8>=9XsSI$=L6bHzA;wr39A~hKQ2gW-Ad~h>0EmlS$P*&K5t_1mBr!=*#EdX6 z)B^4)qvnkDKy|tEIeQdoF+7AR`Aq<3U%4{YpvpNp8HfR&U|SM+mw3A786#*6YmGb2 z-ZOMmrk|t}7EF^!DV%`D^nOG@3=p%X1yZW6=4E1z#o^X3uOdp2p3SIPHhrddP30ZH zoMQ%aZ{^2g{F+ZtU`R|L6Zdd;b%&>y_LGV!x{MUiM@lh@ULT zzyyeSdw?t@vd6QSMJ%$FL1q(+Y}?t5nru(TE2+t*GC%-FO|sjA0LiF%*`8Gpb+aXJ zj3jQdl|?X^nI<)uY-S9T@@$j7bQXalF#1|B95?x%sw}GNoI2+@&->@Qmuku5)6M(6 z@B2K@`S+Yte|}Y`>bXU`A3X5ZterwUMu>ms^@sN1_8a)d*MH3xGJ50*fpI}$kWp5c z%H9N10l=eL!shYtDWFIkbfQme((DlmLMdQqi{v@pDnBuuJj_2*CFF}uy4n8K6+t%$ z3X3ghw*C*Ef-7y{Xcq$HF-L)l3X5hFzWe^TllU=-j)a-Za8TrvfNmXXoXG+ht5y{| zaY3TOj&s&yJ(ND-0)U9QyKT6izg;OH5A>VU^}!x$VX!Ikbz1o9klMhCLIo-%`&elD zWWlVxi9Xt4_8kStA*6aPd5|4~XnY9(3WP|722j)+3l!xdsYL`t!KJ%3A(hr~?mbRW zITMsX(s?o+X6uglk%yp>k>XPkNAB3iYQL^1!EAA$DYa_roV_NKWy$~vqyR<#W6KgBM#Rz5`I@9WP2C@^ZF;FerjAI zoq#82d?mP7;>3zdmg&Xv&Vm5B2Z%DHs3q>Uw5E;oLTi?AcS@5&eEnHOP95<%DRCNp zF+URQn_D$)CboC?(%ClCdRef{k-n0Mn=iN!*SXik)>=zFbHlJ)L)Ii5EP(=*+)|>PL-%W%|E55I*{wSs2h|I0J|rH zYul%r*=amK)q`G|pseI$Oj9PMh1A|3$hwfXcha&X7tB~Lmswr*ielB;RHssY7i+MH z0Xv7c$MLL;)~Iu^zVOx)XWRUp!u4Nzqi!?L_e*yyuj3Veyk(<$?cvEM-g;~N{<}~9 zR{G|;9vV(D1?A}<&ux(a1F}u5{RvvPKikxtWuavLVC8(HaR&{0OXn@=`OEDb0oUs^q%L74!N*g2rkMEq^q_0E6ZMd(CC8=wnZ~TWgKe@$DiLsC;0co;lS+E- z41y)1#8O&9kQhcZPk?zcT^IKAN`9r3Me5Tn%?R&KdHvaE9CvgH-cioIzJ2(O`Io=@ z%&+EV8~JOYEbb%(Hj~TtZM2T*o)`cC2ZctW8UW{}3+*2Bs7RY}3=nd4q1`7fYFPdO z?9$D$A&C@9;yYzy-wT&cAa6`Cmr{B(e4@tZs&r&;)psWq`4L#~?2BJ3F*CEY6J>>3 zxv+-Qg$r@vRvxvw)8<@eONGu{CIg1Kvx@xzmy-I#r4*Mfm}s#W%#d*Dl&IEPFLOpw zT##Q<`vK=!vfm+4_H!v^uKV%6+9=GtU2k`l^{>}VPM1-78H$QXVrYabCT3pA!>d@n z7utL{UE@VXR{3Es3NUf1QvZ8}%6D~(=SKTR^u?rz+m}w?{%!m7^mqQ~iQ=8ggI+4cwY6%DqzW zaJRv2MM`P4Pf%u5?$LV>$HjnVluh`!|e*1e5?bCbz&-=C#Y?nNEc(Tj4 zKL7wc^It&l%y;n)0DSo2)2my#0}Gdv~6v^0hnW~PV+QP*``q- zxJZPMQ=fiSm0COMVi(;JdsXMMq~^!IbOj@l*-38(Y8imF*7hQo^R(CO;^nHUOVoXy z{1o^l13_2-VgPBCj{2S9##wv^Ai-m28F14{zh41a_sgZJ<|ny%4+gJ~Kee(;N3A{C zTQhXwY12HIaM3ycAhW#=teV~yYLseC(0=ZffB39_d>1YS03ttpaJm~G*`L<|K;^gX z+ds(-J3-|x*$-s*a*(UhCvI;sHd{bvQZGL{Av=pD7iMN7z>G5;-60!`LaQ@OE9rH~^%?r687<8Ar&mY)kB-EaZ6)pmlxfkKC9*=Eve>s1^c5 zYaMWAZU4-}F9a6XHV0{QTA2*2CR?D9xp2P9-SXCNU+QxRm9KSxX%lr;pwNn?%^*KR{GqO|jx?xqpVQAD< zKD8so9$iRXW?v6v7u{4K=Rw&He%d2$x|$eN*cX&qXPS)c5=LlSy-OyZu%+s7nx0m1 zXtMc`*g4J5H^MZ?(wb*qvS+FpOA|cLo>WYB%Axf|q2ceowSvF%KYa)Q_{cg!0`TqE z&UEBM`}3T|S-yGtLjZV~J1XFuqgC+tKKy$CzW$8y+1ua!!H2+8Uw;0nsp3EQy^nxr z{_2;X^dI`E11P(otKzB{!P6brJ>!MAqdh4{g#HVF{dk!f#7ctDovao;e^~Aw09M*! z4%=`C=}{Fu0v0D+)CVjQu}yPSVe?EcaKsOh5npTL1>G zg>O7u-McCG(}w`d;|c0|Ci^gH{+4nj5A!bLLk-ubKDMTD6NDC3Es@5H5l!RT=3;}~Zs;VB3l?>CcTdNH;XhdE;aW zGBvbh-9H#%40}N0gHjxZ0VL8O`H?UKEQ|uSrJT{a=|qXvdaR|QEPO!bUo2ov#9qx; zyDID`Cwv8B8KFamc4+4D-#^H6<~0S5b_|BC!D}qd-)Ap zuxbG9NRMvk)K<{tan3vt>FAy}1id!st7~%>o2dIv@Yu)MNZYQuN}>o&YoVotL(Z1h zf-YvAe&6lO?<{UxK|Mp#xanLD#~tmSA1~^SfhY;IvY+)=H2kKY*vj*hG@;dEIEBNg zY__%ToT#08+Wwfto|93GK`hc|vTeOb372ms*&Md{*7pjT@#OZK0C4}SZ+T5AOmvi| zZ*BqLzkF6y7`KK2{7TQQJ(YL=R{HYcH{Z{g!S{aY%ihr+{q>L1?|<+g<{B6lzcI$t z{8LDG@g2jzeP}j1;R*-}gyWdYsu21hqRAPE1STVd^q#g`(hW6t$3|m`^a4O^C_(~^ zgu;q9Fr1FLG7#C|pkg6aoIe}@X#J$td!-EuD6Jkj+VfOUHS%`DbNb0Z9ghCA$N^xG zb9og*Tx-2o3IS?~aErn-e>n$s8WuS_)eao@!Y$ZQ%$x#MK}se3DI{1mu@r-^iJ4&T zIBCi|1fEsiVed4JYvz*;90-LoJ?c?2EFM)nA`q~pgNXHLZ)XUv13;k8IP3PC4e@`X_cA?cg#f~vvrZO+ZUW;(*9pWRiUeGKI9~vO z$R&P?dZ}1IA8LtpTO$=>IkL5z^`OmZtuPP)q>{9;%dkvYPISmvKtIr$Qhy{GOY={| zL<|Bm``Bfg`TiigB}ITwln%_)QbyRFr{zN44PWk(&_D5SZ8!g&hXC;AU+~|zKirz~CEIO`0kxS2johU!;AgYh8 zJhtP1pK%$KW$*1ZnBv`#$X3YUoHdAiK{20Sx+6OFXSe)t$@Z}H(|V+O|NB!^M8tAQ zPFFU*krz5j`VF^l+uvv6_je8D{N-5|;KTpfe_i+=|1aMK06f^|zdr{4_CNij zk6-M+y!`RU|L_2_Kuo`R`}mP-f8YB9`}_2F{`lj6_#!@=!gRp_-b;%4h(AhA_0xL1 z6V*9ae2E+YfJ@83hI>AfyDooULI%=yG-@2#%of#~+`!12>URLH5r4@8@o$Tc@?rv)wV#=a z6Ofzmyb;@{({<)@#?}wO6vAu)J6YXyy&)l&cWEq}&_}1G<=19T|L?!abJW*mUo1VQ zzv-QP>i~ckZ|(0h))D>xz6tQ?>vzda4ew;sOl zU;n|g!2R$1igCO@d>R1oJ-hVmI|RP}tzY`hJ`@5LK5k|PI#GDUT#0~Esnqt{7{zKt zAfkvX*R6epql*N}a8`R@wE)ML&cvcpaV*5($|JGXj0xD3nmgudu&b>h(&BRx6=plO z5bhR{hu47D5J(vjN{+U5Pryz9?g|iRU;n+g5k{GSisoHq!G`CpMlH@yBml7EzO*sX zOiN=o+}dzc?`$T1@nIZF!bH2Fc~Sb?m}k+JTDm^AwB0npzs&08{^%a9dm#Rn|015y z%tp5TBu__hmZEZ?r>SF}?9pg!(4e(B=nN6IXUIjJSlaDyy)#2@$bT5-7~?Ds3$M3n z!2i^VMhyE1N5Z>ieAlVbo3hDaHd34rM%VJ@HSLtS@$}%tRn(vt{mzub*3KTb|j3h94#@WnP_E;6+Ly-s>A5>qFiLRd^3ek6n7YaA& z6CCbr4;}A`T0&7J6bDfIvPl7673Lnn0?)LYG=dxutt3gU<_sww1AZ z+OAJDvZY;O>qO+l44=%{x2^udJAGorgR`HNu7~&J@$rY!`p8(3la?9TQa!l=$a4IZ zQ8OmA5FO4HN=O*fI0Q;|?>W-yAvAb|03v*3WK1U@8Kct+J);Pkv{;l{9^4km-wXu| zi6b9F^#x0-d^bL%ALb$<9|$XfWs_;+a=Lsel!m>xJN0an^2f^+3~(W>&TRnU5@wq7 z&S>Mv=X71bd(7~n{xvEyrl(yrf3li%!w!7njcJoAa${fn+I;UzH`cLt-T{E$_$z1T zTygW;^ltll|F{0iQBZb4`{zw#dd9yxifPQy_4h`kqL{}B70QNwykb|)L9;NcPpvKLuvg_FKNUT5xa+F z0~e^ceR$-D+MEQqJmw&YB9nU+b16i)G^T}>t2(s@TK(ykW(>>9-(^qw-}OFyTv03s z(dV&;#+(~_wEFL8R@^UliWGT)8TV92A3Xo$lTSYR;Jvf$sNx^|Pk!cSe(}v)|KZji zefq6;q8YR+uRZzXlTSYRQJ*<~h~4?88W2bsyvtT92hQD<6D!c#=mltM}#BFpD%+LJH5Am&E`$xc!Ui(Y8AR>C@DSPzcYcD9q$|#qDdaJ^AKb?^l23XPOHy;6-b# zXIPHMD$BDc2&clkc`{LY%M|F(RdkMBf*;_Aonq@!jz>9)oQ`bp_6-09UcLo@-}wvY z1iJE{{s-d^fAH`9p{i&&{Evs)o@OTME6Ca2c-;LV0O0MpXGx5dsjAe0-V*5)%dZ7j8+%X0RLZ@>JqB}O>tkaM zQfqb6>m-ww@CT>Nkv}Uj@_x zTK4C2ooA}I6wd0d(mpx_Su?6jzGNGjvZHj06zF6x0SVDf$dcQ?sB|K4{qLj z#(MMJ?*qUqU+9AM4g>z(ZvX(E`R*Uze((|i;KzUK$Ceh3c!LAqocwC#BLKitwNZ{I z?RQ^4TTCq^r_*#9}GhJXG8(e{6 zvUb$OuySpxV87h0V6Ey&6c3|jR6+plc{S4L$GGeh6G;8sZpwE&_;z{Jpy43bg@xM7 zWpo=~v<+Vg)H2bB@X5ZL#?_9|UuC#5uZFM$>h>C~d@f}h^c?{3^7qr1+b{pY>K;TB zKl-|V{R)5&e)V>^<-zS+;o$P+htuQlJ$PlO;tyV!YWb6I`-b{Q! zdjdf>UUX;H@VR2^NkM&@cb1E{^Yxd3ytpW`r}wwEzus)gw#47NzO=8ra$_|;d<_8Z zzj1aA|H&HwfcyWK8^QnRw}0tX0Ql%X{@+@JfNeWJSB7wmH>)adtwupOPCS(^u4nsH zj1)2Xf`Bml=aXv&`7QEaZ0j*onKqARb;-#p8_q;5s-yPQ&{r0^$2c6cg4lg;`?OUM zM;MN5mWvfTs8w2l+VJdP6i7+n9f=BQ9dz5F)- z#A2D)p-@!NJ%n6U)#QUPwI~2oPt6V#P&>N+DWv7~Q;3G*UrTe-bNNy$9l(GEe)M8~ z=Ps6*yicZjS$|8{QAL}iT1$0ZrwgYBZYY`0pyOhLOwigCdvaI`-FolZdt7C)@HgH! zkV^CyWtOC^`i2v>AZ}5+X;H)lA;>5q|GTiZ(>LLoY8O~HL$fkOc-ZLtY0~TDHPC+T7~u&8iH*^O+Zkp&clro z6pOpXfG7!(Owg@{*0?OB2LzU)8uOZU)KH!Ws>;Q_7L+=SH|}`|-2ciebo-hElka?K z15>AOxBmD37lAh)+Q+Yb1-EaS0q?aJ?yCSl{uTh>=4)RA@TU2|+`hMEsHBo=(c3p4 z006%J!hI+Z`Qx7X>hpN`dk@-(HWM^0*b25eO0Pb_z=g~|lBjH`bI3oO$OLGV(fdPY zW0JLNXkSjm?tB_yYSDFv*qN3iDpd_2%z2J(>U4bXw_oZ6p!e_LI{<)ZhrYb}D)8ce zVs&t!3LgLfZhoyQn1L7H2LSxv|EguCpkmR7TGd)*-T-~gTf{@}&#f(=g67V`7AZvm zYVoQ(F%E-p=!9)MlS;}BL&R8c`5KgdDD%oN8$fEt-70y}-0&pLW2 zH3?Qu%M@xsQMN*51hL!Eyr|St(dVNd@!UL;=2|S4+i*sVHXqAyRRr9QdPX<3Jz!EC zLA6CpknOyWMVsA?tU24^N#cqjjRT1Rf(|<@^_h2XfSb2&jCK780A6|to`UEf^oO?qfZzWD0Q}}N&jT>y&r2`iJ^S|7SIpJ@M{l)S z=;nzYi zvHq#);A&$Tqiatm5}oVyQ^s5;EI-%)TTKO!*$6loDX-A4T!<6nb5E-p`Fh%}{=W`j zv)~X&xgQhI5t)r&Tb~rd7V-1PaH~{H=SN;sG66`Si)2cMQ^5gpjBm|YHu!~x(M*pqoNQ46+i|7tCjz#62{_D7y5&>eX}ilNXcoC$+U?pP?jl`t^3=Qvf%K0 zL)!CAy?N&b0Pr>Y^TB?H?e@3+*+2Vd|LiM@@7wp^y#WAy;VS@u?-Buc;m2>h@dm!~ z1pt72(JF38-caoi?8Eo$o)=yM0K5$V?>z(n+<)8dcH{&!tpxCH<_Md4v)<)i2t;QHQJf|lvz<)J{B z^B(q?z_;z{T$APAm5h0um~qu}K^MYh(O{r_ZRl1tiYX8^eQ!bR2m;41>)-z>%W-WTt~dSiU=_FXCr;FVXt z_9t(}Bi6v}sy2QX0Px)X=#1U^4uBupFYd3=`*}%m+-87bcAT4knnhL3FMmUz7I@$G z@m+`QE6PW(WUhYlJo&5Kfok5jDsS5l??+WL&%R1zcoh15!K2bZva~BZt6V>{8bB7S zTp1XNziO?X^sQ+h0zgELpMLu3HZRs8b-^=O?B=9WgndV)o#YEE4C_4Q^GTl2A-DHGIofBhINxI2m-J~pzsq$ z6UTBVV7c2>BTSSEgM}0n==4th(1UAZpHDkyzqOMEv5_r2nXzypf4bA>j9PDFHRK+P!YA6{xF2yhj!16 z?RIX4vTFwPv`I0)_Zz;OBbKKa^-ycP9ZG;Gge~`~>9czz-FtF!zp4kwO*B<|z*rC8 z6=9kNUBEF?rrHg{6>0_*ftvF!jTCA@79p%l+ZF;rBUEx@EqU&piA{we?&iFu{;K{8r1|9TzwTzP zjc>b!jFS$miMw^N^4S0AGq9{-OQ3 zX-nbfZUNu}I~ily1wZ&9UOQQ9MEJOAKNvOsM+m_6nSSXD@2qOr4%tGzhpF63o<9i? zH2p|q23M=d#F8uL@vfy2%e`GF&H89J-Ms^rT+h5Y^soFr0Nj4>Z`!r**`McHo2l*G z*`^1L-4KBFSHA%O_}wqx*wt^uMTZ}K)7g{NTnyl$#>`i%*}F7&XA+ojSSRl1gFH?yhp`^c>q7A0?ADb)vYq zCe5d~9f9I7CDY(AHo~KMElsxw(AK2HlG*1{CWHkbU{Z$}wdcMG*9mREOX)daM;YQG zu4j*N^n7`B@2L~g1Q9$&{QB|XsnsHasVBpwGh^bNOE>Z1e(T){ruxb{{R}(FHEw8*X{{9ewi{A7fUsyRYRYR{5ph2LOEIS3VB_-!s+h=IJzRJCKe4 zohKcTrz~joN5AFCb;=;o-=OeDcYkweqA13u(h`R>EkFU2cQ!5q2m3{A*7F0B)aq0NlR% zs{Q!Y)aD&l=Wp1bAN-B?fe-&?sC%fj&XryB8ZPU}MTBBWu6x?s-eQXtxKr&a^b@L9 z8ANo#@ESeg9|N<$VJW2?wrJS_U}5G$Me3Y|YF*f!CRutka{05*#o zC+5f(?ve%1N}ZA=kqFzP>}2nvZjvc2y4;DP-dyXP^=9l`wiH_K34_4d*j`Dg)%$}i z@Du`zPPUjS3W0cL@jV=xo2Aa>J93{TwU@eWLAEL8uP$BV8+zV!vM6iD&aM%k1v+*5 z?F4vSA{FxmSemjq!=-(46jRYB9yAQ;=j^xJc2#zgcHc~m&Wug-IBrV3j9V;=N(JzT zU)o-#WIBt&KVH{zvh@Dx3Q#tnRR}ahvdDHZ1!hd1VMi{nZ2nOS5h+27!+5?(KNj|6 z9qMbY0Xdw^;kb%*^sqHz2Mz^z@_+xg006fsKj8frOIvRpf4!jCjOw$`n~L}T``gPS z+OmO91(;aI@btN!C?JZ1b=*~3SF(tk!WZpR+6xhWvjS8aWM*Cnq$*le{rqKSalNBy zUjm0(0`3x!pC^Y}d&Ni21}-p51;hfy9dW9Js%yNAR=`KwQ!=W$qAa+=1@Rv z>HMf7>04%rQuC7t;fvGH6#-v5 zhoVvvqV7jYS|$bN;$(nIDGTq#X5Vwm#xg#u4NCwdZxt7odgrPcFh?6kOczhKaBhbY zd!leME3*nH<=Gv2(LZCgOcfwOj=CRqR`EW&iNwb+CgyJTfYyYlwnNf9-!hwkQkz5| zrDDR#Fp|OeVFG`sa4F#xC!MBiuR66P>6^Lyn620=H%BiOfq*L`AK?~Y&akyD=d*K% zsq_L|QJu2%X^e0kqs}gUimvi^X^*2BTecf|F`y7U$h+h+>d=U1AlLo2Z+E(5f=_%4 zBC#qr?ZS=y`QDetd$mINn-A^Fb6Dm(*pibVG`JOjvuc zs9@u^oge77rbZZ(0mc+92!I22Y}LsmtQcG@-F+=9Ug58T{w|ai~|7I z20K}t6gBn%FoVFvk&7JZn4YsjJ?f`qXc%{gh(1wvaKV(r<`GdNyqV8KEesZ|3X2sW zwW1KV$JCBeEI?W&Ia=-DLsb-7#SQIT;b78$2S*#}raE{^3U*Fmz%xY}vwn6z%nV?sIKxbS_8n z(i9BPjs1F?Y09nrxzVg5RdXz8ztkgf&xI7y9^%muZSLC-5A(Fxn&I+}eSP=2yr*vR zoxVToQ}*qn2pN`od;bF<9iu0`#ZIxXgmB(XpVQ{UF((pcYLdA53A8#|%t8R9Di8xt zTtv%GboS<0viV~GR0DfGA^P~*UPu=VsK@dOqLc}f)|KB$ZLEMf36<@}n(uc-gcz@U z@r?vXzWDW7C7ZBg6&zPtllQy z=U<0#Y@0XCT{u0ZWLc#8)2{lbMAVZ&j`f@L+ZW8mJAO zP})ybV0&+yf@1kJL!SNzKYI7W9{|9MPrZ0E-NEh7RDx`HUc-K~`JM}&`ai$_;Wq(1 z`^#VLRgvc_0D6{m7MFpYPSecb^5d=f7+3p=BF#aHG`2haac8QSL15G*uc&XaXlPm0 z1EF*m}&lCgXIJN;d`l$+pV|kC;zKc$sz(ij8yb4%|J%``ftw0A01S)cx z%PTKObOe<++84Bp`K-LgG0b{o%?*gcc8`h?av1f@An%%us@$a zNtTI->uNQ5553W!d*%ZG`0g9ijV!Gh|K;{}zpWdqPm8jxZ+++ToFC;H|$j9T@gh#&t+yLvoD zws_op0!yC>(vWo9P=jl9=wt8YvrMQ_^7h|*#CzmOaaU_IWpZ^`+BYe^9aRCdWvv|m zTf`AFcgGiT*V#~o&3%JWifLC&hjYBF9GD=Y1DNX)$|9fjri7h}EQNSsJ{*!ib)izY zFjHZVHMGv`3$rl0os=VqW7UXfPVDi>=0H@=_O2*mp%q+-S$d~L6uUF=4&Q$LOV7Oz zWA4oyr6Ty?%}t{Y@KGdq1o)r)?z)4{m6|b}0WR}un5wT)hMxNR?r{PEfJz~dbhEUj zjoglt9Vk|aSQ>iG`74JGn3_r5m8LnK4%D~^Ip?^) zu40;;{_}bbeGvd~`(1029z6NtgSXz!sKYHR)9>$`>bTeP9iNLgZ(e%y!P@{@pcYS; z18mmKP+H>9vj-In#x}X72U*NZt4-s&gh~25gT10e_Hl3=z1nF%4r9z-QS7#&1N{%l6?=t{h>xa z?;dueOXFC7OxR*dC{g$P5Xeh@!ZCHTwO)ZUW)@UOiEqEcwkp}xG=ybA*WP`DY~2j0si zmSL0iOm;YbDoaE}rq$f6-P$A+TgOr@p7~^y-PWpZi;=ygu5H-lVM__|2gq^yM4AKc zHRROiLpO0~RiCpD@4Oa2J$&9jJh!6ht^Y&}5V_^;$CO8r%UA5rYadwUZ{nTTUVG){ zJtDeqSH61-0Qmmb?W=tYrt9B4tS7$iwY-IQ-gy1xC*K2b-v;pTC9mxQzIV~#JfbjQ zBteBri8+aVwO5yKkqZ(wUtY?*u=k6v-g(p6zBH@Xux-zlarc~Ydp%9`9{&8l{q1jm z`+fVO3i(3-!2KIUyh;k5o;j$6bD3R{mOW7u$UEDcd|^v5BUu(gEl5O!F*OBZ>~F|7|mb8)4slXGTj1f6NsXJRu!I#W`GikR@r3}U}sT!8is=nU}Wbo-QCaL-kR zt^LPd@2Z?>BrBZ8)%&V8@$hkUV($?Co#Wnq1CJ@Z8N6wSM;@ezfK|_l;%U{_>juzWd9! zR`+vgM!Sd4zX$yA*M80Kza8uS5q|WoT+0IhZ+|h>g0I<~?>+Yp@bHzFujur-a@mTw zi*4hxFOO-je@5k_Z+`Qef8!Uv?ce_J2LQ&?49oIJXGVtCw3;1;^P9U>I%1l%IW>Du zRJgbdRzEB5JSZZp0*ccKtt5iooUGy$DwW9L3io(4;OXqLCIBir-)LC+Iq!NvnhTWm z%W9;TQ!Jp!Z(y1Iwj}#I6&^k1ZSBI2x7YYzw{O$*K!v`O{Hazf(JJrpt zB(oM*{F@#j`e^`PTiJi`>i2H}0O{N_-XH~TUUyO+bgo z$%APW67EqX<4My(`x%d7J~;jHfgO?iX{6F^OUZkA@X{hCa0RJ=HHfK#jkkC_0d32d zwT8mi?0bNS)G9KiB66&V4d8ar%#`O~#B9QVK$Jn99Z&O!l7uYe8a+_Ssp(k)Qh z!H3N45GFW3?8t1^q*-_{#lvCTrnrwysU^7>yWh}&3yS3d6IDp^)fKN?8Y~_w^s*!< z-yF0ty?t@_P6rzR;O!Uk$nrgQT{=fjnB}lL^R{4etJ55aAgwB>=Zd93NnlxGcB8YU zy%T(GFBX=@W&3NblP~6>%V}g6mZ>HaYwbk)gY^?HJ-1%GgCIpj&-L%O%Zfh#dz+u$ zdIm%knp%__02XT+=z1uCTjrfwhQCqG&9WO_%)EI)QXUF;WLjCawDO(n9d3{9$Ah?2 z>CLNU3X~lMg?K-xD4QC9#Q$KX}8)~dDE<1vrD8#mm6ftXpfGau^}7a4!jH4oC|9(dzV{^a)KUjF#wk3Yu5 zV-nl@i+}MKe&OeT9xx`(`(aML_3{o<-BbZCR7xp(o=(05Jc>_mXiIRk zNgG#{R@2NxpZVVE_U9fn-E+T2AX4E0*gfz5#owQPc*`}jXWklaGb_)nGrqssulz9p zeDVJ}*Agw?y!%Z4-E-5fOEqEmqGX%l#IhAs265?x+WojSy?BE#X-jN3@7%oZSLTPi zIK{SM!a$`nLC<$xh~$0ssl|`~hZqO}a;#D<7kIy64MMJjNR^qVPX@Ry%I1L(Q0?4f zi>752b4$t+J`-n$%plrvd&$f&{pysV^|NPHVkYWFs)hjd_c4rJwYpxiEH;T#+|Tql zptVZ9!0D+ubUY43U0miE^rSs~;@YAbLjL8C#D@!T?>#vG?E8Ot zNv#Iqn%s6_>aGozx`JYkbJ50 zsGGOmy?F)zB0>8XztNs}Xg~aSe{Ee0Zr*>XeSYQ-lA^dQl44%{`7I`qKUy-`pIW*3 zoh{@0`@fjJC{BBU{i`yR1DkG4rTBp~%M|FkU@KyNAH)PYRH?TKx>MZxi0W?#v4A~V@QA=rI z19ag;D`0N9ht!JwQ3ubPGz*KhOQ^kHorAmIXjH%eM8js*lu7C0RRzOS=L8f#%N`mo zN#M7?_z(c_up(k{;C95n#M`yEp%udAy|>>P?g4?>I6B2?7YaLug7Nl;-vRLYGtUyJ z;P$)kd%LZND5IoF)VHHD=)nB;1<9e*yT8%|GnGqJp2v-eDRCF@&)gyD)7P! z4}SO_fWLYFRRF*80RVi*Q>VZ3!uQ{_dQCXe`@j3`@BYYYdG3qPxb$Ydd+@b)zWWfk z|K)${i_u>X7qzl+QF}Q8t_9teU{u5W9Sy?)^%V#(Afyo#M_^%q4sJ;1xiv;N;mo>X zI?P5Ef)6Y8jD~(3L6fXrgj-H@DU*Yk9?uRI;B~=(AGoM6PdV zVt>L;`E&QcU;*19e3s&e5=en6|KcZ~qPT|#6M;*RgyW}uV$2O2VENQ~NCZ`8us}2& z;-V+oHa!4U0lO)5-yX8Z!`di-d-pWh9#H&Tdl+!C(Fk%h$lZT14K+v;ha18iZOzg* zCEY7=fRFKyUwY`bKL0%s-h4ft{OW71l5+dXJMsCoui=@80Py|iC{~F$ zd;&bt?a~LaP+dLnBQ?a5VCM!v%p8$5*yb5D><<89RJbq`nbC$BRfF%PcX@!;s-OX? z=&un7(<(?UTot1@6BUcHl#Nc-(c@b!IQ}a)&)*lPS1%DYbHZ!Vxpkj$lvGn6b+aN+GcI(_WvTn@ zWQqV!_{0p64-5(yJ*I}O)AMVxUsrt3uJ=$4L&BFrfYw?|X*K2M+o!cgxC&QWtGQ(C zy~k-Pt=TF9K_M>q|2ez|IGo1JL{L=G3JWV~)gOiNcj*s&#eE$w-b~exT+L>uFL#}m z+ZM28Mp2O-D0HtBOX#kWtqa^LC7ZrNY#B!Ef6leQ_!qg=CQQ*zt*b7?W+oAQ2|KWZW(kLjUO+f0COuF zL1A37d!C`Zx#1$@LrGW)G`75?tx1tN2 zJNl*DANJ=I79=5Tc-@ZiZnqV^``mlCFTU5le*4GYijNOpc-Ve^*BHWTF}M~h zWO5rc4dap((>X!nWy><`ja)%{#+@hciXo?(%zm?ao6@P6FRoH^Bm^4gNeOOJXe#D3 zM&TAGep{4asonSPuxZ-^=6g%KWP<^Kl3?J`NUkW>zA}_hV?ByVG2i1r%U)iSOH(vdp4{f4L<%GV66Waqmc>TQ((%0`j{i1z%_}3q%pWk~aRm(#Nvk70RS}}lD zoBr-y*i8`O;_Yq(NOdgkq9|Be6>@%KOoeA4DR-}TW2Z@$Hn6pSiya@yg0W8wW3ak8wZ<;;wBUxY`c6lB4qWf3~{zgLAge1*>nq)o@) znX&##(pyYBNev&+K$v&8cT@M4FS&IC0?%kM2z;(y0?}42;+X^lnxL7aRG(YHJbVny z+Ph;xNX4v6rA*gXz3-xgxJmJJ^L`LeTg6+g1i+xYo;`?|tGCPzWnF26pd*0BK>Yyl zjfVj6=8fMvKS}}d;|t$@I(JE2f;D!_N&0?usNum_;kTXdy*hT}onbUCqR~c&71b&@ z@wyq!zB?2JD2MWhnDLGrTC?m2ka&Ky0NGi0S7iXqF>CkT8R`eFsR~j`MnFZJdyFCX z%5yD4VL>IZSp|p&damiF_?~W9?)lxedUgxNSz5naESzndY12~1=IxZPq|UfuArkDm z)uW>?UPBEKvg?Yy^f;?F>BB`oFq%}_X@F+2Sg*Zv?s(Kxjagf#{nfn5&npZyggL0P zV;TORMq&djvM5|uVu_EcsIAT}T;2J!h_6A}sQA*6?vu~9>&y@mpw5u1gb*Zt_*aJ5rA(sRTRv(LsR&MB<5rfC8L6S`s zZr`@=PsasAIbZ(e_|EX?2mZ~EMdIe$|J4_!2@#mnDVv$0b@&!|{ZIbnpM9m@`SQmf z|HJ3)&ZGT%FPR_wiMYW#vwI!lbc1}`_&xwRzbN^YEwwbDc zTT$jNV|&AiB0niY+~fOGw0Cj7-jST-cs;vw6H!Ee8=vK&n$+fA z?>S^0ZAbsFFTJLyY`&wN2+KW50W$rJ)i@BJ0t zigzjIV?U3SPO?1=PXB!r?KKk-5R}Z%j0qqRm6@nsT>!XX_X= z*ab~ZgR_umC#ocWco5jwDRE9W+iNm0mnlv%?UL#BF-UPi!p=#n5qiJ23+IT7OPqg+ z(v1hklLZP*lG{*?C{V=Cm~We5K$u1Y_qz1zef9YUFgU;M5^9TncUSjJuq}GZB}GAD z6BK*2v@ym#IXDIY;H9@Nt^Q<3!9o_);H6vp;g|fv?W+KA|EqB$QK&pVG3LDb+?T#G zOL<{WutAKmV*bm2OGzI5=so}X51s|?f9F?><9+xA0QgP`G~1F;vs1dgZ7j+j0aM?C%q2-){fd845NIAJr3YxKXK`Fq zj3%gFJ)z}q(sKk{T76?TGyrX@;gV>$%hGC!HijX&zSmVsiY{495AKR{ekyhnD?HB6 zSglzt+pgG7q@ha2Om?-|^SOj}%O-YHke&|N$-AuUlEy-hu>WF zahH~Br(lpcP2I!r6WrFYG_D4585y5hy;g0RL#t|-e$+x{?{;oEQ4VodP!(cR7lSdM zHDj!C&aB;>Ddx(~5;mCLBLLkE;xQGLavm`qWbdCs`T6ndFT{tB&sxdf|HB8j_UR_{ zyH{@k;9EDl&yWIm_KO=V3X!W)fI6w$zh&CwbMM*L7oPS@f#xPnLYc9;9>c%Fxc`B^NU0p^Mph?~3k1&%>b?Rbva4=o(AN zzYJv()*LOo-~@1EvnTM$O>u`3wa0~Be-@QJe@=0p}_*q#(aAlZr}#Tg%#Z@>hh^oL42MZDoB{zd?eX)@c81# zms!_oUtfK7zW3K|tncr>3ji-aJ3Ph6Y8Dk07r%#Ht8$10*8;Fomja(RuefLY>x=dZ zzhK{fOaL6^eCfveNUuKd#;65*b2|)1FK;r})m?&XsK$ySsH|lc4F~w*XArWU-0y-` zlNwLFYBTLI@Aj`l3)!U5^p<`yCb?S+Ea6vX0eQiD@HPr%FI1s+xi{UEf&Rl9k)Z<5 zeU=&`GV7P;J(gWEa=xURmTXN}9dGC_O)H@>|5zHGcMCl5?g0_!akB{AO|@7JqkJTO zgTZIAOH%d{BJ9L~jG|)4i#Ccj&p)h7fpXJtM8Fo1p;0n+49?vpM9<4L>(aK#Ao3{e zXr3uvX@B0S2_vrq^Y9~jCum`?xl~PKd;Kw`s7b}%2@6#v-2;NK(<+lfw1(xQREQo? zMWvk9_Y}inj=Tt02VDDlVu8J61w0g|#DT*JBQiU)TxAQJ509eZS{z`?Ng=nfJq^-K zoAa}aGAZy1=_7eOobSAR-pW(IVSi_o6G7?vd*j+cxY67JMLX5XQaUfcdCLCY_pj~_ zbK`9SEz{~tZr_jynQR-YiEy+*+LVQXLbNx|iG$?+4ho8jotB0a3s9Su#fo!km7|UK zl$Im#RA$Rp+8ErxPWm6UQ;P#iDhu*8bxzwfk(0l@{XkHAR%wkWr8`#<_T1%d)I(<{oytxVdt5i*GuYD2s*NqoXm8% zX|9PyYfI#~d^eK~&Pq|?3i(tec^K&No+#uj&ME1W35XNHQa>4yiUU>S#7pOloy%zj ziJgnvAP9qMf>FqoF8C(#f#N8ofr2<*}7$fe9(zV^1UZ(x#uaLTrS;vym zMtIm-XVo;5OnGMe<8!0|n~fco@!o+14v-v9Ou~M*HbusYC9;|hy-FP5Oq(rdgQhS{ zGCZD%lsG}wN-XTzab|Cj^f&>*kZc1?%ej_{QB^$)_1o!*LWPde1QgKYh|AAy!K{KJ~fTkeUfTDG0~rJ&*X8k-29)OR%Qr(?*{0SCm3PfI9=zkywia0k?nx(*wmKt(0Z9=Q9W2Xs2o2iE*LP8em zOa$1tK^js5rcVZoJ-`R-=+$0)xCT`gqtoy5%qJ7X#XODgfUa!ETYjmJ_L<pW zDHQ<@!K5z{fe8gAj;>C@Y9>c2Ism}&2;vP~AWeZdNPAo9(I?u+#Emkc7ZBALV{{FG z*}WvZjsUnjq`+b*2}EGQy2`+`wc0ciAPOD=a>wALXa%50VuDtqI@@9-8wU`n%~iY{ z;R-q)ZRd*0Jz^>pfx^nza<3e&g4F&gSN$zXJgGzn;O-9$+#M1l76)hAoH+TaJV| z72-`)kiU-Q765P`kYbJBk0AgE?FBF`d|mpi(w5Ex8@<5oe#Z6`V1ckutdcH-+9qyO z8MTb&Ak#Z*hDPnC*~f9;_AHBTZ$nlk_rp`7@FMx!l{buC81O?|THEJOEJ@#iNdr^D z8BdIrl0oUy?g&h3VL_>>h4DP|@KU5;vsW#o7l9?#f)1^R>~yN{y)w#+c=&O9^Ccyz znUM`LtxOr6I|4s-8|GpQ#o^lxz`RrPEf&8r0dTEFwpm)%M+`nix#0mcLtbWc_!Z~! z!XE#X>;y|gsFxI=o5MCkHx|N`Eg=K3>5bm)X@QbjumoZPBFYR6VnAw_B9tZ8`bRSQ zrFEp655C$gTw{A=Q=JYt!J@^0lvh0=U^gOJuP#$xoi73*fhzp?@TsaW2p5Bt4l>P- z0MyXGTYlasf5c1`BK3a=0QguGB@Zx^&6QpIm;Va=MkAzu=N16IGu)6O5*D`)FS1`! zvDLs}VQFZ<9sqT+=&)!7psu!QB!qR-PE#sYb9~}0w%gf+y`Fia6D0h(zJ?f+Ea9cOF9%)Ow%t+P@|eABo0lTJD`2KXvJX2 zC*3jYQ=sp|<$>_rrJQ}Pk1icFFoxfw2o4Z;r-!L`+`?V5E5u}3`7A_q-d98OL9#tc zv}Q23fVdFG$4?EUg=hh^9wRi|VZ5oe+-yN-wr;{&R{b!b!Zf(d9{LTotA%B`Rs&7i z>&JPVKS)plJeGWq{F3bW`UsuCRf> zZ&_Podg*xeeos;{=|8ofc8bCevkd}D_ml{o=Qezg&mmR=$RCCcG0q(b#}SUs)ztgK(oKN3A>XQ z)iVe!yq76ZU@62@P%rR>RO)Px0Il^{SA6d-g*uTxah(A=eYonbXEe`@J#ED^cXBg< z?cTWO2sVtqA560h3KBMj{c^mk;JEu-_|67tZvk*8V2GLAUbL*`)H}Jk1%My-A0GNc zme-iOJ*NAu;O-)7^qj)$x!IW3k~e2_(52LA*}1zpljBNd@A4{xv-?j&pEKu)&rL*| z@4U2sS06IF^T3r%M7-z+`t7Vm`*)?=O=}Mvj-Fdv4QB)Dd5ga^Rlvvl+SWD zMefN$&K70o1r5KNMQjXPV+!N7i_)vD$Lhwrb$7lNP6N8AJbF1Xz1B zniN^gi(n2l8+gYVf_cH!uJ7%2^u(E;cC)0%qzgW6vl9V!a$Bqa=9!AfjF5{%np^Kf z2ey;Z(x`i|kQ2h%Sg|l!fVCy82oPC#`AKVS8OxT{ssMQE7BFV#;d5^N5uF7D137&y zneI0W7ZiZ#x}^E>=~HQ%fWS{8YqKWr6TKjF;Yw#pnP(}Pz!nWGVz06tB-7W!bqBUj zEa3nFIk%Q&iTTI&n9JYY*MEXHJeaq~_nB2YXR;h&1kO_$TFFXhC!xK&Yz|>jsGS0A z_ho#VA!X)n{Z1I;zks=~;}e7d&aH)8GHcr2KrYVi$iA6}pUqckt?>~IS=1?Vb2|}X zCPJA3-;+hXhP@Z##3zV<*7it;6gE7pCkk9ff>OG=*V%{@Kqf;v6L_LMig2$UVBrX` z&S70*%fWR4=d*yG(h%~*q)z1_+FvtUo%^D|Hw(7sppct*o3S=u))Q>6<4U`iqsca! z-Hs+x&+4jcuEI)$f{IWQhc`f*&t`@ofQg5fz0*_=WtvvAj!V@R*p=d5zCC8tPKjn; zmyg-+m8w1)$+8z2ZxSXi!z4l#A}y;~eb z)HA!A>s0R1w&>>TcFEYpdaBHw5$#pHyx;TdY-pQrjx2>Dt#<0;W+^kBOW<12_S~ef zG@CO`^6yp)*o@^0j<1M!R|_#1)ed5k<}9eujVQv7`ffx4e<`$hXi=6cD;9z<$i;%u zx)<;3kyIZ5Mmy}}&*fXMN!xO;sQ;71*k8`FPQ_XKP|)*(PcXX=GpOi_iu*)3Zkuli z+0t$>vlR<_p7PYEF)fyxwj_@9y8s7-BWX@9z07_sUdt&kzujuf zWC&W4=QNJuG<(5BC_FlWD+&v_g`#h(H!<@@bAk2vO7!muzJ_m@%6TKxg z7xy%xNuOr4vvR(2@^0&m`iX(j4<<^93g+v+-UP$CKT+b1V4%{uFP>+h{lxR-T$5w! z9U1_LScnH>JaOAnq&se!CW;nnaW;+q?~cijStJ1)gYLgesN&tJf?!gmhcA(2A(&r- z%pGZbP^||S1%YTwYZ_Dw1*)`AEz~=7C)mE_?*`Zz-_D&em@P`Fp>IF!R7i<^%_S@|r=zAz_aPJsP#O$g1O z$|Nu|G4o#V^Hf?$lSM!EijewuDNghGbi#W} z7m6+`)LkhQzQal#*7F4NWO0j$VO4GqTa$5H^n1MK(V~j;?pqY7ha<&=cc2*^<|*?r z^;6Aly=VX*_Je3;G6Au7Uo?CX9MXYfMr2)VJ1H%G2|Q7uBoI+lQ5dThP$ctfCeFk?2ZCJ1g*UVa|{ z@Pohc^0WBxt#=o9D2P}@t8Q1Qg(QneD4C+6Sqo&~1==EgRKVTc6#$B@gi;|EiKB-( zr@*ngcwj@c%yZ<;utSzk>iw%H;TxQSa(IMs#+r4qc?f#+bQ@ghk%cxyw)P)K$TB*c zepkTGfW(pxCT`ljhZ+M^3K9GL-F#=Rj%4&FR~zFR6Vy>DXEmbQNK#6iGa5Z&a4m8y zv7H}L$|q7BHxw!%Jyj!Dy+rR;^6423TQ{Gne^ooLmwI76%7ZWcnJ&sXap!C&T=pYq zR{WC`fpuwHu=# z2*9{76j1tG;t&%dPkU{{WMME+M)`}-KsJS)n1WW9M-MD0;`tBzo&x|y4Qor=v4mow zsktzKgT?772dB!B=qT)n9u}Oy=DMi?nNp$V=}{^Qq=qdRTp-jofg{-xa)fDjwO#P8 zCL>F+t!nwwWDg`DSuJSEw<1Ae zym_fmGE8)Kq+oz1UC=d0CJpAKGa$wtpgO=ZvZ@Q=PK}tEw1`kKMFR>d#0(Wtwa&4< z2vHXvTmq2+wD;l8K=C3!emHAGQJ11KmN^yhvc_XW3 zIiGKH&Oi3W_uivy!BZUxTiWh=6TxO0yUDX>E5D+9HgvK`sCQiFkEtk}>^H-mb39d% zqh-34aLimyMXm^##&aM7)HNu;;;I5tE2zJH7t9zyilRnY-Ae+5K&x>=nQ!%Gc3)OXX11HOlN{(c zO&xqJk=lD0TmX^CpkPzi7tLN4A|~Eh4`Y&Mpc*p6M4i4_XN*D|iw?S;KeZW9(;AIl zx6272(DX_GAkY{;y}%S*%sAoYW%WQhdl|4R*A~-6AWBeDVy&*cxfRQU)l`71B{8T# zEfD4=oj9OIhE;o9>yigwPza{jYVrJgEUFHP0*Wy6H6{Tt{0LFn%dD1#brcjS{X0!X zfTTXuQ$?*xg~XxJ&Ez+P;^N{sI8j0`t~puE4cq6~enDZt*okAhE)A>cDLHc7E(1Kw z0yR8kWRS)M-bxFLvVwl&?e%E$k3kc8`oDNJFwUEAJ^#JM9m3*PCk#IQ8`*MLLGi^m zb#1a!J2T6KIh3|SCZVfFHXm*g$o5~7FlL9F=E1&Ru9Fb4xh&~AV>j#De(BNNR25S+ zt0DiN01O?@*>PH0!S|;>^3)gI#3=6!H z8mtQf8RAn#A?Eg>6*wvg6-9u1C03RBjDUnuD}i;&Nlfh1S;c)z4h)!X*~BMC1h`JK zqG)Gxj3qI|QildH<=P$^rpaP(L#}YUmEf*k0SjkZ+2nrYmv#Xcj98gxGXpOQSy!Un zCRFvRFD*UNPb6<=$(*21>ZVcwcATHPz?ukd=B36o_re3k!`IQY`~Tqm55585*=Jwg zxkHQ_)o_rbXp47(^EaD|2GXH;cPqLDke z4*Ah4vf8X6mncUnxjX628o15flWBhB@#~)9ZJK@8InU`XD2*VN?hdS|!$uRMcS9Jb zyP+iFgl#jCv*-fn3>H*zDV8cwbCS(u|BD^to)D(uuU<|H(z46ULJ+Wh-{xr|I$p;m zQl#xrlTid)VQz8z5^(Z_&6#^E4yP2_ogH;Y+O|OdwU$(NiRftVOI0}&}JfhXZW{QUXkrw6k5iy zNkl8AI*af5)~|lmF4y_4MY#n)IPP7xj(qjA8`Gw%T_A7Fm|%@Nmu($Fh~PMgPRT4(n;WUb*FW~sEg~E%HeLN zfxU9kN?11eSgFCq<*^YVL5MOJln8Y(%25}$bM_ufDCpDNkLZ8qQ%o${bil;FKvy!rk7gy`)h1nwIObHR+`e7}6htu*D3|FOUg~BdLi|@3kURCd>J|I2laVfX*Jn1Y$vc)D6lZ>H`3) zN=0#J$-wXWEB5Vkr-j2Sn1M6$1^_~xJUFhq8KSDBWhdhjY^qY1mrr&}_wEbJAbY?v z->n4QNq;d3U9&N(f8#JcZUHCDFF}I7TFgqo%?+DJ3=T=29Ot3e-l}3(QG$d`M4*nf zC?IU{pBW41gVz2wOxkjVY*BvpC2U>Y2!@t2Q~}rt|Aw@A;$Mc5bhG9WEP|~D*f@8& zBXgb;_W(du^vK$dEVx!oU}J`)e%MExB-zkZn7Y3xX@4jU!r7hzq9DGEQ&BrB6FyGJ zZ#Fi}IKu-Rv#hl9WWEfVNX6meh*}q%Jkl)?h*5od2V>Q$w1*mUp5{fkSD)J_l`~?I zYy)zoi{=~7Yklx~kA;VS`TmQ9XP#?6d2?We%{URIp7;R%%6H5rALrO0W(NT zQ0$QykBJ|}XyA~hv>mhTBG+zF(m6<;c4X@={v1Uc`oqy}=Xx}r30#ye%=;Z9BG4XpOx=kGDN0=;MH=_@ek|@G$NF3F z<3V|`6E%^wl^xxT9Kt ziwQ$&i+e_71b%3Tg{_;$oZOaZvr^0f$}@$z_DDqm(n#B$>a#g6g_&L7Q>`@(jXm8H z8w*@08sTWx3=rM~tsotLM9~haozZHe2JQ_ovXrxq7;v_vo}Dn&?v}R5H2>-3?TQ}7 z`AzB-b!ItKA3s_Gkb17yC&JB|WQKUR*x5Cg%L5PJ0D#wDv2P!|0|0nt>W_ef9a)@| z5Fk#~?B)-qq!>AYlNL&2dL;0MUfNXHF5aIS0eE{gnBJ9X6>{?)++j$bc43T-7I7ab z2Fmi)G-(x(iX!YSxZc#HH3*dK%(`)#m_-jXD=d(Ly(k{O!FN-|?G+|BsPpu*r`DVi z@PTWeq^5##y_5e#jm+)6xLHf%!RrHPA(Ba@%@aH5wOxFg^@$Uu1>Fg@H#`+WT_o_# z##Httw8_BJJ!Cg8Z8*=zm`aAAeh8eVY0!}frtsCpRRdnx^JP$zZ>s?J(Mj3YZCU% zHp}fHtTgCaSxd{h4-eD9!WV**yPJ{_fzZ5lK5uYrNBG0*A+N67lG(qvZTD3ZsA#L2 zu}4CdgqFdwHcMuTazSV;IfC4neQrXhE|2BDCE&yBcm=@2cV4%jpI`7K?x8M-3Cg01 znq<6T8WNUA1~~MP3wtG=$#*aiDUycLkB>_^v0ea}m0en(fe}aUv$JGnCfRTj@;*b8 zN%u-KGSDgeYJ7q3g=T1uY+J9qwWb>&X^iKLKJ4JncI7f-%tb?tkRhYOp-cI&z}{Sv z-8bQmn<3<7!IZS}xIw@e73VgH9l=oin8{tRf#}Bo^Oz+dy8^ht>V(ThXD^gQ=ws__FNjHwPBtWZF}vR+UZl-_0oSo1`hr;!5E!|6!??!L(sQV?P18I#Lq ztI5n0+H^AjKrJN9LM-f=$`m4>{EL77&vB1!=^6f}6+j^-!_-yU3;-+@OiYCs#})Tz zt~!DP?D>{7*M>ogO~)-JiCHPkuHmOoBMZ8lF9=6O_tM06%>3{~`}Gqb#JToNoStzc zJpuvrnvPL(56jA6H7pyYSWHV5#i6uKT8-woTo z)^7qqY7-l&y?6k|^#u3WW(p1G2V8X6xm732XAF$x*Bcfr3 zi%gC}yJ_Kv7&snXk1Ak0{^)B-4GHFAjw%9Gi%u9Jj|@u|u}naOdTfhO+Kh}ZYM8$Q zB8crzbV~%FTp-({;lhW)fK=_zv{y&?G?K0%zcChzToYc1j!+txBWUbCl~0(tpI-5R ztjG2Ro%grcAz4sQG_5H|rm~p5CtWu>TJ5+v@qTVF`Lw}dZ7xy-%Le>b#l0p~sG4{n zwGmYc+w8ProE8YcY$>lrJvJc&paMS%XKPp$5M~xN(p*7IrJxXw0udDA0!!1Stu0ju zbKfwwf6)%8O1}?+q;PBJ)1Sf#kWpuA{?N9){KO)n#=AlAJ-;(x=SEDXWn$-7st9Zz z0RZ)QD5Vf86rcMaJVEU7IqeNjFACY;H*H@AE5J0v2z@n_yvTLt?$WRf$y=KM_LQw~ zTVouWLL+VtM5H4A3lEm$> z0;ivVI5ukHQ9r;n&(4Np5jK6V(z{3@3YC}NK>2THv>C`gCyzT3tse`>{7e*T%RAyr578R$ofpdCrU%-!1fEZxyhqR|cu=9KUTILcN!cy7LSc)|?U<>(< z1VT0$LY(s`ShzAqLw~O6`Xduay1k}T+c|`rx4-hExq^4T5CafKVnpfPcC95sDDRcN z?o=rR1#UjwQZ^5Zi_p3;L!GuLdzFJ^rhy1dGJ+v#dpy81qcX zTK02MxDiNppR(1e9hVAq2cz{MI@g<|l~vUU)n&b17E{Hph7Q)UOBQS=++H>NOV1VY z!5Qnm#F(t;`yHRk&MPN7S6v$c-Fuj#={)9!Blbv}DL{y)Qom>`_wCZKtep;HT5RYX za*_^dxCl~27Tzhk(b$j8;lwU|H{K zeXaM|PWs;1jZI=;H0Ir(tw1ENSZ0Ch`>=6e0fS|mlH4So#m2ZKfW+MAs81rLs)8&i&p@19h%5NQ z`)|HERPm)Zo>EwJawTCfv{YNMtpY>9OxO&zx3fVz@T7ubv>}907Xj0s#z`Wy&{)nK z9q4RtoOy4*wZtjHeJjK3UpGJ9VKSdBjMlI5DF3M1oqU(kzPRqOjFLQNR1QI`=Cu=~ zkD<=<2(&{1#@1an;LsCO`x*>>c!r6g5Z%dmyw{Q-?_)w~Pp8(}N2?GtVwMq-CVJ3d{*h=^3AFS!t*&T+m#Iv9`&I`!^C9~=r3 zz?%m$cVtKtCl}F;QW+A(#5gg`Tnz*TOtvLke694pFJAZ`Suw(Xqb1n0{9<^x1KC)n@i zn9NA&zJ+OcI9z)6H_|rp(qk;f%XOJ_?z)#~Y?XA7KDjZAb7@iqkznY~YbSt#yFR}u zcBXd#8SZdqem~p%5=ZVi6)qPs%OGd&nECUS)N+{{v8Mz(sgr@D~ibx#;VJ84R6YloT2sUgc=7s%2 zd@@aq3<>6LI(Je3|ql?eKOqA@FTp1anIg zH>Yt%A548XD>rKU=j0v!kpSPs%jHb1X)tW9ZM55Me|9{OfzWMDZ@Y+^v-i?fz44h< zcxW^K&Y~uDin64=5iV8W$G8@HHw!5_it2W^){k71Ms2$A)n5*}$LL)AT7FUva& zJy!1uUmRDQ)*9QPwewld4LRvU8GVW8{%)+&yVlTrW>m<-pND_@s#g(_Zi%2rW#Mt< z$HRx7pjjsSh2~6gLHw{!U&Z~mGWIid&c=9#6|bMyu3qiD zPf9~~Q`JaNiS#;k@rt7Uf>g?CH3%bx?rt#{dU4X+C4)dN#cMxVC^MmG!Bt$DNeWgc zY$Bq`buwat8jS0Ux8bhCv1&XQh{ydvH}N(?+JU)+#^%hLGkHDPD^>K@><~?!2^*|Z zussN7ke8hCVenNNmQLcsLzgqbF=22|Q|7L`X&1AJ&}PuE;y7VmT3~jY zDU05+ko>>=@Zl(a7uGa83@d#|Y;e zGPyN7(WkDxEa^ypb^iP$dQ^*5J%YHIul4w=O%f7ze6YClIJL~fbMxn4`J&{*9 z^y1819C_N}Qx@9CSf`1v6dPJo-sV%?6sU#gLYx8UicanbuWFJdSvXY~fcrM19psXJ zoSWR2Ls5&0^y$hAPA4eNhRkx<7o0XLYq(_y7U=onePwXKgYkTL=$o>;A*aTQcDKhE zw@I9N1{oLM`mNJbo}7Wc#-n@1<>3y+1sxwBnlK9^8f*B1(*fuLTCIO;Ci`w7MwjM< z?S!b2x~<}}UQlVUA)XEZTSUMbJY-xXXPzO+ZFiL~P`b{USG?S=kV6o6>NmOaav6D=T@&v^aJ zR@wmUHTjwFT-ElpqbdW%GiFPdC64zpo z)u4&Q$+Y(4+P;_E#c{DtwPZJIl`QyvNmtL2X|fGn{QQIgQ0uN;1kUU}bPYUsL6Lwr zhL#vR2?@3j|0$MBSfz?vD6=vg$7Y8-;@X$baujDQ34}OGkTcTToGsD&%M*T_E$1qF z#D*rq*Eq(h1u>tu%+L2!D%f59GY^{%+D%Ue@B56FpR_(b>MLXMD1oEpSOi!_;n_Y9 zz+}ujm&a|XFLrnwIJ-rbrOCY4Osxx`qj>VCSCV4*2rmMFAN$3wue%pJGiw2x$;~mg z5tvx&9+b9Pu*s%sz*)MTr^3yau;5LJ$SQeK!H_5x`1YgWcbDP6M5!B;EO(uG- zJU=O9n1*W-OT@-=J$Hj>O!dxng4E@r?L*_oo2!gOR4NO`(5z4qPx;hT^hHf6wB5AV_It3XN&t=AVu9+edmkS* ztG6JilRwH2D1f)|`D!>d?P@vaN)XY?HTAob!3#6Sy z2yz2J3AJ*%K@e}KI})142eG3o>d{3DBAjBvG<}h5$efG)8kQMbNYf-)Bm`(%*c0@E zSg|}9(#WxxjTN|qB-BH3*@*h%d0LF=Wj;%#VP=s*b>rNSBYO1)fvoxZ^eE+1n6|6L zGMc(5mgX$kTqIRJgcsx{gVi43Oc9rXRnZK(vEjGHe&y)=JVJsUDgnZ&PzV32pz+8(+_BCE8*c(FfWxOI9Z3;+dMEm*a`!23<;~O)Y!5FfclJA zcVDxZ-2^biqHjr!BRg#>6`!Kn0wB1DQhT4E0FJ({1OV=FJ9E?ml@JOl1Qw78mB2(6 z5!`xOqAh%4-a~+@pTE&s32X#%kZ<$a;6emdm7@)o04^#p{ptxow1M!}RH%iv-y=v9 zart{`Jyg|4_lFJE=EhJ^}LoZbbJ*KSf0MrD%bV#qG(S)vzdlPYe?q1jcsCY7Y0zhm_ zNBd?Oq!BR`A{MnL##2j()592=Fc6Ow%$b(f_Pu3UMaubeSWZG~^K=Zm>f#pIVDeL7 zz-7gEdeQY|YFftyg{~OEor-j+6F37F-MJL)boKg@kLUC#Y@ba}uPG;zvcva+w`G!G4vaFr4F-~Jtm*NFuI;^n9IUhbs|qqW=JMA~+S(lZ z(13;15(7-!8VDPlh33@`8_hD9*V@6`kWkYhv82Wwz$ic&9#?W0WnX5f7OXD;0j|T4 z+p^5tE^q`570)C;k!|`5nD(N>cT1s@BYIK39QHR&6Sd>cE?mo)66-|oJkVim zT>n?BLv0VGhD`CiB$}A!PjUXafy7~K*sX`dU^bxP#4+kT_@;r^$l%wiJ;1(+aGEcp zU}FFoix!zNRiZY}PLDEAO(DsIQVq5c0X6pTj90CXjzK_1r5MX;;DS-e2Ej0t1q8}Bd zN;%G9g37&uL!q2Ahf7T0E;CNCI>9)p8ac~7n#VtJ99Kb`E)TL9Tbs&cpb``d3){Fw z?CJy$G8x;u($$dsUs6`fnk_&P%N!B-(B3o<;8s}zv9OFls16?kK5v5_FK^d{#)34r z0d}LFm^60AWjR8HHhM|sk+Q#qdN@yX4EscBJTec&g_E{2IrrycJSZc->i?hfA&su( zr^=jGYIU@ITh>R>_d2`^vAu{Nc&3)<-;AgGCK~Fp$PqF>oW4$h+cMwlk2Q?;Jm0f< zMU;tA?gtw|uk?hoIOQG^Xeei)9ktFD z>Pg%S@#yc$M8qk)r&do4Rn50lH4da(3uS3lDl2zQ?eBKEGIY`eZ37U9z=To}Ei((; zJv2G4uBBF&Dn*IqUL~f{Uwgpcx25GTRcC%DIE}_TB$Kikr0(M&0n-L`2ny{KwVg}J z-Xx>5Zl9V0BB<6ogq8CRBcxPWVpIgi;C8eveh?TwDmz?}#qJZ?KPUZfxw2c9BM98d zpyj|kO}Pb}vS(Xm=W>O{tX~d9yDepgDx_T=YP$HvWGun+VYFvUr_-m2L2hjW0n`)d zN<2?X6?|3vsQcEmHOEoP*LJFcMZd_G1rSf!Ha;J+k6G5G{qB#u9NZl-*QZBoWUM$} zobjO(;%X^N1Oh3}^>o++5nJs7>(0Q838|(SdgpzMva+HW!2zr0qr2UvQ6qWK5wJY0 zyEvznyGO0NuvE(D5zL3>?rl0s!n%;%H+hpHSkXCO?PTMhOXY zomRq?=IYazw>8~$w)-nhD#7K;Zkspv&wLErG1bYrd#$8Rd);Xz!NT?Uq9zf`_#^`P zr&KaXaB|wZ418k>E;)s;5)UKdU@v(>rG(lC}jWU+*z>U@1(x(Y`Ou}?bp4}892GI#bq1jnnK-~>Q!sZuf zQ8G+iRIpGBZy83_7!@~ZwN=s4RJ+f<&hvV1mON^$ z;w0K+gP2vMCO?d3h;}AT{e%p=)9WrU4s=Y>6sCl8p58T%mXF4pxUwyMy$`?o4UEo<5=iF}V(wtVO5I^BSx4RG|=*hdVtq({=1M*$!G=5^&9! zo)H>3Q2;cPM+flG4!oW2f>X7+bVHtQr3iG`R7|He656Qvg3Fp|@WsoE0#GvXBoVz$ zRPLcHbJ*G20e~Eq-NQQz1UM*IRBCnbDd~Fy<8v%zfOA~AEji(E5HB`B5s`q`j?$j8 zn5eDJT2lI9JC$(-HzxqpBHU{H#IX>~JJ)!e&rS9H!L5pje!UW-m;$oL>f0D)Ixp%{h$o_O3^`#y0=Sol+D{v?R~43MKA^N1Irkb? zCH1so&PqSt>6fC9P*h@YjT&a|$|E|a4fO24s@FJ9mmluj?aFF)Q`&8{gM1bUil|`= ziZkZDcIr`q!OZ}}$YNH+AX4N5xwi0EW`Cw8AolhHQXa@#0OTu959_=V2w*bFJ` zcDr?~S%{7Cgssi9Mi)@qK9_zyGKknYW&FIb<{ zZyQG;vY%mmKu7_=QV55*Xg{&XwN?yXwm|_lexTa13FU4Pbhga>3Cu-TK$A3)8i!Xs;=zwB-8l zl*93YVx;UU30np1sZ%-|3Key&BmU_YOVa++?!~_8HZR^_IV&-@VY zpO=zod?~Ix=MBgf+9ePxGu22THj^46`UQaJh=Vsq;8CP+m* zihqw*(fEqG!LL~7Fs0gz!A zw7o5)Pz$d{LO#Du)vCj70o;;lLZL{sjZy$;MXeU&s8(A$st_EGxnBRPM_9c3jhqpX zbDlCkD4-2A&?D$zIiAMEFP1MTGuc7@9%f2_zS{-hL%^0$R7=(E(RJKt;CO2f#Dl;- zz>eb+@48#`v<(U~32+mO6)oLmM8oLQe3I#zQK`iy>Tn>?BRiH}iv~g-5!f0`pjE(J zIBY11u<}4=IYb2RlOJ(w035*<)uRQA$}x9`r9<{g%fQ%^@y;Q$q{eW@`4hpgP5_!X z13dw8*^jJuk-o+EVYTI5RSpe}7{Hk};(l^6Nvth-iXAVuV=0|^Y>$y^xlN3UqT=Al&Y%~_Ct!HaoXSYiD>o(55)ce-WI3`_6b3|Vqp2&K0>ks> zgn>k>nXsrRAS#+R+r3Y1)D=a4^2xuZI_frNP9MAG1W`DJ`~yncO5wRc((y?SgAD*G z9>00BvF-YSi5ZY!eg2e@R!Cv@<2Y(n%P83!iN8{g5U$i?VP*Uv<4uj^Q8??0his%_ zZ6<9(-Fmo5sX&Moz67sq41Pp7r#abC-ly+EMe`2u4PzuhRT2-20ZS~;{7jB7^kc>)w_!A~38oA~nBLF85k@jAa`i2y|`(`yzdCD9G^ z1tKUECvc6bJ7r=SNW#8rR(}tPaZUaY=C-iA5O{pMdu54La9fp0`ppb~jt0%hgi4sq z$)fpP<+~LnC{q4$xT6i*UKn{mPX$`UvHU*T6c0vN+e=QG&R{ZAbS#E&scc8Mz5L&>>vL2*X2DFNd zWHCx{1x-e3T8l8mOpppdq^;kndY{|QbUmDa3VIM^n^jQI?`}ruC7<>jL9`9oO%D~g zw2|)0*S9^6Ds_P5S4)K2N*q`bQBU?d7y?$HXy>-Jr`Dbp(cn~x02F|GKEOV8Q#;M1 zu-A}A@Msmx#O5sLHy5c;{?FroCkc&5k&h+em|}l~+NQ>52?SqMJR4kCH~{qFcOhd} zLA=QH$k;ToTP9lD2m=^Q7C=DAU-J1Q2VLzw#~Mc8wps2U9(HtP@O1JJsd-bZPMlv- zdOuXm0IPb^Xm|-=onW3^CV64=Py{Vb@@Sh91~tMpo`iMBb_X$) z>>Qge`6LTud!9xTQqU^a6Nx3HLjblT&&m%YRq+5};w=p~G8o_r@WC85uCVVdi>hb^ zD1wb_ZxDe>)#I`yD)U)tE45S=6=*d^W?;u+B0{>^6+;Z<8W+`dS%T?5ozmtk z^<-!5PJQJH?k1D1i3d{Xan~bZ3pNQ!ObeJ;$%OvPh=-lk_mn*BnV#5G=7*{pfx8G`aSUAh6jS;qB*F(0Kg)^YbTE5ak4c|hlNNv#*fQG65jPu4=}_E38nmaXc{j71E{bA+#VbXEd2;@B{l zu6?!3NM8tBtZZM((DQ2!u}wSfM38hAHlR|bHEw^Y^_Eot5GqCgSk2nR77*r%zQt0% zTQlv7&7e(WjvCzWGYKt0Pcd;TY$)Qn?Tb9pV^xTPcx%)eYb~)vlyYFq#x(nDRAEcE zBn5>Cz(H6d#+0AeNcIBPP3&+%@30yfxU-!}LVUo^Ez%LO(J&zXwb07qt#*L9b5S3K+rdN@!Z2@|7$ z2g_lzq)3~l)~7kJ;V=+84IFEDXbUbGpRr#Vnbau&uO-K`j|7;-)BHaOaWZl!t41cg z*_aSD7=LFX_t5|7n(tH|pa8K85eLUqtSOo4wdFBtFQn90{7|ib@yt$(E1M_Qr8Co0 zOt0NFuc@ug;~d)qDX}G#>IYBH71@4`0}oSfH@hCLr`&*_R}2=4gB8*q;ll zpQeK&Nz>|?vS`c%?uhsxVBxONchS~N)SRqczwFo(00V3apXd>AHoLu#prGR92n>(~Mrah%W;7GPLEkIlh>KfB5;th{jpG|aj2t5( z`{ig*k%C)0aJ@59aUo?*Mb=`iDQ}PgGtXmc3$R8H7-+bDql>ih71ACHGb-%^;T>uh zM!yvQdR3$VA}Rrx#QreP9geMF0x`QzwR^;3lF%vjt1+QMY+1ebJC&;&KlFXumX5ln zES`Ey0S|;7O7zyP>!R`*fOb8^R#!{`4`tz|ibY4x_rBCtr(&jkSu`Yj&1IYDL?A#> zz0hRFAsO*t1;41+x{rTCAkRQe#x!!VEoR%CJVwSH%BV#a=#<7hYe2m>m)APcpnV8x zhat+iZw1Eqg3wuNJr@?Tnz)hkQe^blB}Oi^1xOFk*mRhlkx&7k@_;`nrkCC0+UyN5 zQpwoqb>Ze`4P<|s4VtE2y$1-(YEpZuh#P?r*%uzwzIU$l&9P_yTRd|RcSB5i;X0_Q zijAP`QOEWw`WCvfoQi;0=hu5lVS^1WaiZW=50>r4oqN{3n8`((cFto#yp3n>JHYMy zzNuzuW0~>R?R3!Pp_5O|B*k@NDXTvJ^pEeYiY0T>0qz_0;yc#Mor7Fbc5o>XE)!k5 zq}&-vZqJ@z3u#cX#U9Co`Dd(LFvGTuS8q7{)oIV*sohC>N1mBhLfcl4tw^Fm(OWN% zY)fPZb}b4yIp33ZYKkKg2KP{GEDYUZXf|*{G3U{ERj3^!G<$>fi=_aC+7?SMELl1zfX>MAEQ-2inQS2+8?MN$ zajevVpcQ-Xp=!7im}iIiUHZf-*eMGnIfj6p}GUJI|H z(KyVzBmK(2gf{SbfLq+U83*R!iEsl^Af%bq5D2qZ&CuxFNkNDt!GxGD6xn6&bSojm z&gbM3LT^WW^=jvbRe59u!xYo96RD%izcdV>eY#)-Ll>_L=#TF4P=#?oG25NV4ogq> zp=gsq&y}c&0z7lMd|_GfgDK;WX*%@;wDyfu4CU%~3lCiDrOguNIwUYDOWSn#Lj0;8KkHRer zuXUVf za0tPLT2kz}C#($V(!hr97;C2F*`s0rQ$Vc0LfQz?SBqnXCRf_eEVL9TTWz)(#oc~d z9QfY;jKBbJYVLA(SYpF?(fLeFpu`UpZH5(j+o8TdvXtT)7b&;s0>SE7SYR>^jTNMa z`+7C^p%$Y$P?grPp&z~qI8*VSQ?|$R^anKD_jCBoMYOkxh3(A%dkj#;sEK5GgAt*D zV9K<#TTa;(cO!YO=^m}Gtsv)iKMR8xGI)Y0`O)KnU!9nb-6mQE9a!R(Xf!T-VRO>1 z_*4#rCp`0PL&$swXXd07Qkt-5$IJ+sCr!|{Uiz3!FW&}4neN;Uuyv=CvsevCGTwEIEjE}Rc>1hm)pvJ=V38O5kkP0dV zqE#w!DGWe_eW|O384^)Z6mFG~GK87A)FVo5CyS%>6>umpn`+!48lL}N1^V%KTOyvnD*cBkA14E7~B_l)3u%rC}+JH*rt+zTWtY=1gOD9D3 z?kbj9vlPgxUBX^#B|ir?0gS}+nG7lh4M3|O^k}hb4HkvMoRXeU5rDaXK}Nv5dCT`Z zQKyb{tGYiDrtQZI?AWd22 zO*OgiHfjE!OuzRIw;KGSfl7n$+*q8`%|`oM@sk3><|PInAhzIgsor&VAU|4&6A{ju zdhhIJ0(HbxfCDurVYi6R2T7QU9*>{=shN z?1&Ttk+V$+MzT#zRaDf?8I%C*lmJUtO+s~CR-`_B3={ns zzbaWO9Y2Lq=$R%&Two7OH;v{QYH&Iq*-wdP#g?60jvm`w`>;W}>b$rbzF zRraFY`Y;N4*5?Zj_as?arXNGsG{?wEM2;2?>XMy^Lfs@B8U*`Hs}6ieYgGZp&O)kJ2ZBGfe+VYOrGE~Y0{WNKLUSU|v*j=c4xalW}hL)(hx z&}=8#Y_OY#*?Q2kP2w*1gi9%0=BL|#X_fRo^$>Qgsqy*U^Mr;31UX;9WA&~_YRT^QpW2)m@`XPK>rNY^E(hY*^Zopk6Z0gNgJr?FW0 zl!EThsVdVlByIn=dj%)eb8j95eptLZ7K{9n9kdG2CupOkzs@tn?Uf`ap^T+nLk7vu zl3C~3Gl%DL5gSeXzx(BD?PQ_*!LC3_DseDVxOxN{4Vo?>Ks`rdCTMDL#id;7f6zCzZEfuF_w90q>@8L@3xd)9?jS72cEmO+xw^>Q{Rm8 zhID6pnb8{L=feq77~PRte{zr2G6QUyAuJ;!TNNh0Qi?Gltc|>lLVVicixNW1)~4Ka z2lYra%9d(XTTmW9ok(L;4a*3mB7hufL6uLn` zBSCco!xibz1jQ|RX~vW0Fegd~B0jJ^@{_G8M9t~`qr3KW58K=+R)7mr_7zKy2esAB z?_MWPq#Eo!9M%&678bKL`mqxkE{{ck(gxDs-Qu>*4=u(I;C%Glqdk7W;db?b&+) zK%N(XLfLWS>Y(#6yb_vtw%Ww z`PO0R72Ialmcv>cSt9bb9&291NO% z)c)Dnji#A6_nPf?K2HoTD+&_!U=XLvS`htnQ|@T0RIFCdXIV7s+UsHnv>cY#hv!d@ zc`Fe=dPys!K9IrRoIjJjRkClanRk8>f460aVa$QCTe8yT1;vDzNLJ(xxyp zm&-FpNmN1*F}_D!%o8b0Rd8L;91R7m8!cv8FT(C@c;~hgOz=#tE>;B`GKjT6((IW| zHF>gdgPu(IV*^^}x~S~X-esd*IkZ5>p7&44GE+_z!EIFxms%%9zgd&pL6j}hQLc(D zm`Xsz4DldKqiRI}+W8I75RvtWfQpO&2;hL=&dC;Ub2t27j3+=ZC`m&awnG$?K26}Y zs94MUcFLBj*f`_BX|#ek?sI|+g;c*DQj+9XH-sdg@0X>8d|Gb|18L@{-BY8m`O$_m zS_9Ff;T@;M+Ohc_y@w%C$rZX7S%-;d4A!A#h6z`;?BKo($!bHG&;G6Y;%=Nys- zW0D;nnPM12ECadrxQ;s}|7z?hj-{9p;cmpg5i?P2v%@AE!x@n#$G>kM-70EG12=Uj z6*JHwaLRr}EZ@d98PUss`gkE&<8( zd?S9zh?*#v@O6D6e>W_#NXAW^HilD{Er1z#ek;6Eh%D6p1u4xI7N}8>q4t*Bix?KK zX95`6o;qh=0J1zp*PJ@iByA;&nrzQ_%;+v~xyKl1l56JL1DGTI!HUBXcC+TO7`YEa z@}8cl#+>%W<(c-RE?Xbe)u>u*155GV4*K3uj?Ooj*{qZ;Hm&f1phR3WWo{$bdH!&2 z(HWO0>sg3n^2CgOM6VU`2t!>LZ5(7m(vL)8&Q?2o7kNy*re*W1k{)VVn)A~=+Qa4S zWP6m>Q}US4#!Q}TkLO|vbklHC=4kP^GA;@~dVS!svsTU&_J0@1seNw3ooH2n%>5=` zH=VDY(Qt3>c)gl9r4xMIk-56mu-&enGTn-mS;4hqw-PD;%+4-#k zKx8yM_QxR|MVR|!b&xDIslD!zC34W(XlM4dX@w~kiMx!Mlo9W4LmLIUif%L*8PCev z!L1g(x7nbOwv%)OsWk+QTo*-+?U#CvE~N$6LYW)4XpyF;aYv;lKRun4eBL?EJsc|>$K@=zLy6I;|GiO0DLR}fH& zXgQQa_swJPn}#{OP@Xdi=Qs26ml%iuQkgssZnGNbAjm|YGRbRzCp=w61m$h(G#ay zdjXdD8YRDti2zk`PdibCl)`Kh`~d`zmO=*=sRmU+6l&OrLqY8o`-f^Pf+<|LK!8>f zUK^-@PZ)(rsft#QSEnfUb~U}n#(Nk=kK=1T}zvbRJN8nj=Bh{ zRNN;}$Ll?LQu|%ZWU+HPANTyc zWZ{XMazh$NYjWu0(LqinJp={ngc}+%&kobEh{X)CSIG(pSA&i1?BkNkS=>Ki&{5d! z-++De(_P}JX{NcH_!vvW*uvRzEZr;o=sh`PJi0BQ+|5Aa2q+d}iu)BN)Giq%;Ce97 zN$b(J1R&JaJSMVpU@8DU1wi*e(0c40+OZwQ=?$YOsh_IiuI08byC1l}J2$Bjp;q94 zm~YY0NknTcrkc~i72rwzVH8wxV9KD#)Y*WQiP2Vi=+!-#D}ZYER26+<3ugjsmTah# z9LK~MLKaU-Ji2G6gl_MH2*97RQ>Jwor}{|&zz0B{umpSudo3*OT)1#pqZojg8IgHF zntT%k4|7gH9*C+9%=WmU<|xeU9vb57s#CRjDvU-2YfMw50%+BP5rf%OZ=IopEA+8< zp*~1BH)iBJ&V!iw`;w|fJ>0cwv5l+w06hwUnIj*%S92hHdrTH&9Ds*TidGhHra0El zR0GMDh!~_0Wl=Tszc?BqzMUiOtECOMDBysgDk=&WptguX1eAM6DC~6zi)c%*+urI_ zn7ObJ$CTOG9NsbVep(JjOi%+GtSH5i;Qlr}H5$>@BY^yJe6}|oZ^e(CR`j65Iz3K= zluD0`j#D#sakqP=Htb_$fAsIF0;KFk33M0`-^^({lIlx~5j0f8rX_N(KTwIO0HRrw zan?q$NL|L64~mWRMXD2+MPVKfI4FsBffSV$o_k3IUvPP9OfGREXZ*b=}u=sSz>eSAsMC?Pnn zp#u3NWZ@Q|gF@bC=SYPKSb`}TanFt+72pIP&jFt(FH%o@3hM-_Ryu^sok%FnY{Mc} z2U%1%N4jjAR>uoz#9@Lw)qqckp#9y&u^*pK0<<3MA+7u-erTWRQResj)1O368e&ol z=8;#qa4oRv?-6e?XE{cm&2rB+pyweHJ$f{0hLA~d1OiC|K=;g%7h*2#NfqM!yRfgs zc%J(bVhnq9TUXFTYPTm0`-&n%8@7k`@ZP>x1|6IHA%Zj|4@f@3jDkXiB}CJ6ki9)U znI2rCU{B682@5Q-!BxZUkVT8hK5hRI06FRs%UF?>{BDEqIY*Jb7w>WpSs25%OUa1( z{EQ;mB>-vZEa8+>2SUG17rZEuJ*7QmONl9rx#k6;{e_wYYhp!LiFTJ?RNovRJd|Up zsru#9gyM8C{&3@7fpQaNrK+Q4kQ2FFiYy+sATd z6;C=Zg!@>U@q727K?zG;-qs$92X9;u`(vb#-OVo0F;2%G^|h!27$dA+x)63ts4v1~ zWYN>#IV0Ql7VV6(c`RuCNyQV5NTG^){+P2==HlW6QM4aaJ~Qy;BwAX(sPU&(mQAlB zFfl*}W~QQg`JUetD&~CI&orzJZ)!QF{2_{mqkjNI#L>&)!Gxf!3RiNN0Tx3*7n&ge zSXwshWv^V8Ewz6f<#Ic!xcs|wx?rz*3zSR%9D6ZsZ zJceCgnzH+7FZ7W~J&iXHkt&8E=i6mSi{MxMoTEr_Gr^r(a$R19g++4FE_%g$tD?znkcxd$14QnJRDNA_!({5b# zz&n&BGA^>PxahoGmO31*l1vm@SS!(B^zu3#0Ffk|6~xfM&m$beN~@PD~(Y z>(hGXIHqs<(ba;*+oSP*a{?!|O>Aa1$Gxf@wemw+7m-pPG{B3k`SIx>j@vPwS9-5}Tw=yN*GCC_0 z5iIK0I%Pz(wkv#u9kqnV`b2%xC_K!Zlzjb?7ksjKqAunFVzLO+0U_mHD+3Tc)+(PK z&7U)@QW9MeR*10WaDr1!;k}t5i!Z6z$vdkJ*dcek@TRC`CLzz6<+xy+P{t-|j(gKI z7m`5aDUb(U@*aD3tsb@JTN&7%MJX4H)Rxu~0hUTGXhIm2glxi_%MXEx$=wt$)PYFj z6v^qrVGU^as*0bE2SAi^6E;Lyph_)tc%KRCAZ>3zxg(e6?%(+39>~*o9Xsqm89*Lk z4q;Gpr09+{9K00~*2Et{vE|5QOJO8sjX7*>;!qh8I9$>-C!BC|dKw-R-(5d!3edX`iz=UY0S9((?@MF!i%}$Q)&oNL44Ifso9JvD6Vx4;1X}$GC%<;ec{uIw zTWFW_F|tWe1)vC7!NF?--{EN|wk*F+4bAoK#3G8jx>>ka?^wsU|D*}{K2xT#yx zXf@c6AWI!O%u~xWI8@V3Ti&Ns2=R)Vy<`vvY-eG5dx94Cu`^UZwMipt5+VG|6eN&6 zhgP_T}F$9>A{q3 zyG~+M`nso@#WrOZN_8cx4-aX#0$o6FScp&YzHkfOxoAr&oND*m3w&h|#}uf~`*fzFpkgL>9T>r=l*6 z&-V!+Qz*c5Wr?oHxbiM55dcr@{eOyi>t~f7Zw5qTw#aV?LQ}(OO|S zUCqas4)+exDFMKYVlo?Z*!TA8B0x``A!Jv7syVZPxB=uH3-{`o0Mb&SqL696rR#Xs zvXkCmeCo&RvdVJi<%eEAqHnDzpd_v%gRDm^Ff-Gr2DAh>3Yg;5h4X_P#10CbUye)$ z77bfYMXM-CiygP30uYXEa@~VaL{w1f!E`~bfMMbn3S9J*= zTE+CFY}e`PtvG&wNP!euqmoY9ngOda0+T{rf=q&R4{Oz$I=`Q#D7jn^N=(j9XG^YI znK;F3k^B!gj6NDqY7qHJ*HBC)atROBj~cX(M8n`|l>+WgJ;gyX2}K*uDW16_<_$5L zVV(kF%S{F~Xno398fo~Sn(=v-BHh3}{-{fJrya?&_2nKih7qX1Py3xGmfm|6J)0Oi z{P1D$MquSVMU7i)9H_8~%&1^|-Ylzjz+q90(wtt2c3Mk({yEl@V+`{wFEyUfrCCgw zPQXV~(-)mvkEXTMtM?yv$H5XYrIt-~E@L;^LRrn2*jb1&i>)dwOT7G&!jK5!pw+UM z=n-Hu)y>^dK&4h31yHhhEnM!^aJq#eoZ`9TDZ6X6#gN*YJg3YoVAllP?Iz1IneDZJ z6uO95J{(^4U}~{TPIvTFIfI7Ug(0{I4SJL{>|9s02y@G3rKsVFa|zqC%4OaMTE$oj zaV0xA=pDDoZPglOq1Ndmv63UL(#@Yj!x2wWVkIyQqHsi*hPs!9lz`}n_jX+dky_-^ zeX&Wv-7CsK@KN4LChCUK?JM}&$uYS^#7Ke0;x_7JE6B5-sYcMv-sY-M5M%+srtP&} zrRoQqQ%xbOL-a8Mv??l%X%?M0Psw@ObDc%DoAB&;H&4|bq7R$r@YEXbJ#<+Ra(k%1rrleXbhvd-LBxEP`ifQvs}3h*1bioQ z-HOLv5>x^)YCTqz5JiV!ndw1LQ6VMAMh$Ngpvmuo98Gd8N-1a%fg?^@vb{7#%7WOb zpDx^PqeQgl%*eXEivVR2u;u`ux?HGJzims)bcrS~M5#wEQSlTQow~Hj#uR9gT7bh_ zHMJ>xY!f}c>AoFY7b!x+xcnJ0mr{mGL?Lbi%6rs?`59QB7SDFP_H@AAPI5YO)wntrI?}4MoN?m~* zt-NaCHH|q*8|6^bvVrPmPOB%cOc>vBL}J<_uEJ%&hUuR3D-VA0lYjmR%IB>6u>dSyK?O<+ik~{+uA&^V zF%(5nA@{&6HFkNNc~?M`N=d6Y>{IN~tVYzE4t*YN05jmBJ;0Ix=+2?@eF?iltao$c zp<3FnuA68TJ$ld|o6b*d%w=5MUR`mQ#V$c=E#A|DS}|I3+Z?98I>V0JssK`(&Rv)- z_)E>?9F`F1C&I*~B$18%^;!3x=>6?R!9%-MKk*J}IGf9`nd7c6~%wR`IMhHD@;$-Y~&|j2=&Q*a0)UnX)7Ei$R03xkD-kMFnt;%AwLbxOn5)_b7 zk4NC%6U-7LGopV479zYr6_GVhJ1GW^!c684W6t&>6+jvIFBNneH~NiK z9^FYx;7y2NVkR$D0W%KOI3W|^*vJV_X%vmWW^QNXg2A6+QJ5v1*6$f-^DVr(w{jNi z)FN|;2;)GdR)lFJ#Vqvv2{OUK^^*gO*(rn9gJXrB}7*|veKzNAFw z8z!*n6X%~uiN*74Sg=-;%i=HufPsfBYEMTNrs6~1>Cm=kJ1@puhh-#=0szbg+|1zT z&K_S4LEbbgc-KxuVO|N2(%_eyz@E#EH;Er|9T1vI0_56 ze<|(ul~yobW-c)glV9Gdb1c{fn2A$T0`raTaW_q4;mVagzaoJ>?`)XVcW2lY=TJON zLnXiutZDeWGUiDiitFlW5%36?%q7mtMWw z$GTd$v=Crhbp}Qh2$wj;vLOS#4>JB_<(MCk($2&C+%6O7f&nQiYScqjlP&OM*4}vf z#MKLm`QJcSxfp}Lk;EBkE603;iu;+EA(Ck#6+tUn?Psxsz_T5u^a-4a)?B8w&6x81 zjHK+sRT`lP_t(`d>kJ6y9L0T#2+Am#VyTAO((fg(k zIvnn>GIF~>JhRv%L35&vJtCN1v+n}_UkxV%MyG26*etZSkNoZdaQAqwP5uil81GTM zUuwD2zpvK(*ZaS;s(=CDSET0OY+V*M9SCzxoD9~ zp3xT;jalpa1^4}p*0sJ?9pPyx#rH%MNA81Xs^F#PY5kc`6rx$#oXp0XUM*5u*c%u$ zMWePYe)a7w#|-^2Y}U*w>Dym%?lP=Cb6dG+r7o@kxQDa-2x+)}N-DTpSa#~tdYFEJ zxb7;;xR}P*7@!HU-9EhD{-noWUVneSzoACAKbtVsgXdt5%ZpA7HTFyA!d89lUT)y@5E=_SIK=V0a(4X&!rg{ChfW zCUhH!mN5h&9W?kn5t+*iNLp0pG8D|o=6aIF+vIoqF>OIrlFE@GE>=aRzc2}ANRw9;!)y4jeK5e)&Uo!}S}g@2M@;sH4K<%~bf&4aeXJY@g}*Q> zGiDPk=nEdpGKmQaKDse5O3l@XajsuTNN=!4e=aj4asqJiHPES!N%Fn)TS`sHjkK42 z7I;`2h#GJ#ecOrBN_c!Nv-`|mCIQMdGkG8TVj8R2oo2BzVdPlrL^=Y~2E(9&78>eHl6jG}wy~-Cn*wm%BmZ=J$$h zy8=1AFxISEpsZKtU%T^EDm>$UbS(hvkYmp;UHa@lzqQ5|PokMAvLy@W|0O=>5;3_*%R^EkkcAB8YM}L^yc|>ZO-oke1GcOa z7@KIln33guJ?OpDZrQ~<^0TBV@#T;wcdD|pATd#8U$olkRX13c;0_R()4rax-ORd7 z1={&Zh>InWMQexUFyXJ}^Q{vZ$P%<*>I2dr4VRIXI|o?$USl5c$-j~WBHYmki@C+< zkhIiNkd=c4nKK)&5Q~|dGbs)mzj2bW7mqF8y_ouD`aIAXKVP!F*d}R_=~haRsifg$ z{B{ZH%=j1EY2h+6;d$xvH?uOExOMxr)WuenN# zTISu2-*^9P7}@rCSFx+?tt4E6j7f{AM2CKouioT=0a`LWi-fA_@iX`{BsT5cp{!>C=hq6(AwN|UZ@zc#ECwC+jq?Yhb47Lga$-v)yAU{r}TiV90;9E&HBvd~I>PJaMtWcUDX+ zZv(!vsU_B3dQ3~yFN?!hQyRYr*!tUTW+3hFeG3r#ms+9Vh5d^P%l$uSiy2@ETz(mF z@;ma(-&x<|0nV#?C_=VFx`nt-X!%TPWEo#j;pZGbgF*2Wh+yN^Pii-_^bjENMl9*Tt;jN2w1uixDAj8On!OOqU=dw8#w zetMa%%|Xo~>3VVg-_zvp7NXp6K;p$y07fE9Pl3^kLkR}o^9ZAivJeICl!G=8KqOXb*pbj;Vw{s+LV6q`=DvkaL%m$uNMBfpl92%hq_Ndfhe!??~A; zWkxgAW% zW8ksW56i#WM^&Hf0!5`k%Ml(PhT2Np{R`XFc|x}@EL5z= zw$06yA_pPGHZem}r|bs<1q7<$>Wr$wyf+S?6r;X+h67v$uRe?;Cea~~Mv7}dC=KuG z0y1<9Qyy4ya>~RY;{ZsDF!N>WpE)a0Hs>ZA(r+Y=k)W54(1i<3)UK6~giRh|hzhw# z;Dzd?Bk{+6=~*3<*Ei1nAB)oo)j7P3ytYn%7a;9|NE~^U6dr(qhwQxdYAo9iBXbfB zfq*5d&}O8}6#J%Wl)5C4$lR9GVNgE@KBv2#kN_oIg3T`ifJcgJ6%tK_KzA9<1JH!j z2_H#ZjwNY+ZuT5{-ry60g$T0nT-Y0Uyu@!tZ_&cu`5JEz$fpUeLe&k z+CWT{BN+>Z&x#7_UD&?@75}?7me064;xQ1-qS&5bJ7i;&`5|>OwU3w-*UocVDnQFY zkdF?a78EP#&KfCy7!}u-I@+X5agV_A=&^D|t+6#_yI2OLU~&$(m)fNZXiW4*1O z6sRqkM&@EzG34cCu=89pf^5@3Od}g}XNU04^=nj8!e9%M;Ji(%G#rIzMG#tNa9+kd z1dtV_&Bx{rFD@rei==relR&%xy%v$U`%3wOh>H=dj@kGp3GItbA=ne<%THc=tm>eP2tYo}F`yqE zB4hM{W8EAJ7D(5$Vwjknr$MO)v{DUR97o2vxdS*DS;-Zm)MUQLc{&~*0iW@l&C#Dj z%)V<+h$dsUnt)tHxP;vsVi$0WNDQR(Jo9kX z62a2Obw`r67H(}tl1n`2zp$+|L5dL!Fa^Fy+$c-nWwPboOmX-8;0dcv!;7kZX=|rb z8a*;0%&x|ke9t%I_*Ifr@622?n%tk7H#}4SvPFF_q-ZM}_5IygC+aQ0>2AyXl+*LC z%{aSc`K5Da{?hHHSyYz$UKjPD7~9{QH^1}AUurQ%@7F!{8(XJ&rR_jWza7%~qJ32| z=>1o2O5Xdg{(JAcwA+ys@$_GW|NX62!K#0Co87g)u)nrk^!rtk21~o~D7X5-wsUfr zy7;Sy@(#&sOPWF1xmgkj34x&SjyTB4D-fl;yrL=c&iKV!C2$eS<9h3U4ztQmxWkq} zfax=kGB*x+ACnN)5L?~ziQQg5tn-tJA7AjSNHD0zK@@)pD~p_9{X*7EJ6OqlSGvtI zuC808%#)XSybktB_N_{YTP%kR1DxJ1uBV=You7VV?hAz_7z6*}$azR$* z3E)?37W|Iz;9$AjAGr3l8ho~PJ!ZSw8a7GM(tpMMzv?sVs0Dy9b$xk!ezlR% zTa(rsk3L`7^@n$sC-M*uN>1ralnf4&BCdWoL^s!2_u!|b-EQENdHa|uL*o}d=?>8( zZU3bo4+L1xAqvCAISPJW?Tv4UUd{UUJ@#}I7k0DQ{BL^Xv_iDO#{EF6?G zxt;)7-lTSS#&lIoPg%8=amsaQPa`Qh^nK3G#k}|YbDNHenO!s%*7<$nYWG;j^Y`0_ zoCO$M>$1P;nFXOO%d3a0nHA&p>-%90yp{%`~6;K`-FId_imXx2$S&@>Y83Kw*?{>O0AWS*3u!+Dw8b5Vv=2bH8BF z^vl;wp|@LBh;#RFae2cigjZ*MkrydF$Xnuk`;ymWyfvY5=Q{_|1)wjsFJUI$XS`(E zq6L(U%Gll~fV;V8ZLjig2UR&MIK^gd`erZ#(PUjPHqT2rsqwlG&;nhrDZt85-Y#GEGmkvh4VZbQ>cqn_+t9?OkCb`fYxN3r>fs}=$w47TFJ4=+V zZr_ru@w7Ac1#i5T@Rrp)nG##AiY5d7&M^-!<&H~1#55I5iq{J9GR%a?PBL~X&C)##J}Da4n4F;N{6hJNux3!xjgm6V1D_noXH^1KR>HV-l@?<7v;Ko zyR+ikVjoy}c|=zFeq(fZ(^~|wl)DnQeWHPl*fhSTVLmj{o3@NOC*ZoyO^ViMT&(OG z_hTL?M(&9!@cR}~&2@NXQT|olEVu+IeY-$JQIs5l0`X8v+QK3*f@ZR|pz!MH@Nk@; zo=j-ydu+7Xe@&CYC1kyZieS6A7M^DDBJ{+UW~Xo4d%%oY&UG$x6=PeKrcP)1h9rGq zp8BSlIv6+5bEA{*CV^LC@~>`BcILO2NdT@KUf%Z6?P7u75$HEtJoN?)9{f`DF7f8x z&=&qwGW@TO?(c8K*9gef1SuRJc5M|L@T=`=3Vzkr?%#Rf%UiBhxc_1|zx7bO@Z!AF z1W(m51+ESV^*fSnf15u}_)G5gw|e|bkNGg#;4Uf`c;N>FfbjVAKTludISH`@VDlGG z-M?cXc`dZLW&UxA744fxYf_1d2&>@k*(ugPtI)}!C>S75h`${4X}{QGT2FOK1WU19 zpk!=M$l;-)4z}U$0Rcr?OYDU!SXy}7TVx`dAa%vqgweDEzd_RtS+CLjHd?$)p)dE3 z0}w%oPZgJYJ!b${pq_8$v1J$Gc9a)b?i?6al#XNIA-x)Hf&g+QdSrad`Mfg3ytS4! zg~(eZnT%%vS$ff5{ogj>EpihbvC37_*0y`CY$BDExGL*H04A}RpElX$Sw9>%y;^74 z|L@I~VraC6OlYDEk49WWNXtrDMvX7YR(-<`?M&_L((m=J0gu(F$a4a?Z6a}mjii=k zq}5M!u>QAgHzh1ROz&J0RPmyAd{YEide}#|6MrHud|m=<@Z@!C(F7EcxMzH>h=`b| z$-f20RRc|Lj{QF5jYmeAZ+?*P9_qc<>CYkuMBDs=I*@r?s;&xYvhxi-TqD_ zTA@z0J`lwbMdH?x^2&09CvEl{%Wk_w!ovY|@vs-38<)0&-1p{M5U4R0bq8i>_uf;2 z=(SxhU8yh|kauXnOF;s`u*j@iE6^U*_Cqq~iXA-0c%^YHEr?7gRG=hW`k=T0T(B-K zHM#dTOx=4JV(m1}E7z~DKbDIF-(a)LkpR@bVH&rLA#SZ&V>o}o5tK|e2o0!R10YHY zS)4Qz^TSc8ey?`kHniC#UfAa9W*4vMvGKspE>e-dIrOfwMQ6={+_`@5+6zWLgx4Wj zq_9pvm@yIG(aQ_l+uCYGz5zFxq-bs8Y7lw7;<5er@34<4m{+q12+JojcF!v1Qg(Bz zC)yGPuz(lz(K67LWfJnFU7*pamKv|y&%R;HVLNRefZa$y?Ul>kL|Xfh0@HQ?R1ps_ zI*qTZknE?%`6~D>r{m?`xX7kn;YL2o{N6QbmUh#xz?ZKNGzLqq*2MH8UUfMvy-<~Upw&8Olv`TFVvxxobt?f zha2nC#+TeG0^==YMzjq%@@_BBO7;#2)4$yZwP)D_u^jGYBA(92t~=fSFt^yUSH99{ zQh|E8k;V_KGt&g(yZiew**7|*NKq6Zw`W3c1~5K%JmzBn!{Ie@5MYz})jXOZCV$d0PV;~hItVES?L>SKWJCC%fz=;C_xQ`g{ zT^}g|6wCC91AgXK8%L*!?DG^Wf$-Q1CM^nURJn$^4Gok;)(Hc{p)S7Epi9qc;X^bQ z8C7VfL)QvWKZ?3y$tm2 zM9Bb7N1bf{%=tT4gZA!tDT@Zuk`Up3{z=hP3oQs?rn5EZKmZAH5zQMMpk%dk&x)if zf(XaYMKOtlHzH4wL*agU(jfzYk7Yz<%$i^W+mb%}a3cGVoXE+r)WwXUf->*jII&!!}(hRo~DvD5rlHh)mqvY6>myD1J^ zf&9Dugm@NNF$*^ch1xk$0xuR4fHjz~wDj99Fu{n&ska@d2sNGB!A4;#oGE0Rw~zfxA2KAj>xr17qGJJfKt}U?{Xu z0+Gq;P;(RxlRAz{(vVd}5y10h9}pNa8{~F7++F-L$s7P^oDq;iD2T8CR7LCrl#KAi z9_n{G0FiJ(kmv+~ToIk}v=n~hb4%4~Vatv%4|hCd$b>&YAndd_8f3HAb+SnS@DofF zF)%(q1MWZn{eR#;KK|SJF>uPx6Aeftg7|a;@R+F4>5_5>{BW5YBLLH0SW2!y&vAoU zx}ePDtbaLXDQGfF*oZ?aEK;R@UkFrFXk;>a-gtKSAzVDdYOq)yO&HnGti;tF`!W)-zIs|ZAu zB7$>r(31j&sc{J>wRD$iJJcc&X&pd{w}b*#mUs7*^Xo;fMk* z?hZgbnN%YrMrFhng9%3z?vdF-<{}d75dw&b!4YZ`Af$L+S(oaddt`7xrMPl~7>jX2 zAva;91({fPQIdI$Y>fbdABFx6_$dJVwDi_Hn9^eJf|SMsfEiRz>?Wraw4nsyVPQzM zy$5IxCBniy%B>Neo6b<8fCC38@U#Wn5mC(0hv1R(93F6Q@q}2BJeOHGa#sX=BJaUm z8;H+vhC_vL*y&D+BH4fF5X;ET0t8)&tq>^a_a?9lH!uCo|G;h zAMI8(Ofiprd%ORJr4SUr{``3w^z-w7{fC|Z9jNLt;bzI{6gWVbCnXV=GNKZQQm!>Y zIj5y-B94{|mJs&=kqvJ0sFJcZ)8dKn%3bmh1{9@$q0fer5SQITAl1!~JEiR+d}+T= zsgQX?z=lv_43G2p!d_uLohduz%!Ywx2ntLhnbM559Kr4a3dlHf3;N~)IDy_I%VzB0 zB*vPKI;gm5&k(Rv^)}SG0p;XhD7B~D3sQ=DVD(jCK+a;^^8HTcLW@os!xiM0Kz0-VgBGcyjJL`UihlhKxb3P zG;2qjTeusvat<|}J~GB^)|+fu2MeIU8X{{7_PjJDX~C2%(1k2ID6}vG#V8J~VuWdc zR7H71;uIqPW#cf*!^0g1RTyq@LWEKT$pAGd1?J`kO{fb4vNAjc=buQ#YHi05;BH|K zh!;*k+i=_y%gj_V;ZE$&G0l%z2f9#D4T#0`@VmK$Xq@}zOMd{O~QU&124MtUpn07JjoF1{1hiK>d8Dv25nRmB; zF8~Bpget_(G80ksnEqsUH8ceB0ur6b>mCKc4vOSHVI|iGfRtuXBzkyEh&a4L;id*u z0QaRy_kz^_BBT_K4<6EfF$*xk&)N18A{KY`;A>mWfFhG9SiI^bq*j_Kvf3`DE# zDh}W*lPG``C)cCm!c5hJUh>}q4rutrp_k;>f4UGVl0ugcNk6+z4{CFjl8~8ds+bUF zmQ=1y8MSKyFiZ9OAxZwbh<9uT6Plxi>rv<`7LJj%X5iVl(L9 zTCnDwurvsy5T%w=B^AzGv2ZL}Ke&Lo#fcP+18_G4A8zKNKMpM@b{7*5YdCw%b6u)Y zYDZSH_t;06rhR4sXqP1dsP(-mmJ}hhH0qrO&Ghz6-}JI}^d_6L6Q2-BDb2SA67C`x2h_@nM~(I+>~@wU`2uDLq&~UBT>^o{RzHP?K0*fCA0j2u zK6HCJYczDt1BjmhmkK02#Qu36`B?h*j>kU^{P_m}h)@~1@l|=qh?`8KG};b69PO#% zQ4~a0snLvtEMdN_B!`zYGEnn}>2k!73?pHwSCcW#aN>xpeE@NMa1|sfopTW(b%@_* zZVcFq3Xv1do&Sarey(ZdupU?#fFGbxK%t6zFpRT!p&(J;l$sRWXeLQRZHe2rdU%D4OgmakT_IP*p4BV~nZ9WpP45rMP?G zQTjxb2|+3F)6PGB;`sQXKOSaS56=Z7wghkj{y*~^Q}CfFVYffU0f87)dZ1-LfY6R$ zTHsAm+gUky$2n|)_)_b276Z+&=e(;@*OdYVPYkigWx&2A8=Dm!Kp_3jQB{G=&x|3} zLsdup4H0Sm*$Iio_V&GxYuZnj=!+OAN2*_b5O9n0 zr$2tci10We4g(ZNMa>}q9K*HZVP3>U;4t&kg8#Ii=jY=Ailem;2M~)0(?>3%)#Gr4 zf7)q}$@elEppkbehIj=x!nR-`nY11hw??ZfTXf7jhyMuxV4rx@{Av&g^{k#&qBu*c z4&Z+y%+B-t^nd(t1q2M$kz4>n2eND90lKOv6^Qb@^wO#&nPKFETHd#el*BI9i$3;togN27xsE4HrzdWq3;^^!6OC(GmIssxs_V z%k-uMZvZ4KpMT`TNdlFsP&xkVA0Ku~;!=wr_`t`%6}cvp>MuELAYfHsOomOROk0?r zKe&2&u?yobZ%nO+i{RDfhc54mVGd+c-dMBl+94Qa*Im>@fH>TvV&@m)Hz-z0X728O z2r6DfmPy{WLvazZ<5g=RCtsGb@I;tTGfJIWkxT#-5t`cW`LSt;U%!qi3dNF)suMta z3G!GSB5ioXk<;P8!H57z#+i#C?#d1lsG50U0y$FYMes=2lNt#C2>~?ypokzrM2KnG z&4mmg4u>A9hvESoRLzd6HpraO+yq3#BZWRF9@@Iqh|f#9Bg&qz4BilDm;w-5L8xun zKl99TQqd(cP8A1Kxh0t%`4zf6f2$+`BFw;-4n%4(+{LNtKU5DTBHT|Xr3PIL(w6}H zTZwBqzIx5y0tp@U_2lPQ1ARZU${{}h#CiVl$It)rqc8soaD~IdPjeSH`?NH`+}-!} zm^MeoV@Sg^yvj`j034asM=%(!25S0RBz-Q6!Dnu=^J&&7INETP^>x}}m!AlPg}axi zp&4!xNdXlE>2Rp4A2^QTqQVHrS;Hvd2Xb?}TK=8+(`D+^L(?kAM3;2vf+eB=pvQ;G z*ag>Cx@$@u9`5)&kK-h^I-~cG+H??1bx_qvg&qfm{&4$oWGsnM4oW!%TM3P+%FIo@ zlprh?p_6aS51G{iS66@!o|1gg0mzZ4Lf8G~1zVbNn3-oXlpe+jC~^M$`S|1U4+@V= z!#xl@$}-6|LV?MdCNJs%Z!^U8l8paWdNUlTa)%kuzGRDK+!yC_yxtpQtKlD`wkO!;m}_>}3dz(!=TE#BuOQ zF}8$-^{Zm5jX7l&++18N0Oc|lph`!MrBB&;2$=vN9*i&2xt33XiQ#~L0A_^${PZNi z;(`O^N<^Clc9GgR0HV_*4+uo{p;B>1iO*V3X|2;GX`v3exE!!0o`RE3)dt4)NySP8 zW%Fo~VW9w(?b?&gX)*7djw5|QQl_gAj&#Q$ ziYTRdn<4^)_-2YrUE;{om-7^541+%)%A>xJT6Im+8zlhr5rC>5LN###ltM`e4nPE6 z2%q^UVS@kcA|D@oZ1Lnvok9SRP*ePvRwPwbW@YBgu+~FKJRIPMikt}GP{yJb0Z3qa zVsMO7IflsJY$Vf@2u`13s`_P88y810&7Rg2DVE@`b#lvdZ2f8uZyIpWT!eA{IFBFt zAWPvPGv=n%fsr}9F`kj6)q|W&z4c5q`S4mn?>m-sidF7PErVSuTc3pyt*j)%@vI#M9b@q3DQh@ke{ZRb>UUjJn7#SY0!s? zyYRii4Axa%j01zdFjEOq#wcNh5;^RyeIaRNFPm(Il^21_fQsIrHM5#z#J$4jAbv!+ zbfi7iKRlB&L*k*H`6&%siuB1>>?INEz{dxQvksYsfMw)aI1XnS&X@7^QDRq%%ZjFB zB8shYQvyAw1{8b{S$VSK%1C5nUC~Z#s#u;Y1q!iJj*?q*-g2W6U?_+WJf!(k;sg$U z5&MbX{#sr)|2)ex0bwWQ#)uq9HQN-y15{BNCZH+>eVe&`nUV@9R{#vtM+hktA_NRI zfFcwfd{2o^4A2xXL=vVTgDns0>2jz7NsyJoa4K>F7d=v(v?K}wY5=eWgR9t1%h#xg zxo!Bl$xG2FUh5fTb;Phl_!zSeVRTWYYiV=QqzxTizcT*7X^qWxJz&e?hNi4Y;Xt?+}$m>yX)XCA&}ti8enjDcXyYa-)`-nyZi0C zRr981s$RXmefrAjK9S0b(x^y;NKjBvsIoGWs!&j$x1gZlPY_@rzu3s?IzVpFE~?Vv zP=CjXkD#E)p=2e+)PF*s=A1bb4aeEt*|oLNny-JLPP}Gk%ru%twmP+MS1v-EQb*%Z zx4o45vnk6Mn!rYmGSJXJKi}QmS-yhK{{`Pq-__}%b7+ol1omc?xax(57z zH9tl8d4jiz@|UPqhU))n9&p|M^FR!9rm9H)fB1^;f8!P@ zJ7+xp-ThyUzsNx7KM$GV(uJXV{Lo)_2p;D0qYsV=YoAG3F$4jK1Hc5BtI3YhE`=G%mCnpsZjQY_RkS|+~mv_(4&-?p>3&y%E1_lOd9Q{hc z(O}ulogxFl9CRojUthh@R>K^F9Wr1{0|!drA4aDMNx0Xpc|zdb@$vEgzpfMi52CQP z)>c3vBRo3aFOevy6`wWdrE;DIf7+`mA?pbdUXT6xo9AaQKr3y3t@i)tLP*y%Tp)Pc za(sNgV+?oNTg;JQAKx?3*GCKQyScg9`X@5}etv##@BiAD*jFV;c!MC{13QA8yM4#- z^KV&zLayM5Mz5;)WkBstMUSTUUHR~8Nx`0Of(}LUBfJ=BH|%Y-Vpi^VS#B(zu*lvt zrRlBgb4mM=TbQk@-1GHyFXeS#bygM;p5pxc^8sQTHmzrmP_%SkuOKlR)Atk}9v*ab zbjg;E4zrx3ME$C&DgaJ4d|ZcIh^(0WKUA^USKOqqmNt>g;T|v;d=u~QV`(~NZ~uNL zE&h`l4d7;;V%$p%c+3nP#3+*UYpf|_ca#SNWVN9*)Ff#Hqb1_zRXtMBnP)`zhp7-N zbQh+;Hl)frc`g9?zU-AvvOR|*X8e?0Dk%J5vuB+Ae?z<(WA#bQ`%06;$J@ro*w(^Y zyuYX1fY{}XL}|<y6+Z>ZZn~TUx2wb7M1xQ!h&)9lNL94iozJ{w4rpQPtGc zlqc-#TmW5yOuMg@cF}v#a|@a1nVDn-G-2?~9t2`1CoeBAN_oNrxA*sHTEu$>dU{vo zD>pYBEZk7wj0Fgu>CNC(J0VwF+l^_S(#0cPVfMm~*+|;>Gcnrdw1X|jpI%;GK0dEE z6Cw~O{jI7Z^LzaoHKo^XSqV#U^_!g_@Z;^p!zKAEO zWIs`CnF<2o!)e-Vmz_%Hk7{C^b}TGt!Ym;s6uc9Dy`46)J(M@4iw@WWh zTFEh^*8Le#nVzTA$K|D?hsVR^Ww*-a*%`B-ARbQzXq_R{!dfUs-ogae$ovGeFc@#7`7cW@vhCDk`D5P~tc=55@`+99{N z%3(#HX(b%`&P0^t30vK2P>FfLUbYsCSv4pqv{Jb2`{_D3q(<8)-Z<`jM zD!B+>AkK$G;Jv*)$P<=+K_F&2k~^w#`k6r%c06}VL|7Q0Hp=B)d$K^uRu&&0pMAuk zmM7xh+0|u1k>d7mHIN>Vqg3ZqJ4(T1^8tzD6I8k+8pFed#_kA_yTJ0b##dks-Q?pR^}b+w z=T|bM7f0ti@|r0_XsFR@cGwm!$os>cI2?yYsB%mv$hX6{wp;JyvjiYKlzAtF45h>f&D6_18qhs)Agb()M~zTG*dsMg{J? zF4J?xZT7hQNT-z>Ng6*T(3Owj3n+!-s;CnLsP=+t4fg=(xzM8_TYNXHfN6gj+G{s! zxs_(@4y$u%a@x2w8!6gnyLEOGB)qdPl0TaKGH?>>J>gI`{}L5_q}o!^?<+FtI@R%T{q%9QeW zQ_3DYon5nh;hRIZ4;xK;5O*HPKB{@V{D@`xbY3eeDjYUCoz&kTfb<)R7I&IPmG#>J zOUNg@onC@LtPoH^5WjDEh{J32@%FG$_4n_uV!@|WihFE=-Vt;M$Il5I&#M%Wc;4yr zBra0)Ad_P%jTI%*R*9O4Yc{FnH$J>%F4=~6r%9S0 zJW@8Lox#DdT7)yEkvU-NmqB%qW|s2oZDPjCz>RqRSNx(SUeCY)HVOL}4mS|!<12S@ zPAzFPK)ppw_{ms-ulP!LNYaweTk9W|o-dM_UkBWb`QU&GCZ|hW{pd=^J^f+U2qiFJ zQk~vRQ__hElu~#(LAZZzokh`{*vjF(bIBfa3z^)<#jM6e3G+;`Jrk)6^79UuM!DWJ zEnTD&%hC)vt;BC#S;0F|U$7ErtD)|f=%3?aXj*VHKL1W?n`$w*G@Jz5iTQvuyD3hM zLH^q(+a1F}ysk;)6+-&dPBb_$^BUQ+n}>CrEC5Y%GvYJr2YwIrJP=mG)O%`>z7Q7+ z3m<+UZB5}Qu#+zZohk$PBQxcK|BkDwK5s}g13ry_CtP*>8mSOk+mvP8fm`+yzudJW z?_o4lshHh$?m(J3maDMjh?FV3S)9)Ku)C!i$|#Od)jVoJ8%mE}S-a4@9l6uTM%!n$Df)w)#8liT9uOAv2I{^5XoQ7kYP% zH$GJ(tqyAA*9p9B%W2K(3HUFAaJHSm7{B_|VG>2Xkt?q$LXtCL3F~>%E_jV@DJ&)q zv;{Ye=b?=hk?|nTB9QEZ=BOB*u}R=Xcf&2Z@AKG0osNdOCd9E!xK>nVR4H+e<9Lb4 z^gt6i6}$XPv)Wh?xVEwJa!$7){6se#ZdVP{&kDGiN-;PeT$>xY*sUIHD1b5j{9}Yv z(`oS7lShF5WW325A$Pf}vvZ#i?sabuJ^>PaBA!Z|8Rh@TjI8ZI*3^ONMm+9P10DVf zWYIF_2?PZ|Q$fmu^qe9NG@<*N*8w8n77gMoBm;U9mM;6aiqZ4Ng%8fn;kL0G*wRMv zIVXS3HrVxW*{M^q7$F%YbsT}z7hOJ2*N=}wJ}Sgr*}}SjbsXp|2h2z6dPoer3L}(86qoc^q-o&6Aiex8G*Y0abZ2-9-@vt8I^P3Nj z2QM)x8QImHyONzY`Fj;^`$Tc|Dni7$z-PROa0M3Yy00EQ)I5~JLtQN`kfgu2L;OBk zc+o1XcvZbsb=z!GT|Ta9nM==R!^fqV;2rlG&GrgTHSWuUPyb1<2WXou^n5WFm-RV} zOX`0Dgmj{$`kWT(gI;=zYtrRjePz5w*NwQZ))DZVuRT% z?MNGhNWPx+SoHT#%p_Q&m%bVsi$|x#@Y=`t<7aR+b+w1Mo^H9UJVyfzH+mZ!U)0VR zQ2K!YIcxCMC_BqBOllr%QEhKBp+zmrf8;aM%P9~+=xc>5_Zjs7fw+-1Jp25WQ9_EK zmvrOfG5%xIkAk|VL*X$zrsQ{HU?eh(g}-3zN(O!U*L$xkiy(QYPGbjwny#nML4Kj% zw8%86x)WX;6+cS=66N1>c;-wf5|}FHKBG%`Y+YSV!TivHGrrpG!!F{YO;b6)xbQqb zv-LIIV}_mhMGkTlY`!*}@%()ysilDV^HUa6ny!s0Rq}N{a%~a+G=mR(|8Ywiu4_|C zU?H@RYG@y%>3QLJX`J{F{`)AOg>96wiU?F_-z8$xcMr_1_i}A$f;}q_*qASb_3S&8 zC?C`b0@65qHa8-$^K%?={k2JONuo zY&;=0n$>CTM-vqFQbzt(WdQ5emEAt1ptfRS0tSRC{UJUcL{kWzcAmHLf`^T)v>=E&uwjOtOlKvp6#`?=C)1Vq++YY!yI*E zh~OWWgGrj#3(-r)A|pIhr3HqxcXZ3u1Xn4+OOX1?ViK)|-dpll+eFZ%6YG3F!cq!~ zHqQ$niwnA8bj5ueTu0XeXMkZ>Ts&Cv&2xC_g)W8IIl5=9gpN?0g^D*{wgUk%$$8!& z$rJnfuWlg-NDH+05$sM(z!Yfe&xna4?{q=x%ZATQ@WOk9`DT&U>O?pYm(Z`u(qy;6 zabiY*2$x|SxjOzcIe+j*d!7DCBT#5u&Gu1L7<;04)ss5LumU?}Y!+^BSl2Pd6Vhfu zx`l<>7aINIBSv%c6vXFrN^#HPLCyVIm{l;&=CJnfixW=rgo(B%nvLPOUzt-#>YDk3IAzrK*0jg=K0fA&wmAUAiz ziC{?E2Pf-Hg{0g*vb22@i0ahfI#O$SAK-P)X7}Dv3l(L`;ww`6;N;5aD62#jV|8N*(oe22nmv*A_I?**0GI0PmvugKLUxe zdZ(shn9eVSH945ah6{VX{hWU|I*%!ord;bAFkaK6I-*6LB{sh=wsfb-e7!;vI!99_ z2~tMQa4nSnAK!O2p?Dwc-8{uf0d4B3!>=>|fN0xjOq>n192^vs$l=2CwHUZvM z#Gu7jVq2}{)HX@1a^PNM zlv6cxO2o|Ly|xa2oDXfIBD*#_(k&R3v1hdpMjG#IS}@Z0MCuz?JI){iV?a}*V^P^K zwvN!{q+ZQe>I0{S*e&`cBVb&*qC!f#kVm+CEB<+^r;l9z+W)*I#1->aRAV0yCgSQM zRhf(ZFYmS`dK!u(c8Lnvhu(xcwasIAsHt|ITM^%&chA}MKZDB`!~Na1;X})(FRWERo7BKvUPKKEkhAK z-Go2ljrgc-`cKO#BwAfxXZ;)qgCP{6<|KmIqqYO z@sK2AprvB7n}-||keD#!jnN~(xX5)C7zN^IXOnxdS>cSf-(pMJ+X-`9BsUwix?c+; z5DqX^0x*qDV|_dNyF~qsIVMLKw4m#0m)njrHbFg-kxfM-w6+a2elzG|F{)_pi%*2bT83 zXutOMgPDrteCw2B%twYgVM+ok`9Cwq+FLHOW=*OFGx6X7rPwh#G|$TfH9UJyf4K0~ z5&cwimoR6&>xU)o!aG&mUKoEI4l%V+7%|?`L0ec@n3$NzJrfiW@rU$8{vQwi?0!Fg z@_OYa%&jCnA7r&2YR$#g+rStsK&=kOp${BNGO{op)Lp&abNpoes)B2yInQeap3$ zGr{1L7Ahjc>-S|-OCK_8qiR)3=C`K74r|tNrP)I}7Ft;wkq%j9l${R(*)J^EkNzmh z{vKMbmfXa%KULN7aztI8VTClZ_(<$fFv_^0HT`s1)~Laoj70_SA#U7~>GMo)0P7?$ z0yzFoY6R@pCC-|>rKq?XDFqaQM*w^(uVkcLz+|)B8VW^`5Rz)r_Wv z4@3HT1zW|l#v7b|Q2m|QJ>h|)~cyL0)9 zuGYF{bbsQ9@IvyryGAp%PYI!v2)v<@k`FPKlPsE3MF=ZySTXM*aOnj~}*;VLy!Qsf&&L;>X zkK!HWsn6 znJu*QM|}OS$qFx1_19%-YEqsoKZ~B@OuAqu5|U9VVVbCM2{fk(blxdJ9^Qhqvp~sOGYtWzZ)}3TTHAQHA4bGXA z3UrUow@uC#h5|7XTNEY!Nw%ZM-s8ijcA%J?yY6*b_WBn>Dg-W%!W{hCM*rGyr>6IL z3Lc>*F`8emDJA~+>0=XC`F9UZ60(7Qbz@oxD0}ZMsSd|>0qP7ljQz7c8~$}nw_m6- znq$xaB&puDo8QRkOS^B6{6RXUF>SB7vjb@w9CD_=z<%pn3n%jtyWw)V>Z~-hgm<80xfCCcpNn1x^4JMzpdt9pP2_zl zxjL2S9)|P~HI6^2=)z-Z7@Ogu49WN-zi7QOk;CKnfME)A4?}~CyjlcQEKt)mXz@EN zzqAQbGYR>(i=mbsS9-0%hr~xGDxLBoBo%Nc-DZyv8GP(#dmLOV2uEayTOs}k-KgUV zZ9<@h5dVULmwnAo(!{R{2`5Mly8B5cA|s|$f1K9US}^y2gF9vMom3rrRkck;U!U7g zGA6?ezu%lv`>$_X7b%N7A`)24vaq++I^Fszo|gFE~+MPb~9sY z_gz~Ia!h1|CpRgGO2p_Z_qa}GH*>9!lBn*+D(?UrEEqr_Jae)sMJZ~Ka_7Gj=}Srk z8~#>s&yqZ=S&(%$u49CXou%PPo|l;~bc)3w7wh^TKItHgAjHCOJp_~|IbO_WPRo|! ze-TNw1SLg8@Z_ET<6|KdP{^KiHR1#?tAFcCIyhADc9uU$9#su%V2oDAm-qCnWOZ6i zie2}|^88(=m5Fr~1#4r>Q-tOsIIWFce|F)-OX#d!CaexE&CrSB8m8IU{tD1Z>pC{M zp@mKdLvIuo8~rTI{Ct-~8gSqKxTLsWxP;eyjs)j?PM29HibHxAlN7`Y*%|s$(St(6 z!ro;j`l2#CyyeWAKecyCQfHboBP}s9)@IbY$VTTTT{XRZdBEj`m! zo&c0~!CyVF$N86JPj^{dbIopgN+gw7yCROy#maidI62B)m6nu_ym-;ad0&Q1l&`u+hYwcI{9>GCCRygHqXWIPuK~kn|VxhwTu92v8G8M1{c*w?Jo<4iaZ|FnjsI$ zw26gV+Xruo8u$T0)k^X10wjCoB_5nVf<~(Iv*pC-cq<~CAw(>Z1;SE721(ZtsA~sQ zG?d-D3u0`GCFHTY;A&K0;W^ZH^ayBc6X>e0>VWz7)6ehytZBo?tKbc?Q}hIj=@&Jl z5g`aU81R3c1*mGjtlUd#N)~D{5wFXzTbNGUPY-%gWl%F85fsHqCUDY!4b?$H2)YPx z7nZpd9}c0=2vn0rU+G>Hjnu;ddh=?EiS19j%GB8kw-#@bi7Y({vmNGown)%Kd}kg} zW8J!_a#dyFIe1f{%3cZOut7SfUqBvGtd<)uc|1YP$~=BHD9( zxmLws8WwVrq~k=8gI{&v!uw;{thTYSL4;2;i)SJShwU#HND>TR5xtpf_ggHWINs-U zbRG3iRuhNz);Kx?|3#(T`%d>8a-A{*sBQcZf{G_Fz)x=4`R3_Ugs>esZ{i?$+~paU z?F6LJPeIlw>5dS4(ZQ9DfX4$XmP(;%(ip17E9O45&hYP+MNu3`jvvo*%Ia#Q0RTmz zpz7ffg#x}x`#Sd2q~UT>Vq~7;9V$i63dbOA;!xCJBmnDOQ%388yUk zYI?nZ&%cj4f>-F*1jx4y3fe&5r7SE=1*sw_5u~9S>nWSmFv=VrG2A1%OG%w!I4a-5 zjS5oM_?kMjY*G{`)}mPhT^jA&T5VHa<0{2o&Vmq8ldV>bu=o?bmL`q!D;`|B-z(4}=v zr3oe@Q(TPOtgi8jT)y-vJxA|Ax0{%-mXeMv{Blp5jZfw-z8l3SPsw8mhwG;r)YEvY1iK5e7;(_;Vl4HIU!q3%!e!! zd#%nLaq&h&wNX7l6C)iy9*EMjzq3&)y1%v6qXbvtk*h4HC%TI$d+@_|Sx1UT9vIj$ zNRX0QZT6(YqjgOWV8IuhOpWkc61GH3p!yB9?Dd@Uj`J@}QDq>7!*2Ki)a#CbI zL?MgBwX2*Wyj1vrGE!^U-3EJMUymV{OhK+_CL2!ch{z`0iJB-%n9e2VJYhP++h>Hx zBaxs^dm1I0(1lKPUf;-`MPZk$!?;>GnqWOVfH(&(me~-|HmTc7&#h7y5fT!DY$OTD z{9{oXa@|q&L;=jGa_aOlF=2M5#4Y@}Q~jb!V8D!ny-Ol#-^UcQevsq%Ng>Q!n(1Ek z%B+waA#QkyKVYKtPX@x16a7Z#f%lwyRo>9`CPl_g2!vr~QW0rB!7T>1_oPS@1DYyj z>qYsn(?$5V#{p!^!2T zCA2bwKobA{W`91uSA2GqDe+M)8XcpN5D?QKcOd=2fRI|34+t%YzSX_RbQ7g>>T<&I z4vPXb!I(NgVF5i-vBi1^Xso`rMG(sgZ}0v}ryHQCQnxNAkJCrl3z_C<>D%o~Q06yQ za^+?(!r1}v7h8*AJew|At*tqm>0;u@E05uA@#Ui%nVpP}*fNVsn2efbgvw*UcF3iU zf&@x01hLts$YTh&JtZdE7V$oc$6{n;0raRha!$&w5VUzB4Y6EwrtUH!<5IS&v?1#|!mB)Z|WO1{5GaQ2!lc(uE{a~PV4JG>S8iP83z`5BqBGdsj@~F2F%quwf8_}V>N^C`g9ZhSU5d2(D)m>QJh;b9+X zQE0FMV_>leWABQVeS1+9vp_?Y0XMs2>}nP zUMF;JsnNBSr4+3&nSE{@!fdK65F_V}`2KewqhXLLA=bH1h_TQ#iuu`aW;Nxno-f2H zEg$mk-(o!P;(G`35QL#@c7#-7vGq9d81C?hOUiMx{s1)-E&xn^`^|UI3`flsH=Y*r zGpC|A=moC^qS;lZbe~f@a)=9=;CkgXv}IwJ!speJ46mK=%}G^Dx|GR1c`{!^T2=@FW>9$0c7G0>=5F;4DrgGHmX6To)JtNkC4`HG7I#pee3Q7GDj{3z>&LUGy6R~)G){X7-K0u7A=qGo7wBYhCnEHo z+P+0|XT*VH^`!hspK?!+6DA8)H>y6GeYKk6c65^}#wEc<7j*PR(ZE@A;%h`vA!d%| z;Zf4u(CqD*V4Y2WfL9T7nn2}?9a@gTC)9>Kn*1lf?cbZm@_wmCME)|BUBAwUXM+I`TW*+!{Q5g}voLiG|H zeVRVfp6gDbAFb^&vVO=LxAV}LbO}6;a$v-sD&g_lZ#lB#yNQ*Gd%XF-P^%a}+(msG zhSy5*SNj`yei4QQ%@o8f;|Kd$1+5ZnrJ-=qeFSG`X_ao!8e`R<7qA!hP9{yYo1|sQ zh!uIQYLn;1hjJEFb{Jh$46KK;(iM zky}PAG|4OxYy5nXZnj$xS&a=@gG9*f0V=lM%&Zn6(l%%+bQNKB)xyk#aB#drb)=_J5z9<9f?&!M%wBpPg zGH5uTGTr8dKNyB4=`niqD~mXl$7zvFR8*&3IoMmP7cH2K)VftT;Pio%Em5dtP}oRj z-qqC4b?SUv!&_9I3j{(D@91p0=0rU!G<7ydejh{Uhkl$H?YZCC8{O%7vF%Zy6-XL5)QF6vuUxbVI1EXm@MF0+#H|qLF*1{n<%l-y?4`M&ao*| z<07b7f_EbluvrYD(7Bls#rY{-zK$;!1;&3mTaz2=I)^247bS+d5^~A;d5R3 zNbN!gz3sxH7CKwL(m>~bJtRWrI^06ad1}7lgWn=+s+Ksg+^z68+U0kI?jd~F=oz%M zH~JSD=@47=)j8Ts1s(qIaLsOxDhM}RWBUCRT!Qdz(JD>9w8|M_I@P*XI8w@ebih$c zlFbzf(M)@qe2+ri;lh2WQHeYbF;?S3G11BQkhipfMBo~3 z>(V@i*RVr|TX*C>-H-}wPtB}8#X>E&=LMA5i!+G6D9j|Un6P=0G&f*ZilNz(*WGu! zOqU7zV#HM?OpASeW|SO9+6Y%ra76lCNT0HJl940uSYn^L^n}GCWa|7czMV;vO&*{9 znD`aIUY0r1OxL8`^^+4O*?XyO^U~9Hw`uL2)lvbmDjnx+pLK4|;JW^sb4|4s2grrA zY4yQ^v*y-RO_;!|V)MAE8FdP&mK*7kDSc1XBuiNfF3ZA_uSV7zTi(&PX7o2eJ#OF7 zenrcgy=NG%1FTf*QgIOy3JA$GJ}uEs&*^lOfdl=y?ZzxV(L+Nq!$C@VtQ9vLYE2dS z_ixae_hS8G5wG391(=?%rnY_Ff>TVS6C0`UAQ#JpS%AD~lX0$7OFlp@raDjB1KvI_ zwh#&*4Ep-`8>$vWB1vN<5q|kl`fdTc)-;oAbDujU@vU+dUR_^u==mIO6mX;}_m$~6 zDNf%TZa%lF8G$ZCNLhkNWco{7r^->Q0x@4*S2}PRhp+2m$6TEljDr&rZ6Mc2L=-(= zo+mx(>u<>?TgLglT;f{n{8L|qz*tx(wpn0_FkMH_rhPI#evikz#tVxrg$J-{Gg|{M z`avWtOko|G7JE7NATzl(T_U5j!Ohw=J47H;J;Rt?L@J>L#;L?^{?Pjzw4LEL)PRot zq|2~MEDeKzXEZ&mExLHT$B_PcY)Unj_}H27VJg}Z&=w8V317?;T%z$4`F&&9!$Qmp zIW<+d{|NiaujIvz|8l`-dj=2Wn!$pnxnJ4RQe0kX~-2q_}^Lz`jfyQRO(BoW5)!&Cj?fTAYw9 z6^M@i;>?!u5+6vPL)MZplW&m?^a`n#DAY8MLh6Q+{A0Jn^%8 zNj0COY*Uybr6BZDBrH3)L>a+`dv?MKMQ_BnY}2E=a2Rp9_kz3ci0CiAZ{!JR>S>sy zvwJKdO@}k?*du4^K#9r87KAJNWZ5qC>827uoM!E+ZZb7x2^H(S)Uw5O+c1C)*J8u( zJVm8+U-c?R5jzGPD;M98OL8G~A^UdkLU^O_z_h0FtBL3fA%M@U_;kbFcA&PgbO-08 z5H&NVPyruK{g9iiR2FUMK9_h_`MXV9gTs$BID7>$4z7VtB13vI)(o}PH&}~Rconv6 zacG=Igyo6Qq);X1K4*peB*!j%fLFQJG~2HriEngpkZk#&s~{9T%3~(lS{j^JR)9SU z-veX=@0HK+Q>6LI-~i4r>tN`Wx?O(3@@KjvnlrJFs#Zx!OV1(bhX{?v2jPrH>!wA@ zprK`$$ESPZZrH!ha1A@sW~jnp)Jnu{qXge4-OIUW{pBNk6NKf>vUL_fzYNkR(+FW6 z?;zwv?023mL$HV5%O`u0Zq|hdJhL4sQgLN2K$Ta8fxBx+DzIu>pje10MTG*Q*{jvlx+S3h8l64E&_Hqnr}1tc>!t zPl6^Ea@__TX}Kb)>xp+T8Q}ixW|VMMdUFOfnyR9fGUQqoY&arVkf$n?+@dFa0he+f zp=pa12M&$7F---t+&FoB1M&Lx_vd$sXbBqWR7j1g{rb9(mM51nI0aQkC~wUkJ|ba9 zWDLMgEVk3mb2>~NkY>6C_JSzt4iqlb^2CSALgG^R999pS$dpNqV<|L8x{OYs^SN5Nr19D>!nHK_OXC+N5Zc1!3Bb*y!Ee! zW~IphPNtxsv)`Ng&po3eG`jQsl%|#^`J0Eb$?I!91fNJ4VqcnYoGFEc#gN8{?=nVw zicW|W>Jzeu3;bsgFCs8O2yl;gFF=}~I z9-5VG0d0{>Qw75~#CK~BhDL7ef5n@octdl{n_YMQ^34H;MLP}C!1W&UIL_)c^TqLL z@AM!m5yYvhHkty}-0sq)64MA=uVIRcKiNb-0X-@nq4l28Oo7bH4$vPJFF&%kURe1( zA7PnvW+W2{8YCi;PGA(I4iKhkRJwt`-qFx7L~@lzg#}`k5fQT-T#)vwdB0^SJLe_` z=4K@Q*tRref?{@%rM+P;aASIQRXHanp4RIrz!6Q~G(?GrEvUZp`}Y?}vE!a`O_Q9` z=8IK#nt66L_meV0jUj))Y+y}j^l%sWIpwf9d1?XZMp;T4RZN=84)^L|jT z*aD268Dz4YD8z0YmLqF!cY{_KWihqvXbo6W+&S-5lh8K@N!O4QQzwMC|NUOavbQ{Z z9BWP>RB#9_KoPD=YF-@JPz(5$ECAA1m2*tZL=APNzf0+xtf6aT9}4~Sdc)en2Il&n zaO0frNBDDv#VJ~$>-2RdOoc76fk)YTnv_@?n8-2W=}dVcNq0N42WRSES&19q?b8;! zms4HKc>iUE0_s?xN5oA=9-kFKsO@j!T)Ei6{ikDU2C4yy=z87Hm4Jlt>PFdoZUF~ZeDN5rKigH zWg!|{;tB!pnpv*ixXklNL9@~qmsapJ=mz%plK z5$KW}9%QJQQH%pb@jH7bnZ{v%QWoEXw61ZwY`cP+h@8a7elq}P87NMtR-j9H$yqN_ ziU?JePA>&CP^0S(kWd&T93gSHbjRGAcOD8NvTTkLlXLdk~(3SBMn(8`YF-xy`(tKK^JqRL~F`u%FqN$^k(Eo8(4604j z`;uAC>E+=QU8>&gXlxwN=_s1PLOe5*Chgzahv8zh@NkI!e`OujZB~R#o>tGo%UjOo~-qsD@;vv0F*GBPeToR9{QrE?B%ddud8|dgYXi zdQH>)G=6TMD6f0VO@@do#v&l`E$>n2_~LQ`;iQ$YLZ&M$+XV&E6o3)^V%#CbVd6am z%cn~ZQ6`F(BLkkae5^Sx{Xg=RJ9LG5DDpVL1F0z~;C2w0;$2ow zE$gSOxpAEfor?vnJPdUksYk`N6f45uJm*{&_lT}o6P74|ntCPCEf3C`xe{#|zDJ8g6 zxFzExj_))!hpI!nF(_xzs>_FFzx3Zf1%3a)@O76_1e5hgWao!7M2QAD_6<>sKx9EZ zzTUHMuQX{IWlCizxKRqnv=k!{ArQ7?3-W-C-;sN1Mu7D?OTh4Wp$|hP@-#!qzIy#b zb-2>~FqNE!i6wVG`ySx9a!&!chvEOrHS0@UZUN^QmBd0S4wST&PAR?(k|@f!N!y0a zkfT3lcIA1}&&sHtI zKkZZ9Fb<&u%EHusfBi*J9AC;EUjx~+=4BqEDH6T64P$)#u={kOdL>lp#lW6HL1SpJ z9fwjQsK%xdL$05>PRJ|RT|SI+G58)YOHs6*>8M}+B^m*ad24?z|HgCdgPZ0FYzOmg zvH*1M&uo-*x`Mr=MrXI0)5^Ab>*~tM?2^^v2rKqpfG7wLwgoYBF#) zt&|rg@@t~3b8f1k54^VU5(5_eYhblVuTZBPW$FMMZN_JOu$Mb z>t-7(yJ$bgs5tEvW8LlTAOKN*I&Q*n39%#_a*=42mKQy>pSM)D>|~LI_r(7q3K$Gz z5w{|Vy(0ZY(18!5Fa_!;im^{LJ%9S{Wvd%y_Ksyl+sq=`qKP$2{7tRM1hbyWi#0>+ zvPt8p+`mX{vS@YpGBK!9#s{laQ(_}hQ+U|wg2@zIo?XNjRh52>=?r9$cwq(iFZqQX zu9yv;E$tnu5N2cotqxPu2vJV79mC@28ko5ErX9WE*tymX68^Y`9QW$r?rgkUQfZ*sMg1@kUOu^KHIF^h!z9|&;XjPcVVAL5E8tOGQMGw=28Ja!& zye!fp>f6Zytv<==JN>N}9g?aSx)JGsN|vM2(Ma+rkrj~&zyU71jp%%qY1)a@*ruLV%WE*!siNi^iz#G> z4n-4YFCl$RiVmKHqYwcBJKI>>USHZml91#;k1L}Rm(6&=lro3o-bKC#GmIiip@!4` zin)#h?&*boczGl%|GRj#M)J}y3|^Jb%f(hOg;&!_T!KX~pcq7+R+WGBD4eAMybE>DVOY}p5hq9!xm>w|3`^AihovEc;^{3*}C)_Vwv?cD= zmW<`qd5a}XN^+N{`FsWR7nNE`@*XQMbc&RRsYj2CDQWaOZk)=-in~P|ezS%!emxY| zC1@qr_%YXY`J?vHqE-RS9CzO4c3>K?x3w-}HpSw!PXBnfPc(48$HUbDnyC|hL*+y{ z%3x%>CM^)g!!UlCLUg|7LC(GtG}~2dDleQ%}wc zCqy*^z;BV8;wrya?o8qG`^E3YC_lG%($+s^RTfTZRQHeeaSEbl+ACf-ny}C1qO)cm zoT~7%s46!LbO}WtOhqSh8q1Vl)TyvwF{gU33vbA@PyD<);~vG&d(t>KhJQI`c#Yz( zdUrx^*=Q#k45wy!V*HZ9syt`mPI^1J_<`=X-U*%YVgC3f|MyvdfOb7=^x{u)p#=z7 zEN+KG3H>!+ke$`L6RmON%*XtHtxU+Qsk+v;`_f|?_s$?i%nvKAat)ft?~#HK30C6? zwW!;`%}B#b<4i*xp{|g(-@Jx4{P1tmf2{x!?|qTc4)Ph0#mPlVm$T zbYJv8Iovu=2fD5AYEXH#X^1kTDeBQD4^&~CAGX|7uKF#3T@dnRJ^^pJ@K1Cv)oQtfp}4btP0mn~y39XS)Ud{F zG)ycz;Jg#^Q!!VTilpM6^0@pA<6gl|nsX8|%NN(zS*i+@6z=joaOgDN&(9RAf`>l! zCTLutTa)HW9J(PfQxEtIdI=up#XBm{-60AYsP~r7LPbR^(vcl&`E~qJ8TEB&^knc$ zRtYuj@Q2=?Jbe$u;{}>F2!&FOY9_LNqO+5o-Fs`W>kA}iI34J1QDJD`I_%Rxa9};`{BQFbo07ATt$H@{NIJf>M(ocv@qXM*b30YqXg_1?XWp2dt}D z3GF#j7BB!kg%=xaq>nQ;jT#(PwWNW=%+9vm@ARc+=Yo@i<-X%LiD!K2Zo|L5H(N!8 z--{r*%uI25lJmG+&_Y_9SG;7{BXwxOm?AZ1Y}<^D{ilvP*&mLeVfdqA1$oYX@eJky z;n2RVP2r0k!(mMy<~DQv!9OaF&o;|C5-EECX5V9FE6UPrZn`ysZWh zh2s1EK4dF=3nCyoKOZ;onn-*qkVWVb=o9Eko;j{38}aq>%HOsOoUSE~KH1JLVb2Mq zA-R(abhMJ{G-KXMGB00R25ff!b6r$RaQ?e&1myo)W7A{&JPEgzh&L)jBuH|w1F=lbN23d#LI!dMHSjYb z{=an_Ndtv~qaHy=bHP5nkTK}`0=P8=rNRX#%cW&sO%C;-rn5EF^#!d^(q1zKhf+xQ z)So9$V&#xQQ)#!P(h8?b8tmbTy*o25-WM1ZpHV|dpy>C+rKt+?#BnQDS)^M`Omi49 zl_d~ErmQfeD$bT!>Qf$~Z7Ge?4a8I^HbebTSsdq=6NF@onZ^!f%~jg-!_euH2I;;f zr~OHC;jeE7Qn_ESAPOe|<`URqm}In{N12Z@JKD%R11UR-y_Xv75%e->dO4cPQ)Mf2 zDw>YNh-GxEb%(xtl(HRGrXx(ugzCcZF+ek-m|72^rGhRp#H$!Mn)Y*>;<9xq+aa1M zC=|22)MhKzNqUg?;LqbGLLrbt)B&h1K=ld$mdlJ{h>4B%8Xtw#r3-rkb+7%QeM~|q z;k-<LMmN9x)P?{yq#4KGj>q<2p)*%IHD>(E{!X8%r zNd|g3%TCjfXHSQ?<#++Wgmu#{JPlX$B|6Qiv0qpuBYbV(;_GE6?~uYCn?m(yT)}(& z8FCiVaxTl$n)o1uMuROJ9ZNb}_C*hVf*4UDe`CWc<=;T)UMe%BG+g7bveN_vL6VrE zOz^|ukZiX?6n)1j;fjGF6iP9Zc8Mi(X$zuet9n>!mV(n^0gF%=4liW_0rAt=Kp3Zs zw2Ly`l{~pyN;wZBOVS!cZwJ!ezmS5qF)@-`?InJUrap-QE8CpBpHLeUwu6 zL}F2yi4!^G(Ul~Bb_p_E-d*HVB1)c!xbwlF=^$*ih{kgEnBGn`3Q$~1DLHGv{|?Nh zcR@qAb8*<3nPQwF1W_n_3@Rlw{LdKt5eFn~01d=UL7WU^g}Y^HlwGKa21veYUj)6> zv)YrA>)%)!BUtd%Cqn9ramU2K=`J|f`==*Pae>W<%4q{m2d5ji{tvfeFEV=YGfEoR z8z?oiyc(yVnL>^ZWdPGYlQmqgyerYABz~f)912;YQkE@{bQxl%5)iW(ayF2H2wSn# zCuhBkq8UTbkc^`Wi7=6|XM>vf=1``lUSSf8p>#)1%>>6GS7;Uo5N!$#To_FoSFx28 z6NHRaFnc=bVp0l;oE(O*7^m-+*$}qi4{?gk1fQX-mBt-JjX|@v$+pNw5y2=aFbcRK z(m+|lYKkxqq;Z-lEA%Z(M}^^zSJF?w94a}MOGBi4${KW`*YG4q0gG3;)C|GVtwf4_ z@!G2P8S8WyXs6OFk`GF&nwLyywn561pk?h8OF|?W4CJ8wR<+f4kfXjDq>zLK@9C$D zvi1rNoh_7EnBZ6eQjh~e;%GTRd&>~`zOs+W=P2^TvM|rfOtXYYz?8H3aRIQ{6twP@ z+nu93p)!RY$i^EE8MlLwLMGxPghGPna@H$hb6u1ivvetoqhJ=PNm+M7OQ5v0I4QV= z7C5JUnuSnZD83l%akK|IW@?7`X)u>za(#WB#}plNSe7BO zO_(_Xn2$X;nGH>Dcg{RRk_4b4ki6z2$gzu%yLqP zrH;u~rJI;3a3+>jO2?E1k$*vxA;rgDC5vTi^=&QK0s4b6Qm6OlZ*fT(- z`_YI=%&wqN<SPV~mrCN=rIRboM=ETZCz3pSEBPzt1wXeFu6B;8MvjWT3=64Xv( z11W4d$}J7>($`9&v8mGK7m?+xU}u`egsMF@u@P{%#qEib2=hS0QCpYMJrT1SCq+-k zd7!i$(oQADbHKEJKe=c6}C}$2PJK><$Q0U-8GXv$Op^_4H4nru5 zlcOpp)lU1AOI$8{56c$c?o|vjM3K{1*)MJmLu*!`G|q|WMSxq{6r8@>OwySQbyzgI z$V5vtCgLp~VR9D`VIuHr8C0)?mXbZ$W5Fu9nNFXPuIa?EA&}tRQL0X*yMdpp;iW;w z(zqy%i=KWc##t84#F1(qra8JL=(S}q*YgqSNf9T2yUyreUteE-{Np>_eneKPQ&tp{ zVY?LL38!}*+FyPDL?9Poa?5UGR&2+d9wTCJhoucA^@BKFC~5vONfJ;_CMqu?Fl)R* zMtQ3&>X~|TaaR=q;q5$27iN45ng>!d_5&K2U*b-cRT}yXI2SK`!{^@-6k*>ATbHQdyV%x#WAnD08U&S?^hopn1bG^v}xfz2ok$ zo~76+Opr|~ZFAUEg43i>EK42A=(>E53OLIOCqhszY^ zmW+0L=co*o%RS&1v?*nQjJK@`H-@w~YtvMdY_lJVrAv6|SUM-~M;#|47MbRpyZE~) zQnC)_J4Yx%w=Q>`(H{CoAh|Mg`x?q@i*sq-9bn{f)22P9C-;9lrk6AA&vLTNg%y4%F(2@KoZcDk7k-) z|DVWNZBkZqwD?(~Vq7joPM7_1qLmrvGL>mO43YgXG$;swqs%}<-?u0;5bx^^>ZEMp zV_BG|FEfK~HDO!&3QHWt)Lo4PjHS)~sWg_pTY_;B{Fe5X{TcebXY`Mc zk2g0r&(F{I_xCR^FZ`Vg@nmUr6wV-YDHnGo=uI|`VML~Lcql)y&!Me`K+h}Ov@CV= zyZPy22))!e5o&e{1@@sCpo^~(EC-dBX^B?l{#1-4Su>H z`Q)ZD>7_yHmGQ!?>_6qQzhUdorNROztopf-Y)xkf;wXUSGI5MZI>pk__Y;O>GMto( zWw}h3xm+4p;{-IQqX>P{i@~Xv88qKkcuUHN^EoO|$z(EQUfP?xf zxw)8yap|J`e*Muvdkl7+(ew5B$H&Kqhll(7d;a5CDCYO*(e$Xf0Jdzp*V{D~nj+>g z{m%b&GUY8B6UpU)qnx#Yi8WC; z%5ZK#XoF^vGvbhsv>}s}dO_wieznoew{Uxp)a;P=05AMY=R0eLR_KmDMRO@W_I3hJ zCVH5xz6z|+z66Hu=P5JRsR(8*&r=b~9bNY_Q%x{kmR4wCz)o3gHn14*o6Yv4NAV<;8GfzArl!+LGPJPpnw#Eos}tG zzsM!zGrpKy4mA!lDQ3P&R*ZM_t7v_omekkc{u>NxMDfd;RoM1{Hh zQ@}=d`ef*sUbYiT?XxBps%-BXD*$rzHNlS>W03#r^%?GyD7((+UteFJo}R9+uU}qX zo}Zr|9v=KkKhJ(W;RVRn^%Ll+9+fc z(-c`V1#OBTu>_R%mhsm7Vh_|72sTnRM6a+zX9!NT;oL+fXfoHP)W58G&E6thB=Mv3 z==^3&sDyvHd`nXLz6Yk@3MQp+bjR2CmlgJu4x3_`ML3$Bz6!YHdMQI6T))KUO-5$=u}- zfNCa_yFc_EOSg24Ke9JWcG#tR$Zy&7>UGVQZ|b|38iY(C9gD12(R+Cm$F>~09Cg?0 zJfY(cGy2HpIWLj)>M8Uhr+t@2KU+I^)lH|vgjG>M69xIOM$HYd%(7RblzvlCK2X}UcNf!W?kN`x zDg!7i5#GwOU!OzAol20wv}i+LIhRop&?nWDi`NHV_SEDy6uN!S z?(HeioDh&kfxYZ>+kr;eimSojQrMc`J<0Zpxyf|*w*(T+hzflkHSW(MNiXGe*)N+B z!d8FwK*iCB=t(VKdm?6?F5>)xLe3ZTlDP%h!#o|e7au_z1uajCrI+|yb1^p%=Ocx! zhP*6?4@kTx!X);|9j4Z2T#dre@eF0BItTfH>PaAD`DDvzr`NAL@@47?U zy6ZJGQ>i@~E{js*vxOv+;3QS%F%5deUWek|U4EjbQh}#%Xgj#Csb^hCo{rC;7q$`{I?C z)Bz1Q`jqq5?{6q!kgo={s$EDMK;ud$!O^;8$P)Z9J**}42M^D(GgnxoyRVB6{Iy#xXlO^|%k zRhq*~@rR|*Y&g251d~@L$louLTgJsEWA&-WzUPitqHVD{NpCo7=+u)!kC+-|XHAX5 zNqn+6-O+CBL#ZKjfy&EX_R?bnN*4{z%PZ-18O(gOf4cDnHOyK9zDIV6|Fh(tSDD=X z#1bkOORgZ$<{=WNM=!n@>w?gyuj8a9*`}N}dt|vOZ0!}Un$piW>aKvjX{P%gV%WST zwf#{}waldOEm^FsU$(8^)HCUqQOcE#MVp%TJ@@)Ck9^MMni+L&JVZ>63ayfK4 zRmoS3LB3QjR!QMhR+qBRiluxh{KP5v<#M=pQShH$rOYCE7GmXc&$g*c*;Pn9OQdBd zlbUoo5J#`q8dAl;JIz;0pCDlwpIYG1>CZ&sJrJisYDjC|k zX^K3|Vy;YI<^Jp~XHrW`@zX{nmRY4z9HDekm<(ytg&_@TPs&@Ke-b${Q%;*AZ%vkF zJ8`rh3PX^ga_FAQiPw1(k>Ed3p3nGEVkP%sm5R*}6GzBk@2d! zHJuDY*|dEV&>dkyqga-eWl~n4+ZWBzSjoKjUh0w%^FU@~h28G@)XbqSMLVBKirgtp zf;t69y|gs<6l?~~x^Ohagy%^^<;EnF0>WD8tctx0*&K24|6tc1p;5MxmebazZkP46SkqVisl8!s@P2EY&OY&t(g;i5R zbhZV@%42Ck3eG!SCYh}e!xS`zaN4A-*+m49hxiw-n=@OMz%cqnvO5pN8GIwLH@crh z{ykz{5Yv*fmtMBD`g+OIWoRD)Qb=RuGZH_;rN_Ovrm&(=`Bz{4ujo$VAie_bXWuUh zPI(UA$*s)zPOme}d>Zbw&p?~F4DpA`2?#@Tuld59j~)$uhQS3Rmc-|mL#q496!6~0 zLY=)*h78|NDPcmC%TwdBZ~*DGnxLhlRRzJPKHVqCg!Z*qW_DX7yYF9RDy>hZsd9d2 zwB}pBJKZy!@z>6Fs!UFDs9BGq>#^O4|m9eFvY3a2tjM`rVkiY1xS65y9@8T+D~GvCi`i;Q_G zY(?DDS|v@POpR$$KNPk=hQ<@+o>;jZ^$KLleU#8f85#_g6V8_!+TR#EBj$?m7C`Q0 z$k93SrDk~^WoxuVCxu?Lt?4smg&xS0dWUQkG>5}s_&slEB*P?@dgv8c!zp0k$*uYn zl8JzRzxn3o=H=xj?a!8XozZ8KvMC|2udfT~V!)+PTXQ+|VqZAb1t@n7g`G>HFiH0^ zWFUlIBKp!lCcuDOiv>wcm8LxD>~wsKY%F(SX>`~eLQZ$=O|T5!X@oL`YUCZ-JN8@)CIu$QF3fC%8jHrK2YaQY}R;mlI48v?;!_)l!Wv zCkb@j5Tt~5O>N-=(!I9qi(bbenPS{+OhlaGGQ8|KL$g%sfXus`S-F6MaB^zES}^3XV^Z)h-7&M|dyiWM9>PZ$=qlPP9mWoP2V0f_!wS;Os9rWQzOIa2RBiJ_~z565%}ix9~S&NxxibR)kZ@r~5@{ zC*T?Kc~e#bWivDM7Fa8~pViYP~4tiA{*Re*?zyd?{(VBB<3SKh^)Wis?SLrF##2`9+BN;!&4DGragX_k4ZH(ZW#(xOcnI`uM%d4|)Un)ZY% zP=$%-GxE=+I`=J5mbB;rDZSTg*fj;mHy~ZV$G3aUHP$u@GIYu4dSRJE-8ai?eRM$( zP-8Ut+L14=kri>XCP^$gcjiM@Zqyw)?K4X1hcd?5+mg}VjMS7RV2<5VO@~c1J2s(U zm5xq5zMh@pu5UrM)Cz7CSZ0Xg>t!e7Pzn|wr5`X5;&3?d%kb%Pp1kXf{`U6v)2B~& zcXtmD5B*1W%7+_#dXVS!S65eFTI*6QYFeh5@91T}YF6A!@>`?gTUH&*P&UC98q@Dh z0yAIrGIwJc-D&05WM zaN%ItHA@3P@()!Q)mQ=k2BkB-B#JrqsS#%`Y(=LO8ID-cu&D}oN9!6~WS$0FuqDc# zOJNmk1ClZ|g&}N?%2~@CRcQkZ?YlA^k>Q-owb_cOK@k!P`BVe|hh8#tJsQ2(bE&;% zxdydKGi3z#kRDOX0zPDtHptA2v!fS*h+9Gw!g2$!Tn-~<=q!b+yC{=Y8G@Vqd$_#K zl|+WdLz|&;=nmDb`>8HRtAwSAYcCUr#B>|i#vzQmUW3UNRBCHng{`<5E{zR35%852 zmx3sWpncKEt+?3s+9M=qHK|Oww4zYPN@JCpr8}c(pJqqp0=|W#+18x)K)UpyqOnCY zuVS-xsc(iuHkTZl;A{=q3B^GCqHguMDF6T<07*naR6lx|d=kVhI+a7TL`Z{lOgU|k ziIq53@~C4+n`q`}=_nZ&ul-O!w8X$mzE_k_TskTkQ7@x7lmt{N2$cxgB&pX}_m2@W z?n!(~?&%A2kbTWS6u~w=nyJ3ItCWadD&(X~!&qXfnG4!0Xx}vs^`7au<8D1O$HXb} zJZKuTV0~q%xcB#}#h_efk(G;0a!}S-O&7Y&9^{TQ)D-ZoYM&i(;+Ub4Q+Opa0r zqXH7hQ3QN@?m)>?uM*Mfp{E)-cLgE8pPfNW4~4 z_Xsx0)zuZ#>W|HQ|Ni~)@$vij@4x-_8$+ekd+@c{bw;l>lSjQ=uK5@4wxGxB8oTyL z3Ct{gDKtgom01+ZRq7s>Lg}z1Uu40H{%Aoppa@<%@kt(V8?nSePs?GO!&nBbX(mUIGU($3MMESDC) z>l0)mCqvBCB&Ot3xu=aq8*%_`Vlx>^Kv@<0a*2z^&Ugw5JCxIXXpl+>bQd*+VYy7G z{j!s#i?G@Gjw;AXje-bjia<~hCO8ajp>64hv5Jz*Awm{p!Yx-*;<(bm$)V1HQKRUh zrn{gSPEC)sg`;H({TbcSEgD5Xx6jc+tY79V=(xW=60=YWIi##$EHy(R>E*UOG|nBv zOciw58Cv@-VR%D0#zOFtxL%f6g;g2tmjyfx=7G{OyCP*D@X~lF z@1)%+rRF4%Aq|y4C15Xjj_SB2boZg9?V8}0w1AXuPnRLM?!|H#bcm2j(Nc-*AxTXzfJp`g3YP>?-($@+?qg={q=4U}YypbkK7Ss9IEGd*v^HqG%<5^ZO|N9J z>6aqQ!TBo2R?=`ZiS|SnFsr1EH)tCy#+_Oz5TAT<)Q} zy;DiA9u9}+AOD_y{QLU#>wo^|f9C9Wggu(QXY|j{&%$xE>e{vikg-s%he2D#)4pMs!chjM5lQ27#W zvYQtugCZn(EkScg{ZYZ)8A~U~mMcB51xRRL<-BD-)YGw<=Fse@5*o$K;*_Q$oP^Ui z<$`wfGJR8?J9f*WDdZ=2xOt%SMw5&c>m8D2$Z331=$^0cTbNsV9PMy%y1TjH-+kvAR{Eaww{R{?YlQQZTW6P@5GXHpY+XE*^U$P<@B{_V@(navbR6m7PMVSm(Y z%f0BgW+cssm~r=bCBja5IGY)FCyrA*v8RB5W2VO1Dok)DLskhKv-1+)!XYmw;KLy! zDx}%|boOxAW0TP*aw&+GJqsTr_va$oQDJLUUL;oLxTkd5?2nF%B_dzCPBew1)p(0R zR#Kb{4auBec*+(8Us=&WTIY80y0`^h~>~eeJ?1REQj8_a!mjI$G?mGB>k>4 z`j;R7o}Zteo}S>rFW&fFY|>`g@Kt&>Sw{?*9=DIJV|ph^d%8!*)LVBxCrBHICW2Eg zW*TRwrv5E*c2deiOg`-xnq`&n9hwzbD(NRY#ie5w_nntRoa~34I774CO11*&I5cn+ zp%fuUb@%;wj{X(pNwR;%bmY7dR!wa44)HvxU}!1=V|7c zo&0%Gw!9__e;9hsb}Py+uBTOo`Ti{CA48@*@SmFO#hYOW=t4e~-p{fhX7RJgoD}y` z%qKVwUA)8J0w}AK$~80|LjARR*qg#ImtofXm6K^Y8qNcUNw}d6$dk|=Fpc~4G3xgh zH7>%@jEJjOr-5cC&X&9SOW_E3RIr!2<&cbpE%q8K6odD^EIrVt>|KcwouFHR_So#N z(q!WHgQR87Y^fe=)>pmcKx!mjd^J8#=p}Wc_XmQQ^CH3-l!~vHlp+t-(c~W`Y=skK ze@46^!oGNc=I`P7O>WN_w6`ET-?xICY{@rqhB+E>IC_$jbU5_(K$S1lpM*0p-g`#> z{QUg=`}f0-f54S;xM1?0hg?qKt*pmD{X5+hk(})+C%epn6}Lu{gtvwO0a-we?f5jy zLnSS@gyPuEvVeUQ4W%d*PUBLU971LWOC@tgy30j0Sy)LbOhU-b{Z}uB^v$xQai2|H zQpnGB5-QydosPe_+&Op6FP=iDcXTzmw{+ik(qx}_`!Uw9Q}g8MGTFoPC#K*^Px5kJ zLRMfnO+zJK`%5|jITZ@~0=S<^=KB`;D1kIcIrBxIg8pky)knvCXKFfpwO8XpTMIQ>z)7#pa7W7b0#_q+sQ!p&HC8Brn8wqy_b zw+yy^(SBk-8L|RfHhajQ1Y!XvZ{j*&sqGe9^&P>Xiwjwz%#J{pVp5g^mxQ)BC6+eH z@M!v5#&6t1dfc87Hl(w)5K4th%00?Xjai$f$POKa>b|;|>`pYyI-odx$XEy^km;~z z=4Em0mo`|z^wLiYZf9AlClw{5XO$B?0qJ=AK8JS7 zTgXPYJ_7ndh+n18cEsLSr$hIlkiEqZX!w6tbOJ+!vz1nWKzS^F6f-9}ah#DPufb8+ zV&E)i6J~|2e{uY)T%KK-UogSRT$D7+<=b-+(B9~nHl)Vg=CYcd3rb?8fG(xZDpQ!4 zb;qNcMAq14m{c8ILaD&8hX0Sfw_A>5xtVq)QTBT8|7IPZZAv@B8T*Nh1PWdKGbGot zb-+NO5{U$=x~8W&8U|)He0DWgS=@h3Em3R<=e%RX+>+GUxN2OF+b!EoCyP~8-DDoZ zNeZTVUR^k;|7V=-z=KPpb)WYh>1Np3Dk`2$I3z+$4IexM;ShCUDiX!;0^t`7sYS7H zgIc06t}SJx5D5o3oSp?cVqZ6WHY02pFH*jk8Zb>4}1$DOM1JsXK-@%4?BMSFS8z6exg`+z~@8S%%*s0S==TLsx4>5nhL_7zjy6 zEAa3|@T;VR)TGrTa8UVBd9^)alkmy!x3@QxdkQo|=rB3}%wu0_OAimXc|!i<$B&;s zfByU5|JL`-+|;o9jJ~Fcj&RxVT{k>ir->W^ELEk&L&4fi9L>Hwx=7&Pd`L|SmYj=C z9xu)J6S6%JwzJ0Sfm$W6dR*1nyq|@SD)wct;w&`lM1?&P$suwoTXr- zzYak@Sm25(vaet_{SRgdsu*tSJR5ZuzbWI-2#d|B&g`6lU%!WgLVrtsXVqvIB-P{Z z`hg8k0K|ZJ43DjLtYZc2dxq6V%v0%{2XZyXhpl*GF)8ptUWR+|1pLj+ePr#ALuMzYK`uH5Ze^Q$e zdMah=1^?dxxvZ8v8nX7lwDyu0Az-Qjo3cw1C%&Bg6xa_A;RUGVhaOgrjjOsyBnF3} z%?+1ynAAC8j=umLOw7j}A2 z&MwyGX8sFz&-aga5*x#jZ9_o*mAX3A(l&%9v@QCxJL7o#vzN1}|8PyYITzBqL~OfT zHU$71cB3$xSx^P@#~7a1?T^X6ndMnwl}(En{?%}EL3c_c1qM;_R6l^HjKd9lDp3fI z;VG&+;Aiu~hJm)~Vd}oYTVrmb4i_r`+N%=jXJBZ%T*c+U5U@F%FTHtoGlgK$MjFU0 zY~BH$oVXGJ;-~l>1|ddhz<W#^KQ+{q$WLNh z{(9MR{Sx?~p_P>q_Dm~mNa_u|vsFTjGPYvKD9wD?$slrPDspijsK<$iyMl+e$Rnvd zT3oWwt1zB=5=i#h@E+>RNPhhI@%O*~T~*fy+B4f~cJ~=QzZMWt{c;-~(38nON6(tk zWnDiEeQj`J#4LUc|NQ~EP*M#7V-G2jX4xEm0U+BYRetw4oBW(67=vao_31fB!@d}A zlx+P}7V+>uA-swQZEx%jE&W#@Lt?oyy;n4+_MbpEd`q}rHk#|ypV6aoC~dC&3l`X} zX%tmu-!GFC><3;XxIEc-RluLiJud`gmov4gPHu)4roa5za6{` zdg3pd*|^=nhDVEX9{kJmU{7n@Qamvocg&46vYoL2-4?VRbui1J)&v#s-O&|T{$?~eJ;Oo;u*WM#jnKe7kHq-TnBo$EHZC#BkudKtAuGdc5s%3IF&+G?N;wz>Xq!e+ zu7oUynhyahZJsXdx3@Q``uX#xYW%qGqyO>a#~*+Ep)bPcAusKypP)xNAEjS)MEi{0 zMxYz4w4BQ8%f>-0!1wRp^{qfoa%hJJA1W78$>Lk>kUs#fdDR@>CCcR)iDE;mGm$8U zfMfUT7b2vDu@9+MJ_JL}i+WH*5p3(pP?|=7iyrJWKu-~_ZY?oNqhN}pP@eMw-5`)EnjVaie zg4PW#?+TO032PvpHoQ8)$MJz$0CjtX68}#eQ~_;(owl_-Fk+b^FaY@5Dty*$kvO^E z0Sv7ZNoeq$ARav6ozraqF3-hyE(FV2d7Nah6KGIok#83JUfzR0k4~NZEkBdmDg7vKVUpNBBS$uIY79>%g~hopZ=qxM#1)~$P|{Abxhi8jNkkN`7u{LXe-Z48ff z+xbcA06!|j556T~7Go0z9^*pbD&*NECJP3d)wk7hIBeBb$M_q%HkX6v8V|#r>UDM% z8Ny`g-&*r+kADMX8MJ-{J+PFhO{ z{3bw`UVNX4sKmgVaaT(&VR+~iU|`A;rJ*qVF?2By4hG?BI9Y~}It7Ugh85`^FLTbj zNhtDqJmSGXMtB&K(S@-mabiFyLn{lLU=Ci{WVCN2rWj%9C|#~^(e4+wF6W+Wx%i4 z9rfN&UnKXl+epVIMiTpjFaB3{UmG3-i(EtgFM}97ucxbQUL8@M&PC#+c1Vt9wXyzM8wOSZPZ+Mm?SPRn{B>hgfP3H}7lt1cI6Zc-X@L;rgqtY0*v4dbV zE70X(v*P++Z*|kUhE_lnvKpe3Uyz?YPeMryDb@|vWu>ZuYY4qk#`=?{xg=)}e@!vS zYo~Mr!=CqbkxfRBt|ux&zYJzcO(Hxp97)E&>}9TK?_i>Js}!gFs)AY+ z>mp_EbN~{FN9KXfjf-snuU3#S(g<*1>=wr z8o6M2d=}c1`h3CJIEkW;J9=^4Pu9MHW>=Y%7Konw1_;6i3kNu=1q- zp;hE@)`47gk^;HOCxlwU6WfVODQcCg@~Eo{)aQcZ`JV3zx`!|_dh^MmXMM5gBIKZ2-uKu>vo(9joVopWW^rh|;b z6hDSHSE~gZJBiQ!>mfA&NHADtzus`N8z_@N87thMQWpAGRob>H40ub5~T zGJG8sReJ(Brtr&XySMY=SGCDg{gE+-D**w6mM+l*JXAESa?pB6*g@L{zQU>Xx}Uu= z%sU}!sp}Giu*qP!YJMg3h6g#zElkX^KjjxQ{Jc0;VNv6Sp>`b^D}$1TU~i84!^Kh= z0JKxozUp&CNwAzQgY%XidLT#)pFLC<;GLm&jHK>_M6*>k2f|K^f;sjZxpoYv8aBou zmGc~eY0)9_ae((f$l29xA8@WJt^R9eiidO(iMG(}yQNO;cv_LluJ9JH!(1CuqgwJi z`?;p59;&N`gVBcJ$B`os?P$eNV4K2MUt-uKO6~lz@gN?NOx0L0b*l0N_}cISEg>?Z zoSRn!J8B>=|aXFOI=9fj<*JeCp5?GY8c90b{i4^hT`GROzQcmKmS!B)a7jn4a&=! zk^-X@*8Z0ch0HxvcCIE@h!Woe{-R9J{ro)C>9x1Dh@ou@cv9oJV7Sys=Vgi+RWiJ* zEY_ewct_HCk8(-w*An>mlhgB1?onuVCy#K$=|kz{Q>SbIwOtv>%jN;*Rrst@cms8f zINoLK+gs1*TYYl+!jRRU=Er*1N@@+&1M>yL1$cO?+yPV_&YMG4@g~nlhD$RWcPI5H zmdO>qqqD`t4ur6F03=2|0oxRZ&Yk^vNFso=Rq>nQz^DR`&Y5}D;SS+g8%Co)Jtjd9QGf)4BCYOpn914c!RnycxU~r7^=S3&qFb~*z58g z2Ce`IUIAY1_v7m@mzK{Lv4-qdw2!P=!qcvZ^UJOY)1H3M!Vk-Gp9q_iu@z} zXuhV3@VOyW1Rl@p4CShI>0|i%bht3C$~}tp*=uU!c#K|&-=BnE%ku5px7}y-XA=w? zdexmr>N%@(#&ehszuIEEVARJD{$dZOKaTY8`I#ks;_PbSK1C8@{P(&j@!yHz+&6r^ z6otpHaB1+L0`mf;FMhU0fQJ`D)E%q`iJVA{%4SbEtVBAr>PN z4QF5=HH3$x@&bOEr~m*U07*naR4{C#KGAtf*Z`(c1E!WKFc+pDrw(?2`=7F1Gb^Z< z0ROLJ@~lK&7Nc7e8o1(dkrm^z>uh-ZT8k-atbRPNUJepnFnHC#P~Ym&=j5ll=Yg-Y z>vGffFR1pBKHRLUcI**Vha@iBZ2}L4Dav82HP_>O&5~<2T6uGb=XHg1)cslV?j!|# zIWIRPP-zM9*EQPDwNt`pvF+#GM8+QTq1!7qdW8Y9dYF3FP@)~Ro>w~ukuum$j=W|& z6wrRmfPj3b%C zIL!E`0MG#pWV0ftN{+jo%7*8xfkGLm!mmZ-bL;Z^d8LejXDC8wV*@)3d$WXi04G`{90o=gE!Us(OV6ulkVR!F4Z5ur{QA#*=yvU*!snZ|_w|>)#J#tx1j1 zGS9O$1pYdO=PW0ImyNo7@$PsfiN@~K#g?cqB0J$kp%zsb(Sa7JTybPMgWE35^+%#Q zJk^;Re!=tDGkSfX&)?H}v-qC~Z671*LKzX_i{VqgFz&B5D^aK9VV7u!iJ1>jdqu)i zI72Z=>PoO@-xu#u)mCYnY&*hgicOEm=T=t%?!i{WA(Vj48d2+b)|V6;PjH?`1b4}SP!uLC*VNhf2rYH$n6ghGc-^K;Lz2fCtgLQ7^0qrbb&kj-Ise=Se_^CSltD*C_ z%?_v76$8jYt;Yhx@Yw+7KpDRWZI$B(8ozqnDe6Hb_o-CNt2=gIr!yRGMU`_1bI!9i z9eZh(xQjq!BxM*E8u)7X`F8derLwgiRJF5%6Kxm+_`xaG^g+&nO4UV|G~7|*M@_}c zQ~gy>2-pd!B#(PGmp;V%^|B)=ij83<-{Gv7mS=UThK5x|gm2qe9#kEpJR}mg-S>EddYp*4TYdoSc3V zLPAD7VFZcK&atO@>$HdVDlZu~ySL&w6mSYa77T^QFvP3ve4hcs!_>hO#{#o6&nApQ zgjYpvY^;da-r`-JgWZ41J|sDm;l=vJ9)X_7ZG{JTEAlNP?fge*N-isf0)hU2BD& zbyl_u%~D7NvQ8L!Me+aFK&7p00{u9sg4@_foKexti7<@Ko4J{mS*OLhG6eQ>M?IvI zT8mQ!My`0J*H9R49e6<^FGi$pt81Mh<5Pwbk30+)Lxq8u=u8r6EZURHrHx8ZWGVuui>cK89GH6WKl4Q1caj12hk zY#L<8*bE$CF6KgwHGIgmImJeO1^K3i3S-ZI{Nc$94eRb=T#t8*DAl4V7;1ql&xMdk zy<*0{DhI%9s5JjM-&f3R_h(}jDq(G@hqzs1@l+C~+}LFEkZNz{s)4JW03n8ArB+V; ztR6zVG`IbVXeG6(pe0R$-B}?rQUm)GgZGtWzaTHJN2usb^(f1QTu#;6zAg?R z7q1sS8@4JUBxW~hl8ZIJlyjs4{_ToQWmYInlc9J^VdV;)V z07DaW-L+t4iI6t+z7w`KM2#B6up+#gu#RH(bD*ZE%!3}l7`0dar>bkZ>Z$uj0!ZO{ z+^$qB4^fqqDPr*eu2Xp2;4dw^^Q`^kGkS9CF}(_t%}Wc_>Ut&wKb~ubZ%SvNxfnh> z*ny98BxZf6$MjJb0Qr50-HMrK+mH*+$P&eJPo52Y9iDwSrwADP?Nsw`mcN;+-8rG(i-nd;Nwe3~dX(Fq@q$gmhgb^ni`|_= z?EX}A^1&MSH8|2c6WUJIE}l~%E`!%KG&q&p5%ua}ED&X)Qv!VG_BDBt^cu-33VGME zC_LVDkc=SV!6(s>+-^w4eRhS5U3z33FsZrtawT`KFDDjjK;rQ#$;mdqlS~S9!|z?HGhHJVgtbV&%~q=tK0*4-6-s zdJKUf%j=9e7qi|*#83h-rmh(fuEM$Ggk)buAhY067|2y3`8jGa0xvetLTVu+T?~Wm zOAQZ8_CtrG&8z;HV%Y<$?#0W`3ifLMq0Ux7T?KjA&utXW`%B;q*krFBQV)irh}E$# zPW|MxA(77pv-2<|C*iR_fmOpp>g>L!s^Tvx@iND6tOc$i`{}MB)n~=tDcpH{HJ_@e z@>I{Y4zy9;3SG9`qC}-N{H4Nbx*g9Kl(dq~E9na0H%q=u!e6U2&R9tB*F=N7VM@#^ zHqQ$QPI-3v)5cN@vo{Tn=$Xg$yX~jM%y4bCtrr2Y1Tj3!2v3WQ&Q$U_98Tw{A<)(- z7`~>lS{nIP7uD^*aJR)qF3~>TF<0vc6fg9xHaUsarL7@OE)#8rI$N1fRp*JK)iG5Q zg~##Or^E!|i-xBpQOJ%MXJ#|Ivyy08S!DtEY+3AHUm%2q5$QA(Mm8Ch>(sjveHbfv z$fzvnsl}f1+~)~~XeP2<6-O?yGFq?)Zrbp`uRsm=bHTHj_X12Qc<&tBMufh3xI^a9 z3x<^ju9P@Ay&JK1E2GIfVfk z3k37Zh;Vq?j6p)51FWGI1wzI86m0ViGYo8RJQN!nz?rcDyQkW-n2K*b&pe~oRa!4v zPf1f8CP1u;M_seYbuC;`zIc}vI!TD}qhWw~)MXh?vT3_KtuNUhX>Z)7Y^oB>mB&`D?vv6;3Z|KCi68ZJ7R+Ou#!-~LvO@pP8yqo2Ccx>spd=Cs{ zD2!Q#D~8Q*cveR2%vHKoxck{TgEsMd7PrNAs>3dzwWB~VXY*D(RGWs^g{^a5cD=!`|VUSeuc!sF6Q{oIsF|3@Sn%g|44OFVjf#}LiFE9xUYV7dzU zrPSuLP7l9hOSUs;dsn|OwM>t#_KFAO=1x20f$*$BMZR9`hFo1rtBftl3f%gmYKBPl zC@(~Qc{s0ztpy>P{p=;LrvoXc@E+x0Y!`#`tg-uyUJ^rSn@rc|fb{QbZ`;w*;ymn& zkh&N)FA2!q@I-Dq<`H{yA){B4q&~AdAJG#euc&?49?DL!0}@QVogJdu>h|#-&cb2* z`t|GQ&!6oxdROZtD|;pB!g4s3+pE;ApBkM(haIK)R7>)RlM@!U$cr8TA8bThE@Y2Y zjshr-{V!Gi(5?p~%|WJn&p z^(<;m)$f?WuADQKy79=e4yrb%d}%0T*1ySo7WQmIRwX=}l4vfyr=rG3CR)8Xa;#v7miCK}H^`pP- z60;caR}WLwh;>)&sd`VPs{&?Ekn4_``)b9iKY^TS>umHv0OxeOhF|uyc`viw4?MN> zo^I~XsWLBXa6Q-|OiB**%qIpru#)q81@4)l!a&;{L#g$%?U*}5XU$7PWO!@^ztp4D zEK{2cwe9SuIFaP7)+e(4{fnye_PV{VoOJsk`^X??MS>wV};>WssXP05-CNi0Yifsa|ov{PrDyU*yU zd`{4|K<7K(VGV;{?Kq<^D?;I!l@UYbWl@8fjDyjJcotsXoCJV7Utw!AN#skD(ue&l z!(jp2&=bP_R)9(=e5J>uB1;V+S0LMAW!8zHzYd}Aw4y-v9$S%not7LY40zmNw$|dX zY7@wmE5sRwN7W6_Rm`G9_#?yGcBfSzT&K@IXtya^r?2>f0uHH8ZRSHZ0agWWhC3{% zd|5Sx$B}JOE2pQcw$s+x&C64PJ69j&5V8~13VYV6K6p2(u>XiqyO>?I1pqbT!C;DC`Om^uxtwRP zdEFESwmIoQcykH?7kK=_U)iGluH%08(XO_!ZLBheuquOCzpioq zSq!hsOOEbQj_@AE)S)5HL)ck>%T}zf2(#7jL{tQf1Hob3?fa}^34{s*288LQTmWDg z;4c^_p3%4Lx(C%q=?Wzy{xrD*u!Tf6Lp zErdbyA;<7v^f|K^LLxcapCYWgQGT5obcyVuA_@S0&jl5FVv_@=S9q!s8Y+M+ZU`oR z*F$)v^{)DCggXp2H$2w;E)R^eu}dRrHT2jOhD0j>s#-R}S$aH`Fs3vNC+TXqJbu~` z8`^yP@s^eFnxf@g38>)}i2xV2W4p*o>-DZQD~so%&xBWI$GcsTc&Jf_l3vcZtKjRo zLQf3ECTGaol;I3$t47P_866O|!`yaQ%{X|}x(JV*vb zR`o(lMz(=M^nPK*!{0g6`x?O0>4nfKYZ45EM z(-XBz+uIfDGEqhc4~YZ=te*H&DNVT;Z0&r8brDg%Z=giWr)xPjQnYkM4pp=WJOFtZ zVsPxlg&ad*;!!$Z1&#<(W2`ozcNH+gWH79q=aCMvGCYJ7yr~H=Z+YC$RR9%+*8Cx7Ll5*7iA~~r`1|+oJfZUN z;AcwTYpROaJema)u?)QrVQaW~bwk)1C!W#QrSj{U3&{)f%HRLUG1ZE8 zr>B#jL(pN^?QA6hFL^8gyCJ$iGdSC!?aa{1K!%gx1njfeZQ;xw8aK}=We*L`sVbrb zN^^N2>uiL36z2sCTEz$tiHvqRbW_V?dIioG2x26gDu&~Rkd?u16u^~pqIo(`N=T5b za)ECFVs59Nb*je0bQRzp8uhHUVEg!tAs~ja;eF$|)QIAcub9I&0w5L*x~$~K>8S~E zr|i{^9YQLJd(i1l?@!pkYR2kW#j3HY-34$e1{Ii9`KYP}R2afA3{G-k1ZV4qEx<1t zx&~6?#B)D8oOLOEDl#&33}T|;F;pTLxCTY#ehAUlrgPX+wq%gb4OiG+-Dn`nOD4o; z6;eI&djq+qTn3k0G_wv@DM*C)Q-;%q9XhL|Q;9Bss{lxbDKIj;sF?C0i|bMQS%{iL zG#j~G#!KzZR!9R|7Xv>#!95g3jb00>F?`l}s=s>3)duy%bKi(8qzM0hA{h2V z9O>b%0lz!lb`oB%-3f!w#x+>+H3d8#i@mzTbY=uVjv-hKBi4tcTZQOM(DsY>)bJ>l zy70?`pA_!bGbN_DxFErB49=CY0~SUF>bqi)x}qKYUR3Z@G4h08N))U8z^?GTL9Qt+ zkbcrbkTMuL+sbYghG0?;B)q10b;7$I_F+p^^AgJ;+y9i0Dm>(a0?ECRi>^V*D*ixc-r`GPpYzGyK7}3U|L+q(FEaFxZ#dJ8<5alKwjk|IM*; z_rBU%Yo*w?H|0gR4`t8Ixv*_Kg~F?6MH`YlP_}zkB%6MyFgT`k%lOEh#HN^6z`QPO z3}vkM39nGH;zW#Z!c&qwaFu1>j~;dc9wlNpaBjX-4OE*9&(=Ov^cAK!4<8pZEX0s2 znm>@7+RsDA51tw-`WPkA;UVch@`K;$w8Bp9hs~p4XwJ@*);iRFOzKwN{Fs0@u!;@Y zmzS7&Uw72B#h!A;Rq3_6eTwr%;8Xj2Uqhvh{jg8<>Bv~J82Vf6`%>9C81T#E{`=_; z8Rm4g6)hnot36P6OUv`D^Hcg6CD0l9V;JDCGt|1fTI|DP8RT5fyd}u8!xor2)V2)& z=H8yGczjl>{6+AQ6c9eb<|OBy(G&UW*Drr#zdAU;%h2=v_xE>wO^uxXpHSvq1)H`) z1+zr}#C;3^sBRi;^nqt5>56A3)>E$v7iQ<0+0VGcro7InDEGA5D!|LEHdl!Ad2zNwI*-UW{{dV!xOO~6WQnOE7f5=`y^a!5?}`M56~O&~MN7ju ziv%VqhLe0Xo1$VBeApHe&VlE_l9h$jY^MiP98&o?>|m+#J}~QB<*>0t2}!Z?LlrQF z!bcRde_^BT%vY;7M1IN!ey}I)Zhw$JsOqkEkK6j?8SP!^Bm^TezH}H#W9SFPOJ$rT zUp4a-4+;tE&vazJZ3g>5`<)k|EKF z8biHOY*OtjzkqaMHT;^wfinn&^ghcDSQWPEd4$JFyfkEMm)1*WQ>4TAf^IqaJQf&v zTn1Azh6}-?+zy7XIn*lnT41wh@C+q54^7a2m(lkNsewCGLzaur=*5UEj3JXx@nL+N zvv50sL%nwJ*9VTiMi(abf8_w#^bw6|N|~ zbvnxsgr7C^Rigw9?kMidgVP@|@pRJrIp=c0GxEZ0eU;xNp*jo&#&DDE8Z0`a)c#Yn z0jn2F1yntAU4ASm*75aWVC7#)T_FemPC3HpC*o-xf|(l9ZBFU4)LdVP#9(TZke3^8 z^~$-=`MJpGMwB*d3xXAhGOfJbf=yuCxNovFjR4s#tcNXE<~k`S)$2F+?|Y`}bR zo!QgHD{e5r?1nJf{DFt2Q=i4J2xlItUB!O9 ze^wiMSl>sgsHq>Jm1e)n+@>PG7QzN2!&SKrtQNu)FB9$=Z1^z-@Zpq5_+MqefB)uB z-yFuy0KF_ycr|J`7^bR+sn0UJ?QTm?^`O&h30MpXdDieftX(Hb@=Jp}?d9;S7_lMA zvqz%n8w!Di+7+k6WY?tR0*r@re;I=sYek=1b!3;$s@4}eLTW{SQqNr1g>%CR-S+-e zKdlB>Pgz5du@K(PK@$lBJmoOSy{8{IHwzz3= z0gzv--KntQ#1n>c`A-231L4_G3x>-akMry&CF;`+X{H>ER|w<3p?DT9B8*jPk6K|) z`R^0nXE-JJ6xbiTp_2{F6By@wd;=>l+3Q=mn;E(D@hUFc!?mDCsouR+mboG=iW(9~ z4RLzYR=MyGefB9*_%p6kiOBfz#;MK#ret2S+ns-*oULc{=+MHyzrXA8!H*w5-rwJq z_0(hfR_Kra{A;JGQ=6DoXGhB8f5@226)>Jkd(A_C+HlX?0#?oloU^QoI*f|!!bj@B z>oz296tnvVs z3he$v4ZJw|n-jHyhBygMWr?Au{vx)Em!$CcX)tK^DC`%NACef77tf0X41L&{a#gbV zDdk=Wi$W9zut-YzD?s4?GDAAEx}&>X>0u{5_393RV+!N4o(~8-ELj=`SoGv6%}(p~ zA%C>pV`WndM$74eEnw5R;vxGAu*ts&tz4?Fv>}H7eSr;U+`nte%!I-n-SPFYci~vAv_2k5?gnJ+jwB zp?K^cU`hZ0AOJ~3K~yxKYx5Lg<=MaCi~T2Uw4yR! z_H1&pJp#{g?%sakUI?6I@!6Fvu!qo0j2bJv>vV>S$DQruX98*QiB55#) z9WXmnZF8jOf~q;=ea&p7InkG$^$xV1zoz^}ZE;$+T_l?XgIO=uZ2(UhB99a?Ts`3m z4ZQGikt(pVMIggXWNjA=GH7`0lNd(SR~Xg~;E@p}Fr;KvL6onBY(k!`Hx?y^FHKzw zp+<~~X+6TPqN1o6if|R%ru(Zp)db&!XODupGr`<~4_BupAqt}<|FX`uDAc~9DBtjI zle9HBuiU6e&CW&DsAoN&m7UJ4%6Ww_?U1@ps%NFD`q>q_L-6~A3O?njEvlYVgcXeV zIwj8`Aa0*3{uS%EQtST6t6`PrA(!pCe})HPm$Q68p!&1gX0^=wk|G!19?6$P$2vyF z2N#q?800#2QCCS`W1S_-2N)_%KmFGsx{A^HYLRp}E|aJ7QpnAgvfIhmqkI~4&&_Tb?Fmq;&gC)cYn`at>Iz#R>hfr}brhiAr|ct&4|cmf-5Yb%n= zRevouYSXa&9Y9MZCtHN<(&K;6Rv3^N1MP*WC?^z6A2%JwIw{(?MU$_9ePDkJ{56k;Mp{s{4&X$%W2*A zD0VD{Uov4cbn(u1%BH0l@QVlkO1xka6X%9Pn1bq*!V2b&DyF=9uF7GLG|dSgv{xra z?OUz19<3hb_Je|btI*ic7Q<(=JDcxM#9%lw>=x5HBamU#sMxmWI8X7D=<6HNirAKv z|0#v2=h1n#4TiKyYJfjQ_SaA9U2=P++%dG>ow03JJg@VkN-1LB)=gfO1VaUUfG1jd zDx+%LsWfN_bU!x+K`4d#S)1$()%NOYw|%z8h9^?Ttc#4PJ3|z5)XXx@=7PTsj9d(f zij`_f^-FRw^2A)}fi{W^u7RA!Eor;3+ z!J)G2r@piL+qZB2r5fnGmUQSLo$*`iRhCl?e-R0-s6|Phi>w$|#cPB+u}K6WhNfn6 zcw{)3x0B&qEy1ia5`EZEzqAW&wCI!!qN1_#>v8uf!V13rj9%9vkLl+p>}m&}wb#=+ zK2|SToIzFPjz^n@V`8;wcBuZm7%m|-lMUn*wN3z<^(&C6vxZ0_oe#0^r>mQ%dJgrY zry|>0D$HLt+F1c~M(6@|X4&ppkyJlR-<}KNj3|!s@V{>ONQWiwkm_|+d@l1)cooK8 zdc|5_xWq!CYVpnKoNh3x*hO*8ZiMPYJE6xbWu!p_*Z<+5L4~ zF?_sV{XuyQ{Z!;>!ksQDR_WUHxL1XSDQ}wDfrJ!Nv7-E8F|* zt9;m^89=L7dGXIYE{PBs9vD>wa%aefX~DtosVhFfhX7yknYmJZq(>($3Nid$$tgWz z&`-UEZy&^+;uQG$GkX2HOf2&QdSSc^s8=B69d3vV6~2OVxY#Zzq(9onx-BVazPf_?Um z{S@=g*4nvD)QugsJ5|r;fO@jCF8dlz^_kS(2b^7o!_@AHlwDyo5%zbzAC7%l9Boly?8$j{JKwN3{- zWq+wgwM7lB7#i48`9iqef^RxQ_MLRPQYr%}Fwh*}7z!q5I|Ywk_1GjbYP!JtQ1%=m z4DW~!B~||L_}QW-Wg#QDrv*+!znAx*9+=;|Sfi)RT`g44Ra$q9_u=nQ~;1BKtd zedCefA+0ajW-e)NnR!Yhqs5R#vxMNUcdeC&zIl}Fc?v3Ec%Whm561lb9oS$DuV;ThHiMUsAz!$TRoD zd}^-NkMLF0yv&;Q7X1GG+s|cxbH$Q?$Fs@~0ON3H?334|iuG4z*aVJYWsp3MJn+@< zSg($b5rW40O2!v-I*ff z<;R;7RGvDf$UYdSLLBUQ*=7R(4UWO-Mli<|;ls}Kkgx}Gkff;V0_FpZc)h9hu4<8= zeW-He^wL)0lm@_~nB6g8aPip8LPerF1%@fWOodUATu?0%VI0K)^Pz*?uh`9()F=VL zPAJWR1Q449|EAGq+>AX1YZI-C64>7}ta7!qD{%D_UX|e4!N5!u9vP5?|B<05m92E{ z-%O-H)CNNgTTaKoql=}zWWcm+)fpt74)Dx5&x*t`N)dS@S1W^;MZgalRUsN=FkB_A zM~67)K+o&;D$B}Wv#*fR##!D#a&u}wueXIV74B2g1FZvyI@BD5u&n|Q0R#?6B@I9* z5f4{Q%toxg;QCZVp-l!zi~y{LD_ZvtoSJfQd!twvF+z|x7lWgYm%GCdA*%z&yv+S$2iDmp3n>tor0`)WGkO2s|_* z3VsYy2bH&Ib%i=+#S^sckj`jBw%XvA7>*aftP~zFgHFH*WB=f3mrS#$BD;HFKnb2| zxRSuPoFRa43?%V?N;p+&_EVm%XY_AxZ-4yphb}w{&_Slh_c*oc8fvMSdVhcCCCXP( zwQ)FB1_2bSYe1Z?2WCB{Cn=5drueM;!>)S;*<$eJL6S&N>zLq=p^&jgUYFwN2;SK_p?3Fj3K9*jr_AplW1dGuMo_!T~`SlHa~jO@uc zpuv#c1@JN!QGi`W*f4X*verK3>Ef~i=IP|5X&SOjoH*nPB%C*mkPTb-cd{R1&T`T& zRIx2v16U-&e`p+*uwrNf_hr;dMYzwf66TE>Fh1pCkl_Wo?SWy(wHC7ot2MIuJ%pi?c(;XA ze@NjAA*cVOx18ja&@qUCA5Uv|b_WoybPU^E9(dXIx;&i--6P~3VV+C;c$CP~MMWU1 zFg0`4QnfC^gM1$HDmKGnRvFLcVJ*P3 zw1CPM9!1TuG}F_$HgB@?6L^0YIqj_0kzu!i6eWYpVHFDrMj+dv$jK!P3^EwD3^;wq z65_1}i9ufQS~5y@KT$GT=D<4!PUi_cQwYNoh8L@;%8!REG9X`(kP9RpH{f^Yp^X@j z)x#906CPUX+OYLC7l6a?M1(jdoZ!PxNcAfu0=c)T*BkKix_AP|vi zh@OM1Cyv})N^+r79uczh2a)^_1E~1?uA=mH*8aSn6s)N{USpIAfc5fX0kfaQ9E2zg zzelwgl7`?G?BpJZ;4pk&iO{2D^E1d977CT z9g!NC3}ll|{LHei@YEja(Iww`?hG6zoD%iIQEFOExOb1Xz(bkJ%VYZY_xE4Fe(@de z1fDXsp3#5*{{83ApWnZKugUyDxe|NdW&4TTDpslb$ue*ragM`J2LY>t`fIUm-xV8b zeTU6mqo~-yEMfTD6`fP;i&^pb#tp$fRl_5-$9gjZR(ZlhEY}7AQTb1jce7bHF$VqL%?Okly{C#Py?yD)6K z?d7=U3;cwLbF*r;Wviqm!C6DlFc^dnn8PV=CNj=4Yb*MOq#K6#bpB-)o0$jBSBKJ-qyf3{hg8RoOx7RxDxTqCWFTE))ZuCJu< z%(8vfZLeask%s{uLd3+i41kc!M%&C_bA?KcFqBkJkT7&MIbDNzpe1VOif|q}hOnB8 zEMS7cvsat&I<@a1^&FyHb4I6f8|K!@EaVuPV!h^Yc-*M{JWJwYWS?bN=|S5a!XWqI zYcX!hG2S_9R#}vSjPnudFi$bq3ZX_i6B;yR)&&z=vrqzMR?MMiRg`O> zEm{cj>H)omda?$RyetjXX^OnQ1ad~n3ZiBA-*zK0OEPPx#FjRdR{6RP2jo!7P)*# zQaM){wS^!YU{3BfvGrnMf67oH2%|b@K&@c3S70q@#k(GC!GZyikYErPhV!`XML|nC zC(*jQ=d8W;jQ+=uA8&7O{)b*kqhEf;vu|eIIBbW5zlhCs&N4`t79-ZoF#@n756fv+ z_b{pgyveft{Pl8B=p@K+9tV7k?N{TD5@btW4EHtHK$N%)w;|VB*D3ZuB`5ZCjZI;^ z?owlHEkBg+R0KaH7hXJw9gLc20PjqN&KT}6ycF|ny?&USm3_H0LkZ$M+{^>R*(wh4 zcUn}*QI6r5p>SQN5jEhQ_G{XQjg4Z5DrV&VM*YNo9(H3W{{yBDJHtz)?x4WSVE78D zn}^1WQakNx5no!q3s53m4kV4Cd%XRkOmk85s8)L~Mif7N*aEgQ3^3`Cxa zIs`wcPje z7-UG2jv5Xe-tPnUD%6MQj3a4OIBRD>t_)@2=L+^&ehT!~RWbT2qxcndsvC4060MQ% zCEm31{|R_wtL6Lk>(|epKlyL&9_zHN4VaRFF@=ZS5^Z6#2^my01cQAT%ygqo?clIy zeCUbTr-n4an}d@ql1ioc-I&X9z1f0c&^W5pwY(z)&U5aXP(rCi5iopq{MteARm*lNb|DI5B*d!ZADxw^{C#?RY1w$nbbzeZ7E+rHSzW4exY-jSWfl zFf|w~qL%4X7K@u7#Ax$q$SgZ*C}(HNd8m3P@IeffV(1ETZEoLB?TJ=wGv>0MIZ(5n zdd4GOA^uZS^6;t=cdeV`WWjKSINi9+>?HLdjaeVEd+Fgd4cCqiSArc~Vl4oyj0miS z2oQvya$c!~sxV5MyGp$nb?JR7$X_?SoYd=u#Jl8+1%N{EU@&#cAPa^I3q8T?vwk3l zBp+fcmSHe!=$KWmHgMnRv~D|tM6PBX`2n_8C&ZwTe)?*jQWebczBS&bzrDTb*=0PQ z5=o_!5{cA}3W7sqjRnaa4krLpeDWGLrUcfI9nKJ8Ou;Z4n|PPugtbhcJ!>lqxx&!b z4TY1pNNkw1N$=oSN!8WiUD%zZLo9nT)=-rN+lw8rst0Wt5fVcLU4h4D;ldCx)i`8x!Ep)ueuKFZIzydpJ%sqW zw8(I>wOku)0oHJyZA097R-t0muA8Y{##45c)Ov>H4ka}_0P`@yW4MZKx4{a0%})v> zadn6gz%_nIJe*v9?6hkkq<#j#hfe5;TH6C%0ARls+y?McW53~Ebrkii!pF&Ljn%VR zg0#J8nGOrD06guxh|Qu7VXF5+)z|v$J5Ac6x}d!v?6BkjL`GCq7}t2MBET`+#5+u@ z@1EdfC?vZj{LUbIg(UD#YOqymfrk~fdqB&rDR1M<7TIGs$NFqYsyx(-P7e<|*kbnP zaMc`XUd@u!OLLpcZKpuk?i-<@C5(Rh&~3%~N)5G;7o$ym)(P9;LbPfJ!6=CW@w?$| zK?w#(QK1?CDI;ioc$4{*j20XM(1t%AV&d03I3KqB)kzAb)dTXoh%)dTq>##8)lQIx+UwY}6so*%v<_m`77 zi#GO*dG#!sl_;tkvJ2@yIZV$|t+KcnRud^KN0574{Hmp~Rk8^SeA5<~brU=cf3sL(<%dc=~s{y|b9JVEa z99g^~6S6YM0-$=}NA?N>$u$FhUrloP><+*1gcEXeZ@}}o;Tufk)iWfml?qI~E5N|n zPVMlJ6o#EBz-JAv1v++Wx10hG+NiOWQG2qYI@Cj=U?7mAz%Qk^Ed(4StKnI^coek~ zyvl{tNa}1fxspVb1EgfuGlV5>LlW8^rFpwfZDZFEoIZ3;a-r5| z`kEr}73>-D9bn*`cLgg1bcsJsi5`QRB z8gv^BhCt_U?NEL>uq8)TJBxFr!FNkwh{fQIfRKufC_O=vQ%7W)XF&Fd`^3`Olmapo>6D{?np-c?%vr_CU0Gozij8Y=cDx6KS0^p}E&ck3P zokE=1Z3tUq?ou04o#&p>zrVk~y}j*A^nA2H{}F%|1Y7N0kofSWHk)$D!U^bAJhCuD z($$p2aA7#i<+)#W%=*xmqXyph)F#)Au4l;TunS8dCG1j9G)VHKf;rf22-_6QK5J9~ z-WiFnm_rS`cq`VMa2UG@sGQZaNyRBF{9(OHbRiw5K`X3ob#9;!CAEaJ)5SRdg}UZM z7iOh_&ExVan`UPWos6{(wwC1batC=G`ii?GT~) z$Ww+==q#lzkXH{=VMIe>7~o+T9T<=gPF+@uhEI`A_8sFzyNJT~x5|#%LkxKjk-D58 zlt=0ZIim_O-{ePUkPpK-M0)(p9H?UI{w3ywvrb3u+v1F#?_4!1tu2u73xWxOWWN@W zELnX~W2%-+c%%l2Hjp20xCXbSq{v+MHLTAHs8;;Nfql1 zA_E3LN4!N*flmhgEpwZ zU<8SV%wo`0_q4IW0ER#epHc_f9SH0d2A$a_N2)?DFzn~Lj|_S9aFwnu*$VkFey$hN zQCFP;bKg)OUYf#1wrwXn1|ikM6vhrFo`}_}QY0%sxn5_qo!L*f*#r)~eP$u|`3L5k zH4eW-=*?m_v$11E+vV7IegDadOE3Wso&Ls5aO4Am1M zUuRf5Sv@QP#!CNFg~Q`Lmn{tdP=d!rx~+>sFu*k&kEh0offzhoyds~&6&3QFst%I&0s=z@G63L``rJ$;`kMhYJ2G|*!o`U^vLi_bfPtLVfzzY>ic=Ok$@YUm>#J~q)tq0y ze(6!U|5j;`G)!$hqgTFf-@d)Qz44e{3!|^@;;nOI0~!GQNEdK3%em{Ybd$tsYG z-`B}supbWyUa;rX^I; znmWqlcE?E~s!|2u@ZgT5p6jNKeheY>Y;8xnE%2OWg*l9>iCS&p zOZB;ld4yAtTH=zwjZoidRz=PQrlZnpG7UPc&-^iUWX()+X@9j z2oE}|hp8Q7|79iE$cs?{k{vs6g^%zL8?qu8qz>iyKivqaF+7yV63EcccCikrb^z?& z7K|9SVkiO7hTnH;mCvsATvVuPOYn@9t$Kp<)UXvG2D)AENzj0CD(NP8&^9w@+q-^B z&|V7JXD<`72M_+wGUkpwrPlZ7W~B(j*bJ;NUo73JdR=J4s0{6GKnr`3Q-WPKiQ4|S z6WcdA;jb{rIFPH`EDZ)BwOAGiLtsybjlqQsb8A!qz(mDsiU_5_vw)WoB4ZW|48A(V zlG?*Vst#E=nyH_f zrM-YLq!U0ZJHQNmEqqs0HZ7trWz;LqR&y(WOEl3N~D4FitG+^TL7Z?Y&iRYMG>-o8+&CVsT)oxKNl|sc;BB9 zxRVY{W#-O-#bW#E1Ld>=F^<%S=->bI@AvQDfBW0tm<4~z*nLL-uYdhZr->fZE60x? zKQyG^{oD#sbM>nRRkGSx7gFqtX_0IKj22d%ED1)%xJUf=3-q0;)cW5R%0+ug4F*pb z^)e2?&0$-zJ7w>*5lk2iopvSLFINI}#WKVY3A8d8#>;0Nt~7j%ziyQ|FB{1VB&2mR zd)82gqtAY8^=!Jc@>+acDGV`cR4uS#KFhP;;Z0RK<|Xd8T!FLdw(nYl@vLZPcvlb7v*EcA%>AMX$5GQ*EcJlSW~HiPtau`-WZ$ zcZ%BQyo0PYR<>DfFvPI3eJKw+2jjB5k1V{ZRdzH8poQDnv|zaFXct}1$R5MX4OAd` zF(?Y->=k`e(j4wOW%IP!1;^dU*{1nTg=a*Y=fW0}TpIc;Hax4|LJ~+HN~Ac2kBkl` z^}OX20;e+^+O8Qro>$N7^e9$r^!AYa6d-63rVnUCHJ3>g_`kg2eQQ5I?XRZ}u6IQ0 zEkE^uUXP*qgg6WsT+1RP{95PzDt3mtvK+_`8*BuF!Ly=5jEeFDN?p|_+TY*b{joOu z7mTfE^uK@qet&o3Q8GUUq1h3y!o=z`CRA(oZ}W-%g`KKkPfr*%7Ged?@@ z9uMTu^koy^Fm+29v1|_cqvs@*Uq7`=bX^IcKPRwC7o5PPpKg2AJGN+}37(57jCxo^ zqLmml3-5%%5JMsL)3vE@craWcOVg&qiNRuphG9s(5)frZpo@&Db_jXQRvxkoslads z$=P8|dZAt3Y6+;GSy(MUYhhgo-0Jgy0BgW8-^&v7{GU?#J`gzin^23V=pwv z7gSWOw#w{f)}1Mj-+#MKf5GBJttnb1!SmqID{_Sht7RhIWdx5;eG!|A(BqnAR}bJC z&QvvKuxBAQoD4BQV$>{~n}M~lP3!CQz8<9yqPg*+hLo_o$a*%0M6=(0zaS@W#pL)+QL9dt2w}RNJ9w6 z5E%X%+j=6r#mr8BanYMN=R|P(iWAGEM1)|>0_yD9CPdy!c+KN|2!^4wR(wkpP7ie3 zn;apbst$u^2p^^@tt1_Wcy@KHhG@(2vjW=e?({6~uQsdZZ!0Ry3As8}!g%gcd7kn} z4|ld9Z!?QWd5HY0>Kutp_u43$4Bj_z93v}Lm6`pcKCA*GsbKu1hmx^+n-C=+#=l*i zM9kvxbneuP3p=VUK~4z(aB7bMCJ`EBcy&nC6d66F7RapQzkmPEU)0dk@?XDx{lEYB z|Ni*n4>k;eXN|3A^!{BpoQ)xHej+bm_#G_%>LIVDhM}5CE@g>AAki-y=Nqre;Qxn+4b5dkU5H#6AW6aX zgCsEiXM`anFgzN@MaZ8rCW<~(141`cBa(ayn^wcABUnS6^i6>b-Ix;*C_~I10u|aY zfMIwzA~AIN_`1gw%oJMzT<;E^ZIOgX5AiJSkC(le@}V=hEexp%VN-F5F@*sJ&uqj> zDXFIp0BnxIxoIet4%gae9wZGKz(D2Tvl$_g;Z0sqfms1Wg-(|j>Dr<5M*w(1hrVph zSUqq?EUEwuvAQ+^$nc+scLCvN=&_FXH3A&_Jn#&`V-Q$9M0rMcx=pw* zvD+dUigGr$gJegHhd*vpY0K;dVq?(l%__*XVsO8cS8a}jc2kD45$l8kFeN3tYxD4m zWY)uR?i*E4#KJG6e)<98b{ng$2v1;QIP2kENkq+ySi!M^tEAF=O*v5*tqeJLFhh9N zFG6*m**FvMy9Nak?ig%l-O#K&PUy0=w;kiND;s2o%8(lL*X z&Bl~7P>Y@b_*8r{T1ZF;^bnjYLtw5%6uM`XNZr^^C#fNrA&>Bs8rt@4rlLY5L!PHm z4&{?hQ$7@ihOpM0s~9u{ksd2s8Wd7x2;)DilFI3L*+fZ+hHjG@Bz3_?T~Q7Ikqom! zYNZ_Jw(=^M{4NQdZVYzKg$AB<`!?`eF4$2>^w7n)?SEG}p4mq2Nb-Y-q%u?&ANgli zRQ$vrB0Zzq4&#K;rQ{8a5G{=-RbJ2TMafom`f8bP-@g6xpa1;FKmPIk`}hC*zyAY# z&DeTI|NHmvfBy5IfBf+W$2X5z_2-r23yJCn?YUG`In~lHHXq2S$1eb%aw=>GVDlij zE(sVn#Kunvh)YYmmL`M%LPX1|dlt7jh$9OXJsI8o}$T!bbg<0dEDuN?w3s~G^9XE@Nk^O3NMT!Yoh9j)WKQt z;qi2m;bQ1>)f_xpeP^h#nyrB#V~SO)ey0+w?L!1I^l+SE%!JVpl`m&)Da^|2vDhBv zHnGndp4YqKcFibZJMtVebJ99b=knYiTLoBP{48=M6$T-&s#YEVB4Km-EJsS42xm~? zuf|XyV3JA+LjbFE1G$IPhQKVt0SZ)eXi>#`(|mRn;uyC*^^V^$`?hyOQIR)>!qDD! zmh6?BscJabZQt-U3Xkqds-Ey%U?#<;5gFU4kRgmaxy5p4OLfiZA`errb!VhF!Bm42 zNk}f|2y|`U8DtP%YbU9uR#Z+~Nr=J-+8PeBP7VA{OLcK^xqqM{Zzz#pPES{hFpnag zoOS46w^te*)7pq^8Po*6mISbbMTnm&dLR>p*K%OMaFKzJDPGy}SCZ-hyl+tT5E6;r z-`@diDgexKBm%$?MqTyZdMtMW;S4+)sKvA3B%{yDR=0(8yv|j}hZ2U0;^C%3{HIzG zR565YHoSanQHA*60St^M$ld{9oANwX8Q~8B%(l!pG1_o8Rm_rfxUvXoF)Dn>?kU)u zI6V;i$AA8jR|X-F$WK(jVgqQ zMtKOK50NzRu4J$ybqpi$)aFK>*N8}rNKuChKg0u2+uPGHoG{N-S4nsx5Dfq}4FYBO zT8kl+`yNmT44$!dI$&ihFsc){<&?9XTBT_HZAKw|s+GrnYnf-Klh4QpXX~0iNUj}n ze?=te@&1UApR65%!&nIr4Disv6$2q?XkQius~7~J!7-3y9LfNB%9xYx-1N^3J7Va- z3cQm-7sXDO=)BVHgsg;pu3v?O{=;T|fabau^?ebqM6Tzucmgq;c4hDHtIE*ElHCm! zC_)%w)GTyKBs|>Q2|dmD7(tu!` z&glZG|4_U_Y6_>7?U*_%54+CawuGvo12ILQzx7+CKJ*{9;*cQ#YKVTKT$()>QxP6R z+KUl@VMvNL*2N4YOgV|$WC2+X$Jbd-C!bP?2kszQxjej3^4HhICV3G%ORX|U z>TDI}9ztd(!Z2pM&&sB7T|1Okk$$8TTb%^f680BSu~iHV0(c5K;7yJf4q^CIHBxts zDkh@X$*Z03Y9sa)LmI-VJC{InFsiEB_WJpEvS9eJOqa-_<-lK)%HwP+Of0v<4*4C7 ztyd6#Mz30USS?j*g1(O8`}gnf@9+Qq_rLX*W1+fc^v~Rb>;3)xU;p~ow{PG6{qKM4 zF+IOI;h}u{q)&&PFznh@qc^wjDm*kZCD0Xe#(3LiBBUGRQ*;V1J zBy)8!3oT3Imr#&LY|P#nM$;OlNw-|S-F7PpQWNQ=H&OYd5H6P@xR3BDOO&uN`g{yk0P3!(Ff}{Uc_9u4O#kf67 zikpp>F1N^C+bW$l2HS&o6f6AfSH_*ZGtVn#IqT+SBK1&3FjQm!;FO_RMXivmOT?~* zE1ng8_WNys`sP39*vDsUdn3iOwFkKmXC?Ej^9;6Mi33bip3!X&bidnRhMo3djYZ6+ zp+dN#iE0aE_Opz6P0{>iyZu>x(>(zFS;>gQO0Z~V-6|`#SNjnr!_QTH!q5LdecT0| z)wbGrO1+wGv#c7p^0y?1PTeDMb+_cm#(*|F;&D!pe@251Bk?|z?Kf}H3ZHtUc3pIA zByo}yKh5XvSD&xlc__56Q+dfAk3?wB4&f>A4k6kGa6RHq$*AGgGh|o0&W2RNU^pzn z*Gp{PD?OUmUt{&ngN=a7!_-Y<>lr;yKV6v~Lu;3}jSyH<(YUx)3HR>YER5F`rREis zT%qB9x)pNtOfM0HILyG~khci1HhhpY% zW~E_Z)3sTp`ZZg_eU@DN2I(;NV|S1txT<|5Z)DjKw!%E3XGMO>&zAP;+&;zj0pJ~N z!l*RI^O`Q5hpXVRQJSU>86xVbVeIfj8ABnhq>A^9O1DbtNGE5fxf8o)Wa<&aHKSZo z`T0nqPa&b_82d6_(fO9soh-q;E2zSk52p;L=-F%^MdYPczN6E>Ij2ua)gnwN#< z?Q_Na&og(xdsva}tS@m3a2^M{|AMVt{!=78rdO_6(xILjF3;v+5_NI@qb-cUUmNo9 z%HNwrA)dFLBDIqowu`9O8K~v4*k&#T)}QsbU~w@vQ=EeF@Jdm!H{|3tQieY1%m=qm zrP~C1$+Ax^I;*ovx4&vmg$DMm^E2yCEvu8nEW;Wu5B@_EA?xRBNwF`65cUHe45gDQ zUoQa=?@tubMp5xF5b}CC_|#c@>lyv8U%&qS?|*;$_U&(f`ip8Tu zPUsK!tBgAyRAKDDfr(R?-4)N}qmWR`a`=VKK7rGtAVjmz;>3tqA3kflupQ>%(5C}C zJToSG*tUgDJ5%k)U_b_hFX&aw%cNxUu>6H#b$zYEx0Xb-=$;SaA7 z*XBvxh9tyuTmYss7))t3`HGug|M|x(&v@Y^srD5Q#tFG>Y(1m@_U+sI`}@zIKjSGp z-*}@6(OuQ>n7&TAXaA6$m&!XXB&(&N8tQFz8T+=&h)3b%^&Fu zoVQVhJGnHtaw)_^uTa|>;M>^?PF4-W3z-R7Q2$Q={HdIF2`ZuT@>2j`DS4uBiL4!V zFcsCLmp#fDVuEd_fnxAQkBU~MMXn3OXp7f^Dt7w?euWJBJ!8v{LX3b_h8<6kptHud z$X7duj-5)q;!&CHtUG02=!q{D_643(#hwC7j9;E^I~B4qnDt)abVDJBFoih3+fMj8 z`{OfSt0kIwN_K!_=y%nFHW%QwLgaB~w;k{P&D4XcFEvG(7&IrUzAXC!PlT{i{>qD< zQ0@!FL4iS37-YlvgmL z+M=tCs=t5e4}7Ac`5Xvs5v!d>6EGsG4xI=6w0EDUGKVLqR$Wq5Rf1nU!A34G2j`0n zPIwIZ_PC6?ZRQ4EF1aeFI;QkQh=;ApH9V`lEJlG^Ysqj82s`9g6tRc+9l&Y_uC8LT zW9(!R+q~yjJcB|)PKi;&{TU!UQMG7ei|V-_o5!~_JcM9qO6S{Cdu;a^y>jzVzWxsC z?d?sUwb$V;yy{d7_%?kibi=zptd_$(d}RyY-h2#MR&2AsUW8=VX-Gy4_KG~Lv>TkH zfM*$+RcaE^H#`o55W(Oz6;a@yGEl3+{eY`oy_|HX3Spvrj-GiV!B4oev8Jci@vvB@ zJp``+2o``sR`}L`Evix>2E#EsSrq8uJ5ip+ZDM6Ot;1ydtlJgYddO90FR)b-JVT;= z%r!||(S*AgIcuvOgTle^>%#3-$PQ-z%B8ebI!^VdH_BY`1Z>C>FFi9-vyn80I}9_X zF7Aw9&7Nw)isY34!HnKjxA*l_G1aqT;~Ese1-QKm$G?;D5aTcRFjrwQRfj_&O`R&O z@;~c2E5;8fVp&I@J=94Q$kxN`U_>CohLAtw)UdTU$q(yNbDYY%=k_600BCzn5lDtE zLrxbEv(SRq1O@}!9fQ;%X_FI$_4ogq3=TtsRPj@L zNk4Ha5dFS(EG`RyPEU8!R_dF}q3|H#aHk=6qnK`aXQ1++-&^;th@$;f$ylK+prvt5oO=aIE7$==xezuDaxOFnTX z<2)xL0isydAJV)t{?P$~i9`ZqvARog3t@bGb`sh5(pi}gJ&~G9WgLc6I7m9+3^;|S zCy^bJ3r5>srSsQd)&nB_wlTHWq9W?TF!sYH!=@5%^&xX@6yc;}yl`lqQdV(2m{O#wyh8Yd&LRcx4B&HfsCXO z${({D@)hlHD$1FeijNSE;h}0cuMPDdNl?P_sl8E1qyX%a+N~IYtD$79lHzCS`H13y zvrWiKgV!=(<|$Wrh+F{#s{J7+qZr32bRwr#K0WVH;ANgtH>P--HkGAS>G~ z9x180ZsAw#6WwfoEw%Sy_4?0 z#r73(Tb%oXZ_#i|EImKloEG0Y59Of&qTwNq7JeB|xW35f!p_>!2M?#WcS+>TPqSkcRLD@W3-egkw7%sy zWD}rn7|(?*Fgm^Sp2%%t!*C2XMYSnvb;0>rL%K&HG8o=P*uB_%)mmY^2OuNs(&GP7 z&cp7tyObylZ`!K8Eto)72hRmVB>H;ZkinE_5hH(qH&b(^v|ZZyIE)xCU)mt|sZC)k zn3(+)0fdmw1*ktXt(L|Vmm7qSGf2uJUd|zCcaUgEtdNR_EtUjO=cSh!1S?X73@e0`0pRORt>)sJ9WK+XEP zn^wo|l{}NS&4n{+Vc7(r8>_7&e~{2jva~Q#c(~g&-1YdZU(Xe@;&g^v?0tR?!P+8` zT)X&Ti`w^v-BSLrxGP!&3vfZ_g^-n)Q-1QwV0emT1%^%Q$gW=D-5*OI9TpOP5B##W zDvG+kf?98*_xX0I&ZaEw9#A5e@zA!As1TP7RMn_etLaG%`E<`0Y$H9n z{ThMl?#8AzE=&a6rQu{>Z8_3C!KmB2RxKG)%WDm+YPt3?H~|9ejdeR$fo3Dn{qw*lN}NDPwPz*Y+X8_4lX^p98$ij~1| zv)&ND8FdKTlo1U%6vMkRkkvTUCP1W)sCiakQu`ZVZF_|~U~Y)xW$Tq60EE04Zo(p} z4!54szrMcy`0+zubW;DGUW8^ z;-@;8Bk#aAOgRb61AaBt#ya^bu-!ZZ_>NQFnpa}dA-0UCwTw!#A);2B8@AUFdIjKIKi0p)~uV24>RYHe<2^3Slerzvh2cs@FXDCzpgS_>x`s#nR@c31Mz5}>Lu?9YiDh2xg zk#U%8mcMR`-@kvqzrXYF*Vj_9uwkGF4Q>F#@L6mcg+~{alcS175hu*vG!GP~Jb+2$ zv`WfeaWM46p zqBTxMMMft)#WR3CMTIeoak#G#=^;2}w0kTzvo8=yBhUpa9Ucr%jnfSU^5#%@0EEjU zFr~=}xEc}8)}mM)FI+wj5C%@D=*%j+BeAOi4^xp#!zdZB8-5`NiNoj{1}p1^hscgY z*uw$Sjdm8;-3?DyYxh}F2P`l?lucR9yeH*(6B0ViZ{PUD0Y8h_dRkhf!tdJ>g?fG{aPauBE`(;iI%ylCe9BwOuBe*? zP8tqaQ@lcsRG-ppU@DRjZwNJN)~?TB|I>*&s!$a$EB z&^>-X2pd=!ExBW6ZH~k~CrS|7_HY1-$2tE3xKc z1u@`}!EH>pJu!H8KOU8?rK+hT(P|i-8LC?`?D#_-NmWZ!#H_EZvUq1AFUsRMf*d0P zhapO0U#+NwCkkUo5mPYBxWEvE8p6Xn=HI`6zrMbz!?Z5Iwf{~IXX}iPIcBg!$$&hZ z3aVD^A;~7dw_N1iWDpFIzR#Tyz=~F24*}UaTSAZ+73Lmb&y;-S&3AgoJ{Ghk>B@W2xJTe za~=XQ+72)~80e`C$_T*U_%S8s8Y{nRc02UMl!kGrvS9*DY7BI0bMhLJMCef<-N_qT z^})6IDn~_Ppmhub=C!~am^$<*X6X+e8A|OTsPaQB!u8RTA6Q01TB*@bFIj)Bflj)@ zpz`yC|CKTnqVN#k^7B;6g|Su8Mx!v=+LeOr-bv4nErr2Ju`Y?#Aukt#r-QjQ*sG*C zR9JaXOLM@W4Nq%0gKYN@5>7qe`1ttv_3M|O)brRpkT7f-ThHj7>;12P^62-VrGWa| zo!6=ir&b6aQjk3o;omWwJW^;M1i9~$9sb)f(G3yeteP)pq*7|+0;}5^0e-c((`85` zuMVsF+kN6}vI7Pu1_u@gN`$!bmcKe{AHY;{rd$$E4DY~l{etDJ>#PiBY3g<%8tf5i+PGdk_yl;V@T2JcI;b$P&mH*7d3> z+*9#E*bZrwTI7T+es(JSa>*PT%7U0E4SoQ#s+d){Uav6(VI79x3fTA5txJe zsutGT-<(7<>k_m{aUPZi@}Y)g+)E4%^yXmGa9|HDZHL^IcoWdtPc@7X^Q2F&Ja4o?}&e~o@jdd}#>WU8!RkZ_@)`nL z8wI}IV{J(56c22Ufw>wE3%ivKLxA^(p-{s%*FI;96sImCmmLDy*w!h+%i$|d2p`de zHYpi38^bmPCnBo>X2&4Bf_<^-tb6=UEkeb%3`0ieoNdlz-aPPt{{8)3-$D8P`*-~+ z{UMbAcM&${YG+Tad&_WNCweg8-)xb;i>oBCu}SdA;9g8R8U89{+#iF7Av}2Yjr~|h zVn_Kgtap3~BYdUv5I|tf$kdI-zJ?nU5q`Mb?SVu1S2I|e!%hYuhEZ2^i7Wv-JDiiA zW!uDmO43bj4}xu$yn<=DHG8=9hkyswc$s!pwG*B#Dy|o&`qzGF2hOh4ju=)mwn_|l zsAkNH5CIB5tg+=;y)_C+k&D@tAHai*wwBeKoK^$x{V?F<8&sk?{f~C7{GkP;Pe|qXke4z*EZHLDssYWHtA|O0_xP?#iQk*5RCik=aw+j z*1d5Sf1`ed4fr7&`Kc z*tZm3w_L3^Jifd5{DTqTvn{IOQ5{2!n!*(V3+5P#q+VR?%$jBPkQZiu|1-z_-DjhX zZL2TTSoi7$lKqfa!6C3BqXW7+;(e^zQe%fiK6N(m$=!3QPqxo?rY@EQ!?VAE35koH zrFX!i+j6+#hXD5NWvSjex4B=y9AaV!>|f(?9f$?GJ<+^~JJ-SvMmhsohpNtN1fw?$ zK2>Y4v(@8K)b2*z_8xL~n*vwNa|s^B35JvR{1m7u9j9XUD2GXyzfYqxf;pIsaN^l9 zY7HMRSU{^R50k3atSumAcl{Sy7l%L`BKD|P#rULT(8!)TSKGWdY49|m{}uxq;N z;d-l6bWl@{L_=KRmE^3aWfnCr?y-$REV<%C?KrX^4u;LMLXteKofB*i?d!zXE`I?Ib#Zc0U^t(WS4|SdbM1KZ7r)W=s zW9dEia_tf59VT6^T~mCl@+h}`bzJSrj@W?3YzzgCa)N3>mCZ_-`3{=Vf!5 z%wkydo$Qf?p$uJgHJ$wJ0qaTGs2HoQ=v1DRos2N&f1F*@RnK8|b_ER-iNEKU2LOi1 znT_l*WW^(V|07SWg%n|E80%HTFL)$g{Ayh-CurFo;rAi>-C6Ax#uZobv&Z+aBik$v z*t99U5_%hV*nBCSO}|91Ep)gLbE2(h^g*E~>94P^{O-ISsRQG2JOyJY#Q!!lQ-se3 z{XK;F#VoLL>6P%+h5&G*vEtYN4Y`p#!a3K%zdzh;uZj{aNu#l=J4%SDQ33EXl*=Fl zc!*y%D4fM;tGE)kMWWRH>PbD3`yG#X2apKEXQB02*#o{ZJk#UC+&-(pmsqizn^WLb zYC6e-s$qVUh*XJ^TRaf-oJxvgV!pEF{m;q1N=NlPWdVd_-X+!Q>@$$5i_6JxV8 zjwcIS)MwoWdBNCUtPA94Lk2OY>ZN0I+lO=tjHEH#tnNaThqxUXhp9mNkf`=T^I1iy zOZeNX!1*6!SG6wbK}jpEZ>>7J>6w++hHuhV7-}OU&BUm&gJ-^QhQPB^A)6saCA_b; zAyG};dhVsCDyg1U!0fCfJ6obgd6qkF;Qj6$N~(YzkJq(h^U2gd{nbSE#>Az%lLbsL z*WrEx;rtIUd=(yDj(V=E#=Grn;r13Ln}e}s=v8Y~LpX>~M-Ly+TS1 zZK*Iy9xyfP7Eeu7J617~(E+mE6X46kt!MQ5-Q@Zk-(D48P$Mbvn4Wv2Na9I-sORtD zhJSzPoszBVL9hB!d;MI2Z3+yj`{@pm-Y9`}aMzX|Qq6#xsNx;tjRMI{1y2}UQ9RSE zO{3L{Ric{CsUizQ31)#H@j@IEZ@E}{2v>#^t}q<9EnsL}bYPXM`l(kL84kHxZBKAk z@i!**?Lh-CXQ>@?{*bCHbUS8!2nK^$t^!Zwwl16+2*Y4R)P7qkvU-NR`%|LTYpC@T z!y5w3V~2|_@GEU~=~u|7`Mu|EduOO_M^%6|yuEN=okJM{&mp%<8uo*x_&c$BFY)^N z$|nc9RAtBmU{!1lTp>^SIV*^&N~#C&a}2M2Ura>BZf7;CUsE+v_3V^?7*z#$h}%jh z54&B%3Tw5oA(>V7Hk?EPM@AaxM+dY!MlJj>3Jsq9FzP`7-(V8v@*b4*04 z^wp#;_?ZpP3Wzt80LUBZ$R$AV6Xk|;V$0x_MVBYCINPC3?YF$~L+4?-6~OnuV|F?w ze5;{#I{)KrEy^{1b>sE*Ro@A}YR*3S?lbzIKYxDz{{8LkZAdvkrq_Pb(|M8bq&{|7 zeRA!K?e<(}D^)){h`_oeQA^;j4F}~<+m75SqJ#?qRF1#;I!3XaL^V+$4~5mmVokN; zN}>Hmy%_P45qWETzjrdtlOSKt0 zGyBqe_u7mO7-;MAQMk68^H4>bameDz1%oQ0JY7sNjM$wJV$T|fexvJrTvRR!vHG5WpBxRF`M}DFl zRucj9*b2kLqC0Jn#QoHfq0MQrZ!wSuiD$=oyRk#7w)nPjd2V0U8agbCBh%z7y_$?x_9>;)1e*%3*g3XS6cXknVlm^b?=D^ z!3t-nkC63&SO};|d4~X1U>-M&Cer~j?n@FCe^W{f3Rfo~_s2Ved5f^ah+#belx0&e zVxZ-HqdY1Ho6WGvPXk5kS)9Rb52>~o_VJaWdQcUu!(T((vHv_%Jlgi(rmufeKn(t* z-oJ*PHmQSZ2To7g+Cr}IG`Ed?gp++B@|CdLQ%9m8jM?Y|r%XhxhAfQ$kcVHzDpzD& zF`x2(e0;pWzv~N>cpRg>5@d(LLdOcyYDfsgb7;Wn zv2Snx|Ba2me>!9fK=i}~$5aGf8>$3)YBvh1yCRN}R2N>uiL_@GL&UPYuf1ipcVLb3wzP$} z7f4(|m3H=cQa_p$6|*zdEwgt?v})QlVIe7o*Enm3ThEHT?w@<9T4lWEKUB53QWaJ^ zppRohp3PhNhk7e{^$g+vPTjWyzILb1Ko1-w#p1?Lm#ywZ+&AOKq!663bs0LK-Nx{s z7Ee_L=4r-eKSK{orZ0u25VeJiI--0SAq<7lFq|HK&33{$g|`KpMIW+z3Wq6nhk>XS z6@XI)OXk~N?@5?i5gsZzRo5zu`{}uy*Z6DC^}FnPlwX% zNljVhsZsHm-T|s7TBEfg%GZ)*qkR}oTWtjrUIF4!Qo-b@kJW1I1rM?@E|AFAXv<|}wj25+1g2mn@1QNy4 zI^l_O0fej!qE>*<^;0AJp>|_XSeI!4e~~FlmY%k7>cTiBe%O2M=ku971S5OSGIO4t zJ?w)-a^av2V<#iwJ78_pwmF;OXJMX8_F-FADQL^tl2?SM{IOVy9gelT9Ae%*fB&HD z>H}@rxlAg_sV3YGzP$Rkr+z3yU2ay#7ZDBfLbM^ou8gWdNN4li;&$a+vBfqE5{91C z$pOf@$`UYVc!K@uyR>b~-Bq<&p3vT!;;=MrC*M>O@B2iyV`?Hi9(d~g8w~$g<1X7~ zlccWZX5igd=b3r6Iae9=u7fKgcJfeo5XNu_{CBGDK;4`z>~T((z8Y=P3xZ*WuzHx1 z0ifMru0gi&x&`=+VCIRWPaC#Hoy{I46YkBy$vZ9@;-BNfsVH~C6Ux2SV0H|Vlfs9d z!tEW}6-GT-b!HWHN58*U_oDVC(W|P8RoG{%B-P_OnWdA19>5ridU<(KA7uD1or64U zY(1mr3*s^K3-$4*Vr%ZUNZK8Eo|v~$T!9g_8v2f@7@tMYeV4x`4SvdWKh7GCX9ok= zjo6X#6CV2DAuD?Y_F9OQ6WOa+@L>q=B+fua0PevKPKKz8=6DLgmp`Q_%PN=i4|b3Y z$it~9w#7RJ>=3PzSRNu(^7Xj?aC$)03tDl6Ts66?;bdxX0Y2`yk}qe9dk!p-MBqzERzpK z?ysT0&3^kbxrWF%Y?yf}ctYgrTAq~zrw`lC0JuyG!;ayn8G5{MoI7my#jF~BEz4mc zUiB)4NLnP$!$d1`7y=M|xXfQS|1DI5$WJ#1N`|NrZ&4Vh-3R4r{yoryZXtY%{g55q5j48VFA<6Imdv z9;T{sDp!Qhi8RaQHiMm6A^z&Ko3_{G_I|hodlhU>Y1^!*!m0;Vv}=_D4TNAsnPkC; zyI9~!Ey9|p0{CEs0mhS}FpQca04QnwgOlv&8Njq<6(#>B)tpGPbRL5!ofRm-A4V0U zKs_Ya*WKt5>mgMz$8hTz{rmg-pMU=O&+ zM83I)LJ6_>A#atlzcKXxYxHa8Y#?aG#)oRM>=-JLGPOngciSNmzmV!f#G;1~?Fq55 zhZM!4#G`p)ReKcW{ila&2>dW;kGel>t_S%gNqXd|*&`QyaAv-AxHg17v$CiKOoxB} z{{8;`PP=^Fxo(}XQc0CCgaj;x>IsVybpdYkIvAuI(jZSXAHqt)6ozx|*b4N`BTs#W zt;$e%>nBPE7!3I-xh;fQkJ1hdPa7UPiV(n@9=?%K4on`tA4xnht6@x$5l#$EaW(l? zWJ|zVdGL6k$h|+n$O}e>4kAdRD7B?JVN;-IL9?14u`z^)m2yC9lM922gpZ@uQ@E|0 z8tYEa!Qf$yFqm?M9*A8HWMfoJ>k(cV$?F%O_NUWgyTSj5Qx;KiXp@>t504uV(mKxm0y9Cgq`o< zvMY&W>IU=KY9F!@LNn2f;TUX~G3XK=7MG}@a4>F&6K0>nW>(FS-!(`EFaiU^;mL30 z)DU88X+Gt)8e0n&xoh?)Y(&ZkNiie}gK#|i$~|Ody8yS9C9?Z)zi`$?;ipJevcn(B zW7adqR1I`b1ajl6SFuOM9bZ#U<#y=tVQ~7CZ1K!&juGKN>rz{o*qDkv;Qp$%-M22@ zZH32~<{PPkBO_wMui+3r2iEW%eAOTUF2g??4xAo>jS)>=@d)p;)e}@SpIST|r}w9x znE_+y+1XTH6v&VP#tpa8Kzos`-KC3~x4~2miKoVP5<+A|U?775dH7`zg&&XjIg9u; zSRu)d!Q(8+6Hl;tS6^RWHEc254Z#3YEesK$1(jf&)D_)h2#+JN^{oRRA0NMd{d)g@ z|M>C@eRGC)CfFqD&k-kwu{8y8@piGB37N`D;5ZG1N|6$z7rcH zzREbYG$5V1wY?i6;R5lzs#IG-{>lbkQ#3(CK7~lk^oj>02GsfpFF-6!mSz^)%!&9>jl4&Ga>4X-QW?d|RN@85j8jQ(Kk z+h6}`naJ2Nww}>*>FS_~U*MN|O;If;i|b?aVW=JK)K)RwX=hufuc8Bd?R|kg1+jWe zAH~8J7YY8AL1)-5bVjONgOj+Q5C_QS9xTCJ+mTn#4dGlFT;yDVWF%xIMt*J~)awn0 z4HDYU6p1LU`#TWZ7|weoJUCI@>j=TyCk;(w1(H%0_22{?#bif zblBVFwu6UUF-7X|!yHPKrA8s|tPBsVw4qAmegwznhXJGj$`Z38_YD*2>M*KmG=}69d;uMnTMoX)f@g8iX4(TS39c) z(nc^G?8-=r7=q`lb`LiF!EJYfW2W+OJD@YfrkPhGYLRiR|RfgUK^J+VxK zfXhV@7E8#Qh&9GcM+S)2!Q!0K&;Fe`Fq zX$t^1NQA*`70J{cjaeRv5JO!|oifA&8%9e)E)2ouD5p}OlwLU)41K&}3~-=BZ}`TqW{2SIxH$mclcBwR+@hiImd zh-qg@L22O0$Op`d0jwzi#G*FDux}lyKG!`Q?-_=~=!1^U8h^~8JxaWO+0sqRP0Wt~03ZNKL_t&|^tMc;!Wv#CSzv z^P?vDIT50PQq{H&!D4X!IVwt6kq7K>Sa*e(*>bLMWglkQ2Y3oap(IEuG61KB(T9jV z)$Jp+ng&WhE&FgqC_oK_;nR(} z|0Rh-(#5a9RI%y<01T(a`4x=A8o9xF3G9R@K^R90&^D@d)>tvP&J`xapd7!G;C!6X z7WjyC)I~tNBo2c*u_JJCF+@0-by=O@UxM z5YEVme=x)YZT&%1#I|_@Q-|?T*vZ24?9P#phaqx!FalPGEjh{^FK7LE zl0W!$wpN35I?Pwr?fQYm#b7%X&XrN?BBS#-j8#~1?)$Giqu*p#ulWuK6~hC1Hiy_= zUthI~Uh`(6PlWBOtw>+d%@XDiPr)8q9fg}2ol_yzGf>T7zkyMjI|t?qQz3@4&+7tH zpUyLNA@$i1x-kT*Q9G)FjlH4R)tNY?Zl^9NX?g07-C=I2A}}hYEf}PhC&Jql#0Gf_ z{^CwHhU@gYDAoZhTVRFz|H~16rt;3u$W`{0Uu?n8&~vTq6|?*4B+T{gyW^G1TODsT z#1jB#xQiWG=zv$DL=?y+;|0b$DrgZ2vpfuC)N};i-5~Xf`MzSJKwr=~(Vsn9_n%MVfM<#Ld20CR0JNT0||pX1h&^WvqXK0;Zi9?zjQ{U@K=Rk+NtWS zo`JlAZ}B|2;WZtnG{#{$cWDkvoXr;wz@eT%)}d0k-|a*GPXzd)(5QX!`$(_Rle&Mf z(KcXs?BK%sk}uZr6(5-`{xvr8j9x zgcBZrQ-PSBrl}lWoyX5=_ro88^&cAaXg5-8s0+b0i$R`XiysbE0W6L5CecTo~%Y8Q29Jsl}K@vkhvS)cU zkXSFds%is=Tw)NXV$U)REbPR^zd}Wj6p@wIFXrh7qISZ=Q zxm@pRt%tgvJoUIX2D5s&+T@R@npMM4_7JAjV7S@25q1rEg#HVhUd4rQLJnI5@}Wj8 z2M@+I0e)e!C;hFg`2Cec;PE`paGk5ONP2cuv8-)fkE;UaCHwB zyAravbFjtS-p7Ziohfum(#y+>zE)m$6aEtBS;0H0D@IQRtN%eB6-5V>W!TcfUv7mj zq9;{Gf1=HUZ@;JWQA^uEQ}7HMyLQh@pa~eU%?9SxV|w|i7ec93BG;fl^AH}EgTh%F zms+b^dFa&uK!d=S7=!>SLDjy5!ElJ>T5=67{t&R4t|fOTSGBYSEyKZZwkOy-y8^Wr z^e8s^-x3DqLN0~0Md>c`G}_RE$gFpgW{(d8)JZ`1j6Bo}S&QXJ9&vK9 zVEE&R+6RXn=0Y|Xg@@>e6Z)-XzDr#Ek=K*fT|^cqZ*Avs0REt2;k;uCq2=-05OKIA+EL?~%IJQVFX<`Q`cEnuE7>QaEFfqIGpE~?E zOB-^9s@3pXqR1QPOs!OS-?1=MV|6?xQ!5D&lIrU|zw8SX)@P$|e*4Zt98 zQRQ#cVJ0b_7Ur{G$BrF14_n#$E9H%1IZnN8YX!K|e}&flWN{5VaaPrmbmR7jr1Ox+ zATB_gCv>7}v)kn5n8Gs~p0^@>)ietpqaK)*=kNkiXT<4`>G^(@vmfGG4QHKRtOM3`XTV^i*c|xP3_VbpX-581CrYY-we#o}F|vhR5`563JtA z_^nc1I4=HEE+rR0X;RB8;svNWsRafd(R{RY|1CCZU6R{71rsv#J3FL^upN~PVSq; zd*Zh6;c+Db-~sQ6u;B@904^I6;Ne_`s@;dW@cAWr{W;wC_jiQ{(m8kRyFH`V@=zGR zGB3~j`#VkaKSm+v*^RqX*fTMdwn|Ew4xm@=ob5RzWH8hgnPWXKfpThyldHl*TAPq| zwsn$=*!U&WHfrAqtwL(LpsGy^hQQxzs3vnjuV|~hiu41*Z4Md_sf)XlLJa#z&p6n( zh;iBwreT~pwKL8z+YoARXvo&m@jWx_&r(a>hqYb%v_is3mRY>l8@Xr#zmWlX-FQAF zo=pLf^wf|Q$MA3$5KX9RJ#gRlw^_7{@W_HlkQjsvMzF1rQMC&9H(mtBW{V*(Z(SvK z*gwIh11ty2O8J@si2>l0vEtt$L1Zj$40ovhMi}4iG#}$r3Zdb?BJF1+$wMth_&=oz z*FZ&2Q$i~+&_h>OVs_N7NFv=T#lF8@(d|wkuMCFu=DVNz8q!mXAv{#H>Y?Wa9M0hM z*?*c{TeP!*ce+%W52FadI1CX$_`0m_aeGC3ui97qm;E6uhC8%F`TjJfGRsr_ZPNLw zbPX)oDn#JbY@7Y8)Ah8mGeEQP*^qWQAys%ABT#>Qb7eHhLPeI~|YAs}ZeSIC)aag!j)rWow^Lv)-k8rMf8TWl+ z`R&`cyFH^1-5UBD{Qmv>*RNl+n+2f7Y{Zu8@9P{^_wGfp`#q_5_-sb;z{b#5_AIC4 zE3;{-C7=e{xAW_=Y{i_+z$*$712a7lvsvc|kLwILLuDTNOt4kNZT$W_^@r)8+l zSh5&a{3#EDPenZle0X|4S*==K7fzn)r!9j{O%1V-JjfWdDdUc|Ly|j+-_cXkq43ii z&Mx{aCA5N%;?b^a9S)M6;p)~Fv9lg8Cju#OW~foOc!p(_jLj2!uIrF$v$vNko#kDo zeNG_zfhy$jA@*G)vFI3QY0ZR(lNe^><9RTa7Vx!V{XGmKxb_(Hh5MUaM=i9e$dQ8gi zXtHBbC@>0FE8CKjNZ)!d5~m7shEy7~_%P$Dhl#b!`)}}u7>|`p`Q~*zS=?L`rklMtRBHv-T61|HW9HQ5`Sy7 z2V#qK=cyDPIM`>Ev^#U)AEqb=qb}&&^MU+w;K1oq(tNgi!SFbd-cpkK1A0=|>q1j7 zgh3#*e|LkW#PEvfk2_^E^@N_V)0Ar`BMYZ%Rw2~LY^_U|A;?uOB()6xI^$M#$A-k( z#qgFycci)?W6sV7#;9-2hor-H9i}QFR}*TbXLXr4gFtafQ% zEy%+xAa@Md+;ICw&EDi4J)ea+t5YpH+#b=r7{)VI+OFML!EtZ(XRSMZ6QRGZqEI3L zLyY>ahNq(v??~QAD|Opyo-@~~S0by17P(32CxF}HbQ0NkFxu>AomK=!+t`vVq-0t{Vc=lx}eRAVlQIUr-Vb9WcMaxGdnO0 zQy%Vigt+pUIyF=ZF5|em1_8=KS1Er#`%DfYMle@D2PISL(wr!0_lHhP#t3iElnC@8 z;UZko0=tVLkq^o>&<;~WU9>d9hbtnG1NkjeF6=oOT`lF4T9*U63qw)h{gNjZX09os zm}(80(9YiIq=c%oG7m}!kLpB1AV$4AXvzUqK=qJUQsld!fkzr#p4-6qA&p9l0)ee!0X)=LsUj)z=sZ*0G7d>RBy6W8 zS70<;&DQKY9#0{B@K+KK3EQ_yWeX~X7{PYOVTh@Rf2+aEsbYM|>a`QIHT=*Ml5QtF zo3X{uJ!wO#Q>8_Lz``FxU~XvBI@0aBI_?oNw!M?z*A8Kod<9tfD}#Gty`tC{D$o;Q zM}P2pt{s~|45F%ssk26?uU`oEXJURep~~L{ z;jC<)x3v`u0~n`je@7W)YfzwcI=_A=JE9yAQud1Pde0(^FIctf<>&v0U=~R(`X-NO0izqC*CiO~ zJSwV#M25eDWZSKHK++aM?Hu9*>d+_qgV;fnfxIbOWuQUv0RYszoP@*A?do z4BkwfE5iwgTHthy#{xhzXQCS`8SeKK?hm_Oyl7x=HVpT z1uauL5?v~^73{D>+ryO(W=<+$R9A}!5Y;&qQ%GW&f>QuyJurIv?b|ngjw=!xTRGi> z-DW`{{dW(s?!;EfwQv9!D-0!oY%}_CSE)2hAci#jFR)RuBD5@Q}7B$Sa#KtHZc1 z2#Hzzt^_BBuefWg{DfeTu@(qM`UL>*ML80%69SN=m9Pk5=t)K8WkTK>khHVz^ft1$ zB^46oMUVWfoI;{AdgvjtV~GJ!IM)SJb@?=f z29PdWJQV|58&w%7Foby_M0q;5$rZ+`Y6x8|8F!dHk=PXFv8bAV@u5E*KS$6{kd z(?sYggsdJ^7AiC<6WK0ZEv{l9-Sf#<6~e*B=r>KK^HNhkFs zB@W!Q4RmEig+213{*-axWoPy&Q_{FKwDNdJ?iTtPffa1Z?a{11;l zOL`Vp=(dMouK=tF-#gEuN65!t|L70QXN}!w^eXt*uU~I(|2KpmYw*;bUTD)xH}?R^ zdU<)_x9{a4ign^YIN&*3QXD9AI0`YqN5|P209J;I^3uE((Z=kG%KZwIPJayyvTKT3 zIy~@8v;MOVJ6wS~9owu$0$P!+w%O@C z^qf_gV|_M4oK~<^bwV;rU?pVA^SVt4Y@~MB;0zdqo;t`Qq#b&A3z(e>M+}Cd7-Epl zcOA2e0@J3B*%-DV)v5Qg9DpM6?s4>?O&HR-{>qOBJRTVOKnw#s4EH5LQhR&0AyBOh%E91P?jco)W@ED<&)J;E zqpCkVBJtM%kS_dpAJ%ee>NwsNQem#Go!!|dK~8EX_jObvU|LPjj=jnbgQt*_STfSC zHVTGSE&yS8B2AHq)E?rq?r-gt7?Q5o++V>yi)LW0lDOwq1{I4xl*e$Df-4#xkk#XY zeb#pr;X8(t1Ri00NU7U3LNs(v1k34D#0sM+PulJ!qQYpI14E(;*4stYMxYNJ<2>${ z?QcQ-IiRyW!FFMhuAS1pWk)fLSPfxND>nDM$HGvJHlxSRJ4A%+C=@y^N!`hY*YDb{ zFdouk(@5RP0-)dQrG{OfsU2kJ^`#p6-fN>Xf(7<$xdYUTIX zr`dNDQyY7>3LZc12Xd?_``s_MQ$_K6?s{r^*xNxZQ~U<{&e4YeHBbWDSJxJ8S4$nR zS`IKnmnfu?cwRlAk40pt$|z{@>5l2t9w4 z8f`UN$>(jg<6epnOA5fwV(ego)`x`4V5k;p!L*etAl~act=ql>xTEu4#F3ue{jyn| zI)$fhXr`_iE{RjJUPuG^p(Iby@kNfMUGmKtE2$-GeYHgooC0MV|5Pr))gmFXgJK( zBH^ix@;(4_=V8Vf;G8pZm~CYb_;#vQ!U?RtwHRkRt0V{+w#(#+uGztlTG9moKYiHG z3waG8i%%(+XVh#9_Q1#4l;H37TRoD!nxZHX3g&j4(sel0=pu(eU;~v;p&3K7ZH*p? z9R=cdBglQ~tUU|6W1<~lE(Ti~{B@>kHHR~XI+@*hxOH8FU*>K*X2+)F6&P}tx&pU; zrHDinyLw3C=_0nx;!fe6L6_TE9_M_JJxhub9;Cr(U5~Q2&GZm#whEs1?MD>FPzFOM z2^*1-aVIvY4u{G`#ul&ldoxC@IK;I4w>aC3d<*ozyt5o4Z&S3);^djC3?2>nMas&? znpXes-@kQ+1ac*yJ#hRTyFbU*F{J|Ix3PE9g$CGEg(nrVc9L_lZM7tM13jY@>J=Ub zguPkOCM?KL4R@c>|NQy0emT3YG+(V~>-X>9^=D?a08gkViVr>W>9Z zn{88DWZ8@&X{b6Cz5>J9YV!s<15xh0ukD}BT5b1DH?Y-W-E)gJ+6y6UGW5!9h-3$P zuLOpf&)YBu$*G~!o(imB#Mi0kdvyy#&T9;FBIjQrFBA(^)m%MsP!NmZ`zi!8bPRzH zGL)3m7;U;%7@wKd4QHS~GSqyLILvbqa_Dq`>=kE4vJKjbD*n?wZChN`A;7_3){fO**=q3lX@7jh9&6b3ruYd30*{^X9RYEAiG zaBC3N&f?su3yi+{o5!a-TyF2YY!c;?c&QShJYJOBD0CwLG1O6mDrD1kwp@IHxu?Ju zIVp%0fRY99ieMnGJm|r2WNV`#vbSKKW2|O5iYaO*WMErOZ9SuZd3pKqP|&Ts5j@TzQ-a41}c96n>DiKVUv|=2k=NbcSksNc8R6 zsU!?)YM#fO;NhlAjOylSf+XZ99}w&LYi6tNC- z68Be~gx4we%p{H+Y*#hFo-=hQX0tOpYDIOI9+EEDVhAjZxb~yQs?#qwF2La299HrO zBp0>d38W8Ik;tPQVB&EBO2Ho3Oa!67_k+Y||Fzo=3=7oaS59^agcu$IjP>#l2yKXm z#~Uhb5?+P$6cGzRm>GE}#vgOFi9X9Iz>v*^0it;IJvg2`Mo^|A4a}^C3O(~t19R9AprY6Dw^t8zA5H-yI&*+ZDO$n6NqgY5mU=_jjWSRI#?QTA7PwXD$bEa>4EsDgJLitFPYGLr+h(qszao*pEzSAq zb49WNhQnu=3SqF-L~O7K@gX|h={EfCWRq7Xo>d?K839uj;f!H0tcD&H&57ZPVc*Ys zDd}1Mw(7&|ULfF|)L<|O_myq=1Ie(ZVsfkXW)0v8b0@@#goym`ilJ56CD`VD3J4TSWu;?0QORynsf2# zMq8BE!>9o4lyvGZ{K)E?}GFr3vF&5+za5a&w4ITomx3xKc;S9zqo{I7Fyw(hPjBYKO!4R>b*`jp#s^C*SFhjf}60Az7Y>?mQRVI^4pL67s36hpHfKH~|* zsQ6k%i-BQf@XIND1!QGj#h&%I3RgWpOTNO#&G8B8R!Ua>9Z9uyE4I7%Z%^mDeI;q9 z@Q6j28y9$jmLarw+=xqqt;Gp;K}m4VpSMZG9oYr@Ay#RHY52WVhzTJ?C~%J$6(#uu0S z2uly_(BQ43Hi>>mo9%iS9)O`hE|cLB7{ZkZlF0jnA+ixEgSXs+20{kR;gkz#pNmEo z4Yf~*tyw$@d%#x)c?iLn+1e6Xa_4~@BzvA?zr9|B7Zo9pK#Rc?7nd{m?CrKxX{EHC z-rwIN@3kyj&*;?-{|S%&FeZOQIPM>;2R|55$J^dr(|s+f6@U}j+~YU1zyQ8_Xc7NC zBo1g|2g7OEslvPXfdLsSjHg&(b~4669JK6*@Xr~C*_r2F&5?jPm(P-y0|gH-88P&0 zn|&gT7{Cub(NxXoA@7*6%j)cTJ|k(VKc>#4SPug>1fNuj ztOA^hS>f4cherf~E930K9SUA0`p@>q5xVNq%D>+n-dGI#xlXZdl&Avs1=Qm%*fdl| zb{7VTA_{*Pz%T;fLvOF+vE!n{fB8DnC$4zA<&q9<*IdCU#F+7wL7ttc0pkbGDnMDgZDH@y8BiHlkb%=V3@)^_IgQa%T$?pK9&PH-(n%ALWd-R_*Pg z?6f5UW9SSlF-DtOv(AIPq=grYP~H3EK(DNHW~X2LHOt) zg4;w-mMt-Q_0(>+I>RYEJkZLhM;{Lg#KYPJZ9DWVXLUN^5Q~1thppe-4QD%~3GM9T zoLtmAn%_|}v<0c{5z1^BEul7mue)Gqj*k_Z^;gfbQx|I*;MPxpF5Yd=j*UE0U=YjB z#{lCcGt1g(7O)J4XwbEWlKH0#-fd^7HtQAqLQ-7~-1qE0qvzM;Iad5Jz48fzEPp`n zQ7dt6TUX#){PDk9q*K`ue~rKHk2tXO-Tky~e=E428g-*=Cx5hE#n05LDmy9>T?N#>HPwG0m;`AzN)CJGZLJT@}9N$HiFNz9rT5MmA zTJJ2i;`cq|l`-@UsTf0+SujccriiWBHVc96?4ZXt`3!r`?CL_ed-h>Ll}pDFjm4>b zdl-Iq!9loM=(&OOtWvPeqITaZY-0?Ux7nP^?Dn3Eym`>yK{ZHNJ)w)09?Gl0vQ#BNQKY)uq8x5yU>x8p=Wmn0XA0RUP+t43O$ri192S&l+*eMlCDxzz%luAZU4Ib4^JsNPL#gM;Shc=Q5%0`uBUVx2_oSQ8SUn`zRzrnEVC_;AwPM@% zpKXiq=)`cIxl8fX6DMT_a<*C|(Duy9Rv-S2oM+M1)hP2l&kh(5@r<8002Vrx8 z&fvBPtA@a6NLS}vgUFq!N06W5+}WJI)m4;7Mfc{aok}|8nKhqEF$>t7oio-gRB63M z%zBw~3PM)Kjp0E{MU}QKB*GbT)!=E3$Pz<^c&{pnLXh2ls3WTKOQ-yEB1kYQ8&iiy zJ& zt39unQ+Wk$Nyw#HhQaUtmM8G-#&D9rYpOE4hwfnnNt?7{1`p{loU@8_*g(5EwZnF5 za}JH#l%(>9g@b3#eS$YdBCiu_{iU? z@}1z9DlKy7Duw$c71~fP4eTfd65>3UZ5FF#pd0P%r#PcUp`l$hFkUP?a|p4m5lh2* z3GB@55b|QQ%;Bue^27tKLrwwcgDZ@Tl;El1cSFy(X@#bEjRR1A@;Z4dVCN8ktz|$e zv+WUzeqa}j-DmWCs3Xk=W*8lzccS`d_=)_Ps;9zT?_zR;gqCJ6Z40!bQMB1ZlApJDOH4KTM`uO-z zEnJ*T4MvsZc@+poMgaU`0I5JKf=2-FxodM~*+J-FQqUYu&R1$y~{YQ#Q?q>%f zv=>4=t!7~2*D}?2Gm32)g1_n{g~BT!Jith&6h8FYBV0qRJE;SMAA=|v%0Z0U6aa+~=!slsg$1pKLEB>F^o!kLuEhPf*e)K0 z5LOR6R#W?uHj!;c^k6uwGOrp)co>0SotzQH4aEhxFvlOZs|JdebIG@#GkbRVqZ|is z+Mbkh@AvNg^-DtRtb) z-A5}MVsJW@leBh_w3us7-+s=3JQ*$kTT>tvu30cNispEh*;YvK6XGezqS;n6YI#=- zRcoyBdWtsCog|&3HYGW;>}bNAh1t63bFnoq$5%Urvz5neke~rW$U_prh{Awh4EPzs z%#>^6{R2+nBMLU(gd&6%qjnzg&Vw^jGlWnz`jDyt&j#hVes@N=a`_wV0MwyQ=@1zy zYWWV}gJ(VPYhd(5d7VuPd3vKEhqgb@skOL=5K6;v7#m5mfpKAO2g9jhq#)K$R8}y+ zFMs_*iJm8Ldb5FRErgJc#lrACCKx=(z^GuD-JmEJ;3Oo{mvMWn+cdb@ zv4Z{n{hK$~+P6HyqI^(!g%0>FEJ2=Q{zsSdPDKt^ZtKnTgpY#6-T;KcWg0&@Y&U>H;}jMN-PI;@#h34Z0H zq^%;5p;ik7Ig;9Q&1YrT!0^-X$V*WGxF=Okd5}a1dLn6MSRr+>I9}vrT;*~?4|hNI z4hdixemOHm2eiP8BvS z#emkkq>>%uJcQ8C)vP0BSEQdLp+O=0{jBLI!SiBccp^w*wq90k6yenfG0xAWp&hO% z0CEzJQB%mHz(bgWWfMYbjG8MhMgWA!@H-%vQX5NlsNATt)dRle*Q}x(fMCKMS#7qx zrrPj9+bSwTT3SyHz9Oj(LrFJZ{gU*Iy5DI*1LMp!DLt1_1$#Jlg;ft=4BApXK7|b@ z27$8yL#=lX^w~%XXZQ(`9~k~HR^blY!R+9xB*}A;vOOcWSBD7@TMGaN$H;IdS5;n% zY{zI3J;iESQ4XQkg|ljNa)-@!eUn-7&Wsog;e`q3JS0)e&n)j2g3SSLJDdA&vEjsk zO{#cpMG{pF4nP9g7#QTj0F0*^{%%LMZ^Cw)iB=*byPOVCMk-c|Pc7EP z045#pc9;sI5=t0d5?(L|%hoULd4F`I@apMYs_Y$kysP1xe#NPz{+!fvRohpY{y0n( zF{RUhp&Ei154>zc?hM{!G<)szR?p}aD=P3@O3uud6Ih8@M`jhmdk^?meR3E z@{}p`cwWDJ@UONvmAa%LM~suu!wB?P8Y^dn9QFsR|QIie1SThHi!|Ni~{{{H8me|~&?{P^)hKO)olqUVE$ zKQwD~#5*csXnlmp@9oADNQObhB1tpZwIg*^aK6L?=(voPf-R*D1R(-gY&^dEaX!W#|OZ*2?n@b;upw+Ix}s8#Q*U$R*hKm6vc~-6O=={Hlr4Vi-~Nh;YFXOI_Y`%4AlCZ@Jo;xTtF) zWcc2Ox#C+-Ew+WNoP<}ShImivZ1sqfD2$4f$2*1|kCN?u8>nIm9++dv0)IFZVN2V_ zf^28mrK*k^S77)1{)s?ZTB}A+Ty!wUT^oOExCQ|{V;dqTGQi*ogCWSlP<9V-n_Jkx zz=}BLu&6_Tv)$c3mA!5i>7h|4daKV7FpG+{KprW)1Ff@Oqz;QM3O|AcCd2`r zn!-^YvzrV=`87o>weZPBSB--m6Kdz7r^cQQ5xTq;e$|%1hr*ckVVhJ=kw8@q7S{>g zj(+;oj!j0b#b)iX728D43_w-44G9dxFy`0*&%>5#r?eHVO5W+AkS@UQDL&iUeociK zWrvNQ2PhY_o;ny}I5$M{Jj6eh>!bROThz&SWFt7h>It1;R(OW0$X{0i0#jR|ix+0+ zaeJpfK`u_;X**dw>89P%(nCmG5B+Br@q+1Hx80s6#3Xh+eq$bJ@GWxe} zIKb_eUr&UU#Q_S$gW-g-tHSE3QS6yu_ERDd|M>X$_3PK$+nfJz4*pZdiD&fx`@jDy>K{LT=-2plS?ag?SMM727`N5L z_pUHouQ#ULU{A0l9QSxwBm$$A_*VuGpjinm6501x-ES3by69f*4F3b5hD(NTAjh~` zKSsf9_8dHh`opUWASvL%h}s9_FvZfets{^ntJ?$2Y12t$e42-&W0Gr z4@=N)1CM>2Ey3-U8)`YF=WK7iQEs0~`cUw_IwO%g$DsFt>=0|UlkRIBPR>MWqu;|;tlLxJ#L<~du@ zGx1cnO1e|E-&rcp4nvKS=azGf(l8FQ2ziKK@wop~)qdyo?A)E@beQM5uYIU|Uheyf z5u5jfPqppA*ou#E6jDeV1?;Th>D+Dwx8%|jvAju82z#Stkn=ekW)@JZ81PKh>Q1c@ zNjX69&>1{#sAKXFi>gN(sv12=y(RC1s&J8RBUPPb)o3XIuda%er)3U?XAU_rNLnwk zz^txiF;F1=A)MBcs~Rf|BsJtl&s@$Sd9(}t^?E;~x(mQJo^LsX?PT#l$FsO{#t@`0 zmh4m6;b{#T9-N55@bJS2zYbp6ThHkAGXeeTzP{Y%k3ar+d3kw%f7cIDc@U4mjnGSK z74vYjon7hnJpm@#;d?0wATaW3=og;LXl?!GDSd-bl1Lsusdm z25cN3LZU%=5f*RCQMKX^|5<#54?~t|z_e4B1A~o@aj^v8nM1$3u*7#4Fs~-FLx*Eu zp^%W+mH;rwg2B`&gK&%*j;cE49zTaGTX;0|SEt&{=pmnOf1L|~?qR4ou>{&)egf7a9@8d!TBk+l^taQc80-rPPc~;O({{Ng8^fQ zCrA!MZU=bN?v>p+4;2O&4H$EhtCGi zB)%p5lJTf&?-W?0ZuBUr%D>R3UGz+R6WkDS->(FMy&FpnGynacDVJ7o+C*|iFUs~j{o@UpZ>#${4|K~SMtXn ztx6uPwzKY3ujx3;117p0UEBYXAg{3|rN)|9tB67Xw;QYd5zLV~I?!&lO=gGD`FKn( zF^&v*3@gSxwZjC4!Ns{c-Drq3*B#<{gFJ?=N>O@chXh_j&**jw-gJ6)4~b$q#n6ez zqaJOe7K4oPFg!F`JXIftSAfT2-)os_y4j-*R=dQX|DD6{ZAsA%&k2EL~qn4?u0BAD|TVj~1DfrN*DPp#BdbXF)D^EDG^;KAsYP|;_4Rf0(W02)$AEt@v^1`K05cUC z-H%-jy)9&m`khWTr^KP2LqN@5J*2~s463UkJ08v@w!MFuPcZmmxhHed6auK47 zoTQORH@})lSCM{z;hcj#bY|5Yc0d>mNhb!jpx<}FY#MRu#c-1ZJ)8Iy%sV67_kir` zXP5fEU8Qh;G?soMBLJRAJQd*l`!*TtQu=WzLf7d%*-sZp&%Rkv-QG?T{1=8)eW(W{ zS={3`fLn~Y%&NAwVCtY7=TpE9N;KRYyfN z>8cR-yB)V|+E|%a9^L7JQ(&=ea<&X4t;@>P?Z%w?kiTj>OXzsF4^uxGu(_0%RjGDe zZsd~lY+KG=v!v4%p`l*=qVwwoj6M*ZRaj4<`sQ}kNzdiVg{St~IuBftU+~YgRbiWA zCLv^o&A*dDEC#f*aTY(b`7Dd&&f9J6NnRm*Tp^^`G*H6%DGwJNfJ(@Y@&dK=MDaV6 zenpFlaIQG<==XJ45sWI}2_6a=a(N*R+lf`}iezFwrRAC{>_fqLclBUPQkA&C%% zU<V+`vYpD)lRZ0xOuCk$0(u!Ow>0?n6dlxDY(V?L+DBjFn<~0ke?!wU#*X-_kFBpw1!QG$k5QQ`L{RJ&!9 zvz-#T%GZw#IQ^YGG^~cy&f0+#+bPZp9!ellH9R$IME^I9O1t9;!K}U{F^hkPa|c7~ zFd~Z7?gz{)9*4Q@{gnSO#KYYt5QDSzGP6_pLVMm#o4tJ_&t^Jc^WIQ_u8qJ)7@jD4 zt8}5KZjV^g+D!J|j{Z&XCTz~=Br3D*03=@fj3nf5VfY?!`_sky0@ZD%od!lmyDm5Z zQ(E;f^>;C93Dq;yGJ~0=hXd8!r`n`Q(w1N-a14>;RBp$4ML2;w286uVQWT#(c1XSm zX1+bSNUD}|KhR04{UF+!=oZhsPojiXqC?mUpzMPNrev&mR>G>k-WNOtb`5Mjl?~W6 zsq8%&10j0w001BWNkl<==|_GgxHmnw8p-6D*hw`xx@SE|c3M&20mF5)tO zTkJJwXrKx5yYlMMEcX`;dFY`b{9JC1cZ_UR!4>3DX!Con_{oBCtsB>(q@21a!L=O< z^Xgm%Z8>D{sKJ&_Xb~U$_^FE!J%`ayQCcPd${xc((sQOHHOh=POHx8nT&gIHaQCxU zR~W!fORm@eG4xp3q^ncmQ3@xN?K<6#a1C!itD&89o!T~RJUI8;B0Z#&5yNO2C18+O z@8M&pU%BS*0~6I6ED9Q0n4GSb-`LjK%LO}x&r`e4=&APQuYa$vuYNS^nD7VLe9oal z4kL<3S$kzNI~eT_h>Qy7UNx}IQ(hewhG(vD7%-#MZOa*3?vMxluZa5EozPE22pN!OX)xjtR6BF<+PXW znrNV+)gI;cDz?4Q91OENS2h_jgp6Su9*K5BS{|;`m_4jC@DCc+x}xw~@>cT7)}B1= z)*XcTo+kxP45l7xoLX6Lk=uTx$baF;dT5#VBKLN=eJ}nCJf}7cV8mm@f=UT^gjEky zU)i9{Rb8!kqA*sl*8c=&yJ~ITIFVwg5NC7SFYvJ2T&+_XgSJI}aVI5U>hB4{sxOyp17+ zjM^(_-nS2V4gs6F&_ClzH{-800nSx8*=Lc=3J_jLy{?U67w^#7@@M zr4P(XBu$pVLn6%r)`bR`Yc@!f#b3E0LdB(oq)-Up_BMLbfz9ipa98D02cDYFncKr^ zU|UVW$wsZrj$sK}LSk8B6)OgK+SuniVP8!ZnHn5H1~V?*ly^{)pflS=>6mxac66@Ow1ncCBC9S zf2*|>0NbXq^^9K6<=@`kK0ZEv{P-cEFE1~zudna#@BaJLJOY;CJI~*@siy?eVu_C7 zT#34%5bp>_9^Y3p^X$x09UD;@wJ@I1*;alqE_tP6%N`}(`B3hdn0n6eUIN6^wq>UfWMCXd z?IRDVknNnYnujDi0Ozmx|HIz9ExVB$B-%>V!B)MOVgM^35Ck|k;$9u8n{ zCTqI+05LaLQ&ThdxFCQHaz4qF!PrQh;g5RYyb8Pm*w4A$S2E5j#cc7mHwQ>DoD7S( zLM*y3Bwx z1t&<1{dwRj<17A$`eU81B)y6azq8b4tCkwMY#o4y%AE2D4 z!AqXM*2!8}B+k-CjWOo)0Rk~@&dfayBWQs=_v&@*hV1#B-GN6+X#efsqF_V)YlzyJ90_@8M7W8Z zfT|dpHH}G|rtqwM0&YFDm2_7jOC+hQv@4Q_{K+_l#ltJYHspNWJ7D)be*=+N4$-UB z%M>W_>{K-iF&+UpX=#i}2yzlrmz%vC??_yB(Ionl# z&KYtbKan~q2*lvr_mGAqn1-8tiQGG%*nxY({j3+o%F8xvPq>-A+N%}f)S1F#8L*}E z!PHqL;Vcaog39>o45^gD@uXfC3&sWhI<-8iq|Sjge3b1Kytf%V4>fr%6Ff1@hK&&n zOJA|S=CIbwwb)lUTA>U-5dj49^Ni$2KL#VX6 zS|R%(BzxFjGJ9Ls)5lcWxNPR54Y?J$X|0G~-f}pnahP-l{xlEog`Kfv*U-pc!LGH4TDG@$5jF<;v+nVq z*K1^AVa_3s7!q;+ACDQpe1yRl@+NsCJ)xvJKbc?jEKi$tgc?)nToF-auwE7W>kRiB zh9yX`%W~X@!T`EJMZXvMdDZY7hS2ssK2oWrvUv82r}l#z;$q#CE2$h+yp2sr4%EDsPPPYB*-p19!jsoDIh+5XJ86(6R8i~Kx&LdH@~7X- zz@9UTD!D>cQ*pBB7*)tJ3Mc${pnXn%MZsTw51&{{hflj|nSh5pQ{MELFeSgQ2Kc#k z^D5J14DcUnu;nn`D_s>*!}rQ^$g|A;#QHjfEd+V>5Wo~^o;iyLW<1Xsx9O5-!YH9i zdrro4QBj39B%QF$22Rfj&;OGcT7ls*X}F!SnZlTu@+?yn=4$9H;fcqbwJU1sih25- zE3hr8robPHU_XVs-KfQ05>WOe(wwkuxV7@41q0Ymrg=9rCHmO zB!ZE>#FTTUiw8Z0_i)B~_T1j^%!R8hy@{Oy=uf7o@sK29h?@LMPvL7gLzX3%U`VDh z3F%nCDVACeYiCn|$Eb`Tlec;f80C0kK#Kw3sxuQw$om?UHjUdv7KwdzL|^e=b>KF; z0c7Xdbyn(XMI1YAe*I=n9eR$Q(MRh){_zhUW#-Z3w{PE;3i1FqCFN0O%I4Ye+uIwS ze6@k*Vq6u#v-JRyrP}xHU;jAvlFJw?3{NoL6WrBZDdCfb*@R3{FI(!0icL@=!9xWA z!#fFl44xoUSEBM+OH{e=z)t>Ch48Rgkd%NL-nMk&^ZR1cUmiMaVSH=Go3H{iOv$sQ zsf&;d17qKkk#M5oVF=GvA7H38rMfT}7LQY8*01C>H~@ z-m9sls&FC+Rra8VUFs+fUOQ(l6K)ieYiZmD0!TV1g)kVVZnp%1F-VaiJOx`00hw@hnin9k>H%J0m-(_9EuFfO?ia%MF zoYQHK?ImY1gU3h|bya8VkL?lw!-nC&9KTsO!h@ty1ah#0#JH*j88#B-Sf@x9&l0a3)jVRD6vRoLK{Q(ooLlQTKDIu747Gcc$&l?KBNSOU4V zurQ}Cex}047Ol1eV{_h?;1!?X4Zm}d4riz)A%KlRS1|yW$NaWaRCyrzH#MquhOANQ zb=6?z0xesV<10~)z3P~A88c%MIh8B!@80IY4%hRuC1E^h{{o@v)+|KYIhCLZSvfVd3k>M(e zpDBz)1-1kuwT=S7?l$EkhOgu6d9u2Ss%7Es7!tR*f?!Vy`s4EH2~g$g~?Ymz0B)`48Mo}fOG0ObEQfR{vr)o*%e)OZtSD@yq{__U117V6MR2MExg; z-c3lUtqyoEF+~HHg?OJV0as1}lj!7b_KND`{4^mc(2Q{fC`nb_eu0RcM;kt{p01_F!X7@)NZa10i{DjnWUk z$cvdF27x|W?OfWGxFa>MP6?Gl)c!H3`YD}_%Z8y><@QiT^S_$y;sZ>?8iqiU%QCq}mJlKe`^ zt>0UEDTeGz{mah8Nnp;I85-}@?gmGw!8n7=HzOk{Fm8dI2n{h9=Gh?6{lb}#XSmDt z9w5;DTsFjj6Z?e3*-@45@#)BO#`t;FN-vVDtLQy!A2vV-9-5AZAvuWnL@ zkXJUY6Vb6+7e7j_bbPWx^XYaB{1rHd1Ttl9p5?sk%ZbIqV8d+oFYToB@d<3{yvMN*v0A&ZsSs3cA1V87_@px{-~4nnt{%k*??!rRGwHPYx8?*ratj-A_{n_wdNB-c$V6z@hZ_w zQOG6ji~<&;I%!TMnS|?0Jsmb?W7jfevpMM|wx&wC_pM8-s2Y+QqW}!)TRhdA89qHw zZH&rt)gP0`E>*>B=plvz&wWyW45=Dp)-qeVq?*n{4a>lC9`?sl zQ;|L4jOVJ}Cp1^c)l1x<<>n#C~oiMl@oRjU!V{+PP za5!fP#!Q)sZn#BPQAoN1OsNU6|0)rf7|UE>t_0W**i_5x&PbFO#SBgn z+ab)>X7I@w%$30{ilhA0$=Af_taMk*8^4#_vx73;F;odiidC;NVq!thrp$Qs`PD=FQcZj0<(F-dHd)lFu%gjCdBicL79YCx(qXGo4Td})nqP|3itq0b<)jdog$lnshww zBWaqs6dY#&ZX?Q{Fq~+v;}e9ntS;PaDcl}9U}x+SwnS1$X6e%0gvC!_Wx0ZtpW!}{ zHCIoPH~&%VUIV%I#skmj_e58-QF-+Zi)`^6x8AZ>Y#TpoQ#{`NT%|TV4^2Uy&%V4Q zS;hR#0kA9be73>W#XOt)vn#f}-{fpHy2puiPg1kt^lP2kIMi(v$a4aQTYvxc>@ z%XAc8u}kokvrghrSt_w)^np)Em2a@|W?R}gUoou8$8}WA>WrVWuPE8XCXrKbz=u;y zHY&=+Zixv$NYYL4!~i}qT($T4Auam~<0R?3V5~fZ)tuKQoiH3W>Rn2HcM`;7RElb8 z&E5_}dqsX54&Ys6WHqN4ukt%4ig?mtP}J+jyKuVv6G@w-FLtl8!xn`Mxk_%76qPSJ z%gf)yPtR?mP&i}poL~SS8gRx)TW~^h;sN}G;pLdU^6V8knC1JRssD=S(9dnZzuuU4 znkWgC%c03n>#4vRUWqSB6E=CK=jqKq)BPOJvIO6#yqApHa_%8t#g_2 zInJWuELz{jO&|CU<*mXG0z~cWZ^@AtLRQ&d7zJY^P4+9ZoHv%guM6zNfNBq3u6V^} z9eFggC;SPsK4)^;Ng=frb9JUhFU>@5lmm{za1%18Hc_sK6#OXwdzB-Ls%Mtz;V?9h z?^}{RdFj>US$ZsK33x9j-J3>Icz>n}*D^f_qxo00m?u#iHfUcroMmd*^ZRkGxBWiq zYWBmQ(UUk&F0z)KQnNyQ2=m-dtz)K0=rsnC-qG;ytVK`Kr9kRkX3Q*4^Ou-7y;tDh z;P+E$6bFe@)ZOidC*mp7Bv$LQ5*QBn4gdL6*sPoa&q+YKy)GoSJ%rRgwEq?RD%Yc& z%Wju5>*&`_mWtgVGj)CzzNHG_R=`z8_~|VMQy9)-8^F0y;dSWE^Trjk18o=H>1-G5 z-G|H5-Iah%=igD-?M`?um&IfAzkTdES-7jt?88rHsoJ+t^HjW~vOG##BFjmj_j6&+ zht-@K-tv@kw3#Pe3KGCA^REo3s^4AebNtm?FTpDcy?pPo<))ZQk@9B~re{)3Pes*m z;+LN1qLx%Y$C=H*D@i$J-BtvkHj;;6;Qw!8xCu{}obH*5)j8)3$$lZ6g3FVg`*6hY z93(%pz%T$Vf~g|>c^(J9lR|r9JRNvKZp<=~ovEcf9-8fE+MNHFVwUIF*X6OYP)!e0 z8-pl}fHPcHv}Bvec}&r$C4-%2LkWbQB`Pp5_+K&31@pb*XnRzQYvfu_nXtv!S5z3z z6|n8YIZa)`4tY2!@e2nK`cVeXD`Q?sqYxR(H)U6B8-EDhz3CyG>LSKbU^WKgv(~&4 zvPlhwePU19B;xmZ{EQxO^aGCn>ifsQVt82Ry5-uDbZuf6~jN`M0;XD&Yx{@AizIof>h}!vgaIEKFH$J*M|m z*)yEetC7HB&~f&J!LQg5UOk$rhAeZvy}iLR&qN8~@S`;QnO*WPonD$H;L1rLNs&~> zavy`a;(x-AB#e+`nAb=18V`e=Pw0F!RjX@ zk`#yd=U`V^TvxSmnaFqpHhvmg{1xI^?7}$X(oUJY`rgUs#*_W9i(g@MgroF8p0-_aZ<-N#Zd z#w~5NH-Y;O7w0}#s7y%D2|PTI6ZrlA{&Oqx8+4o~n4&sz)%!2})?mAe&5#n7vv!96 z7JmgmKaxONxih|EL;f7eRd}l49D9B`y&|+c`e0{lx;LjzJTMZE>+Q!ZRS?nt`H9ix6}4H4^%urb8H^d zbJlVS+qA;Y*znJ(r#(?!lfi6?9~YKkQJ=(WkuzT48%OaP=w1Nh1Vf$@Jt;KXC8y=B+rk;QqB_WrWN2r zhqE-&(V0~A`Sa(ux3~Pit#AMOw~2*hW4zll`aFVXF=EVyZshWqej|5Iv12%vSbO$I zqBxMsKRM4m;modz&Cwo`bRZcKF!}wz>~gqrgoEcyhv9dmz%~X~f?zl$nQ#++IJG%n zumNIte;<-x!Lk$Jf3!18TG*yB@zer%Vjl7okB4;lAwm>-Ytc70UY#Z9QS5LFutNJ| zCp(xJew`r>yqbN~PZLlQh8h+vQ5XR%n^UnKa=yxGYLoOfkyG2Q)hQl}dBsjf@>U@k zUZpPZD>9a`sPZgHOO=PV9lN)e>7JwF;wJuAfml$$3_L2c7 z1|qLg)M?W&aRYo?p#FUFX7ljy;Sz>GM?LB|c#|6!SXlY7Z=#uaxJFd>)1@YhSW`sM9iXct(6Z zb1-bFC-_=EqGI@UN#bMb3J^ccOPIxbEja(!xn%fg=U)Gd*MR1_nx-V$@^-3qRBG2V@1fV>I_whUemkf_OlcG*2kT8p98WuTcIjykVDUC{(A@At4JlnS^N@2;SW1QlP zob^hgCEKlrJ-`{UE7AVeiYO=I0KtGHP>cuD&UI$hLKp8HwLbX7HejJb1W-sy>+2=J?EOS9G1 zRHBvu>cXhlIlNNK)qjRO?WtTY-}ck|PXx}qUZ5ukmmw*fTo{1Q*DE2*)rYP6jQ`Or z1WscwVB#P0M5onO$IjQN0&iuI8e~;!Rba~ChB^Mp5PxZ_VR0S~D;HM{ZhGOFl`=(? zJ+>=L4UJsd-k-JsLx{0#j-9sQ`4x;=f=fm=u#eFE964J(;gO0xchpBHe~7bweHX!L zxZC~^?Tg?v%1gka@0ooXnISAhNX$QJqalPKGvq6bGlh99hWo~xC_>09{0?8*aI#W7 z5nAHQnM8Zp74qWHM+BN{U&T*p?#7{1IvKSvVBGQqxrbe4S+*|tKA-fEQKImrPvUS9QXCwJoV|Gcx?9ViEyr7(iMAXz&%OVoffz{_sXljDVZckwmD&?OrzhtkuoU7yH^Sf(1Wlt- z)`+Qd{w2~y89+It_UuD88=$ThH4LW@Z1^+;o~u`TMpdNE~k9Q5CCj7#Q$*y{iO5O!0cT5jihDOg(r(s1cN6AY=rDr zxe@_}77s^Fmeu@45+p5}-LTY(okMQ`W-ZVBx2j+;t!)5ThQYS4@VEXe&G>0oRXv$2 z1i%%;Eg=kh!)twoe8*g@IQ7n?nX05UBnm%9rWlgQmBt1GTMR;$!vZgd+lV{CnqucEBB3ULnbV7cG2f&T-%wAPYssMn6GX=t*s2Ua(kBRuMD*&z+ zdj|F=fpyrXx>=*~OFQMTg3E7wE(7Q0q)}J+ck$CG8^!F$U!|&s4s`dhr;)-pJX-0l z5C8xm07*naRN*AhDPFOuHzW~IPEu#v=Lgu_4a7U}T&i~qGN3x=+4ljS7z}5WS0T1N z9Q#bgh+v#^CzHr*IpWfR05-y4I5(_kBWX_MtdbwPiO5>9P*eG4P35x5DCn*AGZWPY`hyed7-C_v}M8~J5=oR%0f%S=}Ie$ z1LstECJ&w`8pyF$YF&72vd|5TQaH;Y_6k`5h8Q#O%44;qaKlFV!Q|CcqyvcuV>1P2 zX(TXeS&=0&y#)^@9v4`(2U!X|bS$(_7?l^=7@VTb%#@ucw)JoDSCR;+11GdaP9a21 zqe246g8tv1!~H&^@c4t+I7x~D_|~9m42QU6+s4FRhELe7$2_)g11G?J#;z8T0%P)& z$5hLnREi3JV)*WaOAVD}mPX+*jK?PGs-HnZ#YI1o;4vUmA>_Pw#lI|V>9i83!*4Oz zORDJvU%kR#g@?gK8Cm?OHO6+~uZEitQuw~*if8&AK4+ivY}7tP$VQq`%M@(siT|ZM z>A7EX8-V^8%No622H1Y6*piW0XNhOe&zdOnw)$7;Jw5B#?yTR=@PK7b`*y* z#*$~=2?KlD@Ojb&vL#@y7I}zGr9?ev?0J&zBq{x5jh3g=y~tZJ05H5#(SX`bF2Vz5 z7zTzL2IrkC=-T&ea~AzE^7{7nmMry7oN%J{nonloT!M232!=akf1$HZ5lfPCvS%iF z^|=E1PeF4BPRH1dJhZ96Cx-jBgm8)B-NB=4L=~tt!!j4h=Zu-r{inUlVy$gv&sLe5 z?KwI6lEqOoS1BRHn}OrVkIQ^oE)w@4cJ>~eWZ7KPr&N0gq&kiZ!(Ox@$DkE3yY|@j zk1$TUniEmsj)l-s6prE9hisn#bMDARJtPnDQ)~>smZY3g zUD`v5ijAR35R^Gy9M* zgKd-Ouu+f7hX4HfN{Ba7?4@$>7^#JWZW(LmqeT@yRAm2|MjEnNyTgwCOwCW{@MX#A4&S8@AFA+# ze7TEg>|CZz)it$bUP^MHQ|GOVXP4n|mQ-iAT?`dfvvcVGx{BGo!mI52sE`|Dd(I-} z(4fzU_@4=zmDU^D6EPGBTNZ-hlH_W!mf&C0xi4_3IU$b*(qRmqHE?&mOt*1X|IKW9 zwl{1wMHD-M!=EX3T2h02=v-8JpB`FObp}paL@i9kFbPvjC$qnZK}A*@o2p-z3Ka&= zn11~D;kUh4xp=Va-NM@kXs^Og{O-UB9t=Ii69dA0WEGLTGFwr<@~|}fc*&IS#;*#= z&3R(E>CIB6IZ$0O#LqK<r7op-;o)IMW&reNyOpj~w4DiHBbN@+7HFlaGAa#Y~CGLqU$HrX7@ znTQZ;u2||a!^WmA41-VDCMHxCX&Zi&$5>(jC(Fzg0G$Ec;P@iseT|ZR+y83L^1^|_BCjE^bK|yM zP?5_awo}NgH@El+=j{PsqUTm-UMBe9u(BZOy^Lt4K#l^8Wg=8z1jZ1;WjM~l(?AT6 z@Y^`dGD)uZjSTq}^2%=p+xvbR`O!8#cOuKPJ$I&~n5}NqutMf=gI}s;-8X>`Wifcq z$*%CbcZbuH=|py>_KD21L@u3`bTce5S7)$dNYZ7j1y|G@P6lJHO1ttqc4;SF!XG7B z?!d~jFQ>roJ3Nv1z8PVoY8$cbSvGv>gt<;Z_+u<%<4oQq07;NIOF~Qn%o}^jY|V6r&YGL|+`%h?y5=j7S6 z^;%^@%iVMTc|5;>_b4jt59SefsqE>sSB1X9UB*x|)hvBms*-qB(R3ZLj0J*lGv^wW9|l z0+5|4hI~DNSf=6$IXo~=BbeanUKa88o`9qn<_|Oc#&}P1c?N(Cds5e?BGQ3@2UV;T zV5U-XULA-$w>rXp{P^+p>(_vJ1%?c#co&;0ip@K!veU^5sUch1RKal6@2TiaG0&kJ zOVfarfE?ovVaGbQmUY>LD1@I7$SDvcsxX)$ibDpBPug*MUjbvwMF|^;6cmV5{sJ!R zgN zVE|7XiazcvPJhshgf7$LTQ>5Thk}3S0jS1Ns4h-^8-ja5nOs@3I zyjRGXXc-I4`axnWYphwQ_J$LccnJBCVyK9!6|}G{JtVwyNfsCq;+{JMSd6?H48Y>^ zMh|Ao=32lt!kQi8x06V6I>5}L0fkKYxXZgRDoPJQLK}lK9?J1g1J0T%@|yK9It#z7 z+EK9$i_H&c(2yB*;#qF9bY^}nJ*n%=Qx(+^4K9Jz^lZ_xI$#VyHmje!&Jx?6aC-ZN z91I3Yr&JfXOfi+i=GZu=2QUUp4A|wv!z_W6bEOkx8Bk%6g@Yx>+Lte1g5l6huK9Ls=$(FF1)wI5<6ByHq1iO>lT?X5(-*-3~W@(`O!sR#zPL`eAIYm2G8;dB*w5=fcz z;3b`nsAUN}MMdeht0?Uw zCn1)a2EM($0pkg+HIzK4+(|H@f{fO;=g?PlBez21UabEppEWX%+;qc>;s2{IY)ak&cf;dU;)g7P1C1`HO>^N zG3Kr!S576?27jDBVZ~E@pt=NBI3#F`QMFTo4X9FkhJLkdDzXzBs(5O61;dZwmR9So zIElS75@`Lli7NgYE<@Z*c!Km5A}}{O;H20mB5w>|nToKGPGJG_W`aJmjiHJMe{oVW z#}1yo0sn*{2E$Dz5Mwgf1B@o)S;Av^y4e*kc-yzuG`Di`21?bsmF8&&_G-wXML+s_fNbnra0driq+nM4O zS~A+h4`^_ro_C+_j}y%r%QJ`Ggr228Oa9GlYB9jHw$oMD&TJJJe~^CVs60sr`J;x# zP#rtdY*)=R#%%UuyCF^oU>ck9Ys%zRLXehcdnVm@DzK6gXqdAv@dk&1qcXz)fMJjh z*vT?g)Fz}lJOj&fHFVVxze&0zF~btzCIi^(M+x{>3>M{9>Z4g|GjL|O;wb?L^Fgt} zT+#0RSx}a>_?_B%mYk3<>vatC)p93fv$9KJ@T1Kz+vZ2!G~n^nyB!TxI(!)ZsLt!IlI$21vtD zRbM_xl#zr-L(ww43Q0Jy+L@5^Yx}hm06b)zKBLbkA$C4@Lw)8$YTNUJq+3Hp7|7n`7BtlFnE-xtJ{( zQ1WrcM%!~qZ>y&ED8H4N7o}r?a!!Vri&`b=jd{e41&U=!`_*ZP_y0zI(R~hMf09OUl z6Z1H`{jq2Fvdw(k2d%-_7?8)qA>(~p%4aMjTn+2ajB@O!fy_E7oD>pIiNR_7xt-K` zO;Gm6`_r;eq4%^GZK1!DdT*BO7;w-&xL$t=q$Eh;jCEi zijOFPbWT(oCYWTm20RrD=dIz(_YzDB^5S_q=}a_FFI?G^<#utAH_7pw2)<1O+oAF9 zgok+xHf5COq=9f&EdChm5R3uLP&O`!iEPUQ$EXi%1QC_pb6R-S#e-BTf?f| zQLeFIMdG0u?6(cG>oQ<(6TXMNGMjo`b&}R0$;tmV7l&aueSmw>uXuu~-Xap67~$DB zDw5bOmgKr7C*)<6c=swKq$p&D#xDVNvteP_`;wQm)zu6kB!m^j^R#jFj6O^L{rh+S zK>;bJKBmgx(McASYQvw8So7SU{?2cP7Uy#4L_7`2qE5Bd<%gCHa<(Z&@sW=I#DltG zAf`5)N$6FCRY-}a8yv}|!e*A8R6@UR8Mcm@21RN;(Xp;witWy#EUZNlMFuY(6QhbEAh2^jf=D@yElS=R@Tv$t+PA z#hD`ol6*eRj}p!(ds2S=u$uv{EB?CT&@}vb=tDdJ@UsvYOu5Fgjj;_s0w@Ge@C*T% z$F>2n{TgAgIq-jMIxu@!Q?r5W2gefigt1Ivo+O$uW2Oz>rxC{gg`H2^=$y36c0HYF6F5_Ez?rHL zwqG>+7B`oYpH|CM9&HhTZ0mFg0G#oF$Gt5lz&mv?*lt+bcI?o6b?EXJd9m>yng5*S#{fTCHU@lem8(gp& zf{ee01%7BqOJkVX_7x}LSAf6DeAZAHFm!g2~{8SIVl*R0QGD7O;u%=!od3Cw#q zvtYPJ^06*|app5{63r+J2m`tNOEo#q=R9l@hx>zDt_22^26|YS9HG-$o*Ket!x-v{ zGcdqL)>BydiZK9QoDysYR6T9;qpl_Ep%1-=@Z$Vj(XHi|7#be6*C?75Gh0QqGrY;Jn zcfckWTfv{>r7nJLnXL&A0`Ry-+odgd17g!s02K%TBb8=I6&MKnP^0=#LznrY3|Gw( z7iY2;G8mkt&^?5l@2-u!=LQQpL*_zE%*I1?v-a{#5(74NQUJgRVGYre&%WbmfE{d~vj%%vOMZ`(bY-iHNB>&s;Ca1P59x|3E>HbbQZknhB;$X?2->}1G^9b+GbylBV}+XrKKqA)PP;JGQC+4C4`FNPEtbjI({nT=sgJjg&{3}!2E z$xz_skTRDHY|iB@UjV9Rl4z-!*>IZKJiuZA^YRtup&^8c+DqLqZvrdDhU9h%D%Oh- z-mh7S4@1Wi6(ekLVib%aRP0ZtrU5xSe_nKWyJzM}wfFGBLp@?mXA;W~7;ueti}w7> z*$8&W(*IdV{Ja`qduCxa2Fk1Xn?k61lAn8yp3z4W&pwduH7MOv0Xvw5WXCwxjo1{A zhMDNf!^687i?&SFFoZQ_&19SxB*(_iGb73jElyIKvuxTDun)yTW|$OtE!kc{+wd%n z*@`9X#5wDA6kW1&Y14`-mU<~a-3#8Yp{2JO5`{6dR|!{b48s+FbUMow55neVvl4bi zIA`_>PpnUQB#HrGcAz}2g8mnVAsI0;1qlWrj~XzzKTnfX-+cW;IlaPI_5op;-N-Xf zWw|QEPSnQZ(?ZVbxm(4bqAWEGc)W-f#;4I3 zsV>(na?x`Lk($G{4&F4xiMYKEGd#3zt_vy1juB=^f~;X>->`X0BO?Ywr%s~qdkKO` zMaB?o!)h(S80=XKQyT;E7}bQL&9H=R`1e!AW(_67JSB-K`)vb=;Vjstq(VI0Fmu#{ zpI|b&zzNGNJER)E#FNy9)7ihY4PK_eiLvClauOB8MJ2UQL02S>y29N0BY>on)2*0n zoRQ{~J=D8Dcnx#--mV@l1)I6>lYBN|Vm6*lI5L)f+XOlt1%k)3Z?8#CZ1@BAp8WCS zhcCM)Y=@Xinnt<6*y$wwM4_{IHt$b!jm96tZ~c

      ^dG!wQpofZ~Dc|FbcJkvs5?j zi{i&oq-tr*?2N=0_xB6C$)_fDP)HQQOgd{rXctv`&alZ)EYU*;5>|SXY&S)+)AtO{SsSk*lg70#^PIBVs$R6l8YYsGW@%ViTpl3K7eM|!p+&4 zrDw_>?wmsc(p#8kZ@K$Ejq=wnkcB`#2O#v>v9QS>uLw9YkCSBz{BZ?p!g$}?FzVnZ zI?7K0cJcOBMee63=Jl}nk320{r)s+MZP3of`7#PV!`$* zdaC(k2HX7m1$PnwTOkS*{QW19Y1B%PxgKNUj=+#_#i!aAV%;5VXAX>b6kkeI+wnLj zsJ=m;tRL+@w8@e4gho<}I8Q%*90kH_zHDu52rmGw=yA{%zei>&+NgYIi&PW(%2R=y z-v@7jp$j#_h7A>sG)FqRK|LvxKOTQvV+8qfr|)3VY@B_?PkPLxo#$?9#41)>e-_lz z`OMmAh(83fLsoot(>+p}UWJ9*0qoINR|?`a7zF(+)hh{>XBqJi-fy?JtUVvmG?5mt z>M#w+nu)8ER-!Sk>$GVj)?r?eA%fp|O@p-HPw}sSbZ?Jj?HKd~uLgx1&EBsEv8VKA z%Co54vr2RoCEfbeB3=Lf`FyqEwT{>30QKcT6d%BYWmxHL5U!GBYDnXhVB|IXE$}zO zf=+2rVDO}SfRG{JoSG1SQY;?ec0Pu^N%)UyG2%H)~F$qt`o}X2$OVBvDy-iqi zU-D?ud3*nNy`>Tam88sSwOI!!uYG|?49rnJT@uG&Va+NrUFJx zpB^s04z9jmL1G)nH~YO#7izzk^XX_-+RjUU?-B8zTiunHWEMxebxI*bh^J)%lOKal8i%0*{_ZS8fndBL$&;a~-LKC#+wg{PQ#QRVWT%xH&U=7Iq(2TjFgjxb+Mcv~F7 zx%EPjU$==lLT3fht+;7eX;Sv%()s9%f?pMK=?~;=C}wS)G+94)3;Ah`D!kX1`wbn% z8xNndcRSW9DDwpIuwdzW$|8BC2kf{G7>uliCx>kKR|gpArMhHV_DPG>IqN|Q$fF-J zZy7C&NPqq!^bi)J#G=O215q0kLxNsLuCE(KE3&q+J@WNt-TabzWE$QO810 z<#a2KSe9=Fr@o?3Jxx-st>1NHqS3MC^Qoes4E$QwE+%JOgTnKzkED{Mxaq>W8k^$0 zMFOF<@udixTd5$FGCt6T#X&g{f|;V2WiHci>`?((L>ko*qOvvpMaCuk&W5=`4iXu8 zo5sAin-PISMI|*_BZ9L+UEbhS+w+cD_fXLljC6cgcPp7;!#;W`gPP?D@y=D+Fk>R@ zMR~9nGW;`x1a|)~>Cvy%3=#yCTB=2?4G@u`3j`$VYsL!7)yC+>=@;Vt7vifwdD-?k zE+Y2YUh|bNIsyZgxp)apg#IgKnx5wcL|rdt{+MGF>NRZYH5TXCG# zFTH1C$}vi2VXn85rTPEb>5(u?y62xSdND6Z=1o0IM>mbE&$~@7LiElR9FNGDNtqgk z|ARohNWk~yQ7_@?maOJL{Y{#{I^10 zDCCu3@vFE>Zj~eHzZ9lr?M?%~!PQVb)-c3B?t2R8%whC#@9t#!M2)JfYC@zN1!){# zB37K};8e$W1Dz(1ZKk4ibRu$S_jbN4J~B`vPvPn{^`UaCJ?!GFb{*+WVp8ljGY=GE zgUM^0%-0!)IY6yVgQOJOimvP*>yAA@%jwf?!yTEvbqIu!0aZjFO&P)WC{D=U60Tlq%$u;&z0i}6R7PTZivuSM7 zd)Yq#?~!&$&5b-h!2$Ug9;p^$g@GP|*<7_j(#x!XY_|~Voze@&iWHrLU{*Y13GVl!m$pEZ@ zA7|rO5KkK)poUH?4Zdnz2!0MEJTDZ)AgB|QWa3aGN;wQU(QL@%F^rEko;xjTgz zfQ_}G1t>;=)y+BvVg!9a)#dn~om?sc)D~n1kVe{{d^*2>=c12V@HiSPFCrH2{O`P* zW3AMIaQD)ZIwSB%FqKuB3;QuHxbaE^iZmeKZ|w`6?ckO!HB^8j0k{43b4~%HQG z{kK|(Ms0CP$7yhE1jK(WG)9efq(tb>)rl`}f44jMFsWV)(9Yup@X*6$lCtb~MA?3a zL|xm8I{m558_$8X5cdg&A6gK`jT=8L?4U5FV+>RATSre!AZ1HR;Itn?a~rlVb}Lpu zNBLX#ij-}w=1MP?G#Toi)~plWS42&Db^N*=?%t$ZmPj*^sOc(hBzJ8(tD8($HiPP) zv0rW9aKa$#^2hf*OMl3@oOEB|!0ZlCEaT7CC2f7w7i_)|mW(;Wqet+bCB_1p5K5{MYi$is+7ZPLXf&Pf4V-k+c6A?r@ zC;mIHV@91Cd*?{-%Sc?tM1+FYtm&BTp3wPkA2s@`kL>oH30|6g-C*4wbPWtc(HsUH zoT)LEQ6HZAM4bi7LXI1=d+VMX)`kh*QdM9E8kp5@Qeakmcw2PoTsx(O#D(v?ICjWQ`FSXe2@|w2xOP$d_J?p!qdrjW(Y;isg+_=t`O~G(HX@ zE-$O5{uU#T9g6mrb%1kJxCORKqJ4r-7yLz@A@pIHF3r7{YfIf(#{cn^Ldv$UcDC29 zp89KI)Ukg-)@hmAWYVM+E69~}fO?*gwxoAiozJFO7q0h|owkKqdISM}8sTz-o!SZ% zFkCuGMpeYN*``(8xC4$mNw2crW&MY$&STE#^w*G%7-_hZN3)#MN~HZsbna?$QXV;$ zo3$mb@b>8`{LeGQiA;CT#=6`iLRt`yEdpzQ!EQk?Os5mxk$H{`qbv0>pzL1O16GTA z{GW5}1Hvys+%_~w_T7Fqa#{Gn!Zt(0xf)4mGr5!&z;R!0%hv0WNc|9f z`$GM}&~e_c6>+dMx|Z!BY$vJ%8mP$GXe{KR978f@&u&!L#iM7DXQw7%DyQqzHs`6D zCy%8u;J>IA+X{+$Hy^x|{yq=y`n&+XJlKtP12K=te2-@ku9cz3PZ+2MHbE_f4}pR7Y@zRSdzpYaj<2OEj$h=Uo*3JjL~8H zxZ_`2#?iJ4!if1%65xmbo+%zWz(F(7B?i~AG((W=ng)7oPaP}sAvh{2!C2~YP#zYu zOUu3tv109rc>&frV3G&cjlJd+pfo1hOd*i$38t~!@fO=FA~hh_-fxss|Jfm5S@fOa zdW&|ZIheEUw+dOsamM?BzVA=<^`Y<%p}um`^x=T$rb{uVM{kUAif_>=zNjZcz_Hre zDvSll_KT;WC2xgBx?~h#(uy{n7*TVLdALOBwaeKGG=FN5j?lo}nZutDidZO|V26ko z+z>W#bH;U%!@Z?N>3x}-lC|kvFPSF3! z8fipVZ@$mxdc5Z}sXhi^U)$yo;{0P^+yofl)nCr7alOk}>)rB8ou#)OmQYPar~?u3 ztXpx6lUgY88Vw`NpW8aix#INM^+{I@GlQ>N(+G1nFdv2h?~l>wazO42PZ zi~EJZfc4{CfQfrRsQD7~B5VK6&#$Ya%vXl8zNr-MPF6_DtEQN4Wc^Fuz zl}W6wswvPdN`8;#0!3iYchf>0a_Dw3@S-khf5$8y0k14@ivy6xTHhWd&rW?Swq0HL zC1?C2r=DMKZxF(a7@wg1&-NKu+rb~zmAgk)R+t^+Kq;dba+8!q{pStMlzB}NN1j?Q znJtyz{J393?-C+7E(yK#DRzH;<4onWLKDHmaCes)_S{@ywzlB6R3;jD46u z=AYEw(jQDrLQJm@1iXQZP ziP5q1rg9V4lab^JU|x$x7asL&0o*b`d=eO0BDme|q^~qK>k;$F!kAg~o5A@)AE~`S zga*B8S{IxD<3{#4dd`I--#|9C_@i+oL2mAoihDinN6#i@Bb%l@!+g|| z140D~uEQbT3xBQgFubUT@gJ^`Wkn;YsW>foZf0g*u3-oQcRuFl6N_$z-kM=nQ){gqvx0b*COMIk5?9E*WBCTacU8Z_X>D@fLn2iDAE=u><+Y4T2Z56__s zR+_-x_;Am?ZE-vm>F`NYB!gX;id?~8-$YVI!CSB@4sFa|OJjY$SpQjqSY>!59b7hS zyW*EVtGB0OIk~cO(GenEbc0St1+uH~YKu3MUAAm)SF^MsoBuh*iD#i}OqP|&6E3h~ znWuHY^q&N$wPC*Xt(CFV%?~SzNLJ_BW>;#aS4Hu)k{+L(odE(wG5v^D`otXe8c&e) z@^i|2b`2|yy6$V1eX{9iHMO_kN9bu8cya_86*|DwS8Ic|dr^9ObpngDApJNGl~rrp zSgDGRzBpR!G#e(ko}(Oibq>b}+2F}uPBRgLO{-l+|0M<`x&1Qz0M zbvTAU3xEKO&A?l@!r{={&u>VZKWNDrS(#_ubjm!k2A-7pwbTttZbYR;I-(jR`?Ugs zM@v#q<@vRy2RJ`R(>&@+QD9*k0^(83e{9$;WC9GMWdI*(VTzej3Y~` z>q{`nd}u`WQgKM4&hAyr)eLGId3_R|i#u+Xe9x&F*1=mJDNd+bR!1`Dv<}Bbx<+zL z9Qv-9yLMvurO?OoG$0;a-j=;lAx4Lm=F0ppv$OLg)XDT9ps#2`lO5Y+AlYH_A`))X zgN$a7D1gM0XXXchUvsx;4p!1PLf4#hGN@#*YtH@x-fEzc%Me!7hcf_=Vm3f~1xDQe zsm0H;fw}scs)K$=zw#x?8uB?jtOT3sN{WubRGvzcm1c6}0}l3ET<=RN_Re<}1Xd@5 zA7bjKle=E9v9mxxHcxNEV^;cPVgjmIf^1r?J^3YUupaCoclOi640gFuh$*E71;eIB z%4%IZ{5M*Tcu}vhmlnR{hLnGy`8rDoEE!M2N4A!%B)Kh=Nsyc!Ce~XBM=<&mSZlwc zFw})Pql(fEPP0I#q$)Gk4#5r{B+gu`{kKpA!!OOCpt0 zkk(Vgc}!=JodUn0(xM&kvr4hF#>*;I9FQkyHr)A=|kdXj}r*=93Sv1Cbj?E+1c3& zS%?_JSb}J+SCd~&>rbtl8zk@^JN4$RrFx%;7c;&wxc|k68;AUtt-bA0+ZT}*+GR6zw#Qw|VZR49 zlo}WzPqdr2noFoPPM(E95Q+7kusoPqxQDB7^?L#QpF3q7OBv`j!gT1OOlkn(Es>`Y zUB=kXFL*K{XOh^;a??@1?yNL}f)djKzOwwe!1csr*xl+{LM^>qzOKT04*UR+rTO_y z?p#%`Y`{ucNo=@g#}0a6`US{YTmgCPlHAzeb<|ddxEC}LjvkQ*=j*LMf&(YUsx2?lN z^M5g%609frFF>UR4RJOV*&f<^+QuDl%1>G(4)B+9&NF;6T~41ql=>&TE#p zT-e#&z4iW}sU^Q7yhc>d#HLoicz9Uc8nBYsD)+k`7kz?<`;uK{P2;Z0W^!aX4o zQPXNKm7_tx1;WnbhiJ{vSjFG06KbuaU0~G)@{m6M#C~7F8g^L8-}0AqHUlqy5|!bm zJE1M~d}rTa$Ju81JYkm!5@t=BecT=R{2LXf=hg`F`3}Qwrj-Lc##tu3iK&+}E$x1^ zvA<8=A=^z_U1}o5^LIh@b3J{!Ff@6n{jw`mGxcvh_-AWP)Ahm1G05 z^?et>Pz&_d1Cj~7>p+- zW=gSbyX(dziiY@cQg_;d8;^2G7q1o|EOE&#y0oWhbdxFgcAR77nVQsh#SAY%o zYb|9!yX+U0)F6tdQr^PW(RAr_c~{cCGkfJSe3fA0e|^C7?q1tmvKv>XDr*0bYXT4l zmv|Sa;5NT+q8llk&Vq%i_?OpvS1BkdB#>M5V^EG?$Rrj|$b--*J34@V*PlqA`qNvC z4Xo1U&{mJ@0Rm7^-*(fQ(Bf=zauWD#{8anW;m;ya^E$@m!afg7`p8;9cph2a3s9_K z@OcKP_r5(pYcpo#dUSM1P7k#4jB#S`QqoZfu513_T89U#R4!e*7A!^=!wu+(zhZ!5 zid~ErlSq%@aa#ZDm|`3zwV!bFeu*2N`lGBtw-RbNC_N%&d`fx<6TKma-W!%j61+;B z|7)ggE4-m*qwNf-8IX=H-n$zPFLFJ@0Ueco7e$~mB(Ht zMi3MqY~S3?mZ@7mQJqF zI-zWV%|5N2f@LlfHk(sxcpWoYwb?d-?4|)BkVtK@CXRYd#2t&53 zig@_mYzk_1QJUn@tR>)Xf88@=q#!pqWD8s9IION_xv9yd$-Q4ucR0KW9Z+t z*!nS&A|pQK35zjXc3Un5=qX9gY^Sb<c7P^9oXS>!?Ym`P=Q?y;8^Yp9>YGcr3f%khR$8z-G$6TB?MlDbvw z-gon2+&Lbz?&gcEs(XuFLYB8++uF$glbl;TXEUvC&DU%-Dye3!5je)}6_zXtD744D z2bUw9MRGZtqH}A>T_hxKo6jfiN6)=c`ROKW4#*6LD!V)~9%c9|&ufmj*U7O&1#@4Z zOx=vWIBGwzg*X*5Ew!{Jg9({)J1~dQt8K7BO51PgyUO*XwdW$6AuBIa4ymU3?d#L{4q%ipcsF)2{ zF5!|5vSAE+jaq$%Q#ns;?hB+U%b}klj7Zx}xdpo`U;(|L35FIkc2FdtnC`@wbPxu5 zTpSHkzHX{xk^PIw1Vo?D*!}-aTtLJSapH+BDwN_ydMIe|^sp^+j}#ljq(Kq&CUdgn z&b6N7?yucCa2AtF{L*d{2~gHvHQ2K+e1 ze4Li7DY%=S*eE=(ud>mVjYu$?vV1n*dJz2e+|@67$dL-u@0qzT6N=D1ldKD}u$snT z$$Oy@5s3-XgZ8x{t5cW9EU{0oC3CWHGcae*jnB)_pq1n2QhHg7MxeI3iV1P4u%+~x zeI!lShN!S&6Lmq3uUt z9q!FlfYfrZi+0?@-u$4qPx}MEs#faXpQEhOWKPMYYLmU%yB6FS(T=?q1Qs|#4>qAHVQJWQpR8-j6g5>n@VJE z{x&gm$7XFk_63}@gOQW{xry3oX#K1LH%Sn4^)&^&r&pNF!L(TqlP9m$&%Psyh22I64T+kp`>XGc^&t&s3d)D|O%- zGM$#DbZyQK7?F>PkM4lThdL<3FL_3m^`7>ePFcGJO9fjXUHD2ycJWq=#mD~q=j76d z6|Nmejd92(8cwLmUDfDSq5;jT5jWOR5~)2@rGo7O;lSO6kQELyv&#`a1MTbFe}+S@ z+&$JwD*pj}Jgp;DDH#8OdKTIT!5 zlFA!I+OthxfzoVcU}My71l{54V5H)DyvHAYXEr`al{p5u2DZlR85_Y|=4G-p-g4A_ z9@-qm;NQxtt4;RqHX$e=IW<>hIJQX~q`z4*d81jKVpgC8)?sa6cjOOKLo|$> zw6tyFaZMwUYKG{hbq!%+kT>mQjA7D~ee1*?wS!5Ef;gb9^PmBvyq67>Z8H?e@-(YxtCLU;2 zUs}$LVXTGsrOyDOeL}3hlIUO0^30z<`R#@^Hp-FsrV=Ylpo1Af0h|3nx0WH{lLJH3 z&oguzfi4z8c+zb^7Z{a^`a#`z^V5)rtinhVt!v&G{Z#7!?LVjDY0R*6kA7VxrMh=} z{KK01U9WuY$h`<)o|&>qS{Tr9g%cRwZN?Mr4AtCbI6%uBbxADwVIRYK1eiUBE(SNB zC_2ky$}&lEZvgC}GYR>#+n&25It($}_RsLbp^^?=*wj&Ky#thzzHLeZnQhue=wPj! ze7VGey4iqee>9{NZxANr1-1^yR{Vt;$~+VNF&+d1RERw=`z)VxkTJmk+5|a7%`;mi z9_t)BbT!zZyKp?ta5zZqCdZcjbp%%;?w-z&e#bsGvWaUDvl z{grS3+G@Qf2axE48t>;l@8?1vFBq{-ySD%eRoQamNcB$6z!#5Z&r=&AzK(+S10s&b zXG9yYnkbT+q7LRp7Za{$DWRH6ML!{c*yp(WvM8=cV?iD0d`zH_B16oV-0xZ;>^d-F zpR6O%up%)N?=TWCr{0ZlY^ExvJWCrOz4m4k z>B}macG=U~0rr0*#$0Uzbq=it619y}CMiJ_Ulgs}V&WoMzWQobNLK(lgO08z zr_sFq>Wu;F3~=m%oIr&RpIM{`4OMOXz+hm_V5ped7kTJHAAs?wqc}gW9tX^TfMx^O zm3-e`9ssxoNNnkMS*pqhidubL=6?!Uvyd%(*3@@sBiYeXeE-dkCf^_(_+17d%%B~dm`u(NB7L-O~0_WZKEo%{XWy2?+Y89E&BwN4((>2E80ICUK^ z^&t-ZgmZ=@=IjyXu*%<-|9q}}Ue4Zz{%WL}sA$^rM|2T(98|Cf@p4VGx=2nAsTtY3TWw`DRe{ZPSx8Hk-Wy=Eh)IcQAG6BQ}(9Z;Ut#fn+b)JOD;dEqv-69%-zL*dXxf4 z-TU+OcUB$WulkLF-gRzu7fH*kg!D@Eg5~^+e()3lXuX{bKQ4tan z_KYxbvD7F=BK=XTflkiRfbAvv$ik)BaPj$~EiCHD|LT!B zw@ALX_M~qB^DwI^gLZ+l>tmctux z4(mdkv%uh?Q^=I;n%4^QHETsw)_Kh0^ft94?9%ZwE_EEc>0%q}g1p0{19%xCB%wzy zoS?Q{kAj*=4RHRzkqO(>k6sH%HDVevYHRK|EnCOZl?QB64($*pj^lbSYQX~kNik*6LSlv~k8{{exA0Vl z(Zp%kVl-`#ZiynT2J1Co5cTeQET$36Z2cn3$Y4&B&kK(W8>Ez9LmosMQ10Z_oB?#I zqC@QL?ux+f9Z%;196DDf(!|PJv#%TfhX}p@nlM8a3HX!3K%AY*nui99i-|y`2Av|| zCwl2PoI0H()t-Lw8ct8s;%ad zh>U|A4fTLa4-r;}HJdS0k>UdXQ3Uq=4@8_jH)EPUJ|cWB65z!GJfWPIQmGZJWO!zJ zAlQmZYN8j;a(LD&3F;ZnJtplRRN%SPMIRt$0idb?KOc~V2HY$D{tir#^UiEf|4Hc} z#+NWHmxWT|kN09=r1-eGoj&~o9^m))g{qjdnlU9LEB)o|zscdf{7?NF5lNV*M^k79I@0zY=C*uasT} z-wOst9~5ohCh6oY+8oLd`>v@Q+1Is7rj+7?GCMSJQNKxj9cy)50(kHAibRl%73yXR z!I6H^R7YAjwA#M2+n0gisTF&{-y-u+q+(7;9;#th^`3KFu%JHAis>XT0G9z20xiV* zK%kOymw~Rvxcwkr-tPc61WkVQMa5iXI_yx_uAv{|_xzuX2Zo)XeUi!n%jC^*?)Rg} zPb8$*r63z4uuLQ z>aJ1}Ewt@Bo|6tMo!}doxS2Z}dqmr7ldbk7a`#fMR3RO=@{8*1DNeeA1Yu^WkPVNq zR`m6Oztm2zCMX{Y;j~orgYAd>>&;CZ>9JnrHOhX-qKyR9eek4- z+hF@G(VBN7iR7AP9!vgq@YlBHybQ_MC^Rb(&&xFW!j;6nai;;PDty@Gxeg`$RdeWm zA=G~aPy6&No=jE1ap2%JsOj&V#&%k)^_!}arsPwy#eOePS;4sKqGV`8)&iN->Ff+5 zBifj1Qd9q=Vb+JP=jE}93N~B-B>El@0ug`X{5#|%A675PtSWz>yw*y-9r#YRUTO^d zo+2|0s}485pwV%*ST`myD8H5owy27=tbZ7Yl>#*6eqUkR^op$`)9UA|%PQ_F+Xx0* zmHhKec;Y_G~W-yQn^DD{D8 z=3b3cB|U}`H1&?>b46Yc`UqAU=K}gFGjgPx%X^3tzrR=ZKv5M?vRYjQ?L=@qoMB*D zIA2;fQ8_OLQ=@gew;zurD7xrAGJ8&-{M_TMI{EoH(_JkvAv^16levoMnomHWi3oQ+ zh@yb93m6uF-UhCGM+mo|FhbiH^B;*vHxoGnM?448(oBsRtC4y;) zJ`;9gs=`E3UssH(?Ueb0QL&kjDGQwfR}_~2S?yU!5H6tm{(Jm+KedSDE+M2Q3Bhgd z{1eN^BA+Y$Galz?7d^BR!~548kus?M%xtfED~A~}6bc#hc%Eg|*o0F+hn?sC!a8zY^NB@mj{D?`7kohs^9wpOxBcyA3}b*}uX*>(35%6#5dy(lzC z3D3|Clw|vAK`@Jjc(6V&cc9r4#?MN?Z~aT)-b`)Q`$rnZuBry z*qs%(4gO^@NEi{idqTmYdzd4qzD&0CBZ$|#;rn zbT(d}22tA&9r4|+yUcjP6xYL84mw496)^)jXen}Qdz%XFL{qGR3%fGs&+-;*LEKt zu{oE{-IG;~ml{utN}<5dPC%K%2+W$%TC%Cc`}95s>|%qXs;c5lOy(;S`J8~G62A5G zmtj5n!nnqh^i0g`LCp9WCM=7)>*RP7$2VwUl;gap7lZQjhO_*W(n;A1xuHf$RkM(k zBGtMo9^SoOaR}BSu8RDM9h?(4-Rv)B5DOH=j`uLOI4ZGX>WR8WylB$y6ADj@!a9_z zaEb6{iwkms!V;n4Mv81$%x+~r?-IUjAl^MaNfiNR=eEH-Co}%7@P*ImDN8%EPmWbT z=I<8~`C(QtqB`5!w5v4qk(LXlnY*fMe|(A5f)~Y_9S)VIfD8K`h3+NqB%}OkRf+3Q zH-cy_BXHnCOjL`s8u5k8O|M`Nz1-bC+!wif$#UBImg3?Mn6^*WV}1g=2H9yZGO3c2jw zA6h|-gJ4loV9m8}j}QkpSV{4OB-uY3 z@^HsA2+gL7>llm;=aKmPJ{cAL?0eM-KNM?zA19AO@K+S;(Dwg9ma5^^;0h$3TG-UpHcX{|i!a@{& z&Mw`n0(Bh;pZyn4`wry3?RHKxKVjC&uLdkIz+*FCvNNOoXx8qug%1}ErsmY@j*f)_ zgjZ3r>@=#isnggs9FDv#zrTh$K5?X{1Y{+@H9ofA%1!0>R5#{Y`92CNt zG^~8^X@~@S4omQN>1NjHIh}kb7s2s~jakZQD-Q0BGAQ_D9FY8p45o!+Q7yGx4e(S_ z9|O1B5wn(dkeIv$Y!D2nvrsrecBE{f_W=@xKWoi5R5=~*D>!`CKA6J=nkQDp^0h#junyZ zrI0|F@FYzVG7;bCV&Co+kwsWj>Dgf~9W+6R)2C&GNCcRWIC(hYk5#n0 zMlL**`4}_|(VU{`!nwFxAq;B46S&5l6Cclym%15>+D(|Djw==nyL|xM&Ba=JxscjJ zkDP|hG%?%f8-3){aCviVoe5QWG+1A!H5#HX^QNTj6|a6-0wsACJ+4U6kWZxhr_(E| z29`%W*KyeL=Aj5^fdG(DYX$@w55)c#-V1PBjpC>^W%s9ak^hv@04yV8Bqe|CHpk%7 zbTT?8oH1CrSa4a%GcF}iq7?qajqm)Um5>}$Y`0CK5$+R=q>d`GliMo$W<~+39sXV) zuXZq|#KZ^i74G@|{(Rg6G%Eu;bKY5hH0UQ-e zF4;gpq_3%|nPBgX8k=;tFGHQfi4j+aJZiy^v!ak=505LBjxGm`jTVZEbg4ty(CK#7=g}cw>v`!fZHeZ=_A4=GV%)};qk`PoOp2vd#ld`r zZ<(qf08W3yHNDHGPVSAUik)|H@ zTM%CrI|1x7EiT3xq6!V*>N-`9_^XqeTWJ|bXhUU58Vkj}2IkdHd* zO9&iqM12T0vs9Zgsa(4Z)*1J1bVI=JfFlT?UXXR7i78&=cj9FYu55T}L)I52u>Pu|I`v2YwXcBtjhS^>5K(); znsRa3#=9pndigvybGm1d{jY>oA$Hr`k=Z3f_TuB_#z?mx8ZVe^q_!&J1C|yl1f~)* zHlXCjx8)lIxoF=Bz~cf5tY+$GV7o+3ZhWdxb-s;-;(M*pD%D~#s{SfCWbc5AfC+Tj zq}d%2C;;^voenYwkib!DGyBloGW_S6@0Xe~Qgy0SQJ5nAD!#1=d{E*X_N1d+$5T3vg4bbD*{ zH%k=k2ynuVakGvk8t&o8E__Wie3yoA-rn8-j||BvCfH6CL85W0WEK!p142Q^p0}mI zQwa|V%n%&}9h%mS0R&0M)z>WU1*>#gP+EQPxFI0g14;x;!Z`yc8b4Or5aBI%Naj`i z-(D6g$sc&KIeWAh4t-nM>rWube;PE9@f-g8UZ0~q^_*-pBeq0yD<#|9N~GwUs&cDE5`b1Nr!-%6BbZi+3RhsDn2;Rbtcj_rWDmnz>|EC2Ar9Ek` zMp&ApntwHwqL3h{3q;qTKsU-zE6M@;dHOWH!;k74S%gKk_y<`&nqucz(v%~n9c@j6 zx10&^CgpyDIunM#jjm%2m84kxN>{k#vg2PHv%W^@ z2-DF#Jw9r%C$0fl#n_Q4lGLxu1k`w#U#ZpRjJ4vbuXtk^I)~R?w7vsk)N`c2waIWv zKxN75b(;=s8eU)P!{!b#eM{3k^Uo>`!;VgT*cc@DnceY-T~+h#9EO2ejKjA-%R|IGss_JC#W52(eHmu5N;z8RsIX{6bLfC1iBCQw?t5FcE3?UVh!sj|Hrl#jI=_7PW z(it^ax91b}l>gg^+uFXsnt2q|3_bDTPU-SjI{I}VTQSjB90jO83xHsgosKRd z3Vad7F7&cDoEdi3o}YA*<%B-wg8S~?M;m<`g7n3(o&FDa@w^_rJ{Jg-fY#8pndav- z^}Ui_Z%DUYDXZuZ~+=#z2Y)(~TUXB|TV+D^wBnzHPThI3FKR8dN1l9 z@u}ZRaMvayafo2m?7wMLDv%hOSOXh2!1nt$9QZu!+m+v#neX>a+~x!Zt~zo%M=d!l zoxaWecz+2faN)VciO!B|vcF7rIEL$uQ@AjleHMFZ>+a_JaQI&-1q|cs?m2IE=N%Ah>p2WXJ3EgMJfaBuc zP}mAJj=YJl*Y>7$s8VTi?!Bmh4aHK@HQag{#Y5B=d5dUn!9Y1;xtgHd1zcFIR@Cj9 zAp1NH!=!?&`vPJ2I3hJpGU!n14$bnnSJ$P^r6Y4AxVbIRBS{S3YOXuOS&Fc|FWybi zr|oVyXC2p^KR)^}o*w)y5n0aMVH}UKo~-ajg}jrW>raO7FD^u0FNrwZ(m6v8vvFk+ zJjrKE&%{?7HZDm624Xus;0ObL{1vq(s_RtS(?q^Nxs0OtKW;=)uUM9OGn@6$qaPal#Y0|mhVQ~8k z$L9JOvnG2t7%0Cfd!A`N1{yyIar(L;sZyn_{{9$r*hFu9$`pS4lNOB^y_Mt7r!8$6 zr4Y|0wOWk5zxfS1#9>R#5#Rk^cB0k#`Y~;N@3>2(nDNaoA4}_RR|7TjaSII1#yH<+ z*dMpIpseD$Rhw2gIK2|0mZh}MyOV6{Ue@k>PRb2H$ImR_Z;9;ue`jST5!KQ-VtF@U z^@+U)fVA_$!fYyb4qrPmv*y>DLAJazXz$tgvSr+1n!wQ_jL>Fs?oSxy+7&Q8$AZH~ zwxJri?*7Ga`Z*ptO?uj}``Wu>lqD*@_T7${IGL8I$7 zW}o`5GqHU{`KTo^cgjx=IuQKIoaYpIImya`#ET@pK>`B{@`lAu1V@tF_sSA)e##oU zJ+_8dSSJscwywg4{DE716zf{j6O%l>y5eY3A+N6e25Z_!nMe_{`}PBi%X_1sAo*%VCEmLx#SLWZ7 z5I=@yWac7fI@er>WO|H4H^RM=J9u^E=p@jb>Msc^q|a+rAUwS|*~4~m&ui=7*ppL` z=Mo0r$;n%3IsL3?UYGhbd>QdR+^6-8Cz+bIjTPU{UOj2vyM-w7R+J zk;vow%coJ!zMEb6NT)9SZ)acCqHwO_pNzXI(tdTgq<6}#hvICkYnp*+Dujy!P~|1C zrfOy{)xSenz+4RV7ueMN#7NG)2%>Ztao$}6f!`e{(>^3be2gxCUS9>8tMRu}Qc^(b z>VFpG#UdU&T{Y^_Z%~V9t_TB2)C^7jQ6XjLandEWevwlxBMW0$5nYz1;xxV|oyyq` zC(J6=YeSGpQoT^LlJBg_mrH9464^0p6#`J~@7rlHdk-lwfuhRD{m;bCeS{v31nx3eD`%+A0D}_f{_(tBn^`sR!oq%UZf@4j%ImDDq!>q}gMBN& z*uNeNHCc^aLGjr}{M$dyr$@lQn%bvuJ2hauUqF9L6Jmefa!qKI#vFkbgg3~wYg$HW zm5Z0x>b5qMT){h6y%<6db9>8GY)RV(JD*_`cBM~0;vGT0&JTC2w<8U4F^oS>(q+yu zz-YS-SRQzD;~1=xHv+ZsyJfd?d6(5dLMynZijx# zU)jtegIPfLW%Eei+IT00QMxSJ{T)wKGhzDyGufhSpQ`@o(o*^-k}{TLI~CJxL&#^R za^@sQE*@%!qP_&GlT(6A4Y`{J!Rr(rm|hy-YZpw*nfR}# z3~i-I2XFLiG%BU5PbJk=s+zU5JUL%48?3x+OaI-DnpN54NNer)eNnHOnq{(c7R)kZ zm6GzqFaE5h>HFokUX2s}A)YOb&VlMefFiU4B7i>zb@TwH&gN177}EPFH%cuzuWjNJOrwbe9rDS;c0tf3eqv@da@9I zJ3mg<0DL|`;~4Pw;@uxk6f>)43So6)ZF_f&h3KIm%;e`4F7h0tpserF7V*}Up0Ehx zKY#tI<$gEz&iz*--p`Q1vTBYGzMH{ux15b-74AOo7L`rfs0$$q(nQssrm6><>PoVM^Iz%(*wl=ed_=p=dMK`%bB?^JF9HTl3n94$8&-V269Ae$x-u9|n2HLzrV`LMq zqJ-Dy#`$*YK}nC41SW4T&*=&lG@XE|Au`5)C55!Zmo3hYDC#{sd{ z^sLf=N*@VFA{QZ%Fu0WW3w8b4=BANmOnHocGR>quGsAD{Yi>Q&S*h=KO`58mKWpua zeB^GE$wLW3kJ=AlD|Q0Qu9_n5l;3}erh=WCF1^tj-27UYnNbq9%Wq+!4=`L&CyKRYXy_fL zbhB!P=lzkGfF{uwWvUz<796r5RmE}{ACJx~nWuy5p;@%xk-&5RwV5L&aIxy{&ciD~ z&*rB6W1eDgA~Zg(NXp9Xe>4r$TvXP{U#TZ_ROZ0`C!|S-ERO}5gbS5PJo~lQ-4Xf_ zB#5D4W(xiO`Ybh5Y;~mUUW-8lWBT!9zq~+G=D}jlL`rTItlya&WXN53tFqJk#VJq- zU$sb`#)wd^wEB#oX-tjK4b2BhUt;}VxYmL7!Y1stcL9f7sV=oizV(skg5CdN(zeXEG!@R)bv6@eg_6#X( zgvWVh1IS1;uP{Aa-WeAC~}O~cU1!C_LOIVX4x z8tRMrQ{QUb7m4+|2W4muUFyp_Era@Ot}rk}fEHszAnS5|ij^+%NJvNs00%W0Vd;g% zmr-7d7U(D7UaiH~=A@!Lgj^<)88o6G%V~_BNM=dn+kS&h^84iM43^Z+-rgW6;**~r zX$j?D7L`unl-xvUy0Mt!PJZTtC7awoQKEUNIQfLIvkK|?twxg#73cJ1Or+EDSrOLI zzN-Si5JKlHNZ{ia{%#+9!D)9TQhEZrMR1%Nu%p*XocZGFb#D^SwEdksR!F^ggb>mu zA+zu1Cf%EAiah>td{jlSR@cQ)tXm}V*F=1A-J-9+cKDP`f^kbwXyT1>yy0OeRWRy$ zK`>;N*-NAeNT}fs9XNaz7hzi2eLaMy6a8h)>#CKCYf#9wYacn0N9&E;NlVmnh887Y zev(Ggh1I~hTR7r2>2nC?3Q=k*i%oIF>YXi~>ckpDCiU`3;?YKhbepbTrdO2-WQSHl zTB_b>v+nqKu=L)G5^XJA{!P2+D#3vK9YppQHDQg&isVHdIa#c=x?-&tj(k1U5xco^ z8aU?tBbw^uK|F)bPlu-D)*xaS=lr{|d&fW6JnblM>b_hzt`cI2Nx#yScfs;LTP&v$ zfv5*XYiZnIksysQzVlAQu34|B_ulL$j7pDpz7^L|S9=vUf4%9knaGnfw%l&;nadtf z({+U?-(@}uwT^YK+2huGzmcA-*UYk-`@#vhm1yv@3r14-}pkDI$CL}<#uADSKwA9h^A%&#jtU?+m~$?5ItJe zg%BrLuFw8v-DgN|1?MSfmb2-ro_KeIEc!d+m16%h z7)Q@9FLS69uUct;^)fLzJdAqo+lG{x(u>fw@|D~F0@rwlrPnfPGAmP~aJVNAHX(=Q zI$CvKCItPtMxKOaDN6M#J{RSWca$4M%rqRRP57yVk(GyFERVz_*I(?9{xTbFsX|r2 z@geNS?By*vlyWxeRzhP@u*E}}eM^5KN;1?Cc36Al5=`E7|0;778YVK2j0Dpg10@a| z>L?|7lF?{GJEl=`Qxt0hy&>PdjL*xy2*Yv_KVecfKz0t|uY$WEX{7gr<|x3(2lT{` z>7tkj@Cgj$TcU5mEKnCFC*wEF&Of8c7SWB6w!3VXF#7$y$XVytUi^sJ~V8tEG3&Yk5fM5X~C{bIzWog>xIEAQidguGOq0Le~L?B+58L&avv^9)6@0yv;922j~xX5gFTx| zXB@@d>6$uGW{ENuyue5N9|qH)y72h9zhP>UEJf|}EHtSxljMT?;hqsHXaiTnTXS;O zVemk`Xwi;M?W}yQ1FfTXLns?14qL> z<*D@6A`m^sRgf-Z;smb^w8|V5y3>68qN0xC83K7S)QC$MwYJyp;+-}D0o;H^N1MHXvfEF9vlfEyd0Ol7Y#_}%Sw?ahLt{(3A(5<2yB$oatS z0f?X#9P)_JDkIyBDcqcp0I#C1a0+wF)x_CfGG$28+9n~T5vJqeuwqpls8MjPYb}-{ zWrm62^N~JQ)EChwW-s1m-E-Jf@Yp&dfoIy&a0sjy9gf~9Q#@Uf>+=Alw3Zv5ue z&+%6x!dYz-O&@h5fzQo$vBKwgS^hdzMpJ3%Cl_l zUdB~c#$GnXrPQcVf(1QN+2mf7-NyHQa8})uDx0jpY5)dmVwNNMzOvEUlme1*k7vqv zyE2xghF;mC0Vb7W5%Jlp6e38aMmto*K2l`MT?+k^t;2c(E}9*G>AzeG9F^t#epUCjJ%QohzZ`8H`IuSsE7)ak0++r@ByFuO_^sa*aH>{4zZQSnN$SY_$@FWs zf2cUI@Rv`^q@VgvF_VW+oKHJdusCBki>+D)caZo;KnAwy&CY3$2YTg+pz;gLc(TN4gf8b3I3qw%Eg592TPcMT z->_lZ`_BkGEDXhDvYo_ zh53!zuUtGP6wR!O6@6K6g)7h!&edevIb#G5-0Ss&E(#+6?!*RM)aEcmQP{1O#2Zb_ z5^if;_iH8}xdjV`pj+a7sLO#D68B=2^kC3{#xv<&nwVn%^$P6!Xx`sE%TI+93~%-bfAg75r~v@tln%S;+SlVMTum;P zcXC(KywD#)CnKij@GYiCFMpA+;o@?eUBHpGjfOO zbyia(7Nmchf;rbOPc?YczH_f_vwJ2$YD38ps``lbP zB~~Q+WqD*OEcZ310)Ex&?+`ME;#N_hBZ?kO$Y-+3 z>QJK?7#O4o{DUD< z3^GnqU?&6-hnV2NLKk9<)=<(zHv`SFn%Ud71tR>tvB8@k&#RHqdlr{_>pESji-P&3 zUNb(ao!`DAHO&}YO{Eav71;^)1b3l0Ko(D{;G6y}sEwf#scTcqQc#+<6yT}F-2+2G zU{d+j%wbU_)0B9&>3&wlGxI*PJ5Dh69Su|tUPxpR%lpfRzX+KLY!kOY;aGa?EyEk@ zRhpUG2{wb@8XNm*GEIXTw|K7!)>7sYv^3ExSN|ixQBe~}!x*Pq`_A)`slD+4_L+H3 zZot;g)s^Z-NBa}>R~%JaKBzVvk>Mb-xoIii5Vqz)bCw|ZH!ms5iiYKj^OpoR64y=M z2mZ0R*r@i)Ssr$L^|05leu_!L7MK+vp$*VNhv(8i7|PUis_iNeNzxw*PPnJaUl+jJ z+3bQa*{4^qbl|aUO}qkBWa9=J&E>Sz$i!#wY2~$&?6Y` z=Zqw?RasqA>E6rKffs5YP=jSNnD!aN%M3Dw?oUoSnN>sjp<<&9n^E?(kF-Aa(CDk4 z#PL^fhjyGfzkzVWczbBA@Uasu8F{4@@zC{do5wHK=>HWNnRN@VAE5ekk&tD6 zZMo&+2$+~Fji+0>tIfY?WGIPH&|6tfOXcpcz`aA{C-xKlU?2DhXJYld|BhAkIjev| zZoH|qi>Z~c_*@IOUa&5~7g{BaaQaAPY0bQp7{_g=%GINVd%S8T=VBuGoechA)#}c4 z#;Z(R0KU*6!lo75k43L<+T51!ofZG`CM@bNe4UwI)v39YbFvHU`}W?&!w;W(d1SwM zO^ww&&*2Gcj$nZBc}-9H{Mg~xp?FkPwd=?Atp>pwcVH6(>FcQK zm+Vs%>2&NI^^J}5Lvr*zq~zqNX0b}TF_$u2o3jIGAuw`zMU1WWhSD=s9KGTy*-6P* zA{lfLebjL8=BFR{t}S#h-QT}6ACyKp3-SkLNxdBP6K0N6dfks)6a<2)3wY_UQ6ziy zuq$y4@n4RIEe4m)Qpd?Mzl{c|k`TD)hL3AoZ^PL;ZgLTkc6yXy9tPYFb>c00t?3u5 zV9GlX$O2AN0Q_cXnf4!j=_{My=d+upSh~Q!_pGpMTgFC(#USqljv8wxiry`zQ$rFb z{ogbzqSh_NXjf?f#$uS^a*-EyU^P1dYv_u7b{oSt_s_~`m$r5033MV{Q>}>ohlgcy z)06LyI+#UaG@D5DlQCHXGXEvt?Ww|W=VxO?AAh6#BL-t2`>8i%&*Vxaw6PMM`8`kB`gFq*YB^gy>9WHx8gY?X1&j~hrvD18s}wCP_ifaaEY>y1 zU^Sv>^&i>FmksZfw5Y1YV_&mNN)$G6P)h!rxnw$|fXSylIs=czbXKexA~Ys_hI z9;c{xb}XHlTb#MCuCA#eBO?XyAm?0T&e`*VEMh-unaD>`VKcDQO1W( zewb!-Vzyv?`1B;WBlmEA3R*m>sOIRc1#z1j?^-Yx*1p5N!0!GqN8IsMg4ODQSXLr* zAw=-CU%gxuYdqd@te&Y{i}|)P*t|{NQ?F%hOtV@@E zAogGR51_DwKep7C*pHgdpvEH+_EtL^A1!={!tK<9kP!)uKz)k^l zZLbeMKLbTU!pUd-%#pbxUS1K!M|tjw(;DxNrxZSWGWfXNm2J}?EU*JJu%Iy96H8Lh z%pt3Cx&>a`L%G}=3X z&x0u^?jGbH*V*|YamyA8I5rq9=mcN3&IDbC^9Xo8)XI|3duoTWlEa zE_b}w%BL33-ae?@uc@g4i!^}WP9APN>E-_%8X98%@oWyU3i{kohFwA5`T^;n6nb4c zIA(#;S$zq)e+VCqRMu`?0?ozogQA61OODi*c1IcyQoWq!E@cvh2#!B;k5<1{^UHL$ zNUq5w=M+lpwWj3i+eT%wr27#Y`G7P5_?Z=sQ1O3>xgObPNY@KvaD`m5wv9(l_@}h# z1Lu>}-T{vXgs~RD;uEZ5B@)3I#3=J}L(T(3SYL>~i3vT#V9@%a$~QFv5_9}j z%;AR=t{&5hFHnC322MW}{~WnzFp;`EK9=PtA{_QocDF#lbwB7Aydzqk8DCvQ9q9AR zcROAzarX3VAnJOEqM09bP`M96p*W5DhHql9gPUg&5L#*zf3Ik5F+?Hsr?s|_cW)x@-4oNYu{$st z*W6!wRM4BMO#u{QyBtSCbKz^;Qpt}ehV)XXGv8ApXeUyOXOJDLr9{H-;a6`PDZO#- zp9lWlnB6m}w>sfysQT=+)1|r%Tz$g~|J&MgEz+8C%nL*>YLV&~cAJ_yCo^x^tK1I3NL`MCeg=B=K z*xD6tY#Ou@XFpbBOrsg=o$Vii?9Raw5<;s9*g;`@suC+0k3o#x@8glHS;>jBE1 z(_@xzM&QXeU(9K<#+6f{a#AL^##IC#EV{o&hKu?Na7s4?qm?e*ucyy}doK zE`E4;I6tq}b`rQkfYofL}qKL>Yr>AcdBZ(SsbAsD5;8gUM$m=>HL577<)EOcdNKb#g7~J-E=a z>js+(Z98jVthJhYAx`JUB_-i;NJl~V)GV7=sA8g|H+upHHWux0_FqXZCE>qkf@Nm) z8CVUh=5@8U4s(KbaQt2Vwe9SbkQgrf@9WB2nb#o+UuxJ%8HJ?QBUJ6|h2*XV{c_7> zWR(NPo6&vbAGXpQdN=iwoh;+|mP=XX^;eGtfrc|xRaIb%196w>g47r?l@rS@VWDRJ zw55ebK*Oqi2pcfv^J0dc84)>-s0GmCs2)rdl}lb?g70qcUOab#fodF1Pu6>=^*@)} zwjTIcaH& zOXe?4CeZ_Sxr*G*xK87thjs9hf~r;>q}M5}nF*o^0) zy)|Lh^~||b(C&yNVE_#5+ru`L;fZIjCQ2GJ%aCnRc$Oj*8y_KLPTukU%no+pM9s%0 zkSY6XjI$qR*V%)YrwN2F35$sd8N8>fTOS8rt{f$%;=hx?DzTUGgYL`=E_a`bR3vw- zg%@4xPf=b2T;3iFYR(F-&zwFmM>zI>nVwB~;>k%#SJd-JfYmoh+LKc#HZ_!=i?|CB z_w@1tp-|2sizB;v->sM{iNDDAhcNu*-i;3HdaHg;T4-b^Re`i?yhyx;9fKA0d#98D z)J3eT_G)W>G!};Z>V^gP~~py&sx09<$l1h8446%aJ?+I4A=$|o?D)GBj#t*yWN3>%?1zWznuiZ#<@U+OH} z&(w>-O>kB)(l1qe7VGn1CfEokA|1{lfl)vh^1CJm!&#tEg+Z1H=tA_aK(WXfmlj(!i@p zhT}${>8j>Xyf=v_WsZtgr6727wbNVGF@~s1+Bza|Zn}Djb@4XhM-m*TMa35Oq0DR~@2M>QSgBxKpy^8N))Im22V~j%yG9Hf9@)Z+9 zD5iq-65YGl3oG?CI8eKkkkb~0ZfM_7=P{+vruV=r>p!p_e-3x}v@crk1gIPyF7V9tgLvE%@CU9{WCI9H=4kvg)y`@!pg zj0(hG*T}>qBX#n|(7+(2UT9K2@rEIW@jb>N{sDc-RruR4A%eln@~rg~AuMUt6J8eS ze~l{J)BwLlD7@bh6WbvY0V}94ZwA%qBIp-D2$$OxcjLXw^*TzLTPGoQrh|yk0=zKW zD{77JaoWELBiL|fRuQ&IX8zkGIJfk3WJQe|2S{`#qosm zC-;fS@LyY>-9=4$=56S~NGaqOD9;<=Smc7wkPMCyJT?w#BA>G-vp ztA?;FkX}(#YlS7;%|dss0@(oJ6=HwE2J5l6z`jTlhnO-D*$qD~6{F7@MviIZou9Y2 zvw93819ApA%>#xjCBAC3)@(E=+yfzu&c=ZaB=}uUe2O1%fLLA4(gRr8_#OgnuooWAA33q`#wtmJmD8+y7@0XUB z*JnS0@VN2smctYBO5C>TLDP+5^c9Ja@(jbs&`?+}jgPIl^9h!%{}!ruVPgFp1amtZ zGYxOxVYAGLKXFtm-QaLF)<2@=RpVn9%T-Hh+0dhL_@ZK~X0wVXwIUNV7|j7HVJHvD z#FTbT91bR) zNuJ=1U91&*AlBP9j)oYUOh%%k-;^l7<|M(5nP;r#3QyNqes#0c9db zZ%q0F!nHprtbid+lxH-ZjM_VDHEZ5NERWkX$Hil8Xb4pHN))`2^bUCl2N$F-kL6tc zk_}d$)se$tNi>Tov+JO)1@uIaoe~rO4K$Qa6NG$nbDPKDUv7@20;4wol2>s#KIc(R zStodVIyqhL>`=r@*GKb11?5o!`-O6qudkp_dE|0)op1IgmpELR^hl=E&yEk1d4rZ! zlx&-a%XN7_fyLuR`(XkBJ&cRbuLSFl{U_@Ft|q%G?D&!7p2I^rCx>LLH3l|n#CF5D zyu3WnDgz6h3-HImyIxo%cxvgwfd53%Q#LAbhjkX4m?mcQzVdE2RrYPm_iaI}>6&Sw zW64bW7V?6_A+KytB^74)VF?nK=!Q)>mR#-z6%I zDth@Y0u2KIc>bdeBLRdKF!sqNDSh|Wm^CAZ&U3x}{LsYEyez)8wt9hP$kX#4SR7cr zNF>!F)6N1$1S%hu%Q3FRPH>LYeoK;UX%N|TgmX{;sRP{-Q*Z#_vK}a*!ms|OtreuTt6J+ zQgNlMW!;(H=!d??XQJ{fB)R12;Q2b^DMr7qu}S?xS8q$Cy>H}CM2DyMVf#GTIp0xMBlD$be5gqbt#?K1vgx1HeSRaeD1F4C`((~mb{eTzapus3 zzN;8c&RyJNc3Swy0np@y0NK6oZ%WTWfneqdu!YCDKPW0pOpo4j`HR z&iND?W&M{_Yq=;hp0euxykeOLFPx0scb9in${+t2ic;JOrYM7+dKDj(3g>g73ptIp zxAD_pkyDIem>g<11>7s_lMmOLcB8+`;BGRe!RAg}?FG8oF@NIK#t)s1tLKeiw zdwJ3!$GweN{;rv*gs-4K*(Xj^Gf$61KBS01Z%3SnZOpF%!{0SVl4FDs>jGFv>c8NR zi?Wei|0Y1p5aIiW_O3V_Hd9 z7|QYvzm!9(_KRS9^<(EyGr7~+jabsbe+*g`z>TbeL4*7RJ;yApQR&y$AaU!1klXkmC_La@KRP

      ovUv zG#aN>iHT0A9P~aF2W7D?O4w$>=8roXw2W1C8B!Zn1=D3)jIUip{`V#kcjk$Ac#3Xl z5AA~AdYDl^D@E7>?B>+$>#vDpowJF^vB@)-mc{H#F=WlPq+rp!+zthQHVB4Mh!w_| zTLCw3h@RQ3jz=~j^wUx*k0>F2$b6M(>dER1Q)V@SIa4`JcIQ}&Wc8!wsK!r}$HvLG zA!8~R41epsQe@bruj=mrZQ2PyaR8=P=n8by292~2*H>=W;X3;<>igjfWR=Ic{FQb| zqCM&^zX|{C3lgfKo&9IY>}lWC*}3wQbOqIX94TiSy`5f(s%ihWxB!%(`o8E6Z`B|W zP-0(p7NR6tl0Ek|#!ia#+r)tMM)fxOT!Ic=Svh@WE9qzWOPOsylE8-2<`^JU~H zTTvwbNlG|^?(=(z4iockkBb(L@%IN~3k-a9dbs@j{PS>-?OWtlRP58rboKDSKsD|6 z3hGvy`n=Uc?e>Dl&6FIQpkz}z{PgJK?MVu5fbJr;LlGQC#AX8m>PNG$Av+5b$)2R~ zZ`Ew}MBepxHnEiU5RdbOyn<}hWfv20158X}**t8aV-^AJR3_*>Gf_3Qngr^MrJE+}2>Vdr_Gs3E%0`%?_-?8MNmbUZvniu$Lt| z146NosA#(P+i)JjhY=S>W^U5Dy_HgUVFL4!Fz3mO6G27v8>&%YxX{E|YV0*jk=vfETh344%l9xXa}yxUtF zf8)77cYB{5J$t58S`{-qU4H9LOke$p>}bo|$M8_ERIqj7R^X3MVN3>r8ejN1FP2DRcIV6EB3sZ|Iram>dcdL zjHt|AA07_PCLyiZrc)cD%zWoAV^Eifc;r#30LCj7()^LukK4Z(pnq$sFT9C2yNS|R zIUfE@4yKl+^|;vH?HMpp1GY8>CMK8zSRsvY7KjFgi#j67ivT3?RBV9eLQ|JJw}3JT z#(I#^X&y=vUl$)NyXH<%HZLUKpn0RB#B>5mdt>EaknYak7wSy&x1Aq?2YA~n(a&Hl zWMnkos^>4@Ta&F==7`k(8ke#tI4{2By>vM=6!Gz^p7=_9K$8gb>qtnwW^{8iZ_`@3 zxGa(m17dH~46mO@Va02-iKv=nW|3fGN^qhWeKt>KO3s}^p!Cf^)Mjz+l6q{L7!h$U zUW)K%ZzUvyDd;#CMbaNKq6#bYPv`Evq5t7(g6mwtkVg0gfxao_+t}DxoVlX<6IhzR z0vDINpj!h40DL0g9OUr!b1sK5<@Y7?k?yzr{O-EwuQ0W;VBQ{b(UECl0gLm*e5mv+ z@ttGPklgm<7W~^|C^DzF;}|_Oa;`l;OSDZu@!IXhD*K%H;WKS(OAFZ0XL$yFD0YdD zl)m33Wo<5FCZ1vycd$BR^OnCD@WP&fye!S*?sAa}%w& zi>R*hqSo{&LpO}ODX^3FX;wv^cn~jrijeD!cxz}G?fGI}G08sg4Pc5C97q%f=W*0= zxzhfrB%ncQoW#R5N@sC+Kpqm#)7ky=O%8fx0Jdy|slq=Tc~0o!^`Pnpc1c~0>SeSG z-}zo>mjemi%q|JS5&xOB+IuYQ8T%SGAeZzkt`kgQ`^1k5EkOQaDd1)8I<;4&H(Uj; zO^7)=OuA56nGmt|nK;9?lkL=qy|-OoHz?0ngeU)hTmZQw?8f(MG7droRQQfc3N(MgMi$=2$fsFvR;B z`k)&=jaUx-nwnBhQk_qIFrJtq-J}V6B>nd%kgCY`f`9hE#ssw&kh-N#g7uV`GkBNci0}a z*%3}TlJBe;C1CC%1FO_kPm|hj8;c@*)02t60$tNOPnwQs+!eg!?Qu~d{;_^HVV8mN zGI9Q>Sv2FtN5Qe)MKY`Y=-(X2KeqOio4?{YPN9-;h67)AvE5 zP#~psUC3u#+T&581_np|<~dkSmeq%iMDM^$e?{)r)j(At-#1S>2a9D#BmbBX~T~(+p7?x zu6f5hGwhKPA&r(+RsV)B52M9}GcxzX{kUU~6WX|XD<`0&-G`)ZFas9DK7r@E>A&sA z%&-(?5n+O3k{UBFQVVcsEvxm7CB8b|9@Z<+lYdQ$?Y1UQk6GyH-3Wq^#U?i~l?Y@f zxQOQti`Z(NIYPSJ!Q=q?yv9I=Awx196@AwmI8ieQ0#c=kOy9u)EyZdFjvhxLR56)p z1M2E0H>-=qMXmRq!m><4IZBmb1>gmx{?oxS<&>Fc31bA!$)G{-0sh&1K3suBQ%_2R z>At0}RD_!gdP&w1l_W8WBAHFj(%=6d(1abEDex96lleRDUV*~q_RlFf9@BwPNKnum zf9B`>PbBZh9Q|0Y>J5%fAhvTDycsHHo+yx`}hU`niJzuVL=VRR4>48Z@Y-P*P(frX$dfX^O#0VrV2)4i< z#@%hW#h*Wnth>Zf8Cl{wnWB2W^}N}4%K|Qy^?-@06}>x_n1j`zOVE*{Bq8ldVIco} zZ~z}L_QCTcwg$E^rsuqpUS?tej-M5+E7>T@eM_U=Ws~vrxhrC)&?gN%k0`)Kfwd>F z9?%o+$%&KW3-sjwXUASm>z*}KESh7rTajj&ke2w`Lzbm4j^YgHg3}!r z8~T$M^?9}loPX1<&D=>4B}S!)U*cAcK$`?dD-a15{}J0~6!vg#pNfx3yRt zI9;?Yf)H{}zz1knVF>v_o5jOYaQJ-}TuXxu`HE|e^v3-+BqtKOVVN7)H&uF`{c&fRTAshd-B?tiEVf}4lG(S&lU^c48?N`a6S`L`; z6Ka@lOmxYpDhv9Qut&&vk_!o~sycgdsv(&RKnA<75$sx=MaT9C0?Pl7rfZJt^9|Qw zwQRRqb}cV0+jcE$wajIE*|u$a*|ltA%gdeTch2Yh-6y@@_j&I7zU~Wg@*Mg_>GNSP zFJ8SK3{#N-Xwhg3*bhM$G=6N6c`d&hoXJd40*3~5uc}|nm++r9vVCCb(R=&`nK?C_ zgq>l6GqcaKBx4EBNM*`3`k1VFRW`#lxOoAE8Yy%<=gN~;m6~t|_-a2q;AgGw!e&PV zrB3VnV@FT2Z)3Qccb0C43BiT4exh+9FhA(4d+_H+7Ld^B#-!#B;T|9CRur?3k<`Pz z7L~t7+&*@Q$;bJv1X^xkk#=2-L*8Wmxx$3HZJuJN*$;=aW)G3xG)5z}C#-_#{w-)2fO0;IJ9LmWyN7PpZevDl84)Es zTT6jja7W*h@~(CdQ=wu!?sF>+ISX?U{SfZEOTz4=>TilVFUBunj3~PAMuHSmKF1WE zTFx&}UFYwYGX$WRJYy;uH`B*JN8kG8J^1%U8gV*0&Uc3y6Pjff3t_t@g9kLP0bLF3h?oP4&GJi4h(9*I9R~@nTEj# z{ujI@=3A4g!O)G^5{<-E{KDH}uFx$`?|8~5T6VdF zxAy~}G3{AG9~eak*Zpw6Bd=XIP}@^KqC#M^x<>FP7?Uy>DQ*xG5qUk{NM*=Nj!hSg zZmjuQ;yRH7bY92LL#nXm^utw4s!vsw@Azu@*1nx(`C^_#_EB`VVvVK-BM| zudj~<20YN;6zrccZCG=CfzLwv`#_OuY$1hhlKQz;^KhRGi-2YO$=LhY!NLf@GKwK%;c{!JPRQBq<|DIhn=S4 zph^n(cOPFKK2MFNE4_l3Pi=IbcVvhL*`ePSSHn^JwxB(RNZZ{ElmF%eS$EB z{wG`7Pa?U|TcYf5fHHD)bhN$QTX;(9KA9f^<39cN!8matqxBHrrpy}q-8!0L+K*Ul zOmqXee_gRYl{C?%)-!L~9%lZ5P#^m{@7Wk3{?AoF*M?D2{VQV@LrkmNQ@p^Neq@)$ zZ-u6=k|d6=d7tls8!Z)?_%j4bPX-e{d5gPT_lt4AG`np~WoL)+rv^0#W5!O5N_w*7 z*B?++jLx;E;K+W&2&&J|W|&I#xQ!n)nkjeofHT_`FXNa3eVd)-YhT!BS;tyBZVtb|HnZ1g96TuiuSD9K zbAgpq%fe_0J`GU;G_jDZ86;FntZTr|xzl;1_37OlOAV{*Y^WA#se%-x+4pVk zqT3zON3HYlnl{Lv6bR{^TPVoTFB39DB8ZCY9UY;Ajc$@?@Y2i%ayu#dfuaMv+C0%X z@`@x?=!uGcdxlG~Y_dAV$wml}-yasV#bx}R@|NC&U)+#=ahuLRTD)s|(RqnsR z^NU_CXN=27eJ8a4;p7w?48c|Pc+>rV>d-4%miQ4q0Zi*1&U z*#ES^Q~%0PJnhVGoS>@aG-LV*k*5rzF&+tw#$Bg5aPM?Yx*D)<9SX;Gf z@_BK#ni*0$<=v*g?nqeDr5VjTNns?cFF|5K$Mp0}FW*H4t(+|12ea5L#gONwR_WXQ z5+j)pbZfBIUB>Hanw7Ot5`@A*l;KE-i~8gA0M;FEQ*RFfoCtVkznB1-M^Lro8%bbX zHjDO*&C94a<3kbU5dLno0~UK?HKdp8|f70|aC$@Zp2C1jQ65f^&lp{G1E9 z09$M|iXe|&%=|VNDa!+Wn{f))ptjgbcOACNO-IER8w0MAebsb{_}fPUstPjiBqZFT zfEvb!Eg`0HU>OMf0?q7K2H>gEbe$SwkUVseD86Sx3t@DI>n;erxe0g-*JuHlWe-8`>@%ans81?+=4+eNKu!aod?G}MQrZo~bc-q6+8KS{Hm z>iNb=4>uh_oMPW#NMBIN2Rw1^lr2I&Z>KPrG1pI2dEMCr^tnzdnG_m_n^1kgAQ488 zzfML>A=Q)C#gs6tMJ44EQ_nlg(8y{maSfu<@dyK9_AV!Utcn!K}^ob*0scaJ0S^k)8~i zCfZJKkQ!WJeY*or`Ptd{!Xa|~bQbDhsrzoBx1ex5j2{5niZH&zpn>B`=tsxy{*LMVug_{woNl|gX$y=0ba4G;!`aT8F?hLRqB8~wEto7;o@5xEH z?O!gvS#0N^LcEN}VH}h8aVe<^TCAL(zJ6G0qDpLTSbN6AYcpk|`C zcXDDy{NE~U9-VS>PppbNqpGIdUNOuG_bZ#r9EI$0*e&A-5mlNc;=^*+V6-W&yzT=X zk|^VyX3OqMZSJF-|AHGM-fu7_Jcn*biVZg-a!?X~2}Qv=GW-Z)Evkc!3j5hz#lycg zz(TW4F^yv#<4{n>5)%`hSwEeb|Fzw$tvi69p?Y ze7dVME1LCwoIz436A}7x7Ew0thuJ_lB3C@p5HB@uBgNh&jLYJW`r}nWX=$w1t!6B0 z<$5bds}mw@Ayu2CX_L=74si(<64#(z{*OP@oMB(d!ir^C8D{5Jg>zCRRWM>jO^KbR$fbm1O*%9j%e>!j~OX-;4jDZnp z+G%L(T+m}4N5IUYQ-D!*UqE$`WquI+)U4)TXy|J%lrt*<7hp-?F4MNTx+)WRhdq0h zG275zN;)pv1I5%7vyvg9tf#LZzJ-|Oa@U}U8;2=`$>_jGzv?M0@k)a`)Hz zdghoxrUSVd0yi=mr*EL+r2#gEkjbPd92-9(@?T)&?H7(rHBL|~#1XclZFbRbSj789 zEwU6%WVBH8r^@gBQ%RrNFVV9Jf;^PWdfm;CqyJtWx8hTQ%i z3_r7{6Cg8=l**}gx^baLEUCf~?$x^=mtfX&!;5If^xCqB*ENMvDUq+dqvDb>wx#B~ zhTqyX5~!ty>{Hc*d#gz9>#7o2T3K;$D2?0#c{7M?cbX)GO^*PC!D?x2EHo3hL=(5H z?n5msYF8+GIB6#NXQ(0$Ext;#Tq*n=uK)g;-Z8L^N9gtFX!y*R^!Br!8Kg&YuW}2~ z!+9NY>1ISD{8UAPQ~dxIet!P6=>C2YeB1AbSqHk= zxJBQ3sWcG#LDY))0EUxG;AXOC!UXLjyFIqA*|r&pr= zo%eq8hP?4hB~MZPgLgTB+lEIw-n`YmlzXS1CkG*_10Edek~K!*BH5Z4`SqdBz8E6M zEs9%xY2*qqhQ4p$61?34PSEiVl?u*yQS~yx;LuCH7q6|*Q+*xvyvyNeEiV2)9K4M7 z5T*FPjYDu~J_YA7U~jHhVQL|-MP zYMyf08+#|sB1(XQf{K4Q*!ZC73Y^VYVsn1nIAgh_7WQ86j~a7p1#jVxa#r(*^+P_6 zXHaa*D&c#F>F4x~`%@poQHkDlhfq7# zem5`WBA)$PU=)0!dx*iit+T86j6vV}FU;(9tZGkp=jj|ZV5=6UdPeB3Q&C8fSW6)? z4&$OfFD2@$GBLl$$Nu%ID~WKDVg*BEyD}n7H|V5)?LM!>4P3b(oJ!n!CQ3Ok4~z&v z7Yc45kffa?J(VMYeX({2hvVaCU`sSb7OMyo18fI{gKj9_QH{xxNqHMAJHis`V0R@< z=%wT!Vfh}*FEc^HyISb;yn)T>0kT`yXJ_Bw^aiU8roC}!q%++$?JQGCYFx?x}Zo;AZFFK&1XvAOSt&C;_%Y=z_)A1C<*5Fswx4J(B37f(_l*(O#lx$Atg zAdIouq*bv#5h9^1Ql4mxp)_X5V3BG8dphudf&mSFnS1g(ans0@C|bw&EZhLWTCh^$ zDdVlrSiV~d-fJ{>mr~+k@uxru4gDu2hTSLY$w|5ul zA|eC-B`{>aGCKO2t!10g4eR8Bq{POCk1|PU>&LYRHj=cBh4-<>OJK~$^=kWTT z*}WUsydaI{`9Q$s(CHBg61iq;CJROx(ZU;nXu4;yY#i1jDwR^I`v>ab9!p7mV_|fj@SAnyeY%zO0dyrScVt^z6eH@NW zJni#*p$b}bq?W|NFxn_bldW6uvDUXp8rvXW9jxpmpA4Bh6{=m@SBotSG@^ zly5Y{9BGgb!?b8r;-2CFqy*T^FkQ>iIA_*5_FS@Jva@_s6m9F*+&hrKz*9H+uMF*r zKsc(QiQ{^c@ckoQhCboSpTyi9{FWP_Q>iG9p~w=Y@QOv=8ZgF7<&A)_M4msa?8Oq2 zRu|Xb;q}(NxM!OyMGEr-lv^-6^->LC5OE{U>?06UanKKC);}U3!LGSVkb160@RyEQ z)W)dPVL5?qGTJ;B^Hop)zAA%qocamg@1aXVhVroMK}j{{l0U^_ZN%ULUlCwYsFkS- zCUZW4L-OAFHV`R4n=5x27@j_-%dn$yo8pkc@io!mI{x3-98^Uq9-2YeFNlkUGCue2 z>a@z0lX(3~9R2g}O*Os(B<7iXqZ+H(92)fF)K-rl4gRw8cfV{h0!qir37liCH%5i{ z##WR7LqV0k4H`?O|E1M_GjZDS@~#fYTis;C0=w{RCtHc{&n-``C+!zLA9BSJ|IniS zYPY&*voWt%d7<<1&a@vd~=)`=- z(}cLa#l^H{0z^Y`b1BrANU&o=h1n~b5+FV3T_@)gr!!0qEM5jS&P{wZo^-#@tMVr6 zOhe2>nlLuyC$3r84Zz+m7@_IQ^R@;Rt{-TrfB`1!=rShCY9sj+vvYzv{bP;v-qC=M z(EHM(6?ETg(ezj7r8i;fV{Hq+JF3p1eV1hlIK7n&%mivJa#<GCqtv$tAa|QD;%2S9|MHEC zDaL*%C97Gbft+}s>owHzhqLp4DMn~{Q9#}a>`th;h(3NC3*?~LLubK5@yW?mL!*^X z$w3o_FjQq*PMCg*NC5j#NDfKmF9(hQT>0m!N)-t|0P&YUB2Q(Xl zvt*Ccn!^B9tL!oap%_fe^}7T)xj)$!xE^SS!kuP|)NR4xVQAMzKLGwE=O{iShnnxH6xx!rhw5hb5T@ zeDn1#$YJ*eV8g|UOwgEXek%~DM?>MoI7wrcs&48q3)XS*4{qP1v@WT8(xMEnEiZHP z@jbu3w4W+8Nab6`;E^gp;ur-%_r(e7=jyzF$6dSwbZ0j=SQJ6tM|Jl`DAe50dP!f9 z&cP{MI%BJ%r9E#|K|cs@PPddC`i${e{af6V7jJ_2OuE(6iAA%VM)z>kXjWR{VZAhf$Y=mob!AaZ0BlYZmBUVEDJrPLi-(CeguE2&4ksU?_ z`e;N423mfL3_V+C9^tobqu{74LwA3t_3@AC!_PWqkixRE^S8W+zR03Nh;njnC5pJVjjcSqU6nzDA(zU*nIcMU zxS?8~?)&CqEM(Q(j8Ln2Pw{YWJh&An)hudmk~*5eMRaT}%oz0oY&rk1o4+(XjiB1m6n3vro#Cm266$?e9?q0t}85^tpiSCKAP}h9razDl644Yknb4T+& z?tiJ7e0=jQdtOvjX070*f4o+(rr~XOrd1{FjW_=@a1B2ECIZPRcQ-e#FJEA6ET%{> ztt=y&S;U)%hX(M0T!H-FJ})*;_N6T&H9p3>bS1$+lJZJ11jf_OZhC|hMo{fS0PdUs zr@)R4yIQTmD_Dt4gK_JTwGWP7-I||n?xPwoZ2&gMd#Mn->QJbuMdYhOR2L~bATGXD z4R~o?WpTlSze`iFhB(G73c}>T>I1&{WUz>V-ApWI5~*sw@(*KhUZb#F@vI?(j-l*f zJxwQiBxP!6s>KK>z7$I>``E^#R&L4LD8Cd%YEC1X;f6Mwhx()|-g0wW{@I%Wekz(3j})AIR$7{ADv?&S`qOjyE=7fW08 zi-ea(8<01V-4$y2l`+R;tQEm_V~y`qo_wz*U!~3rT&3JFuzUSU+VDes7g=H=`|YQ; zgInYmGWW*J!PTHhuiJP@deh|DipIr_;Xu_Ps{j~Yu>Qn{Hqn+7nqg1DjgtM30<9*yjaHaVj66qLC}?*r7N9-V1}_|DBHKVr){UYIP2l+ zqqm5BMN}gFE5#YeNnzj<{t66Q7GD0$x%f6!! z3H%QV1s?!R0YlTRp|K?o9Q`wfjx%w7Gs<~w;1)4l6As0c)YL#4YAMpMc`OBU+XCNd zsp9t}4)hh3ETJjQ!82;?j~J*ym`itSJpV2)S!^s664_CD|KV$M(4Kvud)nUK1_2cS z2F**Y`;IOiVdxy_q?9a6RN(F4a0S97e|-gS(2NB@binWhb%PsHH@Hz#A}|jnu-poU)q#D!-}vg@=Raft)Roc$auCO@ ztLG7jWK`x?agcxsEcoA1*Nf2H#olEm5H*~H;k^LW!-q0{8@BiBq7;rea33H(DHgAc z6Q+FZQsdNoD!2O_J6w}m-$9^@&>1mQtW0mR=NM`gA2`Q4_Kr>*^?Dtpv%USBUO@$I zbGx3dZb8TJg}b<7-=fBl@V#ib7ffoD1&bZDE?)-qBkSaP;WiXDWA$XLO=bp4%Vmx#48FsGh#FpcK|(d7*zqineXBftlaK6z z*eq8h=+J#F^ zX_-QSFiMOW;oN~*_0j$+f5ac8o6@AGER!u_?dhfqKcgf7mU{eEE5MNIeBNF=*+z@S zi<4+bi>`%t#>#e?_bRdPkb|KjW)|o&@iO1MQUXnFe$YSSQx3;k)8VSlQ_pP~lv4b? z7s$IvD;z$gYX46;`R7j?y#tWrfXH@6O}@b?ZiMSGo^j|3s98D{Bxcz+15T@|-;r6e zS0%j&v+n>~6rHXwD`9-a%naM>uJyqtN#lJYM?SE$x(2x;6pFLY=BHoS1W{3wn8F>* z=y5NdP)62FkmbE|j3FsMgC#qAfNTgp=MK^F5pd>te0+R+-F$o6AH&t(1RybR3{@E{ z3`qRLn6OFv*_um-SIFobQm1w=W{z*MwSTAHI>vO)#_HJ>Dst$0!El2(`K*sSjBPDm z(D*kyB$Gg-`pjv3{2{bHq8>@EocfW9DN2T8s#uLQTI5u4_p6b zYnSFgk%2C1)*MHxEy#}@^m7BDAQU2|>(FESdt;-)L8!RBeu8XK7!lmNEn0IqvjCj3 z&_oIW90dup(B6_p+pP-yP`U!BL!NNpKi-s=lxqte-ua1&GFu|8o_l?H+5TSk5hg1h z8(q^_DYOTzqcLhpG4pv`xFNU{ar+FEuK)a)AFc|ITRN17{0%w_xiJ2Q-xRED-u;)?u#0)`(DGU1McPppM=AFBRY>&g8t!uaQW$QS!(fx=)endPJPw#f;> zxrPKO+lIoUOhD{ArgVV-q27V>zkl14ZDAEG<4YvTQ#xT)#Dk3qC)n%D;a6zt&9sQv z8uX<3=)}AmI^2~!49{f+raZ9j_@Hpe&wvefm9mps#7@McP>s{5t_AG8DD3l2*cvUia`3( z-Of&)4U30V*4!ju-xYBfwsd#fs%1e#Wyx&bBwz~uqh1lYDBGA=j-7h=Z0 zYd2n+7ezq-YR6(t`2gtJ3x5Uq(rSHaXN3g-RKb>zx?$es{q{S=R(UA=W=IzF@ST@}>JLRj0qtYVKt}R&G56d@>FmOp`0)I}1hDa-iS^fX=2F4Ou z#4RW1c*E*tG0kE1dLpdT07jx0i8fEQo?YTDzTt0gfDMcG7(pgwYB~Q85KN*7 zd)nU@TT#3x-O;AD!+Qa;J<#(9&gmzT1<()^HmyW{<1uXB$(YmSPuV*T{io7+98qdni-e( z=hRLAH9mSZUcER&ju{bn8+EJ#YK;23d%);XGK?lb#E9G#nCoQXnU_hQ3G@3$3Y&^C z{$Y?SLRgQjM3gg*ns^fLrH_Y9(<}qI=kMFs(EPUauP}$6Tw_A~AL%|(@#NQrE+*VT zvZ;w2`=ULeFn7&LGTw7{r!kLjP+#C%UT*`S=)XN%pM&YQu(4r$N-^KL2L2ymQ9-+e{Dn*C z@eEB+WVcnx(>vGV#Vb2LvrUK0!N+N93};#b-=?gY2BKh7jmCrU+pBp+5Cu-0T+7L? z-P9>Z#HToB?*wNW7*=Fu*?6a>8QPf{CoSe={v}T`wa9vMPw{reTj_pT$wSi=jVcr}%Fqw!w|@&q9o>brTIlXZ{=dC9QknO5|ZKe8+${akYiu z9zZ`};C*|ZdIOgFpy8be^&PmB>>Hj3K~BKtm0v)hIeSK5=}(kbEZzjM%SMY|{y1>| zFe@CVC2~*fgoDMArHat1iDdB`w@7!&`uDo~3pK)qxhHDdp0W<;F<+m$-<|+9LQ;4F zaIFAOV);04|MqBXK1Y`2SHm{&LIF}r7~Z97*kN(=*yJaCd{@=aRS#GD5jK6HqD@_J zX4Y3gfZ=4$YSr*5>&H|Du1K;3Dye*6b6by|t1X5K{QwM7xxEIu0@Z(%NClh8 zRY2AQJ82gv@|0nP5-2`LlHM(;aO?o!fCATUd_EvadVeA@1THDoNs1i!`0WZ8WM0AU zQ+h5~+HZR4y)`CVRH{KO`oH-<3tsUFo5o?6N(cKo;z8AKM{h?tXjo6T0dslWN4T^5;Zim`{3kHAE?HoW!)XMv_huEXAx6 zO?HylPD5}0O&}(-4rC(FU#R8cNi)PtilAiC_ObV9BakGki&!q`=*p7T<5D$t|9Wa> zBHS*;BgoS7EfJ?>IIe~4qV;re1X>?%V3N~75=)CtZW8=BqY&z60757QwW zXX3(sngYib@q6~bC=*OqKt*{UdP^3h;@gh7q0)8BO=BV%b*+Tc8^S!-4ZJ03HA+ye`_Q&SzMPUy7S2qBKnItQ|DFO(kb_zeCor3G338!$)KuX zhpdz10XB==E+Pc#!-SJK+W{NiMaLYubBECv+byf3vQf;*p_Y6oawl zx}nXzfhzsuC7K)?k}8GRx7YX2eVv)7^lazadni?K?k)s7u{$KtzMhhC29E6GOm!BS zrAZBtcnwn|Lu87~AxR8*IxKZAX7$`D1n-qcL$e0u!0@=3iYGGz!Ed!_{fOQuVOf~G z%|M;Vd%*IyVo|lo)78agK!lMoeo2eLaa1uA!R5)+$#R)g{ussH>i8L8@Ha)sjha1n z6?iNHJS;;EbxC^pL2&&Lm$xrZuI1>U;t-Jz$}W(oPALiga1l;bTbwmAd|vt>W}UU? zDuOj)z+K-@=PrIcx0rr-%g2shIDO{pqK#Nm>l-N#`Z2&X0Af%uwrN$4h!;sByNC<; z(N-gV+N)hbvv#WdDQ#IyFzwi?4i`r+S{8y(d?}kzozyEnpG;@y-V<4|!Kh1)6@UKC zRIh;Y3woL@$9xlPKWZ&U30fOc<-R!PFa7;z411{>Z=B32zSBe|9KGLt?+iwxf~<94 zTJid(o-=k%)kdDJ$PtIlGsBv*rc%_%S@pS&4YQw34E-8{b9$KtbWY=gCb&fmBu2?5V3K0|^#K>DNCMbJf+tT%<}>Fhjc6RcA}<}UQLDbWBQy^}%7EES@2KSq+Kh$c`dA#Ch=TPgn-^HG9vZN)5H za^B!O(o#&@2L!I=<>iM%fwz%0hTKMS`v(JE+#+Qbf92zTXrb7{jP7jf!yMu)4CY>;1jh#@?8Ott)+o?fj_~7%S`%!Mt!exTIp362A^BBjpu~@E`Lg6b=7vA` za1b?az#Pr_BJ=I5O@r`tmm%M>()=1jDdOn5Phc{B<4%J-Iyv;v;=ZXmgHnOFrCxLD&XP=*LqiP zPUzo@2Mvnebl8n}?vPe(mtp515zYil?ODw#GWbn44-y^KY?DX|i~o*hINfT&&-q#E z_&b0zQ~v1o`4eKq;~d}h`BT$kAC`M@I~I$n4c!-Z+9Mp~5JBW%rh%c>s0&uF&0{Y! z0frNELng&q3&x9sdBB#^g{&Sa=jMD9Z z{uP}e%@5wrhj4E-0Mf%W6>`rL6jhB{4m6E12luIq1^&d^^W|F%}gVI=k-{czxP18d~!lZVw10YoGxsr)91rkz~xN{J!GmZufz1E zbeicm;?8n8LVCP#BWR>8p%n`z*)1@x?=4aBzAkXX^ywI`T)NVDrZIjEz7`%ySkj3z zvMbAGN;CQf&-qx9WSY*Onr1_{pj@;fW3k4KrX>9d|8tl@ST7#AiVxtpsC zEechie&F`En0|$|u-(G{LeOSa%spz18U?W?Wzh^Iqif0haye{rg6Zqd z^YioBziv(gAPJ*C1CHI_#yY3$u>U<@Z1;l(K9ee*?b{y`cMp%Y*4Bsn%luC!2=x6J z)T0>tXoXvSU|`c%U&^sFuVX$Sl|X0d{IGokq4D~w%A)zzy~1Ne-?^t)Yt8d30VR2%|4& zGpvifQyyca)*|}{{{)IDDfrhmHYPK)_>v%tn;(2e5tH*nJFJ54o&!I^E7pJH%U(Xm zcI^GVhbMB*!-b%Y$_eq9s&{p=Ku?X+=`V-|)>9zg`WBGAhy6V)dZP{*fe(XIb?D#8+=vMNW05+Nv3`yBVl3zhrN#HaEDo`8dSl^{#Ph7C=-fvK3BfB-9$Uv~C(d^w@IZv8yu8ExVs* zm}4bp&`_k!=CjvOT2Esbe6x`5?@v&6ec#-=qf$HfYM^@A6VMUtHiwZHb-EV|Q59<&O|ey1xfs0&|D zF=)2{l#Zre&+wYpUHW5h%byi+2ovv}w>wB{q9ToFejO5N}qMS4`g=zFU zqhu_yVY+$cyZCH_&gTU$Y@~9B2PAcstp*P$hyZ1%eWMiYsDJ*;h5fKK& zP?^+$v|*^$_VR-n2V?L*_NH#1w`esq`$?H)8vH7D-?5LfhWI>`*Ect!niVNx=F*FZ zs8S)r)wI7bOfz>KH$y%dG<0{rfk9~O4=^cTR0{qq_XONAL|M^YY!J&oMFg3u{Si3M z$I^eY(DAB9{5U$=sr~H(1i7#Hu$kT2_TQwrgR$O4W$a z){<7zSr35PR997XdA|VL+z~q-K0YUCVmi-2_Gm`C5(D*BN5sB25=_Z?fmIR2#C zT@jwq*eU#%yY~F@*Jr9oO!1HeoZbi~M;&1gUN5zRg+80E3wY>7a?I?dty+0b^}~w` zG(w$#vlkH5mRc!n+L#D5L>9{@p%B(Na1=E_h2sKRS_;p-BdrKbWDUPqIP=|E&Ii`m z*|S;bps11r`A>$%k1CVx!Ii;=BV?2*t1a9s{*%*Uu*Zd^6A58HZKhPToQNLeLF6(X z@^TsvrXySye(12QkzWk49t8UUyZj*Vqdnqv(WeLTEx?uc0ZUGbueG(t`aL=QgaijN z5)r7lo$m|wN#7McpVs4ddOh6%Qt{^N`6f`<65aH=8C;wjQF&66n6~w@Y{8rvFpw zdfs1vN4LATH=sc|dlx9&g!#SJGq4sS<-6+K6vc2c%Atq%zdxCdt1k4%ZPsR)U}|C| z=l+S`c24r&1p>zN4jz@)g9*YPF)onCmTu9g%T=(#(mhidan>tTu;cjggsH5p2Hu`6_42o%+u`4fbZT?UF(#tMy@deGERKXV60CQD=+HaQ6^i8gK& zu^hxFBu>V11(;YRib?eqD=Ev}>Ozv1G;)_wybAqOW4uPUTLb&*$B&%lVV>%yLN#+)?Fmh4&CW_xUr8o4;CD`!V*_!Lb;&8S$A#Cz018l6MzJQ4(#opK=b6SI~iO8odZy} z`MgfOq5F&mKNzL7y2kvuwBjjKI+4aeH!oI0eq|6Yy@XNtS|C+fzdASUcmSRwcol zGOmfs*Gqwx@kiN9z~t?YTE<{2g!dbG8BAvT2!>_**qFi|#WT67|1WT6seXp8j*f;mS3r{peE~6_cHIgi!1{lr z^w)MN(bqJilr$>o(u3!Ud${BldK3$JUYq5{Fa?4l4gV`PafLm~LAI|J8W!k3=qN;$ zJ|Fj8oeHymFi_y=Dvl&NsBjmeGypSY_f@AU7@VdS0KpvbT(I#z=>LTN7?u2yI)G-ITAVPDm zcyA{BofC{oFteFnzzN`QrSa?MrILT69fzGbEt>TL$9*;A{y#^}*GtrYt1Du!kGJ%< z!k)}low5I>vu1WY0s;P4+PkJD1Oaa8o1Zp07Ql`{LKKJ@fmxFeut=}L7Cl1pmfwvu z7Or04p7W5)gC2lDO>H#}QRKUsNlde*MZXpPAx$cQx)6Dl4qYjB00aP^?bmOWDur zr0HUfK4iTcYr|2#)5jK3s#O3fMO5mXP+~J~MgPJOT)hs=lm)Js&{>&O@`p#*Gnk7K z1Rjy_m%#aa1zQ0YuklzPcZGvZ3MJo0b&-gJcvT|W=pO^V17puXV5s3iS6WyP^`k!m z3;@3YlIHVrtI_;ctGpL`b1PX(h`X|Me!rjmHSoC z9{g0;#z;qg3IAAoBGU(bV?1 zNe+I18Zrnj!Vs#t$XMQn2EDLiRkk9b=7Zpw^sd!6V7nNnJ1OjeN>KkV&vptvg4?Vu zuw*T&C8Bjh1M|x2^5@%pCZz%^S0sl=Rwi}FneG)i43e9-mK8Rpt=WrE@MG1+*@PnH)6a);dv=7F>qB*4UF0|*IVN$-x{UN+zK<~6flK0yY_ zsHt0|N@2eBs-Ri2YSP2Z?j_o>c$y9zcx>~(FCKj%8$(hh5J%X3`0Mj-Q><5)q7^Z4 zJuNhvrtf`sclY5+pl3uvYeSkrdJ%Nr9qVUYlxJ~!NK13`LvWCizj{CXe7pY%$|w-1 zybe0uAdO-*m&9V3@}W|QW+%BLPIy{$waHQ6bIWllcvPXGf3Dh|0G;HrK4@tv zCln0~E=~T)H{i0Rfb!3}Q2;kTTTk|=SFXc6Q}sMA?el4~^u&Pxox;$day-VRoW+Zh zfX@SWSJ-*dgw?vdStg1|fcycXs-~FtTfdc&B5FF!1hpkbm@m@V#KAP42QFN8<=d4A z^XJUeMv##h$V9fj*w^5Eu%V!D5saRhWtk{OLzzUd4#))@HJ@HyUw(|WrXQpbKp>vO z*0Gsss2knh zF(>*eqZTtFFJ|@#CkRAmJRfW<4=oal;VG2QKJ*kpkDt-Irl`aY?|z`Km88*#A0w5k zSjKMJ08V;sZIA!qL9`AHHa~voM0U;3;1`*vx83w_h`_49*ovQYrpY)w3`T^+lp0zM zPFFr6vz*JLE-!0~?UaR$nG-G)pzM}sT@X(+OWNDwTR|>6+AA-cLrJ|oWWS}R>Nj%B zxzMGnRdm!pKO-{;bxBv1mY+c+c~sE%3kymFIFz8s+|mKgPq$~xY*b?wV`{U9`evGD3-mf%C#dESlU*qW2^$h(`BhdL+XSpl5I7zmNsU6&8w$Vt7xz2EseHCYrB{vH4kzHmnbiK!; z=X3mtIG64}BgQoFT@j}qpJ$RHL$qe3 zCnnv^~LWWXh>5Jz|=U{Vf~{) zs0)lNU?-%w4tBk`-EZ))sglMl7kmkViYXfeCS=HRHwOg{f?E_HsBWzV9(z4$qrhAX z3te~vD#VYIJ4F?K@QoM@Nb5X#Z&?2JM54Z({3Xy)>g?~sbZH3}4`NrkuYJo0w9}>I_sy_s6Qia-k^KffoHxq;E@i;Ck=ukK#rRA;J6qu!Ldf3f z7d=JSEC#ulgm3VWZx`jySqDsy9Ne_!QCae1rKh)9R|1H?(PACTd)uy$nE#5y8PhBOfgW+>CaPIA(Bd@`uk>H-n>>l4)E z;)_&{To-dq&e)TRC_lVGo|F`xYbUM$lK8QpP)Mi5e1n(t#F?ZY_-7@WG z7dH-whevB;(5d5}1m`PMu zAcV7zj{Kr|3LcAjS?yH`nuSygL#u2-Gn<`Ysm?N6erg z^uD~54?NnzqVZchf`O{%!77yG2cRAiG92$Rf1)B`9{cy5B+KCMc2qeT35k4)4^Xup z9F%ak0*On3>Saa_#Ho6Gx7-1SWAFEN5!y_(o2EfqI~bzIZ1`OE%e zb}W{eHb1B2gT5Udq*ZSL`yyMGJll{PhWeqvsGu~rNV4v#%uT>S9aO(?3n-@_ZONwH zw|LdK*!3nlI7#+=!5YT7)F~4ILM_^86b)XU8c%LVjEz-9XqrABy>7=)O?)#RKjDk> ze8+34KE*GxkeO|e91eKPbl-^bu&_(PQ}`-WpkP!wx4uag&g8L+x|l`jIj zgWmEK7<#1c1{XBhjyDLhQ5WRAmOCx>j~)MDRba*7HCakoDO;wvpH2rD0ViHyzt#vv zvyl1kcmQP4X>FmIfBBC;y|)+ImzfWi)d{LNo<`-Q5RbhiYGv(V)A)Jad}WFVBsEO( zez69r6ljz&gy71*GK4d8+pbvn`TYZM(kkGjC{H$A1OI>WjoN6CWr711*vV%q(lQ0a&Eo_-2SM*tlLXs3ux;`r-vV9@w?M_$qo+4 zX5#8^TBJ=iO^rT}9}lr;Oj*(Wy*T~*kLnMX|f!dhvk=(JT6&QZI*UsGG0KYs!dr zRyHB*KwHh0Wcb`aE<1Q$V5n!4k5vLDiT1WOKy}^S-rhj5C371MBT5bC;bX=5=EF6$ zHCie901U8!X`=t9wtZ}Ag{uJ0_2DwpP%^=OB_+dPPG+BPR~Yp$NF`6#_>3BwnOQ8G zJbY(Oipq?|_;;TN#I#q@=u0&6F3K7-iu=}5OaogYtv^k-1Qk9)1AtL{_LDF!OOnZ+ zd1`2S4e4n2JN_^PGhD+q#s9EH1^n;FC|nSOXF#&mKC%ORJw2@t@x&)cJ>RX-H>}6;HY$h| zA-UZGx2QO>l}7@?ZEKL4)M~<-@JP47aFYZ-hfya%prY3AiGjq31O5<|nH`Z0TQI0% zk34e%pOV&Sc>UR_ErXG-mqs4yGoXy@z^9@IMUxXUBr-dcm&3bj^+>7?smUOfsAr@Q zQM0aAw$h0l*^+MR?tTIE+SF0sdnaK?xPm&>^)qIzE$Q zgIlws@kDF3;z$nu6iMz#%E^A9{E-LK3&|4Ij95@{C{grJdSbeKZO}|j-gpxY)+ldO zXga)~hi_YZJFMRM3($1AgGO>hv=s_WcTFG0-hFJu?AkNNp^;e1OhoFxs#Cz8b3_RU zjYPfvZ!Gbmq-?-Beoeiy05d&ev*m<>5-ZT~Y{dBE`F4#0=9gGRv3jP463L*nvpK=e z{McqZno`EspgT6L+}uY_AWI2eNUc!)C=SGtkf0SwV_H0pYlIsd8Gc&M45>48nh<}_ zSbEw4qh$6^8=Znk{XQVkUgaue{1iu2o)tpojg)^YMh^5Tkd^x7FXM!CJ+VFr{JPa( zj=;&KowXg9A0cB9XE!zF$V%^mKpaC=rKA1;Ad7Clzn6P^{oQtOgT@UqW0c&{oVd^mMdv_pr63B0b^7;Yc%PFtA+&bi=hWQvBf+u5ERUclT%WSTRL5n7k*hVu=?;rI>9nAGv|#ubfgsJRxwG>O%%Ok==wMh^UAV~1AXE;BZ}k^}uJ$Vmmi0&d^L@D9gl5Usyrj z9_Qm(4UpOH?%V?c95evcKcL+KzO$BD#?4Wm#o^%x1|Ws+$^4%G6s{uYsMVTLFP@ zAb#=`1+QO5WiceH(m_Qzzor1i#t0a(Px+N#8s6ccIS_hp7eIYR3jB{0#pv=r6yvPjbtp=nQ*R)qAwdMNKm>{a9a2nCaQ)}cBe@31 z{K?^Vi{99ZWS}WM_Y5VQm#7mLQ(1Tzt;25qN9y(PZ3}AYz5%VED}f4Vs&ZeOT8*Tz zT0XRJ^Raz?qXhH&e+fcBrpWa4wB8071USd>jWZy+zkr>t&my1hl$bN8B-sWK9(M?2 zbtZpHz_Iw)LW6np=;53Id*>DycqwSxt`h!r!k+!JvhX<=v&UuM+$=1f=zIc%><7t8 zrn-Sgy<0Id8k=eBmf*7KxGtqIp(j+y=&||Nc-0!gB0`*{%`JcfkyIJ)y4*`f{LKr? z^w8Wj?vUNbmajyaH^gDSSV0ZXASU-F|8s=pNO`ZCo5QGaIphwrsNiZFoNZtSgWI?u$%IP4M%-;+F6`i zzVA$U4D}>QMJD5HF@VsJE5_zcx!)kQAYE$awuvoT^oQ)`S^q}JrosZQu3e!v8kuu~ zvSpTzV`*qhC+_!1f3nWb9gjR)cpl1w#xW0R^BLQihbc*4#3}a0(Iupe(vh>e# zsR9e zGQzN#{G!e-v;O%wGE5Lu>3do^a;;WhC zj=n7gz_z@noIFD}ivBLG!$7&HrRPJ30W;jn(bCcato7|~zoVU0R1=M084n%?m^n*L zexh5zV*mbM+82%TrFVc?|1G*goo{1n>-(`9hH$pBu^5sEAC$UnVFiLU ziYiwsgQ4{Zh0H2)ya79#a7x7xiCs`6YfW-}Yqor9R1jkWRvB$yVhN)74Y&6^Me`mq ze$XhrB1E4P@{3o?B8HzfJ1b_P`VUJ*?o~=~a>HrP&)wa^*biHz?*9HH@<34#YXf?g zW1DX{DG|Iy3B*Q`EYH@!r~5^d5y@2Slxg#bRE2ogjnWV}EN??$vWr(WW2Gt=PCmj* z#{gw0QdmwH?NLrRkG%SnE**2yG?W1ui$%uE^58_Zno7H7ES4zMA2CM#RS}(Pw=7`T zpqWQoo={Ua{n3i_z`ZP%yv9_CDa$2EoM?&t%Ms!+75%v~(!u@pRs!&RuKxl@s0w)I z0?@-SHrAw&al|S&8fj9^-U>ywaRS zgpnEjzm>>V8og!tsID5J9lrRt&?D=K=({jEU7QDb-Vw#GRdp(F`J|4bi<>FSVz^_W zlgW7>JvryOd904c*>z++@tEO@h}Swvvr9lMehaH8i?-E^))4?WiQz)O(J<3JE-s5% z%#RFwEp@DIW(JQ@5oe-~;_)C!@fW_Gu8^(k=r900#r07sn)V zuNeVu5fVyN!b4MAQAyoN(Us)-xK3H|0e`gn0DEgJlvUPGl>y&CV*pR(bD4mU(1fAd zY_`jvSp@65dg6Rk+G#swwL;ysYSQIjgXw7`VF$&>6c@TP;V^rub%$xq+O@qQUp+;1 zGw{W5bf$z&mbbxhF$8z@&KpfsK5ABf0UwbHUhY@BDGs0N;O2rP=+qrnbO8tFHBP$d zC3owco_w6}2DPX?gG_%77UItkt@+42nT65}3x~31_IqGIJ^sRMejHCE*~8xqF^Yz0 zmI=6s)iebE4)Zo<0A1YO-Gz;{UmH&mDI%W(>E=)d+=TtTHV&*`=CQa)>oJbbyGRD? zgD`yzBo&W$e4(FY3h2*fj|tGs{x}b=VN~uJX*l zdX&P9iEH5QUsyIf0U2kTN?f3iqJdE!J zK>p6IIwU<+q?AMO&3ZwogH`7&e>CdJ|M~Cc>ydglu9#={E5y?mA{?D5Vv8WX07IS; zTijR_+PqTjD~b=HT(|URA6#Q@{u!~Dx{A|UW?NyDwBNZw6LlyefNi8F(!qVY)LJZ{LU3V^nn&iErda)>Wtb8H0(*PnGb*u z08r_$2Y}|^bxD;ZVvzmhrJJS&b7+^PrB<+)^{O?^nFtDedAz)=RgI2X@q#SMBGnY} zy{AV+&}Rc$8^Dq`=02)AXE?gT;1aahwO|_qQA+E~V55@MX@sT0gqE95t~*%R;AhbBb1sd2*7Cu}x^q_nmq6tvvx4T7$e? z#FAW8wR}|bVt;qN;SOZ0@{uLp_D-+GEm6T0_*dp=SdU3=+kUNieokCcrt7PvDqWzX zEo)tCdLwg}r4_zUvwdqPft8FEbf*|)$6vOIA|D{cJ2!Z*OLSWO6yx4hnFXImSe=WdZ?PZ(-?x>6i zVUfqFoO*a-X<(^ez@D~`Bmf+)*JVVEKN`AQ${EsIhb>v`*iq}}{OjL~%$OE>OfJ`m zynX&Yk=HliVKD8EH(96>sUGO`11YCCK&p>rk-eX%=Q27ap@AMOw7|YU5uDQ%)~D!d zw@{*&x#P5@qv!i-FGfeO1YdX?@a~&4z!OO!;p*$Ef;Sa}5>?qhyp8v+%dR?_`#kCi)lD`|FrU z*|6^=>oaI`{(tJD&kmv~CLMj2oRd5&>Yu9vE9+%!de)iQ7L3$h8pBjq@x#e3c;)=> z6(Ho>*N|MY#y8s7R*TZgN+XK6sn9C#cvdg~G^6<(_z{KWLd!zWH{FTUK?+HQN|T2v za0B%HzZ>1t=Jb^(if7)^7Yxc}6z2dxuvLHPm7+aGRXMqfH5OR%puXuVtxaX;gWR z`ig2AjiM0hZT7R%6y@CP-_1B6{~)Eeg<2;#{u;;003`AvLPA`hM`9eLS&&yez$U!$ z8hIU(ChEBThc3G;>fJ1utSWuv8HvTmtJQH;VbU;xE<< zGg@4)6(3zvFtggG6j%;8U+Wcj#l+59ni$k0?&aYIw2@hF)6hKu(k3t00s}+>5t%-v zQM@sG^!H7@1BMGpq|e1S@(xD^){V&No*ljk6oEgmX@C(oCod1^T;n!E?obea`AVWC zbt0D6uv64fMueAo-~}Z!%=nex!qJy* zstTXS*yXFZgicLOmp;Rln=185D%lQ&>f_Ubk*Z8*FT&hz?9g_0;oyafu)}Y5cs+QJJ_F0{Pz1pZPCW&?99GmefdLc$0e{O3-3PE;cZcB+oPu`YK+@v zO{sK^b5X{V`<*4wxK{O`3iA$2ja6|!fCF`5A=LSb!sAQ{27r->uo01F9UEbP(HYu+ zOJBDJqd+(tGmSdQ8oCepWVcrUjM+6^hu|G2YDeo%g5KNy81e-|BUZo-xAY%jW}l)^ zzwZ5bK((V|a|moNwM@2js`Q`RoCBkCYu$(lG$?VBl_3a~0a!YFOG{}3SxUZs?3$?6 zeXQ_JdZRb2U;6YKr+Ff!)~nG27*+(qo~2adMrZ_7;m@8%YIMA%g3P&Gc``!!pP#J0 zpcKioCNg6+6Z57kL`VO1(TeWwkyR>{?v2JEHw$D%0JN0z$@Tj0mVhWP;B*1>qHBB~ z5jFXeKd<`v`aazpOaKFiS$_f&U``{?*}F6?(^ody);aAWR6BsSka^>uVrxx8PT6w1 zlENz~&zG|8ul}F521~@AJD~>Xy5FGi*|&g>lxSC!N31TW;{y#y&X!f!@2Tn!fzKv* z)CNlT?3y?|FlNvi7?-CV4;xGITg!`S`~)L@p=Z8A@JspZ<%Cg<`1YOsM!JP-YF&p- z8U8_{LT?#uwISlMLkYfR6`mhVQ&Jo&O$`GRMj3az(8PPCq0%)KF4iQt>$Un%eYPep z{euHW8CmLmInnv!`|<->D?Sf@r7_!Ej)!RfL*o4V2}nC#AC)OoNre80d_ki~rz@tR z#g~J!Q{GJvRSD_~p-M=>WtNO=D$h`5tShWta^@rTx@ETDHw9>O-^&f6l)x@u8q?EM zYBfzT4%C;h!y^k=<;OOEH=829lMBz}%CqEbML}9QXZNgB-9faNdDEhROzPA;-~{WN zLD6KOfw@`&wU=WWQOLU%6`$T6();dwM3u&TE4kpD{q*|0!13gZ)@ISEpR^HXG}R6= zfHeA6=^q8@>5T>tNo{JaDNTu;`#}58TUz^s|MAI1Jfu?A*zFw^8}(35Hc{fcW+~~i z14f^Oje?{)6_A^+mv){9FY*0-INXc2A=A(5`~j;+g`cpZX}j%O2b4PL^yk2NOu8y7 zN_Xop9i7viTO)Y?zDF`@JpBlNu^QzM>_Qyv^pVt3SMJLI8m|g#zk>X1G0iDPdl4D8 z5zUPaz^W2EYL41SWwcE zR(hC`WGB*=u6I5&MR96i+!*q|_yf3i#Pzb_bc<0uU3r?PlPY9@HHJ0ZPQ}hY}zz zDbyVyh3Z?_`n&oSaMs~L4E9wQpc(~yb>_iZV0B%OokyUg#O#`6wjzodsGMz4qO+(@ z)&Ke)!6@t`H`a(!5$IuQtkxgIF%!hG6EH{4HZ}xDik0-DTDvE8lUTD~nRC6EMaX}o zcN}S|2oLAO{pX5%XUXcQ2&!is$w9a- z41vkkne?^B)OPQ%eYwvF4r~$|K9&;tTqZ#7C!qfsBOO;mD9B z^H(z0^4edf`x$6EN~z?8GY|G&gA7U*i+dbIztBpQusbz5!}|U!ZBT>!l0yCXwAl|t zL;)K1s}Cz2mYrz0LI>8Yc+bVU@p|F@O1ZdF)uC|9jXWj~lT6bZDvkR8igf>;mexfH z|DACcp3_F5Q<0T0T9l%@+DAgQZFU0@VwE@tPmg7BZj~^z7vIV#p{gt$-7%GJsg|`H zhi&s#*mh5P_-7IInV#f#zIH!-BWQH6Vh-l9Y?KbJ8pCbCI_3m;8A9U-^Rw&kom|TLt*V&*1-x^??dFbo`g*FR<_cncSpNAlu7r&Jw zzg;{pblrEaMHYlEAUzX#juaJTS8XZyrwi1cZ}2EUM|@vNv;_7e9x%3+UeVXYTvT@7 zTBB(;x~y?>!leHN7}`a?Nkn~q(=syayPu;oO#`eh4fksy!v?ZV8Ot%zjXR9>Rfi~@ zqauIMroPY%5ZIWlfoBC>#|P(G3}uvMbxj|z+2B3kKy+Lk^QN%+xJ%m+zYBneUlei2 z+X5MK%UpeD^lklQc`I-(0}hnS=sL<&jlvYXJ2WqV$96Yt^zZ2sz(XA1R}Sz8`W}>7 zKRFPkin&dk!()Vn&k$S?;{1SFs;g_ii@aVAl~zq1I^Y@LCY56A(ViMemV_EI+L-hv z!F@HH&pABfjY}2~d<+rqXk_pPgqr?eaYNo-f4`-F+c7QKy$L2HYbOMVkoPzG0dQF< z4O64i=hW)p&}`A0%{Z;V-5-Ip29%C%4kh*tRid~ol?)#}e$Bdnn><5Itn8W;WZ{Ds z{e$xw{|eY5`DzH3YOE#`MKe|7`l)GuO-*CIx*az*ocZIMD!5%*!#9^V&)b$~;n|^E zk8?+7B|`s~7@9iW;1bn5soVM)9A} z%6yt$5{H7lyNGuNAJ`!qS2^<)^tNP+ zFQT4N*_Sf)N}yxti-d=Fr!Zt;KTlh_P@tqM_UN`-Pgr$m=9DEA5;==g!sFi#19>z5 zA|qcd%ihwJm0M=G6+b}k$inem$MUH*0Aj%ZpwE>e+eb7v$1SBltn-c z2VGr+ZfHdl$%G<1xbpc0wvcR{(anG1vf+tb;%8SAqV)urya53$F@kdYx852s25!sI zUFy~&{3-L*+`G&TqsE65h`Byl&n5}_3ZS04v@<5#a;7vQgmiADMiNXq?%S}~I)#ih zMxlimSbe>+rv+cU(pv;X`mw0{Rp%2d9FO zSkATkg?MrHZzvXgk&rL&-HFr-Cv$*^7YEjOYN1DW8RSReBKRT2^@v?Nm6u=N8wvja zK~Uch4zkSHKdOp*2G$p%+JOp9YsZq|KCk^T*6fR2Wt+Y$&JRU@CqqCC8EWJZGvLmZ zPeCOBGmYlcL`k-R~c?h;+QmCd?wo*1(|41+{ag>i4xdxiKRUyp9nPM9h*%P9eX#Y{ zeHPGO`09B2E2V9e>C2$Sfx|)5V5IC3o{h$p4eLwID-?78?MCvv>?p8>D~3d-HAE3( zV*2uS(RtOD5Fz((ej^6z!c4pOkj`dPF8;F(Qe<31QHl=h+raZC7OUKFf)m)Iy1`J7$^7(eLMj(tfcF!zz5>xc?%;CJr%vR0w&9K(STnI~r|OsS{z z!79Qm1;B+ttJz~-G`>O|#b!OYE6cgA4yb00?yR~f=jXIRV$zc4_!hnGe6|EoBmrXt zK-kG1jOT_E$Kpt-)}CQbr2W8tUCJWb%56#}Ki&HD`Xcn=3=r|M={Z%_$u2+oYKjMB zcdpj`BZmJXJ?fqy!!z>EJ;|~|=o?Ee+D$F`N+sSJ0*4e~?d*}~r0$z+6HOhTb0t?= z{j{OcVPm;<)%<^|b&INA>3?BrM9954Wze-S;dL3L?n=uBy;N9UK97&wjjTnB#ipii z?mJ7uO9;0j`LP7;34LwGfJ%|_Ps8PZRG;5LYgPYA?*VD%mj+Kw-}YLkK3J# zir`wdxoCS~BaZ0@>h-5Ruet~ zL=mC5gE1%!bIsullHe!D^lvcg*n+4A4vm{u8&j`*`C&yJ#-puk#dNewGuEgTvDQC* z^~4Z@ptSAsd#mypVkU|b4!m!VbZ-lU0TDff0rnc9r1^z5u_Z^h;13q7`_M$Z%Tu?? zEpDrJv=l`9q7?jK0(MIjR4SD#6Btly$`W_=%pvDL)v}Q_7I`tLbISzik!72mHSS&Y%wj?>-?H&nC|&ty>Z0 z?Fyr^{PS2Rk6oCUL?mYjcx$^qP7U|LWrcP)d>6e$pFF*!W5V4r|b2CT%&dUC>)2j={?$qB2SxyxNz!;ga!5GM4vI~RT=AIG-! zYE;mqurJP{p*|NG_9v9b<70Y`YWCc1$~1nt7K2GHbrJQ-xI16y)a)+dR&s1LQ~B-7 zY0r121-bho1fTb&fM*A=QjuRuu@p3#3LbgFjya14l4pcAN}>sLNN7un^v)|CTRNRT zJY*0%`}(erz*y)<+*5XCgdmv)12w8A9fnn`6727PV-J7@=yU$HxS8*<@o^*QN4{;w zW*%5-rZysjg(mYzCz3tIky)(dAev>DUffSfnz+PN?+G%qsA90Tq`at5@SDLfHtWW(z|+t7t!qy`lHfVZla z#S`n})3HzZoQ$|v6q+N>RwD7;=@7U5qq0Uo0YZO&|F{=+-YcJCR;rSO8jiMQX%eWi z(2dvEZKs2S8y1p>$)O1Y9c6>5N2%3QE92B(=xP>vmx7$V4$?a=7v&y7r-oZ4x6-rv zh$d3EgO}nxTx?f_nFy8*R6I1ws`{17AZvUkUwNl ztfwT&IF)_~roiKavAornwFtVd&Dy508uVE50RCuEypL&2hmvI7L%@>22tjxV<$)6y z%?EHKUaqd#5&EdRM5ml&8B9dF+FV6PrbyWA<>YaWQ!K5$E2ADuH{bYD^<>=t(X1}v zm-=;3=7fsyZo$#+X5GVhTu5g%z(5E_EI(RUOO)oFq<91FKc9sqt>Yh?&(qrOW5fwr zo`G(4EYsWzPjWx?fs0jH=VK&Meq>a+hArNt$_00K4f$hEZNMB;$&opXx@tsF zpH)7Jj~y9)s*FwJ+2&j|q5b}j@uO~U>P9@4wUNT(m(%O(>w^6J@-xnxhw%whbDJp( zYFM1`U%Totwd~D>>KBN!tBLvc=3xp3HrUV38!0&T;RlL~)x3|n2+!ZbvdBhh7l~;! z5yp&0+iE}3eB@a$(Jr5f^YLdbkY)h>BNepjhd?13RvHab37D#h67U_6Xw*H{HYJUv z{X=8+92JCeL;YHj@B}FcepH8rQx~?e_Gd7V^9}Evy=}tGtI-z|3oSm1t-X8{`>_)87q0oFG{;D*f~|{5ds)p-QdlTjamFjUb6QGK7o6ZuZvVEd+dOm9e?#CukR@ zA0sZPbjGHB@o!fo+fJ>ngf@lNvZ`vZVE&Abvi0&$3sG=&io9r52n*7;ZL2Bd=%a}& zzCORgd=nPZP_q;2C4H?ZPp05JgCjB3i%oH;+S`y(`T1#6spQs;(QO5N6}wCMx_{Bf zFW8C8Ejm#{@AW#i76X!KUl$Q{1{~NSoRjlvQ?D~mr8rjdav3?lcq;_z>}bKp0`I4R z3j{neSE%Gc)AdLg;Sgzf0Lw-YH180iYSKy zz7~EL=wPYUD%ZlTI}ukYr)}W|!b!m#_NcYt-mKRo@UY+{2^2Gfoi*(2QU*1B+)AEV z>b`kHopFt_{2AGiyPq#yPm_+BvJ5dh`)#d=>-2X}PAN(K>d*XE)2#z~f_#Wp82&1- zwv@K&G2ilB4xWmsXc8%KwE+ADaQH0UET-ioruS?6;N&$mMPH*DkWRe2lNxc3AB&Wp zF+fC9DRUg{CV#BWoYb6&CBJuOis5XVwaL&UNqQfc^K6*!iq9P*AsC#KLvt+Wmy{$o+pT9`CR%f-*U1O*W zcP~sygr=hjNY!}JR;e2GeKZ?Qdn+Cw@&O3)wB+oG*zBm{tT6#ucBkgV##q~j=#O#Q zW9JFQ0F_Kh+D2&@C)fHpaxz*3F5?9#OqKOGu?SA$^(vL!AhUvKbcL4q2FW0Q9Tg!N zwYz5V5x)=Ie}W@@nOKvOEi}z2>|?e|HEyU0wHz&@DMBpxV*8e@%hk*d`w&jG3PD&$ z5j8iv&UVS`{U%-Nq^gqSYC^o+HGOMoH%8>X_Ea@E$a+)5!f$=Gu7>{}oWgkxN!Xr@?3xWsF9}A2( z$gb+hu@uR}F{&lk2|7*ff&p=E`zIWcLrH)1eD*cm@s z6DpzafNY4muEd$bZ7v?R!R$SwaFZD!H4F8=UFhN#YM8A2CoK^DS@{LmSP>;MExa=E}d9ZeUr)-(x%a;h=b`|C70RRY@3c+cl)l#Ky1i^#qp5%?) z<(hy7T|eKbS=mrCac)p4??Va7%zCH?jgk^Q?+L2yV-6tV+v3OA7@d=w_wQB9=n-0O zNEaA){{0J3>v#eDEv`G$#?g_)A}Ly4q;J%gS=KS_O_t7p!VOx~LHwRwV}E{IIWyl4 z&3w_=vJ~D!TKA9n|FZFs?Z=`;aq63N~K_MYOfJHqu zH5GTPJTG2do0SA5{}T~8Wh|Ci2)y6X)rDJgm{UF}f|KU#0be>L#f}wqv$g~vEc0`7 z*Sr(G``ff|7-{7r7A{JyWwZjSc6R=Xxr9|zRAYf@&QHQP+yvi_9Zi;SzW3X0ioefm9C{d>`vAz(Zuj=h*!-RSdkxK88JN=b@c&wmK z{cRdqtUVWo>HsIEI;8zWee`L%E!5s=DFoY3K2??3I?4F3Q+%~;54umU{oC9!^k1;T zJ1mZbco0Aq%KMw1p>8j|bZ1rKI5eY{+2KN2sI!J4=KJq^7Euh(WbY`NiR@qDB-K<- z{Wa4QKDWXA(2R?YKKLRi(T*n(mXbBmbRL$xn8;U?IB`EG_Z6eAtVXpHz&*=&7k#lc zef{uoOv~q&;<6>l&y*S)5WM?CKLwYl(T$j}wRrO?!f$)CcEH47a~-KTuq}oX6yTO$ zTJQ*GH6Kt&ZUXm%r({71g7)`^dNTL@^0H2YNB*d&fPfjJm$mI@cXsZ9oBjQLU<$XQ zNGG5HzBTi0e38Kiu(Ml$A?R$>aDk$p3YC8!$hwHUphrDszhGYlB<{dPg+WGc(9Fr< zQ`CwDA?xPm=W~gviN$a=l!khAD?H}afGMMC+L<2aZ-C#a?)OMi;q~`~0FqTcz?hez z1^ZNy1Tz_7!P$IP4`k2)umWp62c-W*Pe%bRaYaNzRXse2XT!ZIbX6y2=t8XH1})d- z?Tf`3#@UoLI*SQcim&4lN%v%EULKjK&>nqfR0|lZr;0 zKh<8l6}zD_b8=$K>RjRdm@MjdC@9z6NA_Cx1`cRTWt7TIJfRrC#&8$q%pfHOl)dhk z?;`?o23qOk5=sKZ>Qa(irU5`$FpQYj7?Q0$-Odz^Yw;(^Kb+U}t5FC#JZ{mU9z_M{ zl1ww(l_bdvTtG}$GXK$lzKSHlvWB%NXlO`fO;S^fZvTTcmU4z)Gj84x_2fwR>0|`X z^m#t+!y-Ghlq`|<0Ketes=#bM%Ue64$j+n=HJ0A%7f7bKv+8~&l!!6c!JeO}mJ4zF z-mcc}*|V2<+`S(r0OxR7OkQgZlW|1PAUbCNkP5n;eP*>^d z-9tl7dCdMR63X&Y{wAEALLUVufv1<>K-@D>ALoFRg9Xmw2><;8P%XepAs(U15;I}fB`WIIq-ZEX}ihR212 z;R~jJcKQ5DgK0YcI%)L9PNSBU`oXpu21#AHc#c@b2|yx+NWD5!AHL%<%J{w81!2y{ zkAN|Ik9s%uU)~$wR!Y7btZta0NT-$!^7UnejaeTgzWZuk5A@Z5u^Q(nsPOs8N-Gbp z<)o#D(gjZMvKzKV4apwa5F1n14WBW$PZT`*Un;@_0D}q8oS4?6_y;+2WMk+`z{e-$ z$K|~ARf~axY)Y~ZbSc->-h3qi&R{|RHhvEJBJ@0_@3+pAnWYz7N6K#ePE>@W7_MZ{0+Y8uywNbDIa(-dTA|XC48_^Os4O(-T!V|0axxM)%GxSqtiKTgTy65>Ms>8}BFWo1r zBY9upXvEZR;rb15E%?LzfI@L#aFyb)dLd%pq-}+6O?$~50ritqmFd?C7M?BukN~tw z^+i2etIX9u=1EA_aO`7mAG$g_i))lWF)UUiRXs1lBTV5ieK*?q{qu)c7uuh)8l>|) z&^x3H6eNU9E-!?@J!fOsFMT=*kANn}e}90L_F_d2da|Fs0-$FBBp#qEQHw4-14I?9 z2_uidYCPf2-ZiknT%RG6{nx)wd8U7S>LIKWTu zR~L~WBey7!LLdSI=sWZs9`k5@$?Rf*xJjnh~aHDsv^m@^75|tFBLwZ^jd^JoZ5EHZ!+en%M?@ zIJx_3Dh}V~4G_Y#1*D+wA?P`vpsfIMPX?VfB`s3dec>UQ$3Ge*?4Y>Z9E~BJAebFh zV%v+rCFe{(G~Rqao2LUJ>2La)?JBg}DC^AY!2*ltU~`8vI~>!D_wST@#IeJeoyT*G zMlHuGk;huZi-&@_yy8kN^B#-5IeZHYJ}F2~;6LEJpX4fx4=Nxa%UXnT-OOUvzRy{* zn~-sRDUgl?CYXRH(5>uhBXw(g8>m`D1O>sMY3BH7A87Gy3S_4SqH_j4ZPYDjKEf}=(_rWcm z!FJf_Qq6G0R*Z@LdnpKMWv?N_xJn+4*zl#VbdjjDGdgK0NtSJl%o0#)^+7gB`De74 zT5;xbB}!UTx73oZg1HR~Sgk-6q$B1#_J8X5J5wz=zp#fplwtfhncgaH0L}1QMeSSt z4JuAvTlNe0?W3B2Y+3ZYL}4f0(4Jr8nxQITg>CB^bzZG&csXG&igpHKoz=|k#l%5} z!{BL3cN_$-KJZ+x5P4eCm?fMR@16SwV}^q=^OvyhGt_vfDyeM6G&9@tmPOfgKw%em zK9ys-ha-v^vU>ln6%&sLABn^981snywe=tCTjx~^?b{#CEw9@4`Q|Af7X2UJ;G#ug zKQVd-yHqsW0W|cjPA?4?V7XP_!Nmf_rgPW@Am#!36AXu$f4DGSU{%@GPxUDb>Im@(YJkR7D9Tn;$n}UkT)7bfe&h&RxMW1jC1xU`PT-gO*?+WYZ^q) z8dn+QXhOW3Uky0wu7f6!f9twk>bIIqN`x5i_e)+{_Y0kUfz5HP;##)mv1jzMys?vY ziySd`+7JdPZASwmGtBC}`#6B{jBtfuAK~(vnoVn7dbo-{`i)R;I{?rSRgtu)*XNfK z<=y(AcoKM(kDVLcQvSe9s5@+47uyCyTG^X8r19| z%TR@7_2U;t4cuN`0eOfgN-d#O1sB+rr~mB@F1ufc(Ap`{-(`mCIDF#u0;g?C%mE@S zINQc#*?@#uG`GpG-nSb-51R%>-{tc6?~95I#MaFL%3z9->+n+j;p6G)gjo!`=?vSu zEb3Y3ypzI&4wB&(N-Z_T3uQ^vKpdNlD+I8z08KPM?~^A`!ZHZfcOcc|yf5jXW6rkr3f ztq8@j1r7v*1jXSf%bocSDk-9iP$qlerLYNLs>P&CtfkQHVCxcO1~;z-60<+LzIO5Q z;uEQR{|=2%qw+Gys{z?m5NWwRrNTFv68%&X!;OLI+x#ilUjfN~oGqPRSsK1=aA=WifCI?dwEz1@Ej_&k242c$Rv_swL_gAlPsa5~kSYBF8^frYk zh5yLOO(q{g=-$zE!re&)o&^peKp~v`)X)@xKe##&3eLT0-UarwduW*om43XoL@V?V z&Q9-1J%sOD=?&NPZ_^lM>2>&TlDY9EhpR3YZo)u@Sb(d)Kj^)IjRr1jA?4yjpW_qS z;KZlXQ3$b^epzY6Ml3wHbUD-$WR!U*O*_8qiDTRFUOC&@Vfl{QpbXyQwI4Iv*rC=p zi#WHKeJFZtFMc}QHpGrB*i-%h=qJa3k(JdDsFQ@$2KGZI^d%*=GyBlHcHz3BT1ad0_$#o(2QcbrT@5gGFdS-K0dLr5B3pVQV*fhTs?R5`9GS@ z!L8CZ+~Rq%+u62jvTd7_ZQGh`+vdc{lWo^zO_L^f-tV02^at##c6&eX{j7Vf-@3ge z;Qlhvs{L|i$$Gt^I8IiS72oz^8$OQ6e9w}ROsoOPXqP!Sd_H@BQe@bH_P0#*1IO-Qtl&@2vNLiks__|P`L8^oY>OU46I|1~lLZZ=lc+WbjTXf{ zYHE$ndY{{pkWN?R_lh2i_YmY(r6=zdx0y;Ln1_t;{k=)EHDAi%(w;A zO&@_(6c5t2)Qzd{jgtGmMtYL~;hG=Ll|AEFUNnO(``l|X zI(s&QYaUPOUTMZkC~JOojo|d6BqYB81qr=ec$76`?a?S4!71|J`?6sCAY;M##|EO| z2c@XcFc&Sz&4FEV+96`TXKoeO zWnk#c_b+%dM@+!*q2S$62KY#tBv!bvk&61XFM{glP@QHXE6m}y7mw$V((5HZfnKsZ6(bEk%ap{?w zq_Fo{ZPJo&u2{0^XB9gHB_81>;w#uL+mg}(V>utnf$;*V+A)$5$ zQ_)fHnI*ThWu^&e>J*z2kv$DZ6jRK~JUL3FQQ)?>j>C$je}52#U>vn>6L-lE*T*Fa2PRU=%BGZckl{UC*A+V@JH3dbq?!a+qoxhECwyQB>Sa!nVp)=u2!*-qa zI%$}wVLVoc$Y9M@&$ePQ`t<9O`>hCokcc}YZ zsz$v1*ZDPthV4^p z8L$wbi#A;0uge_DOwO&RhaJ+!=&qBGOzFs{;Z?*Z-%yUtA^+s9Z>^k>}t&~m+uw%5WR*svahCWf-KWABAc*YBI zWqd?7y__c+DH+GJOhbhx&R(-b9@3i^DNN-tOp2!Mns1KSt`l}T*@iFCSPX=Gqc!~D+ zRAhARaNJqnm)HHF$f4cO7%Q_q2i3V})Az43*^X4bUA+!p4yZa6s)K4cuHi=&>ESvA!txOgU2AaIKY7w|1%GdJ z#6eKm_OugqeN^}orT~X+CV1V2T4twl3K*`Sslq5WmIAo&9QtVoErR#fQ~1+g!qrH8^xghpFE43UAx_iQ$7=VEUnuzDxEQo z$nrtYGto`L(XfMIug{T>zfQp0tf~=yZ%ukr7??ox3_Ymuglz|N>_yK%gs1C2m0N*epm_b-lA+A9lGMReg zxqX1VU9w$z71|puofPUA_M=?KY{VEx0l+YyDuep|;$X=+U0lHRMk4+ekK6Ja_&A2b1((cH|pEHE77ir}v;iSuHEy5bT z+_${M!4FRaZ4prZ<1~=sB_l(Y|D%FOxEiXlfCpxvP?h$n@@oT};<$AYU3HLhr`bgR z-%`lha)+?}%NkK`F&J=|UQej~a>oE7UV!hPPy+qRMI}gFD-D1&szyi0X^OUQS!MjYxlyL-3tvlZxdyqSF;eNq;nOdqp!T&g;$+JVeIU8f)tAo}9U~OPp*# zB+XtVJnCwGZyDc_#5RfC;by(j*Lt6jox_tQhx@ELU^%4adjxhg=_^iA= zMm3`cFjX4$`8mscJ6&)sFsEuU`{J{WMVpYHwThO)Wm@5@Ju8yDk*id#X%Z~-Ghmdy z+~Zb<@YN3yj*sbxhw*J!!tV|GmE-N}X!1*@vSE~KJz(9yH6~*$y!u^n3*6sk~sT@|!VBFA1$BH&bI*YO>Mc*_Yb?0*FGFXu2+cD5I8pQNiYfYSsw^&-@U+mmD7a}HSLGOg4zN?w1p9=7K zVrGE4LGUkcmp2KiTdrkMAgfr)$p60P7YGxiK(}g>T$Nuy=nSE`^~HJGs+gCtY7Wrb z!;56{?K7(aZN=tBArZoaUaCy;JyP2GTO4cQS+RU;rX0ScAiw}LFMv61S3b+kqHT3F z^CR{dXsNB|#GXVo;B@fp2Vbj3+-NrT67*KPn;Zo?1mDFo9Hzi>aEkf<<4u#m_y-2= zGO&r@$U_$$FLj~iGq4v<=G>&XLl7OE8P4qVuV>Wa470g;YW(V|?o~hxcGV4r#JFK6>~*AtAby{*5{&c^kBh&GC!9eDFJdUL zCi#aw=5R1DAZ>TW!)F%g3Pb!d0v0QLH%)-G!NUWvyLH5q4e0%=&|8IawNH?FgPH=g zBN^FE9DUR7A}7kPlntm;Z(`=}uxcC8&JC^f3{1?-te*n|B4#Fq@+O_ehi(y#Jm1cTiQv@-;#NaZv2^)pa1T)rO0kUp_|%r6iU(X`BBR44T0WLBbi@N5?;q`Nf(K_55v*_t&Y5cB-D zes~f^T4L_i4OE|7xA4#2+gFkunTm~doWpNGdHJf^FtW=7hK(e|!eUC1{~3GTkvD_D zPp^3kd;3kcpM8CjwZNn}kxr`fe0}QbjuP&uBuc*%L+ush(dL0OlMK8ozu7N&f#90} z4^L6xu*~*PGgz7tuA2fY;gWevnqlosT=$rBpJfSw(#%F`Xje<7^+@hV^f(}>3Xpl0 zDbEB8{oUM310!Q{Ct_sAqEtZFHmOI?6a){xz$ok%20BT!^NwNN$1vvb^o0S|q}jv@ zv}Pr2GV7R?w1o3VKm`O4BL;5M$rBQa>jr1sDk@2Q|L}BHa=wMvex=uvxu-$k|5PKt zGchl;sK%Y?iE9HE(ZJdhm@xq1b&C2WS7SHo+P`_p0$7J5t;St&)5h*QEOjc{MhzN6>>DK^X1_+ zRTx)XtzQ3jmNYKJNMT*VFORs?k3Thb@WSrBj)8#w%?-=zu$Zct;`GtWOSXL|0ar|% zqU4@58Padu5G$mEhe;$L(Ejm51(g~bAh&98ayfntb-cjhujl3 z`YFu``vp(3Ehz}H6$lw{pYD&HF0XA+tt(x6%Qy)k2mkeFQO)Q_smI{XVaH3BwnlrD-b!#aw*oALPJU{hdd(d%)0v3K@+n7S)W@*D0q`U>SdJ4@Pxl+*@%o)#=G%Sa ze#m-_g+aKuN_c(;)5=M)6ht!>P*pVl-iFMVsxoxZQ6|TKzaAL+nEheKyX)f^s>}lW;GCf=|w$YzI#V4ksX5t5SVmnEQ{n~dBdcS z>Ed=Erku=(-R|H6 z_md=s?Ta~EgiSJK1bWkUQ@_8Mzi9n zqd7K&klzG2u2A_pcTp~lwv`rf>VgJr$>$h(&S-Uea+i$1w(eQkKTwttSEe+ll)-c} z$uqI1l#~&oq|eA0)`YEw7%^I8f=g*(SvQ**Rm7mdZTZ9qgy!Kp?fiof4xf15zm{r-+=Y!~g@t6-9?l0&KLOxoz58sAZZ;1(@?n|*lt9Ci!9>VdzXpu3%U$D9u% z`OKYz_NhQs_|wbut{;8Qb4Z@L2}vb0OX<{4#;8IV;&M8yWb=1@CxP)A=C~JSb(Hz>M`@ zSwr32#l;2S3jicOj|=FLbm$CC`8#zTKOHmF*04!N0?=YO>oFAfKQKJeV1_v@h*)tA z)jGW;-m74CJv~-LM2^bHxoC<$CRV5?e6}2Cc9CFNXgU1&gCM@ z`+qM0$Dg#5MuX#H0QK^o<1vh{UUV_2*QbZH4ta|H261nG+7V_gu{nkEZy7%?rEQcU z0ckh^Fd+k3Ucg@_6!>9h&@y70GIbky;MMjCwN-1`S2qN&y}>5SsI9-IRkg0*HyAV_ zsQwC+7Xbe6D*yxu4CjwGz~j~6f_XYT2zaa7?b8Q@?6I5|l3!x2NlaxKOjR5bvvjYo zEJ&HD$QIz9^%bVINwQGSF-+CkA!0LkUv_+Cn}o}e&{v&On&I|cGI%wPFAbDMj<+CV zufBPCv5=z-<%}0MP)fF$f6r95Psh&qr4*{^{ZWgUX}Nucx8UL`k@F#km$tu8Fut;~ z0^kP;m(3JX=5jZ z^Gtkv$LpNXF$DGo^7__M^B)pH;z6`&`M z^~`AuD9UaWAAX-yo%Sd|>C!Hq$fJY48cKeyc0_S~!G{nUgFX6AOBTN_QuXBHCM zE;j+D@xZ6YKt9P`dDSi2A3|a7?e8k)TRh`8t?SG{k&bmVpQgl0>8r$LIU>0qgnp3ESU&J1xGRk$@vEZ_T z9?klA)dr=qRjuzDBrFzA!3u`vxQ?9eD}3S}=$Z(9g6pW(HSzka(?As7S%M3iK<}t? z_iXO(m4liV_>oUo3bkw^%~}%>5oH(V zaDPh^^wcky1(gSdf=qK>)qfvA6uJz|hrwT|iXW)m)mFkv^wl)FD2uqzrZ^9VIc+#$ z4DzZ(l@tn);PcMvoCL-BVoY_7EbMz6Pz(hHimqJhimc{vJJvTeNCckq>~#tQ6A&-Z zO^s4$!MQC~d`C7GerEoUWn!p80XFjJRTJvYe~}yJXD9dlaX=>glDi$Ev_sBk-#L}b zJutem%;A<)rHDC(-^fRWEp2D8p(QU_!8*=-h&=#@DX`fC`cD857Vc`V|7-h4&Wzg) z#P6dJIYwSMQV!!lZg`Kht9u?fE3%wnBxaS%R7sPUbJw?Gm10sQVy;&ENZ~mXvTEDr z+?Rtv9S2oY*MmFR{+YoXtx2l~6{%a1gX20aoctdW6Qgy71f|^7qkTg8T)~ zDcQ!_vXk17R{ACr&XUIJk{q(@z68D;yIoBA$G0WqNLGrcA*R!@V9Q%9nJ_&$mX_fS z#=~uoCvipm0P*~lVtKP4-J$rs46Fy3pBX>+uD;XDfV!2OF?6;#F0-0U0za88aPl`} zmnh^$4yew-Um{Nu`e|iL@;g_L5y&ob^~uP;&5rRGFZloNZ7bhustex1&zE%ZR~kc~gVm|SEx=Nj-a+>SVU7YTax)DheSN^rlJO%Eu@$;L zQryTQLXGdrbx)zfW6XmMwYZDlseUAGrh~Fjbd_$Dt>5Zo)7*hHSD8*R49rhJo3ICn z+`0fxmA))o{#B;3b{gpd6l3XhDx(9})%7ep&qk8}7`R~~>Y&k>i0`MS+>+&5kB!}e zA@SeXsfVZw*g|_JsDh!S6x00MMS_5Cc%L@iA`ZQr39xp7xVCA^Wj`k;k^t;!gbbi) zWr9EmAT{!Ifngz23wgRdHmLIFf5d6FLnmz?-Qp<{d=~%F7Ak%~HU# zggOF0 zR;O($q9^Gi4uEWBZ=&hp3%8W)@wa(j{*aDUSl#hcyzRxQE)1KNF3^~KoyN9KQr>q` zlyX%nCy|qZvfQ>wrce;RFw#0oJ-g%M(03HlhE+djM2}I|g$R0xZf~3yo=OG&8-T(D z^csM;JVSyf`-J%TT=n9AH`O9hl-3B_XyJZJ&K5~8g^DrJl)y2*0;sJwUHzF*qXZ~h1=|=f6B2}sACmHO@~3oO#e}E(UPdqiWalpXNr+kz&+BO1+VCAq zz~Yx^+#}F!Jjj^6*-{uDr8rU*arj7tl0#Vt=zRg^2Sh0gwFqB#FoJ3JUB*hz82esR z960x23L~^i=g7GeHw2{Wv=fQ@iGsB1%g*6()fON(d>4X~al=5i7-vy*gi4u^$yoq8 zx1*e%PL|M}rwbz{B!o+IX;i2PYTkjLyF=O_`X+mQ%{}!(DcY`aOt;Xp0(W!RJ*9>P z)}FXycyxQlu2I~PF3Ev=TrvuR5Ew!aJbrq@adxTJlO3a84)+CmcpA;N&lSKNdJSLI z@z}r)0S^(7K+ZsBOf1y1vn3hUM72-Si3t2o6uwkJQ)=tFXEO2yC#OcQ2>wqkg2u>g{6v*}k2emkG;Oi4L#`*B0q4lkOPPh!G z%)9~4F$Vj2yQztfcJ?w=Y!bh4*&c9GRr2FKK0IJuS*JDcjbynT*kT`(4SKZ0ixqk+ zhZm1Z;7cNIu(UVwq8GUg!$+Z(s%fnZ0sZbeY|H9nFkW|-AOt=ka{GPOY-tZUX}L+` zA;6%FVSDY2-isxkQ;jO2gXdo?nb8wkO8@5){D*oM0*GNC5``F(M(X@)=k{p7NB8#) zcCPkKM$(ll3>sy{`ez$}zu3HP$KZBQCZIUrZ_*~o`WIJTpJ5_L=)aE=SjRGu7lYVv zL+Xp|k}WY|BfXq@3hNn>_@<2x12zE%a=EqrfD-R=8p{JLZ z7f=f5?!G*J2B4`{d9u#{ToPA$6SmdHy7l%}jdPB$ZC zGxX@WD)Qi{=d|SXPM^G>1b4rGKBautu)aiRtaV#+4>d0GTMn(*kNEH zDc{W6t`*#(ihvs2Voe_3ETUkUN;|+ILARUDhcQ8)#yl=fX6w%sXZ!nhT-ux_(*zx@ zm{hSzCvUs=#Tsmi=dlZ-AEJGIf61N)Czh5u`*TvrJ%_25_=X}+jpEtGCW6dL=cRvVT_ zOW$Q)Cb9I>DM#h_>>>QGtkd`mhNr8J?5_Y;yyo@o1(yG;d!eC_$KNomPK%!d+Epbl ziyD%%V+kl5&K2f@i7DgA7C53?sMabHw%rRF{5V`-jyY9`$B$w`t2g2{_*2w=qMYC7 zEYl1g9*?_;braO{>VR5u zN8H(DnAjO?wAL;p_BxBn@0^I1r_i|y@Y^1!0jzuz;knj-EZL}TGrjLwMRiH=nMd*( z8NISiK)JCHNPr`@xY47JNCq-yF1l7lQm}Q+fF^w&f!)W15OExmVrvh4f6dF2(ZLXr;R{1Ez>gZ>pWG>VL z3rHi14LdHNY&_My=g(;ZRzVIfM&=XikoL*CP_f00x1XP1K)?=DA-jCebUDf(wqm#* zF;qx>x+59Co!2Hk9tPi!Zv&%#M!orJ{m^+ljZR@)&oaNI`_M`{u<3iO`V>Qhcez!H zF;=RSD0zG*xX2Zi6cqt$+Q(zZParDrcE6~kF2wWmt5Ga0Ff{|m3s4mL2sFoRef&MS zBou4)_hfa5PfK8Qgkihh^B-h+`dC=7Fh6FDW&U4+ZWx`0LqA)$YrvCB5l`Kzm1U#zrq zb_{{yL<561@X*|BswN>ZR4SZYgx`+}U%Z2dI-#N&+~a@`2YKRKE?Vez{z;0(zDe%` z!Q&iyf#SJpMfupFpyrnB(J{7~MTciQkm1Vp3J3`B_n*!MSpN&)LuEEvoUm{O>UYOxQy&~p(q+3b3jnq>0AU==1%kR`FZ_cuQk0Qd_XCo zv&b)S2OA&kN~Z>d7=Wtz&RTC1Q#+obAssE97hq< zx&M6E{EpAET)^Us6RdHv%lu{(Gq03|KR3;Co7a%~iOE%yYbN64{E+%YCza$#hV5;> z(pYR0qR&vYW6|09riO=Pr{KmmiPT!Tj_L>!{Sz`~G22bp7ab|_DdRU7KDYjT-tymx zV~bJjeD`8w!WBoWsJaM&QmghaT3k-=yYyCWY;)F8r07oCk5rR|VecH3-=?(Kr|{K68grfd=m(Aqch^qSipb0oH1a>U9Zs-L zfRq{ZDS}_v4(V-?lvJAk-qj-g7(bi{t9{UIQE$CPW1 zmtJ*cFCtTL8s;YxpBL@%9jpNz!lV!Js1Yv#d&>U1`pgHrRD1y&|KY-vnXr)}{r0T? zG^wSEQ2&2laq%nrp@{L2gA~ zl~TamuimHU@Jum-sK2S`Vj};1e~;;aaM8G@u->~+ho{`BTED{j&qCb|#RYhTctcZ} zQxJYZ`KFQ!7#=U;hk(Mil>+iP<`eF4-i9 zhSLWxj7}ERS-{F&z>C8gs!s!=J02~K4)dm%ety0^lB)n0u5b1dugo;=P z#!XPko^pgfK(F_=kmW?wsA2kLEEu6ywBARJDq7Sd3aQL4gHmv;ucvTVYfk8TUJ=Ee z{)*pt1=A$vi+%B*lMGrq5W!SPRbWVYx?vSrsjk`-IDua^-Bw9BjbI4pl*VjJL42{| z2y_Y(gCr7%SypwU~4|~svg+z8T9G|83y}n9Lg2hMZm+b(H=wv@4tdy zJn*hbOK8?`h6@m6uj3lg-=|1LW4kaVt^;}zZZX$$nA$k-DBHOfq!+;IRw$+Iu&?cC z@5^-ByjlrQL1ZjhO57OCPwmSLAUg%(vtIvh6NJ2p?%gFBLVsRe^~Ks^E(14vzo9DE zntK0lW6z&Jf0F_Tc-F+4%VGxI0SfWYx7$ge_%z|c=Sp26J=C_rehoMaCE$R$xn@}w zJx(I;&NOW}&+M5*Q(3sc!do$s}jH09Okb)_LPgT{v~Xb$!4x zD4bhrcyJVAKW90_rlS#uva(Nu9j;Sv|4YH!*D!=N)5s;y+NCYM@{JD?_1&sRBdn6h zsF6T=*}pf1#smg4aG^h-V=<|+-H4c+R)eE{7En-2=3Tc%7#POPGmTHQbnTf+-hh zVRX%umHLpK-l6b`1vmdJDYJAwY;%xpW1TKl&&b6klmG)pnN z3@!48EIgQY}O6-W|-?8;|9olb$Hkzo#G54I%V}FU0Tdsz&!-g!>bvHejsbXRrpzI-= zte+m`hx+WSe-6}KVy#d>#TWr4E5J2RCK9-o0l7+mPjz`&+fp#DREnP<#g4_I3+fNy zyUmm4uUvT^bkRt`#?F_Mu)ZF_+(JYA1~JUol{Kg;7+OH7SlqE}bEFRR+@AhmjmdWH zINg?@S0i8h`aQtLJOja)g{O1YTl>?%8H|p$z~MoJ$ExsatuU7HkKH$IQgzY|h-Ni{ zHUfB)TG~W82vk=xZ^FC%DM6;MZN5DmEA1dr72vuGOkW3r;uu%#BIsM=*fyKAx1eyH zI?d~HZe{e^QucT9AkjxZMn&~kJ-Dm`z5^W=VwaopP)vKAs7Yc1f~i!oT0);#E9|60 z73{VGBI7zy5^&X2_=;7miH^* zWLkIV;0VXJ1HqG_aFIG5%w%JB$UZ^AA-Y9L?O9h>EZ|`D=+J6zal!GsIicd%95>@F z4VsV*+N)aV>K%>J3mH_J z%6!iLJ#k2nPly;&ZPnd|!H2>1;KZ$31~ zHoOqZ*Xtm^^!wiH(UG}U$qyJULYX8~iTEVN5xf{2^w2)vb!2m@74>V1INm{lb{5OS z4FMvF@ssrY3vuxqYbcJOoZ%c}u|zz3yAD0l`LH0-o0beyk9m4`S)C|y`3eQ(O9H(# z89LPUN694Fjsi4?YkI5l6bdpfbV2azPX8BRn+T{c9Yv?L)(1U4gKrCPlGe0jJ4JSRsf^W>d&z=IQZIq6_8 z_fc{pqn!?S_xOvyRC3s8CkkOr1V{vqm*Yw)Vlr$o!Q7<*GmL%7TwFv#|I$*brsYOM z*siK`LlKTy5?Os*uWcc(0+ca837peK1fXPLK(HPC1cZqE=lI zLo619ygP(^skK-^&sB8YWg%Mw48|W(T9h%V^^|`ek|M1}tz(zD2RLbiFn}B%xK&j3 zTf)8V4#xY`L{Nb^51)R2&uL=^r!{R+E2pW;blcqUU>U!gv^=Wz!<@_=%n@?av0Or) zc-mAoMoi}kEBl)`&U2TVkarFJr^&aEh5%uvVQ00ReiH}I7 zc%zn-dkU06)+Rd!1QVud*5)i<##r1D66XOZ-(VZO5jP(!joH@1PLojdg;>q$d+Gu9 zTipv8JB$zOwP2|}L`s|Bek#!3lE)X3;gXI`dy11sy(+&fh!phuQR>n$3|k%*iLKj< z%gvnbsw#aQW10=8jg67`4ENS-$N42l8^jus^ zBl!=O2bVEblPfFHwlOOpT3U7J@!vn_(-BiYW3ZhqmK}?rh$*+C8vs4>(7m$w3r6g# zbg2&^(BxLd^OKNLYdxmoGMmj5!)AYcYMRvK1qY*T(v;lQ3oUon>sO&ZW-PKC#>tp* zb3$fFW|ToBtZ%tBcZm*5>`E`8tliV|-HC*ksGebs+UOo8zv&`2TF&D5P~1kWCq2n_ zygtq#5)T!EBd}A^UNhj0K-H2J#}pizud|zv@gAgdwp1l*==y&z02#(IhDx`&S=?dI zcP=lg1HP`Km{;b|1qbuL16!itv7#;^RKUtp1!@UO0akkp{F%kc#pQNUNvN|&E|bXm z?`iVvT2dFSwX9u9IGjpc|g$7hsvyX*|8*)Ml?j^+klu58cX* zV4zRC&^j1LfU&{ChouCffij~SY#$+5huT$NY>ImQI|9AcN>xo&l0fb;amh$3c$UtN z8Nv@`Bz5icy~zyb1qt^ZdC1WS&3{=@U^6%Z%?x5(rlDl7Nh6@$*1Nh94iYin8kFx4 z;c%+m5Dwx4tJgsQcszEiSNxtLe*RNi zBxf!8O0|)>!1m7M5v_hNrrw1@NChYiGqbY|_4Sv19rtQIdp|mvnhu$`z0qZ;W2WOn zfF!HJK)44vM9`Xii?R*J>XOk0n~FBx$OO{iSUf((+!`Qs>RSZ>HAR7e2^FWBAVqv;!fy={a~`x^?=D8`wQoO}^kr=UvFa}^#_#+4`@k#d z0p37r(JS~dwtZbTUek|Nmat40SZfcfW?|F@#wLpvacXgnwZ^!4&x}Hm?`%3U=EhL= zTLSJ5c~hb_>|fgMskHmU$}grsFvE2oOm*s3tma^rG%u~pxnM)Z3?5XKjP@FGzp~Y zSIjUC1t7^dd5HB6?YMUG@j--uLDhf9nF@SQfS7k-7hp$vLP5bInVx=<3{Huc!D7kM zk*y=Y6$7indB-soF>wB_K`zhGl%?2grvgH!y%-T@Y3zQ9$nWR4h}J_H5`%E{zzI|N zrmj_hB~Qx3^D6VE`TQFGXKD4S_^y$=fH~qRi8q!?==M&CRFZhEe0z3#5GrcyG(VB- z;nZsZ)qE$&pPS`iW&i-ek)v$%9m zVm6}k`QKk$eyiS3jDn^C2=^5FCGK>=3m!{O9rBwE2uj&|r9Ly%%*$fM^c4u}ZhLGN z$nwvn&CAl4_S13XyK|v1OG}0^s<2g!JZ)w#wQ2em+vtJc6)F&3_3pOnV(%?2fEbqB zghk6_)XXOtbb^t068HvZKddHWFYL3Ue+M44*~fh zHm|?9v{0&@7uIzzOV{YsxLm{;JD8dVS%7Fdp!P-dKig&Cn?gl=1*22MG*1llPuW~% zqc}Y#*hxQeN9RRgoDkm@M`n*#n+`!!pMK^2`c=D5li?QcJj;7vb6lqVlvJU>Tij^| zUY#i?6!CCqtUCWXUF}>#(yS?1LC9d5b^4{hat_m!^**#ed3 z;|t<0`FvvZQWY15c=2f`tt%MIw+mGm|E50{mWH>@S7uMu$-%NTziX7>63p?iy{g^+ zP<&y)V%V412(V5Y#9$Z1vJg*tQwJaT7CCrdDEfE@X}jie_lsE1C@(4yZA_7{WqXMK z3Bd{QavNFvy^E2{Pvc#}mKy(3%2q;T-Y!dUEiASM(?}?8=rgSba#bs`wI`{=r46I$ zNtqHU1MK^`hTX^*S~BcdF>xuCR^8^!;G-udkW&)>)jR{6x%h+xt(vqbFqSAhQOBY@ zb3t9`1x_8hTH*m3tN3H^ICYz&ivvHo)LqXJ6?cnJGG(mxqDECon~uF5 z7ekTMNvm*PPkA&reOChQJrSH1ezb%H_o)?4oGWuIIEHtD9Sc(jkfiQ-dlh0Q?L zY0{^rY||WEKFtF=8($pR>`gl^=U+YL(NS`ou`6&o7P(=M(PCaZ?qXftvkc{mm{y7% z$vc71lScLR^_d_uSg0;9D0ES4XnkQ0cM7@8KHj_lHE?Wfma7@it{3)C;Dx4v0d3ks z>_6XKmGZIFV39r7?=B%~75T4F$#T!`au}@Cwb_orrmTaggZ5AkT==kNjn6O*DS06+ zz=|Q!!iLWBc~@+0fvZ{|RK`wLQMI<6uM_EBWj85!8T&hYfQ%ii$?0WWZ?QL59vximk3 zCgatar(-$<45V&Cy`ja$MXpIbLHrx9^*UPAKESH%<8%J4v~N1V&29Ml{3Xx96b^ql zKnLQwZEj0YjkCMDnBE}~sT;GOp($4AV{5&bM-h$eR2~JI)LS3@eX5Anxd_qqU*N5K zqlPd(noYGxc>KeCk9`kq!S>lcdujXqfw&R6ATKX^q10OQB`zF7xCT+LSwp$82hDC8 zADY?UL~krT)|WYS6Yh}cghuXSFB zCI28_Kv)?aKeywjk=dVP*HtA78BS0qeWomH{*3@VD2()%RjwIc4(Y#iEPF%m!oJr7 zGmYC^Ie>&nrh9Nx)&q|#SBKWvQkWT{u8MyW&v(M|67%r<{0yWQw@sn&GCm# zt0Jlh2Ro%DsPq|#vE1d9-i0~&DB5)~l^Iec(K)9!;_P&lf464`qxB=mHEYz!gl|*b z2>qfXT3(PJ%@v@j&?BGWsoH*trT*UR)u%kHA=WQJv_ZONzmpQQxzTW(~nNaWaXpnii7b?Shu$j)|`C?9(Fx{_B*_y>H7fvY9L1 z=+)FR^!7T``tRet(@fIm`@6JnUxWPvQ%6LVXmJ^fT36^x60anb9Jv6TNX~-~z;ivZ z{oO;mf`jwlJ}%(xbdePR;?Vp&oy}F*DrGT0`d1;AT7%)JY2|-GVUw%WobK}#0Txag zikm4G`dHjz2uJgs%}>PqH(u7doH4FrhaPMOvSD5 zQ|(zR>|l`*wd(9HhTAxXR(J<7uIEDqqEk{*t~r99cbeHOr^b>WjDlBnO-nFPwu%(> zN}wj^4KewCNEbUpOVz4hV7;9`IbI+1>{oz+BdCT6WNEspEyC|I7RqYg)t8vz!;~$v zPf#PvMPi<%2N*5|L~JT!E4lE(_`wtrH08jxQ?nFQF-}MRo3v+oW86w?WV33iu{3Z` z@BEINv3Fg`Bh>KWn;TbDW&{(h zCM50xsue9;dEZ-ch(LHmA7XlyyOpCv&&WzL+ZO|*-EP=&W-Eu)tsnCXn95wGIqp8~c@f9juFxEk zcqw+V@b|DHj3&h;SzdDtqV9)vCXQ$xhlGoqTO5q=lQ4#S*J`0dbwu#8*?h_EZIB&w zZi5ZtPl}0iW8b6ps?eQX^~j609@BL2tR+*)QG!OyU(|wSr`uDvsZL0;t@5Cj=Uf1L zNaS|Z;L#41O*JA|rsvb>k%~s6e7wli^ta(o*f}XI`G3}Dl+>4T|nUX=u}WQ`sC`qplJ+CF?o0u#^tX? zT5Wp|ucmyjTvUeQiviaY`lvt%W_rqY<)X;N z{bmT&#I7BMv4Wm~2LmjPdYKAze?T6PMcoGPRn!sMb7?Y+L=i~u7?@~R1$g&g=$Xrn zwD-Q`eA+I5=*IsJyzWzf)^U1l{_H-M0$Sk~ZgC^Gb=Ywl-*&8nIM4PN$ zCU)+SYDn!wQFbC--?x!x%WQ)!Ww#YPuEwqYm1#P6ipHFoJDcF z%j?C36L{qnn4_< z$+MX5p`_>FD&|trp2NQ z(z8QD=UWc+i`h{QCOZJSh~4wgX_l|4^V#cpnh-bt%L5L zkE6w?6Qvc69s>L^y*bR0tR+thSg0lVJc*LBut#oJn2uV`V&VG-I*`lY14hG5OT~<+ z**0(eJQE`GVfen;pb+T+^`WrQeOPAgrlX+Hpr%mJ;5odRzZRE|kFS3HU0!1U=gIGu z4J*_PiV?6f<32)Ht}~-}CM)r)I7kuR70w8Vo#K^UB?fY8vbW{s&${$Xc*@0MnC}}@ul~Vw19M3$tJp<((=QD?O-NEfctSyBa;h@#U5T#gEMh84^$m@?LbMjKz?46CS z$dPJs*bF0jSA5n&ls|zKmTgL zrv?W#Ze)u;Nwg0nSxnMj4ga<^h2~kHeoz+|w7^$j2-RmI^y?LvM(tgUIji1%UX1$t zJkEk$;D=|Z^n6%0ZKjfvg3A&2`wwnrSUW3?x(L8X87r_a1^4tMWTqwUi@KC&bWoIe z2fhMXSjX@0n}$**E|NeL!?9O~VU3oA_s$=_Y`3qiCB0>?X5dXn-aHKy+ESLgm5&t( z-Lupj2Ly(yAlN!&F3|>4#xk%ubPCy3|m=v^Ev^&c$&UD%z_tNtD`1{w$s)01) zY07kTek}o;%D#?W>e%vhzUkqGvh_$CGXSAG| zZE{+wk!mY6VR8che0De@qo211=^c~3CTHVfA*XMUp2!tsFy{t-99r0MnI|}NjgLQS zfyjK`%gpbP)Dq;nk=_RSm_F129gT+C+SR-AwOOP>q14^L$Fp|2S^F~`M4GCXTbUNs z8FnuO>gtL<)q?(;$`wkz&COqAR%;CUh@N)GdaHsK(^6VzT+F5os-m4fkK9flO^}4? z8w&$g4#5@y-O1%-RlxgOpO{DK=)1-gl3dKU!m8W>^^ify!4gnMk za7`Q+_(4WW`V|l{Z|*Q10?AD(U%%f0PwM1k%q5vSfsw-E*^ey4?s;n_gWq8RS4Mw( z4E;Up7fDXLV$*;+J*~Qo+R`m?J-v!saoFTSo~5$e`?0yU2z+?+E+REW{YxTqe0_Co zHrY>9S*ZJ(K>}2h?Hfr*h;%6juNW~b3GTh5-+zHgXa*>{f4C>c?^DSMT*B#C1imlb ziCbNB&85^4e=9V^L>UV=?@&PXjCJia0`_8n)(N2X)R`EB5!zqM9S>H|RL<0Fi;)(V z1RYLYF*^*mN9_ai3*a1^ar}4f6Bp-&nPmPoV5>ollfH8XKN;zDO-U6dTbUqw3FMrZJ+v0#2SB z9OCgmehmCnB#`ZBppn2iIC@|IZP1@#a=I|!jdag9mEJGzV>ef;5(t|PeYCUU6yb`r z&SRsmcx=E!kK>!4!Y9aF>as7nX>x{!ti#nv|2=77d%+&HvKTRQFKMDD+D=Oy{`mFv z72v7@TOfdG4uF+NjX@G7^Qh~9G>e~KYa5yBYL2N|@2mch8os)SJcwb0Y|9xth`G97 zwmFbnz%~`h`m;u||Hr%kja{>xCiU&%nywPkDXXEgs@b`-q6_Bo*@M1iP$$AdV=eub zTlsNm6e3+yo@lPPJU0Ykb8E9K6-!=T-sSoEXo?^oABN7^P4rh1U2MQ+S*Wa9Q4o!c z(gP#o_NJ7N_S9#s^8j>^n4$ms^5SBB9WXJqUp&%tpYnNM5a9U{!wpz>w^@tZm0=n z`OQ%F(gG=Lo5>oQR!)&FXiG;bxKdAZQN15a`tuOj0NI z1idf<WE2w3hjp3|E3Ix;m3#~1FuTV>T zO2?!Ra#ngkiTVD!yW4v$KwE6(OK5T}3`e$MT2!8`Y~lH$4GrXU)~%gHP>Hf@unGiX zUL~zzb~#TB==g$j3ZTvdWaXvyq$`vG>Evi&_B{MgOL%cHN$)Okge+$5U@iGI*D}xAohiYA}oVy!YOSnIhnjqpFJ6-MatV z32S>^MfeHE-H_&0b8bpZ76+qG00b6uHq3}=2?)=O@_x`*-8N6{{z}@&_nVfT^%hT^lZN>rd~W{|?7rAcp#I%Wl)7;|XPl zbVeYaxllkAWae9jh!iLNV8!r%?mlw=XN?prNBKC44Xv${b5!~6H1#o=jIiJ&Y`b72 zxtDu)3)h>aUNwa{m|3{_R7w7B`?&j(Tsd`#_wErJP@7iU%T^HlYj2*3DLaI~;LVA5`<@hjd*vCT1Yxy?;&YX*m11J(^)saQ~_ZX`BCkj2B3RsW#)#3z>J zZLcJ3n(QjRE#~%(w-u4wN~UnG5rT$Tv@0D@u^kNeG%?h{Jvc!ijcbWf9gygI-T&Qh zyX&A?jsJ&r1*Ko@0OO~D9g+DbLYU&z1nNT1a-Unmt}E=49_eu>$ZP2#NA9Dk0Z za1Bj+Cv8OfkF$wZOU0UF(jzsRfbuI9rJOZ3nNT|LZiRtJx7+)de=%4Y+K;>i{s@_;^@z&ZgMwU5*ae%>EUTZ?_>NF$Bg* z5;13Uqx#w6aR1U^pA-?JiK;r~{!$`piBBNr|75n2uf|!t4aIv%l0UiAXBr%220i#S zOiS0Hz2^2{IW6hemtdDd)O}@x0-x}PLmON2U*qx~u+$3h))A?AYoCPjV9>cwjkt;o zP@~*{o|&6)VZ1HwN}}52JAay+zTJWd;=wEe!ji0c+(31e43q!N)8%J!&S>eW5l~Pj zuj&hyEGEX@x@w!)Y~#6S6yvc9K2q6BAh0QVd~DU}8uT+=h_pMXP1nPKJAUZ1!(aI# za_?MHU8G4j?8QtW%g)j$8~(@|N{X1(mn(1th_Cm)jU}b+N;F$b%D5|KNj$B%t-vPF z7f99$EpMBO)&2;mi*HN5wTvN}`7caVA1VnkrU{zx*)~&9IS50}H1$LwcyZJlaSmkv ze3o$e?~|U8HPLhymqt1l2Mw(ZIE0jUZSA~SNatt*OQZzMnu*?wK{-9PFX^ZrC5Dr zGi?>o&VO!IQqT8GWQ4UIprG{KM_^sK0#MmL0jCmc7b#l*U=yi+0eNfDin_K|)EIaW(D9VgE3AwCcS_~8 z{{HQ-=3oYE3z=l+f(fE&I=Uvrm`O`bZ<0s`20+BYHk1y$y|#n#1N8KQ++0Zp1>bPp z#D5krw(F~|r#gi60<$;!`-5HZ*Qtk*g|B#qP0V7o$e|K(cT6#}D_g)N0tg(Lk5M7c zei8B6TuspHfKToe)V{24N}JSmz-j8H0_r~o%N$H))yzzYHvn@LQquogixunxZkDF@ z-sF6FodRfgYE_*(psc9DRX+Ih?MBY0^bYV{@FaeOXD-!YXeSHn}ojk2M#N`;$_xY(nYANRxC=KjtuA;&NWbgeYgKuw4&zx{M zXVKuy*SU&|+3S#8WVTQNaERO0)R_Cxo@dZG?);_CME}}=j&s3a)kZT|Z+}Hu@q`>^ z4iow{OX$u;b=vefotGvz65nfKeUo(>=!2Gj8XWP^>$Fe}W|4;YBziwTrHvQ`y-^B- zf8#A@MZPHsn_9I5kl59Vm8RPhz#IiW?f(QsN5DxrF=M{vfW6Y#y{c`x6R~6D5pRXr z1gJu;a6Z=uA+*tUxJ>fTjMg3;kFl5je=dLxuCL77%gUMFMEju1Kvj#;4rp;>IzY@2 zldrs#fuWmzE%SLVhh}buA%dJJF`y}sIaMKOQyYcvdvE+C^)b9)RQogX&n$xMj(;=r z0JX@Cw!tZ8@>6MUw>lj+=P4(bRJ^kowmzqHFhm~fh6DEv=#=WTnRX7>K|XMm-_RIo zif`}iZ}lDkRo|p^TuzBjdS7lvX)*Dd_0`cSvoHInqQ^X7{;hq3(e(b2r4)Q`v!;2Y zutq@5X0}kBiIfses9a9CArfHK8KpS#^CwwE54(t`CU&azX}82+8{}u6Is!%3k!XCZ zzzi5aCe%HjhJi7y-Qpt*S5^GKY^=O^3JfUap7Brf(2VPlw1|Xx@_Q^7zobsSIe4?Q5)oM;vD|r` zICLn4ZJH3zYF&5h*7qAYf$+Xr3!E?5bf}S^>K#{~IWNwt!AI~FX+*ZK2;W0M!QT)9 z@=w8Bpiob^jr=f}Zl!rg{Ht>t;9sC3Ly_s1%ypAYAcj!8r+?8B@`f*4E#|y-u4S=z zbA!op344^`=NPcmqIu@`;_m9#4f<~nPi%?v#1SR*e=f}t8h?nP0ChngrLfSsj zr7*BIJikl%Za)ujH`OItT$mR;l9*D(%tvTyF(>6h_R8+D*-~agmHVY4;?>Oo?J4xp zd5(1XxjU0ixKjfojVn&GcGbeulh2maO+wH~mQW5TvyPy=GofvCL$(6>uh%3K<7zHl zh{C}&!14mt+*hj64F!}$82YmU2*%`4bpw1*a0cbx;bfy_^K@b6v_>JBrupbCFmErq znq-8EmS(UdVhlLc1(pk1ohK+y+I( z^_;=wv`?|UB1mymzs0V6igsuUNmxzxm~Ee)@9o1IRUIBI!omtSp+-eg!A4M@kMRnpA;LH(2!_qImuK~Bv;h3F z7CN7JVl@)%L&>1vbb|1mi*1B*sEq^cK7^8Te*UBsTi|$XDx%z~H+F`*3^uCKgU^7# z%W2`C(OIr-cz*-L@U;5dri6xE)ph9_B+STyW_Hb$R*X8yM)!LY;o#M71E<|D&rkqd zH6`_S?P}f9QS%#g;=FM8(2a_NRVhqT1ef-qPTLf=GjoS&>aHk)PLu-{pRcSZ&->0N&68iHW-aPrLzOkjvEoa-rf6iE0Sg;43S> z5Wf}(hmnj`?-r}Gzc};f6s!Y<8E1o%?l};@=teK{`Al@tVgmFQR|x_0LDqri-HgW+ zyOho|nW-m))`fi{vGxWx-W{OHak8RgQMO2Ub3~xIB(lfr6Ul+G`#NhkH|Sx~FixVAN*)8{@Bi)|zs^3`)ZlHM|; zgmPoeowRk5DLkbDL z3ha$?U!W^WK?1=w0zM2=EPRIyUg(r22ObZmA0WB_cIQ~0dQ37SXq>f~ZFc)^?On$J zcD{*_CS4A>f|J2t!MI@Jrc{7v1x<>UvvizX*9S?#@=VTiP@)OY|NAmQsjgU#`*P1R zeL9O5z&qWfr#S2Q5tYK|q@!k(Fr`IOX;X?yg|VIXa&x0LyNiui8gCOrbW`8N@V99K zIXhh@euBOTloRUo^z_W479?S9SN!?cv@pgh9XSfp=cF(W#W2UGh#;P{^;b2LLH3h` zKstqk9jd6xw-=B?k)*cO^%p~feP^y;eM~wjY2nb5l|W#Ki*=QF05b!CTqgoaw_Z{Y z%&1%2O{Ru{_%Dh2*hxCIFnjh&?@)T z3dIi2dj&R|Zl`W{(No=7Rh`9=P7-@T?M=9NVfLhDEo6^}NJM4k_H(O-rUPs~4gxDV z%JEJYlRx9=C8@u1hAa;MCC8qJ)4^L4Dt=TwG3W>^fBN*!)h_P5kxZ$8R^>lSd6J3H zw+DW%xcpXzBP#i$eDZTOVhop|$XDel)~alBR!Y6U_xGLw9x@sH}et_H@*s6u=!>_wETAZ2$1OUf1Ks086a89)QhU% zt4HFuY?iyfK_efpc^`8%X4UK(s|p;hhfL#xSl?h@{Vp6Q*|~l?2D$3}TP9fIS**S^ zl}je3(f=GVGQkPuQ-eJXfzdlOV$57;V%|^w@>SP4Gk{xS+SeZ5@}mkJzkm)B3MUtj zIfxmXRLJB6V0rjvC7BW?XdY>_WU8dl?`tU!4=2lKO;|ZCoK{8!VHy9KAN6-}LVH_F z=19l|FgLn}wq!g@*sDGt*}5v$Yk>LycnlzW-DvzMw>reg4ffUCmvyV@yRfsmo+NF6 z1rwb%+kHfVWZMa@+-)p5?2Lk-mnnWfUG^-t#wa20eYBj+?+L>g2J%aFGt%Q);Q3wK zEoc8qISiwW+_1~tu4+BiUl5Fc7N3KPm4ya>$lj^vw~#*is12FnLUQLRm)Awpc5G*u zlRc*v1!p2&CtyvYaYocZi>ikPFAEWK5o80FtJZe-1d~T@N5~N*ggAs^s1P zJomxDL7>ZTS%{egbTz~PVfL-Gn%X3^MlwowGdqQTo~r9%U7|3%Z9TbM4_N42c0@)$ z_9mY>VNc<;DvtX65yTNTdp=5o)c87LHipf*rl&GaS8)Oy*T)Z_WWZl1N8@TsS2g3N zu2=k`8Ot@8fMkdsNd{L~UARF0h>xl~9sx0w{IZx9E@c~VQ}Ia3Zyl0i z-oc9Wtx^r2=IS8ezEi;I;SJPj`S>Ns1GZ08es1bOD?v3F6nM+!=A-DbDn; zM^ph%9XwBtLHvz8Q8ADe*A}}TDw6$XWN?IigAq>7t7LjPA$GumuVTVfjqs<#gRjH# zhMD%&P=Wq08e|KumLfpj=4{g4|!WP=> zTv!+pWwV@a9li>ckwqp{9l?VHbOh{hz$yknbe2w=l*d67f1e{kq!P@SBw7SHBi&fP z!D~BCh$u0|9_64*XpYeg%tQABnBw-lX^Mw#pSCwCnO6_+yM#GxE-D@|B>qU$ z*~{;&;z}ERL?XUlEe2Z8@ca0MsS~SIE3@&6R}*5X->YtOr=ql_O}p$`5jDdJ_)8+9 z)@?PT8D`nn&b`1Z@YBDRPWcq&#%k4=nAC~_nP^;aHL;>V$zimJWBp#dmu;wcReaWo z>6w3mqjhw#gBk0>U=JQddM*E1wh4*wv$|RsPsF*?Nz-kWp>7Ze6;X{o7=G@=)EF#a zZUr3Z+W`vJ$GecDnbZix+c5Usk|07ESyiYwSZbN?mXO#bx-w$6i=0jPZ&Z`xQYwPz z*AboUEsSe_XXVw)@wqTgvA_S5)>=!4Ad|E<8=*+{4W@L(*%|ZGo`PY%Ceit#D?v!-Mb5MP0nR4LA*hDOk+`1#hws8jK33&ocknIV^3L|c*PQh; zRRZlN6rl~D(xUW4CP?|}z;D2W_wxD#o-j0u%^YZo%Br^44}$FH3$@`&auK153zFba zywA{_Bb_o3U12@bxf?gYE9!1vydte z0qNab>9TaI&k)LSjMoavp&PlisrqpC&k3vKj846p&+bay%3Xi$SEmbyH@5FEP|Imd z@Lm>~?DSKe_M3Gaa;d^Mr!f~e?rk@X`8SAT8rvWL;4QTm(jwHgv@D%VwXQAIICv(^ zYCQl_C_pU|Q#1~AKEH!1eDz2`#EnnHOA7vQ0iB-tZ5xpU?7r&f2eIRsaWa}aG?l&o zl<@MlY~t9B3QyuY-CGaw8fn=hTbHN!l9bfG+v(aIBrgqj`zcxY{4& z9t~AVdJP((nY~*_9|1s0Pptw2(-WUHzqo>;%R`<14>NCLpAcTknefopGo$|dhl$Mq z^kSa1hbtiZGcJ1j#1a?RgbS|xY4LFgo@3f6%C zue&^pb;*ugA#Fa$6VseqehcKNFdDcm=u6{o_-Tc~!fT^uyBmGnFBy=&vcv#{eR1&v zW?fp^(Ej4L-PX9PL}sm7t)h6GFufEDgYW-%ad62}EEO&fhdH(wq)BsP8IL=0#h$8a zc%(Mu4XocNR;V3{vgZw`Zx$v*N(=AOV}D65A>9kDi-x{TkBue8kbNNrFwOJXpT$!3 zPsrNV%fQrQ&_Ry|V*-jT8z1eMHl1@W-2zOW0Atqg+R3^eIuLsEL8X8qr|Jv>;}&*z zcJI46oA9UjCeA2DchTr}J?thHDu`?4Z+NWpt7Hy@& z*2R6NgH+^tYrRF>BZur&7@8Tt+7H1t6CtI5_=Wo|U9}l?^3VpsCffeUF1Qf(OL~`mNCtz!y-0Z_x3|178V z7kB?Csstw_PQ71Uecl|%DrBY((e1)5sd0*=xMTgXgBt_HW&A)0e`eVlE``Aum~%-p z7*O%*4t{hN0YUH1=&NB6BJrTZOdolmX1hbF7JW>T&*+*FADDe<4-Yw{iDEg9V;G^E z{d@`qgF8SkoqiU=S?Plj1@8%lpi%?TI$So}$o%BPE?+SCy5tdV-C&pNV$5n(4o2wz z_s2y3Vo;@Krq(V1+#jfi68@H#ilPWr<^}M#pFB>0*AHpBUzh;N^PEbzwK%!l?D*uo zlaGXDJ?)F>KUD1`9IU>mwNaLQ&4u-D_8MN3$;!nq5PEyPfPv%*?H^87Q@aU~&= zLTD>t@y~4y6(R%CD0vpT`;{dFuv6`leI7w=rU{N}9adIUpdHmf?b!Ido(UP6Br5+RjVx)kviERfn9SZ{;rA0pv+ptasj|hoT{(;$*e08vP85R@kgFVG`LZyr~1Cpd5*>a_x^8=mMST}Ls!tgq_RTKFRLkQ=*kg)4m%Sn$pWUg+ zM?6Y!XXqrEqB!0N&GLzakg{$3^m}FR2vdv}*~!TXaJk?gwN`;xZgBh_<#L-m3I`lR zhXBMj`GtI*N+h#>VU$vQ@0JgC0FP_DUk%IT6&_boD6;LafJvvzsYuPxa^K1vyGWU` zE~eBcwh!2t2EN@dO<1{mdfq=jpCt8owE~@j<9=peiXd(ue=`v@`4|8DwS31?JMOnq z?joS6SdfshcmkwB0B=ev2mcMAejNVB2!*EM5lzg9%UL?EsZzhf$m znFOyZ(7`fo53T>MP zrMjNRs;Y|Zg~A2sZ(dC{FV=y5n=SlIA!OH77PyLDD?WHhDvd94Eiv>{&+e_d0pO~S zln8*x+l@45u&rwZfwzmB#QfLj&81#I#X%UspDj8MkWAzRO7qh?d0;Maalw37p@>g( zNHyp9D`n)~0LBThzi?JMfg@AG=ge4Eak4oX?w4Z8e$K&A7mlg5!ZNF^m{3<5il(xv zN*h84EA6N7e5yh}Da`w55vKjBh*;~ZlnB=KXRz)xlCK0r-#}3WatuD+x<9;Iq#E*| zwSXm*B_m*o$DV$}3BVA*Fymc0_yK4z0aI-QV`Jx*HQ@XNc4Co^2+;+BaE39T-wp0` zCo?OmR`|x&HHpZJ#pa@pPp$+&BcUXrGR$w>f62X(X;UzgJw#A}#=1aur)y(^|t zKDlT}yw*MXu+PYI3XRy_5IWz=mFAE?ZDm@O`dQ1Bo-3V&!RhjesX|ehNd;NQa3;j^ z*{Zw6qzkm__;vfWE6_Qw91S_1<2n_0mP}avt!`I8ai5};dC!4bNboQt-{-y736rtN z1_|Mk#v){Q27UxI>B$b8WbrF*r4D$mr6A3%5pg7D>_Xmd#HT28MH))}$_M`iPS>~cS`!%9GlWpZfp>JfJJ#2wsTSZSL` zGQ^5xsqJBU6UsPhQHz_U9kjj-Fc$t2dS^er8x7Q&YdI*6z$$}*8Y>h3pi(=?J}9pT z^OnEqtC*U;IMPkm5`lg&u0>$kWt%>;A1Rh;YY5j03J4^BW;&6+PGv$)4)F)QLUT5W zg~7y+|2Y9KL`Bj7L1j$hZFOfBw_0FEX^E{Qd79Is)F58S^nk=a&d%u<$%*-dS$6+y zOw>|Z=dyoO@NqD0b$)ND^U`UP;W@DDviUj|kBUQx7pQ7|n6}%}5>2pj#IRh+f>FWBb-?jOfyEVUP$63( zBH#eNMnjk|lL#RTk#$0_c*>$mg+m+a3AzmS;rw!0a*Ik*aMa}BR2YO3Wzy(8AXd=8 z$VjYWbD8_VOg+0B=v5gwGL`Bts+p*)U&2UG1vMf}ruo1FsBpE;pI90oePCsu^bf@9 zow&1rH?!Wtp&kp5AY$X6&|Di+=er^}8)4Vi={!FHXre2*Jj{TA<*^XGi&_HmNWg~z z5C}R(PC|$Y>fBXeKjPYJe^DBGom>->0>5j-)a#f}WIDK2TU+kCFJon@ajw9WfUzva zkS9iddT$tbH;p#s-8qzS_L^Z(nIUXM_6ClJ(ZMz`21y9g*v-yV(saRi~TjWS7C z@+t2ziOgOJ;LM|`!UwQD7fyZ5<^lKvnie7rB31y!%IzpE=7K~Z!q_w?_4YtM;@tQf zMuQ0%T$WPMhRAb<%9pxooHq338ZDFYRC|7o(u^z(tWU@4W7bv)Z4r5y^S9YC0W=Uj z-`y#i;S{!}E060^5rsWxr*p@v^bQzV#kH~73rfPCf3>_W&|^=>e{5$wB1`(25Gq}< z=~MX;Qo}WDQiOljDC1L7P&3zUacso?UgL&joo`_bo*T$N0U*mkAD5rkB&4M80E+fO z_VG6`at3gH<)z!055q9*-fma|2o7%mKcL>@km(3VE|ZR>dHIGqmPY-K6$ZVQ!tfIa z-K6f8Gs3#H=}tAXxq!l?%QEoDju0`uMUyTkJBFg===d1Had|4?ZD8;QWc2m+@82Tj z`%OTbTDE?mjfR6wG1TTZTp>fd3 zZvpshkxG%7ek13J90b5{G15VAK-QU43~Zu#7@$uA{@md=*?R}{02@`}5n{FoHLv}} z$&a3VTuxqn#}ue@3VBo-9#LONVSpeW;Lvly^h;0t4)7Sh`TE-Nk~W+Znza622T&MP-UJ!Wp&`D50Z2<=8Huq21uq&VESk zBq?YWrZlEMmOB%DgkG4+_yuOoC*?npGQhH_P4oKq^Qx1wz{2qR?7<+F&7rv~oNr3h z>b=Pi4>q<*!(-2;N$CubMXebJ zzAY?i9eZ#l=+5q>EBR!0#6m90pvsKmBG&=O!Q1QY)W>Py8_SlY3GAP5-vERuDYC5a zb&*HvpxU$P&8wqCnV>xR((N?e2Xd6gS^gKfjgE~gr|Gp_h<0r#1RIyMB0i5kl(F?E zc=rW&I|>}}3|z)^jbJxA5=)zztfrBoOTma142xObZu7}Mnk`-V;To&IlG4=}(5x~;F4d`XUZCQ>|EY~^lw*D>S@r=aow z&jlEPzUd{;^$ntC4|H}`4l^W#1aJL7buUzp&xvFp`UKkpF^g2Hf~|wLoL8?9fc@yAQrtUADs$EPw$5D7Ne2iEt3ca z-z1XxlgT9NSN%&FJ`*UGW;EM4{7qnfsN!J^GYT{Mh#3p6S>3}jshW0!(~KSPLpTG8 zYcfeW>(=rYduA$GU%4Nga#uGS$p&ZA7LV6AE83BJWTqejzYgnxH+hhaTyiX=>NAOb z01;AD23T!ojpTk)PT&0e0C!jqPeK*j)>#+9?3DFF2%<0t>^&jI&}Pp(n`{(G zk&)i0Foir>+ZgKUL#kpageM_cJ_L%XLneepSrm5~EO|8{O|8AM7slkHG0; zMNziunSJx0m(|z=kM1`{?_YaA%aM9toP&Gl7vz7JLSPa0v+IN!d`Xjt&P=TLGVWEd z-?RSF7?1GNJ_z1=B!8xjZF*2`F9-n_+rvB`TI%sK0rJ$Y(+CNv@D{%G75)+VQ3ht_ zL8~{=Lct5`{z*6elG=D2EfIjY%R~=9U|fZ;tWSO@#^9I?Ik7#Nz_l?WB_nl ztmmF||6{ivP)IBQNuP5O0Mg;xC|#@};byq|#An7PRPVlW$JT*flj7Hv-1cuD;&!%K zhze?WKoW9y?A*)VdzcxjaB%*$YQv;TR?;dVtpMiTHpR@El{04pY9M@5OddMMaQq?M z2hXqXj#m&%S0h&y{^T7@WIHtO+C)Vb)N=&?UAX-mDZsEFpeUa{kcvmfrhnd{QA>WM7r9i=ki^j(GJX%m zm7Z42nvnA7R|uxHkzeKgExA%}_x`-pZDeT37a>7|Wc1lYJF_*SAj~H37b{F*bvCBE z2LeRK2XJwsoZhl!9&%)hQ;nG_KUaDgxZqR)M5C_@6?WxnF6x8ciAK>FlOmtEmHu6l zx`a-^C1}EvTEyH?hGXP-mcc?6G717J;O1|biq9Bz3KOkf_J2;uuaDPD#(|w39UNP} zCJDu#;SrsW^S%1e^+PgkJgad}F??09D?Mcb_?g67ffng#g=W$C<9R75S_RZoe~xYF+yL@ z4-QINtLfii+w79O(N+PpzV_j9moNw$eRkthjGx9eT1kb#a!MTZ8KPb8I7L)V7^m>C z%QIfH0@hjmG(*Svgx5bak>;4>jrHc%+BTzI4zH?51rUuVVa|ASseIF_3RR^4d?fcM z{|J_v=!5=(vXDRi(cal9X%+bKvITTlz(dN=KOR%jCik~nSIA^Qj|vDU;H_8Fj1;`; ziqW|j{s0=+GJrt`_yU7P6d(Nv?$s;o5W}4sSx!VX-A-G*#16ko5iKyI5N!@xC zytx$-K$-)aLQ^9@m1bzrj+l$!3Rpx;_ThX<>1BpR{iIp6~WoThc8EXX{Xc zW0VQ`yBJLHZW18}*vUGKe#aTJ|KJRZrU!fA@HKVCO`7T`*iCLQVnrQjmam=Ycdh8V z7tGSEj+%`&12_yjHE@S32e^aIN5{+EaWax)v6<&j zd8Hzy6FG)xgSrJfYLSo9I7|(k6KHDuzW%SCbk)g-*osH5Urz-w$gwz9<%g|X#Uqt= z1#r_RAf9+d(^EO}Ocn_84+olC*ckDCAXJ8_A^yh%wxF|U+i>y`fH?wZ=*{uT?T<&J8nqcDTqQ*OZbWDsz)@jL5rx{2bcI+;? z=S_-#2ii#_?K;(J4KHw%MDqG7kWml7S)@$7rq#SL`3V2qXg~y@0j&4Gf{S>UB{!W-qRRDr@~N8&iXlUX(B*=FB{Dhy2Bmyfn(Q*@JQbf`?{pf)WhDp z092RVX>QR^%cxkgo?c!mMa+HYwT%-VRaz<)m?t9xdw+j=tM2#y3TzrYvY(w7tAzTma*l)9E1e&nK|+QW#!S{w2nYf% z;MI;JzCd{Wi84_-jjUAXOhu6* z$qwLD4?rV;97y=>PF?n{@86`52x^GJw@Do6kM%+hQNBwIQt{4&60mLsc(HGYlyOOl zH%=V}3bMbQb=VG<%9Bum&bThiN9z$yPCM`w5YR{Csdr#k<)i|2{q4WZlc&SH|C|u8 ze)U2)FiGh)5|K{=`<5P36U#*I!Z^CI616tcQAlxg4?8I2@#JDv0YM#-j|#U4%n|0L z>8;I83SlZL5#zBRl!VaQa;y&$3uf2MWB+Cd|N9m12o7fO&`=V^x<%h-=5Nv2UkZaBTYR~ zTh!GoFEjc8>nDe@@k~p=gMgrjsv{v$2)a2V`CAwQpgy#DaB368A|4r8HoXDJaH1%&p+88lm zZ&5A}9DMON3C-KXGt+-QSAG$UR%ofGc6hlbzjfg~@2{+yVt)f}v>6sbfu&#NTgxC$ zqQjXLM^`a20m*f;1C+Z$mR@E}!0+{$%FJ<1cvXb00W7!|pyu7iC#i7us(^jovgor8 zZf<7ZY5MK^&ZnKO;qNP=`i^E!$~Bjm!GmlY5!! zG|qkuur{4ksyvMCrmfxkI(okW(vsgui+mlwp{aiv`1RT(Ow`vUdGF{7j+RD2_2ajg zc5IXimU<=D*77XUj&l^@>GACk+yOJ!Mfh$HMCeTN-8X;#oF@r)L}bu~>a|?!bSX?& z>jungc*0{^jk>|FVs7o>$E0&&RX(px%P@E*g$wRW+3yiHqk+j{g8V*!`xSs75xK=Q zXKCQiMZ=W`9;76+7nS0Mm?Ly9{+Jmzt#x!yS%~zI!b_W zUra_Ba;PtuO03eWT%pDaA^71h&n;Z=jso!2B(oCZs;nWObprs(8#Gtg)O!vug6Ev! z_0`jp?p`O=Gp3t0e^R(>cJsZ8Xwr{gG*Giuli{IXex+xvI+0Cn(NW-S3LN( zd>bf!w&)R1G2e^M0sHAT(nZ{P$vnkt%Y;gwUQ5bNd&#IWA*1Rftp$j7e6U>}@l!Fr zv>+7D#VtbIhE{AJK#!8R*aImF+ohcv=ZV3ZU?z7{W2M;OXGE=$_%u7O1ycl3GBQrp(3nW^roBcXE4l3ZpZN2VLBQA1oktQ1T$ldc6%yDUP|L-J?Kr2_P|{vy8`bW((i7`QmFWjKDFEPiq$<^Bsjt{Wl zl|RfuRc^>vSCk!UW#lI*$OEoT4{YZy=4aHS>m%V}1Mb zFal09v1YpH<|Ldw!y1m9Y!;BJyTsRgMl8Rs4-&aaT?Lpb$Q0XaGkF9oPWkt~od7>4 zAmG1(tqp~r4J=e9nRLJ*mB8ARo(xy-P=c!wA$iNr@puKIy zG3w|f;rwFXooak6ZCo1o@s}&2Rzh!}zUzk1SSYUIo{Y92vH_xr3HUWEF6*YT&Po;9 zm2zKjUMECr0OB!pYJe5U*XbF|y7i7^`8S}<^wh>^K|zISqzf^y`3lf;ZxKS|NNSpL zXO|LoFN7YZL)R*H(J~wz=9ygy6pc6EAD9a3pGCPgd}AxxP)S78)E{|9SPrvT`~~NZ zRwc?MknxC+u4|fhNEdgpvwP^!q|ZHl_NDa1G^qCk>bviiT{J{3d)|aQitXDoRmIEy zqvB_-Y6B_Q41-QC>{BHazr-AH#xcS%W?v@~~p_s;$2jHBW?Yp?yj zPgZ^)`%XPA8bFBjl)g+#Jdb?(d-P6Jwh+33TE#q}Iy{B3)X35+me$%?Lr>LiKt zSHX>Q7tUA{$?0a%NZ$0KQl)HxcWl%D{B>D>A1Xx}Iq5h02=U+R;gC|Nls}GNeAvd_ zj&5r^vpb)e4fiBB=T@-}+@B(V_%~_(0f_&{-e{<%<;^Oxol|xI0}mVly6r2jKN;oC z`#!l-)wQWK)qc+&_b7mynZaGb@US&e$eV_KX)&y3UhGWVAbmfXnf&|H zTI}HCQ#o$Js57D%{*nA!g5>=Uo<_TG1T{3`((vU^D{8Nvn69<3-J+foTheky`83y+ z8wm?PZrm!Y1FMP}_6&qeo0Ua%e26yH1{TM$7E#O1ZvVgYlWhG){wkEqUmK56o+RjG zUC;@AZQ`)DJ|&PW?#Y|Z5ENkMqK}H?rD|tr4)>d9PFW>88VO?V3&}bwn!oxqCu#;t zlD);t)GCdJn`36t8T?aNlS!6pYiUuJ_)T>uE4_KiRv|gIT$H9YxkQ0L4-Pi7qZJ#mI8=OzbsEr_(WO@-)@bVv69(aHSl0X^avB1H zTu}J2%dsR;Z3AV9eV^`R)oRW->uJ9=gC(uIo3Z%xi8H!ZecbehZUMxosILf7lX~iW{}Q+^lVvMrhzqfXO}GgsfVi-%<%>{ZJ4g# zBGt5RWSEi}fgD+B^(SBTI=#eF+X5#B$oAB;gF@A;UPQf^JeI z10*zJ2t$En{_veHp;BZNO)dB6c1&W~hs1H%`pjv{QVvH##U_*4rPVj>mrHdK)fxUq zjMN`SD6BknimQ+?l(VyHAdMR+8ka7{Vvf5rCP>TAM+=BsnH%IP0%j^jsLwW>pjWY( zrQrB0%Zfg@bEPZ=^IW4m+}<{!qk$q#5P52JL)~R}*OJk;%%QUNv4^A=&D~LFmiK|f zT&nS|=!eOj|J&>D)E>~`{(#-6DxytND$_fZFR;?`4eGy=_({oEu z%{39RizOGlC*ik|VvfY^2cH-iA!CPt5y{Tp{wt-7lysq|TTr+mvUdWUj#=}HOzyBg zz00yTM#0qJ^{1ETirbSC)e}i{M%cv)?x?cQ3``jmxZ570731?>-pvLsZ)Dw8i;^jZ zHLrU4NVJEPZSl_!-Y-kX`sjsIVvr1Ubc@u|KkG0H+MsoEgrZa5nAE*yrk*v~5yVj^ z;iL0kVu+Rx+2t`oum=sKmMO9rGqaQY`!3j;BOy^$-U`v`arAhrLF)gdWh5f?)7}DR96U^cW z<+qq_idStFO+;a6)8%yshd4z-fz5dFsry8#qBL4}B+;>}hKh1w`F2qTccu5|P6!j0 z^xh%fquTBY^^HT&a4m|V`6X;{J>E>m=Uz!xwj z%lm_h<)5YpqAB6=uumZ6;`pBl(wJpY%215!qXsIq1Jyb}al88G%pZACelgZ2#!~ zLRolVK&a7+d7piHb_OHQ+3&?ZDo)5y(b|)RJ^XZcm(nmX7#jHU;yY>={V10E%Sm;M z!(Ap{tvTuE%chow+6H^woCrwL8HED=t>3O>9J~7kcRGQ%VbkX2Xfl5ncppEEaoVY*@}2Xg!%V+VyT|RRyq`d_)dAe4%uo$U*1`Aq@N7m< z=M*!^ewi$$l95C;pl@o~JW5*y)bx9MKRP;QkrfNCCBukM;?6fVaHHey5Fw|^70k#ytbUH?!*vcJW(yKz z%^y%VeP!2v8-O!Jn9jueMsVpZQS1M3^}}92aru15eVf;fYV6dFn0Db+mWEMM4y^3j z+S=e@-t6+VrVJ(t;VmU;r68XsmvR+J><OR1Q{9l&*b@f5P z;0b^u;ZD#4a7WEtK%}&X$H>-K1EfcnC!G(!OZhS(fl3BU?BE_tlT*Jz^0v>&mMqus zbNmdu4Y6EFdri7{atTD;v z0d`JEmDQBOIV4RHYTaq7?9`0aq85Y0)gI8M4gj1^GCU5)Gv0&;@H0a68=V!g1m^vu z679vML(CQ9?#Pa#>JN63D14M`239%Hi389lu20IywfRW#p)Q2ZjNheRWOVeEjua47 zLGSTVkSvc;RNlxaX0($i5Y_>D8wBV8PW;w>Dzo+c_?L-Cq|2xY8an{LLQOlY{y^?? zV)NL9$7x1X(~P%dnnuIsY-sIGCPU4>5oOHmQ(ZsomQ7@YA+chqBzn&MCTB$%%7oMr zwhwJM?tq7X)Zxn#^q+TFRLm*TrbSp){g7GpI-BS(97A-+xkSuq0A+$VrB>{kA*UY^_*PNq+4NNZ+~ zeL7YJC>P(_OTqI?Z7Nfa+7`rDcjPib@fZUUlwU{A1awdi!ay|?O}87pxW2BvQ(MKE zZH(n=pj6SbQN$)+TxlNx_XbT?Y)9I=wE$fx2i025Qe!SC1cOPYXA%ydS`v`Wnuj|u zGCN(}idyUrvFL8}BOSVj;9n@qpJdG0a6`@hzOo#;c0z+ z^m#iF4K^%CNXWO#~Rg##~^2n6OKsV+IBDuMaa4~4U zcxwOa;Y}d7-As0>Upr0`MXr19spJm`q*j>!V&*hkWFTH%JSn#1;JXU6Agw zYK{`l2ft$6qJv`22MrTWGiu$XD!C+`Xcyv~@-JbWGDEVL+9VyB-gO`Dvhy8oq}vXT zZK_|OEZ^yGNnMOs)Q+B!mR{oF2{;B5PkK-(cP-$rBP3iMo3*>?n^G0W5$Oc zxLtlP85g+`-W+ zFl$6fF1xaPdMRxgWocNOVEH?FZDC28`%lwYZ|wiI07~I=a_Fv28TK0;j>O~Pg-1a; z7KBDtkMj|2;z`6hif#p#0!iVkmvT>+%h2X4L9Qo#M@Q5My(pIOf{wl(nH7>c?K@_j zdO$lI%|eO3S|62tyW&5Gp&|L3+~ec}i?Gs`Jg8n8Z5uQnoeDd_iVu-d48ChHZL^B_ za|7ao7}K?EFw8ZPI%i<%)5Dc+8*GJ)s?K6FGx%L`yS(z$(rB--qKn_-r)Y2$H!2tM z;pZ($!DJ@}=8sq|#S){$$Pktf$dP1;roYHEM=XA>Cta#!pW6hLK2>UOclK}Z&%hM_ zAM=+BXyRO}5eysk@f*tp$c6>qdp`lyNrm96kDnl+nY_a-G*j6qDD)lR`9WTURqvvvLW!r9O7oORU>)7(z>eJ&mAXU`pmw8Tzk z6%+AYIj3?}X>_vE6b?F>DGeHNe^1Xcbg8J>Qx}yNT0UNviO3+BCc5+P9fh=b^sF?} zh7ZpO=7Q|=M<&4(b65_OxvN^D@v=XS{r&x$v|Jwz$1c*c8*C5&@I0_h?-xe`i;JD) z$&hv)?Sci2(QzBpx!Ilb6ZYVCpYummA7#3;G^Oz6VX(xd45AcNCy|cflYjNd>?-6f z9*ebc;VpCDxeIl2xi93&^zEB9>rdn7G9D766f-kuJqjj~x=>zw9Zn9BG=}k~E6$zR zAYFw~xy_q`QMtC=i(_hMAx#u-d-QL=V2qe~dtQ#5SLmQt*bm`c+NzP$w$~aAfs|R^ z>!i973`!F>k?m-zV*3i$C&|EXb0|jAsU#a3SqD>nBS=f9(1KHt3%M`Z-p-C3mcgf8 z`r2U6ukvAc?p|)R?0pf80iC+ke1%g;(=3U$RbUqPPQ#XPYundvQ;S*1mZ-LMR66wH zxw1)xb$)k6b27{vc$tS)Z@WQ$Ec4Lt;N}I^=QAA23195c_;2}$CX3D(@_mvE8IwUw zX4(NTdJS`G6Jjq4if@?nr@UCs>#__;+!-TAi=GL2Z__4m4 zPT%okG%u|=w1Pw>sa)~AO(kWB7DrusGp@K@+Yuf*)t>q;Cr3611Vtu722Rl2?aPxp z$!e)7siD=h=;gpQ!rmYYH`!F7M$C_5#AvuGYFN(Q66U4dRLq|+VYx6;XkI=<`9rwA zIXwsJ4NJPU8UcQtdVq$G{PyUlHF9wISkrHL0P|&8BhS50!60H=A}meiN;F*em1#y* zeXsadQFzvJh^rZ_{1uqutk6H}F$X{t7Yp;8pAz7bg?3o-NHYP-_AK+P1QktW)=^A% zwBk9b(V-)=o)8LuE(-h;3GZo8o{tx3WBEf0nISPa(QvF2tS1eja^>YDZ&8uTJSC7A zozj3!w_+;<+wpnNT_xxZ>D>#i^Ik4vn2#GQXm zfEK7XqOa-O&b$v~Jy855M3*e2+F@FA@LWq8Rj#>$_`CX6uxXW!E|63z#akOYGi4VrS~xyqth`P@=B(P)0s1kB<46QMGJY zo~I;{Ruq=j?nTQy$WMasqerTj>rMnwD(3z>Q9>u``>4?I($qW&b@&uXT8ft#(^#{Q zr%aVW3nZK|5rjLJbZiuh;H~gw-aHOsOD;Je9o^-oNZ62t|B!N<;yWd>(M$-0e3Vfg zxNTePH^GUWK*9NZ?h#dy4%3V?iv&M4iOzyc1J3Er{7+f?p}##G`kTxN=dyxcYj2Ok zlSdR7EDs|_>57mR!4$ME?JX_tUS2f5ufRQRo2nEH1*SXyr!!7$eIWZ&n2+^75i4h` zWZ}3tJF60{I1zk}D6Xoi0$JAU>+2V&$I}cfB!7GybWr+cR84GnHdq??4JFOKGfTb9 zQ+kRtS_REX>l(Fn;l$^^dcjLBzF8Xb$TQAv!sMlU#YGHO#Fw_--(~rTI|IxeCfh(yINX6R2!wp z_euv+H3-NQ3V#?MXO)1VxPXmW_s9rM5_{j7g=fu|2Zsi}3hEQSFx}}QqBvhyvzDs% z$V2B8)eQoep)?=#@)ghKbsroY&C`v^*25SVv6i~K(=+>|{xzd@7zqEugN$bcqno@y zvK^<%P3?k-w`mNNDyd(aA=sfA&zAXvnIQ?sR$}k)eKD4zi3@7&(rb6|$`>_cJ6dSQ z?KoGIDo_@txqrH@RR;SfVsOwdMGYWw#NBI}sO=q(H#Y!lKCk^#WGAyN?Kw%{0!kSH zzYKlpc=eV4WGppb_xrLpOGHCIeoEneq3FmD-8@sT_B@`bs+n82)5r378Y&3sRf7Zt zeqJ~*^|dfOy1i<#`DuMKGpL(ovcCtXr`(W!*z_7?vO{jc#qiTkI5+f{Z}d!S3l@fx zbBPD+!rf7CwqW=Dk)^P~$)8j>#rJ*?dr>quMP%HcZf03|5KeKbz1di_k-`9B2`a2ew`NJ= z-`188k}gK5HF=dFKmW`KF20dDSSCSHPFt8>z{dRko73IpEBRH<_+v3*|9wylOX%@!$fh;7vHPF`zeA@1x~z^QW*Eh6(Y2*lVCx629bo+2M=6}F77D*8$VD-Niz31(b7$4N`<}Bs ztYoynqk~~48oHIRWdl?8e(kRMI0F}g(DM{YH9L64zkX(Nox&UK2uaP%W2-RDMQRC+ z7~bxN8AqCXNtc_Je@E1VEy9T$S|o^hNYlXPbs&c|?2ql8crrGUw1v4?(&CqE0RHZj z8B{~O%W_Fxqc6TZ+Xq4EiMhVAV7{^k&OXpNgwaU7=3H-|s>PXNErn{Vwq1rmOXOB1s5T>+-ImpgXE76l<*R2i!Jnd&+pMIV-yG32 zjE^>MR*P<7-Bvqi1yd`|L*<%Z)$zjM3FYKsmO5q+Oj_Q5OzT!pLwW5adTm_jCKk7k ziA;iFxcag+IE5vD?KkNV>G}}?-k;|OO=Adxl7eA%OU{EX0-B;GX-?7^o*5knV=^U; zQ?4JhPwfI+EvgRkNBFu&BZv@Z#rW% z!*qw_2D4bIX|i}NN5u3~)NP(FssBV8x&Q&^Jz8tb=1$hEt@iKkE~`3Qy=*`CYZQ8s z`LEt1+n{QdM*y(mWy>nOz$dIf6)b&^z`7%@Vq7-4oI;j13Ky6=0HO!=8ofxEDTAzt zfLf=z`3wh$RfLD<2j^0h^oe_8$9gtGZVxZRF`+#d@7P0bL=E2?=@5)+$E~K+OjgdrjkTyR zLDB!joJ?c!7l~$ZJ?}1KUeT7CP;G5*4~E`&Vq=a5|C=>>g1<+_LkdQa*&R9kFdXKX z!E`kDN8R|WS`!cqtC_i<{G9xH$h4N$uwZ6bDu4S)cch`Z7=99RGp@O3*9wA%rOW>d zKris5?%JZ|IVub3e5ElMI?5`pe+o6=@>~3I_BI$3bxNEMV>li;PR;4qfK|yEm&r5G zybtwb5#ItmA;+br)AY)JW_n$*@&y7#2_6Pgm8@%7gc(6b4sl7%jrHIT2x3@T9ebf- z3|`aw$VW7Diwg9TdFeD-S$|n^__TFUQ{G;>UfsBm1W`t=EVKVj+P=6cs zmh;e=Ac=GZhtn+U4I((tSs3Cok}rpBx@AX_*>munm*&sKsZGp-=d@_JdALSfWI=T` zhbv}b1^HkGClD#2 z*i=eh34b?iZpE@B!%W1V^!EqDJ|%?^K(auSV^seQ9f1)RywhUQ6?y90EiMwtV=UV$ z11TT3ULP&FK&~4n`+hS8HqS2m7Ugc`Q-s7$%phN=H!fVnc(IeN(|=bHDq&*?|<^2Y9dC+!mK$ zHFEBkv=R>n{e9cp30U0ZIEz4B4`}Qbrg%j|1UgQB9v%^rNEc8`JAtp~HseVM{{l+i zp6Hn3C-c$Sh?|P1qxT~RM)tvX2E6Ed!>wwcRoeLl8MLX~xkd{{a3g0D1o;CALe30H zN95H4Q423TQO4pOQPd{n#XUaZ2<@63V-bG(DkjILKMu?7g&>HjPwx%6M}Z%TMxqfFZxTbP+ViPiKYXmInCKH7EXbu{%whC&Q2)nEg+bM5gi2e%Soge2vWV>RASV03yO@#Mo%*Cam8o0Ld;NZ zqDU`5RvXhMb7_s#MJ&l1e>u~50^W7d{10{Vfl(%aYihrr!Lm)!D@&vMX%)(fu)|#3 z=)YvhdlXaoJUl>oUmrjlTZPIFA<|DEsX}v9gcc%P1B(V=l#LjoE8(k&odl10M_JfWM0RZxp>&0S597emc8d{MulkUpT@vnb9k9}x&MGCw$u_7x%|-PV#o zyBs9S{-xd4-OU+qBgK)JMuq^lh6kIV`*iZBpy;b66O8OV9~i$r3HTTk0%KYqY4m7u z5%!e+E1c6QM=F^h_Y>pQ#>xscSAnx%+4c8;a1)|f%?2o3w=?G*$a<_baX`C$H2&{eCI{%I&wf?DfBM>yfXp<;PEozVu5JmNl z*0HeTbDNUjs$1ZE-Nkl&7#-)cjVK~51+Z*X0(OwP2W*>`RIH22FyUu(vx89ksIm#Z z$1G=(?>bPg$Is;s)ib9$O(Mwj=}>hk4-L`&0-{K zcTJ_Hig&fzjDG-?*yT=8(mJ}2@RF4JNBblZ)*b`#zMnV#-|?UfxomA~lWRaO3DBoK zi~cB$w^>r9DHfv+KLMkiU2Yl)+#^Gn7Q|bL;K52>*kXCrOM0luHzhY#gU1r%mydN1 zoEZvVb}Uvfdl$9k6U<<9>=x9_s50uu=E-3!;DJoUI3h6Ka5ZKS zhAgofGB7whJAaXFC7*DIoy*}69)x<_{R7CoO#g4cN{JV;InV;IUYVEt~5=5aP+P^xphgK8qW&K(%|Hd^>@W{ySr)u|?JS zN=Tu;sz!#`W<&C32siUNN}M@K+O z83u6^IQ(RrXU`Q2Rym11le?CFQYp`|@b>#q+1;3P<&A=O&%Fmm^ZFvfif04Lu|4u3F zyK$I1!pZ8KxH56b;OggcPW27_2!{?wwfFf@*!OxuS5`t?JxR_+M1XD{+NJH`I&?(d zgz2a%aw;feWqEEt{eBb@Qb?-2TEYPLriyx;*it*wm#T}kwdiK4M*j?9b%&I)U3E z={#-z>n#Jvw{Gd?97tQnU&EI8jx^%PtCTnKV_x`J~TE`KimZef{fG?k~_w6qQ3UiI2 z&n`FxITIP0MR6W+%g&h>JCxAC?3)IDb9OD<)P$Z8!gI{tOm7Z zy>Y`R7@`mcsbwc|YqVoH0fFo|OOtP_L>9XiK!+{2Qm^`k%}PGMO=c&A9Z|NJ0w4_n%hFf-w8 zSjBuWP-&FPrC(S)h(3DYJd-FuG6Dw!&l`enM(e10fi>j~_QZjFU5WS0r5^4ubz{#5vTnTL$+$l_bn!Ek`Ka-|TQ9KWWdA zmEEBu*D0_jIh)XxBdCAw)&;|@P`FWCOo7KBWFJVSiHaMD<5+?5P3Km&u4YxHj*VB- zX<+8}Z^8w63`XdPo)4_ImzR!!xd)8TN1cnlkGl2Ll5Ke}px1g5yG45YoK2)?A(CG> z5xeh3k)kM4zmaOYx6KbOEsiObjGg&YeP~hhykX#u4l3bX?Sr|n&FdmqdWm3zYXkOhXjU1XIRyy=e5UBGtKA^5-s(|61^}RN z#;3tL7Noj8KH_cn;`=nS&J#=^jfZsD-}JEPzIj`QD&*WXsg4s&E^k@y6I$bWDk@W6HYi8wV>#EJ;&<3woL!pWoiU?j|VYqzORLF)=qnU&O-97W3peqO8q03z@B# z%~;F2BT&?KE!SL@o8ViMC?cY>(wsu?8(%~;3Z;>+eP_&~T9}8nCA*TLQ0;k6Dq$4E z^ojb=7ODeoO0=*gFv-NHd13#Hv;8y-1$M>aR9NOmF=X$-zKe!%2qs=z^i4X0$Pha? z?9IQmRWtqLBIt*jdpDZb?2AzLD(u))@lpe+-C5q$UTA(J|BetfdiSHp@!UlcKF=Jp z!Zc!P(TI0zRe{!IL7)4Jzi+R9fkp-lvUTPidT(6II%tZs*%QdSVyoI%KDJOKMKfOWGkz)}<({7!8Kh;tYjxvPAfo%_X8gXzAE zInZ~izWc7tZuw8r8?r$N)^(#pK@JJ--ICCwJ)J97bHt=$U@5tvS4SwIn?0XSq=U8a zJ&KVP1nm8dOOnj2xJZm&X+Woy5fx&rzb$@5l>{HKIHd@Kfb%y%NJmFU|7V*5dGDpO zNg?xTLahI<1rU7Hu)slg9Vc5TfmgRsVmG2S+K^utMX@2#Tc*!a+afk%JrGepK3FLW)>|F!h32#4GmL4ncA81PPd;4>i!3;Z32M9dn69=+hJTZzUoDo_W#)&&`+x9ach==&WN;$gGhzhblw zye3^4iLSjLu!367*C?p(&QDUnZIA_4@2c&jj*27jOwE={8JR4qf{f|@%j?bc>K79fPiMGKy z)n;Wt;dwYY?c_i2coKZ08Fq=7z_hY#Nk57~1&TpnI6<}IQG9##{v5gChJg5Al;8mX zHozytpu#NxUgSJzN`O(ugej~VJAVUjOWSvruL|bIX}J5=N~Q6K9PZ2$;6ZBWVk?SH zSG9FT&@X5D$hV{|Z`^eTy_L_8`bFC)?(~YyQWgA_fa(<}Sd0D5)+6BisA3iW#i%djxQvuXLlW3U-yU+`{<{PgtOox=1iMff{sX;H z038RhC%{PiWW+Z|YghkeQy5yqRU4z?o%ZjI4ZqiCO)i0^k(>H=A29X6b~Q4V`q|gt zf9kFW_4g}{jJ-HQXfi9qLZ=FjzRuzJS8cBCl~idSULzjKFqx)fZPaQkSv<}KwLKt4 zZ%E@vld11IoKwtSXY2iU=x>F)SC&A zf)xbRVXxjJpP8^kS|xY;KJCZWoNHUJEfZnN<!v>+XvI-7CKudm zWfAhtqTZ1+M=Nl$vk^(N4 z%>9b$=|TbAPHFhWWN#k#?>J|6+HjZXrKm-e1BZ(8FDipX4gCuF+tB!p&KV?b336(9 zKF265luMRt4(MUI)bGqlnGF2qeK;(!cI^d&%X6@qGF4O{r>3oA(J_mlm1#h2IC3WV}&SOD;2cJw3$W7@A6ns22>acK}om+!jG};BoqV*2b{6GuEIIa~j7lxnX6y}eh+P)Ehra}E49i70)zyRbB zz;49<*Bz_8A&-I2*T-jm0Z|--3oGQRX?Kw@VUDWG0doQfJxF?`frVhU&}1qJQ1?6NAkfXc$DCV2RwP?TSA3k>U6ID>=TOgcV};;?8kQ zd6dL|X=fDiyd%)0*&6dmRwtyR+aA0OcCU4=>B#`KwiD%Yrkz zpP&MPd}d`P_6IL3np{U)(I>sKfu#2o5_u+syfRzp0(b=F-{5u(P*~}^@v+f!64Vbh zNvVv{UYPQk?e$kBjJ-|{fG-OaPA%usL*IlE5szh)7c6iLl6-|#l8|$lWBYZLeu+mY zwXwOj#>>wS(#^p5eGR4spzd^fFQDJ)i>SCi_K()TjH)KZ}ctAd()0yl1x12<0tcaJ9F!f#Xf{2ozR8 z(C6)~eVr)y%HntT?;mbD#cbH{ zD8SO(8+v;`_ix9{)M zFayz)4n38U%mk3O7eDwVs2qZv`W#RH`{7R;y$Ky1WwupZ_XvYp6k1c+(q}AQdy~1y z{?A96W{CUN-Y#p1AT1tf6HKrsz7=I{tJte^P21=P-8%qcn*6$$$CFZQ=2y zMR{b(D!r1s1hM0>Xw@mVJz-=0GDEc?Snf_LGcVz$r(j4QJS=8Q=B!Qxv9Yn>P&H(i z&V#omnx;mRJa%JH?ajr-f91?}Rzb5Wm}BX6q6q{ZMq{;xR$~1S#<$AZiE*Wh8lgjo ziX>*X4ZZU^HwK-L`pEQ)W-ofw17ureevkw(i_~#g{5K8FQ$ft}OtM`W!_<3g!o_w6 z(=g&z?V8i&5L-}1gYpyJ8u_l9r*Dk>57x|&*guiTwzW*J5x+*a2p-pZmT#FOYuA=K zd$GqyKQ=h+N?e*qcS5KJb7aSqtgIQ4Mn7~-zZI-Kk~BY-^$)T^qU={Zi;(1a=1*>V z!=z_E8=q&QHi|Q|D~;-Si48W#`W-VNV&~5G+f;PG&6*L)D`8gI47|Ih`z>R5F`sGk zl{7)zT%#7ROj0e>=Dad@#Q2f*BE1%=*=^9n^c3w=P3qrKlmqS}gZhRNF&0Aadqj13 z$VCE91ZIg)vFsH|*W#-*Qc|Apzu1;)Tf!_hjhI6`HF;}9{)|h6&RV9Qot{cm+?cuz zui%OG_Cu7Ke?NGMF^FDlq%}SLF#d27w9#?Pz)i zmq9I~5BR1^>YeoPi`J_S>ta)L2wIQ}c(_KShAEtz$A-*J0o#6QDvn>w^m${sjr&k! zWcor>GhWB+#EIUYZHGYXmMK6Ku)}u@Cc5P;H)ZtW=*yj}a%GWe(K#_DR%cvI797L% zAnbL(+Chl!u{!r`ba?hV?q!UT&MRbzv2&Mmgv4kxinUhNQSeQ3<9V z%E>lGlchq+vH9Sm9SmOD$?M_Fp6rJxlF{@|m{%m8$$THu^n2`MUn_bh+VFc{H{g|K1A2YF$u1yE^LU$m2H>c|pCgA($17 zL_Mt5(Key{h#&gxYK@K>iZ7x*>Q%OM0!0X4-ZxM$Bc*W55v&i%2*&BANR-nn z=(U2(b|jTI(8`K93(0GE1=!;PMH%XvK76E%`DB6mR;wZ9JlnO%G?*M(>T=5uZ0S03 zE#%fMaNN5CDjKCnDH_61-NGUlIq60-{CYvsj{ zkVMvJ+ovQU(%OzIc%C^*&A5xq7~0qhALQ^`G>~&TKbjSa`q5VhO??wBaLXqqzrb;V zMTTgmT2=|;SeHpAzIMgrHGe5KG2Ts=Lbg{aarrn5#eMgNl91}yu+LNZgS zz{-0Cn$8z+y@Q4Nvrw^s*z7xAh^xbiSlg8n-tuNm4W09^QAW=TR(oqU2{y3i0yBt_ zHe-zwidgbgFK#@t-#mxNX|06m$V1vWfEr%6L%0d%CXtU7e9o<+8n#vvyitkU=fu_5((DuX5p@mDW^}yGh-T*g%yz|t z)vvSRV3ttxTEl2$Pfc0r56f|lyKlICXS}%S!6hBSf_Gw=OF9$1~Xn5N8%jajmj3i++}0GLh_w6JEtlOBBz4x9;SMnkfJ?2+#aaw z)2gbuQ?!>U0FscGxT0-^{7A~zf?c*;i2-on0e;}sDIh5Lc5^i6)p?$n^WT90;{!Lh zAy$L;4KhALP1hFtc^dmW#=9GGc7^c#lfAwHLpGtz6s(VM2r7ro>Z_AHgX|oT5$`cV z_B9o`m%El3Y(H+K?Y|#W-;GMjQq|xaZoiQInIikC04gkTxuI-8OIR zWd3{dp6oVDSIY!kt5u0Gn+a-RjcSj!PCK?@yh3WgWYKau*BgMG!A@o*DR8v{d>9_Xy%y}AzNRX& zp%r}u)@}m71nalGb11UIr1<5(kowiUg+9ca)x;v#iq`SMMq&t|cHP&-C_iVMEJ9jF5ZD zQS|R=e>tiLhgNG#Mvh-gqb6c>_7k2VmTX4Se1w|zl56yQB2N$TVkGs#72(ngJgJCA zMcZf09oQ+;JN2>r*UeWR*1rXcE&kEXs7N<~Oa1f>9FeB3)jTJgzLpf~jSAv$m-E$} zId^)~i1m@-v8rO2Ek_#I->#xmv=fZ})_AJY^-`jGO(%W`@jG1%1-ZHtU#{_5M{uBiA2LdxX~>64BhR8q{yLp%Pz&cT*;k}E}Ro` zhTtC%da$S!rjlJkVpn0R`ofXC4*llA(IbsB&JNR42RI{MKw9#D5tTxahbeFvfs$Nj zt=^7qdUEa>G2PHp31jAtqnhY@ww%9U)&GnX$o`j9IQJnane21&zi~PkVF$4*sZSxW z1_v*FP9lLo!rP{O^Z3|yV!|NutS4j)g$K~12-gXSic9U216@REo!VLMC3|~+vh(K7 z^+)-d|jAvQ+i9dC*xq;HIr1wNQw`ju!x;7B<$b%@<%0#z>-rz? z4~i$vzV7H7x^Bv7I2|P00sLncve=Pwq9i$m2#6e|-3zqH6is!YRlc1Ht15llW%5BZ zA<3OgY*P>$o)lVP-(2GB{-F(;p5P&fJobdkFOb*UL$G8WYgWQaQYk=R)oNXQJc#3#QVs5VH;5fMr3$fBE_62i{T>^LVP z=~CG!4P>u(8ykeh3E~qQ&M4A~k#Bda3d>}yZ)_koregN+g`2v=6ZPiV19CEQxWL{5s-P6N z!AO8b9I=L7gi&&xbM9{H9$?zZ%11w;a0En>*t(+W$-^Q`%|v0952^8)&;skgIi?4> z`uA{i0Qj5VS^U#KcIPuBQe@Zn_5Xdvd{W~fRZ4~T2jKyoAVJ9-r!cwTt%8UieTzZ0 zjP;+WGeznBhkBD+CduG;Jw7>{=LEf)BD+kaG2o7=xPCTAX#tJx36%?3$%JnwJhM)N z4`O$*YmsfG8R?#X^g*Tjy|xB?Cfs~{04A}%(BJ=BM%SAKShGMWX_)UKlyAE84A6{C zoGt+aCJ+(^!FP5ZuR}F1N*sQI2Gpm#dstQ1ac0V(*zF zMea%DK9Zuob1R0WwfMvqiNOZbf2Kk!e@aULlZDGM$7_23_b)b&y}dmacC*GGIY!{O z+)4hqbdn+Tx^84mI$C5zv1Jt^j%Ct^E$Yz`jMn7M)$><8d{n)AV`F1xMg{NI!It!& zODFqV8cs(92<>9TIW9Zyy5YQ~94+(TR3&njwUAW5OL@ICgVG4*O%F6%mK`2$?zl2g z8R`Kt5X0Y^5YeBu358?E3(!&87zOX#7?kecNJR-`8~qk2tFOqo5%6E#@uR} z1S%Tc0YO&}`$RymII}j1ZwR;$$`pNa#+iG{(GV77(PyVVOae2(`@6E+&#HmgdGqFo zH87mOQqM0SV9z9gaSlKepnpod^NF=*tR?yf(x~RlqEcze)pDY<*U+a&db@%&MCB(! zjniCv9%p?64Fe8$2*OvDS-4U7PcaKW6N0Rrf7lD*ch8udZ+}5N8Z$Se-QqSF>l(Muu@~Bcy zl`Iu&y!li#bFABZx^&TUg>CxJVi223OXTH9AocaagInN?v`@Zh3x#BT*YHT}Cq`vy zc0*X}z+)DL>W@=BcqSF=K-o^on7l1`F#IQ>(b?5CQDKBNj+W}Tk)%L(8h<9qHs<~q zM<{!_uiw12A@&DyRhTUGtd*Nd2&B2j{W%1>^`>R;>zmC0)(P&nW-6)0>?%XuoT1q_ zA4kLYP|UIWZjk4cjz_z8O#-71Za}6QPVXu}r4tH|WrLi;%6?4rdq4fH;aIYs6<`<= zYQ-ojaSMQ3A10F%U16G>v$UU(#9fiGAkwMorhUrzqJ!U9Kq|2ycN*YbQIo5oVoJ}a z!1oU+58GMts-T!Wf9X1nL}|eZVf#p7;0I@BT~-L`fjgU4h-SW%y>$P)8jBB2t>>Ju zu3O6k#xk^FsQPR#x1l!NLXH4bUM0iqAkC`FqoVeK%)p0+a zMu6r-VH%W$4DE}H=4pBGKU{(_0hETb3~~gFN53wkehcEAH|F@Yg{|I1rJ zQ7EsZzjr5EA5qT>_QV5gOVv}GJ-`)-t7hqh6Frnyvw}ILw?_XCPm<$jeN2$2vlI!d z%%vXs|7!ts3dE)`kYLfE2xqvtxlxO-R?m0RVO-gi>~Y(pTssY-6EadxN+KV@h`BOJ zrejAz=90a6Hhe0)Cn{=m|?F{uS7VV%Rcr5<1AD3iC zVoz3tG7fQz$YF;6CNaeR@sc~aKihBex3kOdsVM?&?G3%&Ga#uz-by9X(c1Y-N#pPG z?=f>~^C5m{AE`gV5-N%f?D5CY(4pJrvi8Wfv)Ng=#JKdNZh59CzN^%ux_b$sacew; zc5lo8Hj6Q*qW`E15Htx=wD!JC<_P-LJyXo_TBYF6K)cReb)0rBY-JRF6@TqDkCEUL?MC*mdNZm z1;L*c#>cn|q`GW8^l}qmPfZeYdf-R+69+Ap+*H(~JEp(#`!^*XzZ5$=Wkg-KI7+Zb zKmuV`TU(Hao-O#A0?B&PYEO^I%z<43igt+DW7fP44z>a|^kuSj4+q(D75k&T^Z$YKO`^rGUTlb*5BGqj34#)b*;y*h+F?$Ev(+x}@K*UBZq%HIENHjjRQhE>aoh8SpVAN4P|{A7B| zDBmx#Yp-Y|_#hKuiJ`XYyW@S`AbNMu%P`vbJ{vKQpgAH*fyV$YD-QF=37*icZ&0)M z$>OPDBBTP6ar#|ShV-QrMvu|Oze!jB*q%Ps4M~EOntvF5wy-1BQc5J8q}FVXvO9my z)vF1^wk;Lq9_IsRcn&;qCadUdrrmEKrJBH?%S2%N4C;?c0|*}xC>Rmry8I!NRvBs8 zg#T3#m(U*V<2xwU3)g79HZwtU-C2FW@INk5u?U@D+ai$GgXQ_S=p<5+FdR^IX4hD% zPwkrY5Lc~;cXPG-9-;p-|4CGU&P3H#TMM3P)T)R zFXzRbvmHxMJb^V0>~1o7W`~8n1Y}v6bzc>LrO)@R>*yN4;g^Ve!h4Q!cX0a6_K&pO z3Z}lD7+3Y2k(JQ*>%%o=e^4g7g`*@7en4Oll`-?!SL1DsKt@hXxqI#^{<#qP6>ZHBgx(m!0qyn#<~yPE-Yw# zOsETbeW#)Io+KdX9)ksH2*$S@q~!w!tw8AY8|0oob4fqs=r@1&P=H?VDCL`e%#Dt& zuH@S63(WBc3%EUkz3b})u?393@^xeLx_)uZsvC=o!i<60behV?%ku&he9JqqFxa51+PBUtsQaBMbT!hFyFlo{g^jQ6)Pdi^z9R&iPal< z2FcQBebK~yxj4jHH1cVO&t~N1Y4+^jPbfc-7Yf(iVvprV!Fm~D;4P4sd3d|6;0 zqfg1~!jO+io%_xBF>XEmKSWrmMK7!pE{x8cpouXqyY{~>UQoC$EIqXP=6N|(}H_jRbNTL8U4bd;h%jesh1xVBFjkvrQ}yWK>1wNv?xB$$<;Fo&3bTuc$G&uP0kZt`B0k<0Ohz=O zkIq4sXBi3+KGC8^TP};VJ7(Qbu4lUcs9WvVeW&QJ*qswO(RmN4(fd7V-ZiB)5A1RB zns7U;cF(lktaqn|6}`61!>CpGMLL+xr!pDu=%xfSTu3Jn#tj)Ejkukp!GoDMCw0{6 zZ>@svl>+rR=1I%aDPA5nkW2EiUmSa=_+3>QZ;*SKIo#}R4t+{dm&fujf_iG;)aMZS67Gz;INLs6j6YT>ozchAoi1G+jULB3iYX1qfx z^tc-`6)qgU#Y+%8e{4ZP0njzHjDlIx+L-AN@$~R8d&JzTdHItY86I{*24}Wn?A-$6 zBrMBamoAVwB3^GNPU~*+{@X}&;OOBJgm4TaQX+@}n4b4(=FwdcN$?wN`=K;B6f6ii zWaVI?bfaXQ-~E(2BPt~4N27?!vS&9h(PWDj=cwhHE69&?sYMfN6g_Uc`?60T*-%_F zY+wq__ONN;B!aqt=&HV{y|I7$m!*iOv#iYW_R=8MOW7h2jiziO7Lcz{%JyhEb_fSc8VO z<7|;k#e(diy@RzG_rU2u?q_V+nAtcuZJ>THoyVjhrKQxz2$Ra-aFcRFZ!TZ&2bQc~ zpw955`d8a51z+rG<3EOt)kaaDOT(ng*Vm0^LW(?$La%jUT(z`sO$0rU=`wGNzGN7! zzJI|nXkI&j`Itdinf{m2C$;A6q*A%Tx*AMbMTS5fxBLGjYM0x=>JDoXw<_4yFzlRe zPEI5cgGU zI*-&jI#b2kybcPSZJKddBgSb%81kdHKTZKAPvbdMF7zEs89tP;j2VBK^l^S1CWc`y zJIy_r=}1Wjs`rbLH%G8~khm&EMWrh5?j<))Jg%CtH#^A#E7mSmb!W=w4=cgR4JkgWdGBnn~nA`;$75JJ5!enxo za%WBL+i^wR!wwz)db@Q=L(HAooDs3j(`U#^A{;UHpY+hi4gG0po)Y?rlAI9&q2M)j zQvu8KsTrKq92VxJ^ZneL$gdpMB+uBom^S8|2+lb)M~L@=Oo+r3DWg}@+H>LI+oeS| zi23eZ&Fp$w6+ddWz#iiNJmmlUcv4N&wf_UIs&}`pFjC7kT~c5CA+HmHxGj{vwfMk4>wFR{rYF z&VkBne}1-Q2mj{OAYMn30DYE=or&f453zPP0aEf-M}zWie~lQO!xT+H2MLK#T4Gt> z`HMa*E2Frx%phv8pzFst2}0!06m68krIkfNy}U>431m7uoHBQUmjv$ajc5fEm`2qK zoFASp?7hF$kIcmJpshoM5X2}5 zQt~-eEd*Lll3p=(@?b?np7(b)^2x&pXFo~7C1{T2yxpZ+%|NvMX@OI0*(mpS_i$3P zMJ!~=J9?H!!O-nHe0tANF^0t|B4SP${psF*$jF_Q7h6GvojdWLp+Xy%qxkTfj$S61 zTdOJJ%giGNxyCnI)BecI&$Fk)ZPs#%rdYjX;kzd#*h5Lo zRBxq1LI{9M5KZpxjsK}gj`#T|Syj5p=w>c{9f$105T|&cU=L5{H}5sE(uiODtjzL6 z$au5S8wSF!I}5$ZidLv_AsRN)J?MwjaFz=sQL47-Mu~4KU?_1Z%v+khpZ6y+z}EFB z$8`%}5!Bg^wn90r;;npv(DEmi-zGzHIfp}xcz(`3DYr2{gj4fSb9^M5QOUAVdfVIi zOf;WijCjtF#wnDraqe46wI0id%L03GIaK4jEP7VH`uMoSGvWPsB-ugCX+{0jsH{!V zlly5`q$w#i5~{96_B{v~I7S5Z9AsI~I7yh0x*1Vzg#K|yqh6t-m;3v};;por1Y8ca z)E;xL3k5Ejum1iQ`K`1PYUi$|MuS}nY16r(pUcVRB^^)$oJ>Z5;OFyeV#5gUXqO2N zf)nrptu)%fWmqLzKOi-%92_dL=U8JopVXy9?1uI}hrA^rx_=`CBgn(!9Ll>hLWf#x zrcr)jg1uh^c^}(Q8CnMmgFJwuqBuEK314i~PNK54E9JuWS|ofl(K?|t|AzZ=Sc&Bg zNhSm^eE@uaG6dl>0bLift_7+bW)@t}udiJ(pYs-URV2kV(H?-_fff!-J|=9>r5;IkK_5DUQv0E1stt{Qw?nAc%TmvHpue({n%$&dl32xH{8-3;m$P~4s8 zTFh{(it5%z`5Is4pmYwdV26j&j~&cONn{hjjDc@}{RUuN;rw*kyCz$r=O61t1c zv1JLPlQfN3u2iImVT-=q&{$V?=w`&6^crHU!UcQda%J;6?!d5-uuzU4GDS7&zj~98 zV8JZ9wx&Fjn8RR|`lFqs5QlfBX5RL*|wCDVR&|2Y_!f%|a4BaZNHNJ>WtY3wb1qvQ@e zvYH_K7wMg4aR2g-bm0K{>>4xTY98#Q%&^d~ME=|ADwNJU{^GE};{Qg;gGMdy?j5J$ zYb!tVzgh#3Jz-$bM!6W({9(Qejs-*pwyPxhr42^}GvT52pIQn}<5RD#cs1vcr*(31yex zTxcT*Gz%whU0x~|GnS;V=WKp)cV8IDl?=zgxTPR94CUvj{q9A9E$j&L@5G6x7vv9^ zBKBvdf_|uT!()xwur*x+YhZ5S=sWGnqJt>+Q6e)UVj8-R zF;E)cf4~xE5Q;{yOS;YS zJHr5Kf4|BR`Wct~aU@&B(c`;G1)@(xq0Eu!4HiC4iPnd?($Yyo#_1X|{1x2&Wl|`; za^R@ux#uzc%0_HL?mtRud=Nl?jwv$eHMXMBbc60!z}8=$yL{S9i>CMPFDAX^GBv5@Qr)&Fi`K0dsH zf|C65Cu9keuG3-3b_urXXLMmzRg7ARmdP!m;+*LX!pERSsS%V&JH4?Xi-w?X>*=Wu|4@jB_^{M-{9cXHt*1p0X#TImpx89S za2Yv4{oyZchPI&ep#k&kl&lCoRw9~c>O7Wp4F75$_+^W^u2w=zpM!u$Et?1~+!pbD zyt<;@z37{Nb8oe6Ox_*}-2VDX(!so@RN#ysRmDAFg*M|fxG|4k{}C636uF9bok2YF z&TxIo7-gpc1!F(sbLTU~XXR2UKhoU%QD#roT!wF4Jzj=44}YbICP`)+)DK`!sO{)O z8a}$eres3^tC`#I+aC%D)i%f>SMAd)2DQTClVF7-?!x^CQs?rO^FpS;FjA&_vY(4 zp6~}8pik9aR#)w}J|Y>IS~7%X3r+AIKR(`_+}&{kV`T%x(e0IDlg%oPuQIVL@@lecA`DL3 z4~7De9^N^lTPWO8v@T5W6Au3SEc=vCsu6Ri#WN$X7L}gy|CJy5bS8^1OFFjBNb(`V z!Recy<2Gu$4n;|1R^fYgn$}P;$xrFMLEhyHvCWI_IC#-zz;iuJ3tvo1%eJr~scX2@ z9E!x9W`)zg>VnaT`4W`Uda(e^(*R8(<#zaJ*iN%P&(6$@m?>xm2+7Tjt9KV5kW!Hj z=q^rA2|s>RI}xlnG))yPVt_71y~~yyfL(iRY7s1P_V;&mV|{F*=a84xgQ2eNKbp?i zaw)YCTg7E6g{EtZyou3>|7gITS*ek61-C+^R%7PMJN|~(;e1)eKbf4q;?PEmAo2-* zq$lq`tOWM3K3qpO^_$4I9vx3%U`(^zKid4qZ{LH>1X~VSl+)|+?D5MfGS`)#JtL!< zeQUgI^{cfNghvA362;-QFl(rJ+tZ(^#n*?22ghG87B}5LZo7t9ocRV&6r`#!2L|yM zRchLa(nHgdiY!Mf7C6~`s;Ghsg5m>Dk4ThI*}1OH zWYe<{X6~eD;%G}PAI*XE%zj?|N54T%e~jA|raA$*J5UD-%euMpE~lP@n-=8iBcxWh z%F7rCR}yP&ZD6Sq*hA1vDI59&!Yz};teT_$z=!sw{6skJA|lX=8$@N}(19NIm_ShK z|4y_EeeZ!ECLko_S&QJ{@~E7%olK-CIxBdZmP=+|DLR%EzrG(O=e5=Pl-&M>G*m7}=FV&)_TAB|? z#TBfHM`hPP8?$j)f53X7pvm{0J>14o?cso~ zkg+-B@pcD%WI%T2CI01m-OCmRR{}gQZjni{KeBJNJ-C12To!1Ga7IUn?_zEc98P z$rLcW;sg}Mu>H{JBT>Lhz!7+UR#Lt*?32t)^=+N%HLp+KXEZELb+_HjW>K9=&-e|c zx;Mr(E|&E~x=9a1VH`{74B_fyU8^O=lzT-LS|T4(bJ{NFZNEX4nOD`)2{1Fsmc_NX z0DJRsA6Q(#)ESSkEF&vzlT(Lm>2LL~D`>*)6&o6xSYs>*-B65*urzqNT83i&iiqc9 zM1zX%MG{Lv>l58OkYh#7VZ>(VOIus|*(zR?JifCk!2&l|TN%pef;8aFc1UhSPKJPo z=kRM~bJKA&lTyJ8^XEyeOgA2V3>MYOwC<#kS^E!BOCu;3(%-D@b=jIQc0>U9P-im->SM) zU7T5MW*v8$OM^}J`YBidH`TS9!YES!S6XnA<* zWvljP9Y_db3R|DrTRNcL?f#~NNkQ;o5@-8OXTl)=F-R)!Rx*<|#zgDL1QVPndEUNE zq2<|=(G4FPK9>r7pb#n{&vRW>2%)WQ_1J+^e!VTeC;sbsqT*4qow1uXgRffGY|-xI zjlY1lyvimuFY_j1-T8srf-@G96mVo`BSrCXoMw2tO2t{G7i!d&qcJW+#LgvBk5eU} zuQe5B01bQmD)D=Ng?y#~gA7A~cc(l(o}hbaA%s{(yit!Nj5yihqQOu;+Pz`oIr5Yw zMCw-fF-o_IR3^~+-PPjD>r@NZ1KP}u3CypJe;-?eJ3`ft2b@eXJuG3emvnW)QPYl6 zp_a<>GIV%x#toB+%JA4=GNGX4U=u_=uwlm*R&PZ6rm-wEHS%O%)Lt>Zj0QT>N;hmt zvZ5SNFJtW*Ikcw$4TkSU|BlHJXWY+xt%U1oN$aU2JM!G_LpRSKIl<;MGD+Mmb8WlJ z$7uEWV~Hw@9b?t%Jbnok7r6Ai$r9v7tn4~2?-dJo1~a;q!voCf-s^eVQ=lzh!@bc7HfiQfMn+NALMlt@>mU_8}xH?OS+SX zlpv-zm65AlW5-?M$sF03(lv`|4y{|+`t0bT512+ZhyQ|LW#Ra-{{Si#ix=9IK*4#D zc-b7ulJ57VgjDp{x-&y?|IjI1-4HPH4j=B470ZtD@JA=cN+YcE5os94_+sVm%>2isxE zrrfI5)z&}O7w58ov1QQ%_A(bT-}7NDVTLi47}#0GvaZ~BarUF^ zJ8m#e*NEekt5mU{fD0LhTHW1$->@};CUIG@krzP^M?@$<7h zqG3PT{%K}w6qp_ktOGj%4nIGogo+6#ut>Gq@_V|CW75IJ3+8KEfh37Y$hJApn*-^d6;cY3mz*)>CMa5%`S z0n~l)+ax9N0mO$h{#tdlKL*)B;*&r#>i2j%^46x62QWm_20g{oZx75|UFVjTO;ETS zb*nf=Q-rI^U6#rEI^f~xDn%2Um8(Z^6_39-kj+DjL=d97K}DygPyaQ$4+?uwBWZjV z*~MZEb-wAm(}m%~&NB?1KKQS}T6T+APKb62?6Yfw8tcpJ>kX6fnH4rJBb;&6b83sv zHjQl{f{DfT0h(fu_Ks-2?@0qNOJU}r8#&0df?ugpt=r88htJ{@O8~A zF_T%QpB%^a+aUU2?6<1PxKjdA6Wa|;F&|JFf@7*6{fa)xCI-jAyVL3^=jJjvYblSUx9^ivZl7y_|#W<20<%y9Nrj%4hBAK;&gEwhC*Hg z<+%a#c5VGK9)(q>4vCP$r})}ED#xx3bd`B~dj8wq4x}GbL>Si8qkTTSxQsg*TWIuF z>21u=*|z406->&eV415g|5=~9utM%b`)xrVF6c@;)a57c!@D+%kMGHn!%}#Y`=O

      =`4nc#1f^R^_ z*4EbMGU#b|p*#Xi?ciAiy%<2_xA}#Hl*k#b^9xy=XSX=&Jk6 zS$rG>9x+#waKe=0ya^wkBz7kC)MJid8X)eIVPgd@be8y&Z~KTB9;o>dO)aEqa($>+ zB?S!@>+?`J2V_h?4r4~y>=BUJrToyAtP|=q!Mjh0|1ZcAXy{r`N+U9=Br4@u*vd-{ z>jFQIyk+_!FuguxGxHNLbC#+A>C>~a=74L}-HAQGTaow`B<$C?2PAqWO zc=ae|1cBcxYaB3&;ygC_?qc;B5~8O$NTCF~=<0GbOdO!TKBb20@I4)Z2-xT6=aNkb zKbwp*`B~l*=9XL5Y#(C8xy&23cK4D2EU7Yij)f={q}cO9N<{47==WC6s=ZsjAIerf zeE4vQb&JcEW-`~KZzS{m5S3*RGQLA7_-PE26&6hDJFT_=$V8*A^Gs0O4Z#^@!mB?( zkglI{{77S>5gbNSaWJ!-RV-zTn~;ZqhU$OQ3>yFFTd}k16Jv-Q(^Y9!0JJRU>*Ie> z1dX~n%$UXD6nSXq(&0`L&|LI37O2FC>4y6H-1eI?<{sQvv^AZymsfwJh9q8}Z>9jX z4>mb43M6Fsq*o_J2LN$3Ysxlt*`LMrYQYOKuZ;dp*);O<@B|J;XfC&Z5GObRA8>eY z+V^!b3yH>?(ibuo$w0XIP0%orW&^+n@L-x-@ifeN=6UZO5eil>%WcNk`+nl$!gY{E z{#smW&s+ctFsL9&e!mSeFVnV0yx*ZzB;C4GO%}uXA^aIs5g)cRxaF4gtS6^~nrXqzR&ma_Ay&9%Rm*I#e`QdXKNe?-FdhkRCA z2yonLi%`2@V|tlShBytxKx>{(89cY*`aS1gOvg^kqiGK2!ihvXc*(*P=N=eY)y7+N zt0%N+A&9Uh9u$r;iyypZgTgjAippyDXpXT(&yHMJ~{)5sjTV&l^Um>+8b-aE^iTmWy}5_%mJbijlKwwLez^#xs3CR&KAvZ9&cPNV>_GwA3dy&EV7@N9`v! z9q~~-q<(cJYp_CbVQ2Rj+9z!Q1FCKlex1c*PTz{P?LGEWXsG?>nkqFEJ7pqb_x@e= zLS%Cs&8GlI01=*w4;w`tDw&R2zOe#4wl0@Ik0f;m&7Zfp?&A)kYoRT96bvF})_y@9 zb;Kl9CMUVn{T;ehuUFswx$Wy~IO7e4yg?U-Ye2h)+1_KO*|pybBAI^Yxqm-b6%HsVole7E5)T7Z%55Zdt6 z0?ysImOO_N!goTv4VRBkQ32mF`eQM_vAQI-=PRa5_4m8K9)nml1}>-uTF2o+q#u!n zhaq!6bO#@NCtDQ*aC_j;GXHX)eA7{GSyyNL(RC?MIOe_!%WEkEvpRF(53Wpp_UL7} zy-((TG2Ac81^r4cIAskJw-K@x|xv(*iS~xc`?@h*oYBrPO&ZSWMMr(j*6AceSlUtC zjtJiQJRde1|27vABhft+5|%MVqVEy#yFEYsf_xeM#jWT)Q5^7tnp|`l-T>ore}Awf z=H!n}BcgRpA(>~F^MOiuU}|de-vu4m62$GO*x2{UDn`9d;Qk(&V`52WTQ+2rsxnE` zZC{t-e1vH<#9-A4Rn$sC$^GA+O7fWmboEeY@A;^Cr zN39(luu%C@Vh(kG9^qXI2PLuyQ6Y|?k_~W>c;=awt`c&rWy1uSor3oGxA;|NMlF-XMN&w(iWY{%wIJnBJTl1R{ zfl9TRD@;+;%hNMu1oaQf)R%ac;86fmAm9LzU(U;`lyYD*>_)?aW}7oxAmQ~z_4}Z?y#qX3b*sP<$Hc@`XvTxWBw!ujTbt$xlloa-AB60^Q2{s6E}fU{J^(J>{GXc_ zFROJV0QRrK=TtmM>^}K_aQ?YSb{cpa~>u(peVfvGJM94sdlPb%G? z_0hf2IXa00?N~^po(GN5Va3wS_#E*Y1|5QY8pt*(`${j*uB?w2TCumP9otO?J#{OA z#I06FUMPtJ8>17$?m7`ECPKX_vP@Q~LO45jJLKlM3p!nqc{nuRYeG%uqU*<^e=?@> zL>~EEH#H@kl345+wzHt3#gYFD=QxyxEZpeQ-+ZlZ(U}{W{Z}FD`d=@3siGwsL)&Kx zG6!3^iO5V7G^jBA6mM5_$f`RBiD@~@#KgT3zmn1YrJZYyk}CQbDaC&^Sx^*5c4Soy z%B((x#nmFL$wo8LW(e)+%xXWet9=hF8~sW^Nen&z!<6*>W`Kzo_As5qa6xZWtuKER zxR?aFnL~KgNk1_xd{@L(+*6*}-!GPp$$hL{eH#Jx^htigH2eU5S)@`{Q-9uOP$ZT2sSRx>nCyG;XaLG8}!~ARP4e z3j@Oir#2*D)q&$Htg{psZj@ls|9}tw9=IN&t9aFI;ibxfY^!&Vc zg`Fg5xd?f)XJ_^gKgg`W3X%TPg78v^LWx=p1^YErSC=@#$YP$FjFGq`CyR80&6obl zMB_BtS)AuSq=WYD_VL@#?^cw{y#`hLK9kbRQuRhPXnv>tFO3wW1u0zCy7!L;yg%Zg z>YIWOCS&96jL!MGW3$Ftd{p+_(S7Xp>MK4qRYj0}?6}5h@vWY9_4jZ4{)#y10D5rE z1(WRH;J}aK?Oa{nuBK{7tcYkQtGA;gbGz76V=%CaYjHa|JVznploi}Pjc0oE;*DXi z=_hF7L{xIEVLm$wjHrWEwKmrvSLiGr->gTZg-2?2m?qBC)wRIIb-FU|U3ycZi>0>4 z!zo)P)CSl=Ai$%|-xw#h`G5)Q3m!HTM_oKkNJT5>TT4&i#{~KBFb6c_Z;gX6-(O4q zNHc#Whz0?%Ag{4!2h26_A!Znfw(bwy+|;i`bwm>Kp1hr1B;2+Zd|Mm9R3A)M<$0T$ zE^^{FT&ZT%uoC}Vs9o-qr%U||&WA)&rayFy)b**Q+I&iKUII<`I$yC~Kb^ax8~1{& z&`@Y-pD{-&t>mCI`aj`~`4uJfX4rtlNs8hR5A+2)Fp@2sZ*B7KWKyyP|fV zr;>3yeiHL_rsQEhGu^Yx_4B8tF$T9uA85~cWncLd|ERDfo3CfDwjnA$)tz@j&c6(B z(!*(Da?J}NksdhiuLHP#zR2e#H0|0Ag{Bg8)RPrvtSjyZA(dW!TzRWztnuZOkmTr< zO&!vp6S}=%3iOj)yJdB(6HIT^S#Y4wkY|x-Lg;cZUyVI6r$gaW z1xAll>qzP}(N9IAegWS;SmLUGz0!4nCHVgQH(xk%vh3Uj%#Zs>cUC9XcYGL4#1iZ) zdef&C`5Ss8mmPC=K9mBFebJ#F*^9MkDnjMRZMB1gAvxsl19c|;ilnBs(&D~Lcxy;j zhv<3=Qu{)Ra$)mlqXn}EhvLMAgxu6PpjDw6L>)t8EN3arcc9iY5tmW$W_eFX^?jkM z4aSiWU_#jjnBbrfXiVeJ`>t++C1{xKR>hJ0T@`mfo}HaxiD0i}E;o=n6fy;6Pfzvr zy~%cJ2DEY!^yAdcF6E9Y${Gdo7t^dmVxZ#hPjXZybQ24yVcKH4;D*JpI$wW70ORys zC^*MW5pPdi`mrfY-r%2gA&lfMszoEET5p+Oalh9$QxVkN2j;fl;z*l`l-1;3Dhrr} z-b7zAn6n@8EMY~i-@B-n%R=v9_L$e|kfj^O+ZYEwQ4KrS39W;rqdY|CP#=I-()HakAYY%dZKV9PCu_jt(Jkun?FEsFF`%s2yEpyba zw`+&mL|{3b&xbPguNS$cN%>jAOk@h9-Lzubka4u^fBx;J-ESw5kZFb`vpld;Z?ND4 za{5>yvB4qxaj8G@8WxeGdRTO)3`czwE6$cr!r1jf6&Evj#vi7wO_=S{qlCofJawsF zyaAp?ADK`Cj0}~L0Pz0X`kYeer1yL{_Q&xujps4afWEs5C@G z`+Z}Q%J-!kTY+RrEvw!^zhhZ4X{JKE>`Vklo}M*IkFVSAfGr`0A(%QYyC<9GLS#GAw_Sfsa8uKy?XU(%6YBbpUnnn zrnexlqL;gd*m4s|ih~*^c42RGQ3kcT!ycIkA(+eL8+ciCy1{BE zGgZ=(u9?Y$TO9U*4eo0s`U-kGmwIXP?#<^sJUk$HaPm!v6FiaW{KFpx6sw6zOf-CI z&2Aptg+zf2?YD$d70>LitrSq`KBu>V%DXjaZ=Z~NN!vv#!19?va!t5hf}!*8)m2bm z_un}E{I|Xx1jK{5np>?974_p{5UM^)>=iYg4LnxFGjQ2bYHuOB@gA2gAkJ>J?X zZRypiK0c4j-N87#IVb%yJ}{eX$C8y1-$RGdN2uX78xd%_7y`at6QiR;Y4z!Vp$MNM#s&bbVFCVZe5|Nyaud zzm-1+HFk~Swv06G&@~-{w;&IV(nUPtY(HPIRe)Bj-`tG<4GmVyVckRX5O*%&hnJI! zSO+05;5&G_z0X?T1s4lI(Qj}0|BO`_XJk~vy~Hm}Ce1P-g%xE$&0u|&=MJnpn|?b` ziCX%0u0jb(A!s}Jmnz20R-%Z zzWc0e7xl7(00e#I0RqDIie7h&LP~Rw)Kgq^TE|7=eY+*rt9qx#?_CdU) z*xDUNlp62>%qTaS0wwU_yOg+hxdbP1goQ}^&gLey02%S#R!>}a%v0i<+>K>HMR#3x zOgUz?mBxlF@ez5wi)X3%ktdgqB7+$EP8EM^n0V|i)LGs>sKr*(#!}iVUp5}ooa<$O z%#Z8;4FxyB=KH0hd*IgRhhzYatsA z>9gXr3_FfS)j{o?Lb6bV_!ljCBGWd!RY#YomE46lPcv^5paqqFDft?cbj7=->HR^Q zamZ2z-7cw})F|E1bMo~GzF*!~`4fzSij4#W3a^TmgOnHJ#71T`(I|N)VUv)%dBT_e zV+?NS6YZb>ogN>L^cyiZ=kn0Y*}TGK#tZx}loq@~-%|jgHBqH25wTB>X&Hal;&kXu!1;a zOdV1k4N|YFAxlMbx)*U`hX@(UeQ0W(i0YXUruy~7Yj?1KlIv;BuC)eW7+6VQe!tRa z)+VR)ihEOGm&7nnKu{2o6ZD%spR7HB%U6Lf8kfNd-j#bcE;B>gB3?cE zml;6;p{{j$+*vTCf~|9L5!WVpMRx%Xx#j}*Ka;gE^pH-}|7QWdDKIyA5c%G}^m&W! zeMJGUINz(ZM}(XF?c0mp z^YP=)K0ZG8e@{S#1taU}+X-RxJY&#d{_fp>OA6rk%OFj@U#0x*Lzi1JdI5|1Fxg~aS!?*Sp^Ml(^ zR1}&g3gUx5c7`hL@DL|ANZ1s=EBq-UEPUHmN`R16^6SfpcpgSy>JvF-7rRC0-rRuK zi*v3TQE{tgZg&rl@;C#>AqR8l+KXUtI0+fSs}(_UJ`864N1=~YT~6F7_O(!%P;FVZ zYpumg^XWy{$yH-yWF*KU;i~sIU-MT)P>BK#B&=svh=LXA(Wln4hX+zgZ?fWtX7eks z(N82K7w-ufn};-4T>InZ$+}OWX010qAN*jK6fPfgJ7sz8yGLjE@+ySU+RI`@5T+(#%1#M zWLa$~HG*%A({+3E7lF@~B&*&^P$~qMG#Y=9h%!$AZOO|l)bnB7t7>##o10a&LZiE)89$jN5z~g%~^!dkX|6ggtz9oTCa}C}c?;j0t zbq#BVrov_wCZvqNtuUgravZ!liVcHg$=KH4S$W0o&PPlNZtemxldrg4Ufso0@Q6;A zKn`2_Z)8H6Z|7%}{d0J|y}tDjQ}fo31J3mqp}-8oRdy)vjG033Zvgw<_g(XscxMNw z-%$CM)mdQfA|SX!L7V?Ua}ueWi83s%YdM89O2UP!IJCYo>Q3>*H9&G_xN?L-X+}Ss z8}CvJM+b|P%WtyA#9852fL=zBwH{Wk9vt!wQ23nax4#?|QqD{~)e%~i@XPd;7B@rE zhR?iXBQf42J_qe4Fp>Nw5K0V7r8lmuN9r4 zBh!d-*LByt1_W^s(|f}As9p<;iy#s*fp|!*j_ju`2C6sm<#duu3OXE>Xu{7nj8TBf zD7ZMNm(x-Hpx-n&|uo8>;8Un}-Jnip4rW*^uYfFMyjQ_IRd6!9Z#mtb1Ix{W-qlOr|cecz$D z0DTEX8l5ls!YwGLtE)Q)74?OsN3?XCXJ-=>qKn_}I8T^2=ADS;&RB8~ zded}nhBFp#59n#n*AV7+>;XVv^*dtKB@YaDD)JB0aYbU|y zdE&HpuamxCv5JKfqib2%tZQR@Ae;?&Zls-@?;UZNB$!_F!nDwKIqAw@`#EMD4sbwo z@I{@15y4Y57)kOjdocQkDNUYwO2d6oqX17!YOyHSGbk8F6LO%KEl&D3XQHOlo?HL;6RO(!D zIG?)^{Sfi2ol7NiC~IreHD7DBm3yIY=&}me+sc>{+b2K<)UZMwR-&WXfR0Ux zLuZ-GSiEafnlsPZruy*l6YfoB9lwptYN6CD74$lRnWGzM$3T?NBgk+41?NO+B^o6wK7l~QcB?C60KNDQjHX9n=*_|2j ziuj4eU8zx~+^}9rMY1Psxi8r9y1ql&`__I5Z@sFeB_j^N5dci-FWkjiFMJ(k-bkw; zeisX|qxvbCFiIwj?s9`>%D;K}f6%W=6|=e#{AjSrdlg(m54i6ncmXlgwe|J$w&G42 zP#WV6_B|gD58fC$4Sz>RxGjNyKO>g12|7xKaWN5zrJO8;yZSblcIBdlPCiOYpJ2$6 zU^kn0P7_ZsYsJEHcQqa&LJONr;?_ay5z1Ga3VCLA4(rRvV%pnvaOvSqaQFO(P9}{W zLsISLrNXSrs_2xR(0_B{Ng&t(53Uqn7Av*lQR&y`b%b=|Zgc)!-IpAvWKUFL?J+V& zI({OD%u4|ccR!G8Ei4a^VLmoFFXajJC*E!tB{B;L9_%4$^fF_d5{u9XazyMqyFM1u z8(>hd=aa;e1~z_dSolZXJyFzusHH(M1A8vNn|N6k7?^>Dx=3dNqDAw?84{zNjdnh}ouOG1)U@&%#Q9kv%dL%*k$kW^Y{LvCi95?hVhEvmX8kzhAbXy0g!CTcS+9jbL$V5= z<%K)%5tZKd40AzvH_?oWOTR0=;QnMpZmPJ&G2oLW-aBZSU)KjTNPAp?S$#}b00>Zv zp)oS%)d9g+q)(8Zk!(m05=1d4W6dgNo8syNTIVrSiLfgarh%(9REJctdiZt4;pP3{z zHA=D+=^IPO+E9Jm%u{&tb|&hOopH<~6uq(c#c`rsnwj}lXg?SVV&jy^dl)p@>+APs zib4BV!U8DU=!peyDzJ?PyL_QXQh)BFVD#R7`>07@E0upNNO;gB_%U{O4C`oI&AEpB`yKaCUvAb z>m7x(l6`Jd8}14AABI0=J;ig^QyUTusVfL7}roQbwwUki@p6}u&P%B zLvCB&AR=0lj|T1g2sVU};+*SCeLsvi5u5Y#)#mlr8ENA1A8DF3T_`RIiLP`XAo;oO z8X~ie4at97WiQLaP9X!Y${$`DGcOtZ8IX!tD|S&I_fU8$mgOtEc(c8lRr1{12;P4rTUb8IRrs)}K7d2G{! z%@OyAVB}L|3tlmrG5+BwZ%94OLxZxJ$-o5E&!bk`H2cAXMQCx|@7UvHicQR2g6GcoI zU-;v_4`#5W40RO}5ec8BkbH+oIYQh`nzt6vlq|XkIS&R(iXiEaZt#Lv&C91Ff|UlS z%yZemSb|sVt#$03Wcr=H<|y|y24~H4s9KT7PkqX%`ijsrt$bSFIV!yul0$gm-eW7W zv5DAt#+wx$K*RG6V}<(^?=(D1<>x+2j}lVZACz9aF7sr*Rtag!Ito7o^042AdK`Ht z3&?AR)B~d98BEJ|(Q;%7BI9o9ui{-csModpoD8}mqV)`L-biJJ_5oN@yG%B|o5B1RZaV2=7)`qosT(t_Uo1}M# zc6(|_`SmNf{jn`6<+#T6*}-nE3SdJQd41if`sF;Vd{&b&P$cldt0= zyvVfO`g=G1O--HrpD^7T7}&npE7MvNr&osXg>@U_79P1tfak^iKLB5>SVX7m&;^+9 zOE=&dl~Z?YzvJukkkVM+W-m!*sY1;9j_QQ$X@h7uy8W7`H-E>#Q97dMFIX#pc$RPJ zkmRCC(UxS1&4XhVN{V$B1qX#D^1|4ZMbF^ez{wJf5v*!R<9HyIQ@faI&l&H`SPz+&6RIA zqsOD;T`cNF#C6m1i=AdP6wD3X=8iikO9bh=ny#P!i&d%3?kuo3%&Y0r*b2!fTrTM8 zdLQ@U7hj*jI_J)ABKF(aHDH-l*ak2OBa9MK1L{J8Ng#BvLtQUMn~xTW)`dNDX6$@w zp7n@F#caoKIj)!d)4f1x4{$PpxHL1kG7=223T=P9opNGCtPN9)JB}nH7p0_6Y5KYo z;fX&@**k>xa6_!~F5hM|XYJb7xDt zZ-aQ1k4Lu3Qij!Ga)4<|RscDVnDj3N5a;>o*fGET*0q1bbD|q0mA63Ts#-YNcOV>G zyLpxl+Ef?qI2jCVuh9=S1t2<8QrzXgR8olsEuNuuMUwPi_wR51P`}el>^qY-V3T;T* zrM0HwptPa?mkWJW%_eU`%s)>pq51qT{TBuD-|5^?Z)7x9S!6o)JnSzk{soyRaUvQjwW1o&yp>N-eIre7(8>4GGlkKQcYcxMQJC@0SO z819_R8Rtz7wisLv7aYltm%Bks>J=TZoxSFO{%t)T-edI)VoML3dFMM!O4^Tm}SfTlOxZHcM$1fMS(nd`^1KVYC{V<&^u_AHooS5)+d@VEZr?@z%z$=~gF4&2#x^ z2F1vJ)R!tYLa)nEtu}$+wjyo2uJhGa0|16KZx?sCce6vQbhad5rK?yft~i50CVG{a zObO(*2mqM`0)C&KzP>DCR`_V<#|z|eI{C~0OoA(Z#D;(D4@!p&==dChi;WeeUHL6O z(q^BKAvDalKYyw0+XPCG-f+@&7(_P6gE2!$2j4_*LQjpB^2VjC3j4bTU+@UYJ6XjP zU##%cd-;pugg?o&eOix>d5`GK4KAg_vgi2dEQ*NORU#WcK1zcSJ0lKDmWW`BD9*_jg(k2B;mR1idp5?8MqsM%ohb2 zV3?&=@BA8Z5$E9VJ`pR_>C&KDw4uRbf*ULo?CHY^O`~(3^NT@ej*SHPT={)2!+dt2 ztB|ccpOF;LwtuoiLYUSg@26D@geAW(-*_f-+XL=vhFu1ce&!1eCRZ*wOOE_YN5%h^ zz!N)~5m%$Mw>&$?>=Xx&KEkaD=tw(i1(9;ZDu{~-0)F=o4ePtP^AM@4y)6HvRnRrJ zAaAZza#6rPN^DV5SmoW-Wpn?8YzeEI6MSzZ-k7XbLq~d@ai@6zU;PI%wp>{+qDq!! zWx#W2N3(qK7(%F8DqhGL`=w9%_O@DgceLFnW4-rQZPDlI`_XeZ^w~V(HI$a^ETL~( zl-lAtC=Pv#q(xu;osFDp2NO)@RXHnOG1_oj_g7Ryw(9H>gvoV@=|>Z~W~kdqEn&A< z^+Su_Nw0oizOu;(;ogz_vyX?9(Z5!{XEue3=i?RDx#0#b`4eo44PBr?l(WCXry6V5 zv)|C|<4jwbnD}XClIU6LMBOnPT~#yn#(fB~zrv3WOY^IE`2xFR$SxmZCzt@JNmc*n zw0?|&7q9mBYud0L28B09kP2zFAs*D)hFsobwZ?YdeLhh1D~BEbhg@T=96{wXdOIH@ zNN@`GOa=Vx=r21V!1SGrR3KkP%JD^H(VEVa;FZ4gH>IM#1o;r>Tm82g3kzx11ZJC0 zVt=nrk6V$`On;@PZ$j1!hNM*z|6tFD8XCgH#8gPE1O9zYE;=DV75PS2-faBKw$VK% zJ^j0k8odc5Z$M6+KZC_zihGEmifccFdQxMNLxeEDdVO6g=`=`C(0rhN{*YmHNt>Li zja<+n(5bfp>NV|c4?%yNmrZA5!z?~)B3I{v|1uK#X8LY$dSI?hFXU#x%S0$Ii zvv~Sv^|&~7$$~GR#^I#(4lY5msfbPAZzYrwaywmZ?`|B})j3L4Mi)n_v66_k;77-A zFdJ7Tbh}~IrWi9^SpU z{|O%{oB_`zJ(x>?d?g=R5J~&JEqf4%#emcSeVJmCXu}4_HnE;ev?9LmW$5rVWo?)8 zY(qtb9G&0hkZE_MYAwJqlu0Dqym?u>+3s!EtnU$Czz~$W&>WnuitzNivar=bNs@tx zXgQVk9z+eX@S{#wBlEp4kaKs>ceAoF^XI=sPIFazSHNa$XJ-f4-r<{K?+V?)c9i02!oQ1BnUj))6^-2F<^S6muP*K4R@5uY&>_qVOO zdfGdrw&_kzF3xcuh~$f@vfj0cLM#TdIqs;Ko;-VH9;5wDn$f8$ysgvzJc{^hCZsL^zSiz*i~sY}!$V6iBiz>Rt_zEuXXM*2`8*q%vs&B?<2+#U%>hd=VDqkS}J{6mvz%HU)GdWWaeP_66 z>71-J&E>E}3>Q%)KCJ=%GfQ-?-rjdl|CKlId}!rS0yp*8!g<(RcpZux@JA!Q4cM8~ zpLb}2U^s9;$SZNGQ;OWwJ>LkPv`H&}g2y|vp!`OMkr#vRoWq}(T=l=q;hPT|17|v- zbXcOEWc5tZEl;X@<(x;*ThKyJLKsXdCoIB;J5wGvl2;}O0jTr!!O z`AFb&X`-juloWWzNQ{#e$KS4q)-GW%m2iUs_jq~9^%ARgdKH!%zC$3$`We?4dW1AQ z)Dc;?$QBC`u zYoEuvx3Y?qVC7b;_j0xC-&eL?c(1U-{?@-MfCz@xZr^s4$*k!l_sYY#c2Rc;qY~_X z$nJkDFP80nw^u-NHTT;5>mWwi5y{IpyDkV%J!{VKE(=JI5$xOiq}U=TD-$|YoFi}d zI!+im5$_mh>)m{rC!i-LySxXvWq+@pzo_|zF^Ui!%=O#UI&smW;An>}_PJFIab#tG zOR})v-v0ktfXS4p9>5FgmV!tXVO1rLRJupaQM49Y$rCK)ymhT_KEp*N(Yp-(wP{%N zndA2iK?Q}4YY%SfJj4p9$yG2ht;jG{fhIF=`@AtD>H%@ocVmY1E!h zceXPO^&TWfp2?HtWX;fKAvn6Yn7VDZIt3ZsKsDQrQa6#FMyJ%&v3Wnt$K|cgArVYK zF!%O(1#|Ug@M`Npiuv%|oUwJn!q6Qe8CFPUYvSVK`m1-lE~|Q^MduRMyZjDw2aE^8 zqaRnZF{UcgroZmN<4KSu6l6PFh2}TLW95zmgUUVFLKKBfs|abBZ+40Bd`vWA%tfH# zK}WldzD2mwNp@b3g!&>&-KvdtITEEt&BQn`LukGWX~##4*%iTT(35N1CaXFl+2<2ZXve z+z;bK1U@t9L%va!VeDyh;o3}7+A-=_#aF4BE-s%xzkHTY%$cEiyBly1gC3~(9YY@olv(_n-O~~0^Y$%++kPLp1!$u--g$!~MYLOOC z5Sk!%Vnoce1%a_q4y%sl9GLuhWYH(a<@9&k)|)3-A}p>HD|Px}8E%$yPPBaM2*&IN zbI4P@tP|y;+zI=A%tX`@58y=szw)22+5$fEsE2 zii579#_QXUY^}vbCn}mbf40hAZFPYzgblqkp)TBxKY(>VWNPWynLsZ5!#=o;aW|KZnNxb1F7qRj+96Gz3k$mBD`R}>T|F)8y6$enuq z)`3X2$b29Q2WQ#h8G$MKqo^c9QwNK&M=A^~a<|MUMXSnp> zt!4tI=cWIol$w2KxV}8O%sG1TrFr zc!M4;O49}R>~3Nhky?z9b=PXCeN34P%6KJwqpovggL78G{Qkv;MWR-QlxrL zg2B)8&vz!^goOBqA4%qZ_Vbn)3E4 zkl-KawupBKb0DNY_A_TNaed()6{0$9%&`2)_GK8q!-$2O=b6&iusS&-AwFWFDEB~&a%wv zLV@4ADB?l3)eYJcq{5w7Hms3G7Wr?(sMFa$PNLCq3EBy-#qY&`>wC3vLl93{#F8tg zT3urCg7@2t*lO7xG#JiY03q^v`Do_cckjpmp%=*Lq^?QG^9hE*5eg2#xVT0glNxW& z2=7%v1n@+qkeKk$13FeWlW5ck0Sb=iVuTeoDVmTjOn%|T0G;e8)f4MJ8aba9fYnSt z{8s_petveJXqIN{V(7r?&1YDpNG@H}=Dlg~V*b<8GATyicT2s1V35r)Lk zstD(?@0QhTP@&TqI1Q3byMxKw-#_aCW~+`2B)O#b`h+>*wpP6(n`|a+sLSaY85<>S zX)QWOv8i_B@=HDkAE*!@i6a#fIkyr`@ma<&|+UTHANEWD&7YX-3?`*>J-0+?}8{ugegWxryWN=^8?nt{^p_{G!TsYNEbfZ7{-3+}76GJY=z!e*Var)`xgFL?Z6MF%5XW zJcLVT^0Q}o>l?XRob;s}i@95$h_{a~;g)wO! zgzw0DjSIYv=wtZnj!#dgK7pG9l%+ZTq&^QgCq=Q0()+<~yj|`G|BPqOe7+ec!({bS zBj*Im9_ROgbe8K}h5m;jkib0H>Y@cZ1%i+OQWmZ_`y4zX@IC^nKt4EFn6R3l7I1XC z**@-P$Kch)&Mz!~zMKCM`EQ-a#@SiSZu&jlg_@&e9$-iQ`;O%omg((&TyAgotfKmK zKND_+sjbEgEy991?I4`Z;88y&+S1g7u8wci&vSQo4rV;}S*IMlRQ}(%}8cS;9Wfi6d1e9yUUsqL0!XepN zA72VW@uX8->&oV2W@jV#>1Gmc-r=LMT()yH;Zbh3xZUF(iOu;%zI&qIP+q8LX+BK) zi{BW+U?7aBNIkY+g+4y8y17|#>hL`jqhRzraT)Rox-6Mi*cl7`LiT~$s+y`gBqW=) z^75xgvs}6A(geBN62-@n6L7u;7n!TOyUrZ}ZI6u3XlVCi_BfDzd;jJ32HxtF&H^5fjg1Y^;8I!TCtPQ6q%j=bSAANJgjZig zFebj?c|sr{06qL-;PCqyYkhnja~X=mW(&Q$$rKYK*&Qz2PI36BC8_c5{s$hbv9u&4 zYIgL7-|_bk4@%6^uYY$ZbJ60XGl7IUPua)|kWdRA72uTLu}04*FzwI&Egr}>^jSrc zTF}b(Gb24vbTeNJ{kSg{@0*4OSR*7xhPH}+vi51geYgwhUAZ%C|rk^GKr^D6hk zML;^tBIebOl17j5THV4N9U+F)tS=Eqr3{XJA0Cg+*HXxfxV<5LVOxs9HU{T=9vqcC zpAnUjc(5hyJmvlZ?@04Yltfax)Qf#K_QRQX(%vnO0+7M3j}x z^&2%$PiQ?~rDVjh#Whq_ZL~xUbi<1pQhivV_b~5{s(IJcz zU#EpSLxk?x?jnQ|sDAzYR1ic-z$aHv-shi))0JAJsWr|V0UvXdwJ82dzJ7lo=*AQ_@e z(rQH?ucpC~3+#HpAr;^>zkTDDvef5+*l9q8#Lq_-%5f#aTxcXR0E&W8;||cu&(j(( zPk9>x{sEIypw8JIU^rp6bCw);;9mq*$UP|_NV%lkB5S3bbH3<|W^|ehKPV%5#Bu(~ zVu<}^1<^iPZ8cV^50b~pO=$VsUWP@DPvB$s6_B{H5~96E$pt)zJdWj1Q7tZUCTo-P zWtW>CqAb`}n|>n9?CYUZ{^i+UXyD1={N~#9l3Nevens(*U492=(v~Gx?f;fau6Xw-Q=65 zElj}LK0asKzN77yo8qrrv;2lPK1{Ikai-@hqNd}KE^q6U55~QYXk4A#!_O$7BGN}e=#lPHt3{oR6sHlk7>DgAoZFcN>naG=p7x( zIL8F6{1Y#!GGiqhP*(!?2z-x2-vvcPLXcfT0ue?P6mV3}usY+9!9kK;;+%a?=((gG zC!&-E(x25kBliO-m1!{;H{G^rPQHyBzNWWA`h`<7YE+lVWtaNK5`1SDyf+eVm*E-y z8-}xQC^CU@#RSw%g9!NI6eY>u50XNaJ(bVq8F&tpSPrW$|Uf37=(?XkZ zKKY?&7fU%WCtTr*+*!CfYQf(iT-`n0URvw3g8>D^^YEz4oB&{g-w0;`s7EHhnKsAK z{_BD|IbpF0Rxzx$er+ymfIE-3?GpXtVPSrJy2GMsh6h`58W@9;3p?}SNrqOZNYhy) zsn^KmcfWj=MkhjIz*Rca8W{+U=eB(KBzBUPvUZ|{wm8ta)lV2~B6=Q@WyS2=9bm_M zJp-dGbl*ro?`OIcjaeDz7vg)^126?4=$@@T_mVIS^>f=g|kJ(|Jvr~FCw}^w_nzW$9FFV zMWTJVI9M)Gkag~}Qxii(zpQ0k%lxNuu0o(CL!^>zi<^+;Li`Mv)OQeeg4BNc1I2gK zb&iQhd;4Zg8EAU1b*tIn^&CyBJ|BQl9yF#Z-W%!RtYNZCD(Bh`vs=d9=msY;@vl(u z{(j&XX0G7iF%qb6aHDO|wTU>3z|A`9Ar&(3gIc*gZ$kHFj3&JWoZqD+XYO6mXrL z#a;pFVCc1Gl3q=y(zNvi2s16xHrdM?fg^I2Z>6h5YQ z;&x~~1*H%*rXKa=HOOx_1dm)1fK%sua7cCfq16l*RMWd*et-Jsk6=pv`U-5!KaPuo z!pio$ne)mLoaL(?N;$Jk$a~qN^|PKY-dH!cCcGQ)SFYQ4z<}27d++Y=|8hs8PFzHZ z%Q&GrHZ?Cj`K|n(tgMh_tZ!-?Q5H_&S)|iEnN@I3OIw>eV@<5lCte(fpECuo$=K$< zbm_v)0954bU$8GBtJ7{H1-i7z$Y#yLAPE$bbi~yTlev)Hj@7oc4);&?_5kQh31||lb9*y@2Dh*? zO-Xa9bEipKF2Did?dE1VaK&xc7kC=jK~sE{!O~ot>U;MCqXz{AwZq!dKpzAro%!N&+Fc6U zW@Tmqol?Z-1}uK2!gUwOYc;vy7LlxC<&egS_|CeOYF^^qaC`A5UT%%>L$|SPvf}I- zhrMzj5be5vHHJ6j`ouFl0w=I?lxFVy4C1%%xmRd(7(x@hdXZjmFGh*EeIvComHR;A zpgENk3zQG5?H-B-#zdCgL(AL-K9YGqD z#`%{oKRqQ92{%Di#&UnqTKsdXRB>;QLJru?2*2jOO^e>W{#ZHAIhdXn+2g}|%4Y0y zZjHA%O&LNN2WYTD91hzImf0=fkaCnle zv*g-;g>Q2DYPp8))*)b*sp8sZs?K;|LNa#?-iL*3wdpn>-jfi#^N;C zdU4^AKu$g5M221h7yl0b-P?pX?FNOGi`*6lE?F1b2Om+Lq<^OgXbb;9isIeBc5tf` zE%8XwGj6>Q(6c@Ci6EB6pse`@MS}MwC(3@|jBXgO5t5}^YXgzfcm@T0AoQRt{VTG~ zR=pB^Qa_U$0?ovs(u=K?#afpB5_Ow=V92r_aiGL|VAEJ`lY7_H-VXc$^v?aS&PCgQ z%rM?5&*ZT|&<4K*dj1f6C%fj=eVIELuDo$Tl7Vct_u4EU_{Bir!@XzU+#I2-N`N5( zEMde41aFJVCfb%OT}|dMa@jGhk% zcc);Bl(0YtDyqGQAQA>>EFAbtbtqy6o+b|?{2GposIN;h9e(OdS}CN9M@Kaq2i)Jh zlO^$v=G&Wc2BG9qt;5G3pJmhJ&g?xr=4CNZPp-jcNRId6~+hV!nS|Z{}opbP61P$V4((@|`%S^PNZZK?KBZO{Y1!pvB_ z`97vqHbi@-X1Q4nbAC5)bxCd1x1YC7Gkp0O67(LwyGmbs0)n+)HYxA!`Ig!QABNFW zV;uZnUnsUq+77V|9>U%`V`DJ*0(N-J$Fbx+M>EU%`8Q~MaK_{RX47Afj$&20s;HE! zs`nF~efGAQUaW8{e!YHbp}5I$8#2D(vsqY@WWUrCqHEsPv?e0DhYd~fu3}j`tI3aa zE)|!dp0z03(&IwVK0;WAH5yezTcfHr-YA_x;L#x&^=Xcs8~U#lAnbE937zI$0UE_H zg{hZovMm9l@8DF3NOrb+sDErMF6Np_1xK=*L8r@sq%-j=dPvW(NyT)8#Gc@SsYZ61 z7LD|A9Yz>1E$Y{E=g^D$8&u7w zTt%SJH7=grEEc=0VMmQZR?K_!u<-ooMV&rHnvKvEzU!lP>Rm) ztHM-55?aURsw%*S47{22b~I>9kn`miwhBLn|JytCLN~UV`X+!eFR##MU@CZGdEWBE z>HwNI(r_zJ(dn9N{)4ew3Q>3C*lm)%xt7_XYD^{6O)WYe1{R02YjlQEFE7q>Ol;W| z`x6l3PdYO5B$bgVsLzlC6Z0v4@BZ?9WP2Xz+8pHesvbiinNCvniW)#~*taJ7q|@xT zlKMsVEeEpaWBIk{o-)r zoAuTs22=D0Tjo0dTcK#&iij;4TE0#^9hleThi!kje=NaVPe1<`xr^ zFcv|WVf|}M3H#9HgKS@@^eZYxTZ6g`FUy%mSW^4>6I3+7^T#V>J ziv-E^GWoV!hX_4l5?{~`RKV%+^c4Gy(S*}ynY?cgY*YE9g4wo@F@7trf3BqNc9%Pw zzKMCQZMNfNC6U|cE2scoCF_cd0wSJA0d}uU$?VYj(%mK9-7Vc6(%s$N-QC^NNOz}nOCun{SCXYusAc zI(͏k2_a&{+D|1YC}DdWDI={~|`2u~&vnCdDrwm{YZ5Qg2r_6|JE z*gb;9I(^oe_{^xcf%_KnC2fDQRA(Mk?fUG*{`fP3Gl{)UJo!N6j1~ol@x$s)=0r1X z_SE+xAbEn`HNF{|4I-JfWzAFzz2bmMrD{!=WPoN~W+cC5jjI_qWQEDm*Owu42Qa8+ z)br9DiKk^ce?(igL|Fd|n&RfSbaec0muu;wAMeCl(+d#Yr!dxyq&L*3Iirhqs+r|V zAaX`%38d_YGX0=RA~bt~PkhOug_T&kZ>;V0+u6t{u!jDGLXX@+hI^4=L)rl??XEQ8 zcj%a*3JGSbvmNa&gurmq`d7YPVab}Po|yWR zlv>K^np*3!G|CMg(21@f{U0rk9+a9aqB3?px#?ukHI=V+vZcTucy|!rvLa%_Isnr_yZ-T|P6d}4 zgXiR3^9K2cgg5Nrvn<(7$ocSi8%ks3azL)0K+tNs7 zwjgMdKvIq%L!?LW24Jn{QRQ>pjfNe-xcu_?NC^iw^>q)v#1RWEjWyXlJE(IzUiKgc zc4l3@%HqB?JyRQVN-BhfCO8~F7)W|O-P~{>b4hkPX)Wu#glrdFJr+li>UdXgBQ#R{ z)g>H)W<{3{H~&uy5P`))YFx*6j#vHYEdh)zU(61(hnxqU6d^9b()J*m_fYgdS3hP`m_<3JsHZs)t$VPCquH5GtByFci#W-3nEV)$@gMc{^xP@ zF0pqr#~!Jn&J>m_T7U<)o?cjzc=w!WE!6nZ7uAwT_4H=*EplCcC3(ya^A|)$D!9NU zbK7Ji)hFO$k=e0=!9zwYQjQ}aON_2J@4gwzZjy|E`(5DL{85c#d7ZOZlNeixH}8DT>ATga&lq{e@U0$`ah_}^~% z-}d-lg`<3Ytl{fiWP0YU!B!M8{_a4j3lvNJ=Y#QjyxIYd@psR}KG+8*2lT|{%v5J+!oyETnSr_P%d};g{h%J=T$AZH#ZlXj)b3%3_qPH$!Tcz-W)+2 z0gvaPgoMc&-hlpMYPGs1joUxjnnhp=?1IaVe?)0C9%ML}Q3FSy0M zM?x5%sC}3g!^r#rcp?|ZO8k8q1c_U3hUob~vZ7}bh@pPeVa>?18(E(LBL}E~dCbFl zgMU<}TNr_+GnVNh7=fLSOmocq1TB-|TmbHzv8f#YeCWw1G=c&{zn8C2J8}ayYEq{= zLQrB%+L}yVpXZ`IVbxz~*)L9j_l%W(>cS(9aEn^Ls}db|>S^a;!HPu7uQ2PMNO75( zt6RvTg2NcN-m-`-KZQbO!OxPFbr3oWPkgd2xk4gsVTAwn1AfS=!nkAxEy@(abuGi+ zJt;hE-q+Auc0u`O_#`6a#5e)#fDL4BlyQsIAX6qTzFy5E2>F@ z{2(8TsFo{F+BC1jO3*ZZWRYgtSwjUOuDMguvJqQ+*C;}f(U*efj~GgzrE{CysNE+T zIn1h>_>opq(R>diMT30IOnUQv-{zgb{f4<_;uW`IN*~f#pUq>L28|A(iwQxC>S)C; z=)#{dc!T3^2Vj>9a=i;XOFIU_&@(M~DcsMN8*iL_nLRa|rbNlz;NPk$LP|1=dYh&& z&xmW~SGc;Dl|mB=Oabk^Yf^Aa*C{8O3RxSjmLEo`Y5_3~Wgm43a8&g5xi~c$MapoF z)QPsgdS}fXomFu55EUi#9|rJN3GeXnhOz{N;>TbV8mFWFRP!*E|CiX8;7&X*o5mZ! zxSlZ0$!r%PtNz(m5*i`~(}R~+Bx|-4-$L6G`FZvF2lX{^_gL41L5@=!x+YqGTCHi7 z%P|z~azp(I=SPFf&3gm|!7~$7y0AZL(j@*^;$}du#>K>=f)WPVGmg-w>ja*CJm&G8 zVIARLaRNO~o(dm0Bt_R_LCVOXoCQruKRLIu?qwLtZ>A-~?4e^&JRM*_Kz9&G`8=1u zXgvcArQoCl;|NfATs#JS)h`7L!<5Y*F6oXDjalfuGcFnwrgWYAv{|`Nwk<-xj5#L2 zsdhXw3qFm&)(EIcV2T8Uoty$R_==r#;|fLL1on2TOjcR*%>jX_L{~C)+g<&(1-8PO zXygoF0ojQG6}ct^)kQ}xv2KnhJ7|u~JCO)?@E$F)pD%EhiM)z>rLML0n>zI;#R5N# z@)oa&a?IPzH4;M;Z@>b5-U=|)48mXl)HP8G+f8QS!61OSYb!$aA?X;Fv#LD9T(eA%|l5z`A z&&;jf+{j1-x6zybKCY27Vca&u3e1H~$^odyhV;%zUor&AQx(M$IKc+T_UErs6udG? zjCDlrR<>a*|Gy(fO@tz^wn`befS zsG8jQwT`FVx02yV`A!QTgI`cA@dTQF^QX=(S?b7&KJ!KO*aZjvl@@jW8YrpnVzA`=9K)-x!-RHOz}||uvmZ9 ziA?(xt4)h@y+@Ek7GK@Id^jB&CTg-4&(+Rqqe_NtJdsY!=~>Uf>s+sEx}|8wc9xf$?UpE-TcAn?e?&vCd1+==y_E9Jfgn>~S2BCi z+;~EKaXXm)&M`u8**q%JL1s>O!g1|KYZ*{aFA@JU*o*cjLy6&5)FZQw+b>nR3?>{WB!k_9X zm#q|S__c_2Roc>~*qU&l?@8r&t9>Zb8{z2%x??2kOShT@a473I^fBV)1_4W*2vGrN z3rLSp!M&a|Q(?Uq0;fnJTIRc9jD6~k)WO|R05Pb4fe9G6i@~G%T;JV2`E4SZ%wnVT zWjcmlM}f?G;rL95P-f=|Ln1+zAy&5o3)8ZcC1|Z&R>Fp$(wr^S>|s*{@~boqmCpF{ zlHm~teC1$RQWfc-UTU}$&rTB7c}?1D1$qZvp0;E2ik6O>N|$OFKOuL$PwhnH&G9Dd zMh(TCE5%XKK*m5Y&$Pvl?uM|Y7Wo2bMflJ!bALW})95weY1WRdoS0f9+rvrU4>e#7 zXW;c?Z6xGS>!VV_sWggjFg95F9crTDGTMOp)2i@jmDQIDmTyqsWaX>F77~qb_Nx3! z><0GB@t)PFW18~<(wU-X@Hp_#s$PI2^e+#ii>K#bpm|MK<>h?$7+#TPOG%pD0J-y;Ooo{1pEy2NDW}JS(ej-2X8bvidHeI#jJ2W{B zqXAyh&^*US9{r>c@>EkMwlvzB$d$Qo7@ZYm*Sn=n-hx=eI*w=Lp4kh(k7rqf9~I>D zF9rtB+3Ck5q+Fb&VPP^A&mglE zNz<2aE)n*1J7;p=PTmf}jVV1W$e8)8N8woCL# z)((b#wB^AlZpPVFRv7q6+R^B;Ww2Igf34(HV~qzq3#IUOgp5jwwMtuEyhVZCDDG5n z;NV(~ij11J*vlHInqzdN!aYiHvh+R6MzCv`@^Y0Z@%zzc26qktXT{ls#46M@2*Ni; z;MVRqA<)afBQKJ9=tmEaGNHeK_{Z>9Ny>u;&aPmlZd+Xz2`yS05iA&^bzf!l!DQE430^ zW<0_Hop{^ED#~Qx#8PuAeJn?ouq61LP~2ZLoT0D2dTNA&d%#l|t~-HuPx*@yCpv`d zCCam5udiZ`{QNpYeVjNQ5)WJy1x!GX4x$x{1_C9qEHWU&<4(54&+nc77c2O9etr(d zHsE2LLTHBDySZU@PAbeW{J3H+q2!AIqfZ1ub45U-RJ|`1Thdo7jA!^g!`%abjnG5N zjE{iy7LvXVEn&vj{ZpL^G%2Q$*6Il1JW>L$_-A{w0|S8x)(Rn?$e5OtTsd_eO`1M) zcA>T?X5P+EJX^*TUFxY^c+^vCFGz~8lqjNgE>$|13AKrKE`pHErSdzc<Wdxb|$koEj zu2;>-O<(&ikLNYffude3Z|lDSkk|Ys{x{fKPgdEMV~YimnhPmodj?V7@d@tAu};2Q z%Tk;kr{AJ_{@vY?3hw2;y_8}+BFCqmt-YQBy-s6eBM^q#ZJS9nZm^qjO}&EHuV$Oc zpQ&DMEtmBeumbBvOU@Iy*tc8*ptGkkqe`8X)z{FO&|+!E`TSH)Fhyh08r380B2t_x z-PAngqe$I#9YM(qyUeH}D^v^_2+#wGjJ+w0-YlpIb@7Zpg?YWH=ka88cY#Xjn14bg z>a!Da=Z9Ebk&dXA;+N+>U0kn{JTJ3!beBb8nS+PE2;oilo{9f^xDMHP{ zHpIH&zz^u-wh1Qer8`z*6?9_L`}zk){;rJF#Q!lnn?QVKq!SPnAb{qWs{-B!dWoB4 z@mcU%8TwHUrasKhu(7>8-01W&(gsK3Q99mAQrN5AI0f>K2P;=t#X#;nXm-aMS$Bt& zc+jw->jz4jNWFC@S3>p$WF^J6HhR&C7EmIq2_b2ZfBh|r7Kyg|6^sMtnT_yg-(IyY zZc5&H#B|FN6*VPM-Z9|cmkGT&wXCChd3b`4PP>b#9ZC| z7@mqWxuL>p%=Gn5J~RFIsmjR@<@T2Qv~HMNg$fo=50`tvVLJ*zly`#fpiY*5$Ph9^ z3t4!0XMX)NWR(vk4rCV@tiujr$jHcUdn_{3 zXL5AtaQqOt^2FGN5y~?YCvk1$@spc+Z32^1@6lC}8)O-j+cr@9kdiKS<0NW24VwM{(TW_MZ;G^N(F`38eb*`Q+#5 z*P_sIu~ie%Si%{?4^5qZL+2`l1#5wx8td&~UOMEM(SO0L`U3>*v- zN82cg_00&kf{+4mg5ZrC;QN0-A+{6?m_`S+z#rm`TEjj!h#kWk;Ev7`Da`s}9coR_ z7dNyEk4nY61T=;#>klcd`;SanEULNI?qZRP{<$No>`itxtXe`vWqNx*zQ(ZYXm4NN z*?EQsACa223g0l;85_(-Mon!kZsbJh*NvKB2pZRo(q{A#iqVD0U*?-YmMgo9{V1(j_1fvJvp-ft zN2R94+V4CNd-r!QmLKYI-+rExit^Y(POb2C(En=YV;n8gxNH=C3I@|O{Mb}emU9BF z^-$#I@-|i&C#AsK?KJLCJHjLj4 zBM^=(IRo;ZFe>aA3yLb&i{V!tlZ13(S1{j>#rA2#+Pm+|<_iYMmX1*m0}jJ;6|Fd; zFW?eA$x>^i-Oj%{X`qxZH4mU@X=#CTIa|(dY-Y%0zk+Rf+Ci;uRGiSd03`gaNeWT+ z*L8P$dw57))CtAIj!WqGFU^=va*8oqH~K#*Iw);BW#4ndbhsUtc0v@rX$@5gx*I%v zQ+o6`O6eGwNlj5Ef$8V@9SDWo+4f%QHF{_bSgy$PDQ*J(L(po?4Z6|a3qJAjaDOm= zHj|qC#;Jn-&$IPpoWVGYK`sO@J_G#rRSd=G0XTH z>-B8uVc&T;YQEO*x_;K3*AxFYyC}ZBWHxq^9P|^hhAVW_?BNz%!OTU-pKb)9{xczTM{>rKV!L>}5VtGAK}oyy-Nm>|ve2GrlXS>y zEBXkCBS4zE@4ws2|5o0rXd$#3$#|XJp0<$7B9rUHw@m&w{DCIzRh>5=mjI}im+-h& z*;IX()U>2ObzwfVwZXGY4&GmkQbNigv0!TRb=|4M4#;{$zJ)`wVew!$Ui(Y}Svhy$ zN;47#R9u{_HmpGKXNM+{P=Y5~tAUE1o}Ou+U9^P_kISko+Nkh^sCz(&H1P*w$_T>8 zsL^Zqq_(D9d^fcBYNmfRICN%9hX&j^_^Crq5F2(R&JCZJgQDPMCPK$H4*P$wOacPX zwOe-`QDK$nxJp3G?EQ50t_18>{0omjNJf+=4AR=vLMF(uLD(2rECObeY%pZmwqKsR;(LdC z;PV8MhW3>U^st6z%n0nM%xPYtB9c(>3jzEtiFWl6Ldo@YS>)luL<{!2#mABr-jd8A z9coLGaHS!eB$>8#eL`9Aw(^o?v0{ zeexP4cRHe3MX(^{x$RMH9$I!Iv!@v73NwtKADQSgkJ=V;PvS(Nhs6a*y!l$Dn7C*RFGIgU9Bp#4O*f=EEX<$r)0$i5$L{wM_T#F z9$u1jw;Bt`Uv>fb>MK_%+L*l2h1^}_`>?gsPZ{m!k~g(@Q^cm9otKh+l-!dU>1gE% zAu^$=CH@vo&&h7MyLBq0aeeYW@y%1J?!FgUfg~qDw{Y^a9!qJ*Ju-N%ebYczS*vv6pAVoI41LasYxnQT)&Y?#*AX&8i_N=<(0rB>9qEkwftEv zQLcsOXA*{Fxe-=3dxWh?% zAsk3JF>OMf2{?zj8cXJse439`2o=T|mU9y-l&gvFe&Tn4@PH!ZVgSd0;Fj&&R(r@c z3?B`(s_)$NHrs1Fc5CG9Bz%yY|w%2m zdMEFQwhIdj0h%#KCOR6b1;{2)Yeta~89^=iXKJCY<)N{jc8!?8ugBk*SXB#@3?>``V=D`B<$Md9?Q6OC9s5B|~9|b>`poMi`3deufE8 z>!J4&#Ph3hXIHW)QXxM-l~J$vPvg$Q5NU?Pt64}V+iNWUYuw9!sy5W8DwJVdqsV&V z!+xjtp>%QybP~)|AY2qkHQ#PhdtN|a1wUvsnw?do7{^;Pmfh1-C^^E6$h4Z;9n9ds zTrE6uV)l4VB6Vj;m0=R{4s#*~` z%nIOVGWKHehAnNJaF2>dE#w|zsMAuB>)F6b3a8RdPQ3$m+Yl{*%$ynm9+wd;W0CjDDlP0a!OqCTuZY_hY*hL4^AFxSW}elX!*xID z*c;HVrnJABL93>XZ;&V4N=oObOQI&`eB)I9(od^ylH8~$`*p;+AMTf_;H7DIbUhYy zG6Ex6$D{|QF%d?0fjUsVt5sqy6;(~F7G%v=GQ=n|pO9A!r768G?zEFpQxdArCzx?& zdOj&O^CTbYBu#gPS40upAfXtBaAIn{ueE_4h-mrx^WS9*6)HSU>a4}w+(*+>E)7er z0Tw#V1wMSV!-=6MDbDqVIPLkavH1SM^iMcR?HSsAR?kEz9o^23b@!`4sBT#bwSn77&LCrn%->L2iE<9B)ut@U#0=awkrB%a-c zS6EFaB57Meyb358JM;V*l2-0ec@X|dbbpKi_Gt;(W@yZ4vZ-wRLZ6tuN8tEjWQC~{ zCEFGAFF0iv7Z(o>ijP?~md@@$MpGr9$@>Wn+}A8-LtMeG;>yd*%jkG-Hv5q%z{R?0 z@BvBp@BJr0--A-uPLTz=CaxSGPMv1;;dvMy z7)5ST5+YpytOEojKt=*k6GiT?c93wm99J~!h{E)fl9xp;nZ_xadZ+y&xTI6(%=UBw zWrM-S_4Dai22YGAn~0s=7|R@2RMbwXg;({4!@em{W~De$AD6WP91B z$1O#UXa^V9Gys=7tSgl}qqAl?W)`5R|z*`?Xx z-Y#9ZJEq*G=u%FXqWODcyun%TL^4~ywJ4qf)kGw9W%K!WoA@UMwZm*kdes5=E3)Pp zu27y3Ue_$o%TmEP%d-VLhtqY7>;WH$((03urML%Uawvbrv_hpsZ42Jank+$Evcqa+lW-?}GVs!AzTw)_eII>EFcarCx=&4v{W^TX{ku3(MT0tzi5 z<|3(deeF@SxeL?eU=H^Ip-u;sC0}f4ok{ z*NnYJFYBj*i64+vC+Il+LH;X0`B`i}1;h3S)J0`}tESA6*I-du-Q3I$8wD9|Lqoxl zMP`;ekUjJ=KR<*Qs%j6cfV_*#{r2VRIIW`p4g$N=7;3t&p$AogVAMW) zdNaumraq4jot^o4!4i=;J(0Qb>}75>OTui%lg(QQ1Eu6L2D>pNo}gb+G~2+jbTG6P)5R1KCp3XzWQgZ`kLW|4 z*jpfp_#k>nuJ>MqH6wSPID3*ZE_husVf}kiD{obU5R>OJegv>hO-jh7=3kKfTtZnjBV@+Y38+w$k<2_U;X zM!V#~b;D%(xE^)BMo(RG_IUY!T7W6d76tO9;5cl`CYoNJObR^ZS2;FRX|ooAUcr(P z@GRY_FYA`R4e+=iY)jjT%}sG=hGV%hnIxlvN|x~E&2^I{4Q|}g6l)R6wvUM@T5%($ zehLJ-Nos~M!e~}e1eB3&i+aLu>AM==E80Dapu5T3G=VIIOYOpO zeoYC?$GQ6Y`1}^qbYWKNBpgo%um!K{T!wgvyoklSFWfq`!Bjg!syz0kbih+|@l)Sq z4?4wr#U4LbE0v@SQLq)f)?gdfi$^z2wk$XWANrzM++f1EUV3Z~H#ZJGJ~5k2C3gWV^SR%9_$9`ib^?mY z%5|mAcmEz%Acgq9>eNNam<|Zt(q7g7l1mDxVqD%Bs%-Tw`A~9jnNPURkMwlmgKc|e zf>vQ}@JOrKea(_W<(J2&jMaCxOas~C_9(_++x1+J<1OtRV_qhcZ>y5|TO_04xfYp3 z$W7~*4l08azLz|vwm(ZHtsDD%+@^AVb^lAsQCTHo{YF9uqvRt`Ejyx6u-I~<^&hyF zdhr33Ora4Oj^ySD+2-sSm72n}?^sPz3=`Co<~-ZaS*bCED&jU}LZtzNm4H~wBVS4NL%r2ndmO@kmT{d%OG?Jl%IXXl zNSTk@%iDE{T2SELXW{=5X_iDm3DXPVc+5s6YLyHihlowX^iVaJHQsUWH*09NS6#tZ zti=irH$$BO*!C>Fpkr&wcsU%dyFi+Qz5R|0p6xvlSO{xK?7sm+l}?PyIF)cM=TA)SWh<}@d+JA)m zV~l>p!)nRY7FERAdy0{iWr1xuMMn5ZI)Hr||HMttdwS;GS)~Ho-?qEfaDil`ncl?P zmtHkhjwWZK4Ni!N>6^BOG=oTTFa;=uMrkraV?V1^xIy$}e0(RQTPZ5|o0B=^Nv?nK zkAg(2)~{&REP_%2nre^+f#4{f+lsK6*U;U4vGsH(Kp(eBqDT#?Opu#JCWl1&MYqAL zPvi%Z;t@U9t(APt*2vqAIHr43t?4;~wYbHlUW@JdLBQw(}s5 z;g|4aGJ=Z2T8W70eborRVcnG{FGQu{$(&!Gclf*r$+bA%8UkXlWE$BWZCSH)0>AuJ zJ>EJ^k3;>QAx~JlJC9l{TJ&S=76;znehGfat6I=}%N^nD#Ct7(&+=_*u{RUnmHE zE%ny>K}rf@a#nOs3W-6!YOa-)I9cPu$f9@1X`LdJn;lw1ICUmRp)A8Gy&g}zYinz> zYl?SIS#1<(!*LQL;qNyfKc+LMcd+y(opuxVJDSu%WZanwF4lav**}?(b(pmy?3eBh z{x~_Q?6w45L*-4Z9>?-2j`EnufkZ2Io(8vjRgq7|`bP6bpCiZ7mI7*Ai|URup{w~; z>vLAd&Flf~z5^y&s@zgFK|4occn@5IU|`W`d7wUyKJMUSK9Vgf}-`AH_g2vy>fB|{BIf#@zMd=03WYX9i!=|>8`}VfB zUlsep&cmXVxlbUb-qpbY(!k7BWX^_%WUoKn+sn)8g=;eWdkN|3Yz^+*0j6Xzbt;YO zfalObtzOR-&~jvF|9ky=2_!q4Dv4F(M2Hg13 zG_@Ih3EWX)`yyuHgR zYEaNWlk32*#r#kpJWcM- z8>Bh`*;`jSVWxLF|!u~^vKz@WoW{oXsnZaYoK&hBf8J)-;&oqvE z_TNw~f^5U#I4{^UJcvR!fe99KE2W2!(;n$<_jUDOgPMe~orVK6n`<7?;-QeJ-eILV zpahw6U9b%#<<(LCWi{J>%BY>8}Azd*rR%efw%fBn~RjCha- zbg<~HqU~eW$P!}m$%$p>2}8w7noqUc!=n0zf1t{IzIc7mUM33&rVFIy9&R}YPW7oH}`eO77e$+T?4&3&~rIl_EnB|9LpHW;XUWF;KFF<0qa^c$c@(J)sc zQ|-Rmd5&=l~^ z-ov#d)|{0cSg0xdhECuy0l$lh@mDXMBgpzW0g{ieiRhhFg8~sq6kTU}bQu|Ch=~}e zwS|>(@Z1gsV<;+gJ;CwOQ{Y_e|B+rjyS*x3K_0L_uZE<-8auQ(N`IyJ_}&Bx0Ulq1 z_GXMWb0p48+f)`UaH>WQB2CwPOJ~NqvKQa}hW)l+w&i!zJ^I%ZGmeR|Ua@H0u0R)z z0fnE5d#I@JNT?}%4t}&FlwpMi$bpYjq|knLSWXf|uzLMJQzHm?uiH5}R%8bi5)E~s ze@SwB7bD#qQ^F%E{oH&`gtTxTI59gX_tEa_j}bg3SAhEtTByjw;5k!X49=2@==6>r zRy%+NSogO_x2ef}uDe#wv~1Vf))sx;P@!}X;=BomUXM?9 zA$c?|5n}1;IArD021?!jWbpLbSJ{#$ECCwsxuKt{b=M)EppV_3`3*A1kIC@`p85ZY zowH|g*$9u2I_$&xLc^9kw6xRE^8+$xg0MA2ZcS~fZhLF%;U6y(-k%rEuB_1+2A+R< zBMG_lW4ouG#KTF%0Rnh)^f95%voL1#t~#Vo;Yjdb>7)FffI$OE`G5*7y_Rh58KWp{ z0xVXL)`kPxO}(;>cEk#}ugrF(Bk7Q^2(2MTMJ+sV>d91+9@C5$@Cb#Z`vAEBHRCK* zR9cV-TVb&>h=rK-Nj{z+8i?y;>V=45FhbIqqv41&-oWHC5@F?N6DoJpEMVP?@H6G zu&Wfs+=Lmpr*m*$j9eMuIf7@QCn>~FDF>2YCXOQO2tXxYQ3i!^q2NJqvWIorre>l^ zfq1^Vvc6LJZ*8xjmh5v@R`alAPo*hOceMM+{$6s2=;Z@XH0Y~rQWgJVBr{XTrKC!J zx9o&MZ@<(g4%ddB9(fgx1Y>}x#jvc$#|ViPyj*lz+t`3L6maFrRJc_;Vrs%wKy6CL+ifQ>=M=Hp&i*+GFA-KG@XRu4X}LiX19ml)qepwz0%iuaRe2ZE`18B&cr!jmSSiZOD!?2(M*i zYP3xG)}FWyWrWk1qX_d~kg=W9EL5)8CFBh`GXg6XKQ3lu=&$L}#08ymBjFnj4w21BOsyJ5^QrIPnd`sA7S{Gx z@gR*s8{V2}GNk{u=`GH!GpATa8e43!kkK^m3%AWBplNE zm-QxG8%kM-aCH_Ot$UfF!XL=3z~nt!1fOYisXA~Cg}g9R>1f0h*Ycr3WN4nEf8?foY#f7>jw6yJJH7cG!u+_?hzL5PO@={mD%W%2Dv|80T$HNod)*F z0+Tp9DTUtAyl9cs*=MRvRVNd#U6QSd4nnn`*6Nc00cs=E4|kpX>z2#1hTjrGTUFm~ zefHB&=hoqs<)?N~jEV-TgeGPwXxcH{^snVst)CyS3y~69&`T;G?(X*OT-mK`?%DVc zWkM<5F7P~vS@X1O3?2Q?zVAtyZ(+V*i1tA;iBGY=l*;|eX-CrU*8RYfz^+GVOY9km z%|(6vaBv{Xj2F|IIcGrxnWrig`CpxhHklL3iE z@#sccE)o;*dr8;NmK@`L>M;~{&W2Je4P=yycMsMQqD{)?uP&wdLg}(5lbvZkbN;{j z{0-A>KmA~gV3A>l+7$5u(QroLEh_D+t6BRk5H8N|>n3;Q+)zehl+%9g#5KM9)NDc= z>V-&Vq)&c|KB6M1T$3c+c}Z!^yb~}W3~sL~R9m9yuM=}t@FMH((U~zGWJ_5;*dpYV zndT~FGUFjWsxq!J1>EGf9!P1;ASL#}46K&VSdvEYAy|*H)D@J0mj%G6Z%?^zR90#G zO>KUG_b`hvSBC}jZR&sdre@jeuBB94U>n3<|MtB71%5#ZZ772){?Bq-6hk6*y`hwA?oRP|D}3looU{ks0V7y6J?Sr z$Z`ny)utL_dC-rwkDRu3cW(laeFCGRJa0xoSp1{6mu}h|%qWmiVLpJ`E?qZH+_GpZ zkq-GGDPy_NMAeXE;ETdeRdxKRq);$3j_OgoD$@ zAcZh++h}KBmSF7e|CPu21I!Zm1O!hrze)4x{C|)aU{h&_?U^?dG&2)5^-~SYJ1S5o zlph(*HdD(LV4Jf-aN}NvvrQ%c3Et#vfs>EGV6)cYD4z-P@bJ(a92d0sjY4h}lAdf2Vdg))d-3Px#UFU2%cv;p4Z3UeIsSMNT zx(_6?P06F80R&^s2l(&7)~5fsD)KnTKl1nYpo;pt@yCaEqWg1Y+gR*~YO&b_Q-ul$ zUfKeAKuoDoizC%y*;rxfsf;w=vT(`hpa8mh=NoM6P~uQQ^N4RbcLo>! z9S2j;Lx6dP{2h)`B1gR^8kX765Rp35uj5}ikoV_Y!+*rN2H+RyV!L9p!j+iZl7QnvVU~uC>*oqRS8@J zCj+_KRd~J)o9xDqU`HF4E?5?eB*=1CiyUjnZWe*es1EeG1g`&hHb=)jOCkH-ll7o0 zR^#B?EI!9=CxeoL7qIg;Ln|Bx=ywN3%RJGBELsNNSHX*6UhfGCZdpze8z6boP;R83 zg-qaJqMxsQL00+$hm#$5j8BD^p*IOT00Kq*wPeCK6N3M3Y;GbER(iX-re3B}4PQv6 z=+`i3$|%LI4u01n^*xdPHCJ_hO4OnP;MKSm;k4u=fp)ZLAwglv>)$KS7rMrVyD^H7 zBNsrm0uo$rd+_A~%o>kF~{NVV<6!D$@DKx>Lt&e7)TxHh#bY6HfV2cv*=uCc+N8RU=2Cd1ev zPf_=GVd3L7trcG+mffW?NNz~k7{;}T%`ie-oSiXkq*2)dtzDgI3-uvdZVIiv!yz$D zz7sM-$hyq4^DEy)Fp`8Bu~Mt&zsP@U3axK$Ui?N$I!l2`eh&PKz!Qo)*Ut;zG2`;vu2|7)Tc>s1!M8q211 zveCTLZ^QV+JZ-)J!1ENK0>QZ?~2xKeo3Kr>!c|{TMo7CY2ffkx?fZI&4^ny8^HCIu8jEV8ZG( z#gz7oW^xk`AP2b3kGaW_~CUjJSCzP&s(TD5sI@88`y{Vz`n zjw@1}1i`(KJzEv+4=tXFIajjM#UkiQQ0LHwp((T_1btX0y$Z=GpSucA5qb^K6&aF$ z{(Fp!f2haD%03u%MUXLbn0jQj$?PJhqM2noVDS?3DDLCq<5Mas2_ZZrJ}4V}8X{wK zOypQE*XT91DtZ!s*vdGkGq_#*GTQTyrsdLER!XB5<*G@D7$}#}e2l`$hTX7FG#*_t zmhlW~9^uBb?UGA){hMANph*mWIh_RD5D@&Lii2PV7rv91m-Y39aK@lIO!(bX6IN)Y zNS1@(FZOn$g5+)|XXhbDrr_H)D@rZB?0b(*C-b+(96^?^5WmMO1x9~al;7JgOyx~r zSkF-&4X@lg-yP|#{Z715fQwFWnrT?enPJZGD|4a; zeowtIP~F-FAwRzwY4!%p{ z%Rbjvx36@T3q!wu)0-qmf1sTd_@uA)m$gl=CN|uZW}y<4Za#Bu;)hYBcWzhIx#h&q z2w5cOE*>V*u1gk|QagQI-$(Har!jmI>q0RbJu+vST%j_0!qAmgc!*kVHVBoN?_@h`?k)mV zzkKa4bY+xuAEIN@UGBPXbE7de ze(8u8e)F`o>>7$MR9gdDm-tTV6cu6b7A&L=_x4}J8E5FViW zr~=!_SBA1tx|2wRL_!vUTKpDK7ju64RggI>iIECy2|lk+W=tMGYSgJo6-kDhV|uEE zD3D6s6HgNIl?2iGkMOX|+Wj7`-fSV*H0`wF4U*$;PwjMvvJ_iUMpnCSio~k4Q5@-a zBY$^|4cXizNVaBKDB+bSLFZ4Wq`_1F&3bQhB9PWQ*2UI8+XSfH8pIYCTF5(-7skay z4c^9Z`V6L|mYA@!q7b&=O$5SX_$mwOSw*~-Hl9& z{pbll7*J0vQGJY*HLhSH>Y993>SY#Yd7*-F{`$2)v13autY{(o?Yv_fPw;Uqaij z9!{%u;K$5ku*56uWXszuV|m~ScZzYA(j}?{Ljb{W0H)`P8B6sc-B*oF_pqgGQ{u>R zUh1jH?LN$ldIaX0E6w=?^ z&$JZV-M|u*#F*q`7BW;JI>5-Nl^vaM@$2Z%!Jyd(TOQtlR zGC}5h>4ye4Fom#Q!Sqk4IRccBO*&#h5Uj3RO&I}9lSH(K{beMve7oHK7qF0#$TV7d zQpJBZf|v#OeP!AmSh(Q@29mk|%PByvfl!U=Up_}s*oDTV2;j#i=?C=o?#(m^Q3Rd~ zzV|33#^TUH(l|Mia=EySlo^eaJ>cuW8PNV-B%*_~LXooR_XJXx%k%7f*qX=r02-W4 zB#Chuo{8Z$4n&fVc>4~6Ju!78oy{Y|%+`zKg7c|OKVhX?V>pGVvx?Tl_RzE~ga*&@ z*jvgk_}c#Si$O~W7rgyQ2M>~U=f-M^YLnUmCaq%ktJa-`VE5A})?4zpF?HqjoHz5G zP@}u;dBG-yu#C4l8|nKZR5bZC$Vl{z*2FW}7CetnQYN?^GAHjki`<=c_4wTHsl6)2pwNmL%qF(AyGxs(U9@8V2n*Dzn8wGRw^wc>MN4Z3wnj2eHq z!{hQcm}L7-)AX(uI6Es6Q9+B$p$86&z+zxIiFRs7g)oX@sQJm162Gs}H}SEM^ZbN{ zLuAPr>$p_QfKR`R5M2;}Z}T=3AnU*Jd4XP&!1a*a|5&E+Q`XnA3e!RRM?d@N$*XO3 zp!)G%mx>kJ_bN+I4#w+UDUC~cS32GMTu`q66BLTV_JeUZv0rWwyYbbsfZ_kN03-0? z9cdhY6JGxxP3IWb_xr#7yu9o!+s3kOTgz^>6bk-_dB{wvC@cFqRMJJnl1bk@IH!rO;l$fjznCyVrz;w8 z5u2*HW3LA0W#D!lLd?(qX47PN5J{zb)hip>NW`s#H1b)^$ap?sdg4^iZc zBICCAE5w_(&TjRN)s^R`GIe5Ol;ZdTXn)>}byo0TP08$5!*@+T+;zn%XEinHn% z9!5WZLe?w$ykN9}{NrvzWdu&m!-Q3xmK{z`T)|qv<%JW%;YrjiOF6>Bnc;$3E3y2? zH5owXfP8H{S-*b}#;($YAkhKgt*t|z*Hm)I4aW_ci=W?l6ULa6i)>ODd>*nbQb_a1 z?7FOP{=X=81~c`)c3ga?lWk|0EWt+=D^ z{FC~Gjjy`SOlagoooc3i%#*=-ivLpT`!rL}=4!fhEB%Y0SKS%XC>4*8QCQBYcys>A zVQE?|Kg3mVTok5{AW7I;TgzB=Rz|gHm?Gi3-^L*_Tb0~;8KTH;?gF=ip8;~e^K7+( zGGfxyuY-DAF>ICgRtrXVkl91VH(E?PT}Ylm!PwOVG|>BzS3yBRpiI1guvY_Nx#6X| zi%VPu1(9@f8d#|9oeq?ihRZEms*UVURpxT(t2}Pk{Q{S)z!(<&r$~I);AafZWBEx< z+rfP*;^<8;U-HU~-Z}kJueuZ3uD_Nk(E1sQRRHQ+06?U#&o+>#x-&rDZvxU=4jBj( ze>gY^2a0O)eHVrB^1=;tbaafnP`^J0?pd(=0rn-Bm}5VPO}s&LqVR_g?$Wdl88&hb zSnx&Zx11`GGV6_Lva6eiKowX|d7d9aOF8#*plX4`D<>!C+^(6zVESDf_pb&cMY%Y% zN3=E8xv0h;l6n&7be5kwp=B>J~ftyUBa z-~Zes_+@3FQnVm&p08Ksn5ww${a5;Oq54`x?LlYg$igmLv25=zy8%>h^kdETFBq%9 z*_&ky%=n6Q>{OBS7~gf$$t zr}+YyVRoYVN)MXZ0zEVcYQm%QQM7GPoX_}1P%w3M+S!^_tpWoy0vVC@1xbH{pUcLG zgw@E5)={ftH>EQkJ91 zJY9tr^9_fIud49@W_wuWxJB(Puz&=fD8B*KdkI$!CVZGRtn1?68-fk6-@qqS)od_P zO?iFJG?3vI146>+ATUJ6z$V_ug<9)e_NRE*i^WtTfx|Scp-cw+rEwd}P%R`kX$H0E zX7$<;o3r(;L#ZNTFm72YO(~m_@K6e?Nw8JsbY_qcA3(>WZvv4gc}ku|FQ{pi=%7C{ zEDgAD`2yptyAx>(aw;bmV-qzfL53P`c;Re{f~wwQHz*q%j<2YtBaK6&82*i_ijr#( z`@&xg721qT8*Fbj+T4Kyb!Dgz=gx4}ql+4P=Q;syWv?ux_{=NDzgJi#JM)Nor~ogdNR@c6*iF*u0F_OaFwf z*g~yB{J5pq&e8bPnRQL`sS`hGTJr^)O2Q7Rj?YQn`lODT)uTq(GvTz`CRhA`KUR+y zjy~gB{{7oErv^K+uCAe`iO%xNmq67y*tD~9#r=dZBIVSDaYH?(aM>jBjJwxAqt2gs z-vp}0my5S(<-xbm zSn7^w7Cgz)+rX1WBD1%x+Bg%VMo>LtMIXqzzxkk;Z+^5n%1KB1cyXZ&)tBdgGZO>7 zYd;L~Mys)yg492^d~6zQN1oY>36$HLjj(+ml}aYgcwH_|w`nJiH1KJrCPF040bYiE zruj%?@Al!yi(X__*$xI^|Ml@so&z>)wG(4*fGJ= z+}ss)K=%u>gEqWXn&1Qf9-jkO3*fLq=c3mTQfbhH7jFXNfW*iLFLbIoR2jzdeKD(n zT%$k>Y6dSQc*GQ_*RVnje4nMW9cV>TePhCLJk~;S=TI9z12wd;5;x6a5%i+|3Wc~x zgYwEH>)!!`S77eHuz-u0MjB3P=97UG_7#2$bDD!Fw&K}7e= zhMrSwvE87=20OPXQ)PLq1F**YMEsWc;OJ{Ne&M{8dY*;ILi~8~KnH8=`LB(|ib}4U6GK7dN3nEQD&T31nKap6Q-m0@2CKi|{))f6!Ik9Cp9lRfD>#UE_>@ zX3m|Ri|d;rO{c{$ed6wA7V`drv60cc_wU_KDk+)e=p>^2AFg_x;AGnAe;CqVc>)j{ zWi_q@5+!Lro|da0uQEcQazh>ruFLV6||jx zD#|Z@dl$2X)2e2*7atdcT!8?ZwHXXAjmceXm)gW>kc^ zM-bj-9PBm68O&c=hXj+Yb|RO>@~q^((1=cMZDmmx{*{24{m~iiBD?QCer)hZpO-;aBOH-dP ze(-q0&Gi`cVz0A`VJYI`X(L-I)p_a8`)<`p<>Q^m`sHx@I9}m6F86zq0NYxA)MUkDd3iY=kj3|Rc6N?`yh4-D^{w@SLRV+o zVEUO+ai@1g+{?QRhYKzqg-ZK7mV{Hdyr;|$ zdGDHjTIk5+mA`GFo-F?R71zRuN3V2LgWQq{X3#>0&H_@5oU?gA7GbiNv)rXm#vj0= z7dd~b<7E3ztmjp_?2j-zZ!fYDbM~!95z=;_3wSn|v?@>E)go11>q8)1TC~~|pL%Fl zwKT{Mg}6u$Um--P#oo6(x<5IacquO5*o=L1mq@R%V@o415TRqx3os#M+=f{hPQRXLi?qe;e*Bo5D zBfs*kY5)G36%x!@FDL$N%i~tE5kuB81egka_uuFT^>be=15xxFh3}g@V)EUg!uPPT zxQkoF$q?^zDz=SVOC?5`CnRj(5ha7+?gRI^V#C1(LpYNYd^9udKtiFJ!!#%JRl53Z~J*hB+|JdZO1MTi1%+ zLq(rPbxa%nYOB*nXYm||c!wFUV2&r61Rp z(ka(ltE*T7&e0=d^Xr*2*`Nex^EMM^C$|V8(hA=m7Z=-X>KUY4+pIBIe~D`f?&S#* zG&E|!DZ?AvR{42b^S+<9Jg8T~v@VH5LqioMFp0DWUo`B%mbT^tKh;I)pP{j@v}|(* zrE^vom>#Sc3~3xQCQvDsJS$R=TBdh=)gwV~x5UCpMCJLm*gW>+)eV%+APE+`!l{si z+Hs#ax-{@nZ#ic)Mf%fz-`2j4gbffM;tSkxR7!&fXL^@u@1;wairU8K%T2Eaa zHT!UT10vhX5;QXLIOxY^!ju9YZ!RAmmK*uE4ULVFr$I@J|Hs+*h*zD!YA%hFPbZR% zi+yE{30h9plM%`KhT>u1t3=spXv^47xv<|vBnj32x^WU3#Y*kV+9!odQxHM%AyX6+X z9zPZogkSO{PI z{K()fY_{e?HH~RPA77-lF`;IVy+e)CJ6kyb#}lQwS4Wai4EH9qU!_+s1sFp`SLpZqBf}p9QH;$hrq9*c&-h zEUG-^`p%Mse;QawW-)LfPxomTlQ-oWu;EYRS)4g;TH)?0+i0539(&jMFsv_%#8INp zD(%e73>01yhk)FTQfrj?I;>?0CR)FRg3FNznXx}BTU*vGHlnE6e@JlAF9eTB>CZa4Be{D_slKI~7i z4|2Bnex5^Ki)kOB+CQjk%OYhc8jL9k+ieonb9m+&yzJaA*5yI7yO17X!yS4l4;V8O zqx&lM1F*;Iq;L4!e$()~yBjLva2EB93<_qxa{YK4)bs2&?hIJ2B_|ZY8p38$kWcF5 z?t*{RyFQ8Hu&e+nWa3gXPGiI2#E&$UYyQ( zj+2h3Y$r;$KyD;F?UfuK#ianBI|E}wf^w=mv?H^rgrA`BDpy5>pG|YM+4P z+2-VaYVlzNHy0yJP=2u&vfDl)OkMKKwbrgnKUlY-a@9PD$$ zn@aO{m`q2O3CnP`T&!?&aza8|`*IX)`>7ExS9C4XuNH45D_#bK$+WCSW(vp#&^>i=tH<4H;pJLCW`m99XX?p@@VMr;?~yZ= z68mq(B%lDdYd_NpqOAugFe58|&^gW-@eF~TE08>a0~pcG?4q@Ix&`e0q}VcwwSP7R zs1q@}{11L$o9gLFZ;dUVhN@@NQ@v<+Hzv2Ns9}x@bam9PM~*y-k3?r3jT<>)XtKEs zj&M@VVEoWP+`_+~kJ_?Arc>Dvaiv*YxD;BT`dKxym`6GD5>?X~4OmUbS<`|;4FCtW zYlM6hyv>bFbLbzG7vtb29H&y5?q4>Nt&tNY#)eVvI@(&6-l?S}ByRSHSN#*C=y%Q- zkT3+a(mQ`3^AQjd`j|bl<5f`Vq;gI8KhMwqGEk(&6&#+OjUPn&KpJ@eq_k5{#e8`s+(~$chB%lTp4V{t&<%Hj_(&o;v^4 zc#e~K?_tTVvF=k-l9zSa#f@BiJxFB zdKjj~Edmpv<&&F0n@c(RW_pceVPX*9OX*}qzCRn-CF7>L^YhpXrq$cRKx|M~J2H&d zOeaIP7_66+=2+fL_lKJ7!+ZPRdsZEw^od)1^Syp%rt*1Da~ualU+t;+xzeO9Hd-v3 zubAO*Eg=87I(kN>NV+TZkI)D?hPDT*>?+Aii*WrLSn|npjW)M9aa6;;5)NsD0V|~bu`W@ zUnxo5e(@wfAN47&tzjHyYH$kU;!&LG7fnTlLCa85+A@M=(fi`w0*2I|vRrTzNLp|E zrv+p_RsKU#`S;QfW5dMrpx~#JaC7lR8_XZ~8v(hv8^ITAU+t-1RMr(OWFnjBpy9!$ zFM&=FvY0;4Zr1P2be2tV=7|Ewy6gyZn(u+)@KGP^K(PnKeYD1Qt#w)#4tIBVA0BjV zEGVWfEFq8n$}S1z2?={H$^Ghf-5XQ`{!fdY(5esx-!Z{QLhZ$nIRUt{xWlHt_HnX z&m{u877~rOI1MIhf6(fWc6>DR#zWOaCm|NUuUXW&BlsjgCyVlWWUD)utR)A|8|dwr@fT!;OhM0>POOd@=Lh<;zKW#DCYOmL@D3@ z0QW{WqyiLExMI?hy37UbZ-Yt3oi{M;2p?CjX^R|iWKs@oDhnoCwrDCT4KiGgkk5AFL_z#Nz7y%g0g z&GjbLLP$nR>pphQd{HgI<#RU~`Z`JY8O&!WNDVhN@!Ji{*$9`7_4Vhw>HrU=nikPN z-Wka}@^d^FEH$i?hQ}0L!ZtVwwWYMq_z7>Y$vssdVRGESGjLk#5~cA~+C)~e02wu6 zi9yRe{?4 z8uY?rV+t-{A!wAs{wESN$o`M}_>!kD_Pqs`2{B?D9}jw6+_!X0;Hoz!#<3VW8>fio z2j*uCX{hp8i(aFB#eV%4d^{zR^9}b}npB$dNm7N>RMBQaOmT|K@qu&SOW2_hA&NsW zkc@Y!j7i!SGwGrdeJ%;l4d-i~frPsWJVN)Q4Pzib?bF%jThc=IHw7*!JECOliS!h< zl&3mN?!6O}(KLLz*^M*=g&Nfd>^L*l-mpRn5p2@zr>#bNro;bbvYz4dzN506O}kz} z1p=WiSB5AO^OaY{caMLEuCK5Eizs1PFXk>vhbM2m{8hU=!OAu?JS@ZV_IF0B7})?KILAPI)<_`E<06vAYW1tKO;x zfjUjzl8Z~?56=sJSI56ALs}>pjyyV;efx4(N$ngNY{z`WNhHCZ zz9d2v&ur{B_B49Qz&{|Y*h(gOQC{XcK^bfN` zBUXcV#4chh9bO4>dqp#Y?p;e$Y13`B?;lb3fuy|FS}$s2jL&-l4ZW9zw455eM5fcETB)^rVfy=y?-Tj?Anu#;$>l zNW7P|W_?LZI5^eBVZ9;4SJ*_I32|c;-N47ho^me{nqK^@!<>=n%OUEQ?}NW8qKuQP zlA)4D=j! z?=AGp%!rgcvCEPj+C;(~P^(Sr|I9-Rd4A`3}0a(CRV zSZCpa5!Gf%Ot(ytVx5x6vE@`n=(+%k;(SsXiv2>&`Y{>i8|>HF;Xe6)X>Y90KpD1+ zzM)=*G}-r`zEBwF;OH~DrKC-1-)FmSrA5MH)jT_!4B$`!Aj8!w1Gm`$`}>2l! zX&CFG4_GO|)5J%%HS|@3P)M77CpO;-PzU#IO?A|PZ84rawjmhoyRFHESCX}hDZ?D= zL_?%z_a#B9(5hD>{|R;qy>Gl>Cyqx##-(*=Ig4terjvKqmlA;zF)P_{WTa3Xr5_I4 z{O-Rhz9kBIYX12Gq+2MS3N~L|&?IydBxTK=$_Y^ByfrE6TW#_1E2Se(Pfz8r>!<#` z&%c@5EyEwV-ExuiSvz~uN)KvO` zJ4odv4X^64PxY9diQ2$0JdJ8ROId;@N3L|6-hU>zX_mK=HGYL}lP0m6o3A|S?&78l zbsPA!fKvaFD@InVNqAs&u#l1J@7g#Ddu1QF4a#LGC7D@xh=uBjfh6+3!#yjXR2zS* zjK{)ryGFOA4wh-X>8%OoiN(5OkPZO!QNWb~oVOtU&oJy`bVbDvDZ?fwnjG+(YXH9x z4&X;BDL668QCgAN%vi-t*CAPIs$zxV4H`z@;zw~(6 z;zi=8?W0mo<=gyXTE-nuc;+z_T(^xY9mv&qbq@F?p{QS5VS&OZ#+<9a+>~}zByyIf zCqOTHv*S8|!=pCS!JI7zqasO}tvGY=coQMdA2+|c&k|O`J#?^^JP_f;QJGD}-GBEZ z9kWa7)FB(bCUQUsRp~)B9$x1gOSP5dJ4E+X%VzF9scy|w@@De|TT^x$dGP_w)*N!Y zvijlCyvWplOBU15g~xQN8iOrZc@yF`nyDUNWArregXQ=XvEY>w5#jqco3IQx%d~rS zDU9%5E7br^3EiN;7T_6HiBAYESkgg3+%pMM@!ny_lvQ!Zj(0Le5JmX=p0a z$rJis948umg9ckwXP7s;GV3h8`Y)Nl@fs*b6hoM>^q2CMvT6n+h+tk@9cYdrQd5}Z zj3Sin%0jME6&H5qwl?utP73?xGS0^m)A^vAUr16ModXj3MPIcq9>=99$^XV>Q{N)( z@<#gSEz1NuU&P3S)m%rAi?sZ zrZorGE>;mKY@9UUnOv0h`$8#x{pKdY2zUxSp3XtJ2Iv89KF-uSxMNi z1|qdc0U7w5VcQ01Cfu%x7{T(_6MnYI;KLZxb3$=@ychk2JReAja%~Q>jRO4qa%!64gZDKe0WTyQ1c$)9jnv9N%+hPCJ|frd zUhe9n)KSWBNU$ltDt^{rl9(ItL?CA!4VLLJmiT5HFOReVGb|osTZq^KbwtbYLp5_K zyv%7dI}%@%hz4ab#l!mP3aBAC1%Rt&vD0~=%_bg9rk``^C3b^}`0CFah3njkr@put zIC2NdK9p!WCi|&zLP{LY*)Ekip`5uzyK}@^n{eU2YJhJI${ju>%RwX@nrGDqx$az- zbXPis1jP3Mo|l-I2qcple?gQ8wc268OT>)A&C_}F)^fgWhYr5IMJB~+rqb6^MBzaI zZi7wA@i9IBPU(z8Vye2FrW0w%d$vF4xMqGD3leM22f07P^sOXTv#Dn3g08^`0th({ z;3zfp+jjn5qNj270QSN!FFl?Ko?*r=psgReZOlO#YW9ccoglAVEm9LW&|_7A;!%lg zzOG)Tsx5)cCO*rsWO&iUo##nWQPWAP{G5r6oGDhAkzlWxm}V-I^&b(A!9FQZj*X^O z@twPL2{BQiCU#$R|7xe6*L2@Z`rrylp#fIEAY6e|?b8L@M?hG6zaafmGR7$CU9Ak+Mpb2 z!(%LCqsmWX)%2w^r6L)AkBj)c9d<=RpQ?et!=59U?)>Y8gk~H1%-T1t)4ru-U0>Lq zC&=4iZC5_JX*^J_3X!74**S;a!mA5-Qg?LB4`7NfsVKAobIcLA%;y*wo6~@Kx*lsX z3V4d>RD)>Y#+9Oif5u8gWMlm)@5e|Wq^5-Rsr5c1%mHUW&2|z`SQHwDMfX&v-Hzyr z;ToxGDJOHt^p@N?R-i53@$(&7wKk+fytZTAf5(AuPg=Y#!`+e*)^WJ&+RvLhPiEY7u#*uBC(%ru3*)~L#mKsYru(Vy?(B$Vx+a8J4ykt1zG8QJ z0;L+bJb0CU!ZPwHQtHBLUcoN!lanisbo)N4SCx;3r-e38O220JM}~XTxiQd$xGvOs z_Am_c6)PGQiwmh)*B=}tN)zdwlmzP3AC&Lwy`IN%<=mOTKM1|;ej{ron&gYysY4pt z&o$l^B0?yeD5LIM_+~YEht4XThWw5XMJWeZ>pLUoCaTy6LlUr#!hs=Hti7Tj<`~a# zb#?Vm1O*}hd0^y%uP^tWQrXi;C13g!y$C0vMikK4=!@_ZfG`HTXP@?u$_o$L*>5L# zq2JvDaO)K)^H`9D(6&3ua3^(6`XJq@BFts?38iXt8`r}J}%LF5LZBrscOZ)@ZD$ixNu zp^tKjk64K5c~`+ftXs$|w9c4terLRV*o5@!_%lm5fD3%bijnNJbCFAKmzkN_f)6~X zT6@q3!mk`e{%%ioSN%&P?||<~TT_6LSu6-rxk<`?iQOw1cd(Kp`XU&EUgS9@L<})# zeOLR1W5ZKZw66?Cqc@+4Lh&zB7U$Hm8#P={n(()JmCE$KCQeK|=vr6d`4BqB41wYg4m{os#%qyaB=wTdQ+u;CdbIkkUN43>tss#+H0W2(@^F zQPfVNN0vX|f?|iYN^?i0(2%cOzV6O44#J78yAN+8GzsqSDN;%X>7FcMlrE!Ta>Vx? zU#-6Ovo5^HzaMIMo4$$GLS%TU^`e|Wt&-4eZiwaV!H=iN1tXH*fj;({WW&@t$~ zhv20~+wJ$8XZDH*X%46K%*xMkR6AO7PH`{7pyT^LwC;ltZ<8!3{z#-3%|Kq=yRUj`+_ffzp+EF9zu)* z707Mq`n!c*g|TH?+YXv$ofE<@A1PA?kax;eBors*U)NZ9^OksgoOjQZIR-X;Au_=$g(NzP(e3MaJE* zClhwyoIz;z6RFJV7|$&spYbD@8NLEw@ZjJ8R6!tg`h8|{_VE>HYVN#&1Iiw(x$-XS zkD*XbAviqa*SxH?OsT5MoERN5ngVLmR%jv?tN=a_CO63=Ri5u9C5*mx%>wg}z@l?# z8dO1GM+2;H?OPsTejPkMrb*D53ebx@O3A1BU2hOMBj@0bs9rcQ{poQG1!ddC=q1*I z$jgI-;eRg);IYFaw4ZtUFqTDcij;ql5Xl1>hF0CYy9j@e6Lw(J7vwA#kWJk_HtCsG zaDz;;w2K%!YhjP0O1dvMc`M8LQiQB8np&9sgZ+Iko>S?HG6Q%zKGnY6Jv23~O59#& zHpf1AG&&+-6dFEK+@wL_q;z(d{~P?vje)fEri0!&KmjU{C$&#PKQsOhUJ%{uyp$Q= z{0(V5+9I1)fA62mE#NOY<@C;jLnkZK5>`Y=2#mcyQ&<9V{mxGB?VjAVwN<(ZnO~>U zB|zx_w*#sja>Z_Pc;BPLmfSceTcZL6djd*Sv=91}CsnxL;05cQ#B!sawpIluM(9hn zna++|2dH#3=6{JhSK=d}oHy*6L#N;5Q?u5MkA4lS6!`b2qZvDK)ENg);zfHRLU+0B zEIG_wRp}6ZJmLiA48|0V7I^t#bK^NjX~j?R<#%BVVhtHlZFrEznn9M_i$(~08 z1k>0zaOTGiZcX5Z_|sYU&ja!37|_P3De?_FMX2L4$r z`RBa#(|3oE{>N+vW?u#+Qr8>GR<|mq4rOG$tMt$cjqslnv-c!%0}d=jxhrMXJ78!b z59gHXW|Z~aa;7uj)mYXZpcJeDk0|_~zK+v+20uCwO^_gZJ6l_a>EAahHXp^Yx8{_x zD&oxFXXy?kT}G%%c}V>eIA{U1ERm1}sJ%OF8qJ8_rOQThSBfUG_yPS_5p@hI?83T7 zy?$jJHTjz#wRVZ)*gV-dR$QNMBDi#KX0VtloX=_A0~3bsm#1>K&t1u=F95IQIRT(` z=Yun0owj&2nMEe^cc1iXm=wCVTA0=!xbBbT<{K#L0#$9Do!?Rx{j@guMuEi-$vRGJQoMdhFc5)1|gGUY2b7f^E$FyI1c($0t zjx+L{e{m9eDBaT~P)aY^t4EIEz-0av|K8pQDU6LKdPm|C@8JY{1}JM_r*m|41Y8vX zy%*yPUUeM%3ZTI;V&>CeAVCdSLgprhPVp)LPtzY;WOS z@pa(^$?g(xjT0vVWASRwA_!_C6oSf9^ul4><(U{HEvNF}USMJ%18m3N*-Sqt zpG%KyEluWs9u=KvMd*+4l+e%}L1iJ9Dj4&~BnXvrXU3DMU6FFnYo4xBE=Ud0m-=~B z69KCH995V(##Cb4X>l4S<-b z-o0yG|M3o?R<2wTZb(lPtM95_K<|78?Xo7pj5l%Sgl=rARnT;1fHo*~bzkD6m-X58 zVhb-ScTzm{Cx3qyI##i>t(WsHV9ne=>>K}Sjs-I+EP36cbOiiH!)^qxA!auNh6Ub9tgx;N&VWrS`H9k)_*=z4C`=D@I^1Z6Y&MuQxZ1 zd4+F6z>of1mVey-PoU8UKXD2>M0Np1qIuM#Q+D1i=aXx~gD=VbKguz#HY07yX?z_J z&xIaJQl13&nlSpd+)-zx^3{nd1Twz?Al?LQuYgqx`ll(`%%dRa`&J8A&)i$|bZj=i zeN;5-!tbjqYiro+DsR%s1{b*@xAJpE#2%|Bi;@yrbNmZLjF=ND&Jwv{IGRGU3j{L~ zE_knVrYKn^je6vYeG}r8pUe$ILbaq5wL5!Q+9VntYp79SP`GGdJaDcy?=963A9f!P zrZ6(9?YdTGU{pd^d>@3APV8AmuLJD=c#L`=1}c+ z3=Tn@ z69ZH-b+-}!4l$_Taaqc32229U}c8a%wf1+g!Y(EfgdkafKQdfP|byiv~LFWM1hlCzv$ z$l&J;%2p|70O8udUT5ha}&WGbpq5Xe;t# z_i28N_*hbN;ozV8VXv1)h*5wvSq0^;)3HFp7dsrn>*7S z`)VwOl^-z)A(e&<+2DGl8&@V_)Vq@gD((?<5C3H?|M!D^c=*z&4{p^>G)^#W0!xUZ zcEx4zPnxU_mvD#>XL~#R4@Gk|?}Y?6Ld>($)!M;GrioE>F<#FL_~O|iIzmCv>l#X7 zM}QYcj%FTkpTJ4wa2xW3FA<>t#aPb%7MoX3Qb6W4V_nm#K|WGfq@}R_Q^<)yov5-(EK`d*4cI7LPLnZpC%n4Sr2CF z=AtpYSBi*>3Jc=4vm$G9`?kWp@;B1WqIY5bFS^n1iJ2_gzWpgbB*FheprswiPDY*e zp4qNMSyB>x;mYC(q0zfh^|BM*+KpX|SMgKMt9?72BIgoghgXJ#Dn~FqDVc-1#msTJ z2=9)A_FwHRIb;tk4bh^YH0p*NL>)%lnxnULQ$HRs)N+WZ?`dy_21? z!kI@sxN^Fmu7IzWo7N*~V7f2TjjqM~*TO7_TtUX~2@+2_LdBeAC z+_QWywa1Q1;;xc{4uwx3n%9(diC2&y4(ko?vuNhI$e-{+2qpF{3n{t-jDX+*LLn;hN9P&ls7h?M%gs*v zXyzn2Q<4Vnd(MUe)Ek@4-~#j%i_+)R*Z0fSn`o`~3X{Hl1wNTDEMRXBN^=s_)L-yj_W27t>GS_2(%vdtyy0a_ zOK<8e+Tsvngu4k)pFSq;f1bS9{K{5YTB?J;-%LKvPJ?x`W0-xmJsF2b%kP+|jnr4f zV^Nc=W2PSP?@4QZ?S!dI?$0V)!D51ooo|`FKVL{D`I{J97U>3hwhSsP*j3O@Jl&lF z869}^4Bh-+#34sgOBLv@RaM+?V*pSNo>U-y1%@C>ZT@#6f30`Hp3|6HU?As?5!+{; zldEB45B&*8aVb7*TgG6v4^@_3pM<&hPC2pgWUxgJy=vw#5e28~75)u*K}3i%gQpyV zFfrK!h@`7&tu9R&)bBs2J!Wwky0Bv<7r?=}AK;)xTMTpm_s6&DyI2XCh>^U5E43v= z@bno@aUG2UbD0o5gAOsg-a~-BVvg*yL^Fi3R==j}-@$bq*oLJhp&m?XQHjj@73eJ^MiO~m&0UsC@eR9UXv}}DiP~;F)6;}avT}PXjTo`>gqV?Lh8W9XvxT+n#M$#! zXa_?QBTE>5b}HCnj81`SBTD3zC}~PE@9TGEh&$_&wU5t-#-0bvDCe&nB^59v*m%c% zSgC!Yzn`XDMvpjFHk7uiK$3a(&0LjxeD?mA#F!s<-sf1!%ILp4GKrU|)Ed-N$BvjZ zKf`gyfHD&Ay}ra{tr`(OLL_)b&4 za^hdmpzcA5(jgduw^GpNA6v>R_A7BOnv#jg%hwTmx;}op& zVO+_37Vk&W7eiU+PDS?3vp|rTI|y_Vw0g;n>POa|mkxZtk@_lB^(Oc;n@{aag!k9g z&X{V0O+KpSdS_l~T#}Puz!n;CrAeUIg*qp8R&B97yF~jZ-u|Y^dhkq%F=>Rcd{j{4 zha#p$kc_uk#r|~b{!LLNsOZniy;cMMok`^{az_Gf{^rC9?rMD%9DM}5sqQ;>_T|vW z%BT81rdQJ4i^k?ELzydohKS4BtU@REr*Wv8eXiLAOQIUw!PaM2H6d0 zP38X#Q*CkzqLw2i5s3RBnSaZd0>z|!vK~C7k`FZElFBMcGM;6$|eus9cIT|^%&Mc9> z2Ph-!U`le-*4hyl4F*4ju=vjBTWCi6MNOgS1bV)mu`y6t&dfq-UPVn(R>&Mfxm>Xb_K;u}LDHY%LdIU_kaurrxjF`Va^m1I{J=9?} z0xC!LtlMJ+wUNd6d<8No#o#{nK}95%F9Pi&(R5sxaFTRho|L^b)Te>3k}>*X239wF zd%+QGTK~ezHscGK3H3i(!rYfFf_W;~&_=C}NG~uEG-^_BD{cOseMO2Rubbxd+rK5t zPFrALT*Bm=A@ut|Uy!qqkEM-A`&;&>vb!o)V`Iev?T$saq#BEiSqh;v4jhherYk9= zhUGR^l4iY1Si?EN?j=X?&rTU)ITA9X4=6MU~&{jVMj$xHW{6 zi$>P@jj@RdkP@^j7k)?~x?L%ip8(9zbrI7=w*Cg({>CrOrGwIz!s!~(4x02EUD@N4 z@7-4AB@}7|11+(uLtN@n9M&qqYwA>3p%~FJr9X4rMGev=u%H98g|A{$1}Uk9l#h3I z%*-U8-jb(A12{}wZ4mHaPMhPDp?K`7A*yGM;fFXzu<4)kLXS+p{N5b|pNza!>OvAG zFKvF`X%V^5x6#~oi?HRtZMe;k|9_o&c5;G@g&HbIJ_o7Oot22q{4hrXV@r{k?u4(` zL_2zpR6JN-S^Ly_;Qwdi^S$?^&-3RMKW!swwj8y)qM3T@Da#e?5g@aF%W9x~)z1IR zrB|OQRH4KF?uQ77aDsV zd(aVYKD(Hhvr-NlV6w!1&e9xnx-Ryi=Ts^<#~#vm_wqW{{9a+Be;S(;gC4c>FMHoH zd$U|2+V5XJV*-gX-?5nhOpy-DF6Hd|MuBm}w|&o38g`=PYKRMqeVQYsY)F#jNJUn2 zca`l(hONbwP8qQ#8Z?xIOEZa#fzf`n(F6a-0@!GGKj&mQeI$Lk7c+{INe%uU60%x( z#><^Q@p=14Q(}UWAW9JS1LN2hRzU#j-I8jMV_kODNg$^!k&#NVg}zdd5WAw%Q@U%G zBcqCXxgoMC&9Bikkzm?7BSROoIesF9BJ!^;p7E_YT!Px! zXuS>;z7^*=WjPhp!4v#9T$7MHj_`W&Q_g*!9G>+rAS9%s#)>;#=6>LZkp@57oAFAm zdMydaX(X5=un}^r5Z56q^#^wB*m9MpSu*Vp6J(m!Yh1;gEq$lKjVWYvNY?7Bb+q}b z1RbqLth}ex_dqghaZVM3Ssl_ndw#X+nrQMdqg+nzqtI>%9Ta{51J<};0)MP#+pBvw zv|?K@`9Td3PCn$Wd|E-0ald51N^(SHwVv&Nqt7>}nczxH!+$g1=tgNtTn~>+WEv}O z)c-aw4)6gPbavAUTj<0Ga}i3HUpw2;un4ck;PB@^HKT?ZR1BDXMWF+pduP^XUh=;a zmlH(f*D}x@A2d*7?~+`G^88HS+nK&cQY>xBCIrPu4QW#DYll@@>1N8 z+UT04jhW3vRZ~}G!{MMsl%4ck|f?0fgL zA$t;0q0n7ax!L;din0&tYCL5S{GF}~L+=*XG}`S^o^Y!(hNER_B# zW$I!7{_`)(%+Mp7D=YE)JuG6`>UX{Bm=rK(wAlEs!5bI$4J6S63n34adV|`QGI#|! zzO9Z0W0n;!;E@KcfxAR_2Fcz`fy{$JQ3p0z8c8e3P73i3SICB!m&Vb|<4#Wnj?%A5G^R*7qB)@oKeSUe;>4mR+ls?UrqG*<7`3+cuZI zW!rAq)_Hc$b^5=q>ihXT&l~ssx;eG}BijZ^YyUPHck4brS9?h8KLc-Z=mHJb<1I>TxfONs_l9Lv4BGq!K|0KKv>3?xfAYsS zy01;CO4Y7RD$cmlDKa!obLD{4WvslnxSz~RZ7s-w`{ z(z4|z_u$fFVcQ>j=Z@POtCGeI2vT6bK_NmZDs_kxxZ_6)>E5nc+x%bts^u<&PMh9` zj7j&h8_=>`U(Z|%M-gZd21-&6;+BMv^9@1ehza#h54>ciWvKi%{^b-?uP>w=?G0}x z|6x_;8C9N!ZQA^UiEMOzWilGxUsJisgKyfb%_gJQB&9wrzSU6Ik6TUAjgjm>Trbr0 zQMLOZlBd$h$OqZAt`4&3-dGH;>(26RpGmlIWZmeUYKI9B`6Gf5#-nY6#;3kj^hEcS zg=AI)7Io)-cb+e=es(OGQ+bx!?GyS~+>?v@q6M7FaTRj=W9vI|x;Ll!uxh9G{+uwY zOa0~Hd4=mMn651n=Y@^Z>6*h4Gx^quO^q7VEIQR}{wMGHvC!lFx-{VVILwvDC>o}? zNt$9yV?!X*p%~(iSj~UZ)x__!At|<4EGDN`OS7_aObUL)J>e`{)CkV2kTW&rs=ii! zfz}z?VN?x-i;gcXr}()HzXWajTjs1{?^X}IBsyK`hS2&oAre!LNjak*mh*jNvmS4F zsRo;brePihw)|~bISo9BW0r?;EsDPRHmF)2arHM+j)Y&?8+AMG!?_ey^O7;*jGl@# zR2up*7*|<-%+kXoVJJOjhaAs0;SgCu>~y~g3Tk>Q4?V@}OfIrTUfrfyW9jTbp z`1ERTU!MAjZ=c)2G{^5d)9~kUBHzI%+ggr<+|mw=J?5E-aew+o4J$naq;Hy07Y#G@ zF=|#Gdh03^8I1#LeOV~%AyIb~v|EbfvLIAN=9FpN+o4UZZ$+tc8-LCBa{DX*{FCN8a1S3<@Y1Nt z9+S1&FD)Q966;*22Vn#alSeA;G*}eN^+yviQtDUO>e-6EIahW2ifQqo_s8 zfhjo5r21#nTQK5pO!HPdyeXPNUc18kL9o9!@AP^5M4e=Q&UH_jn+PV2l@ttwbFn8g zS-rg<03IgOqsCw*EGtnr0PT&M3zr#$WE%-_CnKD2VR#XfBcqZD@>r zd01axPn%q&Pmb(A#^0q*^3NGhU@mt|&ivu?a7kX8+P@}oli{#V1Bh+LaP5mf_Q2i@ z>;rSFxz6K?VujJBf9Ahmg04S-N}(c!{}>S+-8w~aGQ zy}ATU(#o5glM^`)U&g^Z6NUBU>08HRI0dN|m-DNOZ7~ZX(e=r^sJmNs{(XfwJ?Di! zbGq!7z0?rWkk{vD{3n~=e7wA`Aek7H?}^i?yR*3M`IHrDBm+T2x~v|vJ4o4j8ElSF zJ6Wt@RNv>Q>LZ+B7$5Wwv2Cl1=(gCZd^6p(v@rCp%r)B%NcKeJ23m*;s#4N6N6Jbl z2FbccJ4~<#6H!LGgLR2G7Q^#?-3RsfNQ8TDW??Xz*QD5QTGLuE`Jlz2lH`RjDy3e> z(H5e_jS1`QDirGn!enPb9IguA)V)F4(j^Nj4sYik)HLJ_`F4s^yXqNSIONx2)Kqub zzLZ?nyiKx07T-_jp=@JP1QpVUKR8&%%?XaI*m=iRcX=i9n}j$ z=+aK)PT2J81;@upLX`McNXkCn{Fn4lDUxSs_T%qEMlq3|$=f#~4mQX^>F9rnmPZxX};Dm9?bW~vI!_D>Qz~rrm-nk!D zw-XP~Uw9^D=Jd33oN&=_VIJ7(hfTAXYyP1Byg8Ys=R9#zO3`||wSAk5?EjdGB#=cT zjSPE=EXEyyR_P@lNqXeI2&&IkgJM!7xD94>0g3?EsxIyoyh7E*La$8d@BCrt1>*#0 z!II-oZa1It8TiLN5^bh=^@oT_k_1ynu5Ojw55BtPR!)tko9gAbLHqu)>S{S}kFZ;0 zV!s7ZF5XYKbo5{!2gK}w#Cs|#$2zP&YibElX}W5KEeMMdM9Jn@Y6*o8_2$!5<3#_- zNqRHGE;ixq>AqiiED&{Z2(%{Grlq`p;Pd!G)09Z~BYnii`d+Te=o5B5oc_f&cC|Ns zq~c8)TG)m9J;N4P{SDjV0hPs5$;9~J@SOeOB;Fq^n6KCwKun~p`ZXx2D_QQv_(RkJA z@HCgmScjG!@WM&IR=WhkUDHjd2K!k~vh)Ch4uT^aZTOHt8WN`$VCVw_bPQ37Dt^Q_ zF`St3?cHkn@Wj7B7UKv&uAZLZh@bqs3|uy%!@p4cq*Q-sDG~XvM>c#&y>VY#Wvbci zHe?1)aYPF8GW~M`T{g?_)P*D9093O=UW~x7Eq#WoOkF4w6TGrdUp*7pBa35+dj+$L zn(~K^!}#)iC17<;2QB|u|C9A8oH^PzUyv3}shrySL~lx)E-jFl<6h^>W+v>*gdsrU zomp~(!1EOn(($dC9{m&bKts zsq?LV1c?_0-HxwZT=uIIbK{@>W(*Z@4yx#9%BbWWF$;I^BsE&dmEv_Ye|FSSs6<<~ zto`WXb`5TeF%`}ox@#>c`1RH5`pIw;?~G2ss>#UAbY2@=LYVdeAPv=tCkUZ9SZv;! zG3`4Zeb+Cyi=jV%{`bDmm~D6U?lFu-FkI1TF32+-HFOflU6wav-xqS_Sb3BCIi}@J ziFV}@Y05G*80+9z{77yZpJr4m>080(fKL75m=yvwT{X}&_y++XIr4YdRR8WP^+aD| z#I{(LQbVis!Xp&T@~I?SAet!1jvYK3ikHgK1|AGvF_jwR3l_gxZDtYXMOpXBpnd$b z#9}!8*JcM}YKBN(N`~^Xq}F`4Jb+I9O&U z^%ycn-B{+Q4%S)jqRjOh7B|juq^8Lgm9uA+nwJy4Q#;IaF41*e^lX{QFF=u{551w4 znR4@@+q!g6p|~n39wfYc_>3nVP;lo>um1?MsYShKF*+x_mKz#(U$_|_CS$D&`o+OX zh34mQ#2(wmv2JVM#KtRABxUya8bz@alt#3yolWx%sLDc2$5<|j(r|WBQpyr3MnPEb z(nP%b6YtrPiLX6GDUZHwi=knLzc{V6Ah{PnyAyKWX7s7TpkW^xa{yabK5fe>!O-7$c)bF>Fe}>V4~MffO`do$HgT%Jcl_|Mp9QRT!%n4i3T}qZUL@|2dc^8% zkSv*)*@Bvanq(-AD09@@iu!&MrI;fxU(s*fQUht7UsTSEwN)~LzFO(l`CGoScFXZ) zym;5NVa^&^GgS~nqt}Ivez3yoh<#by>8wmIV^kHLT8Njp8Af|xbxZ4#psJwYPwiZ+ zDx&Zo7j@ zLZ>q~kn5~2XP$lIWx=o*`l3Eoy}g7&Rq$x9862(1#0z;rvLPsS?eO3%mBFTSf3 z`8%CEa)^SP7jgJyILr*D=$6WdkelxK24qc+$wv4O|80$X0gutX9L&Jb#ropn!QO@0 z*ueRyCv+~#vq2>EU#g&{k1WVr&B9!Acq<`B`G@tJmDAr8dhrv_^ z^mazgUqtxpARJ3RlqgQ_{AJw|^?OGftd%NtZ5fMjQskG7lcOQ4b&SoW8JLrmf*J&c zX3GntGVSg+hd_OGvfSkJa-{2Xzxfj=6D~&6I7q626~xUT7(5)cal%~lq%n$qhIaZD zEv>PIu^$o_xm3#vKYmTL zEv|>^no-128F&OHrJ>J^tk;v@*+AQYqP`9v%aC~}dqAKwOaB$&k zg@|Y5g2rm8+bZy-VKBN{P4Aq@Uw}H3>*Uz#DF0b1pry0(j6nSzSwiWsCkjg4t=N?Y zXOThSJEVGbHBo)|^v4@X-J@T^0Tndnd3C~v(@5eb42qYt`x-m0te?})YZwzMhW?gk zC++$Wi2R7OC*asjO0|6oDWytGA3w;03Ja7WcAbGw_^%(~WWNdZ;ilr%oavD>5qk2i zAR3zcD#ftGD#=Vm+GM~B^%VaSx;-3)j9M{1e#)@5F{LIwN|h)JCi+Ke<3VuW>rTpv@ht{F2`CuV z@y}WnXt}@-k8{Fw$=$v?MI~ln^d3V^NAlnzrKOUNpI(qKszcl>QSvK6bdb5k5Rmof z5UHmMkV%$_)X=ba?bm^*Z!}kgK4*_^L5Fa|9Hw|q_PC3`;^ef zv*Xgto*}e4Khc4MWW{QI_}f*fm6hyjR~|+B%`K%?E~qa7k8|-m;PQ9A+%7Y8KKHO) zi%fuR??1X5AjufCdhTk~1B7zdKdGYX!6dEA+Q$`z--TjpShCd;)F|sqDt(E{aV2P% ze~I@UsU7h936^Y8g7>aE-CJ#LaGRdJxo6E9OHc-5@qE62N6{_FzRf(q4;%7_HCP{x z94p@$UMh_l?CutT41~IKDuU?bP(Za3=3;gOqo(X<(1%9>`7SuB5pZGqMv}Gy&B^pf zt!G&g%2)6)Jct!dG^iOz`$EX%=v!0c*%8ui|C6@XJjjLbDohdl5t7KXX%p*^ETl{} zR?5^ItWH2os>&u>NQvcbO&KV~xwH8YBp559GJQKHIY5b2*D5pc;FzetK;~U1S|+n8 zZMCi?D*9>cxIm0p)ew2CXejDir5hT3(A43FuCJ25-{%@0GpR99l^g3#pWs5aOvb>t5J13gqLi)vYk!NpSYkEKLeiNql}oVL^{_35+U zlw@%9a)0tV8&JR-4pP5>J7K-U%fr#JPkz2lR-e5v;+WY;kDYUfk(mKi0yd;)P!fTw z@+r0DX6B~DeqY3MPmBSk!%ocnhTJf_zzswvuCCznRB1K~RRu>)Bfz7Ot*_-Ye6F5| zDpxML+#S=jQK$forNnh4^smp+YCWK6M@QyK&vck<5oYz{7={(<9LBBQYv2=bgJg?g z9=tsNa?&`LC!8J@V|63O-oMw(iFgG6OJdf__?vU}7!m;|e8SHN9|y zD;-cb=*J?1e92X=`dYjLa0l-S?Nh>P;eW-L-8xF}iTwZpUhb>;Yvu&91i3p}xDz6m zV2KKzT(nKf*dbSrW>-g^p%V@^$5L!Xofj>!FIH_@BYV=f7Mc8AcI#Ng6fU^!Pg;YJ$Tg=VialF#}$DEjblectbMh@My)KwW&ZXd&B zCPqhP_AQ*5WVqf(|3Ti|v9m8qFA3j;H5_UEV^!+)#cAjBfS*~GPqeSGV|pu~;@nqS zZQcNw?pf#C8mmj&Bt<=a^7`Heu$2MCcR13iBg96?|#8Dbo!(r&z% zBc4mckrjU`fDbV?$UIN8SA*5@W>-Lnv5V=0CF8>Wn#M;g{NV42t|mi@rW_^UZTylI zD=OTWYZggupFI5phZn0e#PF;l@i9ts`pF0E%^n-PkPJ1lF zZx__}m=vFRR*INm^urD*Dy{4h*%9`Hk2Kyf-M#-j?ma|oI+Ixxcnh9=9omLK@3+?% zKs*585&-!)(f53Rz#QXu#$NDnA@m0eb8MNE0t7PwMh*Dzn1Y z7phbgBN)%*Y3=Cn2Ac}(Mi;(mxpE2PhPMMt`;+YB)7%MSc?OGx0lP2}@)o>-lP<8K z03F#6%gFkMr~VRje=w_WbH5o9Eq0=df^R_8JDjW!*B3=oo34IjW$8!WL=W7v!XmmX zM93@&DQ)&uX?Bbc!Kz5}{{B_e8I}?ar)#1(^SA5st>9lHc+Yrf{7l==0d%S8cvjQ( z{%+F3abYr&6i;c%rVL2y6tO-wGPJhza&cn24?egZA*MOoc642eJF z>?t;WV@^5Y@=mC88o<<@=P+NItl4@Gmxe5Ul4 zd4{z)>&^D7nM)pf!1-{};~!bV-1VeJ^RIoWa5pjE^k+6Mo)OTg~{MNL{nFZiUfU)hhA z4q4h|%4UI$8o+7jAlC{Hue9&&Z?}1A4E6o%yZ_kQzOl*#9Hj8N#5AJ}eneY?1F`Pj zH;1#}Fcv@Rn=_|qcs}3!!953Snj+~vmNdMIl-98*2h`etdBn<6EL)?s^mN{KZauxn5U%Xlg*^N0yDnedRdSixK7 z&K7LS)B-ZGI8ccQ{CROBy|==|JDU23cIZ}hCNx0|DnUgZpDfXg>XOt`EaFf;3FTH4 zp^UxFnzp%XoQ2HG%hq-mt1B6lj2zI4HskEJEcX#UNfB@5RUaIn3Q*a;5Y}mCm4;Wt zp~vhQj>smfQ|M4W^jlEwnV0CNT{#Ao?)(1MyB?8Ex(o=pD6p4g#&OMUbbsuUR3p{@ zLH3mA7FxYWR;SvuouQQwcvc^X^YpFn%K5$L=mlBkG{D~By*Ul28 zrPB_}HQ>O>#bu#O7bh|_dqL>aQM*gqXD6k7en5cG%)3^&suQdd|LLd*$s*RAms(oe zNp_m9AZ1!lTF#8}lPGERV`;RE+T3aCNQt(wndPS*_!!iYcRe~-KxiG&gx{>ygI~( zy{fI;;3eJi$OPMhC~6d*r{K+dZrk6QTBs2gw=M)WQ248ALrZ$!(A1H7-0@23qT&3K z8Y;yo%-^s)5jo!HozM0158sC!8PQBOKLp|_bVAjhP@-FvIXD=FmJQkDVyiSl1FhJ< zAj?YMf8DE2yZi1B{E*K-ovC;B!uh2=%|(zCk`z%8HMX`Ze_=v}l3$Pq829h4clt1} zlBS!&I6fY=dg8Et2BsmweLC_E__$(`S_m=3r9_(HmbiT||8z{I0FCJ<&@2P_`OBrY zzW@)dGs$YDZ*)*68SNGH_sLmlmSQn8n7zVSvKm1TsCbo4&^9$+(d)ja)r;6LxJLd8 zUAkhf_}N)DpyiY-9NHWFrt?0}PDO3S=&pDQ%jxKKVEOX~}KvfSnxMxF^PQc@FJCcCGy4m~l!$Q*j(Td=_Ub10)Xbu8llZO}ju58TsY@0;8A7PaKl@csbeW@a&S9k5MzV zDyK+X0}X=d+u4Wr%=LEF>vsPY20U76$WqX!YE5UFhD~+h z*kzmH7bS>V$7mf%(Mtc$x#aUzOGd6B7S(6317H~?K}$}Li>*La{}ExASH>licFkeW z4;x@Wl34nJ$}Df`{}sGaz%K^)#767xa*;1C=b~fr0DB;V5T`m%$HmA3E{~@c^xCBF zVBCF7HmEuT7?swKkx@~rN5-0_679c!=}E2H?%ier-#q7k|Bmu0+EdzS2(VfJ=I|5$ z3N|nP1@cOT1A;e)AK2sv!xk03n1w78!PwnRi$G+=yw&`oNDgJzH!JNkl1JnePr7Mt zL1;bNp~RCunV#54P<#i26T2AJcm<{kLh0-rWdc4gvR|*MmlDO?WWM1jOXXyt_hwPQ z9pLaF#Cm?5S+q1NK*^-%GmV1~r$cn$_)?& zsRz`bjdIWO^a!cyKI9H0O#-@b6hk@8#H`fne)OD1RQ6^1ymy7O^*QN!NLthcCWah$ z-gQ;1WNX?<;6n^b)}K@K)ydl6nj3<)jagGnB2lsM3PU`XSj$ZESQ>bG z61@$rw-5`922s>*Fj+6^hPnK;C7v3`OJQ}Q{R$j}xj$C|_T2m`OKNIjzSj?6z3SLRTX{P<%~}^Vwt`+RRwn#c z)E7+rn%%u0Tp}Q2)jGHNHs+$ss*?N5V*_1raEMYZ+9}W$f!_w^ zT2X3V3n0J{4mrL4+0(-rulv(dsSbygNFoa5rYmy3WebjC)LHq#4VGuc@l<3&3^lOn zzZ~-&h-kuCC++?i)CiwF=Bl3#H^R@g&dpee52=AMHpk>vUxhozS?s0_lxP$Cc3NaT zxZ*Ec4daTg*%fD;aK-nWI^KcxTqm*Hyk`SXSIwu)FTwgpHL%$=usH{j7O~q3YbvE8 z)z&`dofWYy&r)A=!+Yu^<3(z0b~IdUE%b)F$atl`W8!*)TEx5t{&s}IK(VIdrJRQZ{T_;M?75Lsw$1D3QSzbcb89>3RAA#r?AeVHaOi(cUO+9Tf zOcW+JNPF9_gk-0L;neKH7)Ap6NRz~Es4Eo+gGrJ#yHc$2w#hQo8k zo>I={hVyf)Pn6;z#=+`+9W9lgAq4*h*qvsRnP5Q_OyhW;aN8pav_{oC;(ODo)2 ziP=&0Ex;8~p=uslOoKjmeQnLXDeu^u>%b@p*Jza1dJNAE)+BT}1<_q7dYcQ$idxdT zkn6y}j^Z8T4c?vlfRB{EN!j0&grNXj@^CT>%Z3TV>=-WdBob2WB~=!4{;w&l2gB6@*A|Br)EvQcQt2jy??yS3Y(0}fRpZkrZmPhe3XUT z8<@?v(}vA>3ZN?N5-bav>Pie}ugEXy5U*4DTz(WhQyTZXk-SbH%NhB-FRs`RmJ02K z?t^$8?awIo;wXjo)LN{xk2QK}%;|Y`^2+nG;}LUnMd-EKenX4q*B-3jL=NL`RXR$c z7x`&fU6(dwu?~5{s;M~G(A^OB<2`W4dO`P8o($f@X>MFo)z%qZa;*Kq9g zSi^JjhXkZv$2q><29q(a!uoU39!ovxZrFL_>7ohaLyMcgIKUWpA6&aTt|9-uG`-!f ze{op%y34RaNIAA$@3^U{1zF4wBibp#1p*1Rljq7C;kWcfNI|YVII+i;wrCdV@C(j~ z*<>8n;Kv*vTP=QEHo)x9d^qFuQUBpA*|zk&pc;Fo1{z#SKj= zMOQbWI0psCLv2UgbLaIn6Q9@n`HQVLN|K9QO&8K!c{r4V3YPj*TG$uU-gEUdwMnZ3 z{6gQn6xPC2OiSl_ek7=6tK>ia?A!fNVCnw+$LIM^=gV^ELw;yl>f5gF>#omp)Y}E$ z+y2}0Fz8SBMnB%NcNCH;>B6fw9k<|Bn(;8_++>C4=(|fE->CTUp4h4MSN3z)nB=_N4?UW zLm=VS!^cPW6Hf)O(>f4ft=E!Dt4va61n?F>O!LowqQCWn&_-Gpm#9W5%#Su0)%N`% z(-*wwQs1S2$|m!gsi<}p_>L;Ey{XBxL($M7U*3BdfA#!5+B}mu$K;cE0#3UFRGqhr z%RFZ;L*An-+cpvL@3Gu(LWroiUUrAbUfdi7UDJ2fQ=_h40&YjDW#g=k`kxg7)R#2L zEZ7C;e2vL#chn<|BRya^E8;$ml>=r?W=6(0DXx;c%?)$$shURWAZi3YexJ86p>go(->`F>JX48us zq8!WwJTfHR>rB1JG~j*0YG2|fN9<*F?d%M2E1_}R#(ruHAl76}J2!Bje%0fxnAM`f z6M&Hw#KVN7!ra==mhL3Uuoe3e%gIB^ykkx!XE=rL#u*L#2bN>{NE{^@ZF0B!mHB&< zhK?(&zOh<)%?*qAeNRl}EBQ2YRO<}2CT)=Qq|7BZtORzJQd{W%@EdnJ2R*K7TTs)6Y2lj%-$`#04B9TdDns&8;$0GU7LT z*>ecZN&UGS%X=UJ9165#4y=|s-QMA*;Si^!5ctiQHCiFH z-*|yR?B!2Z(+>x^lZKu0c8|MLum`?5n*V2CZ(jHFoA9l;0b=wwVBKUlDM%mLxtO!7 zhxq{m=@?R$A1a%Lx|dCh-c}X>-qhu})rX%Pg~lr=di3|l!F?O%V%iL_nJ!<*ZVRe8 z^NI|tWc>;ro)@2Uf4)xdkETHVqJW@i9GcAL|4GVi$`vuo`0`==xNN9^aa7}l{l{Uw z1l|ZmX0wzPK4scc5b-6o^oI2Av6-OF+|OpQmr2#La&xAD=jf46p`Ays4K0F6LK@Gpt@z5HkAUT5>NBWXfNthm{* zmu6@ld-Qg+j2P$AoE_f)d>0hv``l=0+|sGIKG=6T>XM)H%TM0!qu%b<-=2KljyhkD z)?aU%0C5JaXa22=0Kxp_?CquVZI{6Z^^vSN(qo&3>xS*kBmTz>vluK-MzMX3*^*Um z!tU>kZGSxQAp*pR%~X^9=vQ@pNy=#jqW-|ZC}0H!P7%+nb0Dh}?2Z9H9xQ`8rd_rQ z-offn*kWY|hEsr{vcRW;h5GsV6?4O~qkGDmJP|h-36PF>|C7)=+GT`gb1irb3^#xn zI&6IE=cRN3DlNQvHRkZ?Vv}^M7`Gd{S0;~#vzyx@Dr`Nti|MI7A1({-KI~O<@wi{@ zje=tT8AKhpHPb<~xY*ed`+?ff=Z^iIf`@6%qUk+&$Tk??>z^Vz{@!3eJoQ5*WFY7+ zLu6s&mJAh9dFK`>e}lQ=0x4aOincu<6Z>TA4=gO;pDvlhCMGSU0gxtkvzdH8-tO+9 zu7q5Np=7upz$Qxj{ol$S@V`{8(wS5XY05n@6HR`rEaJEpr?XvM{PFS4T|mEs=bsX} zJz9q$+x9ZgSP!Q)*?{$4uOPO~^#ZB{An>J`DO<>6v!zpj6c+FW0%Kmn{iDu2Jh&yP+}!%A z3IYbNG;UQKQ0UHi(H^Mj6T)2iTbpWrLF;a66=)PmTs3(Z{bT;?^Y^fF3MRwxcO-X8$6(&G(w%v6d-Wh=)eAe2 zybL~o{f{HPT74u_`QXjX4T$IfyY++L1u^hjYT1p>tr9N@EI%j zUeTd+87aryI2P6IH_&CQI+uUca`468NSGRH^4ZOHP*7;LIwFZ5;UL}7oFD1nlE zraTEu{2IdoiLYc_yC9Xh7L zr!t@LnF4PG6{oM#G447eZaKe|{)%Ei=R%Oq$_A}*m{Q|+fRi%ojf*IBFVEw89) z`o4^$-Jsy@$|SdVv`plyQG}^v+R!IX=ZdPK$^SJi&h0zrf&5LnLu>~v#GKK8e!fh5 z+g868Up}qAF(Zkb`_`ffCuGFWU%mTR5|`p>Dpgf&pOaQ#}oq) zs@k<*SP26!6W7g_4?+O0r2a%*aW{S-13gljgQX2ljO(L%CiR{l-*S zLK?Yy9~HOT8|bm$yXMIi@0gNeTb5aG&{=TbfA#V$2!ng~?&8)bSNohc>RAhgJyp}M zv(Vn**R~f{$NO2qO~JIRy4uR5O-tcMXFO%iEN=(n0P;5W1>J%U9+1!s%C zW>c;54VZbRar?VV((3OkbY=k0EL#Q255n*Ie3T;IqHJQJr2>KESzn6co8WkubhBKx ze4t1l*30efoJ3u}l*@VblyFl+*y5^c;%1J<`FJWmwQBi&{5m*d7%IPY1lp;){{sl8 zMf099hXOy;(UIl1HvbB|(5Q`;Ht|z+V$SHnWl5BJ=RWj-s&VG4q9g@NH`Zx@}$FgT^bMHktxZjTu6t)#eQYw9GT^-hV5vaYKC!s z+;maLXO^^2;vw4j6sx0yDi^PPWNtobgnS7IK#^+rBO8_13RPn9o^%z-ZxFGs<8u9l zg7Dg_b$`)nCgcPxwki<2^t5$!@TMc>Qolq({&IWo&+MqRL(yA#K&p@1;P2SR<|@CO zhV@IRSs!yxT69s6QmLfu-oe7ExmpwOP=D;X1F; z2*w_mr8+IS&#w&O|4GBb7OpK8^y~t$GB`nL4DUgSF(xThd(7X%W)NAG=n`9wppe(b zJC*JPDSH(8@b?-@-$=y6Fki4OdK|y?6Wd$_1zQ>ymUJB`01L@SvT2b_#iVdEa31Qc z9k{X6uP7z==oyya8;-mhANTCJ9$16mfdtE<_WLW69NAIERD)gKR4-9lGW!c=< zQ4*8trF_)>)PFw>Jub5`M}_z49@|PWKc;kIJg}PKRoYCT7B)=ij@II!z-L0chv!+FsoPL}9F zcsKjr>)u zn@?0?a$7XJYMyTT10P2aE`>MeeV@Jv>CnQqKhrN`2{O!JvSyzo1Ke6nBx_5!XiTqyB^sjy##D4^`TX)DvB(Yy zJ-Ga^cZSC)8S|Uam$8R8br~7>KDHKg5EqlelD_9p@S~b}Qh4hd|ILb+#tQED9?qhm>XlpkE#>RM|%tXwZl!XV0-&u_W8xBoXaf6RFVX0lPA<2eG*vN^xjQmjM z)9elD9hX|vuaGeV;y^<@lt#~~R6U6Fk={E7B3aw|`i)8jgn+7xL&1v}g&%{rp&u&@ z*`=PAngcrr%x>a)R}}f=j)?k(FE6NM_QrqOQbuR3Pg(4! z<;Q+8vPME1<8@EH^@sBVFo&c-!f$%m&xr9IlSuRd1$9UAeJ=JQ-&MQZP2?!0Ar-Oj zU4P_E6BzAZ{qhj&>2O64k+|sS=y2wl1ey<+MK76};lHqTmUp|l*s>xYQ2`@1VdDe; z_4Ec{S;fVM6}A7zs7)Xkmns8Q<9kn)l@C8P@g(=r!!QU(hVbmaU~w#L6E5JU#k?w-hj41; z&dj8P(#X)=#pS1ccv9*Mun%S3Iik+Jyzn@jyn9E0fEt*mVrL|(BRlfHF=V^_{UZA$ zpg&=BrqW6MJs@qsCFpE6KdGHhogBN~OXbvfHhmkDzZfzDV1sq%%> z=BHp&4N#&72j;(1)a=dK|C5rzeZL5)^Pg_+INC^zjOiDR7WqYSwz;~^`6P$Uj$ld- z<{cQwQhjT@xdS8%S&R#|kMz5LOR6C}d*zC+KW&?d>MXY}9=v5Sxl7095#JH!#7TPV zI5G?vAdm9QA7k{w*4%f@E=K?NzGID_5g z!0gr76B6nFwE&0@Ufnl*Ns`b327 zQ@n?1(CGc~Nc|n}sYM6ebY6k)(E}lbwto@a?xcU)WD1D7o1sdE(YL6YRUu$B@-&A2 z+jO04e$gY}Ddo415rZH$Ix1bWIgp3>FIdJ>vw!f%`Szcv6@!mf1Ew3AEhLmv&LsZ& z$#0q&OgN)qWD-KUZDk_6XxZ-HV#z|ht>#3g`|@o(W8#S`@+u(0cJ{~nK3X%%L9zcd zF(}qT4-Dbl8U15~xr;tNuYM#aaCiQsPw$y1kQ>D34~13lBN3vI@dA8 z+0DI`*ptm}AJ^}i(;M{*EEQlMCRh+~e+Lffhud3c;1Xoy-o{X>y>NzL^k5>SG--Vi zjOY)lCc>OgY(@X$s%|vZ60IMl^djqHC~68_2eACwSC^-&t^YV`03$_m1La_Y!3l!y z^ZG#$K^bMD!<@u2EknLZ5>|)PbA^ zeGhA+u5hD$Km%^R_6u0Z1WfHgEj@-MCCcV)&lyVW#@=P|cc-)OSp|A4sGSD98@siw7N$~zg%UmXtV{}wNC~ATRY11|~Hj=T?n@8ngyAnQ! zOdbH&rzm^|a*F<7l589vhFXekc(U}mdwSyQf}S&DCHVSVCaoNoeDwm{e?0-r-PgDu z7KhY2T3a2w8WA#tyKp0vxMWLmgY;>34eYK4;H#yPA;9tSl;rb}1d7wCH}zw8reMM4 zniU8)Z8+=KVVU;;Tm1OAr2N(EIO#Giv#=2z#w?<0nrPB3tG7b&2WFrNK98eV^z!(^ zvxYjx)L^)&5st7){<4%6b${)2!AfRxhF{i;)zTr4kW%l+OdoEE95yY|Ty_Tq8uza+ zU%t44_2jS*xX6IhqF5n0}N zXEY1Jq*4$<4nv+dLH{=MDLySAW+jA@aa^p1ohIoLTOX^k2EQSu-gT@7i;SG?EikC+ z?SanidXTO!`M+BnT*$8~_o+clY4q%9SpB%IRxe{r8t*;g zVt?EErL*WyO`M98n~%J$t)z@5$znr#N1$LKdegf$_RtQnnOE9a#}bsF4A0Uc?FZ9F z?Ts77j_`;WZGU-46`bQXAfbA{sYP*e?3IWOwU@`Itm8;gibZA@1MMGvS1|Y-vXn}8 zVnRSr zzWn0F^L*?KbRFF8FzgPv#u@3vB(W<~TH%lt2hA|BhjBwk=YIY=61u$u)5H0v3`t@V zcPNFCO&x>OgiRCsc1Uqz0r=@r@OIqjV z5JHVKf??s@1>pp%0zK1o0p<-93LW_H8Nu_n`#*fIH(<*4_6p{2XK$}(K5tL!fhlBb zODJH>m6eg<_4aZHx+ow?1sr}XR9=gGo6832^a=>QVwtM$5-a~?yE#&E`OowR> zd^6Adf!uq~$zFS{cfF7zIX*w1q(lh01a=WSN1{lh<2o#m$#L;sk!cxKfFyF^g92Eg z%tCdImh~De4Dduv0<5i#_k^)j#&RrAW z+I2-gDh&R-I>cWfwLu~x1jcHp8mHh7*9`X)Aff3=c*w(ysh{Iw1jna=pbGqunN_8!bu@l*dC;^#1{%1Xt}be835E3F}@u~jz{IBEjU z%$ZQokyZT5-T~*1!^2YV{kX*A?(r#oSNQO=XeNM03sk%fn;RmYxn`~Hk2?Ud6uD=@ zV~ph|+reE?cL{mIf-IT%l=6y9DfFR-Owc$1y1g6v<~iW?0T8T(kF(#24KNZhv6n=q zTc3dbkn-HaP*faDmJ2n&BJn9dY;E$}g8I)NN|tHuz~fkXno%N8L0uY=6P{&=jm5I! zmjkD^%_C9%X1U92u3Je#EWOGwS6Ja~e4VU*a6@ywMXc8l5}>{aN`=oFc`bvz-%qt8tE}7)QLAg}dAZ;P&* zI8hlAo&DsnPBOk+G-Q7(?st!k{WPMg)=13 z=Ke>_-x+SHa68={P!Wa>^UGK5V>P}!^%lNQ!#F1~i5DJ}pT%a7;U%L0-5yONIu?w+ znN?*_D+sTWwk!LBD+HT$5rthC-yWS?ihY_ki&b%#S~UfdoBEiy_LYIbhmTlb2c`5F zo?=EikZP8C5`GH3-(|@LUD{urq=hz83ef_$wPT*HLH^Yd?bdCEqGTbkE4o7Yg=0YW zn{0}b02JpD@vZ1DJ6&&8B@V^X6dYgxGY7mhEr-hpKxO@f_Ps^zL*9=?MPrw0M}*|R zE0V&lP^pVJ2)?vb*;FkE_6s`md+| zN|~VJX+Q)(pNC1+Gc*LODn0>bX&ogkQ)R}q3zX1X#?TsqIdc)_Y<0lk#@s5y9nurq zAzrDGq)>Mcu*>Yf2R5nK*A61mnwDO`*yZWu#OydBg*b%EQv4%?4`)IIjhmaF-z}%D zgwR>B$5Uox^XH>srop4eORJqHcG@HG5DOZ*opW)cH0Ed&8DJp9?3)X3MG9e?i zewt(~bT5wF!M=kX?5=bF`!lEcn=s&||FmJ8yh`l6n?SD=;oE;g89;&r%uN7{R{-Y^ zY$yim{G0|)nI_4x)TAlK9J|!46lda+rPMh)o}|Wjy_h8)OmiHBU5FbcQ3kp_b9aG<8lEImaUIB5Np%B&)wyZmXMIq`Xp0k%9p-j~i z(5Du^`j|cZ0OMf7Qj9C}9W#>W^pAUWQ5UI@pTIWz?s~3Ix|z?!Km-PLQv5Ay`ycVH z>_u2wV_7c}n0-NoLs&EU1VB*(@cYROuhwE;MmXS20ornaYYhBbsJ-p&6}rmsFS0L9 z(iR>Q>Z{6*fdHGC=2$bZ6`(%{^gaJEumGF5T5|NBGvqi?fRqeWzD1gEzUFVIr4MY- z{EsPgE~04MBB=40lHXQU&9Ql%g$BOg0~s2-CZN`tx8~|qC6z6%dT2uo%XEqswodof z{A?t!`^$#}5z<=hkEsG#j}UC|_FP26$<0{ka^yT2D@C==yz#sS zGY;gaiOVHWfdcFfE_MHhg}^2#7OL|2Y01YCH8T562Q+@$gFEYcEdPI#8adq5L>Qb) z?eViz5u?HJGbGKVD-4;Yfo%5u+FAVVZ|W00yVSE-J!7kFIMfoX6XH>qkS8^cm~k6# zRqD6NNAN7Sw6XbPqGoHiXF~*&uspEiqQ$D{rHhB+NfuiYjClpUYDlgejT%3|#>>Wd zEV+~!aX>04iu4E0O;AylE8JD@IcV<}gXj{c?Lu@EY3J_UQhIzuaB|_-(0`S5*s4s6 z-i|ai^th$QAKA(GiMCGP!TeNmG2~!YM0i-ho@zFxpez{wB+CcE;!zXgt5PYFgoDS0 zzb$yfJ+8MayQqgSNc<+GT2#r#OkEuQd#qGog>N%?5xrJ!tG1-_LRvVpzqTQYsScZu zEl_Y_Ay;sK`V5uqO)% z4mguXppjrb1va-<)>X223jUJ;nRVPryqzrbu1auAa{>M%E1pOSpD*MSK!ep@gRw>F zA?YBWSUQwHdyp%TWK zT2!|QjpDzWR!=~^cZ_@-Pm*vE4X%%6O{6`?Mr&DZRS># zY1kb7JpQHv*a}TVtjx-Q-%7JaI%`or0G}NgGP{+oRqw;WZx9HHiP=a}&}1dnlf{zvi?={myvTLfoRjpr_cN0xS}9{myhq_ zpk!8!^9=i8~cqNw9Vu0DGji7)GfVmRG?OG9mBR}|mar$GPFik87D zqhhLo3C41ZXl63|+tB;u-3|p+YgWQ0DaK~GshHs#e?!u_}zI% z2rT3}kUMKY)w&6VVz|(()c3y3FYVwDX9+{ynlPxCIT>rgWN~<*OqmkJ6~*Z5R=5z> z>8~HBmgz;+I(54C&AOt!l*?B+zGTn%_V+nF6y+cnfp&BmiZSE)RYq~Yt1nR-6&eZ| ziG5{S_N!}iPnreBuOWhMx&kaOLdtbm;$*J^6|fCh`n^}7LrfK9j(ub!ED+ahfW8nq zU7MBSjFzRVnjl-@YM%`jm)zAL)3yc|q?##8#@8z!`?y842OIoX3foo8XbN#uD1{4O0v~pDFg?_)q=!aJ^|F8>(5UEi$+@~*?m2a(at2-iCLEF`VkZS&(7^%68~{na6))=($nm}d|KK};R}okX|M{J3z)>T*z7XMes2#BcWy0yY&b!Up z7xF_^{>SHVdt5UN1ZKk=;(m?;bB}H$(E$a|x^t#b18i0&P{3dZU*>FmNLQj6rASG~ z%+eV6GJMP-{Y*qWLPGr=9VqrmK0MvvmA3n`I22iL7Tpy`S(8w`fK|dOo^sXe-CT&w zW_FI?c%`~Cy=Bp|U0{(zIBqUR zp6GA#*NT2iVO{{SZp=Fnis4h@ePSB`sZ8(T9w>pZ`km7s09phDZ_9YWo&i6YY)U^d znf`)66vOUVY3i4JMn}`VE*pcz&k^t6{iBW`K3TS)J8XT{9m)Xj6NqQ(=Ys)XzVC%Y-`&jW$y^bf-JJoKea~syJQ~mh;y{GbI z4>4eE`GvJJT6m%tWPg2e$RBVq0;JoqsO2^nsS`~AKlXg3`aj2x_xD^IeLX$qhU-xu z0N%U1bH?^~YT5xVs^7i7lE=JPiS9|?JHaIUkP42i!DM4?BSOGX6dch3OnKu+RnZ_>#!3PGp(fACf0Ns6j)5k~aI?%5AKFQ~mnOk|f&~3k#)`*JPF;=4Gqqzg` zkkX0Rd(&}M4v<(*yRtyrGVAm+mc{*LGgrJ!BBZ0ufl5?K^ixy7o;Xn6bEzs-ke_|N|MW6Z4+&wRqJmBqCcW@;a^qyjbuOCR_7{~ zwfa?s5Cv{<{YpSA(X6Bqugq|@aLNn8a?(h(X$oX@A%4asM_VSDQT>H|&khGe@>#v4{N?Uf_~j8_I79>%8bLt^$YL8Q6KrS@3;X#@zR^ zQep7d{ca_<7BLr47vg zyl|9k2wTaP9FT<_pn^T#e7^kWY`F7G-$t3=7e~^(_m-_ho2ubxO|Q4ILv^42NUt$8 zMk7&hZZa4M%?9wk-TLP@HnMQ)6fCFPrI`LoFFJ^<19Q`4*Gj`)z1KA$c3+PDrwE4S zy-4%HOLSYCoy@*}<`4-0q?lu#xKe%Q3P$n-vQeg8Bi|!@u|-mGHycr&=&uA0I|=&A zXh*k}n5`H(=~%@;dX9z)&=M2KaZkx3|FTesD># zx68QYZ9Q~7(gEn{fujo`W59M|WhE^Em*AtnAGj|7dCh;qQb&QeXtlm(g}*?!WOuju zY0lQLJj#L@mu*JDHHO(H7uUn-sNb6VLt}}^ST0a~u;$tQnAj6^ATfppxbat8Y-i)a z9z}00Muvw&@w?>bfc0$WD`B*9)8Pll*r`0#u$ zIVGdn=k~nkbbXs3B>jOTw2nCVb{O$@u0ROj!6gbCf`J%1b;3wkF#lQY>Wq2=$iT;I zZ6O+QJx;ekBKvk%I@&^r5t_6up^}?XIg`o_kwX?AhD?C8~^|W7s-<3g)V+K z$>Q6vQ}{Lptnd$jCj{vHfG0GqCfQ6_5$z1*{sA^>p8#d@EC&Tic5*BbaCHaXaqfm2 zdAj!*9+M*`18**?BNC`KM+FSD*0q=k2Ch}F?5uv}n%TsRsuerEor;P)GwGRfT#NI? zg33AqSfq!jNia)RcSUqyN?bH)ugq74b#|gIEX=@?(Qzq^1-dI3G+Si72Eg0+h2t+q z(IgtS6i=^OF7b%}vu47@>U&gdLmM1B0_O36rnd1x&GxIb8GFo`7|y3%(Q9XPRltS9 z531E@1%Fz&>ta7NQxc0yN5PNDd+ethmb+geXDv#Zyy`zoHg4&o5fE6C#K7c8ac5f@ zUrUMtlFlo>RG0QDW4k`v!0NE~8Ga6!VP^;Fc*`g|W02octk)`L^iiz|Y?^tHX8OGw z`XEm*K(O7>_+r>LuV7EL!hPv+)Dk~{2xA1Lv;#;*be3&Uz)Xq7L5mB<^p`er|Cdy@ zA`j)W=&zQzn@Y^P;`zB!V>cR*_fOX`0HZ$22tH~0yJ_Un-I<7T{xjQWn;}yqwo*jP ztm0>OWT1)c5^GPX4S}@uaHY#@hs2nicDb~f9f#yXLy-EHC47!3kYroD34v5DS(-5q z6N7@#E@@CIA9qV3$3B32{FeQv%;nq|uXs<{J_F3e0$U1_a{}H1EUc#j{__=GE?GO9 zpY%D}j5bp2AyG9Sk~{dPBe%+e{EIevv+5AK@COwoyqpkuUv{9({#K zY)@CFy`^_>?w`dHy5ZFl?PeO|+GCV2+M|t9^jV(1mFa6TM_c1~-&$tY4P_(}rgLWz z!7ZQV4u-_9nt~@O5?9AIw*}}^Dn2ZkL|K3I3VmDECM$QzC&s^!f?Y5jdHpb~Av_5B ze!mYwl50hCw2=}Y`zeXwDHi}mQx~#kkGrR*CSK)o&&7ppaFyU5ZGkezB|xta{I~U+ zf&qxPjrtK|D3|q3R3SOXryCacBZtjoRVxtSyVlj!0cZa6^KXAYz{3VYuaXLAMyO)0 z(Ci6WGO?UXQozYccKzXhnMb$60=^trk&F^TglK6!U|ke?zV7bscVoW+WN*kT>Fpf< z1E_&-oaJF|TX2p6BMNx7moe!wgGkg~HG|)>x`yMz4Ou5V-H+V>w_ee_{77PKGcBWD zS^RCOYq6s4sm|~ov9Dn)PbBKFO-epbsPEQ5w{GC4T?vsQv;y$Efz8v-@GlKZapltvD;rH1%c9Ec0eY#jZ#If}j2-1r z@gz0I;k<7$J0OPG9QC*2{E97zJedgGk%`~)+bGhzb{XVMIJN7#XChXX&)g(k&(ouo zuw@75&Q2n~6fyfKB?>aJv2Pre*&D+NSupGB=4g+h=?d6}A<&!YCXvLB{G*1omrdnFo; zoVc12mNUc`M~!dMPD5gt)2PhGbe2z5l?~GCsSSC$1KUZj54MvSL6~jQ5{l#<(PsOb ziuwMp+C}aoGtiXjTBp~dg8us;0=(-LuNr!sY#S00alwIpJ8zv-yO%(Kd4vi$1NTxqL($UF6Bl}Ppz}TC4P~m z%mk2EI%f^H13tsimk=D#{;2MgJ<%1r0@*^OSzopW6)XJ8LB^cgG=aretCE%J73dFO z{j`xFP53Kzj1(&~2IVytTjC}QD1PB;W!XXaP1>qQmkzX{37c^6>zbe2W9f*j(UqAxNNTWDx zeh$z1%QSek=tVf$37Fl-uJ7?W?He$C=tN*SlGTU!?W(UgEIh zrKDz1`KNdq@}>M!wGQdhehzXORD`$Fy8hdhtfV^)ikWr4(B!byZ>mdy5!$f-6L4J{ z-Qdd=HU`(}SwGse!!YOO;c?JQ?o z!@cSZqjZg!ZQ!lEj~JPmnE{xLM@MA?Ef)^cdFg9dw%`97YuRY*^2+D3cF&SzLS1}( zeB9mB{G99wADsbL--jSM-Q;e)PaEIFX^_tE*!?SL$n&$&ZEETBd zsj8`EZ+TU7*I3Oq1_$0Tkza}^2jnDP-zovvgvEdNRnY-d4^6xIuK zsNUX#LWcfTO@)x6XSNme78{XPpc6=E3X5Nz}@jbcqYdt+PI=@|pYkQCJw zO}6;B!4NTNbiNIpS<)7rToRctDY5{(WOJ-`{7_lY9wcj@6R$nWxLKXj16-7%(v{YL zVm3z>Vuc)?W)R!-%9=Qbd~>O$A)NKvrT!kMT}7C{P8c%g9)yadB0Oi9 z?w}8zee>R#U1lLzwZ-CVW>~0nJ{47Y_A)FrziR#YTWolE_pM`9nDzQ;r1#+Mm-1hW zsUH;5o0OU;@Sv=?X=!4Te%C6iZ5^6K=9YH^Hs?Qu^ ztFv;*aloD8ardfap+dWyGV~plZefGZ>QnU3KuFrk=^>1N6pjDG)-@MTL?m6onBTMT zr4`Y>O0k##xdn`JiF+8FLGdl31AQ5n!o}6RakD^Zk@ae%(o7(jblr7$l~U^IFbbQC z&!r%KN9U?g>P4NH<9F@Kmu1@g>At5_@6>H%^wu;a%rKE169x6g?JYm-2(Lx>Q~Fz4 zEQGZT;_w~28AQ4bMOn(JquLHcTi@>t0~F3BiGtE`KZGF`3mv};QLG%qMj7VVoOHKo zoVqSQ#y+(zbxACy>bGtR5qV$?MCA|{uJru6s-c55m+eNDQu0^0y8#w195xHQjzKxU zMtgCa%AQKHhB{TZ#A&JSg;bK5``=E z-CSU9wwMP^iJ?j!FF=9SAG8pj)cA* zgeK6P^PzM}R_I5SAcI)#w5>3|m#MYzfFxE?5uOb)lYrxkh;T@BQQJA3)$HgVk#pEFt>?~~`oFd>h-tR-%puO3Bt>uG^Uw&%m z1Z`P>0)n zE%@lejD|6`O;N4E-Jcn!K|KrIbow$>aUYWcNE-kp`4>Z zlUO|e6QJ%v1!w2Q)|{Q2`=I0YO~|CXrL_>G5v?Cbb$U(&`qw@K2_525)!BO~(O(4_ z{92BG@H=}pB7-mXD@SR*v$dU2CF9ki(E!YE|0ow-1VOkeVKqAXiz141&?2 zaIprru1*i3Y(X3nuT+u5H3sFrCjw#6kr=HwbFQZ8yn-l+mct*1?lFUC(xDhzG~UNx zEYLAaAfbI!x1Bmt5Zee#6l2<}4sT@zLrf?RALl>baFjtj(9l%NqN}YU)go(=dkVLb z@MWQL$IX{LQ5nbDDAaRW#s=-!qLovQjL9B7U!+bJFU-|Q|Kpi`fl@=8inT&xSV()#bLolg|*NbCvZW7DEVJi#M8Rb4;W=YY^CZnAA$=tA? zSykDc-a^J;cBqsS?{S&v!V6}|yz30X-wSsZw++d#l=`Dl7uNs%4{7@MUO+SY0Y~PJ zn}ka&&qG_G+D#zrjp9@X8T6ry1r8u**}P(Oh;@O=O23nG2@#+G;p`=|`}|3D1CT5M z2ys7ea&quh93{Tx`0Y>8qD&nn6VN35eSO@;Www@{&S535xMUS&=iYRVp5bZF*y$sv zlV`v7=mzprVOFxrC5aRUNIY*e*>}9UwHWxT!V&YguAYJQB%7I3pwkF6#MKu^h|G~T zli3&0mc1-fq#xdzWW>YB#v2;#ir3k+ZyizjH2R;M)(+f%JB)#fP)mDJIt44x6$HOqKmt&I*qkvixWJls~-ElQPK?bye2 zP3j~^oy)KTe31ZP;pb7hrK^n?n22~Y1BkTijpwF68NhEmfvN09 zXKAnasa`N;I#R%n*WZ99c5}gt-+%$@lKvzLe-m=TaMxn*HXYCGSAa$i7gnKco# ztZJGcGdY~$v5iIk+9WhaLDFXlzAi;tqi*^abp@`?wR!Uw;1~ChJ^~2f)fU%|O-l#w z5ZEDr7WfIC6gtg_3@Our^x5-9+?3PgipRM z-}(s})~`9loczFgqvQp(4_Wha1eeSlsc3asgvY>&9W4Ng@8hEzK&}Z0n3d&kiQjkX z&|=VPecD1k^lRT@{MTnqE68GOQ)TNxFk==$viuYUbg$XpqS*Y5C~X!Zn@vV?K<#jV z4}pkA1SMx9Gm`dzdLiqM{0D%xNqHxfuuw2$1#AbnH^2Tge&bx=(F20wZ!Mc~Ujp88 z;&`g>flmgScZ82eUo#!6{P*UVKU2De=7CY2r(I{D@7ZAVGyw{Ko}SXe33ycu{&4g0 z0gkKXj)y;p8RnodVH7TFn)RaH$VM0iMj!qeF&ibt$r8eWxL_5-u;<0Bd-)qD@gNgo zsAA|PTz91{fWC=EshVe**oXZs;53mCH4DPnYKcg9Zrh+*f+zfzmvo>yNqL%@9MF*{ z9`M()0`liimFJWD4~W}F0)J%i0;9WhborCt%STLKsijY41rmx0F^NG~q_b8J*4Jd< z?s*tgmF&)NunM%n;yKY8ZEQDz)KxCyfX~j0!~cyYkZm$f&W6!IRNC#+OA~N{qJz zG1dFZih(RiFRi-V#YZf5+6qz(0yP?d2ez!keN9k|M)G7+e@A9Xh}s9f65 z5VFkF3T{bqNe#0GdmD9G_Sh62Xvec*1odc7mBxTc88aAyN;z57t zpA(z-CU@n6f6TEP$zD~YKK?98WF)sOn-;LLSw2uA8=Tc%Ez&9LQN^LbUsMBa_IlPQ zh37j#p!GveGMRJpr#6?S^j}ead9GWI5s3jQ_Q#+xOJfU8ScDLAKZ_322r`SzjuW|7 zv{Y@FQ;Xx{f3?&fBd1_N*W}(r&;BJ(cD%<>%1fwxe!2}Me0_>k?jGxn2+|S6Ad;Ar zqKva6VmdTX4Cy?62SZT`IAz($WS5Xi$tTPFqN-&+Pt!@QfO3v$iT|v$ql;3kbocR@ zjP9K}x(687d|NRaMyC$i?Q$jrL_5-o&F-iW#Uabl8}w-3b32NmvsAM6fummPmAj9j z>iWK5$7yODS_=DBO3Tt3d159;sp_%qJHQo_Xngp)S<=A3VEi`uJJ2wdIs<)K#Zsj< za-ZJhU+U43scUN2l9sk1v78x+4J{j!VOHw&OONhBBVkb)_mRkO-}Q+qK6Yw6sqi>;H*8q+-6|{>)NBM+EuT zF)d6At#K+iyL9_drNWHtaFE01BvF!7LF)dj&~i5$2~!efF*-?1>)4cH_u^jf?2S0| z$EShE+5rh6n3W!#A|5+7{6=`sf0WAibQ9KE-W^y-FEO-mFCGB~(VGezF8O>15999h z`~pz0MJY&-Kg1X%-yimdt#zI`H&f83p72r8`ug}ax zdIX+dPuGYH5#7Iu?JJL|g;%&ed}TY+F=w;j=*BZQfEGHIA;Y_@i#!W#|C4-CUx`gBX(Ft(h?+b0MFMcw#g_Zs#ApMZ$h5 zn7sV>qbdnZ8XIgICf|(;O}I*|i#VO9kn`)3%Of{zEWM-zY`B+bAPlp!nD>qZw1^`T z)xWdSZy@AL(%Fi#%E`avSDm0E?_JubZPhu=r}{elV;<`Cj6`^{iA-vto7@{F&xa)~_NWUxD3F^ffWHmqc#W#jRZ`Fsj%~WB0L` zZUo^|w;fBWU6$6@&KoSI3JLMt#137B0ZDniGuNqGzL>-s1QvQ`F7lufE3JLy=a&o< zv_MbNItNNyWsE>;rUY`c8F}kA$=hs&+a8nZNvjsn!7R$=#mv>DTc|kYtl3lmvUlP8 zp(M;-zB9X=#>0h7roKyu4hfUq*dwW6iYbW$tD|d>87>Py1s7xjRcF5Rixjz?f zPI?>qXg?KBLN(N5uGEHoWtq1s8~S&7k`763kDMqOLphClD(&~|mlUqfU8+nr+5ozG6?J7s7Q8BM|xp96rWf z2UAl7)+OgQNN`reN?-vp*i;-5{*Q^^bG^R9Ea@fNAZmZ=o-_j zmnt2uwO%)huh%pLSPG0v)P15jU*(6=b|(Eqf-iX-Ijj}=q{)AO29KBW@06->uPI`M zR{q^sQ2>mt=Pn?RZtLVod{|+tHF9~AP4-xc0=>Ycjio4;#2Zv?nm2IpA6^M?wY2Up z@HDt`8CY~^j5h|3*v-G=V6ky$hL5+K0@^+^P-g{28EhOobG1nY{9Hc}%Ml&{0e3=p z0+R$0B_@iC$YE0D5l)ZNvZjX%#s|pJX3FSr`TA(rVu%n!U~r;Bd_NR3pU7R;N`o_S7>8eQcsFEQUaX9bsKK70MP46N zGDvM!KOo-OTpz;)ME}(z+da@2jfpS^f1|x*QmB}K!6;vN$Co>sW!J;+*zDT&S-bPF z8D}62vU9NkE#C>A!?Dq4X4L#9DU!w7#dm3KzkJu!lWNqdgZ*!+3tEbhrHN8yi6LBp zmlAxlLHePMYNdZvUQH4~o0`?n8zQ-eTopBW%Fkf2%0wo2K`ooaNz=U69cKJ|xrr+b z1M@6awk4_%l{KxBgJk@u+hNjcY1wCEkCr_}a{+_weg+7Uc!5b8$x}Qz5bKtPwi#uZ z0K>T!k5G$Qz&NzyeoaT$OV+I5Cj)tbsWNWG+zDBGd59g?VlL_XLBy*h_MJt_@pmPCJ;l%5tpH0xZ`R<-JLRHc&Bvt|4 z*$lomuBPUEBpreU=f#CjE2cw`l#)TP)g9>&OzRIy+d{c}4q>*eK~Wc1H+zm%e#5Xl z)MndV$)4(-RFozbG6sIGUPYqPq%@9|lKl9M(mX6#2Q-d195qpMb8tvuFEN({8((Jd zo&oh5bQv;N!{rE7RbQtZP5K|Y4lQ^oMP~b^pa>`o9c5~i8wA|oGn(9CMu3Lm`nk3h z;|&q47E5I%#<}kq58LvAvbF>d{kXR>84Q~r8|AD=jJmNKkbOz`t1nmT#L8;P$v!`e zh$;<+cT*Tg7d09+#oEk6&_lA&T;CVdp$L)zz{9dOBTk#mo^$@brKmE&tQ>TNI}mBv1tw}1YePA zbMn?Mp3GSH$5EM;3m6j>lsn48^VSm$k9#0JW?gW&c(|JwFXzICmX^@Z)Z!oS7?6^= zGc$CdGL?;OqS=4c3pPCXu;V%7efsnsw_LpX0f7Yr#v7%Ph4ttuthfXFPEwP){-9ES z8%#uMk6fg8x9!Rexd%RBq^p>CuqN}r_V7XS*}$nLSh0AF5IKr7E{UwQ?`N%5tPYf% z0OV<6ID3lR`LdF`r5j`YorBvAOzP+i-9o4`^UJUI;r)HPWLRJz??Iq^iI(*gDSK;U zW5bGl=*-W!=_*5x3!PCbZm*QqoT#8}VnUz&=e`p+Q9}FH)t^7)oyxUW#qjK{ZH$m? zi>3|XSs4m`Pho<_?05iDhjc#SKYt#gHfq9Lrt9=$&`auOJzAMYdso&->^76U7?RJG z{?+99$Ymnm7V|G62>U^EaV9*OR{>F|qceJ4?%0r!Vbl|ROOF&N{BO;@#lStZ((;!rFTZ}WM!vM~sO_Z2KG+bwSR-R9^hWb&5! zVg@e>)@0A$KP=o7C77n|Ta9v~^kU1SFAXJK^%xz(Qam>w4Mu>^P_>|AX5$b2U~8}u z%n}62sm1OpBvz;B+%O0mh5oNochrbL-jjVNfFdNEL)lemLDHD}@bWU=bl}Aw;OA#X zFL0kALH@&3Ch;6*K&YhQ1Z=}eYi%L==DNgFL!)Qadt(++*cGf0C!I!`T10P}ac{Y| z8IIE#t(e2=pY*Mg`;>LWq#X}PsoKZ}(vf!-V>n=JROc%X_mN=mIZe=8+uKp#^0|~c zRIV=-b_TW0u(67(1TmZ<`$#fW;>~tk; z(9Bgnm)H~&DZQXXl~M-i2=RaHVE#|Z`qW0G9w}4QK`qS+a&J17DPBH$VJdm|2#iGO ztkX?mEWFXK*jRaS1l4|%0;OOuwO(-Z(uN$MsbOYrjg}%z87(1p@Yd+L@c#0oqHqPt zQQBV48>__>l#RtTzE*7zOIEP58q$yOwN!)|_b~WZ&pKcd;y#0`6c=rGo71C>6ROGT zEtu^(SHc!=$q+(_TgEa)hl5$=hsFL5ARa|9;@9Cr-TVT+z;+P&X0{ECP54rnZq zl@d8h2z<{!w{@G+Ynr?-Dr6y#6q-0e50#;Yb$N6_CSK=a7|T_EemCO?ahHvLgl%Xm ziY5v73}%-y{_C*w9p)JsHYzT0;%}lzjSIihczTRAabCVo#(6Y(wy;VlDrK!?HKSUgc@NRCNo$R)6(iy<&IGZ>@^I6& z^%%S{Sq36OqHL59&#%PF;>@BnENIM-U))GojN~Ik2v7i63FwUgPceAnNIx$xX3Fz) z`$gTje^#ZdaEYrLM3{5kV%@(qX|2k+u23>X_BEh9RdW5#?to0+PQ7%wUT6td)&Y}7 zBQADWY-t{Q5>4^!9Q&J;i7+*6G+z4e3Rgk(jSU;afEB=mSqMUT=MKSnolVNqbrQBw z2@5oaa3txX8KTOO^J2cXNM8gB<>BhZ(|;O~lY&4X3Kp@Yx|)8KO$t9t@tf~@k|Z%G zw>q0((hu;Ng8ck-*r}R1cA5zXCVfB8jAbdr~q|U3Nu>s;jHd z++zMk8B9v&RK?%OC7v{GC-@bI%&ay@mLedtIuH;I-6Pi%N~Lrh1yLuRrA{oa^ti`X820|!=g%I{4e)=X!cQ8M0gg!6e<}i!wYj`fnsWK+8IR>!BtA{ zox@t>YI5GadN_qN++@fyzs#cAyz+=04f!_Gq?zqb-byo7EKvydB6V6ZWgS{0h6Y<> zb+7T`28$%0lN2`ounuxEJYdTq*C77X#U#<6FPuymx@<(!|K$?%e#%RZbPHBsoy#`g__j=Aq2M!pGKN;;ti9zH98qAO!G+i)zfoIS)0sx6wB@?-CbU;} z*kZzYK)%r_*${!$C4-wJWjK}2LBmG-Azb&NS=o^ri17doi*k1MFG+qeqbL_U^?53pA1WhyiBIaFfw8N@b_- zz{@5&+6y-~JxJs5TZZ&`iIZ)6ddCOF$QE6m+`omrWPfqlo&r(oB~!SiSxDl__`@x{ zDy69@JDKoLQr>8dh)^}sYRk04-J#_shl{8-8Qo%)Z8~<{cNMa~vrv#O)yj(O7Hn!b zw^Pi@E#V2_5*USJQUG1PNn#d{ZwJ|A8&@8{)Wb$bB(3`??a0GJQPgZufAa7Ogs%a- zdl9%fcHUQ!hh#t9McF^-*g0C7IM{SrYrs&V!YMwAfN1%;BT9_s`X+M@2b%=SK8g8@ z@Nuz4IcOLf6F6}VP^9+mG#PXn{Cs@mm{IRq$-*H>f@#NI{J)wR+MTd%29yRWC_uLP+X4HK>m%tzh`C;t*!bs5S^O_deT|4SnQCV!}d zz}13D#+MD53u2g35?Gd$v=`~#vRT-j-@^|N@6V^qA3t=uvv7b)gyciHySRvE=kMlo zO(+enfHkdmI5uw>v9sN`r1GzY8)px@M#*W|KGGIYQp@)n)N|z^78H-twsG{)_3StR zOxBO8;6Y((Y10#8@)A>A%Y~>{e$iHBL4<-(P-aKmHi7 zYz}4pM_#g!kVTPaizb!-RY$oH=Al#e#OW8Z8v-n%%BihzIrgO9yc&Nq>FJ6`=kaL~ z)P-o4C~w%Ic^U(|&SEka)^y#h9b%c#@x&gDe#GPv;?9lK4@3=w^>9gUR0JKlYfkS{8g%Kasj{xv)_&o|(Zj=V8|)|FHkezWRKv2#fED$yw~ z|6ZE!FnYj(U@=PVcq|&Jl2^7>m5jG0Fo}@mLUPm^VisbN1i2MzBxgUL{%jQ`eG^Xd zf<{`qznjhvZO&62dD;nH3rQn`FK2cFNW*XiH*e83bmK@P6&3XHw{*sj6$+H>qFg4y zqy|3Yh+}Q6vK$ksXM%k;`o<=)@W(55ZqAg$1|#zpJP7=l^RJ^>C{m*m$A=^wW>iRfOQPMgFK%EP5xr_Wi#krR-qx_F+~3;odUdb5VidvxS9)r6oK= z9Hy^btdL2PrGA8A;H_`YX)=}80Lc{?>Adt5SZ!#PPn>1c+G=t<``Wr*SD`oebc73+ zLs+cZ4IGTL_`*7_;4pePJkg5Ku@iP&s@vPR*pMjZ7X5%&)e%} zqRUt>?Ur|GhS?`uSO3HAAx|f^)hZHKlwDu;h4fBQZuwO@22E9GH6AwugZ`Wp(zRX5|`t(b{c zQO+NB>W35$>p9lVH&c3$(raW|Bc=5x5Oex_qjgy@v)Z{Kx4e{^_E+498xqW$=xQ+Y|N!jF0_}rYT!>+iAzVknDLwHDJpHXOi-$>8T%43UjQQP0l*)uu0$ zyLH6ogAFP0N)bmPH+3J)-)%!o#a)g{uZIHnY4ga-voMkMi!>V8Xn>GWWH`!V^62c@MU4r14en4rnGc6JFq^7rN@zCKXrp-iso>FV0&MpCu~1pSGF`GHwEo2*G- z330?mIJ&-03dO2oor$1q`BgnYGx)+OP4^Dx52)zn-mY7@>UGlQ2cwBMWvVm#J7!H| zNh$ce9zhb=g8W3>r;cswz~u?J=f6J{yg&Vi1pwl%EchsrR6nJ}*Fx&$(kYW|!1EW% z>joGUfunPs*CY$qzeSNzyVmTzdxA)^>V`4SeKF(KoJ$?#bfN9E#aywKt8pu4KP3Ls zsnf1qNOUw~`W7UXLc^$Yd&N$|6@IY;2e@s=hCsPeba`ns$IkOZ&b;Qdv2E(IaHeB1 zF(~*LK){nHCr;qI3&PJ(mDkFG=lNh%dQAHhXkpc3i=TyZN-riHZygH$jiC}o2&Cv& zS;`f_ew>RRhNfFg@opE~Vn3n`g-ti_+V7-tap-bYH^i~KuL#U{yjOW~tGo3ty~Kpm zwEa=AjXyiKgFeg-iK_QXbejZ8MiHb#C(biLaO7lGohEoskS6Z? zjVq1Nd2nwb9z#CW+6CyiRuX1AkqK9l@K+-%@F4=?%#z>_r!xRF&&lb@9k#~z+extp zYsK3Bf!+GwP?E0LwCFm1@(q%5E!EvT(U`;7GSGA?rz?A;1H0~VRk~Dh0AgTWB4MBw{i=<^Y|)_e_FdBPvfnadDFUa8iuLF;BkV$mXJ z*)vHEr6BV;jFR>l`XR^H8zu>8M1yB}E@4wo`7|$$jL^Dc4XT!0L6@jK?(a#=RqhPj zEMv0My`tb_oS*ZbtCb5sQkznwp@}`q(R9j&5m(OR#v^BhCV=x!M_wH<)&Qt_#{rG*?RGkxrR`B(T7mpUfQYe;kNh}#mm z2EI6PRzZ^!X;ve?&rK}f@I*JWKX{RqhpDk2OtP!W!dGi5r709OVS+oqE3MewqS{{) zmkr?#>4HRC_#vj5|?4{l8$OO3Jdua^BmSF=F%7|I-P%vNWk+e303VX|ZK1@)g_cC`LzAN@Lz z$BL*dnTy1s%vEMUy%cu+-S!>HRT}mw09|c|8Eg8>s8dby8jXnf#mvtK*yx1KJ>WwB=ki$3C3Pw ze_#A34M(f@yOKQ-6Nc@oF|67I`E@AY0y><#Qs!rlJj}?KerHpg{qu7)vt)=HH2}fw z_)@Pb4LbgYV?(h9hb3a8MLkYBWxhmd5d(^IM^2AG5&G>d2!Mg}r!0Z;@?1Q0;Y|Bk z))Ns-doki5*TfSj&IpMs%+vBkp&eMfM`EavFD&>mBO@}<7&uAQ<)8cl0t}h)Ymu%g zRkJ@#!7gnphhh?%53k`Xb(3Y;e0+-AkQlQ_m6G{w6a>9-t<2AH@~6qkWSAnJdc~UN5JZsM}CC-&}CgTttkYS zeU20*F)W%{E=KyS!H{Lpnr^`IJ$@6xA87N`bbV>81Gy&SZa zYGzI^oC1AIS!)#7;m#Y`2h1x#?YpWc`oo7;$bnnLL8QmGrS&z@gDanX296llIwB&H zzyv*OfG8HaIWsIQE;I_9L6eNl^;#iz?5Q6 zU|aGb3`vz&+dT36GLGBV<=%^_ON2aYYaS&!E>V>Jxq4bgBk?H%Q51WG85Y7Zwv0q) z{%Q~{T^IAQ@n$tmmM;p|u$Gqe2)UK5hF;8L-*H|}osMGBP=rnwjiEc?LRFd&RyC}d zMKPs44kf$2H{7Ow<*chs-KCR4NCByTAQ(zuB2Q-lzdiJ=h+C+7jx~2!4bCT5m%qq8 zIZ4lMNd<&%vpCfCD`E{#tR@QRIb46$kj*46V;4@;8Ks#I+H%D!l`KE5>1nqU_04!& zzM;{7F6g>v3qvz(w>BwW$$W7kVh;{dV@-K0N>}K>tu>Wst@5qG0lg;@P|W*$wv}h- zWntAvs(ZXdi2kYpNyX>Ae50tvI^)40;u+%2w?Rhz&K#tyU#tmwYs(Z$cF#_I$f;|; z;^a-(rzP;iW7IQ*m2yz%T7r(W!bnHlNY0KPOqfyH7@pt?FA^J&VfWz>YIdPMtPWJZ=O9!lq({2G6^zX2T|&JFZ-h=&}Mc zM9YB_ml5Oa&O%)@%|(^%WA5Z?MN_cQ(cKxCUjiHagUkR70!vbvRsfs`G{2Byno>{0D_%4 zzkbBJ_+dxJ&FKOkKBlW~<4?TkMI4FAh&}nT_wnJ#bp6`9>&y2w`58)fe|v~SKYYU(jMMv1D`sXyI+JG|LxBoL--t_RZ?UmMep`ghk3PL zkPy`ww)0mMn(LoN(f)b9e}`yGa14tYcyPyNGF_d*6;xG6o*!(I>; zEEOtJqdZ#6QVI)zIXN>(B4x6-HGtXBj&+bu!;N%00~?frS>`4!JCGL0Y4wOM@$EZ% zrfa4!EMM4gTkt$5;Dzl(IsvBRI*VS*DZBf=)+lQ`#j5{|kfXTNE%GFb3y5+Xd>kbK3wEHN-EoXzr3R;Yd zGosH_Xj7Kysgw3eFmu#-ECs2nMvDauxeekWMk&uIH@Zq9%G?7(Y(mMg)ju@4hPE+DYbZ{wh?b6Q6 z$t*CbAny(ST!f?7#nI8F>Wi(DOvLio6qUzm`H@sgg{^4YYxC)92#VoiRyVBNBs*Hb z-Wva$g7{7Y^{F~(6!cO7m8J_TU%Q%oqb4a;%fu;)4Q@QZ!3_yYmJN*xM&?%oLA+a& z(u1K9Wd)Of?f;hrUY2^L*WG7fyD{8e1@KW*884!CqQl-*i&L0kQ3^&ezd}HfeWhC! zQH#&K`>_WZv(bLTr95Ah&M#s!|I`#}B@N!T?6Io1mX+}xvgi$r(t}axxulB@z z8S?!7o&n&H7Ey`qjeE#n6U{>=?$FY5R!%%)`8lf9l_(pTR4$e?Cy!2oww|;g_^Q$@ z(V03)KLW=S3Uj11<>ppQ&(w8gv}F7q=Q(R#<+_&$g^FBl+*#-{nlQOt-F%O_{O;CE zY#a-LD4O`i-z;}Qb(%?1;3IVf#)PS<=&>JRezV9jr~ei`^e4D6Ex62Bve~^tZIZ(9M~QXvo4Ma+XDV!+CE4H+Z|uSltz#GCspI8^ zS^ga}>E@^ZoQ$tQ^9u>mk5Xk$&>-nMztv(1DX7=954|>0A}t)Vew_cAIc|*S=u*`@ zjoiqmGgO+e*c?Sm>r@G9$58*pIO51vv~MI!7cWhHNOKl8617N0YR`%-txETK+Ju)z zxLyU>#;)I#&UdtwdH}E;RHXx9Pe29|d<=Ha;eZK<)RDDLtLw~_k8R%XZd*-jg4BT(V$%0t7ouypu_fv~-vxyTEM!~@}$6cyb4 z0_}9us~ad&JJFNWMH=`K-u$_{=jUqM+-(zL$Dd!gC>JS)b!-TLw;qj35}I^nlx_J? z5}H~IUjf_U;@N-LbKqIaQ?3AVF2L?~;g@y~#LEMFw(NO4DTt4DcXxr2M2I4%9gYQ~ zip@ms1Er%H5y4}f<~ntMeeZVPntY^#&w_YPisa!WTKu)io(Nk!CfWWmm?&YS_F>Mh zjOhM*QeuK1qTEO@zV`?llO_2_67-_jtIkbF{=DQFS`X!kY(+XA)-SPzYO8LhJAmv5 zJ>ZcIbdc~s?E^pvyoYV ziwqj+2>lvt7TKQIo5Ea^{Pd7X-HGJ*a~6rv%=3(wfz2Zw_w2VW?-BVjZ*W;&pK-4| zp%F(5e~h$uP`ymjxu*bdmk%@>8j9YR)+HL!WgU}ECre291N@5xoLAoMA8YqaCxPV_ zmh#@}GG$m^OXZ(xtV>K8r;wBe5=OF-L2XgVyl2YI^aqQhgBYi#>rLr1BnQ%1Ewgsmy)Xy*SpbZ zQ65d5Vo*I7nM1Z$-KHIw1mjwoFzzmF_<~{ zpz^Y(6hso*#f*4fmfB)29}n71Tpv;*9^npX2w(54WexWA_=QHa;lSgV1iB#g~PW9TVG zeEvDtg8z_%kRpeLTM0IR;D?F)XNqpnVro%jl5Khth}sN)6G{{TQ3f`o`+c;0jVqHD zu@M8tddCfV+0Vyk$F8lzvl2=Jj57C$EoK}UN%T>L8(of8xD~QYB z7t3u~U*jhqBaX)iFgI&sBwnZ2vs50lg2S5kaYX5_7g?oFHJdDaV~xj(%Vx6;v%&Q@ z-k(cOEJ8$Fwlk~25>`cC>(RSycM1ZH-?WYsr+U29N6C`ca0@I-ShHfz4sf;hMyK`T zKTdOx;v^k1kZ^co%fXVb(!?+C!tmY|n$>{kgC`9waC9krk}x(M+W@hfZN+8W^TPSg zhKOSuuBBA2qX`jLg?qbL0Xb#yPWWwHU)d%zF|oOEmZjNT2e|bEU-46o0FEMd#4MjP zGaVDpzQZFsC~*<^iqE+eX`*!GrZbUDMmJ$_Sz%8>#$fCKP?rzqALLYuhy2lQiP*+w zv+{sLnmGaR=p|a4eGm}X0IopPUW2d7Ixo}GDL*zuG-^A$Y5-$sdRe~d(M)spO# zk*l{M4F+1xNiHt2-ZPswS$1B~vV54J%`N)_`&SS-WH5+}vpM?QnLlH`Y=;aJqo(LD zw5wY7*y{c=@oP~jAu&=G+?OEI!{~mOZRmhY);!tVBwh1Sw*Qn=r|xauv<4`ihT*yY zUVpO)Z0D31TScvTK0AaKm8~}H`;%!j>7*rK+dtmt!OV~7s)gjV&>W8G`A*7`!4Iv2 zB*F9{I6T7AYXjEEpiV4b5CR1oSAjB&+BMKMsUFu%fNshuzQH-ep+2nKfli-%k=@D`U?ZO9VLAvvnB4lHrT|CURCx%Iz*c@5~#tbPhI-Xfq}wViuS(5MC-c- zBI^Cm46t#un_{=u6n^>|%4#H$_uusp8DMC2)>#pe^F@XYah3rD2JSL8vtr&7ub6sx zuuX@k_MAYy24UiXqoD$Ycqj^aby!|qPI{@3d_gFZ5W9H{%HRv;)egzeaEeF70RM$* z6T&JTd26;g1I-^k5Ng+tx;|l19 z{z040$Ai#w9Fdp8xW2UFRr;mNMx5~G@dm+W^GMqNjH)CySYpPabaH94Hlg3s`9h-z zQ=C1Bm-#!^0HTq&=@?;>*FF(r6JVk#IfVWelB;!>G3|={%>*l)E(>evre7?P6EVe5 zoAQj7A@CRDC0Vt?dkPd?`A%GReWGP?S)x1@1xk(er%g)EQj#In5fdq7XelzOuqqY; z?)UR+WYX#n13X!!8fT(u+ydNa;(r*iX~7--Kg%lRGu2z_rFqzsEwR<|)mMFVBTFZ@ zt)dKF@aa0$zn!R)Mp~=v_C+@)3S_?7iK6bRW-_Z+(J&Aw?QGWW8bVp52a8s3sYu$2 zKwGy_N0sL0X^E=dz(QEWG&+O3a{7?;mc=cz(@3%U{WVFo61yR7uwAs zS|)6pbStVcGKoFWtuM;mEYN$nx)>uPRPemmF6{EGPsMFZbIOZO5c($VVJ5 zx*EDhCDCKk2Y-M`-sEr#;EQ%LW0q_^e0(~-e1GDmN(SusbEWI6E0f=R{_?uD^D#R! z`B-6>oRM3lurcAE&1(rLdzqZku_=ywJif{>;_Uvpe+Cki3&yLG2~-z6T9yMjhPTt| zEEaKtB+{jC1$A8O0rc+XA|6EuS$D zN<2NbL--NS$OwEz@?|LkfyNu4N@0hWt0GcnKun`s&&S2358wVb`xQPX1w>!2QQxdp zdZD+TTmAOTKwb>ef)EY(|oP*8ZFQ?X_rZp?iCsG?wH0(t6b zQu3aQvnJPwh>XKI!8af)tmzX7Z?=VQS2edxM?D<)YsA61o(nkZe7;c%jq83Qxs>Ss zQqaHq{OsFd0Q5GS$jzv?u`nP34PS?SfzCfnCzZc;Ze7l;Ko%=jqnqZc#P4pLLf4T9 z>{Ro}r?{4u{j`EV1E$&M=j=9eGIH{$;?z(!r-TtR zgRu{II*@@*(P3>tiUm|YD4VwR4l`1sN8dho{sT8^T=Bt>AzsDUCEVrH$LT)Hra9=! zDvL-WvN0F#2(fFh)M|NdUtunOU|f(??oU`u$1sm&S(IRF9k?V-iU?{w5bHCX z?_A!}pDjI}^knsw%d0+G4~s0tKmq=Rk!pCDCX^5H{=hQJEVDHun)WM zDypmNKts{EqXN8Dz@35rPjGO$4(k+ROGEoqh-al7UU&_~2 z?TY=`Ouef)h4Vs1a`Z{XZ;Ol>*7CS~{;42VJ}hWzn3-voJtC^8^bUo8I0qcOdBOC` z^9}MC5SnEwvty6}z7_P;(UDa$ z0Wi*7igGr3r^51~Op`#cQaBRC5AFO8H-HT9mJwhgS>Q{imW>pQ&8dsok;PB8|1V}; zFeJBT9xuz170cBSle>S$D+ZT4DFv9p>b-7ucl*0|e6(nfC@e)-WXo44!DB`YesnNm zQufqMCWqRp`FV0lIq)CBif^Nq&>3eLchH^vW$EiSRkU`?Jc?(){hjz*mc;?4A*6QAti^4T#wW6N%NSo=a~fk!12adZK#>;uvr0y+7fk_#hQX+X96#Ecqy9FV1-NNPwYc$ySie4Mh#m8jRk63?E6iq{eOz zRAj^?s~0%omD04Pg!Cg;zsQ6uHxweaYou6{;n#PEp7(h#f9q_PD|^4AuGDkSKa9X~ zn=5@Q$j7(C{ULt5uc!9`lp7QF;=jt5BXU01ju*%N9~JoWZ_3!2~hQEXXDY7Y*u1Rt;$tl2*R$NVpu z-oCy!npEgu)1L^Q4ibk`Z>5*h?)g@ELAW97uJ?$N&QL6)nk|8256M7{v-KB8utTHq zgRB#L0M!=#fhR75n_iT_QjxrHG2IB&kqn!M`&TLM(-E=lL2f%4Dea4ot~FBn^D_;% z7c-M{UYzypAFr#{eb}v6+d|`ULH_&fyzC@OshzL5#`5|WD{lx2E9>+LE2!{sV(9H~ry6c)z&Lpv?AbeYi?C2X#Bt6JAAU7=Z)IKhoo zPl>Rl&g7wqEvH*NnI~C_)Scn!uiM`q|1sH5KHp%GDoLN0RByFqG>;bC746rmqEFjF zgIex1Oan$0H~wezfW(=L`%iQbi|T_wkR)}#_Te#QG7QLCU88ES;YtQX>%S7f=s_cZ zH1DTc)ACMfyJ*_%$w_lF(-`7DJ~^-^_+`3KD;#z<=4+Rw@hH`Yc3!zbD5fWzZ zq+Wy|tl6V4?F$U*kkq1jM>dO$n_1*VToRqg@1gM%EY~Wjm59G6@!sRbgv?{`jfu-1 zf-)IAe7q2kO-@;&bZ)-FIgeTs)s(4OrBQn*?h*c2oYD{bm2k@fE3(M{>xWc6YLO(X zwNFgAhP-gV+5kgcbkByt9xZdqh-m3UjZl{uzcmnt^M?N zb#?Xgo5)#lztR0vhOKSkE_bW`2~1%go$aov1oO+LG!N-!$9Z%wbInA3rew|=LKzJla%)Lpiv}InA_vtb#G;?oF_gj@Xv079Yt-RqIJZ8|w@+fBn>GFtV1;d!TE z@bE$qJFZ`YoDj9d^q*B$hr7elInje5m)6fsNgI}tw0TaTuI}z^%L6S8l2b5~4YG+| z?uR432Uw<{y(G3{xNcoNeW638M&_Wa0JWRyt_ujM?Ayg(znj=5K#nCL<%II%2BiHuJ;ll&mLP7rN|-r};Eh-@J4oepf#2F&<@ z>yYyCHs___FYdwxMgWi3vvbXUSf1v!D<*F>PPX2yWWkIb+A=HR+a!#$zb>rD>VqR) zeP%FWtIfhXJ6Te$;rEr$l&!(TIAk<&w^qs$aKx3jZ0bC=Q*LyLgd6tpE@nerv;Bc5 zl6DV)6(6S8w7DyHg{k(8M932BoV>|{S-%{niK}!qzX&?7_!z$pKF5uAzw&46p2Yr5 z&wtzNDKR#(UdV|C@j>qae7=JpzqF)M3&B99FOt6KN17EXEbHfiS`PtgLi-ZVmYfV_ zf_a9A2*N<*S1S+v`5f!s)NyIY4V@a~Mv-$BnFz3@Ox!G)63Rq29`psiFnqu^%{|5#5SQ&3KAPaJ_1TdX=SJ ze&#X~L;H4e&{T+}f_jQlu#$lBrvOSX_@T-8)a4g+{2_iiGp={2TX?D@g!Cb`4z+;i zhvadnhRf)9a4Wnxydr(x9?F3=hQXppIIhPD&xz)FUf?ds-g7`q5=7r^XXOy7zS;^f z-C&~%QDE7zs`1>2DtQ=eX^AhILZ?SStY}KjUZhE}+m41gqQljvnCs`>&#WWLuw(cr zg#^libP&T7g^L~0SI`9fm@b;}_DAIb2(FT3P+3gM!mD67o1{;1F$M2Ij+>=4Yqf$#-m%0=zoO z{?{RaHA{>_IUao6kgAx@p|pY%5_J>uGL63x90&UHvUZ!XJm3e zXwc6Tqqv3E_&xbkj;);NteEQq{_}A?X}HCl-SY(5ou+fsf{T**Jlyy_3=OSmn+I`| zJB8PgGTjXld#wda6_8Co?ZG_1c806XGbMY4g9lu=23c&A3)!f!JUUu(L-X=N)WIxng1R~J zrB5mIKf1aEg@o=|Fa@N8t$2}d1Txk5I2%iMrjfzmHmxcdkr4G!G7>ETro*Q3`$$39exd* zi9weXj_)l3ei`5%)_T&PNw&BxZS%WWqb0dnKr((HQbEv;ef{-@Ct=u% zXn>K9e?JEj(k}X2%1C13EaGU5zpMi0@5EPZHG!ZmI1R@%G+R&TT`y>sHOUa!3ftm) z4G`Kor-|ni=2xshW|JGLqybjXlujE2h14DI?W6tUg^~#G4}aD&ak51HKWFu$xMk44 zzl|UU+}}B@g3QltS9V|OROc1c3RDKK z(7+{WKqN7x8R4|q|8YWMsaz zG)hxxF3EyX{-81v;gQJdMur+#Qk2yZHb>iE-H6aOPgn}p7Z2!DP5gpz3@h3))Onh5 zo|Y{T9Mz8Pdg}zsr(OF9=HY7uKW1-he#d{$#D4Way@_zX!d>oNjI_<+Pu641#B~j} zLsu|=^o<%KB;K}j_KX&jib%dI#CLO>dBoifx~?+@(1ol$Lv!aJC!B zKjry3DECjp@z3Z)@bWHzEX!DIq3Q6#|D^&=(w~HmC?$TOuCrl2lmM-+fRv(!l#nn# z^TwjPx6#_HmcWPwEzGou}pn`s!W;4j*B+Zhw3k znl9G$CfzzV;ldx-5ps)WMn{kCfil=tM-`rk*XfR+JV~S|y?K(0@~=RM9v~&v(|Q%; zm@I4~4x4rCwX8Wnhi`UPh6nm zs0>quN@kJhQL+La^j=*$PbahrVc({L2cJ*{JVzYFnO86`fq2p{< zB}`Gw0T}#WW4YKQaY#@K6#LdLS}< zSd9yS+2u@GwygsJwzktIqxDayj|Qc_P^p$>|Jq~nIH21M%KZHO4Zg3?pb3RZ9I5AV z(~f7C94S-)ucc;QxAK3lWZt|ajj-a=SPMmAJYG{E>HIHBp9eO9v97sfOBzMzSo;}D zTkLU^%PM2RH4U)PzW|_UL9(V6a+H(-Ktlw|>-I`UhB2^?KN$j!$k9hPMsz5-$`m{5 zB)#7>6e$xc`8IEk=PLrBMB;>zY(qH%)R2#MjI~X!viw1L1xFqk?hn0zhqG1)0eJ)X zq`dDA%ymB_93N129oPpIw3RpOxP{nCy(hTocA6k6Z#eS0aZ&)C_`O#%a$Okc5)=r?btYi01YT1ZcoJ^kci|F$+o%pQ~i461>So75Jw_sPv@pqbUVEM0~ zot@*}6*Z7YNX|*@n;jmC`1w8L-0-;M>&R!(Gn-fGKb}UU$p`PYO#@wPl_%1f6In(Rm{{=Kp7DbO_eE2-883q_E zs^X=*Dq_iLSEDdo0)i$Bn!;NYuX(=)e>89os*jrx`}M|%giWSCoyenPr0Bpz%^NqM zERZUW22Fj5kMA)1E2e+*EBNIdnc;MmKlW!ZQ zb=f66NGl#8`uRXT08hsx-W;ksJKY62PW?M}dSi05bGF|*(1*4T?}i8?8IpO3q!_qbeJKh!wLB%^p9~e|2toTKJEZJgj0Te z^UsNa9B3J*`fXglh|r^-n`?2YO-@uZs53Jr4qo5i6la@y9)Xr|{=8{RE;0%^5wK^4 zhH;VoflHfg&UkAZL!bLgMiI-1_Kc4)2G~b^9&>+}4<{sf)A4AHjf~S6K29(gL0&a% zPh(V^Dia`v7G#_tCoEf>CL6(MgGK&613hVab+UqLn`!W%+f3%HL{ByQOV7g`25!;; zag>T30<#|}1Ur;=7dn@!yCa{oegN1s9V$AcDj)&^L+4Z$B|7VV!GOE&lF^<3F7cjV;cz~dgF-LOO~4NP6k zKQW_!EwD={2~MAg?p?2*_sWKiR4jm71pkC<7{q$oD}0Aj{M<`)P+R$gWNox|eT&z* z8K2_6{O4mlU>P@=iYmkM{A=}Y8#juV~ZvMDn_xMrTozXQr5zN8giPaoY%7*S{h66iUn_emq{&YiBM(R%3x zZ3*sC0$N&fB7BM$9e_#rumiMKc~{8bvue*V2p)tFqhN7E`~H6X@qb=`;r=@=|5XZt zWVJr0)y9S5$>EgvEDPibkqf3U)bU8MfjLJ)WY5ZwDvUV}8gr<(1i=&8Q#T0CHg$~| z!uz=#!+Ez=pp_PEE@8Q zm0yx)geC`G6Abcv)GKS2KamJhVD$ZC7=$BM<*LYO_=szNUNmQk6m0sHCC zPyNqSBcN`rsnRJrv(180<(y2bl@J?liPX+J>}T57$Y$xPa(tqlj^-FlB~lEiC@^zk z3j_D`Z92cDNsxdIey)9~4^xg$IyunYM$~Zr4UT_ERR*eq;MpKL9m4LB&>R)32SP3= zU(i+z4lT2^Nz(W6m7m>&N>Z@4Z7_#2GWfnZxFVxl7U4HjM-5(u*MiL+r$a$%Z5up6 zD0Qa!MJa8c9Q=zim)hq5lBRw#%lra%MrKA$e81su%qV0_pNuHz=vA?4Q<6rTXdEn07?k6D9u^ zY_+Y3&;*km3%_@1%)aW_rb>N1f^HrDYs|dgeJJ8|x=8?&Erm38rF4BXw#kdLU}93p z#b5^L-vMwz?)31!JEqDf^ z%q0AwLxOu@v@$VWSH*5+-F3ZJ`SGS&|2?CuzW@a(fR*d$33$WuSd<*z{d3|bR%>JaK92a^ zWlYzEQ6ZiQMInPJ3D!Lnrm`gxq2MbKhoRkArzVuiRgXwV;l$b+k&vJrcJ+3VR`;6+ zAjK2MIn!>o|NN0>Ql1b7WjwMf!zN>z_w_;e&qcCc8Ozn9oaEdmQ&{B>d!jTy?f_y$ zcp8a3p+My{g)HKe9JV+y48H^fd@faBJHTnvx83|v@OY3qC#R(pMwH8aW9A#h(DZ6z zuuw9jO&+l-8-!RzicJ>=eI#n&Ncv-tm(ND6N{F1judhuUm zYZ{eX0#Kci%SclV3N@53@GIO+$rvZ$%R|rs!>*Jd8(wXlcvR+Ev*dC}IxdC2Q&C~w z#9lNv+znFc?2JB-Vb0GDIk_h3?BAL+9Hi(PE}6s_hcV|A>YCfy)9T6AEZ>7`a~(Qp z&;L;Ua~z8}$3+nNwfskakGCpJb0LKUr&u<~8C7f+8Wc|?3#ycX23;2n0f z0gwu*dYN$9!15P>sLjJ-d5?khNnj>+Fe?7w1gz^%>}-bX5P|3=o}Q;7g0fyn#*KX} z$PqX!p$!$G^l8^zCTLml7_C)#Ks}ELMr<^8oKMoKt~hT~96Y1oLL%H=;|-!cMGor{ zgjK+V&B;HIca7{Xx}nN}UxBM8SZ^lLzmFL&}w9~(flaU?v!}SHWN*Ot|P|sjc#F*lDD59SBaj1*^yjy+;_=jWOMQ@!17i=|N3w1{SDBU|ErGa zd3{*_4@7?AeoEP)C+Fd7x>Qj*ofNssBwkGip+-N`q^#fu1mWDLUUZ|zW}15V5U39J zvBs=le1sBQGHp#cX>)GugwCV9h-U$G2Quivf+xVZ0zCFR*74Gw<4A?-#@VsdQ72r? zZj^8IDM(1q0HrQVadd~ud1AUE0Q-~u%aP*Iq(BOUt7DG^+aFn_KS>e4OLmtl!i4N# z13vV{s*4w3v;7QJHE}ePWq+mi6`Fzdx}67ca}}(%qHrE6pJIdPtVZ||s&u+>Ch#v) zQgDP*9vbxay04#mw&=0E{cST~<;yec+;lZY zFTX|f*p-CR>2M*d=>c)ugO9MsYaQ%)asZFv?_%Hv4IpNE5lzcK@gZ&QnIh(EqG9}M z1RdM*y8H2xBp1?8>Nr!;TO9IRcp65Wm(kSP$2i`gkt4fS?5Hps4> zz}1_vwzy$q^o!rKgZbVf?hllQ?IUWfWTnTar!47_d1`#Ks^Li63L?23OvQV5qRhJ& z!bGyD3q#LQ(Rbq>CD&X!>CS;|Zf8HUn@wh{9rx$-DN8de4-PhCn1%_zWiiWO-voqJTn_s=+$*hh)klOg@6=@t}BS%TN6W99G^cwT4 zOl7qxDUegMjD}73P_^peyB3wG>D3{KUa94UvsB@BSIkvc!ImXLE=p9n4rw{b<>-er z)^cAb#Dj^8WZ092#=EEgxcS4$ zlGy1JouVS0^X8??dQ18dpnvXh3CJ%J?0Lr$seRw0toKgsSgHxtvQc0yJgG$vUIcvS zu!-1GsBhY!++??yRj8T5W5VdFn#N^z=2@&s>bz*g?ANpM+U%yZ;;6^S#0L-w$r}|z z&M>w}KVCIHX9qCk&!>gU*rffCQ1slOC(Uj}WJtsQ_4U*RPGWkuT*9(w6Hi)bl!w+O zK3CK@4p$u+&N+~o6B1Xs{dIRfzv#Y7QDE#>dAmMqQ#AT`|2xz6GBi;yZ10RZO-Zqi zVuhW##OuOF3aO;}S|~;XgOH##%bLVeR9m_S##_RMI6Inm0rNy%zFYXGW-eOgg?sAhI7#20E{O$ibpVd~-N1m}~iD z&8Pb1p&;L-Ve1mu(QI4vSTkt6HcS`mwbbacwv94hIjH5KS3>$S&`2^6`;=cV4DXuu1vNq|?4vUrWR4QZTUGKeC zqklIqc|xZWP6?JC*Rrw^_56V8x?xcaUDdeMt6RJPk8@W_|0v4ZqF7-%8S@gb8*k|_4l6Fcpt1ZP2AXP0W zXd27ciVzyCN_p3n;r=_)C2gXW>vRQ-y`Q9=H@g}z@(hduCs2~6ncTBQ-( z%@`c%llOxQ(n~&MNypiWlIDX#uSx?R(^ht!g;}5IFYVN+4Dx?bkS%77rV9@sT2@T z#%B)6!tH%`oQdhw!gUaVB>qZS^EcFO*N^5bX>)r#loiSRksRMoTNq_9Jjm@{i-=VPDlS}b(~oWb6Izm3sDa) z$oLuHmZI^7!buaWd&MBX*Usd<-l!LW!5VZYpdcZ}1+PRpa%{JT4#36lm8h?wB+(1f zGOK*ML({A2l?`{bt*~S7bP3rJ z>`w@k>~nj8Sq;R~u0ksklx>|Tlpw$kZ%;m5PYj)yGQ;ir}6*UB9iuwSKaFop1@3IeroHqvHH%sJ}E9|9YlBu8mL0Q;NRvzc}frabx zZ_eaT>|tCjdBvjvey9KjlzHXClftp@w^Gx`AAxU;q4|0KxxdcX#{0+(Y`J}G8DO7% z$AhKG!4pHNH(i5HnNs-jpSc4XwR8P)Q(^$*E(Yrtg#pggqt{RQF{AcLg&D1?%ITTs z`P0X_%zISu<9)@#KS`wRpep@hvxuQp_jK!WA&tiAa{M+<*TY>yRU>r_VkipIc zRby0Y)m;(B=Mx|3CJoqXc(R=Ra24h@oq+cccz=A?1!3~zC=~qIlGxl&0)Bjy_cX;- ziV(6sz2er`UNlJo@R`OO8Nlb)s5^0d3+Oyz*Z`YggsX{X@cJ&-UK|*})-F9eXKhlg z`%f_RKX{T1W}>He4Fl(vud~2U0Qnf8#;4}RxaFyDcKIC(#Dp{J-CTAUA{Vok*y>m@ zJa+8A+`Mr6F|$w^Q133+HPA1#a)KdE!pFfKvVP^l7jO{db^mF5W5a6#&y*jyiv%@) z=DL!wSn1^dIXC6n!FFrieA^`j*6f72e`t`T-)j^vDJvdBJQ{h$ zOc@iYkn&;IQvi7hv99aKodBLSV3l;>2d?gX-%p4Q9nD5|`20xpS)!!%(1_3w4o-}Y z8m-kV&;HA|)S~md5dYcR3t6TmYFdSU&5J&0F=!Kx@;yP%m>^p_mOLuUdXdk43AlX1 zjR0RCX~`IYkfJpzD?z~4Eg&^cC#J*G!l#dnJl3k9p~igasc4xt=c}6^WF}zA6SoNQ z)NAZbaGwJQ&+eX|p99uPK9a}MKo=L_Xbue5+fvqZFikZ01Rsn8#6BdRJe%9gD&T^w z6%>!0ZHln16c~dzd9i!L*oZA_>Dc=4bl=hdN{SBLNGhB&&3gE3`VM@EocS^}Ch6#V z(<}xTl(Yh+Iqfnm89gQm*l_?OT zh4`~cKcA@zJN&nYMD&gveE;;elD`}td8P-+XI)q1er@C5AxgXx7w>mHQ+h|Xh+AQ@LmF{nZwDAAcZ@)E?pu2w^ zQ$Ax`g}T8C1_fjGG3!lDXa~Odo=NS{g}Rs}p&$r^I*&Gc4z$ZEVc0zn1urVF}ix zVKO;Ju;0*(+9wW!S@^LsUsO9Z+IfQbLE{QCqU)V0G`6M^P=R%QJr2O6)?XTD!Qv~q{>VguYYVYk(HNbbk+-u|qOtr;j7v%cnyFGUP!w_2cGaKDqOG=A zIbxV)mep_(=j5%kq)|F7;!V+Dt-j#&58!Kj0s~KQ;OlYV>;3v? zfS)NHh4z4wCYKqZ7{C$Ai@wfO8ii@a>z$fw&sVy$4HBKge?J@AmxoOA>48+nF$xDD zJ*j?mqi;|C@&o1UQL#nwTe|sFe#Z9yV3JJh0O06T|G^x-9M=?kG2GE7+Vg66o-BuU z1DNZ<7hqTsBjrjuiplBH+Vv7~;wMdzs^~kRa5e&(qx0UIqzXI!S3Pwi`e~FO_F_bv zYvb~Kw`bC7{_^h+zsI?=KW*!dzO691c+0WQIgug3MIP?=ChH*jy7VWkg)ti=#Yt{m zBRr|x$bn!g@&a8iz`X@n)dK-a&1yTPV;IuUNpsMnijUrO*VHIf!E0pDBng;;j zp^d9cDL3zdt;q9V$%h+{j&4CCM?eK|I=v1cxk(u{*>N-d%a^bfL;UsC5g2ud2u=TH5_tTnR` zV5pbQ2%`nXrjul`KwNQQnGZm#cb-!B<2_Uu9LGO6znc6fAm_S$8>o47I;*t6;vr_H zt>klfKkH2$Avqu!*G-U}`3Jj;+p5@lF>1?|D$S;?@WL`RG2H`*+^SK3x3;un*fv%3 z?wgPk(2O=RI1tibg2|!q+A@RbKVY;^^J5n@EoH@z@TZ3nFjv!3_zSC`PW33*vi8Xa zh8brPix-B3v2>AWz6C{yYVw0sn``plo8im2*_seEtK?`dCiO?`sucE*?&*CN!Gwu9w#=!|sGclf*Vf4rN4n2tK22~& zLoL|2_}S{+ZB=2FmS6T}HSk&MZejFi?-gJ11$h;$W!-`}ML@Q-I`CFfE)ufXn>|;B z_hAlaYrk(alX`I~)$l-5;d-e{P?@sguJCp^2w`wO3?{uwS}jsq95bppE>Zu!iExip z2zSc0D~&yABIY-JCFU!mxj7TqmqM(aMPq1*>;fiFajq8jK3g_oW;j+pI030iqU_n6 zj=jIsiFvnjT6jTR~VrD&6-L!=7hNgb<#q5 zMQ#L%+JMVZ;b2F(09J1VF;rheV!IG<%?gPY)0jT}V*(*5!A9r0=$_%L9;F78PavG= z@tfbX;i%!MSbY+khqKctUMi~z$(@6#9kOeQ0j;xz{z00JVE9m_qiCc^jw4&Cs5yFL z*t<5Y*&39Zi{OkP7CTj%@*bX04A~YlJsYG@+*HX6F5QI7)Y#PMRNzUmX*SC#|JQj% zl@Uf}MXHCwPpKl0dNheBW?iE}=c_=NnRr)q&ee=qFn zFp~FvMhg$=9(WBIb}=BqH|o6p=tcSM^*Lr2<)(t^$cu(Ki-~xyiQrHi zB5VOh!2d1B0Y3_WIr88z8@}W=cli~N4ibU!2?-j^hY#6y4+^LE7+UDPvpB~z`3LzP zD{K1;?ytfG-JPk3vqVdB(E0c{YA~AniVp^vDi9Y*M(G<4`0+!Rt*b{`|K8oo)NE-3 zta1_zxX`~w&*J{MMR@M=4_R&AzC2SgJqCtcfc}OvJLsyma(F{ z=fZ@KxI)uU#-D;1dHY$5pzM7K>q7oRLVWjX zFVDL&x4b}#Aws!05g>DgD(dz)Vb#1V+*q4GLwXJXE-+D5D>RF5F&NakfTz=h+RxU_ z`AKA*qB?adRp~$SDrmr$FYogp zo3qzlUH*OYzX6dW*j4xCc3OP%FVEdq8@`zKU$`{Z?dQLLJBbx^j`rc3CLBkcHU@s* zwQ3IL`;x2#A9j+Cdq>b17+STDYy$XG4%HmWeYkYwP>&Q9$$3OH2yw1zjRc2aqvI4= zAd&X&zn$&+S?bp$ba#jyy{eFuZVzEI@9YsfHzDH(TbUx2k$5iw1%I`kZ`x=vaZ}C( z`AnaI-^akQfF}zGdm0b!o>BQFE$OB&BH!_jQ8RZ*4o$)iV;$k~^}<W0UHtI(uf4g*birr@78tI?!op@n)eRvlV+~j(KqkE4OY< zZwY$cw%o;_Touud&WP0bv(`7*#xlBIy(KhcznDsLq#%j-(I2n{pizoFr1Pls-YkN^SU4>~EVag$kC9aB7B@=Fi`>mqMbx_~ zi~K6FgzK#5eab8{_qF+Q&@$xg zVT+kt^?hlB?CKa1^qyfFbZjo98cjVLGW>ghi^(-JwXxQQ#N?!0kL6ub(oDBJCJ1!p zWf3&7;2mT2EQ*ffU4|+JG#lXFf7sPT<_F7%HTp0#Fj4XTn4CQ#uTNpRvcu8xLJOh( zHvIdFklX{cU?kILz6iT1Nl7@_Ae?1!cMKLITNI^;RDXzgNg?>xy-Vdt=4S45s#L%h zJ9LRyo{3?T#)|+yEF4!UR%e6ut;?JWw+q(u|%ftmqvfBw`SLBn%D7Y&cQgLu)u7qZ#2A@4zWXdj~I`NPmmw ztGA#RJJFBR8upo#dzPU=TOZU{N*~uMzhVcIiKRhzgmmjv+&o5HydBTQs@Otrk-+us zecbm!L}YC&8v{0i(7vGFGcS=NX>ViE>1bb$yAh8acOic-um8kSxsq9+Qnp_OPtMas zyKYYPa9A>;USEjqmWQmo3RG^&h+K~IB4q9C$C7AHS~%>@WHewKweK*zpG*}ciQ8{s zs2~YC`SZtvC#x5ES6+;?bNwR9UsxE|<4@|}^>xxlh|__DGEyJ!9xn{9FVBztfF0B# zH<~|kdtJ)JXf08Ve}Mjo%(N@?Sa_=|L+CJ9aSM6pc5F5r;_RYlLbCPYueU) zr>4Z#x_#-}hZ-!kaMFRu>@$zlvLpUAXV}5voyT}Qje121(L?QmH*Z7 zb6=)OWnj|vdK-J*0o51l>~-T6M~!~)E?di2{}pwlShecARG}_k-{xue|AmW^?9cB5 zx_N;Ys2hlTADl$DpyF@Ntz7sOh>t-)N*JV`qD@Xf@~`VOJ_;| z_bC7~BMksFV&MG2M`GGtC^c=DqprT%;Tw-xT*-a;-9@(~K39y-)m>KXzPC3@dp$(A zeBf&VuKX5N@OK;gu(b5Pl-$F^Rcd-AUYwy8NT`s%^&jBF8S&#W%}M(Vg>7m*j-vyW zNSk?#W~I1uhw}9DRKx;bGXbl_DT%zK6+uTx1o&Q!!)L8_%~a=Pee*Ns}2T<;vzj!xN27lEL^Y`*{jC z4)n}>(%DWIO-4V6CT=-lI;N@*DRY=E=4SAnP&PR-w>CRYYxyao5vDy|DNl*ups+ z6RqilG)oUFC)&Cl$m1)hT6W0>P$ix!wcBOI-$z2U@XDa7vpB}H6Y95m7QA^<@&R^F zA_remjYkH)n22eXwGsr)YjGqCE&9gfdLjjBk6gBNE6IO>4mb$KPCSbpn5Dm64$zV^ z@OfZogUUtpXEjvxEyoZw`(f z+5<+LOKF_EZNDe%NSb{4ozVST;J>O&jp%xgVV>%`b)FkBk%zhs4~67nm9i+x9;aZt zM$H2eL}5d)(0Z<;X$BE!zvREs6#-+^X>R5SMXio%?4rCK-yToi*BF!F57l^y%2z~~6o#bQXQ+@=TuzW&@y&Ye4Ge%JO(2Xd8B!^-2n(_tIVi}3t4NM|yq-^QFzTKj7Z#R}#W$%t5# zac~--(0Tz*Q{dHHUwJh91q@9;={{nSy$$1_-6?(i8)x&m2aOty)6USy=&?hqhxlw$ z5#W6}3-prGAt@`>FQ3H^?*kfW!fycC4DiFw$2gVuXlTS(TB#Ql7?5rq0hg=Qz`MJi z@1|^-`|Ic1y%X!}IUgyCXy6#*sjti78IJQ2Ip+@y@E+o2FdrLuMWf&`4B&M;x2HBQ zJb{1wuXSrVSc>cBOoi5s??=T@)P324Gi=qoX45)V>Z!C!UczZ26VMJzSX;vQiL%}? zB2ZGS%C+tS7rn>~E;%9JO4zj~}qR+g7OTHH6TVc1kIvrsB}@lEQ- zs3w?;xnPpSc9bj(jp&hYZ*IES!%(ETr5$I~Y#^^clsf!Hu>Tp_G(JTr}@D7{QQySo@ z8F?3mv?1E#er8FFQZ%=Lib7?urj6DeimU1g|2}${%(w<54Ft-@y_T@q5m44Kb&;o$ zrHz>DM`#P-hNs-D=#@>nA6g~f+d-_0-Iy-J7J>$Ar;U_jvKWLr){<10aTZi!?0Un# zt4L)z)r?CMye!%hi>1g@q_Rp=>k*Q|Dw8urK*h>ZU>KtLKly&c(k7-y?dMJ0LF~O_ z{;4k_U{IB!W!2A%p$K#N>DDWw7{BjyEi*=pL3Tb`gb_`*EVc5zChehZ2^e1xLz5l`wdQ3;uUmG75zBrL8B_jeLI^XM}ET z?1dCdb!Vtu*HdIrMx*a^y)Np2$*B%8y=jOT-Z@nAkT*gYhWK z6#RpeI{Mb3fU`TSC2R}cQ$S_hwx-=jV5s!*UXv?_Q;8iv7DBJjAEc~b@hkg{qro2+ z<1iQQ%{r5F(cn9L9q1TWgU^MchrP@U`-ezdtA5_G%>Y&fK44O+{qfSpm~DXf%_7UZ zj!X?meZ@_O1r_wX03@i4RR_7K4!^c~OE$zT3n+q_*q=NnZ+@`U;0NBT5+4`3C}-j{ zr9>ubZr1^NdbYzstx}V#zc46f^cFsdFnzy)k^j)O>hr)jirmbV=fkmY=>~}mSr${< z?YGFuZgH%ZL1jrPk%d^XZ~EZVsIHmR@y|a1^ZBFSRFPGPrg4N5k;{*5+zmQ7g-T%G zBe*qTIX)L@|Ex{z z*6z6R85X~jv+J!d9qk-=+gxg zyvxk9r}5>!7&4SVovRhp@lsy|8ZXQmb-ykfit*=6KA`cewBRyg=y?b#kd6{*(A`cf zyFz8N5ZJ754RaXj_UNdMsBrtG+f#%%5bfne!Fb~)y1%R{u-+0GH7p)82#`~2@v1ah zwFI!gIV|EeV2Zv9|2z?=>t){IV?ZPi_DGl%OylbDMA?D*#ZwJ$95hfhmepl0IaIYa z_&P@E2O&E!3+5x0J5`Su(*@vC?Q%b6#GtjaD)T9vlwL8sUP4BCiP7NYDCAp6I3AHf z_}IlLAe78R_;q42ReXi1BZQ{1oTQ3|EKV+!BRB^daIJO}iuAM@#(ZV&IDE+nJ=mtT z5^YW)IqVT2_T>MG=b3&BHc_oqWu zLcmpUVGc9~@lsQ(CmS8Pb#N$EIptr^M1~lSFbIF~&o0#c##Zbo8G)v0w>kd zw~^JmEC&(lDk&ePKOc*1xuPQ+nakoy=@N>9oXso^}v9xan5 zugr+aS0GEncdSK|oEtLwEQQ29ouX-nTgIH6(Ka7I#p25V&AL6kH7uiIFFjDst?*E= zRT|RI)6#$7|A3akXcHb%Ez*yfb))0+k2$6oCz=SN{btnYK5jw{j6jdNxJysh7U>>VD4JLh~rePm(F ziogJdbRbU${C9*liudatSL9nj`D$-2^Mwd7+DF~KbMVO|3`{V~RC#ui?@A5a$&k%; z2ZIfnE7j~yB%QA1ELKJslCdvSNzo8C8mF*ji>)S9HhiTA!)$2%T+jakTxCFM`0tF? zk(rOWA^Y1Zs6cASh2CsD7UO5m!?zPa8E9X}6=IC}Fyh+0>i6$1+Q3PtX3?j+e6*`3 zjEMy-`MYb&sa@vll_-yHgb{J!kGFeT32`!vN2}UMZ@>}$utAf9nA-$U;{E}?Re+=% zWn-&Wd{HU&7n7GN$dWWm{=QP9dSCdIR}K43Ei#4w5aKPpQe}ZR^0Mz_J`$>pMCo>n z`M#ZrN=JsyNY-WNr}_Jz-WlU%2(+X>5u<;)M&*MilI7UbHK#=kgFrFyPF!J|0JZdddHy_Khh* z*g7h`ALnQ?lJcRKhkT46QuR`x_{qM-`!ih*P2@nIWOTc9!`rF**k3`kci;Y+mo&FV zJFQ+^8Q3)J_Q3e3v*!X1koxry;sgQ}h7@2m<-~x(nG0lyH8MteJ1?Vy?GHcmW8pYq|nvnn4~h_#seQ+2uNT1vj&o4z7+=pPICYU}R&l!Ct6G;r=U z;Wb;61IXC%u*1l&#K|_2jMx*eySu@XK`v>V*!Kr5G_qI8WT6_|xPYi>GP zOgtXJit}HV!WGSE(VfqT=t>`WZ=dF(QPPv7WfNDhigR@8BOUo||kT0-Zzpt=R@-sjL_yk5JJhtlJgN@T8&5q~jXt z`ejIFbruY)0bfYM2z6BJo6OW@Lx{mH@*44Yt4w1UypNf-)$4NBags$S;*U1IlKsW0 z5D{w}El$7mKaS}PT`h*PJAqWpY}{_4N#3l|#s9Sb(T8ipz8rjMlWmJ#OtI!&go@yC zf$@Twv;MvxN0rLAw>r_LXkwxDtCACsk2!v3o|B8;Ze;hOg>F9qAvkFH_YO z07Iey4%YxiaAcbe6`zTDEB^fPun!xZe9i4$CoDTBfr6PPT#$ZVfQFK^UvEFC6KGv?InH!{V)EZFSn4?1nt@ujw@Aypa_DY*Fd41%vI z&bC4%@jwM;<|iP_@Y!m#($qgzbNC<(z1j- zg%N)68yqJfh=pgY>ShQ>qUs|rmUWK0bP*t1(c3*~jI{1njz}5j-?nN7;)#apJO$H$ zu-KmgF-;Wid2FBUb8z7Eo+0Lqlc$QCu7Ol&!fgB$5}X(>rTJK%i@$Dz00)DjM+ zT@zYIonKUKi1K=G*N)BXSViQ?_Y53Yk!hp>k@dktb0OsHWcCU8h~HCporWiVE3b*Z z;ig-J@kKC*ju?PdQDyISmb8WcJx?X^29RlN@}I)Je0z0n4>9p_%IkkY=ofM(dNE1a z;hI+Wv8DM9HI&i3;XfFY)8delvzG1O`H22rq23y!7nEs{gnZ7PJ_f?Zeh=9gd(M5x zUj*q0s-%eWGKUg|X;HxucvL_^GAhcJkQr@?sGvcT$;-9ZK{c)rJSEW%e_)S@gK~lV z3xM;x))bQpTB8Q)+TWAJa}fzxONW5?3dCEpRs^rEFD~L!HaD_DOQX^~E#W9%3`BDV zUZGjy(Dayp;-Qm^YW-Z`L!ptcVsUaMK&;9qWgq%U(Zqlx+^sj)%F~RNY$~bP-PnCV2yc7>p9#NJ*AtJZJBxg!%p@>5 zPe0`5d_yhoFWQO=kaTyDZ#m`Et(_X?y3yxqn1y6MzQ$x%D=W`F1GCis9HsA&;qcqykDvZjb57>zj%C&FY@2tO zh8zP`9iS4SH<+lgfTAKr!c!<^tiwF-8Y}(<5B(=JuB3h%29D&d(x#lCX`DS7SZ`N7 zgZ^0d8v8r73E1>7z9Nc+x`|3v*Ft#xWKAVP0-{Bl>8UXvb{57QgbEaZ8SXKXN|qEY z{#4Qna;Cuyot;|cacM1V4iRMTbVQN8rS22wT0LxT;jL5ph{X~BGGCsfF$NPmBt>hJcsPti%Kr*h;ovAtU@G+LP0aS?vM-CY^SG&UBd6p<&AFh0r$Y=2r+v|1|UahTrZUH%7P^xSGC`nQ>UedB_`PF z9ZKcnD(GaKe83%wNoCD)aG?sf>FHbZohLS7~4W_BVPL?EPgo)G^F*r$YZ|aHFC8QoCSE0 z08IdJe7)W8!@U48m{NXC-U-%OU`%Q0scysPaxm)wESCEZ=#c}!ul>3Y&Jc%ekiQ+Y zoexO7NotF+DrOqTFl^LtF(%IW#+G~!c|VfhYvMo}P~0{;~b# zq~D8n{|SM$RUK!v*%#6ej5J@D+ee+x!>M;SuSILg4hXC0CWn!XrA3m3`^cB#N3 z&PwNxa*oRlX6sCEW4Y&Db7_IYZmuW(DWevho4_Rti1@J0{~Z9PMYBfW9_?V^I_~#l z`#-RkQ+tX3X0M5JFAI~az1sJltjT4`%yK>6CeNb+g0Qz#q_*%Wr&Z+XI%sgyrF%E@Lrq@i8 zq%dTbkfl@RJWB5U$b)|w#ah^cW3qm&M*kG#55(zBKWPfVC6j@ECBZ%C*czmg2|66M zo=8UrekFQQO=i)yA}z$DP&y*^rxzzK=S=rUkUnihwhaU^tU{a=P|ruC0{$JETv2lS zvn5jrDxg{At0$-Xr7jpJOH^_+Yu|<=jRrKLx$*|2^Er$|d^bU|x_6!Av1tQWT)I6#~ zWU4p$av53Lac%G(?!rOYX01`^3kom?wzIVA$9&%ih~`lHu~S(ZGQ643Aj*hmarIUGhCZM!^TFH zWls*!5AKEej%Wn0R}#DhOM-FUC9cYAq5Y~(L4OC!$c`qM^_ehzP*v3?*Q~8^BH7Iq zI-n`2_ujOHl~;IFJzJK&0A5>Zc2w$YOoq{K)ct_%@i9|5`)iDl68uv_7!rN5{0Q6; z&Wpw7r4k{(pM|?3{8(C;kf4@CpTqFPy_HpUq{i~FR(O_RGV&FN zFV2N>R4xR4?XtH@MopomteebBcv$qO8^)N+8eV!-mz(tWWHXMa9Z=zMXFPTPLG$+3{saR>I{}%AvcAI!*msGsrA4Lp7N|T0`a+c%fDhCTIzOB{Y8feku{vimfcYQS z^5W5n6K>kGNPR)sRH4LiyVp5w5Ebk8@p-;N)sF#8@B9$)*}?DSUs{8(|EGeDMH=&1 z>wDt&SI@xD0uIt$XMpx*_9Nz`E60KZcxD?3Q|J3S!UKi!I5Lz}=dJB&K6^Lr04f3) z@khp1so83Q$z;D3b>>S0_=%}f>#TU6i+pBY?*kV+UhC6|gyYl~#xad$?5~@QL19-C zYx8bRCFHB(`-h>Y?UaOTCczFF^*S{`Equ2^!kgbaqv)s+X+qboL>O343zaDDNo)

      dFP?ik{c)#+ukFk&N!K>^% z$smjLx4Du(+7Nc{%#+yAjH3$aG9{3#Y3A_!J~Z-6hp1(kY$YnC-n35w7drvkP0B{T zs=1Vwd$%98xOMMqx7nRF(TkdTb(04NrwlyK z+7jH@S{6N7J~|W)vd*q*W)l2zxXRL#Z!K5;F=b&p4{NqEm*7Z&hdwn{csnihEJeIcU zI}Sw#IV{&2D$&_4aA5^{ESsDLnXjYB}8<_YoN?kWwi+l_p61S^E1(LsLL18C}jmAQ?O<;wR*8-fmlC7XoxVc zIPi!?uBnlUg(GJ; z3MIw>L{}mN{8?)jR}bXJCe>ZT|MvpC-hKy}y1*EO=>YHp@V{#>JbteHW$Z}4*F zPHflVx~1l*)<3pOMAK>!D;N7PUA*tIzHHpiMFf1-8Gilqi(AW|Ylsaw1lq;HMUe<( z{tn`o0Vk3Z;E@DQX8vxSMFKhQ1g4+ zn$og)RYY9;@6*fElP_D?Q@L(vZ(0pVAH7eoR5g$h5ksB%%e-$=ARkGi-_E!0rFtD? ze;;@9&;t!N3>RFv3R*VgS{~K%x$}a=H}uCx2vdsi;%SC*t-$Hp4T%oZ!%vqJ4=mk0YcZ~=y%uu>vRRK z@yF8z*u#I>8(M%rZ1%c8vrc#_PT};lWEIt^dtu?g%eWe*H~TX`mG14NIq zUn@h@A9O?o66voPz@O;7fl9Bh%e}(tHyr|7gw_!r8za>6svt*Jo)yT;e7RuJyz_yu zZtx`kpP!^NRy|2PCd|D@CG`t_5Y`H!*XTzdJZIgt?i97;GWjr@dek`zp+=+3$3W}2 z*RCrTeK$c^Otg!N6d!~h_NGZbc#}+z-r6z(#`XHS;&;O=IK@$Z7v*durav`Su&ir} zi&-hlAV$PGG%jOXRo|ro_^6LG@neq;S7l zRWUZq&!qAdPHwLVb^i16?-SVG1eS;q|GL>}9ZL{bh@`@xM-fjxRB7PDr_|SUc(pGm z{vd1d+5(~pK()X}710UTFJFcUYZfvQCnqG;Nf1N|)8jG+=q~bK%Mi@ZVmsX3Ncy+H zw`~}$UM&|gW!-%drX&$C_?e>ET4qcyAWH4BU;W;<(H6gqf(@r*K~sZQVa3=Lra@adHAW<#^P<*FR&ZKD&sSLc{Ucj1 z!66z{-y;`~%3DBoR!12Asvc(xULgGO=9x~NO_I)*=n|N)htzO--90M_=9U@>xNv+j z=(+I@+N^RuCzQhoPHfE;6ISyFqcm$%S0m#8520UZ>jl)MZTfiy!e2RFGu%>M>9 zCui~qFnh})3q(@ra25VMMyT#LDhc?} z8g42pEc|4?kmMTHN|Ns0no#hiTl+@e9UAf3%wZKF#tZtZszGZ^fW;5)sq;xQqG%N!`~yNY#kjkfj`Ar~D>z0%tl;^OvdqPB*+wj`>_{;6 z>gGlY6$f${2v~Qvx6S3-zTQBcYhcm8X{Qj>|H$4Pz8?b$WjO)!cw+M-(nzFg@U9HM z0U;0tV%?@I99q?o!UPfi?NKZ8M_0u?_r#PoN#_SZ4qamn+m}`H@-BQN*zt#QRlq2k zlaq7pHK9b|=a%-Fng|W-hM`Ep0@mzu;U|JK|CBVtzC1W?s?eYSo5Epy|MX(Rw>QV) z6xg4%qAs5^I6mZLD;(NEu~d$VTfY30NVkE;2j~|qvt8i_!aCzkt{%5gI^2lm(XN z0L$f?H)6jPbMv!|Iz@*8gCn=_y@@mu+B^|qE}^SELt7S07j{2M8vIE)bmy_jJXkLT z%uAE*o}L>(ObU~b?NRCHuZ}5;vKss8N~CZIyYYH#7;5IYtwjaHLilfDcrX`XARpx_ zS`RkeV8kQeIlPhXny`#GU6TWF3@@xU%)Vump`B$thDHYt6LnWVVy`x&wGcI&DjG}C zo9b&3HVyY$V5*8tE#*!O;o(T&5M-r9r%zAV61v*DNig`Ox1nNEAI{4(E$EakI4RUk zeUCowZ!z@fud!C#Wmg!FgN^Yt!;ft;V|EK>FPeixD96Wo6i*yuZVSP@P^Kky457}US4@VmIM(qaM(5&Jo;iFtV@xq| z_Qa+ZgwUN>bQ`t+S)DY#0*IA;gMqah%e;)9mT9CuT+dV|2!8Z4_>?bc;o-xHhJdBf_nf78G)|^70I_NH9KGcur_b;r_j5T zn>&8+&4PfC!D{8$%8LncEr2|*&+YrgHi3^Q_<|W`z#6KAG21-;xo;-Uj#D}X-L6=^ zA{jM^8zfh;RCZ>FS%SEzL>q(tQkeV2yJV?qRWf&mg(L|5O*R~3{6X`3bS7_6CmL61 z&@Z2iQJFtQd^Ec7zuLY&(u2ie2*D}qc!)(4g1kqBu5aT04jxbSW=k^7X%e zikbP%qlShiK~T*y8Lz%xLU(l}M#n7c`A^VzC>7J!?;<8(M&sLJR6AWR*t_Tya_oIW zyrMGWuRu3tzc3=OH072@CPCOF=}F2`0zb3O_RT!fZB-|l5}``P6ynPB;Xa6PB~%RN z?HIm%)%QBUpd_LSneK%5W<;KJWnFwLa4s0 z!uDHJ?wL&QY1FT=AzTp*=KhAo$Og8-Z=Cs}>a3`ywsnTK{+<+K)$G6?SWNrfBaG2OFoa zFv6$Z0QY*B;+?CL0(U{5lE8b!T1&X816?|Lm4|e zUzy)yG0dC?G|(ko(m2{tPr`Vyt$)wfw-s^eHxRQ6*O%*$T8#=dL4ZkWjFVL89|?(& zH!^%LYQ!}oo!Rg98dN_O6IW#_EqD(eO%7$?&fv?oSZuLr<#*Gc(}P1WiE~6o~kB z?@5(jFUafS=qp5yB-9s>=nixlZ@*WCVS6b3kGkXhRp6H1U$?ed8d_BB6T zPatK+pQjXZ%!46B=H&4S>flh)F?DPr2`qQn5?YwgML2oG;jMoZ8f-+!FuIK~Bft5t zCm%s-2oy-_va&@t%+UBHvxFUB>{s^$L3TA92fBB^>TO*~Djd~+MjoWJWFKRvpD3C& zrLAf`33EJtw@**!TMJT+#SvVaab2V49u{KNKn-h)EyEE?Nh;%? z)ni>ffwSQ?2v{Sl(iA;(o#G0%`@C@gN%a6Qg+!3@*n4d(HEwch}d~ly47+l!}L9KA~(v z!Ne(MP&1gxtXaYLS=Vs%BKx^Jm?n)8pFuNcAmj}pC0D_?c8*@ysX2f&SwEI#2?=sd zcm=R0x^zifPJP;f-j{;1gGF~1Eec^n*Ynb9x;Lham#jAmr5a(yNF17Zu*;>$cMTtk zGidM;6iAW21|?-pi6cwN{(IXB&x};%-I15xQNVfMn*>E1Nj4V)E0Sb?#QJ@C33Qt8 z@6!$sAkW;I4LS=rd{Vi}{(NUO$jiyc7^aBZ%kuWEwKAMl?^|fdU)UQI438-68!r)x z<6FVVVerrIS3i-B-B@F>r4it?il%tQ&WK>5fx>72xpT{|gBJI~m4JV%0z(3y<{AV% z|8AIR);?O_6i0|P-;(A9nLa2{oqGiaPH*lx;4}#LbL8b{!-+&@++Wl4K8)Z{>&fG zPk%5S6%KLG>{*}KWjDSAjN*O@IZpPS1DT&>MwC_@$)kXhy$Jtd-2L%}i-* zWJbPrt|1t=81T>g|D)+FqoV5HuTR6!odXg>cZhU%x3qLfr+_p=cXxM6mq<5AcXuO= z65@02-?RR_fLF5?Yv#;3-)moce|Ayl_bMgp?u-7jTc>~*vTdprd)_X^z6K6nE&%)S z^XE_3j{9od(IE^DAZo-CzADQ?WXg$nP^Dbz5funG5l1)ho=amQv^BVit6!ygH)k&s z+|uUX18gjNzq1fyZ9;d+4f4Ta&^2^NmP)ael_QFVz)T;Y}BNd1s=Y5 zC=!$O(hs4VTuz^Guh4+>k|nj6mHjlB0vkH5&=N9}CGV4@R?em3#j?l(nlLh3T8IqG zS3(^7VD~kIuVJ_?7?fvKbVK+^IHMrV7y4Fjj$v1)nChf?^Wuitj*w2;?5|`=UB!?l)fxZEgBRe z4xj^OgNZ~G6J_Q^hRWwLbtNXfbfqi;TEY9~{RrYD>uk#lQY2X0^lO?X5Xw<_nGX7e_a9r2HWqOMYJP9 zIZniJ8TFb11F>O)%_#XrLvJu9*WXdH_n$C;o8u& zg;dgbo@ zA10hNYSmL^RUj;(qf$_5mLd*Q*N-KQN}EZ$fl;+EL9j^y*#=R81UoG6bGH%~!~yQD%CIFJa40S?%@V_P##9gaurcYY>nQb*#O_r|Y# zFc+Jfn+NOh#lMV^;CL}doq!MDODKQ(P6eymIl_jQ1Xhhs+;h+G9S$#4iV)M!;J_xZ z+S$Y7J!$L=#}seEN$i9v!;c?7Jm`B#HWH{?fTZ;Tf5!9}Qh)n~X;Pmu+~`^VB2ec(RgnZ~B z8xF@g!(QO7?lXxhZ4w3x6HU@d!oUCIFfLMbB(Mu&&)F?X56Y)cpE~#sfjD}(a-@^e zeXLsX(kPCr6X#wcMNqU&c{0Kma}~N|;2pYj=3_~p7&7boO2sfp#Ii!AiSVn-YIe7U zL$2gW9PwLrT*26^o8BSL=-ni{(p)ycFZTHX*fG1S=B|DNu;+IHuYIy`UPd8HP$`Na zCdZPPLh2n`ow&Zn-C4~3j1N9X$+&AWNZoqQPb46TVG|m$t7NKVSud?J%~uopWYQT!ox|g7%S- zhKfG>v0kS{RXUFtVCMJr?mEl86zVbVDN+Cni6{`rSX7^duxlA`ot(M@g!#9(x3ja) z0=ZFXdBLMf#lL&k1T`HA<9+KaxtWPg{&_Gr$5O>r)DTa2CoT;qQf|WxWsGr$eUR_OBzxjHy?RhLh%|s7zh4&eYb3C+rW{=`gWtPfqCpJkB60T3n^zm-qO&Yq6 z^Co$>K;*a!mkT;1cvhmL>(}fgYN|)!(M!dr5=%}>xLaM?<^Di1NF!wrU1f6LkLjtw+ zEVnZ6hXE#gkSM&S4@p9+2uL1pnmUGLn5)T=)mC&yY$IZl*nbUImw^)_nu;)sn)OlJ$aKt#5nL;ftPmLDR z*Lzn2XA#UuSE-wo7mp#UHjTG!XcYWYcXo9(BF|+G&`KpdynOi7flq7xbb*@?SV7d+ zpnytu$M?J}1`X?#fSo**AQ=I|4vIURjLFA796|?T*pie0Ec3I)gGo%4V7oyCeop0_ z=&wPbHI2VsLTAdm?EnCbimn^A!gTZ&q@Bn25ZJ|2p*BV+@hIPR`Xez`)}9!5S3s8u+j zM~(P{N5t0HtVD-9r_1&GAMg)0aE8(R24;D1&UL9T9HONv+e01az4Bpi%cOew+3a%`B<&Mw@`i`K zqf*nrOq>w1eBCO__V0|P^R)04mH=7kIeS32nXmllVg=<0&Qp+F4cx{%Zhfl1c z-9NK1Um*8b1N9#f7~`30wXbNUadG+ZDuX6PlaEqZStn%5wmS>HTzCr3IPwCjAKC9- zzPm39sE^GGjLeJ#u5=VA(&#WRV^4867=HzyJD~0Z-`%JQCHrVwV1#HE0Sft?}veHm#2ii+T0m1pSVT@`zt+ zt5jq7A+-iI^(d(qdLQ^-ZS?ybmI)oHp&=y*hPwE2P2*=qd$*3CiEDEk{RL0VYg z9;fkGZlHZGeuWr89>4H(y57RVQiw8LeB5eolIfgmazB1xiF&J%^b2tbFS1FELD6l|Ut@ z)Hp2kM`!-8^@-O<3B5PUd6w)DHJ7vZGoI8+#LKK~fwh&_AsAsa~;=d?g)+S2P zZ`E+VrfzL5{t(%}(Iu(0rK9(ZVNF3?tROsAkLW4LLEj+BPEVcO?1de=jhed^f|5>c zYD{7!uYf7;mMO*@mzs$$eqphI^wD|>%&3syv;8p^5`d`d4@G)rg+4j2@8omf5hsv7 zqNC{#c1R!T2r~!!fyomBbi^kAD5R{Lyh!8_yHl#6<7eh7iMMuo`n$&H-lvWK zn8p!EWq7r=Mk0La$oiMh&!i9^L+B|8b-&r}df_k>DbDQAEZjGE3Eiyh1YzVH4@}ER zq7VGb5-gJ;2OGC6&e@|OQd{Cz@^sc96 z6ZlO^_?2O*q)z1qV!BmI;#n7u;bh+nJoquuT@F>4ShwK`O_4Af3$=;-()NDoz;KeU5alid3v({!+83=V$jHS#n9}# zFihb9*+{Sv!O{!=54K?xc7o890kF1LsErWC3#V?~-(Af)!%9^P!blY1Z_9Qy%Y9Ml z`YZhA-hBDfo1*(N`0gqMS6}OUN`7Xna(%;xKv|yBg#_Nw+A>vrHgXJ;sx#k9gTw^k z#0)qSvr4`*zXdYUUP4v~COmi2v{HALjuiZ#FL9WOLsUc1@6&S@qU!bGx@NznMzG3c zxTE8TnCD(^9PtpN0}*Sw0`ISjm9um%FOO#}4 zr?-&ATv2oDNZo?Wv6r5gfWPQ$<%z3M$7K|#*$^l%YzInnH(+KO4LINg<@V24_AW`R zopl&Cd?h<_b7mnxQ>=VPshvxZOGf-Q*+zcI+pvl~)MJXP@%fT>ckF;wYs%*?k5q+f z*@vso*)`nl7lqE;m-I!=$Rb)pjiSt)R}VYkO?DlcUvoqUOf!@;+-yyJdu|gL^i_c7 z&*gfGs&22NutCL58tcU$$Ly$kxwATt0GNZP+4`_#`(569%}&cJ{#InF2^C7TAR6Aa zGKb0gTaTWhcYNJ{Yr(afyOf?z)aBVF@cW~#R3S#{Q5Y=y*XN9-(7Ef_`)t2u+=)H~ z2Ye*s+D#Zv8^6pfgby#py5QA4*|ik4F$^;M7WCSVd&B~J6%ImmG<}Mi0y~ox&x%{Z zl<%^r5h96ftUv3ZdUX9c*%gkq#zmGm&8X4}+WxIsItb{oHUfBEi@SZy_!9FdWklzl zvqe)tIM_G{1q3sygnd0&2N?tZ=LKjA8&Aw}lTB>aPL!)LFc~j4d8f?xN3EgY zP+fctdY~ZPV0*0JBE7^4QZKzlQxZYlwz5($!@Jee_bL@ZJaxAsaNDZYfU(DnAe^gI zVlGoB@G@1Q71&Lrw&d3qz7tfZ?d_r49P^wo7-Nj*&0kTXM7-veW%PiuQ)@E+!!v+= zi>7#A&;2KwH^*m6s{uv385O5js!*bviGXDUBQbvj%gTz`Ot*L6$T@uS{QMkvcWW5f z5MW8IKIeS!gD*~YMuhxo9_M5kD)rPz(T0EaKNWsY$@&+&OB3^byiD=p=b`Um-#4ee zP)GIxOfD>OGTz(25>sBTO|km4$wmkX&R@~Pnc5qI0&@#}X&#`v=(?IllNSKY?DV7C zYudSw+YsLm{(9Y-oJs7_Hk z+t%d3rDULGLfnV7uI63me0z)6noM}*&;%Iae0CS$%6lL< z_8hqBlq9Gpzt`f1-;mwSDZNQr+3Z(OF~1i)CL~MtHplT20aPz+FAvei=v9TJ);wJRyCf(;{4jde~pRZ#- zuao}dL$u+~>g2DZMI1iRDobO8@o2%Y0&@k)`xTY?_e?)n0x-7j)9R=Fn?G-F6b6U1 z^hgc6&KXK(Op`>VwqP~||6`hwdK2SF0jdBYyhSQ$OiML-`k(uP46UQnXg~$(Orzy= z?+G6PRLD4DSLiK%=%hsmT>zOy+YlYm`2GFCFw@is3OWHY(GMOPmPS)Je_sp3>vn3X zMScAk>6F`iB|4`@WU5*W=orW8AW}?%iCU1F60ADSHEXhK_V>@vxz~DOR19fy3ZA&> zN|_8**PJApgt)I0F^?t$Dao3}S@@#Vlt;8-Y*>+0^J>$Cg$uC#vV+G0akz)-+^l&e zv;)C~2)710i%N_d9+X5ZdeZ8Zbq7%2nK{NkUnFn|YJA*@^k2D|Eo2J>mB9~4bQD|Gm~07}W!(fay2z+aQM@NHTxU^dnUQrfJ;eL!}^_{FM8obbKc zh959?(~$qprMMjPdqe`Xw~v2L*`f)d95wJiZ`it=X%^}?*{oLX(k1O-N^x$EOP%65 zAQt-HieW*55oz+lPSHBRFH5 zElTxq3g38$@^$H|5@1^m_~t?-8Og*1epX8I^MoUG_P2KQ$_kb<>=sJInZ%g4O0bP# zV|YE%ZxGAuI zj08yipVWmQPR6JuDe6QF1;)l_Mrf!cXF7BxiTZSsvE^1>!Xk>p)SshvtTb#9rW!^7 zC6}6?UsWIxVo`pP+lx4NR6nH3Dfx|xV;6d^B@weFIp|BCh=Skt(`%?{Ug5j3dABFz z*q|~?Q^kStyDcYCU*>1=sb);j&N~VUzWlyQYjV*U(lda=$El%;_W0swC`f$gTtQ_5 z*FH0(dG79_{1WQ=0b8x`fxnf#f)&y zsFS?h+{{OfD`(+NeZaOWY+oP2De}$7^K5MO|K>Cpma+-{@-cmpIBRmAgeF^+LqG2Snm9j`Yi(R?I?B2=rT5m}+fNqkhKD0B zqtuV7X!(O{t#7-Mv+HYv(T}F8gIm84C$^$!6fgY zxH=4+t5s7G!5A`_`LRWiJjEqReN;n$E9fJ7??-_Mt`}wV_;gdMW=xmYQ}?L9e}qF0 zU7ubrk&|`3fHil8h$K%9-N1_E^IV+1erV~D$ybp^-uq&+iit#~K9d1c)(4Q$*%>VE zCyH2^|CJuT0Y)4T!4c`U@RglpBkX6)2{z1TPD2|BICG(+b2?_Ladc}GaZ7j4gUM4hOqoc#kB61h|=I3yGK-Dz*N1Egm zFp4b(4c9bb?^N9%KhH=A13ft_ggfYDIt`3y&TuH2&1c1F@JW-)_LEY!!0vo|X$0eT z0T*>_76IzR9U7oR)V(qx(1+~|>$&$q9cH|EE3eNF#@)DM%2FhM{lhMhn{z=_?%4*C zv0av#acCmpjshdonb%@drX+Cp)r;eS-y59xZgj?h$&$49TakCofS~Stz@8z@wj&VY zZ?^%L!EgsVpMaQviYGZgz^M_YT%rr$hn+-m!7H#JGJ0wLF88sZP=Fn<2^rMxbGfNFdJFB|88(!Bgv38n+$9o z(^0eQKLF?Y)*8i6^|C7=0{ibn32R&{6mp=gcN++BQ3=@r;~if)j$s&B7xtn`LpevF z&G_Lu=0&CoxGN-4P*hW0=ZJb2Bf4GFdDVGx30Ui7T2Xa$^j?3l`RF&EPROT%dmYL`j)V&cdgq(^xA%%04C0Fiw zQm(0|-1r7i>0_<}$Di`eN!*F04*HR6MfrK=`&kJH{BdIkL>MTqj(af|mB)lEiqXhh zT>DxQ(FO8cAhurmxIG{YbU6TcLLK{E!Ubq+i1&m}t;! zjkmpAV~ySX>017aV{|CYom)L*#z_&+?>KEGG$Ol0sL~s_J-Vybvz}S#&E9*1k2pof z>As(59F67rs;UCC%<_)BCQhkF`g}(CjrEU^?#8+xSaCY``12N2;uN&PKuFSXxT2h7 zV`mw6naWoB$3?{+|JD{~i|o3)zO^4;&aV9N0Hdf%p z^;-1!uPO2FrFtll#ppLrLFoSngR*d`>+(8fnL2-Z$dSt zGXH73R}KD_s?aD&j5PS6*JVcSClf3AP+m1s>UyGJ*b|AS6B>@6B+l6x8}dVL!CT5d?!W)IS!vyxPOX3ixCH<+?kHa_jrC4)LwdjA8et7=>T;;G)cgf zB-*fQ5A>XEt1C)$;GFF2?8PN2uh&ycHGtvuSVUjg0-)nS?k&It8RLNRRE(ek#x ze?pW?5^WB%@RkaUe0TqUEnWbI>5dTcmj8vlh`f_L)mJ2E2-VFr8Qez?o^yB0vW@YQ_PQYl6cmz=WpHbUpi)f7qr zlCONjMVe?O`!Rk&UIKnnLYSW-l$N=bzq#O~Dh$L<5c>&IznAqLq39%j6cs&85o7L{J8~h=<_IPR=OE%A#Z1 z9A%swsHvc`rqJ0YqBu>3MiOdQ>XI7KcA+6DUhNUZH-Y$dc&HA((2JE`&6=_Ck2~HG z1ey(8ap_d0k8lUmTbw($x*u+I=Wyi4R=mxpB{?=OA6dH@WK~ocyF!&7Ar^|3mD+M8 zEQ~GM2w&S8lG>D_&y3JP^7=w_s7m7*<|aWO&oqSJu?NZjnc|Tv+1hh2Y7pRHg}5b{ zT+wOx2BJ;fqA1$1gJjU z5Vu37ACa+j3sNFM9^dUJ_rpy^&v63$fe0}T}#G*pr z6@iG|dpE68N@NAuX2*lGQir)1#uz>LlwNQ^AR3pW{fAYa&mfprP7+G7Z-#)(-mbcW zbgWo0>I2pJ`ua$d&&`hqjzm*DfIp`C?F$i($j2Wt}yo59T8%lw^~aLT+tnyHrgyJV(YC_5;; zX0L%y1ZG>lv!L_(Mpo^IL7V1TP8V108n@;)4e~IWv|>FlpEe!!u*Akb$0PDN4}_7H z)69OoJSbggU_4)g(4qefFH2Wj#`gZh$}0#bLU z5b{9}d!$wh0xW+M-R}K!Q(Lf2_2O~>>G{D&I8zC5Ao<;-MdsLMya#QE?ZFB5|3vtS zF>~w@q*NLKzwUn#Dvc8jyA0`ih(X>@EdaJcU>AixmkE3PxD`r#dY1P7q*9vZoogW3 zW)FdxRIF+LV%7x6t-pN$Wg5vAakkQuzponJD?wKgxDM=jG0U4V(LR0*X;udg=zfnt zq?jOCWA>VZ-w)AHGL0FSozn$CGfkSo@p~h|x4r4dI9)ZLYUetLUmu#mUYC^5i8@eK z%FFjd9_EOaMzj*ia?m%A@~*O(=#qjHw2mtL^k(Ht3+-R2x$h>+vci<$ad1%bQcY? z{Co_B`kUM)n;bCrdk+K9lF6I{XtM|m-C2MH9nw6jXlMXcfa9LgFg|Q&==80wmz^|r z9yET)q=q3dqn64^;L98l%a&WOpfU~ zGsz8nN8JxC90Cy7^%b?~u00wlzEJ=ZD^W@+3^spQ zB&fh8<>~on5DgSLzex|J0#V4PBmS+^t`4fN1iE|#>K80`;nrIq9L1rBG-Z3>1 zxG6Onokq(@vz?yKABey2!_!*GSkHlt;uY1&EW9y-ebZ@4JSTRd<^vA2A(2JS=2o zD8dnN#$Xp%Yx5DKudJB6MJycyp5~cB6CopgfoREmI4+*bAN}&j#Xe%@41^NA%5yEE z0+>yQ10O^Ge=i77F2zDf%>RPn-`TN!1!N=cg3P)tdf%|w&HD-ul=%L%Q4=r0>kjm; z7_t?TgfKA>O1_tn_%1kZTZ)UwUl#nwCQotwMCTTs;!|_Ky-894RO4TzH)EAWE+<(o zG+qwE>peVf{N?%+KOyt(z90A{J*u|CA8p7F9QH+qq(U+2co96fWN}P=0 zPL{0`wy2H{K~k)CaauS{gdm~6ny=^<&u&WuJDUi8>mrN$N@TJsW@$6Kk1U~_i44IWp$k&vW-|n}J7q-3_JA+^LpBB`0)31e{P1tB zMR+PFU!t*=NI(@kou`kl-WlUGYG9(w`$c>4EbNsGjy1K;JLmiQ!}yn?o7*!Gl)PCM z9{EXr@_iH2DKA4%wkYF0zs~+zWjNbpF^V}##+kv9#~8|M`~ z8)5WMtGn0N$xxx0TNz9uJffIPp0l&R9{{iwUfGZht;Kg!huqDFOX)odk zdjtIM5;%H)mW@2IWxh_GAI;-53f6Za^e9Xf-=m!1hN20d*7irYb|I>&BA^rFvx&m& zAQZzc+YYVxx*rsx-C>Eoe(fvL#!Y%)qM`al^JP07sE-*wz2%KXS%)UGG_N&Okf%r` z<*8wQfwR~Xg3(G!J9E`lu@}u#(ML3(GE(qU;^3CHD+ujBqu4=6UQB}FN~F)5+Y6?}<(yeQ`Lj}z#@O}f336Kcj5nt1nyQ=t!F@}4kD8BS zFefT}T%Ih6t&K5YadyUsUWDOIslJd(Em+hVn{D#%*?pHp+@kS)%-jYj;Z#Muq;yN5 zZ&ZmwpJRQ9dS__T-6Wd}pio{N@=ns#O-X6v*0bI@F!EQa6xl-3^f$fB(LdGuxVdpt z#JeQFuGMCQ0tr4^yypKo23?&Z^Gbe=`}h3TtoY-VQ+;@zGSk0(Bmoa5BcUTc*0YM! zJW($ghKuxM3kV>^tM; zE?6ejVHmw4hv*FMuWa?YjLYC-36-}yAO1)kHu z-Ye$#>@4bwrVyNT^u_P57eY95*wnj2h?A-7le4(8Wg7`JO z3z(7!JfYT5JXp|dXHFs8Ye6-jsQgl1v*+#k_a^8$L0)wsaLqNdzrPQxOH$*2C3b47 z?}8LvuI2^foHjg+IWgwjnYflUZWv*zL?jxPGD8E$cVq#~b%K>3CsB?>^i?8H zbLxy*9_L_p6T#>sQ$2l^CLx_z(D5wbpt@<(SJ2XuqNZw@x@*K2Vs&2s)reg0r=8j= zhhN`x@}1k%_=@AELg0JmfM0N~0yA2RFU$TyR0Lnj8tb4L15-mJAa%tH;&_h)0Y|6dL%)ysAJF1A*oO~t zK1aOk=yFSN!!~5QVlM4MSF~=xk_cvZ--R|T?OEkL`F88q@>LB~#m^&4=L`G=nq|J> zHl*I(Udp=XslE7${Klm)yaU!Z+9f&Fw_JaLp_DycaUt$^;M!AEVm7mL(a&R8w^n%o ze&wb3`@h;9l=+a%wxQV&oe%lb-|Fgi5(1k0Z0Y2PRMXo7(>^H}NQ+N!ZnHT}lCQgA z^}0mr@{{A4=)Z%y^Tf@S&xf7q^QvJ^w7Ry-J0;y@5=8iG7mce2(-ojTMFC|De|SkB zcQ8tPZ7|=2dydwK2@dP`ZN!-A=^gZw3vBHv-woMQC!*wMW=_e=PBX%)n9d{u-Z8qc zE4h4XeKlGjpOGsti!TpRqGoXg>EH^jJsi{*?9FzDBHOjF@WX|O3lqIY7IL$8MXGRc z;e|ExOKVsU<10_*W~OB^kk9x=R=?Yeqj^<-`+{AdN|2^>@vQOO=D5Qpd3AaphYdRC4_I41UjBXO4-!HuT5)FKOF=iw9RoH*m zIq$)0MNALFe0o^0o_Ss1PM4C@Lb{f)M2G4;JwGsuYd^3+VuM|~dO3c$=tI*TQ&HZb z(~@<_7zsSKR|4BR&0XJC94x#ulVP0x%i~cY1M;{1uT7EtBt+=&<)rb6PMWh~&u2Ry zHM9ninO4zm@I`-sys#U=Ci@4@d^OAGz?C~<%fA|;3K+z6b7!&lZ**N*sC}CwA2_H6 zNi8}I&G@^f$6Fva17vgOfYBIGUwE@!ra-X|K0k)cb_wxY zV=)O5j3m<4$#niTDy9ChKYa`_*(!w( zj0v<|@@50Y9;stiyUu(Em(>7r_P?7uu&2nS!U}4*HM8A+!JDzfo^ee<<0N1AhTd7U zE5FQf*P7oo)D5o82=SQ~@RZs#cvBeJl6tz;ehv{ZS}Xh264At+h+%{r|iG7&PYi z3}?w6;i7IE1CVlEqmLe5%mMLjS^h$(( z2~I7HUx)fpl}Qlyv)@elX^nf@|NUzc-j2H@|RDGRROznYt0{Tuc)Gq>9C zJRjty4Y+xV^xMO*XpkEFm3fGT#DoT-Or(e4W~Nrr{rI`E2c9oaF`({d5@Qk_p_|qJ z)$Q|PCnjT~76rEnr3jR=6$I&Gy^Q*Z`@5E$>4TRg(~O=B$)Q0L#{g%4aPMJATnB`U zWe0gAidy%3#>H6h^eUdLlN{Qc5A_#aCNXg=L7Y7zBBFNEF_g+x`{Bd*t^AB`^*#1$ z5%XKZRo7cOK8B|AlMlXIv}ubY%;(etKR7Q~M9k5Q;ypHPc&KU8gt>nMEZWa4dngt% z-14%46V_httm42jqlG$bEy8Q#7Ym2(nDcuInSVfK-k5$GW;YtL*@ws{Z<&-@QHi>N(X=Mj*$b8F-N)kYmld z%uYWsNm6eQg1!xAy<<&1^g2v9u|STNVp#PSlE&o_v`$mWqUDrbqgI^|Rx~=v`J<~_ zK>`z6$l5YGCT)SIE%CxcLh!0$;i6xVs?d$tp*-CMN{|963 zf;lJfkl}bJfCCwUy;YGeF zEb}NE!IE`gbz7Ux^Yy9pmPtduF zBmhsT+XY-AxJP@dI+#0qb3^$mc(jcrKx{`166aU+@M}HKbyZExeEy)L@ zvhl=dYI1mdNmPDFAI|5Qd z?~#r|k!>43qR-F?yZ|1_9;#znV0%Ajm!mFS!>K_}%rO0+!<2yWXjF^9Ey{UfEjG6y~EuIedjWo!ZZL#FmAAOQ{<{l)gWYT zZGHCyChl9w*%{Dr{{VNUUYsVpJTXcd7q*U#xE~%9u~(j3kL$L|OB#!!P{i__D?a>E z6HgI{+ksi4QmKqo1jIHjUO%@y0|0Y?P0rWGNsJEsJ-Xxf5HB_pM-*)5z9$h#w8AD& zyF^WAj)Woi$%$Q}WVB{}W|Th4XTguPp?RVEJBydD>(qT%!rj%r1PZ>lksNmZZon{t zjYMeaY+OLurF{wbGxJ3Qj$Q_Q6aN7F?(|RoyDN-VJlX}~EaY;W8S`@{3gT)tqx>%i z8FayaKroU^yXjOsv*7cBwEIP-Z^S0^XXCJXrnqu1LGHGw5Pz(V%1nyaw~u4OyRF0A z(n6{NCHPPXGmA=;Ly-+DOx%)$ zctM7z!Is9{RLlrpnN}l=-jBpQeB3F+OykCKK;oxUfEtc`9*6Uc%9Vm9OXG~KU09^! zE3lR%@Dh*b{nI!hfn|vZ>_Am>pD-B7M7O_~%vi;PT|LO7$zD@2UNExtC#-iKV;p#6 z_^nk8_eW9~PC=26u?xE3N#0iFjiTI3q;PTXkK#`U~eAv&YmE!iV z%7C}i#Le-#cc-Jf`)G~;Gs$di*XYnnRC-8bF;A6Q4nF?nUHuG7q?~Din9Uh5P${GV z3C?w=o|{Vs!Yi*a&Z<~3dNqAhj*JdYS0M^fVPPtGt6G&0uT^}xn;c>dY!HL}jiItQ z|4R(=mgncx1kGB7QA_cRcEAZ{km5y|P8By`8;x6GM~wY#Wx99iJucjNuADXI(XA~* zN=Tnl7e8+m2U2U$>zb3-BtJC}&5ESnn*x9QyoFp4o;8FcFw#1xb`W?0gyaDi#}^6R z3Mn=gpwfc6IfBv$b*M$r#`cHtyj0Ve`uhd0ED|6E+P!0Q#Ov)KVK?)3XsRYMmmq$> zM6T2Jt>9uk1^GE;b2A;lk{Ew`V#$;mt^2(y*`QV+-z%5AD85LDW=Co|zCS4!kRFYX zyGl6mU-lW$g*sNkU$myDrcU&DAk#lfxPTjYo*ibES~;*677P1-YgR~i1kinhr92k zFefEcP?{FSZ?#aSdhSeThs)s!MUA4CtIC)fltCMvkFq+c^Z{q=sZFhjAPc{|>!Cr; z?AahFCqv+_%J|4nDQn4nc36?Ra_l3C<*@nny6?T3sr#_F81n%e2Xn7+A49JYMG{8=7h8r9o$44V$_)BhtWq!ABD6ztOdau4`W&1n?`HQTpNA1nIdaxE2SA~ z1c>G(kCtFQWe|Ug)ezxM`*Wpil7-d|my*~_Tsn_(3L~w8DW#*rdZ<=#3gW2tZIP!l zK0)B;OIv%CWV2%V`CaYD=7Z2Gzh-7edP(jt#^&&xjRS}`HWiZvO8F%FFwtG_vpwx9 z>?>;?6Xy=Y3|IgCzLO=k213C@g88QS2}5ZQ78P%f<;;^=+X4S_(XfF^P=S=#<*Bc` znmajfv2MSa&j$N9wzkX^Pw8a*CpBG-jErD6HaAJ);c04^&k%)eY#AfTSMfhE0m1qS zR&<+h@goW|@5iXrD4sO%O0L7EkKHl=ZXHk)0qBFkw*{wj&&P^`*g2f;({EbAH0tGv zjqUC8TzZjB_@R{Czo7m)mzkyp7k~daKP4}eGb0v4`|2IEr4uF9wsOMuPod{WS65f+ zM4_|?^bbduGAyi9)6;)_YTGXV-A=F*i?J9^tWi8?W$1i3dh_oof7fs+zAbK#P?q}# zgiy&ZUh-Oh^vZ<>?-{n^Xx$uWssH+Tx$fF=@chwzR67ss6N*xJzWNRgCt{!7M9f4E zB5?+&gaQ8mUlh=2d;DL~t>A}=L);duaLHwllfJ?v&L~raXG{^8QIj8btQC)7>B@7J zhK42*x0U1>{{no>){Y`YKh$W@PQm9w)E$}_F33p7R->dQVcCRmW#$T8s6_P6;N}w( zUb1;Vzw|gJ!ZNAA#|GgB@@zOw(+OpmR4yc8=2~+Tpw>6zkDH-ntW?pLR&~tprt4O8!v65 zXEIE~@$dP9n4d9am^bca({W@IA0Q~Lw>bgg3h=YL+eceiCmgz)E$JH(F-_xw2%X@e zCgxC%#dsG#lHm)iK{j@TfLGk{Q}`<9162WDt*(@W!SWRdCeqnLO%9yX0v-mhoe&*wg4esKLT0eIFzeZPMF z3hbpV1-I^9`M|_HHbIl`TZ<3?-#aHb$Kmh#_L~e0Ub&NAYFAfRJ#8;9(ydrBD*`)X zsh}5e@DWgmS}Cg!_mvo7cHImIgod}-=noXt*T4eTGDy-?8TLz61_n}fMksnp%e@T+ zNfU6cA;=p(l30Jh@ykI9OSCt^_BckkOd|lRf8WdzrxD~!t`?jQ%FgYV5E$cSN73w7J7SOV2oho_zHIp597)L5ISUuax(N_Nl`ON4sHN zCmn^=ZX1=)!X1t^Gzl&@X_V%tJYsO>zs|Zw6Kt0wnrgGgBI38f)gq03AZ3BL$x}qnzdjtXs7CFMKt-P z|C*JZmX>KehR?GwXYp(;kO97EKla{wc8))}gUHq2|LxD8(Vy89SEBJFX801x0jwsPV*UD}l*zXzN(5TRvut=)RJbGo4=Zh{<{W`+=jaS$DCBP1=bNk{_Z-O0&2%~>k z|K$1oFoBD!J*MGP0k$YrXve8ZFfn-VXbL>J?X=yk&a;=w@R9#qd9y=A{cc>f#q68yXyNF&i90sfR=h zJ!KzlXv<`KfBG)DT-3oceG8u=Y;AL z0iS&8$8QQ-dy=)>=Ay;EFICsM_c+5{@*IcFSzI?#x_iQZLjAojCRa4UH)wVW%Wq%y zB>&;FSzRG)Nr?yHaNSW^v&iZh9Rnf zw%9B;91V&o`ht)z&@rPNq*}V8O$$e&X4%LVzLt)?LLh++#IJ#pq6rrtpRDujwhXBs zXZOHz!d-Bf#2a`64iVFpyKhNTCEw!J%_U{P7ktJhNL z{@R#rXxEAw)oRX~HxIq-mRb|;NA@uVBbh1$8I`L@bLGA*+kJL*?e8Vur6r&xz1wCQ z`@zN)1Z&Rr+iJ*RC3E1&LL%8zuZd6x@jGOWO#9o`cOMQRNhkBVm&D;A(@gp=Sb9(j zpOU{o3oa1%vQs?Rn_0NM{Y2HTffRUEePdJJWSVA0@OtWSh=k-AEV*~jyP84EXjLAgDDx!qq<1byVnJhDDs|6f%~k00-0PxUdi4+Y!a2 zP9Ay+`vVOoIs4;y$-6h%<{~A`?9F)BV|BLplieum1@^~AW|%Ge`%B+Kn$OMStcqm^ zvsBBNiKhpwH~4J^=x}1tQ!2+v9+r8zKiSf)fyeqcKciSs%Ilg{*m&p~mo~w8%RlGv zM_zQ5N^IM4CK%d{Li39j%GXpae#vAsR+O<*-Nh%05+(?98GJ!Xy_?Pokd0E_U|un? za@f<7c}Y!9edL(Ry<>KMZ!lX$elstXmZ(Pty9323`?Ia%SDYNltzkaqmPwWWLp*!w zgB$Zr)DE)v5OaI(SGkXhf_0i>%<^S4bUhP%_g1V3AcTHRutvu9$9L9WS+UpIha`%t zb$obgq00kDoaXa*Edy0W0r0N1)ED(cA)qAteSRG(Jfu}S0@n0XZULqbE3EZn+bv%g z?~@YuyUu7Ly{3yYIeZv(I7~*1qoyT>A`^JNCDD^kRRbS^zrQG1oX9wT*7WX~jK9L- z@cUv`R@U&lYbd@jV9V0*2i_-PgVk_lp9UVCa zVoJRCt$4X?%_Q1SYN13JBl&?-O`rZa>oLwH z*viz=DqEyd)wcbB#F(PwldP6T)<-C;Itvo_z|sv z?QWugd|Cq_mY=D!ioP71NJ^OevY|8KXg1?Itf{*Vg~6Smj)1&FnsD|qoHD1%XhmDf zsgA=sRZtT|9%OCDSAkB=tOM;!W^^reia0i|f|^jtGMR`m(k5xvCB-!_!>dX2f;mw} z*_X=V>{u`5Z>d4+3|-!2QP>8?zZ%2F;<~)a-&)Qg?@DYY6Hj@6lHl=F+CIG*?XE)p z)ko)y&DoZ)+$pJ8dZD60Jex^W1n7!2gSW`1hSaEP4kE_OB^9IA6pe4JVsH;;?sTuGW_?Q{0%Bukdd(J(UpvdIfU02vERVT#bK z?UWf4c0f%)Ag=GIKVN^~c78IGStOts7E?kqTE$I*ZhUte99RDsv%DllmM^Wrt8`(k zy$%;{C$Y|)ZPkL3-?xBblTTnoEgU2K6x34QFr+x=YGNR<-sIs^ zT3UOw$c3|iX!V+sx99`YF)oV2g$g@SYG{c+PD0RYk?3AZDD5f*#qinI-bx5e1-6yGfWD@~sS zz%E_gtFo(^n@Oq!{NF!W^jY+)4<_Y)H(rWG{K`-AtWUql(RnLRSFe;!ZB;=b5n~cf zgYoLE^8*`eIuILEf#;Wk9LuV)XCcR>;jrD3&YFe@KSQZ zJFx#HUUTQrguUz=bKUJTAWm#*(#u}Xfx4{1aB>VJ!#j*vAzNw$`Xs5`2ux05>H;NRquaPCwtJpXGfyuaD?gA@{ zdrfUr7OI>k)8kx0M!L@iq*Jo5CH09< zoJn+XBXFO~4n8OheWxQBI5D{tTiT`$*pg#$WU#Sc>#T<(U)l z>6br(yB-U6m*eS(ka1pQdr^i9GNFr4ntSV1L~9HbFl*5 znVw^rs6$$5=P;T_Sd?I;)y1rs(}g8>O1NY1fgUJ8G47vdijXufvHcMcR3uWO4#QC7 zYy26-r0|Rx`FVo3?`o{q#xdA5p!tFDbqhtYfkpW=TZFW#2C3nWPk212wET!iM#BrV zlQ=1tkvLgO)#)#8yilN)vOeC*BC)|(YhaP(n)L(Mtpa`#bq<>i35|{==lmwMW7@}i z0$91VkP)ayKkU@U!Rf6p^cz4>{V*4DmD;q@m)cffRx0{KWWMG9JNXdE68;Ec$SD&} z?B-`f0U6kFCi*b8Xg;PcokA+?46r#5E>}*M{@N)s$seXeE2}j%D6;tQst(+1rgGV- zd161GrvD*`-%7FSOU_8P9hu5Z9-jIA2ohZk#wB5Ll&m3GYS2G`qtnd1NHYDgkT40U zblkv(RbSUZ+q@o97jJ3Ha&^6#-AZGA|JsD{Lv(v*=j-3sr^z(7|I(&8rzhua&!OSd7_=7)0 zkoTGOs$6i16zZmoOvWw`4-WwhF-gu?$L~W)yt<%)DjE2fQ29q zs!eu|nxM|EuHuGjqB3OjV-eFD)v1||P&v_%;f~lzJGaBWuJ{&^oC;9>M)rv&3^!Wu zhu2iLE>M+|I%S}$AWY$4^Zs-HiiUsb){Ab^hQ=W1&UA0%uFW^(-~4VO90OT4;NttZf~c|;Fw3~k^ZB^rfE#27Ufb9i$uS} zE4LU?uQQ0DBF>Us?X4GCXFc0j2*MwYdLXU>mNoBvpd)S9^VOtD94pLt)XASqqwqc} zE``l!q%bpfQy>&6<`o=I)C)f-s!K-AX@W+|3k!OsM5~vMfsH75b_P4gD7Z+@s zmnO^~z++U!eP)#+n(&eAiP!}o@ABp`TG}<*=v4*%oJW+`>P*#pa4e&AN()lPLd#V$ zBZpd`()JA!$R{iy8RB-tsEBh*puUu1Gb&FjbhVLOyg1+}QT!0Lo6Zw#9C*MVj^>20Md*`dJPFU<-g5B;n0vZ(;hp`E4;S{0*a~{V%cHi!E5nOe z>1}JWw>>tMt7k~idEi-H4WZZ9EFvAID5of z!gg@)%7vf6Dz<-6P!b2J6N7a-K%zLD3FDHHl5XUAe}q8GLTPT!O~z!CyNG1pRROiR zj~C73=J1f#LLX#9`BQlmHTsrFHhlVeam}IhMmw`PAS@Y^Fx6as{|6hEp6!+-MfF4t zsp?t7dv{k?*H53M22K1VB69Qc1Reqj4sQw@8@VKZ@0Cm$oNg+*fBhQw7rBuBE(|pX zt^C*_GG`_U{tnKEMR4<9ct1qNlTd|^ox1(Qm;E&8GarYukyS7vUqN=P_2P8e%nuM{SdJIAu5 zPic&oV!*P>gAh6lt=udo-~3iMl`;Te*?NjBAh25k*=dPoM6u)n>q0=OD|6XOCL?%z zjP0AC(En^dsZ5dKF)*jG1a=X~u6-^Wz$Gp{xWMg`{x$5DfKg$NKGFr}=P}14!(`f#ZiOc~2$xQ?_^bEuBGp@( zB)$F)iu(hVh5gx-(P+RIiv(O9lit+@x#c6!m7~HxK2bqqJqZ-sNR|T9UMR8EIU9!l zD_-1U2-kfvdAfpgM=3sVTeOArP!i@qysG$1E+SL3^t)myTc$^3F6-4101c(D#C8ArZ>5%%ACSsqxYQyTnnY{pKb1wizG|37K9%P7Y$IJk5EKqOVZq z_7T#IN=@!h>*R--sm#dzoOWt8K14PVp|ji69;ZQ}lv;u*aLvJ!>Jht!8gz=BZT$N` zjo#0~#~rSJaa=NzF}@mwl9q|-W4D1ICJj@MwDgrW>=aYHj8dD$x!2T#Re%4iZm8r0 z+GcQe5JUie(tK~wpOe#BEC8k!T#yGW(L~JBm~+xg_$xj&WJyBUeKw5{5hoUo zS?po`ygEASdKyBD49}T%O24WQ_6;fR-;h8|XWvg+aAFY(2%txlCo?%Zh@KX^0ecDno#N36h(vnlJ#GTxNqs86*Bu+z zu0GHPvDeiD5UUG9s9x{J#R?LAkV$+@{40>2XAGWWV*m6O+V5~iMRas@RLX3++3q?$ z(5>vYm#Aj`tKK}K;n=5UZ61nzhp}^mk`tx#+<6N3(7XWqDR9s&rDx=3+7ZD3Br+WO zj>)X>RJRI9Ase%%0j8*2$<)q?aokQ~A#_|!fu|oVvE*?aCG6Pm;MTG>#k-wa!SG4A$4>$@_y+}GR_Yc(3 z+vi1L`X~u3)m?sJ7HjBJxu4BD_iExY>X~y>bb>$u^1O4!I`Oyjuv9oZC|t|^-N{Yi zrlvyr>QkHvxXQA|W0hbSa;4O-FXo19k(nq8%Xp)Fk5n%Vq}Rh({JhJgno3s8{Fi-P zqu~(sE7O>-M)(B$7$;5UCW#e$c5&^Hb5I1y=47nDER9+Khbf? z4*;aSFdJVPa83c=6rc>=pZ%EK`T9gjcPqG)6toqcwaO#wfo|5s6>5*egO9mDtcwO? z-8PuL;40U`TeLlsR-F}g-o7eV4FjR}5Qp$tzS{V?L&9rFwwq<^h>tMxmj;`1jKz;JDJ5`K7@I41 zq<;%eOR9AEWETJC@2tI6W2A|YrTh8%9tgg?wq_a$xcu$ID>B0m>p7M6Z2xc#)D>91%{b%5Ujxz?a0yH;LM6x{cC=o_*!B?U zp#2#y`7^D76Q+(bkbobbvm;DnreC-nX@k+=XDOPZhX#`B2_3Hje*yF&nWX4$NoN2dFmeyT6{rUo+L<({1cdCvz~PzKJBX;WiLdOP9?m_ zH?E|N5hcf0+v2u!q5XLKZl(XYQi?U;}f@*=;ILCR({Q-hZg@#e&~-|H2aAgV!mR$(N?- zLPb&5&CG<#y=7P~Bl7k25$ofHr!a77z6JK=?t7C`kC+)J0w2o>qrIjmWt<>GpMhro zdJ#wRHPgV$36KT? z;^+SV4$&W*NbbfbBx&pR(`S#9x7-t8*^dDVaAm%v*!JhlG;DA%A3NUSLEf(rWCT0XIEN59~w zav!AnrR6P;9AC!B%FJabp=8rDS4zeq8X6#Z4OAX-T6iS1;#@~cE+GSph$v=0>)zKcJBH=0c8-OM80xlD`I`-p4? zoz%vb`MwOxwNE>!4wlaxr;_o@vC^sgoWEGmvl@%r(}UPI)^)ppr3K# zml9)HY|Q~B6Gm7VLd?YSdyFZ#*PPqU1JC^|C`N>HA6&w9(^ZYXcA}GJB2F3a<_WD&EQm z6Su?e^`h27THHxndr#M{fJx(u(XW4R^QsBUueou$Bg3YN^(ks1OK4Z)=Yn-J8YT5C6@DX@xzhjcKp+;r$IowIO!PeH>(n6$8$UuPX03KVlN8wnyv6v+dGRi;$=ZNr$mKXv08LIwB z)&9w-G!Kah%4^1;@{Yh>ZC*c6>e zTgYHvY17X^8v{Z=WRYr=%uzK#u#dI9aP!=?=NoLeGR;^kngbG#t7f7TL0sfKSLvZx z&}Mq84SR797oF(hH4p6wCPpLWv>AxFB9g>7*`yOV&^+B)rIjs7LTO^-830{wTeUk11hy4m*TpTNz?3hEThJqhRVRh>E`|H91Wt~ zMEn$6``h>R@fv9A7R)jB`{yc{G#CzigUsl4-4PjmOM9tgOmI@TpTgChrsSQO`-27o zd-Rx{oSnt|UjcOnzzy?qSvthXat8-*Y)~T;1Z_=Eqf_E;qDzvz0cVb+5=k4T#5-nI z?hAxqSZD^EK3U*3eq(2!TrfZ)1|m!Rm*d0HE7XFNa0V~gN(XX9SaNy5v!B&gmC};| z*4)s!nabz)mPPlfMOslR6p_t4;CM{Mf@4n-q2U4bWYQ4O{uK$ zSg{!9K|*QBt*^7-@mn1@cFk6XS$VZD04_zI0XxACkhhsX@MTQ{+e)B78=yJ~3#O!x zyvspq=F;IxY%{mWbA#4JpG-?gY2eId^u=#e3Arew+QRu!LH&;;%EW4zssh#!gD{A2 zd7B+|RRmC#EfNPQEY(O#N~Cq{GlML7X`~@3c~HE4icX89WM3gogL}F)IH_NHsmxgX zidj&+%mXS885SF1D<7P|A-;J?w4l;b2E*cF;K12XbjIY7pV_u*Q|r@-A@*tMv18=w z{-5&M=)2XaEGr{=5SF4biwvw#&AG`^A`22E&ZXkrC=pgH78{Z~vVh`fvco8CZQO49 z@EsVY%%m_-=e^^@SEWd8<~eHFvJS<06jHuy)XbukQ{Dn|IR3QaZ#Y&^2ynaanGE`7 zIWm_qt#*x_ClQ~lTEEDuCRS8(IYoYUCLhFK=(%mcQNS?Dclh zxjBK>hVL#8q{H%Q3=wnlrF#h*Xb`M@)2fUdk@u6|qjvf{j-0V}4=*-`S0(eFPb5-H z2VU@)qiuCX$10lklLl5m%&#_#wP;U!@7f8xzWGyk)kN{1H8wWhd$ZUpn?A@RCAqTn z|Alwet`=wi)Bb=3t2c1X0y|`dEU_p;f??zrdm|Dy8KEo6rtGIurU|qD-mz~)_5-Hp z%$gd5Clnf^!S*;bAKbcWg1)HAn>7t&J^%CPN1Nac8-(V-qWoIVIq&pct=K*)m}Wz^=8S$L zKp9Q`8D>t+x5$QxUf62F#HMI8r4GL@wQ$vAp^%#7(8Sh(!C{f%Xd3dxlSj!J%d|7I zvjF>AVm4A-rF+*=Kq!K%bt2 z-BK$*zvNIQ)iY{Ls>EjwtJpueVIEiJqR~1Up8nm9B8yOET>83XS6O3ed&1V3PCB#o zFHb6QPL&v~0IxVD+TCHHJ+czQy8vf_eeHu-{8)241Dug4l?EeLk;Mqxkoe@Kq~w|3 z;r)CU_3~aNX*#-CpI`$Y)-P6R_!;`MmFWPhRs7*!r&QuiULdRP=i?Lgh3rQSDmqPw z=*W8n?1z+VbYrpb40!5lSKJ`vn9u)3J#$onq4WsY`L?#V0Y=E?-KLjhggV51sh4NK zFj_lR>+C*L4aM~nMk;~s!lz$Ak&DfOdVf02gz*mF=a7TU1}`d{TA(EDCvX*W44D09 zdQ;C}LgU&U983o2Mi-nRhO!X0C@hSvh9ypZ1S;E8%9Kb!At4|eI-yJ=g10vc1Kge* zVeFUb(K?TOA_Vb&a*8?E!tI5>gk>zuc@ov>m~ph0ui#A8z)|3 zQRC(J6#y@PTctKCtAFAct5_`l$_<#ucUJ#jb z>qN4mcs9HPmw;p{^EzcleV+hts;<~$cp@cqeYO+wuRPA!Ry85trqSa1#)@PbJ-DmbuQ zesr7}m7!wpjSv^)o10_-gS1DRYyY(#Ze_WSY@jon(a|F??9$B^%JXyUqrzswe!4Orl6DfXf8C?j52rbCq9fDw7>UI|i@ zMG24FUe2sF=qo`=k&luTYah{JoM!tK?hf7tn(2&+dW~51AEvAt0r6VU(&Fhvh)6OHAk_u~x?RJZrz7%_!{ya#;TtLxnmF(sk6B4K ze&>xr1y&xSN2C?;lRG)$pg~YIVZw|qC-GW4dkXar-#CSklA|JQq6WwI5d3jEOe*MA zQk|-{hs7OO2DF0oV=N;KP~Il4S!gHD*FsD#44ac7GF>yHg{{8IZCtexpvGH`{;B2n z8XL&>3wCmBtfYqjg%$w&OvHe;z2gw<#v(3lByuspPK5llfPGUIbK6-QV-T(%OdjL_t~v(MRI?&15CxjlL71MY)m(R3k_!&^3gLd_hg_MQ{n|AE`&O%d#^~@7?5hH({`%gUX1e&yn@7o6eRhq zbD0C9B4dG?TM}U9%0%5Rib<9vq*7j1f$Ml6TxF2lKF8M$qB(Q8Opo)Vnv*2CCG_^PH;PB zns2Z#LF2VLne(Tiy-pmKL*Tq7oo}0AGc->$Ln^ulW=B88nAi`sV@KE6Txb$c|Ia0S z4!Ai)36Z&4j!uPx-Lh}g$rt*v-8lYYOIH%1iz`w zhfB*k;L{VN)x~46gnSN{qlO?|elYW`Yj1DcRGPI^ae>z$J}|o$hlmGL6aQ`h5(IO= znTh;|Y1`{>ePV_k5UaeL$UK9)-vzH^s+2777ZEw~N_K{2r%2VUT= z18y^7ZO=^d!>w@L4d|dq%u$P!$QYdGHi+ScU+h<@X{T5c`uz)O4aw@-ms>?7p}9cg zr?05o*!j_8e>+7u9;v%aLSv^%RH2I1^wD;J(nk;J@Wp~Iy*`r5QhaJ&5=tL_5+IQD zAB5+-;XMOKf+928qd!|qPuh0_O$^*({sI2K2k|zANwJGK@0jl`dsCI*3`i|$zJ!BK zXqa&Voi)>o+2A5#TldSRb{{L}o=)Q+(LkH8U&brf6G{M<RRki z^g#b``B!Fc4+t=x0HdgXFVMOQM7Y{g-s&)QFI{@4@9*!+)bap|3GmO9T;VB)^E3No z)@p;%E-68F&i&oP6%+{DqQ}g=%Q4vIvBOT}_s4=HZgkTu;XP+9fO|jBMpN(Dze)xL@<0on8_(Dw|)dy3UM?||TTQ??1zN9^$ z3tyAWX;(liM~q+{e(){Z-2|QI*MJCuOESxSt=0mpOT02X*DpObXS{`nqwSXAskM*P zh^4!A`wwjhW=v}1#>Ffpp7$Jwx}I*7#G9y@p9r;`hv&UNRh3$tr;TzZPFDV=xv?{& z50X*hS&wQ|$kMaW;r%ipq5e3eMhscZQMM(^@xtjP_b-df1&^fW=W_m9_&U1jP*EF+ z3Kv=yqJt2?Qd(xB^GyXa##)YX?IT|G?rph))sKz_T zGPSNyO{7-OG!WR&zVr6tdm={tuNjFItK=|vTFd~I7e8IbuMjU&2H(((J` z^plPA*>$qTZy4Qgv{98B{j{MdYctU&G#_c1Lv_0In~^4VtBj1;m7f?t;En52!9A_e z$x&SxWm>`3^`?Exf$vW?h&={((VnHJlA?21tONRXyEHpBkeqa72>PzAfE=&}g^>_M zaTtM5{H#G_^J~Y*>Qq+ZL?s_!_*^!q7;>I&|xdWMC7A5_C4VLSt3smjJG zw(6+9<58gz$7!CXL6;GNh>PrS5AWG8u6zo+%{@RrHi`FxBW6YhfyEJU5M3p{I8v^n zBLokdU0?tFuLLxXTi0Y}>KW0~%B+=Y&7^$;IQ8yL=lDQC6r(+I9&TwJXrYM$AqX>J z{hJr#XU;LQsKCKZQK9|gP?z1^pS@0w5k~ZVp}wLoR!)RWt0dw9&aR*LH~;usUTji^ zhTaNX&-2yZpbd9Ncef>en7c>s!C|(HIuYw5(Ax6#?HTXBL3#DUBSaSXoB>ur4>FK( zQ_Ux??k7h>0OmZxx*8phXkiprKcf^uR$kHfnh(f++6b(ZOjxLweZ%?mR#X8})Z;1` z&C+4bcmiLT(q&xw*zQs`3xtRX+}+wH3pNH82yE)T@y92bigw1n6Zh+cc`9rw&JKaW zHOWf%EvLMvz936z$b8vhqSXvrw3eOdea2mABb8gS61)i>0|kame1)R=O_2V=r#q|N z5*v1^TK)4=g~m{&c5GPa-1tfgKmCC7!~CM7%M_NM?H9M@92Ihi<61?6j`V~BkByv_ zU-?erhqv`gEu75@c`6$9@|;H`)GW4`6e^{Da5htGvd$D4O!sGAqfhr|VD6^0bjw~O z?Ux!49_Q3*MV@H78qp}`1}iheD_$96unI?Fk#l2JI>TD_Bc7CF0D|1v{637lVm~yR znfeh>Tbp2yH1zAfsOYEXjoFjer-!F~BEZQNnrh*;q>j?gC(BpZL|khY&Y!IU3O4v1UEg(>sJ^-~PzUdy_WFB!5AaljGDN+n zye}G?n%LPW$}0dYp*q$Ir7SVWr0-AMyk>N5uT6l70HnD5s}zkfEjmas!a~@0Vd;58 zNoXxA)Cg4<-)DQ={sDYQKoI#g@R`pe7dLb?CaPmKJ75>k;DLtB$n5fm!$0JF zEN)pe?W?DzYH-$q#?IBsvmp&!{ZBBpHOJe^@4^{E!-TIisSCpLHHheC1+@0M%b(}U z7As&iTX1Sm3J!fdLi{M2BftE;yo~iwZSCml%AP%DuF~7Y=9Ib;&07UlYeP&LDhy#{ zqn}0OjWHMwB23_miXC**a}*^gFRwk@dtU^BDCrv@)}^t1Y^#byDQN~k+yD?Y=;`{W zoT_iDJsF}1z1+K~^ux)f8Sx8;Vg3w%Sh){jMKk&Vt>3{U&R9~V80Qb2BuS*pe)g^; znCU`pL#hXPNUeq7eJXYyhQtqsFN%&dpvJ6p2yzjap5kMQf{vgWoe5qR=@w)08cu;q za%t^0y1ZhnKGm*rJ!qXVU;W6eCTbztHao|HCCE#Y#R`iBHguLb0>;4BDPjJAy#HL#cLW)vi}dqWbEi(`c8osU&0MZ z1r2YI-b>dcTtc0eKD7zy-p$GpFeHF+H{uG^3P(W#cGhMy%!oMTioBSR`fTVIX;WY> zF)mzwjZs)e%Sy7wgU{^wN!+eQwx58qYLgJ9DyDmfM$`FU*DAi3xY9+Tj&VRBvm^1$ ziMJ-O!h!~5lPTr05 zyC>FFydZ8J4xpL0bwdDYl0m_B^7Z24;&?Xi!x~`|jXvAXXz}sR#6A|2pJ2{22f{>o zAtpsPeB=R=35p~mOkA`Z(Pw?kJx=~csH)wmMo4W=8b+3r_jByK%y(_lgI*@*cx~=z~qmV`*1>{>fq?XQoAJVd0uS{ahlANBzcy>)s&iBj4#*fxfItr@K)kV$?DWQm-M-;#4fpe zDpq<=AF6};$u1d3!C4^XpbBk1MjZV;*v${|@)B1ZSlHjFv9Z1OP9^EEV}tgMN9EKA zgeFXh1_y%El4x5J@SOm16?2+W_IbJ=kRxk0*vlM}9o>mU#55#1W|L%mzjjTq4;`9W zte0={XVj#Y3WeE?J!Tct9Qj%Q$W0ui$!+6n|B5uY4gl0;8^7T{uU&Y+f4dF;hR)u< z-RuWvA|4R&Chb*o&74zzJEA@q?uUfNHbd^|4)X#NCQ2-`ddZ)>jP3um-0$%!&>SV% zfW!dK%sd^tdM{8DtmRY)kOIHhGvM9;Z3(~u541V~v!mglE(i0SWB@O!z+cCAr;oB9 zercX1wS-hmEGLmzA4SqIdwRgNRSs8qE{OpZKQO@HW%W1ug^AVj{I^K`+~aBsu6NTO zZ=>#md|Oz*!-;Q5%SIuV3P6?Kl`HJC2;Mt99DeWUg;QQ!PLT#BbSixiKf**_FNKc$ zyar;B(s0!kSfcoQa9J0v0KyPx&C+e>uZDqphe2Idl)a;I#onm|H#^H2bnPrF?RVB2 zOzD2J!)W4(ivt$;JtwgcpdiS=b&P5a--x^K%rYFe+sdU|wZQ4hulZL@VKV69;C;{Vi_-EbNjahl5_a1BtS;}H#jjnSEP!< z6ke#CYRr(~(X&H%6xYpLuxou~b%!p=KdvcJ#cn`^P&+hICAKFe2oiz799yeeTbkG^ zoGV#|henm5%K|A#Y+Xa0QS(wZMH%(QW%ahPobw!s2VSl~OINzWW;lP|Y+ld5JBt#5 ziw^4FD}ApcH4)eC1~u;dZgb$@EE@bq9PfkR7bT=1H@z(KrI^Y|xgS^Hd{ZLr=>fYb zATJ_)p~w#6Dgw|(AuYfLwBKZ|LLB?rRD=4jxsOdbF*w4LU?f|4xW)Q70Ez5U+Oj5) z^aPzgy_A(tj~cVa(qwJVrLCvup@AaxgThV?uAa%5DM3;cb2Y4Ho&`;)-2$hzOvV_= z^5NC@Q8;i^sHq;W0Be{VAbCpJ}nAxjwU|W$ic0Dng;=^U6vmXm^ zmV|2aH%s{d%YJ5EeU-)l%cnjweL=4)IC$_8w-tu<98WZ(QdxV?uKQtkWgdxk@_|Z# zNTFC-qRscDeGzg;cst5+^3vkgI1K!{vDou2D^?H}t&&!@#y$)?WbAwMh~a+dfFb!O zq9Fc%r&YE?^TmFBG8%X6lNj@@&zH-v<&jnm!KFqTVGrFi9~f7?KD@-I0zc zVM+6YJhS3@!jfpGyjgkzG~pTbZQewD4Kpcc6k60k!%HrPBd5kIk#7&lS zHB4R$ECz{U# z>K|&RO7mkJzC(&H3*cktXT7oV{)T^A8_Z1~9zq3ve*k5wR)^{JoZpbg1*q_Fx5Fu` zRshgifR6Y4;@oZ|DlF_d$*bFj*%3AW?KGb}`vkd`bsj7Fzs1Ea%`kbSW(x5IGHc6< zFn6WaWnNOD4{4~q%76wc!Xo-cf+*aP4fnv2R3Iit5CT=Y=$(Dh);!)Lg*r8X$7(3U z8XM6b4ek8rsP!V__~~`5fY9hB>1l0D%x^1Eg?bWuTO%rQi-fU+y|X}X_VfB2UQiq0 z59Q^kX9PS|=@32y8}sUlX!w3mw4oU39m1BHlNstV_NQarpn+EZSd1jN+(7_{vQm>ZlrjLzf4b#V$N1A+SEJ=qWlDV3^_{ z5WcKe0Vb2I;;*M*n*D{dr>Bf}U@Z6??mapY^>{#L}MiS=6C{GvE?w$Ts9jlomsm;pLgjgXg%UAiHyG(<78RGYu9m-2vUpD z3Ie&gcJeEc{`+^iN?Phm|+nF=>@$jS?v47xulG0Z*>$eAM z+nt^W`H5`wkp|SJXf0b?njHODh2@CN@v}0To{7u!Y_U)uC223120?>^8C-~a&-74k z;dN!x@f0eW!Gc2D@NWg%PQ&*No738gDyYmj_WfQdq8IJS@>INTS>5pc97W=t-^9B8 zlRjWOv@?xVi5I-<0r~RyG_bZ;r%4{@c}obr)nDmg_ys79pwc`CwVWs5AWDNod=%4#=u= zDW<-{CyIPuz%0B|8Bm$0q$|uAz(2EaMZYoOo>v)R2qx;hSeDz z+T8{AK9qRH&lDm@%?O3+O%iAx4wT`+NKMkdqf_x0NBRk-{+Py**vOn11$DK?P%2X; z7g>8B_Rc!lRlL&xmcr&+Gt@r=Y?a_F1N4tLmM+$WZ*<-FWpYkBg8Wxl!#kA9?Up=0Jp}IM8cr<`#DMm3X6*=q%^9eM=QgFkD5L@0m#cTPP4o84Z*ZbVdHC*iIE)mleKw&MQ99 z7R)uucR;icRX_nb5hfHm$;b91n|%9;R5)1;Jy3xWn(8??^u``zZ8db$}iU60zosP{{8P)@9vp1MeaB^Y|d}G z^qj7D*;X=I=qk|&Io|+<4fw-N#Gs=16ST3kt)I|J?pBIy&VquiMkju-wq}VU+ zsp!#vUtiCox~vihqiUPGV>@|Q-d|q>Bmr2ao!RE=W%w3^8fqf4Sm#>MC*+XjsMnKC zV;B%R|NRu^s0jn7xpQoM%?^E-(>P<JSmEU6BTq%8G zi7P>>6I63-nu%k&|g!J5H_{TILNuDn-&ymy(Qh34S2U|s){YDrBb0gEa5p7~?{VI-MB zk-yym_ii-m+UG^4t_zZw3ck;w8j*A{bbAdH+6l{)mOFHP`iS;4A7OtMSxbdSL4h*g z@UX_;!ho3&IEc4sH>0i{v`F4!AI9lW&Lo1LA)M3%(*efgz34@FDaopXoiacWD%&cx z!_s!nYAX5vXgbTNsNS~=(;y|?4FinyfJm2g44u-Qf^(y9x?pw&FXLHoXh2@O1+=mtU z?7-m-Z^=?cqs9a>-s-a+4Ffm1ywN`r{A$cC0f@oq%BaXKH`=k;wq<=+`Yue?S-<2# ze?n2Nff@XtLzSSEM2VXFPKZQz9$8%XepM^8*eHFmCCo}WF6HBm_P7R=Vf&MA_0oT* z%=0C(+ZV5y2?rjo_Tcx@IANzHvaR(2(_XfS0j}RVcI>!H$#Qbt5`nKZP{})3;tT1@Ix@nbdrfKBP)rR%gx9*$+q<7+M6m z2Jz!_K4-$%k&Tj+S~3$QnT=9W(R-YU{$xE1feFjy=E`x;fJ&;UpnC=B z+Xm0%f|9juunJ}(A75m8KJIWRxCFq3S^B4-aWq8nDzE_Jht9~+4Jq;LGDS=PZU3e~ zkDJ`U8oq$Pm)B`NI^fIK$-)-3_%~rjr$}D~XCWACw?ruPaG%p(@V}d8EJ7u%Q z3Fm3<Va-L)+em6*c#8_erRg3WktQwGNoO`Er|(<^dTriUW|6lyxyZjij-THxccoh1oK>bdov2T>tg^cp6GEjjA;xCRTQP`uWaMLnQ;a&^?a0YM*0Q$v_8Mwf`-Cbk8 zEFocGAZ_X^HnmVn3zDuE5F-K5r?rUo7F{d?3t-X_JsVNVrg?|ePNri7o7c{`>f3pO zi7>w3_|(1Ys)0Rj0l&-&rW|6~bo+WHt3v5^a)?ZYv~-ZEqtHMdejWh-vq z3M-}F9j9nML$@xxJ;QVkuHGUt3?3|EwZ#+-*KtjN*E5497rxZJ?lD3wf-95l$^wRX zz-DFJm{cUknR0n&F@-QxCTvBNdr?pKL@Zo`ZH_a>YIRn9gYRlho2PC^A}kSk)S8y^ zOx2e3{)62&9Bc}VQVx>$Z}jvExb^c?RP0sJ6{Yv7YXbwpp%%Qs+aY9pd1u7Tt=dE=f z{S9M-3YWVnpQu+SjR0~}VLuS>&TqUIT)?P90qe_!CRU;zYC3YoWMNRIT>{@Ih9{UG&W^Ll{Pq%hlB%;aXOT#_4 z8j($cRDm=jMY!EUU~yUS{s0er9f2~YP_P8+C&!Uk%k*G8RW2LdIh4<8Mv*?bDAREy zA)v2r>i+v`mTgS~o>Eg!FBDvhfnx`=XmNPiTBS3V&R$+}WP-g+ydPxa)bwy*dvx2y z%vnVI=3DV}y04n5wLaC-(M1Ehc|iUCzvLU?1HRZscyDQ1Dw%Ozs)FaUN z3T2M9yqFW*9l#dth#qyLR!wF#?uv@6vRZ|ZBn4x=5+dP)&m&>Wc>SJjmCh&0)W{dX zuZ7u?l$p3LRII06=Azn9nb~fNAT^4zxa^G*`!m7N53N0_Tq8$V&aaG3>aq9HIOWY; z87Av%H+bC~b1HPXbWKK~JgPd648`peQZYFA(iGtt;4t|=wln?0-$3BtrVXm3h4FqW zp~z7aN4AUORFKJ2YGKe?_O$t_yuX-+Xm6JGYJV>|E?ox1dOR{Mzg$#=4soo!wq2$@ zc0wwnC#Kn!1>TCjpzsY7QLG+I`F)vxKX`R}2HSvxY!q8-!l@c)V%?4(#eGxtz zg(nL*9t_#1Gh#S~x~~5lIsU!xG2H$L)}d%wZPk&AyL}RrZ1Qn!l;R`fI0f*Q4@bDe zzYMaPM&KZJ~k5X;#iD{`b$wrF~I{Da-6yEZD3dqwCXwF`9Hgx%G z^L_fiNhcCDyFX#{N~QfXa{?`@6lp7HqB{Z5?^ks?5!1Jm0xDqnP)n z7L<|dNXQXL`JKM@MI+{&C0p0k*7I*o5PcosRyv}V3cL-RGo<+z?u2S;0C^3P1#?hPnlYdOxXY`8Zb#1?6( z+=J``yRCTR6@F~gOP_rxs=cg0@N2DDQEADvM}px{Yyy}E1S(?bXemlFCgd{{v7{_o zG`~@2h?VEZ_R+`>aB<|qZkS&SgELKr~n;^?-tT74tsWNp5G;mnDS*^DWb$h zYaSjX)}SMztZ17$DZ74~#xZ~Q$7y4J(oZP)s7= zG*UmLPBS0epHvRAbfBAAJM^ky3}+?cf%O=NB@-?#EH%V?XUF^DOvD1Myr%%buTS*R zufClcEoPp0F;wxE9~OL75-j9j zBpZY4eAYD6j7>xYh`{o$pB-nyZI!k4J^f)_v1C+6?%0AC?9x*4iqXFpcgd7D#ZeZ} z(u=(I)fP%Kz?v4z$zCYHaeA(mML41YzNT=)s!~9fWa{xhTbd3-L)U&#Zk41Z0I{lX zsKL;YEF;%mW^pofQK3WQd1VmAdXyNAtje@kP-cOKYyX@p<8_Y%wSD*f79WgTQlLfs z#W^YbAATi^=Ikfs+$0uNarg`D^aBoJkZq{5R!Nw-tD%BE?9qi@LE*~#IWb0QM{sL+ zeqx@fe1lrFIVwg-dj2jJPh6I*Jf6}Agl@FfwKI07Z-F?rHu9_n-UBN`OJ?8P9RFch zE+cp|#T$Nkz6YFpkH2Sq78br@b$G$>X<@5-WewTppFaNyZ?qgx4@cXS6e7a}$MtkQ zXfG9-qc~9@ZZ`?R=Pal^_D7*1O~8jF2KTkD|EoqL9jeWls$)JjQP5(5yefH@;jL@r zNi!;FLT-=T1+u3O0Rz%Hl`kMg*sf=_BI_LNYUBO({ktGgFH(jV82IuL&b#aI>J1Xa z=2LUK(c*|tr6IXODn-9QG@Iv=QR1&m-nlQ&t8I)e(-w|G+z`sxZ%Bcg-1vRMJx}Ry4&EkYiSzSyv+rfgM<)Zwc6ikDr$`=z^{K`grb%{rU zs5%BBAUzU(I^Qsy+D^4_A{E=3cd}40>=`6B2|3YleK&R2kz2gKOW0k`d@NM%?JTx8 z)GBI7R$>A?8*kVZkn-y5Tb+^Z$NQ5dn7&rSyVw8EJ$C${i4CkYM`C~f9W1v5%9SNU zd^MU%i>2DwykvfqLRFr}5~PmP1T8b#gp*xv)Cycmg_mLX4nc+4ijPv(LWb<$G<_3@ z4^&itM%_xQ&OrWe{h^7oHc1;%$J7BwmB*lU+m5(QpTIe*$RXCYz8UOlO`;y*ckv-e zYzBhg$+>hK223z$ML%dlJL?XW1m1d1Q`%HZKm|8u7=SKDl4+mv6YJZ&S)LNblLX7K zV9YH7%9WO^5qX!a)S<+pSg#-+5nATvQPlS5rUdARMV-I>@{461vrOYmhRD*5FbsEv zIW;_3h0L!dbnI{}hjgJ~bZhW(^(g4%M~A|N;{yf8iAEeVjOnDF{f7{}q~k5A;U0-D|8<8BM)YNj97`JXDi5b%W{$J`ER+~%puh}T++=fr@cTf8;!ikM; zJ}F;#KBD)fFmDP9)IS<|$gLb}FW&%87rrdx&cv~~*2KV!(Gg2_#B07cgbj;I!N*Hd zai4r-ngP-C_Ax=;`^6Q+o~?4@ID}7vtq_NeA0BkZWpzW7-i3Wp{L#Kq4nMYUx@a7g@RWR zGfa43cCnn~$;?{NvU%K;jtQqEixA;D zN&cvLiTWf-@Fy{(KnY&BVmj1MO;E1v(&8Oyf_)wtI_=Dk#@%UjEH=4omG&+b?21cE z1qdFiV5*BVmj}Yf_aW6H@7riRe3O||9MGKW;Hy&q+{-ct_rgdM2Xvkl8sJE<@_jR8 zyBCa+Xos%I-u54BTA8c;mX~iyP_rJ%8=sL(XVFm+LR@SM4ePZ|Au0fNSfJ$9e4Z76 z`s~U>_QQr+EBpP7O@)cPV@|eP=VxAIEp1wh^Y><1S z-LxT^Zz60~bok3F3%Jl7%|NRKFX^MXyzy%Ca4$onxGK7~Uoo9FKRq0so8$3da9JDN zd=}6B%jLPrGOn+Q2j@>T#POv-#_w1v+;yLQb>eoFTHa^Pv7F*Bg!D6 zdo$nhaLU9Hij#Sv%H^|?%Z_013r(0je_>wnK}@)9Y{W{?9YAs>V zgWatF`PK2U6&K0G;q{BpIRj&3USmyBh%eUrtE(pz(;~SwH4%fh}P+wRTJQF_hH!`yOp{`{Qz-YTAlA||YV z>&%se!`-J<5o@aKK!RNu9Sz%Lu!=meP4wc1ECywy9O;}}bWzK`oF#wmuI4v=uegAiTRxslC8~2f8OJMiDj*k^uzC-B&IH3&!Mcn5zSiM}!B@3|IL@7W$ zo%Z~4`nCtTLmK_HfeM0hh{zoXRBOD5N?aCX6j=&XyPqgZrH~y)0?el*ym&t@`y|R@ zycKnKg=EdKn#Gkpa%?=ZRQrVEyrQNH28>|lI*FZ+ye?|8eE;{Xq4EazOtCV*785ZO zA7Jmu##2RtUC>};W>f!kLN0>(TegIbAo_g!s+hTqBhf(~U(j@oIo57WOg1{I5D!FG zO&3qB$42KER~Tyhn-5z9$N$p|TODZbRy`yB{yeZK&ANdZ4#%E}gEQO}oso&K^s-uA zk_@Smqn$(BU)cK|Na+J!C|AssG}BW~^VG>j98pD!=ICu>Y#48^O1$C~G#eoZ^s z&MOu?_whHMFCeEz$bFN;w{97#q0bi>;vz`)+2BaVXqIp)B*ugvo(rz4v0%R_gh!s9 z1NBiFeryL(OV1umi-!V<&5AzHJUSgGxLBV6O);MikA*+9&6f9ZefXRFhR z>elCcx;iRDXx1aI1_KsQg1XA%g2^_~KWCDq~F7 z{6VkrCteC_#^51z!#Icig9@9QVU~n~(TgEze>Wx2=GWm#q_XR9#N1HEL>|8+tGA?; zxyP0fI=OPDU(xLi@Udy!g$O$8$gz8zVdQiq>yxT7?`>n{5+-HoVY8O4>SvF#Xy`&K zHjrTovdiUo(=LA~pqmO1JFL}wJg50FA!1fipx2cM10&?|4@zaf|Cj`Yy%r9eGcYvE z*E5+lY{e`>K+qC<-9x-HWC)IrDuvc_Bn8^IrzP4AKN$9KMj`5ARvG}k=I^RZ71iRx z$=eIAuq&>TEx?`uxZ@_%jQ$8p__{@#Ec`yC^s+dm{gYa1C@l2PCXn8+b&I0s{(pAy ziLY6}R{!Dx2GqG1_x28P(_?eYkR7<^PX+|sI1aBV%U7%w1_a(C6#As6p1A_ZmKPtZ z$K9|qDquRsv8;|2rhHNkAM<@5hubOtmy62mppq%Cej2o1d~jo3ZS$olh!NTf?t2-b>7n6u~sI0_G~$sa}h8fNY2%VZ@dj zpoIfUsO47u>ceXfS=C@0xqgB^-HBeu5aGNKst#J%AMa=A{Q!{vxwHvU*$@5BO(Zm; zO@kc<|7z~f+sr*r!>`Cwiv2(&(DSoA3Fk4m-wL-q1;%5DD*?@q#y6B*aF%xRBofb? z!vX>8sC|^nh7ivM=g{egtEU^*+{i089f9lBY7nedh)++df<&Si>Sia*R{ViN&B0l} zp=7vhOF|J<9^2mrv3M$NZ<-IrF*l$A97_8|knZT6zo(DpY-6TAUTU;XqSkMGs;14fOm-sp!woH<#}f zIl4n>Vn_}xMQ!ecp0!dmE5BMRLJM7kLS&L7<6&>GnniP^5@U_+dKG+TRYo2D22i*L zds(?P8>7+NLDPCcjop1km)btFVmc2CWh!k``$6dK9oPBlb!%+>s6)qY6(=-vVBc|b z$e$l^OOAL(sjlV~9Y}SYSzJ^_X+;t``uU$iO}~9$+xYNRo;_8pP|6aRcLGvB+2V_KY?59cE+M>*(_N%Gdgu@uG&;w(^%e6kGr?9<1c)wiMySD(qEfk z>DXCW!oo|-9wd`etgdfgF-347B<1g7UCS5f1o&Ht3>r(bLG9_3Qki|Bi=rF%NgxL(_xq zFT{e-x4bP3V!s^sL{SsMv7LRLM~fnG?1x35tN;87oF|og72~lO%Ar^9wpwakLP1Pp z{PW4|nbi7D$elser554cDL`;b@h%HH@hE%F&dU0>DUt2zU$z(kZql&^4j{Gl(#*P~ z)TmoB|6X^4*Jm$x_uQkYJ)SR-;4|&ldef0t%b2ktbern_D0?4c(l?IxPb*pq6Xb!% z)9W5*LS}z5hA)q90mmlvp5sd6uqw(CWyHLm+65qAo|DytZp8fArANrVHu(>(MNX^T z7wh-J+s4Z7wb zt6;^95^p=toGiHS-|uNC%Qux3{lhe2Ple8#AK;NX*C(Bxi&stbOZ(%X znA-GOA}8bpVtdbiE;t`0vsd|%!=@hEs7pV)6Fd3H^+QlPLGBy@f|qV;19wAsb6?c+YMdY7>*>iy z5d&Ok>X<~l%gKkqcAp!kZr&zxyyt1hOf=!((TGCAx%@we&ZZ zA*K&XL?P|a7>-C?S~#lZ_q8WPybZk^y)LR zavCrxqx&EeQ}%;}Bw^er^Y4+l(NJXj=TZs$sulQ{j|?RmWWz zs<~{pe)nbgFeDpuxoiU6ax{!wX5!u)A>7xr?2=@lX9?eEh2Pj)J!@MhR%mnv-oXxa zDj(&3u2r(!a}IhuGLO+q(wfq}_LPJK+{ymKc}GhC(gd z60YuI;^pY*2zVN4m}+iJ{%#DmMOp|AVWD!1dZ7#2!_=gajIAswro>5SqfB8Q0ryY& zKF^N>pdbMl%7K1I#ek+P^gW{X_4MCd->SDdyDf3!JHEfM(##Sy#^M!!0U7ZV^)4dBvtFULzI(rgg(>05EQYew+#>}^TuLi;W^bgG zej!1@qTy(M?amVB$r3o}nP-xqckgHw4^PtxI{|IgggLrQh}|S9LMS0P53~sQU_ss?iCV1}V!0{W=6*>$%2aWA|g+ronA9PX^0?;&-!4oP_#TcnQ zfm|KQck~f4(3qy=eo*Q387dsNv=_T`8x7ev*nRVTrgVsf-9@E zl>WcH$3Sd?%f%oPkNd(#e41j=#WyaNbGpwzZc&zF;L727=q9q5Ch>*Zi#TLCcd&j{a8I9eEkSU96^ zI!8ccI}A{_4ZyHw^{i^xaW+SQs)AfwtkhTM9uLyBZ3ZjYt1D*yKlsE-O)x;*J1DrUz7^_CJy%!FY;7dbBHX!Jd3t1t-S9b z3(?cyzm}LaWusf6){?*}YzRz<>=K9|yBLCI zzb#)WzFy=YK=F%8)-4r7fQZDHCx$GDIur_Z*X|iF6q;;3vpqZvBdb6UX!HrF+4w30 zEo>zbHLmG2)2LC~t2ior9GDW`3hD;yW3{%o0}8(X@@p-+y@k5k+xIU#f2-4W{~`40 zfO&ejUvq7nz{hKX>+rgpJQlk?`ew=})0B{1@1JpZEacn%?bvx^lW%Qh^Q!_ChMWM> zeRrSknJTOw{kIjT0&x78nHQ~w8f+mmPCIiPS1(qgM(e9eZcFU1=;MMy@ZZ8xxIM6y zE2Aa2wZ2xHRKrgXh(rJm>JZLI>=8)_~4NS;iL-lWyxfHW=&&T zbtrZE*bNC!jSQ@*VzYkkKp>fBYnp49x2N2YxJ4UZgp%@o90j5IH4~vcdf;D?`pd&# zW334!?|fP<4um_F|alcziX_4M8Sw0$7wJ}rlucE7OL?``wpjMd~|Ab(*l(S zpb#OWtd2n;MGs#Z+39<#`|ceJQQO%3p`@M&I3N?Vp?A)x%){+^=@+L_ELqEt)r_>} z)xiB;byjszvQaV2eu0u5wUT^hIHI2fN{#Q>eow&Uhj-)ndNY$xbjwI?R+ZcwJEFBe zo9`f_2w(SH+iVc+LQ;4IBHU)-+22g+WBP-U-u*JPjcUIMbp~~USc%TthuPjfBIO>M zXqIv93V3Z3B1hS?rc8UK*{2gfr* z$@!T#tRUs5TEJC=`fcugycn-^VV*@=b-k4QZxi&tGRl!9G<%y4V( z8a2!P8~)yTSqErqE|5>DjF?a_|GySM`0XK-*oSZ7O1BmL{wW)t6L zuZpS;^RFmQT;U8!s?5JL6XxdTfR_-QpsB&7`};xP|7rygYOgb&v^$>}2~Yqo z-4RnUP*#2`X~W_5gJbLSt6_gR_WUhX5yOD25Wy9^Z#!n>_;X z>{|!f=Hz+a)E^CntW&(FfW#Kq@k}fgma=&$otS0$SCzmpy92~{HiOQK zkkFW`cK99hgp!hy&`{*xu!|p#_=WQM)8rfaM=<=RtXICPU7C6)eK9Qkp_^|n(&Wc6Mt`K=Nh`+s z7XA6sVc$nq*K-r%$2$>56X+DFUnIJYn?Qqcc2cxpz!ZExeQ>#GY!R0r%|dA9MmnNd zHdjD9C(rU#O*~5$F&ghku*f|tW##)L8f@3RN*Tq98(mCS{PXv?4~fa&G0;*q5R;c_ zWtmceYyGM^)a&uc4sJ0*a8hL**SR;lP@w$DZq zAkkCOo>QH~nUihD-(kt|F)93VLP@^AgL};Od|$@Cb4JVI%xDrC!&~b{p{y|rdtXfu zm<;PiA2*&kqBK@P^Ykf7p1Sujo4KizcpEujkw%Jtjc1KcNz0R2IX&+)${WAQvaIUx zrRNvw`!C}7bq!I)g?9`|^-(W0+T8d%f+?;Ij;k`+#j}Wl5CdDs!nKcr%rbkCI!AM2 z!A?)x+$Cc>3VQ)4=*S{VmG}(R~p0v@i6a_Ojk$ zf)(69wzJ|%+7G|Q4Tf9{fhGT}>%GlyQo?$OR-XrNwuMVnr#su3DDA=kE*~^~(TVq?nZ_R94cks$LET4JfUxFTn~T z{+@YpiJ~jeu^v2N=Ltvvx3>7#RK69w9=tpK+Ea`&?4!TWU|aOMzu(WYbEU#};}xHL z?-Ve|Hd=N%@S6(rWdYitDgd-0_%fq&1Q;tk@qyF5P;T;E8JuSZC1Gh);fSl?fT&v$T!~V@;yv|&khmJ zg04UmWr4T$(%t*%I%du%5`V$^qzNxwyPIl`krnuafX)$^dOSUOS+|7*?-`>6hjybQ z1p@sFYgwTaiBO}vycpcW=d(@gr#uiY{IDjnqwn3r1FzTkOoSWj`+Y~ejk7f*Z$$rs zAU}^On7t9ell&(G_4LsqmL`1q5(*y}eg0UN@!xl*iClU5#Qo01sB7yzQXp__Xcj^h z6?r{EmcX%oOShfmK@C8Mwux=@S@30dIAD+m%XSvF8!yAzzn1+l>It^r8M5G zek;jh4Qf`B4*4aVWW6+FK(}F)XqfPO1VqI_q!2HXD-I)hwC4WXq!1?>7ORwPsHTC- zlX`l#9mA>6D9iHzzZn>2UJ5QHZr*LtuC}y>&w3BA8P8* z3yFD-lmVLt+OA;yqiF}%#xj_yGDDsA$f6NH6p>??M12uumR!{u3j@wj#vppO5hl)) z=^$D`n43+Rml4T|uBV#%dZH4vf$tZ?C1nXBt{7iO#{KEO?j+Y1!6w|&5!MJ}NK^0y z9EQu6n4YR7nlpXipJ%O6wVq^NC&1b|IHproSv|#H`BVeD% zO-^gDO98`63>#l%7@Hf2+CYgo3#N=LQl!Ei40WP-Mh}K>T`qVsrviRXwH|6QY^%UI zp9D$Ro~Yrl+AEgtJLpj4jEo^__4Lb^+r;VqjH3eqks0#_om&)2$#V~p3&%d#BcMlD zVWJ+8LEzgvn6-^n;y$4D4@t-qVK)N~103C4xcsLu#{S_SGuft} z;!#sNaV?me`RDxH3%VVr8J{R-zlT+E3aYxQ%##ULJsT!#G>*Z(4*f(Sf_bE z6*?Nd9dT88hrJ+aO2vnP`2wy$Ex#ME;Bm3owzBqhm)KRGf7zBh8&SMy>Vz)QRThE+ zTb`eJiy7k7ohM!?VY+f{^={{HFE>3vBfIVa_X4SR?STCweJI=c*V>e0^2TTxUTR~| z$W#|_CZQXiwiI@m{Nf9e3PYr~?R(C7J=A3TVrC$aaqb1Pk)~#fn9KdJez2&al@nCmxyC z=jT&uVKv}pWchu$WBKd&`Pmy_Qn4xi#vl+zSq0e3z;g`x#oq}`7s*=)`%v((d>$_n zK5+~={Cmu7eb?y6>(@0ocoU$=zkVga`mQJ>LbYm)r8_heT11pXAwyqR1gnZSf8j|^G9}+;O||2kuc6&x*q#M-49S4=FD?=mxS_^Sy-ej z;x>yZ>O3OdjK_Io|!FFL6X zJEK29y2GnmvMfCusg8eawYe4?WK4el*db1Bi@_(5mr(AKstQlk-S$!b>hnR@BkU#2 zYRAOVT};}`k8>&*G)BC@@N?0R0NzBXVOa``a?k6xL+|~r;)X^W5qWLFnb2umZfXfa zm4dw7X?=1y7mg&J89nKl*b1uR!cgBRhoDZbbRdWr1QSN6vpE?)i#8nJB{(LcN~KE- zx+!Ozs8KuOY{G?_NBp&n*NJSmQnGwxi_3f~TJnRQQMt(e)PyAlksqhTel>>-gH*=X z{Cw8fX{BVpWHErA%l_pP>ukbZ&Gx^&V#XICj@mP!WUA{t5)=d%+sqa+UKK`0)BPR) zNp}=#pjl9&T4twB)JWKJl)$$qpL0xwerpHS>Yxe&AC>{~*LC+J*uQCvOUnDGDb z@EUlJ>-##qVN+AsfjuhFCPa1vDAvwSK!rH}ven@Q2;Kin{=y!Z*tXOLRz5-6=oin< zzXAh@v`T(lKH0-!U5(`0*!{~a{DS>cBisswwvDesIrR%!PEkbUYW^N?eyIFR zT9t|HtsYQpQHq!$R?S!>OSf>U1)1^#$1v2#;A%*XwS?*NGBlfqqO9qfa;Fj#V!#m$ zJTKq{1Xx@JL9q|s&{A*@t|EI-9M|uP_Hl`Vnc-t)2{JD;0qkfFNz#;WL1yfo*9BZD zVrMU({Wx3iz#Kv+JYfGFa#QA;6m;skqpb(ORPI883y(fKO0w(ZI7b~Gkk^pa$SVdB z^Gvp;6?1YIWB+~P^a|SwE$TVmSd_m1i+M8+ABT_t8JN3j0Va65JilM=87WtoS;A0R zhZXIz+Tg@ii2UW(vPLf{nZE>DM9`jB`^RGB0zQA}u1N!vKf+PsHMeO=H$*H=I?HF| ztlc}~gs@e%`XKd$E2G~@crM}!B%*9C(Hs9#1VTWVMIwr*U`u;S!P9M4^&%fxx+^o%oPT(u&T7z~zFn9DU@dSeRep zeW)>v&1Ys$u1o$!apeZT@X9nTe~UKIA`8U%L1_7Xe0W)VwhN`O+nLiO*a)#;e;;S% z{eGzjJby9~i0vtGv<9;={WrQ$%96k#5I z1RXsBqDHw$z`|XhGcQ%D=SX83U4@qk+l*2}VR^9**JM31O36(7fO|&1LpP#R;uAZOC9tviT zUY_m%$Q3}40Tv(GqrEA%W#cMYCEW_tYxsDRrGV>xJMsD0c~qH`wcB)qSZbKdULWX- z(*%d2ssBwNsiY{~W1_yum0(fsDmMRIveCDw4aqjvLl;5BP5k#gdMl4#-enRZ_9Mqv zqy;URj_%vq`5jr$RQZ~9W1ZwwnNp-@bl#^%tzBbK$nlJ3aq0pvKN&hU95Jpn?7rHB zq0BaO@edQL<|VRd)Ty16qA%5~o3Z3dlTYO(H@Kg4eFc;;Ksyt)eR@dQq%3&%7d|Tf zi(eTLY32^Eyl{yzu^v3u9yvnMLG&>>!*MVNThu&~)h5io-KUifV$fA}$Xwgf$yK(y zz@E)QBP=0p>}rHe6(4(+J7QB+8I6&)xBFLq<#bc|`&gM-#=L~t#RgG*7%SAxG3N(~ zU9yiO_aR#kBo{Q(Iv{#GtS0plmO=U!Pn1Fdr0EbGtjkF;%hOCOI#!YcmU~UT;*w2= zxb60E*ykna-FjgVtvcmY{&{q9e=cj$if17x9xUFyPLKerDAB7j8sYs8RsSs1?=xIc zsNb7q?UIfjcw%uf@mdH?uJvEZ>~8L?jvi8;*$~l%mGACHt*tL2_;#ws@#DFo-6oOT z_XTV$Jwtf$y=b8NL>%8&x8mF-aRmp>Vvv> zKkGm`VYyFla$nP-MYNHDKk0??1#qPLd;*uzA`E*z8V=^P7w0;>80orEv|kXnq_P zsTOluvs*Q$cEi!A*L{ioKJ`V8PL-xfsW(qkrKP(#T zf}NfxP)gS)4I(><{|7%BI^NAkMcw@^EW-L<)30`Z8eUp@`JKL{k9hGjx4(Nnw{p4u zL|RKEY9QP!v^5GFLAa*&6-!MPA6(hNs=h%153a>XUk|25V-=AFhA8it3w;J`5%-sh zqkj<+tUtPRBqSspI9d%Xim8MIuM+$dkM6%@j3lG2+a`DU1kF60cI7?^D0#M4k5km3 zfpwi~Uo;~m<=M)thxi%wb63PxA}A%8IejuETRhKOBSQ#^@g{TzywZAlwV=#!_8|u+ zRspe6((KI4i=O2XQ(&z*&~(TAs?*l*hKxvVD&5*JJ4&eg5cBK6@%T=l%o6|>tOKm} ztt}^Jq4;-tyh@1g&U~9{Rb?3HnXg6OWpC470NJvN*+4Du?eY5j;lHy0lyhbaf5Ml&R_AlS=rf>hfc1!zHhHtk3vai z24F+o=@Pz=S?G>Zb+tahu;C<9!iLhkdc(a#T;1Qif`SLB^yx?7 z&PuseEWu2f4mk#oe)@=Lkpu;BUN9Oc9yBMw;rr1+n$~r7^sJ8PyhEjq!ltACTD2#XjM9Gl zV@>!6Y8FIwnbijsuk?Q#QX@*{?*+4Ihm5hc~UPPh>}XBbM>9+53$V!ecdj ztly@32h5{n+TSHaH*|o{4Nwa)%1UvoO7! z(Q)gmbH=Ai&Pm%pY>5ZjN8{;`Cf~A7_&T8fN7Gq`RoQi28<3W65RmRJX%M6~ozl5! z1f;u>?(UF~lJ4&AkWjh>=~Cib_wyd#KmNhq2iLmh8gqSA!5)IfU6aoi9&+j!nCK{(~Xo7+Kc z=3f1fNUFRkE80!2Xs1|i#k!kBDDd&LKk1E#t^a6>TO>=sJJaw}3OH9;I14iroJeXC z>u*u(MjbpAF;Ls`ba)6C6qhdWLhMrA;CHn|-KOKn`&UYrBft3wFIH7PjBY#PIyPjY z30x2e3>&E#aV>B(CC)eQgi0Ree4|n8CLQ+3OunGx8obonPe?5#Rfh{0Q^rv#aH6Ho z(tU;V^{G7m2i?)9y5Fv?@G=CjopcUl^*BWe31I;fNL3Pat>|Cb#QV=6##tC;9@sC( zBqB^lH2&Ly*)wToquvU&jr!zg$|iOqA^G!&Ob7z6OL>g{Eu;MEVr)wyqDmyDL0 z;!I=gE>>n=UHV}f*?<;Ksa7J15&epymBt<^y)9f*I@&%6ffaaT*gRiBpnnk1VE4@)}* z<_hT$nXlQ|*(#pUiZlCWXG{CC$p<;1AxZE-}%6)T0iPiZqx6(h*Q{-%sb7 z$5qwjhUehT)b_sE`B?aiKvM_NUz4!Ts82RbD8l~T+6pw&Mi#;b?#lX=Xt>T4-&Da$ zUuUWqSI_`CqVGi+MBiSRm)+hrbsRhn&d`USW}*5P^yZ`24% zU8cP7&%}M6{-#VoDJp{I9aELgE{?Yv`b-VoxSeag(;M48G5a8f) zVY&K1(?u?&1I~EFJO0}yp+VKs9^R%0?hhCKVoK?!CzI3u{sFZV{`Gb8O-{n07UQq) zYWCG*c7Yw}o<{Oq9|DhPWKHu9ThLS51x|GJh+e4Ej&cwm3v>9>n~iDjUgd0^erV!k zNpE;xoW5%=W{heb5b&MyeFt0==Qbv+wf5Gh&{8Ztgu0tgj*(m<@auF}n)=q_4I=3I& zF~JI}r8zlS5NOG+CXpCODGA{8Kb< zsjhVAIGyk4vyGx+>YOgyX(JSSNonDzQM@#v?uBX-2KKxT-}ZSYN7RPiKGI#qCDJCr zIR3Vf6Dvy=BNe)UgHAAC_Dk!ien-5dK1Tv4<3ar#gUVWs3zr`REKwP2J_{vw)p%#z z5@G52Q^!A3X}Nw8te-`A^F@-c(<)^kgPh%o7{roz-2w;n{jMv35I7Q>8g3NW2lR2ziz#mVaQQmjx7jY^iLBXD{~ zJZ70;&KPMqNKy2_E0PfhOUS^o)aQ{=`H=6T$eD?$ptR)Ta>MH%_k>MeFS z5E{X@@EsGau{YNqH@b1DSXMRb$sB}s;i-wj7qjPY-M{Onp-OzWCWm@=??&CzJ8wQM zAoPzy0dwVhbu}Y;eQi#VXynf+A1|*l3zMnX?$*`|1;_3DmE;0+>%WJ#@bHmpbqHSN zZ5keBgzDH9|9l?49ksikfyfE6JW4DHZaxwiAHd@W(8T<#VG=b5kI}t_6*kXY(4E!Km|o*n&1bu;g_>bQBgjD-)MI z!{Ss+{sZ#m-_=@}lH!hP+@Gi4q~4Jo=yf=rp}-q@9hh3k-gdn8{5Y8fHRBJK z{7(w?#HC1zE~;jzXfE|`BjTvGC}!EnB)#_tZ+(MFK8|n>W*Grt!_!&~MLhLrcJv-` z_kxY#=O*&0UX9a;xO0=$H*)!Ks@{tu$qQ+D%M@YkW?G38snY_Yw*v+zMU0Wtr!0# zX^}*?^|b^7GgI=J@_z8YYsd=J65dy(KUTkyPO&VoNoiGXWjNgRE!aylGhvO0M3kV3 z_*(zyD@>prL;UzAI~3ivj)GL-xxr1GYQ`t=qf7(*gW4rlzFYIGwKQC0=(sEnu1kbQ zg0zJZa#n2FAr=c~s+HSCEEfJQWyWfmobk6Z&#Z=0yGGp8>u4sZG@2V@3<~t|hY(xY zrmP&k-e1#CfA&+qY?q|sVztSUuuVd>?QV!wDTzk)t=ZG1MzED5BAtlnqn&q0Eb6!Z z<+cC%v%S5&zi)AQ<-kEy`NOumd35xKNYWs&oKsJ$EJ-c%L#&>@$Y$;~Z&(a?_;Oz! zo$G}Y1rP_0g%?Gg5Bdb%? zJS~H(^qyC+{fEs>uboxRX!@dB!RILUkt<}a^Z1dGL$ zGg4G$UMJiBQi)c0cd1^pAA@8BN8##87&y`{pqoTw-Z5Yt516;%h-=d;Jd^LYd}{FA zwnuAen#Ep#r0D?y^dvDLdlqrLbn@f}O2NRwL^{x~RUZ`4B|*Fy#{NOzebcJ3Tkcj6 zXt+|(2G|Iq0Qoo(6GJZ5goq>>SuLS8^!e}eQ+x3_i(aXTORrZa&@hn?oLd0VY#8)g zv16%7|94Vd?v4L9;T*X{dhUX=v$eJL;r?Q0aWSP@F}{JIw>Hupj;M(A{(EB=sW_)@ zcQnp3j-FvMkWxTV4ZVo)(62ro_PUch?{)4TUZreHl$bNgU4^~#>#L3;EF)|HL(CQ5 zd&Alx7ayh%4iEo-x2IrX{Bl1mrj1p&A<{M+yZMvV0)GilfGCW`e9wX}3#_Oge5R1z zXa~4Vj($G43(RoSUN(*y*c!6c>sm6#IBa~F)|K+!NC@B@ImvlBQY3Kil*9HM5pT1| zN1rOADX1a(4zc6jdRbs)Siw-r>l>EkCKU1~5KCCvCPEgmKPY6k2_il2dN}|YN zQdZeFq2ucaXMJGz9b-ACTntqx#i?c&Nw^p#Mv*CJhEum@9{w)lQ9dJKJ;1>2dK1P; z+rMs#w}v^wFf&&=DM0yZeA#Ou(uVUoN&@wL@7uqD^8#sowvinAQRoV0^v7w}$ zO*j7O&l0Ll&W4MEEtVtD#6@Qc{!~h6EluRL4nOH3$Xt>$#L-w9Ok#ad{*4zVx^Po7 zsEW=8!T?<<5>I$0)v|z_dBaIVNOL`-oduB!Gw%Nuf`%NNOh>*If;-c+00&F-oR&UP z{Ef!mWc1MdCCgaKk0ic>L*nG6FUqa;k}F9i$WJ^qnfi74TFC(3)h7OEI2}f8-G{bz z?989tQalWNZE@UY%#|V-CKHbG47XOAL#_O_X%Rm>)Ti<}|0S?SH)<4kGD5T=upQ@W zw*w<=#-GumUFprJybl6`6yoY^@vIc016G9sCFe0xXBf#x3gFS%h%QzU1B3?s4v3Y8 z&HafuM>lTD`Efi9VscH<5Ae_Bar8LZ#1f^8WT_pB-L%({$%GNH173#0i#}63A31eQ zP9Y{0X8((qOERg$gfQV{43eAMh}-hz43PEx3;Dx8mreH=VaO$}KB;Rrk6oHx#B-13 zTt-OeazNo8BpWD=xe?K&>NxZKPi;dN?USI$mbaNC$X9zfk}4tFky-ag^c>}l+(kCgniV6c*C zDgCJ(Qalw-Oj_CNNn*?|_Ur4`Mb0)|*7odPiAOB$#r@gOf7Lxe=K)A3KR;2D82)Vw z!5puWumd|#WP_0P>p^MYTeqIc2bLR`*ZCS20Q2!nXZj6FwuDkAh(a(=L{c6!Yp0dQ zLske4tYF>7xko4TDKnU>ulW&dsn5RAu z36%;hgI|0^{XIN-ER^LyD<4fj5{f%~oT4P&UO|U>~}dGo~l7%+QQ<`VdCuY zvISHd2N_OC3G(@!IgCs(7bx#tAy~4uQgFLTiOnAaB~FSF17-;W<}&qpZsHjs-w9^+ znix61=z1^2rb@OIozbY+S=s`%_ve}H*f0$`_ad&W>)fj%hS3kl35p1Z*olY~!&?D9 ziCX-$&0cy61qW*5^^HhVEwmYa1s|!$zvj=&3uZZmU@|6(<4bA$PH1YBQ)@!)eXYY} zW4`)VFW?%%y+P+edk?L$3!@pbKrQ4>isUeIj=WzOVS zBjUe?JR)Pwd-?YUa+RKN&&Vk(Qi0ce^fBV41ZL@yypn0FWCe$s?J#XE#G~3UY_Fq+ zUft82Bx$d`m(~V$757z`v^0S>A<2V~RL)sN-C22(n!%84di`X=nZwOc+Lzyq$%E;I z2FkS`-gWZuM;y`MW-y&c$=II{y$=ktgUP$)=2Ik>+zJq+ff&G4q08kDX^}t?m*kTo zDH@_{pd7v88P_>U=_gZxB#im5Awi^&1fW1 zTWXH9uV^wf-DpW#{1pv%hiS`TLtqLa!C~1M+1PiN;m5Fqd5ZL1N@}`ed~tsLJ{$Nm zo<O}6?Di1XRC%vo@?s`_=5kJTyWeYx= zbj1Kg$ahE}PJGm-q-f82Ikt-kyJ3_nL3<1OG{;emDv8R#J_{$#tD$YzBi=pw{PPb@ zHFWqH+p4;tz>h%Cc@}=IMmA6DW@JJ#kQP^Em9l3lly*K?hN_abIVzzQ#>`+23Mv-w zvY==geJ2|y_6W!Fy03Ah$6`>=x|agVMR`-w7!)v{kHhWyQa-rK9><&e^WiHA2H(7;^O zuj`*FFpCY9qD`tf3zxm8B#U4V2HY_IV4(yM7{BW&f8DXDj1&aFaERhTt};buG)eIR zZ(hK~s(!_TXU35q6gYuiQF5|BuYA`@PF1KTba?DShm@EXRO+-odwc(D?tVH2(D)>U zcL4bJ?t8$D2VeY$%~u~7F~Cf>gT=J|VYc)k4Ye*O)PFF(dKh5fI+q}#i2b5O1a zPy_|a*(-imVu5JRlopkxV?6p%wCVZvh*Rsp*Ar8P-)5cL({;8=9>h%j;a%eNfc>xz%XJ^>*q@J%Y?(I2wqD|t{ znWS%HYNV^(iNxKL%tkEj+S>CT;(1?{ye3HUi5L#q%0N34zs%4n+h)b5 zPqg?#9MOTSKsCl5O1DwLJigN<8lj>m51($ik-(B9u3ri*yc9_TOGbBlDjb@#n54Lx zn#kAV6H8O+$+83_xj|~O^p%`4Lp9vbsB-v&xk{Nu%0%1S#yF%7RT3xE!w8CAH0E#$ zwo3NZmsIG|)~Zj;bCKt_GVgJA`~9~YODQl7$hp$P$+nMYgL)E~M4T{qQ|!4&s!ZJe zP^xaut8*3M-xP*Sai$~Auv-{2O=jhnt(o<+4{^M*>WtIt?%ib^@r`ebTfvD^?m=77 z(Tn=A?VX(>T|D*z zL_%}ZyRJh!V;~^eZWZ@k(UuwHPc+k;C}&GIh$xPqLCmuXdBa$Te}f`IQm$o^2y1** zjw1?gT5MYrucV!m3j{HOc6e=`x|}DYIzl-(u=C#>_MqR9H_JlkPP>}*XqMZvn|4ff zN@XYpjp?OD;2?}l%TB6J52;!2{5s2RQG*Xw?b~{!afy#@6gsGQTA92;Qw;^u$~T_1 z+KwzYrnMYpEV$H6Vl?tkzvkk+UCXXNGl@vCL0tbN70-O>0k$i(vs)TerLKM4M!de| z=(AV2VM!jw$fm3^rs+Zn5#1^7igo$>VLWBVZAaO(&SjPYg^Mj3TEF@#Cx%QHk0oB^e)8C>K$D3Wl@Uv?h4(6Wrt5H##s7JiU9?LgM4jeFLn3Z zHJA>A|4x>JJbx!5@WQ`5^iNfwOBw~LO6lM8<9@(Z20wQ896fr}K0L^9%_I2ixz=hY z52B^EU-zXDt)FUF|DgHOUs@@wqi$iig zlKv)Vg=Z~=NE#`R(PG=x%S8M0YY!hEmj^yGIH4~$(`(JZTtLkh4U+&nWPb*-kd&3m#OudLsw#5)pE9d-Xh| z#Z$5}#q<#TYr!|z#zVfd(8DG~&-;N}CFZ{`T7{X%YMmwL^Pa?LWzL(89 zk^!gbON{FA=c3ZIc^H5AJ)*GY6mjxY#p@%BZV>^-VswN**lILIHlfCRii{8idcwP< zqK}(Ku<3bL8fTPibN9DRQ)guKYm&hTG7IUDgqQ6e2g$(rr4vaHfBjeI{WbXB!uyN7 ze;Z)JxXnlxhj?_XcKm zotI`5ONn+SJ~LR2rs2oxe^=$g88a`vkVY|$Iiq=ImF4BCC1>aU1*{$iH$T=cc6Xn1frK%l2qNGnX zpjJ<-j-kj)w{6e}nMNH?=o905Eo_GM0PACGcWuTC3uH&-5!9k2Uty`3BjZ z{VR9O77Lnq-k$^Waj8`~^Ybv}(?mNaPpK&hh@BP4K3NNxolbbs^r!q;|2}J!kDla| z;*B4@Rf>QH?Ry3YW`Mtg%1RvD_Yd{cvGQ<;7$z_D|&JS8F|1eQnty=~84 zp3nZfEX0Hubgg7`M@b@@WyO;)L!&IZI^&Xg^q3^yX5k}XF3y< z?eh8_7Y+hFIsCIT+=(LdKGetb~l?CTqf)okhktc0|8za!BNmJ&P@D5Yb!y>`yI%^f; z*?~4dm3k#s&#C_I&NLO8j_KsCS!0uqFOXL*y}jCyH~gqDqH; z?KOJX$_YIeW*T_en(uti&vT4qn*EPu{E=@eeD@S&9G>RrK73}lT3n?XZ z&m;HO-UE*)iimHE!xSW3=iXW?)OL4%F#BEC2DN?~WBgdx3>!xJ1FhjL)o%?Zhb^Ww z*6Qd_^WAT+)?zNEY{#~epX4KhXtZ1!2(O#($!?RvF>YyCIvndjJxr~0Kv<+wYC)X&d!p=w-Y3qn$jTOtFta_DfxQ3}bC zEGF=0{|!LnlzVAA%_2Hbh%va!YhOKdBGWOMWtDz&6|MO8-l?7!XW=4@AG0E4y$KFlkie zSf$2MX=v;2Hew;z=<=;+f>=k#Oq{ry<951=xR-k=4esp~54xiop7`#IN$Xx5B-#jZ zblA<81f9t7YM@;8$7OSxx)KdnxgY#QWq&C{Q`3;bu9eC$VS&lYky4_=jU9e({r#c! z;YUu@!oQk%N!{zr%AU_-+u;9}6uE!&M~DAr#9M%+ChG9cxCu(ke&yf2v9?p$ejcIQ zGzT)HQ)z9sB7w~blY%vlTOkVM{{ZGfhP!d`*>SQ$HG_7}fyU|cs= zg%>97TYkJfee)-ujF5k}_-ee(hc|8dzvYlqq{#K}n^ktw`y52Emn`2;fudqGLL@O? z`Y8{dod>XNX^4h~oJ(G>+g~vAB96h}DF2XcT4UWnJO5Dm%l;0`Bj6LPZ)^ay=#wNK zb*3gUM#JaE>8!6wI7EH&TkDi3$N86>09|5TtIZE{gcp4$kCHX{<;NFUR@A!^VsB&o zsBVRB41WhGajFu3SfT|MwChHZ>f&)M5#Jf^9rd~)*Iv9zF5AMI?%uEAwXgw!>2QVo zn&j~!cm#S`xZ*}$p}{UxX^k=EZncGrrBq>M%BS-v zzfRfsOJ40W_{5V*M~M6~j7?Sdc;xpfqu9_d@=}deWtm!orV$-*Rq+Ev?}}j=sumgA zyP_T{V6*4;8%|~Y;}m`*>t{^_!3<}GMBW-!mr5l^LW|f@*D)Z%j;4|4+YV}} zB~Ch2>bh5RMUz5OoRu3)#n!nZR1}Kz@q7&lXHZX8wc5ivAqdVkqi>ba;iXz;(_D%v zx-LO7_Tm?*Evb*azj+CclkYcPH@G#mR%PW3u&+waBFbDIbYPxJuPGfx%N58ttfmSq zIi%>zmCT)(CcuH0We6=J<}B%panhWIFIs$gT){_dlifr^?i#qZlk76otezQL#-AJZ zb<3Fv&5Z~X-!8}M*yzU-gi4c&dqC2CN35jC%%v3@kAYf0)ik7l@q#zWIHZyr3%Nlq zfE-fW=NI7e`-5@hKKEP|s-qTlc}5OM$18;M#vHqOjM`J!<0 z^X$%tJQX#ceyt@UH?mYnjx|X~ymY|2K)qOJwP{n*jx0q18w7hIfX^g{lFJ9xcmLp3$= z@p{kI)ztuQ$C07HKO3q~ds;?QhrEkIQ%MRSfn7?EH@`n(I9#MBgB{N3i3{xT%GE8* zEf(?bnh}t4I~g#l{!z&d_RGyZdW|%&3a#Ll{rqqc7W+WLgv6kV(WGDDR$d4KFlYIf z)<1#z==1mbC{FCTrL*(teCyS}$w@Yhf_V$u#y|fo$TzKW7HwR?%ze7n44&6#AWc@^ zB-R#X$XuwP(}#NeFcHiVL@?oI*(1YCrTTdqD;I7~JU#D(OnC4N1Ygm_iEK)9vpm@;Gm8(e z9oW{xi+(?0K>(_GTm0SJO2(0aS)_jpOJ)My&sV_gpb8d3?=!4%Nzig)&EcOuEi!G{ zyvF%TUtd4nx}!vrE?!`{WWuM2l4VacmQYS>Vn@xgUi01iTO&F%dSChTygpK=rcLxr z59&?o;@eLuo}&|O%nN^Cz{|{_v0^eo|{I@Ds57psifbbNS_LCb+hRN=Qr|zu9q4u_&tEii@mI-9dzim3gLafkT z!cQVlCa|Z)2ra}va+^b zcus>8sLSpp<@&~Vsbw`OXMlKk9n>o^EZ`U!d99j3k)m@xHGO$0q(Pmu{;q<1^8j z5J-Jd1<@v40lV`v3ik1Q#1{=*z8rPP1t_;P!6NvxnJ@FkgI?1N$*V`=kSw99PxWG> z0r(PyL=1k`70Jes%F-_%t$Fs~SBdAAa7e{+ThxPQg%sXr2UvRch`~cjhN{vE@=wY;Z-dn1KaX{s>EfIp zzzf{+-DgzP8xQ&jqbP$qZPO}Ph5sXIx!hdEvA&SnUp*ge zfRzP^p&-q0Q`T$MZk(-HPucZk(1(Oi07C}&_5j5n*wsLy_WAi4`~aLJ)32ahpOz2) zJg|P9wQ62VXmBC6MX^wgg@e}NP_N&xcHi3^n$H+t|9>yQ2yT~wLZN9y*0ll2e`a?Y zg27ZcL61sP6_0%3I9sqW|MO=ml;BYH_)*R?vjujiGI+`aV+hg~F|bYi+i?CUdA0tu_ejy>?fghMO zd#V>d`xWRNe}{a&ayYSY(1;LdaplcU>c2k(>x_Wmv5Q2mvXeiQ5?hhFNA^jX{&LBqU)!pJSHU7 zxw=pOoRb!j1d6A;jC6?~F2L^>Ty8fx{WIhu+|CUO8y;JESplQ^*z;{an+%t3K`@q*I_^HU5G z6euM|+gB(oBUw=-*Oxhl(is|26GSu9Z1MZn(q6b@L2?h*7(;3tm?g`0c%cDH2^SKB z4p&h)O!)%F@2jYrw7#hiOlGB?O>`>IZPzUH(Y_L0&K$!vFX3}$C$u05_(O`|5)spI z{Q37zau2#aGLgw8ZDvKBxkBxT8Rm|+BMNW4M*e1@RpT2Tkl-Mu&8D=5Y5THUbf;Ua zxSv$-cITNDe`xt-|6sv*{7pV+tBB746xIkv`re2z| zft`W-$9Cnwx%|*eV)}c%s;iby;UeK1{d)=0D0O&;*yAGqA&7DPD!FiJF@CvC21A%j zmsH{#;j+Hh7U!g&=MfbqxD-aM1c4nZ@NSl_O!z;8@GR2;czYZ720(b^8U32CE-#$~ zbJqXQ%%=c!oHuZ(>&5ak$)!ZvjUXmCmj9&NK*{ed#-=Qr1@yF4O zCD>YIWA7ENEpC5+W6M^8Ex<&q?Dzd1#vd*iXZ~R|Pw9@NR{GPKai#sU^-gCL8e017 z=7<6ATJ9m-m&eD6a{OE_@AHuX)}dkg7N2lsO60qt(%zrx9U|{%67f~*f)BKi)zI>goez1;K6(4F*#iE3cm5 z7OLJiq9MhH^4d!L&13Rco+CYqe%rhzC{U-7Jp4aehe1O27!PIf!|d5aPF6~DI28P(CtT!{8YuY9>wNDS;-qWknpb#RNV)YZ*f-ef)AIBfCWpPFj1ZGU#@KvSrHB z$$QCi5jg3xnuNneG0wpB5OT-^CWkLom7}P8l^21X1;{J9BQcyIJwlCKG?Bh z-9r*R{3xM}SAP-|33v%u$HedmXb3wWC*Y5+6X_UJ!wv}j|H^Hk0HOiWhJ%_5qbGCRxVbew?6nTx5k;?ilDmz`ZRO~#sB zq{R)K2Lk4U)I|lQ#_!1E1WwkbHPpI7(vS5lGjhi==^Y%kP_hmMnx4xVZW8t z3awS$eJ93}9vh~r3Zn{q9^=&0uTQqdTJ9~U{Qw59egotD6Im?q;3p@I!uyL9AqbZh zi|pgaVS_awDU*a}rtfvsU{D)t*6-RGU7Fu)Ksd0ee$DFgt^~)X9bX=lgQD;cfB7%S z#`k8*`r$zAfK&!9IdMU=kGxP@Sq*Tk^GqYL<*xy7xn9&2X}Mp%>O7(zG@ z;$#I(j!BDtr$L~)1N*3?1sgb^Z^spHhQgKg?yt^!z`GDk`z54R} z(}I4c~}iDvhG$;3`5>tNa(-nLqeabbFp-qC;P z(mwz5OUUpOpmj~GHE<{1g%-Byd%c;=(&!7#m3J6eiTvg>G@|8j$BxRb|B@?jxq4Z- zw(eF--$_Bz;sE8+(?=> zQ#4Vi#F`_{<%V-j?JFES5peB%qzgCrm5{bWHs2Obge43N@z4+iFPb}^-q_>EX{h%| z5#N0NqmRGn(nP@|OKNlk;kx(|UyJ;C!guX33QiyLbeb zT@L8U`y7awS6`xU&U_Thl*D(E64YBQn_$J^S3r6&OC1u3#4)m%;2C_MD7!V4yj{vp zUSimKBBcj=X>BOPJ;22T37|uWB>Y+?6_pGexZEnTTB0YZvMTh{0iA5dIt4P`sjA<` zU2rV_lJMkAuDa9zyBKj9`&N?hL9WhkR2Us=NP%xT4sY%&RUAFn$%>+eq!SM8Z7^(z zk~}<`lc^)+0dmS5p;sm?UtyY*NbHECJGZyS=lRRxiq~3Ov$UKDUr$Jwp6!y{W%yG5 zR)V{{txZYpk3g*P>wQhSqEJ_5nC`Bw68KTW=i%Yu6}#K>^PYVxzB%9z@+y4i{q5I# z0NB!HS_SM35W~196vbfF(KUytq?9DuZ@r1Jo4l=$v3omJb; z4pu(o32l@q)^ovT|GOTQ{y`&)-y8xyDtz52pcSL|M~HQRNbG;s&zFaXcR5NRm};m% zhZ{8NW??}dx$grT6ub{^O2F7UBO%RMIbtGqh)PYomzd(+Pj<85&xqCjKKCm2@PpWu z?U351X^6-i$CsF8ze*yu#B9IMEBoNSVt0E$jm{$Wtr!NBz{Pr^!MA(kK^S>RtVDc(|}D-kR*s@Uq) zQFA_(1trjYsp+QY-H|n5Pdti+VWHKMa`;@J-{&2DOu8R-sEOY5h?cEb#&dBrMTzgw zU;0BJUY;h(F>md47bxcmRzUJ@v9nqEBnaPdIlm&QFSD(;CBsFR@!md=#vA+3yCIXq zpP_;+yR`JyiL~l{I-SGhWU7Q;yGs8>5??21HMXrkuIXo>7^f4R!k^diQgi;nn0+GM zR4bQKfSpioTqAq#y3LJhpqiHtEbMEaOZeVvSmenVz;o&j3F(2(#7qS}DD`dvovI-AP}V`j3AX?-Wd!%I5qgdD}QiujX`LpU-( zSlYYpb=skM!%+_3TeY<7ssy=`Hp$Lx_-+KgA~KX7e@hfB6oPGDAaH_6iyxkhmu zDo<EYBX<;kB@I}L0gWYzP{t(uuWs4;nmN!@mPb3hFnRBs*KL% z6CX=&p_}c!mlveKaYSqSgY^2BAA;0~W{8WLO_)&yaEFxS*|k%m_95!1@VES~g#)A# zUial8_@6!s&Ftm6v=dQxnk-itAG%D97W@{7`e}{>8BLy@i~&YYCnpKozrTM}ySuv^ zb@{B=H}4Js{GTz$CI_xfd&Od;?;p@(uCxU`7skuY1suZcJW1;;$pb*y@DVLl@2Mfq zyTQ3jY_^r+{|zgO2Hz9{jxvk`N=h)zENjNZowUCIUlMrMK^-Yi)+C6hfD#0hAI2Px zhJ^~#B~GZt@b4G&&0Qk+5rxqjcDMQ@upbxbDur^PVH3Okg1-;&(s{)RI}p+0fJ-7s}U zR++MR5;vTS#*n~>q%b}WlV-^XKsTSEBSp=x#EZ}AzUprlD_@S%8(co#> z7hY@qbbXynOWVb^d5MAIZV=7P!+8j&y(84Z)k%o?S86+0!CX8_Z*tb6IAf^=%P$2)+46)Vgefd7V&6qX>%W7D{>899CE9EC2 zy>qN-re-nM1TRWRD<5dY^L1vP@rZpTl=Qq9A0=l5kBuEAUQwp69P7}M2Y&-AB)M`= zVCE!K5+xfaHVj`++hrvd3sjMO26LJth{O|%>$LPIdXogB7h7UJsG-@jV`shSSz@m% zf7OH;T+wo{yp&&BHBN$2W<0SLCzG_U@daoqx1} zTk~z=*_k_ZpH5x}5~#U@P~`IAJW4@0Ip=!r`W55*Zn`mu|K$n9pfbRtfSpImzn!8(n#y%CZaM zKlxiSk=h&%;Ocbg+P+Q0XF}^!c6dcGuazywDtwCH?EFPjwm>z!d>kurJup);Eu4_V zzc*EDJUVYN3O9)v5K%7$FsPCbQPhzBHt5*RixW>#!G8`6h{=9I1e=F|)h?s!=%droq3VBR>FWpR7;fu2JFL&Rv@TQ04{(28yNgK$Zn% zifW_gU&zo9HHJ|57X{r2Bthv9Kf#wwy0vowK?`AWN#(`3m|CTuOOm6gHYF#fZrvRQ zJ4hcHGvA2B)#L|6nSg=+>cIyD`i+dv?*4(}KrNxcNyZKZ`$myz)yE_0Py7F{-)eK% z>0s8-Niwb%j%`N^4#s0%(TGKL4*o&6e>3fy{Yk`z60lB_TaRZueNrfu_TWJipm@)*oBX5C@tw& zu@nEURdM5W+K^OW!7iY>*Wl}Pba^?4%1)j0eA9u4Sdyo~>uNAsvotLrwbU->-Sn83 zlT)iZREK_*_z-~Fjk@`U{MLI^9BrSutE;ImF{NN%XxfK7K0^A$eFC4S5-Y7>H@?0Ol0fWy@tyekHL3X94vzE)4L{WXNT_ew8nZA`+rPQ_elGd_ zIrhcORgJ}4OcxTzk$v)7#!_zn^X*t?rxGJk6#Q zI++tTvk=23mtc9;s{<-KG>0Q$n6FdZVRp}L{FZZlvnY;Mm5gK)pUvTO_K$xw@;m6^ z;;5r5>=#}(6H(n*rBo}N{S4+g8fo*-JPK?y^EwNXPU?6TzpJ;l<>(M>G^3I`=cAx_ zhym*(%S@u9c8WB9a(RdpOXAjUQJ=++!aKE+Q@>?u2qfMAldzTwPt#=B#j+PdU&?Mcrv&&xak(VKLzxLO~?l{=qnp(&Uu!*LR!lmcXMKS{B86}x$s9VSLzDEEXr}6{?C&9 zrPimY@wu?6aS{e!ZI6pQU|07#6l1zHgnH?8)`ucdq?&papJ$CQ_O z&{l1qcnw>_rKTRJ|NM7kJWyw5hH1FgdCWT0k6Nv-UemlutFLh1m(cw( z+k6w3+20RKt3DFWIC9LKZAwQ6#t|SVftwEKYf_*CGtyRYA(2(4g7;oYK1lpI%>ew% z*@lO36KRYNpb&nTBQSfH6(iuqJeBly*YVHj=qPY(M{mgv_b+Yk=l=x;c0O>wVk9<< z9dP=yJZvwpc{OMX>TjRc9J&*j4|?u_Z^TDbrZ7XM%L|g?R&FO$HfmH6P&$SE-Y-La zx*u=MG{ok5?d~XjN1SwBbKz zXN;eeKc`F-cz^fj%HY`e{*ZBo>zwmA)>`{IeKv3G*Q7YRxmo-{gB9!lIBD>I%r?gX<9eWVw`;o3 z2W5mC^|!EjxC%?W70y{meR5(*8w*Zb>rezKF|m?yD0x8Cd(o2Qit_XqUT$poss1x} z9}kak?^8^myirg&wc`+ zF$RCTKD-7e$`<~Ie!J6nV1@t1ty!bqlf8>iteFdZy$p9Y96*R7jM6J)S2^Y`$f54W zm=2EFhMIuv=f!W@tsgI04183;+wbn~4zw5F(o1fvW8LTaR_~^zV3K$-Xi$hI$Ln!k z2?>=k1qsu%cQX~Vtg6{}t}Y?@tRoh_c+crO+#emwDj@Ja5NLt$L`v_cW&RZpx%#YU zhdq>NyDF*$8jEIu3ydVCtdlBR_N>3D!_fc6S{O*q?tXQj_(JKUQ$Sk=DecxRLm3HZ zijs6m(81VUFZFi3P(}dDbfS^93(G9I({+=zW>6fVTB0GbG-}{mWev)Kuq5W^88EQD z78TShQ((q6ChLOU2)}J(uJE#EF{Lv7!E7gi!D4Dg5%Z{rALpRf3Bq^DaBa+s5W+lar8~96WPk&0Y zRO92%HD;W5`^U%Qe}V{t0tFImOs+n>nn>?+9edGFPd4v`+u zdD!uf%dK6gLdU8#8On{3cYoMZ%!&{ul;yAlER#F=cprEv*BQi-q?7A2=}4#qpGy3+g-*fpmPg6HW8@h^ z@^p7EwfC!A*s@w4xBfNKR6mQ2S6bg~s-J0TUyf(*wE*UiviV5Mgr1NbKAF=5Pf1&q z13soGS7%T8Lku&RdlIqx)b?>s*L>yZkC67;oInzq-=FFj!|xK?EY zfiiz`91)gcx@dT)$S?P(z?2R1W#iul<+G+t2_Ku6tj$I?LT=qVx!}#D6Y=nNfm#M& z5B=y1$(|m2SO9uuL}yZ_wogtNN=tzgqvz{CAfJZRAXC|ieB_W|f*57RpO$pR@e`B$ z(MJC7wIm$)<_10^WziE*m^c0cjMMQl)?r{;l8~2@OH0}Z)?Ovo08b!ej9wO!@_Q+# z;QpinBNj%R4NHL3MPLKd%^Fu)*&#d@q7fub;&adF-r@^IC2Q+9F{g_c~`_G9xKHm6fpVFW~@xVSjl zS9w>h=18SG1VJByl9EJZm+}|jq&R_R!ay~VmdjH%ddKBEV_24=Wfhdy)VvTyL(ZF! z0Ri4e&Z}mlTn8;0ndNWX>JOx0cUO_x2Nm*@0zs^=7Cm+RW8rblKud)u=O?GWe1uC^ zKC?2zPYcQMYO|u2m!WDcK?EYUKTywQsZuS5=n~_902}r1$92htfwBnq2^$S&R7ze0 zF?$g1t0I`h7zkq}?we8iu&Au93%d)L^#uEtd zyZ|D*2sZ%%`^cD2J=zD41YcDt`$5*r^Y?s--M>&w&)>8N?3$}+-wv*YZ8UZ~gW&D| zzZYPZqU(F9<*teF!tkNLHTq+^9nT@E#|SG#CEL@E2yNtx1x z2DHc~I6?_-yluH={tpdGn+5>k8#qWzMMlVf$}`@^v>3qlLKsEM&K^ugNc6>FS8!RFJ4L z)KCB0mY)_J8B26^&*XehIyHC$-WQwcvGMfTTk-ghiKX{@6On~8T|8|>!fs_S*It5k z*XOOvICFyM^&EJpYL5iZ>zn-T-OSwcb>6RTgv$#nx*Rp#{PdZSjcz9x(9cDl+#`pp z8K)$LV=ntyq^3oVOEcvg*_=(IQe>$r7u#d_uJB`0m^YmLng~c(i%qfmIu{JBM&Ic> zRc9Ogpwr!tNEyP&J*!BGNGYq`lWwM8uwPcK;4U|Klw6eLwS3-V`Ft!fE)Dp6@@?HZ_rTQzN`}NY|D(*>W@BG_{*wg%r zPuezXYb_ISOzd?rmOwIP0V2UspnZ(-bpX#tUYSX-w>OkAsl-Ke=i=7e56H5@>Nkw! zxC1z&#q0Vf@GFf7@N&<;zC7Bg-NCQHND__SRd|ZUZNXlJ@K!$MU%!?NSnc_GtAG2M ztWMmoY<*0Y6$lX!*mHa`c)d!0^wrN1j(Y``Xh2YSW8*)x5#=6mX#?c*f1e*UQ-_P* zK>A8yKjHNC^?AcEKhEvWxdn@uL_Utk3;p>97}c(`hJKVkPvKDmC(x(>Ar7Fq6n*2PvL|a|#`;XdX@1v>OrPG7 zLI)jd4~J#%nWrEcXd!f2K==o!VN_Ruf4JSV^+_`;gG&O5Tju3>-vrCj{x;K&CL18T zjnUY7ne|(I{N_AFC@q>INYL<@cS0lb;{fT)0WmV9UZ(i744^LhiS#-K%;XgFIDgv_ zQ!G^~o@_{04myn?QeRcA5M9oOvWyL^rPx^!>leD}rFi}&KS^EhMqiF&YhYmv(+8IGU zdhCDqX&H!!?1$V?xuOu1JBVzjj&pX_k}QO&z2>Hw+o;qAw#0DWFhkxSP^f;`>Jh}2 zNjD?n+hp)Ub49g2%(WeM(9_Ep46(=%t^Me^uK#n1Xknm5R?SL@@mdLMo>_a+?mJ%f zGD;}-tpd)Cn$pM)vu{{w#721-axdwu16*(ZA?X15Ez~okebSIH!l?3;DI^Y;Z!dzk zjk`s-@DsObTdNwoPROr~Dax>RE-^&LLP&{5F)nODiyyKX1^yK=ODYActmR1R@wjvU zr{N!V{yOik3IA@geEH#Cm0b%8c8AUui)-mxPKoT+Zj`g_wJFe`@_NGg`KGLI)pXmq zyF+=W9yhz?mB5D4%=4NbP|1SgiK${xUzyXl=nZQljIO2WH7xw{YL1 z95S!RnC>(_mtJNHeEehAfIu)|YQh&~E%mZEbZ45O+PB(JeDH7xShyQk6Ud*QZW-EV z*4Nj88}LKI-7YT;6LqEHIndPtVyQw$`Z{ivq&~?9PV=UDo6&Ss^=j802qdEV(hddB z$t%Ae9Yx^!QXfyv6c_HBDP|LGcnTb3T(7PY(y>Csyn(K{yIy}^uFJc-G)})Xl^^lN z*2PqGQg@GBG7VJ;0WMx%(4ahQLh4&b>f$=>nz|Iea{>vb=$WiVz{UnFGQN))Kg`X| zx$^DTfkS!Y;^V=ca+~frHvo7jr$4;zTFn5IH*1zh#o#W{a?0Qo+NlHjk1Lz;LQN2>3NWYNvb<|eV2 zmHBdPy(~^Kz4w#dJEmQ;=&SX}a|Ep4L`pzk6hIC54a`VcfGgob84bY5N5!?JIp z^I6?Dlt@YaBRZfoC_1PUu$a;^(sZ9q7P|pvEe8`;4_eIOTI|#;PecUl9*4k#V|Q+j zm2J~j?4JNC7mwKvVRU$*6WY-&kb2pTfJNY;uJpIumbGr!jDRBxTsDR5&`&4NJ4xiS zel4y}Qs!Ba}r~YKf;j;|dt}-m% zg{_k^zP1yLVd~o^MUdjc6-vv+9y{Sv!gA#5&u{ijqBafj%g+@rXli4c5tFegZT~^*NNE zsrlYdSm}r1Q8MD!LT{C(jTkC0tr9gwt4S`??xb{ItvuP|i3>-4b)S7Y`|$Rl?-X6y zOKM)V_{DwVoqJ^=WJV4=_6sjyp!~*t7hq-XOKYqv>>h zW_&uP3tXOb9*h|(VVHJd+$rXDB0GN$EvSa$g>GXerwntBea`seLnP%!J9Xc&=-aKN z?VebqgQdrOKaXU32%7hpBQGrwp5N7(H}zEGK-}n&=X7C+lR89AoxcxKsup*1W>sxq zgNOgOaQG=NHgrR#TWLTc1W%a4A{_9hj4k~)>jOy^VD(XmJPzo+QpL$0lSG2(&_gz- z2YE(9uX$_pHtuXWd1jYcRW1>vxMuBeSZ!=akPEm-WbkGuQGoZAg~JUIV{9Br~n8TQlVC7bLED>YIpu=J3f)uG-> zKIco&ktjok`X=L9Y)8CzzA>JsB9$&$II1_hDp!4NZ)EohB#$%CST_gdz|rkdHAlxB0+*vZ z;J5-(ij26xfW(^_cTGqp8qvzu2K$Jp6qUh&2Z(E33)?*Cyv1kt;c6KX`wv}KuF)}+ ziwJ`1*Pjp!U~{LqoO5*>aVugUZo)*md0L!7zi^7V7v9 zLEfjAvttDHqs1pcXefFF*h>Lty-&T=eX^)+Hd_$HtilM*v$th(6}A2C`R^hVlGZ<@ zz?skg_-~H)uD@jF)JnFdaiE?)Pu-Q3B1^Z>7Q?~W!90kYN?oiJSCU!km18#ZxDoW7 zHcDNowvk1Pb*96Wb|(Ntv<&l>41aeSYj(1#1u&FBl$*V$DdkRGJ(^4*!G&M(3fm3g zbI63;49X-Zkb<)lH7EX`>#g7p{(v)>s7YJt+uG!E)4VeCPC+*u)8RZtKD&_wM~R&m zX@T?$g;;Iu#pz8uujTyV4ksv`u9?YK_q(`dg{t!57^ouPeIaa48Y-7NjgoW~Q?=*V z9<(jFCeB+Wljv#JU70HP_tJPvqtX>;B~EfVbtk9^5ymIF@-ITu7ArU*4KMGkRB0|O z0Tra?DewaB_dWTQH4l9eWV7o;Xx5KrW%%mDS2ovwvYTS<}5#Q8pr*=Y#sXyYi8 zUZ{9aim1a;ITPjXZHz!OZ*!x_jq!<9sRKC?%q+@(Yx3?uXHcjPZJO2~{%gBap!4 z2y(3KQ~;?z@Z>rML(<>wh?fZSD;QBnQtZOr}nqD)@NYs!XT~k^^_ut z1R$>sB$}gM)~M%-*1=*MtcCCRO0P5XsP%#TPQV(G)tuX&;P`}6wkS@*aBVPBGIYU* z_h$!%B=ufMRCv&Mm&-_g3Y!kb@&wJFePv?&E(s68DWPcM&+I`};o z`zU@*+TVXJPLUT+!0rKBuzW#s9~FpK`K&bvTqu-1UH##Ere{U~U>HjAa{BQbuS z2I`d#+EB}q=Y{a2Z38A&HA$IexzH=Hm<3dH1X)5t56H^{>tSc(V*G+!-y>pxgsow~ zU^>i-1_!@TrYr^~X2r0$`)A@D*YUK)7w2{m@8(m3zEGfeZBBwAWfTD!T0T{b1RHZDke&0|xJsEOutb_hithy-^ zu9pyPOqI7&fa6>pdParD3*jtZCm5tEj&s;K-7 z&VeH0(E;X3peuTGt1yo| z_yb*N_!(cC8xm)sTik0!2Tdt5b1D0dra$?&H#I=2(!)tD#L?=RMwsUVh5M_k?2NR~ z`JB6UDmH$jF_oO1#qpY3qxE?@%h8b(eJMq3rJJ6`X5IFSL57)$yDR_kvudSlWuXV!suT48@|Wn}W0th9|f)2njb z+VODx@luogS0A|CQY$fJkAt{_Cio@1yIiYz($co;vlg zB;QBb>oHwt<_rNYV7nk-`aSf9w!*Fp3B>?auSVT+0H1L@Fe@~Kyc2HEltbk0KgbUd z-7k}#0y47Un54)wiwAAYbgC;!3av#v-~AFmR4g$Z;6ot&4*^6d{}(-7-EGe51GbcZ z*}!fR`-VjRUMWLaDkY-dZRpKY;J>rx;gXUPxY``tq2$dC+IC}oPGKWwnfeR&+2qtK zqmFv3P47twp|atE1U|Mcv@}3MvN==a0?g0+i)nr6E!tO~%t_TdXG%v6c%%*;M@Ppx{qL&@WHt`yiW=eR1cnjF zBy6!GDYw+R6z$tS(Trzr9?X8?P%&Th6`3Etd5N=!6gpe5=p4}Y^Up)-r4;qLSMV|W zPTQH~YGoWGs96nsiP4qwe}i-_`B}^?9oCJ1^24n5DWW4(OV%*N=}LK_-r0! z-NZ+$`i0PNVuD#KRWeaRQ5`K}0gj?oPnxI?TB#e}C}`wm{u^e4jxRHUjJ0o?SyBXI ziGlRC&al)8i)U2g+Q3v?!2}m3HwSB9@R7RRjxiskfdeb{fpcA}LAT9R*`ArM-VvBV za-*m)!WhPwT~)-^{V^3&pgut8%HWE%PaU&E1!vjqv?Kmf%1gF8Z59j~&C&L{ z)czk$pimL^V}uv-U#p#z`SO@`8<%SF{vL68kN&Q%dpnFa8P>{&Hw(nx0+%|ZvsE-{QRHqt}DrkT&U2B4@4`t4X51`oveFiDy z04oZV04{{hF(aoxc*6opXxoKrIS0UR@u{SvaO!o9`TYw~ZKg`EezdVK&c|@jM>i(f zBxR}1pev$yvnP{V;E@GX2j@k};>1WpYke1OEfzr`q0b|WtlQ53(&I2HLL4`c4n>(P@$vQDtAYX6AixAh4xRy9>g#06m#6sxc|C&oQIOYa zps=pHPS++bK`PGLEEXMF1wV5X{F%k*DP- zjMFc6QcXXl-jdtbis-XBzi!_OJnYy;NJvOkOV;(8b)i6<_;Kb7on9)6Hw}h#Wmsph zte{jxPJ`QoR6V}2T=t8^=!b_F5}0n_e+kH{z#-rDJz&OHB8NHMTOaPCKEoa2clq@6 zXBn5;(PX|BZ!EjGTNbCoc>)8bs>A>%^p{6?}1!mt!9-HT9t3Qdhe*7qFbTSPZ0K{|KrG~*uO(KsM+*EP`t z=Fv&7e$A#4QG18zf;I>Y_I!luFK&}bJ}HWLT^cPR>rV*<t~}u90N>cb{q*GoT@{ugL1;R|+kjSA z=N^J1IzwwY$0+W5dP5r~TXpWF=bV@Q&q;d)a(&=oWbC-VS!F^30yna?nSNn|u9_GO z>I6bprX9p2B+h^C0FWr49RM>j;01dkXp7#UAe2q|No_qI3-Fi2l#9oXb{yfz4sn_N zJUuVeA~yyd&%@_Q+lFyw&2s(y{HR3Q0b=v(LuXIVK?uaTW(T-4*emCq(yxO6>zr?S z`ruj!kHDiM4b}0ucjJR1=n(jUr>Cb5{?F@&Kk_TM;t%%zyYw7fKc0@}a|uh?v-5e4 zJU%>Rka>OmN-gpRRA(A|eGF~l)zbJea~+4+9~N#TRp&&Xe_EN^36PHZ)(QU7d;kN& z#_lL7KLzkZrO3H{RGY@JQZjb$?pl5P%B`^>Kz1ExeBt_g0vcGn(qQ~fsmGr?Tj^)S zsQ|ySuh;GVerOkW=HHy`YNny~Y|WB*7e2?H^^gXt?Mw9DbOBw5gDf&rh3IzfOj*NS zN&MeICQ#qTQ7=Eg>7NFGijE%*EMgEt2MBDGUwp07jQLB3SG!!_DE}R!yo)j8qJ%u& zRqsrHen)+D3xAL69^?5lT<2YWXPp#A77%8-&}#Bxf`JGAokv+tBt~R{QpfSK&>f3& zn7&U-TP?;V=y{D&;q($c#K!{JL2ui54;$Ozh($_x=1~36}g>tK~6S z@GtWAHMrry{Gq$rQ#%I5wV2S14Q%-wz3mdjA+k`#mkJ zD0OMsmk_i^e&(I9+8yc^3D7@@8St|8TZqE_E9f2iP z3zHcgsd<|NOYyq)JvHequ4i%yrpR$_-`^Lo#$UNb*nyFOa$??+PVz--{@Eppw;8;Y z9sjwUx*^(9P!FuhcbIC_nr;WU5^*rscse}QWe)Y1#c5e3aT3n!EB&NI&IRdD5mUC{ zU1{uC5M4A(Ci{H9)}MaLr2`&8HS3YsloMCJe=m<5h+?!T&VaMXJ|_-|Bv!HqM>s3V zeLmup$nkHsyK@6I;rM^7p(`6|9>JNZV-1Off^ubqN6TTV?ZCKk(*Y|pp*N{B{2tc{ z`N(s;u|R?g$k3BL%j;Yfu%P&6qF8MhykxJM&{YOP3zbd?5?dKPU8zc72ocw%XG}{|oBy_YHwmU^FdWfrd!n?e1(HI5Po>`NhxHkS3n1-{jU7zK)^K9nKmC zkW&(-J>DWYIUmeJfbXaA$>ewlFRx+m=y3oquR^)X_0MXi?CAsG&(o84<0^nc+;;|N zPZNAFz&1uT`4F9PYpu!2n}Hd`RY7DB6m|X3)dPRv-bv-Dsjn;laZf;$$VcL3rC2wq z^g@eb`J_420~aUx2mVx(V$KH8@e*74}&vVLm0e6ydvo}s-)(8erZL%}Dm z<9Wjm>6z5UVIT8abJ$!NJ)FLS-A``0^}oC8uQ-egLS?X3fFSPprDv*zcva=WQWr4( zq=oGSXa-2-1WWX@_mlEro#@hu^OfmL{1mO0VYKvxMkK+(L*M>#a&r*|lrFuP+Bj70 z!6+oikbm-LrjufL(llzDl-RA(BxO456kqJbhjoLQtyP8Y%M{Oji``JJcY2`hc22e+ z-3UJ=5E-Mo(0`nWNrMm*gyPPHx65?mw2)2ydQ`^ZV|i|)x{6au0Sy4>nDDPQ+$J8D z{oh49Z0zFC*^>zj0{e=pOnbTws8D57;NFdM;mHU;E&@yLKqx`V5)ElVJ7ss5Ww>?y zI1!o2ob<>a(Cu=QD^^sz@EYRrlQA|$?A4mWLs7r~qMa1`^`u|^_&kpsqmX=Q{B1M# ziY9ouqC9VWC*fkV$jzkOYBdAZHHrZ_t{}OFtVtFtTq(D#-B&7GATdMXuA&#@&uh5I z=9oL!TCDhfks0<&6wEdP4;0$-2IYVUp*-cg10sKs==k>bpD%_JiP(#bd#pQ7hF~sQ@99}m$21+_s z%vrMyRBsJ!TRKfY7=HUNf|Hezy0-W^KO7jCB+0$J4_XnJrohrdx$+h0F8=-s$}7&m zZADr=x89^0TDfbd-|P4}Ebv-rT=DR`bWr};SCixvPKu0n+Q@;PJ7bHJfw*2peE%zjg@6~$+p|}YK#J{E&U;~^R0C?hSl;M2?kPjP|zB1eb zYOpughVImrPA$SZKwVCo+y@dtK-Ju6t%HNZs)S+3rDTKw(mn%P*K&f7Dp{v)ffoi3 z(iXTLz@9(qGnWr!4j-AgXZvL}a1Fy+bNmD?TQm|<1#buhe>BRR8jpEy>R%JB{T0vD zS<;B)@_)|P|5l#}-OmiRX!S{0BN(um_rQWg<-%69E)gcnp!NX0lV!Or`$)OZJRlLi z9qFuo21Uvppq{)wJv|+a{sPXBY$8V9ZJfg{&EK70aw>kJ3bpUdM^XE#2VTnkvSx$; zJLNLaX9vv^A1#gC#SN{EA|Jqv_Ws?kVz~TA8|J)FpWevtiMnBxi^<0ZmE)G9znll z@S@Q8-$F4cJjGfiV8SGTT0T}uRu*1I%T84tvP@bHo&#c5FY2%e4VWGHsmD;DB@I;6aAb?ysQg1 z+AIiFrK|a!9we0fk1M@VOiN<0OI%SoRUb>*_2X?6nb$6=kKZ$Rfs)RiXR5u9!ElH zi`lMK8TOLg{;erntox;o`c{k1LCX#7`1=)DYby5YHChF>XLH63Y<9^h>uMP;WmqtO zb$f!9=UvctQlft8U4#INL(Hy_^*0i09~1> z2Lce=R6B7n~BTjnm z;@jwjlrw24P<@gs-Y@5PQqbpJg{i3+659_VA8}*%r(S_Q2Wyn}VMko@8c+aDXyMA5 ziL(G&xTGP}_s-Q-zbhvW&u9js7?btY4R zcbDdA_unpaGab-V{9k^P0tWS8Z;wCxwKXH-1#s>j_X3aymX5;$#Z#h#&5Sl?Dduzd z<=;2n$s_62zBqmnp4mM-Takq2A?d1`=;!Zb+GnnI*;9u>S$FS5 za5WS;XwWQdL2NHb)o1xgUyw3S0VSQ4CbBQoAR0zlNyQHLA^$*=Kf7n{fYR<8p{DZtU54XWEeL!2vLa#lS1S(+QgIyW}rReZ>z!fBm zS-G}#1E?rs7IF=HLX7p~&v6s0S>1NNY5M2CpTq+!K7IhHR$)gW!a_VXZ?`iuz}7|N zaC4mIAyW4E4SY_%2`9Lqs?*X$B%0vBks_hkm>xE=NS8*0#^2v)a4Z#MN|NH_xlt!G z@e+yAu%hyx$M%=CnJlcF3NkbivXbpgz>Ng+k!NGFMgdzT+jE)FwBBalm+{> zSA4Zcm0m42?M!VW@h)XZsS&}BoNsgFqhh9WstQ_h3;`etUisDe0Yc8)Zcd6}0l3%) zajNL(o08sqIU`yrZM-;R#Pm|Oa9N07Koi_iKxHl^G6Qv20}=5iMwTsf;#-)>gpYqB+Kyzy<+JU~k*fzD5C{FAf0JYTv<*bl8pljxHOK8k7L52A6^u9BW% z6fFKbs6qLBuK;Vu|)soB~hrT}ovd&Wu3Ye#X%Z_;? zkemayt&czxrkjt?HqeP>S}Hd)b9nvxx5<1Ns1tnfcDBxAoN>ht z$i?Q1o{K=J}N3L2@8hM5#15I2hnS>FT=TsfOO<(Q--|3Xf^{N6Y< zi5GC`X6Am$;ZK}`{A92}Z9n+UfW?^L=IGcLPQm-zA9(F9E`vPS4>v)mdy|CLV?C3u ze8Vz5)xmkXS0d)GF2MH;FzwL~=^#$wvmc0a2@qxhb0yHNYQubrj7@JTAq=d%?0s#+ zv8pgoZRkGB@4GDYSoB!~Yad|UPG)P6OU}NtT{Kj){EX|N2LD-(y`}qXZCE9Tx2g4w ze9B$wO6b!>WrAn%s0MRnC5QpW;RH^Cul0C7Bi(ssG|YEO7)MImZ_$8EPK=?wbR(o$ zV(ru~`NeOHp3y7c^#cs{baw6rk;sxe^3j#Q5nA{_7rHb#T{`W;xB>BEyrnJI@j&s34KH@;RZS3`~8%H8icU-1(i;TZrsT`6WbELDNa| zFc|iAZvjH_+58n!B=duH1A@PbmJebHRN_4S9j&6jWMmfLu>)U2o<#$j#OIyN|>O9&$3jGC!SEaT@sJttZC^*>W-! zSIy~0>NYTzC=DzcEth`MeCV6qk>Rvj5*QZIT)b8mj^^9Pb5Ye7CU&i;q?S(%at&uc zca;^xhaQG*Ag6Yvw4=ejEJ!->p_~nOOEQjWhwwNf3ro?ANzhWs# zh|~Z0%e0$C^b@rm{|-ml^$1ENTl()qHqMu&T~nC>Zv(%mBsz&4xF+cqI>mq~>P zHD*Se`IZ{)2vxbtujWz4#?kzes9ieI5~&J`8~qKWXYvwr3J!M#Zx#N=b5fz$q=*Mz zxk@~xDpBT2<6+jYi=1D&AUF|ZYBMa42ZG<$R|06ne&d9Np?M=O8s_<^5~ZEIggCf69}6$agg<&@f9(9^?Mt z;9WVe%mJF%yJc#_`{qdS?*ZnNTNiZD@9^V*z&=jZ3Z9Qj{6VVbW1Nu!{7+!iKDg0Vg$-txGU$+p4U6Fv*H&PG(A5n=k!rSi}B zuP-}noKCG%APCI_U7ma(wY-j^c*JxV&}6Qubu$tgNaYhY3LmQo@;j^ueT#5Qn4UJVkPABt?mc1F9L?SBgU#vBSiK~A%LV)O2stfi zGYvr{|9+g-ZKiTdV6uLY!+`J09(ycFTz*eGOEWVJwtC)%Q2U*Eql7rGez`rjJy(q! zaXk%?KCXi0;74r6oPrN}*j$PFO#P_hGg3ZL+zN+ZN=nXPI25EPK!~31RZHQ z+hgatAtIOwEPe)9ZBZ)Y^adEz9=`SU;|tN|=hCVom?pEL3KwVQSnDIKMlCpP5qU_i zWAv}%C{eVyH?{G!pzoP>F`1>dTy(PUnD1xiS_fJC{$U=^Bj#?P+asxQ9tuTQ*nH8_ zaq5;2DSX>MuyvX`l19V^@4)5^Fja&sO{XCwwHtxfTX?MA&^3iPDEOmjol+U757L!_ zy}TupH$f{(t|GyhIiYSQ($LfmuIa&7KOjh{j!+5v&hUGBQ-to~K^>@qDlSST>Irx< zOy*SYgato6TGEHIZ~Wlg|Kc4z2O|9vRXIi#IL7A4(IwE7NYTWM5Q1kTNujj}2){u2 zIRrK8ipaIOkI#*UmtWys{u^>pM+9^p(4%Z5DML^5BF&Q?URrZ_{v=X!=@*nN(Mc8z*F*yuGeT?)8wFt*F{YWizm}f+y-2NaF$s zH(+|&2$nk0`5l4#GCm%ejfe0~>l7#%OFqR--BslZU(PHKc@I|im?>KTY%_E|OjE?> z%-p*S)cjVuM56M`@i3o-P6_u8q0msBYV*!bUOyCe3>u)*?e|m@a&*OpCmB^xLgvZ0NapqYM8qSep4Z7j=@A z%_^l)nBtA(K~C-~=Cx3iI#u*rx35Y9(bf>I(WpVC<5w5mS5>to0KQ^%+m~!a{_9eC zkbigwt24|iNML&q0^yIFtGns;p2VJmMzF$`p0TG6@gDS`Q2ZWPSvWpfjdXDLEkd4#`Doyzic-dTr2lYo7DpUtY ziuV4dI~tOOs2Iz)zU(AW%=U)l-#rCsB;E9P>MVvwUUhI5>-{n(gFTc_?YND^+L1Fn zClVxDFzYoyX&$2U?!R*l?;dLUs`?&wZ1aSYmI>EPdA=QFw8KaW8(O&o1GCNpO@Z{$ zcU}Z{%3h>LDy51zI9wfvc+9Ei;O-o`Hk{eoHajgn?%ozq*O}w=^)cQD&Tk#=f(gi{i-3gDq!lCX}_wa%f!#s=kwGW#SUt zs8ldz?IS|?Q;Vl5GRfhRbsf#W=C-FWg9Qbt1|>T3&#eJgl<(`yD*U2v8GA2=^m62E zkpNaxtlN0=KbtUTlyt4z4<|+1p z{V+ne(UhIq&q4tna*PZ>Q0F)z68a%7@VEf*@Bo!r;yx=yNKmj8^*z!Sok*~53#w%C zhu6ZtFTfXb`GFwe^duGtXO)ADgjN(_(@`f!-WrX~G(vw{e2k%;FYq0_`%mopcbEN3 zmueiq+bPgGZ*34UqvCv)O}NriXP+d(9wj&J&>|f>+uZ|Bq401dxB#aA?l!>PO;=xE zdl6#ryN(fi>R(3X@0o8}`}ySVGtB9enm=y8@OKJ#qHZ=i^W8hP zzW;)Q7puy5pDzSxjw*PEJ_VhqvL7PrIPrRQ>o>k{*|Y~7D{RY^>O-H=YYg@}MUux& z+jTn_FAiV}2i}&fhp}v1bs)H1`ro~V1Cyj_$6+p?kR=}{J}gZ9xj3~YCL-c32mC+) zV!U`T>BxqU)k0j;3W!(q^h=`+})*px` zMgY-0!+=dZ-hI5e8Pd_JzT4W?ytx|3;_%y@`0Uy)G$H;2l;F|bb&RP(Rko306Mb)> z?K_WEh^S2Jh9w1IvTG4mM)sglQ1^565;zij#%!^Gfj^9Q`6weM&d`0fpWSmS&twOi zvOZopq*-npiba(FOIf#ns#bnw^!JO}ugFKAPuCS{%`RD%b9E_xH7=HSR7C2{UpWwkn;~ZaT{PwFZkJZ}h2U40jA89tU7hCp{%)U#bI`tR#f~=;7szYW&2Y#2$1O6jJ8HA?L1^*w@pAzc#+$}CEk^DUn1bH&KJKB z&7wL-*^H;6_5BWE(b+A;&Y6&Ony8}jW~=gQr0MwN5Q%kCJCq&3TL}lu-FMs-m;(VcBytAK^4-Er-2y>|lLuQ(- z5Q{cHAU*(Fyx&f#dOhZwR(N%`4+hPJq*4fL*hq;u`VM=L%~!2TeVfcYmhI{va=EFz z$JovVdr#wdhM&q~o7Db4n%*+3%C_s;rn|dK8Ws)GDY*zqX#r{JPNln~yE~NbE?IO- z3(^Qm3xe<+*ZqFaFMqKCZk*?ubIdXJk=XPz`-(ksc~t$tC*}F`HczQ$(O(lu5h0w= z@u+2laCepvxAmc&> zOT{HfqlYpuAefOH?-=@3-bBfz!7W1f#pDTf>TmikCL8@sbdPScXB4;h63I9(#;8 zc)LY`^EPhShyOTAi`}2jL74RqgiXgHBICDXHUlGeB&rf=by|m%dulnGvh1gkA+Ola zubZ=t$-+)u03z*E-f#+QKLJ*D$w7$Ik`Ky=?MoTJiB=uG1!==&$7>m?9M3N%Cnhk_4H6i&wMN;PZ61}WDW?xo{xEWD zSmaq&Do)>f{RGC60%hQqyO%JR+zZlJ{&@q=>3)HMYX7ppt|Xe-F8DBmrX`t=xJ@hd zA$R6*8Ji`D9|k&(HwppoqqD0^I|+G}oain7_M@0$(<=3j^u>LmR0z4Zd5NzJj<$9x zEwxfN0Dw07rTnuLzSii)pyMD|0I!VG#?+u0SA4H;bWf=O_OP7+Xc z1<|JdV}fDVdyioaW;wL*G2E#P@yjIosVe8$fXY@2H{YoFF(hkAs*u(_DuT5wjs$ zR#{>DfZ*&#=Cx`1LsV@g_M^=7MA*`JMWB3}t(S6(*mge~n&CSXR}A30j}j8H<(`yx z3N{Z9EY-nAZZQ{{tiB$fEr9Upz!+V1XGSIU4-f(~ht41!o#-xap>56LgdJzPG19Rm z87e+Ob`IwtZ58R2#%9}`q42A(j5kdtxHRo!1@Y=prdM*aY)ZPVCSfO*Kd+dG4Y!uo zb1H{O^+~|GZ`f6&?p$QaLJT3RUn@bAe6^(X9=vood^ab?pJ<+LYQBF3(zL!dUDKRB zhMH>~s>rq%(VCAYZdEvyG)e_4QGD`DypG-oYh`?h5DzL&T;3HmuV`<47mE3T+3v0y%ip~SyFh+i6i5M%EsnA$3iY_I+`xa_?{ zEs6{23ng19&KC!v(N_oN(($tE|EVXvW0XQI+I!OPT(KM1grU^AJn|{S%F%zntsZ5| zzM)qQxDz&mdBJfhcv_GYLDU;?kc4acz8D>xz~xH$8y-Bg9(7KWPk*_f_SP0VQwdB> zL;Uos5hP&WD9^zSt3Cy~{3X$MN}er7hr^1Dcf3|HjfnQLtU7_ixdrO4=EL>1Wp=dx zBv3djs7+Xb@gIf;C~}6BG1GW_7vb9k?^@onmeXRZ*F zjK*J@kI5x0QdU_nG;9E%SF3+mYtErfn2k)2Bdsa*N)}~=6+EFnRs;XF_fln5U`bfD zvlY7m-P3DqC{gNijQQ`*yAT=!szD~PNgH-*X6>C@!|!4rfLm68%79_W!t+ zu0St#fa!-sG>!f;di@Ug>62bQgH2>=N{!8T&omZ(6yBb%^zqMj$8GYn=i6~3Hmj+7 z6izFRsFRcw!q{6Lt=#W6UiJ7OGCgSLeObTwN|t=Ssx)8XZib2dLgeiqDWFRz+XE{b z0B4`OzL6w;UqsV45Idb9Dd#Z0g06&B*p2+D@Q0aLQ$82r5jaiJMQVJ=ke&A89S$RW z0O%ZugDtOVtq!a5qvaR2cO(sQrj`cHk#&--9CvsPl9pO7X#bv`KJ=JU1}kuGa3b&0 zDDX}}E9z@cRo0_@O+(MAkuBnqh8Xl{b`63UE?sUzQ70+9Jb-%pSg!QhpR*&g#KJ1X z(ti-ldttnCaw|hIA%=~f3*p>M=Uj95_Z_%!`i8&sBy(I9Z_6Wawj`kb_WEYOt6On- zEW1=Hz)7h+jhFL7+eRPShy&#ql?QWCwGnrHPckx+6S zu5l=9aN#kA)S2aN?kC36rO;Vbo|Lt=EZ6OvPtsj>BHqd49qk#|{^{fl8L$2RNjJd< zrDCrdVnzywVqY#TA$SNZ=~52TH`#)@1H(i$U*lt zDujfZoid|qknU`897x?fKOpeD(W@zfgy)D(7tFH~ETJ!#6ML`6f!*G1UIfO6SH`_U2w z#+>3G6855v@wgYrhx2;O*0oB{zQbFDRi!h=gh~rv^lAXv;A9eTs;~D_Syy%4uA7Zs zAV}lKq3uqPW%2#zq!(`&>D6KklV-wHh{z^T2FQ%dmnpzTq9W+B_La*UnP2=szB^?!jD0S+|a z1O&Q&!F`(X2#oqE8Gq1$P&y_<7zXeigx3N2i>adbirz%$aPOuxJz^)fnXHF_^4Q@y zeFLP3PP+kAACUy?gdF9)<<%iN>Pd7z9N{YhI8T3`yN8Ith9+X0Q1c@IL-OumGAd5q==4hQ`W#el!y@5_!~7-R57>c*H6;? zmxl^+7I|#PxfTmJSDOxWvSi!`*5wc6uea8P#l;1}r<7f+U!HY)fv^1S6-yZdAmBu= zEYdHkmQqqu{^S1}xOmDM3IEJ8R^WUtHd+0ddFczsgQ#n`c&l%b(f#Y{2Yl7wg#BR*y@KSn0xjHFrZNN9aWN$npDN zAzB`g|t*WQ&PNXu0tWDpTR4v16ANxq#;4S5& z7Hl%m@}!H#l`)=jLZm}A(9uPjwM5foItj$8Y;}xPeq%1Cj<8omovP^1p`)>spXW$n z4-=gqqC?Jqr_KwVoU}rpkXbY3{bYW1b5ePf!08x21xpP*q_X`@Jz}CEV98Sud)5>- z*Pk2Y6>}t#=5UFLK&~(*vE+VeWT>N8X22?}RUdInXojb&6UQXv7UON2o6A6wMs80n zy(TeQv>{_{lumbt#(Fr9*U1?Y80G%vD}u%%G1>)F8Kj}s8Mij)L9_-|5jXS397{?L zbk;^<_I8P`s)YR~Fy3~qLGyA=$Yn*mBt^YW97?2jvNC=!(qWZDH>1mtnOW<|sOsST2;izR#4d7lkergn-hIXm`D%=BUW!@%t z@!0yX9S*`4yPEMW?OMv{s0 zL&W{nizpj=sF=(8+bAp=MUNORgVHT3@=8jWjeN`C3}?o)Lvn!ZrI+KT+ti89t z%2$LVcv!An>`IZHO>CX(iXU=rkBjw1ioJp3CpOf+R=k26w!FmCHMnCVWdYXG>rd*O*!)r_L)oh#VG=$3UVBa1Cg7y=9X!o+nHFhv0Va9jBB5@GU1|yf4rw$EVy; z2fX@vf?LVwkEM-~Y#!k{-Zn{NymJL7I-m~e@_zqprXP4{EkIHC?I&1Q?JvP%>8lcy zqwe2V5>9E+fu26GxKSWi#=Aao6|sR-c*A#b^#%iN71O*G&EJNU1t$M~iN@BKHVupE z58D`t>(du_;dqZX$om;6- z%xgJl2|Ah@a|m{+@h7#s5k(q!(l36&|e-Jd`s&@rBYGT{1A6tLR38Dxw;QG#}fh1VkP??tr zsomgHuru6BGsJ1`|B5Ql6>AaAM!P$Hp*9!Ij1@F^0D*F2+&xbzxw~M~!wU~pE19Rw zP7WW3HEFWn+i=GRy4J+%h!MZPw{-rLV=@RU>d#+O-rQq@OFLOjK;!1WslG-CGL9Hx zf<}z9@0~bf-Py}7v)Lt9Pl&*$v1#3QZg4Ap--_}0ZmRW=v@SP`b5>7h!)dGK%BtI! z)BRJ2&iP8-mO0->x8jlBmkwq z5^)1*gb}ZMQq=UDN(~R2E}9q9#Pp5xn!+UvUHys;#WW@inEkWRU+$*2yhZjruslHd z^!8RfiI-adu{NQceLG_Uuf3zX1=;0ffzJkRL_FpyUCOHN?&;Al(N5&&L<*tO#9dKJ^T%|jkX1Z|+FPzNdXe+ySQ6zaW)<U5|BgXot45aB=oKJ z17+nAlXgEM4POEBkJ+)k7c{gBV}I3=mhrCu61i<<3wf7(WK%PHDoO#=MGz zp5u`eTJ=?akZo3m=QYRSuhT#NY5(*8_(>8d3Ga6G$2HywA8*1eWeH~AEynrShpdY{ zPIRGxWKZes3W~6pSc!#Lqj5YNQLjGdow!5qA8AdWN?RK|$fXk_Pc0E>KNAPz#~7GP zwl+75_?;sQGe3{XGT5bB<*~x|fxD7c;@4d;nE^of)s&H22@)LQ&R3L`SG;bSi8zss zNRyqH>_a;{^fp`M+Nwb;_f}UU!#s9=T02UiU{5N9Ybx z68>VC*CCDt&=%hp!7bUkV~&h*`%4^mKe_Jeza%|;l%#H;L>}MT4v(5_{94$ow;NI)+A|przAvvO86am*D&gP0GM~~uylvA$pMYoc_uRQ^ zcGZWOWKPJKWvVn^_w&FKdR#_3sk3V07;Mc)IO3x>E@!r=B=w*M@RpqSh^5=tCL}U^ zll7`aA{%2%@_`Jtimxl$%?Eq8mhH^a%ix;ze&zh_j-Fjhn^ta-Xeo)PlZ2^BMq9rK zn*J@o^Jzo_zsfYY403j6MIJ&V(9ale@0(7dNJx8&9V7m*M=&H>r)0++YX=#WjvW_v zcT|?vMMm*?S~X#hpyTpf%b7P}K-vrSlw|6KjiXLC*7hh@PIq{TAfdy(KnvGCqw-7r zy@=$BEHjC8OZ{D^P#?na6)IyELsyj9ipCmcke&<-3|n%bonkJCZl|7S$?lQAT>s z#eH$SifxVn&!DEMtsl8U8{Sp)_iw&M7vg@^^^pzI6*0xPj}u?MfBzEcC$`dB`U?42 zjU+tI40oJ2@+^cu;Q;>66f&~6cXcU3l?|8R{*O*Ri0z|=LYIScuqDO5K^SQG?dSnEdD(Zlz;k-iIW-#&AT%mnJ}qM zenPl4>mpZf6e`7MgUI??*>|NNA4skGURDd|dNK1w{=FAqDr^3y%48>#P~29~ATPHt zkltVo-MzTDczU8KNYPz(EGK=;8c)`>V;n)ph86zM_?@XuKZ-eL8t@`#VP|x0Obo+p$Sl5 z{4n!k65zO-a_cC~=f;wLD zgVV9|&rXwY^IvQ}-nROML{kUk`$0bRqeUzywRwPJ^24II8oZnh5Lq;4n2lcA#}lFwy3Yx>=SK^p~aM^wicc9?jtec#TBe*5-eC{n($w zv_Y{^;Nr(e)w{1?za^H@)-+9-YflQtu0)_NAd+#I8_=mFY)ANO?@MdAFTrJQl6~sd zE#E4_dgF@%*`@p1`SE{=ZOzM`ojn>F`SzEtHC9JWuH>XV-qB%_#}BPyuZf+|(s&|gn8LS) zkF^WKuHg*X5pCXJ!GkCJPz~vAr5~X?8GX+i1>YY41-4-$ z+rwTM|6`)#3?cHn@sB=qqLh8^!dNX0fzyQ|jmlb`rGl71#?~5KNHv7cn$`?2`+Z2d zG17viVyyJlq2pZqYxu8R@JsKlqP5{XCiofn;AaKaqwfjsA=!7AytgVD6G}U56bHh? zRY3==$ZEEK`hslXJ~OgW;MCzR*(kytL@i6{56BrtNZ7jRbq1lqMYNsG-@==X*Aqhi z%|^l{kVK;#QmH8#Gr@PK-ct8(iTE+INHI^PFtqDJU-Fs-QiP6v{5UNlwD!d}+W8#< z8ebIlUy`pR!^hs?_92<87DxW?@u#@X9~@8%1aXRx`A7EErfK_Kl-Mt$pSIt$39T*a z2{y{-Bh+zrQE~rNsHzk8YuT53!z&bc?o)PZiJtR(+Qt?3j|zKq(+p3iLL z?Ck6ZND^C`ff`U91zm|;C@-GMMt#eKU7+n0%Q$%S78hD9oo__&<$H-+e5v7Qk`!La zjfR{dEf^7H%?U(g5+_nIJhLeyQT%>MMMae)xeQ%i1|?4*TL~VZ|74UiAMx^xb|(28 zbic;KQlfhu?(jskR?s5YIt3J>4<8PO1;kjFCwWDp&`#C>FHZ9L;dp@sV=YPkzm{~x z#LY*SLD5~0_8~=!H~jZWqWU->b0e_8#sUCV(6J3hKREx3Hhm#COm}X8b}(YmKnF|EsEiMdr;>X4 zFhhyLsxby`xZ4e2;OTq1`LcHbIAdU z01ej_=gTx$x(*73_~09uP)EMlwr5hZgZFeC=TDaLoUb-$xwfE$^;PNu`-@i{!(=)e z0&{ppsp*4Dxd}G)KHR}8K{0Itg=zO7w|Kkqk^y0J6r`5UNw#rmgtzS_Yosy5U40HC zWX}^QCQ2d>$F1#6TRZ$M6Smx57B)B#^wefqt=cr@1_N&$_$^PbE>z&xJ=<%<)zTuR zr`|}=lG*MoA7cy58R`oJ4=Wp>drP_!3-)vC?DJWjA++r|LU$JIGOBS>aQ~3V^j*y# z=6atGC`?e^W^o>d6lOIazU#|G=u~$?xGZ8)Cir?g{oVgBeFsx6?oi`N02Y_d+WsTL zd7lan92G?t{|Ew6Q@?jS(aiStpy~r@hx;QP*Xk!QT6z1+a)i+t*fvV z=x|MqF{$cLASVaF0gmOnqyAZ4K2#I}UNO}9aCF&kDkCB~XH=qXl9Ta&gh8ht} zyK0)J4oJWK!tslbZ%*Zpm!EVveq_EvVJ>oV^qOH;KS|Tpp2vJ!ZsC6y+n?G0e{MN4 z7C?|Q7mgQyyCk>fs8{^Fp@;?d7+}l-6~-U`-MrzOC`HDv?%CTA3C>{?x$W0x!o{qS zx~EPIH*_0d{K6}jPb5pAp%>o|nb^Pl^($c$t#K#)f}R*n!(+S9k797{jhp^aN_HEY z_~hZhr&{tZ3J|95N1rCu_~dTy-(mdW{&F8UO8{q$|F9;4Dw4(a#)Ye>{Pe0-Q6YJc z?$fA?K4O>~zyu9M^02TO6I^%G$WYgVkw|5h2QRmle?EE9M`(|BfUYy!PrZ^;7j7;uoAJPNA0J7DGbZVkosTG#~p26JVjKOU|IL7Q{iI+N5sHjaQ#GQ&{d=RHTb@Mny9UEx!uaktVja}V~psKo!@`g;z zI9PUe67Q~CJ6j-1VQGzq&8_mfzRl`}x)7c1=DB1kb}J)*sv_2@j1eg=OXhJ%gOTiN zOS9jwO%7PTp2aAVWOvCbDc5_ll#9e79;U}^9dFT05M6Z%~soRQ8;FZ z@6Z+SDHJocIb7Qb?UNvJ5f79(If#@%&IT_t5_#bgVC2f8OZ9WwYzIg9@Esq#Y(cqX z_zC>f&HHxbI!)Os8h;OQ5Yd!H~cpC;TF9W&c=tjA99vFOcvsTQ=U5cVQ;O zE?r1v%qraKgf^txxMOoAJGM~i6gsHHQ`h*BTJj6^*BN8s=or#k3cSjE5m@gl z$NdJl=Z9wsmX*8(d1sOh&BgxY_cnxuE?G|$haSW=Z}n>>Q_JV7D-tPsGLS7NMpO5Vy7bFjc~$g6PMfvTmC_QXv7;f7ipB7nca*T zIFD$k_O4pTIR4$f^e?hG;dqi>*$&e$B3%&4eL)cWxqN>5{`~M?_$M$B)V&KwswZbR zwdEg`&Z35^wXW9@_p8l*|NcFrQ>BDk2y{|q_QHuLw+rf=e(kG-hB@eya*Ql98_xX+VUAoS((h{0=6oA7I;LhNrw+#@N-b8ZYW^(%c z`E%tz*<;^?TmB5T!371$3O`?_kVobptdWhY4#KTph#KQ9m)Kfl9LYnHsA|IFl%fq$ zBJ~+$X5N@y;5G%x?jVWW9|2Ut*D&4CrX8YA^CqO9QNA9x;!pN1oxQ!lN!YC}Bdt{$ zCCZ;wV^ys+9Klmhiob&3zBpR;KNHLWSZ~423`qpXG6<}6Pk+Jx_{{SoE}^9W1t_1Z z)8kM%N~?dRb^ z8)v%{qb^OKGmKv4iDhgZaI&G6%Z^xh)N zZ%{UbKyp6kmEvx>Genv(8tno&P?bOt)5ivQ%F0UK<^iUYNSh zGNHCBcz*ukRVI;r?9?yR%6qW?>F>O0C$WJLir;kpK4Q#xOk7l4+$8(=EMhw;>wD&G zwCm4&4M}d;N-!e7So&21lbtTSs^asS8UZP_sVBj`T74w9todfC{pJ=A!^?{1+ofV+ z3*`y{CMZ!>9Vm<|Lgg$nS*QN7nO^AU%UI@Od!UQ8{6qlCxOBqEn>?W$Qa>+uUX+uV zur+C;g$p&EXUN28W!7oMO}L&!^Vovl z{y6p6_$=|89lp;M_VMFrah~C2+wPpp51SB@%Nm0+f-=otbCX|txb0q<{VcZ7So>}m zr9cd;#ao*5TAaiCbAO>{O>87%f|@<`{a25WF)`~W9Nzxgqts;TRDtqz)7L%(j^7H) zAcu;e;C#&6rM=2ntrb1sidNpni zXE=h^5ZaxFv=sZY7PEq#QL8+hjRa-iXO)iyx0y-4YhONUh*1JPF*gA-Ag3N>=_bg~ zkl}3S^HA{0YrDTJoAdK1HvSU?kfPyRm9Zp0^h_+uI>G+d>)17K`mMM*(xMTZuDbf3 zV>d;5Vfi;FFVIs@eprOM%5|v3gepJl!RJ;*)v5651pv7pgnXUy}F5lMit#CQrzNgalnwueeDM{JWN9Vph@Q zn8NNj6w7K(y14%y7?HQly%3Z6@drSmL_Y_@fcBUY9JUr{tY|l^V@`nqpzVJTFvxRn zZfwADy#M&+8)f3x+{BY73!%x+-`*!=3EuG7vW>#c&|_Q16PSw;$Rx?+)E+tYlya|_ zPE9W~HSy2erv&As|CRDbNclN@Qf=C00pK zXGez;0x8SvQ=sihLF9}{17%Vl9?c@zc(=cB5;m?|D#WZsqdp<#79k6n$#@Yq!3%lY zFZ5Z11%&BmRHhgiZ_&?X;uq<`$_k_iaYk0?!LqM{QNR>xYGMN3$#~{h$XPCUu;$dW zb-z6-90m zbR2az;*Fzc5b~U}4TH+WEDiDz>;#jKVr{oPZ<0;-YjWEZ6NqHmTzc$i7Oy?mES;R6 zE*67SDam4IvFDBYZhx;5J*i318-uB$<2pfqHIVs$ zH)vP6oI=Q{iP!iWe)F{;<+*ENXa;QW{ywYwDnNaBV~~&DrL~_ID(n@5w9@dwJ;CCG zOS+3iI3p=nr;H_6#hLlXI8_!ybQB% z@8my726T*s&R4kaaA(}pakY(?RS-mUVC9;{tanz>GkKj3RrRCA zdEYijfOfP{UzHxH=gY~~-bz?Iaa6uAe{W+hEo;6&gEgCFS0_Fa!BD;NuO;KZzujMz zq`QtGVN2S=9_eGtde?eThveDxK0t>KfJQ5{#;h6gLC4{(%@gd^1(a&$6P6Q< zr|Kpl{AT`W7-e}wu~%loS1NHotZ_e2U{BPfB(fE5`<^&rdcwkdA_Xf)$ASHKDvJB@ zKzdWt9(BtRenEFsU?kPq0KFGO28y)rmS(=BDvBk^Z({44d8A;-_`e?GF#Q_5oUn;> ztl7tk9^VXhpGHVqhWUcYBZhlGRU4j|kRqkZ4WH?y6GeJYx_F*PwxvIPck0*VH}bF~ zU6uB6?I^EhS*2Fqn$+nKk(<_mtfgnWW~W#0IyOe)ymd5dQxNlcJzNu>Q|f=!APpK_ zvBH9y88h_Bgv%yOb=ilEIGhfDcdrX!pF!OJio72<#=GV7b(l*S7UT7c8_OR>Q~R#@ z?_q_HVy%5u;6=#U`_&5P}g z8T55t>w-Pij|e}?d~a<#ulOz2^o)tx-soi=GJSmfRiut}oi}Klw4Yb9bR9HF2zIvT z*dbU#k>TVO@;PtsctbOs-PP*F9xe`PUvs{WdI1&_)`E0vKeXm&EF+2 z|2h+i*DuT+riuFhpd7_3syPDod|62^vEn~G@8lk1;JHp4>U^jyWx{e%e4nr1&w?B~ zBKwBtBgVqd$=i2y)E1LGp*vm~3YQzmB1|3$%02ouW~%rsT(qEscuqgxiu3Bf{Zz-o z$@RB>*2hKG9rw5D&S&bZjBnv8x7e0tO+T3GGJf1C-FTz&>+j#K-pjNTV<&xy&prp%0-n0QGtcza_6aZtZ*zbt2AEnVcR>ER{>OCZaz zbxmQ1+^`fIZ%YfHP33T`e>(9w|8Z*;J~)d~Bhd1kSE|RH#}x`bo!Q1T`@9E)Erf-^F~L5nLBfL$>Sz3T$bt^@fp27ae`|{d zwZAcq%mbYYV{#Kxv;7uscrVpVkw*`HW=@8w0tqE_)5MPscqWFq1YzLSbSw0%}-SPfy;=;eHo}`|S74%}ysu+(I~%0{gzd>1wdA%u$WL!Nr$2ZMzR39$-NO^#`w5LkHj<*OoXp z-Xoeo-^Kn7kYrh(x8y6z@*p%FR1ytOdWXn|NdWLQ;QJVHW$1HNPs`%?9TUy@`eiYP zGBRwmz~kAFQ6c~8MyUWAJa7+!=NVLpX^8e;bpO=AA87h$td)2f#WlyuD-OSSVmAdg?c8x;Nu7yXH+ocSG26Mu@{xz;=|`1uRnF zS8zDk+S>a5{PYK~jq~#Iz+?q?ed9NEYhU!y)$$wKzw;4K%w`|qx*20$KfN4%XR{_R zk@R$>cU)Fk3(NadBRt19eqNnpy@!;*1>{)H6mw0H1FQxB!& z1U_jpuij9E(ZrpSq64JH!ZFb|cu>=5O#hA^W8Ezc!9NOq0!rC}5ptiK5R?*kwE{CS z^OFkBR{a(rXMf6@2{!E&q)v-gT9QV5=7eYsKjG4C4n|y`= z_SNEml0tf&KYf1mTGsP+_eRHW8Cbqwd+|z_5iF`irW(a84W*x|J0yQ+TM$;gce60< zNWG%QDT+bBAF;}I1Y6VwkJloFOuD(&V@`Z#(OJi ztxUs0yC^liu`YCpCS`=FImGaDH|-nFHrm*KtCM@r!kgLO(gTb!2~M4Ke6s5JRgCzP z>lPTR_2y_qBmD5f<3#W^Z{|zZr}y=ab10EE=}OM@F}`-mniZl@ zyv#`>o#wX6v5)?(Rvb(y5w|O8>95O-Nkoh`SXl^Co2tsvz5UA3H1FQZ*jCp)a5Ot4 zSJ58fhuCKXCs~v3fX5swZ~v)Nl^#9UP~Fp#y;>=~qZ^a>$#R{cs6Oo=wF}1*)%ub} zO&(Q#Jh;wEJ)ipc<-6(J&>X)ER?1#5HY??JtQ;-uxvyM9r zpo`y8D%0wnF0E%Rguy0_Uus&Xg5wyAL<2LpaA>SOj|!D0NsvWyO^)uqZu&mM3L zJ_9wQaMLSJlX|l~JraL{{`g42~6?$LqO=s)&$061}^7!)CaY?N4)Uw=^l1ml*%7K4k1Z+RyTk7 z@z1%bK=B~4uSK4|R04s8@q>eST>gF#9%Sn;q?Z{Xa< zAvq?pVLMDZC7K)sP&9c`lA;Q(94Z!$!E4MN(_oGliv>^`=BT9gJMDzQ8D-Tl;Y-e4j-tneI6TOhRiVo0|K7OBW#1qti9$eh~@83UT z9819o<{|67S%w4EM8@~hQV#_=P^lTB>pl~1*5u13=C@9W&WG!@s|-2Zyq zwZq4(eQvn={2P+z4K-(1F>IZd{q4lC1`0~MCt7mHQl-QUJuwgVLbCgiVtvn<8;=*A#Xu#;Cetzg%0 z6t60e@#(e6`_Q$XaQo-qTgM@%CyvpV4@ze+yO#!0|LzNnQcIIc>z-!lJsNi_1-wZ4 z8_$$~YyD9ZH|&y_xAadrx4f13F3qQBXLii@KxEP7Tcy-saQ9~RjDy5*{>}V-7mZNO zdO%j1wu&hvvgqo$hAb*7j2n8ZgAt(36T7|IA<|R20%`W7e!V*4+^G0bg-A2cxRD#r*;%6ZE~^px{oW?@`C@cKoH^5^}=zAYe`xW{>D)v+`B zJUVS?cx2|Zdfin#Tl^X81!h{xB%6$(I(mUS0mMC~#RAG&)MKU0k!w_4_|QH4#?kX* zvp+PX)0hJ5j5Y1K?iEhyX#&J8hFm|2!z0`1SR1E)ac8H9u5jJINgkv5tO`GPU*QIhCF&S2nhKa92BFOf%3iS|fAv5mz_4i{Vd$LTe3 zJq=DIP#adz0tgE+l<-fnGKq&C6Oqo};;oy0VNorR?rS%#f*Nfz7KN$H3D3Gzc?JY< zemHAr=r}?Af%U=f>MAjg%O}%#%OM|7^cXf7IT;8glvvU1EUt%kW*_Gs9v)7sM>SC( znr)z^KtAK2Z7&^<3_~PjbdM2+J|HMADQdn7dj=o=jBgPNQEQM{y?H}>`O8pDxK*8< z{9fv@)UvIqKV9#*WWx1e$~u{$3NVt9{T>z)s;8t5%GY`5h+ap=rJ)jtmnZsG-!S!f z;FH`xHnr(TsbRekSIihCaW#{PlkcJB0tjDA=jhYGpiM{u2TId>q3wNre|{n*@3knBFFa|yo_^)LS7?W?=kUD@>T!2y}fgZ z%sK~m$tEOl`VT%fxG4g_@)_-l7ZO)BQJ1f`KHSTcN&W(;G>*tAPHV;-foVH=rlCGG z$F9@aHi}k%{y<;3GB)e@7J#w3zqxJA%u5&H?JXAdUqFyh3{n`@>-|C=V$ zj@V*7S=~S8`&!f*SH-?_i*v@T-BK6kb5^Gixt*{~D)g4cAfw1cp~w5BAj>-xYmxQ3 z>y694+dDT~WptFOyVxi`JR!R|@kn>0K}cTE9`(NSe9pe}=n-$!_gtgXLZ;RH#lJO2 z*O+{5?^8c^!Ltpw(6OleTq73)4>f(9Ix}_i)wy(4)1jBVotNgPjQs{3o&G9@=v2B* z`%;L7`+5zBjaUQQiWc?FFeL1k2iXuq}T&%s#uyVh?L_pTm*Ht(}zgCeew~!rFGnrq1aoHK6*jj)O2X z+UOQ4@KTb$9F3S}>9YhL0n!-|7B3HJ)pqNVG}bJmnTn(tsOS<48Is{iV1C0jD6`_N z^pREsBrHKWurIRi`ilc*or00wyc!`l7e3;D?+=R?K@p-WYX06&RJv1;Dku41yn~3D zp5lpMA-9+rYHCM%!Hk&HTo5-q(fs4b4-0Xck57+TsoZ;oHb}gxZX0S93t&M4Fc-|5 z#?wPsk3;dH@$$cafyMgZ1MXi(tK zgDmrEu%PVmX;EXFhhvGIz4kSRy6Z+a$Puo{Xv9!HHR0^(n^n5qp~jnVWq_YUWS|6J z`i#5@>>Nmm{1Lde=yE^QkP=O3d%NG3sX7@j*x0j$8>fFm`OcecV2D6#nBmsK@ruD& zGqbo9(}<#=`O)C++uR5{SKIow3HlVre50|oFXyMaR5EnOw81JQ^cww3X4$2xu_Rmh zBCf2I3PBW2*p*Xf6uVF=v^iCl3u+#{=SKR>>X;HXt}lr=0k)4OOc0N8QrS z%rm(^j=)-`Omb+aaQ%i~+s7@F24NZ8KBMj1nCkb$ElhdELIc+-LgJN99hYnuQq&of z_hYsX(3(^S^spEeC8E|gQ}$M!VZ&d{8b-yw`dpzcj4?57roH4P-p$gpUpe_o#Auh! z_4n&W9d}+bpL$9pYc?v&qJ$9}9c)ND65neJdfy<5!&Wi4nN)U3#k>Q(*0!`Jpq>Wv z%FP;ny8Rk)f6bbftZK_$bSA2hJbgLdpDDGSX-N)q4HC-|8>v*@(cWnd#ko-0#_q{< z1y&$I=bd{AU96ec8727Lg>snmK`YP(_okk12M1Bxmyd?s71 z{H2FyQ* zB?svckP?QHF6nLrB)k+ZvpsH7y|-`I%NhlYu(`Uovqyd=RUjzwY3T|MNTM7D@q-+!A( zrqmOG-#kheF-C@s+7d3Y)wY~3BO>x#8Uq8t2Z}Hu!l(zi12x%@HE*7}pLODH)Ws<2 zATU%$aT^?;oS=mxK+m;$d8S6|%TBaB^|%O~$yinfMM z8C$2mQ1%}WUNZ(j1B%UWpo(7r$&hlrubK&iZ9R#V^KMv^CYWix6#a<*=IehbW;9k<7Hz@^r2` zxd74m?<5~0Hfa?<2F(Brl}!T%Gl$Q;H3GTpJ7LMtN!H!Cf=yKs1&XHjoH3`!jAWC{ zseJ8@3vHG5s`Tr0G3Y7bm{Ib zgcprV_tkF=Gg-Ae#quJTyrhPmR45adEHSdtibh{Bc~Do{Kd*y{EN7~#7==MH{8%_F zR)sMSJ=4;?o@+$WKmD+*JKZ$Ex1MB4ycDLPF=uyEh0FI49$93FJb~3>rMeuZv@UQq zNCe$^f^6phf(}<7k5(gc5bQ3XqX)aY_Dx1t|AI7$nrXtf!Z0yHHUz0vPBr0Q_dJ!S zLLV0|NDzAFWhJQ+)F_X868KX}nVmL%#W6?IuD=tANBq7~hwTdYOH_uqP^3w$E-oTf ziap%|TJ6OfHFbB{=WdylNya)TZ!skEQ@cO@xl%Wypp4V&en%bseKwWrdownV1#dP+ zD)x75WO=F_aL0pGW`Wv&W5bL-V=oxL+UH>jtn~|=K0f9L!2`YFCx5|q(vZyq9d0TT z#G6&C*kDux7B0_YBN4)pm&V@X3yHS=7u6Q`<6h2u_bbx+3w=6XF5w`|PYF!R393^5 z+iu@xH#V)!?JqvVuRw!#c#o1cw)xL!&>#AUc7odY%ZbW6UAWqyt+-*%XO#Hro-iEA z930r^w-4Pg(p9`>3S}S{ExdUF{TY>jemf&CJ`ue(iw{oO?`Q$Ic0r;4t0Z5NL zb#5C!&eOdp8T6Y9soKGdTV}BKdTUsm80fd=a=yv-q09N)xrmz@)}R^RM&K}X+$19G z!&ABCpyCDqupAQ(QvO_#rB5{mm`SP@JS=I9&M#ORQkeBb{OW68R!@DYJ|A&#?k2*< z!O}5-;buSSvgbEi{_c%`^k&ve=8GTlpl1#w(4u#>ENO43TdWGacX@n68yZXM4>1u- z!b(`_mTT{lW-~i6%pW*l7M07Y)xzqyMfyPO)6%Lk-SEd++sc74k{Lq_%VG zS8F@Jj|bpxc_mZ26AlAySVXZahq$gC#=gdN-Iv!!>-+=EJHLufQ&q&@XrpfNV7zcm znkd^EZaio}d+3R5;-4AMK>Li>H-^Z; zjmQN->7zRFydczT2PJ(hI2*V1IoS+-2MWnk5JK- zx2+p)8Jt?*!~IfzmA&C8TN=tZj|=eR`NxN<`-POFsJMEiKB%3(;9HG_NCUPJxlEe3 z!}AZGnA6+8Kdkt(t=Dn|FLE;B6qXIwz0yGxvh9@LG$F?-lJbR@NjA{lyfkE-Yry`( z(25qP80D#@a{k0frKWt>mw{kE*NRTj)!eKgK(fYkos~>@bANvinuF$o5a7G(mBD{? z%HCZK0B_zQ0PUJ6j8I72ha*Mci;@W%BK(hbO-5O%;e8UIr~t~i-uY>$&JT#2yuf}h z1aO;Anr^Z|I3s(8%HQ@K z^(W*#A+qNmLc8lxyKgLu5ZhM>Pw68SJjh0|8r}Fr-(S>B*g!^6iIFcno`UnCNadpy zGy_y5A}VB`3o!;gnM4&_&MVO%2SC&sv_9s!YKc(_oTPvsZj`!XYALzGJ)LIt3Y||L z8J}hcKlJpE+uFjYAL69Zn9}wJ(kOL0e*Yi1HLpe12P;Lelm$Re#obMxZ*zNpnaTEA z31vC+NjDoa#@~eQMdNfeNU16%0b=WrrIR#WE@rqG?_nf9R>EDt`}VaqXLXqAMdUXfc6B-H?*PjIgm7()##@T zZ35V)R<}R)4#TKz10Y|tN4z?v3ZJfo&|T4AUxaXz2qF2VLsWRPR$|_;DR&o)N)q1n zOC2-YwbDuOEywebOg$U%kY%Zo&88oSR|0z(Sr+K&(ZvNHOESQ~iD5Vo2j-v!*9J#v z$N5a)@~>`cfuCJSb10a%U+b$dUDzRC_sf+^lCHGP^RM1QKk#jDa#65teR1`9dOj6| z!>@8F+6>qSM}KgyD~P^BX-G-f6BJ(x8iKX1*BVp)pDnC2DJ_Y}6a9NN64%(!CIOhwhR~8_d8l?b4#CWmE$N{&Y{R-)T{1|7!I5 zT)IZ}M{dtD@Z)v2y)6kOYZg6UXC2LrCs*gI!|u$KtdF!$go#TMZU{QFvjZ zN3!o{7JV0~1m>{@E9fiW>#P9RZwb)E8!vX^cCNp82401B9jyh?AXFp(OIkITJsT(|&e`X=C8Rq_N*3n3zy{@f50|!hbg`dFHeEs6-<|k0v zK+ks2-*l_xCQuZ=r;%?nfS6bDDo0yiWE~zIB^3ZJckG8TTRtam4H10Sobt4HZf=mJ zq1)mZM5WEHc`Jj9?tnPabPp6S9=te5g1oFhQF|jhg$Kl(w&CiXTy(9&`@_kayptl#k z96rt_&|6sI)@0>aZ@Qw%B(yVFbK>=%RHS#;g+485lkHov5y-u<^IOn>gXrAeII{O^ zhcumZA}5{lnzhx*gLCGT{p@lJM`ojRoyC~Zu=rw9Z@-+W){4z)t6(-$$YizRzHh_! z{=%0vSioD9wsh``HI^O*9l|s=Q^>R!`;m1FNJd6lp`{YgU5V}1A{|p2tJ1dpO{ZSWM8zWnW_9t z9G%|v(p;3!B!#kc6n0P-1Do>}FNkTcYJ`=(OiMnLuBvdu5**US#m;leL#(u)v-YAa zyH=N}+Y>jIwTPm)Xa2((lbT|bjAMJk`l0TX-*F5)|5Cn!*oIL{NJr74q%J$#hw_bb z_^*V?`gB%aAxdd5kSR<_5I1N%3BDDGGi_llSGwOV>vF~``P`R6)L>R)`9pUa+Tu=k zQvR>LJw@GCRH?Y8m&5Vw-z^9es$62BYx_L_LsY?Nx>@b4c$*n<4;?FQKYUxON6nkh zpYZ7dx~N^hzWdGHH_qznVQlm1R(^sz>hhgnq17>K6_ACWH6nXfDLDp$17Dt1bRw7 z?|;d@A7t@c%-3+;o2`(r#&+JR<8-vQTQBn3ejNC!Uj=5tt1BzXx*s~Jg*&CFw)e{3 ztWaZMOfIF3Pvjk3iD(5wuf9{xss9bf*gz-^;3vzwzkemlN92x9tzPc%S2`smLMq1rt(gzKVET6Gj>?bxwB@FPh+zwDLka;~{5W9=3GZ!s1hSHxq8=$2-KE}f zlbut2$&&MbCIxUJvzOIcJ)D3Ds*|p#|pY{L`U_xJVF#m{ECTAR5kVhI>^?3k0lh7}owi*61Ns%~DH^nwg81NWWjH-#7) z9-r#o0_4E=UAf;Od=7d-U&4Oip)*l$^p8tI9P<%95rhkwrLoG-Um_``2qkBfu?u6E zXW-wohi0tCQr6r#cbr(?bxd#SJ9!A#uM^R54Vi-`+{Q38V19B+pbmxCB8|4J=)*r z{CKTbp`(#=^aKK{PR`k~Ff5w;RqN0#GU_f@$DxMkV}7Bmm#8`|{i2ypw__|JNx7p7 z)mCS5U94bq6u(zos-xu??O&OU?HzMn%8bPzu-s(46-Z!#l=cdvoR?Ln$>)s9iB!@5 zr6WV0gp!7gqXw+k?8TlGwthB5dVexgSGQVC4nDjI4Lf>Dt)y)}DV?j&FvN0xUowDd zSt^~W7n9`A4uCWPlf&aO_IjS)$UakisBz93S#IT{?TeEvq;xa8Dz3&OP|C~!HX5~G ztnln%f~;)=ImDs1W<|M04Dzp}qy_dFXj%)2HR>Gxs-c~Vi7lzdT2UMkwu4qmFoqA& zT6ym14e4;K){e%B7u$KuMQuh74ygPMG10V6ZOBLU9H!ey=oF#b=6+u>?V~u~!?n_5 zy*yM!&DKitpi8ouj6evPri{->xnG$V8J8XAXjtJ3{4{+VqCHx;3VIcrKB}l?3iHTT zDOV~6QgU5-6k!zauJ$40LWKeE95NP1*r_&Z^qBs|MNLzSCv6Kd|InBWBi(XE6xphD zJ5I?@Tt=TzDqUEVwu{)a?Baso#fz7O=N(RqDW3|zzO$55La_fraT6T4I+`vMH+@LLiSpetcM!6#Dkxd?oG_vBHq>< zqnKd9xNFEGhDX>!%AbMw6@x(u#}p{NCW`jZSLel#`=;N1ewv-ImmP41zt9k8$U;3$ zuXK{azO5&h1LwgK${wALU$5SL|7T)1pWs3hpr!+G-=o}6+2gRXvNZ{6$H2GUFca9hZW54_+t!r6{5>~=SqkqhHd$VL_cG|JJrW4HMqNn zT&I9!j~8}jrQl#aO%_dn`# zlcYF`E$a+`!*!bt{sgWnqc2Dp8-M`P@E5@Evu32naDkfg$GRJD7T9~%iTrtu%igi3 z^!G%xL+bKh5dB38QgyE4#uHHZI0*p9abPSGazYXq7F5IG%s;}b^(ms)jTnUw^6t8S zo{>{7ocu+pCp9y_WVhrgCs9D$y`=&`fjCv%#6qvpR#o=EmfqBUUZ#AD$#R-olgKJW zb}0TPER}?Ks{-Sb;Tvfua}MmdXI;270Yqr@Zm7Ix-N~%cQ9||aacu_FR1D_(5@VwI2%tm)Z-++UA+88lt!1-=B(t`p#9NR=Qd_*xfyD(QfZ=f)K=W= zO(POnBKQ#XlTeW(q}`9@)%v)H$!p9-l?{51q3eZy4_5jr!uWop6*(d{i^fe`%4G(v z2-g#zBlc|;*^GrmU3z18SNS|5A13aor!Q;~tVS>xhq11mmyL@%R`ESUec3uHk{)6H z_WWlKV(%5@^%LSrWyb3`(kAo3C`;qnWKVVZkJyCe^GeTQ{EQuHX`Z$#Wn!X&{hi8- zhB7$ltJXVJh&GBC{k{PHUTAAQg`d{UEM0F>KJYr4V|nsuxe-Y zq@44tWUfQ&;PdjZcLB^URaEiU;@Kc_l;RIz(i zQ>WJw6e>gh%{`TQ_*@Oy!#<=UVY*Z4{j)^b$=eaQ{MKgv@_c2#Q5#7K@(ve<3&Zy} z$goG;b*rpGOgi5-++CmSIt6$WFN+!HkU zjRDn&f0Knu7ld7Yq0AJ!qRcJU_s0i-$Xc|l{PMRatwSWZ{+D^dRPQgKb*STri;JTaGEo7aKX?dL8FN1OrdP{u=CBSDvK=)ioAr z0n7J%Z!ek)&!7@ILWeLoKR>^OVe3;->rV;QourdyU*Jnoz^)=<({1M3+AFcvvCf)M>Z*w050+q{*R`~I& zh0o#K4Coo&Kmz%?Dy_vwh?t0)#FNT87fH*+(0$>OLpC6jNRLKW?U)RIADmFQnGc|s z|9PEk7P*E0XY=MJv*|Nf9s>JrFgUR~?sJiAo0|o5e$55BqH+kt@%ixZoVyVg+6kD? zTZvJb0TB1zcR`$OF{p=FQXtnk;jx(WEM14eNOiqe zfl4)#-I;d)<@&#YW%#-0Zy?i zfk>-k>1T;e=W=xoL`IoSu-!k>LxqkZ=j$I}9nM3z@8gj}d`@=x^B?8ff=WfU=hUbntziHZ(?%Mvbi{q3-7xI7<- zx7+my9RkmVy50${lJ5e6qajwSj`_&-r(|rQsws**O{1N-HB(nsGK0Le0M_~h!pI0% zR*sO0oKF)SlbxS&k)QKBCm|16ClI0uhS#U~=qwY1w%1NcQ1(U+$bsdh+qpUFh%Fb0 zye!dk`czJq2m>4_HHq2uyzP4Za!2u>?VY~!tzl{V0l4~O4b4kMe zeyk^U6c?tixtPBwcNI7g+yWI7qQ+Vp_9>X|iz6B66uPOshs3aQi@P8I+g><+j-7eE zO7rRofSV>`C6VMg4O;ipa3t(lCwFe#-H}0<<7u3*snB8S4fB40c_gyNw4c2I1VV=+ z8C>)v7Qe!O)ktm9YocDZKi(>|dAtyZv>scsR?L6_6YUp>p3u+u#?V2;Rg#n6y4I7k zPH0rvsEF{AiQWBuOvuCLX2fzm1GPgn38}fr0dg)AM)=U`?7=sR&r` zGjSPblJef$ZAmQ}`}rM;NM=?J4caZN5B}csygOQK22iwv1IJ|E2^Q-DpgMTC+?xVv7id2~ zB*#$vy)}+ye8lGKIEBCV2RIZeuM7?>af^n+d)7d4rf6#sdMY6#gr6`rpAew}8zaCv zWd%g=m6N}Q6-6Nq5(;MAR7@!ttN36+qORo~cuVw=W|(%^oEy+1$?xy2G{nh-z1wmt z-kLbkK}P3$J^cd%N6DfbeZP;ePSe&wC3*sGdaP6o4Bek0?rb28u|f)&N_pba@XE0= zFtOFGR-hPoxocCT(7ZZji9f-^ePy_YRctsRmS1m_pY^EAkPyoFeHHE{SEd@?sWZIE;-afBWkwxffEU zNEuBSbFP*qkvhdj6t|+Ev^y5bW~cFt`-9^ntc?Y8@wpc&dA-gCC z*PV)u=QoRUEGY}$yt1o{k|Ols3jlDu)kP%HeQ ze>2isH?aQx3=iNLSMBrRp>#KiAn0sfZg!(2o;mUr#dU z}X%kOY{ zSz``c*QCp19W(P9Z*wsC|2kH(Jzk)7nJ~VNNU=>S+$6kl7rANQ~gdhDSs|OXDE8$5;OJ?;!z*1PF9UCrBZN-)1jv@4=Oq9_U2i*Eldep*FO3kqC!bhDB-Q?G& z+#|Ec9CC;PzXlOHn@WThO#FtLs+)*^uJ7*;jc_wxMj@CdJqN@`H&7>-nu6haTKql> zGSMfYf6dmcA8>Aj+%?eXsuaMt07f?;iU@?8Z@;i`cM~~v$6emyHzzg%DH^LHLg5%q zq5*5~|87Qf~{KD1<+l5dl9OK*~d(#)SHb5EJ_Rzt6>- zK_-82FuZlPiFi&2|MnVK)rD1GI?YRnh|tnNk7Oi9_{59}zI*b$^tZ6Bv6LtX0XVw< zmJL841z`Qx0246pglhDwdh+D2Bv6%jd7(&YFx~;Wl0X+hK%fJ_tqM7%M>U}2a{_M( zeVD~^q+Vy#&sL@tQTQoh4`C!aAP@yQ@G zx#QlxdKN1+_HNsXQ05r?F}7&8-(^0qqS&t-U3_J1y|KPyce6uq+(Mt)u%PD~;$t>& zuBR2f1KRCDm4O9Tv1*C2r=5hbwPBoCoWr&kxE~s0yQwqtC~lzW8ZgCA7vbG4zaRY zR#)~ni^|<{=FePw^@O@wmKVoB#aTQZO<5n%mmO-Onv%V!n_;@mU%3LHWiHq6n=q41 zwJY;7kF~M%Ce4-WMTlyWJzzH!7{e2~o=sb29rNk@<1tX>M@iXJ^Lh-ZGXZS%ZJP#0 zUa)?4#Qh6;UNI3l8>V5nLsXFqwn6i$@h7R{)}7flTm)spV%j5?2-MVbUgU+g5V`2N zm?IDKauMT<$VpOekMbAnjmk_2#@?+A29Ze)Z!2;IiHdvGRo97$!{#Y&uS!R$IRvED zNj<&pSWlEQS{WjAlbq{ZR18dtPd}^o&LV{bU6AjbolU$DZMVD)kCiX`rj3;xB(Brx z9M*Ehx)oXThE^=z$IZsmA>lr!I<0{lXjE^uqYSw8Ose&Kp}n5J>oH&|RBXfnn-S7L zipfk9tu5~Q5DV`QF0pw&QknDQpnFgjk~BaD>CgWY;qiAlqyK|(-~or1;orTzN>vwi ztZa^knGO`HKj^(kOJ(>ogHBt_ZqNS!*Xp+~bDJUL=1NRVwrAlfEhKKNjz^XvriBlC z)h7FYL{|V{-N8uPXfwr1$BXGQ^;TsUmeYiDo7t$8F@sZB?b1dcBWaVaNli9V#%SX= z`MX%N&zg&VwD@G_9pz%ZIQAA+<=5R3yc~A0!DS zsC}~zhRTEMALWepdGd7;0&F%yT!f$RvVG59iBL#a^lH4X<8*>AFSw47gG!LO&wv2?=Hdh_5O@AeO{I)*1mYn`;khX# zVEtsHKpx)pID3Wqo8{kwMDTzlGS%tjf6%Y~JzT`78^L$2_@_NRJ)q|T%+~(?etUji z!-!Yx4~e8IgNtAFzGBq5XF{wDCVW6K_2Y+mUO!pD* z`l@b)Wddxg_wVgP({h0P6<<$(nWUZi3WI_GgSmd_Qey4ScaD@p6 zDMu-$qkfZn)0I?$_4M67RP>gA98qESqM{Q9h>t)nbY8=y zPghVGD{fSw=qrTog1XsnX*1Q)V3Ju9-~DB*uhmtOxs`BV-(9~4m-}-Paok*0#%j`= zP*EWv5N6i$r=N+C{-=*$rYqO9;!W7}0qNuv;C8B2=oIMR*4nn7J`86d;J8Hl+?N)` za0%Cp25M;qk8B6H?$nI+7N-IjNlWAXbLcl%htBLzoW& z1XcoxU%AM9JhNrEskw9<(kp%qHFRJY9+<_HV=R7fcCc-+RxOKFPVmL*{r-0A9y;zB z^Xs;#Ng+jm)I5!n3Eznuy=Eo-ke1uHlo|aoBgiYq=nQM*C7sRw=Ie*b7uEUC>;o9A z7iCN3-&(}60e9xH!HQ9_d^GK_PbmAWD-=~K-I~b$q&&qK#(ox5NHT7do#(0b(Yl#M#yBb|6X7-=*Oylr((vw=|Y-6wW~0eGw;ihDI~antnhWL5p{CI((s72%FIv- z|Gi;s+wZhNqsg1!utv%+{9A;A#547VS|<3Bt3S<*O<5mZO~`@;aCD5@Z}hOz5+}5G zUq{}5<8BN~a=!hjF{*2?z)P{S7DTXWAFHq0zgDL5zxx__ZF~B<#dkrqmE=$Swim zk9=<(CUWR)L4d>Z77q7*l)kybQ-ckWs-|G_yIdLG=>{%iRPUyD-fV1Wj~NQRdA-z{ zsaT0caw9<X7(eb&70j(oX?5b@jFpPduIUE{Bxbz2Og?Oi)!n2k*%N}cqEPCdh3 zGXyorVKGW|UmX}L9Ude9qwB{R+EqK0%4p(XxPa~wom%1wp6}2zvy;snT+N-2{=t+m zWGD9I$)}fz7yvUQP$u+oS|NzqDkiy*jikTx9;`q3{ZPYSx~cjzE41YhfyoS~4#(Or zC@3f-1kAjieUhAC4gtww?(RUd%`|z}797P!;Vw*rFT4az_71?Rtg06&2(OLKx1kdB zAo|S&X%pW_(o3<1>EuS9vQFWu$QCvuTUV;sC8jT%&$PxO)%eUaAlO4ZS@@W)#`^r?a%@Dl`b*Oj2iI zyAKBTS0M2R0)Vy*d!1SU4y)5ZL7e~89`MP!Gk(FyBl%K|2B?xAvBDT@Xk9~Y#a4w$ zmRROwWtet9Mc1=DZ0+3rUWQ z`#^Z#pP74`m0@mP8FxIUBwvR8c2+2C@8X#}MCGvDR1 zy+Sy`82a)=iX3-;E$sj7- z%^1(sveT8BW_5FMKixiO+4+^5$v>U`R*!ApzsEV~d9OHnOB(RYj3clz%GfZUs$|wO zY7GA5T6s2|z2Wz-RK+-)esWvj(!ZajX?*i%8MfC=i!js{(4_lhXBxbO@y+Ofgxy_n z)4%|Iy-@Ak%fn)j*yg#l@Oq3q0y7RXqECAuo_qmo9o|Sp>-4YX(Kq9S80OZC+J#<% z&xGv>f-SwhF;{f+{8D%d5f-y9I2RrYnioj@p5My#maDw!d!p!`Pb~iG`;x0B?b{m` zeOqh)s?W7zztYiYV%{@x^;B}O5VdS(_ziP4A`y+|IR_PB;egrSQjoZ%o+txxD$b-j7!`ql^UEvM4tjwNUfq$*O0{ zaBc`Tm!^07x?x%Oy`$p+T;?t=E@DbVc(r+NL}rxr!g&q8f zdV(+PJUz=_qTw)=qOe_2sl4$#_GrmfuMm`cf^_y&nw-#350Tm!cZ z*8@NW&C9K$X;efVZO0l*YXqaGfIY5jwcwX6GAcONBD!PH75;tIXPcaWRHk6Y@kq#n3_SSOyADo~rI^W$6UJvQ6Pl;4T1XUO4i-Sj!lg-M2QY{v_F}6YE zux(6GykGhooLY7k zG_c0jCW3J`cW~t(J&g*o?FmV7P+nC;Lv@1awz5( zSWI@=vu=Q!!Z0JSSzwne&8eC~lD=7}rOsbeP;DV9n3Cz-ULz%E3ws>sgtsqXK5-?v zd70xp8g%`XMk?&LdJ)Rt`+Bww{9!|~3aIgTZKZr`=APA>EdQFN&THN$hw3;|_{BUr zlkITMk81(q0Bd53P-dq$>AjQ4Aq#8-k4}-cb|$3vID;lLLxr34u+_Awo!8G)0%Gxf zjnvB+XpD(vM9ZuLTFS)pn$ADyjU+PkpTBlZdpvRqKI`IjaCoblZB%9=g4V0Tru=!U zK+4|wtzhWXwDp`NiHmi8u?Ug#NqXzkrg48MCHW05T`VmpN9tgaMG>;U7gxsCL>6>X zJxAV$PDg8LYqqTIu;K3CE|@D0tS>OJZ|$t~9+Qi!=mr1L*M z`PchrV=a)Zv1pPvj};N6L3nPv#8|67(XKBsXm%Mi>qWKY(hn%ikSiTO3pbQn8>cGk zL~dngDC69*FGWnS>8G%>M4Tb94(BUCloRc*^~ZNEK)_9>`nrd-AB3g*d_)A8tKGst-$e*O`+sj^CjQEUC@FE2LemVJO>;4AZ!?%T{R`^Xb%3Os zSD?CJN*M~2s5qHSfmrxL#h!gOLTeQ_MEX3YjNz`>2nhkWRo?cL{`_wgQXBvckAAba zw+F_sOnn}n^uC-PBrb(nE|&mHwCSnf_Ue;-_YUGEsE?e&)%Ynq^EpPTR#_9pDR6~t z2(`dN0>aN1x3;!?#Q+6M9E2y9h`wGH(p@q{eE$ry77OxA!UrbT#u_T3y_6UY!gKPs z-xV?#h%q3S`gS<#s@AL}$4!BP1$2OUQN%CamZpXkpy1_3OA(Z$c=c&YE85cA#h5!J zj=vd9{VAKOGIkd~Xx9$!3jGI^4eat`whdqlr2X^1qhfiPBSYmbiAdSIhYw3w198d< z>GqqDu$4$2Z&A?WJ?T=e@CV@9c&OV^U`+)I{le!`1yL7B$+=oU^&OZX^SR-Ah%iq| zK=f=#s^6VZ9^Ds&nIS=e`$nm4d^p0+s5XCJ8)4a6@kSVH$BPfA{*z+H1ZO^11b&Sh zMeU=g;}JPr-)Kc_xqr5KT9S&UCo5@)|1!ryY>CBX*C zBnAB>uHK|GBTr(Sk>l+ilnb?U+=4NeV5NPCJWWePGmWm1R$qGCM_NKb4AsD$ns^yXHO-gb!!ryF zdar6?Ot)T}sB9isR!}^o5WIGGvg_Bjf1Q5b^=HzSbqR`*V`co2_VL8tnaNn)g{(GG zF$I$xM!LeGwNExMK!k{ulb7%OL5JxyO7(k;0t-%MVRdQ9rs zPv4FCLm}M6RA$JWgV-@6Ajyy#vsHgFGqJzNiK%C_nW~~zuMd?|JkVgGji!AnaC2C6 zj{Wv&;R*MGLKHW!?16x+DHii^NZ+`s0p4~(=M=0WBw1=b&wOdZ=~r!#iItEsKifFr zA`=X9U4_>3NP)o2;* z0eRYfUs7N*l_N4A+pk=*IW;m@Y>B<*Y!B)i?$xT$?mKE457ibw%`r^w-e`cEC;eCj%qK=;{vD{BSE7&sN|ON# za-l3G>~LXHgSh;0vfaP`u}Ap_6Z*#dGla8DB7L$X4ZmLW&5A`W^zde>2H)TG%px^Q zJ{c@6tgbRC5bI=B*tng9MDmQhBR%u5z!i=C5>OZMalXjTcD)1XeK3{(&AiM~r zQKNTLB7BA$?M+q-#t!g zYPs306%4u#UOkD<>&rq<&%Ida_pC?GEnn4pO_Htp{Wa@Kyk6M%L>UNRTeP&;J1}Xt zSmrp_nHAkFre)aFSYWryAA$4tSfV#- zHLPddw=25wT%K7_P>tW9FtV*2$iOTpq= z{hazm6))NPSyRDov6iqDg|ZxD#`XJ%Z|~aWPW=n#UK>ZGH1Xv%4ArG)phYN8otKJ6 z(y7_8zCpy;nv7Bt9UNGsGe2;BI%MoMf?ckX`uD2#x&(P9*G88TP z>PJEZhsU}8r*#=o!+-YERAf~QEO7TUx?eFb=w%^kQXkjOPeWe3NH z*-?Rl+xoEo9?0*;V9Sgiv(FNoBa3 z$5^6FMBrsI|>`XgXKE)5+rhwE)qLpNy$OvCThh zf+;W1Q3@A;(jVB=fV+dDSOs1`IDO4qNUtd9KGI8s1<8&_02L4YC{1yq{2gWb&-4)n zO;IV1r`uG7)%U9{m8*T!!52N6dRz%mDuilg#T`a}Ct%{CU!_hY+4!$h9bs(2j1@19 zK{NqfN{8tQP&hL|@X0&)bB_Tw2ylA3tJ%-}ENiQH3-?L7EBLw}TE5Lg2rBKAd#Zvj zqyyZ~&(3(Z;&wr{@$Yzpv9n7jckQ;QV1(B|TL{CAOB3G^>Y6=3fTyUj8Atf>M_|Mg zUh_|}%eUi%?^!`&Q{(>A&0P5hd3z5`BexE}XExJnZ*R}d%}w;RlPI{b!AM%$m9M_x z8gUw}VmBy9<4)5X0!gqSxs?92Oog+8w6SseOi@F)sKsT!4w)PN91d!?Kr0>+Y=h9o zwzE+XMI=pp{D&Va9XaXY zD*h?ng+S!=!=UjnBZlgmC7U;Pu5Y#L%Sh8zQU%!rzKB2ZoH zYiv}WGju4)q*tlao)9}^XNz^N_^dQ(7Ed>|PeCv*IGWpSjVbFMHA}@#(qV*rV7hud zNxb-#4dyGv6h@K!T~4bDu9C+a8+lY(D(>xR)VbUqNBj1fN=$Fnt(h0Yz5t8zKP@}R zzjt#59nhRokQ@}hN2o_JIkdr_7LnW5M>8rhc_`zftp1OtcMQw4eZRl6HQBap*JRt8Y)!U3)s=16WE+#+G}*41Y(3}w z`#%3(^ro$?y6QYS_O-9|S?nZ2N?`k7!XBu+)rjyh9YY#_l3K$@Aa^MHYy3nYSAk*- z!f07rI7&*|xb2hWReNqi6kwf%{A?Dac*of{T@}m`tg)}>$jy4mdNz0I%g0v29YIZ~|Ya{!|o6x3E2)CmvfKojH z2sGlm_DG|?Pyhtc1S<^dOJhsDdt^8xY$L{M{FTpwjPs6jMs56ID5`YNA)216v$M0W z?<)`uF*Y#B$<0j)%jMG=e?o|R0;aiQXdq@WJ_03*%3()yL1mS)%ai^uCs3!&IiHJE z7zBeC2G9xs2e-n=kSjC;$+5_1h63+Z+NXjKoC`dH9Z(CT%zl=b7&*1iJkREhfDPKu zvw)Fet_4tNod9p3x3?G2&_3Q@fzAAh8PQ>J%ouP(W4!GbooihFia?iq#!GB?-qQ4> zVFx6AQ=bc5zK=qJRg5%2N(S^8H4#oSVdJt!P?2!Y17SB-H1v(gX$i)5&hMy;N!2sv z=VqM%m5MUvsysvZeK1h(1&HnedxF)YDX=q(rA028WhVTg6E`gL9-}UN$(`poiU=E0 zhAze|{<<$S^b|j#re=G^Wu6`?gwT4!R5rH-8^8BM^t}^l$!z^v?#qhLxiC&<_1m$(76d+)6#r%`h^IiPxBPCK(wos94*je}EcAm5 z?cT6}_(K_HWmt@&UDDF%U}NK>|3QgKs|x5>AY?roS4-COx{HYg1%_71>V#yCcz#$* zt=%3&#M`uR+QZ%IuH-rT>XID$bYQ}T@)op zY{N8MomQTBA!fcXuhFpBR2M;3ewCthT!$itg04pG{=tI0fsRX8UTXm_$2E(BMQ>9J z>r3?ltV2#R0h1l?iRB>}W+4Wh?AgJaC^XVG zX_O+hjRJ=}mpWD0)bdE3>J;G*%=kpAZ+TW~81drYUDrh8mh7W1o@V|HAO%nY2VO%O zJ5M}=eu>)F!3oP+5d)I$NR^@Z@74r;8-m|%tm|T{7Ls2-`hTG_GCJkh$4aHg)6eoX z5OCDq%5P!v^yfBbX`lkO7cf|Wtz3aA7_|(PJ3wp!`_oqQe}DfXM-E+kA>oSo-Q>U5 z$Byg)UKT*s5G`c|Mn{zyz^x-{!~Ne5nme^PL;_{CQjQ(X#ODigy;o;8Q_;?iB%+p~ zv9a6Ofio{~i95tLp(-#x3MWk#6Rqeq`UxbdqS4sw2>0p-QUCpeCCgPRC*9dezVIMK zf}u>1*67j{pd!`GaFhCXdjPu;4-e0O z@~{FmV8BdF>K5$}2WGL`XFp!T&fn=wISF6jJT;5OQGVd9_&yUwj02M&3C%C@MbY|ud zM?~uT@}=VL@X(?~uR}|c1N@}HmJ=VoA1Lfu2=CHQtC1}GAT{9QOePck<#xd)_uW!T zTog(t7z%@p^3P$`JT3HLsk z2H&o?IWae|Vl*kE=j8S{u+Cq5jO{-Ia z@>58FhqX+?)a3s+8FY7a0ClsIk@y+BP2i5E$Z>@K01hBPvv_*?@4ZvtDdd23)6=J_$I-A(^A2v*L5o51yr;%m#LphL6> zw;ntmfyPBmomBDIqq37MshHs*R<#9aaV60zHtm3}8G>&1(M=9vC{3Ko$urj8iQJEb zxg`d2(vZag`fX$osr+p<^Ac4?1tqx&=i%|ujj-i=Wl>}-?LX`xZmfy2!>?IGl1lLV zP^1M8=~NoKfk{8n7!?FGHLCO-H_7?%GHm6>%jT1~OV*pZTS#`Ft0~3Wmf=VAFtHHl zqrOenz8UEJZkAa;;R^JAeqCzg3e=|)gzTT2h?tBX5O&d%ri(elw+R%(wELa<)=U42 z*s~IWh9Ezp)rB%Io^zUGVq%>wZm`VM#z`PPUfOMNroc5JDr-~bX-uW&ilF>zBYw{R zUVvS)O1sW%nm`u{3pnBWbKZFJCczSg@q_nYf-n5Ux z{B4U*E2-PVTmQ|M(^IXmYF%mEdj?xofN#8-eV7Kx+LK;(BO6Km~?GM^M!2c5ls^$H^IeuAlF3>MS`!YpSQ}E!WUF+8dG0yIs+RGz$dn;Vke+fPkk7JydSVV$3Y|1EvS1rcTGd6aBN%u`^_zDW4T zQuFP~YI`iR`|$InQfL1gV?j(|q;wdUhAY>Yy7C{ZXJ*Ulv{uS8v{sF)u{du`jL{Xk zJjzJ%NRu{^!lII69YLQ%*w$WVB{iDZjV)P6?q>{o%g^90Y+F=la8I%P+`h-0h z?IsGDqd&F-4o(vfcG9hKT(9zUWFO=!Pzhoz*rO! zl$^a=j-<()iE7iU%kE|H_wq6{E6Exz+px)0_x#`h>aYDHHQcHH9mHr?cAnxuP4#u! z1;!*<_p8{kLVZoMDVXEb7^c;*i8jgC)bu=p~F$e^pC> zpy7w>63$(HMiE1ITQc{CL-Yno`~*u~gi>UFxz+WZjIxQGf}Db)xXRMq~cc_!vi;bj!wML;6Q0u5!?DA&}NRIqWCruk`bTbV6AP%1w;@E9^?L**{ zKX!8Tm2YJB*P)b65{?Z7goLOx-#xl4K6xGcbAD6dlB(6=Vfi1qWC@s)Zf;S(VM77F zRX8|l1*mwbCGk4{V;cSgsvP8>FxOTI=CCbbU_v5v1mcTk?i*UXFey^#Z^i=V16J8_ zF=%reZKIgimYJR)!_!B?sPb+mWLQn(!4W>7soliePbIMtMp_=lQB6ZC7K_YQMXejZrmNj~Z;;y$ zjE|VXF$erY&3sCA+Eji~DZWhep_17b=3~!`W>L1rEYgJhN-6YaImXngc*$%ll6$Hs zUtUU{E){y;v+NY71-u+GrRH_>IK3Z zH5JK{d~41A?UI9JF3gKAXf7M33Xk*OJPa*`dkbS{57hY=H)O*k#WwzkiCAm4&gZCf zZ!vf+=-il)8g=y7xEIx7_t^Fe7PCC}?u4Mrf9p`-7T-A zt6M&;_gq4h;kLVHUSL@h>gj5XP*6bwN%LYq#aWgqRhgqIHN0f1ku@jPc29E9^R{nz zjZ9xRE$#!`Ld}#3hDu}v^8oUAaI|`S7;i@N;^#1+CIOj|3%Zg#G)ONJ2Qf4mISNO4 zd}OczAb|By1i=(dJ@k2Tf#e)731wn*K>@TM+iST0p??Lx#t8cJ+xGtb)sy@5ST_2E z+CE8Y<*!EpM;$p_WyUpR>PdM0qzUVeyMZV&ha$}yL@%}6U{k^qQHm)2L8qx^DAO(2 zW09A5`~?kHF5EHroGx=A`~y@^QC@sQzZ)Q9mG~$>nv`+;vv+~swo0e9Uvxj9@_atn z+k;5w7=cYo!eXGM`~f3DE4uXNorIZd!HFGP_duAObHpPZnnM%Ne zP9KLv@tFEBE9v^XL?<tt=9ZGKXlcFO4`W_+Ig@FMS2VVcxFM!uR5Yivi_UNDukFrx)x9}B8(#} zwR`dJfA=wqVT#JP0cUA@?*Gq*}H$N{|_P|IJy_?FVZHW{duL zA={v{@-=qE4D*lEPCLkIcpvZvTFq-WVx9`or(eb>j4+v>tKp|iKx=Jy0$#u;|b2z{!F6Z$9YHlM={ z-pYj)OhXH+#3+WHtCYG}E*}TFe^e~>Ly6nK#{8Jr=PFydTnh?F1E~EA?LWd+d=sHO zHbR_iqZq^;GQvxeP@xX3&eyFQ7qoQgsx2*=$|5Du?RqQ=1xu}}B_=#{XG*bpQ;2_4 z(h3)Z@180XkS|p$h78U{)IvX-<6LOlEc{Md4h9q1Z6FbTj-awK|L&3&C!TH=Uh`QV znrv>PdA3-us};FyL^BHsD-KuD?0-um;Sq&jKSAdByB5uzjug*woK-wtNSx=Fp^#=* z>}S`RoAnC;vC`^n`LQj7rOwIU-h^QtYfXf;R!*mnl)_(aq{@)F!#6I0al;8IoP9>L z7=o`K=TonIy#FGzoAb%Ew?&$2Q9(_p4KrVhlu33x1J^1k_`Y1QAcg z_5>G{QmPK1kiuP=bKK0&&)?tQ1FJgkm64NGS-HAY;34no5?~z#Iu9MV3F^^z`24YU z6b>-M{v8~c_icy5bi$DtK^l#72NqCe6wrLyK(`)#_}3HgRGWEleOVyS<(aFe*#q|a z4Pc_gNb`hbdBA@~wO!wevS+n0#Q}dE8x!pd$2OqAhtzt<2RQ2ZgA%5x+;|{Cm5@Z> z?0Nqe(>RC$kZ&f@;R&H312OJf=l3rFcD@upg=YFob|9b25*8xTi1Ia88sXS#y!I{0 z-n1now=@+btWI=O{OJCBfRozyWW;!>;;BMP%sNjzSwC|!a#N!R79hV72YktKbD#hg ztY&1ae^aJUqVxqa9B?<_!1Hb^Smo@w3^@5=eT8BgNe@i>DFq|a%4|C69|uy zY9rA=UOxKXz$L|onjTu802uJ)p^dRASNu`w?1o5tKHfLL&GhzGEX|*qpUfKl#vI1G zL)dIQ$8l+7Y>Xjve2xvLf~3Arz!=&PWvxbya$x>6d?FO<)nNdvEP?Q|3HAnosCqjF zX6kP^$!c3{$z7WShDK1XeCFrD{k>*tlxyA=cqh<#;_Byzgx0-%*|z@o^9?AKeLl_y zNZgD5n=kRXF5DuvcqoyKu*n(-7kOx6D+j!hzimh08{ESnX;>k=!JeLm;3q|6M}Ryo zFu@1D03FNOhjSp?{8lJ)gREN+5HD_9ueB`yF+;)m#q3w`j2u&WGHKE}tfI5_h$=AsR^_iif0dZp@}t-N>TD|eXOCXc?Ha~C zkL+k2(_pjzknwhTC&EX|#kt9ydq^*uV;F-GWZYYf^`(rHPUQFJc42|z-K6#N`gf3< zTyxER=fTmU3C^_BPi-qi5;WDdw0v0hJ5#J!|2X)@E&Eq$v9pUNj9QIZadfK=y00ik z6QdvY*)yaKP*F#Hsfz3@?{OuXcx42p-+1^6&M(TztpTQc1-XeibCOcoA2&=v6Iw5I5l#q=rr0lvWEQpy z->^@!!->UM8KFMxxx%&So;be1Ojs9vz{Hz99GDELtzKv>?|c)a8S8ewDmPrtK->^S9(H}ZD z|9BJCbs%~SpiW>%Mkab&3O~UtcEUik(d^34x;x+b9S71%3*k@kG5(c(Pf|TTu2g=Z z%03KtsD|HH&g3uaC}e?b2W}QX{sj_2MaHJ^WR>FIw7g+W=b0~V(N-6JS#fW*X*&Mp z&duE-}kz8N|{PTf1<1 za%BYDAjDnB(pyToHNL`y9`+J)R!TLE*d=0B$_%I`Nn%F-GDPKO(Uop&`Jc|*$C;Eq zqYA!H<<*}qFXGfx-vjS9Akj%B02_pJg;&7s8@xI;wL%uc6UcqiK!Jrn5V92JzYIuM zaai`^jG+!AfacSnqhbjUg;+nIx`6_ASE2|z39}%MEf5$^CRzvBd&V2Zl~74V`ps;I zy%oKc%TO$X#}Ma`R(FMpQyqTTYgq_T0>u?A1@cDtbCpK-ugw~E3ZR2Ia>9uI z@yB`Np7y$wZJ^8M0%USP+_qS@ z=kEG=wlW{{j&uMH7}t)smwN`-(i?CnZd3Zx;HptgkC3LR;&09|Ei^{XD%^MOnfH`E zJojXT*Mf3V_)k~RU_L;T(SL{1cCWvDtTzhm7hK5<7DJtjyKdO8qT_)-ewCIpUJ8kb zG#yEY0W@(y+{YL#{pWj92S%{hpCKubq-+-zM6jiw6%o)v8-- z3Cs`Sp7*|p#a7Xeu1rc!9Gg9gEw61%v}m_Lt~tm@5Irg`fZj9X3fxc zNQVBpxXco^@XUtUdtfjLfz(nP`maW{AV#gEf-pu?TF#|L``+@$kw+fUisu@&J=*SdLB2!vOd6&?#L#^KX&gY3=7@c-Y&C(NYuIxFgvM-Af>es5Mv5MkLt0!&Tv@=riY-ltz>v7sM|j>Ih+X^iuD+`4oV zhKnO%AC)KIcKKf-_6Zn^#2g-)7KaTE+`~Q(UX(>ecxoZ%E(1TrW*vPRH|nE>I}Qi4 z_b08G`SW<&NhDY|pZ1`-Gjg7QrlXEo8UdwJz)m0W4`_90B#Gr**_a;TM}?&Z2~U2j zQze*Z9J7#~s+)jqjY(=xy=Kl%c0tP1!PcmN(0Np1^2!}_32;9glDSyx z^|WAbDJ)c;fCHF288uP@I}#|tH3sX?aWcS#23dbe)Xer$qR+m)y#?I4W#}#ukiekYc)^X1dvM|}?pGV9(vZ05Ox%1Hl8aW4|2H_pV z#%yQowKP>nuFIooyrK}t*rLktwlaxAR!UCC2yi%JsCiiy{E$M=Xrj$tmzh+@^U+&< zfipM$P(+|T{YD_g+WCP^`ptAScxn)m}BfkPdqg`n-jd$jidWWqhQjzd< zh+qX$!Tw){nb* z3Nds^a~?z>xDnF|Z&-$9(IvXxOi-p0b|iNIPPbasB2d~$$G}(ObNV?x96UBrW_DQR zKS282q+;6;kmu}dU^19!@ngYVQLMG7Knr_`%&zmP0)1$dnVIWg1S29Lq%c}M$xPoN z+3;L#s29^QTv%CG`2*q5t)gz1c?0G1G|JqVQD2lQTE1M3;YgL+PaQ8xKiit~4=Zcb z{dji^JG|ak%Ha93@d+>Mg0YCS?}atv%BvUls=r9Tf!{SIjz9Dd!m|0K|NQ#REiSdz zQ}5Q2j49iHu~)WWeV|og(rjW6@2Wv<`**LxM;Wh$SmKJJs*YU7ap1aH+k!y29vap} zqDCBi1HZLjmt`U6K{@|{if#U&0ZPDjzs>=Y7{=-X>s2rv`L6BF` zOqvddxGpn~oZUabT%XI$(_yzBcG`r6iyZXRDiL1|&){G9LB&As2^`TupUk75a9?{n z=_2PoM5pA3qvuPLf7czv35k~d5j2AaiHHT*!o-pI?HybNN=jM>QbR=pQ6Xs+Z>GY* zPMBOQU!V2Zm`}Fp8eq(7el5G?No}>Grvx9(E3pG2BsC(_$8N5d?d^v-7MxwbI9p2N zgr|7R3WF28t~MIpZFxsFHUXi zaZI$b^=9PXl&$z<8id92+(})1cAra0mzrHQ=>!f3HKlMRponM2{&@(@dH)I_G@ilS z%i920a=;7uYyaA^iL4eoAM=U?mLOh=7$bfgL8wV^9GqA|RORE;-8PxTXP^X_kDKxX zOS;(R<0US8qWMl9X_ZWmex`}hJ{LdvL}=Cl6REQY#H%xJcW>`eDEu<6Wz(w2$Mp|D zI>g2r8>^UUl!)OYIeN`D@QwWpG z-hb|Y7rm-c6Bt(MEX?BzA!-ksKM@zd^&5fc;Xp(k{ov+FD_Xz3ZTi9BJ_iZUE;s?Q z)+L@b`Ea_~zB=hLrnj_eN`@WLdJ$i~UxXb?+4@>TnlIu@8#r0IL_aAUMIN4By@as$ zmj43WIv>;hmCC&5rT6bRc5R#flGS!vzjRbOJn(0qK)RESC$4-dss18QRhZHJbW;1L zI@_S78Qt<@U>LtvuJGQfG9?h(T!tz{kOKon@ZiZSZCYN}0%2V|O(Z@|S60`NUy#di zs&ck^j)rGnN1ZV1O0aCe_XN}-&NRnr6N9e^t!H=9ShJNwank_L^_7R-f9KEGswW@k zc!~CgFCwe<@b0vOnk9l9w&rO|ibd!6#3PaI0-Oy`YI9*YH6GWrPo}vTJE9R2h0zOn zCWRSJcZy(>JqDePU3tyt2!yy;o2ycfwo28p9bM;r{e;-@YU(sO=Wg^D>JeTowe4;M z*mI&RV@{lXi1h^)3vh$C&Vucc!jnwTUb+gp&ZTbDVkaUFP7X8r0@^=oT6@b7FbnMq zw1{64$G1c7u+6PYhW#uPQ1P!yxvWOw}gP*@X=vwuU$ZS7F9p_I^eDjFNsjW*7dcCrRsQ(06ZZg;4DE`!AyPuoxR%r<5Psk z5CQ|BLOO91w1z=y0iK-XnBdyQy;@60wsl^gx<7Vm)lJbxLGZcIczmi?0JwX1cOdKt z$oH3^!jOKW5cKE#>nm3nN-9T4h%f<`0WBVu*P)n4`3i5|A8CJ4X7nYYyf#l1yacs5 zAuoi`(7*sJ+>4Znm1HzOb@&b1Tk3C*6 zVNJx6VOGASuQ&Rs3YHW5a_waxD(e9YNFneAXoP4;h$v5x@+|ghFeO7Oegp%Rah1Sj zC1pE~ajszMYG`YPVar31D$cXN=}ZB zz&%2q=pQrB5-Xt;nc!-;zSj$hzd@R41Hd}~o>k@sb7&zCm_)2BD7E7$uw?67ctpH- z%ce}FY863}wvy!Or7Nq2dG*GPC-8V)MlFcP1B;9|CO-;txEann0+bxxXkNZa;-TFu zK!dk3;YzxPJi<8_H5V9o#?UFj3P8MNT(@JSMu`3*+RO$G`U0UPp!3`Ll`jOBQRGk- zwpE&01VBv!s?E#A#gta|bOfjI^E(=cc~e=^`LGA;NLgr z&ou&MBO@bxzpF$bf|HO8>>mIh0KlxGnVmoW2#-wvPM1ENIH^0JL}(DwKA}u zR}RG38Bp9nr~UjSc5NkC5FeJ{vXN8iwBjJ+w1bLyfunr@)G#sOI1wep9&5 z%J~fEs?6{&WM@gGiyqV)itre2<-_jPJk-q68FJ8`VV{DS1tCnsa^U;WWvY({j#vyd zHmV_y&R;9~Owwh2_&laF{Zg=->u&x%dJ#TBQ)+Kvt!P)6${1NW=3uel_wTpxLL2?* z@8v-<#byyp#;l>`-5o3D1C>zHkwek*GxmnLDmSeoB>@tPc{J*9%?D`VWSiN&1y_}4 zKec;$Bdfg)^09wy{1OkelX6QE2O#q_&4?^QI_B}Y5C^8Q;gIxBgjx>fXmwCcTbyvD zd^1^2LzU7!H3^(EF&c5_&T@dbK_?XYVchVAcC~D&_O3DAn~|fFZBhG0SyPKwp{NCeEI+0c zHxP_&vl))E>lpZhRI=N6#F@R=?Lz(YiIo2Lrb2a960UyPAr*f8nl^{!6mTXY$%YHK zs|tOUo&&g|Ci{WGc7z6t(Wu^wM_(lrb9L4Z3c!Yq*5k!Lhx$372*oAnHOF|cLrqFS z8hyb6GfBM;gVt}^1nzF41gJ4hO8pPd0O4?JYs-;48z>ynXB-MJZw(Cji*P5=|H~Am z3g}?~cZ4y7P$N5yJS`;B$`2MbT{&Y|8-q(`3w7uQVA=LXk)bMOG6-DGkor&%9MQ;U z;PTfiqh+cMsKX86ITECXxBU@}dQo=`(SVm`a7Y#7nvJ*Ji=hfSW;8%ynQV+!9D>}C zVN)mcNemKlfGpDsPG{@>o=aM8!Mtr95RP}qh?k;kfo6iqNyN%b@K6PkgR1CRLL{Ed ztW|0x$;p7TReS0^Ss2_0YKoA`GjZ)qbpvQ7pu~um3`}S}QFp@3klq18SSE|q#Liiv ztsNZ=O`7x8G%CFLZ6XF`f+R7CPd=a!@bkyu;E4-TrRL|U##NG88U+OdI#R&%O}PIY zBPAOD7%~KMrZXWCs~C@kGBpUOhjDY0xWRbG){Lg-=1gAAn1gh=c?K?}-~akoi0-BlkQ05n#ZKs#BqbN>)58mR*uRlva zXxn0DgC?+lY(3&q1I%NJ!8==oFA+GG2Qyor(fUqu+)oY)TzMK!`)08=|?l6O)xQs!O>GC%>LYG;eB_> zo|Q`v?OUr!Ml0e_iW#>Ucf~D@aliXMCYObSD3I`#U&MdN6}?h(7X%fasz_@tQExAh zkwTk>;H()A()l6BMQewA`d6=YL9Vmrq#OTpPgl=&*f^tg*k&( z8xZQrs{PQP8a55No&nUjWgnI##r+ewTAtN2 z?Sv>f?3O01{S}GCVW+enf?nBG36u1uY%R;7nv#tg7d;D!2}4vp+0}_wnE{_u8SA`H z(DBcdd(PChIgJ+S#M+oyk`s7R*4{zFm8#0wE;gUq93q*E-vcTuk*OdFY`ynNx)kcj zC=W>@k+%pGYS>Z}C`Ho>MU=A*14ABBO1G0k6E_zj{b!FV2uy24-QA5Gc){FrKePkh zGKfmZ`z;DAy#qB=_wXhJ{IwFK(#<5%Y*y@5#Ag6Iy|KOhdH=`wLWU|G_~V2Kk%Vf8 zzx=D?)S~w+3g&kTo*Hy>26OW36TtVlx{@Eb18?5mr*tWtWF$an?7wQG|8Dk&uCh}0 zssucd$sRDn2#D3_`q|^B0|C2>i;LG@Z!a$hQKy4JyoRgxvj;6AGXm-q$i~hNxkjNjvE_ia`PD z8H-hRhgyApu%_aUD6C0fpfv-}9H7OlW-}55%{LLG*Iw^rzinSW)<6cMH|7N0kY+#^ zSXIK1BH1BU$eunA0S_&plLhzp42(kr zyi?YkK!WeT>L&oB0F+X~SV5m$Und3cb7cJ|Jqds$;Y0-a`Lh(L0q-f0+5wO(JCjmM zJfT3FObtTdt{1|H4{%@~qAfLp)w2x2b`DsY6AQTjc0qhem;p>Qw;c`Cb?3%&ads=C zeR03HLSekU97j$lNhy#4YeB7BJiK^JHXtd(x4pi9+}+&)hIiRm_<+>8+kL8c@q4@?l%>7UnH(} zggi)oWjRizRx}K&hsxy46Yr|sB+>lcZ(n*pDX>fBcj%|fp~VeUGkSsf^9C9cQt^#! z=XJYb2XFuGu33=m%Bz18bx7KCjB4aP-H|-O!UPqa2ETcW`r_#`V4$4HCmuqWqEZjjQX{BVXs|gP@q|6E%O;b`GY`DeHfO ztW=0zVxiVxrbe*FVn-`_Nksn)^u-D?d@4@#!rMx8c@#wOrK8#urPeFBEe}Dp_P%=` zyTVy3_3%$JmG;k}{iWIrT2JICovged+Dp;Ypcip~*7q%srS?ZZ=Tl3ou0^0}W8_({ z`XM~`wYZRzs7Mn@3^u08ILfZotR#poTU%Wgt7*YA(5iIL{OdrkPU843^rP~Qc%wKQ zai-UtTprcTT-7R$zW`UcK_{tOmlHCyf6J2RyM`G$CiRDgTh}F$oWt)D%qKdGKsD#5 zw^cov`C2H$v|t@&M~CcG!!!{UWu0i81|rsNHy6s%f`{xLd1Nw2q5;aL4Uu=MbNUKf zoPn-07syVNpOeaphJL?-(!#Y)+w0!+ZE6%w)0&tz7Iq#&lEO97$KDK~S6XkrY#mHj zg# zL(5ygcqhfD#gw|jxJ}Urh-E4etX5YnRH{VS7r_p5e&g+t zf9eXl(NU-f=NvvdW*WXjEIECC#yf!>%dztB}sZ!KU0n6%E~#ybVT_ zO_&n)(SiVUlT|Sm&N7jGkxp>@vmET5P-~hf_&FEIUdL-n7-hlc^188t+3DJy{6%T4SB7Ss;Zx!sH9ku)WqUzxN3Iy~ncunedJW8-J+aA_O_f+|-! z-|It}n|YZJNFsy2#fYhnH_wEG$wQZIX>}rh)z18)qt=Yi0PcqI?~42)$TTUhs?#&t zIhZTT_2L4%xXrlWlkapTRFDuw7hXU>;M**3QY1@^g2A^ZaxnByV4a^?YjRFrjzo2i z%`0Lo4mP}K(J6&a97^m@IfBdpOL`CVf7@6mG|pR7iq1y(Gv<4$36EVRr4IdLaXeZz9M(KMDnBzn7`bmJpTJO0zEo?|0w{qD;&5%jO>?z}@{s^n7< zVd1(z=Ya9#d4zy&|LB&_#g{+#CTft75u^U@a5{fFdnsFSVljo#Iz!~I?+v5VjNrLt zHKlO<#!G*WgFcsRNFc~HJx}q~x~-17Z>#vx)sa3LPo=7PHymR(GaV zSLX4Y9pcVV8zdpjR;3feU}3DY)T)_Q#DppQ5k~q+QUo(yIQ2Qs{WX@H>Xw>4d6%57 zL50PU|!QY>Ex6GzYj3-p5wRCT5WzNJLSi{f%*&s7q}&w;^zWE1T19D{`I#*Ad%o z3Rk;x_|uiZWaZ5XbCTNVYYe0@qb9HKWb@obNls4*Tnlursx|kunDpL~NH*ms^Kp{^ zx;`j$(_9{TxLdYL=Zs?A9cAt4S{EVJh#Cz?pnM3AR3oCA4~p|xB+FR>ixFtMW_xTn z>k#=fN^~zt3w7{rGP(_1b%2ZlkSB4AWY0D8Ez@-jqTWRkMa>z|at|VARb&%;0;>yV z0aJi$0euB`N74lN^M8POE$}k{$ccD*w&~RlyMY&nAB(z)#tbCLMmGTzMgZCR{`v^) zduH||l&{&TN!zi|767J6K%Xa~2pS*|74YH4%U~xG8gf`5?~}(2Yu>~M91B!*xSJwewf=Nz7ftZ&l9L~GvKxq=)ns*~W|0;JS>8N3uj?G-?6K8vS;`Lh{L%c=50{Vd6e$4}$M;PM9FD|7- zvyXH^lQDA3WHmz1mS|Gm@!=lD#7$x=3bo*d!Ngg7RwCzTph#i%IER5XQ$fz?X~3j@ z)3Ko+m}|epxl3InTZX50ODOQ8_cpyi5MBts0Hz8{Z0|@t&pHn(gi5{J)~9si~tMDqo{Nk^kniQ2ws08os@%-kIn(|->!r1zjiF=g9%)+ zgND*Mk-*P|4je!W&bgO-wyDtCi;tV+S z2dEJy8wq@{RbJYSo~&;8iKjd`Bn5=f#zeN7@=~sX(WjW?IQ8vJ3jj9aWFho!ZaD zppT_ek)r6*Xlo?LMF}eBVr}ba%vx+}P7Q)UhTk6#)4GY|Wy-g|Crn9K))s5Ue50Gi z)Tq0`m|2_1_n7cx`<~cQoW@m}W2DV|sC=(2%VZLNC&;76QVQkT6cMtiFkNf!F}GX5 z_v^ra5ggvCAAqh^w*>fo4eKmycd)&4DsTB(b8s8s;tilzy-X z=I#8Z(tPWiwk#J*r>xU<=>htPJ7zW*FXJiEvtxn>Dlc^_+`+$EQCU9U2k z{h~2K?F6N#avx^9ArMK#UT1Inen^b+wsWasEr8@)QTaS+&*{XZ{2BMhB^ z83@fpL;d&Ae`n@CRQLMrzu{P(*C%u?27I{l`T_(glUb&I5<+f1(Mvf|B^U~E)8y%U zLx$Yj_F`~VYANzOQcWF*cZFOcTv$|>F<1Ptfe>}^!e7QE89AH7m3M10F$H(1zho4f z(TReMIL_v_n2<2WL0a8{xA|F1+iVa}yYXv}w#{a-R0~+c%Cj~5GfdV1qlA@YwI5)T z>5Ll(zPA`KM`M!qiIx%~@e=<4kgNdL6*yc+90u%yXo6H$C#2~K{MI+aE#1MfZUmLv zwzI|`0go~u(f576_Q|?Hin0u&q9fxA5Tbx*L$yygDI^o3OM*#vO5=u$`GJ+7>j2z@ zk{@v7U&jGJ)U(dmHU#VinB_ES$P6%IK`sIT;>$kkGL=7oz?NfH-r-29uYYS`ZzE-z|u=YBAuWCdnRh@T%K<0wUgr)e_(;+b-b&6w{x zl0wQGcEz6C-ByqogckAlSV41Y(2p$}IjGVOlDUr6A_LKWAD}J#uR|Ef`JByvU9vEsR{Gat5`WgC>pMbw!0p?cpQmR!5}v?8k0 z$d==ZV`8o23RF=5c}}Z%G~@fz#Zbblh5t1v(i5T2&dl(>WoB{_|2Pd9n#N`OqLM+E zj|(M#vBk18wZ{4w3(yBKW=tX6I>*g^12{E=y4ZA|H1^Ph8Bwx;+#P9LJU3inNADaj zu?>m3wwd3y-+>f5@PB^Q{sHK!zcFhV0c2>NZ=8a1VVc8;w*I21N ziO_+jaA*;$B1innojsn6LLF^%*5wQiEMaexku4nK&6jnoxlpvd&0Q_WC9|trs}`W- zGDJg>sX(bIhA$<#pfcwjniwkOY@K>_y>T*Hr{WQIC7m;Mt!nmOT-V7Ep--Y)6-9Dixj45tz$2|Tk@B&u+M zVj}%xo%oTt=ZB+Ws_Ck;sO7OY&P zCW9y}>B6|04TMY)JeT97;vCcm^mRKscU-RKf^E5+X{_PjccQij-^3;^it{&51Y;PW zpT?L{*<^gs3eHl$oALZ;yq9hyKcCLO{B^P`6GTCuiqcKjD7*8nU(9KPQseSg63KUe zGfD%9AumPIB8SwOT(DB2r}~I+YCX(Zdxvuz58)D^R4DICTH^q-=H<#*$O@~DU2h4+ zaQL6K8wOF3)F!*IlKm=58I}S}9Y+AN0ayvbjR3`Wl`t|Z5E6;(ZT67%hjmtjPuJI9 zGH`cRUW0p@f*8e<@gij}t0f_^XB`lr$)U8+(#wC?BSOcSY*YEh8-hXZfvbtZqP+pj zhX>+TsYXTM(_OkYL(Upql998)*ce6nV>YuG$(%KLArl7`LagE5hL;U%fyjw2dcWMw zAC!OBP%O6u&>mU0WDu(lvdRNs(aAeo?clQ$ys72*{QT~b82-ARnbVewr62aO(?;jV6M@=Nwhp|Gxc`ZQHhOTa#@!Y0_ldc1@T#X|io| zstJ>A9ucX@B{5LB;I@_@LUk~t)Bo@9CQ1(YWRG~c1Bov@5HO$8mTrw4*CkNY}bPT2y}79 zxOx}r;c$5beo=|Gi-(=95ypKbPhsrvy zRcqnKEy;Hx7Zy1135&D+bB5@IngQ$Gr$jF)M0|%DfMT%%9uA$c(mytxths3#>CsxE zmi{gtwMqo`0W-CS*Y|;e0iXXexdA)o?lCh1e_7kc(Pm;*&J?wIp=f8$={@c4jypd< z;$a-!(QBg@Rb2jE7r2v0>-dw>R4rc!L^TyvFfD^aLuk{_BB+Z(q3F$W)rjIm*s(d? z^{FVNtJW(oJEFiw=R~I%;NlWQN()?aSrn2Yk@tA?SwjZ>hu*HFUC9UinCs{19IG%P z|6%Qcbf2#pjG52*DNuZGW<`>7wJ_73a!FBPo?H>DBU1ko6cKN*JMRb(KEE6s9Z!J! z-AN61bL_$Zgc!Z*-w0ZIw9@v=JoXJyC%U6mFzK&SnA9G1i?glB%D>>dV*1K-hNiHaDxSH(HXTV@k7zlV! zK}=pPrgmKe{0x)H+s>PWE;*buwi$=1)X8e2pXv`d(H~Mgepu7!r`oM?@hdDbRjf&x zS{__8)ctEUgHua`h>RXIrJm1r^QmidovHYhI%EsYmiY2pjC)VmPC|oI3K5I6r>MIS zw%PG>dJ9{>{f7t_AT(dBQ!HVQGu&td=5xg=GJio}c2aumb>6CLlZBlOKlz@_{@L)P zGHgjZOB{bRy@QmTLo#FDUJR;Cb^2lUqMMF#ESf_7!(-{fteF!OGEKM`N1h?Gq+FuUrvjo#!l@>@8GE$ zmyh6@!E`1ICf0xhWHb8=1xpP|MuY!nSCmq3O(1b9f+7k#@-!7Vxj3bSDxwRL(eb-1 z2`Wr#(0P?=vRJ0yk25w%mu-;+7&H*G!veIfvo-kBVp=dxat2mwj4vRHzk<@$s0GblDa*%}-gfjJXtM@7}DTV&RmVMO*fl8bXoF@Hc zPl21su(!)#@Z2b19bN{*}=g>)wRcJ=~^ zDv1=@fVWUhbcfIkC_+-k20QU6H9@@g?WMMggO$!TK>RW$G{42xI}qWk)xHu~&D*i5 z+@$ALL{A}QRscAvbEbgXdPvS~QGV@M<0OtAk+b4fm&y5C=n!#uDW+b!3wNa z4-`{PuorTf{uAQ*;<)1kipIdZJlueEf=uuGEk?+pU!>zcbP}Y-Att@JDv_^7A7~7};xK zvlsD%!Db9QfP)Q(Ix!qJq1z-4vC&34NBA)u5F7Fp1OCe6Y|@jadg!L4kEV#(LLIK2 z`}sWV=F8c_+%JUWv@orFsUY!x9UAOou0@|)&(Hdp0H*b3clPDUPj-bfV=!Agk4bhx z(?*^9S$~1j$udXf{)F06Bt;y>MXNFvQAA5NUkNZZcbx2#21#!xi!iO0RDl@qup5|# zhlG={g!iqHqkpMMna#{N{FTzeOi@Jg!;x;$$`6xsL8)!#{z4eWju-X(5fM(H>iQaJ zxxHrTnB|rs$Ie_j*s0h4PpC?Ft6EMtJ;t++ zQuo)|&6jVo;qR%RuiD2rLi40Q`=|tr;5%`yY|6FGYv=3AHSp^=uW1nPgDi%s_#wMV zsQNm_0ap*0gxFMUo2YGs!qiwl_Zf(pQ}$kmo95ISK>-g4f_o|4HG6+kslm2K(7KzlsF51QtF~` zG==HmBHq{EUsyl@;?kKH2vE=!&H`p5hzxT&XV8+!O^(4hqzbnnDko+c2pGIDn2%4XqKQ8m~&hwKLEyIP9e=G@a^prp9AW-^f^_Be6D(wCsK;j>meNw zu01ayGd4mqN8=gg0D3M5xorTv>E%Yg2YyKDH5fI90TdkHRB^mU^M2sk^;G#$Q zU*wKn1@*G3v)Z_ABn-G_&LD&kAex%$3_aF~0J5c~={!t-hzyDsM0@F?W3un=^(Ig+SoXT39Y1Y2%_U29gqku9m(04(Sln76GT zW=v2WiBw@C(n3heyfu%pA`q%*5e9>_ux6AH@hAR4{{@=9_uE^J>jwbS4CKHc;5vtt z^TcyfTV{2{7`$>E>)@I&vyMBp0|1ujpW-%p%o(%^DIt;+(+v})2+b2fWmh~6ru z!KiGo2g4`o+srCGk?0$ixi>cbN{Iq7wL|U56u~!7l>e$MS*u%!b9e6U-0O8rI2%^o zN?19PKEs7GF%;ld7;VtLJS$J!J7~qoO+{R{NnBU=3;h`>%AY+v(x+81Ue=(UQTU7F z+xLT7K$G|GP0XH{zREa@$r_)VI}g?B7yChRdbF5lV&m0t#cfv)Mk(D}R`EX-mB#OE$nlQ^y zj(yeBt=)kVMAMD&^j1susW@Boo{BY~{Q`mSoneI<^BrP_8WktUOm$+o^Ri zW2UPV$Kf_?Tq&5q+OanYP*~u{wPF3^DDRMu=j6T*Jnspd!YiqG%!k(=BvA6MQpisxo zh)!XcIRa4{7I%0E&mgEA<6lRP5lDZKaPKG+lUATWY&R&H1pxCEAcq}5uLHR(+QQLz zG;p!A1Q`xaUZxAo7@-mf0C><@Z|93DYgZW4LkYs;q@t*!;lx+o!SNmHvKht@V(Z>h z6CLTSB}QuSM|K}bMY$Vn(2GH`OJl&ppN5X+h=Cm&&VDSnA!T{1J}*Hl(#di1AhjfX zaHy(4!u~#=VZbaoa|oafG#rJrK}xtl7&#ChI?c&UG9T5er;lFx5c1fL}iChNBNevli z21{bs15bjl(ATqk6whN~5JIBx)wlJ5w+X-*0^VQlfn)09;hf;zk_{S$frN7Hy1(u@ zg-_srcy;ZF0Wz|fG?6p_(v_!3?aw^y2u?C_Sr3awe#tqKKd^&3V!jsWE$?9ZK1Pwj z$1R<91!DmGI)^Z};VfgNsF#X{zY~tPHrsKAH~^s(!@gKz3Ay>iZ@u(k4DY_WmIlQk zqPNq2!88>+xOAA@j6k>MrXC|C1Pt~J%;=xD$7E?ORlqELV8=@bjyrsRvrevT4&-oV zQ5Gy$k<^|Y-{inQHu?P$ZlD)`K3?Kk`_tJIWx>iQq7j|poA^*!o7s>Ho9tIuIJ<{f zV5M|ZUc^bF5q=;A<2`R5Q0C6yn4`_4kj^zlt;A09mG-U^lFIrS6YcGc9j(SeUlM~g z37o{tb-qdhI~v)$LYH~4a&N#cdcxIIiezV5LQC&iUOB}A+|nLNJ^H{SdApGzR~9 zL9EH%C`|w6PMuvP!^tOmsxiv8y<|jw zF=YaZb%@9}5DH{X2@fj12_r#-eZp2%5rbd<~JH?c~9=jiXE=(iz6LW~}B3zizYLUE^(4Ld6%LwMaCEf*m$|7PXov z2r$_=v*LP$%?bvO_6&{Me&lebVC)dNl^XNtz{W0g&acv({Xa-)CuP1YIU1`Nh^syK`|ucX{IO!$ zU@z5QJ7V8lAoY``7T9(2Nu(tR#s*==5(skOG1Q?CSO{8_2354{)c}g!V=>?Z@u+MP z3UDzIZMGFMNIXZ!<6>G+ZntD#O*#j3w5dlYblBI-*EPvSj7?$SIL3 zQ4c>OfmvCwmZgGpW-OfxZ>+|HN_2-N?;_XSl~h`08GD#^sdk1gfo`V8277n2;PebV z_c+zYp_fB+hgO?WVHCuVqZawB6Vb2J{i}NC)Y8$@V_c)g^*fEtt}4oOp}WE@S}ff=~*gQJL0p$9?5YP3;CKWwsR06f z;U^&H+uY1+i`9ADU0}YiNBFB`GJRx&8mowihX}|o{_IXVeUp*9K&}?;MJ>_qNse7b zK>9R<>z&RQ7fWdnSHvLUR?Q(&`~#E1?gy(?`*rRV2onLOc3&?BRg{fsAkYiCT~LUS zBY@cxOvZP9o>sukIA+m5VhW%aad2=#lYk{br^s%5EgJf89#KAa%-Wc$JAhOL)}$nv*z}T5Xx$vsQ${dnS7+qQ`#;1mv{SXHPvfw8lNW0`+2)HN_!%{v z-BNPxTPN#IgX4R^6&qzUTC}YRF3D0ym$iM;VFo0&Vp1~SKQCO{QBmJLe~Pvx_cgAa zekn{{Al+AgJ|?8g?$NfXg0c`Nv(%L?`1p&p*%WK@1?)qfvjDzoF-sT+UlLlLPzJH>vWmI-mLF^ruhaP{cOVw6A6k5BKU z-j`9kk{04>wc|HG@KEV7^J^q%yF^`4u3AeVSfD&wXEoU|gIylF2aQey&~jiegm$k| z2zCFyY~wN3=K}Ldlj9wpY&O!g>0k5e$(U3m4-{8_vPy@W4U$wB?eqOEgGZ{y!}a}v z?r@@>OUJ;fWxakAy`~z+e%odc;2}t>I$LyXwrk{|K`KE6nsBtzxr5;cT5Uui;{xe2 zK)Nkw!OT>r7z@xN%DsrGlRAAb+`9rwp*DmiE&|$m;%O5zdr)6fEREfPzxCq>L}V*2 z;L9=WGQq#mnfMc;gUo0kbEr8PoXS} zJBCyoVUKzkM%)6h!XChK1W?Ln4uMOXs_S>kiu=0zS`PWTh+NHoLeV`RKR>R<#KR5n zAhzHORc=cW_~v3Y zdCJ>LLhqYKUGR1VtEHAHylV71Z({rH3hqx zu%9)*SI(_g@OMyS_U0*Y2<1voxE2~CpaHWc3oFVDQ=LDiMX9p(*ret}!O$T=kHV;? z^QVo>uE4JB{#09F!UT=sDL9%hGieL#8*Jov|2c9_KwHwv_4FoFex;)<=z$e&iSAjJ zvXkcofPRwV6;&3@buYm0t%7rwp^KQ~)|bHt_FlwJ8!=Gygt@Qo3BdYnr_Tw5H-vQ} zctu1G?_kwe`$Exjr>v?I>s9ya*R5)A8Nu|t&8fUxJt?3ToLWMFOAL+R@l}Xn`7iu2 zyG6+YSq25OUF+?R42EBIU{BZB6r5`z=HXn>-4xipOH<5J4nGMqKgrzI(g_c`=eJu? zw0H`S1s|a)4YTyyw#}Tc*|6Z}0g=_jT&=0_oKa~*r8gYMG3@USjYazwPFdbGNEa_) z2QS|EZO#lC>NfG<_jWq|Q5OvwI9Tmt%U^CSJzZO8(l5gzi%%|;`1mwL}wRm25cdy>U7i#-#OYh1YDCtfe zO`q2^t}znfi=r_F5(Wm?v^Nx<0C}yFRKBWPUYHJiY~jn7ihJBba&o0jDb?&wI-w4@ zfNx%n=N+)>^^7>wFOAIEVNIg8qbkPVuX&D>etrr>vfG~j_R&l1Ui?`C8L8~Is9F<^ zZ+L%mM!!eOZ5v%FB<`r6om!Cm4XdzRfXeGn$ylR%f$}j5G%BBJVgiR=@G{%|iO8?Q zXgdcQMXR6l);B0 zZ@KIQti26RLc}F{q09>tPfb_cvyQNYT0w-S0ySTs8~|vu7ORUrA37Mkk|abE&&M-Qmg2@EOuI}2Y_G@xKQb=V9F;Z9H-PZ2en2fxD>dKuN{HDlwM|cokYfkL zbLm@deig<=TyL?{Vw_wNvuqg-h~5tZXZTHY#Y%^7N@|HE0XElA;#ku8?3DzgW~0aoi}@( zFqZ{9NH$9)WXC3+0(x&1l-X(`K_#-uatQ{F+EGDB;#{XrGA?yXX_DP|On{t^mVGM3 zT*Ah-hKHmRE0o3S3+LkP&6hKEwlXm>0h}Ha^d^tT!;CkUtrT82-=L143?)y_*Xx07jv$Lxs0YBFAZTgU5o?D6QqaUq{5{ZpoHNTOxUui>e6b{XGh&?K zV#ikCe1DmHQLgb!L}cQ;hy8OqQr6JhpIsWPU`p-~s53HTxoalW*dxLJ z0&ck@M%pVwX*M=D>rEt5DZl}(8`$N+p(Or7&Du2GrDd-FnG7_u@68gplj2XZkAa1X z!Si8xWSe~&g5I(G86D6p2O6%+N#CPOIiTwM>Nw~~_6?)ohD~6V5!cR(dT=T`1u8TD z`^f1jLpgqKe!deo0SvH#G+}M+==lCW#l>ng3Nk>R$BBXR1WXOqI8Bq^Bu`P%bIv0zkFabj4Yl270b{i;c}2w5HCFXAU|9zobl0LYC(}t0^+5 z&`Js0V)@c;O)%Ts18GAR%c3nOx#v^M4qct10kUihkf}SeZE0(9ph!wh+S-Ysx`R#7 zf%Ao_CUaT=a?3r58+R8!f=>*8IZv4+Y_;4=E&Cw8RvTR~J13$HvOJo$zty@$yzteS zXoe4V&7Q$YS&iK&rIvSZsIf$EJd6HeZwBTJqHaAe+iX_KJi4+j=x>C6a6pUWc?IHC&P@5AsdSj z(}tyHLq+6jpke!(Ijh#5&ykH^Vws~IpskcmhqO{HW9DMU_-a*txoG9&LmHef8gzsG_F!Se^8-6SUFO}8;@t80;+yfpz(+JX^ zFryg+=x&{XWTL@ezsNj?9q8 z-5}TLVutD)gzN?|ed(crVQOFoXN*J$@}+8u%Sj3jaYKG84qjyVZwM{BJrMg#xN-g5 zB3-l-j5S@rquP&5%AWHGFtLCa08uy|a#wTW z@fDP0=!(ZZ&G&R)FpVUx#+{Qyiqd0r^D%ZCgF$BIVmsxUyS}~#q{R$fyR91AWTEnx zHj{wb-Sr+EF(nMmsJt#R!%FM|2#Z0xR zv81D$jj8SS;*x1gb3_i330&>08XGyu`SYiuKM{8JBwdTUt#6QwK`=*zD_*c(+Ab|4 z8R8yhTz#p`GzEo6_;)`n^g!8diEuZXM#Z4`Ep>``fk<0Lsmskt#DrmGnf1YXkolf8 zh8QPP8N1;CO;8wNHv7StjjTip)BukL$ zV>NcUxs-H0bxCje+O;m4E16*5>_lt&(?0FNFv^3TO9kQ81jRkyVwfsxv{{!HX`zZM ziPg^*xxTMl@LtU#>1T@Qqp!UXv4e_#WhT7<3wz!{w0DB5(W zIWVyaEldcQ(|N2As%h@PVdbl9jET2%OVc94C zI$y8d>2Oz8<%A4{S{Bundb1A)Zr=mWy5D-<+cdLe zP6rkJ;8Q@d0Hq5cLa-X(!k}5f(m^%_PnLr-QPX%zN$hVYisbNXDGwLOP3J0k_g4u= zQqO%wi*=y#K#FZk&<>gYQ6iq@Q{2>w-JWHE%S-Pzh2cn&PY zih6%&nFbHw!W;Au0@#C$4B%%1^A$i)3Vi+qmzry$c=rlq)Bxv}lBk$2}V| zpXRD$fScPbAXdcI`TGsok#8nJ4Eq1>t#2n}=#NV~dpOvU^V2~zQ3?}g*Ccv0+nZ09LLf$O#WU6H zhr(Ep)%ipG#1UehZmDmi)+t8VzjfH#UsCQkKE<=M7)K**S8}=YyrU4o8jvB@&N-)w z>O3QVtb1W*re82qTH;+_B$5L~pqE&-INF9uDbN`RdzSS+<$C-lXINz8da?29i%<82 zjvRx3SrmNGq(UEcn8aLB({A~Josp)`&6sQRebSGsq$uu|VH!;~SO`7SoB9IF#c`Fz zLIK^2WX){Pq~FUKQE+h{HjZYcA@)-&*d~$kovQ~-pieQy3%VDDt(3BQrsVJI9p<5N>Qbeoh z;SNY~bUh+-x{q6Kei3zT^tJ~`G7R|~x33s4-(#Y3ckXoShSarDQXdlF!-)Wd!ItxZx%U&T|q-Ntf36z@) zRj{oWuV$axuA-(te&J9|#xhPVKaO@mmBhfUWX({=fRz=HK*v?3L?zEWG6c^MrR*F4 ztX;v-H^bBM;=S@<)PGmOD1fl_K?#zM;45U^2UbSh)8-h;$DDIhfN#3b!k$kjLBI&(bY=*y z5UGJ2ly2(X9NA8?U_i2pL5kRkXfqslsH2{Ga(|B{(5Q_jy7%^G@HpBb>q4d-2%45n za|2WbIa7k6De{}))Z2co#oyJuZ&1nD=QzH5p&_k~Fy4A8wp<4f^JCl84sejTF_R|Y z(Pz>Ke|s^L2mj&1yiE~Fx7qCED_uZj`{ zUC{k*67_D7B-~*_RX(`sVLY8-T+o#5#suKY1(6CqYTygFT93UXZ*VFf7}nB1k|tPv zoh9}--RAsztm~&RA0z`2+g1}lpK3tw87#)UYi5GP<@kVq;XOa@85mDjfAS5Qya)fY zz}_W{Uvn6y_W6-JJah57F>Xw6H4O~^0hPEiv*_8d^)M##YBYP_ zRAU%MAx-FwW*iLtHhsLTUfORw$WnwLI*j@@x+gS<+g(8O)p`OML2ww)I;FOB9E;2+ z?VB@X*vsXhDTUoJbggf>qsI&hRAkq*SUI7Z_ecP^l(bHQ^XcDs@ zmtVr=k#?C1W6>b@O%n&5yDJ~52bhCDUJ}gj{#IcY%HT^LDJI<8o+9gdhK{9x z`!-3rome5w|7Icd@lRKv%T~Y(pQo#s`D+U{<`uE1Rr3*qsR~DX{Hs z3>gW_TC9`HepV8Vc7SqcD9!Vr-}u-ToBo&-(XSJG5F3^vtK;R+B~zlDnhrVFxQ~kpc99nW?jS+ceMS%yh?v znY+_*Ebm@bo*0*n%+ zI8m#MWF@%d+TU&vk3`odia3Ufi7tv9Vj(ZKt{))rpn;MPpnLCwK-A$05n)ZU$j* z+#W%hflz?|Pr(M@(riSo`R}OH?jVzdTTipdM4*kBcNsh52=Md&ao`4|*_fQnalDHD z8{y%FYI_oH_hC7|jiFf~*Uz<9$n#D3oklha@z`+`Mp+=$f92__dLIAzHI>;YdB5C( zxv@I(%6Q}!=y<#zG8A~yVAqMmg)&~K zT<;SPYW!09xW!D{NLA!j&c!d%x= zNhupFj&&1x&D?F+*h|+&i<8p~0T;)b`!nt*!dImC%o(CiZw1q}pq6s4gp3T?o@O*E zHkC3d&y?7e?sklDZ&wO2I)!iBNf|($luJhY$BKak>lisMmn|u`NTso)novsRC0Ah{y5_)1QIC+jC-P5Yksfq>yomPiLL=3JzLCf1H~ zm3}i*+S?Z!cDY8%2zBM~iUd1RmMkc1W{tm&tv4!`gnsb!8yr+S8oN<>@?5EzVa#Y7 zRB;Y`jvd)gx`>9@gMq^OrQoS*tv2ghC9FkEO6V<&77=f6ywYE_rI>~?7iU_s-HFZ- z@M?~rC1SX|w{Cl&Z|v+Jw@KOm%1c<{f#@_<@|HC4;g2H`=`T}u!kQqN zbD!O9bN;B?RWTL9QDC z(anX*fG5MkRfez&5MlzUQBM}#0}HH32$7-s*Gy_!k8U3eLfT=tJ%bqwpOc4RbKvL)5(@$9xm!ilRHYLSahx=etO)S+fUJ6;^#d9} zAVF(GOec0J9{A_Ij}njDQ1E^V;Hxe}^m&JcABM?gUW^jjhj!I|(RGyogoBz><0AD?Gh62V-D?RicFcN+KKWE^~;VrNS zzMb6LjMEu`2OCdB8Ci>-NyG=9NOg5$m#t{5g;tzq5dvbw3VH+F-mVODdGG!rS&BgA zD|R@QGZ?x3Jr;8dD@}^)eL0ksxdoNhSJvb@HptxWichMRYSxnc(1LxZOth7B+T;X) z4)Q)_Vg7L)v4GmtEWSH|9N{QMH&zk?-0=Y)J8IQAySN)-@d*i8qyNq7O)v71UmUn8 zg3xP+*y*|NETE#`=7x8GCPLJEhRtI$`w%JK3BYlaE~CA)-XG$3B0KbQmYnutmM}sN z?W9b8H+C(o=KUwJ25EsY$*b-RYww zihPk$>a|$MVr(#YLl22IOXXM*DU2I|n=bboLcBVe)XRGna=p>|46{3wvsB!SO->b0kV%e>k& zCj>PzrB^^$p8hc5IDLyDsnP7bTAs zbtEFbU+G{JlX$h1;?wMIghSw=)2P<-F=a@Pf#>6wl|~|IY=inf<~^mzGQPUjIkCRK z{88#dFBh;*@4>NNJd5ra*4rf5wXi4`30GooIkF}BOI0-Q+%SDzhO~2!?&Xk5AlWd5 znMr+4T42a7rKyoZO2y5Cc1rqO7NEE+oF=c;il4IU4$?cWg+?JbddlE>8&->_WEOWIu;R)`+SA5bWY?w!cm1;{cMNV zvUA3&SkXrGn+FH77CRd0s`5WpX-W=4`$MIFJg#kp)=?*vq3ZG{h0a~a+6F0L7lzHH z8twJqc1XE=J5ivOyeJCWcH(-~d*chAE0TAjpF&t}IZZ|1y#ya9`Tqa}2|0ssUq;f9 z_VlEK=Va(W@S~LdZ8XT16iIR{&b9p8T@{S!bclNkhT+n6JnAPEe z`GI2zSc{=-3gPR=N{};^%YQol@%z_$%wEX4j!vo(ip!DhuY^UDFr0ZUjw-~%H^4uBHH@IjCXinZ{1h!t8X*2YMHfDFRNxO1DCI2imX5@i4h0QW@36B6Z%)miC=ZTT2KOpgUG+>D2r;XR zm}8GWr8dvs?CFysNqp)S0ld$-Mh3v?o~gkva?VaZTT)vL>5%;idg)yY_eu#dQo)Ye zKE-SPwW?*noB_=9{D1r_L%1cH0cL!VZGiEho=(SA#oPD_xjVIO;s0v^j`G5$#5s;x zuw$0&_LFV?l3}DJDo5D(^ndCSjA;%@nv=xyx*$oRz60j<)tCK3ll1+`uM|2eQrliW zz(QLvZIDhb!1Q4o<5d0#WrG?Z%2u%n?L%Px;TIGP%|fayF9;YPqxp)BRIYfl$JZoT z2v`mp(!>vVX1#?Mw-*Sz8%^<%tNfW3%f^y5VYy}uoj&}DuJRN`gVHRVrdG+=)HE3Coh zcpHGfCC8Mco$}C~7&hB|C9#ced8fdXlcM@%$M@E{yOi>ldaNd@L8~YRbtM##W0Ad! z{5BHN|Ngt&Y{ulbtB?Gda3~OoEC<6!RULfH9TyDVb=g#Qk(zbWQqEIR-xazinSD~~ zjF4i?&&TA86SVoFPY15>Lyx$bSdEX9PJ<|VZ|_;EJ*_(bytJ7qYh9tIUQ$6GvtUa) z&e3bJtzhj@>nUaJsQ59Sh(R&BIH6P$X}zo~l=f?qB_S5A=@4pyLwHsBQ&&QTDZ7lL2!T@Twb!LZdgqF!t$r0Lp`DNr9aQB|Z z-3WvwW4P*wAy_*qeUu~yySX-FcYLjUGcF~XHjN^MH z9@wNQ1^UX0X@k@siY=0)PxLQ`9IV-aedL3+Sp5a>4=u-&Sqr)?T)&esNb0T(2W41& zE_l2g%ZK&twzrR&^|cnsnR+DFjT%A^2tgAf((cWfR(%FebnEa~V4eJ7Uh4|BT3gAY z4UsuWawZXP2^I|9Yl#AHIlM&1LL(JJr!K?rV-(xdF+wh_7L$OVYkxC`C!il>o2LiW z;;Ik62n|AORf4?T+4(QU6fJQ+C{P|E6p!wemfaFgGV1D{-u3DE=}ETCT%FbgvOk*d zI?cbUvop|)pamHb5*o5D_yZUe#|(idLUAIs;-S+2o07`)^zZe2D-RflBQ#zdItn-#ghNK_7W~={Cx$~ zC;uf_Gr^AFFup=$*0xCjJ0b3(Sle*arjKLaq<=IniMe@G*N~FNy*!IEpUK&)y!3;61q7f(Dq3HU zjah(0CY*xr>TjY@FDAl;U9UCuZsUFe$O#87w4q64r0?l51p$D0T7#JtjRBEKxm?4= z4X#el04?X};p8}_7dUNza@^R2F=GP2OX#^zxUu5a>Go?;c>(W#$c?_t@ z_8YywMejM*JKV(q0_7!RwXJV8u>a|xsMh1Xa^U{%<|<@&0bGc?R2rgnzLxd{w37?8_Q~_Y*gUUL~sB7<4%YMArA-L=v%N3n|^9d%F$wZ z%I%amfnyZU>9~n8=5DDnc}o+$RTsdpDRrd!)gAM9(WgEWg1$#`J@?y0 zX|ue(dZq7n`Byx25>&G^vy&T*X3FLrxsTk+oD;JEZP3}Wtx)VGY7^uPgjCRfYl0t# z+z&0w)CbeT&69Z!r5cVk{ki{FQ zil6$eqfZx-3c`z{Zk2{x>2IRvIvx5ykIit*e9}3X_7fUZB%?9cd0InKOe$oYLDcbj z>lbC{-%n!T#vRbplm-TJKBzyG&eLyzP}E50X4p#XIsK0k2u4(WEjj%r&DKA+ytPHI z`%TF$jB>IuxQb3Q$XMsWNZt_)s+hGZY0FA2i=ojTDFr?~xP(+u-M)GD)zxiFfa)q=!k9t(H7(|eY_?V z}N%hxR+Eh-Wn3T2lg;NNN3&S-&2 z9f#_~-@n9g7J(}m0zX0u4SO+6G*|ItIZIv4$ow7`{6#%Xv=X(@c~R3Ck)fOwRp9W4 zKFp+t1&izcg8PrFbrDv5cXyZc!8o}o_*T}nqMr9T=*}U%3h5q2iQ`Z@M_S&!`bg!AZ4(fTlrRz21$^Q2k;4s|r>OWNS8@S`tGXQ1a`aZIH zWun6Lbaer&!;bFm=@8~Rk)I^PWNk>{(BKA?t{?O=n5_OhMX>ZBh^P zp0qBn@9%yT)w+;J3V*<|vnDQ(YZWF1p!>c>RhALvroy_Q_bJ8$q$m|*bv;f`XvM;Mo84cVBEQkg_8}{YcU7p&d45EAu zgLI}QjsOz+I$b6i?`2dQ9O$p1r`-~q8|pAKAq$AW51~#gMcP#AHG4~jRX64`iCAw7 zgeWg96>B>$oyR%|zW)Sxu8~7kVM8v0p2zA8!VzXE{{WCZ@O&71zqv9U< zCm~}|OnhfKxNxKD2B(=RfWEvyWNY^ZsZyuf7*_k-RTzum|Iu`n;ds7(pIdh~)1AX~ zPj@%NbWcxrGu_=iZJ1`d*>p_Tbk2Cr-~TwC7hZ9@xsLn#Uf=VRJ+vvAcxu_*ZAJwp zi>#B5>?xa7I&8PknvFuub&j07UVB>1cQ`Bbw>o8zzhU3+tF9=YmlI=-4BlR=_ zwOkKbpWhg=GpBBaO>8+mv%Dt}YOU6%|Oh=b#{;3&m%EGJ(X}>5fwD-$An!e*Xy3<&(At)rtzLcPem9@JW zN!N3UTFtV;b<268``NT3ZVIwn43!w{Uo~5PZ9);oY5L%0gKqgEh|frQ zq~7+dsGK{~|0XPzn#nr7D<#x1s`|TUpdpo^1mn>{Ca<9Wf(TRcVUYj<&yapKt?zYF z9aPJehE|J~vNUmJxXz{&2up1fruc=g=dW|U93Z&KUTC!P^tf8>QP_18Lp!zPd*L!0 zWD?G&;$=P?tI0y#swHsSe0#@)e&8==IzqPKf+VBpV5+)p2pzLx*q9KtJtf(}7fqBN zF^m&nHS)N)xOjiQ83nh`_4$egrjZ&gGP>=a6e1X=IQ#j)lnDkK_N8w9;f_4>`&=?U z{2J_I;1`h)3;zwp3`7VnKgXt>FH^2ht{Ux&U5zf|0ml6^cfHi&^gh{ z5EulNirJ{k!WV@3k82E1NS~1S+h?ISK6)jd_zUI6MY>2%`vs{i0Bx#eTo?2Ir{ z>mlQh;gUDyIa}|HoO_&|oX(%0pRW(5ca2|f zj^>Y!7^57Qm_BZf#CwWRa8dynk*34+HR)rHURhx45#(U75&C@*p+L+F3;LSgQh`~( zRC4ID3B{;?QHOn*%a@Dr;FSqFeNjQd5NFYFB_%%S7_b>56&?KS<+xOWr*AB(N;CH^ zqRjiDBNIH5SIe2H2x3q3(H`F-*NeR80m+ZTfmcRsm{X3(K0L{z<{+jG2wB)r-efbL z&*Z!Oz?xhx;;O|tY_Bf;826IV40W@XxK~mL@*NStMhX5}ut4vO-(j!~+wRou0!Mcf zXM_ugk9Y@T#{bs8MPG>yho=@aL;_=mJNClX-7o1G>d@t?e(Wb#JuZtw8kerHpiY=t zx9FmoY}xW97GU(zs6qB>i5Q7~+>%Lk!3(F_?EI|l#M~-iou>Sk*(15aAKunty@dC+ zPOGsNPUWqH_5>5ZdP*_R-lM;!tpm1o`+6JA*@weBtDj8G#A#R0%kzFqF3wG6^hO!u z(^E`GTuw~M*hxekXJ4sP@e0Z4QZ$2e_e$%y?l@!fW|$Wzfc*iTWv zn>lklpCkn3QFdS_2&TEKN-A#i@4RtJn6jO$Z-G&mLj8mF+h0Z8F{~0L)3{`f+U+Ig zPkUJ*6PzgyMpY-x92FTlt1j~L0fKv0rXD3{?ycD^^1sGPl|%(gyL7g3>w5DNlk&qG z`PsYVQq)$BWeqL|Y*VDk_~OLaO^WLuHnP`4DKByMW16JN?2RHyq*58Fe`^uBWZf{Q zb=7-H)9y=@D{d(bMnB@FK9M+l?ItO z+*Nh7s-QQ=4m;(5`$IC`S|Ia%wgYV~wd1@hQ-1UPENqJD$U0?p1rsgL8E!D;t)f0Z zra;A^P-tJ?a|xc~UEry;g4r_g2?9VPFE7iQh5fZkC(wo(AITE87E^J$=A9ffrfRRQ z#1pL}gd`2O0sA~Kv-b{UQ8{mdffew29{_wPN#viw-2-9(?(Xp20*w&Fe=OU309~uz zx87hn8<4V2!3iGRAp2O%q?fE2I~HG8jfJuTguHKU1{br@Cq8||?!{b?6qr6j7hi}GQ+t>ukU?#xPssv2 z+A_tnfBvv7xv^<9_y0uP>(Bj$whuY`9T5ECNDbT$`y35T6CYBhCju*dGubO(6;XECUKlG%hQ5=dUy>;lkegWkW%_`QfdO9kDMN_CY+hj0#i6+|X34wD zQVfgv&Y^>ZG`7O_!thEQ)ES}$qm6#Hy5Og|F}VKB(U)i z4L*eZLwDdTOf7itZ2sX}1g)+QyXy%g&>vn2C#IxX1g&CE$H!w3B05ar*G|jArh0Wm zN>2K|^U6U6(XeLDai-|{$5A=VUm}E6 zjx`zU_(#Z$3XWS&7rC|f?l;x2X)Hps)}OlYL(7?N%VhMBHh-RvVh79oT%Py{L#~J1 z8^7<7*KVJ+CoDo8EWOWW>Wv@geG+JEY5yu*W%AhAwhJ*0(jVL<2}Oxl=x$FVW#Da= z;31ZaQrefMvL9qC;fDWYVHC1qwlt7x*cEr-bZyZn!$X^9aE6v> zWv2{TyiN)+qYP~k2*BUJv#QKPZDmN*DfOWlNe;CvtbbOVlDMy?bhYcMIW%W~eqjln zizaDyksr$GIV*LL*EBH8)?d9~P^GfF#jtL8ue~PO2GNLYE|W&bcRaCV&V8aE;Bjls zp4`KvpX@Ag>OA+JRC%m*bSuBWtw71J`K$MynONRNN9x=`WIBP(FTphi2($yj>N?}t;Pn1i`Fm71WzoP_xQ^Cch#;6p_O(MZvD^tB0 zfmH{*R+?Wp1VnX~AD)JaRO&h^O#_TpY-uY@=@UEDe(8Kyeqlus4W8u^_Bx+~UA^IV zm-pdEJ#(96lIv+}ud#D2z4$0P8~W#)^Mi(gUhr3ff3D*8iwqO2FtkG@ZW^#_1q8_h9mEmeC#FlfW4f{QVibfEfj#GUNR9+xQ>0)goU1sVVT32P7G z4*yp;m8puWR7}%e4kFp0&Y=#2nz4t*{d&NS1_TA(-cLYK06+$iZwUb0AP!|Z9FEC7 z7bG^M86f^CF_dAM*#^I>Z=WuBhI~+*0bmc%HMj%sw2ka=EWXU~8_6E2SFE^#W-YlG6{c@CM+K3q?+AEkmydlZadEdP1bx{|&T|L|Ro|=q z@l$?TUpKmA1WvdPMlsYtPDtqEJq*rO6WTRQSb%vP(5 zRd8IZm+;7Vd7KXLe|q!;m=z)?GW=}vfnSUM`sQZL3FA*qWl2{-XfX1EUb&AqDX^8z}5 zmhGjTc`2XS$Og7&x-m7JScK%FuTDt2pPlP$&{E99pfd)9*U~MFe#;uqwG^|GFF#;G zQJ&=`pYm|k^(&emU%tif4BRaer*KW1lxWpGWt6|dQG?&_bQsl#-l_}uy~IKRLhA=> zo60kw{#{-+khGo3@i81H!=jHyQ0E+;_~Qw`8zpgFc93$>owVd?g}UTz9{bX9C@8?O zhTZ`yl>2HVl3$`*EMl?+8j_?t+mqGotOujLO54O`*Ggyqt@1nE8v+&Qz}?5dXE#bX z%R)|@umc3?(C-2pjVR@IkpuJtn=&Pga|ZsirntxuS4y+1|{3t$%nvF(TC$l)r+p8Vk<>Z#dQYK89ZrV0SIXzMZ zqRFzObC``SwW?;k^DmWRQ+-Mj4CO=5`TG($izm3LI<6%J8aQ8DCChg)2(I!*l9G=7 zbhpZ)mxPAL-C0oH6|>hP;?j*ZtS)G)Jc7zq+M*A(r=@Am7vIgL1g4qp3_zG{Xmx9y z2svG&9V5O#cJbggLT>XqXAYxw9xD>@t*GP%y)HyDxyfe#&8r^g^A#CVua&Y_D8bN` zICSiy#(88b-SMQZQv#pFH3N-*@&FS5yq2WFOy4&t4w;avXwKcDJyt(%;wWOwXFlS% zz%E=n_wrKOt-ru=hkN}^=)x@lj$%tO;0vZ(D-{QMdSJpxWq)6ZnA(==MST#ZQaRKo z#ZLoTuQ+^iikE$+78kjSvT;YU zyoE#!sUvjtbcIi{Fi3L&h5?tpW8zLk6jxr63oyTsSyNRQtpDBK-h!12MoP_uGm{UC zBk^s0J8x4@k7%xPkj=ySwfK)v$T{|t1G)u0;*~2E%EaD{8hKtqWKW)Q`3-SJObGH) z_BIrZO!PDMuJ*?2D$p>wAU?!Hd+8r?$k3FdQV=u4l$DiBI5}2{X9z_fwd>a|?NIJ# zC42RaK&=4un@Fd35)8L%6d4Es-QUnU1*SI=3uuaTNT`Gi^g=!mSOntajwjHZlmGfm zpTL$MJ41?s_16HTiDtZU0@`=tKAM+;S3=}o;%nrKsO{j{WK9HL(%21EVx#qo&+*k3 zJLWC=Sh6o52;a{yH+iKLqa?|J9#b7xT9}T`MMElQRM4bS!#-JnUfu1`ew4C}k^v8$1dGM$gd4~svP#8hS#6vmF@{BWE zdnH-X5cLFH(8wo35lSC_|9!8s3B3Jy>cYc6*q`lx0Mj*p7T^BLsxSk8n}W8N zhq3Ul6s%p*)o426--dQ<4e*W76S2K$BYd#P=ck|}vFz)oPCFncbR7**^zH6Xo)j2j zBbG^bT@v#ThZCFD##w4RlfV=?-ym_#*~{vlnE^f|6qXieO>KW(laVIwTxI?rY41f2 zu{K8=90rhk2 z)cwmMPIhtk{R$V7no+!i#tSInkBJ#I< zk#reL3k%yAEEYptj;2q^XEa1w9ya$PsD=D%nOkUGWy)^iNxTvw;iMXd=eyct*?e=1x7GCRG zRJ!6|m6{N0&s0oY|JdZvKo*~pvE1~tOBpqmNmSYN~5F#N?e%LvEv3S_6@nZ&fogVIHf&( zG>I)2oY%X(`1w06|6C0nu@vgDty!74A90g^OYhsw#gtF($yM>hYBR!q#^G`;%&rpN z<9V`Bnj~i~|5hz?e25xn`1%Jx15uICvX`|21sq?;GFfzQ#xzXhB5t+TKsCIl2F^?- z=<_Np14xB=D{VnG0RW$HzDfqOUxLkG4|mMgOfM}&wD>1w%zpTj24N7Z-TH9a431c9442>U%kKdQe0@Q5Xhy% ziO*mUq&8-v5Fw8HvD1JT^f55J0fREyAq(pihB(!9Vb^)Mr59G|Q~XCnn9F2i4cVAo zI`}9a90&~TRgv%!%0rfGP~|6Q=LDiUcbAWGmm4Q1cHOK%gWI%x3N{CO#78|SroGqi zEr(uHZa*ABN_&EN@64<JG?-ethN)&Vx2HNTil_^?gf`O&&T86N~)8%pfOXXyzCFGd{bS)^`Bb1CTIz zuZg7iR-7x7Q_>uq++6cuQK$zd9npq~cP>uJ6OJP;Y)^ZsemF9`30n^AA`GDBn+_EcNJ2K4=9}wbz%*QQal+z0007Gbjm4)TkPhG}M^&btgE^u)m zU0tt9Y*DJ-Pryi@q5Zte4RIWFl=++%Wgw%kSpDbhEKwhMK5<_*fG6QY$;M>He|;=6 z(8a_1EOZYZz)Dk%Q!Pwabk1fSxU+Mq8{18Y0RM;a&G6(O;=kmI0zSjG6S-l8pH1D^ z602e`A4bi8KW@v8pb?6U3yKyUEj|+@wCZp^ByQ4oLW0<%;)A% zcNgDYq$||!JIGZgiMDCByfaY~v~YZ{Vbp*v?CxIw!M?+xsM**b|HaI>g~|RAC+MG9 za!;wl!s-X+C(2f+>iqRuRnJGp&UXvm$|B+OKX#m7DQxK9<9wo|DL%o zDd#&+7M@=~^B7%G1!eXgwlS0BxR~5=vQTXNN6nJkXT>145~QDh_hT@P-1*2MIlTT^2LOXQeE& z7>yU6v$db1&&RfSCDFeN93I|OSR^#%&$tgFo_1P0!N+_G*kjF2H)fVVoaYLYZ9ePz z;Gng%WMJHW{^yU_av%&;6ci-%Q+st(nHp9vBIahUvkNtiHG03Uy+n?nl~XXW3GCH0 z#64B3Kz7Tj`#_^#Q0U3EgUp2L{5kvyqKyt80($%UcPrUEFqWWu5$ZEs#DY)DKHL+~ z`aFr`Pa{ESdGA4LI93bPd~E;hY+?Zu{@p+T2?QGJ4`t>HI4wllx)jkjG*e{nI;0~g zD%In;y_q(J!z~W*_J&O2dc%+Q_q&nyvVFOMef0MAmBcaeq##6%=lTfy(f<;SgV-r^ z4Q~kvO8!S2@J{z>F~Y*KKl&cVaP|LDpum4;otV14w-@FsN%0|r>;}Ie?)i$Mog$kM z+QR?&p|8etArK3UaJf`aPH}1sXJi=+V4c}q-^%*V&hd0oFh1VAnuKR&gLp9CU!t!M zjpDhFE>dd=Uw9%z!iTfpTD3v6n%;)cf>n)!A*yPLkOMhm%gkd7>OXNX0Ob4rjzk8- zZ2bq1af{Ps-hAe8gu2{zMhrjUXiyv8POgh4BxlIk`ULHLA+wwQH_J6s3*GO6mZ~!f z0)J|$Cl=RdLg70NK^Ic$XM-me`^=M#WM<~;@JIU8yUU}K>f_vFcvRpG_-x~jpecaL zSM%Q+7!iXYpb(NFknMYQ_cP&+g$ zE^5IUOqSH%n+bUjPGFOI`QfnOz}oY2NkV)l)Yx;VsLswwtwfg$IK)pFd&U#LB>14v zK7WG~CrRSr{kUze-sdn>tz33o%8Y4#u4g z)|1jM#2dO&JV{q?sOZWPu!gluRkIFY;z!zhrc!JECuQSs+id0YPNDTcaei;fCf|I7 zPQPPsB8gYaJGl=Z&j5G-Agy?Yr%h>S3SX;+wl#72=NL9kfrE{a;Nd|S<(}AUhlqeQ zc4=WVt9)5iSo>?aunY8oUP?ZalE>KN(923kE}qJk_^)B3AfG&{=D<*Fb<6Up*UbJi z)_E?EQufEJgf_1wWLFOjizFEi8D;pc=HFT@H9d@6L?um>D2ctLH5;65w2UPYf8Opp z)hy1--&L0nv9jBoeIb(U74NqRhV1tGYGf+aTD3Dvf8jP9=ieC36f|ZVKX0_KguJ83HL_WN$hvrRIj@1&2} zXzOHpKqrZ&yQ9!H>!6e92%;_EcY~ye^WPcPKDO0EGZ9m1ua#fuT0F7qEv!;ALs21b zM{vVke~xbTnu@(Dl)x_3@AU7RHORJ7l~0kt=Gd0Ii!PyA0%jU_okTwA!|ZyTWth)c}CdSmWd z7BYAoUG<>V9g0;6N>xu!?eDIgKs;tyQ@cYN2?b>$?u>e<;QHYX_=rXkm(4TEkmbER z1I4~MoGBbE@%X&p5&M}f4iC+s1;Cy_xF0x2L}J?p=HPQ9hlz*AeUmZmhJortu)Fq$ zibvx9@*0U*n1m^G<$ya}O!+-b!CQpzgT(by-X^j+g^&V{p14@(?Jj8X*>i~!0a;zC zIU$kmB`y{h8#}+C?7t9sPr#2_b3a|~M1)Aarzi>i3V}fOiM1!R>rEl3Tj!oZOnsn?TJ`%5Xsk-s zo$;ZFqi0OfATFbLQ)_)9<{MVLh+;xqg0q;(i5yn0?Hr0ZRCX(9qK+V4wV(+6ZGm|h z#1qPO^fRzAGzMk`*S^8^hHU&qK7bnAOX!<&n^!Sj(!+9h_e8M6`KY|We?V352TtE| z1%tRIfno;)F++QMrR1Fj<;7zD0rUHT-%ngHPiwClf+KBz?0jReK|2pr)Ure~9=?Wo z{0uBi0N87?GwKx+W4*PDx4qVXLcmo3`>1b; znF~EnEka08epsO>IU0vxj?9|t=ob|$#@Pnw`Pqa$Pd-vk-;JsS_=?HXJ7c7(DatOw z;WGj8M=)jojQDm9=Egq@eZy>XPb2t4*WAyBYdOgJ3AGhtoeqGWeXHPUl4-r>yUgf@ zTcPm5K9T8Yfa7BGp!rUYg>2P=^+f*qBKGw?^Uq;ca7!JTkMmmD?r9yeG~Ch%ET77{ zq_s)1^|dQ8JE!^NU-7mu40J{++wiP^ZfWvdwnm5D>xSmX)Jt-2D;JC?{wB#B_r~I6 zWHirX&SGn9y0tJ5dr#qpWvh|3OS4N&yR=1Z4 zCOOY4$^jl&Y=ONJ$eOh4+oKwZ7~%A>kvUj1zrG_iL9O80CYt=sx#5%?vIbRd3L|DK z>(;}ER^$>f>+>qk_Y|-z3b~7nxbWLn;?*2JRBGswln;6=$?{dG(`vS>RkKlKHr%zl z5{0{`Wz$ReRrPqT{(bOYUTGVnA<531mZtQ%w#}%e>~{iMN+^fV*=t`N`je=JU2=I+ z<%p+RsgI#t1z^%y+G_hlCU{qaq5maLC=PFamuI$lznVIO=umuhgX1uC^}D!mWuwJC zmlNACt6id5| zzsg}MD#wE2E1>jT+c`Z&^^Jp_1alC$VKiwRZ@}><^#Xs9dh`}-R@NxOaDh-yg(!i7 zU|0r>#2^4Xh{#{Db-m`dBWGgqM)Dnpryl zzg>g~%{^MIL`QTQr3jB6HtJ)7T85q(MIhFg;Nk5pUxro00^S^{h3%vu8c$**4|mZ- z1#n#^q`ilsHU^1q$XlGKM3HaOV4bMyG8f4Ec}O-;6DqlB0&E{YIugD(5NwhQ45>`!kG5YH5PXX%?lGKYieqwq@ag z^(;A{7bw`!+;}id07HrjLb67cr_CBTI+lMDeM&?0KI5zqgm$z&14>k}^ZWNT8=s@0 zHZj-M)-b>K=(4OK^g|TMr;hoAgl;4aJwlceOxSjW22T%e3f0m)H^MFyZ|>=af-yi7 zFO(=K!08ZHKzofcrKgRTQx5zNDr@-@|Ngx{e|@>{d3`$h3O2dxKYyl5UUNA5@c%1R zsy+cS7X~i$Q+mh*JB!o2F4D9))k!J;+7rEN=7^)Jm!*L6RI~e+H6PLzz8R7>tAp@) zJzXB7NnpVr#T~Adc{Oj#pp8Gb0awPQeV2!^No!r=WoC`QSER#%^1eIMwS5l#1HMIxiY!eblpi8ZNRZbk|K5JIi8W#} z6P;gi-`tfCNGmFrL}K@nOE7dq*dJN4>>r!c&gjlk3NeGmRFn^|Xnu0KrBy^Jh#xQO zmEu|sxl~?TwH}(6Uvw1-?6rmQB!2bX>*3YvZgm-a?1856d%zd zeNfjI-cD@dMiBiPEkfKkaWR^Y{q#3pkvw^>OCvHQp4(zyWk60N?zhg^tg1&ecI^B4 z%0T-czbTmD_SM6=FB@oAO3jizWvlk)y=fqNJucZf-rF_%$3+)dWXdJTAxNj`$5(GnpEJNEkz_SJWP6B|Q`LNVGSfz}P75hKB)v zN^ef?B%=%h^dZpu0Qb)46MtXd-EnUdPY4X?)eukbt(DD}P-J^Ws#Gu#hiSnSu}6^0X9xrswndrWPRA;0|khNYoJrV zJvVvZ5pFQD#Ta6a;YB(so)|U{f>=*yCyJ2OEg;u`DY0Kx{HNHm7`E%oEt-4CjOcYD z%EvdPq>)uys1&vG1?*6rx)U{g4}@%eJHLRmRN4+=N+L7ui4=>@Aq*KE5tmux>*H&0 z49Tw|^xK}X1OeOE(cCzL;=n!wYX(#!5>3<+TUDR8iBtn!epTeWi=>UrlT`_nknn7O zYhp0n3oA=Sn#Tz8Ii^hW;G0*(f2w0y8Lq3yEvcCx5`KWF5s}>#4m#V%j)nsmd;n4DBm2LJ{jtMPo$`KGIqE3oR^a$_T5YloF2p|t!CB31UyPS&b zFE}{;*g%>n5E~Y$MR0q_*#vl#{Yv7-fv&c;;mEBzR0iGxH~O4G{wdvWI>VUBzw(I2 zDi;nF@AbxJcK7z+A_@VxNlAiA%A-*DdWmolCeS=x)Zymc*gUP)FUK?c-YZ@1jnp2F zJtxiCBrS@bt>!nwF_)X^r2e(XWPM}XYK{I^^SiL&j-Hqi?SxGI&st_At7g)#<-K`y zD{m}{&la_D9^7HTRDp|b&I_NrVx+ezxkY50bbn!4jPVVSx89(tC8S)wc;uzU4FaR^ zpA8ks*pX$sB)SE0&Xu~^dp#rC)#^0aUPFH-aR|KrWzUI$-GusVzUJqq_T6-439?2^ zeVm58@ll6`>ZSRH1XWozY<|FKlw7n$k8T=|b=2!Y`krsa8H6*lrI=kcq9B4q))2zJ z#esbeMxNcDm3i__*@qLw#rCX)&NPRb-;I&VDe&R!nUPi}C5~XFuV(fAoS_0%WMoJm zpNIF^s;*`XS0?rEn2{beBslHm6^imaIFM4=?azc*Q5j1rc1uYit?|~%e-%;^rA$_f zo;%tOM%9K~__2a>TRc`fH4B;z{8u{P^wSnOR4~vT(AgZ<5Tj>meV2?S@hgoh7?3pq44LSZ$G=k?SE$Vd_Qdxq_xP=Bi!|p2;m9kyI-I)rbT%h zxfyABCc$E5oBL;Dk9*iR^c7WO`IY?~6EEAWhHu4-x2fiL$7zzb8C^K7W$w-L;mVKx z6hBxE-&DcC2k}DBd@wRX$_>Fy5QO+sNsAAF4FEWq>xw)1{aUmSm9QOfdP^eZT1VA+6T;6{FMadmCdWeF6mP>>Z_ z3VIFmLPXv-etCYLxPLg6Tie{kVe$_M2yk{b>3x`-L_5+Rf$7#|8Eb_;WThA~;n;#* zX=>sUJBD>N_+lH82lw{%*GSfIZo06@l8YA6 z;otlC^iZ!#Lx4A2y1k*j9nK6+nk5!d5!J1tGV|0PWKxhNMur&f!Y;17Q%U~OIrw(c zg<1?lC?XszqF(Qk`;Gi&*r<$w{0&r?gNna{`~a{G@(T)5Q^syGbD%sshJU4XhQidn zF`q(~6AW{wnXZ5m0LCO?e*U-3q`bW)EW~cEE&AK6^6=jf)Jtq?&{$pMv;KlSAj$@> zM0(U~!=bH?6+sOK%5;Jlk~+Aa`kLC02&f7_i5nj~XQejvNFFf^o?1huWIu_Vfpz!p zY!&FC_x3FE>Z0x&<$8%-fJw^5MdC)Fe5x^t!@>n2xcg)~HwKCAz@^Z~RqXAs@`F+= zT030Qu%IB@e)M)haA&9Bosg^_Q2%kTb4h6U)P-!FZ)|LUyo}Y=9edq!F0{*{k$H}^ z33OY8{m9xtH-nK{ar%S0K4toA0$h^Og{uLqztuioD&~gItuT}8v!4tOft+N2AO0^? zWm9HuQhR6SZ}T9GK{5nh5SQEC(eYbE_5+~^-IOz*q(e@Q z6;d+awhz+9`-TEjB3VrDK>afxOPBbMuR-?>L7a5y(0h2CQR1ii8LX8R1=xE#z@Hb zZd&+dssnc{U&uOJfZm8tke23)F@n_zk6s?y@;{oCXUk50yBe*?HNvbpq)$#eQ5}=Nbq4n9(`7sU;)cR6VVuXOJ@qmxz?Y{9Sed-R;JIgR zf)Ylls=mUurAeh{I70lBLQdw8!a}BmvQ=XZm z^P}bGGr76ZDc{>l7b+;$8P>c1lt&^jxHbBtyVj+;>bK*t;y!iHaiH_2ofb+&s+cXY zj=+tHK8ekYGVbZR%Y&gz`z71u5YGNEkYR!$OYTiJU=v*!GcIzup6rKsU2ortqa}LN zHNz1@rL3*4av7fkGS68p%h_{k7m1r$OTIBne~~2OszTHsM1IpE)~Bt%R8)H{@7w z!~EuNAZ9{PQ{usb%|?MffQQi%%No&u{*I3B;_NJzhnYyAM&Ikn4CJ>FfUOnFLj21rej}tzIrC1O1IzO_i&A*6u00FP1x=lm z?7QSF{&?qf6vWs-QLeGj#6~QsC-hz!0YsNEJve(IOzz16TF$o*eSOdelqcI1+6)uN z!$=jU*bPYH{bPI>W@ub-+Sav_DET zM3>VyD<~*9K`oH_*Oo9-n8yfJZMA{ zw|`Fi;^y8j>C%Pqx|MNIOUVoL)9^~*oa zn$Ulx>vP_3`34-;ryBmaA?2v*XtH4BtY{ESZd^wG?&P`hQ&QE`ZqTU6IxjIST8mHV zcx*aDU-^wH1n=3JB+*(j{~(g#{!=N&y^htRzUNCWwXXh}`F4NVB7yFO}?M_I`6E8Dd#LxKz{BBxX!eI-Y4AQbl^ta-HLF)s3bLU?crotYLD zF2K$ToOVwxkhXvySyt}%e-(q07en_^-*;ZExxKx;sU(eR#jNV#Bh(=d7w@1j>oZso z*(2dGLrg=&;tCRi$E%P>ih7ni7+CRu{l=voj53%i_zK7m{aWo%C)W`gq#AM3P!51v zgPiw4J>QZeAT1CDwTsiGQCDjPbgX@ix@(=jg`>O(j}EX22ruv^yAils);zHGg9xxo zIn6Lv^W3s%VzHR0X|T^`e(mZ_)T3G&jN z^Kc?xAu)_Ep zWcV+NPd0Sa#!86wSGgLfMGs{3qVxDjPegFuOo1o&MBnmZ&SZrC@O;|k{2L7RF;|wu z7jUW(ga*99)^ve;_WSOWk`45r9x_tW4D{@44luxk@sxNzV&`FWe+FjIm<`6*J$l5f zN&2oB$0zk5E^y2RYAe7&F4CNqJxU8pC#)lGY5FEDM>tgn8mJ2J-xIi9Y=oj0Tr-H_ zidtH&J#uax9$Eu8#o-|$b#i-k29^x%gduK5p`u_X-T`s{B6zw$d&|pa^W-Y)F|B8r z+157&8$`%C3VLw0SU{W@EQpY=i$rl0lG1Jp6hG$ z^`x+cuhL8Jtj>OaWa+uVj`2jy7_pztRGLx)A~e{YrmMeilds)42xs1XAFm@S`Le=B zaHGRxOz}t+LB{eUJ~geWfYFpB1X_MKSKr^1ixfTR+(9C^EK@wk65413!R_`cybNZy zi5&f0o#hLTIIue|Gp(7%Bx&m)?3v>rtMTbHbv%a+9~gI1SXtdtwWnI%z6#A2Uz}_0 z>kuC|5Vpy_5@h#&TP?s!}By^ zhTF+8j^*w|FCK>=NIfjQf|>m^_H9E>iMywN6uT z=zZGaLi?NcR94+hN3l_SO58olBYLjqfCkpwVUEIzB`5nydrUA>@b=|aA~k|RRL?+g zal9-h{hqJ7HYMCX*hNvM@I3y4}Q)XOfDH5du-(q3yQd)gk=b-Bj4cj?5U4V2H z5WNSObpSv2{)7^vKnbi`(_x^z=KT8f!|>q#=(|veBvd1gf4rI5jU}sCO4R8jW z#K-XYCvO$0{!*kWxPp6b(Oz+A@01A#_>Jm5?k-QrSOM!&gL8N*oYBhWW;ub6j}KvV zbN_Auf+?i}Jl4$!^gkLO&ct!hUrJE|n*Xqkm(h3@3opCD4`YBkF^t!{XOk zTd@pShT=fp4bq_Si5E99bjej51RvfFG@o3j&7hy$u7v&#-R->m_-MkB@%#)#ufI`M zyc3_86OxhY37>j@Xj=Rk7${x^lY+8A{^L)=F(nh0N`GKDuZIbf@QD?Pe@h%ETR(8> z5znEnD2$y5&W-`EFaN-$1gQ4=Pnj}w?f5A&!hLpuLQwKk`8RwT1nQJRT-6k7d6oiL z^+GdUzz{9;&WXk3#ys2f7iD?-!1^_6U+`yVXAUq05aQ$GmvDDuVD}M|*U2bgaz3F7 z$ksH>#}Pq)*TwhfnBL0rwg6ru=qQIvQtYgGzk*}%`+OVb=|yodOZO_n%HE+Qj|}xq zOM+<1;SLuLz5(&8w|Akvx_Wn$e$&EOuWEGqd+NP^`hmpHkOZtc^e!-+f-=w6AxS_H zpQ;*}b^H_0VG-X>O7B}z@&JClDC|NH!*I_Mz z?p|eOW$9upk|ke}uqwyg#!*i{KR*yd#sZ)+;Hn6Xp8%ffqiIpn@T2KpvZq0%`SmRI zs_f|sEJtq$H#JQeYR&tp;3ExsG%y^x{$__^80PH@2?d&(ecGvpbMtVGkzVHPOIM}q znQT1osO~(sfPbvZR?!=RSuMZoSM|sD|Jq^Okf&Qm#5y`G^|j-nr0TP~LWgGCY*DLc zGxuzo(zAep?d{3ji#Ae4Rl9Zdvpt^Ixd9Y*w4Q*$5sN+EQa5anhlZICQf`jHaa3XJ z(YIQAM!gsRBJTBpn!;!ZW1*phzQB9V)ie}{PHukipF3(O5)m-o=4YYi;bEGw(y%Eb+x8l!wb_@iCgZvqLEAbjBjQ! z>)+a1F+LvIv&ybBvZ6Q$BmH2@zr3=Y6D~UCd(O=f=8^N4y2Xgl8kA$$UgRSq33}X| zqBFSTK62A12@^+)q1P4u5M1AsE)b=hH)pN)UNX8V1d$!j&s*(G$=<6NX13Cn`FnCL z;<9FSy?gZ27rgz7TW)=~pOxNKyQMePESr+Aer2v&g-CeJWNRf$UsG1ikdIgt;SZ-q z=NfNQd`XMXGbL7a*E8Z?y;fwxg{(e72O7m;&9I|+K zJo9@>MSTf=h{ow1brK!qmg@_M`(t>^9(q%^M0<{a{KrgXTK? zca;D9V2h5XfI)4fjE0vC=uvD(qn6B zvaL7X4mpfpZ;-S|hK~LQ+_A;M6DG0a;wLbzI2NyQD4-~jSas|#NbYd!b2vBB1$X58d z(?ifh8M8bHLFnEhLAzcBKAIDVfvi+9^vOsZh;VrlSsMZovQ3ctT*;y>gQLqCUp>==6 zG+!8XrD&F8G{*^kRs5XBNcA4`RhY~k)dJzS73Q2 z^5ao$!0-_==|rcE$hUL-9%lTp8mzp4T@c&oGjRqL0RX~-0Qqbt0U$>x#@)y@=DFk2 z0x3j9Ow2a^Jr8&{$CEdP^xvyMozPVE2Z%^d8GCJDBeEb|8ae zpVsw2bh5fmy`(xvtE@oXwK7P@1L0)=W}=#85knQg`V-nl(hTUAiQrzFYR3lGH!Sxz zfVj3Fp@ZG@f7{0&02k7vJ{ye_@n--vmsgS}r}t3rQuW7<@955X88K4IQkctSiBy?T z4A07M_YR`kCTIST91+9GY&w6(&!2CYbd2m-r)4C=XbQ#L>m3_!XR;sgbdS}$EAjo> z>LihuUyk0|`NeLOlt(+5J?OgjRHxA;sWwtOMt#8~{}WRyOJT@tVbBx9_9ZgF&Y+TO zx+s?`MuPkC%TaPii`#*7n|)dd22E`;O?m%WO{hIXLjm+KG z4~2^#An#O-t3k@a$=!_t*WJZ)oxYMKEa81tSLel5oUk(hnzpxj2Io~mX^W^wb>g@j=n+e?bv9Jzt_a+k-rh$N1^ z0p#PKgBK50^_kcUA=tV2$)X0+{WWYVS(^KEEmJRJIg+cA#%CphtO;S{3Cqhf5h&N| zOn86md-I}K-8@M000%Hi>zX)GQ#kHzUp~OF{V}v(jbbsugU!jdi0_Q9_2s`HnkiTO z55(4FLt$cQ^67JHqZ+WSNfs}7RA@%K&Bf}3V=Dhg(>X^~{(xKmWZSke*|zP;wmsEk z+qUf{Otw8~Cfk@ib-%y+zPGjNpH}Ov>YV31*!#03RROK7<@ab;y=2IrkA0zoRJCQ= zx{H8Qd(G0p;cz~^O5n%WkUk)XDhqv>)YmW{?4*+$mp-0|&3pc68YZqHYBr}_ir~(4 z?&+__v7msHM^Aw|&P8A?&&@V)`i6sT2k=C)a#_PLVQEyub)lzF;%ErY(D`NU`fM_} ze}bf);V|%wCd^RLVnBkycH|P~#K6V9K=`{5u!=n$J3Xyxsx(%wU$WgH3{T|szXq@q><_hvoPQy$)M(gq(;B%Nwc+<4~;b@z%UJpqcQ_4wDk)h z$Q9PQ(HJN~bkP78Yk7P4Lyrl&oAo)PCJ0+_5HzB5Li?k&%(V ze?5-;@5EsQka$qsQE0P@hJ9GVNVWt71W+@TXEB6BK$F8(txQB&GnOL72P))3*$wat zZ)V&!sYIlvkLzIMBR%P8b5zJr0Gpq1e#b6@C&j}XI`E6wp$T7w=Hjd__@-`5AU|t& zBoiEe6L?=4cvM`tqB7yEy5)uL+*(h@Sc}mCkFF^WHOI-9t z6{WYqtA*P2oon#llT)CbFm1ZgNAh$&jsMovDsS~$$xPv|=atZO5-^+YI{(Mkk`gYM zL+TY05CGa+piGl)0LIc8)yu|~7B?W08dWgq8W6nlFm)%?cKPY29ZP=OCW|F%%=v~V z{&I68GR%i|E0NK148+wwb43p8Km7hmi9j?4ov0a}H0ZNdLFV*f&IV*lmw73O1fQ%c z=`dp3a{*5q*!dLfSgO3dkzMC;Zrae@mfsf9IY2n8z8TY=lx&9NPu)?#_NizQjvvc- z9>^_i`JY(N3{0xvG~~w+kaXGgb!VvGPsl2D;(2(nv~AtbG$XiIomm z&{cLJccV+i=^lSazrV5a04cTL&buuwS3qYj$0OC!rM6(&22Y8Wb~b)_-_%?5A={EX*LFsY^7lOrrtb^KKhx<}V%~{u^ozStB5H4@zkDHUxwlGcm}c`ysWURE;0n;m z{8uFcNB^qM-5#B8Bi{pAgc_bu@X~kl^xn!;{no;f3jM`B!I_yX<V&GZ<_fR^ZDOhIE)s z`sBO2JTv)X`zKc6qvi>$zvhS+7U;y#k9Tx(6Ewf(gcegSgVj{u=M)Eo?NZ?S+bEyw zILf*}tpZbWDaguvj?zJ&tDH=D*=>Kxuyk757F2Z98%L&1vWR&I8e64Fsk56PsEsRS5 zi!Wh~wWryjJsdo?nXiw}Lgt!Pr~abdM~F7KanNZ@S-I$P`pzV(Efk;H_cBo~p%ivrc1hyUE+KK^#Zs^cfvJ(-)F5mNo7K|`%F=ElD7k*+JizYLo zo%7|)0F$hYd|3PN>5@zK=2uU#(`+5qN+2`(AI81X zzwizo);yLl@R4PAjHo)Eq&3)H5YH%UaR1j47(sqx1nBxLUZ>CEAJ}KvtL7@VU1KZl3i91s+v$td2r{ z^1I|NhOiHsVqwO#X(xB>?d==+$v;a|4t$q=AmWu<9G{T5Sc_{D&yxB%YS%n5ai=ng5D(?oz6m^?+@3ZS+s`l!DEO91W$v=6fn z+N;iZ@RB1M3U32E(c_EmNVdcK3U!Deq5ad9*)2b4Eit7~r8LY;?YcjolvT*OzarGE zj5;Uh?2A)&J1{*TnW^jyc|O_o%D`o7m=f@W>?xHO>)HjFXlb(eZK$ka;GXeJ*ZIPF zI#m9u)rQHnNQnK~I7p{!T;c_i=!@W6*3QuBmt=c*MRa4zvl4XcslUp#Ai&a9`?gUv zFVxnwl=)bwD19{`j@VbU%#msP+q4Xsm4koDC~YaHgv4K?lbOwrdbUKjM4y*mZVvZC z6}@)16rC3;#@FzOv#7%L3u2z)?B~qON1B(_Hl6pyg$8;+w%y;0+C^-(Db&T6y%bH? zXD$zRhcGMh)sB|w$B<1@Ek(6v#44%X(h*{mR!7H(A3dp>RA1*l=qceK%XP+T*2wIz zvaw&BnE0Vuu9q`gbqZlMWYYP6xYPR-GRY#8LRznH$m7LSl>{9wr_P>55@6h_NevViL-+FtBlovngs{cZn6SFEAq zqPs2mnN+I5wcZ-u!;@FIbJ>iCFVQT-Z>IESTfQ(E0Ukb(*U@I_(W6XbS*7(*xx3b7 z(Q#c7_`8JPt6-r+~p8|XL@`87O zFm;2jWK6f~QAiAG6QSJk0uD7I$AtuSj_EhmPJaj(5yhmDF?jqhb_je58H~|_Aw67K zFqOPonMHVAzW0mJ&nwT*0GkTdFV5oq$Y;KA!SN+5KWJ3wqM~>yJwNUfej>5__k9;- z)UV-ADN}8>?9!p`c~b(D7gtw{E`bF3qt-Hs2rN+CxN%YkM1%Rjd1Z7X%8ncr#wH8wINQ`_7Ir4`K4GVa3cl=DD-6Cy_9c8f$uv4UaRP5@+O!x@n=GYw$K}`ouV0k_`YTQvw`nIgKw5cXxw*2$`Kvy#+S&B>AgHdMX4Wrj%dM1=`kx#L)qe$CuIo@gudo#M=F- zF85JiP!LCH8i>vbbnkAJwV@F+cVDPc@5$zE(v;=SdZHTB)eUD|C&su6dRbEKQS<6> zh$Yvxnbfvk$}{I%7J82@I=TWiz8BqQb0?=I+yqc>h!0BjU#Qi3eDrT7L*gXf~4RA67E zoI}|XV~$=Cp^}B1`zn2y-jCFb0!h5=@lO`m`TKDPrUJg`wMQCmipig8Z}H-tD7igT zDl(EhZp$0gtqEss0_i&fFVMSGk>oSGQ(3`6IfRHxiltBwG z%!oa0Wo%kb+E}j^;xbcRJ>fUKfgb{r700E>OmWWUuU9Apk4+wtt?2HPt#9Zzq(*{2 zZ4Jg|MQ;});P^EuPsH>X2^70D-roW&pO!AF^`KK-c{nZk2?gQ5)}+wEL79wxxiA7>7 z&xe!e;QN;v#bFn|SQ~TkBnRERQR{0`FAj80x={&T%a&?0VHc0f)V%s&tg8@1V})F2 zC}e)%?=&g}^w=mf&`5@V2G=TjW}25}Fs(!I3D*&&G{Y?ZK+1f|!6p(pNr_6APVKJXCvAlst_a2}e=Y#tJ}k9TQ&fK<;h^PN&>Uok?rv^K%h%&6u)21-Wqc6_*{)6^dq zr|y%Y$dK*qQUFw_tIN~@rr4rQx8WDSQ~d)Qs1>A}*9XnE4ODN$8FA^%PL4}*t}F$X z<|kyunf{_QFY;#lf6uo=%041Bw|Kuu3N+UQES-)3RrnJrYEGtC^*tSg%)|aZg+I(4 z5WorG&$_YbbOEP(48%vDUR`c-&C1#1W4ZtfREZT#lB#if6NAVq=VLvgMb~vb^syVu zb@))x6pqJlCxF&p=Jki0*DI(_)Y*spBx@wqnS+(f9qq{A-_A~<@!k)<$2poIpb@*c z?q9%Z4ESZvI8^p-_{U%0$BuJwNsdVdEXhANB#014&Sa8#j-wv zgf#bPwTyDg!{%E0xx#BjpTj&{BtEQNEz-PE?o8$R-s+EjG$AD>Z{M9t_NAk81s$JV z*+w4X=gZ)#T;6D@iX|M$s4vHteKnpe(=M&f*FOa|yQx`xl*$YR^@l2!RxvJIFXqu@ z(IEe%#N57^_7L=1vURjgxv6J~-=C=YrfEyqaQ&15PxF`kd;Bu`2hm3fugT zeBp6?lNmYj^LtaBQC0nKKuh~z()w5J?P|RwM9kOwgFWM-wzo8=)8_c$or&IJyXaon zQh~;aKoRch^RfQ_v;dbYO!7j(3mvwsmz=sv#NSq!Ar1E~m6~``m{-=7GwYI>(p@IC z3ODsS2R*qW-Zg5m)EKWgm=E6->eMjZs~E)3w7S;U;jaUpIX>k@n&g$We(mcrXwv!Q z9wYnqT2a$16b>HtsNUx*zcWtwfN?%62N*Wy=jG)AB!+{+f=Y&hNc*`f4Du%CFOUCi zRWaWo4>5)B(gSsTAsuDlCdI9oCIP;KJD=dki*#*)te#roGowFQ9)h$fxHek6V%qy0 z1Zq_fBaH!KBR>yCl_a3-K?;E~h1i&a?1p!FSo*xL<_L+gU{rA8V8ncj-@i+%$k&%&stCqs7h%?{r%Cvqt=x1SQd)WN#NS690GIRDfQ51f{k3elk3IU#r(X(EZ6H0H|J{Wn+uFi*SSIbH zT6wyW9P>B!+^cEBxQU0+KxW`O)&~A%oDC?B7y@K2uCxF^{%H-J`(20EW(vigHI&E}!zM<_Tb|P@res6QsUa9;zj3BZeo6rSTU{7 zFMyR*9k-Fcn>8IHazT_d;KkY-LOG98lqn>03(CN+@rElFC`+yHG@N*UcnB3Svh;!Y zce@Y6{m(UF*7K!jaf~<6DgR)Fu()zpc^y7A)l!*3lzmSy84H2tONc-Pogxt-h186G z`FpD*()p%t1$bUqtHsh4XEhDtJ7d^1Bm4qbHq{7NS|fk6#rc_W43DPPvD$~%A3Alh zAl|kWU2ScA|BiH97B#KXp2oC-N&Bp%_9}H+C!FT4RX5Qot!6o9{~KDazp3dbsax3T z?GK}=Ly*hk=o9;TsYG;$KC*gHm;mA@;an@#AxF!+yi3ai{}nyy&Z2#u*CHykzKrf9 z`%HG+__q>yUTMni%pee@9UCOR_YG%?m1vw(Ce}F} zOULoT0G(XgNl(E+N`tWgaY#GrcNjl2NZN&S^EnWQY$~2RgmdT?_yIlHgYt3+NK^G2 zHv!v$Q5cjR>^DmF0RSuP&8&Kci`wSqaQ7nnE)!E$;bWK;#d#NSy}Yv?^S&%_i0TFG zlR=Ya^oWe44@1fjxNYbwFL0^U)?xYYl!VD=<>R1F0F`xH(PHe=*&cju0_Gjb1HE?V zER)DTtL+^SV7X*1Kn!v2e8;lGh7m-B(C^M&mLKqu)Ca{Fg~&Cuo9OpN00({ZTqn`u z8wWlhFh{ePGX>Y5G7S5-vA#|Q#a@XmrURxQoQkNb6{zp|4jUNy`v$@{er*5HRW?1R zrKRQj$9(}H$HKbtRQ&#LkBWi$!&}qfUi^@gVEc%jhf)xfW8~A5 zxkOejfQ=9s-~icrsVA6bDZHR*Nlf@f)!SDNQ5>CNKmGC35}`lXOXG{v_y+=lf=n4x zeIKvq|A8C;9cSl8)oeJ)S4ZG>0q`pTz4maC*?&P^&Dkte6Yayvhl7%RJPJ7vj2te2 zjz9`(8wL>?g6m~GLz4ENGY>}+>{q(~uLxau0_Jz1{d2xpu>Nlh<~X>Nw}NKH*(hhu zW}#p~khOsh8CYM>qC(^z8vg7lWq%&PhG;cxFi=`Y1C%EU;$72P+vn#sSyqiS0Rg~~ z`r!d`XI7i%z;_STOlgKQO4yoT%1l>8{Nl)VR1nxwrspgG$`J+XQZ1{XyRwWk$ek3K zu}t6QUcc9es0O6j*;$^|OhR1+H-UFR)u-+Qya}&=?DBvKNCf8Zw}G8}p7(v618i#G zXbXtwW|W3aJ-4Tm=3wv+6itPz0{1hCNN8!kwG8q^sca6h-i;8|7Hdjx!EgrM zd~uRG=u)jfuj*^`%(vo02PVCP@84ED)mhhBN-`+znWJjc4wv`(1SS&Qd&A9n-K+kb znaS=l7W1VwIku;{CO>L{yRC-JqBFFIomLu#Z5N!SP)U{x%PUVQ8-e-Nh28Z1-d$KI zr`n+UT~2mK1HWmlDmCjjoHo`aS&OLEQHpBA%zS!jA*UB#yyUN3lg(s$%F6U{=3sfsd<&wd+*Evpys zIc_$`^6`Tgcs?3ZtRNx|v`}Ng{M?V+@HC~EGwic~)bGi)dFwV%LA*g@(nSZYCk_KR$p2C zi&=0B;)*;a4A8W<$OO5&8Nss zrjeChBNN4HLPDnm;aG6?$ne%F4sdJ3Yp}ua7PD3|#J&PH*pX_u0@mjEamsL9O0DYV zNzVyzw*YEcNwoHchoSU6BYUW-Ecxn-@KI8Ybq;cl#C{2U3I!tC6FQ-=FZhGr7NiWO z^pJ@fH@X|xg#p~%I5Oh}r8SNq z+~yNb2GG6S;8hVUdM_eG3W_pIi{;f8!rx2>RFO#P9t+xgIfVo z$76%2G)Ja%25k3(%xe2Ra*Njxo|{{>cn-~av9j@1E_9nl^=^;0H4hKsQ&US}+a zQW||7#2Nv*PE&)lk$v5L>IgkXAqL&1EyQi`3_*fGY1NSL0=jjsT+D7TJ?0QyT`Y5~ zIOpZqAq%l9Pgw~CKY10?h{Yo?Z#p?GzFioh%Ia=jVl%OK?aWw)sN);!-{|s*(^mT_ z*0t@drtlEavxWo_A4|euJ+#^vy-pzK4>gNBQf#`!C^rCsApibtCYG_& z4s%xHz>hnDLRNS8*;!ba@~Iyw{3FSq5K;oXg8(;?0$~eUH?M5$?v3T0nRM;}N1 zsm~1j3vdt$mr_vVOu`MAGi+Cg6fhA@D|vpM&d*+Z@>AwUw+JL=4)2@9YLhpn9`_To z?l%QPa=P~Hx6?BVdR{s{e(LEkux%hJFiD~^^`kZzG?7aTSbi#N*{%1%v& z(#i&DE@k&iCJ-`2m>rv{_YEUA5e!LM4SdZcIoC5LdU+We#EBGvK#z*8&)IMbFs;-pYtZrf}JW?VDwn@=#BJ>EDRM$DDz-S1{?x-xL5 zz>;y^DONuNld@x~5RSz*Y-JF`$TG$^3ICG2h2d>Pzuq$MpQwVsDyxPr;sWoi20kF$ zj#p)~M@exdjv;Ht6VpPzIw(pSL(#^}YJ!LpW?6544sO3)QHR*ytG4qPq;X55&@A?j zib&F`$mlCUj&^?w)=XnHZRanm34-JiB29uGw=21(5NSljl(A(Swk!;v$n>Ys8N@9w zLw5@=V)C)DPsf*y_LrhkhC?hBS3|xN?$wd#I5w!Er(g{-2_3D8pms#29`KrbZ{#c`9Fucx$(q_eYF&ef{NR7oYIZpSKr z+Pn)(x{Gf;ZfI}s)osx5OPzB1oWJr1=T3iuIA)q|%?kZBxpR3j+xg3jPm@mJ95_>4 z+vcTnRQ$Hp*_Fu1GJo8h<9ctT z>w4v+5XQpCW_IK!^a&6+KK=r5*N?aB?;kJ6rcH%Yg{0+PU!Rti)DJ@W`Mj@1zs&}v zcPWj*&orI#;0rC0_uR(RKLQ*vpy?tJ4j@bz!%bk9xbW--P7Sx+)jGCgq~Z8^1jGUd z^0@atA3)5MpU~LYte?UJ8z8+m14(N1)ZoAS{cxaf$XqJ_S{oNi8-*?Q&(c52)CR|&q9VpSDq}pjqn;`3Z0oflB>Axm z8Z5VARF?Ws*!CyFS}$sB%=|1{PY^kdCX3;?gQF_K8{U3w_TxXVWI{l3qCZlH=A-Z; zVez~u;IqBk>T-gnWhwFMcR%mV;Nw^7KL2SJMi!GUOp3((`DJ2bu{&VA^!8%gpQMZb zQQpt*@i1~Kh~;T2qeoOipngtgYeYafdyPn<3u(Nb7ahC4<{?Si?4qH#gP1ac9A8W-W-oo%J&r6(d$JH~1{*6CnDh4sl4KV=SNHxp#7h@k!=~Nu0RP+NcsDQqP zQ@;F@rja4%ugBxB9Ui=Uf)v?>)<#ZfreM`@WQKhc;4zI9QYo9)Pe65m2?4tb;XJ5- z(&Rj9UeOzZHza}j-rjvz(w}LoAcwzlK++^iv+39Ygkju+LZl9El`)fgIAEy^fA{-l zA0-l0H`PK_i>K<-hQ0mkbtG>b)3CRuSYBNQH<3D@u}cJ6CY*o{nv{vl%euX2HCGON z|JR4p45z+ZZ$D4ZQAK3|N?_QVRKxVKU!owP-$SDG+J{GBl3A*pyQ_wm6XDR^NVH{+ zCcC$6*;NVkU~gw?M`)9JM3s3JlBdnVedJ3iYDzm^Lvy1Jy~=dssfNRKswdB4$z9<+ z5BP#TkHJcCJYM(fyolN|bie@?#0CkyQ5)TnZNZJ6GXovL;+wp{gU`pGH|yFdaXX_3 zt4uwQJj4ol(eGJ&^+n|nRP&8o0{_>I&isD}RbXZR`vF(0gj9;l55kWtr%1Enr#okO#g|ZQ45!S| z7i-U&2f{GZyc%u9on9BY-?#M8dW_v@#M!Y~zX;F?y;(2-?jSHPpSoAiW<>AD_wW#x zOV`Y3_jCpq1``|I2${!u;osX{pb&q}y480OqOr{%EXEww#Y3u~=iN+74@RleI=|a= zdcTZtBw`XC7eoMb)qrwsOYg?PaE$Qc_Wvcm1MdMgoa;~+nIQr-DU_K4IWs&iyS-vf zt$~@vy@SF$(8sl{A1%X^KhLhwI(`H&fLkM!HA|a4rYsQwO3l_Eg;9tVhjeo&p>h~ii-N((1 zFgd6z!{y1n6%ogrd7{t11`FH>R)r#PKx6pUqtlzl)oDe_dVs7OH?b|MxlfpvI-Wv) zC;ZrAZMvSr81`JuuBP7d>n2Xq)8AS&_~+LiNehu&Xf=2CT#&|q#z95@X$2Td=J{`M z6&96uym7VC9^}%4Uj~cR&Xr&eXTz-T!KGVr#zUcxquFfQcXRIy$~q5hINzSoyke$1 z^;ax%YUh-X)uY1&qAl5z1&SD*t|yR8C`T#Ve)dypv+G+?QsdDoK|n!2D!!>?F+fBW zS<4N?pEADP(W4`$6>}C+KqdkHZuQ1ru^s{|bbJ{%abWOmC!t_p!7+(oj4S=sk90k~v8ynIa?8+E5;HQ2x-lwp|t z@E5M;zG%p2d-?@6X;xUX^sdNYCeV13R2K8-55mUM(7*!J9h%VFm%r!Q?OUDxX*9eb z-gp|We+@-Y;_E@CVMK54d=?v{pU^&>uIBAh=c?xt4+C-AhKv|K3&<7IxN!ibsX>c@ zrKCQ4#&RuJ4-J7lTzQbsL`5{=HBEyj&=#&NfoGz!ssa8LuxRJ@l>|QSz)wm4VU+A7 z)ueUQfh(#OkBAh4A}($f!wAjRl!WNg{*xow9d`t4fZ|JXxn8y%h<+HFXMjt_XeqrO z9Ivo|P9rb4N1$#J^SA>!&$sX+RCle@FjR7_u|tn(nH94d1Pmv?yf!Z%T{{Wmq*zdY z*C1-NS5Xr|+8Kqu?CyebZVz>k)Z5ID6-{^b^bAWrA0ATm=KMVgp2EQ{q3r~6UdOb@ znfBt0`x#c%*izc}F;X<4*ib4(;u&{Y!&AZm;LeEY!u3O`2fnVZuE}Bh)BAnlE4=aL*IP#V} zR@8H9T|>fyJH;Odf%m_FIXRv9kI-P8sPIUx+jHTzn+YW#U_Kl<6SwBf0JvzsHaETg z#B)&!4HrvsH0u{ZyuIaUy(KA71?Hgw49W5(Un9#7yJDsJFSS?*nhgf!w`gqbV|ghW zv}{l-;umuXM?rs+aZ~%yq1 zu2;_mL9n+LBGIⅅSr3@REXVx;_bSL<=TbGG1dPaXt!J=>Xkm=#z-m`P5mSsB#d6 z<}|Yz9#=PGxG`kv^ox1|Tu6FzvqTL4bn7VjusTd2PG><>1iEe!Zv_Y>CR=?=kRl1| zM3-fI5EO{(x+PNi=+O_cc2>IF_%)qC0bBrXv^gRQcl^?GN+`x=`8R8{47r6Rb{ukE z*w0b(PP+c1@UgBRpNgJz9Lcij&5Xr=BCurxEc*{7Sm%h3S}yY|VdWiuZYr{ZE}ZGe zm08DUT**@@SrKH_!1M!kwV(+-r~>1X3$XRv36peaFPJhJbGP-ZPam)P6pS?T5c_Ey#mTqgtDrevSzqx9QgIIjj1-y|K3;t_bk<~ zK%p3=#vviK(glf`wnDc}K5HycfoEgZHmXM19wn&X0rnLipQt~>+DHAP^zbX_eo~)< za*((2Kops=yY!5Khl6kN&51w9qEwk<^^;8i~$< z5Lg)-)o6z_-ihWaMTzJj$$S)HYx)?y#H;t`XV`B^;tkn@L8itMat@rYjP$&W-{CeV ztwX>4BtCOp+1n}&njJ7^Ax>x^l{4u~VErOzm@Qkz3-4>Yi-)B-B+UPJkTrgiA71jH za6JNYd10wjV1ulo+6pSIxJ6wgXQiSRlEt0?ZXXnho%Rur$438c6ys5;YYqq_yYwXR zxVLS)n-62BQB{@Z36HgzVWN_0TRB)Z=fFpb5T8E&-Cp#190lu9n-Ak`Eaf${gr*&K z(N}~q6ss`!hg>m{OGz;GTIM^2kC6R{=fCe^&w{!f0F*7Iltvo^B z(D07s8Az{A7|X9((@bNyvf|lS3G<`h0S=-7<`PiI<%WesOU=oVU0$tu5FeU=o~RQO z%KuLbplV+GFXP;r1Mj|yNZNjcPp_^099#Q+d5 zGB^@=|Un?dBUchQP6-2d(31YJp z*o{S7`LqI$i=EtHMdc;Lnju?C?l5nVWQMtKwHe_^#0OQwI%QZ@jgUN%W$;W+iV^+H?Jp;Aa7bNdZCwKmql3>HbO*SXGU`zS z0ql~NQQ_Za+P zK`0Szl0KV6tFFG8&c+$zP2BUlvVb{`EVTtY9y6%-zQtJPR+l0|>8v^7h%ZAdKS-)k zo8nxIOp5bg4KC!k-kKU`z%E?kluUQHCPo^IBq>z0jPGCdI}x?>Do7cPHVpy_T)a9W zFkym)>jG{-%$uMpavXz&y}i+bOL_M-zq$NT7D?BY*1j9Qs*RoQ1)Nc2In;H_x$57$Ex zC_EfvA#&A!=VoVBRPG9*#oRG$ETY=wwMPJvr8bhPo&y)b%rU@FU=+i4y}dYeN2tl=n_D8q?2iPlqC8r-{LThuQW z2N8mM5DA>Xx9r7KY>|z`cv{q9-Ry=*f~?p~)}gMHmpvYJvRL z!AIB3&Pa-KW_5aT{#Q@kB9Pbq2&xFQkunp6ViXXLfujLF@-_;S%`faca`hW28ohvFThl zekqN^^fxNNjHI7De-Gz6cuw)tFkurSK0twC7VTjjh|X3L=S8@MrKunm04FP$mhj{Q zM-1QEX!3;QnH+Qn$kjk=2N5e{&qeSG?pl9NOilX7JJ7fsqW+qcKwnLDc46v1VAP$j zYy~%wS5Bhq`SbmSy|R*8&h{fE0LEwbFRz`x-&++PPX6iviSXUDP?f3ku8D{epIji= z(06l2)*5vY{%a^STREJ4Z>%Q?<3dcmttqQqeKos^a8sGuw>B~B5dsLU`BSV$iWcrY z0m9SPbGbVfza;vB1~nZ};=)Co^+YpD`MB$I%g(XMPVh4RkEBvQZ6fs&+uD*iSHy7q z<8AyD4=D!aov1|M1r6Vc^_xw5%XN&x#+h&f8&7PTB((!jQnd{oLkMByiG zWOe7&NJME4TSnf=$@(8`JA>9Ua_%qYKO!u^Ey$1Nf7@h36?yq|4gkUQKH+gx!@$mM zD)WH1)|udnSP}W)?oTW;O+O<^^Is@v%^5c^wkYQh_0R|N{@7wQV|4M~(h}sEb|@(l zY2)mi`&dr0u3(AA<}{=A16D~*h3m6n_B#5DOSno4Sb=0RopmO$vg9dZFVwRn1c{*M zz#dN5MH!joj(Y*nJHCvR_E>7VwB@bs_z-~}ra=^N4nJd$ZYrTCC8#Kn5z0&p4C z2lUPT+J1;dyFSPqxXv-_j`iqik^31v&+z$XiTONCM8^pzH^NUZ7HPQ^IxjyOg(1|y5GU?!H`s>`#}9$WwiBzu?6fk!L4}+%Y%f&vud4y`?(5s$$++4ZMi=NIY9=(WGMqLZt^>w={UHO zefmOOVU1dM#>cDbkm%gVNZ92d)P&ggVPE7aujQ}(Zfp{s-cxInqA|1cQPV{tRCLkC zwRWohkG_KVtt+-Kl+;}|6&xEI=VeiNrhx}|yL+Bc|B@_CUl`1Q@MIR)nG7XaCd_yh z>+602?90vofrnyoqeOy8__z_h+z>F#Frd4G63kZNi~kcn&qDsP_Gzn!kjGIIe2m78 zciIOe0O*Yjf}t2J^V=E3qd4M6PBFxXHWJA;c27(%KdCAT7+dGW9;5z|Y*eS=QnlbV zft*cBY4tk6l~9~GJOt_* zai9kZupwWra8nMe4-E$L(XuNrF_VFx2M&)qlRV1j&e`LXZ=5st;7Q(_= zOLil?GCSvM_&0Y$p?)XC+}s(GpYUXXHU>a_3 zrY}yMuylA5#Ms~}4vsF1=0l00&x^B;alcI@l&moU5`vozANOv-^|sTsv`56WSSer> z7`I!1j^x%x+t%6J9Ums$AV&ZkgqHQ-&)mZbTg(MEmOKIlx&wmlC|#jve9b-oX?bs^(u$nH#}BKBV$rLH;p;@l^@ zzEooezOg`q+7o^#D6A!#KOkS-W_CXwou^S@xw#?PHi`jgKLvJEq63+RCc|adX~SFS zVlH$YDUziE`I^fyHZZxOic6{9rT35CkfCd#wFzPNHMFq@NxqT@s8 zX9%pdapN(3v6kow6t!Sqr3D~`{GNBJG`VtNPsat3@ z4kKhpy^R^h-Auq7xVly=l<d=Pl&uQ3tVQY*2$94JBtQKVEHihocvCoNd+Lj>^C;pV!-`dJ7GmfA5v{% zFK1`m@adw|`I?W>B($M>1>U zEr{JD43TagyP%i}T)0|IDHv)XV0ER*8e&l@_7)nlaW&m8S6nYD%W-(h- zwXOx~QQvw?d^$t*H44YsAmxSk`#jwGx^5}&CT1(RomZG95;oVyq6=>Vl<-_pXSC%X zE0VJfQhrVX%`F*6uAFuIa8c0MJ$`Vb?te;0i*dfCnBS48pI75+WO`5qb6|mGJi5lz z?LrfHcatW<1W-cjwCF9kDr@lG@~nw6Y~7#{cg9#SGD*pzxP1pRW<5DIs$SN_OS=V0 z(ip99hcR#-;THI0+dwWT6E%eJ=^WP4uZgg6K3@GBLF&_<$K-~C_N&=F5X1dCuRMf} zbtnhEoU+YGGKO3h$!9ubu2=}9NsV1)Of{NlqS)g_#(T0_v;VcT|;+DcXxM}fOLbjfW#2eAf>c)OM`%PcXvsHphzPK z=)0fqd;Rzyu9?F*``oeCXF2MmywFX=H@v9%=mhCi^u*o43Ve~oi|ViJ+li}!|C!84 zEYQ_H?|v=Xrg^lCGEv+earOh@WZ#0&U0_92OP$a4%$LrMv#W1q&Vke8KJ>kxC^p6p zy~Ygx-P{l|lC&IQN{a!?Gm^@w{Aj;iP`@~kaOdY2kD0O)S14;+6eNMC{rZ8zz1ZNy zucOOCYbob5@$uRksVRd+xB*_>T^KmNQlz_3+XusU?Gyrvx-& zb)&)z@<;+XubiQpLc3B(!)!D*%I00+Lh*O0?1)R1CKRZo+pJqgxa?|Y_NU?(y&(#>otlxh`v z%TFa{ao=%uUKYewR9mH&e9sGhL*ioXAHUeJqo{9)FpALVyX>}kL@VtdJtwL&+MnrGoM4FYj;P1i=VZ#C?;wT?2|kSUn{y_P*u)*#xlSwS z_cW5o3jJql+#pC2(x&(wC}EK7@26W>*`3-)ddr!u%HHi{sAXNDw!XL>^7wqW@fyhK z`?m3v9m%R-8*~XZ7ct?XR9%>3L4;-L{TGKPWFL>ZEY6RPj!rk;4{+QiPsX+r%TL=$ z+JsX@62~Jwhf|feNGj3i4mNMNCBb>vDLNF+e4WuBW{LTu>+>lnd8M^ZMz&@QgceHz z@FRH-=s7ROFQW}dv*0m&YHxQoRa&JctJ>tjGBIb${%hNAA7rhX{&8Yr0tiB4-&lji z?J>$l+8Eg-)7VL>=2Sui#opm?LwGU0*)M z>8-pNiqQilvywnLo%wwZ@1pTd-OB!+@;=3Gj1??v;z3Q+TR^SE1b^76fyZEUpc2N2 zMXGrgi%P52%*py2E=OnbNMH=YElUyvtpS5<_WU;8AYSf}x_SwYt zchj)Vd=9*BP8cT1>ZT{5SAP)Ov%pKTOTrXeF79$$bj#lG|3<+fN(n*2$-fOUsg>t> zD$xBH50g)^6eLTf5ER-tTfgbs%Y4zqd-yfOKr@htr1I3Q4~JQz-xDY0LW_)$^_5E< zk67M<8Q!aFd>3A1H8mjtu05Xa8b||=B8)8}mpCImktrq81in6Y?oZHdYM?X!_=!y% zKjbP1F6&#cS>??5Y1KfW`lfg`LI7gVNHN^hQ%uLHowuyR)J6x7_97^fVsBT)YoL$q zK|7(Mw;Xj%{UE#)&5{@{VQiiw9hR+XYUb>wY6F|W=KLG(ACKFcDX&(={cdzA->|)* zO}$2h9ZrEpEkm#jk}Cbe*j@-<_ZNLyz|wRv{@#M%IC1k! zS~celJcUDC-})Lo6hiZ;#jiH-1r}7kg6X5AOVZ0LWs%oo-+3gDy`}Ss>e~!xl!2-IS?l@?HR4^}+0Y(M)NfK>kR|AHR;F zFahz!hDNH%8ZrDAYt6!4D$)3w`FC&hU2{>`i7|3b3UBm}UEVaAIKgMEfBxwk5{`Qn zM>ygo3i~Lo?__Ln4gX;&}##OC6!hB&#_S%C-^+J{HT)CLV0V6Us{gMCs!sD}K zi(*Tnidaj1qF)CkJ(VlNPXUb4VF%??bpR3c?L(M6J39l8tFUk?o@5R)iQRSFGr;KY zG_9E>+~3%GRCJsaq1uUzwb92R)5+KmbOeM6=T!8-VbUXQ`S9{WtCUtPe_o(gS)Ua- zs^}WJB&67I72I-v)3nxW;5+DZ0G#I+{j8MHeVFi=sTQG^5AMRnx&GWc=2)c))AX2x z@>Mw89;t5hyi`}%9&FzO!06+*fc@fvFy0;qmMGWAWXD$0h!ie43qauh7AFsQSz~Ax zJKH`BOdR2Aq8WNdg)Gie^x?`Lz?_w z=PC|5DFuriJY95|T2!=TQn+dMa7H(GIR<(?J`5{#0ZFyV(d@9Y{z)>Lj;Qfc_|PM| zTpk6y+j0fM_BdTKky%uFtdcmX_-PLvcc!IXGULnIu=vdN5IpoBrYsvR{p$h&bKgxq z63vX#<-YqRr(j3WD6JcW?o`JLNqSiH(PFZd#!R=1)ug+lWcyIVRj>Sa`9IATtJMYG zZ^F!!#wM@O553A!-Y`tBBNiC>i|y3|`EZjbLZjB^W`R8^UVH}pw3Ix+K}cFAjtEnhQ2JNX8F^^YhbW@38M8Se}Emv2U^10KwUc zK0Z}e<9(IRA=fwGi?F2jOMri|Z|WnGd~(Q~Jwagu#H+S7SKtanC%eu0vIErYUmwLc z3Ph7=__6-5-aFOMx{6a3U-liNVam(zK7e19&t^&^0!3V}p17$cA!p!lvT}*OiGo+U zZSQxa3WbU?$dKcwe9^Bm!2_w-rBHPDN4#VHprS%WoOpA;-y2%5?$&cMyJ|6Vbqtr1 z3V#)fa7)RIjF3ic4NAU~0VNz@B!BRAt~%(P42xV)uj&Nl!1~#jW0mAcY?Am7yB_x^ z3*~dI)Kywz`@?8&%t1}svBl|F_>l)r1xCbA7ah=MyW6aiVaOk8olx4twOJIbD1=^e z9;!=xD*lyrTJC~H_QYbOZ#3IQNL9?R!If5AT9#=+0e^mCeWW&k<NqE+|C2C;z_VyNp zWcZ6KeiY0B>=6kQC_)SW$|UuKF5)1lz@Yb8~S}Roykw|H|HowCE1LB!AgZQ zK!G~#Np#3wTKu?dJBjxJFZJ|#22mcG62;BQIZFuy!oq1F2Z^6?uOunQDUX&i_|lTQ zpkcF``zN;%FKK}LU=7|MY#UUKh)7GB8AFqX*DaF9YZ7B% z!O-R)3)^MPG7!BUM$YG8;^7k`BW1^hy8t$buoha*tqDzac9f%FF&K zmvksCOc8?NtS<2OW2TiF34Zv=$y1ssvoEhGQP4U+;V%dJqmeX(+Ebg!}7ohKm@`JntGoi5ThqghEv3VDGYf#iT8 z)_rgb7}OE^qh}6ljWnwpjIFXnj!LVBtII{BlB!4*5Aqyjy|`p{qr;m&Mfm6ipTL1p z0zH)`zHt^t!)=SvUqxhr?-e^2%UzaD#q?Z8CMRkZRlrM3%;e5WsmIE;j2@ulfdqN= zGHeWe;TwaVzMNpb3~U)fJ$ZWC%&;-XeCw9viy`*QuzF}PZ^`P5-K#P8{m2q)fFv;VLpu`x$C79?n2TyDV5@Ndg@eG~q| zR^@MwkXlJPp+cXl4E+2sbI>RmqcL%cRSaBeC#MaIQDhyuh+|mv-$@q^RF81kb_Lzb zti|~N4C3~ise~+yahEAxEcqX{uV|Q*+7EO;>JF}$&>&=u>5CvpYt%ppQ38;lFJ98P zXcA{)M6yPrre656&O?}yXe{3sAS};wj@+sE%5(~-rqrHjRk4Rd+-e5P{8#vGZ-?Y; zO!TzZ!V@o%s8C2v+&B@4jS$hJlGmXown4YoQ=)$kIywi`$+?P}TQ!i77H0$3ZFb*X z>W|GRp3)XbE0-`gD-1Bmj=9KxN$Z_7)zTjkC-8{Zy-#3x#iwU`Y`gDOzTr)*h*HN-*2!Cq(sSX10sk} zi^-b`r0G4NR50BK3>s*f=%O<}Pom@dbyvafQR2HO9Pf%)0R|oVW&cY^i)jkwkaouw z6(%wpYDM?aKn2&@12~$J6zMk?fp)Q|a#5LBNO+tUqoB{SV2Lko@zP&BOPyb`^p7K_ z@gb1q6TV=un(bP1_1T%`3!Zr01I~>TpE&sM|4XS36sEAw011aZejVl?C9`ph(A@{$ z|DP6sZ_B+kZH%FYR(qh&fg;q#?x$sW3|ndPNO^=SI`h7Cl>iZU3eD0q0TAGlJ<0{N zZYZoItmD;SDHQ9^rx&mM*nLuZL)slQ$~G%U6JN|OkDWgO4oc}ZlLHxL;>NVGNM;ME zpnGm8W(BqykcX|S-@F>dcjh9?KuLR9L#z?eTu`ZG1wI6Tf)Q2?@A;!y0o>rb%h^q0|V!5(BKKtU8Cbxu#8X}Xsu93Z z`~3h&j)@E|ah_A{2sdGR1C;B~ zr%M!$+6ECW*T+Fl9C*IQwQ*pmrO-WnJ?`LT)*oY|zOZNG#dN)R%muL!SfUtd@@gj_4>`zwb)6iBFP*YF;qrb81J8Nq#XmiwPf_C6&HsF9T7SJber%pLq6u&rG%g&epLBikD zu=|Q4$LXs3%`2v!$dP0j4N?$ZzKq>Jd1PD@{QRe7jZdoIapB@DM(Dr~r!XaK(uIjKBBu zGr7zZOQ)>ss+YVd+W_JUG@5h3E`v;9q>jamGONUsOYRD&E>}Mnj}cB zvMie{?!kMWV`wQzQF{P{2lk$QHe zXhc7XF==>XV)1=p3^mi5H9>+bay}V;EQvjUB{N8H_)F7+GQM>96o&V`P-?f{3R(C9 zgA~ui$D5Zsu;P0-`@~+f%t1&Rh4(0LFBxpvmYk)^Rlb^CYfu^q>5I=kElgDO)y0Vp zt}Z$QLV8dI!q~iQ2|*iVqJ)0n_3|8bED85Zb3^+bjS9q%CrO>dP~0}2i)XVJv#Mw< zda%>*(@glKoU86QtOLKoB6cY^CWKTO%nje4&T}oKRG-GD8s_31n8JPcIJ&ny&{4wNl{2+)cF}8QMAuKS!cvW z8M)RNVyp}pW6_gW^lIC}&_(;Sz75OSr)pp5u&Bdk0%v-)c!o#8V`|FY_+`RVm5MWC z;@?C5KN-fvC0edB-6GyHbPHNwS9P3bQ1z+ej@?~NBvm%%;$_5eO8v^98N5So`r6f| zVRgtB+WPZC+|9-t`hhL#3hXn#(`Gmax8;2zUF4q69`8)>Wx;JKhgU!LQMCIes!L2J zL8mi9pqMu$vfv^71mqivjRU*5&oq?8pXhhHM+zLB{7z%x<@>SX{2B*sqoy&`d}WHK zFuIJNavi>(!0XvDB)4?qzYPqG^Oa(l^APST99TaDW(ENJpVir8>hR==R6cMjBJLRT z%S+bgBy6mgQ#l?lFvgm-C=tyqE5JY6W?O&@xP2p<$5bqQE2E`>!KM}$X`S5atX+Z~ zE!W)YsMb>1+K7tjD*s+Zu~q%s+nw(^Q41?jE&p=D$3I|c6qOC$iU4Nf>-)}45_vi| z)r&o{*}t`Tc6uTG+q8_E>MMKCvUeTyIKhb#JerHp-CgJwVtDZUfS#2&S)tJJGW=T+ zvXlo56g}~X;pIKjl3+ zv0uKWJ8Uu#gqVJxp@VoJIreB~ikj^|&~oGJ*@)rNUurWF#0`tWcJE7!UT|W$S7RKE zCUhY08sNi)+R7kZ1?M*^!|0Bd_9m6Pp4fTWUi*>K@}V&(SiIS`wPHJf!>bhl%7c zKoZ`iX7?8r*htEJQZRPU>w>r-?({0Yi@o<2TvK|Gd|FHLEqt_QFP+wuf&V!m9hCRX z{nVlNzT~)<{Uh|JlE)`A!I5hDZR=rM&*7B_4i&Us;<0~&deLW;zVq)B z1KuY|ib*Gxu-+^_DW3#Yn}rM3eXDq>0t{U??H^ZjY1yYUWxJ8IlZI?`j~G8Nz)k9o znhldnMm3}xTNVp1qBwT@2OuN$1xdb9N?cE0(coC2clQZmp}#1{Ojz@rOeCBuxbN+Y z`Iac*JmS|;!<$5>yRRhPlo`O>AFZR=!YSDc_Kh?V8TH(Vv`4J5VI~mhj{O% zHFc)6f6v?hh8~82N)R-gpinS`ethSwjvf!8W8kj*9`B8`#xn3lVUJxKZlFfQh&*9Q_zKQMO%CV8?2?>|HEeQGjr%Al0Tzk zw{DQ-Bl1m-WQJ+*CF^&$we>mCgj~YH8kwXGCRVli2-CFr!a;8h&3^8p<1zGCRK)L# z(U<#j$$drhfK1L&?zsAG@cmdZD&eUC!cIHZz>tH_4QBbLdS@#v@%_S58-ghnGzdSg z+YN{qxW!Pf(MhU?8qlAAMNts(3J=Wqav_W*_N%$9B$lVKqMV#lO$Mrg`J#SqIsDVE zED^_r58OTX^BtJs_ohkSnYmMLVaPzDCHz7eP~MAHKG?1P$1s_nkRz#>BMoyBb2a$R zb#c5u@*XU+gunL1<=b3=ubDGdw!qr8(Wi|zaxRWEhjlBa_2Cj{q8)=kWBg^(b*|j3 zgUH4H2f`yW_2Ytkzk?mDc#&VFm#Q4O8DV#U3gLM@%<(3y@^h8im-LWr*l`Ht>b#h# zeoIX}C_Irzsgh5(Z*(oLRs;WEZ8q-}rInE*p%ME(TyDkAB6+^<;@N+p_Lbz98bQhd z{(6dG+ljlp`${vm`mC;)V?9X< z-y&j0+@e-^bV&z*{XDy6O)8P>{_F^qbM-~3_1YO)$2mD<#$Jl6w>t#n5 z@kE}AH)Lt2fhK13ohdL{DGzB$Tl2`7Fh+Xv0i}6M3%mE3wgvi(aPUyvrIfJj*NLR$ zFT89E69ayKNYzL-_!7Zy&)>*d{Yx(Fm`Nobqde`dypcJl_7kvmBL&QkrjGvzs=l@=3S8fhN0AWvC*!5tyz(HNJV@v z)g)3q1YZTSH_>GBC8E3nN`ZDA-mW9n8HD7FB!0-gNk{4DTTkbZF8I1oKM(8MF;Uo* z)TdvCC`gPvKr9S;p!20p=2&M0bJ`0>5t4YMZ-QV81+o@7L}hN_16z-$6iKkE2-g~l zPuyEf+eA3q4wzpcyP;S74D3>T4KH+)h=J8cGU7-m5xxqRTNjuW_IH5PYe&F+v0bSn zhU7!=P7z_jXj!o$^W6%r#f*M#H)xjs{&@9Imh0c;zEZj#$Vs%pe`+xPYAcqkQnH}M zLxYb4g|AySc4cEhV@Y0IPC$4VlW$#_>?rsv1)t;HIoXS$X9P)^#*H%{_URaO zIhd8dd{ZoPkTAvH-=Y76a9-CMzChYJIFLt@NNVzEc|UdK$lw1(l=`kWnWDW#j;EXt zb%URKjp@!f<7^uYX>D{nwiM$NpS#Ot0IWnyd&@loMG(41p&O)a)w(ftd_87+H9{R) z5Tz)vH@Bb@OHJ!V!Tij-w0s4e*fZcu~+G!h2gP{6Cz47fR`A5M?GzMgu`$kQes;d z8HQ^ko<_s$ftf=^#-lN-kt}LAQ=8{fZnika2(L+}5cFI*YM1KLi76a?gsO+xW6if; zot~-Cd?a9bo2JZtov)04^zVa5>XveVj6q+~(^Koxk6JX&D>b;^YOHG;B0KN-n88r6iSP>o;G}&xbnjelB#3>4~A!X8JYfuO+Ba;e* z`Eq_OCR)GY(9emw6BQ>tb%7eg)jIAB2R$%hX_Z9m)&5xWv0vK^vxHgBLQvQP**Sk; z%+i+#Gm5V^4sw`^H@O8(8@?(>yuxaW!UJ1aBs-R}a~_JOE)VRQYca{Q>F(k9KQrrP zmFENp z!+3Ce@mSj#it)S^dDR=pm?e>BGR2LW#MBCJr^zPD{Rff#(b35ZhE%SEaIpC{22p3I9 z4*a4pnk~J#@*=wP*p8X)7vm{5Px)>5Q1%Gy7ADsNmIM>!La zgBpx!5`}*&sbPfvdHxF~WYGh(ug$~PBvI9T4I={a%xn0yDd@ZDbKFY^S!GS3 zLLNnXaLBHgbKK&s!fe*r5){~gA>cPsy`*~XAkLc*?TO=3*uH(fKRH7189+Lyj+1A` z>nYKlGRF9u6_?4p&-}z*k>9BpQ?T$5+Q^*0qzUNCMj#TSw{Z85-TnKQO3g!2iqsu) zkPwXcGb+;l2rRWWdxvYD7z5_3FdbBR}y$tk9b>E+Eo{A@DFQDJQ6q z<(5s|KZmg^yCPlo-6TSGn}gN1NTE&qIl(J0`4&f zl1Z|$wNB$tg+aZY386+q?7>?|qbS2#9})HQOPcp5ziDJ@nl3VW{=(Rh_Pds^4S)N} zZ(k2Tfxn<6V0O=+QT^kK&dS&5#;hk=2L)AV!rGC&h>k6hB%#E4km!M5^bqfKO;l@-x78jnFD`COb*%*&Qde zda={s5@e^Do9)b3EB>6DnvYtyYX&XPWoCa$SQ}aW?6r(>Kg?*BcUZ#%^eyymYtS)z z)?~`zrwVBvwXlz)w#`F!woyp_Z+gGz2%kbzHd-j)_*5`i)3smT5J0d|BYjH-T`AMp zvB`2rvoIb8^*!3n096Q(ZG3LTFC2d>AEsM*epM}aEHo>4&y!PxlZxXDtbbr4eQ{52 z*tNdga17LV1xx8f45FDwdQ1k8{AvSLM=TFIoIvk$f7SD1N4t*(DM1z>fVnVDJo{(3+;_rpd; zIH$h9aOL>A_l7gQo;_(u!iCqDZY?E6-S?8lN`yr=2deOCcn$!r8^IQ1p1$~Jpn~(C zMjytwbA?0ne5y?3{Z+Dm4DaSdZ#JGE^x>k*@m?+vc^7ucerb1JKl8i92rFfa;vh^M z*K#UkH?Uz*oJ*3Bl(haSo~H>!Wrp8`xq%k1dDO4NZfshCV9TU}^#~XBuv-J+tw~12 zEDEzk^u^bN;QXKWYC3XC?U~5*!}p|0Gx18kdrpqf3Ztoqpl;I|&{%c52Px=1h=_>| z;1KaIa0cWfqwVe?JwJC}S0lgrC%y&5Kfoo)ER-wR{*|=JfYiwr-bQI9TUjaBN@tKTUA;04!71 z8^dLy9iSK_YINEI8Cb!=XPuZ-EW4cW=I^~JW6KFOUwx0I5~t6yYG_5Z3GM@crJXwnW~GdvB#l{kbc`1Hw{5iEh|>337c9s2bw(pt3q$-E)R6dq zPeK9ml-C~$yARLu;;kINkkl7QNHaAota!@_Bj@QspUtd}`Rw!pg3d%JN6ml0I4Anp zVPhKur%mLnS51@2gXk*Uh=6=(@5FHB;cPF18dg3_IAL^|sen%2M0h(smsw92MzT#j^AM?Ow2TW8~gg`a@K$hLQQS(BA9l?04 zpnzFy7^`?LhLYe19rI?hVxzBrYb*!;2&P%t2p%U6o|WzZmMho4zFt}VnDkc8w8jTQ zf7G;N{ib_$Qf{+4f@JA&q=9OGhItsGEoNrl$4l;uCEbz-O1KUK^FKNDlv*XpCJVuK zBEw8DXab_aonb2M;9usR{3>)cnpUj=L&zFn6^qi-vlN@L=@Tmz7)E11uPF!h6Ry4g z=Og28;ksOQ!*k(Xq`&@5RWD*0szID&UG#4YeatrZdOFabR^af5Ov;J#{P5|27jF>^^6S37 zzDh0053JZLf}l419jM5HuBd#|uh)Qs`K!M-VW@6QJ63*Oi2fEwcF9JtsDqwI(_qV)wR+Z6k4p z;;XTf_I!~P(LcXiv|vzSM+41^^mBSpefCG$y2uT~&4!dmYBRAV2PDcc(_+tJR$mir zs^Tka${fIn$WMQGC!Y)0$DKiXbwY`Y%w2%lKZ3uC156zs=% zaAviC9l04ja#;xB?#9~)RkoG!=6wHKhb04ZQJL)e?<1)$?ooL<6lMwWdenwM?1!-U zmw#^)IF(Y|C93R&3RixlJ7UMSPDSV^5m$#+C#Mt$h}GB>MmJ<-Ulj4eR+-f`LQ`*& z>IVwK-q1J!87vlN${JnNzs-~D|I-4*o014H3V1eZy0EX0MhZ1z$8_>QQppVP*;^7_ zeeP5k^f#frycz9?ORKrie=<~F?$w%2 z2{(z8dy5+YFa(Glgoil9nufIfvG#JXi9bV4cM%CYK~rNI?Y)YSpvN#ZrghVVs}+p( zoH&_u4?@O&PnVIR(B^11VzE&T3te!Kf$192cq*r4p0iTAnnbQ*+Me=Qy`X!C;x&gc z>D8tkMqp)*uI#KxluYa_rO~`iFkM9c*v%+AziX;CCK*nt@)O(MDPe4J*n>_Ta+013 z1kF#*!jJazXjiS)QC|*@C8yOgr{ohp;1{66%<9>zVNcUD0ATTh&aGycK@W>1owVXw za5zT3Osp|EeagfGH*!3;f(%1cl6Rt|6odDPpC;raMf}Y@BFxQ7b`M#8X>}h zxG6s7_sv!egsa7p{XhFa1tEd-?Jbz3v_5H{gUfm1gO0^6->ikmr>fp8Rki4A@%cBx z=HG%q8u~cyX5Z(KSD`oSTyK>viQ-_#bXEVcrVm@Gzu|)zU!AlDaaq>b=`C(9YQWmg z5B*E}B&k#xRm!q5v(B4RLfDg_pj5-YR?#UUFs6qdr!C{uZtPKR4yv;IH}fi}Ycj&{vY;6__k zH@-;@vnMY&XA9ha32)uDcmT- zYu1>tVsOaMoEcDmM4c%j{({f@aR_G4MB=7c{+>a>a;U!vAHKigdVW(o~%Pe{~61gZhF>EDe&B)!YwMhBM6`cPD+v;B8h4 z0*FxpF2u_xT!V+HkwcjRbG*7N7Q)qw9qE94h?CC^)0+9Fk%D|UqkDd`FX)6gb|f&$vKk`c&O$tNDZm4As=?Y6zyRC;*_Gdve) zX^i$kc*LJss{bN3x)(G%i;tHT37E9eAblUWh&ibpAV9TAxZKkFESy-w#wJ5 zd`Q!Qqk)F0BNaL}u{U(7deeO#68HgcJ51P2$uiMtFQk3UrpyKz^{07jvz5ik#|oxJ zb~{!FG@cnL!Wg;_li_4=aVb)GvS`p%ZNg@v{8*`pQfCPDbP=7{O4#XCA1kupr%pP) zEcG_rnV&P^4wCsDCd*eaZ}%gUNhPyu7sna)8L}t=94b6;yF_n?{H$AJ@zl!8>t08G zkL&-K=*E6@?J7qc|Bi$)00j{8ZFq;mmlZmG_^qnp$?H~po@T%G$*=JiHfv2sNDmu; z^7_6a-q86&?j2xUWQ&dyCCi4d5=AR#EpNTu>|j?ruuJHQw`_7yzF$L%b5M0T3irsq zreJ+G`J+PD7OucJFsmAS)!0|}BPSnD?+Wy8$o7$#o0mHPKH-MYgiOjL(E&e`AT|{N z3ZIqGvK)IX-3HULuyXjQpOVe3FCwCyUYbdCX~G(n1WzMHDea1+hNuGRLrWqn?i4-9ht0OayGZHxO;rAuC4~ks6St5{o;j} zEzRfu6OEP5W8nLETPhaE{rU^YEr7~(VU33%r{7jQ1OWVUFHxfWIufa523|_|DhJ_t z5EXUt1@chnZT>HX6ErJfS-$uo`J{&aW4Ikgn3_O$Ws4`wK})4Y?`R9@^%p0)8PYCo z6U8P|<^$29w0~&i)qdD;Qk1+aQ~x*vG*zO=1t2Zi+E%hH1eN2dpg(G%Hwdz&|R<{@EKP{D3vxPW1$tb*l;d0cg z1wke!?xe9-IiEv9xuG;~!BF0ft2laq@Ko*QD)HRbe?qC*^l<-vgJt?mI>eylO z;SRfCwtvT#^~6kA7(Qyp4nsLM;W)?E@v*}jCR7~9_IkPu@ow3)__lcpmhCmi-8~y& z3SIhd@TI!n-Y6DM_P)bOJ87kUz40kGchbHI49{M($RWt_FsIy`&S9djx52|hqKvq~ zaE<;9GgFz1=k_PNTKw9pwJ#jnmp=$cN#kgZP{hoz3bo0m{hD(u9k2*y=N617H7v}e z&$W!Kvt&#nt%L{Y)$9F!m3Cb;7_$RNL%_G(u7)iXjOU!39Pr+H04F4vm8DOtfeE+S z0tC9g%_AV00=M=uE`;*HcvQuCni0|8;svT#6btEuur%p zRhMJyMn2d)fKycBz|Xjtq}RJ_5%@m`D9lXra&v*XC7Jp4SjA+CB?|)LPckYMFJX`m z9~2VOZN>?vi3&5v-bpWMKGhDo3}BB=YJZ_r5MEV{(#zp_jm2+Gle)*7TjVlqW=s5h z$jxIfj;ZL(nfX5K-%PY8H_yd+iAe~R-d8ubmy0EFv(o*xFZGHJ$&~LAtS-rgAwj}p zfuzEi`IVE8=cAd*NoabAW?s9hTkm&!CDCy#{axaXF(&5Kjkn~nY}9R}^-DzY$59Xx z*S5(_JW_{il=wvGgXTmN_3^S^To{c_{GCUAVuKAbPbF5wG>`Wik0kI+eiN)7{_>7d z;`c_XvO0?YZ61l;MQV9cPVA>^|1$G0mJ^4K3nx3Y-VMeceB}G@E$Uj0*{}MA4jRgT z{eCp=G&eU-?0)u`e%KvA$@OcTFUWSaFpiKBui);K-j!bJ97*t94D9;l*YOQqL!lG8 zsisSp?@n#Yimz*yD{!j;ha5*yOc)`wyM|&mft;LfUG>hs(|iLUx+x?^E&c)g3Nvfs zok{eR@=jM^|i19$iB-GegiJ-SFsa6BLZX2z4GgbITwx%bY0i%W zSJjICFEupFm%U1bRYk?-2Rsdw$SLykqlyilh^VpN>=9~sDVwvr&j>{ipIzWxk|Kh5 zm1;`JQro(FlgjY3=(;miyaQ6fGW|xnh%th})iN_&EyHI#Wqu6-s#3-Bh4$`ls?bMp znJ=fQ>~>}T{``sQV$H3F9~B)U+x`VP_xh#b*K-e^LMNDCHa}-=_1sM%Ogo_PJ<@|K z-YI3h7*(PoxVL3xLID--9LZu`KJVZeGx(|?QML!!^tPrR$>_GCE7|Jh#|GUDF4f9B z9Y$21Z{xNPL-=PWCuj&B#)H0y`dJZuz1e$7+|TkI;!~A#Z1qz58=E&e*MBWSRWfh!+Gn4litGgq;EF2_|guoOq3llcCu0d!C^|di|5pocq`xj zb~?R2p6YZW>%yqw8w15wp zrQXc@C5#4Vc<=A02x84qVN@M@t#WVNhz(^mP3krDpZx!AmYuMFK*@C;ue8rRgni`R z5#akAV$$C*#Y7U#&gA54E4(9*FKPcCka#J+5`>hdQuHW{w)YK)U;Q=U z>ezwCDNi$+vra^$%HpD)y%<%|k~0ZJxo&T5?IOm;6$}_Cg?f6X>~j}a%qZ!x2G72w zKwUF#wUU3IO1Ay0GaKg7udDq0^l;79^W^32y>RAtD-eAvQG+RqquFNu?Z<8B?K^H8 zsp)!fB|s?HrT)JB?{I(G0BUIPh7En%r{)j-N;a^9 zMf}W84qivVl8l4l?JjQuHu`7|Aq{+@=3bp6Qv2eas&z6RnPH3c#F%$Fn?O1NX3D3l zXMS$-`LXt&bSHHQ^$fQOkyWN+v$p&v=$O3ijQu+jND0n%J?PkJnrxOce`L}0kU zIj3k@cO(U5DwbyhC|T`}VxqQqKl2ZD0eYV07>&rvmgcrhD~Z@J)P?+bm5)5eth;Wh z0+1Xs`Fx0qgZD?ZE$x@x{eOy(t89^!m!;ia~_@r{P zDuyL#;y<8|mF!iC5WxRw5Sa)WV}#qW>Qhlmhwi=ys2Czt^Xg)=aSO%F?B({;`Lx~M z4md3`eD-~Vep{2sYpK3bcQ!b5jY9*CssZ*@bRE~o&^HIbeWs86$C2E6aa%?7L*>ZA z8$I>mVYCDWr=}QJefq-L?!3!w(l2Qg!+P2uY^jymP?<9R-Jx(3B826a@cLbxGiaz4 zBI&u6qcM92&1I`UII?IX&c2?zqq{8W$L%-W67)g~mM4yM6j`ug?$~nY!9!oi3Hvi^_0R&jwp5?96Y?z2`>jn{r#`{l6O>}crr(t$Os{WzCwbNaJj9Rli{ z6CdEFuZZv`+(e}!^Lu9F4Nud*Fs#yMQG+=9yim(QPnb@MoBiD0JeBfsL-xB{AvM?1 z>P*PP71FWbeN1$z{8Dygx|v*I7qF^k z9pjGsbtH@y(A=`m$1y6EIN^wfaLL1)GeyB4*hTeK6UAUO3Zcz5%!|vmqH)B9V1wJ| z=BD5#sb$R-*MIFrv!fgCpGc~x zJ5|&>d{I=1(O*C1nQYK{gC5^S{~{qFxuJ1;5b-FYo^#0J(qD*>A1m}+J8I}DrJX!% zXZ^M$p?gJx6$!v{6?x^tovTsS>+vSN10d=~4|6`nPqR*E>bkCn(sa$J zPiJ-jU2rwme3$kZ*d>5o1O>B`tG_UOMC3jAO&>-@+HY^HVAd$p0;tBS5$m_mOGl=^Cr5rLG z6nuDTRR_VfZYzq+*1zSsBmo+_S4b?8)TycU@HDM`bZaE_n~E?7rU5jwL6UrFT~!<1 zB2nD3fv=KWG&S$S&ROF_*w|1?6L@%EWa?AO_407Xrg?mM9oF~%Xu9gCsQPFNA`L3t zDj^NhjVLMIAl;qP-QC^YT|;;00Fr`qw{%Lp-}l~n^9Ku9aA)q!y(jkBXKz_J zs;}}rQnXy3gLve=hHY2+QVgC{4frzXt%ki+o+TNrSK=#FY0B98CemEHGyQh8|KVfP zJq$HaFT*#f5PYAB8(A04z#jPTWArzqMmR1=y5YAd3W7y^Yl^L}p&x6PH4PS)qlgxH z)Z8L1IY@^}7=}8xu<@>?FzFuj(*hw2T?%EBIbLz$Y%DEc+iT)l?MBq!X z#Wj>?gRzH#6$WANE|Z*LQz$ycwy$W#c}VVe%+OwXE4lPfalh5^scqjs)4#*b7AOdT zd%aNnraL8JOM@KFC{68uMZUM;7QXWYEj1Py{s@#}QK(Uc6JKRcXb(Gs`5LEw#i9=T z>X#DRCWer-IY$6Vi>Tlr8L#Vx_R1QKl7{#NM;%XbZ|go8!UWZeo*<^8q3g^Zm^M&T z5|7TnGD^Y{h$#a`MVe|D%I^Gy)lDC}_#CpDseEsp<%h-yReE!M6hao&*nX2nM!;`l znXX~u)OSLAMgMYwk3_skw38lGBTR^)EXYAeWOf~DCTW_jbXp{?OTMVC(>eo;MF-08 zL`VtQ9<7BSN>k%^H!p}xe1juvfZrtf#3<6b(Iu9 zdZ^Ls#?xWEKEb7=xk)@?4-<~i9`{^HZv2brj^SR>t2g`dMfNSqQ+CaY4rV=UDUPN9 zrSh#^ogR2&%7mYj6U-6AJNgY-LBcy%uJ;XwC7N6_c`J3r$OJkv=i4$8fI6B=+>oNt zmq@p;gPx!J<-4WB>nuhf3Axb^g44v%*>Mk3c|DW%`G_VSC%upXa`}dzKQ$+so?>nwT_z z+eRtiJ`$utxOS$eBE!rGV;gr5`y6<*=y93K=FHDWQ#;)}o+9!owMswAZ=K^m(5NrM z5LMbZ-WA+O6v*3|3*8-H1L_b<>Laj&X=-Y^Yu)&Zy1LiGK7ipTdcOR%7mBXK3FZnm z+!50t{`_b{M}X5@H8`vqy8{E+tLq6j1N%QHs?w;)E3EY4is{2= z6JWZ9K!#uO+Kx*(?kD5bi=1`i%Uwi7lxqy%|{qKiC;{QDGsB z2Z80JO1Apx2gsBph!6D*Rr_ca!r2m6W)}M9pHZzYh zpmi>_iX7+hqJi$L#4Mi1rdl8zw|HEuc2mx6RWH<*A0jF}oT5_NnRG_;W_^L4Yi1)h zByy)IDgnY<8^i27$J^2*SGTCWu<7A`34iiBh0FP!Kf?&lSlidjz<*o6^|>3PW;zlj zPM}@BJks_>tuqwdM{@Ngj8RLMC&TH8UNTzz?S}44>Y7VdM6N-|FVu(Rfx(jjPKzhI z@V%9hWsjgO7Nz2oIw-@Xf-Tj<%8~Uc73JPzmxpRo^S7a0@G#<=?#M2hYRYavHA}E5 z(l073Uo3Vj*d!i!0vn;9YIV=-v6L;bXK~5DTJH!>%i&yyiAd5t92U!>_Ige97wGLuPG+Pj?o#l+dZmF$ zivpbtL2U2dPgA*qC$)LAWPD&rj9QSL_krmXtN(7}B01}E^nDFpt23E{taODHzROQz ztJ(%!4A~l_&)3XCkb)~g5@mlxwmmVz8a%wy(^HWjyR2g+KV4j?FFtn-oOb?uvxwi& z)N~8B_C4TSDMh`DQKb;r@S`UnuMBex@kN3*1M|6gc=YL@ZUa@n{VJW_lJ@qsq}TTO zqD-7=-faYb@OnHS`VUG1hEtdnuiY&$V#)d1f7;mCz!T#BdmBiwf8DT}iza=Gs30cx zGdQTazar2|on|Jx@2%0m)`Zy#fhaQ;{*O}Y2#FT6Ap%j{mBR|^w-VVU5fQU&f-s;U zF|sefeg?uyHmmLTlitsYvQu35#s6)0f@cI_@EZ)m;5(`E-)YF1ukR$_indUyf4aN> zdwy~+$^*Mm0A2IAJM)EK^hCln_wW5`fwVVk8KJ48qob+$nEi6;-Hv>axddjI|DD6} z@$r8L<>hq;zBO}mi7t38o4bNh!x6h_uC})82ULji^p(Kb^s{z*$r0$;6_%-zH0KX3 z=O3<)kELR*5s(NO(}Go*|8p=sUSy@5vfP(UaB{%pzRC6>~I^-oWpZ%J5N>qV<1z-0og zuf6Vf@Ty~-bt^>PK%dlvQsr6J}@fq_s=(XeR| z#RUn=mG>pXF9}d&wVyf+u`K1~n~)rb7*g3A<2i^fJ0lDvY5J`m9898?sj{#F6J#)r z`&K|w!|8NKux*yw`@S0YC0Q0rb~&91a>A}hw@u%Wn&pyI%}d!TJ^X2CGA6$!d+fJb zVSQYdQT=?8^r0`})vaHNpJu&&r>_ z@2VaIx4PqIc%yN5f9`O(!=y|Ii@VudH!eRJ!G0Z&v`T@=?*z_fZRq0Df_Q8!;JH zxqS4y8mN}HTKtvk8HBX`YgTtNcU7z=~M6so=*gYRS6 z!?KD;qmJO%kdX3Pse$7L(r-+YEf^PsyWR9ju(`pd&xuZt*^m=6g{rM_UfKC5>iKi` z$yf{=!a6nDlu^de#k`^h zcwFu38l_Kk}sQ=Fec(tziMY^s_{oqwi zg9w(M(l|7R&9WjV$%+*|F)A|ALa+E}@!R^ytjNQqZADTg@&!ZO3c%wT&hAHdScgY< z1th~vhqKu9M+x4&u8jUZ0{wP@K-(V7}s#TN=Lhbin~hjX6pv(<#2wk@AEB=)p&;%g~QEN zZ1D5UP?QvtJ`Mn#y>xFd(B{pw2##0{seIY{^#(x!2>(@=ID6vavff}21GBVSvKR;w zb4yd%xo(;u8D~c#k7sF7Hn+85HSrrHF@CK~8G|P4$C(~Xmx!`WK-KF5N$#Ki-QG`g z6gfNrn?4|rcW|N~wdz_xmS|1O5XD!G`;*D#kNNlC(pQ8tHDtro5~AcyRU;Zno@z{P zr*xqA-vNUP4l`*C_)J|os5u%Wo@yqrhig(^q8xiEaQ(NAQ^fKPNbyB;Ol zwlR)D3kE-_qiObq1KiBn)y#q(^3LQ@w+}JT860;p&3A{Pl@+b=Tl~5W<0z|bo>AJE zSf;gC=qIPAs5?I$9F$V98P7z0`$$c2X6)B~hAfiHGk@@UdAfa{-Hq6b;Lq@(ucXKb zk+T#fyH2>4Q_x;hU5QSI%7#cqQ9$w^vvaDqlCy)ucEtQ~kHx=%aJ(Yyg^2Oq%=8Qr z>m4y!;fC^;2RttbV~se|zc%h%zfWmYZR#7k*E?g$`jsdo1~o{rhIXtaTJ2n4z8L@8 z{XChrrUywEorsCBHcX#eoX2QyYWnZ^{UN?y6K{)3sgr+IahGD^7xQK+93@BWYUkRP z9AA9Hy7u#a?jN~VX-pg@Ws85({FnEO%kF%Cu3Yu-kgLDP8!^CsP;!BiVA_**>Wd!i z0zFapEVW^y6vgyg9GwfIH~XpTYsL(ci@{!A8a*TLDu37+JEjwL-76Ckw1xIGJ<~Pk zuNFd#3nfLo{)#qWr!H{Jc%zoBeCG%>$+hJ$FXAkHGN16fFF%9jo4tO!qbm0bG3ig& zXcGL$+J$|t-e$%X{c8*3t&V>BXS|sW%~lsXu1&LogTlAUD|`@~_3{Bas~IgAdYY4|H&P_SG*z3ko=;Q4%O*?e`$}RfIU%2ReNw` z@XNZ_BRsMb*(lFFqze_QLxI;Ahyg)4pd1Y@qtoeq+1;;1>RWynhooHCD8m^q0C7(I zBaGQti7cqX+H;)ajU_&T2kj5%3k`@F4`~>KbDP<$33U>a8Dy!t3j9-(&*=5=Uw-fO zaCLC#U+yNi$y&fu?@8j#$MII)4FcL!Kup{Q86|(CzDxH=LM@_J{*Nnf=0~Uo`jyC3 z<;XF7gacaybf^^pfHiry#)qR1BV(T}1Sch}>pXdOL0ti<{zg47JQ_S9QXH1j%FaURUk72Q@6S<9R$K3eVFOTc4Z6^qz+8$WO3q5fO4zADb8aKLBQ54d9N5jrGG zAr4cDV9$YBp=4JuzRUXs2-q!$CnJQ^P=Q6oTs{ei!x4*0z{PuQ0a` z8ka(U{-J?|A4u+*)BC#6@f@?DDG##WOkiZoGS>P4R^)setE;QEm~&0+hchE-Ukfzl z+YT-uL5=`n+qmfS8gB2Wx2roKZN7JPqBe~VkQrWz{74VS56hvIVz}#*_?c_^-|gv& zv)fwa5j3xP`%31Nl2Ur&(qO zHyW$W@yQ9!X8W!N*|lYP;y^ikNmL4qk@`_vxgHrA$8z4@9J-iwwt)Ap>1ll*@w8dV z5=_R>z$0_O^*@NoWc$x)k0l5SM4l{*eQSJxfAmw5EKpfi*@4n7C)<-Gv!^QZn>gh$# z2Yuj|Hi{SN#{qop5qn$Pvx}Xvoq}aw=WpA;jFsI$od|BpJv63Zk3Dp!>xXh}I%eeb zgX&jO>#5o(G6Oa;^pNjnFdB#=hijUPba!+83fC8x~+rJ=9T77F_my+|;>lK#E%=GrpQfjbtvuW9o!JEmo^3**H*u-)ZO z?!+F(FLZsppEAykc3nEf?!8~?3d-OMysNHRnVvRgn^E+gXCkXDqps=q=j3Wsg11i| zQl-e3%5>jw#ubd7^O4zAY(gzj9rqvEOnf*Z_6uZgf24WF7(IYJVJokdZv`cL>Z_Qt zI9J(z%tl2GbGuQ}01LRgKKczfv(?%iZs(hUyhAf{K~DU?H>aK0?%$ey@6js#S}J~q z%@;f3qpAsv)640_h>X_J>hgpK$AAX{RPST#ctB zlQ%WIzbO5F)oyDO*YWi^G244WG#cq;Z=$i#2$6=XnMMjS{I~jJ@`wZO=ME+dx}mX* zab%%T@wh9fYsrS>-Y3zXauV8uefevJF%`E_`dYU3NBHzsBxWzlHP-KJCad?>ypqzp zQ)f2P$ET;@La*I{|Cj>D${(-K^9eUp0Yw#~<`LD!Tzg}J$-sz&7AQUp3s}*7P z2&7|uBIC2gxl;J$@WFN~nze##1wjE%Ls_d7832GrivxV;qelK}0o94@W+2+ zv)0*hw>8-y7qOWt$!;=WJUf4;{~P*)6TZOic}fdwwQj6HNfO@nm_T-qQE8)U%hZ5! zHVPKaH%Z}!*POq0M6SdlEO^u5Fwn~eB|v-P_BWO$>SB*E*mzDQYGtkN66RZZJA7WqJPKc zi~ruevN5n3BcB7VBXnwNAVII8DYC1rZASYZxAYM`nV^U<{fRx0=@SE47isNBw7z9t zU$u|YEz<2+l*6UkGAniJP87XpMcJfl>KrvB0AgASD}aVdyY0T_z)FYVMf$5)DAC>W zn1SpMfCeN+OTyj{YTc@vo2Zn4ML+rF0WqV5*6%gcrh3K@o#cr6(i*k@N!E7^=<> zcNu7!GXWB6^knMKd-{Sx`E$-Px(7|NrFe&aPMoH1T<`V>Ml4Z>A1u5utAw>K_NX;X zQ*>c%jDx%>%|#54sqx?9;qbdr?s~IzNTJ5hd8>A$cjTuso2y{YNL*c)hwmy(9q$)b z#c=+#ien4^tQl5-38V;!p~hq^9*2AMZMv(%bqStG>#@t}Hx6VZ$}_R1dX8nW>bsU$ zPw~MU9wC2*_JYe`e=MpQq^`vPITAM1@|r{n5RR)2pQ?v9=MVS6nwWXewDBIPexYu_U1-Taz~$NM`r8;U$`yan`YlGx9c!PhDz$6 zwDmHa1nwjuz}Fd_WB#zOPl)8(A|}Rw;mM8<*(*m_{Xc2NDkgGUz+CkGZ>8$3IyJzT zeLOynPz~`pAXZh|Q#9GrT!vx$n}$4sLt5-_{&~z2k@mXu2l4Cf_mkeH9S8?zLwBbE zLIvMd6)r|RFSbK3bEAd;5TI6VCp;b_K{X#uU-@T=9P1%3>7f*rMI$^oek4on65RaY zp*D|gm}BEls<+Jk&#d8v5*Fd-^Ay_9W{qrc@}LL~@-MXr_dEG2tn{?+$^OB^)Fq~3 z@cnle7j;OdS@y%}Kjsi9#T;lHj{nb#V8%~8OpiynrCp<1Yx*LzLWnSqT&?MJTO_Bn4AQ**S`TnVKQ4Fy*tyC zQ0!9N{1Qj8`D104WTXx55G7B11ZBw^<=fj^1i$;WtCSoGq?@q!!B&FxI|aKy@Uxtb z3jOuLN}IEGNJncc3lX3D4OEeC3{pkEa=e>Kt2Ti4y1wDe@o(G;uyjlrCb-LrW_=x! z$~M!&5hreSyC&{)Ff959+7XNEdwxU%+7)hKn2X5n{(eZ2uTRTc zo!6g{H7}C0QB$g)ZE%iZoV?MGnL}w@qJ4GBw7vdz*R<7M9`)1k+dC;S3rGiCaK=hq z8-w38dT4pc40olhQt)n$EUA`zA@xz}$w^xo9vKJ6nnLb`xOEE8a{auSz2|ugAI{P4 ziI9B`bIW3z?%C@&1;*#UeQEpL@e}KqRKid5!MXGgJ}CvxVo%8m(~M<3+{oi=(lWu$ zcibCIMRd*IdDm;;IbtoxGhkja4?<#7p2(=GV+UFA5!|ZOpO@l`CY$6pd+a?tq%2N& zKFYRP^E7U34%vEmJObcq>0i6o(;tx=Hf1kezXP=dhWU(g@EK8`IdNLIs2L(VZSt#0 zkMFlqW%{Z}dB+DKE;`newEFy8;hiLwJ@*j^QiSqkMPo)pF3||g;cOR;5=w<46Hio# zcUqGOkN7KKZII(dsq+kdcX|uaHgq(0i$R;jC2O za9Ej&kuw6ZA5+uC<-6{MX1ie9P`*tMP&Zyg?t-y-YEg4Kh^;J4f>wUVO{ta;xeh|N zCmcKR6H?ZH({#9U?&yW`oQ`EbE6is(Hfd9`sbP8Lt-7-I_3wPvLYP<=WA=33x>=D6 zQuC&p!_AQtVq@wrAt*nV_cW?&uaA-}4gp@1#Lj?xYT{!Pf|Faz<_j-z-eh zXQYk(n3nR(X*Pm)n@h?;gS=$0Sx_h?)uG0~hSZcS) z=jSh7e+bqEBb5k}Lf9a{2s&!vK;f4R@`(M$-@h`3h81Ha8_1n#LkSQ7h`TVWhOHd# z?*nt=U69ND1hB~if0b4Fzef8h?w5#I?y9hTIANXKZ^d>$e(%eEB;1{DKh zl^E1Y=ZyWR<7obP7hrx!N@6M3Us@A{Bc^pRm@7I1f-Aa7_H1B5#6Mw@Ta;(h=@PS8 zbD1MH!4RTq!SPc9AyrRz|7KL9JzZ+`7oF*{&a&-VC z5kTcugsd!J{2Wx4%;6BfvE{f44sCr06o3m>7K>|gAEU;b3VxSUR0$)g+Wq`_esiLs zvTib&75c*Xs&kkl%KoA<3eF8;-!L+V@CMl?Z4NKAhwT@j$MJsbH_uD7TFL0+Uv3Xb zW%O%?FH98^69e!Z;7sCv8Sa5gr4p!A+$CVe%x#dq?kqQ1de5>J%op#<24DR=6xi;Z z=;%?UL*M8J`Rb;5r zcqpM%lR*+{Bokf^nI;)vjpcg{@t+6|8;*`!(becGV{6zTO_3H=wzY_T2~Wk~`1eU9 zM1%;vBFmzV@~@NGfQ@ z)b{}!8({YgZ3(i1risO{hlKZ#^w*l6FV9c2kyclK?q=HDDA4G*+I}gKg8wtD7!rMe z$DOO$EpIc7nBS3dIuF!L;RnEu@a9xYxzqkxTH@vBAIIQLzV|8p2pXw|?5>WE zr=4USpt-%;;eLCuBYFM-q=l%cC?H{`##H$uFnAZ?Xrq5?%i!kYV7R_Y%`WOzxjA9z zm=A$RINb2_#INP@X!?Uxvju$sjv=Q!2b5C>B#jVpPDcuowZA0-V3q#k?>HBII;-;2O>`HqD#~9~dDr7n-A{!fW^@@LA;5tdpD})pzrD?O z#G#$a-1=?${Oti5W{eN#B$w+28)pv!&FDOc(9Y7+xcVa8W$Pgf4%5-zk69UmXx*vK9CJ~Bql%Q2i1;;y9yf+p?mw^1=*IK2Ucqh`+D1@*^armW8;+E3E~ zZ{w-rPt1wXFIJ4ip6c&7cwtjC!b!gOHnP`ZYkFBT)REhha&f3oJbv0O9?6#W`RGi+ zfxPf~wZA8Z8P&<1{fvdsZC+WoI!lYN+rHD=a} zH-9uH1Vsf*M2r|i#SP)S#o4Mp_}liJ?qx%!%8M%LZ=On9ongEaEvU1!>KepZ@R+r{ zHpy?;C1os8GcSv;prz~6Ch~&w7P|dkS=^aZ#y6&zs&K~=U!Zi;hjY?aV#x!c-vj`S z>ECh6BQC+OMSG3iPp@Ol1avM<@~SJ$>@#&aYpadvFqpnU5h;H zBJ0J_UsV~z>)MQ~P%_#%67ChS4`zhZ+S)oD3TiVj%qKRBj*9v*1C~Yg_Y(qXoi0d; zy{DAS2lCi{jnws+sY8D!zIPrM7d9b4U5%XmO(Vq|7XAQe8^qAlQ2eC;HxVQ8IU8OqHiy;XHZ@+wY3EZQ1GsX;>1uPJd z0u<4$uU@|jr-jRwWJ(*X$QDUYzFk=%QR4yml$+c2`fv{PlrSWg_V%BJy^OJp;iS7L zWgARhj9#-X8Rp2+r%v5}LcV(j{ENRwT#_>+qT|HZMZyOCr1S0kTkW=KEV=Cd;PU|s zQ?t4);2B?{MnDmpH`7ciAHonTnzww%LdrXEPztAg=(2=#$Q^d&i(tp~iD};ZD5{}I zK9wvMORZwP)D!p_iXaM3|FXX>rtzCf%5KIQ1p=C4xqv(YZ8%-)n$%uqW?*%=Wirp7 zItM`rX!riE)_J*_k)00#6p%M<(m9jfKkXqXhjIKU^Z*LCWF0Tx9uePR>M2y_ zNQ?X*Z|#!l_|g=%fpB~=xCU9XE##AsNWyH~7VjBp1k-U~pIV`nghjr~c!z;Bc}5e$ z@j{{Z*X0LB`mbN`l_0ujRv-6%ld#e2UKTr~NFI0J{3;H`g&I%%ePk*oO@@Fq{+Bt0 zJOx%0){gaxS%Kt`^~$ys@eLJ1n0g%;#a-jrcN0lTQ9+ni;W;RFzyUVhV7=V>IeTfP zt7#BkBce>yaM(NK?WF}i^zq;=?cq^HlNa0V7bQvFp3v>wE58C-%Ey9@?C-LK63H$e zk$?(aY)A}#%X;|Unuc!BH9A+-*}UN#}?E2?AupUgjlsO-GT!o<0v!sMO@YCJEm z%bg{ZM7YugO(gf~i;|G%4K=jFmFNRbo>QL@mfoy?JPA@zbH=_8{$lo-AmyN|sa2Xl zqtz?^Ek?7*tyHWdN)NvO;@oD3kogCYk8( zFHI`5QVXe`(v=+F2T8`N{tQ(ckP_4GxPKS)&I{+`aLh|-hR=t1fU!Ne%yM~~maVAY z{!Nl?v}VxWwdTA2*=K;&X;y2dS_(fsnW`4mANBrl#`3q6g^cd^-pR^-sNQl^@=j~^ zOmjCqyZ@Aim(=)i3PB6~S>==3BMqX85$!9D#KQXbi?OzFo>(87oQp(psp}WJSye6s zjhaur_{}%AS-PFpH@k>#BZ4C6_d(g$kOY`w2?vk2Yu?U^(Hj?_u>{`+b8LwOjNnyM zF2OQY4e<<9$xkhk|1ene$Csey=VJzJq?UVBji1iW$v7#ntq@-X5{Wy!Z35C6Z_3$m z$3S2Dy?$sEK%hTyEB73;5BUGCVcG|`-G3pnUj!%~02{8nWH0x~Zi4Rr7RYZ-mO#^% zS(WS>0jk6cDx<_D^LrLHBv*}(K{oHPvd}}|9vQ`BVFj~re$q@^g#tMZhB=*wR%%8i z!<9qLvL-S$7b0s%wHd$boNwcViT~RB0i!s;Iy+K7%L!LRokbBhvu_{)OhB6yTP&TU z=eqUCOep6`z^ykkbqB|-aS7tN@|X8Aao)Xd1Zy?5W)y+BnLc{fd=s5aMn?Iv zN}zJryk&M@h$CnZup->QKF}oj?=^dR{uc%7w-zBLD;o=IYj3H#PF=a(-kkhL{L9RI z0nEi^Iz$d&cKg16`A=Rl>T>*dLYS&!k}-_A1? zEQQ^NhyS7)XtY2x%j>H|e%VT7U>7DAfSHQRyT$L{`Cf{N7@phqkSVbw9&pUQJOX;+ z3m_+6Ia>dO97zkC4SF7Cj9@c-NTIzVH-Dn?N`Sp`u!|}0Bro^(ha2>4aH-t*k1v^v z6kZhhh2f`4Q$aeh1U*cfw+#2^4jLxZIAk@#2-vo6fr~vq^Q4Eyd1*A(j{H328#%X| zF~No2)?KHPGG~2idlgPtvDdy@2?fgeY+sGKsY1N@)1dB&3N8XoUM6L^zEMESIH(u*)&Jr6=%s8Voi#cz~)LU z3TqQ5p{OmTXEtsJ!%5gEBQ&?kV@oq`iubF)5{+JlWxCP5S{5d0RMmY>$B$X9$8 zr<8LnTqHK1AmZ_ zD6H}%^V-Ya4fAaLdy?OpX}&Ba+ObQ$?%HDu9E)6a%e+Y!0ZIMYG63EuGPH2`vWl}%;b5$ z#3R?_vY4=`3fHHt&&%CiL(Y=fd?f+QpWLqxamqDShz2(gB7gj_pWh>{vWMHIBnWJg zWr3+}_5_+@G{KT~REU_0s{$MLDoBvri3(YHbnU9?yLmq^sr zxLH5P#PcTPhz+T3f>qg+CSJnE3s-@UY{c~sLS}T;UOpkAt9!H@u+CKJ~G zql4DXb$Y*KaUYDQb87P%j$>5#yls9nZrWDjIe|QVA7bi9o58&0KEy3Tr{BlU!&aP( z4CV+PuC62Bi^CTkN(y*dO9&|l1PG|vVw*{nc_JUP8W$a*K~r;J-v{ z8$`ph?8HS2`)|%bLLeDYFgn`}b~9*MPRw8{&L?wb2*6saCrMI^Nn@ z$RB$|ubbmVuuO(%s2JSI#6fbC5(ssVl3A&@B}a@u`eq-iw~8S3`G_}m-|8_U6U-cL zEjiGy{_s{_&R5@W{?)`P4(eu;gP-PBzv-#*S#5-)Lg! zHUlr6Q=JaC>r?NSe;|%MfFD7bA2(RvTz#kxn_zk<2~Fys-PtWJ!q$h|5a#tQB>E`1 zNaNDRER}&Z0(}WT@J3=NGhZ>*k3SYUM>va)yR}k=5?sjY)!@(lgP2XTQbjeKE^IH% zXUGNW(Jcrht93xQU*sIwo$MO!^~4HMtx(@fyHM+uO#`5XaH9#j7ALG_>^E=T0QA@D6Lm>~p;>i)A+eiUpo{ZW~?yl9r~F|N%+p8dNC?bW;3Id-G>S* z4+wV8XNRd4^sB6UQ`?*QsdLbz(wpzMdEO|Ut30sIVTY=xmfR z$HQt>zu}~eakvSB1fMRQF_OUkvJF96{EvCiUpHZFL4P=?pk#*?!5P!@b8)!<=(VS( z2b2LfH#gM%DyGBfwk_T6MTz3&7>86YFQ|WzD)Zsz`8kyUKbkMC{P83uZ8xh-GaMT_#oDw(}zZ1*f7~E@zcl(cn791 zD(Z_UITRHmi?Lh9Z52Y|3$C+hQdefln0r3Lq>kxs(;HwX0%taC8>E$$q#^15z&u@!!oLUth zKLq3Uf1#t@H91e6@v}#In$t{9onsc-(;H{t^@y)j6b@|q;`?~EAyj9$$#N6!(9g88 zLQa+T+!Sd^IAzN_^7q3&*AUf1?Swj}R)X5Q3#&bSW4aW+7-Dn(^Empz_6`T`ADLHw z68?~)ju#+jJ*#ML-vZyOYfyFpW=Wo|tC{YB8{A{lnin}KXpq6MxHSt~&9*^a#sqUP zFm!nJhds1I)Y`o_;{uVkea7h@igQUW{ zh|}_2#Ifn4uGOhG*j<4@AfRU6o9`gdNS-o|-*_;!AXC%Y9VF>~`_0F&=Vnllhk@#SK3eCnhc7upOW{pqMb;u1M+>#<#-NltK>B>;QlQ60UKdQLV>`=9L zyLPXZ495h83~hjlv0MuUc~w_g%8eRLH+{Wn=;G<6Us3)Eo~BKEX{yuz#_K)d z&|o=!d}L6T(#^`xJbBfNC4%d7R*#zA9$ChfI{l-kGW4bki^%ProXz1{GfCrqMra5c z{do#EYot#MR8}4DQ~YfAs3i$KRmvGOWBh8~kA=#0+8(0-e>+dRxI`bz>ShLB97R-m zm7*@g&BIAfCt3J`+bUHI75|{wghZ;;IOkMX8{?31&%fU2w{6SX&Pt*vPqlle+x4hh z8tYm?l7y~Wwvw;-7GNbxSX?B~-M*r?YA7T#H$b6MC{4z_1=xw>)Si{4q9zSaqa!!; ze$hfa4AuN|rhclciA1cn5Y^r6*2AYpQ*5U1gr=A@bI4Ssta0t0>NJbbvI%9@tm zRmR&Lry*0qx>S%my%MmDOfHLZ@3CZr^-K#LPD%CVKo{3ab&$ST*CgcnN7#ebL`8M-SiVmt_;_N&DlB+3 z5Xs%&EgIpc_KQo~v;CzZwb+?h-gT>NgcsaKhJ}9ZZ-h9YNjHnr<`r|F^i`4a3xuZ? z8FuKcD!$(n*E0}ZBe@Ch`OJLl5UCnQKpUk`PwV@t7J%qGd~$!e@`an5o1fpvVr;Xq zZy<}i+uM*;!QtYwqOHBm=;E5$d%z$C4W=tGY9#06G+3?@X`$iaZtI>^T0pJyG11&L zNQq?M@tFUsv|>|(#jUcwx5Nc3m164ka_{uRARc6r00Gm)+(O!#EEtSc%Ibv2Xiw7;n^!O z-u(azdsU*TBpyaSg9G=|#()PoM`TV^rAyOjVEd=#3;~*}9G)LHo=Jmqo1zUNo-xI- z!tb6QSX^e6LsX&9`VZnGGLE~WJqnXC47-@tE@59kd`s*|G^(T$Rr?N^ zo!a$?Nk8XX!Nrsx1Jv`2o#6acIVbPsce>1*9l|)}G$qgo_U2b?Q|V1eugWL&jhSs$ z&;_z{DxFjWl#h}xVT^%ohrWXhGz6+-{7+=AJw02rU6wCD7a*<5=G4sk6Q19jUhl?F zTzd)bTx(&R2+jH7JjR*ADxa>bWR~2@6eA_-HFR~^MDM{ITts(8VUi?I@UB>M68USN zzH=*&a^l}Vj_!Ju#`%+d6~mG>!-cEC4d6Rn&)3xek#l^cnaT>LR(Gn^H|xv>bP~=z zB8;B1AI>Zfn**o@u78b1bUZJ2$E(2*BRiX@-MGD`WjKyv_%=H~qs7|3i=R2gr06P* z|F{HQ6mvhX54@%o7qsKNAjTRO0#hr9#uxowA>`h#k33p6W+tW~g@k_{btEVMZ(%DS zH`|8kxWsd)KFO=OA-riKDLvAhOhSAqK+O*K+R+Pr39T9XQ82EET`5_`l0$RCPxypI z4@nlE)~~&?8-i0v*PIHuN0w?xuiuk}!HH;>PLYGB-{|t=l~C5yXZ)~ZN%>yzN46-G zen~a8Cm}{4_Fp}6O-@<^bd&WZ_sSaADk<$wgOD=NF{uu<6z4OnB~62xjTS3vl4!T^ z=1herW(&>>RLSG7=-%&LEI6mdK~)-x5_8kvG2QQqs?=w9+3F;rf2fqxrL%Mj@#0?j z5XUMjk)>U`2&=RQkmBY|nOU=R$GWkSWPpjcyR@sL>X|a4I!$-i6XW1~BMxD8)DFzpo*e4p%fSh7LV;T4N#@N4Xuq zv!IxGF_fj3@w*@wrnzEY(G1tHZ|>Hhv(}Kj;00)qn$Q&_D?BBb4u;6PrXj>UNOVB4SMO7jYA7_9?KYgwLBSMbyb)xg83fOMKp$S zAD_@(w)cc|j(Q&0zQ6uxL$^S=BdI1pWF3DIk|BbNoSiMm!ulcmd4}VmvIK*%t=VBF6^#qgUmvyV%COFG~zdb?V)9jSG%=K7OKkI2Fbc=jmIB<9;6CEoUAC zE_=C!D-|Xuk(lj{F5PVLJe$^?%4Yy&Zd_akG8AA_oig^gabm>vq?Wy8b|wTn5Ns?Y z6@h!nTUjo0fDG@ufR7}(Tt<|SR5p#cq4nB z0RA2_lX`P|OA-ktd%0tA5pndCX&G8LJMEsOisu=~tK$+Klu=CZG7G`)ABDxE_LjdJ z$;eOfzKI8pS}FGn%=YuTx<>zuFR+GRm6HrgWh^JT+b-Bma9#omNgmxh4xV!EewtW$ zdfizdOd-_%n|GkgiN7#D)B!%9GTF6#PCFHBXSG~i94c3nuAv3N#OY4wLFv zDd}$MF6ol)P`W#$yIVp^x&@>KJi@o0Z|42O4+n>tea>F%zONj;2S*?P%m!rVa=XT9 z9V5V0%#&H><$u=J@d1|C%nr#}pt;4jzojFMXOWMaKegen|HevlJ1CjA501giepMgJ}*^Y-WN2+;(|O5EjLDXTRe-F;(UM^@(}2&D?fI( z0EF+^p3;`AD;QCmYsS$h(X&=X%Su6n6wQ4A)Y)2xjiD??H&_E+<9CFUH`97xb`4+t zuyFlZQHs^!!NCD&yTN}mncE4rIH5sWi@Rl6iw3(_0LAvb{OWu8^ZK%VyUXR-`l$M( z;Fy9=c5Gw)e1r&#^8Ox!&+P*N?eX5;9)SG7PXKW2EdcR35DLtC*i1Tkw6J&u&_(AN zbbkB}kv%iWOr_hrY8KqQ$*~%Ut~1%}bPZ8CTRkxx7Z_A?2D)_yyGGPXgN6CxkJ)wb z6;`<%dP3!DoDI_C3%DQFk8K#pz-KK+=xoS|-1e~K!o?P}g%hsx`YP5#j{8O@0 zSE$?cv)^&%lwnt=E5As4&Sc0=z&Pru=)UhBmf{sltKWKgzmM@~s!c44XQ#_5mmH*c z=RT;mt6gQ#MxC9_DS31h9JgRC7WrPJft9rt%QDSHhBq78&0JSHb#VnI%RFgNB$?6n z!dNl1um!%sa`LxBZI&sQO(GABwV&JDX&k{FkA-#KL(%|ShC%{u+7i)3>WX|)4*uDC z)Wc_OYf%3Yljnh;PK`eH%$o~UR@O+X9)2D(&ykKYRfrCMtz{%2C+lQTdKClXV*r!) zg@$JPzc&}_l`)Ex0O&M=9(NIs|KN`2EQVEY;UXYH{@n$=!GVUHBLkJ!DEr^!o!XbX zIe>QjXEz4X;!{8)120)B;(<6Tqv!H4+{4&Xd2lv>+i;$8H8vpi=QzHGR+^uV9J?1t z#rMm1nR@z*ne(uS-U*^#9fb?Fe{sig!})f0msrS+b zqvcQ;wuZ7v{e0zBm@M1U%-81FLmV+jYwG$ix^>Ia>shr&1Vh+h>)E@!9BR{tkzvOs zMKpRnt4!$;LlgpxPj4KVjPV}3?*=vbcCc}Bnfb2aaL|#n)X3zP_kjQlE7X3r^kS3W zpL=?l*9@)5lvoSr8+l>2y^)_gjJz6A7TTTX!xXFVZM8Xzg-zwpQs!CPo2csI zsGaUNtjFm5ls`HWe!Gq5+h}5+d1O##tCD>Mx-fmXRp+EJ)fr4(?&_RQ3206GwzR;R z5tt*qi=3bc^$r`#JH)&v0n?oTk%o1;8@SJ&H5)Z=_VgF?!f9;6wA&sdt?4?`46%UF zt>Rs9Jq(xZuSB$f?Z7`j;|SgY2l|IJ1cWX?!Em}Z3)_^Hiy!jmH-9pleF0$xW9x%n zS`|^ih5)`0Rv{~xWfEnEgA-gM89Wgp!6;+M)EqFQ{VLV-z=Op3^zg6}C$+b#&X_O4 z`G+Pla7|xzYkro`b(-?u<8`r_QlnSN08ySa*822yk^}0#+c7n{kk`mClv$7;C<(?P z{wY^pj)FNNqD#2`ZTCc4b$i+v0CD^O&2)fnJs!%f<6~$k^FXih^o#OoCbzcWMbk=q zgMkt5%84SBC-ogD{JQ@tLePve?YO>{-C1Cj-BUzFBibp%-thdO6GyAXH7GBQsNPfj zoxITo*T%1bw3^6bVFj1f2s>KXJG;JNA)Wj0vkf<)(}z#44~wBVG_B=axtZg5$edT6 zp-+pwm(S1ZxMxCXi(l+bRK3s5STFIDeKs(fn~n-+Kjrsw%=ZQUT}e8?`dkeeK8C}t zI_&2%TLDk(XdiGh;0Xi4Otj3)*>d%}LT~dwM>8b5wL9(Q`3QbC??Gy-@3%RByJr@) zilv#3H{N97WNQmB8=Z|YuYi0K77%!ZJT*rf&K4Twx~?3?ckij#9`RITV|W}7dEyAW z8aZ7L2CqCgUJ6_RQw_$5;mp&ZTByd`QyukGr}e|>jZ4=1N|w!Md77OG^gUV=JaY-; zW0_gQT>2~rSzkg@Qc|GzeFmuw2M5Ds#e(z9jFJONeFnXkFWDGI=KKLBi@zp)1E@8d zXEU2AHIzKlkO2Xl^&oh0qaOLFpD7D&~^GZ-{Nc^p}({$Z6 zy&3Oi&ibWi)$0d&*V&|-H8pK$y4GGHjsK*vg^{NYF-Rj1i-p6PQG#hh#>WZU3_neU z77qTtT{fmCSn1V_Tq@PNmS>9HM)BBOM(_+y)8#;8MG};mS`{ zJcVpMoB@A_St6}}RM8dZNJ)`83BWl)FzlN*Z}JbP93`+)?0m17JQKC&YSjZ7pohw? zt9ldHqp-D9iB+&CT=#KP`ZFMO1;Z}!8YPExjR6=7DtsMiTJPeV|$KkdYDQKMZS4;r3iiOpKiru`0{FQrPj%{AC{LUc>8R z_Whmd5#B6_r~vjt1{T4f*y=0=jrYv6!y@plrgxrNhzzMwc`8THu+W%~e}7U08;^q> z#j?C$q)RACi`xRTN8eEI596A9Rx>{*f0Vn6%jcdZ(mQUE8Nqzd7vM|>gWw%wMQC9P zXrg#GF{@MJ8?zj*l3Mz9!w5@5y5_(5-&ZhdDVf;B<|`Veyzxb+HCRuH<9Ta0=2lVE zgrn*tt&`XTc#`-74_dYW_6%#}^GVSR9#t#9_1YXI^eF2W%O<)n`WlH_p_7fVy+Jnz z$S<%br&E5Z%jC)Q$0rMcwpnoPP0=31@y@s+!7n1!bYo|O0eFd($ZRg&)>eUv>Yk~R zX@M*B$3RhR!l!B<9hli#?E4qc!`30-E}&9NrVcs%m^ghFk-$UzNyB{pgNccS5`RTg z_n78e#z!JfduYeh>=IEBE(4xCcvHYAo!I1al3T{3nDh*|oM!wMeBrVS{gr)a)yN!E zCgx~<#(+T`PW#o9pIN6R*^VUegaMV!}=YRTWEN>QBPm$qv`qR!uREgmLq|SgB=C4S*Q_j^PYxT@oN41GnZ75*(~s@ z2e?~x9yF^&uiXQV_3PP(H`p;-oP191XD(|VIp`UY(hz=z95w>9WV5o`Ex{)dS)AE2 zj_Yt~^A|bUWtnB`M74>2BP>3wNW_^pX1S&&DnC$?-h8~N_IVNNe>V~4O67QaZ1LR4 z$3E^2ff#0We`@PPeRX^{y{4>8?-G=c>Wu`;Vk2k1w+(%?=;(ji=4Kd^Eg-4uikNCs zNp>pu>=oklPx@cQQ)*Sz_bcs^Q;iqa*4EM3Ps+{D%-e%})fw#Nh1e?USt7rxI*}3+ zPFt40(P&hXafr>t9#C?Ljkn;UU`WL+qHIinS8T=Vw6N09!}PDNUs!wMy3)g4vW!W> z+KHV&fPkv1s)6B?47Bmf2JWh%{`GOGFRHhOJvhF=Xwpeii+Uo%6+!jyqJ4Yo<$6qF z?p30Pv1DQGtz%*tW5C0?ey&5i&vm(1=>Yqg?YjKUP(4=GD=S`%BIh9={9A>MXXJnG z57944sYy(B^zF0^3srSVtTBRcFH301pXsOXsE1NhstWK_Le|L--k;W=DNL}6EgE(Z z_a7LiIj)m@DvarrJ#t)v+xVwb`4rrIo|vcb%FjyuhLfR1xXM^;q=&9=D}3<>Q|QHZ zLYd590@D@FkTn}H9S5mi`&T$7EkH02E@|?jzIDdbCcGY%j~zn*42l1D8#8ub?J9b|rKh#i5Jh#ENRdJ9%buEo^mUsm4G%)AO5x;{vYt7E1lf_`l7AdVx2w0192S=AVUVIwRiAn>iDV<5O?SGH`l`)kJ*chJmhuIgQ0 z{Xz)TDNwFRPIp~r)+RYc|CV|~m7}@#LqNsb#H^PB%J+OG#@|4;sSl~_`X5E``MrXY zIcX{r1qPv>DhN#awL1XhYcSiM^3R)qj}zq_p3Av_jdxH46TY<_O3<@|E$Vykx1wC{ zCrpIiTQg%>{rXR($PQJzv!kYt-0^@-l0O?(_7rHB>CRLe|f9U}+WwnJ#Um8I6cX-gR|4kj!p-B7dyuq=T zbLNzwRmTkhE+{h-<`pm*`%dzE`QVrcee=~>XIo?-hBnK+w~{hh`9 zj1$s*dYgcf9{c_MUY02A-&Piy)%3r&C4wuU4W@Np*@){>`U@z$@9ynoPl;bJJNhkZ zBh0^iidu;A<_+1~Rs#E9Vsvdg8n%W$1-4%^@(tMN^^P9FA87u{Zzr%|Cw3Zge0f=y zD)^^(ZBdkh8YZiuq=I+2=3_>iFVb-%=D^IRPL2R*_9<&A@ghtO-7>dnvPaDcCAT1B z1AZV2GRZwLYnJLzu!4gilVq8hc40DMU3PLt#I+zl>{qC6&sCUlJCM#*FXQD(O zC?`cop3gT+QN)pbqkai3rHjo?JF@AN`F=K7m16pN-2V|n;WlH0_b|?B(tcV#< z?oGbSJJd;9nQ?@1_oVl?i~J?I3XB#^QKxPt5luPy|2Xm3vZRofhrg80a0J@R&q~{w zrYd2*8J**jGL*z+N8*2Kz|9k9xXH$_#_=sAFU-n=*fUv*X#bv8YcEU-Ze=H=FHlKo z``*wsPLD142CJh#nB)e2LQ35G%CbrIIx58GMQSP1i3OH_0#%vXIP}~B{_t+mGK}zb zh$Ct_d^;Iq?g*+7&&gcxTO-71=P$G5ueuLG&iUk-7Y|{4XouoUu~5uhzI4rM#9}sW zNCipjDNQX&%q9c&+d0uk-*^U!s$!ql%ds_7p&RO%z7(c<2DFK>|00{t;I7klt5~~W z+Em01NKbsv-R0^V5O8i!44?b`b;vFZ}@(3Iu1eyqz5#p*D6*`Lv>ILdLLm-5%w@669%)b;usQy|vZra}5);r~M|Q zqWO$iDZT36E;U}Wdor2=-6Yeg$oz{D9BhhXrXf>y1-5v&D4dB6)5cu%kNy~61s1Md zf)M!I8&7OLyTlZa^wJ$TJ+X@yJL81&s1O>*L9I@5X0BVjLixP|NBR)KWi{IGRBI3( zcl=1l3)!mQ!%ou%?7SoPxgXgcp-tW^t-a1k6?TnnRGO2);E651sJh-UV)ezwrD?N`!*GkVpeq;QGq1nF z$torjih89?3)~OL4B2-y&YCUw1{U)W13e4wUN%t0WC>rlD%^It&{ z6sh>XSz#C75HSr=_@_@Y*5c4*-qVMNF>Hbq5D94_^IP**bChZMH2A3e#zSa>vM0w) z-aLLf+Ny$S+@i)m*a6h4M4xOYc&RRQEerl*Ky#Ur!Y0aPItP@<~<`geLslvEiIS2Iy#bn@1DHF#v-{6_-0LFyNJKm^2Ix48Y!+2d*(a% zKlJgZJqg=Qw52u;u=W~*2x{WF3DE64{V_)+5z#5Za#f-@Ki9A!tmyz}twZpqTdq`# zyayM{%I?O-#^_HlAat4pfM<1tYQyipBPb%$;{FSMAI9A-Zo)_;yMQQU64YiTPDl$S zWbEGG-KC+oXK{mc0gkL?k{t|lVR$%;1W-d8%DEzJEi5A9QDhtKiOm&k8XIn*!#cvFB;KwKT(f(kXw*7`Yf-??11-w$%u74g{$GL$3 z9S}1KasqkvwAQzWc<<81#h$zFBGGh%GE3duT%1xkR9e6IQ2xmK5?f})mLizH#I@+) zn5su@c93(Te40pC_Pcv|vF7p+DwCwM?cF$=+Gw1Q`S>CM;0itp4*mN~znp`!n&M;2 zm7UU!y9Nb6h7)dV zU~T-|Kk#k#DlWrio!Ud1V;qppUgkW{sB3uU3=#eRv z)UH>}?9nEy&CPwLr-{0U2V1zRD|(O*pu-u&fDXkdeR4BDx)e1F;%Bzf+qw+>rSLFE z(aX)v{9`$1TfQTOQ%A}E!e-5&N6AwTu?ruuX@NrR_$hMR8=@0CTS0_UlISldiR;=u z>kK2Xd10v-ShRD*`F-Sm#4^O!CYzjq0|6oRC!=8x>Yt|>121h#66%tEJTI6fC z7DJpj3mgt>=&6{_BjP$3KGb*t5M@7#L2iY0^ya_6+E-6Fg$iUnc(oXF%`=a^V zkPCgvEJ;XAEb+A^$>4ne$)wh`84p9D#|w>5dfuO$QbLt(Zv{7e&ZZK|6iC!I4@gvjEs?2uX%)yF2mrwGs zg56nbeMnT}b@7y4EL;MtEejy<=n^y0H@P7Y%r)Zw?o$60>eqh@r}e2y45<|tX0%4* z`pY@Mk0YcsZv~_zU=J1%6%G7zNrqKLLwI5nox4h2Jg-~2)=PtZVC3NSTeTb`VTb2D z&(MsU*^GukhSh8(ZA}HTlI)H^jA zJ1hVb8|bJ0&%V?5a{c~p?wOdP=_7&Ml*d1CZ2&_oiOl=3b3B!wkFM_S`*)YXsm73c zuPUsQ>XgZRX7aI4S<>1dDicFr0Z>Yv&nCxU@dOPW>t?gZL~u-J6_h@F&)^^h>oD(g z3OhRIVsF4x)9&cf)E5ZQN&Zzk)+DN#h}qHps1R&czw1)x_3l4@4d~Y`bNLeH!MO3C zbItd5H1ZZ`>4Ej_xb37^u)6*B-AJ<2sKcJsm%=~4?qOzaHBPs5?NXqX`^J{-@?CfU zF6&v2zajDq%Upl?gmYqFxgDoQpf)`=3n3qIBU{|}W_ZzkrY-=P_Z8f~x}1o7Yc-2M z5(39ba)VydUr+0pb6Q2PFA|q6&9ivs6bCAPh^!>l%g4ktc(|Xw|I>n3shL$y+}Fhp z&wpyd@!BI!Q#t%Dc=3mIZ{AE;r~lc-^K~*zgX>Om>5Fk2q-Qk)f2Qzaqxz$ri#UN8 z;;S01y1=P28aZ__H555a-1w`qVJY%g~0?+A`tz)Eb2` zKCMe!8?6%?(O+->c37&SIaz;7vrXR~=**~!arO3NiL*aFP=@32Rh@2@={{sUCjSJV zt*b1UJ-{r3)RJAwB?|ItPEIOLE}HAkp_Kd$;VX1-%X1pq+cVV)+SJ_~8EPADoERzF zNskp>1lwkQw{C#WCbT=jlPhdc%e9E9ihYUL2SlN_NnRbCltOhITV9LcnoAz5eF3RN zU`Q7i7It55GK9aP6$#SRW#Z1(-Lw3V(K*|MMM6S(0G+jmY;%rYD}CD!GY`ciJ`O(w zA*$rYiL5Pzx%I5O(IB6u!D&3C^0`~eLt?pBA0T_09IY-ZE;}q`r6#GGf{JNV4Bb{V z>u;V4yYs}xpB2y5OVXBURu{}oU0!Lzf?(3+Lg_TNM%NE$+r>P~T&q9~7bejzV7QZq zUNH|euf7&m7|bJdPi%<&!-?s$EdES+)6=Rj+TWzBk{xMzy1tey0P_W_RSgmogm>cgD-h)9CmFI=&blq{Fw}DHH09lnNWx8X@{PSyrfKj=$F< zyjPw82LMc6K;#t}d5&RpT8Zkoor;|N&k6bOE71qby@dr4p14sE9uXgeu<{*mT7GyX zb!^Y0XpA!w&0g{{VHmBU`MG;mC$#ERI?1vLbgM5<;!k)C8f&S;V|@0>eWFK1@nPfy zFgR`+U?ob1zDnL9`=x7{j~>1oM*29f)o8kxVu0J%+v^qip9Kq?OyK0b7X5ys-+#M1 z^Nj-gjD}X3EuyxczsJklTaKmnKg*A9*9-RBph$Afk()wMB#u;b-GX>f3==hNHgN$c zi|xMP!p4}X|1x(cCSqPkc;AuVUjqyr3}=8M28dMwb&X8qD;Hk^B`HfZrj>>y+3qCF zr*q)940z$crB3D`a&w;H;I~pU`Y$N`+6h3!{Eb{-!`1Ba_xcvS{F5d-RUx1N=gYJ& zmU3bouE?P;W9sytWJJOgH?dF@&cANED8YJaVeDEAfj4ekB@ouX!VNQfR3BNTnQXom zeBM)aBwDNH@$J{^uT`{z+~)+sL(k5yQ6+t2vEBikNZi4eMySOP09*g2K-#u+#x*(t z&VRtWcDLQ;Fl^NvgPpMMG%r6t+mh8RejEi~JMHT>?S#!HVMkAo4An;GM@vbNn5Ej$ z-fpw+4U#_qCqW|eX^AH*lsrNYv0M=Gh%Y-*b08wm)RR~G+MJFk3p^EZ$kivJQHRl4 zLD!*#MzlLJW?}e7UB5gDsI`t%4+@yn4=33Sn6p&VNyJ-BQ$RgF@Xzz)>B;xw5LENM z!&@9LY)$2?*&Sh?d(sHH%FvAMyzHcD1|K#YHvUzlep46n+e(f7a-~bvFt*^D+w?Qs zZA|&Eli#+L5ld(at&zxW;=5m~$1%WPnnyfj@a z;BCnc_iNbCo`uu>jX+E`&-nIIWt%2;Lp`bj7Wb5H$?y%Yxgykw%`-BZzUa|hc48Y{ z^5&pXvi=881;_8EOUfK0z?Otoe~!&z`oYnKhNDq5EvN#NQoy>eSF^eAL{&v}E$7|r z*O54hH*=Z%1ty<=V2=QF9w=(YtWB$$FS08?jm*wZQ%XvOVjcz-X%KNphRDvQ)~p&B z;^r0*kcTo{_~qAUR0>j&N0Ve{DD~H87hzX7x0^*Z@r4sck~?+{6d(-sG%+Nn74^M2 z0N3Nvhaa-1crRT{KK}j=?M2y3s&Hc&`my0BWkPAjk`8A@RBBCY4}3IS$WU~Jd!2%5 z67(5UDbTwRVn~g*?)w)~=NNMnewwbd)X_b2zH`^WOp$_{DKFiEdj63{ckyzFV67@#C(!x zNK<^ea`rObUxOp)KyemYTRxXnbv#?-DuGR^s4jBi^9lNZ0)uL*Yt!7mldUr4+NZD) z=0zQ&fgMf!@`MAQ#c6hUvnmdhCo6mLyVRz>vNQNbR@2925EW`6#l_we5 z6Oqt>&wMm(8rq!&<6ETV5o3eD4mZ4N{RQdujmAi99dWd7GCxo8S7q5EaFk}E&{%9y zq$yCC*EXOLtVZ>${uPWTmVuZiZec?hssRS%0f zJk9evPtos0@dI%^9s;_8&wHRBTI{F4zdt-8P~QN%9-c7#n5NZ{3Osv~D6KlR66URt zYzI~)il6;W%x08m@m%R3omdD`7tAXoJdZQRhK&=0hd|sF}gw^E3 z5Ni1s3Xn?9-m<*XSG}l4xkJH2MhT2=~2I%)n#GaQ`Z&b4k172nKC`oJq7Jw z)RQW5^kBgI@1#I2x!b2@oBEp z-duHHGz_&bF5&UzWh>klw8-Y6nPKSbTl?<0>rcuC`}=RGFcsO-&oTdlJh|)Iac!fM zbe~240+Ufzzr4^dzvsJ3SXdimGG9Nnjo9DQl`r3gM|?h_RL8;%ee-H4*KAoU7bLvm zIL|B0-p|}>@5UYnNeByP9s1eSvDVh3zk*_BsFq0?KzADOcLOKg&GWrOhO?9#Ldc+5 z?}m!jZ3hPZk+bEm`MsOmEy0CU`?wtFU$||bVr5Fi10L1m?($W*d{wI(iF4e!3|n$N z@lPP%4;BwSmX|*xBV+uq3I##R!jB(=hAjGnt^LABN>2yti>sBGGSMnnZY|q)U3~uo zGCMonZl1w#SwNyNLy4B~N5&MtE@)$pPq4BQyGnPTtGEnN*J9mH5F2%1nHPr&QN;5% z{Kk=*%#v88!C5}>J$;INJ|Q_wu2GIHzr$weu3F%Fg0H*eEAvejLR0Ufy(H8}g`z?; zmc{@-+90JlRuV+o7uJE#HQqQEnr{au9Y^vW+cCoREujm<`*JYmEN5AlC7_U%*Mk>v z8#?gAOVkd}Rh18>=G9%P6pl3Q@$V`%m&FddkN7=lxnrePe`I%1qAin7X&9GcTmL?C zwF*Sxg3yJqA^5=sKi?rcJchyXDYfLd1_xCjBl z37P#l>C`#?L4)i+SzT5{CqTmn7tqeT2&sW?83T!z8>LJw#IxyJk?i+n`%XEZ{|R$d z80+dhM+U^E#-+^uM7^&>`Xk`7s){42``BV-3&w-FjU6xoE^+^*XGVAG82K-B+ba{u zN+zsI>J4)6-id`ZpJB>0{jkuuxV}HdWfPo`c<1n~lJgq%8^n?|3xPPR_LYRvuy3~U z6*B}fBWQ*r#<@j0n_PvL+x(BdEy~tVpt*HtI`2H8!Mfb-OMZ84Ieps>owa)#UsWtM z%`;2a&a0MqYOH>hu6E`yq@&fec4Iw5AAWpZb(#uVTtlS+iP3$puozb23dd2d^TPv1 z){NS6*OS7mt~~|JRUfqL82N+Tvwys%||!JXI5$TT0y)}HXtl=VR5kj!(Zgq zTy>sSo~@s}_OI%J34%k3Hq+M&^I$E1HHEt-fj$93kO^T{r>~K1_C6C^I68lPxFVfd zjV1~VFKr95A-=6J(6PCi*&=QObJ70(K3H%Nl4ApSIoV>MU5HOYubXNd`nlQNp{=E7 zUD9|3-8mko@3i6g$X*>X4+~?Hs(IU0WL+~avpa}7hMV^x1@?n8yCCMA+Nb~X#E3Q1 zS50r+6C71BJ#@k!D2RnYI74eEGWqnhq6q$hf%$ubTOO{it^kMFPw!*k#yo~M&P$ym zRC*g@q1?kN4aOB#fjdIoL12UgnGIpk;@&|FjMi$ssRhZyW&x%Z`4|MOZTRU6C!Op9EiS+VuT7msXSvsJD5|j1+~mc;sp(! zLYo#tT@X_c(98ngPb2;?hgtl+m^sW4rMC_;q;|DOH(>if9XXhOBsGARQ3m#Sy>P(8 zzzK6vx`h^U*JrJWYo@?$_fVQ_f733=)Z&3Jr6w^)U5cvUvWBx%;RgZ|?=+s2in5yn zv>X_Gtu<78W!J!({Q@E;ubo#aWE~_q{3|!AmW+E^zc0-Q`GT`KI9Tn5$Q8@o&26u$ zUQ0+x?dY_pNAxp!Dq^acq~j`kSE4#8)nYNx^aW{rQ+skj-ANK~y^Z*Ebaz7@uW8zy zwK5V?1y0{>yRrdO&|Zv-$$KN*@!D>us)f_UuvD3Nr>ghwe-F<-n$FGv7LgRK!N`Hq zObNPSQI`pto%xrD?LYv!i-O|0=NfPi2EW`Emi_AK=>hOk3K9IhuwXk?`x((XxIVsp z`{wH3Z~pTipX^n4-E=5B3-Id~D|{QNII)jR_uoE(W0=wXKAL0gg~>H@7n%O)n4OSU zLWtRcms1wTHYhTh$8_p{S^&A1fXE;I`wNSKVb=SJ+=h&~)52lk%)bTYBNhyZ+JTzI zf9A+q03Kj)`TFDa*#v{04af6WN(EbP%v!}v{hPxQOI2Q-w{Oqx!j(Oe+bOqmkm-4s z=LWr&l`Y|nWR&or9angt8lF6H=DyddgwWaS<(*FSmyWmpGfEOCpU|A2i(tDwexJR0 z7J^{)*TwK_Mwb5GwWZoYsT4^;spsJwK+&J<${1|gutlOIppxW96FbA08ex4DUufMF zYXP2kHdj)pEoEp+RB>yCAb zlJR!owXFp`;~N8K`f*1_snR^DHH!x#9h?2454YSjb?zzB7KB!g4K=Eg^j|$2^UsZq z;+-CVQ3TfUYkxcM4*Z+px5HW}m)6s8)WRyH;;jG#PC1Cktpkb#+uZ@T;KIbv!wPnF z?Pu9Gjo-K^U%yj`Rxg~)eATyknuUE7?@-jk{Lm$Ctlk}A-0ef9Ylf17VTC@n0dN;o zlmjkC#OO{PDL30@!-K~#wvK^DzNIS|SYWNK{71&dUUnMDjPEJ4-U5~N%ugp`rj_}M zKHAHyIRG!vklmNPVsiL)b-u$e5^pW*x@IKDX^n`z@0`)Wv& zF!wBmv4VKW`jBQ7mbGuB56@qjFX+xX6JTe8GX`}en!M65ru`$_5a^`j6LpAjp0h`w zf05$0oAYLkJmQb7q`Pie>dt^;Xfxa4!!KuDzPKc?n3YSnI{|MVRQelK8`usByZ?|l;>1fzH9m~Q=*UcN&mw2SM&fHK#C^&0}fE9e) z!D${+em$KmHV;G$Ei7DRIjkySMA>qfZ<*Mm4mUeHI{>`LSg;B%6D6QpLu6rr`3*>} zk++c-K+oYQq2I;DWp1jAtx}9@ZxC9`?KlF4(_&D+S_DlW-ol9B$9H)NJ#9hz2;X_i zD!B&0db}r)jgrESe11VluePNuqu{98gqE1E%)ux4P5>mkJl&Ks_{!ktupgr(Mv@yh zjsolO$HbEkHA;@zAy;c`UBkRTwj=R)u%>mb+)j$;$$B?C6QLlm6-CV0F||{mk8r4j zQ8uT6#}b=EJbR1A^fGzSf-!VD^hf+L!qEM_=cxA!Z(Y_wkMTBDL1@s&j*+BFUp1k9 z*J^)3Hlf35X%n(YB2;IFyu!jh-`mJdYi-_dq`ZfJE$STXY}+%w0!o(l0YuJw*)#lS zi+%*ITmR%Nb-^}Z06rF%d3?&^9!_N+o{nk3G*tQIc&C(_FMD z!dwB4^AY{dZ{Ik)9P@S>g*|l=z3~XADvU>micSP>rTA#U^eY9eY`v*jA>?~zTf%4V zpK=96X^q~n6@o$Z8WYW7VCMorQ^6KpAt155oH<3Zr8V1vLiP0z@{57bb-JrWRgR&*5?f@EU%?p&{5}8R3~%W9tFua7PFD(5y(# z=X27ImW0IFPJb#|^rNmq^kuOBZPvm?`Z6bQyE_oOX?=uR)+sFHiH5dK{S>dJtwM7Kn|2y)(38- zR(kgA+vAlM8Q?u#{lYbeeEO9I6;L!vXAb?0$P~ zVH(TT$kny~B_<5m_47!`>*P<4xlWu^oUwT|na~-o;YZlaYjTmap#SW{wP(g=n56pJ5UPGBs zlWmcV0kjhvg87S48c#2npz^a{yWrYnMuJwJVQwR9Qr;@SUC>3OH^P~JZQd)|uTC34 zG;iCDZ+#YjKMyCi=+0Z~MKw9i9LGZz(0W;hRi~9pO~_OGnU`Erd1{{Fd(BcSCxrEWw4;f&G7RTP8))aZ;V^c>U!GJ?*#5IUaPf zFW$*^E!Xy=MsYmOH!IM7gK|b+<>on{G}r_&5Y4n9z}e8C&Ry$eD6(JqA!+OKB|l=! zC+Ay#uia0S z@WH^Wtc{JydHHf7?tK5}%?wN5>>rqX6>~nA^Jx$aTX}|})$+r;xecwY_W(2mT{w{< zzsEq@6Mkx^`C!$Rtehs_rClP`ow6kmhsu;t9S@+R`=hlTTULLQSI)*BK|!oP0NqYt z6BhQ;G^X{#KDfMO|CkWh$Y6L)YJu+l`l04}S;(`rUm~lHb>B@_#s+p*IohR(==<#( zd;!@d72H5hSJv)S4EJF+^kY$=@xecoA}j(ZkX{m9hgY@3;&-@NoJID=ovVDaX$OkL zR?J~VPR`Zj1OXbFQDAGuL0p4ZAepWKv z`S1zi+4fSE-TV9aRQz@pG0i>W`iA<+!nkq5&qNZS+2qN`6@s_T5_yiN^3H$xSW%XN z_Zz%Nzj14QtaODi#5ZCe1=M0QWb9dzgY0!_OI!MA>Z2$&jlS}DL1N5>w$_+sndx=7 zyQkKHt5bpaC}kG`Zjtc?tu}q(_2_7{xR>ko`g8C}(<`)Du5-0LWuE=C%A#@>g5N60 zcJu428)Jj|xT)&@3d;9*Ea{KU%H^0-7(tR{@=v87`Iy1~p79h%35vb0DU!Jj<-eQ( z`UjDUlz7J53aI4%3+4Fu@uQnt69^LjE_F;g;a}afMr(0uIWSpIT-V7wPaA{KYiv;8*C=@(#5b0E=y&S~X?L`k!92-7}*<$>Ct#;%Z_rKTe3tMm3C zgIl8k$0Cl%BWLvZfB9$NB)B?~#4(3T*b=q}zpl-PoeaY>$@J>z==cqZeKpawtTUsd zzX5vzhYWb7^0PGm6&-I%EUKeRSaVmcrNs<=C0#Y6R(;UN=K*uy={3ZBXj} zwb=3q&{gp&)ddB{O6v45WB;p>h#{_`rDy6B+}2BrreIIfDE%697%7DwsvfHTY)!4c z%i&&Chw9k?SstvmViv(s>E@c!?>B-vw~7Clk%>^nQ=lbhW7KaJ1#ORVsPoTO($h=1g0TgxJw&g#3i*>Ke!%ufYMi7*Z(<64DE zWc{F5hE@E2b1ZgQ&T(w}R%t8Z6leUml*Qj2h18o*vjrDZjly$1)>%;zBBs3dqAyee zgu0eyXEFX*+B0jR%E@2=8_)Sa)uSH43FC<#Q6%u_inhT4380l29e!B2Yzdz=$2jz& zL_)C}X&We>GwMMbN6k#~x^yu-hJi}4hRI)*q@Hp4gM9x*;g}_j{Q;Q!%uGVVxdKTH zSG?RTLtTA6iFcg4zkjY|f>F`JCN>@5VBm4G+Mm)aD-Y`G8W`Mtl{uR2qnX01~GMzb@8OVQ9LmFqEZ2gl2FSVUw|HsVGN%)3TnvFC>0FxKxa%`Fg~&{#9x8PLM9k zAUuV@i?nuC`B?OGCkM`A>L95qEBD>Odp@xhGX`oB5)wd96}=JU#Lid`=3e8PekWH@ z5Jpc6GIszDWB@;14-RXxRS5x$9#yJVD(m7xs=-468stQ}x$*nQN82ONW65A%B;ier z7PZD(|B)x^x&{7E?m>DY8IwX;HfyGZb`e`x7IWTM`S%px&Y;FFjk<77tQ8Y)^S=0w zYoTu{ZA5L&sCbN6hhhf6g z0uV1id`0y}LSecwQ`=Hi>4Rr(`bMrp8$2J&@C();))_^#ex@i~7+Bbc5XaH5YPwAQM~MxYR3yClZh z`uP)tZk)(K+kyv*`e&&OGW15AM=2NKL2CvB_QPw9ZnRb2<%bYE~iu(Hne4Yh*0Lc~=7Ty<;A5#r#-nwqFR$Vlu-}C2U>6RB6 z5yyFD?rXCgc{X@TVq&=V4>AC;4{1tMHD8ZH%rD+v_Ac4t{h*gXjS6AuMzKt8eiY0- zS%k5+nk+2VuZ>mcZ(znly@ju3o)2n-5(q|U8?F&k$|$&KL#!lELJ?1o)>o1Gl*lSE zaGa|rx|{^5`ms5sfqr978Ae)RP^llOwtSM*IGTP-zH~;jD04bekT7_{X0&VxaMZ4irprk;bC>@Oo^?|-prJ1(nhOo zpmbgXCwA}*lFN~_NbdWo5H3p^H&phD80hg$10Rj@hg*uH&k9PW_t5p?AsKu4Y z;EI$A4tPs%)R)X(dziOzyuruC_?KpEFr-CPk#T((o}^;&4}urSOm z-Zuu4XJv5$7i6uhDTvnv85Gr!qDwE=UvbWB9=pD~Ypx`7Alf@gRWky8^SY0{WQK_p zT}W-ey-8XNR+%u<$}{wE+X7^~{O0T|Hv2nHP7Mh@EQ3{KLE0JG9U4kq34B|AR*cGy zi@#0Sdlr@2Ws88P%4ZDZXMoZ%7)%Xvk?0`@ZEK*>JN}v_XD+l#`k6pD;O7aZ3RhQk zbtK88HCOIQf{1MNFzJzi{v8>|$vataESrHczEHK=T~Tj*63n{(@CZbV?V718tq2UwPXeiE+!vri^N_DqZr z5dpS7!8>Hh$|z2LK0d+_pEl~~FPb?R%Vp-N+zJ}m^bAoe01F22tKdo8#1Q@C;S_=M zPwsJ_F`r3GbsEilx5psBKGauV~}n5 z3y04nxf!ht+rwtzM8LBoE8O87Kmw1y7v?L*6!LgpWtZMegEkrA=oTOK9{1H=Y&${y zCHKwB(dekGMo5F-B)JM}PiYkORkluhAZ=5C5Arp~`u6r8e2<`Qqf{g6UB%D$*;I+> zEqk_d4cdS5I79=amawchClsa=o;Q-E3e;ODrR6VT+PvVj)|(0$vIjV^`|hOYaU{toKj$N_s>T{VmtqwCZWl%kE| z7{iCi4SlY~5S%Y1#_sVvO+7sqrm}D6Q#n%cEM__7g&uSry}jGr*VwT-H({--{Rf2T zf9fu(A=^nB)@sgjTNx(~!Er4%v`0S1!%mZ-0MQ7i5r&GmY&K$HrBtiA6B-jQm&>Gct#gnPs3BQF!VP&ex*p z-!egLEi%?8Y&XZs7@^BthuTL(A$Z2QNMX{hirSQ7^bCz9Fm(9n@b<|R{n_ee^t!)h z^CqC_U6%>yK6T^IaVaT>e1~Gc(;82uYZ^^SBAZ|TEM3?f(^Aa#&@`f)`&chS?;hZ9 z%Y|T9VjyAlX;E&b)TEw|KuoKx@^kjAgG`Y_GQ3mnxa%!*bnGxpSiVr;*n4`PcW#P2 zr#VCFH?XihWO?xkvzRQ>Xzf*CMZf-YIr%SLeuPcE+aA)l?g4LoUmiPQ0#)zY!&p9i#=tyH zElygnPHBM4ggSG8%q)PJRrrnxiM!mxbV^@Eq?xP+pZ%CFN$Q*QG95mdQ2<@S7c)AQ zs-QYuU*Fk3t0x5Wg~X;Kx;BK}PP^6SV_N-%E>;@9a>W_o8OUseC}r!^=bO*%e8mSsN1oiWazKYngr1_rXdq3hEK0ZDHm}0hU*+x?KP6KHEg4yg-Ud8eKf0MRA0Z~Kn z#j3#CZBJ}Mj1JS+hqzZ-ZIEI+VG^_LPCE(xP#>Yatt}kd4nukfZBusTpGu_o`?qT+ zD&z7$*IUZIg}bW)Wj5$S;4PiVPvn`FEirXr7E3L#MJyx8z2DT8SO3T=y zTq@hB`85OD02V=l#8R?kPc}{&L@oJ%+8B;PWL8G6_X1cL`z6V-UF>&$WzYk6im%fA+=U|2A zWe9nbGPup&pjV~)5ygzaWPOqhx@x(`7%F?eDW{-%f_-JfSqR3!VIZ8J?);-Eu|Stp zWXQWb=!k6Y#kqe%vCuLJ{2zpG0XF%?pm~-6ZjOCNB8O-YYbVX=4)xZ>e0WpW?q()W zzK2o4R7u(>An@h*&$1uN5pzqqE5g^C>JeS{0{gp&C$*T?w>7sDhk$f!{Fw#+C3vL*SIib9246G_0g_0H9T06 z@$+<(_&BqEuMmh1ZC1p$R=%cyQ&HI%ltS?@P=JSX8gl>S;<+qE#Xyi;lQOKT|i$VLHTY;bA6 z0_h@gFd%n!eA&(|Gt6n5wE=RG3<>H<0HKl_AhlU+D2u6PTAHW9_5F`;eaV&y2+1<< zHMY%oIT-YhL#TUy0;DIjakOLoioCs0>)TJa0+Y7%H`RFEr=V_y60 zml-Kuvh)J!uak3n46j#N-j{00{W|(|PCsJf@Nz1#7C8fR`GY0iENY}K_rOYi{o#!$ z5=yn(ln&`pJ)GB|gxz0s;ABA>V<&mx`tK)|%tZ4;yOdmAwBqacT>R`Yud6=+`W;N9 zL)OPg0(Cl@dprR_u`iji9IM8CHYhjaIS$ZIov<1fm@J3sg^sER<;_7> zEP2vN+VW}wea3k7mi{ZnyCI@ozr;S|v63+b{ld=Y-ZE_8K=d8EOkYntTqAbqp8U$p zaK|HVz8;~}=oe^Kl1<0NgWpwY4XhGCglM;08I++IZMCl2l{r2gUImQG;BWv*d!X}2`xEQs&!|x2fp?qlP8X;O0SraCaczrv zThJ+nY7-&)g1oFWGOP402(5`vl~gUhkrj)_*a#I9Elf9DG_>kenu^&A1XBT|sfX_= zFPWTGfI^hr7fCJsp4Fhs>smrOr>;+XdKZO`B`HvM1?lI*#LwP7x^Vf#*T;%L;@)xn zkCsLBQUAjKK#~hkD}YJfyvvKgkE9zQ{I0I1^5dF#nX$V==AJKd&zF}@YP6&o zz7jPd`*3>DE>q=*t5RclkkJR7V~dBeua=Z)Az;uy`8E(i8)OWN?a^1jfUX%eJvY{P z#>vGMI^mHq)3!)BBCdEWl?CZ5K-ybb-J)7`92~?e4-CRuB}~N;Lz&o==k{uJw=gAgM_>t zo~ME-LZaoHdWPZbkvz}jV71|yM(lOJ23MmE^t-eI=uD|sCx@^TiS9$vtEKJud#|-< zlVA-;=4##15+~M3uU|f#pSHOqjey}hb|Co=^5qzIIsyj$L8xmS5eAwjvyo*LmT=+x zbz~Fm$os9F+O9t~--j0aC+D$k7>WEDw9+f*aYARQdHZAD$&BrTUeEIb81C8f%Z1C$ZM*hzZNjXH?#RmXc?0#RSwadVA;L_i7SZb7gv}G;IX5ofkwLf;nCT}>f zi&^%&qDbtrgRjED2AgPNR-UNEg=F)y0o}v=`-)5~Y8Il%1T@M++xSSMK3QE;3Ew@^ zEL&~NdIQTMrlk=px#i!OvL!a|zqWUMGv90SG@A_U6(pC`x9_FUl7}H9{6P1Y@ETm* z`o7fk=|QAG)=(DtZSEUUZt^Xvx%R7HTL*TBm@%YW2hnewlsBUZ;={4YX=wk2cK+EpWbg?;#H# zxu0HJvR)0JaWraM+-U?C?LE73Hn~Q*;wW_DjGC~e_UeZaTc#^Qzcq?gs^7z2cxs5% z;Xc`h!brN^>jVm|t(7j}(U3xzGAT!iQspR4s{pB}X8dDMH>HgLLZ=57j+Z}FQfL1b zs@q-$AX+9{=YxWm`2yi%o^nwe%k%a3pBSMLOb_nSDYA;G>FGEY~r zv9SS$;v7FgUBS0edBaM^$a~e&V;L8>QWg*xFS+Es?X9hU?+DHX$QA-3I3V7+1Ht}a z=J;8vH34tX?N332PyfmTs@!p=}KE5%f?iWE9c# z!VzHDGY0QJwwcuM1Fo>Szz}#=gv<(U*~J-7h^CK31`x7HWKESuA^y^7vZ~ZEkl`Db zs~UF?{sRD}05(0B)oc@dk4Q1_3=9Q8iM{jo46ld=q3Z{$zo+N#&^LdT=?_Zhs)x%C z_AzY469o>PT4AU2*t{U&}7k7Bw z7j{rkVFI7VT@Q@uDP+4y*y%kj6i* z!8L25>s^s{U`kBH(rPXX=Pk(>v4KYgzuwitY}RaHG%Q zyFB=ErF|W4Gl7lYCq5`v-u^n^!NZ8|-K&-7SM|KK zx^!V^Of@Cb;VYzNf)cP&xuum+qf}wim{lDgM=;PUQphax*!G?@_R}HXghb5~E~NG# zoSf5su70(S^fqF}?I6)iiX~SkeH!W0AAfJ}qlAa~`FT*_1b~=@g$3|#yqsJ1W@K3`^#z=Hz~ElN zjsFJBBHr?JUzg&O%XE4~Ye&cEw;Y(_$nEoG{U7f;67(LAju4@X3@o_>A2$8D^w<}zJry3qi!-@f+Bd+E85WD-HuF0)lDGMR~Xn{*>)8y0bz=yZ(`fKz6Mv$FKqR1^iwr6%QSv79Mx!8O?r2c553S?&C7kcdxZ{f!#3Xv zu=Zv^9sjj(Ys?eyK_(z0)*r(oaO7xdDE*$Tv#jgk8c&~XONhog#d2Yyx3aowU#(uz z{n_)()>t9?3UIA+9}yxLtov)n=c;fK(0-6pwOKM<)YwJp?ty?)Y8bnpLVIf~65@E+ zg1ev;mo8AvjF|_WO~`Yx*yNScGG(FdC=FRl$1Vk^KkJcL+2*rjBHMf{p6l`0mg@|b z>Xvn_9(&vBaFkBiDjLvNzY)oD|F?OJ7`WRTL+=Gm>lhHw-PF|ol|+d{(A62C7K$?M z&KwRY-_wP(d^93476H~&fS=#i-W~(ilZ#o7O(gsI&ms~Jj~T8_a}IoQ8<13eAR^)^ z+Ip5b@_v2k9DHaMiI~!?LpL=V5$*{Oe|Ijr5N(ws8UTNtJxoVxrPBY9^U+I0Yc{4h z<{(rjqQ}vyD-_G)@$iH&4C6DY^R<<7Dfys_bd)~Z%b?)P<=^htX8>%xWjH=QI+BU= zbKO_bIc~(6giB)pqH@ZjU+Ob)9M7POI9AH2mCCD{{y`$=qnOtA-Jd_rIKlxBhovC1 z_&=d0X5EVVJ`5zC{spxkwJMEiJAhyZ#Q{V4OXb90e|$}svz6g?7J?d`{rM)Q2>Aw& zj;+5ri4x>wAn28Sq%hP?P0V}?R1B1DxJ-bi3b-FN*v6V_#*Ix?FtWkSlYrG3mMn*^ zM$Ka2;9xo#`lVc4qS`ZtDU(VC(b_d}!cY+SEMsYH#I(f6FG{b{$a^AVjyeJEmnF5i z__h!zIX5e3Z`PZW6Sf?kxGE$ox|Pt2MPAr!aR>CGn| zOZ|Y5_6Oe_Xx8&7Y7`PRAN7?K{&3hsf0u8HZ_+G<(kZb_S}8s~9Od@ooWRk->JsX@ zZWVW1QaGkGe^lt#&ne?ou^X!(E7XbD6?%>K$XJ6m{edw1Qo1}x()@pk8o((iSs|}H zi#)zMd$1PGX88cj8>N;jt=SD+vYDPnNF-DbwrC}BbYC2PeP;>Z!I=C_j#+hMy+u>n zZz`i^gO!veKHNWv;0tAxl6C0WU+{D^scj>ZbCql5jWvhlg5jDBf-xR4r}VX28I$0z zu6MNR&lO<0`#wN5MFp5>7C32oo?;_}YZntXJv6Rt%U)>uy@b!RO=0JXko4)#oCRF6 zx>P=QmPw4k=4))FS&g^c>0+8RjjRwx%XZih_?gGR!-*5fj`WsEqlX|mFBZkP-^XrU zfK3UI10$(Q+((q(BOaaJm5PTnD#wRN`tjVvW!T3cIl%<@>C=4;Wh za4D53bcdc#${tJH2j$}&B0LTx{^a6i@ROl+yB5T_v?8nJaHMwiLava*q-4ryh;&!8 zhU)K3ghbW)ej{tw7s|K*l|Wc%?{@cY4d;~H=BxBq3^gk00EcyijkuQ7r<5A0VYV;7f(>*!<(WfpLrE5VIxnR;E zH#_0>bDO{EIzJ3f_pKFv7HJ#}vt1ax98T6xOSa-zeJd7EfibEtfo)tIWeAb2Brn=&-*c?L_e`#j^eWSw9I4P_-kS6X*1<4!N z4cwkz!m)F3myuBK_vBk?IZ1-nc2u6*E^_oqKFYe4`p=e~c^IEgBe+^EId7S-BZZnf zhI@T1o>2Un&Q!uk)MLClht(P_5{Ti@2NTbp);LCzKMEVwr&5(OOK{Jih4z?~B9s7j zwy*pUDg$AFXu!&KXcy7Q?bEQ$sE3^M_3DSf^Q)@_$DdK-)>*?b9(HHDw$$L&hracF zdAh&2sGFLxRR=UeL7>a)q{IhIkFg$nRx?WO+UJcm7u=r`=gI5U)eJ!-k>l){Gi{lX z5-#l+vIIzP$pyYmOpwkVOJIh<`VJjgR8z<#)PWU1?9biZ<<9W%@Zlkii80da)|Rjb z>l9{Co4;lM%)b1&IOR6SQ9gpQ?)vT!aQ5ygXI3^eZ3Lnrx`v8aT1gs&T>(P?SoDLW z3~ds*6NS^CDl@%JGJJ(d%>TnGc?DrtfD6Jmq-OZDpEIa%FLuDdm=M+h?KP!awBHky z`k+nO8+$l)&pb9Btro?lEbedZqc%FSldM*6Q6Ay1Q zUZGo7wpKtY7i|5VH=gymjtO~f9p`}XOHpP&PwdXxN_)n5pH-oi%OWCe+f-uB%s3S@ zipF0(%k_4pxk4a%cQRMGAB(k`VR*`@-1ui_6%YVfor9tHeh7t;VzK8S&4Ngubt+m; z{M6JbjCqC!?(uT)0|;WE!$z9`#xI2?PB0+y<|;q{HI0Q<&V4fE9}wVRKR81Fj(f-R zAO6S9J+*fhw}k-L-u^Z2U$o`Gm`}%)t!Y$qBw$4n^asI`BWU~J4pzqK`@R7BC zniO?;5$t+^Bm%WhmLMgJ|D|p!ZhE{v(d}Jej%%>`0V7Be#H_Ub@nhkfJ?LTGWw!Ij zm+3Yic8VH=qjFbd3uVLU(0g@EHc4+~vrCth+}JL(m8z}`{YI=Oaeu7U%h7vP3Xc~4JMF>OD(qlY7mA0QE0~-8JpN!uluxSW_LoeOJLL&3L*_bOmbK#M@#SYH z`?=8vs&}s*W4T3ioh0i;zm7_qI&*$AG!xj3O($W&QRE0VJiSI5MW6j4*M62ibaz_-okG2J37J)H16pzkaz>B~ynQ zBPoZpLJx;nV7{d(n#IekTu5S7Ke2JCDn3ZejrRIgs%=w3ccCcXQ=ulK-lJ8hv*+SXB@_=ly7BtHGgD*`ol3Sr-%MCa0T zCzO+DqAWnJZbcPGg6k$0;O*@Vde4AOf<3J|v5;b>CoJ- z9pk3)tNDNy9NRsG6ED;#zT8h{ER5+`Yw93!>a1T@xAm}oX=1&Po$Oi&x-B8rHTTiC z7wQ^Q7A3Jv)~o7TYS0JY7v2<}a^wzlqWIj$^h^9(n0aQ3VbZQ6nJKhxSX&d_(oVL% z=~4`)6(Eb!YgF-j_sRA){g_iOES!#cKw)&+&(lCG-b@ca?k;d7ueh zJhv}M15dX)nkMJ~5R;(Z4gE!~NFmr-+&}1}NYnCr{Y0D!D`^RKiv~|~Ju`>xc>?>o zsJZly|HO2SaCoI9Zs7fY1?ON=u2AT`YGj&_#(z&#lH?X|$zqUPgJt%y1XOXc`9li1 z;#2)Tu#ktGpD2ay@>W6o)+)vX{%n+$d?Gh? zhspX{7l6W-|K2LxhUvS#G8oaOOV32sc7cp0-meV=83c{9IWjh#rb(|?d(rA&PIoo! zn_Yjyn`GeqP7}_269_uSAzWfPoM+O z-q+_Va?g{QSJ*YTH%|^AFDK06XLqJ7PGa*R-Ig zNN#nC-D~M`)sgO;nvq*ELz&YkDw#tKAa*$gDgY7bI2n(8 zY~m^8zRgt-oMS;W|8x2MK>*-Oz}OD(B|xt|gvxVzP+$Luvea082KMpS9l@869w?OX zZ|ecy2yA3tUceZieF8OhG5$6khwI;Rr)xm2?j|(GZ)M+n_oeD zQa5GMa2s_|zjpY)40ApV_%LADXb-O>Y-BHsWzA)g=WK`eu88c3OQ&Ov?rX8glF@x9 z)sCT~aBOZ!gMvV+vlis+#)gYhj%vlj66np+X%l_m!(QOr$HUc@4@m~70_x)7$c>VHxi?4&GDQmYSu7(|$^^}-l z&T^~N2;K0yr4V9Rcd1rg&fEk*30hPtoo+HNs`fjeLc3!5mOxauS~{%tX&N&!qBO1W z1;5JD3^CoXNc}4^&u82qpvuOM0(uqH$E@FaA+|}=7xR^xU~;s_b$mpDaz{&x<4p4e zUkP~%oOv-rSu|O1`ZR``)@&sy>~Uglwd1lyJrk%^7r_R5pC^Nz&gJlHt`L-mv}Fm) zu@8<>zny-D+c{RP$uK-Jd3}s}0YWFRg0*#bPsV6TKN}yv)6T>Ai`8c&hW$Lg^Yb3c z$5r?mFO%Jx^kav+a>8D`_%M9KdtmqDDW64mKM>JJWOZ?Ohcjwug`|*q#(nSLQVM`9 zG;Of^i2D3kzNokNdEZiBNiI&;uy(h?txPAq^W16e)=`@~f!B^>#=f5$ktm zHa}JRn7#BPR~onjyU}WHi9T{fYu)=5tc50kH32Jb7$w{WO-#J9n#t%ef6Xl9QQ&4l8|@c9r#F`0yAWI{wm=bbC>VI zGmagD+Jk>Lg=f{gn(Mca0oblpf{cr=5%Wa1&CShS{?9AXAJb;QA0oA#=RynvihQ)x zL}1jm@u=zl-tv9ChgWg2IKcnqY1tXOVFPaxGz2PX)CX%R=hHuVRoFeqhvlO4+wu`B zyn`ETPE*$P(#)14&jr~#L7AN(O~)y(j5UY0o<_74h5D38uE|Shu@Ka-9iP*Fa;vCOH?*&1yT;>JEzF@+rIUgCQ+^fwr0sWk*gZN~)=A=UA3MkP z$vetEQ9v=7B{b*ZL9S3V8yELw)rIuj7k|SYTAm!9qD2;R$c6`T z)-dOYPt)mL3zoyJ(Xb_P9pMp9@n*&SgBz!A8p9ea5dUS=eOl7)@(*RN^yGyptGQ!0 zm<9XeBWxRfsf{Lsd|%3Hs@FP@3g?-?pAGf->5pW6C@1W4Az!c5iu5WM!Vy^GftA0F z9oI4kk0c5sk_N1Pa)e4o%q2x;2W zL=x+}FBg4jN>dZZbV;e@{X*CNzxyC9Lmaj=`6vO2nMg!9f&I2?pW#n4ML1NP)(9Wl}06K(2f55fVm*gfZC z-|d0>YLa=TlC5@C1F!kL0wT=R*Hsoinn7my|CY5qW%wD1f!6kxol$Z+J3E`c&i0d` z!fbHdnlNVr0Nkr;mSxh~ys|S%fu^%B4-^b*AauRC7qdBjddljIY5FREdUl5Dq{YeS z{5$zOnX{1XWiFnktCc`9J>P@n_91+?nrCy38?Du(;a#4w(RCWE~VQ zQ-C1tFCZ{I7;Q#@BmzQ7U;)!dH9sD4kgsWxKAp}nj@EE>c4ohphoy6aTeV^H&))`U z_1GcT8IO=DBlVfm#4w2KG`JZ@%90TfqH=iZl@^=CM z5b%6#0QkT`0Kp;M8j^`)#~olVm2zXb*^HZ>D*_e>THi7jC19;2+ThOh_lMHh#bm);&_kfKNAdRLC%~%&W{5k8 zC6J`^E&}y-$eEz(o!S3qf z61-lo4OG_vKz75Ao&RWpd4730O=-D2F~0cAh<=FY`bZajNshqv4L>Jz#xWCkd>Elx zneDxQhuZj}4MmvD7gosr)l2w-?7dy7&j%E31O3s&VO&^;opLFgjn{p-*_Er0P z?VKHm{tLu`_Ns`ydaLzSLb*f(yHMM|f1x*>8RrnT$6w$-$&T2JUe??SEhG3UAXnsJ zz{xo;Sze(e>n{k7j%7!-*>AU>ypOnXG9xqr zDz+t5aWm06q?FUI8O+%jnQVg=g_>_(6?^9h2PQ%oNIKp=&Pnux8wxnWfO`QzMIub_ zmCOfJ9rOInf9Jp3={7nwmTK;UsAPG0b6R({0Q`(qG`=%4nuQLaw@98{1vm<5qqviB z6l|zPN3hH@9Rj*QshMO;Up)azel$wGq6GskKS<2u;mRer)Y>K}Ex+xDar6(3-Jp@| zQ_Of;V1-F681ZbyV$;04ZD5WIP-7W!A*0~8D9kOG%M$szdb;^?K)(3fqG8B{68^L9 z-Q8%Gs1o~N%njOO3aZ;A zG!{FKD(``bJwS$x7{eRl_LQFmOVjl>P@OW8gyRxf&dhvxJ`1)tPrbO0t=f>tCC!+U zjitCt`lon*6H4en5WZ7d{|;WHD1~`{-gvXfs#{rEY47X|onNcFXWdQHzKI!Q>8ma9 zwZzd7*Bq)|l^l74`Ee!Wfw2I#%G8DVkR;aww?Z`lJrvUl$V zt8my@TI_zxo6)+eoDIN;t#5ILZl$Gg;0yCc#skZXkH5dahe!AZ;I-Cg zkfq>~xD;NCug#|^Fa*^!O{qc2DW50_``@rjjO_vP5%=Z({@#@n?AyMco{r+>JXUM+ zy+DkuK2D0?m<{F1Vp*f%;+Y^K&WCRPiwFsIy0;XcBsyq6>#Hf=5z!+5;?Q@}KrYq{ za47R&fb-J+jKvGbumX#8+PerJWC^6-Jw1Ky2S6rZ)O_H*0|E@*5Z;`(q8}f>1SYCg z-GLj&A>h$PdK)y?gOwhjJb;u)?SAGlW`Em}-qqB!htKD&;J!jgho1dWz+Q=&dc_=~ z8Inu*28FDdGq-H{@wE2mNl8eDHZ;x~l@7+jI&R!;uj}9{GPSQ9mc;HUicfXaA!!in z{buU$GNlW$q6k4L{zGQaQbZfz~kcu5!S&)wXwcJKV^lVU)Oq?uI|0@h9ZU!v4Vl-puMqr zy#r-e?E=@27w|N_skVE*udQIuz=*(1WRWOJZE~%A(1BSn7YJ34-LCOp;Vz1F0j13_254b^8BtZg2c7yba0hR{GWs*93pmslFcoS0+iMbY%wEUL?6S0cO?-b@- zvhPB=gedt11wpeP)~lV2{KZ&F*4uZ}mH@d@iThP*#g)(|e?j$oj{%3wt`os7-S1T>}+vBW!-br^vCHc;hDyE*;l`$wM zEUdm@i@M!5s3uG$7BcDrFDs>yW9jPY=?M-&tzJ_%OQ6LCVXN|ZltwgMOuSNmInaxY ze@|tRtBJKYLGuK9)j&@r#AnpY7d0W!eR5Ww9FIz|i)=!BNo30vq14a+0*mWMezeHt zH1Vamc~_NNO-nR-0Y?x@xgiReekRW4=}DO0Ff#iRd-6R7(SKq7z@#8X+on;HJs!G5 zR^Jl<)Kc4Hz9(vipj6R_ZwD)4x0LQ#P6)o2OuN4 z4TdLhgjvz3{QuQx?)6Kl7O+-$=&a7Ey)ovl3dKQ%^fwvW6htkTlMl-qQ=;}%yG77{9;HcQ!GXu>rU%*Nn zFS4QvyEP2s=;2`j+E0$d&=(ugP%O7YRr-Mh)o>3}q<+8Af{m|0RMb5nAi&KHwhAe1 zo0#zR&tU#9txEg-IQaCVR%vg)RM%q3S=;gK+#bnhlB2+3p~*9*CFQ3E+^2%W7mn5E4V@yZeHUk2;Cp5mZ_-?w zYDy_*yns^El(N+ONvZfPEnKAUaq{mz5wzmf!0cDohRw&BT@DBTDjW$Taf+K7Q%KFv zQade8W@VULFXI?osnPgvON$?Se*Cv{ z`mo)dj~u`_uW#Rj2gVD)pj4HDMXaauWMRyJ)KrkXYLXI}4RzKGh#ZcfIrvV9< z6Gop}RnKRUvkO?xan?_4Io<)t>R`Os&RW-5T3!ZBgFo2RxdNjZu_)08i;Bq&^z=Xz zH`v3ZTmJy1N9Cj`Xu@?$2)u%}%WsC@4dw!XsyVXJNh}1Md|)(WHl590VP!5WF@V`k zfrZ|qf~|d2iG5K1l7ii74xI>M9*Y~ z7OP7ie~F+BNQ*Qa<8$lY)3h|h5y+=NmpC3AXXEjiP-2Z`Vynje9>Wk4JxBch3X=wA zDE|jk9mC?$)0NZYF7GHfqR%MHD=XWAzmtm166{qi7Adi_29qp}`|`*s#{@XG=nC^; zqjgswtj*;GRsE9dgRj50Hy}C!6m9avVdkn}>{>8aq{+VGYo*|~S2mRD>Q>Hc8ei-l zO`2IpCT0V*&rekgWWe3c(}OT>Z@H{sS!}Vzs`)ry3fs1zQF|d*wcVY;HY%$rA^J?u zayv4A)Xilvoo(T-00ZK8e)dNxy*c#N5z0Z+n8ix*GDmVmqK;FJ0bq1qf!=k!i3TO`)3lI>B|Q(=X76Dp9;ky+!AYR}@SL}t5- zP97+I;(cjZzhgoy2zzh2Sw)lZGiZo7`^Y&5twE_lmN)p{UXNn_?%!`P-o81g;-(Ma zK~2b(n#+1qbWeg{r z5{-B>=@exv;m`IVV&OE5=ZQvfj?`bt3mIxJ{!P}2MbV8;hT6`iqySCm-Y3&ClN+%= z;X#fw(c?lGn)Wb}j6g38XnaN*ZyT=3FiN>clD^$R_Ay;d){iRIE3|Rgg^H7GojM5N z*4589@|*Hk7*JV}^R*e#^<%x5Ewmc`%FdUwyULZs(qmo}lJ)l=8u9hsIB<)YH|?$v zS7TRxBW<&^(aK(ojSr%FmrDk>0bI~ZF7bbXor-xG(o#Jn7$`gkH{~mOs6rs zSElu%W345IHp0qtkYDabQj4pLGB#)Zv zxbh|Ay`+tm6gC`;A-4_oCOS}lc^g5Usc>`#y6Hl;n?9{7vFU!%;C73>s+~lgV6`u` zC^a!4Q2|2!nV-Xm_tQ9M={W$a)>Zbv`EMDrGKOhu0S68l5S0CNbEwKY0Q6zNw#OM= zU0n^*awu0RYTsLY^vz36>>zmykhm?y6-}LIcCjQheaQhX3UFv_ zS;6&^v4K;~#ek|W3!pwCDxNFNh)^dwA4DWzTv9l!vzGZOE_8g3J)3z?@G${FKfeTkP< z-EUT`!!hA&9L+yU%7k}6dof%9pYp>)`xkMv%vXZ!bSq6X`76+v{QGx=nw=Q{6~Ja& zQ2Gm@xkm|HjP#LpsR!E@65UPeD zZSlb;ka_l74aS44L+7liKY&|+Ez`O7EWS*Go$0o>icKJc7%oCD^X={OGM-8MmV5Ob zm?42ZTeY+f{3rx?c^^g%UV?g4aCMd?r@}cPpZ>L_0;PVy|9Lfv>l?SUcjK_>**bgp zz&zh*Gf0s07tM=5*ERZU^%M96aagDDWKt3^|bWtwlzJqX^`ox~gU;SpIjLk30 z%juR56He-be|*sMHNE)$$j(^rll!CvE_BUzf|Qc8^^WeRJtmEU<6WR-n}$skhN)mb zBJLk|wxe!}erf8+YiJUr0YvKCv9&PNvA8Zmg}j+98dtt;K{E zj?}bnDT7@F)EYvj6S>%@C6rDm&GDyG0OA6SLmS_{b`}CWZhv+8MQFY+`cCGZ$Hj0bG`ZG~-@NNaK^%x}! z=bTQs!rst*N!A8p#56T}cnp?A@t2j{K!$qilH}5rjL_VmJY?GHP&PIc%RF*y?y)P- zp6a4Lq@9$W7~r3=QzmCQ7pmRWuTR;RQG>w}IK?TnH(0hxK>mEGKW@`(;&eC zpdjEUdj{G&5Fuh5OewrqYKF5Z%UDK|Bh)C1@|k^H{L4r2^O=JiJDdqO=`^40rsHMN zQzDcyG1;CR_}He8zh}X^3qCU-qSpRdUSDK}z6zk3&*rRZQ)q-p9!2 zF3Z}c@d(lCg+s5YtPB|jf{O?<#s9z$5L-J!!0a4wH+i*K-P6S5HJu$D$IygC%jE+} zF7R&GIrgaPhu^Z^cwT`P4}7_qCSh`_#{5J$fR1=`9)hiO?G-&PKdVt%i$n05)^RJ- z_I#p%AgbnYGF=qgEXm_kE20~S6Gh?=8VFDMJpN5i-tC7+N7gPbs-M?rSd}jhZSK=K zT#)VKN!gP616cKo??<%j#x;&lln-Go(&&p7$1lpAgQgn4h0~`gqQH7>cUu;)?oHa& z>ppVm-7m{n&Ap-BXFg_xS5KF!zUU*}jP4_=nzA+fWA;`2@a_P*B)3lIQJV4wTPld> zl}iXyO+v&yAJ;#YGh4<78Agq0?biJo=bT1$Vj&$un9@EOi zz|NDWCqgPY7>n50_ri&mZgeF(ou6q_+FunWz<-OvwjhU92=d-$Q9zA+T-+r(*PR6J z0j!+Y8!z7j4^t3i8>zHta515Sl!#$ew_9cK>I^tBS8S+41QR%uRQpVMiet3-usOzj zu4gHF0v`TMBRJD29Dgo5AZh>A_B=x&9BssAR|w{LIZf-pk1=Ro`@Wf9{clf8F)d>oXuM zXW|NWUYW^&n5t zP3`8pd?(ywYw)#4l|g~?&e<|LAzI$rPPY=JSht3u+tT=S(seF$p{4o4gBl;LGP%8O zYB|UHtlZbI`|Xg2rY~Y*x?teX>aTR19o<6u>(X0Iu=^33d1H}d0fnx9;VxpLHSIi+ zs^0$Ddip(CxjBlO${?v|WemYl<3BDRZ+iTL8`bnVMU0>;X(SmHx~0~)#a7{6+LQgp z@+HvWe9fbFRiq(!h&ne_%5nKoe4(7#sVwc$VRLw>WT6Y|YJc`~+JxsytENPZW$i;Zd@& zg*6YISgbR#2nzd~Q9jkWnv(YWLwT0Dbm(ysD<^=`PJvSI-$NVh_W2_$i{fqe73SZT z6B>;22V3&+L7QJRAz^|6b~2r5 z3l!oV0rGGV6m7}7(uvedM0YETlJht05QZYY*UjxqCxoky`JRQ2kKY?EL3B5{EPivC z9#5VOKOy(6q6m+8_P#YRX7gnC-1F{PIU+{sQ= zBHLYIdsRBps~S&q`XR!H2LQEI{x>d0}N z5%}7zzzx+&0GIoZ4cp3w#`cDjJ!YKOvDbh}c(BHYZ<4MqhUEyoK=J0FxY*wAm8}2< z(372YkvavO(b83dvGN?T!bFR}P#%d8mWGL)0q6-^2M2%#$PE@lXPao_C9xPiP9I?u zhPbSQ=DT|B8*(8(`mf!ODo-V!Y_JEL2dHqY`C2sOa&XVTClNlK@y`1r&1~TRpD5phd~EjgG~B&%HI|3-TsR*uk`m?PTrfFts`z{t6TiFW9O; zM^;4K*;tpTE9g|JY5=Ib{YfZsi6V1TL?=>%WYJjQ7q@x6-5mIt=rcTkHvx3qv2Li8 zbvWG6q|mk_%T+6lW?w7rZ&|_ipm$}Mt)rV;|3D`M;^O8eZo9y@O2*V;TG1HHo&@Mq zpny@)c*h|36{k-vlj}vlAwJgM3JapW=0pg-wuTs08ZfgV7Tj8U4 z=T(isSIByez+9j4xjn*4^{ST}-UaswYH{A6)4QI=%r-%hqes( zVGOjK*FuTvcY~!88U?vFqp6WTEsYk0S8b#Gv$Y6E={J3U(v6v3-^*OgZKSrS+}f+9 zvN>6*+-D%S@e)E7&ShRLmVS#`{^%GrAUD=W(pB%rc8%{&s|^zyhPMdOj~Gx@s1<>ne^4QNn>@j z(5Lt<6BQEO;4$A1xT(?Mkd~G~iF0l7CN19(SgM2g7ThF&ec;8EAaqG5bXT~$g|MV{ z(yvN}Sy5=itUdqD6-&lbaP?V0yh<#M&9@{Yp%YOdw_c{b&{7xUjB+dRuYI3Yi4G}oK9VqMJ=wDG!MhyH z&#T8TP!Yxu`_5l0T0#Gd0YIZ+@79f#n#)YlGx#JZNTqyx7pMorG94b5Dko=7(ftQ^ z-<8Y0X#z{QlIC+EIv2&*2g~1vA!bh^>V1MBc?)+YFt9kOjW#F6(cFfndp-UZalPR? z+b+fN`N>IZ5%iX?JK}%%OYR0c1?R1?$LPSk@h|ZF^}*ovIMu)(9X1+^FBo6eEI3m} zXwy6vt6IerW6^47SpEx7t-k{=OPLs2M!1nND)WVUjQ(KIiTBC;JXWr^{yPr+xVuL!&t##?4G_BTVY46Wd`FcBlJl9kdoebl7H0w+ zO3&GIP=mAc`dleVS#dSi_g)ZnN3X_u#0}{O9S(Smjn}0}Y)7m4-o2sC!OY+F@EQ0b zVtZB%uD%A?XdjbWsF29+bvxo;xTy*d?yKwRX{9yl+tnyew{$7Ycs)~$W_?R^BaB9xcW;16Zo zXviad#USq9U)5tIQ?gAM;-2~S`*Ox7!O2a?n zE=7GP;0do{4j%*Y?0?;`9X_^Mo6|WV{MR-$q5uPZo*wb#Bw|g*Az_ph|8jt2#qaq+ zosgjZ5nd36fsyF+WDZj_4w|?ev{8zd!GGdv1~)km+cMcl9YhnV4}f~)H$T}-Mm98& zTy}y5jKnJdnI@O{t8<%rWAi%|62`b5K|Q=IkHP=0ZuVI%w$vNGmcJUOVT5LfwSWQ;ng z#2=amOZXlh7@JJ$YZ}YAfPEV@b7R!Lf}JP^G$f0AUhY@LJ(kfcn1(!c_(@hH?&1HT z=_{kE>bkZ8LAoWSySqUe3F!{$?(S|8M3BxyBPG(^AUECJ9n#%=%l8|P{~V41$lhnJ zxvu=L9W&5066Li{qA9h()nTqzgmQul!K=P*AA2{+n;{qJLGstk#;hc&xtuP>Mu}$j z*sBE3gR&zO;gO5x<0XnXG}k4K0;Hr6(OqKw{$lN^^Z-M7m5e#UCggC6sR`(S)UIWJ zA^vu=2vOFxN8U#Hn|5@p8dDs7+)>ACcrYB2Q_($Uz5uBYpfoSuCKJ8I<&Q+149vv` z)ye;4IuwJ>NGGvWQt9j6T*^dF>~|b32q(Gj$z(j^tvDd8P<4fTxnNVWb0Mv~GXP#Z z;)gs=*e4f>qJan+Z*era#rmj5I$; zOnwjPWF#fa`b=VsO4@`}5@G)kgo2)6|8rz_A)VFM-o6TejbYeIyJk(k=8Y`VKmXGL zj0j3|;ADSX1q28f7+7?0WVo91aB%e*KtwZ>HZYuVT=di2Om+E#ONxN#sCrthu&(2U-2;joLI3!YgmC`+& zv)+;{yt$h-eBx^qX!^(+!$ZYbdna|gt zxGoVk{^JJ7`8JG{UjU6d}hTw}hm*39^}`GhZB^hCj_9K0!l z+#S%bgiyX?s;l#8&BJB6JNz2>!$2colMUIAW|6av?&b$XgO%O3&F{B*V3dPqT2Q6E zPhM3r8f!@%6i1*Um!??7uKKNKF7d7nW&n%<1!4jJnLH!*zn4ic7p2^lPa;byg~s|x^ma4+=|@$pUp zZ+-OS)60#%!|Fo-mH><#W22)!CjGd7YzzJx{!<}0HId`yxf+<%=kjZ7%1LIEa3*{M z8pHZ}83)*Pk|LM|@gcYDzI%YEiexO?#t?3(=?VO;N}ir9pcG`1H6RET&)C8M#@K&W za;cd1S&vG7;t9hd%g6;u`YlBo=XRJv8f~>9=B1A3W5=xJj=oo8Up-VF}u^KbmXU?7wN4}?l#=qGjNX`kfo`a1pR@*Z0_*#_8t&D{UgyW zyZ2003t&%aVxT8Ia6>i_pih{Q`dbx`ulTH=!A2)M(ga|J#o^SbqBo7HXFKp_+{H@N zKk}*aoZzT}kjPFjTgrxE3gP1JIh8$dKRc+bjLp1ak1p2k{0`#z#N#nhUpbMRDP=NY z%V{}^x?}qx$VEV-g5pG-@vCueh3)o*wYaA3P4^t%YToZ3<}8HvSNTeCFAGrue9Uj+ zPdw{L4yfEbULeid3X%y}9c2?pujKFjm0x3nl)bo!A{kS`e+VO}>r8{BzV=W_(|u~dr+X2Xk1+m61-62xhd zNWxKE94!lOGnfWtX_1LB(j#A;(IaR#UbH^(q{sRR-H3{g87v?jzc87FB)^ZZ2U)>^ zFZX+a&vSv#4S|mhkieHT-6S{J@uD3VhZ<6wvZA*F3FX{|4(D0`{g`*Z%H4cUy9`T703NcseF;dp9(ELT(N zK%1e?FJ2$j4C!?ROcJlB$v;2T3=E$xd2aw(`(II+W{bIr%CO2f9v!>r*zGs}W6W#; zhXellgBzvf{o39j*OchW!>!%jqI_--o8)JwDZ|SO6NgGcbL$w@muOQDKR-K3{QZ)| zs!Fcm+3t7o%<$Nz0u#{`nh9*bUDb;i0US0(r{VJIpw1HvrY9G*KW)jz9 z)@X~?(o}EgVt1Kbh_ggy)@GR4$OGGNl5>(oQ ziZqY>Z@h1T)&;1avD#4f69W(7MkYj&Jzd@05)DHJwqjmEL4bB4n?TFs$wWSQH=FF! zQxLzUHroeT;r@F0o5S2<>l$`ADuhAXe-B&n%MDvx$mMLxG4SWtA26o{yv|}n%Uy^) zh{0#2z5EHuOuUZvNF6=;L0>LF4Dzs+$6@=%SxqBC5jG9Bqa6-o{Wx)F$(e4pP-J^8 zLz1DWwqHf6q)6zEe-t7!ELPKyH~CyvpC}7$7%eB0zQo9VadQpXkWG~%u6D(ReCz?c z^ydw>@0xP6@pqHUn0X$)wY@NlRN}Co$rdD&MD!5TVG{>4sqxreOGIo_2<+>&M&g<) z<=*}GVzCxx&&VqMup!6@)X@xp}{+r-y_)y~=T zT~#nXTPj#uN$dH7dE7Oi{dQ@3908xnoz6p_m8%N1_}DzPM%O;qP^ zS>ey&X%T7zK-P%x7Er7p(`)O!44F}jv@!I@EA{oQ17YP>Q;k*yC97THHM60@=8c;I z^r|h8vr|D61shx`PkaT5n(EzB4dx(1`ux+(65?tkuB|W^2MYtP-VrF0M4yrEBT@l} zzV3iX+W#Jn4V<%Ik`T-ndqYO#Yp4Sh{vxpR>A_s5Lq=^pk!-5&%#^L*$n;iFHQ^Ba zMwg6C+A!GDhRG(gFHm_;PLd3d*v^Uhhv| zUrvD*JUWB@60Hm560j30K~<=+h@|!DM;MvUN+k*QOeZ?wH0 zv!d~Q^M4vqC;$a)9%K9`mojg;V*X%Tr>i_4PkoSDYG-Mv}UizzFfANp<%3C zpPe}o?$cX)S)W=`t+3Fb>(_dkeDMFX=A^q}?Rn_I!7e6S6EuF}hC9^=T7Kup-6MgF zNo#He1zEUE@>U;rNx295<{6FCCZ<0FBw`l>fc0_1LZvRa`Qp2{y6P^8*1z zu^?*N`bfglCSFbm<;1MeVzPt@JQkEdqWNOyr{XKV_x?0l z_%|aQ371p{Z3RA`?$T)de8_9}HvF*vV+vZEC5D9!v=4+hK2RIl68nh^`5}oPb}quK zl^gKRX+qMRUV!{Ga+R<@?)>t2$1|7% zk7XKH-o0-V~{X2mquUvp%bswgS` z^{K0nVyqFxcE@Qaa=)}aDwZU|x&X?{y;$;$9OFmy({2U1Z7<%v4RcUv%(O>j z<~-q-^vAX+5wrZ)wr?}XbvPhSI}>H>z-mK^rdIn&on#p9*hXfG93u>=T!HEC(~O>% z&B#DQkWg8<{pL>Ec3YHQOyqT0_qhgV3vds@QJl4sz;}P^6o5N&XaX3!+Za*V3-lB{56(;gjmCcASt?c z&!elr_6d=8WRA=t@&cLX>TsqEln=zBZ-@GA0G&p@XSzkS^IJCiECNY{N~F22&*F{f z+q{S3q=S1ej;(hYPBuqG$m-YG zE_{t6VMlfQe$PhqMsXHGl8*guLoYFc$I(vxn@!+M!eyOjiZ0y9+??(la-;3lyeK@mWZ{ zJGmJE(pDfa|Mvj^yJsM<7roxT-hF?~@tjy7^ps4^k4qGy?+oD~9@s0@QGacRxZdiA z2Sp6$ThX1+uHrZ%G7{IC389BKIN=zE8-Av*7ECBy>V1m&jY)Ie6t19D*jcZUo8gBP z<+}hjkLwh)akTlMLH5f^u=U>Wq|~gv1Uz4Bjhf%ND%#YIW~Mt_0)PLF+aI?b%+gVh zESMx+7#ikZ6inZ1s=xvc{6C<{M35G_NbeZ+tM5KcpxD^7eJif-pnCTb-Vq+k6^Wj0 zqPL56VgwJbZJ%mhHv`FNqR>Km?3_QYpQR9>wx>l5ErE23hh|HB5=5TZ^XR?h&Nk1z zbR34Sj}6Hj<41pdy04*K%uM-mYc2|wD3IkuD`sS0?LqV&qA5@xocel0_HNd{B0o3& z#}r*>E1R=36^~~+R3C}IHbqePlg@S$q!U@s?2F}JA`x&k1R7O0Z%fNPAPxbtFK{l6 z{cSux&>VTU2le^M5s~%cF-=`FPYHR#c{kATA$%TK4(j?G#mnTP%~iJu!nb$gY)$Mb z_^4-b69|5kt$ZI5R(lqCRm(!U6yQjE`h=l(d{JIEPGjSltYgMfOMX{gpO@T?oqlyR zCofXNVq+3K#&CwWD}-*zyj$iUXsox!qddvg1+_Li;Q3)D zi>;+X<|N%UX`Cf_-E#llyOtBHqQme00;Ij>4gLA^w&90(Pq1ur=M8b*)MvI!dK^ns z%VGB@g?S=Daltu2NuFPWWYVqv@BjMxjuL}c11k_7F~AHzf7F8~sWmED}BYZ*DS_Y{LnQ;KqKZW~Z_;P=R1QA50! zAo(69tbtGKJM6`J0}B>qhL(VMvP>l~A>&Czmn)@C^>U+GX}CCD%OW;#v*!FH;w-0osyH>kNrim4fQ4(3%q zEtr8l<7dWLkDbP^8|3-_=EpRG61si`Fk5cw?4HUA!R2n~F)NRnSk(^AbDyKDo6;5^ zLVZlGyVLR-{8M8FXR#|ESwGx2rlb0h0i{(YlvJ~CBvNJm3eoXlhNt81>UJIFs;!6# zPPKidr!ve2wGH`!b4>Y{Y;Cmz?7KY);sD+hcUcpXMH7AIel7u{OO z0Bq|FA8lLh`)F|M01xK@r2dSFydJG)Cb%}dbTtISmC{qkvpl143>&yvEEVW3jHi)6 zZBJORmdh1|=^|Pz8Hc1WPdW5gCYYA|u>U4%-eA*FS-jnSG&<1IFngQt#8Q827H;;Gn0S@V^`eqca8;O*w^`ARzb z)R_gFrw>mfqg9!@x+cK&$0K3_1xt%{@~1u+)OS!}8N+}6`~g=~ppV?ydF@|qyS;JW zMp*sMJk)H+)IZ=hHVV^n`pV5*#4flbOT^f0Xtxj$plw+9{?UYms7x%n#n)5Zt)7$b);+Y2DOw@kw4A*nlPv5S zk3RNSW6X-N`9V`5xP(2tq#t@FYCR;mzM0k+$>17R)Fz}Ae5uQeQq1B(jIfvP-D1L* zEJrGCg|iX>SXJYpBo+G(IK(=6a|h^H4uGNuuv%*YkH`O1FaLksK7+(3U=LNK>Cd$C zKE`{B@~IasjJbmQ{WdxVvz6efUc3j9X%Ng#-FBhGK(S20B8bM6cF*-*m!rp2Pq7x zGslWFm(+4XLjh0(m zNFZlfBQ-phWpQ71^TcjMV|`V&LFvv1yt`EJ{@CPBW1!6!7hX0M&1Qy~1G`zIHKX=_VWhC!#K6x2i|ZxTfbqf4#Sn zH`?a((i{1ml1R>QW~+_u{gGDiL;c__1;$S{ot48+JRX~w;BdTeVA^j)g zThP0I#9DikKooG1Q2X8u3`FteUM>DphBDYAGp6Y?{EvVP9rkfbk=F}$@ z4jV1a&x0DFccy4xvesd(zW<@hzh0hMT3rQ~LDRx{jxW~#rMkr#xdGuSScS!p!P&ar zur(xaKEe_FTTYSjj&lG5$+oMj4k`{%Nnk^@n%u`V+5N|0dIOt9NoJy5a=5|5I-aPh zsuSUVDAPyq#;$<mHwV8y9RAcf->3KsNix1$lgTA1pt)8D3R$@F8|?-Q+MVk zcWC36@?&1SmlENJeig^3ve1$ZDjjsZ>*DHjxe-Lt%t*3f?k0iw=p?mMWUFY1#$!E< zRmo5Ju&7dnO25G6E0Fhl{0WYEbd?i#qka2NioW>%#Z=H|!ZHAYa`^eX8(+~_`g*3EZQn2xgM$Hl~tC3zQh z@4lsh;ctD{3nL%c5Q^lCJ&3I6a7atw?Im^FGPCbuONz%m$&^7=GNZ1HsD{G@dEfl< ztQ3P{VH&J}e%DKtq47PzJv{hwxk}U3z*2_=SG~J;w;u~Ty2}(!n5O?`^ewEg#1Cj@ zvzeW75P<^pIuu_dT=IgCOlDd%50*E9nj7o0!ROBiKGkcY@NXiqApeLWWxQJr=D39v zl_8dHvDc25xmPSP5JB|-l%819P(vP(9>_pSOX*mhyrNiEbU)~}KR`+!cc?b1WJPV3 zvQYG_$EW^tCKE4#E+rbN%u&VH)pcrT?PM)y)r5E^y3mGv_*FORWp#euDxT1y?Tui3 zL*tRn(c4G-YhWrToq9XvPcvSwSuLPdl+g_?M>p=rqD0k;G~`9d7qin~eb7H3%h_&l zHraDfkdDHPWTs9(0;w;J2(Saj%68y;!FOeHX-o3=B0@l`Hz)`Oc>f$(&YlMvxe^n0 zQ@s<*l{P}f!_7}W37u~+YXybJOj zLp2%kX-qApXLL}Gm59{!pW)FM zVs}mXu0~XWFPc1ZrhKX=P}2Cso0emuCbCGF_e0H^l4rSh)zAewlP;6T!n-K*KUiuI zjAXLdV@Z>-5+wr6YsqsEISSgeF*`STj$o#ZE!=ctN~f^)N!a*W&k8+Rjfq#bk3q7) zGYn2#nHCyB>6)b!Csnpc;OJ;>Bl5D2Jlzl|m)WDRIxu!j%F;ID^}wx0U@n$G_A{=R z4cyZ!5tfvkGDfs=Vi{t81g{?G2>D}>TC>{4E07_$q$kaEJR}<1u*6?_w%Pa3W}-TE z=l6GFB7P~4y4je!Y5~~S`U2A65NgA(zInby7aTkaYhB@m^u$C4p{vQ6|HOT3d3fAK zAQIjXedVGx?;Pv<4G2#?_5tN{1aScAH%|Hl_boPKNx=v)M4uu;15W(44{$$y-2MFD zL6O(Mei4@AH~AC?HQWOdhG{>fjhVqxxcY9J5l1f*H)E`@h}Yf|ia>h4;A4a7qTb72N}abD;vygX_wONF`G!WB z*Ehlm)T?a{zN&*}3ijP*NuCABo7Jl#s> zQHb#1lHeS_UR*wW>1bJa4>*k=Sy|^DoOJY$-d<1}2ZwE~t!_(Dgnp`=Pvp_$XvKFU zC2*Nb4d~NmP|g*j({xi`h7-3L#ct?II{!B0^kl|ckVY(MADJfqy*f~b9RF0S>RkNu zHcR8m3~--HUv064GQg;<=$f{<`4!bk@`vKFCb|L4V3SYIXeiNLpZmHJp2QL~HAV>} zgG)@Y^s<@h;O0X*jptC`qPvb)R#Y@?DtpG7QG_$m^-Zw)D8=NYdh_%1pF^7koGmTs z{kp$5mNiSv>_2o0e%q0z2JgPgaXuxmZ%8%+_FJ&K;U|16p##Jy1h;}ktX{og19zZN~Bhw`wKwhY86COT!cqO9yp?S5k6B}^OZ zNu%S?1&A(sy*K?zM(AVkHZ&F932Wx70g)TOPG*AnF#&wTpF)`eQ`ZAWSB>QuV7zjvLSDcy zC4T@mr}!H&gnV1dxp`oH7LTIL-gM%CC%9UhpYQB(8Bc==b{s_^y36%|hk$dHX8H%c zxI#G5-|MuV4;C}(EQq!Ft6!IeF12B}Pm%UiA|>X=C>71^f1*!M-bCrG`97D=h= zH;q#HliLd6_DuKT7s3#6+(nzE`vT3&4W_YJk`kdZbGh&VJ3huYo}#%p8)O{CSJy)xpi z>?G9!9@CH1+|<<6)AJTQfD|o2q)(ds(I~~eiSd`*_&hoaEYW(%{DE0?Y&>3V=7o;D zmbz&zs?S{hD8FIe(bQBp_|4X$yHM6Q(=WCjjt;xV(ZTGMZm97ECfPQ=)}Hr<_ZN2?8u7Lw|m)!IqXUB6yF z$81K4Y=tdjDp{u{rn0=uL^$&$-!V++E@}L}lvPJ6d`O>Z*QObKSkr`=4-$c~tbT5r zY5$@v!9$O|E}3)OQ(96oaP;#&3tgfzc6WLh?xzLE?+B!UUwxPNuCXTdx;vTtN!Z;? zTKzp5>opg=DR^x`Qxb3j=7Yx?W;T=ZBed9U8tG#Vfvr!)_xtbtM#Uyczq0Fu`>Iq% z8Sh~#>)@#%T|)CUrA>@qYShpqPB-CU`>pNVVrX+ArqQ_I*4n&^Fji{nUEwhgo%qfDaa@o%x{5X-p;KP7mfFa;!~)NPwoY>9)evmtP;j`rm12b z94Su{Q>xDuHRMUt4;5&6QV8+4<@Ew^MKTb=?J5xsg~Z)VRE)V;bbWBb z9)^ND4hPA>`SR&xW5L7KB`Z@DPo^n|VD z{kdkYW4pT+IgPAugE>x`xQEvImOT-8SFRQb(`gEw2E+&!RqSw8FV*S`Udm01NJcYz zhOtJjzLyQa!D?^CUx0BwGpTRO+B>!Ap66c7BM8rb+lc?@8yUyUZd5>LC zp_k3?tVkWVQC%WwXO>>ai_7wg3PAg~tOS5~=G|QjQ&WkETfoG)J*_{~ADd^x3B{Ox zs~T3}x$z$m8VG{6iy3g*v;x@17#7u%2xwvvW2WCgIDU8_v{dZ}AroMf`nwA~Q^U$j zBy29PsC-q(zx-}FmhFFc*7fJ#%v@n2)%%x6>>2P{!{~9kWa%|@L&H?X$t)gW!LF^A zPv|K@{!LYAgB@D|N*CFBK9!9-GFy21h`A)gi88j8gZsak{&T;xbucslP31)M0Ek%d zrrn>yz&|9ee7R!mJUe$U{Yy1Q)J?fl3z{v<%A7QPD=%PPY(}KQ1AE7$ilZUX6Vz3B zspYXgD&%P$K^<&9T6!O@%uXz3bVLJw8jqEAhz6Y3JSZ{2-o!uLa&)#mzpXe|{C&%l zhI7I^_ZVhP@ucKxExflM{o$?Og!`KVZ==)jCf$yR=x&=!sinTL1;4`u&|MlIf&HI} ziq*{ibY`ceo=KRC7QCE7FogTOrUHUoqMF>{|2WINW6d)a)IPeB9IVcoE$b%Znba!- z(ntLst_G60Tl52-g#D!6ExilNULh4cytr@yT`j<@mdCTAgs?+-tMS@>_kCQlqp`ViMNH?Z+bMB~c<_1Cx zMgNTnH|!DTHRqzSNelsw*j9Vo;5CSEc@mo!utXAnDC;yDm>`LfH6E1FuYG zlolF-&Is=+p0R`b=+{`fe&G}%pV~m>d#6n9#}MWbX0tvMMIO%^S%4&#dTq%cUtW7=BDtYtTmly{_h>Ib8 z9`*;e(3Ye5QYnn}P1kDt}KU_(8EVcFV zBg+b6FD!v0O5B#}h_C?fmUi3WRES-F4gn@)2;`~S??D9$Fg3dHNx-3Z7i2_yoG4DP zvbAc&=qEn?ET;Vo?t{k~-yh7d;lezVHzD=EZLG>Ykps2W<#FDzy<<-^fp2DhIiCy!7?-F1;aqJn%%C^wG!$Suo7)J~u~cR?)C2DtA+m}uiIU@Qv?KJEZ~2gI!XpRXM_^iA|(RVtXVr}&jQ zNqs^#7iuj10M&Lu=>K%5(s=-wqmHMc4ulO%u%Dox_1H!vu`og&zoWm?4XL6M}=&Zk<0wimc0hNg+9U+5aJfdNNJ``|5FY2 z$^pL5?;NW*4$;9{JAznBnc^3;jtPwqMbHJv3b=x9xafJ<#P#$eeUpL?PwYhOZLmu9 z-o0$tqin2DcW83g?G4j2RwlqMz!SN*2hv@*qbZsnaG)(pCK-s#+rb~;6o0;5OHho( zUbNEDu_t6E@{|M4cO>+NeV|7Ko?}W{&MTz07gE01upN zIRW4vU^{K@k>TosfSZ-jYw5)z}wpI6nJSUi&qp&uV3-P|l&@gGOegAIwcV$w1Uv3G|iH>+}x{L#ao12)DmI>h3R+@GNw zV@j{@FpC~EJsx#!u+yj7o^HHY_qPb;h1m2wm zkJjl7@rseD<>%!f*f)F%eg**tdY^&~$b+WFJ{CHOMp8N}qA zSk)MdzRBM%0YF1t?#ToG6*|%Z*5Zte8|Q6W{eXLyI`YQ+n@f38sVZlnJ_TX}CxcD5 zRuypOL}9(N3sVNCcwxefe!`HN5clro-WYhOug7aI-$Frdy@jpqCmTFmYa%I_c~hFe zoRyCymBt``0yw4q`QrY)8T0?%i88IqW+Q>y|A3>+lHc#??i>(nBCnSs0F4Fk#!Kbv zLuDgeli!v?YBvD1RN&fET%DXcQ9zG*a;(K}Lhkbd2^=;M87OakC^%5GT3?b9hkp&QsLb2sI)>A|B%c| zcRtC8DWi5IC_jjf&2F2=_9{{5tT1fZbb#=>s@ZqC5apVJ5atbO{;38ot64qT!C zcCyF%^|vmb-S`-k;%iOAc`EsEo_T zJ1l%XHHKrzCk=by=nrKaj#b{Z>XxnS(=q-=h!qxQq&vE z@((5(*!gH2vYnbM+AC;oc3_O!%~;F?am7=eWeX?Di8Kh1z#+l;UVaoVfOM6Jv?npn z-_|zzRGyX9pp~w=UB0XJEgTbpl?5rr?%zG4i-glQ6Td}1%X+tnDq$!tT5W{VFiNb^5 zZKbVP&-x`qmLz`LM`8%|vb7zOd%Zfqp2P85w>a`gO0w1{M~%P~i8e<1HW4?{Kb`$% z8cr+a_a*>7fsZrUQ0%z|QLwyF->$MIjLCgNrrHK1DS$Y#OZP>W#AX#f=HiWRcfmqx zp@jDnVPXrL-18R9KJ{M+5lAq27-MRoRQ;)!%V*zme6J)r1l!~QEm{%F9l>!6(o(~6 zrpm~?pBGKoxrQ4WM4ghJm^-Ib<1*x(zO>BKA+p#-#ru`r-Ca<>MwRZvOC%`@!W15+ zsXF|!HBpLekIZoLQGBBlt$vGX%7mB1q1+}vq$-S4S=S&5@maGZNs(awfWiuehHT8& z|C^@&;!*!aX4qC)#QAYj&fbAz>ijg&WkQCP@|oAOw4DA%zewWY^bcQDkNWWmg1xzf zJLo-dcX#*j_%j!D%uE4`=RW#~V!5iVwjAPrz8UV=|BssnYAvv|x0-0Ffr(pHD>?Fk5x84ICOs;@m|_G`aHtdTXnVY`MEN1h_2 z!rl~sQ=JYJKpPgn1_id$(BFGFX>$;wv(bLz@q|kB-V?{h&I&Nf{b2h2fE_s6hj6rg zPwP>Ofu>}4U99CRuv@nIS4r9eMxJ3b@_XW*C`qwBH})L%k)I%hQ3Ue>&y%7oZZE;< zYi0RrC`%SJ-1!5?cV_1YY0}BcdL4aBUkEkS`$Qf`0rSCAs7v3 zzu%5z!s{6JJ>0rb>kFr;Jm@r(@^_y!5=*Hd@=&>y3Mxit@7 z9cJjVum8zMHMVYcppmQ6od>@8W5~}GrLSVKk|Bu0gk?eTOcA0)q26|^G>>#X^)+8$ zOz7vuQPrr%L0L#wSMdF&#-0GglJl45J|^j+5}aIcU*59&_U;2f%6=Jr#T#fe@d8yj zrgoglm{TN{CvLjAIJo}}LtH&}U3dDHpfr__F{^5VbR^;)n||K>H^$0yZxWvBgk-Pk zT(_p1G_mrFNRjlt+*#P@j*MH{&0;{p2>H zv6YzbO*ViDV_M>7NuMC!=wU(s!rC_;9`%AnueVt z{vnU}!zF2xkUgNvk|U#a*5^0b16N0ovLcT2byTm)>Q_-@3=SH1&-V5;=&a^VAzwKPHGG}!So*oAU2QZTti(CN$8vRQ1>Az{E zvf#+GUUiCbRJIgc8_B?3BV6y^s@XwFR)laR4|05KrdTO4x_V>(iLRd0j#m)BiC^#W zWLLEXOOO!biTSAZoL-xV3#Vo}L2r40^;>QGmqU|tdZTG%$_)ez-U5XwUiL)xt^NId zKnDSyhf3-3Ba=;GZ)V;os-OGUJuj_3uk>FwUoiB1+Sk+WUB$IAFyK(2P1p12SU=mI z-iqX|fkgw&6zr?u;IU70%8vp~5y0>TqVQHKf&OiXwF6kNH$E5&p6PFbS}5ovu!w*q z$0M|trZ_Mfk5P3wc?PHr9Xp3ITkMPeH`WxXq+ltn;^)1$$KmN# z+tKj~;Dvu`+qIYDwa>&dyW7q=Q?lrryt(I~s8dTX0EocArRN@qAwX$5&94e%qRpr5 z`ntbp5}WJ<(J+cr`NgR9=5UMy{U#R|bDjZlRzGA7i<>O&cCN9UAcw~fStrv+pDQ#L z>iO3sZ#>H^@@|V0D?HCSno{VI5<3W{dC?h=pEAgwnowzlYo3%@*W|0{_3=7Gn^JSK z#~x%~?mdz%cccfqbf(jCO4W=tv$^*!XD*254)v5sDlZe;+mS*BM;akM-b84ZMza%# z^!UPDHE_ua)tU5)@+;CIZRCx3&>N}8ug?-!L~P?~%V7xM*W*I2`p72X( zByix~dVUk2>_2zqH8c)E<0$*7w2)R*@2kMRS%YDuw>lcPH+!mD6040T{1#Mt44X53 zYU$#TO0~QaUO7y6_u{EQx=+%a^V*lX^f)IvDRE(%7VivT|4}uB``@B-SA14z>%*at z=|;{gkOF}nHO(>v5&U2)pWh)E!oJC1{zPBx2?^2<dwni1Pf-8 z@a;i#z0%YDv9J#@S65lBo?VzpW5mQ&@dmC8@5O#uTn0_*0Oj3wW16;9`GdY&!=0?p zpLDmH*pPAU?gCow@&T9^$jcNIcFR6N#sF@w@ zrv0*c7mWK<%D%Wd7gnVjC&-IEcL?gk4g2D0^c)CCFajn)_Ltl4a{bNon_ghY3&%U7t_yt^1N zCEE9ZA_C&hcBG&bwAKC+8Tzs1@FE34G1)?^XhR|8+weSU( zvAT`hOF4{j9R8E}Rei^ad7{xnW@}JeCkUGtL;Wiap}ev(1#YRh4Im?{V157$#5^z% z;zUVj#uqh0Wm4^!xwe(nNy<>H%rW);g6qo^Q`<;xYf!m(gw(>=G6{yR!=Q~!fs^ay zP>0X8TtprRM-t{2HfQO*2B5uK0(#ef4WE0EK#SP3uw=K@dhD|CIc@M#MvOa0YXHpV z28e>Y_vkCpmKNV}vtVB3ZJ9Tf7-Gr4^*%aA5X1QJweBQtadbqMBzHU10+{?A*V;$y z$)!iYD2*T>`Z6geLmMSD1{bo_k2@XVy<5oQ9DY2xXZ>}jrlsX^#dFR7_4)sz{9pH8 zpCJF1R)GKQu$9+J!8Srn78+&RA5U5Up97+107V490lxh60T`0^J9ujgWg!MuTy~@i zSU#8)b!2-?A}uYFZbXAJuv7&8a>2*J)I@ggj!)18*ZC{~9IZ^gBIaW9w#3(peObHd zJx@`mzQmClJ8N?4t9h-QEAv$5NOoW*5>|6$z zI7MJ=>YICp{0bEDJXDmgibtx%dd=;A%iO)aAGwB!B#^*oa+=E&${P^QH4<16=ki0S zxk7lt?tXquT4p>2sJ?kin zzdJe%?T|k44eI#|AT>g;OmEKO#j$I3`^)IH(|g0BG^3d>8Gg>tx<+!hXjd#?Tg*sY zwAvVIj9-WG58a0NgqhsVzEX7h>J<{U`nOIkg!89g@8Qp6UaQIHPPlpHxeP1UNh2ZO z-Oe5zjpz;a%2fvV24^!NMaS*}NsUrz`S=(e8zZZLswEF%dnEHWX{TTJheQf@8hU4) zk_QH!{pDwg7XZS|_}#2S##J)z#bAXq0Q19A?GoQJ>7M307PYoC-i^f|`Rvgz@eBm@ z*>Sd>UZIs}Z*T}FplRIIi{AkuY4%w52jBY(Y7I~|)mbyn+y{)D8Lp3JNG$|RPs}^; zJq&lUgYdauV*boW)oxw+My6dLr)PPridHN$pU`VFl?G~>hLnPAzfqdlDlBzGomv7qI;#G$CgqpM}!8 zgDNMlDfQpQv{gv>;4R-QPC%4f&H!1VOQ&J^h=)IH!}ng3tziy(m2)$Yz_C znzHKvdpO7i0i<$srg1VmbN#vDR}JUEe^}M(>dn2vFxli+Co3|CBM<#KG4W}u1x=0Y zoSy$_0Z1>fH+t>RH4I|RRX=(!j(2J0BN$ztstZUtrTP6qpZ-XMB`wZ*6_Lo-;I8 zrq&WHt(5`46>}p`f3XD~SxNr;(BR{F;vWN85=i%lUa;~BNGNU&8!n!P@^!qF_@AO; z?JpDr3!T)*r}1$1Peg(m{~Mj^*S(w@BWvMWUtCN_|Mqm&gZ{b|`1JktX6b6Oa0w_1Eg(7#lf#J5Lgc)2Q$f*v1L`#P+cCD?sK9CA?SjBw0CWm>59cwj(Zf6_KQwoMVVHU{DG(7BEKf6G zNp(D0nLD_nfpW&(uRKA{yD)9pf$!%XZLbX{4w2UF-J)xWV_{Yhb5Vg8XNh%{9S9Wb;qt}>2hgI2K~sxhgr2YhU3pWE&fo~e z*iq`y988{}>+?oWB**Z)=KSuM3h-W~jWqSR!-W~MvBoPQhk3twXCiQFJp1*tbDY}S zr%5R=i$UZ?^U!}jU09ksLj8lE9SzyyU$=HjLY*jSWNUw*D1mg!FMMpI@E38tFZJxR zTbs7p8^7`S1S${X`+Z+|GJD9^zgrnIHT>jv*Bno8WEexd{w;uNcv(q|z*mzm)#SA2 zwExqkUf~x@dgY5tR+MV3(^}2Lh^rpk|22&6JKz}HxNs1Zy@>p<$Z_c6ccpNG1cY1i5$lJxTp*P zzxfjDP_l!onC^CVt!Frt3<4@+D%;tECB$pa5RxL|Kf2(vGWm&qKZt*cruG4`j#hRk z)^JGHi4B*mJb}BRb&IgqG0)sY?){gy$+s+>0ug)E|N7CaM;P%Fk;>Fp@Tt`7&+PzT z3bq4%cN9nE$T3*z=kL4UuWaU@A{-vXK1hMntcwV6uwD0N7fG z>|>)40V|-;0s*?4TPDRz`8*_{Ftuob8r95jV|=A1cmA`$Jup6wQn1n6>-x>e-vAyN zCwC7OXA4||cV1y(A7bSGc>EzK#q#IpRu^mtQ3QkfpA%Zqk{8jyn}{Nc(VV=eFd!_$=0kDn# zKkEPW7&LE8ygteEDuD+%gTFKX`{AZv6Ol4y!#f-o7h=mRD_Z91?!SB`e1AWP9D%>_ z<)veSaa8*ZC%`77R>M=9NGU+hT1mh^uT58^dX!&NF%}M<56RJ#RLR=N=uIXhc(zHbAqHm zTO)IDjn;5E+v@{u)8XE>oL9EN0(VCj9WpPfQQn|+lu8v%Cm)A%U3w{r$oEV>e!Ib? zonJ4Cu~WOAQz?F_c^MV{W$A~yMnH4cv1I_YU~?l9`CP?k2CmM+IA-x&z(DXupKy5L zI~DOw>AN@o+va^X&t3Nk5w$4`6>G?z

      `JFY^R?siTG3jpt9J;g#`iD=Tu1#i(LK z%$BcxlXThS{{~Q(Osfcg>G)tZtkSwJGU7sG_a7Ow@bBtsYttji4!P|W@M@$44`)oN z9OLu7I-|2N0zp4GO^({5W^KCBu6e2koEXXD3mO&Mk(Yc}G9E&*Pa??IZSFTajQEsB z(sWwN?}VX@l#vGslQme3hhZ&6?wq;+)2Iw4(y8BIAG6iAg~eTYq3HxLOt!Z2C0-J8 z>N#VAZ)Q6(?86rDkiBrHfdu7BP=2rpbGvgRZDY(CTZ(eq5%d<_%Ptskz@OV0{0Rw!Efi?^z=R zC5~B;AA*PfQy$nqok*u7`qWbx<*AhbL--Hne7jW6B^=kjY)m{bHn7;rSZXE+&$C@Y@}9H+!Sx==w6 zuB;HtjKZOS7&j{lZk<_n7U-TX&y=I+ObfmfBEeLtON;4I2iqa|CtLLE>ap*%3(aG> zH5e(6?w25W3WNpySC8`ecMpicW#zgH)9J>6hl9dzDCIAV^$_gj!-S|WoAV}+CH!}Q z;5!>{r7&bri?)VJn*vK`6bx(jJ39VkLZ0AcIhWh+c!U*8`tbrR>Bw`LcJ`f$@-G7< zC}6;N04m>s*CPo&M~vw>Bmj0FQ#rB@z@xzBx$JtD?+^3??WFpd1}<9Rish>fxd0^&L6-0x5r$;uS8v!c!(>^P${+;t*mmm95UVY%OlK7Fn z8aXB4LVO3qET5kOX^W&TjGdhQR!ia3K4k_#F$I3$2#~;{y4ru@{aukz`eAF9Z-382 zZ!8G2G-IxhfuZGV)Ep?Wfw_i9B7+*=C=9}^_MjJl3mPC;l!Y|&VRZuK9*7|bi6wJ) zagmHU*I(R=S7fA2Hi*jIa<+IxO8iyKd!Y=u@yxjI(xj#=NRB;ry)ODhb( zyw7kea3HoEu9h)(Kt&>s^Au2b?fYt1s12B=}fK z&jS`;Y+DAhOj{TDD(vHA)-<-E}yFUA;ozJ_A_oKgkX3y9)oU+N2 zfX~a*#l@ez`OhH!wN{j;xB63*o9H-YS5H>+CX&zGBO=XuuYMjJY#)FXD60)DL!X%y zpomD-);z6PKq$7>FB#<(VTp_OS{!^m)h3sX4n&y!7X60V|dPj35m-LYYm$r6KVn(htn!-RS*Ax7ZoxmdxUE{7fP!$(qia z9mKJ=Up{ZR{vG=J7bl2EzWvN#2<V}^++QS8$*?Gd$+}4YEhm+4(c4yx9k-Gwx^HFO$>#=EqwKaA8$Ke<_s z7NB?!Pi2v=X5aL-nK!?h;K?F~SUAHiFO}59>*$NQF_2m@_ z4A^C;sn9lDhCHQ)kRtD7nV+MD;CG88#pQ_~&>bBRSHS(z+T3#Zo#RgcPQrk+0e+g5 zrKMVIvJbzEiW?W0)zfXrsI?N`;`8{oN-sx_S4TIWsANs^Z$-dN*CBp{^FvWa zKr*N~;3l3ok!v~4JiLGkE`pSIZ_G)IRFqIvi;XA+$8v1@02cJSL%DgqkWI86lU&Qfn{;hQSbb^vM1g_>eY8vD4b#3*|uTby0#&f{?jPicHw8v_nuj~Lx7eG43 zD6NQ z@GvBD?bl%8r_=}hP)hcsI6wIJj{BVqisP4Wcg7E4L@?SUM(~nzHc7Fz%FMMAXW-!w zY2W-&7|sJmb-_VFmE1eg;tt_VG@P$*?VF^JH1Are;W5ElBkN;e!>c@(=EpBe)qcM6 z^nB~e>F)|@zn+`~g`4(6J{ypO%>yX2R9FV8Cu6|~cOXKn zp{mH$)_-?7ds0-(pnLr|${%o8fTj2i&5JEz9mLUn{_xyJAzu5T;RUU7g5V@ z#)NJ`p3TvKdbKOM!4TRqn0xWU+ZWHA@RF33!n!G^g7NltR}CUzr5I&iOG@ih&~I zpscKXN5dJQi5#t25Aj4Gf+|^qBqAs01{@!Ypj>75zCiX>1vpw$Yju}24eGzeA|Ch) zW7srcQ#G5j(R)I8>o!A#KX~gB9|(o@es^A!xETVj0ffvQ@O1Mcg7fT}9op{g$M`Ai z2FV_#hza^QIEqiZ0`@q-X7r4Z@+o;|FtOD8*3LJZK?*abzRU{)3vb8snCu)ExD zjy?sX=svB4A*QEwJb`A&V zU&@}Pm`t1VykE#*p#hd!rpBR_Q=b^DKAbCtJ9H}XPotJ=x0$DSzk;cBiG>i7w~S9&<%=Co~83tEpLrIt-ti0(@LZzl;E4X>jS6;=Q0Wh@E4YMpu(`lkh1% zK%b;;@N9Mm$}4@21KK81oH?gq?CuD9K?6b=-cH1-9mfhC1^Q>OvNP>5M9KrbAnb{3 zu{kN&r2vluB0_F-fCf*8VzPCCnaJ$>!&xS=0cvhww(Jc%`c2MoBo4Ux(|L)Ai2kE+ zW+aohhYS=iH3Fgp$&92@NQYFJnVEH{TRJ)tQp(=X1Bwjm|XD3o^mhC_S%Up;=*^^ee)XDAK4dcHg=w-=Wb@V9*`5-QCzpKtoL(5U7ZXYB9uJ+X{8QwEJPm13 z*#FDE`!5}PY%Btblw94^S?4Y|nEjeO79X7zPli14+t~egTb|7(UOOZk`=sHEsp6}U zA-8!d2Pyp$zPgq+^SidzLK%5j&E+nM5$q%GyPRexjHl>26cKR5(S#_f|Ae zeWjf*c~Y1|{d{Nm{MO_&Wc(PnWBw_|+p2U@pPpkM75ZEN`OV#z=exY_vTt*7;#SUl z+ql<6c7`DfginQ89MCJ;KvC(Qx(;Vro_YU-?of$BaqPg{|J#-`;ZqmP$!@z9>AOEO zD@$K%4Y9Old$-CB<;aED=7S#GH!eLsSWT&&`th|Jwzhdcr%?Pj^z~kxpV#1tgtWpY zv=}aIJ(Th4Nu`|L+^8|9?0(xZLw`dvA1$d-?-_AbQz@h|q6S|GdKAyF%wSmmW zeE(9jQ!MZP@3%+DB_D?C`G)xC_sccQZv7)`v4oxlvzTIb-rh{hcLxWd*B~M$b5+P) zZa6Dyv zd+x z6HGcRVuU9BGQetM!IPs<{`D`|yhT>6Y&Ddi%PJK9s&eo&B4N;Q=M@k%m zZ+d#E3m450pc%{jPZ_zj)$5hQk=1~rZ@h-Cw*zTCf?u`p0oqGKO~UE?#NR>bgq(vnwVCCj`U*Pbz>ikNhQCDm&7+-5@S;ctaJjyo*(gJHeB>wY4^`Y5;tbL;}mp%W)~BgD6<& z%ewywI|N;82OCuDPCWB=F9#H`Srgp*`)S*1l`|Z3CuW8(P0)b;mAK7 zt>?Ivzx0B~WSvl2l8U$cY094AuOc~m0T|`<+4K>Z%o5cv{4*mkUnZ^v30A`7KdB|P zwh?=ykGFSa-c<#Z@n4kOZ{SBq)K=Dh)78Bg2Uci%FX{b^_5VT>j$j`Kn+kHHACu1I zksP&4Hlzx=qzN^x_N0NLK0!5}qgUA3fX1bf;Hm1E z{V+9$tn=9m^ra*PCWJ5Pv_>i}xwK7@`HE4Q>DM5s(p(7Csso6tpr8w@Bz6OmM3%S% zdZF76B&lnJn^JdC=)JI-_r4E)eR)eVwLxyXjO$|hV^KUV@jS4`^lChvwA&qtdw`Ka z$=TLr=G(UuOhZ&JZ=BJM=sbcPJ{^=ZUr=lNvU`(J<)STANM)lP4Fee_TPWN=H`WW; z)t*q)C)wra2n;V}L{s0Utbt&mXEsvzq0Yyv>iZ!Iu_;xuv?&l2u#NZXlMg*~X_(ri z`V|PKF29w$45*tr6@B&93T~x)Q~#hBpru;0ZfQ_2Hy)dJ4s!(a#WDw)iOzFY-p_vB z)SC7aoC=4J^tOARsGA+1{sIiy1>=elGj!2 z%NjfSt109YLmAg&Nt0fA*xE8rz*U-8m|0DjE>SyD8sg9(76?1=k{7)fZrhIk-oua$ zi+E-QFbzQ2-oI@TV}%iRfbr{DVnX~go@PMSMb?Om8C^1d<@x&Z3~WdWv|3K4JxjW1 z+sDU@b4k@_ylme^LRNz!naMYSp)LP~Wr}c**c2K8b#w!^HVfk)t6y?p*p_>r3oM$~ z=ml`RRM%o`SvL@l-!@P;nWG2jImSyF*lw*_EfurH>1F2rjAfou{ z8VIG|APDgbna?1v-d}gSwR5X4V#VWF!+(KNBU4p@6PC_;=L1p6;_w3w5NKuJ-2VWLp=?rnG19)?tzjpvdhMegc$j#*Ld~F^^6!muF&lhopk#nve8CETa8Ar9j zqM+vqZnc1}Vf?tFQTA{JGw7v;AA&>Mz*qYjhuiM{y2`ixeJ@7Cw+g^ePVO};uobK9 zbkRey62A^iYVlt<)NTJo?2FEcAfK|43bj!B;MqzVa|(2_K(%?Zr6xTs%@@<+&==hU z?nSm1kR19r`j#-*k$Yozt_v(*ZWG7VL$7HF5$z%)zPC6qD-U9LPQcMVQd5nTOV9jX zi1V|J-;ZuoxP^9~SHUp{z^~3PhhNIpITNnljH#~TXL}(_5|`(h%&EEVVt(!|)8+wC ztmAv4UhSB9Zrxq&y8-8!N5g`I7z&vH*?PQSXU zH^MIOAJre1$1vR#m8P<@85+%jEayT93tv=~@3hv!c2;j7C7nUTQNk#@h+#yJ?LX7w zGkI=OXhvU4_f*{+y4z9Jm&U2Kglp>5eYI>}?qUZBa$eH{R1Ld*<>E}oLfG`UVh{}Y z9(Hyl3LLygi!Z3y3PKc*{cBR~bPn9XeE_02M;1(gBW_cFyFRY3BdOfDMg%dDXitSR zHpKaI+DXI2qm=3ApAoDLfINbAFMc1Xp*pZ7H!Ac5%m*w+1Mb8kGs>n7hKBI+Zs$cH zOVA@qyv=OZ7SsB^k;tr9BkI7pH*z1!ep>89D`_f_z9+=}3|d~?9XMR-7}iKPBXAm+ zbH{U>t*voLHyM#Hr=srM3UHCp`MRo;G&A zre|ihvYv{{MvA5c$iZm*vbeP1&4p^{Y-{TcwU&d}MA&UiL{R6Sa=^8YB*t5o92tP{^UL& zSxjGwldSAEtBiE6E2tSXWG=;WSa+<<$_&(Zh8Xzohc*`FMLn$_=6 zs*jP-`P*E4yHwp$C&L>zR8ajn?}=oJ{Fm{)?2d4^WsA8AJ9>E-lQt$n)f9Y_(&;52eZBB!s zDVk(_X`gEcsp^p#02dsH{@T^QCBWzD-f@U{&yc*=MQn(mFG1 z-*iAj-8A4)h+3+!S_iULMI!J$)Ep96sq}OnW5mZ`b2_ATzB9sjVnNLoHHzlA?E z9SG`)(^pQ%8;>JyUcb;GuX#PYKWRPfm3;-|@&CLyMo~4Mq$q;4)q?1W2A`d`9mns# zvro$uS86>%3xuQef?!DrsHOZeC1TslerJs6BgS!jdc@QCqAehu4qOfTsO8lZgIg1C z$d67fTpanuIu+jV_~|L_E5|>|iGtjwuKs)!W*v+Hg4j~lUtU@<(iL1woC^@GJfbyp zF|gKa_(lB)(=15rp4@|ZFa+eN^IgyCYuagGxQ@vxycK;gR=SdgVGbPcfFeKHsi!(r z;uDu^h6W9v2TqkF*zMvQ2Fnqc-dz;ha-IDIU+ZTom%%fv#(+BM@utIef5Ujt@J+bjXb9eh0$r;)+?&h&sPcjEF*tqu`Z=QIDv3(NKHr zSnR(gWc+mfo7!6T))2NaHs#hbg(DSj=LVPCtpaRll0a^Xg{_o@fGFY#gpO*|F}B}9 zZ1e}gw82ym#h(+5`bSc{I64Gsa#rFY zjm3Gb1Ddzsiu&R<_LD{e( zc62k>8$*OJ?PXK}*sSd9U{omkm7&2zv~=g}s6Rj9kbKH3HrwNJ<>5?H_`R{^kWtKA zwTwv0P+;(jmU-eEhOlb6_hENgWd(>_tYOZ!=%y09{!?UB^H%rypp4B#$Erf=x@Vas z=A(0&YB?jEM=7{!Dhn-LKa0G9y`L6aP$+|e_5*fcG^ zey?ZiJ;1y&-0Ws=Zx5__pf1IS(svC&lAzG`ze*(#%zeH+vD zikQ;8RoMBv-}CF-#=4TpcOIm`x^b= z@lOi%!T5`KqwlP2@CRQ~A`HLqBM!$9F|hcIms9OaUyh(+!@NrlNSi7q*6ARFedztT z#K*^;1(q~GNJmCSzC6rzzTCdPtVTsf0_?d)IXehjN-^WXpCvi4U2~KzW9b(WA)!Jt zYwadUbK!`Rh_2N4H#OP!ne%Ds4K`M>J-mDOU@rh)TbbW~hXc^m1F(!M@Qz=fYEMzW z>Nq(#kZTQaDIuh0vB-=>>=FM|{wPTm_)|*Z`r$!~82fqgP}-DyGn6MC|Av>%g+Hyz zp(D|NYH@f`<$^@dxlf3^5~!U5rt&?H6Qtgx`mDGGrLK&h^0QUCjTW6)*0Hky#p$C5??&UwG|exrkbIb#(r%tR%Es zo@{7M(Gq=Fzq_)@2A&H=HdmC9Tc0rM2d z$0K=q0k1|)2MR-BJ{Bg`OO5}V$Tl(p^f!P4QlqoOJ*WNJFv?9W9%U-Dchg%NMF0?A zL~Ks2S~QnnXEdt5lH9T~hC5`+uk|(+uqt1<;|8cLGP5_Lf4Q>$IpIx4ing$Pva_>0 zd%A~kV*tf>gkpej!XG*!+zA>=r`-whZ4VzNe5Nifd<*}+r66ynEsf{Di6RrflZ8t6 zXP=T6)2~UojRiA>cYsq#tWx*DrDIkt-I8jeTtURN9-EV!Oh!hn`u&UL=N|D`Z?z(W z^c&-PJLb`lb=;BbM^{;$(&Y-ujjJbn(srGBZ`A7Vo9Sn%8(FjrEM+#c#Q6K39p;>R zaAx&rpG_~R8+3$I(a2937!Hg!7eaR(`Ba-F_s!h|V16OZ#sUfycs#V^Y z`m?X4n_L_nx2)R5qbcJ^^{uE7veNanF_O{%WCUVi=DsH-!mVOG=I?9+^c}sev2m`W znD7^}Ej-J76Q5=qPhmUddmu{HZJC3ix)A0h+JHiia5HLKF5ucBUjc~@nudP!o}8cS z9syGP_iw_|JH{>)EvUv2WhOOdwqZ8POr@LV%eSfDhu(T6f)h_iEGdn4{+mZ2cU@Lm z&W7OPw5mef+>&{Bzy8+-9BGHh0Hw*ndH_5(+KcJSy|#)@70<&drOVARqbK%XB7>VQa1I#lY^P1FD3jlKjptmp;UYL z%3I?`@6vZ&7BT3KWx`IC39Y)X2z-@ze_rgF$w zO3%Us58Z?7%FQgLPM=RmL7}!`yVp@>;vrIqeXI)6gx`JzQDAAbdRr` z!ZMPL(5^v9$|+w99$;x_lcZG0d`H!)gfH+q0L;C%w)XVYHYSxVZ;Q( z^WFvFB!HE&aZJCdKY-rf>aWhEP#w@|>bvQ9(&4hL=#dYy9f-b22D%zgA0IvA*iZ8N zBgXDh;u3CY@;_RsGMlMhS}G%kiohKxcff~kUngwFn^!F*+68>E9oPnW;2)e9KvJ6# zgw4}aW6}tZQ||75w8EmY+@Lq279K65KC@5v`*uOgj^cj7qS!wYjuN*BTvfLK{zVFP zc>zTSb>$W5+CT};Sn+L5LIu=)(78Yd`ciX$>Q~V7qmnE%iJ@~Q4zeT8J^&kf9hAcc zb=u{1qA|&(Oo$l1hNN9mDm})}r_tpDf1X7{+wQ`j(5XH<5$A>;JRBxUAHlT)%3dBE z(sP;HQtpjy3gUmgLsT7s(pE_lVu$nK(FS)gF>{wCc4Jk^Jw=y#b%|<#>W_A<<92m< zT2IkSam+g*zx7S?(ZJfaJrkJZ*@C?cC!B4m*I^`}f0Vy}Cj~{~>wH>DtmY~mC0{m; zN1`XF$V^y3dlA=Rc^5bQ>d$vuBRf-M$4nLRsg(I4uc`SMK`BtP@}Ud)&EwJ0s2k-- zZ5y{{vvsXEm4o;&&;(>=WB@$@z|$iiF$kUc14JtGEeoG^BS#S!Rx*DQ$J3DdqK8K( zs|FrmkxaUZ1Heynq;vrr!7YO)j|nB}hWV|KQ&keWbh43)l@+}t<7>?hq^+nhQO-@) zyiuJU)tnr9@#LUdg#FJRCqYmR65=D*hpSJc0MOs5`Z%Z#NL#~jf zaY!l*H7v~BBqILX5oeoPLSY*5%bLaUT^X+y!9st;00tH)KO=&{z#+j22^~GXfuN#c zB71Ld6a&d?@r5O`bs4uyqzqBQ(jQ2M55g^+gLg4Pn3-$GI9goIpVu!{T{JQM!xpV~ z5Iu?%L=E$F>0}}@Kd&ska~>`&{Ib}RF&TI2<#gIJ+i>~rEy_-Jr;NUc6L!;Xn6Hc_ z17AvBQl%+x_9v3@iyV>mT{rc0GHdFhVY*7gj(OS2ZshJ9G_|l@MJVcC)To(Ev~Gx@ z(h?$P@|n7%dcBZR(KMob5Z92$Y4DGfN~$x7D}?~f`><`>^Cd&O@4|A~i&dCU3)y1r}CcQZlvJHr~=MT=|Xzvt0eU z>sV?1l>frbc9lUAdawDW62mJ)CG=+aFHEbyF8qb1DL$dZ$L_hYmP2Soc6LXN&86Vv z_ig?aL{9+iL2Y|`#1H3vAX>@6ClJ&d;s`MoEihRinYpRc@l26NY;({%)Aw8E%Fx}# z9G&?3vGrnt#c3%k+*gy>4*@x%y!If589!a;V?NX^6NyzZ_D70gd(mx4L>}CP3t(%s z4+qYSc2Lj^l*Man`rst~`3EoS{mi-M5@S9SVUy!f!&&kCf|EsL64CS*X>V5U`!HF) z*cAJB5y^&s@3?<}@5Rg(W|ND1*DUCLsVf5vl`^Urre$=kO*q?!_!+#l0 zX5UMHgZB;Rb>Wd=G7PQvMGmuJtJ(=cuu4cb>$eg3mU+a}{;Z)NZ~{()V1i>aT2UAT z^~2g?J6<&wt(_crtyxiYF(I9ORpnLS+jKOrw19W~Lq<{C-%|L?dHuN>6z} zXUMGAfi<|pRd+_yV;i9Mg@bd{SyPbYk9rkPikBSN~;2uYH%I< za(PLcByvz!V1c>sZBr)B6kaU!?DyDC{^7lnR5fl|y|UX#D1YG7f+ zt>hB+q2Jn6dTdHORr&V6+Fx+%a>VxW;#Utjt)q?s`A3eZXc5cMN{?M&VA3y(eq+-{ zxl}J!n{iXnA@ScX#kVSw&|}!c=JFejr54gLk5{3_K!XfT@F{`7R8;E`m7)G}S`yQ&_-8d0YfvP5J`QLqK{+H__#uXvhazN1E%PuY!c!Ytj_UWmdb+o`o` z2>7m(Bg*2k6PiuYJ!_0rY0W%UJ~s<9Q{v|K2em(A+P~nCw4Z1blm;!y_g4N^@67*$ zaU3slB`8aF5FB}N`{Go)J}#=d&tGOD3FZPK z#-rvo2vaAptlb9iEZ*^h&v5?zRhpNpUc%{NrQ6Cj8w&l~1fE;LL^_@S0M!UkIC^XQ zdSmNz{~R^#Yjp&6*A!guQ>qt8H<3$Hp4Y}WL z5J_7i;SqCOyaD+RK8Dj#VaijG_AGWa8lQxj+-&_S%mX2nxJNN!V7f|tJM5K`{4Kxj zBlsi^s0WZe!K64Me_!^U;7#?Vj=ddO2pkCttskwn44*=CUw(aaQ&WVR?9JYY3%)n{90@%A%dIeU5&1SUSm^hCn_>0 zg@;dAzOc$Wb)tf1qc;aY;sukt47JA+PYyXFEqq!&#_a4nw?~{W1AQmBViT8NWk4od zOb`SMf08?R9?Bp zb+{V=U%!Fxah#k{owg6~Z-r*0-hrieX>}D;$~549_4j_dn+n+c&W!yDQ!Qg_4QM)e z<1Kl@C#*5D-(G1U-U6|Nvy3L^Hjl|=a9i`-4>RJQwy98V8u2v+6gQKgfQj+uSzhu~ z;PJlRiWA8uc$9}d%4uu}c_bKIM3i99D0dE`mP8El(5QirC#dx(_qt79_gU*9hdqWm`7x!NYqLn?YX_RztM zEc0QNv*|wy3lNN-`~3NmB10nId97wAQf6!`MWkX|QiU>=#;bht9Ol)ieOF_dabW&v za6lt2akpfRMG9-oyj%3t)%&f!Ix3CuG zNA{e&(+{1Q%4xXq+LW3KiZ$2@$uix5cLu&UepIzPK2mNN+4izT&lA572)wSUzh-ar zSB2I!Tlmjp4^?T6D)T=66eX#Iu_piNW}8k-_1*)+|31%wVF}Lz`}<``Q1jA8-;hu3 zw&-9~RBmsJb+(#Oah6r{cLI87uqt^W$p*ql-OHmE7GP0vq zCfF`OURh77x!J=MyIp8=*kw%9aups#u>FP3nm`06qVQnsh{SFI?#xibWZM;U4)b*l z0QUb~abdHd*KI7xg1eXzKGv$xzrF>R7L}9ZZnFwLOpOh(%dJ4{pY(HDCx$1_E~>Nw zLI7~GGvEUAkxph$fNEMa-l#n-)Zf?J(^VJ69`XP)rYeQ)nG@pL3Zh&FJ(caO{2z!*5`scP9YNt~Y?Y@pt}tfZ*2W)UC(BH6f-N zA9mRWOCGL2+s)49y^FY)hwQ1==Rg9sfB;me>pmQf`-`iqiSv@dv6yf{@G$MoFedS2 z9k7UuGIput`<=(5`K-y+_x&C~ENSJ}k_{Rxfqh?^CU&OC*~=7uLY{74QHG;`k1@%c zs^dZvLca7_+#jQgC-U0n-EQ`xp!xr_02~s0eGG#{UwEJo2w~p;>t%zpnR6OarX4})Z)F&@{;>DBwtU37F%w>t^jsD6DM^_n1 zLkju%ujiqp3h{SoP{y2H_tQ_qCe<6fHU!U!>T!&3;j(5?@#*QOr~ zg=#C-(XM$oZ0d)9s3XIds|)j`W)gkm2)c=hN_91}!%s1_P$6dhKSeP3r~=6vg^Kt<9yl`!%tb)-n%UDjPV_m(B*%EMkh`=hIZ% zS63>3p1}27`;>oc%z}lfU-*NatbxZQ>QD>aBxGNOSf;V1)_^=Xg3`(d^tKI6bx3%9 zcEH2?{viPfD2*qF>r$D6ARgo{ygKEq44S5uq6&_oWG zE0F}l@_DXOlX&Tgcg{0wI&{O$8dA3V%-d5K{D%3oy1vz2L+a&{)JaB@Q7Y9_L@5-a zNWb+AAi0l*WK}_pNUUdyOGQor{$%NCH!4+fQb*oMeaeR8LzwSdMvGRfUyilU4N230 z32Q_BPlJkmxas8883!pZgE0(!|MZ%BqU&-wY7b|_AA)&$+$&YmVur(lH+r9`I&pBa zNV#&F?s<36y-b=h=geEI_36`#!QL!|B9^!mrMO~m768$7mR43k+QTP)n8PGPUaLFJ zH77%QMTYB+j%WftsG<>Q#Q+Ve*!FNd<5H?(yLqsM{##ugXv{;a?@cE)B8zOj=^Fv% zai{JSkLaRrH>?~bHVxi5;r@P%?o0X}n-L=BTlMg8O`rP6;Q@%3jEs!$pxEl;hh=aV zo?svsgVYgL98H4b+bj6&&~%(=1;s3+^6=~+^^ZdN}{Nq`>*JDC9q}s5~HK%q`wX9`pWJ43PRaA*3LT0z1Dj?Wo zVcIwWra}oW5epjBLEmj`bVDcYLhNfaWA_t2;-5du6Q&`VmcYp16$do&^6`N!dX4l6 zAdF_>7o^vqC|UwU?KSm^t*^dOsWY-9{lZ zYty2i??tX`$t2fZyRMVoudJn5*4gfTt@9iIpti3 z7ta7^VtCiguBP-vpKiG0Tw@+@l#Y7OQwAtu;Kv2V10+qkf z#r>iQ{_G*Oo8LETfZhwN*+}T z+Zo569Sd%olu;|Ku57?&n#dN=87`EkX>doTv-GJ?%g7_V!#DDsCX$yAJ2sL!^~|r0 z4NfByKCD-T4$&auU!NV9j+J99w_!yh^?5Rb+f}uddaAKypJ3?0-`+6>gQv)x&br|Mk=$0 z7ma^H+X>@!7UkG&8>R>{1v^e5B_7 zV|`_pC2a=+zZVwDE3lV7#V|`vu-*g5BIq`OW&HetzwMW{z)`IWP8o4kEHM~eJQ9{w?kq^q}Soc5KObj;& z-KY>Q@l<%>IUeD!e4qIE9IAOHptM<9e}hiedc_?=`$ldm{E%m{6ch)#*v)i8_lR;r zcL8>=RNf~WOc4t5^-NxEZ+}cDM^2B+V#It}SorYSuR)g-`hg-bSP#UC0mRtq=KpB= zs(>iCXk9@k>5`NN=?($uPU%jO?l}9u=N?~t)tT9Qul41Z z>$3mqEC>lrrtqA5;F7rYps?b!N(g3j_MobL_E*;MU+!iJUEt%SD=znH+b_Y|TY`MNy}ihaGr$%2Vy!1|rhlPlg$kV| zQ`8wMDHw~)ZPxzRLEF^UM(>sRn;POKj%S&)RVF;eWyG~=R(SI7-|K&*{T02n7@6(; z`gT+MS!+9j&-6rpKkTspxp~$=ucrSSsyo7my9J0|-Y_r@0|OLDR0Z(?+o7cIn`={V zFY0%%#zs>y$y7$K3|lGal`}>;Hp9LPT&`yYyVD{FmARRox`c*A+77s|Pgv@lUy<=s z5j4q)qU|J&=v&y^m*0j*e5bkUAynZ2E51Yu(A5}lYoApl-Nl+Ref-j(k({}>#tS7J z1w-YaV1p?afr&DO2~{aGTo|ul=N(wE3XoA^2Nh)0Y=V1P#FEiFXS>H?Z-o8ZH@Ize zOBqKIR9MDdfNw@pM%H6$=eywHT*sv^P$@Mq!RK?~2}0 zHIS-W>h-}0mGH@9bM>rcdZ+3eEa9;qHTY(7*cX7l7`z*{%W!=Q`c|iBUitp>t!^+C z3D-67Jk29J7a~>HDZ1^Nv(qp^>eE;v;vR8L_jvQ(;wxUZB!}bt>@eCA0#*SxWFrFA zV}(jz8|02tXE;CARf>pTgjtu^Ut>S!_PKEN<=HQvUC_X z1a2SG`pDklzDvP0?8D}GR2hItB=Z6G z*t>kfXkvbQH5sH#R?$lMCsKGux_N+j6+ge$jt<9Jke|_FL@6lcb^A7$ETucfzg)U= zZ&SzwA&@f>C;zQ$pwt8e@&6l)F33 z5<(16YRBQLIe1DWj|c>QLGLF4;f*ip{DVtN=|6Zl#ukNinFh3`l1rRMK90x=pLbcp z^IyByrY*Dmp{LY92svU>a6!ELGtF@<6tY&q|B->^-1epVyXFSCJ(=Bb(DvMjn#%Kc zVA^D~O-|eEPV)}|DlqVLW#Y#rh?Ly*MyC_CSU6>3rie))4KtZzSf)BK+p{Ov^5Mb6 z%2=M%>PvE!MhIx;d{GeAGJ2sHoS}S8u71$`$6&^~M#nZ5C0umB!c-*^JLR8 zWRN^ZVmj24^f3e0Wy^dKM`O|;y>9fMn)Uc-wAW<)>ApqA?`iiAoj1A_m89_0(8Jsx zt=Ds9tc$(d3B%#b@nD&d{SkHW9c}=hREL8QDaa>}(gl|o{;pRY&n(NV&I{Mbz-pN| zRWRjuq2TuvLqW{OiM4gb`)IXK?jHwBXiR=ny6}89#ydzdi>9^Ur>x_$8=o-h#c~W2 z$lzwR6-ft*oc2E@MTvPS1U}lEh;mWNK93k$JD`!=k~pizUO_F%YLxUl|Jrwi=4hH>q?ols$G5~LSUi~{a* zu)w&hB2Z$n!-6*!|G*cgb8I3M`g%uP-o^usiBR8*5k&O78AtHZW2K7G z*{$M0UaHv5%E`IlM&B)M%7_hY)xF^6wv%SoYU#H%W0DuN?4c%_XkMHu-6XVUm&7wB#lKA(*@V>>-*2+Cz79-OtN%Snp6p5_ z=5G2%1jhzUdvL#vf<4|jRkI$jRkg@UMJ ze_#Ov_S+ST%sQaXUE_9d*L!;KQFBKo;qcG3a-p*i{9^sUp5RUU0#HLEBiF8B?S~r5 zUM2?#n}1U*M3IC{bX(jOzDj8VBKbXNQ-=>%?Tkp^R;f zat{nVrAp5<^Z;HKPH=ge&Oj*2DbGNgfKT_xK7_s>DKw8g+>p8-#3dI}9#D?3fd21YR(=K-S zO2$^#g*0$UyP{@j{SAKRdSs!0qD;ZOigVs_a(+mT>an)*KUor`5>hF-PF0VEc4$b% z>c@`1%&Zl-(z1J8#?Wg+&OxNOPlea%m~fjhYUF#!8kZ+i9{PA6=BwMu>WzYlSbfQS zT7x-P>eP0mw4I~LBBqRElgztBtdTzDcZx2ptkfGuX5N|una2=2FxLV!$*UG4JITH8 zX0s_o=r2(rQOCB!M-_^n7I{rm>Po(DJYPQV?CuuPd-Uch3qM3xlG`;psNxSLNm0D! zFud1*dYSb$*Fij44?Z(IFVD=A}3xi`|#)6p?DE6kuVP%Yk7d0SmjvOB8gEl>2O z)n_3E6qyW*%uo2%5GMU#h2X+jk+;HU-iKx!yW>-#&{xU8{(vD7L2zNUHVaw(wNZL` z(q!=Y^o=37BrfpiKly$RfHSf!~Q=u z%wZzs&wY-bMVgd-#P%Lu0&+|z;ZW(Ye~f}~=Q48UMhqzI>=U{k+(qwKs>Bt(E!lKa zJ{Sj9R_rn4LGcHWl=I8dvD>((iB(9T5i7vp$LQLHXrKDz2{<4VuBb;l4;_j^FYom_I<9 zrc8_N;XViU^?w* z_}uKrmlq=iuj-*^pqgJ{g!TNmuE37JlzjdNZs|cQTdUHuX5C2j;tESJBYXI<3RPrhu+HV$swY&pHiJ;X?Yp=Knu`7^d>@^lpH3) zdY?+|1>h9j9fm}dt@7z=3a(E!!9K(hhSe$e0#bMdg@j%J6%9B?BG_8xa}wr0M7a;R zvvAT2%{RcLh*3gXjkjzNNciOsXy?GfyCuo)1BJ)DW~MS`sGS`hyN^R`<8g;x{p~l) zi@J6!aMz^o|NE6(sK$oeD_-)lMX!V%HZmwM2+< zd1ms{iC(I_3bW6bu3)h&ViOaT zaSa+O*>OQDT!S#AA?rQ`_O;g9m;L5A)rT5=TVNgd2LdG@Y`2cl)#~^9Hr@H*Qq&Z2 z^=k0RFM1W6zcmWweLWt+*_090+@{zqY((c4t*?6YjDMdTAun!Q2hfX~Vh0i=A&#YW z0K$XtY0x1^NJt1`u$$&tahB!S8tieai`%RaYimFp_P~mV3~xaXU|Iev-ORCczuW-$ z1xWiAICdja2;;=fD);0dW6um^@+q63l$0&UWbQ&05TF5y$=OZ;bKEx(45&GmM$#eR z4h;(n19Eo^;_%%f1as^uJU}q|5&U}DC4Q)vo;{`t?2Iw;FxJ=KhSY#EFFI49NLlHm z&u{Nm5hkCU8)Rpb(=6?5uwzR?el+XR2fu1#6bI=rVkD8Orw37$srSBj^L)!xtCyD; zJ!90uGDRPcnXuyG%v8<74G1?@d#XHBwDzS7K?mO+0!d`OKK z`Y%l#XxeNz=-uH+y^ikVlC$5@BF7W;q~Ho+h2MC8I0s5?Iv8Ga53^{U?62Cq`HN_}b$Zcs(*!XPIawW>p`?KUX!bNSoZGJ0bP8$X@lpAEG6p#O- zM7+o^#8-{}!OmiRM~&>9%1Aa+_?_d%DJ|Kd|6qSq7t3i$w5a7;!;N!lU^btdKJsh^f!+SaxlNYU z!10ID7+X0?y6&}7h^}QZy}%}o%DQ!%-*exz;AXN>FrBekpyglIzCUc0RB{kj$sky< z_oJi}D3(*LxpX(BtcE+%a~lh0l=3itqhZ$MDX;3FV*cX7EJ%3vRG(pvJs%63vbMz_7ug@3A7kZB~_Xso_IjE|69|{r0VEkt(b5GRR#q{G&l0UhqDzQMbQ6=4K09} zC#qGFz`KwTqrmx1tLg*F(Nl{yu=Hjj6+=~-|JU~gQsDn_Id2VKksu^t3~?J~)vx|R zHM|-T5w7;SX>Lz~Yl6ZfOuvYh)4jsel&zg9;X%?SOml@wO!76^ozCTX;|YTj;Y6*x z6FmCbv7H3F&v8vrW{<@pl^zSbRhQNd-0Po70?`IO|3en|RT;ZP8+r<)c%b5lFW&@l zvuh(O?C&?CEC)KdVk12AQ+5y|!LlMDf-6M$&KA{Kgz9a8_j~baat#K{3dv|isc?mq zTliGpP3Ft1TQ)l*F$wWlDu(}ZI=AF;kPDA0iP=LKta2BeKtK%8u-ejszhm?E(AFK~ zuDoy1g#5D_mS>^@%Xm`B=LI=TqpXYni5*}4DW=Y|J0AT)IL(K^Ef=-NhIX70F-0b_ z3#EsaX58Rni(C@)PVlPdyo?c1N``t2MMjH@z1(G_jBDWLh_-*0gsvi$iuRGi*T zN6=)C`4OM!EHU?meSFK2%9;HKtTi!f;~@7{umlalErnY5mp_Fq3nd+6mZe=FAo0fm zcqFp=bYL8GqBgomgS~dwx7b(5GI*946yjk;1%~PJXTMM}i;Mw7+beKEbbh*3QkWhY z8370>k)orOlB*PDIO)p0xkG~*qB1Q*@Q4yf&xcO6RaxgkrF zk0e^|dGfb&TUtVy&7Y^by_cA_O%CifdrSxjt|BXulIA*UVVkW zqEwwPx*vw`r{;fKLYNEkpPH7H{IT1X7q(b1kp_cy_GcBkZGk9YQIm9{`qBE^6KcKn z4C9B1lMyiFVj((9j^6V~g9?)#Z$Zmb9pRUDx$Xkpx9WZ4#X8R;eB((>3+WaGhzYH5-oW zs$BLE1fq~hQ5n~p-NMQ6^rK$h+gB{dj6j|KBPyhI+)W*KYpA3zQ}>FBx0;5x#9)U5 z5oW9R=DRj*AGFjEsRyb4?Mx4yQEgz_yZPsI(4;XkpBXryRlZ{Sc-BgHYX?dF{f+T8 zM9=V4%bhsv-b9E3H#?gnToyK894}uayV5`E+htpCSfXek+Gep)^zbLr%J04vtubF4 zVE>v#x)U*5d$}aKHmv@Mk%O=?zJol?<>H7B_I>IxW_*1$P)g1cpNwZ@%VnRRDD3wB zb5M6B$W?!?c!D9eJ8Bd%GkN4IV%FI#Y=eQM#X^bW9h98)P8kO0O#=^-y!3-#EuxpI zeG2lRgVPP44W`UsvM!q7t|G;8XFwEhci^c1c9-MavAY9FA(TtjXIv8A%-%3PS5+tQ z34rFxh0cDz#J&{R9T0)Yf2jA*cbcJb1}!%>`1+%%$8@DkTdT8r?kcT|92Ef>!}?I8 zMF)9z^c zpo|rn)@3GI4%ra$=j!U}+ZFoGX{R$Goto3ObGNS%gam5@V5v= zTM<)9s2w$=JwU{-eE%>!{y)wH+u-^Fpp#dYBMnVALxGtbd#^0#(b8Zp_E{?5&Lt(< zPtp3=F+gJfKIao=37gGssZO%BV4+Wq249Lf$@K@?PWv}aT5!l$HX=mkoh*K(v>#7IF$FZ&H%uB zFksy2j~;{KLY1g+$(s#a8W?37PNz4O@;KqZ-&#=O2Q&45T7ZIr+`tFfr)Shc*KyEM z3cPD?N_G6q&3~2gOP3{l>mKE80~j8n9H~O!{1}x+u3jFFs#%BXl+nMZu=`&$fMaY4 zHZwf(?~gbK1oQTpL~8R0t;Q|ENhX){XNA_916q>*>SL_mh%L$8kPhV_Ww-A0y~%a_ z`?<-qXjr++nS9>ARgIj7U3vkW)>~bOjtx)lZd6X}&snXTq*JHHtBA?Jx+OOL1rg&p zR@=JBrm0VFTx2641#1;} zYQV!WBbQg%Vu8In+seI9FGaCISyyvUr(8c{36m;b{(QfmyPE3v{J_ZxApa44&NSbE zfYnGzRPVEYJiM}D8j%<6UI%_m+-Fk5=CUOs6U6nv_|gBJG(=sP^6A(XmC2WM zDPk3U)V9<$Avdio?5|l>KQ%&bR@S@iBz@x20aXd@6=cF}S9HZe->%7O3Mnej$Dc9h zyhGGY-ifmBXIld0@IC5gmStEAB_71?`;-5j1zU@tLXBHtoZ-;`Fbru|`lDeDPD`pC zX$td-M~rBkwH(QzUrr;C3EfgCO((c=i%vlhQD&ww>o*1@CdQT~W1*_g?if3*Qb5Zm zCH)ZL=ANkfu#DLvxMgTQtM^B;%8|W`oQ8c5@(08@*~=e%AsTL5Pn8;o>800y}j~WZZ>Cu|HMMe{5Mf#E>ww{%^n5I`6NK`LCq^y5TmGw_1s4jLb zE_3O&hbrOC(ac=cQ{m?_`mD74B$Pt4^Lev)9FD)oW`iTrHp13>qt%rdkRj5p5QJad z<1r|eX0>j@)Pz!wxexFEIC!ve#~pr|qW*+D6Na>{u>!;Zm*WNUw`TnG!6*!{i*bq5 zYgVI?gC?88uhPXwOGL=qO1ofpSbu%-=Dy_=B?DMpQvtPmJS+k$LfjCy?ta00`;0{f zd~!Bh#kWl2cG&X&t+{hP1Eu(IpGkV2p9RIk!fvz9eRuG^35j!JKS82;I7PD5&ILAu znc;#`cHWbrha!Dci%$WY!=0k^7N*7ic6YCvuP?r(3^70{z-+v9;EM<G>kFM$*4i^x-AX{eYc)-|NA!$}-jm?wjJ~$W)#^_kg*v3P~h( zkK(^d?Sm2N(yMeEIy>*mk}~}{`m7JasXDWL%*^*ZUxd=SZ0EMqiLegk-LrhpLFp*q z2DU!4@h1vRg;-9aSawP>>iRG^B|8`EWB#BQ%tXEitw=zxwP$i19F`U8ic~7g((iLn zbI|71=A5bT(YdK($nm~}lT43-+x$g~H$@1}PfGt-O-ukrZ1h_;D#O_NQW4mACPeVT`EtpxW@O zwCMzS35VWLrK%TA)jH~%Q6Bq@ei-EsKS5CrCgIp|sPx%E$X53b`V9a|!C?EmAM~;h zx~-Z(P+*H2&h8%IO={DNCQ?j?44V%*?GY_-_c@HW=qvh(p&XN=C3)E!NkKi9T~H7S z(vsz$;(Y>)HMl|ne%JOIlKknr8c0M zzWJ;F31H`=l;GFG#ksN^#BjUu8m$Sjqg-~^$5i;tOG{VLO7|_-c%SaM?H+nIVPEJSRMuOp@TCMcYctjEiFo7s zqOJVl@Eem5Sg8GpXo067+`If11jpjz!ThH}HGiW5%Cd%Tl^2H}iOLjI@w(dXoJTX} zuvo{(VZyoHn+T)0<$VrhD>j`SpL@o%tRQt%7mjwR)?8!Qzb;M>G8EIpnAa8%!IYgI4yGz$KRAX z``%Z?^xRkiw%yh!CdaM15nmlQ$J|P2r0&?Slt|l2SIZAKMFksJmq2}=cxZLH!gzs6*#wBd>Wa&2vBY=qoQ7+3OA3GA7Ye=#!Bp`4r)A34? zm+I?!wj>gkc_^PcRJQYu)+5^CehFF{c7j7f9p9U|>^CHtw&xEFgriFk3uwwmjec0O zOKZ)t-Qyi(8)e_3UQTqvf%U45=ci@kwof@_zSnyYxp1=TS#mFw+>@RaRbBd4?Pe1U zvW(z2AOjL&cn{>tw>M%WHKO81R&L*AF`!Xz_8A4zqJHSq#5q75FQcLHn&+S_aOW+& zXq9gv54~y=ry@s3qlCg79I;~CX6o8PpO^^9M&eAyhQof*Lsh!*jVma-D7#QtB&oXP z?l+E>**ji{km;t>R=Dm6c=X&78} z{54x2Evym7$wZ%7=A&>F6E9nhTES)dY`ri)4_MM6e`0o!z4z}gRJ2(7v1bf?VAyC@ zosEyX`!>Sl$rOu(esNRbam_L<2F3EUm*gwONCHE3r#Z=mS_ z&I(j=FtpOzyx(Ww#+&Z==pfqM-Y&q$_cM}3t95C0X+KLV>Ps)cL4007*MXY4C*7D? z+r)x%t)L`|K1Sm|lb?Ayd(GtH^cW$LdUL!e>`j(XLU_n!F=PGnA?d$mR$(v*X3M9> z3lm1_4fXZw*!gZja5e3Lx<1C$S!6c@s%xpNpd4HU@A5pFlT@x@4lh7r@d_>uxD&wc z0UD+jx}N_!zux^82A*p< z#aqIIlRF$50?N76&e(?J1+$pi+B&~x2D3KP>>$v%1%~an*r~QxBZ6-yntiPwL5(2} zvkv_{O8qXgE&ixTkc-O(7)ygew%HaohparF=oZPT;>BrF-&1Y{Gy6-frPd5~(piw4 zD|?4tz#fd9l~9V&m5r)HC}Id(iNBE*y@1M(&xM#gHsvhV>FGw@x0iro*ZV3;FU;Ge zm&9YK_41Xv^Zi~0HmqFu97AK?tKFs@BgS8?3w>^?Gs$mrxro}kwe!}25!&CsVJ_;{ zRzv#!rKFoH##Iix$Ll&)9Zk7-c3SAx*+hL*!d2l3r53eRreHg-Q(bLLD{=I6QOpEDU0_oG^qqKdjaZDbQDc zD)Z1{eJowBQv9(I;u;X}*OI*Y1aPf5ei12hq|)?`k~FPq!Y$L8Om;=H0310vH zOYQF;hlQ#ARua`{6Nw*cu+g+IO`;$niBTUNuihQ(a`mRk?^DPU_>E%1{OZ|ZybyX% zjG-hhrLq~e8}k>4KLpV~Z@S-5*V|xayGG&EewJE2raV%3|K=+f|HXe1Tx+lYxCy(75Q4 zus4j-9BtKua=do`$nedWjOQx?26kG9PUY#bgmc5_3N#&le@?K<=5H4r$MUSX+8@&2 zY6EW7w?r**sJ?EpFOl1n7Z8>Plv!~1;uhfavYWz+54vztmMh*BO7yN}nPb zf6;dH>cXKs+IIL6Q+Gx-Q@cdi2WS5?sfR5a*HLj}LLumD>`Qu{c8kI1?Pyu`Lq1{t z;>#nUu0vQ?^DzYLV(Ojv^z^Sq<`I(K&_>YVx(?^II6qo8Qq_%z)1OQUMlRey{tHmU zU%7aBNsVY){n-uC8%?@$qBkj=I2yrW5x0YdiV_!3s5Wk(d%;tRsQ|^*Rz(6 z4#sK8r-h)9DT(4uAuhzA&JK@M) zzLD*^of~lFJn%wG&*h9;i)%{!vKmi0950-8IT1M4LO6q=`D~5E z#X;;m8pfu}3#sYpH~b#k#x^lU0=y}@zeP?fiP13-*$v4;z6rqav^4718d8xOTDI-m zpCAV}`-8?q;-kJ^6k~zC_^`scyx(t=4CXoh{6`i53IWJT%;^F+U^HLk})Lf9)Riu@8NYinhsJa{!yAsgRy0!a>ISELpRk+FC@(w^vI3h-4m0O>T@6$%Qbye7E3WWv3h~+sYf~ zC)2vSVN>9rn0COw!+|PEC+-4ac8H^%;M<-M=H<1uVL@&f-YgnHX(Xo8z17PQ(&92! zY!U*lEJp{2<{CEu5Q0#T(Yaya*L&prn^I&1^yQh`kLe5_FV}6=q+3T3-$sg6N)m0*P!G@dD)A8LLfOVXr zMO~U7I}8UqAkjoFk2?ne)jg<*@h&hkH#Z0W!`jj@Z2gi%uA~_Zx#c$Vmwp$H^GfVW zyx5nS=m;!aXyt{6Fk|tbFu{TIGZ8O0It56iU$Gy(2VZZcuO~i)!Ws)E-RT9z%O%n0 zApGrWT@3RPs+;27%{{mdZzMf@LJ*UyGPDgb8t`Lr42qs%(=@H9C*ghXwKf`QGcvfE zmLpb9C(^=cSF6U0(df4K*Pdik{*IjVMj9UeR7!Pm(iUJ)KiLWUm14%t&ziU)<8D-8yv@nk#>JP8dxrn{1lufT;5( zJP{)W-9D|axA%TpF2~l+8w-NZiGp7&q@9epzO9^iz|K=e%u1z;$VZPHE_*qXc$awleB)oysD_1k|{qtTXSHaCsN+ve5 zgwAhH5%~kX`oG)zw{zRbM$^dIeFy?~eOnxe;9bL(>ULa7C(l6Y7Zr;&K*S$0&9LIO&JfDet}dcyslhqh7mwP0NIX{aNuM?GS%Z z{5YQLSQ+ZKr^LFTED{{>p*eBv=N~%L`CE7F4y~8_Qq(FlPRKXZ5ZFfLdi~Woi3VbO z!w^aRau+Kl7VAAbzVo>fy9S*~E!`b~uATg?nXO%SK7z(sm)Xqx#}kb=)?%$$(cec= zNA1eLr>ay`WA>8B0u({0a_@0~9D|~dp>-BoZ%AP}!9>-v;kC|b&f2VDm~7uWQztp- zWx}uaN514MNoH8MmZDZH1X$~S$ZRR}H) zGFa9s(g0%GVM#rX%Zdp`1te^<{AAYT`u}hyiL}$6gMZfxKEeLHn;Rht&OXe`E92uz z%p`zPeY1v*@&%rXF;wDRXWTYTSzP@Eo~FAGxw}A8E-A*eLLh?OhIB~Fgl_W~Y#HRU z8vcRj%+$NC1ws)Vj`Nu`Do5t3UQ(jK4Z4wW`$((rDZ&24TUEu-i}AJ`WgjA1{+vy4 z@}vEy;T<}CN-Z_L4-JWaekuvud;)8}sjP~^Ok{KwS(bM-dVIG(9Y-~m z@+99U7nk@Jw8#~AP;&Awkjag)m?fb}CZPf2t;ZvjtIiO+8g~M|@^{B+e4zm?f{@2O z=u`rR_ma)Vp%M+#-5(2b;o^Fg;hkU`k#@FEiWD1Iu(dg*BjbW9xLTj`4ssvc50?&4 zz*R0{t^R%?#ypJo)-Y2Bx8b@ufY5JH1_Fsx(h4uyQis!QO8Ygoe3&Z~fWaj7bPF8) zz#dq_JNj>Nf+;M=kNQr*!8YJm3RWfHU%n9SL9k8S-7gOgew_a-{$H`btOgk*QU?YM z!U!@C-|xpcw!OSC=TX?LF&Zly-DXg7ggC30D;U2J*-{viUKa}gEMZ?jv=6<|`lxk1 zo|7;bV|wVqz^WYSr$g}TEX>@$w#4KsKq5fZ$m+_<9mU|!9}=JlkZf%c%k0lmgrwj2 z71u#uz|%}jM)!OlbM2eQe>d)k>2)LP;nr8Wvt(<}J zUeF1tvT+rwUy#%1lwU)$T4`%HEMU?te4&f1aXvx!hULESEdKUkyJjI1i0U>^pM&no z?S5F=sJh9=_UTR4{o-)ko+Mx16kFPmaY~y10MHVkC+^=F%jAaOtbaUjT2I1)f(?)Q6R?{e*D?M| z%@|+K?_QsLOZv2~FLvbvw;0A7?7Ip|(9GXit@W!my`$FK`Ou}3(({qqED~xvI-rXihWQd^PI`~7=^c6G*cr$I%&V+;zW*fppXWu0$;DPcO za2L)y5r5$F5VxB79q#!Gez%WZ&)6#PZZfQ5 zv1thvYr15jECkI5*rEYl==b0F#JG<4L6NUtsyCYBkS zV?msw{%AACDyZJ6hr-6AC&Dmj0cK{kg$Ec1cjLf*Elft0@?0w=`Gb`|c9toHL|3*c z##s8#S8a=M{uy$(CW=2aF*F(UWO+oh-j(xjhA+~Mhdh%<>%EeT%sy}D9i5mDKAlq$ zhdr4Dwm04V(b);$Z-Gwyu2+JC5%<)|lyT;+N|~mP?vx`Wz3Nl*E&YCs>j54;8!cCc zxs_W!U!I>PM*1g45?b9u*rAP~+4x-gl7n$X9ZjR&1}`s^t;FsX`*@Q23(Sj2G4#BL zy#M_23Z{fBlY~;Lk;RHSP)=n`+Lyj{Ms3bF$@g#a0_>=qa=26LfFT;b*FoFJIU+?`Y%X@QiFe;NE z-%#B?)pG3Q-~h6GB{(u^qD?)MLm0bY0_}BG88YtDuSHXr8~dREW8{KtKJuHOhk6Ed z_AxoBve-uoAkor)w|TQ-n`FcOsTA*Nu>WAFmX+I%%?b6;@Vu?L`EDH~^>hg$YlPD(U!Iah%5bBKS06Z~BOu^}sDYs!A&mUb(5hb4SIOyEfV=m zqwTyC_e_rFtpvBn@Gdra5!oIqAz@E$D6x(5z@;_ndE*URPFDj*X4sG8@sT-zyMgbhj!X-&D(3 zBt8tib4m-h2j||>iK{?Ao5xqzHWT;2DiA8_WTxD3a6#;cVun3;pH=VL)JS-L{nFwh zsW6ZQ@eI3(_Pk_DQ>#?IZ65L6@qa&XQqHdgnTx17zQ;L=fgKx>bGeSpC(Gd5@aU%g++iXs)sryms_l~ZuL^0=G(-9M zqhmYhaQICIMCFH37vGplv6|2Z@m-~na6bU~d3jkm?o=g&1l9^9R@)VsHayTOq>!Ez zDX9A1v3cvNGr}3*<|LPpPJRKo&mi5AhKlL+KU*-M5ax43zQMEljym;|owz(491N!T zfo~HA)U`53M#FbU6GAumB3^?ejE8;US6a9anal~!M$Htvd`+i!E3s7od8Xi)#>G$E zOp}lxHs_O;rEc(A+i3+{-oprJ`)drBYf^;JC6z^u_u}(!PI5ky_qIx{(DJYc#3100 z5`(}`IoClcXLss&X9ou#J=${-`XfM#20dIML?ag+@L_o|Nc55YDUDF=e;QqvUrbl} zy=nsJO~5Ep;v;obi{&Dov#s%PlNpxP$0~(39+_<^(wt%TDBF5M##kbaCnnI>-OLV1EkVjT={| z*pfoynA=27auA%68HVDzL@U1%quCGBRVXQ>e~P?QbT7y%O2m_Xe;7@nF`ZHezbOQ= zL2G$9etziVwK(0;5FG0o$m2in9bh(UpTuRKs_1i`TFK*|uo?8fF064mE9UiMQ&FP! z+nt%ruSx24+74asgJG21dU*K2W;QcJ(>rrk#6A3*g$h;q$slEZVS!(4B#{_a!y_1M z?*u8v@PQy4Y6W0CR0)rjP;>FSKf(|#_wsf~t&UtN>!{cZ!qgX92Y@s-ASg&V4EhFu z5i5{xY5ETrAc-~0e}{Ae0`IM;kuaX;p)-958#AT0nD@=Ymj?3;1dWigpIZnROEbt> zd4JdY`t|E7DX?3cb*N-*SsSEswEv!@EwX zv2i4L^KgSA)weLM>hvFRJl_k#P4dTAHvKjJav?CA)x>GB^~JXS5vQH#ea;it|7ihG zL}MGJrJITgmid%92v1eco}LWWX^T|)sSmc<41~OQU_3T)(F9)>H!~-PR#ZZ z|LoM(v%BC6^yq^TZGD&bkRiRE1H{(OL$&(_?;JPNRw0hWz`v)7v5dv|IX91{R!?L+ zypE5YxcoYZ{`IiaA70Bbs9bDNZ0lKTBdO-7YR{j36n=!6#rUayM0nL>8S$$>*ncLtx-uCBLl^R z#7j`j#-(B3y?306-tr0o`w!|i%prgUbFPQgt>6795T^xxn2K}2OV!XFFru!@_K%czew9ertptZWCwL{qVfu5 z!Gb?jsOza8iSFlTgE7*DMYCr=(;w_1@|XiUGSdCF^6yk{8-SmI$yYV5T|^|Ava~bs zIYYNyzr+(D8T@~v-$60J<$X}7lvb8aLxY?P(AGCKNe7kZf_DJdgYU2 zY^<%V_4oHrO(h(kgy%VQ&h2~uV+ zgl%0q>0j*>!M0MCoB(`SE71+5|IcJ=%oF=B*I8Oto1_X_^zKSwF6GfuMOng$X_NJw zl;e`eEDUupFjxKg8|quBjN$!R2A+X|PRz3B#XFd|N2*@o3^r!8i_!Qmgs^pVUhOBC zkg%lS|Da;l;4yGbZ(odF5w+KK2R{AhkcnT0Wj0sK{^h>R-XwuLiD)B&aYRLw^kdcA zboD0bO4s|3t2^8f6}BZsngGvKfhJi+&ruh8y1;x%dO9ameK^IIQj_#^xcDZj?*f%C zLw8E9Xx7Fz^u9E!E)(JlGoI}$lIFXOjT8n~HUhS-!@0R{$GPF3rg^_6I_y^D>sAvNyuXtP zhZ=qNkyB^i@XSJmd;r~a-(31D0@NgnMVw&bQ?cTV2&Pg0Ru-|cRy4fwcQ#8a?74!` zAk?Pt)>El{kCpMFktkAV(R8vBoF0#!{6A)sqij*~0Y^dP2j#D;wBw2L1RfRn_Isg{ zK5G{})H>S8_*-q*#m7U32xw{l*;}u=OI%F%{Zz7)E|-Q?JusBNZp*s^OC+!PMuoje;zCmB4pMF0&cYsCkz!9e`vSk&@nD4{I+`W)c6Sy;#=|UrpFv8i{uN z_88El&(kn@R}tAuR|omR$ww{3H(`fDC$}B+Xh&7IEe*F)78BY(I)#{>oV`9g{HKYc z|M};-(8xX_ecBzp88X%PN+pl=2J0rz%O9mL#2@uT`UuL=UO3a3(TwtH?^7|UgRp~XsjQ*dL~ww`_IPf@ZZ6=ATWfPy82sBp=|+fzoVXl4*q(L1#Q#4%?P z_~|`cFjAQ@(?dfDyKz5GZm@-&20a8Ej7fcfWCSttWvd?oNG{tyR-YsA^xIcMetEJ= z4js|5skFAVxJFhU0t09vL$%YN69>wh9-x`C_?Vd>FjR}B-+2$}Q~`yG^z9OanHVvt zdVl&vu*jt59q%wQsj?L_20=Rz%h5OPU=>P7B$?)rZFDF2c_`7*qSzGXp8Ic_&h(2( zme<=RFQ&fm62&YVir1qfFb6&Zg9IR6Ldon>V~KZwd;y3^rP&x3XhoshC1P8g#kxfX zbJ+-fQaJG*x?Yt44#Eo0H9o3|e`T z_T-c@B{2N_1^*;On*h_OtkEU1c{^UrfNaednGft0Ox`B*^|@aggm5o^ z4_A;aC6+%V+u1cqnAn$Rfr)ue51-dHsuepEEs*=!r0xBD#+m(j`W*QJ`^(8hgD-Q(SELReboM^M5%D!PyOD*w)6ZI_eH)U;_j;fEdJh^cV|niY zB}?T2K2Flkzr*KuK#~j8+QLA9u(1AO@S9u%tb(%sMst9@CWcsl&HVisuBuhyu##?I z7-6m$c)5piaiK#|06a3cZsRLXxI%uC8A>%yA_=(m_z}Dr?2ZIf*D?L0FG_f3C&ynt zvImGwgRmxTcnpRQmUFuk)qJ~oMgHcoJg4$Er7e@lmC@;>=73uOULNpp>VAg_BGpOS zTxqtbUtL-evNn0V zyS=N#9yRk!pp;>ZOI({oRy#kc%X*o*`imzmMAP6zPnXpu$FMvtr0hZLA z(K(fh2X_OwrGYQoXb01@4)0f6gW_)S@XK{|5N8nU_tFKy;EE6w%02;Uu{Lah@< z&r!Gcw4?^So!Dz1LpRjI`8u+I+TYGHXrXN?bV8s?*ujv~VOCHi&Hd!+zLN zv2-Qp4A4G-2g7N2XbU}>%j^4)&p_3|m=G2~1ugdDZ-d8FmqU7v&iSt|Uf%Pfl= zkK(%k8k{{lv!sW0GfYb)NZX|yMz*>IL@GwM?7XuTJ$SF?M=Gi>$jSaNDNRGeBM`Fx zoYWa53k?&|BVyR+u+M&LtzV`R-|X)0=D$53h`wH;=mqcb;DxObCx zLBc3AI`3CeQGimsL!HbLJU%=&fc}eY>r*3N61h!Rz}ufDH1%(B&Ltnd8eHhorg-bx zdOk$U-V_}2>s!oOjM}q^DM^A!DIUL!w5LQv+A%{GhYo#txmP$1f%F57vI&s#A#l7I z9CD}ke-%v22PPR4p|a2;0>)lamLWW*nUmzKFpFSv!Ae5dc7;fCn6|ijr`9+i|9EA7 zYCnWLecG%u##qniB5+Il((V63&|KAW6Zf?~$A!?C@BH*s2Vd%LD(dHLAy{T-l8NaFc?&oUiPts^ zH1Y))dRDrJ`$Ek$nxSV#3E+otB!>o3_lnpY>2MGaG@!FsA{WVOt? zs#yL-Gt$-cYQpL#`l4YD*rdfeu&?=YRd*-sjkLLh_0n6qmY3!E4TA@%Kep!(OlU7k z$3!2Rjsq+l1s^M;hMVM+^aC}FULmnivJ2u^y`qrC^e#rCSK_w*Jigzp&GyQhR2jzV zO-SjWTn+sS;)8UY|Lf+(ZBEK%&C+gCGBeb(4{&n7^U8UbR2J|WkQStu0Rh3{MR=x(gl5CVA5?Z` z-UJz}=K*g|;N_jD$ckGe2$@^!z_5|LtJodzF?Ks zE_9?8vyq;0p-ukqFK3^G={jS&V?~XBQz&R51V!^@N_o7Q09`rMRC|{;-ST^*dz&Nl z3X~;09NR0`RF&H2I{X|QF>Rpv8L)@UfF&`Xc!F_2Z4wg2Xlw!#$!Q|AGasr|$hl`6i z%jihdmdxShxs)QYDD~*7>6$bZS}CwxH+5pQuNK{(>vxw_nx|nSPzr#Lo;kKpH`GN- z&hpmuqV~}s49o!Sc5a`$;75i~>0s2F{_jX9<6u|r!OF%k3OzPrO)!c=k%dQ0T}mV` zG^mnF!9hpD1M`?K<3Q=-?7SUYAz3w^`feuUjsWk&5-p!=PHryx4yaNS^}uaU+;9zn zyYxTKhfXuduPkXaVitUlnbF;gv zYp8tZ1YnLI{Hr~yFTO0ZXx3{+fC-1jtU0*w|#AlWWA9_X0tdA{Cu$kxW4O2Be_*?6rV-+s@4BP}2*)z93T!cWr7 zY*1E;=o2v)X+zhm{T{kksJ?)mmn{7gBn$zK0MfhfH5@T*%Phz$E;)}O{&vZFYdY;G zDp6hpS#dv`SnPnQvXDFJ6RaxBfsw?^66q}fW8Yq$?wgtbF6-$zTsp2ypQ{X+XX#BC zca4Wb#Mt(o#KVhFEil-|+}19z8Hc`$#$U+f);;`SpD(rceW{PehXga|T)pS2(zC+7 z#y#c=s$QDXv%f~kgDpLFV$4t!r1-&f;GxqnIuC?Q( z2u%!rHY)-e>o&M#?^jHv`OVuXt!VzopyW0a05e)SG z5y%SKseZ;;0RFp3`+$xHY_R|rV9g%@fh88p1Q<~A4XKnqU6BIvW?Ta@g?7DODOjn= z$z|sjdaIb{4`Apw!faYOC_JTA0vD5z;M0pN}^r+v61+Q`h8Jaz4A4|?o$XCGLPOL)%h0eYacO8HYayj?kn-)&-L!9jhEUKxs%${WiZU%)ES7=rbP&d+VMIPg8t&h6kw)Kav6#inIu3M( zX(Pi-yHvjA_G826MQ@7gr|Z|S#&DhYG%IYzXU?B+@D_=ukTK5feRi1zx+CxrC?1a%lfL8$ZaQ7 z3eimbPVkIk?3iLKE_mw8ucSd#Wj(jp-qtqY1s7<%q1(E-__k!@yl<9D``Il~EK|B9 zlHJYL+hVhwD+m}@*3BS=n?xE`D|1biV7^il6dx^~*)1ALP>n?KmlxCfS&>nS0AtbU z)5ExuZS`-S8Q+|U|5@;JX9Jd67eY|Ja;C%@8$;6kL6L3h$x5HMT%UO&ca?W4-n#3% zUPyW932&sXj|3F^pilve1)W5zleXv01zXK`7yiHGh=!ao70nCL>oziH7yJIjJM*wT7n_r61_jg-ecc|jW^ z3tc#7!;s}yG|6R+^qOm6VR97HFLeU@x*GZmrv67c2Rh~B43szCcwjXGuEC;3EQ3FX zjdFU42Zj+icj1D_dpc;!XRpRaMtc1(9%@73pIZfKc4faHNxG0fh5glB*F1sREE(OF ziJ(wXh~CCX#`&=C>3<@8zL;g1)xtDQE3TtNx(GRrZ{9+=lvG}ovGFb`N!l@>@L*g^ zB(0|8djKG#slI54;6nqx`&Mli_$yfI9s!JxVho#T!{3T7`5hv{_xRX={9SN_>5MPNq{$Ro0}@YpUBr@fm$j82V3MU;S0)h#Jpcd0?MD zR$p)f1MpLVI+RqGKt6Nu3PG0R35a_hN+4~!abC;oNbvB8{JC}w=o-1_S7FW@PM>XO ztZ3HAYm@jDYvqBG9;u=^k#{9mI(CFT^Fd)IgJQ8NF9RLw*Ca7_DV9qNRorl0K@MX^1MUwR>}duE zS;w`o*8GbHlw3Gie>$3^#Qm(HK08DTia6MaKqLLr<#VtSs!nFV+q-iZDU$Zi&)@&` zdP=n6qbqGsUFbbBT`j$!9|ex{(l)JAK)`u>w^8Et0Y<1KTee^mk~-;%ke7ZAidxhD z#S6U+o{CTtw+mOJ*wN7@bRn6uGwaZMdwo*oMovNdla)( z-MLCYcic~wx=%{8Oo@5B*4)~{7_#Nw7=Ei=3IbEkVY9ppD zA4>`yBx+>;X(tDz%L1G&iVZQ)S8BVw|lkb)c$o}~BO7l~k zuRMnJhA2gTNor0lbK*9;?a|wm+ADF!%2;?>B2#z<6*t(~*#X07s_66;g%DP_02TLO zPC{K-+$w)mY0vwPQUu=mk`TB>FDR{$Wa(LV>0y_5YUjiFlcFWlJ+_=1vJ^PKZ;q)u zzE-!k(Ht_fAEX>`^THz1o=w%m^aYW z8{Z=&ccJM@CD{vPDgbZ|;bmG;np}gT-jw=;F+4-PAk;(wxFdBkBf{q$(iA3)B!Rl{ zOYf!KjgXQ*K%$2Qp7Y1f!f{skyWp0lxA%6b2ty>6uFdK99*t=iHI_A1RcA@Tf(^+U z+ffRE=0{wazP9z@5g88;?O!=(q@uRH0Zab6J&^W}hMIoFw-ttr;@|Zw^+a|CGkpWX z+!+{qfcp`MBIR@;ucTHnDWqAdo1D{e#q5A8tJYGFI&JQZ19`sP8X3TvsqANFq2P$4 z5B(hTLf`XMzTXaOoT%sRLPJ&CI5sQt)K z)qE=-ST@Qm1zrjFAW&6vm%`|cFLUlInBVg-Rw?W`o1j=YD0`S!vys9m6r6V6!|33cE=Vi!cA%!wwY@S{^O&?E>A7h@jxfK$-H;ZF*kH*=BRt zZ$e4z=%=K3V?tm7b%yOUfdd2I#6HU*&i> zx1D~E=ev!ml3X`E`)d_QIrcfKS3+%MK{z&PWgQe1J~rII)H684`MO(a*^CY&+hbc% zJYe==V$(M2?$!A^O#EoLRf`kRnEauIK%sip{r_A5H>-|@XR6_%v`0*?Fw)bbXD&vT zStKr+4Hku(*Q&oE@beqdLA5Kr3KRub*w;-QDO&3O*e%YMCnFMmu+7b*Khl=}9&6jp zn}4!xm(p|0D1CVx2oVX|SfqR){9?Tl%KZ%Z5CefVcPoBXyPPZJrj(pr@zdU?WKy4S zR&iuzX|@vW?SGTm0RJaoU+?PUv)V*8Eg)X{<@f$%rQ0MtO0w3D#FoIlsn;r9 zqyMUFU2}1QL@nB(A?O%{%S9LEr>dcqRM~&_vI15tRzB; zud1!zjV6?ttE0n<4B@WbS>Vu`H{H)*k(8slIK&>$+4>h;YM^VRSJH8*qk^r|Ope|W z-lLnf$t=WuKBRA0=Z`82552r}tb|SgMSGjl4gQ;(3ZYSqFh4&#ozTIWXM=GzEY(-A zu5dQt^^^SN>R1F3*NMFRk63&Dhs?4VlH^-@_w%0U>yGH_Q^4Cf@P2Y>(Dh0s?`e3T zm5%6HSs|!`7nL6aKOA6X*xeuTk9&Yiu*au-Nnyqb;NKPkjEx27VbuQni?~hOA{^X&8ah84r)U};9st9+nHvPLPU1~D!`6N~TvqA^= zYmFmVv%Qn~XS7Z8JyJVZILl0|aiVJ=(OWEhGfYr@=^j_AGA_0#;XsMZD4@~2t{p?sRSM7J-NL40V&Z45q!zCzz%jKx z&A|gM94poh`pe(J9Vz1X&(+1n9P^VaWpAx034mbyp6K^o$c!%V9bodl9ma0X z!Hgn^BEFu{CS<6$Sb>&$-xV9{V9ries}l(kjkVGwoPq^Vr!_X}@cK9oz3t;iPL zCOX9lzo_{%7K=l-)Y9`V|Cbe0)dlgp44q%2OuuC`Hkes!kU>y{D9|UXHlkS1v(CTY z2rpp$fOu^t7#u`b;dzae{44cOhnj+ZOIqj8pY9mC=K`ow`af-?d`oo5rE&<>b$x28 zWj`@@hr#ZA>;KaQ+=0+JPiTK{b$Ox6Lb{lkBQkCT*|qQzG<_~O`EMzSy}rruZI(3D zGK=RQjuD@U#C@gpjFbIp^e3u0p@j2E8$f{sn@6D!!Puqk+t`>P(#LF7>JX024{J$P zA2}}j0qshP#g_a1>cP!T>aldJDeNSE+#F_U#n(?(5ucH3JC(BCeBSTXHsDjO0Q*Fc zvj~1%6;Hs^>c;D3LVykm)&-HGU?gN#DOAr--$&>BmTpi)Kpz3J7%55qfMxH4zsRGlysW^vGgDX>nwA$a!%#!Quzt3 zypMR1^u3=U*QLomQv(D>?iQxjZDo5yPsm|;y$Sh~xf`=}r6NjTt|=xkLIIgVd+EU4 z0TextK>O+C-<>R?>yd2*v(}yP{Bm{C{DhsH<7RSTvP=P!a zP#K$Wt#UoOzYcFjQt)1^`2oWTx(ebu!N0;nLTjt5n6py$H`3|o1CErG^ucOYvdxtO z5}SM!S&X#g|026E90|*2hQ7j3`Sl8^SU;>%v+l|76j6yHyMxv0H2_VHDV@@TQ_K{l z7aHF(rp0|QoMYqQkg0b$dBGwsIl65lNgLJ=XYUH^d?)yOO{M0S*Vp~tUb`4TdWtUy z>@Y<`0kL4f;Z~SeRk(Ndor(>)T1d%a6B9(O21| zLt$R*RU%^IwwLk3xXy^&Z~T3#{O&+80t#0r8i*#T=8+dRM%vG ze0?DLoA((D50=U8*xOAyLNk;p{3KNCj~JQ)3wNvH{2tDb#$58Mw~ygujB_L(1M0S= zzSQN*1TEiC7{;Wyl7~DV$>P_CsLhRzrK7H9s)=kigxuB*vTgQ+BUprn8pcY)OBJaZ zCian-vNJU+QPwOLDHPyDE#Hewv`1##{eP2 zH`>QM2z{?8x#o;_s$x1XSmT-`dRYE6$qS=3+A1#Q`;7{tIYp)}CfKREQpPKp-Nv@8TUeFg% zKd9>Hn=r2Bh!TEwiK?&*^T>YpOUv8c<&JDn0yqj_A-^0BwyMJd8ETR-np4dJ_x6^? z9W*4@-1Sn?5Hxv~jb^2PmY26qcZA4-NF1^QH*ZpUtZKer^YMAz9;cOa?Pw7WRY3nd zmNh1IdjxIP|8W}E;$u@quKKfR9S*0HunAb`+BPvQ=C!aiV6EI&`+s-Zxly&S7D^*m zCZl6&fg}sc-q>sbX6u1_7A@SdVea5}F|hm++#A#@*-bIf#BE1{nH`fX7+|^tml~*- z9qsMMIpcjC+R)*i#RhPKlv~`!Sc<8!^HnJZq1I%4Y6*$dBdbE#3S}Luur|`XLV>*d zz+th5j1TGZa|ARRvp~zHGf6qKlX&glLB(}$`5y%stV@D~C-an?5g$p5>w!qK~x1$Mx%gF=&Rw>!u^XIP2dTjEcvp75Rpip0vkdeS7)Zr;;p zaKb%XH~o{3Z?AmM@YWHvKod-KvAq1=&hSItZtQ2(9n2*-r^>(PkqZXqHwCa2MvWmb z%aeWiV1;nQBvw5g%DM8)Qx!Krf*TG#a{t{r4{}GS;qrn!TH@(>uf9h%EVQ>-Mf zP~Jcm1_Cq zo?oiRi&VE{Ze^%XmwaW`fRTmN6D4j2d8!rP6l#P;5A_Ud<6nukIm(YIe z0@)h7i_R^Da}h>U4hQL;@4esnVznYJmcm3y7c(oh8j>6{2I9M(&HfFNfqA|5D|bkILOv(R-1k}hSIDMd|J zE~SoYB~=LpSMjWyQUx~PHq2!C2(TyVGPmKS{`xE4Xmty#mC%IYE6DUrdok!+9-^5O zCW(e(W!hTa6j-jM4Be_{d8hKPu0&f=OC)u->hCv)p-j4J^OU@V-T;a>L5CZf*yfqf zGeOH#&JS-=b-JI(wPCk17lNW&=DlM-#LQ$_-yn$Gwmf5`Xj`6OX1O9)e}1+-v3122 zvy`l4>-fnQM7RH80qoDPv4O^Tv4T+aP>zod}e z{|ie2-@QsSm)DMb^O+k*K7^b0`Y`yOA{EuriDo^k#)6Wfz)W`}Wenf%=2NnS0H41M zX}v_;3jI!tCg0vJWEMY0**DDkj~#;gBsY2?F!=W>smaV11|Q`R0NDV5Ioto7&ZwN# zkt1IbrtxcIMK&x9U>^D5>KHQ%(m8c+a*!{f+$&@rMzwB`Q>EX|O(cwo=q&eYaJ)VzsC@Rb#Z(4LLr9{_h!@d`_(?gKyQVGoHiVR`;Or);vb}a2G z9s2$IczmnX=$J?)%dZZ=o?Os=tdaOpT@Cc|zgF{#8{sXUvcC`yRie)^Ba*aMxoPM* zOeFATk&SO(%xvhQhuzKxhdihdIk84(8Y~8YjM0B?dD8e;Dn^+h%*nmG=R4i2^`IRE z-4Pg%3vNE3!nV}8oAM;gsTe|ayRjlh0LH{h@?dU&lTKJbVaOniZtgM?{mPbNci zXXR(6401gk0oKAi@np<3@KAG!RYa_ynoW+=Cn_D(JL|XGzyu$5H7>KsfkJGw%BSgt-UQb{wW+&tZ$Xn#fwwK_ln&|@Yfr=VWO1>k$HU1L60 zb8dP)R6oZap5b$%Kijwf>sDYVN6V>n0G%3y#wSkbsyx{0kY0nBfwb znD#;yw~Av(2t2|aq~KHXX1$*7s+rTQxPmo` zZozI}^VmNuRUz;@{?d+;SC8sIIDg`x=2%n2b1eg^%Gw>DU*Q;5X_WL{z6*x^3V^g^ z$%s2pZ=ERceaF{KF3JW+9@ZC})GZs!?}8Zw*55PivbI+}E5p^!q{}QM%}m&? zGKUMBo<^A}Zmxr_a7d5On|Qh=j1o^~@)2UAM&^!&!>cGSJGz#>n{vRggt{U>U18t(B-Y zbzbMU`g!gyA_m(Ks;iTWOaFOBkh!-omD{H$N4sP%Z8CodiwkO*2E#roe8$3QypbV5 zOzH+c70w`PmOoRz%=i@^e1$fB+?1zBt852S5t?cZ2Cy2ZNdi7>C3K=a0xi`L56Oq$ zG3|gN<(dPn{>%aJm;y%AG6W7T--dA(d9F4sW8${PF(vwvHh=ypj$BSEq{yxf5k0T+r^&Rn}31i-Cz5Sa0Jk5MjYKK2D`nUYXJG2bNcWBRA&69VQf-Zf^eixUgVT5qUDcNQ0fe!G4xiU~E6}r)zga zvo?uk{Ii1tu#F1X(IDDrfVptc@O5{mF+ruRFS0Pp8{IL1VyWxmVQDY7B;SRJZyQavdyd;}j>h^s! zdjO(yg9^g{8FTgEVV+DAa2CsAz}I476KSU7mP^|~V#(cq=2Ct!@fLbVL2ULTl$7Fj>C|F+T(RwERj$CFF$?n!-Zn74V=5u% z5pTIz#vZxhY+w9G-B0oENSc$}K05GB+JO{7biulWiIU$svle+#eEa=7SQqvW%qeS- z#mwgRf${91z0?z%=-ZF4nf#o&-*`Dw#BefSKAvpNJQ9Q+|5;x5JLB@ZeG)UnVIj^T zKM2D43vJ${Fj3<_d+XPaT)PmRFm973EF{}Nseetm`eqj+4b21p>t1l{C>2+qvMYtl z;8V7*jb6?Op#`DAddg`oU$W`So<^|1aH)kG{|7hEO)jx;r_nKW!}aTH7sN@R@&Y^x z5RO@>EUqXxnb3Ape_#ZhY#bcEv(6hrIX=ZRPkBMt1$7ST2F0$MGpptaWulMp663h)F?LMieKsx_7UEYsM(+OIBM2X{u9L#|& z9qVu4G25?MRxeOFds})xa_ZzCU|I+BH{aKzmYe(dfIH^5#gP={?h3ld6x+L(8m8%n zM4ZOCSCc?@aB&^bQABsOwvsLN_}+WZm6sR!(f}mP^&e=3|Iw&N_x$Hz=-3dkE z)gGAHr#v?u_Ac5j#i&ZG9uAUF%deh;{d^13h)5W@U_1uWK+RaiLSCFz&@ZA;0 zs^1u*0q=I;4N5&G`ud=6+$x|?Y;Gf;$>3@dS)vw&2hjBhZmh$13#xx@1ho-4Czonl-?sHX4Z zBmZke#LdO;c3|%pwkD$a@N?kXw^1s2JFDjAmEXZT^N}!#jS$$?j-s?PcF{!qs|XQt zh%=$8?kQkk0pYBEAS)TH!a*B0X=6n>3))kAcP%8FsA$HalFAD#V*$@8-4Cgfwr_x> z38LryUmvZKfQ=|Gd9>*X$Suu257qu!HE+L<@EP@QlCa;uRHuOwxfL=l)gBxUIcqQ-s zsd=2YSAhR%7`Zqg9-l-1Wk42wl$xg>W4es5K7M#uN)Z|F0RL6+qDHOK8phkEa94+% z2AM|s2+xQ~NN5C#6DjNyJ$1a)I67P^p_8r$*;wt%b&uP^>Jf#9G{%g@N_ zB+Rvv;~pJ9bbJ7kRf+s%>pL$y^sK@?V-D)8jyyQzIs}=eMhzC-GG%O{E&8jP$I2Dx zM(NO59;K3#eo?*-u}GeSCP7_1lX#x|bYE{&HzY-CmC<%92Rr{HLG-hblW>v`g`}W{ zi`($Tmm&X) z!TJHxYlYw!eAjp8%3-wgEYSm*4Q3Tf1MgQ*3;;)<`mmWHnmwWfZ0rv(BZ1zLJ531myFoLY&^5WuR5a=Qh*L+NlGIz%iK4uY)c9v)0vMl$_P|Fh%?xIZPmP1L$ z&fvP$Y(~yUpNX}>^$CbusVvY3(=)~%d)tNrxut`af)9Uz4?O7S|I1JSVcl#f-%zEa z;O<8K!2}OQTx8Y7X2mxB2GrkB^B9KjJNus3E!!WZ>(17j^-3VKrDqAS3U}!{zcVNq zsXx6%51d-pmAqoF+qj^5A<_nzCN#uk*2HA;&tYdojr3djD+W2 z&RnT>**a)3IsC4PMp{0aHKa|JXLAnfrhylhQ- z0?^dz8@+kQZbjmc4L7K;05jv@_iVYBmPB(?wcp3)s)W5b}BGl56O4T88!F`nDccnc2$&XMw_w zpN4sUa82BK4~;(`E?)}fTk5jx|4Fs@h#P$XxcYh2Y+S#V!9)XeEmmlmGbgD|03*Vk zk|)`Z6szE+kBl<`^>g90^ujqK1EWPE7lkt?1!_NLx2nK8rLO=L1W z)@_N7v=~RbF&`G%^qG0|t(maxU`L!rKxp$em|52J2j}}ZD{sxCNLyw^r#H;xww$yO zU=g*YDJYW|^m_2K!aeq{Uf3)c)zUD6A#&7#>9W>q$nyb>#P9x$%!9cDue-$`wgZ@Z2K zi7m6`3;TSn>i2~<+~=hLVNT}LWHK|Dtuh9 z(s)Z(YY?!!`_C_>03@zt*p=3)wu!bRRry=&eIr_AnRVCZXc7ajbQ8hl(z4*dW0s@Y}xz%=CehZ^Xqs%8jWbyR_k#TyM-2 zIL}OD#5GcnFy(E<6V(-(Y7fMvTGp|%dlw1x?m%WT*1UIG61*x}Zo8OO_oSLF@OqY@ zOfKql@>||iyM(UD{ynIPX2qpv)5SNaLicf@*4Ngy8C%2%L6-dSS!l&`P*$_yC7sgI z25p^}Itk}(N*6arbCs2hL!m^i<7Do;TAta#8G~H2_%=iIVg7U4PAX_aZr6V1=9I!Y zpCCCK#q@zehC18?c7{2TVmWUp-i_rZ^2?XiXzdcrpy z)+U^<3Y((X59@c@y-4Iu{JiMKNgGPq4<0_gtv#v8jQkOtbJ!0lQT#cA+5b`)w;^}u zZ<(&sW7(B#m*3#5Srz06hV)i%w;Af%K|;*?7I>2<)% zmY^;!qrIu=QFoUBQ12!A$3wFQJ58TDL3w{K!W4D}y-s4f zcGpHqMV{*}hS(GV2!FbIM`_^ZwAl0x4&s|Q1*Uq+^wJ8wL_t~xZKyc{B0L06uc@?7gg=NCy#=C1=oNC@2bkq{m6q6P<^Vr`82EhK>gz21w^j%qz@2W<3 zc6I_@uk-(-Jc6;iw>QW`z$$j*sojU~4bI^vaL$zreSMrIJ3DiEfbfpUH&t){l)BF3 z(v61%Eekt)h67jgH8~$LpNli9iG}6@v-Z>}jj2}&lR24CC+CxvGf(g!XI^{gp@eWy zh&sl}l$%Dwmm!by=xWNMc9hG*2058CD0jyTgJIffB{RIOkx(0`5 z-ML!d2*qbIkXNtB28TtR|1oLH6EZeGF{M(`QsgSfI*=)uzuj`)`nOg5OaWO`u$qVB z%yottEQR{n(*{;H!3XulgB(_YAX@u%{v7)s6u9*Lv%T_jS||(nGASJRg&d<|WS;_$ zb^!$q*yl7N&4E>H?r)wbmpo|YSG!03m3A4bO#hsYs(8i&*NfdtJqv^i)S!%VMaq$v z_OX_(paXAy!A~J$-85El5{S+>5Ion^Fj+(KI!ZN1lI?5k(ZYQ)37w@dqCuH9l^6<= z^`T~fr6hm%T#FZWy&{*bpc40WoW>fZx=%#+3OyhpOYqs!i!pC`PFtc(5CdpM!HhSw|^>1{Heuw2-|U)k5rQ`_)kdM-tK%M z+41+iT$#c+T)u0kl+V!dIhBN5ZEBvd&wj=o2$~VcrLt-Wly|Y%;P zD4Dp}Uubq5Li!(Rm-`_W*3&F_KLRht0AK-&OMw82A8;VdtY>kAR}Sx(B?NXhO$<{YF%I1UA6PSdW2Q2j%zg`K75N@o+$1Hj|0@wO=T*uT8m8?)hU zDbp1bU};ypXl$KM#{pEdyd9?l@W~~nm{i!7TP72=0f_l#6M%+kg{QKwn@mPqJBj^zr^#$ zUt5i)M_SAPhcOgWH`f4HG7l)Nr#NqJ+SB#N@@P&cE8~Vh9;>>AU$|HwZY|sdn@aG+ zpqtJRR^@}JA*OXXh?9qMKBUzD_pqtif~@IuF(DFt0&YiAX#f0nqCEmk{oUPA4;6BJ zhr{RcCSY#6gOUL9M?e_@j~6f+Ygp^(t5GFX5Dxu}iAL&y5M?j|U#E6ztIMI}jewSlZ7zqG?DXQym!mQ~*v z4Kf8~vE@d8a0Cn5Ra-6^t~&BJ5qU6{{^4##w2iao3C@Ek+jA^`gNgt8y^Ckv&Arsy zuwN+iXn#MvY-lZHW~ye{qG54au2C#`c&=9C6G8{8WQfVnwF8$Em#<(Hy#*m%p!>Q7 z%Ljv#WJ9*bbU3c)!1LGew>*zcs;S7LTJwijUQ4@C?Q z8~DYPoFFDrcoPxZw%ZW4)DB_)8hb!c&OYmixBsmAZSvo{sU*6U&x`GgJxl5E^^w~c zRLpTz$08%Nbrb1dP!f?6Oy~`j9kN^%jCMcPGy$Brc0Q$XUmh*H95;ebj9O!n=?%5; zy8#}eoTFBK+8>=Y5vSs4zC-@e3pFS&%H(oPj9Uh+;DaXe5Zd&GBmIfLRXEwW+Vlp) zeyD$jytL`XE|K`7w*n`8P@DLAt@y5;`9{8U4kabr6D2e<#OCYV2Oh<;PdY6-` zs-gm5Wl;C{#a-6S?Rb=uB9)}juP@opy-c2%9aiCLouIW{F4%1g7c7b-)LcdOKqA3{UCkOO!$Tiq)tq(Mp;vKTWsPB8+XSFc1BYm?CFE!nI-MX&HIn9U%D^mhui4h#Wd|BO) z90VBGe-h-oxV~WQrT-X-&(As9#O}Zp<`KYzKj4?hifT5|x=wFD%Gx*dr!96kLh2Ar z3D(`h+h8MYVxY_O2XM@Ykyyi}EjA5QE$u&uQHow18PA`FO5xrgts+6}CvtPRSZ-x@ zujJ6@ztQ(Xwp`YxpL6nmhG~MQ`8{XKJk;*6LyWD{b-&_O?K=Uwm_DIM2UWF zlUTHiqvFgk%g6`g+In4BljmZ?{M)Y>>^p$fMUskfph+bmav9FDW1=~x5$klE^T5@? zA}n8~1fcIpeW}4kbKCK1sU0k_?5Y=D)O;AaUaEC32hXoAj*ccnh0!aFBXaa)kT$r* zA2FT|N|mtjFqCj}F|$>wkwq_0T&MDqxPIVp91i+YI#S0$YW zrCC{(EQkSF-NIgwCY=I7JdTW$ItDR8PwZz$$J4*t6A+*dPzK$z6skhGTNaD|x=tVn z00Z@ZVX`1-rrvIK8v4t^B7zU3d8}n7nQJNgI^LkVQf3&43aL3!7KIp$&Hb%1ivGd1 z9@`oDC#cQjI5N)fsO(H;2^9DaaH0##7wX4;b80^59!AKPW~a` z9fqd=D4O|vndVD18+4wl2Q||Y)fzBfKtfF_)sG|w2DX632PGIIW<_fU>{{LXgpzZM zPxstKC!zAY6>RJxO@2+wVNy5d88#9pWjS}P8`9@~#hikE)xFMtmDc!)??1657WDF< zHu7$1lW;UG2Ozj<-_{F?r}3{EGw+`~i`q@J$KM0>m#Y6$Ly|P1N4#rOM}&+2fQ+a* z>A#+?ha0htn9F+&Bupd%8|qZgf=dx;(->IMt*Q$Obh#^BQQR=v4c!~fkp*l){m%|k zF^<_{VkI`lFjIY#voVM$Y*8Ao-m7R4`7>OrFg5^c@9biPC)kOY(&TyR-Sx6 zCvsSF8Xah)|Zm&C@2n7uykJjZ+_Nu34m&&idofAwZDg_ged z!;z1KpvR$Hf~y5=j)@)taGE+lX3xV&LW_DF`aZE?&S3o-cQ_t@i=H&;9+N}aI9nDF z(uNGoOM<{*y+igNIskXF}1v_jk%(F|k(t`J~~nON^@scwJ!ADXT*s>-Zw1Jd24q;$75ND0!? z-5t{14Tmmiluqdmk?xcZ>5?vKzU@2f`!hdg%>w2*=h^$dujI!sRAq)(w(eNhDNh7K zJda(W?U1oI*BH&hG^6h@Cmj`%&1>pWKik{4hs)X3y*bQ~O@JF8mUH#FIa)k8C_Mp( zsn$@<0BR9s6Py2549gQ6rg%4y{{lpTay{>plS1_C)mg!R;c0WA7Y=9afDS!$?444Ox@vzigz&Dp z6o)?js9MbtTS~>1Lm83Y4;iel-({WI+%FsfjwcMppLDM`mo@x{p(4rErJ6$1+H{F7$ctjKTb6iA<(Ih_Vwe0|Xs9&eRJDF$8u-|q!r zU0^5y&?lIu7A%p^?!jpQet@SyY_X9J-;y|m0y=WBx%BRyLyca>jI+eJlB*Yc;HR5|~<-mq(hj zX2j3rwvt;cF+y3q>9{Sx(gLhkVHZHbS^otm?(oK)jR5-P?CcCk)ZXmUaGS?dRP83Y z0IUzBLjtkj#%h~8_;HlUPMb(h&j0vx9spKJ8O!yRcS^pW~4LMV_l4gh$X%s0{b$s>Y9?a>Y%yZRn2elR-G|3cE+n6 zJuQ&_glSJgr8TYjIUCa~FK_$|J4z{HUoke^#Q&?cZa~YUVS$0O6wuiXA}$$H&8M)*`TH9M~Ujbat%}z78Nlh> z9cjRhPB$a*AqppKG4_#{v|j+Fs_3*=zt3lOorzvgAqnE!uz=#Nb6a|*Lf}t#{uV@s z^QUc>XmYYAH1jVlp~4LpyEUer&n;@Z$}$ycWy-sWF!~!%;;~R>@|6TiR`FOEyW0Ec zxgaccp_oWO3y`4{;dKUlONmr*Y4D#yiQXCa1UZ;JUEsZ!1H!y)h0UOng;owp_S}OY z-(Gwt2M6-|UQpzIK>IC9D57uWK#1|x(5QMwMPpmrpIKqFLupvg*x7#~*5&2=dQMyh z@n5_1N|uNUi%692EGBEzAyX|n7CxZbtq+{+U>Xk8W{U?LOI}z^dc4Kz#bQ>Y^xS19 z%kH3}`AkKLOsc{)PIk5^rdGS<=U=0YqdGHP8IXbc)d(s&CwychRI__i#i5cfKUu1m zov`aTy7Q(1H2W?-RlJ|Ttl}$OmR}y~<(owf7Xm$t`on5i_={p5dN!iJREKbJEje%C zjo8M#LreP>dd~~TzT5%5IpFT5^Os%bQ&Q?sFv(Aqju-1J0H78Y>G$}~(bk9#VMZDk z{SG(I1$ArKSHGtJgoIf|S7m#bSeMEpFw*$5cG7hna}f^zUVasePqyj3KkcjD&59L6 zkDDW+?9?t~R33>$8(PNbY9uLb(e$E#s`J@dys-}-obl5B#+!UgzmL)b$=WWF?|>xe z&Ew6$qh1LPV?+uj`#RxnhCEq3%VU%*h`<%HOFn0RNBggK>ECj6F~XYH7E*XLh;Cbg zCg@_x+5%%GV$H6}WrBqJRb@;0`LQLf^KmeMLN3+geXNjE#)xBdOJlIw3N{Ypb%>{Q zS93E1I0MhYdz6h|oCoTMDHR@MGYTW&C(i$xx5^jr(&+JFQ0$A_4vOJe14GU#05w5Xx;vzs__Lk5UxML4xX!~Z zAZdH^|Ii?GmX(_3NDA<{jM!ON&|VHO?UJ7X)RTP^9Mj7n`E^^_K3vWA3cQlQj_{9c z1194u1A#QpX$7X5;6inG_rcK%aPQ0_v@6MLSEF)6atezl2~quNYBZT3MV~l7sv4?A zoy_FQRopaWT++7Pt{$qqX-(?y)~S|B2F+VY1`h_zG4J}^VH)Xl(}`J&dtt@Bcs|w4 zh8UM8G5)A3$E$1zM`5xa>n=CZ3N=y|va{iSad%cfuhZV?l+jwhWOw+^L#nK%mzS$1 zBi$wQs7UC1PsmxJe!NBHNsEc~?F4X0SLAV%lkU1Ng+W-=4MR2gZQZNP%PT9ULwGRM z-mM;)YlNrm>6z$eKY3KCbQwk$7l|_SpOP!v^@JaqoyW5N>Qv4+!z~jDNvAfW-#j;eP>pkPoCO*9;5&{r%CQ zh{q}pwLb$nDZbG|@c`;(GqlnlT$o2k(TY$SP-zEH!KfyZX`z7XX$LAu2=Dzx103ZE z^~Zg_Jb*N|Xz!(3T;VHx|NfnW#`I4>36GZuTFirj7aCkh?7Dgf9yCMQd(dW|*(1UE z0C)fpgb;>aOFi2oI|A|^Q4u$IJW6s4(1}adlu3|R78fZ{#kat<3kKuUYnY`GJ(K3^wg^;OJ1 zKN25y$t`+bYy)x28qg;E{Q17I=)ucV?m2FGKQka86=wxF_H&Zci&%584s!3VUWj+E0r{iHj8Q}74)g24H$V`}4 zXEDua=P>7IYU^K1 zTtuwuyk9V>JwL*vyr=p+2mY9o5(PvtX*@`7yiaa*ie6miVg2{Awfk&|X*cesD6Pbs z?t5K=@=fO~h!_jXF5|OIsP| z+lBo}>p1p4p^e~Q;wd)uw!CHL9}XQNwx>V{D*uyZB(dExMQY_6b$Z!$+X|&x4xjO;vU0OEfnB8PUb7-` zi>N^wA%=3wB^$fjI|cT|lwq*wMce zHb}bLv4@nt&SkJ@M2jsqvw|>_q($Tf!3%N0X0+7bLgUQ7N~_pasMA8g3{$$8%N9qB z3y8!DF}G~oe*wYa$y996@a*Qm zFwlNQH;3x^wKHVKh(cODQ|bh?Dn-@-FJTf)F33)tPgP+QP|tWIR_!eK&VO%7ZN4!i zDUa$;Nvo2@9 z4tn?Gs^*?-oD+k9w}PZJQBosaimfhmV`y5pDQfheUka|suhcHG3)EhSe;#45eI5E@H&aw46l;wU z2JRY=bQ&@Zwg#Z_@NDKrN_P`?vEVLJZH*fo{Rk@`{rLR!03MfeM8_^Tjl8|RVFkqy z(=H!qN+zD>rLU!H#@y{{-gB+77&%8VH0ro*&}#+}Y1@w7G~3sIzy{w2K4D?=)sx0I z!=>*p%R^h>EYhPm(AslpC=q7}C=>ZwvcE{j_mFreVHe+ozvZU)!ljM>y$mAE4hmq4 z`O6Z;p>%`4vo=+lX`oJhUqSjBjq{ zIdjXEmNsFFZ}|#Dz*KJX$-5Wr9hQh5wa(#|yFc{l2G|81!nAeNrc&P@?rnY3tG|3D z@|t*4cPDCRg>M^fyBuoe9q~2cMstFl z#TLXPNDB?lTktt&eS-TfjhVjr1uxMtkRpwX-02*^K^Avb-)Q7|@K|rVs%;Yc2NR+i z6cM610E*z#1RgRtYKaJW4z>wBo}ZuE&~E!61SBmMVH)-SuLbx+z2Si@PMH^f1HRab zii$&&+uFu~v03};Dz=?@g_m5ok-X(v!rfIhJv)8~;6QuWeWoRXjjXX$KTCK)EGSf1*UWEcgVUf80aY`zvvgkw=i)^vN_>Avm{#Gt6c5&63 z)rpwcvKUkNwU3-v>^tmFjtzg)f7~ujV8~!7g z$BPAZ@7sL#NUZt;65pCOyR0=_v0$CYQODXxvw)#m5h_zSecSSGXvqBJpp4`6$|W|I zdr^iKisvg3ngONI_cQBUzC@qv?V+TZ8I>s!02H7xRF=`P1JW8$C`4OSXNrEEVn%{s zKn1&57!1_K>)p|g;MI79?;NeNyR_S*zT05Vh7}oc3-m0}=SEy$EZr!;)x7Xh@=n$G z6v4kOBtWhgJ*K?fb%S^zv(T7J{H2CBsu}E1!oqHsU0hgJuy@BmGRa zy)11Rt5M8{AF(v-+#T5Q&}l{ejXkqeC5k?#IB{V-guNyZd%bjYF}7{{=V1&lQV4qL zE;_o0Espa#4TcqP3yH1SgfvdW1ac)!&mQ(Z+-jC9N(!@Y=N1rfZt~@=bRpReb(GD} zOeZ8k7JlqkLvd~kiX?V|z!WQF?sF;Dnn?wwtPo|_A=D*;#!V2B0~kxN1_>@$>Vsow zyk6IOiX&kmE5nyDTT|LWh@T%|Rxxz%?iA_5Zj>Nc(E0Aafc$Z-)Ax_|888h{Zvs&W zm=CkuD5#7uRHu%q%yY%0eLR%=B_{Cm7H09cnPBT$l0Vv*)_nU=qO1Y;ao-q5t5q8Z z@aa{)+LLy7f2r{w`m%RJwcOp@X${>^rrvXxvu2=$J52vd&W&2l8dt3QE!oL#E_>DR zc0r8|#*kg0K_w-ujv?xAX*Z{`in88J<-(EIxfOfsqV0iJha4V3<(-x}k~dLXJEJjs z;gGZSBLcSnf>drCLq(_n@(s*Y=$gQf@5a@4X+6?5%rpHWnTINo$x`c~S8(saEur^i zk>B9Bo=?3Qz7p1elT3#bvq2My+@M|rNqa=FcDc}@XC=u_7RQ7WjViN*q3m6-5ynrv z>7Tnma=i?Q!^ql>&dylWg-#hk@I+63dQRB6jqP@qKaqh#>X*lVang@*FXteRJ(uO$ z+c^=Jk}l+r2a^Hid5sJ2BS^x)myatAV%`Or5b{yQIkG;Kn@@nCBq()R`iev*WBc!E z+btUkenX{DMFgbPS9!))lc(yiAdZ(SMP*NXsDyCshdr zp=J|46>N^MwnM#17o1K23}91t8a6ypPDuVrkVm1Lkm>xqQuKYvq&~IZ{K%`2>a+5@M{Q z%4e45G(7LSbc$Qxrv6IA zgLXGwLBYq*FULQCOEWBDNPD>IpWZp4f0IxuO_FtImxr5L)@4LOx&_R&pM*xsCG@FfLrU0d7oIaF5>AFEr2>oa(h^KM@5|5O1X z?;`+S!Gt9Q^+zdY`Lntt-o`Q5TEV)h6*68=DbdzlF^bE1esaR{_pD;s4NXe!)cNu6 z3-B(n9vri+bN>Q1e&{3Z?v4)j3G8VP*WQuQ)df#lufI(qD$Ji*+5DuY8(f0$sW zXFIdt!X<$o51&lSRfHsCr3Bfved)$Qe1e53j5oAqwI4 zIFj4-IE8dU{A)Anz4py6x=P7$7=Z;Hhz*ardw~oZV9#0nX%+T{xL2aFh82bm%qjlcJ4ohNw~~MqS=CfaeL=!o%6}A3*v;82~&K=fpUZ zR)FPXp9V?3qC<4w9vs;1a0~xhlA?|;wDa4H42rUbCDP#t!SjYsj!yeMDV{_LtQHSZ zt*4aOGwa;qL0#G^;rTL`vHH#JT5q0H&&o%@O~6(anVUD5&)11Imu^ zUHNH^c?w01Usc@maazsm{!Ypwc`tnMbe6&J4Ed(&{%V(5?MKbDtUCP|c#n zKwvTs|G>b9?ite7b9a_pcl}GmxfT|IQ%k4zIo!*Ryvc{7LVhqPc6Q;&RLZShp^1fl z0-q58`Cfj%JosOZu0x&QU)#vipb(E-aOoRX;#4m$>qrT;TLKUnkZI?d5ZNxxcM8wo z-XsIxoyDak7>040v^`*h#!|>qM7SXXtbnkv9|#YIcMm!TlDB=OzFnGO<7$>!c^n6< z4Li!5R}GXAWNQR)X|sB~$)&l(5AAib!ba!YaE}0x1{@XmYXmx~(GsNospSNRrpK6U za5v#GoA~D^C|T+JUx!!TfszgI?E?5(ad9zfMMV$Q82~-wpxD#EbV1CaJm3eNvwil< z?JYG087OMI%zY^snhuruktJxW(-D!R8?H?(ttpu_kt6hjv> zUDUi}IE#^A)TTr%BKGI3OS5(f<1dc6BL1<$Lx!fG_xbtxv7zZXsz)nJ@xMy`gU-Pk z1B44H`}9(Ux30j{t$(P68*31+roOglB|Q7d?Ye_vU6qPu(OvN=-OZ z2(9kZ4MHLP6cK;okWhP;9J$M3IHDY&kJ6>ix(OcVO(Ky!juSt75eD6yi5yF>Vj9Lc&M zb1+W3^G^HP%;wc-El3Rx)|EvcudEuzT2TUJM#?4B#FNjnUU z4BhG3E&S%e%3@m##T%p0>hqZ0I!Fzu1yfevBw?u>JJt`un+~LOU=yfQAz!7fhaEEc zcVS@|ztZeG@YNGGr>>Yob1%;&O?ov*QySS`cft_LO$51c{$*YmYd%DycE_fke$$fv zY7lwvTXmXWuTjg=QhuabfwDx8_-nO(-?j@}d1+gZ65m#h)wB;oWaLd&S|wU|?{{|1 zGv6gqZ*iF9VQ!!#mHTlHfyxUe^MT!Bl(iWcVoWA4Ca$eeG+u}^3tj=WQ$bBv%A412 zb#D_Ql!Q^LC>9#CUj|0j55dX0tyfEIJ1nXs~?8)L3M%SIx1ToKq1$FGo9lyH_c1p_<|1!tKiVAblA4d5}dI&?k7{xO5tif2y%#8Yz~(>m2|nVtfFf+fPw8Oid8vb5UYOX}W3aba|h?3Ti8X;OzpY zh)RYl znr^1pq=vO}Dtl*LpR@(!Lk?oq8nu(u60M~_m_~BxbY24b<%}1NXEs5U9Tx0P_E>oN zz;8C^$ld-P-N%c!nD?`2t;6oFrQ`zF*sjENh(TRB_JMV5rA^dRR;iRLeE=^rZCAnLlf{T6yI#jPiDVi5$c%RJv;vV>)|b?`cNjTqS7m>(k^bH2-)UxkWck>zA>OH-nJ)l=5U^PJ=RW;a zz*nXjobjynM3a8AJqStO^q;zeM%HYEo#>HH}hs;m-wNuJ&uZm%Uq=Y>$LL65j=n8Z#nOQ7M zd|r_H!NCM}!}uZZ$Y$Ag4Al`qD2K3EB3|kcQBsP-{$Z{K*WAXIAxT=hs*A&ql$n0d zT}SV}3*a1IxMF=vZLTx6aX5Ev_$e9KH!)koid^v=(u$duMUx<*Ur#R0i|Vw;v18rImH-;3JpQi~k<1QGl|W&ctGY<2PnQiJJMh0;D2qiR zg%#}<(@QtKA05?tnkew^m8$yTRw37g^8u&m;ld)_Uy`^}T?Rpr^M_Ve`q&kNt-PAv zXbb!KQ`5T@88S#JZC)Od`YD_taBkBejdfPk%%-G%3nAn8qoKs-Lr8<# zM1JgcS6!#H5ZF4juf7iaq~I2}wH<{86StTLXN)U`>JK^TFhydMDd`hj?SyD=(5yt9 zKQ=u#sMOHZWTAVBR#(mw>O2Q-S)TXBx6yTw;|;f=BYj4!0MR;mg<$+LimUgqE|zEBk~E`(x$nSd`Q8f zM+X#vWsuN}*Hx8>+qXKe-6F&&fKGsH*)|$m6oxHZslu*4W+|aCo<=OT=)Rh_dE!w1WJL z7G2b7h*a)E${GD6@};1L^CM4+rmi*fv#6r2Jk(m%lqa!9r~n#OyR_zg9Pm2EXOj-HG3$-q-2&RS6YwGhzfajvL;HU zQU7aME_!zwV-*>dArE(sCWPKTfn@_zVfeCvWG$|T!CVT?p_>G}QzjlHsX($|!4fVG z|8W<#mGs5=0V+R&ak74lEJ1kqD;^5^r&}q~FlWlLehYI4mL;u6)e8JF>ThS+V=Nzq z&*~_2T#iJ1jSNPqi z3oR<@m;2La`{X|DciH}EMDyIb0_yUycB1+MM{3Rmj$N!Og}VgI3mN&lC)3T-T6#G# zCaaieEMxJAqJ0zzlsw$$3W4Q+GMI9WD%<8WjOoC7SN;K>mc*$SZAoWm*hR zTC>6Ic%jB3BwN-w`Paso8|%2zPkUPqO5Ln@iN2;}O%aY}G{(}L;YUVr;^}A=WEM8a zApXhvZ8;x>f5RBrpj83)L)*TW9BZK6@1Zvaoei9sUUEND=xg{->&8TqbE?&9khH04 z>D4%3$FtHEZoicN>=WG$w0Yyib768oRzHbPO*zxX?!GSMz`Ct&-xM|v&zD#2Ci-N&@6kncCDiB#c~1Fb?AzWw2ElbX(k(T z)?eh^T!LMPq16%=ulVj1S7?9K9*nxb@AIryRHTT0$4*>=GK&U~=2zdFCt&?~Vm-$( z%35mE);wx|jflZF7%J0DL8lLWm~9vu+>|Wso~ffm(pSdBrm5tkgNfI&|IUc%u`?P{ zDu-|;6YRi1&#eT*TJUYe(|wUWwd3k z!Tc%rR0z56WEZFq8we%5e>~03qq3OF7z>Y+RDJ)Rg~%}p$immM-%Lh%alY}aYB|HF zr*a(cp0Qq8%rEdEz7F!tY9oD=NV;OIu|&yEuEBf4{9Cs${)&PPrDobQ?s~+&t)Zb1 zH5SWjua{32aosI_w8|N`2=&K59Wrg(%lY!}q0jzsQvLwlb4G`f2yxBE|LMipi}vYg zCt&9H^R)h(3@{9sf?x`F_rE~MhA;%7fGjILxQ=0+0`+k44Y(>mQtNiw}By4i)HR;-bEj;lAW$atZd594}l{0vJZlj*EWFeyp%psP4Hy z2ssIb;C7A3lf(S^J8pY6RR9AN(K~eQPqw&}B1YoOe)k(VD#mYyCbDf9#=EWz z8?2S|e8^$?v$fxU9Dl<4%q7(%g{zRo>G(W>HG41$oB7gw-YXRYCLdW1->E(ZZv*DD zFMAa*D&xkuU5uQPUeKRr3GSXMLI?YcABZb9eIvuYvkWYNoPDMkN&isG?4J1P*ZA9W zPMwmI?8<93n2?W462s}UuLtwMvuiUWKCNiT(3e}>wAgv=#3v$m=v-i4%tMenTve5N zh>MMjlDoK*^7B~vi|kMnwuyNg00v(5DG zZo-e#V4e#;Tw!X}-%S(obp!ZK)_0cFR?)Lv>NbQxH{yL9Rm3}?Y4vT#%S`e5n}l)- zOg*|{x2}^j&mXFfj^8YS9zusW0il~SRhwlhHr(Sf2H0Uc2#j*G6d%e(BL~$UyDnBEX8q!MlMJs2(3R^yy*ELm z0>~mz=lsrNoW?SdlnSPiWexd6VO@%W2+u}NHG%0xQi%kY{-|61toh#2yIx8x^X~^x zBJK!$OMFf|G#u8cPv*4sy$oB0&QIg@4Dx@ijT-?wv9t0;$*JMPPX6*k*+hp&4dY!) zfa#R7!G;l-OI6^?3PpK!nO{W5Pj9Y8SB07T5v$=m@chWx!>jILtF$ZwZOY)N4R%j& zgi%5!$a*$jy}jqm4PvON{wBX}rak|ydkr^JkNL$U;K}H%slc|rR2 zP|{aFNORA%f<~7$$!&MhnMUUY3`9@4%Xacr==#?rWMm-46gwx);Mj9;iJg}-&(HfZ zMoy(U49xPNueaUndbl~l*ccW#MfM>4^6{oB7OPqn`15~{R(jtuR}t?Q7n>IEs}vd4 zLMKXT9?N_dbnM;UV0pi;lE}Q^-*q`~+KXZA%#!oeU00X7TO-w#B+dSXmOcdX@wpv7 zN6F@sv3QIu40D2q?ni1pdFZ}F2ZEG=5G}Ur5}`0&w2UB)AVH#79+(&w^h<=mPn4?t z*4)UkHnPE7>#1=7+LFo4^ zZUYO5ik||opkt;~OdKp(h{=uTuBnb_6>}VZHyVz8nWf<2`mzjY^zYbpR8mNOFb(DT zNeD|=KA$Sq@tAI*QDsZ|R`|fW6UzPs)^h-%f$-ner6q0N6q^N9DLW{(wM2B zOILtC{&q~`05^_QS!xu$9|(()u~Xd761=>i6cWc+?exbnCEW6dn&7-2_SXaZaO`4f z6-y@C5A93m;`6#$8EL%Ug*aXo@w(H9P|nkTxNIeAHd?ZN@x8KAdSZgcdw$pD_g$Uo zgYmULbCut{KZS*w7lwvEVmsX0FYX&S_>&{Ysd=V4(azjv^;$2pk4(g_BlPEKQ8U^4X|3A@7JmHS2T`we^2U;{un3Lz<)EFFgLY1Qz6TjO{$H9y&{^< z;+hb+MS&9j4NMekSG|H_=I>(6w@{FX+Wf$|#(NR8Bm%t2S69Dc7fJFxq0+b5lx&=h z(iHSJpSHy6lEz`FmOd^I0QfMpwq7xT2d50@H3z=N6d`y+JgE>>{x!)R-2pD(sB-*= z_*=6OlhotW{rw0ov9CcEMx@yZZ2N7m$D~drS3o2i=!gN|I`D_ILDh%6c^xPeT6+NZ z0EFPd!LL3SB-Ge#@?d%Q+M0fU>f_m?{aEKn@WD~v@@>u(oS@`Lt57x)htd4fubims z5A5IM3k+0FS_SQ_gT^$c%SJY#;42Ye97MvYj291sc`O`^VP2~@-25)Np&K3-5#Y_@aJD+& z7T)#$T7Zp|iFt>xgzadtnv9@f7(RSrt--wg6O@T3Dk(gqnmOW{vDcqvIQ9qf(ZLk~ z(uk$0<$1z0S8{s*>{KfN=>x5^&9GbTIK}u$Cr(6+OZ;_&6JY`5t zaCd2eDIA}+Lni$jq5qZI$wNKigKyu-2*OZa0+YfFO@1i(hnOchg`7yq;_FYw_-XQE zkN$eZ%Uu0lam3e*WL-(2!&;JJHX$qcjSgBjWcwUz#BY^Y1R_4k&3ExOq`Ir_S~pe8X#c;#&mjc*v+W+BHi zQq0+$v13zkZF2W|8kOwdpqeJrNpS;e5S|1e*h%L8!6HEnm@T#>U4jsKnKWHG(_MGe zJrwQ3g|G5#aBV}=s(4SPrWTOB0a}qB7pOF1S~TLOVK1Bs`dBT{4rusQL|Aw?=QM!x zp*FL7HCZesO^yde(Po{EX5NUQ@xU$UEI*4VUuTqxdzz#c3`Sr(51(nIu-{7dS?NdZ z{~Dcr5y{43HMYZf{g{-5v#z|c6ic0x`zFYCa0gDD?<6* zDxrX}=HrLu6jOZ*Q$9XENB=%ba3W+kyJG9|zCEgUN7<9~CM^;i>H6(IV@hEfyl*Zw zXw|1y+b~lsb7;oH5;^=CKeM}E(%BBt-_RX#h6TW@h9 zs5*FwXDayuk;dn4n-9G(5lTJi$j} z;K}qgT!$FfL1ty5;m_(rrnMLs#ffxBXt*Ien&R7TB-UX}nL+n?n;|X6Lf2Xfo9=r> zkYn2#2dFIaKl(Jr;f-d9|bE;IhGH_0m3+qF)2s}j<<&Jy4USWgYi z6=GT#<2=qV|msStEb^)0=aa0{S_fr=&!^Aqu+lFnegApGD4 zy5UvH+l$6|n~w9YGJC5eTA4wlh1T7l{h9GH+u*IA{FLVX*UIA~1(ig~lMo!6Kh3#_ zRXz;54$!N_9nu^YoIc?CVjJvD%t}4`j9WiAsb3QK%HL`<6*!sKNTT@fTeM<#Erop) zTv>Vx5n37C{3D^-!&F1(v!@tJ@K$^E3#|xKB}?DNct1fphMc7xOWC8hUsy?5G7-OnoJZU>FeFI&R9~bhPf5Ab3KEf-{61vSMueIR)LpxUBiIj{%3_k9BuX9_YlTp?FwWghT9WXf{!k?&`b7#AtpT`2tiP+;W1>LlsG9@s#hVr#F&l z6)Vnx`#bpeGc2}MOcg^-x&*B@HnI^7O%Yov_J^2P^&XB4zEgjIcTsY{_^XAr`+2(6 zH82*0Y3)nR+l2J;0Y`$(03@GzFV8!l(Rq((51?15riu6@Unlj$Sk2hnu?Rl95!{mOyRp>=fqX^L%-J0&H;{ zAaF^^$aLKQt#L08zu!v7=EjnNsun)&43v=>Y)u^IJ-pqw86Y`Za4^jYLU9ZyP4$OdO z72nmO1}+s}gy8I#0ur4s;b(}{JyP^+WO-N5Re&TWUl2lm8gqS1aoqa!&$+IN{R2x+^!}1>csbxdv(&@O6qT zQo-(@mCrgR40*F4gMyA19bxF>>Y9?&+utvhj5>tKJ^U`kTzx65u#^gIGm!i{pdYf9 z1=T@PPq2LbP{RmH<`%r@9bJK_n@`XCL~^uU!ReA$Lh$9RodPP(---!jI2Lb#-RKgg zqbKZ_XnDmfZk~3I6J^bZn){~5(@KxjZ3}T+w**jyW9P0 z=`%^-)Vf^5I}9Zv_11HnaDYw&iUy#*0|Gfpb+<%RrKCpjuXo*Jd7cJp(K9^r$ToH< zi8gl$k%U%ksx`60o<5tMbLu*XP`RWclxavJMoxkKv!s74r>=de$;NYIxDIz)D{nTW z@C{z879~0{q~q$v_J-^Un~rl>k0o+;SUwtD)zLH7#8cusKS2>fPZ($gS7swH2=C6s zE$r{z8*nrBHoIcn55(QDi@w+s^=8m>Lw5NKdF<_MLEW_1m4dmeQfeuWl6W7jQ)>h|vpr##U- zpCTt< z)=b|*lKL4L`A1Dnf|T_T;+F#n%=6&6vU3sHn)GfDie5X~w+#yf1`sqnb(5*h8VPN@ z_y{zwy_TxjPS}{Sg4c$2L7c^{G`|$#@U4e@+iMey&Q%dsiG5t7-fLya7Ty z4oM z@$%@wpiy2I2_AhCQJz?Yv+X%1%9rbT13k~q&d$bVCk6{0&_UX*)?N&7$4hBk#YT@U zX3}UR+Ogavl_alfnt?Bhlh!K0qdX}_K{jPH&#D>?)LoB z;e225oeF=v`6?2RpKGoK+3o48xcxtG*neIFdiv;~CA=4H3@N3q9ea5UbvNuxB%yzgjECAIEx!bsT`wXZM60Rnqz zvEYo&*%P#!6^RHrpyH;aB&Ppk7dtzYOUKr|Th+rrvb~#(_$4Q&Jz)h*8z60<{J->2 zWPH^(y=n@e?S8D6cXiiUQEG z1AHAFe@2E31b@k@fSK4W9Q&3UVDw661V451K~%;vmLE29lWnhz?k~y*VN^AEr7}@PWTUBV%9{FUa(pJ?#Hu!?|+P6FE8GplG zOf{IV%a4qJLj$ME!9p7j41GrpqrR^to4-V+r21QX5s5ocg?#%vB zz&Z6${q`tHH5Dc2)L(-Ru!#6I0{ot&+$nr<$HK3gx+Ta0BkzvQ2ZmBGwm@bFqpGEm z(bvgpYzlTVlv;#*0)W>i2dtqVl%|zGx^|ONF?ogNJ*4C(y zH!*B9wTnms`o-9Hh*Ytc!fYRU@1y03_V=cx{R2FoMeaVRp}Oj;R%z?$fA|gsdo9eZ*y>`b(LUSS>gwxfpbT)PE@w47(sQY? zg6|m^ykLKWMHhvcA6G^Ap)a{+(x_YjaV7$>2;2fpOCbu1(F$ns)#$g|;{Zyn_M|2W z(??~_N$MAHC4>r&DVm~Jc4#ep{aZZBIXEqPib&CsEvhHyS9uqBdx~vl!9T&w3}7?B zP=UD)CNO>O$(n-rvK2~h+;+kwUX8g%6;5InCN z=!7hWvPrH;@&1NS9^ib@;zGX~;!DMYhB`ejclUljgW^4po^PX**!9jzB_!MboE}BueG523g-@i1MtL5C=kxB!@87h+Pe@<$tB?d4E*NuWk zu%!WryNjb^O-IMEu4zqWTZ}2TmIWntPh|JroDwnAbAF-bOrD&Gtf~#q#S7%hgez(| zIZZrM>}V8&4;zosAHS1x)h8vbPo2}hX-8AyxI#UlPP>)?gZvwZNNSquyC&(%&@M8Y z$3Si8>Y5pTJ;^Bscyp9n@m2Y1jm+*)hIZ-E3(gKY9&c5-V$+nNwLd50bNogiAY?pI zpyS;c{wlj2YY0N!+{yuUIzkVq1>7y*=y2n(3-?EO^kb10S}*oO#D*Cf8$;_sMxgmr z((?{W_TwU}>7A{~6Um91n#n-$8*=CXX{VC6gh8^{*;KywO!m&CqPj2NfE5k7vD#nze z47#-cPuusxC=Y&&Jkr$V`NPMnD>CiPW;2a3% zbS>q~1UKa4C6_d_E7CfMRR@|~K0(3lVz`ZR8)j=;$Iz}m_-r}Z^Nq)li>c#+J1+F@ zZ+-+Q-_EW1IDbVIqt4a;&Z zy)~l8I;oxbx*-q|cV>=eT)*|^V2b2OuJ-DRKBq!37N0?snbgqPVo&?SwQz9bE#c8Z2!&nP3GS)qZjGAGVnkpUeFPA0;N#4NA z6|;I$l#T?R;Z=5{dg9M+7K8DwOMTU!?#TZgAM)}ZE%DxBx|cH`V5dO|(buQxqhZ$B zlv1J4H+0s#_)rLa?49z+2ICBo4Y{zOA^ZpDSf%~dmQ{ChSp$wAz7;RjN1%-6 zjXrYYP>6wQ92zNj4%WEFCR%5LuUtVb5|-Pcke7&t9PC=69Pk?;$99*|z{&ky!1H$W zUD!+>T!eYE_*}f-$~Zk_f+J;%hdQD?>e=W$qGIcYN0 zyE&j%(eK<7Q*fXBVkt2Vo2TL6g@*Pl@-B1xlm#Uf#>rTRdtXJ1+?L$*r8-^{r;3Kg4 zf)Or)pa;r)m*p?FjaPbpgLqLY=-$C?s?@ObmRj${F5$8kS=nD(S|RCXG;H)ijxD}zx$ zPT8NewK;)5B>pC}VU>oprerRNS|>eIQ*4vxCnr@?jRbfYxjoT-sXR8A-Xd|BG*ix=2$>gVM{y1M;PB^M*j(E+yZsC_n!w2WR(KXeEpk9>XidT zt0{3LosP56@5T1U#yeoQ19;;rNX-GaRwUFf{t2;rvBo7Qt&kH!jqo^4q31}}!Spl= zbdcH8Px`vEvjeQgU|k0Jn8?>acK#0>q~)FC;p1}>Jp)V2|Ev`~j?MqA7uPN<5c0JK z!&ZYWlYsy{`L0yaMHl~(r@Ki&jpyBR2i+@JzYiKAOZajx7~HrtTgEj*++6+EnPOh$ zi_ta*S;2wXJL{&ZhU%t&u3Fq>Ii7pbpAPDh=hVM})|wVGq{VT%=KDu8pZOD6Xr{gS z3Bj4EUT5FN2<|B%UGarnR6+a&D8IR*+8tR&ifR|Fd_*z<)ogT`^37k#$t($sTGFk( zPUhdq4R3091vaalm3}u({zFZv8$$FV&8}c%odY2al+h!NDC<;k$O8I3V@-ss`#8|V z5d(hB_i?11UtC!co(a;~JZ58a0otf?E^>6$TaIwEv_(ycL6kq~h^*bpi9r=r}dD9yKpG@qOB z{9)3_auz>&J^2i?j-lFt6We_gB>i z!prg{_Ym&eM<*x9EJc@@L~sthuI1@J6U_@SZb5~|Is%4X`K~|Zw==iWs@GNxYAuN5 z-au$RGJI{)P0fH`195&yqeQ_ZczSiuLs_NB?hZwg9GA(4$r9-8ztC(LFQ44?`(b7R ztKkqAHoU_=)<|7nb%aMeQ`pCXcmQIq*pb<${WHEaT{$>eRnvvToV%&7!Q21I%rECk z?jAc`-28b%C%f{EfwSc9O0%{+Yep@Bo?Q!V6y%u}G|Br9>t;C}*QJ+M(Bm;rQJ~{l zY&Ca&6+%Yc6jGascEijBOP_vLqTPH(g&wOG3m)>d_K@hVWR$}UX-0#w)1R_SPS*sA zjwZPDu?KY#sus>)5b>BtPd8>5(NRTA>xj)B5eLH}lNuKV;C3naV&4k?V`ccx@!M){ z(f)HcI=AxQW#BC_Jtkf+udLM9)B8Fu{SG>{ig{baE^8lknCNStF}@`$FhapK$*;D=Tr^YGg>&olHYT+lBc zyF}QM9|8hRg4*h-eYbHo3uovF3}bGAtFwP+)avSJNg6s9wb^A9#+19RXci`}oJ+3}jDa8_mjqIKs@%1nDHqRGEWx>QlQ&~) zw0}DMl9w^kPqa)9l1Zfr#F0woJm{Co^WSbHD^DNBtcPVMWh8aa8IwYM4{bX2HzX{| zq4LhL!-4lylleOlRF74?6d7X(*$r4eK8Ao$Hb2?Rw>28X zGPFn+3MjJ{y)#)hZ0`*2(o?{lJWV>AS>0ixd^$d0?l(<@n|6dR9UI?d#M7j2qq5td zuuN>KUGz>VmC{a_Jt3IQ6;kUA{arSn$~`CU6Ggr*fRt8KEcGSgcc|-FxW-3Ute?4i z+AQ@1$h&=>YwWJ6$DO@?OGvHm_mM_ca@)0D?V~m#{=hO+xRaFa;OSW!K{u5SA(foa zbf&SOJ}wm20TFncAkai|j$m^K^zQ0e2-bLHA?~t6U(QFbE116GAXsGLk*vfN-f!XX z#uk$5iISSy$y1`s{|NwCy1cGdRb}vVUt94dEduN4H7e{yTnz=R_e@c6vo&f_m>qhC zh>X^@0Lcm0GZT8RMh*Ye6lqI{eyvBHXAegT-!UJ%GS^RA?w!1@-2h~QjK*x)YntMB zKVp`yAofs-+kiy!Ej>n3;6h8WG?5qKYwc!?7(Z&R&{ZO~0V0JZ>Uz>4i01s~_^~#5+Vk0AeA2?6aX{xk4=lQX9wz`(gCp`OEe`;Yw)!~T%p?- z;iZzt9wQd{P6HkfS61^!(ksL^?B8@V`IzHV-4( z%Pw3}f;^@PEEZm3LQXLmdnp5&nMDq&mUMD-uIYjlaVUtFY8X4@2VmGQ;Ayp+H_M&o z%is{29smwy)_AHe0G88*s7@@Bt+U;UzP$~cb@W%M>)WT&sMX#DV&KnR$ZJ}UYvXU_LqgB z2enjFI*dxzgTgog(E!q_C3Z9P+Lk1f)AV6@*bjFWhkyN84*}YyySAf;hi3I6Dz80W z<46(IzR1zG7&^pt{$1{k`~^g5lKyc5-(ND z#3uxv!P{nmH09^E$3+;Ow)HTmC-S!Tc9KLb(t|RlU!OR~y#*yXGOaCy?9@LrLj<|l zeh9nihqY5Z07)14EEWEyl19w!w;*W(H|V{bM1NmY!F%*4NDfkaY{(uX`OA%7qU)Ka zMdzyRgQa)lcV|5(pPRi$ z`<-}2tI$V{Y6=tPj{rwV;`n^ zI+Q&)he~FetVNe}545(tTYCi+o-am*>)gP0JTKu?;(pQ8kXx3+OElzQc9gEjr*rzv3c?kbbl4 zNAQ9)rhm2i{YTjW(owCmXr7K^rgU=ap?)&AHvA4lPn#d<*O3E;UZNI~O2+OvEbyvZQLdt&^qZdaI3f524yM*zS`9%WX9Jprz^rNQ0W~P}BL+n8Fcs+g` z{ROGm?D~jr3akkzaSTuxqpA0lHM8E(k&!CLZPU~S#hkaE$=tPSW!gRC@9{xL$pp6n zqT@+MwWfx4tg1DMRYAo4gwGRgi0re@84AwRz#ojYx~XkjALToz{*3dE_J*+O~_CZlX5R2ymW{&DWlfvD|MSWe9t`h?|egU z>dP`sVzfKLV%nIP_ycgey*(~;zD~S72qrCpTeq|$%KXPvSVTUiQWe1Ci6quQi8YvV zo~DARDu=JG-!7)6P&v=?B!2|4>gecbthCX&y16a(`o%^_&XIs}M9}}d z@-H8*cOiTo6L4p+C%L1NrxF!cnfS~}N%+1N-QK77z`_khU` zj<4)oRE=nPlgNtp1O`rB@TqW26Xs;Of|{w&DVnrzize04)n)#`HT#R=y~j__$sOQM z2I6Dpz(SAng@+FS)- ziFfZhZ$a36@Ds~png1gOHx>vB^3sO0ZZ>=2jx07QAB>%4;m>^#RQsd(vKrqU^kEsz?))VM2bo{e})?oeiuh|9sSUPA0 z+4xU0`V-kCu>8*&*(qUNqhDT3g12Pbl)g9GVUkP*6)2?r5HYxqP5Ioit>%P$s3Kg+ zF_j)_Tyi|+#2?qYjl7l6A-LONIhJ}l0lc2l~s!l`y?raE6r(iTUj*9K2sl@fW|za?ge zk?I_nLydE7xHB&R#7^+((^n-OHKW!upyS1C1aC2jov}f7EF&N!T+$)CShi*z`(~@& zHSG@mxVcG@3)NX`%>+&AK|{#z%D5h>tRrRqi(;rER|_N9DfSvEQ!`O> z^h$LbzqWknUqB3Ux8WzN_QN8CqRm;PYdbi3uKU$Wh1(TA*0Q;}faXn8{b&)8dZ;P> z`Pd?hB2!ooLi0J@d7<#U8ltH38~q}S-1BvXU2S@KgSNQbXjWiQ(X#yl5?@@Or zT&?@aDG-hNZV>hX;2UqZjh*hi7?&_LvT!fEySpl|E&BbR0;i})dkO+zBo4R;lX=~2 zZ41(8`s(7K-av4$u-nqmK`(t3=!*bLMjAPt@M?gJsU|BF`Q6t_~-jn^Q-hjW={q_vTfu zW#5;M(DGC4n2(Qn&F}bXC$UfNXRbXtvr%g?YNWnqSgC4{@myS1}!4X znc8(lmx|%hOTGG%9pgFDZkylvpoES>`hgX7QC!j#*X}Fh*3+Co;c6%)SNsPr#M323 zM>o^)YiN8t|C)D&$j&oLl?$CO%?$J3yx{5)m#)mU*9QRJ52yr0l!6c4{+)U6_5jV5 zJ*9kDmVo?8o3=nS0n2SU^JfAUGd!3E&&Gqmmjkth-ApTd6S^_@S|B}`Lwuv=AILp` zZpYCcLH7RL>5-9y@j2Tm^Wo%g!MLj0}1d?i;|NHM8#F_=U{G2kY z!$&f6AceBW7<+H4Tq&?MaqCy^YHd(Gy1`|!Bf`XYI9>pdnQcrVF~`>B)hIi{a4u4Q zOf7L9`UJ|!)IH<{a6yC0#?enOoBuLU-v-oLaEAi{8*Mq8Vlj~*h} zinI(#hpf5SzIPc!91h}WS@vYj&^`F9312Z^b2fC8-pcs`NW`E~q!lx^ffV*B6o2O+ zrE+>wTcL6!2bNx^PIBI<{1zIRU~ZU8a48H=B#B^9SRxl-*MjSS9De*eZ|ANUROu6l zHGFAkIQxFaVe6@qG${e8-LrSHmD_f}2eY7i{3ZCys;Yx<`p8>FAJqNUzHatwLLuba zH^sxcQm&tYt>v3ZJe-SNw}oIlTTYH$t{+A?aNr)!+!-L5;eh0-W?9KV#vYt~zkIuS?E z4Z}u-I{6CQWt0TIj9&J03{T*abELiVPaV{I*R57ZgaDanTbtuBq3e}T8{ls(DSg+! zltJE}hgpLWM2w7N$lv7b=xBuBly-diSs34o#{XydzYMS_MYwMn{vdNWUub$_hA*#I zrNA18O98N<#AN*}gCQoOa-KPB7!Xk~ncWT>W>}in%Kx2cu&&s+VLy>5Mm{Q0CDzBO zQGf05d{D_(s-2`CEq2Kfp=})WF!E6`7qLmA!$J4NO1BZ!ev1cL0wE?x!L%*$Ku7{=_;dmrq`Z z1zqkK8{y7)Nbmo}kfBI=PeRJ_cmuQsHZ#Tt4Mu=k2JFj_vo2|*} z8P^&$bqwXBgyfc!_HY^hCZ)F4);jw5fbtZ8<5>MD;@0S|5Bnz@GvOn!{7(Y8>{6U~ zECNZ6-09KB-*m4gDKKhMJL9*AN5tVM92_Dva3c^cGPRw&1fts zE>3D6Xh0wMg|CuJ7N7f;=8(CFrtB1*ASZ*Zuvhiy+V$zcM8$Hlb3yNWHtQ5FmTSY* z)sQ!!h4c>n5%n4J1V9zwy{_12=n4LAx(#VH+tVjO^aa+~c9r0|X=ol^1SG7bXJ$6A zF3|X0?9s)`k0W+HS3GAd^`ueav*#` zmgT7`y#ww~-$Fg`7lB;4!<`*6pVF-zue5K$>W$PI=cD#{OwNk)?Elq|*AQojGo5<~ zAA>Z%QQdA6q`I{^Blcm}Kj?%923Ta!ZTX?Y@!SVpT6@`Vm%9Naj-Wu=ajVje<)>S*FJcdo%siKL!e02oT!2Y@qh1$d0`xMLP`3+Q01076{m`Z9MW&R&9o53V7 zJMos91^0)K`)ocpTeE|qIILbqefNzQ-7&Ib#a8Pecjp|c<`+J7p+?%_+~w|bw@cvF zAbKZud@B_K`da0v)&|QtiHh@^+kzS~AAy@xMfumlK2Tuw_@a-AWFYJ8TOO>dtZjuJ zKg-(QV3&dp`5Tg3UjTP#Huov)Yn=xV*PPACqd50eP<`BGmSRm0&19;0c0Iw&bh)>d z0(ZLJZ>Jv~bsRao&gJXm9~{dWO4NgMrbG<>=ynNzTcG<129y?Qi5>RcTR>u_LUiti zh%Xh;j!MIkvpOOocz_(`*Vk8|L^EY#@iT152an{@$NbG-wK}DBP&v9lp#u0?0Derx z;xb=>y$H~%z=38Vr!Xehf*BL13@>7tM(C6zKAT1*zIn}nSDaHcg+RJ-J`QV~StnCC zs&ND4;Te*$AVPQQN(GAj04G9Ne@vD>l)HlU`&Esw9gEPxGZN15rir z9v7mT(jU_!awIeb=kBif6j*}A}}`%{J+eRNcZfF=1Io5{UMMMYv# zwRuOGgQC%?Z+5`v9W*N|Z%)>oZg+T!Kf%K;@SEZfEmcGMFBS~4Pv-S!uBg#N8ww6% zPIi{L>8gG6d%v0vZlJ$9MzHL{sg?In^4amH3Yi}7{?xE(R1i#p-^dLVggwpFic$(2 zcDPgV+9>*SnwMpV6qGMZH$a3}{1sv$h-s!|Un3<;ZAKZXPGmvnXsD-(@=RTrTo0Sp zTecYS8mznI|Iv4~vb@VJXUd}OE8~^s`Av4FEoN3eJw?XR-qP~8FZlKVm-g@GUx+Vz z7a;sSjNCm$#VPSxS!VthKTe-N*LJQU1rG0A4pdMG$!w9Z@9IBSva@IW5tdy)y720SBFhK|K`ttJD z*P{5T+f?C;A{;M$-W~k$U_tmB5N;|jAbVqLsS5+cYZBLc4MG~9;@8r?4ee=8<+~3= z4mlNxwf2Ri4h5!PG05N@;E3u&-%}a={O*bm*CG#%S{T969HgV95D=n7G1umpmoR=1 zxs>kA-lVL~aUORo%+MyKVl4wYEGaDQPFmVl2Hsh8-4t_oy$@<on{{dh2yr)T~V4d$P^81z6bI@q;-VF^z;s(ZhMvkLMs zw{3-n!I2uJ@AI$=k_~*AQ9ld%Sl<=k8*tl*|BBU$PBv!1n@I|bBtg&LmNY&ACmS%* zrK4v}v;uWh%Ryn|UYwCz&7mpc0;%balbx6zdXQ;4<{0}1g=X64aYPMxpyJkX?cL}u zIEC2F_5}h@aJB*vw3a^SCxIxmHb!~ez$}%wT0*A!de1T}YrZ z!WB+JA;jape~q^rkfVW>GJUDocg1MjMI#vLxpC#x^xfAXQ&4U7ZJ&}L98_$2fT9$T z2MJs2s; z`KykusxOpzX(K!bgNuzxi4qZ4TJFnfHWl&U=>OmBUP9=UvF?tG_?5zOXGa#HSX{Sg;r5VD@VxY9KvH2j#juRv7LLNT=| zYmJ=P7m0c_x$)sC{?#?%ijc(imG!HGa=c@en&q`f)@T94J>qbp$sr8OwNYFZs4$x0 zPZLyX)kJ6>@Qi%E9%h$iYYlS%RQM+wv9pVzh8AcSxd~8rBVIWwWXR0Stlvg(=#W5r8CanvlAI&4ZoabLFz6!iYnuL^|2?vnuX4}<08hyA^1Z1nZCt>X#c z2bA#TH^E}Y+fsHfGmz80)XvnKwa)(3J=L{p&|eL{q<&pt>Mj~+`ZD;Y0w*O?Vx^rPf$PAp>d7tIu_&|bcO` z)cvxPDcHXd5w>`;vmYzPIU=at?d*hJ_N-GRV`8fj^f<$i4B-~&_g-^lpu(xNvpwDv zVyqrB=k^)6>QNH1Ox9J82QPaY`rfg}KU*t9VV9WXQ!Jf}{C7*MC5LIX#ftPhi>#$I z>~eonp{iDB9X};je1?dw$)tr2>SnEvCT5PNzT@$5lRGMb#sG9htJ|BOP2@xhl@q zxW@(*q-xeUsS>4opsLa~r*_p`lSLEb6>*_h5oaO&#Co4?&JMAU2di4W58n0@U)wv7 zx1mRKgzakfY1EFkLtCYC!Eh}}h&`W^3y+$h>x*ABZHMQb?Rw?Hk{5%D$A^sGamPG@ zwXec%HH85pb1UoXE}CuH!e4Fgd)#0TCDzi2^IHh-!Px;)%H2IfJrBTI%ob9Cmp?dz zHl3)1@LzUdb<7(eG$vFb4Rr*3Uq{WDRe4~A*!0QF(JaUSl7qRoff!sd^y6YnHLPEu zYgmG0DpRjUGYb!Ux{P_d1Z|$US-`IY|<&5Jry=5 zH`9KfoOw$$rH%HUT(+BSI8v)2j2T4Q=w;VmXTUfkU1hig{dQ!HY-HPTYxG~TvSo@L zo!xX|jv!AwY=w!aDd)0kP5Yd)n3pbvK6(G&>dV&gnuxk66tSx&&ALz=^;y|l7!R@1$R~LW?1Eq>W+GMMUv*u zFSLEej>qP3QKV2PMJ>6?U>Eg0-E!GgEJB^zk}K;l*I% zh`q@xR{r?bctn0-)F&a-@_!rj>P9llod@kb$XW%Q1W0^>vkA8f2~$O8+Y1SIILvKRD_}z5*@-uVyBS zWX6+)Qk0Phd53{9_w<^*tm@BEoz2-~<@2Bx{P8^$yW1yiGhXGY%|F5#SpE^;e)v2E zD!kat1V=BxBJ`vEM?^ZK=UjfL<(D-hF<|P^VrRdj`thiU__1W~fGjz^C1AFA_?Uuiu@?1}Ev&1Opd zlNn^$;Q=Y!b86}0OW2|hMJ{);(v6Q|svcp2rMSPU-(2}${;(>ogsI@Un-&+^tg7iV z%S0I;&RFA)&K(+*yPx_`>_kY2bcH+1EgvS*EhWfQy{FE4zg5sbkP1A)Mv6hG@9At> zey}k8`FQ;<4AwJIpYlVjz};w2%m<XI~Ju6R91+2%eyqq%5mBZW|9m(iIhE#9@+fr)uMgZ5f2=v*OmKR|)NdwKce=xeH zl*rwc24jZj?iVzu38k+;3bzN0emqb#^+J_8ms-oh^9PEb=Znr5c~p-GKr`B$jKmjM z#nTzc$BkV09w}se*f`&qKx`CS5xMRwy;v++7u2Sc>+Jpng9@E*ct<8eZBytULq%kM z+e2sjDu18y*(BTu)BplmNNqVDkFx7(qbrMR4i|2J;5CIEGVb4$s^5tfbcG>iYSjsy zU{YjKPxigiq9mt8-xE&jx7!2FN?`D7L3|e`^@IALi%wA8MoLA5)tU_!kJb@&OES@~l-UEAUfy zU^*C0*E*pj!=( zvGxWdKlZ-iB}t(+l13(&2yu0j%|6|6WGCV5#n8&NN$D6QM1K@cVJmO`w?z&RGpM9h zma!BqZ!VdLeYY6d7!ZH1*BnJvAl}P%olEqpH6p%)Z>*@S7CHf?@9F9Pl=h$>39wXP zS~_3EY8j)43|wFQ=KLlN(KdAoSAkBx1GpVO_`m;5X2<$(9w5jUXd-k?R#c*bWBTRt z8aVkl3>q%Yk+S|1wusmQM|lqDl59TH!H^&LV1YUdTlp8a4A6RaJT2uJg~qf>oR>yu zUyL2%RQ@b4^Kfwq>0P`|9tcIcN6{0WQa*D11MAXZiDY#=;^`B*V*fr?7q5B0*u1jC zpgrxfr2?Bh?O**24I2-3v#qL0vi+izj?Y7M+%xnCtXG+JYI|=v(_WAWADBqarCwn}^ZKPc#+Z*_U) zOy|(L`aOOtBSRj@Y^hCKr+=&*qsSF)?NMLj}dCy(wvq6_Y8&t`AvnsEp)Q2 z-Q<_K5koQ4u7Baod{g=Q*AGMocnQ`qRRo&MXVkebHR#Sd<+y)U%!-KTSBr3VTC*}s zv3A8s6u0ECZ6CP5LI#L_*kH?@%%P2y62H91hSh*m}#m zOcnZ7hPxuWbb-Y5n_xT%EY*SK_)9Oir)_`ziRW&wWaY@QJxuuH#CM(kPafy%o4lnp z=7!jWLS^-?>Ry1Y_jN7maQw)OU3bL%sIL zEDZi{uF$IA(gNv>Ti%5hwl+5I4@1g-6Ya$Lc|<|atSz9nVsI)y73c^Qy|y5NzOYr& z5}mc5p?z{avC8T0*AO#doHhM0db{65HtV!w&aKwVFcWq>wf{%8sz%KY22l}SvSVqe1ZEZt2W8Im4J)A0-wJz zF((6LF2qx`AI*@kv^AwOBe>5P9y9K#W6$RezC$gAdRQv?nS?*}BDL__FQc%x`(}T? zTmSNb;96uBJXJ2Pt}BanX0aj21=Rvir$6X+OLz5MoRe!6a~5R$L##bHTQo3$f8_)c zoq8`I!bDa(Lg^D+a$T&BLW&pYXAuN#!216LE}$pj-`~Nzm&NZne`b2UDQr8%c7Vcb zHQt0@Nja(8X2bd=<_QSkz>c@y^a22l;41e7{PG$!Y1Zu9yF2Vm+uI^VC)Mnn zL|a^vRzOq%Ah;+qCh7!j?&*_W-kqGX*e=W@bod8N0o2*7*?Miey$C|sF zw~RimYgw->Q~&25(y)Y@^j9$`g?yDF+7QnSbzzHTD~5Nv@DWg(up;`DCL`(e43A$^ z#0}M?Q#2Da>o9kYWJaH-1y?U%P_E1*qDK2CU~)|R`-^DiW5Zm!D1&5f>uH43cF#!; zb4U3F13&*tQ8q1~sH`ezE6^Wnz>pX7lMn*2>~RBFhFI}(RyFc#qaRV!taunL8J+9t zk4haw+ft$-xlw+HS(yAc;fCk^?Ng^T8&&aFnVu-iZ)Tz9|-_ggc>@PhP&h z`a+LDG{oThl=dnK^ddZ-;|UHO_4VQkSOf-;0SIf0wvE>V1F+Y|d+0?4z=J*;JQ|NS zk1>#H7h|!ev5lh%&=!Er5ZZ%dQAUd(h_>rq(o z-B#^r{y+mIgaUqdAELZ^&p5Q(Nc!a;0=_(8IDJ zi!aVMzOwSrcf+1lTI6---3`u`6s8XY)y!I6bGH3^3*s&0dAmN-wUrT?2t(H1@(-5f zF1}NbZ}$o~A!blV3S!9YlOtr|Jp#kXp`UFZCB3dCyjgaQQ&rRPmWyFumatQMcEwB<3vFC~$#Q z^{=XuHX+u4=~Xh)SS07F%BlE>yFKFPm&kCIpV}elCe)RWiO+|W>GlhtVY!}*oTbxi z)@UE2FG#!aHipaQt`RyfB5E*_4i?udlFjT7$ii8Dzm*vSw%hf1Yk`JJCQrF8ksqBr7=C&tNNzo&EN^UPf|q~^NkiL%-@RG^@j;Qj2! zs91>9W(g(VE`VFeyGszqSNh12mR$1@%gR)2kxXaw(;$|q?ZzY%aY%$t%ybT1W^6P4 zh)yQ};PmIt;D1QBYL1z}1W^D{uH)nzFxdW;KLK<3@|(~EykQ81M4MuHryFw5K!R88 zwzHE{AG5Ao$K1?%++TMPNtIk!9&BW0w*U8UOxhEWAMm{zVoKk*Tf)_!<~6Y$g4}95 z{8T<{3H{H^Xb=Axg;9IDxpBExRiVTG`ewHLv`$uaa3i1HIA|a^iWL#_z>y?d-Oqqp zXgG~OLbnK|v`J(-DRgpr3i^w|_zcy**yV_j)-J!yM!T>#TKP71NO5W1i0NXw9{2#w zG81uRfpUjst#CPb)+pwAwG_E$J3M#N%Q_E=(T_xrSU749j}#}$EyFuN z$VOcqP3DpqTF9IETNXkw8J>UaxX`%fCL(mUnmA$zH1L8Z0dOy=hF*zO&g-mMIAOhe zA22S{`qVG8Y42RxP??1MJM+=uQWan4RA$(vy39~g2Yn$h@I@eyD7?c|whOeriQA2_6u96Z#t-nJ8F z54XSu=LXza+AGP5rRp+Rsva4xyIU4jmej)6P&<(gDX(1?haR)E3iv!9ILM#K868H; zD3dz!y7IxyiIqBEsIuWMI4twjSnLa0uoiidQpGZU7t;RDZn7oB;uxL)Q`hPfuwgaS zN9j7(BIui2jdiN&O~Q1AeHbo%t*q@c?t(psEr{)DeZz@JH&XeklbzEgmJJm|Hk6Yw zsvoQ)|B;3u(=m)Kc9_7~=t&5M7#d2zK66)nW+q?j<*{f#hh_UU}(4q5U8 zXV1=NomT%5z)d08|90CD?Pf=3;+#C$>;5Kz%nB#Uc6Z)~Uv|~M@>?b3l%LQXjp9z_tgxL{(a*DZ+*IUv2-(~Sd)n8q$xN^?JZ_1x7 zHaY0|CyG?K_XvWMWDX04_#%9tw5#SVUx5`f zJc|vj655q3;UIFzigqNw*bai8El2Xlr)IkHHXZPUmG|9jh z*Aqm;*n%h;{%I>)-7OmBk&|FeGetf<&P-9~<7VpRKPyQ`O9YE)XoN{5BXo;ZkGt`w zQ&^tN^eriLdsF(PJUe+HMisrxLAmYu${^+G?8s`}u!!-6E>slO&itbcm)agO-zJl@ z`Y0fB!MSvQSKP*&OsuyNqqCc8#wy$RUtZ+g7|Rb@cs_kA(*x(WLGiSDgXQ_w+bBEI zQiNiB_L*8<=@R@u<8uvKcDCFoQihYw+aPHaSb=eO>p<%kU|y_@4ZHu4CLq?ndtZ zGRyY3cLEBn^#9d`Wb{F$s5J5$G@Tw#R;`uq=yA1Do90$$8aAgyR2G)*K0gy&irWt` zEr$JAe|UHKcVnZ==H1?RJrG#&aeRZQGH3R&uLxbGeTcH^0+{;yn7$Xb@k8VUFCK!# z)xg({4Zk;$PP~r7f%HR@*AEm}_hlr{A6E~;Eh5o}WPPzQ1X5IGeribVo%ghr3N5ay zZiHS@mIxvn+w>1tm)>(C9*sk>wqsp>9@Xj6H$byXI4nIIO4lv*3WJe8f8b_Lv0x$g zyCcKuI;VEW9(UahJbB~8S3y@zPu6w>iwBqj7zB#Z!=oLSo{CJUM?b%}-sFO2=by|K zbWJD^gl>f)`Qdovdf?yoS1*<<-lG`Oq#@1r-RsH8XwO=$DqSVu`oX@_VzCC}2lO)= zj-Vy?pYpif#edOa)B9q94U% zb_OSX8hM;}8L3~i<>#^}AdpXKxhnru0pZl){XG}H;0tu~30yJ}hJ}aeDFa%aatZ;w zts!)$J*xav%&tooxA>c^>ez}83RM?euyEl6#`IJYM1#G&h==nBzjmWkF2BWEcZ(8D zn+Ux-R{Z!f4XMa*-1+_m?vX^g>KJil+VAbOUJ8bZc`8}Y4a@V;TqZZ8`f_kZK`hQ* zv7Ly*^7J7`M?3AMw)9#bDP#TV;aEy(mY_nP@Gmj(gHBKObadkQs^z+#pocB^)b@T* z9$jXkl%%{45?6{0wP{7XWzAjxxIe(ZY_jZbjmMP1KPf45(HM6{BEvZQPo*`d1)^hl zgbsHn=ESO&hYjSgIH>z%_k3eVjX|7n@s6s(tmsc?q35Q^zZqtk;9~q#zH3&&Tu!yo zl-L3H0m&eLY0`)aQqAz*&S2^Y&?ugLUq3ok-YQK^%j?8Ir9eGX2U}R!zJNF(frrx{ zfv@{nzF3}8{TSSF97|W_(ByAO3lgY#PRCGeJOk5P{`?r|RkDPe%#0u7V6)PO;qfM) zQIt`uE3|XMUL`m_3;{B{{r2x)J09Qnij5;08)jzs9+Z~vCG~R7<|W@;kmhBKBRQ8o zxOQU|_j;9(7VDGzc{l*1bA)^<6J=0JVWDDo^&kMSbbY1KFKN_=u4RbLQYd%?yEA?U zW?nJBLuqYI77yj_e19T8;Ld;G6&>76|4e^_&$0NL8Vfc2QFo12a8Xo}=9Sf5yj?U0> zF+M96K^#Tg@H4XYC_Nn2`WSlXNrOunf)%67Yim(U;Z@pmaN%n2XoO=KK842crNm}< zxelMNuV)t6>0wJyfIhUS=BE03lg(Prf7K`B9_s~k!)_fghL^;|bopm{jh)~{{li>A zb>H(H02V+gq2$+8((*7biBIWO-#?BQJ|s}4h~Drgyk^PpLATGLX6b4OX*{QspUX5d z;R^J3X$Gr}6HKx!aM-^sh$nWvR%js+{rNwdt}?2swOa#%bTp@9W@n$CKIvn;j;^~V;hev?)?0i4s){bE4g8WpHlM=-wK+%9H4m& z(#0xuzY_OL60Uzxk>VbnpUO##<5+AoVJj^q(cxya^2G3v|I{QcFQZ2NXa(ArAWIUYnzMz%H5vVLYbTfZeznK@WjpF z_c^L}JCGBqO+K6Nm2F@ z0}(HK7je;xK|plPsiTYj+%lOGGf%$yM)@}Ji#JDNkz&c6qNK(lejxX6r9qv8=Di!S z%SI%>dPlf2z5D=;ZDmEj6wTrVRb^<=iLVDt`1-h4J@9F10D^I_RuBXd&fc1@;!GMTlE0QEMCjzC22@PP3{SiMwo19^2bFL?Z`PG>d5~eXxMZG>HC)3lfRe z^jK%qQm+@!_Nr4gIw&U9%;$E=$XO$M>?>;xpCQkS{N3Xo-&l?yN|ydk(2hn1&fk&o zK*~Ym*V}hc!1nbf>uh};Mti@iD+VT1;3UAsg@ZMFTV}VkZxNPnh_4vnir`O!B&vl> z&!|8E4vN~FzWE{@9D^q@L{2vfjN#2nAr}?&hwE#8{L%?s5j65M|A ztDHnj<2S%cNQnQ*4g9cp?#ogMr*&U=x@}0u0)JL^3h#vom;+uJA(>wB=Uf9v&p-S@ zQe+#Sx}PeNH)q>J^M6`B^LclH0Z!1T@6|%yYNJuoY)q>iW5_1|MZRUtLe|GRAx+5_ zwA4ZIMFiuUzX!eX{7|`+sfd4e&eT7AW);ycMm1N?{V_P0l?jTZUp&F!B+W&jp!mLE z38*vqCR42Tji%`pOJcwO`ipIEmI2gvP}Mdc3F2;r=qt20q|P>KxbxiesH=2xkJpO_ zMQ+-bE5cl#XQmiRL(Z|ug2$t4snu}~_Jn#E)GOw89~c7VE&0?b)7|r$2v(3n)r9sZ zgd%n9aO~ z_mCDR4pviAYw`Bz(i&8ZRXvZC)6OR-tT?FH)zE6$=CHb``sChxHT06R`@`+-`BrWj z)oJ-#AG5Zs6QlU}vZ2#i8jFvstAy4+SpTa)#vuNzz5i(eo`})X65P)15(~dCE-ua@ z2?+=c)C_!qARHeZ$yJNR(FH3v{$xH%V?WWMC=I+^(v`C*_Vbv5pC1oS3)pO|Fg*|` zcz4u^Sa$`15aAsrI{p#I2^3`qIl+#+Wl7$^K4F!I3q&SMB;oRnEpzWCQm6hB?wHq@ z8S_hxq1uP;?At~l9x7^^nO5_|pxz=Bw&PI_|DB(G?5N3nmQt`yn3Z#1bB}o6`*Jaxt`dj=c$0JRJwK6JW z5~C~E3en2V$K4?`3Yf%nBDS;$CEcM1DT%ch4LqZJKAk4TNN2mf(ngh7n5hayF8%w` z!L(F&t0y5FjaAO_5#ouradJWgNF}&RX zg27=a;cNEMpkPE)R*XDU+44L|HL2&>+*zM2m_B)@p3xB1@QUe|?i?uN2Dx~ag$p|V zu4Xp=KDT=qHr&TE!xhFt8$)Bs)N>?%TTjIi>uv`Fm(G3G_w+vvIHe|VHAU`O8-Cma z`|vrmQW*=`E?PkJoX_aDCtEsSuCHbm?28HPc%26B@?}~XH+Nu!1H0U)k~6A2UJ7dc z>sAgh?yd$YLv22|S@cVyA3DEo>DuNOA05fy1rhqr7XmBa zS3v0%F%i=~D2K8s-=oud85UKPkxIL>Jw2V=0XHEG&#eF8G&%9k?*NZR4?!rEP+iFX z?w3M1@fDY6)b60_6VT(mSLWr)^Xdj~e}Lnz6N{3Hwk|I$U=IyZ$mgKRjr|Rn?@lkv ze&AmIR(aS*pN_J=-$P$xmrIqngU_jcv81&`C1D@eU}z+m?nx56VcLzTC;IKEcWaxF zHU;8m%8XeHxE64I{VPoQIlTf|$S_FQ1EOD7MPI>oeXoa`k98{`sefuJX=fgb zb{$Yf6#jC>e^+sq-bCN$Jl*g0YqtL=n*5k%Ba_@x!!H)x%{Ys zaGGD$W_5ja3M|i~rJB3_Qhz>x(R*ZqfiquG>2JNn6@A&sVJ@Q&kLn-V=`=C<;c$O{ ze<*|Jg-Sc@07lWuRu=!hJhr4bxmd+%dX01hlWeu+Vky&PeZQt>tIje)Py7-c7idmQ zu5Ruv4SM^ezo9S&&lKJE(2N`uLs> z=Qw3#*W!9{Wsh+g2f~dp*Lm^`n6I-DlSVNrP>8RK{cq2t;%-0_JG|MPr_|4#BK*ok zayjxy`BLxHwC%%7cVSN-4xz%HUiOX;GPVF0Hf#%6YHS4s-{@Ypm0rk>7v2-P3p-#q zv(-?TiQExX^UKTo5y-H5fC^Tp^Q|?!+*$11Ig4Ge?odh z?HsBiGb^jCjkI$1!eCIAGn?&yI9Yr38M7LQ3a{6DqAU5Ch~@w7KG^t32R5~pIy@jk zSW8k^%50`^&FFibh;2;C+tPCdwu;(XT0%4AhJJE;igOqhb53t9VEX{!3rQ7IgSg*( zdl$Kl1$OzSUfQOf8q1nWFg^LegQF?#u>QN_^@Mf+|Bz(MFQ3z^U_mZ{)cAEp8gE7M zIN}3CrII4jpj()gYjl8ywCU+P>*$B+AGXXs2GQ67-<;#;M);IO$&gGxQ12Z@6c7lK zH;PV;oX}&I=myG~YUU`h?rYkAgZn0I!7z*qA>CREc`#*w^Bc3apIC1$De?O}YkL{K z^APcsbU9k?_f4Y*g1dc(D`urbcx`Ki0&*Q)px6*^!1l<6y(bJ}K-Z7y#U)!|<)FJT zRhXYwlX_ED6vRc-yrm2kJ(kArF{bbj5n^L*fjIoQvvJGr(c^RLUo-D7MKqH=Ffg=) zvk%CNRbhrmT-x0actY%7AIh!0H-rIbQ+j}4(|)X22z}BG_y}zTW_K`jLNp()9nszE z-ZkXDJ}{-BW6ki~l#(_>gu{Sk#L^oRq35PtDfV6JlXTy>B2Y7Z$}zKbTA{x0lleGZ zNyK9aELSb6QaV53OY%Gy%QT!oJiy%bYV^Jh?T31KLYP>id9XVKz zOGrPbJ%*sxFJvz&BJHgp)dfq$;W9K4g!wnH;vg#sO>6XoKX^4Z7;tW8AM7*byUlpr z^_QhH;4$He@;?ADein7fyk^D}8MoNT_7qr94Ibwz+hpBk2^+uEeAvFXk~vQL_YdEYoxh~(THoRphz$Yptp~^WAGySv zB8mVS3nrwm+8|5f`*<7h1txCzatLT2#Jzsm<6zbdLcjQ9f|pR4*QVeeuy2UuQ~F)o zRrodf@;kff97l<^5AlUPdUC~!B7%ifD>XCjVP=J;;_hS(^zL5G&85Ltfg%+Vz(kbt zV?$ILKoktvU5x_neL=<5W6(74$aE6gCCdn>GP*1_b)isdH=w)-0bbyVqvvN(tZ@3? z-jvVxn@!3~M^7<$biSBvd|4ow#9;YrVxsP_*0X)hiZl|&Tp6Kp225i4O@|Ob8m8Wd zJo(r!8p7Gz!C2Tg2?zzH#C2xc&R{1ot<%4LUq72i^+^1hBie!8Qkq7QB0cyEyslot zGf8zrVe!_ap=}rCj&LC-u;~jatFyUux8wxV)sbf@r=y0L0NNRsAtr75Rb$Y(`j33Jqz_QBqY5He*(-UK<&n>iaLcDAc(_tw+VId=5U#e@| zH_A|{!O<5p=_?TG0|MtxXw|swp>&)^^a26md*&>V|VEB7535iw;Sd`RN zDzrzIB}1SLIBF3PVG|&4U~P?@lM`M@J$_tjB)r&=jgTfmWl|_>96}B73owv1k?I|h z(0KXz(`#t-&jGOPoIg8MBXdO1uEzgf!IbQncF z$Zqj2UcoeW5eN(iqu_&GGR)G=Sb+=(Rakxp=MB^Zm%~;Cuay?mD)($|hi&XURE&RZ zl|MYZw)u8}t-lsHwhP3%#1|qU)LvQSaTCQSd?{mqvyAms=I`*g<51v%l@$VCCJ^)V zom0g<6l(V-Sb3R9jee{m+WA=%JO`YM|=+(Q-0i)=y`Kk_h$znX?#~n zmP<4G_WE*>X>Hopop}t-B~dv~Gmc^Zl$m&=P-5Pe3HUM_q}}eZRKEY6hOp0IfB7S? z7O@P@MjamiXnE>FH^`1Na8#yEz9VvOKDqzF;Ji$?jS=&?qSm}$avE;iCW9*j6(=L<{7h%dK0~bTKH9HkTMMkhU>Os(^QF#Myg2dRPrmN zaA(Y)yQ^ag0m{F}(5yl$ng)}qYcIdKD)FFRhe#6ZdDqIyqOG8Xsoc~3NS~dX1Il6d zA4$5z)btG~F~B0>?n{ZP9pV4yGwPeHt^MyD9(=w}7k?@xHw`u=Lz}Ub;6J~eO3<;0 zaA=Rn4Fr=;(#JWf0lF4Fao3Dt^i$7K-IcP|51RSX&ZC5^{jAWB?5EKjuL&PfU!aM< z-Jmw5_y{Q??r6Bslk*;MFZSn>ex8w00k;1}ms1_MdA_Hgsm~*ff2<*x9{)=(7lRM| zlivfmu{h}2C#udvLY2S-?sRQ)$|1W@N#8^u`CVtsbwoK?Gw>=}QYF;#xTn#9w;zCh zv6tJ+aXPknKibwy*vI#oV!2N@u-i)AEUY|TAW3-aV1bZDi$GdraGOg>*t#Ll=$_{;^@UlZvKzY;fY9Da*Xm9W5YMD>Fh?}pH zw+m;Nmjh1M;i{_vCc;Ox#Cr|U4gd?*PGd+CjHipwyGeY&?*EX!IOSq9t%w<(qTR`& z(cIel2u#UZKfcvmA->=h0I58#Zv*rpnzN#+WgEkcVDdoQs$@;XPX z;MEa}o_@$olk``INmQe4m}V>Hqipv7ss=zrW76<=8dAR(PAoL`Z!bH3{?I&)B!&4X z?$V_@iV4&NH%bF){5To-GeaBW z#rS6;uHjtL5rSn+|B)=`{U~sRBcy<0v_wgD{o0 z>r5*@Zp(nd;o>riPm`}nn_Zs0j9apotL%Qr=z%L7c(SkpT)ve9Ov+G@?r)s=~o~oqNI#c_qPHYYAlp>l&(Y zXX2}d6TfIxPC_SSOfxx6=PrO44<|M3JdU*=_I522SZ7E6p2qoq)({Lxt%1QEdxgu# zaNZue#(n^^pe;;%IB${)mGIdPvpnzKcXFmy)N&h!j6C%`M0LnMn?V+%yU?mh57+Oz zD@Z@yb~I8~(A>!oNguJ7@VWpb{Qe3bXv>{90WmRJQru@>~l*3dv0Dg$0$sMFne*WHL zqJPpF&`U&q|FxXQSu~V)9xN zi5>mWfS;WcoVx;u%!{r0`CQ}~620UAwObH8?Jss$-1b%|h9{gP<|vZ7Or0zmry z%j8_YX}nF6A$X%F#=rR`x;pMC8O;>mB?3l&e`(5+6_tLQjN5~lWo+?^VPb~657;um zXZ>Fmmo<;7a%+LzMyP^?r)Ryvn&V-gK$ZK^pEpBfT}L7_58xm!HaZVNz;OLpm|*)w zv%&ixsPTNfzXtgc?(@04zo}gBp>ID?2{J88>D6(qKlGgO$3HvzjIHzrX!YnAt6oK@qxXpfQbCB7^Squ`_KP9hNV+6`Am%1@An3vK9Vt zUU}`|#IZ8$yx9Enpsw}G(UT`KRCC>IzKsZeng*?|7Kv54^_#y_57ORItVo-Ka))s> zd?`t%Nm^M?egOf;6^AcFe|4$;5LQT#EiTf} zx?_iF*~m)R{Y@ld3b+L-3V#`=&{s;it5B!V;IpYDSel*H?ykjYk*e9$lceU;9AB?b zq#Yk4pFm6!tdZ!N5m=)EG=xJ6{u@wQsKRpmt09F%a*Y48`IIBR<2ukH%NCFvd@%{g{Bq*5fFhCwt0Qg6!q;aYt! zcE?UnYY0dNjacar>lRSM$)%C5VJ9oIn>cCVfv_OfhM1#1H{=9-Wd%%JN)AX^aJE!T z^!q*ZTHA|Fhrc2<@(K$F0N*u8+Sn*2#cF>wh&mrX;83F6fc8XZEYg)X4t6Xev+V_O z_Gr0IT2(fY+CQqR$RRo;i>p6q6u;99JQb2P>%xB3<{HhI&W5v98Bg7WV1U96ilBl@DDGzU^3X zTnM(434$~7^F-~<-RnJ z+s)bGp#{X?K0#(F)GJcWYBz=WrqU(e5S8P`TX>ik;YUHr%Obk*KH}YGm^MmYte56=ptkvA#|FhnkRt4zlXxW^Z zu*LXQs$&h3{9EC5#dvW|fk)w|;o4ZOa^;|s*^v1W2BO@jH=et=+QDTgpVra55KChO zJ^xtb>;96mCrea|D4!^ZMK&m`BcMgr%KGk~WVI<6@X)XjwNAL4238{#|M{f3`FSkE z^g5!r(9)jfwb5FfXx{4P?2|m}Q9#p!JJfmedyPAB9$o5ON+n%9onUuSgg?GzYIqAu z!gX#FLd1^3TDCG%9S$8OwS3rGFcV7kGEx`!vF(K{{dY~zS%XQXRs;t$$>CEV)H-c! zgmeAG&5EV&1FI`;^Ub;l`6MsbYRNre3S_>K%ts*LeU^TbLCIN*PiQ^ya2%@4>KK3M z+(a4KUR%r4`3kQaV|}ZH#5lmEPgnwsiYL#2Zs!TF)`${}YKe#wGLtW}umc{Qf{bet zPm9hpxYAW~GWDDfgBC%`fR$Wgdje-2h{yj6cj(|Y>2Lc=Jy$916T;qB8N!9f$o-sC z;5KE=SDslf_F`*`GrUu8-?4-m6MjK36am~h4Bry)$gggD_EoFVu*It*JiyC~&c5Q- z&}8S!()p`afWuy?Miu;1UtV~=`TBeV#_Syc2L*_?X(-GD%|Wv|fbBsokI_ntw=2*! zY%!35vtvX^5bP0$mBU<$+;(I>ywDC=e=t6l%GirP*Zc*cnhAr{5Kemr3Mv$(V6=fZ z5$juN%`$C|>?ig)$d*8$jSUT6fT0J$7$ZiYQ~AFLqMQN7f|!S-wn-m3*i(qnP(PH@!djD z%vHG7wf?fME6l{R;iC5w13xNZ>@c%shc66nnEGK|f{Fb^`{Q`Hq|&7G$5+Fu*Txcz&_LP(c4^D>7wq zK|w)4V)FCz^YLNUyMYL-dkWWiJsSWQQ?@zkLivl13ZCodDX-r-UcBrd52JX2zaSteJ z?}WoL{3-9aQvuVA6{3z4SXESHobNNZAa zv)(|PO{m@Mw*IuFG}%u}Wj1|pVTN~rTCIX5yna#UR-r!cYGLe-1`lm6{nlrzWSLZr z;WWn23BpkE?M0*4UU3KBEI>@i;-dsz^sa`9Mo%7M*FLlXJJQPOsbSeQ6JtMoQua$adGHDq~e8`+C&Dtc4ZEg+78?sfs<$c zDN?nz53Zh`7qsg) zUS5qD#IkoOfBHqJFbCr@KQ-ZrSKK%C^J8!8B9x~A%wO^uh$yYnEa+2A@7qPkLKod7 zNY+-|rkFetH&)L2oU$Q*qF_FxbnA5P!K2)>NCV0gM^QddZ7J-v_$y0M9w#`B_U9&L zbj>BKY^$g%Gm2VQ0oqg(+aki>WXkgImsJeeneT`;5xK3gy(p97mG8uwMy26t&v9ljU{Nxw_ymG& zy4|Oq`U@3(ab17TtOI!%SY?6j2pHHfM*TkGs_}||xZ+&eeu`@&;eO%^i2TE11CL#Q zsUM=jhP7oQZX)wthNr-uDvFj`=e9iNkZX859_FWHCN%}BcRzOy@j{N?&njk}0NsZr zwBx4}5a;{wut>txa`gOk-6r&5^fHBseK6+=ov~t)QY88S*g#ErnhNj|s*5C(KX!1& z)YsMNmw#KUhd{a**i4ktV8;>#ArSS|!M(JsiT01gz=PvkKH;#+yxW2Ey5|okevo{1 zLGhU;q0A4EdjvFL4$YR0VC8jFqJMiDvfr47!T}Sd$jF4%v zb5eVi7-xeu)$Y(}(BTymm#f+4Mr18r9ZZVz<{f8{v>kp6XHV$DRX1-Vj(RsK)eyiXL*sQdni}|Yg zd6M$Jo$edz>+_b&MCLOH2=uIJ2PJMZRT&oKMFBWg`I|VI1=HH%&k9iuruIYds6C{{gVR;KRja<2#mv$oz3#8@c=)>)!O?taR#iy2e&la?^M? zg*@XxUxq_(zSr5R$Q1DlDHVnpL;<9tgSyonT9yPod~@fOYj3-bLX!@}gBjuGpN2SA zWAgBvBU|w>4JSbLY?=2N)cdBsd)GeLe@te5ZsV^JwQ+EztGk+@fWVbM;MGdyd(6O8 zIXhDfQ~i6;ogjm6<3Qq)Zi{xXb$f^T;ERQ9PJ=cTg;ws5evYI7B``2Es<>%I=jEoU z)9$xA0w91H^D%FCV+}t=l*ylJ{aS_rSzO8IJHXfC&3H`o^je#l?X7H8I2l`fBco78 zGx9bQq)r{uZXikn^DCi8h!#hzzQb#umbDOfIPjo+s!8v;0r)K)8Ay_uA)+d1 z(Fi#dR$%z9}-^w74ZrQ$R!`4NZpAl?CxT^@EJF8GGc{ ziS*?^`IwO_c(-f%Frj2S>v`q4_OeE-v%xH3OfYIO$l(n)n!zGA3*e~9{+Fos*89&M z%j;jh7j%9{i<7l%Rd)X0BC5UnPW5o}45(lRTaf^ly|MQJ-e5=cgFj8DN#&h%3#8I* z;z9Vs1AT6ZPkWTy$cW*pAj!O?=wnu_OInTIPw0>z{bf&C7UFH028<+c#|Ks1e-p0y z=RNdh77wD&1J@YXjY$8AcWp~y7xy$2QUA2TzkM|4!y)LzuY%YU1jy~g1Doi!E%IH{ zo3!*!)4y@Z?5~b3_raZ7iwXtp8wG@nt_0pq?_yn|qx-gKaT{M1>z{*LYS{;O`3xkG z0g5UV-O^c5f1;AsRO-#a-VC>zq)uM{!&xDG*z$P~_}7EQGyy6fVZr_C_;hepu59F; zX-6z{+F?2|C&g#Q#Ou91n*j6U&t!vNAljBZ5MRWTN}*GJM=`a|MdCSfb3tpGh-K75 z5ImqWQ=4r+IG8}`xBMAeBAS@;CwOOoIP_B>PBrj)0&5!|9))@3%TKw9#i%o2v*PSe@2v5v$Z_6+geKN`Sug^oW{`i!mpxuKP$@eo_xm@HQ zy`KoQl~j#n=77-G_~y9cuUG>eN>fw}2PBb_)VV>x`MPcP{aFPnTiD+R;8jYBYsHdt zbymua3$B%&<^G=X?G+gYku={Z{{_}=^NY7EnC_&Yv;uEdOqJ&ML~Wmtc2)&*N2U8B zMcmJS0E}edX30N;QZ?EMeNPxSpEBF&9W zRB4WnIbqOR-*0)51*u4gHnSNZd~n+{k%d)udMShtwn^%y0SvC=ws>B$#ZS@wlF7A? z{;~xO!~4;hD4C%Su-*s{awT)}?)YgzDW#vF*EC?O z6UzGT!w-CrW1-nUT>VuQwNVSO1Qun@>8V@)k4g@VwI9U z{9#dASXp_AU92^)jP@&7R7_rgX&3mJ^7OZ=3=x{_C>Y;pue_X;iwl=k-cTZPn^`3K z=`{nNT4H`wxvLj+9*nLc%^&n6r!#nOwMZ1^mKg_f)3=!^pb7QTnR*8S8QM9W8vYS@ zK+ihQ$-#Y2fO9Pt2;d+Xzf7Sd^7W0>4FeH)R;_@~Ae2bCRH8YF>KMG)^>qN<-1&V(4l}4?? z+#%(SLg_cw_>;ME)Eiy>8N4Mm4cBpK=}BryR1y>6ZM=`;NgR#OupbeIzo#H?8MDG^ znjTF?a4Im_-bNZMNXv)yI4RwNgg?@D+m9PaeR;%2Mn-mwe)F>tssbVHG;RZYaJQ1W{#P&R*mxtCkyL zO~%fX8zJBvWcqDM6zr2IE9aLKacU`7>Ale-R`qXqeOBJ&dt6igTIg`&yYKa|FRnra zPKG)4i=1L@{WlXSv`Z5v{mp@Uz|7S-CGdkphe8;-hm=OILBVS(quO#8n8!f1A8Xsg z+4+db+vh9V&ZhJE-p)W1eFP*4ru-8?+X4!=%CPkgtc*{fJ|6IEgl=1?G7w=CVfGyp z@^CAed8v(*`sj9uN;{F_`X+2uJat@O+Y*A%ftc`uLZum^KmN@D()og--V{p5KWjw+Y!+etdZrav! ze0L@jjcmmOOZ9bbD-x})+=XlHCd_xZI=cZ@4hfVn?0dWDQ^e28pGDUeh!3tlOW_Ag zWpF~%3v$tw^?+aWh3;oIbD9TPyhYsdp}U31kzZfpkSfV zzSwXmyaatHD;uN)`uQEY`wY-I{qS&2fm%*yDe0+=dwFBKdl@lH55s#EGMFV4C(&%Q z7|3!g>fc+ci&evIP9!wbVtnQ@gq1Obl~WxH17MlGlT-60ogHJVTjh3z4{y$MeS0*W zP7EB{$F2C$C_w4GMvlgc1R7W531)5_K^np@JZ!f|qeL6sM;(TaP?6x3oVL16A;$O7|McJ5nTjVE;^_Ur zhxnaSSU+bW8aOhE`>t2Fdj#kfTDk8{Wt!jE`*34Y4mBZ>ncYsM^L@u}0C78{#}i+IvYe^7?fbBx#iNg z;IaKHGkh}0#1u2DaAMgzVJ9zdTCC8kn-`lZeX{=^v zC^CI_ZLwUbFh4&iG#q$dTvHAR{$x$I_>Kb7V><+EV9U)@4qJB{qgqPOWu|op0;KcW zU#hcEK^)`R7<_`q`VJVJH>-4pA^i?x;pjr80%|v6W!d{o<^?&bxOGp;bA?dc3-j|X z;Tzyx>?YO@_lQ2!cnd;9=^A?4R3N{iHRTX->=f^#+yb`cqqk6GZYCscW=&HH!zA-w z#lE#@>1aSO)-hnFz`02uSR+0Cr0kINuO0eQx7{gJW7+Kl23Kz^>%HNlEo*EZkl%T_ zxR}aE<+9>Y+9Yd3wT;ElZmm4$M5oONNVN%6W%`DBSLNY#FpJY>#BI2XeV_A@_hz^L zHOoJXIQPR&B8V{t|CJtDU1W0oSYra5jyROoy`1Qr1Bh$drRoM*0uw1y9k6F2UmU)K zQaNNp#wWLBmsVChv$l?pSxN`uhe%~RQ;ATG5O_x2;Cw&8%mLcIN7yqspthy?-KWUK zSH3PT>!*6YK?+hGRnU`+!)00b&eX@NSYIu;tHPt!^; zfU>BqfYHGERQs?$Ro?b^n2|o8YP1zyWDjWbFq}JOer5W^>u#gYD2DQ@hmm+grkHtec(6 z>9@-&#u|~#ZxP7N8QPH6zEa*kvtJhvxi2?`{5|lB`=OJ3bm(7pcOO`C%(JAib4dOL z*Dm=-N4;Z!`*WDj^fw9tK7T#d5Bh$x7_ed(P+}ab{U%6 zRhWrWuyP!GS%*eV;#GYKRHFSCBib2i~;rO0OFnuUzO*qh5DY3}2NglGp`J_jH-7vxA> zT>MfhnEwttj3;nCns(-0Es(>zf#9pYY@O7=-y~L=bBob5T`KG|vwv}sc#(QN%5sSO zVLe5L$9h)!n?#TzR?n0J|M(+~uj0LGK)%!dYjvdBA9Pg$UmtTuE%m;in&j%LEEotQaGTEpB5yDw;m+Kj(c?=^!CTg}G1XkGRX5EYpDS~+ zyrnyTdfiSWCrBktN<2xY=ECg%ZGa!_9G0Y5brsDv(qBVzuq|s*;QK}XbRjQ3o$LUE ztRBj?{E3^wTom0m6|W```ttSC@7oV=UK^ggp)uVLKPu0n$umVYCvdZ6J5B0tBzuJ6 z$}<1SD43ZjB~9w2DDMod&MEbZk=LF27J$5Al!*K`mX0 zG&tY@%MhO~be{Z}1cR&!7tVF~pO@3X(6C=bNGNuwAqlwsB>y$-lLx166_{3Vd9ars$a$`= zWT6E8{QL&Xo12?66wr2z^!0HVvm_Ra;5zZJrmQ`P=F>)54zwd26SV#jQ+y;1t5|SF z!%PTWoSn4}tWi#Yk(!H3;Pzc^@&1IC=yXLTz{ldSG)U?U7ss5x91c=87gttxuxF0B zNK{|Fy~{z#RHvMZwQvVH$3Pea*3TDG1|YpLj5J8dkgm?*nR_>9=NB&3(5cWPVh6;@ z+}-Im-&tELeg~HzXvhNTN5Fl$f!*Qr#hK*s33RSmN5${ELr30~-rt%aa=m7=Jx2qZ z3s4D;JfFUOJ_TiFaXRy^95j9BVw^b5AO^*3Mq)4Ew~IYnjXZIq2ga7W$8jLCf~4N! z&*o;v!4=Aq#`zi+zT7tB{Gg&oc*nnF!B&Tc;(6Pl9}W zAYgF-w8GiNXG-!32vCN2t?h876)_=74_a~~`?}qJB?K+w;HTV;40-Rymu%Af%RqaF zRMGEhpX!4(mpS#_g`}xkK+)UsvrLY1cdLrh3TAmtdk>SMjJ@cnz}pco(w)MGhp=8I zQK6+UIG9aA1WX5aDKDb!`6^=;XT1k~y^of|QXbo^<7_!MTC0dOrGuW-`!n;~*%D2E z8Qybc@7}x}cg9QILkxV^I=|ixkuuSA<4)Nk;3 zPeoKk&VFNJhr|4#FGTex629I%)dQ%3-QN=Y742;w|F@Cxa#k38L*QI-zJHNi%+11N zstmI62EIlRyeFW%VEjMk)*i^}z-XzCQ`PpcRe$eD5 zgG2FKg3hzfz|f=0JUJH*oiq7!*;#G(+D(S{i#E3H8_HgFQIDkY#a$O`$I%4Z*q`1) z6+wM`oULV~L20r~d7q+lUa|&EzD0n=^z?)Q26`{yOX7%^(UDYaQE-XclO&Db)0sP` zU?5riILDr#2L9gd<(_8Z4?huF)Qz0Kq8hC*bbOcx6Z4(^v4>ld&r?xJrJ8o0N?PR| z4h>e9;}zAo2_-)I#q!MkRZA+iy|(!b#=|i2OS;4yQ;)&jp7*;}BMHSLP6R!9zf;pj zV8>G*O}tCqBT0L@TN#DmE#<7JxKnSpPu`v94edh(u;$@8Y!!Gys#URn?|(@Ldk(KC zt){AdbHuBF^W%itpW{T{JFN?U+U8t$kV7_Edj;m`y;2(ZE?HgFm)yF+#_qkZK6`la zcSr+uj7WtUkCyjbsV5?nh6|1mhNZV*zEmejMq^lCUdt}6_5GAduiF9Wf(GiM7kv(3 z@brT#f9K_bNE~tdsGTiBoDMM!`L;qIHOJhUBY2>C0*8i6*XP=te8sOe{3W>53W^k? z+>4QbqRdsT3`D}Pb)NYt0g8a`fo;9Xm{t^5&mNu2d<#3mZFF~$*Ckn1?r{cA8yH-s zBoe*8eZD?98Kv%Z*|)Se;}|v!uLxy$Dz0n#PEJM575v?GRK^*NL*{Ka+RE}W7(z{B zXCS5s@GlMEHVy!k2$-GgU+wMqR_29N$zu>y5#eco86YtD=z$R3YVxDnP7ypbHb3{; z`wT!&0^15tf|_e2T8x!-_t$Wf$cSw!=q5QkYc$Q-eO_gX9Ipi_@|P}`dsuN7>nr!X zv~M^2*woE+-*mafKBnM@@YwYn7Tw5+rC za>1$1AB1H9!&G<|st1gA+0~!SAN6`<(t{PJ#Qm>B>M5Szy^nwi{R3jg5?bht>1%>F zhlvOJFNkK~J~e38HZ(W84mahBnCJik!?j20y6c@Sz z*x3*0=PgeN;!$keoCUQ~0U%3^@dlP1eYBMuwhI&tt zFm|WjG_$o1LRq)4G|F1~eo{4!`kKaKgJ%luYwU^?z4N%_WY1rzrad&b%}5>w*uR=0 z_XcJML6EWM6_t?^(Z2_1UHv*YB(mX=Lv_=Ke~ zY|X2GjRMThA1JSki{CIq0~`Q=DE&$+&{c$K=Fsa^PPrA1SJoAFIK7eDyY8|ne=JV( z6?i_OP=wy*LMXZ#&Gc}BmQMj?mHQKoxDJw~94;plD+hK*%IK+nS0iyNYe`eLL;hd8 z2Sg0FUlEo{?n3IeZ07IYxHTk?rkYm){FAPNlBSP86;4?V0Ye zm65vW__d_38tC4d-$qw;#7GBcMM^EviTF8^nX|31&IL0L@Sdj+{UIiZWB zBK&c5ccs%Ib~W{712UWqp-j+g?8IWiDdZ2RUh~4^z^8|_@pIsc1EkFOQ<&m(e31su zwm{cxY;Pgkdr^mDZf?1%ul+cs!MHWltZG%)n{a;!A|vR3;=6iq+(CqVYi1hwGLC}1y}0}wC&kX&+IcTZ=80AP;_tD zUICJXZUtes@0%i;qNzw^rrUcM?Fz_(9e%<=Zr6-GEkyV$n?eD`8;Q@?1eWgD89lH2 z7+a46aq4cbjh-)!o_C%f-X?s3=H?U2<(YfYs~;~l=L9~@^_((AS@Pq*#w7Rm@c4r< z`sHr*-GEsb=yba!`4NH;g#odVJ!jWpll`NsR#p<4!fUF$ky&SUzi zW&ZT=sN-16m~8ueC1v*OC!*Mj(wNLoW-|ojce>HP!Pb8_)3ro)Q-ocoLt06Yr19ex zqKoYMfB#94ncD6FbE5GH2oilO`Ebq%OYO1_5&QaQ%V#ypoLNCO5k`qcUI){S{fm4* z$TMm(r1Zz3EJcnmtP^U$57YL^vopbWZfLzZS{|JPiv{W4X$8{868(P-&tl@)??oMy z?D3ZAKhL0e;-3YmU)5eT@cnDb4)>=Kr(+hY$;U`$hz7 z-ZRPB?95CpXoiGL=4%nnWDm_#77611x}#N7OY>i&Q=SBtd!VoTHwQ--=AdZGsz-GIpRN~2uY*MT#in;vzwZg2e4lTgzspDb~f#^`qo z8l2-I5R@hz*a!R}qRx70!#~pl^2D)B)n7pFCs(zBR`ydGUPBb!G0$x{DaSG0L^uQs z@9Q7Wb?`GPy-()Q;wh;lOY6)^^CI8hp?B%eSl-3}=)x)D%mI6xTEx6qSn^q9c^u3? z$EM+OSJ`aR}2PRbci zbId^%GXhU$(0tFjoNrRB__{9d~wp?$& z{IIM~12qH5El+7ptp?~o`K_)kOf7Ant2I*+G(9h7G&B<#l@jN~Ow=3v1=PyVk=^Rz zj^V&KW{;u6>01x@FNxX-=Jp;us&r(nVS9>fs&Vnl!l`?*o2Hv3+g zt|GL9V-&|bNg~J7X7upk*jetXAtO!aNtF-@O|FJJnSi31Ok^c1JShB)p;Fc#O=xe} zX93>!$9}a<^K@5r&~XAKjt1#~AFNkDPJ|~9=$vhXM%upp)1j7>EsYQ8N1vcf!)A$} z-DjmC9TVnWOK8KJ@_}yi8z=b49MY!Y9w?Oe1nj1MX3hc`9Fj@xXe$H#g_wy)JR>#vQ*q6fPHK0d-y8dai%xSKTu{THoE+#zzhz%?!$a9f|a$B48wALw~y5p-y2_=%wEc?tquq%*J@@T<@G2lwmDT$K`7=LIKDp5 zdp^(AFV~&VK#+fVap3?0kAP>Bm6Yy%ji?L2dnToWzgR`u%aA(kNJ20+h7>^wn$fGW zJ+S)W&q|6<8}MOYWKf6JvWv%RYiR))G{Dg?ROWfU6_hXd>PJi(v8{Cr7l($xT=GKv zQG#EC0f4Kqss=jPZ5P7q(j4x;Wcy)*TPqJ6qiNC3b@Jb$g-O#$63f{{nSf?0+EBMo)p`r70W^#aVZ2apu+!~y2a zvDl|0Dhx*BRiQ-SQxQ8_#;Wv-AJyfmrQlUb?$j$MvkE72N5FLk8a`#;!aGq(9|clH=~Hgsy}TY*m)>ox{NjBoU*j%bUbjkqOP z$`J}dTfXM315id?fk+LF$l1aZj1|amiHeS1ien&bB(DLt@%4{OyFp*=X+ulmRB=WU zn`kkEhB+0w3feNPgk6`Wh6507esXtga&HsiP0TA<(;VYexTC#RQfj_)@!!oGuD?r- zHzGjhbCoHwp3a<5V(VUDa_*I1gFgPf35dUmRDP`&q895lHM8Bs?5ZcqYRvEKLD_g2=ZAoh_`A z?!ypW1nX&w9*kc!B>}AE3Fz7+skeg}CZ_H;t{m-9?B!P$l=W|AKvMOvn2rI#vA~=$--u?xl+e zothg@q?h)88l-92M~#hUTO23ePgCKBF?>>gVH*B7W3Hz6>{!A#qG{@z76{X5zO+{m&^9HYpama3L3yUp+k7g2kB){^J#8r5l=E-lZS`> z=>C3r?gpG`V54p{TSg7_In-mzMrvtzQB0eXnAOF~Yz_yq_syWZ_;?(1FnAKC9M6rL zZ#6Z~7xFP_XA`ra7aj4w>30SytS!3HNqC; zgEl_c@ui++?u8fv)0Z^d@44{vErv8hbppz<2A!id+W)reKG$L+@lcg(b1jC{fLs!M z;*c7bAg~eP*Vy>aEug>6EOq5yCM+n&$JAcw=RuWgwy9=gAl%i}bpg-KMisH4wWVdN z#DQ(V0(Dx5%NW(@*?*}bJ5ZZKuT04wozSc@xJjC*o4`?K=x~13|A?{+4g$46-dVza z4k=BUOY~_u;Q5K{xjXwYHTPHJC_Udy-I?R`A^cZ{QozBwyR#_LkY?)~XY<9XnPM}> zkvB2Do>uUwT=d5=eI_T7!@u*Hn^>Aba-6b#5($U(o--OjDsbu_P6fqqg~eyHp@su) zm$}HEuj~5W%ktUVF&0D=ngu?9pWrko0=7h`zl3Itn>4Wh#HX4?Qz>EuAuk-Wxc*)6P zVk4;Cf9*aYF443w2?V=S!e?ae+^4}9URdGOsLFJlhJ+xf!yJM4l-qJm?~H~v z%WIv|uUg2=TK~1!OQdPP%d9+pJWcwhzzo(L!JFI0w7&*F6&1QRqpDCicXPlatEl{m z*@_(fxD7X)+C1C2g^l`Gx1g*Xg5`a6XUbgR^tiR#5;{mdb^j>j2Vc=2DkEiNdI;JL(bhzkytYAL^A#d|^hI!iY?l zY~X}t=djY-MnJo)L}tRS%cUCLOQ}r6u2Y}G{E!7hoN#)n@#!Ft z!wNzZ9^oPzAwdT0zZ#qRoHHr+7iO))txYvTP+u#r>WUbzV+o$;$~DI8Jo4tXq_Bee zckoERb@C6x#vFxU909a(K;k!Q2tGU?DfMrkzSQ0+zJk7z!nOXUkJ>%*(q(Z9`<`|S2C0sYtSR;m zUFUAU;O!^(rZ^Iqu@7_YiUr8Js)UFc4QO*(*D{U9j)#bq7jUys@Ftki2i)$RKX@kmh8Xh)-WRoH zfNDY527Tu3NBHf6O~clOoE)_%3&-uhf5%U#HQPgCPasb2$xjDGu|O8!Ui`6^UmdF< zB)^3lVXX-xaLz+?aZ2#WAB)W^t&Bak$(BtH;pY+fGJ)cX0}9sU(%lSl$fexZB{xcM z?8Qv}{hO5)N?b(K;D7RXvx`Gtcz_lZlIXn^7u3-W{8#*5!|EL;i9wub)9GY zU615%lP59@f2Ser!5dZGFz~$&3%`J{EkMC({S#GaX+pED*vf4JNvG0zhhenN%HIoj@LP%!3(rr;;*;w0_gW%)KrP!vxm(*bEZZtk^HZ@U6^Q)@R*BEU=45 zNhgrrkA9GSC0X6nVJQ3}S+@{R%+4NuybQ~bL7UJns=f~A?>smZ=o~hp@N*~HFqE0R zF{h%P-+}v6mhvWw>0>q=+DEShj>+~-Pvbdu&#O1|w;-IcsG}s3{FMp_iWLx#>HU0X z*45myZv$EzMx6q<#=Gp_HT`o@{K@m6y6^55&Pv0DG2~&$#oGy!e#Z*ov`zE-TDDO1 zMgD_YUl?v?S{5_ThSOH`$m=3I&y_ph%=`>&d=&cKBM!h#>lkPlyKe9jkRMnS6g-1M z{CxQXMm$53*R~*&v;m8opTE#i#VRk37DXKueRu-TYCZ0EWo(YKDF51ms6QB80KKzb zzi29*#84;>uanC0FjYTmx=y&yB&MQuj?j0v1t}GYZ)>7*o*t*S|Km%l~3y(+o(@_Y=czZRe4TVAC0vDOXpa{@4=2 zZ(d(Jt4H>3*v#!u)k_h6Z+v>2XBtxM>H&lDRUFS=M-yHot!Vs zgXMS9QuH$KAlS-Aj}wAYw+cHSVoI-Lu3%D8{A0M~3w}H=sEgqDTdFk#( z3MQ`;_5@u|`m)u9zJjS$oKdeP_b_8C5@y#cz`ES+CvW6Q5MhQ;OQ*ikTjBsn1 zJH4L{y)`momZY#uikkfZ(CZ5y=KUGmN7> z>~`So6GJYmRvA_k2y`T%43$cO#nMVf)b>Q%Fbdm%^=a6qH-e#kb2)cmA(bV)w6{&2C2H2+_DxX1J2BKNM#jpRi&u7fZa}?YeP~Z}H0Wu1FQ0AE zXW5qcud^D*Ak_*d;xHn+3^wvi8>KjoRMkXYI~7GW+qd!F!awtiS^h-!I`whqHT~@j zT`>wxS~pWt?xn7SgSa?O*es0IA*umqUp+#y3=p^L)Eqd@n{L8`Hx@V}o5AaV!32&A znCKrxK<8;{x-z6XW?nYrM2G3T{ZG$H*im16CwDm$kMcc;MAKc5FCmhBlkzXpq3idU ztofM4AtS0V=0A+4lLdywb<+&48T0EjZR>YF>yIjv;6d_6i_ab;)u2DWO`9|z)-4?^4ZyR>Hx^h}) zHc{*GxeMHH%SC^xbh>uKT+8E1xV9QSh5*|2^_W*M82JZFd7_q;bDMGX9pJlc3+gH3XmONNs!H7zu?B8GZA z^UAIksqp3M$_ennMJLgrBL;WgJ~mHEV2h|^_?v8qk8XE~K8uRH0*GvNTn(-l$ zD9%fifH*1bfnXmbq${pn9h&tYpy(6V4;X#i1j!KV=$z8CB6W(y`O3rPag>y7lq_I` z46aQVlO|KX8fZ1g5VtTQR8>pgKLXESs>4W<c^*sP9*=H@B2nbomf^lMf*(apPZc3wDF+ zJY<=1KNe=6%RtqRUCcjU3b+I>$G_{ICQ^pwYj@SjB)Ok&vP%w)ob z{;w+F-{m#4h92wH|9X?$Vf=?np{AjMogMk<&>hlP;ANYp_K)r7@!|%|!EN8&*2;wM zDA-c~Mbzr-%PZg<{9vGXc*oeIo!3X~1ZHKINnKzPf55;I(p5|Y#54`5%A6JiyQ&MT zN{;{^2_#%KFAv!adK zsvWU$F@{lZ#R3&+zZ|i%G$Qmu=yDWG41+a=Bd=WWCof5^DiI^_5LkxD$6~kbHJsy- zoO3fiO%%BGXGy_+ZGdEN#5c*lS2t*=B33i)UwRs1sN@CHQPTQn^@@zXjpe>RGk-lH zb=Mm!{E{v5sbQUH@~OOSjK|rTFleFinT_oSYr0QX6G~J;4(~kYOS`&X6gl&`ewklN2f&@sWseIIgZT8-cNzF z3Ooi}<)tlddndFLb8ue!5RrGUJ8sDQ^ST4{{K03~q3S7?c$K-b)eU8*5*4iYo32RS z^KZoGP+qc9lxUEQpPnOBFFk+%R#l1X+w`B1Y@#C6#wS_2YF=(!8W07s{dg3+3UEiz zmZSkf)9*aDYzO>6iq~AZxf;)2_Rimh{kv#ibTM_O+hy<R3x9$Ah3M26b<2 zZo~+&A9`QA3-Cl;(iA%&FLPa7*2HY@{&79{?Hwf zotHmDc^yH;Xu=uYrcV8v1TCxlG(*d|%ozp-)U=H3K&bQ@Vlp5L*UT2>mfz*qX!nj& z%wv^CO@S#bu32D-woThW-Nf+iuFBevU$Uy==;^da=xdLhS}b>;6$qw2w*W>d?+UY* z+ueRDIhfrS8Jk5|+8Y`5KEq}Sr67*YFq9-8g z4j3XHF0~3H*lyq+V>-?Hhknr-ZU)AijWQl{X<46Sd}n2FtKMqoz9Y`V-ed~=@+D(g z>uui9N^?40leIGvzMaMqCH;C$?N`nb+TV=%3zaJ&tUEZxK?w5tKjG!xM^)p?8cRtK z+xe?|o4>ez(q5)KYvvpJMsrmcTRER6bVq^zn$lDCI1|=ju3^FqJ(Ar(ergm{ex3X& z%iKgbwX>j^%C~}~lxorgX7*CBlA|T<($m~Zb{;NfPcvRBBEy&dg20aUMlYsd!&)ZT%A*hN9{~;Y1voPw1aE_(SY39`S!#fJRwL9Xe6pb@7ucY$SxI>dt4G zF>puyvBj6o1&QB9US0!bTL`x3vQ#9LV{&Xr?LFi>O=Wd;d^JgfhUF^_a&xccNzyX& z64=SxU27ld-FbmDf~R~I3;QxmbMY`kab=X1H$rHAr|$N0p>sJL#-w&fi%>b)ixYO~ zB~Pf5Pep&%FbkBLXhS$aYR;S*EqKd4p3=r>o~}3JfVF6{H#!2>(RUB*E|(#U zja?MhN#cZw$d2}QhIkp#UcWN?;#%Ayqv47DR2besrqP!(dqOPL*1B0Gq#K%e4rHff z->-S~O{pPeZwOt^MS8=sey5x3yLQ5KiztwWrWHUd?8a!6!_hXUY2s!H#&0)t#H?7s z{jtOeAA9L@m~(C{vSO^({w!)>V~9`plmQFrLXBJ!qg&86x3I61lmVc>ElUKA2!tu`#_(N$oIh#LvV>VJ z)U(hQ$X$&nWjT*$q~i2S>zkqGI8-3G#DfH;ykx7mI^0>aJs$OBn4;t{c?-qgQulM(c5ekvwVa(Ad-DcJ|5Z-km7bo58m5b5jN38N0~Kz_mfpyl4T~6_rM| zhG>>~CnkrKBzXaT4Td|H961YyuQDiVlNN2P`2$THo%%c-g6JjwVBo!!H*~ne8~chN zVjM~RJw@k*I+lN6;hJW4%t>8fn9?!dG;$(7D@wU~t**OJsyyEqI53@fKNog;Es0aO zmPXh&cXW6Ia%j`7cnORdIRaxf^0if56ieW5x>mc0q?XxePf$f)$}!lrRIQxU~p zuu^840K=p*wBUlf;{6$NiDGmOJ7g-7^x@{nFxL0`ar>+MYyE;K14Aqi+;?NbuzW5+ zrU&%;$z}v%|Co_v>AjLui|ytTztIJCvs(BoX{j(!4KZF8zR10Z#8diI6*;fRt7wtZV;~{O?Ug)D)EIXCxi%p|2Aif>_1V(s03;K2z_xO|?~}+I z{&hMhybDSJFzRae_&3gm3tcG=>@B`JTuVyIgsec#mh-b!q;#wp@XK=fNuYxz((#w( z+MPXJT?hPo_D+Vyh{GsDNyHFTbW@$}>_9X5I+M)HqF+H&)@8+?{$k2k6#0CvETX*0 zy&BBL37d-fCT8N9sRi?zIO+fg#6#&B76seuyjXzO1-+i&Xe~yUO+|%z2Zlu@S>Wpr+O_vcLOBwZPDHO zv_bos4~#~;p?A?a3M7WOtzuTV)(T5Q-KIVO&uR7&U`eSZ+&HW_|G6KaYiDa4T zgqnU~a}Xx&$J*@88f|`Y^CT_ONo>j=0q<{5Rybvmreeb+|8p5wPPn|=$T*fHXSg0U^3bdsz9o3sCB-u|y3XMG8~hMKKOL@cL>g`{ecMcdK0we87Y z*<*V^_clh4&8H95gcA>}ACI#J+QWLf`Qra+oHXLs^us3Ve0a?tcX5Fl^|Ek!jGm#d zxM~5T4X_EtM&WUAcy{2JB6t{nb~A(Q4pLi;b#u4aD}wKqbV#M>ilVB@48z| z8}iP<3?S(a2n^fX`MvFCar%+~nbhd>-lxE_CdH`D(lvbZn^;VT%@xnF_1*q$emq$U z0RU&gb>_sXOY0emAIC?h5Ugw9#h3nI&bIeoz~%3&Juo;2_aum!T!!Rfe1G|mI;E2_ zis|Rqxtr0LFZ)ULQQ8AgQ5y4bZC8Mo#!L;W9aLq$gV-|Uy1H;N`rqohoQxo#vOq=Y zzoM%C-0rSZbttK2+*+);73YQvO_;sv;dOC0|M499Re}`OI~8(76k*k8qcE`kbBxuu zvC3WGpAYneDPxJqPApYYoiDT+Cs&bHu< zql=@>T0<%h5ri@$RegF6hr}DA1m&5e;AkVhiLi-N+oh=jDloV8yQ!jg2{(4&D|UBx zcXP9dbDVsgBpBI8#O#JKk6Y&)`vF3&%PbuZ&RPcm912N?X!}w1ov0MFrUTyXE z_V&)s*MM}PJlpgcYVYaaWK2nyIxp@Y|IH(ALBSU=)q~5DI8ui`s`?(nZF!#ZZn42eoyt-W<`# zvrX{nJu#a&0e1%+@M-P~?q@i1l8z!3&y7<&L;fFH_9>GM)67@2u|nLS5J%Pa%r8G= zE1ovpf>mlW0eFbOxut$;Drqk~V55S*7@U|dBvULlFmw=~%e%<0!FPP3GRrwsgu(dP zbUNQA&4wtHPO#V^n?HZNLGrhN!H`AEtf@su@*qr6vB2^q6pT6rJ|$&Ny2sO=+;)=0@C;ha!KR-j0iI1 zc)hjfZRt18(!1dNb5n0nKFtmvWGaOF_qqeG6^JX-`IP|Cm%$-54&6x+&b!dIhPM3U z;(%4{=N1U;2Y1BXj9kO<>*-xG_#LhQEki#7fd9^wUA5rh{HB5u{gc{`xyCO{MJ&ph z_lL8a+d+32AC_3Hik6E_YYf!~nU>Q}gJp5cJ-KhKk}~XF0$n?jLoyrx{v<+(ONmOt zSoxg8JOWA}26E$z{{DV2d1E9lKK{m z7h1COD}yPiD)iKi9UOgA#lmePHP9+|fz*Yb4Uds|gl)}q*N{CUTc#S_DO(*UV$RI) zLem{@5M$5WkfXkFVS`EWX;Z?iU$9^g=9kvL)B{0la;|7+JLt`ceANi-@{_7v`ZB(k zy*`&B4YK`R`Ztj=G_^cmHF7I=>5ERR_mQgJ6weiB<2=J8w07#n7&aW@Q9`x!fKhzU>5uKW zP&}V@RD|B5kvS*7ORG966NUb20h0jz{spF4*=dYYJsrZt{q@~18n7Y(gk6_(^45u9 z^`y`TQ}G=D21g&o+_f=#3D1ep}1~;2w_dV!{k01`}v8imUWZ# z76)-up_^uEVJ@S;*wAIfhle>iaX^OBqCx+6q7O_Vl3jzQY@A`kPi;DxGHfCRrl5wm z+v4(qW)VIDdXD8`zQrXAAK%n!*7%==Sg|R?e(7K8K2`qFojM4`4n05bh+VrB2sH#u zU6$<~s?XdE-WsVNuBNI<5|`%sRhgyYPn{21?erMhfO+RLO0mS~g(DyBs?=z;i8{p4 zMkj*B=hl(q%4u^^q_zRJfDXci>~r#E%DpI_!kC&>0x9nfqcIT4E9% zRB33gV0zecHH)xt1|f=9Fe%rq793s!WGfMhM&CSx}C;agS%; z6X?)ZTRYX2m@=l8i8Yrg4qoQ7=ISx_n;#~4#=hg1ucN)!Qt5Fc9*|(0QijQVOLYRH zoWt*Au~NiEqlXR?V9d-8ab%^l&Yw#_<@z$1`1C1{z8Cu$NNorKMP*!&AXnX=6Kk2T2|-lgc9MxSP%MskW}YF6qN_%{&-FEOgv@$n(PW=gE; zaug}`V=ms_QDWO_ViMG5EtOdG)U7?^ohuo=eq!+p<9e~ifdFf9wwtv+Y9EtzG)VNf^um4s z3atv0lIy3;Vr?&ZFcSQb9xd0Rn5j4DXz5J3Zu1-2t+pRU$1vXItK%}hb@J#Z zB?dZtETuirbb)bok1iXLT;8X?9+l{Ot+xZjyvwS;eohJj&lu^fzzJX z$#-z*083XSPDgK|Q-PWu`V1Ji|3G3jc&@$&NM`UFYI~}PEXtw9pLnWAdtpH%qC(AW6(01_GCX3_u zf&8yWl81uuD!~X_ z{r8Ee)AUxyXcKJYj%Ii(((6H<=|P3@^}wpU36VK6a6Zt}X8tM{V-e42r};!!FHpJr zX?2$>K(kU1Qi3uYh;v2?*$kk6s)nF^ak@nEP)Mn(ESrEaQFjRcOH`&w^sG&acBQLn zw${l(f*wz(o<5l`-kHNg2HDo|OTfvc?MzeIEXJ9%-Q~DaSa9DuqAedq@2OKaB~Phi zV$pDt3@OCelRzP}ez2h)O19@%E<(l5GoM|=5b47Y&XM0dEmtD~u@ra%cze5j#JtC0F9 z#9b*oiSFG2V8Hb#_20D=Chw{u-mPN%Do{eoW4Qy-x zK|0QBWUUJO1LH_GK2N`3YohzaDy&(n-=Kyw<_*t7%xO~{uJOo-Oy={exR@_^7*Jjg%uG9*DXf7h20E*i* zCLKH{QYd>~vUF*l8fua9cSMKt|nb0_xW(yI6OZg8GIoiZacG937|I{Z=7- zV}j1_M!qwBSTRA&9B>i4lwKkRxjVmTEv~?l8lW2P_5@#O6d4_BSF9l)s@!z<`WAP0 zO{3rQa^3)J%U?T3kLa26Joa!uhB6jk49rAZ+i;uYYHDs&9TvQD>fwXlTfia8@!ozdUG}c;Ug) zFUa?4M>(d~D(dTVEF$QC9-V;G{2mwCHSX(VNJU1xtG=S&TIg4LWM@%LM8H`x_ zoghR;%2x?E6o36Ti;72`61c4?c8?KLW2goaQd!1^G@eyx`G5U9@dIVTA&<`v5Gz+z zRrO(m779@@WiJ5923@htABqP33tbS}5AbLJ=;>=)*uJ~5L3+xK71_qa;t?xgFei1M zuL>e_3zBpiFFy7r!Nd>=2|G|k75kPrx~&H_f;GBn))lQ-sc6e${&noqV7Bdp78K!H z7D6Xhu{f~kfcT+aZW5gjk=29$IQZ~A(TO7cwIVUDXUA$?SoW1j0`~7zen|F;d4`81 zmji)?$n(vOx*`lCUi9_ZnQzLm)3;uCXm5SEnexthF|@Iu@43%P<4XmgSOzAL?;sbq z@p$;z=^L9C^{>%0u(!2;Ll{7ag4PG7!a6?;$>wVnIb;Z~`q4(Us}XwzRpKdQg~J-oo5P`cci8CLnW}r>Q-K7 z5POzy`_C$`@stbBk7vrckzYEQi;-aeX=Ma-m-sS5&gKmO4v)3yhFcoV;(~TGyA1raPKNa zCYp_K22MptG#Jk>NNDh7yf%?C@}Kdpp)GqqZM@#fw3IKk$_&=m3n7@#rOLHzoiu^z ziK*2}7*kjLeS;Y=#sGc|oY`cGZFZDeB|krhk*?nXuauvZW1k_2&c!=3Ik>l?w7bS&fiK9# zWnk?%8M1CTen^wM@TN`NsP^)sk(HKEkuC^bw{k#J&-ByhV3JRJ%E{?7&E!oHT zXTXMJj;iXCOu%ws&ZvO*aK5tQ^fJY{$qy zQ5<`|#H493k$*B-T6Vi`g*4x$=fAvl2fzW}-mskb_YP2!yu=K4r~V^hG? zSo`B{>JgY;L|vmRU5osb82jQ7X6*6(dkvgEV)04~Yr;_Jox&)4?58UMD-0Ro&*^$Q9X6V3I<#e{2$Qrzqp-sqRiq@%VnkZ%S_Dgg@#NRg=yIreV`M( zv}zxvy5|)fbFwaVru#{q3hWaR2+9)XvTPFC&m)Rr(;SDl4DqKQTK~;f0$EC?l`+r<+QS!`cz`zN?)hQk)U z*xg|L0Sh1f>eO#%P;ljTm(4>!kqagGaQEKU-@(Rg%cVO9!JLtVd-=7r+_ z7I>6%0tWn6=s3!>v`7e6j87ns9zo3r9-hb+m(yTM^0H-U`@BUc%6eXmBj-W;=zH4x z)>6MJi~G1rl839jNf%dFy@-0nwvSRVGy55DCY_+E%gbWJQOvH&HLA@|ZCHI-Cy*5q zy|u~fen{u0_mmOa7Afy`Q!~RwDZly#k55IHIwC8X2aZP&Jau;n%&)whhl-MMjH}+oXQ~R?qadFO<(S|^M6_#XJCdU;$I9+g0>hN7~ zz1u<;+7FeNbKQp76KFQ~FQ2N%Zn4_hFq60Ai+?-nx6&7l7S60>Qsp^m&I3`;7Ngb^ zN&NoyfHXjq4VG9!%Bj?frFmK-DhRHzq+Ey25vb#LbcMy#)-&Q=+hX zb)|bcW=%4GIu=_}C}9QIv=yq^~w> zHzI#BB%b8)l}z;;1W$)}Yq|sJeWM;2g=tp8tge;-@wUB($17$=p{=LwWh?<4J3s^r zZjCSp{Q(!rs|E&$tkyrK{eVNtAxMdtdfSkh_|^3H@89Xc99-w`PCX?#(*&5Y6;T>K zS*Ua@1)B3r8(x7G&(zg+7S5X@vtK74DSycdhpwfgO1H8X41iH!eO=whm{%A-&{~4n z0^GW1(+t3-0TTc*N7-orm5V$4;aEl9Pps}ZpZmEhQ2D}d>01;PbkP@YnUv=FKuDO( zc%N>i%mg$oD;GsqDx81CD2#l0FNAtY6Tvf9Qz$F1NF8WZU`)mI$Fk4%G~^)0rtV3P z>-GAx$#aMC;~iBer2ljY21!73u6xWn*2#$ z`af%t_zR5n>8}KipZ>nVjtmPgm>g~>zs+cq+v|eQdr;Zgi|IH_``|t7JBU5GT#qDa5 z2oIi(;#(j;Ujo>nySqEkg@Se5Vhx928W#z^aQ6EEwUnjB3QoARII+OyZ0~h8=ERKW z0^}R=Al9oj?gKZzKmM^ilQe_$FyVnCc_CS!akug|WmBaMWata%s$|7ydA8_n6Ll+7 z0)IHC!_j=tWfn|5XlOugo+>q_X4ruJq}16c6la{rQ~pVVKu#gA@`(*glZ|BOsNZ^R z0m+fP6giiFM5=n1KJ7-Oc=si&tIyKrdJf{*1F@Ptq;!{G6$+)&h|T7LwKHWTg(R5X zUDW9xS?tU42n`i)Kw3#N0v^qNHG)XcC^QLwspTW zv8hplpeq-_`WNhEAaX?!&zaTs+Qz%BuIo+(wyftjvJ)HP_W&|BA@~BoQKaU}elnYR zd8)AT?wQqewm%47mcbgz)#t_0!(nfKPu^pjUqGP91~fr0Pp3XU|NdtFdCXLN0OF<2 zXAm(A5;K~ES5!A}cN1?xd@}gZHV}z{C1+RP@{xu8H7_&U`=u4oe+~d5yO?K>qp%TK zb(04Re^^{ru2!|xw`c7M%zp$Zj{1WY9cgf`oN3W_t!F(~Fu8HsTzTdn5P2AUYp2zV^06SBDh5j(K8}VjfYYCs~!D}cyDWUTi zP;U?BUkMpHd`qR^ki?^POJmr1S9DA#=%8uzVTtgNftuUCB!=xg#V?5{L0S7ABx4K; zX?jkxd_bai4ZLiOVJ1QwMQ$SJHKH%>sC?gRE5Tm}zGlqsC+>HMmISU_i2QpKw>6BD zmyL~X*{`X70^-I=GXPCC`{bDE8FU0n^iF#?(E9`g^^mtXSmUCArjj=g($+Tgi}{ez zr3AjJl)q`=8N^KiF%D@3Ya&w|%WTiR}A0%BU_z zP>H((D;gm1S9yMQbi9^*fez=+mnZwSiC9PS1KouPy9+pBZ~hvq(P9`Ce15((#F%g4 z%P*MUinMKtlMoopVw{kIFuPh1Sw&|wkVHSHo39}GCFB^I^AmsX*@4T)JyMB)FKrm8 zfYGgNSe&IaXNeaHF6=6r37(p3g;>--N{XwaECza*d6?)0eAhbjZ)8rh9>gDJM6lw< z*e%aBi#2|l>$8!0Lub!irs>Wy3OQ34)7hyutHP}8i9*$IW1me4BUPy>{X$?cI60%h zU-@Bd5ZwrRCH|Cd%HQ=cz%djPJ_0fWv(06@7on|iO6;7ShTB_Ys)Ks1pcD65Nv4tU zFo73E*i%?8O08|$RW?Ixvo8Cm=jCop&?wvm;BW==7Wm8gc#&P|KF>ShezZ49aiERQ z{FnrA=BTlhCZ2<+_IvC_&qx@cYBcT#oR@a;Mk-@}$@1Isf;L_3(U*UqrcM*qcTrCL}Fma0O=Sz+3QDPEkq|OTZe~{-x)>wlt5`E#$D_*=jpCZ&)Llx z-1|uPBmEJAm^V%6Jc^%DWgG1XM(X5kX!(x|;r7}vW%DgZgbyVNTN z8@l-n1ZQaNfMCuA_}#@H5Z16mD=fC|M=Tki40SOg)Y>ZVM>a=&MY=Tp_WHbwE0{`J*-`GK9_31B|`Gt`^^dx#CPbvwS^jK zgayU@4<2hK}X_JMx0ai=av`mauGkW^+WepZILd17q$AqBvD+oTdwYU zNPqFg_(UWLqOnh)Et_(1=Z#loS!ylr3@xlUx2tQ@53>d!!kXgw? z{ithd`h9>9un2Ql?5v_FMhg*# z#df>r%E&4mQ9)+X>HqJ){{S8adU~Fo+66r5lc!b74gpk6Sb2VUB3Ef*`C!o$$mRGs zQHPB_EoV4!5cPcRNrtn6mxHx+R!!$hXw$(84~>*om8v9HQax)ddDEsY4L#nq=DWXf zz)!bdxvSsAHu|ALGLhuJIY>`JPS$|e9<-$-A}8JwWbxVVz!@0x=%iG6Q#2$aVexi_ zZN+`j{@t!P60uAWt3{&9k{;tUY@!d>-lp0jH?rJFaHv*@ZijjEA8rOxF#Wh?QO{+Y z@eUYa8Q%W;+Q%?e?x;&lidp-Ex;J{`Rnw&D{c0Bb_f%cTQ>vDpNU*V9^YRPLqUXC} zM*}8HYeY|mH!dQrvC>VM!+v3qZ3LL`v$C@zl#G|1tlU5LMWbWREYb1p3!GHBkbZp} zquUfwO)@D6ffc}@LKv_u`=lO?9F%znE{x-o(ex#n%{Oxvmvbe?v;2F|&F@x7arPtG zj8y-mBjUgJTGh$RO!#JN%ppjGa^w^qwO4l`MjJGhfUI(PGUFJ9_n$Cb+DR4o0la~n z8Qd37J81?WF8UYd-)Ta>kv6x#eH4qb4Q;6a2RuM-+%B_dq4OS(WFP)vEFfZ})P7&3 zI&Y2CJP>^^uLXIGUc5Yl>De@=kyp#h!t~L}EWKvVXz0%wwfX7UI&X08(qN4qFXC0- z*gtdl^Xlj6RhHy+Lx%Oijn*K%sL0$Vq;dOYC_|(RR#_EEn{eu-q*Tq^oKmgC`Io<) zoMumq-qvZujlbo!QYbr@#w|7h39g;FD-fiDfEAXh73Zfgh~b5|x2Z%Kvbk4jUq_lA zi}!QVaJD*TKc=XCX`^oO@TY>(x4$0yy+6HYaY)Ifef)~@&c#EfmtyUY(iD@vT#2Y_ zFbLI**BgIW{VrzhL{}6t|GCt^zt#&`JLJ_cr#T*G_4OQwb3=s~!3_G%f#v9(PO%Wr zu23ZiL|#S6g8{*=DvzHRmsT7va1#2>MRzwh3;d%2medooDPe>q>W}*Tg5Ti5KP$2|tEUsbC$Ec zNBCCRetR3=0RJb8<7=^bK*K%G9cM)U_h$SA5m=8|_{Q3!y=i$SvIE>^b)c_Jk#NF2 zjcstrP2wAQgikpfWkf9&MM+pZwx_p4mNv0BENg@YYUyars+Ev z@+)?3Yf)01Sh*$Fsewt#Bk{D1o5}P+S0~D4;Jbu*9p&f7V$K2l5Wj@<@0s6!gZ)W| z!8T|w8xNW7N%xz@H~Q$gDqeo_QSh;Vx{2&hTR+EWM()cy!D~=I`xbZoGSYJ*BkDH^ z#|f6!*3U*YrcCJ558r4Wl8fLLz--MY0M=vBDG9m&=oV|aiKzNhiOsVlNaRZ6B1cTy zDrM{}(mOq`BhzZi@23){V(1fYC;*Cz{4=MEg?fkCT>xzw2#3OVR4^;;FE0-dtw4a( z|kcz>@}aXW+Oe{ zq^e0z-t6_2HT&x)CwY*V9tTR`X6rp>Wrx`EJ$%6%$n7BXtg`yT?0Nv2tCDPJ*Q1M- zQJ3b957k-ccB#y*rAH-E6ifJ+61ePwq_4r>9Sk+DNfou}Lm%$5c4mYBtnRa82L8}q z*Ofos4rv9T>^s7_xj9zf%J;_j8GXRk{PMUbBAJz)lY_gR0?%|fVp?ZRq+KHhqkT|Y z9<0bQ_l`=b)OB+kz(U|$B=da{5ER7r9sLPXd9-X;mAmI8aPwruqpidTygWU+3K?(0 z8_no9O!^geO=?=KELP%iZuGe{Nbfy935^9-8sPHsYA_|iaBiocRXq4Ty*z^>Mu^(N z^tNvqoQVL5K{{D2ls}~XT5%1AX)wIf9~659?Z1GGE$=Zt^1E5$_oy_iGf{sZIvEF( zmas;RJI0jbe$4fFRGgXIH+%`0$r2XgR7uO#&LRF6;QB%hpHq6Oie(g#`6#)2DbUuq zZ89JzHJtIHwbJnJ$<5pskHZ4L;mgExTf$?~nP%9k1M`FMN%1goLJeznlerByUO%Ny zs;7eMN07qcUb{k?ks%dD)%HtdI}59X&Jtnt>j8Wt@^^*&w8vYGw|*8MTqpl%$k(Z^Du7Q_Y1fe;+L&2{7W&DP^xGq2C8 z6cu=qp(>ogtlG3(e{5=#96da=|5{Kj?}VH5o6mo4cOnB;%0jfv{@C!D$P+1NnQn9o z<2L@LwtXk_x5$E%eXsFCMHxs|6UCqN86NFde;L7xdVwH~DB94EVK5xY=E^REzDyO_ znOyVpQqZ0*yO`;oR==|o3P7bQ9lnLe!DGn%o$P!7!7I4hT3bJ^#p7UZO?E+>uMpOS)xF41Bxa~l zZlUB|%$7z`8ocp8xe*OV)6R@aY)=yM3hyHWZ*coLWU zu|HfTELAPJagQ~sIyn<1JVHBLOxM)_|5eGqfx}A&e@o1&WJk-SQ~;9iTKhdUAN!{> zIx=ZKwTkLnR|uKih>{+g-^Iint8LJt`3k0)vGbQsl%~ezTmd~bU6%fVy=T~f%++kZ z6i4^~fms2gJxo_~9E$1{P=WV~Ac9B$7(tgLVQIQ8A9Tx7WL44OomY<|$cG#~e@uSLs?w9WK#qLQE_w&EvdEg<; z3`2#O;_>M_fI8+kGy-8tR5hB-Rn}x|>0KLlNqEANg1CwA--f0sX0#&o6gdalvBRlk zmPGR_={d_I4M5>`=I)_l)p^wX5Rl@xiWxb?Kz0B^0Y&Wg+b(8HFQmBck$pA{lFM%^ zWum*JmLL-ARqpkJU*Jcr{*}784tw3(f4L>X^(k>NIEBCT_4WBlM-vo}8nh+oP}x(dp0Q{Jz{9D{X)*b4CUa-dCG1x{u5+^S*uT+)_s_r>td{FU~#xhPJT0} z#azBQon7L267KfbU_=v(e{#uTOK7*%u&S!1DSL{7;?g38c7P}e46#PfsL^yZ3Pv=w zjtFDm8P=&!SZ(pka8BL zxGB!>aSO1WAKzU%f-4TlCxFg{6`nQ=u&bTk_n&#KlKLw@0d&H3o!5WUqc$csyG7XD z-oDzdmE!wdkGu6xmHRzvTy$I!Jo)q)=Z0Zt!Us;%VkJZ+zL(pCdrp#jbUT#RXl_ci2 zM22Hxq<9>SO+X);;rz{7X^4MDe4uU0-1%MSJACow9T5P8oX(%`TRZAZ zmCH|A>;(x86+360gP8Zzka_P@8$DNAbuBH2aa(h9=>eEDuDeZ4&%kCzNtp*95tg=cJQ{H7HwaCoPn)9N+S z0x)(wY`eUZIJF;t!%GzJ{rfL978MwS*aFj409*##Xn;Iu?P5{dt8Fv6B3YO5Ns%?B zA?wp>Zrg2I^MxcCJv5tQlK>G$dTHnL0~7L(GvNn8>ueq1I(z|?z;A4H)yH6RMzaPY z@)ib%*wODF5i@mAPwrY&RQ>7qts^AlcKmpu)#Cl|M=S6>K@`Bt>D6M0Nkb4PonRqC z!0@pT;Re!PHDe3z=nL6(jJo%g=fo|W?)I0En5au-_3A%11smyYosh0vg)sdgySqoI zuTRE*v~ib)UZ5??yqn@WP?OVbOB#zEhN};lAg99r*&H$?&Pz>l2>2+OiGnus3 z)*AU+#9u|r&V>4+wk}|YjVWKL=`N0!&_{7Q#6*;8t)9{99ICY@!|`v&*e33-O>9aq z2n}1pDr>xD?svcPeKd5VR%{AiM4fj!wXwA|>SsNA&k;VGl4PNScMjPS|e}aU8)&myP^~Pb*~dgDCb0FdH^2F73!%s?}j2 z4N3%@=3(~h96thm{8cFjs2v>zrVPXM1MW6$Cd{X3a`*SX;X-1}yI)B`z+p?!XC^{Z zbJq<4=UQ&O;wd+98b%$;5;7BNz%v$YE5(Sa)01C%A^#Knx8>*soB_Z6 zp5|VwBVPCg1YUIo2FOg+h@Pq|LM^k#;)Ny7rsn6HH1gYO@E(CRJ69=Z$un#83s5vM zDYAc9XwA?+DJYwp)$4ipOwN>Pxx8HTF~XGdZy2oZzbN`w!qezr=S2KR95OJ&f1yCG zjF+h>sONO9UgF#Q0JC`eTyZ^c!9|NRHNMyr#Sxd{9r#QRSJHQTW7lBJhl#9i%aJbo z^`6{lfHHCXVdk2oQbVKbpq?g>LrSm}P!CUJFVk*9Uy8=Bv zbHD$do)SvmwiKd-xz?0OJ5vWVs*!HNDeG= zaLc$$)RTk)#?@FhRLf#>k@<*eXC4CJ(nU}h1vT*=ihheF{DY>(Q_sm;D%gI!|Hgt{ zQxRXaqd+baujJ@cV0UF8>BQ(l zygg<@A76v#orkO6hEYgUK?Kxm${= zIA_T>NG@TP&ZOCvkw8S>82}eH7Njh-F2%`*Ng*^xIk^&NdLV5W5 zj(WVwKpMxr1-lf0cIZ9>J-MXyWD(wW-668>iLU;)s3I9@BlYOcQj62v8zEYX#iC`L9$_@glifh!x$ zTj8&AOR6Q{o6Z9iRdPPl)XhE(Wgd|AH8nQA<>~-z1ZcY?89h+S77`F}W~V&FS(2v^ z*RqrQqL}|1;gZ_v+4GdNsum@sM(j+sUENm;B{Be=Wr*MdTHZLrf@Su53|HILk7E@m zGY5J0ttvD^uT3xO8t;^r6hiJQ^E395unLWkagW%T({!hZcY5D)Ry^!%Y4woN<>@2d zB|iz8f)4d|uW|s$eWQjWl-QC?#3o%8ees)b8`~9hrv5mWT>y1Ayd zBMbtrNa8&_vgt;dt9(;Js=i!DSSa<3pc#`nLc!jp zhPYxJl}LP!1t8W0^U7+(G*}=7ZB8*$IAvlo376g|QSwgEXhjT=CJzL#KAZ=syDD8YzBDT zqoBdl1bQcwGoAS1Fz<$Zoa;j}DNu$}$kZd037#LxgiRm#n53!~rSo-a%O1mMzHcsU z!93%iGDBq6mPQLeA~u>@Koz`ulv(fgt$(|Y=C$MspF!u+zjoUyvr*TMH#kX!GvB4m zRDB+%u%JH;LDn+t)ZcTcX9Z5ht#2IWp06fZ!F#xq4{b`VT19N>TuN@;Zwdg^Id3I#O`m z&&=SE<^4y4k)4%#`iH9uK|c_yiAfg>I%@^a8#wd}ZZ^`F@IB_kua=5wPE zFWw1O70DTv6wsBS`VorNkV;;g0J*o}Q8LSeW$&sJ26@qRFQEjzTkS9UWDaMzE37FbMC;&)!MvE}FDVwyg!pf6qUU)ZC^ z@Y!ZRaujFACBX1<-m)QYzOR*UmVIAf_8S%lHs?_dvdz^Rr_Q*tIsq{35!Q|>T=DZq zgXxDt5sXLafewT(rO>Jcq$O2&?`xJRr2QBQdQu3 zQA;Bu-}Mf+&=iNkTPAWR7Q) zJ_eTz&-59yib+PyFh*tdYYnS#@iaDKht}c?=t=vrOkUoW5JQpBM_gjERq51!5U2$4ok`9Bc5;L$!`eZ5^vAbIYoSEV)FW1^4yZ)I#`UhdrR(eys#CLS$x8!D~Y zl3b4gBV*d-rhGL6x!HfYQMn<@mu<1++L`$og;W&(Smw z1TWn6vT*67^lG@6b}6!WweaGZo?z<+z6F4Z0)^}=%vLBZB_^M}sEB&zzSLms;nE`g zH@JfS<)Q8)GsVz<6k$GYptBlGJTfvae{bRlYW;q|GC&=}3}a{AY1Zrg()=CV+=68) zKP`?5Tu<1Vzv;Y@JeH7rX*{8-Jyr`f-Usfc$8$%1e**Ns((SrUNfQRjHV8ou85pwU zgX(ZU??HN-fN-N$3nhx!8~eGy=_atpG_(q{JXgb+k$6nKctg#Q)=WT7Sl@Rx`(Q=~ zvZGyB&j^{{){a8h8v7#oS< z@js4J-Te7$<>T|TyNh64QvNQg3}NA?wq8jnGAUueO{OqmK~gl}4S<3Jl)j#r*jk40 zZUN;qWa;8ybfqXE@wBw`(LFgr6H^bDkpd|)L-;+JJGscGN3U(*Vb{EpNpuiqB18+o zwBx*ttz%pTNg1FK5{&l%as#)D-~B}hllY?bX6qKyW;f{n5L!`=R1f9B{P|9v_*IA$ zhDIil7lI2hJPzKo%ma!(Fgfv%$o4C2RI)~C5EEU51~ma8kiPM5KMq{E5331ctsr9k zsY6uzRw{MG08&Q(C3vF2YnI2dPrVR5p2CEN*V}kwRp4=;%7=XMB|wHUW1NEta_GmE z|MYt)f{TT)n$?*5qtCByNrB5fai0;6wG7lGn!vMF+%5ngdhUlFiO*OYsTgk34JUt^ zA9Mev7-0Ua%hhqWP&E7quR-=({Or+=eXFc+=3GT*9!(c*``yfvo!ZZjP*WLY!5M*dbp^iK_bFfHBR#t6mw)%@Ru@ zC_;N>KsZ3f$Ll;rWt1-QzA#mE7aaH^`D?wOJk#}yL)qEc_-$tUWWrZ(TAMQ2*hA_vO zJ;wQ?Kb>GbJsMo{?bVwyolT!fQZBEVl*ka?>u*0lcZ6{{H*uX+NFoVQle)es^bL06 z?(Cw9LX1z#SVi{oe%CzN+>7Y)71ath3ZLlh21C?Wc?=oVC#@PI4KZWKR1(u1L61Pz zJPezVU>(W?#E44t3j#-v4f!E1v%6VF=0PO;*`nIqr<>o9`7GLib2mdpSP1TJlx!;T zz{)N5H2rVo4aBxCL>DDTLY3brQIDtM@n`trcs=b#tO)M*W->f2E&p9&x&$A>5ms$&egMfsxPB;8Q9hKk}ZL(^<~#2Id!+`!&}^y9>$MtYKRx<;Dl zoV+aH18aNzI~rOP#P7s=;a7u**lm0bzdhNcyeK4oK=(`vBC&mJ{8ID}VBSDw6@CLT zA8Yn$vCnjFQqjUE!C0sXglUly@}I;VJK$312(m}UPwXV(8Nk|W zU!X#__d&H?&Dsj$nuSz{Ea!zJ+U4eY4+J!S`+y5{5?Zz_+x5y+K61*~X>ST|`nkQm z9aJ`3=KYq|(Dpm4IflToOL3}0uHDoOqZ5*E7PB1j2dtyt^+3n<1LD!e+gm}}B?ijN zMbO`#zu^!bn;9u)<>h2-*@H@@6;c}>LEnTT9^4fHjodsHl{~Yu_KfQH&kMvqf+*m$ z$?u=AmnP&TCPCv@B{Kb674+u2jI%~9_uJ>_??Thl?G2RVao#@rs`aKg$6;m50tMPW ze^78{CzxkTr1>9ml%sgcKl_^Kp44*8=m5)BVSIVNhO^lg=eua6l-7+(Wh<6L;Z+p_ z>+OUr;im}+WS54t1vRQa1uI%|^lM`?2>-agq-tmd%tS(lZxwV&6l;P67tC;?TdMp6 z(jD$h>m)D_-ZNV_MDw2j1zaa~P)K?=0g(0If=kR;7a%auab3IrCGwJ16acx?RQR%D z9?Da{)+cHVMIDwjm0JA$jHYLZKCb;(Z{x+}f@ z>Yg7KO#T#j?p-De%d;p}`YSZW|5TdIhstDS23O+d)zww!W7M8$Q7u<>X2&-o` z<+pwb%o#$N;3j1nT-(t^v>0O-8n{6#Yc%f9zCknLEZRXh|7!c<=J(&BQEL2FRf52C zh-kjNm#VwFzbjqDfuyt6{nIR#ID=|1#jtr-V@8ym1s~5iYhyrGt-j@W4lf72>|nEk zBHOWRQC#gUXuYh(rnH=#pA;-{uFsnZF~XQTV?p25?Yi4%NdxbicUI7dp8K1>!E8>L ze^F{`NBRe92gUw;-T77zh0il$K9&O>J$JSE<{FSyHjlc6Jq3G&&raD!eJ=UFCV?J> z(c4X_)Z6*bf3=;Rf2)i+;C{l$0UgTg=IG!M??(6LZKGEch9suLC*|j$7(Q!^JRU*( z#AEd{CovfRI?);nm(L4)3pKq@>{PT!+QAZ~>YY1b<@8q6ZlwFIXvqPI7V?KD?zI2v zge2#_yPnmUW2cVv+xs>8;i&A_d|k;5_k|7+XOc zGlvs~i20B+Kkh*>{xAz)HLGeCKbj~G09|N5HX|0MR^eh%$2eiI%_gKelm zYb!D`p33|uQdKLgt|!}z=iQ8=tZOn1BmKJ`coCg0D59E}>IGh*`4HrAn@iAC1~&gT zu?>>W8<#Z0yZkRIRVpS-trpUkgFWf!1poNAC4P2MNuaQ@!M>q*&VswFw)w&`;LGen zn(vs=+1mPtY%M#~`v%Y_0E6#x1}=*RG+2ojAqJF-Q=#?rWZPXNW~w**np-BWHTCn- z=mV7Nr{PpdfOrF`mmQwhe<}r3t^=s;J`*{cm;_}Avo6yr4g}DgEz#oG@&939KTvm> zD4o}x=@fx3o4L4ddypNq0+N96L*fhZca83(3^fl26nC2Pqgm>o_B0R3tXn9?Sc@_% z{A#MnU~L+vLR;>p(L0=Hac4R&_lW!Z)In9T_p!SePAR0}FPtGydTCzw_ovZfQpQI7 z9%i1f3IXDxH}=B5j{^q5k0O%N(Lt80FTlvxy~*}*m+yQ{lIM$oK^Udf2aZYbJAl2N z1mVm}Mx8=CU(W-#DViXyWx9`dcYh$miQ_UM3kmbMa=8+_*XXHQ@!O24aFE!>y&#Pv zbQ@C&FLE5^N`gK77*}L$Jk^RvgE;C+a5M>IJa$XVVz5jgth1%11%$Z_D&8!6z4mez;?mdT&NkpvUFI1Zxu0fR`A7T&h1Y8VJo18@oU6@6Z0|9+)- z=5Gm`ic|PuII-)a@=yD>mt+&h34}qs*#(bacdJA$=!djp6(4aeZJTItUsR0 zrh+7Wp3#f=-6^G+5(ldTs}kX=J@O2}O6no%As%4-kTGnW>Ps&|yEm93#)Weuj9*zo zG7xEZ3g>p@MMwUg21r)Um9bm|`Q~Eq_2z6@Y}0rT4d>o2zn?n2A*oUygkE zXwm=k3~NBx?^!n<&UQ3~v68#LSWOLz7sqn_n0X$@?gW2fYFpn~h@ao-KC0shFn*~W zQ)|xvwM_Ko4;zd9`CdQEqY#4e%~esWn*pp^g8y$W z5%GEW>JOIO0|L(@hif=eL0k7gJ+V%gM7S2M`v`0R5_7yK#s9`OE(2Mp%_e}a@O^$< zcv@rd817dV9^ky)-lisMzX5z_|G2~7fZ9-Xq4Oxau8`bn)$=H%SkL>%dq`Ixc|9ZW z-7Gdl%Y^NG4T0DJp$id=fy#N_7aLLA+Yo|?|Dr60TMVy9dz3C~s|If2HYtP0pHRGK zey=sZH7yMR``K#S4T-j^W0k0eyfH-a(M`rA4add`!NiEp=jJ#ADj`;#f4gSVCU^l^ zP1L=}_w74jcAr2E)%c%2s#{V#Y62yL_8+=ea-0UtW#>IJK4tG9aseAy&*?9)GWhzw zQZo?IF-s@KTaXNJxnyis=y!9h&AF7X$xl&ExkS_Fw7iu zAt^!Ju3OJ_T6JF(mJu&*cRgHILT=w%1kmyZ$K z$G<$U<-9Y&G4m<`v;R+wyI|CJxa0KgZEz#o2;0x4(EC5oRFf1&9!moR$SCO74(?lv z3s;Sqs_);)9OrZrIsKvTLojmjfFJDxYA{kVGUr3xFJA2J1@3!|N*asJFZGS^U12NB%HF&YP zkv)DX#V1bSWt5AU#Fpo7*PlPxVAGJ6Y28aAr})VnS9Dn!PgshO9U3=;ybL*QHs<$0 z)n;Y+Z)` zN8*#J^n90ECrT?T;`8pe)S3O(55Y|B09nDI*^2y-Am&VTNF2BxgL?U%HZ+2HE`Wb9 zD|>}V1^aV>iub#tiW(y^odYO+#dys8CJz-MSsa8iqDc3Wgzp!m<7y!hT+P(7y+$?n z{m=yaK-ac`MHTu%EHGd{?Npp8?zT3OlgT7R&_!2jSTROIuBU_yI%2!)lbv=d1gIoD zBH9goowIVMMle?A7xottIH!oXyU|F&XVDh+<^(Fe*x6a4`CTmy6gtJG;fIls)0f&Z z=lQy=QW5`z(13%>)lipj7&ckG;M@TE%CjkDk=kd##o*oV?e7ohNiDwim^h_%On$?5 zu+Ath#?xm8id?V(FCT-w`3Bti0Anblag0Tdaz>Ux8SH(yOrO_%Te1ij95?xboh?LlKoZ;@w5%}v&#LXZ!8ZzZ*RVo zaC_NPwz~bD`)$bi3c*raTUcS99pBY5 z3lRDK{E_IXojyEJ5U#IaRwNuTsbp$lE9*ET7nK;_mXU9rUD=88EY82x-{{($$pofY ztE=YH34`YA{Er;#wdLinDm2KAa%Mp>^zTP2c&2>u+-vFiRKCul6Lz?nXwhN)Yn{+Q z*@XXSL^=`{Ti!A55=+cxGIFRX?B7jQis(DY=PAbqgf;Ghw`X2&`eDBt_W8E+53yx< zp&HmoV!IM2*V%ZQ}w)N|2JpTY5U1E0ilr-ddbS9@_X_m>%cbQ$!;SzCN?z zs>*C&B_k##2JF!I8=yJEtcaks-M9(Q`ft-bSvoL5C4(X1+xgAI!(x_B7BG~!)TfRs z5KEu)<3PGTlmA3-H1fUeiT5+`@&YeL}QV1zuZcSr^CUZ5r7h?+CBBmhUjX6jw_li1$~ z-Zkg#hE)By*$9j++RnUjE)SShttEwbq%NT@O57`^+h%$5pl$*P;Z0oJb1^1f4a8#D;QPghz zrwCS-<=rU!0sc%Vu>3s(N^~T=OA&~*W^Hly^8cNju)qqHcwO#nr|>@jCS;Ev9zE*f zwhZ#2%Ok=G_M2>YwdoCWjGNXb!VIuxyn>zj{?fCp1*-wN|9nQBsEps2Di9tlbCf%g zm+=lw8-Af8s8hy-bZx4>Qwr3`0Ko+1>Vsut%A9(Gey+wn_fJ0RM~>-4yEgadjB=|2 z`Di1Wbx+4TUXyFEgH$IKFa$cJ+P-mIcP6>MHrQ6s?n+bQl_U92_*pORl}NDZc;f{H zQ-o1z?EHY94~&Pjv<$*pN_~UVHx^Y`zORan_nfl>oS_sI@Va8slF~W3XNdKA6Gz>X zQseJpV-mWrvLumOah}Kqe@pDTI)sP)jkt-m>*VTs18mRdx9oUt1})k^_41!ySDSAi zYmxVrufD@*3ClXHhC_*j^$whhTsoR*=RBXQMsrAPblzi|bW7U)P<)Nv&CLaU4;;Vj zY;A#%I>p=gVRxy-Fq7xuN}~iDrqX?H5MAMuh9S)AFttf9TU(27uOJz6405%hvo1eY z_W^3`uZ+KhELJcNeo(xCmumRQ?k$J_&VISM1y{u7rSoBB8a^UjLvCXm??u3+C_H{P z=(gDe;53kT*`P`g79i@`8|5{rvW3^E7^AjaJ+{jHBS?|jDPd1)>ic&rM9|wlW9_7>|K|f^XU@o~0Ds2FF0;r~d3>q6eI{g6{6O@H zRFIkQ=P4x_56sU#tJ=R~88N{$$T;}rHaaPMRg-1YyM2eckIp(wf<_%5R09@vD>$aE zxjFwTR;PLw9eI7ZTNx&+pAea3#SRXy5t-mG*K|ru(YD6TIdGVOo@4B=Qhi_6Cyy)7 zGobm=>R{NFmTeLvkH1U-$9xOxSH{}7X!=KV@ju&g>Si?27)shTN`H)tuX4xE^ce-gOBF@yaEDD^G$4s5iq-^I9|Hz_XuKY6^=eW zdJ^!MaVBV&>1rdN!WWXT!Co_jV`^_7mz-r|&XV9yQP#0e;Lg$#v3j!z<{w?&eLk;( z{Plqz?XO1)!8^KCMWId5HUz~d6-^wKrOctIX6{inCi(^jA|4lgA)!b`u5eTwm7|Q{ zg5+QVFgq=_Yh%&ccMj{Ks$iGT??VEXu(2q9rv|EFZ<4<^q}&yZBoE7HxqrEM<7m+A zum=vcz*SO6 zEl!80FcP+ew^YdZZ6c%suUR737wI)!ZuMvHwF%m1Es-qwq;FZApktQ$#>Ok&15`b&K-Fa4r2+r|cX=0x z#)#JL!4JysaEXsUGh^09<@_rm$lJP*h4WTT@En7MCZ9>|CBJWr<&EFEQ1T^O;CWb? zbUogur_-+9%EViZ?Ys4v|I-4z=mk&z`|Ele_7-l5l06_fhYzQ!dM%_g@s?Jj{HP#S z19^FAv_0dazIEiv5VyBZa>asdGp$T3y}8QM*!MOBOhGgnTERZZRa@VpR9Q_vMqEpS z(**emlS1)p^Y|p*hOzjVU!W~X+V44Z;`DQoN60wUgx zNyQ&bJ;qGPuRQNqey059PZ^nM2eVBJx$oRbT#SF{egT*Onboo{c znjZx;^V%@VvS+n8SJ&^G)}BF`O&W;90S9VauS)NIZf)7#z)Yl*`ds8Yl~FoynvBOY z6j+=9TUUfNfg9oUJ$fWRO$OVVYdRn2if1{0U|w5Gy^SpYbaHHX-ozx~o0LZm%?%{~ z8RdwtwqcSP!`R#fZTxy6R*f~K*NE{^2z(b?=nU~HCk{&_gW&lOIT+|> zCZ0>qk-TVz!6-(;4{ttJ*+FOm{1gl;c5Pe->##C4K2H;fjZaD5v#EAAByq6~mTnn` zVk-Fof`qc2JY-eUh+a8?wn2djDpm&N_0_paJaE|ZCqEB?$>Y@+46Zd0HG}C&wY`2- zQwxDy0?z^PO)X=09!rANKG*4p9C}}q7=dDX@H?NytAwv94Y!e9rwOcapj+?d@&5H& zN7Vx`0sKG4M8-#Rga&A=z2Nv6#?^1UKPbrsJ?eM(AQSKuyst}O<^lIAUu7mQQ_+d4 zKUK`wH7Am`*PFxWbHB&9mvgX?_&naJtUm*0)bYo0e-SVxBp@67a_?@q0e37=umQC% zc;JM1d7E2XFZ3zVNYE3LoMv9mHpCtIWCg*tQX#S}!a1{l49`PCS&@kj7CSN#UqL=T zBX(+UI+>PFPA)Df>Ou=qSB8fyJge2qd7nuahj4rQ@Cmttf*G+s8d}lqd*vsnH{tJZ z`bLJ2{0NcQp%$0P0I5ygZ3O2L{jq+rv9X{dR;chixPIO$c^rGnkVU1NK-*GVaBzXG zPyo4Zt3WKt`N!V8Sj)TKiD8)!@&;;n)G(hvVtk?aNwUF$;oL>BqCkvq}@^h?!^dTrVzaY@=PG+%TU~~Vg2Ql8rFQ<0IsFr<$R}_+{FpO z2@4F$0uZkQ`gmS5_H)!+-WAA37u6GP)XapBEa-+5v%gIyBgs>9R_JJN$B`SV%p0xm zS^6I@@@uLku;sPc*$hGEsI;HPYRg-?f`Z2Y2QR|UFUFFfNEG(>msS@kSz%<<^TAc@ zSO-N^gA<@ZoSY`1gK(@XjR}MvKV^*4IoR?%fHU~x*vpQ=^A4~!aR_ubyi=Wy^ZPfn zkpPR=y7$;-Q8YD=K?S=_jrz^(KDJb*M zV2|+6dJ$lrcm}gOzoGw#%rp`iO7HjYiEanQ3K{rMRw+nvhu2Z~v%AdqV=~I==AI4j zdl}ZoewX9Rt5d4d6o2B6k`04vzcbji+A3#ZcCs?ZIWBIiGM9$Z4`1LGmLE+W%FT#r zKSZO!6?)~=&HF9o8=KN|{&fXpbdRk0Y6Hi1s?lZMbhiUS?eCv7KWn@#-oV1kP6x10yn0q3 z;Wv!Ll>nsl_VpF^V5<9D zlhOEmyue9Jee%Bl9aKLuHzfEFMCx7eDJO${5lr!Kf6t8!!09*`d-Q2a8TlS{V3vVB zi*3j6<<{@7563O1?$#YZBhj57^iJ7dOL8S zfY)AK0jgI_dJ#EFm6!(1Izq8>6+dcTE{5Kx;v!-(4*bVz=c=i-38YxR97@rWBtz#@ ze^__3P(N#pQb<_w3knvY)zQVH0g1BL?*=GEaJY&*T}}OujRqW~55Sg-fw7b$6JknZkAM7pG;Te?B%?(Xg`>29RELAtv;m4>sP_Z!E5 zjv*V_+_S^Wek(q@@t+ZMrt^lmt4Zc?=5>Stfxa<&RqUD_n*wh!or5|L50n6lz!Esk`ODx z0U?~TJ!HA6zgw~+xyPg#f;!DC{vJTr7N)uB8m?~D#o=Yp=fe845a5-}GvuPyBB*=9 zh^$n|(X(Ud=ZKQ5t&Eb@Xu}v|=561-Jp&Xa&tDv7+p9;c*9=dyma-?U2Xyn! zPNvZv#P*Q~Ug*ekHXsBQn)o-6Oifq)c!*SZ!jS&UgGR=V7#{D9g11@^4;^94>d3`b zppEnIvoG7l=X3N7MA7u_6p$5j{4v#odP+zp#G3M7v-(LqLWee7Q^4qdUos z=E;JEQUpYj!JRLZf;X(e*7sw$gY)7Jz46tGLPYR=3=Hf>Eyp(feg0Dj!{`-LI8i6Z zmV*@K$}$0|lF$Uuu>Q(Z_3Q(wvN|kYw#8s(2bG^D^0R8e^rbwhdbP185t}>gYRT7< z=_TG*+kyGX%hY9i2wO=0k_ob0-2cEyh_F{~JTTZ}*4X3OpU$~xi*{@G>%b1t5#zLv z=iLba>FV+Z+0n5-v!yKgubk}&{7`5Q1)8G{mP~OxdJ)g>VoPzs_iC=?+)p6Y8ZIzc+#TP# z2GTSdg96w87k2L|CyexPd0Rt+aq4&-2mX8IznszEM-l|X1+%nd_d8wckiY9Yvt?*b zp)MDg#21vQR*ASjKY*J&@D-vLAku^Q>(d3k0hBqQhTFs5Q;05Azv&WY#i$(%w@9Dk72~qa*>D7!qjsQN#XNTI-d7PbYw+ z03mSP1;Kyd8zR9YJ;UH?Db&0SIYJTPS0@9N>O@?|trb^hH+S6}j{Eh$Hb-E#djxz? z>>dy`uR`Rv9{c?`%K4R#7^OGg1>oeZt=vDCQ94%)Db5a4Vi;rR|7(>cc=rLSu{7J| zYx+X%e*p_XDk6FJn?6DidY+F=-8;yoPkXd%R=xv!nNvyKB5Xxl#axlX#8*n$)NP)T zpFZhfQtp{a`OONV{w>q6iEkU`jkWsa;KCR^(i>VcB-8%t&$aq3k2e=zU1o4j>7@wF z>+N%}_$@zSKhEkj{h!sg$ie*~JvVpv6RS9c_-^h`8L1@r?ecQ@Q#KYTHAOL=tGb_~ z`deY1)l~wdA%)VRCPzfvDD(};z|G^(#Z!_L3Bx&%nLl?wL6N>IZ~E)Ixq-WET(>tX zr1QNfZ!hW1H!Cmk4)`cKrF0-FWRgxd^d-zNj zGLCeMSO>Rd>RTq}@3IO+++duZUszyfW(L3NR=L=R2F?96Pu&Q+_wbrFB2%HYbbr@Z zDv(ZiNn6SVcYe$t|DaN&{yTv`N$2+Z-10=gTcj1)j=;BaL{us#bZFK+^OdNRv%jN| z^NIH*TU$snI=mYC40HF=(=XLH>3fovh_04cW=Hd9Ay1M^2D~O*fWFak2K+8xR7Q_u z)UmR(3?CAOMKsU2TSAo_VtDFVvUk2gNN7bvydkg(MyQo=uWm_!8L2n!$*O+!%zvW6p=7uN6bequ6hudqG`2hPe?&Ed5BaWACQ)JQsV2FPs4uhY;sObtjg>gO1+VE zYlI*zv&%V7gzg*;!}&bje_ZsfW_h7~NW(f;-;Zu_BwNMAxz6JO9b=N6KV4IH67~u2 zbA-Y&vr^4qO~n{w&vJ4Xvue5yX6v0PeVcKNNVtYQ+PGSP>Q=&cQUejWa;0S!^>wm= zU$Fpc1B(L+9EA(ja+|EyWsA_BU5^Vjn|$L>vdnkrIHxH3=YU9{MbbgEF3K;E!bNmw zF!7@%n9%>niO5stERyAl>Y?-J z^M5`?TiY!KR1RM{>H2Edc6t{tul0OC^TsHI&qjHBa(F3r%P5Sm@G0%)Njn-YKXz## zw|~R)371J0feF}&+}HON_7Qu4RK>XaG+^s0ce(JVWGF~NYb zuQT=ZY`+7*Mit_jg#*Sg?xDkS*vo&^79-gL8q2Meys#ez+p*`C&nF0RBdXH1xp3&* zn7Xd^8P=jghlmD(T}z?9$H#2O8icoOM1A|)1Fk1;1h=jJR z+yXr+HE-nTQdDMvJHr7URFXI?&DkI!oYiFS%QXnf>O*Kr7yWtcAah_~f*mzx&oH(M z&L^I5`;oS4K3F;IIWdO_T%Q+8tD@$;4|10zWqM>(L$RjIsARlqdg9&;S<%nnpr^Kg z3r=JEqYr{IK)R;&q z%7zK2`jGRcnG#_j+seZGW3oL3n|}<$CQ=b=E|p;dLIDr^6W5c@SL~E1w-U)Z3 ztnHZJY3Jsmm`xrM*b!eiDFzYENC%yYbty9HP2S7d-!-%`>dC>2%JSrfVvw{jH}l|r zMc%r-#VkFV^`rU~qH&g~*4;ZW0Q-QvxQ6g|dt!Z^$df&A=+lv@R;wsiW#P`1=q#?M z^o9L5A&utNR{Q9sR+EWFe^mA zjn5l3p7SvSC0YCL-=7}NKz4K&4+7QiSOtRLRAKsg8o!GAX54R6sROd8-HppZ9_LVD zFSJi0_In>2y-x(Rts{fES)Ks@2%wSDM5i7^g)=&@h1a%Jk#S{B6T1hZ@>|qm_q0kG zlLk_89$3)NWMp32a5^h~1%BB-2w4mf#t2Pin)k@)e0o7zvTsn=_&T&Om9R1_q?C*3 zyX$x9X;p1l>USV;9RA&^YY0pqjyYN|Oovh8zx`wF>Pa7&M#V`e*=pXuexIDU;siZO=3kUij z6&oQZgqU1!uq;h^F-XdyGZD?m=1+<{OKL z6pSH&P}Ix9hETSBIUGrRz|pS6FT40nzaf4<7E!DGm$7Hx3LzcoRki<=jF2^3$vQWwAb$8tOkHSs^+NWP-#c z2C(48V*~Dbzk+L!eT*Qfop4Z)m^v&-)XrM!?W1v;_B=Me4bjVVp0$1zo{<{5)Fyaf zuC@UpQJAbr3bxLuaI-oy_aDX#YXEu53TPlA$k?fFMkf|Tns`>60%H~L6pmle(cmH) z4R6czAapjryJ~YT(0$!WDyOo+X9=%mCalVdp5*a5VSl7rc`+bn^h#5Dqu%RtGZ}@~ zs~c%Q(l}X%d}|wv5|3%*^-^E|&+&fzS`v!rcPVR+`Yhv!ZbI zC-%QSDC%<>#9CX>3~FO@38)x#2t$K0Fp?MEQ+R^N581Y0snug??NrHu7M6}?>%upe zGCIg{LsUYwc>P0iGWniq0FiveVxET-M-8PqCjXnsiYjm)?qD=s5eQnS!1J8T1~ve| zz8;V45X@S9`iaza+Z7j!9%&~OezR}8fhxL83b&PBdGl!pXw+DrMizKVzCiKI9lHc= zBsRNN>*${L&v3S?88v$f8rG`jJ2}iU2As=K=<0`q@d5}rD_u0#p@+cpoS`Yh^b_{r zQI+lJcikIis-79<9z{@MJZ;Qx+0|O1-}WHpvZJXfc`&H^u@mUNb=kHoqTx{9BVP2` zxsgjkh|K07-TEP4t{mp&TGr+v@ml#XVT>qV0m^pXe>MFUyhDN@Laq6eLRz5>E(>C* z+?RyV`bx#A1U~pOgK2#^A~3y!n|y7o5#!;qrdNGZG7k$~=}+1}a+L8M1CoZAKUz}o zA}Ofzv5>SCh*q-`A`c&O;V4wRDOjiQ1Hyk{1-?J1&vo=KZFrH??R+X(`Vh~$x0ylV zW*3a$Q&2N|#PH2TuPI5nd_%*I6WPb4NDjwyJUiS$;Dr0$G^#R^A8E`HZZkAS#cYpb zIv61!UhF|!?UkG{AXQ^P59e$QQXu9v*y{FgQ%caabjnVc)U7>Ja`6Bik)^0>2unEU zufc~phm&&A&G7(}IXAP~r%&lULY<~=RFeNJ8ut70OH)3wTf#mv_{->ksSO-tw^|Z+ zv#$ihH8CLL^i$8T{Syu=dLsracXT$}F0kztxgy@!_%pLfoQ_tHrh;|o>G~R6^as3g z3p|yp8lR5BJ`XM=UWf`^u%G9C2CsJmjHUiRliexM#YC$kf;|#UGnVOH> z_3gFYL<~Jev@gVM;_&%dTgnz*;PoGM2rn;u&r;!9{3Q*2i64WOC?xwfB|*&_bdA2d z<|=#`u>b(4yuCNHxQCLQ&n z51{Vz;m*#_A4l9O`Rvxjm_Y4)3W}|yI=1PKR&u$xtpD@Dn@8sx>Xrh-C_p8FxGrvWiK%#y1zTC;fF4TjTk7qP0>yT#;O`_5V;TA9l$f3L zdtvSO;QNCP%}V5i=thLwbbRa16m`Aj|c}K zc?_B6I4A|eI}4F!WL)jb?MYT6A6`LXJdoSp-}5wF9?cXD5jHWKijmkRr0e$wh*P3s zPy6i|y^v$h8mhXRCx2kD3m>%Xa_A8ky2+L}l0}G$b_S>+@GI|keso`6Spf-S9J+El zVGKq!0Hk!E?2@?(9Ap3@Te!A}qqP}{16vg#ERvSB%-)XkT5_{vKrT#>%7hg=1f5nU z9{rdWX)q643wWlb5ig7|dyO{vqG*!D+)mSZuTkUueLI#2>-9AD_gQ&A;0|s~FhJF5xKk!YSdFFSfLDw-s#XhdfjN8TJ+}M(wqiG@CTS4mFy}&gw z?f#q)#unY~HNgyp+G88|8OsmAgRf34ou?$8K=MEgX!E~(h-!-71KOC!W#WO*(W@;N=ce3y|(hh@h5`Mzctrnk*R z6LAbu6651A^>?bV!Dqx=Ozs0qVYM`jPx&(x50>A=w06$VD-pecY6lj^kV1Wd#7!^S zY?qS?79*OaqN>W?;jp034rDbuy~(GOj_a7p9~tEw+(=L(D~E;@ur}@}CScM7&JI)W zco{yG(L6-VkLT<1wSms^Jw(1lx>;AB2rWr>^(W~3Ljjh;KMlo-O26UYBbj!UbL0^g zdQN{iVXwX9W=FbB+4<86?5t>KV^q(1b-ov7oSi5~Z<3uqwhUc5YL8TQPO|!Dta_Jw zov7U(A)kZHg8ZnlPd4QsVRL$wM5%0A_#r5@cs%tXx}fe#E~9Ia%yeor8)Z1}#p^XE zlE_0LGR=~+oT+(4SxsL+Bv>@0Y~JeI{_4*?=;_m6Ocao{1JVp#G;iyo6?2>A-`y&& z#eSQZDoxi>uoJxhq^8cc*ftk~N(gGkrm}S4;z+XTB$($oM{1CBJnd8+r$O^E# z+%z{@EBz*!udA&}Qy0TrzfdOTJ{wWR;zK%Z6K4FVW-zL( zOwV^Wot_#fF~35=YzyO@Y|n-uB9w^#uLa1MW>x0EMsWIJ*6?Qmo#WFncGv#g<}C+L zk&^}T%aKmZZC6aFt_;+VDjypZyN9mOa{d#Uem@YVK-CatOi+nCgY0`X%N39@{ca3l zb0U6EXsOWGg(lq+9RpKZ&LzXDWgoAzTGPbTcK8`42 zhUt$xT=N2i%wlU4!Z@PTR;1U@1c3GUzm*0NaJ_K_&fZ9mH*2-%JYJe6OE^&d62E z&dyGUbfPqBar#5^?3{L5q1ZjMNG|hOP@MYv6RMrC`AABP6%*zpazD+ks0;qrr!vf1 zNc2vvuH6ZP*k&=MH&y{0vL8Mb!gEF5(ADnv8fPc&za_Pq6)O63Mmo7`G+)*Y-WH6$ z_z~3EGYjwcjdRp9l#YQpW{=a3nWZ8a{mnJz14V$?eHxhq*rP$xn}G+!#6V^WDY5^J z!GFg&xX|0$+anp`UtENM6stvBS||n9?ffjNOTjK8R44JBjxHhrSO1JnkY~=NUnV+I zh|02*#?X)OOS!28!K_Qc32IA6xZH-<8?j3Ugyl+&D9Gk9u(jJJMVwLy>V?}EcmLi` z5-NR9`u7_v^&Q|L(ip=uza>I=Yy(HE#{Kv>vXQ}FDO^@B{&M+ICPg7q2}JnmZ&EK& zD?^Qm1~NTuL&|T)Gj}tPhFgx|3F#mg56FVNt1dn!d2PAMo!Id%yWIv1>r!7yoEFQDgi-SR>8j%9cAz zW{%MY1{0V`ECmgHlZ}Ub61P0L(#I;m}tm^l&F^-HR9A z!7nx3gPb#*Y)@$^sezVlj=vtu`9>G++e00m17V?c8raoBoE|w$t-(HW56ve@gl7oz zb!;l};alFY&Me(qZrI)iqP6b9ACrCJum7nhCX_6HM;-X2_k>kMm1<;QH3Wq@hG<%j zr}k-ooW_EqV>uzyQ*Aw;DPO!!3!Q^kchKCKqbusmOPj;MVBE}!J)sisrz1AK0xl3_rHQ7{pdDrawOT*FlZpMnSew3&JSpO@sEcuEoRLsfw;Z3nAz+ zU(G|;F6Q~f-Z%>UcNk%P*47lC(sK;>;*`^&)ZqUVNr`wSer<*~O!vx5wal#08kie#53VT@Ta{#l*4vReERcIPYB z!c-k{u#zX4&p}*B5}L$drN^KzIxIx+@#hksrra(zjx|!wK$G4({4YZA@X!oM;(-pt zPjB_)0~^k6X(R)O=GZ?H0UWfL)p}$uL?pIMqiw#J&8cXkzGH^>6IT#~>=1qwFS zz|jDBT*7Mb%kA3=*nx%!--G!8XQyd)hTB2wZEFPD*?le91o{tci zmeU(!V=EHo>kP^kGjOcN2rkr{l54M;*Rl3cxXYz`>wd6@6E%o-1kPt`Yin?TQnEO_ zi>mZ}g#U&C4-`EAy_G;;4dQ`-t1!e>fwXBbqpolb_a_H}me9b=6rkiKgJvFKLFu{5 zY^;6=@-8->QiQweJAVRk{-iw?J^mQzLp0dKtRE(}ir?Px653%R%3&2c!Mc?Tb*d8? z$M4uXw_+W#GTOFtb8)RY=GgMkhN{6T_RfB}+JAn|@MZfIZG@G#Eepz#_QS=RwRXZy z_zbu;p7m7C)x1o0>FxW>GyB;7@*RTE`(pyPQb&{c)osQN4$JCPDhQmNLojKBKb7lo z2nL0hP)LfRmRkNjwef|!>NN=V_pR;ie~;7m5Ev(}hvC7>oKuNuj-5&$P3ewCt#IJa&hjaKUCvuf2KKwVmh`IeA0~JQtp}rV;Ym?5O&i)?Qs}kNw$@8S-qZaQL#wA9;DXe;v6x zB$?^f`MP*P=KIClQV!(ndLKEmMXnIcoRw?igQQZl_ai`LoqTa~?s_<`DphwBys!^v zv{CJm>Mjis$Y~O@c`=5>$c6s48k>y9&wozHB1~jbuw>Vl?S-0_5ispCUI;m3wblkI zA@5fLN8s*iS&jFN0gm7prC|MVm_|Fa(_x?N=!#PH2Mu1VDrb5tIFN23S#`MFVa(0H${iZJ%qTRv2x6 zX^Ejo*5Sz?1GK5v%ijgirxzOwHC<~fI~fOLDx+X_!^gT57iC|-u8YOKj%#qP zy`f}1>RyeZ+?8PcI%W`=#&OhB{;^32n&+6UO2WCW1`lTR=QbY(S4|apjH=5lgbQmM zJQilG8GKF$6T@F4K3m^=pJt3@r5cI}u~DxH7+7|DUCve86bYilFBLQ*qX zk1$|ZEFWGM+h8Ss2{i}!;|S6F>v6i2EcVvT;fAkulqCYM=vR`4tXjE;3y@JN(h=U8Z zA?cC7TgbZxtnbY z%r8TdZe|EFA(X#r-#!H&S2q63rZ8nKhEXn4vbiWWo>w;hYSx%tXLMBJ)DVV!sa#lS z;=43E_O_7)%g9CASmZwdb{}XTu<-C50UaW#Vxc_i=BI-w3DZ0=h^tId+n<(G%q}G3 z7>B13&GyvqZW;}GL>9?0W&b)^S|aiq_spY&q9B3;%4J&=xsSF(jk3l11ZPFw0?*iHpQmn+xJ9-v)3j!~fN(Sp8AKm|`23N% z%dkW}S}JtYekwjRG{*y_D9&$Tf2j#eR7NR_SvNyg4V$RK{<B0qTJUv4+Y zJ(o9)dV~?{eSZRT2iGa@^#F6-+>8hFe{K$e6r2Z6bqNLH(w#gHfrG`-3`f&_8Glif z-(y^|B!YqLO#m3VE01)s0rk^Ncj5XxqqMXvnRK}rG?I|Pg#V|r-yD}&@&yP!<^sS>_K@ed_S??_TdF--- zRvFXZ3a9>zLBGVbbK1!AclYghksih!V_j0Q!na-ArLCk|K$e^&^tbA3mnmKZYF|u^ zt{(%vN;R4g9_|?JQ!9P%rkeQUb(6rnE7RQff=wsU64(NrP21p=61+NZfY06Rpjey_$g3qd3Cj(xlLmnWWzauX|ps|PSkE^yJy}XsG%cB zfW8?wHT&aNnRkXY@Mm1nH|UXCj1B@x+hDcvD44;cSP;?)&#j}Uh^?h-e#et3fzT5E zu>AL^eMX#k*;s zs%h0`FG6%1`~2HwAJRzE3@PSos8>X!H4U%kICp&eXkegp`Q%3hZwPZRXP9MhJ|a_Y z_msAsS5=2pF1N+L{M}$;g8WDsF22|;vYd*@{5boCwlw`4p$mqK-k9x6-Mg~ExhSeJ zjODqwjno@rfyxW$Q+Z}sN9%yl_G(Sxi<<*wEtALZJSSyU;TcQrrMiJ{P1GsqNHZd` zE`9U!^J{CFHJ6Ky-&36XL0ne%igAO1=?ueuNu7dH{?ObA(29UEA~pnKy5i4FWv)TH z$Hxfcr|_zQ@bx|yD3rb2Ow|ny{gYD9{A^s5kQ$XUyR2U@z<>x@&Z@N&I*e}B0qzyC zEYSf=>(@S0WP$I)wHuUB6pvs~Cj05)Q_$KuRXln*a>J{F6IOV{}J@e$DB_>Wr*8Swn^g|I7D(%`%}14VZ&Zr<5Sa=)z78#tvHq z`@8+xB`iKxR+_hi1I2c{C|9I8#=+_iMX%dvb=Mb`aXb`?9(y>W5fWzJpj2`TqD1Q9 z`iY0CuDFwaDg*HI0Vs}+oBuF92L^XYq0pwE%{j~iE;St6C0ACL2_|L(&=kMSoM%|Q zy)lsQx7qe0x%s}{BjMk+ilurDAX4lmYp}v2eeyY&{5sG_{MF2(+u_^h+*q0p1y#ML zCgD-u;xq3|!=+*9H~zB0RZ|ml0#Z!Mzbb;;XaVIt%m=Y_oRt(oam!-(iUZe`-S9<_ zQiP6b`i4UBb&Sg2Ye>vD%O2{+=pb$^kAm@BX*$E$S*hjvHP+@EF-$9f`xnFN7EuE^ zVKY9`$6ul^F*J>9L@tqooB78ChHzI=t%m_&5EyEp*TTj;&4`)JQxng zx*l?}N~C~2@bULKyIuZ|#* ztga3;5=z5g;VE7T>J4Zb5D3Zl3zgd5Aih$K5*(RRrdf{H|1la(|@JN3JGSqOS4$eo&!jGt@_!HH9q)|s)t{0HcCW&(93eS z=lY^?pC`lRHfYGJp^gPk;(9_11rHIvskfepVmt6Us%H0ekU7>o`t%hMnkKRYxS~Gp zI3G$>8JJcQ6+4uV{bZvNYifxosfI0nnJ+P2b_myGU6TOl8RJi=*N{pWB}Y>&c#MRs zoG}@&Mvj45gu9p#LTi%gB!V>Wz>>!Z5_>v8H<9mxh|-XwY07GSHCSl$idtscbk)Jv zNUuQoeeSQJH_F_lxhIGH^mKe2?bN;myA>0XpwqiJcPA(Dv(qIDE%fdT zW_rzfaJI_%E$zMBbvX28u$#cTt)@gKB5yjxgr@eWPUdH$)Nbaqg*ooSc z(&qB--@iaNhSi4H?^M)sjbx20G&l)AtRqS_AV0&N#ufPe_P?(1MGkW6RUQ*)`<~&P zBT7buWYcMPrcp~H@#C}c0Gh+Jir7}Od=EZ1E)2w8NY#&d1Sb@ne-3d!#k&tbvuan( zDpO`*DSxFh3?IIEey|tcI*-}XSS=t4YsF<|^2IQxG$_!C|B((Ms0%vpmNzz> zYtRu*E;DCL^{e9{1#hlgENk}TNe zj$*!5#bx>wqd9k`O;P3HjyiqbZ*K?^R!>0g25t4O)B(bN8p&6*?^f}eDNn3dz1Wh5 zbQ1@{dEpVeFG^Bp@<@{+D7wA=j2n`56?-o^9{5}oSX9s_Lt&WP}0G-`$nOlX$9B(Y2ImpxB8kR!Wmb~L>p1ULO2g|WXXp-bcl zfK}}1%XsOh79gb6FHcc>I2QhSmYfoUX6@wD!D%u=8_!?F| z5}NMMGvsGu>!zCiNPa(pL5YP;NUs-*!W%p#aDKJ7waKV`peRS-(^oVi=mfM)0DqD4 z-c_|x2(87e9()j%xHlOhiUNUPHxmmw6>kqsr3e{=x3%^7S!W*`xv|-%;*=$C0G*$s zkOCa4)aOkGH-E#+?b15GZW})}5zEcptk1~Z8Pq0wb?>fZN$z4Qz=Yot=Huk2ayWii$~K1xH+@saNfVaIe>)$M6tDT0Yvg?MNYY zK$Y)F%|FDAAU2K69w2Rj6#vl&=Jv82Sr`ALQv{}lufm3W8+(hz#DY_F!1Y-~khA~@ z#B6RNeCDU1?P{%I^3AVR&$NaE-u$xPag~E$7V>cTMg9PiteYeEGFn$ z%7x`k9EgEN1LnFB_a@LAHIPdP-LR945EBcV3NVl@XNO`)Om`4zg&Y|JUheLrv!m12 z7e*ETXhIl4(zCVZ!%V|FkyxJ!Sg;mzmQn2|@n(qbJi<7U94B=y~18CqioW4`?^7A`h z`ujCVRI{HH$um+j4}~JG_Cg)1k8+MLJq;_L%sVZY=w$a3uslF*^DzA&e*R}loi^Ts z!TWs3B{e#LhuVxZnl2hN4+5%}`)!gR4P{U!ZfHf+7||tzP+i1BOuP=$LaBcBJ(q?b z9&gV)w-lcrkl81_NlYUS+g#ZWa#fFv$QA%Y+_rjiVmOQHrWdnUl)>TtInu^@l~`HZ zw17~4z#weIngo*@>Gyo?3fX=DMgn#jOhmlG@?d|znCSp|%Y+RtH6B(MyIkb2!asrB z9b3Nqro6$p_1yHiY!vcj8B4=2foEC9!8D7;S73v38i3%U#Sn{=Ysx=rSi#9kU0f+^nj2V8~uIZ-=bP*&xBl-*$UIuVI0en=S zPFLddO|eObg#gSFn)@4u(h^3q)|}=@vVj*>>Sx#Mfahu;1_#+gp^6*`4f5Zpl@xkk zxTka~8LwZLm+`orw7S01Kt72Y!oB}s%+8@n{p^lc?wCabL%mjp>J-W{Ah?0a?i_-T zVTT=xO=`!X*757yn@tNo59MC=99-9pQ%L9G=Ogl;mGpiqW4j7Sbu1|?V#~p%FJ~)o zB)RGO@XMNx^l8jSejCiS&>(wxe0ng)D#Lf7q{HYuRI-`K7-8;Uy2clC#8Ssh*9HDe z_8L@&hIk)VX{PB!?fNPq-2BKJmAbgE~zr-C-fvLO#M;j-@r zN#&W?D**^&bp}W1iB*9QCI5h~BSxu%|GT9?#yuD?^$==dv1P&`6UzldolL;knp@bz zzIBpE4x`!7!Q^DFE4%*u_AOe4mX%aPwn_f{uiTtuZ^j&&?7Ry1mAee=1-17szA&`R zgkW=BR87cK>R;i2ZAlkb*Q21EVE+E{>@G?6rxouQ;)Y`benIg{JJl4Xp2X?~T5y=TV zp<>1$u%IU${_l(+?m}&45VGGF_sV#>3R#GrVG;P&ly04mrYz8{+H%`}+^FZd69b04 z)}>2?r|4=lcX5yErvSf)n%}x3Oy3A+I%;A2dTh?nf4{k?5lCe^nsuQr3~9d7Gw(=N zV#CykyIa-+H^F7yTJvDH>DRSid9=Qe znkA>`A}Z=cwTv}Vxl?j9#YeIFEpDha<<(C6-$VmqXtkOB*DKo=agt=6Qsq8U>mv>E z7@O?N&?`j^r`@QNBO<6`g?g!a#Y!H&ti{#k z$!Q6H8P66{86J@wJ1;H1eCFVL$v;|#PnpA}t9v|J*Njfkwcd)&SZd}vcx!GmsI$p7 zF;Liy^}2YeKQyMplO1oz8nwbowEt<)&~Q;++z=e|_R{NJyi2Ed*V8#Pi&tziicBX{ znWW$~og|)o@txP|kSS}MEkGZgvlxKJfGz^|rZ_T3jm>l&d*X3uS0mr zX)Ogwm?_EHl|YLB^qvAKIh1 zX-Hyrwt0Rg0{g5VajNwQ`h0p}h`s~1VkN;mJm2=efAeC3-*;0 zR|YB_^0C`QZEO7o&cNP>ysL*glToCDFXICT^{O2P?56Xjh`8zf`$fyNH|ueAd+vxs z5m$4|A1J(5#W!{t1+{h589U~#s)WmJ4!Ge{~xLeNk7|*bHtBXyAp_|f2wf!W0?m@yirp;FZCes7@^g4$YQ^hF=gE1?ep)l0MyCeSIcZ z^|Uz)u^%u5N-|d@XA&H#T3u~nsh_yNXP1-lX5L<&LyOosaZ%-_g6jdSZ{V6H&_R9a zHYeeq8g}n7I4SwnlCFO9fY9K89IppGY@#8S0(v}>hqvPi<>(S*GeloOeB^rhuJE7< zv_#z`_E?+ojb`eZlBy07WdSxHq~6_hcFWh?wfY_|+PIGzpo4n4b1`L8u+w>Ab756?Kd=HUYfXO>3 zwnH~1ag<1D;xzsE&n?SVrYs}>Y#UrR{g#tw#N&WkL=@%-5U-SrhyPheL3BXX ze}-;eTm_~@-nMo7dhW1_p7MR#Ud;*BW zyak?w|6HdaoI>?zc{y#tc?a>kj(q|p3#O8!iE{NW)>q76y(=amr@Ow-(zOPloG4`~tJ1J?!m+Yf zQ5LKiVc0iQD9=W(Q_ZHrt?L@As_r`uP_?}>Z`dX~aQ2pCIflUlg7mnw%so?yJ+)tb z898&}r94{cj#`t648Gg6+E}3)unkikg2dCal@!DZtl%93l&YE$0ph-@pD0jcQ?6lU z(HBtG=y?MZbmgC|0+~o7e*m2j(T`M6i=uHN?}9haD~LGiYYN;Im|ZSFL!%bkJ)imN z$$0^7qonFY|CPXsvBJ)0MlTPKQ^8Enx^>E&WFNvCI(zJ_p==L!2`dw~x^GIFIVZdi zuOJ{Kx>Ak11!y5LoWs{lJF?lbLc63&np|yTd!cgfGOArfMrB75jy%8c?tg@+yvv}t z?GFn}*VWMh&m6qRaTy;$mN=Xv%7>x&o&n9^`RKb!vn7}WD2kp%MUQ`{AUAqG*Awzg{==#yQ2r`&MkF5QcGY7^0>eqyo~vS z8b_{TdR**;IzVxZj6_HmvczFvKk?UUJIA0ZqhmpZZVhf@jL~5m_$qYF@8=xT@Qk|B zC^*C8BRA4vaG7>3XU8O%s9$1uDF-9$dj43)`{1LpX}Xg$EqwG16Do6@E5?HHcTUpv zmgRW-o1q5=W4F>MJF9!@19EjCL<^15&a$~T?fim8#eOmFj+w~Znhb=AEzj1ecjM{= zXAz^Ov}Y1hwLrqX5Po}Z(ACB1b#&5#l_mYsUhcU?rzm5&s&DIMtLCP=9X27qqH&ag z!s)uW&jCg$;gw_S+wN|G^!bA*b&e6~88W}Y;M|-_o9}T{jVBOIsc!);{QQqT>=^Xv z(>#Y|vVsxxm?`Sdn=m~g7qHW{SME4byKx-3D58ZAyuQA6cfTXjl|cF!!Sk?a5~vVS z!jV+ClrgA~G4y9O=Ij?FTT1OIDB%Kp4F?lHx^9Z@9_qyEDTZ;NVDF6|ZCFdBZ*+(% zZg4?fgzAm;{5^zbR-7sQtYc?B zr9NmH=4plqHOzPo6MXaZp>G>42F(w%gxQkKT z>W0)V|2l|+D}t0}rGok!A)Z(G&KofN&80hYa%K zRG2FdG&SjGXtqBmv!uq8w{s{#qeNHCZ`aJ;Z%-R<*&DB~y8Gu1EtU9Ee;PzXF)s>e zSJ>y+F<#!@raV%!LQBq_mf~pErD78t$e#OL$qlXJ@>D861ry^gsy9=h3$DjV5)cx$ z@E#EPaKp}hy<$h;S#baUOM4&3IeoQEvRtjd^oAzGg(pg3E_2oq#fFoAc$2%oM{?Dw zQ)Z5{xNCdH;vzhQRs?{%1{-(mDQc-dAIGd*4NMA6Q{RK2z^Z))I@O#$?t^Wi6rAz@ zN7GdXRl$U7LK^9m?r!N41f)YkQc@bEyGuG1Idn;PNp}f{?v!qj?zsEiJNKXCjH4d* z?7r`lV%N^sA0abb6$ELx8hwxy1agJ3bAJmj{2e3`+k=P2@p}#BFVBJzFexkLaJ8vC z!{XwiOOSoJw?9w@)?*!iYLCE7@x!L5})r_rFB_O>nTWPQ@-Tx9jIvfDee=~{DN&sN;_D3&w#(4UuFyb07V*%R8W67%fg4a7 z0^ZyN^T8S>SInlWuPl>^Lt92 z9FWd{PBpcgx8ZET&=iAEao|e9JJ<7m+wPMzr8kAjA zGTz&`pkAK&^WgD`1s0Djt_A!wBRj%Qh7XulI{Y%^-q1&EtBTS=wJ=$_;r&$)L`#DYn?NT3X6y6*1O+=XdsEp3GGsmO;(KC3?)vy-qK^=Fv|+UM zDBc}Lfk#}i=7Qb8>?3+sUR)B$Zn}T`?Ly)$Z4LCi^%VNf`NLY#SR!+Qfxj_rXE&o&j z5|}cBKH6##AsxB+k77YsHpOIcS~mm`^^BxyqR6rX6Qxp1Z*O4|N2LT0@}pett|?ey z6qpbuL~6m0(mN1>f38c*d`x)g&Tfl@+z3a?c&J}j*qlxU&@DSGO0F-f6=dnVb;9jZ zyiUQp5AYfx9tUz6)@RUu%I&$QD54s0@%P`sN0UodTLC6SvF)-pZF1Q*rBpqBS~HnK zXlbMNmQTTVz}!a{vPxMr&*mpnRm~{ZpWdfWRRRMikcU(UbI4L0Uc4n$6|=Ije4}h^ zXu)FDj?UokpjgPiEXmqa{la;-KgB@rH0B7r12)!xjI`bykrnk~(87AeU@&=Nd{+w} zsDHqUlHCmjQDXoY0Y(Rsss5S1$5Y3wzlE#heMyA%831!#tZvcY6! z;4}<;ds*^-`1-PW)A7Hpy+8f$eu5hTSwd3Ovh}p!cfB$FF%Bjg|=_i3;FoKrw%SN2mZf!5O7a!kJZ$Xx`Os9A#HcWI?Dtk!o;MGr=h0d9&{ zerg`c6LUw{@nf&*lPS_p7JhcC)Wvm{;Ea5jk}B*?N%;eM3Iy1UzuOA{r<$oXirT_d ztp#krm0ih6_X6Q=$Ybz*VBjEj3@<4ZocW%fA7F};!N%_s!;$zi+4gfunjK>lqmXB6 ziUN=w{`dQZ6n?kspv2b3<`4|Rt48iDZ-kwtV0kv;+53ri5&M zHXRUl&|YpxGn2B9`BvoVca${07xFGTCFFgLlcJ=e(*)-?MAlWS-tBF=G8|Rs0Eb$M z56OWpALTjYJwX&JaD#(!gS828e^*4_bSUrzrkb0h_QMP-cC8>kB1wU=PU6x3>7JLv zud#1@>aBWY@s<%5yg_P}gokq8851^w?4MF+Vq7)-O9n%(Q19WNH#0yjIg=Tutjs3T zoLZbL<%bRt+es~az0fh0Mm}$5rI&~J$NY&Q%cTay1%p)m6XVZO%kP1cfJsF`&Hec| z)1V;xD^`(s$}XnCRt2SX{PzNmpEyDZ8@O6>Qc&}i^@yl~Y#J}GYzmu}!1zyP4QvD(ZFxV&#H`3Jc`F^DLc$SSIU34r= z@S{P^2}2*`rZ;7(>+4-zT)wA#)aP@_vWKFAoW{)w&yDXim+0^Bm8PBJpey~C&fH0+ zk0`rkhZ<{-kEAs2PTBR5Tn^q>cu3Oig}*SD*5;Z(T;pb(_(nUrD4KUj@@pW~PDT;1 z&v=`}*<~ZlM-wi;T+ydh+nAaa1}Hj~>EJaS#ZLBkg7A)W+i=iTiPe_~yRylX`&5-8ZT+Tq~(1FbvDKUs4}>)d-=0V=oCrzj#eJ>yD* ztl-Ps<*W!yF*^lsoP~)@%7WKBJKVaRR_X6ZjXQeP2U(N1q<}@7esA7odByyg|FQDoE$jLyE{6H>`;zi zQphF`i<=O72ki?u+KnG{Vqo%A7HMDzdjGI}Ex{<_PT@A5BC#T5vklyFMnW`O|M4bc zjWei!h_-#qlxo#2x??E*c?yO`xISB0bF%Beg?{?i@q7vCuBV3%ZSCV+rJ=#BL_vJ7 zPmfK^{oIz!Ya^IdlY07TcGGMNU-Pi%+cTOrghQ)IK|0vZS?6g6Wcm{rr@^CppYK@$ z^JyN)$n(t^*}^v{&F`E+A>{MZ!(YFLV~}VC+8uz(3+xCb^Vr}f@cCYbYINCu{+*qG zq@?(JR&MCEm%t6+?99?;C~x;V^Tn-p1j6f6ODTJ#%*?1qaL!Tu2XLLMBn`?>K_HJ_ z1an12-vzLI)lR$|c03=BiNCNma4+i7HiJH9XIQni@MgT{pGLAme44dWC2o5-=33OWwfzUdR9SMUp`EgzOLALoZ#!o^Fgm@jtczw;!dw6 z?A6>gP<3YX{PxwDxkX`AWR&q};ub6dL483Hr?8j#J(qwcWIxuQtz zeD2AS&DlQ1jd~#_HJeVK!_Lc$I(vR5Oma3a?q?6`I*_k}@*5a3Jf9v6V`nCeuj^;} zIu|7!(@JFr#bSl^^G=7VO5}r4f4w`em;q^qosPb2IlMGOdHNbjAUx9j6=3R^Xu4Z? z@^PxK{a!9sI3s@ZO2pCQyrH}=m_q)v(O9Nt_e#Nd*zE?xRwo3vCs8D456EP3 zHY{suYm-KFJ3BA+M=9v*Xs|X6B{^WgK@}lEPH@x7sH9%X z5!#u@jRF;N|7IdPoY4Z?B$?Rq=x}byal?nNhY7_BEir zY#dB~s_;vkdRZ7I9agO5BhNR=>TXtB)zt-NRIg`H>t<5yCBeT7I2+i9mFNNi(A zjE~TBw0%dv`}WJ5rM;`0N8fYBTPX39s@LcS4~eI8wV-Bc-t9NHCn66tSUe53FJ5J9 ztz`_iSk5RidWwkrJNngls}h9<8ZPDv_5D3H&Q05d@h_C=|3PY4eXp0=0PyBmQ z;1f`%16=1U<;2)!bA&*DxHk$IZDk0c(Bp=!OjMprvp5(&wO}GPt@cl%4DxoIl9;kb z?ALfW@9Ope#{&1EMr!v>dgTY|*u1ZqD@JZH-}ew_6u-i(g^X@5FcO$jWl%=_sRR;0 zg1L{JxMV=u19rda5F84^O}aurKz#+L8VlO^2r}}odFk=5yS4%luF^~Ken89V9qoi{ z>f&jQ!ahWkVp4vKIr@?wcfbzoB6P5bY~J-fv~9p1<<(d|%olknXLMEb_)f)>x^lVL z>Z+glDVPEV>pr)rHG%G#a9*=R|&SfFekd|n&ezIh%T%G>}zaL(P$**ucyh%N4n z;1(c6`GvvI9Ai_hqqf3cNK*O?@|-a2F(`MPr0I->8mc^48Ch|oHA@RW}~EWb-jpl0Ia&G!81;Nt`&wGj!1{!c$%--9eCw9i=9 z3%wH}TnKlZT3-FFAHT4p+rYp|s4UY-8nvXcn!M{u2%zme1i3t$-RZui6(I3G@7R{u zR3--*<{0CmJG0^^!0`c1YOLre8n2f-g=!e5za*lpJx#c3jQ6!ou^tPKr*T@tFUW(m z;A^ou2Z(iC_eIt`l8WnnKJCE-LBrq%R^-I^s*982cW#f?L%V}4r)*Qm--o^4R8^{1 z-AgpI6{I&}@{)dOk|LBbjlYr-z19M&@ZIpZj?@6DGq+M4A$oDT_yzO&*2sM3#WA8v zjZl>kZkXeY$XqL}WQdweL9DQzA)t7B#*IKw#pqV>cy2D1zvdkQFa-a?!vf^?YQq3%E>0T$1AiCDV6ck_XB-dsyJMnlB9;IGp)`!dH0y z$neINfdxgGK9rLZLyx2MOWv-*`mK&FX_(&t3CabCPi0DdE$c+@z?;-E18zYeIA2(R zz+a^wbK2lP{id(}2U2O>ne>0qKuP8_bT1AzJB=qm;m|I19`EF0FYW4U*9$xNTtY~^ zIK+F>z98)P(vsc>?8SY{-gmMeR(`oLQLRA6C98hR>2S(^LC0I?c~q2(=? zKJZsGBS%Xs(=njqW9&F(CTVX=j1^yvaAU&3vn3Vuz3EP&QrXgwDb&RLjrwYmwdz&_ z!hnNI)m%iwhO}f$TAOz9AVrAjmrA6X9Vnvxc_)OxG(%8D<4AqDC4B&=p0p@VLV&B_ z$%)+N5p(;cjn6BCH&cB2#x#^<9gZm~D^Bz4inyAQpI7`VDBNE~asQ1h%aRdQ8(5j3 zt-m=4MU)ov%*usRP_-=p!0hu0s7ye1k&PkZCUq;DHWcz(9>c2x2h%;7`YAkm@c829 z|JyL!+S+S-o-zszVc{=AUx1piQcAT!voAtKKFp;b_FMy59@r+57JSy;>YBP>Wm5H* zgcW(c(u6ZK_)eJ`9{sr9gS3N>33Kh2H;cRx#xZ^Yz{Q!FndlD`8080ld>7~d92e@2 z6}Y>zBhz^Xpnu|XqENax?jZpt&#MDXY@CZ6nB(r&k8|Osw8AZ|^;>WS_CEfCP7dC=Jv8sdF&7M za^}V~Zqd=dDb$XDsj)tP#si~$U<3!}8O&SkR?Va5J0sxJA^Aic9*n18D4>+F>ewjMxmY-wjcYCkB@WUt^|3-0#kz3 z@7OoU$|g;Qi3GO3t5C2kGdE)!9Q(Z+%gIxi!nCoD7_^1{nz5hhQYoYvM3W6!FA*N| zziPa{T&(5Ow`=G~7osr%swE%`0)w@HsOS?Y<^vVT!q|G#Opka7gPuLW-6~aD*`i#} zv@~u>tjI040`ga~%C>bpUkZYi@EH97d%nqx<&GE3|2VVqy7!ggC(rG21 zx4I!()T=5&h@Z>}0rfJ}ziPvo+r}(*FAcwx7uUZiw6I0n&Kf}fOgR#L&-z`$sur8C zTPt6nz07>(qlz5aaBc|ltdUCJEBw5uE$X{w(sjs0N-wUAM$5E?>Wjd)<0YF(5B;<{ zD{7Sx*SHl(#u3R$=7R5Pz1}2UTX59c#}_JTBxsZHD{5pWzE?6v_4v(~M6^^J;e57% zVNYD(ja+C>R{&X^u5G4QL4^hh(*{mQy{Zn>2=I1Om*>zH`E&`4fb2cJlI!+(3JgxU zYeh@jM)I#MR&SA?qj>ZGc3lHRv^R*yaV3E*xw{vhs>=?Mzx&L$Z1?g~V|{v3=Myn^ zq0dG#p(?8BVEdo-Fpcp(VRDqu#Uo|t)!@X5Kc4nHJ&8Vk1^8Kk+#Mj7!wLC$4ZPf* zC&oQ|yW~#!74u}j%jYo-i8%YmZ9r?k?I&(%XHdUmmbC~>Zl0Yh{Zt9Shmeh}9%F1F z!zS>(J&WMdf1mOXfY+Nn5+Qsay9=XePB@yMl~n`j=b6IcgTaq>r& zC@mlilSvIM1W$%Ar&2VSesEC9-Bg3=3DQ1jNG{?GL&P)7_?%|1mQ%7P){eBf!I)2} z0><;qr>VKr?}ml=-mF|L>NYzfS~fc*-soy3d^JKVwf7WC;u8r4Z-j|-Uo;={L@SbC zfOHF2qLj?XeUuhSEm`$+#5^nPV88OO?c*5R_}ek_Pe0!nqKDZ+BXZb257(vUNf2Z$ z94VR_Xe$qiXXYr?ym9OM84{6GH0!}|a`=w?Q)VUY!YNefaW4WJfLJh{VTIU%xGZzQ zNAgE=xBT|<+%zsb%lFwxzX$$GBRQd;V63_1)YI-r{8oR3G`EAyu{D;)!-|Ys0%D)2 z-CoyX2mC<=Bp)C?&EV?dl2}uy;`hJhp-S|^3xlV;8yndk^wom3XaA`msJ(zQmdCGp z!aK~x*LQ{GZPJcBiN}cu)NZP^rcnWO3Z1+u?PK%^<Gw_hC^y ze}A@xr52+Lq#f$=JhQbm7qDyhya@YgDVg7w&UpHkj%%fq1UIVYK{q5l@%+m2-xisQ z5LAztR=dT~RkJ%$FFgn<+9LZNdp)IM&!H$BPPvz##WD(%t>Eyn; z*~thvw9pt%CQLkkd|Zw&D6~mVy2*uL1B-q+ONmjA)upnhGsP@EH5(wyBUqBM#?##1 zbY1>9P&l&uGl7LVCW>#Ro_r9BQTIeuA}p8eE5+nl(Zc&-+ z*b?C&uXEnfSu^r8(zd<4^m`;HR)l2>ieu0A?*A1r{abAdM#|$UR2LnkhPsdOVP}m9 z?{DJX zCN`>nix&d&s6cx~1@bL+ouy=?2_M|1$=vPwHwu019)zQ1Fl8#s>EVw=k;Yg~?f*xO zn0418yt8nVO7)6sMisIp@dK!t1^Y&_^Iw2210>qTgB&j~@TqSI8+9yS8{h52L^|aw zSSg0W8{%9tM_K4p!b_*Nrh+*{{QK-0vz?(Gt#aM{zRDk+P-EU*mHj;xt1YY8yFwQ= znz;3xM@^%94Vu3{wd*d{-e`ZndrwwgVJ299A#LNFKZ$w${HSU0fQeCF3BlijDpM%V zExz(-&}vRZG4=JLPLRZl(`t<8_R}gWFoC_7Zaj5|#xn7IVIIg>%yNl}yn>KGb+SZZ088HIeEKFsQ*?1FH)JCw%zXuaFE@+Dekobzns;0-3f9S zAAuMH@_`KJKfC4Ykxu32p1-CR^Q8wj4kKaxAu>fP-&#~*4Ka+6_DJ%nv6a= zIhkz#gGuD_I5Dk?1TJBfNHF6`MqrB9J7Yqe2XB000mhrYA$uQPN&+v!3 zM?_a7&~IT)*J9FQHFs=8TUR&>uIf@ckdumnoMvK*HuagA09=&?|Wr z751U=jT(+sVO&zQ%4fcoaCE-T_JiDOi$6n`_366|)M;p_Q{(iHV_#>xZ3HB=Ip{X> zsRZK*4CZt-J8}PF3gV6;*6eY`o3BH(jNA?msSB06{xX`Y*B(N|r&2RiM|62aZA6o` zKBt}X==qh+x^IckPWYG>a7RVxJ>8MP_{7CLSL0ukt%z&Uy_q21r%3JYqt?4TPj7mB zzanaIE4UKqKs|d>Uct^;ZUz^jsEqOv@`sb?#G@5i)IX%}F@#26H&V;Qw+_k+L%SRywtdkvm8$AV$bhQX$~A0Y*j%1MVP2 zLE9lxhhbB95KQ^&bD#iw^Jd!!I9h-h%t}uu!XSQId7+schcwXKior2Tvn!92AAa%5 zvFxn^@j_5^BIWJD3=6zCxL`#@TAQ13z9J!>?}-QtUqJtXuu{Sm5GtFOmj_76KUcq# zKVTI&vC_iGXb!+5y1KjnuCJdtZxDOpNGfZpuCDIr;F#V40R~0dBSaMct%<5#D*y1x zg=sY0Q=y&V;hf#!A8g#dwQsp!3Ix;vE&*b{KkMt$LL3)UEAF-Y zOr!t7c{9g5W!@TsH)HO;HkffVHjJ-fWwQ~BT1d|XztZ<}fc)Jz;#dsftGAAO%S0a)# z88u{cdel6C%lG!CgU@MEa`AhUO|hkt0Hr>>8fwYOk-HNC4Es;YFXMf&Fql5`Z8ZUo zDZX#At-7T;8(@lgfyjI_u~E}{KrL73J+LLebGvzZYWw}19v&b_7b8^irFQ(RAvE$g zh!6lwMWnQO8`lUp1;KwCYE*XfTKY{^y8oo{e?9s4Pjql6*LM@Yfha^GZ#+kiRf6IEZbI zs`@9+z4vDLO%QdWA};}4P~nJ109bE>Z1H~;!U}`Jv^*}INoQ52&wA?ia_**uZnfk1 zAGv8AzxP|OpAD5fNu7z*3lHW9;8sum+@JogZ=8V4?D;Joy{!PoHZ9c44}_5c{oLcf zm!}R;BZ$mHxjvYsN4TbD|1xEJghuHc=*gVu5?rWWTe zV@Xf1EG$egy>}b`FNwsHK?;0xP%rT^LwA065Y)D6|A~q11UCrxPkVuggWwSMrEYh@Y^>ab zY#K*hy;9Pq=}%(XhY?WdB^|TKdRZk7;{1y>8_vie?z`EYBgctRQ}MJB9ruEfpK>}| z;!pcsX!WdH#x4>W72MLn=Jt~h|aXnWP?d8KQ*2$5t>@hdz}T;9y@T}`}t znPAUir|{e53T2M*q~55WZP(eUhJ!uT9*%nanw(W?0eG?WJ}u)Z1)}VsAw@g$oSrcu zmYujivLBuWgoT%umjR9A%9N>g3xrSud{YoP5uyeQHk~B0Q9|iLccYEV1$u{sUbsMk zXkC#@0K8~n(s}Q$Y=!`7St}ax6%ZP!zIQ^u6}66g60qWEl-i?X;>P9qwjYb7*tjk@ zs3Sb?8^a@WEt4?4`y2MufRN=Q4 znQp~z#IaoI)e}EGt`?aP7A$??C=kgBQr7Hdpi$=y=U-&7IZ(SwCICGvXlQ( zXuu{>&x;g^>TwiHFgIIp2r41KUpr`~ql_wbQibU#9qKhUEd1$AB;Qhik(t&8vUoJ! z*R~HHBlU$ggIZIr_bui?y%OW{4&loZk3INtjH2)8tmv;^uFl}2NrpMyrgMx8L< z@;ejonM_8}zsoN`+;RF^$)ta~%f1V7Q1i_tE5=LDQHNBm&!i%L&3?(2??c+6v_$zzC zMks&cA;fyt36~czyxg-e%zD?C3k{z4%k|14fEhH5zE{!DjqAFjB;rcwGlGBa>NPcB zMO{L;@HfRwImOy8^Qo~p2k~o=H2=r=))J6?SzHgjgiI$Wb!9~8v8TyMCe*B6qd(X2 z-RgvAW1NGBJ|P$Z{%K?+=CEpQokT%aCjO6L9cM#dABjlyXn&^09YDQFU;Q(Woo0n^ zd+_%u;tFcS=Zho+!a0FpmA>JW!?$0=5*O4e#vN8wsh;ULRik88Plnw#sgl113;)A} zL~u3IZVkLTqbKBdEX|iFS@;iU38RhkoRL$0X76P_us$zW@aQH0=F50ejeQvo^=DHP z6m~%SCfzmu;Q96D=WrSV(%o`{qP}E}!RgiEC(;Hvh8tyJkK{Au+4tPAVb`yo`FMQ= zGlqYO61EWUz5LgNwyY&9g^0n>%kY90^fiTT&RXraRk4mBXetnuhEdRoOyau%opb&# zGGzH6*Il>9kl$RB$jjaGv(6!F zR{h1IUY z&n$@csX#Z5uB?c%c%#=2HDSLZ?~k^xSJ_YL=it56dA;xcM;0mR$ofV*UCq*Ley4}f z>BV3&P1cfmeg6S%>*KCoz%ZFUVm3V7SX5xNU!C3XuO5^Y|FiMI$xhX!)q2pyOA$|7 z(_xuUBuu*An;|z^2H|_5SWRyak3>JgX&LyWDn^unDI_a1le_Ag2xE02uM&8(GSrfw z+M0kdDO`R}GS+7l8!L^ezEvPG4ZjLN8t|nbd>x8yG@}W#*_F=e_Zv+xfI-1AYH%-X zzeX5-=2X~}!40>zF%|&eXhk33Mn43@yJAd)CF=~CtWB$$wLwL<5<$kNq{Wf?reuvQ z!9ds<_s|RW1IMj-?qOjXChH9cW&Qmov18RddJI%f zCx3sS2JrUu1m|c|iJ4ynhlUX`S_v_YM;Vbr^bKK)<_#xzl%DL={1CNVyIJ->B6CM9 z?we0}EEBP5)Ut*VI?D<42(rm03K>Tu@wMFUrkm&IlYZ4?0_%X;sufd#SaEl^O6V;u zrvjEuaAN5yUF;o#^7ovjJed#_Vs8B5Rjbz02$T*+#{Y=?t2x6Fyvn!r^lUYK;J!=m zJd5CqC}4trnwUtK8K#SbBT!xxK10szxJGmKJcxOq0}l!qf<@6}46IIS6ojxg*a1>v z$HJAtp~0&AdKuO6;_8P#4QaLE4^F553E0V;<*S5RUI%pPR9 z`c3QJprmUPs%hEGwM%J11)dK8?f^6{IB*Q@Y9b`p3g{TXkAlPs(d*)e`Kko69{i_D z;%%8nYK;m5PIq>)=tc8|mZKjallJ21C^}~K5MegO@?1;$f?T%z<;0gKArFWA!}=Ej z&-`*VU*d6IWsWD%c86;-)~2e%HlZDiY(@4o+KMaLMpLryCP^Ny=Nj zueL~lJ?XMcw{~GQ9(>#5Gm}uvsn0>cj4LNwmB8RJs959d!Km5H=ezk{(PTrL+P{KZQmG7D9x*=Jt+yqz z+$Ce651~bEDp)wW%wy-SZf-kbv%vl^PLLTCB6{Pcwz&10R4Sa4UWCJpI??tCJj>1> zRo4cRRp0U;jO^dORouio>RZv2tZU;m(?2msQK(7D-ft}7Y~h?AWEd1U`a`u%PDaKA zk{>}UDUS}08tp!E91Tv$`#HFxUtl|zN&srL35@V@=tjw_6kN2FBQq13waa+h=8s7v zhY9dWVD>nXahIlKhYYFTkyjP!DJoapkY?7%qyof3-q|B#JOMrN5| z6<07Y-(cfUe%y*b1Dub@)9YSF*+Dk(Am2~;Y^FGp%vGO1w&1W4!G?RP>&`Z+)s`lX08K>adhC+|ei=n_|1P-TVdiB~?}#*H8w<^ur$%zoOC48#9INPkNTHhWnvrW^W4}&1f zy49rII3fVn_DUwYy=7Hrzbn<7J7jwe+4tf&lj>_u3$I2IW&SSX3&Ok@?-E|9+7bc3FyIXk3B+@=dFmZ5hj> zV(G*^l5}L%z}IONNj4gcg-|02p`*1G7?eCBTD^B9h^8%G!^lyy@1vXERut`$s2%;1QASrl~@WQSL7I@Bl8LJ@j1O0AC!LW z;exB6?^@0*F0E!bNg0Ua5V9R=64~a7Wy1P^Iy8&~hiLsr>tTg`a^BW7(^>&Or@Cgx9YT>~yLChzTW3H{Sp zTudG6ox0NoZkn>=O2MM}cM!y-_y{dIbM?SFu81GfF)(JZbggfuF?>Nz7ZCI$s1P)i z*iN~qT_)R2Iu?Zu4I}g@bK&p9<GJCxmic&u%(+>M-%V^JLwv7kyMnXzZJfDeYZ0`Kzy@sDPKW_qZ)NPg zk?M&G1GzK82!&geN?^;F1PIBoQ41h4ei=-%*O=>r zOG54R#a4}Oda`2{2j067_6^cWf(W@f3okWRuliIDi^caej#1sU&<%C*4ipEvPq-?b zFGR9YGC`+Z1?0A7^=5rO=gtJBow+wU=4XG#2AIXPL1+-)!$^PqDb&r{u3qFeDlW$|OGe$sZwj*mg%k$DjV7`;f zR1MqrD?f4i4eVqW)ncYdG8KIA{NmyUX0NjRV|!CmmlXBfjFWD>V$^AFb)Q|2MVrk5 zA3op2!znnNtd205IKoba?gt-PCksQP2{#qQCg|gvtZlzxnInSz^3oW!%f-`jPN1^A8zbq^;hmgH{;ny%wuO^ z2c-47PqG189D=n*mx@@OdFD<#>V86ecd22yhjLi)v5eXYQ38tj@2@l_K{BXUE0vPC z=3uhao~#Q`Bn+>PG0`;z+2H5al4Iqeg$k={3pn|_iiFF2$C=^E$`VExqQ3h|^dL^b z6-AC%qnUDf?;JG|zB*JXWNY$LY?!ZnhG+@N#Uuf58c=!F6?x z&wE7|B64|uWs{k9NqzrbOS$uRy!k&|^LGTwhdN_@|E~p5qiG5>gSVEd5B7rcsuJgV zZb{Raoh_>%tKf=sZ(m*25C3>fODqAoL?8h3-*tqHCGtBqul9CZ-1osqhxur&a;rc9 zPJRsyTVmWxS8niPjCQ={npA2>m*z1hhbXai?1Oq?SK7YL<8hHbeJtaCeBaQ(=hM@8 z{?{yp_0y3dnD zg0gCSw7?-W`onc5s&Y$t(%IE^U*WI6i4ur!W)a?Irl%v1V9umpP8jd<2UL?=+GPB7 zaof)RsSBbi{y450Tgc3}W}%}R-&oFrJ!YB1ylPK~FMiL+(tLFKtiAw#IO?qWU{Ym# z42Tb19<*E)rcaEpF}|+%x|RYc5jAS84ebywhXpl4#0zFT!n8WxiV>l4A;*%K^1)uQ+^==|fx#XXu17<}<8K9%Fs#^V7aBaMOD22U z0FAlboxk~oGii#h=nd~@^Hw3r@#gVOMz~D^43kMu7QUH@b4#v}`0-n*Se2-44RuEA zFNstm3VqfciOzi$L0lc|2NloL!@)6S1kbVQ3+K2rUS-;vk{CoL3CzmHS6q}f)&w4$ z&IBG++cUbQg1nRC@|XK*5urhaKE6LJ`#ToafTo-86WYU~zK8&|VUHee-J-6bs}Kom zZAc|;(r}&Z}e27HYSY6i)`S}LgoP~q3-q*YWYfY zOHPz+f>smGqFRFJ&8?8jdUjL_R=6pSbm9Wwnm3Xes$W@jy_&d|@|qk5hZ5yV)0W^T zJ_uIeV9eTk0UOwwq{MYkEFcc1C>B^UvK`vK@>SEGXcZ?xQcV3NigG{6^hFhV6UdFh zaUOv2;mPq1?9vAj z1qdhITORh$%d)}WCv=-2RquA!(hamKFD@)D=5p*x;`zxpuI%Neq1bH_sj)2JIa@lX zH84JQPjhPH;>*gP{Eebs`sEXZ#Dh?ry?=rZeYNuUFMl5$b9%bzR1<1vTx5FEFrEb2 zD9^awQuL-iqIcCUNW&3L`0~RXweVwg>n?hizCC8Q_%tu!PTf@KV1g-$!Z0K0ZvGPIUF+yG1H= z^ap0_smB(QeFqNRGrgZ7N;*oSuRm6?;grsFEGTQ5o6M$~SWiv#GRaNADDHmtYfy!+ z?^md6UL*{dh%yoDbFeuU#_^AhA=h3Rv8tozwdEU#8L`Aw>Xsagsr#XBvu?s(uZcGw z8TGiM=w}ypDD5c@UztV!(8Z4KRxi&s)=s|UU7ClXQDi!OA+!hdQi6^=<58yUu~o`> zX^viZ+6Wq(KSf`TO`b2Kdw6a$zo%!!ml|Av((97M-h)xg*}=R3FoiHAj8W7@=Bf8R{1SNt0PvGnawAs_F^2M#T~Kok*~5yTNh>-^e# zkS#qsOYm(OeDA;o2BcN>w^Yl!7dRW~eIvxQVYtO8NkAh8Q1ZULn_K4r9wkc)Th<@q z&$oH9WYlBhMm;i@%(`4wu7(mU4g|v4O$vMIOKcf}nB3J;q+b$zF)=V&&komO@HvJJ zMDXimhiF+d4Dhk~@A=&xrh{=a3M^Z(>D+vt?tfUGyjHP%`_F6{1K!rcpzi3-pSWGc zp0XZI(Qt7eSR(!#Z3THb-v;hzL#`@b8G+0YyxbEMKwUX{%S||JQ zqo^Z~K0IE1RwYcCLr|LE$dU4Ve{_0!3cPuHdwbs~{Pv9T+tn8K$ee6^oEY0zDYIl= z9XR@3q9rdnC8i9smeZq$uxAxKo5!5JwcuM^S#fQCAG&F;mBxpF`Y-h-HW$B?&?$YE zS?)ZWsjC4}^}LgnEupDs!Zx*-v?8soTOX^p1v-YRogJyvzo-L0zqWSu8`kbTyArc}Xd(%Isv)0Y)(T%rd-Os7fk7Y= z4@H@9i*|W^Dv$fJb@1Pesg2?Rn1>y7b|C|4Cp)d0{^5iaI>IM*7vgOSn?iGoa-GIl zf;QIP{JuHsUmG(M{JUQQlNU5%L{j!`hG^ahD7+z@QrYa|(lHHf{KK^eMhb8!78sj0 zynI@ww$b&-7IIDX(-vZzp4WbuNrs6RSgbpyoMX@1D-r*f>I6z$<)2Shglm4W}&4j)Zm1`2@Ed62eE6((x&z@rCC)`rW`Qp3i=;v3>Ce9mzr z&n^m5QedUfQ3J2a#<0zls1c5GC3bu&;B5S!?{*7>wMvC0vrj@i^V3m33)$5Kh7`Jc zNg-_w^;FVj*|g5T()sPdsKXp(j+s<5D!Sw;lC-kk`Sa}t-#ID=AjJ$fe-OgIp;MA|)Rgz3VF18qk@?{ofc_JIvm6GF5(3jsrhAeHfi z+MRBi-DslKEU#FHJjfWvQXbMNKOafg;ZJ{S6Q^ldKEqkcosj3VcdVY*;50NR3tx67 z4cpkQN70)W$g0R9ar*(+KPU!-jzil&o#7nVqb z#~k_e2LkafjgRVcM7|k)fTwxJ0)pNM@_UQeAih)@c0@+GQi}Be7M}tqBFZhwQ#xLkJV>@V|lb#({XCb65F-+c@ETc-8njAUe*4~LXfuV*^j zsAkFQ2KQ0+s{Uk@0$GY)5xdy5xhmrw7=7+I{O_WsT7akppco($&Go^UikgJ%0Cegp zA=LlmDJ*zHjIr_q{yUF2mzzJ>PYnI;wgFC0I?x;gic0+)9di=Ou4PSHIxlj<<6f9L z%in%S^^Ex8krgwNOKDmaXwoPe5T6Tg?$2HVeI3mKaEZoFU}*<26>;Lvd-x_5n#9XG zpKWoS8D__AiN#(A;=ex)B##MzrCc9Q9#EwahjY8X3{hgJ5M`110G5MNE()2xe? zb0MG8`xhmmod7_-0Y)WRSM3Wm_EM4<1-`vc1KPFQc)^``4ojD9J_l*O{OIT9a`OF6}2EyUk#=g*G zmPxQwHZr1Eg)iaJ@4{58;k>aVJ2P*+a7tlhmkV$g9Mr3WsWuik}uk{vUDz z-hb1a-PXpuQ1)Y{h{_Qn4#^U?n$;hb>9p_q#uh(K=mT6tigTA~V?NC%Wqfbwc6~i3 zAo}}kGdAq&H08)ulVt?&(%Y&9uE4~HzG2K(WVQkaKal6 zKDwNkEVv&8=WLD!-29CUYBS^GP|*34Y%d&ImiS><-_>VqB@3v`U0t(<{r^CY-(1)a z`YLgv;S*GSE7J#gE3d7TF|3sK?0 zZ8~|OJyJVgSi{|4C^OloywdxCOP;~*M4lwVqUDa8zgRiYuGLQP#wa3Qhj=DQJS|kZ zwsb{v?E$BhjBWAGJkTQOQc75iO|=@v^o)nfY{Hu;bDP4}Klytm7W-mWIoqU84?Qj9 zU)tWnZEon-=SQIJy*eXvsAIICiCPHafYe6y8?K1+R|8J1KhGv(jtOxT!Euz;cNDClG1MK@yIFEyu*U;UxTA*HC zzX!WQ&@bJBm78s@GsYIjIJPpQb3PM8daj(V`^S#%AdJVc4afZ^~;2OZrlEF}R z)K9Fk8Y?x(lRfX!rfsSK6$D47l%gb5Aj>nDewsk8`W< zP)uNa`5&6DGOEg~ZPSt>9BHLPkS^&)x};0`(A^*%(k;^6-7O`Ev`BX!LO{Aaz_;gJ z>ziNmXI!&9&%XD)udMcPx&qUAh8gt${6)SdfvzyN*tS)l38Z6H5t=KXo>S~eo09Yr z8-j#wA~1ROsRBN-GL<-vSdz;8F}N{_V@r7REP#yHwMdU-Uv2@Q%4fgz2<0k*`=|7k z>>V9}8C_HQ8fbMN!2N_6@MbcOHA~l}inm7=WhA}ia~sh4#`U+7Y@ZN{X7Ni z%cr~CCvN}|Iy;L$im^=44c2y<|LkL)}<=TFA@l!UTcNb zcNFr|pvTc&F5F*ggb?44T@pWQuE8oIDBX#tfq=vV6TDrajNqJvsnlu;%P?U$);W@0xErbdaNKqjM|G zbjNiy?oM(8d`7X3{N5P{$V(U6>QUIbx=*#hD>z-D9Y|dHy*BmfT+_+S+%${SEJC48 zNolqHq5qk8Kso@1>4E%<%5(+UJ7-X;yuP+(x-Ug<4^u4{bf<|gnucdjX);g#5kDz5 z8TY!6QOv&F@=j8&8kQJb43u@;(q&>>fPulDJCN3;EU&b8a{0kkhNbeDrv&+Z)B>jASbbCUBPilEOX&vF&ElrxgYtf(T)J0om`gbfn zyG&{i;!2m92y_%!wYg$fJ@v_-uNFuGA7R(H;?W2(p@}-=Xu78AHFP>#s3G#i{H*V!+wiews9npS^l2rMY_rg*p z;&(wU=GU^XTF_itn<1}%{E=$~Bh#XiqXlVrh{!Yu%ZD$RFv2yRYu?Mx$VNt9pwi+# z8e~U2i++G`Qb=yBPrF-9{X9I3`uCRqNjnVf23JDk$9<1wT0lvxe?K0JmEe^-b@48G zW`Yhhf~(K3nFL;?8%C7w_i!?BK^7xF_chVKF)Y=wsECj-QkOGkd>hd%HM;f1_PkX+%>)H+5*St7PnJMTqP{mLIzk+wS z=U|S(hnIu@r3U@8j644HInu%IgEZV2}M@ zs=~mJW8F+}yVp)M3`X3J37NYQ+ccQrHwGfFsBoqSm0EhE>vu_H2okfKPeP&ZX#=d% zi{IN}axKGcK$c0Y)X#Yu%To=!m>z=e4%hFSOrAlOaT4lG=Lx+aup8*x08kbw{+})T zoSHeZCB2TWUo1{}F)xJWkfSdy!?us%qnaCU{3~?2a%{X2DimpnQw!7G6f}bmRCD0G zfaKZ*&w}^oj~knvEiJHq&d?r^RU}tqhPH}fb+P&VbI-%EqunJ=?r}p1>%5W|21l@^ ztp`nLx?opz5+%2#spF=jbWzKC<9E^s>*H@0o$;ew?Tw|crJA>JQXXnBY}_{N$f5>T zX9+8mqo+*?XWal&03NAv>|}NrU1sOZGvQ$=KX#8;EIm?`h(3jpYG-D=Q|A=+Furr| z-`R^Q6yC{bhr z-)I7cr^Dw0rZl~pI0nvJ=xa01lAyM?s_=p%dh@T~bOB`jKY;lGoaV!sRQh3;siF-w z!UdryvEVE*J4Z*d5>NDjP~a~;2t%%%aFDm2LQQD!)OUf+kOzIej9`+vvG+ltZY;g^GRS5!~jndH5QrSvCjm{iMH-m?*vOlsm~XCWF0 zgx0m4S_*Dq>$Yj}z^^A9%(-wS=$EeMe}(YJbIMw3K{pX<_NHPX5ab;267gBb>`rE( zmZ`w)(i#=hn|0$%qjMWixTc${;9HilLa9bU>9>-q)h%5ag?;DR%SKf}1GgBnPq@?3 zUtoKO`+9mfCTjI?Y18I%7rnb(^VAAFi?ql)oHs&WXizBnr);7=I5Y5BfvW8(EIDvl zg1=M)b5-6Fm6F~PV(bg?Q5~^dptd=-m{Pu!HIS0;jw+rtIn(_==w}GdP zl2mEWWf-``jlnm!WXuo8S5lwjW^Ee+L3c85kR(s&`L4P!Rk?-sNQ7b=%J5M!T3^Vb z5xU22IQ#pv(q?xHEWkofgnUN~i&hvJ+HhLxWIW~V4T62XH~!)%Vq2pModgI6_$KB) zd~)SYVpoLjTkYN6rd4SgU-BD0SK}P=RH-SqTYR%k3+2IPCRc*X7M#Fy$RNd$3^>{j zak_U$mNOH`Xg=OISaarTS1(cs_8o@K{sy36%s1RoBybx9Lf;t|Ivx$jn(Nszr(-hV zYs?gE!qjUOMIfkA^<^*TZfE`^C*XYsk^xCJ-Ad^%7zJi^)WOQHLydo+_agq+X{uad z9I5)Om5|HDe0C9))Gb1~fcO2D*0%fc!u8olXG(J4v}Q#5ada1s zX>{o(?Vva8dZhJ9>+@FIV?(!0g?(-LCFV$Dr5W;3zU%-xia*6AK>O|FL#bgDu>XW& z*SBgTYDM%tOGi`ZIi-E*ND9K59UK=C?q>2$NQ-_zM9Wxt5n_>ZQXHj1lv&xqgoU1& z4bp0Gx7hEwd~=%*ZRw#wjL*N+*7A=w-d{`yWW@SEcjSQGl?yXYKe@qlT{yxc!&0U9 zRof1u;nM1pPj?$JB3j?pkV|mjue_MlO{Ws!gWB2Gxe-6eOl{%L3=D3pS$ICJ5Hi^^ zYJ_?pW5YE0cl(7EeZwe_0P4{3{f?9iFp5x|BCg0RcuY z$gPN4#TyOqlK-8-KsgyurS?WZxx%(5c2-x-w&1`>bxWUo%&zy_TQZXs-{6R7DmG&v z-KjmPX&ifXrFjSHozBIO-M0^8Fr!k*^b1#*;1MV$cj7q357Yx2nVid<{oBu2lLlF| z*8VC}x$VtFX4cVotFo=nldDKDb6DT7gzAm{7DlV2`<_d%@FyBnNBWsUxE%0A-(cJd zQ!c&$(Fj0$4j2*8QuoQlG-rrwKVPV>Tk`*JDi08^$R6;{YS=vpE7(Ln6-hLqB;=&>;Ch{N;WkZYb zn5B7@6uBz8&mMzhy-KacEj+Pw$}CHF%$ie%l?k4C8nW;>dmoMI0;M2^mDUZxjiM4> zp18RLLEcM%P6HC{@pe1@V`WPW%PQFOC!YHjhp@`rWsOs#N7NYx7U|29C*(mgvO%)G z>$qw3=?Aj`3)8%(n}DYq&@-en+_iVh?M>Y*`8>R&Z1{Yi#;)?bS1kSxDJk);-r{nzf9ecrT_1QSKXwbC`TOgmfr zd)-!s3~`L?eWzJcrn6?V%RQ6UN+g=FC9kTJqi>wi z)gX(yKjc2xbg>eC(k{6m=T=pq7}B zP0XtEdqpZ8-p}D+U8_KOX3~ELB*Q3bEJ`T4W?KiMSd{*_}>9Pliyxa-1Asi(kDkyJ%ha7ZetzW6}}DKG-=?)D*J412?&f*@V%1Ajuz3wQU z&Ws1a#D=9S2>-ne-?#&NidO+%uAXZ&Z*JLwk7l^i9(Ymn=~#*WzZL)x*C!l!;tMJK z$pX|cM5;OjF5v)^@a+|RP&qof3kTCv@o*=c7VUw0porsT0#5X=bpAAz*04+#V?EZb z8`qx;Or`#i>P`c`D=$zEX7o53fcG)ncr}^vY(7*2JLxvKF-ZgEa2NUT{UzhJOKOsIU&=xE#MR`p*ha?x)Z#~Lg-r}NwP@z zFc9%WVA3MybZI87kN=txCv;M-ugas8(XJsyELHcAdaIWNCp&+O&^7X(B9Tj@sS2`R z0=qVgN4g@D?u^*Ku}-Puxw`ta*M&8GUY|J!8%hsfGyqFAD7Q|FQ7Y(PDs`-z0P#DK zil*%@#_6OPVU|-J&y1nT|CTwu*~P=KB%7+>^Q6WVSiLVkMkN!ef0O)U|8eR^O~4aK zroFjzBbfg1OY`)0=>yfxJ5~q-tSy9y`YBX~;eb}N%rz5UaX^>qvBMuFYtMTg zu9pKI_X4^Dp1Rw=tKK`Uw)+-uQRJbRi0YC+O$sh@0t}I?W^j{8zsO zA=d{5iXY}Ao@Wu{K5{GAyn4O=#9SvUI_E3)UcX|Y)P)v0zpE2#P8CyinEpDQoc?%Z zy11W?&?~1|ezG5n64{Q2Lq=e#;Z3`hQ}YfpI~C(9XW5X5Tor7Rw@2``KOxJE;a#8l zgd+2Z=-g4&Ij#~Lf)4ys$DbG70y`osdO9raZ`cF0i1TyEyjvWx+%mrWtY&<7_u|v# z2(glshq*)DT{=G1&tl~&Ia}6Ha1TzEqNL5eED5K&p0oWPIj062W*UnYG8fcN5DTi0 zvHM!~c0|QN(Pst^KpZDv-6z4(WHjEsyK7G}@ThrQ7cEmznx?n-+!~aZ_ZscjmsiM& z%*BJW5@J|N3@!LBm>5Vbe3YV|M1;e!-@YWNErggi&6q22C{x+L|B`?D8`bm^!goZX z28b`oQ{=0nvQSm?P46+NtE;-yR{-=$)f=jQ_lC%jHA_*yYInHOFjni%t$t&i{Gu(H zEX9JKhuP~-uo*RC@j2L)!0rNUoWQR&-V6rhpZoia^+=ps5bFsx=y>DEJloXlo1I|f z2`SVLGW|vjCM5-%+N)kMsPl5_g1QkSUby1EjdsV8?75ooF@j#i?oaekw~qwjhQXfl zefh`N*IKqCIxeBD8!Gg6P$e97#d?P(gbG=$T19mNqUT~=N0t3_3d44cRE=tsd>S#p zx87et^QKI8_KO%(B`c!Z)aIb}@-t(#c~TjQg0&UG*D;#(AB^gs^{IC2LC!ZW-Ff$? zt9UjULWNkOs#4i3n-^zmC_>e-qWfbzphT#L@1(}FW-lSL+E}8A7oSl=7?$o}rE`-I zI+OCqkA|r#?~oWOxyUCh=O?8$3V0|J<%+a}vc3s1JXkL6n~}4OqZ#!lz?^gSs;4mA znnyk%Ib({d<-LDYH6;kweds$e=ap=Pn;kr>WG)evB|maIT<*}yfrXd9A}5F8j0>hE zz{LB3-5z`~RgR{&|E*42yd6?M#uKh$Pou=%)d;Cz$YF#v_8Krm%G8VTHUPwcUuXn_ zq6+$B(0si-@MjWG0E6F!T6Qbo&Wd)ABg7~60Z9C3lU9#GbsQYtrE}a?D~1DRTYoP{ zT7xjEq-|Q!)ZED;=0&ce#JNLZh_=`S(@@5_f7hf@a&^ zGNvOf=rKZ*gLDmq?J*TcZr`qe7O9e1*%4zQscMaI7!=pcM;+V789U7?BNkn=h?Y=X z>%MHGQZQ!0qN1FtYyT-*?Rit8hWzepyF?+2P4Tw{k&?{Ci4Tl6N~JMO1@5|)Atv|L z>__j#N=k+dep)G;w)AlGr9U^BcYd9n>LUHI)Vgk=BZ zJ@wpw{b3T)@2t8IY@dEpfXw8wKi4zI$JNuQwR|8p?E!u<3E)4FmY*k*kIhZEJxdgI z2?RzJE>!LJ^4{+SFvGRDiAUKQ6njQ|BD!7*9fIA)_vU1EczF0TE`^VKA){5i$}0H; zM=*3{_)k$XcTix^QxTm|u>!`m1e(uZ_T_$nzDc*TO?)W_(J62cEeXiEum3eN1pHfG z2c!J+j0$Sn1NA79aPqm)W^61@X=#|6yh=E$FUXQwi=^y)PlW^m+JV&XKMm^RzxBbv zuxPxl@62g&C>bCt{NR04clSwz_6vl0yetns>yt;Xqri3sh0rUm)xFN4U)8U_iQWc` z@T!%{-!qARoSv69sOrn*AeaMZ{; zG}l6wjM%wxrf5#c%xn{)vN2Qg33uYJd1>ghcF-OzVXWd$%aHi$bcPO{>T@ZR+?<*Q zgsb{~rGa;y|DF+`vtyjfing_re&xiiLCIrkw|a_Hn>o*#``KLkMYp$o$*${T_)Yu1^uM zuDd&j+qUEr5VdUHZ`ete3N?6tIop~%X7=RRG;cTAWy5t>9U0>P$77xKfnAdYdS5i) z9XLP|aDEn-IQG0gb%FTPt%Q&Y=UPt~zA``Y&Pfs9mEWnD$k?$tJ68Y9`Xq+MT zJWa1sk)PJXz*lcU?&lQsP9^dntUop2Y-KYT|Si<1xy!Rb;a2FW1+`GaztITy)MY$>rdd=gi zhC+sC2er6JEqWHs3#Q>(SXI0dK3>>%EVni>UoNdZ@OasMO$!9A0AAF76}$r6yWsYf z*_+x2BM^i{Q3Sxxj+a}(2e9M~3=IJE1Fj*;NMYHCfSu-d_T4#>k+>x8Yx}F5SY%Sb zIFJdB+umV156hP=g1Vn>(y}SI{VyUz4QFjb<@`|`!Zr4ukd~O&Q-87k~i|94?S~g&ug8p& zfr~O7Bsv0fR}b^6bC;#%<$nNd$*Q#AsS!6*#NEuy^&c%!ahwm{{7!zs5nYst$?s;F z?Wi95QNm`Ri}B}2T;i`Emy5z<5NA zXyviwLWKHx)XRmi%i+Ex9*;WQ;k?B&f9Jk}}8G4D6=?FKKkTUMC@x9KqasCA+hKXX7Kg>DXpVeJJ2(N)-)YqG1S5K&&4q z5MvR_F6*mc;1gEkz-Z)*_JGnZ>}>LG6U|%&lPN#Y;)LU!N&*v(H)SA z06ibXP1k#Sw@P1+mbv>+%9$fGF1A%2BGx^^w^DbkIeMu-mzZR`m-x&>s;jGkmj;DB zhF}fwl3UB1Q=3M@+6ev$F)>Yn+M|P>pONqa{J=a(az}9c|bdKjn&{s;zZqJboZ8RUIf~N#l=V ze}Lyt!jpdQZFYPoL)%*U4e5|&6B~b)rE$O+UN``fp{ z74Myok;BNcQLa+g!`+Tg#=Av&P*Rk;3M))^bl*=O2XeL~w`|&XW zy$F%@s#~3)#SJry9R}2U5;Lyo=vrLfFehf1J7S*m zzRSBie%o#*h}~A#KUXb_SP*qXKOM1EaTCTSs)6;+x-NziFk_oiPaycw0TpEqEY-$N z&^xfLfn;VHM5tB2YU9e08Gq!L^o526OsMHksvDLX0Xtof#eW#a!PocjUDQ=Mhr21H$Bd1Z#E$Lz*tW@bS5MO@jA zqdP!)1PDR=#CBARic!U$JeG2spwJZE@0_mnR5_dri9{gV(l?HeT_Cz(O^0hbceO#> zCb(2dN)09aY2X*F24-3!A?oOIK71$|FE@zH?u|{{T~u=iKtnsolddPGLZ;Vqm{gMWbOyKq2*q?xOf>x`ZV{2>dQCD+we{WXoCe1+9bJ+8ny zkNRqTqcU?iKNjlxTS(%J-I&ivRHf8GJ=LhpG&Td{OzA;Ri&aq)ge#hJ@=2ElQi-J@ z`pt#VPq@*^ka>j7-{uqIPJyBlW7oYa;-=`u9#Wd4hwyw|@oaZl%_dvIuX+CX&1xR5 zo{9p$>gwx3^GHIvj|k4v6X_*0%=f$U#l!qv+$dC^`$hf=@uedZlPg5i8O;EML$qCRTGZ zggr}Iq_Mm(ZlCJ59%`OC28WH4&3~BEU**3l3f9%IYaWEp9DxWW1I0@_MQzs5KQm@G z+9~~X9f6G40#gWGZO*)vOrO}tV2rOej)akX z9$F|0{<(W_{K13tMV&+<+FD8G4?lP0j*kE3bBz6ioz$+6RrM1I*jXzdJTE$maKZxf zpphS6d=WX}U?EBozJ1jMgg*R2LNh#PW2xAN_=ZD8yX6jd?r;6nETR_u8lLmZWo2hu z)B<6#t$oj@yQH3NAlyIV=b>F{AFUKm7F2oDD6}v9Oyswt@xn|p^_6uZ`tZ~zr|?5v z${-WoByB`uz1)^rr0_d+fh(uJKsPlKQKHIkxlLRNLq7Bgl?SLpEKzynh;Z*%>dyHJC~5A}QtK_MNlKVH|s#`a4B%SMW{Y;^G== zSU%Bhf~pZv=h6l82@y_qascN0?%#mJoc8t24p)_7e9ayN;wrX(PZlR3HU+!`etpf} zD501*6SospTnqf@$QXv<^^70doET`aOg#PkUVEWdPrv+2aBLpPE?5Lne{W-?s3hvV zJ92Tde*2&zjgPSza~0bMi~v?Z2?aE-qX7@KPwwE~!K?&b1wef!AS_(%9E@fDL+}nI zv6QRNvoAp}Ni6ltvncf1AF{dDF>0;tR$K%mi3#F^A5j>TB#r&ziq9J-6kc$%v9Uq! zeH97p2vwS^%yCt8ljquy`oUfFABjWp}U-L-BnR75a1l*llfV5{PzIGwm1cui%J1mc_CUV7g zyG6%Mh2@mHh7B)p$d1e~qN~HSIs8i^{|$eH;?#sD5>ypthiPi&xaX*5n)$n&W<9J} z1_wR1ER;42MblNhPuKTy*&-@nSY25GApl@(ak+Nd)jNr}4r*Om>YTkyASS15r6nCa8SnQSj_d!fa=e<`1sC52-`*)>{Xa9 z96XzWKfvhe@6$sM0H&n3#mgyKgo==9uJUK%tfcTh%4<|j15f$Jsm?FtAuce9KNeZ( z^EZXm%Z}gQcWfXZ`&}*yfB?j|^IaI&E|^Qk%Hx%SnoNP4*Uy6l&7;Q^Br`E5nXWR8 z7&PLGAz3dYAi`SRaNghnCfYAmyQLTvU%o<0Anl*-#_p;l0Q;`~62REn-3&$>xBDre;PyrrU1F*$7?s*s0gPErTq?pdB7Aqa* znSK>l=+^wKyG@h|6781+YcKF4iSV$&`Ijaa(R1A+6ZV&1GKe^157m_LzxpTw5s5X5nt51L`2KYu(w`*ECj;eEAsNU;TWMc!xDT0HlL{_u^rG? zF-k0GQFS#IvanL(3R&6M0Ls-@Remiyz4vp-6eeL}Ihc7QB835^R>dl*OznabSsKA=_sWJ1Z;KS_HxMFdjrDTaQJ-?>l2y-~!ubX#!7lk^?PN*uLC}(}U8GE>@vTEH!QX8ggH<1VL z<@y_m=scU=XjNgs&Ungv;pT&=SoE>F`%!dkRo6A=T~eMs%Zhen(vh=@=fJCprza{` z?$55O9EO@6*7S*yJR}v6{ch2S{B)mSR7&VEG zvdN?MR{Z)@w-b;!rs;C8)Jsaq!uqnBp4^%Vv%Fab^Jz_m=h64=#CgDg39C0EX}%b&9W40`*{ubCmqwNytU+40afF=SOm)0+@A)u zVq<>=S5}O=m5T0`%mjzT2Dcs4UQ}L_my6+>exSstrt|b@-Q}B@d{oi6(4$8K!6Qek zME=6}T5*w=2>dk@ry2Y_C%`l3hP92k$=LT2OT@1}mj5-aUB1e}a%DSzjNQM^mEMHd z;8ust?083{NZM=mna#~jTv2#keLWQ>eQav(e7gFOP-o&cn8g4X08gOXc~GJS(o;5L zy>kJu0M=kKB6IZ(5VP}Y-1S0a$N^an&of^2nOF3j46<}wS|!u}x!j_DtlF!JSZt)L5xGc8SWXiVFebG%# zpmP#zmV|uRyn=59n%AM;hlx~|M~jUiAt4%vn%HH^p4@n=%mWQJ%ze1y{%!fo| z+z8(F3Q?`wkse5(=-~NfjM9#^*{n$BeL{p{!h_qgy*s+Pgg`bOs0_ZpzXx8)=H9hN zam~#4ETli{$>JL46h*I+mRbw)&@V_dRo=VPxlvK+ksFs8!P=SE%XFsm1*pg`~O((7lhgzx=j`AzbF&8W4tV2DB#SDND% zK}+wMP2`VpHQAL`iI6^*LiSR8V#Bw1UN5m7;io_R?=P)^9|~kuF$hdjA4$qwzWuIW`GBzhDCyq)fhnNsoY?L){eLZh=O1(oEWN$sEU)QWz6xx){w7(P3$jsyP_PDc zbzPPyw5CD*h?%);JUwqoAO-| zX`$B@w(H+i+TNwE73#Lw*y+8bgXPHibRMdEEXZ@n{I@a-2nYxX6?t0ps3(+B@YdLU zR%KUAS4ZL&_7E0` z8lzWUZn}-6FQQ?Jn6Y=?xT$+#KDBxmA=x7wMxV|*eOS6;iNz2=1}maSf5`0;ur2ej zVmz)^_O~j5UNIKtJ4_q|e`a7atq#%{9%0s-J7Vt9GxqqF;D-5Zv%n!6dZzS=cWtRE zn+a_}QRuw6gvp3)S19dv!W4JzK?_=#W2NTx+@yrUab)7&hJ=M!qWX)KRiqh9N{`j4 z{@t1WZgq2NNZ+A`j8}ib+25x-nNOFHsdxlD8?i=WrwX|N`S!0yCXxOVLE~fW)X94E zTs5zWza%EZ)VBNBJNN&DM0z*0LAOP4wRFvYND%6;&et2J-|&9Q`kv3V2;IEy=d2%d1Yl(?lQ@vghxzE+IL326z|X$CF-0zR-Z3F9OlW zV99eHj;BG8Bg`oFaS5^UNw4r!O>B^>V=x%AvKc<;zkYcvw#jxSf{L(vkRhj;Zw@^}1lX~NBYBvRr< z-s5kOi#m$E%m-KC8aK2O{o-#!Hn_}-&H=h6_^itIMuuPTKcvm^hr}wlb^%0sc6J5? zngB(=8*DEgP|CSi<}pFKMa%7XqrzZl8gW}~znvQe(Gg!)oc^BErOg4bPW(7wIH~p3 z`Ae@=hxhanj7!Q1((se#P~J={&X2un&++=b%-&1-?n&hEjdZR3GpP)7WEwmU*1HHV0oBJ2>4`h|K zpY7Q{5#1Bq_i7`>j++IVEK#QDa)(5@*8O(+ohPx)tV>^HL4s762t`mqD6xdp^nV(u zBP4v%Mzo^tg=pZICq^t}%vsNj^~+DZI?&}Hf0XSpfi{l6`#jpka zw!gOgiZ_HL@+yWa6=czRc3O8WyE|8*I#R3GX7b9@uKDU zMJaM(gEWfFK1FgEQHt-W`ow@*%31u6Sk&L@gZmHHv1{$@bth+`8U zE0&GL1z!{MvYGI5s}hmkT!Gl|bS%HPVBcy=;oE#|Rv22_ZN<9O;VV*NZqvDbxSbRM z%gh7{^f{G#C85^a@F;wB2Q4+zYd*o|gtuLRLbTc&`jI7(%lW2S_gTTure$AVll}|k zr=1+G`1(^!IqaYbr-BF7OnqQ}=C3?loZ{g|aRDjL$|ot&Lqa{0zAXzsp1U&UsXoT3 z)YO=H>25EeMxt&1K9M!p=Jy=UuAiQ9!x&|Gv-I;t$&~Y^-?1)c(uD(LgaP1pSiyHh zHA-k+Rn6@jV8LmrmBVtN=`%&;RLz7{Wag8k$hr&;_APnJPKTdz)0FPOGVm1sEQu?> znHp-BMxPfbxO{OZ0#ar9D)*B}NcVpH`0>(?Wdjwmv*Yt{|6fx!Fwpv9*kxV}sZGh& zlAjZtS~*HG<1%C*C#@>G1_b2h*7t$5brAL&X;%Ez5=BHc+{=>q2`z2wgQ>Xh>oi&E z5;VqmFVp6T@qj_FrTy+zR#7<^f@P~LYG!s7R2ur`$a-VGkfw@1b=xfW_w?Lz$nvky zNm2dA?R+-p0(~JYtyHb7CS?Z=GGe2ltu+|o-g{ldqAJ4zIDow2^!q^O#GW=@RMpcH zev{tRKj^ZPt(@AbdVLl;q3sF|2Q^=Rol7(z7dja(SW8mPS^r8!z&AyAF)Ftzx(&Ae zUUXob&UfGfJ~3bgJ;)ovDXE-y(=YmgdIW; zjLgzb=m7bO!#{>1$uD4P<9~aKXuo{>GG}`sc3j~*cT+!xh0QN{@!abLCk5YRa9L2F zH7?Yn<22aW({soidl&}}+PnM33hEr?3VWXy^*TK_I)U9C$`wUyenxcEU{2FC;-4#| z-meH-U_^1z2iaGk2>^uMEMpM%hJE+^9)Eoyk}R|E^X#nNi+gScXj_h2mh8|<5yWVM zm%)P%{r8>Uq{Vl8j=x$>Uv?99B$3HYp8aG@V=fkYjQ*k@^QH4BYo4R2P5pMpj!As& zg|YcDO_9y49z=YlGrZfq6@fXd$by)vP!W)D;xiX!H5M$<4`w<)Y z_Njvc-ep@m)vMsW%IC*r^Wi>YLt1Y_Gp*LVb=)JW4_!C#o_4&>3hr@cbUhQFJ0ixb z5C5&yo0*UNEN$y7J&K8tH||MdG3RACDRrI0p$t7yuSs9h-L3CcZ?)FTK5?Wv)ThZ- z3PTKIVE0S9)v~QTl?sX`e5}faJR(f+de?o8V(Ffn0UDrYa(H?4QY3Mf|F+XkYlgpo zlCJY@{;~HR;P~TRUL?J0^^Z(!{aBX0)eKf^Skf^kI6kq=Kc=0ydk%bUj=W~1&tZ&rn{Gw0a=kP}3Y*%8*f z*$AgTCY4eM&(x|db|?nBF0P(pp{;$ELP=P|-!W9G%+DIDOE2eWGICHD zP!>I{tE-sKVXh>Q?FHSKB*dN;L&Wt*FBGUU1Vr<2dc7 zIg%LfV4E_ZGMjZ_7iRzUB-APp>!#VkxTdnqzsdjnho2o`LlVr!{_Rp1(IZ7MM>DnP z^Z;A_SMF~uDb#wAs+JpNWuAYV{|1*I=?ZeUXnJ^h9!##hhIpB&Bwi%rpKPuJv%pt! zGFZ$?{6zJ@gdgl|Z|V`$p9tgLH|j`Qz|KAEyH_JnY(0VoO(pvBP`MnqjNPpVhGXCI zS;`T!j%W=ReeqBJ+dXIJ#A>5dvQ#R)ie81JbbnYnQbiA~X7U#u`e^TzIBi@`eX&PF z=O=$U-l6WE-aFr*CoWIUnPHW-|4{Bezyb5Q*;U-YV!l- zlfsa%Eqh;c$sXNhMA~wUmQ4tw{QdldDY_Y^ zAOy6+7FMpV7hnswY0uG*vGIg2dRc`84Y;3ANWNbS6%rESCPdC1=*c4q9SW0K2WdFR z`@I03;aBOD>J|%W5@TxcIs}(&x6f5YC0R2~C<>^&0Rk!0*;TUbCdM!rka51j8F0C5 zl}z>=p64D-$zP+%7)XY2ja8C=kw6OjAsnMuqAAz}GID8r=(x-#ter2ptw}$MOLpi# zutjzCK7AS*3)B^XVZqupqhrNt`Cfjs*7|IGdc+;UbV9Enr+l0B*!Qx5L{y>B#f~== ziOUiCkF|_6%(h5{TUjBbSNSYkPh(*0v+`(BA=a$i)Bv?z`|j&GLth3%-a~fA z<`1@M=9uf|OO)?uQuqD~4Fwv zs*;eeR86$6udafXNA2btkDi_HnN>^Psr|$*cr^p5SnH5^chvP2_78xpNIyg?L|J3` z5@D>#F@6rSN616zLN|2pNey}_L&1{oLD0#(&~MiP(q|q46y=z^wS!(|D9qpp^L{;U zdV5@RHU)A#IE=wPXP@vQjJ4Ymk1>$=S4CKr(TcCF?Pygyew1b;GN3F4pZ}hm+2_N+ z)>-;ZI%K%b?q!C12>vsOrjo5rlxkw}_jf6X`-6F2ZHl4f|JLz>EGKg|qd4y7CR&^F z%%x77bVlwbr2hOlJFiqeG)_}+;r-2&b8mCJ6XzI18slB!x`hk8FG~UqJz)h%;TpSc zKaJ43+U~iF5uhG~o7OlLHKV#p+*z|KxG?U+XS4az@d*hy$&y^bD#f3_J^m5cNnu|@ zNCuGYlms0a?5MtW*2b-`>rHKT)cD!GhD_tx)8~U{o9V_+^meX4dvtF-o8iW``|^VO zpP4;KtNd=f;@U5&ggbwvn3%d@^Vi4meI(1>BK8`3`Dcv`M z50P>UD}N03?zhN`!;2SGdm~&p6Akv;SR#M;>LaB7BnbY!Eo{h(bn&|BkZ0*rL}1X{ z8<>6|D`&HC)eUeDLfPH$EHM#~x3@^NyV>KA#LI+BVm>hsRD@KhCgQ$)8eoAmn8dqC zxC!hW?k6QFB4}Zh+BOF!xxOSLXzuer0pcPlN zGr!t0jP)_T|JCfuDNRai-uTR!JoRj||J!0IFB2x-F9{~hPrOE;nd*L)PGaklQBR{5 z;f=?LgWCxEficzqbDB7cN~yG?1WMjK;>+05N?JCtKMUem3>>uLME%qsD0LG{(!$dZ z2Wzr8^pCosMJ1T6KNmv4-HGXA9~HbwjZcN1^`qbr{qf4GLiFk)Z-v&q~6^WXyM zgDiq(A8VJ`bRz{;l&wYkC8KwCUd-1C6^yNNG6Wh90nu6irh3`3;)UQaCVqYWnTMR* zW)j+V^zPDo8Vj4#M9%f6@;Qm^s?3|e$7Y;A8^ug0x@avfiSg;>F<;*suMWz6mVFUN z-&yPPsx&LzD`DR<=-IUE#G^sejN$FwcYcHrj)LIUICQGXpLO8*aB*?5awBZLr58y3 z*ik^6Ait2}@twwyFHEeGO zY&zPWj*jsa<5Q~tS}0IB1(!iI#x1}d929njhAk0`E7jGR5%Ai+eap6e-_`XmE-YcX z!n<}q;9I`Dw*VjC?b#5;cYC%00mq-if9RFwYbCcqVA|Rmd4MVMj4YF}5u>@55;=w5 zR~AIaYs|4oL^bN{VanI~=+b!`Jz1bWMG*Zj5dF~3aO#n+C%2x9mC@8n?@ntwa}*?~ zi>T0rgsvf|Sr-&xRn~fsp?;UX0w(F!Emc;mhz%WDUOx3V-99QD8Ej`A93lGrT)5u7 zvlSH8wl4(vM~5fQGPc8&>6sc6KGMrDm8iD@aXEOq0Df%C&jmrrkk<%b&hhiGtl%qw zW6c5RWI0V!`+-`+zxRf1ksT7gE1dU?G9)d(z-$Fu9|-RJH{bKvtWa-NW+M0;!tv{X zMz1JM#D>-2?i}>IgD*_+ffIJIGYlEx+#gw~6+$}L{YfukjD8SJ7&ewMJ72{q>io3!)nZb#}+&a(hdXrmQp+0XX`kAIz5Pk`NbZB?F~8T;8`oqEdM#ujEv!Dt-W%Qi;oW|k^k;O_)n#T-OHXLrC+~>FUb?$k83tO;zo9H31|LBZuz+m*+w=26*Pat>+gnGi(ACK1sRC-_I zevX|H?8plve4nBZ8-qxz?)f=>(?ne>2fwxN)?9&DB`=NivPmFG za@(tLWF)0Q=#=gdq>*lc|AfbgYD@!+0U=SP!F_??GUPr|Mv7DG|J-*#*?SikIOPaQ_ zXbMlf$l{2uca@^EU8?I{D&Ln@DLu4d?{i2CPAdd>gS&~*Ccr_U@GAw%w0N;=T;i6d zN>MWBsV3io2g5p@tY3UKH9bzgym z8ywF~(o3Mcc{1Dl7x+gRe_08O5%YjpztbeVEZIQEMsW&707{yeb$9ehb6OzgEx03| zpTCy?AK>egW1U@c6tF1+{hep$tNqZ8%u~bS+4s+=IMmT-b(e!Lmho)tc*SV*1ihIE zf#&%e&TyZEf>@9S+zjdov8d&Kh7D5QJ335=Y-PAnsEL_|r#Mw8V1<^VJOGUWC@vr!H|{V86kkVkJ*bM6P~^o&}t-2}LSR4>;D%JVR3 ziF)CuN(2PP0`H5Z`BtlvStFS$hBiE?gxx3^D6(CD|9J&MMlgo!3s{NRZvmmescYeN zlDj{~GhcWiz-MITxIoBSp+xpGTL6s8h;D z`ttP!%V{R%^^Y!kTDv}72{RAV*FumT)r&fOY!QP80g-qz}0vJc8xZ_2%va zxcc2g2-tRa(}~W|m~88XCZNU+Ob&Z1(1)sqq<_`e>lgbCoIwl$?+PFwofb(ras@o* zJ3BwS<~!IeU0qqRS(>BnmgK9F5)*rFvc>{1A#jd=rd^B;P_Fg)g7t0K>pnB6WzsS# z(J~nYx6l~IrPL?IV?z9gIN6VA zoNzJZ%-@@Tvk(54+7$hpDS6Q{@|13)XkPIzsR%(e4X;cwtkOZr76%W@h-B?;A;T;v z3AqBo-I#Qc*)p!o_h0fF!#VwCHF^J-M$f>E{PHhZT_uyYBOOxW#NEz{pa})kgA<6K z3SKdqi`&d+uK|9)>3K6KPG=r;vNePQtnzUYOLqTDx7hn|EzuyvQy*B!rp)lEODX(P3Yc>S!=K%s|*^Zj$N43>tm^ht_)%1Ayo~x1)o9+1dF|x!wz&xjhS@G|c)k z8TJ5@n>yih6@;KD&l-DcmIrhyeorYcx~ZQ!p0T-T+G9oMumx$vm;YedP2CO^lO%|Z z$ziiUdm5R$`1+F8k_VHpG4uU1@ZCWx8C~(C29W)V~h+vfTFTp?myDEwUr=#tav2`-*IUahue~r@cy0QrW6A#p1Grr zaAb=;x^fwalD~h%R^ccFtxRY|^Mz@|tslct{GHv(Iwo=rlb|hch1z*oI?Ag0j!64Vj388Ljf@+VfZQ%;#6e>ybP8aippiBjt(M z-y^TQf!Z$r$iUf2upsMR{+9o@SMq{Ii>+x3$i2Y511yo<3t%%t_G7f#24L^@0s_lv z-(hW{ukW#?C#IFF>L@1`nfwYPd>#ob*ZimTmD!On($ZI*HT#7;6hag$kcAB%E}%8? zLmGB1RVqDis2?TS>9ta!vh=YfCmIG*4$e+7@TPkn&3arVjd679DyAE?kEi#L+~sXr zLqyTx7%PfTn*C>gS~*oVfT;yws@xvbx4AN$TO8846!!j^B+v5%?K(a_$9eSHF1@%Q zVQg`OeA3&z^2OqWp79V8S~3w4&T{d9{g+*Zti8L}QFE zGyWMjY@_lYi_{qA2b(Y+bwh1}ILh0?XJ095k$wg6%dML;sWM#{+^i*O>c5+_azV9C zeiw2*ZahZS?N7~`E*5v84@j0 zUiuzssga|@D&qS_4W}L~W9-Wf_?Dk0Q^LsRB{eYdHMv+tx({^8Wu7b?*KFT}ZDRVY z$aAzd+vPyf!XF`Kc=s-(fS>HUNM*bd;G@;PM%F7<;aCvd9erkCl#IA*^A&010T?m< zS&hNL_6ix4ZSDRU)A6$+Bmp9}cDpTRqi--g1-bN8zp{k&?|!WEoezj-4DK#XB^%7= z9!6+vk|ymk{@J2%Npo7rE6rGT8vTO!zZeWJq!tg|yhO1sXP#!Bdr6*1rHW6!0VZFk z(Xw%u*o3~Go|h#jd`HmlES6foThNULMrEEZF56iw=GOElTIU$^Mt;yreVO+SEz`No zmm@^1;m>E&nlXVMZW-;zqyO&(pzG#<-WAC_W*-UM%gQ32<*(s9akk_`CE6E!xt<0C z8?fyXYhmDs_c_4hJ!RS%$isgNBo=s}jctA7j{m`7!h`GmG<={4qbG@QX#aDA2(Ga z_3Q-PoX9k9I#470uEJ8WB9SBH=3ollm;>=A*G?pN2Uq?p821y*MhmH1m?_zT?k@4$ zehZkTEL{A!P!Dm^piG$*S0EI1?W_f9swT6VYMWa6^b zB?DE4Geo~Qjg9LEc@*PDmSI5pmy8ewrI>@?iKr^XC?H?j5{{bBi>LUY073H`dL^gpgNLoOwk;^w7OIrbQWDzO`zHrV5SODPipX`qD2Y!%@UZDkI|oW&H7D za=kuN-2&xw-m|?MyY`dvRQW`eNT*b-Fdw9zEgeEZxzl&`O|b6XK=$!0c9oyKHTMb~ zzU5N}a$oQvvqP5GaYRV|De9bEx2p6NpkCO$)L?%yNE`fc$HF5@sv1NfnmV}`|DK5A zIL&hhx%kh{j;T?Gl%kH%9Mc6L`8Yivtql!@J>BcT{?aryPMa3Zm^MCTgi4urUX8c% z_Vxx%LOLOzDfttz!ZvlPXx*U{pU=QOMraT`t7r1R!5#CG+AY#f^;r}{(f_+~gCC?H z@KCN($?|l83aRj&u8t1SO0yw}+dp9_BhMi0-I*$sj|0x(^4TM2bM4SdnPTJ^2V<5^ z9So9{lhx5Msi7meo_*t37VX^{z_`7(=AP*WB##W&-=^KaRD>E5r1|aX&2jEF{g3wy z|HvSBQqQ(*UoMOvGNfT~?6Wf7J*bcbshb+Mt5!s?ilL&R2gq zJawiSFOJrYkP`j{s0;t1&%n+Ge8!XBg_>bKIbU!b8{vg;_X-M6kE(tsGq}i0U&mxR zV5dCbHJnI(_qoP@zF0VDK4WBacm%J(6~_W?u|L7RIN{l+xq zhejHL`|EbX&a6m)8M1rSD>Y@^;Xs&Gn326B!c@y&rxcfOEzCBoAPy01y$Vt8c1E|0 z2e8m8UwE}psuAXlWSZJgo#Wu-bTme21GcNdX;}GC?&aC@Yw1ZnG?c{x(^pHwuVF@x z+zL6y92 zi3|;=XGx@{t!(-@hqk+_#PFLA@!8v>1W#g%3m!1555w44p(!90wuj`>d8nP!rfZJ6 zp8I~PolwQ{X097TEo_FL;~L5(pE)y%-p<%ux&B@?E>ZcPQTPnb{Of zCuN>D@n0MmfleP6l#yh}%FEA*Ug>YCi@IQk&Q2%>%eg}oc6~)f=8+-raP6vUKGACQ z8I58<#$f7t0F(I~aC8Bj<~5n;h^PTVfY+`~0(sNjs4mSCmwTD1-WG&{BepSuO>L1% z8bhv(QgByxhP-|i$DV#8B)bH_9E$Rll{zHd)!z7IRNN@oCQk?-qZCZn30M2<{w-hB+b5g<4v!FAUU z+P*Tgv&T&{HsIKh@69vZxc9~CnY=U0xc|;G((0~q#y~|wnuf62M1SKKz~puvOD?>X;=+)7Iq|0ozCO%AopKpr5rMnoX* zl1BycqN|BH`Ymo+fjm%+iv{48?$UpR%(yVPr5BEp*0@nD2zmgT(Z5i-{+re}u#OH5 zs1UGOA8(uCl*3w2m0DH4?2FRR+}?6p<+PewuZ>QfRtS61ZkYnH33v)w(7TmSV!hI# zgND66^YU&YIyU|@;y7NaiYNSWiS}DFi1(v`UG ziHK!gY-{|S3g4K0Kvud8O=X)xJ(AmHIcGU+;ZUY^F>5*MEA@6aG@ic+2RaoE5BsqG zduN19gwi12kN>7;d3>RS+k(&&704VB(Pn-%w`9aLi$2}Dlbf?ys01SW**PRK^7%Qa z!QlixHIJktnNih6dDa|j80qKhgZ`o(@CcD$3jvuDVZF?cjOh+#F5!?EL2Lk$L4T3? z(}FPbDcJi%&sl8xoD3;!mF>3wwWo$hRjr+1umv7^dihJH-&~ zeULQ!fQ36FSAfp|&lfhl=F2?ZBIx_*f?cWHmex5QcMSUf)&xB-x7XKyxOaNevV@=@ z?y5f@1Lw2@_}KyVYoB928r!-{!As8Pm7^a*@IaxM=dR!jkI|>VR$xlL{EI{`e2%Q% z;F^bf?B6@zsBFw0w%?n~;LZX=zLM9*_xXN!X2x7!vnlsD_a|ofm}sttE%>ze9gw!bzx8Gu^+PN|`%I|I zpC1m39Hi9kv2+c7fzJ`T_YPzFt?T<1&EN1uGY~(b{QSjP?G<)SE+eo}hY)Py@e36r zT8w~cRIl9wK19ig$xd7@%B-01WHF0I9EwU#et#TbuC| z^HUo)Hs8;RXM1U~*MukRgcw40n!IR>k86R_;Sc)_27;+W+YqeOPx(C-@&Zc+gFFIG zE-otPlz&2r?dI8Aq{ekD3?1#`;d+RqeQu96?IX96gZg(Q=SxfEi&G0i)@ei3n7cnCVK97ie){r%+DX&;l#cnOiM?lF?^2CK9v2kRk>g2yDDq8P;zw~3uP&5 zqteHjH$3g<=t|O?;F47;o*;6(#fjsDdym6MngeMFU5b1hXWri35r{5HRnKW7=wHu+ zOkNy*&V0d^;U7z~hobUD!O6+v^z!d@1U6GW?8$W(33SX=eHcwwdZA& z5C&rP;^ecI81hEX@7b&dGwU~*R!;RN-LVH~;<2xXNAK#dUR2lF#siiZtfCyyjRL@c zVZU+xE;|mFOb5Yv&)7;IcQMS;9fUpd^|A%Nl`%1&&nLLoCURRr2mS}|_}@{V9leF{ z+Z-IkVDt$Zd-qfttU;{Q`CTN? zfHE^P&zC=9lKWEN*cq}4tgsYm#&@Om3#%9ZWzSpbD|2|lsr>v4Z3@LO{x2AV+d9!E zoN^wkrNQ7(VQmVnhmZY1I3)P(79lpVckgzFx`M-Of@MKD0;{ET&l3uI&~hLbG;%+< zgsnS{$7ccKPs$@dE&Re*FEENys+0No;m2F;CG>O1dTgp<Bkc z&>2q3(*%&;(k&qk=Q6@gZH!X-XxaPsP4#BtPnAf}8YyO=m z(teqlin19kWfFLu_sY#~aC1u;GJ-nQP-?5Q@-f@&=0k;obK{h{GHTqe!(!quItn#oKxCnR{Y+#qjA47S1~<=;epNqY(U`m%t3y2i*g?M>7^xtvEBY^ zU#L;Q7-^;|TJCp=Kt1>v0<<1rJB>>O+gy4p@OJX@LRk@DpeW$mx*%)L9{>IwynOpm zndzxQ25I@76lEN#e8Vtl)Z*=$St&<4`b+p1QP-#U?UrAq{`)kSZ70q!=*v*s(!z6g zox9fE7?)0T!e8M+Sa-t_P5l?u(VZBVouh^Qz7t zJhvKq;8Jr`{mNG!iEPOej^+&b!VsyO2VgjA&0StXhy?#D?}rVZg0gJA6@>^x1Rgbx zv+cao{0KBFFQM% zZW;pLj3z-+W(4cU3M~DMog>$fV9A&8gz#{7$Kqjd_I-W5>jFdn7Gr+Wj`fd!m6W@{ zc>p{_U0v^**zNn)*c%Aryg_fUVL6X@pwgi&UgivktfET^x0^kY-9E^Wx0^spJMZdkpmHF+*Gp2oz#-4d|!*_t6 zyuzd0DWiwDTr0ym*ZB#`YDF&Kzd*UjCWWGvqx(vJv3hq02L~4ylUi*7sLu7+e&nGs zk=YARZw#EGn||!0sj`~Z&Q81P-lHHG#;&i_>hHg7O%;rCj~?!HCBX4Qmlb`k6y=G?!7dMSB9S*KE=~RMDSkB}IQ5;C{lhh@=r76n^v_o54wI_2AuLM7 zj*4T*ZeEU}U3L&P!xp&Q*rbaniy7+M^U{AkTLW=s(o3NCMm>q5Sj-Wz32j`_-zh~l zZ6&&fDbEh z7xoAQ#{SemdVy!14!V}h$+JXe0u>X^EoKUBGE$UKq5-KgU%=VdfP>~5T1G^4I z`u4D<&|0{sI;=5s1ohl?7(LL-SrRjJz2(HPMq; zjEYiYPIMisAIl6TcP5OI9J9c+7tC&UJ|PUThk%2jKQ$OJdCc;4`M-j{IS5pHAC#kI zUFadrVlu7Dn)S{=8g;)I=1=FZyWKbnT?^@Ge;A{I%Umxf4_nS}5uMCKCj0br#hRwK z+*e&m-(lh(hm$Je$_i1xmtUmmTSxs@&C&c=%DR^0@t$F=jHI>bWAYCOyg?3YR~UzY z_|!Lb@0nhh>de_*Co93xL`?Ux)5Ks?PMk2Z9N5>bDdDzs4TvI$>swmk%wh{8rW)(^ z%(aaBVxMbYUO5i#H^R5Ag78FD6xt6edxTM5%rD|vdMds(+jMaG$7iLl1{pCXbGwE2 zX*{Ld+NR9a!Sax^rS$>2^4XsqTOb42D1H6K3vWdEk;6- z0O|%womK09)D(H|fE|V>H08;=)y5<Hu6;%F5Cb#zkCq zR#L>JC(n&o(0{K^wBzggj-O}~e{0u$|M>}Y#ZuDIhiPa%7R0Bxu^{b?XZNiT z-5k}&G#`WEh-eEe&i-!>w?}KB;0hq4_?f@E)srVboSu%8pnMj!WQJh)8r8euM?9sQ z{JWvHmW99TA(T*{h-yw|{j;$EPIxA7=ZS=}fENgJ95+Xd;-J4CD?}h834QvkfIUC5 zRD6t9l{?(>qr8v5%o_f`%bStSpSpYbgnv;*`Y`FA&!o&O{Fuv=glyo^_%qOg^Rq1F zzjye){q@$@RMWcB$btU4c~op+Ftm(0Od*ESoc0AG72~ssO=><^;SXk@Xk=V)$cw|Tm|F|N2-rZvc6`9W9+CL z#eA45RT014pq|~2;dp&3R8tl-Hz^Wsz`Lg_DOXh+**}Vl$Ha4PYH10ZTA3SEX=!d= zANoMFC3hRU+0nRNhn!B2jLN6`J~aml&0@aYpf7(m1nk3Ooju8FX3^>u^1~25;{(`J zBnA0u@9}=d6UiU+L4?6UWD1MD3N+MEdT)1xB`HCQF_^>(1s(pCzVj+$^m-l|i|vnN zW^5m~V$wtw!%z{z`pn;l(yDk4jGJIdg$jYR(E^JU(DndvrrqIRkpvh=ydJHIeA>6E z3h8WZ?mCEoa8mkbJOLFh=v>7(3uIN~4QuZN6Z65^ZTL!_na|3B+M%Pb4^kjgA^lpD z+l!(ni{5-H1`T@?N|TdHOO$FkVS$|S#1n0;*Tdu!4QBUQ9_Ou0MiL?01@d=AITL!j z%b(xTL8yq=Pv*fdGuz2v_%I{B%Pjh_NI{J&dPdj)!LtwShO0sM|BOe3r4p)N58=en z{~K!*Q3Ng;VA|JPMr5@Nwh6EL9DhLY_53Oa1i{>Cl#9FHW6~P1objj%t0bqq!z$`~ z)VGoHsQJvJH`?ZjwZ1>t@G0n9RR4w6Lc8YR(NMyFsB|s(Z}O+mXFZ-dj!{wjJ)$pC zeQ(&O=3M97)G)sEFFn82*|z@NL@dsE^H`^n|EC~XRU>vXc{HmOC2K8e>YV-xyru4dQlDabFttI?h zgn1$M1rfz-IBg1REPQS;(AEDVD#Q;jC`0gyAGBd(?i8F1*ZPsS2(LMN$Mu@=p$qy3Uy<#V=?q|;4CpyF zRd#JHQdE{z5NY*r80VPP`VmDF8!^BkTJ?T5VkGFA!VdP!b{X@{I2E{$$ul2jRh{`R zy@4NTPmf>A*T4h}5d;fuHzwTTv5rEUF0y zYU)J)oWkYb*}e~TK;)xg{vB_4rl`>)Ir8qlzTC6-%g8BF6NEWTEwZhMG@|q$0ns^i zaaooxj&r=Q+8VQH_UZ)BpgphWuexf_SoGU#iCab-eiC?VwirZn zx~Trv1UKSCAI=1>&vZx~eL8i{fMX!0o<=`HwdNRlxU@)C;aDFcw)Gzy zoD|E`r?kzP>xz%7uJG2I26+PmUsL%R>ka43EWwuOMKVXs1PrH+eO>2@KR*O!S5{Xq zznDTKC{V;}@MS|rDyQ|l-LAcAyQlR0Eer=FG~ix0C#%T<2Xq7or^tvf)vaUS50%wA z4_3lY;IIrXIUq<4oWLi{9D$!<8GkPVh^m~Ao!4A-+U%K0zpi)s@P2)4iU`R55>E}x zVk&tUOvb6L0I9TgI+a<4OhtGtjEyi&A}EFQy9;_q%(K*}d}Xw1heZ#JN{*}bxi(^u zHGD|VSC5@|O$Hoc#C^|MF0KMzt+L9aR8Eg=J{|k$``*pvduT4w+h|jy43*9&&z8Qsn0i3xc~d{tj&L$~yT;lQbWoe)D9=s}k=*p!L%A_ch4-x8ralP2;@e1>sf!Jn3U3UQt9V}DBtqOrpq_H z*qHgLlom`)ng3P*A*Q*x1_q?1_1irRA8UF5b`2KzSL;w#K{m` zU&2QX9y)u6MID;0XfabflQSx^%m01g9_=&VsVoxMIYAO3CrfpU_o8r~{i(4cH83l; z?2=flNR7*m_j<4mE}(kOuE)(9_S}Wb3)W`_pqrPiQ8%UckkAYcoire9~|-s?ij7e`w@lRqM287dkFlI z4ZPPwb`hO^b9AFPL`$^J;rybyR_`jpulnxK^@Q5HfzH#$#}G;`*fu?5L`Um-47}$z z8wdu4u-=V0WDbq?X(ieM#6ufm)XblS&C^nq=RyK3=(KvLP)5;U<3|`6U7}TVT>oA7 z7*>D6QiJDMOJBc9S;CL0z8AuCW3e%mG;f@e$&77vf$t9ruQKOGaad4zpe}MqgVAF} z4;W@Vy$6;!&nDHrml`r<{Bp~V!nzyUuef*^5ekhDNzACVpr}BXDdL$oNn@4^Bqbvb z-@R6#+aB_g?Wq#IQ+sn}>*6>sjfL5;ns-LXlc??g!z;CC>6WNt`+T=+0dFXte^cJj z|7UHvUr_VAUxJvmVbQZ?$uP`YPEai`-39!&>p`yVqP3Y*t4&9pisT#~!#vZvdjhJ2 z=p@Z`xgpr+^1lg-ug_XHnz@V^IS1N@a_46KQ`i~~$qTX{j-=(VQQM8!6w?-$%3zZk z_Xyz8;?SO`rD~72Gqu`J__^)?0RHK>NcIq7ZKkb2an;2gIM8;1@B)ID`Va^#0c(2PBb*Mbzgh?YJQC2@B%{A z1k$J{$}Wbzpso3 z&jCn)J)@-U{J$4~Ei~AZk|-N}d?<2(V`|F=B@~U5uPm)a$5>AHyohm=q zFRN%GJQ(#xeo(uAXT{#{uz*?yH-d+m`;YMN;&Kg?01$mn31`kx36Tt(5z$sq{ICTl z7o zYzF8HHSTu%CH2r<620u?XU8VuNw(BjO|bEUQ@39R5VAoy0+_?d#cWXRT?Py80wGH& z6>UykjHDWV@-B#GHe48-t}L1|^<81O<({3L3H~ph=;>dH714Fgv+pJBXDJZjGipfZWFuw{Wn*iUasON7P_~grJNse%!k5E$ zuFRyLHJ_wH;7E!Pq0=PlDj1_L4To4x>kOe zjmF`L&>9OhQqIfDeXXizRLhux<;|fiyMUEV7Q}p~mI+(*lgii6PxJl)YNL!({itg9 zvqp0f-McbaoAQ3Tx0kSU{UkA_HC9_0)JgdjWNq{`VU|Joy_eL_KYZfstQy0eSvOsI z%5XSag1-C|%HmTU1X+hM_6>^$M+S|+=N4w|44rUfl6b}U;#S@nx0_f?`NAFD7~@;E zm9s|OZD7p&_wOl%)a-QnQYzIE&y!IdfNcRiS(h%~PIwwj;lQ6)J*F)Mhr3m})mXm# zjA)V|M=v&t>BGLQKU#UTV`RV^B$~t*wG#hagC5Mkbq$V?T6aM50zfI?vJV|yiSY%o z`mGpXQn~@C7j~9M2SW|;sy3KBjX{0MuH})KwX1)&=$zpzr}oLVcXx|s%X&OjknxLS zWR>JyQBY8ww!(E|r?m`RrnR}VlsU$7FE#b*daQs2v(1^+y@v{}QOW*9%hBk`;)j~i z<8Ss@*v5ZTne%f8K)>Ig?*h^_g2Mif{{M3|c^JSg-Ka8QiL5S0_W0L)?8 zwcOuNJV|Lm60FIs8a}|fW0SU)mKr6fAvUtsTXq=nbxM$9VIJesP{^!92G7jTGZ&Hs zr}6{NZ2HOQwN)j6s_emxJ@aarjOTcHwpY*6YL~#&^-RSyY1W=ef-o?@SJvEMpk+}P zd?=4LLz1Q=XDT@h@~Df7QqiFUG2bV}v$~YzMJST8&tHwbqaIn0q*9c{d#()fUG>EJ zm13SFDa`9wak2NDDhFW56RK;?>v#m1Fy<~wKrmeX!XmKw1A`NeLQM%4*u;1R1-shX zFc-#G-M)VxpPnK7hJ-A(o$Ct#Wb^GM^3b4HeCuDalfiW4)p#*`sMUt(mOT0V&=Vli z$btoaIb_ebn9@xd{w7HIV6n~|d@R5U`>zhF>-DJXb)@S#0-jm-GCH<7X)^3|2@YW> z@0*-#PvlG+c!3nHQSp;f0cF~aIG3Frly~4O;RAS`hrOJWjW&)yF0rLl7djja+J0hZ zYh7<^Z%@9+w}t7&!|wKoi~99#x3u`+J2*W2$|CE~>rWSDER&z)42Z&7dEj^lV((zP z<-I9^Xi_h6Faof}dBT1-wN^)_8`y9ik@!ZW5b*a#j1XTGWS>n!*uSwU#)>%~LhJ$| z2H+XOg&W(}ZEHCNow6_8AlF}C1(J8<-i6bP6TWLx53Z29=-LicFN66z&anyg2r$&- zY0rb;d#`A|W$-b5=rc#+s*^Okm@yKoJ)!j_CG?HxFu$qj3Vy$g~pBn@$P!72iv58!3r9_PD&Z1~eG zhu<66)!bcOKa6&Tv#~h(Z|f{rrQT}<8j7663wYnkFmvBA){*~)ZSq{m!f$$*mpX1K zQ;-U!>3)H{igg2t8$c}pQ_sUYFsR?&h8Zx31FV?To7CHXNTQduw=DMBo%d~werN#X zJs_vgf(+yr;3{?kD%N*R+QyeiFoLMAdKKj1@qD^H0oFYyP^$%K@xnU>uSCS7m_!;; z*keoq<(~m&3~YGdmhmtJtz*FAmCp!iXVjJO@)%*p?ot{+o4AY4%2ph`NJ#G6w_F4 zG^-ME46#ilx3l5a`C($hEKO{8bC3Q(VreQBmSj|uc%}lwF9|WVl=w#SsdDTRS2wUq zbN%8v@Ux8xUU4S|OVy3DErM>kTexSdOk|>CDdk<-6(i%XNC}}EutIxUsMzB3rANw_L9Y~+d8(PeNYX=>IX>fEF%d;yDr~3is^q}nh z2xNI&`>EY0@eIt2-IOWb8DFm*C=I&H-GO4!+xyeiHW8N8SR476W{0+|cfeA4frjZ@ zj(Q0m$F8@Rv$vyvG|30Sw>^2m7Z(>7Dw)*Mop!PY!54T+SFtD1NKdgrTa=AoM5L%z zkLH%MgTsH3OHn^}yD+k9gLFfzn#lB1m(CF8{TMB(~X+EowZXdfp>gSe)=-i9>5 zK;`@EgZUkf*HtN@JyJ_RJ=p&|C{FkHL)*V_PAj5Wwlp$ud1IGE_|b;uA^PJi{iAqT zDDvS*5;AS~!Uh~0-IB>x5G7-E)M}6x+Lgv1=O2g3olhsP2G}DlgCT_EjKBhp{*j&Em+re8@4i#3wASpbV92y`)9ukYZdH`eehn7R`KCsl zis~K0vo}V(!#Px1m1()}=KEm|E?kUNP&UTgDssaD`yoi}-{Pu$SHuMgb!`SmfjQb% z#dmJu&`T~)h6nSkZgdMm<)z#rYs02WXq^lR{YPiFK+RF2!W`rN zPrhKA$c#)xJjqp*dj_}lO-|H+K8miOG>7l#+ll|!ZqZ*`^ZbAL%Z@zBvxWNY9@G5w z`wCUq%M$v*byb=XMsL3lcpG;=>`ji1p>`B!5Jmi)XZ-_PFwYTj$ww?G`}k2VZT77j zQ#2M$C4ezV#{2{Q!G12lY^^LVqB~`;QN4AdJJwFVV{btEn%`U1R*uczq>6yC9Bgy} zCf>RUs4Kp9{8f%bNG}rAN-1+->_$vzQi6vT(|FL?+RB<&Pr(RLk?GoZ@J|v1SAxiP zS4d+yu>dP1r=Pa@8)Xuy!m;pghxOw-!DMyOO8qn%0RPrwMm8D=p|O)Q7fSB)^62XB zj;r>fUMsh#+b*p*4`LkL!$U&XM_oR;WCmlrkg^HZ-oN1R1dRoxAUO;Q$T($W6;X*D z{E(WM)5MKYexZahA|9m4244e%yjZ57uFfs^Q0}iz`Y*~>Npi))akoh~f2}S0ek!sk zu&v|FuQ(dWGjk|WUcQJkPq*0TdPK0uZR_CaIdo@>hzn)ogc~SzCf{;5%iKRs>1`RI zmDXYfI>rNaZt%*(7*g%D3BVQy6fmjQ4-mpuz$cq>m*(f^4#XI~knK2#ku+2@F4)`s zh9yyGTlWp8t9+8=u4yr_M{kA#kd^aKKTBNNO?7Z24TXuQ^H}}Z7vuZ=`zZroCVU!C zV~kGE3YNX>O5*+Mk*}|bsAwfcQKhPzhXS&2wx_eW8s^jk1 z|IFIg!To68^XI}`8?7ghw0oeOmi)V%$BY!WmraeaxvIT8%=WOfxMH4kFR1GY_4J=m zKQS>-4>sA(9l)>0|4kK--jesrA(pc6N7^~luuPDxRPz1yOv;qOjYd}#LieTX()%A+ zql?{`Bqa)_uQ{?~&r`zr+w@GRy+aVQl}55jsZohMm@zY1{c6*|ujwRJGOIH`IAbzQ zj~d1Wq?tf7**JxOe>G7L;WfaVKK7^1Z%@My^&r%C>mYQmh#Jd1t%IX;$J=3Ysr%IaPX&RkUWa^We8dSNB1pLbD!#KEth3KGxsBgb8>Uz z)NSfhUZ9-UIgajdFZJ?|98MfYy+01cFZ|~OiMRIlUjEP4=k%}9Y;=`&eBndlWFZyD zFK9uq{<9kQ-bB0RhWp357{+YBzGk03g4_RfH^B}}H5GrF$dTgvm0zpZNVvsoY9Y0R z5pUTYo?xfWH z$hmohNr7_A0eyFk1VX>&L2oC#NS!mhCN%uIZyOF{zy8I58Bo( zrZL03L2~Zo_KSUMC|#jx$H6S?$wWX)$g?;+(MaBE;g#jzHz#fhWQNx7G$OiIv({ov z!s}=WIshIMqe2Zs+T^T-k-RjW-^>hw;d!HSB0o%it{GGbvsxVD4O4Ly$7*5cHn3@b zr+R7bE3KZz!J(+I)McREi;MQrdeK)_mZrUWM@@pSf;78jish})J|52Yf>3V=C-tNm zIW7{BI_6I<;gkNRd__PY@v)KGhT~PjDEZw|T1$Er2eOIMhz^>THFx>R^WRM0IdRez z%p%wWUqKnI3~0TX2GmOgxd3y;$v>LtlcJBm0ZomYd^FNVL1qIeWUe|VqH#ZI5BA>BGLRpilsz9Ih7y$SI@(PFYugV!nD;he`4OEHiI7-`>5Dm?C+RQl-aU;Qmgin0)7BEVTn|jR$`vG*LwaX3P9xX zI2eu{w0nRzu%@f)j0_41rd>T~S;3LN)kB+psRx(e2o`SHjQKRhcLg2aQG4a+bH?xS z|9%1&&tC722+=jbiS_x|>}sOn$SvHm;j0`|$qg1BD;eN+{39HctNREo z;gTR|JtrUKr7e;ADt`3z+s$~)?d33FViSoQBIDZ9o1JU!&2)7N$aM&ld%1;5q9a=k*)?HLtYPZd|y^N|XBA z+D_F|)VA0Ug&}CIHq=jxlyCzoAwI+Uz^Gt-Lyv1&wrX@0ZW?84uAx#C!$THCzl9+b zVTR$OAgl0#=~75D8bMz5=49-sp@+zc2t*_M*(|3{sJTs699q@~Kt4!G6gAHwwF@G% z>X^v07L9MzMcPaTXpyZNV;7cw%foMf`*Ju&msny|nF$b_oVfoy@IX#}96XE|+f17* z-l+>sJ@_D><%aN^K7{7y?6;5k?yxa!XF-^@PSVWhokPV}_rBl0F+8Vn*Iic_@&9fj zr#kHsUwf|;sV1a)XM{Nn_RDGF(Ja}ffu9xxx(TMlt|sths4&0&1YSI*5ZmEd8!8#m zV#m(?7MgCYt*r&6CaVMq`^o{fj1|ou2r`=t_js#+48_fYS}%sGf`1*-3QmX+9-x>$ z=HVC>^5bt3?F|hf8c)*~PHajLoo<$RWs3%cVLxVz%MyR&pllmd% z$0)WXi8%y!PPu|MGG%+6j?I^1M#Mla^-3kP5-M;{vZ$tZ>ubhRrIh;9ZoUC$qN5^r zCWshaiz7NOW-m4VHb|yM*1mN)-&Owh_NOxu)3t(JrrUR$DwI6-96sj~YU54v3Ur8{ z+8}$EHjnS>r z>#?F)|M$8!K&?`9Zzz>$m#2GdDQTdo+u!8#C1}fN%ZkS8dj#l%Ucv$DghJ<<#*2U4 zG7>no2HwT&TuV*Rp5xh93u_@3nnK63xs-mn~VwPEE6A}{iCb6PVlqx_mdza_c*Fo&8 zq@*dM(Hi!tS0+3$MmCG4>&!A?iBKN^*#ccXjqln7LOB*leyvbE$_7PF2ulO2Dvt13 zX6M!)pJ}`l)X&aYp0W8qHW&ar{JUv%uF5*Z?G?qoX)`usgSX zV&OWHi?WV;Gk>XA!)S<1(-_fAeW<+Omp#%cRMn?CK6N(yf@|&ED$y!bvs&}-4r7(ZZJ{+HS!s`%N0L7*t>z)r|u-^Zyj zJsfuu^?88t+P^SP?SR&$`#l`%C8&oO^pyD4FP1QJn^}~swACP}ePkV-+F1lQ$Wq74 z>eg3;_dL^YB|;g2u391Yw$f+y6p#tF6t)&CR?TJ+XL0Z3Wom z!)!-*B?`LbiyXw zAN1`+nAiR@-Kn=M5ra^w@mHdqo?B>~TC(q4#2h2M*kd(-!Nm@+bu)U`?m^0=wB{n$_jy5|HS?ZY`1l{QSO5Jz&r*N1k4}rcZjD|=849G}Coc4f$fJ z>%D7vAd$6ioJ5lxyW_U>)EI%q0NHqs^?}W7vhVN9zw;TJvw$5XTnMiD4{<*|Vv=k> zE%{Dj3SBiM(Qongk@u2V@}-KF;rP9EExuyP_iFgvys}eEL(ba!h72c~ap(Adm~`*j z!2!)neuswzsXy)|?Kh*qrGh*}HY~)EU<1czP=9>}{~PcYRsq5I{BB>2QL%}n4;7*c zTAEg>Y?gD5TuG!p3dC44)$ZoYr<`v%O%n_3f(f}GpGt|U!+TH1$P#?f7`f^fZFD?f zFP+-l`X?^K*}fo%d@3R$$BJAU3C$B`)uAe_CNO7cujzHqqPIka_*KJ1Mf5OuM{^q? zpRuw0QYf}FE)Q$m4UPCaX%E)8(k!?nN5PBhy<&aa0;_n&s(6WpS(3+BZZOy-7?@F? z=b=V4wY39p{*faKPUHG;*y3vLGW0cA3c=9wC^81jtLyD@D*^{zqw0#Yqya$0^pD`5 zxx3$sy|!wHhK!IUr&@GZ_hO9liPI8xc;a@5fv7k~FR%9h5}U7|pB?}P1~Nfj?Ao|u zPQW5Ais%w)o{oC@`US88{~u#~F$og7ngQBN?0bJe_2ym-Y8Ef+ruvB{d?Ck#3Pa(TpnS5)ot5}Ug_?esOt8-ApvT4q4j?^S#xX*U)y&hs z-H6}0vUZ{?aWQ>*4?|+UO|nZsoKg@xZg2F(ID!YGS`$kCji&xlN%O%FVp8bY!u#0j z3T9gq26LZob{G-EPiK)oe22$FLLBTqXoZrA%W=r6-`d_p;*1iWersy-hgSD6GvG{5 z8A|-5i$ht$Oyw-v@NpjUx*u5RL8n!;*fHqmSX$buv2-MzEwo|>PLE-uePv`F5JM9< zMRq(H;pvcJ%NWRpD`nn-i2~#1C~Fww=%kvFp-kyD2J<$#^kV^aT(>5}Of!l8EZI!( zOv$-8#$;C$J;K?IAQ!~>8nGgr^_XmMO-OR6ROP+7X`}TJyh=^D7 zw)4LKOfK;&OthI!nqDzji5y(^uLLI7k9o!@sdU4L@0KL;#5H166JB(4%5g-Gm(QtM z8CRY#yeh2mxNX&ArmVg%X-zl}1UsHg4rwzfvt7BE(0>bj1`P?1kB?hh0f7yXJ*7u$ zvJ_0ms=rTS7uA9yH^Oeu9`y~&NMl!0m%hy+jZ@j1AGBB1t4Xm+NB0-zrxY9ZVQ!G) zed(_yv54q+<(QLaxaghx%RD)_5Jif*-4ulN-`{(DII5Wro9M6uckN%B#eo>&Qlx(} z?l&GtQRO-Zis6Bb3kL>lp5(`d^26geEgobaBu9%v*z08Wz=OlKstl(TmD;t*M<;jb z&lswZ1dU7ON1dwYk3l|}&*UWC?GAbUz;2B;PT!5_$H3U2(=ry8@BI4RI!tflThuZO zh?Y0ORn>4k_S9acWF}7QQenOYU#zS*seGJxkZ66J-}EYavfJLnpZZT<+9Z?%O}iti zw{*^h5MwTgi6*?#?o>9Eb&jgaLjkV(CB*fAS^!EX#>a4hS_p29po?fZE~d6KyLMn? zQppZ%c7N{JS+PP2L!ys@#`q-7M0`f}^T$>nXwJ|&w6AYDf0jJ!r@mOGMx#@ve}~Ih zAO4{+^>wUI7%|m*)R2QTZi@?3kO6C6tZz2EyrW{bVlIs*gxOJ8jJ(Fr66560iH!^U z^h;ulpaqMzPCwp?5F2&1=i}8YPkCLM%-7?irJpT!q*E1W8(5wf9wksM2#p1Bc*bN!sm{m(t^Bq%e0ee zrgwzmH-4h;wzRYi2}vlU!(9URlAx6(_EStn!(vXb%W=Yl%PKOQaHuF5!HrNWm?K8S z$J^?;V|bjq;gcRr-v}wO<2;EfUL%wpP&3_2LY3-ez+PF*j$^br2`2s&{-vC`iz=6f z=0=IHOW!dxL0|7yBOfh+^D_cdliM}o<3Z7zxFizMUw4UArno}U>Z!-r`PjbOMKom$ z*;0JC52!+LSA*#h zaD71H`wWOCkQ#1yI1U0f-oDMWMMDVm=g#-=@_GbyPRQMinM12fOQ6940LIswKYYP; zcBe;^^R}wH4@>zcL*e7aR(Jkai7^@X(Z{Uc3fQGM~HPOT}wzC?N(tr}Xov!ryEO1vS(3<+$8OBjq~aLK}RAvT&)(jW@l&=`ZxZvY%w)hB8@zg zqEs4t8X5=iCiHH*v@AciM92Pqk9zScFSXr~_c7r>G&AB~wr*=_Nj-U?R6!abaPV5# z4pCK!b7KCI{B9jDara|=^V#K_FqyQ_JN-zTOSla=0OGt^$-y?i0|Il3A`_e(gLx;Y zOHdFHd85T)Fl)!!>Hcveb_7GNzOLkYW1P{z(IAWt`6|zgtn&Uh?Grtxwg#jkTe+Ev zz5H5#{;g@13$LS6kJ&1Z{ggM{GVB6x=2suzR+qzb&qMgAo+oSiy13VD|56Y;k+ZaJ zvwpsJXb>i8lpMt@o4TViKms#A=v4qph5ofYLiCi&o14ZP0rj;HR1iFM^y~*X=x$cl5FPOo=zx@}*C}{Wl zNFib=g?tus$NT7hN!-%`MVnEcACJlCy@A^3jV{L9#%k)zOd&HSHr?w5X`VhLi{ZAoP68S1=3l*y-ugC3;Kq(P|y!mGD?iG z^Qrdoh`42^^9Y%p`dJYND$DZq!6{u|Kr;n8PS4cZj~8Q<&N>9AzYb22$_JMorE~hv z+mIqZC(=t`$2VNez$*xM*lQrc_Z(%!_;<0=PtBZIy8-n&ut)u?wjn0&^nP$5GL9_K ziId-7ir!Zc7EZf)i-99bf(z${t-wv(!S%0Ogdkp4Hw$~v5bN!8R0__QYrz+sT6HY= z0mIK&3RYBHp~~;?{+Pe|+5rhHH^<$9G~`P$FkwI=Zu&4TsHehMnj&Kno*%<>m3|Sx zqM;;g;BST-y*Q9D;WIY0LlJV7H`XT$t>dFu$p1&HB|cXfnsZZk%Ud!Y^78RLfbkSm zS=^q_7~ZJnu5*9%U&f2IX$1Gi-Pz_ZunEj2JC}KPe{ruRh!^1Du^)-fG0pwlzf;h& zwzlRpp=>tlu=&f;yihu)mB9T?OA{IEUYujbuO=EcD@BPNS-kgwQ`E+^ufx44w*dF} z=L~crw;5i`$fwKSM<6C5gf!-F16i$8dx*irbKzQ@bltaV5(cB=SUb?%?FMAz0* z7J18?AeD=0cWfb_>vtM1Lbirgvg)0vh|qaCJ)LxyddMh9c4{60^Q9aLL_H+ZQTI zdyqLhHa&d0RuUWkz0^`Rg!A*Cl%d;82vm+b6|$H($fJMQ1ekV7%ff7z5yGJ<-)O-> zcHw&-suyH?n<2V2U2Idae{&U@g9ASn7Z~hGhZ()Ws_DWO#(E}!VfmPC=XRz|e}Ip^ znIRq~>xhtDZelurJ|$8A!?B3y!z!HF7+OhYYRM>~DqLRBqC_CvVFkDUyu_~`qaf8N z?lm%h3f|dIMjysAw1xFW^&P~;*?wZ!15Z{eC^msOnfs>E70i_e+rAc;aYFO2{8ZY6 zIBUzxbxd-S6EN#s--+9Py{SqcjR!qII7WcpOyr}7w<>Hq>hGS=u~sWQ^NkPFB&Tlc z()+0%5GYECij&5yP4f9u>FJtSIfe)cJpowdi#Pm&USeAK{#0ImhVlBUJ@->9Ji#L8 zb;_TY8hC+BIf9Y+Z`dR8C&=5~Pq}AAnl2evndL&TL_c*R`V7C)$3M1A6IhWt zhV)RD^3Ht^htt|Bms*5p%VOpo@d4ZqJYqH6j2#zm@72i+V5eDxIsYi8C1oW$f}ADv zc9FXJnOIj=PH>t7w@K4>(-tzRn<=<-(S*ETyzE|o{t}sLkRk_jTZQ<9-KDf(x)~ni zR6RpPal{MCjZyFKRDG9@U2`GEw{&$-`il0?D7#|F+)B4BkTCbgGuOfwc;Y9~E7)>L zT9(eLV(nK$*Vn8&UZu)#X$M8*QQu2w5I@2Prm8Je%*^B&3N5*I3 zX;DyaoA`V&+c-`x-xSiHT1h~inQdzekxvaKl9V1NNq)-ZyWl$LQONGp^7;Mw2zx|<1mvfmw_ZE|wQ- z14cA*b8R1Fm+oL~lbq}6oL%3B?E;qKY&eqG(UwL+$9i? z7x)@uH>%_t&vIV{VQ@{{4GK~S21R{S)8E4wA+Bpa18`Y{g5n$K&Xbs>G$j(P=!B2b zMDn_hD{VPO@tR=tbwA$ z3xp7q35t}LL}VBTULYzCgUG5E!>Fz%8+j54QjFP25ks|BP-4rQCO@de<6Le|rF!Zs?|p| z89#BD(T38P4!_4tLnFedt+UFCAETP0y# z_{@|a;_inp|8Xxb*JH(>p{se{kMZuvpS~W%<`&C4U?v;xGUoX(H-GU2f%kNh(|&fx zEaT9HI!aZ|SY;@Yt0X`}?Y!nVx@kx@lM~4rzDXp*?D-=hk1mvZkAcy1NO~?hAA%O~ zULyRE5sLbY@ZHjZ70*Q5H-a#ZN%QzW%XH!gmk4eRT9e(e=Ivw2%$Q`l^Sm&PA8j26 zdKXq!bSl+AL|byy5$i<|Xh#Eu@13A^a(g?dj_DLhf?mvyJ=VJ5-Obn@5!LW3!jwWi+H#RV|%U^w>p z{%#Y9tbuu)5-Hdllw>+@3(XkRp`2+RG8A{8cg;)J0JK-ec!)C8%`dmxLxISaW!(z=C-uo8zjTvTEO*UeRio(J-!+{ zQMk>|bdo2Y=d=Y*4xr$vtYj$jwNzHu*dENs%sFZPG@}9YL{hAQ-@zdL>nPu*rRKZQ zUcaPjXh2)PqF3v(3W1RfvLxRp^-bc~4$;>IYOZ}!5HT*Zx=%EV^1sV8i9VZ9$JwO0 z1Yuf7Aq~pA)%BJvQGzI@sGH*efL#1p)A^(_RFx|Vail65M6cvff=3y|)14L%+|d1+ zir-Yt+DbDrfmN?OrCYMl1JDb3@HqZgEJzGgzCa&oJE@oENiNo^tD|FHd5H!#&L1zg zmzKe<^{p=b^cCYpUTRH<0k9*Q8k%~F$9bjbk*}p6D`PQrXLZ>ph~6!YshUMN;sV$8 zF-e^E{Ie$to4++rlgS>KFQl|WlqJ`%y4Z2<{Az` zLtW3K*#sy~-3k6q5pj_$0Z-ExjHf{VY|=iuppC~(*-gMHI`$gL!DnV=U3l*`%(uBu znyw)Jcm{|2?Ck8H&X?z-ADutlFX27TwcV;!6C#s`Q1yF|t&xpzGaC8hEF#~ss7t=6Y`ar# zovqQ6_V2vtTx8D+;^;RC{37b!wq#CkcGYyHXD-YtMpnmI$7Y$0yX%;$+N@GUDOsB$ zi-QJ7WfQ(00 zO43TE=TS6{;Kf}02>VD zy%U2pQK7d|(&Tn=6Tg1_3UHuz{3dNi!LyI|rW7?nS`-Q!U8VRlww_2`p$o74BC0Kb z#R#ru;Z*4h8BGH`Kr}If^$U>gzinQu_Zh{KWI)g&b1DFYMi>)()<9Q_AK*hqah4Md z_Fuqs0mzK*?rwewv+slaN`9V%1KL}ZPX4WoO46|nE!qqTxR)|8A*g8!{9WA|gFDf( zpK9Y;W9J$kz@Q8?GZ+-V#*uY(3+{l58ThYSm6x|+`edA34@BKA2)_&lfAtM>kCz#j zUuBh?!pmtUUTQn3Ph>x=Y5?IY`ox3Ic5*1bK*w$p-qW*{QPBPYH2c26tX{`dQ}i?l zYcy_$^y=vP`7c-RSRAKzEM-Jaeo*9D>NWtT_a{pJJ6HvDkz>%p3}icCw+!Z~RXYwU zjN{F8w71XYd-$$3GW~pkq3AKU3Vrh+Zzacr@)xqZqTk`iv!y9wV9| zRPW`=K~+Pu%|pXz1hs?DPy`-IT6y@nS{jR z@z?E$<5x&6c-HUy8DY=se`hsj$$$;Y<%)38Fjo6$L@j8Kf&U2h1NPX#a|EdG0YQBR zzk^OK8!*bH#T-?USzJJY(3qBK?oUEph*F`0J&|*Ob6y^*FV!DQ{~{ASre@1p&bJ5P zWVVpV6GWG1<8Dj0$cvQv;JexPTdAp>33raKqb`o$qlhv;(abZe^zda9^DXTM>W zYd$K!IinArZx+r6jk%ttr)jP546{dknn#j}iAlg=Hd>N@DUsa&7aqn()_-nQF59&f z68-II^~g@dct-*a`pQ#r9F>aSii0E8J_mTY!p?%iMZ(V`C7GS*~ zO%vy479b9ro4F&Xkti5upG<6xx*C=1<}6i5iqdF{1WAocKu;7d;p(}f!EQ}Hr!#rc zS_aeY+1bS6H-H}lFdgU@e4o$%0$&E!@MeAKHKXaMrSo>5>h6Dnd63N(uDpPL5#W^` zX=k2?CrmGC(q2P3@I28j2-CoZHQhq<9s7Mrk$)mQHeQ&;yZQW2vOA&(66btS3R4_9 ziyz`VRLmA5)@Y|i^L@{`Z=v4k=xCz{;8w6c*F~~wX>>Nf?z#%j)XJ3;W`>kJq=dt3 zn$tgK__0jk60T^mK5E`fZN1f5fHsXpz8q);TK5ja9-l#lag>s7j9^)y>VN8d0eSfy z;Ph=WV~Ic>X|IVnVrC_0k7!|>@b!dLuvTCQgZYcwn;e+Y_5;Y6&~WF0_XHdWKr3CY z3kXEN8ZfVelBV=Iop+RQP$iKm3&7dEy1L^jX6ufTdk>C)ern6M22Ag*)EmVu#p!M4 zFXu|;rI~{lw(=0h-N!KjF})a@lxUcQ#((4ydB+=a-c8a2hO1_Z(vYB??`4xQw>G?!+yA6>Ng~Iv$$P3J%KY|(9<7}HPH$z zE8|_trc)X#tSZ|mtk}-LF$oB{M@I||=fDr|>IrtH8&sgZl9NP*I>{I5(9E(rWV-5^ zo1lvC3D@5+Fc63LS9KlRuyi@2@Iy~+DMvFc(Z5VyymXGD{5s;c@F9cG-|*hOJ#wb7 z>i&#V8Qxn%O^KRgR{ZJg@ns|0yKnl$_Vpj_w#D-HCh61>DfHV#zh;IC2s0u3K` z?E{)1TwIE1DxmIiArDkKJ!+i9_7{g>g{*lC%U`v`O-adjX>f9!O2PWOxjTkifr=} zCLg3@_;+Iz6EdmtPB`@xSl?LZhknG(Jz$>r{x1IWcT)bNnHl_BWwuOb_08%#hFc{o zPHn#REQDeTqDp-I%OmoAs-hN2kNUX94Vh4xR5T1NDN(u|$md#-XO;O#?6jhS=AX68 z96!P12i9aTw}MX!yf+{@3YIFXYSGQURiX-y%OpEH+mS(0qa`-ubWd|^blXHuK6`pI zL)%HAe8O7ro}5&%TM?J}So@WAN`UX>0FBHaot!Z3V(G&U|NH@59Y;l&wY2xNMK4S8 zecK$ri;CCjK3Xc-!_d^_5+Jg0>x!hxGVWt&!IUD{)EUuhoeB8HSxki2?%hvrW zsbey67-kC>!Xr6tW5EzW555L%gu#EK-5m3_?(dhd`l2M#r#VDH3lQ3K=}an zmYI3q5$)9HRiG+dGOw||1JAzu0*#j{jbg?_R9Na8sR0r&nNogRJ0Jg7vH}yS&=%&9 zEYJ6mTaxw+G13MzDoYob44U#i_z74e_C7bT|WZaLF71o(BEO)B(uxzrlEv zxH`wx?`%K?#nMqqVQwo~JEwjN*pF;yBeQ5?_=U#mT`D%T=!tnJ=D)kkxI+1&NI)rF zv^c|&URUf_C&DUBecvcaxrcK3-ui&0)l?EzK5fR+fq{=$vf8fp3i2&gIPZ}}FGKnw zEkA8ohV>J0S#&<#EdQI5fe8a2Dp|>M=u?vSn-`Xh#vEEnYv`Co><={mcvv+wK_E$F zys>N03ZHJ8YgP#p;&ydTBFIBiC5d-IUvOL8&h)LldB=%#)_bQY+~a+k0}9&=4&a&j zLxrXj%*Gy>3bPs458t3~Gyr6sK zI7p7C9vL$X*ER-{6n#5T(u|V&_0!{hZ#w*_Lv!c>MjM zdvQtf9@ZdXzpGnRjKHCXhcBWXCw2XNT0dJ)ZGG}MyX?aCnrMtT^HWght-B%vZv+~# zzyRj1yQ^!HR;9U#WiF(sR+raRI~?8KD*9F1hur9zA=vtZY0Cx&t|B(QjwnMCwb$z& zK4wLt);fIHMF>>r2+Mc>(*i8Nv>dF8ca!F9f`%qSBBG@zrwQ!kKh`>VE&j0uaW-%( zFJtsdZV?ibqhOi_&K%qIpYO~t9ZR+oMX#yjKlg^Cn%eVRMXbc#;GD=KyXS_47n!Am zp$)5Q;ixJ9O{_&mSl=BPO(@g<1FB^7y%1A!Y}^xMAicA*s`0C-7pI4inI2z_hC4lb z71aJGN;-Xxd_8z%dXRKHY26_#S8VN zvOM$0R;A&b?Y-SIo$lXD>ER*XAV(55UCEM^?2nNQKi)E*RAHAbGvj1GR+M_s`zB}i z)vwG8CY2nCk;0C7HLyzW6$>Rj`w(|5icK%RtNYW}MZ(@}HbkwjNWtKxcv~){jghOJ zwD{oh<%nlC4_Qs$fz-sQe&6Q&vRvP{0SXGnDEZ4DD}myOqij>!--Q;2O$~XGWf_~O};SfxXIPQ*ZSMJWi z!0&`7hS^&@H!cSA+m4ucq&L&`GzTFhteaqGV>&J8VA0{RB-Z#SkuNZg4AK&>Iv@P{ z2Y-aNX#3r};J8a{@aOY|~ zOOFr;w+z4;tfWXUVBgN0kRvQq+SW8>Mo4#l+nkALV+Ea6C4#DGz%69!QEh=i2aA|! z4aF`lky!knqRce*lPDoLg*fqm31(< zvns=a2U_~p;=6~-*52ir!k!@NSk6O#ZDTFG-I1e$ydI5J@PPS=^F751nv5fz0FN>Z zaprwZG*x2O$>g)LI5kS=j^@>U=kxWCmrLL0f1o&VV8Ds>pW{tVp<_3ep2^P;@l{}@ z{}xDk5A5TnfotRXULLl0U|vh+#D!#zv>|Zpvd5Dcp83wKo7P^}5Erj)L820dYz#jg57YX|CMEU!a{d|t z`qp67*$%z=xux1X$SYHbphWh33oKbE>){k!4%CoGiHFRf*W}xx(-N<`FE0c7oFi?` z^RX6aJxD7xG#?TR#D6WZEc+d*BkrNvn(hQSW)0=fPHKXiR@QPKVsR#X_{ zC=nYE5|5UyBUfEi%DAN1^h0t@DbM03Z@TD9qj8{# z|Bc>glP?aFqBc_SQlfxR+eGfib}M<>~JNU*Y^}Of*ic ziwV08sX2msw0rrlS6utx6#=#d#E)NL$@9U)T0)Dsx^P5%lFY5Ff@Rew7~LT@8+($v z)FgnL!%_Rv87{Z5u)gjKBuD@*0Yuim?j*lJvB;EG%3wx;^mc>x^hZ)=DVpn;nyx(Y zp`W|EpV>yy@v{*pB(ctn+2LH|UdnK6a8VjjvDpHeO0s@H8Q$&x`sh7`zMq^rZLQRJ zp4?7tas4&V?S^Di`ZVR#;zAx~;t%FaUzl5=g|Dx#VR-NOH#twQdhZpeJS?|*jadFC z)f({;a(bvn>J~KPNNm&9I}0RnR5ez=9rAWs5*Gi`;rwtKJDjIE(|1;0acus7lo1=S zMUToORI{OgeM2EVhH_3dbMc~Ls(r?1RkB_QJ7p&Lht!xU&cXF2bU2)mxYG8gJTXxcIV(;pmscOMf_7%4yC8PXN5Yi7 zpbo`>1$WorCIv^fZ}sUCPO+>k9S`_|{>gY<7s5|WG7wmSW8?;Y^keZ6^Y$|zKmQ}B zCzGvT{y zUB~LhJw$XNu1mZY&ho1$)P1p5wdjY6iC>eGaUyJE$a_b7M3%H{#Vj93g!7~_uksKk?htupQcLZgC?zT3Qfa0_<8+;=~=4y{O-Vr`Z*5uATB*VrmuIDU^nZ z{%;3+zhvW;w;t2PMQ=ztY=Ts94^5N$itYHM)qE5+e7?j*FtD65pYr^@{h>z32!)X? zn1f_7HYjT9oH+k;@q3rqnLH73#jgf2Njryin@?kJc6fGi$ERTLd;JzcACB(6?G@64 z64)tjG5$(<3bjXPDHXHYN7fUe7BFjjpL6-=(%I{B9rvJ)c!3se8(7$Tc}}=P0tByr z5wsf{A0?Qu-kCFnaaf3zEy;e+ZkW&+?|mfKO@imUOdk%ON=H*)_-Gfkpy;jIG>84W z65R%Cu>0L7iYd+)`iAZ$6d&f9`C~%?0jtp;n^HyD&+?H@FzqEuR;WURrJNw8{o<+O zjC4=_DXIhZRsXCBjE~{PR`WV|!@*@!&yXIVm_N z&_%P`cp~AOawTrlrn7^^gzCdD&VLVp$lu*=V?Ta2^EpyrXHq18oIf&^W~&zy+;JQT(hX}dN%2w+7SF*fX;+7 zRHkK?jHc4WZ5*S{f!@V^lW<#|Q1dX5of9Er%`G}5=L2DQO*;*Mu6*KUEuI|b?j>)) ziJOMkB{SDb!VDKvfZ&;bt=V8sc|m-4tfuzQ)Blgl2c2!{ySi!Wnl_*~6J$OZjm4Z|moOnsq1=Ph_UTiaqJv^^&V)SMD+| znxi_E9+r6;8>-C2ijNADY>i&E)3Hr?zcMeBek(`ZVMA$}-UtWl=oTq|WUht9N%6(f zeR3&Zh-ybbOW#ybi~FRdH*aBU&-!e7=(%8k=iXTC4TnaR^HHq@48TwV~um36y z!D6a|F~b+S^1IV1AV5Bq!i8oD!sI27LrEv(!>R$%Pt@FKA@D+dQgB>#7@T4jN4D}` zGmYBSa*Leq_M@qmr~#~s9B*%({yH**3Looo-6^oeon4$AgBn9gR2s899Xq%ciiVz$ zd2M6Lhiuk@O0sP)j&dH$ZU8i|xtHTzT=uv!NZQfM+DK?yzg@xW-L{wHSY$?ki9+@JvaEXWKKnz#KzYsL?fwTCtUPg=5olNGsvJ zP;DwkR<4BGX~kXJoGw9~VPYCRnqB4)e{&l^-$F!bpR+xp2q|53t4)slk{sr?a*y=3 zJt8B7XRg~;bRqwRy-^f*tP9V-P$B$`k>%DD$+*w*LmSd-Agz#90furu)l)pXYADqOn{6|L&LP_$VgZOvAk5MzXbCt`&O?c` zmgZKygjPgJELIv8zgrx1zZKlL(&qnEGjx>pZHPk3mxJZ|o;q?<$-Fc?JZVj)wQnL$ z(f90{9Byru$@ewrDao^jwymm?FLTagZR~h=-0(2Fv4=Wi_tZ*=q&x|O7!wG1^B?Ya zNjXPM^oyABusuB$Z!M3?%Z*O7^Nk&#pp=PKN~&KfBXK^JW!FJk-C4WK2U5d@r%-pPayTso#$evV zcHPgDs1zDTVn04&Xqi6ezsnxe36;8oV_u&esmSAa!8v2s91Jf`dASGLSLc@%3>ai)ZckOG;^1=)znP#;Cm)K{J%gm0o!~d@-s}lkQE}m2a8D$^Y zA&YUy_R5v@>l=NiBmdV{#DqxZ$^tRs-CUfh0D*VgTa>-g4{~w8Sn3megSz0+JyCQN z`(D4j_036TbFzpQTE36m>laf8HlfdH+F6?IJrjo46g>+ba@j@3*{Lx_L*JPiI1AsV zm<^@su~!+sbgHn{aELwTmEN(LV>Xvo)J5LQzOzUtKP`h;KTbN0j$N3j6{aTD>E*;9 zg$Msh|Mr#Gu)_{%Q~0Em97%psOg)UYfFn7ay7_Q=raym;DVi=%ReDUWCRXbjj^^6ff0y{rSaqerckGfN!~^HVdOyu^WGlP()Eyr{_lft z&-e38s5d{F9?g-f73rbixQ5D*WGO~s>$B!EFGBzTM$Y>#l(Q5rIK0M-f|QRxI4w{x z@;ihi#8E`TPJ8=ccYG>NtLjY(4})~xx1)%J8U0IhX$1cYH65dPaeBV3RBro_G+`Mr z%+2^eA&uQ-du0eGQD4zf;hy(U3q&f^%E9Fcodpmy>eSz__@NV+<)ZykpE0+G$Jv$1 zsT4_jBla!Z0iyzThiFhY(4tZOplW{d(~`EU$d=-V=&4-R1dyIUE3dU`mc*leSlF)b zADz$7vsdgp@P9)#osvqO$YbUP=#vA<-9#Mu;)BFE*#}jX&l1&hDcGMgKbdTv1@$E9 zLI=g2HgK;+8WmL6S~$L(PhR?i@ombP*kzFNro@S-xM--iK{j0-ZbvzC8O^Xaf|MmF z;pOii&~ePh?!z~)NDvc*EscyZ|3$*nTYX06y+%wlIjyXg7wm38H5 zWq$H5eQTY*Ov9f|Z;ZL1uw;+JXTZ#5BX}7+m?``!YjS68%Sj(2UDN9oDzi;`{=z&t zL&a28lzu%B0u|S;97dwp32{TF&dSz$$1NK`dg321Co{rUyE&t=yjGQeJXR?7F{a(A zRc^J^KuTIOAg}+)WHvUSGQjl4>B*hd%EJ{h@t9|9Ev{A1A)F_kHoy$}$FXYOXH)*Q zI+P}_9KOTHH2;kVr64@10a4!?7bK`zNY)O5NGn@~yJ>m3@#I(9lK3>hIw($rN!tzl!^ruUPJXDa z6m622dJJ)|sS7B6HNN$6oRlIL=YB7NDt;9vJ+)ZgN669(8+&D_Z1)K<;fB<@R^La8 z9ZWU&76Cd*&K&gqN<$bN8aRsH^KC_xD3{au2jR&j5<^rW zcjn3_f?75G^O&lSmWFecX9NKdSOMjpZYe4p^v0CGrK7uC5Y&hb$l?6{Z@uASo*EMkYjcerX}PMyXp%Ejs;q5<%2 zj^S@^q0vQX(X1UC8)N>)2DaH0H`emy_5hKldjblyixdpY7VFLm4!guz+2%gA`5C% zql7(ko#IcbNv*pTRr%N0w3>!;vZ=nD=ij}qX!4IbI5z}`!nZovQ6nF(U5e6+`a2U- zDo2Y37ciOWbgM=b5d*^S8T{iU9CBDK6>L2Ay{gV|KTr%S%cg&MyiL(0Ux-~9;E zmcimNSfH*5hf5Vl{l{2{IH}bAgM}`CO8s3+nwEHC7NfO)6Hq|6a0mErF0iUZD(A5G zCTjcf>|5yTaNhL*UFqs{ZBvt(rKJJm9epwn*?C0Ya9ZF+_;Ty#<`;!Q_F1&ef1zj6 zGqpV}&Ltefd#{b@oge3BWUM~vt9Y6gEf-AGMAX^+Kn^0Gp>lNmLiJnL;H_vRvIuQ| zx|LvUl-6#Z<3&v&1LG|F2itE9C_H#}wuZ>6CDsUpUH8-DK z!6C5eR5o2!l-cy-MzPA(%po&Q8UE1uB7B~SFb~989y|Pzh~Df z8%tEms$3x2UR%qGE)Ph@itMwBlZ|7PG*sCEuvQ z@ml?eTPP|N@V-JkPb?qW-%4IO7rNnK>m;kp6vuI6CV5rGrKkUTq<509$$&V{Yx5v% z%FVKtYEoVgo|%sSd_qHk^1W4If;rSk1J1LR7%#nHeoc>( zxMW|wWNme|Aq``AvTG$S8XkLrE_>#*`17NvR)Rt?Oc8{>G?M8lTNmO2(SlEp9^$RU zQT-@AZT0do1_@#~{k{o)(kxmC)lvlcLi4#i8q!k}%vxMqpT*PZVzW)tC$uJ{m}%G`de6MHA8AW1pBNl`wfU183th*mK= z$M^8207OQ%$+^dV8`lZhSBl2!!fs!i@%~%NSfHUqbXoJ)@8njc`C}le9FEK0YLWUr zb#_tBt7S55nYXV;a49VU`;SN!=JWSHpxOfLYh+NVNd8p(B)pap>tz3fshFmvJo+?S zXOQXv-HG7PZ*oyk_H9p=03xV@tmva7H2uAL9SEo-0 zmjZXdPkPJX&Blg}vClm=T9~xE0j|1kMv~H-kiK%Z35OO#o#2?6qF@n6xtxM$#C%E2 z^5jTD4VHr{^8DomMn*<}sH>O1JG12RsG`Y%881?IIV~_aOn%3E^xih;HN(kk^W-9& zJnHerpDR8z|&j^Bg(Ns-Bd;aAlIQ7UqQh>c?o`@Op@< z%YM_NHDBl%z;x9*{!upR{6a#17v8-<&5LWRU7^+Qb%i#EYAnKf+B7YogTN3n@z;}R z0wlV0Y4pDcNQJX0JrmMCpLQp>DN;dNmy&-84W zEzRVg{4g84I7-n}hnmyAy~(H^K4A|30AbP+k!Eu|Jgf^2Zcyr@WU0-llspo^B`2A? zPvc$Ao4%g=sMHyQeVYvF+|K`!-NG{+nR}neM!iuas9w|yV`B1uG+l#Vo^QC%u4Szj zmaS#mEpyrSvR2EswQMchwp+{A(yE1X|IYcGKcM=&Z_jhz*Y%~}a4m^l`9;uncuJW< zZ>{t~lDLOQL9ayefg?i9{q{<5?E#c(8j<=Kq2 zzs8FU(Cqk32Yd=&$Gc#a+^@y24BN)jl-S`L@7MFFmXGT{?-jToD}Lw2egk#y0P|`K zy8-A^6sl}h*czhGaYvx}=MEIuFeKRTi`H&FJ{vzph}ac}@3u0o0jHvgt6~Iv!RLGL z&7HH^WMx1P78~9{h+wGg0%n3?R8Gsphh2u4&kC&3o(X0fq+7J^pW_n;m2eHAFa@p< zMbXT#gTapj)N1q5HXZ-J2#{W2FLrs&1FBrF<9u4-T#b}om5oWZ{rY9R(qu5qpxNI@ zpOA;>jysvx;V@b-k+F6ZIIQ$kldvLV^U=r42)iuK>OI6+SrQ|Out!-x`8KmCn2?H8 z#GA7?A$OwRCZYbn7T`v>L ziBCgNCrZo}CY6dFkNN+>t-qeyT#x=|xyKEv8s|`t|0MYB>&zyA|2wd8_Hm=GL$(1$ z`1-ILTP-rpa;4)esm#K+I>RL0p0C|e*UR&<#rJYXkS>aWYt3I05ACN;mE*4e+rQrc z(xDjK*k%#d?K9qR9y5e>3{nQBHNIN)k+59`}#< zicVxl;ra$W628@~o^Vfp|F?ffbOsL{s3pL$02E5VHM`m~KjZ!lxUpvx zbHQN;D-4o?!#yWF;iZ2Fnn^iTp8r|@Q;*(gP$^7b3Twj{d=*t~8!Uy$tf%g@<2Yu2 zAj5+ge?<4FAFG_F^HPZ%JyAS&8f38~i_v%Mad?Ur>>^H!c{2~Ag?!f}J<$ty6HE=6 z5mIltJ)0Yen^ab#T{Izu!7b-UYgZdtV-|6OF7gJ1Htm<((D@VJlsp40yh2c^$D)Rn z3+10lP=)yU0r+f4EC7Lac*6kfQW|L3%6O$u7Z))Dc#guj)R3&t;OWF?JAT*6h)!s} zcBV#^KNz+{#|n@3l)`AfLI;Y6$SlJ(`g+?n6mdV^;QfP-eU=N|1zZ1o|iBR4*;1hG2 z^Ho}^*UEj^rhO1KEG!fnAaAjcl&%%gzY?tE8^g`jXV2nbktb-50(n)Q)73E7fa^TMGHlR$tCkZsS=hoQLa}+PTRD+I1SN9rbO}~+}D;hY*k^SzQW`moUIdo!A|`fUY7?% zNBp~IoZj8|^9sThfpV7Z{07;-7FI#1*aw7kwoxmhAV^8hn#PQ?W@W*@Gh8f*C|qg_ z7^Q0gFjcpUr_H4F@kVw}QHXrB5I_6BoEC=Lrtqc0_Vf;+=5(Ib9QztCzDL07gj#&y1{JdPRY zne;_<_ai9#LBWFs6q~+YUMGgdt@kllY>wuM2GbPRsH}59cWQa1rX;NB+qN365lw7p zIR~{J`9~jJC}vUQxCHep*DR2nyR`6>8=}~$ZXNxW=T4MMb$d7Wq=A%^(wIo9&@&W) zF45PJZp4pQzd0-Xg8M#_n#K6WyZi!5Bf{fwqpWqLK5?X!OH=TsXG7Z<>jS5qo^f>( zC%?J54qm1OXA%BCfojOE4M%TrquiXFoGcso`~JJPJ1_&Xobb?{ zNCuX4$L-93bzA;hE4_eWotr*v+EtHjRJQX(L|cxJqEVj0mF?j4XGwkxM`%e=PuU(F zm4Qrf(cwXGZO%)tRk+jnI#ZG`8Nqs<{`gy3C?Ed7_sIEu^G=(%G>q@HD+a#ejJPNk zyIC<`FT_$R9M0RY=^2l@rV$i^$?!}Zla~hEoU!qIMuzdoiK07S4|TDANgw7f2WV(b z|7TFm^HGP`v%0wCBS+*oEdOlmNPK922;hr3(`zk>lvs@|W6<~pmpt035*{%y#q^b9 z{BSAYzq3(qmXrU1X`*2{cJHjMk%>bvoE`Tvs3S#8lW!Wwt09*(!j^SESTRnu>IlR( zqQN3gQQFr>xl$fchYYyJDvIBk@M+AJLgvrVzH@wats4`{M&Q|g14Kl{;>lzt*MDSg z*enMD*8(5SZgEF9o?nolz&!QLLD2L$ zU#kXc@Hgb@5b4mcTq94kWouUxx1jEl!W`wluCE-vh0R!>NwX$!&RJ}83sZL8Fu3`JAW`Y6eS~Ck z3v8`WNVYD3qB(3brmTiwO^YDZ_E|pLGCkW0)Q2dSl{A2Rv~%wn++)l5dyohV*vmgq z=%;1GA%Hx*Jye6AKx{hDFy@uVU`-}rs1z$n)sUdif7id$ryZhPwr6?(YDC-P&+%Jk z?kPkMOSL}ltk7Mk8v<5Fq|zNGAx@YLn$$6n zRg$J_$m_nQq|%Xtmq%r?Rv@iPyo2(0P;B|)+9?5LJf2GM*Rw5epUmCN_pSN zt(xk|n+?h-J3txEz75!L6CBBinm_G#Uxq?@Z~VvxZyP89}brj@F#%BtFADlJne&FqB6wQ1LL`M?sHj z3=JuRIkpZC&@#3yA4jbwt{^I`wikf<%0&lb@>@oMF>3%#qS$~QLchEl=hYx)tuO~Z z)EAkF?;U`ruhIZ$b+x`sbg>2}?E>@AB8XxKqIHDu^3Z_j3-AWfj#ZMfA4Rc5oV*n9 z7-UoR{uOtI{JsXk3U0=ooU3!_gTC`k)RI*% zw+}rmvtOLcBOh_z4GiF3E?BWETAp)jnw|wlKYVPk4bX#VDZ=fk1xuP9qxCX&s`%EQ zblmRCJ(0@d70N=mk}qvlLa$&f7&$)Xzuqvq8N;CGiXF0UYJ1q7?kxnXL{4sQzxzb! z*Zwl%zas!42hudXFJD@nk~95e>2WdQY`r-)xu;)VI+0OPAo0f5fcqQv-^PKexIP~y zAj^&OHaorHJ*1K+iCuY=1Pl->FxtI#xY#!n23u?@RvdNyrF0iN{>0u`OHHE$NiP3D z?~r`j*F-;{Zu0g%?T(D{C{4uZ92zPy&kUW46NnPnF$V&X6zd68^MfNOIK<=5ILT_4 zpt97Ieqnmnmw^)QG|ISkc#?SxGSU5`&!j;V3sKo}FW^oyT%<7MSKSJFrl_yENrQ#D zA=<~5M-Qto;VzBrfO|h`CS*0{G$ABJyNB0{_d2OaPyP%qNt4`DKcN%SUp26Bu1%zr z=-MPpQ$yUTh4vCEA0;5F-YNN1hL1vFu=QJ*ZZ+p~^h8}PZ5y?P5fWo<-RFnp?h|tI zci+=J8kZ*Y@=Du~YscTLjr&x+FvV=dOKYSNCa2nERmA(Dl{8Yjn=wQ3G7$KCiFlIt z;jG0Z8!bOcL0~w9$17AL$wQ)#ljEo0(_urPJn|+U>xa1okF#UC#P)X8f3n#s2v9`; z=SVh$$Ln)zkA6>!9}?TFX&BCPx-*4NYB(IOt{{KlC_V)IUju6OL-PZRq%ds0d_)GcfxmP$?sE}#QQ>W*`B#3DDY;RHAp<9jC67}w|tV*>@HXY{A(jPm%XK8{fZ`Jelf?7La!c=1D zZarD(tLIyidQc`&r8yr^jLbLO?ukFX#s)eKwt*Uz2;3i@hakOPBErc(Si0d zAK4-S|H))5Q=f6BY2jhPUc&bsooK+1JG+d&TY|iC8|a61w>Se)HBoGlh?3P7SYFmS ziGQyGQ=*3l&ryhqIRv~)gxa5PK3qT8)YG)8ezXCY?~EG?uhtvW0$pI=kjbtX*3wEx z4GP!)h~jwaP_-mM!s( zX=rHpY5kd&|E3B-5p1JPitUd4Z#DU|Q8!c+ZRoXawEFGs?LdD32C0fgS#f_=Qc@0G z;;HyJV!|Jp&ny_PT)vcAY`KEIbfjT)4%n^T@i4cd8T;WUpRIff^A+|Xa`!mh%skPd zsIpba#g<+1%uv1)Np@rr@nXmr05qVd)-btY|3odk(^rt^H87k8P5Ukqq~r_UOm0dg&eZnGOWzx z;|?K|z3bgZ3AgVgYjvMehJX|a_#Xea#1>KyaOZq`WKiSL^1Ss!7-YCe-kqC)56B`r z4;}y&M^)GAy$y z<93a@;$vx2_3MRDJ~59!9tIv6%m?)n`xx7Mg}-wDyqnq&hTVQIQ#y)127`}S#82v3 z9DI)@;A^*KccObdnu;!}oegb8PNz!#FrJR65YIMRsh#KgrE>apk3TszjO{q?RS133}19l0iksiWR6b5wAjIUdv3!)1G}$LBg00AvVGB2vSk>f{-+K zXW#T{Wx-*43@oXe0fQ3hAXM&Vs&!elO}|)oiaYy8Xiis}90jSG28VqAI4%t{Usd`O z)JKg0+7fCpHL8Sst6--?80tEND5k|aHPqY@v~w4nAHL}s7cT520*NLu#cuPue>noF zoO)*-;zz|PE2J@G*?y`+kOdVsasJ)iuDZcR;@&bl%Raehdj`@nV5U-3QbKh4_4tmA zAwEh^p>-HVrUbQE)U}4T=_j9~3ZFMBTDjA;D^5g_Se@E{o0KQf5dWN^ilRlSDBOe;p&L;?OZq&xrv+i0dnR4uplUHwtb;|CnKB=Fwos&6HTz zdin#_fBlN??)U#LyK`Uudc)f0Ks7kMwgB{@&k77puj0PDPxV5}D6AkPt zD>Ukk45>cysTot+t6-Y4kQ%BSbk?SB8g}i!!P=f|&3<@p<8L)oR1{cNu4}N*>Dz%i zI}Y${J&n&LyakP8Ty`H z{{01AGS3+Q_0vgf{2^vgCx=1a6~j=sW~}QeVHT6}Qlh1>s^#%Y80rotNvZ0IAZ1R` zR%GTdhPe`pb<)bQI0QRg57v!ng0g9AmPQ4TBqs}#6?nD5a&dB=AvuQr5s9pySmjD) z@A<4MZ3ejO5ZX8| zufvxfCop

      bZEu;`-hmPXdJ;$6>%hE&H?hdU0)@P5Z-$gxVQ_VWAjRpdqS_PY~fS zX(xmA(1**8lc(hGk5X@9q@T-bIp^xXEQ$_k4FdwaK9F)8RqRGc#;Pcc4NGVJXUYf0 zYJ_i}f@*y+_mlpqkKzVZN8f_2kjc}GjWdnFb9l~IwLKb^lEtLpUW3Dro0?-p0oQ}! z9hc6_-hU1eH!9xi;ee6jag1rtsFUOx`)B zib*u9t+uSKuY*g+#YHZY=GjZ8g5S7c!Yc*1YnML3b~MBG@jb`Tu{jvxl%ETLPR;+? z`W_zAV0Sd^B^_YU31eeo+QevQO`7OTbO|?!guddT8}R%{H~2}i5HIqR)nmo~arY8f z@Lj^xB=MSvNl5-LYLMO44x)u9s-5CpSTycG824iB99Bpok9=%_a`uS{bC}39A+d$O zlq#O;4(ZgayZykT`|IuVZEnB5H2rCvM6ZAFY%fHm@z&!R%a!9?4`s2!=?vUo$ZiNe zq8iTN`ymyGK6&NDUxwfE^V`xg2P0!!A%FH?Zul@*PbTD>26MnwJb^~}EqJ3VZtm-X zfXRo^KjlYeI%|Zurp;SVPZ_EK9@hx6O%DMP4#J`bzn~5wCes|q8}kZ-XT1*2q}$}y zGsh&-YcL(Ht8jxjV_?k3prInExwLsdVK^SqmH2!_eHUPbAY9+wb+KQwLbU7k zB$rn9)Yqc*#v>=oytQ!L?5d{P5aO7lQ;-(2ap7ial9;SI{UwamMP5Z>#l0>KE0MFd zj7HL{)}BXec*trIfAS>vrDh#KCQz&0{!KOBUE+|T1a&y?W%@UHpOB#V$BHjc59+O{%( zlwMJUvWcTP9af2>>Z*5xXGICc;z*l+Vpb6hQhl*U^DvxdQVOmu>GmErA~#2gbse6H z%_y=u4bE*eV9G@he<<13HV=zaVbFYd2Cd_cDQyqoaA{W=!iq|rJ|6S~!Q3o8N9CG6 z4Mb)1P4dY*uaYQGQym{e>>C&+m{oYVxgCf8f&j4lpDDlCJeG*x9IT^c4q1iOTr7|$ zzFg1u#uVFj?Sl_yknw5|0BeUn%8I0t$U-6#_yNDRMogFUN`HcFIS#i1G6CykP6F*w zdjrv};1{f_c}3+iX{CXb5O`9Fj30o{;q(|dV*uJF0L%>nU@=@@4Kn(6EsfLWCVd2i z`<9E)LSW?sa=)p6_i*|bAs~tq1Tuj9eM#4_zCG%M*|g_@qo7bJoww)#Z1**TRFP92 zEVZUCF~1kaenhwVx;Ty`kH*3=pU7JKsC*k@>eKTdd;B^N%B7}o?{ix91z4<2>7dP~ z2E39Vo0xFJ-Jb$EKABdcM1J#e`zI97d}D>*g9U-r;h^+JN#ZNbz{;01BL{!Fb6BwC zHF%e$ZB~40oZazZGM>lA%I@IE_f^we6bGeY$3L01sF!)@?nn=2^LH|fJcVxT7sb>M zwleFHRGiMEPR`0D53PU~eTRm&x6<$eLUI6kLjRrkSAkmmz#dG#;*r^Q+%737yj~lWb(5gPMi%ycrJc6t?S;?tOYShJQUX4Bb+YR2j zj&3&DAu>a| zPk*j!X=exsl0*HUJtulJ*HJWZbIXd>G6_%u`g~>_4?16dfbZz_0$9+@<;_|4hPe!< zFAhLT@CWasv)$oXrr=p`hwwt0TWH&*db=&~My5{JhKkj*&Cq8kA%EW@V6vG>;4tXR zcs|Uw5dUMqV1Hxj&_9|mF7yfp_Uh{D|C~nvLCUPR=fEuutMf+bsrwEDh2URU_h<^q zV3bf?a~$&~{{d%}0kf(ev#Lv~DO=+1@|B=@G%|XE+X-E(_!GPUq5D`lsTUNN_BLnMo`Tvcg=4kQBR7xGGya`87|dCgI48@uYrYK{%@~GN2SR&H|^DY z0SJfWA;@ts(B+)5sJ&+#s;7xKrToh;S%l8f44+>Zg>kL!S0;U*Mq5Nwr>bR9 z{Yc4UYRsUi+~FWVuhrp?YU`&5{HMs$=OPX*$L~6;d`<~5CUa#OPO(COd088C<`_n0 zXDXHV38ily)wP+w3G3WFi7Gqs%A-;EHfJ_sJ!^|o>ntX!Z&(6BBP z8Q=kL_29Q*9R^DEOJTe~z?{p<0(rLl922bB$^|zytzh0)hN(AO0hcgk*vbM*zIPLx@h40haCi zthER@EzNs{D=Ml&NLM*4t6jRA)dO@6*+iSkPfe24p zZJ%HxTsjAl6#J(Fkq0Yecmp;#&X_keBDA7J%gHQUb3KQw(5jeLWQO;yx&W^;LL*!lY7 z)OhTxU^6w02C;%iLP=M-Ao4RK#PZ#Ic$g!uO)U$*P}4dWd&v&#ja&(T<*qfF-eXxx z@V2myL%u!*1QwbFf??0HbhyMvWC6!NcNId1c_{Eys)p7=A|_<;9pVuFO;WJt-M_WW zl+OUjk?ZKl9OgG`OQj2j~d|u(h)b0Ok0sdIBroSv>1XVwCBv=ip!CyeP z+4}gnXJ^Pkc=YUnH3*b1l;rw3uRE-zaq>Ax9KWxl?sg zHyL`>K&1)B(}|50`yy46b{xWvJ@@HF05Ai@b&=D43BLlpju^dwHv#qnZ_s-O>ZD!9 zd9&lFzKB<$-h(R-c;)!qA*2a~+b#hzdbnk~tfbvlSN8|hVF?nC95;<_+^+rD5wlX_ zV-vC@n|S|(bjxIWIig-bQ!67UVA0swsi2pSO02BJ2hmGlZC(<)8O32hGvMzeU$HnQ z14a4hn|BJP{OW6T8>QB5B&XvBgt3uzEe1$NVT@?I@9II+X4t*h?3)9Begi2b$e`=+ z{g=Wk7pf|`;Hk_$+i@QHeEEx{0GUa#8SArSCTv5xjTp020=b!UJA`@8d?RjJOnE=& zVF+0!)sPX!OiE6~ydfG~Cp4V0Q&@X#6PIX+tPuvIyq`NR?3!f%#4?jNEfkl$;_mSG zz+E=Sm_?3QI|*Tgk@G(cMAk;%C*>zU@wva|l^Ulh9V({zM5A$PDcDP~@-8mc2UCmu zELLmYrYP^kAbVGme3*5h-}r09^OqCJ(x(~&=sGp_@IiP0I&(Xk(8KlwSGt+bZC`=U z4kRZ4x&VMr$I4MHO^Gozqn+Bq)g-N0_UwqPQ56p4xvzQ1B-#R^=~Sc15vK^4@>dn_ z^?ohK;ti5(>FIR_fJPUdx7}$(vsjV>NCvd^x@<=e4-X$72Bg@_p=~(4jgJY%I4ca( zqMa&+0ZDq6q>%&IN0CbYCl)8enl^3;snEzptjV53+GlzDX zhA7$)4hd5UT(hsCNZ7_ow^vt=78WHgWIgCTHf2k4JKveOT0hrsF8vB>>tJnY@vAZ) zWD7Nd=}&AD3|=ryncMNF5Z7X`{goo@3)}BS?zF4Aw|#g!0*%N?$W3=G?}h9#i)@yu zv&lBw=XFVF6;NDnCDH$>{^&?|sJ*oQfj|)NF)|mq7SAB}fgrd6_C|gA5&QEccyU0U z_g9uyF>12YDn4hCZVaJ=*v=n18^3=e7v@`Y#!~S4f?|`kZ07|yYUD!J@=I_?)j=_a zUG>Zy@n|%rZ2-MD7zO|9VXB$IBG+6Aad!%# z;e>-8c8DD#w#Z7e!a2c_V&6B5h8yposU={aII-w`5?6(H3BlJ}sIa-WF&q@pwlBn* zzv}82owz%sDEXfFct*N4?F*)8=t5;gv}WeXQV_t-g9f~_KJsb;+7Q@p?LQ+`t$226 z;upqPmqbbtDleh`ZC-Vd!#Rl8YaYsXfzydTp6iQhvYuiBpX#>4iu$dCWvI}l+~Kumz2wE8s$%c#TuEypji z3D?cEJ73pAn_x-$E6PD?iQEqxp2Ba<5Sw!}G5S>1uvXDdR5OPlYXJoA?bu89MppOJ zi5Ii~#cg^kZPpSiB;Y__6+!)8Zjlas( zwvm0BOQ&j#6vC$NbE~S;%g{li-HoWwFC$|}_^(Eu(xL%}UiDH{S^I~@s05)}m5o8a zdbsv@y`8Ips2pthx&pIc72aoO@*nxf`*Ml8cuLfLCs3i=o-tgMNLi4ikhOP#9Hp42 zq?4=L6KZMfrk#_pjmXaoYq_XQg1-NzL4Hy{X)u&4xp9o0G1&;VrIC#t>#0JIo?Anz zPA26z18X4Sp!%Orq|3u9$%IK^X}AgsmUvbQpMrI?8qX{yttk*HHsd!1X;&8(Y}Ij1 z$|5Po7_{#&$HbJ~pdE0r`j$oq1dIO6P+$AT#ki7k9)jl#K$#n|HCMo{^^!MVHh@nI zYct-bRQlCX#S(uN`omxLnY-i2t$eN|xMVtG>V{xi;T~wtKk1igPC5NkWsaFQ!KGoC z=bxtlPO`d6(3@T$!!GT8;BqLBS0bDw+R}+yg0z;HcRo8em*%p{C88<{Y_0V)%R9z& z!jI-RpSi;Gk+#f5b`>6EV20eJoWQGrm+W7bSN3 z)g4XX<$p<<-UJ3W(4m(>phgpSNvZ}I-FV21EE^b{Px1kOIqYI@q$yz_{R-LKU?SM)TzIVZz|>OfO3rxc0z z08qaUmQ+OgxbGtleI^izU1(kqX%UsKYbAkx|;b#~H*(hg)Mg`8Z2X-?LlsantQ>AM9PHS2u$dc^bH(M&M z`ME#JGfpZbB;@~hn1m2_C-lP_(|H~G@E+n@t+bmTi;|5$32>DF&|+qs}D$%_}ZHCaCH7D0ruHTT0kk+hH{IA zjuB=>&t}8l%o%G%*ZC~~N-tQMJL2Szwa*sF#OTnx!+$@}&O-FcCf4(E2A{_KToM6p zqv8*+aAbn!yJT++gzVis#bxaX#l?oCm+Ck4+iyX}R=eyCu8VGKZwvfbv$jvi8` zr#qYKO=Iau)WdiRya6g?y*y;2hc${RBuGCG565u#zY5_g(TiKqEAb*`sOgrHpigh; z{G8DP$lN<+m>AmfJVHx>Dwu&6&r<8`0nxu1-`aP7SJ8EcvFqTJ+AdeXTT=KiRkQL< zEorr{aXE~P{+F=rX#0oSI0Qb&!GXQLOl1UYI_Twg^Rjt-38`EY5va{SJ^WKVo=vTF zb!1}^84(IaEo&)xp&ZtTQ?e#m_|nShl9b{Ko9{~|>8uU|#8);q1p&x`l-Oq6ZJ~l@ zo~+{gzd=$fz5v7E=`C%|NRvsZ^}P#(SbTQSJ2LB;x~&>bOFZ2 zhX<_<91&=@9M6%@#sSS=DMe#WMhrorP%BvP`1nAW_H9oZ>AP8o6@*fvV1?5L*p=2t z3Os2DY3Y(8FqU?#v5~o_K_8E2N-!haAW6G( zgUfQGEmLOmpync(tgUBvUBf0N%{^Pn+XZDF48Gzh^3+J>M3gTZ!pcr8jb-t*v%3^i zOQ$2^Xt{oQm0u98clP_D1YfRHUc#2l)1DH8y}X{q(_~OkqvWv&NfNJF6hbPM>CygH z>MN@I%R$DcB-Rge5^8`a@;12@;l1z*11qh!FVktAxa_8$ZL}xxzZ=!qC7q+<|q8f-GER{-n|n zWg2$(dx@)NfMZV2(+R9C@RNhWntZ&xPmhPW$2G>et!&3yrr`)RU_~FpUDW&cqaE^E z7qDBc*h(d?3fC%`NV^Ewz2AkooYhaUdC20Ty+B04gkdl7;CC9H-Q6Qf(Qlr4n_a$g zr68!Gt?~gQhfo%$slD^!zw|kwx95gTq6y%&XS8BW2@T&-z#rxT`9-jV5VRHTb+sXR zNuj)3^kNPpl&=2%xtE1(%3qA#R8nz5I~w3=o)mFGp+mYszgoT4j7+@mlQn{mmcr6B z_^sgmgZ%biWz5MIm<=i%x_$vUKM>qje#8*_aK+jKK8?fbGPpJ4G9-sHgx} zN?y|rNAe5A<6tuOlx=7~ohruK$25ez)lv5Sp9*611>M&u%Eg+bbwvsh^rR4mMSBDm zh7&sJEetC@y}!OGcTXU`da>JgUH=kuh%(#!Q5K(5eQlU3KhOa{y$_zU5Pxmnd$=o9 zwxGx@ZmX6snc``~;V>I?*{X(G4WNEOPbBl;K`PfycCs>F{)Iimy_>HWg{(;VD8Ftn zK~K$}m5rFd#P4Qkptl0LVXz3XzFVlW^Uz)C^*T8@{mB)2Ezlo70S9JvOZv)GmI?bX z7LxSg_gdW^tDSO%KbK1}zU^U?ZoIRI+#qxvWET2A?M^e=O{wB3CYR)8N_wXu=YHje z2v!X0M}%%UVy7V=7jPQzTE?OgNi^{%0h5c$O)-J(Ct|8>6;6M*qFkYhXGNC8ON< z;)ev9{=zMR2b0?z>N}v68MJPKngbPmhlc7UDQT8bAqnWvmv)b%L2G>Z{Ap}fnU!XPIXw5 z^cHk_HFFzX0?NEAzhY10se&4LNDN7la=rmL} zVja?gi5D}9X1w+w1}pi8&=LzOA6SV+Vp4ogp0kXMrMTB!wSYRwle(vlpXtlQ)zcH< zDu@SE7W~txznbsnYCvKbMd`rTx~oBgG}IA-x!Mk820|I-+4#)kAf*k))?b00{q^td zG{^Sf1zPmfc+sArjw^ik)+C<=sc9G)G%(yWu}~;jtur?i*W6z?4VieY1h3e$Azx?w(DXkOKT zQK*cU@6PRIe!^ko6D*@&aUzU=X&RRD$Itop$5-s_rP&h3G1W?u5s|qO$AkVV5b6uk zS0kgygi{vCbNC?_CyjwhT)r9G1?@5>iRR{h>aR7AN8d>Gs zsq10CrsOsy9yIG$&}QXQmBiJQ5oU#S3v`xtZMxCJe7AT^x95KR(+&Im?t&1s({z@V zrjW5(yv;TW9D+MMDh{~3`Fc9!+BFsYU<28^3`E;7gBgO{@GW<=GmU1%C{Wl!%!41+>6kmFD4ZgTm{2{nAz)03UGk^Seeiw{ZS7 zp*UDQ_xw=umq1nSxUL4hFgM?E@<3kRnNg^sod_|)!Tene&nS)rWF{06{~{lw2mxRd z{{cl6VCuh^S*GxeuZ?58e|UZI&avdhQsD9r{)lH-cvOg0=YU!}DBTK^@c0QGqR}_m z@4zU){@f8~2pp;wrS3%Z>3<1X4X>3W&LyC)`iJTEvPLsvH!+sM1`Zx5s1rAe4V0BD z;cYSg?zh+Wk)|Qz-y>SiHI`#fn5yPOo{QSZ90yawr9ql4ddY(}e+!lg1A5broljz9 zKf4=o-?AOrehP21Ly8E5_0%`Hp~t3tZwQJ<&(0>G;j{*bnE3{1J}XX3h)Z|19fwrK zAaYaW<9|0<$giu#vu#*}7oC`#{cPO`7itS&KSnYtt+&qpye$%C>whh-F^KcUBc}jc{^$OD2V4YMijM;Yyrz zNTmDT~Nl>g<=<&81YgTEJ-D}%YJ%3KxzKS)0kf4 z)xdtvoPj9Ui`{&u_^nU4vI}M(@EV{8=*yp{C*Hs0gP(HEdBayc%VD|9cFsU5kc+As zZD`92HHDFa00`@on6+YTM=(wl*%7%j@PA2;*&8SiSZdofy|g&gf!V{fz*+~(&H_a` zv7Vgih(pL!C`}S1#As%JJbdmiaPgCI!;v^{QT?=4VWWgmZh{%mXxEN}I-r30;U?PH zzr+}fq-uyO=5B+8o1{X=U3gBUIDt#ZEF@7te+D4HhSoEphnjW}(ePEv=+2OxqhE@y zoCEhgS)6$wc4Rc!yg4#HCUW;y`f;vZ$Qlns8U(3NTJ1=6lyg#@V_4L^vgPHi1^)@) zfkcUBWSp%{O!@^QQmbu|X9e`6Tk`Z>F9=wE6@^X<90wtaGFt(35TJ%u4UiKXFKUIL z5164KyjJFbCQ9NQ>tWr2#Y~WLd`?-UG-BKZ3DwE6A0xt;>d2hfT3#Gnn6HOIZ;$(_ z2H@+Rnx0;b0-EK5wR6!w*GllP)B*ed)sv-UR$sIKXZJ6Vgo#ry5I-I1Xa~V@JD{lt zSd>9jB}VMUnUJ>etp%C*^EG3j+uK|lQFu}FUSeiqKPZ~!)x6D>wQ(m-aK=vS6k79( zWA0jdwKc-k-&?-4En)LztfS#%6${alUfe1pH~LFMWnq(SKp~77jO<(A2dURrGB`aZ zl;KfOs}#suk^0EkU$$c$V+|unO%Z8+vo^{0N!OT@dwy~`tE(ild{PSQH-Xe|ZfeKK z{H5PmNXF_E<~HhYDm%x0O?r3Qe#P`xzvX}wL;Xc#q#uYTKrR?)n*bq-8BMKW3OGk!CqBE4?M3c5fvKga1G<{i?$aa%Y%rpJRfT@^8Y|p#O$m+w`^x~n1=^t z;3EsQQWgXbguviFBoMn2!Gxzr8p9kN40#rF400}*{HS1XSeQ58`Zu!g58T+1+kP_I zd|+H3{a5h!^-ZXJ_ND0k2q>>3tn5v&B_YL|ith6=)pkl~h!sTeS=u3w95hy7z-9Nw zf9F{_x43|pqT6*KPZjc7GpC!_-m@vXGV!j#BalM@3QlZ(l8btcTqt8ERs|w5X%sO5 zlb!wi3j4>(F_?MWU0iO!*s?!z(m$um(8=J~8f#9fQn#oVw6J7;4t|K&XeISAn_Npdl766&fS!&uFRCyssufPlaQ2)x zYp>PBWE5d#B!aCnyJh1KeruFJTH4vC-Z#|#zPbtVF;GZAH6kLGePeSI_pIOiApd96 zca2OoSbUn&VZzjKvudhjC$~bIM;0`Nujo_ywur7_oB7^wj?0>GKWj-huh_cV8J67( zlXeLBRR!vU)&f~}uNe^kh0qs!guc5HF5^ck%EcQ(g2oQG1id9)R(4_|IVo6-Y0w$8 zOUJ7X7Cm)3+Ah6M2Nl|WwIM$Vj1@@n9G92IgS>R7X3#XB zGQQnWtmX9ZYvrg65oUeWTYpzeSJ$;#pJ(M@u}c-naGxcdOOB!**Km{-yz{V?{grO& z*E>;W3u!}vA^kNqVf+rxG_qRaX{90_Ufyzykb61q@0CuGObPwxbqdiRZ5e}e7e!g` zj3k9=cvH#F0iJbLmP#1@o#Y427w^Sj9Xw<@+1M{A&%M?sw@5d(p;Rj;%Dw)-5Bl%0 zj3!uCZY!XMCe5>{_)%+RfQqcD8bV{p*j1laum7hf$D`eOgoJmY0Q$RclmaosH?+^}ZZY z^4G522EqZPf(Y}^`KMwT#&cv)=;CuLqxID^9|b@mn1lm&ofJH@|C9PlA4?RDfN;n~ zQV+<+L-7OBffJCEqGAhtSQ z7=RuA8Q>VbTQux@Ht3YxB&2Zh$-TDu@Aw=Y3NnddZ%OPLW=&Tjvs||eLeRp(&hjaS z#~Ni`?2D4Bkx;3_pPy6s?|dK`i|XEaXVzFv**d(<_7&JbJP4`Bz)q+RycKS}+zpB7 zQ$3Y%JUlQ2XI*mMdGP&y(F=h`jn+X+(`x&}X@Khg6N`9h3M;Ve)t1bd=JRfNm4M1Q zyzi}N9{Fkbz~`BDZA;t0MN;o;X|kwg6NWs^$))DCvV&&2=jiFT@UFfq1JIY{BB_y| z?ZVZbc@gl~;Y;z35kCTN-viuFz*t$RdWGyc@xHGnK4cX3zwX@nhS^rWXo(SJKA%CG z(fD&ui=%o&AVop$nsMmDe_~ZlJiASHKJ{na^BaRzLUeRarxW`}_7I)g0kWi3wfj8H zyL}$}KIDmkuuI@s)#ML*v5R?yx-ruMjV9Zf;}Q0?Icaz~GpDEjMO35dDJoql%|qoF zborD);e`H7ExWWV=h>+-B`b}ah$*Ei3aQgGL40?!qS=9RmUXrw*!-t|`8c0q_Ie%E z_|BhrNCGnhoqZ8I%&H;Jk!owP3!q2v^8>-i-%tDIM-N->;u^I2wm{75^i#YYsPdp%HS$k_iB39Lv;N7NhKTUG-4#1Z8nuo z_4c@ci}rcBYZB*|Oni#GFD+>Gi|{h1n9p~L0yh4Cb~Fl8!^g5)j@V5}R+y1)Td%HJu|27|Z?k&G?%pD?9s`(%(T zXJiy_O(d{%4?P_pWG8uyrBNFMB!qn{a?Mz`?!Smxgd@h#f!_!^HyFBMIi?h z+Qv{42w?{?=)DE@_|Px(a|8Y{-f)E9`p_aQ!vXF-`-kW@=>)S5PTsp>AW*=T8Vw{g z7tM=PcXWc08l^uJy%c%v$UB!Q5LIVc0GYKE zgM@UqG)Q-Mw{&-Rw{#;QozmUiAt)`~-QA$HqZO#3VQ0a#J%|hyp);-~&ZMsMaRVBx8{;Yo^?lFJW_D0T$^2y-Y9NT=oUM-;2&{s8H2%NsdeS8m++ee(ftN#{TFfSfyW5V;C zeWCMtTmp*^a;$Nwk85YK@qd!$oE-FoW|Qa5id+dZgJ~~)@c~|XuY}aT$8_}cm~2RN z$qIn0>pYPP`B=vPrturaqEL~%@yz5{0;dk>KYM=f%4g-kbUt!C;H*4GcchA3G2X7C zja|idk&w_oBU@7(^)>$}|C^RXPbQ(Cz*5G?)sb%5D6Hne7nc2DY#);oa78iD?6Zm{ zeQ(|?c{I$*0srx?T$qr89o?TAS*uGPxg>n!=Loh{0`oOcL=6`V3ZTWMRJbu=tsV)> zq&~3bCtwt}DkVQ+ovy-$vT~lRI15q7!3?slChQm?Au={;eLu6Bn=sz4{^lx(LAS$T zZ$^P56Y$c9O>xo~cW7<5xJrhGxvz@|ud4Gf+@FgB*MJ_UF44EjAb|*jlQH;XP3dcU zD9p#NteiE8hYe9Z2rnG>`W`7xS@{}0iQ5WG?}}EbSefp~M)$8L*;@<7APqOX`;g%N zt7`&{PXBQyAiTURFYw>v@$s+;>CL+@tsl3M@leo2V34-^S#;Pwf5D^$yJrj)I{XQ& zuI!D0q#oNMl`h5($O8ek+kd}*PqH%b4?Nn9Q$igbHe&t@ucSAat=S+ll5#ccItLLjhya@ao__E*0so|v@cxlU(IyXVz6h-ygrv4)~ zNTtFvMY83yMc&hE{1Cy_3XmBhEawtj~eBgM_U1l+JN1880O^;z8BLVGoLm)M+-7 zuF4yFS(6xIGJU95LBvc(O~Xy=JDqypeSLX#$Cl;e%tUPOjqR#rY1E`op*ami2!q=0 z-=J_tJ5!E`N>NE*a$;@T0@Jt``BFQ?y2f^P$gE`vN801! z;v(xo7Mm`&mM)8PK$Okk6h6$Nipd5Ju46KF;;yI&WoJk6oXD}6TKjT9^crC6?{l~C z*D^A5u|zW8ZJw(3;gK!sSXrS!bTl zKw`ne13x7?UeE<)gZ9{ayyo#28l2V()@Bhb-J}w!@r%g>_27DxLvwDX)#g&Kq6lbx zYk|I4p1I=32!*y+V7@Wb1a<`^dRRwc!6%a+4k z*--y_BBySRGW=TyM(%>#c^T}ddg`Xn{dto+xchZe0I zSt(F*>6inzCu{`hn~dYf7oyk7v1$-s9?u1?-~+ik$<^OSQM2feipAL@pgoyy&lG~F zgEB>N2aSvXhA_%C%bh=P8C21K%;Hck$jZjaoWXc55KZQ0;Imqs9We| zFP>c&2KIEGlx%JknCFtcOlVu;{5_m1&jteps)zAzK|e%D&n-}zgN zLQvgfKBSU0jSxiZ_e);o^LvIfxpl8be^{IuPgOCAEw+d>o zQ5MMlkIQOB<34^b-Un(vC#O0n4G1AVK8*d}Wo93Lvn15f-oOh^O{k#wG+AzRbkMIo zfQz%M!J623F>$4N&X`u##Lw9|=w-Fh;*nzB6Acpwy{uGs<~ln&FE6@140--IkhK8k zfrD|kf8wMKK^wo-=21Yq31O2dpf*6vLBacA0!houer!(H^BHa(V?chu59j0ejB{?U z!-Q^7e1t>{Q?0c0;NZJ+M>C^PtyH$DS=MIE?ou$kc1VDIAe4pTW5@etoh)7I)XUdg z8JCr&kLjP2bu`iRNiUe=czZeD^(klcQjHS)`BCz<`K%!iRC#61H&y(XxO)Pb{hzQm#MQ?`Qe z&zsb{X0C+?4cNTBKeQA464vFKOZ>3sD#vL@Mn__;b8F?eRfF3`1;Ci_ch8jSh4-AuFSVwUDsC?3ijRgK|S8RR2oJ?`PHa^!T`%)p-&p=#8h|l|?u+ zrRoSVp+<_V2QG;<)OV)_XCBVZmmsSIPkaQtCU18}Z+8I609tjwhf7Ff&jBJb>~vRW z=j}*%X6Tu0g@Oto@r;vGU0Fe5)5;il*KOXfx z9Sg6(Ix#f`P#It>I=64(PhajE!4<~sqcQmw@2f&)BS|g~&o=bj_N~l5^PLY_=NYco z>)RXNYL8bJM5T^Z@YDiA)Aih#(hLoiX5Qwt?L--pNscVEH9!*d4aN zFgo#No#vte=sp6dqYanCNl)qHq#R84M{WO_x-&^{z#+Qv1oIfy&Q zMu1b#v|=GG6;-qGaImnzU z(&7U#ZHOu*9hGj8M_m8_DbOfeWTr7vu+H!x7ycPfcx%GB1Yh$B&*{4pwfTZH9#*d@ zv0ECe6LiIlrJv-R6o&gESP%=7!?9U+rm_t;>N&=4m#U+W5hQ1#V6wQi*Tj-gWvVVF z^>hZ&gWw&ykYXCYVeP>?c^X;w2$=-XuxnNGAXwCY+egf%C#PjQeGjUdH$F`T&G9 zES~~krD_{s+W@}-*0Cfy`M(@zZ4+O*;K6cblH0UKyZTPO10sDolIsJk+^cjyDU!$d zIS7AUQZ%mrow4sNU90O{Q`o=*f|1`6nLZLjewf$Cjb85Qpj6lbfU$Am+soA3OZ?kI zJm5bAU(bwyaKSbW0DB8KKs<#Ju*C&Y7p{diNs$pK%kFK5{_3a&Y zyiKgWLmJbWMZHPi+nlvqa?th1Y#oh8h>m;8phx45?zgjQ)D*)x;`j>vbtMd+!*Z~q znt3X$+|y@O*bjG?@%P{j))2L@VuM)Lc|rs`wOwo-jI^d)jzUOS$TM29RiTff$3 zgk>J6fb*o?W_22aUFLnz(TO)Tp{SU|q|4Qwni*PXW^PZs4m&M~CjYwoCdkooNYA=+ zLo6kn`|QaS@o2uN;y8FGdx7|~;A87v2=8`A!k#loJcKkF6Vy32Ag$YiRehC4a3if+ zAhu_Zwp>JozuBRq^!RHGxxlC^5>~^eLhId`9eyBhF62yTcGyRxjQisNJga`ylq2st z`;5}|`eX(%2R6NRF02b-cw)f z0}2;l>|IMZ3^;Ho<8guB+Sr(gYLYKcY?za1QpEinap?~9Bqn=`b-Tvz-VJDz*0dwf zCK)&f25z|=!4^uN*rCN^ZoUg@*SF})`0M$_{DMb9;TPO0x2&E1@&1Q3aY zljG07>pGl_NpX()4f1;XiPlw6Y3H9$x3}|U!X-&RT^+uQKh$|l^Hi(ch7Ns*hrOTyVLL0I&X~A^RE|hBd4na_)gh6j17B2_{SWq~c{8UAmeCc!CN1oH zFYh`1_sHA@bc#CG)#Nit8bu3UWLY;UTyF*)v-7D|_MLd;qYLov)zPV;Dr3So@- zuIauHE)Ciu?ZE2*s|lbktX2T=<> z;$#QnYY`GVoUdv?RQ*Wa&WmIZqB3kS6lm> zmS(})zz>XYq|aI73-B&|?Z`^C2ul1g86M1Wc;azdUA}oz?YZ<}FEpG`TMgbhws=~2 zHpS8#M1g~(0cU3s$)-{oz2*xbO#)h*VQ2D3el4t99C!GnK{7kLWb5&7=>KdoDx?Kc z#bAe>GU^5q0VePta3~nlH69|(6YuphcCJ}Qb}H(~Df`h{kKiSjSAz8G7YT2Sr34cr zSCK4ka;yP3sL)Y<#*+Ucu+=?5gY677X~}0ghG8?5uLV3SL_xTQe_q&7NUH1V)J$4X zc^^5VvHpQQzT^@%w=+o$tM6xbcb?`-wuLj!ycudwb<56xwM`Y$i7Uc>gF_brR?B)X zQM;7bDc-+OuQNiCT3g;oe9$5u>oMS&Bji(QWk>j)M*K}MhPU~y-@i`$O(!IVe3@_|Q;@Ehz zooBZoqW<}cuq9rY<^))hz#Gb9$xpjJ5IUNgo=YG|7Fb&XU!J$#TBpzjJ0~;SP>|R- zJyasX&6uEzh`>K$V(@BfhILZ(d$%__pNm`u8yXn_ROpBAU&Sxe*90yt@(QqRZ5W;N zc857_(LFLk&wGD>133q7#CoXtKydre+NI?VV>Ls*3!Y*!q)_YiIKz$+pL z{)5(Bs4NDk&TjdIRW;FMlXa;{#z*h!Xtbew`+OvOhJ z+;PS?i1JBWNMre3N<~#pzw5lrp^!TkZ3$B~NKh${p0%QXtJflnhvUitFT9xY<`(22 zzsMGhQPg9`nG_G-^P;~?W;(cjHDKqv)2G!zk-X;-Y&OLR-OpOEPgGWBsOyg0Egp>N z^ib;`%wkCj&RPg+Om+!FzJ+4J z$lZMDDltR$AuL_eGmfsnK!o`Ou+Ji!`R?OO7uuOra|(I0<>puD zkOcw5a(M~ee_XKozI7k)WVG=seOH_)?O=hPlkNuzw{!-bmSg{{%(85Lamr)6wALXR z5FXH)4bJz+!@--7fT2BQA80vDpsCPRdZm=Y5W!oRFnN25XR|1GmZM=IwsEm9ligK) zD^6rnd;z&L?$~=$scKngpsGbX&05Nq_IZ=gh9y(UX2g-a*iuNOIp_YPNCX@2>zMBE z?6AAx=Q=xcshGy!3k^&`l=HmK5b>AaN;IEGcF)(cLSQJoS zCF)DYfr^l~UB2o1@xL4mLidls)P=@dnHcVQj~mqx|rD^BQp#jB}IbX(r%4Omub z?j&k0JW?Yx86Eg!xO)EdkqEoH2=q09G(SJq6L{$++I|mdjm7wts!&UvDDSW5RnsUw z%0l(Qd&qRuXUdXV!{Y#altAcr{;tL5GweCd~LMj8S8H>cxbH4}qd;>Hgv z{apdr#9^NI*KH|Uz1kelT0Pp+(&BpVSKCuj8G{kYs!&S)!oKAPr_8WxZVP^czi7tI z&CEg<4`Mv$2d4}9lJ(YaLw+(sAOmgOG4JtS)-lV0p5sfkQ)FlTtNSTISK@o-H1m1{j9*0;{^H|K*_NW>;x_+6Egq( z{Q2^(W1(K<`f(V&T37&c&&&07Bl{qm2izLchtg0fdV-Rkv=E(AR)Hc#;(@g=mbOo$ z2pT=uH++SQxX%d$s~qs>6YS}%-3<*59UYHAPVey{33elWpE1_Cf&6#^jv)++9|QRU zK_-Q4seA>gv=iymW@gBGCPNsv(`E`b<+>{5jfRdz6ttJw(R3DK*a{F|Bo>mkV*Y|M z{mL$fNLVy}hm)J3@q3x!(ntYKa{?j}I>Oh`i5MT7XGl2kAA=&Y7(&&~Zh_%6K~|jn z1P!4^l|V)k!g4sY0^~ZOj%Gl>zZdV2Qv^s^b)Hl-DGKaX0N&kz&Qe>KRvf3g{BvN@ zWrZPv07e%p>(rM@8I3Fw9~*@dGZ;4Cr+m^4o_fZ3-+N|&W&-`0Dqc{#l zwLzc9nDH=a%A_h~5d^t!Y=YW+s@n>1{cL#nxw?{95=jDagg=1#M5aMlCLrYE-X5wr z$Gg>AyCCGFLH*5Vc5smy>gzY7A*HRD6>FxYMxI$lT+Rc22QtP22oay(p6cF0^h_rg$^>7bclbfNBft%7U6>`&OU-kTcu*251WKdG06>m*sbd5X*Me?J7F`^gIy)`ML zwmF&*CbA|??O?7E-l>-p|KEG0(I6FOWKYvyddRzZAkV{(&=YzuE&P<)@KYBlY=&)w zuyt$0QDvOw1Sb^y7Um&*gC%vC^+aHDba{PvdVffLq9fBE9QE*^C@;EgF{&~0ceX#G zso{8$p}FTgkmw$=&T<)y9pM=?9rN#Z3a2BYkE(<@58h6-Jh1MYAto1|T7-p*ExeQ7 zIbFznAU_R}GiKyjsb~TEv83JOl+!lHDXG=_)nB#PE9oZ&))-*BTc9YXXnYAc^uLoU-KA zS=?N9Y(fc|P}x?;a)nroAX)TLc`sB3(+6=Uz~*j91yOl_pQD^eT%mpVFQ!Ppc3MWK zZ_Aoga(0*~FEn6PjrJ>#!+ApyaWBhIt**7~h5Gw1kDbg+OhHy#Aug2!6rb>*;U+kL z%t$#c??qa54c)KR$+1LPIv=kGX1#Ao&cTSb#9O_502(jcDLC91KaVlp7}OG0A&+5-|lAVU=P`nO>-x z1wDKN7AdY)t2@djsK4Y{SlP7IvO}sjeQX+Szzz5UGlKtZ(|;{N@MZBWyyr=?rTgsB z_A@*~_(Jg6>W$Nn*Up}2wF^o=Y6MhK_n$VIwj2q#s|@Bv&(@#G*e+KBUB*?mPBSAw?WH{WO;L5|HQ0L zWH*eE5ORWMB=_QZ{Hf#2Drg}DM{t;|YjhE$queI){b>lqEJUAQmpvP8=x)^=d^2vB_tnrA z&`@D6Pm(F}kkBe6UK+Q^_=Nm5RzQ&G;K%lQ&sIxWeiCEra$AUzZYxP^xp8rRp7I@9 zZ2W-^FND8&N}RQ3Nb;41s-0)Gp4kIXg+MSVJ%BCW_dPn?grReqVm?Pek^H^8CiQ63Zr(EWw z!L#hJ2J@7!R*CnOp|c*vxM8u~gC^4&@^xZcVmZaJ9M{#Puxi&xr~jt~sEkZkCA*rG z)?I}Rf@3Rl!-MVXZC4wdZ)daxf)YLgb{_UB)w(iFw33qs|DUqif7H>huuc^n!m#2Cby)G4wHt_quLu`_7>@BRTRgMhm> zA;F@*Uc(F+jgHdE&p^rjF zU#}OUlxLEZ`sl7pM`45BnM=J%?P&P4Sfoz>b^GVUJ<~6VyDGY=@~2QyIJB5rSUD1k zLG#B^L2X*q7ADLvM=Bl+CDwiP*X-PLy}rodd@)QM-eYPiq80h@eArMcP4NpXr-)C* z#e3;e%Q;qZRn1~*mR>C!S<-80tNP5a8EFulqF2 zmgHrIsV4jlS>{SB%Ix3lxW471O&$Zj3IJHd=9akod%^%H1#VTOJODK5_fSPYW2afC zzvJN>>VbwcKF%@eLqwvy{qSxbqe%ZoJ#%{Z3DPHgq=ltMGqa#1>_<8k8ctAlRf@>x z)u6-en3f<2V>}dlM8DEO4`>A4FncvvmZQsrn;#}@BI?He%~_4M9;$;op5$mp`*%`1 z%~!yN)vhpKVYiI7g(<_81s@IoS#YTzw4=#Mz2GdVH<|GN`ji~iGW#2^vK1%6w8Q^c z3$$l33#;-gxvM<5h^9nF@W6M7f5IA>ahFy^!pGd-?rdplY5CXwW;=2OVZt|eoYLH>=q-}Ch3vot|MNO*p6;eyn_9<|S~?A}{(3+I-9rhGy}&NNO&u@QO3<|8Cj zm^h~W0`uyzS%y^}a{=rLV9J|-7>SD=dRT5ytDTbSdn`udNE0{7H2+;rcAkMSXIh-X z-Vt8wSH&!J;8Ul27Fjdv77mjDqk!1BXX*%#=f$|+l)tm1GHe4v^Us#*)X7gc&CyK= z;GJo_MAuCxhsMQ{kEuB)vGTvm`Zlw!u?*8nuaVaws>)XE>VZy@t+h2!UJim(5Au&X zxzVMTQV!(GX-^4w#&T0W6Q5jD&N7c_N_@mFr6et>$CAnY6eK5YSNx-QWN{IvdiI6p zY1h%ZC!w`HO-}l;loODv^zw!&n6L3`>P)_ib&?9~hL=@dC&m2&v^3K=Ax-5B<1v^4 z4qXQaW8Z4m8ozevvau_FGHrn006W+6GJvulm%9Jmfr0(?{}9H5gP*m?#=PB zHTabPRF{CLH+KkRP#^>m6lp2FJ-FR|_^8cXtvqLvMg}UZmrVC1hKCd1Qyeni#1H>9 zB}Rru&A6}8@eGq>NLBa-TGFB(zjt-Ly#C$V0+9>eYcM*nFbq$8EM#ea&~HZYCi_vT4Wvvk0D z@}$GN*{QC6so}bdcCpaP%3tTBAq;ISEb?<1kVP2djVsGp^h$s>WTAHVDMXvg73e)O zp4NKybc3tRKw0a*ftUO!!&cy6MAnCgYdC7wXAz1Awk$3HhIz!WL-eB&B0@2uL_ruY zd_7F1*=Za@aveCctKDt2ubG=%lvfbR`nTs>iJvL&=w`&Cp1@Yg`0_8`LDg^8fxh&^ zY|M|9?9;+ehc-s~AHeJv_t0#E&QdIeIa6HbS``%lp_#KHLmAuPOtKalCZ2W1<AqcAnUagRdO0VF?MB#N%46`5yA_zzD$wr&(<|GwPi0dmUy_dTO8M)t^9GrfFCk)NF3??GU& z9L8ypw&OnAra7$VPeIzNjka>^z8CT7TzvT(1toZ2R#Jdlg#ufa2#7cvqO>nMS%#K> zeS;Ytr8vVi@*w(C$Y8Cp_?6--g_aomrz67%Sk4O509U5WdR#aKj$SMps81KR$GV^A zM2*%3VdBNtZ3NumGSV-)B(Q2#iB}0E3~Y+iqDq7I;mlOOY%1RME!!lK+n3AUs~ii| zpxlZ?l=WCqeV(N+K$T2pv#8Z#|3J+iL1)^@BzB7PF%wUNu4Hn4j9$B5rD+O@du9>w zGc>;KFCD44VTlD5eq2vXi9{TaA$C&hAD53`f>z-j_0(wJYT-`N&4C=Kj zI+v|)(W6aQj|=BM0jm5}VkUPt3)D>&gL(<$_tZ%7{k&O~(JR~4+uk7obiXFPJ-t@5 zh<;U8kwMcepF8|~w;*Ab@OOuSVN<%nhBb-t083N=@!)JQggswH2ypjPSVdhL}>aecv1% zzOknJJF2f*ILktdXLX#%#BPQzGv^ULK2$jz5NnW8*#!a=>LfPLG{{Y#YiR_*`!q`m z1icr(rrgIJm0c`vK!o-~8U9*f8{&_qCbi{o83$<|T4V`MOxBBuYXBDTfmRt%_5Ko5 z;aF0T(4+D~iydo_xJ1ezIotHEn3G~A=Hx!@jqk<1aq5o8qE3@6matsEAsg}5UQW1N z8|#>T$O0u!6O$!q;8P*95(f=ptU5^LrzPGMEP$ zmJ8i6O(aFn#jq2%3sGC<6WD_d7e$~C_U`ZXb&``iRjp1nmS$ecVrj1HVuw9}o}NA* z=cXTt0h{d9KTX_}8NgyOFs-p)tE81%>56hLh^vj90O__Bd=c79aV$P&%Em$3JP`Qd zLO8nn6r6RcPux^h(Mt>M+=FA*&aUbJ?OS;Q(r)FXLOAsqK`ih>;SJ<`GSb}4kix@2z5yb2v9E&U*F;$B| zo9@LG50@i*V_gjWQo7g&B*MrQ>dj0d3TzwVBNH@Bm;K%pLsN=G5R9 zHAGLj^01Jfm2>F9y1DsZf-l!2VogmRhYak{uJ$hQ6lc+RWfzaM`F_o|0r}pr{H~eM zyPivG+r>aV37&nxIwy<{4oa>it5d~ZBAgIN>+)7mGX~*|SZnd8fGsuI-PHBg-~pTaT1Jjd*V%uIoup zU^)R5+Mn}t0EP9H2^w5{E}dJQy1>JmgPr-dVdSXOfcuc{TrR}HG#3_3LPD~&wFR8r zQm480+A%V&-aMiaoZ%fS|Lpn6sM~E%WH_b>cfG#Jyr40i2Q_e+RUr#YJ769~$wshl zcqiend2}kP+XnE9XiD(mO+<7k_4!{g#6qgHO{Xo@Cg3}?Q;wH z{s#eG-v4?L1<*7Y5NRZn(?r~6m=dY2qg2#>Dr~#VRiW;r>Dev=7u~;qLVl)`w<0Ra zi4Asi+4uDuUZD5>mr?e6NtybHN8rD}EUm$HAM;iI4A`^tI!_%w)Ezns>(7Qw*fZh3 zBv@R4>ge+RV(mZOC^&DxcfPi^7PMa!FIUE)gZ+LB1KM`?&Fw2Pq0;Y1+a@;*jo;l` zj0rkw-mS1f`(}-#E8m|+3VUsZgjAjE0=f8iGGeFEP8|a}y)<&1IJ4^0Iqy1+m7@_( zs4r!)^VkhLD(0($;i@wdrtYnDh;03Idk4m=tLMz!>xe~NJ+S(2=c8m2G$3GGGCSic+x1N)}_XI0*< zL_`UZ%S^lJ7vkf1DmVzh9|j<%62ILl@*?C%ck@e}u!=_t{RQ6+SOJejz+dLY_nSF* zvI399*XE3Bs$JnX^r)&8iO%h4pz?f7fi#=v>VY?&vwhH|sjz_m#{R3%t(XUw3KL6k z=$~IBpTB~ITs+TW_UBuV{yHPez|~x`?FT}?#@dJsAE$ItHmeBHGg&)2Zi`+jeX@sq zp0lJRcIr_C0y=X=XsH6*09T_?GxnlSvpyY%St!4K-5@XKhhTTr|4dHCk+H0e({jpm zJ3wLOm2ghYS?i%+8tW#1%N(s3Fx`PD$(+;II17w}GAN6Y3txway0e1#Ni7w8@4D!# z!ADS=_p1}gy}i7&FNOX<4Spk`E19!!RGv8!MPcmW>gd8C>&~nS2mOm!8udRqh8@_8 z+YX>j*qd1mw>^IoFT)|J0gb{~t#^f2nj4xnsrO46^@jTgNek?HB3|?IdB^rsWm}b- zxHNHsd&fOwSh=3UL{sl+CFzu9`wWtRclN|wqdGPeUm2GeE;+a9T;*>%E@!#{KZrw+ zGV)8LM*wCgSnFNxh8i+2x%`blV|elONz#I)73@pxcTnpQXi7Wi0B;trT#WmvGx57> zOsEC{{c{V`PkM;JC-ik8+)oWmXx;dL{!fkE;^X7txm07SuBoZ>D&ftiz-J;ZvsPgVg(_ojrC83# zdqpjsnUG==oJY>L^iBO*jo|CGW30sK={G3|$`Kt}f58E$WFmb@9(dDwrbx>;jM{Rx z_`&awj^|`iB`wEj|ItkX_P_A{&#!UFlS{CXwMmf5M zqXlM5$9rs~A&busEZ_XszT*+VqRgAZT^osbwCaC?GEOceCtE@>t5H4uz%cn`K9=t( zZ{iF7e2L=u_uJdt(D7T zU`hZl0ni@-S@?|GbQ7kB&fre)-+JG}#A8!wVRp#YXZ*I_Xbe`2I(!&z`oZn}eF+xP zsIlX>gsFyQVgY4Ia*%*7hnG<0e=M0EqhUP4v4Pz~$`JH9_pAf&M!$Lg+g_GCuWh>j zR*18Q^m_hx8m_X|gZfD9F@nPXomdX{OM3GxNWzn8z5Vm_>i@t=NN~6{up;-o;!t=` zb*IRyh53hk*M- zSu*QPvw6z|O>tZx2sLE8CwB2+B6b15I@y0>s~F#^A^dw;3ed7z#w70y%Jp8Z2c)g% zqa{sr0o9Z3=(KGvYGvz>QAVy4w4dsYu0Gjmh5YL$gSXa$GCwe#&{2@L8uKX6>_~Dm zMlrC;_odV>c(X<0<^Zb%7%h_=cidF+S=LaS;%8~<8JIk9XIfY`*J7bu1} z__Xj##uiS1KI#G*j?&g_#M8J_4m=4kn#h2@4GL|9g8?=d84fYk-g3b30zDnbHyRTS z^zx!njQbr67h3a9w4M${v%}}fJQdq=Vsu}Iv&>a{3H~^jH1|;>r&28*J9lNQq0WJeIYp#A|%e)!@b9UX(zkG-86S!G<E+k~1ZPvh-R9oKh@iY03nPvf z1bz$riu0Map-e_1o;-qok1rIlTeAtWX`(WTz`RHYmu(lfi$4iUeo%~YKA4ee(2J$B@tEM_<~zrTW!F#9?D z9$l3g0ePBEq=bOE*djpe0;kx|!$SjF(5Za}{U`)Z;Kcf3^S_Q3DlLyRVJ%Lg=wCfO zGIvTgrKLBaEEFzyZmZ*pL8(o%q0_bUQZxFwSjP+q=_VblTFq&y={HPmq_~XnRuJ;) zc9_V(y{8)WwK!ewf)I3a3yp{d`ulI(2rw(iu}}&Lnh?Q14cnb)G>Plrj*VdEZL0c+l=eemgdIsSQ|vopknytK>8aEyWI*k?=ANnLGS zMoRSh+mU5A!_QRTnyAF%no1`i!Wmfo6{5+N@RbtEIWUjxJ3n?q%=TrY`eM}8YvbXS z=fnq?nTeaGG1ZDV6|k~Rb{(x+A`?_J5g>^P^5xNUU7ns+Y8#)U2$EtLQ}F&4#@f~E zMA!e24WoDlkfprbTrizofr%S%n8JdB2hU%6F5~xkxXYBtKARZUBaw0FFaz323~Mff zZw`4xiVR84FFgNNQf(w%2}wF;ABg6UbgwIw zdFrO&%ZrsV3?Qhu58S8s`md6;xozKLER6sjW#A)3k8c003B;9Kpta^}2RtO1E={=P zYU1z1Qgz53Uhz5txnV^k! zlbg!zWp`CVDltUE6To?o3cWs|{{kX94wRJU$;5OjCTd3?rt8B#1UV{QT*_w&hFo|_ z%+{2iC_(w$rqufbiK47oq8m=;YbHl0Cosukrbui8KXi%7qrh>#5>FvF)XuRJyBFa8 z*`}zON{CYkDoV<_8X6LP3G^^el2Vo=gH(pa4JKNBzuA(pCf->{aIuG31a-qmM$CKR z$9nM+iF#@;zGm~aWRj=0F1~9K`$4(x4+HBPz>e3=CHaPjF4qJD{Nssm_2DPllvP7N z6F0AzQdyVTnw$IS81j#4);_^Fr$>$_w+d3KzW=ajs|!r&UlYITW-9c{qcPZPP#qBp z<@jBf7mF;|BC|C20zVK4b9fiR?Hw2>OaVuy?A6rtu0_hbE=XVA|jYU>u!dg9g7$=lJV_> zb2oejyEJ&M%OF%bM3Rh~&X`~e*0)l4XA&K(=hz!Rwa`js`N$bzp?wGO)hty?>JjD5 z{Rk$;I5-^VH#B}sCd9SiVg>OGY{B`0@3*=Z8?!!~;Fx;hGgibKY-P$#G(hKnA60W4(wPW=N|U1wq7ASW2jT($s0Nr>jF?$(zph znx=WOT(J>#>-A@0jKyMTp70Iu_h(G&ZObT{5hoT`D(?n*^YC(MZ1oEO>N+?$VE+sUQo+4i7~D6 z^@dFVdL$GkVgFj~y?A*z3|sGrHFtpw$IqQ3I;gzzdL^~nWQXC9yV5#+G_+OA30(qj zhz!+qS(S#DYsVsxn3K(`>P-)^B3Fki6=#EO=R^ij&x}{#fYEi&6AtwJplw&*)U)mv zm$hxFO^67cWPyZN-!S~N9?q5W|tJYSj^ePs8>iIcyI@%v@d8(cuclMIuG=_Fjw zlvhYZG!sr0GmMRxhWFJ)H6cWe+&o)T>3keAnfVqQs&G&1K$r^m46*Lg3$7($|GxC6 z+QdP}Xht=bzY2&0h{-W{G^hcU_8wp@sm)TCf7;n8Fj!Od8k1OR_+V${@1K+PGxUoaPik4R zdiQ@Z^8EbC$X_C~oLP0`=bHTf11l(GmF6rpqw*p#->1t{L1-dgInxUg*V?V`0ia?9 zH>W2H0HExaCB_WozIJw>$|EcRS8NW$P=QPQDXuD1y20o$%+yr5mzD8@AwfGrqg~pB z{uub~)cL#K=_M__V)GV_XtwN!?TfxQVa{!85EK*zBG#?Ox;E< zOI6u!DCM;f=-L^bbRoOZp>qbr7p?SxM|0ai}sshvQ{7i;rElrjX=F5Lp{d zia*$o?=}i}93&_RYDqRQ#-CsDB)1^+Mn5xFHc8UdybN>V9nB!#nU2sLotZ(GZpFKg z(~sE4Seu0ukbbE}8|E;(2AQWX_iIkVueWNCTRMDdePBRd-KUuWVN{BiC*z4@G-+F~ z_W$&j1fHcbbrF$vgur|p!^z?<14EKKTX`kKq+D5=fJjc(S1uWIaG=ev;Zq%P8jQJTlWCz84e$P+`PQB~< znn5q`UH&mPzd#5GRm?eg{AC<{*&)^venBUB%}%YTt8UHJz1glJ3BcPWb~4E{iOy`P z*R}eo%ODwx=Ni4!X;$3}gY*il+p<4drRg&s9@WBB4;E6lAgHt8CIf3Bl1w2K5CR<& z_mUM7Fi-rzs|<>B2J;j1Zz<>Y;U!rV)ISf-v)D&EoW9HHC%Oe67qH7%>+1a(*Ql-t z*+^P9VfkT|_zhnU16Q?!_p$QfDTiZao<}j+@1otwxF#2x2@X@@h<@@53zvx~V|viV z_1uU4Cag$qfBc^nO-TfjQM8BPBM5`}hRx_tjciX>iZ*MBl$qHK6l z1UQtUK)6;S^8MxICE%PRq2aIcV5b;{8-|ab&sUnR+gSSBwbm1C-YEF;Vi`sobgJ^b zwIWrFTUq31CpdXNin%I}y^cpwT~bmf#>xGFK?=^RetM7G#Eamm{tdI9+jKPCa_rU+k0>6EFI+~9cJ6QP{br}G! z=``g3uAeCcC=MXw)dmBvXNow6%GOCu8||$@yFz^@WO;r#h}Az&>iwexH9+8gxG&y8{D#I*W?r+)<;DF&a> z-FR(GFvxtO&*|mA>N4udsa2iGrjqD5HsQKjUFE6CKc_aV`$bc}W7-Mavpu3JFZJZ` zMO{Vsv2f^@%U=-z2OGxf7ag69H3T6QvV6!#($I0^a8BeV;xUIBeh+=?f=}uAaHhh! zAx@zIcSv}<*l8H{+|n^(n`ZZAAED;#5BfI`ZaQ+R zu)Dgbwx5l~A8lue2hG8H1?+0>VXVB?PYmSrlCS@tbq|+!-)+R)uBlyofPds)qF~+0 zRdr44<7!eQn+LX{`W+TolN6;t*e=!Y3bG9n(9v0DtR7~t$R!>pj8R5mg`$$B%)fnq zOMe5f+VnZsop%^uK-ZcplH4ItE5`Z4A!TLYO8kZXp3iym+2g)K5u%+CiP{K`|Kgg@e)&n znBt3%oRn;NY>G-pZ6PU-&a=Ju40z~2SXs6Gtk8?v_Wx))tEjBHa0}Bd-O}A94bt7+ z-HoJxgrszLcXxwGcXz9FBaMK>S^qiX+<2oy<@@$t>y0^|`F4vIFeqK;v9KV+z!{(n zzvEojVV5H$*66mTVKgaPWWVNhP4@94Z?>M-WzDy{KZj>kvDk^#9qFXD_kG%2I>u;P z|H??AiUR*GTu*<@9D~pGy-ogriBW`CJLFcz0WC`wY(uD)q?2hNsq-YsgwkIye9R`WC4iNHGZStNPe9rV~}mm*CGAzgj=;-y4Tnbiz0|N6IU zAq{r!bB7rQwL9U7NdpcAB@8coiunNmQDMRWEgfL~4y#7B8k<1^;=p>`Td6dI41Kv70os@eP(o?X=ZMseib#f~O zT+7-C(Fo$7%VB#Js=*o`5R$$VS7p9a3*$7nGV!}IgAfxuBmsSafqMAtnv68H&{ zA`QEA=7I=jQX{ZrR>{s>jM7#RNbA*HXN!#fMcqKbjWo}V4G)Kz@VD9@@GoW*p;~Qw zIr4@YWhtMxwfy7C>xKLNGvQ`hTXu%QUVkB{wpAZFgk?($a;jZ;N(Q{>W|ls#UzkrCjbZZwJ!DLB)nD^Fws!O>pbk0eP-@|SpfY+^X6aNc-m z5p5FB%$m^@pHswyZ)_%eJ2z*u32hpy&3yAo2>Wk~_nM(1xHhQFEOj8I$zzjI8bd7W zoYD$6RXE!Y=5|_K-99cb%Bh=NiP?^C2mRdEHu-81#SYJ7F}%D!jgsh1R6h|ZI#0(> zW_j;6Vy?(xm~K$Mz-tE0HpIc8DB&qoRK9UfNneGr4SLoR`t|ejr9WEQl+49@&IICoQVmAzy@c zOk_Qe0fSc8fi+dQuJ8*h(f`sJz{HY*O~lA%XlY3kLZ2Qo8fpMBC*$Pb_5i%yy~auL zlPwNBnrV#xr<%}GJN{xq=M=^A%({+~?ShTn1-f-na?VFh7uss`)`M(IAC5NXu|Ji{ z;UjfqU4vZjbSF6H^`<)m;ZclJ(+P0jP2=VhBNvB%tE;J*8*FWBW8Od=fuXJ45%zP% ziP;Mp>*sbnSH>OGR#H${+lwe5hY)8$6ObVbdF=tNszX0lN%}c*Yfb6->g7+B;6o{+ z7*DK>&Ak#jm>RK<(3zeP@?OukG?1C)%llm)S^N{`LMR2E{GGza4Z9LZd zABqIkWNu5p=yvc2RI1?V83A70j4%-7r&wPw1ywS4{&^JEcn~G^lUNv>G{rYkN4_1J zAtjmljDam<<1WfR^*4Bla46)ykEH4nThFj1e|b>74maQT;Ya@c ztb3IU<-6ZW%tU7XHqcvSllnYubq#b_;O&$Mq>u_t!*q6vDT__+rx^Vn(n$ijD|Q12 z*x<$ih$kz297Q@L*qmPqCuNzZ+QI#*IVSrA?sM_UjRenY4(ibQ`#s0L%^8xgt62_& zo$b?rjAP?(`K@?IrSI5#vpW016k5h#smyz- zRK7%ReI@YxSPlGB!f_Daj5G4%95W(*PGDd5FaC27$iuh9C)iKr|x|l+?MA^?? zHyj-t5Fo`%)Fua*ty#VVp9ikU8mpJezvhEFv|_SGOWHEDcwcwx*^$yM_qTM_9Em#H zm*Dp{>mdac|D-n?bk;%13Kl$IJ|ZhOkP|Xo?cMyvGZgPY@?GBR z!$K(u232dXRg4W}?8owBTIFivI9Q?YhaU1+Lh{j$k(-gAGx>+Hz# zs{fTZb2FQD8P@fqZwpE#AI#Ks-0jBWO6;2IO$cPi2Dc@vae8oT%bM$!89<5vV#)$YFnN6J2tP<1 z&7!<5?J{8v%m2+1uOOs$c$TDFY;qK9a}fR1=zCeeLE=dhojCjqDZU$oB^aWdy2;7n z|3d=-sY{u6aLU2&DsO!mvxjJ!`4<=q(Iw6fv^S%bME5z(UUj^|#;Q0h&IDy~r8t@> ztQWoThh)aB-jPf6NJfSv`T)=-f5x9QBnfXe5oVRU2IGYo|3-A$=62Gjxc4S^m6Fh5 zf*-P~W^>1ZM&Y22GUQ#f-t==bC(6iD%O}Ydxtna;DK4PgRNi*L1{1q^cmg3z>Yu!~ zSDe>Std5vmL3iFqzG^X)XpoGHVsBHd>Y?89h2COG4ib8dCnaP)q&tuIo%NP14-iIY z)x1tl&b@R0!Qs6CMHgtZfCX{=*Dt`eo6;Z3`!B^0*C{P8=|GG6XD(40r{`sqg@bv; z_QNccvvb^~hnWYkn*fn7Nd4*8{GgLNR-xk`6~lwkl;8M9pbI01X8oe8G1zBE=|w((cqe8xdBMU|NN`1qaQr#Of7c1}Mj;Uc76_WYdk=i6%4+D|*= zoAXLdZf4ov6#1|Owid5-MSQi(;(!~JuJTdG8nXAy(tm?IpAa$ZQ5J}pn_8Arz9~DH zwoLW>m8C?|_;qtI-ARocu{x>R{r(a-mw|p2j1-fsL95P*vhlC4`uk3S&ao`9bs^X! z0`?=U{{g~4{ZR`icjN?0ADv7{wpFOyTs>%$!EE)(>nRz}({@~i%$uVxmu*Hi8=-g~ z+uS1{V5YJFF()_o|7alv=!+CurLuW5F54*!)%YPd|C^f%be4~s1ux(kcq3b!!?%!} zAxGx3`u2rBBUw zBmch13sg-t8l7P=Gg*ZjjU0|$r<<|?3UZ4#x1bfFE*Hm7bvKm*;s5*rZ5#fN8vL_}oZhDd~JeUs4{HoTYR5;s2D(1YSVoN1S{h5dY}_ zfCQ)t*4-mZ&Q|;KkwaqerpW)p68#Q%23&xqa!OTs2wUB(ajXOQl$8)G#Yd_GE#xSq zk9GBWrY+JxErpikmCc5dik2l|H@{9&T&Re>)B4cxuvJxgr$x>d-t#)L0Xa#Zp8!1Z z`PQ$xXc1^NwtR`Tr-H;uD6&kLdDlBY11iAaHmgbPk*m&6*05+JCfkTqw>;Wl!6yIj%z?8p~hT3 z6E0H0QVndOTj%k@Rdc>x?W9v2gu=4cx}F2k)#aO>;{8F9QPps%YJrlLkNxu5QB_9c z{%o&21ubTWK0h5I{WhGK*0RY&*YLUbLcFz5lCIlHr)fJEV`vl?i^T||eUm(Fr=P}& z(yK1hghQmYYnrPi#wVx+&UC)V`MB2`LP+f+a9JO>FQ+EfA7-0RXX>DLPRlwIOr7n}a86&&+ zhw>fk9mx_BvMuImZR~!WZu6NbYW!N@f68CtBQ!>H_o+K`f9)c8f9=cuQf40!8?v(q zo#D&7oo{bFP|*sx{9JseP+QQ6+LPgc($Eh#aXcIY3BF1X5g0{vp!!Q7yH2BB3|0fmXq(goJ;uMqF#S;Y_Tp>1J&>#bWM{hj6D>XwLTfBnq0CDW=r2JcU4#&4$?< z5uM)RgA=vWRqhOJX;Ad|UYIJNT$k7-zHbs#y2U|LRlgi-IT?Ib-8EGnvi}rQd&v`H z$a#8rc(}T{dV12pZUZ|-rwML9RjZQBC-YE7T;$LC>k1lsh%I62=KO=Fsx2sJMsZ*Q zwtl!1Kq0{k{SK`>Is>J6^YopC8NCle^f2#A_>~rD#tobxfl3Ncr*Ml5nP&F)OKdHf zTp-JuODqfT`v}(ngHnF_2Yaz)< zIQwzjgxfNOW)xH;t08z@+q+YGs0~$|lVW?Odend%v8$}4WT2(`Z&?hk{!cqI(iX$E zP*re5RNPR=3+M6cHzL^Pz~CX$Mie~wEZ@Q$tqjeJ>m^JlJJ8KQ_jc8fPsYBjw#Xa& zY_vQ#CnKtU`9?R8Jr~r4KWypJ(b}gZ!d8F!U)XkD-Fm-1F-EISuGnQ$i?07u8}nFu z-hR@IJ$Ds~Ext!1igVs(b>O0yN= ze_*-FE&b(1%rmDqEsBj?-E|=s-the-WF2U2D>My z4nChj9kWqW8Y$D8uXPq-!>n7{HFXGADMbvHZCDcH)Cz{Vl;GdT}ZZA+LoxgN9P`_VcsKb63IQ(X3`!P`PGO@1!jz)tqk@>dZ9jc>4AYd;3@K- z78n868wVg^>=|!`-zd-Y2PX-JcUgEOvCERR?TC#)tH?Yz^M9#4;E&83MmduSI1u94 z{wjYz{pXKU14m+$OS;~~umEw;T7B`o1zu^c@p}*NAXlIFC@9orBm(FWPy+h&R$a>2 z)t|W(Vfd3XRE|)peasM>@H(5DRNE|eNUGzW3bpuhiqy3&sE^J+r&3^QGMSVbsD8dF zQ2rH8&96-ufD3Omqo#*ncDwiLBww-10py$W=?GEXU;)v21NPh?5yVZHLp1(gtc>Dw zq=wAg`p=&@q36>U=<5XY*lvwY2x~oX-RY+fFS%sNdE^6T3G9E}eR)C%RQV*-_+k;+6KwN(gF3Qds%GsykbYEA z`W3y~%?$b!DJ@{Co1mHHEf?XRyt{e|{QkgP1vDX3)8LZ^!Ugg;rMm>e-)6fW&2+`B zI208@E|RK#T&D|bJ}s9jGl$Cbhp&1XN(0$5ff#H?CEZ~mOWdUH^3$oLL_@)B3XZ~u ztA!OkuOGgul8v+9+13}Mc~$m^Ok3}RxIZKZ9!HQ$;4+eHD~M?rh&1Ivln0#Kp;TA-XE*AUKR7neHk#SOphWg3{L* zq_VvJyI6Q(;O6$zwi!bq%9mCDTVXTYpLiw=Kr5o~p>1I5xRYLbi$g={NjZ=L+wV8_ z{0AYIcZ~?C+A>}wEx|`DzE_79+9qWExTj0JIYZ1P%V2I{(fG$`Dx)$+(e$(0=X7z3 zuCJNoZL?YG)mfIAzrpk$=bEs1i^HQ4v8fi)s(xHV&)B#P#^~khFUSk*q`6zfK;Kf` z9mHJ|{(29bDH9AEV<|l)%JC)ZNp@O`)lvGh1>_5 z5vQjf!hd$#^wEr>QpjfzkqTU`;VAK0-7Y2Ef$wU|JHVC^jGALptx2rk9ZV;6562gM zT)IvCoQqTDG7M4Le0c^QML@xSdWh@E^M5)%I+7^_JLo)pvy-OeNwQ*HA+W~*`YqsF z27usym)pS>>N#I*-s!QP#dLkKLGf;b4(zZDVmO-fn$t8AJoMzN=NQg*ocWAf*r`(7 zCE_3{5y}xNp=hPHN6*&y5;U%vMAq};2M))D4m4Ej8#zn0Ces*KCWfQqNLnBsaiWSP z>e{bgM!ZKIk1*nj(|J}X(}W7y6_;g;!I^r#T<_yX@jQH^{?bT6yIvoTJr~ITvxJ^q zd=}2|p7Bdb_ealVU@YGq&}tig)Ut!Qur!=tGl67Tmhs1W{FIO<;(OqBZ+^SXx_uA-_Vj%8H7-$nc1oi0`V*npTh& zH;V>hc3jXQi?*}y+huTbMc3#urn4!`-G|j~O&zvxOLjFCOWMEvIEdM~6D{c?r`_yJ zoxf86RQv&OEfH13TF#g7b|mT_gna3wBb1s4-(qVyAg8OVgJus5N)4NTUC|_2{<{YQ zTjJe(37j^@EP_J;pRJs|5n*25uS7Q+1-O)%0!MyTzdQaoFgrUq0GGu27!ALy-JP3| z-dwB5*?t-^toV&^Er(yb$dF8pidfRKhn%u&Kll5|6~GL--3gPO@8Recy5 z3SCk(J>9bM%D0tYB%o$0j#Ky=8eeAbLH0giIEd*4yn1l~&jefnKm`!XNv8B}937N1 zP}^WnCGfC2gKcbJFuP2I8f$;`3%5Ksa}f7yNdLw;*ZfD&kLYBIU^a+qhQ)xbYRI+^ z8~$mCWwI5&qvi1bYXN2|ZtIsP2Jsz3V#NOqEudfp<0Js0`5VAqj+a?Y8P4PCZy8Gs z#4A)WF-ffwnfJJPK(ty86?+^fpr}gm;{`qGJnipW{v8H0%Mw?012EnjTo^rd1>#$- zqe;>du9s41>-U7P&H7AXo3R2{@Pc2oL+u*6O5tQG3x}c35-DlQmjczN&dYgm(shxV zud2I5rUZa?SBAa5#Pt0}C1*qz)@Y)U#1-^RaJn-RHYQTJy_AJ=U}7b=@P&TP^iyRC z)^uI2&Yz95qg)%&3#>4W9fj)(IM&IVi=YPn>^0{+*8JgQ%|Ddgw( z>bCpnG!bXQ*XT9Qsa@9p`MbYaXoO}S+0)YD4?nYs1si9`nUdGGxc%>6nM=(fzve~p zuV)vs7uDYQDU=e}9FuJWs05hB@>1Z{hr(+?QcDrLYH0cBje^G$WIm1KG}%y6cJ&N7)~mJ9at!k^_|q?@1C>dbEHS zQ*I$-Z*MPFzaVc@P83kgx^m*~$TUk$HGb^j{}B~oL3aOQ?vDlF!J6P=1G>c$%}4 z|MuKpO5@l|7~zA*7@og3xEL(ev|~EE4~>m%jis8DWO9P-z{HCtzTp9JsOW{L!kV5Gn9xHGG&Lg9rxH zV&Izh2Rl2!BmQrr1r-rgY4dzv6mL;2_p&DLDBNS96;wAi){(oN@$M59 zHpJ1QHc4k^A+eTNL+}PjBPe93k~#GKNQUK=6-x3CW(_*LHAOZ;{m8aep*COcG`Xef zNNhh{F-$MCAyLID9R{@iEtKAqzC#;}g4?bnuj}@ENJ*w1=&!=rrcWSBBWFs>2C(%sm?>h{S`!Nu|@C&*e;g7A+ zx-OGD&tEKz(iael1i9i?&w;YK@j;qTL^iTDsl^ss@Zv`H`^7;6oWKuA*U{z~Vlmv% zuG)i!QD|L`b;S1W?t>O~N|!{ssea!l2K`ULuo}wGx}U2PC9`T&I576f<^b0m4^qT+wbP2qXFJfX1K=mhBu5s%X>Yeq~Oi`vS~w+Rw9<7Z5e}+e6l}HNEz}C(^*v(rLvT~YvK->|>f_?FKkx;rr0FEkBzjdAC9;S;REk{7 zVs_&ZoIw%c?0f-Y3CL~tG7a(G zNDw^&CUuXO+XDv&r6oVUe`l;6TGT0^D;_5Q#$p$Jor$R_OOd??GK3u`%W&H5`osE) z#pR2Lqt0g8WMf#LnB%pOLo~{iYW`HqpN59gS)eb3BW_hG1*WU>AgS{ z_WusLQLeyNz0>6Uz@^~)uWLNuOTjN~{b@Lb$hmFD7}_B%VFSO$N)6%piyb!;!5^aWQ0eLEFGViB69 zH~VUcA5`%Og54jFkR4>1OEadT&JYFpk(9G*{B0%=!1tOg6ePW&U7MzwG{{`!kD$W z#{r$%1aY>%1T)s-O?dLBx4NNh;-TN*v?UH^71ovtVRi0sROVj-ZCEhub+SS0r%?Ai%b^zZW^0~O=-jSIxgJ1 zF?4afn7!wDWLp(tV*rVE*QR#Ls%f*Yk`Z3E6xG^PB(6?sZAoeiKSCcmGwz&ipE!@_ zqY07Q;aj+|4edfsW`!``Iodjj;?`3aj|1xUS-2bYypuLZLrqAbhV(>V@n>#jT4x2KzdwYU3v}X_zy0~^SEp<@nHL1MrrRRK zH-e}|S`#NPr6&;9QdP3um~FKZ`XN4WhXDZ<}2#z?%s`}slRwfGqs`o|88 z!|RrH8Cv90#qr^&K|@X|3RueW?Vi1o(>FYH(Bi03{1nJBE|F*!4H@qf5y!M{$~YZy z)L_g@Jwkwe8KDzjH8jOkv+4=?BE8Y$dh=s;ZnKC0)l!48>JTNh65d4^MZD z#3^}@RUx=89v-kZG-8gTKY@rSzYL;SubxsRon7o~3!PKe%?4?gNNfhgZ3#5S+si!h z<+=<&azV=)UL2#0045+%>Ja@2WTh>?l0p_mao|~uSz~i*?#E%K^Qp;-J+)2G3Enwu zcmLK5KTB)n(rtFy{VgN4=yrnoZF^hv`32SeTDFb9y0$hGBR2OmpV+>|0!n5J{;7+% ze3*Y>*aQRN0mQ4CclFDS?4GBRyQa+2Jek0@TDTg@MF#a(_|{T7-O#k~iDkI#dak!~ zw@hV=I328$=o=aiosT0nZi#q$c|A<9_B?}e`)3$(OYu*%1u;@2T3oZjTxvb*f&+X~ zdEfW zXSH{+4&ELtCR2s@tkOBneKjX&(f;wZI^MoqZ$Efm%QCC}D}J~8ZOD2WLGxiRX*_`C z%JtRcn-{Ccx{2l)uY$RN<&o@??8C+RL$QP3L-CIf%R&cdk5sA+Ng;Vr)X9!&v3aUO zWYbK&4pAi^bw}OM0!WH@(k8cyy$6~QT6a1e3KDRKz0M-q<}9COtK(kSwFmmUPByN} zzUg6_$Are&y027Tb=*!wb8ugLneRkrr!7`7_f-i@(mGCa9+|X^dPpH-|6}UK!EKW0 ztvcPE?R|BVs~}XJ^N}@Smfo`odQ_}9^imA-#*aj`2dwx33gPGVfNbBKeDwx9XK{GZ z;wdeyV%2xIsQmj!-#_>cN<Bz4=1-9ZWn(g?zopJ z-Ad2PxijBjLk|8A5et|ICl4ZjQ=T25VgUx7xBqbWV1pR&a9JSo@jSn`MPQfIApsIF zu49Y(rv$bw8sw+hb{)-H+B8TIah5c0`&0qLQ_l&yCBM^(Jt{#vnGG)!l0LZLt49ds z5pM!XL$yLD19d9<*Af^nPPq>mz%b@0HJpm0_P5XN5|26_nj_t5wVGTV!Aj}xwqjiQI4qBIg1WlEco9UEr>s5#Fs!;gBUk>7Lhrm+u;V3mi`j?uFZE>g+`ZfFMF?RKG>wKYF>$`1O;;FsG){%=pnBVIUV29oE)p(qXIlI4VOt|c1? zp&0oW4~F5bpB`l-2-D9Vrhe9Q@7|Qp!mSULPwo*TLQpS66Rvma{^ZL7=|$UNKQ*d9 zo3iAbg%ILZN|t!~Ngc&+6m2o=T<2tG14447oT>FsRc;Oju^}Wr~g8gAEpTUnNPvb2JWavK@ZPC<+C5n z%~Xvr)!97(ZkrGlLk>trK=BzVjv7=k%wB!5C=j zfz`RW9U%37{P+P@20+RI0R&T1V3-gp=^8daJUliw_TMWFQt8~?CAtGw_}F=?Dp^-$ zQEpvhu|R*p`UK{7KnxDvC}2y)kUr+HpK!H8>#gBKNfP7YAYc$Qtfgfz^IY?7Bm$^s z-4V&{qA>89sq%FJAsRqVRnNyHv4O_AC1XnO5oAfsfd2`A>j9Hrk#7|nvzdoS%0;FW zpn**ux+Max)b`d9idBB3ehNTs@9hwm zt2zDExc9=?4u`JauyaL##|N4^DP?Synr7KB*_aoU*4jNuvRZ9(Lv!wu3Ldc(Z-qk!(#5k%UkQpp86^%rlS)n8f(0|6Yut+8#*TXfok{!d^Cl2iPh$HB&Q|9@CAo3-X zCAFw+{0EcolBK3UEy>(}HG~gq+t)o8GXnU$z{+FJn2FVX(6_GsI^pQC;y0+HQW58d z8uwLI?ROW;*u=*%OLm(#HJG!4@YL+IDOt4Y?^K5^V5@CyDPRBh-LC9Tn#}CJ5Pw39Xo?u=?gfB`o=x%=nuoB2r zVwf>ds2G~re=~l-W0ZjV6PC?m3!*knsJXGRv8AP?Ph_&Q!uWxR_~@3-suO30`mZTwnsbxbG$KCm_%l0Kjf{c zjv~6VCEQl5dUrbCEKJiFZg{u#fXSETC_RmYlE6f&M9O=GYCxA+bFkv-J2`9EoQ-Eh z(F>-18-q+-qf0Y=CU6^H&cGMGqk)X|W1`W1gjsvL6+MypD!Mi5Slw>I zsb$q9hx4Mk6OLLk^drHqK5T5-!laU5nK*em#BozNx*L+&mfSvPn_{{@5MFI4CUG*^srEu5_qCJGj z3cSy%ircSHyY3?wVCa1%d;OXH6OByM_g){!H5&T)is_%sjEsz6?$2`5Jfc!Aa@zei zNSHD|?I)kbjB8m4ePGMNGXa{DA?g0%&aHviVk$e|*qfRI*Mk6aOJzw7F)nArhC>1_3T} zCMtbfprgyQ9|EyIr|k7AE$BVX$v|!ToHWix6Wv~3(~9QEDtQ9tvGqf~T&~EECIg5Y zO$l5a?~t_PNDCQ^U5B`dFXIw}^QaJ(eEZcRrH&NZ*K z{~Ar5`GzC4s^p-f1TIEJ-jCQTP)2PpD}CIrH9exQ!uM)iti;gfTyu;UqmX4HgR14!-y?c;6Bagzv>Zcl8V!-MOB|@681DIFs+dQS`c^HbJ86~OK zH9SEI9eCVTK;dhPp6P|!{5 zMtYw@D|}m{Ok+?mkz_W3b*2LSs<1=*a^#_=o_i+lIR8!|Lb{@rU6JpK7Nh1ede!QlnK9=md{0gS{2;ClaR<;^vbJ+$3Zqg@Rg)9ND8(k^bT1` zFeQ-1t$a9x* zli7`>0bK(5E{tgE5P)**Q9t{REh#bAPAJpNni3&osqr<~m7!SKL%h`Wy!v=~9aS=p zyK_*rS{P#Y()vaY+0XY$M-wg?WQyoy_rPF?LT+tsq^nM$kl8^Hbw;Fxl$sh5+Cxd? zMlM;FtLLqj09>kRF5=Okay)yH-D~1G4L3EQMT7bnI10e)jSOjOV8A9n3d3_Gkih8m z@e|)e-H-TG=#nujr1Bq+GAi~pljhv6McZEztzTo%uxiZT3vxupcMCqOKWv@FB!g@GC?q(XPnm-euJz9J!;h`IZy0Ua>D5OV+ZGVmVDe-MnDe1)O z3OEw^YU6n`f~mCsfPv9;1TN|&{KthjX*a;GV3kB#^uW(u=(OP14o4y!#z4!hh zUtPHPRq*?JhKsDEU^dkGp0sdmrKd`Bl`;Kaso%_*)l;%Tk{>VteYm{=`*~1_ng(e# zgC6pWZ7T)XC*CT#Cj%A7bUvA$Oa{&kkOiBYQzDumfZrNM#tikgA8w zv)@O|aaWO+Q-p!3~ zJSY(u!J|x5e??r^WhXoSYRN;*uz^7OVz@b4V>(X6g=Ildw^f)|AC3phg$xWF#aiZK zF7HPiK-d1YhmafLN_l@7UqEfIl6KeMZa4j&SBTzl@J;4t73S1hKbEc&cnU)*9N^Z7 z`vRw5=wLiqn~&$`=N-5yV>ik6%ae-c!@|r=eytf4s1|?Q7%mUR1OUZCd%ieJ^zSEd zrm&(OTQpMv4n2hr*XHulQC`@V|CB3BKZm|kN_}8=^U-sxy=UJr^SK%r5>ytl_4sn_ zh(^2r_nB3e&UZdB&7SCYsY9Aqqb6&Q-*wW^x2PB*eW=(ksI}S2R!jOszmcBj;L4Vi z8T6hjA{q21FLRV>xF}*t6cH@%d}}9u>l&{4V-~H1AD9mPh!2-Kzf_jm7XU&r**V>6 z7qv69usN?PO1OL}p+`;9Si(s+zLCRsru%95O^Wj#R8t=P)Jf0&EU5;3gZpM-v=fgP z-n<02&aE-ry^pXu$5M5`7?2)0+kV;pdid_QGL?2c^3jSjK;Z-a)TC|_{e1oy!m&A zb08l9-gU6<=^7$<x2engwG z`&t6f17p9hWJC|$3P`}@>Ikb%TmFkfI?Q`2H_YhKX*RHV!|fbzc?YIWi0;ASuUBya zpauAh58G?l`wbvVLAwmRHL9XO6-eaq*D)1e?xZ3XYkJk3N}ksQ`Zs3h|7!v24I@;T zuR{OBh=R1?rHW784!*Rz^Oa4X`(IS5A($}I`jG?iP4gnqQ9Ah3J;`rh7LUdH3I$HDxf z#sy2#CWsiq*wBCJVX%w~->ED%KA<##CE<8`@)j;MDhbFN z6>N;}bIdG=NM_IATy*e;_`xuF>hc{nySbwyBiFjQamnziNJvSw)7WmuA`=KzxG7iH$vL%XG4!t$ zEN-e!;ZZ&}(T|ldq7?4!La7{DV(7BwcFzQgNET-36eose27;ydoQ;$bq)MA<) zDWp%$|G8KI7}b}}Q_Dh%G@yuqA}v!0oTMChGQnUJ)Ig9D5oYQ6Evb+R@<71L2lT(z z)+5|smn@hv6!LKdg@i!N8WsYPmIA3IVSbpcgSUA63$=)FfLjV-_-omM6ajUX%2k0L zO7>7~x4tE&kSpQQy$sREf_%?2#0q99`uA2L+;roEwn_P~C#V_AmJs0W+=}I#7aXVSscHNP+-UZ^2-J%7Q z?yhbcAeBqa=_AHwgjDOS1Xscib4RFgoXnzyTY8KXI#vGK&jjf2get`>%1G7otn-z@ z`#xTWLOV}|_3PWH;|drIPehDRho)Ogvl$aPkz-dc&%*{i0*4#OJ0flP-;p!%4j7O1 zCNrcm{y5C8Z)V0y=z$oNGx={~^lhT}S$B2xJ7L8Nq6)6-_KNE2GL*3co;dr2ww9Jx z=_xTW#R|&l$0FF;@c_kunuX)PoaS^SmUJmW7qZukUW6E4EVIxWKXtv#l#(I->Kw2X zuS9rA9Pobf^P3Wf+=#Y=oGy!iJFs$+#A=}vR7StYkC|Q5zfI7c*g%~Vbl+msGr)M- z_qwMTVu435#mlOR8nxqYq(kp^dm15~CfF@$Rr-qT!jY~|h5Pl|iy^Oec{Pw}&5*wZ z=wo|&0^Hqi0TdQY<3L(g{ZusB{X%PDBjHi)l>}}HEV(HfUkl{;*;6$~lq?cKK`@kY zq*6LulEYQ8+lN7OH1i24q5sHmAaw}f`lMx}W1_wu^k#y3S^ew28*mf}UHb}s?k64; zY-Lh>8;~wpMOm^KvXapG)NJ*I>C!v|c+w8D4~t({Y2GJwb;YE+Pcx z%5hHiuD`Y2R|!HTZ221k%{Lol1hzkl0VBp+HlDNZ?32W*nA`|c2iX{1N|zhQ1o&vh zzs*P}Q+#K7Isdjs*i09$^DZ&gX*XPXi&l+}o%g_E;8c}A426?mRLNIH0$pV{G(=`4 zlC;$7-8r}Olg^(E;xB4Nl7p`-Kalsf&!2#`bdyT|<_8BgFRfk|@L##5dD@9q2UNqR zNJ&)zTXJ?*imaU}+tMV6; z^=~9AM`|!W^#fyO^i^5yD8fTscpG-XHVAlQv0*U!<_TJ8s(}~1q1IbZBXth# zqb3$<>3v)++L^tpz+aj_2y_IHyW;z+LIwVp^e*(M%&>AcpW|Jyt8Nm;OETYSl8((( z!=a7>Qx(v&vps=PLRIncr13Z$O5EL9dn@w-L6;c}IqI1BnRWhld_r+3wsaEk$+oN{ zKH0r`QuROWEHBLJGs>@Y4o6PqZ?0~jUn33w?2?)s#zTuX+Fp{$MC8igICgVQ6iWJs z!9HC&Ej0|SW69CCD|H@y_+k<9iKFPKafIORr?Hs&d{}X_qKX;!(_*5=c!H2sh-azE zs()418SmSOPlkE(OXYjr!f&n0xB{p!&Vg(J>^cJlFSusSC*7Ri<22S>M5~PkUI5A( z73;5EB0eENQ78^FZ66BMlKg_>&r!NSM7ebOXXJcWVQ76 zj-YwrE#!;6xHAERifv7!p16)w9ZV^Zkq#XnAD^z&L4E{}50Jruy9g=z$BV^>SraDO zkJh+h={MJ<=r<9J%atMPkXMVbPA~I|K)LDP4oH&V`yMVN8@=PHfFC4)@2B8w{2!XW zDk{q^+M4d}?(RmqyQI6jq&o$ryQEvXI~1h5LrUqCEy$J&j0_e%KytG$Dj^cs-ac%bs2c&{Z9wJ_8N{aL*@oMN@=!hHpS(A(>GDMVk{1Gq&py?d*|$KhdF!*_wUJnOd-%EL5x#r4evq}IMq z_qEjc8%H&;B^l!E@Uud~+s`mbu^8_w=gfEQImDTY#?PJkr)h{t|5iLHFM~^DW!g=4 zqzy?}k|Y|OIb(3?DHOR4O+qEM zUqv(GZEQJf%*`w(NHh3-Ef=}Pj?PzhOh>V%{_+q-V7kQF2_`H682R-R{ZZaoMhGRk z>A~dWhsJb8C^9b^WYxpOm~?9${dsoSX^fFl=WVRIQz^4VGoN{WORS>MYmwqTJ^4Xi zdZ*$D8;ve3zNYgZ)lR&Nw!bgmmQ<(sOjNgU!*c&g_&P`#V~1@-&}RE!LB+s8 zDrC~!vx0gBP!NQ&wOU5mk>B}cc+8AjH8%1Ov!Zh5%e8JSq$T=32un2Ok|qzE!v0)p z?uG5UB&XXJ{efB?YDsHWI1}=jE)CsM#w~-ObtK%mExxGt&M==fzta60iD6u!zIA~?eF49KKwmwI zI9*g&*mFVrsA`D+my3tT4G1v{>1PPHhTNy}P9dWftAN5d^}v~p)mmOd*MQIV(Svaz z#>^w?T&uYy7r(HW*_b!q`Ba`Nf`gl#7^`jDOlV$g1uPI2RUzQy_`8uON!uHJE1;k+!wy;nlL!V)}*#BJNTaT0|IZE zPnBob*i#vzDVvs9yda_IIn%tRt^|$*UjN04F{_|!y-nnJ%^Q}u4V5pzzE)0#v`|>h z8%GvWR3gccNVz)K^SFy8%}pTKuZXalB#d9wNO_^|$uxp!Ih7vU@@M`ehiG8Y1n@+5ro5#Ot_2urW*NOF1Q8&C1HfhJZ*jcPMyEfgcJJHS6 z2{0hxt{!L}07DsXjB=E?h^y|T)f)<}X5l*$5^!#|{xC-)3mSK|H+fA)Hy@w&uC8&! zKOh=5ZotF|+ejkStc~`mg@!POg@_QflL$zgKy-95v~c?++GF!9^fQXN6;WlBv(ybl zvK$hkLn_aU!hzAp`GZHO_eQ7pQpS}!-|Q&SjKsjIi@N7BVQB~95V+lP{sYvhx3IRVzNorHnOYo3suPPO>>(46ssTis zWpUyaH;>OC0)%R^RCHe7I31;TtHcfb3k+oO6@iY>h9Kncl`Z@PReJ%J*cMd?Zrqdz z!vjl~%lAy;^zw4_Ww+e%q5An1A9%d_?J!XB=vW^nX~>}RFG3Dzp@@jAueZTcy?KVx zA>)BBoAS5nT<+v>2M9K zR8AGAttDj{JRijDe^f-EXS?AlQ;$>^J%a5u|9=*AX*xGU0A$E$_N|#HJ!+0j}G}v&V}1h zFMl%I+)mgkg5Krdqhe7gZ5GHzC_w4i>Sq~q)t2TkgyyGK4@zXA#WUqaPQx=_|4N;E zM#p6x{etuU zJJET@xG`7EF=4*0Mnq<3=_ANz0lW)X?@B2Zitlqz*Rq>4So&IfGK_0Jv1M)qf(>%} z%d&C3m8u?@4FWbIF;rAel^=fp0`YRxLedfq;uN2VC958;s`wrd)l!nm3#^!`Kv9F} zTyc#!)%-z z3vK&NT|M-iilGPD=#2~f$c#C|Nt531lA@Md8XLFiQB+r~1BV1>Uyj1Jhsx?v%Od<7 zj>}b{%K^kanAq0IM$sekz*lVMy_|O0ZI|E&)4jl_&F|r;5bdA$W7})dom*W|Zft=} z`|Hp=>jF+ zN5Ah7$~obW5;r(*7YQN(@GMaqAj{&=$O{9@;e(*9rYS>GsPE?q;W{X*1knSz3k%j? zBXuh!np`CTcqtkYV}3ePepv5P4W1|AqCaP%0~q4wkz@wYUo?!wg8oToc0?_W;*F!g z6jX61+pqAB6?&(#$yf`+{vK>cB|m(a4M8!}*X2@|`VAf~ApSn??d=UjqAw`{t5g`m z*y+8N7MImFXS3jp(tOnXIZ#Ckv2;*7n zZ2$%g_!uBz?h35Dj>vYiwTzNX2e$GvNw_vfOkYRT~B`gklyMr^NF9bBPc2@MK& zuJBvIvqx!>cd;ywpC3X`xuaP0+(KmW@!ysKT2)tGMeTsu^7+I7_lJ}utKod6GUy)bTr5oE>q?UH;94-pE~PTUX5#8rQRE*) z)p9}I{V)27$Z;i8DMYRE!5&WMzs1 z#ti_jCF7}eZx$!RhHRk;fX8WI#sZ0x2z_^gPlNY^%FLmMgpCaT{%O|tKJ+hBHce*s zzpbe29iR~=&5n(?R3jX{dm6Ng>#!Y#XF<=77!yI!Gycgt<>lmrDfBN}Qci4~LbVH-*&U<@vO`MLQq??UV>oVdj4YF!|RNll3 zu4z0tq@KiUtee+mEhW^q{OQM-9=H=Ztz16A851X1gQgIl)%1~mFTNy z0hm?)?D|;6r4e3(3X%MSuN0z0v&d|MOmLYD$AZd!Lt7Ox*yL0di0iq8i>43JdjVFo}w`)4wQoFGyi^D+*p$x})=Fi2BvoDovzxxdK zg@beyyuX@qv1LT`1sOxGn}@ZgEsCMpq~WtThON0A0O>A_knn?G$UeVS<$2NJW!aXz z<^Yr~4bpl=9<5jD?)mvN46uSgK604%?aFvVjK3ZXwih*N6|_Xj;r~|T9KPz+cJ!XY z<2`{kg(DSgC9Z>8I|?b%(&q+(bcf_G(QJ#S>id7%DB0NUO>Mf!Rz=5tb`#xYW0YJr zup?MG5W~IxyQ|KLjA}Z{2(F+K#KqN$5=OhTvLQ+y5f5FHvOGUp8# zvex9q zAHjJ1i8@Z57Er(ZaeGF<%F5b#Qc{_QWu0N4|Ar`AR6M*CI4P^?Ff*^*Vu+{2PsO7l zwa^GXSR(|&&bmXM8LQecy*J#!`z~T@qi}an_`9rC!)5P%F4V^+H2B)U)$)RCoCC9*h+&I!?E7}Hg zTA=y}X2Gm^jiAGOlB+XdV|G9C_UizNENn7nl+h~k`89wUp=0*9zz5t z0Fh5r4xo2p2*fe|lxa(yfcxPMd)E(9Q${tA*$>7c*Wv!OW1&F$HvaKG7*Zo~5lJV} z0uZ2b{l%)912bB*jXY9i@!apL-*nSH`*IrLOPnjF^6VSAzs{tOyT#Ls}89iMjeb}u)y$q{X!aFtnNSvwR}Z?5lYKOo^{89--`gd3N_ zFgxmf{3)B$wBeRPl@f~Z*>Za@P2of;3VKfE9Pt==0wEGg&@-m`PQ4!aU^+OWVoflm z?~yFher4W_1K17%emSj5_mo1Fx_z!LbR_vU#?Xe45X#9rP@mU=D{64TybO;ib$#G^b6qlUT-4;D&T5;S)l!c;*^AHn!a&BUH zM3I}W-M+qd=gaAAD<_bCe*l{Lo9r%F^wymuT?e(RsLxObmjXt5Pne&G-lxVTJX*Nx ztA!uqR&=GOLJGAPO7iX|gZHIp9OHr>=Ve_7K&B^ z%|k6gIBBe6*?~o`8WH=6_sHvBb|eFz8Qr5>Et(Ow2%}}~vz%xIT@zwZA{%7bZj@UT zITj4WQ|n^5{{`WwPL zt77o==6L#VR-&*VLc2p0ELhz6ree1Cl65PGCnn2W9)i08>7f0ziWtn_S4mLeSMxi= z79%bNN+I06W_Be3as_d1Cm#C&AA*ht=(&BYk5XMk;@)H7c6U4)8}CyRGd~A3^j(Z` zS52kbEE?=D(#-T0_^)jo(iV>)h^hWw-c+DWJ$%b3ID%MP3Pl_uV2sUuqh1_;`#&x~ zN$rbYoM<`Cf)mZHM|=`}2=gjYI@U~(=)s5@ruDN`zr!x`adtLC^x5#_8J7xC+r!P6 zjTVlvm@N99N;8WsA}TR7@BK;VC!I$zZ`&q%zDm#QoBae~-8(fg^6H%TcVk?pqn5K$ zn>xC>fUN~$ZCFm~yaCP{d0kq=aSygxQSpz(8q|8cjJ8X^kMzQMc>^~TH=_lFW_WsY zC+t2onrhF6vPP;y48$=z(g*Su8j4pQyhk^I$b0_!Z+%$Lz+esZO!Whg5&*!=pTUHk z(AuvvskW0ZDMBu8s+bt|ju91Pz__$5)3&7#hlw|IH0kvb;R&SKS7^l02# zmb2yZf@G$+r#>0O4sxGeoRD?YA5StooGYAGSq^P#n?k0K5rhOckKab&76;Wgv36a6 zzw>Jc@X>8=m!t0O=|SVSCozQ3Vl8hUMjI&1Y%F78V`c5z?~}qtrsP7pMoW3$VOIp8 z5i@^Rhrd|sd{Lu%oMLDg5t$J3q{OZ(#}zCoeE+@`9E3dc2DvYC4Js)q0jjWaRHGkV z&1&C+G_wKSgxtdx;LvdBQ~#mxfGo6X3rRxPB4fDnbMQpSUO*J*fgUd-&AUE2cfC}8 zc{iS!P)FQ3_BMCxiOfQhtpc>W#l%6tJrhKeN?77+ttkx%tMHsAALm1+^7i*P zQeW4Hyu?1Luf%*8d%eW!fMl+UHK%S1H3_x8`6GQYcd6MVL=WDfvKkFk8GVZi##UM6 z)D$?t;7$YoKL)`KQ5YHjF9`e^_ad|X=)<ZnON3ZfB| zgt>+xZ@*tZZ}rXvwmHVem=c4GEfzsRBIXG5?r4P%uYG0y=4$v6=~l=`P8jj3PYkn- zZf77gGIQq8q0;J?(@>FsYigu{gEB|_9DIpu&F_^J4!l=*>Z&yo^FALj;+)6_^pQO^|GDft9h2;ISmr4tbUis7 z-kxHEIHO29@RnA7sBQHBiBeBx=EO`x8B-ChFh)FM#-6~PXfy+`_46~ys480)>2{kF zJlxRT9q-q$wpl2Z*yfy_$<3uDToa;S)p__IKNNDaQu$oNX;E`VXtKEK%^15_mZu5NA~nhh?MoZ)@W^eI#J{Tr1}|D9SUrebc=VWO9wbUlm6%m^%iWMD((eL{_bw2Z-$*U2+{gRNLwEo(#q`fk)#-3S! zzFaQE+25Q)YTCKHSye0Mc?yYYilC}*;<>$ zonhgb^!tUGYCEU<%;35`#P|0`Z7!nZy2|nD0pHKJA7Hw)iT^#idm+XgHfi6bMmIvH zW7JBzA;xok@kp7izY3u(jMimu?_8t*{MH@p@Cd^o8zXqFG9K7`1t1b#Hlm6E5x zT*0iaU4pn{7d+9i&}e#Et;)&odBSRyOC$b*l{-0N%pn@TN+&j1Y$xAmi7hfM5={7U z8E}~a#P6KoqrcB-=Qbh zn)}EzKiCfYry;|(sPU2etE|!3In*YbQt&vcHNUHVvi()m%9EAUzkdkHfg@^g86aet1cT;zP5^;^?8yO3Hd zLWoPi^%?aC%A|gzzC9xWRn$^Tm}_=RJezbk%CWnW03rw35)1`Q)>M=J$$9xfr=s|^ z1E_WJzraGfkO}r5N|BD)rcQu50zMz8VEpT6XvN z1@vdRDuA^F#Orr0LNd)GC=$*P=N@Ob7~;cgV2sF|vf*oo8EkUVDvO+pnt@r&{KN9_Hg~tR%Fa)p}&P-TDfwCd6wdih@Bxu0ooMEA}vo zQiN%KDhZ;-6h{Y&WhiD*9&DH~$nK8$dVtI4H~?bzzMGV$seLmB3IwbVy8{=>?e5y6 z3??RQr7lV^&)e1BMwfhjqogiY-)IgemPGz$;FY8LtDEA9RaO#(GS|SSBHH~Mp&TSy zMk1nK2cgQ*J!3J2-cB5=(14*0=^`+1vUI?e*0~hYh;MS`6Z$Ka^nNtGv=5vc8;s9E*4$RZzdSa!8sSlfC)k`hn8UhPTF&I%sFi1I)1_1yvug zf7&FX_>CUi09tZxmZ5ErnY(=E(9&nleubSQCU7k$FGhT{OjcR?t!UQU z7CS$M*imdvn)d!UF~tIovjhX)rc3ZVN*EzDOJ5aZg|zxw0n+~|488tuoA0S zs*lE<^$8rCeZF4swfPZ$XE^(+^lH?^WIIpd1^vvX zWoie3{qZ*14*+!X|9k!`P!z1f#U6LjZ%w~oW(+4hnDixJZ>4V-kGHwkrk6b*`Ds3u zG+vlDerVx1kmyQCH*8*!CM-g2c?|IO9u}G%rPCr+ITyAQq^HzerwMFbnNE;xO_$7X zj&Sm|a!iu+gNTC&%67iPGRjk>wuxTQNh%dlnr;7HTfuXArI58x-nvPzr1yLung5){ z_2&S6sUy>mC35_qRds&gy9~a0hrn0t<3@$eN5Anl87p-QVSUxS>=oX*A{4dY-vdNO z#kykI58SjglFjK%@&4in&vvPJH*Yku^@WHVHPM(|gB3rP!hUC5Rt0A?cMX3kq1`o8 zyVgw@d@!Bn!XV$BNh|GjrK_+$JuMwJXnoj7z4CKXuNPso4K!`kW>vQrsjm>t5`H|G ziDA03QvV+G;ejWZYWeA;(`NL?`!TwYt@<`#9RFnga(k=^Pify};pX~ptEvPQZ%c;v zi^qovtc{QGNe5mU?8MY9O7=36w!f@xcSH_F)(d{}3LbU*NoqS(28-oZ*O})8FyXFp zfPxCf6(ZUEYgPl$@~*AzluUKtBJpkFNpFQXd$rHhCqMRdGHAfxeYrzk!&c%Ut>dHL z)zQ%b^@;~&BQeFE>B_;%RA1k`ZZAJIcwn;ZwJCnvEsePA38bEYA1eG${(g#ahWOcj zb~}_>cC*8gdp0+bhIIHGx&AbUP;>{CNhv+?mE@yw;byzqA5OcdbGRWD*E7(9Y#g; zv&?UY?OJRD1Hff$;2OCCmN28OY8ADz^asE>PDuhqI;-3vGLuNIM+#6Q zco_&6{mU=C985c~26(W|X?8aT#l7BlqlOPI8KLnpzz*r?8PHBliff>Fmm{ng z4>#(RJ32bd7NdvK)YJO#j%Iyn`2|gf&YNQGHxX`SjS`QlK1;D~MWA?LNB*#~b~_5k zqLXBF*rI29leU8rCQZmrHs)ud*{#y`v54brtiV#v_}N%-HNYu?$5l2WY-xZi;j~-* ziRP!0hqs4EvorB5M2)%8tE+C3ju8Lw&y-IiBsmrELCnN$SAzzppGH!1L>?n| z@S4LhLi<~OBAd_%I9lm=Vl{oOof)9j@2B>)RWqI>q{V;@9KONZSY5Rbkv}qAt@)NP z0@e-RgJ1l8e10aVr*OpoL`c9a)`Y7$;GJ}ZurPQ6;<;|2$#699?$)V|D{V=XA}!;_ zD~*W?%|xBl*`#7^jJQ19<{t0~wPlwDRna|3%3}ochc=gwAjD@J7IE9Yo>t1N8 z()0F6E|?ZIe<;!dwKk18>Hw?#ds!O1o!_wq(Vi!%T%3th(dX%;k=>5L=NA`Kq(~fn z`LMSeE!WSm`ji6?kJ1Tun)pN?kjT8)^8A3LdT)=$X%SB2<8eu*v>t&?M`tI1k7G$q z%?quXf1T$J0%P8zFasGnDc{YWpxA~o?tFN(gWZBdx%TdMaS%C4sPBGoa-tX|@C}C9 zWxvTA1C1aDnL{i{F0f`4vzBw{W{x#GsiI}otv0%?q$4RIbT3C8uK8pFc%y=^WQQ9eA-ycCj=>fxXASj5FI4-bH)Pv+oMib8VB zhs!*#|F3V5tc;59FJrKC%|W#~Wpo+bA~S8vs`wlHEHyG(R>hw*=0k*Noq(@KQll9> zUulSw{#{?Eh`T1EuN^2_e61kN*mVQp@i{v@?gp|J%XMQZ;mA$I`j>*#?J^EP`4z$O z`$l*s)A6eVNKC;@)_MAxokx(mav>8~OJ?t~p} zH6(2u3VBZ0kMXgI-env-?81rWi#h7pf~EoQ(ACxL*ypNLkVjnSic)ANH6?sKnSRm| zKJy=AZ9xW=w79?$iqX{IeSz~Ep206*>B&nI2G%)4-WsGg;U+Z`saFFE+b^XG#p1m8 z_n)Po517R!OqXb_0uri%-qHQ@)_BO26HGO4L`FL9%q<&+sWfD1L%D0DyW1P9_t$GX z+F*_*(iyXi_?>`WFsToRQ}>hIicM|P;-Y^mF!gjdGWNJ&@QAm%Yx_fNAa_dHZY^RcRB?ZbsA-P=%ZXToy+)zP_Nscx~5}2HUl}Ip{$zPuSQmK%Wk^;-0>uoUb z9ZqMV@#IWBjFw*?Y*yig|M|q8iO5Dl7Q3<#h2e{zFMntIR#RUOB0G_vqyivfXFuAF zweYi5$0dcD9axA*j|%6eGlXbKDLUk<2<|@*j*rJg$&y}qGhd92Aijco=AD3$Vx+opwvm}|6xgixGgEv= z-`b`jF#D&zki5eU-H|OQ2Y^(4%9G#R#48va{BZdZLO?`hD0O^uWo2t>t=4qf8t4Q6 zqu>DKRe1UoCAv-%S}@MZ%LQ60PFFlowdqr)`96V=>~g=o&Bz^jh^#Y!p>uOFkT0WZ z>e*_c6xPq|(8~UfsM9sQvqasAuJchTkGizv%bPC_Xw1fOT zTv&ToQRW+K4@l@<@*ose(^c=l6&7LTHDd|XC@lD-@%1ZW!!3A+phHLe;}138^4PcE88f)5BgNt%Kh+o0x+AiawRh`sm)#fo%!L zZyx!|&_!$u6$Y7)D`3u@iUNN!9E(1!*Ducs#Dtw<8;zwpeUw-HHkvfZ;2T!x0Hj=i zdHPO7#MzPN@1FM`(A8WuAJ;evTrT^n4MG7lAfbR5v+fUo?@4?n)4-=Jg;x!}JJH@E zn&u&t7^YHcpgyULwn3hv@nYWx-Z%g2EVm$B)DxLGZk=!h&dCk$4-hc}NeFW;XIVS{46sShBn z6f>^T_&M@%E?jbifBtBr1Z~KbP$30sOPg%NAh`GY`XE_F#u+GOvd#F_!0`jdT>gM1 z=QaB+I@CyjG!@Qa&UdYThPw>BErz96Ls~;96hNr{M;3x6mGP0oBr??^@f)V5k~^F` zk+>OlHV5?)F#NIR#5A4E1$86jd6zuo?P>FFZFbfSk^BcIW1rQi1e3&~t09sbmz%Nj z++*N})X=ucUYK4WpFO-BZ2B{JHrlmh@#57>Wd8c_km=SHo7C^ zLt(o-X0FDJA%HQQDgPZ@`X@`(oc}h!zU)TiR|clAT*}BtPfAt!$5a96a>85XL&~F; zMFT8G9T;}K&03WXw%-Z5h%*HCBqhT5s3PG*#bZ&^?=3cHQHWtXyrDL3DVLU3=vg6C zhx+Lw+>P}AxhiY9ONsTIZKp`^lW@$=cIyj7wKKJB6{(-@{mkn33se+qq27SA~s@y-%DiJ^RSGa z7TB4qE=N9*TRKs;_nYbYNnpFP?A}N{UbSWgwxLC@i}YzEOUFQ0oXKdcX^(?Q+&0hs$+V_*xj~eqK&hOuO&&V`NF;gAf3^BK6z1G@&CS{Q z4D@B%@0Rq>Sny2fSsGvY1>M4=DoHNE7xc`k^ebn&M{45bi-OBb|;nK$w`KgKRY_lERWnZ zH-v-B%PBVu;3JXU!IqI2L<&tBX^~(Nh2ES2@Sm4gD**3XTJ|#NVSN51Q%h|DXMd^XEvW)~HOuj0TjL}|vp|D;fbFvqb6lHXkK6(cS>NPnUrp^kVV(IRd8K%)XJ&GCX0+tXP+~R&}V0L!VKQ7f&Z+%c~x7+kP zA#^(6<{%O1iaV$3YHL4Et1ByqgOz~Uh@F$1cWx>MT!r7n3bKE5p=;F8 zm3qt*!Yn;-ole2pEq<14yMB9b!R7JPc4!%2D{4)QU1=WFPt+3m>%Q4561nthh-Mg{ z;Xvx9Ykm=TEy2rC+@Mu@MoxrAI#HTkF-KXv2qQ-J{K8<;o11|BSvd%=w?_V%b&h$YU)y^aO<>KG3(i%;Aa z=U78*x{~z5YFiF93g*y_v1kN|fi=^=&LkQHgPVu-p^9b*SSbDJ%$zXrMygp^GlxK1 z`%G3NtpmBDbL*r=nlk-mK@b5B3;q{>9JX&|x@&RMHm z)~4s|iT^xq`8sSVqMLnqP*bU*<8i?u#mb-)=$t=gqdI{}RODs3Z7G;Fi=&!cI1V&c zAVl5Jc7!{yg(7|uqrnweBjWmw{26-1z6+%b-`@P@cLR9-Pvf9_v~W1Yn)`g#$YV5< zw4GsQjTDE{VN6auf+G*3fP`6Ir!o9qHa+e^yy7!4l~zKz zIL~`G8quI=A*Hm=8)?3#ns!{n^4nNfQ>+x_})fzDkaCF_D4Z5)OIXSq9hYo>H;3cumzS4i)zUb{6snOcKII9!P|w=YVH?@Xgf#Ood>n~; zqh|cZ>lzphC{E5kLmURyaAOyCs`+Cm!r#(@<*1?bVkr7(#Z2M1xq_?pRC1`R{OUjZF1YWGlZ#JIOXn42 zQVU9!1%o>>odXU1=Tk1nL_<1-n$kNhl;Y~~9*dmBvIz`%b&7JY&Pw-||2FQX&#w12 zRHj$b#?q?6%$4?SzTF&h`k!dwM3c03(6{ys{%yY)%O$9L>ktsX7ZAA~EADx8wTcy7 z*KK^Yl6@S1OGXQNS5;1yfE&MB%4~JDG$T^kg*Be_Y~*CSble>gPc2kN9czJ)sAnHy zZs8<8)g0)4?EZNd?1`X5S>@P&qBz=OD8movKNxXvoz|)yhCJgQ3(ah{bWzBlQ7nED zziE78+*q9%;#2>E*8k3zCl(pf7t5X~<~#8H3k;l0kMoYDV5F_Ivy`-aVEs39%Clct zoACSa;~(s0RSF{bz+}knL|MuUTvKb5ILUZqslOicj{JOlN1HPA@|8r0@|uK{ls_a! zD(HW&D!-&D<&z@ee1YyC{aEoke&Ex0;~&I&rYx9261ABv=d>D z>It3pb+X-3hIJ6>)Yeay*X-K+S-_^5DS4(M+ddwx?X$skvA|gB@j7P*rxcPKw}B=- zYSNhi)7U8v&c|hKcxM=*b0^DIjA-S}hLpYV)x!+2Q3IVs!G)rU*A%|xG z0|Zza7>k@sx{i%;S@(w!nkrG2G4~@1wixuNqC{Awxyf-yYo7qo^Y5c@l)^VmWN57{ z3u%~bDZ3-lZSle5dcM%#bSqT)A1#b`ik}JA&4#uOcnKxYhhT^Kj@9=|vmWe8J%tFz^`Ge8LSh5!g20ax;Rlc zOA`A>@?w+1MOWqZNDNvoz|7Wuu(GrF`rQm?@J+Vh(Ro|A#8P{yIvSGXAS|s|ood&@ z!rbsR2-Rt*jMq})V%}&%PkII*K9J*oW(8A*P{W`1VJdXZahX$YnPuboTt!%?{d_xZ5%u|wzAVIm(Y+pDEKBQeNdY_FJJClagm-ukMuH;drwN{F<2Oc>n~x;Xc-{BzkLV)QFc)IvL%W7Wx^%$ysDJMSPP+cJ!m5O zipO{Vm46A)e{hs2b&^<+J_b}6^jA`lSb~EE#zdj~u?8_Aq2@9?x5OFzDAt^U$DdU* zjEQ$0&CMQOUPH>HA3J4AkXuy*2aB{d?MQ?@x#{ueE<1piszpTHPy{aDVA_QfO*iH^ z|IZHG($x6hA;P;jGM(kckf#+NZnxG#&Ht$(mYFag0uVwAV?0BA_&qcy4;bub$uR`b zam6?>l9eiq1Y8TfsjO zin+2?u1{Yz!|a_7AR{HMt*QCXcmzIsMdG^r$JgFvl&&vC`qD;dMKjhV^U=1&7%ltGh%oAy z4;N>-J1j^LRS=et>cJ!}m7_+0ayo<-DJu}JhHi7sspuwj!1)Kc(9_#nhkW~DSWqqp zP%|N5n!BMFXJ49}OBNt(_=u{3;l&_#s;Q~_H^bj-8DV95V1=#ht6 zk?1=Nhc39NpL>kU&C&~E6Imf;K@F5VY}P6;T1)Y@S6REi9)Er5>Yfk2?Oijqld5h@ zDOkiFmJRzQ^E!kskhZUX(K-7=maqM)L5pfyPp=5&uZ8A<2A*lWqGdNMV08R{>lgqC zdJ?0)qGTXJb7>9_`AC{jQp=LS%gWk~I{iwU4z174tfjZiPtfkvvaz<_2d-pafbZ@h z=&%3RF#yaZcu{WV{(*sjlZQiF|3e7x{VGOPkdL;UNb&{?v&q@T#d_M%fPZ-&o`uv# zP=ih&Gs3D&+XIQ;2&ukOL<1#;G8gdl-C#0HD2ed((SzzDIsm>1a&7Ne;kUhbBAde~ zKfu@37V`ZhU2U`yf@PTTO{A?$O0CJsE&fpGrbXK1qn@+c3dJ&nPP9T zxvKQ{rE#_gU=Ad{HyX1<2J6o?wmg$8Hqt4EiJTrDJAWCVDji3AJ5K*9mvOHfRv!Nf zU`vK%)aHc6kelbK;(A9D;`DsMMbfqU*5nfwDQ8^jrjNlQ}!jZ&%7I7jzCvrme8bC z_gt&ssA%8n82Oy>3M`S4&$AU${3e~lkfk?EtQ zO=s*+KRtuvk>cRxwUm^F(}rS*@iIu}yfW({f0q#GhGv$pr$Em$*dAr08^NFyV6Tax zYj{8q3K}G;UBp=aoT(_rH2UG%5BWcXVo2cAY?vWMW3DV3c(hB_QxO+$s#*s34pR%% z$P!qyzKwGk2cC~jY^wJBd!4+q(CFXu6Qlhn@OUy-z|K$iQ0+qhIT69c4-Z?PGq!-; z=Jmo)Ly6{}01<@&SI@ubHkoZKYVGRp?b?EV*Vx*L1eC_^<1> zAke;4EG%g1f^kX@r>K~^Yh<>yMgv&`ZFoZ9ELCi^wU{U2oSRzk)cc*fgu5Ve9JW_v zg!CJqAgJ)a@YbVpdZQxH{D=jDl*bxyi;(WaC*;GwpCGWtkOvLZ^w0b7vUn}*3kVch z70vPKygf8iwzRi@iGUZ^(n2rcM$LzUDZ~d;n4NqLCMtK}aXq2f_((MldkMuT`Z@uW zhO+rEz_FyWqM1ruh4{1hL5nS(b!Ap5A`dtD&NWw&qBGQ>!HLP`iM$F;eu>5mK9%fv zMcrcVVbEF2S#;?NM)F6akN{x6#00r?*iSaEo&xH24IIY{17sZU2gp`C%32`5#|+X^ zXCXatA~y5;`1v2rCXp*?$*OX<2b)uJf*bZ@l4DLS&j1yHHhw zEwd*eMSISv{q3#ySxV^1MQ!>&|xI)Z2@=Xqf>{OeS%vjZyHxhiPr`oOHZLLahT4mxB zeMVm3+@7#bP`anF&C^aZv4T0Nv@@11?U6gdptbVcoA>}f!Evpl`*|^QbR8S33A=zV z|E93Fqr){iES#>#-JO}By*P|R`TN0_O6RkNe;5axweOGV)F&47oHo{_R)^n=c`Rap zT=(_NB_!bQIq92(q4Zf(^@Jqh;<>Xg57#*MPX(H?xP%bgJ10LkW>3 zmmmZTR|ExyTf$EocOimB%-7xB-DUP1hp~`}YEmPTFggdfFVWD3fEfzzhrJUtLr$J| zBd^5@s2gDNKnzfXoaKFy8EBaBXH9BpRX`k84K9Yuw-!Kytb`#&oIN&}MkIGg-)Hob zQ8{^r|1!4o-jHjNVbndH&pTFAfz0$P2G?yqHh!#y1Lxs{-(_hf%r4u9$rT%uYOve^ zCgJ0Y>v?&ku6}C6FpmY$0jcUxVaKXO&aTq9kuYYwawu$iSx}p*1Q9LB#3p=-9FQ;B z_@v8m=JGk5qE;64>1B0G!D@E;Fj~GXSt}Z3Kwfj}%u{*Epd8K=em?8ViA5{@5qy>T zRv7r~`(uXA6t3k@oC9z_-envEuW}!vtRa+wn;Q?syuvg*&FvxeP{nXtt|<*S=L@&y z3c;y{U5njWEIk7W zjlslsHWW!N_F6cMT9x=Z&Qpn-QaZ)tM9UgdC4(Hl-5|IUJFZ1Dh2WR^efJw#)f~}( z=0jj}W>N0OQ*t-ztFA-5utsvq$JcsW+;Xwx5q*VyeD&sGs*gM8DeJHruadVO*n|^ck8~ysTu1Ic6Q9*39!)f|- z&*X5=|D)+Dqq6LxERA%Bq=a;XNOyNjcOxCr-QChH-5{ybNJ)2hcQsKBxDN8D5*xi-k&QBa4M3;XYkiEIw{Gvo2`P4c~4j z?Z}ZZsk9mq(jQi2)TPDm4c71-C&@f9%TFiNr7ohw3rhF&!Ohi3*HJ(kFgbtiANzrq zseSTk3=yP%GF|shOe9pf+M%Yp<>Z&KH7v++G=qiJHVpVK6?ov~KyH%B6j*duS$1Ok zJZ7Dv;;zKEOw;m6wn+_J_--D|-VEQSX+#Y3t!|Ux(l$Y#P^$koWI9=DHm~c`;ppV- zVHK4;1i54k{&0rL284onxR-DWb+89E0b}dmryRx+U@FWEz}T_HAqBCtar)il?o7p( z)4gpi32x57jq;!Hse4roS779~oCUfe}SN!jyoAI^qfVWZe|tKh?g znkbK!%hb)zGJCr0#I@5ehY5GP-icr`pbn<^VEc}H^%nFn(wV@kl< z)G8q{zm5#8{6Q@|lts+U4z-_}g2>P%XF4a~-ZNvcBz}{*?nuth+Q)cmWRv*#`5&;R zo7GF5rwJU1DrkXPp*sh%J&6a9Q}Ny5s?d+99_Vg1OLr3(KT6STdg0JT3dpZUbNK!= zZ*~^G9T!?UJb#&t9fK8F z<9aPV;H{U&-y>$K%Yo+oCG5dEFR4&&$eMPNer9p?4y(@Jl>V&WdU71gQ8llL)Ia$? ztq&UG&1s#~WNs;n|MtA0LmixjjTj>0u@Z+!&imDxWEAbk!^dH@kz`xw9-jo^sa;`q z0WvxtyaiBy8&|C-(eY>)s}H5>XHkI#XTtXJ}$_FC`z=SSZD!#ks-jdmixwG&iRLSWaur%qBw_FP7poxNq0NTh^kA?h@&M zckku~B-_^;J@6$sAXs)U+=Ws!Bb0anFjKz;xKJ>~gjWVle+jHkxMH+U^><{A{J>1T zY=Brs-9{~v7Va#Wfb7agZeqW`)Usg3^r5WE=2*M*C?WAN(JlYHV436eAc@T|g-TXH zlkCYX+$e`qDms}j!IoT|&h(-c7(oI0?w$a+)HEsy22&T{Iybgw*0gC)cbtGZcda|j1 z$~Sa=I&(?0v;P`lkqpKVXbh}!K0Si?!RJm#t76%|`011~CLhh{5wt`Xs7N8k!O~Tu zV05%*oI%2_h~%=?g^YNt6wl}Uh?6~8enJs=`MHp zAzXeB(RQJrMBdn|SdoV|oDA%wzqW~v>CVH|P_}4kiH(mOGioo#E!Rdp2|1zB?I=Ih{&6cTijMbqZ}3NZhMeauJ`(0U$|GE#{_wD`10HeAY)JV+ll zap9oPwmSJ|M0kk$8;_WV{e@tHO`S&)HTI=+NddP>FBONnAorla$60L~K4fh(4V|e$ z?~0%W8MB#eH*2%nnkz7~0RsO8<1}#nDwMark8)NI90;uM=s5HEY4Yn-t$`=$t*BAo zH1sn$jl?MRNzxmZr|;FCros=Os|wP<(Oi1ldN}^?CyD|!s!=mDcbC6(=Zp~)cfVJ4 z@4WAj9}#$XxIgD5`WdRxc$@6W|xu3}uMB1|sjt2d)y&_rgBQnz<9 zm0Gy|TQwv}*x}yd`4pywqgwP2bG75R#QiPqp|?G(gfFfTmTo3_)F^SVmOfAh+BslO-JUtY_6$BF@SO9#V`4?ZZmPCWQ@WsK zO`=DC9|KUk^LHMW5Z6r@L`Ad;rJpe^)XviWVIj#I>|S}8`?q8n{PEt%SsLYI`iTtP z2Lu(aSNHc^d`L|?hKM{^wxXSXs^^Ba^5Eh$>cYlvL6>2q=&s3r17?3w5aBWbpk~M{ zQmRv;nuD|&1G0h2VAK@^Pda;-Q-)g6zj7fQzL5+s%$-uQi!+^HfEM2BcI4oZFtBni z*-Jw9YT*1wo=t=5;Bo?loDtSx!BxmK?-7^)529w}5%P%v`t(t@d@-DIkEY{6Y`!uL z+^6-jFs^A0JX&63V-twYP6{g`yYPk&X?(lgcGw|odFs#RP~-}ySH&f~#d+dcwWdL5 zEN9es7glmp|61Zqrt{LOegSo~Zu9=%{_i-4Ra;zO{ZnxTnIbnStY%EiN4z1)Bob;L zEh1ky&tJuaD;)zUC-(WO_zfiKdJBAB)5_Vcf3TDAZ~hfi_isn}O(E2h(8&m=*(KQ2 z(ek78rN}=d6>cGzPkq#rYT8dmqTvVA!(&nO?Byx%;vHXgij(*L$#GpJ#tQNS+S(4oRk$zmU58kcBjA5$Ni#<3 z&I`kE{6X)3i)-f9E2o#nZLAU#8Tmk4p^$y}divI;uyjyO_L0nxJwn*q{6Vv0w~6zE zO8UZcr*REV5at3u6#;~${eao)_6rZ58 zmD%RMxEYF+!4P9S)@no}Dz`h!D`{V88hB;33-qIU*}px@v8lApg;gA3`pJ%jJaAz* z#=J>3qk>XK22yUN%iPAt%3&I{*Z*2QY4_fLhIN0OhlK}?^n86F}0D}M?F0Qq{EQYZl)*FAu2fz|iwVqonr#o+0bP8`9LwfQ?>E+GP`^Ki+9gkmtj! zccWW(+Q)6o!5a72iP%I{>Lhrg`$+QJW+)_L@GLbV`r)lzzWhA8r<{kGmO<@rNd`mFjOq*tP9Pm~ z?R2F@l9sP^IG)HP+dtnACn5X{5Y@R0&mSS?&hM}xuqItT`Hfx%JER)C^QSse%~YhL zul!urjRf!0xEOc8?{ z>%CPT-DkVbB@ykaFBPx3+LnPh1l0#}^NZ9ZqhCIGUmMxK8Q=;Tlf$GajpzEkK5T3R z@TA-uKr~ffs4fPNOl?Jd%y0g2G1YpomJTyb&{d_nH3(Uy^g(Dy*#C$A^YxTsfxPso zR)99ejrA%k0d!LT&OVS50_*|-+i5kFfR;2`ea#iPjcx%1aO}N(TCt5T)0yGbxO%%& zRWf=iqWJt&5%|6q8&{y`1X~bfnFj&k-ak-wAK+b$LL@#;!kTJ-P>lAL)Rc(O zn^>pc=AX-sdcFdEjzUjM1&FnTMnR-#49)KSLUnr1ddXJ@MSfv&$|N+@&4DdNGuFVt z&H<=!24l7^Qe1-mJjtyrfyvvTIDO%}M8jFm1zm`drh{}GjjeZd)Ko8u86sFlP{gF9 zZ@}PmSq0nx-Fy_ts`TkrU$`i^AL(yEw3C><_vQ#11oJH{A(}Kt>Wf)=vH3#eHi|_H zk7__zAk)pRdp~`KqiibVR123s7Da;YX8EH3%m@soKX(kSm;531#p3fc55{PJQNnoB znIg;iS5}Ga)&`<=gULw`raniwifl$R;st_e9z3hob)z)F(In7vxe(gT%|+QKBp3`) z-Fobzgn6}u*n06bLm{3~lbjBxtG+jc_!j@Zi=ON6X5rcT--^pPZpFzC`t2QN%#LWS zkCq(Nawd2qi=YPmzbD0-e4IV`74sb>5_pBl&WINz=%yCKl4ty|-S9fx&TD`?O{9gY z6`LASRkTMitex<_gibB8c^n`QZ6jx+wCOjmE7r|bSOEF~OqjCl@cg$czLo&GBD6{k z`Y<9@nx4cc)bJ?+*I-gMop8?_*lprc8VgTl3$rELt|43;B|SW)jurUhcMdsD|h;zK7z&UP|~L|^WAc0TS1?$&m~ohFxz z>Co)#H&ZM+x``z-7_9(ZKZlEFgZ}dhct$?LkO+Ffusu85=k@vhwj6Z2_q!JA;jkaInpYvz9VlA}SpnGmJ!tyXMU@fb zPk;~!(15q+t1-YC{_l4{R-{E!&`^T)+n=^AB~9iDlrEa%b4hRJQ*xO z*ne3=opCX7Slx8xmSJvzKmW8~4QR!#CR$R>BoLBC{UBV_g6*~u=QtCCJo?X4`(WVP zRl$W*J;eY=@FkT|ty^%jPjGacKDCQBqK6aBSJNd`wRV-eSGObZMZN?0KewIse4WO~2Ja?-n1O+HrQ;T)Ea;^DkT z=SJ0G67i!g=2YsyGsBM%9a(eg@?EoMiH${BH-zD(`YlVYK_IP@N5NYA3RX&(7IDwY zc6B#s*RtTS{6slE!!=*>|FXZQn$5S^WTvV){a}}?7&CKK+Ca_B+&TZ;fvTv8oQ&=9 zKod7xxg@z}J}7wOcJW-cYM7a9EQ4@n9D;bfi9E#pQKjXqf&<;w74B^0Yf0l9l)e<# z<3|)%a|XsqBE!}(OfNC6jFN3(-Vo8s>Lv*eo{#RuiE^$LLKRm#GXmb$W?I-#>XZ$y z|Lal8YFNLf!ZBqgngA73-rj~3rk$(*d{pCynH)vT>0<;-)I|ovKT=9QWePW54JDe# z%1c(EgC5hDy|z)LT=%{pfDWl~@G+wry(ykc*wgzoC8FSfN(ceUC=JojoP3tZ7;FN~ z55PZqZD}b;0s@S32E>9#mJ_Bu@ao-U#e4*jy*3 z(69Kfn*jP6VBa!krdEU8Qk8EkK7Knl51+BV0dBc|FGmKT%?0%J_kw0iD|2(b~itRy2**(0sAZ8P5DaagP8GVEpD>nbSoX7t*Q<5R*=Z+B9! zcmk&c;Gk+h<}?m}2=0}I8b2_|0zN>GAYw#6Svd^CFk%k+B)_0uaT^&iH+v&JA$#;e zvvgGMBjlS3w9eP>p1E&bk{(h(=deH-7zAc9-Y$ud5VuH_T>gJ}Sh= zEuax_;A~yLLO;Fd3{}+MM%kMUu!xKq871QI)O0~Y4*UH4+J}`^PvPgo^vp}VX`J?t z#_jvAs&n?(hoOi!Erm>{e&DD}-xI3pfL8*XuFb0BgISz5*MygvCU<9D_e9W0Uo;VBW(s5?LBboI0e=wg1*o09v;%GS_uja zmcp^Vcs(~sn!&i!`+nApVH9;Xyhm>UZM(nM)Z}QC@;7O%%6@Y!m*ew7H_2DUFl7>L z{6wxGo1T--DMC(4M1;Pn+FPSRFR)zt&dDLaplFJY*Cm$#NfnAtS26grV&_`j6v&?j z##5v&t~%nxBtqw+HD!Q72MGDeth*(-zI42j&B{GENJ!idR|+a?~J+>3bD*`9n$B9UWXmx zl5MuDyHZ#mNUQY7h$nvW(@3IoPBOB}@|86G{JA4bw<##JLr0hqosGE}{atM;+8Fgk z;6i&utPS!uF&*vg@mh%+RIQErG`no0R>$DEl@x-&l7X3?8d`2xy&ILp^x^TU;EYW9IaBea*#D zLZw~-=55Pzlnk;)3CGEu0X#X6?IeBZ=e_JF=_FZVWs!|?doR*nbuk2&GC z4sB1VD+*f7=(Is$1k|a)dNOxATo9cuat$-ET*)oD^=$MdT)5xR2t#0%qiAErH}9cx zpbDvYA^X~Jf5UL3q6c`Avq)3P~K+m1H^0uUDoGR#qV;Mqe@52!pxaO3P zV(%6;9WOa|a>i5dngh|JA1w7)Fk+lDRA|Bi={p6hII^7pt_Jfc5yqpSDWi{|51Js5 zWIZ&u!PVtA`sk3>qn87pU`dsT*8B_&j=DrC5J;Qs+7%M8s^8)3^j!n$smbAem7Majo27Y+z$0!}vNOSt`crAn%c1@6YZLv6C0r=ll&hw?98XD(fR3vBX?Y~`kdr0_f*6w3pGU8o zBZJxOl`7IhfoG}Ge_9kSqkbGp^t(2n+l7a9jb8H`jbqxy*a~;$zABsRCtd@H_{D=(9I;7vY`=e-JubKI!r>5g3hYrB+y$_rmWr$vRyVZ7a;v$CI0%gGmh8v`Pu{S-3d1i6 zRFXrjOamw_N;ccch?wtapL_BL4U;t@*22=#7Lr2UanO${u8gl}iSI&2rfeZ{htGC* zcY%5a7}|mrMm}muAw|3-jW#B%IM4Sumc*s$3o)fpoLowwURhH0_|A#^ zPLzS;l!1W(&<=lVS9{C<2;#a<+pl8`F1pkF)+U9Z$5TGIwbrsYES38orDCEk$iw}h zdqU&Z-e5ck2FDp_#{e7wn48nwBg=cNl>}tQvDHe>UEnCcRrC7Gx%c->dwcEe^&6ro zoUG->z%6$jXaGGu>HgyFPK7ewc0+}%&eH#L(B@HXnCU%G@bdOWZY8Oo)Bo)mvf7v( z_~EUcte^sMLtaOth%1u;Lwbg>`G<72T_7Sv&a^l@=K>fM19iN$GrkRvz#klei9t0_ zJd+z|W480iEyry?M@OTXEKFAy<=ACT!|wrYWJWyI8Lc(`D>xW5nP&Jx>@Z>^4^{-C zzN-&v`<_bUii^q&6Q@1n_)RS6Pjqbm5kx~n&-nTHC^KZsSs(mpd>U)@onHnEQTXL{ ze2YiF>HSa@_W6@5cza@89F^>i?p-Bu{SS7+;*3vN9D3@AV;mAOCNQsw5CJW!E(@Ij}kx==DkIIbad~-!_ zaS9$jl@i{Fzd~Lf)P9zD&hi~1luI5-?!>6PQ?n(D(8P| zkTxre%$Z+X^8=&hEr7?)>n*lzQY@{leLv)gN^ZAyd_n(oD^Hd}%j!~j@KlI^5w8}n z`-A8YL9scGUqT6q2C*u_yqs^lXa>Def5wk4RSX{L4`v~|7ufORw0{Xy9C^(10^=XK zW3|py3lrl$!t?XOsAc&}cD#b?^C1rfV$w1y>?cza2@HX0B|$P&^Y7n`)Q%mk`?Ti6^^VVLVe9 zClx24S_G=7iwjobiAb;|WvM6vMcZ&rqk;9Ro4EdpRQ6T(XII+fRC92IEhak=PN+Eok znA`1_^<`{%DkP=cDp0BIUw6y&c|#c1xW0a|_G&x~(q^E+dIoI%3oc?oAv}0U8Qgkc zWZWeTlqHHcxwhRz9wwtuQBi=2it%Fw${?Dvgfql(CjB2(Tp3MCR2*U;H7;=!h7;# z!Dq^LR~%F_EgdAu@og$qL5MbsU5-X8DjjI9VLzT&?pG>V%Ch_k$Lt=He>Q~pNg=5N zNYzYCOr0h?$*c-*&yH1JU~3>!a}(OwQs6gnw&QboX{)H_!wGpJ=9lpG{@!9;A+^aT zHxC74C;`k;+TpK)QL)zNpU-nto67}3MzYHc%TqGCOq%aaFFP8$P^MSMM6}f2jBDb(Swv{Nosy+N%}ywtlnQ$%q^%IU;J9 zgu#MfKM1QpimliFunIAtU zrIoDeh3a26XNQ67P(-Gos1j!j@s@eT%#dUInfK*(|2YOQ(kGrg5dvlaK%IEVl>x}p#4@BCslMK3B){QYvv2|cqfozL519o{Q za*#s~WgSo1LO{k@PAxqqtfI}(`%pK?V`bfgH%g~$Y)*YN2{973Ra11>=pkPb)D=t< z7&;tJ^NC{>dw4Z}VZNwQTdXG0VPTkUW{G%$3_!Kx$F%;YBzry?vPJUA9COqD1Sv5p zpR%q*%Leum!M{@oy zKJAYo7&+UE=QtJfFV2u&j%&-6=CCT7f7(HvhBjxiLwk!B>EvTK#^)?ER1kk)GK?wM z)h!cW63kM=eR+Cl_r7isl~LEU#E~D%$`w8;j6Xo>$5T^puKEiVr~Yom$XS_Psp5TB zR7M=sdx%x*rJl#ilgFgK3W+n1khYUS_TTCyBKYp*>Qefor3&U`N=LOMxHH>7PK;3a z%RF#=^Tv;HZJ{IjiP$lH|A0Wujh?WW7!>K{|HuQw)DsGfxQv^|=7XAXv9Uy>V`;I$ zo82{%lvt6K<5rMR?isd^2{q=$i22%%Ug_U6uK7HnLuRA}-k%{vec#c*eRb%&p|TKX z%Y@fWN-jFcyNfR`%BUgSvCBbZLZLV!j-K*ZsF^&IF6!9*_Zt|0mk*5#{`qkEiOO zIWMBKDR&K^K0v$6nAh0s<=*e`e%PFaVvsjM7KXzQ`X{N?t~Z))*@Da$KDoT16^3$E z(UG@lbZxM1gwT8LY?C}OsSCSpgXNR?j zh`S7%bv}{}$}^q) z@=uXHBs@JXL)0p~U~+g;Co?U@a4WCfK0^a4Cjig`7A`>AdHMMGcz7_|hV@jEz^%q$ znX&oMu-mGfBT#DRBOjA?I>U!?5UOg2Z7aVW4-n8(RHhXl{doqMMR)`SOQ7-b{3r%6NzEn6l8dS#u0Ak_-T{>! z_{!EOz~aZoC`eh6RO>5SJdpO-6~%G+X-9bLjoU~k01fYEZum{}0_+pv1^)x{!Pgo; z)`08aP^mU$SUn`2mf90ta#v?()$0g;cQ-e4RU#4+Yn!LPvnp0?khpsrCz$R}7h8XU zm27W+;rDj#F5+OjY@QSFkd7lQf#(0U9qJL*wx zuv|Zyfj5l=ZOs6A*%gr;x-odM3tx(Xk62bw99P$vQjWfc?!IlIEMLx=$A&!Bqnsx` zB8T-&B!vB^99`%7NH(=&3tq~YyH=G3SO=(+IcS5N#9XWv=Ot0~D(vWT zz$hU92z%tAAiOl0Wy_n~V}kp)S+_Gff^0w)#~CLX{w;>dugd7!iDpx2#Bn;4e8-hk zMM2AXT9J&LqlWqHCwQNxzoS2ioF>_v4MTPFUiu*kSp8sE1>U|`;Nn7={dwHDY-7k)JOp@tf6&j3qvki@$mKsWjctJ_{xl`6SM^0l?cFc#-c6(5H+%!Xtr6+eIz({z zJQ~%rKjU?J>7zxFnO6|>2bC{}E1vX-3mysLL2!sU>vE)bGVAl-T$NSh-r&tVi`DrT z5hSt#GbFH9bt6GrWPF?uC^iA&I(V-DUUc|}uu55pW) z3Cd|RPe!s&!~@~GiL#r3QS(#V2Mo4QyAIwaxipJ(@F8u<9tYfYyjvOWxnPSH$Q&vS^jBl1uF{xxc_~8 zmb9;!llJwnQIB&(79 zRvW6O3H71R6%gj7eH=Gn)u%r735Zj&Bg5}BbfIH5zT**9;MtgPTLQ7QnI-;X1j5#_ zdn0;$H&ryG;(etXx8Orn%p7iS7nvYOS+?p}!YaG-UE21?7R%6(BD6LR^LFaFJ2)5y zdcd&N{wI@R@g8ffDUh~LnTr3B?PIwIbb0?7kpkU9Kz!#eZU8IDXFWZw{rUFN@z$Iy z2|n$CLxQ-4@JShP_LdIn6kXH{2<;Rtm*dpBwnWIDFL!&~mi11c<+~`=K1foyoPI+X z^Yqa3XFB97Ph`@Doi8}qw3xvRA3PHOx6tAA#(sXCDny<0RsFsT2DnH7iyE6lpNFK1 zckQ(_ty``*$oyzhHCzsm@dz>^JH^cB|GqHEFxNVaZ;^x~6TI6qHS|h>kA&`1pd8(N z&Th2*`W4s;P2jc>yv=pI-mJ8L182S1q{|Q zUHK$Eg`B-df<6$X%8Gz{xjo4&RMI3D`#`zz1OR!!D0PeiNI$@^w){$gZ1Z?h@xd>T zNzhzNSB~x*G}AVv<_;Jf4Y%9?q9f;@nT;v3sV#QyT5>|`Nz-?lVx93-wR6>91o>fV zq-GAT37U_8K{_Vxf`Jy_FHKy2`L}!wyDs+MSAZBao4|2w-FKa^XI9iwGBOKBQE$bk$j5LLjhpLYm8<%o^dnRx6ey<(>!%Lixne3om8-)Y> zPWWYH3fuLMm zEXpJ39G6y0-Z`w`f`R*eUxaLSkJ7}^2uiK`+dikG;oLAJ&YEWL*4WL-?cT%$#^QP^ zPGSG?joD@O)gO;5I64L`H>M-QL%r&m@=!l;q2bcHX(Q|j-JEZ3c1wKlF+^BXh`DCf zv0;R*h#_4xnO64YX3QTT4}>?%$h&^L_Ct zVRU4Nf_d8#d<{a3xmQ-!ZaiqY`x*;gnrTH*AvhySf9nt+$ls`D;bSYHp8rr=<`Og! zb{LtNN%4onvckJ(`wObPwb$Fvkg*sN$9g-P@lN<|LO4nG8&p~R&vwEUv`QRhej&aB zQ$}s{VlyybB+W5&Qc7}iU*D#68_NeP1*tEw;{%FB3K?>q-Ul~nsziVizgRFqH{{5Gu6vW7cbFO{vAaeoqD+G~yLgcUS5tEi$r4SW&_ZQsE54A&(w09bBDIai9d0 z^s%c#PW@ncuv7fL16NQlbUa>bDow)@Bm|!NGc9ub#@aas@<_+MQfRX(6yeBB=_v#H)>PK^x zV`F2^7V|5%kmyXt+l-rPyQSrf%{x-CXt|}|4)fv=DXy`4CbB4f8hu}w5!F$xq7ac@ zOkYmW1k;B)jgw($N@tCbz803`P?ax=(RIp^nJi;zxu`;Gk=8XI1zpN)y*=zWLQD@F z4Gpqkh^w@dPm$;3=3bd^+NX7BB>MdQ?Hsb+j7jtz2Dl(6Nyc6G=53xY=Q-{&8SWre zptm>KV0wdlvOi_Z6UGD?(E7{cAY6Bx$o9Y*3aa7gA)AsK}4{GHgl9+hmH^0Iua<)X`5>RNteNC?eSn?Y9j8$^k^q?-~&GD;Yd4zH(^SVc)XpwUlUT z+3VTtKN|w+F)KIuM)KJzVe2o=cQ6#tDKT(x)0-m@*~yX4o9{W%JO;s3hn% z-N$HVvh={2^h3mhaWNKA4ha~DL(gIuc6){G%crU8xkL-k_wjIo0U!p>a1A4n zhUGePbRy+#J-s#{(kLyF)Uo``PmW~bb|SFROy7ycYPNeD)+#h8}7 zhUKp&46l0)qfX!ZP!;`2r;ZOxCVZL~81TOZ9-7wuo$(lXavcwDs_- z{xz5M#}E#t++d(Szq%$VO;_`3Z$(~tvB*Kx9N{fx2vKm(+(xCw11&did-p+h|dyOwvozS%XC|HIYFUqwVXJ;I>= z3oRDLs`1G<#EJ-U2BbQ(T19-7?1qU84&TRuBqmvL+!VpzJ>mJ8>(x9^DNILC)u`^B zqBqRN#SK{?&=u@T1?hN)#$?KC&-@pbQ1j2KEhyNYPCMh3w4m1(5 zI4I7Q_XnzBG?Bw_D5j_rx(O8<-VpJjB?MI*q{7+^XPPAjs#mAw%vULXlxvb1q-;UC z&l-qUrNnRUiRHFj2bOJz7%P!9$J?TsziH*<8y~Az?lWk5=2`W>cJ-X^Mwg)GCI-z& zN~zAo8j5XyVs^Bi`q*W9Nz|n?TUb~KK$Zz>rWu)rs0tuu)%uw0T{+&ZkzoY2#tg^ws zHe!yEUjQM67~g~XZ`m1FqTL4j#Ik5MAyO!wJ0}h4Z-thsi(DX;0TKq`sD}@=v0%!h zJU@jO1t#`>&gU37RuO69|+ssEQqkPC)3X8zyFSN7k zEBb}c6m&`r^#^`OCv^OOW_7(+M8j}j{RUykhq&}XFy+SZo&sC(gaTQ>`zKi!#=pX> zuRrAH+}a8(Z9qBNhM0>lm6?q`2+n8md<7bj)ysR$A*R#map6%BI-Ip~9KI6C^bo3E z9@+>kR~y9aku8U02J)xpXAqByXsa2*C+}eVz@z4nhB4oOeqP5lRkHV?9Gt+DL=5!b zr~@14au!2#m`7j=nfK}9b3FB7VWUNg^T6u>3kw*Be*3wNZ)%& zpFQ%;M>3c2)OdF&PIY@%%M<+$lO0?1O~h|QMz$ntwp=UMua)L)wwWJ={|_?QWDJfBLxmhY7yBBflG zS$AA{uzVROE8{Uc0v-quW0zMbcm*Di{a3brZ%bCpzle4%`cZr(#tRhhD?L*779{NP z%#(*+$Lze=NM{FgmG3b~eSkezdu_1_Uu1@->b;%)T2<}-d59qOjf)5y-c6aW{yRmx zM_9~V^r#n;UM-`==2Zc~w&p03oQwhQ>W#wen!DTmB+0uGqD}arxKr{M1|hv?HEOQk z@)cAfH2mOtWQvqIuIhASTKSWzv1Fc~wAqbIJx1&7gT+Q1MY&6y6ci#Vf0`}Q%J`ez ztqYs{Ch}}6DT4sIg6gM#f9jMe|8 zq5Pv_1zgYv)U<62s~;lvhF(zJ$(%eWTaMS?S0=CMm& z2+Pb1cwyaKU#n%Dl|?CqT1q`w>xmYxU&`Rmh4-mNQWn5{ay0b2KNmh0RAtOY;8(iD z$FaI%`>XjA=&lTu_Pt6_shzBg#Lb{}ioeqJSE>6GnOj(pBpX6fV1Fv5DH_JJIf?S- zFHV;P?j$$Nf>|{fZFxQFcs&BBM*7u|TDWn;TD|Yg*{^&Dc8qI))$s80 zwzsuGMGyJ^J*ss7{%2==?de95C7VhLFS6jaRRU{cL@hH){h$eJC<`fhAZNQ=XNHP1 zhZ(-}YDQ_e;8KLmw>fN0txGcs<3)GGQJWxw@YOT(n^D>V^Xu3Zn%l0(lGRMHK*Y@b zn2A{j%c3+Xs^{p@wv)0K*r&&~Fl7~^Z0hVTQd@r+HtYqW0EWwuO^CXd=EO;EL;~;q zYar>_;8NbTg$7z$b$$5s(C6S&+H3^0a%Z2bb~q>s0eOAl7HC5LbBK?IV^JL+g=QS{ zm;##{85VBeJj*A#fasKqbq*$DspCUZ#T?0Q;z%K<{g^>6|A~`F zzmj)iLX~6IJZhsgFeG#6b5Da$(y-muBQC|9yD%I`v>m*ZQu}zl{zj{7Yft)6xiz)R zV$z6&>#DHI%5)!={VCT~ z=^A}=s#2MD=FUg2mRt2+gZ6e zVN%%|Ms(b6#?HC3xLbAhoz}4kT-@h7BoIqywHTQ{c_T$+v$5<047Wczr*!?K9I~)X z|E?Or5+6=5*hD^BOgHaMKi}|Uc#Pdn(sX9=vaOsE^Itd?(kBcgJ*(r=iNDB}XQA}- zeb+aF!?%lSf+LQL1bR_5W4j``)3ySh_4c9H(#{#I^pdzvQ2Axt7>=j`c8pA;LM}W_ zdl`7VXXDj1rwKmdOaA{-8#l!h8Ik+Jy$7CbvzHl}N&4bDzzrRba`Y&@lDv_q!F|I+ zo$XsHBT`^g^APZea7fQ)UVMDe;Y}yjsK&}D--~7Xb@&#XzuPb#5EjNf@y4zW)g!UL zcl?INY#{)D&Q8}WD*=D2n+=OOf|^}9R!5CB)6hIn;~Pk~J=XO5r3a~FPEv4Y6M<;I zA)rA!Hy39V^U*xa@2dwYE1r35Vl_7@)6kfr&!9~85tuP zwUTYLZ8Gjc;(q^0Qf;#gz}vu1Ld##S{i_JJEI*WD6VvamaE4XzpAL@MJRYoV{$y9% zjIa%}dY>`e=3-=Vo9c<^`jIgGbWVlL8C|s!Y{@I6@U%jafZ#jZePE z7gsWq9XsGtZ|dFj1JVK@P0*q^q=*v;HhYJV{Yxa?m88kmmLwf$`0L+Hw2pOnL)L`R zh5*uOc4=e|0EV048b5%I1FPy6=20Xj1(Yh2zmfORC#k~_Cwlt&+8PphWAC0MjLDSi z@LKKAJHgoV(%TURu#g9EAmEM*)GgCXBg90F)v%hhUd?oseN0(kBdL#^EH1W{A+1~X z-UN9zVGI?vAFB25n?~v79(YNact(_C$#{Z=MM`TWsqT7CNQp(zUhEm_(@^BR zP2_`3{sz0D`%j>i#gu++UMsFGVv)T^*wyyD9}_=a(6Q3aovqq z1Y0Crwx`PBCtKUzJnuT`1s=2T^j-0xG2d(*Vr8p|mPMb-gb+VD#$DHWyz=l?%FU-& zhGoB3#FMK|)!lwh*~T->YyOz?DyHJ@=SLdloI`f1-i zXTu3a{hb|7M`gZu#C5CnjSRjVp!|nQ8xwk3JK{zfIXkc=*)_QQBe~~TXmRGp6gMMG@^*hfwj-IMxGcP@h)R9p9(6Yo5B#+rr>t_-6^`AV@f>5&%A(ZTi9)m!Jt{A zs0}m#9sj3U0yKE=wX{@dPU(~JN5M&>IA&dKlnaGANSE?u+D&Rjg)Fe^BY{-Lci)V% zEi7IPxbp%)O7rzqNL)M%7yOs1Z5DHwlurh;y}N5}Z(l>mZP+t292=h0;dvv2F3MMO zM%j)^NHsxdrcdpC?ZA5>3bRdwCgMF3_8s_Xzg>Rs==}#sEif!0W0q-t3%}-3Hv`l< zR~hNyxX{k0>u|4`6g%ZUXCli~YC|1qXoG~$qQ)&VM&}=NT!^;; z=u&HP|62j^QbqNK<%cy|5n}m&geR0OzkfN5huNm(8?r1t`Qj7~ek#l&Y|=keeerHS z7nx8JvmO8>>Lb znFz|a^FvO96*wxQy(VVU$~+OrX}RV(wk zu!`r4htbaxp0ZpEx{)s^&3{rSt}6wH*Q)ZIW~lf-o$3xOc-U6dzRo7Km9y*_bMGdV zJU*OWQ5EbKjP;G3-QJqu?AjTeks${+N*;O5D;yOnif||XnGPROGyab`Ua&T722z=5 zW@)D~`Xver{KnFgB+_}?r^Ky)rl-ztWI#=yO` zu&^)zn8CzXXy+POr7oT`lPMm1QMz!y#6Cy&3jxKm(QQyFtp1}E93$Tza=n|Ff(z41 z2~VTY;{Wh;)po8 zmjn3adCu8;ueCngSf@DD98OV_UP{NehaNq}qHX-9BuF&Y4G4DMA*IaCcxSiJsN<5p zD0uXN2+|^L?tC4@t2Svq&P5UfEj*v$@BRHU0efl_99Ki(ngy=>x}did{o~5LJfe+} zvK_VL-+z0ZnHm#WkN=i|qrBsQ9y(X6{sriMrJTnyE#FSLb+31JcK*+u3T|{#8KWOl zoS&5|8O%CpcV)hfCnqQW7c+Ug1AngmNE+@R<~cxTesB7N`(USBseNMr2Vu6=a0vss z$3qt-@9n#}`trQ_X7AxL@AMr^F@O%lX%JYw>l0ZWazneaGu7Oj#xzf6pmqZvomv|S z&(d}b0`c9ni+!DX*{S&#_n{8>)xE{dRa_Ms$<6SwjYyYPD>zx)jaknFH+ZlXNuBSQ z`x^WRw^MExraVbbF#B8`<3ui@4Tf{_LgI|r7vFF%mq;3~v)E1{%3EVppoa7Dor=S@_RB0#>mMF2HfLL0!J;Xkldky=ol}zr z|M_DYY58j;`6Pi{js5D5nt|YS+ac#?33^!H(1aU42KmMDTH7o*zLAlU9kF(nx~u6i zADU5x7}QWa8^0cC^$!k848^LFRcs<5CjVX=_3mxS?Kc)?CiUgyN#TS+%KddWoh06U zl%wx4xN|GrF@QQsUKjo$3EtX939)}<8E@ckb^OM0!mQ9Oo|^pa^p7z_ZC5Rbulw1h zJ-c@?p}d|2g)kP%+@FKxPBu)PK+8_ALg`+i_hRoiUJNxs6y6tFFRLibQC@Nh}_ z+t|8m^hD8s%+UPPj#aBS97W*2BoPzW<4Xzc&(~@WRq`b7o@c`EW><|4=kqloY8`XR zsXiJ_1+%bdOf0*z)ETH(%zKkAmF1@~sP0+F{XBkY2;JN(HVj~GFm3(!)<=!aiNpL- zmam#xBWiQ>Rt(J&UNP_U*RrEw|9UDbw%s09F+s)AV)ZT@V%D*{PkeP?>VR53KU(9a z(19`CHV{3o^{3^+Fa|isy z3){l}XAM5D98$?I#;s_!J0>(pWYz<;z)z0bFc1vTsuDp8qm*A$@lxVj)<{C(_;|MB z#~#qq*r8kd4ECqNjw)~mAGOdmp%hlX!IMze^DrICb=YL{d1yUhWJBv(6t;|FtHA~r z`2J8DwRO)W$}m85yOe8@YlpAvG(~@!HYos#^d9>WRx#I}*5@=#$WEDL4I{IKHJJ`g zQuhrN841Nou=1#_72eVf?X}Xme}oGfBAi!T(p*WtXm6v+pGro-4i@5{BBAmNfmzot zyS^0l`iS|1#S2)G|&4&8~!Y7W>IegE%_xEY{hWuG6(~}I~awpW`e%q1+ zUgvo*or9krf$7kx^?Te)kN^34RogTH-E`1{hTBilECG}53##7J)0p7bpKs4U->%~Q zGq!Hy*}v?Yysft-JV@uHu<<`B6)*A^l^y~I^}jtP|HrAfm#Mdl#h*W4_L%su=@}hY zEHz3(qccx%-!2$fqS`cjrbdY7FW!nnwSQ{+v?Wwzkuc~mm}$sk&%a*gM+agHA>kmY z@}P3^KKO5c=bG?ZH!DPSG2*}}_ke>EHUm4WMvq?G*?PNj;@bDOb8e0R^br>wxT*p% zcQf93WzkEh4b%S!m&6)ddu)bpHB*_2q2fdr@NMh*Llaok9<{6Xv`t5LbvB9%ypvG; z(Cq%gcfc>GQj$Gpu$>9Ndycc&ph+4|<1yU!bcZsConId&kmfV{c)9&9A9>tph7y&{ zwF{xoBflV6w4*iG1ydZKuZ5QzHnhsC7N;F;F@K60P_f>4EgQ&u#j#zoku3g0OgyXG zLibqDd>NOWaYiAzV&|(|v!|OtzCL;RXn*sjBW83$5xHft=8Pta_s8z=0AZI6NL($1tA;9AGZ|?yj!=xsryV<2g5qMYg)rOJl`Go)IgnP4#9l z2ij;WAFi9z*X-0-fBS$pW@{_pJRL59py4iOVmg*O9)85<2lk9K*8Nfo`sFGP17p%3 zk0xSVs$?m-G_H;b4ky`K^dt1**=*rEFMod~sLFmSum#k$Z^R424T|!Q!4c0tJp80y+w`VX0bd?QYnWO+3km}D#0?0z8i zjes3(Yr8e1yt*>pXOCrTYm4d0enxAjdy>|7Q}muBImDY?L*UF?!HhKl0%3JN#`h@y zuuWSgY1yK}JjTa&=UoB;$MH|q>XN*J-MQxH8uB%F3Cp*^{-8$`+C%qk=#y>PHN)fs zi=gh3ZHFKs7jk!fVIho|^xHK8oPTqz@Ggvmms8;!+L-1j(V9$enSz($x8{2K99Ll( zW99o#$;+Zm8N>NBRmpHKHF_u~Fk3LY-l6IIkHW;h`a&qxZ7%j4K2@mS@+&XrsyA=f zMgti>^i_&X`KwMTsvCIBo)A+=^k46{BP6&AeyX{llFx(sGvz5LnX|Vkw4mC}z+C_F zuu?-^)z~Btvq6Hkr)rOBa89WOk%5ul91qK3jJK3oxn~)6FYIJYS-)jp8c_ruLwaO@ zK4Nt!1%Pn$0~MPJ`x?TJywDBjNQntHX;RfB2-B?xET=}z*OOTXL0_wj<6lU{ol`W&C2xhb~x5ZDU6=V zn!6@U4T*Q}RvJ$lb9qItjd?4Va^1~V3W;5ZuW!AUrh^ccaR7q~_=tY+4&a~n)>+np zm0N&Zp6%zu5H@_z-@=wM1gmIpdv*)kixl7e(v zCgXw#W@;1akg4Ms%V_@{_JJ3egwD*&0I-^-yYuE5M2BE9RHt=E`ES-m#^|E3vt04Z zVt6-Q<9qY=JLrEvQ3ZNLwl!-4|1Ob=vWc z1-h&tt6F2Og@^2;vKZ%`tgh<5Z;KrJAt_Iwn2wQmbm9Xhx`LP&1}hU2v9v>UJceZ! z@;4z48Y~I6sC-$o)4m+9(MJ$a))8dctVd{Ug5#7(4Ftv!vl6B+(Z$q?k9*&ZQB5$? z!KLU1zl3XXLbJxC(b3%<>$JYM_Sf@hU;w7czeR_3*hnE04*VluU>}cJc207p>-h79 zY+(S+vtsLA(Y&MHjvEVZV8hK5CL?4xt&zNSH-xws4KUcT^@aSQ*e!NKaD~Y8IiKsg z`*3?1!0+SS=l|;vI`qT0q20aW42btJdu7>JUIqR-72V`@-o?Ac;fiDq*5oJb1q_hDkZ1dLGJ81o*BV{`_r5y4L0Iv zz)7M1Q4%uEo5Xp*qDVnO;XjG{@y6ooMCx}i?KoYLX6uoA7kKG+L()c)D8IAyqqop8hZE-f?S;pSK)?Mp zYQvB~xshjoRNKd}03F)&jjF?ZKV{I}3|GyW2nG0uN9!|L2d*2`?MXK>WaZKIa20l{X zA;0MHGCwxb2+CYTDUUTpo4S?hJyiI-#~0{{`|mqt@L0|fUf1h^0o~uEe%5dE!sdCg zQnwruJLI>Hu>GTVY)5`6IwOz;IbyX}HowVvZDQ|#BR9Ne5pUfnlBmm>huvq<_iMNEy2crP;LjwdAg?$zRpLw+6GiI6(y8g!*#u-Oma zs{9MV#q7xwCDM;%HAd5CHPfG)`u@%oDG`Qx>)smX`>PovKSQ~!p#?J| z2$PDG()Cza>eVYC&njGxDEFM2WiWd&1|U*wHOP*51})&2LTm5FjT?(C057X@64;J* z4GxVP&=7BJk%*_I4oeNYmcLiz5a;*-OIOBhNA!(7TRQfa)Q{1dJ`*3fR-V(U%#Ky9 z{Q)iXH%~V=@opDoBalnXSEF*OLNToW6n+Znt@1!Qku@lab^cT=%F1DZzb}_ zn*zcA>UInhr;ouzMNN(hl__8%?w4!QYg9p@!*HQYa z`pv6%H95n_uOZL>`QENaI!g085zfZ?2jEQzo>P3c8SC$IO1K1gMd){G{Yo-Qh38;^ zAn1Nzz}DQ}b;<{+Bs0+FL^AQiF%>%A`(|I>!yI_SG^^EnEN2I?*MCOPG~=FV2P&IA zUK@W2`8y{ZrV85;u>#Z?<|$Opc!{)+YBxu6kSt?x6a7xvy{uOD1GD2vB)KN7WxR%n zGsi+tJ}NU~V{kpRg71JM4e{#0scMT|eRCSYx3_Q&55M zvn=DS%ttHHC7CWP9=^54q5gek+!3hl(i5jw>NPhO8+WFkY!IMk*H_GpfX9#C*P>L& zpi?32$PTUbvLWf3vBO_8H5SiK{44e~{`+FQ{f zI_uj;*a5UM&HeHw27v$wKt<1 zA%aOnZKX|Ko}(?Fqk{QLPG`}bp{paWPz3Ip!b(Dv<~uwA%Y52?UhG;&=0tVyt3j1f5ih_CwY+&xl7U{i3kgTwdPBABf_k<1Ajw?M-7r zHPFF`5h~ys6w$$GEhe_7M?pI4i+ zmL&F*jDaDar5Mo%a+{Rv&2Wjw9WYs0@)(%_Ig}4N3pg(wZ(wu{#R29NpG64zN1@CO z5>H7D&f2TzFOC`Rb;-Uu9jdH;nH$zFXHdtEj2fITsgq8eQ}dP-8!j-V{zsA;p&A~) zgX>=wU6v?;UcjRvsGs}Xq*tB<$hVYoM;ZyOl4=F;I&YMun z+Fjet$SE_j_Kn%JE$bLZrFp3K*+V*YPBiIoJH3n2wQND$UPnGs|rgE2c&BcPx zk039!r`oX_c_QEM0T#YwJat5NuZMk(-)@q)nj^7;2PqaM{hQx5A1{GZ7fISmSFWIK zqKo<@P%~O{Gq|c+9es45q$IJ633scXu3oOJrh_kyNna|D!r7p$C!IL}WhiL|ys7H>D4T-OAXU%f<#%6} z^YUP1KMP68nz|_kED?dS@%J$HqEc5RQLkc{O>&mKw}gYW#sdo*GVLLIY7XDrLT`J5 z9xoD1*1HunnECu(-dP-oygcj1Z!~GIDjNm{lSjRuH}d3M2$wUy-()u*%k@N_`C!~i zNg#-^=(jh3^)Oy;6LW9B|6Vr0qF2lb#~MhVCO`Dhl*F6S0|}6x@~ZxerX!Jyi_5z% zITB&AvThs4}md!kki@^vHkk>8MJ@CY43#4 zMnV;AKkvr6e*fCF+fYOUMkvSxmpz&a%K*yrE&>$m2E2q+2|&LnwhP!#4ylYi@wLxU(bTc@113T6R;c zHcqWS1O;NXAP`2_dHp*pM4zEJMKqIhi|EwUD*U!9W+N9SM@8HGj(NUr)x;O?pmaR? zv}X^yZwd3>OadSRUuO1Z2nBD04eE94$GLut#Qx06J-#%>fUoRrm_L2;d&78*4%jIs zkl01X5{0RKqK_UhcK_v6ACbcH;bIca^E%(%_dIqsLYIv&t!;A^W~K{yxdNjI-t0Qx zzd1Xx2qSJ^?Ae@-RB&gJ@&ufWYOP07(73F-vnJBmO3w8;FdP~;R=WLr$rOAxq6+Fa z=>5p8dSAii%HTq~lGQrifRBFZbq%_xA0^npiLgs3&SI7%_TdlM@^N@LOo)~O%Jefc z`xYIZcTIvlvy#Z%olbbAQ9;(h~j3Rpj3!+TV!eWzvd1-RzYjF@X5<909WS-e8h*zZIm9NVI$|&o8^E zPot%?d04y{(bM(n`=n<}=txFRBxa6)>T}>!W+R_F)Qe`JfxY*3esa%I?%2CC@uR8Pt<*a=ksvj!_vj(qDHe&i+Lg z0zv@>V)+OLE68Kx)4Dt3o=-zzE#I0#>4#tHpX5d{9M-!bNb}zGtr{J>#=Qj87c2xc zJ*!@KI-XSd<++B7u2EiWB|=e;LMWk>nT}fhpxmEK@U=zYR46+*dElUXpfYnziU zR;x(;W*$C&q^{AdLHFYK{(*qqb01Z>QLs2~oL9i7xoz1cqjGw6vjm#8Guk{9xtEi07$J!N+O%SBS%Hj(5z7|a9a(|j9!EIP8c5HJPmVyad&bez4P&U0hMQ1GLOBT-6KVf zr<{A1Z2NGME~MAxMLJH)wo&CT-jbbq3bs7sEl)+!`dW=@XN@4F^&;XSWgm4{-+m1f zJx^qPPRuHr-D$Z74y4S8h-7IhXPFFY&W$%(5-L*huYa|Q0_*c8Sdv3@#$x$RY*+>* zYA|4CbHsiZ7#np@?#vepEk0}eUt9Ja5DONQh9C)0e9r$ZS5wpR=Vl#;mQVw)UL?Y< z9J*HX+(qgLB0%JfHT6d6fOzQEM0kLCfk%^15JgQ>LTzbjNve53sGAjgpT3Faqf}^`SgoSynB!eM z*!BxHaD!SN{O-UV{0cTmPr6yoL>D{gjSa=N=+ydfBM#_s@HFrd5p746w&nRnwMDl6;g`y>a3)EHtdKEt)OQ$m zGN)T+@*+c2OQ=2NMIT=Ywa+RYOrxk*75W&%kk%9vsrzKbd(pU@(>I|Oe^sbxoI1{~^*{n7PfEnmF#5H_6q4C0*~O&=<{@QLQEI z*G7-ovCxRks2w&o{AlKFuw^D>%TCxX~3A6#hP&4DSkNLD$zk7meKR1_uWNE@g2s zc~wdULPw!lQ%8F{M9lD)&z$L=mD1bJ!v&Wq^@U14qAQIDaxny>=IQkaR$)|KDp6Z+ zfI=6*iCeOI%pNsG@?0S9p$Nt?y7#g^WjxkPdkmN5wc2R6gSiY6ufRoSSvKD%ePz+x z(F~kvo}R<4;wbl_Z_Pbv>LBe|*Xdv()If|uh8 z5-dd?`%(C$OH-Fmm4<|;3O+bvt;J4fr^<|PN1b{6D({1~;7i{kc_8G;$;sK8vgFp2 zpJC(Jy&bWDmdsVty4|us$-k(wzAM}E`YmZZGp}lgqc3pRv=9F;U!!0l>V5_Kxy$+l-F{8t4 z6iJ6`30X$R^Q*PrepX%v3wn2EWsV0&Ym`D+_KL_;rPQ9Y-Bk8z4~bTDr&Aaz3M>+E zo=`khh$P}+^on-GS4Uf zH+H%1;TP0M(+ExuJE~6+A`8?p6-UlBV{A9)>)(0M5@otbo3(iLq=|4tLO%c@sYUd| zl{~Uh6uTnijv8w;m_E_jif*;3@t$~kdymGo zsAm{)cl`RA$7D{Y`vUc3mdNWe+G^a@fz1CdwEvXZbU%WZNzpRvX?a+Q{y(3qG*HY%i3mA4f7 zo=#Q_V|UdP{E?Z{-y>3y4GB2}cnH0={OG*=C!WGAyHuQ7^F3`1yMH4^Uasx0FSH@! zS)WbR@NEdC6h&Z8(cnRMA(()QFN`0ZYZE<@_eV42jvvM|vd4!uK(WmI^s&xNaLYU+^t`y$b#cUXtm&7kFQ&uzOhk7V@Fvb0`MA z+~8ipRQe(k+mCqQ=YR;CXH>-tTG{G-Pgx7I1mP494%%x}1O=5Z&RX_;r||M`jg>t+s2qWn z=~cmSs=ky~g)=Z2h_Nf^(2sj}`Muiv?8;C_+mQikcvM7&tz(~N4Yn*92YK4eFFy?< z9d<#kYmh>fC7z$1NlVlP5u!2ge>(i3W$r+{zMsKRegl4J@ZUJlZn4DjFhF|;Uns?w zp5&3J>PPf0gVt%5K(#BBSUI2DeQyI2Ws>vm2CRb;5gp!v>V~mypALwM(6?O}^a!$l zCO0Qp)~MmZkb};)lA`(`*47_7jzh|Gie{HA^3~0al5lM<=Rj;aJ2wd$5{|7ys?xoB z-v`<9UESa#nl%?@k0Q-O>0U&=Y(=CpU&X1v%h)W&%J4`TrvmkNAi*f}NQUc41CB|t z&m z6^AF0@ht-rLRXtw@9r(BPrBzBM5^ZLY5LTgDvW(w2^1k`Z(7xJX>OAzr>9``F;)Hq zlh%J_MS!SS9oS&$anC=RGqxVTeKNnxRyJC+j(bhIMtM49DIva5!xePRKQ>}K?|Wiq_-&p% z8o=zmeEs+Q_9*mbF``w0hmVgB3Za;y@qjgG)f+Z3#Axpaz#Ty|5F_WL7*;5=!W-e2 zI>0R8$7Q*ZLwucsnLSgHfZW>ZaZD>%Z~Fz;AsaG8neC9uMvt_+7IdX52MPK1bY~;& z@cX08awXUKMQUG9p zhPyJ+U0+=_EYJAmY(lHUmy*~UqEuUuW1}Xb!+Dy&=&2&%M1~btcjhW?)oV&qAy^kY za;}+|r-lky$lqac%bWi$loQ5?5%Hc}LM8Qcc6N4mr#h%amW}R*hyc*nd!Xx(V^NJB zXeDMX&`F*ltbR`Op*9O`9Z*-Z=WP$XXq8_i^*;Z3#Qi`=H>5md-NO5LH|3$H-_qdU zmscBN3npQD6GugetDkl7*~7-E!qIHPh?aiMuG$~8_S5~sFWxhyyw2C0*w)Q#kuod|`>DiO={d;}0eduPbYZzgPr3U(Y{<>J?YH}M@P74C*z{*W* z*m-{WHkb83q)p7CKaMCA5=u}Y`rNDa$iDwIez-@}7xG+pl}bhFXPu#J?@l2sKO+6v z6v$n+yvm=tUXr-85303fC=vKI#$dy6$B$HSmipim4iF=VP$pqNkQSoea=n!c+rQ)^ z5=SjZ$q>KAO~dANw8v{yv?lyi6uyn`exW=9H}Sj3|NnV@!RT;IVAW4t60W;V7)Wn4t0S zdPKaY$mAFZ7-#QEF6$5^spl}pjugC^hlH4PjVsD(hu!j!DSB&lx3>pSZdf0m17ptC zka%DKeO#Vk*oQA}#fHjNc6}g{NN@{Q4eXhg@bM@Cdzm0NH&_|8Bf-SR5#$jzbi_1+ zB(;Ap90jbb5LOFE=x<^QP80n>G z|E6GtJwc9U1xR+Ao8c;*T%`j#E^*He zgzwcXr}TC#!1~!dYea3M(Mc((qQBDNWtN`_9YyF>5Lb7VF|$!Hiyb4zDkAx(e+HW= z<0L!nMRABBDq*4_FIfL>u*!3tBa|(fUdNiL(Cv+9E9vRZm9vLmL6Wf@ zctvJiL74gsTXN;5uikPWbi^O9*o-^+hz5g5D=-piJ{RbZ2&06D#!x)#7$OxS@1sHJ zRfZ+r4`8}`EDkK;Q3%S$I)4i%X|}%kWQnM5F?cTUp_5F0r&BeefAg5L)>*JHOOP@Z zo8yi-{A;t`Cx?I3Nx%K(t=6=g!tat_`SYP4ceZy92%JQ!S3;~8avX37@jU(+4_D^H ztLM$u@V=M9u(V87xzB`Xz?BXJ$h?K^G46xy-VlXnt5W9oG5;_Cai+d7t}FsFu%$r zVNbKZtN*)vll8Fs*lTht`RQ#zaFNf7k(46aUqP&8z_F>9O`r~iCErr(?d0D}8TASH z20Xm%#Uhi$L`0x@d%F>OQ-!q~`~~7_`8&pyI7c*LvayVWLvn0Gsr3LQ3RXIiOVJw- zJ+mH1R8Oc;Nzz(l(m#EJu!ssOv^Z6FnX)mwAHn@aDQTDL%N*;iQ{wgFt)a`L%2<9X zBqUUaXJ-mfB0$)?yma*NNOz~v+JAb=vRfN)3Wsb3s2n{z8bK!>Jqp>#YC)VV-qDU`re*A)s`5U!0e(x|!MewO=U^*fuj|sl3 zXm9;`A(wh1xw*e)0{G?Mds;5NAzsj?5XRTOAH9;?3fH^A@LS~^Qc4VtJE`}DgKj)K zdMD37Wu%)(l`-Yv6)oPwCQYyziS=s|CXLE8KG_4|n^fYZk_IE0srLp83uBX;NkCu* z1mf6~Q5nDC;K^zs#&S|oX)D{Y7P zw&iM`{N{0F3 z|K|lL7gg<(?TIm57CgI+*yKtx_p3F~&IM$*q2%FU;`}70r`3LA(Y4@NnLy#7!z+x0 z3gYiH55sGPM!%eCLw;{v7Je5ewNl}-GD_Of_vAn%nVBom*u>4wErR26wTkQj~OGD6dP@MnGTI2w1>o7voOlF|Dr0RBKmPStde0_O2T~qmF6xo6%l~NZennu3{u%I%yL_KD zvb4w6=}s2>n-t=3ZvO+&dV9k=OPVam!t{KGKrph!Rab=J%jKV8hWuN**FS;6j+jJC zZ_e|N*^A5gzFwi~Mnr1i^>c4;{$8=a^bzw}8VIlfbuB z(oz>!98@kJe%f}$sAO5PG*t%7A&6pRO1o;vc)PQB=-u#+|CSZ{wuNQr-orHE>Km(a z0+v9v~Eb_JZM42 zMV)uQ72oFJ9AXq9#y>ERe3_&e_6;i4eS;c|ZnHMaT0rsllI*xbljR|%|-yE3I zHc*vq2ZNEY=9g^N!Nb*zG@MYEc7dmZpDnGmsh57yh2$>8$LIF3=H?)Eo0L)>a*$gT zji{)!pRaQC6Z<-R&+@H2gNcM15wE5T#4n0(Ui?a;Du0!^1V;O<>y;kbrl}2#nGU<^ zGWM?}qRiycc0N|xC;Fbh+aRm0p9VX4zva-_+4oVY=Ob5*aGwUnmnrhCT)zUVN9@OI zHpUbT>Wz)VF19mE&4nDQC>VF|8LuvU*|jokDNP?UplLRKPO;2uMyhHwb-UlhDclac zco!cve^A4;lR8vyq|O|0@E^zT5C=n+M1%>xfnYQXe3VZ_u=GytyMfN70j#jyK6PKz z3PcV^A?E?Uu_ucz$>#t!v!65FfMeE*HZjE7wL^uNe#M$*Mo&TAl;^17OPS3$(#OtN z0(z!xHm1s^03-~XvAUlen_7%M8WU5<#{?eBXpg)ucVu5pqI)}*GVe8hRP@AUsZo;P;TV+l_act(?nZuaYa!_LjK03Dty?+hw#MAWbJ&lE8HB*E42+Fh^b7qaPS>kzw_R;I z$8f2{NdV%r{XZTj>z$j?8G1okuhXMSJRhEM;t3@iGPySA39*EbQxlvEH~=-t*G3?k2)9CGP$uMc0o zroG#PSFcpAwy_|b-<@Xl{J=-1i3?S;Py691#a##12) zdzgQW!^EawRo38ZQozD|(%ysdbF2M6Kk9p@XDqx~UF>(>_vmBy(}uW}$XnN#Q_BnM zpxgUfz555IhoZ{I?V?S;Nq2LvNh8x7!->KC;1?!-!(a85kPr+P`*_S?_yA7^#SMwu z2~vi=a{Zm|e-)nDGlJTI01+~1mPwOvg6UMG|3|LobE&8j%#zV5{E^3DzZwmsDo`Wz z5hRSh2i48BSw%H})=4}+C8McMQ=RG~Ymzz)P*dtqymU(YT?59mUcSC(_1ir?!fmzA zlqGAb#kizvUcgA6G*uEOCmKCLFB8#e6ds%^i?+7B44K-8niQ4M-^y)wg1V>ih$%FFzWjG`Mqww z{o4eRRGH}NcKulIPEzBnQ!*>eOcIAmlWOG`$1Dz~f3{=V)I4_B2{d4>D*kPQuDsFT1CPeIUR2(g&}%*Ngvj%) z(35)*P6z=d|D70|ha8bHNhVYt6E59KxKxnkrY&|3&FF7tzVrak>zyms0|Tymof{YL zpzFEW1;oI{o*P*->n1~lf0Dnw5J#XEi``y4b;U{VKOnIszw$}f96vZY(gVi)Zc2|mNsj5wT;X(toj?-|-s zFi`H_@s1b=iCvDz{6J4tGY)FrUo? zmzsWSj5i0(J(N)z+}4Z)@{^}5Sso$#-Mk>z%vCr0BPdKiG@<&&BO_to%yEn7X5WFi zIkKWRpGJWy@d^YV&{27Ldt0D6wP|lvBt6d__eeS9@+08=Z}wwFyW==KP8&x|tRuOd z&YM(|z`OUTPWtnEECa7_Y3Ck1l^sKVa#fM%Mexyz+_x7V=@B+d!psCY@+-8w>E!-YE}kfulSa}h2 za@a)pKaV+6-k{M;>ld!^?O1bZ^f-w?b+czXT*XlvR0L$DMlh z-MrOpstrS@>4NJcGp7s<^9Tbiu&NGp5LW1F(5GE&j_$hW{S~=i3HHot{>-ZIw5Rt!emr$O3zrYia*3g>^YTQ>2~uDHN*cPex@)`v{80UR_w!Ib ztgro;eVAuLbgrG^$u*X5mQ74jfB4}p;Tg3+d@#3k=Gzq*IYfPqEhveSL`9YCSIH{( zmVaikSq@Qael3q$hAT)hGhj@p>rsH6CjDESdA?$S$wb>?k*E?H>IRJ(DJE!Z|6N`J7~4jr%m@1SY0`yX6m~y9&xIji z6!TTpgT1Wv(bgrg#9#4g)q%c9<|_yPo54|+`B_Zi-}PzxD`T>{$I*kA<{4H)Ebu`B zNc(>%oH5wXSvz2;MH%QsYTYBKXPff@TOqT6;^_bay%43EACHg%1#XRNE~4mEwpX`> z;1*M3XuJ6Rv0vI}V|hKE{fIF*N;ZcKXrJ3TJ&weLJ%Y=e7-ufHazN5aK9^3ZhFSd$ z%i|A;T@rMl^5~JuSh`jn9UWam&StY`0uv*lL~3q>)S!-G94?@=7aO&qvv~S~$o$tB z%adk8)9Lmj4&K;T{Af;X8*T43z9sV(=n3l{*YUdH{zoqdL+y%mt9Q3{4quC=nZKTo z*pPV1=VsL^#W&R-Hp3+O&wiu0-+)Cl7-Ca@u4Zk}oF=;7?icA>KpnXykql`{Ji@a3 z(jpwXy|%G|UUoK#p3Wnxf9UJuBR59P}V>G^`OD z?tsX#W$kT(x*!Hop)-mrpHS3oyZ~FG$2G#q=*=hSCjCRYint3bwK72l5tyjbOLhFI zm6EZ-Z=4mFK^Sk;M~5iQN^|WR4{_QIwiO>It&QCmS0C%IgZdQLbqTi{J|uNUKNfUj zlRQ~nflClP6wWR;`v_H7!l&>W)-I=%uhRq9FTr-l?^2gqPV%iGtCPhJAfB1EnFUgB z1Su+zP2n-KJ!KiVQoWq7psNEQQn66^+}=A_cTK#@)*bv9UC*oHri1oPGRXRN*<5#3 z))ltiDNa|Lbm(!|%D2E`rvH{5Dnc%d3ba!<%Uy*Okc3_QD}@RnXm^0{ z=$P#z66tdJtR)8-Er~z_<-H+Avh=Bnq2bIMtH$@87?`?P)75-R($+486GS zc5Q2Y?bNC+h$8MZOm!Oyb*x{@{8ihRFQ2~ir0;kf-h4Y;q}~AsCU$W^2a&?sMTZeD zQ^>}8=DNzpzHo}XN^sGpl^iRG2N7^x4)NfY6v!;Fw8Zm>~uLy4BFohB?AF^RP2LkOmseJ3QCHQf*6WF<+?}+PHsU# zq=n-3k4${$!K!HxJfUozb`P&(n`{~^GOYIj1jQ`7-LtqE(n;>(iR*j|naog5!- zGw`YaV?DosK+Aiec`s;k^g@fd2yhI;;OEcQ`u&#S6?mWRinI4= zT&iuQKeX&u?md3zgvKqF2I}QE-WaaN)d31to6uICpP_~Tjs(`DSaJ#tK*Mbgnm#J( zYF9xbrZXlrW1PHTb{PR`WX{n-%|hAO@19)mx&ZB#1El}q=_{kE>e_YzX%Ok|?glAA zknZm82I-dW?rsU`*o1UTgM^ewH%LqK&F3BCod1lmfxXt8_kE=O-&^}~nKlvPZUKGGcC z-|+k@ zk5gq6EqImoj)!;w%xKo{O@v^YZcvgC?0Y8glL(Fi1C|cYk>WFVpn6x2Na6 zN$9-%P;2{aQPS^bP|jN3p4U!!0K{eikEg9?N{nWzlUwUi2@h#H1yd-M_an$JM*qc`sL>-o9sBXNW#5?|MR<7js4+X0hQ-ZT%XS{k}* z3dq_5tzy(y)DYW?9?Q-8ydtpAINC{N>-sCA0OiwyYBq-ASg6)5dE@LjctZt=6|$~~ z3yZIl+0uvYMG(3q_fD+;e97D?6#4MMqJ=$jkJhL16a*7=q{YEPOMdQX$2M7tcHIqc zEb&FXo&OsOd7K!sX}2HPZ3TemkoLK}Tff@hc!JC%q$4mBVHX(zJ3r|5>v?&wBkWMw zwgkK8^@plPy)v#*wLP;~Hay(;wU3zqF8L<5uQ-&*Iep)I zm?*?Rq#}uRtYn!L^sx_r1fCgA)2A?Uabwu80F?DT@1*rlz&5Ex1ebNxEpaxATyHP1_irE}I?-pFNh)TF4tG`FiTIB=d zw731e=fu>_4G+S@e;Sbee}BFJhH!s0Y$tiAuwbGcY&9upt6<9n=|N<|elx;1@gxVD z+Gi)&`jKD5k$(&D@dZu;H7E$&wE}eA{XW1slwtFzB%$!p$TSW(n)i(RV zP_n8|5r>Z4dja!@hlgf&c4F>8)u(@pk;sRQ3r5(=TJH`U*RI2swEqH1d<;SS3P3`= zy7cMDI?)VRnOuKYKqy3&ve6@gcV)GYt&fZ)&y-X+^J?x~NA@$G4pt%t(!TVgpT{A( zJZm|q_X`PmbDse)H{@u2oZ}0_rh@B}eLqZSe7XLL{{Q6fm6`YfMQagkhJ>BNI`CAWtV4 zgtAg(Ig8Da7lL<6khxCOb+(1r{BkJbXZ1e@*!|Tp{RS9DXc;SIiVX3ag-wzx^pt%M z3WYMZb*RtZyr?SdZ57p1&B?wg8~~;RM3n#9#71y^4g3*<35Dx;822375V;ASEY|1M zKYv671d4kUBqW+PvzkWHQ)@EfNfqDC59YYY@qP7##M3pT23WRRn=dFEar5xM+usJm z8W_ud71Nee>o~I7+uKd90h7b)?W$8st~pRvw6*p0l86))K<=JW7qW(9+yQ(w+VWbx0ZoIf$k=DO?a!om-6V5(5gtx_A_Dnyrtp>cP5Ujg;Ym(Z_rXEA5|jAvB+-}WuU6$tV14dsc6P#8hV9L1&Zp?00^#yQx(hos0zClrYS z4tGiiD3dK4bQ)V*{{hdwu)~2vCK9vKPqXnI_CEG*Uf>50`RVa+|JKlL&Eg(n2|u(2_PjGV({9uyCm4=WlRewuyVs8B_Vg| zvS{aA-Rn|7Hd>p6qvl=>6?&6RElnu$6x4z~vt56^7>2ZzMO-Z~Bdjx9v)g9XUgzk^hctkfx^*u}MJ8ZA`!tszdo zEq$2AdGQza`IM*4{tfP+iLg+QNWri`-OJI7u{tk}`Bd{n_xC}2x{=q*r;5b@lppsF z+i&OZHyIBnoUA5a<;JR@q)@BsdQsol|H6f@#prqbLzs7;ofz?IV~-`~CMB#4lboEL zO&>k@`8O$H<7z=|ZS8->cw?FI$)EW`3g@1%514W~V+$OO8c5&9X9-8q9jpg3pBcx`o19L(svAg~qrx&Z2t+jU0iV#Y`-aYVR)AuZ zpC44`%GnISR_M&_phOJ$m$FAG7#~gd-SQ6vCLG?~wP9sc7Kt_S&rHAEJwE^YGxVz& zp&ryHr6;!_9PG}|tkogjfGe1?C^6btua7y^K8sk*Hfzl}266XvHv{kHilnJ)XP!Hm8?Ujj;$k6_aoXH@ddj6yqeN`WLl$`dY&y#$fSvD2)SN{y znJp7K3M${C%HQ+y0$;!3gb#K%0UE~K*1FT2I0aVsPW0tPtc%k>fbO`B!y|bdMF(O7Q zC9A4Mx$|4k?Uk^1JNuB2SWR%cQHdRIBEm0<;1X!5A9JkJ{fzoTHGei{R3jbaJVh+Us=` zap4^dq^^jO*Z$}qarxg2{r_A56z6P4R&$(r>1xs(8p6VP(My0qfP3!y8N2W_)g4xL zTzu=4VdVj|OH-`3zRgT+60G=0KYQ#aK4Sg?>~P4qq&lFWINJ+IVm2ygE8u($6_%B?AeP)H+l5?lp zL@A*xmDL%>0SqTTGxu)DS^Lt0bfk^BmfnMOqUH~fP4ZVW$CC;l8mM9KIlqq{<=CK8 z#*&l~5O@NDf0z2+FJdFF&5c4$O_MWxyXwCD>wBVS(S%Q$r5=ZrA&I4CMQwD$Rij99 z8H_EcI6On5kw0_K3%&bG;Zcq;n&&x_*43z(QPLR$ypaLZwPzbWhOOm$vaDM%alU5vvE#ctg;4liY&{b1ubUuZw`XktKT#BNk0D-um zkP!D@5~4RZt>2$6rL?trHt6*MLD?=b*5|Cwe zT~B)t2NdDMFUfMd3-AiC`S4Yhu56yoE05|e`>U{nes}r=@IP4!s(1_j$%Gh$`Q1c~ zQTRE8EsrzP&Cum*Xvc&O4Ls<|kDQpM@9%f#k->kOygjYvZQy3&zPW^;9~XViu48@z zBlKIZcvqO{!m7OmQ+vA$P9hyY2>GOL6&{>8+2MPc1*22b(-ev4p=n4#GpeB%kx-N3 zr*q}J3}1aePQ9F6`nHFB>(17zl#Fo*mR|LX-`D4RSQ&MGC__@qn^*hIT}x=*ApLo* zzHIIqRRgT(o~O$g_9ZY5y?_|6cOynN+)d8_VvExDO1}kZy!wNz33>sWlxtzp%6WJt zWq%(E42#hkCa08+nkK<94m209x2-)KQsD3gLoM8)@_Tm$y=+{Sqw(g(r8ivB2vCJ% zpP}Gc>SHSKe6lE1;xImy9$Col5*7xv^GZQUj78uE^JZ|!h4{>W7BZ9Jsr%PlaM-3E zHzqAquI8eF&+{Qu_PMp^nPnt`Ip9e7vx`}pODghGl6E&{I%Zy7YKGdMxBJMupXk*< zg;r8$F86OXqwco*qrYEXAOFiGTcX?woC&T!E?Yo{y1%}rrV5>j1%IuqN5dK~ac6 z?lGnW-Ij)N9C>Ec{?inxB$5KOFO&&$XY|qh3RuV5G1`6k+ynx1DO4y1l7Fpp1F11T z;|0)wM9N~Nj1yvfP}gQcHlZ%0XR0cNerro;`56;|Sv*#js){XN_K|oopupV2RKZoP zj~QgFDL7@cJ8qpDQl}zN%R-%|TC`nPEAv|zPr-zft=6$0KS5lcAN-1_CgW49M1~r) znl6prShi#ZG#-3bDUU}NDpx)H(U~`AUc7%T@y4r6$>+x%cT-jgV$PK*yyvR(kQl`5 zH{`22MSa7}8m{XbhWe{B6HQ!ov2vyAuuPLTvx>EpzZwLtC*2BkHXa#+(tgoqA~`C0 zBiuY7qe(OZPY8|NFF{v}Cm>flLRs9L~ zaG$(1BgKMUB?UDJj(O?N@d6WaY>2~U2EqwwuNvXrDU9|~iJ9$O0sm+tS+A&wMm!X4 zQu$*wX&zHDR;9C?IVSyokludb$yRc}bS3q;IjGYU{&h(mAO z{O2UZ!9%F1LypmkDX1d05za#O7Owjol2^y)Molv<3bNJ4H55p8VW{k+oA*@4g)WIx z(|bO;Kdb^X|C{(LkB2S%wh7o-PvJVQk8^5&=&|?cO)qC~l1pB@hxEjcW{CK)+D9)j zvk$Fz8`6sy8;S%2zO6S1^SsltUH zq$Rgez+zHNy5@Oi!1ic%+UKvsO7({qVo?opyod8JQeT{%58f6gw~gn)Q@F{ZAFemI zQqC8(=M!L>D$N`XS)4W4>`=bL|2(N!KXxN@>_a!HcJRBXH_3)TSpKmaXUEUz2_8Yw z-c&!ttQ);v{n;;ZYQ}1h{)CUm!wvCUyqfnEvV_>e*D1k%Qc+ zqa9mSfTOHk(786$bL9~8C0GDDQ*Qj~E_m~I8Odq15Yn0OfrGl0fnp1c!BsId*Zi@4CQeG-*0`?$1wdmJdQ=3 zot--+8LqiT>m0U(Z=wP~Pxxo0uf1hi|9-2aSf2O89%iRY))e@RuDolq+CW#dJo@-O zY0;X(ZLL1lTL}eQW>9MS>a2FkC*hTl_Pwc-yMhLe&K!$;>Uci^a=b?*4ydEF_q#hc zapa$GB=;etSSjo?C%Mpu{H09#I<0~M72U~N5s`hMsJML9^W}9a=xnb7Si|Hl-~3p~ zb)@3rNmH-=;$iFvb3{AO-^b!NETs5~k!D~7t_GoT$BzQf+X-_(Y4^p>j;Tt!LNQwG zQ7K=(not0SHKYdXJ zA9h`bx{67(@!PKdX zu0OBc#6j%nuM%`gXki~Q!Jx02kX!7p*zmOKg%z$W`e8WDN^Sk(*f{fB=_Pm^t?K_eab!N6R=qLfOO6xh1iUR_2ip7{3mWrA zMslFow?c(2qFVMiVgz)~624PS7#y!LhakILd!@G@#haZ`s{3<(UXU-zaPhJ3o25kq`Aj66h`E32-`>7Xf7oU zrTwrr)Qx4-;{jp|;G)gF;a(k`YgUpN>BUH{rX|cJSjP&^E#*@1HZH{)F7DXo)-%)8 z{6Y!M;YQ5Md%(nrffB4?Nv`3F+$YR!Zt`oHYVX%#KM2oj=Cvm)c0S`MecKIMmQvXq z7|Gv>{*GZw4q!J_@IL3vgn=NBc`=X-u7lhZ?RLWnM31q#9L?P=!k`{nK_7c)G0* z8YS8+JM%|XNc_9}zm{F4GpDV*VLDgbokC15PPeeoHLWymSs0mxjULtPP^@$V@69RA z9jNNO?;a$xBg67A({X<*P^`Bs7f&63d2uK6$HH=F%?}N}_k&(Go#+Zny}u2U^y6Ww z{yAnEzfb1?Kc(@H(*cy}u7pxFbN2}tJfYS@*nO)6$!@*F;EJw=%%}Qc`iG`<)Y@fG zr-mUFoh^SBBCcd&EqQB~bsRW)ho%=EpmEnxU0VoDt$v9NO0x9m&tTB}{JpEqOYvVU zIe4P}1U$w`Chtjk7LBk=$%v=(G9CX{0IM2J@|^b9zM)I$7z9&n*=A^{88uGN9eR3r z$bY6j9pLZfo~;y{o#OIci;~(Y|A$T6OS$`@{HF>=sj7*_)bP!Eo{FaRgAqKJGTb9< zeMB>*_Eu;8YJnMjGaj<|pV;g3z#$G%)SZW@hpVT@h%gJ^3vs|ep8;fJO)Z%Sd# zKyap!(RiZ(4-4`!=$9sHthC{4wn`f3Zkq5VWPu48=+6aI>@?X59RP#QdXCl{qwWT* zip(jbf~e9IB^S!>Wqu?sKwCx_E+?WVOX@Y{V|&rxbmk&i{#n<+7W1E1ku2lE`6vBr zluR^d5WP7t9iY^caL>uVcb_hWFelrp(qA_rBdf8} z|D$I2F*I>V;Ni1S>-4+;v9wT!y9KV~K@XR7F|AEuLsi&;NA%jtbILm#F|Tdj$#YnA zsj}LS5MF4>p!9?+h^}5!+rQW+Mojj4iPO#fPI%4l`zlVc{TJBNG(L{cdlnTLkN^z> zu>4_|Fpm5)zy7&5!M@ED(@+!K-5=wU(L6T4kAN3GZN@Vz9qg=?#tS5FpK{5)PJRU2 znwf2%ov{vScZy`t1dPvZ7GJu2$#V3!ky^eeD}9$+h`fM02DN|d$NaUD+xAm90dp!n zlElKhuau~6`xFq_kojIbxHV^Gf-u zCL0B^y2RIFV<(hX1m?CikWP#DLdGeIVf>6SMDPd_>NmYBC@W++C% zdW?ixDTy7Ca`e00T4+{Agh*VWy{{YtfvD`>ISy`Mu8VTE6mZ58!=8cDYsRGm171-o zjhZ@4xfz`47a+eBaJvf&IBDbwCJd~rzkU(&__kC}V&6U09F^vRkU|U4ePL|@6bx0d z^`Fb-Ia# z(YfPcqL?xR&VN-a^C984RI8^;$^Pdl_~w*mzQ#a16E>Sz=y&fFLW>l5P5x3%wFvo&$;m7Bx(?2`bpRYk+mMc6Tn3V$Fm~VBq$ax7(az zBQ##!@>AHybV~#@ZlZ$LXqBl{T9&639c)aRD{oZ>QQVCD1x6*^BR!`+elnOwC0z8a z)1iQcq2i4y!o!;QhxU4G%`a2gRW;s%Nlg8_B&{msmMA;-Y#zTcsWLcaA82KIHRYFBhuD)r1R*x6HAiyQ#5g01nVDl!UJ6Ko~QdS z9|!RF?(g}H7|W-{F_bEvxll9(=5^+7C^nkMLPe&Z19#$;_190qwLfH;6Lj+TFIHQ% zo8M^US_#vpZ!%5bTi%}fFee*1g6c8}Ek!8P=0b@RCc8d5puPaALqM#${FW{JcQ{u* zfwT~L15hJuMd{QZS%4zlUJ}&FWgi*@S(&z_?FBAx?Q(@K6R9y@Y-n8ARPmGhg(s|j zJIeZmRSWW}H3+lB=$LyQ&T2cES~QNV-D6FR35_n4Qk~vj$|1wr zBwPWBZ#);WMPvaYeNisre|GCY=&E-to5o=3Rvmc))Z!?JkX{A79;}5Rt@as&CRPYs ztF|A$d$|)75Wvh#p86EmfNHa1gXluUiy@54B@A4p`~m_;i}X%*K|R~xF*-T1H#2+l zKHdK6{G7eO%)TgAqqK1UYy|k?L8vp%PKrcmh0H`#nM>ol z&|dnzJT1JAdb2*&-Vp#)0_qzyhKY|@!Uq6@!mv zg#_1B3{@H*W5K61nU7-FePbFkF+3{QT?NIlnUd-t$U=^iC^!y!!#&9LJ^Dw#lc<9QT@mc+r_c|@Adsx}Go`>+f{NG(ry9gMnO?@DTe*BtQ zJ_UqiD0yQJD9$Q~C)9FA1Sqt`Ikp$J<%gwb6%OU`P}Tm7_A{LN^n#K4YC3%FYodA`nt@5}v{u7+5IPW=N2~a}iM=Z7# z1S3Y$r{ir5`0&Xq%bUse&TLaJPP#BAgORaey6_NtQ*y$~X(2q&6HznHKez1?J%%d3 zTiZgf&d;lbRp!`l%lnL+qO{?%eS9v~E5GZf`1-8|uH`Ml2MaJXeFh^@uWL!5c8kvx z407{9J@K`(DIaCO^=nyWrtG9;LEBHPB7BW8+()doRaEFtSkoCWy?q* zgC2GMQT|%weQy&YcN>pyXsPd_!*u`3xP#ch#ar-uP43$2#*B0#=$#U5_?2!;pP9KR=;X@AIX-_Z%3B{IT^H z`AX03&{txy-Mz0`G*k9}BG~-8b-jgU6j?U1+zsjfd1wDaNqgs9Y*hTh-;!bx7gjkp_(JPb1 z?5+I0Gx%%}KYd>+^M$=2WqccNzE3$usGFCUjU6;$b_a--^~;WjP$n2qz{b*`S~$O; z27D>I7bO#OGU!+HJ6E(B;uRYFRAIjO1w|U)d5xW%-a&^I{cKrS z#iPCkav%+KcD>(fR5K!EPsLp@&lR@a$d@Zjc5~E3{H(m|& zwx?nJ#Z;EMuXDbT!jkV*^%X5G9Z2UWI6um+(Tx^nVFH);il+c*-C=z8N%e+@O!!yf zJ_`A9MQh!ODP#rK9r{h@?g#Bo|L5tRgA#;e-8)?DTOZ~5`8`HfpN`uFri|n9-e%Oj zgT?rZFb{6ku=)#q!F=$Gw5l8tTY4d`=!ifq;y!qst_}@A>RFD2{$1_HYyPPv=_ht4 zVJXygU@W~ET@mQ=R~*d;Lf2r)^WD(5$|zExZQujQS_JZ6{z`zpjc4ja{sALwi};l6 z1GJK(Hy4ARd5?kJicmRwp73*c@}z|%PNHD4Vu7i7rpzCgU!X-7M019sZ|Qf&rec?J zKEq?GZm8a=CRi8n-(8j_u2r_UzekC$or_i#xTmQMpL6HLVWTs&ai1u<RQKC6 zIk5um@OQMOrt{Sg_W2dSJX$- zLOC-oWLhS;+A#cR+HN;FA^CJ+7bhc|M})2zMZ*>7kc1)cOk||MrR%)@iz0 z3>tkk8^0>Ld=lBLJ6RRhX9`@@JR9(-TVZCt4!S>TzZ84tUAxkAeLo(eyXv0Xxf?EB ztl{Vr4E20<*t*RW1%0upXWT5nUh%@#D^1Fh|A-`HSgKmE9mgW6qmz&I;VrCP%}VP0 zL%*3G)yn(x!~LQGZ5~OR$veW&} zN%z3pIA!IVFsI5@(10 zn%HXve$u;f3VeBCy1?sM1GDp+=TL&gB%D635Q8M)FaJTv@Dd4XXmY(u zGRqNfDGN6|T#4SdbnKgRuB0YYV?4M@fVi zo~6%Jt5PCk`kx0Yl-ZWyCyE&dF$G2>uUwqbI?0~nSYGQTH{NIma!Lko^HI-m78ld2 z+E|~aUBg5ElNxfB*g2Vv2g|LYwe#)S>H=<=sj^ztf=^iNuK=E7b=nKO+S_$jtJMnK2ME~G_CQg0Ub@(i_(Q! zHQpnAa)*9!l!48Nf+u4Fw|euOA?P1a#dzE2;*9OP`}z5Sm@$92tuEd@t z9e1k(Ke;YGVPV|SgBh?b8HIIlj>o8`*7T z*gc4Yq8}_t$>C&QX&HT1h?<^(VV{uGr(fy`QkSk_(>EBO?Ri3-H?qx*!X+Mr^!bgI zr|5}`g~Z}ck4t`2pf9d&W#XFr4aANC0iZP~WIcoZHQXwZ|lL z-EEG+AwGRMqR~n_1ZjMcT{w z_=gh0E8#dS!_4X)SsH4fprZTpiy!9GBG2FUi~f%l10{%rdO3zTx}=;Rrm_5eeLI?( zLXO9*nWLbG)8wiWBUiGx(eb%H5qOK%}#iTtCUt60TJ^CRR@cq8%Qhj`Xb@V|ut*L)}7f-m)sy^(_oK-g^ z?Mr#!MQEGzp=7AS=<7ycFpWLe5~W138j~O&pK_o6$OC7@09|%MR86rR+F(V~i83O> zGmtExd{r%no1qZM6K0yZdgs0en*A2|l?s z#hA{A*nVh*0&=2nkGek{J~KoX1$}rAUFtgmbrYjC7h{a0sGC`YD8??+#fKvC$-`-e zk{$6mN10j7E>*)TUytqnILA6fqrf)9WffB8fj|-GNqVF|Xj;>Lvjgf2^BLaIh0_KL zhEYWEcT8DxHuZ19c?3>U#7a_AsCv3LqR1m)1Dgg!usFuf#`5%+ZB4|C_2_C}wjbom zIZF#X2rUHi#JieQxVmn@UD5-hh!l+H#8s_mQ{W;86@l-GL73 zS@+Sk5ch@Om4rp4V5nxhUk*Ksq6a&fRnm&lprn1+a9`W*G;X zXlkRREgE`hcq&AQ8$hbrU*EI&S0(-`bJ7B6aB{{7wjin9NB*d>^F- zxnb;a2&~M~YF&0(4Qvq~SFc5TC+J@hfehcT(@T-F{^qWk{u5Pi8-6Io{9pM@yEEA- zs$zY0s~+VnDiIaALd1t6 z%rT(KG<>=kacMF;i&=0S@S=GGKF2{WwA)B4&T9oam&RRtkaCHwY<^gnRl(LPLT>vv(UAT}l;pHZvmJtdla4O*((A93E)jt1b?RkTr6gVV zk>8U`Rx}5LXyS8JKJ}N+mX*=IC|$#()N85|`zEsY*ruItBeeJ92ag~HM&u)1L3n-< zQVK8Ip9J&TxP>-cp2S(6IMwz~P<&T7iib6}_2sZb7{b{LhN}W>;ScAYd^##Ry#%2v z>^r$U0=_f9?VCx?q!EaL;rJfDc$8Q*!^&WKE@FLO^uUmZ#>Ul5Gz*hbff#~mX^7(f zJ0%glJa57_{ZV|}&Pc;bC3DT?!laJY^VF3vDH2z#Q!8>!_OQs^DoZeX0|y~@?f7Z@ zzanpoGqna{ToAkJswIUi6QOZJpha2v?spX7%2nztLMH0{$xks?VGvsb*a3_@0HZIh zvrhj6a$Atldnlo5?sfx*OJ}%bq98NCqhUH)jY`_p+fqeg_x5kgl9evPnJC@#m~>TA zYRQl<2qfmDd$A^t5*vRvo|n;zh~{wEm#ly4@=swK@zxptD3{rf&@BM2+(nsZ@=pXj z(USrPA=YW=oUT++ykTi}uSw9WdSRVZFeFEst|vIW06 zq+o^kcsup)7gnE1?cV6fTrJq2AfHoF7Z8bR&fG6#8Jrvvb7f5sAc0z4#`0vnl>6 z>#mAiWoF+|c(y=pW8${|O4B5tYMSq7*sja~=V*E_7a zkliWcC&b|zk=ROBo2GPtL5GP0T(3ATK5vMf?oF=oPMaPMLRGH!&8S=1LTdlke*bnV zes=GK3(iqCc4<>6C{D38|`YvTPJNE`&=-(judAqL6*{@cgt*DD`8pm*0 z)qLYBDs-Rl>DPx>DgSHNiWs=LPGN*+>ZC6Ma3a4L=nic?UCF!iHfkIkIFjs+JAp%g z0Vb{~Oxk%CqGWhiFG-vB&)K1Qg{SgY)^m%F$BJV|U~Tjo0dMtxZpHrUon*5a%dN(-(7zZH z+=swk_}+}i@eR1V`G+&EL#4^>!^+yR6{ z4xfw;+d{cD%J?kU=MD$Xzujh$ps|zB21JvLkBs~oBQ3kbmDj?X#%a!dDbJSdyrdqo z6C+((S5$({5mK-J%75@Xe5G#{DDQ!cJBW92ULVgr2@N6Na&3ugm9LsEQRonE(me$l zK_D$gXDC05A};HB?KoWL((OC5Mt(XxzV73~LYm*hy)3P;PSkznxYgLN0zz5ePh#v) z6#U}ag78DMB7%ZgX|#DU`spMdAhjfVL&w59o>`Sh5j+`SGbz?2z&Y$rN!%M4lK)I3 zqi^P3W&9&n5-k{zR^E&(e!rt4|LSgF>Ie{-Ak9;W&|Db|Y8bEDS*I6Llc+(@a*QLV0Lhd<8aY5MS88SjeH*bqdSf z!q{`Zy5wZ0)fBdPV!U_trOuFbUIOmsjj`|-9n7w^*;hTM0WM8)Ziv~62PKh8cgRwi zRzUIFeUuY1=82B4h@JLvROze~@-bp* zMr8S`>#@C0xunXU7Jda^D8}NDt}e;t%!&1Gy3Qye#AygU^BJ?s=a-_1tmHmApndW( zOgLNJakwae9TgjFsV66|1RKxX_L?yw-a1XKmvi=%1NR4k*auwv~j|tGDFUXd!)=3PR+8W~5F&y-u)6DgqO3+2+%o+&t|KiXm@~x=o zc$+u}D$~)dJA-@HUqbyw(bQxGsW)s$4w+iMKck-H)j6{=i3-8?fxQ#JcmT%V-z-HW z)x|yQ2f+mWJkeSe@uS~6Izpf)f>0Jt#&Z|H$wPO4|2`%)jUq!l_|dOhKrKc>_TId5 z6e(USW~D4fpu^k61+!=Jfqq|}D!Nl`l=-`Mv&_judZ|^m?L6mAu6iSLwak6g3ca}t zlr*nG?l)oIGN*rWp{f}QjG@FS?@#{D)^OsF0x?`Rk8h5)TmX#Yso475HZB*rL$=82zY zi_0#OnJplf>4Yad>u=(Y{5@CcI6q}iBs?s+N!O@@x;^(|=MO>b|PyxHq5JHyt@MVh4O z;CKXtLM(=Z3V ziGc5fk8h*!_2!omAX7mOQ8NUx`)vXkV8V)XdFI_3hzNux6!R@44}*%2he zSP9N{f;OS@hxs+W6mbaG{R5jixPzzszeAv$d2wn|;da|+kyNaHLOBT>{C+z`%hCK% z)mzfdXGlKTJqc&bY3X3{7Ra%EH%Kgg>=)Aif5sT&-cLIH*xpNhm0WKJCg z6^1Kgu&4+k-65`b`=b=p4+a7nMDW80ccs5mQ}Oy5mx7;BP574NJo21#E}QcU3P6M; z@YgwkIh{tlQDG?#PA8DCTxQh=y1nT;T=p__GW#`%_V`~=@h@7nGr3~X+`^4xa35%H z0STKU@24zz=pPDd@h@SN7zuChD?MZAs-~;zbu+gtS$vJ?P0VM$QR_N*-$b?NaN0pe z7V2I+3nH1Oy_&Q+$-_F~OpY^P85A8{r1PpeS^kS|i;tR^ zHe$6yfTr^O6lv|B|JZxkC-OOp*~3>Wy&WQ-d)VL5LcrL8&dnXfY?W`6L4WJakq*9% z&lNI5nv90|8H`t|Jb11@7C54D$uSm}Qqb}@u4Wcme4Z%Kl(^3)@0ICUUyV6hR%|R~ zhy$MPz6qQcPPB$iV};x1QmjOuPiijOaKLJauA zXHsT;|A6DJQCYmw(CwXJIRMtFrI&RVhs7|FB^eP71bgKQ9}mCy38u$L1=*%SD-H#; zG_?ptSbo*x(?0lCq48&Rl$2pK75!h#9t$IGs8g*1l^cltMe+?k*cI6<{POzJwX}+q z*;JFrOQP-SMuLJS5hJD_;Fb{>4LSuOh+pFWd%+LKy$an{mAC4C)cuNb%?d=>bFYm(pt{t+8K z#6SdM$hKMV+1EonXeg*Bf{@~1!fro7;^#1ecAkv+j}d6EK!S3P1~#|UiNX6fP2O&9 zJDBSF(weFvj3>PZrx zkz#|K#~Sr}%gStI1?Zt9bJ5csHOBUloP>VE{MhULoh$&ih>BmZ%J}=5w=YvcLCHUw zzUBs?a9gVnizlUD@e!ks)&}M!1ro%vshd_t6~7_dOARZ_{(}2bJ{(h4lfX zCH*XP)*UD4*ZYix{#81PgnpbFPM^4ndPd6oq1m3RzNpqd&j) zIV<@@WvYBo2X!!cgxyt=g*sj!=H34E-F+$*1h?*Xw4f31$YP9k;NDJB^ldGRwJUUe zwurcxv>u#%2!*%Dhspn==_;eLV1hLu4I${0c@unzyOjpx#6SJia_f8q^nj>P zilh1i&|1I<(js(!b(JVdgCmprWo1RTRT>K-oCA$*hV>f@fM_#%?`D& zNdzl-)gzbD1}WQM=vfH_!vJKY36SWy-oRQ8bYJJegH>~c!)(R^rL3odeVTdI;)u*C z4x_(DE0M?%DiHohX-;0=htOEgM}mZ5UINcDe{>nkcx?ZK=Q~THH1`1zKxgC=D4@Q+ z4BhX=oPZvG=)UiZOqIWf2Q{uQ72V{Sk$I6p)Au=y7A!YQ(K02`IDAY&H3%xfIr>tT zJ%K;w5l@5id6VR1IyjFEJtVPuD#$`U2rgW1pAXp^xI`(G(ZWQ=n@xJp#}|w&H~w95 zKR_H9LB;GI9Ysb+#LLk(tZq&~Cmjb*jlV~f06m!SpI3?;cRadFAM2X;j<*ex{1^O^ z?=dqV7=U{mJ-1D{>UV7p{uFVIqay-BCF=eBJVvPF%zrBT?zh)xLh_1g)T{>UPY;z{ zfy$0GJ1^Ah+cN@W=I^)vXYk^g?uRU^cxrqL<(RaBpaZz|ZL5 zfW(=ug}7Nh>@PQq8*X%#b!r>c9hUET4uMoC#)NfU&F|AMe5WrXaZK`;lkd9j*Tx5* zIHF6A1k)c0MnTChX!lTS2_rszF`z3%767Y~HF*lBk@hJLR6K#G{WNy$KBQi8e_kD& z6ho4rUL3C4Lp8oY9&ZDA3HpI1HDOZ-u}2Uay@3KBU(VW-Q4lmgHu>@1)ou$s8D$6J zA!4ibVlx&o7HPxw+19QF`a7!clDaU_6y{b$5rgjew{zh~=m+xJmgsC*u}r<%-DO zB~nj$D>wn|=uRpX>g2f73i(NXP8Hw$vs}Z<-clh^S|*SM7E|!#MPT(bm6G_Hu(@xA znnwf}8pS@*8v*IzHWB%78U*ZFUhRvqT4>kdBB6G|o- z<)R_iye}TC{0S@;JuGeGXxjO6OH1mh@Bw_~D8wTO8ZHPm;Uok82!YDgyrL||t_QGL zehkW5QV-yR2UZyFrzP_SQc4AJf-n(d1upQJ=&EdL1M@}G;Pua)fX#drAz=u00uU@P z3cNm@R(sky3HFLiQln2IiYnF_pHZ{L6t=_}=MzxTbK4>Eib6Wag zM(4>ZdH`F(nPl>Rvi9Hon%3aEJlT$Qa(z9wagl;>h3^|#RJe|otONuGKv)cDY?gYT zbO}>GI3q5pdV3H4=tGlx94XYualOi=DMFrY2CO`Vy%?UY8<5XIvIQWVgeJ^C8ximBT2!) zFCqVzk)PPE0yk?ZW{Vvug_qaY*B}S(%N+o8P?j9Y0{y<5^#Sv-Tf}#xJt|}S1sNfW z$H)&XlI=LI!(0$NNw*7A}d;*knU_G**4~%d;9N}DqPwza9|DOwx zF%+rotv@EU#J{bTrO^1SPC~tCfZFNOJ83eJ-~<2QXlm-8~Si}|Fo6K5iGq-l}T3G}PXsSl$ryl+OuqGf(-lHy2l*nMhF#-zdsu+^|n z+(U975Mkc8*N@kA_6n=iLY999QuA@OIBFmJ({Yw_hLe$#exosq-R-_uo8QzxhSJv6 zh3y%0dI}#(<954BZl$FxB z@EJ|Mw}YRvPZ1{3{VvU2C---4b%*c!rxiKQHcwmGPwwxDXJFMbe0`8=Sl9=HNcZ*; z`V(cm2Qe>NiIU58L+|f^rfL(|{$c$GVn~SQCX*y;SLN|IevvLR9UCeS*;L*A#iNfb zljZ-jZfTVG)DQcqD6{rKzn1nuQAUA9V-7Yg&sz7Q+b?GEgvi9all~CnJ*!PPfz6pgxe%ob97LS{*yFu{ zm%1~6prF~wC<0H6Pf|yNZ@>KGT24yEL>`E-D>>ZTDsta8+#$>#p8vLJWkiNcluDb3(87Jd&ye(h&_>AZCJ>yl}pGUf@$?vNjL* z_v`Ztw9#}6POsq%=JJjgF$}=|?%V#{To17c6n0|7LBZR!G+w7-3EAd&Gr`B7+E8Xw zZh3DtX)6l*1L}&H<~BB@8FvAiM(Rs!R@WBqBUTcxG4=1h;JCP+U<}vibUh)3HCD+l z`-Y#p#2v&^uA@`e<$SICqVR*URCefQsd_sy3}g5r z-`n40Lm$8dRX^%SaQyHl5hl%zLY<>f0DcFZOy&wn5$H(Y*cw?ODu@b+s^%t^G{%LaA;@AWW)Q_cV>dW ze)WLMG#HN~7zzOf<#DR-P*B1PL$Mo8q{=NKQueWBx+xOT$1WX<8s}dFi&z!Tyl|_o zjd2ppEW%!0!2#-PM#oUz1`w!u`8-Icg4!x&%lSNIvTM!!^RX^sykfJ3FK%QDQxr4$ z0DDT9cii*$V15Fx54?|UlJ7@f$wmPLX3Q1C(zau4TiX4Q|%Zrz^ zLWC2SMPa%c9guwrO$IsyUdd?hap(RHR(aT960ZWUHl&jVh_JVq`3bqUwzlX`SUq@@ znn+VxwY*7&>5^EcIJ>!mgSpIlvZMAnygVXFcEsNbeCbF_B8*IZ=c z=ro-P%7*+Ny?IGuv}QUBkFC}5gQEC7G~a95F)tEtX4G1w#ug)Q|7eIm+SoH=SP0R& z*y|vx??Em>!T7?Z4a2LVp%*IX>i+t^Tid*At-BnJIh@+B4bfw5)Qs#D`HIC-n627(Qe> zc5H-s;exH`Gp+HvE=ebiI!IpOdEwVr8DFX!!{v;chXC{qkn+9=3IGP5=R+YQJn{%`*t z7O3%w4#+3=cXxL|5a>R#ZApYZ!m8_PLl;190FMPc18{VYW%YAT222>a=Y+V7$qIxk zhNgENv{lOJ&0c0u2nIC%_5*KOxpgf(7D>mw;={7xeCQiVcEsLyKQ!N;7uX^HE4LzT zmSq(@29OM}umS=$d$P&nc)gDwKMq@QTGphfwb6txZR+HUHm(>wryl|Qf)vea!<}!u z5csIyfOyo1L#uZ{@J2{Xyh>`GKPX{Rv|xxC{761>P|-;_zW_n~d_AVAjl{+r#Zk?s z1x)`Tg(y6ESNMNdcubj9()L0hdR~iKJL-?;P30+kfu~zOn3_WQ6R`S83To3FnFnUU zMm+@Vwy=>RUcq+IE+bTigF8Vg%_)?4qEcf;9Kx~UKW)y{+&!3SK|+hTtcU+UK;S+( zIRV`X$Tbuk3`vfxfjZ#&8hw*(23&X=jr&gU8GGXLU71h6ORGoKe1g7Z?ta<54RnJO ziW2SVFDfNUgKg)lApd>Oukt++QE%jIPp8MZc3#S<{9k=G6+-NzkkEuE3#C0&aqx5n zi;jvqyNSr;U_e4Q#4qc5W&wo161~&JT{C^+8e+06lOGznV6Td!Cj|3S?(o|oT1nKE~1uWfhl?m#=I zQlEFN|IrTie@tHP$XQ??ztMq@l{EM;ij=+#|3m39Yz!$@{#S~@U-ht7l*Xpjkv*9D zUT+P}!7tzFEA2WWFaou5AyoD4Ts~>}ZfYEjE&iev49hapo0$NJ)qiajuo4%z z1eNs@JcBIW@6ah&PV*^lGPu#Z&igRQM+f)!OT9=|1CU}EbdI*HsDG!8v=ee{W5Eqh z%A$81EXYv!Y+a+$ysuwsR_-!uacp!xGt;(b_5^0I|K4kMMP}Y~DVdmu!mW!7L1L*N z;_X;hVW!3%$X`lsQO-FS&I*DD9;sTi!GF6?y0f+QcuD<}2%I(mCWs(D^v}BQ96E2O zSoP*l*ru&&;iw1cMX;D#;vrP=)aDTu_Q|nW&+7C@^eDuFmO9Sf>(#>46w^ zrZ@Qf^*a#l91vM{fS(q{?r*A}aW$GsADl4~kNyOU8`nsy{QF^sLOj|2uCS%s$m@_2 zyo}10h-B(%XRKU$3Zn|8XRHqE-ltZ&BLj z(xnkY^hVdmG(XQ?!M2}R^_jOOqZ8hpCP9!G#h<;k3}@r)oJdf+;upH0UqNTMD~DBm zN*Ov9zJ*A~Cr|NjJ2al6;WEzG#ZzT>b93X2-;Ks5VszbM2+APcBWmT9C{+ zC{L^L)VOI+##G>1k3mGCXNEORNb9_seMcv}WhHZzq4|y^MGv{G+C)$(u?J;=Zd(2? zo%&}m13NE)hI7P-4X-#tcujNjaJ5~Y6%#h{-gp}G!U1p#9i3k*AHcxoXDzD+Az&NA z{2}ZMa9maK@4g=8K?Eku$$F8aH3&y=Gh6-fjz5;5u(zI6)+hZ(2$e;mjsz}+!8 zq1@sY8nr_`CHJfKJL~liGGf9ZRE7ZCo0Ah6+lXXgec?51ij*p`0dZD^&%faO?M9>Z2GZGf@as_wgI$fR`EQbYKuIkmf7Nt5qkls;W%i zRIpcHIdr`Sr*29`o>R2?9z#0PW$f4JzZ{{?qdcmGE(!Xu^3hDxy@3_Rl+CZqh@`&# zj)tm%Iw5vNyKw;S1N;+U0F`3}8?u(9rDoYE=v=|c8CbTac|E&)2e9caz7IT*bds;Y zM=B)=j2YlF0hJY)o-FkNY31PH;Ls54IQ)B)YXJ6&(zu>z>uDu1AcnVM2Dm7$&XQ5T zNeSv|-~gdjRw@w-Zn)_DDrwDdwtxi7(x*)cOg>6v2qAe1e$LAvs*4s|c!f&FIQZoC^I@^r`-{=6zh|ka@TcYRJU@M$oBnQ=)W^r*goY&%6YF)rQaWO4 zXy#zQ>fT!d$BS39U3;>&*C60uV^2Sj;Ena#bqfv zYao`$H|lDYV%zOJ~2Dl;p)@ef?{KgzVb`$^ec%X z^ocpC6m?x^XHFLRgX?P42e-oj1jwD_RvPuGbNxE@c`Inc+-$I<06QJx*Q+!WsJY_N zh^aCqD+kMvXLMYS4mH0YnV9@1OI2zz#Pto@)ARSJUE~N+|~mI{=9L#PRB`Zo7M<6a`xH<5QYbwiF|=J zZ*~?9PLOd)r@49dkCr84oVG&QzOym1PHZujd@9VB{P*!(S&ou3r#M$SpFjbdoJd{` zrib*e6fxr0(9pPV&elB4vDh#pXco4Gs|&UzY3yl#oM(kelM@gSfUiCcb6^9_*>vL@V;%R&~$7<+g^*a zUZ{k@@L-X%9wSZmrLpoLxpBLBJrRyRLhsnR$N3BFqO23Ms;denBcnqzWV?@J(rX}umpXC1~XmuJIg`GEsY0~hRj8srt9UNjd0ReY^ z)ERKKgyy~#m-it6``kS#YYV6EtOZOCe(+X-wz1NX9V5OHd$7T?R$v}8iHPaGGB;>{ zy1TlX{ile(wY3Ev%|BWhlL`jxDBguqwlPsqY<*8z8up`IZ&5_G^R%}a5akgN(3RK4 zgR6nSiA~H)L{c+gK+$U`t##7=cP4miY@F!rc2>ZeB11dHFMTxxZOpufB)IqYZ~CsO zPhkSdK|0geElpLze@4taf`Wd)uzqwD;S+5HU^S9rZ#aD{;R}w?!*+=JwqL{4He#e? zIh+#9(YxTqi6ReIkFEW&*vZ!y*#YGHFqT+>r6BOMc~56}P~^kO`B?5X$gPK$;1&T- zJBQDTEz`(~I9*^(whYJ(D@d8H8W>#`?{t`xnGrmax1G=lAW(%MO_x6-o$qo)tK#=P zJUy*`QxHAQVQ}(4eSPg>On}A8Yfco_k=%)Gag84Z&ZBU2Qh-O8!=4|#mLwn~^mcnZ z4-~mTa0-43KpiJKY|JJKo_%fi_(SLhR4g7k-`GvLnq;#^?P08~+2eVYp$Hr~UC@DD z^2$Q&I~HW%<#acWEVuMK2%F7vgSXcgd-V@SO`{!4*ervh{rWm>NB-&0t}zXjkeDTG zA(I1yFuIPquoDfFAzK~7&lV+OB(^v^wTd;C> zr{0Z9Ia-lChyAE#%iVl2vx|eFB@Q+-7e0NN>cTBL_Kow@0p*t(zPD|mpLF@LtnWJm zk?(z4aGMezP$M$GWmPF;`~b+3oM~Tv@1qdratpYpjL_3i9TMbjRf(xXboI}Yn7 z#}MC_h+;kYDj!*3@MT@Qiz00=%RRgx3IP8Wi%7n2(%}e|^W8q&IQe%!Hc1MbA&O9PwHw}-daErSlvE8rLY_VT>-_6i0mljQB@tlhLw*(5~% zobdzDW4}4cCrKpjIf2Frm`xT2Z@EGN3b6a(2@iNl;=PfViEORUXzG9!3f=_JC{$X; zowiTVR6A!u;u@}cvyp6#ERv{yXmD*I1=arOQ{(cO)fjhp-<=G`;Fvyu96>gluIWw& zXn|mV)3mEnO_j^}iSluqoE234(< z=EA=*R{<3aI5?2n_`2;DpuNgu97J8e=lY$KOgi)_k(*HA?EKt|uX+df4m|qS%yfMq zW;SAgS>{dz##wzy-iJI&r@svfvC>TP;p*V#Ds)LNc{N}I3h^7%P=O<%}ht+_wn&sH5 z_;KL?SJ&H%jdt)^$T`rkKlLQhV?y8_^?MJX$VtS8m#@#Z;|b@?m1f|=BZFghQ;AY; z6EPGbZukp;rUj#>{P_|=ha%40Fiy~Wk*r997AQ(E{N^DydtiHW00I$euh|4Px&s2h zgihRmD#RnphD?c48xK!g1H6U6Sk>wA4)X;kxhh)AP44tof;=6m!x`a2(rip*9j0;JI4riZ%#(UGG&Jyn!aDCqmCO@c8Ien_gMC ztg@Z^b5ar-J8SzX;X$}A;bGHDG1K>S?!kW-F13T)`?1Em z;a*qoO`x?bMJVg1$AUtF)W~iuXSj2+f z6kMJ2>Su=5kdavL{4NexXInzv(-F&;h>;9by@&A`ZTr9Q6~D*pA1v{i)*pdYPHMKH zGheWt_#X-Z*Yj;qJl_5e3%x#02aw^|bMANm%W6RXWbbeAw6O?L(l-p2D2kfTn&UuV z6o{a)VTHFQ&wT}6Dgg8D_Pp9Pc)K%z{LK-w4Pk`RUg2uOtG&Quen-Z?d^rkl|31Ma!5;*1Qr+o_<%m2WvlOc7Xlzm{#)l) zRy*b#ZWGke``KyQPQ_kNZ1_o;1&PTi_snbwWA(IL!TUQ8jAVi(1?m=O^&Nv-x990L z&587(^L4I;GiCEdzszKIAx1+bPxGk;Nqmj-0hN=})B%nn8m=Fa_z$DRqfXziMPS}A ze0GuS)M_Y)cm{Tr`5tB&A+~OheQa;*tIVrWyQhb03?FENtdTx2&spU*@bQ zgM@A1*>5aDDjI`}1{j1sd#FH~*+1b^P-34?=P9#R$=_xjOBgJc)B2H;L4O5T;3o}K zIe5^^alc=+5+N9kVIL^sw*jvklV0k3w@Zbz-%?VWlN;f|Kr7zb*hr}f33slro!lvP z&tv}-#rf~{SVfF#PT3V9Krl(gh^#Co0*`Y9QC>M}4I5l4sh-Vw%u|psn{_ktCX{XOLM<$s|Z+N&TP!j4+v4U84rE)C9*g z6TpU9vgA$HtI3iwB%*E&+9?z_(5m~0sMdcb*Z?yXNACT|p963^6av@LFJEy*R#F>M zP$%}-@zJl|F}&e4akXL0fAEp1r^X)wO$_%lxJ4X@sc7%Gm7#;r)S=-S**X4eh``pb z)i`mv{{^VqX6@!qO9dI}(}U9dv-Ui^yby}wKMKtW{{2Yna05Q#U)}c2m>;DjiU|pz zzr}oNP;^kF3Gk^}>$VoEBOJ~7_iB$+FDyTaZ7)qPv@&K}6}@c!-{GtOhgjXznyIq$ zM@kMq>@QF8{_?t?DI?NflDJ%PIwN>iZlMo{dwCMq!MWjW*rkwgL2Kt@#vO=k zfl#jO$Yp!E#l}7*E88cV(nio@q(?w7>$1yLmTX&1&X<7nH|3tm%ILjz&&P8m%ECP= zL=Dj;)Z{63_6n@@zGJD%_wU68CUyRBFX24Ll=Wxvcr@2tXlu2Lipf=Lx@Gxxuzkhb zv9p)um`iQHL&xk&^0wIcEq;b!OPkaJY)4{DY+w2)aJ3m1kgiXupI7&wQVR=Db+xL< z`Ssj()cVU}^!MiRiEnrM;iwgn#N;sBM~D9i937hL&q=UCpU9G7AOBqvVNQ>;7ZJO~ zqG%o4J*ILLfy5TvEUK@>POe7{GG`67k!)>EO~DiGkPCs2N!)Drm^O;1hq*^%4g%lx zP>S9WMZar|M33|Yey~<`L%i*+h`r)UZYUf#MK+&f=?Qd5bmavWkeymL?} z@HdsH7|KOLZgLYA9S3?b97iOBa6dyD0p;v&^jvbK@Co6MF#TGfY0sR}mJ)`pY;L-L zV`rSOjSN6HfanlIGaVCXF}?$)NFvJ4c(wEhdrgi4rPB7i6g>PUaNaoTvqs^y^}5aN zHoZZmkGAUPF!0H*Sh&}A0pemdpy_}@XkDX^7gx-xV?qr$Ji`1U(0OCh8L4W1 zP3yE5q=b3sM$HqDFQrs^q>UA9Yf{jYY)_7aBI|1hRTzP}ce{j`{^pM!tBgwyQ$w(4 zE{qie1D6k?itIcq#Eg6|w}ULRLC8!4t?ean^O&HXp^8rqe-SL5hq-`%T^AoUiL<0C zH_n|8)_Np@<)2&Ptj@ukX@n7#(3>qJ$ORpWh)CIJ9cq?{EyjCKrrQusdL!lq!Pm8Y z0tSx3AlU2!^4xWWn~y<#qXRRq&A(aKKsBd(eyoheBsE&r)6m=1!2jn0q-q%}NM%$+ zt;`nmYSRQ@hf_P#)vUgf9b!irD_?sA?DoaHSr)b-SwgO>XJQ_EJhwIVc&r|E`_b0xX_)ViYst&)>G)Qqp~pb|dnpvFC=hp~8uTY`6W7IlKb2QeQ*|(LT`^#J z)tHBICXt2l`bn(|`=@;RIq%`$hl$pvU9x)r@ehHEiWR(zPhtq?N2QAkqUl_{308`! zLKvJ_0bkNhrhxJX*csitqVCuus)=Jmk##8uPfTX#lP?&u#aXQT2f5`< zmaKG@45+Uzt9CVL{gq7Uv*));NB@8`_}`o2<41PgFK>}fp`vjv&-)Cce82!cG&9^m z`PWKGskkuC_!pziB`sOP^rJa56j$g(UP%(ls{5#bvHg8YW+Co6 zG17t6jorsO2J#JRE1Qa`fkb;feMf3d#qxtV0lFqGmkLr0M zG}}P#4W?p93Gs#S|IE9v$%dR-jQl`)PDblW`4_BwRxJZ__k>JF5n?Rrp!3nLZIAxX zxq}g%p7^tL4v%cr1T7}WBIxo+BH22r|2)A&>^8oQce%oH_E4qW=AkqO`b!TkV)DmCf@8F^=tzysMU#zO%Ng zDX1V0_P0MpSrO=W?V0RBdCui@@+AGy{Z;Fp|Di&88k!k%mQ;-xMCLtxQ-qLphN~sK z3f4yW-l%q#dASZ^J5iB=xkqUbM6BlLF;H68*E+Ms zeJ9%Rc*sc)8ue?OF}X6T_s%i9^U{} zRl%V4VkNJ9iQgZH z1%3g44?v*d;fW-%8H;X4oF`aNwVVtPV?l_cpW0kTZdp|G+?9?itiZeDU_&rz3il3G zws)Ig!X#<+TCW}t_&VM03*mNWHg6W|a`JKVLqv=V{DM`INp{^s{c?$xIBZaxjPRHP zLq(JXc?FDrbD~6dcrwkDp5Vu|7sresuxrQ@@TzNURI`mnfN;HAqT~T+rdA3atOfer zN)nm)9>$2nfwDyElLCyP_8TWL{WQYHc(N~Ni)E-SElg@7HQv(FQn4;Ht1Cqff|wWX zuNG_sA1=D@M6a#jP^!j)IFPF9fFh@#b*qoJ#~7naH+PAr$7TYPx2?!o{HGM|xHR_LNmo z3n6@&NRBPTt{pr+KT_{6G~y)>iD=7^yQPz!$F3+xlOzZhiFa7spKJDE8gb{WPGS8a zL3B4-2VOX)%OnWND%ga2MRJsk++=%vZ#8GzM);nDNR(W|FfHM7#$@LMX5gz12zUeG zxc+=zkn}=5bGg|8N37zaFZ}szlCh&KE4?~U_0~Ju3>@p!ht}eLdRg!Hf}tun>BCm; zAP^d)m#N6*tKpO4{~KIa9%lJ8+uBYOy=Q*<+j;w)++yA(16qmf*YZSw!8}CldeqRo z^v+1Dt7dJYc7Y($##1M-El(O&xOC*)v-@oQ`O z%(}|l#QrX$71zP|R<4qZ-^E&_o>Si#`*p*$(OR9XPcLX?p})j9`lYh9X8bXGRyoXeOr9Rf-3zIX51zb3F0eKeVPfy-$HVq_{OC>3S9t35C zeKzjO3vR8nxJGMS7ZP(NKxo`4ivFf0ACI%R7T1oNPV^@{&NiIL;yo!8@o)e zaWu7e)>QU5j6!i*N>&0Z98bch(!|dF7c)!H0+Ge4SHMq5rDS_M!0*p}LDF12Z(N}M7B{l8$k9@xR9#ht5P5Yx zPYtKh1N0;36&lsLV?Sws(iA;@Ej&UV@bJC{hzw{{AHl3QFbRBcojPJL7erU9C->{h zwXBUd5&+TZ+@bs5&^$E7K>*_Ibyg_t?_wp+d#PUVqND>YBV|V*0L)mL^tf`JiZD_H zrha~Y4i51VnJk}bo>qwHn4|L$>q{VN_?u zC^4<_=jhztKh#&BIS5_FS2Ml;uy!4gq{fAOu41tV)j>=7w;AW$!jCuh;BCw^lti=s zTIke?R@&n2eKlJRtizSLzE*K_9q%U5!_(3qYldO?@5&{iXHV`sZ=R*1sW}`2&TPSD z2W$e+y~N3-%*vgzz3`1(CnpNFu1O_@O18v08M?w3S5}kAvddhHzrIj$xrX%SuVSwB z$w~Zq5b%3aT?pR&T>s8Jg7($2#!_|Z$96VrsI?)wfa^%cg@4eGH;z>3E}4sK()5OQ&@*RS7yNpd&4jOE7(E_)1k`$O90R*yV#U z3Z9WX6~XtnEIYucvrk1BAq_n;ChR?ePQix;;wrS+?-h?$Y)A=qaj{HRhv2V(Yji-@ zeOWY#|m{C!}9cjo`)1`KIt+_>&7{RqN2tP zzn2s_9L{mv?p`$>UQ9yaippTn^A@NQm9L3jNRV>I6$XBuu6nF*s%aBouLU=ARd2LC z-zlOhC6&n#gw@*`Ut2I$K|LjaxdzetO@qERK+NHXSJ(TdM z_|wXDGq;#&H&=?i3N}VN#(4H&k$BvSoH6rhC=bxA?8^CrX#G^`(ViBeV$3y= zd}UD}4&DYi6ka~$={#kOz=_z@lc6Q^v^O_@z8IK03f(IjxF8vpuXRb4cYY_Lej9~( zw-*nUln_xm*7qG%BpO|3!<%CLhMreQXqfyzvja$lrudi`Bqt#x7)7co|Ht;aS zEEs+iLiiHugyS>#>zvQ-t0x3|1M;nxY=&SejQYmS&5eh_8>nD)grro060#IBEMp3K zmO?q`OI}A9X0Cv^C!r%HL0v)g@ncNGxc>IK=#l%?iXb*(FNc)ic*}1!GOpc*%2dg| zJrzuO9s=&en4IbWifgbUDNS$xp->;iGRPJn#~x&S4WKGRHW6JFdv`GjjlRimq!uv0 z-PDlfuS*qf5*_?pypv4+PNA1p7d#~t#Yj}Jd?OJ<7?Hkb!>X49y$LD7`5nku?0Xc^i);t1=_(v%x=cZMo^j0ZyFgQsB-y3Z6KoltUC{Vz;$y3|loXLpX$qj<16xd)i zV-MtHFW@eL6nU<~idnhBzlm?jLrV%9-)@MacnOcy%0HE8moN!UCDrHrf%rXLUdN~G z4CPkKw^XWfcqDgW%QCiN*G}A!kYS*c1S?s{ubvfa6Ne^v938Kqa$xt7gTmV6bAEqW zT~}QQNsXqPmEyWIm~RWjJO^4kn{)oW1u^@}`+hFwi{w z{4UN-wYAF7?1%2KF_D~BlnMBSEN*RdH# z`D!N3ua%}~M)=iT3wgb)md?v_1DgZ}!R8u^JXLCzwJK0qBLls* z|1mm3Z%qt{f-*|`R5w{=ayzr>O7)o`Xs#)+p(-v2z-~SnqbCh2nMM_VIw+(y1KTTa z?(@%wis*+=$k{^Ie!Bj`oYj<-wyCKed?)?$r%0&iqjcwJDUgm<>vwv;{H>iw!H#a| z5VbHQoRoBq#Q4lX8cm^^7SW=~es13uSg1tg7C!ux7YO;or;e--YpP{uphepM{+?~1 z3A^?~(daP)*+*OOugUdH=_%38TJe+&W2XDP6UJGR9al;r_$*osm6%p)c5eDP)uf+p zx+)?;uImR^<{@#R=tKSm019<^LMl>e6Su*xRbSiMM1e0bSDfoTwc^*Zd^htM`4+E= z%J03xtWr6W!0gzOE4caZ*Fl)M6bd~{l8A0#NeuS7U#Driy{+y=Z3)EJvv75F=A3_# zOBjjr%_!P#Tpt&_-={w0y?kaCvbT(z!59btJiL{9i~kUo_%54(D}FX%-_Kd52*zGX zkK!GgNpduZhP;ff4xyHbXUFO#%l!#0XynYnhR2W_`v2iTwdyMI|ZU|89c>j}0in0MV_ojc*$%qYbX z;Q7}Z$Fh0Fq2^=-uRm&Gi|vp8k@E=MFNsnbUbdg=_#L!yuh<^y2+wSCD*FDFe+C$& zSj5fKPLodnGiW763rnS`pFWu6qwvq$KA1M&lT*OW0dZ<#cbgwDr4yopbQNA_>XhZ2 zmiAb_q7H+JAI2m@G6A~}`Pl*LrlMev<~WqxjWQ_qF<6(T!VgaXDg`!}sl`h%>kv7B)}*MQ0B)N^R$IVZ*EqJjmNp+_ux6f{Gpoq~UIMJ> zkFxarCZ;k<)XKbYF*T{Ypyt(uRX{;4$+eiyMR4tp_a{D|xRN%Ub?85@MjXEkAC$b%~lgp1>uUtgY*A|`0gOkIU zm0-GPt?rH&R|06)EQ7145m{X4BGU&~(?Y0z{o&v{u1WKQgEQ@NBFy5n{u=qas4wHj z`%w(VLJsz;Lcl5Cbujs*gxh^nXXj)@%Ermd%L_0o0L0)6A=0SwhZBTfmoqINq8IGn z`wsDnE%{p!YTL0~qL_tiAm7F!+a?f^~E4*P%@s-a7>#9zyZ zFJlCKwo+R@Y|<+pal*+gB)QDPmwkjiM-ai*hjfS-jR!^#<`Dz zYHELoPK`W6oopNaLpohyp)%(U?+6W!H3#w7Fi?g|6H0&jT==XD7FjuUOH56ay{`x8 zb z3l7T+2F~N!&#Ee~@A#8ZWUTT%UrK7gK$OvRcw6^_iZ2t;u8~*~N;1RaF{LQbVD#Js z4xk_*71z(Lk|#|a+HA$#cML;B0l9?b{BbqQ3&-@kt_>O$1A1hY{Mcw)b0+p-7@hT! zKaTj638TH^5aFqWSLo~$x;PFDi5halx6HFBh`cyrWZGDKFdrm{XZMzAPdR62XSmy> z7>1|-e_X-Gr{=CMe{XM@ZiS=wwHt9g9f5GyUb(8Pq?3DSDux%@E;qWK*fA~eBN-16 zDK2D`=J_$@pxizlm*hpR;2k9g^!*r(bd&$)vP6t6!dn^55OK@+h}7@E0hA?5vhtq z*faL>-8`V#k)w2=@=JWsVMU(HCU&FwU~xs;zVFAlmd>R!?_z4mPWKw6S~?eTp`@-< zY=-a|?X@_=o)h(Uec>Yu6~q8%1X3Aqg7=CA3dsftG2%fBvkeBXI9^7P+r5>eVL{58 z3`BBz`D*|TO8l+Z{c063cHx#--w!GWSzcPgJt8F)VN8HuUo@*hU6&LlHmB{QYyiIJW|)zSd6rja z@p;O^ha0eed-!{0GGvo#Gwfi*_V^bpNp~myo9=Wfz%a?gW%8HX43K7*=efl zz|AV#GF!~Cj-$_=&04maxwg?6$&m8yYH=5TJ#FSY z<&J+Wtv*{C`nvx){aB)qGKSWeWlF?OEwGVkC1#W zhUZyOa<#Mhsr*S!Q$+-eZN}w?tG%6~+uDS&1R@E0>w*#KDzVP709CAU2|KiDHh1%y zo~iTjT&vpBMp3N`<{QqOt#kp*kOvzJ4DR=WOYa1(kOi@dtVMnn)7 zywI)}V{sySsqGM1-b4+rcZB~>#li4CJPb+!_!vf%@q54PyFb7u%FCj{#fG z@cXjTbgKq=sO?qpStXyq4bBVQvmn0rw`g`Lblrr(^yR?V8F*co)_{r_6p`^wXFmb1 zyT*(dfO*Vs*UYB2X=`BnxHlL0GZ98J&a%Jx$cy}2eQhnP!Ka!^y<#h!K{@`zre2)r zqM@DcWvY{AkJNt^+(79gH;tR>h0#ld#j&YI5w5}ZEP)XTRfS^)7 zBf4siqk$Vy7YRXopaTqfo5+`hoz8VfN40}hVHuHdX0qA5BI#B?+bRa1Zu3YXlQDc` zUYKlU@QM74mj2aC3a)iv7a`8DJqaN(V0E`14WTw{z2;~6ocoGR+`~=%%Cqcb z2k1Y=#&I6lmhd9&fpng$qiP>k78bjz_-%|Fc$#m4T8AoAB=niU!`%L$i12H(abHqr z&7pYQ9{VQVp6FSgstDnzF_ZEos>vvc?CpOpDUqeni5(@8*?z&%>yI=O10q~D4^DWAkjUX;G&zy>=FiHAwh4V;bckNONFmp^9U=^nm-7NQ% zhEe5ab;m-r2}tW@xnU#!ho-L#tEy?+2Bblx8>CCRQ(79NySt^k8vzOF4(aZe?nb)1 zJCy$Be!t`4pQ!A`-m_+1bLLUr-)gyVdO`B~aA9_?9+3Z-o&^XURM#YN@^tZWY>5?F zS3j6zY;_jH>AT&)dlO!_znWhI!S29vxWqSR{upY31+d0-0@TQ9mXxKTWjlEwasay% z95qKgHkWxV14O2QqpyH0`l|wAqt)88T)@u_`7LjX(yF#5VBrc>i@TskoO|89I5c_U z+Wr`j*`PMNpma26fyEwUT8}x#;>pG-DdS-yE5^s$D^Zgb zn+oVs;wvQ4p#leNBsNCpb4jE+1~pyEA#&vQ&uTaYT}7 zKPK1v6;0T0h+BR)pOZXr2@7{MoI3qHYV~ApU5&Stdk#=NSJ(UFlk87l!Lh;YR%|?y z;VTX#YJJ?Q)cPkivbwcW&h>_O18wj`GRmKGNs7W2!pB!$oYVi5P^XKiXhAd`)s$_} zBT;; z>F7AKq~ya7##lyOIrPq>A|xVe__@#TI@Ue|9dF1!r`#l=|3=s-;C|`PxvNN4Nlj+Y zyhCQqnGCs{9>V~#Z0(hog*hLV&21&V^e~R*j)69xe2E`GX_&Vnk4b{w;^yNc0BaJp zE5x4QIWx^|7k)V~bc_!r5rbVPKwTX(V<&V7HA0WT*5RyGj?0k#-do3jQU*hOCPoXD zX>sUbz%&ZL#hcj*`Aa>h5Sn(%O+-4Hhe8W;kTk(HGg3flxUyv81x*ks_3M9HfVi;r z!s$%90n@kiXyn`5tKxu?^lN0&u*(bNDjuo4#;XVoj=dcC05WGe1^U62p|HD(VkWcCkC2PQD7jN2~9z!d#zemQ9T8K0@2v|(U8sHu<6tOv8Zc%BJ8Y8kQA!^lsrtCo02q@_h%D%6yZVU*4^ajDkT zX`DTkmRx$NmCVbQPh?^5k4z+$X^(DXS)^2(ayH=hKi4CEkj?V-D8PX3`F@;Jn-Dam zpu>zX7Rh~h&Qk^UNy9sk>4HSt#rA7H1w{&(0{uCiNtSBI+a`7BsMqF%B=sB_Kt{pF zwNzUMS_rz@#Jw%z7$3^~WkD=yTEaYOwUgc8?qkAL<+b zQhNbds9YyoTU!ABfN)_ZzlYI{*ZU?gm4N)U*v|v}?@OrggW!~N10V?S+X((s3wm?W zm*LVAm6=Gh%>WMc{08d$q?He2shiYF)OfVe>9hM~SHrwU`QLHmgwtZ>K)&&?D%1>6 zf3deG)^=ZyN%{d{e6X4l7S}NDGR^oiOz+#sO6ec1p2z=Gs|&wDgn4D5Bc*8ZcmXw@ z@5|kSdX=8T(Q(VZE3_q_xzu-DGAY?IpRcLdX@1y~P&%IEF@bRb^ce*ccdnYr1V2^& z8?M0@8#gN)?@6=t79=N+89Sj%CJ1crWU9&8<$&T8G*3m;Nl&3P_as$e&seq>o1?4Q zTwr_C!hI!Y#UT?Dgv7WMiZ+sDZvKQ(B+9?k{M38vtgsbJuU0Sy+KT7uC58NpB_3_cdWprL0?x|C zn|We%T!Q*vE>>Gaecu%zG-+?8bMht9qofQsee!^1m%SMiN(zy;My1cy!o%I;$N_Gc zn7!~qP4P3B4)&z6W}poxvlLSWzB!-^_AnUJhEYxBvN78+Q^l$L_tUi!PxUCY^4P4( z3FWML*h(5WBZ$1JVJ2f7sqOPE$B}^!*z@1P?d>f&^9azQj6XAaRz8?XRz1K5_ht%+Ae* zBlSvg+^~;#cP_$AFdJ~NUG&1uZnjWtBlGrys_1Az2hcrzMEZkp@ zn*E=FpdE^z_lqBCURM}9x7WtYT1@mw@~0+M3=z0B&R!~N#@Wt&A<@AAk@MWfT>7L- zi5ZVc=Yeu07y@!fKUKOK>9n40_A0O>%^Prof3@*DmN(3-|_}p zEvXMamexy&lS^&F;_Y^pA5+_Y`RlPS=A=z((=itACB-uc*NUq&5Zjmdo)vY?ySHt- z4t+v)2U+NhI!FEI3?C(%VneMBVRxS~`B`3D%6wq5>gW2@X^M3hFLG1B6sGE)%+98D zFBssDOz};d({rS2X$h~W&ifm0aFNPxtF>6)3m}x@5xJ7&uQ7D`1|{DmPeEOUI0d-r ziZQEmwZWe7TUh=mO(^?Ep1=>z79BL)Ik=dLgvcITY60#!Zs`VFO3ofzp&PldfnS!Yggf!8Dr>Pg9&nTQI=pCgg1tW<1 z#EGs8aH*-}4I~3X_a~rbuE3!j{L6^D?NKCF&Lh#3j2Zbar!4h=N4jb;utSYMe12Z7 zKypLJ=mbXpYymH-MslA425~a!4b!#H z&gY9HUY$~530kW6cBtoD#F@g+*|%ZeLNhYshdury#z7zfRC;S{)?*|E89Ykf>%-ke z(}pkkrAFU9*d&DG{^_|VVW+bY}T z&>Az&oD+p+>B%eZF1)D0>tv)^7DboZIx|`HWzrgCvfB$lVpsV88Ow7qxl!7N-D9kwKqp3y~$NA$c_x7Px;QwpA;8114n2<+g zz;@Sg0dIB<1TJen!$H+Szf4RkKO|qopFe@LIB>n*tYx75$}>#~75yH@pFybqJ%d^h z))ucc7E9E*sh5a60O)xhSe=3r>fhl_9el~G{=fLpG7krb>CFDiuX&21?YoqEtw!@` zSc^uif1nx^R}$|n9RqDOgb2iFpsD!`Yy_l68V6&L2H)dT zQ_5*35Kf*S9$Gpq@8QL9gBQdiT^Az?Pg0Pp3=Mo49C?T5Pr*(Flwq$ceoyu&ANp`y zJ`87$0$!^%ekc+282B?=s$&n2bjtIWxs7YZVe*Df@I(`J0(-^vOxHEo^d>rA(TLD` zV^?QrmhK&#Z5f~?l*afM`Kq@;$AOCm=EcN4b=H?D=SWaIfdP zdtyY72REUA(sW}Bp;@-UDsXqEpqV29nW z70QD&GIk}~(Gka#)_QM_)!>ShHgR5QD{c0ku`5OJmwAvQN%ZrBi>n((aNS=64VB zD%FBGmcOK@$_{48vk3$HABoF@4T#wY8zI0(sxZ7r*W@s+1B5xb>fj_d;0 z+rWnjR$ZU0TU~%c(gMn=|2}D%@(03}NAc0Pb; ztNQ)=2)u&8N&^*$nOSM5otMyAmHX{eWTQ-rg^Z5LHXNn0{tbSoCK)QEe4iZpPs; zw1mt7oS+dpL$hZwW^EWsoHqpY;IJ?6heVh|#t_{WhvT9CMVXe#e1wp+=(w!>HWf4D zc|h)~(w{oTw{A;cEuJa@rPi+(YKB1E7;%gnxx|U>KDVWV`7Y$)3oizQpAi%V0<%_( z21gA=Ho{r3N4#}=O2n!N_fd8mRl|^(uxotC*Ld2wOG%fpBe*@L|a1)yq@7kvqm)?m__>Ug#4Ct{5Q^Mo6rpsJ#bG^DjyGS#nPhPC7(c8Ksa9O8$~X)Km+m%Z^E z_8sl3AD*!{;f3OYyEgnn9j42|;CvA%XIHb71mL$E7SEZ1b1<9J;qSRFmxC>;kyFRd zaFRCCg{xt3Gz@8`Aax^Z>_wQKfuD<+vt{uXd%_rejNB=Xm)yba3Rzyo=_(`}ABF7> zIv7NrHb=Li`BhbLbRz5^N@x zQ2gjx(u53oxwFX`IxPGe&@z2DaLsp+6nB?ne7SC(Y;T<)lo8uYMyV|1A7v#p4oK{+ zDqI*GY=_f3shTJa7)s%S3@6^|b_xHCC0C;Lo*tA_3OM<*liHWQGgj1dD^)SW%1W(U z?u_JW(7{2EgjpOb-#w0LZM+(pj8=TY7{y`c$}aoPEyzHn?^ajkD9s+WC1spi978x% zA{~j{IrQia+@9BaGT6h^3R$ZyPUb+i37_6wzkcv-|I$Sa_rJ3HmD=H{&Ul7Ml_9^} zB;$ZFj7oDmdwVv~SXkCB)1B~RJVn+3Z%?9{-cMW+B>&DaeJuD26d;he%17A!sNG=c zHhJ*f(^vyk?Q3H-4bGrm>D0WwuteWt^y(@w64Br9Y0Q?5ReEM0IS50=LPT6~JT zque$|@@H}qS&W%2HR6wI%)Mot+DuS2*;$TcHq#K6^o4N{XTLcsYKaNFeE0fJW@kYp z8+lXEntKi`Dho)qu(aldf%Vw|mdh6PlR&quE^aWJ-9q*b=gy2No4zz5(I>r4^^T*{ zfVNXNM@J(|{_(+Dg^uY$q*HN-YS-$txMjA)KmN{GGD`{?_*9@}vp+qOzxv-Nheu{= zx!MJPAQAw)&(rnE2FSw%i5JE#nlY_R=t|w*p7di}#$!3{mFM8}d2rfiZEw$XGX;KQ z-B1^wJD_m@V>$5DK;EQ+R-;J9Vi9}!l%ym5BPoF-a^ql?xQ!w8TMR=c!I^pk%Ih-K zItSEjwUr3>b$NAbW(Yf}KSvFwRO+Qd&oUDku_NVFYSe~tvy;|*y0(`|8EI*z*r@@! zcredD*1sHJ=q?leX#uDSpGF8pWBlRngA4jwEtAP{Ui7Lg z;l=gtLXM#Z9Yasr$Uo}OaeJejhM1i12qA#*Z5f~b^N*0O^ zrHNN=C_21N4rcjCMs`i`f zk}@*f!~10V`hE@s3}TDbk})GX`j28~yL@iTuKEaO$(%7a6uN^~Yr~te26tzg-DK5X z7>fcCC~i_rBI`?ywt3;UyB&riPb*TzJlz#H52wj% zgz4XRHSb@UXVZ+ck;LVPeXFg*dF_ecdM!*|ItQEL_%OI5QjS6#vUfprMBzVr8Mie^ z9%R)ypsoFT^$|&77ri}yE&c&`jFxAB=+oBXe#F}Cm@Nv zySoFR1K2fdb=vY4G|6SPqj2hXKbm=FiMDio(r0jkFGqS}h z7AG2L*2%3o+YQMwEl1R(6Jlvvf`JzJ{3li(LD=hJD&S221Im1#Q|v*PuA271KEv*g z_oL*FS-!u))s#DQPfTx`##=;MGxB75u_nI&Yu1-}$Bh;z3I1O^UnV97Wa_{C#qFe( zlU>iGL8WJV?^YNX$rxVO!xG|Ai5hk`5xcfah6$Jdu%Do};1Hl~Q@GFBWPZ6d>QXNff=;7{4>I)cS-21qG4c|A)uJgxy zTBRi&X!m;~-cO*R@;aNxr;U-GQxV1G9%zNyq*=_!JO4Hr&tBO04L>&W$N{MSY~RzD zXG>3H&v4a*?yguP$qpsn>c2kI2|Q&6y<9nW_~|Q``NKRP7ug@>9XmaA{xaIbd6_pr zs9?bCV*Opi)NiKm1cRgFJAEgo+ox<+r)<%Jos1n~Z}q(V4A9whzA!9}A^Olg^)|3o-lkBGg&9k}AuKy-rLz73u00pZLZx|`X}WTM93wV=?)*0W&V2N%Gc5o= zmB?}`c%d08EyNYSd(P|*;ft|KbJ9DZ0O<3jHQ7%e>s_Y9v8O7Nkbgib7^M>^x#1&c z@l+x>-Ap}7)5GH8eyhr@t7D@H(!}(j^?>IC!MBHtx7Q27x97S=tG6A$ z=O3Vv0kEwASU`U!RB!yF+DiB=J65;{n4jlbkTtSjmulo{Tvk9>sS!MinqKAeV;o&7 zmHULUv@a=60_zP%i7243WJ)Fwzs1Db`s8S~Xi1}g%B@i$a|-i=^THVnnfWtA|D#!0F=&<7B{qmIl|T5O!aWpNK&--3<81>^Z@;rD;b+~<+qG)S*V zTDbTCA#!fmqgse7aM<0%#>t6|B$WUYWWWM4om$_KKwn=Uhwf#oH*9+)*d5_T_Su<$ z+~;aryy}y}iUeaq2S&;$LO${DMAR(puMCnJ%0?g(@an&o&koPK?S7=VLuI$zU&iSZ zl{TnDqVN52W0u5xbF>c724n?&#BFE5?F^ov&AnSEKpH7dXvAq6HMIanq_e(1JjN6! z2aYSs_NUxpPz9_dH07d$&-I6F9V23oyaZ9NlV%O8Z)s@+Z$Aq2TLTmq{OU`@AGGv# zpFC{cOy$o}**Y3CS4+Z2K3O<1m+e^?}T( zBrm2v4d=9tr6ykybD%CXP3_Ikv`$`P3UTZ5&xq#Piv$W1dXA`l9%i6g0(;p6M81m3 zxyW8l2gRdR0|1> zhCy0b`M@1B$2xj!MLNc#NOm+>;Rn4fbK?BEe;2nLtb4k`;Y2s{t2BI*y3YhopI9=1k_%L^!M zk8*!kam1>OG{X?k!BPf0uUUQ*V*+QIQmA`nx!%_gDkAWoY`5_DpV%2j0AC$N83Z|r z*QL`Jq9IeDFmt(1Ya^>C05YX`d3is7zR#m?BR#E61Gb)aspcQ2r>8cywoCd^4&Qni z7nhbG5Bf}qZ%-}usq2WkXG&B>o$iGe!S_i;U!QL#Q-^G~3gZfdt*f!2OM81oC09-) zqLzc#Pa~k(0KVMm`_eiTZ5BZ?=<;}w?dSXVoXCkZP>9Yrq2aMb>jJ!#jg7l~zA-18 zaqhu$_`uES5}QPnI}nAx>c2fM_&p^1k=jw-rP?Baa8>Y^burMgGG=yyFeK6}hU60) zWK6$!Qv1t5Zjc}k&#+RJvXXvE#AtDh$g)uu+wjYhJ5dI3rn=FeRbov#*B!KrQKSM7 z(GE1eQ`z7q_@2vA}F?@qG)ULWSl z)I*L3-tg00Pw%Z2)!ocwArA!D|C9f+Vq=qkFK}=Lto6JF) z3{M29?>nstP_B7gm3J3fp-a7FM1`%*ik8Tdt`C_)U_T+<(FWb22TOt zc||qPRudhnOJqGx_0D?+8^#bV50x$AV9ZE(l!>#5_qI*9p}Qu?oxPPmbv6sbqOBKj zkrB^*;`oK$3SkZ^o*J6Z+R(uc1{@cw-k9WiAX$ay7zB{?|9?H>&=Q{AsxYkgEZTq~>DI+d*~iv`5__yEp3;AM(q8u2?&&HM zzrJux!(+N9pt3ZF&Xwz6yu^OzGs*zjLb#v&_c$X9Y?fP|Wamz`XFc|eVn185%vPSzdg{tx3!d`JObBPgXxWv-1I@Vy{ z*i!$=xNfXMo$rCC|Abludj=A!*Dqj#ZEE2NoR7$VGoXGA@wceV$ablpGE`Nb7IRsy zXC8bb#s93GepF)pOj}=%7xP3R_~fk26l!XR*z!LuK>j!Rlk<01zpAa%^bo=fPkZz` zy$zj1Z$cyZU7LOojla&26H*=IXn}8EjofAwAL^wA((SSJmtKR303cC1{f1DQprrW; z{84^kKcd8T4<6&au#@b<<0G$Dr0;S4BI~i|Is7DWpO`Z~$bL!vv<^5FBI%zc?gJv>C?PkJx`*1hz+4H3D zMJ!eg5We$rbCZbsy*@tx4jafveQpn@0r~yT!nx4$uk`)$vX*Q%1IkTmufI)nX*Bca2^vv{@5&7Rl2<%utj@YPsD zk%Em!%1C4DuneQh!m())92e53=dsIPDk7d@`0i zr8gNd(qqA)y7wUO^CYfK_LA?rD011kAABfS?hR_`Lzc1G69|z_W_f117i@6+oYOLO zYrFTAp;#rnyrGP9B2NOG6p+cXRSP7ttVgEC#=QuHP*bFz>lopX?1l<3OMo$cZ#~bF;!m* z!;$0S^-;}o;S{SK$if~$D5>Dh`!AgxRRfMlc&)#xcxJRCU;a@$ap!gr8L(BSgr#$? zG;A^)>uHEabFS(=Y;@U|iVRU2kHDSD;-D*`@=~f}>e+E=JNn1}duJ>J;Dd$5hbjr-&&< zPc7Ap?&tGg4v$>%Y`7Nxs%&XcLbCoRXOw{l4vUOoD2)h?V|#mhAUN}lB#Q%h%cvv* zmy8j{Zg-2ouva0_T&QMtz5a2F)}>EA0r zoG+I;DIV4kNwm|(I4%AOrp{-;SM2W>TBn0H9k5^S8u#dgB1C|&ib*1?i?I;+j{s2p z-AiD4%Dvg002?R3@|YUWvixk#wE==oE1H?IlO2{$;JY^ymfHu4GFEI{{Mw?;Si(308CB<=g8 zuq*#CEN3_JcAxb2b$A%<^=m((!se(Bg&7mqFZ;BE;osQfm9H7mRdfVg9ElWZaLPp! z_q3&X4z7z}JS-lndIptufUw`)g??#Lp2CpDXc1MPzO0{ReW(`gX{PqI`b}?9_`Vjm zRvrm)tLRPnedATj>93OG5MOILPesC1BmI4i4&H~ol)R(HjiSS921_KFgLx}6#N-V5 zm=c$M#ELGtX7+1*;f$rngI~Xv4Y4J{-g^iKzsNS2RS!`^Naq{_i2!gP<7sMfM0E}v zTzZ`0krTv{f>s^3&cJ1bbdK$8>uTt(%^!@r^*J`$P8|mM#M<9uySq3zA`Fu}DOD*1 z#j>|ZSAJplC=96mWN^Y|PZt@=sC0#c>`HTu=RHtP^P@4qbRrsO;B{1KFxy$aFvS_= zMfzG|M@H1(p=_jD`Qnrc-wyv^;&Sw;4M1YB?{Tb(tRpBJDXhjR3FL#RYHKWKVGJh)=?J< z7e4>el|^a8GP)8611bBxT$;hsF*KG1U~`%p8v(5m3T+Bu%C)+*lv?P`cMF8jhd(%K z5y2axqm)6XNLUQ<8Ly;k)th{VBsPs5ijACoPmE_F>-oa!C%K7&9%w+SHy6diP1)Xe zwPE?`NGYtudwgC>^A-GXFaTY0zacmR5!nv>5AD6B_r~MQu}X&gA(^?2Ztd-8k)QwZ zq9M~(W2?2p=rZq_AxHej2Z4Qe)12Q~jTDPH4bEzFE=}Pw!MrMQ-9$%E8U@f{JlFX*=#8s8DEcT~Y5OvMX~i|xr^ME8U~;-DnbV;UaOGC2 zdFcR?)q=hsmh|@Xvo~nT3UZCAh@0S+{GL0`ipDon)Mfx|G(dEX77$Fzbg%GPX2b)0 zBw*NY3C@z$?j4%zsVM1Y9F%)9CbM~@*h2MoppLKl zj{L&1xiKp=tOmYgIu4!A;H%1aU@){ z2I6Tbzcnv4bC_)g`njtKWk7GE!uPobuaAX3`Z$2h~@WR2Dx(hK@QkdYb9!W zCvGs4bH~xk_#I3Td9v1hALVsj0)R>jWvk`+RZvFY*#>5R$Z^@wfS| zSe4|z#&QtzpD`^P(+`7)kxUbcNC)CR`t<%_H6VOEyB8|Vo(picAD|Y!`OPpOmcr7b zOIZ|jidHxs;^SjE9s(LBZUPH(Q^^QOP*O^mVW8UjTV`flY>VK`DFnFXP>eJTc=zI1 z?bqFrcc@(P6f5%8G=H=&gJ8jA@xp|oFBQ^*sU2iUe_GF(sjLmuc*F>ZA16~=zjA5{ zpkp~BhVJ)GR_EQ>;+R9F6OM#S;sYuFtYv4?Hh0^wdid_C@INY96y&7NDc=z<5|eEQ ziVNAi);iNIG(zI{Kd!zmt1TQ_mr4fmh_;a_D0SVPtFm|TSNu)f18(PcPW-<)i>adI$Nc@wh%>Frb2uJNZt{OoB>+2BozEKxLr&%;>f!U za!|dpvX2(t$AbYK6nl3*J}yM7E?n<7L**wKha{A7B5=yoO0zz^^=75Kpq-$geBWfWQv3OwHi#Jr0Xi@E(K>Z|JhrgoMnvom)fw1p9rMQ{8W`n$K_ z+rhPaVSV}LSRpw0MKHjwn_~a1uu!wisA1$G4jR8^IWuE!9Rsxv-w%mDk=B7>3~Bmn z>c_r`IUnD%oXU`c~?!j4Jg>L%8_ru^a;k*`z&F^f>^#krNDazB+Qk!;0a0LD~SXr`F38p41R7~PW6eWt9Gj9;v__vnvjNY9zc*_y6|j`R1AHk zj}h#*`M=nki~mk?z_NCGs5tT^SCIjgf3jkx1#oo`|6;@_D52bC$iK6`&^ySieSG-Y z_17o5JdjJ%@Cg08o?4lD&eErYq`thDeg!N7S_$0NZIFKK{{B;)#^dTPcs}WnI|V_% zdetzuE})SkHN(dFESIF~Ibh6(-ps8h`sV{ zAG0#dLI0^7A=2@LEY(&FIhBiLAI zxIZjvsf`be)O}2ao7MY)5ej3FxkN#)Dzh_Nd93WSm55QmT>a&eN-#my26cf1I0emf zsO{fT4VzethP9P6*46FM5OoS0+{d{pH)dJZr_G`m6XCef2~Klw76laM`p6gwyP`G; ziVfb@S`<|(R;ML?M9{6E94uJ!e~7^7#~8Av(Co+i5C^6`ud--$H^av8F_90LSj)lu zahfmlUI?NXkhJyGe3X``2(j~p@YguDf{(ErNvLywhW`p$QN^*J&xGO$fs`obUyBlp zcI)60fsUBm8NrLO%Z5xT_MM>5xZL!j3^NqygyUpX5JJ$OUCgxDcT)CEvYz;;yIV^b zXCX?0=E3s}RNr7Qu*mUNm4)BfD)_3BmQg;40s|6?E@0N8mKld4*^Lg)Pf!2L6n%cq zpmxM@&LG1i$7GpCqPzkSH*wVr?eb^CtW&0w_F-XjvUrzB{?K1F1Tk}jrBt@l<<}`t zW+NVy?_T&PY+Oj9M8orP{2u@TVX+C~>EFE^EeImRf9co2i5DfG`)o21(YY=o6ok0) zr&5hwa4ESq9b=84aDJ>eLm+2Ar!a+hmisWMEZ?8Fv>>Ulc@JNq&MCh~xSTYf_UQhB%*_{b&i+s2+%xI6N=&Uk%2ymbSt#bZi(% zyo5EGrUmMPbFU^+btzD2u4jj63Vj}UwrXC_`8>Q@QHMV`p{NP^^BR1m+23tU%k0-4 zNeHeqg==+otn(dNpINxeoZ0P=^d09*z>1NV*?BocO|f+58Zt> z%p@{mH#J`zfNg(+`nZ$F9A z44_jm7}Oln1ebylxD8ekrHpk7hth+WT@%zjEXEO0f5UP7LHe-1XM{$KcnVUuz6?J7 zyV~jR4@t*(XrhDlXAINw8Db;PmS35ryI?Gj zUW(}Pm^&)gJ#T~y_(|L!Q4ZhYx(x^eaWb=rHh@>)G=g+L5X6uaPnCd)lHyG#5GRo@ zFIPI29S@H|^`Ki%m|pxXLVQ^8?}6K2)=&5gRw#|Nh?n#&k9QyT=nI`+b%uWOp4BE- zO^x}bE7o|U!?b$5JT@$L$7bs-3zG+anH@z>lj8lr+LT=bDYNdjnaf(em#Jd~y_rU5}wKbu$U1Aw~$u_!ma(j}NQ?SD2suvE#(eYVXV} z@jV@rRMwHb@O?n__0u+!jN73`_*pB-a4>~~`6j9J4G}&DXsT@J=#cXrg%FdgMk)~1 zP53ZgnA$mP&zh+7^0Dile9&Y|TFEd4DbDn7nZ_B=4j({7^>zbFJwwkNCn$-R!`PKf z7+$YMGY^pp$}nR{B&ASBS=l~q%t#eqpXh?je5O|_gvv!r^=)2@N#W*9CN{x@V1T_c{Df!%%TAnPY}nHvLnufwQqfDtcmg|!4p zo}6RMFk22rvZiU=`9R{cbC)JPQ2+)3$L{g*2*SuJw}#$O=gu3seDdb?X#k$GATB zyX1WA!x4v)GNsv;xToU&57!Qhvkx!j))8VFf}_D$8?0}4db$y+?WHCW^Oba;8GJ|B zWo~BKrw%@L51#-&@)dMc#QeoP{yEWm7#o^!2da{S$9oCoBlRI@Cab0x6sLQyuD5&5 zW+|ZdVWhP3-t~Hu;ZG*p1P+(G9{^QMYa#-~`d%x!fv%n&ui)b9s>xZue+15K5@e%g z;IvsGp$M!@8Mh}$jz%X9a5*L(KfrXpHEka*#Iq=_!gF99w`kOihghj^`ICRGC9@A< z$Ot)37pv6nJeNyBZ&AqVoLB?xoZ4J1D-dcbE&i*S6O9dax z40JwcI^7P_*`v~AEp5BdXMI%nEoOWAus*f;vNMaGgEEd`U z4{9u5+6ZB9XO~b8Gl2wFT~EC!^3ptpEG$~}-+<*LVHXzejD@7~hL#3uh59(Y8|>jQ z1<&AqYwW^)cbxq5ViIj3HG4?x?Ypa5*mY)d%^1$QEa&RX*x0}dG-GE7jEl|w)celE z%51v{pqOHR`;3Pc3#9fMA+>zWSMUN+0coGYNh^p7ILIF&wY1rn%akt3|rZLupKLJJn4wn+Ohf}>^N z)cC^Qxqq2sHt${y!b6l3J+nE!XMbcHUXb0;bMwtS8+)b|slwOCrX;1_@HqMPND*J* zTQN*}!#zDEMR+J=GM= zna8HqqDT8O;%7v{Akc@g5-Gx4kw*kGVJ<<}Byd^~ip8Q?T;LHWd5%nj^DXewipaN3 zwl3Bo-vaPy8crmDga>E_jpdePbk;U*FD}ngDy(DH$W#=}qepKRj`$_K<;3ZJ$w2s4BNL z_h(nHVRF@`l(8lLAUas_tuA(l?t19%y9g8kB02GrLt6 zkQEa;3cXu|-{19{&}alO0hU`TOuEdFLo$?dR=T>!P^{G^Ax!L=@CQ0XEn{fyRl2W< zT1?mc)+EkS54$cuUn;Kb7X@zV9RrDKbDK*xXb`(@?#%gcq|8+dd8^jVI_`Jw*a!3f>90@9b!nptI_lyoYw3YW?agiHcC zqpNJqfuvcD;a=t^=5g~=V=_|0uiO}$BlSK2@p}V24**q6j0`*$+>OF|Y*rtLVmFU6 zhMnkO2~zzv6G-|cx7O{{v|x8nH{D z|JmLL;3(jyCeP3N!(h`I(kN^yJ+xMUC-*0yLG!^wQu)nYqvP7oB3?dhdq`ftr!=Bw1Ivy5YUC{)jfmN;fqNF)Sd>O=n+@hofbtHei>Xj@jt zWaXHqmr|E(sNem{)UdApv(JIB?#wXtzKHmM>*YfzxD@GSpcr6CMsKq!)Q6u17YM-I zRYfpe6}5rLX*f7IvgtOOgn{&2xd$+$wq~8IPx&&l9AybYzd;(Hl@cE5j(YAdU@B%% zsbpH3UushR*Xawi$UJK*ODE08MRYak<(iC+jW|CMk^JxaZt!U?ub>>F1zN`CE83uq zov=~Ow%k4^^d*K7`&kWJ0e$`O$Mz*`c8Cy@+V1H~>--bPx!agAECFIGM^>fkQXGLF zV@avQ^bAxj!l`Gc*8`?swT7}J$rz4N6eT>~(q-d=zCEKzoDse8j6wO^_U|hAuAQb$NWhe}nw^MWDpHN}VzIn2Z>Z;dO6#|iRxtEcbbI}YvMFxeiLP6# zm=vKiHotrOJH9Ob`P5?i$tcOnk0Wkd?MX`0Wjt)*L;`pbOs;Qu`@!C|P1+Qzk*Jc-qD7TwXT^I0-qZ|{>5N`A* zg;x~Iv2=!y^XJn2_AQ~Ifur^o7&hNMf-j(t0{DHuSHb76fu3zW8H>3Z>7p=^?}(vO zhERripu#^b9hn7X9a1fAZRJWt=yiGzM+67`mp}@lB$43EqCA#`ZPa~--8FCGpqx%f zOaP+_q?Lj%x3dY<3Sf`-j4$vI=q!k7It1dH{?nByge8hV}?~cc(^$48N#V z5t0Oskx~Xm7gm;J7k)!O{>ULMz(q~F`1R>;z5lL7JGsU})XdPPY?wf?9sVEyqQ1W< zQNgny(TPed+?Eem|9wD!3#SYX3gbL8Y$&0sUy112fmYr*-xnDT(bxT_1{GhH{{LvY z3brb{C@U#p&F)0S0D(J)nP>O`z2H^YKqGdXQTjy*cI|E5e~#?G z7Z&d7l!w!^>A9csWM+2j!UZi<$19Z8N2}>e;ack>nKgItr#<10O_gBe4i?D8FX5Go;(okXG!WKrpEQ@U$xxs!MEem;B#S$50c?i$+6*IJ8sQebxf`4)VHBbDPeZ@^tx zB&+nze$Oj_H6|6eaw=;g#sIIwJ7iG(ZML7dNnXd>;!jE&SdD=diRb0EL}t|Q#Y^gL#o7Oe2EsVlV- zTmDi2k;_g0M^pqupi>~sUQ5$onc~6uS=cFWU*9#ths`Kcc*P8$mBQcH9%815{|}p_ zO{LJ619nbDI{S{>zNP-rcDPJ8Qe$Us!68BGQA-JWIIiASTR%;wP28~C-yc%tgx+|f zhH5kx_V)F%o|vZV2&St=J9ho=IIrOV7`js4OVQ_Dq<#*Rk9%}|-v^1jX}vz#l+O;C z+_P>?;$cLJagA~rA?M9XIo?wgxyjK+_2wPVrYf7BK z;*4Z|XK5S$rlS6V&;%v7IE?M`{kUOwEg(sE#p!kwdUTTD6q^%iNROJ8*s)$=BVz7t zi0w)J32g&z=+RvyZW(pNk-(+P%fn+)%%^sEK;Pg)9l&u2Q_{q!r~w#j*YM^b9u8Jq z=5axdIqG2~bSDn&w1an7SZ2>Gwats0%NRuPh3$g+cgDvp)_=7lgPutxzHr?gM2qvC zX0Y2)g#nNB8hja$tBjGSu ztyntT@*l>#skHb0&A-0-;$%+XAdP2DZm<_*N{f{qset+iT8}foEl_U%qvWrut8;d8 z5-HSFL0kX4?Xh*!F9G|>`r?-h68SSXz?lXD1Xz2Me)=|7pM$y&u3@iWofOz#mmuBt z*N3d}czzPw$y#tri<`TWJ%QEiPHR)s!T|&v`8p=5c6}HB5uI-n|7UMcBdyy_Z&keM zppo@U7J_$W4|{ifOv`?Ad!k9GuB-cBE1fj_3IM}m@j(Dy0%a?ptblEEC5H=X)z;ym zg}1kMBLpuHBlb?!K$(mwd1@yQ3F9<@++6H7PZtQNfI&F0RAfv0q z*auLYHCcy$lDGev7I*8s>&(rW|An8Mo4Ji`bfK-fy1Jo3wTQEDV~9Qd%b|l6rH#UeB0Cd1u?Y zFGcwJI-&=7Sh}|6B2pPfFna>RK0%?meYGT7*QDbc8&lH(9Zt+1gD+Gb6zp|E|KSxC zUIWA)dJA$JZz_F9p?ixwqPri7VKntSw)MQ@vRkj6kr1;XxKSwhvD(((i zZQV{95TU8^mf^=pj2fP`Rgqc^ndz2=3uWfjX_Y?=gOak}8Hm>44>d30>da0x51(ym zuEZbqZ|DvoStim^X`(4%#L&V@lOa_K-MsIc99{2ED!KO)%M|PWd~;I!b6N9>)b_w3 z*wpp=UlS9u4w4JyVc*w~w35z+T+fIMuKmV}KMnjSI(fe3LEKk0L95tk^I zxZaJ^z{`P8EHyNjq#C{J_UpKjGiPA*^H4km!4q(IAb@d^|Gf@|18^ztxNKyrW|VRl zP$WgrGZ+Ni#Vzl5<6!8s4p`0@P_VQ+VS~5u!91$>E%4R{%Ka5pK7pCr8O31 zHua-`#7nVA@L+bygBiaC!xpTKAuqh4q4h`$<-w4MNYh&-L&r+S!}_fY6p$oE2$AE0&5SeXnoCoV)36 zuxK&qHa-T^U$UcPoig7t_pZ+k18g2xA)kiuL|^Z4@+3$2Lv4;b>zyrDQL;n<&gXcEZ|)#KxZoJs zEIBsX5qY27z+sf55@XcdfNQ68#>EX%g-7`Xs!>==>3%XU+Nb#=z_N54GSeJyyrY;* zNB^NQoJo89Vn)4G%(&va$=C*plv2SXLfjm?(uUt}<&~7MabCA`Jpe41aT|BOxT|BD zEdAKw4|Ev`ay#J_T1huZ()mlVug-j$Ijjwm2YzawuKu$S100Q=!B?z*K=V1+3XV<_zc=;9TBuo zMrM;HJi%g=5EA2!_x{Ogf%vNhdu!r&HH!)u@En!t#c?3o(ok|6eq7|xE7RpCRc1~$EtZlsox9HJ~|p;YQQ@B z=D!Z;6Cm0H#(F*K%zkpeBN1_MOXjYcNc? zkIjPXOTIp+G2!u}zAA-5 zm2aDY%kmxgJTJKJ>R-Cy(93|r&%ADo&cO)wI3&uE==$X3ab{uuIFLRiLun7*si$xR z+;iK>zlL2-?-tV-VVa!_@!O`L;FwJCGR^|3DC&5%+X-U3PG$!rLi|U7kp7fYH@LUw!9{ z_y@XF_9AQmAx6`SP65V|@+eoJ^`jdymK;f5~7oD|fN-!yId6h@x?OHCXKC+b)B z437#<;Fo0axDc-axx^*{E51M*pUcHx;ap!vtoLXbN%{{KV{l;C)WTsvlYC1-P+S9a zj=r9KLHk3=YEe+|;}D~NDq&OG0nxIO6}v`?e0h!oH3)C8TuQZz`xowauYBXDrD^gj z%je!gIlCg!(V94*r~CuG?7YhlwM+t-YW!E4sA_!tpZ~MWp~B(W%(LQQIde&eYFHT? zs5j|Z7$hQI%1wsuo3AKsUQak(Fn ze#y&qrFxs`cgf$xWI97B2aHmcN)3M^y;DjFdf+dANFWZ~bBcEqk2JyMzQVi7*C7p# zUUiq2TXB)RM(Rl@e$}5w;)B948Pt1b(QBf#RdKLQyVJ!*{Ws}_*1S*Q&3Izc4YXaN zn+%VxG17``rq>$UNRAkz#)*>0DG?t?o+mIgtCB7$N?6J}b7yJKR}N^S5Z?6;W6`Io zVU@02N?i}dT-Xf!a%80)R?R-dn7j4HZWCo1V0&zUo2Dn3-M&O)cw?vtCK<XtmEH$E+zUv2!Dg6Y7>odO8g@5tPYD0B z3`SwGRls5^*Is%kNn1$!uE1i=op`o8& z%V}9DR?3XO+{&sf@Lzbu7a6x{$%JfvK_rvA1`X=wHTQJ1!1HhO67u0aBC$@;GultI z6e_3mujyZdj#95W(f z2G1(PV6P+2rk(TWCr_m72Pt-3AiZZ=TP7N|8|?p!uDStCeHtzxLbhkU1Yi3%KceMJ z*iMertinQ$myfpEJ2#&qG(qyMeK^8b`VNtF8BGrR<6)`%HU_op+<9ns)&os?AN*<1GO4Z0CY^Se zL5)E|3bt+Tp{lqkY;oekX>R9<0B&I2qKEVllL0Cwg#T|aPPUEhe~XnJBjO#|m$?*! zZIq6f{Vbo;k;^MFo}|qw#T{pU>NvN@Mf#U@O2ZdHM8~KfCFwCxxoO*Fjrn?2Mh4Yc zQ3{X+sOb`#lBZ!WiGAbD6qwtw1o)xWPsjCF}s zrL=L-ak^(?=fIoAlO#f#TPAP$+wTVqw>Up~%8JN%w4!)nU`T|Rz!XZ|hhkh2_I9Mi zXdQ-_J~gMZ$*0R(Mki7~MH*4f2qNr>;P*gyb0G2vwj3Y)r(WsFAP?al?r3}+s5aNT zUkChbE&D5=NC7HG1y!`&^I^Q|&bR8F92{oVpwH#$cxGy&bXR03IxQVjsv79rt|8dX zraX|?-i@nIug|<7Lis3J;gT-Yp5ll9F2-U^dfiANNgUF;xUy15Geu%zlX5m(NNZg# zy=&ENWotXfpl!J13TNKX+k8^%-5zl5e#jWmpf9~|_hpClnrDA>l4kZzmCNWznO&Z@5mUvP3@SVS}nm@J65@yHf z%XNlZOrw=GB5xZtV`UUczZW1K`KFnc>XyxN_v_@~fC`t3g{}9}yHh}wITaWEOj*z> zXI@%{LiY!%ds|D(2(J7GDi0jfjCAY=@#oYC#*|1TA@E##A29tn^o&wdr*VSS8v`ls^VMqz}yTLy~0-oKzFyjno)jMX7D4MOo4Vys-nfpzPio;_v8Ph@ zQplVDvenYmJgP^#B<53e-W{U$?cvy5s_BIFzh^=GAeF9b+8oD%DV61{+O&}C^+C42 zin8WTeTt0QkMlzMzO+x}Ldk&`6N2%8uy~xLfrqftO8Qyyw9(8%vDD1Ies#&6Yzh~Z zj=)9|EW8i|&Q2&<)?^syhwaL66mz9FHI#-~Q3O^J{f(XJP3vuDoH{Q6u!{iuHB&N> z?2@|qev$CU6+fo2!5qL9P8H01vW<;_ld%>=-XZ>dg%r12Yf;5T7H~Ro9fAN#DwvmR zgwh$;Av0PRH2tw7(#sN2wj9YPXJ;>-q(9fc57*SxJUw|&I79(2g*{Nk#PS`L?9-BU ztf-ao$Xc`#`sdZ0qJG7@dU`HR)qy_9>-mw(Bx<*)<5>m{2923apwb0566s1^dW0%j z3oD!}jqx-eNQrx=(x>=1IVoYiHI$WHVOWuSS?!KQ@t~gTUkoGsaB}zDGr^|o3v|rn zAfSp}ag5(GI#RleX)42zs0e-u*?4|w32aTyksQ1Dy1hS?xLE#qR-@5?#8g)vZ_Iux zQh1Lzzq7KmM1ybT@G+26w-tDiDQ>8M%@AmRKsT;{g@_k>!eQ!N(+z+WH9^@PJ+q22 z4j2_K9W5r;h4hc{n)C!bGKS$Z>aQ;os3d1MYe|e`lS{d-EDx0LydT;{oPKlX-qiHc za!uWJ=BDjm(Pd~97}5QDWyNGH-{* zx~JE5ypc2cw8X5>uVkkV1iGCY-&s+6E;f`gf*(X*9dc8Lm2WU+G-QIlqT0q@(XmuE zm!9t=b6{RtNX+9uBSflC@T!hr>G@T%D?I1-OII3TC|;SrlSzK{(SCQF*|4%JTwcF` z0R{3`DLdjzdhV{`Z#dX;z^qs(@9!x1T;z(QEHhKl>h`wY zt$+FY9BWm_Nk;`{?X~K$63WKZQhuMkt}ciRS`y8?9go12?pvoMGn|M<*{pD3<2l^FPZb2MkW+R6o*W6%tNiOS9QBl4+6 z!K08w5z6_7qKS(6+*`U`t~zB=sCE^L_SM6ua$0(=$bPF{gm960X`VAdqd@<>=w<6) z(tn>Q*PMctOJ4Ok$sVh`o{Fsbo;*K0`^y_?-h|CR#jb42d>&b`wQmz>B>h4tl{7gC zMSh3RD&=$y3ga|nGH$Q6gqH|1<-FA_2{&IB&;a;1FHrI9xo}UgHM{}v9Cx>y#M?jQ zqd{mX(q$~l+rmf2?MUA4?gtU`;C&N*`gEDNO<5gqji2~UjE~r;n@hf3LfN1#s zcn-@BsvMrrk%Yx^o_AETsU@1NIDI*ZXdd}yVqD<+_~+Au!}c;x3v9C7`)SJGC|b_= z+KiZOior1j5NTYorK?Dsyi5_kogcH5e?Uo5SNj_Ax?l4sAtgZU#RSGnmvxb5|ITqr ztlI7zlcCR9RF#%MdB)-rwJI5IT8)8Gh*)MD@lZ<%lUDxL!Gxe~hK~&EDd+rNqqdz~ zwU>k3w6v;MCJVMe@JPG-o&~9)rqXh${FK^PGa*aBS>6#d-h42~Hw9DpAiR@~lQyEb zB78v}E#Zt&>(|!xU(C~arSyTIGZS7robquOeFGPT3Nr&N#`FOnYuD7`?qHcUKy{!= zec8FKYsLY6OfD-e_bqG%*>j;P4)FmH8J=6)RyU^%gG%iNM5M-4Q|RWw5z3dx)bATd z)>3Sz@HemezHPm49d|ul=Hljd_}HHIpK^X!b2d3SgV*ZHMLh@S6yQw&h2cIOlV@oN zdFUTbvwSp#Z8tKxX2PWYU?v9#2Vw5Dl&_0fQ;tkH3%LfkJz(eW^WE3l- zwYuTsPVCTA?8rRV!(%vBSFY-Z=rMFZttiAXO4_l2dsHPlsqf7Kl zZn9Jkmqh)a@b7ycM!>)Eve_S1*q9cU4sBM`ug|j>dtTny(En>#aZSsM)NNn%COvrM zo4=c0k9Msamwy}!p0?omys}x%`3Y~wu8*aG|Eg-Kc&Htm{_}t40T%qzs9Y?yo0^Q_ zBB2*7mg2(ahb4I>wPVZfc1&+&D827Hc%>1}YLQCR{!-kp`K%ct%q>k# zLv7}?1)IM%u*mKD#yk~;042C$s<~>(RP+2tgznIKW@~3GTj2pf!5#%niWP3{7+G~+ z^ilKE%-T_>@OKY7P9IqM?F7XZp}}zUqFe@&^Tx#y{)+#ByTyhNWvQ8VqoY`s!L%Q! zej2r#&73SFX8sbso7LXvF~OI%l4{%xsSEV14cn|>!t=_*QM8myZUZWHu(7_o+==|j zbSg{z%^CMiiA2EDSf!$mvNUn83EfUk?Yd{=VPuvN>K)w-ZZK|k`@cPlNPG?J3Y*zq z&5{+}#mPa34HGU3J{MOwcN|}`=}tdk!bvk30~#byZM^7(zM6|N-ed4Bv!0~kkXscj zxgg}PH`-)Nf|xv7nt-YFipPzf*BW&hmlMfjT5%&jUk$#wa%-Rd!DYM;{_HCM|6Bm0 z#9qfi^~q6R%a}?pN5?B*@mktVLT_nl2{_RPTzDtQvELSd9=?>0e>d;t?4AO6j3ih; zMi}%Yra1UUIb(R?PyUrbO1ne~ZdeyKGSKvhSl|&tp|4t5S)nf+CsRE$5HG=;@)8r9 zl1AF2Ca+&CjS`5QwbfB}{X0wGQG;5%hZA`!|Lr<}CDcJ(r1)Vi1l4fUTkBGOE-3&$qSUZ*hb4Caq4Ca{+cQ! zfmx=;D!A#E=ufMr#Y`qU!)Tme2CF}(l_pRsMRQ9RJXKngMjoU*$gu+tcC2mf#hY~Z z{u=YHYYJrY-A~NHKSaCv2J_vabZw-SB82cVn4@1k)@l9pc>#U;01PZLgrCFwLxmk&41wTAWydbw9@ryVR0c*h8;P<$zW@LPT*H?TCd=5n*oMh`=3-iNc{i4 z8vV33|Cno%*JltBCx04!XssC{eaSjz{&nz+hUPo+?6Sv>c=)YWZ)BVCNlf+<;u0VJ`7bP#2qk5Db86synkpdb3J>_0?J(FrtNed^G2^s$dj z*Gg2uVz^I51=O4EeDw8+j`qn_W5JB>w-u@^6s>D#VA>eJc@=8=Io#IvX))*F_ONCf zc6xJKv6 z+vYfS?isb?Fc)2oK%rUloq()W5fr!{kZ`i zyNkS@;fU$Nkd8vssbyw;FKo`90oJv*&mf~0#G1!~CUC|~*+ZcOSuZuG=JX$f^d|(7 z1Xjvf!$rojG6ZKuu{2V3c^Gxl=8uv-OB6o@m#{%qG0BD^*7mS^Gy|)lmKGqDFtiu* zx<1*cn=$&>6K_z_=hxI8q-l~ULr(sat5TX5EplJsdY58O^9}sLg!qTK)*VH`6lUci zGr8FTrJ{UUrO`@fBjqln>fq>XY7VkP2du{8ZHxA1RHV|rc0SX;3uk_Bx?yFJJ_PsY zKKeR$TYqy2u~T}l2$~cELc)bMlVkM|S|(wZ<>r4p^$SJG8%`6Rp_o*(?$r=k_38`w z>y%D%Qr2y`qAMr9rD>}`oQ9NtuiY}BUlvsSmCgPCS^Ny+z(QjG%Ku{Zx=T%vCrA@5 zY=}_bdnW`w;c};6iX+*;h9j%r0qHOLMvGVCPv;wf-x_R8$>VUeEq8X;ca>5vUUS0P zHvv01X|=LMGJ#<8H}1c3sC%R0?hZZxzn$2qi%M=-m;dz89Oy)sn%NK1)B8G+m$^rH z&@K;qayzI-_0Lour>@nb-&Q_-!UnF z8Ku^JBQq4&)Y_Vk-Zdcze*wr6qbE&2bMo2Z1UTru%Zm&z3pCYq1Gao4(he3s-}v5o z%;@~Xt^1P=?G^fg&a`;W){y6(W+zGiY>4D$`(^0R!2>ve1Gk|Gp_m2n0Yx(g!U02a^;Y{kI98lWCTdlDO5B^?VKHOL(;hP4U7Hdc_~|{ct7{lGumKG* z&=PWSas92e?y!P+vmnL;+wW_jm4679vOt)2a)oCm?qmHvD>D;J6ARPJi;IgOp-hSWyw&Atgb{4E z;mF?$wM}aj^1vNjXeJzrRnM|A#G-pLm7g_UpkHYQJoRw>5riL%(yGXbzj^YG^)oFo zSy*wg6^g{qmQa{^IXB6uE<5=aHlf2~l5F3vVTu710X=j6h95rSKkP!8Ierf5xJw~f z&P8?}etwshch23tnGl&iWw|*cOBlI{-chWy#hV1h>J}nejGE2OsgC=-{7xA){e!iD z`G9Uj%h-E5yY@=yJBs{v6w}SZ2hu@d&eeD2v!>N1eRQnSeq#}9NzbyM`JAg(DENCN zM7%YnA0%4NzPiq)TGG-Okeh6*Wo3Hb1H6%EzRF_IR-D;lD;aaWmyRf&ztq&7x;`~I z27pqjX+0A{!37V`Tr+VkB2E zcQg7j@n{Tq3k(o`u*FdTuJqPT+j71SQy@KRnQVCM%^#^C zVDbj0pRHHU@bE@rp3arsMzE8PS?|dcV>`(%Ym`vQrDZs16$@#QHR5nd-rgO~txkp) ztB^Z4VT{TQ6hz=g$Lgdi=f9&b9yyaPl~s!!dQoqcI1Y{?ELrZnZknN7j|sJlT`g zh_trPZx87=X-^}rVowYfjShMA(DwZs2S|_}8R#6F9PR8nJ=?3cH+lx93rZi3zQJ$` zW!}wE{ny_ul8PGmUyv1c-QfuV))sYy@*)yUyc#P`plshZH{i%g`5?Mc zZwjyHBFW&FO+R)?2wM;9nVZQJO3gSxPE z4#T5ZQDm+#ZmHq^?7KY(*6uhv$Yo0*_rCkD)y@`?b%HmXg`oFw`-oOJVEXDIjP93< zlV6EtIU(^R+kYr6(SjM zTQme=qF6KD4V!IdpCwp-f!a8k7qhpYn}%w*iVa`BuzNgvC{wuU;sRF&3fF68?3O!x zeLbK{kbo*Zuus zOArN#Zuv_#^=_BZx2zu->&l}VW-{8&rkv!HQ-J5s51GQ>S7_#!<-y^~r-dn8e1?~X zx;{FZmfcwgU?4B|)%IXMnNhj^%}hqVTUyti8qa>iv!S#&y%T*n_--u-uKc=|%} zwm3Zv!%+p|^hU)%rLqYs@!8wZwz`Xoi|=0t(d_ZinS?mPZ7YuEZ=!MLj-qnWl|_y1 zwP#0SOmE5QNcCeEzx?d`=6%j8nD-`mx5|S}8VOpRl@AtZ4RT)?(<)Sqz21(C0_2{P zO$I9~ z*z>Fq`*aF*G7OFx89mUD37XkqM;7F2G{qQ9B>ear`sO{= z4#`qww%eI-ZZ3&&Pis1$!oeyQwQlpQ*1tsEyf-%Qa zc=*IMpnd}@h$eV{V*Lz=v!>ZQo9IFZ+Z^loi09!cCpWi2;~1LPGV+bkgZ2;~j0qtH zIC}>NW@PLgGRi#K&*j-J=8CfE3Uf69WhB~y#gakB&UX^!s(Lp9kOgzF!~(bY{Z$t9 zaeF8pw9SC1TP^3b0fum`tB%J9fJ(FgHi?eIr>mE_@&QY!1@IUr)e>pr1*F^YBQ4!c zBJw`=@TZC^AMa>5TbKkyW7TNiLDGk}2cqAHPExCCkvVve%dr}dVp)`y%bBgs&z4=z zT<7*xvNJJt;JBf+Yg{fKcCaYsjd>c-{<;GDjEf5<#f9`^Gzot75P~IIF?{~1u+g*y z#MN}A658d9t^=C?suy_7MK|5<#)hel8Xct`d8P)(HDMg}G)X?d@)rk^QiUM$&xJP* zHd#^ZTE8-q9j^@U`2G6rr)^2$%)F9L3D|&xRRmr5USRE)_loFY$G2HG<7C$?@)`ik zz(N)QZm-OyPI%nQ?~}i%TAsv5L`=*E9Kd4oW69X^Q%iXetHdu^dgJsTg7jtC7q&mr zq>*iPOvfrIukbfN9e$H#yXNDV#D-bXElXUNgKSlk$NAq@F$RcG>Xg*`_I46yFGw9b z`~hZEKnND2NS+^pBN8?eeI^T?=202BU<@zY z_qMp)XcxZ34H09fqeDrX2r!)2XOQ9e7w}pu6-xh13EyIzf9Loy{wftADNGe9FQ*3> z)!_Qh^000c1e2ys`>GvaMKj)pvGvKe*qOMx&MC83cY$pX0kX|cA4C78h8e&JM5#hK zN`;?$e17JKM5g&yMJ+wsYd!!I&B_{=+iP$JW!SL+(NHwoF~Bfwf$G8(7E7IT|NiMH znEqp#$o;0*SIojMX85jgfd{eGDH4O`vT?w9JZC2-0374bzK_+`McYL8VclTe2W)Qx zc&}y&zP{EF`Zo~8ycARwp>Gx_{(4IDF`c)oYgo(t+yCuSnYT>v#$|E z2sNkGUu-HJ%&_+Os1R8s$rr|vUA7IY3nmMgCKjrkLq)?E_UmLs{JAI-)9;diR~Zv= z>FGfwu_NZT=yR_{cY;n>j_At$6*=ed9rp;NxqxDYoEh_5LaZ9r7Dcgi44{(o*yIq5?R+SFL?7RaC#Ah!-ZqR=n(0^b{ z1R4YT$YnsyxC0|Eu-us+8vkyfF@<#EK+#<(>JaNrH}+RVIOX1#spVP z{m)WHD~*yM@KX)&AQhJ;DI&d)+`~qZRjE$@;Z+`3)0}%`?unf6x3k_*i0uH)l4q!;L5gaF*RwcJ8m8kGv$y|vrEB41anj|#ImCOTQW+`k^2 z%X)e5;g8O`uZ%8&tnApC=6oCv!sxOh90H`rPFt0D?GZ&&v_dnQlPlaGyeG=`0|Vg( zWOw$~%~+`J^b1HPC^NX}bE-CgCAT}!BLYSp=l}t)^bzE4c#<9my=b`!2?2TT5IjBT z-GG2jtJ?**?fZKGdfpmT4EA$pr+iKT zJ>pq^b2s#dd|SCXH?a|qC=!agV+E_5p!Jl}s(IdzKwgS%I@VC@=84twGXFqnFGjj9^L%iKNJ8ncY&2J2$c%)VoADSSN2_u6LHzdQUS zeR5|!DB{7m0z=FTPc+^ci`IM+)i#n`L~bsqa^B>fx=)IFtSRX~b?2vym4T$=z|Bv7 z>vR>9mr8FkF~wnx;!=YdD6&$eZu{JtE7v%ip-FNPsv|)c9p>tldkU_BgR0$x$3tsF z@1&&>e+v!tmoZPE1n>(8xN3!$*nUit>nNQ+pLx?MpL&fI7+l5vYLgBl-g0MIoc@jJ zzc~S}l5MSi;kOq+O(1ov<-K}A8@1we39e=ETlw8D^S{cn+Y|CkA!wVF%=+$JUmBcf6Qm4gc1M#{0>I$wmZpvr4LV@B@K@6-!{kL<#+l#Tq9=ygT$pEc`_Vy zI0^4bR{sKSW7-?UkKsx5v{B0Bg`%{SK^>`K>dFrIDm6E08fBYj(q^SNz!)7#m+t=L zw+b^iBpqQ?RY4NJ!l#+cv@W{NN2*+tKlqBy_`xWoY!mG&WkOO_r}`4^A7S{~PM)rH zWw8LJIb!Kf2MGoB?;{G0>3vr}?Q#t7J&VVvcGh_qE$btWoe$59O~}Wj(^|D0iSI+z zt5qJjF(v7TX&6~lH9^#n9_|71p^Fy|_P?eNU6&nXvDhHiDhbG6fIWDYXrn|C$xFE6kQi@*4J@J$1?vGfSRdS9+_-A^J^ls2k~!lxljsE5m-M;xt;K-% z(pF!b-es)I_3ydLL;fjDB!}2kvmBU$YZy}arKPcPer4rEnTEaG%?<_UCrT~r$Ge*I zVtE9#gD8YFl`j{dsRiz?pIp)~S#~q*SMOih0r=&w4BZ|fZ6b@lIiln0m(ERFjVe`1Ww6w*%-ktdiF@Tln!Q2TY8k;>asW-A6P(kdN zdlFb&;`2`r_51yZoceYprv!CVWiR)9W1I(8QvY>4UlcZp+}zzYE?GhBwsfK=8IG)g zSUH0J`kMC)jI>}5(TZCSn8rGSu2uR1Tw>&9`*pvQ1jMZ}z!w8N?F8owP~kz%Z6ajb zLQ$>`NV~nlBwp6J`zq#E;gvkVSEZ|M(pD=61#ij)X}Vd(xhIL+{beH_(`Cb-Gbae7Z7{y?jCW(kBaF=fKk?^M<2aI<&AJ1PfqCs4O$o~& ztgthQWPu7DbL$EXOGj@QO9uxsRr}QcP88G`^nV*b-CY=2qoOB5G+SItIgL^b#ZN5z z;V(lsx8HdPi8PQNX6cY2_?&%#u!?Tf?5u<4b3ys>;R{Tdep0;4Gr3w(9N(msV<;17WJ z*_>~w(-xdu&TmT|{x%n--yh+ld1NSGacsU?naq(e_FOC(s?m4XE8*dE0VYB3E)FXV z)1ulBGkw;Ns{JRiHV$Vh-VIPi65KcN>42LAN^ghH(*roi*6dRe(Y{YTzIKQQZ^&4q zImdo%HX|7f3AmkS|7)4Z+A(l6SS1WXT5u&3ail@EmaMFW8ojky{v=&lNz-#~gp*U` z=gNVK?fhx6Ywh7C8s!Pl8E_*OLxu=-_2a4I=HA~v7f+?iCVPQtU zjyF>~y1NhIU$R^rQgF{#pZi)`O0fpMEs8?-V_D+k=NH2xe)F4Mb$M?go5PuhWYdBi zmoFA+SFUVnvL1qr<-MJ1%63)H(%3Ddc|~F1u|E2bQaibZk={mM5_6sUvnKomY0l;h znODSFIXU_H!hQ#__E7^|$FCl!3U6BOVk#;1o(pSxTOU^7g3!z!bSdr1S@=$j7gsNk z2nOarBHlyQy-jVf5#ihxdf(!8{Y8~nccWMD)@~O{GdU+ayf%gAz~Stt@%TvXr6#j1 z4}pfXf5Ss=aHj=7Z(5EhkC_&z2(#v0( z%vQpyZkU>!JIv;|8N3vbFVf+0GhBcPZ~$O6`fnWiI1Ykd#sQ203dpMU=dZD zOKXavD=Be0ShkRhj1xb>^c7~V$+a%o#Om^D#^>%_Xd9QVC`4@$>raB!D|5tzaQ83o zA6`9!$Sja{4JLOG?_gSNa%vH&Asv5w*uYaKC=T=?YnUV$bHSzkKH(_0uY({lPIt&7p#?cEndd^aj2See%qbx;mh5$?CQO-+bnk{&Zb(t2i~%F&F1k6MEBc#Us2J8T6ZmLXZ`3V-%P#xJt}$jh61}?SLr^OuJ+8jgIOJ2{LL#|WW0S`5aleFv;;tmo zJBLcS1tS)0Rdl>VrjJFtq6Xw%n0UN00QoQ9JSSyR;KXarPHz9b$&8n2$@T0wDnhJ< z8(l(I>NgWxC0~#j$pZ0)ZC@uk5`KL+GPm$8G&$;F=T1IZRuu0@<+?D2c?#xa@>9>W z4`Q4}l%8?{9J~Zxt#-OwXQ*a>TMNc+`04WW`9CoGtJ1januF2WZuLfVABb63Bf#=IFhAC zMf>l_MB$qOC%{fH>Erhr`sVwKPF^ns(cLZzM}SO2APEF6M7R+nIseZEP&cdJf63C~ zR`CRmv>Zu*O6NDRARiu(5EVU{eCI#RX$I%(> z@fNXVID2zvg;Lo5!O$SB7Db`rS?S+wRA?nN^C#w`GQ@Bgzt2;?%{oy(i){?C8EQdcVW$nOOw6#{n6-hzf0m?YO$D1>NMXZ|NS3(~u zK^cSsGF#Kc0Z^a$OadRf#j;)A6Z2HzxXQjNh>|APPeTNpe0twsp}w}F?C>~e0KWtC z1sEw&0tN-T71Vx&n+s~TIqpS$y8`a83aem2154bD=QomQS70;wvzMonaZRTEESEZh z45kac$p!UQ{-P{4OI_Yi59*9vN;%q0qsNm+Dec?Bz-wDQeV6!Qq*;*56-oKlN<h ze_QDL!@>xTl^p1wxsXeBBJUdkmkoGQ*Iym20mF$My?ibBR{Z!l3WSo{83GGq{82<) z!n@<|j(tAuzR(vz3Mfx6x-DPm85DR>$N}C1w%zh+*!2h;!&$P0*JVdBD+@r?h}z8v#vtlY#MIg!mx{YgBEp`(lSu0SxuVIg~nZo-vw#(r#}N<7z0QpeoCt%2DtN8N=T7is-x8njS| z9vgi#H_L-$h9Ge^0oYbRzM`w618N2Qm&Fiw;xhH}M0%(MS@IQo#?OGo(QgS^B~En- zGzX372%0bHIL^yG(KvbSPF)v3HVE?fa!XWqE)L-%G~?Y_>hOu@jM zh9)}ora;u^hVL`H)q~k3IQ(^aC{dO#sgN9}Srw*wuZ5lP8<{Dn@_Q8VEW4n{0-PA< z#WraH0BK`2%sA`9#?DJYl^)ZmrUZg5!T)v__m1I>|k7zXmaS)@&9-OyyX?P(-OVvQejoD@W#=P}*4BF@=I~tp{-l(rVWm3EPf}_ENC!o{;vL{1^tt=1>-~7%2X+J-YwHOF z;5coG5nBc<3<6$^eXKseW+OE(%CB_vaEIZ82$7sWvZ~(96zoqxybnlT7$dv#kg2se z$HAX;37;-O2pLG0nwkMA$^gp+Ldm9R>@(IP+Z-LaiagoW0SR@faAgZF!sSKmnk2dU zY7eFNyBPNS3j2E`S~PEA($B`VG|;;evp!k2r}%vN;Ms(fYwO{G$EOq#njg+!N{BP9 zNJvB98z*^wt@s68z0PMm|C+pU#sJpW>UL=YqH*^2#Klp9s>FE}U)N^MuU4vwdTyAE z4l+1WE4OvjF}TC>B(yc9X*j%ox2X&Sq!1A^(=ana1!f+s-|ndl3rTOrb(dCw6P+Jv z>y8#Pp=`*H%Bp+#AQ_y*ivS&3S^|;?A+^)D4%@Jj14$SKsBW?i``r6qaYUv)zu-GJ z{d|^D29xe9d<%|A;QDktCog5qppae&l!E5I8y{won*bF0JntQgN!8lrH`fNS?Z30o zii0l$RoP$RY>~4tA81f=iW}h^E|~U3u2=6J#+3p?zz?v46{Do-rkOmfv4)HJU!U34&%zz;hWL`3(&J?_#G-Ht$8FJ0JDtg z)i+3crzV`oXI3P2g=%WskFbh#5@+G|g(Fjh&%~s8@CGpR23z?6FnyNa%MRf$3oMbd zo9B2@`q-cFISY+spuCBH);o!vJe5;Ti-Z+n)25-Aoc|lMq(n|==^kgKlk*MxGsRelt?Ig8)asIKEc6hkzLuv{F;gJ`6l!W~ zwb;6w#q`#2b2EV@6H3vdg;@GuXm z*YJ&Ndcq5tsB*Hyog_z9P!Z|bT9iSHkT`)#m_)?t{j``YBb*9aSjJ5$H%;%4n0G#`U7GITzSw^EmVYg|he3(nOm z^JvDLNNcQTS>59}hwsA2$-vFi_Yp#UDUFd;7Lr$9YNl@ZaIOu3 zr9fQFAJ!htkSiE6<-NZ>&k;ibrjI!=Giz_vYEO1wX03x8vTlRBxcBaq?=v?&&h9OS?G(Z<2PC5ME0D zOP-YUth$pXmf}ng^9sYoj;V}Q^7#+s0WP`&;`aPNQAN!{N7^BovF~b=p)@9);XiHf zKBU=rc`dggluN+JGB*iet^1mMAYI;yK#A2*!D@OJyhFA`#4xe2kZdXhFmXp)+qKSE zoGSgeMl+oC{=XjuDjV^#X4M}MJSYf-BQZWB#vdLX4N*wfzjthz-G0_$5q;d-+XLAR z&WnrE`+582ZaOB2C>j{utOErMN=5>o+1XoMjBPXGjrs@q=q! z65!2%3LS&`Lf?|tYl~AezE~*7|<^9-Z)Az2nVAShUN1v z0jB;gg#zop z4^^}9DiKg_3tOaBcPDP^$k5F#w<(O}5UN!x*#PL;CA`C1%`lM#3f1Zxejb zjfCz+Ya(0GF2|_;-(ZV>;}c537?iq7N~QsK+7XpNR$or6M@ud6Wj2cxaR?24%Oforg-6W_o$Ab_j(H^% z@R%IcW&XCprOV2hp0KYW(alL)&K&qQzv%wkM3jD%zO&@wTFSi*7jSYpX~TGpLq;qBs4ej!mFk z_`6#gC?!99Pr9SqhjFi#=(I4Am<>O*c7b&8>jiB;wu;(^x^z6nx|$6qQvI<vUu8UCAOMAqFXx0WuMR0lS%5;-Q+JY7 z%QH#G?_g7py>8qfmdCa4R^PRo{P32TS> z>mZEZ{D86*LrR2Nqu81va}pXV1={7P*|X$N(a$WpxgH}q8v0wcAGyM3lC-|JjlPQO z7HE|n7VU#An0ji{9hyY6eA0tMvS<|DCIgx)h$#ZzvRu$Ajb3{3>hZs;Pim)kZ>+{7 zhO&OFb+o8_R#tVGj`2C}4|a~CjIxpP`T4W0@N0A$f@@uqK(Y1rfBsdaHJtJg(B?bk zF|ILEcQ8=NpIFR_gD4B;b3_&j_GFYLXyG5`B?P#FsL>GrhE!+LblB3J`HItWQN{9k z9kXim#F~nQKYgF;6jv+#l)u8JOc9^Gco3q?jmd(ho;_i1N*QV*VpXVCdZxP-n6+cZ z__{9wyW?v{?B;XV2Yw!po1scU1-Tm9fkCXJ?SBBc1RFUYaF>` zq+{3FLU-*OT)VPTR3mp{tV`f3PmhTMSQZ$1T3cE?A8txvOXxS`!c8-DrXwQUaG2MH zhzRd@c6O$O)SicgxS*W|-4rxrQtm#le+vW$w_`Z#&xM#hn%-~3yKbjtc#=P7Hq2HK z$rA#*4?~XE1@AOaVZ3d!3Z06ym3$JiP1n5-`$)V4K8Vm2N2jNR z`1px7mfwiaexPBY0BUU?^zni-4xMe~<*GV4PxId+^{CR#kJ=ZoD*^z?Bq4EZa&i(p zS71vo&$ovhn~nJ9x6b(AWUv)*%Ys(bzs?s*N?j32w*xlmFhS@_3N_iyrn|xl^kmkN z8#BY^+9$@^{EE(t7L_bD)zx2&ZN{|q4y^lt5B@c*ma_f1kv@|J5>gmiC23wkDk5We z7t9k+yFSmmle#a^s_w2y=})f>QJaJ>w;+WPB+R&d*v~Tv(!!pe^xuJt@ByBdjSYiW zV;n)lpb@pa0MsPQAiS(-P1J}T21|F~w^NlKYJEGF_dx@Jje3oIb>_!}PN==65vSVkBnNln7TU`gPqCkt%;_?TeT%Et-3oPv?E0Gc=q_XRE427+z6K(z!wTvy|Dhm`*;XH3LyQLvy zX4(UihM)}YucD}M8@+ik!AM=(OdZX*CqgLOQ>%AvTuQr{nRL;PATGbQcA67nWhI24 zjhss4c#dH!HY;|uDesiQ=MG^JZAHXd~$k-$*L(g`MW#^BZpfR z#UC);KAv@bpf^~Vn*&{5KDTGYKCgv{UbIK-13ms`i3h5ejK(@L7bGTll1WlI)cG@X zFY!OblzC*s;fsgt5O()>PP4{s$WR_e`zP!{WQ=u z^=dVWQ$+?~QoADz%x-=eA@EX1WO7gHYvuc=mZF|C4Ka>m0!;b z&MDacFgDvOE6@K!3L|tA8-w*Uiew_`n-Q9u{;r;>Y5w~W3RLcXoV;)9-{-*baB^}2 zHs05YwzMBwp7D>yIbQz>wXS)3%Ps1x#<>Sm>M+(!2EGjb(L!8ey)_5{x$@boJ->(R zFLht8l5d!0;W!vU_FFSx5sbB)%|S%Q65=B;TpA`%_kIqP4U_v!()WJDH1EvpZc#5mbRGeF zMM>0~caXY#M%aFQ>Cut<%%XinzX@~dsIcbcy$c6J(P)Mz5)*HtFf#e@qDY>gjYPnj zPl#JHx91K|l3|lvc3Ez(DhqH;>e?JG`XkTQY3PTVu?{p9G~83;dCN1eg?l2atW&9Y z|Nc2cv29>Z?~C_CWSR4YM)%9Mp6mtQw_)wW6xd3lrKxRr@u56ZclnY|r2KdJ{xs~b^D5_tjr~u}SqtiqoAnnIXcb8^)+bv;9ArSg@KobPL zP6Z6S=I&S#mA#`rTEeaZ&sgq) zg!I<$!!3IABb?fyc9BWu?_r_Lm9HPr0(Fbr77eJSK`5f!Aodor~PW zS({Ik-A@^YM#ZmEd&hkI)$UbrM1hI2HFG8ZBq#*VrP=GY8F{{;hQDKR!t+wOAdkSm z7YZL&GQc8$XNBBW@Li8Lz+icRj0O3skt>5 zo3Py?VJIXf!k1T1)|?%00saAYEv*}C#(b#@ ztba|+nirs;3H*p3+#q*%jm6^79E)=nm6}C%mWLpT;bCjbs7-M@I}ym|h9r=^hJ^Lt zQNFNN==6xdq^^FpvBWQQVL&EsMr20hS~uP(ucjMz`$22d8fP__7 za$TaMx*>WMk%D;=!2wstK3rl@1h9S<%l?hB=c-4JS^T=-4J5`|A3s08DVyU^ePK^F zN*d-4G@7#Drx9my(~3#7394+-KZ|sj`!LUdlF=&K7b;XxV*4!5?tD=&1C7eIBtMM< zWp}kt8EZ4-I7D2rnwWUY0O3snSl7QxH zSt$*f!urBgmaG93qK~MoG-|qTp~-G}~G`h77vy6|6u_y7d*z<4)9LApyO_NJcgGS`t+?c3fMf zMYzFmOsGDAdQBA&aHAkJLM)E1F&ubrj;?8GdSl!k^+@SzYMVH0{$loms#Z>`2bICy zbWYaVAjrT2NGLlxAV+DZ{V3M?{z1eTS%vI&YrSl?5)-#C#J?OU-Vhedo9q~O(YmY+ZbN*g1 zi0aKp0mRfoM*cpt*7D*Bd^5AL>g@HM zQfrwi(IX;jD=RP1I>|E*E=rIpZ6CpjG=U8JYl;S@oH*~ASyN0Mnlwz(Rw$pQpOA2-M3nb z6zf6^XbjamWf*ITp-?6mF8;sL(y~19p{6TSV{~_D3v@lt1+w+*|03eF#;p7nZE{5& zt#N4~KwmW18}@&IFa&Q`_&9!D2>!+ZmQ9kZE{nQer6DtNe-JL;ALkJ+wkFBxOWXn| zlRUlcH)aEKv$T8I;c~r^d2Gh2<&;c}xeXDse3Z`z7j=qcV1(h>?*;Z80_J@TSbvs2 z=)7b2E@y84Kc8=6|8@lsE_?4#at(cjaaD1t;_gpHa%X>1AI{|~l>AjW0N3o?oHGag z(UWv8t3Ewxy&c4`Mw#o7GjC*MUo4hY%ucKbkdgtmz?g8; zFDP5m9kTQZRACJVPXx{y&&xR*ak??R4^I4UWheo&*WJx*YM?uW548t4V>hR7MMr6C zMqBXwyIH-{OhcaMOrPM3-qjeoL#zPwcA1%WFgVA9+L{LU|Fr;HVba9W(hwdWoVp?4 zB=b#(u=?Cxu8$t?>%ltF-hSF$8U~0FFv|i2?Dfv(;zAACbfxzMMU;5zM80?~|5PV` z&^qVHSi5U?r2;4g&@dCMhz3<{`&Lvvo%Pz~>(n*uIPS%HRZX{M`j3p3fU>BC>Xa5+3N3#mkZ z)shRwB|h|%jJqeSLg}J6Z<|W(2p)eU9_QLJ+ znQF{|?X|NVSgAm}ZyJ$<(hEo^KIyh)wj0E7(*8B!<;)4wuT9)^@;z~F)n4=;_H*1q2J}fVyMZye4M^l(L3BV? z%KnqN_yMGoO`9=2k<3?kA5GnhvTES_$+`|C1pfeM>m9%)0Yaejhb2?nN`K+^vo|Q0 zjqN%v$0p7k2-K~8I1@w8c?i!YyA)-vjqI`+y4IB&*mXpSKAjoU5>txz=0I^lWT?dV?N45#gmta zScLZ|DJhQOs(4I8!w&(oa0azl2WHVv%5W|N?!(jZ@$sIX9-g1^qkcp;gwM5$J12K{ zoDY$;@v#Iyr=izR;JNWW>=8kO81gFsiM^JU0QoSO)pt+QIB_NpES5h9clmtvYr`y? zN-4{>J^GoRnmV?Aepj+q_IHxaPX+2>r(pfA71FnEh*cJi8wLrdn(56k@P--=#wiX} z+<3MMgvHf#B9u^9e~NSDSN@*L{7H*&A?c#Ope#xE6Qf|#^CTqV69`XtP}};o&6#Ex zyDRIKMfO&$^zGpXDXmW`ZFtW|P()1Gr@?pcR1lMHw+Nv;nL_krI%iHS>G5gQM`(W~ z_(V6};vgY7V@YvHC1@klkoJv=m;`}#dm!eN-_pd@OmkqLzL(asfw~aeHl->C8; zE;>N7r~hH%TV6dxr;V_ftrx|+A?ZoV+Ig{%#O1UBQ*%!~K021Z9Z*g6`LEJ>p0EII z=K;N5nTo2te0so&mDe)gYv46NPJpzU*Xw?Yjy)1truOIbApEdt>3A5>C$L=@n^=r`#IpZg}}!HoYc-e> zrabAY*h$I@^sQR-fvUE)74>&0(2g9ZCGa9xvVGE*VBr=c`04$W@?mFa591%M70?9G zfky`t0kOA?{0(9VpdjMa*#mUogOf|*0`G3csFDw_9x(+^IbOi;@N$*U&si^6d(20^ z^721{K9C9hPeI;d-oqxZ6PJ1>Vrt^X` ztov%Db%qhU4r^|%6*W!0nc^8{RYn(bx3}eRL>Cr5tLt9?1)1V z)cYaNXB?lygV>kc3OPg>LNE*au%bR@ThwZ{;m456@|HZ-%v|KxJK)Td=RF71Ee-D( zsw(8Ly(j0_w}8^KfKdX%*~@kam{?&rw*~9KflbPPiiUzdYN^(#t&BR^uqm#_&dEi` z`ba3ihUXqnybFsJ5KRISA51k}Oika_1&ZL#c4|WM!T)BkTLtzV1Oi(eZKi7jk1r)C ztn>D5ie}~7+zpPn<;<}kx_fK0|I}s*8B$ObT&QZQdlrowkzyAc}!EX^gs~YPQMb@?)#NH*HFW#cA z$Pna?jVR-wNbwiL_2sasn*lizuyT;tfDel4=+JSY&|iQ|E`7ie@RW@Q3&J?wScD>|SzuLj zwX<8d?E?Gz&&WtFMT7{>cND{+Z{8(}2a1*o2X-ECYaT(@jR3cj%15sw9W22Q97zTe z;o6&#MAwMfSTJLdXELmyr?kQH7)%87+_2)X$)CBno0CF^e|=?idvgb#WjekO$npZ1 zWlMk%+Gd{1AdhAudU)N%?v0dl5_41*C*yZ3+-Sia<@y5I4s>=1N>h#CACI>I8TF4p z4aKE=U*PH8OV1{*=)|8t@o7tDhh+BH2p$z1o15J{71zMjH5HeZ>;zT|w$%OU*2ko3 zO@v^VU%8jgTT(i@c|1KIKm4=tVsNuMb>N@;RPreFo$AGhY&`05y_BKX)o!%S`GF9( zcq=)C`q!@fI;Rx;JF*JM=t<~^C+eu~WakGc@jqBr)7|C<^2YLdkUr|bhE>XLzQP2&2cyd!wr!5PESvP4K~4f4|Bmx@;dZks6oWJ`8m&${PdfQ(58o8 zb?nchp%J@R;l_E;*H*YNs4Z_iLFbL_G*%!6Lj6v)5Iyr(4WksIgwosth4s`n0uJ79k7{BPR5hlVAw|AvsUW2>drBuPil&@w2Sj+y;C$>1PqL+ zDo5N}*~IhZGi-X;_Gf+8K^E8372Xu~&op3zFUdiqbT)JD>P^up0qSzJ4m=_!e4;gYLQ&*Xw8bCWH*15ruZq8-2S4 z4N)n1Lr%~nPVDCL^85s-hvwDbL}U!jwcpd@5c>^7(=Q>hBnu=O+6J>bQoeo~(zF~u zpc*D==B5t-%j@D*G-EE4LH2ChSOL*++i3Q*dUlC7|6H5sDYbEF$u|8EsgM9ME+UHH@&^{h?k_n%66meO-b;9=c!F-2+*~xDACcfT z1srYa{cyU3mlH__A*ODao&H}dNYKJ9Xw(F0c0@e`!YX<_4>f1IGdXIdT2G5uVXzkf zP?>(!Z}g|e;fqU+m!aY2(UH_vl33jm;~n^5mm4|J{`u(8RfH9asI!@;1@|k+Yr`4? z0mqLm5(5<Qravn zVcZIbi&+CSiuk-72+-woab@lCwhj`TNQV@(pzecbu+rkDC@WaU6qTzxS(-MVkR2^$ z5}W13+aqSCdFncj-v{q0W&mk=e#s4?qiJkkG;x2+V1BN_YCZbc#Wdbw`Dan{9~*vI z8U!dc64Hc4hXH|2%veDdE*O@R4NV9>N9OV6JDxv(ruWVqjpu5fA%(uxi_fcek1D?9 zk4dD;{q6mZ0wLZQ@@64P31?z?v^*wPgSc?81UBh;wyCK)i&O0a?eiK|k*)(v<-*mY zhWm!f&OdUf+C*)Z7mfbdey}uFa=(6hLBkyAD|&Ig+=AGN3Cm>$LYjC!N?&jv_*SWCtu!nn~wnTEj9P$yK|G3sXmXuK&|Mc+i0Qj>> z!4Fd}earJ~Y{{hG@Th*Y^A8Fr|C1W({W#q5{GwY;>A~1M$vcc5#Pqq>vlYduN5}5_ z)oq7>vTXZb$mp3^iChH*ns|w?CHNeW0%S0KTL3zl6D1+}xgvfBLx9IVJUJN)xwC9N zo6CoXv3QKB*QoW{A;TWm&>ZZNefAs8&QQ_duX#D?7ggzd+_PW@FCKjc*Ry@q5@)7J+p}6 znXbp|xRu3VfY-!#si)sBHP$F^X}vK!hg+&Kkj4>%I%4AxZo%~#adHYpM}S$te6WYZ z{FdP$S|bNKMkXD|`FKe+{JKyRLg8FQ^Cvrag$XcfFQDhF>#;w>Dzf6A;|OO^3~z3d zeuU>CIBLeSyZXlXr%u`j^vCW`QqlzR3D*r7G>tcgvA15%L(3@=4K#MRANaT$R$~s4 zFrycXw%4KIvn2BlD{OV+bbNx+`w{x)#>~;3XjztP9^Vn0jvf(0{en_HHubpr`{tk& zL6Ca3rxvUcJflW(%UuR7=VPq5bUrW4wZaEmHwdbls5}vAo+OkNk@k`2=eS4ESo4%Vwps_rhy5Ebi6CIkjqg<9^CeDq=qoZ@b}M!EBI}hJ*MPD9gLn zqp&?ewc_MPBv#-NG6e!&6ylwCd%H#{tae|gSW0xyUGx|E;^{C=Ag+msukt_A!a6 zUPBe*$#VqW7*1b4zO9@CUNqq$BZmg`jo?w4{H||2b{`1|XAjx>H0`SJgk^KhK-5bP z0GjkJWhr8N3Pk3K;%fzH!-|94-~ zHU=bbLxuWH6SPU;9wzrBGG*D>2;Msjy`7bwpo_}s;3Q|9PIxST=_m!Ti0pdPIW zvZISnmEBQg6L<3YE4hUDnLADuo4gQkgt~wHiq}?=>Y?YOzA!u`lgSc5YlI-Pa8|^n z?l+3C>BX%OjbO!#FFZ$w7;*q_Bf=i=whoT)^x}MmUoi^vmEE=fxb7HY@SUmlj7GH# z4@GZg3R2;0R2B`U1cf?Af+*S|G&=i07JBLGNEHoYBk=h63_Q#yF^+awqo&Jx_`hxm z2bVKt?15|PdNI9aouyLFC9Ix@D{zw8k4B7bE-l#K#S?=?(^c4nD>!hNk+=Bk4-vn2 zf$WtJ^WSXrO%3t4wNe3?wjLenkpyUJS;@bO;B)UL}Q|u|xhv^=9(I zxsfd-hhUo?xx8dKvAK~9?#hyca#{Y7_EjuqoiT8=O7jn!@X;i4dly0X<7{c{<6c%5 z_o!R+yrr|dJ6D>FN9#x8SW8$pb7<*oZ*l(!TXVQtF~9jeJ1WaK63HhtjM6Ug2+F*o zl4x?*zp@9OROtNVns1tm)D0JKaQUZ02Xw}v2Xs2wqE}f&f;Ej|9E2ge%qccF91f?B z72+GeciT-dN2%AFMy)+P@$$)?tcxJXAVI+E*;Mm@uXd{@4A% z{kasxkEBTJtx9|ec1Iav7W{^K?b7rK8Lx2FwDRuT2Uz$}ciS~+MSWJ>w2X|+DiB*K z3dIosPJquT@6B9W^`(|m4qB06rfaGj;~&n>*8GY}@@OlK{Wae~J8uix`t&rZu_+wA z9cqED$DM&kF@#NQcz^2~7mGE5WmEd~j>VO8fa&AU$qG9zapj$bh#!cc4T^}GG0$9T zT3qEt`HVi<$(`v`ttNiZ{z+p?0)M@?>hWG9GgIZ!ldksP=I-xU#yCZ}Q-}Va0tk$a&ja2+iyU@VzHsW5Y=;tg1cQZ! zTRRT?jc$CT?|bB!!dhGYq8t6Rjt;&*h9RR3D1iSIV8Uaw#E-mGI?W$w`0#bh=T zf{|~zFOO!~iP$AJgW}YO8Z7)?X3)2WOHz^p7;#z7%OcKJ*8HrY5Z9#8J;eIe=ee@a zSc<5nT`?WEodC!l8hTabE<5HPL)_7!^;KLjpH46pb(RM6xlI%l9X#q0v&#H zpufF?e~w)iy%?9&n34VlU6Kf47W5nU^0^olqfCn860Y7h@xm{1YAD{hqRnt&ZV}s_ zk1@x02$t-!lbKYn&tJ(PPdg=55twA_J7z_#c-4YGu#aDTLC;1B2PDhoooA(5MO1Ixcz9N;$Z5|? zr(vXg|NB#0f1FbJZ6ixL&$kQJd&&}L`=6T=e&gBYaVkSwGIyAg%n*aVV<}gAtIsLt zE7Z5NKbTtPx-$3S!f&=muid3{Sy`F*c=EnS2CQuse-lu^NuP93>~qxHhp7meQpypI7t{P;DPS*6e}4LnmSI3dft z$$fB)4&*vT<|BSZy%&?*56iAz_d0asTB0al^}}|yHJe|r=Vuq+o0x!R47=RhgJt5X zG7Dl&KIY_vXC5apvpfFgJ<-upnfwDgF1TP#p2V(IXHzqaBVDkqrA4b$<>QM{g`BQh zyuQYu&^!~6lBak+7`k<-J~}df#hBVspTrfFWkxufh}}{kC688Oj(`od^pK}=Q=Vcl zkyZEu({&en@SwXbO6>ukPhUw+E~0N2nsG#)%F#}liueYrSAaRE8~VZmGN%o;K&+3s z7e|`5RW6v8;ys=VSrZSCukix`QI9ITf@Yp3CS5mvH|x6h$3{8QAqpwvBK74ZInh|g zKwdo4sT&XopHRWXqkfrV5`p{WQjwq*I^Lj#`+Dp6IQe=I?W60AY;CVk_5Ndy`u~TgVx=FxrHD-m4os7+uLQ&ttHLn z2IN0k-|LY+^|X58F1$E;kN6;yR9HAA=L~3|yR-F`Tl#A0Nk9r<5ZlKLj*Q9V6D>YF zB&3t^-pO(#p#(3AuHd3A;&@EY5=#5XnkXc~ohCi~6RZB48=c7r*-bsSDK95Og=#82 z7K%dF+g6a_6p%;L(9rOzo&^LwcIT5ff35EL;hG@QT@puu@MBK_f>P|M&zR&gkKU03 z{Y+yh{jqsmiYCX|Jup@sJA>_{X0Z}ZUP3AX%vS*&zKl8Rw*7T`=Cwjkk)ouL1I*Q# zdm(*&o8u>i8MOB(}A^6lC>^mwin44Lp z?`EOkc_Vn%*)K(}mBZ;}$iy4p&T%o-*RxJY;^furD{QdF_>-fX8RRLjB(qrIP z86w5u{D=4F?eAL~TdMwhVYTlTZfaN%WhiS^x7Y4o9v%o@*+txGNDvh0Z|3WKcP1y% ztljBDwj^9e&dOAZ!BO}bFT{Kt6C4j6fA#=8d(o{y&W z`m}f-HtvOAP}og6d(CUPI5``enl?PCg7ZH5l=x&zv*aZ@5?m3sKb;$u_15h+_dkGW@%!4CpAMLCAW4*q)gXlssxF3dO3-Z8I#H6Bg6L zdPT!e_;J`sP#;>|>>%rT`%woOeL4|4e~bPpT$~@(YjY6FKc1RPCd_l?B|t*qp;aL! zd<)jM-un1O)Z2==q25HJ*c7)(;$9RgQ?4T)i7b*b;k{9H1~Gi7jwhwL)&m@0lJFQZ zf-?Lm5-eR~YUQSWnNO%bABbL%2NZOqz8V$V9QW%ydVVO5aEtZs9MClEC5%q&lyV)d zT5ua#I3{WMAj7nb71UYBD`(_Rz!j!$SgY~66K~CJfG>v&Cm1HYFoH2R=|>GK8@?P5 znXv4XWIOkSTz*P**o5>%tz3^yr+)uoEb5aJh1nT}owPemc;0r|$hcYHJ3@jUS}A7< zH&4$kWV#O??wz3m_GPtO8)9=K0?68!(6fI(_&UJHrrjf>xmT*$enpDq8~s~8dpK^k zwLr|q10OLk^<<*rFV`!x)=>%?>RT>@ldv2t>KDD--3Q$$wOhgbkcIhe`U^ZxC(j2v zCVhDq6XX+9LZt6OMiu&c*!-a3u0KNra=Nc6Gt{9`ev%BPHx;*EoV^;3Du}TgJmQ-( zHdMxm#O_O2p|V*c2&8$NHRv}ie50hznm=kdsr23j^PaaNXE;6^hA}R2!2b#6x_PUp zpM^69(TMt$PEdBFd?pvBAB9FkyDVen!=v2BslKc}{E=*_{0}GRade@)#KgCvq%2z! zo`d#-7DLKsu_A9KS(rG;jp;EOb}AL)Im%&HHgfV2>8hW?m2{kzqZ(izCLgmBYX&X8 zUoEQ999WNEkv&LopWldPk-)ZFL)GSEexSv;Wv&ZHb6_Je5?N@p8d`}_n-$;sC412& zU(#a$<~TPyJHG&s;$Xy=@!CzVc?ldK=ZyB&D4}*1(sm)JvHozVHl%sMZ6+$q-O1~P zN6yXI3eO4bn%%hMV+zf}9w_wpjVc7gMlapapo|DVLX;<&D@h7SB7o4v90gk1j6Q0F z+GZH{`0Wt7^>#0p9adm*{rjunOwkl0x_YW;$Gdj|MM(vf{lhK*QvpKtOHL&BRpB1( z;`d=B-mb0XZKM%1a(Nuz8ZR&cqCyM{vSx*5yf4*n7I+Dm1V73er~Cr+IO@~ z%NL*24yp|#=#}n<4%L&S=A{?yww{EiNHn_K(;>JEU-3gAn2LuSs3Vw z`DMY193akVJE)8x>j}{+0+7818En`P*aZ0Bh=Hn5?pzZjN(Q(gh_Yq*TWVA;(ChNq z)!%GA)G)?56Au4nIlG!RoKBnwmXLe1KGGI-B1auJ}UV! z_Kv@am`A{nf28gI{A{$eoliUESSwv6n4K{pQ4KFgsyw#drcvS@8Y>doGw z^AjKmQ?WFt!80QqCd%B5ef%0#%Stn{XrlMC!1fVlsjFG1TwRnxdK#&E(Y@8=FqzHg zeiefvmcer)cl(zwiGj@iHcJ5Ws5c8AY#y1oo&1N2!5OVGdPhPkWwvzv-$|d=9b@IA zbmfgl820Zw%ndLdWT#41jLP&N_aqAq9lTL+(84tz692l=F4rHHvfZb`;iji4hsp>T zG`?i@nR2Bah!_O;eP2EI2MOs8+M*}OMDJQIkM48u86Qwct0{-{9*tUAk*3KYI1w@0 z`t#BrFhDV@TguAh}(Du*f_{mBq{l*eB>Bg_B9{k z`s4R3goNV1taslEGsCHCzEfD(FBXKw<`KXVNmD2ePC<>N#AtC-KV3&5g=v`Q&@a7=v}v??a@(Q4nb9K;pL_gVVv`(z&Rfm8dONr^Pw% z7x45)ABmD<4{i0A-x)~n!2=@OJ?_=(iKhKLmW#H($k%^_roRgwuu%$ z3I_DbwkQk>Uu>KrhO%N}SiyMJAlF2Oy3f2o;Kb};$B!PpuZk-8zFxgH(LK3+ix)Ff z%*F}uwW5)2L)YA015!DVXByr_YEdL8#EUbvL&l<+BEq4uQh8j{Z$BYdVcF4sEki{s z4VtejW{5;Li(w=?ysETV^IBY95DRmzx<&ZmGWRvqS2&NkLG*+Ku{LPRtyp|W6;4{EoHApBlQ6r6B_one63D7_@i1J&wjF= zJcUo#!`{_?1Rt+LK9C5A*fy=dMz5&@*q^B(*DR5Ka)QT$;75<@BW^gY+Xx z_?%hFQmyN`KmK%+iz~+7y}Y|xBn%D_{X8pt@SDgtND~P&yay1y0Ctc3Kbp>ht;(+3 z!hm#lcXxvuknZjjklZxVCEeZK9fG8EcXxM}Al)FG=l!nh_z!TeXRSHsxW||Qn?aI= zL8L+mg0*8$;iv4m2%W&c)>dHQ;rZh$5YEtpR?U^uhW-q7j&f7E_y@2XdDuP6_K)lg zd|8CYXk%rcU2Q?bNA>u;qIOf!23%HISwt@lb#=d!Eo^}(Y6O@NvJK)+L$+^^H^B@g zMKt=%2{M*t5&GAsG-BK_v}``GUkS895)&6FuIt<^JgZXKlpIKkE7r8W1|%ryFX~|EEx2L* zQDleG@TREJ=m=eij0DKoKuyT{m7&J5*AnZXI|icE60ZX*o8(cT$#l1_yG#iIyW&rs zbN&p$H(}&{e$;5R(Ze@2F`16jcE~u2<}?lF>~Td`cbDS$>h&Z94AZ`Ecn(G)*Fv5H zL-K}A`&lJu*PCs6CFu4|`_-QEG6Vc1a#lvd%YRl z7T98i82GMRC%0^pi!Lt3okP_rdd(L!qAyL!pW$~&L?ki|^9xvf{&=(F8*yEQqV)Bq ziexOyk;=nrW3yxtA?p(l8(b;844eZ$inDQ&DJlP^{nG9*BmEswamK`z z>X;ZquB&!h9Z$A<>cT&<6e9194V;>O6$Kx$0aY1tAYrCXFRy_9#Hd6Ig}0V_9`TJ_ z$DS&l;H;jo;Wzct0%5`<#!YUq^-IVX8)&ry(R`Whl-aw${z4w(peA%IVj_4=e}cFF zBI^L&7~oE~@uET=bK57u1$vIray&hN9%0NMY>g5oo=P{!Zst9ztZJT?cVpEWEfga) zzYZx+Cy+$4#P(xdw-CiRO)ANMbe#UDOA013NEEL|pPk1UvZ|~LzS0EduOOpdD}SR8 ze(CbrL&FsHmf#4=ABC@Wemaglbgv{D5NRx12)2rru>Xn<^ksyy34QbYU|vYrViQ&Au3L_>33XbI2j%YvM1EB6Q!#rQSbj?rAW zKtr>5kV0eD5T;{RI<7JDyJTqnPT`bHaXk5x$xWj@&do(4-YN~0V$=D#p)X4$#A+^N zrgaExtzf-d-^$F~w9D7E0YOL`M7qef737)%?tqfd1dRxk-@tqXXT2MQB`;UA2g zrP-pqKaPIw64NcUi8QFODq&JMH&$6ph{=!UqBT3^Yy;dhutX-%vjD>Zz~USo>-2ts zfIaa3_z8c3j1ZH$rJLC80(j=i?|uMup3WfQY|4V8hk&r| zaP@t&;dR!^X0rg=whH>D(m^%yR7Y~t9uKx{lT{i8kQHmX-^W7EJ95V+@6!pP1tDi{0Lc!M|>m-LRQ}Z{+O$<>ux;S5(^eyLA$LH(!C@K_H-*2b~ z$02{l@+FRiH=^>Y5UiSO41dW}Dzp8wBPR}DP0W7g*%BA1-&6ar<5+g+G-`~YFP~l< zEB9068%vw+5-O42y-9u~5wE2Yu_yLGK#H*6>nq@Z^cKofpshmea2Q=JP;smvPK+Vc zV){w2z+Sr0%1Lw0WzeD;c6&eAfr&A~%>GSV^Z-glylLWck9svwX9h53@zzP0s9v||(m1?;ZUhd3t4Tp$I_R~T(_Xbh!xZ}-2yaHOFZiWt{lF=99vS2;eBwq!1AOnJ^!j`S(T++u1InF-ifpjG?|er zGVG@&)r?orCb~E7lQmt82%ab^$10X^7=^)!_hs&yEV%Bbm4+3=VoHPqNmf5LbCMdotay6BlLt z+BuX?tQVYhxiFD6gVSbRPszeWXDR24F^Q`o?u%>o`!Jl=EK-zZ*|XF-vwpAZ+du^M z`x!7m@8_nupkBnYa-UfFDJO6sf-oq|*URi?)!B>i07V^F%DRKBpq> zNkTvpG^**ev`U!wPUQ-k82jOA3KPZ{jRt*dnUy`Tg1*=_{;RBym$r{_GhH>NF|y{& zpR-pK2LA<%d;~EzCG+@M#B_Ibv$*TuQ7`<^;N&EVDwI9feAmPdKsj`6ixgnH1G@h$ z5I_q6z}&yx(ToBdENywSFa|@|4g4E83ro)Nhe|jiZsiCFbbU>VjThN%j^|Qd*64`* z=8mJ3*`}g*Udi4H$-DSViJ$WMAV@?#NtMP>t)2cB5xErtSL@jMOCl|Zo>ENRwNjhFd_a#9s>o^&Hc zCWwbI^?pdix}?uG1}ZiKpX)A!ap_0~%8_8*S-Px(I7QqXZ48@Ob@a~U zR&05bMxkqH9^l?lB_`M9CJvb|d7c18&4|56F(@r{T^R7sIV_dwX1JQEIP4@_$XhfJ z&=GS?Ixg+Qn#1?!E(!n4Ygb{%@}yp}h-y*S`3T23)@X<7H7XP!0P;yp8&;Xqxwciv^iAe=*6Yt zi%5wd+cvgnk;Ks&ciwSrZ}TWhA4T1fPpj|)H0`rnjS;~qUG zAxi&gTrH2Vu1a&0KrS>X9N#&{cia7XrHX*y6x*WkC+BvvN@8f_{-pFXxtq}+7&O-0 z7(ug!Bs*|(ISx$871riGz-bKukusT1x~`QoEB?km)l}X2bFxQHVA&^FD;SiFJ#vs2 zrE%18KVn{!{F)b6i3c%6O2W?;c+g%OxEfL?! z5k<1FUBc=@GZms+?`{`cOjfL35Y=} zNxxx=L(d$vs19AFvU$bMqm^2yy}b z!H{D;ETWR}8fGFrXhal+Fp{#2S1Vjrf|llF8JFB@iQp{Rpm?AvU`V#MJm2iTDAS}9 z(Laz`$vZ%Ur#%v@6;_SY`xgtDj@(f2H#4?DN=}koWxhW)4~8lK-EZDAYy{e;o%J{5 zPtJH2k+AhKmQ5M+)>N638Qg=(Bh`U_Lb)%|V65#Mk``~Jskqv`IvTe^R8*1(u3-=r z{4!yB@+dp7JcN5Q13Q<0nd;wWO~TexE)Q{FnR4eFu39y#1($IcIPQn#r3bWBzU=LZ zmDx$1VHu?ik*yMWrq&w>s&kskS1u;oP_i(1iEyI=6Tjw0FY{-h(Q~xBGh{|yI))}~ zGb4!`u6k=7P+^jWb-=2%J+f(&Lr5ccn(VRb5Y{1GLqvxDbD^je{MG61=KVc)ST!Q9 zzdNXJ_Pbc~^EvW_k0S3Ad!i3Pn@U1@L1rJP!ci*I8^kD1YC#UL`mJ_KJM zpUG?4c(@=)#U52fiL^tpZkb+iBAK1;OiP#lT=P1MF$VtdKwm8`AW0az^?U#e5=L;L znu&nh2e|NB`X&zyVP2D(fTZ=!4MJqt+vm6AJU`$#b{e8RqT3}*P(i59%pUtAQ=wzJ_zb5^*?>*%VymDzixTsHqk`Cg10Fd@J{YyJS&+ESl6Kf$giC0UlaU6%FEmA}Drvb=|@`2k} zYq1DV`rKXp^7cN@S)Iea`w3bO8{6rue(RcLQ?(wfQ#iN{7VD>0=C8Hb5CuyC)=7iV|X!Y1ybjcfGP!M)K}_tJbcBK%SRs( z-!G)?SjsZczw)KU(=rsT9DGW9gi*chQwr8+8p}<+j-5#)ZH3GVirNF71J7HIP*R82 zuC*YocMDkWTK~<^5Z|SwL!4fIp!FL3G)gO6580lYj+*EWpHcc~_iG%+O+IXp1c-_) zsP3mxdX=MgIpsi@s%qA`?FX*Pcn9m0X4Q8eCx#xeVpjwB1(67j)R><86nQP@Kj>9j zwyKvN)JlPP{x|h$j|z>+v|g9E{n|*JbJqQ>NVmf^!!ZAp>XF-OgQx0oIG$`dAarK+zYEm-Lhylyd6%mHa2ljg7dp& zLc*Du?srQ1?TFEH1n0Ruz!w1|g-9@9`1PbWZi7?F;MB7j!vmjmsc#sh6{!L(YYv}t zaQrkM@DhGy-n0BHf~!~hTqE*#*()J{8i_LrJZBd81E+%eYd`v9_dIusE8qTsn)(XY zA%Ncf%PKb-CR*}~q|IW1Nv`dnCBd>YD#^Q({4}DBOQAx3JZ-CiBp2*s#0CEKIJy$9 zUTg4XJCV4E*BdQ2r_ADC4Dq&_co=tEQ8z}dhe3IgG2VI>N@c45Fv;g)8i^1y+&xMR z)S~I45k=jttpGK3=m;G40+3^zj6JW8*iW90S?UgbVY|bqJmjDcMnKz=Whds!YfyR z9@4OCWN4(P`d>nqQ>z42juM>g-Z1q{%l73lum2WSaqvw16~MX4du@_cUvcem8t~#5 zf$TgLlbPHdKAZAhf7=Rg5J6?#zjiz!%*XXWsfCxNFbPx<8a)~W0b`JJMg;V*K4X|q z|3++NOAmN_X>nfX;kz5$6dR#lA#`6+jbearJwn9Zyjt)5~&{!ipI6 z1w`=rR12d9{0Y79vL-_n;otO=Mh|v&jBftMVJKGpb80;Rm4$r;fVxCud2!e|Q^}b0 zsf;yZd!1CTd~|XX3d&H#dcs{tE2ZTZF>?3;YaA{T!XTa?)e`7j^kA{4FQOdCte--5 z_;^CsM0&hB;Y6Ip8kS&R)wMn?>vpmA^Zetd$*|HWb4^W6#(i(dH^A1bzZ{!O&;6C; zKsm1b;DG6F&haYbJxAd<-o}1}xNvr6(=?9{^9T3e`QXXPz1PNcd==B^VmdlF^P-G?~5taRRy~_(dW+B&ykyYPneh>=)>Ye z=IDA?u=~(J((BvX7kp&>uf_=2gS|MB<66$0QkLURt=W@cW;aV|RBkR$<{HZb!?JcE9gVjdbVfvomjsAwEKK^2raRr1 zP+hm@&y9&b^#?gOE7WW?11O4zvvY$EvsNVz&*1=m$?;EWW4=c{zNJf$6uWA8I3+U1 zF+vlH&!^G6+}wH*ArNQ>mn7Cj{TpSu&LZdSOWwG4#+V?09r6xa7 zIPmxu+*Q&Mrs0L4VWTnM-!kK8VX$>l)NH?jyu(6VA?LKj)^bTq0 zTe5hc4pNvSXZe(q84W7qvoV~VBFl4?s|_Y3upuFNge7mp5K9(;PJXTmGJ+mhj~J4a zX(T`PSeQhtr$6gl9xG-voSx28w73BcW;EaH_3yWc#OdQq#9?S6S3mFX|D=pbz%M=j z+q6Jun>3L>pi1!O_EA-ukjoo`2>&msdxVc=jX#gC zEA<*cvesCZU#%)~Rlh_iIWBAfa%h3MfrGfiudDt2B2-Hg%sPB_#g;Y_s_01tyiqsa zSN}x@TOqs^uxLXo&FK9Z;DywG^>uUB1&5}M^54L2ax*46b8PLBmEbpTLtQImQhT|Z5kXqc>%y)1I`bDOxOb8>N{0v&L19@wsj2D zM5vUliNQ27+kLqXH0|oc48k7Md4^AQd6W3ke+8_XioKp|_B8N^bt3N>1zOq0f!V21 zv$@O1>l-R(x7-!-;&$+{ON?GQ>Iy6SF9s2gwy2uDa9EyFc?KkI@P}}oj`p|PyT___ zyW|kuh<4vZL+@W_nq@1GPJ|{5f&1yQ#_af2T1-va843i&xvf(z;035g_IE;8JstHo zzzP813TDSE0!ym2KQVBF(Rc6AioQN_47PsD;tYnfb8Jw7j`D;8d=|OW$1h{o$8s@z zfnT41qVim}wVb4$M}KxlNFwZyQ6EW+6zJr3Rqa8@v7+eALkms-I%V8%Y1H-(753A{ zod>bbT;+>d3cWAYxcjG-cYk1cAD$A{iLj8+gO_0Jw1Cg8>^cI4M;@92 zrC}~orcxO&R%%#9ChK&D#D0tTA=V&KpU%CJZY%zyLJ$@frj^2M^L8fJ*C9-Sqvag4 zf{8G!ARTIMVs?1>O(Sh3QEf#s^HnkXHP9h94Hy<{MAy%{gg_x9iR zO2B9}Q;BMgn8*}L(U42r_QFeZ{Xx#|)L^JF@Sd-cu~8wT6~@2T1<#A&e~q0{?Ytcd ztm~8QUv~pqHSVj?=pN0d;MMzAADzGVUI4@?u+6u2!DBAun)I}`#en=PZG!GB{Ff=_xaWFA!0uh%c$LtoN_b%#h?hk_$GdO_t2Z zCgAOap|{pB{aIuCZK69`%UH@IK|^sP`SZ((X8y{sB$e^}ap2_5dE;taz^}5^!Gh5D zN5dTIcC@#`;sawc>m3>O{E;(ijpFWyW7d~?;}5KPRwcxb$C@H&bJvd!@Uu3gVUd%w_=te5VA7cd*V_SBl;6^ z%(75w=>00`;|szF{Nx47kGbC6k(l`G$uEL}G}fV6;Tf-zMZ}#00mHCL}DGm5^#iR^D&zTGy=Jr@pz%wk&P^ji$*-ZfYgO z`lknxYVVaG=m%vXmuamggQ}?Dzl4o)?9{zIOw_K!e3PgSD|8zU#*}ybkl)z9RT#7W zZd&MA#;Jf`#+Mg(gv)Sj@D#^5Llgy-T!nmMo~r2}GriIbd?oJbvXLB2B)`9v%^SD( z{h`z4;fnY&CJj%-K#ngsO!NH(DcTE&G`Z611i(=2S+CC0`mq65HU_1y<&9xsa7dcx z1Bjz^jp8gPty3T$X6RT#{EOkS4IN>y$QxT^CG3jR)eO#$hbEZjt=;@%1`j&*bclH{k>iALqG}u(2<+TDj*{#q zC`ceE?-fT9!)>F}13#zrD0yy6_BH0#Flp}SR72<*V&`WsOU5TcM~U4Y3%OuQx9r4I zFmvU5ioHBMq_SIs$vSVd*NjVd)}&mZ5^!}=fEKwBFlJ!&oEcNeGeh9VR|c*_J;&Xu z|42N#?KVl%+&X2M`vv~xeU65|Vp3SWIUC#s%I9c>xFu6mVy!pAsZHryi&^$*)o|`K zY_N5wN|kh_ET?!VUAmO(R(Vhsid$ zjH+_`66^N2-Y=uj7zZ*9XTFIFo2BlpDKiPY+zY_(lUy8@Q-Vcm=hgmw#mQ#_$Xx-1 zH!mQLW}^TF(dZO?;eJ|KBH)TI6{t`F&so~|ArL#n%Ep#}u)J2=GvGA<*_Yx2t#my? z20H{aK&G9OY331_!`+2{ImnokxvUCcm^wSr*JmgO#!?>rFoGqB-bv_=XXA{USxjfnj1-EQVVt@Wn>@rOp1|nPDJoa{mHMI!{lQ4WvzS3@?Hs3< zTurhDa=hQFh(|E2o4};v%hSNcskoWrRFiPl=shH>K>AHHZj)*$wnG7KRLy%;goRum zxOd2ey58<2P`?}bahe%73V?B;mCG|zrS)K2n1Q$A^z;*uA{VYniPMUfIF#HxHgZ#f#sd;lrLOX9x=(X&GW4>xd0{TE zgkFHesy*2{5FjbsCaeI(Rh78DlE+&?>JgjmeC(gE61|de1L^ECqC*bT=r~RMh-p|O z8(s@%_oed;c<1QsiE(OIJ#5Vm=!k$bYn7a$Fx4&*po9Tjuq=8`mwrzhP_1sCvlq!j zD`usbh12hm8l^0n!up+Gl^x!;WqNBMV&wAaOGf6N)cG^Cd1z+RAH!(J;`|2}8GOAk zYP;A>x^%|gi+d!}VOFImVygORV9~p3a?rdD*c7wmjJ!wDk?+4+Z9!rvz8QB&#$u@TdaPRAHXP!aO!a zQ!={lf;$uDbI|nf4Hi8I<96pB;^F)jZlp0%KS9-rD(S>RrfeC&fIQ}w9Qj8sgb153 zT6f&=e-SvX z;zOQQrv~qayeaEEl&Y4`SkmMv7h4F@gA&mL>@omt{7Fy;1^{S)%=AfcQuCs71o34g z!+Np$c@*7;Frm^Q4fB=B=|hQ_4bCSCG6U2|yok%7op_8@N~hvu2skb-{vhlk!%Q|P z+@B{36#;k^Jd`4IOeKbeDoEB7_9mjechFTK5vj2oh(0uHmHt2_wF_YZ8C}0pdv2?j z@|{+Xpurz3EMw-#+#DY(48yEJjzCMOD1#ySA~b0wiTLssoDb5H=)uHFs?lna;-v{- zE&&e(a>`RNgQ5Cjbhk2E;~>EHnR?)%@kASdX57-jyZP?S8= z4zVItnT25!5u>k>w70~>y9zX+Ibq`eS+f8H1eoqK*){4J zeEas_1|xtW0y6M`Ch-CC1&!2Nf!NKxcD;(z7+&W~HW$Py?lM=%0Ck_w*xP{=IA?al z<+8m9&`5wb1W41!Rw^6AC41@Z4e*UewiyKN|5HPapL_K7lzk_FA85t%_56eS!5&wc zLl<||$6jwa(_s(wGURc?Wh%CcFk*)zs5NASDF7%dwJKz!q*v&wzvG|}>J;tF-&|Y} z-ktSfFQ47o2TSjaXr*!Sp9U(`c%a0AB|_X;lfacmd03b=YUbqZ{At}*s}719>CtqD zTJCdvCx>ac)5$6~1nM+p=QZ63YK#GhIfKw5)rTJ2jHSAKuoA>(+4W$t6w>jX^&bjm zd26G~FY*#lR)3|2rXBV;vD?N=31N?;7|e!Z5UZTUKRfG2txO@jcwe8Z65RrykMcr0z0=ym&u> zR3woZ*0VS8LxZnT>6;4`Z|NFDE&^-E)0+bhml#<3+A^8!TW~VN`HoyVZaqXmR3Sux zRL{0X&eoB+J9mF1LSdI8i^_KMr$xjH-#Zl|4Ah{G0VP-ngB5H44%6T*;26CB z`5T`MmJ-KOZTfxvjIwL>TGJ{Ids2UK5mKp2&|jCtzFdbNEaa2`ZK z*pSJ19G6IUnvi^M;dsoCj447Unw&tC;y(#mE*b$;jt>h6>HC?kwD5h=PuCkW&BYi#0y2rP-iFw@<<8ySh+ta&YUw?6` z0QlqMWQg^@!N))*#KS2=0u9=%LDiEb6(N)}JW+-3E;8VrZ->4mC%kdQ8SRM18x-+C z#<2yy2fA2VKxb8G0X9m6eEy?40P4VRERpF)1=aY4 zVzn3fO39>H%{yx&eRyRBW^H~I7#wWT#j9i(!ORm`E-WjpFwRp_hfR}V$)o=}gfRO2 zy^0GQ*~Wy0q~mMr0-fS1D|(B)`uOn-2!Js8`zqFraa|{HOA<%6-3k<{2T)~}Q?{4E z4Sw8-lnKnw-510#pX&8KnTT~%`{ux85BVn9&i{Fckm9Ev3rd!44r)4>RA!ivdcb_n zakzPdRf{=i5QJ~C6vVyFugjRg+48{BIdsB$1nSN!X7p#JeB#(oU=Z_{?5r0xgHO)N zsG>8$S^xe6K>$-aQ034jA!ro|hWVaQ%GE8@uPrhSOq3>1v5J@l3?zd&6q0!-u97V6 zr{YbPj1thF!;@erEHIv2;7QG-HwC2F1>z%E(XLd5244v3$LJtmkXP9#TH|XP z3UR!Vh$4!Lkt0W*?=E*fF2F31iaSx`{?f02zQ5QjW4rG&aUAZp#eV z6|+g=`hi3qU`&5~?!d%>OXPl2OJ|%+X?|Lxd_8w^VO(3>n_xB=C5VtdKy>H^#mdfX zuq+lb8VFI5AWhkk6E8y$E+6pIQyT|+=i%hUvQclhuZVo0#jwUR7Jo~tGQ~I-K3FLP z@!!?1c=t9Peb@XcP=J!Q)~-qa-T(r%!CD*>&J z5q#-K_o{*I7GWTQx-LZwC$_JRNwNl`#26Wj^!x3ZQaIwRXg4#1|8USNqa@vOg1#?z zk>TV#qY{IK=PQ*M)%SMLcL`Pn5<9ebA9(;hb54wYkAoGrx(#N2i6>!uV9SAYoGt7v zhxwV9|6RJ1*KrC-^4I1fSDGPMsiLSwLy-~d%5`-Fc6U)?5-qI%*?Y=>6_7gPM9Su8 zHNZ;$S$OQ3`nG3Q6dd@AfEjMv=7lXU)m8RB2-NZmO5W0R@p`tXbMva_Rk^1{I>7^+ zy=;S1?;MF41TU=F`c#8rtzJi$gAH`E?ZHg{{E?(Ol_$NMh3pGz(Gp^)w@q3pELEjdx-wbmR2svk)a4j`IkE+n;y zVX!I~#mQEWjDevIxe*@s63)iikYsT*T+nV0f5Vtl_m4F2p%04y@3E4H%!fCiHA+#M zdH?EJj~Wm3Cz7|K6XQur#+ig!*zGEL9>J>P^R1!dpNZ;Dv*1^n?+yEDg%+aY1l|LD6% z0#SKLFYBG;TOb6euc#m)OFXdah@sDpnhF%nT5@LWJeRoACXHG*0xcMz{)LN)@5IFU z9|Jw!C)p8s{h(z$BS$?paTOdY&00z~$$$E*fQjByTMba23yS=t5uaSHnw%eDW{KU9 z|2TPg$jr~&al(>RvlM>pJW(~lRAM)suD^7{Pmm$Qems2t;3bU{Wco#2006|(_3<`X z$hQX=4Z9AY93{_!Opd_H@N$A^qcKf{-P@&GQWvBcx_u*>?u) zwxAz&sjs&YnEpJ@sJ^3HRf!pQo`2J)YW&ww#-Mf}*M!A7b90<)X(nrSH)qBv`q#O9 z@~T@hTIeX2T<;SkB=j!%7$* z-m$mALf_ASxx~1dNyZ%rPL!29On)f_geMoD?%ic}0`$T4@ zTaW!!S}8qZqGa`(!l8;0HhaMc1*Sh|4z!M%k~4x?tIAA4&FsaUsMHcv%g?Bgh}#OD z!Dgkew#{E-&*}!JLj0g%uP>mSiHCwJx#%5E{2KLiDUC0?%=V+k&eLw;$;x7K9y4k< zAj*>+arUpD0M8OoE8nC6Z=TqxPFOvO6bEIJtyjri5#)Ut zOs`>6RUUNxHdGQ4G*i0pph&hIcJ#r0}e+2t~vPo%o)6MdWj*N5@`3+o-W(XG`Je2C1b9p|I|x zJ!EiN+kAFbeb;=rCi(Z@sas26vI)ao$mve^uPj{i&Zl`t&EK0*1b%+dVRg40Uk5hr z(=;oG+pbRl!-MrP5$*Yw@Ru(RMI!)gHe@}0BMuiv>wfcos_eIC+-z7gJnr=Ls_$Ax z{D+na78{;N57R1md!v~_J`;xIn8GgqU}ioLdUktj%d3$L`m`rl3RCV<_A?5hH_b~$ z=ZVy)40Xl;Z=hhM5iSZ9@gvB(E)pQGf&9^K-`B4-%NrI>K0clLtpDW{%|8HK{<2y# zfUFM090cQUDitfuPL&`@&=22;r=gA@c#>UI6}HjuCgcxxL-+b;qcl=u)ipKF|VQTbP3VY4_^ zP$CK8o=An#UuYoN>tF&B4~~R{#8|qXK>k>UZNhn=Hr0mpYl_JqfO(P zYhZ;f{xL%{9|!%&$nUf4sGpxhk%&X>YL?e+d5OVvIj-cVz?WPt{8c9q`%j2y45sC! zuc3R;65~QRVb-C|1?P>d1-gAvfB%1T5jVFXI}bqcfwS_aj=|Fhma+mZyvvL!n0*}N zPM^1Nuw~y&9O+aD__=~n0r@aP+Q#!c@((%&&tyKe#5y6K|7QV8_O_1Bbty9wcYtUd zf!sU>?=x<7Uc_7MTUw<6fS4d1Xn%evOJiYzpD-ca`clzD7f1nL=nmek!mOXP3MuzQ z1?@F{*XWB03NfDgNG(wHwpK+AA(Ykagxu0p>76E`|M)gp_~sr_Z6N$cUiX{*_9x~& z$F76IeV0YrlVSGxXw%?mZci?Dx{60<5|h2YA~}kAVSpKiq=gaU_MjMa2_)Vd-nZx0s95K6wXyR9&YIgyknb2a7R=MnE*im)ERy^Y9q&dMNw?U_ zuwOXXx_jJO`^uldqcH#4ho zE!tkm!8$5SZpHWx)erz`)cByj3I{;*Yh$t4?`+J`g48;HR_(?n6M_0i>O zySPmigGyni_+6C@v8h9eeYg2hMjGGpC7n`lQ;mFiKMkA5-+yya4f+I`hhfzcGE!f5 zUWis6hQt$#9{u4tg9a)~?L;;NLH8aQK+H_*_lP>>C`gD0KBi6a6M>{ z$B3>B<#{%hYo{YEiS#;98M3mnhU-(wY-HVp_V50e9^3tP_}_jX<`DqwU)DTROO`dy z)l||^Ao@2rrq_!d>w>t)N#2($i0)l}h#*nFFTLZW^S+F(KE#S8V~GB7iXhqiVdUL8sO`7m8f?2`Zme5N&kk!eLAtfSxIq z0ney9TMtci!pGpK^f?ZjvCK34e(sLFOCER6-*H!_bUAv9B}V<OLBpp?rL`W)nqXeAv`l3_F4veZl(AipDt2c;!YBl)KxexR1p-6eDj zIy9`#{I~R_6$?DTiVe?M(sc)^RLgh(gxdj=b)bp1&n(5xia@0bd-2I8`1@gt*Q%j~ z$_K#}SRr|zK@%3bX{sz@@Q)HBDyY85ifmGaD=D%vU!Te%!Z#(5f#vo*s!^V@CS;d7 zN~R@5?`J*~3j?)&{xcRq;41xepp1b_LgkZ{D9lW(6oZQstrl+Z{OJOc+U#zyE+0e$ zl=J00Idd|j(n<$yN?BRNEv2o#kSlylxZn=Y%@Arz1Z6QMnQ=id3>C-ESTXc{H4f3g`5(W&3 zE`wMVs^CmTpCyB#zKuz~ROdyYWizxp{UeiS1ILRUu{6l;mj&txvXlm&)hFAH(>ZQI zegF7YkFhpo|k=a{PnA_!UoW+V`4f{j#;jq+O0ZatQ#J}m>W_Jsn6@{&|jWW ziSc@mskjw#Hl~Jku~HAJtb3_3qpqPo>B#{WgdKiJs3{=I30O~b3<#da>e({R(5p0a z?-K(WimN&!#ZP&P-Ax#b4i(&F(65khrB)YxnySuza<_X zZPi1A0Y&9ZNrs*Ha@@vD1hZ54CUTg-;>a4_Lj4TNLqdP}(+pJwETnAP7d)iGl9TnB z1kYn#%{<9&T#xoRQd-MsTk4?(%tv*KWP|8Z2O>wERO~$FkUMIz?gbGJ)4g=TV+c%R zBJ%>JY1Lq8eJ}IN-#Ka+Ps;*;uJ{se9xmq9$T=AM(F00!M#s zHplB+C-H$=aeB36HgiHE5pDe7y?VA@ z>b+kfZ@^&9yakvme>~@Xw7x$KpNf(G-EAZCf^p?|@&AF(uI@m5Qa@ZIp+Y^q>R9-3 zbK}%$=nTF(J+*4oJM0Qs1$u3sIM^V_cX)dO+WM>=Maqj!q=Ij|5$Tg){p*kQ@7;%r z1HlPv2AfX#{X}MnfdQ2xGwV(rhyLX5ly`Mo;Ul%CMgnp%E~dxVYL1T3c}?pq(ugj1 z&IoE{^95s1S+%qPvV*yQlnqSoW-Whj+K2U1IMQ^;$_Q+2Z==Bm0XdAhu7`%Sn>qtt zGl%eE0c3&F=ko0@ey045p|Rpp{w{58(?mD(d&KDnY6$7g5Y~GzP|!I~e`;bFV1$;C z&8=38htQRL6__I(^ee>?gZIh~6Q`!ByO5M#M$^TVf(vK%EPf{JslO_ZmV-N_$8FYOYy45SRq2^aPx_T-VnzPd;L-MVP;!RQr~Qq7~mVfAYoE? zxatrH`C;myJWomdMU0||OV(m&l+rA{BBNb@Byc`2|Ho{0eMX$hAn<4YHL_z}Gj@FZwdo;t?F&GOKfAZ(4PxdZ#7)rN*kQ7myAwpSpCv(tjT#JW z|IgYf`tPEc(y&zH+av&3?_Z~*AcH@CJGHRkO^6@Wtkb`jX zr3Y-G3%R3wp+XE?^tx~dZY`!HGIDEE)-+u>H^P$^)^;a=k#zN2n?*I$ zB)?c>4UAH1qNOW8!;D7n61OaaS8N|Q6<`eH$=bkOObA>fPe@uAwT$# zV4_aSLu{d^_Z!31eT&#YW;%U*t!hW8qS)LWg{YE@8Hnt)XH84Wm<@GSp=)Mey@0H} zSQ<#8{;MVdqX&3>sk$ze%BYecfC#SATJpUiKFn51 zVLTsfQGM)Q=mF}{*7c8&{I^rlX5fJ=HCVFmae1m@rqNSRHFY6kJfY*5ucT#wh;LY? z!RW$;j#~P?t!F-HKO}gX&H?##(y4)rmexT_1vGmQS)=vL4|&;CGBu}Q=U^}o zh$Z~|0OUmY`}{tlbxhU>(AvTN_V^s(A0Dfb8AI^3i?_Z&xi(=fH{u7X!9ckOMXo+g zhsEq)ONN+WyBSIhYiesh6c5Osz%06dl(1>lItJ{@TMsB^SM zY9ODM!yy$>){5i3r_+!3-Em&pPJE~;JqLSA%EtGoRbH>g1+ zS-syq610033C`)e-2U3s@(ma=t*1H1zrg2T`VCq|o&jvrhm)*{#xQZ21eBg=KI?~X zQvCS(58!Kxm|Ho5vOd$VHNa;_xQU0KyD1s^|F&7JQtbLK$EpYyMzW3({uZ(!Qy`-dh_Gzw zD!oSIHh;z(FGzJzYB5?Z)FP~&L)xezI!UV z@5HtBzl_)Z+j1#`0TgK+l%{U%0KWhPyg2~Ski6z3vIs_K@h-jz*6ipMF7t$>20z_u z4o7P{nIcfJ9N+R0RTmd!>L~q4CkbnxSoTM9-R{g+E4PoWs?!Gm|LfLQfM3WR2Nd_V z!Pbg60SnJd=$z@V|3}kVMrGBtU7NV*mXeTekOt{)X+%Oo8bOrq?hvHAyHmQmySqzT zy1#Wl-+2AO(4hkb_g?FaIghzT61i{vX4p9eL+Kf)GXADnp|<_o<91p-&uH6ZV@d2u z8OMXO4_tqFcovdh3Q$F~$53DjN4P3xdD(4{;gOBf`wf%4aHYG5q8h<7J!l@Z*k8x? z6UH_=WF4!{cRerjOw502aABFjGOQ(LY+26BuDod(XG#R$XHK*B)8k+tQF4A>Z0-}o z!bM!;Ujs4ZR}Xd^!H_2Iu!qkv-AY>i)y2DCk#h;d|4^xSnBvp@ih*h0HJfXK8%-`& zzmfPM&Db{gj-HXuwv*$zrV42UCh{ta$pe8Uu}(KFU1G_gy)DaQSAhSEigXfABRo4l z3Y+R5v*3P>T=`oF(d5bf&trVVbSk5`o>2NlN{uQ5R5y~E?E*zq)L(saNr>J8?|p^7 z`7uE3qN1~9G~J;;4iZu`nHpv5!yzlm|Aamk;JqT0*6)NBw*02~*=<#F8BTLWDDI7x z#pBK!0hr_qc)~ z?6^5u-o+GQ^vz(Rb{`tGzf@v0pZ1d!O-%#S?qk>I&vm#z(S;|U{&L;`JNU^0tCWIP zvh9y|_{Qz)x6l;%QZJ11{*eLPbDy#X->pj&H4HsBV9r3 zfZh?F_h4JbjLmb$*C0$tK;Vxwu8|sXP{>t`I83(NLqS60(BB{!_6UrwcUN1Wi%EaCO8N&b z-NTU(Q6)FQR-8@0D8dPw$e>u-FU37XX0*UuvhpWpaHvMBIh^(P9MIrT*0+NNw5O+{ z^3GRQGCc8ijCv8^!DddUky#(6MilK`jxZ9$$gv*sw~sIbygfjA<{>~20*&5rhK;S7 ze6X=n4hq|+vhO~T!o4m;kxOLsEspkPYr57E5xP8&xx-(4QpHQ}X8zfcmLvPjqqdYC z;FWt$(DGJT>gF29jn-mlB-!AyJ(m`UM5(bQdKCOAQOA`(xQW_)Sv)v#A287d zcNtcGq7%wBvpOT+s}%tW;2+We(Aq@YWqxdJ!L7Gt&~uVUsn(`R*YGoNUlgcq`VT|T zmTtqH70$a$Q9EdCIP&N$u*YRv?tFUfdWArPgFaw)?5$u9L~?wPE;*9sU?Gv<^^=pb zgdJK5W~a$wyruIku~gf>1{xAts6h)TaOp{c>iZ@W$diU(%ll5 z`$6R?DT+zZdh#C9>X`p}y7Fw;$hy0Se^?LuvV4jrfTLwxRQOI9@Q@ii@m!vl(giK6 z!hCaYAT2f}0UJVm?&DjYn8~)525~A%-=)(-B(T{9szN9C36P+d;cTd-nrB|u^%ryR zJuTWf0*=ee%idU*e?l0uhO)|k z^YI6S(ko+ET%O9&2Oo>M*)@64`1op5V$hcua^fz&dfk5uhpL`)Agxp#8jbaUvOAel ze8l|LpN02=PX-}qkE}E2FS@A!$R>`+x8wBsJLSoh-@m|hToDe$m$aWIO=-$?nvEKZ z>ZDu7e|m72lNS!{>d5IN6ORPVL%5Nu-k=16Nv3-jp*P{ayQff_wn9LD= zI9P{coBy+CM5iJEH#7AM@$sOAswvjk;V~#ko*EB{sa}Rn%I4J>>#0!WXQRWJss<7> zRB4cC6}#R`de>oKAx$+Hiwd(M%ZLVUK`GS6th&q^GJf^c4T zHdETGrL-t+vSaF5coiX9s~x1VK|wx zP(pgS;0?|l(#1S=*5cDxw@w)as2vFX^YJmDGyv9~$~^g;MTFDgj%&9BKb3B<=@2^2 zo~4hj1k*(=gy>>jq->x|sbN$psk(&uu_o7+W|-NRS1mY6$0THs_t4>{=QYck9VwL_ zPuE)W38xHR)o@4d!4qyEBc$#l(wU*3s1HrQQQPW|$LE)?tiXpHB}{4p16 zESRQ08`>x`3z|~n2@WU^lT}tCWpMw|uvJX37SL^?U-)hpYNDE9&Nb^4h*gO7H^43K z+@i?@Lc@5e_Z-AO;lT}yQWr~=dH{WL^hGFn_TK|4d!qGykck!w#&fnc3}DBt^}^nasW;X#^wuJc+t-vsLUy?<1Q}WF1t)0#Wn< zhYN4Qel<^_{Ly&+UIdiBqCfQ2dz_>dkPZ zMU$9dRsK9Wq&gWf_sRbQ>|@yNsN_@dugWsb>hQ>d*BW~w&I@cs!74#E5l9 z3s)(9h4qQ~n2udj^)Wb-z+|BU>T^s+<_W{_UmS_HM`On7#Be(~fOsMLv z(q>&^i{u*V!*rkJzOYLs^W1>aO|jU6Vd&TRTUaiRr0Bra$6*G}fNVxOwdaR+^MTG+ zUUsd}$gQqH+Y^DAC<+{wtJ|N__bylizTV3<3lM*9Y~}bPYaLV_rjO=&7nyRRUgL6k zBXM!L$f8MY!jU*{)+9xFJG|y7h?)+d#xgf@HvaH_N0E-ng1(7?#KP{?+Hde$8hG{T zu`u-Z!Za|5beyD{-G?z{UR1JXT%B#m0-GiwaLi-^7O^x|NM=tS`m)3{zNiSEw6{UQ z^x}7Jo@%XDyLZrvj?5LbJRm0(vreM~P;X|zY;)0;^^Viy>T0va&v*aD{pvT$%BEVq z(EKg7tNxBcouyI?38&t)AU{7pcnv5f!HEnu$?y3DT>L+vB}4q*Nb{yC+7NA$QOeB- z!M*_3{=3ZO6W|J5n@n?m><;T6gm;a_u2eUN9Lt33ucs#F@P}vy$gjYiRkS&(n9H*` z(|OKmg$5R4h2lutM5Pz!q?wMYZqdqPNrv=}Cx@?dAZjEQ8c!u4&O`_?TjPNCU_iHFWWla}ZXmVFoc@dKV5J?wjpS3XxwOguVGdAW# z4RmAubWVn-;h-Cbm^$!2c@?Xbnm!j%Q-4(AvHTQ#)a#4<6hGzlsx*g1=5;z=*QmEc zDo=+`-IjPO=`Z!cV{gdz~^+p9Vgs#l-wl)I-VK!yU^3D7PADt0Qf zNmv4{po>UKXRu}T>)L!)ypcHD5uAL&SYNTtjVyhj)P)@>vKJ&(s?O^9xUZ<^do|&L zI{o7gvp?Tze0FTp;DK;43)TqT=<_{i7@KUah$tTwL*a;eN0N%W_Y;zKrwav79-p+D z$3uHIUHlFl#}ku96wHWHxB|_`$e|ZXPe)vW3HSku!Z03Nij0s{b7Ay4JUj!r&R@dn zmZq{~)bU$#slr0??@QT*!~ULg9eoUa&N5$bntL>wbJ36Ma<0OI`nD}Q%8>GpVFTE# z18vBagOoc(eLlO7W}KDEM=!ydVIiG$u{>bDHwdrhC|Zh+y@NB|YC(?Q*X?*jsdhY6 z8~!3O!!y{(AVeUe8iJbYc`v2@@wY{+L9=Sfuq#{dA;U7;eZia-|F`@aZ*}JB8p?P# zMG)Q5UqxSTF5xBD_)d8*o>9ueIqz*mg*gSZ3C4(TvtW%nIf&m{6)Cr zrXgyDXHC+gIy6?4D6_krL>>S+6BzPuxEbfW78detsL(rc7A;uJi85jyHx*}UGEaAR zorXi%{^4!h4_Ea7(x+E}WK@8s)8g&k(zFj`^FV3Z)E5bLUA=ChB^Fe&)_CO2NZInV z`SRjfs|~i2c4{0Ib@@}?q(39;=U{Z8Ko~#+mM41>=2w*E9ucf(PC$TycZ1Tw-EBql zcX8FKx&10a8-(Pf48SqvsfZn-)qN5hHun7nj5^G> zV2v|agic;-qGV{e$518;szaWZY;hCbu$m~Tno5|%all==dstz)+5V#-%)=+fYqSWg z@ufIZgR`+9JDhpK5y%{*HheE*V2m|1I=5uav$Kf7jICD0?zy_O6Qzl;2a4_=t~2b7 z09Q!j7_wuTN5?EMX(~<5!L`1=PSn#1P=(tq&CN!yZxlOvxXyMNK;glcHnx8`o*`_f zg*UnD8g94c_hFotI>I*I>vU=B8io2d;|dZMZtKxRG^Z6-0mxS~6S(&4gkt+ws-w-m z<~QzF;*#F_Ic~{FD;^bUht^6M+ootb=hKGqA4)A`ah_*;*&v?|4M|##KGfu1C9aGj zMq83^^NOfBscIPYN{_?y0B6%732CMk_-#pfG4i*Ls82p%BUvK8|E zPClE<#O~(6?H{MG)di!-JT;<31EYD1r)zPOye}`y^O5{rin1z~SpHKw>oK(vvJQ7? zvUkQvqIaeFYde&6dK!7j_f`um6F82K`S`5n6Y{=Va#6d2!tXu@&;;c#(eS!h*?{62 zn=^T<^6MKFf{M`NIy6Xbl6Uo3kE5oq%uvQj9RLEZ7;AeT>vyK5_$=8 zQI*Z@HZ~W#yYhLsM^z6+bEW*3MUpF_BGU2DOQ5}`FHa@%SkDe}1zW~3hgNxUq(m#P zma+;y`u29>#^5^v8VOh57QKps=|jinSrcXb=#o73y9S3??7!(%86AME@bHj4Y}dfi z83$WCAqt>v-uQv8lNHrGr)~RtcxN4(x`qz}-R#r=*ath-@YLQm!&s`<} z>%eH+*xLB9qCWs<&8A_lPeX96KRW&{cEXOyh5J@=@S(jNm0QJpH?*xzyccvHI&XGC?A}`VW8fS`jbo9BAl-UA!cfBz`c}) z4aFxTu-tjyzs#|h+DvHBWy~bnisjQEQiK63BP=+#lYvEw_lfj_ zc!z^Zo#Huf-zOU^9NGg07TB;Fvul;Tkh+*Ptw=>1TLx3%`9fr(mYSMfJ%25>yiSjx zjC}f1BBzdnk44pRxU|dmc*=GgJkTR1x0)bqPC|0p|JzMMiUuZR#Im*Z{_s#%DQmNc z{W$B0S;k|tpyGfBFQ4rK*u3%hpx2 zbSqh+Opqp?3M_PJBeR32Zk0^t4~~9NDZkOXuCe@4X%06&;wM`nrN?UI(71_)62p*j z6U8H@zDI5xgKkOuSSVs;?yDs-HcF^i_uZ0xze7SH3D*xV?j-XnQ1f89i%^g6_sYtO zj=(FhC4j97pqT*%*W&lS7#ZAzGtukOBV%@69v+~r1AWvSe!1(<(0p^7UOdHpf23~@ zn#!{o=OT!IEEQC(VJ%dTt~=i^@n|b0@e&_*-s;E59PSf->k{EnN)Qj8|JkLcfs?x3 z11V;oUh`EFK)oVYaX4pk=Z6v0leo3+q+Td&kw;|}J?}-(mqZ=lLqiJfgu{#`n^wnR z7n>~o{buQ2Zb6GYsAU2>EW42=W%6+v*;>lGn9~4wWxD z9M*-p=7z~0#`pbPU7>%L2r+{f1V$hcy83iK>pWxux43jpeOAyt3pO z37BC{*CgET0As(8<$9G~yEOD`` z%+g@upi&%>!MyPmsnlw zXKQO}a;#ica4*x+-rWKAgYMTuDHW^tt7~h2e<%wgg5amEzxO|@GywwXM>lPgp$eLn z-jNGpi;apC75%#P)&+`$y6SkB`m{O4A=tLiNGC$BCcPN8p>K68a6pVH#`XSx5h zrA`|Gs%T@naE|`+!6S!N=GpPFdE>=PJgER%dP72@zSGH){J^QoNYCUcI-DNW>$Ps}2JN1Vj5(DFyb zym}1FB<8-E+9Z}>zBS_Prh=s#Vqk?X390x!OfEP1VWD)1inw>59f{6?ZFk}o6S_;n z?EO?#Qb{fl0u#79I5+_Gzo%#U9^k_ovrh`Lfoi!)zlX)#0d@!&bjI+(bnw53@ln&4 zcr0BuTPXGn4s4!zh&$T=VUvy~WqfnHKdK!PDt6V9IDJjRFe8~;%w=`O_g_CV-z6K* zOJ_=~=uPya5bZPNp+kEdZw)`XOZbufd!ogMtRCcxl#X1%6UPm^?fT}-Dah1eFMv?k~NhU#jM+}IKK%?dG@h$+R#Gf}~W z@fI!I#Lps>v$nUll6*Q7aS^fTNRCEK{ON?EM$D=nt4nq;{;4dxF&@47}29bxxRnk+2h zsg#ECyeKO_lMwnp(#l&4_@7bQNoJ#=bGzVb)LSdk#DM*VV8kA9A$wSD`ahy;CbxUN zjwwC^jE3&*20+vUu0M0a@VeLQGr${xDKIcyxdsa$3b4hLVOs@XzV~HBG4Cqj z{|n%SNfg#0qc;=tO=2bdPIcggH5%pDqI!LPO(&5My*@XxZ}(neNpMmj!u3b99&U+; ziy*2lLWQSp&+l3AidI_?K4{FIF@7By2KMb9Mnf2`fBGy^JTIOK1k)D3-}IAu z(KR`40@p0?>rP%~=*gF*FuGi|)a|(-NG-74u25el8Z~j!Uh<;2q0zx+9ihc{x>J0` z@r|UkX#H1H97FDJ?JlqTLpmx?wa_K%oA;KOFa1eE!Xl65KXJm%4N-D>$XW3>+tTbn z>zyqam&T<1fzq$X?Dd8#iY7!s7q%P;gTCKnCBDUCJ&F6KQ%XV^2$D~HA)?ye!La!e zqo#JCoRpk&X|Ks}41Y98LP*fbmWRr@vLQXlVCq&jJ+}s2!MnTEPI(7^we^7nbj{Q4 zWm-w2*4$3C@Z%gP_kok*<+{QPOeUtepWTIod3Yx9`wXt<-r_PQq2w7sZ?g&-zhZwD zqMe%HybJ1iZeuJzu^hOED%FDb*vR==>k&QN@%lK0VCL_=zGx2vqvepYhNTl2Efi3j z6iKG{h7+m#(r zE70msoWf;j)g)b^MuSRaJ+|#gofKEV5V?h+R|qdAnWb<6ci zTgvi4&>!2{15sCpFAS_P8(|bDB`uwlh6%-#1n=R~Ps?5MGBh8)oEhgVKLfY>_1YNt zi_-f3U=?k*XbzsMtW!1}J9txF+jq9=%zZ@)a_1Gzc1p-Tp5&Dc6XBW0Sye&qpPb3l z-nF!kuv9TQj7>1>8Hoz#-pacQ|JsH2U+7Yu4)f2SKmYfNIiAemI}MVizy9GnBC#Gt zAh1Ij2Ui;4XakP(e>Qt&W==LvrK?u}F21E>pzlY;ofvBl9fR8QH%C&#ut^fzancfm*3j`}U`?u?P}OHXtyK zd2tp1G^9H~5_Yt<&P-WcoG?SQzvRdGv6rcg6&mBOf``cc^l8xxIx~qtZb(Aa#u&S< zsu2FpypB3pY79mp@$YhIGr6LvWJp)%0%Gop&38@L1dWkv?SPhg;TZ4BDFxa?TYhFP zmL`ApIa>@<61E2ae5TEf2u~Q>AFkfBpg#NGgc~3dT%}9ml?A&)X_c!=;f&kNiBaK! z!PEWqMQ}JjT_z`}_b6b>&CSgffeWEI-ej%dKUuQJ<9{#d)63&oll5$ugT4LL%d=Z6 z?&tRFO_R5-L}lwbMMLK<>eRc!FeVqtl$6$ZH@-(J#h9hvPTv&o7_*8;R%KK?$G+!y zHoN259Kvs{$cwf~P)H>A@tY81`i|LERVp&Wv7-o0@2e=ADlGu_CMscmr7;Al6_I3V zu}Nqf^P?`#(0knZpD zVnvS-i)DYKI`dLUJ#O+KCX^P$ca1(owlbG~_;`%%R5)_Vjw}xto@U@%PjlvvjB5>s z;(G!2^Q`?9jG^xCFZY3(3J9S`O>15sDqbIekP2hfFmH07ke!q!T}B1ZuK3+v+=noL z3!P$wa*^tfaoC#*(ra0nGC9{>jC?m?l$EgY%GCxL>aTF(5_@DI$A8b1oagT8BMZy0 z+~E`FUy@7_QI2gtw_V`;awzq^dy1A$_%t=-mpbVpPl>f2_NPL-D2Aa*W8M#9IXJdt zP&1auv5Y8agg(43jVQg+=XwcY-J9^wyJMQqS&1b=)l_4N**3=XZqei(^-haXA7azW z9B=+4fH<+jechuu*)bMN|1W00g=Vyw(iq|O624Z#&yyZ>UEuLVejO{{dxQDe!h$47 zlZ4K`3=+X6n}sCSEdr6CXW>Na$LvZujl;guyJbkH@`YCL5n0G7L~PS$uIe`m=gfJY0fq%7w- zzyc$5<@#81^K0SbR;x?*CPa$kxBt`LUh!bblJ3rB@#HGP z{VP`K4XHjnCtY_Nsx;~5A43R>s;OX2qPmbOvb0mX4F|R4b4wgx77y7!g(0d|ni6m?*9KD`5?*I?*rL zdg8+R_W0!Fs!C#A6WSNn;W2f*F-2vN3CmaE?Hi?o*@)$T=PQ8J!84X zBY3_s2hrzu=bNj|P7@Qi2xsZ9S7WHJZOZHas+mKg$5=esx6CEI1#&_FT5Qn2kx+Z(diyf!cFh*IzU13cMMCH99e@8*VV@ui? zUwWh)_^ZQUt16V*)-UiU_ZM+&L^DW1nX1urx$yy-4>6udJw4%9pi!KTO0A%NfEc2c z+T64}KshccFKhQG`m3WMN-&#KWmb?Ik)rzMeDF}Pc52O+aq>hAKho>CRw(mCDklAQ za(oQd`d*JWCqPmND06&i|K3;sm^o)uwZ^nf{^eGQgdo()h*azczhuYaYfspKAJZSF zg_lqHI1!nHDwZ%2I)qth9wUyec=N1wP9G~Cbj<#p6-tzoj8b|}oQ>X{`m0}ph`Y*G z?7r{z9d)R&S6pigkL7+ay5y-lOrE{1y@!mb0w(dCN$BA^g-j7OO_*XD%=xHK zUMGkQ@v#PQo%M&;YPzkzSy_DyNDa~iU7eMGP!tVcdol`|5+TQ$ViU*bUW;(93H_}! z6nNXHjp$^CbhGH~!&1alEvcFP!PQ4HvdTR#m(fgxQ5R8xLj)HC_E(zY*DYN^6EtLT z@nm_G2H8kzxnmD|fj=}YYZ*mKkAG)@A#`UR*ML$Bfn~@_f1J};MZ%KN68uVKs815+ zoaKi7gGDQ{0!!8|VnZMGd2SKXG3g%&9ZTzreWMPjW)2yAnoaGWJB^I(FYiW2!FovSP;aZu0 zn$X_fJ|7rMQcE?qq&O8657x+n_o7ZKM~n!}W%i`c_IzpM`%U+{zw^o8AvL{w0mEUw zG-f;$$J#4PSl4TIW~-PBy8Y*84-adwGe908-fGjXIJed`G z6LDrc*-&;BoX(>sm}I1nlbSpHHi)+((?37N1FsTEd9k{X{PRH`O;hydXZu&zFCQki z3o9gR&;VL?Fv*Dwu0cl2;6Ix_+Ep25Mv z<@%qXX#bNL-oFjLlGWc8yJ0?iYn;M!h3T)yQac1Jknvv8T#aWBoNA-VkEglxMDEni z6~+~;eNA}RH13!K*=p9QireY%X!0zX@L_82H)ee7p(M^Jn%`jJhr&zdxsiuql;$S5 zp;5hst!<37+)9*ppv^ZzmP52fRhYvhFCp;Fn6Eb%J~ z^qA<`Xfg{o%*Cs})Hxa&f;}vhrI?a*QdIIda%?YVCzcU}G@(Pl-D1NXYb5xnG1H!$ z$JXLzzYa?>qQTe)1TgGPwGpL9*?D{JrWBJ(Yj2 zg!yw8e?uZqHc6W%IF=pYH0804;C;X8`>8*}CT}0)%dVO&ZjhdbjfUSGH1447xWmw+ zp<>bnnMYZb@l|Scbwwq-CL~FBvLPNnLIf2=Hu9M<5WWy_yhY4x#Fv9a4X#_WcDLj@ z%VOGo{mAhaMf#&&p|@8t70Yi%_G1lK`$3XeUmjohv^Y*2Jp8>lbL&v#Mu^kdH8Y-c zFE!sy=vJ#a8AiQ#eo8DTWkH-q{BT}+-f%$XDV{qxF)uFIh|-#7mn`98$RZ_K=Z=w$ zaDK^Rw|0ngNX$Udr!x7qa@Zt^LBA#Dzkd4%?k`IXrldlI5KZ*2+WIlboIir7bjBLm zS;uVGd*sB>8=%FD036E>}#ot+O*!9xsIub_Yi4{>lwxWmX5Vgy?gN*-=(<95baXJDbr(t)1^--( zwaFOwC%u;oXLnm$TQD}w7zb_`mhUt3icjuZ>4{Uh+#L?(_kC$jCQgxA}};I_BDaS?r+epCI_k&{O1S9v+{I*x-_PY)8(*|4g_ zcabnvGt?~Z*KMC0V~X&sxUOX&BrQ3D9%((-Ei4|j8*#LlrBrvxcug}q#+!)IgV_g# zMm_IMl#-q4{k?Ecw8UZEkZNB;5Biw|$T8j75FaKWyazSSmZ5q-pw!dRsS>g&`+Q&( zTB!U**t_!=AVY9E#F6*Mr7Im+)u^VY+UnDRLyROfOBjsk;@K#l=Z&J{(jo{k7+POG zlI}IasIc8q>wH0E?#<%P9EVWF7PfUyU~uAaEOF`Nhb{mIEmfKt4jG`Dwgp*L>Dw*Z&)^5?7dHjkK6E7!p$ zHEHaBAUzm_RlPo6Z1=anKA*X^C8hVp6R^9)HlRM~D5nS)3&dy<%S@ygyp%9<*d%!8 zl;3#4N7&qA!r**ipAxvDmq1+PhtU;;t1z4FMKTi62^fP6Fw5)yWMHYsX`_f1s%k;^ zku3`mI`^-H)D(R+OiSYL$!BXd#4q*Qg64U#ztTzIiZ`3V>E$-KB=`Q0Pr)v6kIxMo8E@EE>+6L8^ zcHtY7et_dYKV1sS~n^oua=we&TPB~cNU;E5ITZ_A4nWwbT{z8?va_*HqespAtWXWg4%E^T4+ z^ZoO`pNCRXQhE(9u8-!yPrwi#V4T2(ds23!=g>+XSOV~@7LmTDTU!YS=ijR>b1c}C%)Q&d@GNFtz-G47 z3xDLag*c9X7G-)?dfg=7hqRauE3pvK9*%s&d3u{0UGoFV25-}^>vkUk>j%y>mt`T$ zH9Uf^gM74aWdcp394iMCB`Y$dWw|nO*rVH&^gOvCXj$Qre(a}+A~v&YbIv~}soxeJ zUiydQrb*pj70TbA@#sM^SIDHJXg-PT{`=@sRu7^~*I5tUq~CkIj73Woajl>kCRxxh zJ+a!co3cV7++q%6$#gP$dzAfSw|1{!xbx0I8s_(@_O9q3GA&19UZY<8c4amd5`$)u zERty&=&9~T{74#jI;DT3`uNGo12(*c)9UUamyNE3;zRa6^IhRb0<0);SOqCfaW#SO z%RD{>L?4<~zJK{Ax8q^6fak*PR9mOa;1a(j{GlbN$yT4YfM7I%*t4h$o2whuS8y{gH(0%r7ck$K69YC9b{lew(vAlTEZO+)fo#w^O4B+_*?j@@E{_5YZ`eC$x$jLsT zwjIDhj1I2RtCBAS!=_*fvF&rpIp3_goBbOzdhvQMioK1$BB6TBv<4L0Q@ao{;0NmE#ecF`eZxYqhmjqdBtMWb1=*2Z81C)mBnC$&w z71{P|Qq0b0#nr#B>Vb;8vtDG|)1{v9p! z?=0$s8Z)Hn0g=1{>W%9oRNJ3$wW&sNjdrkY1>X!1tss;E2pvbRUxaaI8TKpi+MAlD zVrad*UZ%?hSsbT6zZh2W2m`0)K2WBBg$X!{mTqr3aEz($yfRMou+`s6pIHpE*x1)o z*15^{z>N=^1Zh)7vA%z&pu$=R=a9g(o!)Fg_->daV)0-oySWRCbD>1&)zfS!ahz5>Xwy^l_=<2uQhmOIXg(&&#jRkC7_!KX=zMKOL|xX4sFWmNk040g5qw}(5~Dx| z3xRlvf(<^J-7oxQLyYp@^?P}UCBCsIrKYAHEd4Mulm5*<6H!pd)9r)(=7PpQ&p+!b ztIK$@00+vop^kXqPq=04b7MfS>+Autgu>HXNGRL$%X9M@frFi$9gu7}I9%@z5=C z%#-yksA3gT@3Uo`iYza6G1R7Nen@DJ$G!sB8t9#r6cw*}; zUfLYVYK``s`=IpI%En!jFyG$H^PscCqb%{BGVfX zAq@E=kdm^djhU5qqE(^s6CzMa^zS%*qKRwJyb*t>T_LBsym_#7LHa)}K*Z-;9mt@V zsOZ}3SA`{`^3Q8irs9nQUa<_1Kl9R+Z1HrUkxy;wbigl|LB;;B6SVXgo7I_L-$dHg zD3u;x!*Wr`4?P5`3p)cAc?+3b!isB1M%`iU)u9m4Y6M5hDB#Ti%51Uy!szV`RKSn0**uD_Cc7&OCyl8d~&Li$OmG!%z5vy!rDG6Z{65|YHL}5yC zGr{m)h;VTtg|A`pU=55EuthK;5uHq0)=zr}LABp!pB7>_I$^9ba&VsOQA6D0{ znbnNxlW<+!yYsUWyBD#sT0i_;JE%W*Ee!s#KH)J64iumg2lF)+ulq0(S<+J`$3W)& z&GJz++I&7^eQEUS=AiPj4|YX%h!>MyfewPv4IIYhlgML^jp;%~DF;AC4LYguu`wW_ zu3Z!)Mh8zVSk`(zba(ru<5Ipf*`@MhUK8IOUXm^!xywXuV6^2TJ_tb(E0C{>RwU>H zA1}e>1d(9C9yskcHbgSy0W1V8(iZ?Co=<8QMXi)_nO8+hvA3x(U97 zb7GfwaZ6GAimGMzs&k6M#Wg}Kvgnj=lZBW)2M`1UED)gyK9);Pl#)X!sNAIg&&X-!1KSk2@)!qGh`js1zDm!TwVG2 z`I|w4OiRlQ8go;({O_WX?wyqurjt$U;pCRG$s)GgM2ZPkzpUskRa6coRO^*cvITAB zcBrooC&Yl&6+vd?M6Xwc6SHgQVNITvJ>MQ4%~?cl61!0&qrszDj3|VOgPjM-R{mh> ztAyby+V?9HMuKH{0yS~W=UA+ibPC5x6@}P#(pU7Arh9Ta&y@5ADa>5{E#w1iQqfkc z!Qs)g`mb!H%$TSfJ8ptohnoWfOqe4k8AHD8P$#tgZ{%pW5MxH)OZQ0;!=ufOvm#lk z?bv@a7vg!r$K;&v@8+mV-__m&KMu^3hpcawt2hTS?6F4Z+b^EZ?n3RYt!at{t|YB5z>X2KFD%#-`Cd`FFuxtaaBBwgQ0 zg+EC*a-_D~y^RWL+<8DvnD3FA6+))6ff#t3^{g@wt;yY2% z%M->nO7+kb(rFEah|BzEV|0-$dSbg;DRuY}!I8PIC5MDtwkuZD{fe0Xdf6=x{!&__ z4khN#BbZbcZ4S?4S;Q~Twk!51hifB`{K@tasq}Gi;}qm%c7ZScxN)j#>^lXm(ggJd z;#!kGhx>+!Pp-)AZ|@KX%)P!OV!$k4{{JR{;J5{P4FLQGT6W>rd!^Qp9gtMyf*`utLZ9?n9HJ43iRe?4 zqs=nwey`m{4=Wlhow8NRE4XiVC0dsH@b+(`wA5t8HfXuhxDRSL6*YOc8{ct zZtr>|5*nJ4;K$@YAw5aSwOfJdYt5p(@Yh)cXcG0}BS*mq)uSET#+l_@h@ydqVZ-sY zjZi9Il9Bn!Zh$eHzgd)KA}trq-H>%o%U#Z0; z?V~7EJ)(c8=3l=3-QP&3F`{yB$~E(ok(T4RX^mDKM>%pu7Q;D1W9NoAI0Z5}8!)xL z-Fo}WOQuF4FuIMVp7;}09?K~${^9N-1;-eiWCa)A=2E3CWjjX^oYlenV$M8#IDS|) zgO^N6Lz}W#FKy89+ZKNjGJh$Y2&?MLk~|8S{@gEk_&C2yvf)H@iOmxaeM6clEyI+X zoxe{{H|s)=DI@2|(+e>7G24@HL{!$H8iY17#1dZJ~M-N%bTW~t1Q{{}qF5#I;>*?>H z!u##o4q|`r>fXJM*YHeYBl&GsljOK|O}Mc5J>MEEv0Nuh(&=AMSDP0v*TL&V`Ok%| z>FcyIiXO6mzxMZzn!Z0l$}`&4bp~Z)^uM`Itt0B2QCp}OafzwiaLjM zRA0D{w)nu^=7u(`omIj~eqR!nP;YjC`?tLzL}@ZfIv82H^xV113(cgsTljOXWUD{K ztKtLo+`$pVa|Sx0cc%xN4+F?JnC29BThj=Rf<)ERJsVyke(Dpik)|oRg%7X5c>QdC z4D@C|1Ct@__406iw79rvSe2+);B`N&52_NNR#LPW3U)6V#~9>DWsew3y%@d83d<%pPC(Xu-S$em+S-#(E&8hCMb!^Glm0>hW+7EwV}1%j;csiGbGO4k1;l#Y%|knzTqM; zXvfqOsFjKh!7(RZ3}{AJQ~D`Xlv5!a@#IZTT-Lq`$!$9i!8=%2Yf?BL>hv>Fk*pOsA_{4%nkd#A^6f4Z-^%8&!#8cZd)AoyR{u= z4Y5-DKf&HV?%<%wFAGZAG0kI4MIuRzTm`j$43zn7)Mjn;7w8XGMf3T59r=a(C6NwG zkOTtA2eYT+%sFKiuaytU?eKznt4PvWSO>u*BWw3doV*oarj%o0FTH zb9cZpCP$DZl~WM*XTlR2;UYso(Wy2*y-ELTVHZCd9ID?g4&7+mIjNNK~L5^z{9tdgRmGBv}2y5|9b_r<$#>|0`w9$;8DMK zZ)H8Q{JEfeonte}v+=WO(XfTlE|?LwoEGElNsWQuazi@4Y$5o^fH2%aQH+ zG#N$hB!VdxD>c1sxYrLiqz*^UZ*@S91IvaKLRXW`#?6S-TdE<};Y?kaO2}i0=z%=d zA4tF7Mde3(8xf&ju|fzQC-Sls(R$*Z0SD2%^h1Ta)CAS~ z>8GDKjxo$pw>WfZ5Z!pN1v;cR1MNBhqqINYEWbXDzdk)2Re<2Dg7j=hF!HvxuGD0D zs@+M!bo-{S0G|&LOO#UI5=8@f{C9gYHnbxGls zjpODP;jGxt`^NIen_N8g+jZPk75&JVS8w$SpigCO5Q2~t7WQYhV|HCTm1;d?iN=BALI|~$ z@I>>+qR>L;AWS0y=hYDsvP45VLYiS?!thYlKEtXkKbg}~d$Lb3uV4muG?%7}=L2V? zf{i8zSw!fUD`dX|)ZNq412k`+I1ZOuSFlf?S{l#$J}SG)pQ)JmXev>boSLMTOD!A}7Y+ zRW`$s8b;!moh65C-31lHe0#%+>o1PqXO%UY1Si<9+Q5BR+{$Z%DKN@SuowLoPY&&C z!GzhoEFa&MgUN-+%bI*qU0$#>~ZmZv}SnR?%P$BX#E0^QUmE281rC| z3OxaV*z+Tpupdqr0F|wv`z2VpHZ|*qpay|IATH=24c~GZd6slFVL&2C93g=Q@k8+n zhw1)A6l;yi_F)A}{`VF;ykNk{BCUl|W;wPQLcf;&wu}pTf|uKgxAUYT5&{W z4Tv5j;ZzB5-NuP>+oez_5p&5$=>IvZ@Ry$qX!!C=6Lm)aa5$|+08V|1OOgnK)`-U2 zEZIiHjzjt=mba8R6=}mbcsH@97mfp}Dr=Z4aaVkyS>WJz965_CAH?}r%1w$r=>ZtF z@bfL^D`zcQ|2(H+@%Q%oIZC$B?m4~x1~KS*V^_jRxg!NlJDXp#kP;z)(^}%0lwU9&!Wz)#5QbR3ddlx8K zguX=5E5;J+^-P1jQz zZ;WgC3gdHEn}zOaU2_c7;iQ({)l{QuE()=^Qm(H18L7`hutX(We| z8oIlYZs`z^`sk2O>6S*iyQRB9Lb|&J?(4nl@)v8dmcq;T$ONWLZL2LV;{NsrTu_YXP|#s47*h`CCSB$%QLoKET`4!-fMSOo-!_0O z0$O>(IGQqZdt+*%d8w@!CtKL;bRkiXa*XjbZGH3b03bP4LiYf9jr=OU2nYC?pc%OvE43w)qeO|YD$kwHH4*`Drz@TbnVe!M?#QiQnPI~_90lXjH-sKxs07C~5 zd0m2U9p3k6o16YRz+3ij?wLMr4Vk(21agiUE~gO!uGAPT@veL1k?g%RWvl3~Bg{~$ z+F45@ar0)o%e!F8x%Xtl#iU|}mHUIcJd>~>ysqd$ip8SUj=Zvs)>4Y#2$gyx&E?{3 z$&CDjw05RwyA4)U+;tkYa-|J22XXXyhM1U#64V5$kXMkPKwJk#pi3R%SH9cG9}@#u zh!H1(sNIp43|Yx-X8tg_Z9AZ#9w-Y1)f(QIbPiZOaq6_V&?j8TdM2C~snzG`Hs|1)jQtX!9kYICjtp-1< z=&edEHo0gUk~J!kX6qd7uo8-Nu5kiE)!^dOn1d{MInXcZmh6jkajXb}P)Z~2_#)JX zk>*$KM7^q$_ZJ2+z^RKD!Sl;1wP<+YIz-K&=|@NUnU;lzNx&*W<6|F8BRG!{g95 zIYN{?$cy6@CX#{`hH%;!KGhT@BQzp6h_129{4VQ|lI6U_O&kBn&`d64h+#E}0G+56btD@O?Ke4e+wVk>tj-&!%aQ?r2s3L2nvk=xS= zt!AN5M8?bq5<*&2tavg$pBoC$0nY?5nf~7u!5w~YufT$GAnJ}!NGJ=i3Pu0?9uEwx zfxBYb8bXBj@8asFHH4AZzZ&oBw^2EP>j^O?PS=r}r1H-WeHKf+tHsKL)kDs`QAeJRn}>HN>aVlo@m@Z#5i`n^BZJMo=p(;7OMa9Frb@P$M!Gpb}} zqZv^;wHQXfg}dJ~wM?;qq*-adWZLLPM{!H*p8M9ij9Vuw1Rvx60&&274y9t)f31bzfVs1m#%&aNPv~Sj3*8@E_I$}wc&&HWNCi_W7!fR zT}&mJ4TV_3^L*hp76K)5HQzfj#nF?CslVmk56=>_KD)OL`5&-L%t~!8^+%QB6F?pE z2NHgZMD*G9O9j@UNMj+s!fb7>cePBDcaY=e8E>gf-(xEM=5MflcSN*D-PuVZ$B04n zwVws4?vH{C=}ugd-y#xtus`G{D#`1`f7&l9Vjeum(%82-%LJyS)(nqD;ZE$xf9uEz zr@kn((wKpGophiEG$2?e#{WW~Kd}PM3Xsu@(@zhRp|~C`d;x+v$tj^xI9m)xQm_mW zQYw#XyiI7;8aSkC@aWNYSBuDG!e`XPI-seQz}4qKnd#a9X~&@QMftp{imw}`lZ9xK zlpuNUA3l}@<^*WAUhc_KG}%>1*E;#S3~7n0~Uf- z?rg`En;$geWb}e*3PqECPl8TBtVWg+&}j3V-2GL4p=fC%_FV8^nwJuf> zi7!bUEhQKHgDo@5~Q86O8bhJt&_RXCd3^Z3R zsPj}vpf#k2zN$Uc92&S+i6$fUWvdc}FFc>{!*6-kvsCX@$_MIh^}sdpDrx5yY{q%SYQ^P4ac_s-X1Sa#>r*GuPV%TZ9e1q2CPQyAr39L+1Y z0rAto92EEhmSwy>Y{w3m0`<@f-~t7pfPbscuCCNbZ~nQeUcPm{2f`Bf4OOEB$ONff zurjR<)aq21@`XnHD{zV3`o<7ao5ptnIRdcAaF<78*gAA!e%hbh4qpcxPe#SkZR6_k zV6<8M8@;@8)3Nyfq8E!GG|zgxm1{z$^@EKEG^+|K(Ify;3u zfu!*r2d)?oD+X-K5HlnIF7u;tDKwY{g#>>gBbz1}7K9ARvb0~6 z{k6cT_KJk*bo4l^(FNf17JtFsd0fqZMobwTCbVkS9_DiC{_|Qy8Z7W8Mo8t86^~vn zL@aA$2FHnu9F3aY5Gyk!KIR*L%WR(d;C$K_EfgrNYDg8At}DwT+^ouhfwb4si@ZT2 z7Q~RZm=OTq=|IDe7H3^jjtHl>Sy9xUL`k)VK+I_#%oc=-)XJ^}=A|T~KrGz){65${ zfL`I@l@zp=FjZ;JV35YV?cb~dn~H>WKVtC04RT4rs<+<0L+6Kzt`_qqQjk#yB(d_* zVg?kD(zFqRcJf&VYjCBdk#PIsx%;13CdaI-4lgg`SNC!4l*1akMLyqt$v@RmLVr2gps~5 zVRq!SnaJ*5^lKQ+NCddR>-U%b1X06TUQc{*3{(&Ve5~%2^>^aCSyYx+`KUsPv)p9g zxG~}mX}~Sk$p1AuqgzVGgCXbOu0VZerW0D^``ZmiV5-BUn=1&qzk zLN-=cXO&HXT;s2T5JX3y^+$jH~ro!}{_Z;ui0a+Q=_}jTkFQKo35@ z(BAmlbCmh}+7?5~%fCvqzUkgi+i|z|=vPXC%Rc1*jt(UAyV!4rls1TY@^s`kXFi#l z>FFPj6;37&L6or4`*apG>g_hxWOE92`H>MUSoB!Us!J-$u}bNpX?bh8;M6ow%G7&q z5ItFx_^g3Gh9v~PDKydpfo)0)=gGfWF*QG0=d5rBU%D<}syLFtFikkdp47N5&BIeg zz&vt>;KzJU~zM?1}e_}j|i!+QR(^*fV7XjYiLGKRxK45IhJ&W1T2an3J;d7Qv1mXt7>mqN%w3!KTxW*ioQ-@457lu|b!eIM2 zW3u$ylSSpw8$vTXozu~0R{Ulz4do#O58K-G;g>BYt7g0NyGtt#j$EYYfH zlZGLYKM*lu#pprnz0YE!7DIU|WPsNfOFvFwVI?btjr3*-e%(mNFE+cLkyZcj4@sqB ziMz%q>R+X}>@Bje5E`;z2b$$YZqA?1u0lbJZ(l7Xkawov2`0s`24{jbdqb(K1v$E~ z8N{&QI@wKjTefA`q|LA;{dw=9i@ooQT(5gcXO8@bbPn$bC5|gdd zr`LU37vmYc!1WlLq|2HDe2|Q~{&RB(B#He6tikc1J8FFDG47`AB)8zonFJCcE$fy6 z>JMOI)<2f-5B>Y6)B`#TX2#|U?7lKrD8UHFf3behgXK^rrd8Kynj2D8n!xI)0 z!A@rpGPohMb)M1&z?kWA*5D+zC3h6J%?V0Zj+JH%A_OwD?g<;fme+v1xWGsBqj~( zqcb$lB9;FJQ70XzHZ8}RJyc5)j+XXv7(;#BnR?a3Qpg1SFoUU>kJ2M4WMuNA}bDHl!g}R+AhlEow zNVMjpC)5&M!gJosc@mCQsbF7cn^}j)eD22s|A8C{_N;qY6+BfdJI7s744v{6w=ivU z+`7|UWtVhSvV6+JM1?Bnpdk-hHp-3#oC=&GYpTDP%6udD_h=TaQ|fWecR?M+dkE8( z`L_BPls2Z&aqPd5!A>r{+J%`-WlEnMuZSaaFCHF=65pmaytANEmr( zqDz_@gc~n7gs;|4qT3c87N72z-%GMlH;FbbWkhaoYRn|RSd6oZeaSbGwZKF51^-k; z_q8aqP$b=Lm0GMGv24+|!S!P&0$$_ntgOR3&qu(x3oH^+x4og1w{Ld+7TW_zz<^_X zdOAMaf0)@2m`dFsuyxU3H}hzHkrvq}nzTN>4hU){E33byqc=m?6(RG&fN)WG2lH6L zne0VUjpT234h%>D_5nQczn_?%wVUJrWB9MnrH@rgi*McBJPS>mF{2;B6E`lWhgXA6 z#cLcQU^bkqxHLJZ^ORKL`~EuzRbb=@TrO1X=M(R35W9Up=D%TIAK-%AC=d}50elt! zgFTft@pd1JqXr&-<&zv`*D)E$RpGSNZV2y6;EdB9Zn8W{Wo1^!G4FJCL(g5!Wtkvj z!7fP^KwQ=>E#FK206(`f4kgMY;~0w@q(-B&X7xX@6mH^R@R~k8b7)CGBbkNK2~LJt z9rTQ8I6Xu+7sKVMy=ZUu(B#MTf*#E}Q&5vi zy{zR3Bgh_ti=u*11K9Vj`3#PcL2&%G5T_aMzzXe$%3rWm_FGO?yhE%v`h&WcJIrhm z+mu=LjOi?}$cpqWjc5-mV2#-Jp{xq-7ju8z5+XO-Ot=e!jMIA9Y(s%b>^!x`HymO zr0ct^5ca(I+f6Jn=SNKR*qB<}xT&5Hr@5)fy^e_~t^^tqbp~V?`824UxFkTWyr)g|+PU4OeW+54a2u&;zIkRsXe`<|0 zH>615ReopyrK+d>tC|kxuMRO!p$Np$u)%lnAu5^tOU+ZrL`-{~Ls^tMjUiZ(H{!Z0 zl&9;jDywp3Uy~YSy&UNjbbFI7^4KaJ&r(z9CV7$E>rlJE- z_JA9OaMBNm{{cEJO0fPAKOaP}A^2Ve(BVQ z+-EZJ*f@G3N+o#OK&&r9lVNZaH|YZP0Y`Y59|jq)4^RTpYSV};eVrx?Hb0M~I)8px zKuIuovV9QT)on)Wcun z#Vd1Jlf}42d78V-X}bbGqJ>EFCf{?EiQ3!dJ!p!CjxQHaZMep`?a!vn}pdBoiuM4lbGH zNm$>T()CDx5BiN=@}Xm(&d}d?moCJne_RBPfh5tJ2xGF9qXKpoxJ_A+QYdD2R6=x! z&U|_YW)RBW)7C|rfyP5WSJp{WsQtmGeLpokyiAi=x0YNsNp2o27;tc;T$FekikQ7g zry{4QiPCUIFXu{qsbh%lQ+OjD8Sf^_XTDYaMb*7{e@Lm@LfX{`{BXzMpQeDW{=gTC zyj}n8ASo~*0+tkXA(S8VaJoc=W!aO$9TGo4`Ng6;N3j4-?G8~$d3>A?MPGK=K$ooI zkDznmC<%5^VK?_ZAijMm{?|zVTWi9`2EfPGkgJRXfHp3kErqmJEH0)2?c(;O&iOZB z53W}&AnMI6hXmNQi$+23JV zo$%jj#813|Xht`sVAiH{Mx^@effM9c9LoT9s?3&A&Rhxb$Ktuc>2WwXYypIT1N=Yv zKO-5koB`btu(Z5APWl0~ZDb^>(2G>+KXJWX+zQNlQDNYofo>5|HD?WX>`ZG#8f7F_ zf^N<6-4)p99_>$DDGt4x|8#r#mim*PPiPqKT*8$rMc^H9q?Uqvq`v3rFF6_fJkAVF zYm>S295?`R$pvGfHO`MjI$h?5wrBNe1EZw0Zj&em?P+Fa$uUux<>cj>VoPR9 zG~P)ntO}{MbCt_d9dib0m!$Cp`cnYUUP+-ZH-!^DOw8t|$`HgaAwd)cyCK&Ywk&6V zB)gkny1-OylAuFLHXn`sOmD_=`2j_eD+$LslnT{9f9I_w+f0{mn3}RiW*i}5Mo{%< zH*yP->AD>u@l`Y4={0uhc)Qkw`jD6t+YEjECq!CbjyabDvD?+0G0+Q8$eh)1}=Hl-CMLLU^UhSkXhpOBKRHu4XA~^ z3M$UVr@78vI=}AeGz+bjHlk|kyE>gS;-SvWHgypXFX*qNagJ1@x41f)sGug@!ZMNK zai=*6d~rUKOUu*Ij?8;zUQK%1HXjup+R-d`qKG3SQB?M@-Xt0!MeCIbDGI8f=d~`k zJ;o*#6c~p1bTDJqXyfaOVWe|okne;#Z~Ko>R;y`SBYIQdnWs{Ms@6^%(|m)9zDDP1 zR{;=sP!Nz}z>}rq)+Xe*JX5g5HyglcY6zN1Qndcl?AF8IEhpCs*=W>Jh+93pi8`=m zg;(OB9UA-~6qh3uMBd$iAoko)v)+U_tmIVV;;=kWr|vktJ{~A)9g0&8(=3#X#wFP1q&Fws`$sp_Mg~l2tKDrvbw0KzWjL>@uqmDuGJ9~Uj`EYr;V?j} zkmQ7`g6Z%nP6>LjyhgpR*I&J~Fy?iXHk^ki^xJ5;0&`ecoRU-|-Di|To5*|j*jpuk zN0hNNs>3$g<)w>jTy8>Rq|5yvwtEZK8-`zL3Pkm=x8j_CG-(9{56?qw5O)k+zjQz$ zT<={ca!r>A;~A5#x5mPN!N_|M)Y2V8@lrG{8qV3*=nI-0*vjET6wK42D~>8!R{#P1 zkh^lTs` zfYlqw@%&~V1B@q!&1(Va?6;@E_%Whq?oInBfCztjx7_v%iX0Kzwch=$C8_|GbRt;z zf!x79jk!)CRks7@>s@~Ki!?>tSeYWC^q9u*gqLX!a92tP96yh~q}}}LucdF+p10V# zfsI$J(ehpENQm>Wz}7{KG0IR~{@o#Hs)*S0&h@9w*{8WakV0{AEyGZ)6sh@0I3)y* z3a`LUb(t=c-d{|>o;E}(kk{l`F4;N}g1?AeTQR!;uovV(fRVxN4oIJx@h!+4qSVEu z%wbk>)s;QpLEZw-@iW&|tya);X-A$3(R>Uag;h7$DjB|em93?Rg|mRP2Ikh$6B>Bt zho)hzJxavgT8kA?5ju*s5kWSM$9gf6KJkq8v-js8#_R<86Q|z>|6yRRx2hrk+Ba%D z&yKqN=^CX0WjqQ~=?sNL7sctc_8{>VKvzs_09Wz@02u+8-Rx|lL)G%e1~3K^;^zlo zqgQ~s;LK72rn{MWqXFdO>^eQPkV_lXF%D!6{JhiG>zf3bpai*otTx(5>ZuIwt@mgC zNA8K&Qnz1#;E+gIT(_7upyD{coG|+#xBRyLB0e566|ZW<_bLXlT^`jYhCy5 zwNG<=lay^jklIa4(Luh0&+a6~k2ZleIu+)AjglToU{bny++s|7QI5;ro(Whb36L_Z zMa++oziS&9@oOS(!y#rnYRC zKJ7L+70K)2El%1(5<{VsnlGXa=p?!CzcxFe1h^{`?$hXWzx?6O-KFa^J^Ne7k@+nI zJ!YnaLRNoKa0LFBt&glMwGh?@3h@CBOGz>dX5{aS0x; zyQVHDlv@wsymqc%iaM$GL4P`RC#-iEdMNCeJX}PFs$aO%psP*RY-Iz;n{s1+bHR_bn{{vurZNOo zJgZZr(7E#Km`6SP6Og(OPFo?(QBMW|90^PnoM6wD!&2IW#HoJ$D zmk=uP6fJBJ%YzR*nFqud)E+^vE;h=71y8{R$r5wQL(b6`vLjnNoj#_c;=WEA9Ei0b zMneBi*%hav5Un!>zF}Xgj4OaD!;NDRW{YlE@9A)2P%S_wM7jHJwN8OJJ+?_d;9Lc2 ze=q4dpeqGr4B!R60MrM--4*j|yIMMjBa);@e~20q*{NHK6LM|&76_%IaV!}oTacgn z>`$CKHOdEhM>QnevqNisSO}|V@Kha&MoIBUC!GwXj>SKxZ3-Mg7kF$ixVa0;;r{`H z1afQPxW(qx9f8(j%3bOcBv5-zHD!>8Y=!!}x{_VFSbXD3X)=)tJA?faw-uoD!fpZ~zFCz3CaBN+(&1NIaXP@hBAgnc4ldhGw6 z;1A7>1-{az+tWoXkvCHZmW|l-sW)nXT8y{FbDaU0jv8bp-Iuzx`uq1gj4-AWO5%u$xxap_ z8u3wWCH_p>C7O33FoAaMUqme_p{S~yc&XfkH{1bOVD8cECunW)BEh(rW^#&7hcIth z1hmN77#~CSMwsIQu2}sda1*21>$7{ly=g8(8s;=Dv{soV4}p;Tk>WyIFaE+l?y%k& zUU@@$!J=uhj`}?+he%eQMlD8uC5eoa#_VHrz^GUMKPn=cyVZa0TQcu2oFwXp3+#dA z){`x*WLWJi(s6$lIMXx3o|7=%(x0h2mL)Bdye(hdS;Ha%qN;7q6g0Z%N(1odp}E@E z^mJHLycS0oU5?OK|)4?15hPf_@SzvkNaMOC zmh{ACYl;TKS1~=1IXSNb|Dm~_LzCkb2n1sb_Tj)S%PTs$HL8xmYW}&1<}CCb#%;3v zSMr)C7J~3tT<(U~th_eJNK5V+!i|}O|Z(=)Qu}? zYIQq9^9{7!W2_RDJkGNiE|sD1fiXW!Zbrhm z8vKKmsxB3Vfy*xS2s{RXxzwznwzBWHwKe=is+R&PC*8TN@H|~~y+TBnLm~VscWC$@ zC0^+W%!DNAc?dGTQ%~f@45t~a6*8H%QiGHfWwXCZoirvNoB^4`3?Jq8~f&AUhdu%uqMcx6oORJ0sU>9nlvN)IMJPn^}iVo8wHm#Lj8Y z|L63XdSbfcf+OLF?Yi!=NJ&PPpXTHJ-7tiz1GPlV%mTP${%czR{AGjL`Z+3BE!3~5 zJ})$iZ?MDKzX?-n%uvtY9=wxj04ON3(t}%F($2bPGgt@#@d@1@Xh7p|&S^YYuJtFW z`{H}wQu57%Dtc&9scd;KP?|d#yaShWm)dat8?>`+u1qAZ=?%Xj9(T`G^de>i<&c}) zQie=~57>+{8x!P_oH;-UOuw@or%~*&d2M;-6N@VMy5V$4vVNZ-9sxSA%oM{#~NAx&82)xkcg60 zJ?t#*KA}EXL06kJBcfHB@I&E%EV7aXS}+?q?wc?Zz8xM{kZU47YZVz+*QUMhP1}a} zm$Et9ysS+03;bjLKZF;+D z-lPfph}u;oIEN}$3PlK-in}(7?)i|UZk<@$1D+Y^X^u>UJgj8*=cy2t zAJ|ErWF1~)w#zJ=?fUA6d;#u(WwMQzdd@n)M1>y5_#1+3OBl(=A`b*&Emn|`RR3*f zrDf2>TxMwB$LP4P?8mcckO=>tBE;3%ioNVxxG!?PVvwV~LUlf*Nl-PF1BLhZQj$%~ z#rv_q8{6QHxnBJS70I3C1AJ^1xWeR-L)k$XLS)@ZJtP_7l3mic8tDt2XsE-Ui;m75 zx6kWr2Oyj{ai%@YIp4fb0`U5V&tO*GOQfFj-p)|Zps)GeR9 zJm330uWktY0#(f&<5jFG&$Alr`Dc@LpUFAAh1l65r;Rg!aOTVR8iGYG3kgANbH!VLRf?;S zD~sL`#D7PDVVr-6=d%e{R1m^?8SnT(Vp?)g%<`Z{V$&1(zu=FWU?<4dr|sENBdgfg zf1^YPZ(!t2*!Z+d2*1~~6P}NIi^Q?-!u4n~7ujV2W7M?7ECB@%b=ro~`oL%q21&;} zTDtqVy>b4V-`LrEt1xZXz=$5^@rzrllareAe@X(GUWEv~T==GEYcjF5$lP_fePu#X zz!Lj%L=X`~oVbqt9v4;A&}IaYt;(qpY3e#K=s7PM31O(@^pLZ4l7sZ zeW2gqw154b7=Yo4y!Lit+FPZAnHPWsAAcS&OYubTLdIbG&TN zc*%zmyCRM&H7=WIYLNFJhVWS=4hfD}OQ5dxA9<7sSXwyUO&wgka3>r-H4>2`RhC#8 z@YIhy5(SO+B*{%En?Fviuq_@l7MPC-qq9fneP7=Od*!%aKrjdGi$ZQuo)%alSez0K z?|SO9F$=BWHChi&H;ez;FP*dOa7dXGc3w#^V$f=0=vYa{Hl-ESl84#|c&7V1N`2l1 zihlrRM<(6cbo2{@B|(oU+#PrmDL{2rUcDZ$EmC8I_5GhU3mAEypPwI>TjUt~c2g1j z=@mR)O~=wGprlQ{4C+M&ZH&R1>2fY8A(Lu1jwTow|G6ckXl*7*5-?}?hYn5}ERW7Q zQhv1wyiLRls8#95i>6MC+9b&vo{l#d6lM+zEtFzi|Kjjp6cWf(_QFsa)zX&tT~5ID zFeW-h)@E`+TfnG}i^8rUN}&&_?kJ9TH#R4qL6(?*NVP+}DqGGp$v}L;2~d{+L9GA? zGch>{_*4EKR{>cVkv+yh@C{#<5}fCO>TZwiqesf?{W_ONy*`$O1e|51>lhN~x^ zkYHw6?8kXeW1&V@p{aTOK`Y@xX3ZOJZiey^lFiq*{*5RP48e;OnCMd?q|QKmY!V#}}{=LU6H z4Rbm>b_=Z z?7AVlI;n>lB&b-M_B37C;C)Cibcwj~ohl`>XoG=9IdyJ|Ghj3lB)`_M_)W|-{#DTM zkRN$KCkw%ujXu&9tzS5emN zaPwDO!k*}NHf@}srSchrptYDdBiMncgsMCATO-mNAPXU7(hul7fwz1m5?IgkQCRrD zx7QbdKmBLDKPvtEFm+oSiZkF$rbPrw3!&@0ad95qZ!i{5R25gpdm@v_mJfBC_;32p zV{HJc-w+H#&$P}k0)nPbq!@-Omuu+jBdYfd@^_*eyrCLvitf+UL*n# z|LlqRtOk%txDcf`3aFBZrG7|f@9&+auV#*?<=a|o;9vD$cEG9ZDFgWC*F_96F+L?N zOSqQahSJ>3jo59sXiy74V5Nm;0`Z-YkgG8qmMhpa7hp-+-wn~yp`jQJ4HEe80CZvZg zaBgPIOKPMo7@4!C8aa~D3*<9RX%2Bi5IW>70;SrbQZXp-Y)#&WacfCBNj2`_-wkHanj(0cXQ|~Q<$;is zLotSg&v-wqjnwzl7Fi;n+Cdg|Qq&`+^KNWmaYfkR6!!{YFth;yv!36MoX%vS2te&K zSyy$xI(FYwhANza(aqdCf(wyO6J;1GVvEFoGKEcHl$W0YbpjxD+fQBB9s{V?mQyp} znKC?<`*NCnuy_hQk3gLc$caaf=K%2xtW+>ERQk8Ue)eBF%D$`pRO~Oa4;fIZ@K0|w zab_i?);Ka0upQ^$n-}HOo8J94Tb2Sh*=dd&7!A9L{=B`1}w0Yi7)+mvbA;}_0S z;+^1djBd|R5n@37=5Sw zo8*<-uw!CQNuni~JYyxfmw7)>VHMJDm6_^ZsM6zP=);W96(@g3vXGwNCWONOkb;56 z9=MFx{6vDyv+pu=91{A4f_N}nE)rl9{-H0jh#5TQte@Z5-%=6Ec{Ydv&XXN>T@TEt>xmvd!u60xQcV z`IC{PL+k+NWZ-bMBwcpxC`z946mYr$r!SyX0`i4k0}z$;@aPC33Hjir$aQ)sA}9!q zEPzSzzdS?WmjCm34&+cmNPys9z?|~GQOD1~Crli`LTlbcKVwB^x*r69sVWL z$x5-^i?V|0>$~?=pyNT?W-bEZ$ka5rF%c*#zZXhgdEGFU>pQyoDCBbCRBlpZUyfVa zp?4haw6)sng!$dG<78O6Mw&CAF1k4u12%pIOW2P&reI=lz%(*#SwOS!TprPA@>%3M za_)_dK#i#cj`Mx;4%%oBjt#lmMbRj;C-M^S#ZV38j36P_&lweVZp9)tu9h``m%n zZ&onFo%~s^B>PhvsHWWap~63|Z-BJm4(`i;OIoxfg}Ha~ohd9f6EjZ32iEh|%*C`Z zewBq3t~QTx%A_~v4hPyreE%r>vtx5#Co6rh-eV)K!2=)HIq0?4(T|U%_Gp%}K<80E zhg(uhXgs2`s%Y#`Jx6DdI2B4;G2)%vIcm)o*y}iAoBbyd|po|7myE;m?Z*Fd8i9N1CI*Mjx;QyC1oc& zk#Ey`nn=J87w$7+fF%qXGJ&_PoJnJRP!(z02_z7e8|~?Y9Bn6D7t8u-${Yk)MgxJO zR>e}~x9k*i(K5Ijps$qwHJO}+FnIFZ#Uco&zLxS$>YV7tuT6UgMG>z}4JFXwe<$~* zM%>YxeOH4l$1SADB7gu^=Wqgj5(sNCvr00K^DRX7#2>fu5es*p?b~GtK$NcW4srg1 zm9h$Xy6e{VG@b%M(&chq?su;@fbd?2=tc4uAbRHa4R8Q% zbou?u4f*T z5rnEU#uE^N=ht)Ipcjtl?Dd6^Bn++47i0GO@Tjqh{F3!)%-+5}!1+W&UB{%$^tuZq zQ~PkG`gLMuY4{pT;t8yT;gPlwy+Xwunag?=WfS98p!UfIq?YR4@^B1|-wDq7exL|? z*suR;sQsiz|G8j-Z}?$voV3Guvu|hw$S36$Vs_d|i=sDsagt4V%WUFRnWc^IzpA^WFp3 z6Hw^@am4c~88b|?p_}wJ)@k<)d_7Yvzq8>H_dUf0Dn9(^XjkG~NPvB=vUSoD->o}5 z3?-#0ogg3z&D2!;nzV`nd#+AzpSmSVp1qLTXRS)=y-r-aZ_0N~qnWWqwRHIr)pYP& z>Fz^a4-bV>ev*dBEo%07^xWRn_Q{8`FpmDYys$-ms;a>9Fg#A<%_c%_RC3eHX4t$; z*qA&dEz;!zhL6YzLWg#pSZ7s@*Yz4(APRvxPKpa?Co%K;-%jm`&8Mk^)zZv5>NGe7 z1AKXLxa~wRU+ri;*!O$0f-BCM#mc5D^+F8#>sV6_86D9K6r4D3=-L!nGTZIqq>aC> z$)1=5{cw)M#H|E*%{1bF_?G{-*kh3YF!?J4fp17iMKM)Aee&ZYNOp#xkHro@ls@K% z*v%sLo{j@Hl3dqv_793nh0+oag8<<;nC5$xSdf^ zDY$Z2I*msx1#~}J@>0p-ND9U%adb2sK_ZqB5d1?J(RJ_in|M9rq5c-JNe`L$3vx8D z_|Es!BH$Oke7v?IUjPsTAnII{B4TmYQz(THD)KLQZ-5VYaDm77sr@e?m;LM0yMQGd zfFXO)W9s?&p6mJjjd%!!atB=I=j}%wJj8i~CW?k%bqMclI!dEX+`zI~UM9+?skW}9 zCggt>|4#dwC{Z_B)3sob${ndKmg-+{gx>1M+_Yawf0E+GkYO!!k1s}%8n!@xQW2mm zjSNJXork$}s*JPlV+QdU+HHsVtcMLmd8Jm&nbNUiP)=U{R=(deCE$*gi4iOyB;0T- zpla|e(#j;HgV9LO*S(3scX4SNW(}HL6xjQrh|*;m!}rO_PM2V{heqr%1Y{KL`E{)J zqYa_BQ4IK!OZ+Y(9;p{Q_erS#G(!J|5=T6s6Zw+G1(7AyjK~;W_enLH#&49aSZpPc zTGq)_VaXKb>f%{`cs$?6?zj|PAA4-ehF@CAs?t+h^(=NZLAmAh+l99j3{m$2I{jMI zijQYUq~f8C%-4EZrziL5UbAN17)QwfUQ{$C3yBQeR<3*u%%Hl3HV=8Et)gmvVN2qC zu9XnIxb<#D4iS`1n@{N89`Q0fpFa~mG$(`yI24Sh)tK~ckLM(Iw}0k)qa*}nHaVA1|j)%o~vS%8+_RnFkW z9dUKiYZn?-GVvhvIeCuL$o=+nRTq{U?SIRvHV}b|ld-U#V`5^e7O z?PZwNr`;MqU@>P`_U*yk=ys-RK}j!hpK9y%e-p+k_9z(b=Q_(to5cdgN;vE}F5VVY z`t83ACySzg3=+}qULVqQ|4_SK5GeYRAuHXY_a@I@75Z*{R6^)OMk=7Xjx#$_R9`Dw32vBdZ5ao)z=wrUSL|(9#^t zI&xt!V{qxx<`4MpziP3#o|{{jbJ=(>??2Q{j<_d$Y&+ZX`5C4US|%_|JN%)HT~23x z&=^E`$}??x0(PfWni)Wsl=n0?3s$$`84_e%E{B z0Q&<-PwRlw9k|+ju?%yHVv9crn*VdHxjq8fIc}RGop0X2BnAjUyv_6WjTG8&q#;@j zMJ<)TT9!3Kp2ml+8cuYeC9)7^re_x1vi#)w(w$lFPtl2HXQ$zrvs-BWxJ3!3Rjcz3amSgOpz@;25e~1zYmvv;CUx#YeKlZH=_+MKW=zbV*y4O6^7@LlisO~?Fuz`uM900oEO8{Yv@cpgqV zS_X4mc2oDR$S+;1h854!jjpYyU;71Gg7{O#IJr3~H3*C!gyNa`E&Kdfe8_2C?lezw zWbM$=sz-~ch+yy9?TrW8!Y10dPVg0iE6^4{cm4NLraW~#z(rBMsHyi3%;PADkGqND zG$E%c^g*1DpXGsYac;h`^fxj+;^7@h{=D)x>2GM0q&v*ZCgpO1Kv9kzZjrX{&ygzOl-WIi=5WCQk4DTP2Q-M8uvi+ zR<7@Kqu(khrP%ej#6_=aa$6)Se>vxu3*w9M6}7v8TDkeOC-8)xyUdgz8ohr@x4ajaadc66 zY@>loOAgBmI_wl-aoRET{*Ogf%y{iJiZ(#uXy)dM1Tlui>k*{6NN#G zDy({1axP&j>s~qcdgwea(|vJQ*g_}E5j=~lxtWn&C&6vQk%Zv~a5Dt}4=1lXK~BUt zX2qr=8PUdI0HeP5;yjjuZa}M- zFS-Kwb%0;JY_1oaqhdE1MuD%vzgb-s*)9!E2)!*hoy|ks_CUw)wMi-?Ud8QYo8!qf zhyCei{fI3VyT07d-~Tx+9~p6{+nejc#`CB}8}fA$`h!6(k*FImGb=-W?^yLjNFB~o zINn9Jl2EdVblR)hNNTgRRkX-;C$;k$Z*P`%|I73gCrr60-69m6mgoP5^(M*UD?1A*scToURa_x&*XTcp+8DhD6+yCYpdVvBc8+W-btkLr&N=7$EaVt|Qs7}$ z<+n=MqTCk*lRx^#(6@@RRC2)5LkI>suWfL-AT`EHYTBqK*Gel%V8j5AvNKe83@ax9 zjCRp$;LCVaa_lroZR>p*RhwD7nSNvP9iq~NjFqkY1iDdSi=L1-i2@l4@lRrX3fb-q zd&H^O(QG9NsR8(N4D~6|+uPf_ySs;nhsVc9y`s}|F8!QTI%(#-d-K`#jD8t+G43Z< z-8>E>DLieUW|<<&kEfiT&g}>h6-nW#Ayw_JmnAjamDF@T`@**O1lhC*s2sAfkYQ=AB&(n~CTj$Yqy!&_`MN6+YQZ*SkeeS3d@e|L8$ z9w*U53{l~4dn@N0gWv$qqexd_IwtsKu*&#hm>7yeA;#ntCh2&g&da}=8V}6waT}2! z@oXCKY$8_x69G)I1b8a5_qHmmfvty2VrB5#hqAYrD(sjCc^C*FJ4Z=}4kSkGD+%Tx zi^stuskCJTKvIaDb1AB_RpiLCp4T@g=XW#Q6{6Fl+y*dGE5AM&?2pCg zfu!KwH2ew#fWI2PQL!DSM|u9+7pFy`ocwf*vmLV!KBL!XaP;5X`Pg-wu@EGfV<-t^ z+(+@#3wdaP{LU!=AJ6o@Yb{yP&Hp>;^2EdakKIga|5XID=;wQQl--}vE6elqGv5^u zn*DOd=JSS#LFGhe5C9$koz!K{cOjQE>UBevLP&~gv=|A{PrB!^u2B0y{{@@8qK#N+ zSzmgt214tB)CGpWYJhkG**_z-`1yqmon)%@Xx7CzzS@$6LILW~TLB5>w7V48qTxyP zpI78@KUD1v)sb$~ZHi?B)Nj-!g;y8poIF-RQ;rAhgk+f;3ZePhZ!9j%K>|MfF@#6{ z%0|0tpginwhJlRc#O#PaU@=s6oD20t;=ORn!C;r-(Kg_~vTD9kIHMN%`H4t%6(y{o z02)gC=3PS}y24kmQXrM0LJ31Rh(f1korLCiVAxSzTqnim7fJQdTZ$4F;4%Ub0vs7r z>%&OVa)#3jR}TX~b|?43V>^Kl9uEi88VV$weaN<_`J@&(A)@utY9d0`g^>;=oEk{j zharZu=_K&DA*nUImQX#&P!_}psabxivA(O_uCOZ71$gSH5m;dGyRm{9HD}}(=V(@H z-@bkO{{8#^_>cei<(FT6{q@(Io12G+hyVP~|NP~bU;g^nzdk-b>c7CY@+QnGt-V7< z6e2xEV7yV-Y{FO|#a4#)m_tH#0udJco2v{J23Zh~p{q1Vqyyt zsqtA4ciS-|+bdF0da<#>6R}F6R;W4vBev@I5ZUe-RWb4tI|8)+NmQH^g@cb-{GKH) zdOj7l!XZ(wqGK`i5Ny4$;k~@FuuPG3G;B|$gQ-0v`Kj~^xMHb}<8XU>t1p*#a@jgo zB2gBa>E%SFm1o`K7gg%Q81V#vA;n^dfg#8dbNDG=FLcG@O@=U>1j=v$ya2`-Njch( z*GE9Ck$*8m@DR?@*NpO@7Nn@Ws8&Oj8Vp=fegA~c(Gay5(!)@Om?;*6J4mDk08c9b zSUc-Z@w9AO9m(dN#j`=)5NUTwuz#*pA<6|NI_yf?8y%uLCgzqQkddn2qA(2Pl6(*;CwaHp*iCq9Bycj?R<%FTX zFT!=+*>GZTmIc#Kt~t~aBy1|>(qk*iBuY=2ywyslN44shws%wql^WuN$Lxd8=vB6_ zfr_EyQsV~?eJYjR?;)|wKIP%qVYGNT>pHR0LBg_f2iI1>3=f-<)WHx#N!8Ct8p8IcBjB9)(^bz+tE@wPixaU zW?eAOxe?iYr7C|=)#f9BE^)z%*p(q{ElHjAq$~VhY~X8Y4w!ewg?Uu1;;>-$Qr)Oz zbQ$Z3Jj!i}-{eteM*Rswq*h~;2nGydJw)dV3c(@hfIcAJhxnJ2s1Kki3Jsvoh1TvUw6v#StaZiX*>TsS(T5F+`qK#o(VH93T zT1hPoehl(f5(;mrDt_cqE;h*|qce~lgW353L@fq^7?snfG^?L2iFdE1asbR2bN#?B zVzl~Km?>ZHEA$P{{Fy|3p7ib8xBmNYUB?boN64mH0Bze_=Ss1Gk)C-jg@6f$kw0LY zL*Gc^q(+*?t=s`~0nB1-D!Dj-LU`GR$4gtuOCYV7M{QQ^grdR|u?zvsQy-Xh=6Pp? zlqBCd^Agr2ZDvQR48B7~lIqhCPfaJ?xoA^z#X}p~{N766c!uIUkVAzb7|a^RtW$+O zN2=R%Ob||n;)xZM@^DT_e2S{I)5Nd4{G~K|x^;V(hFwylWZyz=dn>AJ4kmqD>Ax_n zmuNMFaB}slDTo?%poY|17CoaBG>Yz#R40+|U;rS47n7{W;v2w4!Hck1ju44942fh& z6-p;R>*CJ29-4Nh38?a16Q`2am1S4U&}%}zpgSIvaqIV_wQw&Gq*7~&pUk?UDxwx2 zQiYtc1ink5^+IrBI3YV3CompD(gz*|v?UWbH;z1`_lu?%9DB5u?R{kbxq99eNOa)m zl|VRxN#0)05t}Qlt2K&ZyU;hbQFITT7;q|?pIy%~ zLC&l8l70KRusH*%Jp|{(2wDv*N%c5q==UiRP5?d?VpcW)AsF63DItYpT%_!%aTmC< zt#}aDg6nK3Bx)`d*u+@8w$B;rdbu#!TyiH=uV>2j$G&1MgkiW>e5CO35vPY>b4#t; z#yPPemk~o?6N8Ks3{$Ska{-tev2C1f5=bIp=+z{oor)HLnV*`_yf=G@C+T@(uabF2 z{nbQa9v&X}gR%1P?qW{T&Z2YIPHU--IX9PJv@zOrl+(`cb%wSW?qw66K4aiNMtC5~ z3vs*NT;}9lBGh&&8m+>}KhLr`8zpSwj{#Q1dk1LFv2>eJRL$|{GsQCG=Of`G{Ug5% z*u+c#^aMl9>JNc3ylL|I^&hZn+iQD@QLHDb`05$)_<>@*1dic^K~rtg&E`ZDL(lFc zn=)1avCx|#E@l%P0Ezb!SUU`=jwnTG!2kdt07*naR9IFAfI^&2Apk0adukzSg~CPd zw#Q!Fu41Uyb5XKhd-GUx^gki!YRm7;*R$2b%|&ql7fGq23iU)o|AGo%xLt+3*!qSl zD#FlRK+ov;9j!m<^%e9z@BYZ5A&tdQ8+}M0+^O)&FU@TTuiUF_v zKL7cG;T*tOd9izSiHIo)mxcIRfI6#%QdDIT`l+gtsQ zf!M^Zjs8^U84qe%L}z0;=q&2I%qj{Vq4@Kf$3*lE78*y>q%W0QFFt?=Sc7H zsDw?1lYm9Fi?F#E@Ae$&vswc8@JvmF-nteXvFk(j&pc$aIpPU6qA&t5Puk8x6|*CM zzU)ZPU)w*+j`7DFXPgX<4_gcl1?f1-1M8|9NguFRcpPEN~OB`Km???DfDdKly}bitkizqiz59pHhj?ST#msXldaTi<{Yv=ZiO(pp9JM0liQ zSOe7x<+{~0iv8fTqgqz{V0^>4U~iZE zT|jI5w=nseFV6lVn|OHG+veJI9(hKun;hRir5v2Vx?r`QXfEeAW zo=psgaKxYm^f1N6YEA_VhDF0^ ztBgw0o&{GM$6O2n;2H&+)t#)_I3NE8OS zSfn}@NOon3p`6|^W$~-ZqC8-*VK8;TxZa_jh&k5k3E}1xUuU5Os)uNkVFXYE+jSp> z{6zkCrQCV(!bKP`Jmd#mm^ z!C{e+p)kJ0e1_xh?(X^dS--Xs%vX);Ku8)Tb!~2=L`FL`;zU)DYz}p_y)+LQrE`qz zR&9k%JO`iA-+upBuTU!w=#j2fUuj|_@?Q`5jluWFq~^t`&E}F$@;33FS63@GvHx-s zT29ychVT@vy+TDxVW?3q5||qb@j$0_zelz92#kid^AY73+OBlFgavIY*qy>hMpo95 zKg!-)(HWh7p?4l%9rxG1sdX=@+4bzQ4~U$Hc$enLT{;C0LJcEh4ClWe93umJh za>fuRAyvG4=u+DXM?#2ELxi745su+_IAt(&41w1($g31SoGc0#|3$UHoL?E4+N{xI z*P|-!nb^wqVjg|t&4CxRBZa=c-rEs=(SJdz#f)>*BT@ou+S;xx6G6=zK(&zbUl zx7XkMZmMF#Y$990k!SQ;3_Ye7skV_nXjWh7SG&(zK_YJ(Dkq$ENER@o6yEd+W^*cZ z`cN9GN1Xa!FwXCIk8;fQY|rT3b33woNK9$yu~f$zwIS76NgRU)jC!T09_JLBhdcjC zTZ#OI%Spo59Db~aZB$(#6)x~-_CRym?C>lm;u75Aah}fw6$%d@6g>H*s%BP22u64%2?xTX+LkzBay zRCp>0dy-aoMc`$ipNay&F!I)+7$77NqlQd8wVCiBbso+ooj^Q%B|Qu)oPeEBPWQA_ z0<=>&WsIoYkCJK#rvEV}!sw(w?ylh%^c;UiA02T`lq4rZ?~Y%Nq0-tr%x!w4#*xvF zkW&FTV0hk1_#(_1+N*}k=CAZ9%Ky`V^IY7f78j!|)dRSd(Y}Ba2{(W?aN?{Q0CUTn zVAwnp41^akl*sq_MQC3q$$USIG_!COK=(8yezII-5n-#@J?SKu^m`Q!c6*d!-Cx-@ z^{40^cdfiwLKZEqD$u7be9?RnV zD-4_X3$}el&k80qbN2~<^fQJ^6e08MVt{8QmhJ(@nCF_$qG1jj%}Uipl=%C%YAeM^ z?Op-SgS|q+#axBI*sHHm|6k0{=a~46BpdP~8em&lg^Of-VG`=1(yI#Cb(6iS5|MMt z$VEf&j0_GPR3qfi=#S3Ckdl4d(2z?#2&ik}>7=206vdaaB1WIj;{grim0_}8b8y?G z%2r9LM^uQ!sBC9E2hO9Ej9!zB#9T^0JQ%tuyDBuWA@N}NU&S1~BLLhQv1G1C_yDvd zS9Q(>u=G-1^G2j3!@jhDNgI_%L2a;gZ~9HPIjOS=jqLTS^*|Nj2|_V)Jf`#}bQN867Wsy~)v^2%jW%87{#6 zvi)F(Fb|BW%Cqiq+IbY0Env|Q{MR#9)Xp(7G$y1iWX0nO{2z1S`7$_VDJaYqW!1glG4Oa`> zqH*vUz4}5glnfmc!;x{1_g?eIOlXrosn;JD9_=u#&0_s0VWV6lf24~>u>&~aqZ)%} zeMrw~Y>lmFK$uWl1Kkr~Pe+-K-)lpNA%-e`GhGdth*4cs=g3eJ7>1jAob&bAe7vre zq@q@~tC#N`8?A!l+tgQey23WmCZLUKo$QcyR!(6^`eM!TM6&&FT!&zn7gKcz*suR# zN0eV(Y1(BwQ|pxm(uE|3(&j}mb-++M#9%npW-ivtqb9ZpgBB%|KwgedFq;jW#O|FM z<)Sp*4Sk3`-+`fo<|v$oGhAe2V{@C1MC-%YDqhzjiHk>=VpZ>6PVm)$kR`)dRO=m% z{;xBvY~V$<1NwuRE`|Sk!_S{Ti@d&H^7bARpmNT)9 z-vtY~m?dbB4eR#SHfa6FQtXYY4N=FUZzEcT^IQ^GrDbZ*MT5;AL+7~mV5EsRc=RMuu{+h;5=#tot{Y+rh1U>KT2@NHKGx&cde0@xJOY#ahZQB!qy& z@CA;kb~xYMgw&nH)Z7>ej_M#Gkr(2&kRw`n77fx}mNqWgi(&%C-oOCBYfANjZj4ql z7*sVsp>+dJck+4*XEYGM3^uL9+*YGTvV-jfhS8|V7|LTdhI@;0yb|%#nK=vX0-+GY zV@LK1n5BfI6~Jt3RFVoiOdC`yMJbmry03x=(c`elH9GHTXbTs!^Ru{>-*3+c_wb1m7)H|>+*6aLFG`$y)#e*LPiq32uatBf<* zPp(K6Gxxl3x)&BRs_x7JwI!?&hL{+(wAHD*n=UNz0=|MzdZdtx*r>*1g@m??kOXHP zj!LM=T^?G5L3s5rb=auAnr9KdM%5Rb6P`Bwa0#1%N*8)!ct#R0l7q7q#zCtc!vl}2 z!YNvYj%hQtPDObvge`v2>4YjLJkB#YL5kv;jFZT2)jHvsm+mf7HUcmz<{}<1K@E&b zCv{bA)iV+)BzTO`yS#}EPqE44VA)YG0MF>OZgYa%7?l9?$ncCKOzV$84gG(>M-+=L zL)Q~U(G5MRfAi*zK16?ed#jg@K@~$?ZK6eiVHjU#j(=nzTY$wZzBHo{{le+)?rxNN z#ZT*2z!h`+8NImL+WhJtDOcpio`?$sAET$f=ob;#~Or^qun27;c zgdjOeBx()Lmu6cw=j0rp%)=pksR(*wuR1As#+Be{*y5<;xddMk-fa#5^N5dNx~xeqw2q zdr0ksd$V{fH|5FpsQgI62+sM?3F-ViBoYyYL3s5r)z%oyfLDyz*n}J?kl1R(+ZL8g zNa-IbscaJuvL|d{Di58UU}}^+yFw;Q-11M#Y4QGAt^z0%BUYq_aF*Mtk#o|M$&}a} z;I`*-{qEmoAL#9zKh&;^6f(le}n2BwZ zK`{Tl4V=Ls{rUzH(Xx#qJ4+K{z`I}l)c;>2wG3sUlg!enYS0;$iKbPsJWl)O&6}^^ z|Bb*>&ev`bi{XLP8>omH;M$(v*UsSIYJ#Ho(Z!IdT{$Yu+&rfepiJ(XJ5Q zf4X1-Cx&OlZvRIQv#`-6dE%_0gg`ZcDD~5eVu}9W{Fo5_v#YLr7ZJZW}fvO5kS-1`NPni}0)n;jX;)$7jXn7c0cLc)BD# z97cx7n;X%ws7|wT2GYg2{!zMMMkgt}S0j=|Ki#8C5y%3Ce?Ig+L^&&g6O6WmpA_e( z^X{x{z7Ku2MpaL&riWt_B|Y<7p1>%_5SxY)98aOr8#Uc!;ZZI2(^qH4%#?W~d z?Rr)8K*~{~STdw4B!px$Bvf56IsAx zaCyXoL9E!|R6pmtMI;^qZEKKAn^{A`eYUl6wjq%bO!$2m{q!lfok~}1d9>WTG(w)o zVrzB z$fcnZx-GT{kD(Y?1q4K*pq-9RD`>XA-@Oz)769HmCyw7@6B=UD^ zG3A8Na*vZFM6wEsLKT3Un;YH5+ykxpujaH=lM+HU{373MIQZc4<@Qzt49%fX@9rx( z)gg=~2<$(}1)E37<{__(kQgz`R%717g6tuL{Ajf2nV)uT2y-C-HjpcWj?STGeM9&9R9tU~;; z9Sw?=AQuMTYadHkbNQZNE2AVf7FEcgAqXSTmEa^C&&2RkN5ezUB)rWfRbmE!Gg>hr zZ>MU>q^S4`ZZUMY-X7w{?|Z3I;Za`tiQoBy%7-<)ZZI%yKQ*hLp8bGLqN-t$4H>MI z8?yc9BJBuBoq=7eunFSO(dKnqe`uwNtVefL`D_`KZ!7u zh#^PGJ%nTUtlI!uV}h*pPQWd>oX4UdBpidOxxu1f_^I?*Ra)zH%!(Zho_8hOFj{gC2{SW24 zySs;n2R)jH*&jf_i~&sjafO-^5_|wOWY*ah?K82H6t2@#U^~F=31^++a*a_jBM)nR zID2gAQKEJKiV_+)q6MI93!M0o?Nitz+InON8C}ExIH$|N-#VFXd6=yRn*pO@4tVAw zop2pF>8cZsI_#Ly1w@#64>dc=LOE{C36<3Qzk-i)E;1x9;wQ8S7Fe-uAV{&1#fR=} zNkR!23;@0~KI@Ly6Glw5`(tbNk>kdRn06^i3u~T$oPko2zeU)o48s_w3j%zGbLO-okLUORHJ7 z2;j>azD>D~w0iayC1#>7C7X?bT1w#3z)Im+&+bQ2QNgC6J3WhwSx;J#BOX5~L84XPltE3E-bgz<4sn-V7v%sP7)Rakq7_1{0 z4?JnNoTP@lg;7Yw6DVU75cttBWcbkSQTR*x*Y&Wz$n!me^O$j|&L7L(Mp4~*i&~za z*QrHO`7F>6=?2+3%XC%Sa#0mLj>ie-F=H3c3RoCNR@)0XCVM4{v#$z3v|Sr!SE37ouifwqN?oV&g{TL4g(udI&A+Q%M70^~ZLWoF zIw=-y7@M*G23)EGtR{=TvI?6R*jy(o?oJ*`xU&s+05(cwFa*#VBPA{PjI-*&6B<~E znl28t14I&34hVaK3<3WB&fjzg;R_748PKzskv=ct1@ny;Z(}Dso(l$K>q<_00R&~cNnIUjaCyPGIIOAN!)fJmRB45; zYg&fcPdzB$Q-5qdUr317pjCz$sRwGW-vZP>?w-6!D@vUQF~ z@Q;kTPvG|rfOEtXe#PqDM@><|;i<#D0xH8{kH3e)=5@HLqegGqdPc$t(aD-rT|F? z0587pj;PTv1dq0p#JD84gFL1@mR6IOTLZ8NU$0jmJ*;@;A|qQRWHUqn2C?#J$Sm8N zS)YQoHLBVcwocfF%gOUh4cWtd-dbWPmhbj)PFKR(MN9btZKnzhU!fzv#5lQ*Z7{f! zOW6mX(MLU@CMt>9^TXh;Z32LSVE432SXYb|HgYcR=?JeS1c2+fUqtk!+xqVKzy~3< zU)7kin3pgzDIyA^e!( zh4cHv5tXkL7_Uf9=LF`)98lMt6kH;;vhDgtV~KSEVb3vq&l*wam%$LgqM^KAMN8#b z1V*sqIbw_1H(?@2WZT%fSS@Tb*Iob{KqH@p3-kbCqc-M9f{s||$Xo7j+sf+L7 zi|BV%Gz~*3Vt6KRQ2p2)qU<5bt6Pyb3D=Y#XD4^tR{{To8O#Br(uQZH>H~RSGDJ`3 z^$zFm?oN;CA08gwegD_~qG(;7+7(UnTZ1>y?|_>r+HEk2sv1V%U|tU#5xzoy6cr`U z1&@{~I42~&=q+pl7-esH+)0fXz7HL#Hzw=lMC`wZbU^EpE%f#0|GBsMe z%~e|$5PC@MMYWibwh?&ZKdE-a3@xwQ-J>4H`_Ns>H(3P|Nm~p@f~$Wea3UiJgN-+s zEG4@!`mmTn{E-~nEC2u?07*naRDd<~pRR{X97#3nsY9>;1O{6qYGEEix;9H79piSu z&JXFHQz>IKDxNHjRCyo3U~m^8h4OloD{199pxR=FpY;u@S{+JY;2=j90lXoQkJ1Ih zHHK1)5~c8A*il7<&tIeRILp7ChI0+Gw}`GHjK65eRD8L-{Mq-qXRlz{UD6sVtg~3^BZ*Sow>ad}7{M06^`&Htjgwcg&A|~1ugp)u`f%h(P zFk%*r(@FqHpK5K#xAjIvewka((x!H&Q^~G7!7(2D0(Nx9o6u$tsSGg`6}@e#Sp9Yu z1{7jM3Z?d+5XuP^{%VB&3W&=WoSPkMsjAZjxLuK(p7!``M$G}Lmww6!o!$zjFlqyt zqM36IlUW$xjNJubLh_@g7PZCxms+pa?ZsL=#O=lK^RP%-hl|bGR1(aa_z}Q)+#cbN z`LA(=k10{qN~QCaQbjEf&SO;*zAkmW6+s?>#{>t-4;-qxH*elNJUr+zy*@tw_WM75 z(M?=P_o}T8WGB=OWv@u^EU1z?KbW80pr14?8e0q0oxOHLRF~~l zh#{%Vt_oK?yB0TOtnkk<=k?F|U->NS*y?PXkIS;Skmk&s(oEo7Y3G zZ0dZ_Pt_az7o?H(Q#!XM`J4n+THtbfOY ze-ESt=>I?vs}Dwx@`mP8UoEh7_PB(Q`>T9e+|WStdM-y{qeuT3^&jqBvtJ znPL}Zh<_6dt?P*>^g9OUdQpU5YANHo;EU)sd3PBU$ZbPyq2BfyAt#9d<2i4zWU)-= znfEe;06G>;*h>q3g=c-CQH!BO8rGk23^kmm3uX%0H25X$N|sGF>Ozkjbd}91BT9?m zV$x%P=Zh#4rpLFQGiasn>#I-k8AyyG!5PC%Nt*yC^bX+1*rd8Pz~zl{>74ri^FzNM;ZgX=4~YOV97QeqH`!JSU(7Yv zf2Kuq0le_Zd2{Q0cSeE)~X8;%cLw? zm%XdwS$KOGvf=c+IJNhJCm4RzFa*2EdSrYS!4<~Tib0oFz%D>G`WJbep=MkpAy90t zq%wp;1XLun812=J*)U+1AAT39DZK;bCLV!-*ATWyx_3w}3>Yq(2wFF4Qq|>t+3s-$ z>=6J$)?HU8E&^>J?`7IqlC}oSqz2|1#0)=MOHq!jS2@iJDRQ?-cg#T2BwT9Itd^pA zBBsSm@Ot4oQNol+Xg>alaeI5qb9_$U1b?ZiW^h8< zaB1)FXgCLO6P^Bx_LP+5(WZ!*$0X9 z>nau=IVZcKW^6rCX5E}^iYlfhKj8FqbVEEObxchWvyfoakclVQ9O+Z~o*6t`ZG@Mf z*=k4|1$vfs8(Mg{Mzg`z*(%ccu`5g--Qn0>ekVrWDE1=$SZ?mSm0Y!qDw0|>k6@Ly z^@J*6ASa}HnEFYL1AX%lw_m;kWXE`U4T~8$aUnH^i)<5^6UKIJH~EC>s#C7bHMdC} z3_wxs6qu0_8Dlt#I_VFoF+4;5GWsV9^+h*#-~S2r<@>+q@Ba?`e_rmqUK$j&;|9dM~d=cHpl*Oae9*qg-)(88SRWJ4}Ug%U2>^7s(@8hH`$f7WQb+HRqFi~N0) zY?v|pHL$ahPDqB18QE+P03z|EOu4ZMaPY|9B~>IY*zHIGb6kM~cEKSTE2mFgq;ECF zq6a11w&ZbDbTyotDGsz+DLj#Ha@3Ae3jhpbgg@YKIa}ue@=1tN)I{E^5vHXLD)I0- zg#Dn^XAi`hvR(meGvb6z9&%~u6*&^Y?T05owhDb0>DdKrsA`R1YccbOAuP)C^E0LK zj2qdNSyS@VF(P} zfXCI!=41kPOc2J9C4(xiO~SKReHKZmKE$|;RLW4+L zfYZ9a4Mebzj_1reVQWvAeagwn+Y(;S85)iy5{Z`vPwQm1H9W-a7W{9gcc8YbdK`b) zj=O+wfc0atn0>tj-^^|=CeoF&P1ianw1JP|B=GQ5)EmRYvDIPPks6F<>~3^^XJb`PfyR!&-`a$UI99|+S;Z3%xsd1!6Pss_+6E*a_#}fU+LhnGK7>bga2&dFTcr4Y0f;dM@qnN z7XJ0?SAFI~rRiEKS|ssS-P2K>W_<`=**!}90p{Mp7tKpQAG=gfo}ZrqR8Bng%W&w% z#f^i{=(Vl+OOn)2!6 z6GFNbqt@=8_C1?lF$LaL%j9Az!MoU2Y8+weV!7u^%T&d9qPBM5u{E57tXMAr&uASh zn}^p~dC=nqcbfP!AWpJE?)YOiRUZpi6jEitDWfuv0O08lmz_$o?m=FJkS_chdX(F- zg<`h^a+6sAlqj52kH6*lKkM`+yS=_!UZ$~rceu!6MX_+cOgW@mH);pi+v_BkMOI0> zUJv+hRsBgvOFL3t*D*XXtUQY=?%nnfYzNdVKauDD{+>S=t9MYJKY#x6<;$l}pFV#4 zsK@m8_xEq!ywRuW7Yi2*u==KJK0Vy*63ESE-K3fWoL@Gn=Yg+z){BzP>Y3~3Y{t!c z{eCg$_u0MLJT~kzRIK|M67;N)kddfAff0pk$TeYCfr^cv&aVctS4B=&N$MeU0Z?HG zzs@k{ztk*x(22p@=apRIfz5C0Y9q~@uo3PWJdhUvPSQp>pxVw^XV*Pk({>Shb-Qv^ zFtxKq>va{3!jVcd`Sm%s+M0-WUhUK|C*6zi5FE1yh9g1*@GN!j($Gv)Dc7iz_zA=i z!$>OpZuo0pUm!Sn#Ege3S<~0^-E`9+MzQmdxd!eS-ABAgVv?iT&};p$g(c3s^wwRYL@K* z7%DsyV=O_D~1*cE7wx4kTdr1i7s^uLPTWnxLC|NzH^BB%alpBtm zcZ|9sL~J94yF}gmMjWdKE1R$cdgd(4CODv$boMHde1vzJC4s^zyVZC^n=*IM3@M#o)A~ z&5Z_*-zbZ-t!zFzfEaQG6&Xi@+&>tRv{IEfGuiBl6A@!)+XkZV72U>NH zAuxGk#8Nwz` zP0<8T=Yp}Rk?NFv6gUz&Un!5mj*Q`V0Zd^q8+n}*@C6O{F}TYhsV?6I1&GRXc{-^= zTfkffn0To)3Gwi1`$9mDQDqC?ZtO}Po}i7{1H)Q12c+hb@*1+9w{m){Gmnt+J5mfI zyk5aO-q*{skL(e1#d{XtoE5pt6W7Ve;#4uEAsyQ+WE3uc%r3Ig?XO?Ie);m{tFx+{rBJh`Okmq0lhwJ&s!9VjqKD|54DR&OoT%lMuk;RglrDm zgD;Uz?sm%wAl9V?pLd?gQmY%WQIw94Kc-g+@ltuj6ZJaGQwYWtk2_lIBG{bAZ2+5w zvJ+bkF;tPRO&DS)Nn0N9Fkmp{#(Z{^0zZa0=WLNTVtv+ahhet|t#vw;Y)E1#@pBTz za;d50?pYyp{KT$}jVfxa18O+hJkXt^5I;T@BR0OQ*vYXy3(jf)Ba4g}QYJ=F`4u3h zd^idRQvup4?S|2%jD5nD4YqpZeX81C1)UL$hSVXN!yp7d4--YAkM|;5FlnG_A%&5> z_>=4v-!`+t!sC68smYLBG(kN0eT{^n4;ao5k2|rWnfSv95*|m4ng-sD0BZ<9_g|d1 zx3|yF&ywMRT5jE@<(C-e@fOuWg3STze}dJcs;#d2cJdzu!dUSrjdVOQS0FGp zjJH%#oAT{{iFRGkSHCtw~~Oil0$ibTAeMDz0}j6y-e) zp4tw1B7`BvDA0wmU=+@d;k9f$#TGyNPfcK`D2m-QU{j#jyug)mBwol`HNXFG@{zDM zJiuNo@*Km);93AI+S^tNm1akh#L0G26ks=emGP6MHQ1caA8%}eiuO`$>@-h=c$_q? zZXpNjY`QAPLlWAQ#f8b!!W=BX1cv@iLnOX=Mj_Ivt>PQT`+%fsIIWkAt?t3>+k@En zbJ;AV(s@#BV&?`jJkU#%EmdG-5Gx~oRTE&zkkfxwc?81mvEb>Odt_^hZCSroPrFpB zuPmO6wSZZYCc6dAgt);hMis!pK@XA?rPJgZoXykiwSy;yVskOrXx^K#;z`QdfzcEI z49^~t7y`x<<&dQ{h=RwHDnwIkHs|rha{t8kL?f81@;$6r7=U4L-3Vqv@Oy}yj;XVw zwp7A4wx%F()8H<{5{y#d_gXgjiCPp{uO2mp1n8&px5C`n)(B4+HLq^~&)Xt#s>9S3 zyZYO=Z~TYcZ{NOs{`~omKmPdVKmYlUfBfU`fB*Y$zy0>{<43(}efRF2I6r>;`0KB~ z-rU@L`t*s4{_>Z<=y|>N5>;c!Pj-q$ClzUmjR7DGXRaGKzz2rTk2dizg%N<74rHCW zh-Xv4VixCd+dGV3Me)Df@Yh`P@@pU-0`airT#_>SRMk*1kXI_gBd><>sX#ECP%%3{ zgd-!sUW@aO!driE)-o$VJn}E*1;$0j#fZuixlOExtlJZ+%IsiLv`%Jah^i6>Y;(v% z8BfY3QQ*fmE0sKvD;TtID^CmCym4>}sI>B+ z%BNH*{PYk^c%n1tAHjsztYc(Hc9J4hEAD~1anoDZ({2ws6Xf%u>T+@GW@5aT$|5&EokGvP-yAD ze*cH95Pu{~2e@<1_W+Wjit|G~qi{W;q@GrJT#|MLKWUfupYnMGN1`BfW(t%}A=~FF zLXujBQm|>YUcR!fkX-A=@n`gGZn}VCJla60p|*9=lTtbG;uj}N=uQMooSH(Rs$+=Z zFfwXZTacxy{qeShr1{XdmkS_@ZGmTQh!Cn8u8QU)E3@kh4I3e`lmO%h#t8w?8on-6 z=UYf;vW;z>F2FB>fW65$NsY&i`K%+W?Rwl6Qq1uCc+M74I^<1+-32*8*_53{L%G zxW_`cXwWf?2y6@2)lwnKenvxN^x;UAW1>qdAs#-rcd?DY(Zc{WLCU@nOiH4hxx7i+ zYZhnLtb68(D%%`?c-AFdBk2V>H>oOs!!qhm4H+TB5A!C&Ccv3nu&((j~{>g?YF=G{qO(y{_nTne*69R-}SD> zUl08D+iy^DJAQn8)c4o7Z@0j6XK_z-3{J;Xd!@!2brH`GOsxib$K1Y1b#oH09eaKE zj>xG3&WZ$6rw(}5H7oCCb^z7}gF8{ISw9G*jLv9&fc)bF9d&R&_XH*D;H6v3Pn zlt`++2Zk&(jgn=MNC4r90vrzn@dt^Xr$HsbE}Pqj^7@quB|*M2^lpe}k&VDm;^AOi zi2(kxgbnFEsjz0Nb7HeVtXFVWBzqD=RY2toJeY=u=dP-v zZJmQhcFQ~h&;5F6KF7qYYNS#ha*jNN$C&!uWMm{H2>EC-RBAHc@rZw9uqY$IN&mrT z^wddu?FM$X>&6LqWQcaY^=l%oyqp|%cAIF0KN!3mIAaswzqp~2`PC5pRJ-Csvd6N| zdvc6(J<7L}udmwf^@7BymGY~3&8uq-A-P3r(%u z3oFTrheR?MMre#TY zi%a)nx<%M7g{&jSuJ9KCAE>(Rc1W%Du0#dN;!q`Air*W;7UEVOl9aS9_UqTLpFe;8 z@BjYqPoF;h{`>F0{`%`b{_&6h`mg`e1A2XqUTp8)z2i%7K7Raodwcuv@bLcqdmXNK z@7_H=KE8YRP9LoP_U)St*BPpQ(&4D0`O1!>UU?Icjqw8oYoGgW|AAtzmwLXDu9x@c zV%CP#Pj$?<=B%fRki-p zXJK~Qy0P^BK?|dw(bLge9WGKNjiL~s$K`XKkSrQr)F>qM@brO&s3o*ik*oHwjk=O^ z-o~g%$|I!x-$|}EzQ>IXAhzg+2X5MnTdVST36Rv29NK(HR3+y+>;E~xV{6FVQ-zUT z#v(aUECG3$5*0%k{!_7464zp4A@?by1}uhLK)^ejZ2DZwso=_AF<13ah>SQ{NKL3~`2x%3psK>TO5Z8H1$K#xOX!PR4T6&%n=zqbx+t#RwM7B(@rJq>J%A;PyPD zGkEsR^>y&N9eaRY&C3+OimIipXAfjsI|`!%T)x~8VJp5R4*@Z(rQyMdkk>h+_UH_L z$z~Qmp6k{10x8aj*LN@IbM$|F|M%;!zyALF@1H(>y1BWzySw|#U;e^F`FHQ${q1jm z)3+bra-KzMjkT{U^Lj^a~@JegCsA%)U-zw5C6c{`IbUrPvtad9kXM zmvkY6qDFpRs(}n6m>D{(-NOzzW>2oSylXqg{O5~eU1FhQd+_QD{Fzp8nL0z_u_4~4 ze4|$JldTdYR~`E6?RhO1moZ6KUqoFz`!2#*K9tLdO{JAp2vZ;_4Fe?+f$nW|CCr9^oA9`1H5F5A_^Lqp|MQZ)OfitDncZf)PL zPUv9PLP}hZLfqqlvbj73EQSJ)G*sHa`w4BCM-0`k@RmgKYOXn0DPpVCyz=*PSyY5e>{5VjT_9QnmA0iJ1JbR7090Z>-%=aGWmq0GvFlguN z|5-jgJ>A~k-rwKr%jG|O`0(Y+mz$fLhlhuoo0|_GKK$)(e^b5u2j_=}hYueJSX{G|*wGbiOz%zsKAwJTOUhPphmh-dl`oBs@_Q@I@%^O}N< z5m9IA+7(M)_Uf+ilVF{`+Ln{FR}Gh1^^F}%8!@)|{=Dr-mHcpGu)TfhMq9aBy$}mLC#dbuC6cW-j%Dwkt=!|Ebl* z{wr2>1t)6dXZZ34@?42*R?Vk47$d1PXA-3^v4Y<@iJC7ru#pV+v#GeAvI*fK9Uhk_ zTT|}$EOe4AUY9#PYHpJ&ND=?pO=J-}R*=T-mZ0lcYX9SN0(xEKI0W>7xH z%0W0LuU4vts~ZRqxrUrpsgiRN)d~yd7BhEN<*|D`+!xpVm$E1PTtL9o-k#|O{il|; zGtB-dqgGwli#{AEf!GTc7)$1YS=PhpAfGeLVch!f@9!TUAK$!r^Zxz&r>Cbs{`kWi zqW@|4{{8!R@7{@!KQsI0&6~UL|MWy&zx989ewLvx<`+nMxFIhY=sg+bZ8yLOe8wMQ$a`S1oXYKZ zi5tvy7_n!nI}q#HL)(bWLq?bt|D||Va$N+Y{#4m`*iL$dQ16EI1-xPv$j?o+{AN9n zWDI{h6d3U>X0Ov*L^s@ULRY&eg9g^Uif2wGF<^MACJ%n;L?M1JFlqsV0f1K1invOE z#Nb_(*r*P`0Rv9O!tAOxX*a*eVnyl-29e%RI;jTwn@~Qht#bHDMbxV=_VGi+z7kmS z5E+K+;g3eh>73-mQB`@YY*t7-QUyuu zY?Qp1AwAUS`ZqNI4x?@3Cfj+yXcMypq@dpLaNWdz!0?vRnYvZl9VmR2H<2MQ_k%W( zJAHLxH%1m0?+kP)bjC2)VhC6oG`s799)uc7Gs?;0VDtm?S=j`-;TLg-fq^GH43*K# zL~xR|T8{t#AOJ~3K~!L%^3Jz=#*r7dQ57;sH0mLN0l<#|)k&jG-K@XPD}Wx zq81#^Q7q&q4boA5WCXA)Q5)skTWr-sAjW8K6DtGRe%;umc>;DZ6Xj@_P#vCPfkq67 zbQxUJ{G7TIwoQH^1*7>|9a7gJ{6E}it9HTk4a4h-eORyg-k+1jk{9C`A%(1jE0;pr zyevAj`r!Qg_wVoT@AXQ9=PA#-QC~ct7(2h^%{(qyH8I~dT_5lsKuv^&@W*w zRT~>gzR!vJu}0fWoNP-xKUVEEva@sI5M3kJBIgCW?R#&O-P6_g9iym4f7}5T<)>_s z=T8swmEzpdt|;HZF?D7bdDp23^u45T_k?U8`Y~M3dkndli=swZHUY2jf{qc-*qFMmGe>y8e%48h6WlH{&uLkyi)RFw1Mud89nyfw{LtW zfud*;hO>b|6-I^mt0RZ8PgGz#Y}wrDRk$C!c8}NFlhO!x!^OKF!p)Z!iy4*3f6^R2 z3$Mc2a&Ck+u1*SJp(&@TTIs4XLb4fBRk`Q*Gx|u(uPjuy9=xJbDP!n5uzBq=0!LoK z{HLe_76MpT7AXK#55kzL>&Mh(jc5f*yvFvtO=Q%LO~BWiQVCv2n=1fy7%d7Cb>9SrAUPT>>{#B-D3Ur7 zN&ezv^Yw=_?6rLZa}p2VdR)K1Kpd%>H^G-fw(}F~uu-C2elOoM28mB0Mi`%ps58UJ z0+pw8@uMXWhQ7JsRPa~BmAGAzug4Re;aE|A)IOiW*B9WBi!u?0$2WO9>&Vw&hsYSd28HJ}_$sqE zqEg44&p2oB)RC8s=a|aYp1Yu`QP=h$oK3gY+I~JAR2MW5 zyeJR+NW&&Tfn0@Jo<)*2_DW8dB%6-4wSe(i{nk9**diE0JR^fQ%c$bYQ}59u67KaA zz~&U1k)#m$^%IdJHgC}gBehUrcsgQZ7C&HRM5Kml9i1c!c_Ui<81$A{u>rs!OKS*L zB?Y*>eg?)RY09G(^;FLA?BZeb1j%G5{^%-i&;7ZylQ^E10`Mc_NB}oCH+sa)$@MAO z9(bTG2#-Ib=N*){L#xgP!q6KAvW^UWb*7&akiODUFpC5@43Bl$>`}+V#wA9EC-sH# z8l7ja9U>>;p$EZ}keF(7$?0WA)HR0QWasxo;*#8srS$Nyb(}m_tHvpkAu(-p*w{6x z<2^-aU?>bfWzc*X&Z$78O2GQA14%}dh^pptfNV&}4o0*L_Zqcc2r)RP?(r3ws8Wc! zr(9mkNUfqs2Z`fhbEj-tI>FSa*W>XPMH4P1k`~c15=9D-QpL}JEe@S+F@)_GcwbyU zo&lQ-M$mvT&DC*YqU$D7+^1)asZp`Vt%e zqw&sJd+W1d>zIH0_Dx@2e|vk&1A4Z1C6o;Op*&K=@Tv&M*DvHYjV0nN^Btwjm zcpVmpjpU6O+&_=?EFL9WvvW+1YCVhhT+}LQjS>LZB$tbi5^6Y!>J%yJlsx*$qB{&) zHVJH8Hba{OcG-xbbvp9sSxmI~PD-^vTSfZSzRrdR*)m+@?d>gJ)#$a*Obmb7+%{H4 z(HTEt{>>ly9e`FX3Y2qKX;G<$2cOZ?7k-(bucsu3_d-sJ0kdgT67`+N(HeG%+T=~- zPU9UU5DhU)6l(*gzPQ}~`Z*-mHV_kud_Tq1YaX(TBvQ-m3*q7cx0{|>4{=)nV4NRX z$CRIK7*ORf&BiVjGl3Jsse+`9k_L}zrPf$NWH1zRC3WTGfV5L1r&7~Q!D1NloGOrU zofUEt?o<_qM~45bd7-My4HyIP4>#5&9o`iyHM$Jh-fiF2fn<$VvQ&(-Y4#+c@4&hf zs(@XdxTz7VrIB(l%q|+VqRKw7^tvV^hOT0`DpI@ig0_PdVDPJ4FVym@nf|3B{+c>3?DL$go)M0Q(++TKo4+Lg8z{1-P^_h6ov8Q?1o7x(#< zvcCZBPq$lsNKfbzM!grjfUv_UI7%2!MNwh2U=O^WO=^tm&-?X9nZv_P3xiGNwgt^%V>q+ zl)*4!+aa|Og$&m@ibWOS@_4N5062_I89i*1j-2h&b`eHuv=M@*C2zyMD7T#<0+|wi zl+^wHh=ivk-mc)(P%B7wC&Wo0%Z+DZIF*tCAf^a;+O;81bm~(WO;c6zke1**%fllaTooc}Hvj zypwQ_q5xn7(rJYW0D+qZR4`z$H#SKw2=MHpMIl+h_>`YtkQfR9A46a=fW>u*yn#PC ztUJ6WLK0JWLi0&69!^U~?W)Q>yk3E0c5$dm^^;3IsiO~zoE26ZOZftinoy}W4~}bg zyS+-Z{5X+~$BiJ@RD`IL{2Z-XP-z%WPrYfgf}2Q5@?5ehWRohEl0H)f24bAtd$O4e z1~**1`>$%hSW+dT$+S+@`OxjF)*fQoR!9s}giM4fq^$y;2#*ajf<=^u#41V(+w5() zoGrd}ZjwyI??J&h4P?+O27nr+$5jdAo|X!ykiIS52G$y6M_3D!lio6%fag z*v)Lqv*|qkjGj)RKwU$n41NNWCix>|@@|bKfzWxPPCga{n6n{|lgY@)#mgeiz`{@UL`URGtW1lEhYR z${88He30;8l;rV3*pN;bf5reFFub~|y9*44!Xfe6-4-6O<7rMcJPRQh%wlK*unkyT zUp2s*t$PXnm_iuzp}fB96wWz9ygZ)N^WujJ4|<@&Qw{WRe)W+8 z{pY`6;C2~)r>!!WWvb<27JL}7Gli#b482Ri&<<70q@p&;)6qJRUW@N8W${^stZVSt zRx=Gjm4~3v4 zE12kE{7>9qV2B}YlFC^_aKP{{8gu|df%QVffpra&?3!X5h?XkIf==O)fk6s9gt(#E zAc@`5D(C-6k6tQxmLQBNABI}05JSv*;HC`~B<`sla6-+3X9_AjZdAO_${t~yS#Qtf z8R4B7q!v!!h+DtK%TwsAt&sadfDbDCu4>b6qpFi!7!{*j0&pZ<0I?W8yJ$yVB?{++ ziqseaYt@{Mx86bmfLtDC@yqZIKt-;4Hnm}hd|WDqhE}Ths$RM1G%zS}XnmsS!fTk9r-jVz-HEpl7MGh^bTaz)5yrEa$HmI3?veLdFrf``uO`;i45l zPPcbe+A{Ns84cBljf4P@0=QhEhJ^8-0_Z>?2E)tr zDukCL*d}|Uy|9yoK&ZT{VIxW5qrC*D%bwUShK!_8;3g*|u^S<51rP;4p1?;Ny>`EB zMpT`OK;hN=8Y}U!*1#rGg$V#P!f?P4Csl-UGGgpnjuky^Mw}Qc>L4;vG5i9F04ftO{gAzi6~#oV*1@()FP;N7QB_zso3=EBS;rvTP1FWsDeHgKSaxTHt{Mq=$1< zfw{qHCBzN%SHnq0HcNDcvT?CO@)0*C?t5j{@mK8&#bo^`clEX7w^vLy`CtVmQ%0OB4opr*&s*BOb$H zJZy1i*aW&fUV-D(BWYr}MDu}Zru=20cxattWRu-9(i6?b^6~ruHYdR;89t?tO^Dp< z!X}+kXovGt%!m=cp3!?27qDU~0!;iXx!7J49-k7Y z|71S}jO;Re<*->}z#@sEGrR3P^(M!1I9s*R07J#JN!___qZy-(bqxU+1=bKcKxt5| zkbq&s6W%Vm&$aaoKu4KaIBGD7EF`TgN zn(}6n!Viwy0(i)-TV)A2i^q9(Z_0=WC8vy1vk7h))}5##MA=;f zQy4XhsTD)vH3gm#Ajs8TqBQH;G!=j#nGDFCV5w;bTGZxm8i)HtyFlVKMJQP zj70$#fguKi>n*a6C5mw8C&h$0@D=G-)H)j;v3UsmI58B9evtCVFcPf{xdsLmLyW2f zRh}r6YjcXEPI=&7yKd3T@{jaT%LowuXkg67ux)8zE;!t!ZCBpCYq66|- z_B>D>0HY92P%T+V`8}6-)-$%9M@Bn~a}g%|I+z}g?miPLT7khuxb~1jWOztS&4=-_ z4gDI{WoM2blR9Z5Kb&&p`>PNS*`SUeD+!4o)p} z)Wr~(GU9gubGr>`tDf^HB(`M?odLW%b)Yy+81k=oGB|H;ZZ7bQzLHKnwXJwC&eRjB zFGv;48cH+DW2hrhf2#u(3+byKdzW+N|6>aVH&m>rLm04YH-tp%#za!pAGE}(>gc~8 zv-arH{|JmMdxuihW`t_A%35yep*o_jYS0a3(U2v;Ktp(HMQq(kAtZ$ja5YH%stlBK znU*|n2(?^L`87BX%R>y?9#6}uS%F)mch&8dtva0(NxU!>-Z7OSJh4%$q&P2Z{@@7> zb#~L^`)b7IVqB_h7}Nm=cy?g!+_c5UwYSZtZCza4)Binbr*pBgx_;>lWCD<5Ja{gl`t%i%2xr-2RyQUJnf~lqHNbWkAT)0MT z)z8L5WQ$pM{(tt~bw`q1N4o9H_x?}Z)pc;T0SgO8Nuju8R_&ST9|4Lo8jY0X?%|o8 z^_1Wp?V*{wkQ@IE?R_84mBQoeGa{MA^WS1zR!upzCvTR3*q4p8H=h;|`|rR1ekg+l z!Z?e85M$z@!tg!)5NIlw6F(jdanGb=J;= zONNg-cN$WTXZcOl)R^DBr6MCO(had4%yI`B#)F4B|LbfzX63t%88dBnEZGnn1jS$FFALe7O-PneA9U8LotgdjY*9$zjy=@wjF9*Zm3aa%8+LdygeL}F zU1~G`Q#Pq*6awayJq3f%2Aa8or8)T@yZIBurhUQw?sxPhkw##++5%@tkCwA`P9#}? zO$<{p9szi?8S;kR$htnx+7k<5#gFlm;~h>k zyHO7bseNi-YDY4++zvU(Cz5n*m_+$=m+^*wX1w&|5s1HwC1_C{ecyX0RwD||VujLV7=n5mZ&Ewg{8lS-3xR|p-z z_)d`@&$X=jv!&I>n8zeV-6YMT>=>5KsdcR342cX31<12qQ*?| zueF&6J78k-NET@Ib_0Fl;1XB0` zNuYBPp3c0yB9QM46tV(BMv0^wVJ2CM2e6#|ekZRr=|&8?IxkNk!SJ^-YBd9(Z_6tP z7-(a>`I$a1yG=!2=%izz$-ZP@_A3nJA!(_B=F{FPc}5Y!GFgA+b+~PZ{BCv%^!1u0 zzAWJkTQa8!+>F1vCp(2y`cOa^vfQ=kGuC@%&XxyoiS%%17uDsE%@3Z65W`dq3#h5r zh7e*DkCntOg!P)@+J;HcO(GpTFcr z6aAGsyW*+RsyTC5d*D2*@F+=$RTW7^F?@EDI|U>$4pW7^)K*b>(k2Uc5Io?+?@y+l zHA0dUwwF9s5^%xZxlBRjEI60xn7uL1+LlRgXn!|ME#j>D&`Iu<&lcrC+xJ&jbe6pM zm#Z_8_p(E1+StXp{PK&`n{?F;KWWb?2uU&ZfQeBh7=Pf0gm4U|&PL(6Se>ITXN&wY z>Wg5k#SOpv@18tGa+Bx=V=)t-+1cuBoB38G4B+SP%2fP$sIUNL&EVrO75>g1%CShV zvTHY{YbfUsPJA{f9c#wVI%+(;D zoE^%H!OzCbT%7Y{(L>nK!~SvJz>>l{mPEU=58wskP!Ts->))kFiEMzyId{ql}Z(6n;nqCbT5l)$Ut0 z82Fcm1lY$7@*bEUVs<4j15@BEGvH;2wbf4W)TKRBOwY`cRi;w!kQsidzOaBVuqaFN2wleySj38WHdiS^JjZBz(a$>zX7F6=s1-n1}2u$Zt3SWB59Dxp2h3 zU?39X1(J`1xS2i<7G})6jxp;HYuovavCYm&pu@=p9x$E{8sD%JQ0p?i5CP1#69@oL zQQR!Qeog|Er8Vl+tQ91RLYr8At--aTmY0_nGSbS(5Ik*e7RIXC68egQ266 zh^gq|@dLvlJI%k9zbZnT3$YErMv-_(tevs#G23rqKa`h6Pl13jUaKPE{(Oz+994(K znq#wS4|%w|74n9M!<$$R5mZxHg;XIClPF^AZ8+pF7-`F)IV63G+)-?&ywRQiJ3{`M z-1N$UPh|xBt-nXl;-TA1juUa8HOy~&`3mFXsgsd<^M}~7HS=#Pvz0+wL!5`57cl(G zFR0&8sWm^eDW{f$TFe0W#_4wPY($66!1Zg%U&v>N=A_0ry;5j+mj5Go_sVw2kzK>m zKlhup6-l+lL!zd0dI0}cMs%VU<5MEDjdz>*OV7A#K>&JOppjhm0T5Cf17!SjkHJtz zkbGCE-AI-g)&>u`NS&!j^5?HTtx>fsfm)UdABH&G_RE1LsTHZIcZObc^RVc4mdzf< ze-i~b1{)@gqFs}mKrk~MM*#3Uh7-lkK4-TBs4NHZg**>ufnG0e&1aI!*{a3E_scO` zov+kbfM}lOS1n%dB}3uAVd!3ck)+Vl9B2GgfiH8qWZMsg1?;@Gxd2ji2oIa*VaDGF z;7V;zh1JsP#>Cs>UisjFnQWCV$O+r64t`QB37Op)Ty;aZBymMcg*$RCN6?xovrHXG zUYOb?O1fFa^gK-JkT0s@p@y#mP~9|kN$Y(1e!2_!I{*EO@W^2?egIek*xU0YhG*_T z^QWu+gz#Ru34fK%_9)r486L_DPe{_b$-HdWmtIC5%02@qVZx|1Q|vK}8FKKPJ5yWn z!1L79p}L1WB{=x(8Gb|Vz+c_t?3mWJH)pc=lb$;yk`VK-qKAOm)l2-LWaFnQE9YVQ>XcL9uiw>tNvk~SEx8r9Ex`YW1q3b2P zGg=!Yq*%@Z!|)sbn-U28RYva9^dT~4v8)lBgz7LdHIeb36FKV5R#?xZa%r|f5{|*t z#|;Fy{Mhy+uff>tWY)z~%X2ZAtFBo%o*ak5|H2{1GYZj3H=@n{chr)unoO3Z|DB8! zLJ2W;i3&DTI~=fKVXmvC0cE3veO0t+8nBwp7A0wsGlU!-3@|pBo#_nw1{(oLVofP( zCxcjw9kTqKQ-2M6mZUi6@Uw*O5B3Ww4k1iokcjHy0f7Hag9F9W2p1Dy!{5v@!(AXn z#rX5jKmY#wZ=5ssjv!1g5BQ_PyEQrV8T0zuVLpX21 zPBA&rhJcCrI?s)MXE)w;**3nadw3mo?C)v2QrlMRF4_N-O|LK0wK`Gx{tq(DHC#SCF9pYGJ+|j8B(8|;%-$F?5uCJHyZQ0lu53^IguZ?y-WcUUE<)p(I;zR(l&tK2|h*Bgx*gzF>!?4*x2>AUC#M1;S zb<-XeVjfxqRXStLw130yS>(eG0C+8ma9^22^})`tB2E_@*#`{Q1cX^Fvo>ZT(mBy2 z#Iq|u;eq)MxXbvyKe^uI;eniM3xB;Fe#-g#@4qukvHY#qbUq~R}Q>*@l;EQF4NCouR6GaGyF;dm3m;@V^V@t3mDH?05wAOJ~3 zK~$%P#D0arLeR9C-MzxzH6OsNoh6tlmVNLpLf%(2;bqPoQp$-@!!!9Mn69P|BqIEr z<(*klV6ZN1o~QV0DWRoC*lx~dqC(=&+Mj_L9Ki1CN@-IbRIpiRoGHQncwnQ(r9q0q zGsLKLuq8Dx_Z-;;X2|;5b7PZ*n_vVy^>yN5BC^!=)~$F*vIG>vT)r7qApjy02KoRX zMgTjKU=n-A6s?B|WS=wq>#x6%XZ&Yv%g%b`Uy;ckV}E`yDV#PeW0{LhwVRDUJO}V$ z3g)Z@^6)P&Sw4&oc~}vG9YwCCvu4j2z-3%+s@W(ia^6d}(lE&jkf9TCF|iX#%kZW1 zCN;YV1}DY&Uu3vy+upq&DTn=l!F@dZ?yWI(xXxl~Icn%cXC9t`t%{J^UCCmnZK8HY z6}yAQzpUsS;sz4_RMLn16EOQWyELQjJruGFd1?tRNy5n|n}nyP9nbPKJuKnCc9^=P zJue5{DcMas*OH?e&T1(nvtwu=<2lQ3 zJ6omE2k!ejbjY#Z!YNvso(dG-Xh#Y+w(Hy zsLZlmYRbbKjPcp2FGQ7KFPnEiHL?-Cs4O!Zx3mSYn>9FzD1^YTeu}b&XKmD0AWbX( z{g5-35E5a;|9+x_q$02347^$88TG#BwH>l6r#c*Yq=-?&T?sSf@-9ND~WY#=nr!DOE7uuCW2j_pa zLDQbCf=*T-{fwWLioxg0c`M!b46|FJnGz`NDGlCuvqisKTPW7T%Jz4Gb1Po!SUCUu z^G{w|=i#64KGu`p7COtgoV`)&)Jt0a%6#4%a0Sb2_Z*gBmf`fDz=s)^Jb(Q0$H(5$ zTY>Fe;`nd6Sqw9TcD(TO3NBcjK+^dxf^!dbH3Ogai7ALU=<0O!FWhc~ra4aDhi7iZa zek56WU?q1=f-WdMs z%M_}T!sOm97T{b<{o!0rC2z5z;RVA~w$D`6;Tk@S1+c79@Eo>MrHrt*l3}cq|J#rb2)93Dz(+z~@#;D_S6Y>y)=G|gFWcVULb;-kMW|Mr8 za?{$bdTHR?*oDk+;$7MgQ3 zEuG77Q|02HUgcMY6Jj=#cuk9kp)v571Y{X3nWL~xTY> z#|}OkXDDA22 zfH9&o!_-UFhY|?K*nv@wu|rP(jyzP%VoZkeEK93RRUr%yuzLaQ8EC!9IkV`58N-1~ zJ4o&q$wHM68VDSy@e_xi!iO=>vYXp#*&08=1&w- zi70LpVzy1Q}7~4lorkT_P5>@Uzy0Fh$hTFnKl- zeP+p=jz0j$!-`W=OQ^DiD96aEH*E9jMC#>6B^|RaC-s^kHl4}PB=9VI6{qngpRqLy zXBbMV8bbCznaGw;j%`Q``1)5n#v*89)3nkXK-awF4pN(&xMt z#gHf)7I5P?#`couoI2r!IqbI}mx-)oXFCzsPp+J4;Ow)XM!1+n!&EZGU;YMSX>$pl zvcK#Svs4JioZdpkxf}YR<(>tz_u*25In84R+l6Q75^!Qn2JjdGN5k^Z%9Var-&=*R zAgD%FLbgG5A}v8@9WdpfPen{`QyirP~{6nvT*fFh^L%oxq@CD^t)uD=rFCr z6MW8~e^naf?qz*im*2a0(r4`tyrZX67$suoFIX1%DRA1v&EOF0so-gGWI(dJ$WFBn zJtSR{XO^qaWFs6&wQtTL%h`tvb^MA1wNo2N7R9;1=MXaVtq6vl;Wq9t_>ndM)Ww@x=c!ikN&>)is`5i{@Q|YVY;9)n zJ~Spa$OGGqy73&8KMcQ#4dyKS;khFbeW;a+)MNpSb6JR~Dx~l=`%taJ4YqyOwydsp z2&!BNsWZzIU;t%+tSp8-Br$j%pPH?q1=N%!p<#)SlTW}9+GCp(&>l!&`>hPhp@hi8 zpCNS>%(V~_gP}1?d*bU0ovCtpKVKOt3nvJ}ggbEgGd$#7K6Wli&d!52_8SabyC}_5 z*h^!VDE_(7JA70bj~&C>+$A@Ykdo@8#usdN>7!$Qs3up){TW&dCK1^!DYKqREGY;t zB-^+E%OM$ew96>h?w=(9F1C8nA6QNzmt}tG2T2%Sf;iK2111KM7=84x+AUhuqD%d?s-Y{t5xIqTS+oqoEj zEPXk53}?R;a$P%zc(!h|o-(t)EywTKWg+FfU(MW0{{8pgzyJQ5CO$n@<&OPhofO4_E@v$UC3aej{oiKOmUBkR z1eQR;9~J@<1{#9F)HDd6iI|#E@vvAEaF_x-YiH_xW0nIa+HM4d=LQKs#!dt4G6B;A z+oh4}9`euxZV>Q0HhUmvkdOcjV+xX`;gABrc}Z2_^Wr&kP0u8;rdJ~-?w|YR`_4kB@vu^0rr~bP*&EMmd2g8SF=)Uz$LgbmJIwsxsA%N4V-ENeHjuV@v^u>Sw7D1n5NGJh~T zH4_!tqyLJqT;$|o8s+s=nAin?zmGK%3aOb97z=s%Vfl6q)4Fh4a#A7Z>v$TA&uEobe__SoS+ zrH71X!krAlztfmv?1??M4eMxd9%;(+?7=*@uD@eZl@X z;X@6{=x#hb^$$4@fJ*ccB!VB3bCwTz=hSk0WV_C(nPRG%o@G*~_@2wfA^$(?d@(Y4 z?77KneA&@M$!6or5eBd#$zmI|<6P?8fe-#{O{ZIK)}%A+@GNysw`|}n2iRxth0q>E zzA!bL#s%vIwi)6kR4ytqW-{<741S5>{;`_{5E)$K;3ts(T?o&cMipK|$a6o)aEF;q z;8)S%!Ql2*`yW8qxC0e=G!R>}kOY?5oov8m@Z0niSi_3)5LFnSUD_ZqX1e8`EZ9@S zrIP84B!o@C!ILeW)m+}jc7n^F6s&s;hMBcO+fyFom#}#rC+FF7PUP4^=F&HvGb9*F z0}xL>izk@f)fK-DLMj~?^8Rkdt~1u@Ug76yjLUVVOh{wx42&u7B0EV`#tmksGl>}v z$lcocew6SfiL*HS!4A(0fpDHDTXK%)GfGg)T6m7UZRU$Lc)B`#R;e`;9S&$KD(Bf_dbxzB(`Xo2|wW=T#V-Wx&Avy+PE zSKXu|>7<&e$vdZ(9>_U~*&F#C1=ymQ&m~pT(JzkDp(n z|L327e*F0H#~*(z-*1@Yq5ZLU^i*EL#D#rG}-GkV}J;>@A+ycygTP zdIy6BjLWk+Xy&>aAe4p)#U#LV<|%t@n>e&8=Eq1P;4+~&Vb#z zT~QBtI3qiTXZ_At?Sje}3ZJtSh!KoiI-~H!KtqxiRdo_@kz5WDhH)AA8f@0Wjw-@> z2AzSyvn~eU^h&+isFHUcrkR#>#xon`=-)L5{0jyPoraL>1**%C7gAid?gi#c&A$Y8 z-lDTu<852~jPjkr$ZxQBB9q!XlV_59Ro*kps?StpKf^K`enOJ^1G2M<{eBh2#?Z#YEbOQQlIl3f2k2TgFx1z9%X?*Gdrha3Ss$Z>g0mis;jkH`pfILt3=J_lCn zGx$8aq@q{n*f(dLI<|XwAYZOmt@19Mq?fsX`O!B{Z%$z3^(@YM{@-0yN@U0_AcT2W zo?m?<#JQfbX9+VrS@>H+fByL=zeY)E_Q1dk_o^cPIN5b>?~N+5yl>FPi{S>vSQz*y*QaZeUXj8kT`O@a{TLVjS)xwuD*05>RXm=USKw z*fcC@&f0U@V9732;uMqLxGU^Kva5!b=sm zF~3R$~oDaeDia=|?8H0L@Hba&G&Vs?_a{-3%-4Z063oc@oC)#WT(ozdRRT;tT zkjSnm=kgS(QOj)oo!K*UqKrXdoSw2xy2&s*2{_~j9+tzaM)a5KGZ??;%NmqofrS#O$S(r)>5r%&W#yQ0k2o>O* zrlmiaVygnplMPI+clI+R7;LA?xEvC-oLxFoSDxo8yoL#nbJ@42q%OtmoK6=TkC(}U z*!_M69|UvXQS8*4wc0pzz+15Lzn^6MmFg% z0t0?8LzKnlV+q#$)le{qR5uJ_}E+ z-K92PC+|a8M|8UX;h7%%PD)o}Ff1_+anlOMaF-oGjE67)=jH<|{tVqEY$FM`Q6(=0 zgDrV2dEorkt5d+C`ZY*5P}mhAI3 zfI`4!B-b*dA6}gT2E^bw7&``MvHei_Ay-YADt5%!e+a25hRceWbuF=tr|rJRITkx2 zm#y}N&*a4VQ3D zPNK|Kfwi~{T?@_`3v;GYmp{=!yD*5g2RySFmE9TH9;PC2X&6c0cG(SPug1xKW`o7Z zzmdS{fSLdGjPRvAobcnZK~GS4g9mJ?8=G{Lv)t!U0h^w4`6ME6X~55RH7&C~Vzc&h z$C8&QIGrdMrj}Cgod;%Qm@RoT1z=ee56uPUfScB~Q`k>BJ72IlCKbEnuRhn1vkX-M z@W)7_XqPiGRmftf;W?eb&gCVT3`QaqRpu-^RFlx@&Zi^D5>Q!Q9v*}x;}SqRtHN0Z z3uiTFoL>UFoga$WF;MJH_01 z%*OVsz;mK1fmlbC?GW3dru?0j>z!NawPKvOOf6b%EI{LKEVo-h_L5IBIE^Nb;hDC_K*c8)K&2b^Lu}G%hQMP9w9#=tui8Vv)fPqzPIGL@UFiTr_w8%e~9e_Ef$C6Aqk@3vW z$xs+-w4W#p&tfMQ2F~L$$`7nC1nEyt)d5^SmshR~XIG(J8sIU2E%`I+r6&*rhUqaU zb{REf^W%pfVekPr;gEj`l-erW_> z``kzaxRM0mTvZ5Dv^N(Y*qp*_C<$SG>EM8~e09+y-Q>rEHauk*;JP4p_KK~cscH%~ zPL_=Vo5%JHF|BPksu&=NpCzz{`;u#um;{?;EhWxU;)yK-&En+xWs&fgo6MZ21()1_~8FW<1T;{58>k{lARh_l%59y&0Xidv?_Il*2&W|M`w=n2`G z!V^plT?L#Vc}GDTd0&ANl$Q}CcX_uWv1YI;+j-76bM{OyY;{85oJKI&fiCCYfB(%t z!J4-^;U}C{kSiVlwTI~^iSW1zR);skB%+ouWS8>W8$W;k%s&vIgRe^r{++=}us>LU<;v}N4t@xujq|)Lwqy`Hdw9sWoPznXE_8+sC3DA< zj%MPa#uy>N2`Bh_;}BcQN%xR^2F@(!4L0%1q`<5VXF@V>;coT-03ZNKL_t(EVAuKC z_At1dgY24eREf8knsUa#LJN7yVYm!GZ1QDlItKZau}cK<07z2)ZE@1&1nrjNKzK97 zYC7G+KzbhJY}c;y=PbL;5dX}w)M?mFAb1|lBhpU;@mM_jEgI5BU~n!K5^@jQ_0#+} zY{uW)WOoOs;=nWUUXi)nY2!Oj8%VXP>9h$DBPv2ogyooNq&mxedb z1fSyMGE@WUY`q@Vsg#FCWo12|KJfLwa+3E_diV#CiD zWMDIIQO)7}RhZ<;<%P}cJ!uj$mO>A~I54(hzANRCCO=fm{|(QVQ1;bMk{`T_zXTu* zqX4^M@IQb4%-bQfCH0?w{`vRce}Clq{Q5ik7t+rzEIsF*)@)YG&dKT7UB~^M0Zgb4 z;hDe^8-AZaoYQb@Y^vrg@r5U6{;)&LHgio6cno7G!OnT# zt=Tz*9AlEqTyFm1k}=aAJP0UqhDihrV+wYbh_?qqmdqQ>w2pe&HX*6aWB1jz&}%W*Sj$kJmCm9A1mf1EY7Wab*;6gy=65pYSqqnhD6+F46U z&2SPXHQ?|wMA$A604=g-+USIEo~#*VPpzz{b~d>H%mQ!rTSe{GB3XQG_pw3)#!UxE zomv>)$R-hn!*OCd1=oA&w=+F+xq9tg)CD5jjHBUe_(jQa8lc*x~~+$4rj0K_zkuV zeo1R&>>Jn(rkKwmt}e(Wo>~r43sW*YJRma#poS(XyJW*qun!JNQK?D6#si5F%q|cH zj0(hG#sRj>6?~?+Cz^9f2o(i7gxNUf)pZ$VhO(C$a`BwxTvSU&ae5d%&Vr3${LA(| zo00d0__|7yP4%+!uM0#T#@FS#XTBG6UY#Y+(plOj=A4M|1o|^mzHt|ob75n6Q;{X7 z%m=49jeN&m9`GV$tK**@Tk+8n#8k+Iywlt2}DD7o|mz_zfe z*nG05=>SHFM+#1m448D{S#yFUTP>GGMvpjev2mPQ*ZPL~3vEwB+{ zPh{A$vkMu1uPK3+jSLK6JHv$pld2~}Joeiz!Mk)00h1EKkWY#N?;T#bY7d9j7&zH! zq&^$TKHH9}+Mi~#0Q+~gIhPm+>+(K#Ajl<8Id^%f+NZ$RbFN4xgbl;9JDXeufaIx) ziewJG=WC~tXd3Wjsx-p`Y#Q^=ZPosXu>6w9-~aiqNJw3NUu|ewVJbG4vS1=Ufexn$ zPZ9?F=!-c91)^AZr$K40p`r73e8!NM<*j-7wPOr0|5W9IQo* z+Gc2Y$FPRtsqzm0aZmGoJqFoM?Ynd^t?5U8)KNFeCHc^DY ziLumH&H}Rud1MNnjTApg(=LWFtke9!mQ5~U#+anm3(mseKR>6Dw8HV*fOCT50kDj6 zuXq9hnX^g%t4v@qlE}y0fVsy!8|I|rCQ^Xi(9O)22r}1g%8$V?h0mrri*KX$W78Sa zX4aRrhddA-jDu8XFIa}A0od)2g0p4fFNNcl=NV+$vkXM1`kNpsE8G;zf znW`ogo*7P=U@i@BFo&QgMm}>!{BY}opLZ7_Nu&6rZy1J=cP7PC7|WiRfPJFrGe)A& zQwBr!1_H{+@k_2arEM@G!|NfiV%2LBzl=6o`xag%`f8Ai8kSjbXs+7|%uD#VO zhKR{E7JRa#6|--p0g|0D89*+l@<(03#HfCrtoLDV=D|`lUP9UASRey zlo_T?6swD8g1xJ9{CuHb;^PEXCD6CPYL*R+Hg^msSA;0{mOV(?O-&6u(7)mD$q{dT{%I{hC)|=Uw zWw@P`Y-ia!ktw`nEKk9KfvL$;G8huF^vqTl^9+aQ-UvxP!;h!Zne#AZ*i&}xH*ff= zlwIwGv!t}HqD=Udu=l}J$qSsbKPLG|3KM4kyQ`Va6+ZWFu1>7T+_c5%Rd7XLp?{`M z7UzncGVxil(l7Q$75B+xf?=WoEhfRwAfEow99_*lW2#D z0Q7VHd>EL^f(s-Cu^3F9jq2VR{Om0I;n~1@{5#F`5|DA}d^qbi+D;%IU*X{_BP%%9 z(Usb+@Mnj)wxDnq?u>w^$Yr=&x(tEPJA6rXaI)FVcEF=5cs@~xrw9q;YI%6elqX&| z(Nmo9FP(&(4Xb*Ghb;6H&(6rMPEyPG>#x7^qCd{1D&x(cj?uTe1A?sYK9wTmPQmXD z@RA)WzFPrwcF|k z5zDeUezOc}W*a3PNoxpI5)tLRGi2t)<3OArG-xRmeUSW~%Go2ypYY6XeHpV1>^clB^{SeGT(iA;-q?u=o-+@=-`B*jy0VYZBbmn3s>E0*ERh-dQ8 zT$fTwhf!1IHrY&XE+t+C0jXA%ARl9=s=JsR9 z$md*KJp8;Q!u%M6)cnuHghU>*yacE!3eTgC!y$>`D@nq6mr~^C<@2ARXT!UzoXQw9 z?MypoUwlWO+NjXOY7@$WK>>a|7;|cNnJmy^z*B}vJT=$Mv)EJB^Z-5>XBpIGhSw6A z;of!|t1~rKs<Q_&voGhGC79}cezU!ApVi**zfe&^^6BFbl@En?$YCc_2qb6mXBccDS%MLn z*(K(zf!V6jXCbuYBIImLF;&qn+=qe(O3Sm7nS}+qOt+JPpYq)kX73I3nD9RQ9=Ys^ z!%<@A3-(MjJ>$&p8dD`qZ~-zb<{DNA=`aFV<^p3*obxHDa&gM+ zPq;}ui)}#c`~q44X*ho{Fiw|X8_uQSD+vH!Jtq0iL-_At&_Il+O1=5L%bMEBUc%V( z=T;|Oz(!VwlcEwC)TIS+FK}d=iqz=!Vg_cBM zm_j7~!)U;SEXgaJAyIgyK{<1(JXY)FCJTlGX-mE&LNfcGC;%D4iD7c=`UV;jN=qyZ zF)9&MG3G2D*IrRC50UC~eWP<`q|7<>agPfxmroYg+Hg`@cqT3UG5A+u z>+hHHKREKg4m_kP<{G~Kj-ERGm)t3sG}S4}TN>3+NJ2ZQD87sg!IO)nf;m+Xjz60c zf2i20F>pF+X@d+QGEj(r8UD>quWVA6hjON{oFD&9sENUI-~n@EuuMDfL%=Su{M_(r zCwOSP^474(f8o%V!pN{xSB*#m>eTO+b$4YiDpKqWj?WHovf{To1wjGXU<` zYZYaIvT3nxr2qDiC{8}_R|r%kXxxlkD(uz+l*)qkAb17i9 zD{B48g&hVKcbRu`E@5$2b3CjpHS}>f@XuXcJQCJN^6oGO zKxilS&Uh_q$A+IK<0&I~XZGF7R=9^WXR_Vw2UAVkoFtmC8;_}O@Snx_3PU0EC)&K> zpHj=qMBX^%OmXSU@8^=2((u%V!4EP9I+uR#2)l4c-4yr`LxDTyB?HAq=T5C-3&YfI z$x2v-XXq`#xntpIIBK~(y4cK~F~+}OyGDnn300Z_*t84JHyd;*efBSUqofL7nPo?0`>amPJt)-~&0eP(`8= z^7H4gt1v}hM_Vc;b-H8kV(iH%+wT2h|^JpogjAx z6Q+VnsjsJg};r7xu z9p(R14aWGn!>4Aq5qrXl_I~(~syZAzN}fuT zC^wmdnYYGMj6E|c9*mGX>R#as%Xd$HkBkg@l|Tw)Iq+OE^SUX2l*7gP)|vN`;Y=H8 zCPTD^gax%Ebh61k3)Mlq@$bOUza%+lsaP6C6vn(GFy&U@w3yiqTAJ=T3Q33wl`-)^ zTT>>tjE~sKl}{3(`6DTANX{7%32aKucM89^VJA-k;o)Q%!0YT#ak{g72}BP@PHSR0 zWv1oIiIbneWs1@aIQ;Viz}U&@2?`lTWQxtt1KcIHWniYAb^?=vL@6Zy1g@E9_@(Cq z@958&kWP={A&REd9y<5Pv%ZLU?SowgHY&gr3;TJm3 z^}1K?(m`-_BS<^X84t|gFtw~PKb%MjF60~Zyq2OmY|XLjL?nxk4;~Ac&B^wFzZiJx z0$?`VCD>EX+Rgo}0oT>bR5+UH(|6KW*!UJJszzo~cIKxaHWZ`RwPQ>Jf zTb)6CNn!^Q1;A4{FAa-yMVH~gI6)y?QZYr;M-0k0Kh76Y&=ZW1)bIu7xpuFSyd1UL zUFEMKPln~s@FQ(`wxXM)!GPojN-n1GU_4ct+Y(MZ^?*_Q83M)tM&~(SnL;@Ren>DN z0TaW3cyf(`la9@zj1Ny8`6W3@n0`qylqK0Ml5}=1FTYE2CwkeYQVa{IO)|5j1PYmed(Z5TV|RzES{E43DJ(x$^k2NV ze4#umO~+;m%jVbcmoS_N=Jj`V!`s+O3dU81h1>NFkw&72*_|=-?vOA0Uw=oR-{4<7TQu1VvlQF+H7^AY|Olqq%edR(&fyl^4t#(v`dnmJcCnFkiHCZ0W=_ifZ?IB zc>d3LxdUDWo~tu>v{`=UusU}Z6Y%Ono+q=NC-vzpv=cu%L ziHDGbV=89t{FF^Ml7-$bbuN<@gKs^-f2sbZq&J;xnRACf3E$UXtKTUDLpmx zGkm51+)Je`H)_N029j}ZB;*CQ{F|W(genX-U#;Cz z>miXfU|S(cnf+}Ic3SkiMpyJuf4~)T--o(0!h>M}UZD7wFo*2yC@h^dTpo=bq5aic zrb?~TVG~Q#cN(QIspDKuO>Gq7sms_IVzxIsGdIulSiom(7ed|`9wuqP{9ZFH&(0BEX*7&n?~WB3>o9s}BG7zrV(yX3THmJOcFg2DgL zAcS%fvefKDNZ`X19|Twcv{n+E{&)&}jKfqRvo1L444#9rT*|^frKDm#G>`4Nuh5*@ zc&7T@Y_I$5zyGB&W-+Lxdb0Er<%LV2J;d7B@f&k#N5+m2KWg0{QZS2W8kFWuP9R%l z2HJxjNYI19lmlP0kym+_wH#77dBK8ODBXoJXP-i-|v5@`7G(#iri{a z^MFq8W9dxt zrhB%};l653<#eo=O%{khCzNg}extQ7{x3KL&3%!hSO%vA^&t>ce= zc*-ekM+3|m5;%(ji9r>B!*76XtZ?^68n#~&}gqvth!e)>@fkZy7F2Rk&*1_jfyC3&1X3|E|reK=&7 zOeAZNDKt;yr6=P3Sr<_A-0vGlyN; zzj;Mb%l30QKFhUNYgk`Gyf^3-iMThD>sPhNIuV0lJT@xito$LBna?(7iUT{Dhf>V1Lfj9q{?2K=`Z?T0Yq}XvTo~ zscj5+8W5h1+MNF9Ub$=*W=ZG{F9Ev_dySTXZ#wDBYdn@+c9_xs8vpl4m0*S#&q{i; z!)&u>^9JulDTbP&!1$TPU*XH)Q^f+t$n_^*Qo^6?Q^WKGU-u)NrIzYq?AR*mFx)Y4 z6GT{$%L~Geq(s&*s))rv?ac)W@Gmi}*_+{6G2uyX%?S_dj%ON>)D(mvS*}7tKo-Np zVacl@;eL$#`SWM~bvtHvMyc{Je-kgX_7~M*s*va5Q#=M^Uv6nPideKw53h&7#3-b< zD0X3rfuWVp_2u`G!GD8635Q%IwT6elw8by}+$i(dZ+nt^Ht!fIe zRkQcQ1B0^zTdo4LmDd})raY`fX0r{9A9&R5X$hWR77U9Fnn`u!vd;f8_Ur(qWs33( z=|=I$2N;qVi7kd&j`=zpHjHB6H`D*$|NH-6F9+sa1ZJNwL@+w*y#Mu||KJSF{PBbq z8T16&Y)j{j?awKOaPsDUMJdA}i$cd+iHi(K*2cu?pLkJImN`o-XT0x6k0a+T;G`&4Euj#9(t$?1KPxT(=M+;!4rky)K<6z7+f~^7z_hLHoKz2 z&qK34+~*IeET+JRsY1Gtieh`P5PqO>EpWo%drXi_0e-=tY0i!lLeJtX<0E>)nO7|? zlbhlPv!LIcwgKE2J|j2y9p+^LA>6IhlD5Fcc&~<;S&VFB3di6Gcm;R$-uvgabVhh` zQc7fIt6qm-f6Ay_(c|;J6u->Q10T;DhPhJv&vwZxaJ9O?=ZqCw%r%7BrQzHq3Sc*T z-`EoK{%}f~o_DhR!qRSJM_x+)Y~eFI+YAE?`zM|#nXt?j7?K;q$9dw-{IDCWEImZ9 zV{IoRfl~k;sPMdFyv#PmzaxX#(4uO#-5#Qr1`CSR&_2ZgGb9*@1oJ6_CM*f>^)JKi zq?R~y-S*X+hg%zF_=rtK7|@o&4DGx*GO*=grouBjQ{y)tsyNwEOAO$p;SjRNpeSRO zB;VjHZIuzhMF?P+ zms6qQPvQ_2gYP(roeaxzN>XvoVQ7is2TPpX^AD{Zh~QiV80Loxv|?(w@x1kpKAnoz z`q@RaW@_1Dx||>R(iaEr3ZOdy)NmJN8EoGrcuC0Jlxwj)E@#R4f-^Fb1@YDv=Q}%K zNgJt7g!trQif{ln=nwdK+`vrb!~!$P%eL8Q6l_+WqRv|)fr&D6Y_pM~49D)4?1rak z876ke42(s=gW;dMxW=p(*B!291lF?R#{dvo$mzKYw;cxX5Ml&uK;-2oob&|z!9Zj% z=H#MO+Gh62Pe}1|3KCKaH<{y^{+aRNd7gd%03ZNKL_t&qPl{zZieV}*K!#MhoSn|< z@N7szxHv=}pImZ*%@pOiEToi}#E&Tx_QL8MnowI}A|q_JJxK5v6Y0|2&mfI2F%{@x z?V{?Kn}#rl-`K3V>ekIVtgB-pZuTNyYOm`VYJs<5huv$Vd^Pk$Adq{vZZWJ3MVz;cn(I9FEc(x zSh-BN&Sutlgvf0*@#IB zCo-)5eeX=|zz!^X*O@8Oy(*Fq4pYK8moNU&Iin7XxK#T>>)12Z!=j4Xa#}-$d&+iT z>CEn?Fjp-MWXG6DPr0k*M-qPt!58gA+jl$=?hF@R7`nk)1W>s+hUb0dsw>gW(Cg?v zL=3YJH6Xr_EIMD!06g7z%T$@V?DcDwL}%N6nYk$W`>#U z6}wZrgdxUkw%NebS)L_-oK}u!iJ!f$M>{u?z^H`%y!cnW+fVrWeMR7pJbE_=xtWVM(7 z-6wxFz4!yBF2_a^r=F7@KM!L?=pl>c=OzBn%lsDnu5fq&pdXRZ;Qde3v&Jj$=u<$_ zr>Y-6encEvquz~R)92rJrab@u0;o?Q1!vV0!hI;%95*1C!VP|4SiB8vT6V4i&N~ zB&Ta`2@*kgFsNeL_xSd%6FX9OR$jza%5XfGYZFpq6QT-RjwEV9j$R)>uZOcgYcJD^jzx~YdIA69cl zg&%(ekO;#v5RVi6Nxggc0l!m-j37;0Q!p$~7GQR%Q+ti@69RK-0KjnzU?~7vFtEXs zL>W?PhWS@jqBFZ40LEm&0lQdu*l!Rfb}|q`MZR)ocY)!ddeTOQ#ncIc#IZcb`nnVV zYh4$L-Et5Gzm3@t&z^0X<`Udb06QK47_P#!#SlEbtyz=IDb~(O4dY&EC!CI|W%ZO} z%b#JYV|N)pZNqZob8})N+Z)yPq%{cz!d9~Jv)ch+Bt^A_OL1laSN16nHl_%{h-^4P zQjR@md!Du6$(3d@tl3#L=}Mj%Y6{Ny{h2oM)vT7=NOL+DdUl2b!7Qt0wu~J^V4gh- z^S;eB>VSU;ut*;z{3gf7nBrXsBs&9eQWveGK-$UiaZe23GRRkz%#w%|gn_9b$vgKj zuXng?+ThJz-U`m%*8K$mB1p7RlsO5n!&^~_<#WzX4`7U7K$04xkPMfGt2kV& z(%7s^dV&n{Vk8j?$y)&YF>)oTrB6TUD$B7;QJixK)tn;r&!0bk{Pvur17(^|NFqj7$wNoS*PH8X`nWXc%d?|)-*s{4v=fdM;inEks;6MuD zwm}qIKX?TAf*vqGD zZqCH!p`WW>0B*uEg~hx{883)tzFP6H0ttDD$R&5A6TbP%%lY6SrhVuNDsJlHe};{aYxp(hLzGYb!fz$)O2Ansv)P;sLt;***v6IUJT%oASsVBv*Z^la@3AU}VHjMa zZLSaHbYApZKmhE|q$4S3-?YW)G99?|lPI&MDjORcl_&sc3va@jN{U_J1n)d3#U37=dviW~qJ@S-JM z0Hp*r_zOU|6A{I30k#XDNJ1`+Vz!22C}hnZ0_SEnIE^jxL$`1Ct@%r*6WK0U4Oz$X zUk(p?ZptA`c=E}MQ>xhAxd>0L)WS%3X z<{{(DM&1rDHv^m~#PbUc`gYI|Op1#5D)6$RiaKZX>|vAC+SSk`H})=3XzK`MFU{*_ zC8`cr6D-(vk=zgA$EZ6BSuR)2sdxP`W@*pXEn!P1f|<4Fg(~3rC5FY<(nOCdD)2jk z`JZe;!VSgyr1(pT#Sk@(BB^2UW)5I_DsVTv47`NxvYh<~@*J7EgwnL4#Xkw%{5cz* zo8!5>9GN^+yA&n(KJPLx`+qlO|I{-*#@kMHH~8J=G@EU&7q$WK+mQ|VT&ed{gn<+{ zgl^{Cb)GewQ|vIt|5w{C*7jEyl?!_^I`91{c&Ly~II}n-_Agv(q&_U_DFCz|DUEw^ zG=!5!CffLv!fya`@TXDPX%~KOLzJ1{6TJM|7+7t;*BbTI3Q{SBV3=nriN_cM|0|5F z;M7m0wTHi`sPvztFJy_%SqN_iY6mWJv3qMjgcfpgvHCG8>V+!a3_+oJmd-C))_FmA zp(oac%|?Be@E&iZ?KF@LGi!9W-?3rl;#q44;HfMqC#q=ePvI5fZUByf)biJ`2y6C! zc$w~=@C76q=BwR@Z;fWUWoNQLyJearXU|*j=%J2KSBP}>r4?tEsqh%E^N{hO!PS9_ z`wRU10{AW+>%9Z`9&`WIcgN-zI!TRyS>2L^by?0HoCLbDRT0+$))$eShy3q&e6l)D zO|Cc}mi7=39yB;t*_FCxzjH|Ic1f#hE6-E`c03RLIj6-|YYj^Hz?gZ74jVT`)QLgjR}17J&F)GEVMMy-CB`HYd9`%G#oKLFTY z{7g+Y`T*u-W0IRHv;IURFxnVZwc_xXzrr(|b$O3LMJ%%zOg&||C^XD;PjMc=Fk_H3 zQB@8wW)I|ZYFQl_LtZH+$vYmGWBVP>hp{u!u15L;pqi7bR%V$x2!Q8+f#(K%;CVPj zb!TMsmj;B(*{AM$m3`M(b2`NK zPE7o0j=}I8#cUE)y4?EnebE22FHtWWmFQ)jWnjqD>hz%=Eov3$n45-;)FMghoJTNO z#~Q}D`yxi7Wi4l?uLe$9k3gQXeJ1~k*(x?ee;$%rdGQ>g*ai+i;H!0KB%EbI z8;E2WBe9V0s2pD34Xd2FT}g4@(w&SK{7y>KQg2P6(^-tM{{{O%^|1e0thzo>1$Dik zYNp0x!KA?Ox)U-59Hu6C=ZO-3g0x7SOT)@7-ryx$oE4s^R0kl=8k!$_cdZT~O`b=HonPALeBjC3d&O_+!jOcrZwv4#VIF zL7X#+@MjIEFktYi*@Enve2pa?Jkf)yJZf1~CpOGroY8nBVI2Cv?t+%6uQsZpN_Wug+iqZd zQbqm0Uqwz!t9-)2pG5+D!I-J1=LOmsLJ9R?P!Dh@3KHX~q|}A+RCvJbmYir))y3@va@a6lAUTK7OvBR8 z+108MRTv>zu4CAWfx}g~c3_Kq$DUQEgvetyGD_P!d7p}%z52+dH6$z<)nQmn9romre5= z?5W(IrK$tldFqCZzq-su<(E5C-OXK|HS#~!h&C69^EKnecl1dXm1wmSHQqXIUq!vJ zS4eR%D$D)Ni56oVvfN+};cm+TmMJQ#r2M>#BlM8!06-Gy3Vhha35mRX`hQ0-VU{Dg zxYs7pfxnbo4y#==3K?_i7kVyb=lHN{2)^I≥96&&)`8LZaVW0>IK>d%)~iW{IUg z7+}r^!5eHT6&`ZEX&eXbBhU6f~iMv8^aerVd-R7vtE^m(>)DBFqSEH z&X=R2neZw2ra6S~0$Jal81Bo@X)1ryEz{;(}KHNO6i-siAtBXJ~JsH+0@MMiQ}MvJlinuhwPDPJS0OU#)h%RiN83C^)k z&F0v+d$u`s<$NjyI~x+t>MZbC=KpPY-*tAIWZ4s%znsPC6|wDof7qtZ6JAJ9FC|VR@MtVUj%2y0ZrnHAu6p~@GSi{VV2f_A`x;Vl7 zZU#-xk;xwuqot^Qc+<`Q{|;LM*}(9`pgFXw00m<IA?TTL>9wgI75~l zDAY#OL?$Z{cO>}wtpxt2N$Fyja8GJ#FO z1cE689_!(uxxk+tTAS_9X5pdB*Z*Y-cP}>03BHDL(zhk2vo8U!aW1JII$hL5*$9i_ z&xeV=6c8oWkJMe>hX4n{Orod4P4y{z3P2<&3R6R1W#rtM&31vG8sJnNb1r|NId0oT zAJdSeP0vLvVgX@S#^vi2+R8V|+v;C6_@i z{L{l!l;jF&wE%4RYZ|A?fN8@&$q%X~&qGhKF-+dNE*;kQVWQ6h*a;Xf@cXvQOBfn% z!pgG582^GD&e|$ByQRcr=u0}xr~(syz)(>yp2T{?dvAE#5KFqRGssn9To>7^55xj^ z)3Ao3a>Hw?hNUWvox7r<&O=t`u${no#Y;?{qo~Emvw)k~%H^|p6TZVxS3Lw8@6;4U z=WCY3a%g7A9T*SmNDnPz+A#3gfB3g~W_Woht^D`H`tz_3bX)9S+PwR9LsD$kox+#l z_s+N8(WhVaS;}f*(uG;oa`VwL76#*Cg=ggD;X&siUDZ3005H%N1OJRI56yH)NQ$!p z83MyI4OIEk5E$VWkYy@B9sa-n{+mSkze}LPAOv!ZsRTBn?3uQ+%-KtlW#CshAF7RD z`coR%-r2wp*>*fdyBtF9q#?`{r+69u(8J>-F~3<8rVpE&){T!9}Mx}QaO*t(8#f5O0QssOMg1f19<#tfu*zcZEE zLo!xRoP9ZECnVm(0L(x$zc`J=HZsoH5bq5F55^LoL^IuiCsRu{qNpy0!LtyeK4>5y zoQI^*Hg$5p3xi=F)H$gRQYZMKht5-Ab;b+<`_r>8*kpey)*V%0oW;uu!cqw?(b^_AQuKv zVJ?1Od7zq@>4A1yk@cgEA07jLJ4$$zm$!Dsk{mV z`ILbeH2CeoOu8eFn0)3vW(aFh*zG%>hyD;&?cPPUNr%(n_touG(LDh6MC5%Iv|)tS z#hT6jRLZX^a@dWjCZKs~RABOwJyga_68@Q1-fR2!q9%Ulsnko@SxG{?v6m$5mffuV zb;Y|8;P8j`i|^p)1KrH6CFtC62=7oCLY?A4%B|Q5lJ9aZk;;-VA2BPpRWmqKfMCLdjlKUNnHX+ zXA+!cP)_-MI_A{QQ^E@7hTLeY@TZ3KB#G)1s@!6p5|b*-?@Lfo0mDdY8kN|?AI*c% zA?RNk?z8Qz={?Vq{OmM&l$QX92VDJhGXaB~v(;EaVkFSv1^Dcc#riDmnJv}r4s7+G zc43^!nI#LJhlZQaSJr3qKFm@D7M^r5YMAX*AvOHe=E>fG&08g^p6c+fYWkf0U}kE6 zDp7Ugg&}z>78yH0;lF2yD$>P6!!ZE7V8Ho8>@Eah7!&FJ;8}L#TnnCH=ad<2r@Cy# zF!ODCwl{%0ziFrKN^NteTWY5HJ}i^mo+Xa~zr;=jktGpuzv zq?pL*IfrM~GT7Les#X+R(mj>57(O!O#La8Ct8gv0-`DWY4#}BH3B15zC%mt%7{cuG zy?lO4P=Q}Mw4P@ZdG|UtocT27oQwXrExTt$r(4?2y96AZeAV^#KH$G@DgykOT=dp2 zqR%pR4LL8$nX_g;_Ku!Y?WbOD9uM~f>sR_5n0C}w3%)v4*X80&`(9{bWhq(@O@3H! z!yLX$6fjfESY|N{v(0y1JBfnUyIbm?pPaDA-V+Qy!JZqj^D<*!2TxwW4Cj;^@ zDsS4DKz1WMHjWBz+A;<7I4kZ;f}|PJEQQVhq)m_6@!ui)0TKFatRI$T6nxqV*BUE#=BRf!!W<2 zNc4hH*= zmV1Zau}j;6cVZIgS=&q6gEMvQ0A^;%0H0%lEe)74maush0*_IF*123Y@a{IwvtjZe zA;B<1L?)`*W&PNN2~{~^<8taOrK-eC{RSLj3$`q_FdUre$74M^8}Mh1G>y)`Mvi8T zhdlQg?>To#$#pIk7(2=acHLzn&#^lh<*yLRjGtjeEr&a*m$l6-)?*uFIcpeL=_K}{ z0o$43Jo_-q4iMT&jw%OEm}hNsK|6;4^XmntPWa(%3`zZs1E;BQVxSF!scAqJBcBem zhl?i#@=b)Z=Eot@k!8-NKm(EmPsAVz1M)Hqz)qG7mo4Rf4W?+9!zDOQ>$hDzJ23^@ z4J#Kg7RYr)MnXUyjESU>L;*ks#*)_IRycRXE}V=2rst;2M9o-e|M=q%j;H@VHb=mQ zqipBfIzJNj6y&MBwgJDbm0AK`@|ZK_`1o)<`2m&jFW9fYqyOta|B>?N&!0bj{9u^N z2XfO6UM1iU{@?%n=h)er-2%JOEPvLC5d2)!vH*uB)^27|BN9Rmz%*P=y`)A4Ji7y9 zKnM?s0;b8v|NHO11maJPPLXC7(g0#9As(pseZY_qi$SG$yuYK9SZ@Q)Ck!zFLl{X& zC9vv3x$*xWduO}k$dM!48MSoZ|9w~8x@P0H$BsE7B9lp0t2MUzK|>%M4hQ0cWL9;l z>hduB-n!0+-%fT>W)WZvPRq#tyoBvGzo{U>Sk9)^r87t?q?wRdgO?@%C-oIcc%=wG zQ5e7?20t4Q07fttUs6jgoMFi8(h0yRLSA^XPlN1~%x-}{QN;QWM&V3XGpqu^K#0K< z4V){BLK`H4s!H~eabWQ77@LiU;5q*P{`bGX{qKLNh@_P(!<4`QBoU2`hXScR@;of@ zD2$&JdE?-&<9&n_WF!U3F$#lh`(u~Kf@{|?g<*zgHcLSHwB3YNmpf@Od9P>J5yj@m zWAa*v-M{~JEVdT~o9iwM6mVXxmb^Y$2D{7%CU1sjqoV2bI~{>VML2*MhJ_gqi7;v> zo0CPs2@jq!>i@BvEc2dsc20z;E)&5JqqcphE=iKQUfB}q%uN#XxQe+MN*LnfUy|Gr zP)TRV^i;?kB4!uso&$zwMinNv`T@_B1EHP9?Dk6=m@F6wz+i8X-BYpW6c`jHMcyXh zj5Fa&4Q2*lr;n2TzDx*=Dux`=-OYwhms55yMskf)yG2%bh7Q3qkx`C*jES5cnlq!A zswn)ft}t`B1Y0=*X6q)~eGhDxAqXhsJUalEttcMXI0Jokgss8}scmC_*H_z4T1d(2=M;9PD4AKQd*g*u&W6DA`9*gV1eb!MNO;3)(#Jj9$)fGuokgQPiR zbRy0yc-WjhvuPm67%&is^?!^w001BWNklTFkeN;X4Z{@9tFk6w{<(|GudK6})^kM{lh_gbnb zz?q@fFH;4uZf-q{c`_#<7ugPc&Pdb_mW*EGge>v3SFF}st^BUH$d_5%w6cAzu-(Bh zOGaa+s%T~x!V|->Oce=!8+8(x@&=0&HU!(l&qC;unQ_8z10Fja5*trihYUxB3Z$pf zB73|I;$H?%PExaoMSFip?V-y0R=rjQo)o!{rr#CqW+7pBr8MJrH3o@Pi!?2VI?gZ~ z>|AJ$b50dAoR)3!JcF(%(-Igbu`%+>eq+OM3=41ON($1L*!EOZ7fr6 z;E<^n539h^BoF}I$ic)vbJ+t78O2W)M`2^ktwJDoi@~-@jS*E;6mt4cECzvP0N@hF zQ%Dc_y^Mf)tzO-sGOg{z7U5wRIksR+8D_Q}o@Gd;05385Z2;~iz`uD;gYcG z@^DE4RTgx~i9Cv(FvtsR0ocY6m|2E=5K1og8?caoubY8fHVlrRLNJWKX;0cx3lCQT z)y=8ejR7Dp21CNjNOSBY1jDno1DHh_bFgRXT{j@9T$2H0niD|jbX~TIEj<3Yb1c|4 zAqZw2cNswvI}N7@k2?^CiGin5pCzFO10IYb#2;fhyK^Q>X32v&)IY!R|l^U&Rj4oTgPmSLwEp1lHrVU2^F&BDH)f;$vHJZGQmt?IQ$Yn z0r8jw<_E^)FA~~Y$P95V^)OqU3}@8z0FH6Vc?J}Jz`QwDEVb7=eiu~phCz48rLx{37f$0V$Q+7hE^SN$`%E=d4;8rFNm zq;f7g;||0=1bT{wqs{y;*%8B4^W(>lKmYtQKS=-n{X73+0C^#|a#n}B@GQYoUa=Vf zCptZQw&xm=2-=$sG`^B9IjuG_>V2@Zg(R| zD= zv9?3Hlu5A|4mnfR>|F7pTBZmlR7L1;Y)E1-eDgC20?=S)vhR%A0~Q0}E|%>FfDm}% zsr?y+fD_IT1KN)mRq0o7QZ?jN`0N&qW}zF{4rK%R|<&*;%~=*~Iu<5`~sWcZEt@}WPe-M*|@ zt(+IwQ>mH|n!sMf;}qn5W*`P*^0*<9hmwHnSVD#2r+$+kPtoH4X+{KiQIh&4VKY1= z?nYI_!AmE>ds{AhXikH@A{LLo{;-2J8(%sZ<}Y$E#5lxe7wrHRP;AR7Fv}mMdNvu; zoKQhX_xL+y4&2#ZBl>y&?J(KW zCb2!mTzY&{Wn+B%_AQ*=@KkY0=w)?vcLMKYvJdN4r-9xu?hgRA@%@Z9kxA!Q)^YyI zc{ovZPO;mZEDgq)$Fp9bn=%LokKwil=H?T)bTYd$vKyTXWbI-6zm$8_y$F`^|-a(N?Dr=lYqpcad#0>=e>@kavtqQNue7J{=CXJ$bBlSJ906QjaBh zuYPIL_sQwrG>W_mtl13DtF{c;InlEO+(}dnQ@`)|WtN>2DvTZSOZ{A8Ha?QETK5so zH%acax^_hk?+ADha)4TjAII8ToSNorXL)0`b`#=b*5My~H z0YkflF?;6_<#SY!XSN_8-=e6BLBpwcR#zcEZAjlRc#FRyvM@D-YFCbv?lAZv$6)HG z88-zR7Td3E1Iw-rNsZG;6n>LDu=B5P>+6PjT#Nlnn}6fGob?x(9iaU6m7g7zcIA~; zoPYnRm@kJ9pV5aGO@5NcWMhmdITHamhUi3k#Ks-JJEL{q zOK>bUA@S4@*qa7R=`}iYQi2cQIppSSnBkvBc=*X8dnV1HMXU}C3B+G|%0Gv-R|)3_ zFiAZ>`hdhhWIV}L&J0Ti3_CGZtnt{aG6pgden<+*O{0ps88u;aBU44ou*y#%c48C4 z#WIuH!#1KCzKNIXTJp)=XNRhA?r(iqzXyE9DqBq>h`b}hRs zE^3E))n775fpH+Lih_i&7?$7z`OPVItka>vB<1`fJwFzG-}Fv5JQSj`2)qI^fqkJoJt17!@95obJC#1y&Z%`azTZKf!iqmg(pQ z`qNu|l7tQCv&vuEp*4n`IYE}em9YyqfI_CR3xD5FE~r?GXiG)uIi2TP zpQagVId#5&jA3O@AWY4A+rVgdKdlNSGB+G$0>%~*5`l2!~&?Ke6;GOr73&H#z zeFY}g`y?TB4+do8nMNrgm(NJmJ4x`kLkpMg#U7=v?X z*xa-`+G-9k^WzMy6ES5Yv6nE1>}>aciQz=#eKh|!@|RL`^e~o*KH{9~GNsb_Ih9iY z;C)G2jQ*-Tj;_6`i&`^K)BVLs2kpZ&m))Fpt<90KQ* zN!(KVE9x)>GE{evg!~*Ml3Z!>mWO7RzmC$+(R?S%)LBux!V7jD(v~yqBeREGm&JZW zz?tODHzvYa7d+>@KY8}7>Yat)0~p5r(!4if+ru|96LJ?}L_9;lRa81aA8ZhEFv35x zB&2dJd4d6%N==BQW%$RPtd}*+j~@tL3aD9Xgd9(0Ng~4MY^A&09`~t=`R5G1v27>2 z%cl?wD~yvV`fSWQwjX&v=2?<(06((N(*ggFZQaA{F8=4VwCiz2&!5p}h4SNtyp~XF zVv6#Zb=T(qBNUj8ut7x^9&8$fm0?v*9ordsc0kB9Cc`ri%>JB*m~iHqtXot7QsXx* zPGHlxgPBo}JuHnG&`|F;*#peFQSfk2%?;yL5NkGTh|R;MIpx4G1HPFkno&;17%9YA zN&^L&ht!$P6eKYiR>tD@a2G1)vJU zpBSRYv24P?N{o?gEilYFmkB|ZQFy1GQx)rBwU^j5jn+juYV*jRp$QMR%YQZYKzp8Y z(jZeK0%~|>`=Z%e1!r06WL-FYz#NM`YxF_`W8<04HUL8EG;umA3Ve*f(2(7G4k-o? z6Sxe|ZwAag;P9VsAC@~}sD<|46zRZ(xXHdH=2G5Fae$FMm<-)~0Nwz;dk^IIr>f-p zfgmjp=TA0V1$G+f{XeP37ZTzWz4`&d00o6FuSzVx$`3remtD4c%0Xm&)Szd0lcIqQLYjDC7#E{W~C4x zo*F(Te-KFdiLK$QgoLM=Y|B@9emwD!g+~pHR_GO5j&PX}{zs>=4 zncmoZ8$v3zQyK;$OEc+uQ%(4R@UmCQDh0Gt!;ol=bxD2nP2FLbmz&l}lMdTO+8HOtJ zAm;v5Z8F6BzF=o~b{2xjzyA7*e+e>SOKrP`EWtm`=_WX7Dy81)p^k>sEKsz=IqilLnxEpx|}6R zIcE>=Gu%Yd2aH-}B&9%L7y!y(y$(n>4f}wv6g70^#j`?m*Lr{nPM9(k?%XhPrVrSvn4Rd%lg*6S2rZI1p1vfw1uf5fm1`RHOOf! zW0&Dxg78F-8LGya?vBTVckn+4RQSmd}k14gC16;khpI+&jyv|9}vNOj`FNaj-NIfwzLmOge8#EM~!9B zC?_f>A;F-WPZ*A!tw=ag43~$36y{7(QI#Enq>}2Woed8Fn#NT4dHW2~%89*cu(5CA zUxLw%UDUEmmr*;mOF!N7A7ONq0rs;=?0jG^>pk#%wiO39HW*?KXBkWxhmblQ75H}z zZ!QOCWQosVqy#s4ZW|cj1kV&y?;9a6g$G*1U>v|Vr>JYmIi28d@&}eEc3_5+{3d4t ztpraNZpTkX^qAyk_7B2lc03qPM*|OUg2umTa|*&k_hQs6xt7YA{R#tNJMzbpXgDSF zLFH9W@Rw?LRlMpa@hfYPoCpYC6K|dsS=0q6b?<9rIB>vyhl4WQ3`vuRIv*PIh4V(@zs{vMROLN zS-t`slGgTEBF`nyT!m*ikuzOB&PCN7{A4&BoG3BvEZ?(B^1t0lKQX2x*JXPmKjJwz zEwff@`y&G0CwWy;@Uyqo3SXxYc{9;ue!s>uLxfpBcEngY<)1m{VWc4#^Wl*bO@36( zsn2>`H6L*=Q&@bY{`{qkNGoxZFH86efR{VFqU61l6gG^P!Vlof-St3red9>>GfzT{ z;WGe6_M|bhE@s)x6zFXkSY83l!#fwQ_zN)iKjNoUd!V)Rfjys$QT4}n&K-GVUxK4H zzg$?I%zp5nf1pLRyIAO?FpQ))@s!~`5HKMa74oISn@I!nu5-g{?;SQkrK{nmDvh3y zqr6u0X0A|q)oum`R-Ku#Tu1(L#1_pj(dQxC`@MSjj6R9|{lR|;WR^6q1~9Mo@vvs@ z>>(qmF`@w_482hR+hE7Dzhf|D*&OxEMiq}R=JL}VgauD}Pf}!ePFtL7iR#W@^HsV(vKVTFpuo4*}^`a zcM`hiuYN?2Y~Lrm`%sZ*D?6C-KN}trJtO=`6g46*21Bycy1SFLKjBPlJxhe}9izlN zpeoG_BR*eftkbs97_<3NrP;sCI-QDbfoX1UWsz$kag( zt)C>^s!T17(wR+<6MmXg+TaYpXQq%Gs)R6mKLxp7GMp%ZNJYuSI0d!aiB0Sd=4J*= zllikeIVb!mm79e{%=>qSWJH4vFM<8o(OD#jkHL^Al;GJVn&J}zCk9mP0XzpI%F$2k zq@5(h7C8QL@`N`$B=URk3?XUyP|R-5Y$>r140cG#eu;`2=i;VP+J2zrvu1%0y)rVk zJu}ywt;UkeZJ9jpc#@Gscc|`^w&cmWET^WkR*Kl!v}(?*rDFLt5RO1XW}sE=W~ZNY zJ{l7i@+v1gmVI0MVHskP_wD4}se&i907Dpnok0iy*HTr3xoOZPIvkz6-sJfT*tzih z`J?PunwgNxo*3X}x{AVhYG*rShnYozOgJPM0Al!1)YN&nBiuz9Z+nNo^w%<-@$Y0z ztXoa$ne=f#q2ds|qnQH;t&R6ZhHdg3I%5IzQv}6gOpKSH*xnx&xn&&4D{6^^3UEC5 zF|umF%(iqIfDK!%4*v7rfakFhsZMv3>i*^_!pDKdb8}dYbrj1q%P$Wk@y`n;Ca|`s^$4txo#;ap+@XSXTb zQ+}LkKRio=5@tyHKrI*(Y4Hcb5|9prw#XU699mM-JtK?%r6J6Ts$pc5lOY;VHB?hGt#&tTH= zKATx%m3A$)Dj`vu=;0oX|P(qI7V zvdraA0{IJp_LQ9-7I_UzNex}~oXT?3v|^saT}6?-oOM#ph@CS_d6u*^Ip9f{T-+qZ z$?#@}y;8}ADvVk?QpBjg(G(KDrXqiD&56$M0?q=9-v@06j#OUxj0&Fp5KMiIS{6w8 zEG}El&4((v_+`}b_%K^;B zl8j+a(!wB~CI{?QCdB6&wIJcoJC{?lk#M>*el!nToPYlL=lAd5z3s_+)A-mkdUwj3 z@1~9&EX_?{X!Hcv6n&gXrZ9r3M9da5gaC4nxcp2xFdi_T%0hno_RWN3dC6d7VNeo+1%OK5y|SnGAk)zXlIO?Ji47cFt;*;I`W)%5Mn>)>I?b6_xEy1uAzd6CU3T$SbsIug3Ca?E9P|S1acdyd# zqc^8YUNP@VE0~)oeH9K9z9Q4EBL^~UB8B6|!4B*lxINZ-MWNslXbBr<`+0MZsI)9VNz3a#kTz zQxYjId6wij?}X3ngxk1775t76h8=)(lz%47Y-kh0szF6kJkJbgfx&lXj^Qi~PZ&_> zSf=uj&M4*z001BWNkl%#q&lUhJxL??k6$uYq zSSLScoM-qlFFPB;g!tAl2_NX~ylGc0xq|5xyD*;8LkdX1GX+&V)r|}Zf9W14#T{eb zV%}ZYRvT4S5gou-W}maulR)#6amiWE5YoB~odq^Ki{#mmW)?GI?$GYQ{L!JhG`;zE zvE(gb_?Llknjid4gN6j3>}c?9up?v#R@KH=mP{qk;SO2a%O)5}B1&MEUg0?y)d!b` zhM8hVST)`c+!20}pVAKesf7~KaQC)I7}A8gNDsL@MYx@@5i_Tj9wcSf%-9$^hC4|~ zgt25>Iv<2g9*%?W>Ir-1LE*VqAqV^{*Zn9bvM|Fq4L)dER!?M(E`(a@-HI%h5hpEzGoP=FLzbB;$`CKls}z0NzQIjY5H@%4VX6o{C*jLGml% zX(O`3wp^q99Ep~C?~=4~;oliF$AR2I7?jFj*e>S#C6F!DoO~mFw7;3$Kf>G zQ7_rWW*N4pnCc0Y#$U8AN%}0=Tw{&1GXk@U0OTg0kKtCIXSn}d2<5Q`N_WhyX$RhGVb??hKFibrM z@a*#pr)0oczWGX`%k>5M6AZ*)P{>zjPczAzbiPY31tb>1MFk;%OTzh)0Fpbg!61V- z9Xx(tzEAj%K)S{|g6C11o;y5C%x=X$m|~gtCpdSd?fj1=akI@$>t`cN{`zHzxi_Mg z<*-p_Fo)<|-QJBjqHI`F`tjuAMIFbD9$D3jx%C-1UFA*NYFeR<=Cle;?JslxPs(I z2$}lrx8L$7Qo?*@+s%I98GUv(8?h>PQ+6VV^`G@wJ_6n`l;4EhcXI)voNY%&{=|IM zQdt|0TmIu&2RsIFl2&gdw!{x!@4L$4PK<|*sZdgw1a^ofHusTKi4;@xF{-ITr>}64GNX}G6Er&!cXP3^y z-unoCN%BR`JDucKd`SZ*Ynft6#d)X0kSy_bf~><16<5LX9o$sAdP8Nxih3|ib7~XD zS$zY8k#wKcb1tD$pTWD?Nisc&tq$x6yPNEt0Pw~)%onU&n z16=w!xyyt3KL4eFR{;-JoRAoPeKmXGd9V=wZo6K#F%Oiy7Ayy`2iXav%!K5%rb_>E zm`}oCBYVy!%<~%uR8 z3qOaoSe5QhnUizrq1%yH-;`$}s@NTk$}$-W0Acy(&`k)f$tlEv4#A&{%e;JNG&6x1 zJdV$)2{?plOZ@zwI|+Q%c>au@BA1&xdvw`?rNkwYhvv)HFL`iQ2)#3apM|n1$q4M3 z!Rk^MT}rN`&TpL`Zbq`-ISl@Z7I|}vp(lhM+9qAPM_a;XPA>Nf2ZP@RHi<3``d0tX zmK?kytYO{Y0o$ccBe9ppBoEA6B8?)cr@Z~nU>8`#_1Y;QLvgA;P15BSG}`i zFSRlIk2Ws*^AD}gb$Q#|FXvg*j{nSNwL69!`7_TU_MNH7L*&#D&-A~O^fH!oH;*U! zF-TGO#srXpq{PO+UsMJAiXqx2c~s4ECh|)?5kQM}xh??}c&^KAwnK7`bt2wq>hoJT zcg)!ahoy0f{~DW~(3TG#hx<$RkLxF;#qjF~YguM7KdWYEY+@&dDWc*D(nlcA0VhKO z?Vk^k_>dNZA)ka3&L{k-3VBrIj5W(J7}$0pE|b`4R5)tmXVwj*z{!ROd3cJj?ykT{ zhv6#9hM8ERYU(hoxrUYciu@l_~AKVX6Mh~$FsFkOKsEX&dk)s$Zr z%E*DTswK(!oGwF_&dEccm-vITYB93vIv}g?Gtw#Ev1b#K_vd7PM>(-mD(mPEY2Xh= zeJeR2ms3;8684gFw;XffUZVX9@MZa|%OQI(msAG^rp_cEOhm>vjV}@$+Bf(1EG?gK zxZjrIZ>~5bm1W5pOffHyLt*$}U+I#?|D(8)u^c+1?R)^3sh1>oU?Hy*37k#{x%%)J zjD6^EFcSbFZ&>zJnaf0z6RHY73?WJO40rZ{=W>cf5t$S&c{a+k;rGAKIAolG2k>rc z>Nz95V_7c_OJXgoel>na9zWfS!7{}N)km(ThtKG}^IT-r&&PV|sY}E>w9JJ6{`bFm zOb-CIa}&vB!y!&o_RSP#BgDG_CzU!;{(Q=ve+^+CC%tcn0iK-!Y+i+|rj028hB;N9 zYDLX5j1vDIJ>r9@A%XPV9@`F#7)$c(jPfdbb}~FWs5|~;E~GlUmnlbpS2{zWX?J#! z7mRZn*nAECOmc~NNpLBwA?vb~ltf$|6`Vt{DR|<~gnKc`4BE@M9aDu^j@D>bP8R0}5DKLDwRcwYvE&;!SbNSV* zgi*+H6$;Fd?Sbckk<`1q2rK5`dELP(>K7UAinY98I4l^(#6GXWWoPb)Ib@%DzS?s~ z@YKLIyKKmez4YAt+;}JTq16dzxjEO)Zu|23s=DAm>zw_!hgfu0mKst;{G}f!hG`GI z3f^G4K~!WTI3a%BHDpIiY*GXU3A26+D=IKMKY(el3Y8K640-0sl0~6w%=1YW6eC#< zzhqW24l5F*+gq_UoK&;1V5$~V&8W;$)N+AIc<{52v%4hCzJa7Z|`PM3^29VokQtkYt zUhh4|`^r3)s%^>erzNA+%<=Bh`591kP9Ps31ui<7T>wD$X!- z+yJ8uV>Y=|f%KKT+%T1;hUQ^k#p!jK<->zfROjI&JmagAcfw~6XMZ9-uWaK>C7%Uc z)^Z6r=(${-0Q>>e>t0*poQT6q(%ljqc>ZtdpWA`#99I9ZZ)=bFbQ6{H2wU1Rcho{K+h6swgAAJDmO-^_$bBAP$V!oqiy4VnvJT;_%nrB!=1cd zdSWr^d_jm&mEIXT)`@npQAiYq|5tPDlg#E7a@V-a@(cQ3lI@F;!eh8&%Q79i1o*RJ z0mya#9lsbJ3|a17Y~4#cnEmXW%XT^H9eXCav*IqT7#PCC>aY`n;n9cLsuu5xL_xyu z(J#Z3-FJAHQAMKZVG1KjNu6!xdkLhCVs53b-or&{>M)^2(}M zgi#2;l5gZQ`{6VCxv2bYcP^CZMm_py2mRttBE-WP0FcM@`Kb;(Hx1ap$5Y+3&a4pG z3EUZTMZ*SzTS58R+4&{<$*|02krQw@3E{7BhRDOnmBgARSCOO;YRpA!jHjmBo1P#4 z`LF)vNU{_^jSVxiF(|h3+V2qi>pcdT6Zz2(u^1$s9;R%hKzpVg8EkKiAd{%lS$R!O z{^@b}au&cOpPtFUu3JvUd6VbBz*MNX2k?8jX|iXrsTa?|0PGUbkfim%!ka40Yz)|} zHW;RAOB}S#DH1WoZ7`?6l!5+~iJsYk3iM8ZWMbkm8yKQ6n0nK2y4dH2upG`yh;LEY zyrvH4in9iTlftu;KN!{`t+qBY!h>Phv?&UPiFwJByps(*nW8O_12}jxHIamT(73q? zXQibfm6qljdO;x!rW!@}lEqtM=8dOvL5M*hQqjQFuWYb~cOw5;YQu@)6@>7nq%({HP3ye&hsv`Sc24x>Y{{6{uT>S8)XNj(Ko>au=J6YcqrluW zc3Jod@qvd}j05;*PM!5+buKY=lvwfI;vNb-7rVeUDODpbYsdwtj6foau z%bD#ZwJZk$mN!gbfSm#{-anUB7)+C`AvSHCSti2_KX_b=OHQJ^rc7!_Lw%O0Vj1T4 zGvPrGQ_g}D4Za3R6c~Za)q$$|21yJ^z@H7+5=h5hqXK`8#onf{NgEK|QTnm>F+n!?1Fhv8_tcOrI0(y8KMNU3<< zG3I*s%BV;G)$#jz552)<)f z6$n@wyNt^{a3{MPGV!5}LQ*5FV(p()k3B39#xfD|NVJ48TgD7GARXX`ZN9i)%3{u+ zV0*8!lM#F_`6YQQO*oT+L{QliWNCnh5DdrSEd1rgOCW}65ffTZfxk2yg^l6xI{2PC z+t!IqhnzwELM^_bqaBTJHcP=f2L&Ck`GJy1sXKZ$MkN6%a4uc{e?!uG{};vnX3Sk z;cxMrRn01>?i~11EqC4yijeG%J?uL0F?MxTmS1g16=z|0s&n6#Z1tUGVmPfB6Z1=X z9xQz|yoPU9ca!bB5cN^t%X-OgFtres-&mcCJEOqFuq2B&bJA6yHQd?5;Ol9x{WtAO z$1n!3lyH;QFp7oTv$g}clM7D5A)m_xW@ng<><}KJc2m5h=p<>hZ9K?1?aV+vQUB)to37KAViN$OfD?vc!`% zfq_K^v8=mgyDj#YZIZh5nSu(VNHToT zqN3dTIh8nRj?OU%&f+NB zWaorV5_@7>m}kv=Y0pNP_D=W`<0cp2FlFRT80~cjh{Z7T$8CDZF1?u|_(Q{8)R_|v zJJ`%(@|rESnoSCab6L&owFC?+oIvNY4dBw)F<%D$3IN34ti4w1CzMbM876gx7GHp+ z!t4rOO;z|iY!xzx2NElvf$>btfe;d^o8e&o7UPcirLY8M2j(+I9?<{!=bwN5_1Cv= z-+ur7cfLAJ2J*&W7$g@3!^!Z#Q?$H&cu`8pgDhb)=S`BxyK|^7$pd)5mb3EN&jWsn zsVWMC| zP8)-vkPIVr?%N{tms5Y-BG3o73@ecE7!yXNF(yBROcf_XdIcv_ zWn{=}G2`DE)%GQ9R%+O;X{DSHv)Kl4#|Zi3@Jdlqi<~UL;_+``79qnR^M7B<(;=o_ zGQ6yCvUYgjoF1n541mYvbpY2uD8JUg{JqBWXY_s;lz-~T)7x1R3(VB?WQxyu{y(Ym zp>P)kEk?xfmt^8cGq5aYUgNY4Y#ILJ$B#e$_yfVEEx%KoorL}E+c&zzFCBmX{yiHd zRCPfED=~Ao@ptW0=JJ(49YvYG*>Tbe-VCgbzb#mJZ*drqJ;8_4i2Cif-}31{olH?s z#bB5yG(+;hNLyyRYLzE5`yo@MZHbRF%=Cmmg;ZTNY*{`TgJg&?HCz@oL#Bs~T~qlV z6fSPYmZ17mNHf~*BRj1O6RHAT!}SR868-(p0XXP zT^5iS;JKV_SlG0yEyZc(vK@$>o`(b~jG2Au;m>n<)~jj%!FFC02A^R%?5WrebY9zD zO8Yq%7)ymSX$VP;LOjj_ComrP@HZz21RM;hLulG+2#;2LOXM&@0(oL{8Tv}Bx`Icx zvqNR068U5WMimwb!)!wEp=FICIAFgXcrt~&yzMevRt?)r28)8>k|~F$f8V}+iws|z zmC`V5;XY?-H z7s}1trQ81~AT{%Boz^ELmG4?igCc|W#h|B^9oSiXN)D#J))I)wcrpac?hjQ;K*gJUoEf1+px_wCG zdb8-sn^)F)p6E)HRYvn6HYBfab*M;+ z=e`l0`4;x$#}9tHh>Sa`2T5m7%0to^m7>5qVYM3%uuPGZba=`Du;bkM;i)^8!-5fH zCGzm*=b0#}uUb=Hm~VD$hA%x7i|j1ia`^y5MO1p_A(%VHWKINDH66ru1pb5S7Y!?@Z0^6K%(Cqzo$pe_Zf#>FXVFG74xqQMlXP5fvQlhK`c{iz+{I5FEb2E@#ig5@$6mlng zGSjXdbFEbEjp{ih7?rWuyz?is_tK8A_`h!Gy|i26_%EgIR%%Im$(E86Yli8epVWfK zMhGi!*s?}sDGbdAfag~*&Z=r>-Vq!^KD-ig`3Wk>gnKRKml-(!%Z%O5ac5leOGn0m zws$1P+_BFa=?;T2_t~s}M&UX4)~T`0jME0>cG?c$5|)r%I>IrW;-6*jYRu~JNcZ3W z{x`qiRts0dm&%_FoSwS#cY?{gV?gJb!Qr;y|2l(@7F_ZcfPQ}?AS9~Jr3GW2swL?H zn6Qu^QlJ*2NDi^3#KVfZl;K$HBFUyIc?EVin7TCTjdF>cA+ z%x8lvf#rQ?eq=q9Je!Twyq1g*y0-z$>Xw0b^sr3ix)XIDvlKSjSrEOm&&X3j(ryG((zjCyt*5{vgcsiiJAo&)nY0Q1U6qsso$@ZmH1{PuSW`~Lm= z{m1mI0aejrew#jQ_*p6d%QnrjlftjQH4rcZ%YzccyWae0At4|!$hdqz2y80BlRZJK zy#N3p07*naR4D3=pUvuRgl6w2oJB~W{RZQAE*E8R>_{arg`*t&JBE9hMD=QgrQ|X% zyNf^!nqYq0Am{zH%xioA*;>33HIbxnH^46qOPzq_hMBOX5@7ZJu>p+XyA>x#JMZhk zcozPp0cQ%N%-V`B(6;XxGZ>S+Aq)na>kSDo7-D$e&R?4<@N)Sk=B8&>hsXMFvQ>c|p4p7t z?%tLkDZA>`U! z9fV`RPzF>nF7XLRMwL)Qa`CY?9)1@_*d3TOIGZL(9L_Oy^Hm zOC@2bqUb|PtJx(_Ibp!aT62!@$6#CL0h3P_Q+_*P=b%44C3RUosW~hq-a{UEO&NYn z?~q^0rr}eSHxF%`uz1|G9VUJshb$S1CW-SJmTtS}=cHarc0z@~A3tKej%;{li{$Hu z?wjp%#siXiXDv)E$&F_rmdK^E!a26_^OKmw=7dh3v%-o0I?tiQNg9BwUW(aO6hGlH zYUu4q-o)RwqR>e!FlevgZ=l6SvkkQf}^ z>^d*&Wg!OJCeT@&2tXNCmuHK=hDK6IIX^O_B8(+%3duKHBhRuY6|ph+4f^n8$f?gR zeQB@4PwJ)Tur36~aJX%+el?+nMizMu@2jf7o5Ni{<4<*bj-74CQ+=4(LC&doU^pXz z#b7vFT0O5}k{;T-li`fJT6X@Wh9x-2`}ieEIS<8x1T$0P!653=c-+i8AD$tvU)tl+ zxRh6b6qtpEyfC}r#N&za&i-L_lAU3tur{Yd0C-oLDC5n8y#vJWS3>65WGW?irM$cN z+@8mm`JaB}o6f9-q9A|Oh!}p|%HeO4d!^E%9ija+GfqhG*Xfw6=@M**!Jd!Xq;N&a z5|0=9{CNf{!pp-3i=SDH61Es&!wKw5jij@Hxl@ht&OmBy^qYd+J*aRd z5lzGI-Yye?T+YTxIxtDZq9;pH)o@1z=iC^c`g`qJ3yV0LgVY(t)WImiXCw#y%c&Bu z!}|`Mm|RTL?^UKW4C9wh19rBzB^cD2mP!+nJ2Zey8DQnmPG>@LKsb-S2jI676UGh? z7k!+3^_uv9ipN#6C>GDjveWh@pe{ql+NPPTH9NH&^b%}!HAQgUM;m=z+zayEU^Fj*=p0iQ-8lGeQRvTo6 z&!IJ^CxyApxC5L!{AQNO4oPem5=nS!`F4Wmhueuf7ghatjkZmTpNf!e*w3`9#zXhK zVg44`)xG;&O5j;Dan>cGQAv|$DYrfOj_U1pVxb@t$$r8h_%kvUI6-zD_ z1%s&vMph*CqO(*jX)Ak%Vf*pp2Y>o(R`Gssr`n~$2hL(`6(T zAqDt~p;zDhmud};z0)5*vo*{CLm|Fkj@UH(kmX zqWph)e*F0H=bwN6{`>DPZ*|Ye(1Gy(> z{GmFN0Gk&9Q(tW?^^mj_Ooq|7uT($*`PD4d)tX$P#}@G$WO4ymlEkevQ!-?+GIx2bZ$3D|ZRP{W0bC=FfhD1F!W~ECiWKVhFKf@?tm|A?jGj&H&z|{~q^MJnoxf0E(p1hPd+6X}go&ZYN ztOz{D5@Q}Vb0LkXsl)J)mydIYa9_gyAWeu>Rl`|`7-uCRyn`Y2(m+E|)sWh)AHsl_ zQ(z88<+{Uj$e3`Spi1p@cXCzuv*8q6oj(XZXLLCraV`tYEEu9Nh^kNB@uM94!61uc z%XtX*p_rQxB@mveE@$T|L^cgUL#1|gU`U5N45n;23;tSykSF_r4JxijJTT|7;@?!+ zZ~KtNFxzRPdlJtBD%08~1x99FCcjlp(}J;#o$Xw6L6@^^3BL;%>0I_duw5qM;a^UH zv4Nia-D6Lc9VB>HT2mF6@6PpaaVjJ$Sb^0;Qcu{@bHLB{Wq!}Hge{rxI3GTvN7+1+ z?)XjtCxPPecn7l>IUY%R_`5>8bdUYWn+)t-S`p>=6LO~;CU-_t*&lpn!#`)unGJf0 zA;d`AWCV#}sW|Ik*#9frRZFd)8}h6`-sff$D)j_>+*9Q&`ETwqPA*k&G~!{HEHgEM zOBqXNNKCaO!Jl$GoXpJLnM(GASjmjN^yC`kM~va*^{{g;ng14m-!Bg><%nUhm+tg4 zm_p8UY~%Sk6)?tSyDFWBlLUon2#@It>GJ8orIPyqFGr&AVBBXrAgPO0n>if5dYp{iqzCh}RvccQGJgk_4?cNYCwEPcaRR!RvNOV~~4IoC~+_hGc1q9Uw1 z=_L!Y00$*7JB0hePMD*CK#W5cPl5Lbp4sr}*^$^k?K4mCcQBLreGdxIbnYzDl6KOpV{yN4K{Bdp7&t1lXEoJbj+fQ{~ zU1$W9ks;2d0GtJj_^kDvLg2Y$a9-F;7=%~S(o^`%`eKBqj0()`oxtLmLo3WI9~!x@ z_$O8luSz|2X~XP2^A2HUWTmD*on(*sezO4EMe@=Ro)|719x!+w81NHIrSa5B0X7Zm ziEU5tbeJiSJk&J?SXAXvvr`iuXI(5tVpoCq%Lp^SKkeB(#bSGBh{F8s_x#1D@87@w z@y8$Uf02Ld8U43!-_p1o(e#K?R;!|;n}iO zM6r01Xd+({09y=h2X=7SJbSqn;Jl+`_ONpKqV%&@0^?+OC+V+%NtwG|9m*l(@?CIA zLU@|6#60WInTk(N&&Y}5Z*SpYSJW-G({t`Tv@t@GS59cAs*@EsFZu%9AI?Oa(~vNn z$eE>%b^!bYlzZm0$9&58xTk8bq0@0^?ska5WmgEztaNM}AJSk7S^OS47d8g(Ul5Ws zB+ zMay(9a|xKv**B-)7hd>G<-5ArSdZ02+hZnbe8(~o)2er zwV0ER>=+M{5<81x%Gpa8eFludls`d1RXmQ`VNCebY{bypoWv5GA>a&+Sqi@S_BUaZ z*&b~4ID2*8Q?J@2!dPZ3TEKOpE0&@0P%(?=v2jUd0dIDXT;@c1oJ>&%^h(m>p3@K+P27JEoo+}NQ)Kh%I4}ckxJBRGV z=9fHv`|Y>ifB&5?c%o%Ir*51A2vMi8}zvp(o&LQBxwzoO6bON7H6me zW@A_EopcZ$jPQrtH9p`c1f%le=lvakzYzn=BX9p1db+_e;m-;|<)eht21{(GZ40nJ zM}WsNJWa|yW}W}~*T3=?pAJ;Tyc<4wMxVX=+i$=589j${mkB=&@`lK)r}96><^M^` z9!i^Fn?{!Z{nkuoMA}F{@-buWLD}$31_6H z7IyG1-8`r}=_#C4Gf;z@3)bsOCibS zbAFJ`?oAf5qkn0zMXhbxJ2pyNl9zMR=7SC&cMAWH8&-k4rai7JguJax9^M*iS^25> zrKA9W!NbLS$X=LyD2d3I_Q|a4j)yl9j5|>;VGhjIF@HC!T`@m$8L-q7KzfMnZYQdE z7)IL^kAIo;=Q|O6PMtlu1lyTtM6ih3|C4L6w&wWItXhH?&=&rT(yyXO*YzmxY_Gj|!I*__tDi<3r-w!JOo04;zLQ)P4^9;Ow%W-qkY~jiPlEgU3_}yc0$EV}mz$T8i-!XQKR? zr?{}Wz%b{#FweMyq;|iN`Qrhxb^OO~xo0cX$q%Oi{>GzRU|D#(h=05Holy+P|~I$$Kd8syn>>XFWHSK(fOF zAoY1`0ei`y4=+Vcu+`cIx!e`Z{siMq0ThLCU-NE>mkjykKYuJVEZNb3Va)rsPj^!A zndey>OQ-qYS34OhT{W{x$dC{WXbT_z(n*L7Bl8=XDL;w$9nB2sjHAqUuziWK<-#+I zDxL@Fih-eJ_=CZv1{ktllwg1CqOy3~Gw^|DN61RS$qM4RW4IP_P4ZCXD`ACX%Iz|M zU*|Gs{+Gq1LuUozzcdoa()*!&$xBky`ceL6mIL6)Gy3dKuD0Ei`e+S|3hPe6k5Pb< zPW|QgurRC*hQT}AtM1?BhkR+c3NvT%*f*twPUcbzGyLH(v%`VqGZ`tIy=;rw;giC% z5fFv-gJ{F1HhW5m*P22mCY}j!-d&XaVL0oVS;A0JJD4wSr}owCrQBhvGp_Vb6}5W_ z-^H>6$y@aW?@qyn6Z42YdO z9g&rYA&IFvt*X*sHli#DebvwqX+VMW+BhA z6zx>SPJ6~b38#k|@1#KRK4vD=);@qVx9`N?pCE%&0J?}1H*$EMYq+L>?f(*QK$c)TO&c3e3^OMXfO+m04hf%{iYHW+h2hjQ!|!+?%v$&~ zB}D-E!+F@@cZ9JtfZ?~Eo&GcCJiFuc!qJKym=x&WA*Y{MPaXPs=Zutin2|?&nYwB0 z)ZPrAuu`(*Pn5+^9(xWXhGByz1ydg};6JR3F_qL8!V-qF{uFB7EO>Af7+}QMQ>ot{ zhMfJJ4zuW$`ey(6plf+IV-s=-MsRg$7g&W@7zcJ@@Dwct`fn}3nU4qjBxc5rT7T;bF~Pfa1R|adnOr$v)acbj zSgG>qAkh4=y-%W$+VjtXa>-I@X89LGGzXpJVk(~S@OSazM319lQzLyV4E4GMFjLRJ z|NU?NxgRhDcu|-o1#DAH0?kuv7q$R+t#585s-~gDd1I5&oWZlTJOu-@Nt$1#^It`S zge^oaJ~E=g)ghie1I%xV7C_-f#>rGt@JoLdld0uvRv}ZNB1MiHS2}MW&KPhoe9lPu z5pcNHrXDlTS$@|b@7NTWsI-f3P|U(ZKl69(5D9>FjEB|95N+vL3a2L~p@H0Zo}D&S zb831fxIUb)yC^4xhbmRnJxODOVH3_Cnq+F*d5R|`(9c8EY%k?wmBu!?>D{wia!>uA}_lg_3>l|yU?aIQM|TG^%S zVh)Dd^NyTcDQDshPPqF#@s+}=>O^=7dq)U>JsIT0yVZ%J1e09aVdh`(7cIlT{`xE5 zYl@H+3=*{%#`6)^|7S>21X+Klo^W>{AxupJRddQ7bEe@XrXEcg!vdKwyLwrBX%5C) z1MGV$ZsAM)Ile_uqei>DRPpUZc}TZ29zLVb0xw(7+Gl}TJohnbEZsI*mrnSBoedTM14%ikB`m`or%w*@ zb|C<6vSp{Tz`LmFr=q2Syma7FRoZfZ9j2zXc(_s-W*wsqLJTzfGG(^1u(FP-ed2|y zq+#2US1!YBqXD)OgC7GKh4hd^1ek^xRwC1FzQa3~?DXHAVKxk8511>v(s{#V_rjSL zxlsWlX<0=Q`Tk`!t$|I&k#Tl3R0^W#iL|Ayu_k>S!SqQQBt5GQI4&JBN5#Qz>A3BDr62TDx8F;UMia5@l4IMcNbEAWVkwu znJL^NkmzAuq9pGEMP3>hUcv&HuydoBjkdg|)m2?K16gJwq|PQV6{7$(TSGP>{+GgQ z(Mz_6u}#hfm?S$GA|Dv$tc*2vlibx2GO3oZC4ROD7zZEBnU=u7h=K>et43DM+h&#= z&iJ`llKL!rQhAf?q&mv>4*!lH{Z$tw`!jKo9kW*m5 zwR0GvnH_O&XKMzWOZ5N7`3!;RxJKE4fe#FJg)Q9vI-kr1oV803+<+fgydH-3x%c{$aIg$+Z-=YX$GwP^ILsp^e!x4zx^RRP1s{ znRB*yqLX&jEXv)D!psyedE6+s>(wk#n8GQ4uFFf>Xv?{LV7Wj_IX!f0)Z#RWo!B<2 z%uFROwHyEQ?L*ZTL)93who15k9iC+(!)QqQ1HOj%kvBa|d869-j-9>A=HXlvr~PaL z*INy&?iI4g9}KOB)cipD0ikbTy77$X{V4AN+jp4hJVv6HJgM~6dMA}Vw(kgj6NC8F z%ei}#mZrgfhtNIW_2DJLO6ux30!29Uf;1a2jN+jKj{19Tr2b49yqll1XX*V~m);DY zo^xFjKRsuLIXfA=$0q*L<0Ehhz5|#F6ZP>#9238fEDyz$T_S4;zIsbW03SClyHo|% zFoonN3N^*sZte3qe5t5Q!Dg#Ir@hfR)jIHw$Re-s46}kP>r5Jw>0h$FZm2v1Z`K5^Z)=L07*naRD_>@ zTNVI>8201Ds9bclPRFctspry3UJN(Z&P%EtAS5>hPuQ*lwVDj4W^-as*whc0DT}ca zd(uu4z%eGk9@`c8Y`A<|p?j>p4cp5OOeKeF4ThUn&8|z8;@l|KC9n*!W8_mr@svo! z&yw*#%b7JNHj)VZ2?p7di_P#8Qj;PYN=fZ84--h|m*FgvXUha}kvr&5ed zl8U8RYKQ8xhVw>bJofK0-oezjZ?|;0_fojacNW`(hm)s0**R`_A$R56_glt{s*jWb zus<0RXsO&7%=%_dX~|wu#!vfF@UG#L>e6%0bs5gVXVog?eSQgVGHHv)lvOR)2dq~RD`yC%VAzo3c<{S*bOJQ>ngSX%N#}@+3F}y2cqpFZ|m~{TxsW%T|D!YYE&ad#y z9!}3WZ)!m~O-sF0x+9^b^@;g>1HhIYJNIp>sO%YfA;N=(<@M!R@^bt=OA`#cX_r(- zIfeaYFBcA43`fzBI16J!G!({cH*GW6c6j`Lty%Qg&!Uv`)gkMM5r&-}!=^CTIA_rY z2^b78p#qr?Ipzmx49<6q5SkVbv{NvisXS2-f`knNj6K*f;D-kzyCSDPPC8~xc<@Yv zL`+@YQ9eN>m?3u;AK96j{84WG6z(W@%(gM_*a*NNi<@(q!r`;n}rm=)UIPqr>s=^R* zoZh#Y@@p|$1F#rI;^A`e?9a3jNm8`o`8mc*dF#YYg*4W**j^@LrxQGE-V6jzgTOqF z3E)!mUREFY>{VJ;Y$p;=4=$+A^FrU;>#mjldn>wm%>}{Vujl`-NO>^ORy_Qy<8W0OeBU-99ptQf_CDtU znG_`A5@+iGhz2iqJdQ=DGcKJ05Sw&F+0Q-BI>rO|O`}rtlPEO6fA-Ly;Ju4Der`pa zlaq8YE&+vqJVfMVIBQ5zXH0R@2V(KC-0|2SlI0N~I|do?V2~mh648Npl8Cz!!km#Q z3_ucPU(Fw%0`ogimret0zoVS(0U?dTgW*I4W2*dh z3)Mmsl@wHM65A;GtYI0fkqy#;^r4`}`W9{Fut7x>9Vja_n9AI!hRmy;EY7{c)zUrt(N zzir3fwBhuAo}6#C&V;t>KJm^+KP|#DjW^{@!n4PcoVrRolN@Hve}L5#N)jG1IiXBB z#A^8mHvt46K<=5m!cz*FHUH1Fky=ShXU%?O=r-OVoW0@Vm+vw=k`MY_9sduow4xgF!KAL8EHwQ6MCgZ{ z_RhB+Z4~#nJbiBkrV0H+! z7kDa48y7+&JG^Kfe&o|V9=T;zdhLoye5!7#HgXeAL#sw zkSM$q7C^yV`&pZhjH7ZG=~cDMYf5@*R7l_a@y-Q?pIA@vubpav9DGtV)~d zf{el{&?J{OJLD3%1R%h@vQ5-GA|d&d;nP%{e5{#%dr}USdQTd5wh0Hua-7?Req=y} z;VlGz-4*zk=|Y7hAJ5w7%W%kFH7F{97I3CQ2K}KMMFP@F7x9YTmcZCp3Rgh1c`sG~ z%B{NPUT!=4$#!RHg1=0ViGtPm1sn|OLd>964`b-!u2rr}Lol>r#a?()dZJL$O_mVnhxaH+rG%e5BO?w?v zxMG$zDJM?Jnjz5hDwkP{rq9K_D_;&q%g$r^PoF-$y}iljErmr=0vrZ98NeI=m6j?caNckhi%!Qv;Y^9@p$- zo+0R~y0_zq)XY^@aH_yT8N+h zPkJT}T78aUBPCS1xw@H zauY}45dE$xLzI{Lj97VTQ@-yqwEh{TszjiymBzSNWABI=OTe9_O_By#qSU{yJV{nu zi=!|JBuL8B63w)s!szEL^+{sNzI&gsTs1d)3TZEzLe4%WbG7oCwFAjyO&^}gzueP{ zDU6GM4GUxrC7@&Of@wcB?q#NSDeUwUFfGk`nXHy6n8~75+2KVJaJPKTGCa>NU3N;pEo4%LP)OR= zVG7urwO$C?@0eWC13saQHK&%al3dPSS5~;Z*j)#?*OE3fw7K7lbFi;Y*0T0B9AuKh zd$CGPY4F6A;l;h+TXnw+I~VIBRMPkj<*cyG=VSW0W$Yh+j)p8OHOTq=QUu`JH! z8-6*@^-cSdcO)^p3#yQJ!^1M|T<+2*=PI=&@~*|^Oja`-I6RBViU~Mf)L`SQF8)`j zSn{Vi$p=05GbrbSulA3DvNt623j}*r0<{VkIe3}z(#x9!F2KIlI|spiaOMRgYlv*o zq^f&H_m@3cBO5FMSvY@)E%7so_zDJsgYCf(9D5*VMc4^eMxMDeJFl}oq0G_hS?Vm2 zJ1b{13iS~=rt}L7eeESpJq8LtfgbNLg;Rj*h~H)PDa<> zV>VO3qf1ZYbF8GAgpCM}Q{pRJ#5WL&QuLO& z6teB)a?3$M+U1+WGG?k0EPC3MFT+yS7u@i*j1Ebse3|_jue(55Rf@2)d`DIUwa6BK z9$z*_70@!KAYciAEb~H{MJPG5_NFeC%2to)OTtSIA|Sxl6qftNEl|EWyb{ZZ32063 zMabyS%UQ;xm&mqhjH<6YP2nmk6 zA?`&xXYm*;Z!IUud$}F#>vXcU4lZ|1`K34OV<#j|HIK#!k5w=6m6!SQaN~LuzsHTE z;Q!PD>059FAJdZ>)#H(fd(cPcUNREOj(W0Ig!VsPt~`d`9oncE7k<;Vne! zJ^S*3kSJhv{Cq=TypNmLV)fDv=LU)A$!_a&a^C%sOY^U4}*$DhX6Lrw|-sR-34N8QM|V zw=OPsMdBD`((~M4N(9o$XEDZ=PvNWo*+Rw5q^^XfVq9#jo?YZ0MdqS-&M5eZ--s4j zM+I$C@P@`)Sc{)#W+zoRpR7BhP?ZH$hxc3;h=qi014L^N)>)XmA9y-VY7Gp1LTNWFZRWmvNgQ&^&< z!2=n|A@@Qq(7EgxT`v=y7s|BX$yJb@*;#)Ek?Inp8ZT|mOHegT$D8s^!q*pK8SADy zHGu}Nq(e2-EWww`tVSA~Gfhh`ZK=GONE$0oGO6($iI$j}x%z3JS(N)Mbwb@d8`C}aLPc@NfsYsV%U03;qL4JKz(wERt=U{P zHX0Rk){7B|*u7QQ-6pk9tfBb7tTK6$%$6(WCMZ3bTLGsgT24J96SRsffui(Gpqsu{ z&tzdGw^^~9m{$z!Km%RzdcekFX8#{>v_II~H3gubD^q8`4|f-o|Ci_gnPZCdXOH=q zp8oW?w8f+XKDz*6*-O_S(^u!`(!9OBQG6fQbMWe_#JB4Kh zCV4Ax2o3lybm=RE_{s1PE2mPn$ceL4md#_sC39E#I%eWjt(FPe9yddHolAk5R3M;| zNhPwg-*G7BJF~NX22EJbRz6AEowM3gG>6N$Gu$+zLf&>CK zd9Uf+h6}2&Tm6iCao5NV8dg}SGN_JXmb@}M&BRI0Sni%QWkfMOaNIbUC4R0&$yvIZ zl9+K#Dq~4t#&xA8@=h~B=6cm-G&7aV4j(-(>1b+a$2q$sJk6Gx40>LOrTbI@Xpc>U zn$lj&tcl7eg(^{HYDCGPaX1^m_A6pSrCyw(kv3VDB}nyEVHU$BLWR3I6vSBNq5*n` z(_Zoj802dq=g@N|S1si`qMq|= znJJ+ymq%_QFCFRFIdzfq(lLW(O;XmTRzdxBAzQ1`sVpQgX=k|eY+739Y##ZPWe&-D z<~~DDP2wbh^Wo#2&kPEn#qkun85&26e9>P1OM8^Q9&D1Zm`@57E|=0YE9+%MaFSs{ ziD0P{#6VL>v!!g^ma{06RrXBD2ZWnbRmQWuY3|IfBsI%hX%@J%MRnqofjFs8wA^2n z8ZH_O^{|k!@+dGwk~~C7GdRl}C{GVSu-8k$5W3spQqtz#g-OGjNMmWUV9Y}v z2H>H9Mmz_St@b7|9jA@PO9A_dgRzNdKr7~3UDLOowk{ym?b1jPl?XOG!(~#RK7IQ9 z`SaV`TNxMB#o^=6=sDsK$rJg9;|7n}F%Aqe=v8LWso74q}K?(CV%xS0X3e2th85C#u^~-Do>2{MQ|&rxAT|o8PRYmQzM|WXr>;6@?9?X^ewXl zG44UAWOGMQH*Z(81TEM7N>G_A=w%9OlE#6&Q!b(!gakx0FC5cm>1!8ZpVc6vtZ;CnO9A*a1~u-jSX5F@kPMEp+Y*UG(iuj z$p?*=2o4kWifn4R`o-B0R{+m8_J$iImy$YI4WVX#N?V(|gbI;pH6?8FOy#*aBAWs@ zsW+m>h~1TD24z++krlAiHyu-6+M{Hdcr{S^x_mdI=#_<9V)|E@S?bx?OJAcX9L$_j z&=KE}A8*vd58i7GE5;0G%wFvuJpq@2rOa$(pht zHn5feiXi?JB=3GtjX0@P2H*a?5^fT>qDf?)jw17)Kh zI*R9svT}WkuW1q>2kS-`? zqD^vO)+v+XMjgwv&!eg20?D|EfK1(Fn6#%Xa^hqG^N)r3-?zA67My_EF1n zY6|Wt40KHUn#x2b$(j|=x7fIN4`6EU1zlK8?>aITThiq=o!SDpRE~w?5D<;aSDq}f zBy}fr>Sr@lagw%EiICvPR>`3@ZU^HQep*i11oa}8d=Qv5mRakiy&-f_lgs2Piz$Cr z+27zz_nj;a1uPv(PXPmlrF6;^s{T6~yP#=LERdzAK{0V?m9+f)`SY?TDXdIHu+v1y zq|!@YEfIv0wgOYTqzcD2;A>%e$pOs_mpC;`ebT_o_x#!xW|DVkJ^e(y0G}CJZNGVG z;!9W(G|gN->ZXRH(l_tuD?4kBusdCsOaPRL0u@duFH+*TF7VL+FNfMANM4}~k^^lc z)XoJ2o|Bl7cbeUUbJJ2^psHfx zD_CbV9ybn`$DiRe+X=H23CsT~ivDd!?4M5?1M=E7+68yjrVfCBvBj+RjG3f_(B424+raU*U?IvuO`b zYEmv2rhH8fT3!*Bj==7w42nRMO7MVih1Il4GRWSdxS%^PI|qZLJzY{`QVKb{lg}HI z=1&f!vkQ@y6;YQg4mML$zH@kRG0^lfT)JcLYuyjzMOoxSng%T!A{w`5)2pKBqK#QB zL9%~RPOlwig>Yyf9Y1~gDv`jDMLp9IP{uQlRhb1#liUdY@Fd0=Kn(%UI@Jdi2c zVj`GtA`lJ@?!2Z=x~F~Oo1js0b|;sy{IxFw_gV@X-xMak_p4T*Ky*QX&vK2@anfcs z!!2zLmuP1h=5xKKhPD)KNq|{tnDr7(D1~f~9lnG$uzAEu8j`6kpgVdQ7CvSuO~?Mx zxI$kX8uX&QW`04|q@;w+5;;@OvIwg$v$-5;llsER5~a&ozPTgvV~OSSRq(45awtL; zK~_5guCKz70E&``(wGamU}FrkS8GT5O%XW+86cNm+3NTak|%H)zlpBYCA1wwNsPw^hHzrp(=qZ2;x{|-FHE+>vMIk zAAjj}J=V0Gi4^j6N)!CI($snK42^`!R#8@PYh+2&-93_Bgga+-Iwt1?!QN|Cnq83- zYH5GdVCnT!m1jy>|0ih>$Q3CxYF@j;=nAfK{f#+`d-0-tW&$z0B||4?sA?vGw4rIW zsi|}2%h>);VcHxtyF{kT70V)@!;9PJuvntOL_Q#kuNf)KI_qwC`DZ}7;AMzejk=;O z4N#sz4vxF2n}E|`YIfj1Phac8@MjYPfA+w=X-@J7giLCNo|=NP_t*>G44~&vbye24 z%pN`mio4IRa%p}owyiOoU#X2aD|&Y@i7_|ogvBcZC0P}L%=#L9d9Z#>r5^6 z$>Ap8&ofARGs+~a&2AxfdL8c-t}rYchLFF`=b~lxMh)-H?n(O{=biq^aJ%h!=o4KI z_oxrBI!7d^HVQLPE?>&iGJC9K-$_lcoJtzCKyDk%sP1Q zL7Mkwl(0WZF19m@3xwd%$Mn8ws_a0f!+lEy{;Zp@R4j*+(vzA8pV5r*s41uvODbx{Qt;H0_T-20t>fcv}jL%=H6cx)7DR{P8hjMwBp{tg{ zM7H=$S!e#j$emM;n5EL?o>OV|F0vt#?HQROm@I4I@a#KhmyZ4-0pPhAbHyhb8kcEj z@RRiNtSf=6jGGOt5`l#{7?l058QLcghcho$+;taOfe_0>X&Jqsz`=c9dqBuoDKGKQ z%Cr0XuHzvVJ%2IW0cY0doc>`pDY@u`&Q~}mrIft{b0+vU_47ae5&fKX9lT!3^-^Hl zRz`W4_&}#@t`9xi&n`*nuo1FQXTWD>CF4c|t%kf3!K?rPAOJ~3K~&d6ukc(Y5wi7Un0wWk;hK@J|jcMqj+-5e2ahw?~cGk({eYJ;ZoLd zDR@O#&fcYj*rZ49uAl~JY#U=~;KhZ#p#FMxVjhGgnz0lP2)R|4X3G#u%U`CPWv?qc zOjtX+_hL27g2eTz%_0X4bWFkMRp(_@xnNaSi=XLu;bS(Bi;R9nmWlbQ(VZw7sQ+bx zMc{&xRfU7anUwU^#zYjR*E5<~K+&ACf0(knw0sxA+(nasnrY+I&k%muD%6f6mr6f# zM^4QWA!|}-IhFEFv+U=5Ur=POyy-BOn1HCyTQb+eK(=MtXD(S2y~@C0f+US}OdB1& zdYXk(#UDK&o{EqZBui?7Ixa(GxZhA-7DqnG982%bOqpv+R>lhCnUkwyWjt)vWRx>E zN!}$q_>7+Q_P?+F{P}Z6HF=VpsitwsSzUDRMO&89||2L#ZpFkNvd4pVZ-=LN`<1K{fIghLdKQ!r>M&$1y5 zdbVd)uQayh6ms^aoE6>~n_zZG7Cb>7qp=HpUGEhlNqUBYV*f24nQ!9H*$R|dGo|~o2uo#QIuuHcv{O^^(yMG7PUF&00bV&ekU6E(xXvY}ZWd4` z7lq_=(M7XltFnZfgs*@U=DQ55b0*Ju%VAum9Hx*s83H*qwY~|0eAB=;zuuqBezv>{ zGE97DCykv(oZPcZ9F+OG!+b}5F=3cgDO#CHfZ~{=6?W+rba`ILa7#1|vXNNyMn88#_f|F%0NeKm`!^Prr^ptwbSrE-R~%9@19lTy?P#f<ihl5jS!stiMC3+gu< z7SA&i`O`n9%$J@m+VX8zww5@CQ-hEw@dTk9Z#StJ>iDcm$jQmA1=jV>qR-^UZh8iG!m( zKZA<=dlTfmBsOzgnq5)8OHBmH-EDMoSx#wF0xsSweE%o;QNv>cN^w9J}%Q<%sDkR8dobGvMx($(6RL` zId5(Wt#RS2SC~{qSlXD#?4pFyH_y*BNI5ax>>^YO%eZHa=t-!(-8>%`Ee%e zl4~tz1y2Lr-;uT@-C<&oW;XoZ{=rg*Vtjo_6imhA86ZjoNSFAHK#_5up zY$tHCfM;aw4=y$>orz_wi-(wi#${@WuQF3Z=^^8kg24^?$RXe&hd)P&UdLNFP<@)qZbs{amKaH{EP&A zYtCODqx9;dAQ}5%hS27U@c1)&0&_9oa%ew!zC20J1jyeS32Vh?f$+7OHeC5Sbj^4l z3!qh&Nt)G%6KV6LTrFkd7Pj!oB6HC|rI=1VBM2)cD-7(ebVNnYW~eZmg;VLj2SfDfZB9Wz1XnW_3E!cLjU(`LB~a*vdYi+CVI zp~|t8;-p#Hq?|TS%FsT5AEuU-#NM-_+`Tlonq@#bC|wIN>#99-U!tYitg{EjP4MJ~ z@gbZ&lhGfRv(zb5MyvfWzK(!9oWddHY5b&SF4hFh-dI)xgIbQNA+VOQgex>AF*TM{ zA*TSh)xC+$I^&2<>cyFYDP&jY?!!goiEuH{bbMb;aW2AD(&EhU$>lqwQ_&BWu0k@r z=w7Y6jFPbK0xd1t#fUmSCQLG(mhVnrSDXx#d%^1tsX>)Zhr9!PtQ1QxxFy3fg9!%3 zC%u#{xEcWk(MDk!>!pq5N{wa;l2l--yyi|U1BOMcezh`@%bhkmpBU~$$^TA-%6i8t z%~IyEEf09@XX;~>yn>XY+tV*_Tf?+;ai4rAPHGQ6qbCP4q@TQG&Stfrq`oU_>do0t zLeTIF06=MzjwLT2(`RLq6@bo~3z#k;Pg0mwS#j?gEU zrIO03LbU>A3(eYE4ZI4WVioemVewDG*AXT?i&O1%#)OP$vrEg}3LvDtmZ?ay!v~#pR2o425T%ni7>8N~O zqeBQ0t_aHLYUIDny<!Lh!xHr)6+}@JfLZ)vk9{MD0a;-CKJGlfSrty?3ga+wu7R-`D zzNTJ;gR*QKX4}lI2Mq~Z$p-=%@kv1rvs^xVvU(c3;%L&>ja;R8lIL~zBEvA5Uxd2p zf1BOf!R72-$_Jm(XN>x+V3%#WoMoHU>QEPk z`OF<0du|7tE`TSLi%Jwf5~yuJ-?`@(6DeS^k^ozqpR+c~t2S7Utdxn{#c^yD%D#_$j9mh`1aIzBW zE*f_kOQVFzA&)$a^Kw$|)brx;_b!AdfnTX%rSg>%Am5hX{2db9y?2NIxj1>=ns2$( zP_q(jw$d}a2(t8@%0sNX0_||n?`9{Tv!-zB!j!&Rl7;=Bd&fU$^R&s7Q%+n@64>q&#Uj%Q^cBPBDkoy2iU&3g&8WR@b|aAkD3 zk<^bLKbCKUlUo%tr=FDU-U>0Rw+obc?QDK0de>#XJrIOU?d!K=1* zuP$f73ftrgI-=qId(L`k!_p}*-B#)a+zDD{F*BpAo6Hqm&C3lk~FT^?`&%66ZWUdneSYMcL{9>g@m>8Dzik$shQ^nj^Nlo zqAi62EE}Qx!mpc zrTtG;Rxuf-aotRanX>hM5OL{YUf@?e% zR5QPfgH67A>U!JCtgwRo9)x86oAcTAz)t_06D|T2GnFhl{4d9`|LcUq%k(rM(gcAJ9yCm9P0>rJMr6#mrvs0e} z(I>((mvlVK6EN*F<<$Qsa&`NXIn}6|)X+`+n`AMAdQe>HtLc8$%-peGR__e;{A`h_ z;q&-AgqdtMHnOh@JGATijI#8C*rYc#)GA+hfV-ezI*Tv^En!iX@6s{>4N(h?-q|J2 zR2KiF6E}%nrF;KmFq$m|n|d=!$UoIIObd?GR9|T0$YK zxhoNjAAd#<;g?FxWPPSue;Zw05@3|#h})wFl#6RLcZq8CPRPa-#a-$jE*1&yG2b|zSr<3elA}I zEyrC((`5%p#egmF1gRodowbw?0)QF%973EDL<7nw*-oh}_vH}#@_LNk62Fudp(5_g zO1~VsM|_LEG&?ILb~aniX1U1A6*o-<5XyxVQn?KDm{M4CRI>y;&n{hd%F23Yc13@N znw;k)pD0=)SQBT}XqlmzRijO&FqPV;*)NtStJ*jiOf$%PQQ*)k@_1cLGXrHfE58hp zN|_gpyM{>v$EnGz3!Kx&+tZI9Kfb)Yc!#R7)l-wPN?8TW;%JGoES z-KV_#7T`3?wX;e~vx72w<4Ph2sN{ngfENE@eA}KK8zvYESl zaw?Y-{W9yUo)HrerN|0-cxhjPfC%}DWun=>3WVSa#5XSzP`QF8CJmN=o@j2Hbgyj; zlz+(KYjp>?M>ylsW8vk9g0?d?rH{p^(bB$NAB z{#qV{39E6Q1}c|=>%K&T8?U-&ttq{3uh5@OdFL5%kK(# z82Sw+H2(OwfuIc;qac8s`PzqW)#Axe9A}~GtF@BG6kIO|aBO-!F{nTMb!{vEwiHz zAu3`HS>*zxR=(Zv>r?4i4Nz0Np(Kr{CAnmi=UQX$pL~IXi%^ zmX=gW{t1}9=e8;Y?6uU)%}XG>e8}s~1Nu*&KJiOaNi`WR^+~l@Eu)t*@uz!6%s_fg zmo#J69qMMmood$}DP$4UEAVE@=N0azxroaU@U$o0O6W5SBO-8xHJ7qvXhejxL8etS zs}MGlil zW(mezlJXu&v=VYrYKlPlT-S#ZGRI{W>eHuBZ*Om!5d|}!io5kbefsqB^5B#94<9}} z?g@K%WN|4Rt6~mSo%4{jF+&y=*u$#0(zZxNNixWuDQU^_r*Q>kDt~M--IeR4E>?+; zOKR+Cl)S1e`_$V^^K24-P9fsn5<5!`T9=gAFC1r?|C2HN2)^?*p;1yz_{#?95q=x!*fPLPYaK!Wregn%eu%%4URS3q3NFd(^rFe{9=~IE-}XXB6ua;ky%1%%n4vn!8J(1mV=V# z12z>%$I{nTOtTVhGRdGaF%g5FaSV!?Ua6l-XH(!5P0f@ga|KgMdQHIGN@)gumHKe3 zEs<@!Dlf*fb$1|;Jf}Qo^ISEZ<%VK5)0auXVzac=WeNq7%|E9sS}sjqIx~edUdDCF z>rrG)B(clQ2OIT{VP2Zk9Ynm+6!;W95_)*`Am|GC63bue0gsEJAvvJZH;Mwpp&S z*$ro)v^)d4+_)4JLlBk*8R%?a^{QJ$umWm`p8BGfQ+g#04RkakHFha?XmvdT!IOMR z9w=iKlN@Hy)GKRX+={4yF77x;+R63VjF0L0o|$i9#1T0YK`B%f$Iy`Uo(gcDpCnq^ z=cm*}vB*Smm;Lzh(wX6cdzPdROta-M5T1C(_wBteuWdp)iRPC*V%sZlUGYkEDd zxwuj{)0c*VGz77=O3>x}^|S;`1oSWjsxJRohXg@ybf>0<(z&<-W>DSl5{z}T!j@5& z3}ni=%FYcJB4SBKhoGQlG1)ez|v?RY;Onn^~rI zEiFO{rtfyn*>{mE+2U`A($`S4N;&oKBHKa=S70m0D=s%}uJl7ysfLC?@2k)0d^4%# zS@1olZF9E2J}b9b$&9s2@Oq%M6pbz8Fm042mQpQ!f7b#QQF*)c-d=~BCa&ro_rJ1RnIa{;?RNP5`BSaj9`~4ltB$A$ugMXt|0S#6>vjXF8W*X0MF(VM_IlBIl-YtQ_g<9CDt-}d83@n9j)!{NlS$!|hUgVZG8vN9KyVHK4{jk zY=~kkg)+N2yvV1_a+nO=_!ZX%NPTif&J#n+#8-JyNS?T$c?Q$aaIVxu&g^tK2p)!< zjo?fW3uW{J=5orTcsJ`sb7_EbM=V{YP0qS`bJ4BdE=nQXJ1qPfUO}sls^Jxc>o(P^ zKQ-2MRu?U0o1J`U3IF2zV6zOZy~5J0lzHYa9hbe4UIqB@km$)FWp>A1anpUW%H^1| zcWE+E%7Em)z63 z+67uZjoL-of!u39aYXp_>v-2@FXl_O=HfN?%IW~+YXxGM$V-EpN-q=3b;rHF{JSH+ z)8FLq`!t}oS)W`!-e%@6nf&Z5esOtcYx&Ol7c+Udu%4L`&U<@cO_Rs;{0TlENzS9Y zeno(%ro3^;Zzf5&5TIchHM>jjK$v9i!qND_XY_vOpN|d>S>+b8+=l;M36CB9w%5#M zm+!JObWbnAsW3xI>RVPF5p-ebHgH(>bC?9?tT+%zW93}*9RlZRmICJadblhVtXWT? zEYCwzSep5_=gV1?@|Ovj>XLeuOTjWKVCE^1`jit*J}QdHrB4hqIvmN$Lxl3`vK z2xDb*bIe)gi$TlYA%epLnl>d|N4Qcz!DT}CPQ3!Wei}1M|JoGF(5N`M&m8O-!8e7F4EOoNtzQauZEq+UzvAxbNnc+&TWX`kzWTduDda)Er7t#x76_*WWM_6sR^6HoSjul`-AM# zXd}3SQx6Di$=%L<01%f1Bn8XPFbm?|e>mJfg=4K(4PA&sF4qfn-SQCb<`g^KmEGBw zf!uJX4pogMl#a{UpQ^0YxyhEhWggS}V*^WuAZKcIr|ofyzP|44Y!!JKtCYDheNtaG z_YNO?Mo&TcfWqRMk{X}nLM!$65`ABLnD7d1S5)D8#Oack0p&{H4{fqIkjXPQy$qB} zdFK99S%Pa+`n!gbT+-lfV>dMem1Pa5{Zf-&$nLbI{ZzV4b4rb^qUPrb9$}dp8_N3U z{wgzx?ey6R)XMB~N}OFR@o#!%h0_>0HHm4@Yd~d^n6ftce$3hHf;cj{?z^-EP&9`5 z`Xu3H(52GPT9&garK;vJArluFPvMyr&%_0^0@uld zlSRX~Fz*8Vt&Ghg_n>W%vuB1k*X0USg1AQ%B#>q*5j0lV85}^$<@%7I75c6~%Z>29 zeFZ(219~d$?dw_pww6|`%ATyq(brm$>6iv7=N?IX;zKL%3o^73T(HEf@cQfoZ{E2+7ZAY8$zdd^sAW{92Tuh+wknp9F_*)dfBN+4^XJbzou9C zw{hApWk3=^Gx5=2lUb{AtDfTusGuVuB%@FUa#O%E0aH%c)Y||E1(KGBKu#TmEbJ2Y z;QR0tfe4)|LbBXiq2~gFoR$xV{_x?$@{|@Z3!?HFA**V0W)ux9h?iC3UcZeHLC0s9 z+uPE9678b5IFT=U5ZrE{#<2s^JwVTN)v^WOaqj zIrUWgf#}815T(yyMbD}11m!ZwA%q1)n2Vk+&&#t)w#pg29LuX_&rna!R_G_uex7^Q zgw}GcGblaJvAHxz<0;!VPTg$dok0>7t&Xw>7$($C-cj1wFZGrpg-YsX^OXG|P#!ya zDWv1FXewy{hFJ#60=8s=pS zwx+D0e%FCo3Z99(?waLn$xDQ^S%Oq*+8@xCI6B@dm?Mq}e&A41uuNZMUhD3(d~@ix zRQVNLn%|vroljyeW%?ljmEB5IhPRNJ+7j^phSD_W=JMvsLOq;vwcG(mJ_nnhF=bqP zPtB9z-U~+>0J128*9|R0pDpvT(~loNct)R3(i4rViN7$zRK6AmhW-)`LmTPdwy7Vw z;Xk~6eSQ7(>C@}$Yh6rbaz%Lj8NCL5>^_aXpp<)!f$&VlOnDV9$Hc6Dkh z@iREaxVw(J2y1J3OlyOHej-5FSG_>4`<3jC3{CXR%QglurwlR4l(8YCmju#y;!jKC zo&}+dezw0kD_~MmnUBti=#zS;s**Ru-83-tdnI@?;<6{D!5IaaEYVHaG{{3hWD|5Y zU8bxVj$W{*~fBp)nUxMhe5WeN&q<06*c;Y|ZA?a$EijfhoG=DBc=Bvw0FwG3%z2dZ217=2)Y6{qcoP-Tg2;x5=ydzW+ zE?9)vYZM0-e%3t<%3}sJmqKj z6YCiSe1FDTB&MZMc%Jh+B2*c3bxP(xTJZmd<$1l|qtB)1ZlsWtb57}~fuFANop<#Q z3ow6sd-HFMUS3|1lgV}b$Dh$tJ}c{?pav580fL9uj$iri%-%&$6BCizW%TU(LpVUD zJ1%ue6Q}miIaV4c+q@pT_8K5SKpL5#WTqh6oJviurXZ$i6A+DN8kpLd zXU%#$T2C(Ws#GoxZ`#oFzUug!2v+!ARvZwarm)-KGxuCLmzASlSiENcoUaHo)?J#6 z?(ua%Nb(0WkMWx}4$))yL*LC+(_Jg%1@&nT@tq5b->e6E-M z85&F9_X>Rz#|IQPkLgn%%5uQL{!0HGKqvxG%YvlxCQce3m>_M6Dl!0afUuQtZ{UM)*4 zPgkDC8&xi-Lh>3I_x?AjI@d7m-u>yqvIXYNAtlPIIb?p8tCU zon&2~zX&!>D5+1{JN6%IzxICq4~2ZV`y2D#V1&~Sfj333nG+lgPWHPn(N5bb70 zE|~}ifuMqGxg%4j2lj$^o)k%jMo}=_&lYA)mgkIHyV9>E*s(3IomuK}ne?!E05HK* z7Ag~0iDj)?x|f`mDQo5u=WHJJS{?*J>?@2Dr&2he?WRDui9;e8TEOI~@?8WM>n6R6 z;q0{c0;~femm5k`bCK$AWkzNE9bx#RWTE|1lr?-H$BR8zv}u1DMU=RUuZ zlxOB-B6#IhLmW}!G7V_g3ApQ@N#+@iaSv;h;7Q|)UJ?fnV(14IQ zT5?KjkPNkXSlF#Hz2~(<{P&G6?C(dg&PmBmxRSociSW-QXCKZv_nAp8FPJHL4I_rL$$FIgVkcThq%iqsP>XgkifDi&RCdw5uvRbe zQM$O6(IRW?l#S;ULcV72X_o2lmUXv41SRDvNW$)9PAwZ%q3W5#2{jX`EN&9>`*8)8 zrE?0-bs`y&f^edu^wlFee|$~H%n_yb%i;?=3!=uB0Gwr#n`J38-4$eF5pt?zVbPnQ zg7!Cs+DgzU4)$K6l}*<6VDYNW}t$SUNvW#Idm0DV<5>`E-e+bQB#6w*`KLQefegcnbOf+ zqh_Wf8dFJCjj-YV0W!=b z%hgHa%%v)y?gy8gQa%@4vl249l#7^N#c-FS_Sc0f%UzDJ1%YQqi3Ulss~n9|d8wZQ z2xohvoEJs26qE^_6=teJm;EG+2Cs|8x){A`XkHpD<7T*`y|h=E%coKyVNr5{@TOuK z=&O)6H;W_rvQ#hZQXrNmyf(=}Rif~>j&7Kr2;29_H6Efxe zu6OFsXmfT~gv3l6^(b=+@G>YRv$@b7%R2gPSr3b7kXW{&LoLf#R>ir@oGtsEnf4{*2?i7h1)D=3(EB-)$K3?4 z#KB3la$$Hq3-B`w51$V79lL)=g*%dEL9^?H(#M7vMJzLdWO7uz9eCbsZA9y zt5M)Nm2#FHebPWv9L!prtf9Fl0Sr=;a^)qgfyA$)AuW|{UEDLlN=;aOryx%SY-*?@ z`pj1XJC_2)7caWktWC`oQ2;#mb-~IIo6Oya+JHt^8o$pdwaviwj`FYC4iu@ zLG1_Z-ErmaFr!#)W|MsG=t`eVeR?h>JMiV@|DDo5e*EzN9s$83SQc+~rKhEo{KE*B z53eK-b9*L>x44-6;7q%hcv^@!`V8Rz-0REccn1=u%4CEAqCu~~M z#@MiSHc3VFl4tJrq=KPm(EO3X%)Ml}i3t>Xxs{nUkz2vm5KKcjJ84%DJd1c2q2m-} zC?z!&#RN6bWfwie6&h0_fax%onjG=+N+EUVGvOq~SeTkSF*(RBkC5BRBX_J7dFS!=f*(_APN6W9PW0SACr+|Sw zF^M5tv3U#RX>Uz5rgOL>&6`X+%9;z3tV&K+PH`6splId`tS5kYYj)&}KQdveLR)QAODAv3lHD~}Vr7%RjE2*`{*XlVdX6+`@H(4po91{UqUolf( zv~5&vN-*LS$bG)j0Ch%bX2l4UrErZr9?gXc_?kV2jax$-33FGEnZ}kB8rj}3#64v# zT^BX*;nnYWy}Z209}Y>IgVdG~Y6?}cX<)gS%EYJfQbRRp2KXoQrHh?Yg-x~=S%K}w zQG+t~yZoIpw7ns|0=2EIVP#x#Tvh>dQOr8QYq^=qSHW3R%UF(Pm-fgNE>FeGE9D7N z8jP)E?ni3w|NDv~b;uA@Hkyk*hn;fis0y^u_Wa7CBX@+bTn&rk(W=$c+ z_vP)<*Vos-|NZa({onunx4-?3_r-ty^Pm6YKmMc6?HPKhdHfkY%fL_L!=vhMMM#FF zdVPJh1Rhm&l;V#}6Nz6?q%X+-GliaxHKD<%3}8(p!AXmCca3So|!G%_e_w zn993nk<+FY(aHdruP`@|iKwyWc5;HN)Xa>WG6W3stw`11=n5={n1+@f$C}Y~Od*ZY zTWtU(mR?g9CmX3!kO@z{8QLcpbF~m(STvA9Neyw&kFT|~AZij#o|zyVineutaDq4` z;R@=|GzD=t$pjEAVdXh&vgTsM;=@gtpJd3;3$U050?JF0Z?|}~N;QmvP-xt5+0`Js z+zN7@8eom0r3EyR<&?RIKmlD!hQ?I@O)tUC1r7ETg!Mv$W1GSLX_j?={_*VfA3qmsPI z!d)AMtPGfxVwtJPW|4LCd`_i2r=Y!sQqUNUWVkYV&0Uh$Hw6(;W_g`Lki*UBGjR^wk~$+>;|4(bP0n zNF44M%{>W_4mkKan+W=9V}*^V4I~Nbb4<&K8D63}n+d|rb|s=N`5>ES%La3qOsD82 z0fPF@6yL)1uG}tBPN1zYp7lUgSubk z36DDwdb%js5^7Sw-POz~W&1fb_Mys~&o{i2C)~l_o`F2O)dzh>)J%r17d9Gv`0xRD z8xQ`h7fM0IFCmvn9D5)O;zc~$6*O|k-L(@mu|P)W52)<@C=%GSBcP8(=nwbB{VfEVrS zCAIiQ<>soF;pzSnJQQUW#JQ88M%7<0)UQk?saVXvtCSZL?|wkT1 zfW>m!VJKDOGb%-Uu3&@#^iUs3=ORV!@*&#XMo1ZMStCm{>(2OU&M|6o=5iG(a0AH%Xv3K7HQp30Fd%$)sT%+)VDIyjd;pZ(C}m5+?GP-JW3FI`6y-A&=GgD5Gm zu3`R|xMYF3VJVQ7rzF8l@aZ*h!rjr<>a`t!mDcnz(q?$}RK(Lz2BW6*tHI9GxIu%e zM&#o_5GAzRhQmG9JUZf?V-|HR7e0d@fuj_Kbe??ac|?Z)XZy*v!$AM! z--jn&0N;BYh0W{7K;2X+5)Yh_fn`+~b@xwbmmSX_WsgNS8GZ5}3{^o*%Z_*0XU)DZ z`V#}W8u%<|t$zTu1Hp8qk8pD?EZr!}Bx3Kewg)5B zEvAiy2Ty@7OR^*!kEL%EHb3ZPYx{Z>LGw))YdFJDg0To>#qd{-?Baq%M-R2w0rd}c zlmXVf!iE0+w(`81%*i2p#E#RgiWVj|@W6%;8umL6qlF2+W2nxXvnDcr~0$&RxBB3uVTrwIpZr=`ztX^v(TXOzOF0)+L zF_m+pXo2y+a5*qkc~M40pp`2*)KqBBungO6poc~gJ=y=yMK}H991dCbkgi-F>%760 zgU2B#K<>JB)V-bw1{mGkN&SeKV!n{Ivn{$3>We&Q&$nI-4{>i@B*j>iE>=XH>I^E|Zn4ELe>@$@3& z5eu-2|Gnb<`BpuJ5IuOkA~ZSqTomz~$Fq3G0)EoZOy<&f(mCxfi0rl$bO7!4Yb7r} zxJ>+ZHW4E7!HjzKdn$`{>CfTV7YRH5x)nXnOeX0Z=aB>~j;zVA4_{((C7m6%)n>KW zNNS^+zV)4g?`fh;iUcX`(}eAa>+&-2d95=yI0zo+^WS5n<}cOJ_^|D9@opSF`1iJb zluVrO!xTvyw~{t={hRrM0m*6iY!!iV)#qxtmcy$13Vy^f*6$)3BcwE;4Wb&~(jUzX zE+Js6@o@$4Le3%fpii|qlJ+y^_k>$5d0;5xtE@zTx}DQU`Ikl{nr}JEP4C(vYU-b@ zWwtUCfl^ec83-m>v*Khf+JtpTgX1^TD4X!O$Twf{L9?Q&v?>QvzR!nE-4P*PibvG< zU_x<1gY6WRV{fzcJq=4~ge>WeUe`?tyAN~>XR9o5Zk}0tB^z7M5 zgH3^XqKQFfxS%4+MpAf0QSm#)b-7sp1hruExtU|OXM%*uW`LUOP0|c^omt>>xU;Ta z2U%4bseq5>{Db#T=(ASZ$gwEn(_vL7TP-|1N(G3L{3{Am5^lv(>$ehQ=m-2}l{?y# z7YioUJZ-(tp;^(VSp1$gu30S^H@6br!srK)*vBvZrvr=g{b|07e6Z=d4B6V>Phd`- z&EavKX=sM$4h#Y+PyWlmJmNA^ogY(DWW{T(`sbZ?w*NeBWaa*!!jPNY-O3!${J%QM zxS0Eu&sgD_N$3XH+b9n$eJIOCH6W#pOS5~}HI?$EpQF;~Q23bmDTAezRafBOv#Tpq zkzQ=l-${-meApj-MNo#zr*T7fl=SYw7>^M{2}Jm0uz^}!*E{scM(lNYQOH#??bQZf z`qX=?{P7@tko$EC(UO1*y|$s_xPFWjS#ow>=hqv`OBQ_wQmOYYrrJJdpTuX=#vX4e z*bX^vGWEqvUu+B`WN)^$ga7_o=?uC-B^C`mef9JoD&^gl%=@c15fjeefby{2%ZVCcY5|T2s8q!g#hA!Z;GY(&JV$d<%~88lC4T|O>KooCd!i1LKT%k9xUc^l zZ+E7xWU4LjC4mN}(7Lll?o`W;cmr%8V>qx}^VVeDN4AIGfyZnB&LORP{508)Wlp-* za+*H{6=n?Es&`uEj!SX1Lf{sKubyEV0CPV$c|#LM;nVc8Omxcz{t9^XaYm)~Ux-S@ z?2Ak5^n){@{`$=NdJY$#{lMrXfQxkJj}&c=i+LG956V^rS}-*dPkQF=@dVW2eJ%2gtS?MKey($rJWbG(eSvh?X>OJCB(gpc)1>wbOW?8;qpjh)k} z{Q&g{m%V*D!bfr49$!VcDe3%bsMcH#+h@3}j2^CgeIM5VwWJxwMoX;drM~>xU@V!i1=?Y2o!&zs%=OeMLsQL}QBKrn$faO)>iM zn;R9RW{u#mMeo0%)wby}oLUWf`T%0(H+%;5R-hbw9`df48rc)et4M?__!*eh5@RX> zj%=Bj?>LeN1tRE=4aoYASB_P0k@uuJ+iCo}UiYUH=xvweE-wo#nwStaLNG zW!ibm%gaBV_d0P(fXkP+IG!o^qL=yhq)gVAG}agKPs#q%?aUYO%Q9&F6L{2Sr~yFX z=sG0w-U27>$-|v~9CS)(kvlTvbt6sF%@Nt6j``+cz5YGJw`EV9Gi&-#k=@II+4>wt zEOABF4&w+3fIK%thn`yYhrHjB4-@8s>;v5fz8ZAc1zL9l8$A#e+vWHtYf5II9fv|w*V8H!zMgP$A;)m#?RBoi4* zDUMhtLG7oaKCszGz~KQ8flD(!=@psyyScCi%DQtjvk~Qs4s%s4ulpM$n}PA=zSD;W z;XLQi8A?oqa!PX(=M%+syV3)7XTCKJURxg9ZZsZJwD6_nQho)TegtUfidL3ye{?Q( z7=oPP4FsTU9wl&)9M}0j;N$M4-(M3smpD6#L zn2{8VhYv1@SCNHfbRIk?q3@*mw&%3sVXv2b9viY6nqU8b1$uIyHv1S^Jo50mdE!gF&TpX*U$nyiTO!4{d~k!43xu|+?OJa;A^(;Y_4ee-l<)ebm4MS-_EoL9I}>$EWDof8y-Z)1;0U8i-In%yL__qsDf^; zs7L-GPUe%`gxQ5PG7tLu;~TiDqh2iqG8EHD8OgSN;!gc$L?G-rh!nl`%K_Y6omNIS z0XSezmP<~-$=gb^OvSQj7GsEl77etGAA{zZW6^Pr-#2uryuvF zoU{N+IDrTyLYwdV>W6ZONwurHk$S^@6VQY?LwYt!4OO54I=hsYjqfGThNql7Y7Uh@j&8*}Mm8?o8k<7ow?wih zsw_DDwGDH8+3_{wAx(LiZcAeYum54s>^m!uAQl;HV(}Q zxTv_r9qbW`{BK2X_g8NBcjs!4e#?!?4W2w`KBt<*nN4!7AgryPvY|UepdB;}v8V2S3;x&A$WsbmDuim2O^g%Tm8yrtu;B z@dDV4_ggn8%&+uH&K=O|1M~yzZvDv2o=bClfIs+o30ExZu6xprq+E5oGEKzLZ+pwD z(C)Mq03+9vVHu>s)m!diWnLUDbm2u@$`tPjJ^}H-BO#n+NuF%^lbmyLC4zFp>&a`o zIVr2d6{f#<`Q1xYc`y&`Jcj+rhiDCUA^bJ-VeHa}%UJc#!(0l>{V1u{B-~MTBhjStqx(X4+b!V?gYqfXG_@4$9Hnk#&)F0Bj0*ekI6^rcmW{!q=hqav*D;WSH^ z)E3PPX!%e&clS8qBatU9ro8{tw@JU{>~Y$@?9hecp@iQVRdIiRfRgy|MRUC@JwdhE zEg=v+iX)0}8Cl9!vA}}W?Kj#Kigwd*nt|kuto9oKcT-5l*?UWSp8T$4CGtgjmah^j zMk&;rPGxTReG(z2m1J>>U%$*`Wu%!En+>6D9;IsH-|El~ZexPg?KNW!RsG&$SX zvDa~6CG`#$#vcaX{mr{Q;mS)YJEXqEW%oAGj$q2%IIg=~ZVf_%cStaH?`vDZK=4`r zsATTDOGty{s~$Oh^bh48=ZZ6_U+ORznB*(QCEchyN9Uy^GW)6z;w!Oi?tb{L%++a3 zx3S%!^hWEb#&7<=X=g{l%$9X=I8mBId-#aA41aT64PJ=?*>{u2?EK9Nc598}sk)n~ zVwU-roi^Jg?qhc3?TP|VKqd#KJ~TLK7|vSrI11%@ftn6iHhv2WOo_@hN`p-C6!6pA zrM&PvthvR_S06S#_&e^`U>a2*P&Ww=U-|tDOeU#*4Vj0K%{M20MTeiSNE0ksh6~7_ zx;{a;rg53h5Zn(4eBPT|(O{euz%I~9I$2km`i+O2H0vM(GS0=eML4P4Q*MFd%8>;8 zB^dx#dZW4%nc}*O&KsnkO<}>ghCUDo@rSRc8;t=rKD3CKy|oueX+rT_bi%bZc(Md^ zZ-ksBFU@NBBbjHhdyW9_^&hHm8qqH89gi~f$fHr}?3}|N;hShJsFL2huTP7gVU<2| z@tDx$7yrIg)Dg^YVZ{mq=y4`2)BRh3l0?h737^f%anQW-P?c{~7@Kw*5bQV@Dwjrt z%PbA3hV`41y!R^2htn|Me=2gFm<1Wq^Xd!5wxklODSi*0#n+NaOLf7JX${7fKs8U1V5S zpxUeEtqViu^QVhm(o)N;3+C>?H^5maheM8dZlun$i-d)p{dwZjA#97=Ry~(sbGH1X zzav^T^Bn<+@j1PJ9xxd!<^d=PHdh{ZTU&h`DSLD1?M+6C`J1T03!fWy6OS|3Z^^nY zxNnaRzWp6MTcOD*ZgJ(N5N;{(Q^sh1T7w06*)sr2$cMW$&g#RXo zfwj@Sr|DFi?oE>1xWZ3;!P~*_3C&R(5`ZE!a6hslTU>xTr22)re1n-@W@O(@6YrJN1 ztWJ9=yRc;Bzsikk!R)!|JiXNcj95d^T|0g5vtkqM_-JlDQxY=dRS~{`@E;HLT&LUZ zh`q`UM>%(_fFDf-uTF2pgOB(L8A}eY18H+^@U#R>c=;y!WyFy=8IlPY0c#W7#@?^$ zPZhcnafw3@?v&SX(f2KmcUxKkeOXB7zNbG_yM&$|2e;qjNT|%76%cm8k*!E$3b5hB@ul1FLwrtb_lx-6{RD;tE!{{7I4LUFmgK zDQKZCXbtN$W25y3wD*-FF{6DHS9-H( z9za#8d&acHQ``>zu#(O8 zgec0fwLQ~doZfrk59ZzfM*>mjuB2d#lu|?Wi6!|1?#Z? E104Agvj6}9 diff --git a/transfemscience.org/feed-posts.xml b/transfemscience.org/feed-posts.xml index 2ed8b150..b4bf5342 100644 --- a/transfemscience.org/feed-posts.xml +++ b/transfemscience.org/feed-posts.xml @@ -1 +1 @@ -Jekyll2024-03-29T02:48:24-07:00https://transfemscience.org/feed-posts.xmlTransfeminine ScienceTransfeminine Science is a site for information on hormone therapy for transfeminine people.Transfeminine Science \ No newline at end of file +Jekyll2024-04-05T17:34:44-07:00https://transfemscience.org/feed-posts.xmlTransfeminine ScienceTransfeminine Science is a site for information on hormone therapy for transfeminine people.Transfeminine Science \ No newline at end of file diff --git a/transfemscience.org/feed.xml b/transfemscience.org/feed.xml index d656f363..fa9f2436 100644 --- a/transfemscience.org/feed.xml +++ b/transfemscience.org/feed.xml @@ -1,4 +1,4 @@ -Jekyll2024-03-29T02:48:24-07:00https://transfemscience.org/feed.xmlTransfeminine Science | ArticlesTransfeminine Science is a site for information on hormone therapy for transfeminine people.Transfeminine SciencePuberty Blockers: A Review of GnRH Analogues in Transgender Youth2022-01-30T15:04:00-08:002022-01-31T00:00:00-08:00https://transfemscience.org/articles/puberty-blockersPuberty Blockers: A Review of GnRH Analogues in Transgender Youth

      8=Rvf7G^sZB6HL8xsjA&B7-BH2M9ZO@M#g%e2?pj(BJ@`}V#{B{S!Mw;Ocq{A zx(sKbfx*f3$o&k=O9?|@)Pe!w(jeT1GbXCKO52OmNgZN;h178NflEdq(O~k}CZSjE zzqPrgNihjYO;Qf|^oqa$U_g&OwwI3rNOx|WKBNEkuYYfEZ{NOs3w!F%am8QU+$Q$- z&9ikVHIFTzg(|J7XBo^c4IlOesOK!X4b2*R`73HUjDGe(Va&$=*TG#cw~{H}KcT?m zo7y659XiI=#1jn}63#HpC5B#={+~AF4C0Jv#_;T;c1Sp+y)?E%%d!%M!4gaXZsX(x ze^`#$h>ZaQMgf*Xnv6kFOSMJrq3z1$Dcc2muVJNN;ogh?Ii6)dPpBy8iot%{CTD%) zgwvRu2lD-H^UMZvhNEfUO&?3FR&*HG09$8 zl078(YC!PRvb@Z3N{5pl!N(JWSD*apu%mMLGewu8gdt~m5+SvwNWJuv2m?GPB2s5+ zCbBBqP+b{NksZ%f$Ori!lKnv%Ov`q~@NDeO6ae~p3x=N%JbNR|=loY}?6*m^mvk-w z9`@Unn0NG7uBb)Hi;0SS!?ww|B;kl)In3}x6%cMjzCM*KXx`kmy`HNWTwr>I47aYL zZigHfx5z^PVlW6?Ua6UV(QrE3Ptc~ZT*Px5;2VQ*;^B?Y6Sf(5TBp%-_TV6C<*kpj}$|wy5qX`A` z(CdzEKsfCIhQVyLsPruHanhLzIUGiSAJCKQQHJ1I7vvrCY+z{)yMm?>GIQNl!Sx7a zXvqS34EK2oC@`Gt;e?Z-@W7`3%45QM7km{GKh0#Al5dNONW*5C@l>yXxqM@mf{DtG z;?=!EIbe!PnO3{Za_c;LMxVQ%|N5{0`u+FcQIKCV=gGqU2v1bNET?}{iR0?qw{Mia zQNOAD@CzVhL|a|hyqq;Q7W@i#!MmGplytmYP6#JY^ff$iP$j z9aU3_O`tQvS+Vm}aD}WuYh%Nc5hF)^Ww{cWD43VS$bjFf;^e1e2#1i^2+k`%IFsee zg~Ldv$d>R^bt9*$c<}Qco{uoUfB&A3qBHgR^XIQ$zb-%0;HT>Se|w;fRbwqe=%)$3 zkn=e-OOsiorfEL?))awgn5Xm#0Xbv6Mz#sDVOppVY~+;<_%_!S!`=@qMs^p z`DC`(=Fl=&wQ^P>W-&qwdHl>K+*_^)YY0#I>m;1nnZ@T`js=X#S>kEJMg}AsS}>)P zkR`uotF$7#8WI(L4vH)MD}Hiakt}Nr*i*KPD*BViu<5D5*N0B$O=V`*E6y5Dk>R}U zn^V{>N#@xwSCk3a?X^$#A;s|Ma7oUE_^Q=pan(4ljLPMqZIWgMYaJOTwg0x;SJf*G z_$#CR4;4jV8HkUcbSy3g^}=8QvF!o2H!2VTS5dcs1O|q93p-@E5-|NHpR-PfsuG#u zo@X+%B9#IjjEW83w`T?57@vMTA@?;J8I+kD#e^UxMqYix46_ZQa8B{$1#@B`(tTjV z(A(LH;5nk5eHnfz#yqyI#A4DJ&NCR`=`(lrQF7JNh_4c&r1X&bsx%&*1>kod&R*m* zODSiw8Htz}@I#IVG3B|cB7WXmrLlezH8aM;N!5waWARx~U^O*`od71Lbkc{pozRnu z6askfnIk%zgyry-bL~?Jgc#np;hEi7>L+Qa9A#nn{m$0_H~#WF<^TX707*naRKbE{ zQz?RN7(*f|!s8H}%UF=W;(@cOw)oh*a}NVYkkeIEIB!qIXuC2_pV3DdTZ#&=c&9&F zvxwj zvGgu& z!mbGS{{42{#~#kk6tsvcFyO4H8Up)EjEI?pDMqW;L zJe@B9_hjJ=Nxs9*n{7U?eS3Q&HAXsvHuA;@j8iUIyy3YJq#Wnvq|G%V9$zfd#-zyY zvS%w%cqo%@aHW8s-ljB$Rd4lyHN{9D$T<5`NCQkxKiz6NmNGM(QRakaI`P1O!4!rY zg7d$jK_9#poGyM&L(t%K-Y51yWEaV1KZJIv?I7QKF(MwAstFMCt!g2$%X~krqyWP3!5jj*$VhE_MGoBi;Ng~ zy($Vn#=B^^C7BJGo;?YI6Xg~WJZ4#cjcfNd<=?eLDAcv{0J!0Cd|#reA8*RNkcefsqF_Lf7!2Syfql21>y z>}oB&5|iY_bH$7Re_Q#4FqkXaD~2lMJUp9~MZDtwnSM4>sz_;7Ajby6XgHpCH0Wov zaU1b^3Ybr*3OswVB%w1H`Q(!yt#VXS80py)yF{LZEHUt47*@^*F4;b}IQCs^3#h!W z@E@+}RSHyLfaI{s>a&v#z%C~mdcSL7vQ z?BXe^3asjwb%CkE9-^j^>}Z&PpYJKbA@o@~DRt7-4v{-beF-ue|vG$M|>YK(@-$oBZFUOmwEwlX|(N*7Y5#^P}t} z9keF~spn-n;Q-9`UNYcWW~q#~7~`>B7tYrWls`oEgqYhzX-i=6V>~2pf^V}YBpSRx zR{}~W86AuBy^LiQR|;p+T$?s{in^^L$oIY2g$)fp$x!&Muvs;py;?s{jGbpLpBT?Yqp(ZyM%tMt)o1%a<=areFRXaFJ)oUWp`f zEx}Ja_w}Lye#GFpH7bRN?pyH~mTiXz1OL=nY#%g?5@#=M@nAEt#4MsdO^4d6M1aJYP;vf((FHz89aQc@mw|doa1g z@PPj7*RM&$Rlpa;R1vBx%_*VO#z{A-%sC{fYs}S`yvyatEZ5D1Ahd8ls-sq6D)Uy!y8v8{?T}Y{HyJ@rl1D7|%6f*=JTEoHe{n6#S!6 zx3mud9?Jd@crT-tqlWuf&vHYuTp%NVj*Scq?u#P8ek9RY45p?512+;A6VD0T#K3Rb z3G?jh_BsDV(uX;9CF~qo%XdY1=%0D*!LB8+AG1AtLCI$s>WFApY19b zY-|AD)ZmHXz(ZQzF%i2A%sUR=cliARZ%q7Vfde5enw&gXBk#GvnU=S}=dpzh73&zC zR%^RrGt9$ZFY#^2lIO|^Gc660EHQX>bG*2I16aBI9@7mWg?Z*qGh2z=gB`fHX@VsY zlI3F&@naBGm>O1@gxi41&e%Rqfnk83NeKs&C|=9pPw>HioN@Gwo=*e*{PWMh{q1j& z%MqTPmj?=&a>4Or-_#$2R8{rRB)c}`5s=@yaSD1}AJODtQ1~s(v3bA|2Kd7RZGMO# z;`x&q4yW)}>MAN(D9uN28px~r83Am#`L#+4vDA4qI$bnaEob%wvQjA_Lo>KJTJR}V`f2@GKbTU&(#9wc?MU_M^WvfPpQWHr=K(i3-M@k0(jfJ$eGO4YJs|v9HuFLpWHLvvy7y%S3@0024v% zzC5e*Y}Pc1%I_(Z@E<1_UUa-M5{ z`}Xba?ae!rlU0u2fBy5I5t)k%nNpk9 z1RG{{>R?<*&BBi)5+P<&h4X^PN!~f-A7R#dw9XBKPNpHxFw<)FmO)?h!jZysPMCwq0~g(p)+nj{Nn zG344C#ZMOeF_P;cegYHA(A(15*w1z*Be5~Eb~sUmF}I32v4eLT@tDe6#eRzkrw=Gc zfeb7pae9jEC@hS#`-ZUUrQr^*9g-;%mJ$!qlSFAcPNruTDBunYQEBm+Ke)IqDmA8BF z5QVDp*dN=nIZRMX_}-xT6r0-Fkny{#$xc6ENTN9mlDB@=gOjIK-@bjLQY1wTod@7c zlATF0Jv`c?D2tiSc^hWZb_#P;!09A`NFsH5Xi2Oo{Df0D znDFPfUVvp5<~)w@taUzQpFX3{{}#(O%5xSnQJ6imHfEOwB-zL8`+%#VFxVeEJV<2+ zU?ev8YT2oQWjSUG z1D#yH{R;^NCcK7~D70Q#Cw<*UFbitVnb)0U)|#sio-*^&wwNX0y_}`WMR8%64WTqJ zIk?y@H00~oumAk#KmYNMfBf(N{lC9||Ng)J*Z=zR<%@S$Dy_V!4kz8f1Hj=tUiWOC zl_z5kNq)c`8SpQ=I^SR~-i$OFcG0Q@l`Ajf#@EWL$Qhy$_V$!23CvB5yX7Lh(_Br5*-8fFq%VKh@UDas%g zKOr%SbHebr?Kr35>T1@howw}3I37&`5+k!tN|ss(`^~wxZ=+B$SA=~Pj73(`WPxfq zTh1DiB7VAus!evzmbb;uqz|}7RtMw|jN%EX0 zs*=<)%(hW(*rB~Fuu|-YGtuE`gcUFTBCI|v1y=~eip76!z~GZV;fG=Z1I*254p`6D z9ZM1sNM0N69)xxRj+2M-RI~&WWn-RU5?c&3&9N+ZIS+?yDwEH==WHO01b+zz#&Seb zhRoKPA%6Ns70&X6eU%O>0B#qv8v{JsGTSwNXp5oz)C;UU;OQP+CFII5m7{FWSQ5>t zSsL;H)0XUt2?#$~EHYr^@vsO_?X=oLb2j9JlZ!;ivutWXO6DHFgba{$Ym=S{4*q3=re7>gOS);tYQYd+{}pK+hFNrqFk?SR-Cqf`t*r+qqCx= zCn=Bzrq-Rj>{5`^@Vj^dC+rnZXkB^VpQpb<&XU}ML>V(@=^ZIf|Cxq0WR2>eW*cCn0}<))kCW}xo4giNJHb;Qq>~#^u7XQrnSB*vp(-~RRQ_uqg2```cm43EWZuAH;?{f{|^*e}KhPel(*BPYAQ?;Hgar_}rLOeoVjNVMk$H zt*l8%7sJE!9M6)?v!)H0ZXoFj55Oc>U}Ju!9X&?d-Evamu>oNmRuW9!a+(R{osr=GcCY?Ih~9sOn7c+$GMA zoh1DUnA^GzHOvCdJZBGSpM%Za{u~ccUdQwOmaFO>?=F$<%J4-wNSHaVCTVf{j6}%4i*Z$c{At&t+v&Xa<+DnsLq;7< z=P9m`a}lqQSN7%SRJY%eFB4ka6^k z{_XAUKmOxC{`~XL{BN%LbznMM`KqMA3Uf7dk2oXLlact%kPR`LlE8c|F`L^_SHiMU zt~kwrJySE42R$brSXG&3c*rg>S&kx~wG-tH$B{MVvSKp%go z7~a&zIhx_}dNZX2md_~o`@{*G9jukku)4{UdcrYCf%16hIDn=zk-3k1%Ny>csCgQo}ao9OqNIcmbUN; zPg;r$j+f7$Kj+77@?1XOqt5{di4QcE2B{d%6(@Bu#iqhj2C3tZV9xw;`gqJwzwzIh zqJbN;8*I+b!U>W?xdUgs|w0@2s_Xz03?JV22_8QQM;>jo~xP_6>|;u%vTM+ikjK4 zkXL?I4dWrf&{kB0ZOQ?_{(hu%N=Ghn^)O|+kZ&Ahvl-xcYrt&lj!Mmn?TCJh{76P$!4ed zrt9ix4ar8#RhARKFX(R9VId!+3gvE;o%9Xoi-r@~-q3ohR|rGe2sjvUkm&}23YBDqn|!}{W>A#CmdoRv3V-Yd~Pza4N0JV|;5bI31f(^x-Z_PecW z>Bp7eL|!=WK&yR42^;Jcl58quPi>iEBjqFm4C6%&gp)2F@&ZUFIoF}wfY?);!DR=` z;lM_E{fIbyM*ro@m*0Q?{p;7Se3{W#3m$VsH_K3EcsM)4V)MhnOAIHPG$pT`vl3Fz zfcRl4bizyrt$D5u_$Q2$BY_?B1pjTwZQEg>aJCvAW0=MHs1Zpg!oGk1&aUIB9O=R^ zMFM!pU=KJd`ACZ2qrWYoiGfFsJB4R%ZfWK%PA`mU1vM6++)Qaw&wz8gTBFaLbYpX}DU^Ia)X(NHJ8&3B$n?;%g z!4G9Q2b&)a7*>M)1Ua!Vb4X%upFe%%gh(Qj~K|OgwaK2{`9jhMzn4GQ#sj zqs|3Pq$QO-!LN9{Oy|4tm5fisTI6B4*UR?F1}23&kMmK3KSIx~0v9aac?A4PD z_ba%ch55?Zq?lq(a@}HbInEta7O@h|))`>?s;JlfS5?ISw1(QW(U}cNMvU2qSyyf5 z8iv7|ZL?`7EyAv*+yUFhyATrwZ>d3An|YS@Bqv2Rd4nY6w$-fBRk3d7#2{(b&Q&{N z0J!Q&=-CgleVqD-ZaBr2Dq0jhtR{wU+F2CO)^~KkgphQ!ny!9O2R@FrN~2?`h)Q1+ zkaH~S6*kB*$WA)sVKDWV8zmb((_i9iNZ>1mAOB8%zjdAR;t9sH_;F%HYVJLfE^npt zU;g?aeXgjZXY^3#L57Q*EwFT-@gcb~638pZe9qKG8xoWhCnP=rZJvz42G2u>i0JwoPJ97>ton0b|x+WWY(_(s1{#089VInNt?> zIM1MbAM4qWR8axIpJ5);a{~1J0ebizeF&j-M%d<|=jY?|7|$bh?oM)UXBAKz07LUc zCn5Qm8u1zW6k*%-g8cfge^=GzbK?5uKAnkv>$E*NZ$0jIc0vei2L?uICwnFCZm_83JCyV7)ws` zECGaLOxP_+LLS|IGtony2#&UD5j>lsz?>LMo}@l(&PkSAjAgu%7v&JbHa&Y);FmCH zm$P=}a?krmhRchZ1DAH?tsx;1zb^ss(tvrh`N4$2!&g$59u5JF0x*mK%V6rGjokay z14Jj?w9znZ<5^8RL1uPeb+wKVmI>zY0NBvN2}vZ)km)J$3@dxC*Muh#d5H?F{53R~ z+W-hzKG(u5c#c`a&`b|2SB9JcAek^2-~_`IY)pNG;o6frl6Z9o=nu2Y8qN8l=FQ@w zfreM>UQGSd!g&jvzVT=1hvlRXPpGADiLD{WnwkC9$^M7zrv-1a)Gj3j1_wSQOtGt( zDx=72mZ4!Y9a(&o5xaC|cB3;>c}yQWdD&6$KVh6cqfg3wyU;CgO1{OgDaQC|vpX^B z@k;vZF3@qFK;>)&#$pVf+2cudn^V$N;KpAXHpus#N?yO#+IfgwYI8csgP~yNIcu}C z>mae1!(tP{PC#c2hKFqDuqA(-)uMCGL*z+OhZ?dp5Tbvx!#7jW51WTsXpUSewa&S7 z<{^nfros?aq^^Bs%@es4gL7k8{DjS7!JrclhNmnWz|yFC!CWyEK2qy9=%XaxCFk?r zD?;u9!<^X7y@Fd;>mD%ym;pT&PrGso;t6%ON09j=0H`=u(4}cWn_sp`XWri4%pab- zQVxqwQOHgfkTYp{u8`Ii44$hHm@OvY+Yn-HcpHQh9;e_Sb!==FF@cbzZ|pbrRjBA{ zF(({mN6pmd9#kEMSjHyA-CM#oJj7zau!#cmoH28q^RO{y$h!#kmT(G_Z!|dM#NJSm z5#x&R7H}2#kpHSPK6aucNL~S)>pa{cCxnMo54GZTFsd-%JShtBznwAbeWHZ973XnO zZJdB7@;ZdSmg5@DwHuG|w{|J4;cfUU0CLeZJfZav%qtm*g&Bh>jLj67cQjI9m6?6Z z>wDc2M0Osp@RdwbyYT&iv!9LH(83ubuVh3IH{KOhi4vY)(KYF=LH+&VIcj zA7ANVUd@bc0D(SupQ~a7+W2~O%j&i>WO8ZI>~8)foD;lZ$&$;^p6utX6u4NkA20x+3V)CN!?2rmB|n$!03 zxR}mKI6XO_kc0t}ymjbtisp;t#O896(|b-t#9Ach3If?SNs1pags0~|iUE@=BsGlM zi054sSD!rR%`m@RlkdN~Sj3PKPmH&>x8HyNouAOD*$j#0hi)ht*^#llW?gYE!F2WQ z?TsvT3i1aDtjj#c(T4t|l82mdCMv_ECJWBOWIyDT4o~!Ryw8vg+e6BiV8{^<3=bF# zF9-M-j>0aCd6rbwjS7E#XaR_PA}O&;NzSqal+$>aIk9`T0y8A!s-?>)JI%nkD}ZG8 zvF5;O->RJ<&v~M`($$c|GfT{DjJ#Iu&xtvSDh&y#>?k}Td`Aq20LF4Jy`Iqpvcq4e zeHVu1j@mGDP+)ApbLue4D>6yqiE{Q5_Zuhov6B-XlTR2s#A}LkiN{$f?B_69ZjY-# z7^YG3CctMrcWma0$FE^KT*_tYTPJshLDC;iZnq5Q05%&mrIiXG)ff|*5;F?i$^lG$2ZORW%#K>!UYkNJa% zr#O?&U@yv&+=(1$zioCkVD?zVa3n6pu+V_vNfy5=fhtoJOKd$`i$4m%6hBlUuN1EI z-@^8`pX)($b zKk`k(Wb)BV?s`nmQUN$IYULbKP3J&jE8wv)F9u#no&-73MuTCuHec@8Ao;ld3R7yY zVD{GrVxO^1i<6-Z9vGQ9%>-6`E+k+CaD=cZGsK=eH>5@6U49eOflu2>K_ZN&3ID1< z-%_{=AC-LKmj&XNzB!;+xLJi86?+L@I+tu$A}9F7W46LmZ24<=qTE@g4TGo1;)TF@ zWpL^X70kwGidPIU`JDCZ*RSPa8{`2u_jX|jcxIgEhlz;?zYqVM0l5F*ga9qsbHOuJ z1oN0a73D9zC=G)HA%yVfclq-h{cmq?`8|4Ma9!|4jnf_4$Pzr2+CS~(rveCzhEP4U zNsd>>Qi*btu~9M$al6W%;H+9&$9@iZz|~cTWjJJJdEK+;N6bugyI2*=kZ!QS zmgLh}p1tz9K(~U6pW!AEMFBoE<_=6Zo+doZYnbb@P3vyOWGO2)DR6Q|a_Xn;C7X4U zw^A5WQy(#$=^`wC+aHnr7vaqIpyaEi`DnEWa3aJkca)K~0b?v@a|GptLn0$zx1r62 z&o>*Hnme$P!eGCh%Nh-S#fBVXUJgD^Oqk)va79ZeA}!ldPuQlaRm%|Pyo5RS(bPpA zDso+wf0d=QO=0CRe@!I?N@m8y@*3nM!4E@;#D8Ukp`uQ1V7P`(=1pCWLOj`HFf_B9 z8Gkhg@a$5MkQ-?#{LdL~nhzpU@HU*A3f`dyUp3A`@~(t$7m)?QFx2-Z@z4GfYYj;C z?El!C4$!f*nuafr1>ZJoIM1h&eVOZ=WNxSI7HTnI=Hjqj?%RiC1nd;C>kxy}3hgul z{%KTr>F06ERrX1EoHQS>dB|(=++ybcV96b7bmqZ5A6b(Zo_xGVyJ$|Hx#t1>mw)|x z``5qhKrX9pTFAeD|L)%lB4Z5r39Lfc;Yccmt0C=T+oVR{Rg;VIuh_2q^-%W zlh+~%@oe3$F_ofbIDn>)_B0h|0ZGgC{zECf#-o+JV=2}>TxD`PTj78d~+OIkMJ zoUL>WZOo|hJX&MIIp|oFqTLTscm;D$_6m)hZ2Q>YQ%gw-Z8<0ZJ9@~7sx1Aoz^8?s zG^C0mgsoUo3x6_%^91}$VXE`56mlL5va-M48P+sZS=n;FlI2RUQ+S6X06nSQn7y8J z@5kS!C0=7wiT) zHKm`_?7ruFp!u?AJva_k5iV1g)0(M{6mwV2DmI=x__#Wv&|I>Ygzm!CO?+jG*69G)& zxiV7Pc|+jw_helQfEfD{s&-<1u1A}xD6p0W28<10Nl0J}_m-rYD(0Gnr_KyM8-SU{ zJfO0-qd9+ml&H#^A*C@}hWV=yZumHIiM38gg^koaCFiKjA`-%yn()vLC$B`sgJwha`%;0Tcs6J`jR%HaX-=9-<(Ohas&-AyY|&-@|<_ zhakWPhxV++FxngEEp5eS7^x?*8;pB`W?F{_orPZtyLIkK*gv;C03z73nW|RrQzwc= z1boHpECzc=8S}Ia`I5o%=2~-As#rK@NHvW>LNJ&*G2GZ?(nFHDEfeTIoKP9Fsc24} zh(}DoGlXtbIaY-Y8y*afmt_iIHb`wFfLW{qmr`fmgj^L~gtx*s>50ePY=D0VBX6} z2kLc6?p_tZUCLB>99vU#e)^pSh49bi*fW?78(~kxq6D^$;oY)FuIz{-xls^+wB{MBoJH#$#A?fg%6%{bE zD2XSp2_bNH0BwZd8f3(%5Cl~Af-$tJe7!mg2M>vYWXWp7gs>_iw%Ua@0A>pbeM4#t zLddvWxJ|gHu;~My;@TVNAsO?gI6N?C)*qJa*-#6E@l&LqFc|r$ee{g}+qZ9j z{`u#(Z{Jet+uK{x^SIo9eKQrLB>EM=vd&ELlwne3ucRG*OV6ImMx6aJRn2<+{1*z= zSs`Y-vQr@cfriyG<=FESGd!MihFk_X+P!>iTz-_mz4g~fO9mH=_+46^9p-Z-gSkZE zgpdMb;0K9RNTP}}Bgkn$o+-9#)n%CLikJw%u2Y+1IT2fP0EW3n&g^!&(o&vbz>!*k z0KR{*&3X&;xY9l)7VRSVxL%xSz{Yg1|Zs%B+<_iS+ zW8}kKR*>Ib_tS8wI9MQLis#+=5w?(%EBvVf=E%;|`AlWcaJ42p{Y)TNrLSMVvgn)~ zB7^VsbJ~wi`a|;x|yg-|RFB;ZKzE5lBdAHA|CpDIu?DE{tVR zGLkq1JQarY`Sa(`X&|(dkXUc^s?<@oDa5S~p=s%JVhx53Jf4lQWB@;@rU&q{Gbghf z&b_=WpF3Q5nDI}K6;7KICR4=#Gk|Fj!qoII#hzUD)9FG26~+v7loMfd$m4m`s1zC6 z=@i%okP&Ap^3fCwm10!MFjOpg$yEk{SImXq4=cODQIf+sN%LBH(NhJQ>RoKI`)GpM zGH_y~3M((Q4#!?5%H}s!V1NntVG<>dnrDV3CQity2!nJ*4gezn@bSl)`v-ncInMo7 zG@H-)8>uKM!>eO?+$N#tYSk)fc6FSIof&UE2B6ApIE{>r;9z*ImYS_d%rFx%>xMXs zW#r~+IcuJ|u}xm`JVaiV;}b~mQv*EnHomlh#2~K^B{X<8O6-9Id_37RY$rkrMz~wV z;s%^A7ly&Fz_|A|n{8y+SvJCQ=gH1T`6NjQtK$+vp4htKL^gz^wj^$kDH$bXgv#lF z5$IVqr%yFjZZT09o-4e``IG24xre7w2FJd7MFs{)lu#*CRdRaB`wOTH!x@qqk^;l9 zFz0Oxt6az$7QZ_mX5UDlpB+x^EPae*sazqS&iuhQPuqBZm%Wj!{5BOiOviKx7#i;v^B|C`@TA8A~%`A;F+60jJ&^ z5ggjo&Z9_j!Q&l5ULTkSBr2DHtZ!~eK7aoF<;#~PxfAW}qi6I#e*F0QuYdW!^?2lw zH`N>@`%LtO9bD4cj(Z*!EZwiK(i2Nt@z|KN@%YvFlFHQN0f__h=DvWB9aQ6;mItR@MjpEklgOBS_q`V5Lz0A z+DeBQZ}=-VuR>wW4<{!e&(_JJ3Skz15;4UTQLAJFy z*X*s=F3;1eaAd%fs|mIEjRBu)Mp!zNA71Tm=jmCCuQdZGsB}E&h0BV0mUB3^58{vyTo*w=~Gb?!}YC@X>TG z0jdoNO}ho(0ybG{>i=W!UAyB*j%#fYcXBk6CHss2|Bth!C5?vQ0K}z1zRP@GKWDFq ztnBOtz@dE(KY)>u5j%E7UaBg)&~Wlt6D9*iaF4|+ZP37Eg^xC-+0hEONmH~=tiYzF zvVz74rKy=U$#Bk-;nyh?HOH9VqUkl%Br=u> zi;J*ZQ1WyfEspg8B%xB)ev6OXhFeon=Fm&Yd26-hCU^?cQ_wyI(b9J!>x&Id2{S90 z+YYog7RRIjks$`zEKD3JL!^PPK_`w08Z;00)4fcvq#=kY$V3Fv)Y3v}*`I>>3`0wx zZ04*;GDb|o8f4iela}c|k)h$p`rwZX;pmmH6{boe6c?I$86wR%*5Gw^EipLs=h7KH zUqgR!adCZp?Z*O;V5+%a9~%BRdvm6yeyRqVgMA!0UPI&#cyuhsbrHcSmU@KL9fz8%Od3Ekf7;8Qh2xg{R-G4f zG*%a~dMRUx#&Iw1$=t4zLTL({`jo{f!ir7d-(6f^1^l3OzL?#P;v0+?H z+{!TFP2B4F0fTRLb0ALc1$;;YOObP3XSE?9y)6L2EjL4*$KeOL@8vMR=bXeU zQ-})qph2^jt9TWBy}BO9tvVO`#pV{8v=t_R-dA{Ah;b=}$|00Y5NtYpWqI06VTe3Y zW|TR-AxL*$DOZ6i^P#7o1}PUDn=3XN|Ly|$a?k8abWFE$>6L#;B0f++!+D!`@=)61 z^OERWzQmeDoOFqqHcn0j%*vEYmx4nPEWUzfdxZ==473-4(eaAVr%HZ6<&#S}V%{6& z2yUcif;NdIAcCbUdY=x|tJ%x>bq$h$MK(mfyJpH#b>X<86HPPs_R?#VR}q%Z=ub~i z^8*1U8HsUR;`jN!3a2@Ulf#`T?T;>&qbMwb;WCP{UTTJdL!P~TW@K-dP0hsvx5VjQ z$7wjt@x+R`IQ;mo)JKwX>jX;Cbm^98(jdd7oW2$WN6fa2b<7udU3>QGu0WSf1XGjq zP|!>K5>YQ_V=+j_xhxcBTbmBO5>rTb3)>@_zFjz?PY?};f^mnvY>w0q~n?*Oy z?LtcHrPHOaM3)sdV)8jLALe_}#U|;=pHC?`jJDtow_}Ik5w_>`49)x#0>P<N{ z8@G-jf%F|3{5Z;ksA{ax6UhRWis4m?uZ;q8(w(PF(KOqNUg(u3UVD}EKt1%9W*7+L zVTe?wJfXc6y68KarB0!Ey-G7j6Tq&?Koo6Kx-@oY(|!(Ke7|S2=f$9)9}dujUix-3 zS0Y^&M*)2gsv|4X_KNyKV5?$XUmRbH65qW^ zI70CFli{+kuN8L-hq(0S97ql+Z{esH1c7HgGfk*o^R3<_X`sCV_+TdTUPla^(%L7K z&!nkLN1tjtj)3bz=WlitM*{?3@*{*FGic_;sB6|)%`FpoZYdeeN=Cks#_0jD{Pef* zx1M2>L!WQ`8oHO~++g*L{`~y>^78Wh{QuZP<=wk?=jZ31M9hP|O0Oj-7pfP6GlaQr z{i=Zp^2$;vHW|VtF$qCeP75XsKISpyM zP_<9+lyhF`m3L#EvzQ1r&D}+AAV)mcw#XtV;F#RfQP@R6J~Hf%C3G>EL@$muCoTn? zrjEm2C%?UuT(sE|=Dw7Dg%7Mi>pyckIRsoJFeU`kfD54q#4f|VG{}(;;r$)7Bm<`3 zdE#vx$ewqDgJY4C{8mZTCxXgFf#YMcaG&?H1VKo_pLtAgb{NB4N`8QWhRSno_FelN z2;_XHUJi31?Ck9}diX}=%$U+t4(oE#iWla<`5MRNriO_L0?l^^5&r#nkL4*WXws*_@ z_tldxB+Y$=^NNiFA+o|e>vS~GqVF7ey;lwrD0?zZdNp3hU$G?Rp18A1kgl-{p@Vcy zaam~&<0fqlETh5@f8IOHMHd7kCJkh|G#C=tQW}M^K5oR*D{=BhXlqL4USjY2=GMQ#}x$sjjevUZfX0=43B;T!uhQq#D)ujI!atdtol0!{Y07DUtc|QRR`VSMQ^;5pwk$~ue4UP_ zStuk<$%v+}|T0XSgjiyqKRNn0snE2akX`sAVrIuWZxh+tw6wi%iBfw1NaUgXSl{ z|HOJPA4$6CKqxq6=M)^l*^;AQYaocr)@xAR;ZgxvpA1`Q45%}A1DK`(J( z?ttpzFE@1BTN+_C$V8HA$q0Kn=zdT!(+ei@AyXz5d9kq*5t5ECUL~|jqLiJ}a1^r` zC$S^sAzBh}b#zO*a!V|E=?gKZ;t@QDE(L#R^XkgQpxsOjm82Th#PVuZm}|dffW6?l zca2>sB&@8`U{OvST)Jip$|AV;YB>SP>8kyq0{CSz7m%b^x_Waj;hv))#kVvy8zN*1 z2N6!#qvZ)zF|pyN3`Surayd?4b~7tELFs z)Fg%`9qGzSrtw?LIU${F9&UKagK*M*UBV*!l#vlre(QpW&w!ey3^kYw&a0dlKA7Y& zeGY-)0LM2UZE}n(iw}AeN+L^aVm#@x4m^X?gjIf_O=b<6j!vpcl=ZF*RLGEW8kF2~ zI55+=2uXgO+tHRrPXsv(dvgwyUuY1dq|aUin$rVi9@^-BoUn98Z*IhZsAoNSVK|P& z5ng%5QRp3n#=s<+?!XR*Q=1iGNDo-S6()erAs2=Vdl+H@HSYp#Ym!Z3&9mr^OzW;s zdbw?t%d?IMxkw6=0+RS!vfu_ye7y{O zVQ+7)eU*j~yld=wp-={eKr&ebPkQgBC{*$U zHC)m*w1T~kCXO1g)oYf5d8w2?3rBqy#Luphf)_j}ad7WW$i7`T@R38}B&Cc+US5w& zS2p=DV@Np7lyi$#X+hXp)eo;e{8?HfW;!?yy~IRtMy0+i8E$rq(qH#W$CM#f@TG*_ zVM@p2Wb4q~9sQDmyRHV-zpsm4UNjxE6Ij&r5Q~m4F)Kl7PKs%)?wDTm78`vJ5`+@J z!}d`~8)Xp|3Fx?JKf#}L0bXM5wNFZYy4pLhjAlm&L&8Nlgk7=eYje?S81efk`;c|b zaZJp;jHdeBxClY$G%$1lQJ=!lF%1^wGBYOyA)*E=Bo{dxYF0R>`=l({wU;~wd6oCh zig3xnt_+c^Tr5R-T+<;aH?E6lx^LNUWsyZoc?$=9w*)^6I7e8i-WKPM>|nVhwUO!s z4I3@ZafM_Llp6RSh|ALio2m~QOqi|8qu=UHCdZ|w*KkhSn*u@k*~v2>_7a=tWw^aK zTDtCvVCjYtHFhYAy?TUoJ`x)WMj7^^oWxpRbS03JnGg1^ z7KO=5kv&1vxNL~%?JfI)5pzRP*#&V{vNN<^UVTeA48-jAFiCyqCit*xt|YVsx{x<{ zWkqOQLgYY{1k-ZMJ#7w^b3vsn&SKD^8My#k#!-BQzH!^7V4*nrOu{K^-`6``d#8tH zrqIVl5QRRk>>@i}`Inx(3U*;Xtg1E&R=5xVR&c6^F>=mNuS6P@KaP^;#op)1A&=>E zERf3`Azm3>oG$cOWR&g{3dqhF`vXxwyD+ zIOxSCKQ-CQ+{Ge8DJjq;pA`CnRfBsPCywFDY)t+CESXH@T$<{;ux05I(`CytufiH{ z34kP28R+7emMIsr*XDgQkR9-~34tdwAQnWl$p*Me~*+KHlM?A-_-zOv)lRC6AJ$DfD=VZ1R zF71(}R2BlXk1mdZ44rkD%bnOk7jD4K%NzC7+lx|?3L0aXds?v>A`ES?eAA!uly)Xk zvMv(_&PR{i13#zoM8As}~oW^^sPkY+EG1>eF+gXF19fEH# zcdy|5V9vR;_Bt*aPyvb2^fH{`a#f_9fh=rpY6+6YDW~I#UK^S468+wx)UgPKKyRu^ zf#?oR!7NQ3(U)d1et9!1BbsB8(JdM-*`=e(A#7PA8tYyJX%xLpqX1>I80-yHi0PgJ z$CN!p+E}7gcA164RCML$4&XQ5q;Edvk&){$&AME^mWs_s-?Otb>I^IO1t+(xOjB0# zA#kN{jm6gL=$UfXEL-d5r-mB%?LClZ>^w~-LF-SmAJbD1qHGnX)M{^2@&+v>rCb?Q z^2uSVm=gl&Lb4f}$-r{J(h1M}XJ*2mD12JK+wGp7o_4z(w*+6me!aT7@-Nny2!GFt z6f%(s;p|GPu332wg}#TVA+^9qS0n%cAOJ~3K~&-?S^qlt4X^vZ-n? z0V$X(&0H5O-hz*T(R0u5_={%UaSn^U;0o#s=OMnv#eHZjpi{BzY^l#0;;8!&TqR~( ze9$jKnH`fny~IzRg@etxAgt-DNpK@hhBa-vnX?Z31kX(8Y_&|Yyf<5{a8gYs7NN|I z43~1&s?*>m(0su(v;u%al|8MPVVug8liOR%5YC^xT$PDzv4wM1{^e|qD^!_seNJlm zMuO9cxsfAl*F3aIF_(OE$fq_Zs+L{j!$=Y!?)v1Rn9>$=&cF1QaLL&zQJ#{pd12f_ zW7zD)k)8sMG+M7fnZna-28WjcBtCzMzng!&94ny>q{cNlD# zzUHg}FB;@gK6U2Iy?kZ-kPH`iymE{TeR6VA&gjK4SsZP$|7(Vj*;#o7e6=aQA{auA z%yr4*UFz&jOeUC0Wfp0P!ku*5s7XM`zH1FvXb)}r3f<-i&Fi8aLEs1%OI>`oaw+;P_k!kSRCgV7 zW4BlLqDfi1O zAZ1}ve6ze;me{0aJ_{GXH*LZpi;2wYlOakfT*d`@TCTGdbKPZPxq3#=OLOPv=euwJ zJYCxQS_VTdW;m>lAS;4_5OQpayOybU{8H(Lo65PoHFxnU+sYQya9VfT7Hun8$siO2 zn+o!Ak|px+hFf0+LFR%Ns=a0y6iV)rb9Z~ofmh~*jkVGRVVJcy9396l3Zj8SuTTQ5 zHxs$jrkAPfpeU3Jxj7ag$s}RZNdx7Kf-*J8haw2RSIAhC=Y%v%*?}|A-sO*b{=_$P zEC=g!xqm7c6dIn|r+%-@NI7E#ArV9SD~IJ3X%Z16!&xXm5-@MYaM5_U?Q~eCcX_`@IMc6xex zetv#=c?kiZc;SGu1k$(HEr+9QdU`2rxtFc1;Fx~8r%UP&mFL`E3oYlv9J5q@Xe=7! zS5nXgz!jHa=!29m9HTxBGJ0mTQnd6vS~e(x8>#i2b3Qum&`~n<4nrrgA&AO?rrrfE zRCc|(>~6LgE@`I>v0+U*=RS_wY|Y^z@=$3aTTosR3|a&cihk0}QY0&&jsTp*I;e}# z(o=AgAC3iPE3^}ENNjHfIzrbBk-JjD3a+MNoO1)?3~EihouD^u3gBBbU7LU>XTxQt zDvuVprQxSR7Z2cu^knk7JcX5{BUQR=ZjIeR#ENk?bJZuAt+*011&iO;W&-M%(RH!c znZGqI#a;UpkVzr!%gn@}@Hg>NnZgiQehw{F3YZ9)U75EueOxN;nN9*`%EPi_T+j*v z&E&Rau-B$IcKc+Ka!I7%tTcxu>LI#W+8{eLK6&{(C6jzwWP*W=OJX`jduY*8a0+#$ z#Ig&ycu4>knh?NJdsFV1i<**GA=&4^B5a?}83_J>XLeS580FP-A4WMjIaxZRe|~Csp$l39sRaRYvSp13beC<-j-|4mtMFcH2#}9;oM) z2T8f`gw-G`K$LvLQ8PhI%ED%45??f{APbr@dD=lqU63UrUDn!K39{W z#@7G&`571HNvW0gWp0qjmoH!Vni|ZcCkJQsyLay#CNX!r-RIArfBp5>j~_qY-QDqP zc27@F4CU3;)#c?S#u?q!nt+DJGKZBxl!?(LY07R3j=RP=nNv<;uH5uuK)remfM zKE-a4A0z#u1EwuJWp1IKfupTRTtCDiW*!ws{iXtrKq!;7tNPN}v@K;*6dm~LAk}4o z#I{z+*Qx2MbpU>I9u&hzBn%UyvLrMX@9e!Yz(}$z<65LSKzT60sgpq@nw%sUJnr5n zW}kvsavFj}na!4N#cj&x&P0@whpwMG%^Dl8AH=OPzDX~QRtcACaMwDj$k^7Wy*aQh z$(qoc5tRt5T(k9{Bsd<M%B;}iSxt2Ojow8m z1GrIn1jF{jvQ8s}-MoD>o11{W;81x1wZwXRY92!E)h&HxrWhr*N`m2Dxy!9x&rU{^ zLJ2G0?0d%iADgygJzLuH`@PaI*5O0sIX)%14aHO)Od+NM$%>7T&m#p)i!7$`4$Qx` zhkggu_1dk5p;ytnX+RL+fw=gXk6cq@andR!2{Xv|qF8X>d&&tUWCqBmLT~;dDWIL zibVJPaX4%z;iv0KM&8++1gzP~bixPH2lNVUv=F0M)jBJJEBw@90HGVn0)HiDcVkuL zXJ_ZSOF|dP?=x%AB?ZT3lQ^-f`3YJz>KHe&77iYMNd~#L?fW_*e$6MfZMStjyqNC% zLd-vi@&>EvYz@YW3nn@^?V@)>rp684=}G*X?~5PTT1<3v)%0QL9FWPjt)1W9-2oQr z|AGZ_b8>*j^6Kx7+?(quaPw+xY-}9$-@6hEG`|%D64!+{>I;zK!%)RAiN@hQg|fy2 zte|b^pQbL&^=;!=H_Mn+Hm*a6=P2pOdM5ESYZ}xupNYiv=#SD)fp-i&>Ate!YK}Em zI)7X-XHzMENQnj07pY>U;~zMEUkWuPEv!9M`@z3;53vY%jVTz)Jbscl*+=Vkt389+ z3j45aV3X`cjL?(f;&rhzH@g%aky$8XsP?CQopgFJ5&7B{)V1um8zcou>)3ovg&|0h z%0DlsxCaXYPjU$Qq^g_2>meCZDb0sxYd!AJQr~shqxAP9R@io{JKF_?sWDO?<}}cQ z)nacIsm`=iGg}-E*~iFytB)4x=n&d;;M-{%x0Bp*gcYQD%>16q^KKc93S-OSOp<9QV_4C#!^FgRM2_aXavl_xDPm%?8mqB?^*igR9=!(S-z{7Y~Ck zgpA(kE`1I38BC@YtVU0yjY9+D?eB0KLC|Egp1{0X$(TgzfCWareqBdu_Yijw0*i%{ z3$A*a-^4N04w?Ijdr2KxPbXPc+S&Y}FT1uC)r`DNo>|MyPm4)mI!Uu>jx`KaZ(F8p zVTH<_)zLq&pD*>{G$Vx5+&pcL9UMGejKWuZyMM7_GWa?+2}P0oc^22gt2-!2R~ zA45Z+Yh4z$4wkBibw~oigcwJ+m|?WW+MnRjtCx`Pc6c5q+) zoGqdZzV!$Zly0P=z6M{vJh1Q}TulNRU9)mVIo7btasdp`=jZ3-&rOC<3qoYb4NpDwIGgDp5yTpU<_P$xU>nbuFb?FCX@gWst`SJ!PxfuFU zjp6{z9 zDy2JwjvAO0zCYa5NUC19oB3DqKT+=s;f-u*@nBhs)h-=pJkXy-K~PpPBj)7>r4djT z$?5~M6OI^njdiC2>xhq%Qbm!W22VF^b+yp}PFjO(NtCvH@TA!L1$j{3qo6}6wLDT3 ztd2}d={wBK4_HGo66rgZVZYV(Qbo-E3>Le|>s8s79U&$=SN}P|VHw45 zzNM)8YuwA0H7A_bzHxG|@uk{<+Ads5@Pr=$5G-qAI@w30OvmIw%Lr;JpFkv6x<~M% zE8o_Nfpwc#y^^)`uq8x+c~NCCQcoGx9mzq-HR`PdaX#FN-0zv$zgUn(tML8$%KYo2 zG zmIJ@Y3w*KO<_8dy8KSzez*DIK`)YkJKM$2FHE(P{^0mADVH1Ad4M#3x(&p;0R9D%N zdXlB(H|iZb9~>LT6-Yjhof8F@kTN*0hIGc7eAVbryegwOL; z-I{tSlN*PX4dDf#ae^aoarV#i*W-Tpmc65Mb(~`5`>0W!NKjPi*(z^97kr0oDAyEk zG~<9$eu(k)bHlb?hgPv)VxUVEifV&Vj>+3|uE!3U+vvGAzg)PUG8tE3;5qhGHv8JF zL}t=Xdz9{*dGf(g&V;WVZ_u_m)rXl~64RRk$2V`!x}geGo@j!uYqMcy4X3f#J(|Dk zHVLe(mJdEzzkzg?~oeZ zMb==e1La|eDMGA#hjsRikIM*Jxg=dwNg$#2b0NY~QXXmq73Vzn*L{{A_d3V$oWwMY z_}Cv7(_~6%<8=~qUZEi%L3X;(>SG(L)~t*Wsec@tp3X|_vGFM7H{{cXLWSa@qOX@* zaMhSXD&8RpHWy-D$$wCk_CKhtRr4O8kLNb)pO{fc^n5NDs~9EndZ7AH%GZ)Yi$kC% zsj7Fn=1c~jYlcBu=k-*e53zO{$woRqPW~uVH9Dn7MPrR*SN9=^mN=f?YM}zLE`=e) zR=p4xExtw(^E5&J?l(5=4=Nb%j5!%okDD-ye3?<%v-zX#~`t?U!6A%#4Es06f zk3~du&db602!hs)i^glvnd>Q;vEI4#A*k_a@tJf^7tp=^y60ldsE)+ zd~4D%XN5P$WW5HcB~NEYjawb4F}*r=_99tq@(4ymTZx;RbDmK`I>Oq1Blzi6nD2ly zo7)jS^;(5}>M-g{qtu%8{^aYe)RzOS-CUuS$*<)04n2(&KcgE1&lG1Yz7bNtYB&ms!2}TWXJb!R>&e19)}Ybqv1xFt$u46i}xp(RV61&K^o_sK`R(eSNT~=Lisjk9oT*wpH82kvsw0DIm<4a%w z19GQll)h9^2SFP{J(TXn!s3~N)_;FWHHRGhDvqI_Zi4+)$^-vhxVVt%dW$`E1pId< z%^bfm*@Y>U+{r^U%x$az z8YAOEl&FKUCUG9R^7o)#UHG#Fgbh7{KHz*#aSk08(R}E%z#@4ov1j^m?(bHp1Q%?r z1qc5vy3oH>??b&-veeOSfKn!QYXoNZ3Bvv0G1N$BXhoR)H?f=8gbf2byng=Dndjnj z*QB!mV?oQi?0_qqq2_aO5s}rkHGhET>chJldfVRK29O>KF~3WXfJ8I-Rnj!ep162% zrr@TwTSC z5go}l5qH%;S#K1RC8YOQTm{e-by%d`3=zGe&U3W5kc!&9^i=Y9CVAzAC(KML7SNbs ze(9w$qG_@h&o((A9&v-$NF*8amE0mPX&6VHXO*vp%6@o0l~i_DAofm08NLUzS1kv` zW*2647@eo0yYq{Eu1^AQeyLfZ&2uqq*V+XU2?a^)arpD5q&LVrdSH?%m;s@~q0F)+mt4(2M`veVEj#-dd5NlZ z5N35TDtf^8%~<1?oBhNj%Hz5z68eWeOjDs3%P7$uGCC8YaQ;n5sw}i|n8U%Ib#o$NT1}4Ct<{UiCmkHZZxCTUr_-@Ks$!3r)v)DjA;)qtI!#HDjd(O5Wk-nB>wvY${!-e&yv-9oEv; zEVds-{M>U^&auD0FpUDspyu(HBOmqQ_cHW4 zz@nhsAo^fZN(mvzT;GC63ZLkG{Qg9Rh2WN}yW6W}n3n2GyaOTvJLL0c7&K#}^f}sL zjGfQX=t;7KPwdQloTwTSHB8AZpqNpm3|Fmpzd%|{z3uPSKgK}LS@b(;!_G6OlP!O= z?a0trlUH#`pJH!-wT4=WhJJivOwS2`U67W||z#byiH|F5S~jphALzTi+Ih8Omj-9o31XmV8=~z<$5fD6k|kS@YQY z^Z3h<#D_nNg=-z2yEd}q=WW^A6{@$g>OQtgn;3CWm}8M~{1YfIJl*9Y{cixHprE+8 zxNz!teFlypFiqujyw1)j0v-2tngs_32M{qmnM=xPe-I_h6AJqFbt8AI*ihK&3t~>a zsyR#WE+lR)BI!<#C2(*_4+p{7*0XrEqu1jlGM0ALyL<`dq;k>z(KQ5{MS(Xmq?VBBakKbsvfNCo`HD@=(3+)5leQ3+G!9BM!x(&1M zf`V8{qMpKV2wO5h&nD$dZXH2*xBOi( z{+xU3?t|3ib!femNlf1Rpoqb=gtcQL(eHP^>hno=cgj6O!Yd-s)2$H5KEo%VDmFT; zon9Aag*adZHf}7=p7chUwQ9wYbMc#>j>3q>;CGSB_oRYODk}@6Q&)|RCYs6oPHgK8 zRPke_r=WA`zlq`Piz&CvmomeW#yvvg^+9z~L%IERpsmeG!}OM0f@%W3UtOdO)$mop zX#{bHs0~U{dM!%Jp8`($g@;r-c2iz(mQ*+x42Z#7qwHyX(>yVnL>a26^_VKYVPo?3 z+UF?|>isB+5BQ0}^-(08J%VsKN!N)| zFed6F!L5;V$I&*k#e+d=iSNa`->@`@o`r=Z_dZ@mbSLG z%*@RH;(v3+{98LaBNQGlbDRdAk4kd`0OK3R#+#9$Ats&KI5mTKzonjNo?O{~>wMFt z>{?AJ{r@zp{+*G)EbntLTW?i4s?ha}nnF19U69dgSHu~liFZ(j;EY>!wNc5m2R3_)~Y!eVe4Sh$C zS@3Mz9jrBbvzp;y58Z)t!n0=v5>z_mZZ$#T(kWC?c}u;)9h~V^YKI<{y#nXYNYVcP zwE&r$MAIK&bPTzby$Pj4{NPDGPo!*vKjmgMVK(|TonrhMmF(uv@^e)K-uY6JTjcfm z;H(F$l{u?#Oibrt%3nqVd!zn+hTZI)k{#B*InsoE44Yxr!eqc#ZW4P3Z`5gNqI7Xe85ep*fxD8Ai5GFF-CQvb{Hg2BkT^ z7DU1-kd&8nT)r!xa=&IFW@9y0K_mh3pe1gL-m-28;TNb$qO~J-PGsr4qaeuOk;x2S z_Z)$}X^bEz>}8S1*#Dyw)2B%6;`J1Jxp-wqVDeb} zy)s!h@;xYgRi{k-!`Fa;MPwCuiCw&jxc+H>EnqOs@;cp1Ve!?ukv)JsXy8Jcz z(m{$GKI}&4SgT)J%Zo|Lsdr)<_I@00;_$I&X_ZM8uyMTlOyFi&_I_g)cDjosz}J1j zqY`fko^4i)I@>dHM-TnaYe$>ZqbO}?BC}hI;LwO#?}_j zbHlFov6{XHs!)BF=50kHE_o{{m2cZg@${LJO_&b?L3F3W6RUIE6I@N_ZaNCm1fgQm z(cSsu6SN6OlGn125@}FznS$ z8rD;>5g{1)Dy`c(Wc|yLY98nl*9I!!$Pf=lJpQ@$K#H{5;;`X?AuNfK}Ij zFhrN$U2Jq-a7>T(f$hoQQAeHa8+@HJ%*Yw^(QNKnARlwupQLYbK)( z*i8=ZELaJ8({gR3Tg^#51}ms2j%CmuDQOFYqcV+}lQtwGAuB{w-Bs$Qv{d|BLc%JjP;hvGSYV&icAW$z-qcMsDx-~&)A%Nv=HiSO`Tk(fD6t*xe#||17*ik& z6MxVOam7EmCMdk4y4c+iku50r!Y>hT5_T0YO)h*}i3iTCS{J_)S1_MdS4b!lySEth z$&oHS2t8?>j;7=^TS23zZ!p@mme5uHYRHb&Nysx(vnrne@!_)@xJaFRgnN6sE+K-2 zXm2+8PA(zEYO4-s3gqilm%QHb+pXqK-edk%QP?J%|2 z(`}JE4 zE$p^!-A()aw!KpjGo)2mA^b_0E84%{Rv{BQ^vG-YYSM1DtioFkm|V5? zLMFUH&A6H8`El=?txITV(iSdu9B-Z1P_*P1`c3t9;YweaduqZ3SmwpsXxRR-+-k(P z5Q&smH-V4LcpW^Cu`#F32Y;84S;%G=sZ{sW+4p9w5$!KhYr+OZm95!&T!Ne_9MO~Y z-rxRZ=9L@jjg5BI#Gy$QmT)3tnjoe68f|4JRlhj2Wt%U96;X6}n`&TT>lBwq88d6a z5g!;MRfauI+ZkLhD;8lu+RZ@RhS{pbUo#;{+Oa(_{%crKFV3qI!5hl7-#Tingw6kI z8B=W}&6ukg4lQHF*zBPX!iFyDnW?co8CnUr!(-MLC_BpXmGzXSPlH1yYplT+7xt?N zSjYh%)BI}noybAn#@G`Q!=2ZpRjcOnxku66if%`-Z$R>HLP7#L(Wz$}@Fkp_*nhX$ ze_Rn)!*u1#RL~jM3ik_B@v@hJHHZ)>iIBvf(|hde@Zg%K$9m^gMZyxM%8E4vt1`?8 z$O&XyZnlwsp<%Hx`REKK#=5xFvch_rnI|uK3|8qw@&X3xKiP@X2kE`JkB&}-iL0DI zm@LbnFW}{J{!n$hd4xiOBtagxMNe1v2M0W}#wWHU2KKF+SFWW0?5ZEFguqz;YEZyXLeo|F#ccT$fxRj81i^;^Gt z@a!V+_Odx}o!H81l_a_uXNg_2X-8;UsLY`vD5*I4On*Yfrj66;luw}RQsciox5ovT z&nc-o5U&=d;&`e$>sMk}7^vcS;P|*R*Hr3~x|5-ALT*|4jkvbCAY zv_@LVfXV$Wt5JRZg>vC9NTW-d(@IWMtLw_lbG;Q-e&;#qvmUB!2nKe*&*=G@jpjYG zM4`u}nz}BO&cwCS+}i~nId4|zyMBZi$;!iX_s1ij+E2EJ=j^ z*G-(?1ce$_5>lo5*++81*JuGP&51Ly3~gbS9Vcv?5glwRok?(RZtjod6idZ;*Ap=94pN8Y zBO(!j5*3je-_JisM`dbdI(bt=2<8Ne$GI)Gfu`FAf+hYA})v)A6>+3FLq%@ewFA6`SPC7_G=R^Pbp#T zR$Ju;oI>BY<2_q@8!TyWO^jdJ_`6{EO!)LTGa^0QvFzX+W@Dc3JmNREZ z+=IJ?y38iB_$`A*%I#BxKDU;)Nr4&p?;N@z+RBMNr6Asuqco_jQV2eGe^-gX7xAL4 z*Qhq+T2>8e+P7$tSjM^@QsjE7IBjYSt}|kM5lPmbteJc$cGr&*7re;xKWs}SxR2$H_xNxt&2*LO2T(NL9(xL?dctMfCO-1s8;W@T|k z)Rc>Jlt#3t1$s-Gmx{Z;^!%NRxd^aH6&Eq2?^zYSo6J*Eq^$hN=TLYChdyI19J;FN z4L>99<8BusuC}D@zb8=%Pad8>B*f~bO7*55;z?o3)L>32Q}Z6Gqt9V2hF+;(!i?D9 zM@+ga*U-2(>T6P@Wkm-%r4YOXL-3^UN)r|pDp?n2=C}*>;C;py^4$-S&ba&q4b+tP zcAai;QPW1mz)QkElvb5Hd6)*I^`M5r0RGXo7N0f{z8fK6)Z+fJI#cUIoN&KlG52I8 zBAi3`05S5>;crV@LEQ<8HA(hTQ`lqskDeYur!`|`v3rX1Pp!$V3q|zOlVw1gE=oCVdJ)MJ;)e2Vf&qVo&tTjJ>88+UIa}j`6U^l{%mX!4bEH zLu^v|jm^Dgwmf|iNr0W6a&rpGC~2X$COSjUan~}YrRp1LwN|&_T*m4;{Ii)hciR>x zt^J)>qaCuCg{615`*NXL_~md#dB0_V>(*e`29;?z&>sAcvIf>!oB@2ym9BuODByPR z`S&JTdhC3M;s$~{J35MLx&=`1F%;OWq3;iuTY#zqpl^0}caM*cpPq;z)w3-vEdb{O zXvqPzJmBA(Ke?wCQ6ad*2mVAM*;kAY=0rjlKTENd^+I7s1lcG>)fdSQ!r6aaSi^`R>@ZYyk>Lx0u{B^WQ%seQ4D&MbIGp=;vXDq?@r$ zOvJCn?tK)~aTCo+5P!)$do-m_n@b~=Sr=^U9mP7t*Oqo(O-*Qv!iHo?^h4M2xH0j0 z45Bxa0)I!`Ss>XdJ6vZ;=_K$>+8dTjTi5h}uw<}0N1$&`RF$m2VSB0N)9ipJ5~r(& zRi)1Cm7}1rZo;) zD8h-!3ct+3sv8x-WHulYNx4aiiGlVmP$Juo>HK z_VJtD4_@5vNCmuNtTSS2M2`l_0LjEm5->P=ul?w9e4HNoA#2*^OrpqckJ>B^YT#Bd zg}u?Dhl-yWBkOGjmgOeBPg@C_a1I-rw`5kP=V9WF$)n0_F^{^Wl1a&>Q zUx-#UBUXC!(7<4|)|$U>&6V!ugU|adO1M05Xb2L!5-Bf{(`QXZ5cPikHfI}(!uAuI zbN`PNX(8CF_N#xDkR$knDe1OZNtQB2V(Ijcm8;KH85s4wiG-S7ms4p&#>xf%U3_m} zKWDfD`dof~{{Lv2o1@vaHL~1;>+?rI7`wEzl>2tWFfsmE_br|0D=Bw}e@=ByXJ_ZX zm&fbZSJ92yUj8-7bf?air@M>&{r$T;oj2eQeSezGeHaVGz*g?_eLveYD%5N_<@_|s z^*TG79O!4=rDn*A6-?E|1Sfg!y#5@tgs;uugfGj8Sll!gce-|xKHx;l5COgqcay0x zOxV+BZC}`4(Pe)eiJw%Z#-x3}Utv%I zx2-|f?I&e0>VMNx z`;mqLB|%MoPHC=?&!UN5h)@>ZutuZJ1J>UaDAL^ig%9XfN2{)DXudJr2aVoLrXn1l zOY})ya-Gt{)YfNq)9EATY~1r_^!8k&mT=njQx2S06JmJ(7S!}!skS#Bo5JA1Ghx(6 ze6&PJxz9r|$<1PMsihixBt5Y;NC_&xLuKC-t41p|oaCaItS9hR&08rP22VFz=|}9g zgcYt2LbxY8dn?cJ0z+QL<++(GC6#TeDVtN{e`mCC7Kyq*CdbYfi99n~tbsmFZI}8;^c=8L#su`%t%y@U@Q682cU9I918D@1n5oUEB(aCbHmT z-5hI?DrH1~>gMxJ>!!kpJ9nC{SyB*vAa+*?h#_8((XC$EmyFxa{92v#^jB}bKs+LB zg>mubJd9rnm$;E!i$#%0*0t#PaNbQ(YYCj=mm&5Af&8V)pr^Ov?pn=|f z?M2?=vO9X%zc7m7QB_?HP2}SL7WKBZwY6aK9oo|J`0#fJ7!v+FlD=*(E`PUrfqCIW z{H=G2v7R+eQ&irWr|`rRKm$FtW*!{abaaFh8~}Pcc6N4wCvibR?{D9lJ3BvI_C{a; znsDH0TP5?!SS8oP_oWMYN7S+A)U@)KObiU>m^~PMduZrsIW7#FUCiquUSNF7DT9{? zA(YLTL?e4v`HsX;;m+jRT4XrZVW5SM9FxzqIsd>Oe2R8F<$$mplc-fly$UJX zrxf$Gc)j3b{LMU`vU&~sgS$hJ-L1jfc0bCNa3zc8Li8d%VjU$QOOh%VrMpV160~#z z5{n;jF^1=LC%PX)@PnMVs;};}qa)WkI+@-U0>`wY8|qnsI) zg)?9fLz~qhC#Qh9$JX%cP^dNTo7eKi#~DIF7B$34KhT7E3G_Wq_aOeYR83j+^z<&K zy9E>-yOL^?Tk_KLiE=C?md-gbZL$-+7Pgn_yBP#dl!oEj&+V=`VG!-hK^~#Kz&O1$ zJ+V~NYKDbDd{kiNM*^pIB?Ru6sM8F^E^jm(6|pjR%$S*yTHHfsTYYx#efeVlk@r4E z-KC|fB;|+6`Amle))OkvTeMjZ6DKuz{z@Bge~$@AOYhn3fUKFOnh|e^^|`-D#5Fqo zp0g<@pTUj3J!;lh;;~WY2nsn)rhw7#(LdWr{XY0a{pH8!iZwpS%L1MHMpo_E;zsm< zAvAO0j9cY?+$@6wLnvsxa#X@{0e)-m2Ac}5_|&=dugn0yR?QGj^)Gf8%&R2*^MlBf zawcE&=a7XE<#O5;2&WJx&s)kJ}^VMHGdCy`?n!(Xk>)-`nJ+JJF686 z%-fTP`k7T5FQORNcYc&~j5bn6QnZ-1@+Yw=z*lKl#58p8tvRp7U| zso#7;cSe!NIks7oWiW5K$6}L|j}NX~jNO3U6&TcowN^(i3`T3;3Wm?z9r=!mQ4}BD zuta|N8p~>B96kTrtqiP3wE9wFl{UL5Ircl3A9ZcbBU?bazQFye$YP{_-P)M?(;H%N z+uy8ML26djE7!+)rEdE{5uZCD__C}aZjM=tZFAi#?MGiE2qI~#HFxcJF|PWnqOsc! zH$O-xfwL%k8mgsI>17ou*ZgLN+f+GLF zFrfKvTu>QTF4{QPeC+3GVgVEFFm+oVHk#b_zR2LmP-D^7I)Nlz#!3fABEl*}H(%cv z-7n@ku49@vNE}<0ACc1dWGv@?HYWV*uWYCG~4gla6tHmRA}HMI(MXl)K5BDEP%%t zp<9cQaw&ydc}6epmJ5^k_PhyppWo{s*JObbLD9?`SbTrBuxG62C)wzQerVB~3Td*9 z2{aIh^>rlvqVTs9$gVeY>9`I6{7v58M;@GVgDW(Hh>cKKbjSJ5&T)9UeT86JRz9E# zxBq!NS`mNCV6i#*FXr|?0<`mGj{~r@0X;Gx{0s1iWpd+29|BB06y)Rrg$IT?7_{Gr zObFhhPj_~9_V$WLa2Yj*L1-hj&863X1p)Z{&xMfN`MM+Xc98pDoBgUL{u)XH_ajih zU@N@qv~C}pk%QvPJ4&i{BaJA?xTTb?UF)fFd2R53w6iZk*p38kNMiA5b4EUEZ5_mw z+P%fpGh}trmm>p8X{_}$R2Q&-M1X!2d8$V+%5O&>#E<+Jzs71v@p>v!|C&JRYgpsN z<_hVuO|_q<;LX#-NY7wNs7Y8tO@T+8ku;3ha5>E`JYjGp3(B`IRXgp`RtY&CdKgsb zQeW7&4}V*Uw_`dHIUT8}n>nqr{cNFmSQ}^w4FWY5kmeKA8?MbUSepqrl~{}zK3tim z8AqV%A%06y4ow>hyH?6;^h2?E@1i%!7Fu{qcOx{h8!i}Of#6)xqn)=vMFC3u?efN8 zJwm)&uSV6vTm97R@JUUKsF*Q13Lc%=XrB(Y2eW-~QJGZU8e!@u2NMZnJG`m15PyPkqND&wx01G#G@$3v(41Jh&kbdKS;|1mK`;o);!Ao$2n`Rp8;Uo z?M=EjA9(+B1_1J(oa!~Kfis%IE5FR|#2sUepo!L^F};0(;ss-Gf%iu#wVMAv)_qXe zrcmtC3OP?FUT6=(WR2|6`C44Qd8eDF7`aibFTX#+QE}osGpZr~=<7P9CwN#Uu6kz| zk2NTtNq>1*5_9Q3unXS1Qa2Pe&Maq}D zCF;!T=c1Q>+E7aLWW-=XuOXRwQdpx#cpQ)wn=fu#cu(|e^f;zSisq-hw2|xKLEx|f zeMiLY+{^ZMaL5rr9$~ck4`x|B^$kbL=Hhv7x<=N@!6_Iur~F+wVefd|x#t0nqI{6F zw{hHmwfd}SkM{Cz|%!YUSJ<6~{uQo^vXdRs&6?c2OxWsv0p?$9EV7$B53*N(&1v)KtLEPPB z*r5|jX-jZ5EO+-mli5$mpE3rEmu%!0a4om3-5EaCj+O8o2}FhY6EiGdP-g~D(+!h1 ze}X7vNR5Y)`#7p`JY#ntz?3`aSpP`x7i$Y}ZsD2Kx7?gW{&v$^qaMRMEw=0j^YH(*01)tVs%CD!lFMXE1CW+@frEQ0 zm5w>o+g_XA%kw z%4kj1Rl?#7v#ML`QY8+A1DtI{auiJ*&3wm0SnQL>*lzAk;0Sh#-f-t=5B08AY}0xC z4;SHy{0ymddL^ds91#8$(=Zhw?1lrB$vRHnQFr_=_jx#jtY6S?`uf?`;4JMIT7e{- z$uS!8!5a|^E#X~m5F&61i)|f=jjI?lZO4~ad1rZ1Nmu}E zCt1UPFsnXH*z%4Wo>ulyidfCE1?_7n*&TT)t=9F~^`*cfO}py{K?B=>~f70;qqj}?K1X@JKMNaws8%z_x) z56>gcJDAh^_x@tT#K_1W06u0*)zZ?^{;S^gU~Y&QXwILmbQ3(&12$x!2kpNwhXY6_Vw|xg~CgaF8vZcD~0s zjJzCJ>Gg68%mhHRvRbYfAVIwR{Qy2cJ&mp20ML~eJVWQulya7A4SBfIrU5%n)yD1J zyxn7bnQoWKS8*iMGDt9DHQh~~wB;BwTB+@^5jTYRec(-`5zlU(>zY{9Q3pHcp_Shf zvq^B)A3cWa@AXz?o?ohT2R>Dfs#`b_AZ8mg5j=BiBsU5)<0_>bQGa8Oi2vLX*5%5{ z-cy5kIX6>;Zk}>Jq926x+3eG51m!aA=@d7bCcY$f`#<%UNzwq z=%yk&ijnQ_2kAOjjw%7Jt*47{6qH zqpiBD4DTJRjK-T>6C4yOD-U=1>tp=%sFOWio`fyZkQ|&EZTh!m`$TsCebdy({jo6y z6_|)%I0mq_UGz9U5m`jfB~yTHOR=G7p^YuuAb!@-7tzj%W0yX{l+4n8*_`j#3 zA2`Dp7#Khw0|*TMU2aJS?C0L2K`Hk?g)4`vYV(E_k&sCW7IwC_KBawsOj~pG`u_d9 zo7?sEq_|tg#mO1an**~z=gSp9u>n>8377?{tE(Zjr196sPt~1oPm|x@u7Q~W_&MNz z_*E!#=c5C^khKFm8pgl};Mew6Ix#53fcuMh!h%Pixf{g00VIWsiHfeRt-ZcpeE;{K zaL4DhtxeeYGOhRMh$;7jh?tnMkr5ZEl@ik|%>o$y9ji)d1>E3Q)C6f)Q^$8GQr+D% zwVskuoLH{R^w&|N2JQ;Inw%KpMsVd{5i0X5=NK1n=cSTPYxn&QvuPri#`O@0o1?Yd zey$dhMqgSir?uCWiBMFIjh6kavp;2q-MT8B&BHk)UWjZ!34pwpuFtRA@w17$7OdA{ zf_Pj-h4?NY3gaqPvfYDbKT`QdXlNe?mwm>>35U7{NXV z_VP@Cx@F;OkIgsv?G@8=B*Fu=il8Yk(~q;ciIXM<6eY7LwrjY~W0IvT{44RZy)F_a zrfo}x^*$d>;zNC)BMqibyj=2@;clM`AjZfne;}I_G8V!0iz&IjnX*i#%MRVgD`nW5MbrF63jh_s;LFLshM=nAl9VfXoz~zkL`uVc|>S(dve-1%nxHh?w7p~SBYfp zDQb-5;ILgFWXM=jbWZ`^b<2jGB1GtrqouaqoJf^;Kr=Tna#>cGZMj1xSN0w|Z}HdG$HByxPc2`gfMqezqS1`7A4EfQ;=1=(E1R z>`?r-4Ej~LVN6pDqq(i^xtHSY^5Nm(=H>>_16JHU)i;D4^pAJt=#*}`}=SB$&`s9P>7lK?- zg2KYLb}~5KJ~D(}x=roMMI!YzOVyh1C_0R2?G0F^s8%<|f|8~T z&bbcS=CIC!fBu6%xVSgkyYQ9_Np(Q;G9eeNxMFldH$FdFN>196WS8B$u$w@g{{SNy zQcwHXR?lT#$qDrjHhT4lRQWNQRi2v)u#m1yS?sJtJ|XD>t1U=LC0=?SrJ)kfr~`i= zr`RX1jnV-br^g+l8!quB68_W`q6<3sb24PKvy_1<%6n(F`k`SWdM&ACp*!NvU?i)H zenm+Job=6cS({q3G?V67{5mXoxZ1eQ`)yGzzJm02Va^_>pUQ%kr2zv7E z1sJ_wWG>(~R!nI}5b#+MrXS2x;>`?XAolOcIbKCvtnQ4kr0Qou_4N`RnL6Y|s7qbY zA%)5B*-u@$Mt4xfY9NVBft?oh$}JbYMcQJSLuKCfitz$FpO9UrD7OtT?h+^RMO-bN9U_A(9ci+Q||wx>8iu&{KNj#rluX;-5lNB z-OV)9ZJOzW>6n_XVK};t>F(~D?&7^i|v#zp$j zFETZQ7i|c>(&J)QEhdO2CFTXEaoZQgx{0R6gFx)JrOB2WeTPnckg`10r5!=j|R;PuPlS_)f3~`8f zAaJH(yvoo(xYd^g&3xq&ecG}PtWNLl!&b`z2gA84E)@BvTVsOa3Y15&oaV+RN0`B2 zJ3hp6k$xDRD!MR5n~lKG!bi|*f`@R4>lTbfaodWX+?&K|=DJi-zlj_%=#ivK=&@Al zaQ=L0b$#F6`tvgWt98am+NDVczn9*FWxiUP0xh5)^Ga$eER5YvuiL9lb0{Y-L)dxW zi85JiyUY4T7SpFr@jYPMns7y>PJ~DaO6Um`9^|KVy;=&l-9W~GpDZ(g@WX0F93>#gok<=KS_z$xfpn1PpQI4T1#5)-s>NCe%JkW?c0{L!W zD|n+_pn(UhJH<))2R2~W{YmLtc5*=!`Uwvkr;7%P$2vK2uhV+?e?}O&D z^=>#ffAvBuOYf?$uLqzAkl7XV+7$HE6!dl<^tQ6``lt2@02^0wFMwTSf8ZNgOK00P zr&2p&o@ve7&5g(1Xp18c zC=v%juLq`Yj|+fX>DBx+5}k~djqSnjoqy!((2%@|Nsh5T2c6eEBOZf^j!D9-q1T^y zRaktg)^@tBP?LFG6aC#Z%)PWUX;%B93+A!xhvE_W_1mz`nEAr`&PUp`=wSZX&eUeE z3pX>`S$H))*BJ5+X18TEjGCRLR5v#a&9AdX#qSZlQn?^Y=9F}4ogLlkY`n)nUwXj5MjaR+D^^%q>chr&qI^r@|nS%UTP^P=1|9$r-= zzl9sA>~%DVKrmTQs4Z(6>J}U(bf%ULoXx+cq>L5-L#Tu{y8C=Oi z6B$M4Ur9%~d3=#uKrvQ4B;sKwjJ8}H7dA~3p?pgU5-bKKus^ zo!?$H$EV6gQEn7AXjYV!&#DYgI21^!AAN7rLr9*8F-KSFR9A>6Mh=Qmb z-SQdKY5#L(n^}<1{ZK+|Zk61dZR$&jrLm+q853kw{3OmoW{sxWdX1=zQ&PAy!0DC7 zx0lLAhdao6578P1S?LV1ofePibC>RF&5QhIIQZ@nOiU;ik?N|%Q4*VkXPOjybdmL8 zA2nP9L-V7AsaBwGBK3^$fy|JAu>yG(`-H~tkY?6FrC(CKWf}aG^qxmZ23`^=9(`IE z3LhoF9?N({S(1czPDolqCRBB!el=PRvv}fg@H_!Eb@U{JDBSRu$D4kaGbT!s=_WT$ z3=UGClBDHlrkaZ4e@L_Qt3NC?_4qjvS~W%k>0 zU`~8`o|VZi;7G8HE$GJBECXBc%dlf6*H{Jl`fl51h!zf$;co6d0&mxP&B5`}+eM@( z(Ch*81g1tt7kJ7eGgR6n^Ya7f*kKX8E_GKGu7QE^v0|$uBO^fU6M$dzwb$kEpT6+H zG~tDGag7*0*fw+hyX29*Sak#(Oh7J_T_ccrxJ-<;aSdyOGd!LOtJEp>w$l{!AKcn_ zd%f>^z5NejF>Mt5&f8@na|5#2ej)Og6pw`Bb@<=Rfo;GhCl=2+(NG&?eqx$1 z+nl|iDqXBeZ1QmPLuw`^CsQ-f!c2}s`6d@BIZ?Ny3{Y);LRBpbEtcFD#6q4-PQ@E_ zT}b7ye>E3TsS4L=cmF~93E6_KR>Z#lmzF1)U4>g!D-oK^XDmb+e*FeuwNscbx7?+YY?ynjpHri zbM})p>)^9F@=9W4YH)M${(wfG2NX-@liaPEBnc9pOchEdU1r5FUVTxpgB{8VUEE zt@9xfHLZ?i?$|j#cz+WhBszoM0-II>fat=ltsbgd0008-YjQHSZC*~!RDUU&R(GtA zWLFA;UkV_AX4hXQ3Fc`49c`E2{Tc9=Yx3{Qzwt*?vHiG={0wM8PF*i;EiGH;lOiG_ z`zWu(^8ggoFzi%}RKL6Rha9(JDduJ%zu%!2wr@|}A_M{Z6hnZje=5hCEWV~~`LQ`Is zMm19mpTYD)@^0+c_4l?j#+fb|80P=vVcg0th0oYlLwNF%c@GDe1+7RtltSQN$`g{i z@WjL9@pug1*J)tXqsW)sJK3Q+njO@hNOv2X7Vt@;R_HFsbyr8fb88vC`J(*~2TnFy z411?z^=53_kIt^cGJ>g z``fYdZJAykraZ}6c28}b}wh}{YfysH$cvR%tQd^nk z>^7nSW7@c81^x~Tjt(?6{hfCf_FnUW84$hlLK4L_xi7il*KD z6s|PN+nag}X~YC6p_l-MSp+N62=TO05=ZtLf! zI~xBYqh;2TNYk&$i%9X@M^%32x53@g(0ZkcQgloeDm2N^d_Gw|1;Z>zVWFBJ{G_aX zPUqiEJ*QptZ-p7?;QUeNg;+mwPfvsylM&KAA-og|T|qikM3^~-ks;X}PZLN+SH=!g zHlzJ}mKkP?tY z#UuLmUp5h;t3ZyBvTcizuLvr|uX-Te87P#1=fu_k9XAsZ;orf>H@ zh*Sv7$==S+#v@^hTk5}=EdV3rU`{Wx%&7N?w(Aka=8E2zhPCzCuGtG__X$?GhAMeygW;|GiK;*1dbga>tU*}N?=@?=gVwOK~y&IWok zB%B9t=I@IXqtUFz8BhWu*f-C>TIt%w26~PuC!QOrR7xJtZz860%ox}ZsqvscaO>B3 zuCQ9XDEsP^;p#&+RyG}122rdpCl1bnC@Z*!GP9|~=3bcDV=D&ryR%fKxK43t{Z33S zX>g${mV*Zlo*=Whz5h1Uc)o5+f>#9zkHdS%le24Wp7?u35n_$>CJ)pYDVO%Mai=wO!DW4)ti z{tpH5o_qQ)d{_|9h~&gpqe+h`H-uz^s!^QyMvQr~1C9qBOiW#jUQ5hTj`-%3EyyG* zJZI*%;^uFFzW&^B#dQbNqEoMt+=dT@PnUBG3%V*LJJ(fRZ?8{B9tN!GPBd_5OxG&y zd=4T3%z30(Q55M!RsOv>0iRloM1+L?NeGhzew%DqfOP*I(dN9gvA$ldQ|Wb1D!m>w z04f~TM}NreB%v&V9bUyZb|Q1N<^9 zzCW&SBYWU)Si>g`iY}j5l)fX+pbhkdQYy_tiV%bFT)iZ+4l`yvk=P;eDD04LwOm zJg5FPW>ZLB%y4*W(%2!qf?@B$NOrBB>&#zRm|j;1W*a)N^bKl53%flExM$r;3XK_u zQUz3-Y^lB8)7ADqo!M zq#9Tk30vAP-BUvSJScS)J{=>KS(oHYG<8W4WB#{MB^M!+ zGJ!ThRVALQLqSha3@m#H-?T#QE_GkPcwh@%uf!`x*KIb|QmE~aSbVWXgtV#?$_1u> zB9UawHk|n|nWX75y&9!=R<$DOW*fXiZ^3BswOPsjM&PtDOq2eVuV6;_It?5a;n&+b z$Mn+)MWYo|MJqu-t4I7d@W@jB7PmiCMr309@Cz0KG6pzUZz#e}cY54`>3aC?a|7&u zI_vT6_hd`Hr@hlt$F{XAUp~6odbrMwbACtb4ih#I3a}!qem#xy`mX85k{W3V#(_3Z z!=+>2u;%#o@%1&ZYlDt(qa^@9UB;f@+O`((uOHgi3T@B>npQeGJ4pjyFIQoG>z9Ot zg)hZIPya1BH0m*{l+FMsEB0l7KZ1-HfMq~b`Z+*{1pWKPa&{T6*SOBrnq>h~BB zQ|uo-^~lx%bF3^^uj!n0@WuL0DWG|lkf2mh=eLG6oTm!IB-@TzIi{03hZiLE$}|1x z&S%WAyDp(NFT2pwg|a4IAs4Y^%4g%sZ5=_6V~!XllW3(vl)k^X(+SCB&)hEYph3WmIQTi4}yagyKlg&3L%r- z#h;2xig7(Ya>pCH=!Y?NkN%-Vksy!D_t*Dpg15;}xa*Ri-DtSs$|2D8`1_O;9ckEp z=Eh#P^~6J&lz*D=txj}^g?3UWKU1aJQdHU|jhKtr5Trz8&pZ);S7hgoR8{rmHHS4Sx!9p5Yo(1O!`Ls6?&CarU)4-5X@Yq_F@?EU=IJf zY?+2UGoj(FX^aLUo(fq_IZdc_Y&+15|6;9|A|Me+W3}@&pB7rKOjXr8fYymmP)Xh& zub?6(VaMn0ut?98(S;_9^=Jy)kjjSGd8>nkS&*vf&gC|Xf+hFss)kx(%9G^XX9tyf zQ5PxyiE-30SQ$P5a;$bzdj&2}>r*V>XAOE;PYks`ZiLnfv+3 zn9@SkK$J5C?B48oFqe|8^6lUkympwP>#8m9v}>wHC1;f}n^GCHahArDMWU8lOAAvB zbw~?EOnKPk*vLMx?EZ0IwL!ycwBm4ftW`7uwx(R7Iubux{* zofV=oK~05k*0^FRJ_^OmUN07J%x^-*u-KlXy0BqCZG4u%w^eSWz@$dURCYa^PbI9lX_?}#cmzb-3*5}_sCOitVTxz@GpqHB*noAoKot-eFl7G~iob0b`tndMMEJ_rw_^wAd^EMBH_6-VW#H*8M z&7;pKq1(?m^z}t>dd$*4ur5xt*@c}A>Ff=c1De3eX_!^lUU2z!3MEqG>|m506wC;_ zsYuJ80b{XYe&O%H9|XQxnU9rzU8eJ@MoqbweP7+uquRE~cWf>7e*0%?!+s0zf57Y@x@Uyt^5k;mS2lVIO)ma(lq0nijqm1pjeYwB> zX7XM5;`Y|F!$foB?7?5;zy?ODG+L?C8IA<)gGtB4*B$;NVANON*u;;{6G&v@V%k_( zbKn7jnGUM_{Y{ubCr9q&o#f8W&espmfa@Qa&HgV-8fd%zGeHLhsd_x9jmc=?p`FjV zONneXTQ)ISi`JT6KDL8lE|j|RP{0>t0w;fizeV@PAwkanbjT#hgdrDn!rQ1m2zX` zOD%b17t9%HbI9dOM-crjRz%#W1GeoD@h5h@R_{hp%t;_j$)|dP=h9ThOLoYwWH8iqt zLu@Ky=&bPZDdOytPO4Vy*PS3&k*uFuafQm|+!oRqUQ-^+BpM8eIFY`(y3HfmP}y&^ zCd;mChycs8XWeNpMjNv_N2g^Ha@ZqRap;6cO!j6y-&`3K5HJ?-0fC&EwoZM}p~}#c zJKyfZuJoADRCR_Iq)ux7QD2Psy_&&u{a=R7I@$q7wV4bOZ zlkYnSx>XP8oA})I^Prta(eM_l<_dMuqt-OWBpfFKaBY-LaEGM)%)jBWAMzRpcUJ@i zXl(?{nD1)u%;a11{RJ}xu^a2d;tE;#HX$jON}*|&kG zyddDbj_h6S?S*^KxqrxWyxh6u%Njd7KVM3{`(1isRjRum^4>hNT2}!S>UDGLkJc?d zB6math`Rotym+#Ng@qk?h;ANtKNudeD$ zYTSu(WbvL}UVVg|c!*XYS{K5LbD#UIh2Qu$@`N9O-89cY*52_gA;FCKN<;ZY&+nBL zB097wnAx%F?I`j)Vr8w&KaF^}GhX{?L6|n}E#*1eqxyx$38U}iS>T-OX zAC^-2W2+i$=SrzHe9RN}MkirRkv2cEPgj_0UO8wOhHuxiJ%?jR1-8Z|==PN9H;3Zj zKA}WaAGv)bbdy{|Ww#TYQ)5D<=tAjoyzvgfE$Zi`7{*ayi22l%h(Uq0J6C`_`twTj zy4>E7{l*p(PpH4PAfvG1cJdF)g3j6uZ;6hd9HG@qvKOwRb$(pOg=kp@S{}FhGh2WC zUrqRKhYm2y4(xZnW5e$l#JBaW1`mi5$5>0cvdn~uF<4a~ZDg^i$>FB#yLAi#4p*Yu zc04hMf+`2Xf%3v>ec>sMVo$#?sz8F-KdCx0E+txVk^~DFTC`sZVnK%Hh+CAMaY>b9 zH|~Q@B>@HfVL4?<=6EMlrOU<8oLq0X>p7th=-|`h-VwcpvT`m=tU;#93j5`X`BrUR z?BWl2_rWZ>FV!rrt%wz<#r8&uo~4W=BNdRt#8C(*jZ3&Jq622(&C*s_H;yR8PRk*Y z_(1x~IHoG{j}J)HT_X&5#(NO-;*2CJ=o9#1bL>8cGf$Fy(JDJeChq`=jQnW*Cf78U z7E#-ne(e|0rs}I`j*9h4)t6H7MsP#!$_;zm@=JiwP-G!(2$ifBW?CLe6nPiTYG)HN z)Co>KwF&04u>!ToFLFK=l;ojdnJIaqUbeQ@wj9=I+QbH90mp~A8Nel`Qjss7_{Gn! z4On3E4%B$Xf12}k6Ii+NxncSIUW+AN(X``0+r#U0NpAsLl!b|oDm8O!*B~rzKi{7C z{K(x1m2Eb;W9M?Pg|~8!v1viLew`YCC@PIx_0_S(75~Hkpm#%dRF^=Gx#BTJ-ELKJvtU!2Z&4ZG)^rRd&5;ntoD1Q;Up>xkN7s zws}Y=6h`5r-n5hs)EK2mP&$mA;>fz1eor}7K=XlPSv`R(-7zOdphRaxKHEz?se!V| zyf;l=KD8_7@O`K*4Zmb{$s&fZxfS9aW#>PP=0vEiq+?OH2jy4kN_$s-a+T%Q7j^7P*CpV$Wn&u4qbs0CfXl3ABjDGe7mDDe(m*GqGot_8NSbmMt zC>ag%#}_!gE#LVGm~;!3Yx$@(&7F6YrNe3Jyat0fAUX`N#lLJ>Z}%*xJ;bD46+RRm zzG*P2V0~vjH~9p4vvD0qF6!?}d_@#>1S7#hYl*+1+B{f!*ciw>k9tidpsc|^9NSTK z^m;UvCPq5V&Cx0eB4&ODrDg2UhQ3K#6&#%{dWZb2yy5#)^tdzOf24a=O1<>z(ht)s zIhB}}zl^?(9#?M4Ya@cKU`;#eM+W}nO#FER-d`3VUIXmtoFi6L9PpS;80GH}!c2Ln zX1T50Mrnz$OM~%Rrbihr;-Mk!RMry4aT5u&#x!=@-%87}3_aWW5IOUi9}C|4Zx-`+r&EMd{-f3jb6j&Q{ar@)EkprPsZrfo92hr0Y>JRZvj4GEF@U5!c^H-%N+4<2eU~Gr}Vmb*tLzt5I*L3m}yb28uk$nC0`XCHq6_3%*SHi zsEHIo4Z##-ZSrMW`WUMsn^XNY9MZ0ChH~9Ues%S*u3)(hc5gez=DKHu>d)KA=yRu7 z#TF?AjOR|eyV3CRxV-dN8}p;(H3+I4pFiqnn@eNR?8UAOpXIO3N`D&6PST751;wO+ z*KQ095wFSB;m1MTyt`ie@C0d(jPY5A0%?uIxF9Ik_kS&AUZhOD>*hrT9-YucC;E$Y z%;p@$n(CwNq8Fon)GoxP;0o``Iu?be&or0@?k+MOhHX0*^-Q9@4#v~hm{m^N5}x8G zD-4-x$b(#>HVZ@sH}7RJeEDF%RQ9vvnrALrnn?Mrl!3fBcTqVXD#Y|?)Zt5TYMtB+ zQWGn5e4>&uKMqlgeh9zTKvpVZ8&ewhTz?OaVMB&#)NugM^VzA1rnPXH) z+w$)i7ZLHD+VVx)Vbj$sdMBoG!RPHM$$~5`k?0L5=&fyilSa9wrlpIeK08+WkkFC* zo^Q))9HctS;{>*&?H!us?~CO! z>=Qcu6>U{(OxC3zg>I#vIP=%<%p!Biv6>^R@?(p22Yu{+NMk|lk|X@e z*NY9?d}&f56b#^*lP)mFp9jT16+{|@94<409XT43oM;C4|DqL}8+BCSmQt6>nd@$8 z7@l1<_v?hyPP#`;pS2?o`GrvF7__n2Op^)^oY#H3zPsDc3b=^|F24tVr-i8<^Ao^g z)u}pwe?j1|#40|8W7&x{qim8v9q#cD%%E-joMda&XJ-=$Wd%Fo2d>LKQIgg!YL%4j zy&D_2S7H2?%ur5|Gh{%5o$n_+xSYnykGUa>=HzLn@}*U96s%r?n={I5 zsoBjF&hTm2=Ye4~u|Qb%1NpAEW(E4^RP_Xqv>KDWY=$(myGex%tga$%mW&Do>acgM z@EEOytI|~8Y5RMJGY{gO*qF8Me1EoF7M+>^ zplXwJgMS9tG#!Fo0Zh9uxsGW){0PJ;_>1sn?_B!u5v!CYmu~+e7_JCS9{V;x#i7wJ z!>-9ioOHr*!v(V+`25fH`N5ly7%f@RbMOcDU!-7f3{a z@azzl!XO)sQFgV*`yT11u!tXbdyDy}jH6d{eUICqCz#`<|tu_c4DSA8(liXMx~{{i5`Kb2G3fgAM;cI&12r5}Uzz z_dW~+o-c1=;rRAHqulkLp^4D_2eQ6!ih^sV8bFCBf2tEAiRBOB47%9B+X9q#-~~Up z=2vB2nKN#S zFE+JirdNt^sPv+^o3|-pobV^4hYLB&PZEdjEk+QB8b=ExCX0oV0-y9hBYUZ7)uV`wo0+6`f9dhbcuR* zmmz)=L7_7VYkN?f57WTY{&wbAMW;ODC9*;DyJD-oFhUZ@v{2FlerPsaMS9Ah02ez3 z_1~l8zGf!1T*?y?|E4wRhMonmOuBa9Y*E7{9SsTy0JJcgdIHO%YshC4<}O zxsmPLV0x*E4y~o^5L+E-KW1vsaB3t)M7Lwo8!XA#b>NN|q&4(iJwARea@t9N*B(t} z2~}V;PYf?3vU;~X$@MWwhJ^x_I1EC!JjWH5;Uj18>v*l2@q%;3js|lym_Skf>~qV# z_;lK^%HcLK-B^U$6}O}Ia`6Fs^+OTJ`y-(=6Slbl7{jhgE*4cgM@l%+ks;AAdsHJP z_28q^*qW=*7t0itN(DV{r>?3)n97rMz)5v{;mSDcLQsHPJ_+YD>B#>`M6U|xbIvXupI ze`|CLK@6CQp*@kaMkmll6(2%%8T`0Cr%+HF^E|3L%^)O|UQ~X@$0q6BSEgOXQV|o} zXz+lk0wX?cwC6vIFa% zjOnW#WNnx48^wG)v-LMXq+fCX)O7wJ|E>)-5Cm|0*Pg!K-1M;m|ExcdLebFylt86D z<{X$HKR>w0I3L*m=;yFr@vW6pP%1D&Wa@QSp320CRz4AR;oh|Y2#(GhosLb0{(3bF znIY4}OMO44Kvq&Sk3wOSA2Mq-j)k6o&9IQ)L4ZYIG6LHI__n{u{irV#xDpOy08POk6$E4+ zut1DO?;kHNE>@ho07&R{@a5tg9iUS2-mK+#6F9c|6s0f>qkYBy7KIl1yUBUu_1_Nq zAM)})j$Y5MvH1f#9Hb0@zMG>0M30p+a13A#mQ08!nOdzeJ0MTObLsHtdyP9BI;`$W zeqG&$5YeNtvCC zeSrxa)2`S8l;j>`xyE=$toZtmPP+e)fa08$8UsY z_G;n6{M^M!VQdka42xH$Xx-OHgg4jP+J?KDNBdHsqxi!QL_v}aVwr=WH>xW}?ZE!H zAwb}w<^wsB!1pm!QK?YGtjv~Fr7XZJ{hms*jZW~uGi5=tfNxoxquKR@mBA5x=f@0bnD1z*il`*W9gs`p~ zlL)ziB_IzVJU~1{PCiZ|gSC+L-yI0|Hg5%_b23kxXzXj-#JXoFfLS*$$H^rqMqn$m zI}D=lHm+TXho?6fdiODLO)wyMUbr4PaVz7&a$8S;xjF2MnmXlNYUHms@{<6{o;rmA z8tQOL5L5vdY+z&C?NBfEetEPk-u&U)^&bgGhUHZ;B-@A<>>;ya1rA;?)+r{q{uOIp5=K+UEN%%Ht}yu{=}v z-(?iytdxL^TWWSP35}cR9KVZYaLObk%Dp(jMow_O9{>4w-?+p%X3aG-aWb3O&KRPC z(aaUE8r!v)utU4N%p-mGOUFl`G@Qi(i{8OgQYEaY^q-oS=?UW0zm1 zK-a+3Ls~ZA0uX|L)osk$-QE2^EGG%Hv}>nc?WVDmro{bZt26UQ9s&Fa*U0Atl@MI z7|zZBNk$~psLKdfGR+)obsJ7N@!}=Gj<36d9s4W=6nB0(`5`o*7wP0DVvyVu(fpBuJg(*e3B&?Z5Yt_U{qY|`|K47K+Mhl` zgXvl)N;W=L=dalL7^+gMej?jU`M;{g53UMEzOQHdfx^)I z?56717#5GxmCsdp@n1VGJT(dsjg0-hyXTX;y5S`Y?aNjKSZ1cy9?@;2$ftg^<)TtF zJ;QTxB~n}kK`waRZZyg2bQP&el+yq8bAgnU=}dX4>l!EjQN=Tce@kmX*u{gKQloy# zs>GD923JM09Q5<4H2M zJ8e94*Es}%1@BMNEa~fF`y;QNN-$b)4i#D;rC$M)*{DO;mD7qtAVXDzco7uKQ>=6%i>oOL0gmXetpJ9&qUOR*ephKB1>GPZ8J ztT>^*7SFpqSFD|WI`#EzM($h97DMsNlLnne?&cSap7xy_n{AskN2I{EMCUepcTyrN;6{R4Bxfc0-m^Z>hGm)>mn}a{Nv7m5=nB?b`bKHp_uu0;pi5NdB0;kPUd|-=lA>97|VE=*pP_DV95> z>L0HZpR|my$JOuRrfJ^kD$N+NwRe^k2XoNM>MlLxOdN0tLp47DfScb!^DFz`7JAJT_~Id>zFiYfL@=i$;~ZWOLBTVbM(dDjnr zf~;f)o1_-TFWr@!>b!~})=m@xmb^k=r2G;LCpbZfYsQTmT2cU-7ThOD6^n4QaSI<=$d`VQgB z4ax~BAnOXc97cIO&r(;b2r(@WAxZ|*FzP4|L{6HTl9>>SW%k=J`h%Tk1(&aELX2<^f93&VI$|Eij8QN^+T>+@SoC+^mcf`xEu!#^&Uq<#Z->4)4Rw zbv_YvI(;;&(Ls=A2ANBnK$>K z;vq}e-z!;-qR|@cC7M=fPf4DFFC_8zuj4uCElWkak=ND!t|;#pm;*V0_?Nh;UGG@kh&_;K?GHwPyrh)Y{vp>fk6#z?fBiMhdX4tls~GXPLtf z(GePgZ)}z3d-6c0O6#4}1jC^X5~yFz%==9ponq{JyhUOJ<~Was3>Tcy%rGrUmxK(z zRs3c?nuZoO#4^m$xM+NNwru7<#P7Y4SNe;|#mUe%%ly*)>Z#Xedwcuy)5e>1p-cVJs5R$AVOL8FOyqg! zFXIg78P21YEcrmdF9aC9udlDkf}Ssd0CX>Peqq3?RJ~wNiq)*?jE&Q~+l1$kwepX-{wfHZ&D|0?F@jc6|C5JyV zcqS|d`Y5MS?`|%Ac7-Snvd?>dIi7l(vny=2T6&n2SJfT-POQ0hnye2xl?U?+34gS% z)w`%fBfaKR^0^OcF}kux_qs?QDL$X#q@O>&1y-%hA9LHR9m2sUPMbL_r7(;W{oI;i zF;?G1)wjya5dxZJo=ZS3zk33FA3J#L&;L>)0Qd_aWuVEOr=D(HIVSB~;v`{U#KI(* zTP-<|5Km#ege>~F4oB5T#!BW?^>1zS7!+^G{E!iw{l0yH1JShP5=hM0UXd!(`3bcy z5jfJhH0C2qtoC+w5Ri+QoTlRUFiKa9c%~pTV3JIld63NLC-58byB&fGuB}jJlH>8~ z6kvN5%}u9WVMn`e#Be^6ha73_UWHU^|I>`Y&LPIb)+`vb!I1=4WQ@A2pG#4wx8s>X%{Jxn%T?pVFr$h?V8h!l03yS=*TaCR4 zcLkIXP(C#)toY&+w>Y^{x<2?6-szt%{>zA#0bKwYR{*Lk_;N9lpi<@v zfxY^^)$GzcP2|{zWu4ewfVhdsocj$vFnsD>gTX|dxh02^b6ZsnA(4!w;#D*=c z^GghoM8ns?OLM=an#sB1>_=gTFs_)?EzS5EzXU(B~^2H2B zms_FPJw^&{d4Qnuc{%UpgzwshTNthu{x`0#*-`Y}(btz;@CpEVk-yCV5sZEZeHh&UXKA|c>?ru40vk3g{6yaMB|Yei{qVuY}iLC zz?pg3{IKWt0N}$*c*sv{n?bLlmdjyf$4OiAxw+7ZPi9KB3^nLCUV%TmuYUnP6pqL2 zr(JBwgFoPF1PbPt(A18#73wFXf2~^zLtB$7R;&%DTWe<@uO@?h!#_sqF`yjACkyd65F8>DB!o0fGt508LCEo39DjLY;C( z&!N~tKlRkm5{u{Pt|Bp5l1m+F&^N#ce-z9%s9~9oza4q!@5? z)JbB&o%KUNzzkHl=frBR2A?MT1WO*zQZV8fM};tCcaaFiF z;q}bO9-h%EJ5lX%rVObba0?9QTiI=g8DMhG_8W;nAR-f>ni7z_uQQ~Q=S*SrB*Ep% zx{g|b|8fMI@MiOSs&7LPAI~Y)QdKlHk-qixlUftaJC2E}ZoWt%I0-82eMsaEu$KK6 zWJX28u?tO#SFXKouozgZAl>AQiOBXD1$P^vK_Us$rPyxC(HxW|!@Y zBhkFX!M_WKAN?yWYGKFkQT6D8H@igtDN=VOOrL%WI8k)SnOn;)CL-H-z2Mu+ zledU7$BN|EVVnBewSD->xKR=*Um)6l+ZWK#zici0x72JDPp!n z!q5CV0mPTb1TK_+A4L(~9Q>5gyN)F*Y!(z=WhePD0!g~EXr={ehWI8CrkX&qDp;Aj zu40J<=b?kDD$~eH6fx-Aa=WWwgo{F}nBN(S&W0ZpOcl0R4IpZK01JW%*UlXh;~x{Q z|D&Cpwu_r3O4~rb|GogyG7o}{vEzLp_&)N_`^0n69HMNX+McoBJ!)`NUEQ#NNn?S- z1`cEY^7YP6`1r#;a`>2BGS35+{s1hd)SzlL%ms%d213gqLubf^O%NzEH-kv z;ngEr?zv&D2F{mntnr=2a3_43hAR?guna8?JkitX(+bn&p~mjqbt-b`*p6ZI2_Ln> z8kj=fNlT3T`LDHYE3a}1yXm`5He5v{YX=d;-QI-k^EAc3%oooxHWb69Eay`Oe<#Ii z3w6d8>`4Cu%js9x^l4q6Dp|#3D;kZD#om@U&JNkex}LzvgV*qntHSB5uy3P*kiSey zJ8#;AuW+r;9A#b*^2}$ho9d@QI<#iCIZatm#4fWagYs(+Y;;G?1w)_&+qARa8`s|Mh8U=@w}ingK}(>Fyl5L%IZ{ zySqlZyE{ZghVBmOPH8FOJ3B>L>!`p03U@N>8>Z0;2v!NX2*HwLhAT z+CFO?LX)0>PKW;+%l&WBvK6qmv~0Qu?smV#00mP-5a-}yi>~K|05&WkzVW-4U`{qk z%aHjfX2%KTqKC>eobz|19nRI%o}2Nio3Zr#7UKJJ%h(!kqkP`)zWyn`-+Z6KCHJ|1 zalO`9@XhomN$cpwpcBv};VNS{Gz-Y}1d`mUMgI#znt9_@;Ln={>;*4D2qGW4jp}A= z8Q0;?>u+lni{zNnAz`+T^zB7V?`tgUQFB8O7^b-jt(%}ZyUzSmlioeKsJ!Tk6wWY2 zd_zIHw~30h2p#s8A-PT**8se3W^4&){Cm#2A07rnc;4=A#f-qCxNGWlDafc^$W*_oOVe*VsqfdZur~c1ArJr2v#QEe zVZkT5_iwHQh1N=_yE+CYa;pynIW11A#j5zZkRbg9bK8o$yXf#vaT8y$(&Zpy`SQmz z-bb2>43wQmNz3PgPA3{MI_w^rE;4B!NI;FAf~LGT(A&4q2AfB^3W|Jxi51eN$9T!? zP=&G@tfQxbcRGE1RO4+{tM(#GV_DRz81RUx>!I34Mpo|a4$S#cX*;}BecPd3_y1*olz-(@3=?{Q{o9u0;M4;=Vt>j*%fB>Ms@C((T`n9o6@iaRwk0_)A_M$ zi>Wrkb)MA{0m;fTd51vx8rGzZLb{w4h+DXu8^WqP3o7m9r7NB)T#)S}XU7A_h4zbV*W27Ni z%@oYw={BReTMca|M%ePbDb`Tw*d5}C)*-;+_K4$w&PY>p5!5mNQI569zqOO}>gRIF zq)%l1MQ7=&!BEFlA!NZ4fe2;IKGmV0=ih`hW!@p=E&gzq;EBS+l?m{Dyousy2V6$L zd{n>Jrpp?574|r8)nrr$NNIsq&90@hs|zuGToPM+D>HuQ@=)OhV4fO83BQBU9xcOv zIpJRHlHOgk@#gG(5a?n3vGM26`T0FBLs=5%PcjZ_T^?V4BCf$di2Mo>*}Fx^9L+Xd zk&Phk>lxnKY{$&GP7B;ttx0KO{8uG1%KdidoKX4o=iX0CFiV;YjBG8SiTaPdsyZ2h zUkMbRr`vWrb8i|Y-Z$>ywv3Yt)8$;Pi%O;yGz0cF9OI{p*My-vlcJqiNh=LpBh;eL z@_`})18rxA?v;qHGje=~9*Rg#;YVkzCa8HETpvGv1m-~hvcB_YAd_`1=^&Lnpv;w@ zLR<9p{)$`Fte0K`yT||Inu&f1g3aHSDP|BOMt_#|rs1>7=Aa&B)|g7+Nu^ zd~9!O>&N;t^ica$PIg|(Iw52uhq^i7pjDb1_?HaoY%VkU>E;;i3Nvc->I_V+PRUhr zmtNg$yWcu#MOAo)_?-Bv-gv=Pps5_vDex+7>&rGX#b~~)nu}J@Hl^8JFG0v1N`$nN z=@!*kfI#00x~Dila?QPGYv%qb$G2%ZPs#Q^g#kkxY4~pfzA4p0R2&CN7kgh;_{9eg* zu`HNB^W6kXMqM<I!*jb#3`sYx8wFi zsk-9PF+dnzy|rx)5WUy92KaN=9Q8&?(*0gbW$V0h;CeE zEqR~aYjJfS`o{1hugPsNcQz61;u7l-I1PU9?xu3)ry!9(p9Tb#5!bFAH($Qq@fnQ! zt5?br+csP8^Muvvjq9G;uR-V)YS@4BK|y!ZJZnZQk5tnhMh|rA^bb?<)vY7phuVHP z_)al8CHL&5U766k;tiM?aWT1*&Xs7~(I!m_l)cLU9P?^p$$}bb0gBdhUau;z@-FCq zgP1LHxIS8y9GygWD9T)8Q3_eQ;l|HBmMeSq;IW~dAaEn1pQ#;V&u^)41!1AS#-y?O zpdsdc=86OF4&c02M=YzOA9!%uA`e7q(-)C1zN;J;S;nrSu3;B-+XMHqq@p!IIm^_L z)YS~fsm*^ipq8cUlc%fH9%^RGZt7oB3ui~Bm^oB=9F&jc`duxq@(Fv(Kn7!#&)+id>m9b}`J_PDbw{Rz ze@qrn(I1^I+(9?qAb{tw@(wpky(FckeyyVBcs<_(<{uX2^oNACf)ZWN-_zcBZ;X)( z`2by%yL@KbfiRoG=f(Y3lWCKXVa7FZ*e(wF3h{3^uRC2U;?VHC42P)iCo+Lsk)H87 z`p!*7gKI#DcyUp`@duE3ELq(i zX0^5P8I@Rf`2v3PzfXX+QI~azJ>cKN!PO)1Y3BXsD>BJpbi8!w1&F~Y29qj!`7}mm zwMDE(7i}I)PF*{I4PkcXWRzh0xc)^9j0SO$2}w&Tkj6>f4KjM)u!dsV_NEo3Lok8{X_= zPr;nS^gAPCW;qGlT2_M@E|2lz798mavD_L-F!1+Vw;4U5UwzS_^t5ZaqkDkNe(-&_ z5Kv2j6V?w}kYCpcVS(D-RY8=bCjIn)oiP3U8SHD z#JLDICjUX8St*eu*K9jMS1{M}l@af1x5!8dSXhviA)C&L7e#QjollkiK`4%2dH z=iUk%E1snz-bk(g+$6sbl)FPHHXyY6DU@aOM@CR`HKIGj<1@L_?g1^;*M!-Kioft-Kb`9( zmVZ-+*nwD+K-!834VZ~vcL?C9U63-IVcaxUEGx7vW@&+VZ25~))@|D1!}MJoV0rXH zYBbADuLeb=d8|*j=|icl(KLrO=F;V@Uv)p^^ahOQX!XCR;AJ%Q$c)CzU$zl*bK#DV3Q$C`&}{+?sGJ-)^74hWT(UMk4K&NPxjPi zhMJXR&saQl3;%fdy8}Qz;w|z4`x@^b0L%oa55R`H`U7FN{OiSqvzuE=*+xD25T$VI z@5bH0dth58O)cT{-DqQN4Y=q6-KDTGgT!4|)AupBum8H%905eWr_lN(aI!Y6(ashI z=S}|bdqN>=;FLPpH{sg~8~z^p=A_AXR08$g4k_FuFHsC^ZBlebe@Z&KRVV4vA?6fK zY9OrVp+SLa`0x;%qmaaUZK^jQ5VckFD~RR%2(VV(?a84Mi>Pq98Ys9+uqcjU zS&k)YutZpFaYqa6G1UF&mT?l-6}TAJ70DJ$xYc?DQ0O9@qx<|4;nQ^0_=asC^h@6e z?ycVRxTwr5WG!i@(0iU_^gpVoVHwq)GgI`qPlr7TVjs44vkrQb59m<%$`-d~-SG`oje{ke-kd zWLtsC6R{E9tg-YS9?xF{Kj^gzqYv)nc-*GG_3n zJpCjjm zG8E`@^t(ei(b>oOQ?8Izk?sZaB)`Tf;~aLYAJ8Y$1@7DZ%yM@bBTR;@MNSahEU07 z4wEWMES@zEot|3un`iOY>%xz!dUT#33UhQQZ_@5o-4dc1x(^ z>>!2YMM0?yEHHM|o+#B$pL1IlHxL(K)ij3w9apg3IsI0H&l?yg**h_T(<84}`h;YW z{R_UI+^KhZJT%?l%PQJh>h4N7^_q5|fXi?BV=Gj{Z=X&7x&^?Zk0pGO>_K}eR5Unv z5uQBcdQ$7^y+5I5MsS_p((1k&1Pg7|%wx?o?L`QtmdT0i;B5(;PW|R13$(aGNhN42})sTY(P~Vb~H;`ls|#nWEa!O)pgw@z&{`7dJDHrr)$7g z>M`7WaPJ_&Zgc05oMw=;x( zlU>qx4rd>nAC!bw-Y8o8e%Izn*qTP&{@ij^ljqIm=GK&Q(c#C|W% zU!Y@PfCXlQ$%js!FCvok@0y^^%IQo#D&lHVXoxECkI5mC7J$i=oe1Mc#|S<{-RIS_ zbmJiBb1Wc_i7;Ea4Di?i6jYH=XIV1ZedjR-H$(RKeehCmcb9w1RBp?AIsQ)zkjI}M zk-*MB!f#vVK#&`MZxUth4d`iqrN76qS(H+a+4&agn4-Y9N|RTWblnPSK;Bs3QCm^s z3d5-PqS)Q)Y92Cn>&=&UO7u#kHtE43Q2N$oTm8-_PSdp@T3kdad;P1oy;yd z!HE59TSbkO*(&do6x8IWeWSBWA6>88s;L^wpI-aibyLY{}Ok zzzjxaM_(iFZ6lN^_0$AexiW(&9(Dv}a!unI-x5gR6)ht<@0QiZTN-f2T*u18bbUJD zSeR|q>ZaKEe~%m6d()sTKRr7Q^|q^}U*eA=2Z%4{v*8V_)f*hRKiQiUB_>C_^P z+OQe23tti;oJg(FknV_5FSUT7a8U)i2=Mp1>6VKB^k;N0*%?s(ESoTI zX6KDt0auon=j+K^pYa9n7tZ(zMHTIL0XIl|u}KhhK>PDMz`Dw>K^NGx4QrH*1)lGD zivZ`zY_E`ylWKqv{_m5p`M95{_N33@?&giuhAP!lh~X%_f+Tdk80$x4P~9?klHh%IuENd=3_srn-ojBEr^}^wRd`r=oWcF6NZ*V?;6@S_S#GIH`(?VmcZ1NR#HA_R=#tQ#$d#D z8ZuFmIl`zp1HHghl7iakoucbv{Cwq!NN;gO*q?x~)YUYFV)LIjht(3xAXCY^ufd<2 ziQzoJ)%3H9HT zrZe2a_`PZKwmuVE5p^{WPd=BC+mx&o&+^T(ClTc=n6!e?Ez;ca_!AxJa-;#pTgpyh z)q0Mth9A1$GNs?Tv+^e=%kb?Rhc3VwpUC=FJZwDvgjID$2A8mkij}D7J!CGAj>1(U z#CoWNHx!IAMu-Y+P}frAhvR`CG)sD&GUJLncoY?8$^pOwpB~=R)MR4e(xGc2cvfk4 zf2&8Mn<=k?ug=IPVIWmTVNqW0>>Qd0cgC>QZFfT^OgXyIw$o4ueO#klhVV5BJb6iy zRYV{_QFaX9pF8lRJ8zhe^bw)&>FNTWDxiP@!6ut6J_sKv6DZt&3GJNLrx=OMcCI-- z^zQ*08h~m%JUKodw^3loo^d)Pq)>mBnd|e*I8eRbDtkzzXj4AGybZYD>xQ^w9!dvl5Cu+DzR%;5pRndI!YE{_Dru93Y|6OsF zKl1FwJevrUDndqrSp{K@LiQOXza$ErmGeQTa4N2;H0@cn@FXDP;oPw}t$4Mfbhom& znc%XC^XFt$nYNAUuD*mpZnqVo=!P&OLa8W83x4_(lPjrf%c+Bu6=La?C27%7Rn!+b z<<3Q)?ZfLv1;_|CD)i^$+wU9bagc0r_V{}q`7DllbIpqlE7FneOI z-KkrWVW2WY-xw3rUo&aA>+?ktTc73~5i&bFH^LMj)D^g(OCw*8y9L-Njdc36MN($m zXXx@^lb$MU8ivWGY7*?BQd63XDSa-POjGoMN^8Yh)16nE)TgiNRgcEf1aI8Ccm@X_ zX2;jt1+vx~e!C9fu0U}5gP4YGTT0#RFR3lKMc*~aDg&6P#=F*ze1qKxe4eJ*y5Rj{ zy^E$H6jBNel_IO@Bt75JLY`1qw)~8H!K^_=XJO`o)}myaHWyk^c##j@lW5>zUF0+zJn+c?qIid*%)WX0*Vn1%n?4V(8ru>dfo~zAASK z{Eql936xyFrcG81&Pb9>ux-Ok5*e0VoCipl+@4E$XUyy9V8Q zC1APyKbOOxb-GOq453f#W_%uVb?<+V*8a7?;EoseJs<+p@)6PXxqlc8(#&Q&7p6RO zB%8IF$+Y^MJ2}(nG)lzAam10Kpp5e8C7Y&*UqMKq*-4>5-xq&MY}Y+1%FJ-hB6x?< z*E{6pKT^=$8TkR(^!sN6c<3c5ieWQPTc*fvFO4x?I3@Z9Vbf=Rx_=x$9UQQkj1#tT zasf96ka{7Q;}wykbOFF2PX9gu^^*Ph$lb@=dutfU40zQ5ryc`FlQ=#$5l^;}?u)+qMi0>9dmaPVs`OEM35hp{ zUj8DB4?nv$VU7()jsi0*h&te?fw8U$$KqMGe(g22Oe>x%ZSWj0ni%yfA zlDyOwkqkPcAxLv<*mSpiapF>7W>t>T+^UkuHKYHj|FA6q+V`C~W^k1!df^~ysPc$h zm^5w%*VcN#An{s81kTA-&R-%Xn5Z%rGM&CZX6mwbHY*q^^0Pd4iyF$48D`+?X&qj2 z65b_8`2KC&whK*rEA?7N4IRjAAv?pXbpNaX9$!kVe|D#`MS>I!2WeLsrp%T$x0@}) zN0U#?d#2UaL)e?(WrT%!*eVahvvK?GTwzu9?`Q>PaLS1ply(B_lr+_T>R;R2kRmh7 zfBR+DMi9pA8$HKt-d0AWZ^_C08+lCOAyI6EBrJ)+->M=_k+FpyTRWR(H-j3{xCn~Zr{cGRpNdPJHMWv zo&q^}=rXwQIFc|?{d9y*#N8}f%yJVH##o)DI>4{Fppy`~$Uc3*5SvuKt>sh2;sMob1q6 zBwOg2pa+F^Ii04QZv;j1K0JaP!PYKa+9q2~M{A|hX<{tZ5qFtF(}OAxyBVHlxay}Y8AR`Z@Wi%Oq3zrQxABwKB}|usoqE@b=}+wS zi;zrho-*TIzW0fDhXJ19IkZt`a-X5h+-?8X|Hna^oyx4Vl}H}IHeI&o&71W8yuPNG zPci`&blqOV$olh9!9?M5Yb&TNtKmc5e_2XOVe#5zc(#R}Ky(wT#J1O^B6-^CXS0^5M8uZN;#GqdWxdzobzsGN}(XF#cE!M*p{lOj@P7^kd?O-Tr; zrFXsA>o0+UB;`y%4B{@CmAGBY)G*K(u3IGmLYgLPhz>r^LaF>u3T96&3vnB4oH)VY z@ZLQPChO24?RHrgq}fV51y2FXT85cxB=0(=bqtw}vG7o>04%lBbhBZ`En?`AKf{VD zgNF1jfifg0eM$~)KG{Z#eUCpW_=qmw7OrC6Q6YATO_etJk5-8kTI~waY@#BXox;Sb zEwes!6bE(JdBl=f0_ONw%E;yx8FFhcLq7VsWO=i*4pC(8&2MKQQ7GG(+I{TzND|JE zJ=GEgyvp59<B^nK#5`glR# zId3$#_>!W)aab}FD$39ch{%oIGvXTou2A18*zNv9*R^j;GKn8rj!tZY5Wqk3f8na2 zOpxI{1PTSPgW-5>v>f(iGp^iSEjS%&`Yt>3yj1#>B`wqKh<-gIxO&qKI_2H7Yw_{( zyQMe7G00JEUTrUDLufWMZB(jL05Z89G~)mL^d@xhLnDkpT}22wg~aYPI(*}o_(yG7 z%z>v}MQ?*m8A_2LqwKeJWZAkcVreFwy)m^AKZd1rsyq&C+}>6#p<_NYmc zjj&a}SR~D7Yk9r?J3n^>Se73@R%^3NoO%2BTnSYHvhC*k{ez9s(HJ(^&YSZFQX2uZ z6Y}ra)+;hi%Yqh}jPQU0eyODDx_1nI!b+II%V-b9Pn)_|P8GmG{nsROg>iorC=&4U zw+g>R=MrRYc6j6JA`&w(e6JYtxRDN4$iRD)nBcyKVbSM2MA%#E$l(x%k%{w#?MG*>qn8IR#Km{01vR}GGbc_MR0`45z0!hz=-w6x$ZbUK(YRUOXJSS5 zzhWGk@x`3kSBr*cUoCi|b)`t^V3yuXSw-fV9jVVu@Pd5b#gQX_EC5S~-Wt&Cy^@hd z%m!uiUjEFdGMI(19@~}BfI+r_5CTr(&S)h%$t>IjU3ABf&VOUnrzRE^Ay(L4&tOt`{<*^CP~@8Uz}p)qAO|mwh^FZW71a z&5|@2OVNhoa*7T|&I{=iid-qBf{;76=&>;ga}7cSkmsaySq+%^?CT?g<~P}ue>hOQ z$Av<)r}yHArbak*cjGUK=A2oL#WufHAGPNYQ)6~2Dqi?N{o%Yg5> z_Va1b30D8(AN{Cv1W@hoy2UQz)R{#3x9o2oB-2ZU1m4iQ+9}0KE!C2PS4Hf#@Q`Z= zplLIv0(5M|Vp6O%1Z<2#M&CHOrC{_)uC+;he?m7@?urd5;-C?V}D&;(b{e|-~eFfmIEs#BTQ{^jIP_~0B!DeRJ?h{?F z7*KS4zP|u*wEUeBCo%hYl|0&QLy27Lskq$GS2UjZJ$T0>LMP8_L<~rT=T;kmGX)jX zjOgfi>|gV>R38Nt1aM6;EtBw^VAp)}Ccu831jI`}A3p-<18fS0re*uc&%jF9QV0HD z3G$o$!vw$e_Cs;rD#u-;R`clhk?$72bS%RQo08duP z&qQ=G2e4X655|+ZePcxXrklars`Kbf0^)~fk+EMuwq}Lf{HHf7ins0Bf&%Oh@hvc6 zzd)uI!!8Yr&gl0)=K_9W47Q_h$VtGOkb+io=rkpJ*W=M<_kLG>3`Mw#sUnjX2TX3w zxuMuYtlHoK_1gleGorU_W;tdr97Zkt2CC|ciYZis6B_9~m2X>G5b(T`hqUDm1A*4C zrDRAdr-}}>#?a0XGehK~+26v-1xFWGig78EXi_JmO9v_rta1}C^ zaPBEGp*L){Skrs5Enj>qa@`$wJP(3mORD3W9SPXSs*{;rkpHxNcnS~8OwYUUr?zZdOUc! z$o}wdyPS}45)bws$JORw&WFfB(gZ+&(8fJk7`Si}$jGp&(We&ayhy2nep_`LICUbF zTq33RHmKVpb{Bf+<5){HB`w^VMzht%gFtNX`LKoeRXjP|NiCcj3{{Y&bT@5Ec%^2^ zN0Tg1)2=ahxeE*NuY0AD#XWjLW@bp;AO5muXLHOra1T(X$8U90^AC8GBD))DSLLhO z7u>*KWD~g)8otETaciLFsI@ysnaQs z>wOTWM}YHpLG2?2_9NQQ=?m~>kfA8PIBGDl=sf*}@8_()F#=wLPD_pR_kcxjZ!}{v zPjq8rqv>oYc@5iyY}7-x&R*5u4~E8=>&l%s`Jm1A445K5ZP`2She^Md;dsFu6i2LC zP70`}2sMnL7XCO&zs3))0o>okMX!v~5n9jGcmg+|JVM(&AZ{N=X{f4o2Nx;(e?hKr z?qF{l22qrW)OKuEF9N|+JMSZY1tt7m|NZ;aQwRkk_aX}U?)*sHzUVsEu4~N-|AHJN zfPXuM(lBfY1%{5OcS0dNSq|vbMFcxLIxhL>>D4|0P`56j9Od)5kYB%Ae{F3>0yJF9 zdSEo1EqSnO4#ym^Pf@(bWEU=Dh8|@lXn|kRZDc1#NqX(l_&|G_V-3IUv`}2_$XBipSX8jS(-knaMkq#bXV?bOyC=O5 zhQci`DMtm7=mFhJSe*KU>-5uFmwic{;0Vo`w&ElXRS7EM%dSjoiO+srLx=Ny)@Sjk zsj_LT8t;8yzG$gW&(~22lo8%K&J}ump7hMr9<31i^T$0wf%@!gYg&sk)tYUwNAHPp zTO}vH28+}{A%YZ(+o2qy;2&G4gIjrK$4qui^ls+5#j(m42Waw)V9FnZPD1nIp_mOe zys+0%r8p%Oe!(gF=B)D)vsLRvo}j*HsyBVvvtk7J{oyIgSaB=Kq>AOJN!Z1=yT&px zrPM-jwmSKnLU3E;F=pY}!+hMFAELD@i?vTAYRmO!VG(BZezGh!(|`LHZ*buGTj&`( zFWc}1g4d^^*>a7m%@Wn0d9(-;ms`JqC6GFs!){dh94{TVLH9#8Rf>8Ns2cZxn&GV9 zfkeYTb_mV}-?ihNiqe93O8l-+A&IND9F7{1OXFTF|ErM}8QakZHuPBio7;x|B+ui? z33>uA z?{r!TmVa7&nZX~HvPm(=U^d5S3>&vPyuRixb9%~A{Cf!OLd@T;h1ht}&M%OXo$}xt z0VjdGjRqTkFPE47{e8eA_2czLX!TnREO^Py-!s*cRifFA>MRp+gH2QWOaR2K&HHhb zfa`(-yd#ny?puR2B!EyJDA6IsUP&9&N2}*3fY1U+uM*ID1*qxPjB{XFfhrkmP2d;< zuoR8!76CYqzproij~}m>J8!;!I|&}&ZAlnAXrk|QiPyWNb`??SrQnx>nYI4Gsd3Iw z9lfM48(O6a%Y%Vvv9qHLQyq^Q6Q4J?+C@pFlEw;$RZ4511#z>sjs}em3m`e6n2JCf zpf!|NX0&J3!mBT?CD3}X3GSWcV%t_H4?}pbWTBkj1Z`Z1GV4@WOI&qa*y}|yMJ>B6 z=Kqb3`6)+>A{cCls@tDPTo)W*Yfy6=m2LKgY2JW1+jbso7#?D{(>TOJB_X^_kAL-> z3^mwL+ehN$J6;_nQ4fq-g}?^wOTZK?H0Ud`q~cbv`6vUtAzc@&$pwwxpO_I^IrXSL ztT4%#wkbA;Z!x|FrFoiW35GrhF9OES=n|Tas7gS!l;-tfnI= zaD$&eNHV;yyHR=rUIo`tiSa^-&K~e+H;?F4J;mq#i6V%nMH7&Uz`l=#Ygs30!0B40 zNv7PjNmh6u3j>iHgTML}JT3?Np}1YssSE_;1o!xyDN!BtE8XH*A9c)fEQsAkw&M9 zlZ#UNx^wIxo=;tF_SpK*z`*q1My9}z>%m>H;nRQN^4itLJxa|@&1;Hp(SFyap-S;r z9Uhd_5e0o=o!PQI2aXy*xpi|F%2T^_rxl?do#yH`OHFu}^?zD`A4YYygMgFE%&7F8 z{BIPCuUkL<^%KNNI)JCoJek#H2KO!Q1_xz4m;QSN0Q8!1t6xP7V)+1|Zm{dRMayRs zSd{wu(h>Fah;@IQA97l3o7MC=tkXAfwV1MMxdo(8 z*GsKG1~;vqJ!_3P{rERfK4{%~L<-s$h*GrGo8U zA&pB=kPa4@LU2+y%|@2*OLZ=BHYzo*<5`SW<6>o zk`qt$$M0h{UXuWzzU*Z7@(5h@j)*O)jn-Gtq@oBzI#7VrXP53dYTz>-c+`@4q&akq zJideAMdL;A26BR_yq*UuP zT_R`CZI+p##Z@@P-W5BdvU5pBM4NBg2sgwe^7+QD_y>h!1p{VOw zQm09+@`r6m$GAB5B9*Ll3XGbz5wkRgY>>Jp10BrN6mKpuaXEc z`Bz6VzR^sdJh3s2{j5-e3{o&4)cRCy5#^gg6NP*D+S8x-Qq#LcCd~f8?MAdbM(gvL z(wz)m?|FK)>o}`23ViP3>E_E+wh1`!8@_mA%@*1&PvdW*kcH zZjlU(V0OO)TJy4*AZ@~*@yjdbRGjhvTfa;IA+Y{!F*nWn2Wgya9=e z%0+s4d2+bZ_U51UIz00Cm|lP`z{h9h%oB*pXZq$P!hqq6l=(d z6eFBGy^T%ZFI|k^j|cG60t)u*$%Cr-Xg<f4nx-p=6Vi@&`jN?BX2$+#syfY|evHsG?g>ss;9`99=cj<&*dPjX^Xb2E8A|#!HbEn@1Is(Uxw9prrJ1+ zT_Q`pNAl3W{Lt;e)&gg}Xra9-gb2S_tbJ;2s%k2`QLM%u%av?o<*V+hCOAOcmnjaZ zH4DTgBC+B?m=)UOYaq4_IJ115v6Z7{%2-awIc00SK`vl{XU(vK-&mQllT$1kpu_R6 zvbbX0`zvQ+&t~FkErg#=q&H3vftghbW;!- z)kJnW*7K^*B(n4B>5+urTtPYrmgiFWW=Wf0Z!A)0NcOjxLHOFPG!a`p^8|%6gA*32 zUR7j1PAW`=A%cEeUqTT> zV&q)KE!50J*h~&eXS->NCSnXwCmFhuKIFz0{!E_I^g6d>wf0PFY5E|un9ky(QG8p7 z7{)3CSHC2pItF(Lhq0wMUm`^Cpb&moy0n<+j@)8cT_-xNk?JR{0a=`)ZH4$q>K$`+ ztqy2IlCxDBposSE%MkI*B{PY-V1I}v%#9;H@p1H$4>He3ez>b6Q(+SDB9ljsjw)bdZ}Yn<{wFC$nV6>O-A((T z7ZDk&^~h) zwEW?VV%!iLdFFXi7@T2|*}o;u>RVF1( zRXmWABLbVx=zk(?HY6GZ(UFwe-cQolNLNH#PT$9-N__Wl22PcP zc(7RR4yDQzLlOh|l-|vScmKh`-!rHD%y?vb+X&a;xahYx^#%I2zKx{q9ZrPn=mMR@ zn@#mMK?CFNu>0-@&raI!`z7#=sF^7y{Rbr?c3GG3v>EbBD4e=`N{I?uo7L?2G`Tic zE`c}?bYT|V=C+k$&BRst9ItMXwr)OUiX~B?LWrkQiv~fV(HBv=F6C(R;h{%Ub#xcf}SmwXqYnJdsj;ruWm>@8?S8R${TxxfIS&#{;G1FX%!jP1QRz zgKN`jT=DpOvB<2LaLztj=ncE<>tF|NvE5H7h=-asw&4ke!1=|uC=*86?~&-jIbj)) z!GB#IvT-n*am8bhsPqhLTVs<}n0fiqTV!`5mEY!`!$TwfNvlj^c1>7DqpsE zMKe8jI`_g*?DxRH{$`R>XP}^DY+;P9Z(W&bV&`LX6EkxZd)*(+sS`V@uD9D3aw*^t z4b=KnG>ZTbMey8Ac;VZW??p6mNuwZgA1#T*SsElzYq0@Z7c*XOvOBMS(5+5>$>vD$G_e$zCy z$NF%>$n2MjTT$pb2D~@6%yUn(fk;U}G2kn*@%y)G=|SuG*%4SJxBJ`$$91+la6YAyAAnB&cy|5T5;MC^<; zrMh{0%Z1~Zvbjv*vgh%l;nv9QJdy8e*!}(RR$w2>Oz9~pmD%J7XcX8FSon%8di3(Y zJQEG-6N9w{jc8~od-upJvcLY4arw8f{NM|W*zUvSq$a-;Cv0yi)Qy$bbwJ%8@h*ZR zVz+DHD$aSm{p$ep)4!zXK;F#Zve~F-i!OYm9+f`L#BN(E(nHjjri_h2&d9Szpv?$Z zOMyGh32vLe4MZ9_J#hi)Q_b(4g&ZxCmp3(ZCO4?m^~=u&_QfM5>v7L1$Gd=Nxg8GZ z^3yNHzO5Wgc-g)$?kDM9*hm;+UH6D4t1DN5Y(Evt&B~cn^>UKNyQ5TEYFeH2fEIZP zW6jjQp#Uk>qlKs`Gn{*?NDQPf_ev&Noi5js_nlC3UoR>pdWq?NN|DUYG-nJRxnphT%Z7iNEB#{ND3r@`o@(g39yyH?tAifqXxuZZuU4#TR2B-1C3(+T$<)^2j zS;okr_0k!U5~F8`aG{z1m|qu(V;`mFv>9sCS8#y?Bd#(U&c$Xr>5LsJAfnh(r>{`9&Dr<9x+ZWjKcM1XQjo|Zl^vGjQz2==IWT6>PC_!f~N2? zc^dReQjO`1v_liGIj8%Ik6EWHZ(VhD8d65@0^%*R)6{77@Z64u#)sgtC}pQy_aZ?^ z+kivhI43g?&%Px`R!fASa;~Y(yPq;;e1Vv87IN(sJmiHE{UpFgU~BE zE#h>g21oC~%i`RnS<}u_`#>aH!-yPRnX48KDI&ceLtZNyzhuXm<+0eWSH(wy%=q0z z{Jj3 z{OCnp9~v4K7GttvZ1hbQjX=t%bQEOFkKhP2(9wPblWP4cBiIisc$M9 z!K5```Ni->c{V-Juub!z0;Mx6H?H|yPBd>4xYhs@0k^C5_d;Gg=ced-iKk>?=Y)T1(JHo>Y-*8{ag66~k$pTNdgd5%F zabFPJM|85cEm8d9@cw>XVqACL7Y&4~Jk>qyirG=&Wt07ph}mi0@l6KO;r)v-mQykq zT!1d8|0*3(Eb_J@Q|(Z-0u~&R4z9g;`m{Aq5qotXC`^59_tpbQ#@tUL?T!3wQty`_ z)6sxiLp)vPmQ?rl&YfL4N-2V~^AZn~sO4Yo`%k)9?;w-xbm=bv1RSmtywMUl`uMJk6GX z^{jyBh+009oWZM1dI(}R8*PsqB^6}uTK)NSKv#+NP)FfC^J9$>GnH{FvAyMfA=%qa zCDPD5g^xwbqmugE513owdX#n6b9m(9pDY5!qYheXDV1TG0$V%R2K1oXEp=5DsZsbJ z_xF_Nc%>W2)SZ@cX*(~Q$zKRkUJX_<@04*{1!b_aqso8GZ@aEFpU5$3?`BscO~!J2 zt&CM`a#VvzM=zC@mpQRs=m6u=fAucX4){rVHN2#-kmJ$Suv*P$Tdj@MJZ1d=I(dLj ze5LN3_`H*>$;XTIiMsoja^zo&+HP%|QH3{D2xdgmwEU2O^O;#`!p>SaB+wCY!QHoH#!0b0(_yJr zJBR%OmynE4hl-lVs2BWnO9@YjQ-DMn3YI6X9Vmgk+EX<@=ekw+m0MJ_Mi|$`=H+$o zB}0eEGcLgch{#Np^oIV!FrN!6j9K~SSI9foEJd)+`$Ch5=1M3e2et4EnwMsq<>@h- z5U~Y5AJ1lG_7Q|BlcwS2AHFeVVB-aXBdGDBCak`b9^Q_YOH?dQ?D2`4hkg5lBQX{6 zj1#f^4YIfiD|M|JM_mCXlA&xj> zDj>OZl`zTb!}@noxU~6D@PEKF^-GXmOg{j!6#*H-Ddy;`gFUTrWNAgITk3 zj{+K+*EvHvc3ka*ZDPOui+?vNOfmZvkbFG@8P@<$cg4FuQZI!^=aETH%3!~Gjpj}6 z`dT^C`E#d{9LzTg6we3KAyxBIW*sWcz0vq6YE zLCSC}SA2}CIkVX`JWx;YU@HNY+&Jp7Vcr3i-==tlTzkJq`S#XWsX*Z((iqP2iUMfK zG3Gy}3$qWY((V^0=BLrJpYqi$~umBgmfxGa>Q2D-U{>) zGudq1`Ll`qDc>~9`Xdt8Yx=w_6?U6mFfD|SXmeT%kTFtuO|s043#en^!|B@`#&!^e zYawq6h0`(sGtG`lh1WwGrwC%h&ZjAEdWqzoJ!vB)V-)ovn(6XwO-U+@a!Gd94SJY+tdfg%puSyDnRyzXeJaGVa?Z0Gq2 z+Fjb3iv+;)1l4^9zus&}{~37v$gDl7X%BJCecK`@26p_O{LZRI1)utwFF-d7ZGx9Y zI|{t@jwcNO!d`U6Y@OR6XNPrulbK8RdopZ#tJxWopH!T;XL^@%YS9Q38cd28%>5OP zd4T#hPY*OF)a)`1fyD?|iYDqx^arpcvz9filRqP_2_lG{_7odbPt zYgZoRDhD`Q;?UosROGbmE(fZlPVy*kQFHDYGuE%Q0ozj_0Knhf0TgrpR3v~&1EOAG z>fgVAo0ymgTj#6Jv$J@MVlo*I(YU2dwsYdUO&mS|S+Z5fxvXKa!0;!Q+HxX_LI`6x4j94@pL4XXI@1uc3Z3m%}ytcUP*w zMY3QnFx0zIUt@Bv(Z=QR8(MH&VJq?1s-3ex0VXJSL3#+S$)hrCWb->7gL?xwsABO4 z5VmQ(;Lr-xYy+-^kjKq!;9-G^Y>|VB24S%;KW=4zfFf9vrYeT98N*9bjkxw*D|v?k z3o}}AMNAy3FSju&iEpn3xF{IA^OA`r7dCjelo#z6l;rao)j}=zafVrkGA*73I{2Xs zhG#DnCVA1RFhcb@x0s%F>@6_^!1Rxq+E?PNJg{RU1gc8+u)P zNa#{pqP!LZloEC0!KMGJZ+mzm4=MMhZAtWLTn?0eyunJzQ!+{(${dfZO23R1Z%$h% zGm8|erU5OOvk*#~D6oCAeV!$YBBSxa9~m7$_=I?a;CI9|4kftjIZu{h7IDhad^4hk z@(zjUE#x_)D6W-XI1o|N%@jme!A|cIB-0zwJfIF41e4dAZD~Akis)}htEQU>p)NWO z+P});D}y3i&DdG>4z|+vQtw$G8CBDA5N#A$ksjeP`r9K^%%G z4Y;6*q@CP7Yul`R$puB^86I8- zk*3aDsvIa;0B8h(P40CLZqyA``q1t<(8hrNeCqwUHF2rGCj`A^_*A2%3NiA z{FiT{VtG6d^g`yT19Vu#*@1_$EFr^b_?N1%Db7V({hf!q!9jwtlLYVCb92>;*09Y@ zL%c{}g1+v36`qR&08zFt8pH;C3Nh&z748~yKg541O@ec zbKzPnL4YKrjCQ0-XzETdOB*~+e__9O?li2 z%uRotniW<{PAs0CLW6EfW%lQA!GTkO6f~wjkk~gZK(%6B12=GsQc-i57#HoFJm9hP z7+?#scix7^zMk(eS#{g+Apo^^5FBBr)0+V`(q zb*}Mtz1xuqqzyiPm%NWCOLf9Y_?-LjLa%drtxfGvf7WKBe6QuQV1k1GtL82eP!0Sh z)#j*-QpTcr<uki^I~0@^_Kn;sUx`?Z)Rc|P%Sp#_M`Y?IMQGgz!7s4`CQtUcgjxjZ3Gb-&d{x@qq}h<= zSlp_XUW(P_{A}W+8%1!W+p5dveufj3P%|$&;PK=-zd~w}qtZ&Qot27FZv1YzY>;++ z1|M5Fe&0`m9`Ld%*}hVyWg%H@&9>Oe10NjY=~!efTp}_$N6eht+-wt{yrO8S|A2`z z4y*_pV3q@vxQk$%QM9D)Jow3awaFf%!sCEfQ$;0cs7zpOn~5DGFo&sHg)bSz<6lE_ zUc9eQ8Q)?qUm(cY8i>Txh7_;()SQ#wJ7nhHw%_gE5Qc~`>BMKqvNXj~x^2q*MnNiz z%eW}7j;W+!Mp^Ei+B_|EOK|dnU_N=tg5$)qzA7W==}tLT_K$hLThpi01PgYlEKeU|A5Nwf_EJwIkhXqh;Qmo z01Lp4Wk6yfEMv`=m1INx&E=yXX7K$f8fs=#t4Ig@{xss3NRZ}D1&TP!eOv;Ni*tP~ zkfmDrr5XJ6^QVJQj?A8AnrpMK%zf8)s-e~6pCa$kInVf# zz_giq3<%c;4VHy^u)=c9?T2bzwO&Vd;Ht+_FxtXxr0Fhb>B#XPZH4|FkfxV?3j6ID z#^WJuB|!KeV0!CAICUcfI>p;+TB5G6}7o??Y3~i163b(*Cy;FUnWRnD{)w6M4 zl{@sQQ5M8on#sQ>Z1z3$spOQqA@ip_P2NlYVBT02mt#=wqlt{HRDhP0lwo(0D{i0S ztNO{LH6%XC%M%IGe$)M`gjsKd@Rv4pmWL%+JeR@_U+dHOwBf$3>emnyEi90wDtnK8 zb;mL=Z$gon@giBnd2Wrkr!h-^u8BXiiKVdYsxKdm7QD~>KP>iTLY z^pc0;owc4$V+ZBXk|wq^sWR}Cr>=XRor_o=#ecdDc`N+~H^8PsY2th^XWsWUNt(nl zN}#uzZC^KKPw$h5emQc`!nv`ffS{VgLFI?P$=`C^HCaQi35n(9Gcus~8iQS-Cl-7Z z@y{{_dF{Sj(ybZf4%Kl*7MT_UJ}fD3De)OoJ>JGRCy!cx(T5~Qn$&U$w3G{U#v(_2 z$uXr|ao`nJVjLuXjFoou);P2^u2=-4bpc7r2DNOAgR||1RVgr??$4h=;|z>w*I#Ao zZ^iL)iluadXHQ0P&U&ptXhu>rUE60txc!hFz-W`F{w*``{reI3*X%d)RYV?CpP3*H zBf5_D`1tzMdrY|i3k5AWaX<9^v-o2;5nT)HW+SU<0J$=OlT8ys@!8@J2z#C?{_y`1 z{|E??HO&8GTD!UcPTC2lV%BBwu1kQpjLi<~$E(`K{_RycAg=Skwmj-Ox?xO6+$L-UB#=pL6*HN+6rZWpx}~PD5+sX7&n9F6 zQ#h))sj1(04R?wx;N%MUZuqh^GJs%fG<~3M(|(6JA&xnS_bCP}!$G;J0yBVXB(c+c zC+9{=cIZqyE8Quw}yS*@6FM|a$;7=Mn& z=NuU9l_qhVvi@RXQxu38zb^o1+wSJJNAQBrblDcnX5b5StXm@U$sh1z;w}o_Pe_bV zHTtwOnDVa<(kEqvxghCkxG*qZ7dqbLB`;TTn?tJ>- z$-9hmULsOsJLY3PH7HS18LCD%LLU3>Z^7X}ooWQzEu(bfK4Y6|yjNMN)U>cMvA|a$;S)my2?k;zbtIUQ#=e zYU_r3-&BSaX3zE_o>?YavKmr}6r`n52rc)WPf>PKRyR0k|Ab9t6{9^2lXgq6N!oI> zu5DnICYM`qbf%J7iE?}e%Um_-pzL#fj>Pbzr}4|;wSAYU{KTr$gqb5$GJ<>aJKHNt zUVVGk1u<+VPUlM8=$Ov&_{#!WwY1>VT_3_Rrh>%>5@#SQ|ll3 z&sTZ=mA*)Q@3VZduYufzgPIB;DIM_>XaxIDRq?x-wjk)ig=p5&jZIF=bWzapk6emG zUpLAQe$Ii1pJc(Q3w!*SX-KYdK5hS!lQ(iRN7kY|C&b75-RO#mE+tI&`#mo*?HZu# z{SBF`_i<@A>}88fbaFdXb(?*^s}pX3s%p<$58ATJ`(t7aMlF9aF_%d0JC}U)3dnGi zdb$e>O95sNh=xASAF)VITLkWp-&L)Izl$eoUD(m#MVapjaf{!f*4WNFR#2$hhLWxO zf$QNu1-TF>E+mQkpBuI)`o4RE;42{Qtx8*TOP~vkL-RC6kaBu z_254PtHy~O6nG8p%oXz);73PC0MhgLE0N3tNPA#(!K6Ghix!t+JkV!HDSNax zr!{KI%VZRfswTplO}7uIEbX2>h<9yD604rDySg!zP7#-VGJNNfZe5TidA~We!7=}OT({<`<*XE+SW`-5lc3)RZE^G93>Eg88zYYRBF6(L0;Y+U&j(!BTBf6 z9;YOMZ$&@Z8m>~ZE{>hyfYo;q+6UD=xlh zzmAwU3zan!Vo5sep`tM?d5g9p=qCL-n&sc_!y7tgoFT9&bl+-jeF-%DCI4J~UMu*8 zO{tEhmwofFUl{LT8^}(2%7iV7TjlGxP{h!q3<;h{cp~EPZh*Wa92Tu~z{*?u^j3i} z3?lg951~m68u79s-2r*O^31@2{v!8*M!D@$=Fi_o<)UGJE0Jv12)}n^#2;Qn=3joh zjeCK8jW6a)Z`sFA>cQisj!7;(3@_Tfwpww9wBG26VWIhkm!1o0K<_49< zd^F}hy0*3{GH#K%e?Si6#5~Yb-e$kZeROs2D_*zy>zm7%qMFFL#LLyle66#adMTkV z84hMKCRllS3|sU=1Pn{OB5j+`0ALF!sOEvHyI#tlN3T!HD@;R}jUQQtENo5MI0!ur zA5(jYbffVuop%8#1W?)c@B4R)PNNiZ;*k60!9-dqo93)D+1{YX!$)lfg{J!t;XPMN zaS1Qo_uMjpv$3Dw{mrk{_4>XaUeIlk^IFUncgKH|CMp<3)QkhW=v^SJPm38uAk^Nd z!q@xXu{@AQiO&_}$%RsglytkPDrVWU|oH-9&~R+m!Qjare`i%NBz*G3$rlhjBHnd*El zq6TFUGIWbTaxY`9au}b|K3zCng>tZ?;&)QEYinxz&iK8>m+5~C?0H7JaMUN2$sgnL z@XsrCs8xG}uu83Vd2K2+A*)nov9UO4*jz1$bB`>g{RV$cJ?u=vbt?p6Qi_{-eB9e^ zaw23L6)5jR9b;Ban*}@JWha$mtB3@ldJkAp7)z_`zOc0}kXRCj_>ozm1QPcwN0%q- zG;oZ7qmG<(3y3VDVM29ZKBlM~FXgz2%`G~Bx|J;}B=qaTtYgENeU6Czxw#E|Ho8JjlU-D2L-bLD#Q=wNT2sFC2;)adB(SbuFz?~e6*n_yB@ zxr$u-)-}il!GWAgXl3j0y?HS8-!}4-+z|Bar!iKX2;!Q~Ii>yOvA|}XDx_H?IYcsk zAPeV5Z^O!mFN_#|joot74Vgm`TkqaieKbvoUKz_b)S$DsQwfi+Hu4MgHW<9|85gfD-8DzuH~kCfoJx zv%4^D0ua+rt7fg}jXs8EwBY#mof{KP=4%KwBt){{Ke;1Gs1ICBL{#xAx9In2H+F|z}Qc1o}V;g zvw_qm@ei(9mna{n!-2Mm*TLX7%@z3%f{e^uoazVG6sFTjPjgL8uQO&VW4)S4P!Z)Jd;8%YZ&fGIXoU2QBjTp?{KPsXu|;JD`>TzY=JESdM;@=pU{j zI6a8G46rBDrwGeqMM5%045l~WAX<&<+uAEb`Mf+(*5`+gX*aBH86@8<)IqMDc8L9g zkEd4r)59B2A^Ar4fulTK`2nj@cK%mqo=mhNF>hi@!Ij2!mheHwgP0z!ncIR8@>H(IGIWEJi!%u5vD) z+IQKcZslk8lRHjO>KB#@CW9ah{qwx;t)pCv4P{+RMBz`N)+XhLWa%x(2(*pRFbH&a zfXp|L1tG}W#}2eryEuE38~Ey2iVgFSaFyFF zVB3nUAs0gw)2~tB_UT({EUADpv4{h}S%8d%@1bWOJsxJfyMWZBu|0y2ds%MI$$d1e zzR^O35O?>1GcJLcurQX?iRERI0{nA%z0c@9DXr=6G=U8Cp3!HIKblG&tvu!}cT;W( z_0N864$fwul38)sDhOcM834>h7KgTRe}S=L@O_o14dW6UCH4oNLhy0F{>~qa?hU3k zA0MBSIDlU5=I-w40iFQ>XZf<+Y?hXnpS!$83+4b{1OV9z9B?3GUytoIO2ky2f@f%u zE){HA%3f<&ypZOW9`$lo6eG1#HfA95737GGs9&f!-$s2Ye1PP)tnPx^H!;X?t7BYG zNE}+=A%f2^go$*36jUKGbX|SC|IcXO*LdX6SS%mS;Ma8>= zhtfG49G4jvUg&ryUgmNKCm3ecg#8jJZ@qHgX(SR^lLhA_qPNveU)!E5?p9!WC(KHA z1#MqxuPiRMcs!Rt=>u_2LoaLN_{)cUzV}A9%{O5UH1yr|81E~H<_BL=qCB267*WD4 z&Kr=)3#QW2^CJ=xu?UYl$dP=w;(5jVRDeU`<`;+vA=?6RrbG578V`S%ZXj%fX3 z)GQl})}kq-EI4YkWgnTQDuzbh?f-dik!{sMeNyYZ(3PQ*;q1`)0-dzjxC6&{fDDVa z&x@2RR+UL1_0|i-q@1kblu96;fo2bjoy2kKG>G?qPhTc-E~Yb;1Am38@)3`zh7H38 zil45fYAOrmA@ns&pm{4?ow>=A-bj*6P9a!9u7%8c)4kZ+_H$TRMpk`Z{HG@$da{o3 zJKC0)1(iZ!VqD4S66TlT4koo`uCLosy=K=Uu z+P){C(2rZ`P5@$USKR{)pHL3L1h7W=_`J?j2P$}b-kN8dy4s;fJp+P^5sOft2c`2F zjN#tyZX;vkFKS0uetp|rQvZNmvmFi4N&B}%O{5@syQ41#K-_tDnEh}HW8D8EnDVgp z1VB65J3vjsL1SCsc<8Do0BpOGBw149_W@?1(-AMxe~Hg`iT@dSb1{c?eW-yT*QfgD z|Mioa#zz2WYYZmf2bTgNP@6#8_DfS!z!srev3PW3yEW`vy$rNvV_MQwhcWoi|6!X} z7g1af%bKPTjrr#%vt|8vmv|t9;M6E(vkWZ85yOi@8Xy$#!s4;=j4)7?xeTe+zEj~v zyyndON(pgg-L0ertRmKl%dPHE1&BBD4KTv_+0vF^r3GSbyrwAr{^1%lQTDF|8rDzj z2+KyG0x|~HWhaK+IDBry1R<ZmSWb)#k6x4%LF3DvHWeGIf+L;dF`;^>VYs zM!?%GCIv9F6Pm@tO83ZPU~7lRzhGQ6B9eU9%=A=yUn^b)m~a;zd(Wus1L|aCo>AsM8k5eFqNlk8hW^y>A8xPIxRdmO+8wF z!+HG=U#2LR>b+W0LOLa&yZ>jc{1HK1MPCHGg z_~|W+UQ0e0G4R+FP5r`BY(R8sxSW^CAh&GeJRrO@aMY4kSB33pnB%_kTm{i-xmem+ zup+DB;BwuK_cq_Andqa2YCAvO&>%HIn-gp-^7H`C+{5ueC zzM9>(KybbRvop6T=McR4{v8C1A$P?S4z}tvGI-dR4yi84I>JFEu9{u8#l!vlN!WUJ zsAj#KC^Tj26CH~Y^e^Co*>d(3eG%|8<9{n05GN%}`UCi>PYCn>YE+xgw)cZ^wcco!@$tn!xGSnJ-np|! zp21Ip^+bP}G1`6Ok8o#zt3pdnTwEMLO9AB6fk#X(^-0xu9xek>|119Wr4Q)cJ{)2r zbRCovhB17dH{|9QFHnanHCvVIyrXoAjy!fka$brQHt7U{nEjj<;#K?9`OOBBnUt1e zXi>=cQ=7UdTVmP>ORQDo0%*?5k)+Lh)$A)G1-3LwN1y;^)B8ot3jOTu4qEdiViMITIa$9Tos4&ZkfI@vN1_czgqAfLA=d^8&N zR0X;}d>bPcI@V!aW+4+C37KsnsVr{{*kB;Fh{o%TQGD7*GLcV&Dzq}nv;*o&=H{6i z{j#l;_X8G<4LwU;ZOSV8pVH+y;}kx_F(Axqk1x2}TC-T{Z}%u`EW+q0{EhiDc1j>b zn@H@){lu3kbVm}n<~3A5!b;RlrHDQIhSRzyDu7g@b=)TRs> za6%VB85GWAN+9N|RO2k0m1%1?bGfZ5{mL4jZ+ygQ zJZr?TI&x)`CoW+mBgCp#Gd5AE+`RxhXaqe7~&Wc6f1udy0;ekfDsVs^3& zXPoP5$WN`{uH(7CR+9E=gNjX*{w0WU0h_xzJ+{ZD;-sK+!W>VhTP#k2J&H%vw!7Yr zwDU=QS#3_li5fibj-?LyJ96mAlREuuyK=4@>*`}teXMhkU)n)Xdi;@t8s*$$CxW)6 zv>{_k9rj$kQ=*5BwxEPjQu`JEDrABG^|a9y>~+3uTK%it6tS4hT#Ym3hXTvGzW2VTY4}CQZ$L6^tur9 zs@r+09^{mI2s@*DCGLO=o>ASV*v|$96|lUpCL|{3LMb*%`sI|&bLrtreEjJQ%ShN7 zt9Mboo5l^uP?Y~oqB7-~G5}Nipt_7^H}qZjL*uw|*$>NIcB``v&XSkSQ3-xg>FFbP zEox^&h;hUeB145y^vM10cMFUH`u#@s=G-K*I^ zni;4ga1X4mYjwodsK=9FJZ5P7B3%6g-|H%Y7*7-w51+C)dcemVa1($&;a>n+Pe`~YI(gefD4G&vVxAFqAT zsg(wOWU%O{iZ>-jS}q6SbIbnyv-g3wJpN{qZ?g+(ZYY}gFPez%nKSZa^(Waz$xYV) zF~}Ye!v@R`IJ4sF|Fi&0RTHA@75R#DtfC?ZqYDl+-{lmod-i%Kec^xdD-`rGzxL;vHbg)B6r(1Nu{^r zb4N#mzAH(NtJFR=y<`l|z>xp$sMkw<){FWN1d$F-sEO;_pwQFC`<#)DjtvT?c<6fgIW!;l;VvN|Cw_J zP`xj=UX{uSWKX~P4G2squS)3xko_;^vTQO28(*YezH%RwHv!zp6Yv@7z^5Y zj69P_zYib%<8=&a*l&tG;C+qxJ`LJKl}ZoKB$2lrbR@Si^VX`aJpIJftP^TsP`Ho7 z$&5z_lW!c3ia@*!^00Q?NY8qAqMQz5&2Su%z3Sq=S}C9@+Y$l=AtrRp7;#)}#>GnM zsfYM>qJ!F{eRzoX6iq(cDW5GYF^p++Jkke&hfm9XLSgRP0z~lMB;GoijXjWjM8;QfZqQ0km;x1k1J# zA4#=KW*Nz4C%J#zbM`eJ36xFQX&!a@rOuxV_DK;oTu&Prk1d|k_9~oa1V56aC#%|~ z0nZAh+3W6WU;5wLnn_KV#2^Nn8hZBM?Z$<FCPH)9<3o z-eOguEEcC#$tp{zS%2LnGe*iCwAO2d_ZhaZ?<>zQ;Ud0FCC~>)>dM zWtP&M#ZqJ-zQ=p|$0T*!3Mh)rRX#?Nd*xn;A+m2PSwNdO22e?t-r;|U@UH}ZbG!Lf zjIg4T53cq5$swwfCqgxeoBllZ>}C87Re7(9w{*Pv>jn^90e?dp`Ou7$6)5yugYd%U zeeLP>Y$0#%J!yoZkh_qC#GoN9U+DAX#SAU^FET4hx5z`k}Dc891uEHox;CG ztZmzWy57xA#ud?l+1`qzv?A1r1FE3}rR_phy5G>}mS37qU`d+}lVWd9dC#x!#V(kw zaon ziF|1K$LXBQ9->PJWk&KDMI3kCOzaY(p_#&4LGED{jID-bxLu)Qb}Kwu9@qTfab;M ziN$NJ2WfSAzs3d{t6O|crptMOb3k5G$QcSH$$KJwkAekbdxQXLO2c4}sb`UIKrB2= z^nxMJ@SBWHYJX;-(q9>AW6*7S<^_978B>-rN&;dyUGi{Um`J6m7rd~EbNNb%OCou- zOE0gcG5bPEmj|505>d#zXBO?WP+}3H?me4GNG6>spa9At z&dju^{#H9j6 z9UDx$Oth9bRw6c*#~V+-V&lG83DRg899y{ltwQE`NOj3o*j(=iNS3~#)K}>Wfe)I; zNV9(Xw=GQiz~19G0a`922-u`~J@={S^XCsK54|G*4i7|Dt^3S1ZX`)aNI16}suxtq zeWW%`&lEz0z%K6)4{U2(>`TD|#dGVhcyE$A^av z?qN#XMQM`T=uB#8ORW8R(1yDkm=#$uz4%hz00<^hw_b_{LIRGefpx+=@CwQGGoene zPpm^Qe9(~NGFHh$sOK;lC1=K_)j&i~TtXttpp%kjgC_~fZ>BQ1tqRBP+{Q_`vF^^yWwHm527(Dw>=WwQJUt}3cK(sK9x-Z4 z|G|KWythrD5+lg*WVyR-r9Dd@=MDJ{Tg$U~_0B5pp2f_Aa>yIUf!>^+HWu408B1ij zBx6NY{ZV^p`lzOcV+N(L3KuPMqLO<@>T;Vd9wFiswjgP-;QD>p!?RZh@h$l}f^R}$ zl#96~h2RoT6MP%ium=+98_M(&-)%Q|s&)<? z{G~)4p~Xb@H+{d%4LXCa((^V`YaI0ybqTZT7IDNdAt5Ov#6`$kct$*qr7#I{BJS4i zR-yyJvFi;K96>mbMdU9c3eSJ#RsOZ+c1yk&4&co07FuS7k0!#@q6ZaK;9Hnkc#Ui- zdU$FS#0Z0pzs(9W^wi5!T79A2IJFi<*3P4Gfcaw%38;SZfsd#0~09z_k zq{QLNF}f?ml}7;90Z%cksV7tVKv>NYBj(iL|gtMsI!!eoXV$u${n7BSW8g z)o^!-;p?O;FFPe0w+c$(KO@no%J%u^@~K8ae+=97{+3o^yDewOI&CO?i|guJyl+L~ z28&Ji{w(We?yM*bDzED~jG#i=OVF($U$Am1ihc$=|BYV$rJm!gQ$?;-X=D+$o@T>l zDu$NAiALH@Sg5JDfu5T}vIYY4n9H8-Tc=7BM2M#OgUdNPMzD9PEW?o&*!k@32H!DY6Wt#a2XGCvj>%B5F1rN0farv3N4%&DnM^uv^cV-Fm>h8DX!c3RQ6=AEGPSW=`(4-5@ERel}-OboIg&AR4Fh)Px3(~=LpDoZW^P~~t zLn03OGA<`~@v0FZ1po%nmVYZ$v%Dhh>(w98jiH)Xc!)pkWH_qOpKNLQKB=?m!pBHn z%0nIJc=B^l8xN50k2q@b&11ipP-#BPkD`k)vj?>mXOi3y2yg_?+jO5_i0NLR@{aw& z2A`<^hg6CxGxeAUdS8J_-9c@mc?l2a3nySJk*)~eT}emV6{$1Ko_-ErTvW%(Q|hM5 zoYa!13=?=oZSM!YtJ%RJ7CIg|;{gxlpBug}Oa1}klVZ4km0tLR4oHEF{kN4>mE# zBF?F|X8h`YsSZElwAOL6$&t88BKCeHyAeR*;CYxVtkMw(E2SZ5s)ZEDO6q4ebg@M4 z5IRjVRbz8Kq1PmHOw9ZaVk7rr-@{#69gD@JV~3(mu5qF3P8Eqyt`#KMArPY%H-(iw z%>cPrl}lp*Y-=E}_^ySjkiCLTY>1BUlrTEK0;kOp+(FDDzV7vx%IjA~x9U`Gti0JN z(iqrk9~T8|RF4azwEU40RI`Q}IJ0XjwY7~>_09BE8k@UWuiT~W4VK9&&EF5zQZA<0 zOK&ovXX}n5)x+viGvO9u$Sp0OMPnY50Q*q;?h44ZvABHXh{-UzlZgDIZr-&#C!gOA zci%|*!7HS#gI8>49D92o{X~CP(XG!&Dv6O*8c)54;Rs|IIwb3hF%$6&)>7->AVGhZ zBqJr9mXRZmwq1iNlQ;!Qv%T1DU-+S!T}K|Nk>O-y+0Tb@4`)}n%_zZ^nS(4+GE|3x z&)2ID;uE0EmnCzHw)Yh9PzwoS@ZI&?VO-cral# z_(%5tJKmO6^KI`64Bu0qJ*=Tar;w*H-o=JRY%%V^n#$@<&>TEt-xEK=70o2Vhn;Vh zOn^S-kf*;Bw#FjEk>3^pg%}Vo1xPpyYjqJYk-lKjyob!ObSuJ0e2jpt{QcbJ(@@8N#VguIr$F!gYe5_ez>>@M!V}%UjlsEZdvUef*EcvA zSZ#`VCh@L;W}mO*b?cz;LGTim?gwgXx>w-YRAo-5KL<(l$b==TDDogWYUtuJqM0Fa z3P8UBhkW~{U+>J-RdXMwxs@Mrmurmh2__18d_T>bw}68y+$rQ=-rN!3KtjvKB(mZ> zVotC>Y2QQQyTT1n*F{IAJECYB=@NHk#Ke>Le3!{ATyx|l3LF)HhF|fS?fThEUDu2M z`G|7Ci7$RK2B)J;{UA_y9kkya#k__@QB^r0$#vw&j^3Lpo#T3{%m>k)&bqXi{%EFM zjK@!2{n0`arfV@D`WQf9%M`tJnJFn(X*=ueHH3rK}jJ{ zU>t2g+UcuSG23MZiW`W)MEPC^DA5h%Zdta_1CBrAf>XYWlg}2!L!^n_dca*D9lx zF#BRK3WzYJPKht&X;<`H@DOT!9DV7_rG`CUOIb1lc`~fQ*Ww(Q0muYe9j_vt>`W&9 zf2f7p9q|;%e~iCm*JscTk>Qe#E5pkS*r9y!Cvk2+7(Jx>l1iNOAjBbRSTWnUYe7MT z0&_GOgf)M;pBUkdTJ@on;B?6kHO-0w0;I1HyA6Muy@5|M$2;<555D)W_9kMrS z6Aq|K)tC*5v55Sg-GX2%dTpxmJUnS1w-GT>@xw z9~Es|42nk>`~DwI=NOjR_rL9MXH0gJjmfUbwr$(pHQBZ&b851iY)!U3O_S|<_V@Qc zo;UNVBTVhR*7~gLI#1kxV>H0y{qdCl(XP!1tUmbej=0SnRd4aK`qFT6gR$Yo2oMN} zj1bk4s-zDB`%bq_L8HpP?iXLzf6pWDdHebKxw+k3UyD}p1c4fW%M#$+3Ro^1zHj{! z;IEy(2IflKU|!Sj)B$C^=;WzhbbIssoya>OIRMFdTkujxSE<-joX7k$Z2xMs&F$9v zUb?#u=ve@)Dj=M-192;G00OWNxF-h)%{FG=t5+wa>m)CzAfhVK65mJciJIKvD#ai? zw*I(6Nu{1MtQIDjZMeiSkMB|A9rv;R_4Qj2^XH))Pw2)#96`5u0KS`cRoLjQa<^5^ zX;h(Bimd@^VaXz6_T{`lF#URdif11xOalasSPV5Nz%Z- zaTVfG4cRgQNU4<*{HF%qBrc!6K^-Wp^wQoV&Z_*yfbTkuT@J?m+kVii{*S`P95s_L zKI7m{Kr^K{m^k*?~i1iA59fx|YA40%!;zTKw6lmg^vA%ZJ9 zmfch8NC#|)ulAj8sltSd$Vuk9Jh0L!p)jzNlqk*wDK%6%`nml^RHH=Fd!dCgUAe!+ zTRJ&{j(X-O9a(dsu*voS)_pkl0@dk_kip<~K6P}nYE+#&ZFO!0tQP~=KTSL5VY(EByP$^Y$M{SJkP7(u^61p9@rHc4;f;EYVF$x?rF_wx-y|ZG0#A z&6?aiGs-|Cmil&XZ~O(#5H1xOQudp;&s@Q@z}T9h-11x}RvO21a^Rq9LvM>+uN4EM z?E=LWzTlzsAAWUmHB0s|YwdD!b?dZ2gdgY#_o*b;~$T`!$rW8ECL(4#8DC?2{Xm;Fm>pv;U zL$oX&%}}d2*wyILWK181e55KiL#)OBBA@xXV~9X6J}AU2`o!ulCf7Mogx)Awr&2^ z)m2(Fh&O1DZPM8+?Z+xEACGTk7eA&Uz-9__d2h)9ak_fSL!pm&yF+Xw-76|v3M}@( z-&4w%dB>(|)sZ`a=L~=bVZ@0!c8_Kb1@uTQ*f)lujUhblLJ9BO`T~yz1_l6J9!R~o zr?_2ubr5%?t#(a0I_6I1n5)$>AV;(q-q;~<3EgA@PQe>zY&9T=2Izn567o!0IW_++ z(C!^!!A^QpTm&C0${gEcELpO`jLs&d*xGXQKuFIhCasteG}4xXE9cj{JcdLmR5THw3skcvCntS{Xsmz>G++#WSKC8${PddN2s#>NFMDh= zx<^m4QXtO|3klqBP|~3?Er}Zt-#uV5aQexBe+oHmKPIQ_f9fif|M24Xo@dOK1z29n zD&*`l@Tn>b+Rt>noF16FMUCi2YtGX?Dh2HVT%Z!vzT2V;oc$*#iTQ3VOf^2v==h6{bc z{G4bxFTFSyfS4%jQ7PWG;Wzii#9NKDj>D!-8d5i!9>+>6 zNhYTbbOEdTy&WGrNWSOwAwBiRbIy$HXUD4yCft1W@(Iw@G3(j>czsG~tpxU;ZYBc; z;Zdm{ila|%zmP@yGg$*|x)>;ax!uZ$VOY*wGh3p$k|Z#sA0#)N+0l5@oKfO1&pEHM zlIuVkQqkU$^boaRHgX#7o%V@}2{cmYp${9cHtu)wV}^Q#ir%m>KG|pD+ilr~2v;sG zn0i;@1sdHAjqrt**bdoNDs{B?XH>Oa2+Z(;4rGPT{4l%8#!aLn$6b-?5$%DCLlK)C z$W)!txwRw~HN^Dq$fRzZ{HnSnI@#4%_wboQTfy9;<3SKMmg@IO*C=gXploe9Xgln| zr+0aYAn>#uB_c`^2xe}_Dc(^U} zUaXooPp@)8ziJ#$M6JH^VeUTQgkseu^>5Uk^yl~__2DD(>b*sBbKMxt%v|RuH6IwV z4cOu7g$msu%Q}Xy-;)j5@^`5k>5fMRrWoCSnvTffS-LC@PpM~!^|MezavfClm6T0D z$>=1Ooz&&hwM*})4nWk6mvQO;P)kjfvwWgR5=ozc=S@WZ$J;+j)ns*~63k<0k)O!?CrKf^1Fw9E{uFI&uFZDAJO!vNDuF#xucxq#7X{ zrPQGezzKW@(q)Uj9o;-Yenzb^@%@*Q!I3kew3s*f$3nym7c+u`&OuS2D?Jl(r8|6B zz3@U6(BGa0OG>&9sMsL#maR-yH{PP>#;Ym~?Vce)BR+U@?|=4ARCir<=-R#j2n&S& zycPQI1@mrssKU+V0ywvXb&hfNk)1S;pp)OJd+ql#O~3JbI0qQ-URYj+O&_Ud0~q4< zkLLk@#gV-XJ|Y*f`#+&ey5~%_r^OGrG~EUL6juJO1F~I(XwHVFh=&3A)EG30tQ@_EK` zBM?DT>Tz;@U|<07?EqAN64WF=p?oE3Oh>-9>lDS+L}Afh7-` zX}4=O!cCgc=AmuMI9}HnXExB4X*uc015N~9k+yf9mC_;n2#5{S6{4EVGE?G}TD^B- zinGJECHxgocuyDb#th?QG!EhN{D-pHEgB6bfg9{T&*aOab(h*B!QS$;EGylb#OTt? zL|F*sTfNgFnyw(ge~f@2 znI%}MP_>i8sqmdmiAOewEKr;7<7_c4wE36# z(h8)vioA@;@f4fM%TZKlM92o{6S*K+V8_2~mzwkyszJ#pBk#BxTQ}e4no7{uS)2|g z-an_6QE!YfBs+R^r9}xcijR;n3@(uyFj(EGd8m)WVuYkf0`<#^;`S(hue)D*`sK7( zuF^0aLp}a)IEZnZpws7tIaS@yLzc@7 z$PNR4%lyw{)DeKpcR#=sxw~s_?6c?6W5glS^#OX(nm*!J2r~f5!)5U_ee>c07;&#i z-r+nTFoIj=Fbyl8x>0w9)8>y42sjMN3~h9_;f2Ng5@q+Uz$KXg{0CwSu?og#bu4Jr zUa~aL2>DSA(I_(cw>WHEZ+M2UBj)0{rrCYPC?si!@~A9k@{4_hde_r30$?_kv-DkR$i(5Td{DRH~DdJu; zdN;STEMHN3YYDWA0bFNd5|jA!ZF_6>ICc<4JKxwarG^PnU4V9W2ssRDqwwlnCmqzlVD%-( z#r&>`nNZF7{9%BA5J?6LQTkLTfhGR7tpLo<+oob%Qyu4kUZ#Svwncq(W7Lex7!hhX z>-k#}LOQ-p(J;dQ&jLI;^8ogokN1m@KPjRc0Z&;w6B9_~>o%QsuoCsK#{Pf06F0S} zZJCyhsWQ&dzCZ+h4AJb&=}K(zkPhUL9X!^q>kDfNJHttG%TXcW@q%v@WQOt$kH_L3 zrrg{(%I)}^RTe3(I7%2Fe~hDHT9i&t*ai{ZI;syD4VeSmX23*bO4ikf8-i(SSXu&;ctvkevNlqDcg`(?aRLJ+U+}s za+uW~v+kUUuW`|BdN1qbucOmrj7s}rF=INb3B$mKWas$sSigd>(yo$h>h4j{7mS-x zCoO@R6-u@2z*tknf~LXm!BAKs%I24Pq+z#xj2cNBGAXhtq!F!8JAQ)1D#46&Bc)8d ziJQwdX^uE#hPEMi>R3u?W`$hG2JwLl7(tZ7e*ZYDmXEV3HHnL3<=$KCWeLQe&cuyi zdD;X*p8;#8J73bJ`Ykx;av}wYpaZ1&{$YSQ5++J?1^T2Kvngi3WAP%u=@UKsqYgA| z^T$y{_x*Xop+_=2$f?hoxtWC6PByV^9{j^tvHBt%>t1DB_u6&R(%CLHa9VdIFo z*~q}a@9o(G*s`l8_Iw67@O%69c@rj6XaS;q^Q3AgXJW(3;fuh)kY04&e?+muS-2(TyLt_Pm=$46k6 zAMpCPJA8KR{!5?v*ryTIh-WOK6^#(cSkn z4aF%@kv8lz-#~69eKqp&D&dX{h^$03=W&$ceUgvI5x|Z57X3A32N&a2yRTo6rV+Ch zcpWJNeYa8b48eQnnUA}>JJOiRF?B^$W!HRitjKXdu=O|w zV|Di<v& zc7)X55S_#aB^36swN!YC(2zV=tL;Pl=ZvykKFL&)JZ2~KNmJK(%&bMv%qXN>v?X|D zVF;tDr*yxpnRqp|*W|*Q6qw4;J{jS7iZL0=6aIGJ)<}=_Y{G*$RjH~^tHNXS#|xC( z9c_gh>d^qNt=a@a-5@AXG9Ie(N`TubJFi>N9m5`G&6O<9$pk(q*qP83<<<-t==mJx zub>KwM!EC$khG4dbgXJT=iCXlrLw?ckitztxik(9k{9Z=6hbQLtVO%`R+EApzx z8Mom`z`Ygd)hl=rVsk7J(XJ5h7S%i~Rdxwu#CYz}cw(SJfseLq8c#vBd%m_4MjGcV z6xMDNo5o@opYp`&@7=5%fA+1X<}5~NqJP6WVi)*x^Jq%4@q*ymP6@3s$G@apZI)=) znPYW^#!o4XPq{}6Fmb?*N~2LM^uH!$;TlCUrf-NDt<$(yG8Mm*TQTHFse_23+-dt| zDsuvo?F0mXeEVr)5o@lQ_HQmkqCcUrw~&lem4BALL&Y&ONbw%9C?U(bDHxBApV7R@ zYD-}pn}b~2kg7|t5DW>jx=We@$z$-T6O&S_RwZj_Abi${C9= z$Vz26(5q|$ko`J6M$a36WJDeLEYMTBrcac9Ujnw}(zb_=Ww2vRpv-Oko6T9Eqplk| zg!1O$;c*ABEEpimDHL;#K*<2XCAtzQyBm34JiGuy$t)%S)KEO28$yyj6%A>n%bo&8rRmwTqwZu7QN{ zSONOVxFZ3t^Uv`i`5yTE&mC!Rz!lBU27q=bln*>Pz!gf!@Ad!eB+jN7($|Q%V22c5 zn?L)C%tnzIn;9P{#cyfV2sd@&01n*r#D*Q`uQy>I5*an1Cs00|x!&0qlIyA_e9Y+fs2rn47t1daiDe&U1?K(^(`^&M~v{WtY}y4sIem6mGc zp1Q_PhJEla3-fASdB5Yj+IZ0u(&P6%A)u=x;u(Rmy5eDmsm z6ts^VVun%{81uTPslvQae!O2MzC$Re`a|h5D~HPEfXH9u!$@_aS6rXU^5{GHGQk?H z!pSHDjMfHA>2glBJMBFzhkHV;U|i9Pn2r+0S4!4|$MuT`;J>cR(5ZDDI4W*#Zx_dl zApu8DFKx$hodT&C!+8g0RI;#WF}apR_r zUV{@S^wZ79sq{M~t9Z*$s6#-5WVul35-ErfX5sZK^S?A%#(oM4WhUB#)TC5J^ZEG6 z4V*_$a;rz_l7fWt7gRm^eF}x!+T8u1Vt%4_nlVK~`uwXYTOdcynuh1ogU`#$V^n=A z+1ZO*#N{&XIg#HKAx#>=Wm-^6BgZ$CpYvlzs7+WwT&A?JgrYTi4yMb}hoD6V`flnvzgqPN3fw`(t5|#su$ci{w|vp`|&@H3P})+pW*TQj{m~-4TpIqr&Uz zmO)LsA(!7{FXl@phbif{tNTaGL5&faO-VsKAN+4r0L2s=2;JgBrln zpd8gn21(hVObavhXB3dBZ*E0DdoEqqK)9ErH|wYGc!YK$vxZWePmWs3mOG%U4x1kw zBK1a?@UpM5j|i@q3*`?qiCdl`9Da)$*`IxInsIMk&nj8+DY;xpm32)SFafIwbI_c= z&UqxY&#%S*fr6jc6|?2)3T%CbU_uZ*GK1i~7Sza>jFl`_$``6XesSkhC|7%+qv21! z%WB|$h}h&g%PtJDzW{pfGuSPOmpS`jfjMDdjA_*EYjQUDZoQIJ(DQcR@o~T32f<%3 z-^^0sbBJfHo$!Lbv=WKWTN>ZX+i=Gjq*kTTD~<>{W-s8nz)Oz&-xG0?q*>S}Y2mTwe2~(1C+XIg)_y-Ylu*??urTbltxO zP{+njbN!65``Fw0y`N&f%sQ`vZs{TbUNgnO&gnecRP6KhA(9jI(_`E+-H%Afv4tC5 zvh$I)N`_~!uwT1HvGO^eGKWQas%>SYqtn=BDy0kLx1f?OSrJv}z~qpW47w+XFs}{S zIOon!2b{v=_kvQEgxpEk2G zz9UQqg-FPwhFOt0m1V?&VSqbs=P~N;I^A4P_-Fa`&Dd7qK% z1ey`HwUi9H%DgEA?%~k?09(l_4!veTLHO@OK=$^0GaEVuO{JDB0F9vcvqVISovNj^ zOTUf64VgH-%qFypjx<+YDxDwMUXZags>$X|7KF>)n%0)pLd?apk+(kywPcX41&2iw zp^13db3>F@sLsM2=Nh!Mv;YwXpr8zge-i)XI(9VecuJ+#xoXcgCUO1_7BI!+5}!HW z04!a|Jb+gV=zzUiav{PmES6;T$eq|wiD^SPH~HG(te@xDAg~IEN|i-dJISTDOv!Hm ztyjQ53G5*&phP_w1NfF`bvN=nRN$k)w=G|HsjbjFXhD)>9c;>q{1C8PH z5KZNi49sXyS*k55qK(~V$P2RM!q`MrabHWsqCl848sN{+W#iWtyf{w>0h6W~Effj~ zklsC@eDl5iRlM9_r{OZ>+biIUSDZ`72d|dzSU)ggZMn$Y2W`L|eK~vhrX^m&Eb3t@%k3)^1ny~{_~2`bkXAvf&2+a*y!0%V*||qD2pMZ}wLHecE5~@p z5i9doonUI6&xT4m)tUjXS0fiaA5$t{{f!}lR022%;zsuGd?rumKATB6(SM)vO+GSF zka)N?bSzEl{Q00Oc!bpvZY?uN&qOK|dugKJg_`8%j3Xw)MHkfU zgQ5(cuckDlUn4JlCC;c`aTwztZP7qnwXel#uPs447Msv?beS^A1sJ&IZcUCe4Pdn> zF&(*8j390me{NU1qLzcr!NwvV1aK?Ul_nJRJU-kH39`7q&{}^;p^fjESvngp-LX6* zDNaoqricX1gw!s5x~PkU=?B=Sp4HUDSkcBKu||eReJ!{i8C^oSsI{ceFFNI}#@va^d<4v?`q^M(cON(Nc!!rwb%^`kEz+z<=(I-TjQqg0v;aVQ|?y z8Urm`*S2Z>iby5B2>CK~pA?>R;Ymh+%v?0Z=As_B@{-!BPUvc)(+a7T{Oc(BwIprp zr_rGAs}-rJ?Fg;#+S*T&Sgh4bWS#~MqfRkVElrkDs{9JVh`48{Vy`%o&IZh#+c=uW zQdwFO&EqVVHmLTQ9!UL9P{=oaBL*)td&i32tM|W=N4NS?=?O%HRil%t^f<0y_*`h! zDKuI%xlo8w6#F$H6R9(x&oUWT=Es+*fz9)_7ger#_MC7uX?V&w?>P{^d16vKZ2zAm z?lb>+1+{}_i~w;hteXHI$V40%95&^k^qWRu-T)+EJF+FRl56&iaTdf1WE?kO^c$64 z(&h5?wu08RYTxbu z7CoIP{9C^3c)~v0l$m)Rikv^g3b$@XlJO@ef~gqo%MOUFx#xX`Zjm=^6q=ZAqHf39 zW9l34=Y;jMdjL!Ec<&mpMhV6|dnBGhORj&*n453i8a`3_NY8vcpVa1vU&u+gGvx2> zKyYwa?a$oe_30z?sYaSjWb3UG6SXzPo+vq)V8&HMtbC``PJf#_1tp{2#BA~+crN*= znG|X=zetniiQX5YWaN+8WlFcdbG(5pch1a)&J7doG>;VNWWU>Ru{ zZLUm}Dyrt3Sq1#wJM?l2iRyXZEIA1Lp00=DU^*vstgW@b$hfGSI-60P$99QAeT;A^6Ks?1+5=F)G>FE!g0~7X zHR{V%b4j51yQuI}3^E?kOUV@yLB^22Ez^}2owYZ_i|re6@oOM@y^ z*)?X5j8P8G%v+@Jt5pofqx*+^F2#{^Z&f=ewSC@7*bQwaeD#ZZoyNh1elm`-Vn?Cy z76$B$_nNDtPK^W7e2zTvNA)69E|H$fdUUBcD;9F7S0a7tjViOwW5|vh7GndOb$%jsWikEnG;!F?4&%6vNYL}(p?QRkiQyzjL3eKCw40=>68*vk7HQ_ z;f%uoRAYt#MKZO@3!)O^LOxGX-apmBr`19QO_6aiugVma!blz}BE0mOt;wUjP&4K5 zJicune7P;_XZ!mUdX+LQb7F;G__dv5YLx*?6Mi}J{#B-0`4~-h8E&6JlP_ZuW|JFX z8~zb+D4wddD&`LPbX+~zO2QHFd`ts&d5t+g6E^p9Gk0#g#3`BKzL<;DNzU9OM8t}z zXokpie7l@M2xlYEB?pCN#h5=0{zNXG{rmo&SA8p)6`fs;d}_D6;|$MpZ18po7D)aS zwqw}{tXV*jEJsSo6Cf1NL2K|3MmVKhFG5an`gnU^QP@Nb^nEEw3vG+Dm@n}@!)^D6 zJ?CiioL?K<1EUt39@X=n7mo}y7y6~s;2?|K%eHqSu2e;$@bf`g^%PV@FwY3}Nw zcJp8C?LI$01ME8NJ>VP+ti}&PH>VVeQ~-?}umS<-aI=3;1S8YTU6oTT!DK;%!`=iU z)uAdt&haW3bEZ}WjxX~G6Ik--|m15zh%Iltpw8x31BwdNxIm?P@F`XeeH_nKn^ahqF6V}|lc{#wy zutrzLA8teQu!$W=)&0f1AdW`XnjIm!Rj*VEXP+o!yspDzV{){)gG!~Qeb;oS^9cBB zq0*?2+Q=-+J78JeWZR!Rs)G(Hw=ttvbB)h0#mR_Y%wd*xBtAnMaQgr*Q)~UN<#Q9$ zXk*SOV4JXjniTLBL~{`t57_5`{lFM4l&g0xSJ2G~zNe00RoEu@Cx0;+eU=((7@BM2 zo2$QDaZ>6)=|^3x>37>~dWGUA69HoXXgqGzUpj)0F1(BGJxY<4A8Uz2^4m+Pn(NPX z$TbKDgSCwbIYN&5W6DBNA?+SkWMJj5|1Va zK^>9eBQ(9nf7b0KCR{ve@ zT6G>oC6$7h8zk*O*?@=TP<5i-F-Bqgc9fr=&npx*NEDL$^8GUj39rD>;b9o#D*%nr zA$H&*yv}r-{G;we0!f}pr{(bTHJ2hYj9_C)2Ez7UTufdLqrG>qtjRUrruu7Y^r++z zAguxZ#(_j#QPPI~*l#w{a_NI{GP@LFRJd*`IY|Hu(N9UY{tK9T-} z3=A_KsX0RIiPS>ib$b2ZJ)oT;fjO7e#>s|kLRgk2UV5%+P6%IfVr}#H4v!)HzQ*2G7BLx=$8$>4frtPcwo8ZOJ*5Je0S= z6lS_c#Kg%!9~+BNHz9_3(9eAJVjQt26#9wrV;*c{_14%dpMR*fJqKb+62~ditT@?( z6n>#3eb3q$x`3Wi>8xcwB*`i+w<~p=azG5C!=Fes6mGf+>M!ER{Bp=@?sc9jkiYzC zXhCJC2!HV}vEd5hZ*i)t1Bu-_LA_uU7*+|KYom9Z%6e-zEhDYdrVTRQ*mE;R61?aVcmksI`}kz+`S*sc;8an z23yc*tSc-f5f13`0ExQL1c5WsxW72|wkBv?jdnN)a|Nl5Y1(QxoO1DFp95Zip%%;X zN%Qvr54?WUP#Sb(mnPCP?YZpeLJ`_4Ho|^XRZGmjY7)V7HWzHpI*t;MPJOgq_%}jT znPCR)2P{68v{*r;Tnktb+L=`x#~wZ;U8i6HV9j{*cgoAngP}vM%6PGDHs$P>?3uOZ z$e*@qT%DYZ+h&+b0zm@8<_lOB#qua$0f;LidC6k*X{R;`E)qLua?I@w3aUxx45*3t zsNM;!=3adHnc8K$U#fXLO}f=9vH^fY%kJ5oMWNj2m@Bpw*#{W3y8yO3K$=h&@(w(@ zRtEQs-JO%l!$)p!h+f?Tp)hsf#W}EjtGX0TRJU~HpE~;$GfvDI5n#dx-3!^zHV_Mb z*Q$a^MDr8<4v*Z%9?N5;(RkUZ@&C|fXzp+r^gCP#V|?hvH_4F&JAr>Xbfiy7rMB-YnkdV=+QXSp~-B`Rk%QuI+w)>_T^hx!py9M??;YbI!=;B}y<1YZIMHd1+ z$#%fn3u2#IIDqqhNCgRA{5W*Er@mGmR9U#FAWD$h>mtfmi3^YySE30KFvc{uLyvAC z#oBLeZU6!E(*85yR4+_Vb;b>qB_cs6y~wByqFfOEYSW6BqWHo8&jJX4&et8n(m_`h z2uf!}$F1VG(9E=_LxP<1aSrw0Vj4sWb7R)1PTa$o$k2l}SNqcxuE4I$-K@49ye*qd z^{>cIC)u6$z+KH$!p8;iQ~cWmG4f6wFTw~WjSkj|3Y57IQJ4;K+0!T-U+Rq!tsRF> z6a2?HRSWgFWlXWIo+%HXvs`0jF|;;0s<5o8qc=jlf(>-gjMVBsgq6M0^bB(IY7)r& z;>YigMWW*gS8lyy9WtG@0xqGLIy@bPnFE11) zmz3~j3gOb@$~X{;mY#_qbNWDmLE2ME8t4}wfa`j@ezvqpdoUFXP>2r8$bQt{8-L@E zUC1R$rzY1LTJHv?z<`-Lls}4v&BfU&;T2F$1Mb$5MxZSRv|z@}$q9EFgrmdgcjyYJty6)G5HKt@4<7=x#sNebfvq zM6b-oPaSrX75B$gEe$rPO)y^Wqn>MDcwMq!mG2(@$6>s&RI)GP;T~EB+Sd`i7qF-N zkX)cI$G4w1QN+J!CIN-r_wR&mAm6AU4#AfYeRUvHYtKda92U==C65{bO``N?kY;TN8#lpRV~fwLsYIq4F5 z{WlVxGdE%8pGkgU$0+HglwH+Bo`q4ENWMkL86xaygaf9$qYU6?J$>SEejd{a-K8j4 zCdXGPECCF#CZ?17u`HbbX#3`%#86NFQu2H9X+gpa)&BqHdT8Jg2G*LD$@Vwe`=x9qu-s7u?BfNi-p2`*pT31 zsau#srC254dpGm7g$@l{I16swb(e#1?p9oCgM55%fQ%eqg0Ka4L=E~O??IHPx(nu{ z)X$P_#+$)zE7K$Jadg>Ohly_UgooCcCT~JiLB!MiPPR~VISDC5ojye(h|L)~?eS5} zW-V>dXM&e#*uds9ze&F@Q8q9p^9nLIAlK8Y+v(g_<&{gZxk)dRJ!JanwMBJ$tcJqZ zWTT?MfU=NQtU!nEG)Df7$}1{t$B_`-Yqq=NxlKhQi zUJ;qy~5 zO2$-H>1@%jSnP4(q1BvKca@2LSjlp7Jq{y^M3J=6E-Vo?Z4ty4|BaC4$O+@)laQp? zFFg5iSt!$FlT#t>xV{5x=d~RyhcC7pz$(u+s@6R0%m$$U-riC6lz+Wl6J<<1ZtV;r zyVlQmRE>5a*|;6Rl<1SDQO|R%{OH2>IBF7d0yersx}i~EbyN#-Wf%}D;>Z!*k%#?M znAMapa<_rxtqvFCcTgzQ_tdf34!I0pW}02|?e-H%IMW9tuS-+y|0J7(0;Ffh@0CLjRofxL+#Bb0go8xTHqf7oAwXr|m- z5+oxS-;PMXbER$nle@M1Lk*0-iL_sdP_O%Ch!9VcIRuO6fhqR;x>JuJU_ZKFcLFv; z>rP*PeL5RWk>DeMM84379ohdM(sD!%G5PT^xptz-^RGJohnD@8iITjN&fmF(CwRlP zZQeC{KVco|kg{W`p4?6Gg|p}gD(Ug zi#aEy+tlj3aPM^_gO9kqepxTkOQu{uK-gS{8fhGT%S2sZ@|`#omT=N3bvRL1_C@W&Wlhyx06 zKXSkRA3aOpGv*`fDf`8~dM)!Ez7sm>TlMBI21UrG9^G3=uEcLx9Pdx!h%WT9s~tL~ zXwoxKYFgyu5P>4Fr_@57?oq#QR0S=Zhf)_gyM^b}GqfOm_c!TMMUD8I;^xvLb2j0m z2;iSw?@5H+z9aG2{90;}2o#sh(*$EbJfXy{C{G)RA9{a(dXNXPLgiq#(sUrV&xiY{ zxFDP$Miv-C=nkV(FfqovzgGtlHK>D-tl`R+In=F&1{air8b-bShkBs@)LA4dPsF@ZkHOilra1=+$?dUo32wX)9TTlm4vnLpE5;vKJ%{o} zynpx+_)%~DwC0UOCOsNl&4vv#(vazxk?C|7Z!G3Z!t+NNy^q&B#=rRCn5JowW(x;p zhXMg^oGs6!W3e-K08WVwLqV=Vza0-C6UT4Z+U| zV@~ms#p~;O>20nDK_W6U#mxp|p+eb}wHeaP-70Jj4&3V7kbyO_jcX5>GjPd~tDXe$ zG*nT_JNMu7e_7Pbg9#siakt~lpR_RGX#eIvO$Xqk>9@}gNwJR2$a@xJbFsq>?{9C# zmv(>;SCfwr!?iM_6!z?fg%iS*8-SH|3zMG-FbR zYcWEiG^PvWBGc^b*B5Odepc`Mu@I7+Z5CE3vyoSIW$k^QSiQNugDQHR22p2pY9Rdr_d>K1l2CIrcqGns?v52XWy z7z~Rby6&p9@|5DRJv~#SQN7#+W7#1^kd0{N8*X0|XVxEs-^nVb?dx7T)bk~^uQ;gI zWNfj{%Zg<~CxgrNjpoeylX~0o_}Rr9eiw9mRGN-d+671Hc1dWW*2u_!x1X zF1pry<|U~Uo(+ZSS7AV-&$t>jkAupg5R*ftqtX$TSgFHtX2fjR z!qG*AZl^;&qxql-`OMM`@o2LvTG$m@wujJ^86Z0LqVFPH*Yvy2)~|(WIJCeVMio}t z1C_r(Cbar|iOIp_=?Q|5ErH)Q*T@gzro;6%J{g1vJn`&bj+r3Mq14i(We(oY?F|xN zQe6zE$>vPDek=Kjhfkyou~4&>T=HI(kRM0x+4aU=CKqSIn&f(IGC_5pg@K)uQX3VM z*>sj{7K3?xS8W8}L|8#{vN(Y5>B7>0(FvzOBAgnf@US^8(0vYT!K3pMldn{2RP>3= z&f}H6+?$EQ*Z@*K+oMq-2K`5xFD9g__X9v|-lyQf%{y%`cc^PJ7EB=rTK5l-=nlX=A;2iph6^TKXzKTPgQqmQfFu6i z2-wiN#_vHJi{1ROpD0}fM+IfX)C-u@IQHs@`L;F+Q1=1-#0ht<@7|*_mPhmMr1Rvw zX$JtTx!q-DxhO^5r`g=YKZtFqPu&x(FHC#xCn^t}Ieu#jOmPGojha#Yh{Me0A!G>e zv>br#;QBrZBxMH%Lij_ZPsy=std}oo$>vslKe7ba0Nrx!SHI^$_B7w+xF-VM$j4>cJUD8#-1|s`alpyv-HM zkBehNQ5ie&1|e^OP@2E5udk2KT%SNl-sTmse*xqcz?;t3HIOOiARM?G_$)bHteGMt z@5>>Ds)?xcy5zd8CHyc~FvK<$wMN9w*Cg8llaoy~H&$Pr$+Wn2MrhV&KXOn4TeaRg z2FZDJRt4bHd^^5OEO79sliHJ zt%(>T4ecf8@ns$#wvwi}D*13VNzQwlis)wBKeZno=@z|-4_-pO*-^p*$MZ`+AUHfV zue3OLh@(<^+GpZcEH$g#E9g1%1pIMXxJ2s+)vNl`mhh;QzlHmQIIz|2Aeu(in?Hph zsKApgYzqHCQ~H!4F`>oh9V6<*yCXI-QKf3nECsixLeJRiYS(Om6 z7Nw3FIsXJ);7yXAr;qVgaskA~B$ggSQ0k0?Y_dXVcb|TIY0+UVlr|4^IC6q_cNnF) ztN!4zQ(dCUKlpfNS$G3xGR0owmBd2$RNjT8Gub+b2t_|0qR7Em7RbL+#v~dFfg@PPx;OzaC4VCXo16BV}~DbyoVV zipC~%@K{ypvD6hhR43GJ{Q@(^Rc!VF?O0c9 zDzx4*Jr;1eImsol6`bIS{;bk8op{w3v;r2<7B2K#!Op44SzMK8?J_cXv~`)ff{Z2| z)v{pPr8cPuF1v!gTMr9O6TxQ7}`e;Zm z;AM$#84sTj)uq&%;lh~wbE!E_XKyUKHalYJZX#wbDZM$+F(ZOu(-7gq_5JO3Ua9xz zBI3{J{V9F!NE6oh1?Lo=>q~Qq)s?f8*_+P4y;k3(iqY}4QDu{nB2t{6QQkze8p&c~ zbJ4GBfVa(MgedeL2mfTmc#E8_FkaH%S-QOY)-UWr%IB*187TyvRi^FJDvTohIHl4j zfe@$~D;*<`-X0znY7L$iv3t&hMJs>~}ZL);SiAKoT>%rcLwx_A7LP_{Hamm}#<%G;Esn)qirF*P% zNKCoXg{c}c>v@OErF!DUb>tF|2^XrBTstD=47Bb@4`zzshmRaot*rHIEV6=BW2gGX zrQ5Va^h)cT;YN5PCkD|yD;MF%_`Fq0OJyW}%JC|s4xmnlBRJ)>gJUQ2e6~G*b#%Nu zttY%ug^rjX0l`-~|1CiaOu-QPT0w97`1*RY?u5{&X4P%1t-`#*@6`Jw9h65~l+Lqfd582Me)EVwHW6s}iZl7^P!&d2itK^~&L6&YgKhv_bm#>2r?1Rm*{60Y z=-VQLSkBy7BH{Lq#R@~v%Aa4w?<~wo=vox`YPX8c>b{PSZQ5W>*XzuCgv~>y_Vu@j z452GSWGB#bL`+sLw=+>cV0-7-oKPwYs~yktjY}TgF<(E76K!XzdiQ) zKv`4Z51BP^rlsUQbz$yUNilz|zNd*?Q z<13AeZ1fA{~t|f9TesJc5%9;LAtwJO1hRVX^`%2ke1G+bIGMaxhz%-~b&uBdU|_urYk_KSBcaCttMIF8GR5hk!UqS+zn>Y8^Wn&#)w9!jR$N{hWy z{8;nGq{3lBs)81O^qSY9T?fyvngvovXL9pfq~8Efv>XBjOBKa!CNo?wZO9zs`*0JQ z4{bf`lPH}=n8@hm(R?o3$1W2V7~9umR8+Oe%H!)r)KvdjD#&La8b-*PRJPCQhk8fn zb>rAmMa+W4nk^_5jj4c+Z8njJLD!*rSY9NPwf zMTa<3{*@nJ?p3&^#E!B)^7e%<(1-$S!64C}DWg`NE;onPL>)$(4ROcVF@v@(yo#?6 z4`bi(0Qkl)eDnuzLucCCqajE8JhH5}Vi6#YQo=4%>^R%n>UA@6`!##q)#*A$9e56o zwuR18BB>bot1lPj15Z@91Rp;yX;j4)OoZt_WJFx1Yyq7X-`44)knIcHLpS$!A^V7s zviYPqj?WnXKE6NU@d1F@EISU10`p7Y_5c^jJNsx1L=jM7s#RL^#(DHj**4pWMER9! z#WDz2iv01MB>i^%ZN{FyTf*CIJ~yTw6b>31#hCyCeTl_A_OgmBb~k$u5|YdZO30a5 zImTPK?w>Av#TIbAKO7^s&8)xCJ_XXH1jO_#X%#UFU7~XUS|D$6Q{;Y2^}We+PT`Ek z_s?re_NZFi;iVz>m>x@$*!lg_Rb$s;i>E;Sm0F=sRU`v=o&jZ>o_&b-TS?VF(GXq= zquM$*rp)44-Yk#v%gf|{N{ef<36$q}kDe&RbEd|qD;yGbzx$H1B>FEp6}_aSiObQU zZtgOmZq0pbMXtkRlZ}coV0zxsK!HT|g`m)>ul@$uD-p7UN(Q-{o3~1ps58KzT z%$>6T`oX7Jh`=t(+z-ev=4W(E8eEOJdh~kF3-t(h(%MTqFld+v6fK_>@wZP8^50)NXeyz&baTqS|9gUW<1bEE_>vcYsO<=s*jja7 zfq`=2>r+hGD0wbw%=zZ<2HuO;Hym7Hi(rEQE2B7!pOQny(8&t(* z1TX*!5vDl0edPZ742uLxDnX`}8e%0M+%R+PCgW=53fA&zDYS{_O&f+<6&;AD_f!lc znV!fZ_Bh$vikmTiYUYFt!%+Lp{^eD9yk>SzWgW$#48v#s{8J`_=`C^;{oHjw?${;k zq(}p%&tHZF=mZ_3lLe8_-<0KejwY!Z6X$Cmg@b9WJX-2TsEX zMq`sciVA08_$^R1{+vq7SH!a-e2sC=$W)U9W0*`XQwR*dLl(pjzYA!wS=)P2;DBIf z`n0s-vR}URuFTsIlt?7>sCd;&yL8)iel+IqSV5-WW$?|sAVPe-zqBqis0iN+neF?JWoR_pX#^dCRg0% z4;aCNS$&hqoXA^L6rBwH2v~6YmEZ`kxHPuq;%YvKm0VS9~wBvfk#^Mn>N~?*~rs&SuUI4rCVz(}yn%mM2Qk4v1 zu1qGj8pu|p*1YsTliYTAv54{c<3A$r!?t%p)QF90M4!_kJWPuFa48C9r`|xo6uqTNT4ir35L?y;y z%w*h@pCHh&JI{M6<~+)TlYA^o?X%|ni?!RNlxB7?NMbK-icu3`!{qBBmrHh3HD&je zBeKGxEMIqbfB(ojg}Z;Dt~j_HqUd@39foXiLmB3hs$P)j{oX8EHE`eSE?fh(Me&%% zis)SSHsA?2g#?HS3&J0l#$Y(v%BeVpTf@7GZ>^*kx03f|f3sN~f-h}rYDy#uKf-0N zybiCXy>f9&fY(o8kGe-a-K4XtUIB@MEWbua32`-NPQr)#MDMW;3$KtBKX>$f@O}&t z;Wgzo?|Kg58etpE*yK_ee&_J=^QsgJlm+7e9~jIr+9};Y!XDw$QFL}NB65c;KP|DziofO9v3VU=2Go_`(t;3xI73fms2vIuUf-BZM8M*m zP!ZZ#neKVbxYU^Dx}ILyOu#gXGF=UhAiHfB-OC}6i{(XIUthF;YFdrf*nttk3>ji| zFUd-zV6UPZ9V%I7(2hMWPfCmW71n0<(KIrkmh!18Sog7Ze2y!(XOOh+(yvb&KXc%G1OTgW{{F zN@2ZUh|aEON0VZZ>+}z46?_LKED;+PW}>Wqxdpp3l1=kKazlqwJH7}nU$bNfbR4Z+ zi4CyRXm$wvx^qTuJ3^cD_>qB@Z35}N!way;YyWvW!b=LoXB{&$ibM|!l#^%Cs_^4Y zq*ERR5w%A(qicf)^x* zT-@r41Icf7KztNTTH%Wl=;XG7S=B`ut@-Wdcdlw#-|#~}Mg7|4tt|-ZXLl!wqQ&Hq z9p$seun0!~eXhOcJX__Zv3~v(EVXGdxJJIAT93cpY0fsEC~i7QvO04ERdDG)*=#%R zSt8-iE%iy>CjczpTQ!kro4*%-P8XR)V~0+^_T%#w%_ba(x0mR9)>Zlt%q_Dnfv(1T z&-`bI{dH~&8=`JEEgTS*hBSiq5aE)6uxhB}`FtZ6fPClvHHS13z?-Vp!F7In+4@t*$%+t%Vgz7eRZVJaqHr=2DGF1m?H0 zWXE_FSPrnAU`@2V&Po$4<(V|4k0P5Xj8D&F8)mcuVmU<2J*VukE;*3A>VDJ?`2FzWwNq{jYrgd4X-z>*z3)M27HqJS;S^?s> zqw9}d-Adlbal>bUhqTd?K_m5PHC`Sz#N9SgPS}siB5=FVvEC0XHz>c&)TLC?Nhj0W z>2cdTtVCiOu{rB|g#R>!uf_Q!Vqe~2{4N}R9sj~=uRr8pHrj1d&Ec4~(VKeCrJe11 zA3csC9oG6cPOk|JHgvq9`Y5i|j0p%Tx!q>*da*3{Xr3I0N+*sCadVV>a_*iB%KNx0 z52lp3|8>v%3bgR|fBOQccc=v}&PoJ0I6d7$#+7B0S}7Y?fF4g0-KH>AYNA20nbM%2 zLw>-bY3LO9_OW1=Ep17bgov9g^T?e6PYEf}M2Qra+4f8_szJ_KPf;9Tym9yujM-0_ zKMtWJ-Ic14k!8^2d`M5>GVuVdv(3|rJHRm)Q~Njw4gVaxAFykK;fmd zKA&u*#2GaB32+R+x}$$u>M6{VU|+(!WN&OHeRbxbAsC}Voc{*{-R!c*k(w0ABukAN zdf02w%Twm9lws=uE!-u!Ro ztOq8bi7-r5;fxtUgpuL*S(#-Ee5A*W2BunoXzIScK42pRq<@M+w9njyuioQx0j0&* z?&sYuFCg=Xi-9p%>mc^IBUH0KW1P%o%mY)I-R6W*eZ5t61!fI=O>kUA(qZKAgbNO!Z|` z`)?IKhvB&)*UmRgj8m0`DOluh7T!H$t{qxcyUYTF5ZtnN2PdHLOd6@Kk3Pu~l8k9D{LwH^{NN6IeqrGT(4e_W97W1YL`pQ^Nq z9q|XW#wjktDE-X!vx|KAVGf5Y0YZBRf>G)k!hCWNgEWvEe~PNgf%cyD&zrb}1k8`O3iZJR_wWiPP*s zP$2LV8ygBEO6A;GRmx!pc>UhFY^E+Xf zENgI{p^x@45Xu>O?%HuX*!w^9FleOPL&r7-!iAib=?3JP_hIK$lCG*@Gp~)sE`!iLTj8et=F6Q+z$j= zzKsh~L4P!b?5ii<56cC)y&-;(a(Eh2bZXVH!K*Xqm5+oU=!OW3w8rz8$hT6%XGmz< zf??N`D=dUJ3%Q4b%iNw>DxZQe7GV(1Y@!%(l0P< zi`uR}W?B zYAk2uK5}2DOx8x9`{$KNGn6~a)lkCPgMT~1SwZ2Q$dzblb56=5 z^qxCl7R@ATiTRf2h2;nJi^y+J*2ptY6_L~4JL%V!NhrpE;akVOIXQM28=9VwL}B6 zcD}IyWKD8g&@-$zym74QPozlvWKjcd%$a+ZhK(VwnDy6;<>PLH%l!P=u!20zCT6>q zD0M(1Os^$Yeu8M`7~i;jt#Yy7t>vn7v{7TMwc4keUdG(K@W*ZT=l*k7UPN%IC3<&~ zA>tGcE+b-WK7oRx){ClbK;5ESwCwmexxazsZX+EpyVyH&azo5fO_KMLVo`ql9G?+7 z&gmmfY+K`mG~YOp|4v)8k^BoN%qdV-aE`(@vf)(-YLTa>EeHj0srwFgXMl@w2dz-O zlEF)miFq5m_{V@;#}=pq>v1}NW%9F(fp`N6t;y-+k<}GT_2{g=wD$>g7Sh|)9^f9> z`fj2m$iol^7^dw`0bpJ!)PC7jpC zf<xAf~V;J@@R9v^uiteAU8q>Ul^-2 zGQHJ|IZPi3m{#uet^N9woODDv_x?pM+1BhN?BtLyO+QwlEERS4;f=ud8~wLzM@PZ9 zL7~VOCxHw(2HAYwHzseml79*nan5k5zsbzP8#OBS7&pB><|u+GJ0!CKF&@(G(mNsXkSnHb4&Oy4NZgmqnn z^0&6O00-gMn@Mg!PIY>U-kf*i5GGzqYI4f#8atyGRVO#{{EV>th56+NB%(?=~)>mcwq%kDSytOd>oC6W?0gsd7mfoCC0cU1)-)1 z!(66=p>{W>*d{sF)1XqYN`)GrP679W-n8b;i+{J0ujz+S%=h4QH(o7e7z|8s3>cjP z;bFknQ}6v-m@rC1i>6GY+}nF^N*GV6Q!psE36Zx@h5TIz(eum*pA=`>ars%EItF&8 zQ5z1YLkQvb(>{<%HHU65f`7Gwq2+IjVw>!Ti>;Y{%?D3IjP&!5XilL8YM>38mSxie z9Mt&w=0R93Cn;EZoIvUt#u9h8%C04NpZAu+cy3@tT^SKhDD$dmfhzrZN)Ab1@o4&# ztOr@s<;LmMB6Xdq`}_NkNYVj}Xg#mD2s5F8%^JdnMzHP<;yeMo9q>5;#IRY#I%FL| zb=N02c$zoDx#jRe$=4WcMYkD?A?FVj{8ln#Z$6fPfszda;5*W8iC zgC(Yu)2W0JP$7O~{w$*ix+7+Dbo81lcvM0l^fe&LiQ&y^SF7p=xNss54aX@|6nu6S(1;fN}q-n1lLAyg1Y>;HRI1xEubu$HE^gUXO&KUY1cJIq0}r zxL^(Q3=65gTWT>mSZe|_@m68K10l`1FD346Mu7P&fE5$q1yX+!3Ahp|niZi7yEX6v zsTv`z2N5C}p1M1D(TMjUGFx9sPxDEMtl2JBa_yjZoTt&KK600-l?D?Qh+<$445#+; zQ0hTxjvLK2S_hA|+V^`@((vRq(tgnvMmyHSH|UGB6YX#={;)dbDb1#b)`1-|E3E`!O`xk10=iSa^?EeDMVeisOm+EorUkD1fCV;CUuVQVIaj z0IvoxCWG8R`2Y6jV&-@SE2#Gl(Rzk(X8CPN1V4ETQvky|JVA2S=egR{mT_qoo}H4A z8kFdLDdg`G}K@#%dE1@#asqo;$7`z8ai|r22>8dVBFR!T~>FWk|j$_f%p+ zs&`RqG@U>1P4m;igMGYlt=NMGcz8(bodBrbC7QcEy}Pthnw)Lj+G^QoGeJ7^tD=;75Jfb- zhrruSNx<9_7=Hh!)$RWXd{eIyAO8V&l2&8d*7!aDyO<8#wMQFHD{lo7MRG!|9?NHn zcMC4@y!BDv*3;E3Ja8aGR*SsZ2?kg7@~cXrS#P7K=}SmaD8sLbuSrXrd?z&SleQQO zj!uoRt;D2B+!_0(H>V7d%yP&{SXDizU6*jx5oaAtpwI(xbFFa?SU z*OMw{_#^X=L{c>tJ6!ZUjj!NE>4v*?co6O&2V9P0q!U0ZQzy9xO}l-48Sz_Q3m#b{ zOx}V9L#%3 z7>4yJ6=pyg^qBymFoKECr1wl0IhCTqbH74V3owW5`})=HGudA+AoqL?L7XaOU2)c0 zZV!OCiij+}N0X5T*;=&6{HFt@wQC)j+uD!4Jc5HTA7(Hbf6c?_k8JYh=ii!Axb5dSeh!|L`Tc( zYMr!ld=@|Kvipg55i+euI>gOIu2i~da=lSE)a3CNWHnRy@3Mu(<%Iz-*S znOC(KxLyGTK6Nt7BFuka+vT>!3#FT%2(QN-23sVTLmy#`#BT`Q)uS(VXds-}++4`JWf(vFY2;r1$wz4=F9o7KrNpzB)t>jx$rS8;S zrh@Wp)@WKdoKPP^XKr4&6K;GLpW;hmfD6UH_aIeHV+0y}7AKlYHGYA5Ti=Mx$r$+1!DQJT(& zkHCoNe$p)_nijwQlvJQ`N%~=N?2Tg?$nY)ZcG%!>l+OT1{bz2PM=)y6QgVQ7#33%sxlb0$&Q)my+RqChLQRr_sAFY+BT{W~+ zknzH{T^d*^O&nBEJDwHc1T0JH60&Znz1LY~ZawYoB?Zjhd1%yd^ebn#`QzW&73Mn2O_T z{_aIX^5sC^7l4|Mq5O8dwt>pqfqk}}_vd7TB>uddfimw~YBau&?u0PCf4`PQ3t7jA zz=n-P&drkIQaFhm?~9yD)>B5S)Ug)>rY^^Nb;|aRV$G}v{^G7eA-bZoo1d8Zb||kgOc2)^D7BI+yVOxhg21|4!P;I@WK@!G1gSGf9T`->p%RovSX<3WgFex(3`* zF(K`jJ5VI#4=u;^((t2GZb3chk@u zQ<>g>T)O3*)#5=GLzVO>NYj;DN9sH@$L#T}mhM-~Av{;@OiIu`=a2I)h2)oU8^WN= z4heUkQYjmkDyyV9U#oL;Jk=tO)+JDuDgRVs$XKc2iy|Dx zGt)iohWU69G zhQww9yeC#6k8K5zaLY>`y5{e6Wi3;)r8Q|ABzX$t^)VVXv#Q}?6#F{}Zmtrq_HvqA z9kPp&uAP#*n5sB0o|9d=cWBNc@wkuvQ{ES5?I#13d+h6y4%_^@YNK;S5nIH;owB5OsBRN%MeDdwY$6G$Ei_wA~4Dsh|on z?Gxzx;mE4b02%$pMp<~s$XsA)aPJQIWMLoe`%|24fDBIqc#_YZ>9NaZN1Cnqa(jDw z526EO6i+&%c97m5lDx^@2BwIQ6g?u*Zzc8FYL5*rOcH&&Zc9E;&ko+-{k+^A>xnyU%!S122M!li$GFWR&xNc^PmsYSsaDG^&}p(9A0mag7>#F z9bbaaw@hi;MpgPR)k?OV=6Bp0w#tkn-6!?dj{YDW~BkVxaM}&-^PEwiJ8(1a9k{8xmGe z26S}Q3S6pf5o_ut@Cn*ck3Clit}Exmo1?;o}Mr4ODQ1;tc78s=~AO8Q<1JtlQ#zaqC-6 zje1h#^EQ4uxNO_=%T2bXmfEfYhLG!u0+{x`@SoAYPgzBb7m}l1DOgNK7#Xo1qUJKf z;}ISA5?ot}n(=#kb&tCu5N44A*DOT65^%nlZaheHb#+}U`Q<@;kjXNH(5M;pozCJb zFbkYK1a_xsNga%cQ5Zk2{jV39ukUy*bW)bI1jRMT`3I}e9vZC~KQHV>m+qKq^ zr()*)wP804@sP0Zw_H&oo*09xKnuti@zx=Wf}pButr^kqDJ_EUuaoe`<`3z_--h5h zyb~tCbB8b2{a?xpvKguBVslQiuG_tLutsk1O(Z*Az5U!V-{~^|E(57xfC0kS=bME0 zcyIR&h*r9Rd3KY5CJ+PC$u90SC*Dizw+qr+i~nP*O#;3aFhWY%mz~R>M%jJZY%qvB zg+mTTSJ*u|vi-Va_2${@_QFq`YW)+iB>faJsf>^m_T-b^GYi^r@v3jq#=ZFEByzpU?p#n;bG9J+&G@i>W=Ta1AYYal++ zlzpL&iTgk0^Ko&cJRj%eo_I#f)1ftkjaN_wrvJXUv2;@oGqXLY;M+g6fg$Mc8y7#e zjV+3{^PHKuxF1{Z;3u$l{kiZ^%w9R)vhXQsBEg;71yp1D;q}(`$4ObJWErhQ8JT6V z1)!5L!VLA-&5%7|X)-sC$mzDFhO0fl5Ys9MFaR_5U3f@iNx{Gg#GBm zV2XlH6>D_SzL5q0E9NB{xn8kP>MBH!)r=vHVQvn$G}Vx`9c%dV+WWh=t=CN1rI?#~EQTFT% z7aabF>hz)50-N7dMU!sg~CU<3&SM`o}8`V$lq)(0$Fa;5R+9r|Z0@fr(prd<19 z0JBNMkmmaE7nU;*f^p6=GhF?!*CS5(`?B5QdiPE>W{V|~ zUfn@3m+ zlt&qTvc7J42G93(fyE&dJ>Du#%5xkAe~(gX0rUjk|6&z&*CrxmJpc0vc=ee43q?a! zIcr_*FOZyqVW~ex9Z41g*bnfdg}mzNiYwQ#$oR5g>ZoG?tD{(s-L3PRZDe;UH$%dy z@X0?1CoKUa!vYjS6CUYIazz|=Kg;EGnvYb2;}_j)r~cSXC>nDbus}Jjq0iAacSytO zdCOhp3^iG12w2#?b;F$F#OV`^J?uQ*%D;8jx!63ayEs?zE8_|C3r{;yn%nV}=z`r- zrPt5dkV_hxw4G3+5W?uCxrx?BlpQ=oR2Fvmesh_sN8I4Uhs7BR1j`B_cw`c>Ad;Ge zui=(No)a~|*JQw;{3^L55$99>;!LG<@8#l&f$Rw8^l{53o{N(Zc(P=g#6hGBJ~_7k z_^tuQ;fi!C1^&~5S}wq$fc-wVJw?iY70`2uFa-^~{61|}x3WEcS;E zgY#gA2P-fjJHL=ODj*1OM)=V3qq27Mlp+eObKx8TrB`)h8*9{qQ%glbQaAfDcaWc6^p0NLRJ<7GO)u)Po}VIwb<-?CAuyc{1i?_Wg8eE@^ zd$R`;#J=0`Mz0k}&&ptP{VcC{N0*D@9z-r9ekCDzwPxAv83oe%GIQvpKZc*e8XHe9 zloOp3ajF0Tr?kSz@w=Q1Bp}cT2wj%=tc&kgx`&P{ESzRYUX!8Y+L}rIP(CD`f`r>6 z81T+gqKKVjkYiIw1QRVEfVIWTK=s$4`_9xIMYfdndFsYE&JTeFw-FBx7V9>vBYMdw z+7bjTH=69D+Njj%wo=+xV%4<1JM}U`+~J$?^?=g&Cqzo6rkH5B@BF~vXMbRB*}Ji< z3?4zy?>6U3E{p;~{46V{rX?*=R)YnPG|s5<`trrna)v|Km7lsTyOjxa?%Hr!rcN4e zZM_?5)(}4el*&xnGYn>(<+JMbNr^C#-WdgF)641aq#AX zB@)NP%nYDGTwFV^+L6-C?Iv>Rfwy>1*r{@PI&ms47U(?REbv`Sln|Px4g0=)h7&1@ z*9OFR-9Y37ee-+YRIQgD$RwNaDCCO%|E3u^1)Zb zP0MKHr4i$5Ltav{m<}5~0WLP8kpJRgZDu>pMY>~5y2kbXP+Y4gvYO``Agzep_l#Tf zLDUab7K&Ce!QXKPJVCDeK-v0h_gWyC^4itMPil_P+n6HL*FsTz_G)Z{Iz{mwbe*#Y zyk>R#e<2F*DX;G5Te3Of*d4h^xO+rP7&{h7a0kZ9~2b%vT~w-%wYpWFJ_R z*agh10x#bkGxAMLl6cwQW8tbH5jQL`tvjI-P+SF!ZGeIRaC+w?PH@Kl%PPy#AXY4~ zbYi*wnTM5#wBf|V6Lt3u*4FX^RM(qMD5paC-`j}*))x*AcNE&~iFgQ_B?e(D6fSvW zNRBX`2`(@D!OTdomN~VqR2SWTlf$_>vu7v3VNe>C_ECSaRdqr~fQ|T)fJ0=W6sN1j zq#uN#>cW!z#+v-FUj509Gt%6tT$^rPfY3*bHFgJ~9^=LlzP6*SR}hZjo4SATm$K3U zI8V|F6dp0RJuFgxyD({!i6J$T@c^gE!-bAcikKHR4lCAqG&UY@K-^QqpTw7$2#9>j zqTQ|0AIE{`_$~=V1Jucq$|{3Os#}(C!0e4SQ1H z4&saH*l*u-L1B;xt3=;jo>{t);UR_huV&T$7wI6J|9QQ}Sx*T#_zYHB5pT#5NbTt@ z&kr`0S!_NN07&mo1VhF{*3VQO#Xk@td7|GC%ORtI)Puh6jRhm*Rh($&%ll zxo^IRjp_4#Zu&C4dPFfWzI~iWH#~q2$-ef*SQMU^LuF9&*pN{s%%>{BGYSHshjBz@ z^ggtIpjdo5Irh(Nqd0tGBR=RbV=^?~WC5kRsvY!hqB||j^nlrf>+z;Yct%8l^c-j- zS}y1Q33GA4U$l)CEH$o%R{XGRkmj!o`t7V^&7Ezv{Xo+MVEGR~rXuW$vkcQ?V@*r# z1kwESyV{)ja}UunsM7-75~)P9OC|D)0{&q$S_KvLRb2^_zLr@sx!Q#@`bbLqc0Usi z{&lojA0HSEIdQi|-*_*)tuN=%q*H_cF3PRqBbFvypQkqu70SI=+zooecI&PEAXS{n zpJclm8#&>i2g@-gcqD_m5N6%3 z^w?M&8}y$yZe|jBU((A^&K3Y@{a{8Ty%^kPQ)*- zJajidK5{oxI}j6jP?X7W6YXtD-LJzpBX(GCVMCLbD=>YSjixD8Il|YHr@PSE{@kMkbUozJFynPr|2kJo&UYpgaJhgY<+HDGH9$h7$P!Tvgw+!+*JH;nEjWd-Xxk3!z-|j0W|*&C?sEA-i!PJ zpwez3?y=i81Hn?RV>$Sin>~B7nZ9APFQD&1L-g?ZSfS?W<^klNmlI-Y!Q2({Nb?Dmr- zv6pSoJef*Ut_<}>>D6H*Q3G|l0PN=1137H8vNq<*w)OIsNgU8lAC=FL(vfFD3SZ3i zA90XGrlu53#%7|dWOjo$f7~As<)pgYEkhKuKGd8tl|>jmhF#ZZgM*#wBi!^k56!UY zGgwEA(C@U0U74fw1Y-@h7tW#Smd~LinBE&a7pFXHc1?1ZgX6{O1<)WSyt94`B~9cO zWxJ9O08c(+B$DzLiA%)-AL%mapT47rRNL|_x5alaP1rx}itlzsQ*yE4k*b|#^Y&dP zu#B+qq&+N;{^}9v)Z*E+?V#5oup=`IORr`}RxX&N;919<3a6@&R>_h!)-pR%%xiNo zsoO)EKP|0yX*2tzqA_NZ`f=irRc!hAwoAqnT+wo2F91N^(9?j!gd{vJ7Hzye1b@TG zDSHZ#aO7z0Ta_nAGCc0WFu04(_~|%K!RjD~6#!4%xoaCnc18&I#sQ%NhPM-B^d%}a z&T+MDg;=z`xgP3Wd*!Ga7q{eC6b6oEjYCSu7Qr6kRDcU%=<{eOZkdFnWY6I~P^Y^` z&FrhpQhoTP6|%O%vRV}j1qX{%qJcC7hS76Hb;fq*>WBVG>v`<~iDBVEjCQ#hR^TSl_-I4*f$ta! zWBT;zOWi`U?mRk0^b-{vG4Zj9Wu5bqWq; z2ZiaAvfS;FX02nnXxqj=EFpniR5QSK9P$DiWM=~m5Z{+KV)zEvWAcQ2aQJVQHTQ^r;4W=BOW zDi`9K;Z6$f%M?Ztsm|m)xr>Il5FQ4hf-6o692%!;GYm_@SC}e@K9~!TH6aGJtedm* z#U0oIR$}V}7e*Nxarpf|gn-lAW;AWfFB1@Z0v357+~co8E@GPdq%)@7VIq2JuE5Gb zmOEMyohFfdkW>9pI=qerV$)~V^K2{MWY+MAa2(iIsLBM?+dwm=s0MKJNWsc-2opr>dy81?w0QG>#F_fJ|MO>jq(q#p&WQcQ`pFR* z?x&8;Jw%S$D~b_N3x3`7z#lZS!_iwqo7~+Bk0z84!t=w6Uw}ce8&}Jxd9Gc2JYQel z?}*JaHNNgh>Yw>X_~HOG#vOYNpr?NWHtdt~sItjD>#iLM!>|h~@7(_TLtZG38fAdL z*5^eB0DZHgxGk8%83$AX&D@1hNkp1$BAy+=%B~~5zEGKzb*!sU=S^3=C<~$dcg6o z{L2jkShyxVDwN$|T&Ko)C6eG+<8xC<+4tHYqE3G+vv{24{&HY`&XMUTOFH#n% z+1BNh?{8L8!g3WdiQz=v=kVIuS<}dPRgM8lQ1ux|V|atq^*4qqbT)rP=OzPOIlOZJ ziJ%!Wku?4iu|?@D9qCv%wLRKQdQMl9e~Z!U`xgiPwpNVah*uh;732hS?hX$DhE+2m zGxjn==vddo60YTd28!Wde3>UDcCY zsWhthtb6t$vPz;p?;J4lDV846qN;~LJ0~RregeEAIaUF6Y&AN`0|)M}%$s0J1S<)+ zzjt?$hRLI4d(>xg8J6R|fK@4r3R5sZ!AeTr#-9DppEn3dE-=Ccwjs1?zm^nw1BEF} zU{$FB0oWdtufI}Ka#QQ_c0(k+i-fQCa5{_mXzMz0?;Vil~Xx6mcQE+%B`@>^VV{oMV^bnf^O7SY>29ozHM4o*vZsFHFQo5A$^H(;Z7MW-6w2}azI0w^ z-Ettoz+OKC|wXoHVV-LHMng>Y{A8^@?TFfP`}>&+EyWyor*6s>*_x zGXjczP})_39#7)pgXSF5&l^3s2+fu+*^dvLiblKy=5b@&U;zg_?JYy11FcOYC=4Jo{cG6{z5_k7ndmfR;GC0)3mIP{u`rUs2aX(UB{aiLg3blE}U)q zKP=UvR$SSqXA3ycpH{#c_2+2AqXw&)uES^BLXqt6KmHh4IvptN0tWe#*GD>{X(%0T zd>H}acnD!559bE@BX7nQRH^=OG&pNUfQRJphDNa45eRoPxlOEmC&U<2eXtRTiFfM} zRjOwW8%g5IW(#!6uS(+yCrr6weic@q^Q5Zx-{HBv(LB-ZZNbeuw&&dWN_?`oUj|*M zK{(cwpzg{n>RwM7B86KZEjF)I*G{grpU3{3tX0E`?R`^)ddRD*B8Bk_1(zvXw^}7` zb9(yvAm{GM|2eet)9ulSCxzQ;zORaBH($>u%dB6oecQ=Z)f26YS)5MSzCVr#{=|I@ zQ*1t;`kDLZCk`?W4q5~a@Hw{l_x@tDDD+>P{+wRzAC_UiB>-mh?4rOz0iG6mN$b1M z^3quT3+KgUw%7AN`mI3`#5U@F81%G%oMT1i#+_MIAappXT!E6b!?u1rtOgG1{ah?p zU@~%P!xV1!ACj93&t5)e#%~wj+*#kI%YYY${fiu;jxTan09ED1#RV{J_&=J?GAfR? zYu32CyA1A5aCdi?!66Jz@Ze5x5AFnaC%C)2OV9)hfdJw3^M336XDwiQx_jTXtFE#` zK@1xJNV9-e4Lr>QhEf`f@krIh4X|&ymXSpB-$rJOP#0C}%V_^x(HjpKNc$}*D1hMg zcHOC1bWCi*lu2|xNA-W`{k*(A=cm-WVq9^7w)4M1pFf|F zNFUO2&iVE30`PX{b_gfoz5}=lc0YR zp#mqYORu5GlGDZq4-BBi6R~ThuIX)=HpY_&oOGsA!q}s@9R;0Bg6bWBM^!!E-u3}{ zvqg4Oze!5xc$^E@X~R^otSfY2Y*o#Y-WFMPO<+SiQz&jsOH)~W0ftTDl(yX_j)=q&L6rrCPLrV}}aA+b~9$go-Wb%np<2asxF*XpppLt&{uozLH z3Kp|%4Y-uE@;e3sv!11go%jAJGAACt$AGyOn%Ob|i<%BM!?M~ponMVb)oxrbvKgOJ znMaN+he{J?8^w>qosNNS0F@yADfrW0lut`Q`TUbQnUdq}k^1pRj4LDOknNy4ka6;~ z{-7!qzLzS&v?s{zb2^k~fqy@7e7=afs*T$w66^tyoNuH83qwP~l;Q*bWPA!+8Ud*-#A{RcWw*(UfevoUQM|B+x8t&--7lURA=4VCaid)Cy2vSM+BR z)?(8q{I)047fuqyqfXo$u9xpb81v;w4|BgzpMF4*Oq5e2BETIM)9r!1*|6waJ!87A za^hdXJ?8KWgW>YMU+NXw$W}8MQ?ix=NY{1(jDdb;{V~d+8H2AU?!Ny1-9Y^>)Dnar zsN&k4R<04%FD(AkVfYD1H2$~;ILb8W$#)P!2T#J3)o)|&DmHHE5*bY(+#99+(2#{; z*Afs4=m!Q_ckm%d9a6fdgZ=Q20*!60bqn^M{-4&jN+DD)TW$%)@ppF4`}3tML)9g+ z&Bf6(_Ec7RagR`33CqRAa}y@wJg@rn?;j3IgPmE&vBPRMORC=j%_jvnWxsGHv#+P} zr>Z!o%ft&;b94ARk@GVU+RuA24I54am<9tY2m7tddj0ygRPX}NM$4?jt!f|$HdNB7 zSe0Edu|Uh5JrjV)pD2AeqJBCR8NfQaeFExQwgk{sp!-DW=8A?xa^01&|00nhL~3UU z`~@^Lpp_Fq4IT;8|AQLpsKKa#p%)`5&hPxh|rj}z5Y0~=)VEin(-p%C{V2!m01 zK`z@i7j7!NyIa^9;K?y=+uFMxQjwJ5BuNu_#Cw!|Ev!-@u%~Y_D4{0T}2aSp6(d z5^?rS=fI`BwG4Ow{;jDKoT;(OAc*@k_^Sir2Dacf)s`-4{jvf9Hhyo0n##?O4%l@g zojW!;P1E@sJ+XK#eRh>^D>$2(DBA>gYp)0le&>O#dS;9RmNRie_ASIQ~cEw z&G`s}_Rl!^;nmubaL~)1alM6W!?}-vE3{R2oqQ10YEYkhj11gxkJRw{{o&!^_7;0e zZjTJ!O&ADq?e6X2+9%2jyCm(iqygR@j#nbp#5J>bs^nTC-&i`An5420nU}kB*;hRo z=q;?bnDEPw*p^MOrz>Rhm~;k<{&n!f#i3~H5wM=!JAb3|5J@%7o%$3m5OHjrwAud^ z*O}@WeZv5G7~`>|4xCZ10^$ifD#qA@?cm2dz_l3pi;kfRNY1)TK-~i(F_Fe@CZwme#;;O_>u!x1uA^=y*nP9 z3HGm%J(5r)F$X2WyC+d3Dqt%#o-tLVoriFG?CROIS_eYihLr=Rr;NelPAe0Oalr^) zPFALI#hz9rr?KkynfUAb_!*`ca@bU2y zun~}!wE&iD02}e{&K;mO9az2)=AIO^w$Hfr4}!b}h+fceg+krF2C!uL!X;kBB{1>` z1U!o09)IM)mpV^oy?dYXbfhiaIjL04e=iGQq~ti_f{cIp3n0p2c?-|rCG zu3GK9dp{bZTMt%DM>nvYu}lhu8(ZDYMDkQFygSJX9+#y)qlOUnw-pA!*&YH#Q${;Z zWt3BHkIA$*{foz8EnIYN^Bw?k?(J8Q-Ijs>be^fFfXCRx1hSawua8Hm{3f#rwRN4A z#+>apzj^pvp;6gw%h9f&7a6TF#J^dc@8RJr<&kV{dedEfmPI zu+i2>2)a?!syif$mjgPhj>48|-JTe}g9h0jeB~13@HFwv7CNvE5Gzv~6`jpA5zal)HT02qHqi zumNzZQM_CUaCNONkUjTlFM&Bd&Tz=SKNwr;t1?w9+5*EF3yk6F?%__S zM_8zG6n6e$B4Ht+yML4f`2mEnyLj|37%Afi=58nW2n@v|5(vTV|CTiFA6jLVS$tY{#R~5C0y^je;82#C7J~@TPLcSt3 z*JL}ndC>aw5!1hR<8)q3$8x{z`ZXV5H5VYe;F$Oo*%ZEMX-Fy#5<*cb`_Fu^C?RA0 zWfNEVNV|Jb!eP*oo0XobMAaO@t+SdXJz&z25i53M&sJ80t9#1A!WPtwY-p`7bjjzW zynuAvN7&qAX!2?V@PiC+c}f%wq6AHB(M~5Ic!-_0C}BUta(=|-A%PmOPhd;;r#G@W-q!XR32^cG27P)?Yncb7 zJG$n9&pjYnQBeU<3=b{*-0djOO^Cpwz8o`P&iQNQ?z>Ba$VFE|#66lx=et?-P{rE} z_iqshSkScsXTXWb7CnA(*zLmRi-1H*S;MSyqXXU_KL7mwFtFnB*kbMcV$4X!BJ!3Y z>ddVrx?Uu&%oth52jv7H9@K?2%ZLg5-as0>BTSZ!GIBDoO=tm-tRdN$S1i$yVVi-9 zCeXtF6eVHYaJ=qTsMJWvJyvpKu*G(N&rX=(6g~>hq|tw>ADAPNpw?M*Hy>M}lAX*( zBgwHsWIEAOyOfeWhU8qpOtugp*9X_U+OL&rLOLH^ND@j=m3Fe?q`qv_*(ALycDaSQ% zS%UyzK{OfX$yTv#-T=0|n~9gGHwyq>Z9c|*8e@`JvUOsVHqK0r%r0`D&0F1~oNv)K^v7JVgFuiH6~tN$zIZCKg1k^mT%C0pIkoDHK<`YBu=%+?i~H zMzh>RIB;kN1m`*9Fz;TV8HyRcN=JSp7qdcJS4oRn*BL3PEIPWcrw72y-bpjP1-=7J zqn8t?(P3cSBwNp|>n4_txs{ur?;e$t|CvPAe+Tn4OagE;`2j>sf;gE$uHoSK$C5qX zVYRuY4Z}MNO#i&?>&#(WdZJ3g50^kN^LOGNa7$xP_WM{NYl|?90v~LE7*I(+iVpsx z)eTMe_3v^uBLG)GzmsD!`5~8kW6JVExRgK>30U&@bDkT`opQ+BT&E2XXIy@|TSSa} zjBt5HLxA-|6z_0nAD|6rVegKV3C)h&S|=S8e$Nma$x+9`+&TDz|GFxQDB0jUJS3EG zx-T@g37jvt4d8hUMHe_)NCrFl^8IhP#HprTK`$_SA3l#&m>3E+l?3zAaUxegIx6l8 z49DMJDZc&*dT&?YTyDG`h*5A|Pj-DVtB>kcnjii1Ymayt!U~jxVQg^X#BJ)(-`Bo5 z4&F-PVnMDy_@|mlLz3ciy(Sd17Zx=(=tZr&&KPm-coMZNyOj>@lI#oxQ=d+%Snq1< z6=&Nz-KIe%cFNpUCD1OT8;d=J5D*aSiHhKnoJAaqe_ni$2kF z4f`zBcNxdcCJZPua?lKj3E7|ezPWfh6W`E^TYRaka5O}Okg75Jxf;idao7=q;MFTb z_3Ri83}fZHZ!@IMY((!Ma2|eb>_{yiiMuCB#=g4}*!O;O6I@LWeiP1miJk#YUK9q- za~c^)Y88dq#QVX&!@_oNyrcp<1oE?xocLG;G40ZM| zSY`W*1(@gd5J&H9;m_9E1&l0I-j0r}z7fiumz&qG{VhiwIEgDiVGGd9lFZ?Zb++{? z_h4QBoR{?7Cg3)48gC_YWao}+JElEa6c%~_C?pnYdKO@)yU@d4;B)vGrhUYR*o3Im zKa>Kc5S0%%6wg{WFknEl7{s03aCK`f5z{A!ysuOk@5#ICCD)GO`4`&~ty#(qJJRKH zpI@0o%&`cqlxMIpIEv(V1Zk$x-Cmd^nr{o49tsVped$?<8%#r z*Fq=xK5~n0@8g99F(8)Ivlf@O#-VUoyz-*MF~uywWpM%eGQ_EQmX~-C9c}(2?ST#q(TJ(kfMqC&TL>8Bn;&;$vzh ze#*aOeqV`YC$}zBY|Ex|LsDUCy40M#8aQVONqrjh0ykyr)pxC5<+>i zw#|U4$3uj|+}wO`Z|~(?bI^Q#=;=0_L*Ucj*Vk!muGTJ@6ot#)wMz?4tKCZ$JO1gI z8YHONu=`NM2lYp90n@RUZH6K$M3Kw5*{x4WzBaMpV$avv>3vU%eQ@KW47PguMA z`U>W$#b<@M`-i)93cuJNZAc)olnG?Co7Dr~Db1CZ&^d0mb27Dnwu_jyQxkGDLh)^| z+oaav!9hqJ1Al>UZaTI|_&9I}JUuB?hRd`;N)^tPUP9R@qhd^9hwzuf=RP5>G=h%q z2o43Gc2oH6Zo}f@Em8<4U*4L5*(she4VLC>&SB?v0SiH+T5GQbN!rpm*_TKlKk@jO zF@veXH0!I3@4e7rG>{iRqd1SlfKXRo5AY(rY3FH5b747)DRTiPJJ7}8kMt&jW8HjV zQmcm{H^Hf?!;ZcX$}Cz3l2zC|VGu!#DIVX)*HuCdMMuB*;6NiOxf{Ay$C32hfoeQR zOLt1CrLjMRTbzz*$iF9*4)(_ZLrFBqY-JPdR#OQNJlciQPVk$eq!b)y6T}FnIZ-OB zeLK7vtI-VAM%%4ngpO^m#XsWiXsT)b1=?+FLxpmjgk~XvPrZ&RZ1S-?)SÐd~{n zS^b?uMlH@J#Uke>aI&SAvDfF?oFGfio2kjb@fvFC-c(>KpbP~qDs`=xS#Yu7xk2=DlEgRXJv#nQPhj3qFMHZgJa<;lfLz6D z-uBb6L^E5NHWd{#8Q-@7Y}-kKujHSfsgw4kWVq1qHVYFLZJ>x@?d^1!QtRAD<1BVWh<^^Y2tqPlwCNwdf zzzyu&4*u@_HVko$HSbMO2x7jK`JNP|UCqtSfbczQuTGDfAuW`^H-KFPWTe2EuhxR$ zQeY|?(++&Nu~-A1pG#>@GjxGs61_;V87P-BUO6zL<*R%OY@z-R)`DqI8Fj&`~-A9QpGSQaS6kEKl47JqFi6jA< zp~n8o*e~|eB^3Niwa3r}B+?LKcpPN$m*eml(P*;{9wo)JH?^w{?|^G7>l~(rYY5|W zaqGv}rQf#PqrGv`wGrPft5=u`X$vLs^%eZqXjUfV?5-j1Rr0S{>zXRi5{Je?0Rh&b zV9=BJ`;YgUwM&3Za`V#12G2Wc!EMQm!dIKh*-f<3;pFVG6P+!O#S{2$>qKIC8 zij$X@hf{P_PjF-4H0%pNVX%Tbe15tHnic>9@AIED{#{=IE4R8&Hr59nnVJGWLl`>Z zlgmmsRGmT-+PZDhq~{XU6u!BaE_pi$hbRdb)o$j(Xv=iXB!hd9&~?A&u&AR?t&$Ou_Y z{+s?tvwsF@F;mf^C2_x3Yjz_EEX%vRC~`hE+U6>l?826$r+yONqba;FB!$TG=j1Ma z^FKy@`tmSG!N->DuR(VbRiTVKT!21t3N@d>%!eXjxNi1j80#rUfZ;jVk{z*601i@P zL7Sz-!|RKALz*(qwgN$mMe=Z6DYA4Sr?TMw)o+tV!{w(T2H!Rq%1WP|@YcgG%_;QC zsr0YsLTPCmm|R|;okd&4z{LP))hC)QPR(9~`hsC6+N~ z3fu%2$Jw|G}z1qZkQlc?J) zD}V;$Ja@+Fy6~Nygai})E2cWR8TNiTYc`qad0>~qPiJb2^=8itl7V-`WLa&MSp=YV zx6Bw((%1ewK^kX%{)7W`;`%W??#qCmZEBZ43e*YF0FFo$iUj&MMQFx}=|0jz`aB2u z2;!jF9J61{YpwoymHco|c`uMO4>V^An`(i#rPbp@ zurT)0j~{0v+l5W7$DpP;crSin=f*gX?u#zPEZJEhz$ynwtuSa&63n!0Rd3cv1)mH{ zkOy-8(&TR2`|Z`zI>9kjrKkvTh13hCM%a~j;oF81+4A6F4d%^vg-`wSa5qWjuH{bU zVP+MavKk8=;~SH*TlXQVQf2@yBl^=kKfRuuJgI*7zK*Dn(4Z=2vVqC8WZVc$;ybW! z0Gb3q7^{6ovvOqKyYA8)0@@l8C?@n&P-RmnR+`J)&@cvl261vQ?t|nsKshVWR{~f$ z)c1vsJidJKb>+_iYVRYAcLdtb=zf3oH4~JgMK^y)$J9ba*Bb0m*@hB(0IX)P#fV|h z&@W`7!zw_GtLC9!eY#7tIPA-f)(n zxcDA~UtoaCr^6~rO{cg}q-4o;i4-6oNZ?IaZ!eIADTAlp-rg)5pZ@;7YuHe;T^Bj5V+)@8 zW%-W(nvSp?ibmN{v=L@!&mP z>Qd&-mL4|0WO6!zL~EiXcjvcoaISMRx&(a>_%W(KLZnswG{^85mMD);%t+a8P%e8s zbT!AmnN3UWHZ=Tjkh4D=I&sEgma*SZ#z!Qbx8P7vL-@Snxkd1Hh4-ShJu^T{!={lo3p`~Lam?{AiPz)7bgsdEL~+#g6m zU9!h5b$C~4UK>+TikZaqT4*{A8A{M?$gHnqVH#$?Ud zu!>=S$4Z`lU3I+Q(q~1&W|4g%`t7uQ?t?P~a2-Xm#Jk|}z(@4yzXP>M2u(6;ztIL1 zqSxk|QM4dR$%_V@rP*<65n4qI@mTX zO<5rh5QYvoS&X7sjlbuf%z=1>mmiAhv5~*pR(5}uw{knf;+`u%y1#GULkJd31BigO zmuUmD-@o43))*QVO$5ooIVB@R9xN^4`unhRoSQhyQ6!F4&I2bHe#ZgiEz|-J6XQ6v zHOt1DUc;Mt_AYw9{B8cC?Bo^0V%e8$ zmzC^hanmFQQ9M>C|Eh*w!(nRe@o{=i6js?#XQy)}pMX+4D_lFWNyPU|l72s9(#Y~} zi_nEs?_X>nF%N{v* z)Tk(68mk*N>h%$P*c|T~Hrf^PwU$K$PfP5^g1N?%(fYk(?Q&yEt;E1Gob&y5j1u_b z@=z5%@p4gDVvw9^UyNWwZ^dKT#p-a*<9oWr67!HC>|S27EbRdU6d=644tJakQ)921 z;3=|<9&y=1-4b(V_`sh%3|0Mi3%vc=dw-q_!uhFc+(0cEvGL{lvzuGUk(s_v!sHe9 z5`8$WJSr9jFf;%W1$Kfspl^aYalzg*Fz_dqHqq15>c|LuZwz8UuUXLBUtj?Y0BC{R z?fc>}`DaM(O=7zrU_%>`k~YBXdb0d7zXqwJLSq-|$Vio50qplfAUw&^?C$hw;F-_S z3K=;TSsqMLaP7W?K?t!6oq)C+-~@wxSjk4#ka&jo zHL05Pi+ZWPsVdA#2?~tdW2|9hAr2p^p`_1RwI%G#KkZB&DYXE-+m=xWrWgZGctd4HD z-Lb|T=+G2esr!p64P~J5Q-M0TEnR;-YP8ChTr!_LUL=)Yg{@n9?IcSVNt);a_t(xI z?v-}0k+ zT}aZ|6cF-V0*Y3n8baA$B55emsL=ks6nj59dwPcFX@$)C&|-S#BY6_n$$UOFs&@K7 zzrYTm-X6_^Rx1KHr3yZgKc^k?+a<6ZQhfIDnSYnv#`1b~6;RP<(#2v;+=zF$!{Q^dwkm;x+B#1+R4Chj9!NCG zyqx$E)z~K2!1VC%U%r2MLvU><8=_Pn*AB1BL1H|pi-7}g(IswRGQP5KuzI`_FD%`5 zu$*q|+t*J`1KeHCOza{*(niiDyn?|+p{XrVc4aeK4M4MEA|Qe_-qAvTv8j~8R2jL#rJo)#*Y&{`%Sr_WB(#Rmp^cO#pCi<>V$5Z#XDW*xiC+o+8OjW?=YP0OqJ>x_|+ z$SI>KMtBCTdD%MNaT<=qX3g15_-_=$hHRH&C_J?9JLw!0xD)6+s(3@vuTY-u{Y^~# zcRa|=KDJuhu>m$x6WH{QtmmxoulZU~unlo+AYRRn+xOA0(S5kwdq%PZSFEzOgWjPV zUUQh)sW&aA7#iK<*OOYb4p>=meh7Be-i1XG%g1uO-NHzNx$=`x)_&<|r!b#j;6JNy zR^AoBC0&f>o_RP9AbCC=wUn7}#hN%C!|hCn^4^0veF6f8w-OL>TQSE9#|)lseZH_H zallIQ=R40iyPp%U!W)rS6IDmjm~77EC5-5x;=t%BRUL6+KQp%HVIStxHdk(@g!{v@A2_}uBP~CHGgT{;GKIee@*3uNVE@O~uFlTqe{U}{Gx0yJ zks|m1sSM^vm;cD1t-qCIu}v%`8w{D|%Bw#!w4@=38v*QXod&GyzX5=By&*wJh@*An z&;bx;g^k&PKMV5lAxaz@uE8q9Xcx>wMwmOGe*OYaLmHgSS&x5m1PAB(l!z}Qiv_Hq zIOk?(XP^2P0emeeimuIol{=79@pQSqz`%;CnalO%Xv|IS^W_(9h(D4o_>uxYCX@f5YZXfSz@B`w%7~bW;x)tNPrVi zDTVR=#KBpoo-o+or{iBMDY$ld;|Oe}KmStg+md(TA@Yx0%!~yZUU=czoCBHGpDVq_ z5A%{_6_H&m^_lK;K`#RV)rDCa+~GxKu?nX-tJ`>q^;jiC=M~8AtbC{rn(1Ao164f9 zxlHiTuuk8bCcblPR!+uxm5rzj${(DFklmX@ef%T7#nSELn4A)f908SwWYeG7B$Bb| zwm!iary+ZKiPW4Sg<$i$#~@GD%3gr82(CkYi17b=0gNfvUN<&2?0Ji+R&^Uw8a-Px zL=us4P%I5Ed=|ekGb`OjPgL?`vO!O?y6|`khU+G;;$Xd(mPBe-g#n49GbP(+3@Na0tQb307P>?4z-Zg36E*<#h_kEKr=1%#YknDL%_Yr(r-tUY z3?GlrfJ~KIK$ZE7l&%%7|Fu5w#0Z0J=7wuAT)`uQQEQev%L$G9_r3=%hO-~HVRP-8 za(*Ojv=|=KV_}i zHa2(cw)$9bT$GY9uw3)9bmsY!`3Y14_JuTFTSDyE_|ZkKtp@fC{q1a-o_5EioN(GI z2%9p}lBQjjTowz4dt&q;8Gg+Q$?Z}WOzcJjO`|YZG-Uy_n*Z{uJUw`L%D0U23RMSL ze_fq3r;rf$$$A%A0Zf#x22)z4HRa${sje;v)e>)Vj~qJi9)b=-eF3V-j`N8~hzi-`HJgj2#pgQ&{Zn-smO47@*axnw+7V0MfTtph9o(q|zZ|;6Ok91BQ&&1PUhXEN*OUY~|w# zVNpx#`gf3Z4wg#>|5X40(Q{`vyv)lhTJ48DU=PyRqB&+fSWk^!a_@Zo_a+=ANMr&z zP77o}09G`&nxIp+u4!TAn3AabK!%tqLn+I>#m`+0hBosYtn&>mg4h6d{CaIXdgHJo z#_3oCz;u_8ssS^eGX!fPV#KD!a8r#H`U|raDU{m@hM#-OG&aOVH^ORL^kgl}f%QE< zCwYI7knv`D`eUM2X{8??&3lzSkM?ga+U7sh_^*NLEKbdeo(6wvC z^QLt~us0ud2#=}jT}RZG5=K%XGZJxbUe?U8da|h0Rw`5oreZYnE#9El0ri*On@*7` z%i(N~=6kXPH4CNq?1GW(97BO~QV`zXt1Gk@zWc<41PTfYlU@ntjO+~FDX4(xtSW&p zSB3)z5SsaPZm1`Eq=Og{TF-GvNujF&kMbc`a>Wu;BgH+Xce7=5$$;H*l2uv3)-(%HnYQCu%vjs&>L6d^gF=kobE zdkA`cuh&eyy~4bT(;472n8)-eEucnD@${1Tg7FtewLC>dvBA_3 zJ{@OaG@s1Q{!Ep863uD*0Zsj9m)mjd5%yPB66wcT;$Y8$VbLgRkAhoH8pCg2Us3sl{b}G-`2wH@jvI z{FK={wsKaG+!_i(_>=%S>p)zb(yI=3gD|$!o>U$zM0ZqVyOpH$l%{ zm{sOaRb`ULlvK7s$+PVngnGR!3o#aiH`LEm;mAyN{_9%v-;p;SyNMubaiu*l5}YfA zFkc+E&Pn-B$OdjcG!cctacAKzD>Fl1Oy>N|dh(p#idE52I{aLgU(_u*s1tYB7!3z* zvLur5?c1yHnO#tmYrzh+A@o}h>TT=@b6X1f`+!UW_}yDcF#&RhomvCuvwG@i7^=x7 zb!xn)E%T4brU9@-4ewGNIdh51IM(o@JR=-yuZsdqs}<7D`_t$5f1eu-ZX8Um=B~Xi zbH1X;mVI;8)gBZxQwCpf2vWe=eH0K5|rg{BOA-A3!^ z=*XI}&0QHf1zd1))>g5uy5w);8L*=i@}Jy{fwJiOgaNT|e+-o3K4dBNCAHJ7z6qz@ zpXW`i`3^sX<)PF5+x~vy(h1-s>i9PF2zwacJDDF+0U?YV@#~$vA*sQ0p#O=|Jn2eM zH~dgc#D|QG1T3Nd=a2=+;I7roGY0|44qf>X7ehm^C~(@)jcEsI?1nJ;d8 zG^DT{=gD*=5i7&uaK~;Q87=3~e^~S);|4_6N|6wZWZ%?HUvti(((t=!2WCk1ow`_i z^-yt_8;mXnNzzRB=T4YIWz><&Jp~D~6ht|C{-K=Dl`rhxO_JcI7;!T!8SWf7T-Yc{ zG2GWD_tRWm$h<(4q=dlR@ry8seGFmt)t&q&o2a)&Z<6?Kz0zXz+T9??dzBYHy+U@? zw01>0fyt>s^cT!R2j$zNkGscUriMr(LOBeji z*7_Zk3}v`2XJgAWMdPI7U6~B8b}ik9B)z5)(afD~hyr?3Pa(6}AC7Ih__8(PKIm`> zJp9(^fEZF~>Uawx!>z%AwMA7kJ5H8Z;YizP@!^%795OLqeMrRp&)3%g{u}@XKKG~v zl$D_htT}9?vvI22vyYh7|CkA@kwd#V7(N4Ji@l?dZxu$z+~$HVmpkc86QaSU_?N+_ zJSId5HRu96=c*(f=WkLqpyMAPT%IC}tO{13lnY!*StXMM7d>$MUcY?)PG8tN@?X{ zVaK=qYbL16NrVOz@ETZk^M&?p8Ay$Ls0=J#IrqR``8T?{7kQ0KY9pvMDTVragMI-0V_{*zo>xdr zj6P+7jyH`bK*>WQy(!t0DF}{5PzBe04!epVeMKi(&052^B$F`I5FTAbP|yN?oMe|m z-WbIM=gdrm{3)LS!VD%9G zl0xI7>|md=HNy$GS^}sh@`iAXjtjL@!nU5vh1~%CZv}A9BkJ^I(S{D&m>gLU6(2-p zTZ)u_lop%R;nz_i$ZWS|!eFC`?ZoG`@9DGVae9z4hv%&G;yvp4(KMBcrKu@pG0|A2lPZdl=nX;OtmWqBc8a*p#pG6Nd1|rP z&(*NN2ZyKqsc-Lxu6qY>NaT|_)d5k>EXBf_BAh6OpLhb$`3_7(9bj_hA>j`VU<0|Ug_)fIT2<#eO=P4Qdn+IZ`Obdz^=aAb?jq&5B38TS34mb@DlDEWH1~3D zWOEqffYuxvA#%}2WOQVDaA~CyL3-&sz8_ThARscrcs(rwF<{K6-g zapLZBu-HxVA&9F8{Yz9uizZ=`HJQOq)Id$8Y561K5*WM6(Cj?q?xK6AiK{DW&X!y@8*gX> z5nQOtChYW~Ei#<8Vp^s8mo~ijb((b)b)RG1Z*Nwu8cIL2*OxNLLTdRD!+eI#-BDU~ zGVhfvGl;5oS5yyG=mwwW$P{sE;gw-ds@rCKD^)1)O1&$UdyfKYOwB$XB+F?|`f=4} zb@DYlBx`DnRa2r4(lWQ+gvi`xwwnZKO0k7EvV~7170AOI7Vi%YG9HgNXmW-P1kbS? zlryB5(u8fOAumu`_kJ(FxDuerEF)MG;jg3@hCT{N=zKBuJAJSszv3{V!0uAeXU7n)B#*|Tcyh|vnBE&D#DEw=jtR%Np9^JD( zBITOnf_WewY}w7YFaQ^bbrMb-uK<8gEUOLEPjEml2^cd!OBQK^MHy($+~#5XpS>f) zrhLfqu%<681<1riL^^0fGl>PC!pYPigxu~BgdR32}ft%n)|l88Ccfo ziHM3G99E2_>n_I)9F5~B)3{t)&rJ8~_GnQ#VD~ODTimC&^Hcj{Q*<)G;xkY=BtQ_U zwZauDJKUdR!TpL4S;Ai68=b(vcqyAeEJD%O^c@TB{vZrRm6mOWcTBEG2pCar9RZ&N zAb=kYx9<%PRg|#AXAi2$-)QM6zF_M5-B9c9fZi8cyo!}_LWzGDK%V<}Rjbe81sf{Z zTn5KKbiwL8HmwLQHnYc7N-McRH!X9hzYiKgI&AaF&S<+++47RIH-PhEPE$uq`n37) z^*imhtcE(ca?_TPg&$Umg=6zBCalgfJh7o&u69H}(e~i3t9!meMY*R|E7b#5YeNns0e0alDfslOHURpfkH1!@ruq))IM9nojP{$Cd=Ko+st);Z-Q9ZQm$N6%3CRTXL)^p$p^{yRA-+xr!U zg~DeDy%cS%_J1#E)6+JX|$e z90TX_j7HYh2RG_Etop?gd=Ub<1-ObAvY4BKtWry{#t%bK3!GDQXn}%`)=btbWm*(d z#+>%2ja>6pabBybunIztW--GD_ZOM>>+qmBbK30z(mal|3T^ey8 zn=!HDoLl3LK!eaFe(L9RU%X8OIOxI1W@$HM|56R!GxEZZg5|DKt^C%%KfW2^s{Sv~ zGQjaqnMSM0ruM=={k}!{0t`Q&KRjrg((Ryb#8Lfj`|;V;&}lfL%`WbWht%GPDQOa% znnG2`U^O>NKHSr@=RvShc@pg{y%MgMW|O(fHDR`GH4g&|pDB(CPRhU*Bx2UkqO!U_ znt$N2w7DZio7)?Ij{j%KK{{J8ULrG%EjQ&KtJLdY>`s%O`%x085*C8$h%=}!3=IBu z+T;6m62D!1l#yh*$3CLul`?smAI6WA1=a0)4rrw`(vee328WGudS!@*lTes#Da zokhj{5RYAsneZ*mhc4q=xJk&s04lT>mT4gr8T%)2(n{gXcYi-WBUXZK?U3$x*jm>0 zCjw#%F^H`_Z}+I#+Y?~A?n@uOrn?KDT0IwFloSy-LS+Kn$NW7G~&cjxm6+?2J4A z`-kZLmC5?Cl~LpRjqZpfWitt8k6K4za!#7v;FkdJ zbGI-oaNQV0ERJi8NttSu0qn|kl~152M)+m3Wo=Dgues*O`GcN+($L=w4)y)>`MrS- zwSQ@ba$-~tVz$Y%yzW}Z+SRBIZquOy$&6C#(>XLB;%<$K}d*?2h7bD9bQIsT1y^gEDLOc)vvjSV39sm%;8twVD zP>v)5kD6yOJ5HjbR)l9&C+CoN;V}WQokKaSVMZxS4Ls|MP$*1?fDyIUW7q`sd<;t8 z`i(FUn;m&yF*uZyVfNa}aBI?(xF@RvSjRD0(}^BSaed4G;BCBD$u6GKBD@$;OUB>W zf0Z8}=l!p@rST~|a z%VGgP;`U!)f%pqevM;%L-Qn_g7r>l-c>_X~C+;!TX+O6{j9K9};IsPOw*=vj0EUgL z1ri~%R2!mMGMvdASrWeZN@schx5;I7>ks#{z+r%T8nUIm&EB6|Xu1qfnhxzZ4<8{9 z&KqGw_2*iD(wTmH>vgvDJ2*UqslU9vPxWEkB)w; z^i{;J_<_r}gJEXggVN^tXiO#%(qP@u*?Hh!XI$LQ_>xJ>OVyS9vTl zWzjXM;*E!P_FMn3?+eF64^2+jZHj4Q$}V( z(h=EY3r<%8;a;_3$66x5?6 z(Kod=Ow&v*Cq*^Qg({=v10wMGFJ@WUXw_p9>esAMHkm(4xCdE{vnAdgsZ1(FXf7%Aiq+$3OqZ>P0@bBjJx%T zfNM;+-@wU6mVPZ!ih^<$loYR*`s-p)fer?(a}kJ;CdkobC$$cZ;>ey6bf8q6v6Lzp zGCQR`!*IIxNFg$<*d(Tg@{DlC2U^soOLL3gKqc3>r;2d8(!pdRS32#dtaVJezLKzB zp=&~ZaWrK&jL5e-o?fX>c@0>9I&ku1Ok?!d$di+T@}z<+2Nk*AT?+)GKWX*e2=XPA zHT&t=&8#}fB{y3m?~}vkI{pq2-|dxtvV68L3Q#QfI;ih; zWY2|Y6;OCn2NKgb0aUMZVH>fqnj7m<%s#t746qDd{oB+SOvbv_xnj;H-)Am19FJw> z0A-#P5@)J%h$lVCm%w(Ag0AchBPO-MU8%UTBARv%>8M`#tTkas4tqx%41^@(jAiG$ zJw&9zz}y6K_{O#&;jkatF=2i8^z;NwVpm+>^5tn(eVPtO7Hwwl23hdRQ&S0p${7{i@p z`&fqutPO$2AO3O6hb+32BCslJ4$qX$eUMk?!tp2|+@- zySp3d?w024_dC})^Mju=%se~Ry4M|%STqDTIT^Q9!=JDAxWy-qanRR*PMd_$b}F71 zgXj~6XfHU<)|ZyZ1cwE!`}BA|e(d?tykJxRNFvC+>^*Si|He05|3fZo&JyRtwJV#j zcyYY@so*Yay{|nt#K6$d$qsKT{RdS%f+BO>Rq*mm;%5#GTVizXZf$nY=f{NygZKT& zCYJMj>4zjyeIPFbcmN1wsgmpxmZbWxlK{K>aNJg+HIv%*DrCwj%dbq(D|lh-Wtwu$ zj5wUhvE%GLhLi0e8y4Ie1A81Z`;cVX)TrhnBApBg7UTjMTsI35fBIi=1yJ)ZA9av> zq~aTQ>QHK^jb>w~{PFI%2o{fTu~!fnT_{;s#Rl6_PG#bK;GZ&5YB%(6R}s^%7ysrP zkR@O`4tr@v2x2@6>VBVO5oJ^5Drk-wh18fNJ_#)vWUrV;a!s-n9VXrFp|LntQ29CT z9GZqkXV|k}3iZSFe&XZrUbYtfF7jJ^Z5URLZe6)XB!*IJa#jVg*%_Z-x;dMCCFM0r(zTT>tDenlS) zIaVg0ZZmIrDN5sb2%v9DL`u&y!#RJ;7o2eNq7Eiq`pim*2^l&6$cj@d1cBvB!6&ri zYqm*N)w1Wne-Zfl1G^Soq{QjxCODM1@?UpI6xPqO%hDMcy(v*z>W3z%3_4YKcfeC= zpzRXn8*9S-gcvm<9nLOtQoAg?jZ#ADDWebVr4{p~M&(0bj^kzyl_g<_JJ~cKhdT(# zDUd`?F{b$U^zbhz=#{&V)J?M+&Ss{7d|Mhvlc^&C?37Xwd~BV`TH|AniG!2VCD3q5 z%l|qZ7ywdYa?H%N)Dd$(>Wo53A`(k@8zpI8F)vDSX2SPqPFg{hRgL`|p`mHU%Z*^t zZ_3fZFsiyqK`jylosmwUCs5D6PS5?VIfvAm!rBcZWlG9pS}Jv@L{jz(Xbh7Qftr5N zqcO9TE!Z@B0#awHRkBFJI*azj#@FFq22SQ30lQMZ4gj~-g<3x%e@tBLp@iv9S*%}6 za@o<<6ds-YaC&;Ng%Hj7CI;t8lD7uuZIdC8z5Lmj3;=aZXl@0!>Dzw*F~sWfZRG zHAOT`JVkWPk#yKpH|bj2l{&4Lr)`9zN;Obrm{wjKG00L+aj+shXyu+!Oz50`hbH;* z`!=Y(GG~|V_&57ta675hFGWMN~%(voSw38l{qHB_n*;Gc1s*&`K|VZP{+!c}0o3 zqCLqIBQdcBN~W?=))G?9HK1y3y8ZUVja@u-35G;u%xWF~d4SsRkA2Nqg3oIsZs5UzSvq=5X|U%nA!!K`Cou{sZ)CN z3YdQYTi6lvs`GDhz*#wCRk2d}_NR-a2nHE!0rOEEV0BzNv!%>eootL3hF16fF>L9) zIQsWs5DtiwTzBVPKNQJ3M@B~eKgU)EJ&2urE@#-h>OZ8esAthS$|3pjMTl3P5k1hL zybo3*d2G53{0B_lLCf%QXsGBYdwq+vLAKwyr0Uy)GM-rsTLE4uAB-&|7;R3{?RW}C zP8n3h^*W{XbTQ(vf$w*4pa%bwro-w%uAV%}v>ms_|9EJxS30YU@k~Oq#wy&9F(@Tq zhk{1L)kXjcy1Ds|UZouF|8W8SNq~0Nf1LT`+8xr6O|CxgFpL-sfvhFCYbi<SO3IZ*9D7!Emugs# zj?Nla-;VPl{Aho5{|kOpci5ltcS5?ekRf~%m4Cb(jQIgHZb8!tJ%Z`Al-L5EgzL|~ z7lk--MY66gB8g?NNLvAyO`&9ylm0$by~r*2Kkf$H$AdJMOKA+RE{cBdzPIy2`EMLsMH+?deCYj9Qb9Q6A$vV*M`6`DzbZ z$){8ZiXLhc^QIxRK?yJ)RkpetvKGSb*Bg|dXaDE2BGc=)-??^lbhNP{0*z)>qih-W9oK|Q z6EdIN4>akJsbx;Yxx8E6?Co9wu7Cf51sG%<9}d{kQ*`Zu?>oqMwrJYtU*EQ#%XdLd zIjOl&dd0XT-4gFmnOb#DPN=ev09s1OFq;_N$M%2ybGjnYa|Olc6rz+&QFS0uWqF%Rg~09Qcu0gQH!J}S%rX( zeUORA6*bzI;>;ODJ$Xk2TPUx`IK6pYU+WNuZU`^DDxn7b@};tg^vsjO@#tM|YeYa6 zy4R;lNW+3qs$Y{oKF=7v+Rl=nSBr!{WSOGMjqI2qo( zJpbn5>e{PWA7Oko)WT+{P0eo@qe_U$PWY?e7_Gx~fI%4{~-6`!sdBVT6 zQn~Yv(pWR5UCl#f;LWqr-yY=_f(+9mxt@L27uiJGktsBQz57Re{*rC<^y)|2D& z91A3nr%H0g^{PG{j-!wF25tl893wtLq|vo@z^K6W+f;lE&H{p*la(SB>mYWyd;h~+ z*}J~xbUB)OhlZE#MHIn4I`Hjw2$beG^qG_DX&Pik$Bk}6#6@6W&8t2xh5DEL%;x_W z1DWslgh_)e_acdc-|MnfW*CXvuLvgAv#tE>i@e|m_rsrkU14atnsjiVgodqaI*BWo z%4jrx<0aKWNJt!J6wBUO#`KnA@8NwJj-Agh`H_s@KwarCo|Tc|@S5adfxm3-5a=EN zG$#0b3$OTri@iWO${Valb4sG zHzHL1>hufu)iMh6_u|cDxL4#L_q5v$@$q&tt}9Uv?oaP#1=srFAyDd*tZJ@}e(mNf zk3auyMWr{Y731lKojHdKGsgp!>t?SQH0rKM4&ZV};OcyJ*ZkLx-KHl^WSu=%;an{t z@*NW;Cm||ojSbVJ93{2bwzfvFh;?+=`^dI4{HoRWyuaXbun4nzRz}_9@}^147()Y8 z7dM*yT7X1a!c5jBgqA@Dj&~|!+WPV`adx1q8=hz~nuglwjvnnqS~hm1(1in{VR_}- zr{Lq=+56Gu>5<`(ZQ{*JR>}6+n*@x?NHGhRWGl+MN1Bn^I-JS6L2M(QU-`8-T|Oyo z!;)E)h>~kf%TOl_vsXI9-&sw^sFQ1Cqg?Rto2E4-e=&={k3G65Y3z~KX4tM!GAmCC zUG#tzi2l-%4mT~WwS+o|pEUT>NsIcIki@TDMFd$l#mVzCna8T)JzLusA*%L5F4NkZYR06`pIwOH`~sk)Q4OJ3@K=Cg z_?y-t&@pb!nRf;<5l`{Qj2mJiXy%Mjz$G_cJ1ZZh902XsJqkA{FMO9dVSV*0Q~U2f z@*tFBuXVww$~_=g`uUmxrwa|EXw@DVvH&SxgPtSo(BGs|y zQiQ6$QS6%ocQ$XTK4;Fs0!*PxYO^buN&CAM_1gN|{^G;-S)q@D zkAn8DlxElX=U9YHY@T1~Fa^$7f#wVGu6NN-VQ&{tgF_Sj5vrVe+w)uyWSTY{P4ct9 z%ko#Q&9RI%JWnDv-895eX^H7`@xZ#~&tx^hM616{X%s|2WH->3ZtE8$h$AFyRKQ)` z8_)aNkn0)uzPdD{yc%R0gWgF2?>jAbvRYMo(?9IDE0rH$6lAb|6o?+2^hJFq9e44c z&Jh9}Owfl}a%_BVml9|;BWK|M(<7YZg!!&t6Z7bXs=5dt)1?=Ub;T~8TbDWJU3iGU zM^zZkEkS`52{L;N!!EqK#dr3nxL*QFkA`}A99(1>#&Np^7$5F#s-Z_q2yhp;qz;Gyzu{mPc|6HAo@lF8UZ`6j&A@oHCC~n&Z=fdf7IM2upAegG>$lw$Q5462*)Ru5O$3I92WuEUR4j%el zMUjz^VEG7;M%^Kt3=M_Vt$vw?v2SvX7wJJ2nQP;lI?_6`)r#c77J=QJG90e{mEY0a z@IO(!A?Wf3n))vh3XzaLQ$i}U-90@GN;Uoqq4u4sIx@iI-1v~2?1~~{5vcBXWJh$n zj^K!FOPHQ5@~vJPgX{@t&H(sECJ6+n8<>HeD1GKtM4ux-i-LLZdKb4OOD6;HJr?9^ zmpF#u$EeScUvZm)c%<^OG6h9NiUb;^WhI!pqCsK=)-X$hSQhL=DM+ai1`;2>eUUlF zS-8wIv;o*HBl*F~pcfU8zi_;s(vcAY9wTMSrxUJ)w6Arnm^XY@A+6`9C1Nfoft}3s z+l$iVJg8^)_Xj+9)lba21aNtM%F=HV*f`d_BWk2*Y|2wcIq4M*YF^jnC;m;qv_OLi zGRxpD`e^k>Rfp<7saMV2`o|?ts8Eta*cXlP5b<0mO8XE1tA^rl^hAysU zDyis6JNVKA6)n_lmlK|9q1C+Jt1LVj+#`>O0`7#!VmN7>WMQmuf6{gew4CQBju_k<|lQqHI9O4D?#{2j~;j8_6zMIQ+2O_ZHCP z;O#n>dMp4CgmmO&<96m#?w0Py&0iro>c!xMA?R(%(O2V->VS0HNBq9geM zF5p;}VA7}z&)5o!>20u8ejm?e&*Rlqx3JaeC*xC7uC$D-ES!~%FWxYw-uZ8K4bJBT zfx^q$D(0mbaiyP;3>ttX{&!WZ=IY@`ZsN3NNlVf6 zb*Vm`ZE#RLypr$vI#<_tn&=vPbliY{0#)DE>B)(nICt5?XpVs%cF7B9N{8?od|<{g z*`@>(Sdke>)+t~DLoSTsq%Ff`j3?e=w%_KfoY(>RI;6DUmvZ+#D5s!sWA*I0m{HQZ ziy^GcEtk$j0%%dRg|?_WY+tC};WTkavli(3t4(upDK2R(Bm8~3z1=Ia7?n%U%Bn)$ zn1}tYbNpJT@m3t!ODXvmiGX}y7cw3y>w_^!xZ7)+u}1XN3PlTE^Z=>l%7S zH)T+BY!{0>%qj`nU=kVdZeeO4n|@$7`ehTYQSoH&GXJ2M^YDkx&_#k>@kx)19x8$%Ix%7wS{CAR- z@>EVrbX-ImKK=^cocyfB6TkJagJrfBiCj)6Ca|(1gjY@Yv+Y9|dw0YF?(^+h?kw$P zD)v1A%f<#HMLJrHYf#lY5O*HG;O*B#&czJHo=+d{1{@5JW#+Hp-t$0GOxTggTIPt1 zVT@27h^Sh1heDu#C}3>1x^|zVvc48MFwc(tVsoOFtZD?T_)C z4OiOOZn}y%a+TFD#Nc5A@46BQ7&|TC=7d%sR22O2Z$OW(vwj<@WPd^?#WeKc#DN4I zDSe4BLIN;zSF$$er7LLTJclp4zjY01Ae1Qh40uvRU?VZ{6xSmJUMNIlJg0AY^Df{8 z4SnINj(yAcma_rR-YG9a#S*1Bj`olEb=qxyTL~X_+UvS((|G?VkrNs3sTTyl6a`eK zI$5TS;a3GrX?QUTHi?5YXhxJNrc>QTyBK*=jSd!$cDK{8!E`A^P;QmN6 zV(7POYUZGrFxNgr^wh)&Ew+{xSv9^$ys6a-Al#BLD!?z4xGY*EuThYp%G?3uLu94T zFg9IrZ(U!ZG*}bDy^c?*{eZJp=b}wgRU>AuyXFCO^jl=^S2SU&8}etU>;A=8lKq$? zXy@>Z(%1{U+@`WnF(GPFGK!Tq)Uckkq_glwy&GGMvT`+5=sMX zv+e07&3JKsJFLf~#lQ(SUgl$$EbwU!#Lex@NW-ksV}=@6_yu+4^y2Tn)#> ziR%tnRc>r-v^^iT&665Y3x#P>Vb%iQJ*_jsATuTYdA3K$vndnns|t?C*Mr6co2i=K zL{EkOQ;^~Ng{W0$-kt_GXXk1y#%PY^5x`pc1iWne1Tm4)v2I$Q%yuW+NX3M5`Q6%S z5G+=RnwMt>jdcfe=T!&BDF-|832gcaJG0AZ-iJ4p&ZDhwIL_KLn%woLL1UdExt*~> zF|5MEoh?{g@x#CqF-MnxfFMiY2d|*ut~GhE>5)+F;H+PrGv@20paJ!u%#;w;iPXS~ z+aKhaTC5(-Yd+%sw-vV*vf+87%1uc-9ybF(m z@fBRZ`PNh3UBxJP4N<?A7&(<$E4q7Q>Omf5FIh}waYXcep+p&DZrz%e0>a%PD^ zLE@L1itbu~QG1tSSpSSzbJR9fa+;(g0?beK*lw?+wTuK!%ysWtN8HwOXi{^?V-Xkr>%NMgBiSQJ<$q$HwS-@{f7% zu_*pgfWs6JBte_%X-uvyIj+^Cq5_pU=Xa!sTjXBoeSYQPv|*kgyvO0&ZR-epjlL1U zJRh$z(!N!oG`yGmMydeg9PfgUJ^L|HW^kyg%u2}pXa=uz&XF!D}JycFg$768|lg| z8cRxR%kroDldAtImlHEYSvkMoL#MkXV3FSr1L)n|eYA+W2O_Ak8JUkbd5nZDs|trD zFJ@r4h@Ozb#)r>FgtsU~!jM^$FiMca2hN=8Wl~YIWG0NRVm@o_Lyg}uA)doUOFh{{ zif<`)%;sVXRr(A(Lf*+}=JbKAo1<@&Dyo3&q|p@e~8HQlW=&vmsp-yCVzB|3nB$Z%Fpc{3GHf0$UXa*m?-6y^>|Q( zH9uK&W$h*uv;wWh(DPE1`!}4O(>uR0s8)7=77C=3bHL1qdhS2u1>V3%-%a zlDSh$HkKaNv7k92d^ibSgDMk_rXx1z7gb)*y0;}s3gUb%m7A$f_bC?@`ZwP1+B<3e zG9zj}_Zp8h9tk20ujHr**)$w)1Q*eK2R<-Lr47WQ;E)ll0B9f8h#TVA|L@=cHBCa0 z4lDkf^<-cdz4(Gv>svPOQt26kPUL@D70auun{Lw=Q#BDer#;!#vP((s3(D=k5!*qF z0v>YWM{`wtc%G_Gr=LHd#x*`F`MBqO02BiAZ!=p6$J1DjmDBcB59=B zu)JLwQG`UcFaPq@?f$%go4Y$DGdx8{LRLo`@$2MTy#g_@*euP?q9FZ9$=LLL=L1^Z zsyk%C77aBYR5FFeN57OodRjcC+UMVjFzhM-ti<_!4X%WGLXivd#lEwQ%hq8bP*@_9re-mltKyU+psCTMLXfq( z*y7H6&cvdlAzBu~)v%n6r^vCmI>l4T72MI!x_t6Ke=27-o6IfK)wd6M;bctJ*~^N! z!P^$93t^3;+WY$2<}($mxCpc^{6biXTBuV=HuI8BUD=1YmqJA&@GIiCl)HVmD=_s4 z)k)F*uzhMxkO?doN`Pr~*UU9~kGm*m$OUFloKAVdt_Fb06h@0qSuzm-t z5HG3LX`qRM{C!3GER>Vlz~aXnq98BXW(@@Xf!^9<#HhL;rlcX@8opj+abm90^}gq> ze|Za$ZP+=iX9M^S=&P7i*Dcw$t@ib9s&tsr++(I;GVKZqu+?5#g?XCFVOb-TFg`&0 zAD#sMMW?5y8}-UE)xM^Ebk3Pf1H)yHi&w2V(c77SjXO2pK(7SZ5t~LC@!!LV2z(o| z3C19PtNxX#uAKsd2;#?ND?k$T^hxV0DtsE{N*4-!DCoI1vOgq~T&nOT^7W-;7j>4} z!7(y3Gm{&1fwA?|Krm3SZD=9E%3aZMIznm8g1XkXx3>WkPmac|UwxQ2N(IZf7)2GE z&A;MPQpf9($~%we)0gMd|JkTt{9E-3l4>DnTR^S>6Qh zdngBvtNO)+5BK#HnLgfxn2GDbt`58z3Q%VNXK5$1zR&Jk%H2Zp3xE%^bHCHD17H7( zXc2|vmA(kv@GJWI;$YS0>VV_iW>Qyf$U(+jdO<{PzG1&w)g2d3nRdTi%vpjbg^^U;&URzQ>DLRlvH9$O-;BmtHV!l1-8)< zEed7AIcxp;+)G91q*29PzKOVTP9%=ZQrlL)Uyq|rQM`|?qjO~n9EFV2I8MgS(dh6~ zR-CdzTSyz_TwJrJ@DM+K8C3J9clhvDW?YHfl#ygIgpQQysb4e_@$8c2)uOLp+`F+j zD>{lnrkZR40Lp;&*{-$2=nM!ozJLGj=;#}^dv!GpU!4Bf!)%P~2Z2vAg1{L;MQsb3 zV=1nZNR55vo>cIkKWoS^(w`BCa<%dc;+uN3C}ZCSpy2A4&vEai$g0?cd*tBB6xrl8 zvLSqlb5MLwaJX6WZ!;01S3|~5h!6ipd0Iq7%?KI7fYAT(-!CVYj?l`VF;4RDN&gmN zjb% z0ZCcBtQj_>NzBbOzvBd%>*Fr`+MlPx9SB0dSNL}-GOmJe{aaU~n_s>4>q}>(cvC^W z4piKl;=+OqL{z5yq~G1p2ofmAqH}6wgepFY&uu~sOEpRq!3q4Ab3MKn5Tu=Xw?py1 zzp_?USgd|s*NY#RX+m<+8&dNpXgV==>A--p0PCA6Qd&4x$A`Bd{VL4ugCikvF)qDh zUi2AsAX{8Vc{@S;My?*;*fB<2I$Rg|XdSCJ_!D9q|GVI8iwlI>ey_va@;gUz-5(`B zuUh-DZRGx zFY56$x6sIyHI)9905QhLfh!sEe)Fmh?K@Dxevkj6Z_Bk@Pk7hlT9luN_y-~W=Kj4m zidqm%O126|RU{Y8e5b{%d1dc;!~+-sv0?41{{`n=_0{_NI!J5z{K_U3XE-^TXnIJ{ zh`bM()`Bf%O*cprGzJi(fGkqA&ZXc38dqT&Kgo0t9jg|DPcNUC53*OOG04{qdvn*d zWx^$Xo_`zm2)pWAs3%r!OOBX;`tcku0?)@Y(E`Ikvqd>|1>PrH8|ON zqDMC1jsJV(kh1R}>O1gj`{-yG9u)~2kZ6&LAYHh0Q1!Aa>Ami;j!uTWc#k=Ey;iX` z#Mc&Y;h|kHLkWo8Mr;&sZC9<7r0>#D5Lqa6hnvN*l_unD#l-frzecfsRmzspp3D_J zCV=xm5I9T_F^oA=_U58kyirf9di70FKhdOhvtsziBD@;vFll;|R+lKwym~YIllAap`qlk@i4q{f~{PXkgrj}CsuFAnq&+6C+4=?X@%~7Vk=~qS8QlfCyq>+)E<{}vs17T@vZU^ zx-YIWN~1$UOU+KJ=8@}{E5JVzG;w34JNtS@{V|sWh0s*N5wW{S^#5@Itb+X8nWJ?B zJiK2TTD0A}jh7SUCk9ox{%i;GJQynlOxhR4e#wiDQui0``Y1(6U9Shkxu5}UI89D_ zkNgkF79HW|czg)I9X5w#(v$1*Xqx$TRF!>usVLKW@qW!JI;}0Zc3y48jCd|VLP7#~ z>$6O^iqKn3Y!RD0L*P0cNkCRgeP=(6Sn@8flhv(6w-#UP)_7%`WLv88GV3N+bmk!b z!^gbnJoY+O^~w3GiMP$^zDZTt@;hBHKxX+j7&vj-QZ37mO@`rHjS@@Rdx4KJo_aeX zcJ*PRb$VMGt=R=#)W!jlvEl~jDQKSd8R=xhd)hStG3n~vlB|3;N8I-2ny$6Xs^(trO~h~!@tGEFATra=rCo=p){&|rM(AQEHI%r)Yt#< za5J*T=o+qNh9yz=*G`{+0=+gvAQvAz{s_vB_|Qfp(a4ygP6?wPZYLEbGnTi4Z$$qz z#6gK8nkys?plWeOpB;> z$xxl%tHcz<>d@|q_owwZ@kOLEtPqWTvIGX9D){P+o9`9^Y2&t$5w_(_*PKme7&@doe&sY?xdKs=gKHiKAk_IC?)s~CZLF6 zsln+2PQB*8IQyl*xHtr<6~$Q>sq;kAZF(F;ybC1R96f$6|8y@iUDTKt)hG__Kp_b? zjw*I9jBRmPSNtTHT%2U<1^MRIR`bfAsI@4s^|td!u_oW~ANVvKd0J z!*DC=tc6cb)+VF$$iP(V_iqODD1iUmU0S>mZf$O6C1B?}RnE%)k}zU&|!R zn9i8+PzuN*FiAItj-5@w_vW?t<#I;?GsOmfNxs)oJMlk%{six|1}sSG^*`DoxlN{I z(JUu*Z98{sBSKT;+sngXh=h z$(R1vZvEVA_tzHOC*JYaq!yp{**;#FnCJF+%rMeTihEH!ik-aUpZ^U2_pbO72|#aq zpa#y)tc2t#WukFZH74}Dl8|U;$-%aYGE5Znu6MV%{9iG*&E)4X^xT4=80AN7$-M=> z=NH5_^NkSFo+SAfky1%py*bO4PxvMnd9dNR?Gy?w{$WsaeFH3v?j0ZO{GybT@2-Eo z5RW&kL<|V2ZUO(x3G5rh-~1W{&Xk{05aB+*_p$oP@#l+_U_x{oea<&3k&oD>Y(^hz z{FLcq7=Lq~?Y*g|(yS8gC`wdS3VTQ0Gl{5XPSa7aihy~ML|Z9N&cdVfF8^TiOy6GC z(=Bh^_VTOx{Y&(}@*$TUZr{MexKY}qs$zE^lM1qxqm?b6c5%*;d_PNT zn7fV)XO@zoGJ8@Xd;b@l)}XffsQqI1B!-ko{niC~y+k8`vp8F>i)A1axMUMXE`OV! zFh}x4d*`-}uQZbp!s`q-Y!c*l8)S+tApG=uisgDDNODhMvA|V|j;j2icU*`m1eLL+ z9(QTci^<#K@3ioJz@&0-3H(5DQ1OYfqYAD5=;X3k%^POb^+rQa`S@RtDntlK2 zHa?RfXBZUCdF?cdEcTS@)|GE5zu1hUoyw$M8h?b zq`7|vBjz{7kMQiWr>0crBsidot>Q>9m$CTTYZc( zwf2`*9Y<4vR`=`BDuZNf*~YZUJ6LT`l*!JI{*1g#p4iEh^*J3Tn+1Zrye7fGx@^W} z>u%59>mki^#WjKQl~?dpw@-6N>8MUT9(k({e>N^4YSmH8^`>w79AtZs0=ZOO^Es8K zrkm>k%G{shGBau-Wpsh{OSaux>m$Mjly)%kSzpg#`14WI%s-R{-U7u9?VG%))gXqh zAh-trcGiPnj5U$(=3YnsXIfUpr)##+&fM#AC!*yyfECjq1GavnBHQ=(_a`T#uq(vZ zLK^7~LnFY_4RlR?QDiSqt1nNReNm4jh;8+kg#nWEzeyFVy*UZg7$;-P9OG#P@qZ;! zgZg^t-b+JzY;X2gfsOR@$%&nfG6B!pVGNIj?FJWTW;I)aUV(k}p2kof;%=!RK~)W# zv(%@EQN8(CzFt#*gWt1AG~REV>zed1TktB`X4^IL{8!hkTV!CI6Ay{^dW&}_&XDRO zf05;U&|Cyh0n{T>X@xP|!e>>Yw77H2#`5SUsbbdn#Y4OrDZQE@=5kMb4;5_ns1^Cj zGjS1xgN&v2aN3TQLW8Tr=T=qw<7FpV(#;5qj5q?i>@Vmvf+f0PY0dP72$t$7x9kNj zxv{|#HZw1VGIAPXRuBd#4_#H~*q3*z#?VC81y*#n02Z3w{FVR9xd+IxV+_Z;L9`D= z?`8m)Sx~6eSY%z*fb>9fVT@?e-5W%&aM85jCs{LYwB87ycUJ}yrkRZ~;3R*(DQPuo zd7vYG7`f)Zg-*)W5R}Yz(*~QDt{ruZb0*G4dgip!yk3-YoxZSEwi2l-b|5>`N?a)cCb|I`2^Y!N@%D$QwqwlxiZ5r2AH! z^!k$sbiN_Vu+6ijsp$dmZ-4%L=eSLoWKeni4BHs{N^pWY4ijIMvaHSOb0V!(y#-&# zKB@%yl)Ht+E?BZl`};)%AxB!y>R6iB{_G2_)d8BSj=)m8W=G4ZVgTe+e24qDwbgB$ zr13tGX?-Fp&~PF(x#D*kD4qnZ}qcc zeax;)ujMq}joR(4tdM%3L;MMoHLSxwdYqAc2_AqoR16S}P{8)E1(xuPRVmLD zjs@U%QxvOs_PPJGuQJ~4I+5eMr-hJhWXn8hwM{#a1W`FweI=&1K}Pc7qx?v8wLet| zP;@Z41>O|T+bmvg*9Qrf@-*3Zz1mX7EM=?5y(s-GRKvrQSASI_Lj;F+Z|~6kA;9=L z5$AZoAdu78PQROIkQ7gs!a0?0AhnNUQ-`~Ef1j=?E3FdWB5T&L2)P&Ef_IAkU2IWm z#LN$@%oHYESdmdFi^!0LmADSA^7_z&9rDtKY!a z75}AOl_fm^op8li`K8>T<$hQ2#m&K?qq_gS$%H<585p=5I35rk3b@AW`*6%VK3Y1B zwd0;bSYKF%G{l;<*VfmCoBM(E_FsN_fy&%vt-&Zj%3rpV3?rkWKxxm!)+KhbO5&t?d11jg3M_c3C1-W8=ao*;N5~S$NJ!&Da9Z0I~bi z!{J;xiTs<0aQ~Dp7@DA54@T=|D!nW0Au9E==cn&!AGBns!UrXsMdh5BIQ;qMv4m@I zu#Ls@o$o2CNwAVv9#g#=UbdotFvEpg&CLb~7vuR_SNRye#f->RFti~Scln(B;v-fZ z_2aF0s-Mu;h}Q4_BKHE(7Zik{p~N}De)AkTSt6dqgf3?AhKE+0fW4ja#%P)ukZgojzOZnth%l3KXv2e1=qZFYT(qoiNf@}^aL|VLYC^Ah$j01Z- zY0vIu1-;_R87Sh9d84MrPaUlbtD$v`V#^>Z!s60`cjV=^Bm3hDO5Mqo^dU}a`@@93 zyL*)ok8qm0b&FgGZl8In4AR}5Sm#_kk5hY+s?RR$z05|JhIzg8^f*nsjGZUF#YW<@ zt>Xpfv)UmBZ6}dGE91FH|4~}9RqOfG%OkhAG|OZ{lheH!LW{xkP2c{Xy1IYsU9WVz z?dZR>yz2|v#~tgE_ak*eEQz)LY8<6%h!~ag5%hJ&d7J%L;J6W}hdETxgd=cBD1 z$>5`5nBB$$J{TeX@VJ2hu3?-a|4?ApuQE9TT_|cu&GdT7*3Yk90~bayCR23U{3SbD zL4V8~MwQD|(^IMZwO`^M2h`OsV$3!r)KHwoInxF-FX&(d33P{Io1-^0{O=9)^oH5< zl&q)n6Ks7BQa?M>QjrOIUOB7JnJlUbCjsqQ7#d6EpxVXBiNY)D%Y9xR_O=Ya!C|rG zunLrrbe^qsC25zhuC9ze5X|)yV7cxX;_(*G)@4m%Nx_w}rIJBt|N3waR5SO6FNa<~ z9&gWgfw^R#;Io6LXBj_6QJr+*Y$|U47a3eZ0V^o!+XO6XD4k2k;ml0J4B8X<{r4g> zqNBL44k(!rXrM?POoz3vv2ioRt>|lKb6oQ4nJ?a#>CgAoDOyN#=CJN``n*K327gPa z`}Lo}Xaz(hH|o!A*mf?6&5*17WzLSH7EvmClM|1mS)uQ-r@)!d{-dU0&m9`=BDtBX zRg7!p+)&l2*i;+T_SAqWbSkF2817XXLs*T?p@_FV_m0|}VDqlI&2m4$J#-!?S*h5H zHS3O7_L;S%9rP85yJVeS1w!vOQrJ?z7nmXoM$NNhnjenAr%=lV2|ZQf^;Zu{{iU%| zPiOtS_dKic7IIsA914YSiQf2%rA2tvg$QGM_%%rjB?8 z`Kwp2M&lOv=J2VB76b3nSFtpo~~Z3 zkozSm2GeAWiUtGAAn&s2>*;?Mo_pdk1RwN+&vVZ>r_W35*4w?(n;RM&CSK>5aN#zf z!~L#_97p{F*>LA6Y_N(fOkm>u-k0g~Ac*nijXP(?8Wz1Md{EVK26;n${rE%ofb-pY zR}kpWL6F^zt%OV9`PLmxQYvN>OTI%!v}QpKX*aQ$#w+g+FW3#p4!7h>&)~Gh(PJ{* zfyH`w!ntJJ1&ne#Lyw1>Ql><})E#oOpb_FiJ!tChI5zcztN5$JATelik5r5W)xTNL zd;|M_%3Z?*v{_4a_Te*KU82msR*cjx$pg$LX8WrpKO3bbKg?QICB3g0SSg&8FpK30 z>-aOzQu&dZh^9jSuTTyzKM4M~?qA0EWfx0hp|IfOA%B%A{mS)oN`YUg;foNBw~s#d zlLykprP-NBm3y2`F82Bu{4xTk6RVeN$76Bnnj$38IxCy*5cP>;}Da2nXu0t|l-09-k(} zd?pFMi=EF34qYc@+lGb)uBLLq&e|@^1@g4RM&F@1J2(N)T%KKKtD*F-|^y$X6%@O2N)lw$IyYh4mu9Nw|F)L2S>@nTXIGHV9MZxALKopP0z75V$H$h&pHseVyk=yK4{LK2KfHJP!lE2eyz;LXC z(v?yb5>+l?$y+M-V)Z(U{%%u*Z2y6J1Vl_#;p5wiK+z4_eQiLygDfn6ok`YCkqbdw_&g2S+^ zmScX!*X?#YSNm=J72zdof(eE`UgDIUS?lxcSu~?WMjh!@?QL*(FAv6}u!QAY*IQ^P zMH^dxa%h7b3^4uremhN=!(3Ir`x!>Fj$^t5VAH0q#iyX!EFOs^J{yZNVNFWM#nbex z0`7!WNJU-UoGK;H1$V1e;hPJ5v<=AmZ_RREnf~nU9KYe^0z9*HY4!?4CpOi1X|s!= zuPxu5M$$gm14tTFZMf#ctg$291#6>}?~&Ys2>$Aoi*Cxv3nnPB#R+`xy19IM`Z&jR zV%AjI2sKWTvk;x4diNHPx~0syjHJR4U5I81G(Fc-y$j2*GEX0~P;~OVXi@r2?bAsi z5TJS?fk0TxFw3eQHCtr|K)nx2{N<5o^L1b`37X@nsVVRmgz}v>eF?Kb_2qwpkE30r z@7w-nmZ-HO78b^TdaVPiekJ zD;~}_yU~?YI2^}(xC|+pf8no2LRLCo-;SpBpN#ehecajO=E9j2YJo&(V?Qp0manUt z%*K`_i5giaw=(0^xeivE8WelCg=3jnH)c^Bsk($zm&=ysH<15gTW2h_xv+)3Zrj}j z^_nr6PF!uWiNw*aa{_ZGL3&DiYd{EIvXPa4cz>x(kVYz+i#1kysR)$BeWF! zi|dj{MtgQ}jO(h}+QCdVv}lYy-l|HVC^G%N*%D^9zx|mZKO`0_UU!z3y)oG3xKga} zjhQjK2Yd0iAW#7%+W}XJ%8}QnD=kaS+>~BZd79=sMsM!Hb>mCrFLTtG6YDj|jtT2l4@Bkty@nzk5C%;=eI&13;Obl^_ofR)({e*UMpfTVv%7pkZo% zGm!eCb@S0-p$i2uvd70gt~w9qNi6J~TRx)U&ff=Fm~O4Y;n|tg7jd~aP`KNvgSnxp zDGYM#-YUmn%ULtpVZnO&Yh?4e(SBOKJOfJjmQqx7I9rQlulN~Z7+Vh!q@VXcA- z)+{0VKMM(}g!EiE#YQ3)Sc~gUi^P}~mW#Pna0v7te*7bu@C4Kt`%>9QjwB7|C=G{0 zfR2HzwVe*q!2FRT0$zB5Ct>_Cu;!<;on*O4R0}gdBlVGpfzN+!`dpB^FX(YgE_PDx z_4K<`39h$3_U6&sATkANDDok}&W`P~T3E@bocx+wW$B?Vj)s1&$rSeIjm#9;o?R~i z^@<%eNs+|N^5=j1DS-wmJ1GZ4g&|8`Ok4RmWX~R<-wCgA?byBIg5nyJ0eCAc) zTwZF>wUIJXPCyOMm%{A!aIr0W(#)@2(Foyc2=V|w#BKlcOGs<0F5~wy0XEuA{9xbaN8ZI|huPrw_ zJ_ZUvHRwE)S3v7tyJck*e(-2^{@&d5V<(hYe+^AV<1aqnPI8V-K4@n@#08GAhd7(x z@WZlaxJ3cR!WDqE=M23*3JPLOFFT}oSk6wR9siqO10rDugDExjyiP!2?cY)DR zET#!vH~Ot9`*Y;;##KzI6;sv0EBMICC_a~~&(9!+1Ly~v+z~}V;|zZG zwOhE&^d9cQX2KdOd|0lLe4e*|yUEd?hIi()-34!VRyABr=CY?hb%Mec+{bl?U!In- zc8PEg+431N4>@0m(B>_m0Tb}3A<;f_!~a7$9)&L5uTqrczLZp@sHMhpMHSI9ui$=C1rPi~ku`7Ztph$7_ z`GTx{jpgXIPN*GQsZJHoQ3CtrrWOh{?bf#kIhXf$hIdBKvN!4XZ)zh(=7bHnR9t6;rjMI@%5Y7j z+;SwEClpSie6E-OKQvusRFqxUMoLPgOGN4JMx;TyJ7tKWyG4)`5S50ZySuwlV(9LW z4y9#~_|CJw_3{JO;s?XbePZvcb{wN0fFB)vOX2W&^-)+?AZd(&;O;ma+$I5t^PR&( zMePAl*8`woKKlDh zu{Xor;X{zj;cNo=g1QNojg-qXog+i@9oOefyKY*|8d(Oy8at9d4(AB4Qf?IZkMf;H zBPKmetBI7t&jJ3oPM@4K@LXEOvgQQ~^?Q69D+n0A0`{`<^}&;IJ{YAv$!5)#fwc+; z>e7@%xqEV|G;T;0`x9=168szveJpd)n(S1{wbDxr7wk+71#w24nfC&^F>fBpPPTb3 zMxt_;c^l;EKnzx0IEucgl5pLdV`*bEGvGt)ZcKPvxcfLBUUDFIyxAOi| zecbcOc$3x2U>RVWJrjJ&g0F3eT zk~=VhfgB>$Cz^>KR{$fK?hUXLlOzV0ZuPg4Zce#>^jXep?Ky@Z$+&}G(^%p4CLV z^>%Me#dr*=MZB@=F!n@QwyQelg!#q5c@p zW6>1T;iE3{BaV~g8ftAK^|-uzZUd$r?_NnSzX-eCEN>+PUxrZ-LgAJ?ly$|wrU7#} zbX(hsfrM&Itn><6TJ&SGQ$k5BYfC?6MpyW;wg1)Gq^iS_mbp#!@vMqvNG1TREB0AopTGJslTWW^22wUd`^1Q7vx!qTjGNq%cukhD$ zi$`%a3X(NIRjd#8F(Q>&SzGf%Px?&rv>@w087*o`0GaQqcsDLBaR&ix+Fmka4CDYBjhChZW4{{pk`8hcfc2xXSf_CXlGNiNyS@ z=_n{AK9v;fut1?Aw-0*9m(NJTELlfd<-g}MSsSTzMj)FNaZ>1rbJWj&r_UrOT|)az zH~3^a5G83|Ze`uttW0N5)lHFh?magXICEDohe<8)nUF?%+{Ip|nf7c>GvZho2434x z75u$A(p!FCpSx2~1}o;_@OkO|@#BA1!fzIKF;CYOu6^Wl3ys-x$rS7AtbNfACk#3- zwL`SJg-9Fc*y}oJk&gSO_|NP|VD_dCmeMMs3$;gp(Z&`6pMkyjZCcKR zgGb5l=Gk;pg#j=$?MpFC;~V?u#YBy_YV6(q0d5adY|3}lxknyk4l9?V*zzti@7?-B zA=giXto~h$i(?CnYrBU`gNl!p<6 ziTlkT4TG)!9!iu_nshkyd6V6@gDpD)qt{z2SN{N{0B(BPr@L}zyyygH68s@D8$_5j zIOZ9uy8Ut=o-5N5<;b>H*?fOa7r!3>1XGzS^-$E~H~uazF0XHMj4HM)%T>SZ?)BV} z$5D={(F>qi9~>dvk0RuPXZJ&srX_Zbi=`NB4z`yLwdjjt=ceLj|H9!{M6-{FcW95c z8A+AVGU8?t%L(bDEM25a45-5KP2!;?)vD#JJvrQWW?~(9$691!iCw2Z6$9hy3~DfK z5cP0|5k2uHsQ|1EU5x4DbvC4#KWNRE@5ZvuC$%JCisKvF^GOR)c<$z^EYIS2_?sI1 z{J5xKPWF78X>7mkxr!j{buzv8q8t+qKsz{_5q?C(TiJeTsUH0n1@ZqYt?| zm-(f8#O-okal-Td1u-#h{7gRs@+wsy3XNgT!QE<`cS~z?Wol{53s4pS&I#0JpmAy@ zy8#!iK`0wb0DZty^A@@j@=F1HIc=6gTZOT01^)%q+<%aB&DWiycS8ujKoTYsg?1}` zfj>|bYr8k1f&P{3Jrzl9iTu4dIyz zmLzo#zVeA`%nBGkYU+Pe%Ef%e{=>RZVDmwa{H?yYE;lAjxFGSbyVkhPOfB8DCO~Iu zJj6)lKHMbeB||L%AQXl^Cgo`wU@Jmi==)m1xX3NDAs?#Bm$ZMB?-ze97oMW(s3`~^SBpG#td)I!-zC3ro)b(OWH=@KDH@PX7g>AZ3RK@BJ>kXs@u=djQ_!{S733f=X>^0HdT<-<(L@Oy$g7M}YaOuuGr9TYWRO9Y%O*nn&s& z-LCTG%#3aEoZpWHtqRUTc%)9EFfj{dZ}GC>d+L@r$pweMi1g%*tQ9F+o=x(NSwB-} zQ55qFt%al;i|#V2cv{EYxA?{0mK@^HAz5t!adzRr-94=ZF*Gg2UTk0~N8vzg)IA3! zg{$wP(4YQK-ZqJn3;F6smpSS$c6$ITf~xZ8hiXgaT2t(K3T=k@-dz8=i z$W66gu{Q_=Mm<)SczJkO9@DD(Oyjua-dWV{d>4!|r~~~up#J+5&YoQtod0t^nP?3l z>{v?8Le}inYu79YD5s&$(bqOUrnjk&>XDvJ&gnP3D%r&d$&y=fDCjL&FXpJx`5fAX zN`X@Ae~%)bMNlmmO?Wf)2@Zc*B9bAu6W= ztMcq{|JXZ+r;ALduO8x2>L7cRI@&@E4lkL5o>@ndfndEqb{x(h^7!S@Rwx+UQXbOn z74YjanQ?gLzdNz`3=cnzGcj4M)cI0SjEhh;Ze?EYa|-P7T4Fk zca!r@&d%_W%V}UQ>p0&bl?P)ineS>(%5-n@ zg|Kmy3C~wBMR;Ad9IuTZoI1r{ZhvEb?E3gm;Lp%xXxQJaXs=h_)X#n!_86`CdbvMr zwKA+r4yP|D3x4D)^YW_v7USA}4wGH_7bc2|h?GVSX#HVf zBwba0ZaV;O-L-X?a*dWegK09+t64jyitJ?L1G&0i9BB*j}Y^}IZf`m+W`e? zCesG*u%wzyh169!RgMX^LqDp>yA_zmqHavcwtEbN-kq+9)GOQG;~0;DKvo6zLhh|P z)6=?GBZkGf`l<&l$;%gU(}$k+82Ly3EP<@0ojNKFYTl!74kz`A@jg%Rr@^|%}JqxjDg>av7sDX7&lR!Jm%mhqLNtxp#7 zZ2}CZ&K!69{2Rr(oK&6`p{8d+km&@|BuLMkN^)JWCaNJzuv)E8paK0)!*g?HQDue2 z+S%HAd%iP*K(wTwNNb{sxG@P*lNLJ6b>93I4%0{*gqsf=p-M};)rH_K2Rf(Z4P+Jz z7qhFCw{>)Y`9SvoU*iNVA}G27A5Okc?IvtHTm6p8Ut3%P2r+G67xLM!kG)a`}v<6deOv}`5K&K z9C_lRqW@Wfdch1cFpjSf7G{DK=<9oMLQ;kI#bQFFg*dRIu8vULy%z*al3D^G#C&i> z^uRNy#A=rxsBv9g%?bXSzp~pBcLq}GZf+L(>IT!J=xtm^hy-taK1aSYVvc?^sQDdJ z@|}Y8V}^jv1!o&aQ}=P<2FCNx*Yj0o;4O&<-0AC0q5pOyyEb zt~A2RhGGjSGS}a-Dva61VHlxh?)52I&)Q;2_&hjkvT7lgDv}`Rbm|_F7Q7 zbRrxY6Y*y};f%Q;iBfq;-avbSukKR@hVy-XcRt$mm({sj&894@GBMr)`6?;%hocgn8(t+<7VBg*$<5HVR{CJ!ry(Kr z=)%u2&b#~(TQe`z<^X)Z-tl42gG0JyXaNVsn?Z7$4I{oazWK`YP`nnoB4zx2hN&Sub z_0<@Tpha9lVdfBF(K%CpwV@k*n4$6V`tA|u1=y#q77`L#IHnJ zddO;DZQ%U{bt-^Zz&RfA^g{>QI0#sRf_hmEmXAqhaR%IYZ#0VWs@*+3W#dekO6dgRP&cQ#qh_4z_Bf*h$D`7fBKp&rtzv;_V3RM%f|K5srHNGXvY`T9hm6~&MA?IzQ zr#ZGuR&FVR#SXS7U@-uepWEWD`95Q;LRbu$#{f0!Mka(wgU;kiOqUU^!8dE6waifJ zHdu{FJ~#GL-?hF<(Q4XK3&~|cjke#ozD{}<-aMu8^7oL56gK{g#}BR9@0LM9s;JaI zE|(s2jfXOa{S1KZd)eOW$j`OSKb5|x5cpx*F@YMYY&Jj~h41d2{;hFhbO=JkyUfSe zp<4H^8h1UPu)28(3orA0R3;{L6R6DgP)#QNt5WLXBEEYUgzK#Y(PbCMd2kX_a z^ioc6h#T2;-0kV!7%Aw#FBLKf{ozJ|f$4}xGMV_QJBdZdfo(jlW%9xkAgCaT0q9c$ z?`~pg_1l9#LqmC7e)9!BX|AiI-H_vY$H`IKorwAQAeD`!QDvg#GKIK?p1XT9nmoB^ zI`_mT0Gz}7`-2x1UPM!CU}f!4B+*i2(4!Cv24T=V{9Auqi~hB;kUmd2J6arGB=Hpp znt$-puXNBj%#Q)L&+13Sxh!2MN(Kg}jGQO_CC+mveivm9AOH}*znlgFKBAOpMH8g7 z-->I6ID}M96j(u0wF;vJchrS6LPTvXH=yVQia#Jf`1zk&8ziKI)}c&z&1HTNqqE0d zfSPbH;9_+2S;;>z`xh*AP(lGSC5V*;YrH}X^#!2K8HI~2&Rqxnkgmbg04rxr+DX*` z6&Bf#*)q9vb{6|9rQ{k2)h2Nuiq(Q|7?YeBF#Mk>)Gs)^@~eYPpG|RMHwhBUI+EYq z(kr}AByZW;)TcF78n(uMm1&Qd!v-=|ZoE2Zc5nZ^BcAF_n5DgjrEr9m8yv$wQO%wp|4_hu!@;jYipXjrLKxDq z!>JA5#s~Z+N97_&MUGz7wxN%gHdz<=6sLdzDe{ToJ~Vvg8S_@u^FAT#)PT-?^ZBPx zm&s-GPP$&lp+9@O35JPcvycXoS<)r=QfKe0Y3tQtPG$ANs?oX~CN6sfAGX6TywIXS zCYxb)QykkFO)46SK;qc3U`UB^AYvSfQXxRbkVZ=#l~gxj-w`y}JIc4=Kt)okw)e>C zRqKXc4Fwq#$Uz562;7554Z8$EwR|6%ru=h`E*p{-d^D|v&@m=hpm66d;7C7CA!Zfl zh5GRbZja1_m49CUa_S&UQO``$qxU*!x!eeMrI)LhaUoSY_L(NESf2ms^*9|4qhr{D z$68M7dL^~h3yqA^(hiqW3>x8o{!ou9|K9J2Z0}sr8 zFAW@XDLo%0WlKrMVlvdh3%;*R&B7bB5hpimC{x3twB8`w^YYgr$_Ki3fmOYQ3nYVr zI(sf^#3l0~#c?!>kH7*UJ1eWW5iwU9Sws!8a6n_W+sqlj8$@lGQp?0h*>>-tw=VBg z876X3K_(w&rR5FC`+Oqt=+pD98hfd-TP1Cna8m<+z?H__fMP2;;!HCs= zAt51D?;J5rB<^YUvIkn3rDU{&`Y{O!SVHEfQiAX4>LEvGr&kAR?bch#W?sR-L6K(2yYryX8d{m=RFr0f3s;YP>_JG8Mo<=7z>ntQm6QlFN&W!otEWpm}O<_t5Jcnxw4Q z2Ibnofb0do7{-Ci%dPq&scav+k7q#t$?;Y&#G}4ax=(ojV$y!3A`{lUoBEqNJz};M zl@9F_ZS}8|FX-L5LqDRQW#5%|PyIPr+%xCnwu+_M-fHUl4iu@kmj{5a-U)qfu3ha(3bJ(9?HhH^7aJYi2me%?1RmLBnZV&bI^XKX-m+tEa%<;2Z8_sXm?oAj?- z6*ln@^{a|`tVx1~v}aX6QKsUii|Z31n?u6c?P+JTso}S^s%jdjW>>z)NXag1kEvhE zN(K4YQV%7~el`l~0^k{0M%Cvac=EhI)~2UsE7}!s7kHsl_~`0`9LWxZ)8}E4pAxt( zP4(}?222n0%w!y;oYDB{o1IeVAN48jBT1F5jf{F!D;?RZVZye?2_x3#!kiBDCrRs; zJ%L)80!HbMC1Utacys;QB#Hv)0zr>!>B6lH5W)hL6h+-1;|3x_5H6x{IjW<;vW^ooHg>3(&0RTHJkkgHmjAM)8IyVHftatlv}; z$jn_idp*Azv;@pU#Q%w$J@v0+w~}x{%|UXf{!d@`n`(#%FA%kW0xd{iiU(P%+0)7c zjaU1tin2AU5x3!Z1ZO4od!hAhkDh|=XX9C36)j?DfE;nADy>a{K|(ZEdVoQowY63A z2det?$|XeAk$UE1`?V+RPNA0aYp3r8x`wLMW&3x}my;RgxIqbA2Zu4c*3#5-MaurG z@8UjID6>wfYS+tbPYonleF!O=JUzyxRH_BOzM5|1crXMQ7t*BeOq~()Ss4E?LiwIv z-ZC{YKB?5g@X`G#UZm~MWefFB#BXYN0%E(`+Lj^z044#1(T8>kqBEuiNB68hY1t~S zmOwWTj3au>#J}~}zpVjBjO4D6uDX!rYcGB>{7#Qz>hJ|cMVGd~$A^rNH6=(t4^^X- zlYOb$754Y&3;K(ag;0Tm(%%=6r{!c~gIN$`ZFzcy;JAh(D3+pmI!q2j+^0yyL35XK zkAZ7TsM&soJVQY5vgB;!N_nL(K$)>lrhS4lVp9U^!orwx!$xT`y zd9lN@w4mkyT$}itH+5STts$J+G1PO6cg~f{*absSLoBisDG#JEO;gUoB&sUA-~vAw6pBp&C;fD+Zayce>M3lvC}>`Nt!5gi`^4k67er2q@ADv z-V1Yl4irbyDZ>zUwz+KmP>@?p-pz_Y+;Ua7;@;*I(w&Q69_n2i&<`%pM;+8U8WdNM(x_Om&}#T64sUJvVc zsHzBhYa=VM#1t&|TT_-UJpBh{Cat!SaRbfIW9iH65t}1O#HCGv z=vr7IHC@;ND$V=$XzUL5Em!z%q`YD%)Zl*SAo+G*YYy9{Hif~k^8u0NsemxDUj- z0hRyb-NiU;@;~}y1$$_X7#3$}1K)zGu&U=>`DpSf#K@IIIq-L~*i$nIp|_$;#vPP& z({KyFo{HBjA|5qLP2$cG&JJRZk>YA?6=H4HzXgH zM|pkc*zgBVuw+stFC!HrEiJYj41nn@i!tMAo$FUq%1mNO-Z_^y1CPs*lKOdD)X;Fg;UV7DY3m#rW}_0sH<8m79SCHnqHbm ztzHCA?=Ga`6}Tl5XY@BaGJZ#o z_h28~@cMHliX(o0F)ejs79#CLwLihXQxtaQlWSY!Yl00A>F0%r~rrHE$C8%ZA=NWZtG3pxZ1zxdm?_eW-reqLVJ zpt!pSddMT-yB+Dd@ar?HU|^1P7>W6rMWhsJd7&PClGlXCly#VflkcPA0;Df%*tQ3; zu|wzeStrBEz$nnE#7Vugi3O8S`-kWB2N>QEH)nZq$S)_5&7GIMMnp%bm7-1TDkW`a ztb(Ir@LYZ^dHg_Uf6Gm08&5r@H91;Ui2ewZ^CI;qz9IX5WT*lf#K|efhE~lgCiM%jsg!%C;{gZ!vVxZ?Dn% zv~GG3r>3YpRljLUb9c8{br9&>R%tX4Sl&GrE@W%F{W69w5?_WBhK|LgZHF++WuCrt zh^n5gc%o3%urN0E4Lf@Z(<%5+MTnDyP<5-P#&mq`?ixxP+H+hJL{7%%YX3zxmqS2+ zmtTiFJ8ErE%(fTH%|xAC)9{goi!pEDjmG@DE25OI*{MFhkYL4+105ToEaWzeWMbsb z{n7)vmOTe6Y6FFCgRPbAYYqh@M};yCq%`iDMClcYNC5vmW$mcGBI-{xweBXtSn;HJ$sDD3vLv?5B#|4t0B2Z0RWk zKO^cXV~-3_9Uy+uqzh9~ql3ON)2 zdeFrBsv!YbHjuy2qFUD)*20pAJK+_!&|8*C<&d(Wv?^}l$i%Mt*%>B`0l(+PhBcRm zRMab88LYYT@~%)4hs-FJgasdbUk@Lj{YnM#BMOLc7%$}n+0Yz|s5d4xw^ji@erP=m z0!u;VyczC$LcMrz`{G*Nh3Em8GWC4_YizEsfiiLa@Z*n8PuQQ!Nh8~O-1>Z5d4N-8 z6j8w!bLxt+q0GSxHk>uWUw@o5Ll+g2cRA5}{-Kif<^Wz(dKFPcR#pG#=+Lihm*j?B zvqxAGs||a=+AC!x|Du@is)OKueLJNU{Z~&<55SQeau=E=-sRr{5WqwJ1F?R8nd&%c z_X6AW>LsY_GNnnYtDOF}0;j`5-xoO}Gj1=t5n(HM=hzaAQY*Hbh<{hz&{5@M*dEac z@9O-%zWz)2D+ZU&PF4}MX@=%q8xyXEozUl>hoTS-9>qx)asB-+LDhHpmJDz#<=1uH zai&Bw=dtqk6h{YK7V@!_f}(34f!U=$DYW-Ei=?zmbJdoLOm|)_#G1*wc9O zy8mn^#oE*L%^T{+$je|dp1!IECn2j=J5^2KDQG8vAM#pSRr(AogZLUJ>fT{LWMU;8FJ$n>XioD*xJA5zXd$ZVDv(fX5E5570=1!1{$a;d+G+c-9ae z=q@w>g;kYiY;V)n*4hHVBX65Ot={tT(LpAouVYH4E&g3D&F>cq=W~1|LN?;xzB4q0 z2t|>fopHS|7XKcxA zLmvc1U|HWLah)peIb2<0BI%(ep=_iRl zTpkPbI9kaEU--vD`nZU*W6P}08C4QYxzKBJ&Glc^kdgIkjm68!J87DHt4!DB`8CT8 z{lU?7*wZ5!l#W+@rf&Gh0{P~k8NvL*rpK{2vWegrIBa+nxcl7-cnBPhARX*wZsdD& zddi7lJNq%l=QxuK3C6({t8cE zoaBaXa($uKpnv^79_J2tNg%)us78-A07oKuS55j!G}=k122x+0ewoDJEG14b(5Wc1 zLHEv|#B|X+Qka*f^Na`W%?;h?pounlh!Lp+jR0}jbOY+Y{r!Egr(UWz#C>+%P4KdB zF~Pg-fwU1fcf4w~fkJf}tI=4!ozS1Aj5Te2G3GA6wYI%^yd%rSLTSWOZh5+g z_xjFrB3+O%E4g#wPMGzUg8Bw2HIm0aL0hmq;j-@XkJPR=@mjtWFEockTTtmCdHYV` zMkjfnaplfGyhaH@s(Cq6{n7kNT-V_sSsZ;k5L$t@Sy65pj&ixw9e*kgPh<5gE4FkJ zq8higQu&1%IvOSz@>8Ilk?BO&`fTd`?$I~m!eGUG{oG#vgeS0XEID)x6EWB^pO)=b zmzO_0K6Df#$2S)p1EU@gwIf(%AI`T6gAjS^?Y>$yjg=bjLNp9EvppO40ZG@kPC5QT zssu$JbiiazFS*rtxti_-xpRWY69fq_4BDrEq)<0~X-&I8ev(#~L-~A<3uDg=b`Zv>=&r{vupuVIEJMTx% z3sW;-cW?6NHec;MO!R5uu_hgmcoqg_P{aVr6>Ez>Y`pKZG&9&d&ppAt7H6>iQ}pTU z4U0{?>DK;S=lCa~9$KfcR?ZX6%BX`YM47$&aJq(u?9w14yBh^4h-Gv@Ic?O{*%uQ5B}~()Nliy zZ<5ybzVLa26oU$$qkXhqEfY~&=X~++edU@W%EP|C5d26LZgfS$FNiauj)usm{4T||ng3NxtW8gT7jOf#q(_qsVaT9oM@_1BdumSUEC`@oh zTkc9bnZ6Rp_iHPIh}}E5uL6FL=Tw1!?PrK?s};PBbDk3!)+;w zvk5CAxvz)6wte{QZjbaV5}R<~*OcRk>JBNVXnjpYnW}pMl=GK=4Z8>!$NQ9Vcj`D? zI9}3XX`MOgZlJ<#hpaUIkU5G!;n~-(VIeAV4akB>7g7T0PYxJ{%S|Qhnq<163Yo4} zyYzKv%#7nY&iM(`cx&5KalhJ;7xuLjQS=o{w2&*`m*)7=6~hT;!j4=ktE#>z|1B?; zf6KZFC_BJm0Gp=Z3nDGf96#?!fwedPq)6E<2%jgH zm`j#qZITFYwhK!a-15-n+AM|}Xxo%(4y;U=sLL(!kB-g+Rpc+txBQ}C8oN3ZB9Zo( z15BJ_naA<#{(a>R<@%-Exe48mYpqSm6EWz=<(ks{C_~oUyRj6*W_VD48dYxJZ{I2$ zb?ohtDNXQnFK!r|QiN__Q6Ch`4h9W;?zd${=H-n|fu$YH!7iqGD?~4BrEWm@0=+r_ zhz*4rOK`GEUkKAPz?1Wjl8dk&%?H(BgttL6++RpuuQUlOig1FhaPOb0i#4Wka&qEZlz+4f;&;gFXZXd^{+dwjvk1JwqWWi5g7tEPgYyo#FH*+g zyX^VD$hAUD2hu@;ZqTcK=-&8$XPREKd#J=Bugj7|bmN^Z%kiH-|776)iV#-uQKkFA zcDQ$WzPdf+^ybFL(=$;%rug5#4>cE%&4P-hl{~;)0qT9>xQaFHV>Jh2oib%2#FQP-AB|qg&64F)h>XomqO*XAh9!&CCpapzuIG z_K+cP3k-Dr;Ou1};9eh}l$Q2l+(e(V?z7Rn2L+WokLy>AVCvM)pm<-dz1kbLNj18% zT#YP!V*#=l-scgo*9Qk?ZOc9h8*%QH$lTDOeElg$Ngw&OycVm^pNd;Kl+2>!C#;xu z3Pmj^S!OhR3Z4^c`5uLefl%mh_Yu)>iK@9f*H5$?c0v70DFm<7Efbj_v_N#~*07D2 zF>_`=ZedCCHJgjItmZt95KOcHqU+1@GCoprwRMOCZ%Q^mm(5}1iHmL1?r_%5h_TQF zQshuc_M)Ot0>%bl8lLR*Rb;VnvtE}6859l}85`}FoQ@DqW~I*x z8rAqwoim6DDJ2KBGjosk`R}rls6_e}p3bRFVq83oWEF3XOT8axM1Dkp5pF1>&_7jT zbeh_caKm*V7M2W^4Scw3k*+#sWJnGV9mV1@f8|}`fon{k)|!6B+k-O5o++i=&0thq z6g_ZL1wUTw=Q&IW8V6z|z<(nU!f&cne7wFNL4-U+zO|MoFg$0Z(7x#Rg)|`ed7hMP zX_i%PpB=AM7VFDhpPV?7I`TReU8zgE{(w7bG(|30GFuXG)iYA*QXm`2e^Jk{VV1Pk zf8+@}adCAkw#s0A9rZKrJpia;s)Yzc^r}oV($kq9uTPBZqyOK=jeZ3BCa}F5I`@aD zigZloFFpik-Nkf}l-(=_;%Jj$o{?LwpzzuYDK%vvc@keIa@&2IG&aj1+m~nx&%Djz z{ab>34tBvRjU9BXCVI$jK$BEKwk{ekXZu;-vn*kH{xB3FG%-Cfx!9%yp@qxI)nWpEyTKHeAhn*v=AT=!Bqf@vH@{SNk! zD^ZBf^LQeqNK6F6LxK*ub0)5fNO!k{1v@mX*bdE|x!U0VF)p1;&FpR8=S5neZb&!L z`F4X&u`}TTUm2EU>$(Ut4Lc$6boQZ0NieP30}BeMDFz0@7Nh*mb``gv8t6JE7S%6S znN)cH!OYkyS0o}II*Vj*tl`Z|MVh2Zvtc?#+T!vgClG>ly}ya zydVBO)5yVg;T-DW;~3$&DilUGDfh6?0we)<`$g-uQ;ZF|w=4mRwRyDWdr&*S+y@?5 z*KP<4LsQ3-KqJL(^>Y6yLS)Y3y|ACyQ#N-1(YdKo+A~~Myxo*`W4TaS48fteg&RU- zC8;0>H?wD<4EBm8LBh{aCSO=ekh({Fs2#+Q0VwHb1K#MpUb?(o{3RJ@sh?{A3I4C8 z2;T$Z%_LD>WtWHRle8i~nwTM$%A?KA9?4KLsp~s9<~KlhxM$w}Kr_eNkn#}ThfNsH zBzjeJo5S-1dwCUyTriT&yosJuKPmsxmA?7D8e9gzvZRvo((}nKA3v0JJfGKMFs?Jg z)-SZNzndyc|G1Kwjym2c{a1Z>eH>2N?7Z+KQwe5!>FFKa+lF_+9m)y~nh@46NGrFt zLk=vlk8x3iYH?gaYm2KqJ zzqPQCbCN(8CJ> zOkTVKbwaq9gP;-X9NgroPFQf|D^>}#OI~E?01@k0wo?A7M_}>RoKmHNhgE`d3b%`D z-{opBeCife)31c*Dpk#W#Z`d&8))Ls+HK7Cu=45|P+jx$&ZbjKr%`MVLj|^bB>4ls zR!8{aNv6lTpl77L>C`D`P|=GBHH{r4-~Tu)xvny;TvM(?tzFkXi}v}0lXvc$zlNg5 z4zurw^--#?po55dBK}ZWOiR_)>Qc3%p5uSEQfMt##B;W?g)V97-^GG@ZdSl&J%i zSW$wR@Ue&@;rGKCpj1`8paC78<-*5N#9#mWBO@atW&wyDFm$wNnQ9j7Dlj87hdq0F z(|ZYyrjmqZV)+VcO_RIp7aicFNdKIVjCpJLOsdxE1T@uUoVb2gOR|IWcwZnUk&z1* z2mK#Nls17ZZRSJ1VI<{7vZV_H{UR=#{gu~0hLaL}DE;J{qW5CAzTG2UK6jXJw`AOgjaw~L z`4SgXQ-1t7ZXn7wv~5JkZR{^L@a}Q6Z{sO5h4lKC=Jx88EX=i*@a#ZgAnDo9oF*kL z+pf4@H$^9Xz}nBgf_aK_?^-K+ANuuHyoSZ(O5bp7uAf&*pEa$UR9&2{I^i*1+`f_{ zC9^xT0k_?yI*?l7_dUv`R(t(G6NmP>Ull;}=febqpcz^C_Dq}<3aA3JB4D}4CI8SpA@Q6vlWAC){s%9TE349&fn}o-Mkp|!=F!q ztsfq;IDtyQGlI9wR>%JoS*gf@o!Onn*pIrxU*|o?MG4Hir1rHsso=s$4cx!5l_dGM z(JgL0^png#wz@?vwX4avDq&>UUMumt`lE!!T*JHM zR+$b#mIlIv&;<`mo=a<1B|>ci9Q(>B^{YT?JIx$F6I}={>lwBw4{%4+;=H%RwuN>X zx^36uxQF``a(!nx@~zY?{Ehnzhv-9qrzbtjXHw;9*aJStWXa)gIkp@7BzTT-VM77^ zvvKXRQI0(0-rTmoT8v}aH|g^m?$?`)o7xf+AA_3Eg_b@fm;2h+t-Gri+8ydnE8IoH z%lE9J`EWL~=iNdLYy-iH9Hy+d@#uUbb^+i0$Ut^t#8lV<1T0{A;HwFgCGoaUq|PLU zOts+GDwD^ihb`@=p-{h+VaeaCZVJ` zJkm((fOUIs46#`CKP^Bua0w`9*`Qf0o2OFc#zc#&)7NMn$~QnLFXfzYZ;_|^1U6zh z&BJpofPfsrIyl|z(aCyMBa(r%G_&Sr$a?5HGkZDrd*QD2G5{k)0Fj+o4wZL`6HU7@ zZ{3xjnMyz8bx(SvJ`JbF@T>TCLtXreWI@I`eosLU>HvAb3D;2=Q6QV-TLY*ffy1pp#WGy>DVB>s+Jz3e z2LprRr%8^_eMi7dk-vWNJr$@GSzkd2{T9Za1h*1tSeUspe+>_;XLEqn5eUz4@R$7^ zjeGrJbpQA7Z$-_d9$>BpEDxL<+VRWUNxQ(QDRkcd-Kd=pd(Yu&A(Dyyx4Ea&`p%BtmUBo*%`Y7m1VBHyu8!5FBCCsa7=#Gh(LgF8Dv1zB(xC z_In!;L{dUZlL^;o!KBddzd=YsQ>|m|NAK{hpZ>-#bNSmSaBFsa?`f_UcD%M` zPy%<_=hg>(ZyPv&lq*w`MBzFoIgC?}4TO5` z0}+kI&WN!m9dTJ^7WI$>9kjWaSSLE{80b6S`|l9TbX_B5p$a_t2>pu(esLwfiwZ$e zB(M2oo`s@o>EO;@Ty-cX_G?Cd-05T}Ug{MW+I3}{!Y|gwy@@5}QUQ2{>ZBiu{ANM8 zACmw-{YE-8@!Qa;rA}Gv3c{|GBZ~P&nT5CpwGxNxlh}O`*sTW9tq*U7B3(P{>sAp8 z^S4a0@z>wUVe+-=TfDYE{k5UE!6}S}XpE|fl+X>4GklgtL6osbyw9{VIee3~2*JIC z#>VZ(|EShc{d{LFi%k3QT0XIES4sgho~K%xYd`$d1o`asGZX@@)k;?`q$+Irqz^#b ziY4S|(VKX<>DR=LxV;<+iTkqIkhO1{{wJ8;d!fj&05nD9Q#7P?ls%Ov!|;YZY%!#0 zwy2-5%KG07AN2vs0vTYg^lv&8WA9>e$E>+1D@gc9&Mn`83wU zmr*EXx4`O_MilxK-JvY#fkF4ye&|h8^eHEn-8AD->vLSsGJ?l% z2BkSTh*@fWAvv)MEb2vR8pqRq?u4?$!%8z64PPSv$xo%)D%_Bto57Kq;*YRONk+Qr z9RywUW$>42F@wdhrN%$)siC26RjcnHLn@hZ`d?z^u%@%@y^%Mj!FA-2BjtSar(%We z@{fF)$Yokpq2Wg~n_c(NpL4|{pb-HaHNd=GznKF~11OKLK!DwgLm5)5JdZn}}#J&uO$Xj8gXMTW@o zTv6c)ma|=&h<$4wHuAE_qcPSP1oMjOc9mkK^A7gOr4M@bJ2(NLUh~2rE#O%4_VH;L zQ!z8NLqFw{0T%K5_tp{Sd%aj3*x60-r20B`gRBYYFDo1d7tL7@&uaDKBxOLR4A0a5B?&=FU;%%kxjj1yy6j6~ie5mb7B8~|uSamAgKYsoF zX5Pp#clqe<94r7jdUXg29noYgiqde;Ij7`#uKe=xp0znDO$c(=*VY)qCWKC)W6?VR zi&;sx>qSsmU?U;Bj;)CM_dmzS$Cd9X!s%9fnwpi(xY^s>phyKzI9j*}IF~KNU*?GF zLC=M$?QA4~#N}aKB3$gmGwD=Mp1Ctht}XCtH!0$hIvt+#_hdT^b_sU7IsQ*~z!>Y& z(Z7ioIQxA0A7%Z^k1UWCa+FT#^tKn{l1Pq5pENXCg9K{5z~Q?eZKvu4a7G1vuriT& zciR;&HuzqTO-tt$F-_zm8dF495#s6vaJ5KX3@c>+46@_nQVht1Al?K=OU-GFXa*4u zO+#vq1mSf_wp)OVy+(`WV2)DI-yq*Iw>@)jPhPCmdqT^dOsFU_qByZ(pmeb42Z*Wz zxMF&6un%qesro&IXFnf8hn^!iGHktFPevKuR&CiSx9vSjsXJiZ zS8?}-Q0kBOhVR# zk{pMaZdDTAHkx!ym}ID1G6x&Agr?Ovi}^{)NHWX^!=^Tvn3C7Gl8*5Ldk}dZjDzm= z|B>o=1AEC@RgI3LF%R+e<+ql0KEH>#`75dOWwU6_{e>ye$S2ppsW1~*iZWB8dT-)~ z;Ea4ulO5;Sti`MAVu6qyT!d5_XtnUt>+~_Iz#vfm8Q7?zqqJWcp+jB%yM=qGW7N%l z3)H(?kcAdudNp&hrLDW0_s@TyyGFH(tsTdA5s3fX+~f!K3;ApM+EM@yg*~=E%X$U| z_|CX-hq=HjZ!?M4c{~a!K^QONzh1VRCS6=z8(X5VJEphh$-r)~JIa_JaHcMHqjtr~ z)kh6Ccd+nvdjzy~jN6I&UNO|d_rtEdaM>N(*vl9vc^MHIo0_?08m zmQum{^HCEZA<5bp!+1H>#3%`&o*mQII+Hp*I()6#MWVmTjD}Y;%poGPTq`4UF=MMqOl5zE0#EHAmfH7jSt4Z z`{$zcbkB$Z7(aGolYUhsJ=(dd+9p>xI1JLqZwfq)LzRe`oHbm6dfA6<_GTW>UB?Bd zaWx*b`Sey>{#+oEj9vVe3<<*f-` zT1jzHcuYiAgTh13`9=wx$3FQ#39!(3PPUFk#pSd_#_kE7Sig&N+xHOKI@7Yy4YRsq zng z{``u7rcWkQ+YPfPK=Dtf5qYx5D+K7Y=#WW5L~IFk2gkecoV zCUG5vdG^K@0BrHcq4Ue1af7H$xdFFbbRu>JPWQLwU`-4}**2Z6MB9yE>*M0GH3~p- zlvR!~NBtDl@;_*df!#Hbo(2tui58o~R05=sa;nIs{@)#pr@_h}P+u*Y@}T!(iA84H zR)-@8ygYD_J|;a$a+=NOcjeX)6sI6>Ie|S#iM2`*Rn!USt2veO;mqP-p$}3{<@u?9 zM?+1zB)?EsENkNSXy&RGtoGw%gnaDd+U({qYr$pa)~Q-g{#^ETjnBG4$`z&Ro*x25 zs^ySrSXkRZ3hI&CEOhP7G}lp|WuLi-U{#$m%HTA#-ksv8;DYuik|8^pWXP9m*_39c zQf+;gdRa;+c$ea>6YwJwE6Pz}Xy5-Rl#W@o%864)=LH>>_aa4@(j2wWR|kB{lsiK! z`*F1XHJ%lx-fhB#V=?w3d~978GjEE{N%B!YAVunD?9dS;V~VUgn#N zQ&bYLJp6rsruQi*^W{LPoQpuyP;UokvgK*YH;ivHj*TX{%+sG%1ynyQB&h!9qek8B z|Lo9-np9O_eYU*-n6)kZ&uGnG7ndT()5;*HinD}>iLoY(!29$7>YYTHPTUJK5e?GK zzy#S$e6vTy8Tqu#ME}$|mY=EGO>a5Ln_zW2eA4{PF0B73!K$bv8X**@c4Dq>y~)ihD8&AvO;)4k|%G zdVF1kLqx^BS|Vp^m?~ApddK>FClnH=4VS`NHz|U~`kU832tgbx`S?_YvVR#tx(eo?A!oyWL zd&WhI=nA|C9LzrHXBIvOMZ+DOQQ~-t5c-$C!&R&U-Elk7)HN8LpazLPUy3ePThW^> zk41tB_}ziYH(fNR$rn*JBbmULcLjGLDo3f9J*9i}#MQ^A5|-&Tj4sH>XQZNSl@?0L z_8^b>o;WejtaJWdQgGMjx40%+WA^$+&TB7&k+2`uy-X6m$9`Ia@0xx^YeBUrz_`K2 z{=My}uVmbbuYRb7`b&#cq{`K^@tJZeW4p7IJtOj%nr7RIWy`a!pmY9Glbu`{e>iJ? z_U)ROlOugH%YQj*q8?7p@nruCOw)6Hzu7bgUYzXgY%pgpA3AfA54x)JSaQQD#gdQ< zUE3^uvF&Fw#7TPjLI%;d9qHxN_wT`QzZoLAL`6k`!pODgnoLygZPJgIMmpsvR)7xJ>5OKctVIsM8^@~Yf~iM6DU!b{gV z;%Y7(G9VVcD3yDG$Fd(P70O#zUPVwo@gEseR#tgQuQ?09aLTJr7X#%EF_{RWFRX6% z_zIp@4P}49lnUw$0A5Cm=FSARzxl8s?IATlnI!mP@*n$)r`-h51eLhL*FBd%ea1Jn zuXTwFWyaJHK+<%To)TKk{3G!b3ntS8c*yx2gjpGWMBSZPp(Pwa(ZS$T!yQg*J5_h= zQn>*#=SE)=KuP*m!s909*{1;XrvP>C66qVRi}43PU%ng*%7R{`YBwK6f$`GqtWj}e z_)iZ-tY1Zh@{|SJby*S9)R+gnR9tnp`dZ_vMFc2X;XEmU7B4I|dwrryZrCi`FIv&- zqQBCqdF~*xan@yOBVppp3e{?|(uoa%d|{v&1K3pw6ipV5xL$lP3&mYVFj81p*!`#% z0SA#(%H2MyF(fMkD1f&fdVLbi5Bm)-_#i^ahlpzn;!YYoj2;FhMU{=>&Go2{kiz?g zbUpQW1q&cFDiBL+Axtv71>}-lh8fMz+Bt-`;>(Im%uU3@#ee4OpTR>6nnr}wPqi9f zMNUnrZ^Wzx5K`#g(7l3E80#|5BpjbA+PUwsC^f$t%H>MdqSS^{^F~bj^#ZH8p5j#z z7fSM-?B`tJYv#w}jZ8YCsCa5-f`lCvS58;PC?Y&BM!h90*K6w266cH zHpbnXRmfAnqds3nfIV91DvbLi(V&RV4%<1~daJeBm{Zg?p5+W?j*VUAz+DeBIAg7* zDBEvM;!vhLrXMR*4UD`?fL6Mpoti14=oWuSWC6zTq>jYRnqj>WD|$;JLC%>V1#%h@`ooEdC)w zIwqM@d)^`sCUU>0J4;vxmc?KF$7rCWz=Iw$CxoF~whSgXJQ_)zH!59lm=mEOiA6}_ z_@3A;qQ5MMMak9@f0fkb&GHjeOby}pOv_J zKo?nIGVcoxjHDM^JC+~b2?qH;Kde{ny?a9=8Z?n644%pHd%BI<8cMRQX{*-sal*vJ zlCMa7Kesi8@PnAegCJuJ>%?q3Rb7G}zXZQ&6e=)NfM9~vxtT5HsQmVWItGh-9^^*P z=?W=EPIrcI`c3yL@%XEhGyrGwjf!8n^b6FF29SMzKnPJPGf?rq!`?yhFE*@xSXoB7 zY@eif%B-rF=++f}H@VpwuMEfVsD}{umb?0k4|Un`;56!KQgvE>Lhamn(U}jrNS_4j zAjX3Bap+a$twbGx!QX(dB8k+kKleL$E_mfcN4f)s_bQZ{l5tOYY&$b?L#p~s>>ZQ; zbT7v9>D*O8lxpR^<(v&3liTHE$Ym|{otop!_58vQHoo|+_YrUKZJgEpJ`JCc&>PIS z#&p{ZQD62FiBI{=!gWE5R+&mN4(n^EK#DY7e*@aR^;PQZ!w{a+YeR+jVta3ok%0{RcwGQS0S z(lHDgOmy68&fluFi4Zt3F`-T3>wmGgS8SSr3qABWQ8UGx+$yd%TiGGb+Es{3JE)Ti zXPKHr4QZue#u+XV&pLJ+;`2)L85O~7ky`1AKtIrC;^S2NXz34o6{y4W(pxtQ_w8jW zd{#wsA7BpxpfM%#Wm0I0>p7f=urNwnPIxHuXK*rCilSk_NGWxGU`X(UScO51rPAt! z(KS!stlrYqYtt0|e%R%jX#Dl8Wi`9cWHo$uy8AY&qA80R-!BvVy~ zBABUK3%lzSpyqm!9Nl>omqZqj*Wrw7|5o^sjM(uXz7VJmp8F3JoI9`uu4Ar3x=!>R zws6TbF~3Mn;lI^NLa#-5#T8ZUnyT*m;F!CaHqsXjWa10g0?_% zEc=_9CPcf%q^6JIisNOIM0USLTQ7%g=OfNs`3PQijr{WiPNH68Jw&m_j}H5fE%oV@ zq*IqJUvG*EHDXXLl+(~&`t_(B?zXbDsc|epq<7dnLo1;u823bkgs#{>vRLP=vprst zeN4=VNy>8a@EEYCt#8E8cOUc4JDSDZ7~q&$GCwHR$Nx`LejKTjaS~Bpps}8jt5s zqOB_^BW^Y3xOU6pJEY>BkIXyFgRzvLodTX%t^wnYb!`ajmjQU>Qj*;v3Z&1M`{Vd2 zqB!htySsm7i?RGSf|YZ2Vn7)-PxYi|NoGIR_ojwp*@qzMwh+ z(#9^=qp5rimB9-$2NmkaJY)o8-2l-)EnG{#p$v4ZgxdKfMTR}GKH$ptTuhW4Wjq(Yt>JF_LUWFomhFe*5p9Q>;?$e=5 zV^9YbPy8ZN?Vu+`!kKQl&>ucXjvmXmoQn3H2|wzwWT@jvCWPOu`O~ML3E@T2C>)00 z-9i;$^02V?BQ6CinccW)sn|fRCHx=31ify|WyI;+-vql*iLk)Xuq(!X!m751mPr>G zlAo|xv(Pt*=;moO3hLm%34?|6;y;TM$1Y zmzn&bx;jL1i_%27;ZWuH#c`1Y>2?9-JF$kR+0DKKH4HL1IRaCr|*u%b8!IkDYR%_?%(6sH`5joqVE5 z`~sANe`XU=Wl)MFbgwi4|2sBQk64-gq&$4-bUx`%Z>pma0@7&ov@gNMX!~w2KT_wV zR}qw;cgF+>r>5-$R%c>%>{I`r3m`w#By2TumyFHu)>w(RSpSc=>*BIW-av_g(w7fK z0?C@0oyvS(j-U%@Yi_1Zw*lI9;AH-@MG9mwNYlm&- zkZth|!Sb^1{1^|h&*^dE`A!sYcK+$)LH7I2(3?Zx-~htn04Q0vmWsmbA^9>pq-Sf^ zX%D+8q9T~8kkJ|FP<)?KJDexmLm^Q)z0R?EhyfW!GlWvlGU@#x1RvSAUNx^aj4J!}+X# zl(mbCPhUm+9&h)?h)-%I@DB3qnpM3Bhug42s+cH||UNm1A`=bPxn7__tERO9J#^oG<2z906s0Z12xJM+ei zlCiH+Kk5xRkYi;h9(&}8jU>p87FAiL?bUlSUoF?k zYZmAVf-Uc_rIfQ|Gz}L0!43EM>FEO>pFq|HY|2^rx3s_9oNRa_UtUX5987_8DKmp; za$GQYf;$HZ29|jMIAjY$>}^2_&!eQHF+B(LZS*aK(|x&t$7J^$aPwA@s7fBXgzGmm zhq5rec|#Dayoj9esTwDBs+*%>4HPswWfIw6lQ%m3pZz|y=jx=BXM8L?bu(t`1tsEdwaXP&+Trftgr6P5-I9Ae5qW(wUt$J zy|~c!%$zw(KYnWO=?Fa!x`kaens6Qb@w$foZLtVbS@M|tXOmVx-?I{Ux?ZAxr?|FWHT7N!9+eg_4 z^qSj*lhODIZ}|b>ZPL-)Y*~pd8qr^4-WlTga{Qfn+55Tpx@Y-$TPJ)>mamD?Q$kH) zLx|baX}Jto#+|F9$a;Ql%{n;lc|Y8)nNSj4QhrExFyfCQHCJ&)j4sX~jh~F~RV;a* z&5ioECTm}WPw((&Wm?>llfj(avJo>6wQpJF9L<#|*v${yxiY6KwrKVgl(FMMFHOO< z>oyTBf}eZJp8Rxm)psp}ao=G5Z)?{7UXC2S-ytz1Ns5?$>lKirrJ!sN-)*__R9| zJcjq>C3*nUG_VK*B@WmQGf5f=ei?qe;c2kP#%mte`>^v=g?l*#rdYgSL)>|?6aR1y zdp|G;0rB$~v7=T~M2(P5;t?pGBmaUlf%yz@$!cQ+19I-iH)2fASqQjOdq$bd)2`Uq zi@dn$vX3~{9Y)d*>RQO@;Nb9k{`<$_)5Q=J9C%=l4(={k{zR!PNI=+EE?o0_Hd&a4 z>d;TJhx<+?U(N!b!f2!@Pm)lSJ8*dK?(X)B`fEqOnl^#Q)c=oI9#3{HE&Ubs7@Nmy zJaLXs_oV^sx4(baf;jjer2en`u|N0Kp7c^bAiu?9nc>(6*Y|xDCr8*Oe1!O$UlE9w zvU`kS<#>N#o$m?Tz!zz0xxEGgpoi1u6jPBmKiTv~rQLYa<6@^+x(BmMbtvMqu`SL8 z(*MhzZnDE(>OWG5@?NPV4B5xwUb^+JHoF^3a3;TCPzxkU&AhNY?qRK){lu50UH6Ly zpD$zAFre&g=gZ`5I#O*TLI%d>e=A>o<+~JPkkX+7NG%<{MB%8G6G^6n>YY*};pLz4 z#;Ng*;h?3n!&~~$JJynzMY+4w5l7#L?;`hADoqw!KV0<|b)+pq3~p6xkAbYE_c;}286|L0XG-mfOfv0w%RMT5lxTMA+Co|E1xmMy?i$0PM8Y-H0Fs{ zu@|-B@n7`b|Eib$?<$;U^itpnzMIiqFWVg`5cfTR*LFbp)F!>Jc;$jXOTFQ_WFCyv z;Ns}AN|R>KAf#wh@hi=Oy~Ep`k3o}>n)G=|EZjCsC&6LPZtri58**hg6~H_kMu>sF zT-MmI+l?2xHWo&fS<1CI7f=7YGt{XPWw0J@QYCu4b-nJd9P+rsw8CeK|MrYbRH8C^ ztqUif3oCS}5h8*wt22g~RuHv+Qd|Ia$b{eH)5EVWeA|m@H_s1*t(d{!Ht^|*daC3G z)~4Z=om(;fqM^juNGqa*m0%2{m%?yhBa2jU>2$b-X~ZE)u}q&-hj22oP-P)XedSN9 zeS16A{Yo1dX|u;Vkc3_J;{S9vM=zc+W}Y2(R3Dz@ewcE}Y3-0F@w5&!*F(H660?nW zes4#RIT!o^zKeVKhEyFOYuy7r>m;We zbZmeBeXpywuNSUOCj451z*xFvSll>@i>%|HH6Kx!>m=>#HM+BKUBGWU-a(1#=qj81iaoY(4Z3%(Q=0S&D;2n2xQ zzh9EKW4BfB{r&VrqG4HzUoSSX35UE+|4j~yT29q9anwyZNYyy~hrb797)Uy);=Xn4 z{_6qE$$Bfgq>6%d$D}FqgXKL2@s-dj@L9`}oWk(pGd!-D=+^@;W^0_w7u^1c(*EW& zbj4;1WQFhCf0{AE-5hI!CiMh4g^+r5xA0&KLxXa&XuviVT zo4Ly3v%B%eW?U}i+20*}(6{AB8@6ru>*L@>U@ZYUIxZq|0$+bPI_ zil#q-El94ryZoiAz^a{;N2Fnz$Sg#(l3VVdb$}|}*w^EODk#`1( zvU))Qi|&uyVix+=`pc2eg`+3q2xd0bq!JeKE>0ZcJgVvMEA#e(7vGbAzw-s!m*U<< zC)|q!&4I!-q{Z>MNHOPNw(r$#AiRrRL-I8OE2nTpL`fLr1grYvm>I%-n2jbv4aCcrRK`YSJ86fFwHvPl@Rv{GZ z%{<8dwS8OInV&%{xrvz1PmgfU@3tN>)`Lo~Weww(gxWSw%<|3cU*OWpa5`P$Y;8aL8nNWNMa z9n~C&pesgKbh5Nz?tiP+N)CMUeWr|UN_Gbn(Gnmp`c_bPIf~8@Jt+gJMuOO4!X*ht(OHBOhtWP?IB(w~P8&bUNxIYC3XN*znd$UiGsqfB? zrM7C_LH(_PI5D$L47n&h6 zj^v^vitIe?8cZ5c2ikqPhuMYVYXrayJzEtFJjx3f+{3&?Tel+kQF512n8t2b5^Kn$ z`GL>%9okA0I=_gB$DjCY5fPDp#z42Xw;&cM)KSAH}(TC-jEPut8(8f zE~SJWalFv{6OMD8-m$A@8uHH(8~wH~HQ1Sj$N6#yL|U*9uG(>;lv=DM1#A1UP)Ej2 z5Gp)j7>5GDe9=zm8u}L<0-gu}4{kTF`?dei%$4eQi=C}h(j0iGfmO`bsO+mPr8>X_ z(NVtfjS^Xs(gD5x3Q2(E%NqtdD86TyflUZff4T;ZzNeFuk(bFRJ{_)jJyo-J5drhq zusqybHy5F;pyizE=Q~&1m;$QR>vay5)lvOp+x-OHLS2oX*8V7l5OQ|Y*LEyL-@Ryh zb6$<9#$86B5c z0!h|gmsBZ+Afb_ji+@C=Y9YZ2rDLc2>D=&Qs=yjO%@;FRt{n;}ZCVS(@_73#F}N96 zIJF*wavNqpWqCDLXQZVN@bSf~UNqj+;u+hBFnMQy!5bXi@CEiEInqiFg)LAo zzrH)bvv`RzW)yQi9{db4UeC9GfThWu555gs`Mcmo7ogJG+4H!;BHC6i4SQ4+%jNSv z>qf7swAVnqZ8+M_{biu8nf{TCZP&F<4zAakX>78YJ?@P-A3=BDG}@m2HW&V=$+Tij zapvM5sKE)$JeZc5{fC9U5=tgpk>qp%tO8&yR<@MGO9NH87|Vo}vRod&_{#O*0y1Ahxx~B=h{wgZ9pO@zpun;KGDcH{Ka$rZ zVZ@l3KC+Q%S1#Xwq=QoP_=3YVsFpjgYG`Znm7hLl_|j5Ht6S5Lu|A8{R9Bl$6LPQx z7|-+<#<)`|cgVk@U5ebuSX~^w!~M-$5prX@!D?PwR(1;gQ--}uf0TB{TyO^Zd0?an zcKv_=0GeZ=1V9w{SHmR-U1H;ICef-{XsSPZ-Ep?Kv)|kg@-G_kK@n~b{(3HA?heTP z`Td(rs}GOJ10R$&I@IB+Ma1{ug?|K~Ab>~L{h$9H9Yt0RniZK{{S4KQ`%pKO)bSsl z3e8+3P1QvIC0NZA(v~FmBMS5JZIHc0G~%;8&omkVL|>c_zf&02 zaiUYT;d^1Z*w}m=-lIpk4H@jKr;_=T;&1+`_?y$fo^A0Zp!VUcZDzuwO-3h@D`l>D zua9w7Vsc79a=RYxot?4dF&~ipxKx(6YW{`D#E7&mDZ3B?}kqdr!md=`t@(gY|goXOOy*y6*Qdw(E}RYBgID4gT1ZFL2BS z=tCj=85p6b{6uIv&{af!Yj(e~tVnR&-0h8lvrzQu{3|emkZ{nR^85<0RdBWVu81kU zMi)(AVteHp`_##OwIfvV6nApn1Df;0!$UAR1KGJfvGIdyGHLGKR(b)-C4#pZw%&qR zMA+ipnC48t;+1!Xr-iH9%ndds?GohA|CH)T%l}9^`jwG_U^oW1@(LZr&A&4lNkdH4 zu`$v(C~rFUCd`-vEBi9Jxxup`c@g~~sFcza7vDbf(ZAUQ$pSBug{5#4??!8nF}^Yn znl^Jj>d(^I=xNNdDSB1>6i+0WZA%T}Tj9-e_Wm%ThyP+=F(rSb{7h-m`{*FRm%MY9 zR(PQC9qR#KhHD1Nl?Ena-p!?5!6m{+eYu%ee55j79~nvaB-8kqva+-(T`xhX3}kY*E!E6OE!e#X1fDx`sr9ys@(!1oXZapm77jXdN7M>C6fS=Lufa z2LgzptH?bFny5}wlS^ZIAB|SnYg68v0U7>MBE=8H zAKL~=dKwBlWDDswHRjk>)(<|-4A6Q+YwDR@w7ylkQBBa&L>{U9l}p4uW`(=wNqb-P ztry{UViAfL{bGTX$xFXZ1048DNRjkc_!1k2%48!=yP+Df^rPeh=E0w5h_?jAw3`0p z3%`QyJ^vh=BQ}uyve>*bKyYl?waD*G4OII~gDmXNOKO|QxBtaLayTzcB3M;e<7!Jp z5O9=4MF~98H{5AoBjbJ*UH&xsLBF6_QLZu;NH#zCXI>BWcDJ_XebMi51ritWU#?N_ z?17yQ@MQ1?ELDSUxA395INQ9(22^#+&1O;gDmK{KEX*P(|K)R^B!Zxm@EbP&?ve_4f5Z^a!u3Td!y;p0|_);HQA% z{wIP74&fLjtjdj73NKU=dgZmIbmfMqC4Mhm(kKSlMp%N+U;Q7qQw{w#g=tB6@Brzn zozePCRY^m0#%&zH51ax3ALRoKM1KDB#(<^*RK1x3@N@xy5(uH#9}w=^=V{b!L%Fl- zPIXnXrmd>=9!ZMrJd|fVLrdbUtWs9I-Hqh~XwJ1az*eXGGy{1NqIfM|%> zHXXgb)kVQ%((4?hOhXhbM1T$lORn7u>*to88&j32Im-w-NK3*0hJdMEyw3 z5`=WApdUeT1n-;L+rPNE{p(!8;1>G;u}oS-m(Xte%_^d7Va{&3)N~6iL5sJlaH+^o zrV@2DT&HICxf*bks2~6(@E^U=GOi6yX44cpavs%ib?Y5eczZ%bnJUN)V^p8%-lQqT2)oWI2v1V=8H%IZgRXeeyg zTm!oi&6w61@J*{p)E;Ha{PbFI^foly8xXacD=ta2gz^%MUZEiMiojWB(}ye3O+<@#QcMs6ZIJ6GMXPM9GI5JF2Nz^%1dm3OEGaHYNfM4xs zD!P4&r?KmD!dD|DAXnUwl#7iqAifh?MJSpWA79DRkHBfZ1!O-^etZWT4&lySLpixu z)ffor%EWAD)5Kp4NK}SoJO$nCjb;4(>x;}mVZ@uS<;$i9245(z*{7LCzHr@3RX8QN zr;(%xJyjgKt4#Bh$dSwpk2!BCqxz-`m&p)}*7o*eEzXhQ@%gnilJ5b8D(^k|nZ7Ub z^Tce;p47+ddL|jSSz5pysMP^z-T(1C9D9nHmzhdG)<(a0M3ac_7pXZ;^uKlFr7LM? zEk^MNm7w4_`bvVBi)@g(i)kqn zu8-+&R|)8%-5D8bJzT5^!t7a@HNrEv$BCy$o!j42darFXZ;KVugcaQuoWZXF_eb-3 z?0Ii-caGzJZ<(H))6hFX9h0lr`tRF59`X_BDu{>~b{zAs-Wr*mY%Fs43JcaHPUe5; zvZBf@ohKk8d}@g^deL55nHp%3~A zYW4qf0e+DFo+`oT^o)$N`AjDNtU&SR*Z^WM7DAM7u3Hlj(=OZ11}Bf*(5tn8!;-eH zWYwUVQhg}%}5dG9+kS5f${}?2zI54*uVX^cb?HTQOD#m0E?bG{m zB`7>C`Kkl?MrQyeJ{&>$0ueSY^dwp+VJOSSIT>;X{1-siX3Vrjb7bnay-AG%w6d|U z(Skowm++pGTMN(Wpkb>D2+8!`Do8ecohv1HCRBT6Msli5^c`NyblrQD`WKji zz)N6dUd#7$%Z9^{wNM%*Z{x~B%WT4FHmj_fvVW&h2W5h(fG}u5PcfYLMxQbBlTO6r z@8573YLJ8L&xOC|{jEIl4WOUf8r6)IMOwqbS*MEwIvufxtE)H0N?3d&8QTLq6>8)6 zz?EnBPH*M-9@L$dg)0!K=Klzyi@>RIWA~PuFrHLM+BmxJy?zwhwcDX-riJC`m(1$QNi2Km6d7Xe{0KdJMUu7&=4lmm;!!zB zk9S92>SPdi+2cbsHfPW_VHhepB=wFSpYqVmp&NUwI)p6GBg_Qppnj?Rsc@}*+sdJk zyqIEOr1g~V5oFC9yx?J7eGh%f0y~EWwY}03H2OHAO>hx*+R&$J6tT4+gT-UuW*|m^ z(9YX7riqQy)2bRXzzS;}{P$@`NAgstm!|2GlRRbSq+w<#!ZspXms{JKXbwrQ|3XV% zXX$_Qb#mI^gacg_7#rTLV6J+wMQ!$}AH;H8G6_b8H8Y4qS6B6U2POmCACngTK-(3sGNg?7 z&H+X26tu_xG}|EJ06YiJw_l%cfg@2ODbl|AmBT4_$Z7LkilbrC8II4ui%Qf4(~meH z?N{x|VV^<7_nvC>8NeD(X0h{QB_*^+674D9m=Exe5wufATYlM3p$t|#Nxs~R1(sS1 zge(Z)6wIeva2aVm^@@N=)0xo3gj#(ogwQN1jCg7EFS1^-f5V__XC)K}C$EDqzn;~6 z8V@Tb3;p;BS!Zb|q0riy#zOMi&0_p&?^Tv#jsm5Ejre*Ab_MJ88UNL{aLLFbmY?$c zxXOiEag`qwM9gU9F`(sr_1bp5+84Mdki3QjRH`G~+5bn=S4KtoeQndyKe|!6b7%w< zq`SMjy9Ej9?hff3x=XrKLRvr?L{dWHJ-+|-d}qyK?zzv|dtdvCq%iqRwevI&FN;80 zW1b+ENU3pA=!%+J`^#8u>7C>&^Y;W#HU?jnsRs>{y`k}W_9`Q*KW{@UsBpRqe+KI# zQi*E+sU(Y}v4?FI!Wjn=>ppZ{fm)@($iPWD^CkAe*`lQA2Wtui{_MMj8m+mdB2Uo_ zTEdK@FKK55=8J-TOMMFFmPNiJ+69U8qOl=}!AlOO;XZ#+&tEOA)f6CvN6zpgL-MJa zq0*9OAFA1Oe!Ky6@#>{#|#PI4Cf{TQu7X{J10V?b(MLn&> ztIrFaj`y?W0`|$N$)Xq72?*>D3}jLy)^4G^8djC`nXpk8CX|B>6`IetT~|{*=!mhZ zdU3C^Mu!|ws!&X>9sn<5-CS_;@FRiVk}5qF7o=&F^{j<>BGprz#io*|eAYN)Kkjs( zKlAtLmSzEKR8CaHG|c7Pz#yZUsJu_}j#*CB@Ao`{9EBtM_FsHs>`K|LcVU{TEq)#U zECDEI%xavOmEBT8P-fw%f|BMHJ8&x4H?~;yT#K*4$Nma(D5FL=Y)V##Cjm)DIvS?6 zKRu}i?{s$+&)X&?CJ#SM385^vE4P+Od8ndeZlo$wX*ZZP_1i6ef)*4H5Bt|!_4T5( z^`5U%Is!zyjl&>Y3Y=39Xo;Db+jNXJ?^_~V{E0MO_tmGT?r6lzZOaHd5ZIo;HsB6?VJ9_yatU)A3HQ()wFX80l?3rp58i`g9C8Zy!G5#L| zfrD#n&eBzb{)hy;8a>Bc_0}-8yoj!zZWU+Pm{*JOrFQCi(UbNP#$!2HXftJ>68WM9TpyfHsz6sH>!WJ8@{eA=Na33SrNoB8|Xwo$p0 zSE(a8pK#r2JKD2V84hxW`pM-79mCIIDG8iD$NiTAG3wA9jPZkswL9jnb+HT#5=fP7 zY$TV;#R*z7cQ62h08HHBUG~e%$m5biV+?~XZWE&iTb)Z^_0%uzulA%A-YiA7>*{JU zgF^4#S*`rJNMd17L9^^Al$XEd#S!yX6tt1xQuhTedkJ{c)@2g8amUG8zIbF}6NzO~ zk;H=LYusr?@f#@#Ga+9IBL?YI&5$r!KzR%!3(lB(oT;JVnm|(y>0O5^h$4XmV+x%aO z0_{eqZ$P|BdECoYz;pa>*k#;~wl;oY;a}^Kp)fVX88xLKzR&aSCvg6bh;6rB9>hJ` zJ)oLpCuQw%KYo4hC@hiLjv9@phbxcwN)<|y^O#+PuR!-38Ai(>zbE@mN8JE+Vlt|c zS|Ca=kbm`yGNUDBo6FGf$^|EkGA3MNqd|VGif{(E9j&GqoPMZ;yc*IEvmOe}N@rK# z^3LLG7Zp<~)T=z7{{IGlXox~^o7xd{_?tODG>(#f>3kvPz-8N|fA7uqQqe&B68?Jo zov4Xg)#be{u4^vp+GH5RXT;YxY}+~D_1cnCY_@!cGbt1eQs*B|RTG0AD6vVp4=KfBa~&75R0U_VH7G!IuDqa*K5+wBCTAX4O|Yb7Bx(t-TaIPMO(+~B$GZ^p+0;xb_v)Rc{nvw>1stP#UZ>mK zA^k)@Hb(_CA+{@N`)H|{MwPEDFs11H>*H*#nkKVN@>zv&-5_-N(zI10kQ%DX`s-R{ z^_Eh{qyGyXEik;YtNB}vqM=D{E9Hg~1J6WKC?r6mg=&7rlJf*?awY#PE~b{WK@3=u znT6`V>ytU{-MArCGHuSF9$X`ihK7Y=$ zp|k*2deJKL8~(mR1fFOqR-Gg($xN}&$B%L~`{~u-cJWaZAOVr`v!ZXBvTnZxujsfU zCcu5h$&g=6&=D-}Qcw%M5uU+3`HI%*%Ep1R6~nkRkW8(%qRaIqFmb}3BdZV^bUK%D zocjAKAlnf`$}wP9S&Za0WDh+c38Do4DKVc>gzQVw`57W;B z&Mt>n@Tf%kb>sixJF3LP>GQX_E3n>;JdI001&_Na%F+M9PK zxi^pU)0U=Wc`+Rb9@0Ey*MhR`nW7%R$_OyWA0Dz~%sT2Bvpd^uh7d$0K=>-&I!3n$ z#yADg!+YPJk>jVRpQ|}PvBPt*7q8GGe)HD{a|3`~68oc?&mxdr8lyNu*&6ED4MU{f z6hVX+l|6M8ipL3BEX&$oz43qlZvlzEH*jgY$!o@}-W4tL3s}k`^0ygJkiFq5+21aU ze2xCozyueOgY%UB*$v6Ymx@MDqFz3<@dp|H9>-KT$3RklvPq5t+ZKxUpj5}`Xw@{E zgsoj5fBgY@qD-zpw^`4Sm@BPbZs--+DMh%m=Vfu_Hj9*0|GSLF$w~ch zf!1t4*UQ=6BA<_N8`wg8faL@iu|sT=%nt%&8Z;4HgU!kj-8Iw>mmthoHQgrpZuq4v zUqE38za$*^!FLDV1+evBj+F$9>7Ma;z4cm~#`rrQS_Odg+`uu6aEMCV7c2h&6t1DO2R#qIw}swI%d2dB#taJAg&GLCO`fs3=~w`)wVs(isM8FZBlt zf#c$8R=KaVBdg~Al4)~jm`$;*gTg}eo&$;Z_#~Mr8f^M;cKnt+4kGNbjsd3*YW?s6yZ{twfm1xAA&sa=uyJ%bFn4RmV zUa4A{a;4%To9JKXh8z)3a?h8@-o^*oxw=kEx|Qc=r&aD?^DGyTimz%K6H4D#Dtg|FBmCH5Wjg~;ZpvXZJ=iM(e3BWU1 zxabAU&H4vjVm1WtLt34sqT*YS!TlbHkR511g*g}Qs9)#>GId|Rav`99LCzzcUU*Bt zfNZ$!3c-ey?N@1)GJe4vcQ~W6F6pcK+D80Wmt5eB6o_5{VQBsj*A*HggSLiJMenUJ zE$hE!E$IxCp@q#EyNv!$)AppAS*&_*()tpZUPn8xxz}|n;TA{E@cYj%d(rfgPfrgw zySw7^_eWI5krF;^)C_uG3(^ycTOES5OFcuG>p*`CmYm>a2Xt_KHq63L_$Ti&LcZ3r zx6RKlp`ot{xIwM#jFZ&ZqpI^oeD&SR-L^e&c=pIlRM2lricCsLnd-ghZ_Q4UA}ZxX z1VdsZ8)enPV&QiBFk}l!VsgF)qrUs}$Y8rkl2=qvDtZ-BR#VMN;qpL5?;l*30ZBH! zDY1r7NIkE3>;xl$6Vu?9QQXHF3T|baM16hzEwqZCIIeH{_x3D|{^(KYCE}pZp8*?n0NJse zSCc|NrbnS@e7u@4bxL!>ahi1mat>nwjdr3V4+6QRhUdnD8zDE|{q{NKGldU#^VlPg&yq1T!1* z3)W*tvZ8dF`?_|vcmnTc*{9LMj8HfKD6>F4=C|?pD?hqFdinTdrZ@5vB}))^C-xl|_lrGkh<;`+jkn=+ez0)4mCN=63tuw)j_&TgPm4T+ z7XnKXnrKbEGPA)H# z{D+$2kdfJ7%8L{?{Eg!EgM;d}V|a9mPv5I`ajTrZ!EO+~n-Xo=-X=Q$Dp-&o+J@~w zYCf}U=KOayN8U`KF)Yb`;{3YhGqR#exm_ZyX2rX%5yv!n^s-@7MjLt0`nL?}M zhZ5mhd8Fhm*lxJNJc&zBeBKqZ9ib~St1bu(@CC6s7RAi)B_e${1}S)>o1as|%2#$= zkH6Cd17<7|;ph(MwTNturO0 zF*EoPYV3I0hAKz1z0}lpR0KQ_S6{uMd)tEEZ#$QFS&BT1Y#s+@&P}h?zI_{mCQ*{j z$>VxBz`ab&gAQ?E_&kG7PO-z?^vS;X3F}*SOtoO}baRy!15r1fXw}~rj>HAWA(O_p zdeKjNnR1=%`~`+TxZ&~2F;lg2+t@LD>}@kqYt44;+~GXTo}Zr|aCaVr zdkp*#G$JP`#+MuTWtwP6;O6{fCK>BGlX$$j6tC+&oiWfJJ7PjFK`~}>B zNPqO9<09o>MBqK9N+#!pDZ$!t!@qHNFv)2|e4c8KF|)fXCY;o7Vk8ikdm(+hs4Mwu zYJizAsh*LC2Nyp(@(&?b0Ie}Tv|r~7L9Ju-Bud>C0(VApVJJhof2e@rJO2mqPnLN9 zkr~!$eIaCsB(^qd2Gl$+kkoNv;kHt}G(V3U`d*#efL|}qx`^d>iz9*a0jFP#SG*93 z;s>BYYdx}96n$)hNIez%*+a88>2PqKNbgXRI2jB#DF8xybqMi?wN6xbD@75tii7S} zHAEZR7QGwbKujW+fTI+8iw|v~3oc?ulGEJ-Jkvko_ZF9PZ}mQ4w~u+fwxCE*F>`YI z4dUb4mM$(h{SCczbQdEaS4E7KWMk2K?ulLzaA` zBDMBs?WSlJzAP8|L+MxatL*9P51yA|wK@||GrADcFvEJ?^h67Hve&Qka&nw?70^sb z?5Ct80+?+i?F_3rRF-}|QqcQB7J$nb;Qjr>+^BgqWPTy*;Ga6t@wnWn%ka6Y$lBwO z=!JyaXmQS6!@1`mnAUT!uLMm!8@z^Fi`hheO-Q#l&x=^8CMyWEqc1@8`KA=r-e}iz z&sTF6(ButpU#;>Zv={iG`y9;Cc=&=Ae~!~y;3RZcse#$-kJag()>K^#o@*(>G#jbc zCfhA9va`tBx464`2EVB8}ANYIw`>nmKyC{d0cu<9>r7q!UuchE?9-%ou&qto4t;v3()r2{6x*!F1oWsAZ z=3{f_gzw2;zdmLRZafA^hJMV4FfJti;37&`3RV>}O1Q1lS5mthtv;aDh*pGs^XZFV zh#T?TDeh}qkq02$0pc6LhzEF+pS=a=Sdt2!>5v;s)@9NK-0!FW^^F#<_Zn|KVBz}_n=uvOV&V~H@#bhkY1SslK?>zd_70MY~CZ)HV^&CFsVBY)(U(RV^b8WdaE% zH`(@thrdKUrPC7lN!y!QQQmO79%oG&rg~ct249KYhfOX))UH}7vgXrtlNaijjq@r0 z=w;v8aT%QyS#1-4tfx`ODlwc=)Z7opaiPj&sQ2L4Fl2r=e)p#Tml7W4eP-a*%i0A& zf!My%wc|M70P{z-qAte99BEFo6Vo?-J;3?F1WWT2{_H>ObPS?|gN?%OU8&%W?hCKlqZ`v$$YaAm4;xBPIw_F1rK#}@8fy6cU z@5Hoqbx_ycAt~BeK#G$LuaS;UcXdD2jisq(O5RdsyIb1awYbb(B;vr_oJv{J-tL?4 zC)J)cV>O8XkYRBC>LS&abxmD366?Qk%BNo2P?VzYBgxi3`pZ_PnlLTX^9g(L`e@HS zU+ztSPrz_V`~gZGD5aN|4b(FvQ)Dr}SEu9?m59nQ{kaoJ)uP$MVyCNs$jRBq=SUC@ zvkfe@F&o_)kCE*}`YpMpG~auw0jU(L6)kfMrIR1)TdU+e`QhM+jIVKb5>_MySo+6W8hGOFe$-8 zX&S4VMcDvn&oAsm6ixh+T!5O*P#l#-63ZKoc|lO=8t}8V+z7~Zen2l6dfNj4kY)Tv zee9pHUx8=jZYynaf6DKP`o>A{C8aVXoTlKvw*;_M9oxXcC{}*^3At$gF)wP&m#o{W z%}(5p2wx~k8C%f+#u)H^$6O(zX|$DC)1wJ+W)qp?Od{A;{aUo7>Z49eo^Y>b zvg{?Y`r60rO>isdq1$+zlLhV*^fk*6i-o3Ce8+6-WSM(67AIB#wCo>cl%g3>m6N&R z;}}Y7mP#g^#H^84W^gs#2^<-Q+n3ID!!D44dXO$=02Fvd7bzHSX7;{cpiZuE)alAM^4KeUAdkqI zP}h9`j{~%^5jBy-nas(hdz2X7q<@-F^Rq5^9LnNINrqDHL9PzFWKX~g*rTX3TRKmm z4zw553|&QW%wiwpM7`mY>%dys!>=j&+S9{p6NM}T&yT)9KZ~LLhf;}?FZohN%y!8- zRwP0m#W|c4{o!m{D046tv0+UbRoS>T0K89ITQFXJE#Fz+_y*BQvb)>f^_cWiO8^n);6tB%*X1ME;jV+#Gr=MfBGVPgqlM zKRS{y{#Ajp`u{L7Rp}7^yTmHrm_oqs*7zu|<~$!|EZ&?&aDI?jVQGDBVbj_I(YYtU zDX^#S4&&08<DVuQ-dsg@529b-cQ9FXj8Fv=C|`(klOsVE<5?WXz623aAHRb(s+AhgajLfh@%rSGL< z4JE}dO$NE?uBGY?i(+!Yk7zyOgACYzSJW4HYokR_;r4EAhzAq~7HhKo1ce+ijUkZ9 zL~P0|@H&XZ))8Kms#qV;Hh2;m7%ngK6)+D=QytNA(y7t}$ANOH)&^fp`LNeJm(|q0W-y>cPWRu;%vI zA54UuC}&J?BH+YcsY?ki%ErTs6UStKl9g8K^61I)on@t zy%9l8_-E&VhB&H|$k zHBpNI=nrW=q2_IvaWER+A!~f53FziAftM|UmPdbay0v&XtO~{az1fZXB!w3%3;(rI zVT(S0&@xjay#U)zUOurKi9&D|L2f z3pv^*?ejFJy`a%Z!Gw^xFj|kE16ymW-C2k zx?1vfev`6Cc$~}Zs3N2(^H@sh&NLiX`s1_rhI{yRT<70W{dw}8#wd4{-akRQDwZCt zQWHEVd?pClv;AFjCQ;!T$c}F?RKGVQ3MG8N^`~cQ+B|Jsp&Iot>YP_<^$=S}eMQnO zi%c)Cj?=nrTCQJ`(=I~u(cAkDfF7Wv0e=V=B!|Vu!Drv7?$Pt72dakf;cLJF@!oiQeN)f7X5A1AIFeXGO@B4%jr742b`=E2P16(EM&A! z0WqpSy`J@xRrLHKuS^PN$V`(HeVE*;x9D!+P5RaBpoa>c5B}Cq2R|KMpDF5Z3jAY| zNC(Vsn^)F@A1Ay?wwgt-*Fwk~=e8}jvatx(d4cy7JwNn|Nm7eW+E^mVV*PBW|yo}UfZ%QcTZ)QtUS z;A#7qeSt(Z`VYVc^i@u$x6}zTmTx1aFt;ov_Kwz0AE;Co1k#FeC7 z#*9`8vAjJ$)q%!@n2}Y(x09L~K)~rFShAvwwW|(MdhhK~KdBpSFwxZ*#p`Ujtjk+6 zEqR4L%P3(JxWfGt=7SkCI__OW!gls^W@Km}ij_=ww%-?7uX)-*@#OoL$9p%e z%r)6vq@g0V*D~2U6jQ05ZzXwS!R`M)UalA4fV*7GM|fqTfUE2`FJ#MiPmm zWGl4MTk76BG946e*<`^PDVgMX?tCh2CWx}A8AR*|jnBx+U7mJy{G}4wZ7}Z5a(oQf zef#^8#gzjD8UaAe`r+N-4-7L!Rj{xGw3A4AZnF+H`4Paa1N+~*Q`huBp)$&Z%(-t0 zhI$TmqkKZNFflQZM%YuNDan(qN22$cING)BLT|^$O245U1gf{?;Gn&&?94Pu#ToA^ zHP?`pPf@jQHsq{yCCIC_eBiMTyvj<#y)?>xp3uu*_Lm(aB zcEgk}59|)63Lyj2hP1g9@jjkMFejf*-!A6b%8JXamRc9X&6xo<0!*vlwT`%$6->$s z0sFc=P2jM@$oBL7)xmY$m3-WV0QIu@h%EPrfao$eiG}}lx#sT+{HFW;1X;-r zf#TVy;bd6^YL27RMAL7w!dGj$NWH&FFHtlla18>Lf6Z9R12B#6{GH{}z^t6gS=v>X z0eWXjQA94vXnY;=|A>dphyC`KG^tpqv0c3jv_lsVGH>SCX~y@{;+o!aL;Jbkqb06{A^vDwx*w1H@f(c|4ixPTv3 za1s)^WVF1j3qFhM|K#8i+P5mOXl(S;J_n)ZE3W+f{Jm|F17ZhtOhHnyMrbc}4o(AQ zd4PtA&ZdG1O2yLem|v&)fnO75m6yo%>S1|ktzhB!)^OBYdDKa1;L1ux9ivO`h}I~H z`XKqwX@imWy|YgpXmr`}&J$9<>s^jHgHRw;pDi7q+_+BZL{`6@LDt4|UdGNf`7M}Q zG-{5GL(>P{6zri4xT{a>Fh<^fHNbk6rIr9W#6b}wxr;TV3jaAM*TU4@=_N@V>J+-~ zfTVQQzZ9~GC}q$%9HJZ)Ahq+#?>a15peNK?ZMAT}|Hi^sqZ*+-pynl;#i{9)3F_43 zV?e6oX{LYjgn3E(_E)5V&@eT85vf1FsgNvR<}0cpX zx2B7_dwW~=u;?%Ng|VyDwonc26s6ZbioLhzQRh?Wouad~qYM6uEVHObyA;9{=NL< zBX@ywA;>{sDFnK>VHY1y&or)wviwi7o37)nRH1sI!u^A&4!~OzWFg(i0^0uh_R{Bo zXQC{!xY+q}lD!F7vfGJCc)P#holCR8*SEFkLv;`BN8rnSe!lhkwO1Lq6;6Nss{htR zntoy|Vi9JHZtJp4Vu)WoDf*Qq3PN@ev)mwne4$R&$!n3lW~yl;HOn7ME;@lqX^e3Y zm|`qo;giCy!X6`H`lA8(<;?&bvMI`&R>c)+VD(-<4^z!~xB0V2K!B1g@LvRXAyDU& z%fSBl!ZC}3t~-jwAqgmg|7thLwsu2IE|B}`yK8c!dIyfj1Cu@CDs;QL^*3$QI4qto z%eWez+Xrb0-8pS%p&z~1nou!3k8pHu`7aAanW1)pQ||@l&7kSW5lNay4{~+nPiJ=% z*S-e~oR9S$XF-g;C>EAYv{=u@-&wbdi15VW82{6F3^*fY*^8pelZ96he(fska z$`LGofS#mzi{3zTWNa+5-Tr~4E4Wwwr&*Wwk|GCSO_SemH5H?KBbbwNAJEBRNUG;f z^gnD?Woo;V_fIo2CIQ6CIKbG=g5fMB}P#&6ud({4RWgV|>=1 zpJ_&36+aCv&4+LBaJcj}f$`j-FqpP9HB~i%4=U1ul?)CUr1TcpUPSw*ZnR21Ytck z{xn>19TkqHRpZfAm^uGA+la2ic0H?K8TmOQ*unNEVuoj@Pv6(j0kEx8=mZF?se+)F zoobzy!%`2hj$_AiOIb?^c=MTiirOe092ZANM}X4;r{Km5dqcW+m1+eQ^9YNZ&|hSn zqp{8H*T!#eY?I1MG8>D*-BP|9q&t5|Md=eBL{&4D${R+k%L3cIytbw$34O?zC?u;k z`3yEr3Ej#boY+aLwXPqT%p~=uWLJ;hQ8jT(GAQtURj-cvp%93*LL0;LR~T;BK=<(2 z2aVRPLuS^?!rt8;l)7?*~f5Qsl)tW8mJ8QmQE+OBiSx=D-T- zEeRkyS}9)RyDS>f!qQ9Vtr>LG-6SfGI_7sUpv+nC-@;jC>X8;SE~{Ghtjd>l`lh0D zKU{uubf}4vqhewWV!Yw5%l_6Dc!`|05rbGk^1C1brKkpvJ#DS(FTY(rZUlF zL+znBVOPHb!msHj)Yx!#Z@%IzVto-gzfL9D6%bPJo^dG{Gj2(G>7I9Bhq*H*E_eS7pBl2Q34lVe12W?6?{V(vdQRdB=Gp9zW(f)hpH?%2*SrhZ1 zn?TU(P*IktRrO3=moLvY2)5RfT6goXV-8ko44iO!*h!tiqx0Z>hr9`Npy`}Hhc`Rn z!0E#$@$>NT0Ja}NL8x*mA`IiJCWTxQuEro*9UpcS?h{3Y1chBLR<6 z(-z2&zh9od9tra$XtOC=b@ODD1nW^p4e!}>_w-mUt*@`&S)U&rG3KYgb%y-izsow3 z6mJN>`*nMs4SWni{8?^(zEsEh^|)JIL(*GDf!LVd9SKs>OZsdwbIIf^waKrdg5kw} zKQS$Iy>zY%xn5f!EAC6aisa5-DVyA{7;nuJ*FgN1tSf(N#ohqT-oo+zTy+!KMv37O z`19~k`rJ6hK4ko&qz!P-<-jE=g{LOBCGSz>7R{{~3&aIzjbK9<_TPaB&QLWly8}x$ zb8V#qf`xClEvS}l-Ob$!geTl<@J|Q4xf5IsQ6d;0NWxsxP+(=(ATWDDJNya5>ltnG z!drvQfgDsS742q?-{s;Kf0uF)658-wg0(QS3EHRAa<5<9@*g}EbLY==vCcDo#1g4F z<`R1?R(E4~?X4jM(;%y3>)mn&T9B-s|n^~`VO59c~{x$#`WiAUW%a!0rvfku$p^4V_e_71LJZz6!t?T-uZ#YWVNY>)(I(J&o^z3E%E zdgfG)p#vS>CyVIhjUb3N!}dy3MVWG{BU`D4Z7b}z#0sD^0V1=1?g#&Z0tCiEm1&Ea zQfNfw{`Q9(2{$e}ZO$SJPvZ(a0m7q*|4QVw=RgYua`YUx6P~Y+)K-Vv&aNad*{1_v zUqyfHeb8sUS*#Yc$q;S3jwsD7dJmh`H8g}rWMD=%oP|@0GLm|lHMs)&{`=kI^}G`J zBus|8V-&P;nSU;{ypr5ONvX(GA2otjcpNVr@A)VnrVl_V%XrgdC&_aJLHtX&*4LGP zz^`$-1`m)6Fk|ineh_4Z<`rgZtd>3AT@>M;{8Ji`27&W>6ZER!dKz05 z8&?b{JZXG%r$@g9CPmC?IF+myCP8Z7i*h|g-#{_7Meq6Cjr8DHaA;s|EH1mlcyX<> zcPB%_Al4{W)}RluG1V-nj#)RSyZWT_%aMu;|B@^|C`p?MsJWi~a%lP~NEo52+a)OY zAB+j~WT&;pU@m(m(abZ6kZkGl>>Se)9of`q&0Ba?w$Z}~VKn!7Mt7fA5%}H2oB&lj zM6Hu{G_pnkRt@HfzA3=#p;_diln-6{rQd010|xCzq2kw~JdI~IjpKt+*n0KzWmU;; zzy)<~Lk0D7{#H);;zMClY27ncK_&mlds$wWk;C74IkNT*f3p4%E$PbGi=}>)I7e=r znaZ#fum6wCkAFwfyI1cx8yec?IyFHt3eXu)HpR--u3| zA|6DbzMvygeV36H4M$5N8~a6OfTQ|xNgTt6RMRDmcZ+-XYYPmT3BMgC-GqSD^xH6! zJGg(yT!wY8U`&plv+2a`)R}pT*RxiANaM(EB_r!Pvi5+c*RmD(F?Y_Oe!!k4BpVc3 zZQ1*0)lWX#GyORN<74#Pu1lRlQuY%dP77}V& zt+4}kA-@#1fO!(resF|l9x~@X_Z%}ymo=4f2r*uHJ+KHR8S1Wo{B19;$XRc8$=Z}< z+Eg>a)5j8rnOH7fn-y5bTZ)n@LyXk5>9BttRi5l@s-I)v8M8=H)$!YeI|8oc^R)Ig zl)jLb$o6;syQFz%NptR|#}<9|mgyvBfq zba4ew9JKJC{5QTQDG^u4^d}cvWMRfchmlgvTs9iXb#RstAUfvld1UP+Qx%^xwJOrE za)uXEzSAEk;!`Ln~9ff8=_1zM`)^ejnKHgZ7^7rD>pq;TJRNL~D z?Z8N0d@OQJ{v{e1M7+=%XtxQ_f0-h%!W_$w$#$|DAw;pcPNe`s^1w+cUz^OE7@qMd zww|gN$f93bY3)#H;%ayHT0Ro_9*EyszvvVA>HL@p-O7=X_X5s??N|d#5U1wXDr)zr z(K%o!;n};HQZ2>&oP+7&Tz8^u4YesMG=D+Pdv^;w3pNav5@HyyQk2Sv5w(5+#Zo(> z-uz+OPJaa;f#m}TE-!C$a})I@W53?*qv#H{`*9-?~QQh#ybF145c$I?YEWS=6U?)0RZ#!+>wgP_Zl#1f-px7^_0UlICY^4!nM`RyIzIt<(LPwH zW{6`(C*VW)3sz}!NAFE73Cv?Sh#6)WxViYLz+fsg;Gq0hV*Bc!!^Y0e4lpTv`qlbF zUlH7a7JQ=xn}8t$29nN0BrBi7zf4DB11sDIJofmXWqf%mkOvt4HH6tdXVxBzZ?l*3 zl=*(ytDd%#UEqol#9-5^(79>|Q(_kU&UCpQ?{jyKW2caWfSneCHq(Vw5abfEo__>I%SVaA3H zkKkMe%-*eMkFMa|cadY`a<<-s@_RN}mDdSP7fD~aIp35~Og&CrQ+3D%fyJUQQ+~DP zM!Efy>ho8g3!rvBKeNQ~k8nm&{`{y^G;Jz9!R~BZ{wSc8djEqdQBpg>==F=<_M@yh zU1zeZYU1AajDq5fRkz2PmP*>)f}_eWx^Xdos_u&gvuB)4qdPOy_#FSjb&}55sSwAU zLn{>*8YC>GC$8t*$;+mXKaS3bWCiWkrMh`%s@*XBr`RUJhx3}TX)$1^FaXQawDHmJ zub3~cJ#}2Ag#kVUJtg8!hwn_y?fHN$)b0r&+LOwEXI>s>fJV0=`+MC#0W86+%wgAO2_Bt%Fgp3lfWWR*^546uL)r%NwN@hS750xlDxP` z3njh30C$)kUgJqTDr3~dHaq7<4lhP7pnOy~AW2cL{2=J{cbnY%>r5RBIIyAb^zxdK zvQ6KGj+{kUI42qL(RK)6CsbMuN+&Q#X49JP-E?g7=!nxs3OFaoJum2HYl^)WvzG~x zyszwKiZk}FO;Gm|^n!%4!vD)=|EI>Ap2qYk3QkxM^I!&yK0dCjf@jI7XAf}n)aYh2L9{MkEe31_S@%$LTWerHx<9hB;4R1@XIfZ}K4|2P8XoaxqA-uRufu}3qc{AWQQ%4e1>M5cP|Ng@SIW3AzxB(-o0p5* zuP@|D;^fWSE2@>3dbm9{7vQ;xFN29DU)bBv@7kd4*wqzfAf`QbO4{6wGd)C3i#2jA z49Y{Me+cY1$a7s*&h25+GSL0wK3~og)!1cFeq7g{s?>LaIFM)h{p8OLwA;Sd_bM%g z#tXc%w^2Yd_XAn47Qx3F-}?)TqYb~DBc^9Q8Jgp5wfONBd2=rS zTg0YAu^ObU>LM5^W_0J9>N#AvdQz;G@AwKp-s3aqO8}7%v?lAVvp%4`5hRw)P8+t^4l~pC)WCBzhr~gZYefDDbc~4{^lt& zPF3#YS5Hx7z#hG`CRHlrzOYzW7qvy#^G6vcuMuNT>~Si4L{5Ibk&)3%Io@~4|VD?=a+wRvdmOM1MpL?h)cSVWQVn`+Y>dB5&r_mfs zS9y=PekZP0s~dY1QCnHhu3pVr7?}McJ9HB5bE1u=Sck(Yo^uSQ1 z?WoN|e4W!9_#{yv{B#tDc0QTcG69nzcvnQ# ztLed>=WT3=y5)Ub!iGH=GobM60nT)yYLuvHtTxk-i7kEIttiW#X0~VMIrIML5wT*%)W|Pto22C= z%t-Xbc@sLni$c%;G86+;Z?FAjQZw@uO@54iua|7glaK9Ew)M#=RjO4Mx*U3qqCNCi z!t)~w_A+-$4oU!of=&ZlD)qn2Q}{*+5~yCh)eWt%OO=g97uA~we!T_j7dH+iniDY$ zk0qx*nypmzFOMaUemTdIpZpHG9b_h*n2AI?_LIo6rZ+GXoA&8`qql(l80hV5e1?F|xTwwmnW=NtX!k9)r^yVq9JrE5FRo zrtP{6+U>#5Zu5?xyo7wfwlB0eXEdXq?dX&6_t{2%KEwu5Y%iSR6uo6h+J)JKwo33H zhI66HjVT@5iGk`@6L_krN$yfobfb#-w$H+mJgBi#1ngV6w1GX%Ias$&S*=GH?bKhF zNENZa6#2cClrCTlf2s$6!h*W!OxMdPK2GlAa|%&M%)gO#3aKsUqH?m zQ*z=NJ($W5Yn?&+8XJ8xQ{rsR9`dJM#0!5nb+ z=g-n>KP@bVH&1KDP5t%0q9J1B2He08XI-iee9!iyAcL>~JDcL(EV`ck+l)9(Tv`pH zB{e1rg5Dm7gim%cle*){;Y+L&9#yH#n8ygVAh8)}(@QM5W< zdY_KRYWI!Gn_J8U1dd*JE4#RX;J08HdvF(_)?~Iah(y%+~v%)6q9^CccM1yptvA% z+fuuR3ra54D|G!ULGroTfdJlI7)l?47hLK&CS}?sX!Sc`wGI0BOGCN=niR0w%qN3* zcevdW4;7}kTh$GcPHBF0!a?$nRz1fvd@4RekX2kdJ2EQcd^)(cRwbO~hEb!(oN`(A zXQ!tXKbf`Y`r7~F0$9RLltQLT?&sDu`rlTJ!wGY7lJ=CdbP!?6L$>kkNn6)5*cB1$ zJu~<$%R^zVL+1XKv%|wfz-whC==Nk&?bLb4hqUUxzOr&Z^6ps_j@T%cGhOul;xg02@s9VYO_f>Cj%i^Qan|sd6<~yRH9n49nXm2GoV3ngHZY9CYVhC6ul$mb0WAj!}mec9ubM*cXN&s z8~|7~(J?R~l&locM|aPkSjEx7RkSoAa zgu-+xGq1oT-2QlUXtp>kaPjd02t1vqs9!1*;L>i2acO5rjp*5Nf42N&YDsBG)SmrM%_BMH*o7g5Q zlFo(>C4Qus=k>BfSUP%Yzj!@YbWnwFiKzAxHlHvC zR-z$XbbnVLL(xShV_*d)t7zX{R-&m}OzLD}9VQ!!3rADW>aI)VP_T5Y@FPK!Xf0EH zRrXove)Ywp+ADAqAAGlITTSLsjWVIS^U0M3CB%oKy=`DL=EmNCh@y8FE5i7Q{X^|HZ%XPEW93z!Lf(KZxt5 z$#?7<75S8(Pp|>2X-S@#kuZvf{976ZB@G?xrCz=>W!-LU*MY|$7Y5MRb zlWa2bzwa~P=K>tiqT6*?G3Aw$GY4~L<%12Ud0MVt9B&gnsx_2gXB+ZavBgF8%H&uV_rCH3^LTb)7>A#x4RA z&}A>9rkD0=4-h8?4nGEhI;%yvrl^r}Lt{VyO@`{YcT}U=M{z36 zx7-vD#5PZ?-Dfb&_3G0ZxW3zCNqW@`oAKdC z?`t@vVyvs~(U5l*LLhGQC6e1qeM-J*Z=b<>16&ruyvs<$(A-mnEE1jF-WH7Hw>_D9 zW8>W11t|=29s3BJo(~bBA-`QXjp_B+6DD_H*9}7j(2y-`Q>eY|ik;;gc*ZkdC3E&3 zL0dxNQ8N5-KB|AByq1nxKX%u9YHW-N4w;3ximkgl?JP;)bq;%tkjKnBP!pIg(t?941sG2MukP^5*uy`k;S zux1aG7b2XRQaW)D{a|LgsGn^#?@p^u$s5V?0`=Mj7u%3Z25R_ZN^i5Y<*Ks%_@PJ7 zs^_bZmX?hx$kF?Dxb}0RRsZ9ErmsCdUd@2M5>B(!tRvGp%(o~4zb_--tDU2=+eRka z+*@Aj=X%oa7cVsZ^uh>y=~pGHZ+TNx6jGIF94u+12?d9kV7%J7e}ZU$FBl`xQ@w>l zeR6qxp%G>TZ>@utGr*Dptc<=sSp44sNO`3OpG@1iSLmLY&6j_1ql?ky5dPNT5s$7&GHrK348a(yy4nebVy6TdK#-*&p;Lme?j3C9kH zmbPOg9G^)82UM+8bd5bz(IJ1xln6WK2tRvQ}v#$Ty|VKbEM?Ksqh_ZUsGTYd4qh z1-O*o121CKW7CYMwXaXvq9eWbq@AJ&$fz{)Ft@7Le%j@@-|CqWqR1(kP+;K`X(}d` z8B0|uK0{6Qs#<@R2o>&qnQ4n+A%C~%g7AGOr+=8aPc^s;wFH>HJ-BFA+&q+TJioFM z%P`WL4y^l9&_c%r)5gH7muN`M7*I7^?rTJNzMYm*&OWYmDe}V?BQ)kDMtd}|&=fmh zhf8L|_N2l?P1yH!ebnNJvo_6_rsm~hADe{FZ@7g~vviiUBJVvej`rRe9T)vKBy;i& zJ2&ooce{Jvyq#ihL}jQa4#+GK)#{w(s^hzgC9CIC2CRO60uzbrXwqCY5UX6 zOx4m1nXDw{Qa0u&TR7d6iO{anNrR6|)WLp{vX>`*3^pbCh+X}BqtmN{x8Br+if)QY z-qH|##I!U)_rChqbH#rI3X>{lYJ&1`q_-YbbaE*Obrr(QBB_QPlBR@BJaSg~j55|l zPk;Y@>{H%BYiqgpyHCWxc$NI#z$9-ycu7lI*NDLSXO$*(f(`?eA9@s+kAZ86tav^Y zqb+^1#rtaxr;t1XR3ZR~qYM+|SjL|UR!YSvva5MBC=9un+ z|MMRKN-J$CE~FK1jCDE}c$9SlpJu&PcW0xr5AZuNUfku@?=*Dpwa7wbJS z!ePufAyaDm5Kt&Q!gF}^`U5?aXaIC6JYS+bL}Rpq^VxBB#GBCbL8}6sYh=Cn|HzM9 z^C2Ou9xFE2c$hcdS`D4lkMUv$;|Eyf?Go5lp+^>!qnZ?B2`+6o>EBHcq+Lzp>{DXL(iYGTf{I+?c(h)GvbLW0LnlIk*i}DvUzc>|ba; zZI(Pr)CO*{F7~%!#Pw(`0=1Ff$uO54jvc85<|hSei$N|2=KXV@brO z8`-U2&Pa%Jp*TGQG=Z!#SrUg6ljy$tZSDjh2KWnsAR7jmB~~;iT6iB_?SNBvJHt+F###}t-#R0k zvny**3gGdP#Wq1G#wvQpAJ8L&*N5o>H|wucDMEwqO%`oflTxS1e?Frcc9B@!7Cn{dtC^9enN=Q}FYu33er%y+D*|H&C z0$3TrB@LQJ68L3n;F~Oq4GDQOaSxDJ@Rv^n*V4)S544@eY;#7pV?jXgmYjsFbs+HR zLRLi9p{)?fhiSUMW*)qoz!3)eCOfWlsPMCdu7k_T@o_nG{M;vLt+zmw{vRXx(G9Z( zvx1^E?Gb>auoV%jY|LmRnYpa+7_6=dRMlY}|H3S_sdS?_WWKn4&N z@0^s}e1MVXQ|sgIsX(PaqDLSWFvX4DG8Ovt)=viqJ5gUAk?9gXjqMc=)KrADv7*MG z>7(>}0&Qd;E)ist%{ZwV)@+NJDxV^ z>?_z;Djc+&E2K#c;fzTQ=v5l@;e^gk249e|t0Trv-@4~#`=nkDl&;Y5yh)lq=zZf@ zGFl!uHc9V>D4s(2xF(znjR}+r(RQ&%p9yGWz6)EwuYIj1^i1tJE|L9>)k~5?RqJh& zXwT$Puo#YguAYW2PZ!l@cfCoNNoYpDqp%F7aQa09KUU{N_~lWTKxX8*fO_3(>Dbsy zt#d+b%8PzfpRXOBUQ|(B@N2Az)_81-KK$_Xfrf7uG42>5b+oVdyLD>v%85$V#RC_e zPe=Se^2)FF`V`GIADzB~xUq6=*q4Z<7x7fY)w}PZVQX zNHb?pwIj(H5t{u~Psdy9iMb2=%4(PYmrEZo)HY;QBM=|Lvsaq1q- zIFbY7)FF)x36pDIesAGnXZKb-uJ3pQh$p~VGM{!}?Rf@3zU|%m@hf{nY3^E1Zv3q6 zPd|X_0{ys#@Y8*DRrJUXONf6!n- z|IW~iJ&vJeu)5yTK$WMhx|-3U@MwWlpQF2XL4QHju&}ja%15u(-0}<@`~TF$TUY-{ z5I`6?-qcQS9bxjjxCS8en|0w$JK}+NBx)@m{ur&|EEO`&?nY0YVS;WBec?n?6}L<2 z$EN<+hl@e=qi^%&!T06#zvQ!DDosi*4qYk}MEYEW0O^XtXKi6WmUlWM5^_BznN-g1 z4_(LVL_GDPiP6l`u=*>YfHC(#+?0GN*ZaGw=#Ow6>2ltroTy$(j8C)M#D40$`Megi z8KSc4^}0idQ+qTu>?RPh%cnbY89%l(c;{l(I$k}n(2UN`-1+P+oDK)2iera@re@fC z+l`9Z^c=mo*YJ1)j7Ji`F9gOac&s+{15RG5hO!28s($(%o*2!S*d@pv*S^OHsDA!x zC=hmmIwmA@g>^7~29L3QK4Mg#mBx!jl5!NBmlZ5sSpk!-b>-omaolF>(929@H}|f) z4E^>|(*w@kGEP|So6=Vox|mbWx9EQ`#@f`btOD%vY)+QdD8&OmZsy~Sy{8HaWZ~Pn z^s3P%?C76M4f_wV?CSdWYaDoB>TVlQ=${K?CWFf?!pQa+xgMKh?2(&kp3C`gBMy5M z_Bacduw=OkOY7&2`WUOV9wmkmwk1=wG`GtVnJq3pW^r3?RC%bQ2(Uw!mOc`2noyUbzYiuWGFbl=;oQqe6P?n+ z1s{NA99-+a*_a8M3O{)GP^!~@j(US;W+|xv3fzDthmg=BdQgLest={HBAG?pb@9)i zEYCa%F+i)fW)u};G4__e;0CHYtFv{zJhvU0@4@{<5Bw_5+P)qIiT}(0$`GxK=h6IP z`Kx&l;S^OHL17Tv^gk)h*{;J1izjPCYZ8-*dP11aA7nfC+R5M2-$ELEaGFe5)uNU_`_ge1gDIXnX*rzzK}_ccf1v=z542neB?V)W4?#Ci0_i^1iiHSiu}@y zM#}ei{CM|qQaUQXqx_8OqsJgP3hY%f&|N>B820(rnag)Q``f+qzU#(ns2t0;HCF^7 zH!JCKE!|wX{ElwBM6B*rqXaHKbUge?uCD))D!DC}@8}>m?f#2^@)GZXhXK_;4jZxF z+tQW{+w}3^vwGSTTmwdy6khsaHEI+fhg9K%n+7O5Zxnl~xm51!Tp}T|eem7|Q;xMr z>$A`Wft#wVQ_x3PHeCZpGKdwSe140AQrrO;KE>2Q{M=2N8|;Cr@~TLlIwFg8Idg4W zOn~@&>V&4x#rF=^({aEmROe}yF2x^e6(Z3sudD!%_P+?~0FWjCBy1qE!#>T^Yp8)2 zTY?R(tyWvWc%s!n-1P(JpDjZ-9%EnMm%VIXFhvaX0ad1}^YWx?cKVSyh)#3{FCTz@ z?yrwPD(5dSt%T$iNsJ6ruxQZYeX%ifr$(um;TVMvb&?w{w49Y50EuP=Do(9orq>@~q&FI*> z*BWVE$o9&gX0QVZ)(nsyU35J!yxap<58!ewY>P(F*93k{b&8op?;@S_BewMP$gjr$ zMMr+M9!k}qR+Q93_^l1!DT;h*oI{t(b)&o?V}FVBN(gVDqTOF&7KnUT@%aea7y zzuY2aR@Ja`981L6m(U^j-P(Dn7$4<@KE64nhl2-pl7rs}2Ju!iIa@&vdVd!;;k5FJ zLO8OPJ|(W+DX}QLg(b3PNm1qP*J8M`0*C3GFkVuDY`utMm8Z;@AJl3)3?hPSl~pJ= z>1oAq;{nMqk5JS3TRFdYM0Vf8>=2gE&(|D`Yx|#G8gia(wVmM2xXtd{M6#IA054w- zuWR`;7%g>0K}%v+_4OqARa_M(E6S(+)RJumyKl;*KP}SK>+acEytTUD@{qu04`ii{ zHGF7vKsCgsWT#EACUGvUf=xgS3G0?z z8xysOnL>}5hTH>$%y?OwWn1|?UOX_nNfC|?c}*4ty+Jx9Cbsn!oea~1H2(K-xZr7P z^TH`0i32(D#*7>}69_WpYD2Ry%uZJV#)mc~9x3q&I=g5bW59@M1u)Hg6YsN(Q^GE`Ueb^qf&)&&g+DIKc1k z>9GOq<69_GYp^+l(35}WH6jBDaP04k6mGs&<8De|m{Qr7+1~XVJcysvG9c<1B0(tM z)kMiDB|lrXmNZ{?v1xy1`jtXik*^aq%xSlCYSZCvK}8)fkVQ=+C)b2Vl8mz}F*!2g z+mCHSFo^+INH>CK_^Bvo8qCb92-NZ+lb%RFakai{U-N=t=0pZo2k=gRD+h_2NI{R&SQ4gc)-MxKnj{}JCKUIB6xYJpE|7N>;5 zRN9hCJabR*eAFu&92|$^NyoZU`Zw?Fvq(q57~HY%)})8-=BfDZ3++h3uMbuNsZ)P+ zhE`KCCCZ+u4dD`_X|qd~diZdN(|RfIf(kD>TI~yw1{^VBW74z8aB&Ta)~31-lsVek zpwaT+S0DZnp#@L$+v8nq$JAy(a;0@vdrykM^Ogd9N4l#4O$K6ET*nO0WR&c7lJv&z z8RnROdt^Xt9v;XSXgL7aX~%q&2NR6*8aLemoO}8^w!|uVY_)HyD{NC7dzo|@ji6>7 zn7D=b_>c|nwTQ!X$mt2U|E>A{lR_u4ZS4XdK=?a)&e<oZvK_BG?z<)`M<(c&@fE zBr@&ofr`2H*Y+n^KUDObD-H8@fivO1A{kI|fD2X0!Y1rsc~S65IeN!Vq`~oSU@q~g zZc}c{U$f?J@ruJCVzmJ2Gtzhu#{)2Tfh=Gfl~m3@@-~g?JaU$0lEtF4Zgg_h?SIBQ z&F%qn1<(+{_Ka$O)k!0IKdeRKs@1+f4{*cawUO)Qi)rcJXGfi?3?x*8gNpBOv@z1zzlLLM2pHMd(q zHZ+ZpLYM2|oujJBZR;O!1b4)zLI?#$I56x(P&jDzdKEi+DWXtRmw_b|L)Gm|MVMce zBZR(~U==s5Q%1RnN?)CRb9N*z*98jeMdiPcs#0#*DGbqX!VjN9sZs3>M4cN6EHXFk zMB2eiVV={_b5wnD70sy5rrY%YR*M2){?nwKeZ7k7e(B3QC_ob9+tr%-Y0@MGldZ180(xaUzp8s%A4 z5bDORvpv+;ltnn*PMOO6y`9|cOR4h=1!|3XSu@p_JuW$#T4?k$phSX=r&}mZqt<26 zoai7oSSAxj87hmqUOfD^mU7j@-5Kpfmc!bDq!cdcw(%s>>}K=chOMc3a3aF5{(Q|) zT!61_c^y8c&%a+mhA9-9V}+ef#KU1Buhv_97xsc>RUeIDFCJs>R~l2iL<4rOpvNvocb)5G_8-z!~=M?|rQ2L>r>`Qm~@+Tr#F;y5gUY50Wv}ap$k1nw1epi~^(7V?9emST6yq6*EZlOw zQ;m_dee%LZcG*IN-?gTl%?qP{g%~GMF+jQVkT443!!Ow1<>f5zWGdz%bq?g3Pvhoz zvTun=(IblUg`XjhKJv|Oy(S8cGFynPZFp!*q6dg({5%_UEUA71zTN!fRHpPEvkl5&ohtv{{4GE zp``u~qxy+F6)G=`B=YDiN*~>y`}9r(gRf^YrGerbbc=zQ9sofffq=Jz1B=O+9M_k0 z0<6?vqvyQ;(*nFs9N@)QV%8-nTO z_#o-mX*}4$C>IWzo5~J{ZXjFs(RPv=SDr>-BY8rrc%=7GMdWBi^`AT8y#4~VUh-X= z6Q&SUZ-18}0B+~8iF{4ELZ*IywAC*|lGr7Z#jA8AdiTXI`s2Ptql8ajC)d%TNf@!@ z-;xVvLo3tGV3$1Ir{4)s*s{dK-XbN^B|QD6O*y6MK17Bf^OM-qibU3HvAJ8}P8SEHi=hs>wP zmo613=_{^Gw(c@>_5%(L*QpW6ZjrL-Fy5+)7{yj4TIL>ZzRL>EhbI{h!8Mq;V>{k` ziYBxDPw63*knQ_?NBnXd@*v&@qcsx`$|AMojF>!X{*wPbOh(ManApN%_BUuz&Y{FR zY}WwW1NVQR;x-0yPqE`*o={eH_DW?+=y|uEuI~SjDXcyt>^eafM&aV3x2?B>{W99F zzNJx|ItPPP*;J_leM7wWFK@Q5Ph6pX=d9r@D+L|XvS$kavg3?ShW#Y7dl@4f zONaSp{?L*|g+fRN+z6DBkyvow!hUIo3W;F)ISkD=>ct`T2Ii9&gx5PLQR#N?9nAoN zCpb$3Z;?A#mDOcqoj=b16}$7IG1QK-{}vIl?1ekMq^1t1#nH*7|6xyTSLWK(ZJXg*{I@EhEPhsrK=TGn_Y$_ds%-;3scs~2%^O>Vy44*@qjdpT2Sa@ z4deJb@8C5z4?#d&?_D(24&Jo*b*ja2aRdVF!0^x4E{vDtCbHcH*;eWl;q+W6mLzAP{BeK0!G!kbG-hzEzCLY@e`_sS%rifBJ8*;Km`zUj0bcq%vDNHYtNrHr)1q2M2}!- zbVZ78eg=r)hZSkTWJxF3EK0dewers-!;dnoFxO%+{LFOOpRJUhvS14)dH~7HOQtcm<9$(9M z3#4^NJa|dqP+vy0^$v{m+5>0)c#Q=maAx~FT`zzF?K_$FZi-Hq9w=iUxbd5X5@;~q zDv5OD$5h^Kp}D!xjV$(p2JH?sjMj=0ydeD)66Bl&B}4vkoy#use-a_QAO!H+^&s#A z5#8|f^45?wR?w_rhN)%K{%L2CKO4J`iAPdyQxT<@cW!h)?*$A(3@Zw5tZ2TihbAfH z=LtXt%+;`|UQY;(o#Q;ScB#j8pzY_WFdvV$zW;7mwxl?NB4Au3vn}&uv1-hvjh)($ zUFALqV;<*4Hfkds^J6_{qL>06!N0EQd;RhiKcigYo%qs03l+_UHQ~tZx3~MoP!3bB zz&qo{D`c`I%Q+K@UFYR+2YKr!Iw!}jjAD{^F{v~}+euEAYE4!O>6a!zS@Ay6fFS*j zeWXAbS076o>NU>Dbzg{B+#Z*h4P6vUl*S!G+VFuxS!v~6Q3mQLdh%Qt?Q!{7RK-e} z&LQv|@Z1h5TgKq9Xc6wUrz(7>*+%!%!hfwgKa)wb&%>f`KtSaH_CK zN$R+F z=fN#ljmVe2HQBAdcP}ocEhKJir3{t!z{VmBJm8`)|D*4)+)}>4 zjd1sPN9yjqPG{1Pcvs;12_$-xkjdb+{tNaEoFvm927KP#TCCAgqij?(ux0YF{4x5e z7_LxGE`qO<*8m+wNl%+8fYl8R4b-TujPEV|01Xf7W)BOtOM(SQfgtUuM1%TrBB=Ug zbQwZ^IIg$~>?`dpEe;YLboEkRp|(G5FQP-b#=OP+E(hvytl!H!_X}Z(5_ly^y>UZ6 z!;7|{Aqt=h*}CI3qs|?Ro%g((5EDYNoYri;i+k7L_j_{q!*x`pLeFsaX2MWhU%E*3 zt({-1h+Q7HJ1rqqBO`*gys6mxUom5O(0n)zBUbxst31^W^Bwx#h~>IP_5-;zvk|X< zD&|$6%;qyYiVIrn7PF<_oZPiy!BYCxKOAL!L0s>`NZnI<`szJ!i9%+aXm+M*z-JoD z_KS@R^BUOwwsx5`QV#73V0QKG| z&|HPvDSFo}HB;z*gFh9ng)XhFto#>B^PVE-<5(pY={LX{FSn`N8z@dWEBPFv|2aF;hAP)tL4f^n7`CJCDp^CXrZW!OG~^00u0KQ zq;G3D*h)irKsfsOxAJGmDW$)B(m(=jJmr?RODcM*(u~HkR4*X-fEaCwV@+w08ox4< zs4-V%J(xh6@uc^Mz`CA`(P;}=!>wPjzc|&FsGlg5-6j=?re6T*7qIf>%NK?YT|%v@ zadYz&Y?9NH6V0rYEl|+qz8#;N_sOOvBQp~uK+{t5Lm<-s1q5DPTs*!!djn%4;Fn$A z=Q)u|F^cbibhX@!VMiv>P5NIYQ7Pcd>+9%%|Joul2jx#6e;tcuddIiT(L=sFFEN0d zpb(}V?Ckj-ACP_=f|U^QO%QQ&EXh&7GPUyU=CW`d7|I)14|u2^@lfr4f}K4U#HV@Q zyw*yV|6a5n9jbD=Szj@`m}aq=^GYZ~=`J;SY<)zgmf!UzOe z$ybl=1>dU;_7QU{G|M@LtOlFB27U>eYsXqhe2A;q8Ko#usyZMt;msu?$iPO~&NrF+ zkQSC`M9PAqfY|T@rZO$gs!>l|^uadZFPI}ie#Npi7f{s_3;Q@vHtSvi*PJFvUOt;0@ft$)A0SB%Y5RRPU+UK?p8QL=YGa;CM>h1y{JiAE=uNqu-;?OjdW-0 z)R&={ncp$hs68}2y~ls6mJ8Y9%xJUY<=~RBSp-1=A=dlaN^F!W>J{zhCX80EOJLXn zcd4Ym|{2h#-JP|DO#0s?o9JmsJ9J(=gTC}R&TYKpT< ztz56T<^~w$^d70k-M0@91A@!V0_!#Qjo!Om_Li1#vM;aB2i19!Ou6e+H>P2f{6lrkX@gg4c7vh0Pv$QchtDo|xjQj$c z5^7)Xz}Pb%R83VI-!+Byd5bWbPgaHgRz(htt7|-wj9>-`l3UaVxmNY7THi}q$AAC$P$3#b>N=v8(%cgg z`b7nFfEVI(AQXn9bg-1XORUXtMsuJFJG|g1pf-YX3}N{U!CNYs9!<))|LX0c%6hZ7 z5VN%W>#eEKtI}Oun1#DZ7^S8x2q^_VZug7+?VX(4RVIe?Kp*cgmq`cbgq+%CwA_vN}S0q7|*?US8J?NWaZ{C-2spU+Vs!_Y#?P4nXSZ+1an% z@Y}y4OSwflDV=h^58jwS3ewjjhIUuC7eTJG&;8YK2^6?C+MZ8(E%D%AcI5iXFYS3G z{M9L+B1(g)_<5@nGIisDj(7H|>?;^yE5Y$zLej0RLi$y^X7v8DOcR#?U*H#{msL2= zCK{{WS`M3q$n0O8wXuNH;FL(y4L`XRfzRCq0=r41cI!tlj_c^;kf!I(&^`77-#Rb_ zrwm%)FlJ?C)w&xbn!NzP30SNmr2eHn0}BXHLV|c2Oy{Zs7=&opYWG0++~~3pmT0^< zT5l5$eSpw{q$oy~>xILTwqjCET^F%zU_rBkjgzk{ z>C4EhQFfM0^W zspRZCB~`rOzWB$`%379Gv z8-^4BBjkh^z)KctFLDv0>6Cw@qQo8I$Q(C+tzX7GRDTw4UTyh9BBg)0p^bCOy`0J= zCt)EUVPe>=*(r=ig_0v`;V1ZU7# z`U6CBJ;F=VL&`V|S5YPk8W9qC?%nx%D$l^veq&=pRVt!P>?X$i-S0?xM9Sx?%_nU? z3kN_|ILvTZQwJxBa4|a8zTbb17h5Nn=YAJIaa8Xxm8{MmZ^8|Nmw~_=~ub-YAIL_mGQPH#R#1W5;{U5JT<-{T|2a3aUm)c@(%MI zo_QI6sLW_{;D03(BF^?PhueS4^@G)*X9t33L7LOXDY!%!pQrLkJ#aPSY^V~lbS*cQ z!r&i8SWOGU+^8rH*ltRRG6DVUD%P5)JB5$18s$~lWR%Ca}nl(DS48izOx#-HJ!y^=b5}RLi^!iwS^By0A%g&-^vgtA|iW* zWOiJc0!W|`uGLNeGg9Pu3hsq)mf#D8XzI8A27{s z3d&-LeP4a*o?B@^9-C50H9PyZt5W|>CR<-wN_)~6;mcTpUUuCTeulRe$qcscSB?fc zVVk3aLjA8^GU(NpFUJdRq^jT0HrxrQgql$ocfiCe8G{6-{Y*+?JbzMP*3RV3C?Da zPz^@(a=eGTP|b5l#r{@$mOWwD+~svAmY5Rvd-KxQy0GGJ%+g_wF93Dzf_jVhj@u7} z?ZVU`U|25hXYNdkM~F|Sby-Tl^G!2Xo}S3S;G$=pArx|GFvKYwS)i&w&SxqIQ9H5@ z9KTr?jXtWmVPa*_7WZf>sLg599yqdbZK>4o(u-S@k*qSLTjPFx&oJHgmXX^p zC{;6fOghSi$BjhyD+drXoeS=EtQ6>LU=d@$zWPxv*eY%Haa_UdQm?J$ds|qLQ}%aS zrznz53Rw(RNf7l4J`~_NN0s+cuIq2ql*Hj`R(Xf#2HuR&>T}R%{HM-2zZ6vfe$6n3 z?eB#$!gsVnJQ%A)zc!qXHNHbz-e<_IU6C(jxgu=@EdXz5lzyC=K?N+m?2@hM)IRFy z(mQdg%B7edURnY+kSqZ74o4p0f9R*Z?Qe-A2|`G`fsDoq{XUSI5Ypc(-~*KFB5FUc_uzC zpH(C=W-c!9X7%;trmwfmP9pgfoQW19O_-sUCUEh>p1l?%Yl>y}_e?>KUwb}xb8#6! zHYKOEzW1{rHrEmboL}vY+Yw)K2Whv<$%YHoS1FXjk#*+;@En6({z3}&IS_f}3(8;| zOtH|7tPAdGSodm;ShtTK>b)@P_+j>n0-f^wXoD<}@&d~G13+zz<{))QJ)F&j>w0hk z%MRZA`SAkV1+O0n2|e|NX0-@rjkwYzWwp0qvQzf-R6N2Sn`7(i9S!USPXk{37EI$V zPUu6=^bx`ChlZR;^wbqi&k0vdhRsfcL2?M))(%?vbW9iC-iI&noir+DE3BEWyGA5= zE$F?ZBML*Za1BzN_tq8s8`kniUxvy@#}pdWYEHQb9(hkoJ2`6_wk3?e>{Vb8{4%UyL$?9s&2uT@Yq%y7k(`OhDVSDp65`lMta=B#{iYX{m}O z;XrtPC*fUSR8zhg*AD2Fn3|dbs=xI0Z(o*7%CWd2vCijl(lBC-n%ZZo$VM0?3*Vt$ za$s?;(adHtT%SesP+fafxYbo(Fn-G``Y74m4Y7yG)6l1Wm8>bV`g?8d-vM}ivtJ&I z4A4x$eCcU#4?6I^0j?P7-}93vchbeGHhf%!ml=j4k!B%2wQy$X>i%(2>&KOXbwS5=!;gY}W@{WH3<|c(G zs@0C`12#*!0va*z%;G>iRwTlXcldfrKYRv6eye%+&=KN=9&i;5*EQxNsD3?(hB zI%y@hLIkrj^@z*wn;I6C^q!}Ou&eDK63=u!NPITK*6;=-iC-$0Vldv6Nsswz<>(#n zk&FNP*JB1^Arm8X^tr%Zm1#eDCYwyE+HZY6=NCv)wvZm3}VNlQJ`|Iq}dbq-xLWmq+(mF>3=0r zF8D-wKl5Nz$Y+Zv8{7MHmN)A$-rq)X80u&iL%H%{a zC5|N6ia7hM9aj4vmreX%;J#^8Or?nIN~mCF+$(P^>7-(MFW);UX+Rs)Ht~_+4a2ch zTQ$whhNqcjW`l+hC+{xZdE$+Z-sK_&u%K|uj3?jGGAksP9+gPycnFUp3K8|A*gbo^ z+iP0$A?KDxbtA;G1sKa1%mS@5J)fphgv~Ac7|*gsuY?3?M$Qf;#n;%NIt8;~4a{^G z3dnrD3sRWXe&&DxsA#*~9S7v=(Ja^%1*7I%13n7_zl#p3v|l|uiBm+$yO3Z-s}5}p z_7#J9$KISz&h+1Ph-z$HotBZa@y`C*Vsu~>99JF!wny=oS58Ng#kq^K^VR4GH zk1glcbxWZIKL7r%f_jj;_VuegO{YH{02O6dYKbGyr-qHO`iTY)=JuYj!+u&xV|eg= ztdjbG2=x9rO%$d*>R;jE5xfYv{WY8+P}S6*6p$J6nZXy{Q8ug9i9@(yASwp}9nf?& zb^{_G%^1ie`RD~PCqFw+^8a(N!gt;m{LpsmkkDj*4ebcw-i)EODP)+=zd8jXWJwss zE3je%`UEW10F>#iPj>)+0)+O%zyN|m6RGRQBtR}~vd$~=Wn4oCrhv0}Ym59N4?q7* z?B-f}sSODTk5QQLW+NY80%qzNp^zp6cok$}HUaof zI~S0c^IdYb%t=q+`T{@i%j2FfC{+WIBP2t^Jb8OpliNAIFV9Z`mHZU%|4$2$oUbm` zw$c&!Ag7kqpYE+QmLttEURsV9VOB=f@AV_-iTl(#lYqdD+>@$xo-;OW!lz6`T;+>p zO@?HEh+gQ9=1*$gAbkdc5ucQx&qW0=HI|BBOABFpFtQTx3$_+ny3p&hDL&mGX7^GglI{J7fDd_%#_lV-33M zb8RTbDpeD_ndswdX&(Zk+H*LPhqvUcPnX&*Yk4R(DJr(@q}qy7$p{B>uLOS|qC71~ zq!2-~qjb6?~DpC*T^?2r2J(xyq0r2n+R-c#@>kK4eH-%*m-qiyeH?I9_>w2k0P{WsFDeS zID@dLoUlW&gYZ-%<5ZMw5cuiUyD@%kEosZVFC)M!oz`ss`I-iG)o!bvEiYAZxXgS` zPx_A+bdGHF!rKY{y+<2cGd+GKKm0fHM2d*s#65E=U2ytAW7Kcy^)dc{tH7M>$b)TI zZ@ZPSbSVX1B9Lg$jH^1S?)_8h?djsRNd2XAeI+}IRZgTo@l_`Rs8oYm%bdkjjD zXQe6X(g;%ZzO`Opc{Ps|sY6raua=ixfi z;s-;+QP$%xP%J;mAyKR@R~6wl2@K5`&QjHsVE3i(+W#eqD!T(WEx>+3(m}wuKCt#X zJNL``Iy*}kHIrls8XwBb7;UCFkku9;QZ79*SK}QN{!JI(rGGGaJqFQ=->c6;=X1CP z=NjOYVR+FK9$sFv@-COT=5X%U2yjSx2z;*9`={G)D05@~M)@Mz6BT(7*w$mZJs!*y z{pqV8gn7x&C+9BE)OiH5Y}eQgW1OF#d_m0Qe_!$W(cR2!4@l7)Q#X*Yg>N^d_y8mZ^ul&<}26-{5Gefz1Qwa^TsZw z(s|N%dBglo0Jg~Mn&vsxDA&0*i0|^S`}&$QpJ*H)t$^3G2XWLlrGUg-$FSZ#XKB;7 zdC=TwWX7BtiUd|*;56FLVKjtIdIjkSQ#Z--js>6eecU1jAjvI=R(QUf^aU=>B}^V* zisI+LyaEEiC^palznTvv{*TvxITwEZM2Z-}?Wsy&gsPC&P$^-*In_KHWD#EQ^pG~5 z)bhu%O>|aMtZ&Nx>-%$AXjadSnxP5M|AT0%7XZ&bzNOO5{n$&MR$%Q?u^n{AUX5hv zJ=UlAuV&;}cdJZJj?$m!B#-i(udIO2?<91V5Y03Tmu=IGr+-ql2-hr{qh=^|{|>u5 zCISoBWpA=#T-4%OUzK%}O?yH@n+TPSC*Ed0bZTL{AokT5ZuXx3T3p@9j*Ch<+k zKMQ#gkzN}mH)VrDi?N@G7@@=P7#yhhY!$PmLZqL|-m4$MF;7~w)HJk&)-`OY!`6Lb zwsW%@PQKqa+i|VWtE!6cSEAcZ!6?Yq(v^E1PFUyhU69?1wU<%?JAHA2iYkU!eqo*+ zM}FveGLE@K&z;APQrh%cEv#|EAT(||Ha0f1ne-}~jG>|DxcXuId{Exk-o9JWAg#;e z+OjhR8@faKxUBlD9>jKx-m%wDrm_5gnocaQOGcZIUdV~dFkYsOBe14F6X_w0GG%<1eHs? zNlUsq1w?cJ!v%#6k}kI2kv``v_Ph@K>=Q(G&kLo-!iE=V;2(EnT#K?PgBCUaHi)NL zOGu?WdRR*s(xPnBA`_bXoiTB6%qB`sWAqtC8iqbq5^*SjQ9Ioh`~6yyD+I*Cy`TSK z9@;x`uffR8G>*7sOZ$;?zMZ>MHI_M;^W%_DF??9B1yeh2=@XNb7d?gnOY2 z%S;ixwJ+cesaCO22zwg&haD zh3ixlPO5leGS8i3%K!L@C-{_+d!E?O8}BP;;;kvCH&C0FptHrE8-bME}xSu!%7)DuIHAh_r2KxDGT!##W{J1F^Kh)C0 z)fCF+&HLne)4s?4kpCAYS}eUpYaNOEs``yzrsbE%aH|=$y^QfXf$IiPYoos%awb=R zkC&GM*HH0Sy0Qh3M|)3d!J7jElF{tK0s=f%jxH{0G_91FR-kKY{psOflYxV_@%{V=TF7D7%SA^x1nc#3nGNm zC07nfVgP)e-pe^vr%d!l36k|3ovg^L$zi6l3ZGj0^DwqIP|H`gzR(R*qVQu>EqmHu z5||3|v}hDV#8g_kqvm&kHyoD`e`5J6mve&N-Uv;+Z&Z7fXJ*$CURS9vcw3V6iK+YA z@FgU()<&_Fn`FLE>?2je71~J0WE*DIkgMzfLN|-^D%Ae|7MD+{M}*l1D@nl{w^OVY ziISU>xBLDn+vy@3+@>l(u{U!}+gcUkv}@kspi3g+Dn~%cAZNg;u3e^}_!7tQT~52M zE(SFutRkzD_(ipuPMf!|N;_7+{z5f%_^O{<{^yW^3D*7zfs!iB#9_bS)bZ6k@K_HT zfK{JnD`&u~tLNv=?>FoOs`eP1ex>!9pIJ0B+L4;e zdgL!fAvAc-}eAyx^niQ2g`0u8FgVVGEm$|h<8lZ+(gqcFt_(@M=!O;lI! z@H^hjJqh0i_Jv-uQlz6}y8E-@_{X~!=vs|R6?i`kr>aQFTSF64#f)(^iWVrelHJ2S z6FEQ>aBAX=S=|!+uUA>UCr1YQcuMc{>=<}Zw2IbU>L%cD-G=3`7UXu%t@4bN&S@wXLas2c^2Ez6o; zm3%xATI-pA^vVb85`~N*n-r;SO`@Z>cgK=-dosvp-PwhG!aOZJz<=uJ(UY!dA^EH*E%OfVG9PW_-OX$P8GD6zjX}C6R*$B3`PrAq*!OZ*{%fAgwGKO_OFUV+m{b?t z@!mGPxImFG{))uJVG5S8;{a*mKibLULh2$lx5%+a>^RYHon9_#I?gRs(Ehx|&Aq&{ z=w}_{TEDJa-k@zcZbAJ}kpk`H>}-gKuA|k&JRMZeB;FcuKcZzG-JkbwRbX(~+ZO&G zO;;IIWf!e!>26U0>F(~5?rxCokZz<)x3X?w}(w#M8V=>P67KPm}sMPM!4 zaT!Dc2AWZ6eEtmoEBhS5mow@zIuiSgvv65v?4GS#&?sAd*VJOd!^9t6!uKfyq^VzJb;oIBe#VVB}81L<^ zn?UheAZ!oSI^)7^!wCTe1PGGATEqYTqNl&Bt*wvxOro{DeLQuqbbWcbR^Jrj~GP~H#TYs*t?E6sq|AzG3O0M8k12F0vu-@F?m+}s(mXK>l5`E43p_&79C;*6OGc2#K?-nm&-GFF$0b$`GLNxr%RL`D*$WJHx1zGrE3a;tu zl>IKg%mA(-pGKDnyV?X~IS~cp;f3=*^=z`*w@$jFh?Pgx2T?S6+B78q+cPh#V`6bF zj>~?~fk^^Ubf6Z|Y*U>Qf-4@XDFmF4h`4FCxnUN$uL=7=y zDI@%l!$I1XD46ren&?Yp;%qr5>U(6m*1)fH(3G805t9_g}1_X(YaGmn_1|s zvmwDPuRIIXA7O&pE!J+1JLNZ7oE62#$AuH(j%~criUtPt6D->Qlg?aRV5R`_19;d2 zO}a?(Pr$*dGN&SxBuPL>XybKTsV4D)+ZKTH!Qkb;kxB9^wmylGNk695Cwpk z|7}qT0&^@+CPkmx!yZs)@D+Ujg0M{}{4mL3X5DNW8Ay7pVyuM&QyKG~DrL=g16z?Wn{gX zxHvC-&oS9XxQaeZR|LX^`My^aYfy*OpXZw6Rcv@~6k?i*X{2m8z&D|8QI=1^e?K<_ zI-(p%<7rUZ_(G&FF;{?2On;<2e-Zg@ueyO}hO@=wFJhOO-i|KJojem_)vzim;)a z=bg!Ey5`Im+f1$Xf?B~pMY6_CnKZT)RNa+_11Ev$|u6;psw_#s0%)vL=^SKfyOE=f(FCj3yj+@g3T`VS(oDY_5-}R+0D+@ zjPXNvv%aQc0J?Yp&NF}`xIOgE5c22Aezqw*6t3-t6zySfDkb@NkHpz>`lCyUF2{E7 zGVZozvJ8A*zMrk_n=3UBm(M+;dP3_<;##dS@bLhmra~4)qlD6f&bWnV@BQQ&Espv{ z^nOmqSmR_zN9?0kayG8QoD))msc%9^%d5K{uly+-|Jk0zJ2H$PP!{sKS#tzX;`~`_ z>41}S5YaXV<^zfIIx&FR!QhZcO4=+6?wtuc<25KBzwcs<5KpZxDPuZ3UIRfFeO zoHtj_tl=J$S!-C-do7WpLP=OsmST-TMDB(fTv^sfp#Q;TqGY;0I-%PW(D12YjZ!W$b}eZ9X>-vmAG zteG19k`v_qYYRww!cgC=%pcUi*F?8uBbh0y=hdyyyq%yJ54LP1*WWYaV*iqvBcfpu z#d*lk>QG@Ca`4fM&^rui-0PdN@hsc49!-N&ZY07Nix+~TzRG?(jwr#`6u6pBY0~XJ z`Q$4c3F5@xi)rcPN;5~4Zribym6lK;?!AnnAynS^W3m4z)_*5B;O5GZ!g!m`L>l6~ zB6|n?`s64@rjO%7|GswJlrVRwvpQNr)upk41~yN}*p`oL{qc4;gSMumj1UrEvDEMS z+yJ8RU=S>+8krCSN<~7cyh(ui-OqN1mR>iDo8BrZSJenR0pu-R-S zs2Sp_e(S0bMG*ZoDD59Te?id%hA65DQJ>ML%B%o#tevBXK93}qjVO;%OcU=d^gS9 z9QctIwIi$cMW+Or5)X#?WcZOcHM;K4^g~fpgvY%|l_GHb+}b8=pD2uAJ6$H^C{L}t zWrDk4X)T6k%=Xm%sK`&o*E0RztGjeQzz0#ZNQgH&1Xncfbb^$a@=4VgoTwvgIBr3G zV{B%oCyg<0R5MmJz?%FoPdDnP?M)LoFE{p$N^Ox2drnA`#a-8Aqn4IO<|0StXE*_# zwFAJL!>^a++n@Y5>-{!~1URdMP$J+(EJa%P*8KAh8#4cHFP_PyZp{fnWL`{EntTB- zH&(vPJECKkBUl~2O2X|K3C4lND|?tciDDDWH?eXG;W4^B8QX7(Aq!@=cDdNs#}yjh zy#Xz))sHARv4;gM`{h$FlQ-85jo6xam5x6~#u+M~_ zYwz?=?ryCXYzbQ#b=SR8Yu{;p%`(*`e6S^Fb|L(gOTs)Jn#c!~CgHk&7(cLT;Q3G- z2~MosF6j5MDt(3%rwZ9@Zfjfp{W}jOXi}HR4OC;yUDm9DA4R+6$Y1P7XP-te8$%Au1$- z#iqA9Wzmypd zR#-{3&)G3~8uk7yVJ2zAN)yX2^^)Wxz^C3BAv6h64+d~q{xVjCV@ypN$wy+d*TqF3 zE)7++6||kh{>SN_tNDVm5#^{-cIwB3KASzuJOK?k6VTl|)+zBEb5tCB z5hIMRr?zqvmOq-jrm56>!r?t`+({PR9|N(FrB`XbH^bpHSn9B7r#tN{RqQjZ*=`y4 z@);$Aq=+|gJjmhl-))-qUe5X@_|*eSXO^oi>4Y$R3ofxqM@zh$G)KZV9yKhkl3y%( zxRH1Ma~XT*n9!RXt|g9^eKjLm!22YBEF0BtqOBMH-(7w5ziFiaU4DBE7+8RB{_~-R z()1>{uIGXSjWIndcV>->?4jVBI+mU*`AO%yYP;RKqHzv;QhfAKGtuvKT&@cl3LzP# zqkNaWKbxwWhl55)6kKtL2#zeH2=MY%QsDI_jinZj$fsp2`oBGsA~D=)e}A5vBB0B) zBta%U&hdhy_hY6SGZhzsn?=R}R{K<4+T35mL85)0mmPnekE`p~fbCupn#j4QyKW)ae7O%fw08HZ9;8}ki!b>&1C}pGoH@l`!JFh5p2(r%$`VM)OHQBG zC#QFoO%c5yxt@=yBr=a3GLZF*gmvana~g-3w4NDtRxHI>z(93*Dq(krlFzVWFikDDx%j>X~H?nwncszldT$6?*5#ai|SL8FIIq2Lt8yI%Z{QM@L;R5Ix$1nu| zI~eK4T?R@SPqV-2Zg<4tJj9*>0p|+U6Bd2Sta18x1vuHuE>T}ZF&8VYXWDqx4w`H= zyi;Y2#Q41}_{lP5>_u=UiF8jy+F*3H;{kzR!ikyt00siC>imZnP(WY>0Q~hx_L`fU zF@I{_wAwz~)0)UJ>88~$v83NK|8m8Bl#o403&n;GP6vvfAc0K1NRRDljuhA>e?xaR zlN6VFDQ_|^rC-rKPcO=UOM*8YPp03rmC@z~5PlkCR7R4l(TfU|9vHFR=zf3*jeeS-0D zk8hCh7K+XVZPl^0PHLmVPz#4#W0rY3rUxFhHQxd5SIe24i=ZNFm;lOWW=lROHExxU zR>i6k^uo{Z#t%Jd-FC>Z@4FtBC03C??TH;SXI@-8K6f3gOOQrM7I0E2z~v=Zv{$3> zLFr|TN4ibgDOQ%$Xn2UBdtGc}_LemER>F*0b`7{dCo2mL=|;d4r77}Tx|iHA813<~ zw(Z&0#|E+oKyQXtGT2lGbk2PeUS+2rm)ZLB6Dc)O@1{sJQ8=jD)i=kSxFv%(RQdti zi_7wro}K+Q?u*#YZZ|>mE#$17WG;_J#}y@!&6gH-_G5Ltrp3Vis(Ee{)-dV!+e);x zq%0{U-7SsYS72PlhaFab4t56v1EEd`_(wMbEa)WG`ZXjx5=bPSz7M^oHE#^XsfM?x zLQ*m73n6Z;zoV~-R2c^`gR*6P=af}Hs#{J5OF%R!VuzI|Zx(kZ_@O%bch%eo9@LiL zxr&1yPORrm^kjq!r3TpOp^d&<^04*O>))m}6S4X|@?$@ELruYrJaJ+HBOTPWoe$;J z=)%YjI>@4N|IY=`)eC-rTnUACaX2{SOjq; zp&lP8Wq(yFVn4GqI1v@9SQXBAg>-=3v$I(3I=Jscg6cr)UcW!``I6kr#g`QpF#752;8~9uFXxzApRYYd4kR z8W7M0CYczTxZssNl0}+~jQV=5Pv`32r3XX1n~;#v68^Pd+&l1mli-=0>}7Anf+cjS z^>in=Syaulv~hGi2juG0WsWZF6CQ;^{kK&X-hlkFzHT7*g?bt&Zi-uYEhiYZ2{mIA zBoNYJ4&zRiaLsp1vNn>~!}=uT_?L{8QM7g6&PZ%1%tMU-EmtW;hRT#ndOYc;t?4q1 ze7t1NGgac`OGx(bJZvFPKiuD}?ovelR1j6!b$9p)2W@(czKZrjeX<`iQsA^^i{BqV z`#sZ+h}xCxN6+cZof@+`P*S$Ex8J~VO#PdfK+6zuS7ELAJF*e13ifR4I?R|QC_T2( zi&+xnl9HwA=v3BBC2NHg*J}*iV^^CiMmu*o1tP7z04)bSuweEuIa^zjMRHn{E5kI4 z?F8@Fr^)_aicYo2ejmox*l^&kT+Cq^V!Y6Rzs=gviU=R(E-LY+&9mrA5jG-BNLV=h zZQecZ6-5oV#di;&OaT7GKHUiK6oTyzhkj)(4Pu!2IN0WztHAJ%^2ZKwp4guKJNxV` z@n>((0(k6?o$kRvGp&GB&4@9)@Flvvt@@UKfE=UM!Drd^zydisGxP$et@UPldjX=~KT{YO_?E#BfchvTD{&tD4HgVyobnVGo2I*}N|H%6 zWQBcz#IqV@%NYfOk6VnCo6u;8Z}?}!%Yp(zVFHgfn=NVcc6G9&{2Ek+QyuAFKp>wH z*g_Jikx$REhuhX9FRg<>Ts=JxoT$4Rvj`y-70n>rib3}LKT=iUmxn)pM85w5*}^z? z_grmNw{rD4b-Lg1#UU?90gb;GJ|U8nbsr^tfRUuagv<>6j2M+(k|(!ERohmT$+?2G zjC-bIlj4*{-5LzxbtA-L+0ReKBz+OJgSC@IyO5@nU5Ua zN8EJ8Bs7r+>0%GCZN*<)t8=iuGpDZ?PIyrL@C?I|pb`OXGK81=lhuzre-cvN6d71T z^Zr`HIPvEViFC$w*QK_at8BL9`D07fd`TL$iBBQFI}-Sb#FA?aUPnc_TkHk`UR^9ef7;fx2w3(Zz*buGysvr2=x}rSy7M4qnIO_#x&dpQ@X#GZ=v2TrS4J6?dg zEc}PMTnit2(kP^;>@85Sq(J`=oETluM-BnVO^b`z@RB^^TffSC9kLimPMV|H>thOH-A~^rS6+MGv+0hL_!ya(&s!Bs2$1K!} z@n-_gAiC{K@58tt5{e?&rl>9D<>hOaR@mjkO$4@o)^wV{F#~*ctwXGuanE}METn&6 ze+%6CNxgJPT(!ZpNjsjmo$F%erJK|8VLpRSR)RY=7&w|&caXnRy##!*JY3|4m_Vs<0^91B02{&W0RqDqSK72(Wuf_NK&;I48i^>I> zvKbyDOJX@{T+*V5-jBp`q}^FxNo5al_>lUo8SBaJ(uvY>K4kc5B z4-4PG|0>4Rmzm!)`?@Gi!}X>)j*%t$5s#*piM9lWRn#n#aq>p(yFbmVS0J#EQ?&l| zWM?Aqwvw4$MYk*0(L?NC{*8nk+w)vC6!Gr{oaMzD`2LgLM@f{coy==8TN!u z-8gU`v{11|zH+M9Rtnk_N?Ymm*Jk}X%feGd`n zBSf0|@}pSN;g{%HTFDDnmV#wz--n&xgO9ynoet-i_`{pdZh;bMO*Ly`59EhknZCEf zBFSNtKqC4A;W`W30`r|dnPNPqxxGt2HDzy&#JEK;k2~gJCi7uou6(@)k|MTHU){7n zJZU_1cS(G5)`2ya9`P*al$OxV(Ij8Kyv722<6b));O8?>g{Vd-AowFof4x-)LVJ%f zTR)W(%5(5A~_rHWj^8QF3J%^kY z02#-)`*;$Yv*U`MxO>9Xq(cdLXSou+kExApA^OXmC_ePBSQSr z&x|flCrqN)|FzP-Bq80n`J;>P7I5v;4~BbeVCQ)S9CQp7DO`f1T5H2>{w6;z%u?_c z9)S54cz=P$6fAKC6U4r_O56$Al>RrIuC4ik06xX!8+J8n4|bfmoW8)3oTm7??T>Hw-V~-svg0vEcDR?rH4v(cxoq?(DRoiUr0nGPK9OC zLStrgg2AD<(PeTryHlOLhewl|HwEQTdeX;8f5>wE!5^6X#_7hJ2=J~{o%gvh5!Xe! zfXE3K7r-PpduwNF3*6a-pKH>C)iZjtBP_=>*x&Wu%&nZBR{pCPO@e~%Q)2^*azFOK zGjfSTRU-r@<%^q}WTknt8JDL`o=PIShJqU7ntIkXDjW-%#n7iy%vpT}*@oS3IWhOC z?xTxzFDTccmEZQJwx(CP@nNn8ADK0xi=vUO%G1&wGryERJeqv@9O)nm2Fl*-~EBEKr>eoT98G2E8KnqK)7}HXi2rK4Rm$vj|Qvgvo z@r!5vuuG(PDVGS4ISyWy_T>Fq2BpF-;cb zg9j$TS}|^#=u?vAlJ6>5J_zZ(?7x}63BoAXXGK6=BvzdBmy{moG*96E2*bpnZ7BbO z&wYG(nJ~s?fJ4>whd?h^(kqo=N~l8SsL0Cy8J> z06t9I8TemMXM=v=md8Un%dt1+9s1i)wfTs{cD4_(;{!gi|<&tMp$q_-w`Vfe8q zer(LiM$L1OPa*;{@W|t5=@&u?67Lc?=N!Z=%Mo(N@613pGy%#3+6lzQ9&N%YUghKj z%q!hIr0vDhxn?5ntjT+LsEL|eo&)} zi*SdvWpCc51Zkc^1zBv0K^;OROdAkCB^1p39_e+=NdEMW7H& zp~$r`6iFA3J)@i%mYSjp$hV`Dr15`!_Mr8tXUcZf)n!Ng{Gf!qumDZvUS##Yd_ib4 zP`|O*m(;-HS95`T_0NH?iE4&^Eu&a3=j=+LX`6T$;w^=YBPw z@RGS?*&|{7J9gmXMg-kNtCf$>zk`F}*jCyP?NPl%LhvYx(8Mwk5zJ_62$adhABFOS zH4r;^eNWy|nQ;}yW6n!NROa>6dsDwdj3;de-P%+#H8vGbY!wfcwwdDGBF2NwEhcxV$}QBJ@h~hL-#m zsc&tzX-wJktO~Pa$+^tNLw$$1=yvPJXqMC1O9j{QH|?(+jD8NU)tCZiQO1pZ`!FJ- zzf&0U4OY<9-wh_NFkcq1w*jGuLut($=Dl>c2u)hJQHd?54|KrugJ3Wvk-SDvgy`5^ zj&Pouj&Gjeu?GIpe3^(rj)lci0`($doLYr3mxBZYv~tavOq2u_o58a9*24nwORaxV zXMhLpJ3~AFX!c>-#?u}Rzf+M^u)X}q_HpkosFLPkf!PZEGCah7@m zCdVqmLgh!zsNERcE3yQTCiQDP@k-OoV&~@M9%Y-|y`ASXN;`kVQ2$=?6%3Iia13HM zcfEV*YfRdMxR~jXe%_d{$h9w0w5LkJ*(09A$O|NS()qCCgbA#hF8=08A~sRTp?U>v zZtb63<}vrB1_&u^pxR45qzfeD8oHbZ;CD0)9^C5w&i^4SOn}j%L)BM47`VO&MAPNJ zzbICJQDGOhz_%%FvnsP6t`MD|p3+1CKC&znuwtzO;i}bi{XNQ+vm-YLhZ=anHD?~3 znY+WmnzsF_Qjj5%e%@?8_@wBslaU4amy&DzI_bHTg$hM$?!pKm(VF39@A=JuKhiUB zKJhSb2$px9bMm$wbxg6RQ=W9gag18w8Pe6|Th(VApVu8nvVZ?X0(0&K41mg~mBWpi z8yYkM>uzGNK5ms4(+E8%^CU56WLggfMCY>Y$2IqE8x(XTXjr)yh38jGYfiDI__l5x450VI?`v8gnUic2-SH5Kf+~Q5{@kZ<0#3FSvc+MskqGYDxZyLWCArA#HO4-Yq z0&1!$R=RJ>Il0fB6FRunfiVXX_rFoLTT@hhR@&;{b;`FtqQQh`EICasq=z&Nhv$u~ z0;Ql_ZASh`EiN*heqK7an#-}BaUZE+U}j@o`4zCqv71rca)olPj}~Z1!}VqGMkGKOA2uq6x1_NyRp}YK+AsZ*E0Q zli##>Fm0`^*ygD>>)eh9QcST>esQU_xCo(HN;9&5oxKo0&^{u$*jM-8=g}yadK9)8VWX!(eGL0Z;wcH>UozN{|0!Exx`C&LPL}Y({=p;{62f zO1iw`aVR{dF5ceWz)TB>cYt%h>=;YsanN_JHy_=9j20kNu6l?{mmA=`Z^OwGG7dCZ zA#X5|DRgg?DIN$;BwRAYs*y7L-0&|=ot_jnV&sTLtzy2pEER*DQ)8Nq1}E4>QC$~a zUd(`(b*^E5NoaAh&x|PK4_rXz`FjK>6|1@hHGL1{iTjXgPx|qu%<;YJQ@zoAEpzfD ztG~XnA{`|og_hMEf3NWn5A!7ZEPc2?LiQM@-Ur#o9E&R4qukhNbog|`>PCmD$)zu`ZA`(rL z7>%#(ivLii6S|1vjr59dOyvk|f64x>F=Ih%zIW6!w)XX>aHuYH-S@uZ!ax~JI;#}9 zPnokwf`=new9< z0{JM%-J95f5RCVn_tliWLKSfG`JV!S>ULN-HxpyV6pi`Ck_ zrB_0%{ueznDmJjU2wLvy@frUMtXCJ?Sd3F$VqRX+Of#4$8Orl!TSIq=&Wfg)crI;J z79mH$HDq=qdmdz04;+&TyALL6jBO%xl{u(24LAvAUygR~?%XXcKl!JI4-7n=2%|e6 z!>4}#dxHmaX_D@5f3F=vbQs?WV3Ul5Qw( zfu&%)4HL2>w2+(6E-xl7low148|11YRjsyrRH>4x+wGZi$5Ql`Ma(*V@}@m}`6HVi z99#*~^k*?Vnk8SwJ3-Ff$_W+%*_yB_1!)Mlc|c1%IN5ju#K_9)izc5taatgfZyT=R5pYk_pj8z$Y(-W=zepPv8DOh3B_0w5=5K3NMgOiNCY1b5x z!U0Fle__Lx=m3vt?T~=W%lI=8xoco#v=0m7TO?n#wEZlQx`ls~X`n}*jh|aU0DkrG zcw0`^Y(as4t3pIvPI75q}QafT8S$^A6gVw zWVqlGRKDDUV&V*BiK)xqOLZE&aN548)4Eb|0+PwtC?^YM6S`ojb*uu7y3cp;hrtj%tZ55X^Yr>kHi23pQ1?yoyyYv1wE5-4U4 zey6nXBKW;)RX{I<2*xV|);`I*cP)j#{3D~4P9uN4cSXjIB{a^xJFqWL2c0lbqZfWZ z+d1!ZRYdlZQMjZx#aqV`EPo+k|7iieBjB;e!y`J_M?qO^e}va;wk#W5_%|`9<$I6P zjfnPJhpCZZ|GZNJBST7A86733e<$@?$6`YA&4Q~9O;az9_V*`x7-UI!?B>;Td7hcc zB)pX|x(zgYo5Zhcx-mC)T@XdQKv`;(n9}9f(6qJ}B;CUFZgzPb-CF|Af05~fLY7|Z zEHl$S>S%MTDB$oN3UIB9))5vIj707TL5@PiuNcB_RcN73!U$fAS&%ik`c%LJop|cD z3!nV}QOtUI=Q}ZaKvle+K0f+C?oZ|U#g~19uRRm$-I!>EA65C-#Dg-SHyYn3@L9hY2_7T!Tw6UA}z z_@ACOH-iefeop)}t<|+No?BC^M@|}{Q>dbf_J>U5?hpS$bsob_rBLz6*OeCJDE>I0 z5z9^x3a^=;*@#w5X8GO%{wJnuyZ7bHfZ23BG%m@$CERSJg)fiflAWSC=Ln|^F8TvW zoC6P0&No}yT^Gwz^5(+KcM`YAA5!7a1Yybva?SP7fwmM7=Ulb+1P(fySJkz-da9YD zFJS&=i$S@r5F*ZPYop*V(dl8rDeMUph}V}L6CZKBsY0frRLX9MtVa+Wh-$GvJqBe!i!+c(?ur8xFd01p+aQ-(fvOcKuGW2L_u4Jx@j9&FP<0i zVxhdjV!F0Xa0k+EFRw_R|BOQesvHSNnNIq>7hxDomrdag?*^L*<8)qLp855rHHY+d ztg)#*>g5Pnb7h+P=d)EMuVH-ueDO%FXbNcp(uOD%pMR&T+yskY!Pb`LPlq$VmBiAI zH1W<{FRtBYOO(wiRM^)O9MnVKtsv@Orm4BNJpqJ-U} zvRsh7LRhy$ir6F{Sd!u zSf&1bEwzcuGS+yczVg+No65?{Gk6yj&aV#h9~&AYAbx4U{SK_tKlM|=lWk@s@M@Z?L%Uo?k*&mxua5zH0c;`qO?e%uM zecGV$V~T#Itw{T0X$pT3Dgb1S;LQjCo4qRGsdMmtE8exVB=$gcxmvPC6Zl=;X5be` zTrv?awd)x`-k31C86=*Mj3E8(Ww_|uksMXt`&^qdI}-hYJk3!1qj!I(0PizqBg~AC zmXzlJEBqVIwesO70w-FWpuyVc8skKcOg>uKh|qSgsrv7(c9`SZwY}L1rGg(i)x*+R z%aU|iL}?{DECr~#50$3&M`N9zN0S7?hPS*XKUG{|hiK(`psB?4ted3neHWw3&B&rp zU;9K13ectf{{o)Cp*cEIhnyR5?UnG4Hlj%(f^dduyJa06@z9yqKXs1=+1 zI4U`uO(Np%yJM3-2kZ&uZ?ND+V4Xa4ft z%d&>>Y(N1~h9tKqFCsP5o(I#mq{P-2lmJ+ronq@S)dezkSR@MlnGkD{%#bt77E_?u z9vLZL;=E0a7QXf3h-|XVXHNPk$^Te;miflJfk~p=aDrOI+$&Gx+f-S^_vdrGUWk}q z2iA{er&Q4O25Zh(GX2A;;*96MYe*l;v%i(~+aNBsQFP`B!(|@)p&v}QFND%K4&?`xw6=$8qfhYZi~Q-~0$ud6HUzJp<= zQzFX73hHeA&uj%UO(x3yHcSH3J43-Zc z(gGgRfJKm3F_&$Mp3PxtoCi@r|X66RuY=A;e+JTVc18o!P< znVm)3&YQbRR`212r3)XV1B^T+oT{tU!++v`oWF_1)3?Kmx!IUE;wPy$1a#JfwfkeU zz505P_M0UUxc>cUj9%OOb|zvQm^w5QupI!M#Wx^^0a@$;z?pvE6S53Cd2n;~6w%}M zD;OW&kmLn2>s2wWll@Q$mZB(F*oUgEoec#SkU*|tmrc6l6POS{ex;*>16U2nRnyZd z?a~bTH}#B()CJ31e8@^P?AgcsQwLtPb*8HV3sf8^?-7GcNKD}42 zZ9sQ8u~mu1=of=D0jyQk?0cz)MHHvf`IvksHkacbor|MhT?x4SjId=m1q5T+Xl`>I zjWa&U*~dp3@A4t*f|%j!Fl(;MB4{b!dV``=09@&Afn@-{iir#OWZ+N-44tco>wO3N zjg^&N>Icj8#t1Sy%iw)eM#~aeDmQVpVXPZS;d_7L=3QG`m!^u*nZA03Eu|T*l=no` zIb_r2r7K6$p$`FyvNR@N1-?p}4%<0kQ)1@i^`pUupW^BTLJZ$)m>=&LPWR=)EUzAompT zD8b{K3{sB-{!E@RvL5?^t3f%tN1i>qySpHI9^^{_2M9=ho|87oJ865H(3SCcD;0MB z{Zd+oj(lBNy?n(EMjAD|rdJn-0<3r9acC21? z9eSJDqX5I8Akt0+tUcAa@n^1_?Mq(hG$c~yLS6!YXWif_e0k`+RMxw}3p#EBi#Ow= zM2``FkR0;fRBeAKV$oSZnD7zVFhtDD^b9V0KCkqre)ef#GK*ZO-gu$#wMd%wj}EM! zDdkO%&Vv-{RAu&xy`7Ug$-lryJ%*1@%l=VTiNbk9XC&QI;RSyxaB)v(JI^vd6Sdys zGe}uV9RcD)K5ptd@P~b=-UidUzSK-eeKK+UF>`UTZ2oaKZ+z()upU7!m+2=b0Pn=YqWz4v z=amVo$(X!*i+rp{96`nxIse8}uHci#$Z*|aZ0oLg-_L1=Pq7>r9!$*TxKUe+`m&cj z0798KK5@a#if}iDI~X`QSt~l~3p&i_&0isT;3XhVHX}|~3mG1!{5-Pzo?YGu2F{;7 zg(sv{O0X&CKQ>lg-WWo(_iT|S)z^VQL^(&a2@+sv`5(XhyFwIvfZ;+EbTfYK5MY~8 z7@?GnI4?ZEkn6sN3y!e;spe%yW=7hWj zgXRrB%xx-f;%`e~bd(irUM2XX=MI5XD53={7CG7U1;_TDw7EZ8U|KX9vE-!QWoLe zs3swC``X0gI*_V>gQNpWVG5$dmSCCu*6ZY6OIGvfyrf=Eub(VK*fLm{OKHPwdGuX# zl2fxT3H0x~FA}(2l~?oVo}BPEU`|Uu-vlyw{*5ilKy0Y67us8W{mIt<0^>~vrG#0` zlHMMG;9^jr<5j1a^HNj&K{H)Y6Wt$y%Di&=$~ZG=1S%*Ker@D%Cv23y7V1wWTS)KC zBm|`{ZT$EJ@Ps9_2`S#AzD?r(47-MQYpW`c7oS%|T=L1v0?Ri)(+dv+10!3qPl9_C z<&e!SB8mM-H{~MR!jWokAIcsuvCq$41EC(kG#Pc7MM(wd%^#Vw<@C}a@lhu8q+Bv4 zxN0dymOk1+wi{ElEw;hT)7noVumQG>m46>~QHUGMFBO9slU7|;>%IG5r zth#O>rI^XRL)RB`0uPyDb45-kzP2U_rEw})r$DZBoflB2(%P1RgHU&?l&3YC-*j@L zmcvq8I#_P6cA5XS4erCqett-%j#M{57v8E2DkqdHGDb`e14*3R}zIPl72X#6h~Cy?|HN!UUBIN#T|;_{uQ+ zOBEke9LIr1#L;l;P2n*$Y8xhlAVcVcd$HX?=6J0Lw(NyEqk^i5;CRn*i6ILex9{N}bt`KBIHCR#LCBI$>5@WX+zU-g(e}Sf+}$!4caFq}K))Sj8g$jJqE*_vdZ`mr5Ei|EyL3&JeCJTG$PaqC z*VT3Y7%DX*%FWd3OPpu?<4l?|F9bn*N%NA*W8!*acLB6>28M>k926+CsaH^I&ArMi z8+(#X2NCFDq$oj%9zM6^Hd2z{Ecw!3d2MK3>Fy%!FbyIUfv4+Jz5L=>#ILLWq3JAu zvh3QfEj)Bc2}lY^cS|GP-7VdD1JWfRAqdhP(%lWx-AH$LcmLb>pU-g|$5F?)uYH|+ zoogMdQqM(BL$np8LpYr5_sAOSUgPSq+g%7^x-8ft4WuqFD>VD8&l3pry$DV>4= zAB2YzS9}KU@7--tMX4ipEgMNY8~*&U?_)2gBu;FY&$pSuOd=F4chj9(0=zWfa{`j1 z^PsJAsJCUBDH%$bC06F2#>QxPS05inhNdZE>Uh@SZR=LWpb*&&U<(8$xtC4Bmv02J zU66v#unBul%3#q+FoxXJfDBJZeP2}C@d0VvX+eM3nOZAJszmZn*dy$xju-+P>A5n<$)Z&@Lv7i4~f_z$>S zFl)7^F8rkJH`|{b47mqYO5rKWy9&NELR~S+={s5EJ(6@)%Ab{-r%uFwrA8j1X zofgwN^Lgb3CTqIKlZjY zZAwK~#Dptgc#%*A^Ac`Zoqf~Azw6*V)|2+_^jhxBO}sBGjWpWVplpRPh#kEi53x?y zXu0WTX)Jwi4&lo3a%1#r8Uf)R9wSYIS&KSHljLbPC#6Nv8ciI7#mF7cKyjkk8w1)s z>d_=|qbl_g_Zyn9bf%Wvch)@oMplz=sOWa!H3#J*r;*0SMqkXNQ;diC^U$}qkcEGb45$rM&5p`nZoap%>)`*6ygK`_kdgq?ZXZK{V* zz#XFKrIMJwXs*c8Zgc11KDw6LO&Buo6}-QDsUAlx4tZm2472Zgp)SW^Z$FF$UjtyT zyfiJRA$F(>mfCt!i99zi3*3sb9Stg|?aEF?ZmE3qB~x0hcE zEx22i;|P0@!6a+)S;u&B@HOs)IxJXmBxF2B14*rnnXdeUQJt1~{O;m-3igWr42OYf zwi0gWq;pTl&+WSyfPXHILo)IeR)sWeN3tw2LNNh8BIF|v6XCvS;VISy8&UfOs`!T} z*-fRNzbJb8!8Ei^!ttHwx{)S~f@l&wFWSnFCL%IFibx%MnYCM`Cac>rYaTq!rnXa- z;CCNV{&%>frrw>ouo!T&jJCK&C73byn)8eFcf*+?@hY#qvNJ-2bLA9u{d8V5B@&Ig zK273C{3tI2FZWU=MXsHR=(%kWcN{L51363c8ZE4FSr*U`dVF;Bk6MmzFM~)|NdLRh z0x6jb+ejE?RdZ4@_;ay6X9}=Gf)^6FdH@t|maR48@5Ga^wLDT|u&DV1diE~*2-QQ< zk`ugsKAqhcvC__G+&$l}dQaAUBhizXlE6Q6=%W^+J%7UkGp``z%KMpBTR5?6;FUcd zJd7h_H&u7%Qcf|6r(qLIE+(W!h&IK3QtTx% z%hN7f&k^NYE;RE)fI$y za?fAR8VlX)w9DUJad?&pOPADNPFJ_D-c|HiUgy80mPHdket?eo0aeI6kQftx@V3n{ z$y%=6z6t8c@XWW4*_)Q~KUP$#*aOFBD*<;{e|DYlk-YczpAHaB@L3@&t1qWqAG>&i;>gcc1BNP2vyLWtgVM`2l4U^eC~VdMZKcO&iSK)?kUepQS+KN#f5Ljw|Oo}6Orckl!?ud z_`Xp!v?J~yJH>)~t#tM}EYAfK+5XMvF{1Dk$qn*gSe94I=yaW9qy8 zcB7E};42>u?||CU5nM-wPsnSg8S8)kff^^K1xx%q-p<2}}2!Ug(IH~YF)TnTN}3yVW6`JFbB zKgGKAdvf`;-VJvK;Ax-pSTW=d>3>1|+p&J4f)CQ(U_-!Y7-*96`o1Jrcw|>|vUjDI zRPALRdQJUW&KX6KDf{@)ot=GuF1r=#h?77b;?z|478x&fQ|?RtW!)#lBc-wvp6cX~U=JYU zPdnbL8n)%<=U-l40%HZZ^^G%>!2+zR-J-9lMNdkZ5ybW7h{vMsgi+?CQdgKGlC3w%Uq$?=s(4WTzQ zIvU?$X0Q>RN*#1d(tbYesyJ7$`5~a$6YNj&Slt#lI6vc55jMKGN+Dh3cy!G0Jnpbo z&utp+WHx$<$UHb~85VrE3uca;4rdyo&5H7mFst0@RWHrq<;9i`L=w3%Jf?Ci-NK6| zQyUukVleO0>U+O_RMEpt`$RRo;7U2_UwngM>t_T01`h7z9!CAHRRwQYbySECx=LsOJk zJEOGY1%S%{@hKqBdmH8m{b5wRQkN8}Q2pJJ<12TG)1`OD@*t@Ow&omW{FBB^2>dt_ zIefr(hCl7-{kSqTBK}{M<72#HfFZDN@a5(94*@hqSu7 z*ohf5$-1P2?64odmnZ#h^N?u!oxEIvadzEN`MyA0~2KjJ>Ll-}!+WCqboHCluoLc7%OZ{NNt(*WmFWovD2Lpy$? zGc$mtsx34l2WXws4Sy|%OUH2j_Hs;4^5da)V${B|m4psOn+O{r~|H#&fIfuyBh zNG3s^6Gtq&8HY`$nfr3};B}x3I9K|=D9)@bBF@Fy?H^7uw;|EOd`DKzeK{R?Kr=W`e z^8&bUaf1m9JiMEmn?_eKe2Czu&jDy$ByQM0X^nJHO_CXQ+!FClQYudYsXIp6R%`4? zL2um#ttdtUxaF34UT?OF~RVU~&6_t!@zEj+L z$lMQx%@EiP=Jr;*)cUSo$ul19Ajm(%7(|(eT?;6K-XW}iD#=f(*r8uemYe?t!;JVS zx94vKXG6C6d;Oi|u@c^zEP!F@L{p!432e-PEqyYJWK0~FVzv+>f25u8Vm@{LEtB(v z*7GZ|MfhJ8u|v>kasgcAAVb^S@Q0iM!q3!Y^9Ya1jTy9$7ddbSfivfJ#mwxBD*c#~ zj3|C7f^$J!u(uTBk|mj{A*VHCh#!Juozph$T)E@6GADClxOpX(F*i`1H8~SIU!TcY zv;S#$yjBlrCZTIg@> z*#KD|?pA!!;GQzL~@n79v zf-;2cf$L4H*D=id)6o9cIVIL@%K3x$o^KNwJwgd^$-N&xn@J#(glpJ8-9uPBn(pRl z++}<MZCG0V#0-)Y)f8uNj~}RU3jFb2cr->E1u*1tUd` zSOyWc?^eNd^oZ~G(r$JJIHzkTRx?5?e(}&;M%{Q+a>kh5*voe&K7OwjLnW^FdEUkv z7Ot+*EHCJXx#L#iLzhE zJ&Y+I3wkd_#4Tjn=vsRMxD(j~uEo;}kLhb__6!yLj(t%SN04GDa&neeSDWv<^Gm@= zrek!DVY*RcRb^9M27&pWV54;?jvVp}e3rc1)!13%+#ABL9n?u4ATnJA zZ~X2rb7R4}Y_M}DXz2P~C+`<`L@@5q-(AO`h9)QNJX#ZUb_Io*(R-JGTvK^kib&Uw ziMnR=IydTQkI~H;C-$3{Ocfoyo|-|;;Hayu%9hqKu-7hoQ+#T6u}S}oA)-````3U= zX(CFVXhF{>ZA_hsR5C89+(BU!VPYZyK__uVrxr_vySZgVevd07o}sc-Sc~x zXxG*Xdmw<7MEbq^_1~Gf>-&X`%_{q=Wo;8+^k@s0O$>)|Jbh2&OXc3FQ$F&Q1=P$I5-Ch&kVrB0OH)CUwe}A zR#Jk)@o$=3WnljVreomFGjq^$nxwIvACE7~olSiA6+Mf2Xy~l5Y+3K~y?xBWxXc{x z+zrG~Zs+nUJ#@(Aj1=PovZ3V#EOb*Nr>nK~;nr3+#9E(jel*X`^v7{K2h9Tqx=*;b z=mpo%$@F@c=1)j#`;P%^vnG_>zxlywWZBeYlAC0Tm-n%X!u%Ru)p<_INw{G;A&Y#T zCQVa|HSlD+*|KX_?)puJ(&!y*$4wKS*)Z`DoNP0TNh8o`^MwfEgH5i@-U+;oq~G%; z9O#q(7x84r78NT>E)Ml%`OYNY0}AIPhNC{lI@o@1ykh%$8)!(}5IKTOZA- z?1f5ZNuSP+J<`*UuUxonl-V#g;ZlEj5cLzR%D07LA6VFaTSd6ZwNm;hSlITi!jf<% z&Lqab0Q%$}XbiwjeM-sQZh>(^Cez`ev2@lu$u$FKs{;PAywi+pad|kt7(q1)Xdm+S z06U_G9W)7j{a^ps+JV&VGTWB6mN5K!u5kUxRV!{*23P@ZH=B6AG29v)+XhQ75V87+ z=ks_of@^J?vwOJfj+?og8H+?d9bjD3-0bP$k=zkt50Pq}y#9eG?jP$kthkL3K!HQI zc%X62^sWjjX=R4iF)gxy@468{MSR~|vBnvTn?~sTmr*`=k%+dc|2Fpu?vou4g~~ol zRK&Y_$lACerHKn-p5k4;LI&`&yx!FR0lo4ALBTU+-ek(dHG8(9T{v#1E3H^*&as$p zH!N~6qs<3ScVFQBV3;f^tzs|CPRgdU6X1Jd-`s(@Q0XaS-D9i?Q9pDl%Q<59enn4 zd=_M#{Im>IpWX0lvg+nw{km0 zGkL}YY(B_;r7h>S^%rM;l|XVQf4{oai)QL*E{i8D2bTrXFnEfG9aPTN_sxPYzc?QLtV3!Y4$}ollod6gyehhfw9UOm?>SHoHkg`0h7s2aJ{Lyx!QVfcV;Hu6Q2feWTHck z@@$vwk}QP5eBiQ9FJjsEb4Xnm4~QOsUIjfSf$orfSV+qQF%^J^@McY-*W+DoP-5zDk2rpLkD8Qc0? zc$3a1=EGZvbUSNAniICp2d_>}D9e`cfN)3VlzlUYe14bX1~u$IbZC6{PPkzlM|`t$ zYImLEe8a4ZdHqy7$SA89)k#PpmTA!$7vD?VQPFLIa|fT=F-r8q?}szA`i{B}V)a}o z5_qGiFRoWaDGekA;v6~EX!(&8pok*Bk44#+QVw7&>+{D=yS?X z`5xTxSBs+YmFUmtS8yBnhOL($4q7n4%<3MPx_*3YOJGk)L1dwvXTqS*z*U!=_YJwJ zp!zQ9WQmY&FH7zxIL|K_6--*tD_H zCUiOM7mLrTlQoT8>pvf9!Qh~MT-&&Ry2ouF-5Km%45OE3q+~379jcCZ(b+t^p|X#d zP?#*4UL_n}eANH@!x(4m`G?mS5UE8_u73G3kcjFQNuO4JITzsiC~uFO>2s&j#r?Ep zScm$O8m{F}rpf32oNuTufh%dUrsk&JI^&?{5FKD`Lh-Jk>%HUyW2({vN)iG|3BnF zphJ}pI&PzK29vuvNUrB}&N$)fzHLxe#_;uS98i6ZDqC_K7+0V!YGy36k+`~t>);Z< zsgVY6LFj37DvTsggyCr7a4+cr`-wTp{&1nV5vfRfXICqY*x@=Qyw*9VmXhXTbM_ia zR^GQDTHAhCHjzjW*G(IKG{~Y^z$}ZO_B#)SG}w9G-7~#jF!{bdu9mv##Wlp^Pr<<7 z|Cv)(PMMDOf=^FHnOA2*H6VM+h}<#38ZJ(;@XhvGs=RM^s3F2wa<4wSg#JM z`IP9>TZU~Fj`gD$tzCM0e>hBQt(3O@M~!4fOJ5~MQf|R-bL0r*A-Tv1v02pf^>F{$bTjt1d)5j>pg6%l#Qr?_L|H55wGMzW)pp4v9@TM%Ot6n)k=<#1 z8fP7;1!K083|5Bazbj$0(l06&lA=_B1G;oCGQ@9uBf$YujC<9EV?bELYMQ^|0Kdvsgm%UqZ`?hOqmI4QLtHZT9>F`#{&fF)(U z_Cn+1{7E%RsTa{B2=>Gs2Q7yiJ8k*eb)I;GWD^tUcHq=IDO$1N1V^8zrzbd7F9*$b z1;RaKW|BHJj|zDl@?`fe35{8E&7u!`CD|kmF*sWRS~3_CcWG9Q0at4pUeW0belg#1 zsQ6AO#Pq+9TX@l~ZJsM54A*fIeN4aX?59PFA&$sTutix}zm^<4lOzq{FbL5p^8!5< zq#8g71~iWs^`Wt(c*oWhKVskW4exwcY3t?WK_(eq`!l?RRRPa0ft;d0GC)CzUijel!`?GbCv-@_|65H4QlRmS_ z-bZORG!uJ!CR#jUqr)w{2VRAE0!|EZ3aK|!cH**|+QqmaR??h~|3XZ{d4ENL`0Z%X zAF@r~CxwvG*Z-lyrX%qEF!z5J>^DmjnrY@b#Pyd~ISmZxQf_QrX(;kldj&51_tJgw z#C>dz=g;J-+hmA|hU;?@Py0LDQD-R8+28Ovspe*z3I~l=l z2BaqIlZPv<$AV`MQc9W(d%Zt+EVF@S=$C($TA|4`IxdN6qe7O79w>xhPcG*2QxZfF z`VTSjx5R{ImA;(MjHw3!1SiLyIO{Lkf>Npn+iC7cwQ7wRyXpnHZA(#{>6wqHKJOWm zhcjr6gAaZy3@AXQ>SkRW@%J+S6iQhx9m48-IMzvT;Sfh-K$0)#HlI6ZNE;FA#o-Vw zB`Io{q@qta5d;Zw`F|c_uDW%V&pv#jGP2f8D-G?ZAGHDneyG+$4B3-Cg#sQ zU5K&SCekJKVEkxytjy}@ryifXz-r{3E#ExcCz_#N8lDxmXEK0UhXz zC#}=aZ#>925iYH1ued|nJ5(8k$u6-e%8~yCS<+_%2V|HRj|1G88ypxDA2K zy**)LZx3KHyu#E!UqHR?)s?E3phExOVMbYiIS{cl`ql4d_QY)vJh!l5)x(G&L(Tk} zdLl{s-_S;>n}q>e`iF0wHsOtl4z#lqMtS4;R@Ql}Oidy451juAd@|M1(W&xGm8;B` z^jCaadX8jqG11tGV|mqXR=ppkxN9?*pZ)`5r}SPW-!OcD#x|MUEb?%JdYE(ZfJ~{h zbazk7#+x#(9?Doad;p0~GmR2KT{La)lfjjm$_#nH_?!W)Xbj4Xhi=H!QxS8q7@jgP z4f=X}N8~z&J0``d)6XQ0#DWfPt|%+=`&hnz%{5?y09z}M`ucq83;Zpvhu-tH_W`}c z!4Q2M6}FUNDOsqpv9Tgh%I=Bh3RZ9v>Mc5nncr=BvD5a|2-@HJ^=&Z*WUx@mb(buQ zFw}G$fm)aKhX?#WDk9UrFWRrRfTDVW+e{-1q)93@s zp>q*!Gd|9Cv6pOgK|=hfdnoBs#l?Of1`6d$_-CkwVng;|s6&K8<+4$7T>D zjz%TBeV_Ai_??9PYsHAqdeWQT;%kC*%mVIp%4Ab2jzoC-ODsRyOyfkJL6L&e&+e4z zcA&SLpPT#sYCp!pa>8U}okW~agFwEr-z2H&23&oMpNyoE`P|=Rr7f8vS5b=Ut3Ci_ z0sJl1amq{#tJ3Zq^-@9-Ggt2K?`3QA2vT^1oRR%&aEwYV@F`Lft`&K6i3HaZ{~AL*Q#a#aY{35!$(6H04R-^(uT zd?|LM{2>P*_=A%W*j<@*;5Q2v(f_0ou=Yz#c0cQ!&Wm~50-N#dEZvnGlIymp>Uy3Q z?0SNM9Z;vzU!*Z@=Zm*oxOFbko8Q4r`WMq7-Lg5==@qJueeK`hSXAOLx z!FOlUXjOt(an4DV*Kiuw1?0#-|CzfRqsl1>srUi4&^sQY?;Kvo2>Wn7YjDpD6ncqO z_Pjw#jMxbkyis)U>Usf=M1FcUCNZmrv&ESi^{)&~zlRm5_|_~xOvtWFb*B4NPyP&U z`d#SMJ2<*N1UT~A8qx{uvuVXUs%$I;?C|d~kQ}Z>N%_~zL+PPdy&@ue_VZwpAW1#?GLltC<6z31v=nz zI)4OTpPBy)cEaO_?Gaxa{P}LZ!JZ^g#wwp|p{|~;x|jUQ;W!(&iCK;_9Of0;eKgx} z@zWFbUe&9bBRXl$itGCmJtd@-1rK*Fhd;2(d;(YMKU?|nlAj2qx>-CC$+eLfxdoT_ zAGIz2Na4mdBr^71zaAaQ;>JINk%UkSN6Dn(2yMchV>f9ebc>!>dvvd=5a_sI0t7_q zBdF$I5aZKi7&GQnNFcY)q|1t!EzCP;P z>sR3ufHQn2N@_>0BEGx9X&MV@3VKX>tW+iw~<%#CgirLk^k$+=%ho`I}^%JZCz9jp%(a#6pQxDitY9 zN(;qTiE1n5Y8btuTH+nGX{Zr>X!AImJH~=*vWdS)y{ju-L3bmK_1!csRp=Ig1jTIgFAzvR`&VPtMCP zJ6ww@%po>@p}m>G{zef|8}-mgsUUpbVZ!Ph0%bVzbcn={Sc%lCjr+IotDtoV0`ilZ zytet`;9;cC4Wc5}7dq(Tj^U(QJB)$6!q9Jm8FJ#1zZpM|A?-%YsT>^!(R(JK-Kmof z$U*(;1`01YRjv~Zd>kiGOFJ9tL&T80rNl{%vN>ZX19YXzT8!U1XmLRs=A?h0e=AfHX7O@NUI1(KsQ32a@dqr{6 zmACtJCoTs(Ze)%(h&D>^eGpV~DoyVcghD)3N-d_%s_%bEPwpu0--J9}UDW{Yrt2xa zuxc{n;gJWAMw`dQ_E5s>)7b0Nt?%pYs?X!dE@L>q9{ROI+KAt1SdvN|nqb9O z^5XDDFyR0+cHO+qc-ELbemSWZP@3gaa#DfJ$ol4eG(tKt+t4$;qS)~lGo#Kh40hRH zTN@cty@fJF=Fw03lx`RDGMbHFf0vBQY5LoQu4lbYL8?``L8SAzeif`mQ{^jG&EQ9$ z%Yc96&&&N+C#PQl$wVWpuwryoFOyx15s6y&g`(uyI2J=2q=`{fg}>)8-9fAkyo6q^ z4PH5nc)FLGO5&8TKa;SMBOLycC?tJLp(%XviE_v7=NF!d0uVoGJY#}hd=UF;wv@Re zgthMD>d%~Q@)ciZ-|yS7OsL|`f6NNsMw-?avys#kCEq`bW_xXF6&SV=mj4!t`=cob zONK6xv@ceBpGv9lbHDRdj7~61RU({6rMr{+lft$bE-I~}qE#b{ebc3tT(Jvojr4y~ z1A!t}3SUINtZy>F5%jR9ij*}YT19@<>xl6i4z7II$jTU7_-!R$aVTG0$0%x8KBMit zy!BndhezB#0M~0NDxGL7AfU2g7ZyV_fbzfTicXWI50Rxv$aNv>4rptJ`dK^Gw<~$K zyNk*6NT}`@Kil&@kMJNT4(sUFM)`{wJnM#Nl`8)BSN*WmMk{oy=yk)ljLl5lF}oRrQK&0NAwmgxi2QKGV5 z`xb})%5BGMplQjesPDoZMs^O^1KoH7@*y){cCl{aG+?A+C~%uoSinso<+&_!qNn;@ zLHJ5t1qKO-AfLj8He}muUywNaD{bpGe4R#FSzYygx|`VWZ~mPC@^KChXZurBAHLL# zUmPsf+k+ir27z{q!<*k;)~Z?zruxV*N2jM_aZ<)5?pCNoPYOt?D*0H^=$eanu*H9I z%|a*^_IhMyp1|u2oY;%t>G8dMiJs6+2)2Q>4kd6noQ^+~2kI*QCo9a6z2sX-7G!aA zilhcLC=a2}83iUe6EUXyu|MkXxBtONX^uDEq#q;_RK6o}A!2nOJCT%1F3LpzrIr0| z)Tqfk$dBC{Px|A=4`}^ul5nDbF7HW-Ym4*Ds*vCjrKwf{43t(o71Kno`qH@SW)k{8 z=fQXxhcNu3R1-Nug)#aZO;=J~q7i&AZ|xhc=SIZx)R==v>0pd=Fgs*#JNuEQ!biJr z{DPyyTmH`rU}I}5RX~N%Z#qBkQUf8={iO&9#sNr(7z4FX_h4=-bdA3~#@3n&Tadjw z*ZG^+o)5EaD9>3p2dEi33tz$xpkp-{f~W2cw|Q?saB&Hd5epU13k?jK&3aZWgn}_A zaC`T$C*%~T)=K8ms9b=jwyFhj)l1uFVDixVq8X!QE8vCmB7Eg$VOtbX z8~HW8sa5VM)GpS7=EC$c9V6e@O_4mDnmfB2iqh1M-ca;NPl)CQQYRI84^-%}q|J-} zENF$4n=QzMfIJ8GUh$$#8|q(LLlvoU#%zNz6`#zD6mUvU^56%L+`7;555gU07a8{YcbK0xfgUfj-lX@ev0urPMk!FsH2?so^_ac z44x#mHgP+SAv>{=nlu3$I)_q4X69@i%)|eJ0-LXom#2ST4*!5N6=sl^v=U*w+B;9* zZ-r;}dxG9ohuG@kqDV%PpD7QD*7(w=D5=&%oyrm5*h;UtI!vX5>rd!sk-T3^@{u2{ zv<`w&=FRJ6xc`NQ++Ls^89T8K1)Ht-A2PY z=qodG5bFWs!^!=>eC->d#UAZ1+SDiP!Hz+oOGr(5So3>IcLP^cZ^aa)bsu@}`jp}0 z%X4!?n5^$?xDv_3#*M5Xyif?@GI1yp*RULHXeh)w{~6P{-Lv#B*(f39unTUzrauq$ zK;KZ18BIfn>!)K}BMs@e(_IugA2SJjc>$>*2z}a2Py0YfFe8+RyF&66VxyCC)TDI^ z9;`Di$FDqRG4vVcDPtAtqB=%;9HV>ECX49e^(KR{>URhhx=-;v)c8(OsIKzo&{F!M z#FG4@!U%74^8J$&XJ?JH)znqetf1#a-ttAW;itI>(#o(#Hh+(Ns0DZI1u zg@GMo9neHO;Tr;U>M|8j*bI?GW?O>y?t3jKy$0R#YT7Q~?%fLp)%h$O5WJU~^P!u1Ie>{~(ZHZ)+eTovCm?_C|mSDn_OVd2lp z!M-Si8buGQZpc^`Mg)kfPD5c;3|<0lc|kFvPWnSelUNigNoI$QodLh~i{OsyAw5U1 z`#Y=+Df%THs+6qNhNe0ORX-VQsAGcO{tTB?r>h*#YtGXM{A4C#yPG3H=8$(DR+rVp z=v)Xy%7`VxVrQ9o%1^Z|ets-FBH9|xlb3M)MvRoj^;rGcB?DfX#SPYNa`uWIFxAf! zqgpYws;GFC<%Bgk1L-g%JD(`O&ic!#3k6OtS;YM{E>o)O3N*5Lni=oxaM&642%=|^ z%|eIJhL|}s(t$@L&5*oE^T0C(p>1} z_RPoT6d{Ca1IF~mCI&&ny!4KWSRIS{@Th4EcbijJQbn?KyKmSmVskh^*#@OYp_BIt!MjZQi0bC9cnJYDbiBwahhb}*dm zH@rT4ksbb;@55PerMy>5OCu{d|KBR+_d-5YzL9ca@hq9e-|w-rw8#J1tzwCLwx1%} zvx7xn3|_Ad!1>j)2jNDLeEBTJr>7{Adfn5L_ChZ4i3~mU=382MErB+X@W^s4U9YS{ z7Tt~*Y4dv%e8=&H#Xa5FXU;3#?*nsRU%%}Xr#D4yd`a|5AH@*%te*eJcLp8jS6A#@ zMgi>P+cVqCCB3rmg&i>Yy{lmY!Dp64YCRD_{{&nEtG`V^c`P7J0kQ4%;jmmbr`TuM zsnQd2&?%zH-M7~H920{D&wpuVXx;Uz6Ghl*LOFS5?FSJdp%>tj0OU-OxsOpSAzt$0 zuIL+5`W%ZNl+b@z!V&S;FJ8ee4J=K-rOZyH@$T{zP*0A&ye}LN%ytXX*H+V7$>wwC zd%7IkC3NUtS<}e2vAo ze-sOD#TNY(eA~BnWY}jNxLq=@hbuOU}A3&>pS){EMbMN;2iUGvutM zyIiu`C~L85T%ND75-Vn_`&t^n3^pc$VvS($bpedG+JB#`$0L}XwYqZ{o4K|P@l&+) zyME>+k7XPVV!>~ZC&o!}DNgY8AM=h-wx*#S+6g=jZ8sHEkkI#+J8O42Fnd4u=|7ii zN2SnPh3I9l&bTsS^(Pto{SSBB*f`K2J!xnYV(T@d)$zqdj20eW@&`6glY47v53&Sle4)0 z@XLodP>0~dZ9oN5{TH=#`(o}?5f+sg*#V7r;8of@3W=Sa^MJmanu>9L53eCc9MsP2 z=SQTW039oY$JFHbD9yw`623ST+`ma)O(-$E#6Qu?ifg=XV6zY-wL1(WUmz7!vs8_x zSF05=!WW1c{}CZQAzEYQ9HxqKGg}K!tJC2@s`SI$sim^g$Ge_8zEJa$?Wd9|#w#wd zys{W|`v~u^Up4%ING6@c+#CrxA6L*-%2^Ds+FB-CD9A4iI}F^smlqbc+X#E@VGSeX=jWft1UZD6 zFoG{#3ZSsis#TCdndyiO`T{sFPb7kKESAlxLys6Vn03m+%Vw2hFwu!w!%EyG#4l_C zbc516s$gZ&w@2P%mctkq-| z6Wzr@>wCL4cU{D<^>pkQhmoC-$fgGfmz5JDcNX#hrkAI#n!Z(FbJWk-tb|f5q?(S`O7f+n}^q^%Xhsq_WR|<)mB{lGw454PO z`%ZqIczur68tfh!(k+LR5hf_yRbf!{0IR@A)F3#uOrLsv3pY?+?(F>6^vXy2%^jR>Ey47JTNWDGo~f=JyFJ0_AKAKyEfYeD z_Ii)lvzKNMS!}bvH{(DL40CO+w;oI)bzTd3(2Ws!gD9rYFR=|y+l`HlTfx_dC#gfO z-#~vI{m(zMF07C$64xD0l{NPGyW{I4Ld%4L5vm(?MJ?IRo2T%<2^}V!%&G zL`&6uhv7bvxIey?^au`%CbE;Tt-S4AN>HpC^GA$)5No*r#%=h52kn*fb4Om~x0-h^ zwxrN7Njm}+TccleX10lA_r@nf2a|O?a!D*!CNmQ`BA@ThH_fUmE0a?XT07uKhlysA zAcn#mTEF=ay=bk0csg^|u|f~Y?$geGxu|Ldg)EZ}%CSqp79S(aK!uh+C&byoMx z{Xy^O#F3AcUYiz~6wDvm!j_2M1%FeH-F_~3&4mn+f?d4-Bj1%TTuzIA>{Es;e$dE` zRH@Oi|AP*&|y2C*4tc1Rz>1O?- z4I7q&rAJ2rnbC5N4ap2UIho}Bp_J9!p@!-TopDN_9UfM2Q{L#WGBG9=vYRyfxZRjq zZr#lphnaF5g?^FAJzFH6E!@(bv4jKJ;I|n_4DV6;AXk=_JfwRV-WRi_*&wpzb}WFt zYm*$Kc=JU|#XR$A*OR-TM=2^wS$S9H8&U+H;61`YLRA8Cr!0?C5AF|Vh8|DW+Sg8U zrcNG76GVSOV0X>M9f$-Kkq0yVga|a4@t^7KG!__otz}k~gtQ322fmCkddl4I<_+s5 z9JD`hLxJ+5RY0_QdLsOJk6FIy@2wns`-PxOZGl2X7L5dRgxX5j-}cCDz1YZAYRQJ{ zqlzx$*0dGpIXSB0Pppi=IS!K_9v2QC^s`}bB2O*HjNeOF_i>?RV2%PBxTEU_;b9HI zA!q79iOw}fW#ysFLz{s}C;T%NEmm!SRzryOiTTIR*^A103m~ zCa$5SmYJm+4}(I8#w_7Bg#9dik6Lc}i8d$dV`p|Ju$ocz&xO=(RnSYx;qf9MLiagC zac*cXw6gc07L|Rwq<`^VknvXG9^%O8{Y2>-YBB!X5}@91Zf`B~2P}o;xo^8Cjb3c- z>M(V%>CxBN+_(%(y(c}#K*}xq7SMMqvf_JKn|iY-aIpT1^ubm6jI4!%aEtqXa`3<# zG`97ThI#wp)UmIV&qCjGAB27jZd76t5+8#q zw!5$AuDc@f^sS9nDi+>2^k}4P9_{G#EXPb04pWx$c$hF!Y8=&&vEyKR=np%6>^SPG z>hy3JPJ?hIYN-$ErVkQGnK)Uks%3Aqh*gu_$q*|2cnK%1I(H7jls*?6# zwm(Q?V&hP&`RcjVQ8MrwFi^jdPb=&2U?t_#p<)%#xt#w#)_Km%uTFH8BzWm%hP9ct zC=A=vX&9hg{LX6dm8PZX&`Y75hqN2DF3lAnl76KKtbdSZLYE16FE6~xQI;g@gS@y)r8uGv0_B5 zVM3#-@mYa^@cF(E;%XiBtPO8v-Ub5Rn*cBXL@vR za0o(Z7;1s=IZV@2kSf|2d(e#{B;vP%dI3jgxr|rRXlbPs@5A{B zb_)X7baDE2N$j{bT{E(28C2tami|__VaL2YJUsmTae0?O5nGKp^`n`OU3@Dw)2COc zj><`;m`B7VcnSBM`kG(1=RV4*3iwI?m;}I|?JPdx(>tuQyH1`WN2qgT`)H^e{`lz0 zC}i*z+5aseAc@wdRJFD)tJPolm+*qw*zUC3oV*`FQGPfPe^`O`cx8EMsax31hHvS^WT+S_zv$&9eG#WCgNHgw2oA8H2| zg_P^x^Erceq}j*d1Ra<6mQz*`l%D6y)*Q?!W7Efo2;nHGfeK!~jBSLLx1!=NJOlr~ zUq5fRu^NuiLZOuoO**Yxu1p*L*eS?hND05EW%o#&qIR_695|jBe0@)&fhrC4WR3*+ zJK$84yxw6EXOJcEv`hVh=VirNCF}U)rEk~2ZwaWiseMH|Q(q}Y#S!law%D=>;!`Z5zWC;tJr)lY15SHVV8Z`i- zn(?hz7i)niqGh_``h&i}#@qYy0)?{CA70H5wx8iC|@Cf*R<8Fw)S<@$u2A;{T*OTNfWy+@scx zI!=KS<#@n+0iao6@d|RK&QUS-q&=J9cEl<|o{QD&FjPO9;uU{)=A|yK?UfwKosab{ zo&A(gH63*6is-v>V*Rb&)-*b=JNA!Nz;0l@BuAavyN5w=|LdDB^6JPVAOad2MosBsLI7R)Z6WnWOj;UI0;2Y|bSlj-4{l7A%o{^(lzd2uA#uH? zy(c3?nikLfyjwf_TztJSa;NLs*^@VEH)3=ihIg98C-PVP|D)+FgR1<(Ee;4sOCu>D z-Q7q^cXxMphollB-67pbcXu7S8>L%Hn!Eq^&i&*#GUMSr=j{E&TEA7Q0>{Y9QNLl! zxGv^kGQ>;E?e(0}-GFR( ze`~ATzLyp?_OQG~{IA}QiGu%0Kdx}wR;|X1r4{b5S<5BS_=E}1x3zCYO=WwbiqbwH z>dbTq5IKgI>k~Nea28@Qj03zK(L^dn$)7-|q*77a1l7OaGqDsf&vpgJtP^J?Qv(SB zCJ`mYQ%CE+QF}R!olY-(cv1q@-@r~s)|qlipypProeG?4vteD;=x`iAjB&q9F?9J|yPu<<>m zlzSk461=_fJ~}kTzqOyIqM6l_NxdFX6=rxAMM?hHli+#gk(fXKxrbQHI;5QuZQQJ< z-&5>iL*8-MX>)bt@8eETPJ8A}wC{NEu>rjBF-P`e?aJKbEY~8%*x)!A0E3yY-7Als zGoW=hbv?@;t^WP{cXyW(#XR`R683Ll=-0rok&+}h8oQ8&nxQzBT<1h&GjN#y$F@I1 z@fw5f-L;{;PTWf6J3XpyG>TAP6+l+#j;t;OSee`UJKsCAY&GEU2?=?_J@@EfpB8-j z1LVpC(Bek(z4=RoGbvsEim_mTtY!-3k}_+syNK*sU?UM5_Ak%E1g@~C0i21y{=FnO zO%0n+xk*2~3zAD5x0VkWrM5d!_5HeZLV3pwCjMl#Z_cPAwEnbf^}a0#4!}dr`D}q9 zKhMmARcN_7@l~D6(7suN`t7gu4j6BmeH zVGK2D&L0eli|jL9&M%2?*oHnQH4O*)`I$YH^(`#?fiV`cgpGx%C9sYGsfkN__&*nA zE@K*yUU@V-jr0OMoXe+-NL-UdAbZ}*8zZ!HPPd%!d zx`~j5rqU8YguXWhWr5-AQ(Jqx+3@_|XM+fKy(*xn)+J~uembOC?#5veLa}T)G>zYP zkrKn9vSk#|49E>wY;_D8tP?WbLO@u7p?sq!CM6%H#e{}1lbL2Oa85z$;91d+mGk7T zY?`4m7=xCe7aQu@DK(0ft-3E9{%bH~JJz`r?gy;*Vh_(EtFtuY9)2%c=hpU&#m&a= z;=?GPgN(lY2wmsuyxDGyFIa8IB%*XUNRp)cGaJSl*K2? z#E)<`vCf)ar4t4h&^&Y6_q`$LMCjhWKt=od#u)OU_;NY{7fwDI(d2gsw#MUonY^+$ zg||u>Sxt|lBhpQx@)B>IbW4oOi?qEu!7^>rC+~R2yS$p2sJC(U+EY8i-u7kFFW%>< zKBx=!>&oCSr0+G=%4nGPX&0)uQuXi47n*9sAXIuq*%t|?JBGvoj__o%l%5oaGTJA0 zyIvqJSc3H-{`h<0iKbB07PjMV3U0=p?dPw-0}kKL;^p9bu(cWH$JMW8#Q9&jQo?;d z^bEweW*bPA#MbX^y9NXRbgGVo=z@FR_jQzj5%k)mF?Hq&3(^JE_r^0lvkaKXLVt1x z{)8r_@q0P!7W7yg=*T0qVGVy3dKE9f-wswSriK|%uPm<3 zsfOrJ9-7PjS0mnQG>We;(~F|=s3ylSq!#1*8)Icve1m+l1caMFps^zRUP$oD{`VBV#}N*Bl{00eXx2J=(ijaYHw+ z>?Tt9PFmCtSjz(HYlT@TQN*=GZ}MDxeOLc>iguV8#Ao_D>ztzrrml{8@*jgcBXI|7`%gn0})Zp;(YK*#0O&&RDdUV1bsemA`vlo===ttCwgtY*+e#A;Op>zyaf*a zuYoUx)5@O)lEgs!KU?ME;?%+UmU;9(X(=YkIAU zP{Ez-AnKWy>Rar>juf;J`P0Cn+>9Le)=b3cC3JkI0Ewc)V5SN#hYv{sosNO{#t%1d z+^;z?gxy&SyOh_cF{?S(uTQz;AJUKB!&BH#V}F?z=>pFHVRuaE6+B+KL60upel;tC zV^UXwhvl^?vtMnz2vZG(iFMw?%mGnj|$z@%fYU-`bJ zEKKiatYupo44(KkcqJE$kt3HH$JDn<$*>#F5jhLkyjIHXjmLgVbX3Z%h;cU9pLx}f zs5&B&_~YH#E{`W=E>z@0>Y`{@uaRX0{%EV>b6yM&MF}t$;$;=1kbZnbXLZhbUo0ss z|My_T!@z+Z>`%79bWgLb_~S+yZ6zxQOVca0>JeVJ>bgy;0K1ziN^hg+A4XZXg-Idn z6a9g$SwVPuJ|{OfwQKwa2tR%m?FXg**8RulT&K#i4 z0`GTI{+<7arz8IGp$`0(12R=o76K5q^|U`Bp+85mJaZSoSHf=LzJ>Q69Vy0LB}!aP zsNp}y#Q7Lo`Cn?y?_+Zi;X7BcQ{+bPj)V1BNnMNAbcOeb%4RtzClvIDwJ6o1#$nCq zib$X{Q3YTBy<%0vU5ZyQ5vVCzkRhn6F2xM6*tVfm?!PLKU9km)F8RGz#jTk0hF8c$ zwPQuNl*aJk7xCu7VNZ;u7eV??XXb=Zeg91nkR}y}d_}XPczn_9Uj{wsc4QGwaK$XO zYO50GF#32)K;KIXGj4SAJ#3U-*AM}g`zoFOFFoJ%x&SBv91@9d4P zReP8mo2oLH?*!8P+s6bm*0nS2^n31tU#ue)g5uW*I68xnz;4LfR{o6Yn>M5%*4_=i z_jGk8G7A>naE|Cv<@kn-EGn~FjRaHl#YS8^i7Z^Dz>B*86XE%C&C7S-kOu@?C7dimp0%f) zXj-f~peX@cD}Yu76F%u0T(n;X9j(pHU%Dpc6VfV}JeI<0jSpP{C(6E;Fj2(1i|deU z(nqz6!z`emthNyJh&%zN#9TQVhB*z`LjOnEOa3${5j|iq)ySlUC}bI$)p^`n>eTwn zzLe^zPUm+k;|`hTCd~uyBHHR+osNX{bTjX~1KCpub&q0{J28y+$Eh(djh{+b_tp~W z1qQ*Zuqw~NCB`%0D~$|2Kwu${OF=kM!IDcED+_^BfZ*sbD{k7w`;@*uDc+fNXY^Ja zP&ZEYc^{pEBUTEXEICHG;HxyI1i{nw9^Qud0WIHrsj*WwLG-?C17dMFacy*m3igUFn>D4#9Ak%_zPe zN3Bg%CMuMbsV3%_?#R^~6PTOae($_MOm_y!nZGModf@3r+OYQ&wsR|mquXv}_~V&L zyG)Id6bnZ>mHv4s7&uSL0KR+&>e6J5^P2hT+9r>#>RI(gMscT2aIj|-1+ z=iK$f5R%On{~OI~wIlFE1rxF9tW;bw(2FI30E0Jn9U@C5+bC04cl%I;VFIQ7gc_8M z!Z<#&Px0lr3AkU|IUMTyDnGHUQLd}#SvD^`jFv@rJJGka`}GXS?DR67h`kPS>X(qP zG0Q?KoQa->!f+Yeh0Xp!I51EtFg@>{?yo?;(m9s7iz`_yf_y!7qx7QLX6A|9ezZg; zqwR)Wk~9UE)#vb8k+9*sn2q`C{)_Lw0YC!inHSzHbgzH64NBaDZ-iN0 zi}#omm*f&CL8i6?Hb?md1QKm@)ZoUXf{~&78-S;K|6#FQ=+*8bWh@X(J&6pHt0uEO z|2l`y4dL9dg(zu+mlZyqs(b0moTKy{OUY!h5nB@0bmL+Cg|i=+9)3TD56KvqGkl@G zI6PD_esr}FSy40Aeckj{F+{q0?RtZ2`0zvIX^C+uj4ii*&W{%^82vAv(&SUcsmj|D zrxK&+r?*GE`Gco0WrIVqr727g($H{Q7LvomEm>!UH1Av??ceNRr1XqcP$=aP8e_{J zSjVzUy!d_$-*Ua{kt>rnaAS2NQ+qIJpQ1U>T{lS8e`&{CG{Bg1Wk_ODM8H+pQd4ZSd%L>3t0#o775ryq_K*V?-lQ}EzSqqW zV3?z3=MjqRDqr~S6U4^em88DIX+GFHIT=T>y0MIQP~WwhCjN<1>CD*6Yl&K^M7yuu zcQ0gH^eNZp-&s~_bVY68^RXc?b$GP5etZFvMgLC(-K3#OAsFr=cqWw8JwcZX?J9rT zI0hB8${%4fMwe6-5s;^fdsVX`!-k!H&WA{vLuv5e{9m5ZK1iW~bpa0{@CsHM-gQ$> z;y160xA5PxgO)bn;jkFUoevk~Yq7Zc{u-`nKUcLmX9%dQF3QQ^bHs;qtyMdG6t4dd zdhy5fMTOoU@h)bMFpB@$-zG{yyOM$D@sJOCP(yE{_(U(3l)F4+3*BQn)*f@7F9oV7 z3ls4JkGbrRT{&qSElfAry=T259Y=G00ls9C!P4Y+Vg6-x*y$1p7j&WOiZ4URtt=Z7 zsFZi1>OzD%lNztC3;-a*$Be;I?}x)>Lq=( zNd}LzyPU+!?mw_GP?)7cx?leEg431Hi}!Xo(Wrq>e+fOJXA`rDTEuJA^9QUupKb7) zZ_08=4ne+b$K1EHsC7~3ca~v@jmlT?$9&3LaR6B0yCy1pkI#@QjQ;gQU-4wuboEWw zl~ONXyk0XKdr0Sd)iq|Hv(_(ZbxPm-R&7kQ@a3DUr)~}J*t)tJ-ZH|hUEG7sBOtW_ z&9yW>)bfKCR8ZRd?tiHdvKA`@%IG-gF(3#Ovy zK#8Joe!J`QvzZut2y`H@!iL|$s@6@+QTa6Qx%RGdSfZ}02Rme z2%n;TR-$)Nrc0QCpU4#jd#7)2DI}=^d65VpN@O^IZ#m@pd=W!U31SvvuLKX{Zz_%!#W+%@2&hF{BAe*r*Ku^?vp$ZK->o!a zi}$%u19~x7IX^dvoB1`fvPOme$8AQ9NzetdP>?}X9_6g700i+1`?`AeC#xjkC&w@& ziha!5OP5;XF`V?`CMk1HPC>a`&ddc4$!2GvO|7kbH?YNxdNG|g39qpm=D@VN+;7F5hDt@Y6^wn7 z;JDWZmAIJND2jyggxZq{G+0DgPvPE9k2+{OG|LI+TICULi{}Z$F-hX9a{_+I?=YiT4N!?Ii|MNEXcNQ$i zJUB|63Xa0boXkuhg=|AQJUEcD!{+7{Z5DHoj}i~d`DO73LcpPzyQ50-8MRIzdybfA zqM{ufJ9*84pE&f7+0y18~T zyPADzP9(W`uo1SMN(4D5`zcUa3mxHm(Vlth4>yU$*9gM1SN5EX(txIK5Rw!ZeN8Po z0U2F=ZvHv0WQZmm_YB<26R&$vsb2Q@sA3Y{n%Wy`c)`)pVyI6yPv-*%)QLRY9~{Qw zl2GZ^Lp&HSceZ;O|3rVoY4rD22`fbJP;!D^l~F9;fG@CSu1Q@i5C|Jb&QYYBH_eQh z>+pd;X;gsF3(Wd;Mw%pi^y(Lm@|P++_bYFBn=)rMb=eoGpPs!uofHP)BXQZXsIcTO zxk!xPB442us$fqE#^e0DIVHScs;T&;4?R`XqDXES8`au)bENargu{Y$>BYm1EmrCp z(zC*4I(6i@MRc?#1U-X`LXnb%*v;uyG9vOFwSmLb5IWAZra`9 za1`K?6n*URE1RN77m}I29GG2@E-XA|ycjt?)rIxDo?uEUCdGi-nV&*Rc;^EmV{=~b zbHKbdfRBH~aC}>M$2&3iIXr^!LsdI9{f@vRf;yI|cuqT0;$|f3xsbfLfh=B*2y(^G z8I&pAQiaKesrI0Y_R8{OzH1YWu!l?7hNK3z$W$q=qBvMGMzk#k0ht}61r0LA#g%j5 zB0sFQcm!3c-X+<*>Nb^dm} z1u3)QI;TBpSLzy2_xyRZhJl7Ph%L-GMp-WV)!?}V8-$e!ty;j-YW#p6$!C z2;ichhM7=INP#%!(l8jvNydNim#9JT6Px|>^mCLF(;-@+Rdlo}E!q|9C)ZD?(y{#Acx6vm zHKs^f(IkS%JGpPzzwOzJ;F!#<>HTc)S0_v#PIr4NC;5E>_I=98H%7>u z)9u!B0DL*7pQ*90Y*}g*0fqjPAfr$#&U7~P10XD=k>A8Siy0h(_BUX3?Z~Quj<)IAtQ;?q@ zglxy_R;I*COG!yF#1^bc?*dT_P!@mz3^*`T-}0x~B&Dkrw|LPNtfIs`x;jh7Z6~NG zj#l$V?WW;enq@Zo12Q21^uRe5??#uibS%|8dFH@MaiYK`t?}fnq+g!oji6j5rGFc7 zh|N)WFMPA!=1D-6>58E8LQUjokIl*kGwQg}-qO}~mBeFdOQCF>!>n)^Ox*|Ru9)MU zHP)S0_pK7F=NrycpkT!|ANH7VU0nY*&0h|Eifb|qKvV}bAwT|ATZ@>w0P~JBsHsz@ z6jC9>V7DgIgPIYPsMKI27w=oO^#Ytr<-iAh`P>RU4xLW1tp3%*%})41g5yOr|0>Ze zzb73Fi*C3dvWG{r&Clu}$TMw_>?_|a-8t$by?A8)$vA3Hji3L>I}Fi#;mLA$$L4R* zLknZ7ZbB>__WYA&>Ku~&M{BZl?UKuUxOy1lUS;p{Ip_#xR2%yG`RTHBXl*1>`Z`s4 zDzR70VYf?aKVcXgZp*AL^#JSWjrv?uj>~?j<{x|x!DJu8HcF5XLZ!>!Td*8)_l62L z@FGI^TC>dtzAy$=W7UroFxDF_nC03*2zyna$H|qZuIdI_zFwRJ#zJT28?>ehrSwpZ zDsBs{YACF^4pED#)Bo#Nl>Phs>`(tRgX$s|)&Yu^P4JB@`PjCW61G#?F!`U=`rl-_ zG~P0Gq!j0uxTS)i|IOEjKI7nEI7w_VrG|!kpmaV;_utaJ`vH zF*<3QJv*qUjS;Z6sKI*&f5tY{qM2j0%p8#c8edF_ZtG$ZXuKk}U}lSyx>}qsTg)@$ zpW=};t;qFYeP@ifYt8s}7;|L1E_I8|QzJh()H_bwn#LK%hK7>xC}%+Z)94Ck;QRvu z&Cn2BCDxOd2E*Mka>T;pki|f$`~ZMaYyT#a6kQ+~(uxkG6(SmN#1wF$EW0=e)jA%n zt^qx%wWKMbXz8}=IQZV*R|~xkW#_Rw()TrcdE+s^(83GmBH)+z``QTB!ZublN#Nwy zX!*ZdF8++G2TFoNeXKxSX_93D!P6z{iQS2b7|N1&7CPC|9AivzW^di3uq~44%@Cdr z+il2$s7^^|usc-EYzVdEV-FH)#Um4aEGj+5Tj0h=Mj{YO8*FLW!O(7DNn;&*6tN7y zH@qvihP}qO2h~LJFSi3hdXDgbc=8(3ETlKu7`sXm1C{#s7#@}i*=h0=fS!KwU3%s^ z5f+O&X;xxJ5OR8@xQuzn_BGj>WF@ zzz`}n%)f9ga?juE)&6DT``#0W{}cx=g!1ov@<7Hv1mx>Ur}s77xC!SL*h@$f6wFk!9)#X&@E2_01K&U2*UnlCb^m zzj3CepRO;*(Bsy*X9u;~kmH8SibAO~u z9YezS^P7rd$UvW|CLKE{{Tl=y=CfEPkg`P^nyqV)=WRg*Sx!FruvlHg3+ zbK3R@ ziCn+yqhIZz@VkT~AF#(KOX+FMidea-rGG5J{P7!Dz92)J7fo1BfO>Y95|u&ZkFKeH z_44wvwb)y6k#ce2qM*Lwo{ z6;ox2t5M5}K2|f!&rOL9M&gb)hD+pg&cQW71TSa$s27E$_`%?lkrM6YDTA9_XR$<) zMCR--yOJ5ygmJ3-!{x3l|L%GXZEnUFYZIK!&L~ms+b~bstZ_13&UDr8t>TQv>s0dx z*;3_b;!nK1xgoBn3`1dRe;l*9R28e!rW%jIxHjg;kC6? z!XQ7K7cgJWDhlP+(U&PjOR$(sRi8Q08p7Kc)JR2cbo$#;dina=YW}&rjDPQ?p8ZL_ zU;Y?$GZPmeV#gD;h9XPAid)D3wT`8GLbEanJKpKVwI%wSk;EAN9*a`YNS5EZIQH9F zwh7_L#smEW?~Tb*Ell`dD&5+y$9-}(4BhMq&?s+1Ad)uGx(Gdr_;|7~g>o`~lMz&) zov^C{Xy!Q)uqsBKN1MNdkv!!;Ej+>)zx<%WT4^*6#`eMKZBNzu8B23HD8nW4jLuS7 zQa4rBX<%?i$m%0(dZEf-or(HR856;Yyeg-%b=nPI7|pFahagbv(2Z=Wakel&;Hcy* zIpAfjblcrS%mo@Frm@A4*yX|q4Q1LM<{ihbg)oKMX+eW3KZ%UoU8t9N*Y?5T#zRD&j zU>@-Oz!0oBhNv%OOa2{E>p*^BF>DQWvc|dwzSY6T&Pole2_o2X zOJWu=@lxvBq{ zSK?_MtUP>W$wF+mNR5y<;Vg8s(Hk9oG5-im>r=>#|Mr^4%ya4wtk zeqA-M#l#H5gF7HrVif+sO{mb}_S&H7ElMHTmp-(cU5t=xW2H)*tf`KGQ0PQiMe(p) zP(nZX2=WYA-jX}nC%m;q88bp)r-Dz_&ej(`EPcJOyXAgch};2@=#gJFoyEp7IWikU4-9A5%9zW6 zbE50r)1!&2DPrv5(LGG=sazV%qchs3%K$|hDAmA%fF~4ZO4ISSj=lUU|DONIsRBGJ&M_s7NK84yQTq5?hR;ka1O&%-2 zs${m@!cWl$O|;Q1N?oxCA7xktfwl5sa}FJk$_IL+K}#Y?Qr_c=v5*N?PU%K8PSE)G z(`4K?gs{*(6_#^N&p3oVWHeMgGUNo$Ea!ZsF!xxihnn@{tiFrgF+7p&iRE@c6QD0^ zU0Xi;g$%KO?)1JI+|`8nwr#=iIm#%b^KRrhRUSpev&aJaAHj;$*4Q$I(I~7dV54}N z$iZrq_<%G+PE*UHbhY|gEv9QFNY*<$*___nGHrNflgw`<@iN(v5zEq|gzy)bYfOje zRu(s_)LLSm|AL@T-d;e#EzU8#rxRAB8^;I|r9^3H{+M%O?|W~Nc9BL^)1!c6x(#ka zP$d7cx>uM&<|#O9{z! zI;@D$0x+ktd%@{1URNKR{*HW*1E=H)FJ1Inq$d?r?B?Zlx83)(eu)h=yr4}s?%f0Ok-)n2c=g6#;)U&rp+_5annr+3eMAW4J%lGT(FJ;(g zlaw6xpD9#DT{y`a$nv7^v4EJ|YS`xs?zm+vb$u9(CDtxn5F^c8R9PL%>FW4Ll#U7| ziC-{0H5Pf>^G`w%77P_@X1_zLqw^Ge6_}5*(BT>Btea_+(Pl6sknT3=+BqaX@G>xF zub}#dBTc1O?GRbIj!-NxaF;EYedU!vJj+j=GLj~94DK3{sTftv4hEq+w^ z557(9BXwuPe6cv*x}EFi$hVfV1tj%gbp{eF|8Lo@`v%?Df+d&Sv2>pT4`$+Z+j`hx zslBt)145&QrGrc;j{p_4v$MOhCjh5su35$G*s?+#`Bh@rx1Npd|Fr;*((kD}g=5AH zZm{a8X8T~f?_Cd_npgiC`SOvo_Ppl*$v5-lKt1+sLe0;`*7feS20Qe%afG=SG*z z!^`Bp9=$Arhf}i!r9ZEaU?KB+?Z!uo7t@?}-Xut`RhYQE$BsZ~me%>w<>6tekx&2I zf(XLPF_vk@QnY4y7`Ffre6YEhA_%Jap;;%l=n_R#2qBt9QK}Tshy|0TeMz#lmYTmB}meTUvS%w;cC*}c#ZVP*=R zim^P^4rA<8xvHu#43-RyK>0lGk|d&f7LqQ}%W?ussrQ>-=!@{Pmehw(~rX(n%B zy&jeD5Cey41aAC%2q-+#7O9AEW}0I?13$vTHb;50(mI8QXwSHGXEz)#0snO} zN2txAq;vd>GE}zgmuy*W;seSmTq;OoLhi1-?~((3k|U2DXEg{7I=M?2u~GU4V-~H1CfQR{M$mQ@c^+t%Z~yKd+uG|?_U1?t)Zx68^@HY z%iVi+tkvS^Fc7_CMs{{xC@6!-+l@UrexGs{Tbv)f_JGjhv5_~=vwrPjJxcfbnVlFT zo`>YEjqwVG$AHm6s8~VD&xh_#=ZMK%XCR;6NrNpNtBKbG7GYaNE$=fyGdngW%T27l z+`LzY{~}!!@az|9EnmD0vvZDkq)nHx=svI4RyF->q$xH1qLeOY`0$xV z{xYTamG;O!h@xXaxJp3)(fM&3ry2Z3NpJn@?Vn3%-^RI7UL&UF|mU*Vg~Zp8TvHdUQr>Z{N8*hF%jH2h+Q{ry!b@~s*7_Tmh&({ECd4+*UxtBat85OGQ*ehr($R({!V=h?QbBUy0}26 z-DyPBIXIIAswRl6q{BeyK5(NV0w9R7mu$ zXDuirZBZN)qSC|9vyvTh{XRU%m&HJPw|*`!&;z#|}VeXoHSa>+5R2dNbN zp+`p%Ah<}u#y4tj{&;h|2*fuiQE(IpoK1%c!;IqoUz%dZ5$t{DrxzVbD(_;DtGh@^qLvwz z{c#weQ9}LYpDV5pXI7@gZRxqqrw22U0A0({3(r8Nk6Dl_j=5!mw=mtqv8`^rw2_T; zk1Lj)A5vcwr9;B0pICGH#g^)EK@&mEuP;ZJd+9Pwml2sbb7d+#gAe21xt@eQ9mq2Z-6X#1B$DX zW5~tlBscP0KeRCBJn@r&0BPLhbc(=gB;p?Ue4p*tR6wf?ZwPp}u7;SdZ8@z)tMXno!r}SJJgC@OzQ>K;UT# zd|{mfOd$WDOs}Q*nxZpwb>}{gGqA0Cx&m7v2dEEF`1W2uf5-~0NlhHH6aH3XBVm2_CV4I`(7~7Vi@4_-yH4cIXfk<`duNzP;BP@ZlYd--6ZKq)y zV2iOAVD0Z_HSI8vnwa`%RU8LTTz{dG{Z`fb7|CB2$M-rLMQUc?Q;Qy%^U-o`H{fg& zc)H}VAGvTWj1M@H(672;W_)ZrDD_AMr#lR=`y(t1gz;@e=k_tFV6S=R<{1F>JeqmS1i8$DT!$%N&ah=s3S0VeD>?y7-`mtAo<>_dj zYzOm?vS+A5GA;A|V~Ae=$MwVcO}YbfiAlpHJ+apWdZB$5LzqepS#zWO+_(iz=(NBD zm~`$NH3WP`C;YOyiD189$@8jHm)@88!Q(JZ6o#a4MacMenrHkgA3l7lT;Uj>`LsDU zbEqn0NRY2MUst`0&iE6rKGve#8a^lZb0Qo8-4{ePoW1hh+;n9p7pAmhd;64LJ-=Hz zl5u0)x3GSl={%Dp@;KjR#hi44zLsrd=x-@8yF&+bs3F{^V6*VG;TmeG#K2+HCuTVu zgY!_&=jwEod-@*0gA*RW=$|&k^5I4q^9SSJ_cK~|{d7{zzBCwV zY}Bb!chOVTUR2!JG-*iI?&Rs|>EFvgYGd#*S$- zC&LVn(^kR_6y1nT*8FXSf(~z{%=6&leh;KB=(lnLq@fF-Tdj6V^ zB7Uum5rTun4p{QCYUIv*Q~>%meN448UE-V7|5K_X*-%lbj}kDEy^~1x-FVH zIL7J^@}xRDUqHkrAb)bF;OMwHhZkkOwM3kn6eM)NY#J>b<^<@`^p>_V67V7>@65w*`XU&m$REiId#@_mzb`d z98YgphIQ$pZROvhqs>FFO-f5gZFh!R@S3qM&^0w2Gq~BxRC(xcNhJ#;+TzR90qlWueY~#0V6TKx@6qW4*)=Xo&1SgrXcWvk@`CU zjA-3c&S2;}qu}AUVk*edOIZ%JBan$7zX1ZbtEtHo1O~Z$A!nwF0;A&`y8#nW3%nyf z^^B|cN3;Bb652BSWTBJrN(gt{S>X!6xCT+-?)66#z7qV& z2w3@j0|Q}EU)FLu!Q*vu`ZCdbt zlWY#usvxGn9WPwu}C{~W%VxW@xKsaX6 zS3fV7#WgJ@)Fk|0y28_aU0b%Fs}wGVb=q5v3!mG(HG?_KteoD!fPieJq-Oac`z^4m zdj=Gm-vc}Y-WmD2dE*q7{B+N1LhLYN3Cv$wZId*g!Rr7kzWab5rreDNcGEz4A}_ZW z{pa3~P%g|Nt?A8<$;es2-xlz6+rZCB8(E@L)uE4;*$hfY=25JU|LmJuKcRT}M9m+A zt7Lp;Vl0y`qJRu4E&KU;-mi^ehmU4Wf)myLH%CdRKR~S__q7sG3`6wOU8giQ_7bdp zQ#7vj0f##SOR(5;RQ@;CCCcpN{$ygYM%h9yms#E|yA$Tbh%JK9?9sg@*-rwFhe^Ie z7|!0h`O&M3*UM8F>LwXa#?l8cnGvGRirI7hNh+W{MP3st8fx!0nZMp^)@nS-LSEg< zg~6N{*f}J**~uaCOOqlMb~HhjNX%`!KU0Fu;e29oQo?m#UVhnGm)3 zteQl)ehkGB87>pgC5nRib^B`Rr@GL->+kS3Oi=;7u`p~z;+zc2$2yI=VHcjvi0s9B zdA|hfG1t0s5Y9Iz*iwgze&ayt-_ep@x1Y7OlPwV)TUpJ6%yZw6pkQdls_&YJ5@J4N}K z?%V>Ppkofmz7%$RMdZ#>n&>N6@?@7&WQZVQtR}yF0&|Egv@;4j>YvnasfUhf_#^I) z-s`gu?8vsurbrvf3oEQs!ML|FGBiu~nv^n-w!sa@ld7NoV8>Aq zkrY*Dg$ffV-AV-(ouyt+>bFkxC*{cw1+fvoxgr9iaKhYy{()4vehY8>;Y;@6&>+Se z40hHBjR+i+sf`PuNArhA&sc++eV;Z9_OY_gl3P6y!_s4k<8ULp`~BXX4>9$Y83J=6d(%35rPmG z#Eo52`8BKImv*~+=`i)ty4ijmavb&4p%Ir> zo@d{QjScqG9uoJy9n?I&(vC?=FQhqMQB~_&8h>98F&J5w>f#QjSqgG?R;6d5vz)9i67M^Nf}LEAT!`W)!bY#N;gOK~Zny5m}FI4qng9yYH7)U~y> z<^uuCPrp-pS@@J$Go_tO`oe~-q2;|mG)1qL87J!mm`{Y?k1=-{C5Xw&G1(6OLCOjL z6|lA=O%;S_fD@YAMkL|ZrbPU2evOV}Q^&ZZRQ%RdDK~f)ejhGoU&7GNc z)PvhPt2_2Op%L_DUhNS7j)CTpPQWb(v(nX+BVA^ST&Rw69{*<1&f8E1K4#icFWr_B zt|2sImlzBcRFJ41A<}Z>v~c@hAlWDX*3Qn(*4Bsr>JKn)1sGZou;i`g@9ym}7mJfl z^>ji)nAp|X*$5Y(VOCgOSC^jxL;~Pg1rpfhmB^}y^OV!Xr^%{ZY_0mE>hp?aOwN4l z3I7}c=qV=`W9X#axP8`tr+kca;zqhPp_RO8>5u8v>E{L|Xw@<+)bTW8MlRFtSs}S( zH+n=Nf#^j!9gY~j5?;ySbr!JNM*>%~MtJG4b)pH)OnZ7or<*aF!@}J0O)#kMvmJ@|{C^EB+E9M2v+`p^S zofXmDrUeQJUPn$~xY;|5AE5k6;PGbjdS5}|qx`t1!xX2?Q*C`mtT7d}ece@M`mZ2F z;GqTc zU=gE6v3f)eYU;p|BpY$R|`)Fe@HO(x!R z&-(B29Dd-U^n_CGY7u+Dd6l+JA$Gjai%cL$rC~4_gQTCE?!JLCpVMG|oMe?!qkPDlp zOZ(9~UW@P<))3w6`N2JxN#C^Ufv2;gDc_iH)r($y+|tfe6nx#oP$u%jsAdN-J(H>H zS~TlK8IH;9_9qd0RwZ>IHe=24Sng0cV%hflSK++YTIUUA{Bydo{~AZ@&`r#|Fzj*@ z?2J_6ejdeaB#|VhdUulkAtOq)jXw!=F<1Gbi0~#!)SCpPlP=RmQVxE;C@ky>d^Jd2 z)x-ycpvXVEa6EAuu@kHI!qp0&H`>}HELzn(G3+_<>7fmwAAnDHkWO~BVeY%856>SZ zp3YxXGKI{K&0ZSh{rKM&kw7_~mepB7Xge$%_jr> zoQK58$D?_Ayir%5|8h44r4u}N^4yW?l`(tnssE1?3(g{+$J@$$%)g7y-1w$oW{7KB z7<7g1v;&x(Kxz+^cBha;l{ys0U+*N>#6jT*=*xayURHm&1nmp)4KLOw5qb4(Q>_;& z8WSzE7{~ivtatY_bs3dUYthevShap*MI?Yj@kjH+q{vYWcK7|8QKEowWQEI8Hl6@^>B_+Dlf;7_Hede9(UpjL* zBj>kg_q(5jpkc*1UJ4TOnaM6u!O*5FD;H34N9Zfy=6_eBG4+ zjIEdS_wGBU&W>lQVS1xVZG<9@PJ~1LWm*kMkO{2+QlA6)v!`@2Cj{fTSRpma=U18^ zk1+r>=c+h&*bwSVmW3n(yF5np%UUamP|As(zbQfPJ*H1ORAT0vU8Eqyypnfej68Za zyx#376XC19^Wb^6dqz+|g;?q@dzpoja%Ek`pEEv6Q;0A(l|lI#!##cDETMl$jJ1Cq z3PC(5LXvz%v%t*?*J<|VjxrnB+v9$I>RvN1T|&B$fydDZkA?(gm=EojNZf$YJ*D1O z@ge3UZfE#tTfWY>iDxo1-#wSrey&SQVYXWwfqp;@B~ z+X_Dt9-j0587$VJOz@>*WMV2(R+QAxwzNlvUv+x;46Nn`EN+);YP zv?~53b9CX1G9kZe0qsZndwFEw<9h`P)KJ2?l0ulgX0#d&tl^BfUoAyDiOTu;X16M( zJ(GQy+1UxgvN?2nw9F2iWJRC&252o~Q7PLvo{5;)$KmldnyS&uX(RaH6u@}SZRzxK zXmF6#FqHtU;{J0HRYWumqZqH~@rOeM-iTsHkS?tFAbr)(&O?u#!DxY#h9k^A)=J&) zzQEpSZ?DKLWkQ}p_i-WjRUPu`l%eRGXb_5Ognx!-sb8B!n;G{fRMzmk?b10*r+iB- ztJU;%%wja!cw-O1dn6#)wp!HU*Vi=WtprT^mM`iiujKTVS=X10gs}<#FxxNwO<{s9 z=#(0+OQ(F$m$ErGSBW*D^ZJK002a{Z>ldnf4|l8Bs~DS3p9>J4-&miQHJ_ zW6jwgu?jB?XX4ZpC|&9-zym)28z932v(*!{AQmM**Lmr2?q_;Hk|}~%zTW3RQ};^z z0og2`PDbT+kVk}&NM_x=e&G{OZh(V|{_WLe40M4_fGFU>LGd~~pjmdB=3EpTEpuO=cw?Q$`%$>w*L%7_) zcq{SH-Oh;Q9~TRY?Dn`WzQ3>Ink$M1xw*Pq@J$?nEzBe&B#XlX3JJTv*;AHLQ=?hA z4UCh-_6bt~sV4-62p%2>WJDKmsb61Plc5cI0>?%t#olFNe(Tn+vOv(Mi4q~F5cgk< zri>kHWKB! zmoEQ+nIqD14J$$c#kk-%Rg(`vM0t4I-Y$MarThhFMPd#4t>Zt#YFnGJUSpuz3Y%KN zDw?bG{1$^btV*qoQNT*WePkWIT$9i{*4x^u!+x8!2NPO5UH$Z>CF>T3C20~9s0=O+ z#9j|0CJbvEb0b8m^9pWQDdL2OkJF3%hqS{{wu0eLzfz51>qq^xmiwmWbcV4m!ppHP zRVpUCPdgF($RwB^iEFKn-Sa;knc`AbQgc()Yif$D;kMRTy0REB2=vjWUUECt@An2h zr^Nr0-FGjR=N_jV^|Y8k87ZeQ63`N65UP+6PJxv7^jyF|7SX}(3`n0Y#lAipCaJC{ z6kq#2NRiS$*sW4z0T585~Og919`JMq!sbF{gd}A7;?jE)lHrA>n%4r=dm%EWgY4XiVUfp+7eNUb9ojXzY+7n8WDPX zu0Kjb>ECsMV!F-6h{&27V7*Jgc)mE?T3ARLugmd! zJdA;|Bp$Gh)nTp zvN#Kh?;8&PuLX$XNgu^x=?^W(Mk-f1!Fw)yh0sQEYn4Op6!(DiR7ej=4zs^ zY6~kzc0Cy@KmiIfEF|Xj@>b0FUxWV^8=GS|)3BO$I}Njs$LwJ+`dlytIYzF8v`eDR zUi`VJgCF=sVHVdOI_fm)&Gxm3f4x41v1DbTVdrxHlDip!{bqf>9z83~vF74r)l*v~7Zx~VAWmhn9KB)+>TV_0Ndlu&AiLmgG}^4sWG|B{wB?MD)I65B5m>|Jp3=%+Ovf%sbeVO3{uCIBx_uZv^t7Co&H4_fFl%>D;(LbmscaUZQ|IBsK5DI)wQE2!JXH_ZrJQ> zHkIK1dpw`0koSELL#?N!&W8w~ASVm63qYAlW(I0-n1_=op})4~5+v{#r+h*}T=}id zXyxBN@=dQdPiQE?ft9 zqZOF1re47!{Vrh~(tIqY`hxuq|AC+*WUW@MM5ErrbYcea8oO2o4jU;Y$HMmoFeqP8 z{x~nD<&C7PDmrbVd|FxvS6|2!MOBX&`4GS(3o&CPBJ7if7@O8P?^53Py|(FJWfCxR z#54ZUyBTQMQOqMNWl&vZ|C4BJ6LEa_*P21RVYLfEKKSs@4JUH-j$T+E^ zNqgl6_P|`$*8)k|c3+b(@^zt0`2ms+hCg-?{_KRf$O+vd9V&BTrmuHrVZD?*YM+V- z%vDdxZ~Ii;mIKf7ONW6<$wDKp6B^pzDX6I?Lty;dS{ zf8cI2DHm~>^xf6jIZ@7vaCaneRXn%;)rE8;`DM@>p2D_fVlDH$kWus)nO6HW}NwF;0(Jnts4J4N9w>+KB6u8f=2Q zp9&$Ny4aibaN;n`7M>%w!EydAntSm~{+QA5MJzP)N)#9Hn;4j$q>WwMKda$Ao=m#* zMs06gA@)Hb1t3>V4Kq|^g(tL5dB%h>kS_pHk-YU^9)^hBhzW7*)O=8QfY@fXkV+WT z33CWB`}6WZ87kn%V7?^#!dAw|Ab+k8i5g;qwqfHBdK^i`~)AF z>vZ}lsw;g8^v-gK*L*=p*?iFg4XlGBvlsL9*fwH*?XV^lTOB|33yOtx5?0}jmUbFz zU&Q+9CJe8!!U}r*bu<5fY12|;-7GV#5>BjOgF@3gK?d~USnE?4$$6lON!^8|fQAhy zMlyO-W>OiKGOx8(2#U!Pq|c|7T|cazdVT)d(h<+R!<(W`p=^3PY=aS{9m%t5xgd}X z8w}OJ5p>v5jh_SAUQiR8*6#r#`M?F(IB{{w_LN6JKrL@z!DD5$VUvd(+JDsEP!&-P zF40=>oR-ChE4IjR_R?V{wKO`92Wf_5pY4E8JS#^lVN#7dE-lN!{Hqr0FVliC&JL8$ zt!}vE#J_p|?yK!)my3@U}Au zL*cudo7rrZxHxFqX!OfXF@tPreb*pxK?Ls@3dDDVt-c@3+yF)ZCkfSN`bKY`Hz9I^ z(vWRW{rM4UIDj4X^z~l>vM-pQ@$uYien-m4h7>`!(3zUw#@g~rw{;EVej?k(Ge9%j zwI$Ibvrw>6G7#ddx=>?-Ev9;2Zo^_N*@Id$)?D>|ZRsqL5M#~-;9P&8E3=Sin{Pa; z`j)Tqy^f?7@MvCM8P?_tau`l}T3KSXB-V(x%d%VxkV~^L6Ha=`536g(cJmuhd52h~ zd(O;(#WtwPcx-SoMiy#L82=ChpxNSKC5`fg4GX-H-`xsnmbxWahZ~b<8CbHCeUcw2 zSHK7#n3qlx$jcD%Ek@`4;|D`UIb3=n^CVq3)3jgv%$Af+&|-vm=-3>KP;vrc9#8J<;U6w6;v z8B>i)YbyEQ!xhV$$0Vs>;e~;1CdKa+q=G1=cG>5#|Dx;wpSxT4S|&fjKC!%Q0MAe6 z71b~E8Sk`?T3^zBcw!wtuR|#~I#!p|f7^7~KqdmLd$!#U>ri-4rg72cmx1ivW^o8; zmjhULRZF;^Yw=$|*Qv4S%qor+G@1WQ;U-3FjdqU&<0DK_8BHn9Sd#>CtMunenG&;L z`_83mQK2aIm_lDVXc5R43{FCa*4%W?G7msvq5*j=7&XPoB0*-gTTHP9t(_S2eWB=m?}$xlUG@DpcW? z#11L2_FF0^2^YT>t^I*3N&Y>q!;LG#O668e4$=69NmjMrc_PI!TrQQ$w~UIsK$F9q z-6-R0w3Wih8uXQ4UMA(_r98gGgGJZ@P9%{y>tRdthrI6x7(W*+(CS-#$2jikiz$cK zpvVe_z#2{SN8e5pQ;-b8@~%TVSVS_0enU#1= zT!m`dr4EZ)DJom}Z?_e(#K*>?vI@zR3NJ|WKV!$ILPzUg=@lBxufr9l=%BX}%5?GT zzWPsn`G)*;&buzL1Ye%typchAQ~o)sS!pUz3c6|jN9|P>x^J+d6}mWbhKb7|YtUXO z<9Mo}$&8G-&f#sZZneb_x*huR8v{qNC+A(uH8o-?6z8ZtFdng1*5+}{hK9c1j4s{M z#g~o#GGp32L)%X=EK|+1+;!#S=&0PCi5Je%_B+F6h985)h!acuxTl`UqJ4bG)sO>i zKrMN`MpHkJbpAUE?Z~xZY`f}!ZLMail@59S-41mCgEEfQF0s@wIpgm>hXDXlhBC!1 z(}({?aJsw#s7^Q~-10vN;{?rexws}}&k6{PPfW>pE#bw^zd2=^oI(>&`43&Sc&mF@ zHrLkZ5H*KMJrY_;gC77Y2uK*mWUB1A2==z8V0o-8XDt2Z^}Q_PUiJ@CFk=Y~13yMP5m)6UcW5n%-ffAoL)CeX>p*#M-OrXE&<-x~BlJa9h#h|vT9mjJ}1C@USR zO7bdYVw4MKL-j**u!>dk3^QQkTEy!fH5Hil!L3Tm|C6*lY=5$jK4pL%TKgY~wsZP!{JHV&k(TW0?{4aK!dg8Zn1!u~O3Bi+p7;eRHigilM>pZV%6YF7606?0BfFM)JGm=$D#^J^u&v6M-K# z#l+rCLAT}1fsKa+(@<9_!70CvkYg&8e4%ekQP>gk5NL_D`m{|~jn(fs$ErxUrPMZF zOpP3dD&FR=X-!PL^4*~3KihX8bQVo3R3=v)u8lfzMxB;o_NwVq6Rd9Dbq69OWJ3a= z>^_-5miyvu@6#s0g+Tv|uI}^Y5Yc}P4!@*SQf_96*IYo-&oIw#o_+e&e1Cn;hJ*T= zh2)338P>}TWOJ%a7NY2li<~dK+&AP=p#a?8fV}04>z7Tx&w!`TZTl?55ev zBNT+M5$&m`O^|L(XNRxV8vaQpT9vxoU?-zZpnVXa8~xn``cKb;0ghuGnEVG^OC%SN zNurHFz~67s0|DkVXDZ|55VMz_m%bI?g7FZSk^#}?%e3E)_isq;#@|}MWUqjXQ|#v% z1RrNYPxgvsYPs45tGMt=l`(7BSm6tdcS%`Q7tB(`zH^Xru%fJT)$KNfj`87ab8`{! znc6Iv>HcY%nyRruVqC$|*%z zBfCaxJQH7cRAT(J?m_B!M%I5FEF~EX?&|@$9;YgXIUr<7a+^=v>Z4R@kMUhT5Dk9J!k_S9}dek%+HAW`VT9pe; zQjdZ=zrmHu-6MHguc)NqeDae2ka21j6Bn3wlyvAj*&2f|Wh(sJ#`2=DsXju>BY7ve zwp=P$iwE{rkz>|DoRqS?KpewEd2N<*Yd9x7p2 z?JbS5oDC7<-dk|2erw+&b^Nd%={1ll^Z^`^HY7Vxa}K(n69%0}1_Cqm;VoyCm$>z1 zp*3}^PT=t9n08tGLLk1E@%2kZyo{>{eJ=}uk}h(iWD?SnlaH&@H%ksD(WJbn1DzpF z-Q6)z{3mVL4CuzLWTB^NnGK|sV6S7`8UN#t^bt4suqEg)6La2+n;u4p#0-6hn_<+|!nPHe(qh5hq4?VM*Dp5F=efB8pp(fCP@dAu{RNT=Qs zJp?KybjoYL|1O!_qt9-OF8(83<6Z@Gg~0#c{%QBnhk7CQg-O|5m(KDJ=F4rim$#3P zkBiGb!YiI-X8%rp#3>)CF!2bkwa0gllCqG)7o<~6e`_U)ua4!EYof?08fypH?46JQ zbsu`%RLu(k3^BC5;cpO7hP?sYpg09Wp!~-k=$Pcw5ZQ{bbvs7JFd^~3*Xy}DTWfC8 z^hajL!Ei%w{Al_DaI5{rQLgzgK`lfSD+L$HT$>_VIEXh>qMP2(#pC zf^>ZJ5DQdUP32P^YcnFtd}85VRZpl|#}4khuGz?@_1BT=I~m>3+k=UZh?<5zvh6+t zld-)X(G-7~zAy^mSbFKK9pic>N&gycZAj~JVkqa?dNt))ODgSH$Eyez&BgCCxT_L% zF7=HqA+g-OsJZ0Sn)jwrb@J$XX+`B>PY=9pgu#_=y}U;CzRA0--|{A(uNbnysb8Sy zs{hBF&%h1QC0uMf)-T*ybHQbNLmaYe41Pi%#9WnuhVyNt)Or?!OFrp+M@kNNr zk++59l%%HXna5|5W;CII=MV2_l7+|JH_-egKa8kFX}~g@fU2`9(J#?ixY;bYG_$TU z%SjXSfks$PSwle-T`S+ezzA%O&q8m9Z_i79FB(edzUEslM(aRylIn7hvBBkn_uIsc zRjxwqqDBKA0y$^m5Q!y#2|c5Rqo??evRiabidY2L>x6`awpLa^Wvv%r?Uu^_0!d*O zbB)mX8WU?exHEy%@azm+(1)|Y9zx58tz!IPyQOC+|HGM`0%H4 zmC@|172xZRj;Po2q5K+jOGGV-My?$IXmbHVK*k`@_jw0B;^(oHKiq|6t6Y2734|gY zyRbKEU^xo&42VDU-e8NMFSYO_M1vd8fh*e5XP3E(==+Rvt z6P3Kkl+!Mmfw!|EEk(rerS0EHA!>MJ;&u_uCv^XoWC5xRr;=7FhTh2!%)hJt!HD2z z709#0tyF5byxg6wfm^umqu<-lWU0o&`r@Vw$+yR-5~nLm{{y~~jTOx;iOCMlhjCog zm1`n7`qqpO+NU5v6wyL1t|v?M0Up*W!7H{DSEFP#D!&W=!1-gkTZ4@;=>yupnpnfS zEc01RNKAx(?9qQMLtB354MUtY%H4m@I=i}ngSnO&P{jN^JS+;0t7Scz2QH|S!Janj z5^W9c<(%UgGse`GE%h>!Ste3==CkCLJq5CVbcEN9_pa7GGcgqVt5w#1WVNJ8d3G<=f+J#Z!T_u5gqG zg^xMHK1HgqTv(t8v$=~vHz2IpZ}m0hWSbQDcC~e&1YN%6Bz?uu5&w6ZDCWv#eX;l) z`n~4ktnpft8D@inJ0NJRub9A)N$Pc;F$ZGcdymvB7KFzPazd_r zx;v9AiDf_nswN}xw)>s|J8dNS#?mUCW2f(EiXrZT3cbA_DrtpJ!Hx=E6K-(4*L5g{ zxe$5#c1iShS?%{SMiZqD*|LI3Fqms3M#=gKM}mE3h}HPOys0RZ$4gexM1)JXDoLu9 zLT!drul@80OvIpwJ_Lljd;9v@3iRP5Ejj_R3%nVT@{&)*1E?-H)9=_mGtk$+!aG_W z85y~}WU*^SfpFgc@UJeGAI}Zuu+NM>&k>DfH(k>y{U)n2S`oSy^#?q9)v3m@Lay=>DPYrN+rWU zMlPZUjkR|i2Op$rPze88%*#=%iyMTU>3oX|4F50f?b#(z67E|XYtQ*tB^RzUO%$>^ zDo~1X(2Q4~ru}*0ppUt}wS`>(#gSXJo(iKPva)%;DSb>wr84w-K{ppq)E?X0IV(r8 z1mOt6kxglsnZAAtiKeDA{r;wgkzXrYAy7d@;?;x6XYFef2X@OuuR2wB6S`FR)nYkD ze3WNb`abP;wMLxJVy3AKZk=VIj4f49O3Ir=G2>n!UF^tR)KfW(lU;4`$j#d9(N9c?n zf;p6WcfIdbLYKnK!azbBqP$&-+!)P|lb}>I({zlQ8?IExVt%(<`-&sxJ!=@7_G z+8P|25L6e*3YIi?t!X)pV0RuY)S4z|X5#EiU`_yMu~0l-P_|@)4##Rtuobu8+TGoZ z3*s%Y`ey^)S&LRlpk+UA|Ege(vLam0Oj;C!RtQ{lYT3cmN=ma$o4D86IjT+lP-Z_g zv%kL&gg1ad22BSsJ%s*geSHomCFqJ92+GbV79V(GeGQV2d~qykX8kVGWVk;-OfUef z$NJ>|AlhR}&`2S3D4U4bv|0qJV-&e6QXbTpivRv;XNInt1n)$vK4I-%fSrz6&0-%R zm19CroueQ7FfZrE`=gRNbClgcF(HI#e6hb6Jv=8jxV7m;7FQpngx(U*4QvJXXstAv&q$kmK|#__R)M8x(oi9 zU-aKZc0pJyROrK5R2PMV%s@gIgCHe#BMD=KBCBH5wqE{Agre&FNGhM48rkc6 zQp}8N749d%QvNM4{Asc%!(WnJ{E5YwsuNKE;9Bp&*DE9_*dzrudCq=iX3(pGYQXtY z>tZY$=q8Ig=%x+T3qPJ{nEZf-CqJ;MJBBkhm;9&%vZ{&XKN+W0YU z9UTekbL{XL&r(mS3?K@FUr6X} zKgHmG+5f9X?a8>BJZc{|(o2}X_{_1-QeYvIK!&-=Y0~HEr+1_~_!pI6%Q4v7CqO7F z{H7qUV-fUyrWRZa83m9nXh?YiP_Jq23AtCfR0<>0ruj$wF+f#dhpSFwa`QhwytiqG zf+@IkuqC{$B>wR6d5+BS3WUyCfzjGZv`A9QZZO4$uhZ`>TOubbD{cWSIWB7a0)cl; z73|NRVkZ`#q8c*45AX$GVjY{*>k^6md3_nkwL$q6r2rsjH$EK@De9pO8vuT8#v2WO zs|K0=>2%B}lFe-fEdjU|(sY{Y+HQ|PfikE!kTVfpz36EKG}7PCe^X(+yj)yde0_m^ zB9t=H+!Y=Mf@>x=>WF6}gGK|kh{rXfb-Z%Mpwah=d2X6uIG1BVzA?%lEB-EfPj5a& z1M;U?aFH3=1fntYGG3*oD6`I`cr8N@Oen)Dt;uXHMCPXu=BN6O$~l`ChDjH5&!Rkm zLW3E|9;u$ktD5iIM%;uOrR-bk*@j-+hz^kBJZqx#yzC-tfe0h;XZ!ozI0d1m(>jQ^ zg?)jGS98Qqioj24Pj58|N3_fAfVxwZ0U81%L-PUf&UeEf^?mUuRfxiKclVJoNtEYWwRYJ zxYVI+GfyF=^Nk}mQh!gJ&cT?YIc|*EFPU1q*4*YXu{6Dqn&8JV zXW{>A0g9m|b`H1H<&3m54iNJ{W|A65eEE+00pVpJ`c!IzVOL2L+3nMrac^r5bEaGq zXHK4q`7UPw`;06MG(UEQ5SDJRs{o9TveP?*VV#ofkB%rD0Z5Rg>AZ-qK^;4Mx;YCc z9v5<->v2%aQ3;cy%P#<0_FM_|ZN?jF>ty>n_RaQ1GEZQCVseyb&|8xy?r20M*izm< zZnsRG$wP32`_DgJri1ljB)cb`kCa7Xdj9&tCEKf+y;5;+WkP3gp)kIBH~h!QP{&!Q z#jFR$rUU-8vIN2((b1z;s6}ciH78!PD(s-t+0AW9tCmrd>(@Fg4v#BJOo%@OE|c}M+y240coG~C(I%Ovc*x4;PC1KpCWKV80 z(;S^53WUhF2J^Uquod*gj0%dGpr+5%7)HeKKX!Hsgl1^nGMY5^vviNgMNfYy6FN?$ z$Jn$MP2ydq%NpyCc0lz0hfvm@8*kYor%mF*mdRze$t>-Qj`Tt3GImzP23*#2MQj*c z#|3GYfE`xmgB4dW4O?mOuui!IMLcuS(aflTH~bzgQ*fEX^#a>0cV}@)I@5Joj>?O< zfu9y<&x&`&(-ee<89m6szzjehK7CaBW2D?pdA$?pJ(@8EK`Hy} zhiUU$8@$1p1*~hl$>h!TB$Ebu;-I-BOkgb0h8*9nOabCAHQz(zs z{71|0a@HEU0AEpbWvvYI|KM`_p0`ZcT!^=kP1F&I=ahNl47pzE(9Z7=&QTA8)8ux;g3GH+)DV-HjxP;{n_)Y2?>jx)V(3vUK?O2gF$KauQt}VFFHKM*7-~Wq5(&2P zHucVz?+mKRw?5nVFd>c$WJCO$x)R*)5vToA*=< z(HzY9?Q<7N5EY^GU{n?@yff6_^1Q-%eiLi9GOQN0P?z?^d|=J`fs{Z!-O-AAR+a;A zgT)#?%y*VerGlpt1&98$JIO}9@HA^NECw0uS=QG?jIPwSq711%_E`uKTXqELGf1{h zWmJZ6{6wkReu0b^QR%)Z&Ec)8a}+r<<{eee!&xccZe8fnTj@jJgH(TFb+x328aqS4 zg@`BSm$CI)5|g^D*>ti!Qb7O3+KdjO{U5}hWX95QK`^uTjSb4zZwh_VCA}*@MC4xU zm<4(y=_D!oV~F#X5+pN(ZkgNEQvd$3PP*mPQ0^o*U*j9 zx?W9NnlCbs^ppc{W(5}?FD@YJ3LGiu5?^fmHzZRW zQu97%M#U#|Sd+1$$AE{Zg;-yWtwK-&ip$?Q#3_k!TJ1e2hOm0cjwc^e)&|7C*dZgP zqjDnaly`tEs9kaAskY*N&ET4Vx_`v>IXevD`Up0?qploaDeTOr6fE;o7jA1|onJ3Z z44aw(rw_niK`sNa5N@v;TXHtH`;QDr3uJ)Rl@=!+q7Vr_KVMHR*0ZT(aAcIT91D%j zGgxf}RaJIrs~PE@j;*JaJHE|g8sg|^oI4YhTlkDfRef_~>j(9%z&)Ry2LkOjssnLM zP}ofm{as9y*sSWzs-y~U8C4zLMgSNKnxdi_q6?`?F@w={2osGDJp;4*Mi8+7yPJ9jUT^v9S8}__mV4-J(BgNf{#YPS#k%`SVCT771gcC;Q8>sS03wqjc>W`UfaJ3wLwi8E zjq2&PosK|UGWe8n2uvw%WONNWJ#YV1cl(0E)SH_`c2W!ag6(5WhSY0~5w6QV&DWK; zGAoxhe`x`X`W4GEe!qjW!t?7h6;sB9W;{rgx4*GCepfS}df9*R%$Ag1QpbJ@F-jf! zS61I(Ho}NJEX0_rtj>6dAw2(07umJWLVr!MVwup&l24p8r>RfqQ&aMC1A$%NhB>2`M~*ARQQZ2?i3oEFGi?-N5U&}*hGv1Z%9LqqRIR7fAZ$UqCqQr_#KB0(M&qz|Zp7pmUj~lwK zOCc`TwJe2jM+5wy|@Nz#t^TTc8YTmuUlhZ``n6OH4ta zeqJtzC$Pt?qQw>nd1$&jZ5xf}$`QNr`W}y36)IDYmz%ox3j!I6$eT~5`ZF&>2 z_3=jFYB({proCziSVQCC89b_AfcInL2nL0js}!q{==JbT6hGA(OQ0}F@yF^w+`;)6 zMqMgdN|N?aq&`Urx6IISnA`EG_SvsSJHjcFaNSb;IEU6jy61`W-Xmq9;NLc)BorBwW6(wA7i8Rwrw2?>k+?@?5FAuhX=G-8F@#856Q0Lg_aSuzr@ss^SYDM67iw-;*0~ z)0YE)l4C^8i*cK{@s~={TXwf2pf$VxN#Y8OJu81}Qqjen;te@s^2$B4%(+dwX2!ZWEIHbf|0P`*N$%*Hd+8=>i2y z(NTofM4GCLHR>P>NCZ5 zy#s#w{&Crg>EH4t^qlr+jO7i#F5}d`j3cj-rdD)%|d>5jGixzxGw}{ zFu$HFc}dDmmzP**8~8|V{J#mo8Vag}>0?2Kan--#ahC<%8F7~+$iq_Ut6ygY z!&rAV-CkHI*DEpwOU7yGw&hMRPHZp+)_M3yO*1$!y(FKxcAn1=`DIpmknOFn^dV>R z3{_^c_lB28gX+dynoYb#5GsqyETc- zc!Z-lMfmJU|Exbl=86j(F1MH8<`sGn1FV2(!kLgw@_@J3814rXM^L~5yOr{yUrSY| zck*%yg}>X9t2;qpx`?`}pSD-#bmYU~$$1cZY0Fk~LVEbX zq*E=KDXku*m#^<;K$^_gGhT$B{+w@qVBwLX@Bnc~VT%WmxHeZql$-iW;+NpI#~Aga=@b&Zs{%QO2%+A z^z_X%55@G^Xr{$uf8)PBs<&is97QLpX?Z`2r(zX+`6s<{Ee=k^$rFF5;g z|3=9~xgcBQ;Q|d^1+nL?MK}A7kLd??wOSd35Nvj?+yYmj z-YPi828agFo{T8n+t?AU8gkM+znbRw*n|b>@dwC4Hc88Nb#x@s)1WmvIWM+wHS|#R z%zh9v(X{TzYVdR}7AJr>7HXcJI`e*Knm)$C1Y=GSe&}w^0Ab$4MT@wAH-Cok4BeEj z|VcJacJ1w|1QLj4b)d(d5*@7xc$g zIF#S&kFCEEQnYg`)fVJ;0F=HW;g&1;mLChRA5*S1Ao#UH5%y)z1sXmb%EM{&j|t{` z0T(9M>VO0I3lbemHXj>-EAh_!C>6j>^K)~#x)gSkO%zE&(HN9 zQZ1*#Q@IIySyMF%AWvM{T4ND=Xg)dDq%RvCikE)d1tzXM^S>&tu*(g_{k|JIFqo>I zPm;boOPKo?x(N{nQ=s6{J;tCX?>=^6uvC9o*|sB4}Pejb9syDop&ld0DeL zz`tw`peOvUC7>R^+%1x}O&_dk2S3L&v72~@=-E*>NG-yu`VnsLr1{+oAIH|m0)rYB zlceG$&+DTBYD4s*wcNcp0oQ{JN&gv^iD1682lxK|#}_{WZSOcXKC@Fniy4dMxfBDl8!J zANtwLrPXArV!qMKVpaHUG>-I5*yxkzdn4>(*?bRf*`jE|K{~3~BHht5Wg)*wErku; zlN5`|lDn#y%?+c!Na`>` zq%c2ocK)&elE^mhB^nR{R##Oa*#Fb#j{&yfzo6n4eL&jzhcmHTM`A_#n+8HSqB7CFw$4y&-D+zIQn?FCjcMYiChOqW@4 zFOyn3AfkR((|0qRy_%m|IZQw}6p?ykp^~xOu>iyYSEfaujk8o1O04&Mr@ z_TumBviKU6Q4{=Yoq)4+EsY@I>1xN|$Bb8Z29ik@zQeA8X>jssNl;VS%9bT%?}V?y z>AOtEO6fdB-0tbn;Gmv5g3u(W;hz{Is#8$x1Kz6N5w7J!@N$r&08Pc&6Ijj|iEbw< zaEW%cb)-WQnFsy#$9jRW);=4*bUnUpAjibp)f+|*LrnUC^<4=!e~fFPJ8U%P6w)ec zy(ut9@mti2I917NSx0DF_}?Zm9KrZMI$Nd;np#&%r@83`RiszX49W$?do?V`l|u?H zR78~(5gJv*lJ$<}NjZNt47RS*D{Cco`4q@u3Wa2ZpyvMyCLpL5QHyjQTqhN2LOSl} z8VPPJROM3+9Dp0V{GN*AH_&5?&haPIu;gWMUxi-TI}?i)7f4gU)xDTd|6D!S1!xLz zwIT|EG+Nz@_TH|q36CC%UjHtJ)&)P$5}kM1g>s+bxLkE2XERbZa*^@IjsU>l+Y7n1 z;K!cX;8~2M^JeqOsc4lEOSP|>;rThhq90lNcXEk!1SZi32#YOP;W+VMTx=BFbnTO- zlx8+ZoOw+89o#%Tmj`%%ou`$f<#&EV-9!&fuS~OwmP-6c=(>?O#Y{E%<#t@}tFo%2 zb%J|bSL6^CSNPlUP;PxKnL{VB=wm~19lJDv+bU$3z$7ST0JCo?4~faeemR#eWuF@d z|81{7ATWVLH(X2q{c(qi8@B9gtP|!2Uv}g@P&4?{;}gx)pBeE<{y^%w@jE$i@9(<- z02ZK|0dN5p==~=qI&FihmdKpo>`JlAxNsRKIRsE77$;zBX?Xi%hV?ynEGv}8f#lR7clrip-jOdY) zaz=T8f8H{(hgfT9&gVDH6SbbC6P5E{gT**&)BG*)!;?mB;-@Tdy2itj&g4#UUFM17 z>R8{{$YnWY8ZIzBz(i1sPMyYA_*>UTdG@Y&*1Bu~Xm8}F-M~NfY9;F6dfQ$ah@u5x z!R!FXL1^C9^Ff$8-(KS)5MkFLxy`fLX3qM^yuY;}{$1>uF#0H&k0+85rpB174sC>1 zzb>YCuiuLj-8bv*!RuGYtfF(+lJtAh1e-fk)$JKR8Uu?Q;q%|(y}&KsrwP80zZjSW zZhD3-E{wOJpN~04%G^i5f0BEm))!ZajZP$d?X{W#Gg_>qDk*~!hy*d@Q}lA zw344zQV?ftvl=$%h=@XDdHnhHO!$U zN5LD>1|q#pi}&q$ncIzArR^Ju+>I$}o!vAPK?N&TGiFo>%tBwM^`SHaLcmwZw!)in zP027~zHlj`FGN3>=7g5**uuv%uXp}&`vy*Uu^kC#4c>sVCU{N|=MJ1R2@dSLAP&hZFLX@Jr$DGkDiBa`sv3-+klDyGX?Z1F#PZCibDB9dakL? zpf1}!*y<-3&#ltiO0B2umY=)c>OM+5{1lNvLL?$MQLpEvH6hxzh~B&hi5VR&EvfB| zMdx?sA?a%D)g{z5ie;*v#@)pH9P*O3&K@QV6u@L1rGqQ(CQ)Z7)@mKq`16T{IzYEr zR;(fu5-urOk8f5YFZ*RG(vYA)mDm2*Oa;PB+eebSUS!_?S6|@1#l1rGcB+)HV&3ipvp2!8%rulqvAk>*@?&{x?wT0LS9cZ;}5KG^4 z6O)#MSxoOopc}Xwdh^&7uZk=Wf6>2m2##jP2}Nct6Lu7}2I8vqCA2Z(1OIXkI-Is} z!%Y3zVb8+tKB;~O+S5sQ!5Mxo4(Z}P#2!h%V!3AuL?X6*CGa0Yu$d@eL;E~%xvJ^L z%l!9_GZgQxWOfY)G2Hg=r-#Q|y5>bf%D8!Z(gWnPTPR+&8o^2Jd-vAB+rEKKImp%s z=jY7%3>rSI@AtMlod1xB|Bt4tjH;^bwt#d=9wa3X-Q6MGA>D{{cbA}qgmiZ*Al)D# z-QC?Kog&=l9pAWr91MRE`>Z|JTr>K`WM+^x3!|_xLN_`Ap~&1i^W&xdy%kg3enTmp zj4gbiSnkXHy;sO1m|mbx7q+Jc>?{OnLrM`oHw@{lg#lpNxw>v2z1I~3c%EyLZ-uZ~fM-Eo)@QJ-zp=v-`}Z zk8my+uMf`fAu&R@#g39q6pl&bv6X2rN)_E#{x4J0XVH_ctPo+jFZ!>iDy<2xP)xK~ z^VuxJvZTxACBn`!*BZ3#79>(_HSc#8?UsL}wGW6hr|@gND4I%qdY4+age}tfwqDE0 zp%`~86fxQcubZD*|7MnJYX#FDJj zGIXW#unlrno0;)#2>2rpi*~;dvgR>jnOLrc8iDr0c2hDH3#{6nC8f#V(3y^*jJfMp~R8R0;Sp_ zQu^_clt3Q_l94VK?Ljc<_DBy@<()5~QQPA%{)dKLymul8cn;l74O|Rhi%@$8q7VJ2 zE99YozZ)C5BkR{(V>}1yVrhpo^F?sk#jHnEjt~@XE?eS0ClF`!;U6GxqKH6MZc(Q# z>%;~bv1c)8c%0PzEbGz6dQzS2=UmA{j+@Jw6c?c}=nAP%KWtCK`#jc*a8m=5d}57+ z)&ByRJRHNf`)*1lRtUJ3wevrSIbVEiT51eQx{n-C_rggLu65mszy8U0|31k=blCE4 zuzC>?_C@=^!517^6;Q*_;RFimS{5 zO+b6|1v%nkhc&UG#e{t5BR|Oe5#ZScX;FVcn7I zpYyLAWc+SlVr!%6UtzBpq#vrw3MD@VAl4>}SE_DXqOLDCZDzx9r*SOXO=hUP*gVi% z1xBuMs5*UjWDe;2RNaKGw}pF-G_`` zSyhVZEk0-clku8fg})2zwzxJsEnKL^$6!4KQgk55b(hZgL9Uj9xGSE<%_*W14le*;c~mSLd?Ic1u_$w1ATms(5j`XNsWvQ4Z#CpY-~L2f$Dv`qI0m`q~o~a zaOG4N2cE~Y+?Jk-oK04W)jP5XN^-r=sX538ULe9qhO8wTrv0E`-R=8<(8WL*)f%FW zd+KGTA4FQwuKW^tS6{qv>-pJ;PHP<*_?R_>zUf^07T_OUl-!mU1%eoy%oM;H-7gfJhc7i}%FR+O5`eq`6e48r({%+xxycp^O`!pZ>a5(v5 z$IT3Uza_Po|B}ySPJ*B5L>$dD(u$vFSRZ_pAr8B;Kua|9c>4t5>`)f0yO| z);?K|7p*l_RzA<>iZ1l*ryt%@ApSWs(da;dR2Xiafy2SBg=lX%)*6I}F5&Vkn;mvQ z@t*I8YbSyw-bC>U#kJ9h>>orP zvo8xi1*pi_OOQ>5Kq8XEXc6lz#;Zdhnb|DoKjvMQJFtRoS`j*@+(Cc=_}u_z(94UD z-hl8K(a_`2TA2@v){JMdx~ciWvX;t<--e>9?m-ma=SRbmb>zK zdpBa_n99OidVkcA@{{5_I1;%lPI8p$Qr=mcZ}wONDm!|`ndD0UdZz~y7n!Q!do5}Q zN>%yn%5p?$&G|-jM@ni%T+f>95d9#L0INHA~3*r%w7Q* z1wjzl&zDT1N_gdw_oneTl9q1(AD zYKdxVAE|O(79`EkE+E?bVN zH!QbcX1sogh@JlVgJZJZb*uN)06+Uqez8`cp}C7T9w~ zbw&8_UneNxnlQXFJu-$C2Nz3onOVT%))o=j@e_+@mN&(0fPN)MQiW#JXAOkbE@j41 zTZ(~8*AV%0w@gBGuhU&OY(l40a>^9`n$C#riFGJn#M^%b<6nEDKL3s(^Cl%$**6&Q zRzcA$MSbC($h^5rq_Xb7s8+mDg`v~wYI{Uo=QL<=fVgGC+g)3l%srR!;4YUe)nUzx z{X__!>rWTfOEvJV>+)zyr{SFSv&<78?EEcMhua`ST!IO~b4~_3`SJ1bA8S*I5?s3H zcrK5JH`?dk>k;;Ho&!c`ymi7^Kb3*^F5;UzdXS_d-PP`CryOePy~;PLsElu|!}o#6~exSjz6_8<#$^{MDU2UzvW;_uI6HrHU6kX|f z{LLa8isae{Ra%@w&qL2S7AGH=Se6WizrJ1NU*W7Gi4Rul|tDfvC7KelY zdg|vyCNOGqva{#J+B9Q&fx`D#QvS`+N!$F17ZC}*7;xr69Y(KzLgHFbYIdj#W&SC? zZ*rCLMbqgwuu??sF6Tk3M0&cJH~z?W-yq(Bbfo)}ad|0$@a@$|91#s#v50*Lu^&i4 z@^T<0Q6?PbxK`f=K@Jp$Xz<9~5t)1+osyfc7|U1p_b@*W88rCFO)bGl-1(_kaJCG_Y+ev{sGwaL5{Bf z{cPMFNXy%qX#d2ZIIu^?}=HQyE~dbJ1gAvt~Jz0C>`8dts~4BKR&dx`@B+- z<2EIV&*s{XkaX2y_{%S+vCA=AvNUq5lJt(1+_^OUlx%M@&iS2USGt%@?)gYT(Qbig zPg@CWCWr91Ntel%7Hwn~*evq-;&h^I){+ux$$;05VnH2I4sc1tDJ0|QUHmC6bai*K zT>>?IV46#X4b!;1`x2~Vf-%Pku&4s zNz168b;vU8V_7Ye%j}Q0K8eye4>KXM&5!zJk#T$WOH_9tA3~~8DtPH=Ja#=wF2ksX zW$gidG8~&_)3kT9v$F#>F|bGi+kd06)QIFi`f@XYGlSZ&Nk}ec9ki65frsqs*JOoH zNcJC&qY*n_0k6A$W8cF6jwXQ|8@?qW9R5v*M@RB&T76w)5s%?)%0isZidJa5g|qqJ zOGBBKUlz@gbp+Lokgl#Nr?|Dg?Y* znsU$(ljzdrKL2~n{S>V9RyC>H+(OX98x-f8)l0CBdu#EwUfZ`Tuh!t)FBeXQ7qSeF z#E1ILM0HOu9)!erRGCmt0@?hhTW>_-89GF{_h#Wx4s6bGQ{`q3{(jO`=lR-Kcc=kwx$4j73;A zo9ym;)Sj1Ao@gutSpJjT{@Z%M{W0LXw3Dp%+F7BiBh=8?*q8msD+QyshGd+8GjeXPe#=dd#9K$ zFn|y*85~uoPSX+kn$LTf_7=au@{z=!l!V01+4$^~pVd){?{Qnj&B)=o&GohJQjSWb zI3KDB3#@XjnS2--JHgU2chk2Q@G?($-G94XZv2| zTdm&vrK&hr%!rt_MX#Z+Xr7~aiRBM7{36yG)UYQ+ zi$p`!dMH^N_A&7JDhD)jMtLHG3OLL4ciDI1rjjH%KSVVVTm>TK=Ig9OaqWGLJ#b1~ z0zR;A3F03cFyqV?4YHW41bD3~=F^F{&hyv9gnTNoBHl3JDjKF2^mo z&HHDmCy5$4`a@m!bq(W0LhTW$>f5L3-WJv8^_4)1FeOG>UBb(V2{_oh{h@q<-c6pA zdY)(o3Z{tY3K3!9Q;Qcc293Y?fPDo_KNVo-YWJnxk67IQD=crW(SNifq&2vIpE9e(zw-WPlM#n|)|@Vwv6rcqN~d`_;T z9l63CoDE&ahv*Jo)26KRKgeWoN0ubK8%|VW=!36l*6w5gq3sc@Y`^v`vB>P(nv9pI zodQGz%Ag&5u(OT!*%;~1%Mb=@@A6n1Avydo z-a`2e6KsRb+f`(NYX11fVR}eNs@m$H3i~?-QjuT!5k-Xm9+{>su6`5@i-mcE-*=&i z*Sy?b;xaC-%df8UY0BNiAy;82Uz*+|kQT=oyWKL&oBrmBG#wVbs(+hi3|6dLeC!I< zpS;4eA0C1I3nb07LVHCjR5&9(rI17Kj}bMIL7Sz=Qv#klVyELfSWK-mSEtdGJ5lvM z94@;eKb+=v4c9Zx1FPMZ1rdE}AG>;)bt-vumKVs#3_bK`Z{~Jst&SlVUu2liCr0@ z#HF!?^DiKSHCGg75ddN@rFXT^%?~D5)j>Q)at0X>7&M~%VjiQtGrv1|Mq&@AX@XT z*ohr&2fr`!<8+LYA4f04zKYl5dI@V}IR63=4<&VS$G-WdjNv-@WAtl~8kE!`?I!$L z&0G}A@b@fO(wVk z>&YgYz7TpNk$D=voNn3q+%B`p);jLY?Nzt9^`!&^Tb0IZ;x-olZL9jKZJE6Ddq^F9 za)?C{NWMWJRexA2$GU(6DrIW&O(M;OtyK0^#Yj}~_siGv=a%lPv^+ON*g@PEgGy+n zha*O=ze}d}-x&#&78Qm>OpEL{U1brszwy332a*|wRcFZ72Tp(Lh7a!%lKF*{%sJ|0 z@D+2;?~U=uJ@b9qiyIGRXNA3iyR7zgM{%^xH4U z4xyiknqLbZCQp(7&%jveh^-?dj%^Cnc{4mkwWht(n0ZH{JynW!H%OcE8#hWDCoeRR z1^zK!U!)D@AFv_b<`=b}@%3CMFu|5QtAR|fh*atd-CR^us-K9>PTWy>7Y-dP7GYZ= zpn&iN>?5EO`515{|0@P-r|Ue<=9epu(^ER+sHEX0!5h%Q74L~ZApKGIuI$V}z<)@& zX0k1{qc6cn^Vu4frt$jc_Db>?spJr!KIQ$6iweqK zyIQ!pj{Rk%EwScCtEXg@MDVjXY+TZ&xC(#ieX)dI!?j@mM@59sxta-MQEZ6Pu-iOT zk*K<3S*D&s?_W6^FO;FjyV77>%pprXbwwP$7N!EfzX=Q(wc2w(GT2dwoE0VP!yOvM z9M{`0e*Pr*zG6vjYm&$2PVGN|GR$s`~Zuf7_rJT-mPB>4!ZVQ;CgF#yh$XJ;Wu3MdkWML{g<}UVm?P_v6|n6 z1&^?#9J&yqzW%MTI^q-lmi9H$w9`ZD$_3q5zNiHi9x40K^dl_WV#A9MeKv zC5HP~TL~KGFdg%V9kL@7$C@Ntqg#_FlAr}3NNbw$K_k#-jJae4I=O)lcIY!C(jUC8 z0Gj_@a4EG2SO2*QaBhNvxO!XPYU zvR8NDb=gjwJ~8`ZrC+J_;AWN;GH@$&>UZ*`)vkZsBZ=mfgns5V(9ajg4?}E6l7IYi}+XD^^>xXeby2W9I1APXM27(q`CL6Qds z+F|7V8Y@enZn>7(e^TJ-QP4F2Mh)12lBqPr#DhIlnrVbqaj+hVsB31iqcMLc;MBxF113ih*9yguz~eOsHgK zTd)VJ8~=svl4%{h9`Epvua<&XaT)(tG7XU|oZ2?ic49c*k%$ zPF;G{0FZwIs<0X_52s6_qR`%e0!y(&aPaT_U2B+_@(ymC$<_HQe`!f&wHX9RCBR41 zp1tslZ-1lIvmEXo435FKfgP`@8^{p^Q>ebp^)hvv;($23xNeUYYomI0L1nZL%JB-u zujUF>$trv_#EmgbDCgGEn(k!@2~DfdGEw=QlyLW0;^_Bcn9kX;7(IP_9%BQaKK%ym z-+rK<15Gn{NX?wlyzYM8VDIDIWJ1g6n;6Yc?*;;&fiZZ|@{3LdAHYwfUC{G3PxH_b z5RY3MIyGtK>@d|`Hn^+Ef`5SRQ!66E&i(s$WJG|Y4q-yu{KTibPV zll5_c+Ag|MBwBSnaAsIAeI{sM9k+g;3pbu=szLXZF^FV!AkeD7rT}z546mn$%gYtt z*3N5~f5k%)<5Nr(U#nbw@G8!6MVs9+nf;=#n8rNZ<%7B@TJeI${>ZchZ$s3~4HdH# zid^^Mt}bRz!`mq)^`||wy)6lA+0PRZAmOWZ-o0hR4IV84KeZTHu| znKjjW;WY4NBQ|a_NVFE;c&*4?7zlJ?r1ZlVmSBA!_#PWlq&u6EHNxVxjx&A5Q9pS^ z#>Hl6Zgl}it=G5ch+l1OTo(;;bALgvhd?}nPN>2~5TJNNc9L{vw#uqMCD>kJN8g$Jw;$^A;ND+DXLth*u@UR{(7_EYWfkDq?WFYJBH!MK>kMB)YG?BZS?z13d7qUBYZ+_jbsG3c+e$M79;T}{pq<(lFTALV?nJGXX?>oi2!1@U5hyTEz)u!F z@A=eo4>DgYL2Aq9uYZj%w;;vG|Ngvd7(+T(h|9&P$AF?k9K&gE+0gf5*ndmWX~S|8<;#ZrqO5eM&>tKmVCyR&{7t zKCB;yqW@ACBWO!ceDy{EA??p9)MfYIDDK4JVCoWBQgHCO%Oq)hXHQWj8FwXcKee2O z!X`p6e(X58cu%^mNnzl9&xAK7o23ERqf#kfD&A6I*DX&b7-8q(<%UvCZa#6xsg&Kk z!!mbqS52|l_XEo$+x@HxOCz;7^p(Q=k-E5W2SFBIah_oEhf5}N`l?+;x5|vo6{`*F&%q;cf>1v9qS`l(*W8}D;L(@?%}}U{un~=BYy!5SsTZLwD|~6a`4swKXGpAsm}t0lr)>2 zTn$=|H*=S`tg@rSzuKdf$AvBGzTRMtx`q8|T#L6-Kh;de7Irf+>eIGeijsW(a(#|Q zkZX}V99rO6!Nxo&o&?SS;Dl0bnir91Ds*4pKJ_6fr0QeKbC#xf130-mdz~Z@Kq30? z8k7ef0>Eb8=wL&m2RNM_hlqwAn?5AAnUJY?B>f-R_3;&# zSP$?b;BaIFGN?tlbB*Pe>M}9p`z?uezD3&Eu`!OYXwLnR7ZJyZ~t~F~3uFZcy(j__JMwcHu>!_Zr&@BTkzv=F09^seZg74 zvxpdr+|?|}rG1muUigS(E?7|1Hv@^Rr%%u8W3qeX+2XN9+m|Az ziov%EPGHl)rht6A0kj>g_thT8OP|FyAW{K56nRU6)_{Psd-_zd*dTTq5Ev62(){b$?!J@6{+NAnT?K~4M8_Ruz0tW=M@^HgQ zg;xNAMTyX$UKVd9wJb#X3v_SVkg8LMP9jK3hU>Na-u(f# zqDO!z{FTP!B}YqyB}?VnWeK>8KZ)>$dT%x(#ku{tKR*|S2%2++N<5dbolPnjI_i;W;FYYC_=#DvI-nbG{di7aZP<$5mS;T$)8@VKB{zO ziZ<>themWZ{M+Jqus%J1+lc}Zn?$8Ny4nun#O&yZi`^gPWYzOFv}R#(cvaAbVnlWZ z{^H=HZJr(#jS7=gnu?qKdYx;UJj}pWJ3;&m&<=A}5cE2U#)$#`oCCt5k2982zDSi( z1QOE0vw9-|F_FPFAM`hK`t4xMkme`+vHxES;QmR7Dz~k4Gei;i`r^Neo#N{i;KLl| zj#W42GH`hGxBTI7q$DRpu!&sZ__KbWCjF|_y*sLFbap~4A{sd?$AfP19qvg{q@Qx~ z6*!q1L8awjuMbfY*Q&FYC>dCWt}2s0JWNg;S#vL~^~KNq;Uv}Zpn7QE$B6v~O5*->FY*MTY5g-mjd1JZ30h2B{OAC? z;_?S$8z}K7H|HcZ#;O!u(&jw`MUm85PAwvj8y4?o#7sOrc{N79-gQ$xI*M062?;Bk zkg3rodK^r-t%U2$4P<&DrGckaP*@lU#M;jkUY`G+v3xNnF&SW3B7EquO_}^#mgZmj zP8I48(gVS&<&c-h1aAHP{rx~D0lv78r!1jY5=zU2l+ELDU@n!2R15OqLr~xUsu#jg z`bvMF82rd$MNIiaWK|+$R4r|atke=!_nzEV$Z}_LirhXuK=0ZveH?wYfPB7P26ea) z>fl~hm70h!bD7}!2F{fa<`vo(6hB1f#^Fbf3FAj#R#&LS+&@gW5n7%RHln-6eO^CQ zhCiL`HjbJUMa@^bDNxbuqvbpcq~vSn-YlJO=c(;#XxqKhu%BTaj<1&RGUNL;Ij{3? z+{VOGv7*ZZb$PR4fy2DsEuM2wnFBhePyRXECigRMGDiJW+|2pBEsoaEt1UjFdTK>a zLQG1BA^Z?}*vxENIIH-L)NLqmNqGgs}7o(AjiXcxDFX}ScMLa&8Ez&4LtdpLa5AEw5;c+Kc}ZRl?LBZHXg}C}9MwI`;F7TsO?^a;{rV@M zZKDDF~<2=?Jh_l)5ta{#~?^vMe@IBCI7884iJ<8;ON7 zV_X`^gkd{X?p5B?RZId014BdpgmXd_ls4*6w+J4V9Hnebc6$zI!zHrLsyAsR6&-kS zA)HD?=6ciqAI&U)S`UA}US4w70hdVZ?*Ot%V^34+E{7jW3E% zmxWuJ?s`T+iR8qP#;3pBTaXxvL%sbov;XV6c?imS#(y=t01TZTReVaF%2jw`pUYi- z5AoX{H%Fv8yCcYC^x8z^>P{ms(%M-G$e6WJ%l;#SB1nE9G7LMCOM|!`>j9rOaU?>4 zM1m=-XI{{;u8WLm{iScpv&~0F!g}MFy$j1NBzZ-m_efIU?GG zzT5*Ma86WyqGe`@i6d83vgnjWhRO`E>+dxxFn@gpCqGjSwW@PV`@()4g{`CS0yfIS z9DBeNInvIx+nj-X$)q!yvW=9wZ;^WG2H?oZ366c5ef}?b4SmcpHL6DYLykOQjcg7( zNc5X*4VOKS9{OHjp(%N}x&xwJragj>7jIn8M0a6`!_j#qDgU95#fl6)mz-=G{|%FL z?HE+&$MwOMKoM~3D*GO#($0+#^Tz+f;!P77^*DJZ^WC4gkypG9i|KOqD?~qTi2#nYL~ZlA9}j#^ z5Iub6l7V9j&N~iYc9Rjf{emcmblqI+VA(sWdq{*kM(vWuRBNFMA8}ds$tY?>#|kE5 z3HP#QHABcI2K9ISjzV`3T`(rFktuL;^Ro6^$i3&!jG|F7TC?#VmqI&jALSZib zHSYOuWQSZO496ycVlr}}w>XCI;Z?Ws+hz{wjyj{dibrYI`7fnyT8sHpB(6&L0__WA zaLhemwgIBUegK6|}45{(mkbR_T8A|4~%tAT`LlJhW z)H#C;#*YrBZD3J2lWCpUXau_W>%(bqlIqn(9svwiE>K_TMY<)ToD?9O=FKmmFLhtY zw9ZSL7Mu1_Vd|of(lRO#n6p|8?eFSJo8E)*RsU@+On(nG5eQejafNFCv$qN3+OGmL zC4HidQrDcsE_#^C2wDW{pu3#sx5wr|3YUMZCt>6YVhw|z`&QmFeu>bb{$)UP0u-m| z9fC$}EaVOf=RTZNd$^Izayrxp`stum_eKeFVhxaq#0thhnO&PKv1C4v5qSZ&epmQgiaTWW`w z&fzuSXZ_DGJshYnE>=rJb&8NeoBdg#^FNw4n}%YNo~-f*VCO z$P!fSQE1#oM&YDvAJ(bCu0V>Hd|E1WkBAvfG3{8orf701I`ET$$@94zj^P4Rg7f=C zfee~{5cjf#PO-u8L99GVJmpYJbo#?|?n7t@UjU$>IAs2?A1pI7vjo*rj6H=~ z^Sze|e8L}c^XRoan4qKTq*akeC}S>f_CV)Y?~D)>Pr4E1G@A9C!JCKBGWdWd8&@~O-EiS5m;v+-*+r$7VS zZw35S73Q+<329V%l7rv#Y9O6+j-@90P`onJkl9#CD|Iy4E7|R2)v)ECzzzeJqf8qW z!s8-Xi7@VGq=XMztTzdt;kmcts4Q0?T93W#4*fP!^E%+V0nnZ+=RR0^0fq)Q=#&pA z$`)lGnjqf@c0LKA!7t;TtokLJI6A6ydh*=b>+rdS9OSkSt79RR9>m4SFfKo#JeAcr ziIdtU2We_hG=GPxi?L!-u5zW?DfDdS@-;cWx{ue$d#KEJH*TB3h@421kBQdMya7^} zmw&%r?qYa>i%-P=(G3JzhcG!Nc8kW2t=R|)juz^S&?Aql}lp1wM`-h3rbYoeR8 zhz`V;qxyz8J1*h(Iv{M(&Mdwt48;|1?0O)ad!zjw-={J*OLm#eT~Yg5E-Tbo*06vY z>gnw9%ipH@h~|}U%RJ1}<3f=Q3C8utPeq6{x2}|F<%8r-dsxC*u{LZ;fF6!&}>SVB4_aTb+5AKFbExR+i2O0dEKG(^s$fM?cwQx6Rra| zos?K{26qKV{@nr-87QU0C0aobtaj|?(b(J1becmtUAQa{0=?ZL? zpor2HP8|=k;!~7A=VG!{!A|CA?+g{TPWxU6qvBb{lq*YocJk_p8R$PQlX_xPvnne7 zs?4{N+C{E$4j7D-wAp|7TX-NKAX&j>7~LXa|7&^x#V5bmrG9y);}7%R$lr!9@^XxN zJXvA6;1B-Z2mfR|?#_M!-vN!ByD8@DLPuHi+&Hs`x3IxUOQO-scIWR25#VQ5jMO*Y z>Bz(9czHbtqY^Cs-uey2&z8@U*FrARs$1~ zi!M>sUWb;+EZ4_7JGD5*xVox!*p%p&w%jw|mLq5V}dQ-d(MoUJC5M z7<=&SM>n#*hT(PXkN1XE3;xIVKd$#5s_3xe8>XSFpxJ;nFS9XCqq6cFrBHktz2r8Nn~gTxr+Dqsm-7oMG$aN{QM7~bOKCmkQ@^D^6!pk zNdyA4=GQ>SO?XGKsLY^b*SbFoN#o*pOjDv#ucLo6VlfwRwCBOc9r##@FQN=vD#T59 zue)?zBy)IJo|nWqUt5ClKDtk%t|8;+j30KDOx~;o{e4B${&V zu*GM`#23AuVoM?NOdo1NE_~A|Vft=CxL6EB2sA5qL z>>VdqPnPRB-A|K)Q_*G@^}$AKI*4_l(3lu0F8h%@>n-S;g(h8sSk?NH;t5H-PCMjA zw((hs+6MF56g4=j)2~z(v;mV0rNcld;-6(#<{_9#9X;CHR202)k($VZmAd^|9f5>h zm)U#ATJm>hfX8(?IYDQPGt0{ z=vF*LYw#O@Dn!ZMy}iCg%dS?ZHArzuxGElnV1a^Y!64-Qs&M29YBl}vo@(9;& z?3#(^5IrV11C6cV=9-eqCydYT?&CoIjmIQLLeLgR$H{G*d4%BiJ57D{AQm!`f4z2! zp*FB<*AvYPfXm3YgEbr#U1@RnD~VDjQ53lfx6oJu&z6`RbT=%%FS-71p`M$sdfOkj zZJ1JuA{(lRIhB|8bh%cvdB4Kx54#Z}Mh&U>kuhf!)EBSzGUbkMeZ^LIV$PM*(`!K2 z?uWN4Gp<_V(I*nRxtfd_PYtiIVd7T7sGA`+i^)z_3aafYARe&a^~gmSn1X@7e>(gf zj6++qqgJ=Wyb&6FUuK6)@>5+$(j@##CO1%A;3wjB(3@+Vs|9t?=`bqqcZeS#`h~Bq ztN@+Jf7KgM6>PudS46Q>JOj)0yi^DrnSv=E=BE!hm9dQPTM&lFFRK3o;>IGG&Wb%s zqR9xpS9_!2a9n_Q`jA#e=3pjs{9)^^Z9x$_7jJK!Rz=4a#87f!{u2x;5cv~&8t|~2 z@}FDSHYJ%s<0?nat?FnvAwG9dvvoUM^lyMlGo2sP00VTyLRiy1_=!$84sX4HGfJDx z6HOjQ(D(uL#;|hUjOFM04N~f-e0XROe-3gl@r0VQe41;jjhg_stvKP9LE;tZyUTA- zQfTLqwM@K5hIIMfqy)#@^v8#HxLoVY%L!R9_W){wGvB>e;lOph-}a2>)+>zZl8?8Z zw|Of8(spt=^v)} z@^A^58jyISjsYO#&Y$~-tuk-#-_x3l=m(nvJs~bc(0ZMf8F{`&XUXR<-U z5vr6BHoQB`qCc;fYz4QJn082PcY)GZ zrQ@dMbJMt4Dvck7*d7LZ>7{QXkG%@!ISpp8<#D}W7=;83Sjsx6tpz_)CS`I@Xq?Wz z3s`1Me6E8@kX}@FH8W$;-$_Ytc_Um?$WtL^XmWXez5&&>rUz6bDK@AB08bl8jX=&i z|4y3f+d3Mu>cM3W;ex2k5<*1nMKvDPL+kqlMcJ@LTB4SiiPJ7WTE%E@y1!wGFILE3 zW-2a&6CakLP5MIAg&W~B>&!pJR_ETHvhn>I82_gBQpkx=Q_HxU^7Pw_y|YR!KwW$0 zjEIlkfOkOU!nTL39=(e;bQnC8o11y5#YU2tn#6SI2^eVS=u*AmYoevq-QB8e8Q5t# zh&G2tzGF%OMh|Xd3@1FzN`PTz*~@-W$RUUdy!&IAvYGjOaR)M}IaEagpGhX+@AjJ$ zpK1_P{8Qv3-tae(!dMjtSX!3skh^f?IKWDeKk!GU7m-WW^?ijgTl(zI=+Md+enrW~pqCa%@r8^VUA zt%EL?SM?eLiUug`UOd2xRLOkP(DYTu0PQqFaeGW2HyCkB2~N4aa-Q-7R%*alem6pH ziQRa+YPfZ7`>W^6gY7JsA&JaCj2mivt#HX-)iQzN!E+%&jAg+>`VmfYxb6<_-FW1p z3!y(5vtoYzvb9xI2>co#HXEX>MiVwFn3rOb42qh)zYm@_XmhVmLxb4Le@Z0bTlgo9 zOa6fb{WEBRLD*b+@AbU{aap3t{;ja4M#|@5l(J&{oWH?`!bJ{UX|EQQB5uH5`262datL~%$8&u!eZADBITM^djz8SZ@P@j%x%2+ z9UEy*r5x_;$xM{OOc*VR8M)@xjfFlLZY!h79wx8A@Uw5?Rz|o39v`@|e~<*?Q%dd4 zuPmCrL><8P+B8>{i`@b?7<#x@ax_p6lf?Cm!B2fzHs6Xx|dDvPhGuV-ZGaCpU1> z$fQ`0PwCZA_6iIw<`ghW*-GeMD73L^i<4>-x|IeA0hj<`Om2tAi;HRGpzWjjDZ9Z% zg2vR>)6=qNz*#^@$eh;+BdLjyW7p6VRNY>KE(u)(63L4mIk=kbrjGJX27gu^C_G4Qf_#^!k{y7v$23eqDWqrO+jpBap@e8L z^yKky%ZlR+M8sc~>!RD4z4gJkuu$2~CY0fo0|Mz1qj#v^+FSI(Smme)aI z)}@Nn3bq5iz3yc!XK*m&^+tBhmuL}+FE5nV=+7FG8CV^^o`A-*8beUuZ8wPeF;L(( zv36iJ6CdZ}C+Xs|G{49Tbm;pry3JgFWL^c9{4Z7mB)P)ba{tvQMQ8$&k@H@+`7DrvLc ztY(qj`cU7Lw{jm-26%b5x?UcJ1sl7$bs0kuW>0XcurlPWuzil0D;}k1i%d{=nCC`} zAhn+xY(6u`UOhf8S{^F^#`Zx2 z6dU38`b3Pl9P|H+pSjmrWo75T-|9s}aRz}Uz|#G&`Q`0O&1t?zhqVM{+87xX5$abW zfV^hz(%y-<-*#S*_l zu=}OcqK9@54O8Wx;y?=Gu(Gv7NtR@>+3i%@Le0R#A~=$?xeoA#3ey%H{K5RzzqNX( z*4|NK5+P?=La84c{ttpjS+jxtDQSY%kEucj$R^p~@MDs`0am zj|Nbj_fg-9G>ih}eo_Sb`sy3uA9q1a38jJ*Gox8i|E;(*5DkfJpVj*Dc+)E zWpM}2Ljav*>q)kpNCiCu_^l_(Y`@4hmLE^2-e~Y^Z&&DTr#YwL#ZI*F8p7YXe`;eQ z&AGQeTS23xG>Do}^Qv@KPFAb7OuP?!dwT~5Rt)YlaXV^j5qEWdb$zF^PYX*Lf%lzx zQj$y7{jb@zjZs?%&b#mUBWn<&kVlKCU;i3f)S+|DHn`7v&u;ScscEIWRu1j2!;=MbAyR_mbE~%|GK2tHI1i>?Pm~LENU!I z#mo-Bjk&9jZYGcJVL1HH8s66(K>A?T2Smx43&m-%!rt?gWJvo{b4>q7(>J)~`M>XH z4jHSKTefYxmTlY1#?rEFTg$dx%f|9n3%}R<^Ee?)bXg0z@)5&z1POJeeS*WHE{NQf&@V2}Kjm0<1(^BlAA1{EK`6;?A63v`?;@dA9R75L2%_PrDbx|5>=A8qy9{1e z(xVwlneC4AhdQjiQZ_ftML5PQ21QCcTSfgz3K{bSoU2D1AQTQ_SaPy*c0{T-D3TL9 zT`nd`?}aL&=^%wv(L5ddUo>H5XqVWhi<363}3Zw#z zCXxc|@!p|u+9Q^C4e@YOpreaQb>mnw(ya#U)zuNq5mEC%Uz&c?c7yB}_rfO_OVn+n z_wC#EzFh51XXr8R(*;o(-q7!19eUN>^nZHnX!||!?-?sSUU_$2C9Y0;rRuhq35I^z zr&XYtoulwin37z$%%A?0a3xH3>xFNsOy`2uqv=pi-HY!XJlUMWU=Jy5MYzw&&Fyu2 z82!(dR?1Ur^_Q9_bq=aHdgn|bK`VPatPrh26ar))Wt-9(J4NTn&y9_Z)Fx~56>jGU zp6lv#O@thS2i0MEmL~E`J|86hMKy^EH&n>gK<9uFEqPeOTjC(adB#IVjX(k{ZpVld zix2P=v%lsZO&Q``g@l$-u&vHv`trVoxy6NLD8eewh$@W$Rl4_ggum*@R88XrT%Rj- zSge+xP8TbZ&-+jY%3SwrNaAkPQoUYy8w-m9A6`_i1j@dBK4ei~0nPwc&%eK8-o!#} zebD`Pa=K6{EKZu@QSGwt#zUe64-;jn7{p9!|LZ5Pv2|SZ=eY8xmiT3Q@Qw(9Xj%gY zuWzEAP&_zYu9%0HNvRO{(O`dx6xP$%cSbG2N z7Y+r7ztCBYN*{K`#wnq|?XHtM=A}Yscmv>Dp|J4xc*BqIx^N^4g!P6R89l#^KH{#89?9uYvIXW{fLs{{S|3^nx7NDTY>=e3ljkcMW|7PvOnBB393; zhHK6~wvc4aJPSv1;Wyn$=@voeFbRCbiz8-cpFmre^ zX;JD6xCW~}4=3l3cT<4V8Z;YDuAEZoO67$kD*nADe>lk}K4xft+J$G7@Jv2GAV@7{_l=-^vVY5~pfhuZ9&1sQ9oA;y+ z{D*~_E`tS-f5ue=pycdUuu^sAKMZtt`4wD&Ig>H_t$(p+I@7vNLh_?9OBpj%5u?_W zQnB}Q^y-o+D$)IW4zY52%sv&!W|`D%7#!FYF^YGP!tdZn3S@;I33xI1fOsX zQ>ZM;G^zL5CIDx73qXC(&l_G_>Qb;UEMp<-($70*N382~acfeMaT~i!1+pR=zrU|7 zW|F76j5pN4BE3FwC$E_91nI1|)jY5|h4>3wU^i)g($Hb*oUyVcq5V6d|F)xYhyeFE zt-DR(#d3Lkd<<6V=Vxz#A3i@ngQzV0EJmA|pMGf=jJ(|3PY)M(aF&Qi-c1Kb7*&XA z_{G^WCOd$K0*Y!qhRol-niJ}_VZj&(adamJz}f5ZwfQjV^;ch<4E6NPocAyOG1oj} z?9@C%0E7{Vmv0H83y9m;Xip_U=G*ac0-@ z3@An%u!co~>_VsS#O3X345wh=4GVTfC+qI8s=N7!N2$=e-C4|Q#*hLLzKToLOAFno zp=Vd2P(&}K3@VzS*GI-iS{H;Vgop#1D0*`p4yB*8aI^KcECj^gjN23~o}Q4sr2%h> z{E%dZfh@jh!)%4lLKx&|Qk2Skx2MT@>CcyM^63V5fhKb!9L6@K?z+{DEC_HFj@nDiQ3U>@-yk3ztfszNh-Jfy=9;dGqbFw58Vo0#n4w8!-5{Ezw!?2^tu0~vA$7M8 zBF3RSGy4PsAKRE?Gp0a^lTL#N`PLZsj)89PA4cfAd)5+1q11Ob1SCVIv^_Cx){5C< z)&m!^=FvBaZyt@hhv{p*tTAh&f(D~>={TJyL=4^I9ihN^`*Laccr`-)%% z)eb7)c`suMq`IJ@wf_A1e9^K6nms=6->yb`)Ngwaz`p@3P!A96RPW6p3c8=-Dm6ns zuXY>^VQ1yg>vVh^s*TbagHK=f2EHUIIUg#d+N)e9Rjy_-R70!~mJiFI9s(4>Kp!h` znIK!B2i;U5=a2aF+|`~&nq=RSF-f*sfdu{IQtm~l!VSt_@G0h+*Us3oG)^ue0qFZX zT@w2*VB&*!9K5u3{fVZCg`m97&U|O&HN`rgsUyX|31=iXn}qEXL=`YaRE=#8fv_VS zbj)7~)E-YRv??BAd)epG4PS`1<9^A+6Yn|8aNVrNc3p;jKM5s=1#fJ*MVnvsuoxzF zPZcOkV2)iNt2O!6X`OldcD6YaW3YJDj94B2yBFfdE$~vROL!+%IarmKz~^JOt*Yu`(?^xfR#I|qVlVI8?CIN@ zEl;gphVtgW`KrIB5U>)tkoZa`_Z>4>VDK~zP86jly|-k$;AsJ(*P1tECGhU*%D@!_ z7{5I~HYoOONKXG`IpLz;zAO*JwP&`QKh$3JqA_aSPG=L#SU~-MIGPUFDD8;L)VV!Re z1-tX5Z1dl!fMSk=>qmZWsF`pykSP+KBkQW5cfhVS~UVn7$NT1DK=1i(mGP^6#ZHOU zF}U8t#^=!w;LTMhvu@RewMl$rx${w+AGkL7_fyAmziX@KP7N}-BW0&uiqb!$cS|6y zFh_j1HATP;|Gbzpk zRQ>+y5Gwp^Dhx7V{BijE0W}q~oxvwtHP|x%x5#Z>CiWA-#9B|mlAoIKMb04Z3r*KW z(;(aY0NH8P_ivypGDR5;zTgTj)zHgj7T!0SV&LB{rjEHkoTKg%jp&Rm#zm{OV0DP= zFE}qT+-xgZU(YG;O_=#$_hvKewDn<`vGtZ+{qcfj3^tcL@Ta+JfXh>w%)xTe6dbHC z;)goqkarKXnm|oRkVS&*K{cAu06=dX2&f#flXL=+KiO@!XkS#g9f$O;sP#3zXGD_c zpz}cz6_=qLfejkCRqObZM)iI3r9U6D9m$1th}2ZecdXb^Rdll+))6WW{PXK;*_}`S z4BBWyM39si{OFzg_&_l)a%u*`q+Wwg5Kb6WlVLks27j$tMDXBRb@}=7`S-tCjbABS z`rUFj6({@h(qU>o*=jMAPruhrhCb6xunm}MrAl3P3Hq|HdB~#9!h*XVDyV!|r%E5n3V)mT*u=!mNaCiTB%(J#Sna(b=)hrQyps>K(~1JS9@{+IVoX5 zYUG?#0J_3)*JQUWsgR`W{g*e8Vhy6OnqC0`OYh~{JP}|XQBhG~P@11tIs3i8Hek!m zrIEAp#dz%wJsUAL@xwpV6}J(?-`lV+qZm_&NiaXhWk?U3Y!eP1ICLP(Undy*; zI9cG>@E8u5pN^=OZRW+NX(eY916Dnf=LfvU9~X3(8*l^47$#dv(1i~y8PoL7b5mK# zP3D%o7K?UHEy6Vk3#zJiP=r`Nw8FtU{afwhzP@%@4WCRtoYSyiqr&1>z{FbopnXAH z@cufA6D}GxWOI_0GeOOnn`Nv2 zB_pm2RkZA@R44S0zGE8hFc`LuT(K8MThQnAP^*NQ#=as3QK7jG1$R)}fHD7vn}LBL zB0!Xp%Yr{|9%@E<+Jzl?-dpv<7t-CseT>8f*(%w4+BfeqVXmrUIy4_LqJleM_TLr( z91J;md0BO?B_Kwj(Hz6a-Ni?73&-0`;)sXTFH^s0SMiX@?tjz##a@qJ)HXjfV>eY) zZir?$A2Nr6fVU{)emEWCm>J|CuU25vfRO$PfBCcQXjS;eFQUG&LmrT@A|@8R#$MAV z6TljL5oXrukVUlmx|-Pyggij`2HF%8Hq2W_VvaLOaT-S)iulS%6NGHW4|BFP3BJp} zAgB=scNp=KYcR3itf#xJtqyC32Wl11faL-~Q+fJF5EABrYwdGo&f9G7RLM&$Pi`hp zx_X0rHHDBCzGK@EC4NNt7M8^mGuAb`Vh6Kf!QDu?v@j*IwIZ~!X|NP$S0l$Q>)B*2 z=g;#>zD!+l6Fi%BXQQLoXP9EvjFILmDJ z0>I6wgWdwf}Ku_h``mAFC3Rk+^Z$9~UbjIuWAG9O`5KH-SYbZGo@{ zm$HCq<+36P^c}kA-({W{e_8!w*)@i$CRKa5+8kTV7C@{u9m#OR`cynbK~HKdhBZ%hDsf{wyE)fW3&gFQxRbDxP?V`W1?6%J zL>EwcBoS#{fui-lx29XMVEU;DlYr`{Ch_06ODtV`9 zlx#+oa9MR^i63#b(L8JBba^(XQ?*eD;@lqhc9Vqu5PJsDXwX+-x*`fq$HV2?pmljrb1Anc7#u%u zix#REl(w~KbN>n4ciSk2L$}#Ips(-!fbtGikFE4>VWB5haon4(Ms51xH<*6_2OFHg zc9TKu1~`1>WM<+M67ulF4;+`dWz0;d%A1{;Rcm#@H@+_{a1gqgM##*{(o_J{rn7jm z&pB}+Nl_=Hq@xqt4nB@Tj9x#C##0{e%AB(4WPr5H!PoZ{Xz&3u>i|Fv#~@G}geHHh zId^`=eb9rED8l~%&h0=V>}YR4?aJ|sIQjbEBne$HmPDIC&U?pwoP>Q%|rmd$~L@f|n&>|}nh&I}Fjfe8us{9-!C z&y=>baFQym0a@ggQS@Fam7S9O_>_KQ#ShmB+wvC=-?Z-{WB}vF zU??Q2YX+5+4NuzR)G~s-1US&p6!CHpU^( zI~8D_A~rZlWA#1Vc(&e5otsSogrCo@Hk;quTD&1RUvEab1c_^n#tE-{1S6D%r+_d z-N({piqT*DgR1K}37`XK4`xY|#38ib&`OE{RZFpJ@Zu>X0d@Ej+Vlyi{xM!x4`A}# zoLV5@!4Fgoy9{m^z)!KzOQPC_lZk0h;HQLuvV|}lW6Ul?Y-Jm5**&P3c*sEZX_kVd zghu@;B~i@+BPi(bN3ykFNEE{Ozi5p09@8jcgZYpCCB(HC;aZe}0^bthDMT|w4dfwt z6!zT0GbWl3h=o!yWE9xlaOPSSVnv4w-U8R3aX+eHAEt%;#MLdq(m^{Q*#s51oqh?w z#(e??eO{m;Z%C42EL`0yY#T&_uVSV?Nr1N_In65XSt=h^)vZeNg^U(qOcdV*;t0Un zAX@is(OH*_Acfu!PRh)hVKg1Fl{%-Y-{u zNX#r8zVhvpS{Wy0JxWd0hQ192$(1@aTXtR$-*(t*;u~h)f=QtBl3*2_*?$KG(BiAL zGrnwYW@$5M8KT8XB023iabL3!<(kV9jHa6!z-NGt3KR?ieyA$$GW0%NnP-PpsPi*A(Fh;MSS)>i-0nFrM(Z0hZ z$DxtjfA%g;2%g_-^V14K+b=e99+CN_>>f3lL<(kcNQJ6@4w$_zMLLfqe!RjDE{eeR zwQKHTWz8TOR7q}8(@*bDHl_cXoZ~9z%k4mHEC4MpQS{*4PU%_2k!}e`5AVx(H>T3u zCju^kz^Ym~<=RyXVVx)Q%N@nq)EG*_r9ywTjT+O7EZ1u93Kh~d!BW-5W8qf=mvZb8 ziR99(g^5f%RsAk-Ne~`=Z@_4&)J=!nIC6|Z^yKf)s~AnG7!w&c1GC>b5Oim_XF0?ygL)Du_<(n*r~|vIF)-p zFXn|wVsOp-=TO}yqZ-z86%S2bB|9xn7GO&@joy(1S{Gj33BY=DKgHve)n)i3uG%Kw zs*rro!f6FFEZ}d@JUm>i11?u|8;~T+Uod{9rNSL;EiL7mOAmuEoM3cK7l~WSpV5yk zC15CWTo?Wv*NV!Qk$f1rpC~UBD&A;C`zaS`VdDox^uAN$2JC+&`RwgE=k3-HaBV|w zfkeS734vdfN-9yxhK?aEFDe$WhF*bgPS@yAi?^Ctm#(WfHp%zTB|#PaJgTkFf8;QA z_*Y`#>vLCn76~)h(%OFh1lS{>9oST;1*D%qT9FthYJLxej8*eqSW3m?K?0A2 zmjE7rQ#w?MH%h`>Z5QSWBNb}nXqpeK)$70z(|4#lJWP!2hNT~&o^sPQD$9^;d-gcu zt|#f)f}fz$SP_A94!!c;Gk$scl*xoIn_lnlvjKrbvqNWcngo7L|1h-74DT|W6)RXq z)@&Kk1Q=1N$YpWJT{Aq`OToUD7Iwa6B{EeWcFu|^KQaU=n9+;OJ$1)R zl!|j2_J7b{C5~m7eZ=oSA}#~Q!^NCfgU$%pG_=o+Do*b)-E;PK@hc*K=afWd$ z!{i?_Bgl|VPQU#yqVXKZ_zPH=$}eD$1i!}COcpM~YcegC8Y#>VO9owKEPM{Rbx>HP zGv6OJdxoC4byTdQs|#3*xE6QlPOvD)a+T@w91FbNySuu&dU~d<8)_$e&hB2Y{m#N+ z$2Salf9GRHe^Lg2r)yq;Q-uV}{O$&ut{oyrK8oq z19^c-6UNGuvz~GO@}w^K;|U1~Cz;I9#b@3kxWY!Al<+PZ*pgHoRRpY;Up|@%CBLU` zyYtC!EW|A+bd{c0-Ik#f$dFvfq`na;Ca+F2E=v`yomyHsl-7=>KeqhvCRsvmwbqFu zHl)qv+z}X66~V$OS3CKc@bl;5Fh##SB*LtNKick0d7ZCkzjtf8!S`LVF~JT#$EIpr z6CIMXgM&dYC+7ZI^j&Oj#KnKU=;HqY^s?R!8>75fsJi#0@8s$_{E?Bi#>!O;E zdQy&jF78Y7M-IR=oceQo%oui3E`+87aV^jj%zyb_U(~yng$NUSaQJ0|M?h|Bl~z+; z@2+xv8BK_$?y)ShDgt}^-<@y(V(sc-;OIxSoZM`gpmPDAB)&*PX9mJ@g_n z$$&CK&K!VwgO`=Kip*UPcgOV!_$kS6@9pgYa~c^-(28SYV^75EPcBIQ9!rua$Z}4% z%>Z<)iCBFZ^pdP6r_4eAScG~@{ll(`!-`BkY`VzhsIa+xmcMiSie30}uY}G2#s$CB79~R!71p_2o3ulSAX0ekLT;?O)6n^b)>Ue3=L}n{m&_1T*!jc?3Dt>F4fg*{PwtbKe4y0ohKn) zs4j{`xdocrVz=C)tD&L5e`j31_jc)B`e=UMC97q0>P?0|kDgg9M#BgK`<*48TuXYr z6z+&Yl?^Vr0b#^hxvI`dWh?QpKdm0d(#{nFO+SbatB3LF#6RAzyx1~$Cs zbr&fEdx}3{b9ysff6O;{w*L*~_H(BcJ;w%nSpMTDB=qnIl?PXDaMQC0U9; zuDAyWN6IhVf1Rhw&A3}Gx}zc}%>J0`7xSe*vb^YQj{T%nYs&6ajj|)qX z*3Y+-=v$qK6!)q8T^V*j$k&VVR)1Yz`R$@N?Fho?*^(HQEyfXKDOxI60Tq%Amd+#Y zt4*fVeyQvN^$AsyF9y#34IEp8qKS&wg4vmT>*=}ajOOx(%SUtfrtx|QIo3254B_ss z*7-t~C_YXi5@r1i3x-`T z%yyS&mb1e@B9>j}+);cf+3!@`sd>BEOU8atnpw!I6Nx-zyaC?7xI-1LjA(e&Ax7yE z2YNANn?=67+g)q9BbM_#3~PWT4Q;>^;dXXnz%Ge6FfzTgk!Kh zcly1(g6fgIU!OPB2(z~O+RhRnBf!hMJw2G=SbvwH9*9Pr(^FO{f3#Na|xV@2c4 zRGevkkiC}iy^3DyyK9vY;F}JUi)|+rPokx=RVFMH9%e2wf=3f*=GSOle;5_`-bdAk z*f5vW;KMZX*C&i_F%uK)YPJORRLCaxJ znj8{&MkIFb9}pRdr;gb){_R&n_5BILqW&oY-o~$AARz<%8+m@Y`1)Q#>2x}1z^Kpc z_pA}vfXHJn@LTl;W>r{zC7W=!QfSmfRJNVy9BmB_FnzXInGWq8EhT}S2>YRlg|ERW z;_JGz;b^Z-%5;T~%~(duv=o!2iS6m(fs*^1%xH`;UBN%%bmDv3S)X%+*w^yb)(|$P zfW)@6)In)`v92048SLbm41p6GQ406Qjp;tb8&!WQS$^$wlzA%>0=!@n)PqJeQVI0e zFKSD3SiSDn2`OQg3(ZP+MDO-?5!h2c1NBX|!dOGw_byxfo#fwlSIheD&hw+cRD|>l zT@1Ux6#$Yy>mUstz3n;2Y6c7PX8fb!dolTVD3qwC7(#F&0^it`8Nk z!)>vO=s>u+R-;k^i(_((GdsFW!0D9e`SNQvyNBs``~F&b%dDeW>DP7x`9B5xQ+i}R zUp3K?Rv>~$66(wiWkZVUjAD!m`Zvhj!|_)dhhaL>vJpg&n9V&WA7i0yZR~4;ij^Yz zakI*dc$1@ziEJ{}Q#vZt>@)ucBWR4w{Fhm8-0+j(qL|K5p0Ze-^u4({Y<5l#vMi5) zyNk>IA-YIrIbA4?$W0L0p?iCk^0C-dbymv-Ey&t=5t z0$$t&{!@b{g9ThT+X*h%b2om+@Bw=m*d4Wv8Iv+_prSm%F|v}pQS<8N#>w1#I0zWhy2}TU>W<(E`KFh76~bkrmp;F| zbmDYM1YJ7-CqlXm%j3+^el?-|qw&PmC$@LQHi>lNQwdMEbDzJKho>P%_2%nYB(+xH z@Ub$le$6>9(sP+%6wB1CpC~WnGOz2-vOA&I+e9i~YVm!!o}ikVKah<3ve_K?f-0*= zpYRa#V=N`dBe~n4{?6#}X*0(|>WpfC$r9_Rs%s!13Y!o2-aKj4U1?Km8|?SToc~nJ zndSGx;w)^gBb$w`8qyNP9a7JKF@`Owq5adsW_P3v-kB$9uj4T}9z(QkuD*P3U(L+q zzR?|BMG`_s7O_VXr^g^JV|cH_5Qk8D(EEpEYjkwfd)=9a8NcHxTe-BPX^zg-!A}hX9YAZMxZCEq}#vXfI;7KyMPnn!L{f9gT6RmLL&!} zL!eH3X=Sm`5XWICj_XbeoW;`T{u@-s*(ng!ev{hsQ(}^e{-XGxOT#+TBjn3Gx<5Di zEdd(WjK8#qz|OA2lhM!sH|eaMLNLn;wzaewV-oIsN>0 zWUbAQ7Jhl<>Dk_3S2wJAYZMI0f3V5<4i>1U%$Vp4OD^ojyYmh>7W9&^tjn!5mAXQn z)o9&$X{mDfx_=GUdhBogkoweAQzoDcr)qE2fL-=PJ1k^B;m!N^Z?qITMAJs$_+?W0 zQYQ;T$iY4!bCdkLKUnZfa@OrKRX;eIBy7MRn6ERr13Q zq$Ln-^n$D?tN*bP4(IeZZ}I8UPBE*a@C>`t3s9%U4YOrS_lA)6MC841A$Jyn0XHY_ zwwWTiwUmY-X_-x%2Qb9IbGjzo9cR}}-&ret;FsJfq%BVNn=anoa6(@2cUgEgX<*Pq zVNGd5yjU`2+jFp>zWKcKS=y?7??J2ZqnE9lZDNY94LWmZK!ow~rW43a-I-`Q_Qo#M zBIUsRLRu*}{+9ToD$32e>)W5HL21A`V1lUhAQEO9|vN^6I9|gdayMX0;?B?0HPB@82FvPft-R2FO#j{lAnm>_Mk9doq|x_xyC@ zVLY;|lb5heR9}^Kpujh5yw+@|1|#sOx@uC7>UU<@^D`1;w_VBo;}U?Kiyb@m7mmRy6uWxv6G{mr9~&I z0=JgYBCP%(ZGf8@Ang761sV}(s;)z&O4*gxAB+gD0m<7tdD_9z(Gds;eSLi$9rN}m zQP9`yB?7|WE{?+WphXpc=cE6B{H>H(9_v)(<@#jF5dgLV4|O0pz1J$J%xiz!iJ}@;;$N%)wx}G`cI@dUE7lF9X<(*2saj%nx?U1@} zdp!SZ`hM1~u+qersGL6RFvt4E-k`((X%>es@D%eTGU6Oos8>Ue8F!^w$4S@rz-n(|c*5961C=uhmINwN;{)qP zAHHAKPR2HladP^GCm42!e0e>Aiizj>Zk|OKMDwD$8IW@Sx*(adY9G3~ySKjQ`>dik zlVlS-JwH0bTdvP~dVAZ9G1>2)H41gg9GD8E!x3#FCq^(CjStcMy?4J=F(vbW6I}hw z-(m<3n{F};DN5mn*ZNyOJ;B>N>l$G9dg3G=R9fN{rm%}ejl*A8U85RIS=fLKw%h?# zMk-|nMpd0u>`Mxg)2|aFLkaXE;Kt*)ieRCeKgVO-YF%+OOY2U2a^r0EBhAj@)QOat zSXPN7^sm~zX94+Yrt7>V(sbG{R<0(VA`yyUOm-4gjt6>ti1$o^ZM~3j`A2qdHsy>; zKJ=U7CB-i|bE+GgDxi!^TB2u;>Nf06OHICGMxQCN>~Im8?f zijF#ni;<)jhA%fyi5-#Bit~%KyCV>a9n6?7q#slY#ic&=kL?11JM!-HrR5(>;SHs6c<%kgaibd z%5t4JnnCp)9p3>2BUI_5lz#emNesM6pRcB878Ka6DVO9t{HO{jarqT!a~>JNrw`pR zrDzX8f+gth9u`t!AWy;ZyoY>4-#6EJ=-$B-Y z)A_|kn|(WL3XJ6y;DfOp`L^FvkKY$z!O z^L1V(%3(vid)kV!f7hRcsAUodq^cS>s08-pCzkZ$YUlR+CPqe^mk~UIuHW4*OcNAM< zmlEZ8{M;9?18{JbvMEY@@MYhUN>IkxSw1C<^oN}fs|WL$C9h;|%Q8>7q{CE@#$qfzZWDwR5#riDk^3`4{^0j>TiPE)B^-A z>La@hSZRTD6zSLhxQX0s(`G^R~IZh(3&3xf5J3OYaT)8ZKi+A=C`bg25@ZQXSltV>V zD!(h}p%veQwaWj~a00gX;dvQhj(nViAi-#S@6 z4O(NKb(F#@DKn>-g&*^ZG}GTzlQXuV2}u>zh8rZVY5cT3cYo7K4-U0u)I!|=eO778X5V`fh16?D!Re*_% z=7n-$r6Q56qWF3JKj%56`xZ>=0ektadn3+AS{PZzXg+-w?q?U@T_#js!u|HaObI@(1VeNU}g0v4uc3M3_$w#ptzA z9*vS&fQS|kiyOE2B9c?jnWm^NSoARE9+70-s-d_K7>&~87h5`Kr;F7*JD`}V!uJCvp zz2oA{siSBn@LQ%2)5phhkCKEmOEp>RrRp9V-=RIAp83MAU3(wdR7fYTkg!mF zW<>z)B)~rmK~s!blCo|XvQKWY0!^OKCA&iV;N*oQFM%==m=7p7FYV0E3ZmTNW9yWT8^D_p8=T38-5mn91 zkW|TJm-Y@LW;D|WM5=0L+>hmjzBxgPuV@}r-J&7N67Bu*SnzX6k)v$b zmHckkN{m$>LqcCN=O~@6htbCoYi}AdTy}wnL)b{i<_*A{ms*f7V69l<<*Fj`Z{?|+ zBr=0{TN#fwo`5D0R7<^JYnE@&VHOjgi|ojf(5l~DfGkiS;A#Ku z+qgd<&H*jlpJxJ_Le(?wvOmqpg(K7CNK#J)S)>eBlq3zJZsP#5|LG+;nh0#uKV zphfW<38P4;%95k_L`#ld=Z5GCC0jE~j!rJ~-_QzojBpfX4QNU=Oz9R9JCgw`6A{eu z`KK-}tTvTQcwB*k+&@BO}hc@Imz@;+9D%Hq$2Cz_QX+c%!(6$$s^mH zaNwB@$$(?aOIwyBzVzRTE>VuO_sPxggwj~zsi(LDQLeZ)kPjbcwrOy$;tGd@L&3^M zfPP3);ublnMEVJBuVVIK^1G%wZo!5IUaqgOO?|S$J*(XW|I!`ps-U?bBGib|H1`%r zM9J}ceZ1Zq2CEz<`5&0$ObU?T*kT!F&2R1ngQ8FOXvm39#PFr5syp(gF{takb+qq( zI)u!ZaWtf(9??;34{?!bu{cXcJa03?EVbT;;^B8o0QdamKntH9V1d%_iMnEyww6Y` z?ui6xVxu&pz=JNbu99GM2RQ6loX3YuW~@Pyda^$|kniX9{p{LM&odysI8+;>whD{3 z7l1Bt-q@AB9^A+PGU4vbdCHt15m-N79(8_9^f`MW&R$5e>yN<~78(`Kcd=r1Xnc$F z?B=OtLIdS0Z}fDi8<3*kgYXK*q4>rHhu6^_`%44(@-dU;k**#J*JYPeTD{7;SP7td zw?tk0yom{JlF}H*b}o9#!){v%2Mp0Q~h2l1}sS z2(cmThVT%oYj~vhEE(PGHM&L^{sJWxr1tC_i4VpCpfJyoX`H*|K2O`RFDsB7q~hrcQ|f!`w`Nx%UQGF?y+UjbWCnE zuIAf!I{%vl@+EM06Kml)!MkQVQkF~Jq<;lE2qs0FN5FmRVTPCRd%?T}InZEJyzPE_ z`5j9r;8hbs)Y{oV%qTb*8yJD{l9>C(b1Xu=PA!x!XhyinqriL1l^4H8YuH!1`C1ZQ zU*&`X`SH&b_1ry)yk6!a)t{g7$jf+ZaK3++x4_}ZEM=njh`f&_#};jPnTzy_?b&=M zZK{x+L~YBq`i2mNK2s#@k};9cQ>rxDj=<6jMB6`Nrc8fJn>g_&9kgCMP}~DtxFBrR zYQ7ls=~S$%gaq_M!Ht5H$KwYuOUu>Tjr+byCCs@xJV`#PV!iVSI`Vq~2!qSgf5|?a z?3Mdo+y2zDtu2%Uc#)1x;+xyUzZrLsQ!cHFk}yK)6*L))s6?i9DZ?T0~Tk%o68 z^NPFEuhV^SyQY~bHz1oMW|o1PVOQQza`?bSn%36-r7elF!6cO0FheP{`2B*~tu{)Z zTg)m9|9nDa6b^@EQVPr4k>HnT%wMv!9`ac{$O?(c&y6dxw5G|Y4JsEZ#*DH_!21^z zydJmD`1pYOvWo2w&pznOJ}hmi^jr22xdDj;JR;vvry?ts{^vOcEMovE9~^D_{?n)* zj?G(y{9E50m=F=%rWocEY0Vvu-5JmzGk{e|$Mq7#rkg9nw1 zG-&qA0^Y%7Dlh&P|KkET5`zGNEsfVMpJ2;LoAZ{CSyQUBe#q2+*8ndsE4%q`?pLe$ zmkxR+`hRv5h>>8xr8zq*>wZrDAFa*N{=XZwM|ALcHdXX(TBwW`qRJ=QpgeMMnFFU; zrcO#1BuzdN(J65>txP9+94bDBD82+kn;|@kq0)_%=8L^qGA@1zlg*S-fK)fVdADuC zl^sS`BCT!fgSiQ$1}*)U9W~j_Q5&HId+XY$m!!M(JhYjP?-y11Vx%jn6-oZpQ)(B; zzKJGV*;2HAKTsG`@QL{jNbSJ;d#ZfgQgn{ax%&9dGD^_+XoJ6jr)8qiX7#rM@KTj)~Zkr-kEWZ~rl=bgb*sz)3!(J>GUbY|Tvh`p4Qk z{L9?xP30N~S6kPFhpnee*sO9$YQdlT@v$WrhW zZdJdlOnUdP>W&7g*iPH*Ma9gsth&2h0FMRJPccPf`wo%gim+|hMtXsTolA@gmuOd7 zg#}(h?ZmmmkqJ{;URmZixKa}9I#>I}gA=JsOU@Ck-1eCwiyyqc$yIV_^jI`G1yDh0 z>#XeI-@$o*DlXc6=K5BckO#H=IZq?B7pxl$px z8Vcj^e-1#zMOlOgMiWb!EBx>u!ZrRi7Q2q~T%c+hSXzRBnJa_0dQZX<`cS2t|A`x) zLBbQDRe%O`x>X8ZmZ|J770+Vh)mwtJ-p5!R&&aITk%_ zuD!wn{D!Js9&Llq(v~yd9M!d2s_wQK0{wHuuxShbj|*@nGoO=c?n@nQYgOTW#?&a+ z)eE3hV0yi?Lp&G3AEiFg8yK;urgKrD*ztbvHj7$2o$?n&_bzdEbp(7m#holdFu?>7>KEhqOQelykd)SqL^`E|J*NH55Vo8;RTbi}eWGjVw7wX8P|JZTX- z-?em>_>?7m>pAU;i3vHxbbT2H3>rVC6yD4thkhpOq-?YoQd;hDcoR$Yv=eDD=LoLH zF+7`?Zj9>4*~;0X-z;w>a{{OZIhDMfQjf3mJ}Z*)<=sXM+Z>xO*pZI|0Yn~JvW_XK z5K31Pp{oYr$82#8Di%w=@4t#Gqojiy2!`9q zqkfX=mf22nua%e)Hzg|9dkT0cB{ntvNLXr4a;wfvRjgVJOVYt$9yJpBn*5#w_;8BS zD$o=%gHm}0;W61*0yyfmcW^4JB0s3hR+aK>D}E4rD|mLU+JFA)BOK%(@A?&lpU+-j zJKp9Li)37Zp^z$P=(1x((UA?lSdh_}wF-|4!3;L;L+Ppfp|Ga_m4`NU}DWTyH5l^(SoSGH&( z%WrVd&`*Ovh0j3JilYrU_hpCiNlFDdydPPVQ3^mZuqz@a!u8jPm8RxO z?Vg9@h`@)mQiwQTxq)hkEUx5>-!DYi;G*!!d^!dEc`#kq^BfBch<#MALw{6~Qr;U5Zh!yq2=hV_HG->9k!rbDQ zZ@*qrijQHqd~5e)CW+G?ar4M;TLtqZ!!A`Ht^HtzE6On$+btaqyXwaV2>pcGWkM7j z&_g85yW2e5>RMYZwhA$6j|LD^mCc1)=o#_7U96kh&8_9F3#?%8-S<`Ks`|~~5g)DT zT?oR@u@gU1X93p}HAP1I!MC#(TZ{BF|0KCF?3W__c!-6-{k=Ug98+^XZ=F>A)O+m? z95l&8TO-}XZFO%vCBoDOWyjP(jqh>~y}CZ@`OF$+yd4Q^%gd z95Tis-w+!Xov;`s((6ncGB(#Ag8B#~Rt?IgAG!c-B}EBf~<{D&e{J( z%WwG+WiLaEIBg;_ga<+Mv+M5{nu}d|@tR)VJpTOlwAg7WkL51#c*g0U-=klxP?F4uF8C%t&UByP{CEy_ z4&c83K639o0cs?CeTCM~jU~GqE!VVz*hDJJ)MtHxqr=C?X356wBZYOwlG^N4^<6Q5xJi5!w@XOCsO*VG8bN zD7S~dCG;5_IB-$un!~M3|80Gsn&OGg8jw$_#r2X3e7ei}gW4k)T5)h<=&%*G?Lajj z7-W}3ftU{O+u$cRTycYbwZMlgR`j|~F}#sB;}UQ_KaYvN|4kEJQ|Id!7iGRbG4H8~ z3|Pj3AkEzcJ67~F==atl^bTf@L6k#6&&A6>vag1M7Y2eG*beR80?s}d_$-@;8<^~- z6FD?Fcp=Rl9KWF}m7BXzph*N&dRBG;WL;K$$h07*NJFdl{gn9o-`D$u?6s*fFx%pH z?^62rgy8YOer7;==mxBb|7P3P(lssjA9I;sl#jzSXpCE7OpgF1N#I8>v{@TYFN>8J z#1FSV;p&AO;{p?ow=D>a?s~Hf!Gw%TfeddSyMno@(R*i{I@3Q(lHKF&4=$Muk|UH$ zhm1M>kaIa~Zdj4g5i4I8ZPWTl#eNKFl9M)8@dAtfMwwGgp!c_mbTTKkd&HT}bgZV3 z^Gwa2qc|cBVR@Ir~4As;{g zGXVu`HXG%CR^9YDufbCD&4vyW=x)mQo5FUto8#qrmYbV#22W0INOIy7DLE%J zrFjIhRI^#GzjL!*2gr`mFa`czz@n|5TX|wtDa1~DpsG&k#9YZe$-7$U$w>W^aAj>p z)hw6R-xxRO=;xDspCZe+mugkgFK&`iWDjRQRowJ~4C6}S$SA1GCdK@gawAgXkT54g zK=4gSDPpI2=aS=3=pA>VSVrRCWM&WL#Oka_@{d-?h+Qwv# zpCEf#G-?>80720F63~wLgZ_&IOcXI=PM6O%9Gnih^bkmXbvtV)#>U}~K@_qmZ6pzJ zzyGQ?Z@XV7i4~a4!c_4K(8=gRTq{LI&PD?oZNb~>hK1hs0}@kfn{D8`s17S7iqlY&9yfW=tK1a zAdaJ>Vqp!mpT^R$xh-%kVI`_c^jSM~Fve>t0;r(S)9+gUB})FF73y0gSoUc$KJG^i z_V{$lffzMs1gbn#Is&xw0M zI6ds=!l|KHvAB@Gg26Dz_sjV#zlO0f)0!S!fjOVSAO0hcI1}ro{-YWhIc)J0pjLw@ zLeSEJmK7-DwqLlO=MtKZ^eQ$~g@dJ_{aPnks|WQNG;UoYCK`uD;JU=2nduSjzzPXC zrulcCvo(^RfI$d6Q=qTUWcqb;iFylkRTrs`0SO;tW1~4QmWbq{=1nF5f+ z@hOHvst*+d3*dqd@C}>>rvYJZiHCvYJ}!m>l_QkP`L(h7zaFb|HpSs5yqIPu+Qe#d zvMulf*7kAt$DD$#yonbhtLW?lUms`Fp#rT;DX#O(-3@8{)X6_{9#p+3gIE{?w9lrT z@u}6#U6j0#G)$NgkhZEs1%9S@Dl)S(N|?Qygzp_u@^^i2Cfv4x-(37Tp?RBSQl4li z;g`+d$g-QjA6cLlskXIMOMTWhdvB-D$cwG^f3s#3uT0Y<1PKhWDXBs53y~PdGh`O_W(1Okd0pv`iy3fQ6%SH! zfh?gy?ZDIv!0h?SD~`X{wEczPcgB=Z`z5F$(tPPm%p<EghR))??I_P69b`4k?6~K`Lwj#y9;_Ch^@}2tUw&>8#9&d*Xy8i=;b9|2rbF9O z{J@~-R9$JI6vqCU{!=ILx~Xz~pd=H7_Bf4qi4qV7yhV}pM!n+`LVuXajc0haEO zCK);JnUk4nvZ`>g_`E+bHMT$(2KxAzKk0ICkApP@Wfif-I;!KOoOCRnv*KCAvX^P5!>JJ zRYp?4(VGviJ)6g@fWm#iw{%g*+Ib*sW?HY-;oMkp1nuZwkrJp*4 zsP)w51Jc6Kw4Y(FF&_W~`%iD`?q0gr-7PE=%Nl)R5pj2hh(Oo=mCZE2P}<-cr0YST z={}l0Z3*qEej}Q*WYdVy!o%P`&z#QtI?h=g0o;_}W_iRZm&S1bRTsOY(Fd}JY8jIL z?`83qjyq4{<^Tfij1NiA@U+2~pmO@W{qcD_^mz@z!HTz}#d!id+jPKkriij$nkP5o z2y|LZshO2pF-Gg_XtezN8$Eq}b@lo0pUvA@I7Ldr2STu$ET`EGf*e;WkGYF(J$Hp7M4A}@ug!I{GH7O1UZnlc{AWJE(}`j6vSE?bI?H`L+4Q`ToUQN5+1{7*i& zVMDfL-5aBTCrEY&98s{xSSIG~1E%7s5Z-LEl9SlP6QIi*;YCw5Jo6noTA(@;)!LlhS+%T+Mhs;`LZAPr+ zp_03R=`s2E{Pl@kf)=pW<8yPQg;Z!go~%I0O}I&&crvNA4=*I5dk2NdPkR>kCSCD} zUTSY{hqV-_fWH0TI1M+V3yA1vfF?6x@P)Ud9t@Qhd$&yi-e6> z-h=x#OL{S>0){PIAt5kUo><8Vj*2hk=gEJ;U)73E4$2`9=twyrvH;4-J!0pRY>Dt~ zyLL(`_|fsYuHGf_duWK+wuta5%ddW))jwcq3lLjvrBQyTg<%3Wa0si>u&8aP2xSy~ zxszk_bTs?t}sc_Rvry{zMoYylviRW;LFJjyV-LKIyO~k#Mj4Qi;v1xTe z<6MnN-J_K!8)lJ@VNLo{fJ1XEo-eJQ>l`L7c(@@s22cNhe7%sh9j$YjUI>GP@ZM|X zG*V#L_4(OAnTKpAsfs%t_ym30x2H86Rfgs<)m(WCN@DA7GHNpXs)DBftpQjj16aIe zrv@c0BCSGku|nnugMxU7m1Ip=uWOcxsi>;Wmg|SEqe|BuFpms$ws++^6}b}|dzDV! zGzg;o?iky)U%VdJejkP3)sc zoy9}Ma>k7?kf1L}_G!3g`euspl1n%sjgMfojTWc!>9Dow;O;J70~L}<7SmcQv!J9x zB0PLR&a7uCvzKYmCAQeYBz(f*>o+Ab#Rpib>0xX7>{cdEUZ^p9v+CkLerrYHqR}nL3qk6y12ugw+|OLI@B$Ej%%sGY3cs3=C|rATqwNo7p+C&5-B80L z8!sg)^%SMDb|41Ayc#EDCnT#tMwJ|hJQzsXGpU~>qtr>x;Em{{aBIy@bxmprAya?O z{3~NKIl3l>CMrQRxrJ3z@$Aa(NhcVQ+1PQUBg{#LauqKrSYvJbH8Sg8yh}$%L-pZ> z4W%sqf6(&JF%FMn&gGkNE_lNZNdP$qpKy8&E*9yHeFHQ(kI(yHy$7n7ZG^j`aam<3 zOD!V{XY&V-{9D6`6YE$`8=CWx2vc#UcH#*qAD=8up#tDF2$o~u_6FGc>(*BG5*w|? ztSkE_wX$6g#h~$1Q2UbO$4TwC`$bU$H?Lb1(M-b3e7OLPJjK{E8Ox-*d}qVK(wW96 zrk00Kn+H>%!<;F;+-Ns6S32`PaM`ai=ikh0r}ms{P*wM^{+v9oy@=%nfG(fcL!WRL zs0W~|{lj&Qq>~BdDu5}R_JN5uu5KbGBYE__mE63}G00kR^zrd=b6XZuS#PEkQypL>5lnwZ<~R9S%JTW-r|2>*U-(mKtcih4#5VV7vx|ZZy4ny zR5&7fHbJ;q#1S>oy4^WA(}&Zi#P!Ua**I_-@Gc%>dU$%awX{4v-IpmgaNGhw0?*$% zAKrMe)>ivb5OB4Dl{d^?P-#pCBy+s_5QLbNrMs9mZ(aSU>{5oVm4m*2-m{U|0h-L* zUt<~dA*>WS0V0WzxlgiDaevC(_lLHjZbza5LScP(j}F15E1KfGqt##+>1VL4O%}h<~>XQGIgQ(m;oqT;sV}1&9;%H^_m~ky;_mPXSQ2126S9+kp*MdHmb$&~?2`B72 zAmB+;c)Q-6rf1?V)jyV0xgHkwfq_0(VlFP(QLe|2h3dxw+m;Gawx)6ej7iNXO>ilV z1BR!R!#KkqvtUd21hx?QR_?zaMC(0Px>eGab^5xe53}Lw$7YYl!fb0P4h+2c(F(Ei zQP`Dm)IHqF$(LBhl(k@fyx10MwOROoBBS~U=R|GbZ{7c6=D*Re<5_*s(F=N~L4MZw zCLML#Ogv-fVDbV6>nZZB;uyxNkIp*}4tY|oaxCFSOlgXz(vY9T>iTERcXJfs;*0~* z+nV}Wp$N&+2*ck5U0^Z7cF?pYXdaNG(*u zbgV2y>W&>%V{B#jo|UzUAkx=Di5*Cs=yU0X44SF3JC|nos{zZyLo+6{9W)R+1=(OF zJhg}J`n-s5mdf&7PxI2aVrE^4q;h+k?$p-)WE!LRV7`fA^ut+veSR;=pP9c?$#c;c zvluU2s&z2IBt1xh^SbX#Eoodf-SbV&q0zk+=^4C`-Xm@0nlRd|CRPfSFP)8^+-p-S z&K$@dbAMweBX->$Mll4qHf0k98W1Agf%f?AW|Z;mVNmc4oz1Af0H8-eJ|;I2 z)}68+?E8I|Qs;1;Xy7Gf*Z-zk_Lghv9E*rn;-}u=RnT1IKNbaV&|%u0TyPya(~c35 zCf=PH-m-EQ=?6%we0irK6B5Hq&FOJ2eQIBoD}912x|XhM2L!!nlVS3T=~qg2E%xe# zw3!#UmxAz??P_>^T2vawns{nf>ByL$J(eQk;cOz*#>t7n->9dY_w}4T{gl=V#F44f zA0~UI7=(25*goD-KoOZO2r7^lX9L~C)5!T}64|I)z(Z@m86ZdhyInl_X_5u~x41KN zDqHJ4pl?ouw?4ZzpnqNc^H-u5lgxJUXn z>~m>qzx5BlB$U8g&tF_rN*7QI89^t~B1(2ZWQldQtoJ)m0KSQHCl=3M2qo9U`-7{W zPKKE06xjZ;m6s2i)D$IMwfejVW`8!g!rlPQE;qukrE z*)oqNNU>VQs_I2fnK>F3Rp(PzltWq$ti%lc{e4UH*H%U*SY7pc7#m#3<*+xQy$e^I z`IMZ~DD)WTURS;5P+GrQ#C9A4re_OYgeqGRT_E zG)@~m^`ZW8O-`S`%OW{Nn#>H`(iJj#HoS!K`5z6R8wyeVZfb*%@$%m z%T}r2VNU?917>=>HQsuG(>hq&@gk_UcaUTJM-B&-y>Pi?R;~+ zJuugOa5db>@hwshwab=BG?70=7|ByT1X;RELl^uj>6093f#e0+}5 zRqF`N!fo@%u3%tVvD41lEyCs5526|l&%j8z-yqNPLWqbt_wixS>Vu4 z1IxJ68Iwy<&5yvpPiwkn%Ct$8LU~`=S6jX4c;u^f`ZM|Vtb@_YFDLBcv%F*HbG}`swn9zRqK}&Vw`KRO8RpH#Q$fW&CSbe@l2dKO`3yX3S6SnhBDIA zL;u?%x$Xw@!l33}ote>`H}DkKD%w|&lHJY@(NCoTDx@1|I_Ze7{<`-_By!Ff7RM+rk?d!0BN5vyphEOBMHcdIHNSDyJ}` z9M`x%K8@eLAK#!f*a7ijTbskT^y_ST*W%P!{n&Uq0wX*h{%SE-*(U{Kz+ad|)yipX zuI199|2EJ+pV%DmW0Xr_Z>|;l=ayKxx*yNx|8oJh860r0Z^*?&kkjk2J{_L-W91zV z$Z*O4+61~a1!jh*x@g^6{-po#4QqRn1p?9h`rNMr7TS%u`swH2Rf6Fydi?$_eQ`tY zCZ6E%S2gvsE22DtTf*rrnd^y&lvg7fRT$8Tz9wY&p-09iyXr4K@nYS#fn$hjz`MKj@}rvK+4z%5Ebj43C7bzPeKB(I5Mas6p|Jw){6 zQ~7b+Ev~13t#7#!>Ye&mG)|5>Zf~&-nK7)S6mJeq`Z6hc_8i#D9RPDYJUslfZQR@> zgClTU^X~({95kCHT=mC<8UX75*aE7}BISoT3=`IS+Z+0e*qXnV->m50_(%#%JTZ=$)hDk>i&Fduu5 zb#WAYw||QTg6+Iu8`j%5#R)`HQ#;j+`hi@efC|ux#M$~`MnziiO=n6tYC~b5uKm~!&rm{biNov5A?6Fu^W|p9)V6N z`3J8GRqo0Am8b&d&g2mRbo z9H?bhT?cHkI7?I#Q)B9J*rc344&mMKM6Q0k1B-Yjl}D|%WXlQ#4V{BnQ=U_QW2P^@vDw>s#h@1 zt;xmxiv-Wv5}liKGVJ z{}g=Gi;7_ut^5ea##+N;oJm{gNOLQidANo=Ch9bmOld^*(~gMsHTC+&M#^{FLi`AQ ze$%+X=bfMFlqvGS@~21&x79>sWyKTF3T zJEP)1XLY{2ee0)$>*7d9PM1#}X`ZPLl6(r8$U+;@AR#iM*}B%}4mR!zQ>J(e{{=!^Wf~E!o$ci?RXct>a}Y)R^CLJrI|HR0%;qV= zOJCe=M zu`A_u?EJ>JkxlOLO~G6eGd@tJ!=)yvIvze($$xC^K!dvFmc1yi<+)EVqk;=HdC~o_ zYfudo4>I0hBzRohoY(cCPzaQhJc9p{I`m-k@V(vrUj*uQ?|XUoUkQP^uRB@Ir8(9} z+312F2vto4QIaGPz=`9|NIwFjbvTShbCnq-rg6D1VW?HzM)Hk% zi$vH(y=7d{dwa1oub! zxnn>L3VY+#=Hg@`H>mwm!5^Qj`_?JT89J5xFleUF<)(h{&DeaXzaDXDl7h(ud0&rA zI4w#l$V3Z0s{+P&`?E|DJTdF%M0L1l7NNKwb7f>?McCIm$+f!33;46XZ1oBXR4Ze)xZ%KuYtmrvaEge_ab5vW0_M&-SWA!>Y9hZJvb{;$2 zU~T*j;(&97A&N#?D8J$r_t^BVRJ}<*U!;K#TnLD@8yg!ZNoAA~(_j2ROGSAG#(;J4 zcLJu#`VCw$5YVbhM+l87iWP453hT}*4cL+|1k*Qjlavktj1(QvP5e%ma!uR< zDVGvzoP;;SQ_wOmx=dwpC`U?DZX1&uY?(>R%SpjRXu^y-Nz`EmrZ^@vC@zwojh7MU z3baJ)#-=Ty4r@@m;U6ytIYy3gwO)*0^BaEf&9;F{9WZ&Kk|qq&jw>wDN5xwz`q74i zd}}c=uYF&lI*$7*%`5c1D5S}@k6-i z-v_zD((${ti_;kh)MU{Z!C;X@7M516h_-V6-O8Oy9FB{f!Q#R$N*k?MgX0@Rlb!)v zrc-JeWyv-jt$!ce4TQKJwe1bbiiLr$uzbJKqtUFpipk=W{4@9d0v09(SI_gq0~e{q zXznrS*|n$B&rhfw^7>^a(=|^mbzt@FhXR2ZFht95tOv2no8f$d2K*y}pb~B*BMlEO zcN&(bjH6VIwbFhx99T9mP?FVHpPBr0WidM|KoGRLwVy#szquODndxI04mU+}VhV;Z zvJNdtJI1QFHRe-gE5ZkU&6i&_0##=i?g53lU;$+ z&|b8Ik|frqe6qKIDs_kwJ<2fx>b?d79{Y%VU;(KagSMI0ek9GXf?nn z1JoC`Z*G3kf51R}>a&dBQ)YxTLN{sZ=X(eoWm~38W;y+eih$*FO{u?c-oY&{MeD4V zqcUIem&ll#yB3GMGmQxQTJWVv3k^C0v*hh&KLXvm?Za$M69cD;zpBf`e>K)mzQhq8 zD;1W{ZM4>XDy-SWwPaVU&>&sT1LRddEp7t36`#hKIr}eigDrcUC_=n?V^42y>jgI; zPnYhrjAIT81L;=23~&)4h*J*7hw~@e8ue(a4F0>yj_8HK2Kk93e4hqNbAKl>>Yh1^ zn5+a)o|%dm#cZ*_a2IS_;I*<56L_{QZc6kzVs*0_!4 zOxg;#)j%}?>LlRx0Th@JCC93Fa9E!)bVJ+B;tO9qi24c_;0aap@CaZu`7l3B+%BCc z83_S1`}UOCo$9To^--ho=y(LLoI!h|PZmeNC8?JCIFro+yC1w4no2$r;YF$@Jxn8;2erXc2-n9-cI#l7uYT z7qOp&a_BiJ-pfTP(`D6+G20rxM#;1(tT|b%op-tAx`m;dwHI`qj<(*KC|3@(p3$6w z^iwp=d-6MD@-fQ&L0?RUJ2M6b*)j0T$1<(FGy0`w#k>zR*~?;daX$`^oC)yuj^H&< z241`VeR8T1OvN+6K(_ks$>&Li<2$h<+4M`ol{wGi&|AxkpO|+tRD)l2!`Ton?Qqp+ zk0AnRUvcbbbxc?1LY0U+<)OAG TGI4rOU6PmSR z0LR>n58$T}!-MdwB(dGPf}E!hS^K98S@r7G)Ue6lINZ((u!$Hm1XVZPy3VIi3vIVr@NxREbrv7KP%OT&r-%=&5CrZ znlp`lyR^q4>g2+CkV2`T@#&3)ayaI;_x>{tXEli5*0;Hdwhed=r_5}iCO433wO}<^X?CUF%$2p!&^8eL%KsF&}) zKAl#5FMB-{d^^TEZh+a-o|g@i=zIzM@hkTZ?P-}#FWCT%sb~UQAER@0P_6*{o%1nk zxc>22^ZV?w>#;wE2h8{n;D=$wC(aZ}fzV&g!;b3YceiV$C=P0`OHC1~e9hqYHo89P zLoBOLu+|x;MSb{B$R+O?eD()S$W4+ttdHT4jRu-M{$(d{gt7;Itf+vZ=&(4Vp)Dz- zJlH6guzfCpehg&NK<#z8aD#PxUKaXE+Ls#{VuY<+QC=6|1${gf;b9bqUT$hKi*&v< zUY?inNP#d%!>Q5jt6!7F|HL&FtRJn439j=EwJNul)IC-O#M;@{<7|Qz5y>Xi+&DOL zVyw93T|0LJf)PxxMct{~Tx%`7f#a&~GCk5FXZ7gf*6uYf3QcR{?Q7mzgKYZer6%X; zUj|bcny{}KVKZ3G&TFAO*)o}(H2qKgAw6wYCr>pU8BFZi|DFjl7R-EpAn*k$1wVLt_+W4P}hi&?X`;`pBo{12NI3 zo$$HOwg(B94Law|2WkuGt$bJ|1nIwQd85!*exx>MWXcRRv?t{#(QqIyw>C$E`8YLL8 zIWXS+`32IUyT-5mBaQu~J-!81D+>$)OOAdXR%5oflPQ$-GO5iNugBN*1>?#9-apta z z!@0p9VF~Pn5xRmuV_)9o2D^@1F~$)3kdT=b3%wHzGB6mK5bkG+E*Mv=g$TXzV-8`T z9eL}}s^mP4RtiGp9mQNPe*acQSsvJR~S{_)*d=ZW=$Mz)pA}X->Mnm5!ZxqmJi|+o8+m5iO1@7B(o(yEgJ=^ zCAmSc_!OkTBc)~zlK)ujWC4IIqs?&K{7n91fFzNr9*%R!7xDenBKi2x$9^|HAdAXg zM~8v=G1V(fO#^yxvPgNNrvTIXJm;|!k`8!}oCC%1@()Vb!bl0)kVD|xUtp)-MV&msc^E=C`7mnT znsE6?>GS*E5J#PKd;+W?#uv}#3uyIW1$T%upBpodr>w3NC((|+m#1~dr)ocif~>H| zH8kM?Gh#HJRtaj{JHFm<`Y|SE&+XZnR>!X&mI9Tus!OfElw%Y^z=^-pdfl@DB3h6z zv!oOP5ZuZHN^SbOBDO20Jc^2+Q>**?1)k2!a@XQ-M?7A^vhl>HaL)4cg$JTAg+&a0cP6HIpw5 zIFlfoLw_yMv*HsHy6*+>IK|1o8eO>5KS0IQ^@*u(lY3*cUsVL5w{?fk1y?^%9@TRZquCq(#mM23A9p% z7jRr!Ft8?c0a_wZq>sN|u+{-1fT-l*R&M*>7|1_XY-Po9vVmDRNNHJAZ+E*r08+9U z3`>5c>&M$eZiuSI>1wCzIprVrAJ9=YY|a#iQ?kEm_{=8up!T0;kS$bUxl-XWL(7PK zvn1rSn_@fHuWo_>DFdL-_IP`3XY$HBs9_)=9zDOTk)qM_PnidI;3>c(Y8sZhLZ%1P z+gtb&1poeoG+&mVdUb&&vz{1lqWc5n2h))Zv=eMi<7OWW5*=y$wCSW#fz=sM=rGuv z)$t%xKj~kN7N!;~6_M)5zhzN;6JTuowrRrbs4k!%8;&aZb{~bhxLIIb@6Ch?Deaaq z60!8e4x5=*vh#6<%&Vj8Ehg(te~>dRxqa!SWe+1%9oFLdJV{gV{uVg=#Vt%BaG%o) za>gV}ea3v!^?#L$utGcK7O_lR6Vqe;Qlv*{bVB_hjo`h0gG$Ry{m$&S?5as}oP!Qk z0`x;EYXg;pH&uhwnv$e6PPyeJ9;1VqIF_)dwHEcd2#JY@8Xv3KYT-h?=(0l)8eh>^7Ha#> z!Um>tK;wVGV48~Ll}omM>VZ##W234~z>D==1+LPjWNmiT0)jj|_RIg!WIzYB&j}pA zK@9G{fKS!Z&>0C+p~zBhoVq#_2p|7`#~zp`0c?w9?7_~h=TTzBG3t{?D3PrZIIKF1 zt%0Kf)Kp>gAe~isV!CR{1s(l%ub4eK`F*gm^-pBiAJv1<$&SS{ls6wt@JM&k{0nUm zrxXLEwUlUQ9<`%H*SGqLp|jv{6q=#dHCa#N{vhy-m_lx>EQDduS|3{mu@r&_#Su)F~S>V((iAz_#*KJF;tR@*?c zK!d`01zJUJjGOk=lE-wG>@Qt(0iRn8u4h3tEPfEtgsj+`6`RCmr+aNy#zrH~%xv>Ri>g{}2_0NZjYFxlS8}YDt`~2pHg`jes z&pAeFClUG|0U#hmM7qZT@PK->h>TzmPD3Fr7IQ;cGe~@UvcWNadpQ*RM`UepZwEDE zTHY?bS<=nHmt-+kUCg+aq7w&OX3e`=4!3FO6$nl*^&~7lac)4?PB)im&{U zsZjV@BGiddDin}PNT-kr+&T%}u+}|D1&~Qo9i5$>O-)pInOPr={gm^U_U3~g6cB2t z3K1h%YlX^G|3->w=G2({^ybMzXe`ci(McoBjA)By3ABfalf-rTv$tpDr#0kMC_m zkd=|4qpgimn5CEEab@-2tP~*(WuJKA6~?7?Tt_l*r(FC(g)b|SP{2Md!Zjc%lOz#G zi0*70XuL>z_s?na?3A4-M^e5&*nJ-aiStKHr~>pVKyd*G;Xo3Ww>JCXk+Aw3VWZF` z;8tbsZ;5-P4N~I6Wv^c|=LG&hv;Nrum&8f6R!fH6j3*#Sy$6sW;N)1JgODkKV7TYp zz_TxW06etH%4k=``c#l|AqsL=<%)EzhN^kAv}%=rMk}7|&R!#9w2xI&Zh)kFUH)~6rIk^!2d|3!2%=I4z}%4wv_zW0LG<%l8P=x>MT?$ec0opN4QG zV|wa}q#f9;krb`~?=E;G;CUEjUDQLy5e*X=M{$>lhX*~1F+-CcV4MO}?;Cd`sbKcO ziZ^>b;d?mNzTwh`&2{J7++dj-a9?4IoP9E1(ZGfbYHhNESMGNWH~m)hA{Kc3zAQ*p zZc+8u0UI-cKvq1R?IsL0y2yYHjl8KT541x0_qnH7(}z+nc9UQqcqs-UJoZN_v%}O2 zt`9GxjGb*DB()NN|n8m`<8cY|~ zMdE&gY9#W2YFUQK8B1h7W$L^h=`bQQ3`BLDgLhGdDlQG5CX|@iHSzll4>;JIs%VLJ zU`W=@__D+b^r_x^V9=zRS{AxEJA+s;5#BsK>w^*HMs7F3L>R}q&9QWRp#NNzru{x; zcos&F^q0|9N2Fufp7lj}jU~1G5ulWwGy?{bobBP$lM>r1t50l7(~bY-LOId#g@u~( zCNfGj5%F_Zt{_vE(NOoqYbqt{M?X*M9N2KOYM^z%D+$-<>zehWr;vp%{jRfM<>I0? z_mkEectcLdTh|Q6;l&hU;Xuk&xkjF{^d*3GL;}SA#f+L;EPwzl{^RC$s)AgVIspyJ zze))dJVHOs(cZD6r-VBy);hKIebf6e7^viqCB!VlQnH96J2IL-Ug(|afhPt(eGa4x zfNcpp42{_;znN827|G1M(9Uiig&c~pcn>s+3>Qj+wrAY&B%*~0)Jj18+uY>6Ep@+W z@iPrGHFJ6Wnc2c&w-AGX^Q)y~5%GHUK{wQam}}K)=1|b4!m0kd462VKZVazT@Lu~rutu@33+|L`Y`4>H^b7yN8L| z!{Z}2gZ-&D`{Az4mr00yIn|3pP?Ua*8{I#q)xADTZk7r})ADcf@^ZNf>0QBBF z)*oE=K6UGsW$AeICT4YRn}HHa``g87)JSu6sI~4e-W<#x*r-x3Tx`iU6-_u%mpw9O zjE)v!9f;elFy15*f-y%bxh#j!P8MYeGMwXm#!uV`{;WClPK^y6Da}G(^>GF9Dl{kU zaLBL~=ATOJQnTM_mr`!9V~novM6t zIts7SW8M&(DWk*pz7(==))Tfw(Z=D)6{V-t>Kk&3&vnK_Er~_!Odnn6<^061()w}!m=*iK>aOmI4N6(aX@}~OywJyB2&GRaH zOD%8}k~-r$4!EIfgY?IyvbkEO@nY|xR3E6$|Iyu5HJgid*5ZKauiSR{qXR31If5ZasKXAlot_#C9U=jQ&&YqH1|!zh&#Hm3hN4RNB-E6CNUv1FXozd1QbF02}&L=4S9Nb z(W9+ERX;)nIUNLi8-u7H?*8o`UqMq@UnA@atFFao!F6&VBes30?!~G*G4^FUWtIs> zH!ot8p7s2^2m}I#{so%D7NbqvLN<7TKAkvBllRz`l(AtacS&7y(1%vdvtz*l;I+p? zC3SLkKG>!@C66>Djg8>7dya7|L^&Al-#PzsNR^diBx^~Z8bNaG;2e#ex*7lp`9}!g z07nE7C7mCVFx+em6I-qO3jKa17006b)EGGJy$!ClbKED;!gn-`_pf!wmzg|`d%k_- zKyUq1$-?2ngpm>2?xoYyQ{XyfX*%@5e%a1$ZEYb*%_!E1{(Ci@ zuD%^w{AH!TAA}EMeIH-9A&Q)cl-I7)frFR(@snK2;ztrWhXyJ1f%6<3k~~iiQ3{#8qgj~>e0}T`n8OZ zU@@rNdB0HsE3pFkp4W(Ae7CJS>9lPqKod@p%;&w5fak*&+k9^?RE-P~tJrK>@H<~e z(@@Cfj89rD(?U5oVM*rncV}a7HecnfbzI&bMml~IG1gapa#yOokSP<;(h9hinrNA| zOb|F`@J{g}PhZq|De+NHaMx%g`f~Z#=FHCh?&TXInbp;vdU1*BNLAew<-COzB)4$s z%jVY?n9qN6@6Dj;&PK&01(A(OAo+vxG|CKEumw#Pz1$lzmJehmu@)YO>jhE*l3IjP zHQ<{${41PaB_O4tT>W)+$$JhrkM;{_@HnrU1?pDE{Oxev+jt-@e#bHhy(6>By3lVL z{9W<8xwJ$A;}TNJ<+(|+zd9y1VPuvB951F{?r zMip{MoSExjzzS7W#S!a2$vq`~0*8Fi8MHKLhcJJwwt0Ja82W7>K~-H_tHfkqdjMP( zcgTnz4;1(!b)7#7q=7&{->7UiZBSejrf!Ig47s{OkEXRK+j`%*O$S~^)f`EtJsy<39> zB3VkxH-z>)nVPode`vbOsH(bXOE*ZTAky8^-5t{1-6E=pclSy$_PuZBu`7upAkA{%-`(-WG^ZjKn6kb!b)4yd{7Z1{M z)nS&_ZqjTU&xL?$syR7V87Hn)F}b2OG>%z9LGYWM}W2s0a|W|}bu z!nZWM^l?=N2W5}1OgAA<@Nb4kzgd-Ltc-`&Kt7ag0(Ebfj{X!l=$L9gRu=0L11<~b z5^ZOGWTwR2sar?adA;MaeW5d>jF9zL>FpF`j?ijo+NM(ZMD9<&0!|T4S=57YzOg88 z?c$}4rD9%kMxnIBn{ta9%$H^$OVR|E^sF3;O^c9}p}$QJoF_-$^hG!H|%G@>J@O z3I<#R(C-@2Lu#!Is{4=&D^?(&9sIR_d2w;^{P_3j5kU-QUa?oc=TyGyM1=^Ne|jBqX4ak ztRE%#ibR`dnu$j5ar5$BORvO>*pIpS8kZ}u#i-u`zXcZI!2;J2p{RRE!%^q0oM?}o zB)s+-OLJEg5>hH6{LudW!*yv=E|i2Vt_s7mAaP$NS`2FW%VCdcdK@mf5a{X-pvDxR(Sv)h*k=vgVdH|Amc2=Ec zx=G|)ZA;>i#`=j!t<;qW`d_$oE`dGw<=}oM42`3XiQs?n7XVNPUL~9e?(8Ery|{h* z=R-p<=9p9=NYMAe^@I#LD5wAIIxvePIi+JcPz^N&lEex}rFv8}<0VJ*iYPxP;f2d` zt?`ywl_qChla+$VCPgo1nZ=|(df53yMKoJGF^U6vT^LsQf&ECbhZh%^Ql6`lSvaRw z@(^Lo{1gO-{01=ajp|ckE8(z_X7Ccu;3CTZRzA?^$!bjPPuJe`zC@YDqgaz_=f7jL zJElBCtjV_58TbmcY_r>{6zO9N0|NtS_u@k^2=I>IF=FYSB(J*>t~4zE@#nxRSS^{5 zc-O~kI@i!X5Ou(BNorU^wKO;X1>q1kEW0uqfeSJ( z_3KG1@wx$rAZlwjWqo-WCPJ@cz{aY{kt%tKD3I}$d-{Hpe_<~bHf9l6P1X>hM@x>p z3Gniw>Budmbe;v6*W=$mQ@=8Xdqy3jqgPEqv1Vp@)9BrpGTqYN?x^0k>sI@dy;rK; zG114U_T-3!wTqYHbMTmo*;qgE{I0V5ih8X-m+0@tbS}lI67a(=E=_<%uXDR|#x)SQBu z=V+n)=(!BU@P@JSj_SC;=cP@UVQ$ z8-_ww`{VZHqcR1G8gNu#qgNXH(K>i3GA8@|`pHAkqIG_!_CQf?a|0767 zoxQw0@Ha28iMHU06pgvnki<4ZuJBEsQGNn?^}D+}&~B^@0)CW&J!5JwXzf9!l-}JH z8Q8eJ{3jdR34D5E4?Tb_%i+NEWlH2aD}QhwD@f;_)Fj!Jw1(?dzz$5h_h9t|Y?1IO zryWaO=d<8ZU|cB*ilK*mfa65TF+%~6YGdGt^XgGk3&MNcm5FNT}7JM_X>{&`BWG>#D3jaLXqTbW|GPz^f@DlSw~R-rP$Z% zf!L28n)3sRg7PU5)<7QhNttAO`k^gszT#K}ih90phLTn_J%VS4^3$l9vts9*OkN66 z=ErPzhhP?HnG`0|Z1pJ?S+-VZLR3HI2-0=xOo*IIW+wGi{Zri%=5ec}Ng5|kOb2ll z$DARR-=w)+ zFgo9+!nos?)auGd;>0F|m3C{F-~>+U`&+<)>w&`;?;3u^b1k;V_v-5FpXZEauonrY zB}8YFn=02|!D34NfTq=R{M5s0ePaV8<~Dt^ zREg8gxHVDUqMA00?6}n~hM}cv(G6{mN8?ssx>1^?{y`I-%x!NK-zVCTezU(%)2TnM zDineU17NfCViFP(0QZ3`t>ujk)(eZPoO9wHI032=w4N{*{&U?^&Gw^Ih^j>alFSKw z7#Y61zctJFY9@Tog_xwnRH#oLLzIP0H>C~ZyLNoE;mAqFL0d`pUz{E=rlV$RQoOO= z|7K$)X8Yb`&*n3*-1zzW0&O$cxmJcZq)dPyAb0KlGdss|4evNg)kgS4wx@HVGW)7z zj%fCr@Gt*4&Op?eAE?0SojwSj;c%Cx-dxigqU;Q3d;vIa~6+Mdjh6KF^`mNKFeb+i-16d8Dtgs!Mw5tdmg}8 z1c-3J^R4zopVAMHRrEPsi2?P(2~6&}a{q59FE5XO=6As(2g@k%3B)it`r^vSPvpra z6;f{Yj@Sjt@>-0#^-i4Yx_%WiD2hd{0o6f$g@3^aXida7vH!amG72&G;pXi6$auN7 z$}N#sUr>@9i<*c$;f1>&3Nf>FbfY1wwGc%JVt|PL(AdX~TDrzTfG4CC^c_%;hr@2kE>GY!uM{RJeC!O0x>QckvBMx3+lf`+)9BX$i% zymY&$I>-UaJApA)sm_}C?&CJ91%uog=XX#{;Z=S{|1K)W(V$op67S;}N&RyVux0U| zVQQZc_+=b%#tNLx7o`+!5jE6?CgaA4o;Z|rL%s(;5?5#1Xw-w-HT*jG{Ort!r0XhG z%QK6Pn_%6EndrZygk1G?Y}UtYwj*r9wkgMBZBjI_rfQmKBelm!&9J5%DPbaPe%qgW-EF$4ixoZ_I%#%j{ls-O{p-5_ z)*}7&ZQruxFBW4+!Jj2LLv1FRhYFdGd$Ur#wN6pm!kPogJR4xZzP%r&6{jL!px#p) zh}{42#SLX4t_GHT=bLV=QuqQV2v07*$JRJ1jg4hdt{2R`_w(~REyT`Y`IU;?*Od#K zj4(v};7w>%hAtd3Oz>u>h|~G^)?MP z?gK^W6bzz2Y5?tD0xW(USkzq}ubG8db4?RYt}*!jiHLX!T|L~f0bMeu2In)luSvTc zO81t2$C9Qs`0J^0s*9x=Ybo>MhHUcq=eBV8=$Q1HQ@A5!-cfBH={kpz&*Xi~fu*GM7Y+5b(kGWp%Yn~upIvlUicIi`+8(D;vISA$5K0zeH7|zU3$sR@ILn!5_I%X;s7yWFH&d7jVm`Fa8+_IrA(=9Cq% z{Gwd65^>L?OFyKra-VenOD?jS{Ji{AFIS0e-Zsp1tmy@X^W=%|?t+sjP)jZ7+a~z$ zL9GY4`R?8NI@yr4=-yI>1ZqSBx1Fu6Kad)Oz|<%RA%k=gHS#))_Vu^ViZBKHdE1AUFWSO_%JG zTV6mtRIWuRxeyILRm9PAGobYVfdtv2hNgRIG#F0IuTp5R4bwx(E>Khh%chE%ZcxW4 zX0UIzw|h`MwRUWbWZeI7UT~2;v^x=!j8qBO>Zto0+SFvcrgF*JLHhKM$2m^0J}l~< z{`pR;VI>yFB2J*^=$`h`D0J%B|JfGZh;-}lW##%PsU&e;xZ-Ts0vIBUnU+{mF6S>Bl6 z8r9ohYCXb}6?L-ItrzU(&5>6(wbFBTCaUs|3sRea%?0f0*9D0}kV zU}|1@I#L-Hw$qVpaeyq$*SYRWx2~pIrVPwGF^)Zx*vn$+H#0QEmHvN!5jf6Zlk5ph zFbnpSog|y8`*oR--+v#A4ST~#lf&rF0Xb$i>k6VBy%55}7VA^X`n<#Kf65OEV(^f1s;(q8GNvrJgjR_VV`O zPrtYR^32g~TZH3&SWQNYthO{og+76T%zbk5HD|W=0-R<;QmOofK{MS?=|i@w!;&gN!pWCr-qX3`Ps2`iBzIrgFUs zFfakf#ZPlr{4AmvsNgid<1SpANO$x9dv5qAulV@B6rkATcY+(gdyr9+T+aD2fp>i; z*vX%sIyeokq?L?v^YF~+O>Bxg+Hm)XmaR5oD5i6iVu3amT+m$`8DiFVc;=Y*wf3b2 z%!O_;mOX&Gp%sUtGnR8S-8*_Y_@@xQywDEHfR4Z5l}%G^lV{> z_xwH?52mFnOkDAE^I*}@6UQe*(FXvGjn*QMDk7?w`2UR^N zuCAG})_vC+V>7fzh72b-p7>v|5RlxLe+S$WVBbTO^^P4@zcWTnq|z)%&qa)CidzB* zn>$3+65l)GL8TZRVuUs_;7<>>R6T(@hzKiD+h|5-=igJUNFJH*N4mV}BNV(t9M@w- zw2sDiS3VP8BL7h9ac~HXD$Yw)@`&?YO|OBI4ne^$3!@@w1xnUb&`M7$fno4+mXYlu zvzt2+hoEIqjgq7d5^g<4Ut{rO)Pd@gT*AScGWUiDa3lED-rgwGd&F9iFtfp4E-ty^ zn*FA@&7m88L93#m9!jnvFu04a^X*?ST!Og)R7iQK5TuUtW6T5)O0Y#{+07%B8M&+GF&=0k(r;I7YL27+h?TsX_V?AUDIwO~N*E*AtfaDx%57X6RsR&#Pj zKCvx=pkVXT+o3rupFO3)s<oXlO<#C>M8O;@PcR@ss;SW9cNCs%UdX$RmcE_D)nh~dHuzu3d9R;6^pq?_U3w6> zUF`I?|7A4e&pu(a=esAcsUrLs+hZzW?JUWaqD~5ff_F4StNk14MEPHM7=CG{ygU1%oye3aE)Hi>g%4Y03S95V-f#c? zhBKeITYw{`X^Fw3^{M7+Uy?hbr`BQHB4Vt8BL;@|*2T%;es!F)Ns@8!q5$<705lN4 zfUOsXLeo;~bIHlV%DW1kUNOS4HoQEuOA~C~O$9Ci>=*rUkS9oP{>HVjd5cLF;4mnR zMPcc8=wWIJ`O+(A=Iqf94!oyjHRqD`m>%5*n^N^pV5XSt_!-^hu_K=tjMVz`=RF`8 zbO25E*$R)o7U*Y{;Uc(r4~iy&>Tk?9P@3v=@$Q&p$2dIYPOy&3lKZ99fASkkw9WoM z7vN{}?*v9J;IWM<#{I>OhX}(Vi2Lr#t}5w(yvC1gPm0ZjJbb<+p3;Q;#gO9?@%L}> ztCgykOP9iln5@}H7rFz=fAc5m@cbB9WCcm!+ep;(B&m>Tli6#!AWpD(wcT= zCL}6%ZO=H5{3#?$X!a#AHQH#iv)aV`rt`#!wDL_Qn8twdaML89^u)r;rp_?wMG$L; zl=voCR;s(>@#dY7%5UJJ1SXkGWyMth1m^VYT)8|OSN;P>66}I6QBi%f;5ucS zjrCyA8`QcjJ0XzX`~2J`M<=u}^w*g*C0`bVEXL6o>l}IRE!2z&0hPZHnFj+3J<%VW zt(1c~Yz{Nra|`1qA6Q3yqKHjl*CJYNjcRG_6L1=syJ)s--9ysqN5uZfPXYp6%i5pI z%c(}}0%8vMIHehxPE;csqwPNMq`Fu;XlijebsrL=p(k=rUM|B|0lxFIrN#EWU3+s& z%Mrhofcr_!2(q^xeY!ag^^}EM`7!lJJ1hw|XMR-%k+Bl3D_`2lXvthnuH2Ju+Dcs- zTeC5ggQuq_aKXTTQ~Wn{s4`&X5FWPF$mVDenn3bHQk!{9kM%nV2S-_XY@M~fJ+i4- zjq7ob1r}2hV(L?Z*6`kerl%H5 z-phB>6#?M6fQ=B&r0>I*Im_02!tz!em!acX+@7b*r*zCbBcV zMymQ6jYpywM6{aDAb2xFof5rrJT;t}l^ZPl>l!856b<>1&8K)j|A^Durv4Hv|4G6y zO>_D8T!Owq7`rXAaREC+7oR>k8y{0Kzd!Aa?bCr!mqkHxCd-d-{DC&}g zE*Jyv${f9tsW9aQsn6n3_7OyHjyy00R39&QWT5ZY(RhW0y>wrJ#|-MZSWNoP@ZGng z=fyG0x&--R9jVdq2!G})1bQ0l(S5=EAf?QossBlH0dNYedEQQXbtK7}K7vAdbJHNO zZ8(qkp0v13X?-2=a-)rcq^3OGJJO%Qz#+cshn+-)fFS_lR=V%V$V?F?t6k+4094TPXRPZ=u;_4OQH1m^u(2^S=jg8d%q9cySY&F@j8Ci%l)Q{>e{O=tg zyZifAU^zq3QxF_9}v zAC0wU#_xL|60lw{I$Bj7zU4J=_%=!T)?q#mV~qqy$)_TH6wLn$=~$Rm`11PF|AA)5 zx2~@+C=c~iNWUbJ+N?`gxa?yaL`Raha`c86+u)l6e$V^y9Olu6E98ua@*4;B{Sa5A z(X{<3FxiKHSeAJ@Z+hoMPuP^%j4zRtT;fy?)6E?3USBJWN3g;fZ5=`(fGb zC7G)-k($fhNZ#733RRKB@>!F0tOjO=_%k=HRb^o|e1H+L!=g@a(w!k!Bi+M4?eLYZ zK2Fr!-?lHIzYTaAbQ1bGq0<++2c&l7s2e#Nk?r;B&U`KZ>n58*ws(mEbMW*rH5V5TN{$itf!vC z#s&tw5rUeE`80dj^7Qa!l@=7^m=%Ym$6v(_X_8;h{@%#-FLl&p*?gReGptMwf72k< zi0l>~bB1D%hUnVV)C4?xh&n2|jCR?n`QWh#u?Os#(#_;IQFi7ZuD=r*$At7>^nT;b z$K3OS+Nh^?Ql5*`Xj@AWwYP^X^fpv2!K}*S_4e(5r#AZ7h|V@;-P}9T6&KK;Rn2!C z=`x>5{e3BHQ_xVtB5h2VVDhE9$;jj~7dpX^Lqjf5}S^vy*Tgx0+uzhI6!GUJ)TA-;*b z^-^!}ro2 z94cW~F9%1*+jPgoiqwSFJnV-|#}DCqNqFUaXPqpV+mRIunJSvbL8P5r(P`L?lTZXX zHH=#MDjzUOHCd1}VP#hHlzVv*}or^Jbn`p0Zp!Eu(# z;mYovDT5MDpfU)rrOEUK=^HJf10srO)D>sq(p(rekvLVr(>>Og3USqj^DcD_DAc|H z)4!jH;Lq{zMM(K)TFNarbwZx8Cw>)5uwv2`juh+fr-~RTM*Jv8Uw2)qvcxcr7*MJ}@eKKH0=1&dm*f-WbWOR_C+#>WWlpI5T3V%=*q|-SENMo`$EIZnk~o#^4kEOD~=4J+j-JN(itPr%0EvlPzK z32m74n3&JZi0RAOQzE`kr{Z5 zJ|I2;NCO>PxVUx@U~HKda=q!PVNsu?nGu#kp<^09adO~%$N5V$TO5NCr}e<}gqu3T zW|nDDt2hzaV2EQ%nsLvjK8aFFCD2HSGQVzM)<~>dR3DY=(a4he%gFBs95bh(QJkcX zQbj{qy4F<{d`4={d73pvn`B4UyVxA+8!)7wh`b2y{})5&=Ir{TIR-o8;l;2{Y zONkn)u+Q6&2R}1ajt9%iyfM=xw4*2j>s7*VDJ70q zXy+QAf4C4v&R3EbGaF5ZxwKD4%J3m?JwM1m#K^I9fh!ew`Oo$9#H>*(AV|A2)|Z?T zLhnzU#)w!AJYDWM3EY!-q2nm=GoBmBj}A_dc{5&95EHiopYGMjzlBS>@PCOh(VM7z z+4=qEPnJ&xI=fCOvscz&FjDVm2<^u}f24_kuUPm=Mluu2P!rsZX@4uKZO@nH! zZ#V9*m7q>u?~U`xnQ>e`hWN=SFED6w%EE-IXq3~~NUQ3Mw#ceIcGfw-?N#*sa|kk^KWAO;e-ruY;NXyM*-Tjf(HGh# z`kb%K(--?XGbnFNm*->LQq+Rgj$BW;rtVsrkAi`^5P2L1b zlDw9-nHk5*(f9Y-@N6-8I6a>H?2RuCgUA{W(5KeBhSlMBvD72AD4KiosN!Am_7%Lk z4(VU*WKh)AW0r!ew$GKz%TKR|Ed6t$C{zxxsJBB#O{KZBb(=jh8{~p7qS~c=&(6P~ zA8toG;<`4IS*xQ?p^F&S9X&aHQ`08hI;t$7W@~g-;MGw73uE86$gxcM`H>M&U%+H* z=HPP>yqo!6kXfx=wqO>39ggE?E#ru;@djK15$_&<^C2jtjEyO&EO%XlUkIG(hNN$~yX9K`Q6zN@R6pmZ1vXF%_3j@_ zvT}p%(rq?@Ih~^ja+>8-V;#p67$gB5q~sK^BcZ8danhE&_|W7csnUH)(kp}KBt7C` zb$iB$%|r2aBZx|QKzaU8j`95b43s~-aNMSNodhL8n`d!s8rY}o+R040Rvig6>4`hx z83af2n4$Kq=nS0p<#ac}qer*Gi{x)lQ+<9qIXQ=7BEmySaAm~v9DV=(Ogz|pK&Tv= ziC5J6(_2qIn5VK>lhUgHqnzGmm{^xPtku-)c4;Cs^GsoB8Qt}dXs425b)y*%^%7p_;M1xU*AsDkMZWcud}?-kdqRz-WPh- zf|#l~Kndd*r5|XxBN_vEL@o|UK>)7W{}E2AANKYv8~$D&sGy6Nq>+%jP%xC?^U{lS z|0Ek^DkAJhlX@sv^aI5Z%UTiTb4jA%htTxNZ~7m=K6>?rg05(hk&Q56{)P-4jw&(t z^&pluIBNr6nTG$paVV;NK8(6Cowc;UJlZAQJtf-;(lC^PnXvt;8tYFH6HcTCB^&O=X_495!Q?CJ&ZS6 zFmi+vt3@U7i7#GNVUIF53UihAC1If9sc64vpo(Hl##spMK1@O=Q8x1jc{5hbGBPy5 zBx)XbxNWVi(J~$u)Jzn?_T{J{jmDp%x}%!ITIPY}ms5~sM<4IrLQXbANQGIW!FGyD ziVuB3TB{Lm7IRu|5cBY3dE>CQ^!SsA<|r{X9Cw>NUUdvGQswaY#}tJyu_0T9*qHxC z3YzA(#XAil#PJ7sLh7p)%@d9nnI?pAzEDe(n+!QF(Bh|jptIN7GLLRI#c zK+w|$9U+tc5jyp=*?7!UFl`x!XXa!SW=;tfKH*)GK)MO5nVu9`s|k6uKSd0fnD6(& zG{kX%o9@erK9}w0t;G5O-p{!?&1Y;g<*Lk^AyliRj!=HQiHQm3IQ*$+u=lU=02rgi z{g}%>{|6&Z8%J>gr~#&;Xdskc3R>ZL zseo%EacH~0z;A)=RF06fW+gA(nd!i+Y2S196u@a~$swaCJ$1Y}X*G2R=qSpBptJp4 zIOX_#;vUxBLi}tPv{XPLV zMoS%ND*%Pc0UCJib11B`+Nq|8e}aK>G$th_jY2m0RN&Y92UBD@=qvuG{qWx9XFi(d zTi$a>zztxpFG?V_Ym5@cgic0r9{xfE6Uus+$vZF0udYYz!JC_LpC3SDLmJB_=4CA~ zLF((HY<3`tpBsXR6&+Sw4*EA|*RKrAhBE@+gOq)z>eejVan>U8i#-fgKFQ?0NShu1 zCOXwoA7mwvl+~$YRyMZgj<@if@7IX&&$)o>Rjg`DH#U}=(Y39yR?4)l3>~9wUl@e! z5oBQUc60Y*c`fsOzjHvvd5N^B?jZ1dU7tWc+pyoN7XF72r1pxS+dI-nLw|RN{8CA2 zU~Vl&ktEDuU===+aAXpPpMexT2K{5&YMdfxqYlzc z!Jm;;1ziF;j5^P^{&#J_7Sr6+#GgJ38g>x zFu5S(Ya9lxZbvbc)rgvNM%3pUhmym4aKWTin1~Y zJHo)g;MbYliAR&vo-X3|YWnT%c>^HvN=htrCT3Y1bX|%9+$Z&tF%S6pDDS{!A;mH; z<9$7(1e4&?ktK&O`i>&r!jXFf97_0%UJTll(F|6Q6OaB_4^zJC5lX3?I}rw3ZFiI)}Nf&ei{ScZklo*#*IeMlNjd268n|u z&X?cdNX_{D#>DnFNrb5A%n=P#D43a6sZyk_V|&*Tbox@A5=XO&ddVcE%RG!Pf(>{2 z7mcn{>Nu70s&TqyC)S^DKA6J)GW$18iorpdZWYbqPPTMM(o-j>g*G^IEN9urf$eTbZ2n^nst8}tIe4YXCF~pMdCp!h(^RMiL$y#} zCd`x(sASu9U@Jyb7L749sl{Eat-r)pE5=&YEnDN=#8;h_0g#Nx}GWAi|Tb^GhtwrAJ0pwwt7*djUSPGz)9yL zK<4jHME(ksN->owm66~Jjo-jMqVmvH!k@5)Nitd~cfjoX@8P!+K%JS`zvLwCDwKt**2Me9>j9k(>5EugZT*p_Hk35SUKRB%`VI&Zfay1X)Yr zWbKw-e$;>1#MLqR>0^Ar>K3#RL*sL^i4#_RkK5D-;T&E%p6&CBjL?(T>D#D&T1tmrd3=LH<1McR+)OhwE+EIQBjfCzpP=H zEq#Sn^?r))u%`T1?=*Ut%;xsT4dpb7uakQqC3^@ABcd~ze_sKbx+IBL4FkZ;L6atg z(ijk%1UdsiIfXxE^?lz6H(@%2??LAm{b9#V+;F+v(rw^9?2gp>SXw(#4@20>)ulzv zO0f5O>6i&$Jf$!dSf!?mG%~%4ck=c1 z1p&K?#6cN6BBP2D9_L!z0yq(y*%>D{C;c>S^_U!}>gX228dZkn7m7$K9!m4M?Ztg7 z*po#>dDIK$KIY02aU8+clFkm2^(I-pRpGYT$t}uUyTVG6O74X)y7pt@d3M$7BvzI$ zoXC{V6Ac%y#GKAm&fd(HV+L9ZI^N$u;AT+6WvO*B;w|KfAO1_qR^=SxI$@A-G;B}B z%hmL&5G5V!z-NAJpkr%kRxvKe5k=gDNwCWS_Bsu5QXXY0|iWqAbT z^#5{Ju0m*RhJh$mq+LDFOmt3T0X!~05iLqI0wHhDQ;7~`>6UbP@2Oo(UagfY>NXw$i<4c2RP~mjecYK>C4QE}Hin(C{8``WFpa!eX zRHtBt3Ws4=A8)cqZ!Quz?p6~RFJm=KIj)ywuDy<4;VyzLt|3eE^#gU}ii z3u4AQ{T~ND?ED-6L=14JAJx@xW0Oue#W8HkD2h!llBIB@ijrZOvB8^0v3!NM$d5?P zc>T!lp)|Ey#+pP7&8d$n9KCF-A1!ak_T_XOGQ%d4v%umZJ~ z9a-b>pH73GnhVQ}{h9lgldWpe`e=Kj8ZFXdK{^THcBl`_+Ov)PhXq~wZR44fs{ z1qq%1WQqz*2=AT1ggrQ+WdCAM4rtB7!HB@rMS<&Wf*)j!kn1O>qB;;!1l@?ZIj1H$ ziL3l4eM0*df2Mjh!8OqA0VKK-Y6BDT8Mt@+HE_#ylFxOK5G7}RlP=03Dr5AM(1fGY zPmwBB3Af-Ovt3er;E=Xl^RSR~ek1VpS>$C$FMj?+wX!+VbvslLzf#*lGVM}_Y*dRtMMHXnGmE|F+XB3hov)gF;wr!c;n=#epy#$6mtWn{x z1OoyCCt!U1{C1y)Q&QWN;BDS-nugNqEz~XOQWJFYPU?n1vkNn)ra~>V(xlO2FM@{) zkp3R;_pcy;thcsa;f8Y{`-Zc06o(b&wN2U}_WEX=(!@%x*&byA`1;=8odHw&8Iaa; zjtesl7{PUd9<_sj%Yc5k+yIDD&3&im=ldT$j@~_PaJG<}jufD{F7yVxFZkP4e zHM6){{_%}fUYMSQ9{d%|r?-y43_lY6Pp0qN+s(~QpkyVEHySXG$G0jWc5KHFRe*}> zi;0kXPa`RDeolX1YbG<3lFH{`Vto8+s`+yoS|_l{Z)suAVlFY!yk7u8_OP*KssV-4!SvJ|>m`If z+&Q~GclL1HU-JwOH0AbHc%+OuIcdVIT$(nrrGb_tnit0jKfOIHaFRt>=yB$P7A6ZY zzpNQyXnHWVaGLnm(}t~qDyI}xn6;HjSd z+7*@PJMVQVGx{MxH?v0nuJXVn!h|2>P^}BgN^G;QQpbo8t985gn+!WSxaJ5_2xZf4 z=8U{&Feg;TF_!rj{Y(TRg<^gRMRTo;_W9qU{Sn}E&zi17TZyTw?6lTy{`=?a`YJjM zi{KW{mTn`jEaWt=9L%0bu4RL*!3%4ju59eKO~;pFi9&8#I;yZ-h@UAI-Bc#ZC~YOf zU8eT}akkPxYN#7@Gy(8c=$vKonzy<`Q3*xt#am=ccS3Cn@66Jp1qYRO$%IEQO7PND1f+(tLfXa6~rYm6nG zY*In=ANQTaBRQ}b7C#PInIvAS$pDmZqb}g4k$1VjgS{nz-=5&UWaK@FF zjErn~$AdBh8JH`)F_&Uo(RE022K4HG|Ma+o4rmfxe)s%J!?{pTkwHk3C)o+(#u&4I z>!@f8P)=;D>DI0g4ZUL|((SKq-%14|<0e&VId(nsr52t|Sobtx z)KB8=vyx=vg%t+taBD42GfmFh^!`)V<%pg^lG7d?7lv%v?AZ=Ny)mHfD7}IFj@7uW>Z_>2NhhB85xfLD?RT>qs-4zQ=Y=wp zVszTzi5Ss`OO!?2Uz#yVV@APOtb{99tLw1uV#|jpmpfwssktPMIdR$yo+}LxXSZAG#{&w9-L22qSj(5-@qSgbLZtnE~`Fx%GyCuNSd zweK>&05z`NJXtKpiWg_>a|7zpksKyK@$%44OBi`3W zk>O~^+ss13!Y{WA#(3OC-;{pK!CPW6dJV+SN2O9)X%4#SL z-0D z6wk(HdHy7a#a!0~l}%FRbJG{{so13(?Bm=(7u?xt%v7{w{q+-_;O9A~?H=rTHAQ(C zM)Lt(OYrbOs^M8fbhEXgcQ_=!2PQf+0Bj()w_(Z%A?|`M>BPfgtRfGSv$X4%7!4*F z!?KcOF;4-?d%0>;3)smDuawSnw1O3f%>!HNk2uPK}=ZU!x{X_`^5XY zy!UvO8+rlo+K`;3KYbA#IG^bp4L?m=A9)BZd;2rRaKDlSya1m97-Cq|5qA>~Yae54 zqMPCbIelirX$eSc5`_M{uUm5k;${oPsfsJ^7*!NMDdgW8gX3#Lp% z0;KdV{bXpeqb9=Tu(xHXf19I5a&1PQms~RpOh%)OY?$&sn!pn>XeCpJipp@btt8ab z?Z^GxSX^{bG9sWrU75A|GSl{wn6ws>@c`U^=+@7GR?qq)ke~GS0$?cv0+<8h;`sa= zvtwt_q6jXb6&HQQ^+6d@xoM{Os1?}iZ^ja*)wgRqGYyg_dqhXX3bhckGmcOMP6Pe@ z*W7*Lw)rhu8yn#jXmXM=9mhl}iy{FROZ*ty+PL)Xw}g>wrQl8u+l1^MPsCWQx=8hh ziz3p<9)h)vV;0-}!M(jbAn03_`~?73Pfu!c+-W^+No+s6!(cfLqSUu1OVIFE*$mPP zm@rlKH%BTs>UsSwwlX+ESO5!6lJxq80;Rh;(rxCRBSeyOPy?w6L|ONhME6qr``xd9 z)P(AbeYWPeclOZA;v5ZZ@6Py^!m)2;A}>jz>u~S}#aI&wSaym(J6zDHx4Kx4meXoOI8tUg9Rz%;ZNGj>@QgW%X6kF=0{ePg@nwnB0xd>U>3LcHc z$!g^9arKJIjO(buDGw69w7f~mqC}=~%j-BaD{RRCW2Og)>f!l%17?M@GiLq+GZ#Cf zeh*(7)%F>WXFqB&UM5VKA}wTpy5pjWiw}fH7vOR`ynfoq%%G@r zj|*jZk3Xlz-}(B|R(_fl@3h2(6AY1vBa-k0V)-Ue2Jr zZ1Zci2tHx*w#;5lxcnBhvuXU%#VmQ*Q*Igmsit^-z>!z5C5Nw9&A{Km@N%-IrvQb{ z>hdx$Oh1~;lAvlT=Nd`2TyK61IpzCdI+|;i9{d#7tl4l`5f_BMsw3vbQO?Va zjyozK_X9x^+RV{}n(#M+FQbb|v;DVJ>t^HuCAU;a85ZG|ad_;%NI{p7M1Jf@*M#Cl z#n|rh>65j43|%i$gq%Fj0!~u|(@b2Wo}O$c?Qx|M!Pgp*APv5s@LzZ-d7PL3316kZ&JaC6=)ox1hUjN{GSAJXfjZ$F8Jt(F- zw|(!LKdm}v*R@qSj}M!Lqgwq_NJ#Cr0jr=1|9@yY$G9-x|Ls@H*m5mw)v|44S*z8u zZQHhO*RpNfUJJ|i(&|3Hzx(xn+#b}f>pIU5j^lmEOOX?W_Ngzm1KrdJLbtJ>kT;o2 z17mp&BRT2ln6IL@qOo5%>u@0ZZuPTQ*;Bnp6}Lp_)ZOE45d3?w*7(K%^p)XIKZEii z3d=qYnOlN2+Ap#+j5PoxCbln!OT<{s7m>q%BITmZa&VDK$h&cD9wq05&<}b)(1ySL z+kDF^C@d9$gW#E_)Q5WfSiB|f{NE1)>+?nnn^?$*6Nr%>#>Sy*-n86u?h#d|l+(wA zBgvTY^4CGU;+ksgA0JX22=t%g$lg!WCVK2Qnz6XTu!mwtm6deEXs0r`oa-Cjoakd~ zBlkZI$NOjnMshBPRdW4rc#lLO`Hy`#1Nnj#S$>c-u*ML`#I6=Y{e*=b&TPs4uT_0} z$$7g0s!nhqpJNyXhbvI7jR+^QEbD*4Pan)Vh_3uYJqmjA>odGR10wf3nLP6-euXMf z>;{9eB`?SbDDyua;54AaeH}(b3Wq>4gh&TrBbcLsHz1vyN6*?yKlbeOG#8GM$E|W+ zmwv}-Y$Yfbc}u1N5%WrMDlr-D`$kd#gmGnsJV(6`;4}CS>pE??BS`Q|w!7Af*U+ta zUKiE~<`tI9x9IvSa_5s-p$eWVIbm$X3-bT@jud8!l^^sMo3%A&|Jawjj#-?8pgnp1@vgV;LvY{^UPvX)IU`9Bbf3}~g zXIf(BPdaLw{-i%kh@db|Ri>W;|6LQc%`vKyx2H4}1K)ma<;EPwCNAt!J3^twI6Nfc z>D>ofSzZo$gh6!9Gq((?knM)e`v5{t-15CxV@;Kfb7&&U8GM-9#>PdztB0Tyho7Is z=MRlYit3SWumar-QC7}!+!i1A_xGDOy&a7F9vbz9%ghk74ueruyMQ#w$@%y*$R`Ck z3$mN{_v{7!KZqa*Ir1neB(AhDnUkD!WW}M=STk_XPZGWBg9#Yvv(QaL=JHxk12?e)KaBOhR_ zRb&S8kOh5>Sxg-U!FZ4CjJEc647Er%E_o*@w$Qxo)zKh0V)(96HcvWQDe8Cqi{{u; ztON+^ixsk>wIML|z?KoNMt;dA=IaqbshIhFn(-Crb<{xGh(muWLT=0Uvu6O@ie|yq-lYTe@3p2m%vl6M$4!yc? z!OhiGy|X}*kdT4dgA(WX$c1#p7iik(RF=LYHOv(GY!)Gjtc6=ZRDxrd$?+qyx$yf; zNXW;>7j_9!YI!+1CCGZ~6>Tj*AJ0@e;<++zZd9s~2!50a%x*b3KF{}bq|?tDwDX*v zjZ{mJpn}gH(tus}cgMg}EE@$ww5I8Q;Ewe6{>^2>@q3FOp5q?KS#NG`!0bX}gna~H z*R-VLS7!|RE-Tcie=oqFM3a3PNw&f6;4@5b{F6+46HRsa%Xm}Tl3w}c>Q6`w7f#(e zoc@)uORc%Ox?B#HW|4gTaD194Jg8!WK7w`HT^~VgDo3dWfYe%qbULe%;NHhP>Mt4p z$~Wn-wX?GWGH$RL!BQxB!MCmJ?!Itrk0|MxKhIsSl?hp)D&bm{u*9b&Qs^PhfDcRB zOIM+HQcVE(GZHx@zGN1+_$I_!GXg~mun_P5cfaoQGVJs62fU`>nf)^U?<9Hq*ZubQ z>Wb+GnIZG_>Y(ER*gu}F5U=z~!mdbEAsNX$$2ht&xV4P0hxr|g%dq%7zasw|aKAo~ zz#6$7D;30NvPAgBl&9XTFm)=?MzE3#PqI%vB^sPF5geQUp-?Rsd%}jK)H6&4a!W17 zLMxXmT{g(po1)(m;r{jC^OWCri@s`Jbh^(|W^QlmX(J-}YS)mZ7+VPDj-Md*pgnV5 z&370c4rLD#O}PzHNZqpuWlGa7#ZXz4@L=_X0uWt<0(Q1&a{t;P8J5&KNya)$Wf z8Y zKwfO8F&=;+ePj?h^4;AElv)Rr{wgJX@Xqi7cDjMyN$oYwQ>>i6r6pjiT7Y$ z4}c~>*9Sad5snyWIbOUu8S-bn)A#qzg{h&MtkJ#>xh)BCvi$&;->UwSNgd+Gx@lqb zsWmv>cYjC5Y}NR0g08<|JtNAd1fP^OxsyS)LSywcNjCk@w0uQ6uvmv$B7U?^mh z+KeBuOO$cFpXvwg z@#K$$XNhhfuDRE1tmo|NI`aPY_6S48X|*)y77XP8dgrgetNwQCEYv5fAAt#-v7^RP zaI(F>wL15&uzES!yhK>Sjky8`x)p_ssuf07XM|$tk;856?-Rv!%`PFrR zB|lGvqR`k>cWkVIi~qysH*Eb?*HEq`F%*W3g1G=P2QMWjqFOQ-QGUbZp+0$F z3>tk`Mg~ZU+^zjQzdUMnXTzW6Q=d3Lf{y}xg^!yUTikb>Q#yNE!2$KSxm-}0J}!-i zVBkXwbp~%fHtIr+@Dgle>W3!@9jt%o7ZW@Ju<4HKtKJaeLz+-RBd26%wDC+6(_s-3 z4>-QtPg(=XAx6hIi6B&7o{TNiIoe_v5=T8lroFZG@%}6WXB!BQ;4EojhgbUVT@meJRVweqHKtzisd#cHrq;~m5Ff&VVb8kw z#$|-aSZ_vf6bb!GWu+g&=338qZUOr)H(IJxY}rt$=x!{hUvkon)L6#Ifpm}KAZ3_g zmKcamoZ1@bJhi1&BU*ZTd!;lbr9#KK`1$uQ&7WoK0buEr;MXuI68=!U#0RVhC@g8T z>DC)3J+21YomZMF9j0+?RXX6ZtcPPhmf$VM^U*n{&>-x{jD&=f2NwOnDiMPdI}sLw z`kt_fvcEvO8j*TE0gLQXqLP6a#oZPTdpzO_9A*DS6aE7N$@21YkT-}ZU5BgpY;@3| zOkt4biHsGc@D;Ncyh^M|UZpSpxzn8DKlTn+CaSai_`@g?ZmyC>&=q^y`++?C{MW_o zd-^tY%Mgq3vdyfG^tR4UClcrEgL6rl_fNnr^WG%HTpgLK);nW{sw~oCOz_B_QmC%# zjWgxFSSI+|TP#0mSU$NIIoQ}#mycFn<3(un0l(+3cL`d{B4~yY`1iL^1^{E$jNIEd ziyIbYOgVW94JDo!6XfewVg>$XrrgTP3b1*A&uYH9`}O!I_UqxVr7Atl+j?zje+o4d z>;cm+%1x-Wd8p5E)^a(8D-FgT1F!sXH|bcDx~gSHmd`1{&fs%M;Bsh|f422686oKz z(KBf7AuY%}j;>*|R(Qc55VrpNU)q+A&UBW*HVk;vVI*CX^zwR@9MF}Az@8e2*1Fhz9B=BGf9hFto3Q{6IK$odIz@nK4m~&%~AUi>F zg$Uqht~^U0H9sA`6U(o?s%lErJjJ9N!g$JtvHO-`*K|2=85LqNh~3G%{y^doUu}#7 zgDsHp6E+(cB^BY#-Fk_uK4O`PMfx?Wcj{QEeI&6Pf_bdUwln2$p2SatJckxBa8B%X zhazVm$j3Bwi7OZ@<>L`xY# z*5q;=w`PogzR0BC4)OG6&sDs@2ekaaZ6P0LRO`ulZ%i~qxPra$wezm8K-JX-+Ykmj zOfn%t{)QsWMoy{Jln0Tb`m$@AwxM5GcW@ z+9(=e+00h-iMW?-aN#K|Ts;w`u|mB={hzKAe3FO#mRtTJoU(GB8G0inVxMTyqNl0E z1f%W_;cL-dFGDOxL;H^E1&KiAr@yOi+;@rQ7?&BpTCf!Vcn)i*1Knx605(u0lO8@n z)8&n_ko?)H7NSV}Bw`0s3Q(t2;n$dP=k3>D zY5Z^8rT-z0H6;Bx7u0*-p#zKwE+7)L)~WTXZD7Uy&z#gB0LAYwS+_{Zk2q zu`J^}KEA37?N`$+zN~OjwP2*70nSyd2}`N)%a{U+jO9TY+hc@4$IAK^Iq@HLkhfx} zvXCRq-{Id!a5R}C7PD#_@Vn5cU$v4UFe&x)v7vvbU+r|=S#ZvNtLyZ1&5j-cLfn{s za8BLFCtt5MV2pZAv(W}qts!;7)Bjs8mta*A#e~F_>C)HpoK}(T=zncj zO5sT^;Wkk+??7zaxI`*d6Uee3r&1Mw%caPEPEmvo`Y<0bA$v*W#}}RqDHw8hv+}#@rb?a><$@GLUA5bjimDg zIqDLXF!^gR4BcT8=~xZo3%vaNK<*yE#dmU0v0kF?O*R`yetRhm`_0>gQ3iTwfhunF zZVss@JE%~djFmGA1FNL*3mor_PwYF_`-g9LYQ@pmX%0k?OFcM22h(b<`_l5BQ@3rq zZ7;O*y4#nl#Y_D;bRB&EmOXDR2-r02M(}=xovRXQJmBDMlQ1FB;OlQ3(GcDto#grv>6i)C7P4_zv%T+8042Roc! z(0%1FmYK%>jO1}*(;!eTn9>sPAEs>#RFwpTgrE=l5B~;kZLpvf9_dsY5N5u6S^Lk1 zc)2Z-?fxObzrNYAhJwT-Bb-fFhA|p4nfHoi{&=<8fp)(Ss_YG#O$vkQY~k|tl^;U~ z83&4yz-mfNTE0K5bZ5p>Ws8>dQlA!MEjWRCv_|5P?q_{bF|sD+k7fY}YGlQ}y^3#$ z%jtVMQX2o%nTelQ?U5GB2#d`XTByGgF3XdoWS_hUh9fm7J#&jKQv1(96$C8ai>{uN zLWoEDHWq6SsM(2hVwj%cAXDjVK_VO!PhyOqY$ri05`^d8s_8f!)27Es=p2$YER+$9 zG|z4M2;rY+x$q@YlL}Nr{?6HnbGCp~VL-n;LS}xmXBgXe+)t;_c!*b5Tf}p@@3=@} zpRImNc#)#`xKAsC5Ao?*_F%jmhS4-+B>bP=H$loEB>R(zpQ$O)uFJVrW+9B3qP0mQ z%7@uiv8a3n>r)4M+s>RV`&x2EtHAE57az*INPDbcX^GbBi86r@@xA@@#Zj{;;U4ND zN%R(ZT``wh33+KmKYEPes>1frBCIXjB*Y;6v60$`VV07#p`yTv!G3J{4-_3UjuCmi z$UbeXKP6MQR0>A$xSP?|?$1x}kiX2xGQoTzuH)<=Z&W6;8PA^&g1BAO9R6aLyyR)b z1Sr7?Sn#Qdhbqocr@!^1 z4JVTF0~Z=iiCbdoa2| z8UZYN+qy2X3F@RC`m!X|O6Z($1C}UhY)W)`f$^Ey*?2@K+3OMG)AHXEe>9o50I=oL z9j^QTX#t#238i|p>n*>vi=h=_mQP3kBl=mO-v6*)*9IF*a8#4sA;k+A~v+h zOqne392r8n6MI%{uef1d7zoDnh}S=f=*FIA=Ys)=DZdm;-pE8an;0Y7$V`+a2w?!N zCJ+(PmVq>fgF_8;1~Y_mf-c27Nq`M*O3RI+)3y%wm%KO8P#V0Al zU+gFC*Ftzk2RY~8oo%4H0&{GQ94tNr_B*QcLLLZFZS`p= zh-RpD`p}bCTRwx)^NJ`EV%o@cT+%*kVZ}O6#0GhK>9l*pwmP1i@v^F86vnURCngw5 z=CXVIQRS&FvwaN?<`i0+w%CpP(=x@(ci+EMWH~8~4B@uJIBL-jDvH-f9_!KK8mBRn z?K9#eujKE(s0EOHv%>PgjvSM&fK1Mz6+3HG%XePtRNg-e>)tA;{-YX;RkZ)dm4{O5 z7)BOzk*9>0ks3kC2a9k`llD}{9~&v{2>TMvktnHN!dJFdtwpa3<{|bH{eyhAj~P+K zi*MLR`(7F81zU16xwvN2`RSD|tigKSx1%1bM`k9iwBb_>FI#ta>MFx?790bTZ66b9 zx`m|aWnEtsLt>`?5F6M~hjpI$AA005=4s{wrC29m?_m7;rnS~m<53^yFevGNxtG% z90!1uPp|qCph$1IkRLTxd67Ocn|~<^uf`$At&{<%C<``3MsOyd#Sn*bmUP?e^!U$e^81;y{2tAeAP#6_zS>YAO{JM z?GHpA59xR-I#1N=c_XorJ3``w)&;_L5W*biCZ->|^JK^3R4iVr*|zq4;<~r?R;95_ z$m`=KG3l}tn*MK)~&&Jd)9y34tniv-p8q zClcfGIn*EP6H9vrj{9B#?{F+X&Z*Y7Y^?sP+16rTPLt-S`jji|3&CsKCC$5v6Z8nh zg#yvReR*yYr>0N3M30zCi634qN3Oq!i4ZlCEF2|`q>IrtqAJ_(PisoFjLztjpzJFo z`!!E4J}o3o(Pm=MSFi%wORboDAW``hHESA+hbDLOl`3yZTTpK% zKDLa)LETq4pP%+S5mKyr81DXnY?Q$PF$UZ>5 z?0$Ws$*f6xjC+)^l99Xqak-Yr1&%z~6;g!nER^ z*J^IT1ZI(pZO9Hn5T@5)ICXkT`z87C>&hosB-J>Y!qvvRNJw!XrY%_Miys_j1C@LF z%_YQ>kmgB=(f6fcN4XXMIXYH_O>{rf<7pn~JJ>HxVje+=Hh)`+_*4ib2G!x#ak zaYK|M)yBZ!T`PHhZ-K3_?zd`~=q>8g;xSNrJ{jUQen+4i+oEM%ZAFCX$(d=QHhEw9 z9hpYo!lHZ+VwLi}2t4o7eDrtiB|OIX9CNp7e!V^$>umr+8~>L8`nFbmum=MJ!o-Uz z0g@4NS${lg0xYMHML_f{NBcEwlmOupNT!O^QmboYbFsCRdxm%%6KE3CNQKlas^+|( zDeFWLu!WSI9j;ud#u8rWsKKCaO2em}x>GuVPKB0PmwE{8O46KZ*0UfH0E5iCyi9^- zr7G=KdG|g4{0U*l zSalK&Wk&orEZ}ITOt2=X-#%MbP;8OHHEDT4126MT2I$$wOgE=3pSZoq{DzG)sxiHf zFgnls0>N^3;J@9U*7szb>C;R1=2+d$26ZCAXYOW=_*qHlR8ko~lLxadUG{IEShYG> zktX8=&5}tr0v?^>ER1UdtS~aVGF68gYQ*j7uMOhmvWOYQdx#R}4uPT#TlM`eqH5T) zK3@+5e8HBe3Z_F8s3?7Yq=(gv)s0GuGfc(rdSEoGgh%w*ytSr&xp&N5{C0MR(xv?k zI&iQgq1&<;jG4iVIVUrdfPml!UFcig?hLudIY=5LqX`7ARYrGOc(I~d33sd0t1Cdk z2MgR3uEB}{6{PjSi9U!pT-hefKp*BBHqW1s^$D&jc;MHfpD|IYD<|0qRTB567d`?v zc?M>o=?=D&j<`4K*TtVKYz^H#U+s0{Z0NO*=v(2`(aomzN&ZPGQ5HHCD2fq z0S5O8?4k@W&+q$8q<}Pu(B1__H{GJKck;& z14anipY5iQ`{c8FF+9VkN>=S7P?3gqt|5@tKF4P;@>Mvy1(B&=FM?MbS z6^TZ`0;;<_<26o}pG6vz_VzMb5fIT0Ho3LcTT@!UNCd7&cPOtwd~>>b!nn5o+i zxlt`Id4IJ>Yn1zd>rIMB`jW(Zr%Wy1oKd{N_&W@)AK?QFueBUpMIUJ~wogLM z6_y06!%K^5Ie$wi8p$p#%-DBO=_-c$CNfD?8p%pQgkvaYLb0M8<_Nr+fJq>G49K*Y zXH}`56z=0kuq?BC^u~q!*!v`;GuQAfK|SD|1VNA8Z_nKxpIDgY;;E(N;Pzxpi=})g zrwzvozkRv~88<-V#@?z}y28CSy&t;qn~!vG94RelP=fgM<6kw4_L9;M?r3x#M z2G;$0CGHna4a5>Wyu6M`vE@RK6=Do|H(=OdvK&~ps%{(oA3^2t@DP~Mh@BvEG2Rs4 zzYOnR`W}ncA&EQuZPT!gc%$(bdUWB@pUQ9;SOW(Q zGV}hzb#QP9Xo@IRfZ)S5?uEPpawM`G58hDCe=Y;{R=)I{Z7+X5Ab%4n^@@6XJ^xF>AKiZ2k@b z?JJCV_&df3^?%BpRKBBKV;_DF1${AI{+<@L#c-p>QtVtDo9X5EQ?jg4qA2|6mwnI7 z^zm!d08spHmtQS+iV8sL;ZA$IBPG`3AYBaoqBs-0&HuaHUJA3IIWE*y`kT_2!A@~O z07E@=!BMe0;y!NB(o>5lJSPg;EzM_b#IjYL$(+kp`}A12lD_b_r9<&*UBZXwr+c+^ zu!-g8FNO+2SDFBVL2;iKKr?9Hh#cj~x~5YP{h$<_<@pVFuBX)(+eeQ6JLh$9+o`TA z3-{Z$R3+!CwOe2%nm!H$GI^&$DPR4l1bXi_KXfs%)(K<5iNZc>(JXieVB$mVE}^Eu z!vbcxfj$8~J}y=Wu}RD=4Ch_@pZ?$VqVzV%cGe@C_qI$<8anJ%EaHaiXS2xd^e|QS zs>#VqMDL?z_TN2~TXiY(CydjffJG3P5uC9T0{%TL7HI@+BP{!{YueACxd;mCroH|B zVq9owE0J`Y5aa`g%P2BK&hELab*vel2#n0YXg zLX>hp>z|XWl4}cEcWhIjDZAj221z`qge57KZ>PEg*3@dM;pO)v(Wn$T98axfr)CMq zbW(h4CMtFKQ!^rZQ{&m|KFkcAfHBdKA+CBQeTLZj+$zjwdf{{{>i#PN_ceB$vqUEa zlQ4g_Cp@_}0rRSz(?RYbA^wD+QIqAL6yk42 z!GwP#GgruWma??A2236WjYfaSnLdQYoI>ua{G( z9_2HX^Z;@)(~bPw9^<>WA`m8MUc~TsHcxM7Fk0b2eBL$5d6!4-#uk z&25^x-JolGMpToDgQ;?ZZYS3v1|f+xVfq9$jp-6Ov0z%Fg{s26c?DEmazl7b;rZfJ z|3Kbo-|*RV6|D(e8(Pujms0kx`584*rt87Gk~nJ<0xQ{4xHF+SajSt!YmPU$b~G2K zr?_l*Q`SuN{8)`ry!P4{twd%8!mJ1!rL~T)WrQk*2qRM{t`YGRPcJW-m`<1mAHPQ)t!}_`g%5`m9>mCTc0mnU<1?&tQwDmU# zk6^-^BCC-IL(_J#%~>tU7>PHC-Rfv*x!Ge_)u3SCwAa?oCRq$Q0V_z6h9ozhx2|#T zb1Iqiryf`AQpgujK{z=Xy={%BF!-7Lk&T=M;wOM7uDi$zwq8DpgJ9a?gQ~5qCH}Oj zyYU0Rj6$&Z#nKmcapuRL{S8dU1N49z!oA#YeR(oa#PI>O&<4q06RZt#H`qdi1DhO8 zbE6W#Q3)^&8a;KV5YK|TrC&k4wy|7akF%XPw{9^C)2i<$_kB`SjRiD2*>ifMZ z7;cVlD1G|C$-~pn={~Gujk%RO%n6zU@YS9_0GCNFo~95%1DU4myTwokyZvAOu>pXYCV$1SuP*pha|yV3U;|GvWBW6M65ck`sfAzRWC#f>0@ ziPBeCJ|lNPn`6h%eT0){ADOd!OEHp>l(Z1IYa2tnInwmaU7la_sh)9!C^LW|WWyMc z#%u0dVB((8T3Nb}yYi4P|IokRBH4gPBQr)Dbs+!LW%_St*YeX)$k&E+Mw3=pB=@(i z0}F#&4I%l=Yo~m)fW=R*M(j3qm6GgI`KTS4vDrI3Ew~N zK1_b~`Eb4Y)8VVF%&g)0MNqzljLM{~9sO3B6m24=U&ULe8^Lu+eP`ZPqGN|6+ z>+0=>n?Su6drOsvJ%|VyqtudSKeSY(68iqh`ujd~@LvPqV~jcG`q3+S9aqaJd#5hP z<(E{ZwxHDuQbSzr?emAYsXsbAwRaJRU5SDYXZxSwwdVV%frL-2gHxbh$|`Dq;GE! z55_nwz?tAu=m;Q2XMgf_-{k&+E^0wW2F5}O0%yeW`Pp4K4X4gaEYYwa>xX>zOi9ahC?Rv^!*40%~Q5dxt z^_Mt)8AI|T*y^VEN6Qp>S@QI^HvVw8dd+;diZVt6IoUo(T8O-}P|r5LfPJl=f%{mT z7L7CLJGb!OvFd9;8QU2yUw(%eTn)b=HLU}K7p%2(RnaWQ+7X`rpIIn}n*&34`S0j| zT7Nbr?`<}B{iO^O_GEnbgA9iqFFrw-(OKpCHLxo1lO-?szaETB2}&(?xn1<2wyi2O#8K&$T=i<*G%oyw6LwJRFI%Fh;!7BC>hS#34x*Flj1LANvZd^(pCDM?z%-X*jsWXKOiFM&27jrV}=Z zkRM5{*b~bPytUN}BxKj>eu9mKd>00?xme7fU!MlQG)% z;{NfJYsroJS`f`j!Gscy1FCtPAe^}AYk+mqP+J&?c4R~(Eua5M8*eNcuRA&wy`7%J z`(3VjPw+(<@Lu{;7<5u)Nd`I}flIVQck10lgqle|9Rcp7xP8bFAQF2&pEc_M!QAoj zPfS<1+HdtyWCv@a;Q1M$haMpXWBcy69qt(^IP5OTQ8|UF(WhYzaGzj6B|iXf@n@fx zE0C<$qWtz1hK>YC&1**g~zhwsh}>QURD%NMSTNR zERYL$dw4v9k>B5S!5B*C?lcZGhqqHyV$g4L93_-l##|16_E~wsTeeQO-5)P9S_~Ze zOQM`mg7VZkgt7L`dN8j~DNYh8sB(D@dH?ZuI-S;WyP7GsS|kxI3>{nfGIS_X{i+P;$nIE$sEjH6@!SPp`?%&{_Ny zpM30D2luAyiV}u`MW}hy#+>70vzUDE_X9K`i3Y?Ak`AzJhaHyFb(9SP-JSpV6(_fvex<75YajWYHyac>Amv7AAeMfUIWu| zOJFozKX9zDnjqugOW_+yYa&PL{DHx|y1AkUW2MP>@V-(@EqEX7$td^<&~3c>NkzH? zhZI&0JITQ+A|9NyUG(FFf73huj$|sgqnCJ`c>0CBGY_c;tZf=+etE#pHO_(1Wl-N| zD855Qb)Ol0BR@gzSWn)Y#dMDdei$@J)y{>rh8+nwqG7FUacJ==;dNQt4$gRczp}cF z%6P%2_Ficj58Ww0RWRJ%eH(C_{KbP*JdN<&0jU*D{{1z((+aq6X$tOvmTPOvS6X#s zI+|p;HFh=A-`;p>dLauoZG{_HT$9sF{|qTUkXC5$uu2 zTVyZuKeIQg{ixWn6c~5f4q8`+Pl|s$Jw9a{e;gZUij47cOKZS49u27c@@XQ-%XCgm+&#Z3NKW@Gdh<73G;8UF=WhgRrc{KK8i4d0Vh(86JE^0}xgIK3@Gh}w-* zxtlBp{4eOR)f8cf|1i@$|H@Cw|I^P(mR~zGyjf9C?Og@;u)zFLfcSn9TfJI4m@QDKN9H5l6us# z5-XV#Gy&`dJN6Y%^?Froe|8vtIQ+doUeRSDRyf>WA zU;+4K36up=>4xbFlm%N(&XClVudJrx7%g;kH?HLr5HqFr-*l5LdcFtXc8>eU&4ryU z%yWK!@~q0B)DX}qlJ^b2K(Q0vI3@XzV}_yT6_KXNY(ZX` zZCWS%#bh$tPY$Ffm$nDMtzq?_ zmO+~3bHRoJr2DN){UpGYb}&Kd#1CWEm?a0*lnBl-An&~x&Okf=@$T}fR&s%jEf{&% z>uh6v%N$~;q3FwJI4y=m1z8ZTN4@4S{i54=^=ETPdfUE-g zuO|TeyDQq0GeJP#^^zV9`3y$S0-g^&GNU|!q?=`!7{=^Bu`O$FgdJ`N{*jBhlCVuR ziEBVpEsm`Gl*F^BX{@<5PhxU!%lVS>%(R#WJ*75b|3{985sQ?>@~r6jmZOgD6HJpI zrn=!f9s@7wKacZ-+ww{9Bq+zMn6v@l9?Z0guP@iBe zzW*^~7$Op+?~Eiv0L{fR8T^zc8%8xxG48}(HpqISKVZz~wMk78BVks}-PXa}Wvc-W z(v1foPIYy2qxw3HP!o)`p43mG=zrtr?miYZ-V!>_dAT*Y1w(k?Gx4F3h_x!~%ko-aKk+$UGv%jy(v5@l@pJgOGo zd>P6STgV%IJI~;9&PK^Taw)abj?A!c1vc3F7H2fHQ6-ExA4$tuh+1yb1p)*uL!=$PjTy1P($Cuex!x!U9h!KS*~`q5xt%Uq(uc9+x~8?y#~(k8h%l;P-0Ty`_|dP`2t zFs_A4FS?aR*wWkTDRHpsqeEcX)G!}CQe}KME#CPBy|1?u+<#(Ai@)L07&7Np!U5?!+s}3{;_{`2G0=t0m~1?K5&B;+BUp2%wb)Imu`lCaP)g9W)OR1BUM!X zC)++R2-OoO1&o_U)l&@}gO^Wg`c_|EzHx5ExP})JS4530ALaN6ygn3k5ajTN zjWEM{rn0_4W-jEB;>QigJB|70hfV%*`adl|CE+27M*|zS(uKgEBR&AK;AuyPY=;U3 zt^Ds3x_>$i=KxZ_hacNO){Cdw^6vLTFfgTxUv61b} zFkBQEW_hJ7LYL$zC74KG(mE7N{`Q<`g;7+y1Ryp zn~7_vK_19(9(ntdiJ_J9(e)U4F3#5h3d#qRqQId4Ux^Mb82#IqY4FQDa&)DUe$)92 zfafWcnK?P_oW$eu@L$+g1*^0r^S0FLOS#?hGA$YZiw4#*xX(Hvf~0iE$XxYKHhH&l zzaUSN^;%a{k78z)bTNCHZ(k+^=O50D;d+-2cVTb=bbLzOiABv6*88 zYj>5##B$$$1QelWFN)tIexiGz6*%b{-T5?0KmWA6#TL|(S=EPOJL*1*$fGaC8%5}Q zn9*9+9+>M)&SDM!{Z@Q;b$tG|uK+JF7_HxjnI;hmtHhPGwHvLHE&Jt1)vna$@88!6 zfg47qZBW%5hj|BNnoPg0$&q`#4x$e}v9$?y2(9z02{arj1)iz*PNOw+z|6F9ei(|_ z=;`>i?MCqJFJi=3FF?IRhq`i=N zmdrs1bM~5A;44W-Z)9-Tc)$Jo3)Cs#9NmzFQf2-~uI%uk+KxJQk)+hwZmsaa_#mIU z6{{XHxC!Hr-SzWLO$5a8iVy92LkQc7dg@tH$!vzhGO+h#q^bSp9w3#@u>GwK6|=Qj zpDCP>=^=Rwu<1*`6OzpA!I=&4$p1r>DBb&|`h6~uP{tgu>G4rFrnz9QKAi@-T#o1d z{cOS!^TiY#Yj}JJ9?IxDg0=}lLrb07t!nAZfSN`%c`Op;2xPt>i&ZrLLw40JRcN{IvPX0V6g@_P1EYX}cB zpR?A?9*>39es5|rKK@AQzJ=6v)GNZInd$2lc;!M#h2@EIN= ziDzN4N|uh3L;-Vhd9V^q)(^&lHhO3OSPhnj%pU?H1tKuxh?K6B!@$s~w=pnqF=>EM z3Qyh{J_Ps=y&oq}tl_>fs!5WM1*SetX}YaQCpV7$GZ%UxH+&efc7 zy5+B1b_kSy!R_G&yzwSvelx5Okb%F<{gw3%TUov+IRL!58eYJpd|^5+c-QT69?CSl8J69p0)^FU@8kw*llwc%2cDK^X zSeA2g#1M*>u_AGZV~ydM+g2RjnJzs8^~Ck{H8@SXU#=r!CZ8ID>3-6*{_b$=f5oT) zY8_yX0At(pD)86RHt<|f{rDh>Z(e-2yGv>|y#)v6M~Qbux}C{(=C6jA39-6e3XEgW z!lX6Y|LSz$@stl#io`XvvbI=<*Xr?CGw}?2&C?LReKDMl&ye;qNm1K>XIPEAw$s&< zLukT9ZKQrMUxZvFdEC)5IacXauDPcAmI8zMI&NHTcDaV@CBlp-k%RNpl6>jq^3Z5IyA&<#GAX{Lv^fMR9;@Ipkyg;*l=>_x(aB_iYE%EHYFh>IP z_7WIPThlSCPQ3IFd?rjd%Vv(YlkNq`H(YFI0oY6w{Mqy}kP3fSU8mB0j>L5Dx*%z4 zN9Op+oDm3c1TTGNdI2J)Vk@Fi?km+ao zj0)pl_sOTdxHSJ_Fa0#a8RKm0DVOPz2jcfj$`>alv@At6LSpM==9z?yfhZ2^Husxt zHQn6|0bLVavR_c!DPR&Golc3bP)}GVPajWlPh_o(Mej@Bsk5O8{i*ZFq;(HJjesJF z{_tUqo;;yS;$A6tSS}{*dX>8^IeMji?B;kkm6ALbW`uy*DGmplHH#!hO#pR2Ip)cP zUG0uNQ|Tkdte6H))QWPrA(npqzuiIT_63_)%S6i&Q5!RX%7ke5&KaYsag4QbEp1aS zES5(-F$~@fDmK1rN_yM;%g~097&o#ay3e^V#240cq$hbiW|Av?=2KOJ7AiZrHBg>J zRL=VWH&uD4&_Hmo=fO}VJpg&>;prDFHr(40R-U4K-ZuC$r!TVxk5Z3N853vm6g$r! zx*)nM7EJNpZp>CTWMiJWw-mi66$XAdm@IGHTIGmcxcGU0|7-RD*kqO`4>F~>m@*Qb z`(1r9Z)K*G-%V|y5~KXmb+p2UWUTk^dJiccP@jQ51hlxv{@ukkIfIO2(|6ezOYlDZ z4qTanA(x}$>c1?#q|x&^&uW0s-2q`lCTDfRsSu`W5gYR5-``CEuc!Yy;P>((@EFYy zdBpx(Wtuj|DkwW6w&*r=YMc$y^wxF@%Vcz3tfkv6KIoAh#)`04i5!<Ea4)0un4m39hF%QQhPv4pOhA1lI zC$#@t@HzQsefgiYX3XQ7>|czi!sR7Ln1rc_VNS7h*Us zpRivl7Bf%xm$8^+7guKSptI^)c5xmxKIV~~8MpYyy!6+*iNx2K#;@a7_TfEWiZRXZ zWEor8M_Mbrbiq0Zx)bGU_Tz1gAM(wwn$!U|Pkmq!g@(4iHc!7R=x7yQgf3d|C+Q6hCDSn zforc2Z6!#haA7o|QZ)gEoLA(_R^zS2bC?F5h{yH&6`3Z-Y-j z0Qki3k~-qQkZ*8S8!@v7rXX&t7>xdvuonJ!h}Ipg$FnDuMpEF(*3cuLX~kiB6}?|U za8O1=sG*xreUTR=t0%>S{ElbPdxs$V<>&v$GHtdGGw>jG)lK)WJ#H~S{Ft}_nOK*# zwCfq5G%3@z_TEJg5;SD3u5iat)O|M_Xl3VDHl5=2a0$uOc|a+Jq!(pUGsm9MO&|30 zrJ%F3GYmJ$jI%-qFVH74Hz0kFtgvYw3dcutBFhiLQeg!1JdQ5uMCRk(fb3hm@g#)B z{xbH6imkI*%;-e$-!M3LaBn#~Nf&$Ku0@-#5EEZjpU*DxWlyV^fFqaT7WH_z+jQwj9cB>!Hvf=POS zr>+%}(`<~l_*NR6`JKzeQUZF^cMJx`Rw{tPemtJhA*40DQU<@*2iWl2pReMOT0#r{ z4nL{8ccqr0KcW2OTWc#H)S>D%Cy%D2dfwa&HhO%xvhu#PS{jMz5%g`MpzN*5BL%#8CTX4(c_W zrsN)T%UjoF*ghLL#oMt2v()QBBbB7Jad;s*ajl>(SSCI&uN&3IRs0N^=!JyLQ9(?5 z2qsr7Y$4Zc#4?o?h#Uu})w zWp2J!C9XIApvw1G0BZCDl(qT`r9Fn$iLqvVLx5tzPd~i+`*(cSC=m@jrEs!@v)hHO z`Z7BN-uyu?kE*j16UrH|SAR4*(DP*ctv&wLZ` z%hmjHYfBvZ<=;PHismnSfekv_%KC_6(ZHUr$?5P@R!;}h;so+q%A^%L+RH@|tT}9{ z9886&DWY00mSWGBuWoZeU5h1d=M`|M_o@-&6DUeP8Oxg7jE0?c&mpJuYxX*#iRt+F zuQc0@S$``&0Y;2!k2uv@cyxSA_CABVrb#IrhK>(O-Tv3h_`>#irg5-;5b}eP5mPs5 z%{a7hBJhT$y?TiPh7DMpdeR2j%8|#O_=zSrO-(p$!^=v9rMZ2@M80rKj(@kwh?I2k z^5vCrWHA;{;Pe& zO`iw7nD?kmwVl8-O#pS_eminHVOZL%^gRUbOTTg$EhYXV|M)oYgEB?xPOD(RrfWPQ z2IH2AITTun>}B87ed?g0d3XeOv@YBM>fK_WuL(xS$twc;=qu`0e@t_>0+VaY&zU_O zaWnqQ*uPu(hFn<1_U*D`VRBiBc682poIIW`@aeYdqqYVVG^ZTb$LgZ8J}P4rYUM*X z|1s=@pU!C5^m`hM6Asa(gH^@i=y`a1N5j#Ifam`&DJdyKgrrB>*b6>wgo2nwW%)aFHi|@vz7$L0jU4KX*HNSV;GhAEu67m2^Nz;HQLnY z2Q#bI|48HCvbP@N#+D~2U}BgCb%y>|dogVP#==d^+lnkO^Xpa{vhJ~qI)&{uK2y$< zG}#37X@uH_7({&DoJ)2~CfAFogl|AJ(1rbF)%geI3EV+V@MP>VYdfX(>r>y}ap&)3;EjGS}mJZDUAiDBs{-JQRiOS0{PGYDW2{Kv8Z2}48TVRG}& zMP52S`oj6x-)Ci*HK#w+r=fS(L}7{XSAnz16}jZCyuonz&_<1>YF*GJLq_ERdi(f~ zZQSH&$>Bxu49g-?{qYEu*s7pk)u|tUL19ukIuEIy~`1$;Kt3Z)=^396ZWxI0d zuMN!qUNxwW?iM_;VB`jb(FL-7bD9DXKQnHZ83L=? zP?)I^L23vE6o?X?Lxdw{Wxg^-U86^3g9RWu_E9_~=`XSCzHle8rD#ZEvKIw> z=J2=Y0!ZgRaAqhgEBp370zKmX9-p0@^P{JQdh%pO_;b#y=)&&ezWb_0jhn=DL91f# zq&+f@!ilcv>gF=R94|SsV19S(ATq&878;PTN(-P-!BL9)vVr_CLRrvi5=m zTTWIM{t!Kesd8qJ3gtoI*R&eY)cgXn_TX>b>9oVR)OW3yxUVj}HGnBKp216Dr0Fw3 zZBmomz;Z8#s_$sI9j;3HyQg122fKtMC?^xQS`M^GBB^(h&%JFGALl`y;CH=G=!{h| zsV~g5$=rj5nAy48BG4#XU=q3TKni7kDk&ZbZu2BX*G9)G)`&5Fcn@a_j~%HVJJEbo?(%h zXF~&^PcY5A+I97cx{~W@`f_(4386xj?DtUq^eM_I+bd zM8YnbtY!U-mwRq-Ho1A==Pa86t`jWp<6N3Az5R;{WUmmeZ4&qf0iawU(xXW``FdH zXqAv7SBZ>(g0@&3ek2S}+g_?m#!&=2mJxyF5}qZ*DvKXox5IMuNMkIQ+K+vutRLKy zTIjbEluBCs33id$hx2R7V~Ulk(<~3drxC|!M6jC2>ky9wTUYx_3&zjTCB70S38ZkB zrFDkoDgp74vlk84OPUW)UY2LeRH$5k?9a{(u|=wfZi80noJo_FEg`~^4ew9!={BbD z=wW=!QuMWym%%nmGgL_ndrj40QXMZ$>Wh&JPRjR*Go4bYAcEBIUr760?|PFN{-a27 zxiPNZ+|0G+w-WVuHmmzDJ_Q)KyLBQ>ix=fpl;nXDriAHP=({U}j9g=vhUA8Wv6FiK zaL?|<4e-jHcmw;1>I!*7^Syo|@$`*=>|X2u3+BQ_q?-94PTqo@m)G6aRv!_5b{vbs zig}W&Z*4;sMca~{-S|8UL@($hs&}{|Lj^|1gun~y-o9MOF7>SX0Wp{2Fh4u&oWfYW z^(GV1l-9z(6i&LCj@9cIx@K&w1E zQ?3RVqb)%~D?cK%?>UwPWp1Car{*dDwzQy!mT(3QOhYfSSNYEz(e~2oDV8gR_g52| zueTXmQ;sb^WzW}*$2nUo#^a}gmVh*_!A2wzBVQ7*3(5|*}S zx41W)n#!d3a|8Mtjb0zqZlrQJM8yQ$B;%p&V;Oh{U{qR(Pl(=2>o60CJcx^Bd660l z2lSa6JYd)U_Sde)JR`IK<$v)SQi^i@yeNY0q9((7$E=N#yZL~ zHH|D#w6I6_^Urv3L37!k3U7ZDzOkBeLN;L3Npg@baSH)`18au6 z8NqhY?l;l8`9+3ek8H=>a)-#2-L$@IT3-%>Sa77G0@+DY?@dBsKJcr_IKk}K7kA7W z!!r==s#n$>*U=)H>z6*1Rc!&C$Vu~@m+CYe2J(}uQ4Bd3xSyNt_AJJER8P13L|3vV z4m``>f#b+Y;ycVSNM5FQMSbSq?0)C(Ph~l+X+7Z8?5GT2pE%K*pCy}-?KxjCCFI6# z6EBVZJc`0IUR?7VdW@$d!9u;hmvMBqnRrOOM(<$w3<=q!^i@aZ)pA6M~Q4=`UQ_I&P6w@@|*&tI>Y7z4ae--_~YLc zN>>v40mYAVye{%+h{IH$ruLjA%i3u?(pnFDJ`1!P5S%IJhY<)c8R$?O{ra}ZXajxS zDux>JUlz!?5`?mw;-nk{pFMZc)wFd(hC{Tg+dcOJd z;lZalZvrRN5{knEN{-VY0j^3GA@14l>R--n?|S>@7ToOD`(F*=HS|SaHhGwDi3=^O2^q1T?LTT94dW2P# zptyB7-4|C@`~m~dD4jZ)SUub^^w!B6s>WyfevudGF8VJQ!uR6*AOz0o7DT;}npd4w z#+AfrokI{b0+ih!vaSs1kwdpdlT>?mN3GX66R-7u??%4N+s(Qjap!WtEyYuaxgo6+ z*_G#h3aM|%K(G(c42>Ui%F2at$jsao-tCM zxBP7?0J~37ky<7Ml8|5$fs|nNHuFi`6T2)iW+YnEi3H=)&DOCOC!V{E_uO5~&8`!< z8Y!6nc}V`M0Qj#M0`vo29!j6NY$gbLYSgW5!wI)pw}vo8`1pX={t4V@Rt;SNbeURP zgwLz(YQUR>e(yqyHwEhk+;Tx$j7AvGLaZ)Vwa-^>7dW~A!`p+Yk8xcWp}I5Z^iBEH zB^ZvG-~RAqdJp#!@OH?itl|NAt+tsHH#*;kvIEVN)cpO#DSn<>1ArL;zU_r!UNbyY z!ypdqBu*q>E2^gVFfzF&JKk6u*-1fUy#iw;S3+vlYLI$#(n=PT`Csu@(_{D5<>Wt* z6=|fE1uqS&nUK(1mw>F{mrifTlHagNo|!8v%(HL3K|u;Aq2My7*GvEuL)Lw!zznd)mOSz}rA8xogkz6-B2Rq+|fdeaY39bszUmAb8+ zYtd@&KA)mw?ArRDL=+G$U?xJZGFRFYI$YX_YzHyxRv}{+hW>R(_WUIJK)R@OlUwg? z;e%<**h3%2+9SC*WJj@MRPEDYuBsr4BRkkSQmj5hc*2_)ZnjwBu>8baP9MFz)6JOJFY{KD!m}&i( z;*qW{CJlR|jo>P7pdeO2ud@@`%GD^;U1GmljCV0IL1_9=e(Cft*DZ^rq8WcD!CK<` zhzo=`m#)*8abJfuEqmP@%EHQL7vFt8n-8 zrjUp#$Ly&@<9Zm+(p{Rthj;*|uCkH-tuAgSPK7qt$Pv1-KVl|%56 zRq@`(5*9FcoeYsQ3U-DA|2?K)4gbkF{Ull%1yO|4hNfs8Rxw3^;!aAeSAarF% zmJO6d;II6`ZLB`%w3RNDQ@)n-4m1WZGcE2y>ndg#SZY3Yh|c4Yh@YZDK9 z3s;seC4a*INz>LHmeh&|1tURi`x1(M&l=;dore*-?{J^psQV6Htjlp1Ta!b8q|5s)#Y;nsrI>6`*3OdJ}w@{mQP*53p%rmL5E8Y^^Dd7kFk zj+UI`0ST{i=(FT856o&>>669#xFtaT#GB~PtbuD1^0Gaq4-+iAD%WYnh^S^4Kw!J@ z?+9xn6Z$CJFg|D8Dfa1_Nr|-ZKTxb_Hp!Xvf3?#r@}p3MZT$bv&d|Kt;4?er&r4j= z7iTbLLJ%&q34ENS7AfaO)wQ@<@zAma>VKX|unMT`e9IvkYRBu6JtUsvl|_s^UM`XG z{rvea_Plt|3+^hAA6OKIPbBcm!C(nkMmsY-U0oAYKlYhx4?Z!X~CkM7edMbz`%->v)@F8xe{u=jVJz8#WRj%>=E3z!tS2|T< zJ*<*>_CxgAr6=APb`u;#BR0Bm=5^vvrjWOX?O%Fg|_|XN;Qq=l~uVLeTiY#2~>2YP`$Qb(8M6JhFV(r?sgR1>* zYCi`@៩L9NH6N7Hxj40k6sFS5vi%7}+g>|(YyjsYwVQ~{(dK!oIA20+26VA@S zP|u%KC8Ec(5{^zdGP7Y&1>9eOX?T) zuvbB*+mQ*da=RXo9@5@yrUgWn92g4t@I2n6D=ICXq+~g8=$O@?b2&1H2l9yBwrvVH z$)dvy>2g&cvL8c|s)B=4;o8-(4Rf4gnn&77ouiacQC-je7=$fOl~*v^KU|>xi$iv( zFO)FnS{3~wBxtFD>xZq2+1FC;Cz|xtKPu8t#cEg5xZc3m1G@$;WM(c?l8&sgT-v05 zO~2X4rt|6mo@jIh3_QT*_I8wFeEsxhE#qfh^w9fEz1QdG)xqCPB@H@rZryw#4hoqb zYikr?@FP+*%|GHK2RkMSn3Y;NOfwK>ZB)AW+YhzIN@0J#hFS6Gj6{xOrxcGHy@b7j z;NR^{NtN)sQm9{U!n@Hu8Wg`TE?lbh6p%;qu~Rv+!6{(O_M>7`Jvn5NBhp|-?!ASL zWMVic-=A*?nVQIysV=N(y^#0WZ(1i41fK{K#aHs_{i9pbwG-cvk>_im8(vrB(ltc{ ztIdQrWjlPMfx1cgW-6F($=>bBbkD7&g6BjeBrF`RBQa)^nN3h`w9MM@4NXJoh$Hf~ z&R$i*9sRnNz}o1K_Uhd76E#swH!-2l@)XV-tKF7)Kz}*gJ_o&aXoR*Byl6(bG?BA& zQcPW%225^-7;A09!#C5Ro9AZ$$Xgs3Z)8XB^UO#*$={KwR6+pM|NE1Zu}=j}yHh1b4X z9U&G{e*d@{R~b%`;~OZm^~?hqt6RsTv}Y0!Yc4qs=1RtSAlx2b$L>`1GBX0F6l-AS zg4p(w<|0jFiz|<=EnK^)#--Pps1)e-x<_7!+z*KoGr93#qX~%_C~V~#ZM~&JVK&@8 z|6S`81PE7{)jxlL`O5ND0uwDL%3=zyP_j%(_jiKs)i~8U?#3&4`T*zw=#L%MoZYWntssrM0ZU>YaU=dF6y<(w z0hg)5#VU#7Fd8tl3yB}77($AyQH*7v!CpUM2IjLsbfC(50Tr004vq|eNvoKmXEoH6 z9ah=Qq`}=5NO>H7HGGN6NTq}gD6{-W;y;0Kl-9D5j^)f6)`+!9G$uT~G-GZbtY4Ka?I#lL!Fg9zjxIrlzdekz^(P z)AOa~eVry2gqa|L+SnS&~@r!S39%^VkOGw%&zTq$KPmGHQIWQ<5yHmh@db zZeP*(LVNln9qFGul_gZw`^F-clBJLY2`d}Ir|-fKg#Of;$b8PMDC}?N=hi>mZ6cV+ zVG$yb`*%7Ec9VAZQB-Be)l1Tj$@B}NR%-39#2%Uj0hxeme&tN%x4XkeGiU)T5Dy~> zW6?f0R8g0UgAdCujKP^6rM4A6~@Y>BlVgDdBcA7+G zpS|v`C`%2Z?w1YCS<|_~zc@$g`Kc|3v?Hv>rGJYmFN$Dl*3AsiE$iDR4Uv6OKbkS= zWOAo<>!(XN-8z*2@z)%Gtzh>pv}BYJCwGTveO%q)R}!%8KDP{Ry`d%hJRB+&z0pH- zWgR@F625CS#n2P;W4=XAD4aoJ5@`ob&)%}Q*fiLQKJ&bJ#$3B8;5)~B+2ID&R&zF+ z!7-NM+g~RtaRh5n78EYeTtFyXn9&_noiM5Pgx^b?kJbR&ZP9SlXK8!uOh~6jZ z{nbm@Y&}@{;Z${@U^Ws!NwOqL-+-c z+4-BFf6l-34=|HU6??Xa$QmJUokaMp7B_4`jbh5E5 zMG&&$(RAbT^zQGT<%rumIZb}iy$ycYW8OTJj4Ol>!C9aU0nfK@%=Dg&(R&y0IBxMg zlqED1+Y80ppO$t??R|jd0P;Drk6Q3DVP&W|DdZ1^=EI!xYn}s) z&2YG!3mQ8-3lUtkIJCGbQri5~J{f+ZM6rm8TwK+ppvz9_Ha+bYrS1y$Y`DpdquszS zblBxy@rslXiM)Oe!sN-Cw0!h@7~9R-6aD4z#$Je;*{p>=K8!q}M@I0QrP|%hI^6=X zDdvm3Q>YVfX9UH%SA=g!B+hWM6)|DT%o{?IG_jM54Mo(1 zvqiaYLc>KK9@{f`aL!wv3elZpK(emOGL%2>N=Q}I?u?&Cet%k^zp!`vUxy#avC*IF zh3b3hEb}_8>7-fAA*DYCSrLuy9Kmg>=wTmm93vNukED$*p}#Rhg%Q+E!c}CUQp4f- z3egGo3?IK$P{L;cPI2wz#Zzdmq6%F)MI6YR6g;VP)V+ulMtlLXjEgGdaah4oXt^ZS zjjuR0A`ZS+`?*v8{C`eP!FU%StEQ(DSlLF`HpqAGr(0xU>r$+hk$g4dN`M5UcZ@t; z;>DIBlTHvuZY2yKWp#_!V2KTUd9XtMA$Yfw z>-j`X;XdBh@pM`Khx`TD;DH*TytF+^vyP=~X%JoM-3)`zN_QRp8-_}v!O8W$2Yh~cgFCiY|A zEaoH23lQ$4{CRmu8-}j`$f;0Ka2bMVXp3m&0CuCAORy~o5wEp-H$Rao*t~V%DEnQ6 zRmk6NiE(q{CidZUS@G`~$l4Ha)gg5iYMZ8>y%ie`s>m(K8IB1hR6$62Rl!zA4aYk< z=XgA6VTxe7buXq_%(2Xa#=(fUU{Pd^7J1J+cSUy(nm_I4RjgmTS-N@RMD#TFDv7WL z6&813Gn?S^EbS-qf0;48TFs&CAuCeYs&ZVHNb-#9S{ued%W~LG%`fy!C?t)uBUJWa zpGm#E5Rl{vv$LCSD^ELJTT~Ku*9F?#KIT@Q+dFZ-ljGpY?J`hC5F{RKk!G)EQU+No zp7C7MVdRCt*$>T<4sb1+%ATx3NU$uIi}G$5fV{8M5u2y6$%}K6m!9K zq?Xg6(g%))YWXgM)#`7RZEO9!xR{TKozFGy#2Ri^d)@rPS`b#{zTD{fGKl8~ib(WK z)vFCljL1Fa#BaC9gbi!gI}25tx=F>+CpEeCdpGE&2c%s_tEN$GCaPBdSov6}QhO82 zIP&Q-$76*mr}z~2Hz+FveV3^w$0oxdd{VjOJ-^;da^ouzx_r zgL580sB!vkeuu--;QO%OH?p*7P=Z=r(&~mwD?wW*W*2Eb8_`+u^Aq&hlUZ+Ny!NvH zO!BRGKqCrT4}}8aAy%!;4g>*3_%Y{t`H#mZeJEed#K>6pJOXh7!vAD$*4wUtr(1AF z0jE2DRi_rWi+~|_y_BG|rldFc*0rZ&*)lf{bqX=R^L-je76RO$I11+--e~a}s90e_W^1Fm+3%q27MR>)J3bhyO5u9FF^oz7sk8?^ z#ZE#8p0Q-CxF1{ozOf2$b1y~s`X<=2$U-1GaB*NYT7_)7ttSs)s{%p>zKYLy7`YqN zR|Ia|snt>&JRP^<#bC7chs3Uc(a{ICwB_ zP&v@%p-3vO)>>ic;Fsq_qRwe0a4?0O**Qfd$EG#XO%rnwweufKg{5lw4ZlTNIY0S^ zkKqI53&nKzcI3^tLbKsjKgWhbei)*aQ`a4UWz0$&v%h~sV!$6qO#32OBL;cM) zKgDBqa&p{^E~f=EBhufHUjepzm&BBk2uTk%k5tUz z*hVJeh~3NO?kI>2WD!vhGbeL)LkM)wVldho4Yo#s$umy$#T%rqF+aZy14$`u@BlB6 zdMqj?oab)Ph9a#I3$8>l%$GC>O5fggL|v$^V3(p~14&LK_RYcQV3+gu8%5W|B%;!% z01B4o8Vm_D`gkZOQPq`Xwb6|ApuWMQ_G{E>n`2@M&TvVQ=wK2}2{Xks9k$SW{~Rz0 zN|nbQ8Xg9py9DrCK!jbWt1U0C5-K_gRr>~W{>`MzBX=h4D_!0@T20T|6w2T;v;g2- zoPqzd6TFg22yHT3SvF^P{F^S!P(b83B~8oe`#E$~Zq)ooBXTmm#NRE?X@7ck6{k+% zG*MB~Zf%xUc?Fy9znstao#=#0XUMXwu*C7~w`(bfJa_9vyu3!SHHQE#QUpsbyC+j; z!nOQEZG3)zTrstwa*aMlm8)$ZEcfVoQXDbQAT6&x z8E%h|FWww*S+=;zG+BK2X=S$Ytc?x7kfF_1EvA-Pg~knW%jsy-ESZ@Cl9m-?do-p-`=)p$!x{z2&k>0o84UqP{j1$Y~Kb%@{#Vs*a7O<<=<$RjpNMrfs_;*q?pBUoc zC3DS98mQll52KYT(EXhRFOAx&;7>$S3V`sY(Rj&t?jT9b5b4fYQIW8n=K{k731Y)5 z>*3&9NodBI6GjKHx(@VmIbKpIzBrQODw?%0q4&dm0a$PB5YOrxzXRr9lQ7z9@ z1;|OVb_(%-g5D8H$vS7{u_Wy7NrnG2C`l!-FNxmIIXV15BdWG<%^$2<@{!3{42S=#8|7D z%ZFx#8xse*;SiPdCyG9yC#Oe8y(A@?#Dh_mwHq`QIG+$O^bB~Acp;Padf71^><}2J zrADiOtE0AL;X=$$)sPg{BYO_bMa4TWcVW;E50^}vDp-G(g~bD{#-mY73CJb z_cDoSi84AMR~T#>t{xT-Yt+}Cs__L6x0KH#7fz)Dal*j&pe4yK@fGB|-P|Y-R=+CV zyY{I-*~{b&YA72|=ts{>trzIp8d3<;Hh0j-|l}yhmx1W zL&RUrzG5hF6wP<^7Tk94z1Xfn+UNKAgWs&FOIB9N*x*Cb)?TbWBYCtPErYb`%NEq4=R?F>0L+hOPiBHPmBn;Nx&9bX)Q& z26nTRfU9|8Ylwx zctsTjj6z*O+_#NeqZcY(;@-F@-$a18K#apN;1T+-4+Ah#pVKH9vFt zx{{lJH#r5S*&+v{-jSm;FsiEVA{u1@`gY0^9|(8-!Y!^pk0lmU)<9LG6S5V(sY*a1 zyptUzyRL`l%v$bej#=)hlG!}Z?Bl3jf(uozZ^dsO&uO`E%^bRh@rJ>=7iGkP5eX;{ zsp5*ymN_MQ(M$|We zoS^Ar=jBJSDIC~oZ3lp!6HN=ZKC_MP%OZ=$yDxes0Z_hQS2$C8Dx>Dy(13RVc5j(_ z#C+4-c^)t%LA_D<-kKCD`fBNL^WN{qoV> z%uZEn)a~S!^Dt3{{R7}m1~f807Qe0Y^LS*Pqp<7ZCIRbX-^VczzKAT}fd8x_V7rY! zG*I?p-XBDfe`!w8PM=2l@5JR`8NQLALhOY}+5K(;=w6Kc1D3{_QIV63qfrF|G=C1K z)#bcPPG`J*vuf1M5YUK&cWRIzxS_J?r&fC%#DjAHD=Y%lbc%7PkN^=RI}E(R5t29h z?nKUZSE+=2XU{*rO+z<}S5it3)=l)iT;@`=a7kJ*6y8HbYG~rn<=e?rtlvuNK^jD; ziAZo*T=LAbzifGsu`)RsSPKzghL@B0j6xu~ck4bYmvUMJA-92Oojcj&UDi==I*|b{ zCo>rWzcM_fjkTIv`HOze5gD&qzez6~>SOg%-Tw54euJY_Uhxt(_juL3Zt)@HGyUCm zABi1ds}E+c)KZz^h=~D6>O__dqq;4$jI;uwgnQI`q}t&9;AwU{0C#Bw>BU?xDOYU_ z$m51#r46eRA@YuriMFz&+Z!@AePzhr;f#0h!)|UX3qi1ZX>9qvJtucXsy?#9=tKR3 zkcTOXuWOSh2$w{k@$yMwVn=jG&iIEmm9ROLnJ#>T-}E<9+edPRDeR%Xf7 zrAB7pz5yu?KoI(dSodF%AvB5g$j=pod${oq3yM$W<+V`ToO`yeD8^W56D>d zPAzd^qvd|Fi{$!uwBNy2d>WmbEiPd+Xb3B5_`-MP3=EBsx!JIM8Vywwc z9&*nVL@A$wktFUH5O8We&%8EBojUe}ow$eNl1`XUXG9J5L}24P+d}p?Z~g?mZMK}w zf@oQAq=Zb*y~riJv&2Cq$T>vkqiM$ITG5TpzeSt%=`I-B@FbnVviKk{?%^z9a|%oY zftV}$?|K&W3l!(0_nng$E63#}&}u_6G%8&)G*>e!pY5<<(gTsdfZ@Gh8}8iW?#g z+cXP8oMP_d!D-_4c~(XACNLeRdqKmVOR-zl+8oghRo#&2E3gZ%qbW6cD2BOWcyPh> z-f@VZ;6@@jm{u&!uv7p-=h-0D*Mx~H0B7lkq-?@gQkC*RbNX>Vsw7zmL<6TX01f#spkI`a5<7r^RV(I9;eG};mLqE2G z|MttWrMmkZU(DKdow(oG$@k}WI4&yM(?;5O!m*KVCf>Vb$Fn#F4QU0T9L#}Yzn8VW zmL!Cmk?023;F`lvMNe3+bzF?Ex(~T(PHvT^l8`t&T70H=~sZj?=t5qv2I9 z25-+(H0SMaQOWrJ`9m51XyR$CtO>GhS+?4>i=-Z9Sec{I9vL{HF-aO)4y{47nrF4_ z%+0TI5rqtJ7>&EW%;XMcK5AIN4gESe>i$?$l>f6}zx={zMl8^%Lepun6BG6LY)|ng zzurZ$!s%4=KP9oS=3#3=q<&&79C6Zx75T!ep>(qSha@Y~ z(LF^<6(%0uy&3;G(Mi-95Yehrlm_`gL3uw=GxG5=6QWr03@?(a5+7XC-VQ+`)03Ro zHgB|^(*7ikE}-B}Yb4$ng3)Nhr;?WIv84CG*?pVJMbOjJ6KFudBrX#89Kj*p3|@Ue zI&EY+Vy3gyH%wJ!HE4dZ8H^cSZ#3IXEa=G+e8^3bFT-v#oq+|hKR5(pe%WQ)GpfzK zy)Q%~+jz&<0rmXu>Ywg()9J<^S0f0SG~P4?E4I2tlzT;vXSrJFYjniZLMWK-jWzrt z!&)tY(;Z<8SM!16a=^JXPo?6+tUZO8hV^58;6(OP?jI{4<__d3oepuxKHge>sQwX3 zCajC@W;!GHxsSilte!eVWp-{BcWLT)nyG(FH=~}9v9$56+l+ZEbOjGj7vqK&3jbe2 zN?B@~TH^OUh4Xb|YV@LT{%~ka;WI=ej>D_XNf*$wC6aKS6B7oDZ!xLWx4Tn=G2a{A zaw=q@wbp#8y+MnQVJD84rBZ(Wqd2;fDM<0jphN#4##nZaVZ>>QXR#!nprOnH5pET3 zz&E=rBhwqQg2tpTg5c?eFo&trw~iz2dW$h4;{VO@As>x%Y?^5it1gp>A1C#!LRZp7 zzWma%o*uDY=;=GJFYcgDxrD^_3vrnY)(g`l{78KXhE>`K#QWBoK5x^Y&`NjvV0H4~ z3(3*x1Kz!c>6LIMLOJ8O!TJulTbicisRj0Ja809U9*iukeYY?9o;U{c19VP48Yzw2YI*RAd_?GIz-1H>ExvzrgbjxR1SE>61(#&+(D z)NjTH8a$ZS5mI6-q|{Ep7P_G&jY{9f0l>2FfKzOF|z)Lw^$bbdv;$J>3sb!4SD2!BNG?p(PQQG4O~5?tBZUE zx*b7~+;TUxnUmk8j)lK1gZUf1fW-)Oqh$Z(FXmf1-6#!3`fnyBEZhl>b=9wr)xcRF z`10J!IsJI4=3t)qUZvf^AM0loH>ZwK=rz}du=jU1)q-SOvdwpWO=?;Vo&tZxNO}6?22Q^M zp6>_n$@rau{Zyp8Uv?vxkbHVjXAWe2OT@#jOiJ5#ozFU7J=+$W;)}t$_?DT(q^W>CdMM}NcLjF{qE@8c%P$)1 zh(v`=FS1@oM&v2VI$b^uzjN zE;_XA$%@ZE!9vM3cTwx5)MSddvixI1R>I}UV)Q#JVHsX5huVn5!+T`2#yrKE`m9z+ z3S<}lkN@>!X4&;43xxUAFj{2U0lF`4!dq?RP#1RKusoPaQ@#sPd%S1?rDNi8DXpo; zvuO#ttDkNYa+>xq|B2{}nK+&6@)S~(&Kxyk9?cyb2R|<|#`gte4pfYZqqI_w>9z0C ztkQ@{&Yb0Ql%JPne$+Qjizz&PLxaf&dL=LVbozv+$F{5S1z1H5;dZ0mq59 zr|AfqIUhEdH%UmTQumv)|xN?&M%6soel zy!~HxWhwUB8H(%&ycmV34Il~ z7o~4|eZ3o4YX9x$8qZ?$6LIQe7$h~#|5zNL_kfy}2_*T;Nx9#3?#wnkK?s}5Ef3I+L7^*PvcKp*QradIBbO;VhZ=H6O>hK<#Q_%PTPCSK+-L2Wi zydXuU_DkmddlTU*oX}d+!6JPL;d0+Y zXzM!qVO)zoC5-=eTymL40YcHvm~dFAA#J z$FrhPdST!f|2MiF+G}k|xcp6!Qf^$n7)HE#Y@yQ-v@dN6wX3}|75pIsd)z9D5Vdd} z{sgZ7Qp4c73Yz`AtRpVHdTcCcZ==t_Lh}CMS~=8%s;-E`Rz0JnQtUNfOcysG8G7rK zoj3n(cs2Y)J-}t>=!iigz}eXuJh(0{7odE#LPc9ZCEJ^(7MG zKO26{b?@bsGUw%0f~${u$%yceq>s-@-ASk#@=5@ zB7zKzzyMi1LVogJc`4tqK7!lh$ZFvEDH5VN0$Vij1lX=3Co?StgGAk(YtgD3tB+v( z0Z#CaXs7{84ogMiT3-6_fs*maSBoXO`Xz%n%Yg6S z6~?h2GwM{6oC~cPX309ChwjJZ5z22!6ONGNviN7 zH?I0?D&c?c-OUN9!9laV&pj;L7G-?y#Q(R4UqzARsg?mHkLLX*gsIQJ=<{VBPFd|# zK`vE!Zc?UPP_c!4+$}SIYBQXxs1kz}MGY$9WVE5*9?qA>a<1VkGPSOPC7oXnpc@#xDz zD!if7#CgnEF=q^Kg6JrPnS|__z{Rv=G%Og~82#%P9f%CbREqtjsv#=`&4;`k@ln}T zDfofZbc5;qA1p&lb_vO$ zgtAQ6V8WT(*SXHPEvc;RXf1l)%qs=#0U!fC0f^!2&VQHLJ)H`<{QJ}BElUBGf?D_F z;bG~NS5d~KnkklWDi+u7gU}e%ugj={BC>U^C5YG)x)EI2vCZWhCJn~5;Y@>0R z>e`Atgyc|(I%M}{%=<0-o5ic`%@QX(h*XaMe7gH9^-a>{IhV}+LPhA?Up5xhej5G4 z%3X7`IChvqWVPM`^`o|u zRy($l**|w^%TuB<)4s}P zY{by`b_TQKHyOStsm}5VKPKd_Qj<6qxtg{LkG$j__;xQ}AKKg6Fw^k>?Z2R*!9F`M{^%_E??Dsy^OPol)4@K`qQtE>1B{h@mZQS7Fgj!OyumYW&o( zg`Ynq2wLooX{p)f>Ry?3FigC>76z_?NohauUa0c4HOqHPZ~4Dw9-!A=L+7)@vk4zT zu&}Y*KX`>s=ka&o}5s|tTE6qq)Yq#Y9BQyC9a2#wLGRUPbnBQ z(Wb)$vWq}^+wuU^phlrq#QxfU6rD-jpNOqSI{hxT<3w*G4+jjDaKT-|hOvx6@(kgd zpiFwUJ@YpS-tk!JLeBn@u&_7xXE^pN2U-Jsiyy7h=NE(1Kd^Uu<1y~W-f!?o15Gr2 z;gUuM3qwgnQ1EywE$s8)XE8H>E?NCjo2tL+Y(}sbgP{jPL|fGO6g$z~XAC5tNA!-} zgOxp^fiqu_wbENx>>rS{uW36C;7qWsaizHo3K`uyPF3ITV%a;-1hj|FFxe}2I*k;l zAN|mCwFM}*Cjd^x2n9Q9eSJL;Q@|D&m~Ad%4Rj6HIjK~#Ro5i77^5VM*<|k7j*xI{ zWQ;DE-0qVBv@y$D)`wvbHbXDG)coL;XvDd^uhxleo3X|{VwsP+0c~EtYmg>fHTv9| zw=-STgUk)^BD}AZ&@B5XBjP!(zt`(n*BSk zVwUHVn;(OmX2C1iPAFRSae0_&Tl(Wk`3C!w{;s8ax2h)?=~Tfg1XB@D$m(YQ=Qna0 z|7;|)x_$8&cD7VDp$n2~*NZ#0deb~D_xh}Gu2kK0_7C#EGU*}(8Jdg+|3}j`$K~~g z{k*Vju3ENRExVSrY};EctQPlF%geTH+cvgrYq|ISz3=Dk|DJHpxzBZdscEW)TTom3 zDECH2{YoQ|VBE#*SEZmi%X^y5Yd2$2;SIGoh;}{%KyXd@1 zWV`C*&nm&k`S&!6&`5cC2Cy)kD~J^`M?LeP%ng#Eh^81v_U>JtGqtbgm&|a8S}dkV zWrD7dAfSuf|odrdF9bXZ9rXFCBmY za*`8XRF-x6&+2OD{75+Uh`j$SR8uPvI=0mA`g-ShR7Vh^5NEufu zgX|b53hJ>I?p`r(L`z5^`ttPTw&6e#q6$LA7UEmW5v{jL09pZb3Um=*Cq^k){G8ft zNCo%wf2vCILo*Y7^Y$)ngUfhGU`icB>RBG8ANX(>PV>Nm!S-bw1p9U7tdO9<)XP?V z3^V7qskr#BusyZ_5KLuggc$bIrC4Y9K4h2(~Z`k(vZ3q4bAFb2<`>EcNGhQhV1Ayw;OW0Vc0Az8p_K_zJ?^A|o+6 zM)0Zy?tM`Li3%6mCd0mq8P=N}?hToI?RR5>i1xAIw=a~+(7ATmj7_GT@T$E}pzyv2 z3ZUKT9Wk(Ef{Szr%-U6@M+F2cUhebV5AI0cKWZQeba7r-DdraR1|-2ILGdOe`;K?# zj+TBtJs@#-KtIqQuTQ9XhVk&6#lTIt9cga5uSFmanYI|=yXG2iTdEP+x6C|;w+zeR zaec7CGsO)=4htbVSwi)Y^|g{BH_bDB^`v1{M)yAT;hj}!D{s8NSug}8bIpb&Zy&%5 zYj4;++v>*e>sJu+*8|kUU!cFet6ECJ96<=_BO?E7rs4#NM4=?_Cz@0~Yy7W4wPErt zkpne+!Jt+&%Ww@rlbM9o)W?!TP;d?eqkWc~A1VHpmfVB0i~o==8;9{zmQ~(Wp*m7Y zLE`dg+CsQ2^eZUrIS?iyH*mB=k>| zd^eGwew7B@508nW_xez>{5uFV2MzSN7?r@g;^PXm5W z=RN2EM*BK;+!LY2pY{6RIeL2we!Gd6Cm{23J&Lq7_7*Le(WdTN*fweS zv6|K+ACq(D2EI1gyuI_rg{@bM=NLiaT>1nPD;pzU$fVR>IHdoU=5%{_caU%}UI_e@ zajI?Yy^PVSI23rcEY6@$uwoCklpNN6|iAcZs^7*nblKf$hzH1gcsmQ(8JC z(?sbisBI@)F4GYAK=3h$@7kVc(*p-37@%jd7xd0%n0bW=Ru(i}2a)_rWSfGmMNzX4 zpK_&_2t4t9iUtRMf`a2Qg^-=>x23F1$3Dc@Ie$~vkmHA5_p#wt-XB$PZ z2eotizN-3#kX#Cn3aYZjoDa|pASp_lJ$y+~cr&Va3|68xwU_&=J&@KKPY;wp|41Qd z_n}JwSoz#5$G^dwPahTw(;RJpCpEIzT>Cnb!5qCy2A^*aO_i3W7=62|iqA|dH}h$m zbW8!+LIJLOcrs}Gz_a~6utN(B^Aa73`w{E; ztDY>$y50x-@^9HaG5dp)$@L@QwC;cdbJb(=f>Bb4B*BaAbn=GjX=VLtFE6e0})pierfoHh2sjrqJ2xSJShV zf|eez;)19f3EzF{Zz)8Uy|YVS3VWwYX>7XL5Rr4;u+IN74Rj$>bRh8=e_Fut&OhGY zmnkGI-kCxAy$_i+=lI!{@JHjz$9}kU_4DwqAxh(rIu0JuOr8|%ByPzN+9KMti1Bp^ z5^QO%GyJm?u#L@?wFhGmug%h9Mzm`g;mV6^0C zz;7Ajk;1kQ$iK*c9%b4}8_9t?Sl?<6o8C5#Ns4G1V_Bk8T7A!WCLm{rqQAQ=R+40G zZcuu3S-qAkP6=l*i})tB4kwu-M}4G;9)?Ov{(7)JqP(4eh_n>nL*atxS*_n=>&8Vo zO2K+6BpbGoRb-d@mcLmr={i~E*Rnu~Y=Rd=z3msvIQ?E`eu0h+_L8iQiNL^`PX6Qb z0*z?dNZedmCq7cemIcKI`rH`LCk2b*?rEcY!fn2287^YW=tY0UDT|cXoE>Eae6Onh z9AHS)!Ncd8#=LRO|MaP)#?u-~I~%b{93#;N*ZH!mcmE@2{iR&}ho>tgI~6Q;+k`+! zewP}Cw3~IY4Ldh9YxG}g-;;v8sM{+2L0r;O(P&=ia+;9|7#t~zKUC1sIX_tRlwa4r zoeJ`N)NZ(npB~p!Ru%PF_2=lA0{vPQ7~i$UDD%5RAJS{+dCNMJ^7o^U4W z>gU&iJPSx4fQibW*a4jbbxRCH5@X$?XY9rZ%Kqdhc1i#*D*`PjwcGD@%u%l~|G>*^ zm>?4#PRT9(!m&CiW$)#Stj;$Sm9(H-?H@q0bv(BhbB_!E}>W8so2 zVUz-oU41I|r;6r12wbbQ?mx1w(SoAt1?R+8b}?|(3o_^)P`BMtUn3YG@qZM z{A`H)OxEc0=Zy9-i};|Vr_qUe0XKtrPRm*)7xQ!-vWu+Wd zRZ?G z$=HP1QwES*04~5*d^4G-1m=u+h4dyr+UND9jWIG%^Y17LwDX?n!Xa)NrgBE?a_@WkIW1f*)QHTmM^L z`L&5Qcd<~Pv3*4sOWk{qg%=WL))OSJv;^IzwSH{h723zas?s{@o*GeUXVkf*J7{Lt zLv?Rg<3G~guFS#=-PqK`CnSXTcDhtw`L`y#w%ebB_Ya)moY`d`yXe@No4JFUjG*UO z;FqV6Q}Sssgx;z!_UQ$y6OC)hC&k0aGch86U*7zcCZ2o8(`G;0RXZXkOU$;$SLIsm z9_YPM?`gl>)AQq+@uT;d&k>zeJqdt*o1|iymbhs0{{4$sIpsopKz`jwdmlm20F@z} zV!>m>UsYqiqn?vo7PRe$R#iuBeg7v%8-4ca@60t?t@)(vPi;lz61y{n%C5h~1*p$w z_=p?o{(SuNp?U-*x2{(B`P|X>g)WYb#h7_63r)CcZMl-uM}7-YFNU>iOAdOn)tR=` z^om`wL#4}e5$*f`{3;NdRpex;espP1LtpmX8*7QG7L~5Hk_*gVcCA|Q^8PcovMykO zwt@}2?JNfbl-YuJI>73*(QWLWjTD)@gbfYi64|MHke z2^!7A*Eu5uo6<6j+~&AaN5c)Q6slHwHygpqcC<9xJd&N13^ZN`eSLjkOY!pXK+tiB zCvmlfgMQ%o+AYM{Vo&N-2hOWK9U4dIS)ndpQ$j z<%_M>h)B<gy}Dtbdf^W?fC3Sd2izmkN}_8 zA7=i|M8U|eMe)c+lk+9{Z)t1hObjgIj^)49Px%#3;>1j@uG&|=zRgO>(S};2d;aoX zp$c{%%VZt(TQvZ{zkH$P8pZl|@-=7Q>CdFxqF}>8*&7FQ|6d%g_htz!P0A~Xqte^L z@nTp%!wa)QP+&P9OXs{B^&=VUkBC`#RvcQMsm7z{my_fOF(Mgk=eoql3#*>K$Qm9P zsd-q?Wt>eDRkYZGsRLvYQE9~Y^to~j0561WWO^Lbb`p zm(k;Okn<1P&)%2zJwLapovSIP7(I9&YB=Wg(EadMahMUKRbl%j5I)D3>rX|sFF`TW%<1?M? z@p~wvSC^08gQuHXvgsC!JLfDiaREZONoEvzaEQ(@2* zKXykI$GIDhHUh~5oQ_^oa6mhos3gwc-@)ht9CNgrk|A>$(K~k(^T}Mv0s^+#>cOR* z*SX})GjG$6mg)=F-PuVM2LW;q%uis4Y{~@92}|(oy&zoIb3i@hm+$**TRd+D9vUvZ z^G0y5mkhAA`b_PuuZwuSbanaLhJu^P?l;YQYNl^6P+k@$oz}rOUV?3n0G~~% z3v;s+^kAO0K}7g;Mc9FIr2}n>hI()8*d1Kd3&(wdn*rnGZDe?tX~)XK(wljro5(6o z7$3CNq7P@psgNG-7TPtCln)#1*u;p3$?+U*J+8P^S{4TKvUyX+Zf@KSVL%6zSe-SI zNS>(;uy5lY>XD(|yb0{GL>z(%9w*#s`c@)Zp5sI3XvCXdmZ>Z%=#D z$Fwf{jPmhoqY(fwYi({`w&MW{-{~zEC2fcrzwsoey{Q_UU$X@vLg_CXh)V20RMZK1 z*y)eMMaogDqgtTyxBxT+Xp&NPTPcF@GiAQJ_o~xpE7YI3@p=X&ejoPur6jP7{ex9z zbT((zeQ0P5Q6x`PW5HjD}J*D3LA3x4uB9YV>dyoPNplLGcTNS$TnS@ptl$iFu zj@eYH3oMU|suz_6>$WD7#vmIQow~emaawGytaYnO6hpZP|EM|OnuiI$uPJvim#3J| zxYgK6Ru3&$Y9x^DmN>n##37ssA%xACK>7i?SE|oe-`}jEVhX*I2F~38C1T zQ)VMq?7QS|$-ojaJZ}Gj3=x|=E=JxR>zk6ykcWf&3B2l}8O41#eG^~1)d~DJHd0?( zh7@~U-sm=|z@O~w&*!0@$o&4&<1V7-%ufK7;*F<|>&a?%JfqQmVS;m7ftYV|uNstI z7Ua#WY}6O3@OP4?QTYq|-ik~KW6e*vrou=GRBR*E6xNYqyEj zeT%iumJ^;To60+^G7nY?(;CclEST;vrXG7f>MBWou~?U;o@ zN=LHacv5Thl=N(dCsUdi$@VQXFjlzi-NLIQ(sPx@exb^tzDEII7JwhX>(k*LPBmLy z(;YNe_}+4V`f#jVGjSvv8|`U-mCqO8aUtwH-l_3dFIi;*dn2l~Ox<}<0@Cy?Qjlp2 z+{Rmr(|g3Wc$NFxPxm~3($Q&gVZKMusbWXr?kfq8Se@<#q|topWL6^(67Lg>HG;h` z|7Z-pjjFs)+!a&E>CF)kwCR3XDJar0-UJLdNXWbullv-9iCl!QCbO2eIqJqwfWRSo zlNFS&!2ISH&MXG;tL>5B3NEVpm8597o--Hz_^!wDwSFkow(TY&%1}0}nwJTCHw#3x zi=^SMDDpwGOlbYW8b9BZk@7*AGBX7{+2AUebm~6G(a-kaTnn_GT4<++ls}IDKeazUBfJ44=i~q_B!%J zW|DpRjr}7c@!#NneX`rRM-Wi6V2?Ry2{))s^Q69$^u_ntP49E@%GdIaI0wZjP*n;X zX>i`E`B4Q~I<3qOlpn_w&&< zd-G50M>6M=T;Qi+byYY`v~@}Ih!3XE9~FFJGF54*|9s1kPj`e(()aonL&*T8wz;& zsUF9FSb_*jA~L+yo6u(I8)g=!fGXN2wI;07AcMN0fYO;Du#Bm?hH{Ex50nsiL1zs6 zNLR7PybztA-H8e);?d8Y8fUXRooQg>n3CV~yokXAL50Mzd}^P@## zj=KfXS2aAWH*B2Peec+*AVZLKjNp<4Dm_i?rKP2=)W{D{Km-QY8^^2xgOI~xE~@(3 z-1q)6sO7&(Vu-o)8B(vl zdVA|tEPw~gVCMobAnO{JgBfpg;dnNFYJ7FW`FsO?wJ9cK{~a68XyJ#L(Dw|D$Tt=~ zPuNr|?u)(rVGRY2M?ug&bPU>v#qvlf44q<}r)mx`dAQdz^F3c7R zM!9vZV(s`#M)l8EI~kCvj`=efQj{1BBfDX33W8o=|D`^R$=dV&!BM-$^{GQOr?UjssERl>zMb}imXSvQaA`2zmj!_vN>?3O17`oF*kvtb)H^FI?yD-iRo zL)srP&kB9;ux@qnL1w*OWdmspng0T12Jw-mEgz|2WY@yB!vi!57boKkKOIdEh!F)& zZYywh_Z`Z{!ibF+$uZlqP(bXE`RZgkE!^AbYH8lS72}$z-VI?KD_5*N?CJ1Pp2{@& z&6WPDX_#n_#aO%LspU>D`dt=1a2uZZ6B5&kn+4n_gr|p_qp2yCW|RsTq>MN65A&o% zk=p}>(AXnmv@3Q8_HKGww}*~jVi-!;_&TO;qKe;+GYouk4L!Nc4r$isa->9^h134C zITbs1WdCjTHImjSha|wStIB!`Ub6DbqE_KNQW=^))`un8Rw=i}9w)`0+ceA%RZd4g z`7Y25vxQ!^CfehgwppX~gorgvhl3b0YTv4WXZGjknhd(P#ZNbriY1<^9FhR4IwGM?C)JSVqs~J z#kwtOre1*-q0w)RBxWKOiU!6iu)!T1s$ZZrv+n;hGd+G=p$HnHd&Ozd_(6O{f3nnp zNWP0d==w}^d~$jU(#!s=t$7Ab=-a^g1I^y%BfAvL;2}Wi0WI^pcp}gGDp9l7E}?L( zV=9_S5Szu03ARTCs%6AWW_7q++0UdOfz5SGZ4~Bc-vMG`(8e)m@wH@~xg^kWE!VN# z!z&*RoSPS<`o*0@tN+|lCJpuU5Lrw|w$rF?XC_aL{!1?aW>*k)d`}RXEmZ!g0V?0F z3~0T8PPcr)HlzE$9CMID6vCIQ(z=1iM?-)h)~Hn&7wTy}Ezlz19E!S5)xjV6U`)Zf z3HEP11vEILK8NTu2#i6VbCp^N6x8-%tmsu;(OOj$v{cHcftw4fMgsUqzW6=W(b}KZ>o~hFXdKkMv^0jX zFSlz63n4|AaX!X))A!;EQ+ct?_IO~o<^616OthZxTeKW)veH6_h#d{=wiIHZ+z1fl z`}>+A6V1yRXA8zz{AIqT3E_P(r2EbcwL5uJuk|k|f#IpH8w{XZG2syuf~@4k)kc4> zJj%@~$5CD`aulc&7L^^)(HGU-Es@_!>rVcsGA#Jbd zdb%x=LKUo7bxh3tn23R=)D3 zq#Ja2il|*KcBjx-78Vk61Y{Hwp@sqLy84!mDO*-$EkCnTkXs3FuHMsHB`f3noqo7bQ+6^do&gnh zzXP-(%*giM5-}39WOq3EDr1RxI^EwvucGkaR+bX_w2@a_kG=&Y-ah1$co??P;~(wo zllBI{V_I?gIN1+;GLUKKUqPdrNq`KX#K{*Z+ymRw*0+grq3C@u}h zO~>}S8Hp`S1@)Rc^TIae%lctw2t{D(&dv(_>3 zl2GBCXDiSTp=9S_B6t)t9Ww3>9=NkKTl3pa9D)(D<|TS4j;rS8DJwJ83b{0gv$C_f zM=n&AA>18hs~mJFlPjb}N{TqMb~GbNSOl zWB9LHBDlI@7FNH6@tJy&0ijdYa?_}_cF?+HC-cSFxxuMalkuRr%XF-zq2UX#$eVa& zNi9qDJG0m6AW?sEI(UQ*iV3=Nb>K~j_>^F4ASx5rW<)BNxbq&@_4m67%G}op&Y$Q;hE7vuS}Cu)W(4?7r_|m#T>v``s_KkNJb!O`fIWDEC?V2P<^zBkEf@# z@xIofR~x7i3RQ)H$4J~F<-w_bzw7Y#=Q%ZhX`5iG-C0Y`h-FpY2oD=dSC9TDxpTzJM^%Dcz_c$#f zefbM@-VLButiWSY>yoNZ7M%dBVFUiup?SMRc`djW+y0(NhN*5syr zdU+_g{^O^R9s6q+cOt<(PoaC`2I10kY<4fM{v{N>z?PGX{29{&ki#}=xCA;fm=JBr zcJNm3v(4H=ozX3Y*Liy(3PjI+Vrr3WL;W7l51*ktD2qez_o~-4dL+M6X~~xbYm{Id zO^$c+@c&UT;_@^#h=@VUYYghUx=Pi_Yp+3lx~X@q(U>(+SvwF^`$s(`-Bqd6r3KTd zs8hFwY~h+~No%ni9`iKF`*++WG#MR#=UNON*W_TDAP0i%mw(l#<;$}Fp}_JE zZ!CUG+CK6|mAN;;+qpgW9lDPMbiv<1ljD~!d+lpH=WH6veSAP51onvZ3GzW0o%XLt ztO;@HguwuA>xt;$w^2Sx+Yix7wH$|oQs6$ZlG3WQVxj4{RJ_X{9@O}qrYidoz)gML= z>-*Q734LblfXsWI_3w;@? ztF zNJe3pRcHQ_LaA-O_=uAE;>4mc+4Q>7E0_1R?im|ao~FVwC_m!^qQkUf01k|Yi47;G zdMp?E+Zn}xc(7}OK@Mi7og6vBSe{B!{bG9?4mOtF_-|-kS<*)~iLvFBZT-c}nAVH{ zWF#l*MxH8_pdm1}YIJ6s*^E=;+D|O{wQS9^VkL}8UN#D23G3LD8paR^r&X^j%NJ@n{?601^}u|tV*K~(Y*aAM)9t1p$te}?|#xyO6!&;$pGBA*~qoc;G?;T z?FQHk!Cl~E9lR$ZCAKD3aFcpErdzqSLnlQ;#*P2QFPi8%b1?PmbB9W0!@rH5H?;4m zd8UR^#)1)9+gaBX(;ZE}Pqt~$3|3p3Va|$kaQ{}9vG!_(~g;5jyoFCEaFe*VqCfEkE-8 z1e0dTkq5k*R>hQ^P{vMQDt-kG&#zcC7S>qu3PuPj}BWs~6*>ffR z#VgqYggo)Ejw<`Kr%6uZDlcMu7rU(dY>T3j?U~=Zfui{=oO4=0@h7>o05d1124AIV z9~6tKa-tA^V0h3U36?2^fv%X>2<{NAW2%2P8$kpp#RWtfh7-;?A-nr?O4hMR;@;CF zv^|wAoaXe~17wgt22V+8^Ku>&*)(r+k5HM7C_+@GH%WNe!&aI2OF-5J*A{+ai1tZ4 zBAXFU%Vyn;oU#;RQ3)1)`H2Z7cI-+8p3nBJdmoHNCu3!SLe{%!EDi}K z>r@@)_foE$$QcS9apK1Z|WUWSx7l6>#JLHF_*<<{yMpe<#{K7sV=n zR$8lomW5Ha+Z{vTutoKg^?W9rhJ&_$cNMn!<;XrO?;@Cwzd2nu9Cu}_>h9n{-PjA} zW7nNA-=aYY{Q)uB{k6xPRv{=fkG(W+x<`^0WL1|YU`x%Y=u$QhL*Zcxay%Djyq&Xg z2U+$o`-=F~t$64O*JwzjBqW2nybzZP4pl@dVq3+)K}f|EEFsR^Q^QrVxym{oQMZer zcr3;3hT$}(4i}DKk^!nwA*2Zkq251vFqf62o-s<>nt6F)$cok`qJ9Vxioql7Jq>nT zq)9*$!*<3ShWI_*?C|U7wPPS&O@w(rKWLD(t;xNCv6%}ufn69OBOzIof;o)qO}4|2 zajV#Dvk9hFa?vk7H!)UW?kW&@;<{FH*EOf=p};#w6@8P8sNP%Udq@?Tc3zOdeHK5C zkN)j317A#X(ShIH0IC^RQ_dnQ!M2)i*3xzFwsF6wzVI8=@Sik6HoWvk%ch2Qg~Obn z^Rwm7XjK8GHz{OWcwby#L(7;%-X2Wtc| zeKVW>6mrfz?JCAPXL(~{}%sDyeIYzXMAc3GcYz1a7#cz0-U)3$HR$A zTd0>A7=o*O|BzuPU|uF7deH@cPd+TZ-_0q>VE&|x4>Ry})Lg++Ia1007QEhpgcrOO zYHi;r5b@&&X%oJQAp3tUK&|mAHFLIq?6kDQQ}2D#%Ltq(bRc-h*Y8{x?&~ znP0%u*s%96QL=yLKLL4!F)y(Z=q>K0e-Q@mcbhomRFVt$q@@GcT4weoOj6nUQ!4#r z*{oEN*{j1m(I=FUvamXt&dJR_0}oT^tuC4FWEU#1w&xRtD@<|o4XgZA)> z{qglJ#D99V?7cOFAA9DlD-w*uSFK#Lw+%#EQNOGif?2;mWc{5Y85G4S`hfCmTfVZ? zN(tx30k6}#Uvx&DBQ?Y6K7QGe^j7R@yuP-Y+9RG2huAW!2q@UKE6R1AWgKHw=P=u}wNX43jdK!jCd{PftwHRDR~f=rl)sfnTxS&QSexYJm#I zzXypNY76#wR+^7jJMcfb!mD?KaAh56EYVbQeT7z8Os9qxy-j#39?HDC>op7qvOSTe z)~aTbITOl)_K^+6$Mii0s%X;wFt6L{B93hI^Z(|c`8R;P9nqA6Xf`ejtej8iD6v|? z#|-9To3#<`i@$WrOM1;z*m4Bo4;zX_5ea+KexD)Q(_$Iuam^DCKst6}9)h*e78fDZmb`)c(d6hx%umo*i>^!rR_uJ?$4`L-mxL?N_L})+cVF0m;F8j}d zKWH@=~EHXULZX2=KNY^aEp4 z7Tzu(2PnU!|29lDw=O~u5Mm(vu4UMUZ97>kh;?7%)5nj9;-$DAWW>Lvv9sMwi(Nlo zWzV?{#dTrESH5L;E%1n&;5D6@K8k!b$28$k@+)6M_v!ea7=F!0#+1vv)n7P5OSx|D z>n#lFbNEg;#L^)3k@)-bUIoWyK9ohevE3@2`tU4(xKLB&EwG*FZ!Lr78kC3_(Tiy# zgKNWX&d;5EeA1@DqH;GN{6gWGnqh?JVBuIJn(2foYmEp`AF&o{J}2U|ioa2xG-t!z zq9C0o!1(}q5&VbIaPCTz5++&CgXF&pffGzcds{IbqDt>NKp2z>pxC=PgI(W(KKN$a;pVmZNJjs!S3g#uCaTRk)~B9#w$qLYV>v)4&3 z_+d{kk7sQ3Jk39U*-Vv zS~0!X3)+_yJa=KKDuHt|CnZHiP(%uTh|jTGbnEdd)SzK1DXcVss|yfeX_jb6IMYmH zN!<GD5f*-o8M&erstKj}bI z-G8gs%C`Q;v~hB)m|vc0gWQ-mDQ7_|`UE#KkeB|$Q-{uRNc}IQdhdF3_S#y-k-vC{ zXrl@ZP8^=2&)Uii&*Zw<2h$NGX2Hu#o!&|{$=MgqSfp3=Kt zX-v=xb8DdQy%Ktv1_tn`RN<9jHU!+V`7PU2p_<_AQj?TAKyJ!Dgp5z5(1PU`1l`= zK0C7iqQ#IgROdW(^ysvB-(=;mSee6;1?#en*c*#!b$PCL79@MV{uCBsG}zA?TDK2< zLX)nM$QiGQg+GQI8*6D+V9#94he{leZ!}28U4(?SRpu#y6mytTM=wr)XPf<|FiIzg zfBkw@Yc#i~K+kfVaS$k4E{V4>ztB2`tEbr>Qk zO%?R^H5*|d^4d86`mYd$89#Y~7;%g4!gq|R-lCyt)|gh9ohxYzS0wt+G?WdW6?m%{ zT%pA+4A2~ot;DRgn`XJbPe_$%mZ(Zci|={4GCBMCb!`0^XA=K_Uq;{f(;3L%-khbp zv0!J<6uOB?j^IzvMK!s@h;*bS?XjWQ3euLSdkL{oe|dTSCOxcY99{Y0{VQ;KkH9Aj z)e>JS7+YEnyrFFg)x2w8#U63wzyDwItU~@AF>Ts5xhp}tYeG#@e!KSsdqZQr8pVs} znd^spJApZSro$>8hn00zL&F}+`|(5Q6#u(>0vs6)c}NMSy!`( zR<>6Q{C>c&8!LZs6$WBM{@_+~Ru@~9rt`Ez!zXSm zScmP3O>ziHUE*McwhvQc7(D)|X@(UGv zY01tmW&V@VdL#6dhz9_RZ_?}uCV7` zi1`;TIpTK4%WkCQ@uJIUU4SSN7%StOJPtD~e>S@hflacBl!y32<@J=t4YRX_-{cFdg zuK61?ECof6GQ=Fy1}v`6Tkl@A$}~ZY$_hw0?af3TsQHc4H_)~!VN zkA8^R6`aNyE12W=A@LM$L7WtHYXtp!J4J;$C5O|I7&HgLx+0HSJ&Pj12e+BOO?I{7rHatqU)5z&C;l^fea& zKNhKstwKYp)NZM?JQ(#6UP)pmcsBw&uQ6I&Hs|7HlJbKfIro5?k~v+a;LRcqlTBm= zjCWcU7MMB8u*`{HVVb@xOk@=X*q}g>Q`J&U=QkA|TlPS62=L}C*(7Y;(Thb}lrM_6 zBn$i+v$)#%)$yP1sbW@9o7g^tf0@3oheGJUclAQkiXE5a=j`AZQsRf=lz<>4yU*tg z`=?7`o$s(4J5{|~5_RThuXM&TSXB$OXN|>Btk+U8Aez`4*#Yi2oY)D8?@m?NzZl^2 z=Qr9Kyh1vY9?o0Wd5_s&L!y*bj4!8;2i%yxV@5V`iN6KRjQoN8>iBcD7*v+_2Y5Z- zUSPO$-GL9*NyVQtzi|z?S`0i8U+#?wQE<8#Ua`h62~#l*hqt)K=9Hec59#rs(yCP;DOK%_+7kZ9}FY3lghAicn4@CU|OrrZS<)oXG`33S~(3?r{EE z?DYkIB`CKu!D}d?UDJzTYkmFuA_Jm^@-7O3!=}B3M2>+1gVw%|&(hKf#O&xMS=vFg zQKyWBg@uVeNT6HxI66!oJr_Eh%z}okUX@9dS><6l-p0f@0KUlK;a!5nrrbXdrE3zC z7Q0ROZmW@C2sWjrnrW~_0!e-{BVHx$Y{EFw35JYTFA*GTZl61nNH{W;syuGy-7K#2 z)+XYVU5RDl@q5DV>;Hsl*DfJ%pEY}naevpPI%l<^8d(g2^pc!;{%F!&*BvoQc;{^j zn(pk_PLGzzEu4V&LL8WDE8CEz?jK?k?8eogd*g|Zk27Ujm%Qz+L#6(&mxkleCvJ_x z%AaDT4yepTp(kSDJa3>kau{{F+<69u*qjMxym2L?qb;dzA>r9Fk`TG1@|GA0## z44UIc8grjH430nIoSdCO4ozN$aNUUL_icS6LO1XmPMMV1{et1hqBGbvyoEBp4GIsy zVhSc;gx7b`a2dXIjlK&gPsOWY)AU5YtakOalSzR|91*>LxUqd#B7;F!=$++~baFCu zV^F5~-#oRZmQbOZeOb91=dbV;9a5{m+UdiF@wc1~=@ zY@0LCi7mU9WXX~iqWB|1yPr&4=wi8IA7BwL?SmQr{}h5^E|ESU@u(6Jub>GUW?0|w z6zjIVfI92H$eFGrq844v^`ETZ#V?|`r0``6Banq4?A1Tc_6-lTsG4SMSdr)9c-tS4 z5b2PsU9rGYP(9-A;c;vDdSeLqw34(R$L^O{8#t3N!H>v*RhaO5QM>Md*Gc-kC%L6Ln6#tGW+)t%fF=? z$~`)0j``a)kYh+K6_D=6?+a|CV(?SdWelya1Xl3`8>-)3Q_c0J`M$n91EEC6%MELm zjm?aQWHcT_fbdLi{x4oZxU?BQ*D;gE^$<#tKf0XH*PK8L z{@Lpkyi1?0M^79WbUD)iMp~Hv?pnikZ%lcsQ>yV$*C7#FII>`CyeWO?;y$hJ9~8-A z$jr~dtGV>g`SJWiXA+8dt@P?_DB+?%i5b~sV$t?8oA~)?QOZ-;%yM+E6$&lJiWXCr zNj}3Xxx~&gDZu^;y;rB%*`nh}Z}nrVJ3(~CvimUS?GtCx?XlAOad`M9j* zDEt~m&=whRSLfRl?vEnZu1{t!XX%0EHxYvRI}(CvS=X2CaAEVf2lIs!_gQkcGwooe zu#SMYSrsnUee=MAE6eL*qg0u2TXfnr2&q*_@SgMe4MqKU!nHSh!qyd6vV1LQ@cL^F z79_K*$M7(vdA8}~JDe7(I=CIb;~KpoEyp0e1Ti&J5g(MIiQ=e+_bQBQF~L*Z3g<}6xRZd9=gF{g|H?+)c0!%M7d z2^~_JIm~B|X-rdIATw`;$LLVmoR3aS4mOX;nw1>qXv6kn@i=c@O}eHjKONV*L1e8l zKP0tfd{>CzBHZdz@d|DC9sdK+%MI?skVWL=f7mfsdDS^XakT4}M!N=)yS>Ilre#EV z8n*CAhMV!FIGv?tA9e=KDBj?9E=qk0Q@NIMc*m@+K1*bfNG9seGN+y&zr$E>cj~&- z8eubISIvq=S5l!wr1crjEQUPVvx?D?7VAT=Z23u{vc0{9WbIvN^o#gs3NpriFq@27 z%zPFn#&qnR#>HAJnu+Qx!7td_=w*;6Vkx!2o@%?N*JTooZ(3?-~v;Sq=hNf50fA7C@tj@h9}M2m_-~JOP~Z(kI&9@ zox?tiQh6O|5n+YtN7>jTwMP9deLpO=64GP+Tmxebi(>K42MH=6G712`T20XT3hhBG z@WEADhvaXuLX*QV+f*~(j5hQxq9JFJb1ip&DRTJ77TSmCYs@h64Z{AqV$GIqV};4K zq&C}|;1M4fqx)zcw}EVKZzd;$W8w1Gr?|qOyf_1Qvv8jq-?X?dTdP}@7Tu;RBdkLc zQV(&)fBtvdx5sYwz_&h=2cPxxlLHU&wfQsl2_GJGMn&bSH^)&($-yWS1Cwt6ALV?M z5c*3IQUn?nqmAtU(Dap2L3LfXfOI#ANJ)2hcXy|Bhcrlch|=BN-5{-Ww{*7;-Ep_? zH|}qTdN}N}_F8kz$U;)>f+WY!pMxrVpGzh38f+|CoO#@%o<{4n4Y}-6&{;}0;1ikT zNZa}K&Y?+nItP?AustMM4B{9FG~V`O_lRHdkgA0F6XQ@!rfhK3rHmIKMX-v~u^@I# zN6{}d+{fD5E-UN=&k?Uo7lBZ{cmnS_CfyH#OTpm}bGcB-Fus2G+o`QH)5EZW z9fo_3r}5tCH^Tlv%bAg8_ZeV-3Gqo7|CiQ3hWyVEpxcPV2el-VHluurM&qtirliNZ zvGJ36&^l?MKlG(}DFPTu?#0y8{1a;nt6yGTCe9R~buT?tJNU8m953u*3PY z^Shpf_d)bG;+`N=_dzH-LiyBxMcPV%^KeFwyYfv#*R2(Ug4(0^9-=3R1l$c&K z-PXr$<*Q@eV6BRq$3LJ9lo{;}(>1Jo?l-&=iVYf6vcD;IfszbNhHX9Myg7bwr(S4f zg3{D#2sn>Ef*Y=U5QEH4^4I3*W zodxR{fXIMRou?A3GMwBAwyJb^S3h8aACFa_?55bko_Q=G!5@D215UFM4qJLneobHF zozt(1opEJho8);xNyeDD3nmwbn09>Qq;AX@Er5sTNcbo8DIE1nu5rRmX7;tWKup*d|* zj*Teu^9Xg>0mQ?X`=lrnU*|D|&JUb&@qTnSrT}Gn1(b|E&xn5i`&_hI=+$3`9~s>t zpaS6c2vviFiWe_0Fm;;GtRNXq`vJ1g87gIt}-iuq#@RRv-fW$6Vzi%6%HwAyHp*2**< z+>^3l#B!elWaX#f#_B4w;c22DqK5VipV8_cdUEWtNy9=SHtmK0T=@f#GiA}x*4}Qz zA^MZ6K&N&smG=9aL80bd^MS6x_OpERVdl@TBV-e4S zac6T%Q?F&$zruej>$vnaw`xXg0%wU4homka{}()Swv*2+`H;EuFH)9w`M|U(qHjve zd@5I31)spqg6wWfUqH>sOT0(=X}JnxkcXSQ)}14tqb;zVU;HYxY%N*Giiw1~toGci zQ&vfl1Ht^nm)QA_W^(-KGVBEKmpxm?Vco+j^dkUjZM0r4pFd4xg2g-5aAdV z(oQKMSik>0wG~l`9>?fCs$KqkUt((D#O`Gh9Letk^_ zXafD7_eZ2UJeJ1%9|*6$i@SIM*13RyxsnWFvygy5l5Pl!T{>)VD;xPaj+Zh<^=k2V z*M1*(ePx^SFBgwGY6odM)*qWW_`e!20&bWhCGu;|h*)`_306`0>Qu+C zhNPwVA|x-d5ga*LO0@@9XZ0c{yW#!gM3>($*$!56Xt^9trjnm=aR2^Qx~aK@niz&i zvTTuG_qkjg@z?v-we?9GrY1eC>`{h^-ezH*zLafcq9yuLJ@lu|08A4mEVSf*K20*I zo-Kk0!Y)Cy0bUDbTkgHBD{rP9Lcv964n|*13}3mZC*7drxfD9)*{$Wv(iyMLOj+mt zo`x&HAQMw_#Wh*Tmhfz7rZ9Y@llS0%p%cq_sXfl%G6?8Rq?^o9P(EPkG5fJt`=~a_ z7T%z-3oD6;CwpKY{Cv~N`x@nvg>_}cHOsQ}Bx7s(@LzMdG2 zXQ?yeC#FoLQ=I-W$5C`B61}B}mC%LHH4;~&E_0l;2S%z2fB{i3ciW`p|LPUuR}gs= zK8)ak3F#+72&o`b6L$(O%>^xB6SbX}?4FhJ^!m~SD1 z5kIpnU~ly?9%U|iZ`KreVh)%~sr`v3YUugwioL0$ zFm(BU2+v+~*&+$m^lWw`4&=Q7cn$YTCR}V`!Xk-?!$X9dR5^wPn%+WLd#d+!8}uvB z(!afbCMTxfvA(p|i5zshjtK}6ONg2Rs~Pb3eX9ahldOzPK3T00&WNR=#jtfo zTVuuQP^qbsqG~C79S`$p?&%oc3XP(uRPZW^(!j-eyACplGRXUi`Xl^*F2MY$nwRtG z?Fx`c46_bVMTfQUM?vKJM6B4cZZT=M<$lJWs5+Lptnla8tS22`9+$f`oIk1^x<&|g z$4zZ6%dKsH1CS;!KR-VoAHZH;0AlHTt*VS%H5$UKCNS!tS*0hwpWAQ=*kE8|2C~u} z+ou?4*gGPPi-q;-q(_*?d8E?J>C=Bfa7cf^%{YJS zV1U!@EQ-DlCtC#W@w*qG{)~gDn7AomxGSQBH|hg?#Gap@@9(+&-zAt59WX=bL86&% znm`F87W{FD;xU0>1I1Tg;qJ!?+mGo(AKFIh1YOm|{}J1gBKhzGUCiL8pOYm{ndIO| zV?@)iLTFX`j3`Kf(EywY!QU$)Q9xR!$9kE7tibb>^F1A}I(}B08iUdy zI*n{QU`|lMMV^cmj zOUoRxtOW&0qy7X)OSR#}YOvJgdmh_ zZGgi1DNL4&mFGWI$zPo36k>6AFr5+LhZ&w!i)-MqT`=9+n*9WN(>mYj6qbS;!SNyn9% zbq5XvJe*@QNcl;t(l6MwITS@%P+GOsyvFc)Mk<;B2u z!*Cd}5@o44>qHJ_x|LRU+Mo3Ow=W%lE~SCh7>~*XG1Ai9t}RRyg43$@vdXwApcss? zGJO8>j(gRCJIAhK|KYY|L}J#^4(E7%U$S)n5nga4NGad6Qd(ezO&bUG{kLms(#KLA1m70ZY3lV*0>7 zB@e^1TN^g7Hxjab0r}OG87g-f_5^XYg-S%OhmC z@vSmx;zra7Bs}&BNmELF>pt<9Vzh#|P{x9jA*U2aa8}+zM49ic0F`-X@JB7J{EuRt z9L802vNRRvc=#d}&aseoLoX=upq+@n-alXOFHGkzjgLpe3d zq_`GTQ>jfEtMhxf{gBaPcpeV?p6)jMTdtdsDf{a8$NSnmze>B=^16s8^`h0$oP|;? zTQJxqVDnGfqX*Q|d3kw78Uv!JodFX51AgvukxUd}o^&Q`Gaz1pk1$CN0h<0F(W^WY z?4kOy&eCL*?fDY;!5|MzGMOF^&d~Mb>3CtauD6gQZ6-$3%@7k1YhJ=N*bU|)m&ueT zCQteM1&9}LPOePeq90>a^_)dGSRl!(t=$_$tiLs7g;Lg|kLestri@dkSWnlcIVU_? zyI<7qtKpZdOhK2hka4(i8wKVGzU<1-Qk}A?Bx-J{2?z)PF4d-zh>t_tRZS~hIH_AA zpP5`L^zz-YibLajh}@TrV!d>qfjgmsjloykRp_u zpb|I`7~3wb5^Ci`U&=!?PH~>yL=hU}aHD-KOGH+mLG&RfQraJ?gJDTHja7$-ilcST3N&V7Ih5`pN{klgs9%=GNPBb@&nl}X}>b`FAK~G$^#|nHjY5i`d;7OSPM^qo*h1sb~rP~hG$`=|n ztC91YTJ?yEF9{~lUuud_^E?tpa0%*jLna^dDF56vU3WrXw>Nj63 z*8c$J+fH})+w0RjvA+%r(oaAb_60(~=IS5m=P#KF+`PQoUaEM^-JkPXc~fZoKK1=E z(RJv_Omu$57qY1{JpajSJ3}5?@T=zw?CRe3ZMPY7`X8Nv^&zSc2x7@}DB1Qa<+|S7 zlJ<<#=|lk)#)q2sM78ZdD&8l-LJ&$H9CBr6r}o1Im+XFMgV)DBO^jL;PtDUbC2^5{hZ}7U<>lyNZRV;v+>iz#qv- z@sPziiW;^(w%-s#sf9`Ed>hRwP4fE&lNz}jw!#SAv#l{YlU-1p13S`BquF*=%AWFQ zy*8Ind~32-u2I^xg)5YY^wrVho|C6JJT)u0bB`x^ij=)8Y^?nSDYTnSvYTY7Q2Z+M z>cZ*5f4dPOd;ziM0=jFUV60OS7X>fVOqpZnR5E-)yfFuBZ3P*nk5Z7%F~#yKGEmz| zbIIWqFFUqnKhMP(*b)#gFK3&J;1GRRe2jo$nJ&wMmS}W)$DI zl{zGS0txRi;@DFJk)yX=OtH-E9h*}#n;RnK%X>S&v`EzqE8%>rMi`jDz{}hrQ)EjT zrWSs?_|bjiJ)UuAUP}g_4CfxON5BPx`uA3U`x!BD%~mb=oJJ?o2a3Cn>xsq4@dll4 zgg1>V& zPBeX1RG{d2d?nd8(_4z6V&IbIl45T>I)%A+_@mpwG)M7)^XK+bw`5IAnpuYuKfPz~ za{5eS0q~-;I?#3vP(JsSprJX(S9(A7#zfRcSPfoXJq@ z%5&;e@6*c@D3r`{in&vL!D4R--_0}sa2o)JqzIjK&$%`zX<3NKxQQ5T>9$+T=Ry+P z)lcR&!_g5Pscx*YNflCY)?%&ycJG5(+bvkd<=WV`j@g>m)ftxUvfWLpx)&QmHmiNat^(P!MV za$P=oHp;($p?Ip$|H;3;emx;na=}B||9tMlEKGjr{J}23i@Fhi|MpfBK1{Rl(Nh^e zRW%Aah#M$s`cOer1&8p%sPBjm4W@ZlE32 zthr$|d+6kd`uFSXJ2rb{_5)0#Os-pP=wEhs%x?aQrbX#SoEU;kq|q;^M;elnLTA99{G()J4LU*oPa zZ$)7o9)8#2UqCF%<2#vdW*uO0g!w@=^jz%?jo0&;QyDc!UmM>?{_aQ~% z9qA-WV_yYh{^VrN*>zCAWwAUS3cRoOBJkX9aSnxX;wVeF4oWNOoEzI3nl-rY%$?dT zpZY^j$?RSI_Ar7T9aw&TKm)xm@k0LG^!nkj1_u}3+D+ZDFKfy7Pu_MXS%zZyCBBua zLrf^e&;2%D*lmoc>637{;^HLjyPPFWH$*f~9d4FKd5oCM&;)LDC}Ypf{O|BEVp663n$V&C z?!(gk7W>V62ONI=TtOGlRAD|Gyx`a))3k)Om+pUx7)wf4T*?h}6DN&m?1?(Lmt zc)Z(P#(ehjL99muU#%gBEMPB0wgtofU=SELzjnXfy@A#Y7%?~NR{6cX+yNGi*AYsm z0jS2iKko%0_06~vhk_ZQuJx;%qj^81F475(CS|f^L3-1g*z6EWiJwxv$@@y_k3z)j zFqMSi(t2|b8aVCvG#O-**moDvnl7Fpt|-;M*C75<6@AG@-NO6;?CFiY;i@fj@(lcv z(~~#q4KM?FH08EWKl{dSN9LFDdRO@M8D8NbAra<(UWq2g_0Z%+KXL!o4tI5*7Z`%D1q<1>?!{Hz?&Bj)${ezWBkG@mu|Y zXRsWE?`-^`JWYrl?0OjfdiBt7|U*iDtXbiO#X9BO*G1( z@MBzXBW!oF6XjjQTbT0FEv^M!!5CFxF3mX)7V$dL9Jc4k}r?uDj1Q-YjV&tN4E1CA&E*ple0nxaqa`%q2nDT=yY51y)}x5|qy) z&nph?|LJ3($P@?)2_fM|e^d$)gOLb)h@5%;{jR(8oeXj>Q}?sz?=x;7PiXs1g$Dgu zGzu)kP>KvT`<*_a2#VYxqX6__?AyUZzu+{$Oi!^mmU2_Mb+xG#jt_*eGQ9$2;$(@D zNvz2J8!^$#v>ZVP4eLW5SpY6x(v$jFqtyEmPo{xe^05CRG5TdH1xThNClADK9 z%35eP&&kZOby`B4A}%c;kRL}qkJ;DwWtB9@4tMtp?R-!YH+fkJmhAU3o)YSU;5zG@ zXF4Nx@?aKx;vRRcd#)z@$w^g#^RP3*CwBmsSMR3lm7A3)(9nv06HH11vhaPMnQIlN z3)#lh-XylE4XH(x81!=n#g>?8%s&I!hPCMGKd;d?vR+%L=^Q`d3bEG8Wj zjcg^f;qgT6cFtoQ#Ezho0w$?ugXDvb+om`04<|bxKbTw#b7^BK2fX0X5I7~^Wz38F zX329bMlA|A_z6skp3AE;@RoJ0r^{u*86H>iHfeaq=-|y8KBe7O<}AW`SB1CaWO(wI zxQx!>`o-MqrmmxRVIM3Vfh*%9a?0|!{YacfcLk=o>?Ou%zzJ`IDiL%sgIWVuy9rOF zjc0;cSfhMPfUi9dw(lpa!{hZH(fMTv9wrGHn@c>zEzTPZhGPa8n}IH^{=!It2n;K- z57*#RY?YGCHpBhP7ycVd2chmusy=%3bd_!`%|Ip+#(s!~jtiaY+m=6>5DqED?6K(S z5s*}d_qC^6Z1rzGdsJ$w2M|)?Fva-<)r#2Ly(O*9mBnlo2Of>sw(O z#aSW2rf9Wq>}Dp zQg`t8KPZL(r-tER_BJih27&mHhD5S}Y`yeiLxL8X&ijyBrPIJwp97b1Dk5}hjDlTD zm^7;yHh|UsBTL!!jt5}`O^EihjoW;uL;Pgm+pw&?QhNUS@&t$`cb}87Uaqebv6oI8 zpFuqUYY(@t5V02Q_Q_N;Ga+rSk%cI=<8koUn4dL!|c5zXo zWID51X|gHPp+g-oFGN&>?Ve=2UtWBhT7>Gwft%w?T4E_c&TLgO+3x3$$G2N(A3OGc zoqRj$FR_!AK>)bvZ*M=pfAYC)#&EP<4!RWyZUF&?^|fB^f`ay4CVYX#jT%f4LLSo!R5(FQ`Go zmUZ_uRkiGhn_BfGC@4`B12pr&Aq^g#Gk|^*GM+})>0E^kZ8%|cqs0<{@B6b~A-i-u zUTFm#4$1q5>HNa=%^b{d+5V)B4I#?yN{!6YJy5@&ZCcSA3gsSsHJ z+7Vh!4@?f@XlM(sTqOo;UcbAa#%m!NvCUF9y3!uHTGUm*r`6(VPOITR)xfTtKtob+ zS-57#3=dgURtU+sIXzZNehb6@83*+<@GItRzxA-#d@3O zPY1jEI@#|y2K2+VyfT=hhZ!mB16-aC#HZ)7S2*7KsUl|y>mXhRYS$F$Q43!i;DDVw zVCtYl?W;PWe-z%~Vq;@S(lIA+((|-BQ{~b2Mn#lrtFcHCQSPSmcPQ%@1B==n_OO(wS^ZUI2odL>8^4m{oXA*B!yh;j&zk%%EsMbCw7P<=_ZjvwemB@ zX?{R)5#;CZk!%|_cMS{VO$!Y*NvnDFdEd8DD)fb;!g%N*1YTRjKwn>5`_fIkQdc)c zAcdT9swinGnJFwz){LwtYxZyRt4t*tI5fOf^#kho{K31L(!n4y;pU3O6 zjsQKP{_J^ftychf&)7H@)bX~%JwxFH&SCm0F4GqWuHa%hE!Y!X>FYCCjbpS}?+QZB zHJ-8$0z$^J(?V$wO*918r)}q2P=Z$sg5Dn=uloQcee~?V<#zUkHEnP zegy%kDuS128yWyc4OieAOdt1ngBtcNHleun22;znVK2dkC*C5pIgvBaj;TOLMXAVo z$IfdkVS}H7bEh}#&G=m=5iDDGsS^Yhq1>I3`AcE?{)%|6Lx~s%ahG;B2@KEvuu{Pt zy4?HZONwj#tH(kiJZVpiZ*RM#n1z`;gp zeyE>jirm3*E!A5Q-BQ~ExGbQt?UyVPA^D$C$H6_S5!j-~*!sOEn z9uC#j*H-yU&Mj7%Lm>_Bv?uY|6ec6~)s+>ngzE;0jkjkRtHwEaBTms18*6J-izk4u z<^OmMh+t6^^KH;JkPg#^iBL0up-y!R#4)SEK0tai+7!$Lj57FhPVM^W;Nip74oE0` zpg`)9@FV|jt)`ucmo)p?b&R>@aK+xnZ$)TvXPht=K7xDD>1=+HuZq?@=HEl+H>P<; zyH9=>X_oopQDbF+=qIA?>bgt8BKosCfo4TggNH$i;|5tML~U1;Sr^X(R4Zt69m*s@ zWQ_}q?wWDjd#;cWGdTXkbxK*a2o~{2FjoS#CKd&W6Nk3fFM9AyYJHP4!edKR|PcE6^<~&5@7iO#3U)~3x0aF z98KIpp-fGv*rdlce{=ly;5VZV(tz=R>dpD;U`%R2#6se*b%dIq^aCrci*S^0cCJR&bXiuc&pwN`Gj z``16Zfs?7=Jqw<=HJdXp$NKKo=dk=lpDtNAB-H>8l~e-O!tuW7dG!df(vjDazr~0K z-#YHoc(a@&>m~LU{f^DtZ*<4AnTj{AxDdyydF!S!9UbiF{hFEKRIA^}qcvpP576UG z1)pvAx)~(9@rkZy>wl{@STKrS{bx^pS6JO=z<3{Rm#6!(c;=pmYC82m9+;Ny>TVJ- z=a5wh-Ey;OSKTS_a>ncblyJ^@z(>(QGEJDipcVsT(kPCy>ZN5tNUkm92seRPSo|+L zoM$6bt4_$KaNHct0H_c=gqynzEfBatV2xyB(Y}eaGPd%WS^qw>QE~ zic9k@)A$FWO&pVN*=;d7DbSC$hGrp&cgO6dHLYnQddjnY8BWyj~xH*IEubV_`Pg8#WRohh~y>>f^xDWdXhqGqY5$%@I=2_%9 zcy6bB3nYa`=MuO1Z_BMbysp1uNYsrPSut8Tev_NHhGY)I4k(mPl&IO~j_}%1G}qGb zI@`pHZ2o`-40Xp!*B64}?uPx&lA<@fAK3~K?@-V;n zR6!UR*V`m`UE{Wl@mj;aJil+ya0&e-d}W`nwOL8QQUf89A!?7;qrMeWXY=Hqx99EK zrJcjWssBfhRA!D@BRFoRbmhhIosqc#OIO*&J?@OO!oe{jQvK<5YKvKk*IqyyPq``K zOv{Qm(*o?bBQ52R)ty*g^n%o14#15;KspWEAdEmqoC&FE4(ZFCf^!Y*Xx^^;Uw??- z11>_mhM0>-TI6#!2;nx0bx%A7n@uno1njB@6xyP14p3Hv*mnN$BlW^-O1z-u@ukh@ zHm;@*F@m|X=Pa>zih!5}KF09s;U5l(j}s?r{9R>e1Ox?}i%=ZxKQvYHcDEhjtcerhX1>QWB=)bmJ~2(5Nosu?07|skhhMrk$okk;{;tqR5+sNOD(j3h`L=hEoom%YA+5zeMANf}7}QjL7_Q;eueGPf7k;a^dOzQbxlVrB;Jc*kL{ zp6u#SI$oN6RpIWfr|9aNM?L`y3LyN+6qNa7Y~Xc0m4Rt0gLi@WcX@U;VF1-A+e5s+ zoT}Oi0Zj#~Fl4bF&)YO(jM_ywyufaq^?Q*q$w*s!Mn(oW5ulUc-i7S}!LNcBR6CB^ z2k;-qb`=@j(KZZP@BOQys8l8zophYI+01Wie4Z50+k=BAWL{)miK?ehF< z!lcWVQ9y^ApT7~6S3qEopAXZl^2jG&9iCnjLQaLPigh?<%hGWci@6t9nfKJPAv=`o zcz_&aT2VISNVF{%#bitr4&^81{Fxvs_ETguwCnKH){5yWJ-75z3_w`yBRblh%-!SA zl_yrp;(5_clYn~7kw+W@gfqeF(9mVH;-x>%}4F2k0t*Jkdr1?a|KN)d<&O>Q4K{hT3X&=zuBOPuMuuc5qU=w+(kh+LzYkuA782K3NVs9l;!9{=a8U6bl~AqB}dFU zMxzUHOy$%dZ(Te`qgb|9r7NdX z#dfB6JUS{DSN6Xh_F5UZch~X{kZ`z+#o}nex+|)uI8OcdF+a0#Ut|DBEHo6o#ql|c zD&;*^w#54|OR6~G@y6Nwt?h$TsIx*s72+uQW-dRAqJSo9%6r z-#7dEGtZK9JcTzl3tHLua-n2W@QbVdXbj4F#kc5m?P9mYZ})=$hogGcGtRf0v@emt zFwYas(sLk})1AE5fE|C&`bV|m+7Jh1446-Kxc3}XPFEl(TAEg)Q0gQojk&zB}@z`3d{1yi_+htJQP=1S0Z}rRpNi;L*nGFsj1l-x3oLss?FYY z{lHIiEWuKIN)M6UPZQl{nW67K4fEH@+(1iDG6cO&1jBnFO+17wc7=4m{dxe!4p?s^ z-P4CdOA@=g&ocf|DFpCfQ1-wBNM!GD$o+-h9219`9Y{M8YX|%0YK~-agRA*+@J9j7 zEXw6&j#I?2b422qbl9~h2V0t?$nf)$3wM+f#&q#wSVZFDhNX zwzfzQmQ&vCf8?twF^LRymWBoz8d`FrgqLzGp|3Me_jyeIo+~y(i114g4VCC7u$UN< zpAOGdNqzz<29V?dSD^6Y%*mdD%5Nu^#6!mBCc2eNnA{_&I;62DlQuly}pS=e)vB-rhD$vh418pHHaD#Nk;sG;zBeAp_He*S^X9en-1|^D74| z1aF7!zJe9=tQ@(PmM%iA=xJZEB{p~9t@LB@h3l&|DJv_QIj%57NzO-K7ox1-s_?R( zB{Z4q*mh=kP^|h%tNSv(@pwX}j(wi~{y!4Ve4|PmX*9gUQFpE$r3RtV7XxSM6W?=G zi5naP=bVm8bUfTb3{C_A2lJX9qP+Ykov6(8i&_g+d6jQi=M;|0_1wTV(H@Wp8+5Cd11K zet22#$20aUSP{B9t{FJYI53<2jI#Rc9BD=oTgyeHEiwW&D_s=EfQ3h;V!#IFMG1!h zW8HEx;J+#@g#HjUo`7J|G<{{H&+(xrC0jwp`9;;ZT6c#w+b-olep6H=w4`gn?6{-J z4|AZzX=F2NIq1)&z;0g^f|rjP-L#3#VetX@JB`Ne_Kj$7`Inkvlls-+6U|iad@c@L zHD}7!zJ4FrSDwRgiZZ>j9jSIAqQYixPdxmmacXjmFkF%_ny}8CI}@g0>}`zS^6-DM z0R8e)o2ExVY)bj;eDB<0?&O3rf6$I_(ovc+snyBBywqJe*O%-#Dtd2Sk0U=|6EbSs zG?gyiJH^8DsbmEjSG{6h*83Dpd)#`(-@GcFbX7os+-4zKaixw~3RGbK+1j*j&UbXgo$PB)R3K+`QCPb*LKZouAo^7$FGY^xWSN7qE$3Q)f2z>2P=$L8cS5#Daodpd)Q> zcQzGE6V$~yyu)GQu_aVELD}8$Y;zqlXbg2#fD_W2S+VOWP5;nn<#yMSjwcb=8!K2% z>45ayGD*Ny9`NXeyngKT^+hwG)3SZ&4L?jG7gKIF`=pel(e>@F`^^``JRi-LLv>4X`uLnG_Zp|X=53qrgV6TlSWE)E`aeaY51*~?1=Zk|5RZxep zO#2=aWJ-;cFttO`;Z?pf$jx1H@R&yn=U`5wDTd)1uY#8KO6V0V!WbA18;`t2xDzEu ztU^o$xJJgTZ6vWhv8+96De?#Oq)HY~Za_a&7$>XXJnK+V39h$z$WdsfoHdzHKqvE{ zgm}wE8agS5;Vc5Z@%cabX$)Gxl;}S&0CbY93s>q$Q0X6WzJM38H;R`-M~x;&C>62l zhBcu!SiNoAj7X^$Kk!f&bDkC(6y*XF1~4!%@R!&?zkKQ1ul{>hFvwWrf(MyWpipm} zM`kh*LyE(!v=y+}=`n6O8SPAf>|x(Mf90M|ggH5joP?6@ls0<%jbz;Q+sa%}`BAqv z35OvCJO1xT?uzrfM}AF_7c)RW(3DTVvOeY*FH> zhw8gsxM$|f+|)D;f#5BetuNo1_V=4R+K5Hx2YbL>37|I+);CwefoKc{pmw%db8Khd zCD;)lj{xqvpHHwj94t9gnl}Jqu-f%z-lZZVJr5K9?)`ayuiUo`#6w+A+197yff={XM9f6Yf;)}s{9JUE9Ti=8D zvur)DXjV2%{k1HQ2=*6UhuyQYAlm`RHKP!cQF;rrs1zAk4_PJ}xaN=~M?AoY>H-+! zY>85vqOYI+BaaN-w-f(NkUzY8taU54Yr`u6QRD}@8{E+=0n4wucaB{_#4jma*!lc}?R_xO7l3 z?(A5GTMj|?mHKg1JfdJ&5Sypg-`jt$F%goI<`zm{TgGwiHrdMj7A zb~u^0jWCdtU{sY+--~*9_`c_53eMXrP&mB?05-r%?KnSR$~zDeND95WK)6&w-!%Z= z$3gkHcI)y@EE@WD#Vp_=B}*5lraJI;w$g%nulrpxN0y&$Mb9L#3RTo0YwuI_mASU< zGQ>Db`C+7JSnqbp6WM(v{0X6fWQ&Mg`U=<(KGT^ zWEO%XL7q)aDSCDug@eJj{Cd)3toF1I?k#-9v)x zNrb;yZi-UjHa$vYb;fK`7E`ilj9;F-S32e~CK$tL6!|J>d^q2DAfIPbh0c54IYFn* zW-_4-X-(#mko(zt9LFLHCeQJ0PRNtB^Vn-bizg*=InVfDA0ItB$vy%`5u$%{A_7Rr zE#cqF#vbWz(IrJWD|KJ$&W)c}8etOOVTeW`k4G zs}2GTd=#ar=xE{{W^=;F1gkG1g&cvA?UWTQ!k4VT72x86MNR;_*Ya;{EsdqvA=U6` zR6Q=>2!X?p(HRWd9tEW%08rd%K-HuzXiW8)J<@Dy2s5yWFlGTM0K%zPGRm(`6` zF8F5cPOBCWvzOn$31~|3c&5?WB1{yJMAvNZUE&8CITRR1WP~}&c;e7;_y)Oeh*8~& z{JCo~C2)9-(D4J;pp5B~s>+ZMVV1$24e(q+|5qQNul4Y_yE)PF*kpcnngXkSXCI%{ z0iN?ivxa5iPv1As0|tD&YC&Z+uV)|Bp+3~i4_VSVVle)}e^7d5&_)Q_=sg0ZuirzC zqTC0=-+$+H7DoL!G!rMkNt%(o)Q{Y&?)j(Xm$P-iK5kJ3rd$57xTt84$-KrRW52*x z#_90Qf2PaM&X+eQi>k+$mOe?NH)W@uhJ^4dh2JRif?A_JgyVPZ@>Ge-g(ctIWNcy>+h9EPGdH&HH%rR6OOD_*g`zu}3W@OMm6#O3c@VE%% z#v<{eNXAN0szl()B^tgHKw-FFF8W@>bJWLGhOgUM7o34{>YqExC?1tM7*;4KBxn!Q zO6_Rq#D6!ua-tmkC@Lh=ih~dGfV$lu|G>gZ1kasRlpgOE^wfnIkTQ%#Wf1YP8skFr zzu<*rhRl1)t+O)*ifCzVRQ_sE9cuiaBRh=!1*@=i8wc$7Rd%pD;0xh$)RcR)hGHRw zlvVXiII%HwVjEgo?m!i;El6cV#@x-bNHLdl>uhax3R3t7*iX+0Oj;SP(-xC-+!hT~MA)ra;BvVl}mAk*Sk%~jy;aSDC6iS9y?LXbbL zRtecgO`cBXhjX2lfk%Xyigg+(;Pl(dPmv;fiHaPHrnfTy9qzryw*K-P#Gz;jxew=A z{t9LM(4XqshK7djZlSw*>2fn&8v?zyp^m*&nXXWH5cCFEd=~#*fh`EQN`3L40k(Uq zBl91ZpJ4S9Y)kZ#i93Vp%@1_p?Td`jqT~3kHI zW&m=bM_?bpZ1Dg9K_}2`t?c+&eC3m|%OhQdVFh6SKe=fDSY+?=uqCz4i_lyStf?k24HUv3A1+KOro@Ods5TdhmC1lOP7m8&LfcU`RjL zC-#s;B;+GJsQf83M#Dmlb4?0tU+QVtrc_)6w*dN%LkSNLPhDKkY-6+T>OE6Q z@3=I0g2SA%z)b^9MPFw9Y1ps7rD(c+9-P6$Ui~VBll<*q5zd!d=^HZRF1^g9WC$KQKwH?2a;%ot5 zbf<3B>w*94Al`p_FF*w93YR5}JHjI%@UqzbnzZVIA7tfbk4?_}pp1G){AD7wGTOHg zSrze1reb^%tFwtudNl3zR0?T*!gRwlpbYr3r9tE74tB$4A;Kqc{!QE(f#pEzR}fTy z38?K@6xn9b$LX*-*&ff}Y9@_C935YPlFC-6GR2b0KS-71pju12aA=Z%XqFf?6=vhi zH#v6~9%j$fbFtdWZbUOyy;p}f51b5@${8fj7_7rN;OBLN{u-u752<|MU%1_UFf20y zV;5L=sA;CrZ-_BEz0!wTR)HW{fNs^+$UE#;z=-t}Q|i??H+54iI;$=Wo2K{E0AfLj zBadqb4v#);A?eY&8dmmd!6lUTZotWpK;mQ8SlYsF4c@CEkT;5XoHPpT>SwHXK{*&0 z2l$Da=S{XrD>sx*Y2zUCez>*iKo407Jsa_VEL1csdtmD^*;$r}x9#ZHGPKvaC9k|B zlr91%9yI+IafIZO-5kGSfDOfjhMf9zRuSB-Zf4tTDkK9(aJ8yhZK z`tl$i)x+Q4@ynJ|xyw0|GQr*Z?;ph+?A|fw#L{Z|=$0}t!atQ+6bwGyFl)JMCWub( z*;_)9pGoeoP##q98@%W9Uqz-Vabs7=$Rm&;xOY z@5J2C{H~fLa#w3HcWus=x#_<$)G8mbLLXqpm|njrijriWi&-&tAu>A?;j(HT9B+ys zA0qVP_lCGPR@tLbWpadAqH3(l>JJt^i|L6t=uAfq#*uAq;{k;06C)BWnw>FXUCgVkW zf#+q`0m_V@Ch4)RdVoJ#Mtyj6kv={{$JzT@bIof;wX6uWEb*tdXdAKttV)!EQX#u~u-f?oGQdw|A^8o=Gd-S?~G4ztH5-=`*=%EO^SNvY(OhBK~rIW0AXQJ$RCBlR}uE7p+9 zbVchkcFi_DmyND1Ht$(0*iQw)ovtTn{#Sc@KQ!Qvdj7mCRnbt8x4>*Ls5y|4_dV?e zNFoC@v_4A+-HI(${Zop_Hf~bvCt4*B+8J(rjRVqI7-^-owKWCAkde*cm!~C@;0eeo z6dG@6BQi6RfJl-;wH@v>Fqj$tz@trX-q;zI>*;0#Mgh&7)hz~meFKs0Xzvg+!zNFb zIDCoNocxNy0{BRl%N^BS9dZUsa41RWp$AT^@=A{mlnqLb$BlT!fyyCMeO%3shm|YoGS1AG;+@!4pJ4Df5obEJQ5Ju{ z^iU9)R2VWePDeWV5Zo<-Q+)EB+&JrfS};;b%mg28-F3(N`!{0uuQ?ye+8CRqGMn1& zUrU&U-rRcKRj|JpIy#|OmzsF-5?dsGj=X+|fx6JNV4P*XwMuG^dkRQCX!}>7ZZBLe z;s<5adbI0#8oWY1qJ2WbJjr+c5EB&pqZBv1B`Nn0y_M_KUXzNC_cF6S6SE{li!abg z#3D?P_d}Iq&j|w+JUvNOq@0g^&{^Z+8maPx$1&nJ2F2v|g7#B27#uVb#2`;KI$;Tp zkM@-Zlzcgs1X`c4_eA{s)Sc08-&ju{^~BVTJ8aTF<5_a8oLYWyQ17e?>%6cyx!GyqoKeXVM%6DBsWV+MP%6U*8*=E*=`W02&C+MY=PZ2GQ+CXL z$cU|dTYxZJwl!3dcH;^*19&mOc>`V%WMiGe{?wrqHG{K`>|}@{7b2lH2eM)f$6*RW8!=8-rZ|(s#|7gp_oSH1F{hI-&!%ID9HWvrmT@%J>Az=5F@v$*mL+SO}?G z46t$t;r77-m-TKZv;$Tg^&Dh`{HVG24ngvAOY3;Y?uw@kvL*2ga7BU2!Q-$m)}8cS z`i_+sLTN-Z&s4~Tmg~o7-VCX9KHq?L%@=F3KhehfE$HU-1@W(V7$K9NzRX|a!IKOL zeRe^uSmt~DZd|c-ykHz)2t{jJjZdnub88TB7{zlz_s(p2X|mZZQ-4&GY<{mlh3>;b ztw9k!_{Q#h<*Uf?DV2ZYLF@j*9~%SQVu|I_$AAWRSIF=)aU9QPkg#z1(0Mh+CP?am zogN9q!EPLUXdcC70veug^SG%*EEaD}W;2LZsbI>hNxVsPn?*}087PKR z0KTe1g>OIn^{aQK#aj}xI;XV4CF2gOqLrH29}E93j@M2lWYCDc=;6O0QviJ#9_*x( zf3p4g&~0qoxAEUmA6y@Vvb=qxo=a^k18l5d1u`*;j3A#{AF7Ke|ma$?yXxzU?<36 z`|zBDpJ3&yLRV~4XNrLt@e$2K<2l70fn$jz0&g->P38x)Ws(X9#Pvb2y!x_VwN|Px z#WXYT4LJlS+v{0L@a`SGZ+HMsY#2pQbQEj{5lgB;-(EYB^URU>{XM_=brkBLwK)Mg z`vBawa`eLD;4|8wj<&cy#_9J%s;-D>jHf7+{1w`&HhX9!qswPUhib8HB%~0UL1xOv zhXRyb%qnc*mPZ)9LTAot$9KA0474hDAF6r^dawMND>&FPjkBJ3){0@CO9hKItv@hD z;MXX)p(2_odbF}Gr8ay3b;*_za}2J!RcY-+r(=&_t_EH88MJ-<{Q8p_R}MAIcn@9X z^LbvtDgJZYcOJ-_$q=m<(X~q@_pi>y(Y**JY!)~XhLREKf${i~u@r-FgxRIpp>Mw% zjV{phAA-Xa?{0Cy|DtZ%1+M|>Y+7lD`v9VK@eHwZ_-;~0hRDr->Z$4|td&arpuYSS z;Va;VSjA-oSZw8KXU!~qwXbnSJ0tjK$qzF_YaS@Qn;RRNry@zL# zmQmkMMaX8*VjZ;Q9)hQnQM)kZP}e-%I$4yCv6_$b?w|qe4$y)GcNh9cExG zK)6o2zrBSNUX5a0E^pt>Ii5faGsE$3m))fOs@#HcvTWis=*B<*RYULF;+hWKuJI9* z3T%XbhPmpRJpxzSHw|`t)4XM=nKv;~cDk9Qu(eK^(6# z7HGK-A{^RcNR1dlAMq`rj|tmUHD{QG4{q|L^Ri!PHUHjE7kxg7pe?4LDjI4XEakrjOTpEAyb26S zCT=_MlOj^sZ0jY!pAvCD%@&U@6znoQ*$083#*7F=2t$^Ji)1D1 z2b_uY?NGh>zN@RI6hE+`0O6JOsS8^SQA7IFOWOkR942pzV11inA`d?$Cel*e?Wq5< zN-~r;Mzv;m9ZRS+xvX5SR|%Jx_4ATy?P)nNk12iNYgqG%bCxc7da5hG>K<(5ochMgosFodH|7b)WgWTgWmbG9j! zi~PHdxshh!e!%5BZw=~Wzn+qE2e{^xNS`&_z??th1q`&6!W%2ZMcz4w*9$vH-WKUv zm5bSRO1j%*2TtlkE#zm}9>&vuwMieXxc>zZif&60K}wW!(dgRFIQZT$X<;A*S|;C z;3aJ>f}6}B@m6D%Azkt+F%-m)f^xG*|Gb?pWcxf9LQ`KcEJqlXtBnoA4xHGMLG1*N zA~yY?L~52{F;&+GiQ#B0iU=)S!sO1dJOU^mI5fZ-(_;cQ{u3L8 zUOh=X5%uDC|7YlcA=`K`NG~Mj*Q;sz#grxVl&GVLZMGox2StHaTB^>dczW@Ff|d5Q z4z(K6*RB1KV8{#5Mdh{WdRtIN`rh9#o_{w)Dv02J*LPkfd zU>qVb25m3Pj_SiOKS7~T@I7S5*gYJX%Gc0c!WgS+nyZyR<$M3;nq$zVFMy{RE{UuB zwndEFFBq&2$4hjF)ue8vLW>1L^*sKqGp2p#nZT<06Ks}@su%I~rJoK3i!f)f4r15s{!AEqrJ!CF?$xbW~f z0IJ=@zhC?4!!N}#<-k&AR17P7?f5cW%Ur+A5+>Rd{d4)F@maND-I6;8I&m|(w!6w&X5zZA^}BsXLqv~E<>zu5mEY5g)s>ZAED zpcbPIwzVRp@`_&b%hT^)nJuna+-^8>DAZz-peTzA%H?gvlgENgQY|U^?H1YCss3xN*qMzrJ z_V$<40MvYlwq6#5^6E5nYfY;8hiXxq9(u|AwDZ1zfPkqyI7(8DeECt0iYtiIWWZqH zCCJotUNb-U@XnMNBoW<>3fu^7-@tbZG`s|~IF&thF7c<|7!wicmA~OjllH#Xw@23Z zBys#3k9l9O>0zY3@!a7Qm6b~Cuc1474U$OlI)ge_Cq>s;gEbf|vFf+q5;IVa%UUsT zi|J>cL}Sc=Ml(RjfrUTyWly!l>J(eLX^xgMdP$sYpec;v#?y5MG-a~Y(kRv-9jZ1H z<6u)!E-&?7ImHoyLx#>U*TABeqc&AoqJ)C!7KJ_*Urnf0>eaG$KTc~THg}jh*4Od9 zzj^jZuR~7he(3p4^WaHxzPqpQfwG-{nU9JjWIkdrt{t06$Stf(PqMw( z!S_k1vPvxVfLlR~t&mDA&d){yK4Rw4)3iovI23x%UGba(cQGra?msrGaPwVk8m?8g zidK37!(Qek<+ZV@R=tiXOlx!#$r?NJcNA~Q+o9CHq`pN~=K0r+CpM9CSX~_Yd9r5T zu4E&>UtVo~no++)SWh4vncT|R2xx!*ypq})Ic7BWV3(@Uq+8P_q$R0i^Q|6J9WyjS zVm}+F?rCWsE+6rR_2}9gVrnQ3RT105KvgYoBk+IMr&r+tOdS1@0`Cu}YTQ?=_MnK3 zUctcyR{GoA|4L$qqpem_tybvjWjYG3s~p1`%ZU{OnHh3WMM!;-WjkQ?;ZNAO=J``I znX&>qV97%HlbO6fQh)EEn`CRoUift0ER}@kB3fBrSWFsKEG3i?1gf%5@C-i+l&BG# z$ywUF7Q}ssI~i7M8LS=veuBf-K=dI7{9J&T09vorkQC4{Q9zjT`;Vb<1!%z(|N46a zA(jfQu^vNnN})Iv!R6}p(AR^R4$ZYRE;D@#$_A&TqrB2>bgAxau?=uqLl-zH!^aaI zP3oaW-#Xf%R$bQ9)Nh~*dnrr?14q?KJu(r`Ibsjj-*>bQ{9m3$#cuj|iX^Ckpsu2nHZ^&VM-b6=9zk_*SliGpD>x7|D2EiG&3VeAEbd%mJy;N0B zq)XCX+>bwyjWFZ7Kk-v|I}NYid-xHgr*U8JJ_6sMGhYsPA~BEFXFix3i(#JTlCxqe zU|W18oeGPL{Ut);pf0u*E1kesIa$ zn0r|lfRK1{NE$Qvmm^hR!D{H%TsPl-VD2^e<8Y$_Y~0c8V+e>o%W&}<8NQWEKHmoM@u81{^xod5?>t7}%PW>OV168hy z*=yS2x}-La?zX;7Dh@+LP+MyC2X$0{dUok@=9RZ=zD84{H>n%VB z;Pp3oy!Z*t6S$umL$8St-cDW-?;FCB9cSvZ6*$Vn+&@&r4L52mkZ}YJHfH=k*_#jy zE^hok;%%vt^k|UUTbiKum3O(CH?Di!{qbnLs@~b=36W8kq%~5}wr1ac)pSb%%k#8I zvMksS5!#Dex4)x+lr>jY3C4K^yLF3HM`!DHz~xZkDy=T*sJ>{0Efnlc@KAmf*xiXo zAT}kK^?{vcK}_-$w&9fBEFOs$KNe3_vn4E>j~9I$iVl7wSCIZL^UAR`oyrqgUh8PY z+f1$Tl?^XCHraSue*J>?;%2Q;i{RkYC|(dIP5X)^mFqsst`1KKY}r&9UzJ}PDtUuk zqDN{6<5h<{O662Ts)2#OLwBWC324}V`@SHEsoZBQk8h! zon_EX<0Ss`Ahv2~*uJ*!I~R1*7)phFFBI(RQp4#{N_cpON=sN(E}_@9QUn}|&q>pR zumz&~g2Z4u?cwTbnzo|O%690B!yPt0YWEWB@!He~QQT&H-3({yKN*LQ&rg1^u>`rb z&Dg5;qsG}E{L@^y2xkJuwjI5z13Eas60y+~NS^?wv-}{y(q?JwgZIj8;e|Fz_VMC( zv}GHR3H}$8lPD4&j%|X7NhYxux}5t<^wN&-3NuTbg|eRKJx>`&n(uCGv9A{Ppj66o zdbQ{4NU<9xQ!;IIXqzD->9r1K6!&-cuOsPv9A!c@utznS3M{xIvK+%)y`LW^R;y5G zB(+KALB{bK$KslYMyJQPph?!A6E08l6!gSK%pDrx|F z--zU+_uM~Qk-VFW-#@{3^-X2qqaj}doCNN};B9V8uZ%pNd(zi8F_Z@`*&ZDiViZ$X zlN;~YKD*w64$DPIBk$*##fg3%{M}i*uFkL#wF}VW4IUTx*8mh{xHbJmMlI{sPpam4 z^>#76`o1+)<3w9-FnL}+wAkh|am`dr1~i7uu@L3R%pSx`dD9qaxS|U&jn8o6-#0n& zY-=sz!zTXQ?gO$)z+NrCPU+nsBf}$K?YNc;>sI@`fu?oRCR&hoFz&3GDs{1lJ67o; z8Gq!RfkK9(IyqDMOr#o(YUr)4Jgq7$=R=N?E*A8tkS3g1GD4f6BQH=LjE${mxgNdMNZ~TpQE`Rio<7x%gg5U*Zywc-Vou8*Q zSRl!{1}?i+KvI#lj$5jp4> znTLQS0IP~>)(<7%66Un^mdDh^+RVwP}6PFK0%`h-}1 zhZT52-n+z~sFNkj3aun{Q4b8b<`%zLu8#NS*gpOpz3`eS-?`v0bZAHnf((C+mMw~9 z&7TS_u01;F@+Blu=vT@56ydLlRY&+)qfQ%sq58bM#PN62o=1;p?zK3@^XuL3I3-w0 zkhjl18dSBuG++6-p3dN7CcCJ{VvBwn0T4XQEmM zO%Q+cp{drV_m^gp8}9ru8aXer+?5{D2Sd)_9}w6jEL$HtqzPE}BC>7eGfa0|n_B2$ z9|WYuO1OpAHo1%rJ?-1mqwU+bCN3Bi;@`Wqz5Q4Ef>Hg*IJecw|C2a=2?3YBld*Kg zGC6LT9W_%{qjLdYry0*7}tSaWH6ZBZb}SM zvHH$Ye<;)Xdv81#z^NoY zXR9!TQ*3@6TXLr@tw=(1*jPt=l&95UniJzxsCX=Om0Oqk3 zFh%>(;(dQFz|Mo@Iw*LGY@zyI+OlP!uPtNkRQul=v1-NYz@DMdBwPcJ!seg6hsdeD zs4S4(^sOmme^_;R?s@#RK|8)+$cXyBPF4oqU#^bDW8P2eQq7ifjy)t_Q^XY!yc(pp z!g-c3_B9x(bY2EoaT~>Vq~AD?WG*!VSBl5vKH@0MFly=N>h@4p=bf1WP%R(1^|alt zC8k|ae^WpP?Ic{iGRm9O)O$*ze1p)sA9Nd^)Xd0}fpOeA@s^hgn}eVlPK#>jZ>t^y3n)%=(2#&8c*x&ds)wV z>cNK^lpLmoy*U-#=CriXY_Dup!+BO)0HJpCEy=QFn6F*T<8JyZ%2Pj=Hd%*u*C&kes;)YC-FH4T@x z{od6D;_RJlR&llhNXKf_IrL~UU;*j_g5dG)@n4qu>uYPkA0fmyNI6)45MBDw)8U`L z85IS}Lgbf0D@wNYk;Bh!3kTV^N>{Lb-1ms`P*y^Fb^X7A2Hjp=u{%?hu{K~P8WF%@ z<-6cvX@kql-xBVVs_|| zFzeF&Yop7dD!gKgr}n(A-?tb|&!EdCfWSH4Ckmp72R+*U+0QTu3N=2w+98N7UwhWq zVhJ9zl0OOFS^atH$cBeLQh@Op1xp*`)6Myo+DEmXIoUepAWPo45E?|HU9^Z{+LM)U z$ZIq$MD!WXU6@Q@Yg!rL+F9M{7Y6ANJEF55`iVUfYd?(CRYIN4IF1pSjsNJlyjhfd zsn;#Q`$c*G7cH1Z&gBjU%_x$`sNNY~JLOb&qDDxyQL08$L$vbk6)KW_4Dr{;^2lL@ zHay&2+NA<-g4_9ASH8arU0d!s9|$n6-UUuNA6ufC*d8tv_Y`n@xaugxm>yF4xt*;@ zh-k)*%KvAj27ZC%U_K73q}bKr6;2Z=3Jg0g#Ny372DRJ?yE6DPSWdPej;V7V^&Sl( zY$#kH=ZYEu?cShaQ>b3nh8nLR;?LG$315WVj`4Fzk<2Kdf%h5UUEs2joa#IE?`E$I z_4s#pXX{}+zE0?)ALK|wl03FmVg^{&Vh%@16d=*W~cocE=H7d;UXXdI#`hEaTlO>1=(eEj?y6-E5S+2%%94Y4~Y)5%FZIwK}Ebf`q60d48OKg&9d+XOK1kvz43F7JtJ-Q9=p^(-bm&0&7F z9NZGVFO{Ce{$pqSv>dVgcws|ffGe6f29xPdv-cHSp()84HkfRdR{@7*1-{H?NDPL_ zV5?Nakr7qn$HRX>`b1{6ZB8e|_@y`~FsU`kvwu-W;ZJIH$6K>kiFc-yJk($J{+*xy z;vuSCqIz2e-xZmJ8s&c8GW44j;YiMsVV{kyI=a8-iabO!WY@3A617!T#}sbDF!fb8 zYJkF9m^9v&R9hD=Ywo9))+D_FqY9Eh>nHkXh6}tVdc(J$s)ICgqhM7%-(@cR_#_k) zA!}2|F8E2S8vk+WlqHf0Pus9rb(&2f(9C-Nt3Kf$+v_D=aWtxIToeKbHTz7&a()l_ z|7ig-Ta=*IE>IbKB@fYzKL!Ac>cGh`=o}ssOAWy(!r*0zIPfa>zqRej0EA%kp^tGma_E+7Z zg2l4%uO_J-QNDL{NPg)me{}{b#I%U_aIF<&%i4*$-zNct3+5xQtHL!fU_>z@>@l#_ zuQ+C6d+N-N-~9cYST1L6*R%s`Ay=nmZOSsp#j!bGRt#cq&jnL}AsyTh!JbS^VPGvA z2}!7w=GUS`8EY+b>uX%c<4z`7KHNsj4t)of#=Bp-xP z6w>(6kgTfbfmS!j6eL&#JrdcpJHNYi=H3Sn@vC4H_A+l^m`WvZxl0#Lcc~8*cgl#8 zxK3@vSFMafA`cWJb=KyOkkznZzF;#f>h!tKrJ*mDwWDI1#2GYOF$Lb8hmO`~Ma+OJ zKQ?!^S@^}17w!iG#GfQ;YHHvP`d=U>(l-3P@Y$(> z()#Hq{ozDUaYSxmGQ#jTRKAiy`iA@JbC(RT$3Um#SL&ze`&F5(u3%k-Z$)nuW^O=; z{<>_Vu~LN7DA5wD>XusM<_Ao^xCztJzIWcKhQFpHOH*w$BKq~?Ci`PIQ6LACBQzNi zKL}~s+&|ua!`kKp)NDMcXE`<+iV~M;-%@cuDx@0CfaVb6pN|VkQtYG`AasX~6`J{5 zjS2&AmZ=y;rce3ceq|r*GN?X4~g@;#rTRf=4t zDB*0!1+uf%Z1Q2sRGJuff_ay%znCu_SRVNWlxTRM&DERvf{7cIU9oB@_mjEWweeQ?&rTIxyvxP}LDsPa+#AW0$R4 z3ew7TFi$$E31HuHRMa9I!2a0+wlL;My17F%1Cy7`gwL9nA zwgQ#IKF*k~ktC5HOpQCO-(=wIPy^oXF5|th%hBrY)6GBp{l2>=czk+sfwRTSgrm9b z<8S-p<_og$L_=$e9~*>h7@sk>qK0R0tt3QPB(MiB&X?gHaw`A}q~`$nqbHT` zoeCmPokFpLM8vD21}A2gcN?~cZ!O>F#8}2?)t4b*rO#seM$v0>kq=w8d(jQ&7EYNI zxpk_58RI}}< zWT#a*_L!9VUU5*EHxTe-FYc=H(<;|#%Lr45`$(@ANZo}$`gdtPna4R`px1_ zv193Y7cNk{|HTRqcfXwQmtT$L+Ww532q|JUITAQo@yXikq(tuY+y$%b7K0IyD?yfY z7_rZFrVY8SbYAO}FHise0_GS5v>2ZQant@fY;T&xM>~jkD4RsEhlhusUq_N|l8OL_ z=S}5m>c~e~nQLxxj1W|H;cYwheiIKXmUq$i2G@u==*f6WjfXRt`p2+Tf}V8j5l9G& zV=^b#O;l^m);&(?mf1)8akDB5Qr)FzV7;OErw$we|87t3@AXGbp}wsTnThU9+h^@G zftb-MC=Q%I(e}UI1iK+v-a`CeoT(c0so;hc4n~aD4k@)^gRLA@vSEo(3-=!is1sqb zdU;ALmDQOe8e&rjg)2wAsq(Yy$|%>7e%(-YVV3TpzwZ-?{)aUN7-otM*!jnXiUK#6 zG(?J=1-?N%CiGW8=%dNdgr}DnwO2(r2K9B!>&iYqD557YHLabFx9Glf{gC=#gmL5- z6R9|XezFLSI8U1izGcSA4cCr_DST0ABNT4Xi_{r#qFQn{0H0Ae8#f7+s^&=11a?NA zWD(rR-&B-9op_xGhCxC%D5@aKXfW5h;SYc3@aQdKCg-Xt>Ng$U+1GeQ{YNKGR03ff zVrVInVUJ1}K4e|4a$2r$-lijqv}6AQ#=)Cpd@R*N?TmA!rM>=r%K;2ZO3 zoPWK^T7Y46u|Kpgx7qruL}Yx?YoD{ab4L4O_r9Kd-C@ftgOnNx4`DikKyOQWvZiWA ztU6XuSYkRgLXW*5)h4JxhMvJ`={bn4NNZ^Rc$lW@bkrfaW#hk^SLv9@h$;1m#Zfj; z+AM)NtP?=aQZ+Twk279+Dl+v;!*qHW?H*92;2qlh*xu6viEd#ZiCB?Fx(*N+>!9dB zzRdy*+9>_+*1jJRf{&$R#`7|mx^X|dAbk3g^Y!!q>aMln*+~Y$l1Ts6j|UY&Y@{$N zLV)_9hwShlfUR?UAhIz!&$o{oBBeOgWBMNb*l$38DTy4pIeUDAHB_;n71t)QG%A8S zGORXk*apD^Ur;&mTkXr8huqiS0tl%u>k+Pjfq7E7c={nv)Fk^xaMrlEZ-o_WQYt2~ z`zNmO;8HH)*%pJxdEXaWmNC(0kg$ZA^qw%dEiG-xun2uje7oM9v|L@lXR-p{r|&AM zN}88GaupHbr~D3YXUuP?B*j54qzZywNJspXDmz*QcP0S> zeL1V#X&FPuBLU<@_vvW1p916*(r(Jka-jiDb-qh0Sx#yhua&(I85WyVyg+aJv>H+M zuvEXr$A?(0BgraM?>g)K-h6t`1#815=Ts)VuXTns<1A((lfB90CP z<6uE^ayhLSFHuQfdx4Xo*pa(CT#>^}@7JPwcHShMoXI~+_{^R>R9FX=1@AhRKft5& zaTjfrxN^LnP^_oBJ94WF{#DqUZXd0zx9z$hUjI)VU9@l;LcZ=YEv-se8v-5!q8xe~ zC*?<9FRz=efoOntfod(eTZWOjyS=>~l(d3Nm9xNm2?1#?zy72$2h9MTwU%N&Hee?K zmLp6+->H~DMJlfFeN>PaqRzXE0akV&dW+*o%ko&-&M@H_)$Vk1V%8az{Xx{uIt*=C z@xCTL8g9Eu5l&0B?s1Ca0IBPYyYDLzg`x$X(AlqFh1KZRIWA+ud0M&iF%pd{A#+Vs zH!Au*;UA-QB(Vymj`UfL55K1TW!#juL}j~mCS&>D(*vr+88@xp8Nqb(^r%g zzz#E$L?Yi)^%PpX>fqt68=04sv#VZ%4jnn*o*vpiGlcCSi(juuQp|YgDg^OGU}^n1 zJtZS2=h{gce9UH{;pW3Ktws1-Zn(6w=Ba64q+cp*>HXhG1vChF@>`Oc$oQt}#6Xi> z!Lxp@A__${NhEJLw8||bc`OYnB|meoZ;n(zH#x+Bz5>Oy6*Eg3zG>QmOdT^AQd1Y) zjv#O;SnJ}2NMzSM>j{RQDnDmqsY|`&BJ8&h~7Ar z(Rc@1zI>yMdbpaWM6oV<^VdZ#3nVXtnnlyr8&|jzBi#vY)f{DXx|svKRsB~{q%zny8 zO24eIB>Ho5nX`@7VU0+=@`AHlhcePC8PgyrVK_mxlMLjAm`XQD=>`MjA7EOvnD)Dgb0oq!}iLyImND#0vjV=u%)_vuq_)-|@Il-hgMCxUcHq&1;q zQ@_-AU)js$4!fcC*GX4%BRZ-IF2=-0Hw_Mlp;J>+)M8S#LnK@lwn;K{pepO8v?uVO z?1#coT1;rgj1k9DT1Mj)HLgS7=CUJS;DDe~{9Fpm1ICrA_}e@r<(UxDmr0$Fzv*A( zpMjr7U~ZkDfSQX<1|H}0^VnJLkIpoL2R9kJ7K554hq#4yFf!Oo6x#-a`uxl5Tsd9t zL7r&s4@e2&O#H7J63J7uBc^de(La~l{ZEyjnA#(7=Nm%JAZ4!J-a1o5o@nn>lATk0 zsn=2!k*djXVThvu4wl_cG8v3jYqlSHGI}gf{_fjyS845>)&`w0p>V#fJUuDmsGI2Z@K{J4FhPfLYEfV=1wj zI2xE-D*hZ6^&qS({~TqJ*HYOpSNFxa)r(k_JxQl3ib59GU z9Ju!a&7Le35M3acS5Q%0vvf(xd@F?>0q73Mu-2>v%jzG(=^@jMZ#RUZI4d)trtPuh zb)eTdu9_;p(bJC(#@Yg^gG}WkA=P}4AYGv*_QeU+JDbsdexTGFW=czojKh8A-oC{? z79FFZKwVAk0Ed4VPYbk36*~v$J#T;dKL4LSY)dB!Vb!$wHKIR_h4{Bth1s?TFpoax zy|03cR!|UJ8W>o1HRy-1Q@u5tb$xB!p`k_=_;@$7kiC2lGF|{UL@1Mn0!qXt_z{GO z(`KCWV56GG_C10y4JBEh_eD46ib6jJ5_VQo320wXYd?>J%jshGg1oF60muf)+x;;g z+tDbu+Rfew*39z$g1b^QV`ux=pc@?c!OwAE3a-$Hw_kPAZpfW4cmF;eQJ+CTPK)<>Xv<@5BfhX?dDU%QhXEwnY*C4s4Oy2Bh z`_K9A8eN-Mrh42qz|V-bvnaa~y$G^z$lkZmEa1jVHVMY!6T4Ji-VIaR4+}`%W54nO z5@_IV&r`BFc=)sP0M<`H5&&BFj?Jm9$&QSoPxo{z<_l5*g4bkF&?nn#+*?<5>Xi#n$S+F;m%OR4J0k6Df#cG8-hAa(*Q z>R*6UW+s+VehF$F2ZZGCQE4Bg@VpZHQLmWf=^LqkrQE}1s5>i%}sjM|mvQVXAkUd;zW}G5;1`(DAQkD1O zP!}yHePE4gzN+xvZEhnOzTEuptl*bZZ}4xuH2;-8dR6)oAr|n(6Mf$N zW?G0-EuHNFd28FOinqu~)RVl{a7++~Y;u>jTp=1oIfeCbrCi9s%C+KGuqnPgx~#`y zlj2h}6xHl}D(EXQbJu&%7VLH}S>k`xqy%UosMnKNjSVth;A{vW4I>)Q(wUEX;WlM>ySs=8@vB5LrOA88VWL3kSMD46 zl8Y(6HTpvTWk12If^UuwYZh%b!=SFX0)vZNY5N?{8Y6?`>K!EcP4dJxtG1($sCtte zy&6+hE_)J(^Bp{K9=@5cG6jn-$lPdaYAP|~6ey7D1Wh{4?yjzHJC$G`Vi1ZSh?1QT zeK$|cb%O5B`7#OHjLCG*7fhtnu-~|8s-vWe%+x}GWol;rclsf#-eIHdQ^8u+ zC7y2(ei}}Htoy=6v)q%)3n$m3^tN(yA6ejNwvfpCOTyDq@KeU``$2(f^D9fS-;Ryk z^{Nbp(fG3vm|Kh_w57?VSH0j$=;!I_>F!RgVQXU}|4JjCTwyw%WA>G~-1tLD2~C6b zl55+f^xQYhpDPrzi**|Uyo}%23aoUvN6I`+b=rH*sz|?l2ut85v)SKb z&^+W=yNxO3XZa$^m#2OW7prp6B$TBoi*O*R83?vm<-!Y}IGe7*zjyo`Hq9^Q^{eHg zrHzZ7IC50KzhU60R?7+Sh>^XTU)=T+XG1PYl+6>Bn9mfZJKl);|CvM0dJK#8FAUoI z0}7FpO%3o!w?wEZO#!fAK?meRfBmox%-DU*I%tg9fxW+DLJFNZ?g`9LinjV~o$_7A zX5B)_1fEi{_27qC=x5Z1PjD4qL)ES3`h)zyy`h#inyUc+6awIA(FH!OS`PM9dR1a)J<8X zq6$*ntwd!o!?31B2Nhz#I2s5{wA%)>@D`;mv{)-dOIX`)=9yy~PJ;=L{!4w@QF;|LTe8Vk6Bp;NiC z28lR3J3Ie{HvK2Y0v{{GHnFrSzu6DtaN>WoJpxAan_xl@4Iz?En5#EU5pmWseIz4! zcYyw5`oEe3i;c1_E%4~rTaB1%I!{`A3Z&Fm<@cqw6K6P9OgVb z-P$tyIhQvZKR!$fdjXuC8UCk_7a$jbqQE*=K$<2S=T#d`*S%8aq}9_cOwiMf?&x|E zW~cfKnB*XoN3RDyK!1s2t6YoK=pXC z8rK#FnSCnR^3ipT?ixs589YXIeHq(_u`l1qa@9oIzmy~_E4cut!^Tqo5dt4D>VPxa zDZ-b)KgE$+WcoN?6z4Uc1hndug|Kr5A((Ez+-;WBgq0QHSG-qaDmA<*XnEo16(1@o zJNfu^KaQ{^-qV4c)`Pu%rivL^&yB+i*DZyFFm1;5S7oIinl_%~C%I2|I8IYJrenzq zJWppw$XG;2i$?vHH!mOiHxp;d=?Cs)rVFG@m9l=LFm~zjNi#-ELh7SxYUyAlocfYP z9*7l+p3~6SdcE_~EkDcN2F@h1oUAgOm#+ z)n;@edv!c*vCyT`S51$@?Uuw@yIL+7VcF*hwltEEba^+u-sSg%BW#-L@~q8m(CHs3 zouolQlSD^+&f6Tx)T^^qD~eDKbCz02 zWH;Zd@(3zLqbV-wETK0G%6+1xAFF!lx5N+?d5m^3B=N99^;OBjCz5SFwn1P}gr~(P zY;X3!2Y*gaf-p=4ZjaFv*}{%!)uIEU?)1m;h8G|$R41X`FZr>8ipqKzr1sH*zBrUV zkI7pa&TR6D{od_g#4|?HO30y>%W0~XqNPBny3+X?mv$yHn1HW#v7L)_$0MU=V^zsY zrpcHsY8nhg02|-}0ktnlwMHObMQO=S8UJ*<72OEh=v*=r`!=K+I?Os3dY6p-0Rr8pKkN zCHZ;oVP5@lM&u$jlD4951D^T)Fr_w)X5ZO0S;umF7`9N8x0!=-w|D)#bKZyb;)^J_ ze=(NPHDGBh3!w6T|88rDvMg_3iA{bAj`@Eyods80UAKjS0>z6v6qn-e?(VLkxH}Yg zrv*YO?(XhT2=4CgPVpAM=N)%^{D2ISob0vsT5~?rkMG`$UO|yroR)c!9I6#5Z6B10 z|DGa5mVcC)X{s9A+R*UTY5VX{I^+svpu07_Hj7Jqs(gercvW!2i04#dJj`Qd&BzjLVLlYE-i%O}d@6 z=M-MIor@tk6If;+-XBh608?ImepVijb6kNOv9lrpdAz-QUB|vO*Y8@GeeUOnuIkfP zdNO8-<>ZJ^;1{)Iq%^hwOR7d(8&Rn7Qj-(phhewy)5k5k@m6Rx*^1>zrl86F%w@`$0RO9| zD{OvA2K@OZmuYBw7Z(@1{ORMqV_6=w#feYI@EWq!lLR17q6FS~SeFD+eRjpdoX#pB zl0ZsHcPY9zTpcZKE&Atuj|s;yAmjw}VyPi3mh4o1;I?tWgo4Zo%Q>dN#l+T*?(Sv` z_67o7$K%lll_7$a0ChTVKVY!s4!$`KCcGhdU%B{4D88yqPOPsjZclonO70|n1h3B5 zo?eO;@mn`Fwpz~B#UAo3}Ut2cHW*u=_jbx2P=ANZK!@Q46w;A0~njgvVjRW|m?jCR6h=5hBZ>{Mk8ye?ts zhSG_63qwS{;-+q?_7UH$vMi-mTOp3>ID_I`iHbv0Jm>lPpq^UtIL<~U1#6@3uDhQk_5L5Qs~nU^H$%X0j5cMSQiK zsV~NPB3w8hbp~$O0KntzEjxVQaQXI@Ls9%!z;P${V>sSfLI@)br1q+g#3M}Yc;0g( zT*T1i3K$Inf2<7%q|~h|5&@F~Sr`v!ShB|4$hc4rRkxhfAH=6HxFuk(zI*F@he0gG z|6>2r98S>jKP^C|sVCwxf+)G8EgXFnYzSYo5fyw4K=%=5>JPn{V4#2oQNmx@3qNau zh?EQACQB_m^FcE!F(olmTpfE4-Wv) z%=9ru1?&*pHiHNEYbRA_49GAB)+>9b-DV4V|#u;JsmLt6{?yDV#tchiMDqh{MeufH>w zPI=TRaMA704Dt6c!_IR^cPusxZyd>XaoqHF>g9WcxLW70?yq;QkEky97Q$kqtM~Ov zJg~{VU0v1cSDA|+V7a;*F(3U_P5dgitG!{OHu*Km2>W~@Ou`2?1|4Mq%dwYo`QsE- zpmF}O)^iPEimJ-se<_dv^%v;anh7i|K7TPp_j6$*lj3*~9G|&YdUQ>sQ#BAS!J58x zUz#H%u)#?ZL7soz$Vt4;2R+PAePKL(KR>c39WQl9GNwV#n}^?t^*^2dvP8Zr%RCX0 zN-{*ft~q>J?}CI+dc$kH~!w;b4X*$_CQ*>1Z)vzI}2+ zPrmZtys*tgH5GDjB?588Nj0eU$c8U3D6NWZtunm>7+P)d$j(tF{4?33A*6JMptGbh zu~dz1Fc6~ z`@dUq$3RXw&=AvG8InBw`v+u`cU%NVNCyS?CQ)xD^5_?V06h6dj`5^$p%gc82EQu> zQ<##BRG=4V%FqscS8zSWm+_qi$LwbYb3bI_7}H}>rlBV4q3zitf3p8G+8}bC}@cbz7TC(jyN?hqr(wK!)j zF&czWIFpg)%TJ_{2D>tUDD(FBC+Q1WoE~xW35yxAcE3oPfV!`;JS47s`uvfAPJ!~M zf;zR~t;1r>s`4?gekFe2p9 zuubO)c#J)okIo92;tn>9HYXaZnGn&MdkoG)}DkFDcsC+*T@XzA!c{>tv9$TWYV5zhJAALoH` z1WIDA%&{(}^^tZmL$aWbQsXAUqEB6Oohr>7OP4}C0mj57Kq*YCb3AUovr3`RlJ~XH zP8XMTi!83R`p*2B?Cj;_WaKC{ozgCvx}}y~AdR^w>KgXLRpt)Gv+H5)ziyKPvcg)O zJS?JtH|w(~+F=cYkjWNvH3DqT~*%HWIS*vm*RE{%*VN2`dQ>C`Zt9NF{Lr^VPa3k+yP zawajw-~&BMi>*D3V2{*U)XwgrB-Twv{men^VZxoO~GImYb{2UOqYrZ z8#Z2>xN?KLPVI&$LV?QdPLkb7hzHc zx2U5z<5%G@zyT+IBg1Pb=saver~NAb-q^39ssgXLto)RTGw#!^g+{a%o})Efp5yPx z6L>w6e}P>)?2*)kQ@7}Vs$8Be(W>13$~2sVQ{4O2@YgCbb76m#6pDpi!_)>KHl5|t zuJxE-54bf`^?)JLetzE_lqg*uoI3Zbc7kPPP)xe~HfBqqhK<2yr3pr=<#&l~K$*XF z{p4U@J9_m75JfE;9$y|gnktS6>jm{Pnx}rc5MN?pd=)J1BcY@CN>OM{kJqZZCJ9zi z2a^3-)r4GD`8{9ZOnM}zr9Z+I`XF%QD6q5Kup+08GA9?Hh4qOlU_ts+@QvrAWo#i| zPdza-JO`B4!U}N@4w!$%wObzoK5r7$?N~U)zx)4!z-xUQhWlssH6Y+SH&6xh(zV?)o7_@6_IyU56+Xpxj-70` zW@l4=s0CbK0_q%~s3`>Ul(NhucZwGQrqgwZD`Wcxe)>ns~%1y-YG8^N#_5hh8* zWHsogMA}e5xBLnTTgtY?fQ#+e|kaw_spnak-F1^^b z=?N)5*kg8R1A`f$G!O(^#N)%2M3Hi`oGVsdt7axPDYyXri?=tOO)l~WbkELQhFKb9 z)S_?-bDOpTX${Zk31BpGa#ALg7j9&}MThty*gdAR51&;l>A5fV$M5te7$^QcTP_6xa9Ix%+kG4a5DK}q3!119v7>XtNO`&>CY$BzngwK$=f@MmAsc~xwV>qL4u=Q zEjP^L`XI`=-zHqLHnkPhGp$ZrgWW7sd1J<3^B$K?Q`(D#i48f8UDEE4(RL$sopKtP zW0fR#9Xria^Rr$WQ%Xb%l{5TI>7OF2cniU=_eq?i%1clE zXW4KfD}3*iE^ZH_qFq?=iMk7^bjG%kGAk=F(E?l)yArO}YR;$+-6Xte)_o7A{xS{! zCRo9D-AsJgm(O%O)Z!T`dBj{Jqf^dyIPUlmG5K!x#otco!_&#qRp)UaW*^mjxfZz| zn@iD1rA8mpLQ57FKuP;{Z(m90jH%w`fJd<%1cWq%y^-hv^hb(&e_Qb!x)?B-NB$ua zV^z|jJ;G14GB6Nq!y`~vrzm#2RL6M~zK6d;Lp?gOja9K>&kd9oW%$gjEX3(hfCeXM za`y7_0#M%peJL;*Z;N$n|5j_%DVMs;jfwnIX)0n6t@}4X=!iF?{)Q212`Zio=|9)Y zM2GxBP%A?;7qJlVKpAcnMEfE|4NC((O85|i7yr7aAuonSazj0fu!>~&<@u(zR$NYf zpM%I~lRE6*lY6a2@P3^n5jKziucMq|WR&q;VOU`;HlJUZqQW_~8JsOPpO*HO6CUa| zVRcs+UJD8J%~bPLva3+P5L+>-Ylh_6!9L9!Xbk5tN^eEV$*X@rbO`4qp+K~p;jdWf zdvOqlhsGwUC0?X(N?D^xGp*81ZR=*E;Y{IaR_r@pPFzb4+>@u84JuzeaQ(o?wY+d`F4*d)m4of+CA%;^qNd$ zhPr4rV=!Hxj?1hULMNM~&#ft+IEFSvC=G~pBK->h&7)dvWg_6ZvJ~V-M8WJ+*=;fC zESZi78_1LHY4{w%v2-WpQIq}-X21VjjwgcgCz*Iz!pJBSQvoE0Aq-rtIwvo zyn&MM#VH>Nx3~_xwXVv8!fu?2HyC>i+J8@VMTv)5sq zk?%Q9Xq#+Lg^V_O`}tAL9<9e_=E{w{-O)5zOX@tFfX5S!51F(!nJ93v@dua-(%ehK z5&B}wCUSUrc0TM>ioNiPNp&$^@n3sNx}X*gVZZE7!O;&SOqOGJ)U2{*0`S9R2vB~+?8v` zA_e|E+KQcN*+=CFMpNo~)f20r(dct`uq*h!(yY0*0aMxI)mnXo6x-aJo2w62UunGs z#qytse)4Dy@?^6RT9OQ&P5-c9@X2>}8o*$r?mbNToM~a@l%iGmWOJ13GwwLJ%MGiq zMU&1(?!!o&iI?I)?@Iv~xY6i2zHg(&X|D~MPlp0!LgaZ5){;owpGE zMn+~*$2AT}4LOR##IXMH%B26xZNO*GV&w%$NtH2D?txONpEZ11!XTQWpz51Q$dBgz z#87t$h$g_3TbH7K4gmZ54^Dpb>3$paV=Iy{_rHDnx$#pP#4WMi_t1ndnlqC z(tp^@gT|`KNwQSti8qIM_$Y|BYCKd1qIIzEK*18cvy2K#qhubn7rDlJoi^FU=o+Ah zY*l}~%v~-~$tfIq8kBe)3hGZsd zW|8!*jU<~YztHuniALQ<8ggcv* zb_bPJT|~E4v!8)zjdZ~BwZ18A$t*-rIGvWXnGHr>EZ!b7zz4>5fe4ZCM^V=gB z_B6n8IRVP15mvm6BYV3$YKSh#Uj4f^V8RCwyaHTnUS=E>=%S+C>chxnBd8Ajk6{Ot zwZ4Ew`xaj}NJ%}yWGS71Q>ws9*Oj#T&e^)|_gEfx;sEnNNar;Rw1b~?XU+|r z15_jGcH43n2H-6KfM^v67xr*e59hy+hAD47ptD;t>3hs$J?~6Jmdy?DT8dF4G06NN z+TWlhrrv#m2SNW1%B{P-aoQd{%lU*j%aFbdg(4%nL0fTTE$9lTIH~0{e)67W%(Ul$ z)~XfzN9_I}!oZSZspb%z_LS35D%W=}nWr6l6nOUEacl59x+bnoB;3-M5KCrM)7!t9 zGO4f}y>(7lU@{xm)hY zm1zVw<@e90jbH#}8u`50_(->LAo)$|G#>6fJPr>EYBnzJ^7oU6g4~tqS)RLKFjPqq zFBCAfseI>bk0#SOfKPWJ2!>i1Z{NX`5V9#=>5UV|F{L>}pFJOvwxLOd8^?nB(4Z3O z?=3k+rl`!-rQ&kP>U?=wUS zbp$<*wPM1N!RdoY4w;Pt;|HO@(B#w%kiSUtq~6Yk9(lyD^IaatObVd;@(coI6m1j# z@mi|1_uWX|Y(Rq&9pQ*e`zuLC#88Rye19zWKgf$;^bZ3+P=5(-o~aGy_nohtsLp9XpD=KNqLkuh_8JJ6njN`ywGx>fHFUqd+~^=K z0WOm{OcNOv-vMc0?7WxaP|?xMZzZl)YFpwqvUpmQYVl@%Wy3TnMzU4q`s-HR_i6S$ zceZ&m+W}(Q$u(gy?->!rS(xIlxuYK0KGYIPm>e8-z5mD(X#`v7QpX_9s(8r1{hyn| zx=+rKh!NC4Y!sZmo9Q&7NvFnqxzg4GbE??%CU~pyQf7Gf@NqBhA1QB?f%+r0v)1|l z9#5=X5fKr*;P4Ura)OnSGfHr{Y$i_ZAg2kH`ZqeHg1mTJIZ(B!D~Yy%?e2hN=HUeY z0o_8+8s57~Q4V@GmsaZHhTn6^LAnkH{K-fTF0LrEqTPBh!icDEOd!AN-KU^`I^;U6 zSE&q`*P8%?qR11{OM>ct^alv~9yms{l0+7q!{ELjcm|Z`b=!YMcJ;P79^O~XOM(dr z?^A3`ugt8i8Wp@QiaM{@~c0_!|ZPdCSwPcgUHd^6?C}2XI5PbxhRd32KSx=vptpb_I|a zl32@4!^Vz%6J2{KeB2Eg#bVlU3KcxYH}h+LcWJq{72->d>WB0)ck&l;*HWQWt@ZO>HeLULGC?lA5?AZKEP) zi%-kaG--2n&C+k5oc=ar>(o=75=L{#g~+>U*95$OJbN~7kVM3kom{oNPkTM&#9Flc0OZ15PC5tSJ5@fR!Z!r-Ljplp70)uvz3HDvJrIX(!} zYb%0wOT3n~a2eal|7i7|_7jF@u*h9+-$GmYANdd;6sG*{C&rODETkik4y3u{U?hm% zqLog8_fO?~Aop#6UmxKeL*2c*c2gDZH(Vn~y|s!Cf8El6(LL4eJ8&k9TeLB$W3KZZ z<0|lm@f+8v=_Also+MN?Dd1~nr1D5|4!T#jNGVOtO^3U-w=I{$8S7lP_D~UB?(dr$ zo8l~RUH(OCt z0pmI_cAMqQJW6B7bQoA*^?;$Rju78%47`CFARwrI#omv{CW0kAhDu_D&PuJ9bWF>d z^hZyeEAyzLtC+p;L(rj>=yZR^TjtlB%tp2X+3NJ@U&79iRZs7ir<&gYk|r?l59fzI z5-#O-ra!Y@a7L}4<{#hR-rjC*T(hn4(&f#Rzs5rPUlx86ZHT%koQ{C{TeBfx@02!se|Q4Y8gX^iWZW+QCPVdpm6kdkkn`=B zz89J@YxI0mnc%g1Q{=-ePXN7l9lEvZmkC~|ET}UZ9!qu+b>(0EiEn!L%loVa1&^e1 zzxLJbI@V>y17ZdEoIF*YDe{9R4-Tj==Qcg%e%!>XnpZnAE+Q4(wDfoz~HH;HLTFz*$Uw|7;#X<#C`L~wPAY}@D#e{{b8<+}E4@_Hn#J`0q|9(KXHKR*w3LM#`%?~u; z4M%CpyHR=6{Pxy&)2@n*oFv@RP$jlXnI_(xldFKy4o-iDG$HAak-sgtuDk-s}L12jX{Dt7EI?rJTUnQGD7bZ3RDpY_J{j3?@EonZl4ZP~1BO;|qvX}IulD%$?fl&qac zaPHiZ-ckR>f|Bp3CpI4}vto$GwEhdCS6xwJ4N!rvC)O>@Ql17Dip!p{6)~mfK-N3* zs0vT@le4&9>qhv*p`*V^l9yjXBKv)O`r{Mt<$R?K@n zX@9&CwKNU>U=%F~{C7njot!|=soD3BkWgv?Foao#C(+{T6Qd)rT&j%^u~X-3u-G)N{gBkbvrqlCOdb)#@|Oyu*P+pFQ@qvvT6Xgpp!H8KP|v@e1rk#NQCCG z)dHs>r^zu!RX5L&)LQYQ<5Yabw4qP;Gc2pfoI%!0?iDf{UX} zpOBuBCclDEdY7ILCk95bI@?oGNO4)y`|md~ze(X*+{o^B@=#W}}U1}C8Y81Tw_RV~Q>l!Hwk0I2$`~y%gV?i#ev~;w-Z8~EZ2R*Q9%Mog!*f{6lx)x}O%fxS;c`(sS8VZ;)mOu%JCS-`l6rzIhqQaVFfWn&BF z>X~6-`nj5efR)vumsJnVRRud2E$q?s5NC|jzuA7N$;}8rj`2Fl?(+txT^wYimig76 z?lUVGl9`f{$gVo-Eq(9PM4tf8j_tG5p zrRu40TfrU$BYW%!WC2i)YqfALa@-hp<8KJSgqm z-d`{2a;M+2snLNI7{H0}k6*+=pnwbow`sUKe&pA$vp!KAQeSx5|^`s^y5F?^B-0oNNO9BcjT3OA^zniOH z=+}W_*BjB2Xu5@T}_egEB5VT6=UfL@!z`h=x~gr*^`CRp%5oG+Pv$bmfc^R z>h*lG6A(!W>Cy;VCU+>_!a=NOjH5l5B5*tcOGf}{BG!?U_S4!`@m7g_KPBSAg(nav z0l1?UndB&<=y@#yHw+4*3auRESJCq_^1kWie-`$0b`yVaz{EL~4YfubH>m9G z>M{oJpomu^349K7PhsVOn08yzl9A5BpVpr;S(}65Qp@7lf+uv!>#K{+B}SMskEswj z{^D@P{g-J?O@Lm@ZB#2-s7sE-D92zXy0#$Mg*7rK5gkD*elt8R7#}@$DD;(?oKHZY zVM3Z+0MvuhcMhzxjwiB+5Ird^J(Vq;@<2b`WV9(i5xiof-(12*JQ5xN!;RciBB=`l z1B5z=_DT}DQ>^YhCIn+2&{g_7AMEamcY3?b$ZM=IDPBV&{-k7l<7@S}7GbuobCw4^ z!Q7dhl}FFiXfv1;9^p`|0uQGbHK_&LpC0I{EDmGEkwYa^){77W8ss5`cnnt?CNrLr zj41!gS<3uiAcDGr-r3&p?AUT15M&GslprF9=A0u~l_<1g<^AL=T+yKjeWV~K1daxIS^&drG)QK|^JltL78v}h$@gpvU9zXg z%^`QL0F zPyOU`B1+N4beQB4M+CSM9O*M)?z)wzoCoJ|S;y6bRQrrMerWp^IZMy?%J0 z`Md+DcP`v5aRt1+;MCyk-P1vbg^C&W6b)xb-M`Epf%VEOVrg}em2=PRc>{agh4{0O zn8^J)g((joo&4e_rv|mdweS!sThFSn0c=fOUd{F_Gb(G;i{JM*NZ!!R_(f;~+vpL8 zaB^Jq%^^SWjfX2I4NMX*cYS=0F>#b90Y*UFZ-f-SfVIja#iI}iNH&7uC!1!6-nlRK z~yOWb6ai#L#< z0&Yo?amTqqyl_uzVR9Mnoe42qyGTJMZ?RjXSEOfUo3JZEt<}0Ffi|1H2l@;T9x0J~ zVggl$eauLtFUdR^N_}l}hC#v(AqYFHFsv?NVrnINpcLyW!3i5;)Too4VwVpQxihrf*RwVJHb}>&3mV z%Se&|(anYDSwo~0B2jhI80+v{nx)FUSJt3c#f~9@q3p&$pE*V%=A;$>Jhleo2;x+J zWxcIlVPV2WynRq%k!`$sWP*e+?YGJr18n;xrqeb3lsg|UFBv|4_r%Im25g6ue4-Rq zf`g8-yYI@f0S-)b%-Pz^!+NQ}`Qz#W6ybkBCM1v$3-O#qm`04oyLwW2Zit2Gu9Mh# zTNpArA=ZOmspJYfqkNgae-CCFL5XYoY^siUyQ`En$S}8pTUPN!{ntr9L7h}sLiFCT z#!p`&g^({pd`S<2h68W}!R(7w$#Q9EbET$rxjU~Wfz=ck|IRe(G`03oFO1|TMQ^l~ z<^@gaZT3XHk{1S+C}r+QF}ah0v$wx{CkOH z4C~%)8}hwXG;lk^xg%4czvtbEeNXQm*WB!M@cAg zDv}VwN|m3$qXvYm^d2sR<j+eQ0?q{xLar`bkrZL4iN^H}rN-{6s*DBWpZNWkzh zFK=#@zymt>Xz|r3v~UzjTBS3?o0aj)(oVkVdN?D}Hh-Cx3OmMH()vZ=Ng>Ei*knP= z2?uhEEsy-#WPPI`638c=g9En|$E2Dbs&`*#8{`N)9GR0%L+>4>nMP@abu^@F>1fFJ z97Pc=9R*fMvdO)sScqgqjhi#%_7L9+dPK%T9klk3ceMc-n?ztUOx%^Vtv zk|~uIT|b>lx`0j>n4L9SppTEX?|L4RDQ#x{L|r=Fd(yPwlG{^Mp8|umVll3;Kaz!= z;U+=1F^p4AMn`I|Fq-M^O=@Y}Zf}bUV=FYGbRd=#Wpcn+L361!0A*c04QRdt0k9PS zaKWph`UsImdy({YDrptPoIrjn(S{orgx!`lGJQWYc~=K@Y{*w9iXV_ArgQgsZ^OZC zBLRsBlqbvshc)Fu)GNgGA~%Ua!@!y?oZe0G%TBaef$`Zh;FjBP{2lP>1MnAsAAJ;oiNFc-b0jT zpo__NVpDd?5t^sH=E$^lyz360i0`-4r_Y+v1#^boz}q)uMAqaqyvy?z!mAi*|C%mQ z;r0R1HtI5X{ovm7n_cxbCeulzshxqi(@fk`rn)e9+`Zn{^p~4P{QocKKp^_3xjzuWziK zz0#vfGS@FgmA=QECNmjq@C~6bdPg+GctJcj4~{0)oPLqM4A<=h zhZ_H-LBDc8Ps-&R{~JX}`=o9Y73Tgg0hZN#Ft1wv6kt#SP~yPOg0z)()L(!5;9$Ta zVv*w8pKB zanX=>PqhCQpT^2z=4)*de~I?J{=C%Jid=$Ym0VToPw|JP%5I)>9TTVaZ^EL7?ixK)9e6 zNAQ8{=sQe$$2U0Bf#Vn<3>leJ$IpU2`t(Zc)qjQ5Zk8B@#GuTE+W& zlY#r?@_&rpvnbDO0cc#GeDQ4d-~Y~QM0_Uv@O%UZO1cBqB})Qy&9J4u1h2Ypi}?qL z!K}MSA&;&unLVe7ZZR(O>!@&~65RnRWdM-j|03P{P^B4R`$gC8rD?3Q1Wc=M<5MP4 zGc7%q88No04})r~Aq?7Fi5=Tk`$W?7nMjH{@Zt<_Jns0gM3?GT`SjU2tr2D@mWeS9 z$G=B$dbF`R^%-0X-}PvxF-bJ19kNs;FO+Mwam2&hrUGm?`}CE}vJP-vls|6L9FB2} zD#q>7LUx*?r#x7OkIh{qj?>C5L(uOu=WUykX4(LMByOfJ%FcE)Imq-ECe364(od#K zNzI?A7}|+N7-gv3UHd*uN+~WqxF@rHC<0vvr42u+TVg`$%8TY_9L9xzdBfj!ilaf? z?Dk~r|1c8u+x;ya-{jRMolP>;Pc+%K0b6<{h{y?oUyYD;J2qG4#*w4 z^>Vtn1nf8Rz9SupKrPz{w<(WXc*^O|Ey_MdkFy{8J|e$>)2}At%s8ZN2hET+hH%RE zu<58jNYq5D4kqpzVq_%V;yjjtyh|bdNv_foW2o7591-aXSQ+5=Ii%hajy@jW4WsyD zRvVL~u|kz#5jyr*1i3r{`X1dKhveJM z2Y>xst#2ZnomXMmEzAEtCuaKB%woDLJ!+(m&TCT!kf&fKUh^kWW`m-dtIk!nhlZN-;;qY1{WF3a> zhit5>tRxrxJx0)y~lo$@*we@xW@$wt%#?k<=(kN7xYc8c&x;%io) zRmw&Fv=n+(viN5Y&EJkp{!n4kV`34SY5I7k=?w;P2U?#>$WHSt_=SZZn(_#Y)gnu& zW_=YF>lD>-myduw-<>%$*MIJyy-HxD1mAOZ#-IgBh=38 z30@qm8KsVi{RwlfX*c-cGMs6u0+E2e6|qgjswKN=Y`4DR!>Nhj&e>>x zi)*D+uY#{L3#T0yVF5>y(-{ulf2mUoeYyuTUD?s0?x&R8N(2|_s3E)cy7lq?fj^M| zPK=|f{Ymd3!ablTIfgyUcfT>ze2B*kvMH#r&KBaZjO-bUCIOg$L=$=?L&6}T^8zZTJS`#&FUehDf9VQGgEVZhoW zr%zL2p3qmy(4hN_R8I>hF0QE>HKkbEE*C1ZHK1kQ%F)oaJ*4sS$Wzf`2~ubKVZ;UFaD79wBEL67sU+csQO;R-uLQ6n7( zOT^ikQ9~Z%V3V51a$IR}vOvy+A4Jl}Xm2(Q>*+unK^axpgN=>|SE&7|DcwveYrrEX ze6@n$F@jhD3p$KJiEL=Piv27lq29dT#RdU54zd(n$Kq9I06kN z(PhW6u@bi_=W$jQig>uP)ghzxmLMx#U9u}OHIvno1|2EI)a@hzl+o^ceZR5e6SpLHfoBMFL4+%F#bc7Y>q))T4$-FcIr z-&i$i59mv%aP;Tk;YeexkZ|jiFjo5^Od0y zX$~3rJ7lYi7sZ4snwTeyt~gx<)mHk@xLy+OVtj2T#-%?-YWGIn(q=b*O(+ z9d4GNKRtQtBi={zHYCuC{AQ)m_ypKsK$~l8u_WjVz)APlZ0%cD zcX#*e8H@Rs!r$YQf!lhFCSl<5F#`qfeC8mR+uEO1^}sU9K;voO0}s>>(_DXeFpwLw zKMECoflXi&CzeD7JFnTV#O*?eHzjT>)wI%=FBm`0uT$#qRq3aigwsxKEObZII-*pD z1DY{wW25+cn%@(PP0+Ngd(angc?I}vr2KYtW#O@&S_h!5Vag28J&`O^buHjs3U_b| z2_oz@529x68|+Z1eMWCnM$Db^@#GM-RU5`kxD`oH8x|8x8ELg?H-xN6aOXu%SCdOH zR8{3%)pSQcf08YRapT_!RT?M!gWcWl|If%E(uSXan}_5c>m}bF`2GL{gr~(Z3^>WJ zz{+jJdL~p=&0Y6u!$8Toi~T}W5cdyO&i(7B*Ez?^UV83pQ08;9}FA*n3l%M6gN0Ote5L2e>UZ+*<{0%DvnA*j2Wjnv2G^Z)mGf* zWAR#xvO{Gcs@U1a=v~zL*TRTSpN9v6ob#EO`1T5`Sk8t=oV4YkIKE<@r^f0|S3Lps z@F51EAF(hq+wY7k`)M}+iTC~K-3WaSQUwNT>l+&m+!?_3>fc}gHrb6Ng}6t^hOSWHyZ+qM8BJ(7y9R9p(jZP-e8E%n;XGGoKrIOq$$R%q8D2< z`n!OAy#xaJB>E_RnYi59>HP~{CgN(`5&QjYn)C-V14bPL7jA`NJnT+shNUyS*GFH6 zIW%`68qFB;ozUztD%9=$g3bL^XpNU+wo>EcRfO2`{!HPs@7}Mg8vPT;%Ntiox!k?O zL(A0#^nshYW7Cv~kT2r{ovD5ib1D)t;@P@-DSSBRx=9$S2vIKlj+I>}{dgX#KIdG(14$e@~{csNe@g5b8MMRzwa$64IQrR2QfG5H&d z&yn6kmEKQj?HRnYpB@_2a8)f@G{r>j0_L^I7ZL~va^QbMGQUpXc^pph?E=}D^1x~!U<4m?2zVm{T>mbH}gk4v%7@UqS)GW^>owGzl=olwNN~_iKSe9UUdmS zK&{7Ly^?MhI*gc1moM^YQC?}R*~XP=-B2yr|ApmkzHMO_-*UKcjRoV$6{+^!{tiz; zLitoha;muXlAF_$>M^PY#GxL*Q6GjW4IGy+u%9?EFa8}R@N+XPtq$A1sxK7TRs1*kQeGX;C&7+O%#~t-Js!2}yJ}bO-Y8hM#REb`l?^wp3}~ zPp+hk?o!Iy5Hvepwr0Aq$=>P8Pbn zGF6D`(taKqj;Vw!+SCv>Q=-iw-X$=~Ss9P4qY+v=bLJTVFkD+Kv3u`M0Wt2S;0T_D zuG`_Q)FYHbp46J*gg7fOum@&u|83d#xt_D#h!mLYtB5 zb|uoPC+(k1Ig|IXA`d&Ge(*fJM@5aTMF=P00hSY9j$c%XXbt*Rk}(&GP)^JmcpwZI zw|?!Etm$f9F&^5u2cvXf>agOI{$*m&9P z$Q3{4-z5-V&C$*IWFLmHcHQ-1$XN#4stw0|iA3wk3cA|xeQ4u}m9c_`A8}n7=2G_8D zS!23-pA0ymzasitrg(`{(H5>;vbY844T`adDgh*rODzgJ@g@WAgFy;{m`DD#5{8c7 z5Pr9@c>JRWulS&2w-{6YDIwVZqv;x>Dr?_C2{ae{;X-U!%J5R2=H8KNAJ)My`w&59 zg@~Pb9uYOQE8lly4tBOd;N=G%PSGV$)eV%x!#GCb)ol?OX3j5sLR$I5RFFIssYct_ zI!R{tcd)IjAZ+5Fbn)J-=m2nF2%{g_s**yQmjqd?Y&}$c205k8(BtML{@+Jau&d;C z^(%>h(JVq7r?%{Q#QB9#DqUI(BE=i(>A`!GXb2n4M66X`1?S%V9F3FSeSq469j5TL zXwcNR)YXvHC@nd4-d*fTA26 z=}u+|c@u2OxxsK9)Kd1Te@CzL^0**ZOFiV7lkf33&@Sn_?o%eqOB;prcu=J@WLd5W zds=~hQ6+JFc|`Xx0?nO$*PHL|ai-$Jx#7C-Et`o-TJyrR*u%$HdECsqY;%4L4IBt| z4hw3U?ZH{H7@3zO5xi0csRGhGsevz{lK5mp0|9`}^9RXz;}6>kh|beUXx}m|BcoZd zFH$b3kY6jnf_&1j-{9<+lW0&#lLqb131a&{&kdy8mLHhB?9k)U$|{@0>yj7Gr$Ew5 z3L*Ug6a3Of)c=#!Z5*2c!=b@SBiB5Lb>{mQo-kCGW0#aBUtvLtCthQ0P$Wyif8PTb` zvT*-Rm^KP_A&#K+lUvBKwhf;vLLig&b@VVF9FTcpM$)Kj)Q8>>tFYc#)XPMM%c~C$q9gR0+lRp%iF7~ z+ASM!8*;v!A|Vr=Ux*g8#kaZ@ht_0!d+_@?)4?i+7Y44sO`6vkQpHY!b3YwRe1>KR z$U(1f-=rY`fD-#YOvRaSgg$qCERufuG=O5xMad7jlyo#287CfG&|Bx`&w<#g+pBeW zJ0f@Q#MnZGfoLl6EJcS9{dd2qyo2sMPTXFpA#-<%gmk8Tyn;Z=OQ!!1Mp(H^g7%J> z?=R-JO2dHeL~LZ;mC+p!NzEN-g1y;>`)9zOC*+(c0GoTe{}bo5*%@82PmKC@LmX9X z_FE=KG+y29n&hJuA8U0#Fnj~auHP8M%P2GB#V7sd=PJ!{3feO>GXbJ*K~J0&iQmoS z-t&WM+O=3ktBG=zJ@-H}#2}C~u-U8n_}wSd4%3)MWO`#U0{Ly@t%naZ|HrqV&~T9Z zVVF2jw~$LDh#CqtJU#R3G0aUtIdcE|%RM|u341t0^<3IDtC`MMAzGQNk3Unmyubw@!Hl5c7HK8<{j( z-cf&>CatD8I`rKTt}FZV|2O<1@};mCgTx zv^@WUyv=YClns|r10J2cb;xZ{kHh44B{>>TWdcj}7ZUPe+wu49)dEO9QRELr2!wtM z+6l0YLd0=+=pFCY7eYerfj->xrEcI~x0Dg*(I1|R7uRfAClpl{G_F!yc(}hmki7sz zB|wu(rdXhTqas>H=5#>=p6~bX+iw^1k!;X^JGB_dT{Zja=Cx|kmEZzPOR0_p^+iw4 z2n6Pny%7*Tw_-aKa29j(8>TL*A~!E@Q109_2aarrv~|cD`oiV1 zH=GXI9q?C+!nunj-REl>%wbM;S7HA%4h0{*;pny)x2@U%9tFT>Fe8>&pb{}jvfHpA z&5d>sQN%#5%;#m^nIAi z&gn1K6Gest<?3e%n-B;~{BqT7#JKyv3zeu)r8V}kl8nC3HhY$Webu-DJ} z!nW1XZECTTj?hZy@8ycNd5Uxh3g#d1Xtz^t-tV%eZzyz3Bj)`VSSw_$o4Z?0WjE`M zYsPsG2#X6m9ug>35^1?Qg5&`J{x%4QM3&~Zb_n0xo&Jm`0%lCs$2g~ zVpmH~l3o&@05V)vT*N8yqb^PA54sCeJ&u5MhVHV{|5p#7(Z)nM)Y^;cUG8^jC`y?mlX$g{XBtGA0^;k4+JUC>rg7-S#iQE&KC zarD3DMIaPb55hA~wNBfjc-tilkwrS3W3<1dbe$=EhD^aiz=h+DHfkZWNmogpbluH) zTa#c-RiR*=7~?Y7M!_=wM_1$xt(Lqa(t-M4ztV

      +Jekyll2024-04-05T17:34:44-07:00https://transfemscience.org/feed.xmlTransfeminine Science | ArticlesTransfeminine Science is a site for information on hormone therapy for transfeminine people.Transfeminine SciencePuberty Blockers: A Review of GnRH Analogues in Transgender Youth2022-01-30T15:04:00-08:002022-01-31T00:00:00-08:00https://transfemscience.org/articles/puberty-blockersPuberty Blockers: A Review of GnRH Analogues in Transgender Youth

      #I_w+qviaAD%8FIm~8rFTKSyi|Vm{?|*EroI`|0PNyz7aGIm z>R;+77d+5!Bnw>*iVEQjH!cY)#~4d}`rI>&QD_yLaG41e=mD|?1`fz5g5*x0(=?Z< zI*Z;B?RhF;_d=wq1(K%E|MlaOCIF5|3&>a_;Id#rUIZXXGi>M z0gW>ldChZ7O*JUvpk3&Op)0LQskzolw#&Rc7l7AdOUl+Z)J;sGw#^CnWu6MS#I=0J z)xPnprKHoR|M<_jAcVnp7Q-~>P0|Vg9v;%l)PMKG_a8nSk3%37fLSXMK0p5W<6oXj zWB~~n)@Z~mrdy26MmOx4g$*$bH?+so+pmo!h zsj_CrUQ%JC07(n!Wqy8an>K)L+3BF` zhQQ-t}XlZ_M)|w#%ufWUkZhq4A*c}@Z60 zu98t5220keDrmwnO~n9Bbgh8tyBMo5N8>aAbk>1t_(M$_Yk14uz{#hM>a62 z+93q=1@_$^{@eGX=M>i^Dg#MYR966`l2iZ$;&0s0qk$|-PL12EFLY0=D(Yne@oJrY z`N}I^xR-d@4t^bi)K>@?h0BZTmL;mMil#4TYYmFD!mb9PUSG%7LVSZS`_^dR?&>Ms zWVh6X0iYYIfK+=aAc|}>=3U@+JDqGuL1i?_<;03AF1fH#yBB5sMWEII6zL5x(L_^2 zt=N2ewbp3zC3XC!Z=rqzwAHUnFDoRT7JO&^O-e052#EhVU^w((NdP=hiGss8ew^;_ zrnL+*7iS%&=l}Y%2FK@R$>oosbDBi}8>)a|$Z0S*KmYar{(t}aCp9XEHw)_e6 z=l}Kp@nh<)dVTZ#_eY$5{&a?}49Nxf^bB)+_b>nBhj#;PaF!~dlAwamKmW(S{pIsg za#PNC22bv|tUsPOTw~>P)XsK?GNWZU-F5J3@H|h=Q1_lhyPMH3=i5GgxO<+n0Ox24 z07B?HMH_Ct4tr~dpn5|a^RDf>p{-RYw6E(9m&x|_xj?PL%3EqBuAEbj4GPx;#Y6(Y zptZUg`50XK9kEpMWqn+h{tui}gX%r~ug`8A$75%Kp8(E}_jmO;u~JrRfH&_Z0D$Sb zaU8qODDVJ5++-bdO4Wc%^;V&svkMlFhwdm-T`3Ij7jee}&QB+~|M3%RW9GD^%1}T} z#;kLU(UAt}lHd(tJsn4h3+Gc@>p>h0v^BUsW@j}RKq5a}^ZER=4)0yxbz|Q-`rF(M zL)Vekn}WfsO=|-x2)nF*D{M6KbU!b0+qElR@_H_R{XgQgqQ5#~`F|bWf4CZlabBMO zQ|Ri$dp-Ux|9Iw~P51GC{ErXr{`_!X0ABIe(v8k-~RZ6t#RT}TQc=g z82?_B*_4ac{~T}N3CMZq&!TQ`$9FfQ;q(3H$Me&~kN^J1KOHIFoo4Zk z*&O=cU;q1hLPVY)-@og}5Nc*@{ecREZs>cb-Yq)4N3+Y1{ZLp)WB&Os|7QO?kXJ!- z?}x+9Uw?%5@|3PZisHME-y`&0Kq@8uuo_rNfRiVjoegw6n*Uh+kzvB%=r0(?k3W3; z?$|A#@_IgHXFz8)gbuvSOTzo#BOa zT(dQ)`bDbcD-BtV3$x%GQBOgUYE6;s8@S!ETQ+xwz5Su<-ctS_nuvvYLnkP$ptLantg|5Jg6=TYCFKI^$kk;{l>t*O zLe+*lL*C^GK%|%mAjed;wh?x4%RVUOCBqq`JdE>3X|)L*VqH=OyDXrg>kr36@Pt}; zP3ie@Du6bmG-{45w9{k4GevV8vhd77^otul+uPcnZ#$E_Y|fL+$9a+a8@Ai{^6-+zC5)mdWCm+`4WdnC?zfJ%Pr8a$r5G_yYO7q^FYEZaDkXZmS!!zr=A2Uz zFktH^E-8Ur(9e?tlu=|Wz>=1EU6TTo*85Xtw9-Zcyu$T^t1$3@uvntaR0f7L@@524 z8vtd)P)dQ_9^MUtK0Qt|lR=DW1+=!7G{AW++@Q!92Bb+!tM;5ydYYCjV!K@WP=S)O zv`vdzfh^EfvG!UYywgf}BO55Kv{7;?+PsYVW{n`Dq;WpYI6CEhC`%W4IcrDI$S3Vm zPDI9|oY+v;`KFHVB^Own|FYWh^fawm7=R)&!(h!=7*$GTfyin}JJPn*ND5V?vVgQy z4IR26<&AFGU^{@^VeIN-yVWOfnIo`QDZnm3Ja000A}F<2l4g3drAO?PEJ z6&NB;%XxtS+HA7*Km*be*;wP89gH$|?2!P3?QpU3P8@Gd3=xqwOu!PP5`laezW47A zD236YB<8v`H7)`Mvi8C(Fs*vnech0}K!cTWgz=+@fcoB9XUE~@dQ`lwbIh5AStL90 z24a07KiH~Pprc>`U_^l%ywjJJyuIKmeyQ}JehKM%=@NYVk&g7^}U_VF7UX=-c! zy-w>k{;X2pK%u{S-?x6(uvy8e9R#{}-FNx3_9o3T7pJnf{&<%(_)Y%0)tBn4-@HDO zdZ~&+VpNo~KBpqZ@)Rx1KS1_I7$S=SWv z#;MQ>2GF2QpR7D3gx>Z5JkS_ia<(waz&RvCs0~%w3hKI{bD1#oCS^zyfcXCYabjat zPHR@09C>ZQsg%OSDy>PQAW2;x!FfHMo~L<5CO34);~=zvbF4(rpiN+#;f^=jcrs0z zN&-MDy^9a4z1Vwce0+6tAbEM7Fe)DmWQft>ba=imK$*L|#z2;W$pFvZdo=qFHHpx) z+-tK=k85sFFq)io-O(8=!VPPUsL@zgZRl(T3nXh=d`T#}pqSyNZf!aOpa%nMZ*H!x zeQymavkK#Aj5ZQwW$gz&SO?_7sa#efDbcM#gmVFs>zq);=l>m2GFhj!oToEdB?nY( z3BrKQ&%#~T2Zc_A$OYF@;(=4CNRCMnpto%_X>F_{pmAb2A#3`>M|)I>1eI%vag7Bq z8nuuD8A!>Ej8R58re44h5tIai%^<+O&r%Rv@BHBV@yb~pv8I?xMa>2t0F-aVV(5*? zku!w0ZJ|-d^qt*y3b??!pc-kS9peAy%iTxa(!H+`F0Y=pUxb3K=et!$+N)OLE1vhI z<+rWuT7gKvl1zZ;3Js-q`1Ce@yNQI>n^MeXlMMg{6>Z}!y+ZdXT{okU*JF$MmEJ}s zz13Uw79*8@%Tc(*dkxk0DEg`+sb9M_eCZbc%C&#_@k_Txp+XrDi(H+LBr-G5IXwNC z-VMFk_GMK>7#7;~Lt>UEjx+L<<2n=8oY$hgI~Nvxc>-FkXcd)e)!O41D`fzjAJLjz~d470!`1JEB!8$;g*Xi!l!xXWb`B@A6%l99?e>XVW zuuP{ZQKyj^s2sDvS@S)-Ry=1-FiJFS+5;OjUQo*^-hcX!zf5zMK@yjg;ynNS|HSn8 zBt~0+SU96e5lGBsUb)mh^gsOT5AP4bkXLAu&gc6%6#!gMY;VL#TsZ*%A#xNu9B=;A z-9MemaP$2wjq7y(SYwr{#&_=>R&>{glHiYr&Jtwz&69#oK&Z<}Gr{9 zR#0hDOG>#^f;N?zDf9GzE}u?M4|B|QHMSepm^!Nq3qwN_ z1f*awcsab^JNN>wttqAT-r(Dwb@>wZzC6RE6d-x}Je6DPO;6I+?96iW$vqZ9$+9d4 z(mOB5)UZ5tDAm3z$Z=g~L6=L6A_fo`?VLM$Z=R~K*rHLBHCD*jPIMGBj%Icg1cVw9 z-n(Ve3+zfsb>;WC$-)Cr)b)B2?M>}={kd~NMYycr95vc-cQYU~0h{S1n z2+jdcD_!REq$|T(6lDp87*N8-G%~|Y&SGIK(8`)hP8o1s+W=6L5*-X+yiWiN%dU@P z9C$@EU;)x;$pU4dYZc?+Ns5JKHf-1$FiH_{TepyBh2SW)6`gh7k{_=Q2AuOLm5t%S z#M~-dfDA}klhJa9CBV2YI8W%dv+GZToh< zrcu#!-HxM_ew}^-XicaprFLude}3$^y;|$OciValwY|;v_P*Y?-rc@>={{83;411{ zL0GFTDcl)87h<~FG&;Y6yMD93hp&^^i&TDtHkzCO7%UPVBQSW}t)Fi{yc>EC01%Nv z9O0RwLyVIZ<~vT24jcon-f+dg#O^Q_L9r#oZ&3N zF>?dAN<{#6K^vg+eIV4BM{({v1ItNnhqiq*QHEMtvZLZ96_yOZxCRwmFtwm?OzX15 zGoz`dJo@9+bq8Y!;Q8lIfBWh5B!*Z@K|J04<H%$bm>1j1E z1d9^awXmV$Z^5laMnyMXzKA9oyL#^Y@c5TM|Mh7Fd8Bojndi@sKmPBs#u=Wxw*V(# zU9zA^EtyLKy7%9I|J{wX8l+lD%k$l*=eX|3r%s{gbuKBP>Y+pl;qdWK@4u(c`O^R4 zch}*E)AaLSfX7;fci;V?Qw?G8j}iXZ_lDXcm4&O6EvsGQvYZ^2{y2`_7(iJf>x?7X z>gvkC{S(HLS^(5qr6H%73;?%4NWWmXEV&deRTGTbsxI5}dzs*^qCtf75}#HP2ycrG zsx&~b7Mf!!r6jYKd77TjF$$>FhDw?U##l?LL6Vdtfc9QHl2!;gb0AF~_NZje2~xEZ zC_i3}JtN`z*n>8}%d$K@PBUyZT)0+fGR_dvR)Z5=D@$1ctkdVUTbJ{6USn#BjP{3{ zn`>7(fK;&NVuY+L<3lVEaDSWBa7(%T)Ki%KS4}Gt!Rn25$bKg0C znhP-FA@S&qAAg7`<>zN%G&uANaydspny>+&X=^?Yy#Y(fM5+}sK2qqqK`0eDAz7U}M*5$^rwp3Lt2&vDym2I|KyH!Vw9m5ka=JhXkc!Ei5z- zo*Qa8&2vh7Y!Cod42y6}8Z9pOXFQJ9SfS4LorMd=pzck%ZE+@SCLC{h>aUQ{6{Pmo z<(DMzn}y6x%>4x$sZ?ukT5syrdo*g>B$1$@HBiA{URt4OYchOAH2rO3N9~A|=C^*^ zKeIg4zti-4bBGVkBpVDm`fLCqM z4XRqxdg_xva^wI=<)T zh28_OLuW~1wjDSNP!~)GX-(|*8PmF^2xn9S$iV_oM3#V7T3S+EmpN4y?Eu^N!5X!d z30j=)f4X0i0gz_W>%)(Kew;Cw;4HGh`_6v+?rQXoqzNEZB$=%p5!X`Nw!7n!GH3qy zUAthAGBi*NXMX%V-9M}tx*>pIYQv zLQhD*V2uJ=OljFfo^#;>Ja=8dJltF@y;lS>#(QziveD2Q)HMAa$o02JZB3AuoHHOC zb56|PruOR!Kx+sfxva~&azkMN7*{aX2B1WPoKnuK;booXHKhjS_R6U?o_y~V3MZSa zccJUNSG{SHAYGBwkZv%_G?RfUl^D>s?*AdS!zeAji@N$dt7azwHve=pw?`6PKwNkC-&IzIh3^vH3GdJZo<{={is zl3X1yJ>E@hrU7n9IsmrQWWQdo6+rs$H^B2lL~h9^PAW1 zDdyXRtZtAw0QwRUUwytNdc(Xb)xHFvFI*3OiFSGqcfaY@2ncE`6>ELD9_=A|xISk= zTJc;a0qEK`wIO47k5yDC-yIKN2za}s*0|)K|7wErfCelyu&MP5L7VRS<3e-jhT}0< zpnq@Hm@2gO$VNLTFv=MQ#`<}nwZH^#m`Ds6Cjja)`ISrOH6WbQ^f-rV;lbuGVCV=$ zS{dC6a-Qd>=^S@?M?W5V3*o9ZS%o~G76Ck#2NTQs`NvNaD8L=XWWgBv?%koYhPHK_ zml+$hyFf4;SqUyo=>S1qM_?h zHDL{q6mtw93CJPg`s$`90#H#}TAzRZ^k4t=P%5;sfwb-l(Cdnbik^ZTfB&c3Bdy8w z){Y;p`#`Ri#?>>IG?F>T)Eu|nh)r9B!@_3%t2tqB)3~ps5p_CVD3K&d7t5U0O znlv`2$A9J_+uD0lYgw190bAn2EYcLgY*kJLrFKoBtw^Du0O94dt_!1XB8;Pf6q44q zU&NH-G+={O~Y`!xgHOlCueFkrWV0uh$?jB$_h=YDvsd} zwSz*wfKaAQu)m9%O}kaCKH&J&ELhN=ab>I3P5B5A{dBd z#MARB$5iNaUgvB$gEIPK)jF76Fmq4aciVBTmHw)3_c}ErtrbXq$y2yIORpw`-nnTN zT321$n{@BXIRp*5wjBebchtd`1MT+X8#w!)AMI5>y0PUqKL%(mZ~A9~U$pn|QpJ5; z=xi5@qs#begWN=EjSD{XlFQY-3BDb23yd$a_`i1XZ#YBhOHKI_vB?bNhxt_VX-1o8 z>YVw|5h(!rbtBexLtmwU41f8MkN59N-9A`Dtz0WNC~ZiYaJ^cSR)i`iGuZ z)=;6#fJUe*8s-KlA3}Cd$3ruYlo-XZVao|0(F=|Ly&cTo|ZL(tR4EkgPcw%k_%_lO5ystlUXckg5+8N zi%zUm;Jf!n1Cd06Eb)B*>2E*YKS$A>S3s@n4A(hNfXL#E{@uU)q4$`R_|T8zAs8)0 zL_;Qd_u+Qzs5FpmsZ>%;N}4{E=^Qf%(8^Q;t%#iM`o4FT06!>attC>5XnSJcLW{pS zr(VyeS}SU;5|_9b(#%T~X#&~+n2OYk$MZh4t{P3sx}FMGDU~ze`i%;~Kt;c^v}m?@fm`2PLv_2?{m)v88FK6_(KX|)QMrdmUj3Zuqj7b;sE zdt(|Z>S?;004U|X_sMX}EjCyf>jP?@skSnorv)QQE_ZtdrIqms!VoSq0NPB7K#&Tp ztT8pA)!KB`&=rkK(NM+$s%_qC_2p)~vZ$zF$wlCB{$xEJg#Z%cdLSIu{MU6_5F`w} zbGGZKl#-#1MdOr9Lu0pDzPAd7xrapykxR{^GOd6}kBHq!2|%&D=B>f&icQNLBN!&21HjZo37C;MElEHdZ^3D(5RUJs7`a3^ zT^}S0gNW>)D-It%*k#Is3~j5@M!|?C4_zgIoV9&tjSZYsPIKA2z9|fqwj(~@z&W={XQkKG zNog;&ke8J4HPlC-TBXZ9tY4g5F8?ajw%yBr5ct&B|JmODL0~{8bX}e~5L%kPSVcg&lXd=)Kuo_D~wpyhlk{IWQX(k@fY}eV~bQJ+K*rddH zeORVbY|sum3|H^o9S|j9Fl3;NbCv+3`7xjM-MW^l4M_WABqx3xN7orNrY0hJe)#cD zPRAaxhoqDm0r@WwLCjU~*M7Vi13`pm;|Owk{yc47p;8uJ@?2uhFbLW+Xn6PDZ4Z8K zWnBbBZl8qjZw8X2EvvSs_4)IszkPaM*J7171YYonvA;fa1~}bkjMpDVugiK?;W&(k z;1rh<=a__O9J)RzDlj@I)l`$bo*w=pb1onRSSLk5VQ}u9J@$hq2yT1Q#%@hBbFrEI zC&tDbYE@c^%W6o47?-WRAOLL>TYaJD?(KR;l^oX<8yO&qbZ(vFx)uglmr`m;DJ>zz z%mvoN#2w$P!|`Uk>X9c*fyVDYyc>J#V09JL5IgRJ(Le#0xXtfc0dwqn17Y+7)hcUE z@$q!>p)_Ut0BTq!CIR?60u)>@Kk zR~T@P%V~-+!DtEua1}^qW|ZX!$z@)aIhS=!5w=8vV3T!EtD7;csYdrcgl0G`W~x%; zRP-`i)PycKgQk%Uh@7;z!kckC9uFOfAv>}KVliAAHxYrb2oXvV5m-AwWKC-<8xX!E zG?D=t8DLFZ;cb8PWjZrZrX1&aNdSz26*!2nBH@(eQKSG?yg5hEaP3^XRmao)-D4q0 zT_$X%W!4QO7_M)v<17$C2N+))Q?pQprGxAHt_$8&f0pPVv7kQ&tK=bTepR&_y}XaFFMZXqBRvsG#8i<0th_u!MJv?wTLE_j`dx2|Y+l(-ym=dJ&i zW7eG>|10@t)o%mk|F1@?fYGEOS~eYunwKRLl%@+76%D0TXd<71x~s!NSCDnVTJJQp zYHMRoDXyn>t3U)3`Vknf#)H*ON!8w9a z8cl1hb~o5sYAUZJ(=Cx_5+ZWd5r7iU%aOFz&UYXotSIOJ8XN#ffh}uJnKmn&q$vj& zV@%gppn~Je9yK=rvg6Ea1YmceG@ur}3*S`z>t3`~ns5blkAf*EpgJ-HkVl0r21v2Z z=hIDuu^waA1te*TbzaUXVduqd%V36?9KmqT%QDBv+@vWmaIq?^wQ-r(HHyxF?i8Dr z41k(oyI2T=KR<)Z<+-Fqq2Op)OE)rsNlXD z$h15?pV32Gyn0a3B&P+a7yw{isIyg>gYw^mM}835iLZ#uVqJisUq$abT+#A#k(t?S#mNJJpOS>JnW2>+A#$lpBna^Bng z=^u~UL|&VgT+{|zeWe@p+n@6$R5gGvRn48Z-jvpAqt|cBh1Fo&+{w$uY9)FrNp2P_ zdqd#TncLm#-hSvtN-I*kG)vv7h+m2%7yNhyw4yC_u6PxLHFji?Y8z>2%Rz4tWM^Do^#q(Ww5?6vDjjAen-IsV>M7q-*?CBJAv2lFmwiKLc~~Bsgg7#SFWvzaEg7N zCkz&Kg5!KvlB_MCKHtZUUuOEQ8+y}BfFw*e?`;u(W5Vc6x(Bf7+0XfWKVJ7v z0Sh^W@_f3R5@gB+fdU?v=P5Sp57(iLxcQfVy}{|`@hl~=h!C>t`rZ>n-o5j^r5q)v z_5ASTr%!8y*U5UFFhj7~SPr+>dVcupqw5AcgJk(UNk@vPwi=i7r+@p8wfp|#?<}vP zxz(yNX-|^k^zbZY&WwJb;Cm@R-}ipJF}<@^wSvxTtu!f8+9-`mt$q<`*|L+p_z8tp z0VPVmXiNaA)-Acq<|cG597zm4LmBcuSlXQ{6e-9q--_C#3D>+ne|j1SFj>kP6P2<> zMh5BLDmVpRIF$nBVPK5SsTzB{`R?X;6?7e^6PxRg@5at()fAe7OV&{NG-oMQ*NP;p z6m?g(SHo(OhcrntP?L4KKhNf9{IH^)k_Wij!$3D5fA@X{cv&;F z<1DGhCDnDcz;L@x!n9eLY zmn2~bEMmb;In&kpWL*FVb?-eQE)Yw!@(PJj&gfaBjA4h%u^WC`$XO^^1<43I1 zV_a)xsNTZHr%$szt zwgxD*(T@~B7hb3`^ku)d#S%0qBJh5F>H@8~z(N$D)$4Tg@^QAOziw)p3biS~)Qy^O zL0WDs`4_Jww6-5`y9xSop4W)fOU3dMgD%#1t)Xse%BZ!zKu7BC@*Jy53o<6f`ddy3UW!Smt?fo`Ayh zbdK6tuMbyFxK%=f5tQ`!*MI-%oN@CVw0Fi=N2E0=4OnX->KF@QGsnV;^_tdY}HQ>jq!fr8WdX)z?Y zw#a12b>lb|0AL218{Zwy_fu9*?ylYiDa*=Z3<0DxS`phj3$AqYotz5X_^waO9T*K< zQITDI?8fW9_w)z@lxdz;5s3l}&ilvQYJ(ZBKO78qx4-|suk$!g%i}pm*nsH5&2a#y zbU0XolvA8intuHBFc*Z7ECr3!a)vR2uJ?!!e>-0}+oltj{MQB7+$5uM%=7c-N4Db+ zqb~DGtqQm7T(4_W7*KJBx7MRAV86`Mk9X&U0BkG_F<>16`S-v7?&jyjBDn}8K04nalfd~9OQ{~@8z7uZ zVf^n7}s^)Kp%x}4HwwM7(B^~ z;)td_)~Uvq5V9}4UylocTWgjJ<>2j5yXr4qj`Z>u^CpB=NZU4)`;(_B;DQ}`M%C_f|;U@cl1cHWiO znCr5v(E+B{`4~&p0GzkZb%wdD%bE}XgFrh!AVLw!(&T&?ue?}5X`}+<;fF)-uh!LFA845tpj2cQhB3Z_ zb)7IW8;i9FkRe3?6ydRIvAR3nTwh7j&6m3gNay7@B=hE3)r81$Ev^3-WO8NBo z`AKL~O$Lw(tah#&`k^z%TacK#@rm}T+~2Q$)C-_%17~b+s2fSd80{b+>onLXW1J>S zO4|#jMJZ^lp;2o?tDNF|j!Z0o%^@~63>dZ*nzRP0E~wc192%`O3wY@6{qO(y$7}DM zW*$mx{wg@y8fO|X)`#})V0GmT6nH3Qtq)=Fg~$enT$tPX>F)6qQ-c9Hz=zJKloQ|$ zYO>IE<9CU3-UT87goSJ65)EwP20&?3X4W7$tIUy*Hjyl2VW6n7LaWfNRn#U`H?)n2 zTk%DKUhONKu24W*=2(yuPfu5#q46hQh*g%pw3aMgm}*sDAH; zI~2AW+CrLCM^Izq6`*kCIdsEt(>ViJ=Kxy(+x@|H7HvH}#pjtQxS?|%UP!qNZJcp^ zXUKG+ul+Fe+VOOiR|6BsYSm@Gb&EPt8Q473LAEMOL<$Wl#gvS3pv{)OyLorh_s%`T z^NMBpGI6Cgz*{E@3F5r>2CQ`eREQa{B&D{k1)>aieY(4gQy@?lfeG(!udb~R1@xU4 zhUvQA8$dN(_1DZX_2!>#?!WEDef`t7o;s!FTSs~Y4XeQRny=oyHz)sL9aCMB)T+M` zRCWxf-gybSwpTIN0IgLnMT68EV(KqOt4%7P8-B&5uL96&3wm3|_J3+9?BP?_uSk@C zXXvV6`+WP|-F%8E{ka!(*B@?f(9+X$WZRyeJ|P#$r8l61#PcR@!2l|=ZmQK9=cmVq zyVG-i`ajNsy1U9~QfR``YI#va0t^v+$mPp519G0NvY|_{KxF_RZM;|D~#Sw zFcW%#H5X)%%;sG3jwxWOG)oa0Zm+$?)=9L(2XT3ta)Bipyar%Y=vl(CE3qv1{rH`^ z25J?N1cW0#es?ooh1i0(?U_yhYFZ1IO3tSOH!H_$vAma`XRH-qFLAim)thd-KHhwf zp}!gk&buyl{_ze;K>aXY9SOOXnV0z#SJe1vKF!Pil$gUXB2U|9W}TRyA0se(Gnc%i zDF{n4sWM!p@lP@h1`(PdX-(qzZa7{a`!ygO73aLn^YSpA zW)@%|6A;2Mc)lw!Lt98T##RAmAZw+G$bdl5rU5`nCSNK%JYzPG@Y)g^l#&I2y+OZC z@Yh@5hWcx&65EH=03hd-!IJOZ^+M8r`SbL2UYYr93a)Y)Jcx_~I2@*WV!@EO2lIC=ZKmP2T?>prc))jz8r+nX8 zZ*{dtG4GDnz~u3v2VlM1*dzczIGRIUw(cBlnaN%>hl^lEiF%z5s!O`}<%L?dn(4M9**4~{qxLsGtp=3u-~Hk7X)RHH zqFnX+1)Y`0&v&QnFg-sB!-(Xe4z>jE@-8GJjfFL;$U0B=pYP9^pL7I(V`t2!7hO0; zkvu;gaMxCl3zoFu^zh@S^@@VK0%}5@h6bgr zQY}Ke%qcA?%8TxK#&TwLB|S)tQX0_y%G|C`Pg91o)^J@4ECub%^%ywKvt-;F1*vge zPEaET_wM8E_|XfD)rnV!!YQV;q-tF%uyf}!X4%2%R125^4Naj`2kisk2h$Cm*|H<6 zYnjh^#_xvf@j6&!K0llvetMn(Cx1yLZCZN189R=MQUFWHE3Z!rtOl=Z$!iS9@#rmb zS}|HXe7AVmbc$XP#1zj8Qn)PWD7rv4z*=X?XzGuL+d~)zZ2t6nty1Zoi}WiKW1FMu z3yNv!d|USnw0tJ^QZeskWn?X6G7TY#-<5a zN=_0DkZ@%-yh9##eP zKP`9jv~pasCTBL`(M|$}4lEOpmxoh3i9x3jf@oCTA8gk=d@xKkvhVAHM$ZXo2L zxI<@xHAXd#fN6j-WP`F6Fs?&q4GFU}kXAkfR51r(07P)e+uCFR)z$_>#Eg2L=QSe$ z4mkp@KVDr8!?8c!r+kh%e_1I@D$s_U-j%kDu}y;veDL5}{k{!1&S&S5+DIDAmX5x& zDA&Kg89R~!V+^EKsC_xdFEX8NR(!2e@DIY>Tk87@R{wIOZ|;^};_d4abFvirCpOH#Dd_JnQClAR1}^%gX#D0lFVaWtCGp&E zLfya$+n?#zWBUf%H0a0g{`8buDvyY)R)2Fd#K*fopJKp#J_#tW6d~^yYxgu4wQ;Mp zwpvSBPmd34s+=A&SXz^ABScq8Q#`G4eVXS8TdKA~fbk)M$STtv4#)S0P6;=%&I|xA zPo=zqYdpU?ARdNY>(`gR(Lk-5EF^RmG1}|#Fb-ZX)^XFLUJegj3rxt`uOv#zCVgqqPuu7;CMy23EZ>pWDJ- z;q~@N`}!=jI+b-hw*6rTHIOyFu!vI)Ix92 zdPn5U3C4IlOWg4R6hi2R&JysH=XhoYuu>0lQn4F1i_}&t1L_sT{RJbr7s~);LVxo- zGir-1KDt?E^Wo+6)0CkMSDD?<;57SDTLY~$~2t)*v#PQrnt?0H=*J zr@FzS8)0&Vt^$Z;sLym@!kd7yuHJXpAsug@7QMR%efiCo zh5Fmi)$4^^V`HAHFGqU)_`G@3u6Xu~gI3^IqUEcxg*}BY%!9Ybc?CdGU*talY#y7n zw!|>4?ftob9Mrb9-P_Chm3Jv@UeW(JtiDJRk@Rr?`MDTX=Cx9&ZLKm6NY;?4&Kdifs9&X)Tp6aODk*dNaOG>mhCF=u z^r@`#S_B~5Stc-Z5dnGckJmRh-yiJYwIVXQLmT?LSqQW$Af3vWy6ZA~Pn0w0DxE{v+{e>KT)urUrJ02r%1hJ&NFKK^uH z?1%ytjzedCkP1l2=f_f|a21wTG~3E0$ITWML;y)q(17*U&F7k7N5B&4gS`ZmfLc7mUPFugm%TG^J9wL9{Kl zns6A7!E^?LNdjcB10Yp$$*e>Kh6Oi6+!k!)n5CHpWe~1He{&eELZ0UHc`1M<@lm@z zR4~de-&9)_sMfx0(=Q|k)zn2|Uc0LgY@gPrvtpFHbz1P}mm5Do^hO(~@oci|5{yL! z1xvKyW@noug>LkENmSO!W0OD2gieFnzVKyJ8R)(JA7pHBTT zC{Q(kMrb)WEvYe2rx+%K+#z#LIk8n;H^LAEZKHgYl%oLo=3IDi8q^1}ni^-8vb42A zTM-t3L{ers0Z7kxPxGox=$tGDW!`oM|+2* zs`eVV@|wJ|VJqve)j79L8Z(NKHwU3(x`nOl>bmf^Mmw&gh8|NFmVvs*I=fQ4yg zi<#sP?|=C2>Rlky4Hg z{pZh>FW{kVg-6+NG@6`sT!<7hlQKWW3L)fKu87Nt|Kb&GoT2sA)cZ{`@dq z#Bi0fG=wfV&B*8K3C`u=>ODmI-l+nk05rz$2V*p#9aU#_MO`PEVGN*xHw3i0*-EKA zNUpg-fYHEH=)ASBX5dyC_)@~eKZtzaoHknNea+j3CuOXAX^ic^tpKW&B4u8tr}KGb zKq$m8yv$VX0y&suD`#QA!5sQt8#is!YUuhQ7(f64Z%^Ij@FFRtSZc!oSJS){tUv`y zGI2E;ai*e{hbb~wuC1YhS2D-#-5a>-lH)ZloTC(mi6D`P;pil;g&XpW7s)4M9c@h3 z=`^2LfwC?>CEE*tS8y$$iK&0@wpLJgrTvHV`NzAbGf?hNPp?ddS(E+Dl$YKc5vPUNXw(18Ag)@VBA;$tQClYDh1ELcze_U`Ar+> z^!YEvkTbym7n9Q*Qx>$P#PHJ*JtRF(Q$or46;+P0%uf$1_XgPB7VB?E%3tqBn-?$-p+OX&m3+HB zLbBDCwL;sotJi|?OVUsfC<-} z68#KuY_4xM+ZM180~*HLR1habKl2d|ZL-k??zYmw)*4iG7ltC*uddS?J4--E`%krp&I zCX5_UfHR3)5F|Heg6XB|wmc5Y;7XmJW&wn>){qjH`Mkv7ke5&9eD}GRX~y7dD|vnT z{AiBHTM$`IMng+FuW@<)fB)Nk76G75t+pep0m%^ng~5_VA%jJL&h_SVYJd$x-IYC*`ijF(ipc6LS)Qllu|47PK5ad@afz1>ZbHo z^Vo_CXzBvWRtlN~KxGBl`n5(A5onvnJE^DDR!Zh|n${(j6dMYq%5dAfHr9pC1st-M z9E%1BU4MO~?orNAN^1(1$S43(s{m#D5P$-ttZ6N!fsOTD2nm3i0f(*lQD>aY@-$@_ zG264zI8liuuWZi?Dia`rCTT5sol7bSC4wL#5GlE=b#0pwu>mw{1Q8)a(&=ekW7XDb zc}6TrL@tuLXi`~GZMD9*hw1Gu>#BA-e}fJ%A(!Pae*URI*5?V`%e^l`Jq{3HcxSjg z&W|T4@4Vjoi>##-)cEx2zb0FS$vbPwx?voxBS>C)hZ%;53X1lg0ob**vTnzJMt|EY zRbY&^ewO);ChNPSHKLK@($uaX?NrA)Thvbc(6fVoy&` z|Lu1luC4Z3qtHs7HUZX#K=V4Sg3hxr(5fMlCg8?EoF@tj(qKth{dn1-ldar9HP@z#}w;2VLDzI@6GrP~Hy z0~A!-Aeoo(mX`i{?6f~%U(eJVN2HBRSpQKDSSw6J`7k${a)7(N?hLT+X`vKM@CjLq zMPY6l&V&Pmp|vr9!1*u?D*)zP6E{d)tRhQ|^Lm;q*c#FVy)crNl49isWSqNJLh0ynw&{&$a%?~qyNZ@S;tXcr-I5i;8Q%qgv z)58R6Yu7ssiSv0n6(NTlCz+n_earCh%QCn)JuUB!<3W)nC=hCi)8jmS{yPKeAo51* zpnM2naL#6rl#pR`--fAZ0CDnU9v3^yDLcO#zzK9Iz3Z+05(i&QWNHw5s0C>@-uRud7 zoOzv=QxB4pP~Gf^&V3qwqNS#LxuW_amXC#KssRy#dHBsZ-k^4~jIZl(NRe zfRJ&)h15_BZ$*9sH}DdHysi}<8_^j^+UJ}Wx=_a;0usH|1;|oUT4SzB zw!#d6JPWquGtTR};Xw(}$0BTYPM>TV!J>Y_)Y=0d+GZ+B2&Uu0Y!pvfI3|5~^>P|O z5a9S;;(2;}&JOlkdr}19N?fv(_4B76XH&>PX(BVY@#?1A=%F^nS}hqJD?HExKvzmk z06EQde*AnOUxZ*uYsqJ<)!XmrJ_Md07l~q znWq_8)*0#4E-h&Rq{LL8A8!m9RZ@veuc_Nj1kB93@-$5+0Md%DX?}W|L@gN$y*YTv9wwI08Kcf!hnTKin-`_viAkwddqzy>v@&u|DzhDz62xvwX)4G-u~@4 z^V=&md#4XO%2ARj+IrR%lZD-FAu+dzAp(-gKt1e#GXV~pfWtC5WEao=Y|?n z^gX~B`=L+qF!;-cDlnKsh~2Itc*SzM|MlbXq+oW*2XEAOhaoZfX+w3ybm(EuAT;-S=Xd@8 z)3Eq<9=!y8ZA?JVNUH|hxO15T`&U`{jlb7a*DUjCS=J&|GL$8E6$WGjz#M#vd(ns8 zR97H|e!RP5lyiED8os0!l-$sqWAbE{%O*=o#Gbm4nro0|aA29OE2_}CEKm?9sKG#1 zmvtW2jAOw@)d4J!HLoR?BAOjJZ(30yR&t)IR&^9NJVRRnpg?WSS!D}FP+1tcY0qot0!K6V7y?zSlEx}x`ouz592YRGHW zdHV9(g92U~duG}XySuyOJz5TaQD_*G4;5e#JR)1&ke(#IP7e=pzxhxxRGW1=++yeg ztBTZ`E7${u4t^MSL)S#gst8b3I&<>24PsX@y}!~fq0E=wX4|0uU(MOyag?sH%Bx_))3o~P^!BWH zclpM{8rTOAn5-%A9a-6Sr5N498K3~$APyih)%LPf{@NYF7EU(1Kvd+bXKJr26R%yS zuaXK|2Mpk+?ZM0MUz`Gw1LB+-<|&j0MK=}c+hwC zFQ4zl|M0`7n>*m~*YoWjr_)c{Lud;|#;*^*embvaM!T`^c^YtkzdX7h|MdRupi-7v zOtH?#FTei!X+Ec}FWK^<04N2YsGURvyS;=VbP-)wv*fj?$TE$7xZMw3eE%a%3!aMP zh=+J%Bh^~*aE4k_fy2N3 z)*wEpg-(uN{`3F-)0bQ^;}63;E8^jB-*>U!eldUm)2c18xl2Xe3NSf#glEx|Mo(jD z+jX_q`z$zY$&4$EtTh-61Zo0nK%HsuF?7pBUFVq$5M_Ts<`pxoRo1GxikfqK+WnD6!}P0A^mtX7%hh6~@E zX}*BZteM&KJ8-^1hqwLy&7ZN}gy9ZNL=?cAciruN=pu-4d;mP^uSd>@vWtu=d7foH zKYaT9X$^s)=nlJK*!R2s(6NVGPj_$DJQo0e@~7i8XRyyow+vm^_3S)w{8V>7IP~us zewrSd)E|$3x;uD+n=@|zIUfGI7|xgYfbTWB>KQ%XPWuYC^Aa_8 zx$7%Ib!)EzonK*zp0D`Ac3zOtut1qO#twZy4iQi>DO%QLwhWHl zg`Za%oHs{cf)#u$%$of$_CY1DYc49t^Kv>)%c^JwPm};q?|kweBDoELy@Q9cRAuvB z5a3VCFbs#j4`B=tb8y5&u7S*h05hk@<1{OGV^gq?6!^pN{{2lyR^|PV%_OBeewd4RpVnP+6!a=%wt@>+F$C^9`f z+}|%7)k8Sk-3-H+(%1!NfK&34bIw`)x66TSYrz_QkSrplh{Bs3!y&-}nSRV#a~N(~ z>Ow?6gxGVt>FfKoGDMTPJa|pK377T}o`X0b^3{SvA zX^x2K*)8zZdkj1*QDYdOTu@;m(;_h;PoL-*qJb_po7mp%;|UFXwLn$phZK@7Aot7#Qi@7@QxzET%dUAReB1gu=qj{^sT|4D4X0 zO;wbG0#Q>Wg8@EqN<_?Ie4mF3g9 zU$Eu(frq&i1;?RJ@!{jI59^|YZxl+i5OMS&o$!cSy9)lCh*q869AFisu3|UQu5x1!agxWM5bk4GFwW)12v>e zmH@LrOuyf|k`v%7X#$et$WMFsOZj8l@B-~c@{giolswNC9Ww`Ds=2Pm5h0BZHN+br z3||&o9{PEmI@VIBW6AUUIGwYtg*?aI&4*ndx)?%q4MvfowKC015!1GDXsbb?nu{tM zV6~hQw9LozJd5|7>h!ro4N&=)>>)KBv{OS2DKG~d1hBQ7r+Gf2BadY&tFAf;2A2pY zY4Fgs$gEanUFLOB1vs$g<4V22v*!bNSqlsV_TBB>`_a9hGyCII>zwDgD0&KBe3@%i z6T8gBeL8dr=+np*swO%wGojQh0Rg=9LrmVIAvf^`=X^-eCIOzqK63AUo%AqJowZ~# z(L9}kmwbv{DR5>A(<)`I^LcJArVe>Mo~9)W5alt{!w}%sb%;YxOGo#0ETUHzVJ#Lut52=`Td{ci{-Ilq$VF!1a>Ua;{@%5pKtNl5@RG9p-q9OI;SzJ*qOhCD6M?~SZ-%@! zHzX!b$pK7{N3F&LPz)S8G01rP?hkJchZud+CRLjtMm2!?aZ}iiK8D~u`)>CKzN@J7 zJug%%fE9{0FTD5NI7CL1m!pN9uQlh(-X;wD!(o`El;s}BJo_HB)I6O|rPn|rM!v%v zU9`^UW7QuAARc1(?sj+E`Ifb=IAXg0c*;8L4`bn#0iTi?e9sOdiuJsE=Tj(xoXdPZ zP6{9_r$udJoJI0IcYQZLoW1h`sK7JVvM8X4e(1VBaX?iLA^FIB2@71K*_Qxb(5?zih)oGYDl_74a|zfBf~!amvkk zSyzSI^R6F{#OY`0j0p0}mbFFIaO~xD;*PAI1*l z3tIo{TnKlbk640a(%G8%w+}uqY#5%$}~}h zAA3X~ETuw_RE36q+;=T!wWZek^E^+gkwcxM&-0SkY?ruR=wliJPzF%hRD;%e@mQAv zH^kJf-8h86$fz5MvLo*-FV!o1haov&d?)>YrLF)~$!$4B*174rj*d(TQu4Asl;wC* zj=c|3&(oB%f>H1D{cYC=Kh1|XvB9Y6t2pM1>2wXJwXZ(=`rW^rVFUo}`y@XvkNR6& zoKJ;#-?VluIlt!iuBLC(PIx~1=UfhG?bTEI-D1JNuU#~H zUyJhs0NAzWZu(LyV&^EZQ!DG~j0(*zdFnfWQ%z|%-oCj#bdh1LEJY|Ibj6r)dxHY2 z==$*x5*+!V@f($8iFOZU7|s%q=ha03en?&T&J%5yw-VFP5Ajs;@px`Q^I-+rx_mhv zr&x!i3lP}9U9e2$c+U0~K;PdSZg2ZTfQT5@BQMkGbCz)nax#D}6N2kF!c+ua6_~nX zil^oL<#Y!1Ap*c=DbN9Kci6q{{`?bzbu9qu3fM7J6O0FRaqOdq7rYZ9E+ik;~`=>PN)4(^HPrUc`D)q z3~4OTIw%14fjp6uAwpL`kqV<$bU55&wrscx^o9QRX1rgj1%~QNZuB{Gg4UenY1T6| zUyD?chFyon54=fk%e*YBqUCXW5~YJ(o=2GxL>vHV+U4%mGi$DWchlh=HRJ|gj%C;l z31f=W5df#)n)4leOwi*b4|6zI89Syq&`v4n1LeYh>_T;uIuR$i9Y?C*F#jt>_|~h4@d4|L0O9}6Tp7= zRZ_l907|X*7e%|D#%%YxZCxoI1Cp^j0!HqV%n?*Ac2#Y90pZ}9RU^9+-lL# z*P?w9_05`DSdSDCi|UWVnZ(CF)x`P&u$ zZ<_%3yZWx%`RzL*w4|46y6>IoK?X+-0u{O!We4(6qsFApGWG#bjb z;qbPTKo^iHzHt{XSK99N%Gvo{Ki6H7G%tSh5_lyem>W{9(uf1Y5r_V;AMPap4ZiC* zKouTg9QxFC#3(XNXBjiPVO2!lA5hAqpgYVLpF1G>Hoo>slc3V=Y3^@&cmDd1G+>3EtmFpM)of4IFJQ^0?+7@MuX{p(Mk z79RVn5Z5RF zV&w@0v%RRFY3_z00gexalP7i_&J&`g6qAZBNv4jWs&$bpf|LMGVSIbo4`TqpP=eA6 z$9<_)057U*MX}se8pJn{2T-SFU9w7I?{E7t^a%h$$3sU}jt}SKITW>W{KJRN@nIiy zdi={@KCP^^gX&gK$K81Qr}w>14<8>h29Nb&InDwPtszDZ6+ohX9J)Suzty`4Do~*q zVn=Y$I?wl?PZ`Mr(4~f20QgLyivu(E(Rm25i+W^_E~kx0TN^^^lYi?s+Rr9SQ6AR8 z%d+G;O9!94?`ReQ1Etg|rdbN094oRQU*IJw>-o!h$z@&*wIa*Y9-&)hsi80PUfD4- zvupNh@xHbvch9{rFy!zz$`0CBDyi5O{_B$ebh5tu{yXgnHu}=KxrXOLfcE;!YtQWK z3tnQc{>2?!e)VN~@8wy)?*wkq+Gl6>^?{p&-d5}0p5})UuBgx7E4F_E$Nc_|pj|`5 zm$I|V)4X251!h)*cg`t%9B&3|_1i+pm%O(h&R-lP9axO3{yoqR$ExM?HsH&OOJeOQRs&XMB^`Xq4 zD^S>1B{rhK92_Em_~!1=Ib!HCZKEUjl+>6u*&D#aOX!(db=@fBJC#zn@Wb(ZT*IM{ z`yu6_%MH#;0T8;I-NCO4DGO`$P^;e5v=*=MF~;N_d%BE^ufi18%%G@WrsHD;_hUDV z!|rfkLE5^K$M!VDu6sig6Eb4k zU}g?*P)DYvb6%FR0N}14#xggcH4|?RSQ4YEx)!`*J%nWjlvY+urCAIqIOwr5 zvDRf-t2U__AVnJQ5gAD15E1~(%klAH$#@$9S&umI_=f?@ifkMMn1UaN!(r^>QkZ=a zY0vLTtW zP)Dr^ppd-eIu`$wq090yx7o2B+A-x}Vm{HEhNkCcV`@g)q z?Zcb5NvEIw^6Ly-wa0x@_%Pnx-u6DfxqVm)qOV%vJfNg;^i+Yk^WD3{+nYU$030A@ zSZY`%^j&gjDpHQe)1xw9;y@JubxTBu`<*W_c~-Ql2*=~WbEk2)A6bD4$3E#B_(-M@ zQx&P}3YktSq6!W%0mwNk@?58)t5zt3Z~#FkR0dfBGo54rx3_ z#4*+&h#k7V8#|_Ega8I<>|)$7PYSW5aJ;sBviZ|Zf*nA)sl0iZUyr=sTYb4f+k2Iz`6qxL?`xT91d~z zOFaUgj_YD0hW*{4%jKp4o^fmdLK^z;22JXT%PL^3)d_OC# zC=@*pX?N(!-Ny3_0$P5-vZfoY3I(_>bY0hV3QvgIc`al~`&ey9D*{e*0BY54E$qi5~%!#Qk2P(BPdon9|p4JODn2%!| z8OP=5Jt*yB(f;suNP#a)CqbRFQY)-Xr*kcHVhU^uHIrOyJ7gDPpTKTiRsls4IhW|c z%3vUdaX>pmD?%4g=KIgT-HzkKsC=(9kp8QA z6u-LSZQB09)p18rm{fHTcwx zJ%Hf6_c49aS|BKS?Xiiu?K*-1Jl-Ch6=~}{15uF@W1I>$gr0W*Gmi%ZFUDc20MO4| zf%RiuGmr7`;qE4gD&PX)R8;`>jMK%thk$Dv8HgO48Y1V zPg9%#8DOefpA18-i}0+XwdfUMi)L2JQi1V~4`SuN zJp9|gd^|1!sE7*8^$`I2j?pT7^!;Hx#DMaFn*tSR%X5OSY!jOZ6jQ$&$3)l3-b@h2 z{SYNq?02Nf8|kG14jIYC?Em7?|~2y0hv6kd46dT{(IBt7vS});_hz)qyODmMA$c$ zcXLk-01-IYG z`B%0CTlVl8?V@MT(abJc;H_`$00MIZb*HRr=tEymb*X~3F7uK>rlm{|_b0z3_(TB| z>YSkPh<)FAGP@8bxXqXX0I?@HqVz6}1Lh*F{#yFmcX#>F#ZXJm6&{_(3P@X*oUxRm z0Hv`Hn`|u*<0myiwNR^CW9Bi25a;uyz(-ALt)&L2rXJ|JRe)9i@k-pqzDM-Z;CU@` zimo#rM_pu9Ano_#=(SZac{Zw2ns~>EWR)}z8^6+oJ-e(XwtY+1~OIO!b4UjrDKBP3h8OUl4C{+Lz ztJCug^1v46;MApV>^lPbAPq24lW`awxI-FjVIm(&@&Yw&3Ijo#^I;7U;zLZqt7CAN zg6EgQ6u`EbeGN+o00$-_N1R%grG~KY21rGAG{B+CJe{U#5+WbE@$UBakU$J@;qlM| zF%6yxO%!Y}B{F2IQ=W^oDtfW-6@b)g8z2`PQUWln4FLtnG(P|Uh2Z7OICaVAo1@U7 z<4GR`Yh+JnqoNeN0|$l|D92L4ftVbFqcUsOp# zTCK2lt7Xm#@&W6bYm?OP58)~T=ljeUyDlaNQ?0qw1*TQeMeK)efCL7bs)i0^KGUX- zsbx+$9*;es0`h^VuIpSpj^_zdD{v{xuFN2E-g|b$uu_lrFcTF~W%dg0$P1hg%-{s* z#$eF;(D-?7y{u=uEVT5>hWvH$o-L90vJh_@8|{@WUHd)o#_J2Y?;3&aqxMZE@1p19 z2;_*rB`x#-K;#vMYiLx-Jr(qtJfT$;z*e1aPdRMU)<6#6>sIsXdKsYC%$vja;5Hle z&gGkLQi7LrcykiX!9BT#?fDAVyrF{wUJ}3%HXYBa5#C&Cqqz5nCEgY~^g7k)p$TzV zPN#m343hc&{v3X(Az}y!5Y%#fTzrAcaa$odY?@yH*r_Yo6WE2&!kF+lEh{ET_aEQg zzPTN|9DjK%@ZG?}vP>G`30lPWK!3PBe0U3niVDhFKwaoVeV{NM&wNPHwd5;yiOCt& z^ZmyMFr#pk5rCRX6uT4x^#PEE7cu#NzJFkOD)u1e>7&BC53kj)|#Er!QZAdnoe>h`4$4_I6;@<#_)1d0M7w zD5`4}K}X$M=HuaJ|L1$HQbh!_tn9?gDh-~fF?mL<@t^?FkpB4}ZzE{qbD(Rop&6V3 z+?@BYstxSO5!|LV`y#G?egBT2?J4B{dKYK(Iw`T~rZm7Y9Hh?2xq&O1!Ue!Vn^!hf zt&+9nvMEo*4MZOxZ+xAW>&&VP0;?grZeW$_k_S8iCD*$55HCuwYSPS1#8eu{hk*RB z28bVby*tj2fBEw3=VJi}%GFF^0@1@VpV0MUxqhkQ1IU1TtYt0B(b(m!KB)l_?Drj& zYF{1*AhuhdE{(6bp zhoo zOFzVv*lTXQZCGKZbzUAGJ}s*<3VOs2gs_-4fLu%g-j^e13p1GpwPWT=@)+Y?)I=R^RyTZY3TPnq|~w7W2QBrALjdcvNM+c z5L06C&fhNRV+w$SFaSLrjd%tZ@Uie1b^22I;p3-inG^-RK>&8$IO>X0fZjL;9|Fh$ zb^Y9og7+xv{-z%fV+3H29Ak=!JeE?<$K&)4#C8d1zFM-MJ(PAeFwX?k1ha1eWDVF< zlN_$`&P!bb>{?{78J#OF#bzeAny*XV&48_%l>l>urcVbxhYz2FKbJ1Fs{|3#mbe3e zrmgCeJ}*GVURag34#3DZ!-p-if5mcZgKLhR(S@~)Ttl-4=RoEzK(Xu1ZJZnqPdqg3 z)r4`hQNcX{t6y#$)RA)z%_+Ml8sSUv^3#jhjP$lwzATWso5gU1|YEtp0kAuqU5E#Ve}^ z)_v;b`0;FjEug>b-rXL0ogY6{pTZ&f`7cu~h=D9ydIK7UyZ-JStd+I+MW)3#>;{(m zmcIP9@Vi4o-3<*lLjZiu)5pK$e((f>Hy>*;23!>r0kC&yaM*KVU#P*OE{{i05+a!% z^j!~Y6##2pj$iJl1wDSa1w_Ij9OMv(F@>OJNd10D$-!@C!%U&Jwpts&%!c{l^UuGY zXI&Mj?Drqu_4Sxfzy0)a0&^9tp)Prqd>jLohrGLc`|<1@AbDQ3wYq{K0(K!)$0!+- zAGBtKn|J@uKXslRJ2d0xXtHgimjRfyst958Xc!I-tv%U12X~daw3leZm+d;zTyxyE zIq>8|>U@4&a^m8I0N!fV#7xoDw5&~PE&>WLWYx+*c+<^H%Z2Kx<}^4~9Qn;H)`ydo z;F|NORkFcL?HK)9iO7T?O{F#GQy(bH;~#pa{oR3&$6tSYd_10&0;MH4Gk9(DV`V6O zZ;i@H4Olw{K2pu6XQ%CfXnR5WRO>_`O|G3)?$#9uTNC-8LNr@0nBsf-s8u zK1nqVw>LMTl~UH_bbLHcv+nvgAO7LPZI_s!Wto0EefgXZeM((&R+Lk?aDO&kPapsF z zO$R?fYxhBOn~uwImL25+x15fNV|c1(t0<6)#Conh$)tnd53IGG)@+*-T5#r*zfk~X4Z$Lkp*QwPiUCUY)b*M_9%8?cconoaM3f;22O}pXumg zrd6*5bRLi_Up>Ql1rV0=&7pt0OzWnjnIw65w7PDc2z_El08~_#WfoHf;F0j?Rmwf~OsYCx+h2Dn!cuuXl>nu=7@3x*aM zNi-^ec_AVq1Ki+KBA0wXqQj^wK%sL@MQgd-5_hV5pCPp_0J~s{@M2GxbIr?qd^pdw zn!7|+8U$qc&4H2gl&jkuuZoH__OW&Su z@4xzLm$TZ%6?~e{|4j?S)kocmkO{wQ_nxT1h|tU_orRaz5}3Dro83=_!uLj7DZy{S~jWKV93?^M1cXoR7L!00f2M5@B06ckL!ZI zi>c@1C|$r}n1R5t8&b!LTJt>JKOXZ!)4mMByY|a}`LrB{H*xf&S$vncNiDhLk`M!I zsh5ONg>BTI+@(7{qy)7pWs2kjI`EVwD|mwQ-s$u(30!Bt{r0ba`7~qLry_U#;U=Kf z@&zd+@68%q+SG~Aj8sagYgNr!Rsq;E)%@l7+i9xM06^z;>f7{XdVH8lg>qk4v7!v` z0Y4O~HJ5Cb&{uLnnoE9DO3w``_&({e1J={yO8w2d+ZcUt40AAZMw^_;rClPF9-!AC zt>>H`T}R5(ko_AIguliT9=DYMg=Y zJyA^k*c})=^8M<9>&B4hc~ZM@=yn6`^Q64Yk5~yHQ#g1)2{6^^oR;O`)5E;xrf87p zDV4}I!FWMc1?V>sjw${lkEkpe@Tx&~Eh;U>M9u~=-e`YK1dq&DawA=N2ygZqkH$KeJsM`gmsyw3LnN5 z==yy>cHT9q^W*1_r=O4G-OkIo+%H&kmlAybvH+{pW!73z6wC<}x*jZLokgaPpS2l0sce|82tcw(7PXM$oYh3~Fj}QBVA$DAvXy)92x-Jh7$E843C5A$N@WCZU zwR|eMs4|E_ftjINS9IgsyV&3U;gFaeS~J99yj`R>cXhe{vLPFU37C(SIA?j)0Ekq^J#Z`bF=M* zJOg?T3Wg=1TB${gsPjW&*K}EpBBNvhyWp5i6^gVugQ_B`Vg|s<;)ge7T?7KpF&rih zJ(fjG88PxE7*i!Lr}O=BX{K4=JD*EAF7@3c;2vG3$Sl@OMXSJzU!JKd%mkni#{TUe zQXjoc)0F3efDnLigs4CiDN&Q<%Wn@Ddi?tFr(eD(3sW^7Zf-kNDGo7s4{ZiY(KEZ& z3?_M<*Hft~lII!l5t_^KJgvEjXM$=u^<6!FnLZsC1&rC2HH$|d$Jh^bW-C&Q2NH3J z#RQQ&AO@A>yO7A%5;2`~>H7CS9{QBn17z+h9^%}~q;YG2$2VD~r$OSLQg`&kQ}&`3 z=S8Nz!J)YZGJgaUPXWOw__o>>KrmEPgd_FGPhT>8+7xd=4$V-4 zGl{M_?Q;g9{{;8DvoJ$}AF zFA8*r!#)LO?>LzEnpEm0w889{kri8146g6PCZAgcX{qoKmQM0w;)&3iIGEN|BzFjb z!)hfMBj*fhh|MPMhG9rPU_A_>NI?c4Zr|RpW*#_y(RDFGi~tUYeV?L(mgV@{$DfbC zF1SmB6f7sL9EaZde1B9((Yly|S4ETz&lHt4&z|$~*LyHLP>P=egP>VT@3`v$DJu@J z28diZz}NM78hGqdU@f!EP_%WKPY?4N0O+D+1P;vX0h#rYJi0n5T$0^T4@asGoMQ?kQ7tNz2&96)W;>;+}wpJ%`s>zY5cz3yVSs6?uCqO6O7oty{sx1PHi|NgX!0G3}gVliauUo z>Fz4h@K)r$uc>RLrX+jDDG@TJPC-m54=9JL!! zr}at-UBQf6r-%Fd`?>N1{?<$9_2Ng0iYe5jp=S0Ton9h|KK6Y-e)uCt zvPB;M^7xyMp5a2MV-htub}m?5AAkDGZ#wpV{`|OPu#A!NGw}hW>wNTxk00mbdD?>U6_Vl8czAQzM+7Z7vj=%% zrY(Hp{PqUT_hVOeU1g_>RD|*UhcPm{%>lEE>W8}us&BBzZ-&J+4)J0DY+0&jzLxJ{ zhT*X3C|s|gQtUM8s_clpyIzCf9HW`kyp$OpXwCyr1Rq>t1_udI1Ausk3fCQO-`xg} zQy;x&PZ7E1l_MO%vyWq9LYO1480|Ve$+W5hid8cFJTZGh~PGrh_)9gwGo^XE_Z zlfd&h_FW3WId;U&+a|#Zf&+sH1uC@xa19hY&t$DNtEMJ>Y*=&xw6O#LO{A49)x-qM z8c6`C&XDGIlt~eX+n5--Cgeqr2!7ag$qRGrl0!BFg#;iCU5f0aOb@^P^6}^CXp3^- zfR=L$2R|m!WiHTa*d!rWkV}B0ZiSvFV0!rcDRQTbqCiZENb@wkV;>j+>smUo=MbQX zTbE;x4?cJ&6Y>f{o!4p2t9D#afmk{8o+FBuby`bV6<`jm{q4I!PxeqE_jm8dE_8_< zU}o_B8>IW=8V<}R@WZ~}1x)i0#(h7?DtWbj_u+>Rw>?8<1Rs6iYaPH>v&TK#ycaX> zDU-J04{hTte>(F;F4$<>y3#wpDwr(*X8Wu`@V$AK6n0tWO&t{ z%pNXbUuO_807U-x_`07xZGyQ?M_`MyYF;Y>Dj-1ex3_l1YUqAS*GhX?>vazhH+4Jg8rB|~^!a6lM!=v|rTf#9p-8C(Uqo~QG1 zDGr1+X93dt>9?tT{x7`raaeO`XqWAdsurn>GKCZYG(kk{`orz;;T=$y_4w2O{uu!= z!85w011sO$?K?7C9zXx|MPf=}<+Ss|+dsYg=Re%O9Xpbyb)dlPpiK=v0E(u%uKD!k z%l%ZvG|$tzO>O~ThTL=yLz$1r>C11qtRR4y$vgJr?T@#2L+=1nY3RDp#eiBagPmiD z7`5w1|A)g-E+=?apk#iAajoVg`1~Y77sGYMe7`>&`V@Td z;O8>0D_;Nrg3OBo>>-wJZr8LlxDc@Bp=0iVWtuNp5xQ{M%1|`Q?5U2XHSTI@Vk@45>ZT zhZ8C`(T*4tzBhnERjl(v#_7|ic}XP(R4Bm7P_<;RCx+GXSoWGL96ZO!3bZoKi*F4K z?={a*!O##-Q7XM{9BCU{;(e-C+`{nRSF06eLtMA zr-+Ph==+X`Lxt`SL*g!_aNGam|M-vZN7AN83!zUfZqaP_Y88F`$9Me}hqj^2Uz&iY z8Mr|upOaV@Gonv_gPyKy?Xu;4MS*v*J6Gi9cF`BVqi6-Yz?T5Z5Ej{wEe3k`C918{vG-@g0DyD?DC$PLbS zT^O153G6cVV;=#}T8}3Ht0zCWckgblwaRGvyy5#Q+Wk$8u$*0=`AJ15y^QUrUB@Vvd-Q68JX83@M+?@!QZzQ2#w6A9?v5&FqW$2d` z$Y5_}`qas zeR$lW-b^k9Rt>Ef2rCdm;ED-${OX z2dH`a?U%p&a(`CtnLT_QcXyBDQOD%DxwaS(17oZUv;tv60Xbg*=!Pz1_9=}+mvpy3OxzFM z3-L$=;=bE^fXYBY7e2%QAdVVppORNU+)8}+;ln-mmuy%3ax0xNzG z!ud`<{11gbRj0MCbFLk?Jbn2zA+hiJ!V$7b2vK)W?MS{5K+LaB2Pj0lzkfeErSDKsd-+<#Y1XV1v=*gWXahFMRXC%r^mV+ zD&G9T_E5ys$5peGHT0?Po)`#1Jlx*ijXrBW{r2-;KF^wct`#wX_V0ld?rwJ87M*7S ziW!09zW;|0AKrFv#t_*Ipb*(HkwG1tgTm^P%jrD*_W2>>A|Nl9^_|G$ipql)?Pg3X zAuac+AZ%d&!11uV>-(s3J}(UD+V!39KKyvsdk}Pc zM@F0Fp(}&yQ%u3V%nAUYCka_|?$tCQ`)Xu7|JAl|iMt*LlXY2FAeo3TZy;=P4u*z} z5it#dh6Sd`8NdQ%V6CNY7NeXf?YhKeDd!YS7}aX#)6zi91SSuuB5*!)?{9#ZoP=o8 zM1Wyl%p=AmS*JvaxuVsJ%&$w-C-&Y$pn{?efDauPgWIIG8^d5Mu7Sy{cvNdzeQ-G!tv}d8@qN5;&KA`y~-i zuqUv)DI3T!r>-1)nU~cB@MJbW@WXt+wDWPQj`jLQ)$UKSJs+`k~J7y29hKM0Jp)wthr?$vaVoI$$9J}k5LZ`6?IBI3KCzj73 zZQ2Vo==Q_xfY)5vTO{CWSH9H)xp1hEYg;V_faWeG6it-$_jt;-?p;)3uL#s@GV^)q zdH$U({Pb<3*XHP=XZsv2#a|PbFwpZp{^^XT?p<$ii`z2)UA$HFlpJCZGt30o{P5+W@e=x5k3GmcpWsC@fC1G4RPh1aaUxR-@!h)*KfLJ^7jb6d)9w&` z0&vxs<}}{j^>0Hxx#~fL;;{>NKirM+!u6`{#fTz2j|97x<9x^Cd)i65Ys&8uG5?)m z_B6UKOK#J=0n4?SLN9ksu+~f!j#7=R(om}*7oZlXDXNHVV5at%NSRcQFuIEku#9Xu zH-|t(&NEcBX_JQ7dqT&gb(*##*}_K3v+zH8#=)+)@n+p0^x=7fw=9UYj zS+3ITMFyhbc}q{&QgBHgFGDFc2NBLQJJ=utf2 zgRhrbsFItaGB$#4NE4uB)?5I|6@fIw2viuj>yoEd>T;e-IcX7YF2sI(gj{UEJomk8 zrdlfj;JDu(e4cbkf)r!QDxO)qW0(TW?72q_*c=iQ9xVM~AL zq0K0aNgV=w7|`#=kyT1rPwTzL%7ZGNSKP164(K8;^t?P@D!&2a22)YsO2K?Rjh-{Z zmwemT7v78@8QE4h?zVi!Dm^Z%rk8CvZ2=%6CUVW%b{noedxzW+vBK%j>iX@l+}Y50FnWp{?3HV7hrh z6~-QPNp=HfTCkM`5j<^V7P(B*f)N)vGruXZthr{LjuV21<@Is39=C4}aEK{JVAYb* z^?e^|?5k9S*pEZsrE)3{pFaM)BKdWreDu!ucy_ruyJoUK&{mv`Xb7y)~s10*H)daL>#ID)vRSv z59eTTP_-heE>ldAi2%|(#E{frBCTZ+(^k&PZNNHDbI%O~PQCLNm4RFfc@=noLRnpSH$Ac2NQ0h4NY}m)Qv54nEXusIn^71wEk6U?ymrC`B`l-7pMe@{FD}&Z_bf zHpDOH_{%Bw{C^_{kdK;@4u{9nT10~@))un+qxQ>E5#YyNA3b}zVzcS`4h>CIP2i>F z`FO-MGH{b_V%ZJze9w#6BFwR!hb}GV$cMcYH870Gp*}9tyLL*>|qMuAL?Ot5OE=;o>4_g(+W}64Z|o! zKsBeT@D;V1tvik#Gy_P$;9)59G#5Rg)g;ZQ7?TIgGob4#MgRmGN?_O@#_>^ftw2Zv z&C(j+FI=heR2*jwoZ_J}n+lp^C%SEqz|H%R8sK6Yy52*Z1r7yJz=Klo&T7@=be`s> zUb3{OMDA7^{yb?eyQ)_Uy;0jN2Ps)=s$`@u&EmJ4PlxAJLThdtGT4IKTbaz2u<4ak za{-%NgND|AH(hpZ&rEt%%{8>P!BX0leHRyF@^Z!STlJptcKPQB=cV($v2K@m_J&)d zZBenU*3PhTKy9H*580qHL@(Xt7p1}qY;_#!F3^Klsm-R_2Hmt>!d=>)dH35DqQ}6- z=khvM+Dzc0Yc9R*@t42+VHvHK5wN91ibkkwOe0g+DN(;Pl&iMj{+M7@}x!9s{LK?{(e#GmtV%4!vV|Z zpQq4mH_JP{!!*^${yZP*zp4h-d0jP)e*a^?91)4SKPVnoME>!gcO&NG=cUF_aro1p zZsYVtW1dfw!gu)7$T0wJ95!x3Y^q%O@zZfa3WT>G{{26{kMc#vK8>Eqw6#cPwMmtd z7uQ5|UbAxS6Lfv}6&@nF!N=%4WHJH#5O)k!T_nrCBVc7sz}veY|LG5ho?Wy2>3{ow z{eM3C0H7?;wX6b&_v5>N_^0=GDT3KSkN1Xu7y84$`=5Ti2>_$21Aq{TXv2o-bMeZH z5iYdJ173y?Y;(|B+Y;h0zOd{6zTP_mXbLmHS}6_PPal2Xd*3P;3>V0uz?zg?R8mqL zPmeVK(~(C#pK`7Mx|Ww(4Ip$_Kb<|q5WD*W);^uja-oROY&!sYB-ADNEfplqO4jtp z!}{s-ulI1y<=^guG|Od94AX26@Uc&cpk+ybo-@+ekCGbztH6QrDc>t~^U{wMSr8JT zm5m<_ShI(V9?Jxfi-8W1&wh8z=~;^m(X`Hxlrx+37_hE{=&EEJ%E2*!<)AeI4&{m4uk%T9wV4A z^L&!|L>=L796DXg z>2XqyA?lZp?Ks`%H~)UH2sI>Ybx{BQqx zzOU2i+#mXPnipU_pC;1Z^spNT7L>fqlcsU(>-6QPKTqSK$L=5Qd;-LSfO%OlB(EB< ztgWs~ne_wUk#kAR9t6ivlc`s1U}WYZ8`{%W`7+a((Jqs83uoFh zS(h4NLy~Rq3*BU3(Kb-j{NOG+n?_P1T^Pr53Bp1De<~!Gf$S6uzmzdvXcdAPV-r8-W!TKo*I? z%uI~f-`*Z}kwoQu{P=mQtx8cwsijI21GpRZL!WvEVv3<-<2%HD|K?_3b61zmfv%yi z_CyJIeeLwU2svFx$JbjO(%*}8ZYMMYS{12QtwABOLOntw1#LKUGZVmHD*72(CDfef zRe_gmD~i=^z=$MSxrh&mLfxnu1mb}j>kLUz01K|6HfiuuFwkUuZ4|Pw>4E2OwdiKUQ1nZt-tarQnec3v1*A$YM$4U4)68_ zWmPnQ*r)zbWKk=^-g^L)5W&HR1Z{B9`=sRv6I4H;j_tGEU z!65T-Rp#i~;YugxbX~yk3@fIxE^{t2FgZVljS5R0DYdU(^JQ_z3rFx(NUPChY6hTDwwF(Polf1`=9>!#C;0t+}Uv`Lf<`e&YoLt^nF5uY5u6*mfHm7>8V= zzq(L-)y>y1)4zGR1KfpA>DBXmeT_{L&9&$7>i08BMYoKaQ4X?Odf1HjN_sRdO` zwW(cI!5Ih*a9|%DiwHxd0vDkOQH4UQLZLV=dCq9S8lcOvssM;X|L*PWZtOa0miu8= z1!M_amUU9tZE!<^AUBX>N1d|buxoJf0_Q3a&y1i|!7(N8J-T2IBp&c75}>V=QfgUe z$<4Lpgj#_RVp3GmmUA;mGms?si@F73@ZBD{D)oJ2Rpu^^9D`d!h~AN@r%J4g;7e3Hm{ zACr#+2eBriW}XNF$yMs*Mywh7=q~iOrVU_UVS=rbSA-kcGodhWNszcprO=fiF%q=S z0yi4j(sI@UVrHMZyB}_&gIO~ewM`|{kpqFq)S%_`c>Y+HX=6e;%KE8;3>|yK-49*H zK&_NU!_8isXoXf4KOH*;rxbeEszAWpOU8<^?*?|FChW)uB}lc0<@9(z8C*ELzj+h7 z@^-<6g3q&e4nW#ZC_wNu><=DhqS}C}P1bg>dx%K_6;s~?uw3gl2nA@S%`UlkR)u(l zOkY}uRk>%(nE=i6vC?=LdVgY8mSV=_$6Mfmi9N0)Xbhx~e1aJ$^dX4s!L&5gNn6Q4 zE>f);b-Q=v9a&kA51%z65wnM8Dk{*`D_qyKIS)Ch>?5JH+?Lb4WYK;c(qXqt-oZf4 zpmd=(yP&}AVpX1mTEC+#MAtd-G$mht>+t$(=<|P@;WgL9@3t-X@jcsf;j6&+ktYtD zzt;>fGrFYno^y`hAWOb&%6|(|`Ld(5QM5R27l`c(c<;*}x`JXaX3GI&FTSUXUbEYR zquVQa-blPWvb}Zy$sEAW5#U?E?nkOi2JU}ly6gJb_1*sTAKbHd36Qe#Jmm1P-LhxGZbPheoG#C_!NdZ{) zR8$K=VxN?r5M=ZA-fjFf_{Hfs(2VbrLiwMe-XwjB4ED@fvqn2{^wurS0e{m;lWR3k=&1mlzi9(n7T1~ z>LU{|vA;Mdmvj#)VbiU8F@~_gJdN1lJBp6~4b8cRCS_gDGxZ**Sd#;%(If=7d1{yH z4hmPMn1Xf9xjyCU9pDM`c8BCVJ1mSCJJ_<8rDnsGKf>lv=DvtXD#4-Typ#ff;euld z6yUhI$OH&!be;oyb{-geAW8-(umT7%Fc5ki`$g;iE|EdAGH1E$b%E==AaD$vI`5rd zJhc^6)>>0=3e7p!E$n1w03Z6n!OQ`oKq}&8D^t5*4X&o|<#TMV*#%*wTVXLfUp=?H z6!bl~+HqNhIE5~C`*-hdZ~M4`PRzF5!c~KV0EN}{{N*o2D-giYtkC0+Kim$Uhm_tH z5v&?OWAGJ+Ei5(Fv&{?-IvQ26H5!|ptUUEtyaMR%Ti5z zlLY~&6$;QNoeoZN+AC)9ik#P)cW-WQgC9}>mQ~=m8*T%B>J*|)8WcbRg)aJ0w85t? zBTT=w(!C(tWK&*xaNE1Qq`ZD-W^Q4_CnB&HBXlFEZuow^?bGGS zUD4gwz|PCVpHm{+1o+zQ@wO}eo4nM2t9>gl^taphEoA!}-~Zl)uEa5a_eqYxXz-xj z557(~Vf~9}enT;Y7(4!tOFliEr?o&D`hM(r`g8yGeI@}AJBX7N@C5x+);yo@F|Xo5 zLN7%12d2n^_z#KsxXBZTmTqWKy_U+5~c3PKknb$-Rx8FP$Kf)7og4& z`E)#9b_|m|=Hv0rEdam8T22D^d8naIOUoB|b6^w{LdGhq&ugVu#ibZwF{z z9v*-D>Els?c?LL*Ily~+4xbn=E)($01ANt2!vzWjW{l+aB{f;kN^NyGkOL# zic_rfd=(xSV$T#nB@mMX#SBm&04@>vA%f3E2)J!H;q>Z<|56nk` z)dcwE@D!S(Y^IDFR1J1wPuaUvyT{J$;VIUr5X&W8+RSbF+9v; z6cNXc(X?bG?!YSf?AQA;Npigp=yTEJuMpPAP%rSz>`~EbS#yP`h(c9O8EOh?0HMFY zE@Tmf^Xc~X_8)&34>x`988FkDw~9b1n3t&nn3ZKId7g`VF9o3x0*)pMj>DXEn)6in zJPf02C4+f9970{{Cj87~(57WA(|kIf)@%TLVvCB}@*3VcQ^4y5o=rZc7$X8Wj)$B5 z{_Pxw8T-R+e|Vqz7(8Is$DZms|Mv0Mhx_B|hs0eM#y)^CDTG3|zq>v3!4W%zZdd<= zVIIhk*CLm~nvDuc34|>S_M%;pVMO#IJn=j<8g2S1|5b$Ys#0<(QeqG^foVnXnH_H# za|5v#RNFj1uj4w&(_*qc95B(w|KpguIC?ZV>hBJrKYH(uTUbT95ECkB94@%n1d4uaxBj|iYa z9Rb|iupXN%iL_UZ-0x-^44{|d2HU8+T%xsSL-IT3%bXFc*=A+!?_QNneS7Vv>%5Ak{I#|j;&zSQl6{>Qe?IbJ_@17#BN)HD zfi07;ZERfw-1ZFk8|Gg0>AIb8ZihVGua8+)1$V(EXW)H1*6CD=2ME6Jx>{wG-W zstR!EBEz#rpL{UUCbgV%UP@((2wgwKKsfO#$a(R)kuXCP0QpFP#}0^x!{IQFhjG}i z==Ng-Lg#~PA`OJB)0cnyPrnva^qun|^39?-2K(oTGLYUTq{EI5Z45{5uvD|Z7O`usa8cT zh8WS0wEzIcEBcB+6evhgaG!Qv&$$A-!{HDR1Eek0fD#eM9>K5+fM7MEe3~a^54fwW zM+KxrP#~mg0uOSIdJeH4fk#Qc>v|xd!ZP}|9oMyhoIA^`LY8YLhX_Xu55h+5>A~K2 zT?b4ChCx-Tw2B6^ESJoj>&M+8y}eC6QB!sRLPX?dQkSM6+W4n0v+xz%2ml#v36m{1 zL@snFbHxIt%8ohs?y$eTyLjmx*|h1%RpA;vOCmS(#m3-Tl~e&iwyB^vleg zTDm%y*xXFbR26_M%uGZ)4+7|7ZWbPySv_a?!Cegy5r_yc#6)!IUbv93YeOrRh3pDO)j{go*4y_8^FFl{P5$u!-stu5;H{ChvWU-=P!#rDXcNa zP9iw3(}Et8E~Qogye=24g-hLGUZ$dTU41HRK~z&kZ~@(rx+s&0u6bT+7Q{ZH>klKU z-=#NYSqrRWgfIfI8G!3UjNSt@9B$qoh8R*`GJFidvyaTG)G9RR$HzbY>Cb0)*LPz~ z1l;z89f7C7hr`W&-+6*5g9CB5U-QG;r5wiS8QyLAJrJ5x2DIr*kB+WlAb|U(2uQmG z2Yyw6=(%aDx#YDd$Oi^kT@wT!9MDuH#cht8dtPOfcBUho`4-ysI{ zyH-+v=*Wl73wSrCxs)Qor@T%IhULu8!3XY`oCnx}Js|L*izu24!754<1)6P@*4`>W z-MD*uvwOb_>8elZeQ?T6v;rH>_Qktye1AYbq+~D=tutyp9T$PmQY$Ei z!Lf9xGa7_E1W+wikQD-;TXR*0;}oLzjBOR}QZ$%0E2S(RtV}C@+aN%*WYT-v+a^@z4(NeZ(g4CwT1lU4P1ZLr~dHv<_;~h1Isdwj`VH2yC9AQ za^W7myeF|$uC?X>f@`Eh>VRelZ-02#GXRKAr_+-2RBEmUYOD&>@c?P z)a4;tN@@T0r=LFT`kTS`-dmMC|KGLw7UTPI803TD|^?lHj)S8#2!!(}Ow+a_tQOj=2A6$p!K7?){Avv5mN(hCp3c5P+Hor2QK&hBnRfTx*AjnpfS% zRD@+%txYWefR9mdzHpy&U{QX^y}^@y=c1Q0x& zXWU)(Ox6l;*?%El12&-%nEKuA`yY1ib}n3(4;MPXxB4X140@V_z^mE+^rHAmH9?#_ zh(TX!T`K$=^*3+d?%rRlYCs>^Z}P4x05#XZfOq7`ni3~S>0?ac;pYbpW{~@#-ZZe$ zCJLD6_3q1K4Uic?NMql}!f^x;I&2I)T5B=Mbp-T~MRH;|jv<89UDB4E`VhH==s7`Q zMTBcT9Xn?D+gW!*nNC3D@e+xIWyQM0Lw}2TKHB>mDMdp#V0_DjrPt{U)6KnTavj)q zc`XkM0DJ*Zm*ep_fuV0yXVz15|9wZfN8n^_~*jo?ctE}ay+gA zpf<5B89(Q;Hs|kt9@_2t@cHA(cQ;-Ba`NwY?~-QR^dY7`CiXxa--`Dsmrq}!QV8#F z592T%I!0?+bb;T*_?{Qvr~JY97JcV8a7t@`li&1*A;6Aw$n&D;Hu_At@YefODRstT-m0RpFCOeyhc zEf>v9If0{3OuimJzB}x16Y^UAbOfTJizx$D#S=4y-lg4s?1$uAXl80v1#n`h%XFO2 z%l+NmvLJQ!oVuHvA)=rsX)VUi&>!|)=h>mD<3>b)nGM4%Zr4YTdZlT39$siK_-zSK zrJdUh{Cezd(p>+ltyohPQ2`Q|845xGVsgO&RU}^*I+Zf7Ie8y?>HIdcDZsXHiYH3% zr==p?zW?E-WL1?`WkDx_Lo^1Y8A9wmTAt_A@o_CcJoKtsw;_Z|R%?+4I5qEM7_d27 z-f`pt1mURTAqF2ADw6$>8cNOZp~Jeg(0SBSP@N=7$p^rLLCo+XVAiTdTvMyoZVxw}FFX?Dn23QAE;Oyr$nCG|BrhrV=14CRw8}=_bynWw^D&o#7?Iw- zz1a`sStDPj=4w!1aiDTWp$_mcpmqM z!&niR`q1}Sj#%VU539tWvSih*xS4$jDF!cqX9`1%jDEj6Ohq9gIKrks?}nQ$?0cheOx(ohK(Mx?~r9 z@X2v=w8cE!bqwGI_42D+`i5k^5R+U#eC51dR^nF@I@gP}YaO=xwMqi~BF=vKkec!3 zUfZ)#cy8DHo@)-Km&oUK)U&00D#bukC>%X|X`7hs1y=s@US53gGIL2=uKRnp{QL=t z5iUhq*N5k;v$_$cxeYw~e9qHLx|Z{Acc=h;m85*lsmk4(-^-$sovokO2o=l#w5(Gz*^y@A=QiC9+^X-v$3mc9#EGS~##6pL4MNHvye zUGL88@iyh-<4M^Q0V1nqm@>+`=JaN``OWX%9u6sbVsZr6R6TDoB=1lIBr7-$qX+pt z^02F=swmR18{V{vINaPGMjstoO^|g4I06VV8`a1`f&`PfKFo6k7<&)`Rs-%=jkj+H z%*%2Y@}+Vp-Ild5;^8oUIJmA){oo1B5w#}klAG(IH$5Fs=ZE9@cy0*Ycnsa`ySE8~ zB6NUWBz&#<=+;uPa)adJD zu3Qt_K~ANL2e2^^(cnQ=)^)DRffy=zSynUTBcfvH7iUu8EYOuw+0b*R%>BrsU{(lf zg_o=d0)ZF6R6GNB_vcR!>#E@0ZB+)!qM;hX#thyJkSgMUX=Vnbaet5j0Cz|TT}%lW z@^R5H*ua*rvGB!BJ1_D7Fb>^HOP9Ni>;>VwU`rt)mE(l;B{WYj% zqNdGJ^z8jB5IRvvDIWF?5Dx}q{#1{#NMTpzdOsPJccgOpwbye4V z3jm_EXf1hNtHW5>(=Mf4LW;vJAV@>(7j_W9mFfB+m*&%Ra6U;gkj?zcj`#JpKgZ?KYVz%i#`T|$UM)F$2fGsr>^6zGmV?O z(oSBShi&fA3vS2_=J-8s$}KqOp5k=R>$jny8Thgba!+Lx*MR1hR8)5PYzltZ7>XUuz8xj@etggz^At8({4vw-dEXIeKf3h+x*5sw1{*X|c7}A=rzt z*{EtR_>os+_>OIpjdxFk(ngM-^Ka@w4qGYWhWUZvA~o;8*YbFF?nS}=^`7m?J>5#A z&>EUS9l<%*%(iXn6@qp>)_fnjH1sNwN;!TW4*T6<|KYd);eY)<{*V9uP{BSWXjw9L zSdD$To4DisKm1R>8993P01>2Q(UnifbEPh^YpuqJjJ%Gk=B8-gYmA9?{d7D({(;Bc zn2^^3#IcK_^SK6Bvo#aY?jOe6AKo8^)Da9@jZEWPr{`lMxKxh7e4J52?~yac)ByCt z0PlWxJ4%rS;pXPHr|P_s#sKjbQ3WX_hBD8~zRR>sr;qoO^0@2%j?27E%c{D#{`PRw ziDo25)e2p^{&1`S9p3+V`{Nt$1G!c+C;&}QcRxSO7<$h-ugB@W)D6csJqg+x0K&{tdkM1SZ;u%2_YOBkj3vU`w32ZGgTQXP0DkgKGi;xo?L=t{b8a zuSHMrv-ULqF8^+34TO*+P0M-i1A(D1qn@nkIz4=ue~UnjJWr>*D3J3*>|z?FO=||n zaEL8b0~vC`Kpm(akIu8A)@3TXpsXq;0`VxvF(G+(dbq!PJTD5w&#ChPxiq&}NL^i(`5-=&W)el9FP62x*9H^;*T~ zUePpNTy=uUQz}R*!S7Q4=BNDUPaprV@Q0uN*Z272yv%4_$I<(ZLxV_4nNExO!`Kap zuFIl8o8)z#C;aC085zFo2Rq;WGddbl9On6azaR-#pK?L4@rR!d&2b=TUUe6~oY(Ui zz6(7JbhzzMvWR!2B31U~*mXBQ{)d6^h5OFmqAq!Aj}Mi5J=QX|ANRi*-SYM^=AVy8 zj1J3mAOKLUS$tg{ZJ_WTsD~RlK2$|FKoMd;rhd_)isFK&2Isd`kBPf|oIaL)9FW&_ znrEqm5Duve26TkxLKoYok0*iC<2iWtJRWwpz0)PnfBENsd595MYN?Be_haDyrYZF) zC`^u=k&^Gn^yMG_%OB5axEV0t-=^JR2;PA`1$LW;3aB^DFz3aX<6qj0s(-xK2hZ9be`rHcM`n!E~GV>13=%FF>EUJ^y$mz zPY<)gr}d%3G|dS6?)OnQvjJHeqE7=LV8#WYPptyEn1-S zk)0gB96u>^5di4MLri~bXW3PD@|*3N*41Zc@LwBme{POk2njH|NN8(hA_{Kiu{KZ#+=f6O%Qu zjff69*P?*UsO}k)TOl${$A{BW1)=xop=&8C5aQg$@cc`)7DZl;4@0~O%tU6j%~L%c zmTKfZKpcD4{LtTsFvyQL@H!WaLn0v0ON1fxLkF0kCQ4x#Vq_wYDIpEOc+)es8oMo( zzb!x>0EE~1ICnMeF9Wf)T2uvKZO%Y)Ign#;4pLTKb19p!3d%Gu5PVwEXwF?Y z+uJwa*Aq6uwTrv=az}qHM4WK8g?r+oczd*P&H0PeOrW;{4Rc-8t z!{5b^|M}-i2CGvkJxe&&?lwWWOQ8d5F2_A2pEIHmJaV4cg;1gO_;@;sB0#23Z{PHZ zL^QAG({!9xS4F_yd(Q=}PRECbC^5%#RjMuP~mnvABW_0&$U#=Ql~he*7^82ubcuy@g%9a)H(s5 zAFC?3V*rS8JK%gg1eyHl)5p8VdXaEgc>!Yg{>L9~_kHl*LCRFzo7URyDLtIWkfQ zWXkux3*ZE}+kO=szZ|CpfK*wtR#40S7&Z7%KRv8d)}nxVh+mPVR#DaB;C(;~DJ6J8 zOCfp>L@cMd)McwKW2~bCcMk0l+}+MNMx7SPWz}sa$aRGa)p1q@Jb6@9VNUf@JQz6C z3gTwO2yXZGW*^5xp9a7{4B;FJWa^q!QFy58HTmwo588X)P760{U{K#^+}$h~K8!tT z1nLQI-F=?Axl*5kIjrY7SE~waMIs6~CAbh%mptnV zI!~q6T&-G}&JV*L2)lkO>hS6C;dY}V;TRGXUSnoz5D6iUfjiEtnJ7RN_Qv_Ztd^S? zrQQDBZw{%R?&n%r0rdOB?YL0xqoB(daD1;$dD&N*eg)`RZh`ucEB#hzSlc#ThOmz6y$7Rw{ckd+iyP>8_z)_tFE}ILjKYX+OhD zkMTvgC64wy;zm99FLEm@7Gmi%a8;Q6|v*}aXM}OoSo*7MC4$f& zS3?7NA5~`tR7x(Qr7XwIaclFEr2@f~kW%Q#oQRks_>Hoy)#KywJ_}9|$y!T;gM+^> z3@#s+wOr_X7^+Qc6*SpmPbmekj}ZbzhcS|et7pS%^I8;umU#i#Cl6?d2SF^ltdd3T znmI6Q4azWR)7k)tN0y?j-U)B4cCD&2p$IVTZf}3=W7zG}xMk4^sx?4Oozyie!=z** z_;2C3=^KB+qd`HG9Jy}1$=Z#FL@1EsX<1azD^#VdBBePrM05S&^992z;hnwKqedV|Cp4oS$=NkGD62_XKIKm`Ch8R-NEOk408Sc1^MAD(Zsc=Z|X`GxqO# zZnfldz6cWM3vU@QZK^*VLzjYM&2<$spslA*G>7h8zYm*aRT@A1*tZOIC^5rxDTR~3 z6y2D-C)>(_9RR_eIiRXm$q2jmKmK^rGaer2vN;Or&HgY(a;+&^Q}&Jw;0s{G16~?j zjLCawLtP%f{OM2nrjH1SWn0HCR_X=#7Vj@fFtK#)j}y8=%SYJR35+4Dr~I44cB<#Yv>s$jl2m2Y~VON#-u@z<1C;1j43FW7jqG>Asr-C_-EU4`uGOF1A_*S1dVe z*F`U7MTik)Ez1Ma{CTQyfK2BvfTnOweh zK0z~(m+5q#bMORZt)iAf=z3HWMbm01Fw#5fj>qF%OCM8H=rVoz^m8c!_I^`(1-L)F z`*1tsB!IUmcH$K*Rij-gLOO34Q_ z@j5`(`Hvqzp3pJ6E!zdp`yYP#aM(q_HOuGY$9wD{l0Tn}q5vCk)pKq@LNQUKd@T1U zb&(m|s>CpUc>mKd4Biv)Qh51AFMl(J_EoOn$ps{{b_u)jF9xGs$IVyQGKU6-)?7ow zrYYM%907ln3UKRKWo2yP4xUvZ4OL8YnU?9oTfA0L12R=1fe&p9eZ@E&_Jh}a{Q1wH z@3R1pXjY3_1FryM1*F|?jQq_&9-^YP=r&Bvb*b+oLICQ5JbLe)2bV7=tg5C0psrH} zdmpwu`5=mirAn@KdmZEjXsvFs8M9gzUy3TAD-^ClGeiZBtHD{L=+n*nAKu5{hAzc` zExTf73MfI!x++6u_L{&ibjQBAY(0PIFIjnJ#C|76p=WYI=P+9hVNV2Dt7TmtxDP;` zAIj;T;hEr_=RDuvnILvR93o?xm+4TZeA(PP@-ajYKn!S*^+^2!@&Qah+7XHvrec-5 zVPHKzEaBdV7>K+J!$D@GUfMGK{4g!~EgG|2IJ)C*eE)9O1!nl@i;7xZSqm!-1Bbel zYbmiXswh6+J*=H53cFOK<}8=3jT(_PKrO^(VFmF4j-fBIAEm(Ck<6@B*hp3`yv+PuOA$MNceCjjHO+N-tT z;)z}8K*?UM`Q)%|@0z1c!AKcU*v8@s2cu>U&SOhWZvhEMU+0#ZGv~f*iGMA?|6Ei5 zD+hk7nf+^m$$t}b_a$E29E^!tdtNzV4xD__e|Re@lGjC+c{v`H$KB9lx}V_R0c)L( zi1XuA5XI^QS@Nz=pK_TWKHWcV8NR$c-W@twruqE&^Un`C=Y_6Om?}VCYZaACO2Rgk zTK4El=wZSc$WZ-EJkCpL%i#uSR+jru|8fWJ;YGoqlY$RF{_Y=sxY>I&G*h6z@i91* zvR0^+Je?mt9&vTE)WcHAyr5}r~>vmg>;1gkCZ1-+%b& zHyq|@&V?7mYF@6(xe}URI1{COSbYA4De+7c0!mw~jhife}%0{IC0I0Bvmz10?j>C`d zes~W>a*j7KS~bA7(wmakMIw-A3`qFf8#U(`>^ylFqBeNXAePbFQQx8)04=1l;;z?W zs{?v`+~9K_c!y;Md^&{4X-ursd>@8(hXdKvk{96kzjE5k&N~v%}%+Uq% z{ItMtr}IUx$4WUp+@JF3d;VTu|C=W5H<%{=?`Rul5wNRx?i0lS8W{8dsC}K^0{|$f zIeRu?Pmnm*wn)(yNBG8>%}Ci`Pr2}~+a*Z+w1;Td&4XQIw1ltob*-sA2bV7=87{my z+l~D4t|O_SH*gR;|8@YZ)>_u}FMrgjc3tRQa`VJ#OwJT#k%x!Vgal=& z*FW%>$2QG-aV`aNCcRG6%=@r)4jgxS~Z7l-C_1MG!eJL zDzqY;%x!|lHJ zf!bQ9FOPrucsJq5F$5p_LoJ%~qyTriteWA)M>2y5fqcLL&;bALHy_^KfW0F}mv}k7 zPDa1nLh`l$UU%rzp2clr*sw+Hzm{fbcybC~T)hEg&-p#HrmESR3djg4Th1*PD4*d2 zq%KQ6=8OV>8PmEfrI-Rvt${ZLiG$?TJHO#r0YK^F|M~gT{nEmYu{PMI!I=plG`OY) z3O!(IT`ZDw%?5CA9^5BSe&py0{W2-AQ~F}V9g*`8 z1jv=$0Vqf4q*buh0_GI})LOo968e6>+r4{#yF#Bjc$s6v6}9O^pHWq@XY1M|hb ze*Mb7y-jwsWmxP|QnW#ay3_&O?}tP%hGv!umzwi~4iL18f~8^~`7rpH`rsq=-nG>A zh0J9Ix^e8`!@!E@>G4>n0>m-!>U}61deV2cj6=e@K-aZO16c1vinK{$Gf@`Jcc1U> zGd~o(#qs{(T+R8^r4YN`I|owY!{6&^(UpL3d-LJ#*!-M;uJ0JO_=2T|eB7e_eTQnx z^qPe}R0TjG^_1BYM?h5oxTFNjwXSXI4-0$mH>!H2^waKcou*u~^(#VGw@@(pl=^~G zs{ua74g_d{)@5CDt#BN?XZ0NL%s!4$d}edh@TM^`k(wgfu|t94zf zF2`;PoP3Dsg>cTcS#94aBKp;4zpxgU0_|U6m){J+hIAxcxY1s)#2egYxv(whNq}9F zTL!z-ylqt!{1VUk)#~zG{M4RlVXm#cl$!Xq{cf9Y1vGuW@N0APLa^|4{i`*YgMDpM z8}vmn$zJF`{C!Kt?T2OwZVDz9@EcD)OC5dpBBR=?CW90#PJBg1@?^q2+XWC zDOCju_6fR(Z{!GR+mP|lIRLdxU+zAi17IEyAohmw-QWHGhu&|tv>Ct&X07CDStp%O zkEdl)PP<_kQgX;T7l31mfz!L-2>IB>>3Ei0SFdikIrLrXnM{=%v{Xg3&@lp(V~=vY zefRcFA015d^zl#s@`vLBUpRL0fS5Wcq*aJfeK;YJ? zrhoJ?0l6$W>sl&6aYV^4X|k`SHjGxY@0>>k9YL&p`26|Pr^k%s5f>=G<}Nt23J=SzuE*nH|Di1v0n7jk`3C3x zHue+%ESr$oihAC7IKds20vM#h0B=Tt`~G&^?S=qUv}SIb;949MP=Tz=Dsaf6KKgGX z5}rPK301PKDhh&TWC3s>1N)ewA9uUXGgQ5URsbR)bfYBKa;>@4D(n-5t_$9C1OqLm z!Rj;+D^zRWz$q~eL%Kh&=d}Q_8$(F!oFjm#kq-%4g+$8~fv7mAeuM=wlv-<1nLmEK zKcDnb4&X1JAC9@X&?jOH-e0!YZ~kW-^8!i~Z+?9HZV-1O&=^91qG&Bz$|3-#!}}p3 z&&w+n1V_Ofz#;UtX5qkB9}93E4Fa99-YiPa!AK;la<3f|Al6LHw1$oOJcL8P%+9u= zz8+Al0JIiSyNarElilvkiXpIJ!_&8wWm(f-m04&o^ z5JQ)eyW)Cb{Hx-0-)I|o^;fb$?NZ0^J@aYL2f{XCMt2Etel^dxn!PKo^8$G@7@9SE zA*X&7p~J?(^p)YhSoBvF7kD1l?fJOxHRX#d)t);41+AYMUDhPKqS3FL2WwZ=c=wg* z(@g}Np03ljN-js&lKks!zk)$H0A|-3=k~(gyX^U`X>){N1lKf{7(P74l6@%)#)uMP z>M{2UlWCn72UQdx$}+_-+17Q*wVHr91uXgipUZJx1wO(PF~LMMrj-Nx)Ln`mL`6-q z&nvU4N&tzekQeR&8g_@9+k+>A)qJ{tT#x>#IFSkd@a}fkQJ`xfqi40U%+qmR+v#+7 zUX{mm^V`%7tTG?x`^rcubsdcdPmB_hTaMF7XLOpneLtj>7)D^RoEJoNh)`8vp$TM@W92~I zFa}o3%}J}J765ynQrCg3MD|^bXp|}z$qbV9G^G%m1*pgXld_(t^ZxDR{tp zv}WpfZ1p66Nt^g|y*^z0ZOjy-WLCHJi?UKtUX$Ss!U8*}q8Z+Je4fGmIQBojeY@|A^qu(-VkE34T7b1? zkneXtf-x^shUbesg>&AEuVCV?vn7be2td7DmNU~z)g;cdm}fwwNUgONRU?jQkdoIv zm;fLe_PrlGIQZE2BcS>KK$nuGA~13muuH??++pk^Fi+mIuJ<2*ez@5SeCltO?#+#N z&B1S~zuSz|>lEUU^17DhLrl?MNZ?=Wcm55)mi7zO{naASn)e&l$~cwRYVGy!QCM&@yW z7Iu--RA@hXh?rh~Jw@z>1<)!Y@Gz^}Zn;}l%{gy!T=1TOsc6KyuDLn?{BpGxRR-9H zU@yqxnl`<->kPkr5pNpYc=PUuH-`uSre$5%iMKj0T#7hc@ZJ&IX88<&ET_lg!@0=$ z{%)y$80qFG-$mrd>F2vmo6pDKQwr?i9i)3V$^;W2#^7V}1ou>T;ysY+qBVf}y|Fm%ap!lr*qd%|vh zHz`2ow(9dsNdMnfz^BhW!sG!HOsJnj?3hbkjJVcf77dU~;GP^5@LTm(@PK9V5tt~i zT|JJ`PkK z%epK;K0*cs0OuIkgzFu9?*n*UYyp~JT^ux5I764EHQmC@ff_r{A&iIqT5E0%fMYZ~ zYYtvh7TM{q_uq>nw(ZB3Lgg2MYjQpe!=;wfBvVh_fG57We<5>UrvtWFCGaQE0MHd-B#~lMEMJoaTaEylm)ihsJ*RRbH zO9T1fH+hq5yP)bb!K$>iY*9H?6|L*(I4N9gyiEqJ7c^oDp%4J}E{;7+$|@ePr+i|m z3?L2tD8vAC<_I}|{KMzRJSh-wMfYCeZ4(Q)Bp+ezY3sBj9$K2pR#x03y`tWYfKd;l00rMCzi2c8_|=JZqC|;SB?xs3Wey z`*yt)8JbqXz9=|C@-ht3r!U8RJYs}CNK}!nz;H55=y@ORvT|hO|2j@eKn$ayX17S3+QplUM>A!lH zLL5_KMYvh>!|9Z%=ZGwxqSepyydd5D)W82Hl^*RuR^|;yK_U6QEUQxJppSo`Kz5pS zt%RCI;X{x!IidhHljbOelzL_?$_Y%!rx4&B!?m_HsI+=K;{d$_qF)!5NK6HT{oTcF7{yzY&+oxd&$wShvsH#@tKXaMIS}-Jkz-cXwWp2IWh)3r}5A|3IZ}04h&Pr@E$3$M}W0b4Gj=+OdGhZyM?r3qJpeL-;HA;lyOyE zD!__n8n)P7)U{@##9co!qu{)(`RvQG0;%&@Q#bth{xAk&*G#eqdtVG7cuGN1H{3=k zYXCdanwRW7Yo6{u{qdjf9y2%7;D`4={_w7cN~uz6Wgsfp1@E*FHIv$Se8;uJ&4>Na z5h+yj`E>sCvbm|XEDKQ|m;lYWRFNjrm*b!R`R7k_WA4XYS0GkPE(Lu|ohh-${wIIn z-~M>;t%p`{e|tFKFlSCQCI=N}=Rn3A0bjce9@qt!vi;AwSF!h(>!@Ak#Mc!M*B#L7 zbn(||s2ATq(W!GHgYQtGt}z&OUKLt%E&`V*=j2_8P}N*b(2ANZttR-0kgJagmMhle z6O6cHEvKm{d~4fN#BPXXF(hSATN!dIwg9QKu*^=S0ifgn@h0$!2}qR6hy?U-SP?q( zjtHKJ0nO9WB&}LMlaFXHaBwWRAO^9X7?H6q**mJ$v^3YGRzvX{HelP|Z|ey8O=6sp zD0q|=UPw*Nnh;RtxpL%^fymCZ^3}Y(@UgEeUc0Otmkxtr+wwj~q#e*Oq<+^2PYwuS zI7t5k0P4Fwh2R=1yf$mPZNv$#8K}YPX;~#J{BHjq1*PMDx9b9%0ro^>2%Ja-|c+@1B+BC0)yA)pJE9D?*pMUG1PTA#Umj#$as`5tRjH*!0LqAtQ~wT&^t+_fN!QbIS@9U;JZYV6o>v9; zUG%G#b*3@^J^-10Z@KDRWDddkZB|^uD$WrV&DoHKPD3Aq3j_f%DZ6X#0oR53(w{FT z=mm`5fM4h_Z2#2u)d$~dzl`u)A(}7zp%(}7QwY=f7bm><5hBp$Ey2;(aZY#nuU)p( z-%(m1-!3`O%MG}zr0du1+4#TqI-k>z&+V6<>M!r@YI55*l0ps6UI#;8xQyy9NtP>y z^kN%dU&fKbxis!}-I`^Bj%%nzOdD1eWXCh`8Nj!15$9Y2Xtv-Cd`#i0+0>s_z@BYJ2?>2;LUTV=JMnnTUChsg~E6XhDE#s)SZ-?MX zt>`j6JRDC3@qntKa|ltbNI&J%`AA$JKi&VgKTMArDBbMG4_PPGsK>JFMXRoo3-*32 z``eN0!vZi5@87*0prZO$s(p+AQri0PvY>u%PF%B6zr=t(<%+MCZOa|JDi6A1ho7dZ zV{WdIQA)@v(=tEa9nZ(AQe`VkXD=$*dj{CN!dFvmwV{~_AXOGLr&3UI=S@ggR+B1v zjps(cxzj`(V@T1*6!@cP1tgbvo>6N9oaaQrx8liP3p}(6Ap#8Y=U~BuKpO&|2(9Mn zv9m$KrWzDSLnc5Smi06dP_Wbl6hk!wnMuROP_so=w}@tIVq#hWu&0pVY=&balTxMG z7LVVsGQ3Y+*mO~Uu{vFG*zKziUv$!?k5pYc!1sxX0N+x7;Ccf9F~;QFwoUf}-O$<$ zKpCVE)Z;^J@qqDgW3$A_j)*wG3)m4kA}|b;0dV8i%yIwb#~O}0aUao@`e$i?>koar z;jmjqG;m+gP`JX!1E8Ez*NrjH%Uau}K^MF6J#KFgJxoo!@7|^3m!;$~-5*Pd)FS|B z<$RP9V&CT~Ri50NX3fL{hKl7B&`X6cTt!-wX4M-U2R}qlP?;X@Ki*HvR7=eU7*c?m z)d(*DWJrCN=#3`NB3?zZU6SF9L_lQ~)dGgDfx#MsWaLuGu}VdQ16X}ee)`_MO{!dbICQPQE(ke_Z>@O253ft!l=7^H*Qqq;teWefR!Pt6~A8 zls*dpEG43#1G*JvDs9PSPC)V@bsQMF7Kp#l>5b!|i#}V*7qBuGz>p0@tJZ1`j+_TH zSDEHjH_tdgji|f*>36q>;2L12d8rEU6M&#U09fvHIqu&_*7K(?M+EQcLK9IFq=4C2+Zz~^w;5nccsijH=zY9Fp;gA?+C7+HDA0H<_JiUvK5P=NL zWqSDR3f9L@pZ@EeDbg?;#>0myHD|@L;8v>BHCIK~b2{{t@A3>z z4mS6%%g+7!v46wW2;@ApIr7OjNM7%cUp{@A)&g5|tF{GOtu+$`1H6ruRu$M{q^hMs z{Mr;+vKKW`t*SLYEf&wv8&BNDE(T&uMJf>d67mt674U)jAW&$Jw3R)Uz{P_DIF>Z7 zSpkCcU?4jHnvV&L0f283LNA8gfTruTRyYDy>rLt=*X=LKx~o*^b(`3u&pPVh|f|`))7S(3B$s zyc5X7Uk3Ph@i4lg6hcbgGdnm>#2kpps%e93b}dqN!#ng##}Q*dsmnbS;N{r!?{=xz zFANVKYi_Cr9^Xe3cpsQC)3UDPwsj&-!{Ob{IONUjhp->3m!q8?&qdn+-?50Sr!N3P z*XPyF^&4-=ET2*PM1Vo7z ziLV_2SWT-M43!oDF`}GK^Ksdr0AA3h<44@M9spF79Q%!$MAq}&m-Dh{2>anMyud>K zdbDre?-qA`aosCL*I&Ppza5V9;?^!Q2^Yj_+kWgtwCVXL9T}WH7dM!*SJ2ky ziS8~bw6AWj;YykI+@4m6@7(F-{Wo06&FB?I6i<*)+V&r|>7#9MffhF+(k-y_5?Kn; zD`MU`IENMn`*3{ZyA_tnpsi_>QfjEhk3Ar=?Mrl~qlVUb;x2jt!@L1--iM*@hTwUu z426hr#uoqS8cmy&JB5xaMDn_3QFS14ARu+!`?t3@y+`q`uJgPU!270xlssYVi|Ulm zU%EY#m&ZT+<2@2}dOSWZQx*W-&F}xy-~aZeXDM19A3xt8*K@{Hz~tCL*V8mL@xi09 z3s|O5*SakCr-$QGy99_;Rc#?6VAJiJK!bFdI4}g@u2!$os$le<;2kT%kj2)ED`wY(=!?GQm7TO2Ltq>B}Gg<W3#4m>4tAO9PHw?BN`ISk&dPLW=zh^%QMs`J|Hg~~@Ufb(* z%+>0sO7H(%FH+O=?DJG9wTz?S)Wv-#2rKL>Nk$Pvtu1;GBU zhVgzu;w{3WCbbkb?qy?9qs_D)l~cd%n4ZUlXU_=C{(66&TtjOG5fLoQ<;@V2V3k~o zHDtI5hE=fZ#vw)z)rHq(S}G7>;&^*t?o7)H4zZ6rE?@rfpY9R*sC8YlC_JUzkH7ut zhnro3Ld)^);kZ_91|rXdX8HK(?u0O=VDmI7*X5Xwd6}1-m63Cd~0(D*Lx|lpO;0hz#X+NM0^nU%e<^yw}&Hmq>9vahSk^Yq0Mat zj^9{1n(1;v4l$)Zszp~9ldcfV)FqKxMZf@DN-0KW1B~^nUT6T^%j7x$*ak$~OyRZ< zfuT7je^s}307uqsE!wc|WX@6BqS1sWyd5{hl!jPzI1CI~Y8ZwtZ3(zWj@fe{=g(;C z+FVz;_qnk4KEkurT!KeP!GjS&@HkJmJRIKtIeBj^ngP$$6|^-sOzgdJNL>t!I!&KH z{`rUxH)(7!V6yd)FhF-f%@Bs6zwNn@SiSEuqv$I$7YGZK|F^flfFb1QZy}7^*Fo<|05$&L@w`SWDg5DjNXEq_r$- zk!pb<5#HHS7VHmWK->7e*c>(0(mG0HSYR@Vk!c3-{2r0P9y0PcN~gz*e(|tK-U>X|wI2Uc6NYTv48vr*#^s8T#AL zM+FLc=ODR2t00A7D?l7j4Zu=E$hApbVu!V;7+4ulSppP!wpFSk+NPO}z#a0V0Y)JN z4>QR{8r-#zQPnuH^MEuF!+JiR7es`GOaSuCP??sc0WNhnQ9u6ErwP9H(u%-?!Q<_Z zzx&}$pBT(K9q&FpRzuf~hu%9A!oz8CqSYvZ9M4-zjQf9w?v!TBTYu<}G3e zkMDM*+K@c<`*BF$14NU% zR<&Nu-gidAx1ym}ZRV>d_iF6FPBd(XJk41!JT<6Qt+E^+?vK-yvowHjUaUMwJW3NY9UMXx6aE>LG5*h_1EGT`hOq~sIA5-N3c@pY z(?ypAt^su+)UJilkNq$tRxO%W&rl?^Ttq4eg5XmM#Eu-Avbk5P*bNTNeN94Oc#-@! zxGVdFXTJ1ibFMMiyhDR+QP}I@bQv9+cfk#Dc=IFvgqt5(b3^F+-ghCeXEf&>d+(T( zMb;@JEnN=N+I6m{NK)4`JfpAu8wB1Kl=IaIIXf41Mz5p4@Az- z59go%@ZaY$j&We`+jQ<_7kbj$L*U56hxfnz5ja9n*0PbBHRmq-42Ra-g*r>!g?Sv} zElbTcSF3^G;H9p)Bs0~j0D=ccf`{NPqqPz$I*LW7f_@k>GtipVlD9Ct51jn22kVN( z@)p(bU{GDld|GPp1nvaz9kA3h-@X|rIcpmZS_LAX{?GsVU+yuCfia>Jm9N(6R~>rg zPI+GRe=XGb!aaI5b}m88OVH66-%d*XwadOXdEa&oulUo~r(Pc7#lrEO-@b6dUasYy zf{fe0pA%;M6drzkAtrjU0KGis*B*D<7;LZS7Rl5{op}=)2j{(mi{p>@ z0dc%J1knQT5%#zHK7L2TK6QzHjBNBABGQrp(bi{tRruJGTNX3bqOEMHB5=fSs6kFx?m0x$brUfpLX@lXZ&?f*W?4enVR+KfvB`|SJ z4v%mRkhUR))(wy80zn)IaKUPbyMu3efmM(dUE7kE+5);@C2Z;KAd$Jx`@Z6zXdw>T^@#6fLgm7?wFyv zmgDCiKZL`7kh`TEyB#tOr1LIvU18Zk)GR9iOVj6vfBx@(I-TPXZb)=J-rRi-?@~&s3;h9A7t5_6I?oijV_qI4uTw=! zJoeRMH)6^QfByJpbj`ynXw!%(%YXa-{I@?J!)l$=m^_D+UK_sW4h5b9o-g{#;K=y9 z`TFm~IqjA0dm8Fp2q}~In@%p|60c1gPleRqdVmV{uI&gqW zUB1k$S_{;+DiUr?E{uH~>WvFarT}cHNq_?T%#=JUL@Vm@5H*mY>T)_wpg!c~QX>sa zx=xE!I4^%Wj@@dYZanl*Ra61eyAN;2$WRynnU*C3?|-=c@lD4ln0~&yyPsFV#LHq3 zNEV3qu77{%n9GYd`fT=aExYL;+JJHV&EJ3MX@24 z&KYq2Nrv`v9Ri#us5CJVYX(ouT?n4V49%p$KmnJ)9`#n?8k}eL89ohrl$?tv04tj0 zT5F4G1)!P%$Wpfmxo87C5Mnb*fwZa4`10`i=zGgmKn$!{R}e#F%|Hr4sx)Hqt{I^= zI7&otu*fO`U8QnnpHe^eT|A7a0!IdJ7juZsV-O>Twe_? z*^F;=7T~yh6L0qDlbloV36u96JhQ)c1DY9N<@_LP9(4XZ4?j_$;D~`I{wU^%1;Bc| zpWk#pXu5wmy4ZK{u<5t^djQQcP@(u7gU7h4)n%Rd?(W0Kl;?S#vFtzrhj+J=fB$#? z)6K~E48X@A>$DblB6tEMP zH)H|eB6K}_1+w;pIqh=v~==vQmM59Bu`7aOE{0gb)5r^*~YyNsi^YhLY3>rKB?C84#HsHUGUXH)B8U+H7&!}r;4L)KramOcj{JItgGX}=5iZUan94=- z2_7Dve2im1$X)=z6T?K*2qC3-tRazuH8YfBUU{xUQ#-a1hVC0&bxtB{oCk}Ybr+8e)n`(~ez z^h0-?jD{D-`50LPrT$$Bj82w^VRuJe_b>4+(Qb)0M|zpg}}SMtYxhN z@BDb+3aia2$y?EM7rW&BSxuU3bwSUpeFq{q1vw8A<1mhb zyr?FEsg_!+0VUUVan*EPEJMtoO=V->3KByM5G&B>d^~$;q5#Nf&8HQBwmd7C5Gp|e z`M_wo8Q?r^R55_MB3cwF~$OXxTFe25p*=$f5Wuz=iT}L$JJhwMO6AmRz?T z*MdLSfJ@QXHFt5@@Tdbl`{+-QfNNFm)}@Zeq=}->o|7M{1W(SvyNjfnfm$O#=A~BX z>F#drbbpAB95Gr2im5``plhl1I4xtMx1wj;Ll>S6t!3}HK3_S zgU-jt;~|nC4(}>B&qVzGm1q!{2h#Qrdj zDcC-hMTp0@{Q;K4IN~0FOb<8v&U+>!YFg&wmoNYQ)0f%EbXD~hhP{53GJEdOC->I;qi`zMRWjJ0hCI31r=&$*LjRwVi6{T<&oXyu+x~E*s z%U`qW&wuk4t|c1J{{lejw!q@$Wa5 z+pg2_jj6d!ucmCyu4LPe5FGiWaOb)CWc^UM^EvbfJ+7Jn4i$x(3%=`9Vq3F;f@cpv z*hgeE0OB1IbfZxS%;_-R;7^KH%}hi9W(BcY@|+mC0=D2DmQzf~%e-U?!NXV;hUyh2 z2HzN6lI9@rG45|~Bg9tp3Z%n8B3aQK&AGt)AUM2xcQ|;+H2vjI$J2_g@8b1My3S$P z9d`TPZ~8k>U8gESjDV_8OJ1rK^#r%hL>&*i{jQT56Im`RIG2*guJ2O}L;}EvgAq0` z8hL@1 z-E^*Nxd=B9pkfF<9sCq>b>0UU*RbybmRf774qCHph*8-32=QRXx>VW5Ju8|CgcyOs zMd(UZv?@0ffUM#qNH$WSTk=938&hJN$kYXU2@2f|-d(1=ffgE^zU*hflLys~a4(Du>oF30p4eC6i z!PTcisU`r2?)LV__dJ*LX%U4~lLlOAiIHVXyh^Ec{+!l|79f|}4;N4n*Rp1@_~$w# zAfG>dnbs1W_g&w2$e%55!>Sw(QZfHtQ2!eq#}N>eGvH_?D+gFW2nX2VCHq4NqKQ zzibyxgkRd?Em{2qxX;`*1-t2b@{40_>HyJjFPVYr!(ixHw9{=^*L{>Pj7Uh4>k6RT^{koJcj<*{Jk zuJ6HG;r(!^(^Um11yF*L~ zJfEg`7>4=bq$Xtn0|9;Q1R;fyS1lDhzP;HGtXVf(8={`=*hP@#={OJX_-wd+fAh9S zKK|if{^>7|N;kj%F)sH2v>~NLvFpcPE6hhsrLLtYfOzl;bvdrf?f-LrxH~T*5%ZZx zKOT~UtXVMJtPO^G|M`Z;L+_~o1gn7GEQG4t_0#Of{n&dLMX*moVc+r4}L?hXFq{oTjo zv4R|dY%Z1hcOU*YJs!{5r+trQ$-Em-rzNWuG?Q#CFo+$_I+jK{+V zKmWH)A`ZZ99EQYLr0oA5AtbF(Fgqo*rUV0n0Mjet{;O^8bHoL&{(5!9wsdT4_SbU% z?a=sim^L^tm>d#JIP?c;xB)vRa=6s$IRMVd<3In52%GNi)-q=}W)B{AU*<0gsBs!b z_oxg0(@#6hi2U~L&8JgcR+rxW_T9S}Qrah$MO$KcO_I6C%@|S=7m%p6z&qoXuH|RQ?Ai{pv=Tm+A<+xVMr>MXAkf*zkfBf^8 zRYOYso1s5=05oDc*7<(+{rKCz|Il-jHm`rgT3SZ8mdHHaFV%Qf_xwSZLzEY{wi8x z4cK&%UzY_ud03{z#;~ULtR4s>FvFz1E`G44O%+xVf_JUes$rw;@<2oT*N5u=eXU)1 z`hNXLy0~$_h7$TK?bWXkE|IdQFbZBLmYy~YL=7!9^=1{4fq-$p8-DY7Ne~s4Cr}!` zjs$$wcm$a#P^+qh6l0g*LwZ(pyzEp}_1Y2jbu_lFwUh?f1}FCburk1m!|j{fp^GZH zVo?P{rX~0k$kyfI?*6zMFdv(BSRcO}6}|y=r3#Ma<*rJzsOGf*!9@XpqChUC+WMH6 zy3Jk+X?Oen?HHZ!#A7}_o)*x$1AK@vyh;!PAVMVjp~Td8UHDG<-eoR0`gip5zppu; zB4Me=k1K%DOk<>YAw4@|^d$NPbo=29o$xz~;MQ-0$!MP2CXykP?Ai z;ltrJmWv=Pkk{D(Zp6cHbXLy=WEM%jpcnH3CV zNER^zq_~Z{KCcyO#iUG@o5ER>Yr?ozVvgPJ-QmMHMuyf^W~ox8oM!l#qR#XA%W*OR zPJcdrjGE8)$JKiPWkJynyseSU(PM!_t7TDyz+eS*LWi|1rQi>`E~^5DM8o@^e)n#S z?7VO5!^3e>2Y_QrDR@@Bygdcr9f8dBol*3GgX5-8I>s*u1QZSAm|jnyYjwwkzzFy& z`=3`)26qjL0c3xREpFlPfBeMpZpP*2bQh>;s zYi%$pe%tPH4Bc=zj0`@1fmI|*2agaJ9NrwFvIi=rgmtb2V44XDqpHkGx4LxducOl?w8p0Qdw!8VT^B57laETGY_(W7oqT zXU!f;3P4NlL^8lJx`$9o4KS^^=e~yz0Fz^)OEmJrd%IN$vHP}9_cyhtD}DQ0Y(~!k zTeT3J7tlp#)WH)BW*}%9Kco-Ds4Khx9+Of`;XdYtKjoPFFn#>UcD}#r_;O*@X)u_Y0ZF73GgUiZtuf{l)xz^-;fm= zVCp}_q?xntc86g|3e9G&XA0z6QA0=`&O6O{#dQ2~_i#Md98$j@Bg)b;q}5!@T9&$= zvk|f5`6#7OjKK#(8gKRqIqRybwU)&A;r-1Jh!|J}Atdvj5qVwLQanYv#>k<$oTlTf z>%(yZb8K*g)&%g%r?m*Xr$zIk?MAk-E92#A`fVl6SM3FL<@XH9#{K!dVc@Rlk{3U< z-9>vn_AWNWwJjp?$~p14R1$4sJZNx#Rn^A`->1+7@QRWazzdz%7iTqvqo*Q7!!I$d zPuF`M>ldHktK0b{OWU8gz2gFja&RI4=j z#EMz~9?}se@Wg=$w!pMn0Uu%vtQG&VVuG|)MDNUU1Dv4i-~9IPe)o3t)FjWJf4*Oo zIqt@>k6V6o8v$1+GJ~NA2JeWs8a*RmQx|@s`OypP!M*HzcMYL5Trn%(@g?j+R{cCv zo(&|ubnIUZ!WWlv6m=MI`uK5z35(@w1ZkT!RZ+7i@9wF3;d-v?`amtqCYcUH3uLec z3NiNmE;#*sk=x;}2Z7M{9hf&^Ymu@DnP6RW2HciG*)FeI8;JU)Va*VqAwVvVQ0z=H!yMkj7?KNlSy-0wR#(UR|GDGo-#Rl95fd0dd@QRP!t%4P;x1k;s%4 zA*5J+t(sDWtq(!rJAj$^!Y*_nk07H)PwV2pu{~euo4xEVo8YVAb0F|_jdTthnYB~E z#la0fIMyW(zX9N*PfoM~X;cHCT^~YZcH@A$XzIJV(N!JICvLRNHL-m%s}+y!iO%@bM+XNa$`1Qe86p3B_em0ex9)qYF z8gDMEv+u+(+OO0}II>?FMg4`LdHopMm0$a8FCcgR^{2le%Kp}#;rS4%uhN`P;OWa% zUibpfd?DM@JLf=fF2b5<=jAjpZ*>B|j3U)>MCcd_sRAVOP}DWIUFcGd389Mwt*nW{ z(;IDu9>Z{0rUI;sK{m9fnc%8S*RVPR(5b5MnvqLwa6VBCfn%sxOjR_`{SW&@R?lDl^eP_S ziCpzcl-wngt>i$&j_^X;?W)vfzrbLAHAtRO&R4E8yG|wtaC>pqi#^}VG44E4A8`D9 zw|aKk@|@*@5F|pbrt-Z}?+76TsA$eoujNGsRcGKBLf~P#@Uu}f0WqV=I;eu771{El zWQJv48X6e-yu26yU8YAt&Y+M%KwWDVI5q}gq6?{Hvbt4?c>&CtiB~2_1F|P_5fK=u z53Gj%O_#INMXV`Q)df_^dG-)>F82M9AT?J=6>S>`l>l2L7~q0u_M3n#Ikyq)vARnf zh(PYwNi)9nCZDhLodcdaa_iP;ZJVkWUyxwV4BE(d+=I#1<;}Lsf|%AlAs&tu2ndHh z5j-n&J{83MFwFBj@&W->Dv zJjc}cDG|2vJVi);=zHc83Lqeu)LIMB#6ul{tUvgKj1D44`~35#hvS?pY)s=}EQFQ; zlXZ1A(A`h$P^CIKu zLx(;D0L|bpBJC74m{o%_tDMmm`FyGp=o(tPBKKc*aocu3+Y0(CVeS{CCYNFU+P=}% z-}}xUm9BuauTUiRi{EY+ztG^p+x7UmrTQO79r|nSuX%~hew9-6+h_mk1bb1naB&`9 zzM2cZ#o?lq^mQY+#?7UEclc+3km^

      TCx(f(kU7=7T%Cd!(kNPP^nAk ze95#PYM*F3(Us3+tf2bAn>E;;AV!W8NU+s*w-^+<&6}`(VX&r(UdAloC*;%Jtn~*9 z914DoGje_{zrF+jy%$a0G3!z8g?j+8NpK5uAog;wY(v)n-%!c3 zuUpw=IK|I7AcMK3%SrbE)W%_8Q$s!@-7!4{q|@(YARd_^x(ayhF z6M)pP)dEhF-HD=L-x;m5e(*gXQTZrjv1s8`X;dVBEAt|PkuX>w=&~-akvb?r1BvM(&M7qbHI}7^p)xkK)kB!mMQeu z-mfR3119z`YmNmT-8=U9xq~edv%hm&$zh9Xi~X1CMFF-?gDvhI>aR5t!D24=Ce0_F z>}&cf@gB$78a39cUz>)7__Utnn!^srx6BhQD-~OH^8XOQ5v*#%v!j+ep;>`AdGBPc z@2iv+$CHSUt&Y@?n%uH&a9voC3G0YwTo1Bqgz@XMhNcAvmrw=j3>tVp*wd@1*r0W! zaQdlNaqtCAEWxPX#x))2Y*LzeA5yP_dT4F`Ykf+)kc!ze{h8vY|H@E5%MpkmehQkj z(M8YbLzr_`=tVDKgYvKYia#oCZb!uIRKsou6UOHt%y*t?>VVxoNgU9oro0$?3pKPM z4B8v3dG+*1(touBhN+@Dlo?w6SE_fkVjQ>FF=z?cQ;H1oFSc7M_d=S=L$j?dHhKi> zQXXOwk07Jw1OVGlrZ0iebJ;BHQqwjzMXh}FJs2=O7!j3uaaL3bT$0y7qW1{7CH450 z{5=5mmbWTbLN~}5wkrSI-FQT}>!#E7T(4vyv^P33ss-lG8=ilgb!av03`VDw3AGE4 zu1Wt@9`Wn#{tvqoGrveXblbFc9Tw%@qAfIVs&P4{mo30y9N`O+R8kZRY$gA1vRpyzjxqnbg`GxSMucjWTwAFhSVtq~O2 zFk=6eAVIZ`q0@X*9$4x{yR;->{1>=g2q&=h0_Byt>N4XVd~L{g{`i!onIqRx5?Vji zPjZ4%B<4$n9>?*O%&aRE%wcu}H~!N%vP`f` zS9yzLUp10zINBR%AXdFcK8D^jk*Ygy6{hx8T{J_^kmCEt-~a0_30@l{2rI|w1ge#M z{U0dli(GnWx@2{Z=%k;5MC9{lP4G zQIfAJ-_*u`)~OAkG7B9?`DMlnEv9t~Yj|?ouvft)28dtaF;j9V3_yc&a2xN&vCxVP zzc_l9vDK${F(DC)&JewDAqgjZLUN7_5NJ?5O{tj+#luu>Bb!M$;M}JCZ21vS!Oa~l z3fWjM`j)xMcwbQP771@ItWy@&afR+}^4u3C3BaIB?Xzwr!LnMSCc9J1rif`)T#52O+h#Dd2&ijl)HuoOG# z##QNe_8Pguw|8R~iBDomRVLuj^A6R^RYA#`1?6yaG%Dt_v|HaJ)Lr_Ho>|_Shi0CT zU#GfrQ#D~Pt~V(0(Yqj5c?IlvBreF%q`uUPbo!MmeJ8i(7#OU5 z&Q3I)5&Q@e##~(jP6e+AwOTB1;E7FQP#X(@e*gwrz9bRQZ(L)Cyxs4e$Gfzp_LNzY zJL$;mb|wDa%vKHgDa8JxSx(r^aBF@<71NllBA6J5f_|{YC74U5lTRLE>>&rE9I(VD z5ef7XNor4Q`eIh5v-}!GR@DewyvX_3oHTF5V_q1`df*!2G+>hU_V-fETJT(wJL3Y+ zDNVXvCq$4oE_!_SFslr-sg9mrdA;BRwY^s^L{+Zbir>hx^yB-CPe1I^P~ zm3B8~|2}-@)a}gEs7&m4rchK}7*lPrXInw=!0EHj7mqbD>YYcVTjA*#nS%_spR3kKZ$WX=Nm4zE*A1 zDXLBPQ(K5r95yw?%YIN>xucqy7TrlIXr5I%sQB)VEg{)yQqr5Znu?B%BycO?mLw^ zi45jbqRrkG@nM1GQK#|MHkj|%Op+7IZO)q2e6XX`sI6bhoqdMh??+utJm?F5qMwd* zFYTs4cE>HB=G#!bxgX!v;udqQ|K8k-pe7-oAY$mx^F0O69YCWGT$LQ-*XA3hZuAeI z^dU%G)9s@K3zMutJRBt__w8vn%Ai9^W~A;9oUt+1r#4f z=tSAD3Af)oW~68KtP2g~P8!CEXhDF^fEYXCN6klrI0r8b>t1=SWuk*{s5x*nRYca8 zg?$zsfhXK1-bHY?PkL^o08@{hiYZ+w5%M1wckIHMvrpb7;$q3Neey}|Xf0@{A!?d* zH@GhRPWyR(Mylyi$wJAxn2}Cy=7Q0v5Yqc>x`tf7Uic_^`OI9dNRTZpvH5&6l*1#- zpZFBj&B2onAoO{xGD1Y_2S-{~s7{`V)(p>|t|08NfR&Ao%hwg=*C&3R@}CU8+`@km z<0dj3u~16NBx|u0caK<=J=jv^tMaR)yH(j;wf^E=q_m!|b19~m9BQ{sr{eC~nJ+m^ z8AmNi$0JIyFMRG!Uzsc#vQfyY7_&Y3Ui0>k8@cb}`@0lx3J(0(LZxRntX>eK*DlH` z;HOE9+&W763DO-79^=6O(0Yj^V|-*#bE|a_*_U^U?c=Py^9_s1hKb#16mnF>QEAC% z%7`qbAU5GsZm_Pu4ZZZKcGRm$>Lrj^N1*R7@BY4)i^klB9<~4;#XIo0;7kTnbZv|q z+UCsF4BvBQtAK!n1&2QzipOoZudx&RI%&G~+6A{y$zLB%F1c+ROOXVlcTFvyBreK# zVFbLO@%WiP8rXHL&&`49iI?C5R(Sj#t}=KOR~O6`Jj;stuKVushIuyZb(Q*6>f3-k z`0`+@`$q85^5gE9J=*q>XP60dpK^H6FaOj!denUJgUv1s`uT((Wd@M@KV=sh=rEH# zzC;hSvicCe=%S&cJ0Uhp;jP46wwe8s5{a35E|UE?6gfOI7{f@4vLG}#UCjmEQtKI< zqKf;j#YVb^)L3W3G39RqHYlLa-RL-NSz|H4X$!bmdqme5e`0xj*z}EvD7D`AiWuoD zXndf$io>U<@{Oy0=7_E)LdrNjJ%faK1{MZbioGmF);#a@NPA>WH zl&pCb3N8XTEB^$yo2bg$K4@N1I@vn}m7T>z(P$>|_-B{wo?1oj_e%c&eJs0S`gopC z(`{M*rBDH;5@<=-Zxz!?mvVDyW!UQ-$(SdZRt+UbA`*qZ8L2&b1P$Wh{E;z8o6BVQ z%B&g+;~99q)vbmV0(sHd1XuMgR;qQW1sJ)fYU;AI^$QYtGrP_o+AAmI$)n%(h z5QFM{TxjW-v&6&X>8kCI9DjXy)h+OmlyoHb^AvO-#es^UjT{BK*%`_p4sQ3{~9!mzX9uJX@hg>F%cj)`kDM_u=0UcBOg+ zvh7U%BCWyJR7X~&mbS<4etOzn!>_i#X+*NR-e6whc>C1F|P$?rs!9P zI;du(Gr(C@551lc>4*P|f!~HE2km#6@oI6sT?hv(Z9m|gjf$jZpqUTUr7r`T>0Bqh zf_`g*W!4PA*OEL-77>hbEdSF}M`ze0Z-alsey&ZOdaB$N>Dn{cq{wlU#ICwttD?4F zFnF_%`zRn#-KlR;KbwBL)$W=1B58xVBAIFO3|!q;<{DCa+WF?#r4JpXLo86CpS*45 zbLZcYAW@j`Jf5kIgask#%u5pWW$T?)54=AV47(+{4Q9vHXz;u75LBFQb)CES#QU4PZkOdnLLU@;1zm&Q zHH?0Zlln9pQ;L=_RQKg&Jy3V~3CLtbvT5^=FZCWz4$Hnv-lAI5n)LUMBPgO`6mfG2 z3U4R3g=TQQrfLb`1&;CtFQ^a5&@Kkiz~Qpv8jwECJ-M$jKW7^i3xOU|zj*8B9wNva z>H>`}CcHx%IgZ~Y>fQ|ox3j-lj$*+z0z&gZ=y_a#^a&QRG)x4CO$P1tZ%VuGqYil6 zkrQy=?SoStM0BV8#4c{^0_q2pXSv#D*JBlsI&Bgg*5l=Y+l;E%^m3+h5qr_f9kK8Q z4^~{)rSIDJ9Xflp?a+EY+N6Teq=ZRa4hw zjwdaxtQ^#7csi!$<8dpt%`B-bF+eG;Ly03?I2hS-rB;?!4jPt~;z)6!Q0^Sy2pp&+ zh^QziC>wqF{R_NqzW4q8eBSTtYDsIk8Mh`k_A*F=+3v%#{ggc-yfkW$qokc!xR@gx zP%_Ta7>QJII(+StCrR2}#pi^;?8Or`mAxtuFffe5NV8UFbCq`B^z`Db-`z@yDTKlk zEtyF>jC#Ko>!A#N+uYu$I?=;MOsK$>n-vANSnnJN z5&>yCt5fxe6xm&wZom|G$nD&cgr7fz$eOE6A2wAZz8J zV*jtN%U`TEwY;rXrhw0_#T?k;5tz}4&O^i5?goSpJ!7&%8R9T^&dqbyRNf_xup#EU zRWHl6t1Ce%hLuJQwOA4ukFZ}6naNp{YI*vPsY0r%(UM#{Ft3VcXQ=>M1vX{Itz5rweb?U0{cU$$pYKQ5 zf7I!%zen2phYu>-(Jd&Dc>h0>tCn?2)ZMu=xxuACtZUV^Qj&dkhu!L2^VC>8Pqox8Q4LKie|Gxcr+jmN`jk5ej|M~}_m54;H{YH_A-aicMtAOB!NpoA()y$h%& z^1@~kuPoEJpmv}+=f>br{pi380>DF|-I-qVSh#>k&>#NPuWO@~M;5W;rXQE5gj4pK z+K0?LU1t{zAdHL@FZ3sx5AbddK1?wLV76y2yt2MD#%X?37BPh5+e}xo8k@{1xz^=n zI~Wx}X#DUK>B|;3_rltgWyfGfWfxRWxjw13rO4@$ck4QhV{ozYLK!g7aUJ&85w_d0 z=_j=H!xU2N;X8GCoQOItm+vrNeq0c2k%K)HyTR3n+5eEY$DuCX#w8Lr#E`oBL2v6< z1>YBl%^BUVs})BbtQOBa&dt)F!E~J{nY}<9$(jX|o6H;Y?@PDRBZ9+Z{|4xqoDjs? z!GW#+lqwu&k?E~I(Eedtk0kc~N&S|K`&8%a4acnA$WdKHd$Yt$%x4Fc`j%UlnyANC zFQkyOUs_n(OkO;14+vUIw9}iL0|EAAaSrD!BTLbzNN*0|K7>IQCq{2!C;U+5EO~q3CFYAG3YQwc#`#K5h?fwOQ2BKTr6I*N&4%hCCE9mK z%PQV5o6a<|8jQeqUY{=o#NK4dJ!OGdVO(whh=n_KyWIM;25Sb@U1Z_7;9DAHmv4j6 zlTJq zI^#~*sUx6xLeT(_!Kub$`YBSOT}@!A%;u@>_w!*>B?yZR?5Up{CJPJ1Sr#*HV`wAd z$R|&`QZvlNF#pKA9kGr&^R~mv+iCiYGRZ|VXt-woxO4*;GugmT%dq)@7Q6vCNYx~E zt;8r?qS;!wy7pl;`anL-JUKMOT>z<{n(lo_i*aq)t7QJ{FStEG3TIp$m$m|Omz?fJ znQfdT@2+OIDGTF?VZHPngFNERb&J-Iv^Z9u5!xvm`S9*(u9XL3@YMmg8lEq#7sQ0a zxLu`-f4C((ups>F{B9myBNJTtwCeyCP% z8>{x4KG|_wrXF00nq7&42Q!R3kl#)>1kS-Q@zu*?pBbt8EAsi$rUSp8!2`RqhmcKW zq@vwCa>6*74vWT$hn>C@i1*A_Fn8WbN88!7*Em&t0S8jS3tbzmm5Ma@ka}o~J!y(` zq32EATn*?es36LB2O6`;P?qw@b+z~Fde(GW*GbbN>IERamoDQS&{eTQ`gYsPs(G{j?Z*TCJa%#BIoAQprR#f=;DuH-qor~gQ=lX?bOCMr1w z0!&%QMK{#HAK(Ai!v9ZnQ-mN`D^~=zc6xV>p_UW+U*^wBIK7r;p5_5YGcOSQ_vn}g z<;sxE06D|2c^zfn&+Bsf?7Qh@PB5SP2^CQNc>3gkO zi4WT>^2raZC5!#xbg|E4@lPS7?g1yPbT;&`nVvfQ@EL-2U_P+GIH}NhI*hWs&c7++ zUvP-B4f3qOX)$ljq9p6Qdh#c>cWe&@yANlGrY_CZ=+7DAv^}8uoyDf89jG(Pyt6v( zvA5@a&}Z{n&>vf@0=_*gbu8Fk?RFyYyZA4t`C6!Pj3Pz1M9&Pf##GT!Nv<1O`eKt% z?>5lY_u7$hlDzn>R>9nX&L?1a+#Gk|g1(t1XTz2oZ{!ayuK6dq@X1tnThzuke{GFq z{-fuv_uPrHG;{fzo(t9U4fO|tQ1w>uzNZy2-OVqKwTENRz*ib> zJ$BimZZpp?-I>&s*g-M6Vr`+Fmn}b%x7Y2Qn7W9&QQ@pBVL;Epis#Rc-f11v$MW{I z2b^o;eLDT%JSos8{R}SOYhlmwvth488N7=bQzP%yPl5|^Ry%PnIkaHPoi}j3!n~e= z@9PLHlGaQ+)EP`_*&_%JlA{9`3)Tv+vPSo?wXl-eq5-GyFzo&y17>gNCtOTf6IEik$n_W@aG0gZ{@uz8 z1nQ0X%DszW*0bhrpxJ^U9o&}}lx!@b#Yq5gQogye0+onCLz1G8idHJ(Om{B0V&+85 zjf>vW_DZHx1f^4pd{0IP?MR!pF3It75@(h1u5@3+d~oYy>QqRK${b&Kz`l@o=trXb zRzrG_i2%|?3zg97=a;LhN<|n>q2-*z;R5yCtFPYENaC7O;cmVTK1d5;i;27EdS`q` z%Yi8F#yRobgbl*gB+(LmnJ%1xG*j*d92FN+ct%Uj$7FrS^Mnu^neEOHIYTr%5- z&Hpu{zZ^U!(%5XkYFhH_;h3~CTuQuoZ14GL?w{gtDz7+$LjH8ZuJ`qzDBla7w`{5J zl=|5!_y&GC*EX!6ia&S8S)Db{S_dPwP=>T~AYN5mqTf7d`POQ3tU?fZR%J$a1N?6z z>GLUxzISf=cI(ef>+382LOOhlaZ#ME z(_!hJu9JFGOIptB_7iF0i1G$>S+V(ATmK4#+d z67Ma0FxT+KPQyFSCwl1 zZjb%IN@#sa;057YVa{_yAzn$V7t+P%z)j4>RDy391O5Au_99muU|Mh6b^pBdNxJki zT|alKW#+M=>`cN@LYUp=bWf7c`?j%pM`y!%B!8dTyk}mg2XZ{#8RZMOgsoD?w0B(( zDo+P^7j*4kowpfp+3f=4Xq64;QRxouq4mQPS2T%cPjxyRIt=B*uwii@WxbM^h!dbo z6&Fg-Z_vMs(HbiXq)WdSO1TsCi~)7+S(E!D^V_3IALtz0z*ypgN$LWxlx3QarAIHr zdsZQbGs`&5jLn2Q%2y++*|l+voKZDe(Jv|xm_>W+SBG`G;2uIH$iez*iu~7A1J>Aw z-_fupkh8*$o*5@I-A31hrh7XvH(>wzNUl`Hiu`b+%VUctABPZgPUQUt5*b;#iJp#! z4|7b>HpT-prYFR=iOMbUv5M|9`ZeS4+iF9@I16h~dyE+6c0o;G&3+n`8`6z@YZugj zTHXbQTgl^OaUw-QB=!DPBwQZoG3nQZSA}|0M_wT{n|ct0jx|)sSJ47CytpjRb$O=K zh&?y_-vH$$OKbJh3>6l^^*mjdwRV*oNPtm%FdIE9{T}!EgKwY8=}pX_obb;QKbM%QD6$)ecd zmvp$o5J7g^*Vg(x9G#|6y<%Xmh4~4S?D`B zRUQ;pCw@u@W;hdgp&6M4o3W9e%MW7v4M8xIuj>}SYz9c`d|1;!S#g1e54o@WGbX;BP@5R)PbnBVqhV&eOs?TWG zb$gjTPzT|=rL&Wr6{WaPJ;T7^04^MAy4QEBLCa9f%Eb060f6z*{i zsSQA5FdfH70;|2hG)4m_eZp#k^L5=PrT0s-p9kf2WN^>PjdUJs;T5r=>4Qv+vIU~} z^vWcjImZGzMDzgIj>xP)NEuZEv1halr>>*s8&$+pmU_V4{ocxu=^Jor-rGhm9fD)5 zw_A-{*%T_2&O&~(TR1>*xzt#1OMYLHlR&@7RdbHN(SEvSLKc39IIHKd4Hty@W0LBd5!2pE-PZM zg$nP<-=xhhpYbLAU^>l)!uY=wRX)CHs!k(%6OVle7Iev6Vn3|xFT+Oe=k!q2yEb1vPKn&OmE#jgRElvw?g`&o9R{#3Y` zV~USk@m}vJISc#Ui;&FX6X&_7mWIWi1iXzTJy))-_MYW~De9Tr!A@4)g2$5^be#kn zNfF4|BCy&>e#^!7Bs+fe7#m{u)=*q*pRXAobMrx^fUtGo;@K{OBkeRjd1z|5_keib zX@IVuFaK{4_q2eZgv5~MPDJx+Q3oVJ`_hDA?sPQ`2BflHVo0Q;La<{e@F4?=;8Ieoh) zT2z$@Nq7nW+anTWV6MH33SS0Lex8Eo7T6asnoKkyXGkRkHs+o^Yw4%Ye8LVF2j<=a zNJa71i&?@ij@pF#L?)i1xRU0$(2VFcpJEvXxjI8>&V+nLEPAzXf)LsdWGj( z@KToDxNef;PmM3nLu)*Z#4_)gRfjfo`AWh5pX|C*5{E&sG7*RVoIvvn7;{mA>fBnP z4X>$h+H)Ke+(QX^-y`{V#$`uiAm!C{cC;M(5;s)%M^L>$wZfq}Jd$75l6Ykp(TgQc zOM8UwQp} zj$muxP}Vrz<)Cs2Ixv+>cYL9H$h#p?AN$UGDTPuwfZzB{7S1mc`D31&Q+XFx3W27# zXxgdh{>$N(6>SH}A<*XE(V-Q|q^K%IFMBjsSBV;c=y2y=4?YXIrb-MAC0Tvct|W5H z&dWxEhi`;u%oW77&A*_(7H*7esinV}B3o23W#hj^KZXaELPjJMNxdzk_~5nCSB%VJ z-v()DX!p#3%=DbeO6$9J-_nRZ>Z7>o(><-@#6=Qp$WW5COUd z*leUKcAWW{-CSy?uT=E6|BlnrG&e7;oj!H<%}Ij|q4!#zT)rG>;`vBFai&mrJB%C| zQuWR1IOG{n3$#0MoV_M`k0QVw68Ee0_v%GUYHZfSWlodj|GC&zB$`$S{A)kx^~f?e z0=;Eneqt|E3!V?SZ2DJ)eBadMw(#l;Y&G-l(fE-U<=lLIg@L&zy@BG)WnJA{D?R$F z3~n`B6Vm9$^$}q6D4BC@9jlSPmBP(7n20H+6Q+c zzek~B4i>+_2iCL6L^Rfsl>rhl!L*Q|{AJtAxTJoqDM8|2QxIoJ*PC(Eg(bs$$ zIrXTL?bHTOJ8KF~8ZiMsOi!pt85+xnjMf`+{Jp-=@8Or<7Xd)%M@qE$F7B?P?e-Wy zq&4UC==s=a0AyYCbhDS;HGqhCLZV*iYYZ-Zxs;uNA$CCtRB3LhmLrulS&R*KU;h5O zE>WQ{l$1Jg6ON(0<(gU!NK|s11k7R z%zvHa$O~2s?^Rk_^!0+#74*WSjB_Qg)^256F+qdI9q2?M$Z4RHkG294j-`3`#SF`yYV1k7+@_#16u#P)X&HSkqI!e!C8aV$D+$tHRc@E*u%BVZ#`1!Z7fkxrTmW)rH zIQhenjk&ZxO-;ma(~Et9JpZvbk%=G#k(^NwT~Q1TrF1rGvxRpZ9{`+VIlja*bxG3t zA;vv3z;$jwqDv`rxV1UH!69btQh!gZHX=bft^OagPL0I%8-SJ<9 zXv6_gm|%^?5w;lpEb#8AQT-cs zje<_D(<0|;T`-Yd;r3JMJm}~H%R15Bw&As`wh(gj*bgBmxUNFsXQM+@{W(ExkPm9R zkL}@bjqntQnQ)8kwa2@H!?mrXyN;h4-zxv%GFGU5yF;Ag9XV*#7?^eun@b1X0|a1; zhD8pw(lBmOE#^}k>C?*oeC6KpkS_N`^>LF#(~KK+I|VXDOMuL3oW8R$ZMcd8tkQ0T z20wH8KpWy&$-hQk%ilPMcC<-S2d`0)j>pWDT7%V&QzS72l*Tv+z{9rm` zzfm>sK<&v*MiU|;}Q|4bJjYXby&s8#q{zK6GSipGN z{0j{W8*Lr!k-`|A)jHOa98u56adr|{C1v(%)P~peFu_xQ#qGtPrED>$eS8T!RC#<4 zw7>3oQmndT&F=PnVGv1*cD0H08^YM*Srz{b0a98tW0~Q66t%W?{xKTHx{5Vzwb3V0S-)xPafA~5s z*54Nr7nXr4J{>Zf7Fu>@@opw?VZpj|^saTaXWfL4SCT$PKI2g>A6SPa1@4P+dSwKn z&5_@Hv3L$Od3-|38Wa=O$26aA|3T97Od)%DlhBNNa4CdO|mMgWuC$^SdQH#kh+X)Kq>Ov`3G` zyF9K%25)lPLXA%oc+b!t>v*^PPm|$A&{CSef#VJ^E_f|GCTPmF`vDE8>Vr1xbhn`+ zKWVDL#DliU0NYpn-F}KT<-flZhrfyLGhy+{B}(>F_MFE^x{Xttpt3#V z8ZItxDAcXq>$_jTcqRq$Z2X1vWM0$~Ig5CJc?Mkv%nfPX?!L*fw>2pM$@}Tp$jL1$ zePbrpiV0cd5#Tbm$@!OPjH|=cy#GyfXoY)XI$Ph-7Gtoy-2zu=Ym!OJun!pCs#!_f zJ%Y`dfHso8WsVLnGE^Br7lN03M!mylbGN82Stdj%o{f)<0O_yWKaAXH&T;+0d>^f3 zkTk*gDn~|6mdVTkb+*G>AOF^AJc-G7F)7~FD5bx;m{owq;u3*E41|T9cAc$ECy(?a zJieSi(pI$lnVe^Ph(5C2gpp~w26ZNncaH!ZruezZ)|YUtK}1KUy%j5T(=ElhAqJ>D z@8vu>@~(>3$0uu;U&2SZyN9ASC=9*Er51YE3f$aLjQ)urZf+W~Bhzo}q4deW)f+<6 z`sAI*VUamHpJ}@FxhJHacJof_ah>jjuC3xMcs%VG{UtCV;cJX?Zm2l%b*!+1c^3NT zikq#1U+I>aOL5YC0|Iyhl6Ir3R259pobl=W=n|=m6wTRXd2j|3=j|$Slhv-xmuJlm z?7mI-G1aM0JDH~}%p1Ay)_9AKZN53HO)->R zMX?-qCRGoSUhpm?EdGmEG=5EYxZDhGYVS0^COcFbW@FEshvyf?_B3``Uv+KW2wpAK z)-QRhXKT4#BF^A~;_T{_a=mosr+K6P(wHqRD%5%Su=d_k6R{lA5Z~MQQ{~B0v0gK4 zNq3QNe7r->xCTpf+IXF9uM-NECY{)cdiEFeMv*0F~q8otZCxCZrIJ#{f`Z&;)GUiL^tU;o=Qk7(O6!0I?zIV-Sz2+D`3(g~r@@oQZRN`+8T}&2yag zHb}x{w~5(eUCoPNR>1zLp>iIz(T0XbtdV~=o&Ko5)TzTkgmDK3ticN2IUG~ z;`!1V_f2yRIBA<==2cA&4u2#E7aEw}8*15ctYB(WV?G!`lBnYj_Iy4@DrzS%VRnZ= zCN2o(kX8Z54yak3{l^SyAEIG$Y7Vdm(ick(w$iNiwDHD1hxXG{MNegcs%fdxX3*7Jy<^aCD=L#8VdYKX?9T~#+?v_GBhw6TVNAasGaX;ot3#P2 zp0+yCua65THT&ybreS%j!wT=PKDQ;lexa*vWi`nDf*xe;lJ9G1A;GdFBQ9t;M6|>! z$8j?dFp198YSL{U*T`>bm4q-p+Dk`LS-^Xa0>6u%Z#5v~$n_PRxoZ#zM@>i~5C z5^QFE_0U#0$&nqI&ctxL->Mk~M*Vr&{)&q0a7|Sgh-wQdsC`|@4ES8^80c3PrZ}=8 za{e=}e?_tvY#<8UiKbMp6ZFP;b|Z>gkJ08CyxQgd_G4Z488b6bzDw9t>xcIlg$*;X z-gIM6j}n@>4S_yp8+pw?gs4y-SL_Pc>;@yH3O}p2ua8%d7#EN`7#Ld6LE%V=7-&W_cT{#9G3iFvC z@9SCj< z8@L)kbU3)h+!8AlrVC-{dY7Sul-iudyI8_3_q&H^EyqeUw%=PldTenk*(D+_3e@M7 z<1J_#Q>e3oIeM0ex?hR-)p9C&A3kch?U;qN=rAEo1u$4rG-^D-UPD#p$}v%!z?~H# z$p0%zcuT{)Gv^HkVD>lud3;kFW%QGrCQCil1Mc)!&m|ye2>RG7htgrE*tK=)0>S0`)ZahWoKx>>Vqg@1<&J_O=t0!`20p!t9 zqx&Is{~58Bt(p5+jyne!A9GhohU{I>k~HLmzkw~}g!_|0niE)irK9;w>fZkZoR`fH zCsj&`dQ*Dd;^F6sZF2F zk!bN;<%0kl@x{$72P{q?^52SxVcf^7v0y>K5p(aA%Dx?$)W9d{=N(pR+Z=WlU#y#t zU%sk|z10)Gf+9cD4D62kYU^=4K?l_t?&nVQXWyBB;}jZy2V45-w&ql%!2A=KZ*v>7 z_^*yYW|6-%4YTT6GwXm$DjF?VD6FwTItaBs=pxt-Qw@3F#0kO5yzObHkMsfpW`}t|3yeU*ZkUUViQ~VQoj?{k z-qp7ncOO3mtXXz@@aqh~qkit|_V?8*_e`sFc%J`LTiGDam-g;ntb0q(u9fauD?4e) z-LRNyyc>l3RGNr|&b!!8DKpd|OPknx8SO0S?xDte#SK!-<;+$EXceCtX8V;t7aw zqU)U7OQSURy67Dx=om~}e|RaLyyWyaY|n#dnn0#alLxFXkG2XeK^`MgLkY%;v;Nj>MP-% z&Lq@eHecJpd=l&45PRp)-l8|i5bxt#pN2g2Ig|9U$J1Gh@!6PsOfHxx{nmHZ;6O#k->pM!T%6P~T1;;(2?#jCoOvb|UD~fl*j{ zJ}GZ)92tDQk5QpKTD`cxO;@o!^SOu#kax(^`*yO`bN9=EYxIwN^cXs-=Je~H#!8!0 zQFcD={r7bPtISc4p%rtvyJPG}R8gxV6??l$eossEVRnx!AtR))2y=C^IS0f$=V zzE3JPsZ4_}+nGO7(Ei3Tk(E3Lc9aWJ0mWKU6-kbr6|c36awX$lhTrh4xjJ?8(wRE0 z?>JA7IqkHrF!F#E)Rp`9BRh>c3?L^K7~d!CzmXN*n~hclm=;@5r-nb|X3Dk5J|Rm@XPd8mgc;X+!9QbOnztpP)NkIu8-Bqoh%)!Ho%bC-1e_d z$R_sq8jkXAAHeR{ubai;ZYf5kj?uKG*7kKREXdvHZ=UD#j-j)Fb+E-O7Sm}3laiue zxx#C2i*^S7@1R&*P`p^@#wOqM=secUkFGc(Z zs2+5QxMQkWir-)?Aa@9_oR=tUDfk`6lD2SRiq;x1kq;c*sbwFQE$z_ut1(SE-fPED zo^;r^AVT9vR~ZU-qJHi;@S6lQ6m8^(7Dcgpqrr3esXnq&9QvM}J;=4^#e0R&iDM?R z5}Mv9ptzKZ){UWSQ~9+22FR)B8yrBy+K6f4bFcWBY!4Wz=d)+Ru_2i^7YbZ&|a#c}^aE&g@^ZL|1A4liFP1M(%4?Kb%6-#-eqyFTDt>%rJ-B!6? z+&nE#(L(t+MNG#Z9wGMm$3hW9`26P8c_ZlSlG6pc!Kk&jC7{Am}!cvrjsB^SXj4vp#2?%Wu=4)9Ka2yThu>8n9T2rVs5 za!g#YcKD}*wa1e(3AbU`R-J#qvb?!$r!p~9{UX6;ji?YK0RuRl1t1OMfZ`&E)a{E= zC6gsL0lXVlv>QRKS4xaMsJ4GXBrYBZMKIKmHB?_07z)!6H@O8#*7x6!%F{)VEBkh} zr|YeWnY|7mub$zvAkl5#T?{&pLFe)Ep=mhRzY;R0n==-+13Jrho8R@F$}0QJwCz!Pkp_EDT)z zbpEm7Ei+C%=FN&Sk%7cs57UNU%t%kzkmY~cT8ryKjLp-H&<(XtjZJOx%S~-Vaq|5u z7WtS^@=ACK_!jk78w3D~3+XP3EmJ=t>4R4K_mO2<-(PEetXL~oqx9oH1m!i{BX2~g zeqB9NAja@@$BEYBoXuuqX|c<+J#Ax2wH%Ll+;FysW_vyH1H3DV={!SwC`3wT7J1rv zum@+rG|#Fe+-Z5`ZzI7>GOuw65&T!Ua<2bk*7z~vcCQfFf_P=oV-#2uXTGc%7@4is zpUMW8$6Taohh}UAnOTp{R!(pwC-T0)>o=)*KJKNAhvCS!*^fZwY>*Z+5TgtX8Fl2` z*B%GbT}`i1A~bhN1{;->F9tgtY*bHXy{rkaax z3HqAH>B8q#9c?eD)31u^lBL*^$s48^Cf&QxZQV7iKytl9|MvrUMZ>qE_<`#KK*`KX zUp1e$)AY^`4enP$-0BCR%5A4nb?tx9^pY1`UK04LTJggd+w~&E(z(dZu+@NU@4h$R z;(EJWoBW+v)gsUWB~PcnPVNbM7hc-@z1qk#=a^1e^VHqfh;|+Jvy-R2w*B$fpGxL6 z-8Y-Jvs@`BkCCi2sjRnu@AxdYU|Ph(CYu1cu}_wkpqbD*+0p0@gQPM*{dDR@tKbj+ zsXt$dt1_P=t>-|-(0c8>AMRD4)(3OB7CEPo$oK5H-fDKw(~y#-tr$HN(*j3kF9Vp=La6w#HMy- zSh2+RfU?*c9W{D~Je)fGbm>jq($YFYMDfQN`|(k26l;&(1laXB^)*-)kE^q zv}cYzMU~uqw%VwT(?0PRf%h!LRTCWAZEpHEnEt%p38bCk*i`$v{WJ$EL$ovlOx(7j zm!8r&XY&FCN>v<*k^!{XGKcTx3HMH@4h+sB-8+p+&{Al4_am$Po@hn58HbZ>OF`Mu z3-C?WEnCC;6W+OYqGfk8AZrLw>AbR=9z`}`!B+o?tm*&NEgaK%{1!%%hZ@(=j$w#v z;7|cED7rsvoOj{z?_>F0KzL!ppne}B*X(7xF&^NUE~zo`l!(e#YF4+WlAg_*i(8Ob zyA8_KjV;6#L!sLJ8Faq*CCJX-b-0v0B03v$U6qDbYf-vV8Uk@ypm*D3VQv=-K_sPN z`~g2Q-X;_e75XLc3q9o0b5L2{pgw9(Ya-^VLwGmSZ34)sA5gvRHmPM}jHWBYL|cI^ zXgs-QSilVoMgG>-n4ok$nOzhkab_WM0VOriJ6#ss@D*(vmiK@+%^JJ$I-SQ3$pv{Cf>Hq-X%Nk2Ni(F#%WZAV9J^Sb+n{f+`ST*)pRg!H&8 zkUI#!apKN8RC3-I)9<=eX4k`=T+!8iwEYQ^*0K0xFx*(jU^=|<=X=Sd$yVykE9R0B z^-V%%;ZAMi>+iCV*)F#qpz8U|isji8kBi|6U4Zh)kCPLl(Uj~2&C=VUsn%PBFX(ub zA9lr{;*05UEoLW@yFSnlP5@KoQ;Xtrj{3sq<4I86wQ~#8D^b-o_GBuf&V=)cmy}_X zAC+$S>AXi+?9(2@=_$h`dGZH4X8YJqezEx@wT2Cg8+S7gzIeWb3op?6#uG6Q5Kgu$x)O@jr zklOgSvBomaZM_)a>Y{pmtLo&hHoxJx+Uhh0yioPCl)!1oy3=liCdL}C-aC(QSXEqA zOpBFEeTPVV&(S{j$iF zJ`GXHb+ucP(R{8@H-%fh7~Cxq(><1Lb28!(k;{_znMiJ+uk~8q$?j0VBymR}NgQsH zN{ze*>t4^Pn*ReI#eG8Hl){y5GxkM7^=18pH0=-n)6rDP_&>AWc#YK7W)K)%w#>Rv z9rDJ6v$Ok(fVSNjmtQ12YjfuYd-%GbAwB@>AgbAbURepa=YjYvsd8FN%`pa|(h{5* zeuQZ*iSO&)7_2jVGb?j_uysq>d20Lv0Dg3$>lxs>`p(`&drw`jckBB0qONVrt~D9i z*()+gd653Bq)-9c@4sfFMtLTy?ZWYLXH3+d)VJ1z5$si`Bk9;z|A;u-&DqM@7ob}W zNtcDQoI9UU@UsG0dBtW^Gh(cKg6C01nTzh=p2$fy4@=kr=C;WH*oKZA$JH;@n}~<~ zFn^UzGMk#Gl8p4<_?ngw^_BS+0y9Vqqhx4_^C8nXYR4Yh+sdL0t3Ca#ee3A>BQ?=n zuabyxZ>Zi>PiTN(U+&Z%W0G+0VaP99jfWC)#6yn!)6Lk;Fn{l2w~ID6C5SL*%9D-0 z=XCTGbiA0OxCjc}g4zd_iL+bS%iw_6U#(_{PmgGxHa%C0XV)+oyRDYaNNO*q&B^V< z8skDS;A!rYRbGIp1XLq=OWZKBe8M>#WezqcPg;bS-L=@3L=`8bZV!KEiLHx{iT~&d z$5r(^L!oJ79@1|f(O-l{u?}?R%NzIa4*_9M3L?=BajsHKmb75nTwQHV^V0${Lh^Sb zd-@JpCnGvaOQ1>SPl? z@=ZG5tH0!C6Kc(;I4oy>62}9ZB}@#y+Bk!TFFqw;p0+Vt9yW=G-FjBj0PIMO0OY(T$xSO-txf|2f4v}pu&aNjD*lNXT1MAX4**jXSI+N+@_G4I zg{$8En_2jWpeWqtPLNjt%~H=T5)=oUL>_Y=wu$x4N*BF4aE(a*=;G=v{JhjH>C4~$ zs7{!i4x;BJw3_yfm4Lbj4C#nMjq6-Nw019raGMFibctNk{VX#R_%8QWAiy<6`ys8Yrk|xrK`+OI z)ypO=@yLi8Um~v(wFgfA&nkfT#UI!vCYlLy{6nLAp9N>{G-tYaxao`kkLIw=kW;@H zEPx`dE6=y@UQKac{xfWIYL9+Cv!@29Vy??&=5Ip0Rkiq!`5T#Evkpj@bLbT6zO!fE zxtcrm^8(>HesuC?1`aiw6KS^}x-K;SB=u#!EqC@ZIWk=#eJmR*;h)0hZK@c064;UO zK{fS<|F;U)uyo!PGu~R}z#6Bmu2r;Tx0I~95c#ljS6SICEI{GiKGL=pIlSH6B{Fb5 zvi02SGJyC{wyRYUa}#TsHEL0aR?WSso3bvLs?;P*SXdFn0hgN@_+Y_mSeo{1fE`-!oumi|p4zJ0W&6^riHx#I4Q~Lp!k!KYWu?1v5}YB^hnH4Du=DqE4IBe& zS5{=;x&AWdCV&2S{@wl9WSzsA#HV%QbRX?MpZ<{II(#busCBZhn+<>5^R{v<&I;j- zN_VR2P~-ZtZIQuc$|&~b3lXvyLL z?g^*;SS}G*>b5$^cuM7EPrA2sx%U3ZZuwlt7^n#&v{WH9Osz~8rcGpGZsl52IgVcH zgHy!fq-D(RuCZM)Y=NxqC6FB(RrEA4tH-k|Jc#0=yJ(n|-muWmhd!QCoO$EOXmp(F zuS;H+{A#^G@fm=V@wFgj_V#A|P>p=@d+IIYV@qC_q3|`8A1aSc-(4?{zP@~_&Fg*@ zDq+`e0HuXu{6ydn3U^1S~s}nUpf%Z zdkVnjF@9v;!ktW)2thWIs|}czB0p_7cU#WgxM-%()wo*RgZQgJjvCS_&UQp-z6tPk zgMg57eh!v04FNrN3F1ng@ElU4gqcCY^OlHvA6-!E8EPu0`rfYiN0#)(|-COu*7Q^41tj#5Mib`-`HE<47c>l~IA*8(?c)K^*L z?y>#M+^!>cRR|Wbp~$TbZBe9FVkkl{6=xD05X*mR3W6uf61l!}5mEVez0) zH)mVvy#@IA(!2z)DsKl68>fosyVa7t4%HeX=U~l=5>W!}XmrUzMj}xTxrAFE{B~4Z z7pb?4)^3d$n?Za=WFg#=rA2BbjpafTa#}X0w)?`*3yk0vr=$7S6{R%w2QPUDoitC7 ziXVh1zSDQ@6FyTeoj^EV*H!;K$os>EU{mIZbGunfyl8qj z)vyDa{r_!C4gD9LW95FS6eI2tDQQ&9rgBipLrmw@Jo$6H;9Dt-``gSy4@k4Ws#?%>V2sHL zuwordo6AYdtBM$wTSO`TvHDqqyEqDVZ7Ow}*`aH1RWcr)2wsT^pei?L%vro)r4MwK z{A=|yuuQ$ZczNEslwB?zw9nlxpAC5+;B#iF%@M_TY(syXIj@>t&L5QsVNqoz>g-rv z4S$=p?2<@F_MB-;;anBPiH1d1l>r%$APppPjlL5(h?Jo7c@s*9j3%ea3S?&XgQ}gW zn-#&t-C)ra+Mn9Ere1g*SqRxmNtQ3tbzCBqQ;(MwjB4M6J`?DXfVy9@KYG)_qY!Ol zCoygr_EaUrFGs}0BaGX9U|df7XSyZPdT_S1x>0AZ`|!X%TB7a6T>5_KrM%iL67k)s zqc}H1;EAPkF9&3bo01LH>MqMegN176_BP%Xb;NYT|C99o@l5ak|NkkK)2Xa-N+-W^ zRO$%F%ki73RC1Knsr+WeIjzi(=GU+vDisncWfj}{t!U=gFl?uj86LLUZ7A7PXCA0oXmTzv)(^ya7O~M(x+nb4p)k!`8ns?nE!zAnoXV;lD)Q3= zaGJdI_8bIAO(n218rmAsF$DL2=B7uwVpO?LIgD=}mW%%YG#9*@nd|CRd-<;uC!W|@ zdfSL;yR_op2q#9?u$PFOXjABstRwUOcMaq+y@}38GSmIg&_Zu{i>0496CL?;Sn?>f z;|XW)^}@DarjB23_Xqzk^W%eXBzp1jUyabwr4d;+jp}msG}>00uD%)i?T?V!)Neya zWBM~gz89pxDvT-2^)<>5Md7R0zxzZ#EjD=3PSwqPlB{9i-C(`T1T1-4RD7JuJ>BuY z3GKComoulX6lmHD(b{B5Pq1}-L+>MbJR>;3v2M^%l|Fn@gWUz!cb$tKcZBLe!UDiN zlDC%_9qW&HbD=WK`3Kk7=}hI1&o`A14Bse|$G*=P>VgKb0rwb@KUpxNJn| z1x(Xbt6tKv_)+732#4cRO+4}bWz1oVN>nndvYa*SMT<_E7|sozIO8KpVn1W{CH{jO z+kOD7;QN22A+2cM#8~KN)s$sDGU|y#(c+!yx^Mc!TwvP6x0%ayzn_vnglmYp7d9D? z&}$?l&q`|Nd#{tc&#AV>@UDI|qi`?RAqH_fzy$rgP*xZq&&W&W#86@WV?MfG|c)uMH@e?HUQLeTwi2*i(ycud}1t& z+tW88z6iuG?m0u%qc^p~If|FbzD1`U5e|Db7LvL9z@hCc-R@PlKr4)z3xkSxs6UG4 z3iNr|eOqanF2Eo!| zbFyIwZcna%CeSy+UlHDZhFyOP*Q&W!jYkZBB?#`C=dz=w?geW{vnE?gCW9!YBC{*J z^A;%uFIw+0=E)xM;GO(V0pEbr3 z6P~f_YDJShBYw-}Ud=g+eigj0>c0vdu10P~3|P=}3ZKNjbKa0<1!gfLMdKe?CbZ~m zbaHgw7~FIo0KW&RcPjFU9B^;ML@RW!G;f@Uz@_@Qp7*6eTL?R7WtH1*#6r>G7yBGm zT{j5FQ;o#ziSjxAdZv#s;eVXu7$ZMvH`okFpTz&5)md~zL;E&nMQ22ju$CUd4Hm*D zl^aM*s_eI%Tk*AsSOPHgS6d4AV{guMg| z1czwEv^tFuPT6Yeb7_d%>;j6{aemPsC!(+GC-8G4qi?g8bDo5=#SQ}$eFy6n?#4CE zm-41&smR??;ts+su$xSvH0OcD4`N)J580Z178hUJm#h`mj=2wDH?TL2PTw5Y^C~4t z0uaYLuz7i2msr+si{budKOg3ZD2f*opp3_$2(AJDq)*|-a2dh5H^=e2&C+#?+>Hev zBdDJuLAWG{?R3E!c(2X)yhgkU^H|Etgm@=Wq+=e44dMwaFo zm1UL%$|wnkwX>7^G3A0b!3&@@)Y}pm9AeFUfy97r2CKe}d408Pz;pNFh_p=s1cuJ5@&t|2MhsHjG56nOEL@VwI&@>%OhI+T;G}lE|U4Gn!5L ziKo~+d>HtB$jnH5Rnz9$@>;1*QO}LSC1}$m;!~p0nbqF)I_?Lf8D9Qim1(zKlo;#L zVQqR8^I=s?v`m$1Q&xKF9tX?w0uY^rr!|l*81>Q-C=PUBCHQ%=TrtWaE=bLlG^kbH8JNm)lbxrrZg>RnLWMhmX=DzWE+s~u+~tTJtSxb|B^ms(ZdkP1*$ zF)X7-zK*>SnO!Yl{`&^9X9D)k!Ot%DoNW*S^dlr{Nj23%5voqjEPQ)9Rh*0MWo1+4 zz4s`wS@ttQ24tx|X!dV1WB-llqZ)7(R<3wF-*yKKt8@g@K@k3EBIDAKJbY|ewITVn zJY_8c8oa3amk402k6@AoL;+!(Kq}Ijw8&l(s$M65z!%oI*duQ=H}pk6>~*g(G{s96 ze=Y^ph>4zGyni5POB;J#z|0f*F&VELVKc6lmfG(d6JMg)Aa5uB)d(QgQTN)(W?6e* zainKm&TO9X#_8rwEnNjIb$q{aFD@Uqt$Wxbr0a4213%fVJ|Jj;Ai*WZYX<~lzl~Ym zrdRYPy|Z8XP$w9Arn8dnS2I%4;_T(y@Y_BcmH?6e&o1{$ZuCIVxewNw4Byf~0F13V zU(p9ghG8Vsjz(3mh_+K()#{71(#;RAZcZq(IYi8#OIvLZPMf;Wvr3q;crZ3`@RH~O z@*l(Dupbb?a~P0)K_7`Nm;7dz0zkZ#3v0kF+R2vX&;!AuX@7VPFlvqsM^)`Z;G2WT zU8xS_>|x{OP|_cQ*>0+5iVs+p7XweGa(@SjNY^bF!mIe#gTWJ0p@m77k4WQ(UY!K# zTUIrymFjS|N}yK>AWyopxE#dkmejry`|!^o#GxWaW0Tm15<9F3!;2DXkDoR8{4*7hh$cpe0`DY1~RXr{GkqNf9 zx{hTjP0x}QJCI_E&j(Dl?*i0j&@lxKN`7;76!zf+r}sU&K`Z+YuP!^zu~6}T<(wrY zy)rd)7PXc_&IP929V1T;g^?Wgf9rFZ;9s=U!+%&E`(iIx{&-U;elyAgB}5)+wRs(E z?`hxXmNwn(t4AR#ORP01701zsX{oRo8$?hVqt%N)1W6VI(gY>gabfM39Mm{6R#>g4 zsoedomL0(Y*@a5DwePpEa(5|9ik;rsnM~Fx>3>Gqcb<{x8$F75$tOSL*%f-kGIuHs zL~7NXBMO!W##!vTJa?}Iad)ND$3|}(?R1Mr_6mWH zEruh0zbt>pV!G!I-Bz*gW?e$__7NWN8zP|L*>N5Gb7K)PW%<8#P0xo>Pp-UpqKYyC zc$3_p|mkIZAX;Kmi0J47?CbcqeMV2r3S$@CQwW20B!img87(D zgeJDG@0Os-vr0K6X`EgI8vz2@{u67Kt0ESjQskZLB%U8lT5RdEnAUjNG>y=AM-n}M zSd0#O*+qLYw%ACfH?|bo>7flW=5@wwP2&6#LvAsuDUL*MM2iz)!%w>HI~?m9;%l4S z?=buBOx$GXoeML?3Ycho_Y07p8RC^*=PBohPmF=e!=AcU=})c3Wnt`~4R)hiIs}@r zQFTPx3&Ra!WVmdgkJ9Ub@({l)#ezEkdEi~%)S2Hwfk|(oV?^rF*hs7uN5AX+#YfA? z6UeL=E>&fG3bNff7QKl7U=c!moO%xfgMeClx9jhoGbR|Lk<8BcW#y{1Bq}*Ryf8N2n*6h$ z%bv4->(*{wjR^nObap`)s*bAMHjC=fM;!%!9emW-RG-^}L*1)++gOkf+KK5p4s5W@ zSt$KKv85(EXAEO}%eVZW`2XhP5;}r&l9cu=j4HlIvBfl%!41XK;;6rP2CKvN$i!JU)Gw(;H3JrEdsom0oGRbo$ z^RaP-r&Gf$)v(AFb#IYVgTNn~=^iTb148-$-+>YGi)%USih7$ZUyik~T<2rQLb-|H zTdajjAo7AQbb55&JBM*qwZThR*BE5}^Izrbr5o*&I-yx}duPv82GZwygi!i^`b{N0 zuil5%!7omX9)G%*{>6T(Zg<@H>`&2Y`#o%hgT}O7%%4nZW{yyK9VfE7ZY4_ft~tKG z=R)Om7b&BmGJlgLVHLZf1wHijwuA09%)>t>T# zgR6`+S)LV!)_1iGO@G+8#Isg(GABkcCjTZT2yWP0u#ZR#28!;omRtYrv!oS}SVH$A zbzC+zgVat2_~p5~>s`0{NDt>(+42a_7fL{4^cM!Ag0dEDYfc3Y z`Zg!+Rv*qzF2H*)jD;F+QVO5`OH4d1nH^fu8;b3pZGt#zcctcGy3KT5OFpq2 z@f3veSQ_E_DJO@T-4?fvc@Frb=u~>MO{tGg2=eK$Ok0vXazIh@$1IMJjEl2S9!Te??343Jg!%MGMZIM>(gNU z0~=KY8oAtLUfXp#;h0{&kioqbZU%D!sLB&L;tT;irk0`d=3~S^T(Z-F$3w znzTOf+7kH-+>6`8wMq$~_1$ zke=GE{@xH3;U)5Q6n@v2GFdo|$eLz5w=iT6ewdgkM%B7Yye=6q!!mk#b=$T7 zwAj4ktMiA7Kd(>NGzOxrgom#}U}EYbQ~mgPQI>msLo?jIIu!f5IbqfKL!y?rz#ewUZ|nT@Dleh+U{uklGS?cUO0ueMzb zGK`LhtSFH3A#u3))PM%u^Z1^(XpyqwcIyJm0aq4YOzcZXl`M?B?6YG&1W8f*lTV-m zmsD0p>+V__Nx|JAT+VeYY5wk=eb4`xDkzP45Hc8pNGyNRj;)cqm>rR`I5!BWtYbq4ue$42s4GQnsL=DG=bR>IJ0IlQC>jlV)0 zO%w^YLXn-!VUNOf^Rov7e@61qm9L%6BpHE6TsZk`fXul^^8zJ94z%ftcu}h zc=t01cTA#9tFG_daUt9X-Kll43_j^|&>=da%3Eo^70PWi6km#%*@xWv&L!MBdOSk3 z*EF|oCx-C?4gCJ5?%SsC0sE?E!;y9xwfC=K>XDS*j(5Ph+-FPI;5haF#@gq4G8T02 z?pyeDztVL)cAIBhDAxbCAdV`*7K(zv)CYd5>Fl4_uWL{-9QTtQr-s7f5%vvb%P&Qi z`IQE^(e!ByUcL|g4s2VLROzC6zklxv{~t3RDbd@qlljML3c{tOt_M;|N#k`pX8m9t z3fyS9#KoBFH=eiNcG!ivXQO9tRhevLwDY}!enVc@ER>F+ zKxHI!o2ZOmM2y9NsY{5RB(}98j0SmNF+%AgJF%T6>cCXDPS+Vs0M9Lte^35m*!;Uw zgt-{HA}cML{$PW(10Lp>`6z>&>>L~W&eSYMW(l}KD_9z`-|C3DuOdw54W$?^2PXR5 zjkHM5hgRuoN;uK;$^9#xbgwDe=$CA8#sx!>cG$*C4Df7TD$AY|!Y?c4I((r~;a2Y@j+$G7_ZbSWtQ`%?mhnPD?8> z{o$*b)|<`e(C@ulM|2-(t~ysFSG%Dme>KmquMg-uT{WHoEFDyMfkU!!V$@2D9u{+h z6`92GMsA&KmlZXlxA%m@Ex94+l#Wx)v>7sV-0A<|T^~*1t3+Z_pz_Bn4Y_4E97@@= z%>HZ>PF4Qj1Oi!WGDHa&UIt={o0rfFMUm8W4bf7`EA&~B7G)6M`_m6>rbm%AB>t;Q@IDg7H1ZkH)a_dQSd2x(ZWK}=<(I`rV1xPrLQIwX zOu|-9Qc=ZuI$ZTmHCp?=khy&^#+$P^D$C!rraA8CxbE`Qh*;i*fUjG+fOTI@ zIo!#Q;Bgt_?Gx2TR`;fR(2+;4#^=uIFQxMsZf!uv*Pjy6id3 zIolkX_XLGwc{ostDr^_Z?YS55lHbhO<;rJ84&DPzq(}@xQ=PijV_nYNTu#s-$Z4ck zM)D_Rf^y4@RZJUJCY4E#eADLw#KPcEvT5-A^Q`sPwl#*(odEoR?=PN|(vU5F zv)z~w4rML1B3?DQ=Q84Hl-CUksel$ubw<~U?>*i$W1P9wPrMj!ubWOd_4_IpDq9bV zIC&+qbgs$i=ft!`WqsP&R@c0)>1{pYbg4_$M}hv_!Az=Edn@6x$j`!Ao2kOe_StC! z-&2`z8o%IF(;>`g`g3_NL4N3lm$wKfW4P zqmmnvG&1YvE-kdtSkfu+bA)}$=187uJMi&9S9ttd{&i1ObLWkTs(9_v zSBDRl>h$Hpm{Q$()9u3!7@Lry0I?X1W(;9sJk(-rD*`?bL5Y^?&LMQjXVwKTo`}mE z>fXqyO#4M^Ozes4L`82Inwn;zY#UMCFJ3-3|1Rk{Si(|Uj3QcP$6a%o)b04wKS*UI zexGyFv5(W|(gn}-_)oPqo2(#2SQ#<+V`f$Nvy!0i?Dl)2mx?>BaMkgjAhP_$pDSYu z&JWIpqPWM~%q*rI?$*VV2ZwI%n!QNbC2FjZud4t%#}#qMn;~sarBC%7QJ${nDNUXw zSS%=}q$VuaHOR(j-P{10n|ETEpk$Y)v2@t1VjGy5DFbjr0*IN@<)fjpL))8$--Lyq zPlVH)T2!u8bkWtsSsBwzJIz_uak8{9Kg`4%j#V*F`mE~p+&&J7wH;4Pnc8>Ot&N;~F9MqrS4@-Y%IfKmkDT&i_1HbbGWWa*+!`c_KYlSOBdRGEJn6cg@) z3r4tzFHkGYefFZpO^0lj7;M3b(gYFZkw|0p#`2tc>On$U`uU+_r@Sg*)tAf88*dN( z1VLM2r@tPY;l0{G*!Mgk`u!{K-?5hHIt(cKkOf}#6)t18dR!6yMCpY(wl%qzald84 z785P6Ib!TCm2LrFEYtT*uG(Yc>isoqR8e5nnDnt0V(GO>_&FcXeEh18-^0jtVJ+Uu5Eb9E>0ss1p5jMWV#4<~OQn%xQj?w$`5MdyitGwrv5p3)!CM3qag z;gj(9m)CvOPx=U0L4AY3D*+Ru<$rSjCoR4>CYUoNPdfMzpB0@ z>fMGmKnP}j*0eG^Ob>e+;od2yeDg5jPt;)!XVi4PNG^X|Op3!E6b$EFScM-_V+n3Y zGtdvO2_&O0%`R!KiS<9G#XsP%eCQblrR%6MbvkXjc$jE)S_U~Z?kAs5r2KEVj^yr;=o_2$ue2-!#kY5Fh+JErOP@B~WF zcN5;b@qKeF%SNChN7G_i0JQS!m*4JNX0?H+*G_&Pf*6tLPI%Si*l&M;p63`AGLDQh zrkW8KbYaAj(WY(E!GnR(hu+F#Zq4t8H4T3ElV{52c(+=Mvy<5%v*0+fKBA=0L%5!jhOhFa0co~g6qkK_EK71### z-E#I5)gZBO#3k5hggemWneAqsGC~TR@vW)v{aZjM*8|uA|Iz}k5Nf&`DOSiX2kJ#L zlYfA(QSqDQmDV5IWqQZcUghg{kj8rdXR@Xq@phC>aD&E?*SU-3Q}cdeq9jqUkoZC6h zTK@QickBL`?mi#c-Ppv(RXKmAxqB>0m!qVf|B*xTO@2*$uqx(A7t z!|=;MF|F{jJ&xa;%$D=Z_p$QrvXV5?N_)~A(++&!ez;2?ktF0DEKmB#5o}lOY7}r^ zW2$8J5RWy~e1TJ5-+r~XgWH5)Z_Dhjt}lrRV@2l>XML#QrE2|3@1HW7hz;=$Zj7k3oXcF{+)qHS^+cH6EnO$uSPe5O^L5_a zVxKb`(1o4UH0paYE9X9#8%#*{YsTtE1zULpHhPMu^KxmGKdSYk(DCkEHX) zH^DHyUAAekpt7M!90MMPb6T!6*hfFkat=p_gQ)XnoYy3UyU!>C-%(@vPc96Stvg!i z_BGUd)bly`(7XLD!387tC6AHZTQSZDXo{_k%6MEG@C)l1I?Yyby{Mo1U&{*bEIKSB z#f7^G_GcGZq^@=x%`WwIeiP1KtU)fRCW~GJ#`dc=sz*9)RxeWB|GD>AD`nVcF+$62 zK!QP8ztfa&v`PRNes`oVOz^=eW_;u-pyQtw?OwOMOEmxaUCF&Sc5)aFMrycy?rqeIr?TQJ^kO5%rsrYmAgNqjf{8|K72YaWF;SrR9WZ=wouQAh? zMjC*nX+AA_CK&!_0v7nIZGA~mx-oh*IJ&h#I#fX*732j_J$$jGq-5$`ydZ#0UmBrX zzES(VS_vj=7s4Y#fO66oZtuLBsk=p->)BU;uhsxcONVuYZH$E`SrTn%Gnxt`(r||U7RJ0hHgM2ruF3ZWQM#4-qm8L zkM=Zll%+P0$ok-ps_lvHZ+KNnc;_zAGDxw6be%2oROh&jx74*5GuR&Y8Gc5K+p-DE zKTi!&IzeTN*j)zUe+Gi>*>8k-e8erwC#@#hBRTUsbtax4czcIt&s&1g&x-Qh__3SS z%!lW5Vn@8I`oJzJ*XJcEpD?Lcio|e|wUWPSVcNl-`D%H4Z_02*o|gH$K6I>R9xaRg z$DYMKITK!-2)PgZW=L>uSZ9ft5NtG)veh+RM9LqD)Q-Nl5u~P&a?o(y7yFOFkvs~* zIKc=Br!E+XwD0m&%52A|MUhGf-vAs@j^7EFsz`T?X;_Yq>OgE7eB9W?l};VHU>Z@6 zI`N__;WlW6848WFFw_Hy9{P-g1^cM>CVg^z9k53iJs0}-^WnAzd0PYyn3=1hy0oa{pk9|=&qr@q{j;wSNwUXC_2bc9Y;?-!GdI# znnp<4?(|=!mX#HFBRY_dLXzb%2K{^%HOH;LXHJr>jVwt1_T8&EVEKfbcY{7*m&-mQLKc!ac{TcIZfFGoh` z=g^kq&wcO>%lGFu%_dX{e5;nax0u98>BZU9CTw4mzd(C+bQ~E2 z*88L^TEEp+kkCzL{>d*?HeL(|0iGUimTQ>7rFd*D!cWzq6T(-AKG|f^!^!F0P&p^g zqy-)CGeu+z3gkP`Uo4LHIca)nh>I}-jWK3^5&21N)5(UY3wS4bLUWX1hR{y70oxU) zL+y5%f#{`Q3Fw0@gHv^0R2U`k9p1D zB?y|AN<_dFiJAOplk?>`nzX* zEpN7(XXB~cWX3&@w+~c9V=TVEeR6;GU%_J63G)g+59WDJSf;Q6fV~}Ue9^B_(DpRV zX3i466j%KMAoA5JUh1x7A)*RA$6CO26U>}`P~hD8F~kh5=`k*x%GB#nksa@og&?7;&@zqbOB)H z5(Mpi=HM0;p^ITA9Dd#K_`u|)DplOGfSl{(IH9+HgV4nRoUtuKVq%)iyy$AAYzqja z{HR}?tKOD5EleBk&T&8&FnIet#uI2R&Xm z1PRvGK2C;Y*Z00HNvM%J+5ptCA8yA&%Dk%~jmV(dY%zyKn)1V`Uu2}d+j-`6#iq~u zfXB8}WY<9YBSC6M5zdwL>2$n4mzv=iREpX^=x^C!t(`0nWW%vA4N>g%D15we|GI{R zF!Iz9F93GES_H~M*^dfX_f(U`Sr^Ab-=ig4<;BLU{4?gkhx46Q)lJ`u1jXiG_Wy-B z503_C<_sH)ju>&PO>BGhWmX=rKz0_V8qu9ER-Xj0n!cT;l9hC~^@x*4yH&w8=pOCi&~g><%*lu-;_HjgkxPb_p;j}f^* zdV1~EEgy)hHmH!&bUP}vC4G>VUYB*$3*EW@U(NnYG8*b6O+bNEsCp;4S9`#MHFu9M zzL_7{PY|{Y)>EJ-@!_#8#?4O6JnoS9D}bk@_sbn`@bfn!oRtKlE3Ai?mlSC~!~xwT z-kpVbl*uw~&f?WMvz6hB>}T&l?iiC9*SFuy-*Yi6lb-ZGL9iCBIX+J7Sc5d5L z9(`46pBRIpj#`haPWvD<&o{(QS(q3oKN^GQoyl7>NWqwFGbMChd5<_8+lG1e?zUrA zG`%1(Is*IkMx0%TL9%d-y?X8l-l#fn3};8KY+rnw$k{0UtE({#Qx5cuPfIa2t4Gq$ zokraGz%%I@<(HlpEmh{I6gMYtl$N!=S}tPBp-~Y6?DI8CRFbePU}s0;M8hJ>{pw!#FU246j3;@JEL>3$=&PlDKiH1 zDCDivfP1Je_UV=xjC9LeE`($)MBJ82&-cwr#YOwN~ea{h>=&ii`6y5{FU|m0Bv{0Q3IAT#v&89%s>L3yX`r#GO2KogvF1ynbGKv8cB*k zun0AvIphc`DkAk6KB9p6bjmtwY}(dG z{2zMe%N81a`h-oE>cbYf>LzJ~+BBMyX5PW@`!n!*Rl4dA%-+=-k=o}WpeuwB#s5N_ zIOIQe`qL;?IPC4xA@x5okRi$>4fmb~DT`9u!uGJ3H-;gCw7yy;om;Gonz9)1pqV=L z-pWFIc?S37=YbrRpA*P?u`y-EDV6^@hXVaGwl?pH(v5B4VFv|?0<^v(Ahq<-^J24a zx+Oh7-XFH{o7MDI!(;b@hV2nq!_pRxPSO?dHvenps@p#w|E_u&kz~cSoii9Sx=fvI z?Dbo#`f&diu0Y@6(_FfeY-8T0m3`Z=ICA+5xtpBIbEzNJrra;>;+Ta9TqX4Wl5&?P zCca*F!@jB|gJ8qa2-SY`Bs6TQPfsqM*d*ok_(A^WM5t~n7n4yzLub&^7nn%9!dTJm zf9-+MX@w-%?@5V=AR_+7B7bVf{#pOK;c+p}|0J8K+g@E>QvGoP`7;Mu&9|nFkT5KM zSGh@|ph5||Y#BDh%^q5rY$M8J>3#z2oT@FO2JwC6uxguvZQhx3ZN1kRD4G8oF{v>s zP`vRfRa*fPoG(>tj|PCVlU8E^Xp2{RQAx?Ni*D!4!E7U$(}$8CRdM>7~co*W|$Vm-?JFMwBk$ z_Nji&C;mTlKr(ESvwLOwC6}? zZZvx?ufzmq=BL2Lm0J6ms+D5#ERw#ys;Cogft%jRq7UxRCrlX=+p0$UHRp%Ud`L-{ zTlmsNFD(L_@@G`d8A18Dgq~&ZHKTVgnhZWM0?&OPDtdmbV9Zzz z%u&KV)E&Mam>LTht`-;vqv_SXfp*#>YqG*(oF5p3zXWo(yU0sT%9DRea?d7|>0yxMr;rqNAXD`)y?e`agN9Pf(8xcND z3UJNYF~U5{7kbDjrKBQ1LU^I*7S(GhpY|?LIT;5~twA&D{JVC40rfqDXwys)AMP1-L#aH7vw?o#M0 z{~V;_p84>j*UnGskJuFb?sRI90qF{8xu@$ks!ac74Pbgi%GM>8jcVjEJ%M8rvt0)Z z+b|vrB>6PQD@$k$JPKV*Dpc<0kBu-k_yHRWk}vjgBqI|S(w`OqDBSHZv2JlsWf$c97*|1jzWR)m0c2;xS|I}8>Sd0 zb6VEY7Nj6?J#NmFqoOZT#$W96_W+Bhb__#EWW_c9#zfgB>S7LFM(bO$K|bz-f2(U* zNr+2sF-rGsSeMmzz+8mWyoTWBqo17PA!}R{%c@EOmrpGJjckh)n$J?~fL~}Ox`~+Q zprV4lHuNiX3r*8viI*|*yQ6I1HjIBI>1vHSCw9PMir0yBz=KsvrOY7Ru1`@OL29HW zgF>)!?CF(!3Mt5y;JsviScKvN6CEl*Ty~v&I()Od81N0#*Z{=NZUrZ=t3B<2NOdiD z#-w8!{L<+=;ACaOl%{}X34fAL>oZOVy{|#UI!`ttpX*Cl0|vb5lOEDN zaf7_>GWl#mWNDz9PRdy(uhT9Z@{t!fnJe~!Rf#B#m3J~X(lRf7V_d+sUpkTT6Iw!6 z8+aTUs>f1p_6#0>JomlBB0t7#l{M}MHH?#n_U}uo>n!)2v0Rz5TuCZa)lL9sY^J}W z=w%U}o}EjYst4eK`Q2goBc)wATlC`Xqy#S~P0J~~lkhV>61d=$vnjmq0xh*>FyS=! zm*{0P*=@tfWVLtlNO0He_ozc(ZDt0oJXin!%$x76eZf{F?^_*V7^?>dC_n$5Ys>btRuE0mWOkwX}y9NF()16NpKdQJ5E_JeWGI==!*-yJIjsF`n? z%e#q9T6)nVQ*SkMziE8UY_@Zk9gNNP}B+tjOV>=dy69&*;aVwEx>y4pK6PG1$Q>tiH{Q z_@$y$-n7G@1kpOOA6b!;OmA$S(aQlbDDvlR!LqrLTwf1|l$p*K&MWF1Yy4H@#T@~G z{57S1I?t-rjUbn-EsJ$joVLWX9xV?NaKDs~dNF7>B(qunX*z5yN20PovZ<>HH4Xk| z_4wJki;W~zVPx}EVYbQ^KfT&$<=PiiOIDO+*h_^OVdlEW)7O2LPow3giC(~9{14yp z>DHLmWVLos!)AZndF|A&efiQNcy2M^St0{GC65JhWbI6e*=Jitz_m0;$e*?OLu)OzkV^B;f-JuDG@&jB;e>%*Q0(9 za#>Q&8lG7ux3p^MZKgI6b^BNgR@?yr=-%vzr$-j@-6fx<3x3WQ^|2Uh`}eeQrb&;q zMQ}DSnmdfXa-+~~dLgX}2^{lT)N|MC8WpW5E+*1_JMc$rRTKU9CiyFWJXGMmxgdV912lJe?kft9s?S5 zkcU_UDeRNgd)7J#@O!ZREF0aqZGfJ)tCH}nf6V)R8iQ!}WUvwEaD`Gv5LMa*Vm;T+ zDgPdZ4l*Ge4;0zhLz~iDKRvTvKSc|*#qoEo^1!gkfoR*COD;MJJ z_;6xOIImI9<6Qc%kN&S8xU?v`qx5{K@_OoIxS2vdT0lNv|H!tV;ZnV$a+tdfa=qI5 ztuY397v!?4h2~c}V-C%DzfeW*Q=xsK_>_zChc>yYJ0wj7$8DU|0?os(&l1&17dyN3YX%Oi z6@eH^YsADXqZ_)<+CM-2{j4Orv|BfUr?ip@e}lt{kObe#VZ z6!yx-$Y&_ni@Q6muz!q|X*Rf{uH-yVeV?Z11Y|$S)~?UINPS{L|6Lr9{yOq3qvmUS zlWLApS72QqWTxh(D<)g4u2-yeK8sJC)z7XXj{Lf<}L9|WKiz+l3iJALi5TK z4+Z6YH!LkWmt%#NBSLBq2GX;&yX%S}r5ubh`ZXYKA-|F#I(>BSITT1`$yLO+^j3#Y7QN|EW9KV)`kyv_HFxXW8;ykTo~rALjM;=dvX*(7 zIDw4Qm5SDiRND-|D?f9(T~XBB-*l_o5{dGct~sz86}$#r%K(hfNCo zcy{x}falL@UzP7a7Ui9--38*-`!aZlX z^ks45m|;U{3~X_I5_B9VZGRi);UuY9fwh%6-^Wl>9hO$49f<3=Ct6;(q$5=1z8BXQ zCKGN;`+>8f(r3)h3*6?(&+FvF&pNg>?C@)y9%xCE=9%IUmuG{)s6VF-d|DAe%|n(+ zIS!o8`)RByu1eTpW6xUKE4+}M^mh-*A*EL6HF-+Cb!US@Y8&+D+jHTl`q^sDC@}wx z_)sd68{j%NeR3HT6TLYx<8twY)N-}OUuI}oQ1NS;ZgmnA@^$Es#XvF;Afp4 zs(VEUx|`VF(!S4v&Nm3aqCz2Tg!;$ph5jWDnTy*R#!HRq@zIfSG(EsncW?x1+`bj5Vj; z9Vv?#E-?Vp-`PRd!Zu2WGe~uo9ZpZ(Fq%VB|3-4>XlJ#Yj_)@n?(W26Nzw91`jg>+ zf3gI;8qFpod_(?-MbNoi!^xXDbq4`ZWbO{Xt?eGDc(Oy$^hmt}_fefQEUd^+bPFG6 zCF%Wn#aqLFHNV+CU@r=&%8}bD79A6jA6?LHa7f)HD0SCJsm(0Jo^qcO#9q1qaGZl8 z0`!g8dg6V{5F=skSeUMf6pXAFFqmLH%DBdbt$nzdkXYZ%C~L@wwx2RC?|lR-BUxD_ zT|tv?vse@Auj=)@$JYeJTje3lJy-1_!1y05q_|yORphHN5DB&r%G>v={xyV_O7z`m z@SKuWDeY|^{gKSyh)=0n1)E~G5M&cii~OL{CapaLA*(AJsk2oWD_B;zC}7A#Du0MnAlm(Bp(s>GiFFVUQ{&`+m99SZc%NNF}P^>>$231{vG$|WoY zDc{&{LNlw)YpHRbS5Y@9ftPv;QO?tzj^!x5K#;g+^iK0Qd*F$~!_KdQLh&p6Sd zdf1fO@U;d(ZH5XTfp~L0If{Sd{SlX|`uz0tF)sF?714zFm?_N~`;5np_DB;br zp3Wa?$l|{?f)?Smp2boqxIXSPD-3+9`A(Ld1wtn7Nx_ zY!#a%H<7uWG0og=w%M)W_xWA>19n|w`@G+;*Yo*!&{5jDyZ`*(OvI=6f2$6^13mnD z*!*zlqtT1=k{kb1RvwBfB40Ue|LT_v|BDJFYA4cZ^n2rM4n0rt^eukzZN5=;c;fPN zxW136K_mEa$aJbFs+^)gZ4cr4FETMt)VB9Uf9O31tS|nXYHUCl-o?dZ*Xz=^hontzhtn0Sq7jYKiSFrwy&h^ z)3e${4kJC2m8p=_(*T4?VTM>^cR?^UxAF@NW~U~Uks{knQ6&(u&9?FNQ-rnr`SxHrwebksI|k9=~Zl&GH*{lD<2R`l9#I328K{87eha z*XqEb@F(;%-gRiTcY9KOgK1}G!@+z`vt3sy{^9R>aXxl4Z1kE&YE7eBR1whgq9vZQ zqH&LCg{ZE}sphQd=@{@k1v(|(Cc%Rz=F!=;Zk_xmOV9@J57o*gl<^)AT=mc+&uRk+bX?9Z)HDPY!U z$NY2HQqQ+^^f=cOTX5yU4ZgrJTIm^%ejE9xiGMU}mO=O0C0z0)5gexM?V#J$fDk}A zF-$1M)Vm;IxV*%Q)u9hcD((k0(nbJJM4IDb7U25RGyU;MJ=i!2G%XH+A0)Yn_wsWl zvk0uXt?4cXa_?3@y_wpfPpU*8T%1{!de2&qi$qXAVJp}nJRI4IztEdCyfS@cE0o3F zd6Dq>+d;O#O(Hmg&Rl&5`aEvRQY`eOg~#riH1C88CI}NmNQZQzZDB2spb%;1Q_=VF zPtL`e`5cYiWtYildl*Pe;^J6Tdg|yL>gKuY|zq zxwcx$Vjar=|03ty$p0Fu+-{mu=L5!>eHc}#6E&Kc^optN~bjv@AH?Or$w=cZZbv5GcnEOH6&l;E_SzehR zaOcNl*Tn|*a361_ugC`@}6ti zZ^AgrI{*r@)f@9(bg&+Z`%SwEsjLRYq=aU;S)51G9DFi^77}_{%Eu>x^pkXGf-&~8 zk9((Td?h6okzzPy4EOP(yG&oD$6BAIdX`^m=$sE0-80YwWZ5|N2R}Y)=nG-_Hg2hX z(*kN+a3Kx1+8^+JXeMhpi!;jQaT;56g8tb)G3Nuc6TH$N=hLlD>+)w@zml~W&DCyD z+Ae~MB`#t6RAMwo#QO8dEZDG@KAzt;hH0!xSf5e+OO=&w+}TcGnKc-3$nh0ZS*=Yl z@iu+_y>RFh(|a4(vXuW|i1GUbnTY4py3BugE;4Tgbqx5sj(7g+hU}{oz7$Mk=+%Uo zK}S-ARa@d%%_nCEPU^n%^pmpnTTA2t6>lNockAY~yuvU8h_O{|?iKFS&1etns4q`< zf>HMuBhmD<1Dtq#>_pRx`yJKeh3D{*cOS=FW#Wat{dSv(O%W4~D9+k!*w7bWI z-?lxN*wE`d$LsR5GBv7(eR=UC$1JyQ;=qd>X*wbEiTP=m>eWQJ95YxYTvYrUe07J_ zTVHnC4LCBq{t47HJ`^>ZJ3ZEDwaa}eTDvxLf%&I6r!>eYwMIfbA6<<&H#Tx;WCoTG z3oQyVm()R0#mEll={k@JwbsR|huvBI4>h~ z>t`h0B>tQD+L{KT(GqxyvcFMYpr&uE(l^AKM%bh}y};cK;CS^^SkFPhzmSv#GNVEm z=$oka7~AaBkY1tl)CswCX{}u~ubu?ll!{E~dbsx=f9-DASULB+RJT6am3c{+mc9A+ zKT=F>KN~43ZqC$kF8UhhUu@ZX0G&U);qwRF4EQUr5Bne|hA~MA+VGh=lbC(J$no>D z9hT-0=<#wV&C}O8iUa7_?9A+k`wvA+q^K8EZ28v3x^K*0xKgUELQv7P(*VV4x#R1(qzGqj?I~PRK4DHg>hTQ}4% z?9D{)FQe`iT(M$h1D7NUS3+9C?+g&sAg z@*HwowYxhai5?B|4O@~)E>Fmt1emE2Q9G4017JbfQ( zt?Ve9VVJZiAxB(eJK7DIdAq@oWB*ZUVne@HWYhWB9)M&${d#Sy?{bTT z*o#SF>jE$kA!R?_UOW7-(GrFf_++Lz>Nyx*CA!4Q@rn}- zWb5b)IkZHD+6g{pPen&!l{q#&qS3glz+G5t-X`8Rhy3}wUqSY#s~Up&k|t0;=C#AE4i#ul>I{cwd|bc9_fBxkb^_X|>m61Jd z6pFsM>Xb?_dY?UGZB*~E2=umx;P+snw(}E#2PN!C@14oC{WB?$_HWJB)U&%~`ANfF zm%h%pL^kHY*2FG|wTHvJPbP+e*f&kAl;Ncl%Ow!OzSDHo2PcV2VU+)ReIQ0}RBvoUk zxN#IS;JcXHlQ9QxlI%*d8Nu9Yg4}vQ+4z^l(u>Nvr2g>@mova1;|Jn3*hCRguJ7Xu zL~5uFiUS#(kKI$IG7~qwvwN%yy#Gq4uoz#DW9AVO|G(=(`9WA;iCXn|6cO3Kws1fI zX%2-bPYA6KeQLAzJ^MqkhSkvJLl|+X)U4_cKh(xcOxz zOa9kR(NvfeS9HGcXGpvWBrRV^>#|uMjBN~EKnr%x9lzBfu6WDqgB%THpql1Ql;6wX z?7?^7{)57RdnrvJJ^&umZYe%`C7<+m(8>@ZcCFm)=Zv_}GI4U|Ax+s;5qB@W?gqUu zYxO0ixxY2p_rd14#-ofYK;^LCG+Vm(5z`z|?vW4jZ)nWo)>wdYhybS3QnyR-+F*ol zY!(kuIE(W?jB2c6cuvsLE)YoM1*t}PJPe5U4kP+*XR^8(CAOmJS^MPG1O=%v-^5oV znk?O>CD8AOc$@3>=I6zjHK!%V3m|DB+@S-qfI=x{=-ngGAj4BAKmG;`u zj}jVdMMj5JqQ3{|iBChe!K2De@gG};86-0%s}}jn>|WsqZ8P9`vx}JPEPM3p=FBs* z`8wA@kBOf5FX{g4_5;Z{#A+aVF?T7s3}WN4J$eh)Fav}uc#3oWsL$tm2|xbnx#s+;vWDVu3V@aB(Wv#{;+79k5xbO zjTJ=P{Wh+0uQ4=A`CfMvvj;ajhF%}$4`Gt=(U`4qEN81^SK5m5-SNiVeq2XN-Dl?6 z_@cJA*jgxV|A0>yEVSnFCe2=IllZvmX!}4O>7ve#Bb@MO>&)-jV~=8s+)b%% zT|~$!Xv0!kUiHFwVsn%6c;wn_a0pF1jag`H3K~oZxssO{%vujC45a8O`bPYm8$z5R zy3CVTcRYBkJ<>em*)qzlA-3Y|9SetO4)@}t=dw3OZ8W<|q-V`%-=DY^Wcm*O>CW1V zI&1t&Dj^Kj^>PxPA$zS%e+o18A68HcwXShqNJCp`b$zQN2W}w$(GDn$|2G4FW_}~^ zv-Z%;tk~P|d&X=&JRm*Gral`&LxRGvzGJ9}P(UZp-)gPwmVaTJ)Sm9CiViKjkM*mj zc=HPn8q zMd4zz20IALTs9MrG+1<6i>N(PCVF5-AKR$WX?tb{Dwhqa3VmjB*X)eU6V zFFN<%y8j96g@D9a=ao?VI^NMcve6K-8i4i%)(w1Oj@t3_jlPkxW2#HaNT&1%5{z`v z+$kt7s@>WH(VNzLaiVi==;tCnD|X59_z6&?Xp2Rv27m}?J)4&4xmtM)ybv?p+2B*Z zG4spkvX=HcU4-6PpIGTjvJbalMfq~s^s+&sf>8-5G_p&`jmOi;YNo!YZFDagCcc|F zdpCh-kQ{5e+yONcUDLo-++GE`6Wpg8Gm5)}K}T$Tp)Gb{F3e5&k?n`<^VVEQFcd6R z;3Ok6nSY=3SO;bu9-+>0qSu6-;8))r#*W4>41Q~>EbKX$uL$)o&Seh1$8Zk;z+ql! zfZvg~{J$L5vq8^2af(ch*@4@Rl(WGFG>cUkwMN~3!=fa#oc_94`sv5h`J1SM7QPC zj<*!dtTpXb(J;}dK<& zuOiOkGzl_c&XEj^JtgI!Nrgr_8MbEypB<_4kuiGp!hE=~(se<{4< zbJUHlZ^I7$2CF6WxRMot4afeZ(M`Xq(x%X2oFAcD6@C*2=p$W%Od*Vsm<57c>|Nr^ zte^+wrqIxcrqrOS7)<|kqL-_fIKepd#0~Xz`r<5-=T&$pyD>c{5z@)DEWU9P@c~^9 zaTi8D`yYR*D4Hh{t`=74z}MKGkr5SI!FNImwe2EYYOnNHKt9|F3QpU{b#5o? zseEXoz5p6%vJ9Hvse5aQL=<|4;+Ir;1an&fwY9;Km{vsMFRN`>`Ez{X`*8B`)fE z%YW^0sv!!K!{KZjHTN5wdhH-6j*jIU)vc{t8eKxGd#KQSM4q9-i;w*0}uvmLVXUq_BeeXhvok& z#ULei-QZ6C?76IUi{y7HuT+PoPAlNJsNwr#8oKuze-;J9%5_{29is|BT_~-7q4_*B zddqj1mR3YkbF*)j#t9hlLF|qA&`8G54&h&qLZZrHvEE33$jEg~(J%I*f_=^=px`37 zfB69OKbf;{MroaECIsH&$iD=ovr@0v1gQ5997Y{R`K7Fi7egM_M2_fnFN%k7PsC3= z%|)2Lljfn(KI`p$@C+3%hyA5zUy`BzC(y^X*u!AsK#ei(JCyX8QXBJN>pVKU-`{W* zh+fCLKAyf=KvV?EKN^_WshWQk_z+VuD{N&qtA`9%=8LI5tD9E9n)eT#6ou^32`rn8B5TcwM>CZzi-N6z%a? z*=P?qC5h~t#oLVe)~zL$YzuiNbEgBC`hum2!BIgvTOTWt9a+N~=_*ZF(Jjve?vSoX z?7yn+jXlciz_r$ttvJQXk*cjcH?|=uO>YS#>47l((oOy^8)-A)kA;DNZ-Ca%k#^0c z1jQ2B>ECkKsz!VjzxPNfG29iy7}?Z>VPNNbeoxF$v4!`lJ#F&jwvk2u8=QhmaiCZy zDfX7IUaAKlmqSFcoYwQ>hgoCxqLC)2ag&h#R-x|_Yvx3b_^>L5EA(Hm&)kSeV#N=s zCR&xZkZkns{+tOKVR;amD+>emq$wrY8(1O3|CBN}%cNkjTj>915=k+oHJDUQgttBn ziw0uSpw74Jtn^vW3QU@-N_{h6$7xQ0Oyei;LQhundpKv`SAPLhaSnHw)APJ{b89BI zE&IBAvv^<7^vebn+D}K@$`jZeS9(+y){uK;vdTPTEp5 zmBjTG(M0PYA4Urq={!7F7ey!`^K@WqG0V67)_EqL$fXwzO(D*an5oAkKhbx=qu1~y3|JQJu^br8-rpGBTBTm6Y)uN3g7gk=a&;14VbyJByx96S9B1= zmQZT%?h(9IuRXh^AG*h?%ukPD^+p=D6>29v3k@7xZjs))~8!euSEhqZ+L{O)zAmLfMLrM_CJDnXOpv>@~k68p|rJn~248 zN5=hq37qpPeU6_5H5ncY=vVIa#ofV1&%S&s4D((O`B3*~8NZcU+X$BT89ocO6O{Xw zC~Edmv-i@e$yZc?iMGyVEsv*jO$mMA`GRxpdrxlU8^h0*3jO=>#5TnFP|lU+v@ZQG zzWOWro=Hq@(hM40N{RLr3W96N-w;`lZzjrM2$eMoCBOTx`$f>6VO^bmOKr@Pf-Xw$ zA>e_6x2P~I=mF&e#I^2AhQrw=hQ!!a;!-48_!l6mJ>^BpF7;tU3`Jk}=|6TvUZpl| zL1I|CP`EFN3^aq~e*1@Xvmn&@al3?c?UgJUBFKhgv^Oop&x??TxhHWagk$$OnHKE( zE$lSi;l~Xc@%C6_Q((Z^cnGq2`?!u^i~M4IAkp9<{pt<_!N?I-`zd}@R>-)g)KhKN z7w)@m29R-7=_RUtB@WAS=<!J9tETMagt zWuR8;B9R&Z*%i{gF#}w8;2T9HzqIaXC^9U4mGx@h#V)6#AG&VAcPamsB6@rb>Ys$i z8K$aQe;N^+X9QAWal_;EzM2Co*`W3g43eB8!kypai!^r89NBb#zq;)eL?3x58VVWL znBgv7U^fSN?@wbtGRueqxKrt0&VvZzdbbsc=S26^g^pL?d!WwsqW(9Wv=8F~YJ=tz zf~?tV>{HL6`9{xG+dbH4tq*ENkIzHtr3V{w2D3;Pcig8;0yYS1fDRaQI1wG%P&z*BTX9(w-doR_z3yqfkncZz_9^$e>u;WYfS3I< z-a@QBco6hYS(D7tzP72xBuXLNag9VaU_UFgEjSDD?#87Ov z&3`=8Z1U#z3Cr_NY4~0jeqBrdZL00Qu7kP8W9HU{ix02hZ2pV2;F4~4xxri6dK3B+ zp!R~Pu7Sb|lTLK4?RmgAd7y%_T7ez5DAouW=H`L0tFLc6MdL{Uu^pyx@{^1hsWQgV zuG;DyoW=|+FSeX?%*!iRvVO;_q6)J9&5))KOw0@8Y9psk5Lgs{eJ^_}%i|StYi%U{ zquHsXBD%DRma5#x>XnjZMC>DzR(r~{@cxdGdz1}-KXyK+3eQNZYJP+SRrQ|ircZV9 z;Trtk=O7QobIQZrZ4qqC*1M*s-gXf0j*Selz=jc>H3J}3ZgxctKYf| z9h1UrXQ_!QvukwwvK-&R4cLlPeoQn2OlQ3B@+a-+=a8Yg zrL}Xzdo9~6>b{XLJ<$~p*Gh3=>Z2VO}d z&ip4UZduGylpYihu8#G1Ht~(bC?Rtjlm_AR!LUe{hfQo+ z4c{k#adgFwRNx4ioeJJ4(2t;ZiD38tRh0W$6}xuiDK}@g5i4q}{G4sS5D^#GSD}Tc z&BHhqF476RNwS0Dk)q>e`!x&_K$Ojn2wI+j>!P;pwbb%KM!c{Ai6`CZKFb4jL)cPt zlUQqb2JfhmZ(jo_;!CDO7X@sJZsv6%B1=c7^WQnHUM~0CqepftvxP8r`A!r#ni4|F zjp64Bh7%`)`$q=%L`GGdw{Y>I^#y$435*RR^F4z?V{6&XKaJUwU|$_^KXGDS@_o}> zmAhKF52*)_GZzopPe*k33?H2B*z{OP+f!3VsoH|8)Xxgu+!!rrcK0Bd!BKmSv2i>k zoy@GRNeF%AGmr;|&QU6II-M z0|R?vm%n)rvwWI?I<-!Yq8{p7)>Z6Kr?Fn{eYfCw9gqQF{37~xTsd%@*A(|bkMPj} zuiT9F5-cTTFXEUrIFm5Tu-B@9&F|NcEVD&d!JjB>&SJZ_z`kbv2Vrnsu=< z3U?W|Rlknb0KqRU=?g~nGf9~G0K8OacUGs%>Wuv8P=}|Y%4m7Ra9Qb}&=_xBFBZ7X zd9VJe{AUUODdH!Th7kkC7bNkAEYm3Q?;vXvy^CFs3ao zMK@hvJUkZB4?GJM3;=B57su$Lud!>a^>22-^d4DFN0)dDQ z7NEsu1M-M|mMoT!O*zxyu^90`1lz$P=Usm8pmSKe(ZT5m*N0IUguI80(JVLwsL6x0NW4pHIGi^zq?H>-tDS3hb591)KO@7_^ zV-C|*Z-UZ|sJvbD&G^`muqeC8sE2f-JFXn$Lb1>nNfTfe^-FA3!eVl4T;bIEAK&du zfrC8%9`>Pi)AYVw6?Gn%cQh(&B1<3=L|7k^MVO2P$IIjBO9jK0h$=)cMplp{Yqk7s zLeSM+5t|I_&s$ebx|_0J_9UET5f&@tyiLrR>5%}<=56c`@`f~ZxIwaeWBf13IwZ>L zZ~6s(XIQ9Ev29^`oAOenXvqba-O8LM}M_S1sH=<5VTIyGO>ccB;4qJvId^<9W8 zj2}bLCoDysNml6H7ST!9HJT$VvoZUurkgy|6} z?oCB+_A*eniSH;+z&N)Mfs?~vh3eaqWo2G{N2}w?VgL2}MMI4~X*oCpWvAy~OFwQH z&i3h<;88Y1jdrusS5!vtGIgL_0Dc-|5=L9*n*fI$Lz(0!RG0#wNi<-#Mh52TkiczQ z%GBlfjdMc(-#i;uT02(P$7A1J#-PpaYY)Es4Eys_ndsNtoU&m>G6#|;^gcc0eONW$ z!Xa%Utop;(3s5LZ54VG^oN3o{-66dPA4}r^rUU3`p$Oty4Y08WA4X|8H<7h5E4DBQ zYp&DDNP&zulV>z5-{Z;tZfE<_w84^*1)W`RLhs5?um{UYmoI|9zqPzgYJZNDp-#Y? z0hp)5A|4p=Gyt!D53U9K_iKsSy;Xu z%H!F5O;eT{Ai-;jzW9eN?Vd^`$sA7}C$J(9$>H!)bodJ8TTOe?qv$Od)?P_B4nF0?J$j zxKNdVkF9Gf!PzdpEa@VkPWMK_|Er4vWh zWK?IvTb^N#VLUR`6`J*BGL6cQqkA>%bOQN~V;F;i5e(^yGV1NzbIqz?^D0ygnenU0 z`wV5NU^{gy1uvz4A~#_;%XKJP8W*{cMqX9!UG2eo3K7eHud?Gz#S(urXqz%;S!t#a zC=bhyeiZ5SQr9hQO|7Aj)Sci8pE&Rk#C%p5pIpF?7FHL+19vDFs!m+)-#=V87XO$u z&+F;a)flGqz~sB4$|_5<3Q$&kLvQr}6ty|%?w@qsFNxv8J$@}njP+3fL9Es#|`{NlQd&Gt7v1b$||F3O>*fuv5cE^8b1llF;d$u3Ty*yT{G zc+_j~{;_;j)Tjp0;&aWbFHZ|_&8&vY^V6%Bdz~eNh_x3;K(^+=nc z`?aP=Hf6EfWRE7l70hWlV@T41YyR5`&L%2U_GXt~8*x+Izcxmhc{=n$vXHCt9URS7 ztScuxXl=|MD)P!`l(RW>MkA*(Md+Y|+T*|zx-C-w2a>s%mhTG*xVrO)C)Ca7Qv-P) zGA;PK8c3C0-T&z7E*E{zi>az#mX3Wp=#^7y&Hgovrs;S8(){VYi2-_l=!Jpu=91mN za;-fLtRt3_bgZw^xsoe3RjQfc=ZS$Q9(OZ{iO!GnOM-Ml{h-!TjjK@A@KsyxF&Zo3 zQ}^Kkz->+*RdA#FQeAEW423J6SYD2~ir433RSEPAH(3(AJj=xIszzn+9Ok5Ze$%or zhwaf*CqvF~8l}7v4yM1by>3`F+U$EsA{?70c52s zo#XRKdqW1!Z~aZ?q)8ODo{=QQ1Jl8A;BwDl=SO_!C%KV7Z?GQq2DWdJ&s0iA4t(~s z;zBKk4laWzGRpwfpnZJ9O$a+;6jI!l2{4f?Iv}9Ag&ayv48tlzXRT0kdPPU2^Z@~C z-oFg>b&|UtNf(LX88h4Pqbn{Ji?{ffkkAxMzIt|`lNNX0qN0x6ZuCr1AHc33yol7| z>eC~v;Q?0*>cQG02hi5>TR$9x@@m(`x37FnPtyeYT(ns0L31sb>L_Og%wO$Dm^eA; zu)4j$v&il#Z>YIu)V@RzE{x|E)T84JrmJNu!;KQ`on<#k&+Q@0z5)+?@43h&s@;2y z_kuzGHkg%n#uM!7_<=)IbJmC4WX?pZOY@;DdVpUI)aWNAD} z`^j;URKuPEdan6P^&~Cmm7i~<>CRNG>lB9Ix8jLw zk6OT-Qj26q*@2U?(6#|Z;l1_lCb&m)W^-M=;1t@k-v`Y(*>~<5d6lmgW7MUq%BUlH!O=`E6Y^5FzwukLoS3r-DB?S$(zvNAot# zDBE=4O)IfzjyJ=42%(961|FOF;#&zZ-k&wEgZ`|Uu=tCitTpof3BqX4WylDHgh7h- zK=aRf*9j*EWzYBLYtjb)!b+|vOr3^v=i4;lxa-T_AG|_EMeatt%a4m=YouvI@|3fx z$^;7d8vf?Mh{z0me3=izn-=72Uc(1TqGt1vmCTEvxQtQBznMK6VOZf@{8d7FTv8Vq z(dZ+@dFVT&9go<%awIF=|zkt@QUbf{VP_ut|Jxg-onOR@1&5Fn_>_#O>Y~925kspXyzdP;kz@W}>gaU~Ooj z>d>w-L4m;NZlP8bpQMdS&PB}`4aetd`=vVdu3bGP>&gkoHcV)X`m+hEn&J}y@@7aY zFJBn)C9Suyebca~Z|swa7Z81!ZG%C%MvBfExurAI_n#bVj*kWJd!8~XMJgjw?F-LC zp%;6Wg3yhSIhkm=xjThz?CPC=U z+Nz$gSBnsFT}%64iG|m=2DfItB~j;EAQDkABMB6z{7h(09tfx@h6j{N)BH7;Qpt?M6cA972i7!+5BF4^{!Do~ zs#O>mecwkD`-rTyqCAuuX1H0lE7~H@)4Mgq+9r_Lj%mMxtbvD0`em7s!>E#qrsV)?ibq$;6s26$0+%1pUaPP z&=W@WCS*}r*~HQtsq9Iwcp%SY<(EQ*Cv0uL;y+A(nWr10h9=<|yVXWsEu0xXXIErB z@NYHf3TC#q|OR{W&{-h1_N}4q1*gpxOTJUR7krmVGz)W!I zjh%>AKZ~~Uo)cf$B`&>Ck~dAO!^a1EFP}8SJ~KPvVTW|b{06f-&uIY`zEx}pT$<(E zmOfPI1z!uy6*|1EgDt&ZTl#un;0554Dc7uFtuL4irudJGQL*M7gXSIpXa2rPcYam} z^ul8y#j$q9H0vpoDN5aw zjnTj51vm+_dnm61?mIsEf-zI4TE0;QYg{LMSXaf=S>j_KndHx~Hgq`Z<3-U=)~m3O zy5~mWAh;6a1BX*_kw~nva$WxwA3EG;E*@eC#|A$&a{lj&909!1H?MDAhkk3vZ zBt-~8mqrfqoxrJCrcIM3I3-IMAlP2n^40OdR_hV*B~q_c#qI@`<|~H-N?Y6Dp{kHR z2VX3bEsPrYHZk5UoVa20;pHR(g2k%85aV)7kcF8M*5L&k;(yLAQ7;g7Vm~?Ag0b=- zJ*U4O2TJJ5=Qh65=_DBcU9TVaMsExS!8j3KliHyL!l90;Rh3hf*`VsB$cK{Y*eQzY zI_$54`o$Dl?!%KDrs$aZr7IzG#a^=~rDgD(sdKOArwoFu$p?_Sx>&(e>S&EiNezwQ zj&{WVh?trU&3pOR;%)SPjWucJpAW$P{S_~j$Ee|<=nc5Wz$Q3 z*};@;J_d@#9l9M8?SmLK8O4d*&iX1nRb!&QSCEB4>ihZjT83jcaUzVXPbVCBE_ z(OBJHgAq|fa1E{9Biyt=v1?)e>dukfNVd0>9O%T8gCc7&=lKz=W`vR->dT$YUi%xNBn3Kypj5_XxKCJ{K8 z5zbi(?LwL2PHqlN?=fX3^JI5x z0=*Rbvvu&cm~!u$?g8RuR=yB`I$f|=DdaKRiKcVa*K!)&3pOXML^#Nh~cjngc1VHCND z7#^TCa=nD5%VZ3}L8`?R6js6<39h&ixg9x2e5h2dPS1(>+U(XL+A6->{ zB*VR2wSC~e{Sa}5wXCBFy{>~kkG>%Pxe#m&Ht|goTXaCz1Mk`sy24|FI@4qOhsdc0tUnL0tS(-QMA3B={gUVYek1VQVVR+b&Iv zV^1Gfd}7`I))cyKv!NnwsFI#}{IX#SXFU1k`VXx?^Fsm%UI_P(dq3pDOmit!xvdvx zPuLj(OxF$DVdw@RHj(`QHV8VC-2J~yPyGIbq#t&ZK-9yq=IgZgwJ%fiR;05E+m?Oz z)84>3-b()(5Z*Q+g$y2Zo3CJlazuM_!f?tbI$DNtlFiYM`EZ`%4#$Tk2lX3FnQyZAa1g{)4O(c8 zM*OPWRbp4o$P9Jh&G@Z27ULE$r-pcUHU|G~t>bB0LEGm&PafF{zo=F})J2HO544i6 zgiGF;n#d}8HLGi&jM<-0!m$#Tas=CA@H3~Y$!mmp!;k+imS`2adh`yz2h+qj@5+B| zcbtg{&riM`cC1vNz+;d^FZ#R;%U$|xhFa|QZT~7a@N_B)qK#6rp$n=4`~^~^*T(3V zOQGF7laHP3ayXc(QOWS`%7z`;%K5Vb~PwC$7Qixey8@wVVw{OMiVxH#R#N9Zi{HPC-8XgT}haOy~I zOy)N^L;ywIA*J|@ER>nQZ4yMi4lmr8(D=Kz$gdKw7yjTH0@pclWu}-G+r;vqJ~3*t zW=4_cj!)e)NZKBM0~4<~7Z70Ivrz@T6?-asdVWz2?2iAA3Ob{Ty zMxd`c2-XJCHxhFkigEEbZi1}1jz&93@4 zSgRstNEoUoO1_r<*?oeM=4w0Fah@QU__k8c7+owppurg|kqUhJIK8Ss=Dh`ql7cv@ z#mmsEnz?@n6#{TDu|YUSScWjTzNL~vXn)llb$NDr$#5w$cGW*aKXC)7OACV=m390M z`4()TA$kvjZ;gs(I9sE!77FG**oHG{DRW;cyt}n49#Rg5MjbMXI66a#zIjTU#z>m) zD6`8YZRIxD3~sXVTYcJYU}$RiN^v;Cls`XV0B+&>uIWoIt;|WvAPkZf1u$|H!1=79T>B8YE#Gcp6KP2H@zXpy&}V~Ev2tyyt#x|2ltFmUp` zc+PM*zS^>_3Q>gZ=N^G1&ov=}h|SE~Tez>U9PF@PV<~oae;jq3E?E6_uBw|^vGGF^ zY94N$4%CSp-*%$;YGdLVtnnkkJ2A4nLbD@S_!5eRe`E7kT35;?`Z{ z`gn+YG(C>4Jm}o z?r%+Z-Ke#ZQhH+W=8*3PmX8+4KB16__nOY*1d(R&*v^q=oYgxmAK6O0=Ca1jJVl$q zBQ?r?p7pT|BP@`N3~N#UG)2vQX8SeiFUWW7*FlzA1wv>e``UnW@*6}L|9oLSa(d=r zl|yG$MR=^EgmJGWIy_lB1bJg&0(bb=~AU0(E8!_kq-|a@hD?t`fu<1@1Vf(5&oc4hB{k$N5W9AfX zcb8%uh z3>LPp0g|jkY1EAe?dsPkwpPn`g%-wq?igd-u?^q_ekul;WDt64tG_zYB zNqXCT4R^FqF`U$M0rV=)hvmUL+A@@6FJy}wytcBD)ZcZXW^uN3D(F*vnZHfkxG<&`t>n_Wx4yEBNoSPD)rJ^JHpE>jO4OZJ%rkKCN zaJa3?u3pu4bXW%rxh-VP47ZJQe*qPAWGh0H4o*JLR{aRq$9qJEa<0x{}d3_rT)Lfc1s9-x1b((`P zT73?o`|32$EK$%82%;3_d}>2}E9O-~kAcc1t5bC^x*P6E$k$JWJ!@OM4cO-oIK zs>;J=Re|4hIwXDCdYJsW%VlSeQf2;+1A&T6?Z>3+^u}_efvAlLjk=-zU@7E=&d-6Y za6&t`E*Fz_DQ7l++V#(MWmxYTJaZRxWhJEI#_A`Uy#PxqQ%qsTZdC}e_v%l+Shkz)65ehN@{ zlayMP_Ci-NLI@lD6S1YC0bDUy^y)Bl(2lxtVLfdqPr0v}sZC&O1J|V!(5Ca&D=ENE zEfiKLYet+S5O~ir&ra{vL$WhR@_S(oGm10{cEO;YGFW5qeO%(!Y(mt)HbmSbjie=l z<_b^4Lrk{?*0Jj@!}6n|fvWMkOS}<10;r)V2LYoSx34jVajMFCtrb6e1By9_K0U?bX+8$NES3>FC$+E*vs5QS&gx?(T88PW z5xO^e^Am}}&Db8R@K$xbvL@TmzX2<^N;2N2!h}K#RwhPmygV~i7>|mw*#7kpH#TQ3 zSn{m}EcAanL+&oqz?7rbe}Q(jH4e`xOSI=E5yVDd^n7Tdi#(p(gvmqGu$SlRo}l;* zKGmI0>txn~PTb&OK_`UDr4a9QY6Fje8EGA%|d>p zc}lpMexy>fChg4&$Jf>u!+2Xpx=8y`Z`wSr*zw6T6*(3J%p|`m3N6_9zyifQ_az)w z_96l^fZf+@KolWZnQ08RWtjN(WjjeXMcR|-fc>`mc$xo(2;cS3JAAc>KCw1HSYMge zJi7TeWA|cX{_Er)0S3f@rM}&psFiywbIwQ8j;73ka(^*nu1!v*UANfxXc>?X{KCZD z|9DKF7#p2tSckqDaz{IwF};16ayeCVWshVV5H6ZCF_dXtfa)USui9N_n1iHeG+A>Z zSdnVKr-U_q*KMs6@`O3J$M&vLr_MTrrW_jjudyyYTzVzvb6TO~Q19ZyfKXNSt37}e z7IV-sZX`7m2AFs{Ebp1pmA`vH=8;Rqqk;gRAY)QtI`8#*!S?>hPhr!0ZVLT8IT&U| ztn7(DWH#6{vtTX7GAyccKqs@WZLn!D8;R(#%Wps1-e$0|jXJ-X=a~9`6rFn@)BFF& zPdO(!$|{x0tx~D4a2&a_RXWL0c1jtB71hdIavf%qRBpMHLM~gP6lTQSZ55;3CfYD& z88&0a%w<=8`~9`Q_Rr_DectcS>-~H_9zK}RqyGUr%)#-Jd{f8^-0CX~iC%^YrN5Uf z53#}1*G<0Idd3$M*KQrhrEB3KE$pfYxDV9kp=1tMm&;&tz(qd~&J9O#ComS7j=*8l zf#Md#TpcmBp-C$FD_G-GA4z(zr!RVn7Vl+r7ubgg6;vMQ{Wyi?QgV;#pOBvYp}G|j zKob7H!b;08Ee#AOiGo1Vgh4yY8Yfd}Qi!>k9 zP(p)6xV8bX!DRBgQ{!3|3(+u@J|t%xU+TF3+}A@dMBL5QoRCu@hZn_cM%>`$Xv~Pb z@D}pRlW@Myy~WpeS+ztY9I-+f23yV6@~|$w63h?eGm=}D;Om6jip01}DaVY$g|C^* zCWft-rht33Dv!%O)2s@X6Z&?0B}Kd$Pb+?vhVsG)B15OMl_A^_Y6)j;g0PJb6eiFm z6~KUh;)359Va*)A;l#X8%3?zZY&)hjKjr=oPQ6B8N*+xcfO8?rRrJHQdDEX_*B@BC zh3amB!QX@ra91XL>SS6j~<9Ptsew z&k^`p6&GOQOYADbNlR^SsF+0oB)3(BDK1S!h!`RQsvnPAoDl9ylDn&fLl@-@4aCqH z)cRSLxnfM2J22gJc30YVfc&&~u1tgVOuN(so5>{@ogo4-8ZeF5f}Jqb-9_n zBdY$A6ynaUGHz&Tco6h;NN4O7IC{CEzNM@>s2O{OS_zM1nbDWlT4VKBTxZ*SyknUF zfhT&S<9)lTuK!lPtd$@Bo~nA2iJA6C6Z^G_0#~N)WULgurRwvS#&l#;8agwV0Q#0d zR4!aXF*MturVOtImEA5eb~V%dc0$m92HQvw5N7~6M)yrdGUs}# z(0;ISA}k>~QD+pHlZdhChndyQ4|$Ilw4m=@Za}Z_E5OKf(VGR4xh}q?SahEKyPO9x zkR0nj@f>FJ0;|3bmih0H+l&>(Abl`D(_!;oH|J3}6m?xe615ccO_~~-B>=o*pKf>M zh&xIS{W^iP?`v2LWZ&?Ou1K&hjlEug_YAt}aue}-;{S^ieqz%oaeKz5TuFx##;5I> zH2LFkT_?Kf2;L_pTJ_q^?>Vh~u8^;B($Esn(ujU-<>HC1_WYR82YrSh_FUIhAZKLg zxWu1uSof!KU5xF2JHi8PPwvxP;nfgWCn68niG3?|t2Y*{DpL~D4p5#Oe#CypSu?CD zH|!B?&-pj|p{Ln@P2HN4rHVqowsU~ZLJN80Yfse**UDhfU{XnKy(Zsfg zzx}qk;(X!U_3*jD4I!jZ8t~6b?UA^w07n?P#`c#pqn5rr1k58#v_;Q91Ywr0h_9+6 zS{84cssgQs*#&NJ6 zARQQY5U{drkv#H4KZ>vVA+DXC{m?xaA8EDbWHML0ZH=SW7-;;aIRJk{^gz~-!~f*t zgZY-;urW#-J~3LkF!zLQf?av2r&xTn(M{=BT;4R&K!o24TA0Z@gZXNR%hGL|hF3=! z_3RW#H77W@CFga!P?8sU;Z?Qb9}yz^%;xVF^ERPLpXcUK8^ra4H;3D5i2zW$p;|~00JJE9=q?;(BgW1x!XvyA}c6u5u z`U6-nj0Ch$6+$0YLb5gex3WgZ*4bTBrJeF|ri86k8%hktiRK;NQ|Tkkm}^1hh6?n0 z$~)J&)b(Xk?tk&<05y%U<5JqI_>DFDNeX>}T^dr=N_j`kjl?g4(|KBU==vVWn1rV~ zK{VZrjsh0?a4kQY#Bs?vOV9NqjeX;*f1wdoZEp$y7zvs6rTdSimDf*RI-!E`=(~^| zlGUaP8)GtE{54H{`E!V@Gh;;^yR#K1^u|F&I!st5odC zCRs>nj=p}&J*vuZbiR>0Dk}uII)+ku+q<4vJ4*%)LTloe!!?+qPL%#Mq@v1bUb7s! zQBY>I9~-euV@~PtkU7)titXrYdPTf+uo#lPHm0LX(gc3mGGAIK4$7SC+Bxi321Cyr zzl+NL1?%T+g;MXevVU8M=OzbvKd6TNo*VekcWd0QpXh*A)Gl0@QJLR9!baHRuq{9( zkn2T}smT(>Fy8Mv^lOOpJLgU-_k0n>PlfkI`lc2!!#bFpT^~uJWlWbfHeiqZ|F^?v z-88JWAt$wE_21n1@U<|6I@{Rl604Bjxat*kYr%c+c*Q2-5zCO(qw-+1E#|zm2O1yl ztA=-sTGhfY$X6qS_Ct_g1Xbwe$j}&NQ&YaTWHms1jOWd?+dM{j*ue0HRfwkB561LZ zDZN{ZO;5y?AcaGsGRScsXNcwmFwN&O9v~w!BMg(;G@Ff9`m{DvxuY!!V()KO`hiNH zcqk#blWD-&E|bNW_D4wO&?T=7ZXt?HP+tkGqkW#)PK%Ap&oU#;wzrhFFiAuAHxXK$ z&i)(mY9qmIYvTzPpHO#q1U@*<>>JIW_qkdyT>w;*TQ^eWQJsX37iELXcN$nd1K2`No>wH~H8O6R<_8PP0J_IhUtIOSC|G#bWk* zEmq^M4^gADjt4HhurJC7M)~XKHy%+wcWTTR$KzX8sj{1_y&(EG?ZI zFqU57>QjClk&#io*kII%`J(-q6HG(Fan?TCUj?iG)Gzj)DDr(P08+2w+)0= z$$Ven+f>Yy5Bx7f>zGY{jZd2zwXKvJpjI($O-BfUVFE9$2gt4iv5sWw{i&yE&A~;C zaD{`)cWr^*#!RN2yrfTmQ{1JTzD>Fq7^ZrLI$t>MnDy*l!QeKv&#KBp?}DmiX-j{- z%cUMCvm;-jr<JIT>_j$v^|7w&ZBYWINUr3=Ouo>DRUP5~D{n5i>qj48MHCo8A)(M>3@8^NAMq zf#RR}wU89Wv9(%`sa6&*FO72clr#BbTq#prKn3`+Gi$as=AL=PyjY z3&>vL0+)RT>fz)Na$x!pRj-atheuvB=azGaavyJ;{G1=7=r4`s)zSdMm~PWLa3BOO z@ft4EgnT1}%En`D`^##_Vis)XM0xmBPqiWmzY^y!0b9FZOSR)P8whx&ybiyyeE zPJC2WxR?hbIZIwpW`1J%I(79P4jwFUO%*xF(f0e%`1xE{ds159`5J888DymUdX*19 zcKLe2OhkCl=B&eH5KzV@@!BT)I4PS{>BeI#7%L^a9})}pXaTQ#xlu^_R zteJ^`Ex2knHPG@+r(ikJ>z?tq+W2UC>T%b_^BY1WwG-#jmGBa26KGN_&59OvA#ppI z3;gb~!n%lnig%bSyg%AHTzu zK;6Z=Q7~YC%itm_VYC+izMw%gIWAT8mO1llBw@qd&MhYmBlq>dcPeknk^0!(0~~^R zZOoEW5(wBzkZF9>TZ5VufY4I`B|)aCh8dx(Y+FsnockC&*9!-eXI}gHj#?5|eq0-q zOlp)a;0}E|H>PiVprR-2`WPmA7GRs)h~EDqvAM==zCWq3LnDsulnajX!mvZe&0p=D zG`tU6t@!9cF;+dQDoh?(PA0flDg|X0Bw88kf72ep@-8hUa=5k=kf$`ZUeNG+-<7)> zG3J8cY#)HekM2V73)5G`-yq?PfKuPzar9J|kv(rrk#Z5u#$fFsE>2S(PyrZAv&-H5 zT?<8L9(MBc-pM-`6qBn`)LE@ypR0M+H*_i(?#?Q-h*9RlA6ae^ORWR0Ev(!B*lp(t z>I@6oNiEH@eon90c?ttut#z5L{+?;?z!luuY`3z=CD+^8_>MY8dF{zeSMQ`Xg|m0u za7#wDiWh3zIXRW!Z-gc>CGk4S516o$b^{oi72gD}1yX+IW=3u--3OB1;HoUuQaK$j^+Q3;xpBV7fHI}5d1SKe zqSWt^$I5nnp!%obOhi!Ft)j;Zo2N&Di$t`z)faBEY@n{>x~7727Rr)KUBS?dxVc66 zkwI+om1hgbzdK>XvpYI_ykhFQ)W|5o_IpTx9ijrJ+r688{?O2tSmkhr)S*+<3HdY( zhX92ie2;0Y_N41+-z%CP(wT-7=l6K$_~5oWxSR|AWHzPJM>uP1)Ht>nPpKcTya`q*b}?Wbr_Z`N*h;#9=Q(r%{@;HApW{s0_- z>CYMMv14732hNle778_|`Wyvulal{G-2rVVK5Yi5;yBE-h-H1l^$%2;LiOZ>Gs8AF zOZGdoa6;#0dkQud`F)dy7n|-&%v2>R_Kz@A%SRWS*Zv>J=DihDy%gVbe%Glt?1dGLy}Y7xK9x)*AIzn=Pn6dNhfs-;6-_6 zs7*>HNq@b$A!Be3EshHcM&8W0=@_G9M;Tz*zg|Yj0p(F|WuD8~7WrV0lWpT|h);## zM-%bjkMpe}0L2;X;{fux6zA!0)McW-D-G+h_EGW7s^v2&*J83gZ{_kgO;Ei&S+|>< z6LJmfJpW$?=fS+^gS(2)h(MCL8f{i^YO*ZP%TicPw^fr2cAIZ9I3X4L)6_DT+dgh4t!-+6zLynIzsHOhv+Wj4r49$-?jlD*`>WE_~w8edrP9Lu#p_Ws% z_=JA&`V^MwW%(E_?0zTO(uu!+1lXrKMenw1ix9c_9=q-+bjWmIb$G)cL>?hK|FYBj z&pVtiYFanpkro}Zh!IwuZe*dRS0+j_rh>ZAY|e*m9)24_T}ldkMl5Z4=V0kXC`=Uo z`(PWb;3q_7(_<(9-sJXaF28!L3tH8N@umMJyZz-WSY`G9U?`oXW8}XYgkNdQ&>B;$d~?rI z?cn&3B<_6kkpioJ@E}7QORrLBm*ZNN9xZV42!U(9qvk~i%E*oN3@PbyBz3j_Zx(kS z^`NpxAI_XK;)xbDX56YqqeAjaG*|j|&okeRF7wboxusU|2OnrjP{GB$SqXtiG^ zFd3(ng?o$9MT5ZlC@Du-WBH)$cTb&0E(YLavi8dsQ@PY#`a)-ky8(%k1;}gAE1SEa z9x&}$kL*Wo5`P4g0#_=|$x1?e$qqRxLfw%@#z1>&co5q>eO#3W! zr<-idxGo!7MSdw({1z0>UMh+|YB;`-UN3spmKXNi&1}WaF+pRCC7&`iy!b~4Myu=4 zz*rk69PMcZCY#^XaPlrkMwb5}`b@X4#_wNwrZxb9A#YAKCbvH|Y2hzuo8XT_an?Vs zvSzw-GS|){j1}yxI8n=1jutPq_*EkM$lP7iB4?!>Dq=`g^#8E#>OKg3%hER>y0A~% zuGVi=C!o*M$SG9R5O)~VIrook3pCy~TA1m04NGSa<}I#`+Uu+7iavvwVL>LI+Shd0 z7@>TAijKaV6c0Q?UU^^;H`C(5J164U8c8|j1=cf0z|9$N*U#HVxb3e`>nYd?G4-9C zVZ%JbPLA;8Vn70v7CHd3; z_fu)n&z10Mk1;Vg+DkSaEiQCheX*9R8$M$P)oxlYBslqx)lqu;VZ(AT*NQ|oyRnG5$1~13+S=-qE|a_C#hoO zgQuJjr8O3k)z=;vCM{x`6a2Ca^^w{JR28*5Sx$tYCrsRt5TLZd2v~j<32Bz9PuZ=T ze{%==l|#197q}9S%v~llcV0!OkA;k&w=047Z*pPRCO93GbAj9o2(^Psy&~{GMae<>vK?zeKMd z68T*A7ahCp2yT%t-+I=<#jP+QthQb8L6|qzl^64kpE!P9< z`QilYf(qASZwSL_tI{LqxO>+cgs1#`koxE0U7s%ewPm(Nt~mZD)AF-@%HzX6N97|~ ze^xx?bR2QGAi0-lTN)SjTkObk8bs^edCBgtN>|#AnGyJ<{bx@ z{b7-{u9>7m6tGc9IAggIPj1bhLLg3rDCEnpVZ=H9UUFm0#d5bM<%EsNuXQo4PDeEj zgU`=v!y}h#H!j8Q%KV*N9lLaW_$(4}kxh&ogg6nAopHDB!A7&^D*Lpc8(a1IAtwoM zHqR(&Qyuq>&EQv_6(zCnrI^oo&g&q9Y5&7CY;=sDZ>^ScB%YhhMWz}DpN)OJS_5of zbBr>Q+|y@NtPuc*)}H5;s3`SxL_RWJn{_BLZ*=jHYrsI!Rfo9Od{Bx~7WF|@QLRkr zT+Xd9OD;Go8NiGf)9&EWvn@(HYQ<3@1Ck(M%Z#r}21@QJu4Q8V{JDg+4vVlz7wS1QXKl|Ev@ zd6G=W&=+U-jMwq8uy)>jhl8j?F}(g;C{Ngx^OFHJZ`^3xV@HuDN@ zh&VCi^%bkJWMC@s97>I`xuNAhXuG5Zv3OPBz3{qCnH1?zu9EH#SPn=3gKk{FUkZ=T z1-DM+>1Bj=RfOLPEW)ox#g9zJud>_l!Eu5Od*OGo_w-DXhRrBcbQrV;&@}mh;7V)H zG}>?}DYczE4HiCl6%upK;xMV@mkDm|MbXF%b5yfou_d@n zF_51aI5=NXD&I9& zN`BmJ;f^0tqxcrH^zIiGD4mfp#-Q`$11kxx#MwA2Rmzvdpw^o~9pO)tZ9F#k;;U&; z0EWh}S!f!{_aDNfoa-=p?+)xqtWF_Vgws;) zis7c8ac_cT?JrPZPm{Yh-r@zw_*NQts{eQ98p{7s4RP*nA#SZd76mQ`M?PKX0(AdV z0KR0{mhK7FqhGRlBGAB#rZvuN!{lmChwN6h*|Yizm*22Subndg^|doLGQ7S>L|R9} zbKR7%pP#JI4eYT%y|E;_4c5a0-!n`nln_HcqtA*3@fx$N?AHe38&tv3`I~#G6IFeN z%!a%WOQc|dALk{@_*}oLq9^NpLHoF^2dVf{)pkpf9X1%dzomlcyq-hd-s#Y8y=wC? z`l94#t_$^!f?b2Ox|gO5>ay}&Ejdh8&eAc-$3Be*a~r02H&$C}rI($%hwS6oN}osW z_|>*VNwO2pndq0|CXhTRTMhAu^DtOIuj?EzOe1uHvz#JLaza=Cl>AGMO;DQIsWZAO zYN$bl>!80Xk7Ec!7-4kcp1QY3oJAPx3%5q`X4**+8u>1^oBho|XIw|p=0t9f%_gIf zuji;R>hYOB_`*mgNKa|=n$XE8q@vLfXZB};u5^?sFr_t zFPMZh889vjgmi}wOFoh4WVe4eyEkcmiv%{$bHe>8fNo zufPPqw6vO~3%RY`-yIl>VP4_#!AMNn!A)zZVYNk4g!?Q#X;TOjEG4R)dwO)x>z{My zZ&Dx+j-@>2x%3}`B@aBYq&8mIdo|SMgb(Fc%d|7V-7fKrdZkX-;j*JAprez{((>xgmAJf*7myBo=uJI-?9lBrvhCipI?D(A75GB z8ZKXE71KXi;I2gZoiT(BZdw1epjz_#Y~48f&hy`kNHWI{gnD!@2Jhv7rGH7JN&`&06Yr zL6Y}_%(VTG<_kD%9-|Wq5UTwoTnrfcgExAZ=6V`a4sJ3buhlneMrqgPbJBwJEoZ7` z+<pv|}!p`#4=10avuuMOLa`eXUdxbJ!6IxN6=RIbVWIm!%w2Bq3%sG);U0lgsC zbUWE-K@W1#)|ls;l3ky#{l#jV#6OKY!7QKxqgL~wi)cJPm|~)ImNHb>wI%DiyH#eVDg+Z(_&TH6Hizs~lK z!efgZsC#~7mW0B;H99=)7h}K7jY@7Np)kw%SBW}ywTJcnE{iD^_rXO@sG+9QKn!0w zTdaLzcgBgp(6*ui$N_h#vckKrx2fp%x|p|sqL19S40TiW1#q7Xu?3BLqGEyxQUu!4JM zG}dW!9>ekd&E~GSpU>BLz%Ay-5qEe*VQ&+G!nORnch5v@+GcLK`OD(sR+^Ym$l|k3aD2v z#Em~l4`1&Ca^bvvt$B_eY#<=c zUFcmkIR^e!R*y!Q%87coRVcHbWvv@Ub8_)ASgHME z^~)D8*`>qKlUh+@i#qotG=WY{Zl^Q+BH3ekMM83@(BQor;+{dwoNcJR!ga0`y4V`Y zBY@%$kx{XrVDf5dUJ(fW*~PegMzHTT6(;*#$~)bABQXFlN*~k&BTUq2#okpOL!Fri zxVTb(*TT|OPEXrv=YtrYNNufPg3gy}s(Pi#F!lFcS@1YB_5tdEZ=^4c@j4Q|pil{1 zh=eQYpzx23WtQk+i6zQb&>}EuE|vHgAxZ2R*HyvizD0!i$DM{>=GqGzE$UEF+>}X~ zUv8pAzN^{p#7a50pO!?HhbHMeXDyYeZ{0VQG`P8V>8|4`?p$Mcla7`9+dx=S3b@?t zb_vtLQ=sHahiN-*FLAfmO{#|b<#YG7dLnOO&~s@Y+c4!? z+7^w(OY9=R9w$*nPm(eyy}eFv>03zQr^Ix~l~2XP&Gkfjt=fuGb`L#Zg&cm!O8>}= z5zb`?oV=^>;?hMUqYGVK)`JFPhU#YGqqNrpM#0p7k5);PVy4@KD~8v{JsUu zAJq1WK5B@gOa?v88e%H|G!XOl7rlIPY(;$J*EJDD_9DleKP$@!Ly~3aL&Or!;VF0Q_ri5_k=* z@vY3ewYEa#CA=mIpI>KwhN!C`K53tfdu+lpV$9U(fYI#H~yvgL+TGBn?&(sjmY!0@%nTOvMLx8uYYx z2W1$T+6U0T=_8=MRophPjF+$NSUsqQoWdf16_6k6hf0R6h9@enNR&gAs($hASb5b; z09ky(FV7_vJhFuq7q$QA74O#6KZvLdv1S)08)LQ0+V`w`-nr`*WzR7-DlC4KsrxO#Odc=Fp~L$%#Z%B0oDX-lpBpm&GcNL|G=&&8kgrrLMBhvC@|ZHuC?fP}+3Lrg*k!m2 zS%ZK=@ZQA!98x{^;7E|Kz2WOQ~%~TqMRn= zQ=!9y!%t}mJ~E5XtT6C?%F_i{8?nvUE-dJ4f$q2h-98puV`n~(5P9wusd0vb6+W$! z_}ZrMQIJHk*W8mYuVRM&r;xAsM=QpM8O=qX#RB3sHoEq`8-hw-y8On&YPB>H`UW9TLWC1Zexl z%r5a?T{-&Sa?Ogf&sq#{LWV_}vtG4UafC{|S>4k_ha*M1!<7xT2JTulG7=t-@FVc! zabya|Ab#NB3CjPd0Zq102--|)f2r{K#1F}UCG{e#<*goL)kVKPnD#GgeEEOwehvvz zd;V$#J!>|p60S(vQSYcZ81yU5Oqt6j-}y#8w#aR{M%OL=+?k)GH{ugJ7sYhvVejlLU{ z91q*ozR3cFX_0_ zJc+Loo6!_|E(3qR0!AFRMWn<=2hX8=FD(jCs_(i0Tg+bQI*vc1WD;!4D?q=NV4Nkg z;P@P05r|zOOPQwo!luBOIHm{3QP^P;A9N2LBrf3s2RZtK#!*qyl^mB(Ygx>>Ebu+F z|KoXoQKF&t8$u4Pwn=_wz1CZ+Le_CB)TWj4cKu9GFz>ri&lQ7sk8&Tij$l%MSAz(fS%-4 zBujnD!-r8?u!0oYVy&YzkII#Vt@-6{Sf@w*+dcii`@7Fpo_*fn7G1! zLn4+#(%WkL`aR)EaJlg0`~8rUs&5i;7H=~}VS7ug(XIjDI_sJ{U9d==T-I7*5{Cq` zsa;YtRl>cS2>zHChWC^& z*k;2x!SEvXzhQd$DZS{0+A?r&ml4)WQe&>aj!!4jp+;IqtD3~acUhjoO7Ha~|8mcDt_PBdJ(Ij^T0^n$vOXvw0beh7Nub4@q&2+bM2Oq(c0 z=ZL%Fu6)=spQO}?GQ|+AmQTW(SYT(oFhi>K5M0t)ku_fCa=hjNrhsE;eG~tQBbB${2%9i>ml&MBg1{B~Q#$3+y=B z*o0c)MS*tNSN`AukMc!dPH2QB_|F;h^13P;RFFVjDY;s@hRjlxS|XLOhETEoX2a-_9o_ z@6$)&(0^B?=5i{3aB~4>t1rxxN*u5IdHI75EWy-}p&pv1FDs+ZYFKN=;vx1*fks1Y z^1J9yM=0m>5$4hEe{Yi4&$M}Ruv(>+Z6?hCK-E`o~$9~x#C642XVfs0x zj`(eUjTY6erex)Q&ajYjq;sxWDi)8#o}R7MD$9dR7i-X`?&uG9mb`O(Ci!VfDm8x! zQ(t?lzh>jOu+vqd*;E5B>!f+cea4|Fw=ze$pp>+is-F6RD?R^^8GAvy3#=8t^2k^w zc1vs4&fuDW1oW?x1H7SAFnfy9#C5~S35{sX?t5*#7x2@RgKw+1Um7X~i(k~rJ7D%5 z(Ra8b0i#yKaa*+!mc09;*~`BA1K1$N&$F;}lVvw=aehf=S{u+4>-RQ0SoHhSIa`Qn z-BXYUOqOM$wh(S+JV?wS*Ls*B%J5Z6r<$wTz!VeAW|19bahWEoP$Jo$3gDu_2BZ0juQqM$bW3VdGRBA>Y!;{SJU`Ut-OU_{pk#5CIQokg4RH8bn4&w$)jsRWeDTH{aFQu?v+ujJ-o1uxtBxWBwhu}B z(RVigR8F8>Gr&zrL>ggDSpgikn@F4IqJ-V=C5w}FIBe|`8y#V5xugFAb|^x-eXU|2 zXmu2&*9=GExfc-FhmC3uh`51yk^$3BNm=mrZ;-a=+n2iuy2pS6Qfn^ zHeLuKgIGPiwUOjc3qGfw#@+9mG{XI!S|Qz=i!s}c;E9Uf?xZxedVaRGfd~rgNTW71ai~!H(o4cFVT(=7^m5PBWE=8ZX0DY|A zA87bBl0xfrn7~fJQMzLP1}_cy&sV0UXeieF6}!1Lj9(|;FW+?Y6?aTYc(84|{mnXx zDWjhJ){6VMaH+SO@k5^&cPKvZELooBqP_X2KtA-NY}i++cfc+cFJArzhQ{%e&6ICg ziD22dzTY=<*+UR$LFFgmP7)znIJscn7nr#liS*C0_?V3phX_jth6nVf*f9Jy%!`v|Y+z9bC1PiZFIQ`S+`N5qpCs*+~nya01PI|z-Bh;zcezqIcsq#_;jD?Y-s}m0*ErPqZZT6=UkVAS8V#@tNBQ12fU??wY^HPk6Hq6 zv)k#l&R>&16+HS}6*=xOCHUNCC!Q5uUr&mx*{8oWtT>fHA0z-~&a)@r*-NyRHe7p* z{!op(0R8?uxc;!dFt4YUBbx*pQ*{RQi zy;mOGODk}l3b+?M?@2a)gtPXi7iH76@R1WJ$edvuEd+0y2rTj|XT?eX19pa1R^?!7 zya<*H1-6NyYm~6(#<~NlQt>dLsKeUF-?nqKRD~mP{xp;cDL8An+JN3_r$mG2GB_i) zRvf1BsE5JXvf9Gr;@Yv-t4%$x`*On>Tql$!TpnFSwI0Lyb)GZa3|wj?bTHQcYt9O; z`R;x}j0kSV)bxZX)}8|jkHzzT{XXUQP#+@~c7<$) zIe`Y2j;{Qn{;}g6EbGtu+<$W8cm1BA*Z=47li`2zR0!llE0d6O#MGBK#aU+BHbOM} z^cTIeS=XO@d`Be!H!QIcyXscPcEwuOxV(%v<8^6v1H>WezE6C&7=t8_{Pu%Q-Tgv( zYf{`QGH88YcBz^)eJCI?c1bGC9isGJX#8E=jzRC$zN+4;`yV2UR3o_^&MpAeEcZcx zmy%vZT-;M*BOXQiPM^zNGGzHxYB)T*z1|{Dww^_#sg;q!vy)%L;PtTuR@})I_1<{J zaJ+)NfryM<5vH`iUJK-Dr4iRYpbyhNZd83l%2e=3I`5ZzVq8>JGPfaCcok0!_>Ime zfrMra9Qo;Ka_x*-dYdf%EM+;;?t(lvo@%_T{v688la6fNg zR*_K3N%W0bskG5AdfvFb+GS+w5&MY5zqTehJyQT$cc$JWefq<@TC@rQq?RbgV}Bar zcQ+j>SZwmb92KnIX+3(8+ZR44n)IP5yV*I>W%ou`G!}O}meZ=p{nyw3XD4DNO)Ln= zieGOh6j>F3znR4|;}bUw|JvN!{x3Dm11+LB|NP=`bYsnZY~$>j5`Y|hx$ik28I+)s zYTkddP-C1JRE&vj*atXGHS$>)YJygV{N=hIsl%>(S`8dII9xT}3>zW)dA8i((+wcQob*52F-+gyZ_HhUHZ-=79ZXf0NEytF}tp+I6V! z>X+zu7K08xq?@e^O8InuG?7NdS*M`BIQ&4}L7%m3Ol?>2G7{tio=~){VEneCV+{4d zqwlzNhbucQUUR)|F_=Lr`_;K+lu{A|^bME$vZMtrL_f{)Bzi0IH8P}-<{g3BMtjPb$Wm-3gp@w{l`{lUhVQhiXQ+{2iWM5j|$cHWDQU$?8Ji9QF z3=ULm`B(PE5GMHzUS=!S;fd1qN5mN;T$dPYC%zSntxBrcXLdKS#e5_N`dy>WS$6KB zFM5{>h!eNXEh!*j*q#j4uX$M!1uD?|2G*f`s+sz^Cc&=QRL2edfVC~Bvht|%<>6Km zy7t6y|2cSNbcI!i%d(G--{78kEDUwYwk7UYV)O$Mq%92}`PGT|H$7AJ*%rvPaRxit zrG=W@Xxq*i*{6b1%=BsG9y(A<>_6cUbzvN8NBmUgphBw|7X@iFc*RaMYd!l89Gm&? zbc#oJP`JkyAfh5%ax9BvN%r%=M5n4G0ipi&l(XcvOG(wc-7JgHX2ETTeS$0u!InI( zI^Pk&HVg5&OhFVL80tz%Q^NGjeys)OwcjYD3@d&xe}vbWi6DKFu67nlrP~}DWV1!F zd?dQi0O@OwpIY7+%mM6Gw?jt3pBp!pvcO1!jdxoP0SMxn6J9jEuwaS9u1E9IoUerPi|{%^IfPe1`o z){@DgyW=!Mw@n{_*z(WU&&}16>CO4~L^~yq0(x?;s}3|=Y!F?Lo<4sVJzzz+Gj;GV z`u$wXW#OVM4;M{24^WL~u+6DC*Gu|e#HG)$CJunlPOzX7%dj>Iun(Z6zC!hzLk^!GwRK;d6jRK?} zCMZCQvL{s?=XC>y&a$e^Eb1w1YV)^+39ux>yj>!nUu5^*d~6+oAyPa@lKVa`y`CkR z4XB>lvGrHV7g&>v3cvJhSBtBe*e$@>o?7lV_!p(NGG0E1JjNN>ie&^Omgy|bA+#dA z0HDp#BrTZf`P_uFCxidK@Fjce#KZr20rv0<`-F}sKs&Bp9!v`SJO(&9c2oaT=+x(Z zICnFoxtGBkqKT^NyOGtIp(kpAt5&f2QjevSC%^Vt+1=CYwSZNo6M1us&H0>ckXBt& zTEMWnt%g||S^TpwBetS8@u$AmhVX0|0C(#|C!+b|9_QAU9PN>LpiLox`e#t%v3756df(c6z7~hHJ&s4u`qvC5;1G`T_RK z()s9CFd)dPFd-u?+CgLb96E;cIg~M=mRro+zV|Q$VTCt(IUwQk{zCy*zIj>A`_)p~ zSE)}dTX#c)8Xag55Xu0cAK2VbN)ZJ&i)L?C&kfzaasYh_Xzbl~cJR7JX(_?uZqQ#{ zAv`LnVKb1#>&-bV^?M;!A8TJNwB*hoZO=!+@{}~|f-Nuq27P|AFk*%i zbc57%SCP7QzoN}$KWx?pQuaa>11?|CdJv}?W7a@v2%nFmVEMaYP9}^M5}?uDdN^=g z=d-N+&K1qYUD9fRnd;t};7t^r$Ny{7HXPvNn+>Rw1ozvI`)B1u#$=I5Ps|HEtz9L> z(KSNcpLZ3H%zssjrp_d>CbLyqvckd+EE zJ!h`0Sf7-6{(<)5j#sx%FDC1>{hbFYgiz{3oo0TL>05w92jeiwbjzb& zDxAWF0#QLIEolu)7AkA#4p>)$*@26)HyQQT=DVDih8jY50v`BXhEI88W{DN0VF4!F zu%M{|%@un(H`^3vAJJXPOTZ-^&JXO%@TA<{t{FSF0F$|~{mfckx9yZW0j5>O@`GjT zX_=l4Dev_LTe9<;+o*|7eI42v(VhA3L44cgx4)6L*aLn&$lth!>*l(3!QNWM}f5qFUSw_Yma^GtlkvapPf7(-+cxf|r?? zgZrBzlDnypAzjiFyofpiaFWofCHNX!8~Eq234yrY{C#??o$>|rt~5^M-IU_wJzgR< z;cCFOMk19od3mO>Bf%#9o1@B!}~D)r7Fe{A{^vzVCn;8)Z4Dw*wQ@FqODQDJoFa+liR z?uWO)yc)sLUQ|Ghq#!0lLDO9q%NzuUmo_{kl za1*w1Y>tFu?^JbbPtf}OMFR)14(oC|< z2gwhLhr(`QzdV)8%C=P^{0i%qpG5EnOmxxij(ifmbbMt0jvP<=6CA!-zAwvS=?Bye zl}7if%g2Q5?9tUP%z-=vi%GsLmhg=$<^Tv0ZB!G;AN@_f@JqgVJvM(y$bnc(0h?Dd z?#Kk9CC0v)EOpxQQLyeCHQeeq;QG=+TsND`OT3~mN5O@en}@5>X>4nY!p59iqUHyqI>_Ws5R zKImaO8mWxfzI2VYY`!?()^>41{`GuYl~vy|EG;1JNEO6>usnOFd#7{U`I8G5ERs7g z!b+ZgmQEM|sJe?Tucdrb`#Xe+K@34jae9GQX!_N*ZL==76<*5516@@4e~mCVuq@*cvr*6-V7C}OOb+Z0*JOH^D z6R;z1@qe88TF{V3DQ@9bAQQO|a1dwr14*lO=!<^ua0EwoQ>{aCkSsGo6(Z(F{roRsBb&@OoKnSiF?7h%1Bia(Zv!| z9DMIU7sItZE!ZZZ1UtUZcO7YameGlexnOquP_vkfQ5k>^!;)ms>eP?a<#(gw@#`fM@9kpOBVWhw!Q*~>WJxXFMxuqadl;Wp91QT1uTOOAja1uS^Nk_PWBR^|rvCj6Lfq!4aq>5LV>C};SVt^r`Y!h!wNh;H<*QP+ z{xJNYoc4`m^$;4}?u5sti_B&x{tKIoMdesK98wRFWQ>xAoB1SJ0^v*XJA*p%J*vJ~CDNab6hsSO1N5?Z(}^VerB-K3a}xCxwkq<> zt1~6m6HiA{h-&9!w-@ZUpVCjr9{5HeN5~IrBqrk^r!Ye2!FTflq;-2O7_n;mk4v z3lCS|K9;mIYV(WrQjI@_GEx%ga@of)qlaA;&?4nmt(lR-=$So-@Cu%g-;c_mNv2bN6!LCs#yQyaahu zVIeCv(ybGD6%+5Y!#L4uISzH-&EnHsAd90Nuale&ONkToku|3H_HkvTreeV@=;O07f^2f9ejT|n(z#Kic|ZZV5h+C- z8~H8Hsg6CElJ?sM#!Evq#y(Bqop4aHi+w|wuO|}7GYa^(i|O}I zlD|g13ySAn=4t0++OND(WueA%z|q>{CH2-Yebibi*m_)@lV)CKI%>J9{lz=I5{6K% zSew10OSJm_d3OS=c$}2wTFEZs9eQht|9{{pHTXsyq)XkGt}f+yBb9Y103b` zZ7TM_^0*@dd}w|7gsy3JM`;>h>MNyT*@6LKjZ)u!FS3nw&gQwNHIdM+PbBgFO1K+( z*K&8_*e6pgas@Hq)^%&mhc7c)zUw(0@be9nH{?)H7ut6F)ADR;+s{Kzo~1PSSkJ1G z+(r$H(!a%hQD#(g9s0}LZS4Uegdd;&A<|UzqPz|=@3Tgw0DeoIxt5&)tQqp_sgzaH zKPV5Wvfc}+xqP+IQw&en0E`X9ur%ac9n{7*GMTbUq<%RhVSB0Jsq-WmW9pKwx-;gt z01?JpEl6}#e}8oerAiwu3r4&yK`6#?p_4u_x+Ql1L9VP2GJ_wan@*0wb!EHsy%k4J z|C8x#SNyG36`JtGtaiKf$j5@uJiGA1#m`Aysy+<7cEfB0MCae!>qJp4> z%mdE9+BZ)}k?rRVK!K(Yax><8%z1Mk)Erd$NbR_8!+)wPAoa222TC;T!NDryuG0n>#LZ*)bMM;p|UC24kk-TvoboR zGDq#Fr}p-HXQST%ND>c0U<{s3M$VQS&fo4{^f&xD1~~~)b~kX0HKVOIo>Tg|#GcXv2=+kV4TY~)vsMSSJffA@?Xrz|~}PA>IGJcOh&TTE6DTtrXV=Jm12!ny{(I zFP@Cr;t8v#st>v3=vBvyO+xV%ijz%My2kh;^Lk;*@NUgH0do$Vxyxp^3&DP`^F7xw z-Tx{kU-+ZT^SeL2u3&Q7-OcbSe$I;1i)<7~(Zq0Yb=L*3)^6S)Saf;{9gxvW(|8X_ zy)}=Zzqr~1>*Wr-opTI13E#fg6_mz3oRyy{XS|BA=S|OX+`~kFS?kKjpDl-#%L$r# znakT^iEF=(RpQ=}K)C>`Qtd?9T$VYKkhn&D8)~p6g+!LkiJsV2$Jev{ALNI{MCh!j zK_oVK+4qZ~Q{}HU926tSI~4>WR~Fu}Lh>dPetl~t`}O4T%N|#A8@`3~3Ql4?_$Ush z(gYvO@oOAbVp>RBUFl)#Q->t*&-*|@7WD(lQbUXw%?ZE58eQzEuD;mi0_QfKnv{i+ zjFEvcjJ3f}8%@b++9Bc*uNqk9(Q>UuUI{ZWpC`hWkfMAK9t>XVQBM z{aDs3Inaqv|K}^B3E?dBp6Kfh4|v=8VU6cWkooDhBJ+yCQ(5>lb@t?yUoO3dxuAcu zgEGy4!Py&5EpxxEIb2@Bw1&TEel%cgxYwdH3nmc5tabcoS=OCvTZqGb}Z&^V0+2QYpFC{&|}E_P@TNnEiS%J;<6$%A5t*n*r240_7#+6ZU7@#M9?9eSgcGxy#qDUWBrc1$#bCIoUcJ z9oo1NJBjv)Eoc8-;t!M^V}A+=K0kOkkA15&`13QRR#02BXBjH))(sH#HQX$Ewy)Py zcow;(UjX-3_Y;0jh^==R?8ts(uox2z`Fu?^w(U7GMAr;1#fE(UXTgVMwI_c%4ANus zfl*-londIbEqcxz6$Lqn?bln*@^c(*xd9>hweQ$#<0xw^*q|L-oYtpg5+*JG27tL;V@7$<1qragI4J`>Vks9sBc14 z@KNT|#fzv5RcEB0((UnLEeJE*bJ*}n*3#W_2i-bSkKv?r6FyOXv;p1A6Di9&jWQH< z4)yh^Zfo*onz{m%5JE`FI<3y_m#25TL(JN#XWnJhjmWff^kU=0xPruLRJwt%EX{sJ zt%`VM`Jnpx=#S11wmn*))asFBi}c{Ly5?ohqBDSsRh385W8-AEi6Y;UK@6nq>4%KB zQ_CyT$AYK*KAn~6#u0^79Ygr z4n6)2(&ueK!CeyW^{w>E4gZTG|GPAFp{`lio!7QsQ&NeWGp~5#ESl#W9({zX>H>~L zUW{tSHJy(WeXq4tU$Lhw6gBv4=8kyNbf=J_>U?aKl_$H<{Fq|Cc?fuPk)BmnYU)oO z$;z^70{aY`(=ZkPvf6jZKCy16THY%P2=4-0>uVMI!jJgFsET)J^_dL zxDz;ZDaYTBmiuO^;+E@ky_f<%BDPWIU0UjEE8YRi$Z-q>jIh1lnrJonS-$ zzCc&{hlWShe%)Dn!>XV#!s<+_%OA8OCp1N}e{>;C;e+NdiN8xv1+d?{K_pipBkZn& z(hAqRN@MoaZtSqOR#FWsDDV`8Wb~MB_sfr*F+URNqFD!3iw9nIe<4V_%kdfA|Fqq6 zUFz4gr=GKPTD?~|+Pu4L0!w&Pv3iaVo{SfOf}-nIpU#_C4?I><|^$8=py{fS%?t|y*cxKtqH1PTC zW73JAS4!$h8wcWSIe$Y!zK5$dw>#jC;)MGuJU)gN3QMbXJHiRhF;zod1ZA+GC!zW3 zc$@8BHT>K}c1V+Olmf~W+tpW9`{Ln_fo&P)I6FOGU;Plj*(?fkhnXnPolgw|*5Tw_ zc<#=&)n^>b74FKiPpPf|C zE3O*JNgeQ6w|8*LbVHwuokkhz4xVeGW>NwfA1ZXHUv7`fQ>VS&@qEkfap30To=FsD zb!s(J0e|A&vtWsq)BGqE2mq{?lV%cE$(&w_v55xGREr!CkB1v3_0CM>?m*d(<8VJ5 z-XlvQKj^FBx9ECQb*aAQ2xrj=&Dc5a+XM2U3{%6Z*J0uSAXlH9wxMKgDCtJ_=I5N- zgcYbu#RnYpwpgg!eOi5iYi#*c@M?2r0f6%O<*BM|tE>O|F~>FwHVtlujP7#8ygqdo zEoN_PjOd}V9h_+W~`)r<<1sj>7-1#HOnFM315_ zCPhl>JS0!Ehb509%tR=x73Aa`dwHfXD^agZjTMn{WwM=me)U!b+ij50{Npi>XyO`V z#W(n2N>TpS7tr?$!ZI+l8r7Tm`OSUIM2Y$AhTgim)J~ud7_FS_tZR~uk5#KhJt4~? z=I=rs^&fXQ4FXXkyrFO3pdj|JVBe)P?#>%yujk8)bMUL5-K`#I&U~FK9)5cxD8#yZ zC$$lIkPJR9A)2;p#6B`tikn~2*Se{1U!^jTchb$$C5iXcA};Z;^rl)~%54}t4?wO> z7jporS|6aj0jd1&;|PM&TKDBUeR^*|@2AeKaVj^OS1wwNSvomy8Q9G0wG`|Vmc7U? zmDE`;qRBPkV1cCY-6Mm!@eCC*w0LwQekBw>3#)VHiHUa&fr zlK=w6kQDOG7gpK6c_W>stznv;AxiNNJ!_pxvK8$E_V?*KAucL2V$qK?c7*18c+YZG zbPD&7QDddGXYO?V@&l$%Y?|)yvD0zGZ+M@!l@71UL)J^ze2Ru+Yb&Nq+K|dy$Y@=S zz0&rL-|=lkdkm$ENYv($#RV!RV*`IQ!C3JkW61xWmKOzDWxn~aS5!$f#&R`xh4 zWrNL(-BnAiZ-}q;D+|l_xt=~M_Ant&?mX|;LPK{tB>wz%aB?!Pt+~R~bu+gExUr?@ z*0;bBh9x3Y=^JTH5Q86AD{CC2*QG zh;fd!NqJvSWEXMNxvE*6-EF2GO~gmt0jp<|1eq!`V{Q3wBlEoA$6(S=V_@Fh>!B*O z4?FO#I!x8#pr639k}F~dOdz#KZu61Golz7AZ52K12d|1&6l14_oB61HLfv9lW3t5r z`>)S$Ba`^kj9BKAe5>2#k{<6@WWV%2s zC(h4y#^2P!TA6NJmzkO$Uu@5*CeEn|8I-EC_9Pod4Gkl$w*1L+&)XDe2#pfH&Utqe zbw9U{KtW8bmnTYodlPolQ2dDkQgyfoiYT~JYzyDt5T%H+6C?WTAZevB#NTD_@o}as z!lrS8)qUA6tv=Jx5RvQy|M_lIkTl4kSj4j3z;Fn{@;mPe-qMkRT@Os{sIIj@M}f--<-AeLc}qNNXZ>(&es`LgzC{E$d$`fF z#U2Y9$pV9xi$a>~iQ%ocnA9D%!j|^uMY$up{d}snG^UL{fv>*SF!U=8qUm+uT({Mx z&BA-yO(OaeRt}KzOfoL`6$<6|g8Txw4BoPjJ^KMZ*>4bOC%kZ=V|=sDK{H@ zS1UE@O#go4kM5n*JM!4ag!k0h+I6a`T zz;QZex;oPZTPu7w{N_f#(UJI2Nxa!^%eFLEXB9CnA|9t)t$AXm+OYr79kBCr5yP)Z zj3N_{l(Qc(3Zj>D9*y*v1Ij}DI%)o=hh@jTR0rz#@SVK%^^>2giNu2u3+7JGXd_pdfSZr<+j z^lY;EtoL2Mw^r60ryTL7c2C~)_{N*}y8k)PAF%#@==!~+ttu7IdH&;zv6R*i_bvgK ztE(q3Qt^9>bw+Y*5=nk=dA0wbA{IOdy0t7 z=*h#GhF|(YGQ!Loc9$)%UzJ6#m8#E5yLz7`bD{S0mmWh`vQ1p44RK$`uXiF zEN-w+ol2H(1;#n`thC)UWPdywSmN>!^#ZMzl4E3KA;>bXdgH z)8@J+yS-F9VYTfhlX{aNkJr`@;;*D6{QT1sN8GU(d_>nT{NFIU_7hoi$G5>EWPihq zfWYMwHZk^x+Zu0AsnwU}*}5S(mL4UIA~5a$Gyr+Tg6}KCzN$&UCUA+**G$0u@_K$w zSg4}nNS^pcp6oM4Y#fmaeQ#MpL$7a!9K=&AV`V#FP+Z5s9GHGwA6+oLlab;*jy#}i zn#>9qgFY@<8!cuv7}E-%&BR3p4K6(ssj(VLmiCA=hCsdSJIZ@zeBNi5bi!O4<}h z_y(wCihU?&5K;lC77#7l1%}*zzGI`sbA9{LsBQU#2K0s|cThPadJedw{NGJT$Y;-( zpJ|rKU_ZtqP?B+8@VU*++K!_EKN}?Sl^hCRw_+u~{##mNx+6ZKFeaqQS1tN=P(jvd zO?c-2$#jsD9gI6$y#$@+5oY9+v_4;1@WN}laUV+=^LGwKJDLX*gIXEvPP#U4L*5tn zdB;lAi}r(t@)sVr9ST^tyFCn@M2s=W{c_Z+Dx9=HdLI8e7INEo_8)bsKd9bKwx@B- zHYxkDBC#3W>#w?qQ2L1BNEG|7dm}|FNE#-dnVj&6Mds z)YO-CR9TsqK{HD~;(^XrPCp^>JVLBJv9jNkfz=o5oEHz+j!{;`y{~~YTE{DhMZ-J; zP|7~MfxN7+d=88odlCw*T8#&gXP-=uoP556g|Kr`L5M!qhhar7WuvS~-#Z;x%>2+7xEj`zQ&bP-bOx?eHC$j9<&>m5Hyhp=l z)56REi;$h{Lvx=A$L6InT2#*Y?`{u)jBJ#5tva7OTrh1F4o#xg#s6s`GiN)537 zgcA5$5W0U~p!>EL}n4;MfEj{#-_^U%h9fJ2!AsAi z;p_|Rg&)1?wRSO_!Xoata{77H@M}-m?!JFqt;_49(s3Y?I;p7b!c3Ou9VpH@Ok4r( zFAc~+*}+DAO#=ELOhoLRkYRz|;_8NRis06BVt7+bs6u;&;D@1BlQ;5@r&qA!!3|Ac zjhU=(s2}?n+b~X^VriK`6m?W#NI9oS7*_@Q_=X(OMM1%0$IpHDZd^X^=v2ZVu2*~z zJj&-cBiW6Dc%OofL{g!{W>nZ`ZW;-Q$mmh1JY7rN5{7Uvr4nRk7T9|O(q zR~NNd>l>_v;Z%oe{@Mp)8;o2yRjOAzVaouMGmZTeSD%lqwmrU4O6I-=?z%x7VmXal zH{Z#}PwHbC!cfaa%ZIpRvADvjB70|RX)FCtx)pUF0jCHa6fv=@U0d`Y}a=t%-!POAn)UdcueV{ouoEmt!!hqc! zw%#_1EM)ELhgj6XeEcxl&JW;MG^QWR0*_OO^yy@WPO^24Sr)skFf>_7tYh>?w#zY7 zYuTBw25=6Bv)2I#$67B+N96Sf{1@5@z<$JZ&Dzg-DGBS*O@24qT_RXky8fyBLk(#7 zRmb(K5&Pg;SMwV64((m+%lySEnC;i{me^mF!@7?UonNl}spJ3MRW}Q?ar7U0V_VrI@N^xJdpmS`RvceEQWm*u3LJpp zOWmu|azH0Mapgeo#SQDSK5+{X|!l$`;$18wY&Y6tTS=NB9%mPv?K z6X#xm!O4zx?~P7RPQ>uDvfepHIo|UKDUH+V`aLvKhY)7a`z`azZDqw70N7dvBUtC9 z)kXGI)b{dSb~kuJw#Z>89rpbR z@moHbAAUNqNKbS?c{@V*oxvLpRx7T9^O z(2TJhpHb7X@@j27hjw`_nALDvefh`mxyVnr2yBK()&?xJcVMjkf@q#Snb#0lZMJQ* zP&DlSVk4OIhs4`u;vuz!x@o@6*k&!dR7J2s@N9gQl~yf9TN{Jl#bKKmoYTih#$vA4 zQim#_75C1>dKW~jiDVB(OYNbTI96qW3@$d#%nFd z4Z}Q0P00wPSW7PRIFp}eQuQxDwNM?M-d6ZeR<(7G&ld|XT?u1#cYc6USz)G><$%x-!d>S@f^IDrqUf0~m&M^l%h zJANKi<+fey15e}!|32|lk$y}FcWenT8>({<;o9Frb3yT9LPn86XSqw1?#iBm4sZ+6 zF5;g{B6#(GpR6R`9m_<0!eN{=@3i{IGvYWMJeRaOOnY0=w_p$DO|0I?cr%aXXv%NdnY zeNMi3!?0$VtJ`JRm6qKx&^&I~g9}PZ)yo3>sLR&`RjoEWQq(I>D2uV;GWp~f5Vg9_ z78UYzrv~icC$|}l1qYp63_b@~9zgyujITgFwI+pclRa7R-H@r0ZwYWni>=m^z(cn# z_XAGbaf7>Vm|0f@_P6+8-Dmr7fW8MBYM61|4u0wX99(~*) z+x8&7GO@P7*5Hq|p&iD+BNJn(c^RxiM6|(wPM6rl=4Rqw8B3n4uOY;NFwlwem98vS zfM&ROEAwrEZ$A9t&xmdE7uWw_44%d3*$VAH`p@|Ax^>Y(fW$YDDitWwTfZ$;%Z8a< z3bBi?eRr!adizZ+VfTCH)In&hEp-xLEIUkfdyYygUz-_ma9sO&M7|I&U)*sZA6K*BgQSfB?j+#_#$t34^pOsmMz~{mk%9Fk4~xZ8<{fqz#1^R z6LyC34|*VFCu(;=kz&+(-kBIxK>{l>nNCG0&H#G`nsLE*6*AwLtx;UD2TMNpxKU8A z)76{nWj3*s@%gEaEBZo#B7VjpA)s8@UnX0aSK;r|;^8|O9z?XsEOH-h1gikPHP%Yo{kw85}6L$u@2>!p2la&9$==}?A#Jnw&P zLY`$W_v=eEgUt;ad1(;pnaQ{xnXG)o`s`A5ZQz36CROR9e0~AT7Nw%PmESZ~T$n55 zC`zfD#RKYbpzw)=0IEdK!7_V|Pg5>A&v4eZjQ&#*>e&L$J^x3<@Oqx#Ue>_=vWke{ zYSRx?M$AGKrpmxqMJcf`Nnb*yoQ<_k;(V2lx|IeVvp&r1aNiA7v>-||I+et zNE~r4D&{jR&|hOX0Oph@M=iMhOh@ZZRp3zRqyp(xRH34R;V0dOmFUAzH>CQrngLU& zn6?o+zDI^joFL-P;l;(-$)JfsMk+vEF}W|A{byVZXNIiW;>q)vN!BuUIK^OLK0}r5 zggW4XXOo=hWOBB+`-UU+9$@7AS&zjiX1oN9CPFfw{&7|JKM-d-CcKpP2K{Jg~A?To39?FXy{Ar^eFR8j(cI$wRZ zBmd{$Ea`20&}!S^ZLuV%Ou)2D&2w2}beAyqCx|6kX-@nM&%6+rZ0K0dI0&s;7C^j) zDcq(SdAp&C9so8b=}Pazy*EHwxb9N2>bJxFK>l)N9rYiNwKJ}MZB1A=N^`uE1LljT zk2;2=>tj$q^mSd~cX9Q99Y6^DAo^-%u%YqB3Ux&Km7P|?wSk{& zF_CXlheiTyrB1vyC_>^S8e4pfquqDXynd28nXh$!qwHvbsl)*=nix?STTDvoj^)UQ zwhSNAABp}lVNihW8!HNQUrkb9+2qPc2ONO#k;=se_eaY1%oV>%WAtJnk|>{@Ai@jm zuCH3&z(;2-Aw}(gXg!wB167&V3&o-UQgWZiTX=#mFc9E)wMpgAWq?co~p>56BLvSh*FvG`U!|wH~UgB{H{XRHq=Zw+fALAE!%~KcEnuj z+SldeVTyP*LPBC|=fd_#V(z%l=&K_>;)!AtP2tb^fPY-O;y+eH8Pa`}R4Jw8C>C{) z3U;JkO)YU6^h#iF6-{W^Dtg>1_J8Tt=|XaP!&W67hDp0F&KDe7b}`*Lqwyea_Upb^ z6IZRjAANiCasg$>K-MWIa+zCnYTKKNJwN{Zjnenw!C7FI9udw-LSxU!ymDJ84Vp=B z`VI;sE)6D5l{U7K0yU$akAqe;{!IJ`xhhWB70ce7_(lB#h8vuh)O&l}05UeGy;`e# z9&%;sr0!Qh9PMlfFnVP`ODz<~p7$HI!8$Wv;>mXQbDsDmU#HMK>rhzm*Ed&?^E%wi zWgYJ!rd?HQQ}3hVfqJbtyzGRS^$ANXgQ!FRt1@CWAV(uH&Qr6^C@wGV7=`iM7 z_eNM5IAJBWywRb_ckSh)xJ_UEq}!7c2-x9CWMH%9l#x))MHw6uG^y7c85Zm&HC9a! zr}9gMDMV`dQ-^XduCBEwap|%{b^D~&bP^(#(QEalx~cJSN?riDr<<}r!WAB}k|W6S z@BQ&3%BU-2sUu@VvFQ|x>RML)4V*hv;)U&M&Yb`#Prdya<*MqaBzXvc;x^-s;By6I z0+4Mc^;}o){=NExtT#6WCcPb7+fxmPDfX%UB;G0be1unze}lb##d^AnNE&k_O*aAz z70-RkGv-s)%PXD`W1h~Pl^RwMBb?7-x-~{S^jCx~)&!okYx!}5aq)&GDIbTVM*fIZ zKpdyh&m{TvvI$UI1Cd6yI2|ya|6t@@@-H{$PBhSZG4yxYYbdH7-8nH`{#Tg@53yKE zNQJMX>AyxvOvg&?RK<0_iSEU_7)D|JNR%#{zy92Ooa_jjzzRk0w^5s|RO}*OmJes; z%fSQfgx#aD)D!7!3v+YXO2Ci(S-R;MT^NSDXGLb>5$huvN`PZ$p*c827^r{{M#hE! zpC=RRXZWfyB5Hlro*BopQFBkS$X1QZfiOb#`>mqjvWqK-=#s8awl)-}xD|xxYzeBO znunctxEX_@iNgMvcgP^|gkJh`pFSTBgbA1X1+vzdU!hl!a|fcxh`s8q)w~h|1WZ_` zp64R$?%?$;5ANsCvg~KNT?~fGnp?uKd|xtk6ZK1w@E$9`3yru>)mt8L{1is6PtZGO z!KFlTuADJ*D#Cj3&A!wsw%gjf4mrd{*wkU8RGJMQO2PMzS!8TDMyk zlnUBIx2md>G$=-V9MfRQF+9sjT0-+?LiE`lH)yeAzq*phBDNg6nMEbijXNR4>!b_z z#Y!u%ies%>;t=2*H$hAtRGko9`2QFXAoq(!+YNp8Y!6%`!mZ(b7zTedME;^&1}7v_ z-n|nzdTGSw8`7`huYLYx^~z{ehS3hazFM%sEjQypt&0!td-O`+U*)mGaer5zqFgrT=x1^p8C_JbWE&I|SX1?nHz$@^pQ7QrajJnP2;*!y<-6Y*wbwC09 zW1AhMxcF73r4xNIM`=_U(>L7Ca-1bU42v{xtZQ^1$v!Mc2q_5fiu~!>np)5bQMeCU z8q(W*^YX;CtNyXh(tX#j$WD@dekT6xJ7>3amzK@yb(qrXe=5F4K`7^H_;NQs8>N|> zx+rdE*lVn12LEH$wsW@gXmbQn#wqoYG<2wjzQ?RJn-;(d)x%NQuv?iXnBL-W%m()b zlwb#an$2@{$3qZDXLnn`G3}!tDC^dmn~7I1*Xgw9McyaZI=1G505-J0eE7>SZPB;_h)hb_LMYD&FTdaC8sTEr=gJTkVZ{ z&TzB{Wf9%b#VpyZA{;Mc-opH=VC+mG)tB)cJgR>ESdLs68fpG%d1oU~{f7-S%_A4) z8wZ;lHP-|YQq3U~TJk3WR!makZ8wPzW@rm;os*tKiimwF{`=q6rO)5(J|?xa=UN?l zvFFjNV|#8LKt{~;2W8TY5QTD z))Ws}twjKN;CRE>os-+LD9)INkJjQ+lFhpUwzE5~VW&poc@UUpR#TfPgMFHwpRJCR zdF5yx*o{;#P5hkLg9%~|IpZ+2m-PyE7=>$$$K4(YSRTjiS4S}GyD9bH8I>RqyCxsK zSD|g`Vb|rBpBDy;7~#B57(s)U!I(RjNBUla$q3>50HH3R%5!#iu248M`ExQhiDWS1 zty|<%ZBhG-qSR8$A!tpo{V6iWv+!eZFx@UB*F!G*s}9oz#_x?&uBMdg4X8`*>|}32 z_Le|S_PWHHARZx1$I}|f^(o$zC|FJ!C`o(>qPqsaoH`BWy*69lGL!si-DC%?!jfz7 zGXFh|*i`5@;NIxcSog5>n&1F7L|W@}%OQwfWO3J3iZR!RrUn>o!90wnAZb)&XnC}=WwSORdTe_Gp#V!uDj-~A!EO1Cs6*&|` zyvGuPy-&y4C70a5G2nViwbQYc}DHcOHG}&r$5q5Bd_LiqFpz#gJc}U=GzJpBPW9 zpwxPpv`ZR?>;ZS`X-`&#|@5d(DfYaI3yM(h4r=3oh6wXO3aj6k+s za7XNQM?@TBAAh#|!F`G?YN2s6Z)yo538*q3l~Yt2@dbJqg1^vH zWn!b0e6GIgxAu0J4N);YWT(JQGMZ6MeJ`gPfHnIZ);uzMzYq~~jWs!-5$UPZW zj&0Qp`m=cjPBT&BmwSGmT1xatsT=VfFzbnL6jqs5Ze8ov(%qPIPwDijBBFexq2h80 zje;|kJO?-pHPu8bTR4S@9B z_B9+l={))&v7+&}yfqz|VkaZMS-hMMSbp7BCmgQ3==!`*)aN6Ak!MZmwJ~FatMlbF zcjzfIdI6~!{qF|+(g>nfHn13LC;W!5ZV;H9>o9EbQjVs)r*Fq;x?`MmvaHB8!w^+A zG*QBF+n^1FtqpztGHX3SBLk0lef>th(q0Cb>pGeDZKq7nQQCF6X%sY*h6qB|DQnVYo9So()?&k(H zwwP;v9iFQic$XE1ev_ux?*{ZSG5;8rHYvZ{;^PQscbWN(^UZNcRN4D1J+OjNNVayS zw$RqfKgG*u&1c|#4(Z5{nIl)9&z=U1LzWOPm9?@$e8x0&NO{=2Kd)MP2bF1!CEi!X zB^u)ten%_P-mg#J#3F8@PnA#RQDBKI%Q;f1fKbdjQ8QdmJ;qq;=mvV68y+nQa{AX~ z<@qja4Cm8D?v^d{an@)Xvf(3i?eu>kD{ z0$E5pWp2~_kQT(8UYwPa=rS?84YA~Vd5fzZN7pkjT@{P8(Tu3Ql_4o1Ti(Q>$+EVi zn!=Qc^%+qXJ=jNcezl0M^IUe#^D9a`6ndGveaIzM&1RzAY5obp4l$bGBVpubf^wJL zQKF*p04rDd<8jg> ze5do}=|X}wj=<$^5Ez6APz6rGDB)BFF&Pgiv+Dn%!^I$hKeJHC!PQ|Tl}=xP{N zQz;voVVG@4DwpL_ippgJX5+WtKe4?(&)4($c$5{N zc|&fi_m4dvT^3jh?`MUb*NYmeRmVlE-ZIneo>$p%Wv3qq--HT!e*5!qYN?q)`W z(vD#Z)SLx!vA4t8%MB6lw{#$Ol8h|#E$->LmE=%g?ZS@&0J3gfwMk9~# zP573LgC4d_aqKbi(tmQNg+V8X2?SQ%d=4itQl;_mljw84S4J#*yL|yoiS`DCde6Z{ z)6qFCx%f_h?8LjaKMA2Os?d;VG^f^RXuHB>xzmhk=Bd8ATw(lt1UVO!Lu_gpm4!VR z(Nkxd@=ACS;y2=O8C2J{R8>c}y78u_A3+Z?Y7vK*W;zGZC(kae3q=u@N0bHFqvN9@ z{VJntBCx5|DB-SI7zWt!F+l%n(r_oqSE){$wRUutujIdMnk@k&u%ZR^yVIQT_ez^D zOGdY~2_{chvQAQJVHSuddhSs7Krk9(y_|TvxOID8&Wq9G_E z)j`I^UPgtro(6-MLs~?fS_vFg(J&DjOGWoWIg@RZ#QR92CnX;m!KY^Q$LH1Yc@@LnZVTI}ATR^nN3~R`{Tqym_^g5A{i= zF?t=P#dxBC$Gy0Xt~a&AVYH9?tDA}|Wu>>EBtI_+@YAvbud88Hlzu%yTEnRLc z<%A7X{kZ-EjhPWfZVip@%u!`I4V6eMYh2hieLJq}@)qrrxy+u~Tyb+)xMNyc22Vf;d;a8S#4o-Owy5m#w zLg$RY(ef1)OPef=S#<8sX4j2K#?>n1ot7bChxa~Avf_%Yob2o9F53JQTvkZJBA!`o zoR_~0?epRH#)M4Q7u=2qlL=9Z;2&PC^8IG@?v|VlB`MZ1SOkB>KC0eI7301OEaJrR zK>~ODmS)Z2#ec=4)*WV3qu$N6ZV{^Mg+KlW!OY0dZWIX*?ax^p;60srN=^utD~`qM z4llFHEm#YQ%G!@&=$5D)9k5w?kGGiVJ~X1)sbg=d-rPueY+x2qrh8e~FOBEoG!q1C z@!y62@hu-3Z!h|_k8#1)YUeP}3hVEuH% z=wswMhONwz&$cW>#x%U5Sz)@P`7i(VF6SjuW{b$LS+Dlq9I=|v=(e7shNUvoq5l2* z(Ug4k!liEPrXwCOIHCfRG%wqKx{o}y&I0W)C;d54YlssN6NijmQui_09K)pNxd60` z5A(o(YvvYTCfR0C+GgARmM7cK$%0#1pa*JJWAZ_EMj{EnyW|$sBS*O}kJ;B53mjktI&kI_%hX z(78Fq)~wKx;GG7K8>DQjzamQduIK+{QQ&D)GUYxH_h|YTCeR`lWK~0j8WR$m(O;Sx z7hcJWYd>7|0|RIOZnl86(BGMaexlVY15s~=sP1F$%?ksi0d`SIwL6HYYka~#?V;BE z1Z+o|p+#7dtgEo8ymrWS-_;g*vu&#BXS00ExnPGfZ3Y4IhOSfI9ZQG~&opE^@bY}6 z4u1YRHjlt2W&(zeD&^ooBE)>@p>dAeRng*l)85k|^E}rwAA_0!Hf}@xRp$C(M4*;2 zps^a0l6{+1A!EW@`K9xX|N8d3y|od=EXUQ{D(-{1->OPNv#{6Kaai}}yp?-WJNYaW zASt3LrcU0Hu6)pe2oI@(%kd*FZFA4b7IX(NqA{ig)pJ74ql(+GN5An#TpxyE8BaW5 zaEybldnr}9P^MpW$*YAm65ebB7V#r1_m`2*HpyIr60A;~tU-75K6f7b z8(+b>e!x71wr=7tP}us8E*j^tVd=tuR>a;sBSOF&d~+%M#h&6&buYy(>e%5ZO7#?) z-aTH4)!^~Rm#>ysh%n+0gT;x3gwXoNug=7j>KMs8yB!8vcsC_DvggT`4}+T7y@sug z^z1;QcNbP@kHF+WZkpPo@>N@_`SBX5RGtE`O?mzj$H1YeV-8L6eJ1%mtBdQ;?Mfu%vM2t`sYo`~yXAjoh{P^jeduKP!R&VJ4_e(rEFf({3Y99aWMb#aTn#IkqHmrhS2xz98n3 zvE0ox@dCT3#l?wdtrnZ{Wq*6L{5R5es+l-5(Cs(27a|?sC_m?6Ekr&JFjp@eqnFzP z5r5@Wa4uOvNt_uXjGhv8h}NMG?m*IwhLlxKrh58qdC)p z|9xjdCv>;2bG|`_DeVtdmV_gRxk3@366C=p6&-*tkgcnxpn8pw6Qo0nLk@b=&vmde zQwx#fQ)9cU2XMB}iCu@IQ&czGu(E@66K2U+K`zv;%Og(LSnXuNwMKSpkZO+AAS780 zU39yNN5T9WBI;^ySksn@hy;3`d0Fj|jYl^2r=XwY3FJa$E)j7#HDXZ5rfECO>#nu=hp#4FM>Pb^9d`l zrZT3l3uGQkB-o6?pRWUc{{z=EAaToR3H%~TCt%gW5ew8Nmoy1bViKGh*|Xa+)U;D5WBJ75_D{Zl zcV7O7`45BWuj?%#=sY#ZHOs?B-I)C6_t)uXiu{swXp!^qGW%vy1G8hLJJSMM9HxL8 z)+Vm12k9$1Qd}1|5}PNxJJsx1vJR$=9J4!n&~DQfBFSn78S^f(1!Vp54!~&N!<0W|Si3B=vl) z_~De#7s{TUs4SUZfBjiz#KK&M>0*6@ z$R4HN=P)q$+}0~qNiPbk0&E!XtU+2cR2VNLXs@(r70tn{-pPIrH+ zfM*+b@@sP$x_GO0kh;XTUhNH~9+(xCwAp^=$49F{km3VK;c@I_s!y2a$F!xH0}GsT z(B=q@zi;YegR;q~qi;C`?)3cyN8xCz#ALhM80R zRrUddabp{GrqnQMS4iVNWYb4Zo6!>~MlmbH;4M?TK-eWZ&~@GHO`coPY@q2mO{+liWNGN$5w*7LVXtvVRuV4BkdgZT$VMDKU*~?D~m_$2HV~(Z`B4<%KuYlwg)3!rWgQU7hy;3Uo~&5JxzNJB{y)r3UbaM0>i?Rk; zXV0xEP|o_w-JbPrF?%Cg97rqxF>*bhi}Z3Ku!nxK%mBFfnFpaAEs4*qMl}^+XzyO# zULGYWC{LUncx&#zLOYpYwZyNiDnnSC{YmTJ%Wcz!?aDP;%)mTf#SEA7Pv`^Dnhe^O^TAnW*~wnVL?>*Qvh^mcF7^)<7aQ zXB~BQ0I|bx@(Sn2#-F_+>Jx`PlN%qUToy!Cc($rr9EZo*kRLXq>`W}IFIdLt$aU6q zj%1O!slG=_;nJH${tcY%GU09??IIQa&NB)IpD~0ft_i48-Ar#djI#2_;NP}Q1}+BE zoEBdDRQqaTH<&+%>aND#)d8(-t*v==(;X(LB=L_q$^VkDy};FLVmR7ILIscWIU5|DywIKTPAaivbR&;Xbb zCqdXfN}snnqHA!(2{)E|ubKr8d9VEFR@N{-%h=6_ct|DOdHTnE--*N%bQNPZ#7)@F zsr2vvt*M?AQ$+gE?X3}$cm z3;NC~a&@xYRWk1taYboa1?T@uZBokz$fvVwgTQA5!2ID`ydX4Sw&=hx<3rfUa>eqd zW)qnwnZkC`@5cJ0Bk>73ck2ZMXfT8A?}B>!Hz zm_Zq;ye0jm#i>U&QJUQqB0q|=1^LS@F-8D_;*gp8)V8c534dLbz5fEqLg$aeA&;!4 z{MgS3uqjVM#!Uo+lM?CjVX%q6lr&Ex)H%J2@|cW*EJqInCp2ti>?GPFGKtQ#iXG#Y zSlZX|edo9=Pm`Ix!Y$^ee5(K%9B<|4kRs1fnk#cG+a%OsnMkv=B9x_ZzEp69bq&Yq ztpk+N(s=VtVC$0ELtfT|5*Tc5#N*R_ecNbq8P^*-kq2f5A@7=FLbfuF3XH;$^*yiudXhA~Q>VNK`ZC0dPjNfl0*&9m~6YCwyn?s5?a2<3{WJO!g z=K*O>C4V=aT)tqwI6oq`J?0T&0Y4#XJqDp3XrPI&BGpou^4P!f;2Qa7kZoWg!Rh#z z-6xPlZ$f;xG*dGrGn-ie6?6DQiCOoU@-e2qvamu28v|yR1riSCxEfug;5MkYBzz{H zXl2w*#|0g~U{Ya(tUBdf4OD=gf-mKz$sRdnQX4lKz=;JTXHLv;SgZjRuq z@5KfCpqK}$#OtF%2pw9VIQ}#_P{G?U%8S#zzwvCmMV9f58a~X-%vI^fswk`dbT#>%nv9d2qz-VnX8Q(R_|m_j!HH>6zM8NieW*yKMS6&=CNw zdfIImqnp(Xyr*%fuV3jn`Wfv4IrjdWF^P2s)1PtnfiOrGG{)Slg_*6~gLnYyP7@^o zkpZLn}c0cgY1R^f07eomtl1eZl2R|-FkJn z?lcMmMz5t`6PX$dlb9tP~oez|n4j2-idWWdz!$k}h^09@z z_e>1{ccEC_yVk~D6mbl$8|t&*gV?13!pdSq&ck0mZY$VzrsLc~IsU_d&WP5 zrg6@BiHj<|dw+HYUHzxL9{cwO8voE-{mm7M-FKPevO1uMTd;An%T->kb9MhcPWpkkI8 z(Op=RmAj`9(lnN``SDAqul7~U(&|@fVA!^qpuy--#(8W@#MJBiy~VaAOG}SHcgU?$ z>7a9Gnf;9hO1>h;04iCkIy5b<8$~{gd+iB4iLr&lvn!aLPj(^EuMPa0Rhh7d7C(%C zo~VzEsM1;i-vGw4i&o_F=wh9*ek01-g1-r*T&QUhtxs3Sk9N#);qKsd&YT$27G~V= zLHNH+xT2Lb){D7dN)i>xLMn5pv47fZ9MW`Cx$BD9HvNXM`RRUVJ%wg^>?zQl*#R_m z+7}j{uv~d~npAtp9WDKlp*QrS$>Ur_>C%^YStg{lG#qtP*&}{tbepgEo5c(2J;m$D zd`bT}sIKYsxCBOwFT84iEG=24WI87;T@8Ue$VM0Huua@ATTqxG?fuX}ask+1=I@qG z-5dyhEUixp;nzxe2a@vkYB|d)owpg)mAh-u*MA$29UDMjP(t(cZ}N4b~90 z@S8G68CvDR`5xR3FrvzvJflhuO~f7_J);W}F$5HkUN4GyujBIbcHVpIXwKHlh1b~2Bhq2?;M8@`)GU9dmK(NrpqIFygug&ri2~r zH;1>Q#bz6_jX$Ir;8u!p5iXEv;rI~)ZeL?U{J&w+TLTR6R?@9??ywisQK#rn4pl^8 z^?n`MT1b2JK4%iGJxOX}aNMM`9*iA0m&wi3DF2}yg7=Bc{UwQuJyc_NK?x}?f4b(I zq_x_v5Er#F%udcBkyleT%HXnY2lNH^;k7_#{wH!owT{x_ncP`u;*VMQbum)bW_=Y< zAh#aVrs+dzu6M9B#9d(htLC4^JJGL zq9}6rqwX?{*I#262|BPTreAJSA4rgLx2c6LNFJbn) znDwzWInrAuJS@CF$^ZKDp1=uhUnLQcS==iRo54=OLB&W#OIc~|2&#&3+uo2F>U&xQ$6@e@Yqq&MTU zZ`uSb$sX3wCXzD1F##PTa=e z(`}~z{F2=0{?t67u<%M=gu(PoIcSIU=k>E*cz^JTp(E8NDP@rVP2c`&I)5@h`puQa z&z(0&dlqZ0{58VuKZwDBX|wFq%K+Pj>pFhv2ANYg67o;SmdeJV%vUapCv`x;7LT~@ zhc-niv*}Y0lyChz`miG~y*A^*M)^EB{s=(Eo;vw6OfjSrYR&Gl6||d zFd&p;K++1kpRPV1G1!RtSN7wLMMtjdL!_XAa|zXd{j&MI4<&<8J;wclH^17Q(-!jO zz$6&lwxH9>M8z9f_^n;Y&uxC#lfS6>(Nl#CwVvqkr)#Tplr;dbSSTISt5cjGah^Sv zY47(R{Zo3udRjn7?L?kgPH!)J*CJtkjsIGUZ0aIR2UPX1Hvu6MfF~oM(&!XtSPZUf zDghR{jmkc=T>L3L&Y?KGAD@YlPNAH?prY~{Wn)SEr2V4eM{|6T2W7sN67ek1hXbfL zLH}u7IkhFh`msfzaf{t(P(!aSp#4IRXL_p_x=zg89PT>L`;zJlJ#(-#zy>}S z>e2DP&LE7Ds_Qavxl;Bv#{Fkc?jG5A)msJYLZx&u-3)j;lNh)-tp499AW2P5?4b_w zSRIMX&EqJHCx+zaX>aF0dDt=uwz-7;`S+^Oikx6*m>WU2uQy!4ATjAvy)>g>OKIdh zbM{{2J}nG4Wd{7VoVBjhNzBdfB{QZ#wHO;hWIva!e9QK~qCCoun0OBX;#EMC%)}yt z;hO{KkLrCqa5+}#<1&1_dAc;X9+2$fp43%vhYdw;45)b9aOd-?Td;8?*#Vb zu!TnfQj*-t7{J~H-NtvLt2`bJL4a=?ByQ7)aia>LgdGhl_~qxaA+m;_r8in8(@3r#{^W?r_DN z!}B~ez3af%el9FKbW;SRBm*mp-6~A8uW^_xb#=)bWe2wuL-WJYkE|;_qTED~k)U&F zr_L(Mn3sZ~QQDjHp&pg}{U3&b+i72SD5ko@=FmA`gC-n5P;H;$ivlg-qBQk(;Fpo$ zRyg3xwi@q~wp|iC1Y?xuxK;bt=G+CcosFd zX!<(5b%lC&-nCAbd7`mXz5bE_i4ltZ56ax#p?r@KYO6o;_B^WcG=rN08%dvEbNAo%e=KQcOd(i1JYvGc2O zetnCZNsZLlc$~S{RTqTz3dOg2ovK(p=8iOR1oh|gVULRkfGrC54)niaL#97(O#lpJ zr?{i!=?vYJL@!cRHYWHTvDo%TGT}Y8dAU+7+eSH@9)-9mm6>&bLKuP3r$SgnyLMuN z(jwQ$Ki-$Tv={u6K;T~?9@5kYkQUacwlRXiXUpY1F!_Fye)DU9s#yE_0tmxXCd>rV=r+J>Z~PhdT;(zy(8;?7=`ZJ1V*Zlf5Yrerqqolez2gcsuZcZbv6R_ zSsnOvj2boQbz$51LX+dteRdWAOcm8`GmD)7LzcLDK)ZOyCQppttSdyI{v+Y-^ zCraq=Z?!o@FTCqj_ug5ajKM9BG~iTTbYyY1>|g({ywq&n+IF~aP|(1nutu9z(7q~b zAi*`W+1lfAKB5Uzv??SLXxf;dU!T@(+WKqbF9)YS#*Q~Rg$9S|yT2G7V8DR35uy9* zgfM_2t~H}=>TCBU zKV1U3{tlwo%|hm9rrwzkcMv5y!t!)>x1Qr3M^LLtn$hgUx4{69yqCJZ=kK&rn%=vK z-g2sdEo@jlSZRT&?xoef@L%j17hcb7Fn(i8i2H?rskX%I(0%hk`WLl)f6=4iwrRaV z+GEwOG&%ozxJ3e!v?HX?ymm190b=614k>KKI%_fc+8;#MR%EBg1=Q@ubJcm5<~N}o zN~{r|eRFIIZ6cza@$|N638Mv#FU%>H437_nK)LB_QwmK6dm5VV?b&HsF0ERZ)9XX^ z{qjKrItj8evTlJs@QHG@>LK6FCSkeLUy_y&(&3yUMY+TI0kbs4EKfIQTFFXV?agI7 zOS#VJ(;T0A6BKt&_(-wNzosd*_P^XTUjY>f>G{-o`auIBw=?BdS%|0YU%7-5qb!3e zn>`ht5!_(g=`q~|r}VrW&rEhfcj9$+`xDlru9wk?(rd;uJDIJJ=i4zz77=si=i`eg zT}BJYneONXMf{RwH@@!n_$#_H4fWC}9sMZ`#t;;`defJLGzslL!qWqq0Ojo4d+N<| z&t2Y6+emth`@{3s!@5<`S}S<5;3u5u)ZaSwU}hm>?w^V$pE3DgJz)p@8-dUTHs_YqWY!3UL{ITN67S@eKj>$a^0OL z{x)YKadS6ii1p`e{_>wB-s5l8r5TKCzH^Ouy2hblJL>n9l*{W-hY;lDklE$+w=5RA z9D%@-t)iB_$0^kZ=6SU4NPKR2j9*0GLB_xaiYiHEdaa_Z}>@4H(O=3febI0VQ>b35mDy4=;z^yea;htk3aX|CjQw|D+e{Zh6GesSP^u#WkSIvW+(eN ztmik*vacvb{@b@8Ve#dL$Tx>H&y6iRMw)s-0y4VJ^%e80>XD^u)DcVC$%xpfrTx(T zin67iTF3MX_u!VqNABU?)CWZQ($`zkR3m@jbF}5Y0{&6s))(_3zhIN`+1Ka)jgs{+ zs5iHDd}L+?3afiSRL6iA=+;F%HN>RWe$?sR31xxZ+Zg?Yw+@5p?4}0|+BkFmpM^2+ z(}``Yh>>Pn+Z%;`f_Et@Ysun-_t10nN!jAR(KT2%W$E9j5?69W{%YxG6R%=C2+41> z1v20{wCC6I$&C#LBdgXFsq|_qg5-8}g2W4yBql9_8$kZa!ne#b;?Y z@ zv4L&7ZCU<~4{@;lCjXr_L2d_M;PwpQ?S`8grH^!VZs;GqJTf#Yx(l%rxjhEqXu!XO z>Z9RDIGsKVwaKWIRATUCYX16sSNHuoOt zDujo;@WU`~fU_rha7SM2?4Ej$+|L+ozV?)oq{sZ*Qe_j0%j?_lWxsoIoN`TM=#GVa zh_3q0KLk93`eoOt8gIQ{iS6f$d)D}c*Qa`%(OcC05B)v#bik3&XYGYS{t7rOt$`WJ zC>nUh%e0B9$qgeG32)}v`M%OmzbT{t`jGAT+4AU^#u0a@gq5bC7~fj1qC#5esz17V zKd`xbu}yiJ4WhZ(LW7)?w?%t*gS5K-3X=an>FuR8mpu9g8UlP(ma6vzixugsLf_?V zBy+2oG^Uaoxx?eAAIZh-#M!C3WX&Eu83|Saur1IdM6&cODRmxGKj4&ae|LEnH2hBCo*{-7~>rYXlU*hm2wLK~o|4GlXsswBs(dJZ7KbcDo z)g4~~hlhkwmFy}H2UqN)*u(q%`kk&Re{CrUb>MGO&wdY@{q3QnE4l?iaf~7S>uzES z&yX2eRKJphI5`f#CIUGmgQvuc4?2e2Jm8!OIJKJEPp9hk{Ixpe?Uxfi1dBTp3w;+I zRrljIl{`uO^7eUP#f{Rz$Tu-0)8VA)<>AaqQG(5YN1=jM{#KDE5E3tkZ z_k4W#?=Ei<@r2lCmn+qL>S;xqu3F@^JO%{ZPKUO-9FKwN=H;hwU-{8?(agyW-G-9v zamBEh>)MBYg-!wiPc%=pM0BP^I5lyHuN(G*Q!A9a*$TsQ^n7V2`DgU};K`N9t(rHt zwDRS5RS=d04W+M?Y6gvEotRfDMrSk3)nehB`*{y~3p-g`F~+6(yP?IKQJaKj;eg6o zWT9M@{{L$;!%z3CDf&y?^BU=RiFYzCA^ox^S9}6>mMcB%B&A4zbADW97;1k;SIQ4O zMzUSRPcT-xAIE6}bQU2~ZOY9X30(xNiBy5|-E)Z3RNNGrchQE9j9@>@xrLe)R!^SviI}9G+5h@oIR+m5j(q{K}gUe&rz;+>T5dEiA zpX=1!#QClOZfNa>^b{SK3epe$bL`n;kR$~-l&?7HQ{29?=UxWr!TSI><5&39Nlq>1 zFbq-K9T1|aSVQPQUhx>7c$Lqj(GPVnXa%aio9_a zLT7XTk*y!fj|J$<`)+vhGe8xz#g46uUoN+OCtEn}uot%2o5hbN)~VWg&!zu0apF!K zQ<~m185pQPt(Y6!$sK+TrUi$<4$!GSFZS+^knIa&dI~-aH!5`q0M>^&$vj4-+zJ7U+&FdVXx+zU+AM`LHZo)MPa zp6iqiRdmsE&Nz>okFl>RRcU`E%xHG*x=0|=7JuzUkqWaS0xxZ8i^W{Z8o*yKr8_f{<}mNkA|hpERHeIUtO zh}av9^mt9m6RVjDPn3nw=C7Ex*7nf>VMoI!2XvG(j6u=~i%!j1#rlBEQ}FjBnu=^y zxk|B5JX;1Kc_#%3rd`4FmysOJOkoAhffkq5wWlgt-RI7jm@87K<)H8Af=nv z`t+y!@M|;@QVw(1E;@`^QmPn~q#MMjs>Dquf;#6Y!S7?7Io)ySp5G6^Ees;O0`efG zzyOEXrOc^)Nwg>56NSHOei-*&Hj`9cxL>Q~PRMd3Xmr7+1qFOCI3oRJy@czuY|~@F z6YGV)>>p+*#@6*n7Bv7ZCKTdFWR?Dv~6 zOhZ7!lyAeH=L0K0i5^-ZbK}E{cTI1cJO9-=Z>M<6J2v3-BJ`Dx`~pMHVY zg+~t`PiCa`k8dxs508@WEbh~&S>*S9PF4EX^}f4}{Az+qi0ilv$EdRCPWaTtwF{~3 zTiC`6VSdvSHaX_?d`eYV@LE>hze$t@GQ?z2wXge0^}KG5p-l6Ug7iMo)Q_gY>#T9H zGglkctl-vRP($ziLNN+w3pv9em`z#9LIoGxdv6n?gxYA``5%g@)u2=t|VmqvD_S!Ym4fIy`0_VFoZ%sU?4i{oqQ2h(!FO zG4WGGqdI?D4<@+9avAgq;sEQ00I4O}{5A(yJydCH_kLW76*ElBQF|x2S4`JgP1mza zy_Kg4_zW7FkxVn>Vsbt+>s11x?KrvR9rG8_1)G3xTeTzrT2DoOolvh9;9` z&o;3a>Vh(SrgS~!^Kdh*Q5A=48EolpVX9setxHKnY+m}1x9Z3DW*@}kEjwV6TCoiJ zstb1~-~4TY)fA7W_zeVZ!(Z;z)B!lq7Z-bk^3i-R+?$vl^T!?-+x}M*C1ux%Inzqh z9pUw-Xu+-gC0(agId3+jB~qFEV@&81fJr=)-Yn{}a(M9)aHF0?8Iv!ap(Ft7riU#P zH-*`{X0>En9}``x@X2U4ESOZD`L$3-@#;gUHbgX z;9Z{53Ch<8-;n+y^XH<21^L(o)`dwXZI-eP{3e2p&+ z?zUKCn&>T)uFYwr8ar*S?hb$fSA`_3HWA+w644PXIM@ zNvA3rOCHh$8M}kmh2)vpSWn^&mN^)~+)!6(?d%2f#z#vZYGc|OC+1}DOV7_Fy&Gk@ zjHWmYV*9%bepbA?82zDfk3_Y0V%niWa})pY=Ts863A$Bv(9v9H=sM=m$>JH!eBNBj z_7DO}HP|c`;Puo9uoX{|_O8q6UbmPa0TET*L0fc=TgdqA=ujyXv!QuuRJEEVslq+- zkq3>C4h4=Z1q7#;k~`T51~Cfgt^CMQ@-y+wQh#X^E?GysPGCMmf#Ok5ybyP6b7DVk zVVj^Vf8j;0CC6rgx*M>{s(RPDK*oHj7%3lR&FL!744;1q;v4ZZvNd4@@5Moge22e6 zz0`u6s*I^}>v(CQ=)DFo7qR^4$$|q_!LZ;9DGPmKCtI(Xt}YLpCZHm6U{B3?(W$mN z%_lPE4?^Tee^}xo{y?AO=ujQ$5To2Wy16<*F5IDA9I8IFKa>&`(ifc2xg`9IQB^V! z3^z=TG&TN6!byWKYZlrqgLZ*FZLH)CWfl1%8D6=&wv0>{E+#6nO+X&+F_9LpT zy)tCeYWEj(XMV0#rT=oGg4eUb?q>?wCLk%UY`B2B)~erCcynwHF;I7fL<}!?dd}Y{&;6^(0B-DbBhG{ zlRtBOt}qNnGSsqf=S@%e5z``~=X=N&SjG{0$}Mlb%hF7X*g1n=Qlo&2tdAT1yAfs@ z`Sw1mu6+aJiynk=n$KdV&x5*1RIG#0fj$%B^n<^n!ouk0^1kEg?qHI(0PGx>S%r(= zPA}#R@Y4Bq5E7m&8}!lfX9jLsH&2m|@SA?Qc; zOE<`Vk3j)vrz(|ZAMr}?u_Q3G%x=A+F=S1ye7%7_^BE;xH8(8Rh&-Dv`84y#$pImv zmu=r-a=&IKP2|)DHdxf3M$Mmu$Gy8ARm~n1DpO8`|F;qB^?S7QqTj6eB{87Xky(O` zKgf774LmnTznl6}tK021N`HvjZp3KDbvC?sgPVA??61MlXs(+XRHs9yKmup;#e6Sgutpyo)D%R(h<;JXUjYl)EK?SwyFuB7`JlXay8Fig#81BiS7Q z*;YE6-#d%Rf=ANzM6yACY}>3`V^I6CPPi3BglTP z)nsn2-0Nd(`Ghlx&TMf2E6b5w?O01C^MrUOH*ttD?rbThPRnkU?8%4z5+dH9;SF}Q zRm@|aK$KfO#C_sGrS*?{{M?PPw}Ry@fT=f(hj9^~8KE{_s3H&Oz)ng= zh1-d4eZ89%W^bdHk^yrqsX1a`PyO=mD^r?_wJ9?#Cw>j3w%m?-+}5o~>AP9bn)q3;f@5xx33jXZmC+k=X~DTj5I zAIsIA4HHx2p2td14$|k{hs)N%zgN5WIYzX}c&M+lF(r~YZ)%M03Y9$X?4dv~&mr)I zGx)M4;V#SbV+sO!_GlRT)))hjpkn|t-s-Dt%qh+w=>7_mFI0J`p;yz%ET`c4FNWu!3>b87Li0L%G$@RnV%x?f2>Sf3HOJHs9#&N@+HRtWLy++aeT1%|8Meh}+ zzIz^d50&xOq9gq5&{S>HakBOyTGIn^)nV^Ba9on`5!^7aByqg+x^E9ZICVa4&pwD_ zLL>0wLP%fN6Z+J<&`}QGwkiN#L8Wn=EqN!-jS6?;B0iZ%cJJ^K+;O_tIiF-Z5O3s~ z+eu}8ZekhP<&0tym0OMS?RpQ7YEED-w5mdf_tb=PIbnYh$WsG4{5ND!pbl!g-9sQJm4ML%uoI~(p>xdzRcfOC2^W6m=_L(i`7 zxa7_%W2W%(@7lQ5459Qcc_G=eUAYm+vWw=VZqMS*t5I2*+t5H+VRk`ZIC$HH#I=|M z_sNY(o~v!wIi{-Hg2eECYyF)ayA~M`(qL75QovweYeDt5`zf78G~048m&3m@7?P2D zT%@w6tFL^GSj%`s=Ko>-2}i5x!O>>&=0@<>2qjBrklkJ%vp;j(b4jK0Gf7bwLQbyuactZExi2A|6S)dxwF$W;-jyWA2DSf=QvvyWgaD zE_(rx;ksUn&1vkU-`C6OOG`uDZ<}7w!(BRA*XC#Q73lEYCerP7r*m;h@+*sZfsPg) zxX2KF^YtWkM!GrXW{g8`3g4!5dgvPi#G9Qs3h3h>WX}pbj@r~jlxqRGiu<(2cc1^^ zGTvL*L>%%cF@#;6u=O{{a;{@*6t%`)%fFwdly^Dq$S?j)A?5}(|}1U6Vo-Q z)>Nzj8m=$>3*vSyUNq)BRDkw)*)#iL6{wRCe2xR<)igoEr!S;tPD^69Zsj&g; zP`=E(B-1I~y#{s6Vt5C$tls%ky-QM|+~+iM_LYuN#SB|Cg`agFDOIhmNLE)IAbxB^ z+n7?sr=wxE-(al?m_Tkl1`hFFeqaURflCf)J3<6$z7b`Jrb|d`skt&}M&}3aX0ASe zmSp>uu=L#^fjQx811w3Cj3>QP{#pUvb}~fRIuY8|$8~K%CGwYFC1y?B(!f&O%95i) zA^TVT(LaAhk)#8f3g`aeZD^xeM=bv{Eg_z~a!+7=O%UBjKIC}%iVv}++`)XlbE;{v z^{_h;&i#$o!V4PxTili?JK+U}t5X5WwB_y+5lvhYA^sdgc)4WX=|ybGnR6diK3WN6 z7Ta^h<>EsMXb?g7Xe;ukwTyH(F)og;b?`6`EfyAcw%H*1w_v zi^N`v!1c|vYv|`}2JAEJHbc^45QBIsJUz#=Pk96wP*R(fhfNAHni)d`d*3e9H>$>f!SL zT_0TC;hVT{`lrp!L*&W5u(3PuQxl4ojz^`V-eRg+ag1-f35IEkCtV@T3e9I4;KJGL z>u9HOc7hToIGfR&ybxt#I9CiiFmn}A4=LS6OykyYc_CM+f7L3McE!NDOns`XI&xhL zeft9sjklHWbdP&2S0Gqpc%**%`i_KCixU&Tx}~!e?SZal#iO)Nu%LCY&xssA($x2& zFTXUu6F-}$YgecZs3b0)go`em&2&x+-{diLkA$!e2KU!bkzMvWM@iqIqKr#*3s7y& z`bgD1-+04`%n!k@R=d83tPaLBsyl6K7^qEseIev6khL&2yH{axXcqWa7sQ{@uD%#d z<`zO3S$p7FedmbB{e>^D|-SIlO)uc;8k1HEp`EerbJKLL8ltuQhsXyw8Yg z2m;XDv3(1fdL^g^jOpW6ngOeaw&^7Fhn$Lv-xzh+6}pSQLnZsH3%rsU ze00N)Gq1dV{O$uM0!pSI6dYD&cu><^%u_nQAK2M2y0hFHo>l2xn$$7kwQ?k;dfcS9 zU|*1CUGP13HDD!a;eqk~QQxeU{zpqEm?Roy8b5<+Z~skad|+CyKAHhC!yw^OC`@6#r_& z9R}>9C_n`f;`QIDFpEpl>ESt#{*2s*Hs^ao6FAWUtX_$1=lWucC-XilnjkYkpQk0=EKL`XLuHxYntY&2JOZtdrkib}x1S zRnK(I8YFJJj7%_;y$bH>=&Bfy0H!J+Py5)X+G`C(dK z>!qU``#O-!-tb&{ZD6}6IG*BAHoLQNrQ9)E$|^OCNCt|nO)zLxf zzGQVlvgoN<<=$d1dFs&U--&-()xUc~Ci=*yD<IEj`|{Y0nhxUG+>`uHi!U4y_P+alsOKLqc9ptBG{L*P&8aH{~eB`%5g z-2ln-r=|(5e9`EuxeuQ_EKTA)UPym#*qYRP)9Se(_%?osCD^@9D`Zun@^ejJl+A$4 z4sf1!!vvVh<=ntpF2Hdi?X1{owh-Bfj?AiPFW!Q+bjCikz0gHvKsu;KoGl$8YvPLD zyYX3`h&d2pa*qe>&HR<@s00eYl_p-XAgO+lvSqCwviZ%E6R_A~H*o*$e%95q8C3uI zC(PoYf5};FQ}Y{*4>fa!9dpCf*Vx``zAuB^co9JwJ>gMM0M2u$DaN0ch5ByllM*2) zsx`h!2tH!e*4l5jqv8de-=6|Abb_pu0Rdq;;&F%hVw4L$!Sd_!?{r}vA#M^althke z6l<3v_qz#yXB}8F897P07kgjK*ucCu-MX$-GPo*TJ?RdYsAMd5X8T- z-R;O+fo9Z~lsCYtYb7}4+_Tv;b@Q~Pds*|I$i79lyal7#FrJO_UOQ#wpSIFP2>T13 z7hAvNOd@McSDy;VD^FS35~$f1fpd$mi*E_iyzZ_dB#)7>?5Fr?wVkRN0VSdmzA`g3 zm{C%OutAxL^|;Lgc3Ie9KS{ zIyX7*b&Jmo(B-B;BOkQ~be!O^O`E@8S) zT*hvF>A%p~=Eux$@hsc4D^ojSeax(XgC?`PBmxS!wVPCxiM;Dw<$hRCRG-t;aPTuw zMF?fjmHP2x4U+*|D2pT4y+#AfGH~;Kz~b4Y2}ogB(HZt%^C^_U}l0H}@XRKdg=CN=rFCZc?YNv-$wWe!&Jf z)T)x|7W$#I#JCly#*35uHUxy_W3K-;R-;; zZu?SO(6}9~Nh*bIJGvphr~F)J-X3S|BTphtuF-2jKf!r=eO%rQSesD`cj{L3@P zO@%E73{6=iik|4y+&~}pakyLOlXwj$W1dqF^hMoaRtt4)oKp&^{t=lL*`hOUKS}13 z`^;^7^HB*$NO~>1>)f9Aw!H;~hW8i)y0+fLV{Lb!sxKWdlAG);qzL`1j%P2nLau(xd;%160J#Ay0Tw&WJ%^2%q_F_JB z_!=gT)vN_zf#a`BJt*z2XM`eF4Zq9^^O(qad$I46wY+m{>B>p${dl*k^uikGm1QDh zj09Hi&z}9H;ItMJ(3a%-nc{_pnB%o5-y|^q0N>37mBK$TFk?-G4XZCanyA;JtURRM z&j!1-@VlL>XSXg?{Q5i_I!X7q^-_Cj!4v5qHH&oQkI?m33gB{X0o>MtIc&c?thung z9eFI(JZ7yQx;g3@;R9$^09>!WAltCe%z9szGhB{Z3UNup`e6E4R_-4*1#~ zwO>Q|$kv+xsxI;2<-Ic(l?DC=IdzTh%Qkq2{+~a~75|2-mflo{9OC@-!BAq4SCn8n zpo^_JR7Ht}kL@DQV@Sw?M5Vf#e>T^j5q@%C$Rr%P#KZTQPyz6lslWWbdH=lK%$gXx$Qj=_hE)O0f;WUfDPuSL(La zkG)jgUwev0iqeziW!cI%BGNtSwGSqaT&JngKcIxbrGX@JP2Yakq4MzHNX6sq#A{1Q^F>I({ z8%>w%A$35yY893zs94*n%6oL%_vQ<{1i<>B?a^-83&NB%hw*5F@5jaZMujl=!>~XL z-CqCkbgAK`v9Fs$JJ$jajkT`n5smz|&m_g&4}sEIB7gM7=38p)?}-IU*|Mn%F~kKy z;3m@;&^jbGUQiShMiG{DV7XDvzeA2kL*>6j&ArCk~?Do`@txqDTdKB*V z$3cIRCrx4+h}WpozdKhM<~k<6njQi{C5x0P&PSWz)q#i>NSr8;X%{dD(i5Vm$4(*d zfU6QE)mve8n5rMR`|-7U^8Vn5Rr#S+H&}z3k>^qkB2Z(=YGFT6JbLuT`H{Zur<++( zSV}ABEM{(jRz68p7UD)GU#at(ecjXxnhTX%zm$h(F3gJ_+njnjwxdSxj*&ZbRJk62 zx_8I$9P^pQFGiE$EvL@!e_sYKS9;d`cP2Ww;>NkuSNRzA)9VJep2PjJG9m2{mZn71 z9H2LVeJ@VK#@aEZU%jBZlkcwwCQmBw3>*D<8OV+(VcY9n2sJx*xGl%OJQFK5^0Ktn zceu69rNlN4v!`-QJ@-oSbP|we+jMLt0>nAECQnbB-k_ge?Lc8cz*C69TokG7d{y_L zag^!AR_VLu2jgwPd@FY)q*tHJA(7`1CJ60(9PtHv&YH?2l zt5;HS)|tf%!OwD>zS5TCHOAuKw0}N>BVRcs3U+vDKJm8yy}33BYHVar9mpmY`YS7r zE@>~d1V_!*7aHh&M7US&q^*?g3FYsD8vlVox(~y=SmWL*+-Tz^3St zPhMz4+1*93!LRj{skp~%ZP_Qk4r$-ZyJ+?HmbH7_OBz%~*dl9p$8=rM9ZET%hpx!v z)*z=*bM#u1UWh-x%N#A5?|nW8%z|D?fKJc@ac}jB*ZLg!!3OMwuJ7LcGjxcFP_TNY zyNy2InL5VN&?BRK2I+4O@V9X@XviI({+?0rs=v#AncqUzX*Z1ZKZC6-C1v3%cjQawBIHa*JNntYG!M76Emnt7PC%OL(Zc2vXcIZ}%WJf1mS(XesAX zW`rQbt0!O^=m})@ujGF{7#Zh-`2sW*R)R=qea+%452%IFxb~dY)hiFJLsGc%(69L= zZ+2Ga`^3z{M0~+t@X&P<454Mwz+i~ zoN^6riBdb1fpkC9vC5!y*&6LHw9QMQY>g>g^xLECP15ZR<(?SRW_aR_5E2V!eY+dk)?N-5R4t zqKV`qxGD*AQ>YX(d3Tt*<&m>Hb*ZEtuAK#8e1{9E zt=dj*Db)d(QHTtoL~p}#y7H@H*pY9`ukVzrjx*(9$_oi z<|=X)`@kkgEqk{#P1z3y8|+5e-BO{#lTkej0#N<8okhJaH;TO(#nU(Cwq z)NjU8LmAEx(#dzh-y zeNeZf)7l@z{Xg4bh{??Af^^jns04cK`vzCrUvE-ma1xqj6}^FC4;h&ZI^;_U!bf;Q z2X{|s+mvX#T=lR|4g2Ng+6O9>eW`u93+N2V%CL`ikzG&{UnC@QDMy)sh5|9|LWSJZ z%?j}_y>8{liHgYb}5O12U?)m9{4+XuM;}=EBfK)m@4%qM0=2_OE3B zs>L~7d+m>MFfn)QY!>W_`opSc!p*Z#mHgvy@={0gQiE=K(nLIiha^$ZZQgCzpL>hl zuq*MTMx5eGY^{T{Uz2{&D!-EsAMi?9>2LewK_LQ=VWtb@t6q4nfg}}IwIiqhDL!ww zTDCk?pR-6bNc;r;LN#7G)b4?ywodla`uq741rW87KwQqO8`QF%(q9=xhsba8sM@5BLjm~HNeX%=6f17nD=z# zOy7q7yW0=sI|XhRlu`eD``^H=xu_z-u8%LbS#Z0~p0QnbS1|Rzj-gWa!~RT9#>5Ql z;M!IZ?&J%ALiFlEM4*}G+17}9UUV~>ff8~&UOYRLtG2-HEwu2x5jtEB8w&2HRH~76 zDOr7M7A=xqe_t0+s5Cjvx6Vqa4xzCIz;asnV=p$s(zCBVG+9=4Lv7*eZ&u|B#q(y0 zxK>oWMEnR5SCF)XIz{tasQ&&DQCg?{kj681t-Ti_P2mz`_Ix{BolopN7&F#c$>yo=`?ozeWlVM$jm?wJ;WdzRCol|g?-pu^S zs9M97@xdVFjJ~sioDrEdcTbox;ySGck_LD|rj$kAwnW(@t)ExBjBk>UD@Ugs(^~g{ zxA|o`jqEuXJ^3A{{@phr1Cp?3aC9wuJ`eoU6tZ15=(v}oU3QoLzE*xvfqu{DQu`Om!wH)P zLAKw8`}EEi;4fO5Epbd+49bm7oCS3z^ZQ8oG3q3^Ja*|LAAK6@te+Yxe@XU!bnKC? zb$fNnWchvASqA4WsXu}jB4mKv;PMU-VJf}hL-^WTJ+=;0)4ur)omZO7_*RXb7T*X) zYk00S5X7l0IU+Mhm0ZMIKR<>Qe<-)m?ZT zMk+j&6Z}l8n~#nN0=ZSzh95>Az+FvvWeg^gRfp!3*<@r2S&SFsG#TQLrDPd;fC}X2 zv1k+m%hjeb&OVzmy0ib8gk>@8R>-C(1KgStMdFm8I=fEH9k}uXA9G4NLGLZHc17w< zFg)!s#AU0heDg{qG9j%V@Q_xq5{X~gIuZiM-?kke-iwM!gucruK)OkHUm0t^UosLp z6J0wD(;gA+dEn2NvpPX0QOlTB-X(+8eD|kB>=GK%7tu7Ff)J)S^}#6P7fCLR!`3`f-{w8oPjA3h1dG zEIytVt+Ep0(HZapV$t#XI|(kg&NL`*b>JD;#VYaY6FV}$kHtGJP8in-BN|%H~}gsbAKr zit9Fe6=f=zyr8$B*i&bFH|eNj1Qj6MP&hI`4%tv_sgOM*7?(xKS^6@acH0>pdLHM1 ztAz%D;2-mc1pcI09vSM1I6l9)7hn?ewjmXvyyVRx&I{}J(VscFm5gb(jF$F`@%c8+>@{(}!;Ew$WWezs{otnIe(0hk^qPS$mepd37a#4+cgDwab{YLAp7u~3 zEu4+m;~`fvuUUiaDJ&|I>LP4~j(O>I%f~z7tv+YZ4p>x>H_ik^ViOFJ(TkIrc~edg zJv#XPuij0&m8_k)tcI3U`v)amTWeA46t+j*m40JsrkuzQ$ip@9+&u|wu}{OHwa&r!@A3^=GycmmoH6|lUxfY zhXVQn$ADjPa_($!o;zcEcvvx(QhuESB`~nBj9$V#oCL82;kcs*V8JY5Z}qRpLrzSbJAEd;Onci%MkY|x>^&h&D9akb!ip{+7#FpJ+&>*PQlfB2)hd_%#ce>U;D0j6 zb2mFgrIyr8&DtakB3Dk7IzS*DuD;xY(qyDNo9_HaMIn$M z!iVy&?1!pmLNvo&E36&~Gi0k`AK|Lzi}ivqUrw3m+wsXOOZ8uj{c~{jk0W!ZCelF< z@(-;|jW6+{BqcG$n$4G+r(Iy9TvDtf=?nZ^8rXd??qi~`XTJW+*kMB3%H;yJB0KJ~ zV6~f?f7`aIEDIAl!GHJv4@6(rZY8qr-bN@UeiaRKKiB0y2g)ow9_G}7X~3(rrvP-> zcf}E4%!pX{GCpy8_qQ$4-aQsbOjK}BXBQe(7!5BM^c%O-CnuI0C6bJfDlYrXbfww_ znAh#jtjF$AiX-ed7dp%aloJWFNe}}Je1JxJtF_2kz{c!L^T57f${+m5FxyeUCTfg0JVD<69ZazoM~# zmMpeMx}*R-Z?+wgaX`9Awk?I8|L57Rsg=F*z3~|VW{)!IXiag(`QcjvvltZ98H|Y5 z_r&(-7Qb-ya`^uJVA#L8=!|1BuQZZ1w6&dBr|Aiz$^MzXM(N=1IR-(da}(y{Jp<~# z)`DjqVNg&2 z;~?zl$uc#=rYu}J$|EscB?|G6ax7&XqGbl~E(KTva24#w#xIC=dZdVIholDfpZ0ya zU!kcU+w21cb8=%4%A!BBlQAltnfO~b^~+vcS3N*Aidspy+fQi>fNbK}Vhdz?kz>v5 zI)xaGj-&?)s;fszHL3PWpMh%fV+R?xDKS$v-t6KZ^8)lOLVerzk>TP65HtxisaH&E4Gku+~#}S)Fyj?4-)E!j1MW_?6{3P-N#bLqxf)Vzz`Zy}p zU9IYQ9iu0FZOK4-DUaVaBRMRPq}U@f#T(Gib90j$=*^yvTG)k56L!SF?&i|!TER|~ z{&kO)&pQc>=4m&VL0{>JE_&-$+RDJ>x6R8z7FDR(n|;}&e3Gs8=tl03(m;{PN=X5> z-WKLNN}8^|V~dz?MlJ${U-%kt$7F9VG{M>^0}76piu}APzNbd=^4e-S9!0H{)^{B* zL~dv1Mda=v`%jGwthy%-C^$dl)KYOq$grnv>sP1oT;Vm{x}Tec6UfAe^PL2CfU=%I zh$x~rE+VdJzSUzJXFG{64GwRHQx-MrQFn#-H+)?JN%81rhhhI0FU#V-nP(X829u$w zEajiu-Z-;g_DcvqHO(&!>6ve0<>H=*T1jAS=fyW>eQEK>XsaVITtCHaV%qU01JRE* zW;PETS81UTgMC47;JCJKn|*}Gpj8ShM45Fh1XG4{OvDrO%I(~y`u`0|IFx7`=}L>Q z$OXH_+l@4d(;CzEd=2P|+E4e>OHb zjq`oYG8uP=sLpWB9^_L;EztkXhYVFGNN;v@{;JLNRjdDCj3^C4D4vGS!x&B|vy(5M z{rPoFR_0q#pH{;U8Q?6x_^hm9gD{r@oRjPIm-XyQXBkv3Y=2Y(%j@{i%B$SxcV~PX zg|!6h$wHvR7zpL~47RLd2qs4;$s*uafVt|Z%cnrOWdouU|f*7KLz8|8tI-wMPj8P0PL2#FOZZn?4;&e-4W& z6Rj5u$>rsuyQ8^3i`I@B86|{5+bx}=F!BgFP*eZ{PkEq!^9OGA*lM915F3h4Y$%Qo zN<*iWCXI@f_e`kIFLyGKRy{V%p^l5yb)(2O4f30|D=^GEs6*3oxU!fdk$GNnyHXHU zBm{0wcaM{PuA-eA9MfFg%kOCf!$S4%eZDFJurNt{3W%pX*&mX903zLPE&O5yIB_Klu4C4q+HqI#JKoj5ymCNhK^=%+ z>EF;7gKvt32N8x?_DhmYW9K z`0Z1a6OY0+rEu-TtfY4r#xH(TJe#;mjcsd-ig`Sm#m0ibM#lAPP&g@r9K>k`~`jnl_s7w zjNE=B#H6j&qBBYl0*gEHAS{aR1fl6oO;sUa59$h?>`|};eC?`(gO=t98_$zNU!~+L z=Z0)Pb;%J+MaROy3({W(;~8yWw_=g18`hWnZyFw$;vhYbla!DTTxoM&yEo;&I9~s^ zTNL0A7dYm{KJ}MEZ`CVhrR(9D)iVS3m}L7tJmsDFZ9-uBpqt)e+LjWe(}ekDcc?|1 zYE*Z2@&QgNU23+U08}Vm-8K3SyGye!T*=_@{_=^77}wOT;AmlA{d;lX$RyimmGf%( z&u!Yb${59jl~KZY`zI&YM8&e|$gq5Rc33;k_l^hV=h)xFka;4%J})fTU$;Q_NT_m= zW;-B- z=OZxecy?^KVse9cwgDUdO1Zx>F)Mv>*z5$;`EnE=AiSF})H550jasH8EI)A0qbpnK zpK4Lv%Nub+zwjNkwEqE;{?%2{O!)46zUm-xBFKn}d%s^yglOG}sR@hh5Z7WUx(wmE z$aK@uKY>mwtWEaQ!;4L6(kz(%Q&~4PbShG6NDExXzlIkRktYP13hln6{-9TB(BmE* zb>FrX?LIv7=wGeys)?i>;4OTyS z_}LtakcJ7ysCDbiB*h3ur^v?I&{u`-CbP2v!JH;}0ghnQ|LaFUm9K0X(5l?>#vxt$ z4ZnA*eF$6*@vxRbLOqq&Lfv#C%hFW0K%{(uIN#)E)+p2I$x?G;!Xk?{Ur0CKcK5GQNR7N3_<_MijRKEokkrF z#X;q(6lqNxA|+!vqnXo3)qtn&-OHUf{ z2cp8TRn#%uC~a-Cya{%@9L!ky3PvHPv2Y~5rnCtn6&CF>B0nF9Xi!Lf^~dL;x{T@Z zH52>e<(J|Pi|yAU-X1V1b^7AfrI-$)l;2nN+rVn#sP$a-slmVo^wIg(NuG7}V?DAg#B7%N1@-osIj}*l(1fVHe~ut)ukR$d4DG{n-UmTSm@fVFO3%Twu`@U zH?5>Oq??pF!~=%Ln$dPfqWOF6SE}sfNwVId$*JJRm$|ftt)OdXBwM$p~3p>;%sBxy_8XnL}S?JxSX>x}#$8fWa003P*{Z&fg%1 z6CdOJ#}#{71@V?j#zNxr-}V$(64I-Z8HKqEq>-SH@`~Rc$AEVbtMV-|^2fh(uTQ5& z8h~=pJN*dj)+$vsVnmGJ;N^s=_MK}ch3tqQ?_$h3uZ_EJ`k0Uv&IKXobU`PSqPCs? z#dHmSFOAd3te!@_$tlGmBIaKUGK(0F@Frj7Yd!U0Vf%l9JJWmh9qr&JO2cfv2qU?3lgUX)9}_qqn!B@ z=ojT60ls>v003U(cn^!BE201c29C7?*BI_oJYgw_*vQmCeDsYU>2yiI_fP>z!mFlC z2P#y&zBGx}x6BN_1`=&UKK0djfMFM+(*0S)2Z|{otXF}3GR$^v710UT6dq}d5TDp1 zg5=&MR`8*}fW%-SJO7^Srfc^H{FOeVaxHoAE~f0F8*Nm_-Y}RS-%-vZku`@_PVYhT zt+;@}f#Nja40*0Ax{r}L+uynd8@WaWbNl?Z1jTgj{)0A*-KIIP(=j&YrR4efjccVb$_aPGr(1G$r+M6=noRSS>(yCIPsHSorf}O#mWdfJEW7L-yp$S?pEYfw^hwD;7 zim^eW>?U+&tS{K3hqFJlM8-oml)o37TiT=_)x35M*6+x$j0J|If@f;86R z+72c74IRMytuFh(48FPj(#`j{G2{1D%+#{W0S4opv4P5~Gcl>c?T+~{Wxb{VHT{{? zymTc2w`Ip#YjPS;t?890){3{WWfgqqhd#<6WzcOXV%f*?x};luy>a=Ei8vjE$8z$Q z0R~J~|7wJ>f2I*z-GN(p!w3nCNNh2S#p`d6VX@^|rCJFk0!6 zhOMf$XC{0p<(d(8+*OOi@JF3=_+0s6I}pA|arUkEly^c21iZ0ScJq(G@Yy|JC*81{ zs&biySDP36y%{x!kO+s|?g+~IT#CruRUCV;oa*m5;Y zxgHQyNkRFmg@#6qGS_rB{=)75Z?fKG8?gd?5VsvF^;x5tJ2W0_+Gf_7mcM7SI-~oX z4LD{MJHr!*l9)fDO!x5j7gB6smLYNHELqc2B7v!AX?@m~toeEg3y8=d)WS|lG;1$l zmi=<&>gOdEwkNffhE1^Q31A{3uo7*q6hxKni}3B^CHT_XRt^j1-6!G8Gv@$;Yvt!* ze}SicdyIYNaB9KFq|_<#|4#4v^K{CGq{~_BtxHaSlKGc2Xe~kA()l62|LnLuZsW?R*iE9AS{+UyazUD>R(SPxn>(10ohI^|x9W@ylB5+$KHlbS1eb3NSbR`iPY|YQsQXrH!~0;c_Rq z$TKS83=_ldLOaPcBS(;KcMM)H-GW(6t$R3|jNDvvFDEP>)Ggt0fnn=H+uv}}VLs-< z%&gu?gOpFtvsIKxPfXNPrtoMzxu&+(XyQj`%f9suSHo*+Q?~Z)AKX8be8DnvKEn06 zfl{1OA0Tm=i<+8B06l5N_jcvfs?!T<>sqkY{IM~xzH}yA%%*9wRfv>>EwiNe`SC@} zt{Y=N8W*Sf=iZ2V1K%GM3x|gc0(&zI77XfJbOEy+Y9Y7!B6BP!nr--VKg4#*>YtoR zUfj;v*mA+k{GTwU@ZGS|95}Pl36%dG(yEyPN-=Oa_d@;;@y9? zb*<+s;O;9yf}{~a{bPO14WiQx&*dwQnN$=XzfJk|-OCpS_QT4eqv+S_Gp{HMbG4W)w}~aNnDKf zBx$@tqj_woUUof|2C%yah0}rQ4BCZ3Wv0H%ZL7T=rcK zOBNZC_y6=+dJ*!4txhY?x5BBmAGXtm2nq?`Dv z2}@|6mujlKXb>7!9BNt<>FH>RR%` zih?Z_e;fc~m+<5B=hc)}(eqv87TuR`w2QU=iZR_j()C;e&b05>rc5O-@@mK24^@@x zK7rIHLdSXs{xe=iC(QnY78|5=?j+kWC+w(0f%`t8KlV!}e|GcsCq?vH7`n!WyLN&~ zLk1HQz$dFt2Sa2Z2*cpE;_oM-#SuVYoJQTMd%3I#ujI3Up$E~t+*i(%1 z#TWZ{sv2n)%>iNUafxh8q^xXvFTey3TZp$WH?VC>kPqebF$i-}JaQSNDdRAM4H_Z> z-OfA5iB6@_Z4ooH(iL4wxJeibSG=q$gQ~rPeC6<51#}JVC5Y7sToHYG)xkEP{HyuTSxB=7~t+BDW9C4-oCa2kE%;weX!I{k?_&m|?3eW!4*hc@sQRgq$9rMVFjVMX7@3*R=ruiQ+ zhY*+8UD~dezjErlwy!z~;%^NMXwU1YW(aF?0#1cU1C%PX3$6CFMxD|AfxhZmp_mHU zxZ&>;skFZo+I!r}Zg~B0qM!a~xtW~Yg{|X%r0J-r>`jQW&AqYa29d4%>f&qXyrT-wyQi> zF~um=j@Q8ok3c%aHJsmP0xcN`lHJm4n`6Ox;+kpKp978@BQ4?e&PJz?+e%YRfbr!T zx8?g*qSOLAW*sW;z$JG}I<`x=5fd$WID}K_VkT{9k#}^cW=d$fFgVMtk@y9f9UTho z(L_0gH%Vh@R=hgtcT&x%{P4wf^R!DEK_*fyOV_TZ#eTl0y^?=cLG#LYBntW|nG}z8h8Ub}AfWL6nI(_CVf?fMbhzXbHz@(Yo)ZyeI*hgDCzL|sZd@+{2G+aM5 zzD~`zxFvoxL899Mc#wUty!cZ@4gAPmc)sfuwD3?{hU0E(76Vd z^Rw`wh zF|tfuX~d~kyrg!K=p&_cvK{MxF|LK+$d4n{n8&?%8`aBM)q>BFm}1u(S)44eE9G0) zm}PjPbQ_^1SKZ4P+NIkd=HW8BnuXZ1vx_lL$CDN zbvdK|E9jbx24D}SNkBt3bt%MzOJ7OuYWTd*^3IQ&8d&!*q15|uZQgKP9!ZL);Vp^& z{B5F{7k$R4C4K=uL4X@7#3%pk<^PzUotdPcY@ppqnxFw|Fx)A z4!<5ihK8<*`HF05)?BY~`7w3ihE{HR@HgER125Ccd`q*>*x6f-^Kah9 zcoT512t$~PgR%)95OiKeT#KODah^maF3jB^-*)Yy3sfT{WH73rWy@NGVcE(0IRTD% zhdp^EOYh4Qhnyq@X{~^%5_!Pc(oRCYt9jiwg8x2;?**`W8Bu>ix-Ujm7Gf!g2rq6a zh++J=I0#N>6YPSL%feyI{D;j}cv)@f(iw(A{O~!e-^Hkt1qu0WIP7OT@KYgsl7}Vg zCteNj(VlPeEh@HXq&O^3O%&uh)@OJ-?GsM)Y6v0La^EsyfBZu*f9b2!T*%ZC;V9x8 zjT_w9gjPo!%?P&?$o_%ObFN7`TjNHPWA(npy;XM$Pc)gLETO`!65dg1c|H9G^wD5J z6fr2g93L^Un?J^B+!g|B;?WDkuV&4 zTOp4r@`jNH;N|uq(_9=PJSNC3`_`Df-l18_*R({rE$)ExQ$4}bd5q`joFPP9WV%9X zRAHZu3Ws-coOJ7e?Evm(jb=X|*F<(o9(L->D*lT9K6B$EjADAUu~SD_rShD& zsGQDK9m0N4Z&=2h!pHuI`6Do8FP#e-CaQ_&q6>{8*ZwZmuy=junVa)_OOp!PfS5YO ztO7arPnyPt>CD(JOCFs2W>vw!%5=D;sP{0~tlbwF+o(HLoHBNh-)qsN&txHB328ff zVV`IG-wSrF7#Iv?wnGTfh{k11tF*X6Fx04&k5`{0q<+g&V;~}f(ci=qUz<&X8Z*3` zo`)_wJc&a#=HoCu7}5bElG!GyeXRFTF!tAf0#v-510vJXRtj=$t> zj&A&Rl9`O{%(JiR(q^=PpMaTz)v;kvpMkB~mcyP-V$Y$4RDgP*PPhvhwPd1I>R>W| z#Z{-X8eWkTlo*H|aC0mGb?0c)MILG7q<;YokntF-c)T^0SdWGorJWplWorkgV(peD z+uqv78A;oH!MT-j(~G~aO|Y6>BF#wMx~=8f=ut14!f4{Cb+yKsf_Fq-74*^oc9*{3 z?lBXqVDSe(`S^R$#orzmgYx}mF-EMcf%hJk$ z2FrR)&0pJDp|Y}3D@)9Y(sqITv@wR;U|=ih5N7p+_xRdKIVFlbjb0n8B_OE$N%ZDhMW4 zc((gm+`p)XYFJ>+DN6U=kW9RTRtoOefKrmX-lY;=`WCGX|4K;?+zgF<^dgVZU6p9N zCI3CP?fv6bUp1>%X_rnPKYAJcBrlR@-|+?z^NjwLcxFNiz4+Lxp|7YV z?#_(6xPY#^;ZSd^N2|hm*RdhxIzed$AVEu93{2 zdObVW6hQ*-jHFl>lOwH`|d{YKwOCSgAQHfGLPWQ2^N zW9y}0qU_tgaVh-T7{$IQkCrPT7@5TkT~G8FDwF&-jSyzG@mjoE?8%3Fg{rQ@EQ@RB zmbgct6moVIr63CKy_}Kalra2zE4`@&p$s>)jUE-q1=6xsIrp$7gh6mGd)ceQkH!8E zzjS9`!pG|+b#$kYW~Fy991f?B24m;F2j7lny?r2y72Zb0FNyb_l&PN{-Sv=jXXADHw&=qH#tJV@*$N z{~D8cPR={n2nwW-nk2U;&8x`E*X)1^-B%Z$$sPh$5;|w~K>d?$)WCSAsKC$lSo0Cr z{DjUcW;JuJYgPX}3vF4q_#5IAxcjDCMLA#=?Y@is(zMibA;s2ini!x=cC%r$s0Z@$ zclaAbA&!){@F}K^3YS}1&E<~qaeF&=aqvF7LuG6eGhbDVue!a)oO40Ic?x+$H$7lC z3_=T$E$k0)#2a1e?P*hDUuE`?f;IqvFXfGgE%v@EG9e!Bq;=VbCLPbwt;6D**R=7U z5n|&%3En7wS5CNoX>f`JRMMUTP>3zyW3(Muj=%XDcvZ?*qhJfzo%n~=#p1n@Q>cFx z|CnMnS7zi`Bw2_XDX{_6neI-Y8H^iEATiv{ew9mpnt^|6 zdsVv)uLGGXGT>}ySI1W?AgXB#e<2q6z*ma9V3-~ETQakrv6k{kb+&0`M<&diUDrA{ zUV@v}ch{boh1Qf%zVxoPi$SSUQqY~M3aK?RLskBDw!-OoxY)u&gyxj0zNON$nB#wz zh4(}YbJb+}A6P*X3OL~>sDGiBrZkg#ETDXJH^_6@1}kXeG_@?HE~|29+E~zac-zco zdDaN3s3YTtak*QkZ?594SC!9l5`jF1?4LE`jRFC*H0rz&r-?vHKoGxDi~cLM&ftrK z0F{LXUp?L3ME!J%6D0X^BUAbs9ZsOf%_tts56?DE5aR~e$9*xnYIo1iv(A}Yp*7c~ zJySPx{@FLeH3j)(N9t2AJU$W6^R|JcEKj`jsZp#;?aucp`EF4gbQ@5Y!8ta!;C4fM ze`a8p*&YWfn%aM!?ae%i5KZeX5&j(uT*;n4ZPLYf z(tcch9$;#}snJp5atrZv&U$Zdy36RJ?EqAK$8h1l>1?qnc(XMsb!n)pHCZkG=A@}^HKQ>+ zZd>Y%@tr{zVWxMpKe>)~f6^>p%kq2dxpo0V>6sGH&ci%iuvk8qW{Y#zQx?Y~Ylnt5 z$6HavPkiYn78J3mX}E~v8l*_65VhsSD?^6@C5=OV~Ud zAXNu}i*g$6K$^1)&@D%xPgxO>t&$tDsI3^hosc|7YlBPTS6iuQ;DrN&Z2n zn`;#NKKW1+4>hK|pp8C=Bi%z z5PFG!r?Aws^Vsz@n>+ZSkSs- zd8(!0{p#2Dx#oj!Rvd^86M2!N1N;JGhbnY63YgP*FC?h7NDoGUF*x(oIwRh!J^|8v z$eJko^YOO_QmN>S&}Mp%5ASd#t6aB6l@cQ{wp*Z6sK8>hf?OGx`XHlSmV-wXZ!ng%r5f6pi=L`OiZTZ#t zwQnWEI=0({mCTH`I0e5de2$_vm5zhscFK!qZ4%0Vuh-!|`-!=tOfY=oYp)gr=Xx+Q zcqm5LJek-A__)X780%#&dMa`t2p9G}BxIbyp8DDVzYq75IvXveT5m>4_bR>`{Vs)% zDzmdq8u=BgZ)=x0Qx;t9!%jewTB9@k{>&>+to6w9Y#(r+V`&yx=z3W|WJ{zQ2KfQ3 z@-zIDS40A1*RP1}V`ODYXFE75mMdx3yJ4TCTpIM*$f;n39wQ+CfVh0$R4zC1^0*|B zZv(^3#ao?$9eH`4!ttf6*2NQtzktkkzjJk9KeG!$4mFy)K@=w4B~BFeBd>YM2Vy9L zjFjI?_~<3G%1s!lzLMe6I4e3ecX@d!KZk7YjAOR86hO!MWY0U36YH@CIwGVr?pHc- z-C}$D4&7ktTLHzPMgZjJ{pRaOldVrXUT+8a^nt20O=}_HnyE`jlr3uk5fvXqcS#SB zRYRRLqBnQ}Co7SQ9Zf~P1S(n4%%jws6*B>n6X3F*0p9s+jKhdq85%Aa~e-*_~b(fJG@3)l}Jh40IELE<~Y>$B{uG`pu0povXKlPC;E%i$5?FJtK^lCGWFM}1fF}9GU zN3T2K;Xl*aeBgFoVV$FdP&aFYM;>c%Cw3m~>m5kT84D$02)7mI?Ss&##y_^dNj^=| z=^_jn?;P5c>*OYwr}+Cm=JkwlTEs_A_Ags_Z3`0Wm4|746i!jzpzXWesxG2G^gK;nM#rjEo98tG%839HQx*Bq28|+LfzUq=z87BFYo8*7G z_4`#S;*I+k)bHqE&1(-QeDRp|HHn3LOY-Gng7}K(BO1pfX{$ZQIK4UF?vir=wr~91p;U zZvGH8kdthmw>7>qw&oYp)bP^v{H_G`4^DPV@EM ziqSP#34j+nR^a&)qEW1u?eal(zeS4I^0UqKepqwg#f0#iz`VHL4B$V7#NIty{JLYB zZEJt~_B@GcV2M2cv5Sx|idKGhC;4rH0to;zpmmU&jmW!&jtGih6T6 zP}-e;8SKs$-r%jZ)%N(+Qi0Q{I!9kXXd@ZrKBr(6L}ByL$!EbB646hANkRlmi@KOpkj)BH4yDJ`5Ud%mR2L_D209zf z7c2mr3q1*5=2KgD&~7Kr6IZn*Tpv0{y3fQf2}WNm);DbKSnw#2><;a=_vn2fjSruc zXD5L51TG$2O~L*GljUh+4-vAc8&6tS#F}j-1xxCufE zKuOfky;Pr1R*C#r;+UM5*?ZEEf1^965K|<>8BQ)tBilr{et^4&;4; z*02d7z@7f|o0!Vk5pK`#6LVHbQl9$PT=QN50mncNOjQJDp;f|Qp=up{r@!VHV$@cKNz5wjp{;)+psEN=}sW-OZ@O3()0@}0LAB)bwm^%7Fv zpZrGJ2v;8-4xn!77B$?FD9XAk%z# z zlF!Tu3PSyYP@9|^NU~k3QL}PaWtsF9%Y!xFgy^@Fm@f4~^hIyI<%Wve8y^{)5*%my zw#R|^p8Y9S*H=EvyxeTuF)G$k$M?~2R;c1!UiFwn=w9q9eQy}i99#iL1Vr^;)snq+ z>OJ8!4FGRKBCktJ=@>N)qu#mu?ibbW`Hbzy*RlV;3c9uA^%n~Gx9NRLlqoQ5)8m7` zSxrv&a`psW8kscxv&O%+X^CbL^6^o`B}cmq*H#a;xEvl z*E_}vW$!4C4ukKYuaigCs0g%N`(buF*dD#x5QFue-KZB%aBvW~?%w4i7p>>BZ+LF9 z7Gx*G(g2%54I~}Qc<)G>=1lX}W#yR|h27(UT_ZQ^nm5&94~~UQb)cqfG^4e6wtLC zU7pUjUv>4HkUmDvI8yY1?zGre$h;YX@qMLRoH1 zp?l&L3nN1|8kBK^rT=RSm2cfop3J0IAQY z`;I$OAN4XuyG+&m40mK_WcKc>QeMNg4fDTyxB;{JE|zCQ=6 z@a59LVab;0#}*kfSADgWZe6-IBKyD4{r;&zW71u8X>o3nR38v18R{E}6S&d(0`LZI z2$!UH?7C*NVrvE~IJWjQRAq&V+T1`5m`D%=ORmp0%&r=RXA@+H0O2b6OlMqQ+%HP(} zNHTn)j_{P7;0y;W11kZ}Z0xvauXj8z9#qj`On?0rT|Qxept6I;}fk=vhx$bqjIVb1>?A zX#M6NF_9au-hZ-dYc9bt_3S^MwGVzDMzk(oIO2M%vD$8sQoqz$qKnM$d(>EyRB4Y3 z{B^fH#rA9YJ+KifwzK0jQW9jaA{VAP(2Ne`y$CgFTK+PZjRCoB8{pVfi4RSBnL*>1 zM6bxrPv=*Mm>9S*J}NI)l<5Uca``Q>4suEODWkNPqJ6Kn8ZBP;^ATlw9rEol1>o6> zo4z}k9U4;0c12f^TS<%$0VBcG8Mm`K@PRYU=P|CgZ;MVfq8YCHO>}%u?bqA8!0a6r zzsC#9Tx-?@Wft!!^ChNyYLw1=3MM(wPijUYz>CrJ%6$G&NaUq+wr%R0_z;3?0F_|d za|O>hu#fKn5#^;fKWN=t9ZFCfD2IXV?ngP!_dJP|6at>vZlk#im~QqW2shGdKExdL z#=p-W@p_@;Ngrm}>~}?q8&d4$mdz}hGWCVF!h?jawj+RyZp_J6iwNLduB&xeg5e8cHKTa}rM2sar8xrimzPP~2&q)z(7Jf&;+0CTh4Ue-2 zCck6XwZ#3wkM*e>v03RmaM>>`_aN(p=n-kzY9tsI)IO4W>0H=3a1AF zbr6@lMXNjTJq1KHKj73#vfZhg(AS5hb-xf(9YH}LLD*id@oW=$XYsT#@}nM4_2LNh z1H!i6P$~GoSA}ixpA;AeoI9#EDJ}UNjD9ww`s*!y!*I54Szy^&4(`r9FZ|JA9y%k{ z5BZX3vN%Uhryn47Ko8)jROfv2JW!@w0mKs7UD}cvWXNfi9QRo|3hOb_jIulJs}@$b zg_(i?R@56)SIIK&-V3(eGJN%I-|zX!jj1%HdZsO~ig6S}KT;xJC+UP_f`e^=jfNe# zzhSc5%kQ@ZI>_(2JW+~TVa39kt@it!Z{Z?A5N?EN!c^lE@09ZVHWPaCU6G&aPlBoY zmJ+t~j~#Bq^gQsu!(`Exkg$6w-jVj5B}T+ZEZ?{iniGw&wUV{)U2epoC3R^xs2k zROg@glqvSA2gN7!^pNUgj<=0=>t?Ni!5e#f*f&k}0VnO&7G$km7QN2`uL0$cVPH{Yeaj4U);d|_!J?HB)x zvnxic{hVu2=5zgiUbcuY;9A9_c0CL8p4+EI`ndbi4m{&n{o)Ihz=ozVctfMl2sb@8 zo@YFF!+^;-T7aPB3?Rg}Lp=GC`R}^&Qw7w~gt~3C&x;h{i;LiR1%rU1t-fk^DE4z- zk*j)?%swjPb?bbB?w5&icM0E=6-?wyUJ8M@_ei6QLN|Wt-=*FHnA_5*2#LY{u%+d! z=A4fi%9$bu2kEKy5}8BgKtT0^lCTfEmf*UAyj5r86TaW4CTMKbn(!jNfhnHYKHpBH zGz%J;p#lRCOi) z3EHu*!E-qNMle8JI??t&neii1izs4chTtSJ?Hs^<+b-OPg2<0sPsTg|1yE>o3h7Iw8c>ldA)j{}!Q)R=ACtLJd zvs0ZD;mhcVDt9ZbXSZscMu4vYOwa`*lX^?3aFL&(8rJz{$bvp8pOm78;>*j|a%hDC zE;8JvJvGsmd4!AR(vejw;AKp0$#S19WqCVB6Yxp9{xs&!&Lqd+56p!;ky;kaTACzJOF)P=xdu_=mVz)CWVew6=Z0X|( z3G#ioY6A1$03bm0 zQ@LDjENgjmbd}K|NUrQ;q^cYe>C`l5ta+xZ`H3qH8Q#Ink*BefNhM_d}q^@ga#HPR_`0mwb|SOZ&L9!ViQ#?oBfA&MlM#mTQEn-q)DW zV3)vsYaoT;6Rt_w%uo@wcN7AN&CV-mbJAxr-nYOcCw$4G>r+-a>6BDg?_zI};#I!A zZJWz*9nR=ZlG{)RiXX}pMoJ((d_{KQHcpG^6ilj9$PWY#inMmo{X&+KyM!}% zq#n0127FEB8?XXT)ozvFhp%*EiA-w!B&(Ay&kGO0Nr!~8QAC6;flOcL=+1qdRLrdPBxOJ`QS^xe@I$*mD)id zO&<7x48!rsVMC7q89>-JA?mz6z}X)^q*9kjw|7FjW>k-fwgvDt2dvSYHz(WLbtsIw zRN=O;K19Zn;(;f~YSH$jNHy_zsjZCe$0)ojucmxf6W#{a+h3sW*z{{GICk!KY_N9W zHhvSQas#k^0eHDid0||=5O@meT5rvGqY)HRoLfvdG)`(mr2xqBC02TMuGn`Fz6 zjYR~Qg|_vED+vfcBrMQs$2Qu%~eYjZDiBR<+V)wWbSqh3&(gtcl^)w53FX#$BhH zJh*F*$W&d z-;WEuljeHoZ{@wyG4?l|%+@`%dy#oncp*W5T<@;skD8l3c*jEp2dSSRrsaTP^-=Hf zI|N8j@Cx$4HT(ZVH@@Udb%t5o$&SC}b1t#chqC_zp(&yxBbmJzp<_jf$w3VC;* zr$^X$;75#ovg?)h`410dxwgfIJ21|6p`y3t(U$%5)}g8@`>L8G$XC&6F{Gy{AU)2Q zjH>e)tjoR^Q&VBz(LCxuAam4so=OYN)N`k>hquWq8anq!+XguM?5x_ULxKV40`d<} z%99Ef?PTI>MBP>qM6yBNc3);USYsWaqs=`2RaneshoeYJgfl*&BW=F3PM!E5&rX%~{t!rW_I^c;7I6URKU+TzJ;km}Hf`A}xP$40Q(%{LA zLDS>L?VJh|*zLX!QbInn7Z!V(_R=0fLHIs)NAz7~n+sA752f_vrJ$#_15&bywlPyy zxY+$&aku;2wq#tUVqs|1&*l9r3Nq|)4m_`ub)~d{|i=! zuDaiwD7q1!*!v)1K4S)R{;CHdKN~D59*|)R;dgunSn)fOkW&pO#jiu~JhOfxpok^? z5l{>YSh2opAzF^Ug=#+5!ZjmXd!*w!1%F+e1@Z(ug!l4o0{rr_UUArTK3`G-kwwkYl(xGDsL^$3 z-6TSr>;(1niR`#5?&wU}6H$7SaSxiebzT)rU?^YKxNzp)%z}Q6SY!nSMIY$ zTaVTFA6tP-`pmc??^xvXRP&|PaQMCeUg%(vFOc|0$H8h;$FZ zO?*0XX25wU#2zion!Jvba1g(tX(!y zzA|Y|>N`t%8en%cgy-03)P{K~hv~lu2i6KwF5f_Vk?(RK#;^b4Tm8 z2@GQx7$CIEr>b~pXL=|`xG3Eiq;=`oq*2l=?67FLSZ{OYom<9nJzvxIh76)UPk0S} zenrjLr2p;AKkl)JKfc)d+>pea%MdQfx!xYN8UC>G;9$Z5%ZtIy|J(o6KJ&!jEB0EI zx;(u&xaDgMek0ZC@;S})&wWP|qs<$tn3>4IjF>kYx?&BFFgjcC<=%zo$QIpHLSruR@+ z@O4UP6o~xt@7ud2XMMBm-}}jOZeRBv#E%{2L*^IjBE~hFft!Ey&tjHewbe{o2C!CE zjc1x;!~5f@P+~(%Kz96oV#Fz8YW)UgN9E03A-A*@dIvJZ{X_eX5P@1V&}j&y1pG|X zN0|5$tXmnGpOPgv7F2GuKwX1N-tS$2l5~%jnA7N)CbNqUduiP0dJR&^zAb5_5J;dh z&CDBnAJp8z1QTrC%-sAG_MdXwDi;#_S=isH`cx|nRm!#2`$Q4}gNbB41YQQnAj0uD*Ogdd2Y74WWrZB zbO2q4?KGKCZ>5rEvj4-o>`M^qFD+gyl%27gh@B7ZZR=hd*`j(gZ03bqC~P~kgZA3v zBgfH~$H`}DH@(q!jfcqRF(_C?&@?B1#Qhomv!KNJadt5e@Zx^<-ntd^ez zO_aAyikQ;VU*`X%5@zSRPHP#Hj_|}&!>(>NIGq=~0^e8VDe}QY$tMu+Q|j8K+*1a!R0*9CB$jDnw#M{$nVaew)jlPa8Z3%Z&cL<3Q|?|3z6QsV(PAD)$##GOI1zMb*%NO zbWHOoQC3-WnK!>Gj0ZPad@tx?DtLMO)K4=UKymN=gM!RIBOO0ja{hOcb)qq*7d_>- zFgm2pJgNs;N#K(}bBh@kP0CW7=Ik>j_k|6@^${=cmPQ27ii8@PRt^BUY@s5LoCOK` zyjX7+@5;X$*E&aoMl)nOCG?tDMkat4sjP}AvBTfTwLC8#ojUaqI-3F6Z(^pA=lG)M z_H}U|-7Ybt+5}NazHHe$t41g8)Flg<;1+&q z>RYZ(_jl)uHQp*Z;SZ`p*vg%SjG^rOTiAnoK+b>vR6U5xfk_thbSd2r4Opz~UMTtx z52=Kt-eLUSWL?j|hXONe_myOR;QpcNq_V`7WKsi~1Jfk{Rgaoo_Hp!hjjlwaYGPQA2Z~Vu4lns4-0!TZ#v7Ihg{{4 z&m$d||Lhj&4|${W`D2aMZjkHJc`z+vvp-z)F$uz14*JbxTlAl|7wjY&D4mIsAKPP| z!b{Nl?CnYXk-$l!GMh9+`Pe-$Y8=XS0`%|F%_H(=+-QiCLB7zZeL8TYO_}QZ&F}$k z30H_3_58OgDl)if6!P3-os>{*vW1v9@S*_&9Qx6AZ15lp` z0esX+e%&K zvsubqB8g#KF+M%k>iJKMdET{>kbA@e+e~XaL-Eo?^*BkS&&^=Z5X~d%8Yj_PAyir4 zgd%KE&q3)?gSY+a$vQn=Y3mz%7Z8_Hky2B)hxoTn$W|`?y$4NVPkMlRIEV+nx@>(W zzL|4w&c775IzDU(Ib+(>y(cSN$=yfjbhwSnTVgkuo4UAV&kyVv6YoaO=EVeHl$}28 zGs9~qINbjh;1>OLjj!}(f{g8hSF(xB-&mj67@w{Yf=_?o?A^<($<-?j10m-Jui-QL z49sHP0n7%??=CG*mz4fY$$q)3{InUbT2Q#E;p_6Ev)x>DwbzY_&dI&rkM+%3{_y`B z*h`F&aJiCh2#_>WFfe+oWD5}hOg$<#;2Z&4GUv9`W$d0*7iKqc_BmlE0(3Owe`7)( zNB9@lr@Tfk{_wqvrnqg1jY6T)9Az^ENsyuV01Ig?-Wg|XQ**Pg$cz7$kJ-osB-g(? z&wQ6E+WRheRPU0-g2e=qtBVtj+PMA$wv3d2%CpcW$oQ3>w|%j7%#kCG9O_EuS?LgS z_AGV$BkEX&(F!tV8U#S0kByT!`MC~r zU?PdC{*)|v;hS=$FvMQNEFD&k{F@&t>paJVDv>wZV^WSLb)H>iw4&}v2VHt>6_gkj zWJ#cvmQ)3tePj@{jC?jxj)i~}6CP}QE}C9nQ_xZ2pqlA+^l91xsN}+DXjQ5VLooX`Lptt>AI9>Xu7w9{G79)^tGc}^e*OLO!Ly~BO$6+KTrWxjcCq9 z{0<`f;{_3dRXm$-G;uJXp;#yy3ARJR@?8&=eTOV0hgR@WJ>a8%M7L*a_ zAar*Q#I>8g13h_t^53#}v)U=p7VF!>X&AlLs12}iU3dtn`1JPhUz|(D!5+OKWs)qr z$V#{qUWv#EL(TJEpu-VyqVF?Q14{S8jO4kb&lCH4A;SVnUGOVWdnnS$l-eek3$fDB zvf`|Xr;2+t6`8{Hfa09PB7tV`Bf|S-s%rRsCibZ5Bb{GD5lT&1rdUn94U{Ag(0bc` zqJD(@neeFF#2KAcV**AkH-XOGX`D4%bl8BF(EM5E8icmF?#{FP#Ag5}#eVQ^>v-Qw z>bR}lfP`DBsob0lM68bMp{Z^M{Ig^@;2#q_{A9l3ol?z1m}Y@-Gj{>#6|lRy<~XUh z9GQmR3|)~O(zdNt$KJ15zUL^l+ozTF7`-i%KrO`^lfU|HRA0={x|_VQod4vXb4_t8 zc9CXroD~e!>Gp`p$?WL7x$aIRqRNsKd9Qi?a?rxu)_i-E#H9jtsrPkqLXTuCs2^&D zY8Ho7Cf7iD$b^&ZlNlC^Awb4@_Qxn}PV?w}iysFb4rdKByg(4-(B@ZO&YlwSK^8FR zN!%;2CI6Wi-td?}lg@Xw)c`}F8}wF2ttKn#9QT{res-SZW}dKKWE?)zs5J34t1b0A zn5mb>{NCF<58UgCxF0R5wWX;=FBZ$Y)P(8008_s)R8@>^-zUttdk`Z4GQnP@By4Jc z4F%w%=y|{zT&QZb=n&142~Kjq>33fIuN|b<8UCQ}%eZmXM#GVa;(UCP>*geEdUkR- z`0;|XA$E1Gex=q;ZZ-I*x{F* zj_`#Ytd!)U^#9+6#$O9>i>SyBPA8SOqBjg_UeLj@>}5!nFYL+W%==tZZ21W%UGrdh zGcY9G4G&N6nSppwqSC4c__9dAVt z$PMsSs$NEu`;#hHHf8C*GQ@!AA0uCKSWV=^5Y^-vJgZ|CKRJZDxtaKqbH%pybvX+a zQn_y0%J~^SA`aBOZP{~Rxs(#mpWW6_R+QC@%+Xb*@xoJ>;p>L81pRs=QI5@5R}^Ka zAVfLC4Xo%Jjoi!|%RnyqNU;Pp$3lD-%)f?P)F*(rTa4#y@r;yt;>%f9r~s#Xj6-Ky z3jkTh)JSeoOjR-m8kJbN_Xt&alhx!Z!Zumr*b-AI^VL;QU30n=Ky*T@R8qho?KJa55*36}_f%{*tHkDbgda$=}R zJ^|87Kw5}ydbIoG$5j??x#k;M(3gL@eN9lz?S5rly)#m=|DuxHB5zR-*Q{PAhVh4etv+g~0U#j?LQtl1xZBG=}rd*;QTA5Z*(rW|oNB|Sv*HVbN{Sk-_bsMO9q z$@{vPqtnV*C%w_++pzkF3hLYp5Gfv(TZ4CJrE&-cZ>fQO-*%?5<88tqX> zz72f`Ze!}Nh#wQp7yF9_zNZ<<)N^&EP`VqwPd9^440YFXpTkM_Bm6@??&StolPD!z zfA$NMqiD35>I zgCsqQk#NluH^^axaT0R20x2cDZA1rk?`wNu7M?hDW*(}?g^hF{jhu3scAg;Qq0#f4FMFaxqM3_m3~$r{S*mtc?$62uEBbEuTzW zaCJ5Xp>$9jABQExhEua`@dg}&nayrCp7!n;Yk^H&>AzsMxlEE+kH;7Yga<4i3~Auh zOKqI&a=J~2zkVx8RJ8EaUeB1G*Kj{73_IVSgwBT_%ZGY5c_08V5%U`Ew1L|2=d~Mfj6^QBCwUl`L?q zIDX{;oRBoJA4+U)z$K)b&W4Z%Ni6jrq zEpN|XQhZe9{t)JJB{gVt$LCGr0rD9L%pA;;APWxDG?PK3FdA(eT(ol08*}TY>A?Jz zgH9dED)~Rr(I?E&(>A^}>Y+W4xP33+=0_txf%&p;fKaQ+>%jI=_gLLp9vr?B_tPI9 zJbjfQ7q|bbb+%r4z52#kc@%ypeqJZ|=?9#=wTwE_@x0ix4z2o?Oy*%79n)V{U6N=Im-5CLmU0{}P zJ@!AQlygGfdEPUYXVC*uZOc=pp&WNVvCA~Bh2ZaF&A*3FRnt&Yx?wZtndQr|9R4Vj*fv;5y{7qa|Az&#`63zOU-6EG+@%qpyg!G0Izn+f!E4X`nF%97$TlDFuX zyc1ao1IEM#x2Lb{^WwfPAM@!P4NQ4Bm{CuOoij13l)PB{8S)};9_JHZQ5co@XBYd0 z7c}_%Y4kwdJI7qO%$?>djWN>4uFKx^y%Se8gm3F}kEx&~sIA9vyd@~#{z&+?1lvSf(8!O4n zed*0PpCQQ6p@fl8Go{U)pkZkzmh1#d=huV3F!u%!H-NRqt+ivKknHyS^R?!UTEiih zF{M8x5c3F+D|r9=jWli}7wV@SFu#tn`kjk08S)MGT45mOiJz1yfkt@d6l1cIIz~T9 zUS5BLOjo#jbY>9w*HRAZCC|?eG$GDtah@>Fks{tC6FxhSuwV9>$!LOKm^1Hsai_W=vWlTWA|s{%!2k#nQNYj~a-Wx1@GLp*VC*oX41 z@!z=15Sg7rrq8!I7m-t*a!yQxb31S6?eyIL&Ive@U#`w4Je4Z>;w$Ho-UqakHJyyE zMw9w6R?^c+W#-u__DlLnmPcB`X!nbGS|NIB-6P+-AP0Z=tY`pQcmtp7O|G>-?YFM>C|v{k2%Y!zJ2`cBVicBNU9sfRkvH1A}#)w+&8Mx9gq$|_;Yt% zQD4Aema`|uJ8nTbnMLVhJvXaRb^mz~hP$9-erOg)o~v9=H~jEUy;_@4GHwQ;gPmj;Rld_~Fg0K9+sQPI{k(N2~S@{7+ zsu*f&o_SqEiZr9GR1sDQM9z)owI5=l;`b<4qus!~_@^KqAq3M&@O7#h_h`p~>0^^* zRd8cQf?`zC-@J;lZ1^i5uN)PWmyy39WB-7JMQM~_LigijXcFv4a06D@O?7qSY|lVW z?%0R3g+hN}~ zC&UCP_gKkY*8JjgXpQMezHGNeIJ6t|N#T7`J3OaOlKl}KDOw+n;FLT=Y4ZuEQ=Ssm zdrl#zHqqo)x~)gdb48lLHZkIRGtV-GR&sM|z>x(bqfouCZ;vjiEH`FbmYwUPZ<`FG)x_r?zRsK&)L z6v@X`hy+HrdcXag%@F@XFBJBuVQqV+Vz8Dzqt|kbG}8sc13;rq4hY(;_eK=}BFEWj z1bbMVwUL9S&X{p_p8N1ymTQiUyJ$3A%P>qVY)sT}>-HdD5~KU9LQs;0!??0GV#9@n zUXjtL+)DAd(OiDnxTH3SrEHS&mlS!#rQsXi9hrKW-W@vlZLd9MO8F$ljro{yH!6|8 z-GMb4_bNQpK+zK;Dk{WF7&@Eu0yGM7&Ir#r(n2fnZPlS&xNpPT3PKb8Rb(30)UBhb zWnfp=X;op!d!I7sqaV8>v(G;=iu<2YSTOGNEziql3U|zX!;Ur&CRj7VoAv4)DUQhr zsOU;~#^_~reE=AdF6yOzT4t8*NQ;efV={2#sSlI&U^#GLu83}zCjWmNoq1f6>HD^8 zoW^mQv^2BHt+KMl)bU&H3YC?WDK(WSE|fNz;*u*WiTmDqH(;fZI~S*)eTcC#c&~pR~w~Hz6RGDvJr?N+u@cXyJ%u5x@N) zf+pL>Hj0LpB;?bQx+YTH@R~xCC7Q6|WJ9C4rYr619#A{4OPgtCn=tJ4-#`txJMjc> zKp*2R^9-rQfquwTc3^dU|rgRN?bh$@(oG-7U9YBeA!zf$0c454Fg6{IN-Nc?Z2zQ_L$@1xSGZx}(S~9QGm+8Gn+U=zCZ0@^twR;7>>~fLfi?g>w9wK6wbfz}rTaviVe@Euxi3yE&0H{LM6V*sqp>yezFsEY64rW2iR z*LcL&OE`Q@$&f3;rpM{dXPGv}=SDOceduT(@ke#&q)py8b{t{H%*=*!Pc{gkVtA3%nMaShrf#aT)5KCOVXe%WrzKIB32t~!e8&^Ft@t(#>KLR6ZD zU*6lLJO?NX915~-?(gdi8%`B`BW$pB3kl{q%1i8fEq4Dpv9~)Vgtyl#2C%xGg_|+w z_L6KHb)R?;3(qxb=k10cmLICu;mi%%-VE(}>@jFnZS=r{o%Zs_8CGVMwF7R2Se)k& zJ=p)J!;%-UST`=V?|*tr3$TM^!P8@A5PP zxcUTCQhib|p23d6)<)f)cCNjqr;?zfhPT8E+FZEB&J!lr#r(ifKhu2kc)|fS7luCf z5v=d44LO#k%2(DA#M)~N+*&cLJB0+UY-dHd$6!G$(m_>uKPq|(jP7NMG$j(=CLp9! zTlR(L-U-(Zzu3E1U`@wo$XTpWlW6u;4PXCvPK_FGsUkM`WSw6e-)yorR3)PhG5V`0 zAPS856|!|n8Qx$RJ~A=M6@hWKHd`6$E-3+}{XX`x5{fmx0>dVdmP98VH(~>(z!T!i z64+o6`J8Ra12~LdpF|(9iXQrBz4UC4gaIZ`5meQ?$U8Y{&P@3agHbDbg?#nXLV=H} ze)@gCe=TZ#lWQ7^&_nfi>+4D$^JgZfyvZNg919&y#4SlvswgKaTpQLOkY2c_&7@$V za9_C2G~#6tF8fzR3-2Cpw=~DK0+9!7$f}v4_!fI9XBHG8to(|tYxqJ7Xvp9V{{J?T zBX#Lc^#W8J(6X+`qC0cqh1OzmL44Z8$=<74_B$-i*#YKIT)67(BKhifJ!530SWYyb zTFgGlD3=Tdx_v!^X6-80{XPW0_1~Mgc6-7hqH+)hn=oarUv!Igu@b%y0;tcu243A^ zpq=Cwd%jz`O%YT|#?2ah?uF=!x4pHY<~?hnfdt3z}Yc?1rwae{0x((2F0LijOTc z%_rSk@37}&_YX^RH>O?Eb27q^uEir&P3*}p`Kp}q>AILe2E8r%^YXtKcWa#RrYAvE zDj6#59e?FM7$ZLZ#=|9#k)VZoUn$3aVSO6k!&H>Hz}Phuy>9kzf`}P6R8sF`v~3g2 z_Rc4eTlS5>8QKO*m@waGM@OPhp&!X~0JPHBz`1K%<$KwU&iHLdG9$~{hw>8U8;=xT ziWD@)@Gb=A_x1l`xA=kafQIdPK^_?r;?vrnhRi0Kr03ug&!`6C&Pn1e7zM{aB_h_R8q>Q*bzTkE^)cU&6eU3In2!tBlr?$8)44-iWwmAu;WFxUt)W%#jrLXRXq<%xU_3rHWq0IF{1+*9 z`3&nGli|^|4}hmKofTW>Zla9CLeW#S=Gbfm;!HK?LVV$szn=)Vu_gEC>0!4&Ykb%P z)YcZk=i>23lp)Z(a~C{z!r9<{uKd7;;J5jSB&^F&>}bn;ExZmkxU6r7jk`!dMQ*Hw zSsTMRA0U7`TCmO-8if8ZPLF0o>7TTWTMNRk*ROw4Dyj&0=uu(oiH0nAXw0_j;-PXC zd7<=0wEa}aE$GbJc!OuQSRAV1zeFn4cYbK^)syKx*kB&HbC&*^3X~OD=oa{1H*S6p zIHhY4gpM$fn7&0mKb^Ttt_xs7G)H>hN8hQdOMqkuA5_XFrv@6+3FT{j2@GwXiz2oeBZn@v^j=H!yEh<6HG42M|4;-ELb| z`!e?Q(Zk)9DQL!A`Hz|U$dmM)TEfs+wzC=&I(CPiw4YN%g^V1XXR(*7Jcc5_q2YH)L4vZ)>(fBy}+SeHRWcLj--B60!-th$r?3L|~qA^m1tq4;L2n$9RyUyYowdJ~>< z)R(LtNq4!{G|zF|xa#o}NaGtGsoXfyh!Sq2OWAAp*(btqeMACTv3fk(XR7^IMGl87 zth&Zm5XDVKT6|P+00DInKOhorQA1!CdHx?Af=Z?z%%oLNPR&%^=P72T_rkiu9GEi( zGu=bh#*OeNu9d()IkSf|@uo$#Z=97gYyguLZDT4q5G}~B+10Tz?d7y)QG##|Fp=?& z9RPA_UVZ<2)@i$>r_hN9Nc$?t+mPh}A%f2V6i+q7Vk`{KipL|@k50K6A8wgWUAVdx z6+hEQ#ndt6UDJ6*{cF_xs~#eDUtI}$W1YG2bls*jL$Ce=)%=!nimaMqsyJjdhpAcu zr6~k+OXQ7p@`h~RwVWCY%_QoT$a61ge4NUv_B~N~?2@`ohF#EeT^%2=PFtCpT3J2B zCRlG^U#bTzB!@_XbGCLA4KTg*SpSP$8u~?iVhn%vlP|L=U(Y$aYD+wFyCxFR(_eTB z=uIahU)8iIVr>S5m7(s71E$(8!p{%Man_bma{yPT8Y|jZcI$+)pwsetcahVMk{-9Z zpXqE9ZTRz|`5KSJAY&1$AmY|Guw2lj#&ZgR2A=NyDuZ>2`y8 z@iXwycx7)v-pW#Sjd-p3F>xO5&3pwZKtwmQPr>7@jqVk=u&#Q;&J%NElKREec&-EJ z??|_aCD{WBm+k)h5~Z}jBH(_IIQR8O&_p}zk$gUcQ}IIX!)9FGN)mB^8hu5Yc&{#Z)ZG*UoWocL>JVnlgyI1*QVhP%y+cN z6o=L*5j>jmP(Vmm?&K6+M+K&_4lw%|`Pgt3YccI7%7OX-|LNGnXWeMCvw^xxGjhu= z%_3b+@zFi}E|d0kR=$WK5?TT}TzIPrHbW5`&>m~lnZyM=v;1aOmj*i! zz)>WF$q`SBD3uMb4y_ot$jj(zu33*F zu{|_EFKX$wUqrN}2szjDn9)&xUfa{{j!{Y%x4m!xqG8m#v5dJT16p{&IiSY(vE7Yv zGkRlod}7ayDaC!WZw8g@addAyy}1nn!`OU>iK4K&Qw-IPU%#I3UNObW4$_uutRpea z{j|lqkgqm*l3!~ReQGW*{0E^y1_--j8_hno@A=t5&i2d&6s7P~GJK-?bK);cwrVEDsa9Mzqp23U8a;7j(7ATLNs-s*@RK+~j^Sc6sCTH-wKu+1dah-% z(8GlF4;DmOQP|mx#A#lCFo@vX!fU@vx$_QYovf!kY>3T9+$KOvFirL(Ac=_Y^Ozlp zpzQyyH@0uMZ^{n`T}&D8&*YE%(NKq{O|DJDGz_O$n_v=0WUxroTWOvzRrrDs48&QC zCYr$nOOsHr*k|ybzQEf#(ZrurhNT5pJ@I~+vXQISkE+gAK!oXG8?rkaJMN+6gPjZa zb$4Xz_2}g-gIHbiS1_)X&I+z4O!!Gc{tbkz9-1e&rDjv{FO2BSGaNd4;r#j;+5!gD zGi@-IIWqt=4<7yygfNU3R1|c#xbOp2qo{vvxztVv$2x&Q;dSpP%DN4wHyNOk4!zE; zu;E1MKLN@SqYW(BI%q8Htp-6HR=i^BIlXPhc*b;XFObM7kX@vQx#HV-C1;fEAhe2S7~Ksj!CfB|sYH@MWXg8#HSwXiCPIYz|N5%~X~c4=-p2xS z^-4_GBYZM4{Y6Ylec6vW1*NouO4GNo*#HMUACvU5_L6Te~bfn+hB}! z1^wlc^IeTEZ&ClR;2(vyf)}nqB?f^yeg=g>4K;B2L^1CXzyOBv|BoMNkjillCZ2D% zhnm81c!R&_FUPYECM~=|KMhsi+b#Tz6AwQ#SKRL=4!bTLE6~KG=^MjW&=RfQNWI2v zcvQ)xQ{~KSuGL1uS0_X~H(qWSFqPWDVEtjsbO+vCmxE-FypT^^k13XuMO24YNy1~a z!b;$yNfGSoTz&S?`(KX6Sf}BMr2nvG4Cqyh{Jf{bG)I3XbL z!TmH)56Ey9ULc6;RrM{aH?NrDR*aBAHlQS^Je{+ZC$owysVriOrT2vhA#>WY0lYx} zMoiAy2&&Bk%iRXS$(3mf%Z^MZ0Orc*Ay8Y3oD&_mexRZ_k5J#jzcYt#Hj4)O`-q9c z{Rv+OyIaKf)|$n|P**rq3YGp3!=v%Ouar74mlU5*ukG_uilTm}%`gEqvd^rhY)W%T zUrM`SC!7T6R<3DMG+;kN$zRxM{oUZsCxX-yw?m^C{9|POezfyV4^|a)n-;c$!U^Hb zO<*fBYLiMkigk;N5a2%z^#w%u2H(%HQ}n6&?5qNN#lyCc8&$U*d?G-Q(X zsQ>8T!?muPnw6vFrtbh4Ym++(4z>BjwyNbS5czO*EmKlOCU))zgi}60s6;kaVHHc0 zQxH2*=xcqZSS=dg9);9@7qp$^NsB z-TGD6d-P0g@993${BZG5>=7fR%fFQQFepz2cuwG*PX?x zea1kBAO-+k>&3G}VIK-p*S7l~qgX}@?za7~2#)hDT&|9?rJn0P7r)ei&oKameA4tR zwSDIIv;s?qW9)3`EdCG;nJWLppD(JnBUoFa9NJjdW{SscWRs9TL`TTNe?rYy4?6^% zY9%GUm;APRa`jyfKf;T3zS2ov8{>|X?FcIeE{@a z|7*o8S8L%Su-&;!2 zMxZen-Fl1H^yZ$giK$tOP3KRwj}D9@PLZV-?P}ufL>W?)k1s(sG}D&YGEx=RwJ<(8 zbF6XU08Y6$uub+@>t+}LiVq(aciomwez64t#)7(s@TogcT^f9U21DVQu7VzGDg#GT zpF}SVq#_;ign#F4mrAPKzk7IneqDS#_n4W&s_y``uKUg{Hf>UTbWQ%cDC z6gzCtz&0PFqwf*7AvNb$*Qq32zuJC>V*{9VwbP}(WB36)9lk-w5JVJq4-#72plRguIcPvpOki}x9;j+=?K`QCy`$V zTc6u*fK$i(J$;Rnu?qU}mOJy{N^EsNsGL>tyf{#`<38|z+lSiVko8eS15iWbQ5=P> zkW(9&;giI)xSbSttGrpRuu3vNL#^1z)`vN*4(6GB)sRwXz55mHGhI_Z)<7F;ARsc# zq9xIOu#)7aR%#+^nJs*KJHylY(}QiR`*fp`eI9j@NE&}d0P`*;1+x8yRq2@x-90sq25@;^F8xn^!VWPx7TqJ4t#4D$=;9w2^j?P5;vQvg z^`X&m6R~;b$Ms_Wnh)?%?y+T#7+>aZCn(2XTNFYTMw-3{hOe)T2HluOJ>xs|dte_s zza`zI?9!pm?lD!*m2*vgnnAwsQcr>F&sLxB>U*T6;r`qH5}v!WRUtBBU3Sy#r9Hk3 zv~lgH0$hwRITHIB4Y825O9cJe$UL*l)H9hi-; zAPVm(Ty+)fCky+F=Zyz&E654-xk_RUZl_l#GON8|5PWU{!vnkYb%}Kd^W=;iRqsO3 z@2Raeuujz5mU&kkXhIG~wW-PP+0vcNjuPL-K{RR;knn@vpM%deN^on^jPfe&j<>=_ zi#FB*GF;WVXj=4TB|BDRF`SMTacf*_I=^%v=$HxkQvk37j3;dBR#!6%~AF;_5Ru7MxmhHoAE6JLXK8`ztoG<*=s4rVN7KEF5#J|P> z5S9nd7z3jkaZ4wyD&uIZu`uFtfj25pad8HbbKJJB1prvN3nKLzl)q}O)UjD(jerDH z8l*%>4#~-B5j~q(zGm@OrdKc4uv)L-Pp{zAL>9Kp4PsxrVyDU5!O{d6?L+TG7P;DGzE2&Gjo8 z^G5xc*X&K=CRi6S(&u-?zb9PeD#3uM+4Vx=5LpA=Fw%c8li-v3P5S=N+v!C8`tTrH zkjpvl>sH%CFl58bPp8d(8?EEfk@f2I`bjrujiH5Z`)=SJSyiQ7b-g*o$38alz?bhD*kZH{PYO*LMI@} z`iM`*=pWz6kZU;f-9R&)pl{g;FZs_?r9(9MgUq=u_%-Xn%npegQA!<7HECqq+Vu4Q zk(ichw07nK42`?uHaS;0(kAhlb`uUiOrvN4M@nL+-?c5YFR;%8vGd~tHStGxJ+lZ- zmdsKI@F_@DXntD7VxH?~u%+NrhIdN%@N=WdiOF<;j(GgMZza-3s7ai%ivlc_7^yma zbauD&_m8iSm4dzwbO4wFy}lW_a2s5u`RH(Uqb?c(zQ~D}qoT>mh=72ZsG5bEjtcFm z4c&<-_kwwzveIuv(_)Xn2?M%8&v5XD?-H#}Y{0p^RSoM~XQgSYV#cWSpzDIa_;XUG zz~ggJnFkVET0r1gEzXvDbdXUbIKe0ni;mU8@wBCP;cqrRc}PQ~_x$c-T*KlQGg|e9OB=khq0|6!2$L6 zv50vqu6dBe8!=2Jw0>=7G>{Kzm=s+x>tC*}5UIk80?*)enxY z&g@DB>pFkvN&vJ3VfHxX{jLel+=W7)uxGY`u2yuiJVB&ApRW6nxLcwvb-G3waZBrU z(!jL7dIT*JwYO6=o3*2cmK*E_`E5b-2*6y~GGFpkGV?NW!=>-%a^^YL1GB@d{<9Vo+WxMKiO{~ z?`Dj<>swrK$2?5)vECliU_U~6zB0EH$lZb}g#uNP!Y1`%c9SBT{l-==N{SFT?6Mm< zR20x$_h5y!YppM6htcApNtosj@rn_npoKcu_kIALAwL|Ri(VLdC9hb|B+DYPdvA?7 ztsqOlNj$|i4jg66W7LqGmh|lmlK+wFBHt^b0s}U5*c-p`Y1sM(o5JmtAY|qGZv+}Z z(A}Q)iA_J@j3@WwR{fBl)?MRbLn{`hgH;4s;h0JhT z4w#O(a5s-+z5~#O>piaF=HQd{VQu4K1A04J87puT`@bq_?nZ6Gcfp-0ePraRxwTSJ zsEt1q!a1*C+?4jV?McM0_A~d4PB}a>^tJ5lWAwX*+eB^{rrOZdLM{7!RArX@j2hxq zJ>@>WwsZ>l2$d9FVr#ur;_Nwct;B^gOwG%7dfd(>e7kKnkgysF7~LXbSIxN9h9i80 zg(sra&G&)UX$d7q++4u(8uA%OYDgS3>O>wl+5-chnv=0DFjUm3r0f;K{m2M@hnm(d z?sp{&pCza2tIw|&1W7NXlGo?VH)LePnLG`D`$O7KG`*1d!xLZc-MJOt@#~WStGzd@ zo_aUkF!fVJ)enJS7bBe(Jss=@Y`@L1xSmhYquaBcjs}e=*5rr33%^~_?Qi>jZme>y zk$13~>*+BabkF@ng8aHw3|ex-Caohx(#Xy9OayfuK%5*a^ZI(hWSU{{h}=f&?Xg1O zi>R;k@}nfDapvDLi?pIz6m0J``7RIqqX{a(2%9*)c&e)gr9n0uuk-fxK5I6jZnBLp zMsSoynYN;}{DcA)Rk*{({I7Z75y$oy0f}4Xn^dfE9ofr(WftC;06XMeei%AlI(AO z!_~ONvGqXwQvVSwW7!Xh{z-RU=ij^*rNP@7v7#rhjr~=@m@B%O2^JsLjHdoZ$Jv8} zsy!%A<9&x>1bfY_%DUbmk$}x3^=j-T4QU`q7q_<^OQgEfhz5#&e;fszG=E;|FasEBJ=@xu9E#vQMvS7q0H>4S{p~Hu5JB%MsxIvj zzcVQ9M`_(mI}g{E;qv^$Y^Z{^`hLLNvW@a&5;AZyAWC6Yu&T2by9uy9eLb2P-aVw5 zQ_5FWr)=1_j}ln2C)3jH%m#(c-!qT9Ru8whd^}@f$6gd&NNl9J>Szmo=&YQdW*zWB ze9qMaP;Hp(oXlO84#IB((%237QB|xb5mjvoRsI-yneXU|bPbINz8F>wbeg2xrW&t4 z+X_{F#Pj!IQ~)gj#?K-|Vsf(pn#xFEe?_Wg%w4`|0oQRS91?!q?NoffsY_-UI*)(w zH)mY}aP8`7yVh#I>_hG;u7si|9l&M~QQy_Mk(#Ej>O|1m1^pd#Ss?~#EmH6m@|qs@%5M1vzn|pIj4w(-C<94b&28Px3?qq$~)S`<|4?whEnsrcWPG=lM`Q7(#~eaTIeByuAx zx1#*P{2;A7@uR0`t(QVTuU9~WPHfP^=N!RN<5Z#1Vv`oEtmH*;J1?2b5C(ZQ4wB^c zsR9^(s5P;{Ewh_meP!YGv7cprv=uu za4Vt5_9mGG#@?YXlV4@h@>w62Q4dyH(_m}&mqREmXNiOr^e!NWe@&M#4?O9d6l{cS z(WO3&?7}_nE`f?2B?df20j_hyl?1b*L6}{*`i`o9)gEYPciC zL%Q1gbCVUqm?zoo>^kP|LKzVnQUCX6TABMN5Mm3Y!<7^l%7>7QwJ=Vsrjq=K`|*fL z{|a;IlucFxOabcHJTSa~aZ8VJj@jlI94~(hfHi5PzRZS165G#|TA4f<1DJOSs|fRE zI$KPJyBgu2Nv@a(dSfmwYlohLZ}Eli+r^V!JQbhdkVI=5P(hS)cUIP z`5BAZW*pY;CYGNAraYic)&X{C___OdHCKQ(OBIDaQ7+;FVFakSvU9;0tt@oiIjwgB zeL^t=RSV|^^!lS*{s~P*v=ML6Pn4o=tQKH$W{qB@7~B5h|2}f*YNYMYz_aol5gYVx z-3Jtx%iAJ_R=I5<;{WtNXwfq=EB$C)Jzb~QW9#i^k%AeImwK^8_s97HK2@4g zgC5Je!xipYri>{eE)3A8l=M<@6Z@=rmlzAfh zdtKi@;yUldLlIz8g3~%$wiGSN)8<9R({Pg9Z}r^%)r$v}#T>UyywlypOEZ$A|BTD} z8-3lT*Ed_u%0H3-K&&0*8l^CnQUn>Z_HF6^xmh{NeYq@OHrde#A02I;j^gjd$U__iWC zsM1*<+fU6sZb@T6as54S-17;l2205~w9uaJ|EBT~Lh|{V)=y%>eFdZK!Az?wH201Q zzlqG2d)3FjA9=iEfvpQK!N`9oDE-P$R--ZIP51|qT!Y$R7)YIsVAt8t?t1Z|j~Eor zqxZ~LbCt)TGY&}$f~CNG#mOMoF!}jcUK@45^KD_>_M{Hc+EP2L0}ip^{eiPUlDKC7 zF-?ba7ssVGqdd1AoJy7!e*V;#wv zw8T_7IpU(;21}7oBNsnb?)jJg{DB=$05)n_S{8Z9yngr{ooj1qrJ0ZzTe`(n-e3T? zGuHkXDANY<7c>fUWu1WL08dpk7CKy^_B_UWv0{H~|AZ>=3eqXL%~ylgNB;}hl z#^u@`DeUKzt1-}8AMSIE5&sB|&ted|-p{8sNcc4JDVG|u{9)zp?^HDKhN^4K-wC&b zVjCxMF|(}aOiay2vpJ!E61o37HKp^Xz7*Elg^guRB^Tu|W0}3?D|Jn--1wK`>c$oy zv2EW0C~4(gW~rF&k}t! zIQg*6POTO^F8E`T{9!*4)Zno$_z|jlbfvp^YYn(~G|$2;z)J&u=LOesu}2nyrxp%4 zU@{e$Z0t*!X2<`CZtPF-={(-PvSQQQ!-cqHsq#l!yq%B3AxuT=w0Ma%p7N6*b>uqi zbS8?Jo`cy4nZFW%UE1-M>9nG((^La=avX2zFWd6xlaLF$*w=6bB{9uaiqrVz^v4NhOQ7mkHqg9AOs?PGy?f$u z-y5gkhY;J#Ciur^TD55V8qa2u%=;!3-#xq^rL?RGmInR;{-!?{{7SI7VN$VoR4-45 z%(^}I2!T)Dd#gl@I4q{VP%HRaC(!bHy7zVsm{mKqwsN=F!Cw=F)xN4rU-Qf+jXD(v zBy~p7?FS{MVC!^CT{#_WEBC#Ew=)IEX53uits{NM`#aTj*9MT)|16O7jw1RS9c}0| z*&sOeuJL6r`SE^?Ps`-ZR*A6HoNKW3@+q8j=Lkq#MVxqStv#f~y=AiH|a?8@88>;S8vEWzQ>gwSTaV_-OlHjQB_tvns zh0OzN?_78qELm@OdpgNU*_$V0wZY4FQ%^umzrL!sphCK4t!L&c)*r53L54agMK_{2 z7qg&Vr4G9bo6w}{9XFY7x^g?-?~~;K%e5!}F3|R+(PPv+m-gGBVEhLR6NPL%B9R!U z{j>gCO{e;vK%r6Y1(?$aktN1_oyhkRI%xgM@3I4D0r~S-4gA}X#%G}E6w8S&j^k`o z93|$QQ42YYH>m5oVOSRg|9L9s#&q|8WN9v?Nr8H}91J%K&jByCxr*f%Wo+QL8(1?` zsPtave~7O2@t}LQ2)oJWo`7C)JJZ}=jEF zCwb^5lgW1Soh+@($L@jPEodS)*emJx{uxYcJXjxz1c`yCo=%}1IS6e#iTk6S#?>!< z-IO}ah`-Sgc;fUAXi)EtDW@V4Ft^9rr!8xU>?TuvFjue6by{t(2Ca2Vb5~a9DdtHN zUTAK);>A{<_1RhB=k@909Xx`!Zu31YwrYc+9o<<lSZRkP?XJ0eZuZ#HljWhBg)8J1=_9>ybLbdjHfT2?u@1C|1U( zL3v6CHz@FKbOUh(8}U_fkMF+q^zZ9U&T~8HR$Rxjf*@3!s<>QFaq0JOV4M#}3=g~r zFy=Ex9xPw#qGkdZ*3Lqr;Q!!-_jT_!8mII{E>fmcN6-)zM=p&0t)7n+#}7Sw_$q@kqN8O z+iEMDxK^EDQJU4&!T_Ap0KW>2ivz`|@LVh1Y@$k+6nfwu z%YdD$wOaOyuS$ovZ&z)Hs}+%VLu1#vkEO=+LhBsQs`Yys+QL zYIwkTy;E(t(nlTAW^$MQ4*JQpj&~m|7&mANBX^~nsZUV$3>uLuQaKsB z&zF)PjZ^;fi%mHN1Ba~(CfY%lb2*`$f*wtteJKI@1oa2c)9M%9H{J^$1GPPw-HIrY|%EMy4ja5A$`oOp()0F1*C%RixIn&!6J6{l- zsqLu0x_WO(JH4%8i#+*u_ukk=bH)$G)=0gh=BiC!^6)p)p7z9YvY@dw+Bo+okhzF~ zU19ro4QfDK$dANn(aX_n4?&qCt8lb0z$fl;2F+yynWXzQ683z;!`{kr?4^#eQT2|x z`6qpNY=!yhrTfAWu-@sg>zwkwjBmRs3>qYlOzQenB|1Uz3&5VPb@~_DbuRGa6sa~( z{0ID!1#!s@?%*;dzcp}Zu&$}zzE@|l_rdND27Flg!PrAf_2IZXgJ6`1+TCtA+IS=v z&7o#l_cl1V3xBI=(zHgB&K7#Oy%&;IBWDt?cM^xp?RHUIj(gt4MWyEo6ydqOo`^Hs z5G@D?-wtzWO4t>fW%7D}S5KRmIw@*&DJ63-&#*%|-5=qS$?fs@uuc->N*G*o4_{Y~ zh8AwCn¬kCMJH-M&&0e+l%C&7NE@XT;6=?cD{yc#D!>huV}iDTC9yUF&RfAYE$$ zuG%2OT%G0h!#BH0%&WnN!=3HsYc%f^IqygVqrAW3Rb-TntdBsPflahPw2c33V)+MIAFUShe?Aw(SP+T7{#r5ETZP&An3A^hh1SFN0dM-u` zO-BjuBac$BIpS{B8Ihz&FIFh}bKdo4ao78x^_PCxD+u3niJRKr#ldtNC)LaOXFBRt zmR*hf*>v_jI4d}o*#>&lfOyT{KI6qJ;hDjG;1w;dpHwfS;XL88?xFckkC~UCj zkX($F0MD*s#QY64KTUc0K}yP(vKom7axKYoUF)kqtIcl{y)$|@83?ofO~xt?Y}yCrNu zZLimM%{EE?IMWYfCBhH(wZDUsi;xfIt20U*`H?!`PL%E;L=msTU{upQC4}DZG3x~P zT#@5nFcb%j0WvG!lIA#zrCw0v+j*tnh6eRascIGqzer?_*eL$2%sWz>5N}W!IQRH75=gMV_kzi7p{Q@Z^p8L{o zgU5&Zhd0q+rDv;{HjF~A{zK?HQG8*cb_UGGl4%X z9#0hsyZtse{42u>Wb$s`nf2>}Yz$xNo+8gHs!$jv1=gm3h{ z_(1#Q^6#-DzMO!(gnY>ZpCsz+LebAWV zKcb}$++?*~$z*42Z6`*1uXh5~n#y`{0qL#c@_9Q$f|ln?pUgKOZe4uRxn}4bkom^E zp7B(yE$%y@h>A8I>i_WFvkJXeL`E~rKVEp`{?5SMZT%i|t6d$0)elkTt;%MuH;@2A|Iz% zn~>gPmv_+U`Xxg(*@uk*f`qcFJeM8L+YyX|^o+VZu*r=%!nY%U9an0wKbv>m$=5~^ zYq3*Cum#vjXb|JdJZ-txr%X~Aw4Cgdtg3_TQlB+$ zPU_WS>ZYRDJWNN;)5MWRi#Oq1}2G1ar!Wbtala z{^r(h=A~o&hHP)dr+BP4$0geE_7v~+k#H8mc{+GJ#ZuErOyQb!y=UN6XHo}U(a^pT zPlRC|C8zZ#_V1J3b8EVC9b*`q{&QVGWxvkOCJ8S-wT7(Uvf*|4=xzSz6kXVi9qLUY zzb!*ylERl7wk$W0Ajg=h>-Y(cxRrwKjN^+?VU2m&GG#$>Upw&kRn>c>K)$^dehxR3 zqdBbe$U>TtmYx)hgGm7_pz&DP5Iz8IuaaCD5x?6lJLG5k)0h|qJIlLA9iYS6 zt@dyuaJ=B_X;>gOLH-?d5wF@_yf)*{!(W5(Kd8M5AZgP#Y&PVFG?#@T4ep!#kEX&Q zG&JIGm(GCJcQTRRwImu%5kCy?{5N*_Ly~3;lF++cvZfx3!J|HfDGqEPBSd9e1gi&S zz8?4vKmJAH0{7T=$IU6tSlc;de`rcm6^W{$bUeYe$9=TXoy;#KCmsoIxo;cge4NRk z4r2*3xOq_~xQjh%`X&D5aXRWUw;D9<;f7PJJW9R~iVGdR9An+75ZJ$IE&2SqRi0qJ zyMVPlRj!>_#XhFid0Q5CUVXpLzDs5kZ8ub@FmQleH;#!~AMda`ayC^gC%ljhnQTTk z()lLem{J=SsiBZ2-&Nz3BYH+Dg$A#<#$Xm$m0mKxRlRu;5zyoh-Huypt_ihfKGln| zzxd>P+!w$*BusuW?H{@JTw9&@Xln~9YW=?`=qU+%^Q698hrvp_YKJQ{;+sjh$k;Ok zO*st^H3WXrI3lH|)s34&VZ;^vw-164ub_e5A!$Z*3YUD37*`vlg13-=!G;i!S#Sps zY>I4xU0%hww+kkCCL8#7bwqS*q78N)@J>;~os{pSn@tSO&F{g^+f0z=-f3TEMs$h# z>e9aK>B{0`%==CzkC44`y-V${fuXiBMi~q8Hh@X#;G(gZ!8=F ztFyEsyVg;^th(1w?0K_*b%PR_O>QiI3kOB{a)`zn4pR!B1MNh{F?f@uesgIB|4xK~ zc9baL(;wB~MnU!Dei9>sO1d3G4t%Vpy{gC?7;Z(2KN8yTU_zTdI(uJm*n$o%zpb`z zcec3jM9XQL*jzeWXURZ9dj)0~p0;(jI0V$NyuCLe2eYLEiv6?oxfSzW* z$zc+Vv-JM~mp407Kkr_AL+ZStXCX(a+3HemBY)*c@tHIvN@I%A;Ew?6rS$h-hlQ^|F=Oe!T~2 zhlN`H8_xcEPwYveEplFc^0^;WqqM;F&6|K|nPfF(uVH1N^xMyZ#eXu5r-FTHI#U~Y zU5Mf5*3M(cf=>9PS6n^3?aH+SuYo1_OMhQ}bxK;WSSVxE?@wBZZ?wr#Z^~#do|-|) zvmQ0Q{93?D*(dch6+?90FR?yl=Go--i%W;z1=^;g4q&^CwV3l_zi6a|og9|;d5URc z=z#pTBkd-QdXkJ@(m>FbFQb;V&vX~0X|5uLSJt)rjAG^rYGSHTH0V_yvG38F(|=s_ z<%0IM`T#L;KRO|7{_krys`QS@DW39j$q^f-gpzvQV%K^k`)`v3T&tuO#geKw;Xn%Z zC);+DiN*41;e%xz|Mvay6WDzYCkBdw)mi={Ul`hPB5sx4g+jvZh5of1!Ba~AQ+_1w zW2#+YH6DGHa?gE69HyH<*M0q=65UE_i*HLs-v7ZijShYrTmh?Hz;q@{um4DqD&Z{? zLaJKOG_kuFYJwm6RJeFF#U^^&xhLEm{v|ek9vm1Y0FWA-iWWUyAjr6L*d70mqO*@@ zdVl};DW{xH#pyU%xm%@^O4(5-_uG;q^;O2H$lX?`buyOQvD?Zigpi`bmQ;ipmV353 z?ujYP?Y6><4P!I2JAV89xBay}9^2#nd0*G{x}MKS`)rHb@XuJ27ouhr-AHuYBfN=K zqnOdNbm5&B%C%Q{+p}&o_p&yUtxMOJ<9LtGn5qbf% z@iS$%S(29Hu1ORPIE}#{1oEoa8rPFmgXz!s^pSfWp_a@}D~ed6@M=l{LcYW&F6@3B z%X0KtT`|oFDnN9*N`iB&%~xSkDH5T zG01pCY*E&nzkG(9$PdaZ6C18qURrP4ia95rWVp26(M=g>9*6q9OprA*e<2)vI07Nj zTY4Q3!(Tf z7sx^ZVKE=|*-)s@l+4twV{Ed`t*g#^Xq8J(p4n~`tFMc)ExC1&f&HQv9}bC=&<+Z> zc`b<*0$`eWohp>PZh1#QFtCalK-v3T@QZr0L0Bx?lbEVAD!W%=@OhL!Y}dE7$h=m0 zcST<|?s6I7$V82Z;o0c=Z%IT#jhh`bZF#0^EV0<^HP+;rijDr9+dUA9@;Y%7CvZE+qz}aZ;S662uL|#!JYprV1sJla@UD@T%f ztfdwKokbO)(LG%O>%Bg z-1mM5?z%5xeqya}%3Xbo9KzeA@=R^lW~yT~`1@cfWs;nR0&Q5096$at#q@z=q7M=B zKr<1Q1B@u2H}w{rhmQ6Fxr$mgcH*QLNP;0u*ijLU6_L>z@P5vg#$p8|y~k^HSpSU< zdx((ff#tP1HmV`{>6o?4tiUbNL&K(q{Fav{eu>!cWY?KAPU#G4R-4M6ESCTI`VwI> zPOJ);k{ThV7nK?--RP7KGVB8{3@>n=ysXdZLlZw|V(zo{wf6_=@y~l7ubXH+o^Ac2 znyt8&DEvo!Z%oIt%N;nW-b`P8{LK4#-O*cF`a>lycz*6WBJlAx~YwV>Sw zAm};WO!MGx7LzpiX(GMnP>4klivN)9gZ=(bD&4^Rey?t9V7M$!RK6;sPc8k4*u2cI ziARyB3ua%(*REMHBh5P$$t7*}bG|1$xO>OwX%1r5j{ct5;O>iL@-nW^s>I$jSVraC zCk{4Ye_8q>FN>}no?&0(1KRFJ3&EGAt9u@44~<289<2d0mV)ZEDZ<7dAxvRLWRAq@ z)gx8DSb3mnL?v+L)&1B)V+f917Ph%1OCt9@P*MeN8`7-#PiG z2_5H$W3PUGo3j%PIxx6#bYx_EiSFB=R*-IexBFw_+I&ZfnRcN5y%3Op)vPltAkCJi zTbFahF|uY}_{>i4?TF^5e*IrUH2W$}Ni&&LW%jzY!}1Xol6wsg0Je+e_!;IRxr?#h1p4QQTAQ}ZX>;_PrE$5t}Q9>~B~ zE{oO4i|`vReN65?LX1|3ywM$@oF5UOY* z$wyJp=cRJy?MbGuFHq!tMCJUwy$MSe?yvLEBC~DPjTLM~nPvuKB+}f6{1qUp}+N0;_Px zgpIYpmd`h3gjX&@KTq zI_`;~@K~wr*;x4^FtO9w%3V^PJ~`m3O3#S2N;Y3GbAr+40&`q{%u0Z_G$LsTTp+1ZV7lp{S2)baAw~tBR(iH z`_qcccJ~f*pT+|QoNysKyQ$>+vN+Zc;f!S=B7mwWmPlB${ zn>X~n#J6nm676Nra9vYGeK^o?^Z?OZ6^dx+7&EtCJ0k+uA#Ti?0Zi!sky={w9-M!<**yW(_w`WgYmL;R%W~G-vJucLs1JcO%J^kr`TGBC>4`GRhjQT?i()v?uL+5+zlkR@M6i z?@pRzF4V<|drfsWx=$ zA}Rhqh6>0nNGA4+5?gG3TKM!{q1pFpj@>nPXMUe*`Dd~7ouoU-F>Bz{Pr7O^22sNG z^GKd&h`)(|&+ib+=v^?#FO7ah4v`jI1%*xB!0fEr#A4|d^?t~s2eEx_ien(IuN3$gEY-&SjGS1~xe% zM7pDwvYuI@eWeu`EO7^LfcMo9Aw2?fHv&QA*rwqyvASQVn4v9T z12#3;0<9Rfs9K#4x-kxtSZFNzL&a5}aytqG_1nTt*+tf`aw zr@)Nx%qJEm3UPQGOX`rt_C>e95P6K+Z$TOK9?0eh`MMz`9XoHy6o9PzGE{EI)k()#c=4OoZCm%o(n@$jbNlauA6`+QXi zDW7WP-?YQwM8rm2%f_=?Vt4DBLz-vC6znXnZo|@WBj?z9UBZQQYArx=hJn;FJrTXX zwlo6ffE-khaptIj)`R7Po`&;OJ5FaaBj2Uu7`zVFQ-0J6)t=D5C>AcX_PnipDXS*5 ziHWs0$$D`7dWrtDC6qv`VMO_y}pUS9A^((M$ z@3JzdT(P+DIM)p(%0>U!2LBCHkp1kf0sqnj)#6P8GDVu=7QN(39Om6`I)%r@d~tYs zNf8cWn-v*P&rf7Wh0f`&vu!CH-M+9Bm!a50HBhj5NZWsop?K}y;wJn{|Jt*On)ahw zx@}?l^kr)8&8XiNO`a6=UOKkVmJz#u++w172GQk@d*TL709GR!VfcA?KmbClUSOP7 zjyBN=_cbWkaP~%sv1s?=Sf5mfrd;ZlgVAY?!DKa9f#pNhNjp&#_;>clo8o*Q@I6^R z=YdRebwXi@FR6{ok#6D4Zfk@e?`+o1_rf5=8i@Pq-T(x?&lQ5M5YvZsxB>ID(MYFrI+jI7k&oXt6&-%6C0-3u-b9*oJlMpfr zRXl0&>9k@rV|7JdGUuAE+I6NTA`$AaRQPp60o@Rwp=Ljue2It)hz*RKG5two;_#99 zQDS}x`ltN_cweRq&xJ)w{$FaIhkkBO0hSFAH$!{60N)El_cGZh0@rqu$2HEf_Dzv@hZ1J4Y##$bOWr!#I zH$*tnuq-JXo-}kc^#lP=9|9;>C+hEPO&wh%FNbn`M}gvkkqBbjKcJz9B|iC)#q!Cg zF2UAPz(U?*yhG0ndw(-FANrTsXAy^-FrP|&Z~mH+mu7!Iq?quR@VK7;Wk^uLdaydG)OSJi;fMxaX!5x5#lZkk%l1<%5a8Ar( zJFvVn4)-@f%Ry6R;|T+sta~uSI-~4hs@eyXk8ObD`?Cs=U$uCRsA+XpOzcR4lWpu} z4gcQAtH{$Cc|fevD_wH$2a9y!ci~56i*Zp4$-2STQ+0g;e7`A2se4cygLz*`Iw#bJ zyw-G-s+0XGq8pe;5%N^IIajxV`$8K#gD~xQb;Ne(0L&SR!Qfx-!kh0ZH?KXT&F?N7 z_GxO?$M3I7+6g{-P-|2yu7}K@8mbM7xkDUFm zh_d|>NhDNeHG47_cPQ{M5tE7^)eV)k`(ZE`n&a&-(OzTgM%DB;NHpw;FDN@gep9KA zNf!XMe-*-^8mmM8@&%&q1pIpvDoV0A4=!=P(A$DbCvgc_GRshlf}%D#+)zl}Tj zS4~b2I~??(?^)0Z2evMUi!^NR>E)7+x(V5_%|!L52hhbO#KKZyIyX)DMSA-m*mN6P zeuvb*4E=v;k8C5mO}@O^NcTZE@z$P-#6)=`;{1j96fvsv3p_hl^NEkx`P1}Av?jY$ znYkX#evNvy&PE?Z)|VcU7`upLLQJ1s3O)!Tt{mY_z6!}@%^V!&m@BbdUo_7gcR#BZ zI6oqC^k~=TwH-NR9BDE==7&YmnjA{59Gfti(|G~!b|ao+th)9Em2B(U1fpQGnd7{^ zrxDd*u)KTNY}RBaC2TP2UJ2c=Y}hS0vKXLtZF83CzMK-_MEgKA%LM*BKM(e!?2>-T zDUz~A9;j*oKv&GIrww(d+}lo-uL{e3*yP*EU$^?dVjr>kQFrS;t;|vy&iM7jQdyLWr%Ij z$3#u*xcQ)2hvH^ByU47N>~_$KWCxxw{bfNhS1(mp9MQL_GpnbJ#Lx^I8OPG^Y8Ye1icZ`#&r>Vp7_^jqe|#?_??Pv%0(WFibW|+MmR4RBkD}K{k365RASF|x2}>b zvlD%Y%lHXXo_y<@^>sI{#?Ys^eI>Jr4NT(6&j(kE5)|#CC?m6>6nwTtZsaSZhpsS@ zy9(|S@EN5Cvvj6&O!qcMZfQP>eo9<^(n4ic_xXtC{yL33vbVFR&MsxVur!DH(`+q* ze~lUe?gMfC{$kXLM4-tclgUp`xj~0~V933GZuu|3j``aKCG`1uBk^eSpivNgHAMS^ z|3%D4B8voiXx^)_`_i*DP4wLPf0$Aqm^1WihsdCec4EUY*W>Ntcl}WrnvrQJbewcQR=+lpVNck0pzY*9-WMFo%#h)d>7gtwwIAAMQgAASA`XQg%*%4DjKE z1FH0ySo`Ezsmh^R8y_xzIUPa~{(}sXzJuA~wA}LL+2T|E<4(2E(>dVBBLkHio#|zD zSm~xZd&R1&-nqwZ|2xznJk!2czQDcO4X49i1+?kB<_2ne7T^S3%r$uOcR_4^u zi3o-m3)0io$Eno#nm7kppPk;E8}`c!m{xb2sVT|f{}Qvc^>}RPM~wZy^J^aZAh=?w z2+%(K1tvB#k@aw#r`ZaWI@HQ) zvp|$tdta$v-Y3p>6DNxqugXSRPbLMQ8NYSnlzPc@+9Vm7rpM&dHx8eviIITxN19&c z>DZ5!yM-ES4p$NQqJMyf3q$GC71o8oPh$i=a@ZK5$%j%wHLHAgp0kEQxTxo-2eYOf zQ;b>Q&V=>_*mPN8`g|YKoYFhXac?J)KEq@W%AAE?9*r!v)-MvWQT~yMxt(yLCCtIZ!n(oJhdI`?L zZ@WfrQgm)9Y9UjK%>qg=5-H>;art!q!WF`tV=`l9l=Tua<6|c4#1i~pGgV#Xb@N@l z5x2O+2f{9&zi4)K_&bcudD5_>o;6Y=?6(qNN_FW&o;DYC(JHj_TsUEtDvc-Zia_;^mw7 zdX>Odb-F#X`}=ed}3pYF}KT|OT8Ye-Q4Xh3Jf;U&qDT2w>XnseX@ z_JN35QD)OxMqy6@b_|(k_Eh(1ZIF=wP57Rs+C|H$sWi(3(60{ZghWmk0nm^(Ivf=c zj(yeFOWpne{xsD?w#6o5*{k7NI2H06?Kykspg<@?y~vWb5#Q5a*T{Gdj<d)!lWC!%JyMow?`TKOzb(+ zVnSthnBw=TTr#-lUEEKd*I4IQE2eY+kS%{-`ZT*Gjeu%T0hvnC@3(hE9yJs?np$nFXV9Tbr>XM#QfuhBaCME_ z!ao}2&-42<60YA6-*yXbO7~V1^zj#$47VDTBvDL$o@4o^AzGGU|1;GBkQJz^uEEz> zM1Jt$0E618Lm<>R|+qi&dV)jn^tpdUK4bOjBNHK}L! z+UlO@w4HPWzq&-y<`!xuzaB>fpRge#S|6v9VzflnO2JQSY})EU$HVaIv(x+`@}w;j z`^A35kLr5O^idloL{CwCvmxl~XkKd1?o1!RSj^N<-S6|vBf3Pgv6~5_1Bb?i@HPO3+eD#XK)F0 zM)ntUt)$R<~tg{OmaQL5ISB5$zUUv7`8yBcCK4Lg? z&nKr3iQi}HAcnSXuS!AKfQt(|Ije^n+4QJGt2@l4Z~Lq?s3*&=4{gul7@nubE$!`L zeJ^kYf3|!57;;Zrl`O!#`^Q zY8i1-ioMx`F*2t-x8ocfB}6eb0n^OB?!Mko6!oJAGKyp8w$IAZiu>8FSBB4ly#ZdwWx)(ynEbLzSePaqarI zG%qz@I2L@F7<3lZ^Y-Mu>DF3tAcM9Fjht=duI`=gpvbS22EPE~Ry6O)Q>cZ#2o+-S zj~sf_^v81XYxPQfyI=jI((wAF9X*W3r&CwL`?h2G(NWtci@(Hs>3VppBai8R zsL+>0K2D?3V35`rD=CkdqaATP|LKmB{9y6P{9HTj;yUR^${1L7qAVSzA>5E!nO#NZ zEEGk!D2**h<5Lzt!$RFtWdCfS389#|OA~&dDYurdP;<(`8Hqk3*s@Qy69Q%v@`Y(* zlkNyVTDyk6C)+-=a7o$@5VPUm+p&olQ5!sek@akE%3kyY=ebD(I(LdwDwk%nOgZ^% zSs5}7NNluRh7=i_W2&z5zcjHx5R%G-i$qVn#B6Hj>Ne+0?|Vop5|S#KdApXLg@H5W zKig|=n~R(Gk?V?0dRTt_I+|-8T!D6fegKfA&G5OzU&-#C5&F5^N zcFfS6S%^F ziFpnJ=|YCkbDGhA&jVMnWAP;LzizdS2c?qsU}pGYs$Uiqg|fZ6JMiS9$!_Ya#G z4;(V8^)i~zg`%}E(Zbxc9H;c9o zyC98p{n-Mf+c2~%j7r7$V!Q+_7vYu)sJFtaXOC~8&xLxSf$+g^V*cfem3Q zrZK92kD2(t14TZXy0M09g9TPO+S=_0)EV8w&_?g{l>*@E5^;7MBD;6y!W6u?S1jN_PSY$Ye%yub{T{3z#2E2hp}!M7`E-|hln(J|IaAoqp#FWJ> zb;08QHf!YUJ>`;4eUp{E7SKU>QS>xbNNpeX8JLkKZuPE(j?zO z6m`y}6XF`>X~U78{kY&_+g!(a2mkmLQ$g|wT5l9Zy3XUFX0ITE4+E92fQ4^445l*S9;3F#qAlCFk>Ix4Vam-UxQ)S+E!`-)SEXlEFJZhWl?UpzLGA#96Ts5i|CsFF`R=Tqgs$$#K zU-xFwJf3>U-VW^XHv9Sy)yc01;~*@!)Q3U8B36Wv(&pw$kv-sRpWUqUWMtq8$h0R* z)@N3+Y2Aj>$DZ+_rOkO;Tvqi0V7jRTuAU~B&G5yAO_|k0$3Z6!Zzz*!JDwov^(gMp zb7`%jNSep9u3)Gafx4!`=l)rZH^E?tBbpT*0b3}vl6dST@YPMXco0oP|7XTIXa z3or0>Mvlk8*K8M6FX*q(Y{?5yY}ZIwnBus1jcp)HnH1o%uA***K0;_%4>!FoqxE8z-)n|c-HS)$7#nI}zDyhMf= z^J!ur!RNH(xc;D4&ssL{a%^zQ^j{_MK&_;dt9%uHO1t}JN|o>A^`s1A#Rpme#r11) zPSP;uNB-Zel}6S9#iJ_HW)fZ-CAy6U)#&pN5>2*f&;6SG(iwka$E&_^Rih2P{)y4> zOg!C1g6-b<)&D~xd)Ag`GF=-h`!(iqUNXaNY9_w`|LoFJt-hWlfqD1YMVbxH;}url zQPJ$NM!W+}{S-&M^Tujjsh4erTlrbRQ!hfE+r9%Jm?0>m!YzTg{p?biXBvDN=qouL+GjRwRFs?p1@jiiT@1Ja7&#lRO*i$%@H zeTelMy^8ed<=*p75!tmcSwqtrpoji1Z%l6TB`hG|n}wCGh~0X+??IE$jrGu}bM`ULDK(rCCkyX;(y)f3@7& z+*b^4!u)odC#|oKehdbIeF&!`Z~pRI&hd=gDX?z-avbIi(zJV%n_?a{4fGq&Q%nLu zw#0D#2D)?{?)nk(j_@qEi20pC7PIfa`@_v!4tD#{C?Xy7Y z{JlDqZES=HfZ+dZY>+w3Gj-#?=M8y(W=nk60et!HdnVJyewKYgpGzYOVZpNpL%iqH zE05%Q)EwT|G#b|`F@ztXe$#0ATbx(ZtYsPV4&jaTU)V4?@We0VIX4K04ivS(DDJCt z2d=<#D!L)TMlKPNMZSIdLgG=-ba|GWawz-ava0W!>YjL8I{`7hZQp^DXDkTZi<~4Z>S473&Z&6H({mUzbVrsOc zNEd&g>UKtoNfWD8y7#|4Jqlh1{ris@CS>4yZ4@6T-%wLFq-fGe0Yj;`GFmCXG2LJ4 z1lHgS)Aa0~IY~u}87W-NgVpdY<-*@B<;tYHrb!m*o*tunhowSy(9%MSYFfU@gb638Ms(TKv5Mg580Nh3q;Z&jvL>{o@-?S1=JK(_fwCOTJQg*C8gVkqX z-ld9s6)&>{9VSJTzzHKBCkyN!f-h##7mpR&8!wMt()^nH+32cyX?p(2s6p;tdJpJZ zP}cr>G~-riiqQE(b1`gfM)9NQBji92X?4178@u%|^s+i>;Vs^Vd-bQXA$=zjTZC3p zk$|#i!|m8J)wOPieQ{>Kq3D54k?~J$y8(^SueeV!*n5n+HpAeslmTDoeKTAnXA6p- zORKORCTTV|Ie68NCPI+W$jp?eg^}mHJ)i30odQR!r$ybP;p?;&E3FYh`J=6_=IZEM zk^H=_<}kdC8TYJ%x!Z=lsy4Vk&+H!ev&qk&Ny|-Gmc8(hU{hTrJ|A$u#%gwhM~|1~ z;2h?dg)q%8w>+N&i@0r3^`>#pLbI4&Owy6Wf7r18z%p5M zr#Mbf6hA;lCA!mu*je!DLysL9EK35Uqc@YaK!`0AfIp$vOSepnM{=65@_9#{y<$!J zli$UhTks3wLI}F2nshQVH((avW2XF9omqoPRd@e0Rpkz!xW#&Hvhu@_K}6x|_wHD< zu|TvM8|GD+Q-0xboW|X-^^7rT0rZ6L4xIkarr|1S)F&Y>Ei0jCU-n7D2mci+(+d&xM<5U2ibcqGkwMMKgGxVU7^}hO2V-D zQ!oP6S)+B1#s4*);7Pm{{H;LK4S8dk)4RX_I7w8hrB9b}7p{wBsexEjnG2(9KA(U> zyo$pg2g{Oa>dn6AinQC!l?=eJ+!S4&V!>IM0+H6G6q5Gr-&mU@`HFN8lc`rxe7eSN|x&6Mmsgx2spbJsDV- zJYF>4-D4ztn}8fo_~$~c(WgCKzCh)5{TK3}5}22!B;08)Lc3`K)9>_x%zBr?!@^&+ z-{x+A*FY^At|Nk~+x3BjJ0tqPwzD4-T6juIf7hA_p%*yLLy>ik9T_HXhZDz z`hQBCLr|WTgZrWN;c)h&Kq4&u!&W@1tnWO57Q37(dTZBq-%bnb&I@`6^QNRK{>uN3 zy*vFd$A{=8D{^z2-)GpYegDM{Iv0Mtm+Eu!2|Ds1Ty|fkENfqVfe8Hwfo4$S39JbbL!h6&!jro4Joo0#dzbn2Zd)oH&z>}-Ww)Kc66nMp(>h|nZx z;l@K$udl(Ku=Cxx6}F+1p6T7ePyaR2uKGsXRyjq|aj31@cx zIY7x3{5}v*q8p)2uw82=+z8g^zsgnypwrN#%w=|E%qgPlJU}v9jW@Q?_XmC;_eq|$ zREOcinExq>-OI>KnwlYLmVIm77=4N`@ngkiF5aIvZT_zu!6_P{ovx*CY$Hz+|EINr z`(Oe7p;MMqmw32$fQ62kkvjV_m}J$dL8bgz_VS{*&m~fCJjmVtuq=syX#fQ7dc<`AAVs(Da(#+P5OkSY|6p1 zAe`Rs-P4zWLT9iuyM*TFZ_9;z-POqYK{#xC*y=#3Eo$v+N~iqIdIcP~r15xXfw~Ji zXvI^zPUojB?CSIP#5fH91{EBlxExKFxc^cPk@ z;g?1teOCT6^0ZS%5%%@!6%KpaZzJPsu0=d;1*kBu%YDFtMFp)qLYmLNtS|cm~5bSDgk9Q5Nbe*Yc;ZE%4)fFQCqNq(8jb zPSZzka&qLpZ+7=wSCm5i9ZL}R!YdfJ7!vhgDas#w1VT8<4DsC(LHk&4g7|{DBcn+C zwB^!VjA3E_np^0)m)dZ7Ey)ljp(+eQ#(i&6P#WSR?U%<4p4^(2^Qy_aMrz@gZ?WXd z(GoeUd}^3m7!nOd7aAWMam}xW2M$E zTA4N||A7*mw!GePguU{?;LYw8{;#c5hAWzub7w2nz`Wcn)(Xvd?iKnJ}hR1WaABEwk z3S5a(L-%|HlkNSmV4Kl`X!gvio(&w!Z^rhd?26raLmr}^Yf;54t!QXyFhby)o^+Fd*UGKX2TBi~m6x@w2#X`aWl41qIDs`PdJ*kR`tsTfBNL zEONf#&G?_epJdp`VnKIpx1crRl5TTGi}ExL$t@yU0o$_742Ovz_kip2PejW(_>E=Dr%Ha-rIIq-3GihW%+asJw|t&xZ}`b8$b zEO``pvYro|UBnGF3slcZtz5C`A~T8GKD)k{zIl+FpH}wF(ysyp44t`sXL!}afQB*l z*kCs}Re2n$8B-nO1%k4lM?XpfT%vL}ajTWz9YZ(jU^Aq=Yh_TBV!BaNKGRF3d!;M! z7g=Vd^>KJ@uZZwYd?DUVxwzn1CqIaoyaFJ|r0>bAJAM60egAA!>%}i%$bG5H%04JF zKb@O1y)r%c;u|l$z3qDrwBcNuB%}z#9!=&bcG08me;(Zz6YH_&4v1~~#c~o#X++>l zN(nZH3=$Yl3%Y;jyzIIox;>}(0|Y;1o|NORc;2(+%J590OO(SklevqRX+i@A@sWRD zesEr1THdv&9t30=e3d-?qd%SkiuP zW3l6Qdu_RTCS|8-QtiVvWWtDr{(LRG$zhp1${z6se8V?x=;X_Ef-teeH+kmE!eb<& zQOgVnG;;O2ELE)DHq07ZfD;}SHN9G2%I_=9v+|}bm)d>5#LEDwALke%s0b%MU28CN zUHKOiy7UyO^zV^n@+`Uq%0r|FDDuh_l?oJmaZ&gkWxB_)lUkJISLd6oMXy6~S%`MR(1v5O&Lb4Uy@# zGewwPK`B_g83*0w?#G|%p9>tn3SDaN^!xBlw;Q&YCPmE4yiz5W z5IvF3ofFHiA&wbHO1Q)kzE{J)rD|^2HScgArOi9Fd&2m6>B8)uCuSVAryz;~Mz+7? zUPT9_;xitE0E`jg{0T<`s#c5~pEN_`Dslu*WYhTA@J_{PywCrUbmo6arf(ab#)@g0wB5>u%*q-|#vFHn%*tl0)M;^t zQi~baTv67{DJwHHO)CX8r!+TIau=vva>sJtpcF(wKtWJ8dHH_cKjHb|e(vYFuJb$& zgFmy~6~jT7RJ`lCc{9ATL_7-fCO^%Z)=gQIzy`f7ieJVaAEjhzE)={`MwXiC`rgIyxo_rLhd9>myJpZ&@n z^gDH0%4@@)YIodC|HWe$fp-;vvN`FCle_ghvp>A@m-=XAs)Bn_n>FTGJ}(Pn_oBg z5`r7h#3>Z=Dy~)0y5j{>6u%npWx`*^94Hc6FZXPi!po!U%BACyP8V$R7q29;)qE`M2T@B>gx2v3S1n$cu={A3>ul28lNOJQDd;K z=M>A$EVWQ;h474=AK;qOL#CU0D)JN;zan-}&+w}I$uDMx@YchjHtS1Ykda#R0Fw~- zuGng0*y}*k#`lC3$1>GHrP*gy)ffF1@JG%bB^*D688HKzDst+<_?hY;(UUi9*d%B+b&y1rp z*D;(-X^yiQA&7fiqiemb_Ui91PVO#TA4N~W(w+GnugmSO@?VBW5Nuh!T|?Yi+j7Dk ztgS0CjdR10?VmsE0k3g0UNdv);GH98KoIfS5>NN#kW_9lsk-_)Y}_Srni`yg?nrfhB*l7(Rq`}693WRB~dXQBz|eq@|INn5j^BTQUAAzL+drkD$|<(!HwOcdVqwn zwtSVoPQ7S&V*fGQZ^_2r*zzBxjgC{9V6)ir!5%0HU%hYwV6$ULDM)m3yh`or<$Q7Y zv6^p0@24YQw}^Y(8S(b3qkx8Sh2p^6R@Bbl@DjFhxu z6eOv$*qf_Lq_2QS5x+|U_tx75p1+$p3CJo(c^tfw4`V08#i|Xtv63Le0Qv_SMY}#T zenJVyPvoWn42l)v=OQ+5%nsvRd&{7Ld~k#Z&lNxyC%P%yy2!>4ecTIQ^#37sU8n#e zTwwi=7&7ebD4YiZ@TD+R8>;aUrAA^rF^B2>Vp3wuRQpcgo>28y{x7GcoiU6f#6W8D zi`Yt7&5>^g&#uAw+T|E=gG1~`|8QxY`oous$rh}Y?!t=Nc)V4mA5+DR{laA+Y0g0O z!^9m_n1w)Rvs`;W{*!n?%hopKm#o=QYrFb=w-+b>BsTwi!-5RHs=ME(v1sMhV0)K` z!LC<+I*A9R*RRBN`UR*SjhiqczNq z4}CD@uui$$zf4+3hyn!_Pl{Bi{}ddFVyI{{(fC{ zI%C@P8{kVOlJ+bWjjg{8@<159v!W^gb3t#k=;n5Ecw91ZAJ^BNEQvxI4 z6H3ej#T^c2&#tfkh}gi|Y)y%DG5Ll3e)LaL9Xh_NQ{w zF}o7j_Z`Go6RahQ^hA>C%l8qf2du*LE{#?iq)dh%!>MS;f*CMs*3)FYS@x~yw-8NAxT-tJ0{mr|V zH|e0QYPpvHG}b35_{rmegX* zxRdlIL-5sccP4XgI|=jEC$T}2I^r1>(Zc#s6rBKQ^qoqdc;30_uQ<;<)$77+7~cmKA5RP z+9jUAw&CQ}Zs@yyJ*0+@2k~u5?mU$5?X5k7)YI^n#qyKxr3*Sbzh?j2f92hy9 zV+8HAqqlFcNhg@Sue+);^Vwa#$2B62;*K0Gu)ItL&*vq?Pa8EzTJ-{Iy^1Yo4A^6k zY-H4evzT|>V*daKEg0ws1sk>LcY|Q%11|`Rl9!;r^9;#vmAw&p(i9sm#$Zqf8~oXp zE?j#Do?Mkexwg(x2& zNbix zHub5oOCj)auL8=7-|H5M(xM~4FBe(jKDz!60k6xgm-lizSH@n?(RMqzfR1I2#l(N=g`9$IE7pxF(mrL03L~)%mb{ zopZlfL_A#_)fD@rY)8^Qv6!^DdM3XSjo_J8%`zNs(Fb3qdZ|k6zCRtFrg*xSy^A}T z3Gjh*u59w@={My0W#Lds&_d#lnH>`MbKhd5g?Hf-}CfCE+;)s^$PP$z1$MVWX z@gOcB-vqxM^x03R=|a35nW2%Irab>h1o@`cu#DHm{}Z|5qqh5(!VX(_r^St_kNq!! z?~ws~Cv&wll-{`GPg$$pK>f{stii4O*3%T5&Ew@A@)>~CqiR(=2_$+%#~l{A{b9dy ze=7)>5)jip+0uGYPa5ap@RP+uFLp#bbn!O878EPWfJJn7Se4wjUOg zvG7tY{Op(a6gF@?-=k7osw?4nvoPP<=TZWwRrS)EmJH^C8M9$)gS|3v7W0Y2xyJO+ zotr`4?qY)?xj&Q1^#Be7z{?Zg+*Z?5_o8HK;dV}iy1%&PPN=*l0@gnOd#RsHUW|9o z%L!>Ms|U}(g)5WpSHYOM=C$+_S={b3mTRqjsoR>5#^c&bM*E%79*co9X*-5YF{5jN zKmn7DRA-6O&gqsha6uK9qRMVcI?V!(5muIt8Sv9QvA#yJ(sXZU!jFmQf%Pn}HdtQ& zucu&|=nI!^v5XjoH8Jo<)`0!|dNgeMS|_}^xmB_AMmXaa_@d{k2N%l%?f{l>lR$0m zaow4bn9xUBY>~9ETHiECeeyE6?ITQE&_~T0@hK_zV-md_wa#0{(bdnZyqhd#@>9mij)zdog?cmh zT9_6Al<*^1K4o0vGXaMCqJIOqmbj*--E6UOb5A&;`B{E~`~2h)c&B9M4{b6v>NVTL z9VAqkQ{Ahh3|tav5;f5fRuS2o-|l69qO^WZ%ZZ#aKEnS+MBASdJpO4e3lleDOj=?#zd zZ4^&UHyyCN417a2rm5$>rm=7-X&`fb;7}u}(;Z?!VeIZ~Sc?^$B+CASy>UMZYGPUi zK1Q4%HC6C!1JnYvEnIfpqQt8Gtt46asxeO}ud=vZ-8UJ@C+al52Aj#AJc*2xu4hvy z2loOw9S>-<)XzCiZ9xRe4nO1ZeUviD^4-WRz4&3`$!C#SPjunIywl?2x^Tr|vf@@g zdPK|9X3s^7_8%L)KUHpW3?KbodA8V^mY&z=Vk1A>mF`<=#d;XVK@~%!oxu7OVkmCX z?fo~9Jy;>ZZSp>~AltJN6!C(a#h5(Zp$71F@I!@S|SJ$E5NX8Qf2l zx&4;Kp@bm=Yer<^_riu;o!mLjb_85A9M*4}Wy+@biqAc8(utLPq4a|S&~ud{^@FBJ z^n)cK`wc1Ruvye{pOyVL$EToM%74So*s$8KJi%xIvg0#6tbYEOKq0fn*a|bD2{~?| zXfay0+S*b|&R+-3exf3o+o9LVci`AFDG<1C5LIEVD*mN{x^DOE?s_9!4 zR_`yfuR4hvWhl1M;A$go(EN7eZriD-AtzX5>L%&Y7o&dfL&Ky`PBf$ZL9J;){_7u( zRt*>Tf7#SLbN%zDyq4OB>vKPGqSP;3>ioPAM|_&(f9uYPs_OohI0ycxQvtXCy}pvs zX)i37CB9)CCkh@K!4?Om97^695AAA^++@k*srC5_60Zn;ek5w~Ku!_LhJZo8?FDTB z4pYQ8EQ(LB{()H7!+uZ-h~pOa)2pqW@X=Lf%}`GGC1Nb43y|M_$PHLccr3}%WR{QR zXnt8cHY!zKd$LkynTz@XubkD*355oGd>vSCC<3+$T|EBc8yZ3YB`(=;r*Rl_vAG}| zlMCNqbDvK0U*fo0f|Az1KfJiDvxOf2`|2k1Kac9Kd+1%P4m)uwC#CfeG_f{fF?v4b zEY*2I2dvHDeR&5t>xv1U!l2*KctY3FXs#OsGkefR8@1P?Hc1iqhI5!fE+HbWj*c;a z4j=TYyFlp4)pq4GV0l^-$l*vfMw;CH?8QpqnAqjuay}$`JirsK^dv~3#O%-*koKgQ`ywd-o z6Z|y8A(y?f7%EQXfTpG?HnnZ*>X)nZ(cjG@_-yF9;*Vf3H5dq#TJE@_`TR za$D?2tUj`8S$%GwC{OLmCR)8`Siy{9<%0cHq$dQ@n~-N#fqsH$vd!u`sc*4J+|;H| zk9}gQa3qvoAxS%?e5pF8ARdWD!J3%qvQXvn;O!lei3yenhU=g^P)`4$2TNyM^GBFmZ@IWKmnD<{>p zL&UvWe$MDFS)fT&Ql9(a$ZG9gR;gc}+E=e-wTI%?c3wHL+-|Nd5LvSs(*lYK&uDVh zT{5 zY4HoD5B9nZS$Cs&k#d3iA2J_X(|`UK%l7P?G5PjXnjI<+v|KQ;W?2b4XazEx4f*@h zV#qMQPQ0^T_4p={M78XYY!ffqdvH6t>L_nV`wszU=3N<=xfpF*wl~B2@a0A=U9^Aa z&SLOMT-;SR?5}(CF+HvU?HM`hx*X0i8?Zz0N~b)jZyQ^m_3BW`(X+*n9=*1I(k{uL zeH;*m-dOulUYNOI9b!I;_tx zzhS|Q!BD(Ox!YffphP_(?qVG1hoTXGP(5*y%nE-C8-4VE)l=VOKKI(CPy?2Aqxg%_ zyKEjsSovm<7>VJBS|DsVr1FIJ%KDq5t=+FvLmrqB&2qIg5ON^xvE)x$BE8j-b#pXd zg}a4c{!^3bzg|?B*P|>`X$OVqEQ_b&?>=|u(%?5oA!&MKOg3X~&xpoRNlw4KE~!QK zNj3j_^Q&oRQ1FFj$=(%?FHN|n&YMJ>$ZssK7F}j3n;r9j{4nf@%&2Yk9?nHFJ{jOo zQt1O4i~5#Tk9xfL(PPLn@~f$}od@jU(-Q1RwuHI-@ZzPgrcwD=!i^`qlsxGLqWUJ_ znN=>2bH$J)P{~GD?Hdb8#dg7jCq?bug8{h$AL;^Co4guK3F)ar?eHmJTxNXO_fB#M zUEOV^?%VaT!xA=uITVd6HK8@s@U5~44(yy0-pY+(9&wwkkLv5|m%YgGC9L+^Ygf6F zsRV`;r}c+Am&^7If0q65auURC-!JkJDF17$jg{{xTkH5~ens^b4hF}308nSLyzH|< zz6S4qE2euBJ8~rZ@1xw0dS#VQk*SG8NXz%iFEQF8SHZ68E-!UKawLd?2gJLp5C!_G za_;+W)N4wq*Z>E0_(M<|Jx(X~o5 zefwKw#!gU95DXhDxxe;3U&|>xfP@Iru!GumyX`}QcqSKa*+qOQ+r_fPx9f(9Lo4iI zX&fRh$eS8n0#Kbs6xg!?wIeXLi~rF6cPW7za;2HXINH!7(`fWx5&U9RZVKjsUuz~d z%NQ-0NiExZs^oS-ChnAzkGy{GS8lUiaHmrUv9h7wI4HDhMxKNzXQZV(8z(<^B$Gru zR}b(UW+u4PIR2^Qq+Mb>=OUBH?KN;5ByQl7l9+%w`MsG)oa)eQzezOwT}nANX=Mi+ zfqs4|S|zjIk6SI34u_NSQ9EDq&sp<5kz1?WBMWUGZd3k^Jtz^L^v6>pA6LuYQP)jk zz{C2YYw&NX4?=vJkl-+*ZSfv>4F}23c9g7A@Jow2hj_XDE+{N=->dBm? zpUJAj_{X1%`e9Q9Tp@uSbp`J)^;oB0A{Y@4YSIr z|MG>ESitah?EPXxiwKK+wyfJrt%vy{eG;b^F6<-c5giXH-wf=d+vDHV^F5s8$o#m^ zje`R?m@vSZKy-YoEJhb2?^QeYH8@sUH+^tN-WF9yKMR$w=$Zl?M&x|q3gn#dEOM&y z(LWXzj{n_`8ZNf6RwS>{93N?6k34f5Ub$%}=rE$SuDK5FV-XyBg;>y!YSkl#br)e< zyQZbMH3?1IK_8pHUv0c%w5@srq^%MdJpe$%H5`k|skDV`pjz#emXo>0gmO$Ryg}FV zMNzU3b&y9XXBxfB_Ogj1_GJwDcnjwV{~ybF6I@pXzZnxj;!)}nA7YigaByJC+Fxk& zprgL4YGJPC96uc#ATQ|uv2g-zv)#u&&a1S#xe3Kb(AtmhwZP$= zbP{S3;?d{Fd%jF4etY`NIq^dWK+4XcsZ2!y`QSA^>{G@8+v`E!axYE=ey-SKU{k*o zTr`5(AP1;Al)J|U`RgFP-U%q}!Qn+AQGXceJz<&!Do*?dYm!#`MfQ6XokP3xK5uj}9*6k8QF)#;n(_AzCo)_rK zGF?bU(|%djWW--58! z=TPDJ$)LuA(bV_IPSm=*2bPC%Ozs#-x}0&1E!! zla_Rnm}{{A8GyvB++#3SM)7Sei;_87WH;53)5{%F1s3mfN>ovary->;r|jcN8IsAy zc$h=x0QfA~5)66#v95WjX5yLAuNMt{SBNf+@mb$aj+eQ0rJ}ifH&X6w zX8%11Z~Qjj-XjL-3_eKiSNuDQ=cBGdX9bT|f7*XaguS=Y1pd|CUxWe)i3H`&1%L~j ztpLTXwLV?Hub7)I-xcSz&x5bqH>`TdR0i3jiI z?(rql+?Sp+&Z$2|f(I0Xz6p<4cSEUe?RT~K-l8Dr5>oE;ou?1dl^*mhXBKORz2=xV zl1BvK$C2srOO+r6Or%fdb?f~X^N+LUpNgnxZ7bBoI2zhGD~pIpF=1KXS$*NSeJz^N z;F?{;+&YaAz79Z`zuh-o=)MZt$!Jn_>Hw$XX4xXjR1 zJ#^LovzzHx;^2d!z@FpiVD0*2<8)sJh6f0N&W{2HQWYEIk6id+UDJH3)g7=$GoxJ! z_%fW^e*t_x+M^k`pRavsHrCC=!}7MpG>vy&shB|nx;`5^geog{*W*%65&kE{TDEh7 zW|@Uf!^?+7eFp3!7T)#Q#!Cb?5`D;3UIQXjcw$a$~zgI7Nu;*<{&;GB16UoxQKdz4q!*sCx=+}P0I|{*` zKuUg5`>4UJ>@F0?h5;8%X>mDddy!MW-q)>lYjZF1!)&~wW1NT`eYPY0&VrS-Qi}_W z1H{@)ck53RS%W+2sL@1OOOtCJzyG8*K1X-_>j zy0+84Im|#?hMAd_woeF;H}gC)p$$k7#nj6j)*`kBacA0#KIoS(J_S{G>2``)nB)F( z!q=H@*aEc`8Jq6`ih%Eh8q5y9!rAnni^6w^itFkLedFX4_~!MqH$RK2)-CX^;2!vn zX_Y{-bN=7311Ys8`i_5g*oL(j@LiYKrsIR^znF6stR^qOu-hu|=~M;eiu`GVM)%yD z)sOZ<;YQ2XD)D#Xm(?F|Lg08R2O6X_FRR7()%s07@N-YhkWoXw7*2H4+2-Oc>6tt@k@ zf!19H=2`vTX!n5$3j>uQGcIutHZ4=ycd!gV=_UoNgbZ@vVoO3g`OR~L3*CF|6Yb5e zm-@|7;`DOH&vWe;Kt|w_lrH49$Y1Q}q(Vsk%6R+go4EycS;JQ9BrdB+QXLA;3C6;` z_w&X#E_b_IL|0m%7ML_{ar1}qv$1!A=H zpfzfLAkQi1l|>hVyXI6ZEEYtzNQNWEo^wChkV>i5%QrvhYy&KeI$@K zolU8I2_E|dnnfuE}LQV6JfFq!(t=x%|&&?)qNo$HD5r=_S8HX&#x(e6k z+D(v~1>l`2c*K9|X-g(#IqmVd)s1ay00&Ocwmtac0Ygskc2hD)aiNYsW9FtWa(d4Q zUPy|9EGzneOOX|EGWqF|oM)y5TiZ{MbY?o^OeRO>3whquzz3*l+)&O#LGAIneN~OG zN0O#T{xK9M#yzVb^P)ODYkeiXu@MUyKE+-Us(070!v``P%Sg|KQA7GA{n7H}NT!c# ze{AiZvgY6YZiG%XzSFJabYx@r*WfMKH<<)G&9UDZa8ya&lG{Q7=KXbgT|S3+5xVkb z^&KR=P_?)tScRWsA$-H;j+8Tdm{k40Q zVkQ#UgNS+Hm595Cv7HOOr3|BMK`Xiyvly7VuW*^PUqKFAKUq~B?+-slydW_31QCjq;pgWAdg4r|^5yZ50l~}cU zb-C@#G*K9ln4Ot8WUtpgVb?JoRZ(kEiH)}PDi*n~m*~h%^@aj0pl#RChjPpSb)4SK^%gb;BGTePDz>d>dQqQrBg z3T(u%$WY*Oz8^{5t`{%zElat8+tJCegOM=*>5bxTVkwV=hV$7jkjF`N4-`4&33rQu z@2rM0`?mz#C}xPea`HUnHe{QP28@Q5g)HqBpnrp9xJ`*ZL*M9pq!gwQl_0kh6k+uEMojpiqh)m`lR z&|Ix3eoNWp8t)nOOL2oj7NI_IA88LCK#Mm_15N0ot5+8L{TmWpR9)OaLH4IiL(uKt z_L_nDxubI#<(7%7rRag?2o1PMw$T}4-aO^)Sz#RMDj+|c*f8SeaJSt7;V zxr)?QZH8-l%>?|nfB(mXRi@pa`V384E6B%YB{eSeVlg9e!FFV{KPW3QdWZ|+e&*&t zR_kFj`QCcWX$|`t(7=(N5KK>xLNrk>cT|Gs5RygAw`gzrcoo8R&dDK{=o!PWAMNvs zz=VcjIHNRciJLegav~KqNvnbzH1Rf|**>f2r(EXhy5ekaD+Lx1pq<@*f;@zdYMY z&dF^A?(9{2JP;8c*tq{@Y`b>;H}RJqihgkm$AzpzK&Out!k&SzHYDnu zi_1k;oqoD{!zQPgdC>Z*Ths7g;EHP35cBi7_dw3lk{CFS9lN&I%@}peSTnLvOCA^3 zo_!nNcAK9fzAO91HQBVSf zKuX|@Ot))S+r3;MEm3e_yaN`JKT#%oZ6`mrc?ndEjW6F*gh-}iGWSICr?uoy_;2ug zyt3<2`La!=I(iGgTL4he6H*M6m=T!e72VWvEMJ9a{oJwkbD7^SLkZO})q~-hfy{u$ zXS0(8&gm4KL!tMuJ{cMIm>7TqZGb%q_Aori&BWK%K4?3Vs?RdwEY>7d#PQFO?)M8g z)1Y?!%rr_1!=tgg^@ZWdXW@%8NLOE$@9;OHMya=ca{i|Me*(n!5rD8!n*E;u5JGxh z@t0c5DvJ_vXr~Xwh+Nr5lL4OU=}S~Jm7z90=%?ArUH^~_1}ob6x}}j~GyN3ZMzFJD zG{+UrR>7-QZt03ZQmL<~(0I5R6KAHiL?>tt4k>q3JJ)McV-L_CaO27Ra)m z{0&QGj(O!u8-zD|$yL|KUTDk34OX{W8iR8%aTad?ev=)z17z&q0{B+rz!&AE>`Js#ZWt2ff=0U2DVjDf}>3xm<{M#;2g!YTwm4Sm=P zzVAYH79v(}A*&sql~47grL~mrPp%CVC;=H=ZvOA1zZEq-rm`5F<-@{BpXp)QW6Pk*raJu{_75kO|1z+w zoKTolPF#}znjMETC}!mm zjB--I?+CnIUU=E`&ns=wBn9S%zbfQ)N{z`@MZs-IeSTovgU+wliq+{cQJrhI2#>w; zq;&p5Cxw~*=nCxg=3o=zbI#V9?=I`S-!4PJC9WO}M?wQ+NRQg3->mqKQTE=_bI=<; z1Enu3e(*CZ1tuhZ^_fXwVc&7GHU?G6_BCvejWlOU!qBDzy8tMto`x-si^o z3)F3kl`q63p0N?zK0VX8)Ea4jFN$hzyD>rTI_iq6sjsUE%wZ`0GEjFqB|2c@X+tTF zeuCi&O2W7=p$m` zsqTrpkW6%iXmm;r2vX;&Kdy|&J10L*D_8S-==KKc}yx<;Fn;y)j%M5Y-=I7yzLn;GKE3Tp=x z!fO9TfDg;l6B`V7pD2<}`(Iut!0Ns3NV=5xZLa-4g9Cmkfy}5pT+p$%c{c0kXm_&K zJ07Rrq)z!J8>L8hWQ=c>M$j;o8ltPaSTWr~F%mUjkwt$rSAJ4QB_X9V2SnhL-klS~61Ll4}j z14dq^$E~!uP_Kk0Jf~PXqI=)gPDgfDO8bCc-EgD&&GFJ@GoKbqEjqNx{{Sc>hYQjO z=<0g<-|5L;Hn1;#d9~2<@MyYyORRr{`o;iZGwk+y^=G~Nm<;*Ha$rB|=J@W9lXm(@ z=+za|`(rmu=eYz>i@)c6FAtjr-?qg!&bs62(t|5Y1J#wDMxDm*JExp8B0(>8!)o7| z*~8H<78dRP+&t_N5hA=5ahc$5xx&!#0LlaD@xy-@zbvZ-{98VeY>)TA{;fQdauO=H ziGUf-hEx*7T=RkCzyb54lYNm~45HcTSI}(V)@z#AW8z7}1+mF(v5bUk>_W!W=*tQz zPf+oPxVgI1X{{o`xl>$s%tqoW>B`Xl`Nna{_D4RTQs?!#Vb7BzlZ1r#{PasQ4xK+~ zhS4SiU)2M)!vnC+!Giy(w?Dri&%nG1uLj}rN`X_BJNmwjCffH;3q)hB`(#lqOGVK) z+Z_}1gJYH`UG?abw%ro4wIg_X*Bt3334LlgL&BYkXLc5F->#-K#s{mGfxv^0lZ?S8qzWtzv|uJv+abIIY}%KVRWD_gWQM}AP^5T@FC zA+oc>p%Kx@6cL+gE)pbWVNZ7j_wW37BTK`X=DwPdvX9hZ#P72eUDMxj(e45S9yjP| z1rGX_Pbfh*h|UQ=3IDLs#&5bSC%*0&#g0%PrMdxfT=TarNX(ul%ry06h{Dvz-pxf9 z((Q|Q&Ya}lLT1gT(2j>sorLITEGAF^^T!o<6ORPR1WCxV_^I!DjxCOh8O(ykgHSt- z%o)0PU*mQ_be8%Bkod4QMRbkowpK|Ovt5KM(h6ocHQKt;Hl&gv-RqNSa8JSTT5q$+ zr-`2H;fbsemoD~r} zOhV@-BTiU@uKbkrpXK3%p9kj29E26 z_BDHTZvkb;ebal_M|meBQFs;l;}0|RW{)%_9AmLdUW~FTD{vc!(`>cvsVNGHOah7y z1*xk#$cZTVuf`bb4$#R;jQkB=tAxk7j?VSxA0vtitg5SkRWur3ANPAPKC*N5nh?1@ zL|^o(U#_HT$@2L(@{88YF=m^!%2j5-4e*ps+r`Cj5a1UOs zZ{9_il1%R6LjY^N3)-{z7Y(`w`L4`TK6~nD2@h;^-;t%m5?)(J6+awSTJm(~%A!O- z@9CK^HAd+8eUAuxUwI;Ukpzm&%fnSC;j=(Nzv-^@G_L-U|NIp{X&)q6N}pOaVnilU z-FwcJpT53$?4g%>ZPGBq$#b?kU2cgx#LH@>{8oyL7n-&hSkz5p$wEfNdI>3|+8zT$`mQ zUy*x-3wPEm7GQtNaSWhyS0X1zoIzSNY}GywQhVKHIKDviX)zKcc7a`%_i+Pnja&Gl zYuxaoqz-q8C--&Y+3Rq;T%=LcHRm#03KX6tZvWQYcKn^K4$>937T6o~@qlR_X`+<9 zvj@VG)3;7^NKNnenNkX$4c<_MABI|t*d?Z$mhMQ%{dF}q^g+iD)RBc;*VAMj&i`9hqLKvgP2>fef&K>axH=+9b3KKuV&?SpQ+Kt@z+~V zq1)fKjP0?4vI}wZ_^aDSzPd-wa(8_-XN_!N(N3%#NlB=_5$?x@6SV`0Ni(Vmw{o7Vo)UFG3p9SN5P4g{3gB zq-!4s;AH?KvMZ=(9NcHk%E@L#OjhW|u%e}3>%GLtWBoJ7*PlxNah3&NiOfGXU7K7i z7cc6U#VjDIA(f0dP7$+z`+MBGTE7&zY{V&d#G!bAGA4a&Cj-zM(#k!j`hAEyb>rV^*M&d4D!Z{51Cp9BK)Ed~aaDnFN%0UEl1 zlqs#`wpw5_;$wsh(2{2$M5qr~`Kd-DdeITc65YE~+Kd-K$sG%I7$7B$crVWyX@(qL;fj z@!Xr{79^Co%s7j+QX#fDZnHGMLY+xRQkoos`eV>j%6g>wFLgF3eq=vmyJeYv>B*lvFxRan8sid|S`pHB*G|M8YTTV_ROK>qy5jGcV;~hT$Isd?Im`s^ zCf)n&8X@K=Am$r7h`c_C$R$Zau1bWp%x`Rx<+prDvv|8#-iRln9flPejnZ&C|?(U2upL?Rz z@yuR%?a`FzfUKap@#Sj6J;`Zn+N7>~mOJjXwAQ|W7yDphu%ve8D{G(h@N1pe8FsoZ zy{gI6a(-X2PWxHZFR?v4*6uK;fg!c9OR^z~OAcYA$?vPFo&m7@h&la@*_4zB!af$w zTdds9$QN~_gfX=n;W=-*1gRFOc6HBb+}26~sguxzulO45rY3hB{l{EvHteQk(#~%+ zz-=##lXF?|kcFW%J5)rf+RMDZ^E5w+t6Qp@-E`5wqsURe)Xu47p-VmmOAv!UAw2T8 z$)*VuuX^+yQJe4&ln{27Znt16D@&I6kw)ZV+Vc1tWO&`mS5EGUUvmPhdyE@dUDC%V z)4Pfk-S$Lc>dh07fJS}>!#yMM6r^3M?m;%IL8rRiDg_3{8L723KSijuFtvI{oR$Ft zo#aNBU$2vr!O6TQWSHFKZ}7dv*Q##7*c=7CAgb-wjzS-v#I{&HCrdMN^0uCn`2sI?-U>$e(sqQf zQh-rh2BlP_;cONu)pgcqtiO90E>8mL?z(P`u~~r^DnZ-Am##Jl7v2v=0Z+iSp%8&8cc&*jK^l=dbDj4c}~fIbp4@X=jlIJI3DI475+Y zo%3>$eW)_!pZ;pD7rki^dAH6awr2eN;P*_Cu5syR=#SrYZ#cAHD9&SVUprdt3Ova! zWQNoOCi%QypRPqO@BBSGWuGdTk==JM|A@j9+uPya5_mqa7QQ&IpUa^AR5yacmgJ-fR*t@WU#fXX*fx8DM<~9!(9<6!{Xg@7|=8jVO7p!~MLhqd+MknX_~4Gj3{Wwe~=-R#v1LX7kQ9R&RB0;_EF1I-|z# zHsZb!39_y3qbRwlH+11}YUiOC%eC{vhTW1qV^yx4&6v^LG}pb;%vsJ=3j-){iOltUg z;DEoeP-ULAtNGX>MQ3DD)IIv(#A_WfvR-*YbeSiiIlfUiScSbRgF=N3C98h2ys%oQb zZln$r*i*6kb6B6e^n5T-%fJw7faZ-z=O}qerIE;Z-bHlgl<1g8zUUgxd&%Mqjr>f) zAgC5rNsC5^Z8nIw^jThMv9wUZPr~dd>C%e4bcwAYoSXpk50bHCs2 zaH#I^_6^FiqB@f4*}Ce*Kjg!D%BOkvamjaVR*otmWeX|mMW|0^M$+X`2nBTBe#xuf zwit6F?tJ;JRPn8F^|{p8?jx)n>IS=#m~f2x_UQf@D-GL2t=Kp06^aoMzxbHOkhCeW zfvJYIdJ?Ky{&4i=Zve>r(thz)`IeFH`)TV#rlIL4E#i+|w%lQKHvW$%9t5uuJK*pL zxT(6QKCeeVBYeFos39@_sCa)ZEFwCa;9s}CGT17~0qZWy?1lbP*iIb++m|5mb6PKl zr-O!FAWPcD{|~*KvwAZ(DqhSa$0;};2;k#T^xpwS9m4o>)Y1c* zUP1O+_?BO4S|%^OV+PKCklv&9RbF0DC zp2)&lq1UM)^bQpL)@;9k;>Oy6Vw`C@rrBYH5lNrF`D_7Xi@zjeZ9C14B!PbJEQA?5 zrd0HE1M@q3rlft9ynctp4Ui7$IV8-6OeAj1Weg|LayzS?1Qjf|G*3hlr~qD(4qflM zW54jvRZxW_PI5O)at^*YR|45>&<*(7gKUz+9M^5v4=FohQ`35fhg&4i0xWYZ=5P5C z4rn4HrvSnQYAwdd;Gq}$fK2rYGx;J&F>+-a+bO4<7V zadhT?NhSWKH+vSh4r7s#w^K9);bxKnD`xaNwoSvh5eYo=5xYF1b- zq~?l1rQ()iD(*@uxPXd)sH{GGpZ|bg&g*dQ_kCZNx*2w?l1|dj&~LOD*v7dYO2up8 zshD0(;WXY6^2R3dd2;tu{-oyMY<@+}1j%vm;|w0EP(h+2i=?h9KXIyWEp}CCzvs;I z;fhK<5A(pwyN|!5TZQ^rnt#8Tx}KyvYR^378 zO9mp@&aZvSK1ys4kF|`^^HQcR*yM4J7KCAwPkLq$t$C5MACBojqY z`b0n;G|6q;=rQbl*{V7WBWbQxT@5HjrrrAt4BTktT)S#{lE|JuIHYwZ&VMvy?j7J& zi2~%LxIg_O5i^{yb$V-6P5SFD9maky?_A#qkW1wtkgdf}IWUB0j|i%%yM2)(W>}Rj zFi)%8fteLK7U9^bT4QIuLp^er00ig2z9Z;0+B$8;n@{-<*y!bh=+c>v?yLDE5drUv=~)Ku0vdabg7dP zbAeV~dkuli`o?(7N~j^?DuYaZhluBmv>WOnw&o*0fYw?)7T1c&NkFixS^}TrKXA6z zMQNF^4j7B+t^?&~DW}duN+xGPFA?-kJ*NGOt6QC;!T+P*aplA9lq2e*5PYJF@-Fdu zXf%OP4F`sO^L6@tAhVopBs8hVNUGIJ-OAZ>L%*G^dzAb+_RXr_EpZF3um-V4+cvmK z_fD|Nh9e!F+rul*#Pvi#gaG77^=0+7gEUjVEnB3w6pb%XeYJIc@G+QhTpdrI5KZuz zdF3{L@(H2kmdo|aHoSUNKZTdJd=@xh3=v*sStkaTU*DlKV3S>jCOe9Zsr53z=ESD| z%F~Swn4qw}mFGnNL4}Rz7$pfghAXcUYqVh@m=kySMoNl~e8^hvnyfkk%Xv0OCTc*B zturCRYWy$CFO7&}R(jY~7u`hLzQjW<>(@i%0?o>D+TK z^>%gw5qPBlKsmXeWw|Noh^QQHuTjYiztr`_eEfl=iqtt*2!Jou_V@d*J2Ea;$vHM) z_M+8X&mpeus{DceeBIfnc~8OK@`v%QCV(dG&V%e9RHn@t6%V?q^l=7uEkE)IJUZ@4 z!EbE0olOxuQsjF)v4%o}pwG4Ro2n^FzGti#DGtfG>jPJ7 zz(%00Z9w{mgR*-5qzra>LcZjTBNa{-oq!3K^p7Z>7|RX4IM@l(4N7tLNhvS(NbNc# zn?7_o;;CQ5X{e32|L^Dz4!dPa%iAwy)2dT<{gK$ZLje zjN}nA7%(f3^!>;t715?P$hUPM^1&eBy zj_xTYLaAD(B0hJi~c*;x#X%qm--;M|hF z5!LVP4iQ`APoJm0wnvU!iu%uAHQ~$904{lk1TJW65k1HnHcr5Oh}#{aM_G@Mfc(rS zehDk3)J2h2&8Fq3hb!tEqH-lLg9ItH^v(wzNsszb8-7e$=DxM|zZ~o(l1_IsHNU6Rdem;em|w;|Kb?f@DlTPe=IjU?x%q z;U%o=4biHzDudiu_YjW>zmCktg#<<O*t=QbOED_zHlFau z8xkrKngsu!AiBAh*wvSAulOr)Ir-cf{9lyUGoS8iR2-if{QIN9pY^$qUL*ePzh&g9 zMDF?gpfzPaG>jD9gi~#20(S7n*`o=6i2@^T(>u z$^O0RuZQeopIlG0>1{u7dx!tIGlG^$pV~{u0WTQmRAK8)Qo1~|%jhKFC)5{phi?ld z6k`v3vl*iN;-Z);^;2Onj}7sqhu4MQX>&}EosxFPW%7{tK1tZtr8YlqRfd&(w#Y?U zFS!ra0C30t);HF)+8n(kS<73m z2w(JDaCAfLIP=~fPq12@%&>Wwn%v?@@2MyMc)3|_mst9U>a#GH4vdaN7Sg02@cH{1 z=1;sb)l+g0ZU&Y_VvORYo7ofLf&$uUIXy-!O&vt|t zs6K|^w`OQvM`Q4Qz!7>Ys32+reaI%dQ6}m4y%av-JE%w|Z@M53zHx{X-$PDx4c_OY z68GVp5~fm1iR&IsvTMq~RrZkz8&*&=1lSo6eMxe%fF1M9c>Ct^{AA*BD_|sc_n17# z!kzyHT^4r5oB~uT`J2iipaKmLsofO!v5=jX*4ow^d z7_cZKW-~q8fD(K310PP(z^F_?K(sj7>Q0My?gQ|BYTEp(<{UBTArN)r7OaBvr21>7 znfsOF>c>f+q#3{lwwl21M(Ptk-a@~9ueL9*P(L8nMkMV`U_qBv2F?XU!M6OcfVo1< zh;1!RYJ=w^06(1ce~`pEL|1Ms@J zcu357tKvmbGTAV7WSa9RYl(bVCeJRe%qxnGM&+CIZEo{KhnPp~?8s>1CdA1P3#yDE z3E(0C(-X`M1%XSI_083zh0qCV*f@E+v23+$yL1dsL}rEM<*MhGSh0)epp#xmTqxm_Fm;b# zYQc2IA=I47^5oxin0hA4XaoH-I-Yfi3!JptO1J5a`LJbeq+8 zjohbA+^bb|1PuW?eC7yE_G&Lb`tN-7&j)_dO18%)H;B@_kil_Gxp~?txj@|d-Yhx< z{Ty#U_aM#hhl77>zi)5dq!&cerT+18@Izk*$sh8UbJ5Wrx!kYbY9T)eA>eihOUMBp zw1@yFhDtuc39lfej6(^%Gd9rtB_5#D5FGTO`oWEGhU7js7%I4|f37atQ(jsPt~VVr z@!h%_K4;8Gub-1Bt6MlMh{Qrp3>O{xI|G!bI+x&JP_(jgT zeE0FCzbYPB^=6n8?`t#dYW~3**egKgp*Nu}8&&=G7vVc~ju`xL?3Bj7YfgG> z{r@y#b6;LfyW( zRUS@g4~qWNhUV{Xl#sBG94VPOcjMHNTIy$-%G`eP5|$a}v)JxsI{akM2ZsV1Egf8i z2lFZv^+YsbHGj+e(pb8`up?2~S*e&$`b{Ri3bi?7zEBsWniP6!{SV7^mE<@oJ2``n zL;Ag0>QK4VwJsBo_mdWu1T{50mF5%>(GSojYWQ<4){uPcbUG`n!l3MAzF#6YH70TxaQ6I#jS zJDjk(N!zuN-9sezV-_k92n_9Z5x=T#v1{IMPrPiqwIJXpios);MpY_hvx;-%8&v`M~PMF`^gVlGhn*{2h& zJ|~AtX4`Z*_VV}!ce1vOdJ2Fo@7MG;31tpSQrbCRhSrkOVMp!+n0Jc|YrPJOxDmUY zC+ji4qqop5r}RY2bot{RpbG1OWW$o6_Ln{y^&5A^k`bxP@uAeA__@}_R~>k>SgkH? z$>6T;B2%4O^uhxS|5fy{$hkLuf{BJzNk!23t9wo#bvj9CymwMJO}jR+-e=FmV%d^s zI~{V=!MNCHKhX8~jl5lcev*^>owP`Jbe%Jgti;nG+I7yMExev_Mi0kVHJ&%hILfNd zyqd5@g-?OFJGfto+S>XPP-(1A6>qKj7fgN^^_6oz2Xq(wIjt;qf9n%3Se6;%uWgW_`M=#-F^>V!o-L101X%((6Rh3*IXe-;Zy z-`5R`am1QziZ;2qk@0Z2;|JEsZUQs-T$VBsbZ-XztcE)AsDx29379CD6|1oj7la10 zSdA~7t0WsdZFxri3pn~`bzXZP=nnPXUMb;lGS|pEyqteTgi{XVg_0+{CXp8TF0WTBaT1c#@x<%P|f>ZmIsPs zj$-@HMlezqP7j}-`+}aqdG7q;N-YD;KPL{ogd6}3u4jQh3wiw>VGFY)@m*9N!}23h z#~2>El%+pK=z!#A7Df5@2SIIVu7x{d@;*$!0>`bIJ8F+rF5xRT>czoR>E%{qp*Kjn ztqzOR?bZ|T7G0@7(m;dyN67}I$BwH9hEf{GlBq+>>pnbTNgBbEaV(tFo+|QQrjI-w zW0}Xl7r#gwh7{n8laYU>PoYhPG8ckPa#$2;5JZnDg zE<49przx(4jyNHwy4A9F@Xhjb(A}Xo-I|?sJ_9W5OK(S`y~P5l32{2YBnC%L zI4o?}?b}DTHJ|)b(l@&UfeGuI(0wy~NqW9^E<1fOHPY+=DBY_~a`Mt;lkLII_fXd~ zTDQ$ie~KuNtgM6I5*>dZpPN-rxCQE7?)57i$u5qZ`(2QfcQMii9v|7&B`MN+#63Rb z4LryORppp$`oCEo!f3f``lUSq))MU35rNAZB_<^|%v~7Fi*>TC33Nk-T&emHMy*Na z)K<^3mj6?iIqul0iQM%l(W_BmMS5r9Jc$_{R0 z&)HWSlxzHCM=4;ny~5U$heLy>D!>xuR`ESiTIa&`WgIL-4k-^)!h(i=a=&FU5RymE zF_X8Vr;JCNa#l4~j!Sy*8(t4fMQ7uK5(5_H*-Z(@=T_e0DkhD4$(TRH$KexJmPZ(n zGTKGyS828#qVJ+|I0m5IMI?VjrBvAd5^=?e;mf72w*AtMD5fdJB%0D5j(CaMwGS7D z_;jFk-1L8l=*!9QmSi)bqHOC(?D`ZX3%RbQBN1Ee$v(RR^D)nLY(nH%VlJ^fO4j4~ zU68ioNtT3W+LFe`)mnt^f%;3}_Uk==s>ptor(yHH+-kF-J_(|gLh$4dC+sbDQY{v62DC7M)Yr#`p8FJ8`gC?+m%IB>`${P+C((LLNuTRvFg*X0}*7gmltEhIRZSoRQP>W@vc(h(c zrhF9jLH!E=W9mXJC7GUi@3!1}LHzFJ>|oYRs^niE{d~h{@w%;5ma2y0W4=b6(?z^r zEomyn@A8hOX5kYPK1Jtj%wIW5%nFxA4TC$dvg8yV$qd^9Qm;a0I8i&ke~quiWV;2R zc_;M=KET!1VJ|C0L_KKL4a`ROy{nTP@DBODDQ)fOdoVcvF63%n3AT*S{kT8wX6i1= zabIiI;-&AwYWvM01FPO`JmE57Z*!BWi4)^YXZXx76RL(IiNFj~Wr$lBzYhT>b+w3Q z;96Szj2Op_4V=VqUb!2dS)1tO6P8Z+`jnL@!gezC;V&F`Up*=uC6`8gVk%aq`$INW zdd;_P;F!?>Q$e;}WLFU+6jCbsT_{%3Pc}SdMz);y4!D9;lmfF&kh6acw@8LSzov?T zTMB010_%*rMJn&PY;VEnQ`mQ+9JXfIuy__%kv?mYOpw6@qPm%E@PeNTOd3d*yv_AP zfHE%j`VL2gtD<+n9nAKXSA`5KjLFHzFBcy)={5o;N+-2$QrF)`7IeLdnki*SIZw0< zS(K2BNXnC}HrE7uYgwA1ragtChIHt>=!8jMi1ugQ{_bksjs*A9ej7Lu#P5d8t?|!E z4}&D`_LA%N@;8v0ws>)g9aRSYPUxy(xuf7u)mtA)FFO##CcPnmOfSwG^{BfVmY6lE zi%*_DDx}2hjCtz`U_O)jM={RbfWG?=w^A5@IAigo%CB= zbl7)5kN%I_0V-3-ji$w7<1W%`6+aUOQ>CK`j7CNe7IDZJznqR`t@sE}IGNpWI1`|| zMTeo=VB2D+s5o2;PWZTIg(&xN&I2Nj4@37#ri2BXl7d7I zwLQ)=7cK#0!vKmP7{ z40$uRJ22ujrZPOB{UZPm75Zl;Lf`%juG&8RtT+*~dw%7K&OTUKDkj8i?V6oj42V1q z<-jH{LyHH6s((9~1!lrj?~0Krvi~!d~SO2eu1Nx}-$*e_dR*p+< z$s+l1PHevxBw!odL1{lt#j*URB*CW%lh-7jc7B4ji&TO9j`8HXK`)ZUZ`_Vi9q298 zbw3`0_YbQc`TTTWx5_MWE38wiqu4ZeRrq_Vh+>)|8H?uuwIjMGwgfJ@#w_T_?wMIek%84gqV_dQ)2T! zVxxgXvs1ipkZm^3@jn1_e?GkP1( z4B(Dhr9i?e*0_uhv+{i_`hazTnGf}x4bw{|bR+dA=1%<~Ch6DKTH~f4iC?9Qv-2iq zy$Den%g0nUn!&j?1qu9;%qk)?@?SH8>jy9nq{zQ=>;rfzhn8*b>W@h#B?3kALJX}X z?-cSeUukj){ed#|N4<1od17v2DlHAk_a2kw`V`=LBj z&>V|{1;Mou(x0+0R^$??esvWG+B`6)D86K7px8!Xlh$D(x_A$}lW3c1%90*(W{+Q3 z`X?@G0d``%dTwp9Z#` z-5w&hGnI@(J{#3z&V|lftM%9yXs%lURBM?!VrrM(JuuG)4vo4nVjy$<{!RtC&DSdR zo2`qDoC(d8NPnY;9!j(!tT$+W+QU1|K<6gnU)NV|or5DRAgBob4N}v2hV&wGVa>;a zwGkOYUkC-BpJ9`!2~=%0MfcHOM?~AF#>r}kqd5QTTrf*(Eqb3`!Hx_;4`zFS^Zw2c zHv9NJX6gL`ldsiT#Mmci^JfCjn zqz|cmb@!YRFjQcG4|b4EbODFgN6M&Q(j?xERZ)|2&Ong0)f(#KcqGPzFWt8gFfL;u zPM|sd^BlUvn4{?iQ8R)Rx49A8U2irMr~*@Jd{R@Y=Jj~Lw=1_D(sbgx1+D-84?xn6R7NDTYjc*KDbMGsM zhJ}3f%K^N_4Bd@u&HzhK@zj^?*J+9upo|WNF5Vt+wSm1uK+*^#b$7L?U2`5;dt*T# z0(Am6e|y%PZf4rJ=px>)WdR4epv|T*fAzOPUSua#=B09eV;+iF>(K;9MLr|VDQfVh zue6u4EirfJb%k0?9QWd)#E9pkodtS&eVKW}A@Uh9XWAeD*>3wJY2LfpRrn|YwHxp3 zv)oRiST7$C3BkVx{Ye%GYS%g+%HM? z4#==){0*HnnlP#lA{1D@NiS93NNHJ-i~4QyA--UkLrn~=4v1pasV`+&Z^RNz1Yza2 z96}Q$m$whxgvlXQCbo|%_d_R22%zsY`;l`&{*iMTOBH7SmjtaXNxjiS78GRCs&8I7 zss7VUt6Ni`a|rFIAIJUlG=i?h9#l!vErxgql%^eeNryy3#J|JyS%2!33R1Il6SK!O z{YIFicgr;^dyPlLHFv{e4L?OpRS1~YBZSQ9#gR{wR$nH(mpdUtGTj9eBcAe)WjBN_ zbg}#E%W(d_mY#fvI~1S3tB=`3)-Q}RbP#lMHHFyNRXPG*B>S>>16hd;tB{}0SmAFm zjX|Z4BKUT!r)a=l62ivwg}#YJEk*NQ0CN^uqImHQPxHdW} zBbDE)X!iti(yMA{`OYOqOrrv+XZg*mwnr?45MHn07@wayhKN1=EWKE@kK9h`nHIU( z>N0I2yGK?J9@|V+gRgEd=T=AS{6!rW;3HT`p>+GA&~fs$&mQ<}yfo%qXn=CWDCEje z{qX(%HqKqpY9lqqghv_8Q(NCXIY(dCJ{}RbbQBd`SxQ1jer9}(wVGl&OunY<9?J_; zuo7e!=?+RR^kLLx;Ck5s72hBld!Hfw=lu=$)DknFQ1HJ{L#rFKVI7wCbhB=@TpX;_>Z~7+rKIZa`MI1YqmA1KgAGzv_W`eLV zWz3!PkZ_Zs2qbNrpX3A`#y(Y{^e?D%ydP0+y!l6Ifcye~@XeE8H`~nXm#WxLoQ3e zr7^%NDNO;zV6&uJeYuT_dODQwNmBwt<-C96k4SZhI5M^SAkTrO>ARgX>B*7t}@oV zck-tMbZKU32j#cXA@piWW{2H(|A^EtK;O?SUXhOgNw+web|4p^S4dMl4t^jvyTnX} zH(Cq7N$~cRkLvYJT}8-|ezWv4H64bFqVy7Wv1jezr`j?JN%~NTBeCm=A@T zUn}e=UOu_4*_F<5VP#LVb(flaZlpDX5~ZrW^7I?Q%sc$^P4E4nD!;=o%!ulRK#bIt zaiDIynbWn8&tmlb_eH-@h^CL#i=%7D2U^l zx2g@jHB^fy85l`=C*MVA?9g)gSaD3d8pWUck78k@x42|@Q4kdzrZ_OS zM>sMx0-v2(;A$}C$3F%0%9h|w9E3UEphbqu$T?cfPiLMqvm3v;*EC-MKw$g2mMG>!y{zM(YV{ev`*r97_zX+E-W6ds& z)X|+$OzZ#|JrjJ+1@yd4{CnlqwkEL2ARoIJ2P%vV$;4 z{bsBq^py>)*SI-erdApCqPTW5*$UPLi9ygITUF7jM>k)E-ma-tLcS7_wEd*0Mzgn~ z|7{wV>9OjFy>p^8Ey+j?qQNht980}X7h453$_QN==%Wmv@=!yH2~+~Ys}Z&Nv<)zc zROSR#3)}P3qZWI{ytMmkCi52vi;5R16&?f~#jRxP0eW13Jr!39?dp&$0oT{lHKd>` z1|eYMHBXatLN{r zcmU-=jElAWBWH3?d%ZQ;7;_0jZ6uqMQpc3qTI7vV@08#R3qrf(QAwQRoak0S<{_sJD^3avw>({sf88{pgO75 zH`;&zY{;+&)5TAPWqnSwr>cld6su5Yl_!#s!2gR1icjaV;*oV#vy|WX6BFe9n8wLw zl*2Zw82&-r*ZqQ#YES(Vf_qZJn*Y-!NI7X08RSU-#Gx|;Nm-SwpbXP9$Fj2gd?+dd zdzPDd@cBS-srLK<62R(tlBp*Pg=F2%t%!FajO6I#&z3Z1$QLu4?y>C00tT>bw*n;a z;!=`6is~>s*z$|jirW>+7jgfAy2r`EbHLhva4iSJCY3SDj%(-4*E@vo~l^9o_AAG zu_V8yRJH*T8(ThYMkOa_A9Gn;X$X`(_?m7T_DjV<^GuRO2cI(UW}seKAzu7jRQuu76}}>yz`mdY_MV2aaPT*NMq?iGrbK__AKf^orKU1l6sF zuvVo0=C#ce&W~+h)K|K-#-p56=4N#`TmKU#Fe`G&7qu`FLCRxN?X zRz=OpB4&e%6OP#4v2dtLTD0G6p+FRpDBThRYU?rTMAVcO#B69eE@A`C*0$+`0OtOC zOS^IaA=7atYOL1uBxi(XtFvVh<|F zH{4YWPTjK^C^;{=YjQ)-g^G6Iek&LKE^qIenCTJd#^QCzIQCWiRm4+EP776L4V?&B z&Rl*T#nR^Ku;jH`!I$f7zP-eneMZ={;YS^sCRYx@ly9Q`rMW~^GVl73$}_j*LXwuR zCyrM#wzw}!Z|HB19pA41z-xc$dPrqu4rJTJngLSvXbH?K1f7Uogh0MQ@@j-1ih78( zBS2nPtzT|+Qt02~FQ`iN9u2t&)^q)l)Jm9(!wad0lP_qP@{DZ!y{rk5y z2)}Bvx;acG9>fwGd=ey|E!lji{tCIU9&jeO4DboFS1Va%N<$Y(&xMl&$cM_6WT<=t z^m;fz@h_v?DoZ-9e+s5qRbgIfLiEc&J8Ef;jv0Nr#Pn_jmqxs>3X2w8U8_Wj!wQYE^QJ8%J)0y zN$>HtSaV!Y1@;()14T5feO&!8J$S<7Nxqb~rRP{8=f5!-1cxpXGHQLQ;2yZ*CDdP9 zw7iFM*_G=rqt432%9+)|yR|7(c2?ZEd;$duT&z`t{7vL>+u(M^zCk)Rtj zQ^rtIj>|5Uo#flHGsf$1dX=Nr>6XtuL}}+OyT=><18(dEjc`A|*Aia{jVdg-YMsBp zEipHDoa)i)D2R!hl-fuy@P7{`U#>MLEkeJ#?cDGzU}{nx*8k|&9c=5Il47-Z`-F+V z6M9r_ZK3o0KIxVJNUNX)`T;NQ1s}D7UG(9B`tdn)qeF#q&izy2)lhK7g^I;Xa zAd1isLs1&Zy@m1n>bEltqu{X9~VJKyJ}^wMcvQ}*tQU&{0^wBw5}osg*o zC15|A*f7JJ#@f~1X$O!lW_3|yFQMQ=DnpZw^%%?lK@EK{rS)FhD)|}fZ!~GyB3-z3 z-1dL^wXj>_<{lEm7uVcx{kI>~<}pjbqbYft8#8H2NA=eq_Gpv#JiCE@YbtAg{3~jA z+^6=fTs6b^-&@8!X3U>b@?%_e0NZFsQJ&(PL9cYfx7B##6a=!7sy-AH&5$p&p zs2^WTHWPH%3kK+Lr7J|hRkxP5)#;b0v8TR>9~@^%x6g*YR(l100lTn$32-K-tsK)~ zZIV8HSZZLwlc@7BFEeWB@@)cK2;3E_yB|0b0e@{+B~9KKI*WRfUaxKyo@kAaI_aDs z@?Me@sjc!Tz`tDus4X9iLi3>PrqQSlFKS4!@5z2UG~Ae6ET%zUlgx z6EUG`F{{Inu&g;8I@ycnjNmlw)&{!{9U%oFZ;xC3U6HtGo)~2 zfzO^p1Z3cIMXAzLvBVD73Jxwp>FphO8rmIc+6BYr8x^dx_xPIUW|8T@xcJA~>uThU z;C~~yY7Jtvdod$+V9o}bscok(uZU=P1_KRi+s8Jn?*>bc105xIh6ukTa;hkf>gv2{ z!!yyfW1`TOtSs8w3E=IoZ_1Kp zVh4;E8SOCwL%A#b_s-1{(%d&poU4f7zYuY%lZM_;)z*!)-j3aR zhQwbbSEow6GcGPTpjXF7%>vx1oV)s&u@Tb~Gm{rlpxER_9f@#!Wv5V~agbl_x~uh( z>n@Dbh?J6_+6ZGv5 z6zUuiz4!r95Z zaLKQUl5_II{B!FFtpV9_9aC`=)n-S2tisO!S4`Y=w$Y0$pE3KlL+ruQ^1SZyqUmwP zO_=TrYz9tQ$69J$+p{$M+WK%@2_-Zlt2ni?(reDaZ~6evRilu^BtpH70;`psOZ1K) z-DkK?Xa2yBu{!B5xrPVxqdq6n>lT#O(j)1Q1m`<$>>$}qdX{5kZb&t6QrPjhA&*ysjgufI;(%I zIs0r5`j8k|+go4b%ksNW{`4TzNO8hhTum(KE){4lj~bJW9sK#azWK1vy*tEV5r<8c z@Mf~txycpxpwA`g_l7FciSa9+wSGv)BY8IA%0HIekO<|zaEz7(4VOF9Q?N?Ik%XcK z-j(psIM-n@>@JIISOyeYdN!HL-lgIJ9uk<9opt4~C_z=R$hP+P5VtWWRT%ek{$={VHU+u!Ux2&r zgRB>s{Y{etpy-wxwz{#keF5o(mD*ih2a?fu(pS~lC)$FWMOz~O@+(L!RoBuIun@QS z?Gz&wvSU@U+YKXJ(eTrVI-?@}40xbJT6y46&ogPGo6>AO!lplSM+hgm*#DdK+4+Ro znQLbMiEm-r?uD`IM4|1~CzNE5PqBt;k|ZuWsIB`)&!L1!_H~sICRgq6T4!|Y*U`b& zI>n{dlYRjq=&d!eJ!_(t_v_aN6l&skWV=x79=z;py>91@)14?0srDVLBu+3^iu6=2 zay0uue69-ud`-o8K%TG2L4H+n{ZsPC7v8y1nD=q%T4WYU3hr7DHm%Fyw!m^2utH5U z0BaNfE(LmQuh8Zpx&G@d<`oqgj_O+`Xw*$1Nq;lT@ zyIkV}lgW~xJof@I9sxGK) zyvd~i9ws{i&=^hQ#NMyRK*zv=r+?*5*BY%Q`DuMWYFb{jra{v9nQM~oFG%k*)(;Mg z-Qd`lD~kOfDhG;q%faeQ6l82&f4pbw;US>)!eBsU-a@dUvGbQPwV)nAD4mnF>q%E%omcN=QsqXa)9j}*WS}EuTeg@uFqXc`gy|rsdOfF(p z*x#tjZfy8Lj24~kf#_lLwS@lXs73XmF4)(iB$HvD=H9bq${OE-Y4_&Y&&rRQnZ$y$ z*qQjKfuL$_?xBq2vTQL_PRc+{O!9oA+y#HuWQmzBjUSsL^#B;>SXJaaXwi}pd z0T&3jaX!t?U`k9xh-nyWbNH4MGj|X#`(-OD0df0Y+BbzmhqdTqsaK;X;8x6-H7X#>)psS2~lL~M%= zXx`zIwK2JNHs7ca#V8|yv&fz0Prz_1AG>LlbFs+N!VujO6G9|@wX>~5VcjwtZ*PaRf3>0 z`~RjpFWL%5rewOOERbJyJ&Oar7g(+ePXj}yCE<;-8^AaIGr?-sq1NiiCj)QN6wQ&? zg;_ugDS|G|t!P>>%OOE}`{5LEanh#$_O#X404Zn224&@*rF~C)4&?PusXT8=Yo<@x>CS)|1JNhzR96>#UXfgd5$9=j?BY}pOI0B_BRvo23n(7k zxLuGgpVb*YFR4^-s*xrI8C6)ZIPNsrvL}D!$?vF&{GsJjg03QYW@JLq(rsDtMs`H) zP2I8|3#j8j@kcKmZ|{scc>I8m$>PYb6;Ma94{i022!5$qzP#`22vMDT`bJeDb?K>B z9MD4Jj0ufxIT2-{(J}ubQOPs>DgBkB{e4}e^@D_$jBG5XSQOv}yCP$|(nEQy*M=0M z8TIFCK;{cZAScWR%xs}jPFH~6;GSikW)DFItL2Z7|D_c70G6wt*q{QB>nNpH!YX!0 z?CNmP=j?BBhfCPFG-RfDTBT*l@0Zga)(p-}AB=#=v-ngm$8eu3Gi&eWo|uOFfhCy# z%XTM6%54`nhR%ikc$gTgplwgM$Y1$PHLInf)(4VWOJ9=M_b}VdM|?FFtx>M^B7{II zM6{29eqN5AbC$ANVG^+?CBABG+^=L7|9 zMzK) z>JKulrGzJ07L!d2Ifn3(NPb}{LtV#u_BSDEd!h4;-{xF8|L2U6?tX)yz&2*hVyO039AU< z@m#G8@IsNl#iTrL9Jy7Mxe=)KDDaV#a@>&h)(bwaKSK9{RSMuK5OiYeM#zFX{b`#s^LU*_8|V z|5_b@E;w*qMT5T#qLpQM9bkuK0ec6Qo@yU^n{flXC}z-PQecmYz>kGb!64Izk2}b( zN0`iC>~6M!Itz_3(ShaS_(rH|`f_{bn+U$VqNcn2m(_8-IQ3qYgVN0E1imfZ5+?Ehz0&#QKiOyj@QJC2OJ@Z3N2zE4kKURu9E4c~JQ*Klfj z*?J}d{3PGR1Xxm_L)>Mz*lzuw{;I|;3^5DTC~te<3p7x6sT~A;gg5Emx!YEvyudNh z(*5`WUB(Qmuhd!`Hf)Gc5k!UUUV_oAp0wzn$wNI!iVty(@^WX8yVNU;xy|yhmNR@Y zITHKPZKrAeb+$Szy1-DzOelk1R^Bg`hm8-O(~TAGVIW?lY?9{|aaSW`Rqpc8<z;z^9>gnab=v#fmZTrp%u(qjbmjjzm-O z#10tz9(Yqb2*62uKIQ0K<;YoiMhNwj>_TWbBkgwaGj{or;2g=>n{|+!LP&GJ)cCDi z&%zv_CY@Zchi&M6m*DH6b5~h?+(~&Ji+50c`NLF|j8ik@x}i8(Bl45*VlA#z^aoG# zDXnFl`8)ZBhI7N0(MP-;;X6G>D!?5-31CEaPztJ)e_n;LbVXRem&b2X&B|FN@kMi5 z-tNFdBhuD|Cp^Ck%Q4n2$|yeS#ky4t9R#Qw3n6D3nI;9o_r?`UsnfJ%Zu9jba8m$GOzBw7r=C5b&Z^6_ZMmLqDW{VW zl1nH+{|Oad9ECcG$KF+{IvyK_0Lc7mSw)0@SCLl36*1BlA6erwpgWiWHdcZDMH$xX?Tyij>oG9KD<}dyxA(hhX~mlfS$yL4Vn=f z7b9e50;}GoiG?Fj-j;ITGJE~!swYmBmVXb89+eN;(#G80z(E^zVG`v(j0?7bcR^E? z!W4{QNDe$qsNUCEj^s9D_s@;)`xq_v^xPQQI8dR9-H9=hae3wjCY@5`_50>2av78Y;%YHMm*A){Z z_bfD_DBf=@Iz2asX1jqu`-5fIYRwrNG46?vhPTqhw2vnM^23Ewhcd~yTGdgDnInuE zzZYlAki+YKF?DnFFfPz;Yh^4Y-){?I{5V$rAvG!d;|s(6b;IkvW}1d#f8;Tz@NqrH z#afI1YFJt$?R_YSI5YKiNvWo8r!5KW!K`#Q$0mmwL`yA!)?dat?P=+$tZl&gceMOR zSab?e^gj2<8%GScU_FX6cQIEqRrtvI2>ryuq23;nten9f(#)U)7YXmlb3;^>WC(ZE zP$-4^j)$JXZfm#iVIy@eq%?by)A-YCcxM5 zXctJ(4d`3>=Wf6=dG+k4rP<2ky8iy}X?+^CY-_^b-*DE2m0It7q&swr9J3~$Mae5q zzehYxXw^mA$k)7CtEtJU9+hG8ze`!GUurHpsS@qg;hz?J5C-^{J+aD1y?c@AFzJ-b zsV0L9wTWD*uXEcw$G=mpcHjo&R9Sx-P$Ojf0?E>529{I^dNCFnlZd=>8dcE28;}Pt z1T8^=HCxKY&+X`4@?xWDK}*+tF{f>x8L$%PYE%&M&rHWuJS!3-*5%PDcs+Kz0tN?oD##=<5VOd5Twav9@M80|_C_u0+nCmw$I{C~j%WDKRyS%G71qmUJkX zH!2H-g7b?Du0Ao;aEjZ9=)rPc??@e%5}==Q~Grt zDUOmLb9Wi-#O#;Qoi?RmE5A%08S67@m{AqR3O(*Z+QR%4=SIlOV| z7v){i+sUMIz7<#Cmks6Gxon;&gm4`jHOI!4u#qhPm9{m*eq}wheksik%h?Zfm=kv@cCX#Hf;;UZWCJhG61Ebe)k>NVV@pZ1_kU0mzu7z;nv2mmr1%l2iZ?*AX+3-#l#idaV$hFd@&!-0p4GCcQB)OaQ_0;tG}wpO zSbT>#YT50S%5#MpE3f$6(pnUz3Vm1Bum0j*D_`2BJJuL>u>&i@1}-LxCWB8^g#x5W zDY30g`mM2vD*5FC3p)!JxpX7m>L6uw?nfXE(0>;N*U?lp3hX<13G3$x=C&}-+-GhW zUoSyiun*+Sn7%WX_wq~v! z7(R;riDUlO4T6ts@3zGLn7gKl>kcrd;5gw(w2rhSA|z<>A+R?0cq>Umv=58zq`zeQ z^_!2iao(QG=~JvW++`>O%@fYML+fBOFb^B#+(T#i7IU(Ai>(GAos;7)d%@ok&MGOi zOV*hjBkI{-{W=daZ1j5U{EAM=fYLE$jNRuV$^ZRuv zoSeGlk4^z2nsobImMERlp2T?@o(OUm?ZgE0DM5^+K4CkWBDfj@@1Zz^y`8wq=s~dt zc(?g5`H#758sjO`w$i2|C6@K1Jx{HQajz#)$LxB2u20a|C?B232jkRF;5jf26FiPX zh#c|TAXtdUR-yc#c5ydJZqv84*cbaM@8z9B^6=A$h1Z8N8i?cayp(s?M38t4yC%N^&5gOm{P(>gR7bj{ zM60t`es-3Iw+kg4JQ!3Py8h+uA^rSvs!K&zMxz~-jWshrGxsA5rzx zRYwJNeM9bD-`OSfJ|@E7ENW=_^wL?{MN|9QEYZla%c3O3)+zDL@_IW@gWnPY>Dv~= zs`{h^8=GA5c08Ygb>#mQfTT~&NOnH_$yt=Gyg zo2Vt7oiw;vIP81I+It%RJlno-HV(KEUxPJgnH#J)@BWc zgiH(OW3DPL9qm=RNS^SK=9Nk$ah4q?Nz>r!7jB!A!~4u{Xg?gw`~-#KTldPlr^FST z!Xj+mt#Vsx7mV>uaB0!)29O-hbud>28@A6Rve-#vM}}S}(Ec z+J&X*?&O5z7?B;l=h76R7Q^+X##a!*CNwGIFrK@ZRu+8saesC*ggSW4n?zOUX zK{5ZFl3OQ!B_E*gDP?$NQD?c5E zlVph^2ffv%K7?;pfec%HS$FQMRgnAI$BmOjGpMN2@}ae6he)M?N9i<8Jw%T(nc3H7 z#?@w6aV|k1PqbiIii#?I+6c5?1ty(II!9 zQ{LIk+9_wlqrL5(dt1Jk?p{qS17Fb!-W|iTAmT^^Ns}i-(&Yb@3x|%M3tWip(z)p- z?reJ9Rt{-+T6)k%Ir+Y5qtcP2`93w{BTvyE_(WEksDo_`@{i>~xzcONiocy%FGK%z z;tizr60~agidQffH}xJ`V;FdcMem5i3h&{}?cKqXw^F0~nMPk>(jS@l(;2*$mq3F9 z$Ub)eW$>bjpEhT%4$w}R74MG8r-My-dCc>`6;>!iX$0(oZMIPn*ER$=l!kwKkV-T* zM&|$<-eUK#h3(Q`mQPc#&06{1q31MKt%A{I#XaZHh;NycAo6;HGTsqf(+??e{})am zc7FgKq!vzJ6W${jQ;e|Ihjld7-0kyqL-<3}><4oh2jWGS&K!H(v}W`hYX_)Zy07eJ z$2-MK9pFrxWytQQ4$khr>)R*B3gN?fFIw8$`=ncX=MOkmbV8Q+lAS>k?_^b$lg%gg z_0&?DQ7u1PH+NQ^jLIy_VTY-I4-vsP{xQ=vvFAO%=9B1%#TxT9EcA&XFo$ozHmeUS zG##&LH{(h*Q*;G2<_=4?Hbc^8D{khNN}R3AAUF6~rB(997D00^2vH7}9-KoB#t@!^ z%2ZRMhzUCu-wgqmX%Kt;%xd+1ieftro&>K^9kf}Ye>`zHmYyX4b3NS~an3A9%vO}2et11+kV2+_WK{T z#mo!wPY^;*Eh4Tyjc8LtHL)sALS5pCO6u3Il(`_J$%M)8K{*g9_q zZ}*I-veEAG?A0!f->JTo3@(A50B>U|i%5zhChoo*6r%e7Ajd|irwa7Y*5fI>vgPac zY)7HxXtUVqVDaC92XWbt>{}Ia4|9yXt6Y$8_CksOeo`L2T-VyxU!iT~o9@4YDg517 z@W!)a@JVO%F828MKOWn*!qO8qVl{DzGotgJy8aR75N7eqVjD27B_H4j`Uy|1OC9d? zCar(H`rE-w9R#E}Hnvl{2K!XuhP`DH<0K1emsMong2n*wF42NI>0?`pIH zjyLim72}pp>=vjue-cHf<-v&O@gJvEhkD57*$^{nYh#mg?*zCJA<>A%$D;_^UM>qg7zqjn^pvGOjv6M&5A)MTR;8ys9IGJW0ftkVKdSTr|uxZE|V?{ z4X*2P>yxUe>5EQ082xxeG}Mk5Iuih)bV z=TbkWHip^_cDXR-I*!ENAo2>CuIj!7yR%0liW(zue`9r{WJjwP+FV*7I5r2flRKpN z{@K7vWYcmP|BY&gOrDAb$U>Hwqj7bYfj5DjS{XM<^kPu>sUdMlUKuKp|5$y5PvxiQ zV2z#xBgLSDxM{H&&?huZ7&A9=m!xL})3}jPpbChf{3UiQO;0-6q}TI-p~xG=>>^5Q z$7j4@tsk6lI=tfy1RF$Zy`7(dd5}k+5tqQlbID!XZBTuSvb6`-KgO0hPX{)S6@k64 zfVzeqaGxRH6Loy2Ij(e9lIGYr+pRN$rnB&(6AQ`G%b^bDi8VCEjjyBZ^{hE$QcUKxSdmtHy{F?1o}AW=DyA}C zhn8#L`te{pZ!-AqFn6}MKb`vprZRUU&s5|DdFeQ4)5~Pi4q@gK; zJ!Fei4!*&7u-5y3M_R%rsuzhGB% zm;D}CDxd4vt-OV3LTC!F^g0eULdEe+)AK&NWIr`w1;bjGbhPK9qBZUPr2NT8HLLoe zIVq^|MtpL!y(a(Al7YW(%!e_Ss`HMhm*#`K9p?+fJ+Y5Cd6APNaURg58Un9Kt+KpD zntvE1Ti%CFV0%s!*$!S83Ch6Z@+tOc=|;$Sd*4Xpxg+wn3g(wM-=5jotTc*hLD8=- zQkd4Cv!Yz$&phnQqHvcU!Pf(WcZz)>Gq}eshLki|Iukua;4R_VnG56hA{zm8G}V#r z_{ML0W8O(lV~1qWH+5Xo5SvI_`tzfRusYnFC$xTLJ(bn5wl4~JWZ1qjAw#xTOaKTc zE~c&&jnBjjc8>b+K3;JG$!wY|#UNl90q`@`r)`39&fR}{R&^66wBG!Q<7Cm=-qT_i zk2%i`R$#gq`3uTz$TneF1{Wh%`~^uQf(L*nw3H9w(8;{=d_f=CqsP&raKUBcZD3%? zwS!&S$ZY(PFe;KB*ai6&YAf(Yo&XCKsRFWxO!Y|N1t~8_LYhYfzQ6AH^_SGnPlvp& zB6EU9xqj2>A&NCh-uIyU7dslMyt1r>n!vNO{3pYpIp}Tmp*pLPp4-Z2WnuFDb=0Kn zA#K?;%ynD*s*Rb>uW8x}?0MZd+CL;k41GV%{;BSY$>nV;N$lI&Lm~6~%7Q(Bi`##u zTBz2ib#!5y`JEe*2J_#pZ`PD+85D_cxfvaa}30n*sJ0Y^~TvgA38mq;#=?U#Iw#DF1ggH2U=yI9h65&cl(nY8sF}=*jBdLWUYX}>xsot* zB+uuyqh(RrI;F!Z+Cp!Td4hOCYk#x>XUE+0&|`3WUrFLF@ci4wtCIFa^RiQ&g%NS9 z;VjUPwIhzvnm<+jx^=_&gKNp+d#Ah2CvxM%zT(jZ`SxRh7b~anT~Ctp+l`C*e_B#4 z#8+EJ9m+I0gGaMa>Bt5lK}|WhCk^~796Lc;db0F$^!%If;j^K;IBmBQMk8*RN1o3M zVpmI_*V#8FS?NYg-x1>QD{jux1>%xb1-?hl2~2(S63?^SoN2d4@{oPnH8YtN)_6%* zon6nNjKMk(7&d&6@=~9fcO%K>SAI-b*@pt+p`m>%<1I@w&`mjOQw_M5caQgT>;I%8 zv&7SX+i0Yh64MEdskv`Z;bvG`hqj{7*8bP#LGY*7XeE^@TlJY2Y>S(wXpg^rcwf3N zq5t=?$d zt{c`_)-Yy*5lwR0zdEyYh|7$^NRgud{cNDjXHR@^)%wB&h8x$@qHMrK$e1?jg*mCg z2dLEeFE}{p6!4g6roG-4OCf_uQ_sC)1qlcb?(jl^ZPI7k=lZ!njhaRB0?q%Hce~~b zElXteHojF405!$Un?E^*68NqF=IZLB-J?dHrJV44$To?V0nfzp4(bfA5kRj%y+haQbCPk(iSb zBcgCh3-!9I3^W1Ly85*Q;8)ajiUf9W(Q~HgHSc67?n~_4M33H&(W|9^BDWBB>YFfW zWtXmo6Ijxdcif5hl1O(etirNu)cdsrx<~iLr*TpSxlt}8{`RQ6^SRz;o5ql5-eF}D zD!=OWSN*x_d!%PILvQ*6FRk4u!#39v_d|8s_GOoiXXusJ!4sLs&lDqWQEkkJpT}G1 z$hl43r#+}vDI?YQpzB+sdF(^MX~?}y-Va@inTPxi0#@#AHo~4NXH1@%_UoQ8udw_o zcZ$3(OfkWhCOxG$(l+~2gnyuZ%dMOibM?p3p*? zmfxk@ce2sbY`VvoOP?#6K>RN=c({iBq@`Pzr#|~lG^$$!@#gA*+?ipk8jVQ!u=Nmf z*aH`m$@5p^9|h?O9RcI;%EqZsO7eu;lAWk<_1W|UFS2p7lWsOZm*H(!!6MvRhioEV zN9p&X$l@6LTRx1{8MmdBo<6%P(pTh66&5=0d80S{M;nK*`}=Dj2aYz$ zWxH0!mqiKfO2l*Ss;&^#5j4d+rgefFSj#xK_SJ5yU;?X5>*aOTVzEQF;(JSN29o%I z<^D@Gw?sSE84SL< z(yOPo=$Hrt4kc%K;a2e5OTw!#@!DnI`iAjh*55){7ik7WEy=)h=~s&%M^=5s_ovtB$yz>>x@=uu z&&BcHO=>fGMqUPiPAbmr9I*zte7$t#vQy6gP68pduY&*G?Lc#&g`7f72l_zUgIa$s z^3tcIt?CAh82g`DQ{O7mJfTNE06#HX#sE8wb`kEUOe>DU*60SS&A(MRsn{s`9WzXI z;0dRu(J*=DkeUDRsO`S+8MkqxE8$&8MT&fC--kLt5O7q3k(qcYudFbF8pt;1C(@E< zMkH;f-MYYVs+Rix2xNd8(I7WIGp^`vZNgo0(%B2Gj5U^sxB7Q7Ubgc%hw9uXN5uKu zsUI6go3R#F(fiA)Xxs1_`nmn#iC;zp`=FrJ)s zAJ4XX>%HLT9$(WwBkzSlhC(Bb<>wA2_%#cDK{DA0LKmCCZymW9FpGZ^c@!OkD#`ie zQSK6yFQ>CQ=k`MfM8xwWk-x~_Z(VSqp9VCtX_m;t16)0qhQTmY6mr&tG+*N2thmjH zmG^p6kYL&{=PGvb@aB{y>@oSQzJ|2oJP&bb$A1wq%60bW_wrIY@5e^NrGPE$x{cLB z#kqvU-TBf#H}L0eI7xZnRafvo0@16v+yc!n8zkv{4x`5f#s%Uo%|E%PV+O$Jpd}{} z^O;Vfe*yR6QeG`-$eL`P(|Rg|X9BzTf`Yb?& zIBX4vo#3|Ra;;$vl!cR!k<1CxPM~H6Wpb6`at%LiwHe9GTkf8nmCTSN=34nr2nXu{ zG<_U0lIaz}`n+hw3h7AX`eki3e6BMZB?|(-9~y34*C62>mqxxbqPg8YFMA0|gI(}i z`MjOCsBMY6gxDBa&S3h*q^=r%k^Lc4S7b_ijdhv)^ad}%mei6zHfIKGtKFTis#X!7 zW!D?JDWVtR6BP&!-{n+zmHae9p5g5z{aFiA5WCUE^Xt#IR*cK0H=OnaggdpjZ2^~Z z38K%KGq&M(B5+iBElFXlWzi-h(WYOaC!y`9$q{P`Q>~SZO`%~EcaLH^wcKVdX)+0D zQy7R2brBiNv=>ubLLpB-6GM7u^|>CT)oq6*UG0bWvQ%q(YC;#1!}i4I8m!+F=@*L8 z*Nt+IGuCB?e;3h*$Lr7DPBEOKDc1KQH|T?GyK@}jR=aTjCWamvY5(g`KlIy7zys7$C+;mp4HO3fBz7-LCphrSUM526_rYzxKVd#b|;&2=y~L#Zr)>YxAYftxT;VC{GH;n4~ul4Bsos^|5YpZqy_2K=?M3&?*EX2M^}V2<$ddl6ItUL z9!&);+~o_YF)MbL{nESKe83+-()TZC6&JZL5wS-%)-zg&+>@rQwF-&Z4rW}AIq~En z>Il7mlkFJ!MsLKXrT_PE%+dVCCHkac3e6;r3Aq~B+;)KJBhKG=hFI}5ipjqTDa#&g zF3+s$15Wr=?QBbYb{eHsDmnS|u((Qo>VObKlJ_7tmZnzXuW9g0l`bWo2g+6s|Cp=e zd7XL$G3VQ=gW*y^=IQB`0{mF=A)|Q?4&}jcuwbM=4;!cbdqq13F#RLW$tM$s9zoS!D(C$ zFY02Z;H3s-l1!rP4n`r+Sd7e{k-)P;BZ0dUz>JJ$%LY}e>;*|q3 zY;F``JCjEW!xv7ynPO+I&cBbZE=;?i{*!@uPs<37I?rgk2T=Vm_i974MBV7vJbhKP zJ5Rpx?27@USDYTwZoLA z!CXwvZ=NdI$|w2Tw;iFymQ89%RAl05fpTfYjyr#9&Yd;YPYDkDGPVL=zY*%XfHOZh zB$_>l%$>agK*$LRQjBYbKI-=AYR<%{&F|6VwWj%3af4AXjnz7N!ZSTI)>xRnIrTy} z_gjS)dZLf_t>1JE2W;@>%`l?1tY(wIgxVBk|15A_X%f$f)V-Q2|1>dAfI4hAFiA7A z4OQsoS}1g~V`7soihn7sv!geb$3-1mN2|TY$u6#S(63cW8sK0U;w8zRK)z>r;^nEd;94I_jkm z?xIYSUFraGDI(yj&Vq>ZNb~-`SW$!;{vyq1f$r0GGEZf42KNy2z88*?u|0ws@$*kC z^fiG}f#tV_^&g^hpQxVI^qcxQ)oMt@v55!Ds*bdT(pR_U^Wsg`*m_!oIzT@o$2EWG zr*7Ezgf74NaHwwx?;UDPBGy^$eEW$tOP79ZKR83HYW7G`>OYbs2rZS?*?o1^ZNFOi zzZp9O&nM0~ptd;$rqscBr&A5a(49IfPUO?iw$k5;yN!llN=hfy$tI|u>pB9ez^EoM{1oU0-;eMys=h`8s!M5$?Z5h@vN@Ko4@8(bzUpu*U z!iy;0&5?ePoJRmT44Y2xRJLJ47Mr?6j=^=I7@f(~owM?%l+9W8jSV=^A^AB8Xy1^gCOIpjT^QWD#??8&jSodey`Z)KP$Llgj!jfI0hkjv$&u#RUoS+W` zKjfy1rKXycJ^2AgsSxeW6@V(N2N;zrkUyE@N!mPjL-x0v4>ZhE>=j)QB38nTnt|@u zf4a9^G`rsZXOU!b#A#KW(o+yKazOj(AU*>)EESYoraP_9e`g2LH!=^mv~yYB{+7Hn zdu6dr>N#jMZ}R05C(zma#Y^%W$E{(2D$9+>XVockPosK87SgR^CE(GcoWO0lSKJg@ zhkf>i=?^=cu74b9GkPlfpmfW5apj2bYNBRFosqC*v)%9MkiTff{VPX0G(}8qZ)?0@$ZE1sAft)h%#J7$jLf!FZ-Y@m04+E8*&yTa%EaF{~tLZ~D6g zYMb+a*8-?TeZl6XO@uTCZ4w_E-&rXY(_$mJIMwN`Sk zjhCZ4PGlFw5|i5kcb_v4Ae}^x%sK_*txfwMM~oa^I^|gekokBzu6CyMyz>yt4v#9C zto@bWwObuHw4!+`nkA-5PqBxB)~5=i&g|KDlfwF_*Ew@b^S-&ye>>juD8#a|OY4g+ zLmBkTnC>1$XrqfYKsUsmTvec>oJZwoHnM2XZU{+H^wau9aL7zr%J5QgH>)GMYR z$yeJxnZ)oUJB6~Nq&OWlw^5cZN(s9sjb<>GRGej<5s2J-T zn}StctfNYdZ8~N97&x=CDqj<>TQAXdne^t`&1`mw-pbqm7f`NCic0R9fEHukWHoTt zY-(HUhzcVS`BB?7(%?WTb+kSKBV*L-KgX+uQ%~E^SIK4}~>tHD*0!?0Yt-F;i;!WufWw z4IlSV>Jxz%-N(gkM@Aq{@^{pW{YAEl79CRW-38q3%^&`zgKwFz!r@8Kl433x+0(GD z7>#XVhx#A_tGQFk>C}l$hSO2`4BPlpUdpCt8p>SmUVmdP ziTDZ9({f5!eckjkq9C@l;YITa>A6A?|ou^ zzh<|e)6e!TbN0tg{fdY6>+`PG4LU*SGwSWc6L z7d@bz7hh8PvOrplb=`PY#p*cPF#1K}IRKvyEL&TQXtHLXlm&WBaTSV`hnA5YNi%X< zdPn=|q8T1%BXcY1Q=O4DIoC~nx7_Hw9F|IS6+cvUQ_Op#X1pW zE#>;M{=2=-rv`1Dg*a`BO)}IjKK!u(9r@n|0@YL;gExeT?L#T^ez3 z+G(Wo_(j#r>kDyy~-&fP1ZNrYOd8hl4Vaq!BhW#Cf$VH>#o9cl18ux1kcVNGm$`xAx^6%IB!&xt2 z8#5+wsR{0LTFeIARUMZAsASlDE2d95*)w|nFpo=ZETxA@sZIrqtgGb5F`VuZyktaG z$CbYwgpd;~fSR5Bb}5{we1mF%L+{F~ESL+DxcH{MBgFgj61R}6?Bko|?^ZZZk-jT} zR}B`L5X|eILIYRz?M&$OtY!r4Pwm7oZsC4*s4dlfN8$Gsni@_+&c;m7;s8PAfvyP_ zo;A&VXa{oWH`>eaF47I7VvngHb9rdf%IiYuqv(ky#Ko?`5BbJgD+f8}@)!0%*-u`> z9iwbabJ6_4Sj(m4Nh1ug%Pv#{Z;~f|;6w5!WbFjTT;Kc8J0JO-yRTB*%Z{OEWbAdn8p+T4VVek}iH$ z$e2g6p#FqDr?BCfY|vV^Y*Bl_!P~8MN7UsPb6yesD#tX`3%ikVY|Xbs5}1r(N%FEb zs-9d6zS76m+)`gI41H4!$Ho$M*&eB|SPu8RDXr5MtdUa^XEP_;Do77YnGgy|6WiQ; z&N3Y~(1Y$xtdbZq|HDYS`SAUE+#18NtFa3WF`5N-6gNdz`o{jtB~iFnB~HN0oOlP1 zc}JD7pO~Mc1U5Cirkn;FOXLq1s>`inwk=WcQiJb>tdrmkS>Erk+To_tRG_Q z{fXc@DGj=Cel5<2kZ7b2;hAB$TI?z2v$tGDkvX^=lkI3(ySccX>(|*#s%jzG%xuIx z@%h>hTJB4G89ss^P#6BF==2ybwm&MTYML?e0@E}{%PP}S$jb0}lvdPa7%D!9Wj%(U z-TE%Ry4l;2otQjiG^a}=b~hiIj}V3RpI3$g=MF~53SxM{`F2COJFENdp~t~qxwEwP z9SMp!c;>iZ_dw`1a(<8i`WHpP?uOSqj1hy1RK_@sngY}zNWwtorZl?w8SN*a7e4nt z*_E~h`uKW>LaMd=A?ykMuU|5+03FQb|C_owJ?mp$zDVC8|L|UXHdOQjIbK@qv5MrG z5F0+V-_1*_0hvR`#u87R(MV=BUJJIN&895qxnu0JEPr}6$2KwILmnII!_DzmjzOMn zCABZs)Zm{Wb-Esusk%++>V+?Ss-=ClY3e5f-?CK3m%Tk6<240vkm8yN>-JYsO);wx z(y5{D)dF16DJ^{sQt4;JWA@JZ%lY5dg4CCx)0h>*>_{t0JDF&EO%qeU<-{_a?AV`L6Uuoe!+}peAIz zDn{oAZc3?R(6B1GX9A1Cv4SIFy)jVDF{rgwmLpwg;XI-W>3!<|Y1+s1?+GE?s$~YQ zN;=-s^G?s9Oz^$5>2r6|*0Acluy6sP+*X`PsG(d3JA$=cM0Bv71U9R#6J3n#u~`m9 z1Xo&q8}Py|G7zY18~O8IE#4htZXXH1O?oT>bmmL8vYdzlB&wpJCb8m> z$~?oN;d|GEV1xPKV`MOp{Y-;_PPt%FGCkFWnqKaHaSgO0xW`PUmJ**ses=5+9B`V> zwZlni_>$AWt8H)4Mzt?E&+d40N8P5ypSm!t6do!V9krq8A0kv*QkGIcruK%z;|20? zoAc+AIH5=xb%L)m^6dE43exE2gY2w;M|$s19xovm-f8R zq;CcgxI^G_RJXVxrEu{3Y|mra@gwP|mOSnU}nSt10a> z&w!RDkn=jyhX9{lXNbdDy3Wq-rvu1yA%?}oZ4hzGjuMJ0xx7ffYfJU@gQ2;A>PzZ) z&eKOuLX`gnTSZ?*j&S0*xIaq5D~{OVov^~W>toJq=HJK#mXjsVK+-?n$nf1SpDwuvChyWmj;en+Y%fDqVH z6QmT!^bF0bzzwMB7;w z@1OZP>5~tWe~#5vPH~#*H|FVsn>u;;bOKMKb48Beb%ml-^1(jM)sBk$P$QZeCGiUF zM?28W`iNR)+bde(TY-J;JC4NcE?P>L@55>Bn`XP^PicC?1dCup0Tjgi={O^ zvxj9)QsEG*yNr>WZRCi6$=q?m^;*Vq9&m!bMsUdnc}{M5cZjC~U$R^gEnpUA<>fC98;Xow2GOK%ha5EDV&hdaCT5rp#)Ee!OH>`e+S_Hb#r zfzTo9nJ-XirepV5d?Py2XzldcWm@hQ>)hIxFioMldV5E6r|Cb77 zv^Ao10jl#h9v~e}y848X#_9nqhzZ+R-AZO!%e_l3-*8@#{83~t+%g&4*>Ti!t$qDc z1L8{p_MT|rHtWed#c^i89as#p^V@Is44`jwQ~%glL>~;&>o6hrU>INB+{tP6n9|)| z6YSf`ABp%^6b5#)B}oHzmTb{O5*;S>pnY|m|KCcxZ)mI~BM61%`qzz2k8HG3eZY6Z zrL5(O@DR}D<14p*}g;Y~(U)Gn&rA6-~%2=B!7770E)@o?C z#TTFL`k|R+W*%pQ|Jglq`QxkN_mybJpw#O>Q(pSMo~qo70mVpEPt1%;tZNfVJeZ`-v~c6TWwFA~U4jUF%FjJ+5j=hF<{u9h9}-lfov{YVKf z&6m~__-Kh4h*&=4U2KFdSPwtRZ|4lZaRCQ;IkMB!d>w;Ibh}PJ%eR-rfp~?MmYVA@ z>BPZ*DMbP656w5xFjIAZM{0Iad`@#|ytpQ!YUYs@BMRk~yujJs1qZ5TZLU^#m-9}sN=I6Oh1Z#?S(+U#ThZ*_eXOBp#z|5mQ@!e9#P;WBJ zP@efWs~6^Zp^`r}n+bw0CFt3-zVMIDo6HK8Z`s@dugtB#lTg%{?v<>?Oi`)w<71~J zzs#YQtGX01p*r@N@AA-L{JT1fleKu`70b6V5DbD6hM=1H9nY!WQ;fDH7|`a z@{MgHX+0Bv;6R7TP{WI}d7=&r(bQ_&Go-@R#;dd)d(+VR29uApd4W2^(y?4OdOBRG zd)0`zOX~DfcC}CTHYNwPPBd`uABIqGOb8R$sKo&yJn#2S#;zZqQAh zY?nVT%`0gJDwJCR(3$jk=DKum@0fC}czo`i8A83_TPEA}hN7dm)l1oUa$1XfT}Fy= z0qr?O0jNIgeU<6R!rnM7pMv8nUvL9lm`S($b(x7}vA7&k6feoQ7Ju4Fp86mSd*@mz z)q5=P@<0=Dcps!2kOjAx@#=TQmBadbx=qg6aaGgjK|w($WOpUK9n#$kdp+srl^fa4 zmQ#IundLXLu`8=^01NeeS9g{D3KnD~Wp7G-?NvL+lG+owcnqh{E<3}Tr=OhkQ$_QqB)vHDuAR9Lj1;g`5Qe9qt zb5V4gs=NRrD+?+sddcmY{s3Ks6H;0PRhDVDBCbCcsocuA>nRNl^p;V=9m%gl3%Xr- zt1T%`vdpHj>`T#Trp@yXQ-8<;nRd)$jAoqM--=nTXjeUa>DNGA0&lbX+lfijZnUEz zCo&0I7x3;>k^V%XHOUo&7D_K6Cfk&CI#s-5B+$7Ahzq?5a)f)e}XE1(tLNe7Nk$Yf}hYBET~DsFwy-0MTb_a zydu?GKYxsT3sJ$_z9QaRM_-H0a6`}5TleoJVaJJ?4e0LE*dJqw63^4&Q+7vb5o_#> z>&gkN#p-=1K;Yt^zbLpw2k8|7RBIs=_vubOFmaWV_aPw!+_5!V@psC`5-p18g3*nQ zy5zzY+_`JG&TV*kyF;iPMSe7&6)dSRB()H^S#i(&x6MQGf4+S7--944*!OeIzZAT7 zi~se7Iqlp#k2Yb)xjy$f#bsjTv#m_k_nEfaEwwEZyzw;W0P}ERaZ4w8>p%8aTEos` zi@zEE9&VHVs>3zhc463fqc`khESY9&*D8*K6xWaA_I&8c@u6#IdwEiaZrzdp@Hk)K z8@%ns8O>eVpEAnylYDOYF8S;$40datUPP|UgY~odfdS$m^6;< zWMi!Sy*~mrf9V1IYSf`pX#V^G4T>875i;jno!aVs_;=RY+o<9?_D;0&UvG7BPM1rB zePA9~L$dlPpBmfhU%lYkQ0`ni!e`nidwbjb3aNgvk$OZudt~fZ4oh|3A0p`SrA*G2 z$61WEYlkbpQCV8ym+|fdBZVqD^qBDMpLN6#sIie?>#t5#6aEvq6Br0(VvG}JGc{2j zi9Jz>cdYq(HJqN*Ye%*o@WmOsk!_$O|4B#m`YRM<;ShcL2UOD6E+@I=P+Hy=!7p|F zAf*B@=6z0iEdXc3_4@%ScQke;JnX-KsjV7qM7FY=Q2*rBi2scr+6S@sA8*U^1fMOt z3CIs}p@$hY4a;FIO5|Ck*8j2e=3zXa{)^$o3TWv z#at=1XxzvZ1%b*b%iXN3RM4z6H&jAY1S)e+(Nqu@C>0Sv`_mbHi(T0HXe=|24b4;OH)RLn~ncW6U$N88=ft2!t$nNKS()bf03d->=Eb%&41| zCci{rcGXEVF3qU#Se_U^TH|b=TUo^z^v;ygTI;UHmZpSpFVw}5!L{+Wb`snCDmoe` zs09bh znK9nFCciq1*#6kMJnyOdaAZJdN9|9;S6W&?Y#fv;E*znVBr%lD9T zKKE^&7vfz%aS#s2pxye*hhm&oKoi6eI4=;GaWAtX=9rX@f^E-tyss&hzjYfl^&hc( z(@wuKtL)-^A0?Ej$T|GnVw;jwy_B(_eP$zj-Dk;=)HC4%a?UV0mlugO3$!QegUgd! znMhHAj71*ap*e2+pV%sv=#zdVpE8m$it2Yv6_(%i|r zfZ5up;`saefkouz68Yl!*q8M)5nY+rY-6aUblvXsXXpZWcoBg<0#Wfk(w%YH?3e$Z%Q!?G=$;kJ3|>;|oID)}aZ*;_8(_)#bNrTj0(;98dn`>y4g zo>4aXJtJHBYhC{ZZ%AzW_*|rX3OWdi+>QVu4N@%Sl=BTJKSdTB#d3C=n-WZs!a12! z&uM)N>f=}rF_TDdXxL06<413gn6JIdc_iC;9TsJ=XkU$KmZ9G4j|&g7!0qhBZAY(u z>KVB?scR_Jb6<=XMC@iH`-epCm`)nVHw`pQJ(bFHo3#Q| zzIY@nf)^jn8*2Bn%-A0Bg*8wCUNvBGJ}`YIE9xI^)BW0V75lPLFW>U`Cjct;dr-?OvoC_Qd&ndHk<_+{NR?ozCFPew7m)cS z2>1j|cvYtje2eI*Ax?zw02#rUO7Oc*z(4d9RCpUIjo8P^DRbW8pHlh+mM;8}s~pn+ znTR82-bL=?oOXI=%m=Lf$ovB2FGgZaD~!lYSDkkvMK44Lslhbrj%=rEAcUmZtD}g>qlyXIfiRu7<>| zl@SvU;NiyAR5JN}LDw1|VX$9GWKT7iGm(Oi+< za&1zhuv3l?<$|@h(0Q5y@!8N5!GcuQ1K74W<^mRYm!M7c2W$ z`xhZ)Y?*OYdw)9Q6^t5xUjhR+HYvLbjU@?5=5+>>$@pp2ow?(5K@CUvseHh{N&aaJ zHVC>;Nk_j~4LO`H>|vIS!W{kgO;8AS&(hGs=N~Y9zb@zJ#jcKR5K5T#WH94e%NO~! zTl$G6i}5chktdm}dLyk@LaVmQvq~YkHLf3maH?r`R|vE(apS{-I^5u}2~u8Sn3zzZ z0Oi%J?*qG2r!4#Q9uCWR|HSrAwdri1`km9gZ1w-;DK^MQA|i783V|;yz!XquouxVLtTJpeMT81v&?l-WX9yfHs?Y_=GIX8WUAby{FeBdcn5PxUY z`vSI_zWxNUUS($y=>zJBFkBwkQCByx+aQ(Y@kythA4goF*Dudr^#(lp)@^#g$a6Bn zIz9C$4<=tZq+UFUipgD)!`qtJ`yxBOYg_AY$5>ALs-{n@oB2UtC-B)lwZsD5?#2;_ zZJAW{Q4>E^D0S77&FEJKPE|I$D3odq4*A*hCby5Ur-U$Frj42{PgPDeH!}j9mV$#j z0y(-d3K8@hHmpr&NB1_lOt1rVx3vX$A)-YShf+?Dj$05(K*83)Hi^abNLWK{1;a2H z$=f~eqL;7UnlI`&h zeT;OkeuLICy_2#Pm|G>NQlGYhu4ekz3qz^{%=*t8>pMIx5O>9tNwzoBH~j?1cGLm z;0S3lTQzD;mj2ZwwW9bXU-#P{+l+yB#A25sbrF^|p=~7>B5(5`DcFzOzX<=lzp|R+ zA*PDKKZq#_t4_oAulPT=INxGe&vFK!BvbggQ=Z#aUrStlS7*ViS?Z8ZgZUO1rC>DX zd@*uA`E~eoRT{=YUQsMBJ>Hp&aB&mt|AV0~TE^{kIm2Nf7RMjn>ovL4a%CSmB=vhB>gx?J3E%Q_81m$pG%6xW6 zSzNUNiRb9At?wjH@&d&Jf48pm=7JMKjF}#-MO`0NLJt{}DXz2Wo%#PFvFcnGRo7;H zPrcoQ%AXwgXRk$G#x=3q1erf`@&QxyyuESneWVW6@|Lv^p2!s6 z%{N@qmliL(iVxL!M9Sl4X$(Y^&wirSxZoT6gO$W<$LJpd7Vn@Zj>9KvnSO7 zb^r7fxyPjAsx@BB&W?;$ht|q@E+GKrVIzX;YRhcP5O)7xN1fvY2CL_80iILJ9V9E6 zX@S*0Td& zNkN1S?ZyLR*KU+|YRvf6$;`30J?h(THM;r2$m0!?Zn6cc*81M#|EJwCfxNnPHflLx zZ7Z(~rV>84)^~E+Dy#(@|4o0ELUQ|k`QX3G`9#U@Jj3aIB$DSM^@^~rEByFHw+94= zPkv)B_JP`(kv5jU89MDT@yH#i0Cs%S!*xbwULyD?_sB@7uBy81NQZ7&PR(>*b zH0&At7}Tc1?6+#^-CFhI=!W#D)mTsx#H>JeiJnz^C>~7F`@(P>K)_C>n(ua`9_Jq4 zSPpF(h*6uqP9G1ONi9F!IxGJwoHd$G9TwGm^+koC=S*gcSWHiPVqBP1Q3pPtlNWWn zHd-ME$JnPkQwzv6YCxW6R9(+)<$a zbwRb@Oq?*{lUILg<3A)Ji5DmRj_^;D?#LeyMj^DDG-)b2W0Y=36N!Fw6gXu@P>xP4yJ$XxcZn{wK~iab1QNby(E_Kbt!b9T1=dr+x-|-2@ic*Q z!F~1o>IXz>NO&NIx0M;dRU7XGCK?_LQ$-=WF#*d2=&V*wH#&Mu+5u@JKQ zIwj@nP78@Ar%xL*Z~5Ag7dU{n8m3UOYzjhdPw(`SR(cAac&+PN?Nc+!w3>$Y+8)OM z^a!On)t90F2h!JxbKI+^y1`N}#ulp{;;^l;kHs$MxaAAGOCmOhfyeupvDzO)y9;9y zFQXE#gbllRN&s<9mY+Sey9#QLUyZQ=D9@$So7X6X$_M(fy$3_i*B%S$)?4;74?E=t zY-H%uFDwgxvj9tP<3&jQ=T2==n)b<8S}W!<+kqW)SQ|o8A?BQi31HC;~Q$eMJe@S=f4Qb z@-ZUK_aWyii#?PFME#kI#SeYW&DX{P`bDrmwAMG)cU;kLUEJ)SGFL&oPFPIQT5qWm zU*$Me`Atvz%0^FXqN90$stzQo@dw^%Kl63p88f4d23hK#`bpW>SRJr5mRfZd7lIj% zE_OwO-!}&h)m}$`WNu@V3_3NLB$x}ef66t$->!O-&00Wrbx=|^{+YEpPH&7PHFb=|WB5S7dRstibBNkpxsU*RX~|>;I7)Kd=j7Be$IC6F zX;M3J@f8Stvhktk9BSQR{Q#&K>fB-DEl)PCWCg#h!`V>ZCoAVO1JIi=??X%lesRtmo^jkU@Ew;;r(vIt^$wiVaW0qJ~Dk{3J! zStJGuH6ba@G<<07dWQnED-8Xly*ioAWmqbuc{p_+pNRzTqbFohte3841NK4V;9sL; zqtu^!Geee91}o;mbsJAwD;;E{s+-IC*=VSo;IQr^3!ScXfyV=(J^+`=7br%n61=L} z^n)}gk8*6C9TUyl6esq+lby%)rsA6G!* zZsO8{^V$oU=%tdk8~@y2rKm1}qO#$(;a91ke=>0?9APvUTaqh$RTRxH+X&T{Lc12S zx+`Ajq0kfYWQkqLN$2THZdG-P?{jNBoQ#R+2*R3CV2#EdJXVH$I8TIFxrHxFj{uQz zHo2Yhx_|}Gnc1Sk^(X1^B*_wQ9Aiqf&W!*Tp2&5BbvyBLvn*^Y!cX7;jiL8K_iN7r z=6iGL{biHIcQB52x_!M<6`43|-)E>~Vr3aZn-PZegWruw*Ix<>U*x64uI=;yhx4wR z4~4ZSq3rdf;+eb1rvtJe-?Kn_xOV4E_}A#0bqy-ffM(#Bw~-2)3x8^*X3V3 zFE|cnme=M3XEYw*%sVZxNSIVCytw0e#^%9zSBP+q}wdKWC z6R@jzy4(TK5w=yiKN9UU!CXRof+#obbqhp{5XUXJ5;D$89D?q9)6BETXc&{%w|p96 z7P$J$I_X;=DeF(y{_LuS>1HgH7R(D5s^%d2zv+{a*~2M!<)H)%e}2;PtF11W^a^K| z-^}aN@t8bi0mCW?x*tm4EtNlE)WY2kLXvpRkpe>W4}!XdAC-&i?kmbflLWU~+cw#c z)vLeh!)ltRs&C@UtVOHU96Hi)IpzyJ|J(YB(%22fe@N^H_Cx;|kX36%e(Ov^s|UqX zbUyKMMO*h|H5Iz5t>iyR{7QCltg<>m2#S42?a6f=w~ABk+*PjAtHzTGO@t--x?qlA zChF0C=RDiTE;QsK89mQEuvq5y_bRo+lK7UUx#I+&SOSeVj)zlHYTZ&+j!J^^b^YHc z=&i@lHVoOZlRfAk7$?&09sA1mRH8?)sd9I4#}RO^t&Ud`1MP7KSHYCE*B0Lgv@QM|>Rj_IwfTc7xEbep>RdnZ8(k*C#oo{E znKizIh#hjD3?=KQ7TSjsn-ZGRI~OeiiXw!>TAcV7$ph{FGjzRE3A|lv?h_1Z=AG?< zc3GqCXP_@p#xLOXTd#~`vv?EW%G1>Mp44`ByCQv{qhR3xU^yy-niw=Sl{^3cPa&=u zWNsw@a#fEO_Z?|^^V9qMkALnO+MhYrz_${9^TfeTN=_+neW&vLz3BR|>MPIh++XCO zh1J1A$2tR1+#4Xg$)V%T{`7OMZuQDoug~D{=9cW!yqC<*=s2_B9Nv#T{ndIlNTr(V)IW|d!CW%4X!9~7It^B1^I^HJzYkOnzK}n(B zxb~u~{`ZMjy~k(U4!q=0)50h5fFob8fpA|qUE%zJlLTv- zaREjhlnp>uGp}gAE>e!`+@`7Gy(06WA5-TGIBVqw8(VL@f<(*~Vre|Ua~5#l4EfmD z@ejyU!H*)BKSL&7TU{ioME6qGW2xhSEy%*M3QKexZRKysxQ88^1(=cU(9bZ!#RXeL zDp6mk$**PM++@~MjJ2jlcSY{nbCm~4KpD4bjkgi$N zGi;d$mSmS1w-NVWmYkvj_Ve@3qXT{+;@nOd@N{yn>HQ6(1v#`R^DwQTqywpbkE0Kq zSnj!PC>z9iU?z-YPijNVd&+_q2nc1Itug8dtxed_psBeO29{YtO1n&)O5%9&VGpTx z9hGj&$nO(6!u%{LCW@ksg)H7L>6nW5eI)x3P$sk2j+($G)12xI7SZjN}PHTz%<+7^dl~qjKn5!v^C3R=c-lL1o zD+lck!=uqNqYs85uo+YS!IoG|fR_oQBDJ4)VMFABR}a)33(u}m{;Wl|{B8xw%^fW; zIly(!GuLgzqpE(z=S`{poU=Drxq7`5@(UO}6W87`N!vr|Qxn`0$!bgmVMS;KUF$^O zs~|~R5=4`v!Dh>#8rvXHJUaLn4+w_9AS}HFQzfePUCNNZEid06!PSHuJ&AgEb1_tI z$``4c>oHnzN6K!q7!9H|lMtu&Us395T$GP5Bte=8n(J_oTkI8OhY)dC4C{E|@~LDH zhKNt$p-%FDUYaqm=71enLl&oQZcMeWZYiE@ZNOd-8alV>p#U5=@$ZtUdjy=_=WlhBG_&p*`UrL=tUOkK5Q67|Qe z9MocX2)B&-UmO9fly94Y{cj|Fr6aN!fA*YDrf#-xn9s6OvsX`Y1IO{w8&y4dbg;Z*{FQv8J-z6Q%YZ%Cj!YQ$i(|7$A_PJ|2gYxmVT{}e(bB*^FYEJK0W%| z8=~#ynL}~-shjcB6WVFS7Fe=dQRw3^rw;Z*>_bSKvmmYYwoScf_RNuzec&a5_$@)V zirfvS8mUU?T>O%vJZNpe&HFNR%29X-)tPyaFu42xwq zarA({5vkFxikaW&U+Jc0*$tk=y5(1odi$KG20uT zVno7?jMqRSQ@DG{DB9v=7V`yNZ;D5#7vbk^H-mhM#V?WP81aLsza^*Va4pQ0zwoOq zIV^a1(A1oUc2|z5A7J?*?{F$w_ZJ~nf@`K2#L8zPMe|xn>Ze#5^jHv)xOo z2iji~d=>?m2t=$ls7+hE;D45Tz7hg?^li--oQ^wj(6HtFiD(U>@Xuh6Xsji{hB zT$TM;1Vo1^n>|%SJ6cczh55Xe4*2*Le*X>Y086Y?#Nkv zk04c4p|G5Kp+dqAmA82^6~W~JRoT!M@p@uTmhVi&$ByV=kdlKN0X8ySBH0gn{ALy# z?40Vi&+=|kTaL?#4b5}%6K?%G@e90*pwzj@)qi4i*&~v4nE&2f=oRa$WcKy%)sLhY z`ht!)HUt)sT^F~G2aGk80n^2qM;@D*x%wZA!7+!~lYKic>x+*U-3mL=0Q~e;QM>cA z+}rT7r(5@8dCQ)i4=&_7Td6J>gkFS_mW@1_6BGq77+e({`CB?Ovn9^;Pwv_%;K^1{ z%IwxPpf^74c!@O6V`S2q=HxD#^_mJi3m&-9a(D7GFLLtvF|j?2_80?pr`-}o_1~#8 z7oKk_s%G3nr<2MVR+aXa(Uu+i362!nnE4mR8`J7?b(5MZdE30YEfSfo5B~HZ$AN+U44!m391 zld4z;_bgK8?KkX?MS~ZB=*^0Wbl%cK!y_Cjc7#b?yU6cE-qR%LhjZgg)q^G6;Bm^+ zmQ{pggwvo6e6$+yZsW$iRY}-vttV5t5bU)O@x&-ln8=c$n7N=G&PWO!87=Fhd&yYu}Zi3gi_4{pb(Nh9MwE8`MA zz#FQcSUz{5xWm#eB}O{6VJLw9pkOFzV-y?cQX z_=Cu=lgDRDHWWU#Jmak4U-gxvMzOcz*Wu^lNBGY$U;EHA;@Ftk-6rL!JQ8|8yx2Uy zTu~bTGu9n*0<4pPlw!_kX=Qa7nS}dSE7yS$kv9Q4D5rxnFJTMV)+pxG#SkBJnselx zwnVwyz}mB=$x6O`NG~YLJQ@@`wmdBins{<=uH&Pbr_LVa5o+t2UIEBMURgXTyvpB| zc-3hJ2J~51<|1(zTIzymf+B3uKp0x?e=c3I*0BXPC>K> zD>J4C;Ce34`X|mQFFO9gM;W$iddnsSP0PyfW-^&$qu6&QS;Son=+A}%mZOaH7Aya+cw5H57FnVXA6@a4%9o_< z-J^Z|ukFlYW%=85t@bJ0BIjfZUw^)xS-_BX$s=d_bS)BZeSsfRHwy@u>9>lR3P{-< zi9W;~-&gdcf@O-DIkZ0f!K|-cnb}8R!1=@%Yg6`K_u;N%lU4V)^(kW)K%Klji~QbX znW5tiQI9D!;Lk3$M@uhtymXKBSGpK^ktV3!KJORnY!+S$Zqgmuzf~5RAdEQ{7a&<8 z7A9v2c^LQ(BRd@eS|Rq}2&rc9g@Fe92818X9sR%{uYuPd-)ds1tYo~{!wxS59mz?iUmpfNogEfnCUbNkL90mE9&g$UP}ZIr7LdJf`lXvQ-sb*-h%Y}h$>v3?DwO( ztGF$j?8Zg9UEP3U)%w-yTZzbx{W{Yx5)wB9($nFd(t8EFuNz@KGhNcP=UmxsABS5o z`gUWdI>wVFiqKdVr#5|VVq#G9bN48JGXZi<^pI1+O0abZxk8Qf^eaY?Uco0p_a41{ zO}UyVcve6$Y)#+!jAGBs$#%l?M(kgyZ`-~c_MczB1(&#e%zKzN2@>z0RTr#ogw9N_ z9F4b1F?d#x8C(*J$tu$b6j7PoC$_6o-}eo-!3@w`rDo3rplg}YR4mQxt_H|cKlrxx zXA)5lg}-t*V~(#RdESY{f?UM+q&46rrCu&(rP5(p;{T0IT`HLbT&$d+jquM-p8X7h z^6vZ5Uu0{2(^EA=r>UnS2*%5wR`r!QKkeW}t}@tVo#m%K*TlWVe%l}s58#Qw8~9Dm zmDKNMLcdLu$f19pVa_lAD9>ap8kJ~*VuFhkMD}iqO+94Bb^LQ_HUXD76JBztZM*~F zaO;<@_q5`wAM<7Yw$@z&vkI%j-Ui3%c^2O%uK1sno@CcyK-C0aZFpL5nd?YMZXKjj ze{Q9zDdFSz86TR-icX@aHkR&Z)YGbdWsl1$k}g7T*QHQD^u$1YQB{7O{T*d=2f5pC zN$bORgue}R9x_}hsvw@d?-}({_?VxQhFpU~eUCkI>zE~9VedQJ>F@^wyFB|f{_=*8 z@(JSD;C@fl^M$|Y#lxO#U1hG*Cx<8Sj-prZH;dg74$!wdpc>s~Ms&Tk{^@r3@m((X zz(T}Nvng{qT>dS-0TXXGzWl{V_~C9$3&-gtz*A06N$M}pi$>LVJ4Ch3yIj#0c|<0I z+SdLISqGQZ&(xDlx$8#*7@d}>_fmmO2+g)zCob%Rp+m6M@dDOY9Q$e;KaoZI=;uJe z4KRuP&#BAdx<;>O0tNg1hPYUKWFGgD-gLF?Cdf_D>QeTs8zj{Jl)_!$R;H#ed7Gs$ zI@E~QhmyKomT4P>)#kH6+UgH8!aKFl0dXhQDprQsDg%qeHQur6lCxR3>k}Txj#JsO zPBLGPdf*Z?<62uoRXSl#dHQMyLpHU?Kl5V_uP$e6;-$cw#ni;6+3?WnSUT%P0ZWa{ zQBcxSxR>T*u<-T4)cA)dur&_}I<`;%?WTx$xK3L*-1#7h13r~{`gWladcFE>tXVrDMgq> zs4KRaS`F-OR((0-5ob+5!Qj`gb@aukKLQ&s8`KtM!avu^BTg{K+Q*NbDcd7R@KzuF zMm1_>_-tGb&Bi#5#M8!en*&zs7G*|bBW8GccaROUx-b~cb*>%7hNUQq&eQe%`=IE@ zj=hj~H!-|xJQn8)xF;|Wb6ueGPaABP?US95by-*@S%x3GSP-+5vZ-fY@!i6QF^{`I zjKd}~!X3=KG}qO%#iZ)Y_=DpcabK&qQj$CVN}t^G>75;Vc?TqDIol=5f$ULg>p=GY z-E$vsdE_uoKTMwVzYdAdS6%jh#ANwSv76#-mccK<%Hy|$^O*vn&`_PM1$N0jZ)_j+ zP_6WCoo5vyZ^d{GA}DIxaqR;<^{DF0m@`0m%?oOqe8jP3p0M=@7Jc)Y ztkOzVuVsU6J*C~?XN86w*IhUF$(DB%Pkp!Y{qWS6OapI-H*Yr|aed{HtN_la zjN`-6U#096QZ0l!Ke=xewQ4pVKV-T5p%6ue9oA*WLi-#I)>L2pxLNX37O6UUAkyj# zwaVbr8;$P~zp-WEe^G?oOoV9GjQ=uK@RmeFGE)FU@R?@BFOonel7E2Zf?09Ludw&z zn}~j8O{7x{$oE%#Fx+b_`j>mD^pC;t^(W_DkyVimtwS#FFwrk5TX=)14Uv&Di<-sP zOEK6XoJA{z-%}V;^3cjZxzQd2J7|J0f;8yn22%u0v#0G^@+fg})Ve-+idsE;XFkEI zZoB{LDTV|$8mmy=i!d_W4QIhYQwPOYxTMJz@wFWu8k%PdJ}KWH3g@r+E58hu}ZQ+s64L@yWrFRNb7h%W<_s48DGr5!4A>v< zMRvcze}Oby)A}DQgg6VH>rJJO5?A^cw-!x*722kE>JA&c?>f%WNeL$GGt;LbH-R;U zeBoS0bFG<2YtQJj^Xju4On^z3zo^ZB!oI5sePV(TF?W!n`o#cGx$kE(3s?(Ks!oRQ zfFQ1AV|Avg4q#!W&Suc}`UL{ItZ{ECOL(8mi_~3$bqcyaz-)@bJF4KLFnklaXSgQ^ zD=I;Ks%t&C!>G3pygF4=e21gRLpKGQJo1$9Yg9ZBM!&s3N^Y8&)&n)Tkh>+7G?P{j zR0slpU^ymh-sK2CFIV$1=i7Lc%?Y_YxnbGK;>CiNHQtU2s6}cwK%Vtij!BnkN$oXs z!OU#7$m?Qp)Md9vsCWGD1STn(9~a#$GoVxQpH?p6mvMe`a@^-t2lf7RO(p{{k{j_s z@T5J5Ex5B5cYt85LrJrq=fUhk%7S)qJB|!I*$WlclnJwq=Ms1qX}&6{_tWivaO3OI z{{~rPn~1Eax`bM2V9d$$qnnin`kn^kANFV0B=@inm+QdUqvagz0W`by%Rvdcrx;L5 zhLQKIl=y+m%tv;b7G7vtj4w^EIR-(*JCd0}2C*p!xV$Kx>#X3idv5WcZ|@F_7Lhf1 zBynI+HaqW1`I_4$jl)LGh?_NF3+T}0XeQ;-_>3I7Gy+*)K{gH?3b%>+L{Y7;t zrULic79UyCLEf;(k>C85GX&qxK^vrt)5hi5qCEMvDyL~vkH)Lfe`Ogwej(pUK*+Ol zk8l@iX9SP?EFUquMZtidXB4IF!4O@uSMWTj&t(rH|Mf&0s32@v{!b9#>P@(?0nZXsqUAzm-9dG;4*eGN$)=F>7hEf5*NKs2WjV9R zLp8713AFtKj@_{o7LEQchSQufvrrmT_2ay$Cv${~e$X9z_KelvPYo_2`1LZ@@kZJR z47&Y&mm;z&_9Cz}sFz|MXwS9(f`Quz+#@NpmH(bpbXoS6)L{C`)*Zz%&YlJ~dW&oz zF;-|+5{F1{E^7NB`Au{A+T=6&q3xrgtTR9`8U2ZUPBxzlT(IBXN5V7*nTqHtN$*kR5a~hI-Xk!Khemj9_X9#8lww;;Wsx>Ls}wqo^R zZe|omNt5Cq$_zTzN8o%pC5bzVU2VDYGW`W~>J}gW)w-zY;A2L`yiD<*A4b&{^|6^<$t+vXSSDe`Q|JD4&U z4@fasZpQ)th)fux^dak3EN({T9R$R68v?ptxT<432>cMn-Ov_bM>hhD#y>Vex9+Pu z&Xi3Mtu{a~*~!BdakjLUbp`Ga?f7gdYp(m51wG>DK7f5jgZj?emUUMbBxWUO9`zcn zYd3ZLX&kvaRSeY8BHtJ;mK1BQb-8KU-89K{Wc|^ekP=$8yz7wmj{fr?sTaP)ZUArE zahKU~dmz*POG-hcJdlw49tT$}o+piXhQr+ommSS3F`! zw>iQ}w zo{BC7qeSaUPcwtGNnH$eLdFeB$34C)_%gaHMV?o zlT0fuv6QEtOf8z}sY=vV8*=SJYDCzXS>R8q@=nDLVeOc_X}N=RFJcEpk`X0>GmcIo z{s>~IaW~J=RkIhek3Wx9Z{=AP4v_2s2}=s2CO}!hSdwj4U)dEOpo4A1r1MgP)Qj2Y zIQ74nAS90%nMXh2csHtwj(aI@q5hg1*SakDMuv2JJ`5VMJSmml#P*d1Id(L^De$Vm(aSGmVtDkmUAtbcBy!gkM}-n}eALcmcj-cE?J^hi9aZD2&IH z?aJt~jZLsq={9Dxt7<>m}qarR)1wZ5!a&)_VaJfAf@N&tZ_!#Za?oBZ>%hW3_zaQ#x3$@+?P0b)0&R{e@56``rI165z zF=JOIoBb3q>G7pAjnp3|A30r5vPm@<8w<3QlR1BDcinHZr6;7Nz%f2NGihXAi$h3F&POJWV5NT$&irmz4N&EA46SE9&*ATp3XNvn zrd~hcQ?4N2Et`@nc23Ey3Paz7*b}g=uEPc#bXV}O8iU{n7+_4 zuQ{>YM|Q~tFg!*!dRbE}Vyv5A^2Nz+SBo7J$`d7J1762w9@Ji`RFnDd8dBHh3M>G) zW0geq^S=#ayqouo_QPX+6R)Q`7s>73qHtDMN3~p4MxdIk9n9%=ao@Pg z0t_qKb+5Xla1>+0OZ&cB?|FI!l9r~JwXTssrc#m^L4a&?nY482JH_ zpq`EN6?v8IDQrA8#|Re0bE!j9Jv!pGNbi?|4&UK!^Q(Zh-n46%3Yh|VN^?y9w0 z!`Qxk)kzm?aQ|Wwe(&rj`xQZHA|h>9c?!c<3#)jlQPEEdT!2_6&rt45UmJvQdq5__ z*DogU)29~95S@>D&esU@ARC28Y3W6Q!=ix;P7iDhXW6`zLlufAaF8ISKX-lkpgxi} z<@7HgzqPws_W&Tk9q;9MiNdEwkzS+SS!Ar4pU)#qx~?T7kq^bxj6(0-xKt0cFRx4&Xd_#myyFe%E$Hb&J`wyby^ zP(@4;RTgL6@eXS<{qpPT>lNFYAue*J^7zRp)DZulf$nE@<~sn%cD2L{g?31tqq{JQ zSCY2i3;X`_o%4yOaIpioVC*S2NH+zyp?(}57h6md*E@Rr48^I@`AVb3@o}m3s?GN^TM-+1Goh4z~JORDcgp=0{ym5PHQm%TAoZN`PN0P@iQ} zlnR8mq(RI1qE18Pl6diwULS+n4%XAC9*cR~1Yj!wtv{b4v1C~7BJj^2>n2HVa-J`9 zW?CuLY36=rf4db`$~za9g|}-H_X9t@8Am1UrUb#;D%;r7>urxUo%dC`_S_MI=9vd- z5QUYjB{P^2r{f-DX}3tVT;!AO(`f`;F7L)UTf-*gBRuJKI?Ci6J!IAz6qe*@8MWcl zdYn34CT~!^*Z*m@=hIk7>B5rL-w?M|*QMcrb%&U*9s@p>QL@6L6A}K@T1L>(CX~0} z3@_6WzD+ag^{Q|*GlMmTL`C8$X2s{Fns3uz6`iJ9T2Yg@_&^FYN~4L{HYT5Y5OQoc zv<{u5(v)I61Q?OwFWtTlB@L>byAiA2(TgIn{$8Q%=2SB!omwm_$yIFAk6dXwyz%Yf zI`~7|`0)17yi0w(x@KmFwMCfI8ORQ=sFt2;X8*gKL?T(`Z6T?u&7y*78DSo6|h6Fh!RKC^?EtzcLFNSXF7n^sS$dJmYu2j~^WPm1g}(bW>dWb5Zgg>;En=>H>ho(8 z-c@B~i7bLsx=TRQg~gz|nleQzdS4&>kCC=3?;%dnQ)RKvCoW4y0al*X)*&$cC-Jh= z3KwReQyKEF%M8Inz)X}(f3#%#AG+?-Chb`ZUgq%0o;r!p3)Yq3cbFDSWhd&!zbWr@ zN$PMG$MwNxO6}7yg;%CK48oz;<~LZXJb#g6|EFppV0i%y5QWN z7cAOOv8stdR!_KsQf1q-{Y-?wFOKor2>km=9IH?Dwh3p`t^G1}$$SKCVw9C1Bp@bw zF3;dZ_a0<1QimA~Y3Q*|U*%=!tpAYH+a{28Xjz;u42X;KG18`{%;^}~SozLr-VX~( zUvB4^Gx<#(!K!BCv=kxAw6f?9@xI15s~z0xc3=UJw33c*M*JZ8sS?*93V91e4zX|9 zu5_5so+K=HRGYe|_!&h76Y4Saj7|9Y|Kc*zO45Q&aCD zlB_4zW>F?TI13hE*tbRA$+bp(nMnTjm&6+C5(3Svwbn|p=~i67BsYDX#O`pW11kZc z{fB|W4TCr4G9$Jv-2Tkp;1n>kdnk^R)vFwFok?KOYOdXEx!n@ad%E4?F(HbIYVK;) z%kCNRAoD$;YuaxwQS6hDy6Ul~&zOb7g=xml{v4CU)YSAL8U0XAxgSjHzE8=>t+bd{Kdjji{2O4RK+ z+At&J=phq^9aWKTLF4xR*wcm-J2U48 zSrBx`@V^$DQebZyK$WcU5|f+fIJBihR?8FV*}l0$s&UhU3icC7%Tk(t(*u0v@u*mb zPJxGW?Tm6<9?r`T!p!pU+o_@VqTIoH0L>FDXg;U~t}v)#-5wH^u+wrcWEM{!9PrE=9zQbN^BlT=DxvWjrj1w$kx;Az`ZM$X*Ml$B;kXFJ8w?vuLs4PX@}y%ZA1aw_UM? zBT&K&E4SrX@%i89STEWd`}rN?@NJC?QXP6{92wb6BK-xSCqYV=dj&-Z{JSo+{vzkf z_jcLr>%(B@+<`}o|A(UU@Jl*>{P>ku)>Ts1pmI=omv*M)^>qtmR@7OkSC<<~?da6x z#DTKRtgKv_6_o?cN>g#>WYwj(QgeVCb07)|0;00?$M0X@0iO@=_v`g~KI`aJL5Z^) z0-klpdOHl$cfoiI(?V^Rw-wR-1xvyq7D}C5S%M|TYZIgkG=lMA{Cqd(!Ez*apg*P6 zS6?Zx%Nnz*5X(6xtv!+>r0RcQ{i&-Xx&0kfGjG@Y2pMhd-ZHp2_xkaehUYDSfcVh~ zkJSx@>%V>gMHu}|KKSc>uc)jq2U@tHFO$<#FP)mX+f#X&1$v>0*M#KFNb7Xw9cDyU zD=I10j#fW6XkU3dC0l*M{@!HK*2kY~LD{QEM>^fzvk}{;6YxH>fS{^EuW&xN+=t-?TMA2Ku|hN^U!ofG4iexkN z&X(L7vwTMA`tX;r0q$bp9#mz+{7aKAwA7GgYE9Gomr@doJuj%JR0LR{*Ya}bq31k! zE{v!?JGf%6P?5IF5LXmwblkE%mBk^z7d7p8%cQoyDTkY1p260HGFJW?}Z%|i)`meLnI(Q}6 zefbQM`Z*0~Nb@gSIHGl<+%2=O6MKwy&01xn|$vAI^7SnJ6^2 z`Xb2GYGC4^SD~V7f0>ohUvAb<92cKIq7LL-unmN3^5zwv0d@-)VCQPq7l_$Ael`V7 zEA^FkjM`lRE@3#Dm&fg*#>Y3ehj|E+(W+RC;QO-0FydRX2rrXu4}08!w&n-#kReT$ zKH=j0$Dnqe5!0WTFU>)InchPgUXeznHEF9q&FkgFs$`#Zc{JLj8`N&l>N-VuZyG

      X6= z{^7aYq5`bOM4vHy5s46T&e@hSwYnP{?os!p#3&)wNtI`3=xEC@6tw@NIO>Acoy`Z` zl&utiQ~o=)_}p~(4db^aV_KbG%}KIyt~8ZZg(7ck#ZS_*JM^?<1ehqHtY5?XR^$*fG3Pb+|%)nU21?>>tnk69Xejw$<>$HdcyofJC+yh<5cQ#x0# zgV6{laL> z5)TfpkEXoX?(Cutqho(0=G%-v#`j@JRPgK8pT{Ork=IUyU~=t zQXX1%&_PEseR}&#aQLg$7We0FBg~8WSAi$Yk|Gl4J{UfGZuH)P@+Qa`XvKXIu+FMF z?+Qawb;r`Ol@!>I6_-PxIwuhRN0--_ZiV~+vno404 zrpc4+gOL^;3q(mQ9LbGyMnN7tYUjVVB^Ex-7v$&(}l{>`tkbEO>tCKz1G)Wbma1s;-VlaBqU)- zHh_p-3FoeDBZSE|eszucPGcYiBF0c6#MfuU7nAEK9I<8k1n*hC&Z|a$*o>Pi>x?%R4%dm;Mb0?~1zgeK9t2u&TsRzEYyo`H$P;sBuGe)Y7j7 zM~4OEZ{Ag?@a9$NP`Q)m?F{~6JI$YSqK^Ere2+i-=|VMiJEeT9ZMapD$n6O0QhiUU z3320Fp9?1DR?YmwDj0Ij6HB#3Z>#^(dntOWWtRO+jW5jBGE?8&)U{~w?M7q9dAwo6 z%8e(;d_A3#{CKy>)mX`OFPix5cGN1h2Np~RVEp&xb6D>yt!yFX`rhb9#_}1~Twlwn zV8hv3T8QYIi24=>+kCD)etmb7V%g|vC_>D*%P?+SYkxjuB889m9>nuXFg9%!mb#D( zl%OiDY70{z+VcAA_EvyH%V&1G{xjqwkAbV>lUkm9O^$>_60|8Z*E)&wO;MfrMVxd&3)s>uW8 z5-7irh?uaBcXEkUfSVjT5+w6qnlcCZSxkq4e#0-Y=3Ltz>d5{K6SX!n1|Ue#bewN! zbM>Zw_SiLZQ1j3>pL(1n9t?$Kra3j%SqzGl9*{Hmah>z=OKUw7TCmv=dFf_JVa#oX z>ty8at`YPlqi$d`?4aLIV7`QFIq9XK=3bRnEA%WPF+0%hq}VEwKxP0URm+1I?rnxM zv7D|;79H5a9^Q)2ERM~ln~ooX{2X1mW(Hj*%G)p-s){`0+>=^+XD90)n1b$r?1KLn zvTRJ?E_&-4)$ox|b=Io4K_pKm;Z%% z15aN68fcyKfak7|pA2oKo@kNf0-6gRE{q!yrhdhe9>td=bzduM*0xmq6NX?O3Sb)Y7Q<+w}u*gGcN4ZcddJ@RI4f1)0B?B=%Cd`KItF{S zoX*cw{jQF8Pq_a6NmF)k(Y+dE2G^ktS8&$JB6g^Moo}f)v1l=P2 z@gB(HC2Zub^0?Sy<-7W#T66!BP7nXc z27Vf4secCT`|W< z=AX128U{3Ok6PF{KQ#8GU)|h#iX*sMOP8=(jDM^f%x5Qw(qv;WBjLB@uVI_dajvP< zPbd4|^r#%vv$jpbsiHfxkKqeLu#WO_J!@uK+JbV~F?7GDv_ThT#WaR~^b&usf|d8A zWw36gqCNyr4n0bZ6RsD(X>oT!udzogApROJu-&A?q2*!j*1SU{?{d=aP3JH$tC`Bb z*!dSm;*fiGvMIz>f}GGvqcu#K?XO(U0+uPs$NUw~`hBXPFn8Ijk_@^HWS9m(Z8d{;((f-_L6a<> zLcIX+4hWiskWp!cUI&~CX#k~^qGEg|Rd4n5!pN1%m4!n2&#B_gJzaf7O3OPz7wjjc zY6~@%He^v)4I&^Tl*yBNB_=rZHwr-22}4}IVo)if%lD6jDARR>y2~stQzvykgXyL; z4x&*Pv60d}=Cb_V=y58}ho3FYYqQRbIaP`_mq8Yux}iCXJhr67zUv=Mo5W%m{$MqH zCDob4_b9hzOIIGFC#Uh~FkQb;&9IzI1jxU;h^G9!;R8lO5 z=K$7hC)Bgv4+;0%;eCQt^-C9TmyN5G`Mj?o^k6B-d)3>d1{1+uU%Hd)Uk~X|SD9r& z+_3Rio{3JzC0x`;H;BJ#^vuO3KOGwGl+rcfg>1D_bnPd5;W?`6^h4JVApe;4t2Uvc zAIf;!yA^n9YPD+c*2ATnni=RnHkkj0PKO?e|3JotuPzj~IS78V>1FGzvK;b5TCM|) zHk&HVLJkhjgct=WPVHEDk1Tk3HB|VB`(*8%=-JG#TWVh%sE8r==ClbnT?zs61*>ER zKy9cA{lh$20SsfV%m)z`0OZY@mW45Yif~6)xzQnL{;(X$OW5oR3vS_^%KvEVt`e-0 zmDqn*sw9~;g*3I&cA6h)()v2PUZ6@7dyde|t@?2C1OC-6oBn<>rGg66uVPhr1Lg2`DraL!=%Dl6`DwPyWjhlH+6KTf~Y+1wGgJ-T8c^@m6K z>bKe%VYM<;km=Dnn6kUw1HHNHcaM7&k-x@v_PEKJ+tvhDby@a{fYBnW@jl~AQ(Y&< zQ27^By4tjxPrZY5cNBKM$Qw0VV&P6o~*8)BXb^@uwsPc>%*(Nvp7N{%)2~1JX4=meyqxg^Ec4& zUnT4URD;f{CZAs4_;^lkvzh{CkgU%aqdAE z0SC(&9P9?aj6|%b`|n}py#5Z#g<8i`Z`$nhAbodnByD)H*Z2CGWOx!-*d%Xeo} zg-2W$2NKMmRa0t=mp1;JsZ%I7iMJT#rD*w&l55KBMop17hpz~FKH;U{!wm%R&44?5 zQ2S%5IHjnhs4?pAz2jW*z_@i;VT>8|{HgfFNPH4usO6J5n}|ZNV708f5rD$yG5K4i z3oFULVZeSG`l~xn4)b7aOXGihe%d;JhbaD|rfDogv>ql&MnJRe^tc>^ z9QPH5S&mks$Hd=eGT3{jo5f)YtzklwoFG}sL>*AJ5a5|()-s_IOCB*;K?m`$$ctDS z&t}+G1-kS~wb%9ze{2oEOb@%fn5t%3`e>*|(MsDdGiXWE+%OcmC{hJSobo_BCO%+> z!1sBrE@cq+QMLKWgRHqpiKsdGnWnXO(m#e%14`3Bs-Rjdo{*6dtrJ#KGN6gT@rUrrX znTwNK%3s}HD(lfdu+CNQUy09|RCb#O&CmzJn$+~4ux1RET(<7T-@y{~1s1O5`s#yh z4|#H0NBsJ?h3f3F#iac5O8oh*0Dx8aQ>+3;(ObKY6f9uFavNn%LsyZX;!L7LcM^D8T~c zYAr7kdrx|YN+Z!7#B*j69*y=rkYNbEEK1!xlaVh+?`fUwso!pyZ%_Z<>`;#*J-zUS zh&~zeBkmsRu9B(kOH7PfUdaymgB+4fl0@e;qH?mSG4iO62RgGFtk_Yk$nq}aNM{V@ z;;73HkGR^AaQ25bkXB*zbY1jKee!|^yHMPF%TY9&J2=w=57Uh^p((i`p^?-x;F}d6O^xve`!y<^Qxl9n*j13wW|M9(!+*xB zuWJjuaMJ*%(Aq{w%_V8p9f&^o<gZu7t@2W)d*^oIS5 z)YU>_y*{!zd^Aj_E>}>ha->%B<2mZ-hFP8I8P^7pZ+kimxi?8d>JM}@?%DlmOM>sp zH(|>b%E&K&toI+xUCF`t)v@wJ)q|ez$_H8Xf$n89*U>3OV%C5@d>V+6&XsA_Wb?qHZo7gbMrmbDE%nX08U#ayn?rt~Gg^7ammd*@=L zoGQqacC#Z@BtukYQgU!WqrPWQ04aY;@QA3aqN30Hm0pRiC~3x z8F%aCrM3Rwi~-I)hIIl%Vgoj>V8p^fCz<_&IP+Ra zJ}t;~v=-fk3DU{RP=_E^l<<*ZoA$vmf83gGVKMwgx;tDF*do3UBsxVx*!2rR&UgT} z9}yaSgbK?$qI^Wd`%Eb4?;hFyx2La*%@t4GB6^izUpu)nIR*7bSq68#m1%=z|FDey z4~w2Hi@EFr9l5t^?d;=NzN*$~VCEDl-fdlRZO@zW*E*CDX9e=@vaX$`O7Q%}2+It) z+n1Rm+(#;|ad7^?kHj0}iB(wO9F=`#AE3uyfOs8Cv|)WfE$oVCoA_`ELwew)g- zy||;R18Mfy^LesrORW+WtRHAI$@=S24hU2qacX#|6U@1{p8UG~e0tj2`;gFHA^9HP zw1TCt)@QqFyBef;ULMHSZl2T4;dWu-=SHnwYI(#h6Cg^4<;!dSMwJQJ`vJ~ocjC^~ zp?+%qN`wHhbL+qVnNspb!@;bpD$(pxZKkZ`+Owm1x;UT9A2K@auQx^x@2F29dk#Z< zw>JeHYnl5qqRh4LaoBuymG~0%xI=x2_mFB-*R4taPc94-(59%{(5ES_*zABRIHVNL zmz>I7K>J+u?OD37_^(o?#qLsXELHrc1#TXSf=ham_?VQCktl&@h7L7*v@$MC#oY2s zMyqAZod8!vC|)2nU}NdLxpsYg;KITrFYEv7mW>o*Kv zDOM|V_mKq&^q2V!Pt$VK2#1?fgx-6=hqV^a$v*rdEqYTGsiAHJA3|BVZ}gXWBVkv; zB)n48LRu|nRHqN)Hq6q0;kC5v#JJ!?S+CshI;D$BI%CQnmydC;8ZwWU6;%N*nIz%km)PtspMpL7DvLEJ!i>Jl= z&ErIyCu7&?{x3!bF53#NgG=$7Md(0yg#X4pRA#u~t{QvJ3!57jZG3kyPMsV!1s&&J zpgGrqzOqo^bAX~SY6-Di$1tPp^7-X5Xjve>OqI z7zTIiXm#P*-Cm;R`#|5ruFn3}V*GtFVZ3O-!M8F)KA|I@Ft=UVm$0yw`c{;%bY$;x zU*K;#G|rY;_Ik<6l9A_%0ULc@G4}VDN2KsiGj5JyF zJVFQKY(Z1$8ztLkw0eqw?0YZBnQHEk7PIY21Qrt9@OgAz`>1$qnN)V^57N!CI+bohCL-AQ+*YQGCi8V+N6ox85 zAevT*r#WioV|DJ}k33ecC^E1|u04r0I|u-{G*u?RhxD&ZrG_|92wE@$~yP2aRDP)>j+YJI5xCW1Az>wA=-jeFMixK0FX63mN67FbEMUDcw5C1qZw-%vrf+$ZnJwDA^V#-mdP*!~aotURzdddCiD}zpk!i1vR$#L;LJT|W77QA< z&R~1B_S_|v_>r&Xmc90bPWtxlIATdYMJ>POXIO}Q{lwQB`X}N@LW$iVvevET^;VAt z?vLXMqb+s03mvHKRjSk)(xV(a*Vp>{E6gUjB}d!#58Cvgw#*;lb+rd>fD5{#>Y-KM zkY(avgyFocyNSDfb$b@YS(l-qbD3iNJn>u0bvHHBrN~at=NSdsRmnS~6J+&2Gj`qM zlz)(3l+yZvG=Jw!y>26L7ku$vcskrd*k58BzLG}WS7?UNMj&T&>$Z*M&F`KWpQvfJ zm~;p8&p*cm&+`C2QtFDUk*EKXI;ILzUsy{QB#TyBV`uMfg^TNql{y8GeQlBVX5^lL z1bjaLU%G=Rq8^8m2@9c$F)4VWYbkkZCB_$JM)bB4Tr0qmJ7~S>VuJfbvJNPXUz^@1 z$=E?f7ClJcntyvybai?wZXr}Bg?~jO?CgVd*hCj^$Ub&=0aQmUN;U3f+GPjttb?;yYPI*R|eLEj(^ zRJSrMxS#Pe6QXqRO$<8H?LiFRiJkXP0;lZg;=#pCH0KjP{rrx0zSkw3!JGzdbmCJ< z{Cj%%P|&BG(Id<^1?*YAEF1Qe7(gK3u^aX<)_RLC5DuBZN%!i)q7c`dZq8G?7vl>q zUpm_LDp%6I{!Oz_Ee750t<#A|bFOX&bNbS=~r~aCKQPcrr{D(#&m}@!;fsTT!5M$){@u=>O0yaC8vOb+Yw)N*Q!}ksa z_%}Poml~+nT}@(hDsvMS+ut)jpv&J>o}5`x^5(V(`XW!&F4XQATAfvQSdqO-Z#h&Y zSX=nC1N_buNJKt&Y5EwS&3vPz5`aynFXk4`wF3S&lCm1eFQDY|4_v418CT<(CGihE zpYQfmWT)&765t=u`_2bv!w_0_c8)@xuKV)8VLS;CkZlKl}3D5EGzo*QZSOuE_|$V?4+Rm&x=Hb-DL>9+QF zm~QpGCNrNq0k!r^NZ^$0uevwPOFWBz*UjpLayP{+SVmA>z5dns@0MD0Yv!Fx?`PhM zhwKqf%5y#?zqvU78<#nt7?pU?t%1~N;c11xzzmUZ0_d-@i!x_ zp*1fSm03KNh*Dm0Dc4mH&bjE@#MeT&sRJ$I!c@@ayJL&?hnfr#jREmlVSPBX*B#O9z3MdM)e9!y+hX?Na zzOM5;4#XE+EtE2FKhOuh`&CgO4-Dl98c#Xl-}s}GSy;CAO8!5vHb4)@+LsJrsJ*Li ziVj8otrq)ZP!v|47ZBHUurb)jIqv(?7CjM4{PiPkQ}PBNo!jgverWc>@nNH|XBj*3 zdm}1jZsGkrV;?ZK?C4?O_NdaaaQmriO$U{BBvkCocuU=hN>l{Ur(Jk4artK!KdEZ^~I@{gp5Z&dOhV01M=R#|sBfT+;VNTdJz*p%72H1x zrJkn#fz2w+kOjKJQR6B5nW>)6QMyx0Nq_te4An;P!(^79S?Sm|M=|vc_0ISW2i0LQ zKX*LFSZD3c;$`e=_sh%%hXtHyF2|U#l@&{OH@n26IW1+L>|=5rQa;7B*3B+nZ{eLg zFq};E^hsSN|42T=P3PRrThjH6+>P1x`DWbsej+3^v(GsSU$t513O`)80@k)`)Q4Dt zc#~_soj*fEr4YO?t|lbRGEbE0-jYvxif3_bVOv22^Jd<3DIVap5Hi=~jwk9YTcZ)lji29qRXf=dN% zMy(zkb=G?>J+=I)kHz&N~EIAnBa5t(KH^##?fZPASCR-3aahruRR9{aW&ZR8*gZ~Nv8G6{*7 zP)&sMwJ~>y1E?3Y`QKzqM-{NIus13VCIoE?b>K{lxNirTt&5L5MpV+o0yj6-DsE zHiB{+YNgEo>>4FL@kq=RlmcF|2KcvvIp3$k9}#@!eB(|6Eryz?z@2TA2E#9T!|y<} zPT>6ZRD0;VkDh3w`(ogjs+*1~FSr&@rjMeW`IW@&s~%E!Av%#*jS@7eZm_2{eOs69kOTrl*c zC~&q=-s2u~w(xtg2Z<-&)(or~blu_dj4aiQK{yk3=?US2JeuuD+s}YcWdE#9Xm@Cn z5CfVumX^!Y31(Ae6q(aAa~(xs76_QKDe>KZRsUlBSM5HXYdMu6tUr_5dQndWqVsxKaL=OSn_;QZ?IUR&KV z9Vdv7*t|p5zlq7uZ%-0}U_#+w(Wv)%Db>ZICJTJ)_$A>|zC$-|NX^MNyyuJ~nSHY* ze^*xjAQ&3obF$@A;%Hdg4}NLkoF{-HesFct)#PTtMQLw)r0V|{z@4@gvobQ%37o(X37@p$oR+x za$M)&dTmId^4NQSsenCzT99n-4`Wll*{u4G0)K(s$d$wEMjrzQC1QPn7pHbu zopX2sgdfgo?JbNk#0C!CBJ4k86|8BveygUro@i;M`=&g$jFyDBePLwi9knpn9`O!! zFSRkk(Z@*blfRKzgMM>kzK9Vz{K^oR$W@xe^Thonwl!NiLpvhF>Vwb`@psL>Si*I& zK|~Ru{OkpXjfCM)f36E*-}F_}-6@>g*p*9hB#Q8r;}5mt0@u2giOzf-r39&xfR!^y z<%~^Zof!_7-FD}0brATT(?ZNoAfs8KT*=-g(iw@kFnxB|GGl}x;<{;XXr`|p1b>|G zmdw=GUGy+=hfEJN4P4Uw5>xDE`~FUHYu z7sS50RrNgjxBYKJZ@H6*ZLe34=s8O3+?juyGbBm7HV1^!Z3iA@M*_fs<0~LaX*Rj1 zqR*jK7so-LBEk%9l&^-fe_l1`yJoeU87OkUvF^^~tvwiI>~w&ubg{bBk#4*_d;KhQ z!mjP@K3p(^v6G20UVHDI0wd;Q7VpEBfuJdywWaC1Nz3y_A+$=zb1|>IpK*aodob_T zmRfD&u#41a+(_<8ea!id5SdDAxS@zpbGXKFM4W^&v2dTl7}8_yEPV6=hxp=r%s<1ZI(2_f|6iL; z-<#*IHlK~3^h^5bEbt3&{`oF&psDYWV%jgcS#RMmh-!}IM@|IxBO719lE1iCB~a2h z(ZU%vcT_zSZPD&hb*L$jnZKjeaaLrW+O&=WiOtjww3}~`>w~Hma(iul_qABA*m8XS zL`Ebi6>P#ttvjU2`DRI|C7Ogn8zLn!8Acy18-j0PA@@e6Ium_tHLKL_(n0#_H|*|=!f<3jNxmbk&!o2 z4~_l96M<4XK=7}c178)-U&h3_|DB(;I;=P0@pO)^`k+mqa;A-&;}`HvIdT)DL4?Pr z$jREP&{QKF@YhDx(wr#U`!^{*fG!_T4mS3^sG2szbg?=9=TFRdu<#Z(9hlc_)JU?i zYUk(g*Gz~t$jG&TDgd2%Ov(>W>6udew@`vq=5^E^Uxm*paNZJfITI( z_4rNw$S{b`H0o~Qxk8&z?3r<7)B8C1DeUgK4E|e7U^8d&ptJ7#&S*Pm3Jlj~IgLBk zJR0itv8F`)Iu!v!3uCuBA9Rw`ei8>nfjq9Dn=Px|^7K^U5_NXqVkuK*XG64BKE4-E zd#M}tg6$MjU1Ufe6xEGbyee9`H~@{w?zu`rjXR`tUDOv-Qa5%o;;jZV7=5xC^~saM z&#qCqmZUIhWYp~N^P-H;*LbNBYlP5)Px-O+2%x^kk7a3H9F;TLeY7{{+^9%Cv_Sw{ z&K^!Ct8;b-ZCp_7ZfoclPB9ZQV&QZa;B5K*;r(({S%`}J(6-}hSU?N?y&?p;VB zaU>ja%rIj0`~FNPr??0MnxECPnt#P!CQ$UkhYBl~>5_AfN7sJyMBcoy`d&VVI9xgg zRK&Lnpbb*H-AjeOq&lW=bIDqVrcJ<`lpn{~-YF8@&Et$6eP!cb-p&8NORNa~*?E7O zHo~AvkPVbnXWx=f!a!-g&&THIiseWr_tMrHL$eXpkSp!)!g%feasI6-3ZbzG9gu}I zGa|LzM78JoNvyk$7RqO;i?jA;aKY78-lMDek+wIJ zZ{@FTX9KvJ2|LU@p9d4nVdC<>nMlbIPafa+Zu=@miKvoT^H!UWrgPbenKkAx+la_! zTlAb*xH6XRffTMhDRXL({H5#($<4z2ka;)bJDz+qV-#ue#x5*sZ-yFU&>0>x#|-6J zH*PEr`9kaHs{gG)nOjQ9Y-@g}xAW@TqzJUPj-rS>Z`zHO06^lz=dH{}a!#Ka!DGU^ z3`lhBiBBqJlgG~Z>C(33Yxqm(!$-z$54}tcoyJqu3!G7K-CTk5MPCj1ql0Yj z3yp%xB&Owc92y`_ULSLNVE%LZN57gXykJ3;$~w-zX@{xX{UWnrm*HwjiC(??rzX#! zE2iP)k@?C{D$zP8-wPEHWWCG3CG?rzPgmy6nz2ylXrCC_vnXZBrK3v$c}6Dn0igpS z20FPn9GX|T58@4N;AI!9mNQn!ZzT)rn{>J>q9DCY<$s4E-#G`t|L~os?JDufyQ?ke zU{A;3taqqG)*bygL?7tv2$BY>x8CrndUSQ-=&RLN<*5;?jwkb+I<{680KVyZcIocV zAIU!~JGK3%j_Sm}TM>u(VL4s*MZcQqvKR$y&iV4hi%}iM_gDI#UBZL~LaRc`{Z1I3 zB=!S8C2ywT*SUpSI;w-WlPuC;+HIhmTMEv%m85v<#7yV)73n_DSVbQiFYE7#z@UT0 z+YpWb*UfHIDj+;v>bxO!s833L9wTFSLj7 zu`_78u!^UL=%9W;A6$3L20s}N5W}J`0YMdHjGLO~s$EW>^ji4XEA}`8d}g(oXWJE* z=a%glzzgR&3-|aEv-;!m&I7x@9AF?-k!L#Xfl?gOTkU0q=hSO6$gh+t8A(~emSI=x zbdhH883sc9%z}g15cz({-{JEj%wjO#IcZ;445-F>v5c3J&iN%uckmqk{0sjG>r*i+ zWPio(%2!#z!fxG#!$%XWTsrx)2_M<7yD0(9~D8i)OI4cLh6=_esz1wnd@g7UNxG^c)TrJGy1GXtW@}Fke8LZ zR>beEb2#MS(>8s}{XF?DEU%*Nmm7LMa1npd3=#dQZj)lVV@SX4b!dM`e*)e$F;;xc zpzfkpFm{)rKuejKhN^`x=8&SKS2a_2y)dk;zZiGOmEc!m6&&=vQ1S-|bF2U+0bJp& z?LBPy7gh;I)*yt_Hv#QCg;(O^z12}QXOP2xmbSuzyvJfATTrgX@r%}^zc8IZLmnaa zD^yagn81L8`6d%Low^m@v58DdDqN_m9TA$m8jQE)ojMM)Zl{o#$v+fZAxk6WJIUz@ zGV4h5p^6Ktz0Z@3O^6B6x^DPM;{d7c6y#=qmqXaF3FOi8`;K8sg`OG%tnNEpdY?IS8O7xBFvD&i9~{bH&sh?Np+g{>SZIv z3{ni%h1r#63)-cHg(4D2M4?42MeLyP8T{}k^gJU5p&V+ROVhrRdl zzdp=xzdxWie>v&*G3^7o0B95XJt<=a9}WT=9hThYf!0I0r+CLlwp8^VjE;&e=Ks!2 z8!M{Ge4{yJUM(|kI15$zU!m{@3xQPxC&vJivsosp_C&e*#~;KP z?%fqgbB#csHinDNBzA@~4vBKiaeg^fj+FM9eIno1e+t(x#bhyUJYh}zTrdP(Rp6Bo z3&aGh-}?MbK(;BgG`oLEK^=hbwah|yuA7zf7c#LI!isP9?$6V$yx-*#_9XdSfnEW# zze{E}4AwCVEOGi5AAQ)B1PUmN5mj0sv7-Bg3khGCP4O&IM z`|vHuDj9y{&xy(@FBzgV3kZ1}+8F&D^@d7XZ(*r17 z*IEVjBz$Nh>#pw7UiZ;S3e`k;P6+*~(^br4x=;i)r0RtfsNrU8U9S8GN3UIE9VtiQ zswUN{rX1>r4k4b(QrNSm)kIqBU1X|a?4qN3%gVt5f+DS|ku`lHyqif)A~l!AU=q$w z@AyqB(DRODMTheFGw%PmLSj9g$(P;94#tr|;S~OCen!voBgk%8MF&U#Bpn*hp zO~6J>1EQ8Qjc3-$K+?f*MYmUHKO$os_0K*B@sIEE3>U1pW=YsL; zKGo!>EA(uVjPK=fHs2r8pLqlwgbKS+>M40e8kr;of0q<(iSNc;KdfSW1v#|j&yJs7 zcxhT0WY}ydRntUCQaceB+b$AQa9Q+wW*tQBY`=}3hW(zTM7Oyr67VLCZ{y=@e|xhrzed7LWI?IH&xh!JPlcz0%7U z+UNm!g`&g%dyAL1b}aRD>gXL&9YXaX%dS!PGfdoB<`ovlDmI+$=miKD*8vc;@z^x( zf6lBK&l!Dc1FW@dyeBPQ?7| z^!;}!CQzKsu^~8BRi$~@=m;1;YxDIKx{uXI9{srg62N+t#I)xcl$PrOov3bO@qaa@ zYt}m;h0?KUq5HtB&|&t3k!+3SkGI} z+-qBKQ&`NqmB=b~C}2y}0*n}j`wv@y1%4|viPgd$Vx1EW?nW|R@5^}oMK)&pT2lxm zUx-ht2rmO$)Was6KqU#BPWb4ZdHmGiS}v-V2*g|xfn6pskG6Qh9H<@ukQ~7WEkYT( z?dQ-Sdu)IEeEAq&8SSdMBYO9wAiYf+ldS#6{gm_%+{SUPPz0X(^b_big@hRga`yYR->woGOB}FknGttJUto((lAb^QM4Zv3C=8FN#uFK^dv}0$KR8 zbFNRP$y;Qt9djTaioTSVrfxeAs`roHU10u=Oz3w}cHiIE9nN2EUa!~S?iF4|e-5j1 zMNJ)4GJ^|J^JR?B_V=Y{>>v6qT+?F(dW{BJZJnAaa4VOx!Z#%)4H4cOtopkC$~C3U zR9_nl+pOwycKevGLuVNLD3AOrQopV_A-R}^yXg?@+Y1Q<(O%zOUv^G;ob5jqgWrR2 z{8FJ2K7T){I(9_MdfBJ zqYxc{E8A$+gH-0!y)jI(PCnV03Vf-%Y?|wsHjGp8y(j%X*=F9?8>LLuw^52PGndPO zPQuzTQB=DKT18pY0?y32PRuuIT{-!NJNBDd+iI1#7m4D$xJ!T(O4v8Vzacbc-0}F! zpD?0>6BJDcKn~iXPx^KNc}~Cf;sv5LL;pxkle#^w4tb|0=3NqzW@RD)7!3(+kS4BN zqXYwd0uvXE#{$o;okI@K48g~Z6}rz=AO8TFR_WY|0DA{gOVJ6E(60VAa4B$<;G)k( zZom?sv#sH?#4gZWT8w;q1%J_Cdnc^L_eNtqgt)pmdc-Q|wU z7Bb+orISxMEmM9h>5KEHc`go`OsKG9%3%-U*Wh=FUlXCcENpY(F|1Gm`hYddUE-4? zQxudoPjn%n#LFtz!Plod)xx>$A3Ys}vqfC?0$h{;*%>~N@H7DwRlWo;JPgum^ z%&ZRtJ$bI#8EB&RCG*Y5;Z=7+qpTm04Kuc0%cgDw53BtibR5g98^`#7o91r=00j~J z@_UhIe&~nvXK1$UR2|ErvMPqG!S&qv+4(pNb$WbD9r*xcV1IAEphiOX?2QllD-Wa_ zR`31!t!LkLytD!%E76yrm)vHZWfyS_^8PsdLgVQAu4}ThZIW7W;sJ%k4nFT@zEM`= zUD7@iI%Y5!nYEI6a%b|#^*3I9)7KTQUvOyC zZ}5@MT)o>qZLOO4yGQ>?+E9 z%lpH`W#jU1Ec>Y51a5+PGRKuCf5d5_%z{)RX#ZSim$Ni0A?%=ZcG^lK94Bo3#%jF5 zBQC}CT>Ff7e)AI4QY|&PICiP!4LDDHUOOU-cx%SJu!+!T7w|X1{aF)wUaYUuyTyB`)Wj_iP6*}u4QIEECvLU9&0w$CyGzyAs4El#I6ZK0kff<}M)!MH zLUCNku;~7i)?Eu}TLQp;J_Z$EikB5N+s^Sy))|PZq0YfP-PR(`VtbYWM(z^G=MK)e zkw{JVhPG>pTp{{F-3V)+LC!YjH#gA8yZhF-*kKJPY5rzr?4cl$)C8G4_X{RE96h_o z6?}fBfADSg4>On4J{$A;=`8Y4)2Oi|3mx_ZX6`G0D>30@>kD%&tTh1)Azbg-0?W+i zlglQO93 z3om~gJuYAFQGbHb4x7?Sk!r-gLju6)mHskz*~znpB%d<>I!GK)pRZJCRZQbJvaRIT z<&u{)_#@Q#>^6rrBh{6STuixtT*I8PZsc)cWK2bl%Io$-@<|9MQ*-%nOua%UFB>?@ zrK6~o2f(Z0R!l@i={hXb9Gh4vpPrwxfe1S?vIJU=6cBA@c{+gyd&P}#XLUMY-Zhfv zA3$`gZz#1liq{^{eSM}E{KsGl!mZ(hW8sBoXFk+S@K6U5 za?`l@<0r}s?ZaX<<_hUaFZ`;R;5>fiZfNQG*#A_>(l}*KtIIGJEpWPzTgbqE*B?%z zHSRF9N5tWNZQ|Sj7kn{jvwXJ^6!%{eYm+Y4e{(<;XPq21pJ3&TiMEZNWV+v3!y5d2WaGHH&q({S)*N@nSCLy&JO1?y=kAGpqJ6oMvs9xp^IL zF#l|_+80DrC}pj$vJ4+#ZBs6RS5MD&86*3f4+Bb`3tOkvIi>+I!K=?k;)Bi-GJp9+ zwQ}zC$t#*w85y&=lVB%{V)YcVi~BfbGQT7-0XcY6ZBjS?u)b^{d5w9!lxz}t6gDMk zw+k@XaA@m46Q&uz_<>9T8{6KzaTCCnmSznyOh$D_CG9M~$6lio!1ldzilEe?nf=kN z%!*g08!Kr){q@`JjPn3ud3|Fd%diL*2xnyHpX&Z2DAu}y6#NaZ7wJ) zbD@yE-fe2;-g>4fb9y+>y3KlCM}8^T7}*KU^{KT@0F$zM^_XYd zejarB8GgNvyM!2-e?WJxPedleY*!EJG81k+te|Mo@K@j+Tm>FZ}$;})tY6bnOI5eKQId!*=JxbJ-ofjc#+85T`P+;Pc^m0vh zgp@xQ>^aD0v2{9CcHpOBookN8KuLV~f6!4icf6Bs(-; z^mS{qln(L$Q zLJ$3mWdsi!2$E~_m}O`9nP~CR$m@tl`W8O?yZBJ6{p)+F-s_{*ajPVxqNqHzu{_9CD112k6o6N z8Fqlfr5@#ExA{)~*DgXre+a z2lJ*?e`1VBoECIHyP~3vJ(VF~R|5YLR&#}z#UgQF)xa_QLmzEACMzz03|_&TFOyb}Mc#{dQ5wueovFFy3r=s6B}VZgQw8_CWjy zM8Lz#Ql_Z)9-873o0=QD_J$$OMW220hC7PgWTzz__rLU{WbpOke!=ULWo zYU+RHHq}b@joCcI|HvMi&znCOdgFu>Fx26A{i^O^EPec{K0icRvRmgY5G)x<541F| zz#ZF2(=d1*l)7GY*r4hUHD5xw#B|EHnLl(WdFEnWAgO6Ns85?sx3=qWwR=8@q`4;U zc6g{SU7dKRD5}dAZJvIsmudBPWR`S@v!qwqTzfpnZ={i2tR^p4Qiq{}_AHRQZdShG zYqlK`&eSZ4VH81{`kfB4k2W$y9Xde}_s~UsPvuo5o^`JP%N?J#ep)te(liNN_9r{< zd&PN|0xwdy>Q*)?NzxeGUW|7i0B~Rl$`3PP$f$2x(9$d!$22}gXPjS3B{a;LR_qr* zlJlLrU6PHlF%^u+D*NTn+9vhr#Ft$JJ7A@}Qwp6LVSS@Mdhea5Iaj!`zAf0gVg(=V z6p`wY8x9_qT&}K&_S;v{mfGPW&-FA0W-ole)p>$9jqOf|mipLBxwTVR_*k%e(w+%& zN?_dNEz6(6{tVhN#NV~N7b}m2*{9kVgng*R+qBn@Z00RNMKFWq>w@&e`bI5O?9;v( z4h8ZjvBt8!(yi9c>PGLly z;hEd4Lv-nBXPQ^$GZ12msbcA2jke6+zU01A>vL99gnF54M0L0)Pu{TpF5vRNYK9NZ zo6LVIjm+kcxPwIIUs9?B@7z?UEfR11Jo5+?-C8=(v@H4YL6fU^^VXL?os-&F5OZyj ztL|iRvYP%I!y4icOLuhsllxxEU72jk7nxe}Njlzu2`oFs-M_+pm zkEf*h!^7bIl*$^BG$6P}p0#_NV`B(|vTU`3#o5)ZDb?t+=7y_WmK$DT^vyMxw)!r! zuj=hBiJpqZe=FJkCs;C@(K*wdwDs}f9#8P=ALqd1q5*BMs;h2IqtF{b8AYbPTC0Y# zUe|lbe>D3M@dSx$0Y|R~s)-u!$)2mdg1E{|-})LxKruYr;r2X$Bs_-ju~?}%zMAq3 zk0Gj_Ko5`M^4YpjPA;`RnJ1QQXD(SDh2u!GzNL%Vvl*QE8c6rj2Sed%c{!d{noiDC z9z`uwBrBdZkiA<|w?az{m9xomou%(MX)JQBbOJXlkyivDHfX%dQ4+hj%RKv9M1%3a zK^2H;FM$|O?tDw7uZ$yttBr{eY&JHjJ^;&hu*_w@wgn$Te5Iy$>kN!YD=cTsJmcfd zM&<*ClC+9c+nJ{XkIJrnG9b61Q`ciY#^uF*RAyk-Gf3;BB*iFcy?`VwAgv=+0+NEE z0$`9`P;5PSzO;EQ$-1O0<)K5PLsOg2e=xyoa{l-iU^mHD%uJ~i7!{lC^Pmful@%-+ z2^7(gOa93aAJ?ff3$?X%Rp#SIo^0OmMRvs3E?gR0yfXjBU>sD}`6&gTx&|iV7?yvk z3F{L0U7U2z(XA0t6O}3PF=6_%bPkvm_UX0D#fTAqmCX36jTzG_3X6H(CY2& z{GkQZ^hQ*2YzVY3)+ksLVQ()Zu}gi zQJ{g@DyfbvKO3UPzOi;yK{c_FwF)W93o}|wwl1Cg>e&1ai7S0a>XN;@$8n?yYm5QQ zds;=I7YclVH3)Tlxh76J{R;XOvGM?Z&3Rp=;A)h8yYure!g%27-E`}J6Kem0WM|J6Zn9o&Cnm7Mb;$h69r0??6Xad;5$2l14LbX|2yzZ?Bu4{c&*N@{)*^ zZ(3_!Z$21Y7GY5c^01gou;?1?CG4|?>{7$G{yOP4S~PBpoqw18}Q< zh$!#}t9^D-gkB9FXvxE}0xrf}pOfV9%V57E5ZnSt?#uG`2 z2A`yZNc51pR+D_%O*0(>Yw-zX1Lofv(%#ED|)@ ztray!-`LCq`NUPK6o#E`w};@1-HS8+7cM#`y^~+Thy{in0c|#fa8Ft|!gVJz&+Upo zWr#pCfHNOe7u`%*02pc9E9c)>8H&!;%lqE1Hdb@$4H%u`@A-Dita?Gdi1O5Xxw_~K z5Cw_vLv%Ip?yRMyRtMh7%w|wzD~*@TC=n6boyJRuO5y~wOar=riLnJl5h^#KyOHKh z0<9F%SVRU!-r#C4pre7{B5PxykNf8+PhX=R1Bi%+UXcqi8^%2m$37%b@iZeR>xr!qiwOONg8M#a5lKsT zI+wQ-#%o-3!>Y4#OZ+Pw~|C9o;u(g52vQD-5)c_j5$relN{uKEB^1LEPBDaH0m zlO=uye*Ue7Zvpv&()C#x-;vpgEO!b_!AJAG*iw-h8d9I)rxnQdpqDCh1E432JP2 z=+zE8zPGq-vQT&T9TS5Ms(BuCeD!K3 z;btz9n7nm=fn{XG+(QcXB{(6_Y9Il&^*HKBh!g+rxNq>#yM3kpDd{^%^k1$b%-AQg zvp>ns7>`tK<*#H%=g_uSg=0rPZ{;G*;W>suWi7KO;v!q=rHZexs_vqF$q8?f8qYE; z2@Er6D*V+PlyR?x=p%Yi} z81j`+jqfq?!c09)=s6HJWKYK(cgrNK%C9VTm^50Zj|0m#=rj#Tri}C`FOQ_AhQXL# z>sKP5DPo6_UwpUEO&%d78~?aaq1@Io?nWtHN;tdZ0uwJSKjL4*FF!)B8+E}riE4Fe zgni`iwDiu*RZM5p)5+4_3%9Do_@U{&k+d}jqvqr=V}seuDBio7w~h?zj3ffbME@t{ zQdr}QzI**%G=Ig6m-1>rR^1F}uJ9qIz<1;1Q|j%rq{6v1JN@zS)O%TTkK9c$T&lOV zu|mHhz|Jfn3opyT=NjVHuP@T&hnTr-XN2ZvP<|>@Q7m2DIg)f1bW%*Ijhvkc8@BFY zylV`1Jm^d4&;8$b9WRFgN(%DX6WdO0)Ba$WxHtCrviaA0$NmC<(vuUX5H!;)garmCF#@HzHiuwB;`5F%9w2gf0rnC3=?Fu$r{``p103rEz z(DILQi(Xdvk?(hW>X#JfX3yN<<~=X|cyaV~EqqzLyZSERx66a$BkO{qA}&C?!L z@7lL_bD*ohM?JW&Jbvwdp1krlTC> zCDDLjoj}b#q^Qeas642IQlj0P1Qz;?ja{Yom(<{=0>=E1 z^Q1O39CfGW?zdchTkb$(#?M<0Nw$Iq(dl%js+gteZ?X)5SIQSm^{cFx884w51ls8O z-m+H1uf_1J{DcLbN;f!RN^>FT8I@C7@$bP=V_dlE=;M$OJVgsXt;3iBSVBDtQ-);D zl{D51$mug6n$)<*Yp13C8UcwM-dea9QTXE+;mBxPCMjC@^NGMWI2+wP!P-e4(sM#z z!9TJ5x5kSnZrfGKBRWl4Q6au56S2zSLkJ=jH-5M~LDJ`GVG9ZsKF)=_D;am3Js972 z737FMoxMbT+{t0q1TDODM{si=Z+pB+NJ0xs5QtFt{6l$>Mw~U6EtdQCpVXt5%ZkIQ zcp2_%j@IudHvMZ%i>xBLh^)58>*m))DOaX)C-DOLUbnE{uX@Dy96N68BCH3^)~cOS zKC_Rdy|^DWR=R+`32v1mtA~F~__F_)-w^4_iQAQ;d)bJC;8aPV!+iUm>QVUUg zAaU-rgrU|Lcow`t&Iu5^4akkXTai91S%zmTATM+46VxHG27xwv>{jiF!oOKzIlK=03uL8Hv7${8Ol<6SxC=}qQ6cZO zR)jEL$^^fH&w4`I6WNCOHEdKyPB~RwuY3ftDN!rc_#3hfLb=pu)5yKKv~4LcJT)Rc zIAMv@&ay*09em}xgZ;)TeYH0dx<>ssQiyHg^mJ-3Sl$9K|JXw%}^YiOhHbnV8a!N(wg*ejZlNs=aj=q_2QK0d0WHMgg0yEjVk{Gw3ryh(fF!={3U*;{U4<0{BYAb zFq*c%@%CbdzHac`ho#FCB#rr^-3CwwT9Nd9npP(hS1R(&6XyR*^Tt+x<)5~38474TmG8=di8Rby8aYLGpxChq1ExHYW}FXwwi(ni&e*m zsy^w1BniFLsvi<+w%U)~2)gv78Txo??<}_lB^9t3yA!_b7A2l z#+ewvRQy^YZ+%R#TUmJ}Cpi$e0=Uv#DO}&F0$Q`wMm7{IY3-pAq6EM#tX)gxTD8hj z4k9AjoO-*ZTvYimwNq9SsN6jko%F4QRvZlm#bZx8@a)%?u6gNW2kmP-y?BjfTCoU` z_;XEET{pAsr51tSTtN2Gqg2suSzR(*b6p!I$x2AF!ITVuFb!`G3+-oi3E))%7XA}X zU|buwD`?Nijhfbsk&NgQ^;Q-{13_B1UZK@)jCJYPdoZK;D$|h=!O(k5_=k@R`4JFn zsBKL8s+Vdd<=#%K-Mx*l9t$|3bR@;Iv@8LHQ4C`gAk`vU(afF*yDdMTcU5Zwx<%!dJQNJ0+_Q@+F`A1^D78+aqI}pZpv=wK9OLf}?j`367oT)<`iLrAvZL zkAP6G%;7B+@QaIJaIRH8sv}Y}$ngLv!XihonR=6TrpXOun9RtpNIm(dweVpH=)by# zulj)v{tzUb{E~g-FIs@|`O^J#KVtt9=*(<)Z$`aea@CJs(n>E$vnMp+eOlD&&5VGm zf1(_dymXB`<-y63oT_66wcyJut$&X++zn`>TZNY142vU{O#~0AKW^8<`ALVfyDQ-a zD=E)%(Hn1CSZ>U5P#QO15b*SsF@k>v29C-)93+>`?K!Lx9Q?95>fuYjc=6&K%oC{`cp5wb;#H@y!i7U>8Ic#v)kOI*h+3dM*8*`K;x*8$9Zus~WEP1W~ zOsz4SV3c^*{Z_I6P_(FTt6_8{Z=-KEb3aR>Zq)qKP01X{Z%!V`WXWbIHxZ+OC&M{Y zk4Q~*YAleTB=lUs{|=IOl~bs1#{hzTD=bHWe_N@zXi%B-HH0^Wd5wgcX|5n4pJM#-5c#Ke+ zQt0iQ84S=@GgddYo79WyCiPTD84#ADVT8BbCw$=_yr6G}3tfNUq1wxUn_(tU# zdwyxfWg`OvQV9La(}N9lxBW7EZf;x7tV(^+w{z|bYeRc(1}VUe*eR&ru#}64zY&nN zLp<*Yo;@TUjBH)Owh!Q# zuHVzxQo@$hyKn& zCbik~5zRy*sezf2#-9jZ8v8Lf)tQn}kOfcUj44Im>@)~+LStD#Q;yO&-gB*1yzNKQ z|MXY4g&}-gtBjC!$9Ka+axNh%m%`9W1Arp29ZQz3&5ebU_gWPINIJDeTqDc1O4=e} zxJZV(v>-1X1nq>THF_P-toegbk)oE+EO5ixWh z`|M0h5#%5D7EY0RVwfh?0vIj+e8Qtp=WGUCxxPE!y2XPdYInafPoWp0Wo8$Zk1gPo zKL*uw=iyoniJ|?Q3{xnk=0k3qTGlB)M!j=)JE!`GqPtyYrWa53d*(BPoA)4SD3YFw zd{d+H&j-D=DA7q$Mia{`|F)s*`gxoG!c5Ej9fO3$WX1#254k7^*~|qTzS6ut^=wnJ zEc{Bwr+w96_wKIejWSfoCX#(-@xGP25q1${XP^87W(NvSZKK)(ag5*UHrmGa3VDag8R<#7QzwR96n zCcU6tXCQe>t8E*5n{C(=cj>~V4Zp=Yfz7Yszewfx6QzgpHIp7*9WNz;q9E#{9-*J> zKtrd-4*)Hjw$QhU*KYz9!nW_y-A$9zNCT10)92`$OX;v+AO#8NmLuF-kpoTXuyFLk z!V8=7k69_6xe<%$(~r>+AqA=jky3U}_F08fSQr6fkJoRBU2UHSAWh11OeVUid-2tj zN$}zE-x#SaSh(HLJ|eq?_DPo6S+}scXDvP0E43<_;>c{8d?`Rywq1%JHR(^A4!AM( z1G*{(2+?asHR4NCl?vpYLEnu_BRoOrHF;u1Wqckno?^PBJFqh>ND4%r`R^6{q*HAZ zWGps3ge!kAJ<`gpA!;viemRcyr#9gg4+?GoGCjK!CP@E zh|DY`719gI_V}r5NU={)w~9!8gnBE_q@Yp@uSrjk0}b}3gjJ$`Lb24Zf&A3(=x?ZB z>ugH1qdf3!g)h%w~&x)luI=`XZAkHCA5gK+x7Y zxa6G0E44CjYj6}XAUbv_C_!-*Az9AMFXMl|*@c_UgoeKj&Cd?~rqPVEf+wzd9lf|V z#aLZwe~QjnpUN-Xf1BPU7iG{4qBWVUGIYm8 zXZp}KD{T{<>Kwx|A7PPoE9Nr^?}e(WY5G#mict7q%#IstIEr=`gsJ<0{?g0>*%$ep(5DsOADL*iwzC?r zFledL`%Dqloa)Q_*gK%XUlxFzeZOavPaGd)fh!d7$7AQgT1YIW{l} z9dDN1Z;6Y64XbqQ1%IbzWR-d6YcnU-VTJ_v#OiImCHQevS)Yu=Y`!t|VbIor`73%) zH;>TjE}4sw0l5N)RruS6AH$J5HuTJ?`*1m9EEHkmPbHn6-E*=aHA;*fdlwZ=0WjTR zQw(H_H%`g0$9J+4)kSw|(D(X|C9r&<6!G_Kz)jImpz{|N79~!3Kl4*tB~w$-Dq@p^7x{fzM~mML@h9sL{+ zNBevGPxrpuIo0}??%*6eZ{K3^!7Vl86T@@#`qh>aar6X@#s7`z0TjJjy+#0)l=o{-AFYu^mQg3f>b|Bkn z)B1GlFaJl>d;cZ9|NsB5rpHs}>FCjNR#wz8<&>$pppK>WvZP*?TPR1AqNe0#oThuE zC7B|Xr?4Ej%?0J2P;OkLf+&as1OXWz-rrxo|ALo`PagOC{dT)v*Hfc_Su&4Piguoa zQ62kZST|<8A7goD|Z~bVC5gQYArKq8DFYuua^k& zK4C`6?DI{WyD*hq@jpiT90~iq1&`7>exTw4fu@+(1Z@`{xo%ERN?E0eBWmhyjAO

      S=1=#TZ4NA?S~4Mkd(6R4@O2U;dUswC??ipEL~WWP)!kFk17^vjeOLrlGkB` zZDnyAz0Vt%iZt4Hc84;U(ALqiab=mQv!vJ?9X=K=bN+_}_NQ$k-mPd*A4rQqHAdZD zeR)F?m&pdRR<6N>WY`ON*trg`iC33w7sbdomQ<>gL`{+w&(@`oi6m?zbNwyDhh zSy#$)_a^u_qv5bkCPleLQSwq5*v%O1rVotkVibJ7kSF`jJB1!q>wc%@|KbU2glOgeUx6n4HuJj|?Mut}%sqz}v0OoY+`9o5 zO>6;D(MdM;iM+N}4TYx^apB}nK$Ow~172oxFdtRp(15`nohkK^l0tCDrhP&d?znQr&{85Nl zB9Pl`6kereoV8v|#7g3M-R_o+hKj>z!PcV}8slmOFeEeQljWFZg01+cZjE1(Ujh2J z?00P$ua8tVT&-J)^=}^|YE`~~4DTT%fl(2GV|`kp-l1n-UiZv~NObhUk#~HSyFV~K zyg?&J*rh`@x~~$1Co_LZ>F@*xr`JIpj1hVv>x&}(#eoh}1}e*upSDN6k&{|E`<0D?k86d0GQ6d{!HTWIC9oka!=| z?K*xyhf`qoWw#`M?3hMXn%!MLuEq-9M=(|yM%%*qBSjO3Fj=t@a|+_V$!%v|!l$HC z%G6*`Y8dQllA3Ht*Rk@&v$-X&<)E81_D&VXcNK_6Q#E>!c>!o+R5@o9Vvk9KoSf)gvJi)DAvt|2Vp8$TyU> zS6dS!72@huCX=E|^Fs@rSdJwW6Mv_xB%zJ-EyuoLZt!@0s5XaK9e2Oz)sxy<?_ z#zdV5trnQKgK|lfc}`5qYs)^v>o}X>hk+C{et^N`fMnzLeEAg05_xB=f z1Dt|ardZ8OQzP^$*i7_u6+Les&x`T;+8M-4uyzQWNo|mH0~#EF_iUTq;O6}JyP>A*MZB=jH)b2<=Oqk%5@#>lrMbB)3dC*Qy>?g`d~!GZ4qPfO z+kwE-{}O$8;%};uJ{*Y%>CcTg{SQe0hIHUCNaBc}4VjNI{ths%+BJ|U)u;VEbv;e8 zJ-TmC6#P$UV0!x}O2hr7-~l*R_#2G%8euur;*GDRUpfy+Sb@H1`4+Z*%gr9t+cOgd zj06Wm1ZJ6$>XIt(^bdOms>h5jn_b$0ovv+G`#I!WDGJg?TV?A)VxWz||A@B>ms%d@ zX2`FB4~p7NR{fpOpE{8@_o?u*_vo{3(=i%Zw)cAmJ?0DjtZHK?P=Y1N0Js$}lt2i+ zVR*ryWB5Rt$(Qx{UGw_kle=anu*VYShF>|J0D1Zlrvr6Le6VrXl{)asdyrtGvi=Fh zNcXB8>Q6O7cdpMvRUcSF_;!CaUs~A6XpdgWDXi>RF-*9<$;$!S(*FyF^=*1-SCP^S zMaQHq*L^z-T`B23cqAbEBrG869N|;9uPo-JhNr^6i|zY!vz zZt&;^VM(Ih-jc;0Md$9Gwk1GP3p(Dxzm*b$rh8j^bPeCCXoy@SZbG z<2imlLR{CrMi#R7VsO4}Vldk2{%r$_?SKfpioxhfr<22oGSXuukxRI99G1vZJoqZPm~n9G?hb{WDeanw%UJG1Ldq zwi;a!9sFnDWS&1(jr&`W8t)5;xmAOn|8{Mq-Ofkq09aGqyJj67x75%4nHTjv_I^ah z;fBYLf7SU_S`$~jX>yKdo=Z7ByLo}T-G`f<=sVHa9(83D;7Bt5N4V4$_Ig35XPrT0XfWb}{M;Hne) zhwk2VeM@P`O7}3TU9Ox?-KqE-7wK}Cav3_hogTonqK;A<56?pn9m}jrgzqCYetK6q zu_=2Cef+jC(T{*2X~eB>>zRGEy5P=Z<}~a5NY=|Y0f&xk*A8pJwbNoM&s(ZqvOV|a zOA;G8Svxv=7IxfvBC0?wU$I%%wM%39Q(YXRDx8=_6_^-M;Q^J35mFJgm#*-VCE?Qp zD(gO@wOywlQbp>7PM5GHty150tSW3hg_xF|S}m~S#`;GUa!5*b`7fj33HG*)@H&Dl zh^;;VsE&rxr{Kbm`fv7hI^YiLFZRGa8y02#v8q33NT|79$N&Lz$j?(AJ97UdKF3v= zn$A)WF+~_JI;YR3?V;*K8|f8!G?Xnjf$S%bMTSf8AlNH88Q0L~o8)72L5vr%13c($v2Ye=-OKt6)uBhWshPX9N9gk&6A~=-CXEDna&?Aj=+`$Ibf@$OV_7Z zUw1dWy7qj4n!51FPvE_1(^Gh$AX(M&Je10O>Dr9COKQC2zpa+LGKOoBpZNleS_VGp z_#0AsgPf(8QrWoK7kP$%&0NXJx>ja)gbvn2xa>?d< z9Y(Cmw%rDEW?svg{j(vDG#Vf#4Kk019f5i0<_8v@h zGY?*Q4gi&=FFy5rGZe1W4&Z&lPD~VR&+{qMXT*}EUo~yxW{2h4s^%M0AE&DgnU^+U z!-a8w+stI~gtvT@?bkqvWxGV|)~SY$SLs?kRYNlA-;hS@(p5-Q;aZUtuAu)Y)Q)c6 zIzGj3?7^Q4cm#@RyPxm(kPm_Nm@9RLZ0_O=UiY~+cL8Jm{jz&tp764giTv%wqX{kX zE?pH6TE&%aCq_a%@wJBwePlXc8XMk5(Vfg6_?;0pO=TB7SsY4Fn>>4B=6z+I<&~~o z;~fX0;#S}H=N@REf4nru<)0jFd7vMXdRQd`M%)Ou69WIt@g1zE?dtTAx(w@t;y3W{ z055MN*!o-P+05Sh1N?Wl1i_y~EonWwp&@Dgo7u$;{7du-wHDu+yG>zbPohKf`}R>B zbUA|-|MEJr;u1cigZl5r{l^aRGtUDSYMK1`ozCLT5>$=*y|F7{^pnQzIz}%cBIY4u z+GVQ&NAi+5@^2WT_c(^^;ZD$qEW1?8h}}rFJ{Uq*(PYGJ5P)$NKv<8b4W%D2%hJKjR(mz+Tts3^5HhpejNQR!6=_7sFQu)FN53 zozjw+8~_ru`XiYY3O06;{GD1`=Eq2_jT)qm!OnW5yLz|8Tm;#792`_P)dwr>h?(KW zRx?(C%HhQ2wq8q+pxA-;wDtwwLws>TCFQ6aH;|@nnOrBY@-f*Kiv8ZI#!}95{kaeZ zEsImODr23Rj2rcurWug!5>@^>9<}HO+-h?dUvg(hR9#!ZlZxg4qOBM!}UEgrwA5W!_^e*u+wnA|_CW9r#gEbZf$LVKBz3pt4k%Qv~ zMmKlV-GI&2Tk`?WInSzQ!$vJ;1R5jG(7>K&{0o8Ymoi$C${vbMmFV#Ex=g5SAz^pU zA7K6KQ_Gu1!99(6fclVD%u6#thuP|@u0Bw{RE6ClB+9K#lYGy#bR8M@wDy3Ofr(?QqKs`NvEYsz zQa;b3(=8@WWZoXKm(e+m{B4v*{L<597YcTWIgw}B2Ory?h6bThYkic4(+@_)lW!dB zV$2-T;7xL+{N|+A$f`z7^|F+qz6OEI(?KMT5q%xhR>Cz=Q~ubzo4C}Wxzi* z@ED6)1(l%L{yP!UX%$@!v22g9r>Cgqp%Nbr!acM~J$~>Ut8jyy947#)i%&p#e9TVB zX<+x!m|pCArO9m%*DZ@Cz4I6x>6#9xtY<=_p7vM3utmdZgtEPS=tv8Tt))7VUk3XC zm62U~JD*dZo_URM)iG5*&4)IB5JOa}ICb&}ZgRAI&%4xo7e8E+dDMdMLiX6)4{qWo zolll26p6EV|CgH0?ABv5AHMXRF*YZ6%(X6M=VhW)P}O3d2Ua50}I}B~9_T)Jk_=SvU|De|q>$mP;;> z8#Lo`;7pmIJP%YD_te8c>c4#Of5=*=k-e`Hb%OLm%julF9cLohnkgEYq1+r-+OJhJ zVhIo$j|f!zeEJ9k_@}Xz0B4lXk*Kb`W0a8!whgSOo|HxQys)?I+WNgE_zqTABmYjQ zkLhsXHt9be1-A`8bx}j+Qz3g|eFC1U$%e-Yg+p~2#g)b_Lv9s^NhOnO-SKctHkoGBW)WCiYjbk#U1tGO{g;K(tk0F0)S+MbxIpjs> zZBF4I9*2njJS|3YQS`& zG^kAAwKbgQ5;EmgEdW4ceucX>Q{(7^wkCYK!?qvqU}+D9s*d!!+VaJRf;=eOkuQAl z+74ptV(VsWIs~ah)$Z5UtO=KtXhxP|w#wgbeTXfwOBlI<@IOEDZ-QkjcLipEK%|%X zVZkQ_r{&Cm63@Xexy z!Jr{IhCyL!zOwkfT3#D7!oQq*H6)RSYY?5-3hZ}wm=yogeVF#zj)Va*ZxnEzG7qaI zpn^)C#BQek4}CH*JR+q*&&em`FBoR|{lk)Kcroq#)^-R1+vvUiGQ{$`$CI)hSpIcu zp`*&ER_A?F=AC3b{UFCCi2gLVF|uS+J&fNsv;b+^Ni;`jgb5Do&uZaE#ijRae9Wc`D^I`fm5**YfPXrOa||_ zQ;dqr78r9MDV63ettI0zuF6S!+JR^T%|bD0E%a0tulku(o+i<*r`7U+m>NtfK)(mi zhg3GVW-c~wPoQgKZ4ltR4;`UlTMtArGUuPKD8$&pQRIb>=z|BV$HYF`G&}Et`3JqA zCA`cy*$&Tnv0BWI2<18x9;e52!{r?SDfls}*8%|@ASo?Y@d?j7gx6&wSO5tej;C6Q{*h7ay&=sw&T@?b0V6*h5bRLfy@WJ*irP?MxEzxx&+_t8h= zEOGWsK6{RRgw2PSUrKL0Z?0Kc&)uJ5LdbH(UBJcQV9Ybi@4IvRf^?_Ni5)E!|6xc2#eMZ~$I0qu zV8Hk*Ex((x3uQf7K^}WMg&`f6Jq$l5>M2KH@)3f_O6V zwyt|sK5v=u7bR{q8yrVC5*JNZ4{<)#QA?hg)oKu`+d&DckB1%B4l63^oFumb&H(sP zMMQ~swjgt6_T^-ysBTrKhrq2u@%YzOcPsZ5r@$(;rFJkIq7AooS+6M;e=zr1%9HTO-_OFc>YxZd4yeqHl%k+&w z3)e3_T6r=W#5)upY_2I7r5U*sgPlL>Et!zhB~EiEoCQmH^VQx*P|c%HVP&zs@6IjN zTa{^|%WU2{L-Sii#Z$b@1rzdmN|gNP4|s`faVj|%6gZ@~)U?7cb}DvQ$*b8c(XtVB zl&;7>ydwYnF>{PN5}z)k{?vqntfwv1Y<&XCBveD`1aYb!OHD+sc>L|# zfm%>Lojdt)qU>98;P7WTCI=jf*mU$9m@0p!I&#l_8)aRL z3_S8h!OE~SiuAs2}ZCVEsmXd{xNS|=KUH+wp zckrimdw7nX365*d=e0Z-op(33e<_cgXm$*l8}0u?AawI{)0gY( zZtqK*{{to(J}dWk3XYLFiboqJwjV^Yx@OANZO%OWPX23|^*2yco~oCi4z@WRHucpg zZrCL`$>1m?_iEH{I0setpNu;+a)i$LOsRWf(=d^UI8xQ2uCFOU#aqQ=(&vMSdUsR( z8Y-To4X_gkiHN|&W^qF9=N90}Sd0&3=W>m*D&K59%grs``>0i5Mp}c+%lYM1?%(dF zpyoNm-pI7i^^&*yV#~A|I;CIlo@V>F7zJ7DFHGP>MYgIRX{V9=rVJ)JaXu1*hxUCZ-mg-{)e04cDX$5QNDffzG$<2hBwdt zs2~OO!sYnX+_|Oa7UT*(r182RcBcgMhw)jg>KK8y3li5*!6^t}2g5rImi}1_gEXCo zzl=zDz&<2Dk#B9w9(uHF1*)tf95L1xNd4laHZg5w`yjWs+S50y#m5ViTq~zGJggem z$6UwPdkec)P0@$O1UD!GzX0acQreUx=j!_5Ew84n^AzM=wl}H~vElN+P&mjoa0uzT zQ-Ci@oz>a1*!6_^<}$?&0-rkuU!!LKD8$+MyqAsa#uUwE`M?a$Z>8R|%-TceJQq!w zA3q%f`wb2Q9fm{mfpx=ayp^hZTPxZlXWu(x=euHz|HRFe9G?p*tLa&`X?}eqKqd>c zXnIHw0S-gz52P;bL|;B02u@&jSB$l2e##s*ykRJ~Kz&^}5d-AXJyk^*YTl*Ij^5@npbAF*nP`8b-#S$ z>Rao#I-k_PLw!DyF#rt`5 z&DDgod|40chOSt{c)QMMZqUeoOUfzXC#C`+D)_*%J}N+Yzdt6vUcQewZ3nad{)b7v za6N_E>?+|$V~U6t{FCG#^4c#as2HYqxAB)7!d@orj zn-=#1mg6@q5&c6VeQi4|chfMXZ{gMSf^+!%A4;d$;|b2G`YM4!xXAjHGM|k1^Z^Mb z$vH)ZE=7T}Cuxw%$}tak3@d*}DFzu}+vnriWruG4q)9L3*%e?e_(2GL7UA6VF#!t% zZ{?hIo^10;@9Fy_90RW;S^cC|Um-~Vo?BRrVyD2O>$nc+&M)GqSyFv)|8r2FaW^-_ zO1SXJc|-Q?=iiH$o+vrRxEl!OeANnn(#5DD$W)PW+05_id|%%)Hv`@4A;r<4j?Z^5 z68D^`qLN;~&V~F-{AfNo+OcO+Q{d;={OS*yXXteeetlw#j9>ND<(%9NW`l#-)S1&b zd*%RK``7c;n`gG=jTwh{#-R~mnezV>>4uyrs6E)xS7^p>ZFkuPJRnLm=!|XgeMh2l z)E5GmKf9SfSI0X zAKB?&Yb{y$Kl-Jbe&ayL>eNQ0bNCIViw+8t+5v-GFeEIJ;A@5htmPNe=Pk*lJy{0^ zBqzhr&a8K8BlpY|oDpUGGgtKZc#}2rM1qNppKvkLIC7(HUy-FkrCgS^QD^H`5T&IB z*vGO1V-Q*XYI@5#2_&BI^V3J4v_-=W^HRltB2AgBd@z*mQ3_dn?omaUdqr`J9`b{# zHn*2VZ)wB5&^x>zJc~6A*GW7nT)=-i(sa0K;f@4QD9$Q{hS8vp6lF@EzT_BCI3JJ? zk&yfg36uvD_W0^WVzm;ZM<#mT|P2 zuSAQwI=NTiMp`}As#0K|Ds|adUfl4V7MuV{KtB1KrJ2soM)^A)%hsj^6_spWp<%-F zm6>^1lED62bb?ieYxm)7M+YQvgR->E7L5 zVvUL+T8eO@c=G1U;@YVTGfRE@HzGEzvPmzlz4g!(hrz@|A40z*gdp0xroVmzHo1v9 z^c{?8?L2CVeQDUB$IXOBb*6kWN1`xHC)|K2yL^h5?10QD zpQyNiemDe0?hTbVo!KetDYCR#J6SHqAFQ2S(r{?Ug!bealfueofIw{`*%77alo4L?q9X)_ivPX>;~ zxAqopK_U(5blj(0yz@D1IdTh0>xkIflPBH07$?GQ_2YGg1$ePuq_5 zVV{Ky$oN+=AW+Xdt<`Or)o0wnrRi}E+eWvT#@Po2m30F-N^SZ=c!0`MY#-XI9tw6J zt#+l|Tq-mFm(mPCy%#*SP!RxD`C#6pMo1t0U)}R7Hm4l|YQ|B~ijygm_5}&s^Y@gZ z*!2dG6s#(1=2H;&wUZHlq^b-(cA_Pah?4a69sdc3r-0j_*l&TQ&h<@omt`&-<^I& zn}7covKMG5efQYqugH_ffc3{tgpHQk#a{>y+1p}pfm)0) zk*_}c-*r_8MKh|C)MdBYv9ID2ka^x6w!B5&I0fQZG`D*syaTqR-2f_u9Z9{W30bMl z%SGfPn2ibOLZ*>^+{=8F@ahWcdl0vp0XmGyI>0QpR4K{~K-ala-|~TatG9{c=c5V< z_y5Wk9HXQ^V{EE99Np~~_o)mAgJ$a$kp;tD0Cco)8pTyFOE1O{&Iw)dETCBmwwGBy zuQiTvSf6yV?Tc-ReDfWt1un^QXgNWZ$)@m z*XcuE3gZ!tYtD_;lcy_W5Ft+GiWac?9O7*AVdsSIBGvUgx>LFv0REMpyJh!prfVr8 ziYn9~B0?buMXDRlXeRyq0EArlKq^)b1NEvXgUgflj|dJ(wzR$TZ9RN0jW$EDVMX_m z6gpZd=)s(2W+JPDF+u(i9NO|_MD%osT@Fz}EwJ|yVV9@#hfYGG^HmZeet2U&hOx0- zKJ<}2c8rE}D2hAIQ|y-T8s3oQf&#itICy{_pBqKt>sA%kCuH=8IiE067CuV2yBz0v z^)Gi#OjKV!r4aq10q#soUw0tH=dR>QQOB)&?|*9iYCt7_`T;wyYy->Mj4ewH8?ZNb z7|U=taj|iJ_Xl>|a3g#xQrn}&KN=^*&8+;k^82(22f(502Zfi?q{hQjg(;uF`=OYn zo8aG(@*Vhi5AX<$G%-=aF)5Xkx8{Z^Mh;t@ftY(VjA+$Zj^g-kPvWe;IzL@a6A*y6-M|u6gVWrP8&BOg zTL}-j3f1^JQvkwj{Rx>b4EWarl!)Fv;z1eT#Pn(Y+dR*Y%eKywif@Gwf)f7Ge3(+b zE^U72FK8=o)Vp9NY-#?Cqm`v%0|%@*)uBg22r<~+gZ=B*<5S&Y)O*be__zI*J#5!q z@%SeaX-?O|@8I}nDye|$#OqY*sRN89VnPo3F=67A++5}gvqq5geyms*uuadxj0!}v z!+ne^jN8K0gibIztkg}UL9U%{9*ssO7mBTawM%@pX%qkcl2zv`yaN2~egL`%;B{_{ zqwb?$I%8*#jwx(bNroNd+VC`@ObnJlcG_W|ZG=g1eZ6xRWci^O0t(3AR9(y=6gI)k z?jwnO5B)v$5S`OJr?Oj&gD=(PGl*a42qRI9CC zM=uwm!p%wk?GWrzvQph_nUQQkL==iLR?>|f4%0E=ltFCk!mstndW;XT{^iUk3QcsQ z3TZe9W7sLN@-HTzUq|f}>x~%4Dw%;+fBDSQwLK;3-B zji0abApC|Q`;PifaQyxv5^*XW&jKPVN+3JMcs6|L$EDF-IuIjsig|O(_)=?Oi&$9u z!Z53dKkoA7%Ld*MxFeVErZGY#fs%ol&_fUJz?zcGDqsa@1OmFETJ}vi{E2PY@V`Wp zR$c)9xhMbtiW=+4=Bz_^Pro;pqw?nS2q$*KTE;mYyS)n=a84cNQ1X_qb8t`&zIyK2 z_AThCLu|DVTwlwS2q_6<)3>L0*M+Ud#nOlSr0b8X-vN^#>zw2W?o*5BFEmwjG5TF+ z_r2?A&_qaGC(_r>jl=EnS}r|ceXEMkzehwQf&&a;xD6mhfcsz!tb=v zLjE&bzzKXLO=;t?<8ge@OSNFi02lB%n$LNOY+O&@VC8AV5i|tn-7^y|a8RP63~17) zeAk5QitCEb(HmT5=cR_yYc(>JNc(Vst@ZR!2I_~@0K7{Mdnb&T!&4hD9$eGXm4^Cs zz_e)RYA1G=REB<>KVuz*OR!DP-<%*$+JvPSa*p~08Y}VBy$~3H-$K~+vnWb?b%WAi zHmKBI(kmLBb=QaPq=Q&dZKf>{^wT+by-iyV#SK^>$tXE;^C(;|49USo531hx!=!Az!wo8jk7&PO? zW@3wT_ao(U`)TV5YeAAGsHcvSL@MM;fX^{O6f&!CUmD&}n_>fVQV7e>QU7Pd_X7W> zyiJ9iP>cH4+1vwO+$5ZMJvQl|JS}(K$CPC2V}%!1Mw0qFqGMQ3{Nlgr{t1Nl82q?G zbzLqNKO7_ia+^!)^_CN&lgu%oUO@M;30nSCNm(P^mLf~O^RRAfEL?>0Ftr0U*}WMf z1(zJRhre6h8MtD1Vc*8ESLiPr=gp;I8GN76;EBfmkyI&}KJ{CINukY6k24RC#96Vs zyN($5VXMj(Sk|z1*kjJ$9X|L)bvh|@{>r-b!h3IO;}TqJu|U$A*F~C(QCY<(Hw&~T zxk#85F{eJ-x}c6QXxg09W{P(c-E14^0#p*#sJXH~9A>Yur)N$TqCCNpIF>Shd`V|Z zr+RhgA)owv5g6ldgJO-Uw0_cVpHp3E0sQtpfRgxPvZJ8q`&!Y*7ichAGZ1xBFJgg z;2|A%c;sZebPSk@xGg-~f|#=$^zjPuY-$01HC8?37mqw1jlJV`{R%57tohP~@TyDk zH<|%W4_ob&6;?#KdSv=`a(JE7P5EtC3MzY@^*?siIIBE$8tOZc^8wE6Ishh!L-I-H z$&#w4!C0hs>#z1@|A`uUhhdrp7mcjGjqvd zI{4Dao+hBv&6SEOPSRUs^HIRM@Ukm3;}CE48xDm$VhUr)bwYr1K*V2aR5az24mZCu2^?e^-0pD~vo6fFQJ6TWQ)Q zE;BzF<9FOt^1sz9yh}zJ-{k1i-=cn2mSBB$d^f9e;P~pXoTzHQ3X7nlCX$zX0^LZ= zmr8z)3wdLj{L%zGH^kj*QxwTcgf%WV|5Fvyk`zqgHzoWDaiCX1bDJt>+!O65aGZXt zCeaYxX-S`zI^H{Ux$~nD%dPM-SQhRfg==M3?EY0=B)lz{fIM`JOC;KOQaF8D?idc%pCVa}rQ*U)P|fZ( z=cw#-$_YKL7Q&Sa&KF#5?YtZw+QuJSxU0e#`;<0Iq`?^?-`C;tR9@RP@@2TNa9JER z3dzsW>>P-ZSlj-9ry#gfg^Bs-6V?HWpLdZ0jim)5Dol8xvbERsXhI6wA5Dk|&oX)J zwmCWeh@vPcR!iq{H}a_ql}PC*3O@PT@1bDVMv?wtxNnQhsVto^XjfXeo=bcUpcIHC z^Z#}fN+1t7cm?QN-loX>to5M7d;wR#FxYl}`OUz9Ii|`7bOO&T9N0LpR^~8&nD*Yu z-eGNd!DesV%ra^-ZHzp)Lsl5F)R0*5!SOl3iX*Y%*i0kuN|N?h-Y1Ant(1j^%9T~c zN~W?5#>}h2-uZ?MqDdSktDS|<7`!_Th1V19r;m*+0pHyKe<{vIBq(^$ALxOpYV$nX z+gr&KVDiR!npme#PEqQ8$@@U=~b(ROaAE66ED;w zRZhmhGTa8M6NbE(*&D@s6GJH`3UQ?gdnPc4FeZ)uN!N~t{gv5BcpL1*4>MvEhhK(_ z3(QaOF8{Mm{3G9GkrCf9Mt*Q9$RymxvjmR*S@}$+Jy~40 zf<(vstNBnYfI1mi>Y;OGA?M_zjA4l8I5(ZvM2p_+=DgCP9D<-KmzrWk6j`7NSn>G@ z+2)Lg^=GIp-llHBC(|Yvyp%*^^l~9}tb~k;W_@G6F|_9=o|kO^nR)*vd!*z+uTPAQ zd+yXP>43G#RX}OxhuF6w4lIs+-kdNu+NEM8;>V|y+1CXPjC@r~LrcXw;(BBe05DVR z2els2^4FXJK1_m6gjJ$jH`0s+kEA}ww;ZQQO=;`KdFWvi`O*b*HC-i=z8J{MA? z0O&e|(-d)E0>5So1D}rp6W1RhgdTMQKtY|gw~CWTEhs8mFU86JnCa2&00$JHL99Cg zp=N}ItEgWk2IZ8A4~5X}UC@ECtElea2iUutCB=F0z7#6-rb5*k|-Ta=n{qi=4S z<1Mz3I{|^nxgOC)%-yGcM$`=HVK|#AYG& zo&El404L)=KqV_fi@ku@ZUtcs<)E^|& zKO|Abx!^m_6d8Rsl<_#O^{?~qQ;89@7pLD7 zf#N${bIi`zz!NRhnyF=?{nCd_=PutuNv8!a)u5-q(b5Jd|Kf^q4W zXeJ#ycLmPNuQvyJdhz2amz6uGUzHI6_DiS$4-Mh~r*tKctBO7T0o|JGZQ6`#0|==>ZIIn(gpS_(nhs9 zqRLu|GzF*A11UQb%nK|2FKHqVkLdI0&&edR33IoMLEj)8kf1IjEcUaU=sD>TL3mJ| zT+i+^5SC7$2ylnh*%xuoH?A(^4I&SMY#gk4m+Hg zOPjuapl@-%(=3YE{{=6s+0!iqpsqgHz7uve&G8K9|DCF*T)~4!G)i^&2K) z-(0MFraiY80-fH&ypEnrhPgJu=R^i8)Ekt=TZ!J)1E3n6z7x?2UAyyEk+BJoG4wH? zqXbbgy2^YvG@`FE;)-ueV2Nw==)@0l%kCv!?N4Oi~PtGkAdvbyL4fVk5=C`jt zUyj*iNpC}>1_yig(?wqP>>9=A+5<@#!hR9I7&~%1T|8eB74f-2?>cCE-W!_jq+=z$ z05qC;qcr$MCNd28dH=XOuDTSA>Hh)mNhs^4Ow1OH!NzAKrA?4G9y#KB?<&hchpwD>oZknKh7_|J? zLR5hw2HpG97g!kBhYeEhqxf%W6{zMQ3)G->EDO7?J^u<_h1^?K62Lt?c`g;8I0Cjt z`72LS-|$;bzZsfdWm#x)bJVP7Nd5u0+RQM`)l`)~A{GGqH-Wpv4{P{N_q3x(61Mv> zz23nyiVu`2kG-F;0uxH^31D~+2X!J9V3i69uwO!Jt!hn|DMxd@dbB)wI74slQ{@Qo zq2~g^r|^kHU&4c&vdr}T6x9do@K#bL(O`2gLA%P&;hgX%lQ;2Y{b#0e%rD@i7%dgm zFp9*~8dDGYY0Yq|6dBOr%wtKq`xlnp2A5{=fX2|U@7xY|puO1QGk|k7SAVU{>FD!` zWs0qstq ziC9B32l|M}x49f|2IvXeoq5BLi$q_j9VtQ$)xt$2-H`>nW*~U$^u-p(g*jg1>u!T& zGxq?&hu~3*hFc-k9Trc81A83h<9l+_%uySQivz>eD3uf+wQsuVJ zU)K4L>Scg`t1IvD(wQ#nxVO!aQX_m>c-(`|b1!C+^H=J-6L0M6{J?*V2Y@TP&T8&3BL(A-ijq7?K!dwQ>m+K8QxbD}dfTK{(ZtwukR6#@f=n&#AUYBZv)M~p z*+mHP0^nzA(8cTKoYP(5q_m{HR%$m5>`ff(O+G_-$%-gtb*_tIqXZlE(b!37e5d$T zbM4fG-HBX>aEdS^Jbvro&PLXSdck3Uq}t6|DYSu&q%0nZx;Q!sw(2-m0tw`Q*XJ&; zFFu<)xb)0F5s98V?o)Wcx*$4od?IIlwK3vGn%imtBNoA6eThy*jDe=}uf_Le)+el) zQO~iZv{pbwo%QM(m9fRO+F8~FZ;fw06We=74q7VsG9uPUL8flr-&cWw{%D{81}Ed@1c`$1tor=)n4#$T;sVpE%I^f3U)$j%#(cY~M7H{(gl` z>pW$u^4Y7>(|7~z|E$dcs}h;qY8$VfG7Y9(g6HIe>Swjn8c$WNlz$h>?y$2Ac&rd$ zpm}+*uBn){{b801zzev~ccnCj9Kpnep6-`K-G6vr`1^fjiJ^UEA2Q(vc_b7H>gn$> zA^Uz6a9dNd1r$(fzImLm@q9R*uB{fmPjag@>qzPHZ_}I#XI?tmndi1eBNyUy zq3y;;Xh1u%;7&QXL%!a%NYc|AYk)+fu_(+fRMs@O3rqwF!o$G3l(R zFCWozDgS;zGcTMc{Oywi_&o76j2WC;FOz4rEhZXX_LKJ+;zxq*LjDP+7v_;rV-?Lg zh1bm>o;G0CL&24pAk{BvhRk84;Ua(zIaD8fzu)6@o%^_F&zR0D-F6=@!H{*Sd3<6% z`Nb-0WatF__p@N+q>uxgBVl8!Lia8?EZx*PK;Xn48K*@xYpoNQhmDhH$L`rzMzi(s z(d#iYQsNg$11o`puPu|SS2=`p!33hb0UC%cBx%*#x-v~l!J-?o5xGS~XExhEXypDf zt-xcPY<7WsJ4p5O$T)8;x6oPE;~8x<_#&3GLeGU}1JNmbAa2NdO7@4dgNrrvi)25E z-Oh7vlpyd^;|AFT6J`MV5-XPPD0p}~idrz=Ms>7Zy;m7UZW|!i`WB6%xD@teH}Y)W z8wXt6amPY#clFpz^%U%smr8}!yLv6-$7VKA9qF{}2)UxXtDf9S#(oFZYT zPNs_b#3D_NX+Dk*z6Q)c^ohNqlUJj zhlDs-ZsJ7pAW91`{5118|Jj;jR(l>RAXSy$#OP5tQT&kL3doC=3 z_n{$Pzr%dxcTk+X2WB-gK#3Ji=~1dHqRKK6k6hy)_*l0qn-T z@>~EOP&zXZ7WB?n_`{$qv;mlHR;PfxAmoF;tSc;k{y&b+JSxfbZ{yRnIMt+;m6@fj zLyaj@PLdl`me$WnYFe~ZsH~xKAy;IdRxQ`kA{QXrtXyz67oc+AAom?|ML|SX0a@N> z-gEeee>evop69;r>w8_FD}dKiEvTyjPBc}8TFD*Z6pA}`&(LlZQdRkj!*)lhQJU0x`!H#e?eVV0=`mhB*>?0%06_oAHsquHK+_H#bG&THWuE;ce@D04YtnTWhn zQRJ`;LWZC0!z>SO`+;96Gv>y~&Ykx18)`;2Y2L>^tCd|e=2a>OsfR;0SqaSZNOFuy z29EV9t8Ipf{IYPl>@TpeapJwPuXdXd8+sc~me<^oSA3q~kL981Lw8)_LB*#Rh8cHA zHrFG%9`?49JC{Tli0_|Pn;X|*m!XXn`$b#X;AdGAhrc@+zi2mP_5&D@$3CiN#~gJK z2J!nQiSSft9#|K3w`_+tFgT*>M|Ape#Nk(nBY##+OS|e>{&JtKcW#{sP`yE@KfCgT zLGaf6`{%d$#XGqjlE$_@jfY)Qg*!IdVj>6>ti??Wbks$IzJZXeeLSDI7P}WRErj#*%Flq**&9OyMi0;aK9in z0RQr|0phXU{mA>@%09HF%dWkZ*HcRTL&Eo2TN>{&^6h-bOJ*Xj9w!_hkVZ^xWxMuo z(bVTAsXkI%nY)jvuU$t;&JYgdEivn{ASnXzbvb3+S89!i@>HmD_e;;ha@=@Cm(gW7 zdAraDoQFS^hte&@i?mPk`fmrp>&^+1_F8_=C%tigYLI0z6bbbgVPd@*O!*RdL{QR?ufD=}C?&_i}t?#7*XgP}k4(e+k}` zYjd2v7J*vHL(m;jyG47@vI4_EQkr<1vQgRirGL`M&bjxTeHA}<$Nv|z)8 zS!$~0ODfyodQZCwqAz)5)t@ish-yJ35(F_B)zX5-%U3~=t<|Hw_kA2i80BRKyT@r< zfogeNrYR|`eEDX~P|y!2J+W|{vNX0i!2(1*>4HV#;d=OPxdOq5#oN->yVjXB2&E+%z1w6Wy$E#* zbDNv#7KkgKwY0opPSwdm(f0zp8P+Xp`vl6uRl z)K|I?%^xwV=eAInL||4CaI*=()ttOU-p*I_2xrrR$|!Jr-3uGcQ3C`+Ix;K!v1<%j zuxK4;ZJew(V{?2^r`M>jqQDD?H3L4nBH&9HlCT@AKXt{8IVRTJHMw|6(b@oPYlqqC zxg<X%bGUDoFjNxAGC+b( z79-~Jn$=~|*xA=?az}#p%SKqKqazqbnglnjM=)PiM?K5^NCD*sq@4xtS9$J_gN}^3 zhb6>JT9Bi9`X(zcf2YZ<=0%A`@fC-ztqz#Kia%|UFV@_PqlZI6|6;X-iEbs?d>o>c znoSHzMjXQO`W_)vz`+*^YJp!CcU!N zbC-rz0`;8Dr6TZG7_(;=e`8;ZtGLPD>4@t@VWO31sKia`zfk&$Mw#S9wao{` zu8ppT%3>oYZ!__}yvg-Xme&tsMd&*XF%Nq-ihBL}q4u4p$znvacg-^ZL|dd-^Xb5l zxZeC>4)4!`IUp%g<|3#VekR6A>*D!@eXe5iNeov#Slc!Dxj2I8?!2hEtCn7j1`rSx zk`>b~*MkPMB~HXVgglcY`7-tSzol&X!-z|_NfNCC+?vAJ&0*?YHf1z$+NVlz{QatdG7LQ~0EG!`(6@#C*x&;{Or8PWd_3B|>qsc+n z>j-w8r!tXE=&T-iHkmo6>Z(GFX47US;V*~=nO*Fh-^j+b0fr~3beyT?8l4)&e4t2- zvsnyHqXQqk%BgDrp!a+!leq#>Gqpjs~2f5DTkGZ zN9Hp03?$)E-Rt`;?_6^eZ4P|83agDvL`+w17H>;uzUG>A=iHtUpg-nPOQ>dxVwf8yx|lr=0yBW6!rPr%LXq?HG^FH_3qZ0 zfgfT|!lyU8(8F(X2SQAzKE$jh9Xs%*(D@3n^R%&hC5U`uv>_E=dJ+@jNH>Qc)aCe( z#fKnF^J{Oh%h^`s7s!|%Hs*>IHAZ-Wc=-w4W;~a~9|QI1tcEmx{tJ%I(40>pu7C6~$ZnIr9R z9Ef?3K)>CNn43Qh5ADzTE(`Ug!V6gd&Ox=hEjLOmw*q)*E#9jtc=?1dSs&k=>4F?X zo946+hS(g7;?38^UK>6$e2%3{4c%MuoYCGnHrx0SGk(`;XzuV(uA+B}P8u#EH&y++ zdC@&8es56-V%NZ_!gA@B_>~&$w}!hq4{3Bw_RAcb&pjI*eQuIuoDB7G;=r>;TgP;- zA;g@&Fu{IEDt~H31ou1KskAkroTgl)^buEf8eaHC74M^)*V{ER`r=PLq}Qav$2E%YFlL|yz2I!Z2Z}XwzHqL7?I59U zAWL3xU~Q#yv$E6)IWP`#7eA)JJc_j^LlY(b0AHvM@;{7csnbO?_?hA(7+KV6*azpuP2j zwi9)Rt1z8-zk-xoNH{RudK8@H$Ea<+S=M%YB|BL#B)zT1R`1xI%Cs~0y5AF4* zr0F-j-N{Gx(<3wh6?1z2+eq^HwnguL<|mZ$ikwII>P!+v04Kr^77*w0qnfO+5}=uU ze2~AFX=U@DBDL6Mk;Q@=Ay#qZRJ&(ae*C%O-W>~5P@JW$4IYz4l6VG*B%Ok|AGvq{x~JDBIFuP z{Q_C!41h!v%BoA;UP+p>{2Ay;gXbA;v15we)=3np`lY?3<> zv&C&(nS~mWzZ8@LttYH2bk7Bi9o@|{6O;41y%14W^i-F3mz~%Z5f0nzp||}-J#sd8 zhw!iLUeLsO(&X8E52xlH>UP<<>B0k9>{u|bSMyN&KzKJMo0JncLJX1Y`~o&cIxaL- zsVAdV|18E=`Kj_a<-WR)6{J@YHZw(mHc{{$F8bgCX}7s_k5A=5pkV^VABu2}?2C01 z{@QZj=gRMB4hyqsq@v{zdupZyGGTj}KU+*eVFucn#3nX33CO-|)7u`HUCNZ*@G=cn z{(~>B?C6PSibUqyv~f(|xVCh2Gg&QqQ5b;&Py5R2FOn5i4ng3$^Qlq%mEoNdj@1}@ ztNM>k?5!^F831AL^Qw_S+B^^!dn5_>qwzOrYtQdVPsx?OImr`ekS->@Cw~o>e(@&| zg)aXi7+QPwVt^K(mOa-~x9vu{0eAOhu(9EO1oN<%-(g<oZS{B1!C{VS|wIl{Lzzb2*joDeWM|DqD(=;z52FVLXq)zuUE- z<(Ijtsw0&x>t2}o3HB{|9ce?~loL&~>?b)9SrW8tfcTS~;F+JuSDR{%!@dr(Wno8DBCD*%4@2w(x}_t>&nTYm50kyiF-+QwhJ zFNGarQFvGNjrrxmf;_OI;=dT$aH>%ZMF zzj6Pfg*f}@)u^8XoT8j6c)I!4YUg?X^8tS`)25MvKU9GXWiYQlu8Em>cNN;g?)PwArg>w-B}DuYYAtw4B6g!R z(!@Tjh}{{%!(Hlhik~idsJa#ycgZmGsiI2xwT4zF$aM?!Iqhe&e*C@p)1_3|S1ym_ zIq(x%k*GmJ5u)qc1%;>*++}wl#i1Y03Y)RSU%Evee1oW22zZsG6A0d#OF5qfHA?td zJ!AqO(fJgz>@|JNd`JeB^ZP}O{x+|q+d`RGnf`%Ku{nSGQD!?_x4+o< zoInd+XnPk?0Iz8cT-axvR+z<{?N=tX_gQ<7)LRCHX|cy}1CoW6H8OXwwj^vStblxo z;uB3*9Snv8hRB7ZRTY~D*jm#8SOx8jX{Hy8vaqi>)#p0X$yGxd10#A?GYB?{Dc6G)4GxNlyiS zTcISR^16jG9(@O7P zPVbU!t>U(4_N9~e+NTZu{Rd-3lycmZyf1i|wMn#0)9{n%7kFs+uufh<>?zS6_W-lS zcZ+KNP2l6M3_D%Im~m$XBL|IymO$=l`B+CQ>imAqd(?hzO#a z=ef=L&wVeD#kjxG@wJStJ^t`qlYDDdl-|pxv%O$&Vjp^8&%&-sc|FVZi}m8!SRM5M zJ)3|wofK^|nLbKiSJYz5@6~=`v$}ygH|0gv*wgBz6)OxgV&ZT{DE_n$W74jIXQ!YZ zc{D8r{X?2a1o1gOcoU^xmM~#rdmkaE*2ZcVGdwNc+NkFn^}roI*HQYOWSll~R>edIyk^7<2b&gz69@|0n zw+=m@Z?FZPNNn?plC^o``Lh@7sHdh~KsCjS8wmT4N~42G!f%Ntt*{$~q^rtMZJ~A^ zsJSC2PIFg8<}PJO{*2%g^C?32G`mj}DSz}7TFK@ql1F;rd?5!8-SregxEXfVNOP9^yu?hKY}nw+2%)1ZJi19 z{KFGB#yuhz_YD4N%(1~74_K!C8+qr6+02$c>Ekso*uk|82Vl3xH(%Ay={BmHeMsp3 z!?{-AS==~1_VCM!9k_uLoaLMwocfOCW%1z@@8TXXdko@fA7lLzx1*zfIV3#{NEl~$ zF8;Ks+|kLd!=c4*n|^tyaVV}gAgkv@h4psT8CKJB(i1>wUu1od$gSZFrVo=<>C$~M9gN*g{_zP>qK zbi)2`zp}aXz;pXqqN4}mmybnldNQ*$^5QGplddL7rH|rYhWJ9MNc^}XL-LDR9T;A> ziBXdg%i#^a`cA;6z@nc*OKl2S35vxXo?z`6{yOb>q}s=PFw3eBBir)>hyl@$Br;MY zvU`5qTA`iy$nAD+DtkE=zr{Nf11%1)5k+VUvH21;NU{=Mj8Vk^s#L4KPSz{2y{8Oe zMFP8cIsCh25E{C}m#F@8O8DHi#q6y)S*dckyQx84 zSxVQ*u&MBt*Kp~a%Y0qFq`sPZ->32|hLrQ9Op`YyLkQnw?xb!)4g1TiimsWV*XwCR?+MEh5YTK z1#y)M>gmR(k>CGN4hOX_q(iXWTsMprK6<(HocYMUVUVlKYuZOhD7U{M{}xQ{X1*|- z=(@NtZaQIEQ@xiNK1lPN+%gdcwQWQ`1G!<|kor5=c|SPENhF_qw;?SZOehnh1jwVn({bx>&!T`TE4vAqPm)ZPlDT*-f5R3Y_B*wJ9Rsygv&STU`8%k4q$FEWL?w! zHKmZqNn6v~@a|pq*hAkLeUo7L!OACeGidI+MGT!7^s1za5TXx1G1l6MQrj4%Hbyny zHsr4eN22!x6H{TLJF) z2ESEf^f(_g*jMcXhh8Up?-6sjj{XCqy(i}9QvenjcWVU%GO$KBDR*VV9r^zz@9BS8 z800MbWgw3jhmnmYEXidTmywHaSx1w`((;qx^NDkye%`$@$&vAM%%{wLNx4s&9`bpB zzJVOp8|luMfWC6Bjx%MNbHVngEWa8BkT8gz0rI?*Z|Ot1{-317@eN&u)QGrV{;j2n z-)VX6wpq{w(BsG7a#*mVth&2CZu`vS4zU1zh(FN^)5C*lV`YyfNA_mbjM1^B2*1Jt z2*kDLd|N6|8sKFTy0|e^r$}5k9Eo9STaml{n)C!(^}r+9T@ZC%L9K~y=WBj;_M(rK z`rQ*-ZkDP-m)N2WaA5Zo?-8L}o-=bq7FDzNdvk0?<>9^@@eD}w(L}JNmn@}JI5vk8 zeS>wgT;*WJzJ_=9IT(^`101>;g#s zYIue90z6S>F7(;khbwbiTBSiSalf`kK)>{Rc`?O%JRPriCnp`ip_jyiV}=c{6Ab*NPP@|MCtGf=y(DfR1a$p5GaS=Qe4e^q1EY z2^Vdc;qiRUH<08+%2~c>-?P{QuoPnDDF1`C<@km8B3>{nW?(j>hV*W6WiOZ>XLBeL zdWLR^JIcDfz(y9qST>3r$_w#X62t>5*;>9LQur3|(p1FsEv~f1TP&sBUY!FZglpoL%+R4@ zL)!TDZsWnM4_uMPl5k=NTY7OtPWx#|_oZMSeY;JCBsHL~;@qaoV04iTJ)H;iiVWXr zLC)B-#N&^1Ub>Js-cNE{nY(x@w0>W2QhRMX|6{~XSPn1If~Fp&`qSWL>=I(^tQCYK zE-6x9hlL*2i)$`-or)H^j&@7-=QHS6^fVGs$bqNbSD=?MZr@eB(r9DGPT1Oda!uX( zs9aw+^ulm*uaEO>MX<24T!7?azJRvDaCaJ?RH5R6tfw0xlHsFRD-9nN9K?O0e;AIr zOKYuOnq@eKFI~%~9g$Ly2HL}s)b1JN#XqVXlz(k{7$85v$k611A}8KAj#yQlYeGc~ z(mY}`BQM35&fBb`>gYwHcTUjn7H?c4@x#<2{rg7Hkg|tXD6ZKdl08y=IArDY>N-IM z{kE5*Er-jBe0r5M?pS^9Z$Sns2-ph<{x_%m@&QvHxODP4-#k(-wifB;+#VA|`QQ)G ziua9_qAf=X2s4Q`>t9xwgxh1F&X~#C^2?gvkn6n=gr)(igsedtC~VDt^|7#77kF^) z9zV^Y7eV@iPadmB{AXIqn59z`f1YdvkHU(m4!1aPgJ`+mae4v3jcfHVh_IEP8vPl$ z@gbU5BM}FLhulP}UX-tU6x-f97!3D*~J2m2`{+Kq7u!M z&VVfEX%LD{;IP1s9=<$CnmB1Rlf>7#jW(m8uQ5e%;)dR6O*@?En@Pp|mcZb6@*O}& z$5%$DAe;Cc$~PB!PNKB=pCZ7gm{0<=N~;d$5#`1{NJ*+74 ze!XT$JjQmwL=GX9V%Ze=I?o@WJbM>)Fu?i2W?6W;0r;0_o#-T$(!uFJfsf1$jH}T(td#Whw7Qa0*XhnZpHGQge-NsU{Ge<}D z6#V1X0V>shpy7@|u;3q6rHkN$T4V1s<-n1F;@r>=)?X+{=Dl7}OS~IjnO2bTHOrd_ z*{N3`zbT%*gT6<ZT8_9~$gfhqHmIKc4Q`r5wjsPX*Y6eF9$44( z$!dwFxx!8qv6EE_g(hhqm2%Cxzyof*i z1%piu;lB`?TpJ=Rrm?rB(zn9}j|e6arKHp$6a2s0+3cQtN8>2GBy8;sS~)JeZp}7?56xNY?0D; z$~HFG+hES>AU@=ej+>`RPLWqmFFYPujoN#eq$ur!*Zt-jI~m&*EnR8cI5M_e_T8V_ zvqh#{X%{L(X5YTWjMy!yZ=ub53oaO;U$wl=y5HRMcOd#TV)&WhY z`LiNoCwqX7gHWyN9&;pyiNzWW6#0{r3pd0~G8bWYX<_9;9APwya?`YTs=gQss{kaI z19;x?5l^?k=)M7$TU?69d9i#0-1KXe^#yzc<}dEI5xbFn((Y$;p~I$K)?=RJ;V5BQ zhr_VyGs^kqTM7d=e6n1NJHuBLS*OdH+B0lQ%MN0gIAS4!Ic>eqBwQOjluU@aI8hB< zOL96Mb8Tn8zl+I;i`pU+jPIn@``3usQE#$Zk8X`}h7$}!RRR*+5{n*76`DU`(*LPeLYp<)XoR#OvCDGtLYEV5Z^P+F79)3BqDKfbb>`%= zB)TF(&y=sGPw#KZmeeFJEOVU64Qytt*S<|z_Zt6(dP7|`#uXyQI_+HO zgPtG*yz|)s4^VI$`{G`;YBJ(A*soNcL({FA7+*j2ZMw63;#u!h2sGewV!&kxqoiQA z(9d!y4AZuUJJvlb}Hz1Br-1s*>sH{1kV%ETn>$8bwrj2)9=E{~#zK0OR z$qqU)YVqlcL7O_oy^j>9S%ZkIXOQJ)#(6XHS{EbE#Kk#$Kliph;4w{}hY#%3v~(By zX5tV=G!xX<*OXyKT)1}xJVa47wI&&!udYFCb&3VaY)RmQ$0|4Vz4Q)xla)BVk%q&K z%^vMHK#%?!<$R9$LuPqB$3(eAshNFfMn$NnGp%vACOlVrA#RRZaUXJsKA!Q z&^P8icX@Y-^mk&7wvoS1zai5~NJy_h|H9z5ueTgwk0BjZe?|S{?CursW&zSK#Ff~K z^uOxf6^3!6VEZH5drJyX1GFXIG?x9Sm2%qGS`eMmexXL@A3WzJ)%e07S*qSMr?njc?QS2c zcl~T=HPg1eR$NXkk|YgLovftO3l`mg{=D6jS!#hg9bN>R+tUQB-Lkod?IQtI>==Z^ zbZNcBUd#(FwWkABPeX9%#Ba$eSN0iLg$W?@$q?+@`&Np0BWo45magv>pNG&2%B$*JlFV=yK zw?*PG zjay^15#vL!>T;e>6kUB@vZAsjOm46>JmJhG8h+I&b;MXSdzYb8J&v5a<4ZU|H<>Q) z*!Hj8?8h$v1=_4%`d0l_r&|gmk7iXkUhGRX4W`B`5FL-(l^)l>FUMX*`YWn@w*(;Y zN5_^g6D~hafku0YKgL|iYj~%gNe8#|)t6cBs5kV3?;*rR_{n|w@r)dWWT?Z4oNFa-Ov;na?8ZxChn z7Eb4DwSUS2-v)75q+MX1Vy`~j&eL%MancuP^<|akDCV2v{YFm06#t_!XPc09AhJqG zxLR5!u(5-E*oCb^v4xh;yefr{x7H2U)a~0u!?lZiqF$HqC+|%ZItwGF@Y!9-PTH@r z&?Zl?@W3^$8TmUjC4|@hRJ}Tg@B_8DX_R_6iuQ}lvQ7RGO^w|qUgM_xfJ7_aQb;k> z_}h-Li5I{>!7fQFAU8wYYi7~TlKJZxZOzOBRSv1(w9<9QNKdO-R`?s{zTdt-7R~_S zkJM0nVeu3YD1}GT3X2dsn3)FK#eCGlSY8QJlSaBX(g)wcZD0J)xe*RqAnaon>OjMh zG})ka&6^(l1%WVEe9>msc^fI!nBKp6@=mWJZ2^dw{3uQ44cJXXJnqt`(?%4>ipy># zd6N_WTR=cfEmxI}V7Z=_?9FR9O=^G!68<+k3mm$&#tk_EVcQ29)Tgq#{?TuaM-9We zwg=Rd%mEQkSKMCfJn`Jf;KQE!LBeU~^0KZRcaP*XX;x!H)HnF_jDKxl zFYX8=jeC1_8*KR>5Ut$dCNk{Rcd#ft?;`XHIbjK*sRWvat|Ko-7!Ln*1HHjB>CD_K z8{OfB0qIOqo|$Y4zmQ>XbsR~W!i_ksO+_D4-8X;pc~;X*mp_;vC|SPCg`TML&C{L@ z@i@@KAuYOlBil78_lG|PSl>?2+W%BFn{s(Odvf~=-njHsA8LU7%fzs+#W~vTInT3m zMnlwvaMc$SvmLV=tl0@1GJl}G+mDK`m4l?2{FAiRfaz5@zH?x(qlne~BQ0O2Fs{l$ zs=E=AC&YL*DKyORx7r~Pt><@+l>>G0Kte*iIGClX2J>HKy}n}L2tKld;wp-_RXF;N zyjwm}<`R`bkIq2=R>;o1744I=r|7ME#Nvh=63hL->w4Km!CQYInEpi4$ldj*gytKpS%oAs+Wu5fZQf99wr4X;==p=pUOf?7y)w7nip zl4d0PI+PAFn`gCOEh?e|5U#XZ?O{FDae_Zhexl1WDn|sfI@)R2h>@G@;_sTU?rm_| z9m=R;#*TRCL^M`@~=dUoi>ZfmAkrF0E1Z z`=9Pzf=mb>wUKmxBoByU&!TJc_P+O*qw);F!sk)?e1_7JJ)8{L)HB+xWPn!DKA}Wi+Cxt90dTY?>NBLh0|O;$&=|XOWlyE!zsaAnd2fOz^1(onkiHOnw8szl zJwCnAKIKy1;Lg}|u51k=2?_Tx<%|jO$kcaTIRbYN(VdK2p<2#)IRwlp0gD8=uZczt zdjUP6EF93-ZV1E|Il^_bFEH*h?G|;S_k<5TdK)o5XY>4dyD~39Vzqa0$gG zJ==9s(mfy%^c>Y|BCip_c6pGCYr#f{S{_5(1gkEDh7zJRzIk(FQ=&&Y2;X0H<3P`t zljYOqkF+_5ER-AImRIHh*aY#Vj{cHJF5ly%MLn2wpw%MJ&HYJF$vb~sgJNq&UiGO; zDwlT0O4L~JbuS$I9NbAabPh3#jaRm7gcpODP(8%{-5bd4i+TA z^HL3&nW!g*M%v<y~rLy3ZbbWg-##=Juv) zc{V6!vcVfZr!`7T@ zGnXiMlQAu@L@S!2!n7Nsm$^H)x`ee%F!>-`2)MV?HmfR#Ez4i>0!+~kybQ&)^RGt9 zqOL`G8*|#z&8|lbo`^rU;8V!zq zSGj6S7lf|MD5F5@XKXU) z`S>N|h$yuw5foZexN=Lt`LXoYcZ3)7vY>4(_lK8%icgO6h2@CH5~}xd%PJ?A=0i;S zc_k<8lMz2FI$u+EGk1q)|G7~7FCkD&n*w)(kAtq8x0rOt;m&rxW47)^Jc#WS-#8J5 zZ@xRP7T;@qznX!yxI!7!eJH6B;+4wcqY}-8i(du$RpKj>v}SuGAKYI;!@h;a`)Vmdb3ykyYtyxGt=qG5w)LLB%<{I*P}7h$y3 zYmQT)%gtZcQw^wf7hP2oJv+=kJW}NvUvt@8&Dqe*UFE%FyB!+&xHkB`hCAa7gLz&5 zfwUaMM93DWT=oQ%t031*xsnaHiE@p;R`@jn-z zVPw<_4|&4A+E(i%uD?_2+kG@3KWe7oo~~O{H+AkUKKDl0REMi!ANk?P0%#cUj2M?y zyTQ+}o^mhC3*~@zOC28rg~<|ylhw3iMbW{g`9p8sDQII^B+^DJ0cH_ObnQ`?>atiW zm+`IH5``bJq0EedV^vis&3QA#!PILi%OGpm<*YK;S(0o`?`Rim{|h>r6snb?Bi%Jw z*h^^g&!h)P=2rrJ$)-rIB!A5DQQ}fmg89r7DnU8VMWq&M&jx+)D8*){*uSlI^)>8s zIcxX9H#iSJ?;1H*g2JRY`wB-0?E!z}t*+lg zvs^hkl0rL6@=J9J2Zw>eDrOD0c1J86iTqSV+SIk>aR=gGCt~>r=%|I&J7hr58E+-l>sO`J#th|OkZ%Oj$xYp%DOxI}r7_ID&-o~SR!9F<|BUAz)ylb+V~W%QAO z_8~8*c%!i7L0fJjOppRQq)dOkt1(=~AgZta0;S5@Ju4po5&uj211~J{I3Sic6_n}2 zy65_Xnw;r6gz>cjY|SF}ZbvTrPsb_RQOS!%J{o@0jeHTU~(h5%Hxdk*MQ;{8l- zT*G%=H_~mqGqGZWw;>h2mld`!zjEMV7axGT)TDwZ$|^5(rAsc^*7@Ol0EXkag!;q< z)5$%35hJe7XVEW6_mm^L1iThunP-sg7=p`MRgNA*nR5IpF=5}V&L>R!2=M$X!c+y; zuF6RHWu&0;-t$;pf%Qv9av^rsm8o|KoT=M~@4WBOnELEcOSLA^+fom@JQ9 zy{q$P`&YVAyXq>jXK zoQWOSV&E^8WylkY{tmrpsF`4}x^r;xZTBztoorl3`r}8^uHQ(Q{~4txB_Z>QSJ3a~wR_+D>atb; zaQ|s4&^5{KZznfUMGx^Wvl2h>QUE$eCl^KfiumvqzutH?fy_Kc<&;Bbbo)p7hLb{ALMA@#!DDwui=Sq-R#=yV6XW=}^^)B;&z~dS>$#hQReJz4%GJ&c#WS(* z8oyTCypV{S#1{HArZ)W+{5#!JwCzcy=7_F+&7RmEtjQs8Z?qUDEo(9~+Z&Sn-09hV z0aucyM^fh68(m%lQp;j}<)gC78G3QMr0(3@Rcvdl6*#Z`6lC~6>*&4!UF0CQ5Z7uP z+3S6PBR37VWmCz=AON1|UN9OeglrH1?1enG${~eX6Tv`Ul{4EZ$K(;e;^(&bV3a-< z-q<+fZe&)K7udgCrW9BxE+YS|1=4vQV2?f z;q%gqmF}tX)WJH?y&=NP^W-Zm+-gxc>}hD!1KobAZtMms;UY?3ki>G#F_BG=eI`oo zO&5!v&9GNZdv3F*F}Dh3>HJx|)7f8B_$zBNUCGid_yboWcZk8_vlhO^69M0<`^PTe ze=scmn7LHqAX_f`=p&4G^hqOEY27^&hfvD~IzPjeE296J{D$K~2|Bs0ygT(H%7m$q~DF;v|k zE86soet&Pn@PXNkx%4+x3(G%c4V_!dpzOH40~Ew1HneG83vR6XWO}HH?GQix7&&s1 zI;#yVpqTG*p~Pgv8T!U(^+WdYR&q%lFD~%{YP-m(>#PS zp}3*6l~4K%-*)_TDoND~1@lk7u$%X(nTT8<{K@r+p4>RvOkvDf5dd(l zLAEt{ZmOTSma+9!n0$`~g<*(VL99)syQw%+|8M{K?5CpLB}@AS05LaSeRQg)*YZH9 z*^mWm`cMPcTH0r}O}h@h(5>29)Z^~>CCB&amf?IRU7Ku_!VK+X1J|fYuGIF&rMv0J zS})BJtrL2gjP0>wElbOg9wMD|jqdp5UesGC>{)*X^}dRphzUNqMzsdc*mcGXiMwf! zJk;+O;VA60aGXqDe)lyf4G0b zf(rFEcH|rux7x_cYOG{o+RGCn%r170grmO}mBGL5qU3c5#e`cO3x7=$z6yE4$h+JU zYf+{I9@aYA>u?gy_WWk2l07kJSf7yk2wr#=pMd^L(0}dH)t!EXk)g23l#~{S6#1%M)>M`R_Ac&kFQasp_R2l>OnOXD-dlGJjygo1zPJ@g&F|R zdoo9P3Ldj(sb+tDP_SVir^e9$r0V0JAA&_ZCa)isAv8{g4OS>NIs2(Mxi?R@jH&dL zT=cAI$Yc{jOm7J;wS-|!eoyo7l?qUY*^IehC(YJ2- zm#!?VI%M)y8^=+fts?X#6K+(We2z(YNn!#_^(Pp{o!@SBt^RpJHsH0x;#!l9 zO@OwKuFgas`~$q8j@0y5CE7pxusV9;+rZ?;B2+x3?K9;}QC{_gYG)uZRr+p)1?o`s z$%XY-f|ed|*(II%!kIMhc)l8IA=iSFu*6Y3xa%ZKcD(1j>6QJA=ac47_*qEY?F~r8 z)b+EA34q-0p){eNeo&!&40=SHh_&8!@O&b$DC%#2hv`3fRQ=n>nu~v;qU1rRS~owj znyem#Z%d)*h>o~Zfk}g2Vex?zULgaWa?5kJ*8EAy!z9X4eDo(EI&j{Gb(#6{YEY6V z<8s1S{19u0)8-xQhO&(&A!cyukrmDKGsw|yzX5F{grD)H#^K-Y(C%2oPNDfW$CI=M zTn3%sF8F(Rmh-uN=B<@%=~PDu09Z1vvU2%PRnQFg?zrSOfDJFgZ0jkpdS;o)uv?|0 zE9>828eol)9hI0fZXi2=6$((hKk{~FI!M$F(~qv_xYboR({v-RVnyR0bHod$H&JhL zNg2DSWdWH!s+`kRnMRkl3;S-E*WJq`V0Ty#O3yT0_ z5zj0=9L3Lv+thm{&z54pi4(qPZ`Ww*kkrD6!+m$Oe#q~x%$y7YpY<~=n7oHR^9`(w~fc22yp|S+aD3bx*T9!aD_uF+s zi`AzctEPJHPat92N&1~WD6aY}WKM6s@T0RUS7>$O*yy z(juQ2&(_{WBNDGr-9ClxF4w1+@i}){)VCF1$WhNLoY)PjuA9l?3ihx?ZNPEncF^J| zHNN^yk=%DqTvGF*u8p!;dCv`IIJ8=FM=kLe+To2ylE;w}Z<}$-f&pDNH13fF5wEL=LF)Vpd(*bkpf1_$)MR9hrCcYN%p5!F) znm=Z{y+@ioJ$&28B>bQ0w>}})uk|O(LQb=wC2MXc9n;rjGo8fIhEXOnv(5V6L~mz9oYZpg5OR7O85pLVxZlolpOqT{Y?> zV~r|MOl;_^c`GFOM_!LJ(oZmW1HW@X{QM1{GR7zm()WFmgwpY8Z6< zmd>p>ERGJb{)h@XLFD-?Smhadf9;iKfWMxr3BR-oVqHr5Ka$SGFUj=%{?oMBs;yF) zT3LgQrBkNl1~sM5jFaS8nW<1}QMr&SDqCe`rlw_Or9x$e<*vCaR4%!s<;#x#K!K-Zh~oR@{ELpo8F#g>3x0?0)@#|)EvxLRCCN^Gf9!+_k%Nz>rb}@)ls0i z3GN?;GK`$FPG-4+eh~V5u29Q74)V)?6sH_Ps4t}2f-FH7TqKQ0d!t^?iFr>1<-9xm z|LTl>V^lL!jvooq)qS?-k~h39aEp=lx@vFqFOS(Nu)34rZPRAD#ElPXHS(xWqsS%*OhoUC~bfu1h zQJj2wh40h(Kmqn!2cSn-jkW-frqJ#NnlxsF_A85}fa}}Cl@O&>Lx+0lTn>j7{p|qu zn+kVD@^?B}h}LCcrpa-=#FY*#@l~1zuEl?nudT+Za_;oVJrf4=MbBEip{Vr<3!x5@d*#>_?b1E+OEabn?^zgaZZ?C89KaTpyW%wydS#D3UZQ4^OIDBX22G=YS2$-;KeDXUOSQ!iC( z^y3;f=dr%cwiMNwA4C6X*wq(#UD+7b^N{$e%!9E$pVum z7>Lbs-@4wr<;9!q1c4CFc7z{}&lKqcGA>!ZeGt?O!Dz?cB?#ALvDC zu;|Jgd^t-f%iZu`2jGj$AY$*bi;Zwn^Ml81HSH8q|8goL=DE^!>S@Jxv9&w_weO^+ zFw7F^Fq^Jdv>EM9Rh?>0-!+oby@t#l%y&8GhixqTw31;(*hEnFK*Z;E9e#Z=O@<{} z_BgE}4D$;dGl*AO9Er+L*3{vPDFaSPOpE-JFs~}jk`k4a^eNX|Aaf%{9(_A?4zurm zgyfxM!yt0$04bWRIjC=!+1!Rls`t@UIztK#fX*Qq%+POLaw{#mtafqKA#?*-7P#1P zpEZjKl<1oEnap-#C6Oh&Pk5?#8?NbuMPwF*DSo5%>5Qj+A|$m9b8yQN%Xbwhd!g#7 z)-y->bPJS^)jXeuLBf@xEYN_Yz6@GTguKJfEI#$YLA!vPP#-u~$6YrJONSQ*h@<>z z86|AJza{zROl^(Ucj0$^5n4JZ2RI1jwaUZu8o*1w#)fX_{44L~vWZ?ZTEr;xg9ZQt}=RTX{$G-p`QYtjX3- z>zBFz6&P?-w^0WpPTb6BIL>Xkl1q}D+0)MQx~6+bMqA3a*!`YE$TP9g@hoP&(h!9@ z)kE?@>^prxPQXlBz%F$PAFA5M)=n(%pm|Vi zu7yDM-O=27UU_21Mfelrd)^O-&iP)@M$gLs`*oq0_bu#nQt|ed+lV8l82px(Ax~W# zTvY3nLy0TLRX^Mg3Mx@a3k>orQAW&a(#*VBjnM1|z$WwGpKDF^=%5eDV`_YA?)6vzj z%BvL-=RsmrKgiD)h$Ko#2 z;KtbQKkMQ|(9Sm(;XjE}z#h={YSyD&-7xf^ad-q2*fQ9z()=^VPc{alwambGYPMh% zA-1HvvBxS$DRdl_o-n(IIs7MA)co?~YiwSyll6HFN3~7FtGL;@zqX77aO2`7g!XsevZe_O8dM4pOBBo$O*|LGO!Rz|V9o zYFyE<`M=EUSB3ijkrk!<${#AYkw*c|?@OCE4L+W=;lX}7DNEgb(C|S;!hpZcr|%8w zKb>PY!EmP*yV|>V#?n7kjumy*Vjo`Qo%h2h8!u@&4(3b4+e&Pon&%q~FkT^*1=U)v zTt=(OAY;k;q6g-2iW5m{3##@&l~<_CExy3)xA4UxUTxxD%n$L0sFSf`WU3y zo@+EmjHWuB_e(tMv|GQf)V5>)9btRVTWRa9XtX^%uG|4{a~?hS+^Aamx9Da?ZO>c$ zBVq?#8aRiz-OV4LY4tOQkNU(>s&!;Q(WErcPld#ZL44afM$YchW3*qPZ%YN4`n3$# zfvvHmU7n3T0Ng;ZdMCQ3eNYBIHb=&V6|q{eloD9!;Y(2#9%z~s$b@Sw`FP)Uo-&+c zKSb@D?y2udHW6V0L+%g4BNowk-MLURl+CN5dLVxFT+Vaa%6-=|&$xpCF6VbcajL`t z^>|H-dIe|cVejbT{ediccVc|MqYyWp1BEk+fk6!;hAw7xZx+5xuCCODk7>d+K2PVv zoXhM{KXlIPc%;weGb!1H5im6CQjic=rUd%4*_)PJhDYLLZbPpoAmZ z%f&SjqtWw`$Y(4IXF)P0%jO8b2J)2}*uw5s+bshD+y4`^#5R1gt_O=aIP zmU0Vip4wzkEPi{E2~gI+h@MRTXSi5UG1hyTHsd7*v^)^J<2VfwGFpu&t6)Hqxr7bQ2&t}@fCla z%9j7^usOfWXAz`!_!kUNeomEVGc)HhnOn|D+HJqhP#=JZLjv1=GP`Hws8M}!7UUml z&;{bvcMWCGiT*Ek6$UFGHZ>Nl|D6L8XGm~vWHH*-e)?pWyH9OzD zpk_k|s<=(thjh)E!fh-EG<8@y1H5>kEpPOO@T!{?uy_>9hdCCP=WQ(B7Hj6I&aI|0 z#^Zhxmb6h*=b+qIE{L<~sY+@~&1H#iw(ZpmP;ICT3mm~#tg)fzB~#A$`AgrIE<%jp z@wvm!uO!>xIkuGOOGEiUcDRr9)rA{NTL=vkGDcrPA6)LTCzNXvbbSSF@-$TUykkE1 zss-QX{$gF$Zeq`9x>G{T-(T+ED?1Lp!nI{h~v;)C$ zyK=}y3%i-jan%iH?!Yi&xZ0B7_@!i5^I`tt;05wS)8RepN#unLn}CQq@V4r>R`FO} zM?I;=Lz#ky@fGH}B>f~=cW#CK(wJJqY0x)5Q0LL!f#9iPx309n*)Z7FjFPx~U0)^| z1#@zEj?G`yT&3NTUZgIhKSBJ0#4WhenQnaBj+KfD+OPtZ<960slUFoOP&;>ir`_yH zcVfGCLy)+$K@ldB9VZTN%2mwdhLHOb8kA-4ZK~ZY?aSSTqu3CaUu%I}V&$=QaZ2mw z{=!2rA?L2hG=SSmI7v>)*A>GKZ_MuU!$(@VM>MaB_48?%n?8`TkeaeI7=C@xlX^kP zZ=8Y@cPIOZpXDyCl?G!!+oR~7&h6wWvH;jXhOo$?;fhn3poUL2$bv*4#N@N|o2pxJ zkR1;sXN`1e<;kRI&{WoP25&mqUew|{1bniy?o$Wt2?Fp~a0q}ymXQ^zqfDOqzE9&C zK-lSXxX7%pp*XWj&X6Yk6UUyn;mJT?z?s)ju)k0X)?N?8JuJEpGikAh4xFL(yhLj- zabhEg`4Se|DeL$1y^!0-EqQwZ^+Q~m*?sdfAwyQM?|pL01wB09;Id@3 z`Xy^@uvjU+MBiT6aG{59EO65=9SU8B%D6>4mg%(UsY6Z3_B{TM{5^|uAz`S+aJH=y zw-_*6C1TC|AV$>vV$qT>D)w&qVDtZ#aMvMiB4^BeNlvbnGG zee*3&`N>9hq*V6RadVyX=(<#6=)I?qtMwUa+zxRN>JL3dw zhdM#yGRdig4Bda!J7)Ywh4w`rC<@FT^4P`oIvv{JY|+_DSUBN1UJ_~%itY07GS_X;ySv|(&%^AYiXz3UD{mWdzJ=IFGopMA1NXXHnT26lPUzv|vxk8HjnMs!uMot2?NZsO?% zq)R%{zI#kxc?l+{HUk(1Legg&!E}itD~;9+)kcw4mdSB@XA5;JXli=7uFy~{_8$#s zYkZ^Lb40$23G_&m5$9S`8|l}08h$I7{g%I{h3?TTN`9&{shQ@}QEzmd(o-3#w$_9?*-UzOr~2tQ*bgP=B`gKvDu;fQfg_ z-Gt|d4(l61ly#agX!Ks{!mln4zo@(Sy6i5P;h*mV|1=<+i6w$;o|hDH*4+3^ zrW)W0s#Iz2?0OmWt!@EHzo?H2lpoCz=*>#;;bi^hMp4BuY7#SLbFK+y5YF8^#bVc& z!0`@q7I7%Gk7gU}9xUjs3(7-JY$XQ}Su`$6w?@1O6b-J@`f5wAki+A{$6K`(A5mTs zOk@1Lgy>#I(|guEvZ4S?`%j{0E!4~BkbwO&LrK)hN}AYloYfOa3-_<=iK`$4^u`f)P@}l=m#H~ zh{$H_0k=?bkMnrt$(F?=(AK`;mf95Bx=*{WQ1d zor-I@GbKzo00o$P2mHuZo#-e_GT6LFX2aZ|JPk_TBy!`8<4U>%<-d1?&jB`!#;Fof zrU6{Q`6~9QiphD65p)5&1D}Y_16$?E(3U~c_#+Xn2#3Abt;w|Mb%=pCnsng9;IK2$ zF0|wA&=}%FpQ@56^00q*yuhc1SBQ^pddUS|%&<9T5o6l5blThhLiWn+OwX}6^6NP2 zI-p`v7C)>3&{bja%WN*{z<{e(U<(P_s!tXVtX51W69cE44$UibqnfU7$&I^WRDEoU zbyH#l*Wd^j>E9Bf#x{8>tytg=Fu>=%m02ATOK3XXilpN&jp=e??1~XJob2%Ez$*~7 z30q+HbGsP*)UOuXD&56QUzSjH)dNGm4#e*dg7ad|(wlk8A>^3)@-3P_ME)amUKf5O5e=BE#5HxX$SWAoI=_=$RJ$| z22^7}lbddBY=4q9%?#+sb$-B*#5??aA62ldR`3}zx4$+nRPfTlY+)4f;5*!9cgj){ zT0Q3uno%d3LDfdvG&a7f#~sN_C#m&880N*!<@|t{YJ=<`z{d&s4T2;_)YBQ7k)G zUL_^)DP=gAllbE#z9q#ory(05&>ZT8qlUoG%r729Us)v2-iJqD3SmI+J^N1Npd$o* z)s}jb{rauqc-Kj9GKCbwEtPf+0UnBAo)iG9>$^Li4QA4 zMdS=&zz`yiZP5r5Rk3bsjPZ_gSbC2TBLt|;(pcn^j;N*Sb<@ z*TVLGp$y$SqPKp{sNMIf{*NgOT!YltI@kl((Yb$Q=R(E{>*}_ZFCY20)#aN^TWm}z zDH^TYHT6c*g7RkifvLwLBW}m~qCAG~`I^_|OfNFhcg|+zm90BQmfnXVvZ52jUtu4| z7#0m0AMYSLAMZSnUF&Rrh)wDsU;OrC)*i&xP~wly#;jsLn*YY9nA*-tvogEy7Sp4a zzx{3=96&2tt}QZnxb25u--+msH=s7)ZDn`cVSMVj0Z~|xZGP9M@vpGZf|j_=%E8MB z_?g9)qH2?rbQz^A%W+U<{?fgm(@b&k>Cm^j9KXbvt+8g|Rm)&X9(P|2@0%(hduhn< zJx#qlIIeY&5;ieiXfP;i?g$rWXr6h-^H?UmkTLw-Tpw4uf#VARau>NrX$tV^KvVH%h(& z7fG+22j|n8n>(4SaeK>#6F#h}3mrpiTw{q5G}z#*P3F@`_s}r{`J(3BKpV_ z2Hw6ZhM4>vHWhT+y#)Vn_#q;D{qQ=A|BPr-_k;M8ik3gcfE#J(mm{S!qqI+#3w_u) zhiqNTKST!+@$g7e4&XbaD` zs89Y3*T|80pu4ATl1=Mv+@l3&V8`v8UnTv(PZKs@*B7 z2TX;V3M@l4-KK@}hnTg7i$mz$R&Jj!=z1ynkd#P$s}G^PangiXfRSkXGjqu`?Vf5h z(5cB4^~Le;4cH)@r)5_-*XSr+Z@N(tT({*sn1*MbuY&f~b53f1u!!71<`9>s{}gb@;+8{TpoK(u%Tw0nXCsy$dKhm) zlYakgMEWg3dr|(9c6%O7FrHt%$23TyH5_p``oF^}%c*X?o%M=gSZFE>=etd~rEvbY zI*F@8V-wG63`hOeI_dx$q=+m(hbMNYtsM+_!mD}lA!u&%gCS>M8-MnnBr{~bN7#{O z14p9^&KCNBJ86S0E1b*P0}y?JC-p&56N$uz#ta+wf2V_6rF+~PZmft@vVC?{&cCmv zmd>>tuf<;OaU~n&UyV?@S@SsJhnFOeWKWEwClRuL9<|C2{9KN^b~=d)u(D@`Ep8L_ zfN7}6*rDyPDS;2yNuPvcuaGvFO1cML_K})aI*jwJ(oIvcNR>N#VeCH9L1Qt;cHw9B6gBAf{?CdD2}#5)Z4|{vz?jrY+W&}YyYTFWfp&t$R|eCadvep z$beJ!S-P!xObp4me#VBZfa}^lVK=AmN$aoSA8{+z0qboN_u4rCGqpje6kBX%a1ip0lGudoD7e&AysE+3UuW1WR zQq#)_JzMIzI@Ml+d`*aEes#X)w)N*#wV@lPwhmp`;P$z4ZsbC77X#>)3%VP)b718t z%I;HM<8d~wpWJ;$JDKvR=asq3#B%gkA`Ex4d+DR2B3drVGt}QmGLL)UMQsI={qmf) zXK-$ZB|&|EFe#4jOJrM8Kg}QBb>PWQTk@2^mmrWE#!L1aRf1iwIhNi3)=n; z!%UBc7sIf|%5lYFSErEzLPn=x}8}C{6#V!ntF$jxtZZnu@0j$$V9y3EX z(uPucDRTg3Qdv371Rg<(RFB`ZACcP*rd7x7cT(%Nz#uwR82#(8<~ki6cclV~F+;RN zzaIJxp`$LoECFYuHAQALFO8`Wh6@fa@6-8>30X?DJ=006BHRh!R_InXNb3b07!WZT zRj}nxX;WDk)&>Ym1OSYZv**CN*;8O>ncjFb`;2B>-2#uCwxEFr^*f@z3wfFlHm-L0kuSl{h-Kf$@=>`6|2$!c0!1S>WpB zp{$mDNZKHN1~iZsP8gyqb9>|`L#}z+0FP?TJ_UeJ`vn#7&!uf??4FKqwT5t98~k(4 z;zPV{SzLA={=xk|E>Caza2aHjorXG?RX$T9wwXxYx9Goj>qIk{@YaI=31|= zfE?_aO#g1}&`xcOleqU*!z)4dg}?m810UTYH!f!zHXeO_@;tLhDHp#6JqZwF4|^Ft zpwB!2gour^Ex%lJfwF%>mpL__2G`@B>H`Jo!@ttln&*_mzgAWpun!d(FV4Q{euW<; znhow^G2b_x|A8QUG=~$e$yczhZ5Wikzj#J@9%8O+N1wHBTrC#=MIB^k=rtW)yKoJG zRmEg+5bD&W#_2U0@Q$(IxT$#nT`Hx=#7*U@l=r=_B8a@`#L_e=wD3H81C zq24u++?yTc0c)3Vs}RcN<(2D1!f-|ZjIn5q5-Y9;_E!)Fpki4y-r(C-UPId>B*E*5 z_RV>iZXXy7>`5*?+|;G($AX&T`Wjn&S!z?$ww{p>)zr&F1;pj%1wqshYOF{l{H4)W zw&grs)9zU~mF2OtRwTZFt>foEhaVW7eU|QO_a=DJGn*1G6M7OyZ8Q4z!jx-^(gqfb zNx%**{wOkAlWB*{Nw8wYIHIUlqcL}B7jjiQY$nJthtNZvNZ8zC(I1jl@ll!cD-vo{ zm_Ue0U(D*&wtTkRVIC^({BZH%GbI>s+|)X}8b(P!opX5@m|98k z+kguvcN~7Oj`xmczlV7}YWYhAr?mFqUpkBIZR6yz>n*VEpl`u4O-ZT)Qk%Tt`qo`grtG#5V`r2 z68cQ%a*6n4`}3smhRpH+J?v|yHZ2|VAI{;PqEyqu|B`98gvu?`4JFF9gvaMZ0AFuB z^gQLo1G5)dMq|;se{-a|aCXJ3i`8I2Y=yO>g1!`^HE}2?YhuY{WM~%HZaPBnj&YQE zr+0d%o2n71%!V4leWN-c=zcuaguvZf2E3?QZ`)VZ4rm7WHL1un|oK$?&9 zkbFGDjDXG1YajWl0jjNRe4MwAppPzH2h&lXwxOXJ{;3K!uc){V=sIzw&aLrt z0hwlPc+Uk$VB?-Lw1?F#Fhy;&s zlq4Q8*|Nlx))gZy&@X{n0Dq5Xy|hu2E3nHEw{-li_Xd-&gq;l3&$uKf{lY`XDJ zDmk#>;c4UXg%0}$NyOB-Fl8LKMD(Im#Z_#8CIjp2n={pMw&~)*|c7Fwv!RVjpBcL z(+)O8nmm{20OSqYL7nc|TlT?%?2uz|kazNbvi{BSDdSHca9Z3)Y_YLk8vhxEN98)d zMT!y(5smYk=k4>=t`W26(Wo)ooAj@w@$n?hi)o-QSfo>2{;pTRbm{sfnlHl~^LpN^ z^{*eKH=T^tz&~Vl|9!q|!xmmXtAVg53bXPEX1V;%{Ib@jD*3e+Q#o)ZvQ)4kkZh{uL--ypzr?@DbTS}l zCUDW|zhx#ly)ZwZh)C+u9v+Q6yw^q4@X*IFxEj}cz^1mKET^rg#mX&)oo6=1aWbi0 zg65gWMprQ^;nADebSB1Uo+;c_egL_Gv6C^9IbT*!_KT7lJCS$8B%B^QtE<=mm3(+HJhhUW_@M3s(j1jkt9h`wz<>CrCJF z?WR-6Oo!^%9!VH@B672=c9j;J<|650XMI0i#@~`X z3Oz_-XOC`x)O*9sJt(HkDSz5GRhV{-40}m(nT9<*=o}v;DHV9f0?v9`d`=t7Di`NE z`9rYnz2q(xa~|`zsGHsaY{vb7LQcRvG-vfr@)7FH5Xw7i(|OikYqQ{Sy-1{!5$9=u z+N2Fc(fbV7kf#pFO{kC0`6){@8tWR~7b~Fb?YPajw{fp8c`~_Ll_nt4cfJ6Ne1FMR zt5MTGu74-Ly(rFelO!y2f=OvDBSj^BWT^}jrC34H@$`N~NGLNc*K}X&|B^D7gUAG= zvuVd|X~HD*a@fyR*tg()ez_c1PKCs^!EX`PqG}&%eT3<|Zdi?L518@S zolz~;FYF8`-%Y!*LbBQ@=5gw9c?fMbcJXd-z{I8u%;lAiT*l$wI+H+aTbGpSqDcQk zoZEHlmuqjTPO+Ejcb9}w+cFRnwGH)ca?rf?uUp6?@eiM&`(6D=ihRU!-^jD%UeW&J zvEtX>j{@c!+y2<=Y;(+i$s(TZtrbK?S=#HZg8J5_7R5+g9($8Ltv~Z;4*r62ukJKKvV4(qrx5mj;h$Ba;K+xb$_)jX^h^V6 zxDQ2HYlup}rD0>NnLR3|(kgfq=WZF>CK?%ExUK=j$U3ycSR{4eE@;m2D3RZEy;_y> z?5h(I;>a$NqMd>buxDyz*U*mGN5RRxJlmxjo@ z$KRWTla=0bjpy2#0^-PizuJp$pPdl+JY~jP10kc9j;cqlb|jgf;DA#^L7J8!$R+aC zxwweV<)o>1fCGe-&x*tBm&u*qDQ zCVL#{+Ja1gr&&APNfFrY4ZL0}5S>=g7ezxY5N`Ik9POQ+iT0A)(M3WP$Vrnwjn>Q1 z`t9nhb&4^rrmZecIbLxkK=Zz6-KP?}qwuT%d?ai)iy33{$9&`dfMcSMtUwOf10xOfG4Ny##V@34NicO<6vC$a-*$gbcM6!uWDB43H zi1(A3oBG$)NjJVvA2E`9$>Eh4P!XNe38z-+RfFk38^g%5`cQuQVbh@ap8bCRtt&_I zB@7>n@osPBn;SmKLLFLAO(Q>{)BGm=By+XrE9N|k3tTU_=K zxr()LM}^0n4>q3*}I7=J;vu8b-rI z5Xq@YdzhT# zuU~7=+|seQWgILdxhNTR_E)3#>iRIAEY@zqv6!s$I;%@a1f*fKNyukdX@d(Y%F=q0 zGpiGTCc~@&+T`GJSqW)+0^lh?C*HUi{dAbXPTwD3#mjDXd;=z?ru}JANdMMrHV;Z~ zqc6mN?S5Ud(D6YkhAq9+!~h^9d^vi@ z(W~(L3l=%B-^A|mMhFWIXmKl}9J}FA$Dqe{;uMOsE90Pob`1OrF~NUvj|?95@cmp1=8o!q3f@1i z80@rgXsdTF0Gr(~j12LFO^9mZrp6U}81pL&yE3&-EFd<$h0;|W0c7)+&NZ&KAxNUM zYbgybiF3Rz`k|yPg5|wV%E?wF3(yx7#8u(S?XWIj$JfWQ${q+~Ca9CS6)z4p2$T@Z zSXs-K>FacOVY=qa{~be5Jy|r6`6q# zG77=&Wt{$BC5$JofOf`0^DrGeb_4s30oWA3I)~Uh(9^q<0_X6B_|ZlygQp1WD?}6_n`IgA5S&e{4aK+kt8WZn?4@K<6Qs=u zc~kEE73F5uU-a4tgzUR%+!ANfdM3$~u=SETU^dn{dgr=EiM9?uskFJYwZyq=aX1%i z=>yI2tL%N|UdO1Uv2&A_P9WO~zSr1~qQ0EuM}f{2)M-nur4lA?m#l)?Ckam&;ug@z zuG{{(54vVOdCkbE7VO+voI=Jn4iOPBB zc+bFv^=H=20@NzP_B_^ZP=EYE1D9vS#x(v0V!l?`;DD8$)?{A#&LJOD7L028Zzml8 zEj^+3*xc~vtUb9m9ByN#^)D5siz5Q^+qzCpW)3O(Ihl^p0j}niQjQRg`clI!@FzuH z)P1Zt+-4uUg!=PGlPw73r!lN1o@C4cmn?oYMV2k-$_Y#~) z_4!_CZ#~a>Pj=ek1|}oS6Y^A0FZ%i{_b{@3B6DQ6p;z7feJ_zRuB(mZ_orOr@H8IZ zAP(=iNBX1NNog{D=^Efks$)u%dMAWi2U1SdvbsDGwktKd}x={_-A zW^R9Tpz(5a@a$If>;P9!|Ki(J%#qx+6=9;M2J5}$*9n1P=&iV7c-yqlfjJ`&E56i) zCg1j!yRjzPb;-oRn{Qv`ZSnj5cl+y2;wXvyz#wY_=azl?Lih$Uusn?sfC$l30fm*< z39S#1smM330uFj?CS+9e?q)FvWpiHiG&k;H8IhV4)mWoUt}ZVOK<}UC?Z2A8&5m(Hbr))|)s5+3q#+kj*M`-bKmK*0B`cJ6h+))8Rdnw!z-gY$%v`Aj?G$V-_BBhT5(a$J2v09zb znnEOy4?>Gj1j3p;YrsVp@4WJDrb!Ezuj> zSet`8jj}a&*&$JZ^j|_#L!Y3jn{uU>odtJ@5|M74riSg~{rN55!w-~geaK<`qWzh> z21Rh?mNwZN(K}&RpUq(M6o7xyZWW*(>jUrllzqA$#=pL`Zlhbk&aQx8ys}O>m$UOz z-e1s+(Dpln`Vi}5{+{z6yKz5mfTUj?OHh3UnWLlrMq?|SD=Y0qt_HnHstT8U8;$(G zFRsj$jrs(4Z7w#bHo2Xmd-dJQMlv|C@f?VZ*x8)5F5AuStUK(#6LY5gawA-RBKiz6 zM&g4$BTHyPI<`>!h^f&HmmYNFN!~*e2G(use|dP2mhhnYS}K{^IAKJutLrwaa@$C^ z{OupmZPJ6}wiHxwfkAZt05`ubds=|B+luCD1~L)$kCPv-f0=iK?k>iARoXoIy~HnV08= zzEd`a0IzP%+h|0~-?D$WYqArS{~gm_v}ydNS_46}v3T{;1EQQ*vnTg5t1BBjrtfF# zP1<~Xasu*fS??vGLcxBv96ZE?YhWCf-16c}Wo!I4TbgLr^e z8>%?Bod1&WxLBL&Y`cd(K+48aTP6R7JwopjXs#qWM_I@pJqW|R5caf&Q3W^%3rE*} zOy@c`r+@$6;Zl-E;?|GG4T@?BWJ!HWY0qfaz=PNEA$4=>%#{w>7~&sU+`;2JNrHzZ!ssc9{p~!n{{(n+{`N*xsLQJ^R?HfYvN8X^0Nb+3^!2C%|r&8VSGp zc3`-Lk5iGgL-GeMa-;FE`IELNO4iB)TgoamzaIq5ar=2?__c4y`bj<`0y8y8C zOT;zp3ji_+a|92C**NJ}Q352AA3){s$@acATovV*dI2?E=w1Rz@`Hv*9s=&T$@XG} z6)YxP(B*e}&$#B4D5HBW%G~8LUGz8OB{4;d8BkrZyS^W!~Vk4?*$jK;VYzvNhw9l?G_>IDb%=YgOp!?q0Tb) z@AjbHvKVEaAX$cb7o{NL-D2 zjgw4XS;nUYe)AxQg{ZXoUx{{oofiEm8-F$-KF|8v{4OodvQmG`BR$8QqGbKv8p^vr z!$Y*t#5T)5ge`Vw{ zN6Rn2>N5|Z)i;_?CQA*aMPuaSRa-@-;j!TJgJ!rpeXLAk+}O7M`*Ms?4cW+s z?sv7vLNF%u_>c<>-zYohfjSA$z-Zq}TLHvI;UO-I^_qrnbHc@;+S@+d%62;hym$c$}yBRFIOc>P}X}{lNHP{#DJv8rfvSJ`V)9heIHfYSL-;$n!2j* z2mfVGt6e;2Mhcl_sW!qA#F7qum&mF?9Md!iex7iKUdJ)yjg*jLEa)He>pep-X`~=I zW8gtu_3NcP4X5u#x+YZTl$1cVI|_?;x<9a{e%`FNf?9^c%6DOwf5v=>mYxqE2s#z# zM~;(Cr#=?R4v=|h;OtC!vL?2h-{%%w_1FP+yGN5SlL{=S&Ds;ipPQ6ca-M zRK07@paBlDw~F)ee6;Le1g@ac>?|Z#wGSTKjg|)hLd~ht1{I}BeE7S2^zCAdQDcFn zL8QZ}`L@8$H;R1Sq6LXmT3u{SkO!=;t>dRi_PEEa0<L$Q_>R9!9IX}$ngCKBOTNM)D8@A!X)`oOES`>fDFT)oWXFvY7TIL z7&AIrzg}}xH#a6^TvTlZ!Zhc{Dnz{Tsmkt|tM##JZX4xT5EH0T_*<8WLrk7CgX}

      YZBrjPOs_P-rvAquMd+eeLT7_^ILlfGDVQ?)cram^BK^;VK7+z8p4J>lpCUcfODus@Sr>` z+~q?2wW1F*jJ;VFf>OtTofx5OB4DTv%IXsCU94-fuPco;wkHb2A>%vNV6P6(cOI*K zhSc!+yL`dkO@H&Ue4wduZko8(*HzYw2*ceraSi)!zH!gJ^4TTB`>bZ^%pWDjQBWYZ zJ~faX+Fo!)Z~zleL7@vJ?ZpjCNx68D>ngt91xFRW^~o7*3?9z%QfCd(S9dc$C&g4fTB;^h(Q|Ildz z8AxKh$dGHGn*XfHTpTwoFpn$E8f9k7leAdkNnEIZ)r4U!h8s9YUd=y=O%lUt_%2N2 zla!IM)0`UE{Obyrw@7p4Gpnh3=hy#_sdN8lx{v?ALs?R$TqQY7sZ?U5$Y~RmtAj(A zx>OExDisoQ-iavWSSre4qzmORhaBcG%2^oEoXv4#4r8;~*=L{6_m}T4`vcy4-`=n1 z^YMB-?vLr?EJy3$A#&)6()stA~w8#}jf#+sWO0j^~a-7E2ES@s!O zzN(c%4qL={1Sf5LQR&hwVzVTdFUk2ZWf#4L!m}LViS(e%Ry*dUHS}C;-;+>EE%SL5 z|1j4Dw%MPt98@57-{Z;|0-a}#Qx4}VlxpGOyvV+b++sNDcj1h-2?`tVa~Z=D{S$Tw z&NOA^th$c1*gU(!(%I{4`{ECN?B$lq<&x)BKBy|OezVf}llP!uu@#TzscZLt1=<-x ze{>ix7hYn{7Ned`Hrh>Tm8dUtW=xs##UQ7{=GpDAA02|JQD@@hZ9QxXaxUOxJ0jWp)6Y?0%TwE`&ABfa@XexS3RxCgHmxwdc8-D8K<76(G#c-$MEbOKe*fNRSb@#E80pRbtG#Aol zeb(=XM3~Y&&*A@+d(xk^cw*QXKj&KwSs#=tJN*6BIcYevBw>+8k2mTGEXnSU=+6>k zefMSPszs9*JP&uu6J(2it>X>JhiGouo_&NOjd(@vn_b?YCE~g}i57RW2JVp~-prnS zm98w31A)Ia4wRR5M%43Lf%m~jj+#P)7Eg$I&M@NE=gLNVd@EySHJ+eST!GGQA=T#; zBy8>KzO3uopRxT`X4PG|D9!QpFLp}VDxGG1ez|tv+Q&G~LD>G=h)|^yitp)bbe{7U z`-{q*SFFC{BZE)qX70wYj55F};&YH)SE#MN3e-V=zAa=k>fsuZ9T3Nvu_CE`e^tA8mAQ?Vj$s1{4QSi&*$%2Iv- z|4e^YD9k^6w%tyQK!c1piaxk`X0a2r?xU?LK9M)tcFsUpj?V@a37fT}!TPS;;}g>_ zGyD9SrG&!C=5dFWuxs^$`#CG~&fqRyzw`Bq%=H%-JH=`HqM_P~#V~8BV%( zT_5^%Y%igvJsK-9CmY;Z?Z0y+)K z4V#&Yh?v*uss-_pbjU!JAo;ZN=Y-Kb#yn1tsf4=}hYRaYk`x;_#fF!8;t}$ml~CsO zSD(B=rAfgNVQT^WB(1UrHML=aWO$pSFh8XhJr&AN*O?@9+^o{G5yd+?38v>jbHCx_ zl}^QLp_hz5D1jo9>!V+HH}mrmp7{+hZ~42eq*m(_*HF}vM)e>VJ^6tjWxZ_5VEL$# zAqW}#h=X%<%T|L$3^b+ZJZRDicxBpI+Be30+2#lP5y!D?@ir7Yy8X$iCJ4LBWc4-v zQRBOI-m!MUFCtQrtM2^q>F>1*zT66cfc$8wk` z4>y}Fc|u&o<&GLbohFiRdb=+F_=@Oxwv@FPN>oa{i|A6yd>oMQGL*^MJBEDWALJh< zrZVDq&F=gV_C{OBvz$I1Tqyn&xgs3#2{Vr-*-eCY=}xdJ!WgmGsj?yHjxT<8fzC5y zCKNiu#*ll_&3U1J<6Qllk?Xt?+_a*&nyfiNFtz%O_iKV$6DSY^3KkDN!_S~@Bp9%5 zKri7!#YtpWzVlm@q84_L@o5{iDQ}c*xBB|7juCIyViO)Z*yAsn&#n|siV=-O!BBW5 zY;sit%Qq*~ixKf}n|_~J|2X0Cu)UYsGtC{Cc+Ouhx5b68v{UU)0%x{DJu?Fhmth9u zG3}(x=8TuQ1rw5>zNAPZ{lq$UFRI?*HLn`Y?i&olRhltGENr zzl>!6Z1H5lWDkz3$m`810@Lkr(ZS!Bs)F)!UuCKaeSYF7{OfClf+wi{ot>EeJmQb* zn|$O}_;of}<(uC!jL##0 zmU=fcxWc<#RZV*S$d~W2#Ba|@hgr_AN%B)+D}c5n^dV$Xb;BNp8Mz8d18hwBMLa7U zn)-tN*m<)IN9tJLyIf&_`%tRf18z8JR*Aeohrcvz{$p@B^i0#zJ1`^QACaBV9=ZVA zpTI_JXW3Sl!^kQLNex(2^+4*%vsl+-YC$zvG%~H>k}?P7&S8;!e)J9lN=u zODD(ot$~%d#TnRyes}N9c+qR(3|!QQ#ZAEG*R2{Ub_#UZ3U+x1i@{6dk+~#qhfN7$ zG@pCY$tt2K1#(#*hSDIV2ZtTf8cP$1J#P1!RaO#fR}4bq(n}$u3A)t_6Lj4d*M|SA zMpY!grH(wD+TGNAg?^m=bNXtH8K-_xt`Fhvq4Oc(S->%VVC@IM9TgWP-}DvNU3Ckg z0TkfUv+VYB>0uU*I)DDVc9EWPs&~_h&6sn96ge9j#=SvTYnUIHP-VAUdDj1mUL7RF zMbE7hEW;7E2NL!|HwLW14m5YRN?OU$Wp?082!1s1jWsx2pqDS|ej`uj#%8BYNJEx1 zg+Hu*6??Nj>Ok4h}$@^F8VYr)M+hG<3rM$@t~7{%BN#Z0H))v#o_v}C>&`l{*OR0BGxg& z4r%O{!`f}D65#~+QZ=9SR)+*ESwAl7gMe@m;XQ|`^}K;Iaw{t(v$D(Nz$Y<_t%agv z6aTgIzKM&ClC+wQ7ff@4t4pU%eRIaLz4w`pOC9)533s<|qH*D?V|CMT%SdxdShhOwPp zbJ+ymq>gL*eEuYPFb#D6(js~I>$X;Z;{)pUP?#Np`32MARDLElN12hfuHC$xKeT=P zzMHUyG&!>gLfRt$1?cm2Asj4J&vSf&ou=7_CYfe6T-Uv zXUO<7w%pH(o3=2LRyI2<)qm40G-1uSk^gY}^GV`T_S(7*X)%fMq=d4r z3<#qd>+*R0-pHACT^XA&S=`Nbl&R<1swVXUsuH^^t;FkfXRcM zGn_J5OEX`F$~~e%p-Ga-ZyLm!Ty&J8n4XDl|)vB5u+(KU9{UZ$ir5XoHzG; z7q0!gpQcDeA}pXPZr-l2(XNxf^QWy+aVbxe+(zh2!$85$o>XT$QEgXBg&>arnRPkG za5VW76kWG)JGh208xN!hhR0S5U z2#F1a1EFCn7NKkZs$*`uq?)PMkDW6lT`wmmY|acjox@GKQI{uIhn$2eq!1$dJKKm$ zoAmn8NIWTIHB|ccGY`MaZso~orSvVs=Ue=I39KF6$vJ`YX)5`nso1|pZo9;PLO^le zBkh`vvhY^*VMfMg+}0Gd5sBJiENe(Em0nuqEjxFL%Y|$)#Y#()98ym7h&7=>I;*QQ zc?>DVJFptsw_jV^w&D{O@=UZbN51x5=$~|Whe8%MV7A4a7<C(6bEbe+ttvK=;P#!WwA?m$HM7#ZBs01?e2*WH{lrN^^-3WptOfK z>c`T_$xDLgr8WV@nwh7~^X2@~pDkEEn|e5M)yPHfaIteb@LIq^k!wCLLUJ2ZwO!Wm z_FQ-P$tW&3w?XzsifM}W-^a%e!rZ>!s5+W(iW%26c|ToTa#lXS9%2M1PA=cZZ@UNC zt}Vow`=4l&>TQZKpf#sIb4y}dRX*cLAodKatIb3oM!f;=YOWrGF?aKFfQCz2KJbp( zfQ`PR=rv@EhxyWwrg{WN=~CF}&uDdCXS4$96TpkWj(U^9`Dv>hFbPDu7wWWxZub$~ zyq}pxTG}SlW>oBf!t(&%-s{RV`J-a%_g#^*=UYc>|glmbtH8Jb4+P>xXnL;^jK z-uc*eEz@K}E-ZOevy%|45goU?SNbvWfh*OcC#t3;T&PS<9>yF>0&YkWo6a06Q6b_Z z{#X|vRkX?F?ajY&w;DR|pL2|!zcyW|g7s)^g&&_YG`w@m)ieAQ)`N8VK^nXx{IKDK zVu8AkP@>a=S(>exQPWk_$EEQ1j{cp?b^==XeIr-b+u6HNS$s`BCh8<6pfakt`w=~7 z<_4~EtQntU?6UZIeIYstKuh5cJ3yFc3zCdE56~~P#TLxz^a3y}wEZwpz5ci2kx-te zOAeE=gpB4@5z3+hzQ}GF640k?A%fn|F03qKh3KRIg{ZaoZ^Ve!1)``g!x19(uXH+m zf5m$X&VHT_It@g{VS#pN`4tdo%G>Y0_R0hGd}zX1ZJQ#W)xOZYY1#2y$0?F@qso{H zBpR_ZQ&qQpfHR#^{sRc_GJSo~NFAp{_a%f3Uk1Sv6?sp~l1Zu#&N`9IZ2=0Bm^2;cI>1PM-? z5=-Hi&~l`%w_D9==fNr1MkMmtAY?)gUhSBib6`F<1xQ~=4Gs5_P@(;lnIXfYfx_Eb zUOJ3p%)!GyNv;7SRB*_E!TJubMJCq=>!gj(gf>026_G4euSN7LnJ%fAF(gRW)Emnt z!6XUuxtZ3Ba0Cv9N{fc2UY@=eX%g0SFm04kk}_Fg5E@^N*ZZ(AmNq_?-_(xY`dMom`<}twQbdXV1we4TZJ8zm@Up!~kzP3T?5{U>W@B z*P$9$v+CWne|LJ&Y=^1BizLz6{+JNb>7!0hb!iPU*-Aq-^ym&>-^j8H4^_5Yruqt( z1TGn5HCq#Au+BYfU^ZcWZbikM3J2E{DHq@luqH=6)L$J%zBHSUD-^A7PRat(nF67s z-xWVvz5p+?`2MIgrsTb(HHY@oYJ?-s2$h;R7SZ>QuONo9%|@0oJGW!-#^8nK7vsJx zalP%i@E&J5AS=+3hy%1a@|YWf3)>S(qH`aY@|g^xZpb~^K9 z3SQ>Y^22%A_^K(yaldx0>F&a{Zm*gSKkdKqoYqZ-2FaNH79ghaDLLoN$dm4EmXO zyi7H|v0!Bey27z&tv^ZXs@P=oPpaNmQS#806j*UOQ(9ti+G{iV0E%31DY{oJ6`%)Z zN+wcDvMvIRS3xG6c2GdkL~L@~;46UqpR13W!^&HgOpfG1eD&=Z=amE&>(VVa(JJ7) z;0IInxMv#LpGU?g2irRQ zZ9kjzn_4amOlr|a9z<2+$y$i{J7U4Z-Y#=opZqkZ-hnFn6dWOQ(``s;(GgdpQs5F$ zd1eb}%TD}HHaryXI;*C#`C6y`w+#1BbbU(8h_qSf{;s`38_}Ueoo;E?MU*MsXXHST z?)T-%d%3|4ABMfT3AFYgGT( zx?QH3H9yoK!BepBALX<(yn4K&EWY!hpgx-WxqVSSy$As0k>;b-x{;H|l8fw4W{Md^kIZT_Tu7x8u$C`M&W>}te&I6bi zotQJIO_=;Kg`J)qGTT+d=zZ@kyLI3*cxx9!P91&!1=wA~d&_xTiFpFkJaZXSGGy=y z%)5Gy!ik==>*6fs`kbRsZ2j6!T;ummJ{a})P*JS(-^$aI*Tj2hxu<|>k1jx2tTBSg zjn8J=mfuvHCDahkYI*4J(DD%9Pqo2&woXLmAo8+L-~@#O&?Tf5{9}N#5r7J7r#L|# zyQ;l3OgmM>v#YlZhiiYGzeH^dN={+-R#;$}UH5*jA99<2jMSUg)+#U?#D~Y(JQ5dR z*S&3e?LdGY6!$WToF`~8v7$30#SsNi;X8>4a~$P2eD_lW>%201c?`|=h+LC0{B3>9 zZ4I(SGwzJ+Es(@VsKYn8Ph{EA;4Da%9Y_niVRun_E%hSwx+?}P>tp85E5b+;gM*D+ zZ#VrGe*vY!3<~3m>v*3o_?+)QBq?UlZ$?7ex*h#?`K;O*8rbEEx@CrK|Jey5(1y4L zS~*L%eCtEm9eVyx&%AT;o+Wm0rzK?(4(bC~NF*KP!5fk>?;g4I1&Z$1yOGP4rS^el z3Ns8lbTLw6@0~%sH_qEtb;#Q))LhSp|Lv^&QnObHIgbR;$NdII9I$=-Y_o#C?oLPK zcJ7}PWY~W{t1H)XCAJSiG?hfIt9*M&HC-o#CF5DfuLsZ;RSBegsnVTD!mh?q_}9g} zJ#9Pw?-S~P*OB%=AAU+G=U({0Wb86yN|%&IA4QfA8qlMqo~9N_I$8g%7HN*&=$<@U z>gc+r!J1K87#v;F?<5IU0m!hv{U}n`G1OZCqE}j7J#{1Xm9ZHcq!!r(y!39<;%}8W zYH2bs;NL9&}xP@GN@P4G!7h_0Rl#q?{2HI&P90b3{+TC zo~ZSKiefR$hwqH67fN3`ONzdd0VWjdXI-BFxc42gTZ=F|_x*7`7$fY9>VZO3#WXE) z++R;Ordc~f?91a~q;jAYXH+K|?x{S5zb4o3f{5jc3Ga4p2`a4ms9z_4@px7Y7uY>mQB9M`RLCV}=k<9kYCG!|uW! zcb;x~9qJivI)MklQz9X@gl{SRNF5u@oNg^nOpd3eQXjz=0UuA4gff0Olid+?1_>z&=p3UIpb*9 zo=8C~Vl@W;QQBmDQy?|ReHpOUz?Ej6(1phb$7hvS*;07Nw1|hR!$=!eu3HvPar|S| z|3K?GOfwT}pxdwPBdLHIktIOW%tIom!aq5({!Mu8OXLSD*aq=*g=3e7pRpoah1^&c zXVc#`_#g40{)RYIauj|4Z-&y#xCGd|!NHUx>tDH=^XPt66#+lNI^yWA z_dI3#znc zhX~lusCQR<)|ZfTZDjkY{&@1p{24IOGMJugi<-KeS*Tw?Puq`#gCCVjP1%5Yr-OF& zYBe`%J1;x4Za0uTdwF*ZeTw>HDwQ$gbr9}P^^Yfj?{KTdMcDiFSH*SM9@&|dA(3I$ zTrbKjuSN?dff1bZIQIlzi8vH0iaTSN{bYsr8nb)loU;#tQN6iEB?d1L=u#{rCvq{8 zd>)8;wtd`>=6HI-US)>&1@m&81kg0*;MHGHjf-_3>nx@N{33RUVlnc^i&F<84?N9( zWOZv!R*aqZoxSMCuW5QY2Su3&Bsr@SSioLIkL2EaTY1B=z}|`%po5*9jUx4QMekc|yVe{ScwCEZGd{5kt>8n0BP2qkr-qqNe1&vDw-*0`i5__}xC-=pBiH2t~S5QPYe7eR^;ydjbt9_+s-g*WEp zNDrs?dNQ&Q^xFU!^4h$p)kS8GAPrPD>2rW?2z)y~9Z`tblHTcUa=dJ2Wsz=r9E18P zUZJ+!u&Ih57edTT(_eMo9i7lSs2teFfATr*8)mJTB5UF&Wl8U!RmW4_T-vB>_~#~< zVu8H2uoM9Pu<_*Fzyaf6X7gQlTUF$5Q)Kv~V~9jGONnkNlD~HQo#T`sLRZUk_05a)xeOpA`ckHWa}qdm+^vN zCQ^uaa990Sf;qKw+Jg3YUR7_-;rNF;_?7+DQ8ZvsQ~N}&x_xa8T5esBSD?#6aMTe0pnV%%U+E!!@Oqw;OScykO^u{aE$y+8Ul>hGpyy8ICF zm5ujMI^bi2z%tu-8&zXwuU>t3+W5K4bldep)O;}dC41~Pwr{Z7M3MGaS>eu{m%(kc z@I1Kbbwk!WEE1X&{$K5){bMmodERw)L0WXmfXJ=#q~O+6FH?CREv)OK*$%akGC?ng z6?%MN`|FulBUwVK*1NlaCA+#;aX6sxa!)Vt?DyMZtwU{)CA1xP#rHV|A2CRR@dy$YRBVcreIziFZmR}F6U3jNaOjfdr}PY zbTpJ$Gjgm7)?81VtzRl)lj^auI3afl36k3S>;pP6b58-s{iLM{1Qd1FE8kBuDr)Y~ zi0$tN`~Um6?R}%2_C2iBq@Y&UQIgEwtpm>2ih$sG+o9X_-U(7i2Dkg z%SaEmq_sQr4o1FzK0;=w_;#q%a=0tCRC1?n(@{(t-FT6w!ta~fz_1nQWoZtbQ@u`Y! zUQBfL!JckLZ(f8IrZ(N(mi>x(*^{)pMwQ0zrynAC@OP0UvTEhSopk#DNdBn+UtODG zULOz2LPzqQeK&8YJW?H@k;jz&yx*_}M-mb`rWO>P_T{cohzEvc?iB3j{)VC1#7kNl z%@Jy_JpCJ?qd^60CAdKA;BVS9*Hw=Cw7zd7z}49uaLv7jO&3x}IxUL_*y< z|Hfc2YD+$MDn62KS_W(1G8WeT`$$MxrTRk?n8p(b$z3VcbTQU}goaq-0+uC%FVk); znOeUB3a!SM?GSk-ff^|nJ>g3^N75>;>|;LH`I-WrZWYA(#_^N$1A46xBud|DtgBl- zCenZXUo!`{U6cE{fw9|;%_TD~2UJ9Z>gSE-Bv6W(_oiD17nNleU~z8pFa+~ExGnmU zHbCewhNmYy^grOFzw)wDj86FF-a*eVR0SkaqGH2uU!?yw34Cp1UpF4J`Tn+=M=BV7 z44EMv&~=|&ax$ob={u7!+U9=c6_7D}7*>+q3Md(De-&{|TujWCQi$OfzLZ~EfEZz9L_NNilUZCcFQ`#!zeg0w6c1K&JpchM}CB}#^v-`>#p94i;n(` z*WH>R;+==)I}Dcu#pa9CmnZs&vMkJqf$SwIF7LOU@DM}8Z+&a}hrpPztFN=dSOZ7w zG5G-OZ4aP@tk-8mv^c-JOBIhv6z%mnKSA2M;^T>oAy7EswS#Sv!;#j2^};$Q=~bHD zKj|YWk&ffySBZJ?aia%gI9OaE8SVCLdeQFAqf*7pCNrVc!aPD}ApJbk{IWSTzj)$6 zrEc!J>dkRUs*8V-{3!3A-UrIFV?g*Z=$`wFiXHy)FZCZ_>vz_FsqJ!$iM*ccdvL&^ zXyx(1DG8IEv$h1+B&tgEW2OZ)H0+z>1$JWacyyXPe0#)PCegVA-^kC6x~TMc#alig zZv@aJ(RD2Bvx%$g$Kq&+k8Z8=J3Nx#?6qmxe{wulA~oIJ4gARNRPV3YLlD)CS=j}v z1J`^yWtv_f`&1N0jDVD-3G4Yi%wceT%roIqZA>rk7;n}}<{Bb#AIhT+HvAaUmM_yX zJ{~?Q&9&%m+-lteL#Z=zf9=WhOhFt@Y=7)BEM*)^?8@Q0MSm)42k3Wg&fvv*pc$lmj@(pB(bMt4d71en7?sbiXZ%5ke&!B(r9X4?}@ z57#CE(1ly##xLY{Z)5Ke1}^Y!ud|h&e^Td#rXwC(RI&=C61$oFi>0J9q6rxwN3iPau! z7-jfEa2{1BJHF-+c5L1eCt2NC`msNyDWL%jclqRw_kAaT<+X@x+%49+;h~~oEqaHs@ z7u}K-g72hMR~v^mU7m0_7oY_;oYLkO3m{Q;Jj`!E(9t3DnOk;Cc50+`9p>9W7I(Gh zs0$P)&BEmhZ0RvtqT(Uq>%@{gbpJN94%_->J|9)Aeqx}?U%{R@`j4mO=x^wngg_jX z@sTQFNe|E3{wxxS0WE#)&Q2gUXUkSPfX;korAj7maBqK&0%*Eg+f+6jd8$|;AS@zTb|W0~vG!FzZ! zO2?PvnCtqQ+Y|lARt%I#BrDkFP;>vF_ns~d%IeARdPiRRDwv>r-yoEDWUxw}5aYg& z5lKrI#JvRXnX#HtQ4wtPChWWf!uEWY!Th-1Oo>g(U&_jv2<4m{%;GYKk5wtVlO{`1FR(h0ra8acR*03`B_a+j(errN!UQ$B5)^vMg_esMxC>@)wHO$S4K}ebFw0 zf7|?uRdij>9)0>)zH6oSeCPi0;pX|Q20}D`c>Sw5;Zw+hw14Py3>^AU!Nkoi$LYh@J%WMiL$#NiY?{$y zsb#PqTPTL7j#fClx<7s##;yO^U5129Y}5xZ49`-IVm3C`L_eA5!2v&NL*}GN8%gu% zWuQlyZcMV03xzh5R;}dRb+f)XJZgV>;2w}`&RT1X{>@=a6lu{)QT?9{w^+a-flLDC z>ATo7keMH@NBj|+Emqj+8FK8ojmQX2w3Z~_zL|8I9IFP|m*;JECl}nimcWZVTJ$nj zkK&1hM-SvFDRB920A+j;m1{v(|5~gTFmRRlAcocAInA5VFFXb6*NeR*&6c*8hClsR zCdDj{_&2(*um0uc?!Y+JCGf!E+=QlplDlsKW1)MLy>0%1!Pv2=?;+Q=KO!aSx86NC zMvM+uOjnItgGkS}ME4G<&gOYyCeqi{+;ma~kJ#By{1il)(B4A_n~-}2_9~w65omrT zW%oCS-ixQ{UkS)-eDFI*z`b9mGBX6@-)-}pKN-uSZrwtUIGF`#Wd^<2JTmCHRc-IY zIe75~qafKV7mEk}IYZ1)Ia`dn4Ws$iFF0V}x_#AV_B#Ws-B-AOGSM$ZEvi?AS-Ji1 z%jk!uFnN9Ng=#sYO>+(SOR+T&+oA@RBO&Yx#Yn?Tb(PV}ZQ&n`PO4?)|!9fI#WdRxM1stDFapg?z4qS6@dR?t147a351VlAvGRr@%?9p0gMj}i z*VIeCzQl06eanXZa}+k~LgCi2z=2E?%B~DeE%~NOYqq2myG^xww|LUA=DZXH0%8cr zpf07E*1D~mDhq8Lq4Y1~9@0NF%ZOpQ)9|%77hiWg{A<+hrt|h;MtEGciIKdf{>HD< z!N4f^{Dec$W}ZK_EZ#k30tok(pH;FXHbB{l2hkgYjgj~d68Rz(EA;KA{k(He;gvcm zc)X#vo^ZvEfVjXS>_ws98{YYMs_@GcX+-fUwK0Q0gJq7Jye_L)@%h0$6rZ+ZiR$3# zmQ&A#Ltbl>=e$}uuZ4=HT&Mk(i0hZUON3h&E4Z8kk6n|rK{*1yb>10UUQ(zfQO_b2 zVfXSKwy17GC7=>2Y0gM1K#jcD*2HzE4J*NQ@zYPU4CkIeb7+UgGhnhBIC77w(PM|5 z#chTnfwk4#fm#g}x)aCXx#ee*!itYLE zo@21sr0`hYf&N--pPkSj^19=_v#AN$_a>oGxs(6O#|sSsbg`c78!&$Em!)0gxzD|1 zyx0>>IiHurPTWdE>aMwRlFTo< zf+IMuzEO@8Dc0ntvqZ?r;L^0ZWR#l)csUbzu$Op=vz>Rh`MV^R^CAm1FyE>+!rosg zE@LNLpB<{!tpE9`E9F7SAEEC$8vkQ3_Tp|rwbd&fGlm{OHV1E@L~(B}m)_WrEBQ59 zdZ-eX_*S@aS=o$7j*acRo+`&5t?&LJG%P^*O}9nkvREZn+D- z%JRWn{S4ncajMAAF9X_#uxuF5gkOg&5p0JkvQ3#r8HC*Xon|Uk)5@T1SwB;--)XXe zT%3{T3-)k0>rqx3R%?L0kk2JVf7JF_)-FmZ6b)AujNe0``f`Q|5sDkNuC~5SQ*%>! z5&b^3o34^jmGEZ&l(v$pibrNawFKYB{jBA>cEH9m4*M{M$NL7|sxc3LLCLezqq;=f zB!l@nHcgglxhdLrs5iFbar<$jA8T`W#_h(49d~UgI-d~Rm8me({$ejs%lBY&x}l?e zA==1nv)Y~MpOaVx{4-x=h}~%dZ{)O^=h01b=~qY3X8KUrGN?UHdFm+kbliTEF4Z+Z z{^TX8ocT#p>ZlxrV-HBx)GMP#HpqvX)4#tBy%Jn%1wl7%4>-^rI}RfUe}WIC0wbn( zn$j26a_psNU4d@^TEJ=q-+S(dz}W zT)Q9(#Pgo3?=Zi)Cu&d!H%?eUC<}3`XNhUP9hobN0_A@)lok-l0os|V-bt*cs*L`y2!!^sZyWTpL8ANz^}?r~#UNsUU>$J)we&&&iyh3R5}Yp`9B z+H)6C;$3I1?gka{(JJBY zp>H749=m;v?*r5b&Rw=rqbjax4I6XVi}F$fZYq8UrSRAFq|~yXzg2eTzE26wvxD!( zwSCRjqyFB0v6*xk_v7xZhX&htZdV@fHxx;6*24##ACcL5L3?-@nnQqE&Lrq+C8ADex;0^CRoh-b>D60Ymzb0bl`58zu(%M@He>d@>jt7g>3e{dx{ZV z5@uXpXU>ru~VqTfHXIqD82B-l1e64v>pV$P6_faRsf`$4tpcEwr!cH}Q1Jt;- z9d#SQ*M+IsL*@^?!Cu4;G&aBPOELBxc8+3GPGsvXW)tth$+_dE>7P_CET*=M>|#98 z8rZ&dn3m<+0C^MP_G{(tXtC)9^yYBL%BHMVw&IR%>{saJXIh}qF6Sy+@pIonq+A>2*-%bYw)A|R<+W`oB_ zX<>GGqVL9=*p{qEu38sJ+M63t*8Pcm_H}dkCuECirl>KeD4U0ENi4+7Mhr<;k=b_VeDlY^386I}H5G^z_NIX|&ji9SvgFR4hV)$xUJP;(9L{>FWN7#C!77t%SSx zMXGDa$LMOPvlZ$WEd0>=5|)6oUC|~S7&@#_hBOD0&kJok4kez@PkiFMa`l=E>Bc0f z2t(Q!T;4&)n3eyC)r>)-CV+YBCJKRja^Qk$tsI-hmLsVvvSFh)c_scrI7E4Id4%`I zYE`LeV@w9_H;czoia{;TE(b)NV5DR3b5)_OZT4?sQcL1zwp6!3mUx z*0l#xAjja?;9I_xxP`kDlz`o?{FX@+EETYoZ+ra$sbhqGV&-(tLaA^WwIXYlPkH2g zP4}q|-{fTjT#fxA zZ`k)H_N-Y+-l=P}=-7QIlzwNe`4<>1o}@K=(v@7U5yXmh{+)91@_L~eXnj+m$Gr0z zx$R5g#tCLo@(J?bWKxp3z0z;3DU%~dZOc!y^0TQe4`xTGSysc3Q+gaJg7=~( zX^$Y}3;IU~RP)=R;!$L}wYrNzEQP>=YZ?lD_p+FAHDw86f7-I0#)PkH6x$$~kffFJ zpf8#@FOsf@)ooWb878CI@2r6{cuIdqw&ae)#~68ti)XPqa_;B^KboaC?(cc1tMsNz zc)v29c)bHB?-OUzxbhEhTb&MN_y8nn8vg6m(^Jc(!Yd$qX$Z2WMYvbFX3N5bzigfe z9^(t5%r>pSl0Lo~i2ahNi~cKK@<11lG%!(}P4DSV&82x`-PnD`awG^^d%)kkpK5iRg~XSgpJ zo@*U7hAWk>kvSIW)u{A=YOuZMW5B}uQz@*iQoC#Y@yKiNuT$^BNycegG9H+F{M`yG zoj@-_q~N0yz>V;SwW}KSVtImlIPK^uOh;hp^wwr^zVS}cqzZ1cw#nDF*Bo@!uVCLT zu3FRUkMKNV&VM#LXVkAMkB-&vt*2~Eq~XfX2-$Cj!ejU;Kv%C>0t4|t2an; zySUq2IolBu{9maz-4Z&K&UMZU84?ZYfqcOA&!*`MF-hO^1g2A_$o9j|W6$`ZN^;yO zZU=5xqh=UvhS}`4KUJl{)AI?AT-cHViNf1JLvbG!LH22($5Hck*u)NlSC!g#9EEt9 z|C4e*CCMDJY<1?vM1pw?kVF}QKi)T+6{`R#moU3B>%JFwA%kfV zeK8;SYAeMKJh!oBK(-j(O^8ccSpkT*OQU2|1+_PcsG6gMjwAe$fi8IXs!wjbl%Rbv z3~L((0uOJbsIeoFUx89xiIS4nJeO-x(qi$L2cH_8bm6;6KLtjL#WDr5`5Rz`Va=C) z=6~NaGVI7R3|rUAhsRe_Wn56>njT+^p+Ze-pa-;Q3Sho2*HXYzTRh8U{Y|TrNq&KJg5NeBsOAlk3*FZHK$XShSH6mSmrPsTza(P%hp`N z3oGnlzk#D(i55*d>yFP&I#oVtySe1hlPCprKjB##fJXd78bE#no|#8Y5MTA(AMOb5 zbkrASyP+L$D`Rj;oPJh1z}X>m+v@lBnRIREu~BNg&4_c$zbl3IWINggoMLu)_l$Bg zHvLlCTKf?=DX_d5$=mOT{b)^V_`wAEFw5CTo(pWM~#o8r1Aq3NX> zVF5PTPF{cxOCuG2;lF_5_>tQ(iybt6oUsMX;&a6Mfwsx*6ZCf*!?!_}*5=pN5tE1$ zVZ31|{<(FY%=((>k4^K!WtXmsiV!6CrsgD0ytB%Q&xbAfy&y!yQ`qcB95)>O-XZql z=U?Lu=Xfm!E$}^*ghP^h#Q>ASQ|oEN{YqyuT3bN`;}rCdm}=_J zPpfY>l^3PM+Kd2v-H!%=5k0Uq4JD?AotsW-#q6x&3_xmwrJV;D^Bz$ML=}@i(HfZX zHo)JZ)Ty-oU(sFZgm*KWW-Vss7=@L&@6XU~v~KXgS67trhlThgt)hnv7I7(Ds>BE- zxpRWAt~afCFdN#wb$8qz%^Dw(W!-SAx_zo(O7WAiuW^)(Qr8d&r*^GB)`HsOzZ_$V z*XzG~%O1wd(Ki9WoAS_Nd6S25>&Wpz+##HY&8NY98y)q8{)mFrt(<)1+sgZzE2V}@ zdq=OgXS-A^+hUyd1(KYH=byUES2QQ8?rL#8?${|8*qw0Z`I-6o=pTG| z1zQ2Uq=B%9RcksT&Vi&zYom1vq7y42>kpjP)Jz?d?HDnW4uU~Ve%piZcEhVmrk8d| z`?pen>@+~&dU17;T#5m~{Kzi$qhwBJ$32B`v2F)E?;5q!@jS-5um7@NA*4u$*;7`| z#o7bvlooGmu^D|r*&NC@buYV#k>83L&Ad|UTdwXX_!E}j#dE;A;q{a>Xbe+os`4)&#%0bQ{PFTS#19HZ#gyc zzBdYbh1h70KSC9728}T~*Ih@GVNE0nxyvn`_tp~m=SqXAT{>wxJo&mI%9b=Nb7&B5 z7}!RuSWUypjRd?to;bQ4JMU8eR?w@`Au|1%rI9T@l$*5_pWN89xVut`1~J4DJ?@~w zuX^%cmcmy~3$jB-sBJ21PhPb@E{wA5En~IKFn=z^_@N@i0@OaQf4> zVy^h{Hn?8?*{3`MP2?D5>-Q2Bx3sn27GtpTP}A9$Mf0NUqHwVgh%|W2S?!SpZ6DK1 zs-86@)8`Dz2L;ybq)Lq4%{w=NZH6@Wzt!47L9Y1`{Pr9DY8{lZN$Z;I{$1mwo#gB9MV_4urc$R z7j}M375?L4YYH&iB16Npdtb_Z%|~m$p)Mc9(E-c-Z3)l$#xLtk9owNtGe}z5Fw5&h z*Ae}n(L+6tC{7#QienYL?7iA%`~0ygQUgFsXm17SsAqD;C%inwHjGdiG152z(bf;R z0VEjq55(_x7S7zcK~_Htw^{NihA}+i_k0B|n`38X*j5yrha#MG7RP7_3R5pmsT%{u zR0mrv@8u@t1YTHu0j!&FK$wrQ)>cYG#Y^AWSI%VK@s8_NPX#@)W299GGL&V3|G9bA z0);1s^f`|yQK;F-z87_-(6%g6umRY1S!-mUaovs;YWQ=FQf%eUr=J@-i=4mMwLeBT zzbD{N;N%dM4c1~x=J&Dp#E%n@&D|3w?#s1&$+!dFDinH*#QIX-K&4TG$aYrKbGlAA z{fwW-cot_$nlzqw<|R`459G~$wW-o!F0K~!aWd-pXQd}FoKIDTU3*vQpNOtB#3E7j z1kgJHeMR<%AAPW@+PZ1g)r!%4a?~J(Si+tj~aqapbl* zkL~2Vf*tXVorjw@dK9$0M2^{ec{-_)Z1bDnt8{|gid&M{e?KIMGf!5Nr|O4@?vTez zM3m2P;Fe-;mY1iXdOy?x=4_3Bj$YP~aSdrh`YgTV%!$K7RW?8!0<7Yy%NAT zAe;^HbfJd!6RX2Vp5XWw0I=h<A0*At{_49`P=!(3m!X zyS|FF8UG@9HbeXT96F-r-%Z%&>Bo*5^Z#zxtGPEwY;F0gI_o(iym36lRFFgoI#f9C z{?=ebVuFoxJXsn_E>!=d^bYeOmqco^Fd1p_iZIPN#&I+keN%QEds5qc8UFz38r!GS zJ05P_=m&9-So1DrCH zOiD?Uk+$HHn#58qJUs65>o$1h4$*tKcrSbW z<_Jh7uMS-6=--8Ib~!54hYwMDM(;XZZIo%cH=v9<3e@m+(w={61<7}@tS$-(=3Z5c zUkLV98EAJ?qwfotl|t<+>Fq>$xfW$Z-6Mm_np^e+xug%Y0UC9@E;w)n5aep~CloBpK`z^d}RZiYD-*maui)?QY?H#kX4n-y7^Vta>uvqZQY>kL>8m zzp81*spf?xiRP?FWTfX}KXQMZ_yF#itDVmTfMTV576&rFqj?GYVT=y1soo~sJ?c=~ zhmcA0rEtJKCc#5z2I#E0x@OsbcY41gi0=D0$}e6@H3~$5wvMOAbXIGD0<=tasg{Rr zsVW4irMG|TnioZ#BJ$L7GY2%Qfn9cinPFK~a6_L=svteY)!gpR1)ra-oONA~?xkb_ z11Yo+5JTLTRtn~c5%U|5W6v<-baH#Rmk~YKex}!o;y96$YIZn%P~$ z``D3^mO{G-e-5H^lsdxs!-X2(=BD<8J_?7!hpG#2;il)|2I8CWZ;B5b^74Hjd(2Az z;fgNf`{*T$DF=Rpp0%YT1D}K!Rah_&Y{}Gby8}VEX=I2E6To*r23$%40z1%l7Tmcz zZ|s2{zM8QU8a;OiD3ly6tl0nC4dwj7ag~CEt@Rg*q<5CE`gSL^=W#PAKuG&|dTci? z`p0-6Wz7#14m}zMTxtPsO-lzAEh_M6OxJi3H;#lpBl^#Ti5&S1qS2o8^4GR57wf6b`2<rF2G{k(r zsv#-fWb#-a@aav*JCsPXkC2lfEw=HG3%?gfH~t&HrD#SKxeUnb+!6F3Azd?9OPB_p zgaE0I6R)cErcIQ&x#GexMoR*%=0`=6tk6|i_+_FR4{r9Qm(LylhQhyKL|jK`Ja8|;Y1P4~+Y1QZ3meePM`v@MwQiQ?iR?osjW?^^Tx$^Ze z+`f#2BUf zy#KLwG~{7RxG+y;`f=vSvFrFzNqw9>|I=K5wGsH^?emfWYrvoI@Yc5Eq&Ht$=iXn1 z0G+TM5%rswT=c*13$W2IXY3AA>L_SCa@5PSFL*AX=fN+4RbA3Q{N*=$oI40kg|cu} zeS4qSz3G45O(~FRX_X;@)H5gR9@m9;0py9%g~F2X-+ zTH=;j5j!NT6vl9Ob*8{je;j0xRi>UuN?5g{qDrr{!0{vT zr*2TYjT3rhE}WGGi$nj+D7EfSCCVZl_c2e$3$DP|FE-$h3+)??5cE=>Y{n}k$|&bu zw{9nMv+?ElKWfnWQU2ik@+mD~K#Htr{4m{D)B&s(m3{u%Vi#m@6Y@`1! zlJ*y=GZ$c8S1q^cFAz3MU%$Kalp$JhTnz34G08k~!+`yA!hDzW=3mp<2@`cv+7}@s zkK=f6L-{Y4^Q!pLV>3j8;Iqoe+WX5=+x(XzmRt^LpvC0AYoF>b<@w=DK#VBW#83pl zFrCNl>KbQ9D?VRa&+bXT(_$h~&XHdqzUz>2zv?P7{)aRzy}wWr{w&)`9?=Q5Nh&7; z8a2&>I>Z40ZNb7-4WAxsM2W)veLPE$@Iph?c(?Ai!Ky?@jhG+wRdrJNG42J_=jWT` z4%J7XF>PLBg;n2JP9Dh9H>}jFhhie*1*=s9&HMW3Umhz|!&A*17q=VqwKIK}K; zi+(s`1SskYXE9z?9~P!P&#V6NHk@T5XuXZZWg2*)^=OX39&XgU9Yb{(IbbXt9=?qj zHw9 z)gwy?1|S>xYSPeqlhJng%=!A$9NFY)nF44oaffSQ>UMpjnX^~0&H**1;-p3UPlu-l zKkf_v?B`D(SZqt)|HrD&`oLCQZm5TYM=vo}+>O{`0YkUg#BH0RZB8Bxr%e|RW{Ls# z7v4`0t%z*VjasfVNRXPG@(6+DdA^0Fo1=U_xzV%l=(EN@wpgdrWsm;$@SWdP?T>4W zJY$)_-o2i?Tbf3GTQ;iLb3V-JfZ@>)}~PlG?zLHfbtLI%z&bzpytjmDHpquTTByN*f=wmU8*VSa3*@XsRV{raj0?hw5uNrLv)W6taKs~5bXusE*=%%_h*Yt6>z z7vcDOdQ#Q?b=HD3esUwRk`sTTH+2FMG9Ss`v4e*Au-2_O1t?zJ&55p!-P)Yn{mR&% z-v*pDB!<{C|BEoQSbB>*SN>V2A5i`8JO@A!?jYxu)LQgs6FF0( z`k0CNYyH^kex?x)t79L=QHChrsVrC%eS0@;#q>8XjGtE*I=hE*<#PYkjm;lPpAjmyGyVtvr7JWIZ@IR zK^zm%*D<-ocYHx~-Aq$q8TAx0k;GO<1cqkk6Pp(zG;JTP-Mpij4+#*&w@KV#b$n?h zGr6ZX;OYX6KHaUe_`j{(wk-UOEMjk;@c^v^J4%b3zhI8nO*?v z`pfFGtlO&-Bx@eLaWDbb(g$!RKfFJgx^l~hCa{;n{joPOt_kITdOph_?%(b!zok5O zRo;~=MY=j>c9=)PbI;HgBdZ}snqk1$Uq|MH1A7-_4CaLZp)5ZM+hCL@kGa51s{nFh zlIqt*zfCZ``I=Qdozj0DHYfon2Jcsb=0v$5Vp(Y>z!9MgSGxbGJ_3Ucj~bwsuzJ!` zp37mE%D=mM4hBAEe6ahf6sj#mikB}x;CjZhCQ@`CDNGdpl(pc#5&FALnH!Micc056 zqv|q3<%DBGmMo%kM(-ic9Em-^{-gt98MlZgg(jT9<3iG{t)Yx1^ST_w5FP{k)kjwv z(tipO@J+~%fnTUZqhv+~*Dljb^?SSj_w4?s$?za{-wgb(Cyl##D2J!C(@yeUyjG1V&wR=88Qfd1BG#MK{ZH_bz zC$3F8vm8=H=XD4mFKvL$5;;LUkg{RF9TL4^f|4Dx&kL=LG_?rREHjZJ1pljK{O78N zM1+aYEUSdm+w@J>uKfe!y}HrE-RW^)PJ5oyc~yD8x9gj- z@FHak6JM#{>7`C*WjgMZZvW5N*yNcP@Rs72!c3zg_=EW4!A9*KWDFpK3W_@u?cnCz z%jnzhEnX6pgbr5a`*7{F7qBt`m$!f4!O8IpsEaukHe6{W_Y@~*<>K5hs;*_y?UhbQ zoZ#G6)N|)L7TC1PXtgkSLFVksdD&<0WZ7wsl(e(dLLqclX3A8PLoJ+!?n^qU>px#*W3C2c(eM!N%{hATtpttTtP zOf32Ns9$ll{q(R=n` zV?^uinFQ{8JZn+IU0hw2`9epFtOM2C&*< zZuuyUaGCZm3B^mP4zLN^{-y6_2oTVh)zxCA-j4w&XXeL@;$t=YNY)EM_~la$Oiu*QzG1!0JP-%@^q+)j!`2UU2KKXy;TfGJz=*688Rq_sSZ5EXqs=9lbxuZzi% z3t7!Fl+H2kE+s&G36@#%fkT)>8IyFT>$Z|(V2?j*w`if8V5*!kdFY|9&ZaKD;AF!2 zI^QoS6Xf69Q3WO|c@ycFDbkgQBRcQ=!0~YVS|vLEbunG{nxIqvyg(Pe$x4Mc6b&z8 zd^(RA`BjpD~T(d97z$-I1#;N9!Dq*S+6H$Bw^ ziK^8huB2_0>RN8a-UAj4{3tmJMQ;iwGwTM|fZMUHPZf=UuniB26ZL?FPk%~}+}ly( z9QQbV?;j4S6bS}}Wn#Q6l6rp92-Wt|{IGqBMNhcPK!shdlbp-3Eu=yX&&e{n2Q;MU&3*KD-kiWC1!sEkd_jXwDyaqxC~HF(xy_^d^PWW~Giy`1)bsFw zViKNK|707|pLqq%f7d5p2RLL@%3FP`$GDCdoZ?Op1*8~JrzUB)SZK5=pPn)+k7hNy z9JAkK!BL^PQtbQ1qRUz1m)*yW6%C>tH^Y{(_`g=-`J)?kb#d$ zzB8t*?c^#guTJOIiPH_q(jNY~UjSg&dHTHSBQxV)v*{boc;0)870B;TZVWEANx20YPnlD6mc~zbJ&)@YMm4SV8T& zqZXYMdG6KK-0jq!&l;?I5vYc;nFSc$(;3krvc128i|Ie2)1z#P{5OKxVXdI~mjAKW z7^(I%I*@mEWz3~_5*uU9Tq}j4$eQAjLMo{$Hga!{8951wI2MwN;HFBR^LG6x>YL*1 zWqPb)^|*=V$zRT!7V>H{6Hc*}p7Eg}`I+Tgui_NTaRx6*Sb0}kNtRmPR-AOKWbw!t zRO=vB09RiiKj>c!dj3oKpG}^I8Yfle$@EM*&WAdaJ&)%Tu93)edw!GM2& z1qPPgaDy1&Cb=_LcD_qF0oF{dmJU??K2a6yb>r%wYrf^EI+o)ax+ zO_j+$ilm2hsNc86gQ&e-UXy+A&2Q&f`c7pYnzv`Cn?l1wGPY>@OSQ{F+c<(D$_JVA zl8h1dvQh`PeDS0M#rOw9UsnD57}H(&y?y0|ZO53aV>|a4mh~%+QrIK+wK>q|xPUoQ zsxiyS4h`#JOF){5lnrcrH2p4);Z=fng*bMriV7c^AgtZ2HPx@53^?iskWy8Zg4DKzm;>83A!q)Vf3 zo2#>}=F*VKgjz}wD{hPJBaM$JW0>JxGZ%*5#0S1rYII9A-)#J~_C{x<2!sJlSDZM^ zjyrL}j{y&nV|>@6Cv&b(g^|Ko#qYTfbqhxE*1U_L64mvJ3&aRPtm`${xHb8G<9ld+ zoycQ0e7x_x6%oy;7*H=^{bFQ7WY>y(gsXQu%sbnLmd4q)r@*@d&TX8^u!M^J`gK~p zdQ8D3OGs^+6-L644^_)8Wn_6zy$HV6FbDr-UJ1P*?&Bw7W_Oi@7-thbSh+6SM)C8O zo2Sqa@nkmsiMbfjl-YVq5zaCK=fE;ftU1)1wkv7~>06h1|JLh1lIcgTdZDc#AF+ex z7dC~}kz1wS{b|AHMr`2r#L6^YNro7tA8{Teq;7(K*%1Yv?$!O_WC zTPCS+jI?n>>GZ*jAU0%BeOgx=$dnFaH)FNe%JtDw2cAgh2^=yxdGI&oM|FnmojH*K5oOK>jc*TcT!6K{@NjKsU~vjqtqI?W#}IFv}4&a1Gq z{UIh!%E-6T$7A;)m08)lfd*Qd5BUj;(4j{w^qmy-IX(Ip`#m`^Z-5>% zwit;RlUFL@9jyM(_V4>NE7zjA>;y&evG@kLHW`Q}P4Ib7!`RHPM}3J1dfCnf6_2gr zy_i3k!>@UrmH9=YR|V)xIww(~d3yDcQJXHABBDo&(NyaYOmNsaHV<5xg({oN*MtO`j$EV|dmEXPU^>C@88#HfJn^wI7&guRzG1*?g4VWSX&<(v z=$r7p!<>2+^F+L;^Q~Yz_Sw*9QY6m3z56yViq{}&V~NU}@j%pUw+3TTc^Y_D@1t9v z!Ujwd)k3U(e8}`$NZ0pYpHYok)(w^l;wjx>h8G>hp8d}g@h!ZEVmjZ9&~%T7^Z8M! zUO>+FL5J^N^aBR%dl^GE=~z^zENGv#W~z1wZ&*`nFg}S8L(V9NbERm_ro!=?in;op zmLn$^wl_gq%<&sHcXIAD7}*$##a|u~@-pFpA7J8tJS3zB-6}?(e@hls#~-4ME8Ul; z>BGOMCk0tl91dn|7X}@-qc&V6cBwgcR%+R;Kgkrz>1?XbFK#Y$Qk8~yw9rV?SB2_s zz066o@(N@HdSAe+N_#zejo?{{Ti}Jj)sHKjb=i!)fzGq7hnI$b2(zB+z#JNgsz@zOKW!gmj!6!5P3A~S-wQ8KxCWn~z*@5dOdC;m)o~>$m%dL?osx&b z?hU5l(|>T9N69b#!lgfIW$8#n#5#OPgCC6Jt&`b;}baGzHW zT#wJb_aR_b(ieIZk6h>_ID)#$cul*3&RUvf{ApRJ*}@UP4xur?YkCHd;~!+XV^}$W zTcDse!cTh5i#C1aDg~{#q7c^CY^VnUFs&U&G(deSAXSoTF;!(*2F&O;!F0qxqpo@Q zxI7>?`w4#1?!jHWyYeWp9OVF}`ex$pe@8bAM;h-o^}H|+KaBqnAyvov1v@u4 z-pQgcm7Q1GXg(nX>7dnGiyO6ZmOcyzQ?1Y&o0oMY)VyOI1*W&>pCC?v2_)UZgaeN> zb#8*rr))=k0mdvX?Ir}iG1Z5(4XxCWI@*ZW9Y2w(N}9+rV}XA^srUtLs(t?PIc;>q z>T;kB%2h;9XN$luj#D;jgbsyK`m+blLnYitz~1ozPttJ1J+?v@tnIer4}x}M zdyjl@=tJ-4e_nqV?Cdbf>Qz43P&IvDW@s`XNDj>m4^v6bBb@cR1#gH=l;ofZ4EfR6 z&q{aE^Nt3#TpTm4e0avl!hLnp+IenGWp1;2JY9h8oA=$4&ZNv^c{`^J>l=h~iu?)C zTDN+GJ?h-;%`Ql@s93?^kAfT3>$rFMQ8@F&P$Mn^BNL1owFF|=Mxi##^$G3?L{%AQ zcX)ZYpJb&tFP6syXoFS_w%+f;c-OB+`j@exmlGzf?ldzV3#i4~ZLP|kYGxRDi~skA`%-mgfrYZS_{_ zQoEZ~hZaW`MKP{^3*s?MO-jJR(~uW6gQUt+u(;&LQ~CnNdGPHU=1cmaI|yO`IYY<; zc0}j71~ZxmLHWS&qGLnFdjrJA@$Rk?Afuc`-{`}opi3}?QhM32-K0C)NQ^!M_a>QK ztMy`1Mq-V;uQ5r3Nh z_ZX=0`k+v{C9E^_kpD=`XYfYf?)_!@5ZT7_aqXE9t5VjgTFO5KSZ}AR!}o3`7`wmI zDPYRTXv`96y$H(eJAx9oRML{R++? zrujgDBh)_b_UalxJ^iT9z& zW%oWQ#%M}tTtc~WDgoi~Tc>ZQ;R_4OXHz39x(AGN*&CE-C{%k)FxutHIj_9W!iKWj zi`@sq=CXfZ^1%Gq=VtXIb?K6~I zXFfS>#x>s7IlK8~N&{SvxMh8!3 z{PA+G9Y_04=HcNa30oAVP=Y<8e2y3|^_zUUv(Sz@c$B+)rP3cFe-qGSynrR&cRkR{ zJ|)yF$+GCLKU_4UEZoO+%>TZ~4wiFAUJFdmWA}#MBM5byQgZjGC?@pKgefX*~vzZ(y9VR)*1bHCgB3zv&=j zHl;~*wu$Be%j=io4|rkkjcy(=0Mm}Z=r6N2jx7IZagu4x+HHlP#?q|!P!dV~Mu)vv zTsL}Fta_RD3A3V=II#pixexjyW27jO?&@N`}6i5?|yl1qCN43x{}0Q8ex z=o0-KSw1jgrhIlWzGNZFT<}syI2`;%Ul78m33%WPx642CqvFz(6Wnk%#xVf*+QF^$ z&z?iSRfB&>m+&E?!_yqlaQ&t$yJt{eEa7#~uOpYb9kw3l)3I6>K%D>+E<@YH~+wNHD{*>$| zSh&VF+PNU}Wi`|9raM#hM%AJqSg{`OmL8(U(UHeqzm~PPvXI1PwZ4L7W9e0MH8WS3 zdL&k|B37i9Qxl6jBQ=*CqGxh#dpP4PwrO^cDKhH3k=5jsf)>49A00GyOIGu?R_V!v zYA>JGhvxpDbBYYzF8E|p)SGS;HEiwboL`lc z8|b`cQLuYsOQfLD#&v)nA7+Yt57?VH{~_AMB7Y`)H_%5V*nkJyp5GRoV0+83wQTwO zNNbaI#R?c2AAPKZlph^^RoFH%wUDf`)^iIp>#SYHc^Uneg;SGB6oUQJMB6>e@A?iB zekMmI&2OX8Vj;uWiuOcIi-qBK%q}8A_xVp}n4=z)luMJpE4Tj1PQi3eSoCBIEumY5 zvrbm+*sx$zztWCdENP7>2&wapo1m=UZGUv#@n_*@IWzmC#gG2x5din0>N(LJEB^9? zdBwj%pJnJmRVFvy0$JZGfmWJa!bj}5+l9$-D^9DM#9kWP@T(l4m)YM|z?l)I4fOvP*@!E`8t9frsqi5*Db7sk7?DkEY*8_LlOqYJ{0N zCquiynIc3sIL^rPzl|%!rOm|T)>IfW)*QtUB?mFk^ok3D+wC@%kakJb_f>CRO=VhL zSJ{hP{N=J}rS}TK!Yq6$WuvUCX-HzqMqUX4#N_~kSaZg9s2^57Lv4O5nS*Lj3YbVY zod1XitDpyUOU;bjMj64OG6WzSoiO03N7P5H-ElURK$^DK)nF5#trhCl%5UYJKWfiz z*wO2y8)Aj~>68wnfNTTDG}Z*85Nr5s4YSy({VGYxMwN*sXb{sxtg9^*Ih^ z=$tUTR*o+#XD5rT`S9;B3G;dbJ54l&md$k^z?SEI*Xs8R<|@s}Jw! z7I74acz=ZP&T8rV{1?lr;GyoxO2n$vf?+ANQHS(eB6!rqRt~}v5mOp=HRSMdlsz=Z zA`BLi7azhf`)*sJ14q0t93t9Nf0TSbGTbD|(6yvK`H=XE?&I{YI$fiK;Xs ziybq3F+F4FQDRv*_q(X7T;f*f%94m;qt5zKJP4C_xgm?Vb}=vL3nI%=6j>1ZwShr7 zB+22+qc9!V9LJ}hx4)E{XNtIc`(@vJ53=6xkA?7BpUvqj?f&HCi*~xuLq_H|6OKOut1K zl(d^YKz&bjDDkLhdueuIE-y8sZ>U1qo~yv;Vdzi41_Ok(?8}OdW6MOE;3Bfcq1GHi zLz}G*%RVPbDA`n6maqVVDUHuLyNiH~s4g{Lre*6;ss&S$*viLUNAjawG%grKXaVBg z8NNYZ9MTg<$7r(P44*UCYkwX(qBgM@nP;{P*wT5W3+wn)0y(C0GR1N<5wORKT48Uh zjn&&0M)~c9cvaXYD!LvywtoDWTPTLIiw4Y({8&CCl+2D9#XF z*4wO)YLXI7EWA6CYJ_T@_=1S>UJVGS|Bf2!f?}(Yj>x*G7kF0U2--*6O#xh4J(Xi> z@L$Wx@kx$hSzAj=)3KOnXdv08k zT>JL!)&`D{J$-zQYwRgs$GS605X%mm3r_ds zk)*1)rk(7Htk33k|NRz$5A=xdunzV{3U0Z@1x8;-3#U8~ZGhp&dxBO5IJ3br?97{v zMCUDHSosCiX^X49h1I@T!_f-cc;`L$fJm6hq*76F{m9h71c!N71=G^=Ii#zoeBti4 z{cK^&u9-aXzlzHP7jZ<<72YGdx!8_4t{@=Vc)pGU(2tz6Md?vAn{xntFQBzROBiZJ z-CJ<5BW{#J>uIAq=8t9;L|2nsXVq{phfTp7%H(g20n?BP?H^wL8-MzQrQ5>N&`pnM zf6Lhz!VOw~kF%-!nHUNr%q2u;ZFSl;5An_YV!UK(nhLMmY;5mqI1mFRNtq3`*2kN| zC>?Q0nMc`LCxU0XaWV@^O8M4%Q0)NIcV*G3$)3!2j6`jo)HeA7;xD+3cR`bd6lwYf z@&0x;@7;bvnJ;B`PRLM)vN_*N178qnjD6N$3I20O*We}g&%$qf29Ya?PtkcYm?t)+ z<=>FLxY$)lR0G{pQ_8%_<-hjW1?#T4ly{EsMu$9hUcchkRUb$o{FuwEHB70iPzO8d zjWZK?A!I{zpr7<#1<6_1&cCSRxw-}=8iz6Dxu4?zzd-c(KAl*{%x9(Uv4u|VWUt;f zvJ9_H#j$+1&k4vS_M%|0UA=9%1|>F8WD#oR1rC1BSI155BptJurR7O{dK|N3W%0fE zY}K>op~BS@k(L{u?MY1{yQ)i`uO2%KhL|pDWDnz@50rW_6}35~62P&akH=tgJK@%bt2Z=O`dy2suVSnIm%Mt^u4;}V!^_GI*PVg< zEwI5Qe94k6Vc7!A9~IsL5v@>fr@4WDWtv3yRlZ2w)HLL}rT|YX(Y2`Rc4cTQv2dks z>!J74*U@@I6X2Whj>1W@4Eni}BR6vy+@RxH-l_JxUf-`dbv12C0{XFpth{QUSdW_0 zt%m!o*JF-4Y%xg_(*8Hr4!qg%)O)=zu)~RQ2`=GeG9Fj_QXL)0RF_8S!?<#X=1hr! zx4?q9;D{O}$tmG5vP@noBMX~Fa|DOsd)x|3&wO$#IBU}f090CpA#fCd`qf6GWozx2 z=)bZ1BdPd^uyS0ssQEzFC=EXv|-P(la8Xd1Ja)uc?6v z=*yZ^oTOVixgMSXyuNnb1=ENfk$X4$8@py54}IE1w!k^HrI;NHslZjsxY}T5UB;}% z)~wUopjm5S+0KxQ%c>RJl(OVCI7POO?hfmhX$1^h+rn05yf!jYrJO@9kz&`%A6o>C z{Tp5Xk|RA4N=X7Tr<1RuBG;lb_gew}s-hhMC8BJ7dXh99fL@+H_ImF(4puJxqX_~2 zDPWF!7>T9$pI@;E3)LnbgSZ_lcD#|Fkl#X@YT9|hi_&Wt8?5<`cE%OQ{Hfg9&WEn( z#t|%cw$7qo(E4t2E_~ugL?!doT1JXcDQ|Qu7O}mBj-@*OLX5emXOg7t&fO6$rmAhtT3bx zhjie^$V#WJl{uB3MfjaWZQ{Vu)z^4JyZ(l}jVKt&RX*_JJL?i~^`I2QGtFp8V79aM zVmtQx5vh=U!Il&9MKWqO{NAkEQ&>yyeDqGN<%BC8wwlwP6>V;Y)_PJ{FJ}2RE6Zxp zJ9;!+pS0)I`ykfu?H&Jd;_$_W&KDL^XP3+6rYISp98<5Wnlyz(6oS{c?3$>q6`%!Q zMf1{w$ho5&)oQe541wL?Ig=)J5x%G|T-kdcQB-RYRw8~6__ks35s440DUerNiFKgz z+hC^F%b=|_PtAQ^sJ~CZsbM6)esa?Jk4wS_P?Y|(vxx*0uX79dbK}q#{iM8V8A0zQ z{*jZC9Da?*l1wT-3|e)UqaDh)7221lNXno41gLqA|0{5+$^1DQyi$y*;%>^@8B18_ z>Fu2Ppi7Jx)*HrcJM5HEUR`M?Lnd%&>F$B9S4M$X)WBOqXo$QwrpWuxFnfAaYpY80 zBnALqS>;$P^%k7m?iHaJ>r9G)DP&(uBLqjoLpdc#-qN1>lL zTPYeP*l*DO%n2P^1MZvErT0@i#mX#>Y2XCLb}nPJFcm5pwk~3feZZ%|(8>!0f&8;q z^3vQq;;ZCqwY~UR=^$rctBl?eN_HYMM{1Ig*ZZ7h?gz5791;JuCAqyT-EcGWeowDY zHyn3gqHK$0$G$P!9Hx>d;9wnRPH%TbAOF~g`7efPwd80L$7GJQHSJ$|7VxnIeZXce z1+ltMr5Y@+zTlK@F+d}D3})fgfT?P<@i7m!0&U4}Fr$u~?H6m$EfM+Hmp)GhXFlsG z7Zo^sJ28D>;AJHanYncwm^LKw;10A?CJNKu7`*H!K-NIr;^h3}{8sLTT_{|2DAx;5 z`q(c`o(cRbD5lB!a11~-HZFWG_g=dUNRwv}4UlF79lHPGt|9Wf86QaRNv-@mgY zxzWCHTz<>0{uj$2Q`XZY{pV#bsp*|*)faL5P&jFuAewt|q9k&s-4723t}IJZ@|`NN zjc(JR(+#-4z&L+mMoRUfE!0aGt%2#S2_6TCq*vnNVo9v0gKYQft+u233jTytrS7rg zK?LB)7+j;{?m&AAE$yq_=Fp7;YJM`@i2*vAagb5C6tcs7!&A7=k%w+XqSltLg#aqE zpm!A{JzJNCt}e}o)n%d7&*?pRbOY;EI(2C1kSqL`V_0e2ZuaE;wp*@azkrmf%b~0| zU7!A))M*+<_|~oM+vB>$jC$n-pHB_r=TjP_owMi{m_6P5yY?KE>dy~yxfE%&Ho*XvJ(@VC)Il88m+xHN^V4t(0 zyd4mUxZkK#Gm#`>$>ePOgFOKH>jSh-X|{#(sZn#xF~Ayt@p`OLQl3MdsMq=}Qy5kz|;KC@5poIvG zTDrU=;|_APuTs0p>&7pdxvweZ2Ymgth9Po-&Q;{x*<|H<%LIh{b$y6(f@naPReI)k zN&FAGkusr#!h39=KC<)RYc35H@U|DXJ205z|~_XYAU!`t<9Pggc-= zE$}#b-8r}!bWCaF=wvu)Gl7oHj?@n}K*NF(ExiM1O*`&u_7-dD2@Wy-v;&NegYK#% z>{r9Cm$gUVwGbJa(75d_`y^gzsdiE9%0CvgSk|k~BMAQVg?&+Qn?LzpKq=FZm%mZZ z)&Tb$`a$}Sp#7|DjaI0WzLs9_TG;NdWC=|&tTfh%-;A8?A?&~yZbS}{3?;p_0xi-i z;K4zQu(fb^${91hXY0t8Rb$Y;M?P{EAT29iWn;?bg}xPy*_{vQpU$v(hZ7?!RYM8U zpzzYxmfM)6#D_50E8e{$sbL z>rM~)51lQ>;y94XN7okQMQH*5?IpwJ{G)ZLu-&D+MdY6>O?X|cW5as8HO$Kj2h;bN z-m^Z={X4j13gS!-eNCPUgE82eQijoWk-@}S-~KV|iMa~=cGodl%F-*GaN=}mS4Z?% zob}ek87;4Zse%o)nD(r01YwO3r_Z42UlYyghYEO?WSMAZN~erDGhhlcou&=uSLVh3 zuAh^|&Y%i$GFXfULcMp?yyU)qs*((bm*!?U1qcsLRO*KX2HP!wTDK$SK-=q}?V11I zt^v2_8bm3f{JcyB7))W+abpFuQL+V5J|6Cd+Qg7=Q>ijl>@|jP2d|2Xbe3n!~oDz{46DW{NIZky=jR5GPn-DnpC|>*m|K&2#Eqc3YnQT{j;%Y(7#cP-TE9Xj#L}Ek)m%Ex|x_b|weL*o++PC~Pz|9b#}6N@Trw;4=uch z0B5r>0;f7M-ShJ*K~Pf6jnx=pZ3Z3^{4PviCCsEtQ;*n4ZT6QuNd1Y(O4? z2wmsStLf)}#Q1mwK5XGa9-X1isPlA@!&F7Z!c$93_9$kNvi}JaD3u};Rnel~LVUJ1XYeuxUCVS7x18#;(+(+OcwVh!Zwb~Qs^+zXbS!hs` z!6r1lE^n<8<%6F=OHdAdh6(54bkfo!a%oOS++*2dOJ0IH&R|nG@7j>IT1O@rdgDU7q2a5ZOXs?Qb>C&bm)r%W5*cL{1!4ZC4p?J-YQx zQ}ONOefd@OW79G^suQDW>ekyDRy#$e{-*c=;n63!Ogn#fgrli8=hp{FE+IN=;VQtb zKHpz@k@C-+l1<|%>?!rZ*$u;aDO62gkb+%I@V(6@PM!^t%1LU9z&8}|k@cg3Ujdt3 z>4jguySDZl&E8T)h_W_{(GI-8U3Q~IN12ptr1H#C*2M?l6ydLhFM5<}c+hctM_MQ< zAN^_=E`jxuTK^X->xo>Jv+`pDk~pA*qhiS#>nW3T|Ha(>8t`72F8KP9NI@wc8kNVdrf90T$u zX*T5Y#hnkk{v5SQeHf-t6`?Ni&plP3z!_lK+Hef+SfU(&)qW7Vc+}0sT|a+$Lx*V# z^@f1nQ_|kgxB7962!UaNQA&yGWh%BpYT6-P|VElQPbUnKlRte7?O9MtHeO}tcxf3ImgO@ ztB-HVrYPoMe5Kq`^~pg~7H0&xa#iA2sKeTyz-a3S^6Q%fLvY=oYCxfTj#mIxrryH( z#%2cUcLqOLA9v}sq2au|ME4pkYaV1%q4w~3QJMeVAzSY0fKP0Aa7t53vAR;bjcy?@p~GXnm#2@nCcA}}v0#wDU6b_p<+=UwTPE5lw!Fgp zE};0&y*@g9ZL3e~Wze9~kxAZBGhqk7S>fvy<(N61&0V2LRiz-=8+z(RK3SZSyL5_W z%bBk^m`_F$*7?v zbiaE2{SajPL|+`;%T8*?zcV!&rDlBh%R_8;1Z)_Y=V$6aAujX2U6p`+AwV64( zC~DK7Zu@U}motX6nLmA)e zibXT&WS64!>yO|Vyu@ZSEnd4~P_eUC_a-uZTL!^roXhaf@C{!mQ&_j2R_;l(_uqCL zoHB{7%?yDARW+v#ZhNq7J5~Z5ywLbVEh#A_{h>%jW>jJ>7{6O0@Q1kKRVx^GccNyJ zEVadbwB=Q<^53k3@FPrXmW-X880n|;v|RzmGY;u6!ECVYT!$MWdU7{@dd(SqkSZ(Q z#HxPF@S{xq^gl;L*Y~;cvKP+~cQk5TZBqzN*59e_jtM}aY1LY)SfR6)d9=WN+K{Na zCF>z_2<0F&?0cnSU4UVgxT$_*#S~?ZbW&rB~4?=`Zl5f4^s$0kj z++sw0Z31L%wVfXG>fUv3y((@wbgeD4%R|u8i*|dS zCCN5zPU~^>f#IjI_MBp3JPhN1-TE8$*0=S)YFPuG-d&F2!uvbj zi+vXnHb4mjr4_3xzW&kj&lxyfab?b6rG9)^gQ6G&6)@4eS6TXY)$PPS2 z6LU{Z)E;51;y)~6-Qgk&%tmD=w{X(v@WTLF{=tvu6ji+=6)vJ=dX6!~;aB{@OS z|L#iJ%%gw&CUnf(;-xt?i{&b29@`PAtUM=*j0^UHiuPy3YD^czsT1B*{szuFkfE@- zm;aiD+)G#*iET-w#Slvp1_S7_E!>Bla6bQ3TQ~trmSG%q+tAy~Lop3R(;wX$+2Te! zsdMhX2+0uKdrXC+1Qg6C)m09xo-MyfsQbFxY30vT*lQz15Q1x%vh{_|jn){={K5+H zcl26BuBt8E|UYb5K8>gzZ)xhgwgy)_KKKnP^vqLJK?j6jyp#sQ!!a!~&n005_>OubQaq#;> z@j#K*%*WT&h0*R-)V6>ZlNNI1q{+~I!7!f*@nl|{+A2r}Z1grc$_{kyoR`~XD)m%Ty#Me+wcDR^#R76I`8bwk|_2Hys(8IX^=yC2~A}pJ5 z+R3y}mCe{KKBY^!%6FAJiy9-PrMqi0Icw5$?(C~ID?3eRz#CnP%1`YShJ$a2r1)A) z+kbjfG9{_AH;`>hlv5$1nL_|Yne$6sPAWIrZSD2K;jXJg?^R!XbNz%%ac{kMV9vhz zZc#U&j|*9E8FH~U&K_4Eu|W>^mwU5{c@m27jKHe-SL*|?`NN`&4>Gh4lhV_V77mk; z)(1M_Mu`jfNWG6^@+NDD+dJPt(XoZq4JLxpX5I#9d|p96`@(G5SI3W--+7fCf=A<)y=-G@8_<#E=M{KIpU!PCNlokN*svB9|d_fQ*f|8q%F zR+jVA#+GCQws^-vpNObMTgsOXU46Og?fa(us~-^s=p{MJc|YV_ul%*DiChz z$;^*nU0&B%c+(bu29vBZPP!pT;WHeHxWw0ix%x>h)P>d*XrHwm-=8_Y90lHJt_|Iv z3h?1HFC+e_lD2Q{B304Q6rfU0)hLGS*3;QM-?XQu@miA^Eg-@FDx;}FeWP+~7&XhC z6H<WZDd!$#N^nuL;g0NCZ7Cm24>v2ToZz)n@2Nc5+!yA0`mL&r43^d1sjk=4}sT z0vfq=W2;}cgp_+O-3DpGVE^!Q;~Q)l>oWWLS^{g=zcl`PL@L`>rH_oFIdu@6`1?vh zM7}XEGbOMovjnn0E{DI!qeCrF=Zrw`b=)p4jZk8p^8~|;B5hqQONTm!d9P@>R=<=p zU3+wHNjBdUxF@_xv=;iEKdX_oIelieq8D(c^MJ2LSYZF7Sja*oj}g?M@W@lk>y3W6^#_WDBezEIvh45ir+S@fiI{9{~Ux7&rNjgBbc+3WaSseqfy{{!Fu9 zQ@<7x(7N(@1 z$ipXpBGkX30Ca1%qpKESv+(2ckK>2z#vx8YfBwBvYGBVJc8+%1rq#IgrCuDUn=K*3Q!%aPADDkP0qOSUseR|p9-@!$z?Zbg@n}-8dAAqqNk$RnzWnOcxw9@(q$jt){ zM4?{mfkCSBNZ($D+yYa+Cz+?vq*u-^7<}JrO9j5$f4qmy4u)neCxSmJ zVV7ito`c)t%@^MAq?bl@TBNxMQiaI?QJGzkW}Q;P;$HwgrT#;&(w&8LDiMA5!MCkV)?}AP zGNC@GRXtcpjaw)WA_>XakNKH@wD z&C19VTeud}J-S8OZ4~Zzi}AamTV>|h?UNArTSJp=7Yozzb2a|iv|mo_u%2Ewzv4;U z8D6u@Mw;qc@YdfeuyJfpV_vP#Pg>#ZrMZR*^&a7bD2%k~_$-rp!uh%!BQgv3HPgPz zYdzU;+eH%J8*i9H_Nd!4gcRgzZYSzUbr@{!ezfv0zyz*!?)r~j5SyWgA)sxpvwkz= z&|93}%2DgJedeo6e$$?uJ90mrO~g|Jm%pSy?_X~ip3S_{Q}df(rVey01v;K>UYqW0 z2USF6-#qVZR78!@E$ywpu%1W93^?D2c-K+q7JWjy=2@M)o(xQ=k*y=?LJMG(FG6Y4 zrkcD8yWxDNNLl?X=;8?K!5^w#Tt#z%N`6s_zB%5uqNeCKxiJ%m+6@;Tj;>$4q&j;^ z=kQ>FnJU~#sh2k@-=_3M1ArnT32lnHU?510*+4OEc~>pTBkodvp7ZCb0V(UkCNtZ_ zQrk0Y!dd}M39I>pc}BNUg=98Bt>>m?`abY}j$nRU#9|=&WJHR#-~l4HhGa~{dQXL( z(TRaJJ4Bf)V@*rMb*?O@*cAlkW!S5^ozL`uU^P8Rv#H>G6?TWUnb)n!W568m0Fc-E zE)w2_?VM}TfJIv8dtx2dexp_#C}k*i){p35J#A}#%T8{YlY7FGVCm&+FbTVV*gpqh z#|l}o_eKh`K_(9;!WtVTRsP|EH%&p9um>&@)bKTeJn_hh%xL zic>&`QSgiDCPyUZj?zGPp-aJqjkTF1{oAdeTXEp}<0>v|X5Ybwb_Dnx*3K$jG=dj| z@9>d3ixq|&Fj4CcSAE)`WBW%qcxrWW4{vp8LA`CTaFuoQ6y$?yb;^& z2>Z7ncmnxObJfH@*|Fzv)v!3;tqSn=amLJqB=l{qI#i0VpWJC`oFzUvere@2X~cD1 zVrC+ov)QI%HZxLI^BquoL-B_O6PHI1byew^8hXLaJle5Zn%?gLo7~xumi=9q_|b$| z_);Trvs#e4I!Yd)k)Wq01=D%s3b@mqTal0+M!y$jcHXV6AV7}{yTBO2DDXpY??w8M zIm9bgDVdJK|MQp(7cy%)DR-xA1!1amiZy!lqyEhAnQH1ggMpzv1(ias8igjRk;^=EE`Aezx2Haxx=S< zUBLLl*4#WSXQ&~n0aRCec4#cr==&ooG3K@Xx9>vlegf|a{m4w8F=PwIN*d)%oM4l} zGesMdf7HZ$Z1ntK{dooQ&)Q!(N zx{s#Lit>7C6?3CotMa+Z53!K!>G6Yu8RK3_vS|5rgB>UKS0po?)gF{~U3jB5G1Cl6 z(ftg+3UHh*v}QGbGOUPQ&}-S)1&D&r!sa_s$2-z>7xR~-a{(PWe9yGUTAN~;e)rK5 zz`d^US~(xdC_DGoneg-6sPSyncr!POqM*n%muymC@+3@=#apB>EX$ZXmm0!93OA3X z0RAveiDj#v8QswAc?Q*np5VSw`77?1ew+2n0~eMmEiOnbo%YEFU^9aO28|$p)qpyq zxyYAPaZ1^1Wx<{k5HPEBpB5gw2q!f45_Qw7BH^AZj-c9dAPC^O3^wVtjhlk^u2Du{M1@^LtkeB)KE3vAGhfS<9Ht@ zVPOeuJ|6jKz1dzeDBq)R|5&(2tvUV6|Hm3;Sl~c~oHo-zme+A)Ownm+^GLt7;_NbH zGY-S~M(^bn^t|K`Q`e=?mzsYr)|hBNqJj>!c;D{c15Y2$q|S~_c33`&X>QTLbakmn zc*fsH2IVN_qh3{)31zzOt*0aXX2kuHVC@1Kpq00CN4GVCKY}4lwY$Au#asT1CXtgC zcJ2UDqN45$izUymfyfY6sAAz*z^4)jeSg}^%{zuK934YQgC23yh-x-?fcd6l#Qncf zp4gljM*oG}0{mOepl@?7xL<9n;mGg}0sm!@rdH5R7)SOQlY4gKCK6&2@v&Qetf5-p zIA9&l3H3DH0_8)xXg!FV$d(sSHsNn#wPN61eTM*qkS|4=V%-^8Nn~$kvsvOo{qd;w z!7MK!qGH1F&e0sv^;ONCihs;4*L{zhC?zr!Yj9>vNQUpKbkeUZt;e!iP{4q4D9Znx z#>UXv`-|qk{5>MOaMa-LLe^P*qcU-S{->8&--nG@!@ZRa>^-W;0}~+M~eYGhiR?o}|x7 zb#V6E=C)yzY+Oia339@zs0ci)R!3l`AgD>@grU&Wzu>;tKzAS_OjIC=D(vn zAiU>`56;<^UYgM%M}Eh!@AOkPo@QLNy?Yx6@)=oQgoZ9yk^4lqy@a)q8bQM38FJ`T znje$;i}MyLL50tM2A7YY4SKaeasfT|V4wB8xK^*hsUrvOocTx_CuED7W<1f*e_iL? zA|tHO^mP3L4%4MS_S%k*E~T389-#Y-XH#wM@J9jy-pxS2Azg4@vtzCe&{jVv){$rn5hqhZvBF3ce{NM&~6bQ(@M)HC#$* zAl-+Tb+m`quaV^7JnYxC9n&9lz`%DbmNLtWUjk)tUC$SRh;ht)=bjq)n=R55jEN=pEd`&~K zD`>{$?lJJzovNP0%Fn(ij5^#8@(+tb*g4rxR^RsZ)U@WOd;GcVS*H})j`|)u)d3H& z_i+f={Vwr2&vv&uzWemleni{IdhokV7rr=uh#PZ2tDL>JtC6P+*Zq+4(rLjepNVEw z(KgS<V5&zm!D6Pbfu^kYZD+@&$!TKFDON97N6w>vXJtn98t7|U0W{yRHgvADDNTY29V zF_6)Lw)?0O*CeqV=#2C$@kd3<1{n`$6%$Kv;_SnuOG8(24TWAs;!rnCYc#!VFaTaW zG`BdD2yI}g4BM{n`Yx}0lcaAKWnP7Qd*WzcrJ0Hv^T2}SZf=|?MQ}VMTn2jk46p8A z*a4Bzt;C&u;7LVA%yAGvJa(dJ+Qi9U@Qs^}HAJsXw32miUNG2bZ#3x|ND~(YIGrxh zN90#=&El0#_~huTzBM#&yT)zszjS^dIv#~OX(?#fb3fUy!kVoGtW&QuXLd(@fvKG2 zxjElglsC*_24hwqd37O812(Nqw=Z$ydQQV<_PGNaJNciN6WTagXDuGiAwUBy2KKP73)qUSj!(VudIrxe18iuJu;9rIQht#?3}rATfIFMEmsA zR(X@&k?jlSBO>HSqtZ8BbtKGgj^QB{~7tI#TTa%1@wPZn7&d&UAk#2Ps&v`bn%qd#Zaea{t0z{d**v5^;kJ`yK54-MO?E zKW*Q&wyWx8VOE^w=t8Hrh2Z>H$i)pYhn6hOwo&0IyNS5IFf<*#P^!QFk(z5Ykz?aU z0_Kgw90TU*Nw@!ka$y{MgP6_I!vNz}^o4rMYA0IlPV5u!)Q2-WW-U7B{K$x#`^`@`mEgRa9i%#9irrR#HWgNNV?R^GX z=h5-9Mq#9D{}Cy*{n z7f)iu?~IyzItM^M&bMKX_MSM8S+6G;MKw*3!eV$QB-fz7FsQwS!ZgIYdG;Ki^%&B~rQ{h>JgSI!8ol2|a8aN4^r}9)f!~qi~>q#e36| zp({?&(I{*-IXYl_x2~Y*Gu$!&*a<2W=HWsxf8MNT(jNc$HR#cWryBMSLU@NZ=sI`s zsFh;?!-j6dG0{x0p8*bCdV@~W-T8#@bE`PA|_TFPl{W>JYo zMB=is*7ydx<9^_~8|1Qs3pcRXHbQN1wVRkqAa-wd&hlOQsHJcAdX^Xr!D8x^FYfId z&rqLPMDYh=FF49>T8-Tx=Xa~`9Mu9}*t@GYy1!GB6|S{lK38wis&G)#Was8Mw3u-s9=v#*Irn}kJ;=kf3F7FQ zrcgcCRqEuieSqNYSS`Cf(Fjco#jWLmEw83TUS5eBxjz8YRkio)eme@SB<{n^@N*s4 zo8)#9e2O`BfdgR-C3843rs;wKB~D<08k=&G+(kWrXGe1fPnFir@txuL3`CkGw8_30p-^#)QWn7WLR_cy} z6@KM}zvFnHjx+KjB*idQK*a})yN+tkbzGqjZd|{B(S9?|i9AYu>&2}N4>EX@vQ-qN zymf8`JKk6+V24SqOpdO}Y>Yry?-l#gSFOZmW>|x`ceZ$_^mdTw-S@jJ#&`tQ(VU#Y zR%+HPx97~sY*u4a*>tYo1kO{iDK$4fPB0p;s_{QW-QyW>b|)GS4%(60j6=C-4r#Ey zja3Y>s&=>ToQu4Qj!P|QOp{GFigSX7W@N8i-8lp^#}892c`nlt?S!(!rOz28E`(m9 z>kZMg-jq+Im6dtweac%=2O;#kKYnGVgR_xY1~$fDjZQl~FY28RYq-DMxFWbK5!q1nvi!j@BVq_>{W zJD1OxsJ@5?<)FF2vRIU5vf%~c-;GFTuhR>0Zdq~I3d(AJyGZcw;iVHU3CVf~XPnRT ziIn+dV7d8=w$H?4fxg{7Ry_}@b@GfJ)(H;>?=hApp>HTpw$#(BGcg?}t9$ zC5gqlLheZhaQ%v6){+h(egIh)$OQwod=dP@V%CLV`d(X_4g%|^PT}PKzDGwn^yj(? zU-9QIGU54rrxuBHl^o{n+j2ni{PhJFi=sRS9$k^HaYe8=+8g+hH(YB$G3mdkxbYnq zviuX_wct3ZoUYMNzcQe`Q?MoR(LS^2H(l$|NVV<>)~R2g8aVy&a~46D@J0lIgMB-r zDt!>+1&ETKx+*ypRzWAv;%#7%{?@O#jQY3Myzi58wv;l`DRw|YpERTv;F0C9gwb8h z*m*C8-c6yg;%qj5)+;}Y#I(=MnwJ=3d{N3`4+D`}%1f8NbhEtM;~5I;8szj}xK|4o zyfoD}&YAA2-i$UB^ic+|4i3$r_u9$9K@Ee3`9(i#vuYEcw5E+#S-hZ6Mef0z2q6#G zD;zw|oqG}qUk*WCfzl+W(`5Tm1$$8+|Jp~?zKp%-=0VI;d9uPS`tGmEy4F$rQL~mf ztSS5?i$)fldno}mOb7)&Hr_N2&b@Zd2$8I}Ib*5B7%i(Y4%GY?fn{H&4StU`^w$+V zYlVrXVK~J#W~RJyL|Hla+g}Y8+DG%0>NNE;<)8iH6_{eybrI_y3imd&nC9he^tv6h z`#!wq;p*$a1z%ivVs!1nj)K-oPI*oh9AMkerSX;o_68qJLW)j(la2H1!mO+3TJ5ZU zv=!QH4eZx#J%^-RK}%q-T4f?icp2_JoV#013=31w{;$uO9BdgtZv3&gMY7DZ@an%P zLQ1s@UjxX&JqGSInZ#_jOqC3m6X~Ykp0hKcNuIa+cal6S|D3XPIC5S*(Ezw z)Ui}4aP>t*`0o9>`v$k7$ zAID^qI43$4wVwO^Ek8_4Rtr=LRMF>VJ12lo_PBmmDFLv1a7P6b-G#>d_T+%zwEgnuM*z(Yq)1mM~&U^6mN zH^vj(eUfH?k@u7JZ0Glpv=a-b&zD`|i+BENU5=KD4KT54Fo51yY^{VoY{=6-MV)aX z9O>F+N4bn0By2`tj`Sun9~f_6009Hu+}B30_^aP#m4!#)stsjTwGu(+a#@gof!)}r zpLkZahImk^;{+*b?u&Lu#ZE%dlnOi_#2D8$P-S#*TJ42Jgne_E&>x$xc~rG*@}EOV zi+!A*ncHU;`5N5ML`ZRLi)k}?*lwbRnIq8ki!2&YXd6v_x~1m4eL#!OxUrlN2+u|? ze?Ipne_Z*SF(=PM%{w`~I9fSpo8dnYv^(Y|(G95fkQL!3vN%R-$YCZ)PRtilv`qL#i9~Dyt#gM*Z6Xf-)%>`9r8)aXYH*%s0 zOc~!_xyH{AKVvi^bc(K55?9Ol>+JJzSs_L{^51a>-9kmhf<$Mm6?Df=*^HS^n+*UJ4- zwGwU1U@R)Evr#yawaJ9-@Ki1!L^`b0`~LDQ(dqXWv*)$ZLxHEX(8F96$QjLV z(+~1TXjidMBo`{!kbs47J@mz$v#TY&hgN3%FAj}_Zca&Cqf4oXM}7E5oW8X)4m{{& zM0e9qZKzu#Y8Z90tBhYJKLYJ9szzMoy@t_Z;MmZvR*gEGNQo@LXH+&@jAvZtq59$2 zmr!9lp@;Df8Zz(3XbntYl?DTXrU@k;dw1uSi{wEMJOZ1qI+Ab(JCFeAMdAVIkmO2M zoZA(Lw?~Hknhx_}ti#CQODwaKf4nez>G~@>^oi%W8*&@Gf=|qF18o4%Y4KA9r}_^! z__5kfJ#roXwt?t?Hp!j{6+fPfOo`(j05yf0;I1$JUl>Lgss0{di@#U+&unMy#>#<3 z(!|)}t7@$Lafph?T5#m(wvRNL%k(%A0F_b;-y~u`@Q=}b{*D{M^LMR@?Ok_{eXSzO zk2W;g%vgg7^L93(1ManmDnY}4R3pkn$I%@TllFhE{5T(Ej#uw_N-E1i404-QHjl!@ zl->0do_)N#v(wo_5N+gnk=HoMW_7y;C9935ksTPq1%>#qZHBoCvP$nlaY24=b;>K@K|YP@xQAF-r@yWR^ZCt4v+D)iqwTVkdfwUS$+#8s<Nb@5 ziLLPjc>qP4xBAH&IEVD8{<3$S=&PT<^KDEym%Q?|$q~_7wchOzx}N)2XI9|7UF+Xj zpKv8%n0RhoeHp0$LgAkcpRlOIFEJ-?srK^%oo^Hs4os_Zg^Nd51D5wS*0jZgRQG`s zFj`F(2iW@lsB@Tjixze8xD-RdB;W|+m@;yjTTG$4WHr48w>5_AF#h09K)eLq8G-i% z!M_9VU8gQu=%BRK`)f~HUg5TUSjt06ef7G6vOwsn;8Ocwn~~5Vq;N4jUMbkr^|FF0 z<9n9j1uxcPWv)6>m4A{ceiSLTc3l&C@p1(;4CN~3Zt@X3=+q5d=M<-{j0M%s!&Y`T z1q((nUN}(>eQ?-f<%@f7m0!LNrwAC>Ki43%Jr}MUIWvk@GK{U$wl{Mw+$0V9>Zf5} z0o)AIkVikXUnDKfRL=BbJ_!vBd)ao1*8JY<5&uBvS8QlCBv8h;tE#-^(Wp-k<28R| z?v6>xknhS;p%-=0{gE1n4{e`wlj_O33;%n>W~5sd%{AqHsOwM7FLJ$U_~Klb&d-~u z6rP9sf8j zMfZgd6_e-BY8A3+yt}%s$xnbVtj#ZtYyD2o|C;wQsr|`Z0;!IZ2 zqWazN6YUkMoD)%bHAWr$w6ERe=R4VQWd)RZu$9Bjbd6gGU%7jII?M(~4>$4Jc{gfN zOrS0D2oU#L=c>+?(!?&R}&K!~5=f!BPY}Qe&$90A zi$)1}?gOMcYg%eMwYBq7l2;T!jO^3AIP2Z8adj+f@mzS-?jmN;pH3o>_u6_@b)8+d zyDiM9!}y~Se`rq5->73z{sP|8Of>57WjryA<@yDuPu}(kuMg?EAZ9&kUCPc$r(Ea!4n6=cc$#~LPOGae4!r`4B%Ky0n|J7U>-GOdg0xtj;pbKFW z&LG~}@wefy?a*2^lbIPe5mjnGI4)-`q{@I~*h!{_H~`hTg?*csEM{rt2j7Y{ERP=1eEA>aD{^T$ESRZaoRS!;_dr(dwWfzD z*i?SbeOl>)f1CXe;R)r1|hYuI7v6Kc2fR58ww0a>_XBK3sh_ zR&OS781CT{(DNZrlxLN`5@K@G*wPPh6C$APICC8W;wCv!-y`s}U(?m|@pxKXN=*@= z=XFiu(wzlIYv0&wBe;71rBT41C_i+nr2QI$xFY{#1pRee{u_*LaOC=~>IDOTZQ8CM z!#C)PKdTxuyRSZ%ixOEG#;35)emWuFi3Ev&k$+y!} zH3kE+p$nyzKm1Gpl^Q{wb5oIlfF_X>8(-?z9r9WMzb0H=RYW*2IxyniC)7f@nQD&s!%r{yXT9-H z{%J)MUu3LRDh|N>|5@g$x=UUchh%a zQKQ>u6c*}|#W0VeR+kL~7SS=QaXK{ICsKcCM+L%+pa@*=h%aVKfBY#JT)O8~`w6u9 zv8NRvtvR%-z}p}Sdo~JWbixblXRNAMxR_p)DrmP;LxC zA(-Vh*Gc$NW})ifsc46M<%i~c?@}U|5ja9?a8}Fc)S+}j;!4wFSxTVw`Wdw>CSn1d zRlN?GK@^F8RvAHbV3UTDE8<9*MxRQyLd=NagTTI6@-vM!4GQYul4#A=4pmDiqOt~3Dk2Z($ODf;da9RurB}%e3hSWuG(c2PwYfX=mpC?IM?K2O-xRb zz6VwtBv@3?P&zRiJ>PhZ9>wv*#qGa#v2GsOeOak{v$Qf}!qIg}N@NF0=8qZ4TJ9(FW&RsX;arHFPn+)Ci6aNC89 zEDmoS{gwSXdX;%T$N$v))ow9U*1ufm70Sldg%^3Nj^eyhe8X1s5EA2*r;6P#IP*4~ zAT7{!ZOBO$>0M(D)n(nZboOeaX!`y)TDyGMpFq`hu$!zMLCRRKn@DJ!L@W5x)hN%tjI3D}xW62ZqMjJ>y8B zVJ~_&ljTTBx;$z32*R0dT8MGT}OSG#qe7nMQC-z+*6e~gR+oA-!5q>?S2&Do?y{i`a zvbz!Yc6=<6HYylK+l;rfWT)Xa>A!2X;|h_V$1h{;FV#kq-WkJ8oi@YLWU%(UG@Sax z)lW5NjGKqF*gj*z)SxfcOho^vHLB-`S&)`r$OX>vjldY8>|b$48DqRj+nr9Km>BTM zzC2}691z!JVYHp58Cav0Dv~8Y9CTnqK|yk zecJbXW;`Z9$LXj3g24yyWSsbtB0XSM8v(bwl3#U8O;i@z^HeSlDRv1l!sz(#T(Dub zIx4uZ735zS-8J_BzbXzr&JLY>zZSf?ga~@0ELcK25lg~i<O+_5CTkLbA8 zrx_Ps<94;v?<3t%0a0G};5yYm;d)pJ;g)B$C9p2l<}u3VlMNohwb&;=uwUs_BmAuX z$o+UTOz5e#QTTJ%17{C}7vAOhNwh*LOViiCq7sbD{bOF01%5KJy?dlU#LDh^Ge7-x ze7E01<6uHfM7t~f#014)o0e=ed<z z7}Vfwkw^1mB(JGoQ%?moe`vzeX{0Ql(n9Z!OsUEz-uU{$lyWA=&3o9Y(_a6G;=)nQ zTvb#&a7vxKZl3v7L!B%mPGAWu8GvemxV~S%}6y5j45rnUbKZ5zK#4Xt7?aTuvJ-vp-ck{88 z=F2Rt=_=?=_8T#*nC*)F{io}5v1QhHu`CR8*s;0i%I%lo^N|-j;cMB%I(q{oWam5U zvs%)1s@fg5hKpn1y2XNEB(nK%=-RjEAOA{2!#*Ok1u_rPQ$)S-GQOQb=2@i285+h< z8zW%7_U<~%ZiV-!5ij29@tmf|CLglTXX1fh;jjze|i4HkUQ%tnnclG(xVupJSnEtm3 zxGO(cZA6=qyp%Qg#zh!5FJD;lK59*F!_;!M-;L8b z8}n8N*$RLr&JXf+rWK0b8xx@Vb6#qgjl!f2;i)%0hw)-|l)c*;PlC+ZgFe-z1E{S^hC}~JC=LSIsUFv6B5vQiKABqCc;}qXhiV-aqnf9J ziHI`r!Q+er?oQ-omXv733-;IQs@sZq*)c-6WsTMeYRkioF!U?Vr#z_ZPOmB%`Z<9q zsm@7JLx5bmldUj&?mA4R*af+XR`XNC-Jx?E;#sDD4jV7_RB)y#n2!we8vq&fP0ZSW zo&q}~$jM{+sIAItYrlvaHJg2bWB4m=LNBXqr0WIE`qJkM?B7rmkByIN?&Q&%uqcLH z8eBSCGk4T9!Hh$6QjRP8ATyom|Gc>YPD}CDAKsKX zu92I$Ayb}lB1q=O5b>2Q!8*VIFRmb9J%!Ly8`EM;9{%&gbojHz+(=x7iWWkldv3=iNW zOaYM-T6m=K;?#~Si~iyC{g|fz4yrLD4klnF)6^{1k(8}l{Dzgo2|8Yq-#@+rP{?oF z?A-^7_9neMGCDT;e8syx%8WW3g{&WB+^VzxQ(aaNEpX8o_V{x#n#TT&{`c2AcGF}k zh5TpoeY0X zYhIwbZ}i22Iz^A|3b5}}@g~+@k`5gGdUou47u}C>8|c>;BZCDm^1x#n+WbB z|HfFakFY{XY)2=@0I;zwWd9tp-H;g|)&8hS;|WXsVk&5VSTE^@&x1iwoMte;f5U(ALz`cZyS)K;W5{P$e0R>rsxobp zLNV$svXeS!Aq9*l3q5ODJU2qWMOe1ad3bpgsyc=>ox;QhhEn;b!tIxO_esF@Bc*~_ z=u|rYmR~U2sg|-6CJhIw{)Q&zS%WoYNko?7KYFz1V-#Iy8Z3@_C5s1U0)FRzjH9$hH^se@+uskouin7YNxV2E%uq6g<9VG zZM{1BYtZB71H~qjFHAy|noGMtxmQ^@P5%Y2<_(o{vr(lgA&b_?0ypWmMRhrODg|L1ghaBE1WpdjCOsjEF> z&*Rlc`26$Q3@hrPldWm5$Q7symA@<=96mq3nfwx!mF7^;AGpu{sF?HEJaE|%>F>~V zzljAVm=&PBQqDbfHRf0nU>`WUS2A3)A2_g=N@76j&6?ZRYOZrWdNMa-_i+sDSI#v9 z(c0uMhCxh|fT+)cjN<{~cF5YvHJ-xPIUcab80NOXup=>iSmu$l#*UCnY}w8qi0m*> zfb8#KJ7IyUAt{r6H8b_AI7t4dazjP$Tc_cx1zsc95gpC$Vop)jE4wK@E?tBc z7fo95=)_~jlTBaARMno&h5AdvAULo+h@EYGfo9+5OuP_`BvsYc*vhOqyQU7OCXefW zi9A%GBJ?MefnGB{Uu(FA-Qt@nuK zl>`d?jQ2Qwk)s^z_gyV3s7xf*JWbar+WoU;#wss((L1iVfmbUUp{9{E_!<=VHr%5# z5#c+`q%OPy>=GZAn!HG+!|iR|)!7Y6rKI8cXEU1FMCz;6t89wze9=iP>mtowPk4g~ zcc5@W5+~(dkqnFqE&IGXA3?gAtp|vealVelf%={H-!%u%W}pQe)+Wk=Nhx%6_KNad zRJm90r`*_}5r-uaxi_`}pzJ`(C17DvPevP|dI-zfTDDBOV=5S5X6cK|;GvXoU-;ob z8r;<^YJp7JHmG@P|93bj@E#d$Aft8r+02Sx5Qa57imHhiHVEnD1q~qgaEL33=YNp|c3C0p0p9{VANTd0c4Rj{x+#qur>1FwwOf z=3^c9AqRlBPnl*|^^Jx+*!ETZoCMa-@wPk1%pCwVB*4Qho<{WEV zy!>tj(Tjo>Zcv@$6(-sS^sTHjJZ_XL_9jDD|3rOY$jB;o;WESgbco6MoNXVuD~lg+ zY~wq=OQ{=MmsOG&tVUAuKWuTk`ElwWx6zyH5z#fj(`3UE+HY^BI)6CKh2xSlQmz&7ZP?b3LQ*GuXTTdjwo8$f$jolgzc4uCX;sib%O9wG~fx zS}DGtPEC{VV#NBlAghdPzU@Ad5}EO`>}m?z4O+ zoIDP_!F>q37;ZO2lc^huo3jdGpX7y>r3BgZj62B~Fji*^ba|1S(cT(6Y_=Qhs}B1q zAg98qyvYC2-LRtM%O=MRhDk|xwhg`z;RNaoq-ZP;+-@`zTiec!nh(Plh+p_;#5o$n z#A`&6b`VhQfxzDCOPPt!w7-dlnrr;_SBs@?3Eh>7#o@Ar1}#2RoOqF6O-dlO{0|eo z=W8v|h}V~)_kD+ry+)v08)6U5zSJHS*C`4ueF33;I~dQK`gjBsdB^Mz&1*Q>>q(PT zy9pJ{1C^r2vr2r#6D))2e=oOCJ_nD}{Yt@TZOHfd2z7DUe6y7~y^K>_m*X0LGFb@; zln*X|%tEDz==J(2Rq3{S+0;QY^*lW40^`R$tBp2Oe?#Q9mZ3(-;t^o9XP>=(ID%PA zHSIV5vHsq84D9FB@Qv8-Su5jw?Rbn%H@~XmVd*mcP?SI=>prbvN>~wu1doQ^anNvi zmXl+&B$Ir-`uI;QUw9B|Hn6`XL|E(OT-_f&;i|q!(qvt9|7hK>ZhdQosjh5F z6WI|ex1)+aaX5=TBJBQ7tpBAG^C(wjurY8vo!BFui74)*diG8H-{ zX_TdXJf!A5qs+SS&&j#$GG#-$8XQy*_QqQF{V#DRR}3 z!&2_>CC4H##tWczqNo(N%X-}(&LCAyym-82Q7lj;4v%2L~hKqONH*2@S$E0 zeq&LpRI^18G32@Z&En&oVpDz=Yd!r6pEJD@;!%iM98lwr%AQvOE3&jKDVg}PVPgQn z7Pp?4j-eOfR{ELn@{5lKU;J25eKuPt%n$cj#r6mz46#cBBWe_{dC&E#HR+*dt=CUx zq*A7B&HVA-leX6C_aEF5bABkzQHN6Xc>%6}(~Rfev~=g?J+s7eXkZQBiMk$nD@9Ky z>A3cn}tjtaY6m~b*mK&hO$raC}0@=Yks`df3nlq{C9_xWxtx% z3;Or6GzIR|QaYg1tpd*Skf_&XdB*x#E_5+^AJ~8{`av%OZ%xF0^F|0yF(&qQkikAu z;{=bdIh&INjaTmpLo?e{K@LaEVE?o9Xj>;{PZb$zH58!KY;eNOmjA-=!>)7hyL9_ql#XT3MF8PERd@Oj z4iFh`FOOVlkx8=)%lr*ABI}1uuHnfO??}aNysmTD&a1N0^>EH2s7qT<<&wRWJ;`^P zxHOZ#k+U@WR9x6=h#Te^{QgewVTg0v1&_&H$*m%fx2V}?wfmPx%cH>>vWbcS|We2(-7JF z(#W?KN5Dl1Ip|Q@FH~sa9J%B$ypnd${&?kTJ?+^(xtNO(yE8hQ4$yH?;y;3i&Urqv zFC`b>_5w((#{kM0r^ZRDDdja z+Vq71)gd3y9eYJ575=y{FjwOPr~Rsr6sm(@ZMh$p$XEOyp=+Qv4D!vNtk=K20G0d| z%N>3mN4M`IKRwU9az+zI&AR3{v-_yvW4-DRMEag zJZul<_MS!J8?8Q>L4^s#YFSaSy#{zanw!_sYJ1CPSuu7vlN5&D1QzIVN5%YGG}XQ6 zB8MJjN*jz`zuEzXPCc_-_}Z0tG*(@%1dV?Gn{fr*fouBQdj*_~4s;ktAG!jClPE%G4nF27SHAmynf9FF>P5eCp>{ zhGTt8(M(z-bNQI^FM%#ZvM^%(T6V2crtUGDwu5K@uFk(dQ4un&u?h{#}69x+045XJSv=xY4!U_B=)N+Z2QAHGxxZr zUuA~`FA$i>^RxI&M}S%V|C*X@?=hxEUgKmyMO@oUNq()cnTsh@9m& z+c1Z|8QNgJf1^#mn$P%^_&ap>PWB7aS5Ffsd}l!{AuKZKF(|K;BMev3B2nkr{%0WF|$!Iv(8@7GICX&Qxd5X&DP1v->0^qwPLyIwcGa!v^)U9-0NBfnR zH1Md&iYW+ei9e#q1D$B$ikW~-x8LUcNa>%~co2T!OkQEfYJU2P#XQlg4^YVugP-tU zI)1c(nCrjuCIeHa!Q*Ps2^-WtiCr7N>y~#kt+ISQeRd4auKp4AU8m`BC4g@dYhknR zH$6t5PGJ4d(_rzZKAFAO-14}-i;*y_uyP1i?!Ef;VYm~aE-lC3#J&j~w^V3tLm=3# zls^)o)%BdDDnmfaSv3(gTM36_k0SnQ;pA}-mbf7z^+{$)A?YYv8^nFsnmHP}oJP4h zl#YTpcaDKi@6tqC&mAnOHH_;)c#`gPM@~rFZ;4_r*T^h@_B6#X7CK?q>b)GQ%q0iDNieLuO^xdZUSc=VQ@Y(fzl*gy zgyFrXc`SIQ-!|@Thvly4G3pDeK+H3wT^U!8sPOAG^|GM=IbroTscxE!{M>E#h!WEd zJh{C~d9G*MN-1vX&sr+NCY0-So&HXLG$_(yBfAlLL6I4F~G7bI13~i?yn;wWyz_w@-HUJesaV7YaV&lmY6F7r4oV>^0E& z*l9cBB})zE$6${8cHx%eix7@kX>{KX8`Xtf^M@%ayH0dLY|A%!#eAk;%Te?%#=o6B ztU>vXoA}0!)cI~KNZw^rD#>g^27Ef8%zQJRr#;}JU(L$VU_bBsij#SmZC2`=O0T;mMAcl}f^$IsHq zKU|qly(9U6hrUDzp%vT#gzn%^ijR#mONlxih@IpSR;t#(cQhk>bRYqTDq0ZIwT;`!x{ z=Ph58-z5+FD;A!p`BP(@yM)POA`?6}T~S}u2p!a!ay`fnsCiS@PWKs0IO}xs;-gBS zYbPG*PSiakst(8jwv&LRputkgAO<+&k|}NjH$BrH)7izQE$DA&OZllWTF#`7<68x% zghHY8Vw%8I!}VCG@L@ltGWb`6watu?Pm#2j$SBgBVVr4UEKpImaOH;x_567P{d7-q zH%%Vi2KhRal3Ouk?Mv?U?}N}rL|jtD3O#upP(|FJekEw!+XFbei{D&@_|i19pIGP` zuYkyUVlmmInoYd0p8^rL=A_=J25i_DyJE+y0swRQApI;XxGNnfYNXDV`+UPKrf!^V zjyF9*-#{Bx|MWp$8>k4Ys-l%oUMrs(Xq@)l7Wv7B%r&0IFO`ms5e{5`toTL{R;_D% z;OWd^dl#eU6Z6uO5P!k089OaMGSUo_g0wZC+JNo4+8k+#*ZVzQ3!g>!AD}Oehq2Y4 zY~p?#N&^#i^oFB5)(Ao$*)OEvzc=k%*x8JpJ&|clzf0QwijV#;+hx_qxyWS5m*+$J zZwLopJBueb%=_1SgK{?V5QH25|Nn2LsL9sHX`PrCBC8kk`x2e`2>x|0KI$LqRr}Nk z(tp{KT#`1vuxU;4WI^mw3Mv}bhmc>xB9e`7=;{xn>j8b4Q!8C(_4pP%#w03Bv|N|C zt1b?rhYnQ65)@(GR)M<{Chfpc1bSWc%{S_yL}b{+8wtdAq_C{XnO3RdYSVg>UWujL zw{WyN?1UiWF<3AP@Kmk%bYQ6avs52u{lbXD z0ZN`=xGnL#z{hKH=TO^!Gi7OHAFm3pVIwQ}(OZaW2Dj%MAUxZ0^T*iZU%u>F;s6w# zJE|R$mc2CS6OXsmqEAeHIVflC%Z?;<1UwL1^f&Ae@f}bL*3Z^H4Pke@+PJb)GnvVm zOLds3@65KSI^l6diawLvf!;1!2sfI+Tyt<+@i=@RAFC4NQ6GzqfB%8n78)h2+GaI< zDyn@G7Bl=U<1g`V#);Jr0Mw57-e6jju)trv8H326E;~(})k@eQ*g_RVsTk9Kr(b&d5N-ow|l^CzI;57fST(Z%jp{>F^k8L4N@RB zRZ-S<(<(PtGQJB(@`;69{#+4VWFWVGlZgAk6>0T^O@owXq5EyVe?9BF^$=e=0{+lI zD4zQJ(UGz~il=SnlY3a(Ssdv;;nDliD>WVxlh{VWMlW9XjiCn`032bDn%JFU{CYpl z=E7}bN8Rp6wWP)u1RX?R?^RE02fgn^q!bD!sUcH1BtqV@*!D&gKXq6i-qY4fWq;X74GgO53GE0tDs0}bm#?FWKrQ)J2<+H-&<@D}f`*7gn9 zS|d}UU*+5v51d6pt8%H%J++$xL=SNEpKnj+xYzufoeqocSVoZ^??&T4GQwMlJ8J~0 z=QjF<`qgC{npSSKdOMXV6n5sn@Yqk>647iBpf4Su|HjUY-38%O)TEEg z>zQ-+}1&oefV$Y5&`{RQ=}eWOpB^w^G_+;x1}vu6mTHyy!04Uz}Qq z?fVPCO%3s`v5Jp4oN|M%`6GTIAobqdN>}tO{tns3^v3)jB8El2I z{m1vemq#{u3^jN{WL6MjM5{G}6v_&-MnxyeX98;8&_?xU!y*!c#Hj6AsI(YzEpr0b zmyP!UME^}NaR!>=qF<}CSik`JMZ#+=V!psL3*C(xG?e*u@BVZvnQSJZ_}_J6Hwv%p zAL;cRZ1cnG8%rCGbW2twP4y3#kYda2^&cV6`@0#-0#ttlGfaFHb)}V!f#b6gWib-8 z^>g*;E?DLD2?N9{?G_A(G21d4*Ecpqah|P>jY1!{dEm9u_-I>sWB;a8u3bpsb@tcu zGZr)x2+Hx6L(Q{{rq{8%%=vVj^E1k8bbH@=)nhs-=-Wz94yICMO0ft%EUNMIe5lJB zSs7tc>xpF+hV2b75h9BToJ>3^Ze_1s-e<6cGicp#a>YxH{`SejW`jHQ@<7?|rB46N zPRBTh_HJg^%713(`_&JB`(k@HS$c57AjtjWt{uvD^Z05;!hQS3{n{$yVC6r6g~zqz z>)sjFz|1Xl6iv(a)Ag@!&vD&+F~fqFD0pErvzsd2;q+#x52rl=hSS+&ndy;moA!{N zNWPhSzxS;w6Z&jOC{|P%Qj`t$pYPhFeQr+MO6D3c)IG~RJCz$y^rCw)TRl6_>nIQv zzq64j@J!LWE5{__$E-}aBf%S6zuR3Ic7gUfDnO_k8#f zc2snLaJzg-b>XUVD=t-riB9QY?&O38J~}EPZJ@05TR2+(lj>wHB99(neeVPN>P%qQ z=kZI9WaJ!gk~bgnxoR7a3odYsL0D!`ewDb;yC^V#O}%k;mOH>26*#v|5CzAaWMA^q z1Xi_h$HbK$khB*1b#9id}m@=KuSl#iV7BcXkONk?O}HnZA?h-fxOVg7y&qQgu&tolR z5j0g{%$r0@Sng5A{GDf)JYwT7tX|ncT&oO|rpHZ#4)afvm`}rsq3{63@6fXD2&WNLs;v!d%X3$fJ!#{DfJVZ&V}K zcwSc&iVtfxJ44Y@ZOX0raI0t@P*x z`Z5x*%mKIJ%yV~Mr31W4v9WUPPrgdrHk1-ndEXwOJ!B&3FTUG+3sG7O=-C%9fJ96P zZ$mx*$4H=0`v(^$1Da&1xtOrb5KSjizEm-w*y4D&T;_UVEh55FFw9Sg)%AtcRN{#F zWp|%wP9!(S46=Afzf-yWqm=m1)rFnUjuE_*`r=RiZ{Hk zW~1ZA)N|Mj*^)ziI-h{1lxj^pZDN1B2zSexFTd|-4kxGDk^#LV6S^2 zD%*un>1xSsp&+V=+MKXMPg3XK#>*1sL!vO1k*AkC#xGi97cBf)F$ z4zzOjK+f}^?+WkVrB1TYki7=}{QBRiny~SD;>OIq%ll@--3#T@?vhHld#q*eTE{X; zCUWu38BWnmI01bUM~J&AT$=*Mg;k*Rw1@1=JT>8auroiW!z3p?tY_BkDP%D$`R06z zWKNm%$MB`V8p=_$i{%|eF{5Ep?or_o)|*8JXnju}iu4%CXhuj)eQW<6LJPODF6|}+ zB>ax4rKppQiRF)GuR(Lj&LwWBEAg|Z#BKlq?V)@OAXXnN??jaz^CB43jGzY(KtzI( z3Bn3K1@lJ=9*iAb`u=u*2dM5W!r3?J?zi|e=mzntk12=`EHb#jn~A@ek?fZ&(6bYl zzU+R)nA-|F5N55(ou!Noa*DgjsyN%(udt4BUa-~CF&eo%JR zot$si(!zJ^0#aA6nFZiCCSHAKU(MXw^DTAx(1yChT02fM6&60n3bA53WgW=2^Nhcz zA3W_<6hf*VvBYC-ugGTQS@1QmbBJcMj&Mi-VRU(6(`uLB?N4SlDYc@}obV&7x#hZk zJn#rfe&klRKic}OQyE(M=xXu9VD_+JOwRpZ;9B|jvlf8@y)K(vUche@zOEjBN_kkU z@esRrMxiD5JDFjrbJ zL@$eiYlzQ8eB68^`+h&IJDArslyse**x4}c0>^9Z`FX}T)-x-H36a=hJEo$VXwsS9 zwMteW;V%n^z}SWTglNQ z@QTH5?`UCkSEMP=;(X5fqX=Q`3q_i0IzL-9c7tBP*!d#X?XGx}XR(Y`Y zaZr}nO|@ga*V~t*HU|$m(xdh3;?!>+L6ps2d%iJu%19Fl*SZZaviC_}p;`JBakl?T zWffm5jpskcmP}zadd7ZZp9x*z9|}%UOS?8DP1a#Tep8>a4*B)9?IveB#+1c}AvB{G zi|z)9AzxMBkczPa^)~U;GRFZz&5eXx4F+wEfbi_3tXL-{{9E+4KGb2X14SmV^)j;Y z5XqHe>WEgGCqx*rLR?Sl0%L&GMXKx?gEen!qrxvfhlid~0&AFRj~q!M_Lg zqY&tsQ7L;2r0q+}{^Ab*nrw*CPKe^~b%=Ijm%kYUYvd|XUhA;9ZZqPN2zi+}?YXDO zBZ&b2W$_Pn-+a67&Xd^pbm6*t&phV}wOauNCSm_F!@>C41jTn?j>rSA`DNAQ5GbS9 z!vy}b0LJ8^qoW9kE6w4<2kG~Teg&kM3J;0h*r=r@GH5QzHwF{zEl37gt-hFclQz0N z_c}73wbWH!4F3 zEK#07xW!QwMZ=JPb9LU|>)^-m$-m83Cg+vu@F)e=zJ?+JX)Y}!{ITe9TME!wgStlA zrnQ1#-H&|tKc!hH&z{1ImU|X9#a&!&I)Zo%$S8=5_lJPL+phb5(xNDy%Xz3!6pHD| zd+HykX%C(Lu*Jpn#W!`Y7oHpw+X*oUr(I0y-^STxRDdX`A_h^KouFtlYu*&dVjAv= zLL)m2?djBn*W~#xd*7Pd4Thi_x|NbGK^A5^P)vX);Pp_OZGLWnAX;mb3mYH`f? zW*w^?G`K80!>}H3v7z?F+hjeU#TG%WYB^9$(12H7rFAhy{qGmg#9LAQXH$S;_5H-z zeVdw679zH>ybnc$JWi}Rlj5X|@uuxb?w+bqq0^cT7^P<#|-zN2~Zy7V@lytKRdQvyVxca@0N zTc2vI%Y)>U#2#Y~`}k72z2S`~i)<;7XEy-oTC4c6qZe`T|3R-&PbM_ZBNL zJUdN2iclXDA}K-Dc^+ZWZ_$v8s~5`8j9%n3r?TjUliG6S?}376Nk1$eB`L{B;#=T# zaSKzu#tmL1tA@Ys-EZq9$oGNx%6f;$4P;Vq?8%f3Xu&V={;QPOIBM;?vKV`EEi||= z3Fho7cVuENTZ6`anfzaVi0q7v!zyl=lrk=wgCUQIi8~Q zUf#Q&xxQW}@?QoRc>T>j8|kwZ7-V3t>iyE{nzQ{2TrXhgvJ?03jYe<3_Y9UISE_o# z|DdaHhi7$2shpU@8g-+A0Cfu-(@k$R3>nS&lyi$g-K6(8BQDlDW|&uuX1qjUFlpjBdjsgp9{K3bwD?eR^r09x=pT^}Vv^P6t};*H?NY^Y?`D-v-Y z2|^5mOD6>AD-9^}E1GI~MQ+5p^kCE=YR9ay@LKV(u}2)M%wb)={@O2ikXZO2+u+8J z{m+KYk{*?;>3VOOq=4AZ3JKJ0jaUWD}D0N?X+eHxR*5 zPelI#W_efJufFphJ_kE5$(!Yovi&`Bs*>xbaI%}`_SDvX+3J{g>hi;M^YcA>)jKLx znLdYz`jM*BL)e)X?(0)4JJz`c908*mHU*;7u7hHiYGutZ^fcKZ$^y=Kal$45`fMlO-7ek{w>>3YpP?XY2Si6$LQ0I>nL---z$EC%n@yJ?zNqjxQEl$ zaTJ_gCeCdraAGH>&O;SLj%rSKmMuRL&yD$&dcbbp9gJz52e<3qj0IyMujeZP_{#*p z?8t_$@cuT%*d-U<-FL6#SGvuN>m@5f<2lQ_8qD z3Z;#AFWw)z(JIWx?6uD+26>@cpwIUiI$Jl`fbJ zOg!HenLKf%tZ|b>zC%KI7(;5J7yIX+6utBQJ2b?#w})^TC1knQoq1^UD$oow)^6;v z;(1Q8R2ZK5V`Z&p>V05TyII2157yYQ9VVG4GTNB#-*09vk3Dh_2;W6GbbMrs98i0S zoo=5Ymq=}TLC)%^Ebc-ec6NcG(W~_~h~-b)ggfwdJLYOG)gV1O;=mm#v(tfg+P)E% zEBDAPn`Ylot8s5M_*g2%HW}gkK;5hAD^{}xxc>r0yWsAU2Fhhn{^LXekO-PG4NQFT z37!1nQzKZw9}sLp1@(kyNN!=@`Lv;|APvaweetp|;(@7p19G*GmRu2ZeYbRN2^IgT zta-nqgElcZU1=@4J>;3doRC5|iL`gL9)CjTPyqqa(2kGNTs}~QZYo+0!71LV{fc?b zULT*MzIdRT^V3j)l^@K^-;tPIA(?@*^Q~<5l~(!-z`-^tNk5oT(;N6^`o)1i=1vtl zz4sC#X=8PiYR2>Vtz>hNtz)$8A<%jBj?pT&obKGlP63K zlQ*tV*BPHS{^)Q*yu4#JG1aC?=!d}Pen_18@(~#$?Q=3?wtq$>Hm5Cnk zPh(^2Z+niclUjy(ie(m!tHU?8Rgc16dYvS+h0c#VC`+BpCM|NuHfv5`)WfHv0oIKe zc%%_??djyGn(ChBG4lXe8%8TSu`4E6=x7T0op_ zZ)2yF=X>URA#D1B-`nO{+RxIzC<^Q%QavgwRBA&4z1HDfXdNm?P9e`_PWWMm9Hyv zf}gS`Wc0u#wo;*CoN$ndBl5zXWpL>AkmQZYqCgX@Q?3o`$9hXl&?gWx6uV%KT_~dI z#5A3PF#A^SHFR#bGRx&QUb$F10SQyql_XzMk-s`McIB)i z*N9l;w!nmZ=uoX%U$jQHZo>ZJ8IYp`cZO#S;k0(MGWZj2n?a0N=r}TOR%$>lrM zzPDXO`-xa zqUu8m1!eu2^wRsCU*>?rjn*FvQ+d@o`rSjB4-%^Xvb?vld>>^tljELHF_i=S2gvFZ zTOtWrBaO>Pm>G_`gXyckW+esXLfzygvFM&1E$lK3wF;IQ>V5cwjb+F`>U~?FOMuiy zW_@osmV2Ntmq}H8+)XJyWxF)8Pgrs$$lPu2w2h>=!6RM4!-cJ6&%2I>s2te=WBGPA zcP6fSE+>;_VFU{5kkA@8LBfXiWBM~thnBpX^M|ZpmjY5-&Ix*&X1mob$b4slhYif90tt0PX&sUVqyf*$eN? z@nzH@^`6|FCJ`e1kqO1QaVsv5fRkQ&KXRBgvD=at@QP}?dX2vXR0Y3+vRVH1Vp-Jc{ znZkqk3}^+*Afkff2g)AyQov{22Ox9IIQjw35pYJ7sN1v%{Uq^b5oCkAXI=G{>3t~- zf~ZhICq$He9=7W^fYO~-TC`LG%1>2|Q)N{dW@}m0a|CQ=#miG4K=k!1wI)HvDgJlTVm6aLLM{Hm`TLnp?_Wl<`M5qGY=0l>rYzM~&r<#9t_v7VY z29oS|83S@03`NGS(-3CP(O)F9e~HP_1YFjGKL6>$G7Plpk^?1;I&N5ldF;_n!d_b+ znDT+s`j5=v`tn`hK;_SSORG8aIxz#+Gz|~L3KyJ+m%Rcz0(xFS5mlcW(`1w)i}~(b zMZ5wvm+O5C(W&Cb#NFg_!o5VboVgFM)ag&ETbVxhS+4agseg-mY0L?B0V>Eh?qcwi zDW2;>(e}miEXZI zfhXcaYki)ba0L|qm@1eJC+?g-;JCj=TDEu$i->61PcytA4ST*5%H^}(@%NWd=Z`88 z^s&VTGD8_%IiL$d6s1{@b@TDWtcyJf4>JMftb#zIr)iUWpZt7%ylF z)#-5(=(!ort`Y?*dm+yO7Rw9Siu%x8s|0qT3*0u?!0KXp92JEfs%|T~BA^U>h>&q> zykn`+)p*Fr0uBZR+?F_+I}0fog0lRK2Su$JW5wEqT6Mh4DXz_e+w9#G%A+Ft7oxhL z7ruFo46d+VR!@`gEcILGqTx-=eUY|SL*eM$T!+7*ExDV~cdx`qxjwi`o1l?#c_n}D zW|3@cop_U=ub>b5itl}do|p2wO;!$#ozK`}(L$gQMdy4G5$W*N@8YpYYh00Y2uubN zHzu(SXQN)}Tb4_-bd_iKRo-*iy*3;t8!%bRlNRRA1STt6-9lTf+zSO+w$7GC1h;@$ z36*ozcetUNzhhcy@xb#>8Ne)s(n=pzzN4H&xX^?#t6Ny|4Pr>g3t!|dEob0hF8!4k ze3&HqO-4S@JAk=_HHT417j4uKKoFQc!P0?9V^er%SO|2Nsz}WNk$lYSHVO)C0sjO_{+#s}kL!Mx zl6agim;^cXk}qVk3zmA%fYiMM`s4eH+dsNLpQwZYUoBbHMWc(q{RU3B?V?J&fLSzM z!d!gE|88p|swZS7$6QtBVtte|!9b*&C-ec+a315C0$z@On&O~m&K;U2Wb?-t+SEPH zj4Lb5`zyTot;~%98mw>4E&SSLPw*F%0s2S55@`FqJew`>*Kt%BfpyW=tsjQnmiiYGzDEv@%rO% zlg;p`BLt7w%}PHgDr=v26SnfWR0e)s6Xu4HTCVAGV3OpX{?fh@s7$L%9uU_tPj{2@ zn(#yFm8z8x?<0Ui%y#JX9?*Y9kF(A)_RCHR4xrZ3 z->=fnFFS*y7TqVPq0Uz|S-+FlBS6>79|2|k%5OL5j!%0Qw!nH4Bwp<)^}X8q>@3#R z%%%~J+uJy>xV^7Ux-s*E;-BRm&HKfO>ZOsuR2aHH@zW)y#ljS?er?!3^h_s^;a@D; zgAtx;6sCFqWrThFpnwrn&sq5RC8?>jeb;^Q3tSLGSUQs0`1On9(tVmI=f}PsSkPk5 z>T(XYe1u!O&m7bG^>6hl1C;Xj1FLN}LNXUgHOq$9D;bBBm4L2q)a00TlAt>I&^vMC z#r3+L9XTv2d_8X)teGl2GI4_ikO)`OE1U1T(r;srqFM-+5a5EH^i8s1UAAJ>Yali5 zwJ}1#?Gvow=mCKRI-K!EEV`uWLoAyZ3xi-IRuqKyssdO>@c7k?W+1y3Q0l`pR}-yT zB+KI`4oy`Sh-R-4b6B;Ky*RarFcbM~V^1tqYnS$@#uf!VpL3J+rjo1A;n34rB|(d0 zE$_Yshh$aSlPOX=UvVYB63&xiPmWcWLfA=+=YniI0_*9xyE2a+(~4JeBG|jz4i8r* zH^)P2bTLLe`Q5Mp0S>|enIi`fe?rB4Av24 zIeOaPtHw8>gf+Q<2NoF+Z~rX5-UnkAh@PsjxH?;m*V!Kcky*$_$?seZuPy}TUqm<0!4CnQ+QMl)@`$o6SyniiU-7psX`mGDrPnE>$~Gb&FN zj^+#;1se`eIT|rfKFm^ZmaBwH$dPPk;(*BEIHNYsxTfT4z+|2Aa8}krP2GN;kZ$0< z;@XgQiWfUtcI7^&D%T%mq9#b*-lFTu^#`&d1}o$7bqZb%+&?2(u&Z6X>y_u72{~(m z+wBZ31{Aof-1SKMF z#e;fmc7)|Ay!5~{ZM2B()DsjB6eeZDplKP^nvn8#RJPe#^qk$Gt};sOCOP0#kX*#? z_w{<4+{s~idTy;T?sX9)%$-LyS_@7I@^UeQ{@}=7n@*1!XwavqsOgf9MnH>Z19ekg`5PW5B0KW6=V4uHU60F=>7c`)NeVa}N+S@LgTG#k=504ntW_Q=`GcS7C27uSu!+JuEP(j;{LhXYoxs^i4Bs))77ty+No~ZaGKj=z1s<0=n1(z_Q*Xk&wkV8Ab279 zAf%^p>b6m<{edevpTECh zW0aqnmJzMo@ubt)J8a2hO>tspM+qNdRTQ32(*@P|5 zF^mUHG57Chhwl=uB_ND7nQykab%K&OGAFhCu z6ipEJdpAGH&IINd?gK7B?odph%j|`y{zZ~NW`r|>gKd;Ak)-DNo?h7-G%5kHZ`Rip zTBN8xcVH-=CEr`4>UH{0nx#E3=((NA@e8?LDekDCoD+@b`r&OCULvKF#dl&T79&?y zcP=&daKMXkK1Eqn;fY;LqvByWHl&3#*|hLj_*f_}z_4^^ zIdZ#rp6lE$yt3q|qleG&S`}`X^D>vG{BzsIb17PBIX|0UBUXfBDmr&G5?N(v#)1=>q%&$xmXo}GbtlS7Z50nT_xK;j{}DXD@B6y0_j#S?>lEFuq9M+pqlnvKY`?XFpl1><2gnKZ zh|QpGrwd>?ln$E2p-7Tk4E?%=%A%OZ4anw(`?#ldI$q`+DZLHE?9>E~TwpMV3~@;9 z0s1CQU79&`TJgP2ANAco8Dm-eei8kH=M(y9Tw9i-EADn7L_;4MwZ&B(QrLK&?+PE} z@3!?rW{F;&ConJQcA_vRI=8Z{ z)AG~BI*v;+DwAty>@IT9<#m2Gadube2H23Ti>O~d@I6vwt?_C35Z!>zccBcK^5hpxMz&)mZnY!8x8Th4GH@Kf$ugh0O z5VyUq8g-P|nwKKcUy2%#t3TJ}f6Tdr7Q`kl*{a<2(J=F1vGH#4f!em8bUOn%WQmux zFvq=Db@(2t`I#=bz2;>C4p!b<=gn_T;3Fo>@oe;Us!h;vh$L{ilCj#rt%Okz)2pE< z^<~tBk-q>A?8m|gK4|eJx_@bBN@kMgWA!t^*%sE!D4?*{yVEaSJ$1r;H5~syi}4(u z$i7Lcppk~)hJC1>i^ksVF!B2MnUNSWlT-%od(u}yC6++0j@ZT*+lAHwH|Rk#t^9M1 zsaY;6|I8zlgV9Ru_mcAslF_K#Q(`$h5WP#+xl}AV{^R_?KN^aGy&L`KE2lP_eX@TR z7&K`E-Upr`$t;RRcoFPw!Kuvxo~<$S(w%~9nk|-_)6WW^+DRxzt{=Qu{5ziD`T1+s z)HVyT_7R~Vq#e^OUI$p!*jhGpyLh@mTQ&jbd+Lz2rRkM)!g~cvNZF=){@~DZuh_C3 z$AULIBvO&c_Cv_StPPIEjX+QHP>Aw_69uL@2g*D!zt^I?wT;NbRHmk{^Fd9Zzs`ls zpJV8r^p*ibJ`Bm#HhPNzrz2_8jP)gmkRdh1;=;Skzab0dLRTaP`Y2o08?#wA13Y|Dc=WPrp2y{ZPHTf!OWfPme+^s6=mNmcFUiR(Wn3v!wbLvrsa}u|+Kt-|*|Izj-wsYy+=u zTyFPUaVFR#k-V6nMA(m&(89#-bQMJ%Vd#-oWuEe?wEC{gLH@8+c%I@c` zbZzQRiIU0oJ*Oow3sCGRi}Z)jY7pl7IZJg2i-67#|H8P`h@_WY;H2D1S;sJ1*`w#Q zidOe^@2hQM4%^tH)5;tzV(l0>o1Ep^lBQw;=s`-T9MOklS|IUk*g+nzV5XBQ8lnra zQvy=$pbxFCqkVgCpF6UVISp=pJ;Ehglws->IH2dy_tl-b=-=X=bO{0qm->}?SL*q% z#`a%qE>8crKXEdvFR^u-&!DvGI{Haf^Ja$g5x;hd^u~fSR-UA(YRA0GQJ$lqZ|7qK zrOqBTmhRW$KDtX#x_5>$^#%tvM)fqrb)Z7l-4>TsqqTfg)ofh5ez+;?9HFotjgwFQ zYe1RhS5h`Daf=M0>#vvE=8Z5t<1X|Lm5^NK;eCM4-8q8h1J!)#_{Qt*flaS7o2!%` zd;^!uai7erylzONJjR)(O9ryxobX@QH4w?rK+NwfBa!kEmE}KYue>k7E(RNf{-{>{ zEWW2Y@D=ng)cwwiX8|H7H#$UIzV9+#1d7f``7^UlrkZ_4gU12-%D=LVj;uV}0G^!( zBaZ(Okk0Kia>J-c_!xCYFLbpBy87AZ&-+KCYkR1_u(u+qH5zw3*X5x9aYem!W&hmd zNkM}2Gs$nRp!d9*UTwsUIpU{#06g%&CPI8dJQI-sxZ4cOZASf8IbnP@YzV@#P>joKC1vY#NrF_%Qw%v zi)xw1Ffj+m{8YV3Z%fRh;|>k$wL!@N=9Ai;!nBBLUa-R5^V!%bmw@FbC99CH@}H6K z89iKiH*0S%Qw)ZYjRK?A?@l@d3!ZF#F6;9`^;A|E6B8Owys5VzILQN(dh-32{+>VA zZJ~+zp@9iZ3@Jo>Emh|pPJ9_Z+m>+Pi`LH(NzF!twE^$VIiop7^^)>WgB)f7-w8a6#I7*dT<+i+xK&*t zfW<|3QH#aEX8i{EMr z!clZ>f6QrwH|q63%Yi>zl}#+(6CS^>J|@bgGlt%hZ(A!2FUcQFWG98zK07?;<;dQ5 zsMma?Xf7?}TDEIK4H-FP4aw`=1mo(Waw2k*n(?)hmaQq$;<)EzeYy%Wz{ep=<(@V( z6ks9Aj1XV`de! zr0mCDtozStX!=ho?&n`T1v_rL1&su`CrAAmNUEc0LJ!IjX=t_}*|=5SK<}Uf0>2V1 znA$I|YdBN5I`s#awXDog0Zb`3ZjOc&=r!p3AZLV%VcD7-* z5Y0K?-(2_J-5c7w)0&VFm6+9_+dNPwm@`P_&?Lvj(PPoi9M44KFKhei$TwZ0CG}5z z&q5-$=5AdK_mEy5-KDz#N~{t6I|5=7+v*09ABRBw+QpRrq>;3~YbDL5o5h*J0SF*^ zU+#Wl$z%-X3(n8mytkn?fp>#t$Gz}EbP5(9gtlgujI1&^ZN=N>Nfnny9;*(;Y?0i? zoE~1pgj9)xBEajQXL^D;AgA$x{LLg{ZX4^v1ILHEblqW%mNt^8!eWtk zCsUJRD2OKQYTTx}PkF-IFa2WXw{W0_#K0k|p$PlS@+VbP$A>^7?)abqvfZUA$w}1w zMIP4W&lDRtNgq^kZG@uu=GV^>4*11mcuX_O+@!CIdRP6wjg#X%+Y0+KF@ktuGYdPH z5WNKf43S&GK=G$(?j?89P7|)}h^`hJdFpIMfS+%!)gvYdm)oW}cSA_Zj{|13eJ#)@ zP$zsFEwQa^ZrzbEuKK?R1=q9>LV8TEhlF>Wy;%^wG5uLrx~vE5zTyYfNL|#=x8Coe zUHs)>O0|J`HvrlHQ!zDV`y%?=ds!Sv&($MhiJTHCV|%-S*2|T7 z=LxKvL4L}8wUQ@pqf))2_1VIX+R!plGK$e`lIl@{!$7V_VI@P3)NFS&fh{{1kR(sH zr*hoV7xD?Kv6zq~u=0;11&{UrDVi1J7*Sb@!gvYX-QS{(TGe@nM8xazC&@uI1m`~I zm7wqS#_#0YnuMyG@Ef}M9lf6J5nI0hnK^}8uV9LLjoAa?%GN*X4?YV<{{7fGxEilY5g_pFrIK&ExIFv)X@`gkH}?=F6qS zQqc|R8QNm|>VZbGb^E~~GSvJ<>UW!TZ&vQ1Wy$n-vq;}Z=hs`?VjRp08VK))SNQX> z_fbbBBP6Z!e1p*Hc9s15g*j$x-S>iz>di^Ly>OKc^ph8Jr*ua{-T2-kl(gPrz8o}H zoP4%45<|W>v3vZ|r|(AT&9{$f)_l!=j5hHtYRE2GxI>R17{?j;v9cDtDCU7}VEpKE0h>WF8Qce>^^c-XsQtkOl% z@MPxdjA#|)wceZ+!Lp4)#mM{LeewvvbnB5F$=1C_9{-okHL@4AxjZ=ToxbNA_V=7B zd&lU{inW#GEh>uen^1&3^J-Whmqx<)=D#5q&3g+nHYTVS>flFlb#`CONeWhio(E#% z0xg>}E`?i->@UOCsQNCxuIdZF|Budvwu$Tc4D&o@Gb%HAoCHDEh1HamQvNBn%D0^n za0|v3bNNA2x#?bF)Xt@=!V{xdcG(!iuXXML#&2*u;3maU7}8H@QJsNt`SdKuaEn)# z*9B&?v2GGnaO{$KlDzw5MQQ4C1(0Sc+)MNC9SEq9{uM0p(QFky`O#@Vt;zwbP}CEh z`#E7%vHE1c0uEs8&#NN9aELjs=b4;uh^gj(T2u1&T+4Ia9lJ27JH5MHpC%7j1mJ9je2l2%LX9Cq<>n&JkR(~e| zW^|uutDgXP>HTlZTfQoDEV{ooX95XNIy}~-&1_i###-iOU^L`szq!muaYq?fvH>pa zn|UdCeKuk}I)O2u8Wmy>Z=X068?)3I9UcfX@?xzh#=QUfYKGeiU$&m4554 zr=6@1lE(S!NjeztS7}0%b|Os@vKDYB)dEst3m~aCvI7zJeNq{J2@Yeo*9f*P5FGH) z(ZL22j{lBV9-lw4yY5JA9#D6XUTj8iKA_*zzi&|xA=&M{0U30Cr0_Iyz;BIa@WWzr zIr%;n8GPd{!K@27((L+#XV9WQKYACzy4(&-;9r%a18&3raAH63&7;2nOSrM%bayNk z-h3PoFsmT(&Bh3}5i#&6yl=@?#mYtv{r0Xiw56l!QkD{SN2JWYO)nLW;9+eo)n$ z;VhT0s{<{MRM~C;Cjtyp)%YzZ0;BiwSSvO@G8>z*FsO(69s>mFs3TSUsg^pR`9z^&cEZI4=$dEqVZR#16kBd^Wec?8K2vYfDLzy~3nz_YJ0U${Eg&>8~`cQ9vJ@ z^rPq$C_036*JjB$%}0&g$wE^ zU+OJ8R%w*}regRhZ+N*R!uv)Ds-G#|7};2AK(Eu@apr!!kY`(@i`aVOBVYVy!&n*! zAWK;Xawo{Zd;WzZLQs6KK$IQRLc+ecJ3WVd}=yYiT9g; z1k#^;V8GKU(7OrI>i12`Qau)-V!SzTDER2?>4d@G^(aM;i>P^gprzTFobpBFnuZfb zGuQH-$t1q+lo5+4#CQhoJ!AdU=yAybM!nB+87kwqchhNW*60>b{dM%;`x+|aVV}NM zeCU5#RWu~wmVikPVWE0Rtg~-=VzaTVNRYkkkId~|M=(hS_)qh&94cS@kbP?$cq8U{ zyPS7h%iH5Q;7p@dA2(n0q{-6gO^Pq7s9q3w&6QcC`7!UMjD*&Gp%YztV8WGNnmS20 z7x)S5s(+}uO(uFHd>1f4U|!&lKKTM_>D*#k8+)tWg`%GqZ2BAvRd!&PnQ*55I79I_ zccKVXv5LRddQT8$Jv#hHrgNeAVY64Maa34Td^b^ZJqm}MX*BbIc6w3Jd5W&IxgcG zYTWB?qPDejE|eJ3`(fkn&p&PO7;@RVnT#8%|WGd|4^e zG}MeYFLg@4nX|b8eI9|Iw>7_0@=DWkT#=hnPf%6{D&lh;B(-TTo9C|AZc2><^2On* zO9R2tWzwHXV1-@*pk=v>s$p3TMx|0}6skO0G*z`65LGhX*eE{%xE}PG;#oZQm-@qC zl6N}&Wcb)I=zipnMCWMj7vM+|8y(J1!QPIBugMck7qxu!byp8X2My!+^3!i5$_wd% z{eZ#PUcad%szxVR&Y+%nF4L__bepQ3=AUIa`29gQSzHT??<6bA)=)OT>ZKdm#m}Vd z|C(8^2gmjNGV|c&&(Mw6WBYQG-lZxGS7-P~c%WwqXEYx+_1V@5M0s z$Q|pp*@?-giSU9`l62)OE>u%;0;#sJ~=v>kQF_iTVqsWgZU zcJQw~789S239BFZ>m?IIWc5x<3M0uKQE|PL77AKji&GB`IfPs$AA;wF?YB!Ms>KMEC z(Py21t!5?c?&TJHkPg&+b=!f(iq{Gv1WlOp>6f>;cdLR~mUKx#aaFJR?j&}?U0Fn3 z+(jEkWfFR%c@xt~v>N6YFyc$W`L(p}b_u|0=tq+-s0T_E?EzhzgyC9uLe01_goAjy zw?J9cn93@iXdVZ~3!7h8rCio;`_h;`q-C7Q(2pEn!;LsIYD2Oas}qhbsn<~y(ZT(^ zS@$Kg7#Am|7f#V>3oj{Q)-PQVmM)8v_B5))R)y0osZpaGHdjL!g!H$!#D4ELOux#O zZDy}`x+gAlX6~L+TM}5Wm8F5^c?H1!Z!iGDlE`w8dLbX8buq|2U351O>Fi!re|Rux z`Ayhr4&)PlKIl6xd?&s!dFfkS!m2>uf*GrwlWON&bqbo6!(Y|#bsB*7mLV$JJ|)=& z3D$UKTDb?tt*mBl^)K(;20Gb&44Z7xxx)R5wUqVs)mwo}=9`(T9o+CE>32HiyHw2^ zCiZ9@_{pp9C;tx-xk>$PccJJ~KOpL%As8R4W9j6&RkrH*wuwDRJNEsiFctT@A#W+o z&dMC-$oJR)i=MK{g?cy^BFBNeOZg67(fafBWt!W>fiIpE_LgEzjtx?(pZ^K^tno1o z#cY7+LiBga6FvUg+sx;#1ofCi`K09fO*cRA&-T1oDr!7@FGvY-)3?+b6y=)*TF71P z-98hkC4O02vKZIIMHs#0bC=*o3bJ#aTPJ(Bk2heC3Bw{3#H-?-*Y#zhez`1g3!_#V zb2#m{?I4aOHR7@UxdSFm_uN}^s{)|8qSWgioHNTGxWe@Rs?C@07;rfY=TXZKmzcNhWCeK1Sj16c(vrS46|+^NFm zoanPQ6s5BLq&d9Qlg(C;ec(rZ6kA*-YcZsYSjdU{*X;U%5!BiXBYA!62YhxLQA*B_ z^yyWNA9Phg#-W4-h{hISLu`5;!z_&pFj~q=E*aW&TfmmDTa+k8ZEj%KwsbSYqAJH( zcv7a~rZO8&8k-8@9I%9alAk^*0@ZMw;a6g^jpkT8Rju}8fH*SKn5WQI`{+Sp&) zp@AH0_6BZgQ<1H3XuOR*9pZLyCAlQ%w!iy3e1Bxu?qDLr1u3o-n8m9ec-M70%oF5X*OgjsTGwsD`h)jUJI_+66 zPMLC+gwc@py4u+!kNpo8Cq-*aC1uS05OPK&RBG`WZSaB%9f6^jY{@8oMtwrDRN zwrbtI3OAl3O<=FzUpqL5bxYnRt_QHf#*e3>{6w_kwI}29I>in(nlW|NDB(gXm zNy8x7SD%ojJW8lH^%N-yLCXJ8&d#pv=;doAd`!OHi_*x~1{fxK7W{PFy0-VusPL*c z-{X(!a=7xG@;CURe=6t^VfDKcPPCI#`Hrgu8#Wp4CFG)3K6<7?tJ5C)!G`8Oia7D$ z1v7PuxCKA=0m}%ld8U7j@21TCcSe~74~t8Z_)7^tfM=SgtkSO%LArKBOV&l2WpkwK#`5YtE>jy0UdiB9aFm_cq9qfbC(FL6&6;#Kc(9SS*=?_ zZSJQ|$o~a-y+BWKVfD)2d*D?y;Hi1T-S_Pk4f3G5El%rjHuusMU4W~5=pB53-wJG7 zNR#p>WkwGD9 z#3Kd}slVv(23%vFGqrQx$^L_p^hd7z^<%pwTSl_EpG$qMuZLd(UYK)g1i1yp!&qe` zTA9i~Pnm0Fl-&(ZDQFxAL@Ty+;)C zYa4@v>r&Vopiz>Jb!8=Q-n*dA$`p~u)0xuoJ-$l&%~^f(2j;D(OaEZ zJBdw@&*|AmE&pcONM@ZN*}44I9k1%(Z|nY4)1NAi zw4&Saap^1ix8VmOi&?brIhc@?miWuP(1XasrVbR0-U6Kz6{Mb8?~&l(Wv4n{&&u;` zyky^GMUelDm#EUb{)i$A4DDBK{QejBT=_b@9VL9<1)|IuDgGU`9|2yG#dKtv9wmZ z5IMI?{UBESN^=1K=n-6KXdI$A5dV&L1HbehV>rQb^GQt(N$EZR zIaYN>ZieM1mBbO)EyICOG_TJ75Ukbk{evpt4Lmp3xtHP~=5|mWXXJy>xmkEC!WB#s z63^@JS*m-QPf>{LEWHW2%(JcZv;%jOtA`YC zw_TkRT*#TbAjw!^gY<|Z{_3~yt>mV0 z$!fj@M0V>~*jeGufovY`|cm1g4ZJ00u&98?~lq|nAv%7peNc*FM zZXpY&h1-X&v1g}U3H!9g6^dJ%@K6oVegjaI`T5P%`+7>}pETE9Gvy`=`k{W|YxW8U zSlwls)cup7DZTwvD(fgUtBT8BS35#YW~|W*;kplu5!n-HWvO<+&m&q)4P{e4gXTIT zpjj?+zLM(C=x6+Hq}$SOstz{-uL+Cg zNex1GezevS@Cv^gEL|*ww>=kUw5q<2Id|l*EW}$D2g|vHW)aWTP1j)MP~bVz(nl+m z+8k+whzmhAN!bJ9emCjF4zCRMW)3Ln7OL>WF|=w4K?kc-M}GZ0MXO;55W z47{IKLcHTaIwfIf(1Z(_MFj;o#WP#_t>+$)2PUMrl=Peohb4D%Dgn^fl{(+c7WopS zi=-GrLc}gXS3MvRv_+M+>HBYatjzCw^O|DfhYTEBjP5o!#}u-Rkg@xad5QJ5E8dUt z>ktrl%e$38AHmx&m{THN(P}v7I=Hl15XAt(cBl{3VrY2G#ZNq-gcp= z`InVluyUndm^eV_VXTM5J>#=a5pYCjE`K3ridcujnDQy99Z){AK95!59MBc@tYu~k ziQ;jb;~e2~>_glFw3(3@)Ayz8qa6{aIagWJt1HnZ+ffDrZvpFBO!z=&dh-xrpD) z{gC|@fu8C>TV$*dRI(IXuXi>`PjPDEJx2K=QE{1Xopd$tm*Tm4;N@Fh zbpUy`t?oWly5{fMFa8a|NMtgGThO;uepr~_qz8`Ea<5p4c?U}18>!s#s^~&k|2Ewv z7DErPhLqHmqF2|C{fs2M+0gVBb$3^$TN#-vUCFX-wbO2jmfnzl{Lq+4T!qLzd&ro> zP{Hr`R$p8d>w#UPr=lx{r$?47xu<(YLlvbZX*K-B5u2AS*o9x|A1YGSBg@TJ%c>~K z|B8+Migy`Mn*1855ofCHG7}ZY@BcPa%LWd|=d1jLL3*$cCBe8{v`;>Q_*rsYPx2C2 zG=Njw!U+`3+aXYN7II}M&vSz6z~_?3nu>KldKL*Pbsx5ABIe>PW(Fv!H)xNd$1w?I zMuSAr@{3e-^oinO%!a^f8(DA_x#i@w^QE3aqVwt3qvDy37Z#6S{X{wkh=}PB{v6Bx zhr)dh8J=x5jLx9OoshVwFKvM@>I4$cev!^sU$)l&?UNkIw=XMyLf4hkM!)IyXFIr9 zXWTf}tJCu`OHbW&dT1~6lOaMH2;6sM6rF!_B3?F)D|b*g$wEHHw+%1(=G9} zBaLn=9N4(go4p&NV-HntdPDMzAG~SV{Go?1Hu-Xo{l?0!Rc`-J5GY5GaIl@9_S>v- z0QrwF#qo;A+>qbGubJ@Hs%FqIR=5n$dNOlH!#T|hv*wRwbP`C zvA$fICW&OVhxxQVCDK5VkX!qS+dY%IM$L2K@2pwB8uCU7cM634DK>x~3y{7*Lg49} z)!cy2wCM1y0~PRUJ5{Z*i@C;z+#b+Mf*`t;wyo^MTWPu9@ck4YiI12p0ckEBN0N2B z7y-4ogwm$Bd$GOnw>6ew(Kf9%QykpP^*UyKE`AGSX?uXXC(QV#HadfeZ7q7b^`6eMTx1RJDXzItg>O40r_)^$4*>Dq;uA zK%lhf;_ABhv5tX8l-1z}=M3+o1B4o}iQ;(X3I{wI_+|siWnxo;ta>OFopHwwsdcz5 z0;%q^Zh*>V3?cSNe@24wZFFadxz2HI>bk(VP^|wJJ50@I^b1exd&}N8O6h(^iz4dZ zn#xoC^~5<_oWV@e#DO|9`2i+9pKIP%Klxh)y!bj8{RXUj+_$`0;Q7E~di?N7_>?o^ zt>G*xhJj9xvuK%XHgqygwj`gV`x;u+XPL#$9HrIW;?{?$`c7?~BRI3^Dx2Jz$9+)C zR|HhEBUW08sj``TjZ`?0QGZn+m5%Y!A~b=RQ=! z4a_I^bE$9d)d-W8${Z`w!LS;vN3qBdY2nJ#=W}2v>AyrPUhE%ei=c>K(_n-j zYN|Ob8~cTo7Lh~$NhDHz6dKy7v6l~GA3glk{=>3zlggtesZ~1In6SefM^Ja0IpPHo zNnY?qNzvdVqPha}Ni=FX&?une5}ED)iGD^MLT>U5w9Fj>)vu32dE1~(x>-8bdyt|K z!Ke@J9a!GB`uIW06(PQ4(I!&&B19h-L_OE-&lAN-C9~-q4t%Ev$&K&HXy>b5Cj6k` z4L4pCu+*jrYS7ANqQXBP_`xqw#p|$WbQz9+nQ%FKWmeK6k+(t4TDi05oXC2F#VPTD zM(|w6=Pf^#7Bg|7?mD}#x=6d9)I>AmpeRICREHI*f_2mXbVQoU3E+H*Q~7jPx#Xny zy2pxl`iSqCZ~F5@`H}6P1arydp2Rj^NVRX&3P>?)42^ZZ0EP&K1uy`2|qtGy!sCN^?fEjT~^>td39 z<=xTMjxO+C@3T{+6KTqm*$=&*g>?3s-uk{st7Om^3oilM@2)O~tx&(Rr$R>0@xQ=q zc!!8>S&Guj9uA!N*Txk!K{b*Ccr$UW@XM-A(TF03k#O!d8F>)pS?+sB9_jA7ofXcC zXdcO@7b7~8bAbpSot-YHeY!JhuvK5@qvcFg%X2Te$kc$OD+_a~{GO1oBj_<3pYd82K|$HNXZrfxSnpd~aYy zyau>8(zc_`MUtJ^uWdkOUi!2XA`c#Z)GJuOG}e_brOXi(9mauCwg2COaid)CS9jyI zye16NG$G+Pb!`CjdMm#GJqJ{R+$l@O6Fs)xO38uZ^s1P?vQMi3Hi=0l0s5TXaMU(_lg0Er0f_?AeJG ztxu_*?6lBw3PmUt4oh+MZxpn$&{Z)0y17{DbaN&My6q?C*jBXYV>bl`u$T;x^zfCMd>p3mwBbcWQ&jN zO`)tMoTv{FO-9C)F9{9g!vSJYMQJ!QB@|(`+c$k(m_@`^<21_d&L#&q_#EMb&>cD2 zlWr>Sk8%F509`g&vSAh^eRK)nwp1re{c+S!a7)tGxVtMk&%AZ1yZW$|=U{HzW@>O( z5CBMlQxog&vN0zFF56PO$;;t^?gL9HK%?s%d`g%Y0VA`xqkoFQAVvhOy=%;KqjDM%m zA1kEwsS^V1_K{++Khg04-^ehwiCIaMrs9YuaY~Nc_60WJ{Q&BpK>mu;gh zElb>rc`Lq^QuCI{^Vu@!PvguDfANu7x;1AW3=4bAXQw%W8o7 zr2Iu22=F`&!x@YPM@2{Mm~Gc?SLyG+v<`S2q*=hMkoP4mxK9UXGi1Wv4GRvb47ZAt#j(*}^`r5jM&OeH!?YICb1keJ&2NWa+;2)T35Yy~7=L zU}$fiYXje5POr_H*KyxfElESIc)ofEDsp#g%3Q%&$d7d+OO4H;IlJmfHuR&BkUqBN zz{+53-j!A%+*Jbpm?Ii*PMjg_<1n3_2@g>A`Rr9My~8a1!Z+F>8RrkP9e~!hGOkf=dQ>5S=rRt>MoetrQ6*W z?=WX)TB4&qNKW`vS(&fS$EI~WEr@7)DEQ6N{%bNREV??w5vcJCTNOKKvo@j^gAJXx z*Q2o1<*n>@*&qxzW94~2&ElN}(1UpYTHoK+R=09d;OKosrIr0>HfSJBo*_Ik++j=J z=t*3G2*!p#w-Azoh5{H5H2JE}?wNSxtHV||tb9t~f0XIs(Iu$$v|UERl}*8QhnX(? zmPTc6&3G;y6)Fu`Lv8ngkjW+^^c@29otg~`$>}rgX99(l#NL#uvu>FfJkh4ezy&%J zwYA20b|41jygX!P9L+#JSN8b<0^**s*`q`d{WyaNRmWxdREmJMIqTN=mGuQHM*Zb3Au7PS)z>4dkF!yR)^nrvRl4zMh1Nsd#2 z{88f@R;ks`#HJ!B=^C>r(iOg+PJ8S4RJMZ|%z~zAKpiJhf>2g?lJ1A~sZ8L48r{WR z>igzo>1YOr5pWFI>>WE6QrLBm#(1B8NdA8s>u~w9eTErl*>z)r_29-O_3a(_u6}tC zz1|u;`_*gL6xwI;(pH4Me=MhLJlqX^U()i1W4b88X{*hlp$;d(GXL#->Q{kddzVGr zLLqRoCnOZ~EXDID(SASie}3XU`lylbhHyd)r z9Y1&r^x>Rt08^HP9?M^Ht?m@W9@JYcmLpFDVC@E%cSiELb!DuJw*T7n3EH&nfTmhw zDZ6c`AtRVofH%bu)q&3t@A=epAKvh8eU*AbH_?3Y3hsGmUAvMCp?nRdk3hH0o;Am}gB2DsM3H zRx}bHT2MpZIvW-h_(DD6k+K`AtD%3We(Bv#Mns>-I$zqmC?8WlKm-xcq;dMR)nneD z;#hArax2+hG1io|d_W(!HlfdOv9)996RXt-ey2JWjVo41T10@Rf+B)zjCrOL4?l?^ zYc;Mk+XiV-m_^)Zup9~bXzSdU8dNT(6B;d@6|Fh}NMW#-3YoQ0V+m zCP(bSZ#21C=KG`n#_YxK{dAdegEO8RzT-YDZZL+uzLYSC=RJunR?vjkpV*Wvv`^Ii zEgwlOX%RsRWs>E;_8I|4x5)9ygMQbBXcd_k>nv4=J<-6)tL+Ou zB4+0O`gNrEHa(rzcT*6G`loc1jZtQ3z8rSdOzm5xz#Nl}hf;$|X# zsrG3Sf+b9eptZ2~F13$8>s9TIQlH6VM^)9xvs#QxoyMOg{jZ64<1(-eJMKZ+CWw&) z8N@^MAh2giOwi>m&*A z5(3IK>|VrdV6V${g0;A)JvP(~cxs1You3O((Vaw$a2h|MZ=}VJF$Vnmm3ENj@?}k} zY2@-jKk{0A)#3y7t-3>3tPt4C!l$Yvh$||(us)AHl8SS>hjLwhh>;I+!nYDKwlgh5 z_spz=Mt*DF0Kop1iif2sZy7EBaR;~_)oqsdVbUWHsM4EJz3*Fn>s`{?I4N1=Bm5>U zF({`GX`<{D*~Nnl^-gXhoraZoD9l5k|(m-g}#zvI~NN=t7?9X z2_BvpBwlZv{EM@)qIQ#Sk(NwHp=z#O@788t z_K?!~H@5oq%51sJt~sS8-rU1$u89W~-vF;82L2K75@kRf?HJu(;7zctkbpJ}zQAz=mC@*G7Wq$6?tpUx^i`kqcvfmRNXQEn z`%+Lh&|;|GX;n>Y3Ttx3~Wq|S^X06LpbgG;XZ>RW8Xpxj#_kDQjG-Y&ghvrEJ%DB^_@sG4 zWeqRBl8-7k~y4CTx8w`((@lLmIr2%JPW1ovq)>-n9S<0VQNat|%3Tw-SwaC;?<>kO}2G79eK3fw_FoYR@+9BrZX} zdd}B%&Ht9^_(Ei;ko~YjR+qSP{!wc6?a`I(>9@2EqS|J+X_d79>5-iXk9_=I$ScXk zdbfr4-R5Bo70aLZ1<&@Qq+Y3=zPh}b{$g^J7fDEogh7iVPytetP;V0hB)a|nk*Q#@)rKbG} zW`aB+wVp3j+-26gET7X1wCoOITvz-#yj+~ogLjLZ{^*cfjVMF$hI8OPakVhyzG{?q({vGw4m(EXSa>V0n1a{Qa z3HfTMMr(GobvoOF^*c!CZ?0b@<|k7!)jQugS&*u;{Wl`%)^*6mA!W7xUJWZzW*CCU zzZzPB$}hPireFf>LPiU&-Y4>}6>CG*EiIQXI((-k80*NS(Jsw$hHagd@^&M!*3BV{hR_zPIp^$zCQEF?aZ4I%SZil?) zmU~-8bql7mKH@10L_4%3vZ?B9buLB0bjD9i>()h?tE=AZgO4+hN50960L#*FjzV5( zvFem$d#x*+bnyzqA~CR?N8u|X&jgMbGpB9z4N?*6&3;sdb*;Hjn_PDbnDnlsj_Z@! z#yA6SXAZdBOT6y@j>hZ#VP^z=LAhfk4!!*e?*@4L`XcZWZo6@70%4W>Ea7aDzwhv> zxp|NmEfy$RJ~{<*95$NOKgrG#(ZAyUTEZs!>ryoGCY2rcgS%$8d^3C}+(4E00iAV8 zcPnIg;-X>wQ}Mn zmnJK6#iZPD$w(0qY&XlLvT|dotjH9|6ciV%RLD}$R8U+fQBV<35m6BMGN0#{=P%$F z?(22m*L9x95%)0Z^CkHc!7`@afAx6>%Av%gFq21%@pd->l?Y}vh_V!s8-VF_n<}p{ zc!M)(r^4pqXXHhNiw{#?ifc5|{Pgl{leKH?cP&+6x5OWOI32NTnbPa7NnABje?7fv z$Gq^X+kN^IU+)a%*SYc>)e2e5UpX@d3${OlD0QH#^cq0kb}Ge)q8YbD%yyWbQv;!} zhLA@lah&1eFEhPC7Ts(nA0iqtg#q*-_z_A551TX8iiCUh(bLB}0O}K@76!0oLSxU!9A<8+)_SEB8nD;ZDa&PHKVn{R}kc%LJIc@Vggj3##{+W<-+P= zm?&cs`e9~IN0pf2P6k{pM|Q_Mo#&_yXd11&N`|}R2}Q+)-gPiSvSfx%(Kla!h}7r$ z^0E2ct{r$$U-5L}QUKwaZfJx+xhYnHRQCMc37#oFbsQ&1_9w;NOzmb{z-TtkP3$3l ze3KB5o^1-^JVy%OS0=wG%OKy+(%{o?Zs4r{>h<5?kQ4+ADkDnUMKg}uGM%0_vnof@ zA~9EG$Pt$$!Zl${hiLs=qy6V>RW*&CzG7w)`ViDOUp-aIF?~H0iupC;(fd&s^xh3f z-iC#tn^CJhvWDCQN$&~mX5V!Mzf}V$_6-2WWw>G$QgQa(hL=#>o0JpQBgeqFal|99 zrs?*tN;Lky#9qE&@i(sc+aqhQg&;>%&q2;ZY=rtvd)6#n)@Ma%zFGaIX0xr6!lkkj-M*3hv^yxqllXudH*{v^@VNryNQArMpAY(q z_3gIfL-v*PTfK`#4?8mGf3o+m=sHfaC>G?5t>`#xGk_QM#~#Q3|K>x}q9Q0ZHwJM} z7=v`yvd>u0pzn33y@YV5va342Wb0LtHdF=;P+p8I?NMBzH?z_mr41|}Nvshv-hbvF zFc=X9`iN1WS??gX#2#1dhgdOy3D=7y)C8eqzBJ{OD4Zw^5x%MnULPlF8CDCRtKZ># znnutw?tpmz@S4^O99MrWh;mdqwGSjoxA;M{udTqVJ? z&Q3_5L);^(40JeGZnUd?FhD5mPJR2|kZ{l%dEmYaczw4?Jkf(M79-R@JPXtfSD6dr zMTwS7jzP89D#B4bRcfy+cUgVDrUP`Da1NlG5kqb^Rbe`rY|cQ)0SNU@aX7tyo1{WJ znmG*B14u8+8FZan+($s^>!mU~B+orNt*yuQI4b6vg7wg|@s)EJwPfeZW{ynvPD3Bo z`9*SM5!t7~TjoZh4i-XQdqU?#{$b!$?fb^@;Lge|SC|f1G9vLZQPj&pt^^MxsLo~+ zJPXfkr$II&8w%1wUA=k2>-3R9-MG+0J^FTL<-LLxyP&Vk%8&a*&xAv|s(t~t?XQK? z4`J}v+5_Ok zL-T@1OfcUAI(%Hp{NbK`Ya=hcGi|p&v_97z%k{ifR}Z=>aP9XP0`eP!0P`>}c1p6v z%OpQaFp;oYEsaI2s0_+OOfIg{0k06Ml2Cs7ZUU6Je6U80_@jrGR#@pgd7NkV9uL`_ zq4?fMhV7%%6WPu>sdvZ8P$>7H3-SXbek_(YQ%LHlmZq|ochkt8U(_zlvV^$+8=J;z ztX1L{?f%t0f-=L@eNhs&{5ux88N$2%0gPoWqaj`fu*{zQRKIWZvDB?CzF9P_bBc%S z6pw)}FQFcyGFE_q7SaVr1_g_XlH|#Tqx*$Xe0Z1gaOV3VT}7E98rT*Fuo)fA4CUV; zr+V!?5(3aOBcW~^xW{9lzOs-_VBZgk*bQ+i%#gY#56&k$ACWq|iXUE!YLQb%*3uIO z*}XxjTmBUq?iw!@9cr$Nls1pD}23x!AM`%S%(|l=0#BbO2;*!YgXT_ zWJPjsvOpfTO1?o*M$fBSmx@fU%6>zI$$N%8xM|TdPaa^;slDqlw5>Ho9h4*Fny28Y4qbjVeb$oDhbyNcV zZVbl(sjlO7zq5;jFEf8z?JSrC1uM3`l3H=_j5^+?g%CDJW|hHi6*j~%#5XkUjj5UW zO`<2cBH1o&wtO#4L->8(CNAkC{L||2Cf5`T$GfSNBNlNK@Iv6@^%JfRvJNV-D<~>^ zautYmS=qiFgW;&eYA?(H#1g$EZ_j=~U@fmG})4%yYcdY(* z87BOW^{l}b9}C0#$)@Jta_p!btcG}1Jh^86weJKsJl8+2a<^xHBy!yi`|?DCWXgcD zMg1(G>7|tV`}9S`NZoFb!FG1Wb4Fd$(|}xwu^g5$On_P$Zllb6QNJG3>uRXR@VTR{ zShsL3a*xn(?=o|x;BB5A;r52k1W{bacw0f?bRdz1qZK zQbh-4o?xyM8_KIzzY$5u>vJ0WP1uJaCH&LS=K>cH<4skF5%iMm=+}pRo15mm`d|or@POt`U@K;y1AWw&NaP8-AR?e$95_ ztd(3pKibrS<{RXR+6Dt-6i#q)-29S?$$ z3WW6cjbPG|`>$g8pWQa%&V-ce64c?|ye-B08Q`-4oKaM-$@_biBXBNs<(E9yx$0nx z8(sx+hORC?)tV<#|Cq^M-+QlK`hN zLPkeT8F5oAM`qB;@sv)q7`EX^2)H1?Zh$(ymw-2|s&pABQf*E=$cN<+yXDIXE4Yb1 z!SHh>Nzc0-?7}!}a6gpShgE@XeX8>_si3h5uZFJ}LnmKn95=Lea3tQRz8-z9zP#9v z1|*xzmw>-J%s^YWJh+p?kk}sJgy12E2}!pt53)!~#nP%EX~q)0yvVD*6x0AzqWb*y3ud^eALFO~9R!L?aI}!l&37A2xVgw8%*J z@RM^+7D7A(&(@~=({-_tAAtVUiugy(^pX=OB{|Y}iF&M=c=%OK;U3i9Ez%ng)lh)TlDF(hS|=T!;GY_&=VGfTWou{eM&`!`c4`qa_j@m&3kk zZOVfTWr0P@b}J!8h)7JpeenkSW{_BWaDmYNkp#w=za?7)7s+qVd0<|9&gQdj$z~)W zS}G4Pk-UIE!Ui^sn{~h{y z=|;G&PDg3gRh}8k#Ad`qc5veec|u;6em764{i_}M+$x{d0{)PSu1W8vTpv^H$0dcOI}z31zd0YH z0E^mjCz-LZ6G+#zSwqR3uzUdNhc*v~nE5dsi0ekd>R-dLf`K>}025Qc4eeFiq8T2LXduy0aEHK##=tls5B<-#6DC zwT8wRHhNta{ET|-8Liz*kFGckW_frTuG2-jfR(ojTV@LNyyS_0sJPDvR*K+nm$3or z|6VgCZxG~O?WPB>bRRR}<)MmSYdhpCpgF)+XTjk?farex^@Vb z1+gqyzqubwR0LlY=_`7)Q1w?2ABl(5k8BpLUC=#{keX=2fiS8<*HTNZqYGN_C`(o< zH0JrqH0nq9qAp?wnRM#(keQ-Z zd-8_Pv^2EC#VOL@lEXG?t5&qE#UT=z&8ba4X~OT<2fJvp-8nbzY1pavDxU!R*i8$&vjca4y(gAwI2Js^L8k=|>OHz*7}fPnG}8A;gO+Bs>QzbRNLo06I-IUBncJyx}w^DYLfa>-ZY7Z4gascLnc zvi-c-BOO$WOiqX>v<_7~b4?F5KOp5U{eD15QID^>H4n9FWavH6laL{QFLQ74)CDS@2Z(LFcGAn^Tz|jO7X}Sn6qcnZu#5F_c*owwey64?>-)*8k&x*)yKi*Spwh`sj7QP8e0 z?_a9FZ<8DzkR)vnbr_Bd28$n2fZ+i}rrp${AF#U5PW-3?41*%xrpO#~&(;1@(mwW| zp^s8XJqY9AcfK4p6*%klJLV5X$xvJJ-y{`%*1X^j`~ywjEjR>%UUGb_jRi>GXDFt3UK*&_N?Cwn@MeRMpy|WCSXW^n zE5u0iuvVX)^c_%?${W`Sl>X}`QzXu`!hR2E=b~6zN9z<#hpbMCuAwNTgR+D}DPr*e zc8aKr(^2~BG7qZBdO>4*7HViZ|7f)p+=*d{H=~dNZ5`NpPDuF!&d0gI9;-Ce8P)3{ zqe)PcZ6g^j<#zfF5T$=BdNf7=-Jn7hGAj7-;%;r#bYJtJO&|RxXjL`A5HhjU;yPXj zfiz(C&+^#I=VRogQ;M38Ho;4iFHw&7UvfwUHE}@GF55qvl7l*VjPIh2>QX(hcc>Qx za$=;;W`+P{mJ91i)?!S3!hcV=InOOBn|lWwjpIHz8r;}pJ!3H#XTzRQ>a4fIY=3vf z8$#jwI$jRqxpq&^qU{f)MT7M=J9o&4MNv?c4JtbrP&mty52*u>g%qooxG z=|`*}MB|T$#K~e+;jy?WNR)x>SJb|6T1rbeX0ArDt#3lFdg@=!Ljt*WchF2=H6q?q zuw3xa^$V5#>6PUo;q3vIGLqKS$!0HJu7#5#w81YlQ#F0hI3~23Q9yC zV;%(P?3>8E*2qV>A)bI(ShCmfOb-@KgkekZLE-eM5R7QjGuzaY7xjnYd+{?H(=#|Y z5z&~hH?g$GTQ9G`dz_DW`Q!P zJtXxCu15qS1fDM}7~+PHTY|fC*HZ#WNg)lsc3H`r@L@ochI~sg2P z^iu~b-Wet9bhpfZ^}a&udFBsOv~^#3;B7hU>f$dq?Xn0-+$^JOg`ZQx7Ez0m!)Edy5oqEo&q-d081~n z+D}$kMPo-#aWi&f%VlWfDo8^|H)Vy(4Cs9kno-srR;_{Lm!rvcRMSeehmg3K z-3V6M6G&u301WKB|lHun(Zu?WZPj}m}ovd*^Jhp;&Tqi&% z1EO6t##4bZ2LUxpxJOR(_53M3seu-*(VjNZ2G}BB91=_{+%Tl1N!bU~n>gAt(Byqz zkQa7a9nTfnwyO*4045$VX>N1W7gveX7+gx_QAr;deI3w(a$##X^td}xK%W1n!WJ9W z3|qubHG9XPL`Adtp!=}AJDjOeg!PZGA5!d(o+;sJ5o{{tvbZs`F<)Vm;nohlmY??# za|hrSTCaHYJ!#dJas0R8y76}C#bJH2 zxYC8BVUiP&=6d5IckpdD##iz-eBarot>EKYN@%9K+yfXLWkG*Y)vhlABcrn$)prA}XUSBLRL zGE>=e9NOUlgah<&fwvmbjFlD00lsZ^FWLD%Vm%qMf&DvduX;G7i*UtzPM9?}fM{eB40bM{bmPJ5(bxq3dDc5X z>v7VvfT`2sFai$3U>yh8Y#LdBm#;~xe1*Y9&Fg+<`i*3Q=h`;{sC*K$9_XOEcf2|!gAt#HQl|3D14;O3T!uI9(LT)t7TcNBj;MQ*8mM<{l zoe4F`8F%pzlQNmhBr*#y5+F3&)3)pwtaXC z)M`q1gh6i7>063%@Hc?{;qCWp_bhDpywukatg62O@cbPDh={itw3+YwEY9d*Ropgh%Kj@^7z7?=CSV!be%@zi5# zyY~7SGucY$!tcb6uZ4}!4Ws3RwAe!7W+<1tjuKYzu|KY`94?8TDqp}a`nt%#vN!Lz zha@lV6kle>Q_iX@u9oW-we*-!E^Y~XBbn?srh6Muoy4~~!)AAAy z{UYF{tX4;OJDwrf9M^Ffdm8Ff&+OObMcPAhR&~R230tSd*hBMMfLy?<48HDN==WZh zap-aQq}KTC`iKqHDAM0AAsNp*NW7|!<=mh1rUhGBbvfP1o0rll2b_`o->kYPMPUAU z-r5mXv2*NkUQqN<%}=LrlD3_r@jk$$c&Fp0DqGo7;!pYKeB@l8-(;})>{g!J=F4H* z{lH}f6YHTFIgZFzDcyMV(j?!_-@!jFdFbe%GGweP!5zz2 zI=yryp+&R>!@9`6E&UH71KrFhcqA;=8x$KA-_g5Z-X4>2 zwWiDSeWD0r9VDe!o2VG6Uu&2_tJ&ECXEj@O1cz4x*+Jww9+ed z_$OXmAlV+yZ(LVsLp-Od_vCD;50tHqGp}(S*wONL8mIwG{6dqjcXuNyyBHJq<2+1Lvs}IYHlTP z_Yj1AH&HDw(^a*H(x1dz_jXM}1|UqRQOwi^St6%GZr)sZ!?(5g^TN7cnH%%8{@kEV zado?q*kgb2o7 ziYqlbGcHz8jruJ4PKk5neL3tIX2qi32SOwAOc7WcV4>(rB9aM7gfQV&DNUpUl6Icc zp%?JFurD+Ud*KElFIJ+VRD z0RAXjofKxN6X=m|4YfD-HPTH0L0$znb=jdfc-$E=wzGKLo$?|}2TD2bB8=QepLDBf zZ8*l0z*Ua+gRSY`f%N?y$9WFa&9plULr>w%?M*x%Gu9&4HIay2-zT^FcR+&ZT3wuJ zsx&qF@(v!D>Cm&CTP4V0-x)Fr;srQcL#kJc^o7ent3sOMDgj1K`gf>8*{e$m3Mrsw z(ccepJkPX*GDA4}FGm+tp*gJ52IK@IfudU-4D>)q(y&EGuN>sSQS8NgSn0(oaavgh z3gLG(8w*>x1}X5wr)GXGUhpqT&G>pBu9HOP{k<`+P?UG1XU}9-qUE}osXKO$4KvbR zKE@B;w$`wZ@fCMFghX0lVEI7L&*ssK>h2qj>3RQJAX9-d0GX7ELokslRRh%%6k&W z$Tl5zd4uAzYY;1xe(JSTLf4b&cTGFAa~26|Sootu6jz~J<&#p^>Av0JlsJ*80>Th<@I-msS};jY8tTGIP!hy?6>P9CfM zf~6e_Wnju5wXrgp5^-v|xXGU^3J%}yVjW(p&309h&uaq`3Tpjx*Dow;ic5TC zRO#ZMq}5m?@oWRMJ7-FJWzV|FS*Y*zsp<|$rzhV+IJ6uv_{-bEOSQr|gt7FvS)__3 z&B$EWeQcCLki+&L2`J_3(%rG{N9`n`x^-iv;b>*#_0QFdZ6Y1K$t%_Gy%w8_#xIT9 zG)1C@@u=DSyf2D7wr*14Y8(gv@TM7}tlihnxeuSr>xx1uru!5j3u~ah)3NRJXfy!W zcgKdKXgjGbUj#6asHh=aQck)taZCqJ0}}JOsl$Tw^mFB84*~kf^9!GDY2+)Lg`^z!g~^lxGU_;H@oW1Q2B{q@xC zd=h98=(03spuO@z<8kVaD0YZ+JxKO%~~!>}Yq751*WDrY^7A|Ak{_7FESzYb^Ur zGbs)ei8^f&ta^Vm5nDR-=%8ya^aNxmwh&yHa{YM|e3|==01#zx>>1=7DE+Zy&qrLa zXZDatSrm*@7K1-cyhL54&(wmYgLBIv>7PzA==*Ybnk~&K^kvCaR!2A%2l$}h#h;f> z<>l`f_V+TE75}KKs05^UGFfb0Yu=rIz~wD`xjUz9*z*b3pC{NXZ;6i^DQ-f(seI!Q zoGE=j@Gmth}EL+F9>`SMh7(iG5aj3q7dVhA|Kx1(@c<5(cRL9xiiKVs_N%I@> zwhFKWsVgi{znYnG%z_~@kKffzH)*bv!2@b{8<;aQfHhcuTJcq}YA)+bBLgm2Dz}&` zQq}xdzyD1_EbJStU#(rShP>%VaWvKNeF=EGKFw1jAvtxq&<`O*JRY|1wKQ zWpW4fg~Bwhi&eb*AmgP$)4_Omo<}bqjLdcE^asS}tfzbq+s5sZHv9s8u^M2n66;YY zLpAmCk}D}l3TH=e zsHU@1*xUQ$$~YhX8dOV>JdQxi*{~2%I^=%INWAAo+RA!3D$$F+N?87X+WW48`Te=F zvC}yvyf>=fTASrE$7M@X@=Ixd#2}jXbK@Z06sTK>d>&kC7&rR}!S?9qliVMdBIm2{AiP1O?WAmvcjH6O@B9fAjTS?Iv=}@PxK8DRd2)si)Wrjd%1S*dRIa z5<5JKzKjpuw=vmOe*)%95>}R&EN# z%Tnn_BCVj9Z3%f!BZVmu*bPEKy8QWdCs=DWUW&qvw5$79^5$K7y7!WIlwuJl zq$HkNQb1taHbnXCp;vfZrn_GD^E#tapFo!)pO!R^n0C$=`cX%!hbM#h-Urwrxa3dw zH>f9fF8pOqwC4H#YV$IN$d|k){RtM{xbljjbQ`xs-|z1Nv@6Agdly3oz<*$Um{F(2mNNE>&@GKjxeOCFh>7ZQp6xWjm@CGjeMFVEtUYFCN< zdufB{LQsZ0K(G`Lgcsh`Vcg?F#?r}KsI&c(U7G!z?x2r|*!ovZpTztaP)E5Gw~ja_ zNq@=>U5rzu*}xiN?WIb2aRL1ZDd&J!+Z!h*$s1*0-la#^KiP86dwtzv==xg+QyRKs z}vG&}n-Ot(AKi#T7 zjJwC-8Fht4W>odpmShq!Y_&v#nKels@{Y%&Ym2>`hDutCpR-z;C=ng`&YjUq*vCb!ypHkstnS!!%B56RrqS}#v zon)3T0HL&xDhnl+4QiZ?uo=V}_G5+Q!-r41Lj|wZZ+UN2HH|+xIkGM0Jq0qfQi6XVk1G>7MmsT@^(d3Ig!FzUNVD znp#krJ=2oKU$C7`nN%$<`42Bqh?DvVA8M9qyglb zpgR9x#(3kv#Z5AbCPo&BjzFEHk=`pVpt8&a!|FAv>3l$>RVhj5>`HEZZV&yAThHUC zs{g8G?*X;h!VgOq_IV+ts&z{E!b*USPWDMcs=%O8tbaSHTOdnM`sOEDmWoj!Egh7W zXg#b zgx~2b+}uUC&a9mm(CHaP=hc>d)I34|cv{fFT~naUx|N)NM`l*cB3A)tV?AkW{vH=e z!{QNn9nbCB-2}BM^kQe5xyDk!ffdm95bXNUJ2En&Sn&|Z@4fGJ5VDf9tR2(^2hXLV z?sh8=7wDE|`DlMJMCfWK*;=hj_Rv0QCcq6_!QJKg-64=W6E>kXK1~N%8{+Vu&fKjf z@DtM|GiYAykl>w`9>U9FJBvJ$oD~1QKkC}$s%TWm+}~UGUq9c}0puY2(!=`k`QrK+ z=Lg9T8I3-D{=(?zr&*O-bzn*ioD{tu8EGZw`r+(2J;A|9or>?`=%^l)S*fAdalI>t z-KUG-S&6wthRV=I12D_NX!e@llOImLI08FA9u;nmR?QIVq= zl7_RJiwoXIe;eVVUB!Yh3=J7xVf}?7|1E}tTZ0iq{P1t4OYEm z34-Th)C2OQ@3NJg9mJxADjMBuEGF~-zj>}zI8j--U)G*(-o6Jmhn_Y2Tj-YRHEN%- z^q)?!snO_F0?qr{aQ8eZ-SmeU{Kd(1I=ZkqC~HFgx78a?zH{|WtCAv<>RXfd7P&V< zJZENb(u|Llnk*$zy0!(lJLj_YJF!w%c17G{AMsI~EcB-Ik?#bWFyt}5qsV)K_;!AC z>SUcjCwxUhFB-y#gZM;n#xp_cZN}~58E8BmZgyrsvcXilmg^+cJ%LP)RKNKj#l-nvr5>R*DJaTEJo|mERSUvK=*#Nm#+hJ4-A?Eg@u(-p^gd3)qV9miqX_=V2Xtym{p9&@$H7`6|ELMxeEqg z$%mU}yo2<*nO-Gh_m4i>T|44Y81iJkb>SfLiJ<>YwV(6troJyfOoQTb;Eeo14998{ z#cEA3UDImYHo1J{3!+G zoVD`#W;z6R&);xHBTvl10Gdn!zxs53++2;ZDVN+Yc z$Hwvj}U zENIz54ln8IL7`s?uEQO12%--7(s(5O1qQ*l;6!Ki{cb#S*koDbNIK(TEop(}TKhB5 z1PN{T=!Maee%;7+!Hk2tE;cC>$lGp8jUw9*LW(~1H#G0jX4QMNh&-?6Ypl~j9Ye#1 zLFReu$*9fX_`%+k);;eQ_kQY#pWUpJMb{S$Bqw?6gtQKz)>J~JlG%L>;#|`+tW$MA z=b~q^*9b6C<3s3d#{W#PeaUu&<4yF!84IA_#sT#}w506?euZv{{t4uHBRhlT%K&99 z;!|_GI7H!KR5-CbRWe~L*=mPdJPS}&180I*6{mR}P0*f~K1fDyhOr|ji|JX}^jcH$ zKy^k$b!JgnpTT85L-byYIL&|?Uh+o!S8z6rY0K&6dK7?;;(VRop(J7>XT%Lpd~CPV z4xk6dh4CDn8tYOd7iA<{$}f%cOhH-lJ^Ae8x~JNP2Mo`6==w?pJt6AMC|9gidbQOj zedpEw6aPGi*?Y24gk!u0E5q(Qpc(hgm4sCGt8}N6F&)xSUwiDWj;nB6#Va;;`Dt(d znrD>lEfUd9*dY{)PMWs}~(L)ZTi7LN|JMQ{@-8a$99Lvle3n z-ZNTm^-=L#w07tWd{U+Tq}cEFVjm}&aOHFLzHu$!{Np`O4qdbNF5#zQCybvwQT=;i z2*3Jc;gd}w%O_MAkQ3uP!SEPf1rGouEs0s}B_W@*b1n+mx^&2$EB-T#I#te1x2-nv zU9!8(;84MH+v?xN&Rbn3(96uP3*E#R&!!z};)wqh3~Xwdx|*eY(jLq!vnRd<5a-7X zEHlf&oNeIZC}NYD=$4m$wj-`x{p`7~a^T70P3OfB*USW3bFJG+Z`W7+W6X(?)SDpI zJ?hpoL)DoV_K%Ba2m7yP=PLHPX{wT@@#rHS%)K}*N#GYhNt0FC;o7>rqU>d%_mE!J z72C^&!wSRs?xKWhM_S!Wn%h(UuJ~6{|8E`-j(a{#3aoPe7&+gg8CCWGx)RyXz>rf- z%$O35_0f#2k1AKRjPwV#{_8Ip?M{vva9su|!xMpsSHs^GmV=~r4L-6pb+8I5?cw&AJ0Ql_H0-^3ip2A@7>pNu!Pz3AEN zO`j58_7=S0R2Uze&jLl`VqjyXqM(VWFjwq&af@taeZwd0{PU=H(BiqS3mN(;{~W^> zLD&4#_IEE8K+$bmf<1DBtlGwffG4&x1-l$_JP1-ZNHAjn!R)H*z-eZQ4uo z$rb5q(;ku~gvinXrciMhji z)R#C{!r7>w3>#IeQ(K|?G=5j#6I-5%EXn|t@!!3x0lc30R3os$>l0=+{xyg{RNg$- zp}j?`HNnr04>uNjttUMteUoI{l(|d@!?YDk?bN1x7MJ4%{_LtJYinqibtxXq=k?K^ zk{;`IYP%ILT)S09i+{C4{v_Q@3;TV>+7?s}liEUxu+&7<{#kT2`YU`gD&=W8w4hRL zb;G3~kr>#B7b~JhR55>k4xF^^8CB*QVE|@c;0LVGe^>zM$%Q}v&^B+mi}D>W&Zu(|Q)G}>ZFnmyhTJzF##NQXL%jrOuO;H-t# z+i{qQ_9%mOI*Dtp*X7NPz z%;LAChjneXB5C@pX6v*=FIY0af9yiT4z1wb<|pKP=&;~L=}H$34|3m>TUQTkBpyDf*iFsJHY zjCOhUPk>r4_4|qzKABki3cBIG)BVXGN=AqO%F-;QH_Q@fv+L%r8iYdD`G`6$4B2w+ zf4Vy5wVa+K`Ao5gkFxC-4VM1;M6!h&=Syu}D}yV85l$`N6)5O)+d23*$EOhGPu@_K z`(oo$_d;{^bb(!qHC74g*tQ62-xdl&-5+eTQCE0n9?Yc$KaB}3`eu<*?Wbx-Bvui<4?7i3Ehk8Mh8Iw*PWbHmH?{(Pz5xn&(0btwCD>IXSz(5Hf<@&MxkQp5|eoM8fr(b2Xwz zH+<<%APHVW!gicCsih=-bCcdC%m*IN%}3)VB`7lU;d8riQeH0X7< z?Nt~no#r26c+8q4^Q$3Rh^{1-I~r>{ zo}TjfOw;-*j;~_N)QP+q5e^jo-Bw&Y=&t?{We7x0!C3)MRnPcYA<_^SB+Hc)4H&e2 zycmT>Gn$m+SG2nr^;XUc{|qpJXn@>y>feFu(h&NY>>=Q`DCC&wr^GDT_};DcYTk0B zcqYaxAf9=(;Yu-X*htyN_5a4L9_mGK0DXpcaY?^+g17gK4))l5gR3WO0WNYq?lktG z0j{R+ps)@oXjQDe{ts6Va72H4H7!~O$t1~oFHKfY6qvy ze4tHHZBwQnun%#Ei0n#um|Uk26jw}jd|BG<-Zr?6bA8|F6BTk53Px*7=GYaVbPuBUAo{Qbx3#$oT%J`aRfc@zGnF%WTNFbXP$x#%I3&5r*&! zJo$*?Zr#XsUO3<2U&~v>owA0-Z;v-c@Ms66S=B97s!RvYP>hHd<# zTrIQv%|0T5jT^f_bM${xLOzBpfyF8e`r@o(t>f+;FU)jqE2g4kj4{V~p3DZRb)2pm z8(6^hJ(1?)igfHe-zys=kEH5EO0R)XeCVIju^i$*-8n)XW8imTAmV zXmXS+mr{$0)KOGYw$`!CG$m7%rNwj#1$V^-GFKEOSKO&oaD|jjHhp>jeg5IPo{RH* z&$-Y2x$j2$&%?5JX`c4u;EC82OpEqrb%At0V)>2Yj+<|c)Z&}#VkS>tBfSyP|NoYm z)rvGd`yR5h%!EL*Ej&Qqz`jOH3pI|dpt}34Ph8LC6xn_e&fVP{vh6e{%C^rpqfS;4 z72L=W?XUY$_mhp~S&wepsj+7yqU#j0(eYWC$MSXkZvX14O4grZt;M2#VTG`EJQ}8a zS4b-m>=6jx=p^zlju{i+?Yi{c8S`oqeeTV9}*P zd}U0@Z!R0r3lTW&!w#6J?TsX{{mK*wEymB_&u~16YCFugkm5Z!7hMRa2vS&J7iV+z zyZf$b*WaXuMZ@raT)#XrO=8RyrrQY>RE|H}`G)aKcTDo#z;~10hu$^1;D68@7=Pl? z=86md?E`W)HpRCmX>w)K<%*R*%60X6BzW39`dhu5^`ivwkSu4!bXVMkH@|KOgs&Os z^z4hE?{GX`Apc7my1?Gnbyssn+>dD6$vnqWIuh;$w+!1)eco|L(VGyfpZ~dex>zh6R(soYHIG#-cYI4XO&KDB>>KCBCaoUe{6zIS0kNNE5Flh9suhH5rUw zfc7IM+87V{A8vqueqM8n*Be;jb;-~%iFsHVI3jR-cHb#KWWogr|B!RV@1$ffkuA+Z zE52=taL57`zCxqE)i34773#xT{uC8Z`Du|Np>4JkSh^LW>8d-C;v`Nop84z zC4%E>GE*hY2$mDB(&aJl=Pm|Y`WEQc)_U-1(~b3Vs~O2&_3$V~9t>Vj5uj$zq++gP zA110!`r~KN`>0{VEF7xW$!7&|c|>JC6O~nq((V`XlR(%Riu@@=w`pu-UhrPl^@b5X zuMoJ%SRXLMg|oBxzgy=HGLgIc`VlSN@%{H7cgfj_$Quy|`=aBsnj514o4PBD|CMK6NZ@^3Q{em^~ zlafubQT`s3X~WuE6>z9FF0zyqoO>N_gRMM?KMhSSGYNz*-RQ|zJIH{dmUxjvtIgbZ zYHLZpV_8^_bBHjdF>|yOk>Rmb-mYz+1hu{xX1hr&Qr`J!8(Z8rP$BA28krGhu=bgS ze%xv|VLR?yP?6(|as~3=0`PFZ2p3au-ywc+d4`Q)JCyYvQpAUZZ zNuOt%d%WZTt7VCXj$p|{#)t3zO!x(Tx|GI`ejVp4Sc!HLxqFfXimY;GBFU^xxs7>1zZ(B)2-7C#$9tiCIVzXM7o4#yVy z`X8lsJRjMFzZThPNo0M@w#2pz1V1Ly>IVj#)DO^yHT{^@V;Hyl(-nZzA%|x^+_buY z#xM1|p3vqFkW>k8McWzjFYSTieU|3gCzle2UYV(PIs~UGbEEe|;pm?tRh=1y zzXwF#!<#whHJlr$ZC6sFVyFzl((FZ2{DID!kXQcuhcuaia1ZC5bOP^h_aE9#al>H` z*}gi@HkUy7;cc^cWaKfk1yoCWcHn~ZxwBG1GEcZEu2gL9mUf_u(yO-I3!L0KQ85{C zogLclH7s~101eBm!@JB`?QyNo@7uFgiL?ePg|;ykdT)MWjCS!!g>w5hSB)P_2@C{| z`>pyr&3|1m?#WwyeqwU!bYh$Cmc~FneKOGH^M@Q;58~c*aw2vd_Z)fYY5Q`7RjaE~zeMnpx_yAkZSpB4c2MAWksaC4WFsKA5u860-Bca*`~ z?U;4os4F~=pnAeC>}JUk|L9wKkHta{10sCM-Lh>vaOu^Bb-D{y0f%SYr%Uhx0;thOA4fk*of zy73pYx}@E*Hp(k`WeX^!D!HR>-wyCwo-2M?KBF%K_1M=5*tL}9%S8gk8ROqOv>$Lw z(*aLx=r5`NtKe-y?CP-cP8VPbbdY&+|aCb^8>-BT5cmLh)>u-Ma=}YGg&cpyPwXmVv3ETm9)4+ zvVLMGSeDM?*7(frS*c^6>ZuY$6SK~le32hivOYz&Mg=?Ae{*OjFi_kMtCX6;${}f4-|MGrPbm# zKXRJPI#-NjIKHL_B5?&maLqLXZTTpxoacV3{?{4E(IRN~90|UJCfaH?T|hm#AY_Jo zI!faj*FNplT)UhUlcoRQoqefjO^N%u+Uh|TuB|_jgnw2G;j9g6^z8A_KXTNA4pZwf zVSLiy?6*MXtr(7QCtZZ&lz(Y2BYu?xl+yl1W3~D@>#HY-1q5^YTax4*7R1mXPAni~ zQ6&hD8rW9FWjFy#woL59RHJQaUtp2b-QfKZKmap@2j;nmf1^F@YS0vx#Mu`6!Wvjd zf%dR$T76-|;z62SRo-=!>M`eO9e{ z^^lCI2^VxubmKcO#zUAfi@LOmxwBkfc>Lm)Fto?aM#}6IrqTk}YO*BQc_pj&2n&K; zu(SFPlWF2Tr?r6-|IO_2MlS~~Y(`rOL$Y6*4&>LxhZB~M@k6di*N4shIHF*98#5~# ztm_jWfR)8u+FaTPwCb-#s|Lp}LyHhyJLG(0nQn;S=+6pju62_cwSaM4MWE=RK!3(x z(D1k`8RD!xM{xSju4H9KKjh1^M|KP7*Q#FN7p&lHh5GG!kI-N2xPbEDdxX|!q6Gs~ zOc=dz`{?BpK~tN1#=~QnBth0a6jNQ%T~OHKrQKJ#I3l!|MHz(?YRt{7`h;z4KygQ> zA;O{c08(=P(a1#Yb>coyyz*w2+W~Et6-;m}L;ky$2zo|r4HAjdm;UnB#paxys~EiB zq6tPqGc#e1%^sV{;wDMhY`1kDi^?6-9u!eRyj1q`V%U{=lg~kq*0C}CtG_`N7Qz&v z8dw+$q_>w13K4Hap17*ct~3-w*@8p^1;rz8`oW*ye=pYkCayl^F9%7dkNVaZ%d-~G z3+z6+n!KypvdGcdxWW<%Z?hzCQG^E|0K@%(k~(Oj)&8bE0of(k?PNQy#(ljwaQ`qp zURuW8N|EXF7PiDH@7oL)&0~x3KBfEcGf~a&0jj!*Jkg6hVW}E)15gl7**Fo>t!i#2D_*uydC}7TyUCg%+w3 zGSU(XC^1)!_Ly?fe1o9rh5<8s(pi0eHPCSA!7`DEZdH3RL9`P5h9<#otIh&L+f4{B zSoD;&dP5-9p22y3C$T-H4W@Kp_>AIUR3lNW{Vl*Z6){N{_zp{N+SMGIW(Qu1){b7| zx*-HTFgIuNz!F44x&gZ|x7_lj9ej33GxQ}GuJh-T~aJp?89>{_)(JR&ED5;Aku5(M>;yoyp=lVf1zKJ3u`GzvGvMs^9Fz8eTkfPVCY zw*l3^ILMwOzj@rrHqVd?Vp?0r65~CJQ|Hl=40Q^EEe)LyZx`ssa>7@Ffhp?D>{;EW zLB_9SG5*&ArV%NvFsvkh)DOKhYTDT^jX?`ha%o z{XfvVAve3Z`r_5rW#@-m#m`p0K6~m_Pcb1y^dL@b_L+qp?X8P;T*=EShrB%NGi*Gb zYrfXFJ>&S=2G0E)2RY?n*K9bQVBwpRLJe^T{$+=!o*8x_JWwnijE4-_2{&u^NaJLv z)R0r+!;jtAh>Qur9$gqmO#XUtE-$FVGLg*s9&1HAA0y4EVu0H-ZR?|&x%S}K+gjc?+{kUZUa474!?|F=yFyvt`M4K|N z2=J9XCvXsXu=Z4b+}qqmj4}GDm^zP;KX&`wp=j?@r;ErCVD7jlK5T;QzteC+Jh@|O z95ih*!ha*5!7|Hldb&QzyWNu0#ac#Yi;Re;F=_ z@Gik+fUGBa@e7>{SMOCa^LU#1<}-aAa+y^)<+(32)-lOAB|fJIBFfDY-^_p0UxrI( zT5EdY1650S3;E_!xa-QM!2+-RI^THrr9dFL^$oTs-uLI=*ovIeYh>jX5J z0Owt_%0wDYi)3vypIE!a4vm+?c=@TYX`C4dHSjOdFe)vVrL}%rMi&duSwFxIX)f$&W;xG4Er>j;QG{ zJGHu_L|<@X&;7IDh)Ub%t2 zzfy!|8Jz#3l~?{Vo69|_b>wLqMhknR9Xr2tBu(y_8NBKIlJywY2AP56FPy~rzLy*WPo7f zz)zrDLdf2h6M=J_BK_UC!tnz;8g~A0!ALp4Z}RPOL%dbM>e!+`fx>+oVrXmf$Nz0=N#cU%8ld zBC;^Ipr&vt;KUyEKezC%LhO&s$B?~BrO85TT~Ag*T>8X>J+4aN${UBb=DJF1LlEZ}^(~$dl4=c) z7G7sLn-@7yl>=?q&757>-WNS=t;^81#QnD1wKHWuyRsduJWfqPpK7_wciO-wSG(Gc zN)o;etw%4^*g^#_R}stnKwvOg?f9&K9o!G?@2i~2 zflyrxA#wS0elm68q92540aNuGE<{(XFft^|d1;@^GLIVgQ^Smg0@-s+^Db13k!l7k4xsmlz4MvJVbXHKLRMJli6@Xu!674uS1};wn zZ;t}9#OXWt&Na~hx8{IC+Zg;?d1QQvVMXpYgQg+5!f_vISjR>HwMrDlnzY8={^&&< zUnJb#K&}d#W51s{G^4g$A%3qNnv*z8F+M;v^F_DNmUle|K zrsHcMU6FW*`w2L0>};mo;#5ZNi6=7%l#_Iq9Y6M5yQeI_a?32GGfJ_YVIUr95xAHB zDIxpLV`K}HD9-`<3cPJQVo|{^Fj(S+k742&|v52zO8EZ!&THr3Og5fr~$TBFgoD1p6)U|BqZ9w!H zzO3KAA)7JS>1RdaR`TkjLKyCe5J6AVO&Ml>_DtKuQ|Kjn{!^k`lNiTi?}sjH%^P3k^eF9->taC6RDn{+5{nA-oZ7 zGdf4bHto&Pwb!G;fSv?crH?KLw@12RZnAYefDY-)bT?}|lm>eAwj8iJ+P_Hho6lTX z4^f~)F|C-M=&&JJ$Gn0Iblu7P9ZyAy3rDZ&Qf8W zzt0n>xM9goQ(7k{GG^x5Y|cMogrby4U0f5VY>?@pSgQTkg( zYre-$JMpR+!~SkmN0jBRe64Me+Uz2Ck-TkQE0BWSS|9sCVYdouYHZP+l!}R)X?31a zah07G9ua$5FBkInx3cYa06sMa14vz)ZZTDVJA6+W44O(`u`TusU&2ha;y>pkT=E@3 z@^5(H^Q^oz8&Q*=G0(d8^Qr?!qL^hb?u87vXT1{&{>y_NuA)UH{w^<;J*%*#ZD!7Z zB`b?d|#(knM1YxuJlb znbvP5Ym;ZIb~s{VGRppw#QB}9eY>l$WQFtd>C9LWBzFJs`FIGjm{n-L%#(33crXgJyk`muRm6bwy4kSM@ zk>=5fSB}2vRgt*JgqDIz&bB)!ZF$HKf-oA=n7axiG9+KtE8iOK+sByh5&?$GU^MZB zNbZ;gom(f~9Q&=2`>mlK!afKM)sKBk+TW$i0_!)JQRiMh0Uy8A4V-=gl8-$H@!xf4 zO-$MlZ(V05t=}~f-qpq4%os)3li|DY+qZq|}dtdT*URa&pI?g+p~09KT1a{w(&Qk_Kzt3Y_c( z=C(n2xCea9&(wpi24jWQOq}fWF7->E$1h(Ge5C2tJ)Zw-c2d6;l#oXY??36Hd`i9d zv}Ywlu`qZMA*eK*g6d*+dR`>9H+!7RO0Ze|AW77rMm!Iv>ANJmw_6L&FyY}4>ZOrN zI1~TtSlaqp)z7Y3CEHmzjA>6zh9=h37xsyBwVfAuoXDuTT=imd=g}Vo-^pneeI>A1 z+j3HQYvqCi{8*I)c36CqXj{tk3}v>JT{c6fxQKU5Ab%f~)V2b?Rs#Yv5$Q@~m)Gng zbZ<^9jWN2IPRL(miUUVx#;#1YmSwuWW*lQ47d7UcUA5pTcjvY~P)+}rrJP*ete`u| z_Q>9u0KHexhw!q*jBw)Kg_t5qS!7!^A?sI~Fm;`Hgfjv>oaB8J5z9n`k3QxL>i9pm z70J=Rw|MZ+vSf1f7O{NC94!uVAcL)}LmAbXBndFWQW7`}pKED%wa*$|JpedN@7o~5 zT0u3A-`N8O&L`;u@9*A)y(md8S{qoF%3Ill3y<7LP#h@g4cGfw@sU4&TyBTX$D9E$ zJjU-vtsfpAc7V9mQu=+7J*R+@io5;Wdw>bvN~V6iAyJtb?U0nRfABztM@v3b4OCDG z`PuIZCJ8r5Ym0JGA6(?+z%y?mRA)rIaL^8bhYW3{C~4m?oG(MX#JtCzQX5@Mf6R^Z zKoKK{sC<$@-?>yWGAZ3zA`WdFhgU7yz|@pQ;L zK{hg#!44A=4_zLk&)h}v<+a!Mt@R zR}S-M7m2wEsWQ&WMSZ)hY?9HZNf!wGI-!vHm6e8ffnTr&OQ&ZY2Ss34!mq69jgaR8 zTdcv4MvbCPSO_9%-K>9Ltm(i4U5Lfa2{Yfcd7V^OOW(C}cP5u?oWFQ^w0>67CL^3) zIou+{X;NQp;|O4cM|zOFzw4BA!YFlgj_Zcvvlx0#!tV?NAsq1S?P!C#?eXZ9EECR> z;4i^p4G#y85nyH>uUICANTu*zb~?5LF;TAS9j}WaJ{WAb?1@xM?jhUil{j%A6TiRI z8B{1SB?vU)xqm7IX|F>b;E9vi&LDS^24CA62>(_{Q;7eNfG&H8vA`(o$kOKUaWZy% zb@L*-2JKJ$USD=@h1?dBdOG@N&5oNu`0TN^v5@)C$%hMQI^ONp?$zI)!1N!ZwOh*H zLFVg@!9SViuYE*!Rd)P=WzN18_!c*Jwe0+HDW~L$#gFxYXGbW=LK{n9gs-!qvNKh+ zx7Iyyr1?sxW3R3o@r7f=th*dxBE)1s4i31(Bp-XlYLOCnw`kSx1w?6FkKiOz!57aA zrDpUzy+W)#Fp${X?kraU(RUfR3*5xjNzG|3F0QZ;l_&}y_tDn8|FS7myu;?2Hhc`T z^XtXgaN4XbV|VYNIDhRk6vJhqW7L-`14qpd>J)LwoL;0ZlG~E=b&A5---_vG={|Ad zqoKL;eq#20H~hed#Q2J>A0KE5Cq?J)4By5Q z{?~YsA2wSiDp-K)y7MJE>@xG;cP}iOa9SP# zG4LCn`x+0AzLcc%gAJ=KhEppz@M;Y4Jj*bNr=4vxJPf9PXekRz)yhELkf$R~`)4NB z%Wu$oDYpmEW23hVN|>o@r;)N!fHr3dlZsMr0L;iY$?dsKdj5us1%Ek5Y-i1<5Ff@} zOWSFi;{gk$X^GMcx4?z{Q-1aHkg1fItQ<& z-|9n&X7ithjW_dj1E=^U(fSCpgd;wf$__irY`M=l z8X(ULgN)@`&LAbLO~}~`Atb^MP*3z4ZkOYq`Qy$&4k@+lq$mOA|1t>*I5&g78gb{T z;EUg(g3qWEt2jhWnZMr{lyJ*ZSeumgjQxR0J0Jupgao!H z^JX>&{#~VXFIJ2bw+-r2Nr_&Pgfk;WdZ4i`vCaf{ZdGyX$lxclrkV=OyyjYAWXl;! zQZT76;L0uh<@@JYx-9RK!Y?}>A=5010l}RM$s~`vg;>v)zN*RqtTvj13WG#6?fh~O zK-S+;)dp{lx=0U2?iLmdA`&ESiwkcPCXN1b;HMSG)!-4lS=1x@e#hhdpb#Sn@bDe9 zwEfbUf&~41x3Dpr)4Ls1@VRONR(%a8xLeti2 z`na&cP$BtD{zetef#<)Z_PPVx!mg6!R8I+X>OUDj>Y-{du>VJlHfuTIeZ4M)Rx`?Y zW2OGVZP@(@WItYvo7+!)68B6U{^k&BKtfU8C!izu8Ts6le&K+{gc~d-7;u2OS86T< zi(aLqulQ4z|L_EWL%im$?rs@peMRy?pK@c#xtupJ9Tlze;9-@N2`lVrkJf~Gwj57qf+`&!})1>%6edd zs;b?Szn7hCHymBzJoMyG%V|m;`ffS6*?pWb)b+_nm^K3ZNoV1*b{#p|* zy@A~jPbhF(BO0o@_P%@6O>)3f(bJlj_FtHEXxBi!&#wH;lGk`KowMq8TiRVlmIf>mqHzqc1CJ_d)(1vAl`#A5U&L} zm?C0AG+i}(Dx>FcmM*LKMf9*I6XV{E(O#jbkB#extVU*n9uQ=A7s~*Hdsjpyhg$&C z+jv|AL_1|VaLi=A-~{j=ROqaE^+F%{80Ml(qnbJXZPP4ztl7J-({^>BI+<6WF(3Mt zli2dSzk1@xym{b^aXdRjO&lql1FP5MXR8J)jNF1HpA~buN1YtlDuF@e$J6w9Sp3T; z5vwttLQmY>M`yv6(%IJ3LSXAmM|9U!t55hDU6YgE$Cb78tXzEt!udsa>u$}BCqEmy zw%?#9%nvT?fVi)lf!Fgpl!}JIU}rJUEzy@Vb9Tww_>p3@bnc!naVzw(hk1!WAv-!y zv#wou;h)u2k-Dp+c?)@hzC$mvvljCydxhWLa%XblL4BhBq07BaoD9El@o+f28kV>~ zax1`psVNm~zswqTRxSV8vn_FO5XD3O`C)be$7R%n;1bPCP6~zp?kD9*m1UCFbn5-81 zE-PCYG#ohv?QXePYWu;YLent`E}qhyGByN#truB-vVO7XCMrbwot-^$gA^8#G6u=N zFxjcMPO#}qVXoCydJe6cm!Hi~L>R5OE48EF8fx%4Uwzmg4^_1U!nJ?Yc}2ZfA4y^a zPq{66$hzS4=$1bv?^}6P&Ss#F&gn6eBNE)timyba2%T($ST(M6!FEWmbK(!!Q0TD4 zLi?{DEDzA~pJdBp254%5Ta?EZ)zG7J|WXPLpP_9QY@_&P9EsF{0C@LKi_1s3c zezaihAU%jCewns0E=S>156;LWD&k9WNw~ceRnq>PwF=nG&IS*^J|Aw^S=GW0McGo8 z=5*@*g&<_=@Rpl5v2*iI_#V&J9mtQgDl3AqhuUqMjQ3W3imr7K^?B?K3ni&Ly9!)q z8UtY$n)~PqLlD0sdP4q^wm9mk9>*SI&3TK&a}=YhdPg@yrkp0a1|RQAJ}NH4cOBRE ztJdQ#v>qyW09F5D^qOGh#@m^l)dvf$1Mb(iZ6AcoRtC(`O5GX7(+7g3f8I1^DRv`3&?;=yaUb4nc{VVaG_~WA-to+TuKd&o!Kxt<4HX7a2~d z_D@VozFGRa!bZEt(w(Z)F!JDTEGcm8zN(On?0Q>`{2ClhquEll@ati_di(HM-ox<{JJ{zta^@>%|h&@H8T=RKP2smLLG?>bh7 zOS27KDgU8`di3*y(Y#xSjjxfm@Fce@%NAXC-{}A*;fM_6Z&>k;VO`uJ#ec)y0a`wY z1N1d%EmT=qYq^)>v`NoB?W?*1U|sE*X5`qy9WhT`!-#$C!&%QQ2aLY7VhK=YgL@@} zz#|;#z1iS-qI%y1Me(G9fv;QI8&KeCL--Dc$35t+3vTdiPH-N>2tqroM-u>bp{u~# zb`nW(20J>fi;9EuvRUFx2w(=fSU?*q${MU)ZaRIp)_%PCpiJ8FJZiu?txxeD*}5Cy z8o1C~%TD&O6B#__*UQ~!EL?k|1ZzKH&NL_)FBs|LAps4(V2Ke$tZ@oNc`Q`k}iqaNp%i!noIR%tuLnDWheA5AK)Z>H9&6fW;M6Jzz(>QLQE3+>Fx%0&z>pc~r`GV=OJ_&d#bMKS z>Ku3$D%JBYywK5|8MCNyr}!q+U!JbV_=zzx_mhQu-&NqFboAMjrx6z!9T@55%Q^W z2ji{lLT)O)z{6rX|||2Tmjo1+J=nD zNtz2V3CFhw*#ZzTNjw6O6)w?Pl=QTgC%H->@I?A4^}`a`l!ZXdoz;0Nr;fmgA%AU= zA?CbhDL+(0+d-e40~g|!P9F;BFw#EPN&}{@Ss`MY^Qw|(^yRkidNaITUr&q|&HGOd zNoD6OL2({-j}~Lp3llc=v`O4qu^v_m z1+Sq$_57AXKVcT1XNQ;R%dSNk8qB_iIIs!Zuy15WwMzoSe`pu?3EG3>4Y+@2f-)qx zlqu4f&Wjh}+~BJgy_)AVVk@=@osAb{KT_a_uNu10bhjJ1u_=hKNbz1VsCH00*s${X zbKwL{!?bAdq zy3MEz8-X>o=n^dS>j-xjzixNc!XeZ0Gz)g6ylSnkYuDm$4eukBJ>NT+v@it8qLrwC z>Tg8el99*?fj-xKZC>?x67uoGgP*2H+u2^R_S5jAv-f`{Uxvh85;!p@WiAmguaIXY zil0?BSacG_bPI9)S&yB#%a7pAX~>{y2%7zzq z3b!C;3Ad^rP=i{~X$V8JnL`l@G=o9(zWMB%?jFX-86(xYPLaJvx~^C_ds((>uj?pL zW1t>{G(dMEan*J{N?U3d+}Vk0O?1+7PSkgK?B({I6_Ir}A%fEr?gU-^=Zjq%QEfMg z7f@isUDUvvwnGw&;gF$4+NCLKIOK9F8`1Ud?7W}8Ryo?d`_2VlvwDPcL@CqgFElrN zuj55J5kK;R+sjQTSRUbnHTIh2LWkk72&}ARU2CsZ?<}>FuyAm1JnuG1#y_wCm}z|z z3klNwy)K-y(JjEdqFT`9yNwv!2avC5QrLwf!N=6r^3Aw~rMlULNpl7IE0~9S#9o5F zTII34;|iC)`&#f+6pbE3aZL7b%}`-JMY*omN!tss852#nF>SkR;M9;ap%ALI@}eWB z9G&vAfV$X|c61gCXNtj{KH-58cWxV5$FKq1Ku&pweYSeWeKK&?{!cBR@-jkORuyOo zy$3-Q!|du$2&roF2u!xQ)FeaFSkbpPYb9ZCUY9j?Eg`87F(5>b%GC~m!VCNWil+)U#X6coIuD@NC}SY>vlG{&0DOCN;(GK+e#3=3 ztNqv$eX`;4$FBGBZS>>m9c3B?4IDpSkA_UR{acrV&fr|2$2K|L+S=Xvz-U55L-2ED z0<12l>-20nQ9nDfQmCjsq_hpn*52t-@GFZ9O-W%hSe|>~23tVLLxlJtOBz<1T#+l% zLG))r zG(YZosHy$NnE*eR)zb}zEWC)9y0SZ4#gbuOdU`A2G0Ug*R-FLx?veX15R0aC%s)_^ zsM-^O4I`e<5WENS+?cZ(>#yj+LNU>T^KnR@tZ>v@u!q5-D|G@r<=CwYN_!28ifl;J z7@dQ8?q_r*+y!(GS>eBo_tTI|{?(i6$_A!r1bM>kR9hbRe}P}ngF2TnNv$%MzD=#e z+J&6t)Z(*N3uOw{o%#t&)%#%W%8B^!c|AK&y!1c!s3x`G(Wq=$!UgGXyZt4uI<}kz zJ|Z433IAAd?%YbtWx^HMZ^3(i6>bbU$i!X^ZXk|}n%$4-jLrqclgP-|l{3~#csEn$ z)VxK;OD8xN)@FTT-w<(j&<9@95OU>@_YEgqP_t73H)3cdG56w0qQ_v)22tPCkhvh{ zjKfruk#(pz3z%UTPH3+aKXWM0;z7A7*3$=R>={iSJe4gb%jCTth^fS;9_Jpc z4S|bO;9A2@!65H>5k=1?HmVn4PbcXTyNI%*5=YtYTB*e) z8jx!(oyH;Ry*yTKWf-mld_5SWYwG<15BsYgu&JHa;hd)S`hb%6ivgt^sVtR&1Lm)c z8@uT2F?dWA<}!mL>^1r#`WyWSDF_sG;*XJ=B0__c7)ZZiHkMXPH>7=1-j+GZ)BDb5 z`~IOT?38~dhmJe3KTpoBtVIIEM&gffQ3p(`DG|^09c23&+R%a`9x`W&!5{*RVEX>%ymQ^%3Ag5<`0# z7r{mVPw`764Hvv-i&L|$MSg*j_Z~u|2sN;88HicsuMt}VmE|kpC#4J6=E<-VA+uT! zS(E>0ST|Da6}8NCel`9EORA5mL5#}n{#)l1TJT-m?Z`DEMja`o(M4C%UZlGwC{qt6 z(hXN25m&YWc^CK7$z5mp`{mg6+Fp`f9Xvbh$@Q8& zBRwU)JeI1=ly^S&>~&qZ(0rpNAMvb$elJqupm9|uTtw)=6~1=Lf}OU5BAhx*NcUPk zzLav6=}RFH+&yWzB=o5iDesSg_I{beF{@14n+Ej!Va?P zHCO1;kDBkGuAEdUjzkVmE{UiQw8%fOXx{}$BO`>;T>GJ)c1=px~ui--hQ;z*KPRfW2eXY2( zF&pt3K7E1xeHR(KY1;9ILMn_l*Nd^ZPaGE4^n=GMAJ!;wWYdVJ0YYTB3cMkbcJ&yh)8r!`(t3WT8eTI0n zGp}Kn992_qvT0e*M**z~+zCs(VE6gp&MsO1FyLv(g6o^qT2WH4kE;A?sB&~=vtS~K zb1^Mmr|-lLdVm1YkVjuc(TkX1aoD^be3&i+1>^s9C?G8t)b&a{m%0}@Tl%C(IIXw0 zOxwAt`Kb!?(Q#gYvigFQ8j!f}SC}0~?3zz{SbpPp#=m4)y)OEi^b~{`3@ppNkeHD(prX#G?$0?%2+{A2$u0wRe#~S|%YL7~wt^L~0t@qakoU@bB0FHgu4_USj4>-lrlYG? zvCLFbUeu?S)tx67xhdZakKuF@zlv^&zr?CcJvBDN2A|@#rShF8CYSq!f;-p@Z?sGt zY3E@=Es%HK6ck#JZ+XZ;%mH%)T;nwx9x2Z9c6#^5?DCkqFEJC_^^WD!qrt7G%AN}? zhH@Ii#^@8@c)Z8MYQ)zBzwENq z-RmZpSKi-vo3*y@zwhKN7t>V;%B)X#WCCFe`uMyb`m1EqEuaIZgsmE9e_x*(o=Uo& z^*T*KGGZ}4x??G8$Z5vTU}gMeR)n^3AY1m~!Xw%AM)_arvB2h+2n>2i`3WL>3AI#{ zm!)$&&FK`@GvAIkdC-=E3r{k_ne9Qt1%;s>x3)^`)wL02X^gs(22TP6f2xh_rkCHA zf+jqRMXKMi6V=A7h!ENQ7!DzR$T@>euI&eV-(k!miER3gx>!J|1k@ zsG6~GC$(CZVhYv{)R6k1d+FBE%njU?wOdMd#xDJ~?_PvtD12qsi3}&9FtN{?c8B+% z$J`4>(GVGM9?{aiQlE3cxumj13#;zwa5E2^pG?jS)?Sashh~B%htB}RC@}~?%9{w0 zGqnm?EckNZMw$8Ht^+sdaSQ9~q%Pe7>5Ic=Y7J!ypW(4aR;1n(JL<^0z+qXSk1q+< zf`;s;PX9z6c#C#T4|gIaWkyJ-VYf>EEa7Hwf_(Y4l2ezIb;Jz|X~R-TT3YBW>@)ON zyg>F3ck6X%0jCcQmo885*0OKS*CyV`RiB>4eILNp{EyXQYqSQ&1-CS z>BQgaoA_qSU8*{+Z^ExJol19Kga_6JW1scBUlTYrSqqW$z;$r1I{0c=^wln-({)8- ztP)){g#Al|%tRSc0;oYFAg;XPFSCe-xirABV%sBbxm;_~@nZWOt881L;e5nbb7tJ; z!FZ&cL2+jPz@o#fw>IV}6l` zn>Wa3zRr%NZ!R zXJtJ-f*HUfDEcM#!ae99`~GLjnJD$B?Tp=oqx8Zu9}gd`P07_9(^|vE;q0lh2#DCZ z-^5bBUa^=(-_YU^`O#gO)A5EfnOI<@_(gXubzseqvyviq5hAfGYv>8{oj5~ z`)XyjtJ9b|jgzL1yFlxhr81MhM02au$Vg2QNfD^5%u-CvQ52!YBvT>RLIqk~5!`X7 zTtGxYWfKs5_&;xWd3XWmocsRX*XMI7Lk@kQrmx{YuiFMw3pxLb1i4`|pCLX4ukf$) zXjLE<&8dHtvCZIjMw`9T*dOx1y_j=m*kVKqFz4~6t;SFt@Y|;pg6(8SeiOs_Kb8@8 z(5z*|4>DblmP7vpR*MnB+Jtg^bEKNkd=hMENzD* zJzI2_LmbXx__P3$j1-5Z*BjgBe9(7IkHC?)wo;ZNsQKM$y_L{0CBq)1@?p|2XEoiSVZW?#XdM4v%rAjwSyz>ZsGkhvYM*l;p;cHt|4=r%idt&Mo*MKrMw1OFUpLMTRkI73WipAm3?W#kTD#AH6KB;-YT~^BL4a};a zE7W&dQhcKzH8ICyjw8{~t+Om@;*mTHt!tCykC0~fId6@xlR(ZHDJH>3IkW$Y_yCnU z81KRkQ|8q+o}#Q#0ygvz0AE7YyU{f6xIQ@eRPg;y{|NxwJ0UIUMf8_?SAB?u1mSlS zmPvNX)0j!hx7Dws7J<^seX6WyPf>>Z=ihNPsQ|+-FkjFEf zKh$Ldynr^Djmkz7Pk^w%U&Qxfd-SiW-@-&z3+_wMJ1zP>q;XHJF7e;~G4u}j_>hA} z*RF2eaJ6GZT-3SFqVv@F#*Wz8f&^ajHuV+88Uu|}=7cn5$xD?!1%KrJrGePW8mz1= z(HNJKKt0ow+V3la`oTF#iDq@vO0R?yI?d! zW?%IbUb{Vq&Ay%|@HFNvFSNk37CpviTy`@}59>Z_jhFvb{_I-{Q8YMw`G_B@4o!16 zfIu@{%T@L_7gfi3F+dVExsJJ+u}0jsnUq5PVyX?0jS3rteRoWfm2Is7s{Q#uCthox zG)K#~vDksanu9bUf0ap>bH_lSEix7|wfx??`OnXmu4Xx>&foj&aPW3^vWT4F;_U^CjG;eyYd;v8#Tb&< z4}4{rHX@@h$K>~fsvEO?edNMzf|+3VY_}I!vdy3e#hbKR-tF-UghpfrNiXbU20U7N zSgwso?yvE6ifAq#hO<$Mj5+t?7ArMEO+8lZsgmRIo^8M4-#^%NFq=8{J{-OSMtKqrGq)ydI; z>O>1C*byg@r?!sv8|uB8+%EKnDgW&%M=RNzX_9WE?QUA2RX8E{F^y-AUX@r9e<+{> zI%gG0XN}5@B9Z#?5{66avlO62y&=jc%0AB>)xplAQLnj@7IWVVe53pS%NAUWLwkti zA2}!r=rq?kZSv09;n{hwNc%qfzP14qup@m#Cmpp1?ni(HIRTg4j|xu{L@J{I-=UK7 zJD0!~L)1zFa+atH9z?V(e52GEx~Ad`*i*@(Po5m`@~2#qaeuZv=zCWBQ(2;%MSNBX zS>UBPc;)Ay@Ao3T=-Hy7@_#;{gI;3KnYIN}Zuuxm!UVLqxj)!uHIh+P7+appHX4eJ zDu?Ky+9li6Ts_YnsBY6wvfztum@ZCs(>`x48rz5)hE2*1F<1IMDJr#KbAmSlPQyW zw*~H!H%qWT*4mttDWel6KZH$jRYC1YbC7+(H7KV$VKMJUj>4|Pfk9nSNm5J;j+kw0H%Jk;S#nJEGih5Ph;~ok$!MxFKJ<)wS7y1UiRa z@jTgtPfZw%(YpB^X&!(wcTJ=K?HpgcCQiswb$>X9rynYVjwr60q-Wq2pR{e{8fwS| zRC7>uQ?JWm(uP|-W3F)wl|vws2&9waKQP~!;YA?P;m;n{f0_oQ3-r<0>Q&0@Yo ze_gTjdasY}#IV&YO`}iZy@e6*r$;6h>MU8abCg>hYHg`o7t9!PG3L!0D*&H{wAK(E z#XFs`*@iWyEiTJ4?E}e`u17FZ-fZn8!PcIFAp}lUUeg<9L)1>BP15^gq}&XK{rcDj z3o$+hGzM*Kh4S?`rgpcR=I*i(j8z}YYmH%7#C1ZxpfMQDU|Gil+df$EVoeDyPd%8@ zq<*OvwH|?YvGc$6ILeP`)h3t?MH5esHm50G2D1g4&sIssUr|X@CX>M6slWPCyqmm& z%s`+Ci=xK!{9M5sPA=5;GxweK;yElt7O-yl4Ormj6kk$Z5+$I2)s4QC&JlkfvmEfD zKXi}jtm_6QuS_Bj^an8m!}zQ49@L#5l;p$Qeis)j<1P7xi&wYXve_%osfzJ@E8F=z z^tV*UC(vENXBrH9MI-Z8JQ|9V_XLZA{x#(l+J?U*7*- zquVhR|1_KMNtp6IuM*jsLAr>g~!>7FvhCb;pzq|lC1P)tGVUO0w5y&<+7r%7Ria zZP$w@uiO%Joh)Bxy9Y86Z?J3b&{LYl*ugb%KA}QRvc1G&qQpntraA--YSGIkUcg{g zP2ZeD^l$F=)hsjE$6rXZoF`&W!6!7Aq{K8;T+>%roLksURN`{Dg{AHKop>87#QdG(gzz#nJw%!qHOU+N;W2}IjSB&Y`=08J*bJnp20^S!6CWy<5M49*NwYS)um~V-^r`X+# zga1p?S!WKEFSSV3=MG6xmvC005R`3^(4Cu(O{n5Fm`s^Ah9vHZ$ouMqVrUdV_Z5k= z6lB(@Jdl(FN{ zMAI;}o2-nz1Yu8T{4hV{?i~?qOz&&vE8)vYQ|>$T7UC< z6m@Az#=3g^U3Obu?2e{^c^jkS>-pM@rF3B)1a^wFa@qc1S&Z!Cspz-x_XkKXK=|bp z)#Tn7L9NhAbzL_O;D)5gawf`6E$C^umkfG|1^jCIT_*l$!@lyDHcK-@bNl0uDc;%I zaJx+vi8lSOv6Ms#f%^eivXp^Y8>lf?+f!=ejOOkD(+g?$6gc>3V@B>IK|L5V{-#2C zKSTn?9hQ^t1Q}f=0P+>P)j;$)^^Ef-hU~)=&T|3`I+iNamEovb|`QeBW5WDowvX(%`7OTTVI?+U77fm1mroSGPVP!EDs4jE^Q8&GV=DznSr_V6)U!k}A@**X1MJjQ|B<*C$<>44z zV_5fI9tzold>Q*vv^oxK{ErQ+!=*`R)vVYVr`ukZoDb%mo3XQCvJU1$V)A^|-Avww zU0S%jA)={9Z?EJh<9-eM65bO}>_IE$j`l|)XY+#D> zzI3(cD9ZytO{?tP0DllnG)x38*0&uFa~M*p``jl{*QQMUfQ^)-dNcH^VKt4tuT}cj zoN8@Cnes3&q0;_(He3rYsQVd$-ESoYqXqa2fwAbM<{HXmqoZtX=-?Wzops_Q=X);) z`AdCy*=ex^@rn`+ z^oO!B9d)Wd$6*a@shw%FF0OqbU7j))xqYUVp~N5bm%8~+WxxNg_C8>GWYG(7zp{WG zgWy3at#o34p`o#JpW)(s_5Eb@`edh{20s~C>zmlhvz=Fo(m~0;=wU;u<=dw*$C+u# zj;x&6YbL(iRW_%1(iB@diQGB?4nF zzl0$J$h2a!xt;}m8b~+xLbv2a*+*pLN_XPEvI+8u z;eZ^H=NNU`L0YJvOERaP=Z?zCvs39JLXbUDaB+zD0G8;DUf!qIysYbu(t4Z=J-71t zmqrplE}afJTlDR60w)hOg}=~+$@UdbU*;K=B42@Q`=F!CKRe`UHLV&CPpn(ORnTR3 zDAA$$*bM1Kh+1mWT3sr(!mAh05frP%STP+@^jJ;uH|H;6yvZD%F$B$qt}ib%?f*k@^(^W0?yi_E@i?@BOP!da1YbWj+%G`;klyhj^tEN1%vj?p&Au^au9#PNXOX$=~$VG0+;RCa%flENDo- zm^vcZjes~>RY`=+l9lCdqibkrPpSgCVj$nMZnE_svg-Sv?x9o$K=Ub-caXwdW6 z1)Aoy^b*JlI39fGas$--4Ucy$bT!ELVuBaCMY6ZmljrxW86xa@LfKoMnC-dpq^Ei@ zm)*NbF=^d9Z4sAK+Z}Z@p&ls$AFQK~Z)K}JFQP0!8!o7HTb<@+>3(exuKm%(|KHs z>3&!a=KIjaPXME4lXpQmk=DW`wJijGZ`l%=j<2zam3%L_7|NU}(cxq{x)+kqfVL51 z!)n<5NNZbM5Nw(-m$VJm#Jjp|l2Vxv`)kzD7);$#i6TJ_ zT=$;Ce(^U=hadCA8jH3saReusOV2&fyzc|vio=?pcn%G6kJErC#ELgy?)ZJIr_Pjq z?Sq~@6y`)XGgc;x4~B20mgaC4HkBRPC3=wFN4v^Z(btU2;P?f9urarqa>%JjBObH2 z8nlvre5&$6@n{=kHS}$BVZXuus}s34P|6WT@Jn1{XPz&^PEHmiB!(N9!}{{zljEAZ z4n)oWt;<18te>3Z9!K;O(XYBmEy#a1e{bA^)|MW~#`j z#WfQg%Lff5ma+(UVnsR`)CqD_gWez@sw2jzyuJB(llu)NJtpdqWQD&+%gKA`X(2fa z_TbjoZdJJ~p*SH=y9IFV5s0IkSpu@>n?DCAi+ zn_!2Ns*4my!>ZVH_@G-SLm;VIG(hvTVpPkRw@A%$;8&SM7By~mHMXByRY(xD9Xb{C z4K=@cF0-<-rbBL&6Vtheq&Cu~B<;Tt>f$6n+UBCHW$+MqK8uIM_#l@l|mij5P z((chjS#nQ^-QE?}@1>|dkzN-SEguX0-jSGpv)X$66?LP_d-kP&n+tmWMqgnk#Q}vb zlCHgci@>n+ycERe8r`4xy*eWSZO94Fu$gU9_i)Y-O-1sC1C#1tnLxf7?gtW`3uSwb zLH`s0E{tx8udpF`%zZ2|i1o3v@B%~`FGr9*C)Wt1hp(C#!&>X}$&bX~Phl~`ofg^QJ25c(3N>Z)o$!8-C{f8wJ|IQKRx;RO!Y!J{-1Gr#x$bUSsm*WSa`n} z7)EjY^0)0Hg_(=rUfHHncw3vz^ubo$y?VSGwb+O)I>^_dPqkG+`?dGKg9`iqvD zP5a0KX6t{|irLXQz_@f$W1epQKT0a<+X9aLSu<-qd7#p{r?ax}E0J-Wo!pDC<`xi| z*#NuDrU44P1O2_(npnJY2u99q0qBv*SC(_y~u zp9Fu9W=+eJCpA&I4gROOzpxP4h2g}%=C+{KJ|UCooaHIpG9}+(zopj2F|$0=VUCu> z10n&Qrbt^}_~IKPY=kN!SlXCZn(*@a9~oy$e(iTZSn8%S;!C&YyM?pMRK9ll963Dr zWd)aYuK>N_p6fGA$4m6dVIM|zS+eQpk*c~r6R&Xb^pIirrBvH2%-$OlN%tkbaWOuv zchaj3inbJEHQ{sK!(iPi(8kIxTLU>c-;;t&KT0)1#z(v>)fW5Ux(a7UQ%0T|H4RM> z>CZhu0zaDf4Jd(C=)l$dG2m6%3(r7tHt!(AE`&~#Gl|?x*KA!jf#d!w46|EH9e2tJ z>F;wnuQ;<06?2T7xDg{oJAA*&_D7-;1i?4F;OAUP%ePW%DzPkY2BkBG|C+=&r92}2 z1%dY{p`XWYs`Y|JHB>qIHQfpn=*7iScS_v3LLFri=)Q#p&D58evtCM52^UQD#*Hh` zv4Az|jq2Xgq80Pf@Wx^d^boAe=~X6VC2m6v$w=7TcqM{L9QdFIW(EwWVg0!ik)yN+ z@?IeUndqbzI*%xWnjbQhD%(t!`P{JeV8tc}>doLOplyeJ>h!@-9Ny9q0*ffeWiQmO zhKFsB^pif*l>3OT2hEQye?BC>{SGu0-N?dUE^j6lJxlbe%R!S$y;dQ*>UC)4;+<6ajWQd7 z#(vD?=Wyd%JwdTS-T!$&rN?^n*X)yw?lZ8%d{!dSQ8Bd~DXs3lZ;%g6Ce zm{N=LgfNd+2ndLCW4WXX`cws7KyAQlxo*({xfhi`x zfAk~fm0V9@m5nSKAU*rH4*JUFgRzZ*cPA9v8zrtRC%d-6TUL_P+^8L|Qm843A$ zNn?enO7-kV3fK!aRA@S#Nn@Y>$f2>W9*`tGXZS576oZxjqA0$c4B=&g;}jnA5|IEq zWm?4z-KM?@E(xk=*Leee1n9#!pp~kNe&}v&xAGNMse6!1lwTj6E@4P0EK5Yb6WLeh zG!=0uY)NN}6Mb@}iJB1-`C&Q}{{che`?r|!9txG45j~;osr~hf7q;~ibh4b|d9H>u z9QbS%6W!MjW19`~X3=VJ_oEP)y-+|{I2`s1Y;-T`qZ!)nZxZ27iM+M?bDx7YY5Ubn zuxwhmPG~8;R}_jM*XvomWlzQ_f*5K4-Rt1^VFd^EUZ?x%p>S;taaq3{?lnib8D;9( z{HQ<6(@FHaj-#112#*$$VI&zrN_5`e?kwcSYCgV_H*%^6U9K}f#+Xh%!TnY?@)2@? zUk*U%0ae4<{e+19z(AAgG)vPPe0 zPXWE^T)3DQVI?5cohO)*WJ}Qg57JeF8n7v)cH3kSwQ%?^Jy<)|2l^iEZmFJl2j)K0 z*_VK%1>*vfd%#`dK!YKY>zo=@tIjzHi34%PHSh9aMiS!Zs7w+?*+{LF3$8!MMOMI z2twVWpsjbIVOs*EMl(JFa~FA@7skS5p(s3NHlPP^#OWp*=)`|mL^`?A@o2WL4?$Sk zvQNKV-&!GXJQhfDgS}t!mK`fd-*FmDW>5OC~KqsAM+cya?;ygSrl|oRs#3$6QQ!JK^T# zsUd(5nhR?~KoL(6U;gKjE!F>TL{`J;nJt$H5PQG}whDvUYkJ8lwu&Q8`;z!0DOK_E zZskX%x`XN|ZkX7uuk)zYo5BS_tu*Q?`b#8|$YB{DB&k9lQmdSJ$==CiFHSoosV=mY za=itCD4|W>9AyqvksnKvCd*=Ll@JlHF;kd~mTEvedUoiX+vl=*L-G$uQ=!Q3?QKYj)9z1i*&Tp8}{5M)3s+)Z`FrpOCKiX{y3v%W%Pk5 zYoq{6?JoY=ht`NYmzFaeC?mdM>OQdUdLYG(cq{ya9vgiBcl0%?cE@LEKg*#xoA$?x z7|Ck48N{FJ1nVfujbN?6LE_ufQM2EJ)qjo~R6?$7z1Bb`dm-%efNwav!dW%{`m~0u zo^Ura=H~CWj9UEaE}xBHr%e!2aDaOq#au*9%$;u_r4Y90R@oMDK(m#STnOe4B&tX5 zF&6)<#g6OkNi1au5gkSQW9&50ZTzwzgQ5=p3V9TAaYN!_$Ol|`5kiw1qF9yelo%5_ zpS4oF*Gt=Jtyz!e)r}#6trB!9|V(U%vry?C3>N&T+FKEemTajanJ?tP@OZ5mA~CgvbCL&6 zaQWbBcz5hC?A{54_m4w>dF@vM-Sc346@(8|r79{yh@j@6E{_dpcEz;ED9%hx>U<<> zGpYKo*MXc&yeoJ2P*{3`0#L8FhnrjpE#`i9kOJ)*=J^bm?ya1q;&_dSEn7P)v8+k8q@5+gnJ%pEswYndy2EOz)5 zCzb>+qu(v}czhO=91;*Z^>NKXb6e1ZrH19~F|uq}AHL(0lo_;DNu@cqaLg1Zk#<=S za&IK3HKFZr#cQ?GGEd=8q9%OoU4!TMryVWK7AlPHa!Wv zVLx>a>wJ2UE8ZFI-gG_(YrRhTiNryv|5nO?uwEO{V^opr39oqi%$9@kJ7>EyVT-Tr z*AqVd$jwi$dM&poY>c7*X;OKcAGrr%*0@n+zUSei1mDBWnfEgl6C=he0g&_A%F@$X zMTw_AjG}Q%B;(LbUy1QNJO8tM1J?oIK-5RAF2#j?h`3 zQvpBLQ0rNu3%*wbF>jSK>a5H8mKLK7vW5I2s5$evJkr%HO;mB(#LaCw*_VkxZIO{l=}&7FFzLTClOqjxC|QAR+poQ8yboFG8AG#CTyU3P zVI!EAJz*76xspZ;ntG-ga_n&y_~ge+mR{JL&xV&yjBLuBrgrYl<~)US<~N&?K3`(@ zBh0m88eF#)q*t0>k^4M4`oWE}NUPTD&6S+Q4pNZ zhV_}<2$hL2(VS=NDUv5Cgg#V@!r*d7XqV1pZoxW)GRRGzP=`z0)urUe%4M&0qrm1U z?EQMa+tjZ;BWGs3)wE{X_2qAJg>9GixDVTnd}LY{L8OM$iW?r9OT4l~?*)joX>P!3G}6Qmm2qUCfdp8u*~k{udof-{Ju3o#OKe>@ zGgNmD*RU5*5_30$_J^=gqf^C*e$O#zt-O)rm1OCEa5_cQ7Ro71g}xI4hrXs4!g}0; z`tn?cn|+6^x|Q4ImrZ`QIdU&@(eInj;o#Pv83+RQOidB{FPT=ad4b8GUY(V>*9&q? zjW2#a(a~nR3IAf+?0d0lZr`_G4qThx+o|gx#Ie%$>Gl{*+}f?T-5*?D`kA(r_amgw zcFf}h@yYDXJA0D58;pWAWl2{(}ZRXxz?g zQk#uCdKh{W5+mX}`P`f~tIX)U(J<8wz;6Nk<&?g`Y03)=S$$n4DK6 z-_RVfJ>dMTlO`KTT3C59(gH>JRbhQ&Ec`S)g<@j68n|u+xCO#lgV82Ca4A1?2~Ey( zzG_&2zCv;xS;s4ChTN;ZQ=8YIO*p2!6wHj7l6L9aiP+Fn#^!>oP1g=mr;1Q6eRe-l zUqS|Kj&S32Rz0dLH+mg#&!uved5y5BP|Fj82nm7XhtzxM5S!D{WF^hXD^%Yo7^!aI_1c zFR`Najg9=Q*-(a%-ua897*-O6K(5S@17%+jpJsyx)`EYHd_9^Bw z{5b;VCM-Vk&9h;*ln|H2UTtx3`JT&_4f|h5C0vmx&CnHBg1amhMtO+YqVFO|D6w zq@C}^RgTjc9m5E*udC%5Q0w#4YK&3llAVF(Z%zp`Mcy}5*6JE}%hY#lwQVTPM#4gz z<^DhuLzO^JfQ0@>hIF7fM59bxi^~2DxA56Mf-=2&G{uVAy791^I3*(3exzGQy%p7Ui1A3LL~^dj~hn z35R7~qo0E;8;I?in!wg4W00ATDGaxDb{(gi z2U@NCRieg%x^~STbuWBq@^ZG4ZZUMUA=z?>5s_Oc8;Upa)w2vtUmng1gp7OC8*$4< z25;V5Y|OYUa|)I`W;{;|ifJW$g2f@M<$d9Y&hVBNQER!&1c(0JV35A>B`jG=x*c^H z37mRRj_yk(k`#*%j#61p+>Au?8RC5`=TY4ENsxf0dd@PgO86%4Phs$E2SMl6T`_7> z(^z0$c!gCKP#V;O?5?vcPj;Aj6FnwaHq(zi{Vi)c+Cu1k_3<{E5REL%SbQ+(dmL}~ z=SN8I;dflDOIF?S@BcHPwZTpWVlfiVylGZ3_pN7wgJXa7J1ap2=hq`b|_JqPR z%B(0Q>F9CQt>H!_CDQnzv_y6w9te3M&~-TphQ?^4LpXL{a>V6{8P37d4_Ms|(?;;H zagI;_-!`A@x1ra`k4y;snP2>QwEo05nQrmr&)EUp{33tf^Ve{EeG`WyX)|<{1&Npy z1gA?1)6;^k0+B*z^5P#=29LE5LQWUMrn>To_YkSsae+mBW!}OPISv|DSp_@?&tDN z?RL5WIUXZyj%9Ch6lVc1_nx*0=8{#{+kQTm=_L)7?MJy5MPw_QBz3a@%=s2HIFP0fLZ8s9=!?Uck2iA! zY~9RLjm5;|K6T^hXezQtby<2w@pE@nw>2v6`z6-w97HH=XbCAP&ySb73kc(cnviY) zvu8!-HhP*zy5dt*$f$Z$8ge^&3U*dxg*>kC@wwA$5ot;%YEikf(^5-*#w3Bs_^{!%ooIK#4l)#=Md1Gdv>LiYs<=l z@d>Wv@I#W&)hG5O&r0 zpL}rT@0|wB@Xxh^!lQN0jy_-LiRZcIYNtn#+qcrwbCaynOSgp+2)vgeGo*oCr(IT) zh-obQ=1+{ff-7y*D4)eB*&HpGm0|*CN_ntpk=dXMFPqv~ct%qMge5+j1KjSYj0cPy zGz)tZ6E%blIgFkHu1Y$uPTb3|{N#_eDXX3|+6M*D)~iSQpx|AyMYOY!(7E6WIst9F zP_<$5wxz-NT(Tv8_&M22N9ds-J__JlXU(%?J3V(IKJuL-3)iE$fi`G)0bP8@$`85~ zb#^-CPJgAhrsl%%5zc91u1CwV{a$68Ki(`ndgfhqTM+{EHCsqJ&t*&`Fd<2wM)aEN z`CN(BXH45cSw#lw)~tnmuF%<$SpTEIaZGTh8yplvm(`lh^)%x=ZKSnS1wgvGd9=)U zsaDCaZ(GA8(j%FEUO@7`nV-W4?D&5qsKHDZo242jdUSaya?XRmEkQSk2S&(HLGHf1 zeYl(;(&BBj{7=FD2eOkHPdLtAvAg<(poGCP{iIE<_YPoF(_v$lSIFhl?$l(-%#3?P zZYq3G)4v*xKd5YQzj7JOYYI~R%k__JkdDIKRv^H`h=g)|htQ7#TRT7YU|A4PRn!87 zpH-8H%^t!=X*#L*szKG>7dDg8pkf#sH9w{wLezN2k%68Eo794WO8?U>R>}`r@9>Hs z`5VGD@KBS6B0A#qvZNf@T-2B*ffng1%#;I_*pR>}yYJui#s(&#SrC~qT>*S;S@qx1 z=1uyxD`+m16DaC!H(KiC2vs{!*S5kC22~0M$Xsf;$O_6xHIY_uF6)|;kfP`MaIAAo zNY0AbQ+?Bd*NIpSZ+U0IJiR$gyM#Ub%cOuabh4-jd#k*?GAXE11oaPYPBcP*^}2Sr z`XZNLc^SJ%a_ujK-wjq6*1WN#Y{AIZDGXU=Vb1-~A;&rB0g(su$C&w2oBbQi5N*8+ z_DO9qX;XioCG5vL>MZ$fA-!i0vp>z*V86ZK=Xnl|9dRmn5ymuzj1royVHe6PxR$(` zaDy(P{||!dEhm@8GHgB6=S?><#(MDk6PjA@Q0zTOEMxz6!go!tA%78gmBC$XXp(Ke zcXWGVw#_pGj6atI8@hbZ3!r!YuX2e_+Qw67DUbq9pVjoz6`OqIG1PJS^mgHgt3Yk3 zhtD^Mgf9gy(CE%sKN^t*rk`hBeOR{?J_}&NJ_R+kA*hB7rXMYqIPHmf^oCa#HY;5{ zkP!2c3HPaOR<10QR-_(Yf{*pkrU>J!`qov)sBggE8*Kp%;1;%TJ0TL zov?q#@yJ?%OO%SQMC<)CG(4N-B>5~^7rKdq#d_qoK>22*!qNS;(7W z_8HiKJw8EWdSC>FJ%C_3{rDMkCPQ99e0BOH}l#U*VI;OI*Ut>by<%;a@q z!dXOCj(wK8<%t{MR>`3_y*s??bvSspph|HFs@K@qqv^XA*(2c3O(b(W@z}4NP8V+% zA2^RCkj#t_WO=A>=&@E~zl0G1tw67cYwLsGBvNq=Vedf7J}nWGw$=^x`%uNwT&Va& zt3HuydoN$`A=Ga>!SeP>#2VOR#^*0V?XjZ6+CmskYV+KXFYDU}eT6RNs;A#rPmCN7 zLzV}D38em_3qD+5sy;K>KJpjn9vD^bJ*2Fawrcuwk4lVYlCIO6Eyr!lKeJ<~kt=`r zRf5C9gFV#_g5>bfCREyflr(jQ1I+zi%0I~ifCVp)l~Yu+>Q z7y1hlN^_*DfUdWB3*CyfvK|Z6f3X!#nnK8D6Hn&Aud-AA?f%agRV5{1?_iinHx-_5 z7fMn8OL-5Wr{ZC_my*x^biO+zY)bdZlPKh(XV9xAK05>tQHEWAUVDW=D(k*mHT8-}k2DNhD53&G8~xFQl_ z9Qd{{(f!H7v%bW3EoW(3D%}B(;3SJXyh%+vNVXJlE&RnXh!#ew=chbQ($B@A9z%sG z)313kZam5xo(vB-|6aO~W^i zy(Xc%Od$x@_1x!mt#|kj#*EZ1Cs!*Fu?*n<= z>LxKXyRv7`dwjA3?eDGdo&6aG{KQmtln3{RL-Q5jGuTjrBy)1he)uU;#fK-&V-W^9 zCSI;lj`>A5mwsTUu=smu&P z-T)ucP2psjXw7lUemHox685Za=&<|B^g-D2)OJbishs$Nb-OWSP=g3X4eaWRWtKio1Y$8d9FHEMs_nAqpLAZav zIubkOv%D#;&F0OL8EBoIV>s(l$ouvRG)BLH1%iIKLP!}kvE|3OqYR%Pr$If^)VUa& zqWRasL;Fx?XEr^?(eF14;-fX>!De~~$@CxloNd-02vmNWUM zL;F%%P4pspb;y);c^UkTmG7~filkXR_&aP>>!oci=<2h9pniW?HQ`3AJCkHi~Y6k7>F~F^B2(5!T$2%U!{AOIPdT$PYeU zq#9FkMMhAdX}&brd?>O1v%K^=t!+abZr_MtBsXJ6`<;-k9%%pQd&druFSg?^(A0n7 z)*UkU*O&J><$=VH(`8du;8a`T6mTPeJUQl*AotOlic01G9^pjqSBx zXEs}b*kE{MPHaJ+-fy-g5+pCsT}g5FnLQSV2(j}MS1W>_YEHA*u!lggB4S--PaggD zpA|ic1pe!lqL?cbfhAyiAd$0F^WhWbt_~TS0IMpkmukU1U&AsU=Hr zsT7Zk9qq%F2L;7@G7$2J>Dz3ukS75S1>vblYJu~n9z`jGo!`n=T>M$HC28lc`4 zl_Pd3CLMu$)muv-lIM(OOUE3E+YMgg#XQobXA9HS%DWZVh1?gfIps(-tML@5lLkE1 z1RbGK|H(|+!6B%oVT)w_qaN^rIkQD=d^%W8tD;PrR9^R)aZ>wS{J;$^oZTg3t!riI zzwOkAE(B=()UuD}G-kJhU?`BKn68Pfi**PNu)-4~C6Fduki+>nysdmA?u;OZKp& z0jbBEoS4x0Jbl`-S=)w5RUPC3SLt@nbR4qVu8v$Y_L{oUaYR|2xvg@S_U+R-rcT7v z<#Va1!~Af90w3>%y0^4nP_5N$cFOm+ke~NDuiD)C-lOto8l3IM-gYyjOPMR7{>{BH z2KkNnlDP8v6bRjQG?Dl`M$ss8*FJ&DG&B@|q)jI_aga|IHv(ghB58)$?jB&o_u{g7 z-KCGr3+jRv`EvJ$!4IXWnKF5ya(*Z3`9!4H2lUY;mc`)D)=6bPUB^!v$?h+z{L`R47qU5lGntME`t$kN)SeFCTf1 z=kq@IeO*{^Qk`}j5eF2pZ4;^d@@&Pb?N?EI7lN@#Q&`yNAgNls_8@t?lhXf~8rIer zah_crCF{821DIviweE1l!t8#k0~)iUGO6B89eqUVPOJ~rt;^3w>7XzG79)2sjv0wxs> zvgz^rd!+~<>jNwROi+=>?p0*O`Z*TFg%9f zi|k#M+a)h^@On3;7A1`13M|mmx=9X7QpJ`iQ`}Fut^qtlP5T?F?F)czF0v*8xN#cC1yE@yz%)a z0;wPMoK8I6mKvzidbcP*{VR&WBm?eZxjNpH97{|Vjy@Al-h4TByH$$Nx>&ghk<8_O zWQH~JFIQ|yLFve3ALdeLL$aeKj;*S5M^St4`N;i7xaNMA}x|A6HD& zJvk?2?EPtcE1NiCy)q@&i0yQj7&_T~pX zL%$}ZP!hCBVB|VsuP15`@(e&W>=R*18(G;aHxoX$(LJe^)kbGI4JJJ0RTS$Vs3v!D zqyaqm$*teRIX^PAw=I&J_v?R0bOemU_jl>Sd^zun!^hgX3O&68le!Puwrabq(8bIS z-6wfkt&DNumYv=YbG3O0c-(qc{QUfiHqldQQ8B4pJ|Dg$c8eh(Nn$f@3_-tPM2S4X zopZ`h_0#3b{t^N3x7cM4u?sKj$3Z1TRPh>juDb!dV>{cSq?ikjO43j#s3C&qC(~r9 ztHjZ^qFl{UBL5Q$cMn^jZJ-=b2H1(3MAY&tt#g(t?fjDA6hEsI@qkp7ooFu>z$9dg zxwT+9Av>d=e^0S>Du?Dn0HEzal4q?gM z`%pa?9BFZ5Abx;06F<Rj`qh8oVuctEZ*C)uHl7%O!^YywqC_6ef#mQBSZwe|}Bm2s_Q*4S zqRc_BkwS;OI>Mc70FaRFBZ^$lTK}NoM)+Hiy#9^>Mo&&KEgefK`vW#2bcdZD8ZI-J{-4>2J44-2FiNxA`A4g8Q5Sjg>a4# zE3>pnCXGf4kcITVef8M&s6S<9+YH$WYs^K9k!l;Eo;ega^mWcW47bhxwec6uh1mcm zAdb1?LOgyzWT$jrJ?P^6>z!+7oisj7(B1}SlZ=p2>Mw%h-DMA@X`GyuM?>VqWNK^= z?uINBNlK}{tZEQM!ZXVDVJjjpw{Fm}&b4Y?E(ejl9%ll<8rd9Sv7zYlpX zNfTWLj(y^3DnCxHTiH^tO3PZ17;p`uVvA26jigeSp!WY5&D)fJa-2t}H(IVwG{(rV z*|P-1OWcGSKe}fYWBVHWD25+h7`x3yj!?8jdAu9vQo7*#If z4U#|kB=5N`xF=bgsC#)Q8Qx8{wZIR%79i7K&B=;pHAA^yyq%#s)fy*mQH7etcGC@j z33xSrBg*Ltkot&jtqVd|$8!O$PFLk4DQ2S$J#cAav+2_-3RVN(Bq{9QqJr$4^s-0`Ia zxsqt48I9EwlWRMR!rLi&zvg{1FJRXJS5-m0baJP>Q1d79NW`CKsgSce-Pzye`|~RV zsh5OW7$X;Aybdm0}nmk$fWv2mQ(gN)UjSlBkNhWTr1~sSP z!H)(D%b|KUuEJZWeDFXJBQaJSz;}YG+-vm4U&8Y{L(MLD_TV>En{=JGgSj&8%#J{mpO zESK-eeHb;n)W`YtYpmAD1}j<*94ITFbeB0x%6dclXxg;w*wKq@XY4xnvm-=b z2j+Skkd9>*rrk4@**S%eEXmav>ThkH1LCQ_BgT84KRjqvOWv=W!mUdg3>L+M=eQw% zTW6w=b9<)bVNnsq7beDra=WOQ%4+O}$(;dYB0wEZ3~7gkFlakK|3dRgtEnur8^b;C z2Q6yZF`g*@Wd(PGySJ9F@f~VIapOO;|4Q8;3EvQyg%ug{Gq#W+EY7n zw~}R@T7=1g9fLsNd$Erb_DG`NfsmIovWEsCD}Ms?6oGU94%n4?*IPJkZbs`b5M=L` zVv2xSfjr$o3mvpdFuC9wA@4x(P$gbLpV9aK%Z)<1`9dsjN zdt_d`Ff-FZjzOelCXGZ%M{ZkR8A1qOQ5~PU*m|M{41)+Cet69hov7uNS6B-^yRw^T zevtLh(=QMg_$q#@bmvr^!Fsa>_YJ`&ZHyR6gH8%T=y!D@=HWj8oQ&bRJ8QI%?=h-KE5rb;*(ST@=Ttg zQ+}cKFT_YR&yB&ZIk)1UO}k_O^RXg zXIm*-PQ3aX+eh{N@?*Oqt}1kv2NoJB24I8~P3X~C(1&97niN$> z_%xzu>1uRVXgOeZT*0rk>&HdA4u4n9Pq78XU@$o}=cS=|F2aOsg+=YGkp?|I2-Dvr z-YBM-<-@en6$I61Ze7aEza1$Ix8B1NY_`~yb8G1lx&KLHmONC1{#lv44FE^PKOb5v zLe96S?v(q+(s1caue_eni^C?Ud*j9G4JoP--F`y>6%reD2(uSus4#V~6Wv2&jHhA? znLVMGVK0EgZkTh3VY;|&eb`do3V-^tm%bb0n(U7U!XVu=IMp3OJHh096J~IRG zOa~VelyV{g#K|xU_+gI;@_4h?YJoHnWTBfql7MpJiEx||JD#DaIQu~&26 z_#x^Thg&ra+N)n@xTN0&CQD)UG!nS+{=*oPukXT_ZRZkuTi}K4-Hjed>O+-h`ie29 z_he&nD7&uIl~^EqKGJ*BP+)SJtrjBg80O!jhQn*fRJn1txNl{{@{FxIdJ$nogHdDF zQ;E-3z=X1$%+iVpfFbu;mYJa9I>RgGsTV$@!XKuz7;;;-vAC+cijr#`!kuRa8lnoD zidGd9Xhm?xIjqC#_`cs^5sw`9%LW;v^oZ>;nt`qz89ZoJ<+XEnV#NnL`7J|I*T2cK zROBXNe(i1$mmU0)KQ_EEXe?|XS-9y_SIyIl>GP3rN(&6hu91jNcjQuc7@80&llO@E z)CfSad8YeFj)M)x@Olz|*PIAi_;Y_pSh8+gTroLzX=n)D%bJd3 zc(Km#XleoYjI07Y!EKyid0CQoNC&euc_F;VNl)BaD683h`eP&e@=ap4U(?* zRCl(b*G*D2%l#9dlB}7Cj3)Sc2ER7Z7qc@CFsFAeU~S_J`uSdM8RgOu?1!U93bRYS zD7ctUY9ckhGU?PG->*!TtH=~^ugRYs9s@>#`KOJQkG9Mi#tEC`0nDN}SPG~zpXC6Q zE`mPn`s4spJ8&}d`Tc=KmM+}Q^wP&<-Fh(qXUe{dlfR2Pycx;Z$Z}bDnhM!-(W3H* zK9Q)n<@`zCV;-73({nTXpBCD!x_oHl;XZAqm?GaaVd}%bg<~u{vH~yb_6p^Q?Y0V; zRkTOPCb>2W-nNVkbb!@+Q1evfL62D?KliWJKAcCxF zyso!@Y~H*9Vxiynr2TJr4eW2g&$#WTm6E#JbNK9AmSA_bC1o50bv=OcY!mhlCyaF0 z=~Fy=Yw}Z~4+C?3HOI1&^C+UJ?rZOQn+t|c17i31s{$6S^c49PEm2$4O3J0AoNiHY z5}X)+g$y(%=EVOatp#jK$v>wh39;W%`(B7<9%Za25=3cgOE_ojh=bRSc>_;5RQ)Ks z%o+Q>xQvD7>iqM)TTNM%+)4&L%DA-Sy}+^LCf`0?_Pj_omabMsjI$M8jRUlQ;^Sr! z?NjnkM}j1SpK8^@KF)r5_j1MrPTAk$&1c5QYC5#f1qZbq$sNyFhmqGavS`=ad3Gqe91_x){HfRDSyoA$@FlzrrafnES)j|Pi0jyhf<-Z-qMfEapQZ?ngnx%ivN2-i zqf8anZy2&#FCGyb4N~8w104OwO2W9J3%V}6 z_C7tLsvC8B<@c&tI`3W~3|*ns|0XSg?J-jGQj5P8&mJ{6VIF8I08h zMnELcyarNnTp-w{(GbxueNk5OhxG+cgQ|>15(tM;B<;D%{%a+!%CE-xA&jmi+YAXP z4=hsOR&eO#)7D{l?d43Jhg^eR3qvbI=b*1DwpL{T^vn7CZu$>)Y-TsQJoM~OU#RmL za>zbE-}Qo48=GQ`IqkTrGCW(0O$B9(Zfl!(1s=A<5YZY|T_%vmtN%QfRkN;Teu6TC zwNW!U!Obt%yE8TNflyZ%ism)+loUV)re3z1bv+LIQC7$K`SaHl?aRm$BZck^e`_o` z%Do?onzmT_#-7vQ%?&}F&RH_X+QdsxQ!r7SMmIqT-- z_lLrACwXrO@U~*)pz+YTfitT+5gk*qKirci3(h@L=QsF@CA%$^iKGP8_8}*0AI#Nd z-F2a-?VRsS1V#`k2!6KWCMfJRw2((thuIa#x#Pk;bN1;|RwX2XYE!^(AF`U~OCV_g zf6?Px8sEPWB!)i*zOJRl>y;%;@slX277Sjfkd;MPR=QFf$fqo+)CRi*5{=njC5PZ> zA19ZlvsRa~SC{(tSlm2sTdc=C9T>=apIJ-|67s{BXE^lJrvXT4}zEu^GE`?KjzxeCu-9WSV#4(%h;eq|xw zrhgK?bhoXo4o_%`ox&{63_cK1eM}7sX|2E@jEdW@49h#5$ zV3>HOr4VhkDp$Rmzx8ZDMChROF6--EkM+W*H0OMnkfUF>JkyHhLfiax%f4#MmG5Uk za6}eM1kO)uIc4M!F=99i*XFz8l622hK0?|XNyU69dD2nT?CJ2o{qM*9?}%|M;Rvjq zGz~Po>`Gt@p;g!7`cTun*A#DE>p5=OJajpU7nb{PLom6m7$pZ|*5q%ArHWAM-$cn< zQg5p@;5PQV`xyl@c2)HH{Q36O_wM(*Y&g(8JH-FhV|mKlJej3+0Q;ErRIaX#S8bqZ zhovDOq|BFND(E7EgASog*$Rpq{>l~I!=%b^GA5kf@0PJ6e2lm7#K6oe?0fWXhAS3(HY@ zQ!hbgAH>dLPOB=hySywhZD#qYqWr7)|C*IY<7yTi`msNy`qu5435NXxjwx+E-G?(xww_%MF5I^j#c})N0vEy>T0?>7o+U|iIWz2BjD;bdIP2F74AtP5gw%#RV*TSS?BztG>%G{s zVLoL0_Opq6Z7wMEoS_*W>J8ct-#0EceP7}=|Kt1n_;yS_X}34FO-)p11MA8AvE?^D zq4WbG@&)Z12p)FVx_ddI+Sl->9%>25|4Gr}!W5az6gJFW^Jlab%Qot5TrJ)C!`~$r z?icm{wx24!ZTiKalBMq-A`EWmp$?d+PK{L)STY%#b(B z1aDW^?1oPj&Xnknrx8pQh}UEAjL(P7P)q z*y%_;nmvlSF&Hmiha`q@-59ybo6)@qIx}qY51npksv!-!=kHaEbjUu&NqdtKja~1QB8^=JV_s*con&u-DWaCFzS9;M@TVlpq;>pRCqD;X! zl=A>cbWs1IEMniI_wQZ#Usexa7MfP>5H)N>3y#P8aNSunV%(b}D#|XyzbM8X#olG~ z9`eSKaTwq1iHjvf)*sNImTtzkX}%{Sgj=Q_Xzh zlslO?ZAxxa($ou2pT*`|*yH%>z4Z$KBJ(h+;JhJSRE;+SpbbEd8n7_O>%wqpt4B6H zyWl)4`Tb%)`2)o*z>{zU>6u+V89Y~%$v&^zkJ9agWxE$6ukk`9Xt1^Iz!CjzHSyeF zg5qHdJ9;3Y5BBY?J}d(;zS|ZqT`n-1$&Mvkt1INac~1nzf@A7KdPJe+%v)*cgxMg^ zm!0GMCO+=qXVc}^CGjKF#o;qpOmT!{`0Hkd0r(p*KT%lq;Ugo8Mq4zHD)LGhE z+dAS5>V}>}tvO)11le670a$u_3QDeJjR7iI%SU#2TT*Gcp>+b#Gm-ahHfIwlS8;f! z=_+I4CHtj}yutERE%FH5U)7gz@hzsk)K6Fl|H303ppYoy6!l-+5_fKC&#*;dKrVd- z5_{gY6{>T3c%C;Zw$9ixi`m%tskbpBn$*U7=Q@3j$$Tr=EjIqt%~f`p;Tb2>Q$Kiw zo!c$>oN$wa^ep9kEzjCukZ=jcXqSEfX1KgcYHE$ZC`GhjDLyO z^hB)8@>lhIJm$yupK^)@OMTaFeRA*RF#~UYPTcXa>G7sA3Y>?2Vwi9qeX+IQiy?Ni z?=|2yt>AK>5M^O(#JKIG$)AOT^;n5p|5~^&+Ba&MUN4!ljhi73R1L2eBJB#YvPn@M zUAb#v^VNLVeB!Mf^3dnoE#Sl-f_6t8eu#__2em|=-y%nwFu&$flETM+PO3X9F)@eY zK4`+@cTX;6IEWgtr}ij675h8y$)fA4k#g_&s`c`1%(4gwakf z>ozx;EOI=f9J)W&2}<=A3PzQ8osm&xM^f}<)9?H3+(9j73~6JaZ`~T86B#{PA>F8M zHqxgK131($T~uxfjW|^Op9OQ!V%xF^PmH}5{#Hf^?FmMvb|3N=ey8QNd+UjkLzl;{ zXDh-Lz=VuZ3`g;lE_+2*04zIfPq4C(TL+|@HX_T(Sda2N-a+2+HeS6^Au=ys4)jf^=v(~>fOJAon+hG%M|!ju zOPVI1?uzhJeQNHCeYe9uHmx35>dI!HV)MHIwC>Zbv#UdwQ+SQ7n}0`geQ|xq@hKv| zDY~{W>F^`NjnU>qycYLeV#{JKuuuiRV?L2AxV%htm0^0p$l(UPlIyZF_K_X8sy-z5 z;K-)zQD0xtA$dK7^}1)&N~osVu+^uur#PX7qAS1s?&V2+=1_aC&&vR%iHYFC2_nvN z<296HM1CUhIB0nm87*#ZN$_~8iKdUn6ad8lEEGi=Xt|$}3l}7yc;e@=hRuS5E{0bs zLBGLAU|7%r-G(eD{G`Up4301sZVb&~m~-EF>vL0fXb4f?|d18BAc% z^x#TT=x3DQCnkw(KixKdNOf?kx;l2XdH|M-(jAI%T1oUud-Uv!H=>0UYyWxhW`XR? zzaPIU@BJVd(6_;D>7#g-2u$FlEE9T_b%v9?^qqQOFouG zAhC5Bpy})Fhc1hXWfXH;{Hr*zJs;Qqhh0aXmbZ`erbq()Ku%(ugOFg?c^AINWEE}A z6Ys07c$kBa3vx=vM6)WjSx=R`wXGVD=rSg1podbFStk5)NTwpsz%bOAeK=Lwywl~Z zhmh&Y6Qq{RlniwoR9QAw*cLA@ax1O` zGm*suHl{Q5W$Cp`z zvPGJsxe*>PpFFj15Jz|7ZP4Xo@)d;|YGU&{KnI|uHL_b{rY}gfPdBfDBO%jp{P9+L z>wvYJO0(`pvD$J5`W{vZNMaa`qzZrRx{3Cy{Uev+=%BeZ#Ic@~qyKvc07NZ=911*S z(jb}T6N)GKV)l03URw|?n4Cu%HuaBuJ(v=dEszorb?Upy+WZ^)v46h7Mtr8cAz?Po zogI5!5$Z7f9Cl&$m~d_WmOS=dd5}rHL6khLyOK@^H9TZ;aA`nkYSGH`00{KrwI>Nq zXXd8dJ_KU4&(x99?jq!Andr(7!tNYydDr^@QVfB!A47OW@mTNta;)abV~sm$QFehx zNEdlv!=9!DK+5`^#ulpnxNy=2V%x`Yt;P2vbpCq9Fn{+R6bzWOd>-s0G$Hs2ZRR9e z)OLuZA3wrBXsJegS=AW6$Ca%s9Efzq?%zU>V-qu1*BQPYhpTo+7vj1~IYlNWn)C99 zuQMH*BR<2^6t9VWCBFa}P~L9qLbkGUrzqo$8mJ-6`CG?`&=a@34RI|e zyY5F@L3Bn8PGmYX=psHFQc=FTS+PlyY-Y5Z6AXx5!$8Zd3a^V!>aNB2aV}T)z8|qK zht}IdOv@<`^iz-eT0H`6SAl%@olZf+_D>Ox@}T3=>(dQBSn+k1&I1`{J7pnQ{s2sR zpt((NzN01J`?3W?@w-Qytp0VKolBmp5zo!+Foc3@xRi_u7u$?YpHS9?P;$U{D6}sc z9M>3eq72lcco#OdD`c$pY3N6*-S?cSvmCb9r_q^jJ(h-_Qr%_gH^kWtWT%9}T*6v! zfF(Ps(y6oQm;+rF+;mt}HP(#b%^bsu^|5+WD(kFjoLga^jOy*jpnes=FL^xvC%caRPf0|l{z_Q?WiM_$ zmVmt)dd?Era*_*THRqjVa%6vG4A#f3X~FH_THm0i)TISGt(fH}!?CvR2B8&7mijbV z#4`5*F&>~F*M}~Z#My*eaHU+fgzhMWlfYKBNM02hnO6gl?BJDM^9&ECO zm$bOkMv|V;W>X&$TLleK`M;Rcb`v8C|IBeIRBdist_F)#tYE{Mv-(!P!w_HhPbz z9gx2gwW#^tcGX8Wa-SlQKGYfVQZ4?dDe!JDy`{DqqV)-3={UmfV7)gtKz12P!*{PLr{ zWed073Cuk8q&rf72*)wmp;)ogo~;nHAV>esO);HWFd}9Y&>eS((0gUes$lIJjxzUO zQ2V`{ih#;^>pK+(!PjNhi+h#K_>?Xvx`anu9-iiEd@B6Z|E20K>CdL?hJdg2>k!b@ zvT3Kkvlo}4NFNdU^xSS&fe7rEr#nOr2(05;&+z;d__zY4ByoSBHo2^Y!?KI}6CjW- z2F9n56*a|2QaTTbHpST#qXlm-G$quX(+#_Q00+%RGmFIjwF}rIb0y_sf)(<6^=KtT zDA_fI|6K7(6!8Of(YG>xF4auv`7~j;Adw{O3~Br>b-G2gyPsMC^K2^tTL5BY!NOm) zYeoV}u!->z1FcC1`&1=`+#kIrx@_dXJK{M`hzj;InQdoi=i09K6n#=W4E>ha*llJw zs8n5;xhe!D)T-UQ1W4$37t!^w6;uS#T|83a`5_%wwpX;WsxmYt5<@oKSy?r4`O=VP zzwL~BSkbS3?3=lVcY6b3n(aK!n)T z5xsa`d@u+mM3Jjr3mWX~8ECqpvx!&Dk{##-7Gc-+4#LoHVf$|IE4!+2XAYF6<*As~ z{9uIWY!m6+16%G_!N{w<5YFWmu57W~+wxh}+YXxoOD-ZVqbdlgI$ju0y&}O(8_&6K zJWPqbG8ca(d8Lc%JTmY6eSqa>*?iMV7@iDh3A~uorN7`@nhzsx zAU>Ky(=FefZN#kO+%Ld)mXdrR$Z)TcUA2R5ns!?#UbzHm zzg?eW#U90-xsE-(+Z!Ke@v#^+lba_vI8~EWf3V|`?Uo_ns|MD0%N^Fr7R*~R;rOyA#QN-LD&MA=njwrfn7*QP` z9Ipyn#i`!<=?DO1Ob<9N*`ZLp0JT@{)$Qjxh!V8I<|)K@UAgP=UF>Zt^jlZ#A<-_*xH3KGOvh(g znZ>yZBz;Eg_|d}x69;3 zc7m%JVeLQ7H{n4M&LK7RSN_^982#4VeUp_Ym_m4nE;dl}G3hSEc2I9?Vu0kywh zHB9`M6aMeoKeMOI)kQefM~^2RqtiRw4Fb#})XGmYRc9_;eT%%;GI}XAg`ljL8OT}P z7qV^}E^T#J2C_qA-jJh~PqmH|sBHNak@SN&R!~V&X&q;ex+Dq*uZaBD$fm#|Kz=B2 z>_o-bqb`=YRiYnr3Yf=yS$mhyWBcB3CI|7#}goa7pib7e&Pw& zDX^nQP9o4>gz8GwJ|cwd0(+ByVBC=+Szw!6LW}cyr!d<=w7ISg3H^w;k&PLmrZM+C zj$JI$BE^smuMK&MEUCNXbr?I5`p73fD?0NcG;p=@={Cf`HD(4;e8UKtY6NvIudFCd zZZz)9M`<#yFE@Q2PEDDhUKnO!XRRyA)dT9QO?pXAoL=(djTOrHLjaK+o4%y?Nk0`f&o?2UDM9qU+unJk_45B>JKXE@G8b0KKSf~nDS%K`hK2}il&YCkR1ojTh%Z1&} zhG^$v`QLbKiSyl|3H{5wNxuswp`Tr5G3`FBwV#y{1Ifc%;;1PH%0<(L72Ug-4O(pP z_9&QIQ1nfozME<1e)Zm3hT6Gpv;-&*R?3I9w@=9VC3R6a# zIaQG1TPB*6tv1Xq7wqrh(;g4Ej-n*6DFaW(5daUk8W-4DlO52!UsAlwF;E8GBUJp> zfJ3S@W~Ji0P2Ab^kSmTADL__U7Ia(s&GJjTxc42<{kz&?E zHMifmo_7D!%NwAPU|qAM_$IW9+O*&=X(|cZ?M6>wU4~RSxpG*Cgd37taD$ERBR7t) z7s6tGkNxK`G62{4(x7e=eY#4_l*c*6+*E-RY zDI^!rfHgPXfVQb)HkvmDAO>D0`JygoKX{u3O1N#VCxIU3zN}nG-Lb`y_k4FC@T*TN zH1_XA+*|`VOO3kmu1-*vNBv+rv3Srkzb4K<_O_3%wX2Bcd__))!J`dJ1HkJ9#<=k z?(~YglDr;sAk6C-ZWDZowpK@^1EQ{GCl`gQhbYt$j)Rh&z?prda8Mi11De9E^RDox zM`K2^^BBaDxJTLgYndSc2WHJ+Pa&#_cyazzM28d4=c=Acojza4MEz5KiCULjNP@*` zrS=soS7$}bunWrg9lBGXTB3+Dn%t4>uJGZ5Aae`9@s*d)hh#UXN?&B|}G(N&|$r5t>nwtvj=|OL6kMqLuw9zm)2FpMY3)Y}7!*BLIQ@Zsqc# zpQCznWTCL><4>-bT%-l4L`cn)52q+!daJ{!+JS{Y{U3t!&43#a>I|+T<)2J_;d~OX zN`{*PCP*HaX^rNd3^{4)^jTED))6C6CS+q{-&ZxkGVJ4Drixt^ll6G+gudf&=gj~X z?ixIMB!~ZwzG=Bw{FgAlzE4}9lnPXufZW(SQmu3c0;zPS_V%ro4o1&=KQ7(~woqdfhOB->5UjZU@~JoP z^T(`VoMenUI3lnZ8z$bsQan8Af-K1=B) zP?VE-G@^}gG)e5Le1&SrTv@q*UVQVG`?-SJByA|-SyFINvD@%gN~o>QHn8qQctHtd zSvu)A-k&L%SR!jbH0pSqd9%Nh_2uZr2F85Pc~VobP14HWF=3+x9C%0T<9S2hpTh)b zM_v|(k~?cAuR-ZZEWP{P3%YcBMUxOV>$=?SxoS*JQIz6*(NYG>eDy6VCD9W1Y_%a) zJI$Gvwp>?ZtF_DaRVmhf#xh1cgjpeFWl0&>3^2|J#)R z+nE2iSP}T~wHAwSd9P=Ua_m;RQdzTXenXoYPqM} zAN$-ETizun)XmCOv-k&|l7qgnIidQCisxlt-z6W*1SIjdHa4|Rd@StX1qZB7XfI9M z!Q>^|M01TxhmtEOVcGN$@hN`CE5=aGpx%sLO^>+r&gd}Yj}lMvNCAyN8t>OU6d&UE z-npN884r_@uBU`yPsmF+;?`$L%B-F7hJJ~)VTzZnyQ=_nBHdnO^x$~uyh#v zh3O)uw*-u&R4K7qtHuz#h_B)IYl$fTU9g3!7K)A#9I*nr8P+0RUHt#nL7Yy4e=$e- V?@h2`XpLd{oc2FOJ#q2Q{{uHRYncE5 literal 0 HcmV?d00001 diff --git a/transfemscience.org/assets/images/high-dose-e-breast-dev/beyer-cruz-martinez-manautou-cma-mammary-dev-no-caption.png b/transfemscience.org/assets/images/high-dose-e-breast-dev/beyer-cruz-martinez-manautou-cma-mammary-dev-no-caption.png deleted file mode 100644 index 642f7c842b333e3d1127f357626809737d4a0af2..0000000000000000000000000000000000000000 GIT binary patch literal 0 HcmV?d00001 literal 946655 zcmY(q30P8F`!=4(%7$aqF|(YgJa4{bWo8bjKpiX3PfBokG)T&iGxc_{Nws(J-TeWKWoGpyS5ojF?@& z8%_TXzO^H7zHDhPVEetzkAFP6riHeEp7QW5JrR)|MyCJkWuZ&Pg9|=?sAh4QkhV)q z)v{p+^Jdb2o8~(|{QIS9xUL#X)C-n^pamhyZ>x1nkpu?=Z&?dZfp~iB2fR7oMD7yi zyqlqw$O-u`GsJ(xJ82jG+pZ9nu4+n|<(R)F9GjjdCBif7{WvJyUy5{@*5!k)WxC`4 z8Qhgm4EwLH@ucRbb4!1{Td+ZBP{){#|6?iio7#XWebKj-N4LAV z9HyB1Z=UD_v=JD?%)o1p0w)dzT{YX4%!ndQjdMM}|@VPz-jzpm2P3dT!>pNmA%ohh)RgAeh~!U=oi8q;^SioMN{Wh|QhSg7<0d&I<_E}_ypA(v$V*T+5|}><>b^Lo{8-5F zOZlTgA}>>PeBdnniCR2ArD(Ydnv>5UZZ%NzmO+BO{e&WW1}tbm7FiV4d5y_D#h56P zE`lPL&=CY#UjV+Xx~@$9qP5jWno5!0S!_`IEPrfs%$4=q7yW;IvYkZ%7e`vo*S0*p z2CeF&O~#((lwiqRf&C) z+&Tv!O)~S=B+o^<1P{UgDEr^>auj^=fy_cQ+ZVb4JS&-rl$a*dUer96DER=#+#W|f z28dM>+(#0{?aQSy* ztlSFPteWaIU>DT4$VPe0_gM<6IFyC=Y4AO>%VoG9mKE0X(ctk+++P#D5|)Fr=zNxc zc0A8cWv^SjGH#oakK-3Rp8{$tq$2UMGkQ=o5`r+mg=o!rVLO;Q|5!d8iBDuK{OAVy z+Z4qL3brbfk|~^pKcM!Ip`OIvrJu76tc3K2FK%j@hHIj`;R>A5Oiej7{_lic+UXlx zcBp*uKlhUV|RxbU?lREGweu2xB21$#L^x=$75kk|I zSuGUB2T)Z5Z9U*1rS4CZdt9wwUB`T%t!!r-3{xiw*Dk`&3;S;H+RPIXS#_$Y2{nyd~VGO-Sn)P-k*_i5Rb`-QGL5>j|%}C6QpK0`HFn+kkunT3sJ+xrJQ23UZ!M>m!jt_V^!fd|L0fq-0p0}0J6ZOvT%LRdbGO3c3QL8WvBO)@=Fu%wi>oG>zt zm@`=jib(n5lcz6QoMoh11{S|5bg9vw7B`{pqltxCL*pIX3G>3`^0@Q4i}}XOB#z?g zQ_8~srX*greJm~!XgRiz6KuL5!2P^*ezYC*cZDoRxELeFgHEK#(q!;r%qB)W$7`U? zQAfaPl4!b@`_xS^*~5y~VBa}8VPyOpt)Z3~4oqCy*T`6zYixK4@#aFyzoU3_4P-N2 z0)@NNkzU8-5^x`a9XkV|ifZr`i4o+l@UKOk6HDjhc3$oCkHH^;vt<1yK}t=qZb=-l z^iK0RKyF#i=QLM_B{6-aR>wmAF*q#&18GA z%Ge@K!a|HP=|afJ)0Oz#{y*^}X@wLDKmj!SRp}oie;0iX4&{j->B0nm?13q{p%@7IV?;x*$A48dCVD>m>!?5NFHwr)^_|b^mB{76}oi}k_Z`Rp9TrC&hTHdNch}Tsmavt

      w6 z#%br3i9978vlDMQWnSZmF6|8iDMd?yW|i>e80L1I29&h&y;4Oy$F|wEx_yD~`Ok1L zk~cL&+vlH-l`mGhsuyh3?G#HG@3vlLGPz#W0I1PFk1!q@p?#e=PweLdcxo>Ya@32s zhv)X<^u#^Wptc6wU!^Q8 zp90(7b5Yc6s9-8<@dbi0iC;Mmw%k0t@l-H|60PmdU_RsL8LSquHynXiBqk#x;55JR zTCedCMSc~q<>Ep-x6?&lpOci*e<$U{OF`q)2-fOib%}~!I9*36MBH9}5}3@CBu+7v zQk_|xvk&@;SSnr5kv3nL$ZqwTk&{ijmj5mj-BoB0@q;<`LB%i8sUGI}YVTt_)FI$k z`mpkHcI)}xu{0JYN*DGXwb&_G>RhR(mz_dhEw5flyGJ==rNb?k?U^{#o)9YzN1L0k zn>6W{sz4G@q8@5!TVA}jI$_bFoQ_{91Wo=)1kk%VUKg2#q*{gU8C@ja4`w#VTMd0w zLpJgXFxOb5F|;=Sl~` z?ZG&#{sTRA1W*SLRe8}mmR~R+iPe*37;VgK0}ecrf$d%P`Dlw*K+2tPWk`TMIWl_Q zemQ6Hi9PsAI(|Z2$k!e0+z~_ghd(|`)rD?#iAIIIowic{H;%*>9O^F-^$9mT*xas zq9Sw6xsbTWR)zC0JpXB>=8fl6-IoK25ZpG%OOOl?>NJoeM>!S-b_P<$Gh3YT^m&%n z;COO=zIsI0p`(F|$OA!5T$nzuFlS3QpQf;WWhx~jB){+i+3lHb5!qH;B4~q1fb7Dy zVm5^U6%Tkaa_dRStt3jNg=EYRcapjPL&!jgI?#q=R5*TVaiJ~9Dv&RZ$nq@j1K*i9 zmyh>=H@bFh67S&}x6UBwoSzzHl9%Y|KOw#>q%&r}$pF;v0XVD+R ztx9LZ3zMk8Z2O?8^E_-1v*tisDd3z21@3FQEGqpGuJ#;@Mt zTWlt1v+#=zH737?wucGK`%N!Ru6qmco8`J|*tTS?{!i=+wh)7UvPi_Qqj?g)S{7Sj z`kGqHLA=1M_Pwu?h0{1eIAiK$;#)gm!4a}5R~B4xK)L}1DiFZ`y)O9$(a2Td;E#|B zEfN+9(uM;ufq|5XUL*Qq#}-j$uR3kPaNRdX7n?KbrJU-=*-?qv8;I021?NdD!K&Z+5ZkgkHRWDa-!Y%8!xJs?u@GZ+ zD}3=ise&jhNP14M1}^A2&Ml*^1U9k;?=|+*$q$s9g|K<8c!EK~-lbV^#jL*JYR<*0 zvk?}kCLv7cvx^9-9TsCDow#;Z+`Fd@xYMrzC?-|dF2xxKg2#o9!5f|Msqb4#FeCVSB{v! z2)X#tetm2nswBGz(gT80Y?3r4!*)C1e&o32$=PT`dkH4?c=`< z9?iKKllfuE4L{*#*bOZSc^!VB8{p-PJUVA4$$OeK@u#Z&fnWr4{f%j6LptdRB^Z}( z2#h%jA99tUho-4_8l6q*HA!vG@u#yYQo03sx3l}xkKDIB3yi;$^s6L4u$X4vMZ!<* z3o&9B;=vZl$Fao{Snqt!TI?$>Ckb;I|6L$1qkgcUOnbnvn(;uFCxA*z4irGTfsyz~`4@rF!03Un!4W_4X%qg_Xk;@$`08g8m0!tMiyyf$ywSb ztpUcqnz|7Cq29!~BHUr3EAba0f`h9lk?GylyE->6o_~h$qV?=>LtD+osm9=j&61Fr zj4d{hAb@HZ$W|g|lYYijZS!cxVYn6OAH)SzP;Yc^Ymrxvz@;V{xCU7F_8N0B3S3}J zUihp4DPI$nenrV*tu#3v7&Oup4E5No%cT z+bo{_t%^U)Tg%`&<$wA?sm2o`(|uM zNg*Rq{XJ{YY_3z_#Yl<4{F~&#cUC6Gu=)ZfhIGldix5UA5Dgk|fvUh(brCI_@oXif1wOgxcT4qQKRjAJg0kn%iWanJ?YgbqT?0mh=TF zWujdtb-xP(;KydSep6n*$8fgYwe9)SIc1CFljH!`zm2nj!Q5gz*N)BA9_4ARB%JT; zBRw_I8k?%PwdDie%5;?(eVZ~od$Y`i7b{c&9a9;H^jTxW^ceDv6-Z$de+4vRm;;|c zCL8HD|1IBhNZ{_4NxyB)J^Lj%dj=4g?I5-79RiHrOXl{sM#FO(Z0!>@dlnOcy~rG@ zVed-iOG(zT3d7_BW$I_H36oOr!_#r5LicWfpZPVm{V6y%kXRfpNjn-14AmwA-pw>a ze&vzygkE#@pqzj6ov0JhGtl-v&Qarik1xhT2o?t$7J*oazvA4P= zE`4qonej{(fPb1JRqp@21u$7&k6!e?cDl zL57at*RL5m&kmyqS1)`eqWv!S_(q{XGED1}jm2m`)$Q0dy5QjmVwXdIhTUda05QJW zo_7y5jS9QXOqsjqr=P9hOdJ5%j$+<8OhFScoR* z4@0bI5zIuy!_z>?MYD)G({W|bQ^U=ZyQj59{o2Mr_?%IMVeiTUdkq*f?Q9dw`EFNE z9`zK_tcR3@%~5H?N&(D6fBF{>^fcSLF@=BlI#L0x`21Ci7oKTqFHQG47Yw@%T!Re?G%oM44#`mUVSBF%zHZM`jUxdO)|EGaa}_}|4;$XXBWx$SVqGGcx-i9t zaX&clpuQ1ZYrDougu1;QP9%3uSbrodSX*XO7VJ|N{J(z>_d#co z$Z+36+0>M1RKJ4p2Id2P{KM5f4rQH?EEcD#X5(JFZ z1GLPzLDZClO!vXXAKn{-x{xS}c=2|gVHoPcHT<5e*8VFSJ~`&x!q@vX4K%G5ln}M8 z(V&8%?U>)|0XVC+2gL+k<23j=g@uL+*u(2U%?w4YYsvCfJ^7pEucA>GaQCH`9-JSJ z33M~*gEG~}fS91Z{wSCMCOUM@RuohwEk)tBi}ZJhReS_VUZ-1g357}dvjcNewJtao z6e{k#5+Vs$?uD}Wn^E~Wh;{hK?ZH`R;llpf#nxySd&LG}Sb{H>*k;x2)=K-7wEIM1 zzcE5gyUhWPQ&yZckkbD;_4M;>lsg@g;ZhFE*SM0Su3sUYY;&kV9d|c|GL313-rlrs z-H^*TzpvW$s#*L|-H-O*1=Q+#zBAQN(%BfyajX~7l++D1djs*u{FqYXt^pn_Z(cPK z)L@4@H+x4ijHm!Xn$DNwMw^lpqN9`w;?rlCnb-6q_c2W_;rjduXVjB27prooT;tqL z!c<Pn3jkrGUBbc1 zEfaM7I&d!{WXQftWR7!9itxYXwGKRBVRr+{Gt#QQFVEun2ICD8it_)LY+~%2)AEpz z$z5JMaVUXp0zW&8czNREHR;}WQ%|++y)Jk;0ti#2{q0cRbn(v$*JsdyN%p3SHCZ!3 zOw|Jxz?67JHK^n$TmG%x`{6aQ{vmMFyb(&fE47Yq=FEALD0Vkl2-rA7c#TqO2m8go z;-2B`>Y=9fSP}C+Sb6;`H8yHP!Y0M8K2Q5L^VwAD{ki=h6ye(7YtnYLPm01PrQ4wt zK?3r67Ax*ER9~_81>X>(7`549;$>92s$DKz_p&$c|&~ z29#3ZZ#dkhwN4Lo5#_eCwK(VG)6;#)&5PFmZr#^qnf+2}^QO-WCoC%i;8^e@&(g{Y zTAYo-J98=%BYy~-Kcy@SvHFfdIn{uY4GH&^cMF_w1qfl$@W9*-Uq+F+>s;%+F*ih|A#@V226M%T4|!d@r{ z1fq`k@wl-;ClqPy=e+fnCcQ^}N1>=w{Un@3V2kMFT+V9mv79q0=+G+}h1C&DuJ*#M zj=g6sMb*NmP_Zjk=Bb>Z2Q+9LNK4MLwN=7N*7k?b$uiGr-_bH6jfIHqpF3gX^C5QP zMOtg1WVMdgbhCADuUP4kN(twznomxL4BlHJKv7sMr$ELm&J7ava61ZsBB1z_Fw1ob;cr9_MXb}xkKPnM zT{_=ik$5}krS7(-<#lP8fqOz$07>G$@gClIM0!`96XgU`-$l=#x!7Yu+0m?j&qiEJ z5mIe`Cpyp1Dh2HLcpg!7G&`MzV_!lY&|)HTTa#L;Pf#4-c2ASYot@V<>5)TuO2oks zH+fRP1Cix5;=HryK1F6W`HXE2@xGOu-ruo4*}eE>zqe8;Q;Ms*1-6RN*`k{&C;eSC zG2E(k!udo4WYqoI_X($o+);faz8@Q#r?#(YC9M9IPrr7@-&RuPgFO!39cbExpqi_$ zWeI&QW}v+=93v*gZrCj0T;_zb6=Mr6rLKVdw449ncNda9oqTTQPMB;oB&VDFA*gh% z34G@Pd?qA*hg*zMq%uMY4*hK_e8VkVz2ll$`L%=Y8iJyzFE`JhsQ*wq^-=V;wN*j) zlr%`zPb%&_H>mD^Gg<|_Lcpnm-lJm8N^^jlKX*KUL$RJ4B;r@aMcChWKE+&yuH5^h zYs$CxoU)>qu3;n!GV*$e{jhHR!Z)u+{(jSszvBA%Xv}MT;2qG$dEti;ps*RG65C*0 zS`E#!FV;@?|{_cpIOmC0*zT z!+DF3I@FgEyeK;=oFp4L)L(GzV-f(pCR-_(wzZxsuF^#v)DwGmS{ymq3nE-~Y^Dk| zLY$Ne7gUe}N+FY#ehTwvWL{}pF~{-bb6m+p0q?@4*m1(_{BhY1x%0lc)4hcPwO<$9 zbCLQpYJ-Gv!*?|C9&M)0a-GhOnT&&`YX%!Ga)_w`R1t&tY1Y(Zx0atO^FmBR#@GkN zpOe(qp|PD~!=mfD0Z{Zqlv(A!;zG&vh>~|Q9`2Movtm&%|*7>f! zlrsMa=}b=W7F@*aLxQm=!kS*2g4?Q=1;mJic%5OrxP_NabGZJ68Tx&K6qU}eC0WMGLTjRA(iZT@VaHn&*<=YYOWea^KM)8z8)65Ht`$!(;;+#v= zE+$!K3F0~0SIjo38kY`w&g@nHfqE}}81S@uH;F+E19V0=P7JsC%nuHbFelSisok&g zEUrP#zf~V1dgpRI;?ym#)r7FB=`J@f!jI|8Y~3>$NuYh)$WHc0w>&fFG;{%i@k?-MY;i-{ zK;aSLq_a-)AWOH7(3|&6-L!FDK4>X1*@fN8dj|ZJ?{u3Ex?NKiC;sxr2R9UW53uED z{pXhH`ic7nVO}*&Mv?B|XwwhG`~;Ys3HZJCHXw|%K?6z?vwGyWRG)&ZPuE3lae{T9GVN*A|LEM zmz!&f!+a;-a0BNXRBWt~N_7O|eu|xPfP@3pIAXUf>}1UkX?d`e4~Y^gBGmT~+iSeB z^e15NRo^Zio-&$t=9+0+(v!)e+k)QW*PZUIUs%ua;o2{~I3@MV8}!nL=?du9MZQCke;Kw<-uJ5l?20^A+x`v@&Upt2emG( zjn8c7orksooFfQk$d6C)!x@lS|F>yEk1+|ck+1_9i9{}2jgT0{Lv6nd=Nhc~ztKyS zzlI}Bm6;Dz6{L`yEQ5vrhehEvM&~BgS4=lz*hZej*PKK;Us9(ZKyW%3eivow+Ww~? zV)Jim?;3dzY@k*$ks1CV3z0$n7DA* zQSiC6UXK12G%eS{NN*X{vkU7~*$*E4Pt>%fc9@w}@^P z<8j5$?A;)v%GW70@s>=_&|=a>ik@YANlu2Y@Ub^5K8PNH8uw^H_I&4JQ7`ITZKzjX z?N>{y#ha!^(B#BTgJzRw0?z%n$#k$h-0%X~(f$B- zaO~#TO-rA17E{fNp~oM=;aw1Ung0Wc<6wqPZgN;%&fhXv=rZDlSJ`Em&t)nR#~*~| zO#aOsj^A(t+BHUc#Bq;ziXHice1Ex?^W|X(@gaEl7@l)kCB=HKDeKDW5`{$%q5Bn$-}2Qr zy-!0NOd%iJLfd2c85hX?u5qvA;0d4b>8^J{-kxvRb@3r3IE zdn`R-tgXc4BuV?hB<(|wov+Z=5^u=l-^Nyo;T^&9jcYJ9JZ;|chOoJhjqHz0b7d&3 ztTIjL3iX<)a#7k6gV^knS^^T+0wHbHz2OHHp04o{TjpdFBH(MF>YcNwrXuII zKXffl{Tpx7U0Q~RpI%O3o9ptasz>&EmC|RWWK1l7;P`^J9fKswymI6T$p}dqIisVLHWrT!c5Wpf-*b$f7zizd*kzwXKmGqIidapc@gKQG73C^o*Z>1(7LET+{sG3zPk{fLJS=A z6x#{klfz6e;|AR>Cng*uKb(PPk6I>EoX!#%n~|MClX=w}T{*vylNa`zbG2@qy&;zX znP@2M;XGqRd_k0?C`d(xA029@7Sq4;(2hewV{D?!i*p6I*Hky%1pt*uR%+I%;@2e2 z^(C)B#)rbEKMsf3k7jOpeHz0#nLmw5<9)WKZVT%BD3ClD;Va#snnt&DhAL*S2*CJoP*y1MP`{HaA~!I)+d1vhM5i`4jJSNf8=FUJu?0JF@(wjk&ridw1j5`}>SfMQ(S^oQYKo z&8^tT@;=Pz%47N+4$Z3Mv9jrKQ`FnE2DdAfK>g>_Mc)}dnL(FEav|jzw5{5BrdfDJ zi{<>_5jWaw4k$0MP-}`B^IzV8Zf^^j_u&Cd=6nix@}pi3KHt34mB%qSBcdu`=%KLK zrDpLBb(5$IpRAgDInSmej_T~(`p8kl%!Z6<99Hf!+~#r|9!H$vZ)^&G-@Fd7bj;BnP7PiuxE7Iy?^^Lbr^ zKQj;gF#@jQkDHHwKsE7h&f?&=^V_!IqU~S9nE8MP`l?b1-YAm|QGOKSeW!aGH#`c| z>~AfoMc;D17f=e0dabssx&dW%Uz67-*|HqC;)|d&f$~&Wc~9H=S=DsCldzx;KEL0M zm2^*;oPCRM5$-8|nWP&)dB#=|qjR)<%j*~2L=RPAr<~HX1ZrHOizPsQN*85>DL_Qn z;<`IUU5GKgl~H_kTYd_8uB{635@@F-G@ayx##=bd%^k(mKpEB(Ic+^LY77Iu`-lUdI!6xJ#~0RID^c# zZRof7>THA@EOq5^&9O>eT9wPbel6y^qkvYWWz1Ed2%PX4{dH3;Ug~VSLYfyX&t!DB zHa0G;!|UNoJ5nGiNtzp2_l4_9BZ<{|6#w5_6^yuV-+E%oT}Mrus>9b5S1o$%Qw}ue zb-wC<%0NjAQ>(ks#|Nor3q_T`=zkR)eXs0%UA68=TP6v968AnsI{?6Q=_Ry}^`C}^ z2^BZwm{-DruZ%rnNm&Z&!itCubK4$sKpD%IZu!<@LH}xaOC_;8XVUWX{e;P1hYPn4 zRcV4?d+dRnW5vo>Hg8R$H;6_9reVvif`Jnw5ync@ocy(}(yi4Lx6cfF7w}lv!@JZw zSAC8|KUFMg-B*Ern{lzB>Ooy=8&Y{!_;-NG_C9ajY7DH`Sl(&}oQV^jyoH4=-YGP6 zF=~pG_oO=_5s8vh2_%}OC!bXDsFC~6dSxW-3FhRPE;-0?2=brN0CRjl7tzE}$cC$R zm5v{{)U(VuL|TA;zHnrBUB)5nZtHpC4JbG%@ zkIM2_>E@He{L_*8f{j5I3C^-+#^0nOY+qq4_X^q6+P;s+1IcDS7_cEfBQFYUyS6yb z(S0O#trj@h(jFxO58 zXVn@-be`I}qIW<4521=*hZ{Y-a7*pYSB*V4Kn_{Cg)8Vyjm>UP0q5rmgPi6HQv}wP zLwCL-rD5bwFiSY`YmqkT)z9*)4rHa$`0f$gLW9`I=BsmElUGYoMZ2|;DNq(G^{nh$Go-wPN#t1Bj zn0K{RA2GqyeX<^AE+KzsCajfexOXaEA$IltSOZ;sRCm}<1nXt;PBd}DqU z<<(N=TS2@{Vu!$-!D&D((F_sH6raMRZmIpT)cw5dP6lcrL=u@*>KqIKf?ZXIMQ7kQkX1??) zXQkC=^YR@Z`jbGxPiNdd`kG!XdjIMav%zw)wpO)4I=_$eI4h_h%pvS>mt6#PGn6iF zr97XJUtAmFJ~y(hT2J@FUdW|W*{T}l)L^o`?zq6;vDK+2Mvo}R3-1jQzYelb*nAy^ zq(xHR6Z!J~*&$~s-bldx0VQ}2$NWCq630#KH8Dc{8hto?N2qXZG-_#oCvFXX&Yzay z=9@AzaGsg!$hripu5gpY3=e#~l5f$JvI%1LJ$LqBo`709Exl$fI0Sl+_@F!t#_Z7gxNKKTJSTh92Ll4vvj-noCl_ zb(w2;+CCm%cgi?Cv(O`7Lg_-?%@M{d=Sneh>bA2O36eSS5Ky!NAxCYJ$_onPgsT-Ja6Kt%a~sNMfIaj7TzcD0<1ve3 z#-EChD>7uXJj+Dvd96GJFKZewDJzXXp;yo^IdF}W69L&H%YTR!(Do;#zoW)!F|JpA zBNb1lA5=|m;cT_JL6e+j1@`V$iIYqC1(}bt-XsFYhpo9+LIm6k@WA=Z-dI$#Gntvx zd4Np9hwZ0iIMltm(t#v9fW|@yqx?`Iq&Q23cN(T))hnBqqw0lj@sVr;jyH+5xrln4mCc*vjts3>6-OnV=6Mz3N>V2Fz+90R z5oJD0=YgFZFk3GK^O8`T?_9rsmN>Yh-DpsGUIAU7Bus&%*QsjghU(M4$*2xiZQsB9 zBeL6zgCla-xL5EM$@Z5EZPwBx?Z<5<&D%xmvag7P+~5=D`Fi%5O#d&xEN>m}Cw29_ zp$s>>uPcBP{>fJ7+@Y=#v<%`qp-b*4|B>WgniD zMj6cWAynRA%c59GoTg4`z7NdG$^~leai@TsKfK{9Ab^E_CDc_Dv3n{KKQRaof(AYq ztd%ozpcQ58K*&g=39hx*1a$2C63*l02!8~@G+a?}3%3Fje3+-Quq|4-EgwtSX`2~- z+?P}LE7J2z(4Dw0IT7*3H?JWEdN|y=yMf6^I-3|+Bh+NvW)weeiidr03U?x}!6dTi zMWw5sx>{4iwMk?Mi7u;gYNzM0d&t|Yg8mOdY@+XuxG6$y(g-)FHx_`v6^ChV&b}%x>T(f0RNZe517^zvy4c&w^bD zUlg*zW#YrL(Bpz@PigmQPw`{dTfA1b`IL+5>({$31RWb$_;DrGxg~uO4nbbgabccw zP1N^5Tmx6&Ofl_-GeH*=#v-8+cJ>YM>x%3$ZpD zr5(40i~L>p1X-H2viC}Wycw*9BD4Rd@grlwdB~2WpO`bT*+~_1FAvKAZvgRM1KRor z?^1I+$!zBWh}7f_{wy;I?(vj6?XC>&cx4>v8ljEWvae7(S4Ig{cPH8TzN8oVFLIg8 z<@&i_<-G{`J#N1k{E^qTcljjd?FyXt@&=}ez8eL>5yCPzcc2%5y&t%xoK;m8$RR*U zO!iCK3l7s%Zh0SCpwd@y=nolm`JrncpnehYbvdK*->m_t>h9-t66K5mbo zir8*@#X<<8bA@s@4>wnup?Y6!nijQJKj9wnlaC>NC*D&ph#C*ecM6X^qq)`~etY@e z7JW0?V)n}mC253M`-W%ztGekmW4aW`qVX#5&QD$EP++GUDtUk}+I2A8=Q`YfkN81! zqx`^0LBn=r3@CDFauc!|KW~_oh$k^`VauJQ`Wa6>iL$#NNADA2g$X0P1}E5&w8i>{ zrX}v4Y~I}Lu^Gu+`k)o%6rDwrL^}>j+^%6!&k`M<(MuQ_QR8+V!WI>7xv}3ygnOrX zdQA?t4u%7d#w5^RJtH5HmPS=)RFg(f-}vFUAFlJUUlePUf|e&4md~={LVDO>%u7|a z@Y-oYYH(rBnWSHFouG-@#>ERTt5eIIubjiZMZ2jvpzlyE%GEZA_8oH6?-bJ_;mYoc zmVd;HfV4Dw0PG4TZv%1`@<4Zp>!F{R+KJE28+Frefj&_ z3=#5Rzfgbd_3q+azb-+r{Z-;PWVSk~*IReSm+tCY?@F#bnKO!npjimts*n?`JAc#G zif@`evS(c?FT|*f%Q5;tB=QaN_a~9y_Loowfm%Ahm~dda7PpE~^sleB=GTj=w@zH< zx~`qSG&5wKrLMoQn%U#BvN8}x7YprR^1jw0Yx9|)OW`Fcs7`C~>)*0fE<}*u2TIZd z(Vc1_IaI={rWZy2#aj~Q(>^Soc1`(M)AHVaviW`W6W5ap=`qVd&*Ybiq{)E|aYEO& zC;=IKG9Bj*1CSW}(PCHHd#F-a zl;;C&3oBxn?_%?Ql7a8);yRd9{=+bIGuuPhB)zx=du%z|9Bt$F`E&|CCWeB0Wv;7= zZQg#JZ0cdbo$QbNyiL7>6@D7^mZ~&BdIY&_?q*#_QQoz z!=TXpB_>}(%CbF<`)H!y8r|wfxeU8mobI$}mSzf^33452#-egsOZ){@jFJ#14$Ey` zG@QHL-=^QK_X5!8YP3@9CD@U1xe3s{Cpf$osBfu`NAt7$Xyh&!Pm6!d5nc__y}hL~ zLjMjv5>ev#P7_rxJV>%kR9uQ(gp}d50g2fptX0-L;jnEWYQ|v*?2co>n7^!ODc~txGh-i|{L;D<0xxO{p+$ls{8f}K7yS=2jWnL*#A2e`| z5E{a9q11U6kDEN$nK3Pz4kB~4@b=ZkxLYXoh{mUqfH30LeX4sm;~Rzd7uj}}jUY$s z^}g_LQHmy^C{Gy6Cb2xu>WdtPw9QW%>K%l9(&wNR6~}Sn%34HoA+peE#lJh3HNNtN zg%bp?*EcWY(~j`&1A5Z6LQuO6Q)5$&o_XH{QROS4{wu^wX|OV1P}s?O0$^fN=- z=RWU+<6hK%u`zsiHU&v&E+PP4%e^C7isbu07Tn6x-GSq^ycn&dw!Qq`&&V6ZFf4S~ z;WC4=?ollD^p+*CU?4|+o3FP}f(vuK)(G;cuM5u(n|;NsyC!AZxB9XCuTdT!R`zVF zj=f4bs&*J`WDo1;{K4n*{{2>)bym!IE9T;yz%U1262=;YewxqS^6+!bG>v#d!;$w8 zE!W8@VYnBfXF*OFPbYo7%9@f#Pp!h;e@lEf)A6byOsgt_{3UAMn}&-~-W zN?VDB8KU9dB2QM)hV2+jrk;+Vo){BFnO~3W&R{4$(0}s#09YO3_Q7u#o*NT9XWvZ;4=*-G z=DP|Dp~$=Xbx6#)M)slT5B)mRJcku7!-o@Es^0t^iav$j8r@}UlY!4Jkqu+kSkvLb z#*&IXMNwH#-#Bw`o}`?oiSKDHl=TvMca~T7pXE63vG|k}Dx*1@$o3*9JSoH)hjJH@ zaMeQ8*_2~`InpM^d-FMGpYGPrcyLD9_SbY#n&IF!1!C4#dR5BS{{<+>nh|+r08ACrMBf4cwMAz!aesqjd_<)o6e0o5Wa(E zp+D8Db_<^o$h}E9xA`>2Z7Hr>XLIEA88&-si$A+vcP6KDn zXG>ko58bb3ywmKSJM({tdKZ7D`#=7_vkn*PBO$b_Tvw8-O9&0yI_qeaYL&xeIW;UT z#~pMght#D5VIyU^u#w}ijnY)c95;qdRvViUJFywReLlb2_xt@9-tXJ{^?tvf&&U1# z$h~ZE!`Xq>!aB^T659p&zfJtU7@5x9aCeclN~20I1P9VYuCI_xzDa8Yw;E_wh{m{j z`^twMak&8UEoYLtJSjSJRM)CG6*!}&t)(TU^vh;AOc%R>=L!hq z*Ej~O)UL+a>!XGhuCLTCW0>9188vJ6di~531mep0hBa;^5r`xfm} zWdZdhX0LI^O@yLO=H~C zQN6S)RQey4nk&%86(EN(Pn%|VBRE~e0a)V$4ZB2JbKhrm7?j0`Au?aqs>U6Ph%@MV zH}wY2o{U~Fck$p_8;E$W!49pPo%LTJ664_k^vB@SrrE{^x^{vuZ`zjP`MZU#;?SgD z)_sF2z|Fa3A}dSq+&}HcdsL%g#N1_g%{P&O#=9hA+h(b_7>T)n30qsy1sSxB)BYck`@CQ>pfVLH4{b9E$aJ^(3wx9i-an-1gGI8aGl1 zS4aQJJT5*93G4)8W9{06>-`u=5e7X3|-xMVyZbA6zTUf8y929jM|ZbGUA#>9(N3- zoT6l*bAYeoQs;|P@Kw;rvrCz`Qfs1s%KikciR_z62U_%F_(i^Oiy@LZm)Lx8CURYi_Bx`nCs5%|evg^>U5Pu+4g8F*(IV{+zN1&jWTu0q`~WTO&Amy@Nb zc?yx&&R(^VMuwB7Jr*OpHd$Hw7*40dY%HUbY(qUDLKZBxx$ z?HBFYkZs7_CNVH&s1bt9@!{E{r7=bt_B=D+nkCq3=?k!oOQ2^BW+7Xv6rK~WLSqDN zg`s_ZU7pa&#m&+P*Xup><``uSvAK==&onGWo19}-OYk-y%5!jF{KohA^)uNCzyr^D z8$)FD`8fx#jeyn^WUGOr%Ula46?G%`PKj9?9K zK&}n}aZ+NBb#?-d*Se|7Up73RCl*X^5z;D0R`%e)pR><2CGU3PeozKf!@P$FgWGF9 z=O-@i5)oYXQ?mT>`!7;5K2g+DJ4Fa1QMS4Ye|+#Z;9=sFCF=x~-zYPitP(%$6K!RM zMm6&XzP;6mva10(Ai|GzoT)3%_e}3>RYl~UBAVDPQK#2AI!7I5T=B}+q{fP&m1?^K z`FzX^pK{fqZ4?|F>Jt+AE_SxYb=*xn+5{qwxrImW4LJ;GQGbIgO7p@{A3nzhbmey* zyphYc3MQKdmg!n+&BBL67-PFp;Teqq%e9_qrS3`!%d{pJxq1#a6M78MgrXFlBn z5AQUT{cz!1#Z_8XEk4#mCMRrj{k?IPXtNCiv;g8J@(Id@fmhs{s`?4n+WN=T=ajCh zhJP>iDG4KQZ_8X}7oJkcgDB_RZ+z_o5fZzsI1*gHw%yrX>8lXF{8%$g={fjsOa(QyP4xhfaAy3I^GxW1 zEL5lRI~e!5y6TmkgfeggMo<)fDQWBlkA_ugWV7gwvz~L8u2lMGh z5BDe0@AlRl71s!^GyRkgDT|$!DEgVV^X1>2*Zzt`k#mLO5S7+CLK{taS7Xm>tvX*Z z53V2Flnvb33s3Pm0+6U)2Xrr(PFP)qwIqux7+HG8(`kEcHYMI+cO3Blcs~T*fDrI1 z?eD|jJIkc=caC7!A_TK7tcN4U`xXOxEyUDvDb3~xSm?ZI z+2i;mHfG4ZobBAgV`3k11g$(%g{*gzVgl&j?bqSMLi{a$VR*|9wh@})B)4%wJGJpc zm6H~J@W*&drJc%IdjtF#-ZMwoCumn>iSoI}1yiu0b!h)<{4-773byfnU9#TI5q&>C z94xlYIh~K;scJvp*X-$R$c<3bOfa0lenh7)D=M0~hctIeYj8Sj9>5!X^ zsM?;T3S*m6mPgEQ&UR$t9+r1{g_VhW( zV*M*|>|1o=Qxrc64Fth(L8IcG zY54HhMRG$qTzTHNgwV}*U7{}jB_h;#gQRZ3Jb&mjed?BEPCf%ED)D*U784#2ELAto z_=S{9kS1CImSjFO*J&${03VXS4s9n1CXvFC<|3wyw_0}i&i@A90GU0lu+R*e3&-cZM$$l;glDrh z^Ixb7{|b#UDUkY$>gyDUrs>pl<+nAODdD%c!-CA#{3!;ZM3>?ym~o%~vWPdGAHRYQ z8A^b(T$S^7Id~93(~RA7iAt;bXol5K({W-Rj zBWxAHr#iK}<7N`=CHVgFgbM+SH)cw)8A+yaGuT|jteir;i+hyx91sJ-s^-8wO1SC% zy7_=}DrvVRWa`OXKh*y(S9s3y6aII}474z_U29W!TN?q62c)!nb3}+@)|sS)s-x z*FS$|?R=tcVeE+ZZKV%6Y{|5MAL7&0=9;?$y$7mk`tVFnHU>@%eY#j~sFQvFqe``N zbeBID7LG3@&AT7v;zRO^LMzsR7Z@k!cVu=aOn0k(fQG2C(sfeFdpE7uo!1KxhjJ*m z%L}rX5|n9M;lh4-s@Q*6kUt7LhvI9Z&by90$jb{Rs^bRIoCYPThV7*Nj%_bXPeX8S zpz{p|k-36(>H-F}fo+@J7SDxNiuJF^wNH^y(GO?h#`riZnFgyx?^ehr^)Tw!G3}($Ke!VDq+0kM6lW27Mtq`jdk+mu@s@ z&Pnk<8hK2kaCf=XhkL+@@lJZ7$t!RTLVfcJ8{YY0qHeKR5E_i&CX9VY<%xKXw`NSC1Nc()CpM&{8uiHF#cZ|GtegsY0ssk#HUVh$}`5kCN(wyVly zSMruC_``&Pcj@UQc;vseD# z9{y7NKt3N!Vj1jk*VSDHh{&Hk`wz$Q*8C;hOu z_|0?bqY3ykGRcq}5tylz?wXtX%wAX~!BzGL$`ZgWeqH8hB<5quPTlXe=}4?Jmfd{$ zu8%CE1C~D@$a%{2ATbv2I3g~?^Y60uJBA{wrUrkLtRGno*l&g9gcjXq z=iBrE#|<=5m}LYZxXVQc-=q_9qQy4fYjPYxtHMbe1R-rzLV6bb3LHkRL1 z^Qo3JQ3aCb=|PzD0_r7OA5`Z=+-J`=(T&Vp>%NYvUi>!-z6jq-l6Ig}lRU!H1i?M( zaIy}V82KzSFklsr{m3QMzar_nNcS6)jT_9ZeFED@9GEs?G5Q_jB2^%zEa|Y$^-|xu z1ZrHf_{{X5ObbYf?gw|#?OEsN0sHi!vGQ|+id#J|sB3QXZDm(V%-(r`FIpqZHSBYN;jW~~^^kV-Sx6XGx860_w>_P>Xlbh}dByJ9N($(M zB|=tO>A7D{Ks)L1D+o@*zlH;*ISo|&$1R_lDDPBfpvoGrV|sRdU+qjm zIkgb4d6{F-6}cl{3tk>zc8tC;xb@ZWLK*F+(JzH|$O#P8dncr<$p73WJYpe4kC8r3@h4s~aIHwI?lGuM%el>!Do{Q?U z*gbQ66Mf3mb?Y>ijI*BmeDfW}c-&>+$12yvJPNh5@ueug)}%viVb|}&2wg$jnWE!W zRj3*!+M5=c`|6@Ku&Ija6UdmqB{z_NE6eihyzryKr9I>D=<)k&EA^)^P}a3yj>3y( zc&E1~vCBc%suq1hjAaa5C&3?<9Pv~y6=E!NAX_No7#$vB(re;1QI(lk)tk_LX*d~y zzC2x`KXyv1Vx=B}{ryAD+~EL3FvqihrMmFF)_byrK1r3AC*^>=2Lnue0tv~9XJL&I zRChCky~N|&MbFDcHPx77Xq;`3pU{HXLr+w7ExF%yshk;BI9O$~_hSwSLS>4hyv7wB z-1+O8yTG00-+@u$VDH2lcsC3n_b;R@a*o_E;c}*P?gDv@u{c-7p1CX{ve!yEa$}dJ zZ$9ZMnm`T9?FsNSTUFg}P)wGdc|c2;DtGzmF`#)rTxd+&eTRUyR~~FIj>*!%zWFoe zd`Wbe69tqfIVIEVdzDSeyS0Vz3~Ud*CHZdWT>G@m5AfA4V`(iD=eh`cOhB=z7#~=p7i`wL!i?ttLi zk)$!Ld#`{W(#he9jnH=zb_bK+EtXHmAf^Z*PdNIimRq*ha@mU#_3MOUPp&4S6q2pi zd%0g54z1^Zk;hFQEofTZFO61j@cq96qoR; z4%Lg(QPzqeZ=n)J^Jt7f$!E~JzQ7Q7>7x^z1xH;Jy)#|03-sOIr} zWEb%1EAHMt0q`uB2isS-_(TO+?H#RJuDr{;Qv((~6+IXE2fyGMG3hkm9Aobl><|SI}8FQ0@56Ps`IlGzNNd7C}v_BW7xL7trxsJ zm)gA5RB6fi7w|#(HUO}i7borl(q_~5LR`rP+!w$^WSH00v`X;M{?%Kn?v6N=N#wnN>_%HI6G%LtJ1_g}nJzk!3l*g%=mNwae5>QQw==70Gb!qP*YLj=s%wng-yv}lk8X;%a9g^I?LPG? zfB9ZbBY@j?{xUL)s)ri?UYsV)wYM7wVk-O#mqHPmvq!Or?oO-|VD`%@06*f{8%i{8 z9I9b%w-t!~4a;@EwWF+Vn}iZ6+5LI=g?+76$C;!Tyv^6>^N)3XmzGn8PBah`*k4$_ z%eD0qgDKJ48P&tnlC+4>`uP$;vxshw+tV=@DRVfndq{ed`BJ}>jwz$Fkl*o>C7SgO zd^06FVw;*INH2NM_z#X)04YMoD5e>IjdXrY=w<_&pO#jIH6dlHvokKF0;JUkM_h59 z{@x$pt;|lNi(SeYjxRFzA}C{|Of4|_Mf+uS^-tcIvauca!si*O#;tb1He!CLZU@@` z%THPtH}xa($W-3^vE8*Nrn@^$bEGFC%h}^#(-_$^-WSupap{du z;Ac~9gsUdSv@oBY8H1`_q&X6c{#I#QRg7j5h``N4*Btt{>-rGq+B`+vWv+hg<*mb% zi;$>Byk#6MNFd2?ea)Fi~l&nT<5TCR{UPgivx5HSA zP)7;nN9zkiZ_w~(+@mX{fk@f!^R`+0Qxik0MG2)pH4+NBJ5(4R6e9nwK52z?s+7Hp6YNWmD)xQ=RxFqrX1J$|7 z_61clRUP_Ob=FQa`$%H_f%?kE^5>k9zDGYhu4 zE_oEAxV<}ThT5z}4c}m2Fs3W#SQ^`<68UdL)slYl+?1pj5|_{Yet6;6!@0uhM4jmV z2c#En)99H}lwapT|6q;OmepZ6cM`$#5?b01luNfNVnEt|n5fvZ5WS5sb^u#EJk#gJ zh|K<1LYeygjQlc&_S`j=1N;XIc#s%W)Z}t8MszRE-mtwlwt?=%3aQ6eV=u zU4|i8W{il|vg8w20YRFwgkR-?ll&9fRsT6Ug))|C!1}oiAI5M%Ba^ zsWAVL;yHn3TolCh0kqIGb|WCbHG7x zTW$D=^Gu>Sd`OWKC{Vy#UfWinz$zzgHxaj;=2bvV7rO+f?~7xvE!&=-1{US0FN&KR zDA6*};0^2p(eH8cMuz6Nwk#7blAupu5QWiuxmost9A8D_KMA0b`@l-JGq5}jiF1$J z6PGBq^Zvn& zFW+f53Daxh(C*2-{C?mihbj3wrjXIEC^L=5lWaoSD~8f@*uLR^715dO;b6`$7UgX< zxkm2}X>{Zx7XRw4s>uw}l@POqPehK#td*E8o&EP~PoN!%)D~(i&Pt!$|2^NWt|w29 zHx;K(ebu&G$rB^geXNA5?1b)O{_A^u{^r|!XFlYt_N_bef|pe_I5zlAR29Z`Z34(c zS5ar6lQ?%5v*t2HWe3#jB*eKpcpvZv+HO6LS86@;m;H}XR$(Hy^@{X?i*;cFtL6Qj z`FyEy4X`#-bZuW!I1cxG!oDgqiwHE0$qPom_vp`;zIru1wvdWTnEwMjyb*Hw!g^!R zZFumqy9V2O48~3n=1x~0L&!RkomkmZ8@`(nuz}~dPVYw_m%Upw#pIu6I7RwMY-(&k zHsTi(jIT_Q+tKX0o$8Y@xk*Q}-7-~VQltrR!mTNkP%+ih6&Jm zPlELP(DQ`IK$Va03{TV4l6*O!PS-+3b0y6SKCe&ZERHqR+Ap7l9U=D8HmH6QcJD=h zEbC8@qg+e}BXYm^LEbr%_|U-V8lUu|lhQxp6pO;Nz*dLHO}5{6zrsaw&sPdeIER

      +rI06RfN5gd&NzQZb1E zv05%~(w&qM3zc;XP@wX+GN4UoKBj2tL}NlMSbQM&W5euo(XNrwm}d#wOb2fhzdsi~ z#t-#clk(oV5ccBg=>MX@tIKH0iqEI1sSit~zd1v7-eFvU`D{GpDx65?7Oh0WS{I-d z$F$k=>l2A-DflO<8w@9I4=DfEdTDBC&BQm)G>iLwKWEcL^LanKD*F?6KueZ}r>%RF zm9fPD(`aw+sZC7#asO)$Q>0sC-&E&nakmX6yKnWFX=GBPXyZ7{!^VY*`KR2fk@pmC z2U1L1u5y#30#OSu#vw89+(jUJQQn`B4Kv0bo?Ow;k9D~y^sXWBND}dt?F4?A{-Kw+ zg^*3=w$nx4`l|_4&YTnR{d~F6JpCGz5}}#uz53y251Y%u;x2kwsaHfqOUk~}?$_7W z(%0vWrGiajI^vG%8k47ldLU=)zmjxRTXMEB@EG{=egnXJ(;Q^b<{V?Gg>wtXQ@&lW zAfeoHH5=n&vu*l*ecG^(h{pP%#z`ZI{RhQ+xwb6Qol4GGSAVVkCGH)TOH1LFax>1A zB%v>$CQtkdZl%PqzQ4x@5l$*QDcN{mD|spH^w3-Fcz^{JUa7s`ym>lO=vxHtJPPp2 zmYZ@$ydm#C=#w2JRhyso!@m+McyZozOyGOupamyxUI z1swwOF4C+iOLiQrPOCP+rQ+B2ku)CUh1VpZKm3XFr6tiFA9Ak}#*KfUfB6@Gg|rXa zrN$vOeK5t*JFjVv?vxW-u8EwyYp=q(>S(#`SWb;C8bKkuA~v=#!6`xjuzF3P*roJL zevBXL!{Ai*V(w=3Jv!)X`UD@8reV!}1O~bpUB-m)Ov6BD;S4*NN^gCsD`<-&BrmFv zoj?Pw&s$|p4i{Tv_fW|artE_b-nJAC9%&T5xDyIy!#!9oqf&OR$U{~d#+a2-&*VfT z3Mbms!I;C7I8L{L?(3zI{IzKLK{U*`3{%T1XRjR(En{iA_IFQD@LPEj^Nza&`qA82 zT&hM@$gaNF`Z_%&R=OopE8_-O}Tr?Q3E-~RuwNVpsP@CIPM&bV2627u=f=R-o5qbTeI0t<2yYAl#|hLAM(I0 zZ)%X7xI*=P97KX@L67&Tvj+AQN9P(&NWVXs5CF$$B9PioO=b%RQdx|!eUNIkof8^X ziyg^~_LZH`Szy2^s*@NhB8~XLF>(r}`hx|URweg6iqF`saS1&LjihAhmen#L&rYcO z`S#53r3VnK8B(EOf{zttNM*~K$bc0Vs>Z(}WuxUuJL1F_hD^xVj!^FzEGX`05!RK=TGXR9aXVOb1Xsq% z!P|iWYMey*)uj*rv#P&-1)O3R;li4besvjjn|=W}sQs{|2shvptSRzvL6Ej^hZ?3OseV(oot$oD=~;%>w;POJ!{XBDj@R!vSa`F!ukczHYO`E-%NVR zJG%&sxPcg`T zlqPKvlu0IKH|E`9G%bWp>0zGP+2z<}Q6KL|(JcyJb)Yn=gE#()#pOXA*?l!@oX`;w ziI_?U?pf;(Gz(TA zeB@Cqzc>ZqLI@t+NzY^RcWYkoN?_?Z)ls;nP>}S3O0PgpRKT$*AROLlpOLdd5fmvZ_iB=!h*9P&c2L*F zc$%!baoDe2ai8fy#1l<1%h=(wZ#hkWkJtLyg2y(@p(Am6KVAsj1iQJJ#4Wt_F|Iv+WEjvQ3&lB6Roo-AH^oZwGr{Sxa>Z0&E$wu9-vDQ$hdv2~bF z+LgadgvAVvCcsg9v^BIxmADLdMXj7dE*?Sp-6e)LFZ3P$EdL0`aJ^oO?XyW#9u(;f z_7&i$dh6I?f%x3e*QDMUR7Ng6zg;w>Y{CbV86W$V%h?k@>XcrBCZn!KV|5P*^uoRv zD(s6h{uZ)Qq1Yu!TO1aEF_(SOQ+1eF|B(~k5&He{NypkEcGpyJX=P=O%F__(<=(uraAm*$HF_$`s$(cY=uVs&)n#UApRm(dv`5Xa zt0bU_tt?}X&jGmZ@heS^KD|3_gXh-~GjDyv{M&dpV^KMSeN8IJ4KmW3T+3mKVEWIz z@lekQdd*>+Uhw|8=|x87012SoKiEv`1hH!>VcZ&|F5j)#H7ws_a>I8G?1r3Pp$ADu z`cO`ldSx;DtC;Z1!NH(b{~6)-*7#DS{936#wsODPF)J%02A~Kg2a76`!E>e%tl+CD z6x+%V$+U#UBBL9Pyy7nNZjG#n<*BKe7Riin za~#PouhAwtOVY1{3HPrCOcS!6atVsVAw<>wqm4G^8#J5PjN6BQ(SkU)_dVHE`2_c` zy<{~;y-PFU!43+7A4g<3z!HCFIOTBlphXda{T@idK8yt1e8F(XCDLsbBX9MIPs>|x z7Qdw<7^dt5g4=!+J*&F2&py|1vS@sz%3WJx)MtO|=l#IAB@GMTFX+D7wJmqrJCK=A zKF96yOmSEBB^_Aa+S$a6q*B8ECjOZMKdw2ov*Ho%fVjL=FadtOLk0OvBOKAb%%b9+ zGq*A-e-4LX5xaS<+cv*<=nK%T6S~1~<*6F_ZwLHpY#@*07=eZyy+EpG+f?>EHQBlY zK^}D2S4)S6Ev{!>HSIFKA^%OfL77bDR}jm$ybm4jJRneQuQ{XbivdMissaIV*;NV9 z7zw5!(=CU7C^OHuCGI4`(m_&8JU{eUgHl?*TkMBB;xOfjG{p?Im>2}s&HSv{Q0^=y zDXY(f=x(LvH(1z8I(qA`R3Vf-R)@@K;;PWRc%#W4Y<~E<{Jy)keWB<_G>1u znN3!VSpAsBZ|3lVIsKga9``Qi-eXC8fTYiZ5yXjlVxpWLusW|>H%a)uU~yOZyu%fF z8!!~Wv%e*&0@8PX7<}Fvvo9)0kQ#l|G6MKEp%tsBd>k9hxz@)vpMo)1Zr-`>-2s!` zm}5Dv$Al33|86rNZVXkZn_@}#AW{Es#`gyAP4Ln6LUg_Gg&Dxo473PU27WHS&rvq* zsWbS~eL*4PFu)_1$2_nqGyT05lD^}|FMczW2JUJ)%Q&IO*Jd(`phTDP znRfv8H}{TGqT^^zVI2Xj8cRIykF*=8lRhvk`;IM|zY~yuAAO8sxzBB1@p#>QR6}@a zKsTpJa~Dt8qX_s@RQ)QT?v1}_YZJUO!9UxLsFA$hK%mc?u~HRQ;$xs9Ys` zr`yrDDMC`0XW822Jg@<1|HC8tVjK3jRz?k!vkpL-^}MOE?f_&!^n{Q$kh#}O|Iuru zH+=p4H=@F&Z8CT!LhQ(@N6C{Y3vF& z%8lU`zNh`HV%XOhFm(bqb2$EtdX3z9aH{%dY z`uOo8pUK0Hnc{SIZ4%LJPRn;qihf)^Z5#;JXIKLPFFYof3-E+UBS~ShkGGoIEtd_} zd&xwxkREUYH}Y@h)7*2`qrS`0HW{nAguCD#^UiU+RbIM;JGz75zz>jmB|ogUsx*+nNUcr0rF~ zLXSqnqKdy+B}E?cM#jI)|5TPXvVUOmO$WMPG#n#6A*(vZWpxOgC)lKg$@Sy!-%+^R ztPfcsSNY|_a0kV@A7EDq`i}NL5nxi~c2&^|`%3gFGvtgX?5zutzwu((b_9cQeo0&87g_@*v#w4KRUsWL`=xNl zx(f0g?j0A$qr|a6q&((Aeu5uLGa*#Uuigdoe$~)j54h=VH7n8F^zx&gjsyc&{B-Is zY}jA77iVYl7n0(Bwzs>DenMhWsG{xdpEBJ<>)j(@tfsi}Bvbi0z_x*JTVU`=w4qO1 z?xCYM#MsTa$(36npZ9lOafITk6Z~(W3@5-LlqzrO8U5aDP^_rYZ?n1mF11uFg3I9M zXi{P;DH=u)C$TraR##n~UN6%Zw}=v0xDuF~BQ(0)FlXKm1+*1qb64EW z@u5+rY|!28Q|W&~r%}yp>3}&Jys4x!ucMqoi@?;Uq8EOHB4q2XVrKt<3#Ebtc3_b% z;xa;%v||Y9V?09_;wzISrd@0d^4k{DX&&I#*keIHZjA3n9lL;Fe*bjE!%Rpy;+|a2 zd~q5uVI?`t#?_woaLQ>Q1g~aY%V@;1XrY*C@KLzXbvuPxsB@pjd8&hqk{+YLI9FC_ z3iY*b{)a*HU=d+{I&8|`u`bk!y|#s&r-HwR!gE}MKTMQC#I_+%WO??@VF58+K$g-c zMUD@enzx&MriVPVa~_UKXtukuq^roOqY5s9Xva>{2F|oiBiU|biZSFr!vAu=T15Vk53r_kQR|3d-0wK%{yLMg03Jz?U-d;xg*6B_dez0BbTi z;)|I4zK+@9S98&|4=S(=mNb$VTSb{+D=GJ-CIez%)C$lLAzC^28v5Gn8QHBd@3!x6 z@~IMCgw71H8zy!}?DT=)YQf&r^|6{8DBI#lX1@LkXKJt)cjg-J$epsIz0#w+YgvNs zs*B#$5b=wzqWjGpqH7660W{)C>n2iXL^q%BiPHR6zrg>mGjjV)-T4y@Os0q!)*bdT`Ct(y%G^?F5AeG zc>`Zs2C7UV7Jpv>@*OoOy|<{i|M)WH(4y!NOmYhM@G8ixB_&%NC}xL8 zI*>L2R`=Z(-(CTqGUNLMa=_h*ql-JikjnYj%a5@ST&$_pG2!roZ8Ga$uwEo>4x|J{z&but4(zF!tFQVrqeFni4y&#k@Q~P8_MSArEvSUQEg={ z+AredN*GHMh?fGBHAA5oQ|Tvv+2rgFP{c_5iKsM*{?ffx|dD3+S{bBpSUc`XnX^5`VUv^uuuQO z5@>ElEn2Lcnz56aei7#6RX7OASR{J!?V4Ch5h!+FGA=s}m`KRtJvEfaXZjjr{que| z+WzF(R?sO#$7BAsLgZMpUWViqxDOx{F%BAGoQvNJj$j3MeL(W+I?+VH>rV+Wnil<_ zhEsy?@wBbIN`uUSEV!|a@L^)2_CIpRTJIJC=A^4&j~7?5LUoAl;~=TS)ZrxMIGgE*q+gcm?ea$Mkm*8Tb>P>0!k3cIq z<5w^*M{IY{>*~!oo@V;i3%qbizmgB1{J(`MqqT?P(IT@7yyLgSnFb^j*mHOz>ad8{ zQP{C5{9CNosL_gi|o_393cuK0$u~PWgfB;A3`Zk`m<{> zb;g*ORic4$F4)|DulgFegy_UQj!>Lyd%t;skVo1$4X*RE>^0VJ;C#2;Ua!P(Qe0I% zx?NrTe*99E1qJnYu~7LzNPiHSuYG@crzBof(xcLrH-M2U(jZ$H|~zdTtfM zZSrD?gZxTp`#a;>_1YE@I*j+gWnkr)#WFfG(p-ow(gO&%Z=i0oXk+F-?Q~xX@+RL; zw9AL<*Fh5W9Y*)@xf{Fc*Z~zJyE~cO-k1{H`u$^W5BLAl-MGgNEhtt$lXCXdOeB34 z6?G2hLXmL+aMAkH0FDk@>OYL8C@+y3N{GO;MPKg&5cItS9Bmm`af%{R&=vG9ZnTqh z8C{fRkvY;pC#NaDU(miKj*=+)Ko>@RzHy+Go82vU@>*S?<>`G}QF*`+9Q$*;KFO2b zA-+}3BQV7D!bGc$*2h)Ve~>T?j_T& zJI@vlw=`J@O?r~MExVD^ISyKe{w!r=7wHb>1msB_=bVJkjTjFV&Y;}=xu+# z?eWL-gU}9Rf8hplWn>^Xl)zpW@uLoa*eN3HSm2Ku&GwqD=s*B0Rnzfam|RE6_i#Pg z3KZA06Y5{$9VOt5!)_Ge<3_rOR)06Zjyc%gwB=3yT=`3Mn_jIeE*O#D?J&R!zGL;m zrYk!{2VWa7cy7Lwb>qqA$#)o86>bVY18sOx^J}V9a&*LNuPx3JB{<;FgPY4644Wnq z%ECJ}gJ}t#y*__0?Cw$8)z%ajOpD=R@C>1+r{(VsALkPu;qt>*PJ7L6pMqgg-N`Ov zW<|{Hqx!kj$bZWs7dFgNTfF@bC* z>vhJag=@_H+$rEyW16_NLF|06&0?tqu+ZXwUs5M6IV_%3pq69|U7BD%Uoig}wWLBV z-8K?cLa-X9p$w3ZJhm#unVBHF*|YuVh(gvBq4Du9^jf7aKEj3S?3!J|@yc?8G8%y} z&st62wmBOway4Kj_S^WORKwhtV9*B4s-*1}_TRLa)f<%^QN{&bhK3L{xHV(bLDV&xz3z3j6=ZS( z5E1|nW@;mzajub~{ZRF=Yxr-#mbxG|uK;vfLBWZl1?4sx1@Ijd zeGe&AO0R}YrkBuM6}XILI(yhCW5nY{Y1L-wxYzKSSlm^$(X2LaAn{!2;`)tsx`5zY zsc{OR@T#Z17{-z}%`)0AdV>npiv_h5q(XHM4xfgK}FFKr3r$^dIXUgo+Itx}y{bQQMX2h7b z9@!#@L3g@*yzuSG(LvIW;vRPFL@*i_OXl!r7<<(g029;L}td- zAV9h%Dq2#^p3I=C#$G?uXtsKw_omYNNulq(^AJl#5KR$$;X7dQI~<$Cz9Rp*E6MSj z)qW&8LU+gJavf-taRPlu-F6ARJ{#~a1M%NnL{}(>NI!|I1{!#k;CTfYG#If_lGp5A z7VT`D-KHgjHB_^R4)HFY2MpWcUF#>xetO?He{Ofhd|j-JB)v!t5+SV;eC0pv`O|?| zj7K3(^K^qh(tfO|vLo)F3ER%Em>!hUqA@84xVf9rU^3^*KqCBMJIfIc5_fOQdP0IU zIfKd_0V^gzg^U$7ccWi;6emr$*ahMAO;Nho0M;~~1jU@~d)4veHnc*yH>NcrTkM@G zJp)f-CM=Fp?JPClSe2DOZ-bESFJXXIu8WHL%5F3)Lv(%_MDD1eR;cW!CaVan#nI=b ziMm{M)geCNPu3=gqj$PZa$kU=pAqwH59K!f8r`nd@g5o-XE@aXmWUg`w#(Z@2Sn^0 z{NDaZ&^>uLarQwLrGYnD+MwDaYBJdyTlLk?EP{zDfaGUY#|7=7v*O+mK_^#e~XNQ8^Mb%ASBc%7jN%r@N z`Md63nnPQQWb2&Cvp@ctL0`BoA^d3kNW1i4??dJ_TsCzKHHlmVO zce%psK|Il*#F0^J@-e4~4tTYEzN1M6GrY$i>>S$Drsb@^2&+Zx1UbiIhl1{K-!y0ej> zJBfA?teaIBSa{uFN!L`FO-{X_zA>E0L9KX_VIWraho*v+RdpWe&vFckGZUj_<2efK z&i;P&1KePHo?fy))|7}Spc5ZroimlYd-QqWNV)`xhU&Hh6cZK*`Qii3K8ifGKI$}= zQ);*=@vLjeQWm|od7+$L{}a-`&tS!mW!zrA=GJUXULPuJ!Y2PPZujQ^3vrEu4;MQ^ z!OMRu0D9v^Wz%c8EoyA`ytn3_A;@Mi1$_(2HS===xXLW6Y8RcOB<`2sHx3Vfsy_2? z=-ale!08B{q|B$q;9rk(fYz;?O_34>1xo#3s&OD^pgO>zp;qR- z`w_^-|KQ#w4&L4?tlg$>dWm&38;mJHT*3Z7uE zCwT1o%B-)EJI+BQVP@RiZQ%jva0d+(=NKD=S7+V~P{uu>h>xDuR@DN3Y5!MAxp;o_ z45UQj&@BpJ9gdJXdKqv^M)u1CeGcGo9$cu1H@tpdroPN44|({yYA3nI`BGw}r%B)x z^-PkEMVn|guT)!*j1$R@1-2r=iN@`=1y{kD_$~jAXxm~ioRBhP3m2ch ziR)AStXEyi38RbR9_WJ~xRUPu=LFz9ss1;wKN2rLy*q1agQ8@K<#lF8{9IObub`Jt z3=NbrD)UiKEdlbqSB-C=N2t1wiia9ArK$2Eb}CK-3mI|3xjpOEoNPu=PI^=xC;ujL4u>3PcT(}T3JU5S@FCyRhB%~Ljqv-_7ZcSv)i{5h{Mj#;rQO(- zhR;&HeZTZuUv?$APV*)cp04L=k>~(8`NhY<9ScwHxx`-gKbJSCiUTXOy$I3^kFkcgpF_!<&HlF>;CTWj0Uq9(86aX-N&H+xl4klK+29oqIgf z{U7&}N+sk{5o1@E>q_M+B!@X{m7=RcQc(_*6=~MeLN?o!3OQZAKIpr`e=i>-d znay!yb0}&XGpwB$DMq|*FIk*ztU zb}rbzB)O`Q5(~68l3R?kltwjP#kT~yU0)BOBb@AxKg)4ezOWct$k49REulcqtqs$1$N(UFua?*EgOOMogET%_$#SOUhDx zvH?UZq~2hPI!hy*XB5vDCqI?uqCroLmRMSP6LF2XBE>b9hkaU{QSB@E05fd|A!T{L z4^3m4W_77o`5+=5zzh1*Nt6X?bXAz4QQ!UiM}NU;`Qec|(d_EY_8A>^-C*5FFBeis_rOlB{rTeMHArRU7&N{NUs}^^jgxK_ry)A+&WF3Vd+|H1MA@-|l%3E87a!jCN-gg4962{KXHKHC z7`&(^Rr@Pjo4#4WpR#pk zoF?|CRPby<+NkZm@Na}NgdcCv?%5-`3f26#t}9-&&o~upT#4)9OwzKjOoBws6lxxb zV@;CgkzDQYdDZA-b4Amp2ZCPT5H~?qZat~KO-5bSgfg9j%@nhV-f#=>Lrtk?dsYnH z(%9w>;>5NlVrbW>iCrk+IhD@a4(mzpeIy%aa0qmkZdoTEn~#-muIAD-DpazMf^JYQ{zYHwg(ssFrV+SH(S#SY<0ZqaB@g9l66sDj(3M56Hj?{aIJzK|m$P$SEz>1@!% zti8~nNI!55$f@20meX5m1&Cwel1oA53WHAmdb~|sL^{#~4fDl3B*;$lcxD1m##G~e zH0lfti1kcAv90VesWE~|wUx{7lz(OuK7FeOd0PhWL58Ny>{xbvENc$?*T&z1jO*`# ztjcPWU<88f#5PA-V=t{cq%*x9l8a?xKkCG=uIjoy%*Y=ZPN_Ooj5fsvE|mrjR;^3X$iq0Rj}JrYS5EQ%I}o63S{T>9!@uv2D)v%Fc@iW{WkY8OAhn`jKYxV1IPuM<>& zy~PzpT?O9)Bu}xA9!~J0*Da2`O81n=v-T+Vg_8cjDwD5D909p&3t_0@oY1p!Wrf}l zg4hGKkq~qGEgvjI+1ioGCxTvu2=w{Y$XWJ^1d}{EGwfB9U2L}UK>#UUY%HeauV?Z- zDtT>Y1k%mi)&@UO^v^D;(rs?rwnFkf zeS4#AnFl$ldtg%LUht>n%vyWveZzf#n&lpl*)+Aq)}9cO?}rzEnOB{^U7Y~At;h*1 z%~7U#W>Zcg95MOEMmHU|E`1AaB4LQ4?i&+H^5}sfE%^+fO#p8^L=Pe?_R*fXV~%{^ z{6O4W^Z!l2-dCI4jScTl5YNTb4q66DCQIVm_(>|P5eT}4uzvY(tJALJd@LU%**nuQ zYMN1s6X{#JFwzzJ7AExn?tDMzxh;PN3h+e37(v ztVlj73D=lwCT`V}Zj}oslQ#a06v++<-8r;@S|}j#$kMTB+m?~f^LNbk>Sv6y{oo$< zV&;>^eG)w2{cH_Tl^-sTYm;xY7D@pDGpqW@$Tz1X=_Y$%{{RLkOgkgqx9*+s>9PDz zGf0vc59xM{$O#z#pWWwu@V)te#J_(p2&T@RXN{^Ok)pPzG(lc#6@5ZC=X!3NuZvRu z!o{;oB{^R^jkF&qdLKM(8kRfmrJc%xq;m|`nb%^%n5=Dz3^cpl5x5(y{_z);z!|;D zycx5zD{EAq8gtz8d;5a_dBGhdm{x9yZ@0SSM3l(JL4)C#tR-x`m36-loZVSg-lxya zCb)+HkF&DItzUv;TZ#r^&(q&rF-MH(f%QZ%0* z=c#N=MZp)&;*m!pY0!d3M=$AQq?c7q6eB7}-;BzrZeKj3Eb}xx(FTKeX30bQMyy2f z*wsZ}iN_b;M1^PSpnTv7c-o4cwmSav6W~yaz}?Z{1&k-<5bl3aA+5CBTcCso;h94$ zoICtsR=DyEQL?r+j~Vfvw%cs6Y%GhJ5QN~Dps|xa%uB;#rfuB1eYs9qHboWzZWeFN zS-Lf*WwrJuF#PhaerSkc2W$NMo#Zd$HnrSI=_$86)w)PiuZuZMBr!6I>o2j<-OL?y z10A<0v<~lj$D8~{5?eL^HzzP7`@i_Gj<|fvvMAAmm_8Wii$2ALJ{qx{=7bA#y0eA_ z2LEXNfY$hUdJsQ4{$`F}-KIM1G_MYHcp%z!Ys07;!HNdx*Z>mqntJGXxG#phN}D0& z)$VDZ)CwxY_4Uikf}l*2*%L5u1eF6|<+RrNS1p2QYMnz|omIb#{Ecwu2;rtGw?@}_ zvTGw}gSWBLJ+-k)+$efk%SZa-R3#YvFXFH66I2VA@gn3}t*ZP#n6-ARQN$u-ei*ZH z*4}(how-l!Sgmu>8E*zhh=??2bxw*0y+=r1E#)40!JsnggRBvuQ zY|iR3uRnO&A)nRa7%HkYVBy~BnJ|x)jX;9oBR=^n^QG3)Ztx`i>O8V^$ufAWq;WI+ zuD)vZwi70pyV!pe$i+ilhbmVZBOfkX&>g%0p|P3R^@AA1jpBC}HymT4TkN7+C#kMe zI|$S!XxJBzg=n{x+3QuoTZj+awmn*G+MH8PWwHwG{d6x);eJsGe7|yv zvOok1EP<*x9bV_4;PZ;j@(1lC-TsZN%38VuOk9fSQllMJTwyfl*s88-A?JdT4PTE=$uhSKj4f)3UknXc+LLe%I{@AW8L9B0DVIqA@>aBqU4rxjc zOp^HI@PTR@Ax#@^@PZ$`2yoP5Y6u{SI*RqAaH8lu;sU zEZDCjazUg2K&Ga?S_QJc0wdlo*tx|1CWc(xU^c(Qd)GHsMokW@&MzOCh`SQ3fhjRz zvdRKjkv;$q2-@(|alq&xxA|uWwc1~TGMiA#$Ek9=4h=deptlt^Hqx?Gy5PQ-DsE9# z944#ytj@MBn<-u#&iSf*nnp!qdPr9Ja#GU}epkhWmqp=~`mtVzNMx1sjcV&V<9mmK zOL?|cah|Ts^XWjRIE$>uO+E;9+-=GDKp0&E4KYCNe5qV+sNlyftx%zTu26A+SWF@W z+*{h;!De{~{?;Ncs8g99FQBro;|)9Pa6^Qj&$zYw9BGzMxy_qlTj5*ndfblU6LJ0W zGZ+Zn_rcGqqMbAcAAbhmC!EZx4hkzLuf{P0zE7sZlK`oHZ?9L>|ItT|3k9Pi`&^G*l)vPUSXVbeQ*bnWfd^AAKlic z#_l=HFib{N!~{Fw+m$u$&Sw>>1_8)6lhrLqQ2~E(V|{UB8n)iEv7ETEma`#tr!38o zK2rH{2T!Wa=Q|EGv!1oA9T$SvJBiDQL`mxUfV(jfVmCF~ivEnK;C3yZzwxSVUW1ko zN9O7*;?3V8on<>l%MwX9q_4P4Mq5UH<9p1VW9CK_e_dJ3r8wRNh6-^(cS~y+t*<9q z_7VGH-9YiT>VaVK<0{2ooD;fYr}?1MsbJT$X|L)}6s;@FO<=)MPi%o4-YLs~hxarX zgCN6N?V0p6C$J0eBijh%gH#AC2T}(fg_s4Tq;v2e=am)rgxQ%|hHXhjzB+4fWFxJ6 zFg6t2-D4%h0&fmzZg+(=TFKPX9~$>DOjFq3Kt6cWi#hYD0~tTr!LaLMz+*a?f)XYZ z9!?L|IOVQ28m)Pa;jMH=X7SgBPDCbczfWA#R&6GfQwU(nBD`~# z((1?C$MqO35sXWK!jap!BW&+d3rCml>37NIs5+f&zFpx6?bS1N!1~ zEsMg-#wLdkT=L=hQ4hk$&!pPO`a{#NvkA z|FH6(;)=1Gjggayiq)a?deMLLJ^q(({a*&Bh60$X6Z+M1(4^WC`ttW!!Cr^Z4z1no zolTo%k4L@o$QnvF*>Sv2Y{mjuPbl1pF}DWOu(#QT4BvXq0P;y#*8vh48Q4mq6>Xwa zHaWosJF#;d)!OABM(`Kw%|!VkL4>2oaWLga#;Ru(6f2IwSF26c>|g2stov@`d(PS` z_}UC{EtM#euTM^`{>3vJYzHNkt8hO;xh@A; zjGy0({S$~u*P&&}Wd1hZZGR?vcYobY|D|1^Y=jB9O_2#MYyNSFtIaG}ai?XS2CZPZ zl04tXXrxbPI0}fdZ>j@hrfx!I-ywaiHH@Q_D(+_9@?mPa54h`5SRejVaI9=*>}>@n zGr(p3hcWHOgST;{y)q!li1GUa8p~{aq-^7}R}Dk|v^!LcH#+X+?h8{xeZ{ciSTzrY zW8QH_c4`6|9$39<<$BVR$*p-dZwWDGio=!V$(}s@G)8qsuD;x4X{f+$PP1SZDInSs8l7knRioz)uRVi6VLqYkLBG(F-F(DomR_TPqC^$ z80l$Czczd$_#mI8WRON^{k~=^L?p!QY)10{w_65O~n~gVrogq zZymphTHO@bDj#5RN97~zpozX~V2RIo1c^Qy{LUZ#)Ny&&O?;s2wu3+xW~UwU_6oR5%T=hswvqph=JUP9xB0Nu z;Ej2c6}648;I(cu*7C1$fnWM9~Y|m0NnPnzTV;(tM;bKA1|4z;`2O{4DxOyVGE32(wf!qWwtnG zy)4_O-cH#ewj22{d1Gf(2gqD`-K!^>tHM)w(UK=xPtdhH8BtHIu*AbEYdp-x zlGetO?#4RMIpjbsMewoZ`VHCCdUx#AaSr^H*Dk{ki%iXU7rZR zLB%^)#nB09tv0uG&MUcnvAxG?iEeZa#F_%hYCh%|+=bKdmS6ln7g~APT%4)aEI)yf zEFb9$dk4uC1*8Bvu-5HJ;gHOOhUxJ$WW1|9s2K+4AIVC9e%fo&+?e%te`iL97#pz% zlUMy*p4CSEi)eNwL$DLWWUvRTp8`XS)&_V8?H`wZ5Ax~=8F;;s+|7Xn7<03%>5;KG z$ilRBl1*XQLOrjp{AH9Q^hvP#xcxZ%`vLG$bWpj`l2;E8wD^}Z;oxbPV~b}=yy%6% zVF0-n9+O4A6w8h_y7^uFqIFYPG*<-1iMkIzfnj05OWoGrl(g)j<+yU)Kmc`=GpEih z32HZU3Dy`5(ow9uZ?uIPv%cM`-HI=;l?v6fF#(g0c*ikT*McsxXu*yJ_$neJcm36M zMwc%3UYknUKm zz^Ss1Hih$aX3}NJtB@(?Tv_a<@EhtN>0@Rnsvlk{cm1VM3yC?-qBn&%J?B=*6$id| zGr;{LE04Qv97319bF6H8>fuSpZ%k>|pe1$~v!5#BskKa^IFTqNuaCG>zRtWQ^nGr9 z0mB523?<4nmCb6Q+rdXR{`-DVmU$a%IU5qM{Iy?_;s1tHWV4Q;8WO3h^3CVrOs!AP zT(dvMX-MYLy&>@2>;XswT}>Z=1WCh&xy#z|CFhWbq94gJV%Pmy)N|7ImT+57mLzS2>Y!s9tHj0&Pl6m-rfHwO(IX_(gdh6&MqS|JLW(8DsI=^lk0F=O%xply5 z3Uet}8q*lObannEVC=zEt|yF{(Avgf{J07X8DM=#ubTPL_Dnm9XYB_Tic^DA+8Tq} z{7slU38V2+oKR0i5yk=$*F~B$ZciX3kJ^k+cE~0qm$OV^1KQ-;H2Ls3EkCo zUiU-S$}9jp+z!V_u&?fBpUPs>v~F~+m&R6%d{gJXw|0z)+ReKJ$9%vfyAo$JqRSmU zdeY_Nd9|;fm`y`oV0q(-;{B&9P~-}AEELn|<)6QXINr8L`F7(cd|i_Id3o)r(Wu&z z!_-gXYNjOrABG>Zo!Is^3vfRvQjgReAZcL4FJt{@hmfkWZOcE?Rc2e~GDM5(6O>im z4RF-DHYlfH8E&%FdwNZD^Y^!M{ZWI5Qw71sioahqDvwOq)3N}vf_JduUn-Zk`M%k9 zJ@sTS;)jl=s{bN}greUSqc+A^@~Wf?#;Xw6Y|WJK76gtPR=@pBi*?8S-sboSUlR-S zY=k~m4$FtDuetc*DpN4GsQH3MIViWWAVLbbl0tV%S}Jitia?i>&1p_$1BAXjvWT6j z10%nzc@7j!go9pH&m2B|CYHvM!xmTsZCN}&HY*J(>u7@PMd>J8jmm_sH(P()oZw|X zMB~96bKQr>eC8$9vUzv!NUaz0Jzrz5z{D}Q>L7dunt6A9aG74P?r%IAU9KVv#24e= zxo%ufRLXW05R#UEDo(Ims`mYzxvD-f|2X&ota_6?V`DJ_V9ng@i~s5l4O}scSiVkm zD8rL6TS93opeK_&ce$HZbkMAB{<>N2np)s?3=!Q0+oC%6pDDa;B$|24t#!p{*XR-1 zy`d>^Q9|ED9w%@YypztRD$Y_>Mn`xZ z&|;U!T?ZZJf{XwpNW3;8W@R5TE3gH9>o`Ir+zy0!S;b)_FU)gR)7}yO{V}5DgFCsn zUtZRsb-2P%spy2iq8EGQ}2N%{5p?rp9tk09MP(#bf&XlIn^B}t+%@Cp1qV>J1If=VjeuXU)7NII zMkS&EP?oYAHAf(7%%ZAr$JiI)9ntR?IzdM*)FN&%V~VVD0fu*z4Qe~4N~_qYf|;CY z+yGYA)Dom4DgsYD{)?nst1jJ3d)~+YPT362Y_6}qT(l_g%+ZK;xWFyn>V;hVHml10 ziLHr~Ma8uyL?ws+4u^Z1S?YFOF z>mmw`GSH>|#Jow)}o+h?l(vjLCb@>}TfIk88U&6)1-pH2JZarCu8Wens4 z8DOwj{Y?T-`#W0V-dTS%JFu4!HEZ_g%C67*@55IUo7R6*i?4^_4l5E`Rji+R;{}L& zs1yUKDi4^t$2Wb^$pF`3O==>EubM%Fq|ZgWi6%d8)w{6VZH0-T$dzGBH?XXvt&W>z zkx98i0ou@>V8QWY7OpK6GVT&G$xcI)^N-Ky!vqNX6?gcZ zW9cHxd%d3Vna2t`GdDdi?kQPT;Rt3k{j#bnUl9OxVJc~s8Pc^18&wTOiEX?%I z8TVl*LH+9)oYBKEQ`s@=w})oo3qS8fg6FvU`eepP+g3a(rvS3%_|nmwNBAmtk4{Diq6~qUeptTZv9?HSmJQS`~S!_%f^;2;^^RiT+0pWSW3?Y8~r>|1EKPr&Yaj zaM*4qF6|5P71eC~{Xf#t7f*^uS00YzEM)(Ht_nCUxbGOi`b zBSWcC8UgHsQVzFE8eZt{4Ii_1Qyj;$Vb-_ia_u^(>C1K*3=MI5{uP+=Q%BY~sZm@Z zRSVqHp*H-Dd@-XM>SxNmJ+fL4RSlD?=8|S7-<33hyFFB*ChO#FB8aF!d(b^jT-Mt7R`inLA$}XQd|bwk zOi9yy?8?Zu>+TErX>?WCrYa2ny zCT+@Q{S5xi6Mj+4C~BieZIJ22U(e=jM><1c%l3z$E~2f6a!Lq`a>AmC2%LRjdAZ;= zEVa^Ie%DnYR=*U@@4@Y!*ETdJB+23`WxXCSL7L7@HwR3BdzPq$p_i?S`N_dB{?jP8 zIH4Io8PI)I~wJKl-P_Fi-sUE%_$_$aHi1cA&=~{+*i&m;fDD1Uzlr79Dj?VJ>v?OxN;w zmd1V$tuS;yO-isYXU9EKt;|LjQ7Dp)(62#hBP9o=ew;VaC&kh`5Wl17)ens2OVw}F0;&o(kg z8^M*a_=ND0Opcw`Xd~%%rL8V&0YUF34b-aL&KF73t7<#m;AMZz@m~opfqBUj zcYifk9+cvrta}!BY-h$^$5o$NG{)bgw}N+1_j$BFIL(|UP{Hn~uJi5%C2_7Faj&ck4e!0y!z#bnY&#WQkKFQo8!n5H7?=eqT5^!6 zVU(YG#U;TpZC}xvd;p@|+-mGt&n{>inYlpO8A|9j+7qq=c!gU(zpoXRwy{ewDJQrU z)`LoGo83U4-|D_J)Z=hl_UI2d1f0I^SE?$jOpuFTD?(Q`!3Gvcw-i}lt*)#FKiH(4 zW|)0kzP+DPGxIib?KFeoI*LDPyf9>!v^VtMu_OG0iiicvSf#lgE7eyPoYY2oY}Kqq z+!2x#LHz5J*`LabpFy8Ko9%3zQg-KA&8uZ0f&IpL%*3g(-{>Qrs^g_67C!L$$h4M% z6KQ8~~g~J6^B0`W3T%GGcp=pb zhVl1E74ECP#tKH2v@1&RTH$68Fcnzuz+c#+=cCKL0UvX zXG)JZa%v`R}|57encxjX~A%LX%^IKJq?Iv1vbwb0?kH~ zRB);@zV?gI4{Cy!p2JtW8vep3m7s;k!(~>u(j0~wer^%^?P10Cue_`QrC`V^Epia_ zCIL@(@N?(19PCzF*u`=C>E7w#ZhSMZR+jwrMnwgLHnTk&eL~X>!?-X%Tcdj)|DRXx z(qW0(uqi(uvga$L$5C@`A{Ba?)M&z=Ok7t;(+5~rtJK~{2|ZhtD{XB*ei2_CMz6NS zLfOQb(j3R@sU#oycgm@xe?0&mQaKL@#t)OG5BIbvyx>01ET?r%)~25~mF49OG?1&Z z>0Q1+F!y^%#a#Pm|D|l+x7KO=W195!V3s+)tU$|{<`8H!!}YCOp7jJGPip6M^Vc?~ zGTh4sVsVT6UpMZXLssj~>`kka^|g>;&b)Itr-RFPB44Mg-^hXFfFbI{gaiuZ?|B|9 z^t=UYZ{Gn+z=3^I;=%mHNRW59|6{@EE3Y*a};>hFgdLRXXzv}C)dTk}EIc%gwL zkBBG?-HlwEPpvKHH2m8^yP6~xd(B!s{5=(0?D|qMF|bUEt#dUQaXmc8FJ1KGXMo50 z(TabWP!}F`J92Ur5~=tmHqX&oOKRs8O(`dUyMm$w##TjUPAgA_r<`sszWtj(T51_H zSlJ!AzV?1%fW+@$93WWSb*CD{k{$DVQu?(5{kYMxnM4k=u(0YR{-Joi6oy3s2q{-@ zozy#)fH<(o!2}p493^lg?rqEkxyRgN-t|3IbdmP0VWs`*pEL{*%ggwi{&-;YaNkjS z-^~^~^U2jg2lfRFr6u~!|LQ?at>Z@T@j6nCbhT_PN2Wq?>CcM34g&)C_0XghM8ywW zITBmdPbw<5smSfzCXRJ2A*H2Xn0P&nt^O<-dn!%?z|YBwN)upcp`^Du%~;QwC~&TO z!`aE-fb*21^^WlC4>(Wsn1NHdF|*M#xglf!^nF&lv^ap@yLFe|ni}WD)Bk8;VZraW z?+HbOf?l2bEHIhjYg(p7UW+8-Wfp%oKR+>YwVF%$urN~UCZAjdI`3T!-daZ z!z}ng>G|Qc&XvkD=f%JE*Y4)USJVyZ&bc&a>V!n6?7gE=Cp7KbF*2~A4MMh3Gfp29 z9w}3u8S-*dmJ_ySsB#~rj_Bfh-xwmwLl6eY@)U!(eCx9u4JlP(`OQj=ebMLp8F8O9 zZWfNa1BZo!1dC}=L4J~SccEh){w&~=3hLa9csT3NeWbTq(*cLLQO zmMeUuba0!RE31zx_pnD!F!e)`l!Th2m@E)8pN9)#|-3%UYc5S z%3%j|kv);7Qw6dPT_+B9GitTZ67XMITtMJj68~Udi)nT0;UN?571s;z|8J>>KW**|#IJI1R zx!=p6I9W?0;fJ35zC2ozU@5pxOqaINWn_WK0X|Xp+N5~#G zm1)@4F{#z$Voz&3fBO`#s=t}n2CfYwOlyyhaGY<%7RNH9-icm_GCQNf@Z&;@7c-t( z$!5t_D|=9HJdN%{Jx^`~64`0_G6MY+khly+&}=Q;&pJNJdFi>Jf%%wZCLCfG^-$9- z9Nj$NY%~Y7cji#$!tc+lntV(k-60f3LIiWp7u0-u%Cs&_nU)__AZAurJyyJM@Uuw| zvy+>?1P&$UeI3CX6sd9KxU?F|p)M8sS21jJT)rC3qP>4xJGtNNj5fjZ_1pLBL5CuS z7eKb`gDGam?YBw#)E6NAVQ1D0vaB0WDkip`w}A zg8?awaUnyI7`A)<#d>SXZm~Wlah2Q0`tO6r&75{+WX{dwhKBwzFn39_X&I9{W5YYG zgHTJx`|uJ@@`y!>*OSH9rx!jxQg)dAv6_6l{7p!{Ci~b>+n}g?+a=<=I)mj%$B|jf z)Z4v&xM#Hwj+#ExAB|V|Xtn4SEJod}U?zYch59~xffX)enurn?qU7wOQ*1#tw)MHs z;+sc~p*8;eT4QE>@@AC46VBQ!A!eBr@>*4^NAK9Q<;Er z(~(*@g>+#v>wZ3kq#kD8Szz`XM-U2k3(Gj(mQ(w{;2zt3h_Effn%Z)2PoXv^z`xjC zIIeX?Yp4QoySm!ljnj|qm-}y3xQ$U`yeke%8veqd@6=l$St8aa_E1;u1%lYimG@q;N8{2xLAnZ#lry7K zdA2y#j+f{`ufN2h6_LdY9tPnGmJn^n=c5@Eh--dNbIqmM~C1B9qv>6^M_e!vZ6gRHd@xn7PHHT zNq6$c`v8e)l&v+CCK`)V)KIUR0)gJr%l4>de_w(BV#P0TtZ+|{GVu~DXh(fH41gzj{rV0HKUK?rM5co>R%Q3p!)I)y zI-Pe$sQ)$}kO|L(qU|^ZqFiM1q-gzD=+9pG`p@1A9x``jq5 zoOz{YpzShWN7vy=gbAf+7)^c6-OBoi`5??93Y>iz?8b$f+PJa$axE8&!eQo2$kPQugwS*Il*3t>Te^s_k(@wjZo+?(QVZpRY&VW zd_zyvN0Pn`O#n)AH8|zIt8Kibca(OCEDKuL6Lee43~PNkm2(swY*!MQh zSI#uOLph{=x|Zo8Zm&^A#>|=}n~YwI5mD#TXl;BBHjz;6uLRY@GZSRd*Y=!(=TJGf z{{3M(6j@ECOHba&beV4OPwuU%qrF53$?X+#)mxL`op{WV0D6d7`GpOy0Tu{U?lDo; z6ZLB@O8IxnC0M*F0~1wceT2YlSCMhuj?h?bCLIzNqu@Axd8iSIkt{+tzD@mUTk;o-hPUZ6Ih)duAkZ zXId{IB)X?wwx^!k!#^rD|8iv_c;8gt4|dHZ@00dQip+ z+qi$r>P4TE>cK5au@2d64YPv#7Vz{~f7iCyX*>kp5aoz<4P@uTwiZC&0mIf1^5 zz3=eErGM32DB zI(02sBSv}UjxM}+ZZ+iLx6qXlr&N=uz0+^UbP){SBB)-kF_wj>*nv5^d{G;7$k5BA z+7-B55wRB5=~q~`Lva4sE9Pplb-9P5CXNu=lC{_B}}lTKCTt zokZPCnL#Ag*-z%*@tM_VjzZ43Uk>4Dq+}X&`0G1$M9jI-s``rTq!^>i_<^8A4=}_2 zjv)HI&{UE$-L$ib`LVY9`D-=o8nu{mbPn=y5=m~8bwIrBt@my`KA$P>-M05;=iC6Y zT`j2FA#kB2C#s|r-_K}^2xw9KN=H8NwWjmXh za~!r?nmXU7(aD~rdLyyt{KmJBRebvrL+e`0W43Rjgy)2J&?`y2N8(v{p&JYtqKSe; z^ttJ&#(Uy8$!6t|UrLA3z1^dQadYVxc=M2t+p=fOG1poqrRg()ySi4>lt;B5mWgbc z_j-q#tbL>@eR@XZE#R{_fwbdET{ihQOftpeP8nV6KvO{G;j*%x?B zS=S>+HZ@KV*ZRwbbknK{VWvYjpS>NWH07)ST!*%Zg@R#$z+<-dnzqsS0cO`r5jCxG zcWA#3MG11lg%RD=z9^0RWajr(Lm{j&BNc&Vtrt3 z7+Ti3C_~VV3+=%^Z(m&Df$aS6+N0)dFt{@{)e~8uQ$%4QKh_YB8gW9z;PJNZpwgV2 zzogv0rRuq(C(>56&LDoII&$jeRT)b_Gf4UxP9Zl(S~M>jPYRa%vzmS)`l0Fb6&`XP{EeJ{)5(X3WU`h=<58)#TP5_f#2$x#Qfv;6>MBOE*$1SLwm|GzOID}|4$ zB^M^^Z0aUycVj0F!UiVuMcS(ch)WxFwI0O(Oupyo#ughFVty1ZKBs23W@d1oGfh*% zt~`}V!azz%h(S%2#?ZDP@Nfua#J@6Z!Y(o-sSYxzma_MN|E#Tn4dHT%ZeE+-50xC^ zm-nJ_t-Oi02=2S1bB_N)B#ew-LvLuaTlPpz6b;Ub^wD1z_w?(kNCO;hDbkDVDhUs% z?^7osowSf7YT$U)POLaq1o=>pf?F$V4yX;^V{fuUx$EU$ZpB>YRS8Y9=93&T@r?~B z-)~u_H*uGu_wekb5`a#R0e%p}*LC`3`ekjQ;q}Bf?#d9-I|BEvYw}hZweW-}$4@WrS-21Sn*p`sk2LWmr=FWw?cPxMb1+HG)Fqrr6eGd*N@qLT;)pxmY;q zd$Np*300g!*;vEy?J^o-YSjwBl6yJSW^S}^MFI_eA~v*gud+kN1%5fTyDuCbaSy8i zX$!JlO30%X_Y}1-A-7S+zD724;q=?FnQ!s0%>Z!$FL+N$E9(AHUjuV8D-q9*ud6d< zOV8oAOPBuE%oC!|#Z-NoCHPvT1Qa=X=eQup=0CX{r3NJ_b8%2b5&}sKG&;~zrd?P; z;G{wJ=eruV4>bCAzjiHxD}(>!;a`NHlC26to01il?!39tdDvE;0z8kEzghY?Wd~kZ zlTEmt;#XVrTILhmzu@4@s5mg}e224G^;=znB_caecNL_}8n`x(4j)2m-kxr$-70h= zRBQGaINgn%dXHE($gc`TnzBv5M&Ion2t)B64eSGzQskRTh=^-Jt_4*AYzwFu6=v-g z(S=DuU>-&P;hw%OGf6S6@L=S*2;FIHNMI^$ExFUXhx{NuthRe<@ql?f&}JQ^d4@7T zRAEMFn6Q2uz9F?Ca+7jGO_Y={we!a_KAO17A<9^vqYr;LdK!FlUFmy&KJpLLPvh^r zv0rdI+3Q~&KN2}lHF1bctx!wNnuOT~b2!VxfRZ^eb^muLF+3Un4=PmBS%jnlfBAkN zaxtSgl4k7NogHD~g8_^oLK|)iGiLpuA9^WEwdwHJ28%NW(l>vFXZ8)FteG=m|E_FT z_@gfwUfwuLFT{zt#{WBE-1``>h7fG^qJ~y0yly*|awgBlIehuz*h%yP)m-yRFo?~q zWioHJ{1tw0``?Opy5Z-;3lIjtGjlVu`tooeZhiJDaS5- zPiz?xW>l1hq-9$65Zkb?r4pM#I!%{#b_OuxjAVlau>J38e|U_eo*V#J!7}6 z)~n`6v0JDODbT1m6?@jF$KgmdY->yyZXxUdAMbRwU&}>J|2ki_ zTe;if*x-!;RrOP1tvt7~p|rW&OA@OhU1M2O~BJr~ZP9ti1_6VBt~ zgP$Co$#w~WZhX+T1`-}ZXNI+EN;eTcfvWcbxzQEXEL}YVN!;8HTcpo8`QJ|+bvl=%@6lF^3hDQ_x=io%V**HgtadiE?u-kHk2*6nOOF(Uo|{3Czq|Wb4&MxbCScE2ZuE8)+d+F zeA1Zc>&+V4%Lan|fT2$fMU`^>ZI~g(H#23g^i3aSxB`!|Z%a;qll+}zV>ML=!VzB% zzKO$1s;ssdG*L~<{y<<_kQecxn+CMswpr!!HVl5)I1dcCY{FqI3pInl)VScq&2PiWd!^wG9{cVgMXW5Y67ve!C3+3(OSt^N_-dtI`MdEqqsV~J*Q zs#0-d=2qgE_s)pyxIl1C6|96|IJEGE9HxwpX`)vlkDpq!I>dfZX6EvsWabWqH{=aU z&`3Ibnp0c4zH@$WNahUyixt60EX{4Humybuc`=sbbxL}D$DIKsQO%p6|EbZxU8 zl&_zjs!Cq}Lvv1Ae+Wx)?icm<6S}iNv#R(lH23mzNL68sg|OY0`s0q_f=VCpNf^fU z1FXApTaRdVW%u2=@XEhJ#$O-|OdQRFG#KVQ#UDnslSLlDG@3&J7> zwa|o`-6<<6x`iC zwb{^IE$qTyS-rpr@Fw-|zJ1w>lzNgsY{aYbF_p7~-9ir&8YJeAlA2^UQ*!2t7n3|H zLhJPUc#nhuGI!q*Xu8PV)|$2Yd(6?}(gG273**P<`bVe$my2YrlvmVuLSX0J7W1BA z`3LD}6-?2GCWwEieOkU5{Zt7Q*K(~s8?ixV)`HHcIA#&`F_@3{wwuZFTf z$q5abMkCk%4@=+T&-CK|e>y5%4(h1LwemShP9d55kjm+Tq#~D*l}p=*xec32MPg2& zXk#R|u(jCSH^Npjm$1!TR>sB{F^0|MxAT4c9*_MA@4a8o_w)LKI2_&0d9bvD5Z-%7 zVIZW+SApkM3rny(6WVk=o|csk>q7A!A}1$e0;-+JmJjQ-`*pN1o*1Y}XU!XV(bV=~ zX5cUiY~pc`lgD&WH)6jNd%-HxD~NJ7u}>mwtaQ=f)GVrc#Syo*4G`1%P%=8{&x2H8>`S7tV=>G8IZS3|-j?P*cAS zlVA*KCsWNQ29VseZ}JN*Tdl}uz)@hv61$~v#m2Be9Cm7C^|k_OA;=}xveQ+%mf`ww z=L6-{Zp1Bf@nb7dlf(tMRMGFEi%tc<^Mgxvb?>&KABIToFdH6m^MYgEnT0}40-Nf0 zzN0|OZn!FWtSHQC7QyH+*EF}9ur&T+S&CU+f=1Y55SLS9N4L*Ar)*+3wetSibdb+* zKqG+R7uZFUx2m{ep-WEWw^fe5Gxs&?=6aoNZ*a93q_r3yy9;?(X7D(>3%+POsKBg9 zcjCpOtDLoP17RFC!KINF)~w0V^Qd`7tMN_j(Vpsmd%QpJvL(aGmU{(d&cKS~SI~V# z>d3p*+gd|l1bysi{ID_D#F>$qja$KHp8m#4W$jfVCH$iAy$(t{b1SiskprVQ9I6>L z40rx$wD_~gN^&Jdg}o1iI+j*VIG1c2wZu8|+6vNpsO(XAWOu(_94GCzA(Fn|L_gBU z!O2EA+4JMJnx}_DDHK`AwVJpbR7JZ!Zw1Y1XF04MfKSHA_XbbI09d?s>e-tzhHeBSN@x^XnGU z2)^hr%QM?>VbtHL=d`?_XN`LgSm}^w9D*?pzXitkrr!b^O;=f zP?#3t&lLk{+*!XJfv1;^hecO5v{|pk{=-C%R>CrAlr2seRF2azw<Sv-|_nyi}e3S?Z6;s^EBa6 zl%>)FmSS#~(HlN@)&V0uxa1K&c|dn#=_cK6TZSfophWZ-#0gaX!TBA+*vWWP1igXy zNPh{$FgftbFUU6vB=uFJw)>aM9p8 ze_5*9>iVm{WX8%ZY*q@qpu3TmiJaVH7v|BW?%n0C!=Em3d8AWb81=)HRYe)*SW31- z<3Z^xEc&RN*9Wqw@_RKHwz1o4=HQ~Y<8q$I#(@?>!|hrYY)1{rZuv6U)kS(;b2vR? z^>CGFS{(g-xxti%)y#3!9F{^FhdhfKz7q{U5#a*AA$bhwCXqOBU~?bDlIbVg=Mme$XWuRfD+6K67* z3GM{Zz#GoM-1}sGt6`zxc#u|(LcD>*b<@B%u?{NE6Co(gJNwq`8PpFyRbGZqP<8E{ z{2Ve8=Ht1tjV)d`V&$lo73{-Ik^?fX`N+VeeBY#v95b)AZ~RCAw{F0JF>nvGK2!aO z>NI>t7Ng#V%@Z8jQWmI4aZ=5+{cQljB*gf&6MNAVG@N-g@NcPmDfg?NJbquU6Spy4 z+QZjp5ZFdE#9xP|98WQMbpZQ#8pZ;(s3>N{$M*%I%k^I4JRI!ow%qg2@D54kKx1ep zv{~`CCjFfsOF_opCIZNIOUK^47tuK5HP0+va6~EdB9~DDRZ(>w~KT(4RVnTS8THXMQ)`(oP@J68h8L+rfk^;t)kala*$(hqc>i zyNGq@C%h0H4#ce&*!H|$uiRXGLtUTyFRe*!(z=&%cI(}<=uAHEo_>5*zDGn+^-jtD z*`)PthO_JVU-zafN7ZR206OP;AkL|3P|rSJIIWiu=G|zNByTp}I0S_0wJR_m0l{eN zEnZelk?5|paK%1zE;Rq{W-|M)whzK-zw}MRE(K?f!aiY*OqQ2b=Hfm%>k&zR<#bQDfbl-6! zL@UMCByh**>%EClrmrb2p7bE>I~+jAS7C~sCBN6ZqrK(1jRzN4%A99p*Q=T`W`EA$ z!DTU)f$%i}yLc&Hjh_?!h*Dxd7>$_qx>*BBj4(?+oMhvxD0HiNM1CQ)e(4VDpEIZ$ zRnLCD7Nm_48FocMl`b!TU&!327MIs6k-uh7YzcS9(K{@rw471}!@7rfJEm|OLpbD0 zX`-~$Px4RVqJHAy1$rOga}I2Ya&~g-0ZZj56SuX7OME$>xFw_7{i*A>)e|GRYxCo- z(Lc5WlM2^$|GphhxEY?%xK-gnr}U^bc46d*tk*#FZPrzbFglwg*kv-#4A-)T{ix z7e#_K$Y>2FgN&5S?J>GAB>tFqN4Hhyoso58t^Io8N6E_ywf9wnaq5nA?BF(XuV>}% zf0N#lN@1tEUG2nubaatrLtsEvN*ub=T_cF5Dz+;$Q&-%|mvskm9wCPoA#E?;ZnJ)x zaDCW7NXP*)=xa_au~~VT<@7e~1#;c8<(ixabQ?3e$W3sM%M8V6<|0L@=8a>&YRbbl zU{_@6?r)PZVKTIz+pyC8DYdMbhZ!^epn8Z$4E^h&jX`N-Q*`EG-bwE3qN|vpvG-sU z;=1Z*=`rZ{e>b_Fn};pTAFRfO`gafca3Y(4%pbJt@k`K)h<)@VOY>*#FqCqxO3wE z)qHeVG=^JK1Z&nR*Ue+?x0>8-iki+LzCaS3?Ho-@SVXCFeu3!Fx9~zhPZcEc(^GT| zwBK^RKMv}XehHp%AfU^~BV3@4+|j@+W?_195;7qYt1G!8XGP7ANdpFEI(?>s!vr_W zl92n2_9AlE)Djoe{6N9q=k{Ln3y4@MEI`iwa)@0R(u+R@s}UC)fVG}0*tGKskC`q0 zBB&^i8a=WqKxL4&ai&OxJu8Z0(sBOhI*9p3DV7bLe`0y!F(p`EO7^{TT7UF8I>fGU zC$IHpld9B}Tj9ApZ4*}`vWjZv91>lLg3WMk`l$fTv>CgnmN3B|_3r?#(D|I10d|U+ z7Xkck^!Pb+>Q!q_b-w|Ox@eD7O5I};w;ddTJb|uuDiG=Xc1NWhmBKx+VYD?#O+e7v!(K|0ZuQDZ zYv~?D?=~ktpWhJ!YmWZ2+9L{ujq%LC5y3n7*N>A_noRHIn|PHG;e^ZDMSbEc6E zFD;@OWm4&%VgWju%%jC*oDUQX(x=;U>@ZU>|Xy0d0NeH6Z&ULVZJ1- zoUrD?qg|*hlyICAsj>VzBGeICG2>O1%*Y21`zt-hfotT@nfVI9dSit*1U+0FE~IWQ z6R0u_bq!-gHS7H5hI*%Bz4+;oD!2hvb8!4m0ZuARX@IL|5elTUXx?kX4DKV`3*(Sc1bB1mYC!3s|A>lxe9av`+*-v@rHRI}nGfv2>S znFXTVNPJ5PQ9u8R@QzPBe;V28m4#P%5Y|Rt=vMNU1th?C%Llx|HyAv-TOY!%y49vX zBB_Co*4#D}7tCnw6NXn!sYRk4kmkYQ=x9oP1*WlHru+1S!kcunb);WF3l|dnf@o&F&+PHhF83t$wqGgaV~0 z^%_OkCDR@QBjdn4T19h%W!Qr>J(B6%a)3?GqZ;2|t%=N{6cR&YzvQr%?>FgfjAg22 zA<$33#McNIw8w0zQN7Dj!1Stgt5=BUWtCDM+#6<>HU#?Ns_?m)dh&wLK4tA#3dDQ1 zM^Es(AO7%@+5y@Q(g5l zNBIXh>>+&FaBx=u1s!HmqAcS-W%Sgg8!U# zCx>mm@?_z5X800JlWcJfLvEcv=-;)*X63Wlw_WL=LKJ2zM0v^;tU6n!N@QSHLv0_8 z-eO&%w$=d{Dq3HuqMK0o>5^DlXgl`3{C-u4LuL@s1EzSN4fxCcTH;xM^j zG0b>uW{;JMG2R41aH+h~EZPIG?U`!fy*GPX3$^NFC1BNhlmv|W(8zpy*@uhmkc^qu zk@RiVTXG-P;%55)N#0{4ADctqv(DX`7*Q(w*1QtQoJlSY*TNA`-jgigEK3;eb^Sd+ zbCmfu&ao*=m;0tfAb5Ce)=#7?BX)x$8x@Uf5=_`HbzluJaR28Vt z=+gc+v&Aw$2&w0ILEOjJ(uUgwJ@q%Hs_XBmwmy5wI3>WDMA~bG3^%p!n|aLi_x_l> zfp-^`8o^+*dIJfc*E|i^f@8D?ykE$>FC)g!;=9=%7B0@qMLI0GPtDsKy=2H?GnIcz zb1ZAXT2sS2k^5<$diQ8>JGE(vpTE8y;loccL>hI<=i-?`TQ_=Yj7noWZ?!!! zp_@0-9N(`H7z8VhZzd|tfPJ;GTo7z?A@G!TZTeXP4<3px#E3^CX}SLH@#BlWla7W< zHuk*9qn|;Sb?G4rmQ#9?D=Uh#Ph-Ex2^(F>n*H`d-=B}(stl$ib>Y?GxkMk1?kW=X_`iti zjJkhiW6#EA!P5ShFeL{JC-f|TaP1nNO&biK6%;lIt(9wP8$MXCIp;-+e%>GRW{?Ys zF5_Ab@foyagpJ8e2MUvfrTuc>BaseVYz$Emx}eat&4V2|D-GzLx?!`V-^gR;u9gjR zoGHch^0H*wE%UxG=41St{uCtsp2yNl1ng%1CuHp-afpl9mmzO0Kdnv(Cpoa1T;;rB z<0SThPWTPI6WbjCvTXSMtQ@M9_PAL~F7PM50G~p- z$?>NkcTabh!>6NCVWQssNmd#dGJFT;p}dH0_61;vFAN`hU%wrH6_5wvt6Rc6=80HZ zm8SNBZ%j!1XV2ng=kTi^N_Xxk5uNuF6^fJsPD&lcH5+_J(Er&T+hW}t8%z+qi5L5c zjPwzs3t_Qi>v5{H>BP8pw!PeQHvA@p7fu$v;ad+qlyZ)CKhlH8xIc7>mtNpHVJ(u&@rWaD$tHygBGE89~ zH;3HJoe>i2(_~r9U#Yks{q?^^9ScCF)q;klfM-r%1H8h!d4OOj41_!oP|hmJ*{ktJ zGK&jF1#8;bHP#$9C8H$zgYjnpNI@_)fMQT=g_b@f-F&O^Q6%_NGdS_ZZeeFhQs(A% zNh%vatg>TX27n(+?&+ zm2FUn-v>H#r1~^P@i)y#Eto?1thI7`MWl~5u|n^VQ}9)p=G2<#H;L;ypxEvjt<4UU zx~OI`g~_meis%{~Nfnk=EETn6{z_@LxA8BbQ;8PG zX4`sYw~dd>oPwwzm+qqK*iejVzi z7I5f{Ba6%faWB)`bKJEsCI?_&Y^$tGv7oqD5cj`i7PTPh zu!2@KVECPKS4Z6z{(1&JYBwy3eU>}`%1Jtd{KyItXZN$Sd$dcNs@s|b@XR={l)1P?VRz$l$>fd;s zgNw#0Qq|UD^y;B|$rBySbq}#2|IhW4#;{ayc7#SXqpyemEV`>cY8ssWT}zc_MOoIT z>Ay)l_6Dhv7&WU#UF}f&nLIaSSm*TT%K3H}qeG+V_~8|wPx^Pl+Q0Qs*S}HM7d^~k z4+|45TlQXGISup(@Jrfi(it%6rnCuMXPtgIvg7+|kGIE_r^6rC86DG!yTDef#~s_* zdt4DLwESLL5&+tfM(CENg*8SsUFIEJ)*fDjM&qp`^GbY?*@oU=vJ%JHPjpgP>MI9i z8wG;T5E%GHh)o%&_jW0fWXj~P{C5xk^CdejmFz6lJYen&ZGQBf_F6N~5Bi41 zuO5D2NJB# z917V>HvG6Ylw4jdsy`Iz4gF{rt_5}V1)uGn?SbIcONr*>aKckdCPf4??@tEss$B#> zEm=;@D6QLJvky_lKNQ`m%QFOSP{6FbtQlk6Q(mDGnU6_<7?2jQU4S!ge!0NxOxMXy z-GzpaC^Q;DfTayNO$^vgyBw1QQG_tLf6{KM{_Q|$5z$4S5O#gFQf3@BZ{yCLvMB?*PP73zz#7Md+-Zec$=V+$XN#q|Se)yR;8R+}g-3Zn zU>SI&h zFBjTy2?_J?;FI9v_pjFEl9%dfP2E3)4HAux=si#h`s=I$DgmHgou3NS%Fe9-S7+oX zOxLk#a_SRRfM1TgAx{Tr4wr`KY%pW#Sh-o*vCB>n`F%gcJ1C=fl>r;pNK>JmtATXM zMIojhjX0_S>hMh8?O{^tD)2VZS(a_2?(^>B&I5CJ9>>VFMWhp=+NzD`ur!TaT_-lw z3OE!IX7Zum=@H*Uf5}^4_B-lJzFpBbm6U~q=i<*V`bFz(CRY!PHC;KwA?p9?;V)ia zaurGc=uESt&jclKRztis z&to#LS}~X1+p*o@6@?;6kh4f$aqUp|I<3buqe{fU^!)fwT#sgW7APUJ}c zSK6f+*r8bh3w=9g(fsoJEkNS%IhQi!ffu~~t#*UN9fA4GqNY^f#Divyij7R0d*YjO zy=W^}3Fm}rBpmJI4)vGGpOHAqzI)=y!0+(B8R9XlT0oB%!*UpJ8-QbkCSLCu>9xEX zm~cOr^|f+upl*&i6ihq2ne`n7?j!d|Lz400r-wZ-v`pH@iK?e$lk}N7!RV%q&?vo6 zqRqDSL#7PdoLTmDa^vPysSdmuGUCIqhvC*iqTw-U7XO++%k~2fyVMa5&mny3U^72O z_d9tnYgHw_OAjY}1S0Xhb4A~M@~FfM%~r7a-e-Ei5t#)O2QKDGmfiIw*_(<7okgGXBW7*{0#J@-(@tJ2>^l*9CgONb8 zKd`G_u|Py|u!ar1jJFO#KaVDnU?^#Ui<`&RIB5K?5&GclKHbOrzu5xfPfFZoOV^e5 z1az(G4eo~RNSS`&CckbE(8&Fp>^cwkDLvr(qR|}M4sea~1#M$HPW!|^&g@mq>L#s0 zW`g}XzBotW10JEOkPUshJE)c^|WT;XYT)8r>6 zIdSNO>9rkY@SWWBq7|(0-q+RU=Fz5sDG|f$merTI{2^*1T%5MW~5>9U| z?E$l=!_qD-<15BVekIOy25$sYyJ5ib=v6SQ%MEuljrzxA?qIc~J4n@d?f{WNM4jQ) zq(_dOk8{2AakeGixj0hWpMyH@ zPun5Iib39>y(yA(_mZ*AtaqW_6{^fJY0#E|w~O3=BQeBKmTzZ*UHSEEHwUPX7uvPl zxAv@dbFx4z&HmT2eRSuv!Ybs)&3>B!@xN(`;k)d*p8m4m+ngAoP+EM}p&QG>i<&ATC14C`Hmdrhnmxe7KqqSCl+RYpiJZTQc5=;WCG->** zi_83x?Jg#OkI0TqxktIa+K90h zM#0*gn_4W7N)@?|^B-o01Up}726t7g=*$$1T0*FUvEL2OL}_E7;Ogj%?+cw>hJ!sO z(`;3Y5`8~JdaDMFcYt?GE~PezOs7Wb0@ugv-c#|#eEq;-kT()0uVFhP3QVGZE9tUbj=674%$nL9_=bDqpKL8VJP&B zhxhr9QNUdgGlKcu7b>Qq_oQ8(@@Uj+X8)?xj6ds$EJ;C`29?WKXSnUeQz#yz;jIEb zq6s11zqxjBlh1h3g<;<9UpdaNGdJHpDk;7h4*vKxF!7bO*PHS5cuh>i`03is>TdVh zp)I@I`r|d0^FFG3FsDEkifo2CL_(MtTU;>dVYX zFT|V^hCANx2DSNLmF3I!EW8vRPj@%LS!Nq974ex3CXl8I_@^OKw;|$lc27AF5;tCY zYJ8;eP)tB2-%WoiJ}<(hu6rL)VW~A1L(K_N?bRjHP{#*Y_}^)-MI#Te(uh@|IZ;F0CH-8`N~JiP&cHWa$PB>ey&dS@BM}te&+OXGqD&MsXh! zgz!el(FY(aVjmde*HoW-`OB(NcMiH7~2ibmKfY3@z%?Y|wgLuRd9Ar13s$Hb#8j*b}UZuv* z(xdfdd{`RihDy6z$~TQjM(J7F>k9IP_#Ch*`1wM^&g}Fm9avC8y(S@_9Pv3;ZX3CR zkEskB^Dz#)-t6{RB#M27aHTGc<1HSX<(W@UHraY>NP+; z=BFTD{o-?cpw;qT|76KaJ;`oZVFS(T zXm;dkW(BKUkW>`)FlyQk{B>ZkI~r#7#v1XtrYdn+74lY2G|XFm2<Xi)XL^uV_|Wg<^wd|d5k4+nL#Y{MFPsW^T+t6kSN`|RN|`7uYKqu z-2P#VOCpCBm9b-DPTEMp6N5ckqpj_Pxq7ISIDVIc0}ArkE`*-s;O{bU$p;PWbI;qjeI81cmqNkdfLT?n@Gu6MuC zA_COZ4XC$@p>b%(Y4xvAlzow%rK76L5#V_oCmChLW05`1%h;yVXTC!}Yz|yW;-@*8)uh?UvIlAjH9TLPAkW zt5-Z%mZVlR(7N9{fjCe4XV_%ssIC+5`%1mm_~zG*Yq0p!DO(d>CiIZ?-C~WGG*e20 zp{_9Z`j+%Nd4834X{+kv>r?Y3VTowQnlnPo_j|SRd=q2t*E-6mGH-G2oc=~L%5V-$ zyCfbNl0MD&2flU>`AQXSMvc1ZPjgf0mzc`kS)uu#I&vEr{7cYQT>62}$19Aq5c|LG z*N(O=wN(rK^KcQNDh^OX`S@KI!<>FQl~JZBEIPFLewU^rfWe8yss|0v+>#@)0ABj@EWU-wh9R?Sf68FgQ)c<8cXO$H&V#NTlG9tY zNAkI^hxw3HNF%G6Wy4bA(SrXDxZ3=QIJ6Ipp=YJ{*TH8=59sdJx#aHWO`uGW;x4Q0 zcCe6@1jJbo!Jw~}r3EBhCQ{RFTi^a$nlp2AVT5zbk5empdpii`RlA_sNOm>Oryo|W z1XuUr&xoD^dHpJZO_IUE%>%k6RX02|@AB>OWzNVChRndxPWQm3OJLG76h4>t-xMs} zV9L-w)Q-1N>Bn%}Nc$@--l#UCi(P$M_OYY#hSLaNEPJX4Hs*nc%d)W5QH@#N~i zu8A`f)nTxzJW2c7bCIx=Q8`Ef;FAK7op<|vA8n+astIb&tT4&p#Yh59RhM`i7;tpZ_pE;OMBY`3fL z?G?|5$iKzTWd)gUKD35pP)$Nqi*Vs!Yc&FPXmdCC9`v;YB0oZT-C10HN!K-zbF4DJ1y|{ulG9umD z{JCo6z@%%}O9fp3#^XnFmF8Cu!g4puYV?LT90q(*Q8&f#TRRk$#cXf5RS*^8fg?;- zkMCl|>i&8x{`oc>w8fNfr*U(LzNMm(eu4N5@_t3alMLyGcgGq^()64KUpc%FLKBMz zdv1xKuGEahT;ir{hxq48QAAXJXTKTclL@O5%>1?AWs^2n2hUw8Exl$Mue4%6?sJzm z=*qn$^Eg&8T#BFm=fauxQC-NLsk*KrwN%K^)kPiF?C1J%l- zTSuy*Xm*pb+J6LVMmuKKgl~my^>JeU*4Z(SWsJ%~r&6=I?|M_YT+J)gOfsaF>w9!4 z?TzG(uRhL>~J5oK2(Z3nadm@34ji3}9qq2THmbE+Fl%_>?&fQ!t z2VwmL)5n=x-dRdH0#G8L0Ql>Syz;6$P^pkX%XU7Rc#FY+K#Y%{`x`ybn{FBxAU9d7 zChrodc6~+MwnGL)Q|w(t2ba5_tEZ3(Fvn{0zU4h+9r-*Wh%@v?etCUmbi1E8j~!s9 z_;IICBExaSeZ$)}@7sHdd!^!+$%MB!z3YLekq={So=kSw8ZG8xR#K!db(b=kB}!!; z<}&+)3zg|$m_9o54gCAMR`ab^t!&lR6U9<=`~m4efbGP%1wk{4EH~9^goxKBo4lwz z?~y%SlpA*RlzGHQ0zS^o1H&1eyp{7pph^_gEojQUr+2glWQRi-?6a&&KkMNbPql^1 zykPh%eSd-1U=Z1LflQQC#dNQoO@4=tTDBrp+4m^0FRC{_UdVSfE?p}yDO`T*6k;O+ zXaX}6)MTTaoc?4K;VHWB^i<08-klrieu?(nH7^|Rp{w9oj%H%J_}uB?DObt0QGnc# zF11D}N>ZVlQzhE$7~e)^4lBcg`OS^!nkFhd!^7vU+(U1MShsJ*>@6#lxr~Q6{y}>R z{C%K)5Pd+}kES$ugedtZUM|N+U3CGw$9&3k*Jk%1hEZnB-Q!)J_!U+FmR1cQ$j5N` z{ozk6$QxIC57D!fmPrfM;|*(Tg)S|4_)l>=6&d@y7eX;1lsSvffy+EfEn;T2@s13P zS|05#Z@3(CS{C4~yU02;t7q$4ns869`gPylFu28I<3$5e&~x}bWVkJ9CT@Tk{=O@m z^-b&@53@Ye9mUqty2B^R)1>v!p1aR6V`xJyrQbRBe)67Q%)3+316MFPD5DUC<(K8v zr{^6zpREC0;&^U6$?XwiW(|=MPP3do@L+DBHO7oP|IUcDjVo9$IWZ1ueOuSFhE!RN z3?=u0d6cKXEf+!Yi7lLdPtKIy+~Kt6R6GAkMD!mcMrV{uNimc?Kfvj`hzaPHuvF=A z6 zIE01jBOXVO9Vpx+*UC{#oMY9-fFAR~pE<~0>Vo0fzi&8rlw{Pkf8iUO9Jlod?Gk9S!&YL$4&d#DDkBVpf!SM- zJwID>G!3^yhm9($!2{#89M1Yzhn^iyGfo5McmUdA_+EumiK~oh-9dUqeqk1^qi?d) zDJnBpoK+hf^GUS&HSisbfDsmpo|8GoTv&Rifli$8hu37oQqSlSpNdW9i%nByWHJ1H z;$LbNth2Z#N8mFtBuupcm${fOJfjkk2;!F)U51 zs0%Idg|GsP!jGGFA7nEiH@W01Q4?V}z(U=;49T>Bxmvvman*Xz4T|X?cDBdrul(5U?RA^NeJ2@w5Mb4*JMx@_wEv;xxL3CS_ z)hSoanA*(pvw_Q;LsB7Gay(!JHtYS<#s$h_mSbbBfE`hi6QyQ-gn@2iNRZ84kS6Ek zz!}0yXXU{(q|?Syd5VZx90qRTEB1$i`8%R8D3sIQdLMIis#%w(Uz=0FZR;p^)yH%H zD;UlC`qkruo!eFjw`stye*9#2R}w|=t*FcMyT$P8d5qLpMeYqJ6wGH?``|2Bz8ae7 z_s^eXy{2#W!~JBa(Au6~2Qk_t*Nwnr7bNS=Ou8Dbsl{>K=-+il-`JI4p1|z>)hCG6 zbILy_j~QvN-H}mOUr<*UzrR#_Zxb}m{WYi3;^kFju@havV~5XtP+rp0J%{8Mii~z% zGcvk3N3Uj?ToLae%cPs@@-fP}O_29h4b=>#}V~A9?b&*~N ztOFdx_Ze;p@7F#jWhxX_;o#@2-st~;Kjn!%8$kMVi|R$=YdI^3BcNidkjen6)VZAo5#c^z#lToJVTb|hIwi5}_N2KJd<&_U z%IC=_;V|xZrb#h&$zved$2(n=B+VQl4&CywwZP@~FkZu%$?o}%7qA2<5nm=+vh1je zgzYEd4X)!1`b!~y2^$Z6S1%3UUSo)E1u$m>=ix0iwSXQ`mmYs6${Jj)xKyYe|Btbb z?EFghvPjEfvAI>@hP<)k3e4ulgmpud(ApvKRW3ZjD=A&7xwR+2FjKA_TCpQz>a|&P z)MTpVW_xK3^AgXeej&zn z2IBLpX~K(LBpOaK2uKpG!*UQ zC1@vx^jl7Z{fti}j`;TIt$Ab+A_|XmY z0U0A{3A7WHEDNYHT2#ku0V;nJ3-a4v_K>##0?R*pvR0kDbT@w``+-uW-}_{*!`JVq z1y>a#Uf#|yJEoa$IFD)3+HWsV0eN$8DHgyJ+xpg6`E`|gkeQLD7x?r#nEyR2?+|PH>JXOd-Du9Gjy`fQxbKU+dEr49I9qMm4B$JC$=Hm?7= zk_=eg5#T3uHyB<${wdw|U`Tvh)X0O`PTDGEvUL;qSHD#{S$J##q}Z#On5iRLeyflpD@kO9x}oYWy{gr<@+&Cf}}bf zraPYI&xgiK^P~rj19zwkZ0^$=_5zkxkw&h#WqBrzzEqK~K)WXsCg#DEi}sEqVJPod$&67bqj z-E6JH`lq8bsOm-Gv*u2+03UGJySy@%>o%UN->~{EQ(E@brM$6qjiY4EU~BdbrEdF%`k zyhle&%J(NeVe==Zk{ork>P#9h(n&oBI(*n zW%ELxbtsTthhLwyihc?Qu+rR3N+K3_M0U4%k&SNOD1v$J-_bRqE%W#fwkY1GGG~<3;DB#p4UO*m)%a0XIM$YcH$=@Ts zMh<`9OUU?y1a$QHf;EDK`HKV5oW9yX_=lqCUrkFRHA-?9)r>N$XzOA%A+%_LB#3X6 zB+QGO0yi~fmtgouPL!1)y)LTz;>0bTYDG=ECa1P)TU@1mbY)!tB89lmnDQ>)r|FLkdg3}= ze$dL@5?h&T2C6chq~CtqTDo-J;YN%=yc^?pZ?QeFtv+%ywdv2WPaW}3Zzp%v#o&sq z0Wv8`iLtR=)ckBe;V)jS^RYp@R%w^R?BQ>*-3v7!eg5i_&U=J& zWmsPr^B3d!l61*Bv_i3lu$8Bdkvs$F$b3n6P6gzvqFJHB5_^G?wkoUyR^L^27mX z64P4?;-J$B!mvL~TsE@GF*kbpETq{Cu2q^T_^h(Zj~s4II2JB9d~~_vLL4zB5(K3{ z-lN3)cOzG2F7||Q@AZiOTgj(P*lLSEGV9pJ=xh4$JAY`dWH9}GnVyL3Y1vs?4OmIA z*6{lH_(*sluN9gxz}k3MTy7UHScy`+PF1*SNO$|(n$^_4?^G{RBQ5# z$Gn0@FZfQj2MWR~+N2+k+TqNBMJX$cR3fMtRg*nrHyNQtMm$hXC5t`D7WyEfnVQ)$ zC&!=8mIM7&AC)M6%PluW4q_{^((I-Ye@p8`QhZ8G_Z#qWq55^S=_oqXjK^$ z2V@EU+12yrmntuXg4d4t9Dd)%;qMvj?_C(P?em#h<(MG<&B?R;@z|qipnhL+^MRQc zAIU#Ze>CnUTJwG4Q4B_(rLzl!y=+=?jQ=AzURB=3wc-E5HoVKC^zCuxtznM$i{%?y zMiN)z$?L<0GU?TPjvNZzo^{2KHPzo4laHA+WWvI-jAh?3_jxY&6*+M{oZs)<)Z0$O zF--FZ$K#NIkL!MWZ3Z4! zDO*g-nKZtG<}z_eQo3){{wLRY-_ppt3VRsIu^<}e3P=Ro591z@pv%}L*S?r;hdEjw zk&nVRYa`(FK%rdEV1;#2K)J zF`4x+FK5)i#_&f!4cYzd%%}^I>N|pg01-PHKC{!g>SWi5Pq{Y4`nQ5?zg!c1KX_r9K)f|XGTsoBw5D530N z3?_Wp4O^BQy6jlws5nABPR%zwNg~vqcyp#?llL;18gFbYA4kF9F z(lBi>=S&pep^0`7RuwPp=4hFZ9WZ`P(XuUdm&c)`%u>Y9(;&#`-6CEy{$T=WxH+^6 z-l;8K$G$fs|)mvME1e;vLvvW3`halgc+lxZNHVbUA5!e=rpo#Uc!9Yq< zsmhB#(i6;9T>r1ek189TN3BdIzfZWOM?3OnlNPM>Fn>N0baK)A-R8kFiN93>#8Tsu zoZ7Y8wL?7Uv3CDCt@1YArFR!OO}&$c)r}%Uth;pr=UM^U0b1yZ;JhxiyzgsakHZ8? zQ;jIvLrzloWiUyJW4FI-s{|KezEcE0%Qy7=mNyVxM3x`BY4ZzMh+zFcK=hwED0wI} z;5&xhl$$q;>#h5^7Lrs$bIy}3CWjw;f3`TEBCKz z1-T1cr}bh4ibJ!3{0GMQ>M^ zh7IU=se-euvB{g&z9p0eZMe1}`p&%7%@3F<$gD)u(Mp-*FrWbIX%>uV$=yak4nyl8 zA0S|@x+kVO|3TPGaK8VDnPKxh>?&OpZ+px&`09DzjAF7oKEkU%>r{7^5>kI^J|{dR z9(ID$1y3r7@08aN8e&aDwE0eRWui-I!)Sh2+?Pdfq(r!n2+U2NRc92N$fAJ1-|9QoXa&-;T*?U~ ztbSS8VWKlsvg8o-uwkj8^S-DYZsMc;B=Pn9kjv7SPw3xwfolJUNN33$e;(iR;QowywtQ=UMBn$I z5Z0r{maK1mOP-%CQBA`#hoaN`f#C7mNM~BN_EkErZf+N5kD!A(A$vF6BRg&D*RIY0 zXR>(dQcL8eaCANOiWQ~hL0*Hi(RGOFt@j9VAJ5pEQI?vJ<_lYtpGn= zg>7gKH9qd1!eqs<=ahI=OyffIL6N6?Jdr)5Wol5iw_X(hKmHdY4}GCrXQCn;z4az- zboEx$%ObB0pWl$r-o#_s)U9NfKoE{V(A|bvbDDriE}a<%Y*5^nBviJ)Y&i zzr1vtSa?m@E$rt2uNFqn+?C26lKA&_T=btm-n! zT=7R_O*=gGnRRQ?skG2UtXs%%#Z25RgJ_D;O5?j72a+mtg%hpq7w zezTJyNr!BAQbB<-H%l~ zp2Dk64uU7uUpF6*aV`vIL*LgWZ=3XW3*&G|Gfz;YW`qlnS=W~rkt#vR*j*t< zxLHRcrS`Zk%gW-*zs4%?PVuulU?{ESW`U=s_z&;D!g57Vmw08ZOEXCApC|5u!b{bb6)U{soCoi!kiq#q1OGG-h4?jGw*g zLpsmj7gwy@jloe{^zl69R%A=~CjKO^QRbx@H@ggL@HYofU*b=ub?*l%=x-O1x2u&aiw%=|a3h>Ty#j9(goVt=R4 zVikQv?81MQrj+grvsrH&K=aYp+Cw`3O}BPKa0s_6&_m_Hn*p6&LD)#f$z|B7{aJL1 zU;Q1Snlr@!55e)GXvB&2lEC=i+@NBLaD_>LY+7TjDd|h`93a=A7K0XNa^BT)9;D}Z z{2&9S;PKG{{3MbuyIzr@@c zF`2Ep%+(6}oFa+N?dq@zo#O=bDg)A zqhnrjOtEu=_0=leL3GM``QD%$Rd3IDjv^SY4Ye$c#|W1O8MQCpnq22Z=2QzRMzSXT z;sR_jfn2u8ue5HFdC$`fOQvEk+*cePy!m1f{fQFdajvpN`P8g%WZFg58nFdZP%&7% zabCehadi%acWYed9rLcMRfIchgKbc8YE60JC}faP6ZM+!Zqw0s)GuuZ%pk3tsaaXC z86UyF4L1deyNj&5Z#`n1nXI!H?dgsfzneGRe;Ll15%!0N=G?V|&f6GFa!e+5zLJEW zZ|lBSy0~Ro%x_JNY)Yw@h1xI^+Cwf8DO#B0KyF4kYl)N5&tm=Hpn0#{C}JX)bGe_#f#kq3g7- zL_G@R3jJvmIL~kA0%qd0+m3fqe+lp#^l7(*hc@EI*and(9bVjKt#@$IeCE`S3KIgk z^;oa`DSuSo7SuU#_mc3I-4DN=Jv4hp;z9m@VQ?a;930Ykcyvz&PGSI-6wTH@bLKKV zUX*##R_D#2t=9I-n>`!-75Nv=6jk4O;33Zl=%W~!jWW_L3Gv~K54)(J=FW95T;4mC zNyG;I%eFj8O2c?HD7bGc+xqGmptRl<+R(R8b9}=IOX~~HdV<420)^_nphX#&%5Btk&!9l~AM4qS>Sw{FJ#*sKpi?7DL({Jv1u#D0x+Y;yxWBTH5>A zsBG;}SVwqk!B}Q+_n}Nq$Oh8LzE%+J_TN@h=an7NKV3wT|Gw>8GZin)i~ z5S`YIy^c$=)j$h*6TxvOkq3TKIcN5Q{7PfHVl4;6zs(_yrY7 z&vxtKdvBpew<`k*oSgacXW@otxv^W&{>o{1R83pn)69CHOOe*79sesqFK%xeeb2FxoJeh&mM5lJOK^ct#bMUQ{7$sKSqk7*jm+(W+fk}OPik%| z_UtP*J|dr+vpi2YMt3P3_ z@6>vrqm|isR;S5Q>(tuxK~>=gRjot1m>`W-l8K|$NqjeLw&%6gT`j8gIUX`1ShEma z(AI(jIrgkgg_RZlGbfm1fquO z+^)bhTdhN$ubh=7b|?Vo>~w{HsopOp50(GPFY+>nx*24Uk z$PVoayeK6Cof-vOAm9eQ{(@_?n%)0?=MiUMzq8r5pQGM_km+6uGVbe2vc;_x>@R8R zIxAmH*)@^$xGT~-Pk_+ktorY2SxlB@(3q_~)DkicD*h6j-Ub9(b1x$Vwf9w8LlRO0U^0I3Xj^HJIU9zioGxKxlG5g9Wy z{n6%GSa1ai-?qO1`3v0^9vsWa?#L=DM$XlhbT7n8@SILd=C)KLfTBvf-MQAkWu?@I zvA9*ho;X(a9xHM+I}Mj8_V51OyuTy@BRo4wTQdO5oj==?bRI z3Z-5*2b!0-y|nQ(V;D4##a`blq_$~q&W1N*JzMQ=Rh`5g(0Y{xadYk7%>XJYrn z>xcD)8z-fNF`Hs&F_15*s**0sMP(U(ASTs}p9B~NL4nfd{UlMaJA3)gjB@>FhPb*H zU09}})pJ2FOdzezw^NSRF9pp+rU19f=Fw_PIfF&;3<(~!G|GoK${NnFBEF)OFF!4@ z$VZUS%5ePP?n>eVzsL;w?aMwV(MXVC4)0b7I&?SY^grcuVPEgmsWl7h=l*P~0UMaD zOvU5fJby$py2Qdw5zYK>Tb>iWq=rKsD(r4y)!!o%_k@K#8rtCX=x)D_Ga+YxdB4P2 zVuWX$g4(vBcQY)C=A~b5pSQtq69tot_whsI8zyL=WoH*uyGv5(vrBN{GD@eLcne(I}qjXt?w_v=&)tnUKL&y^gSj2iFEL;c1~SWhkbf?L5$J84lx;W^fr zZb+H%nY)6`9o=C%&Xy#X8KB*AxH&giBX)XIEDNpx1ZeHUoTguG$013ohchJ|Ek; zcSdbmEBaR}k@*w+hvg^Oecm^R^Fd82Y0cST7~eYUte6(FH-mtFLkV>o$||ZUFT-lZ zf7$O)^Kojsa?f~@&~@xJdz?T=-XHaxLeC7Sc?Mt^J_3Yow$gi8P2d-tG1aFzcDyJ? zV$%u(#1}}{M1&x#mh@-GYZ*CiUuYGrZ6pgZPo+-Uhy#Y(U7Ts=x6m|9Yih;4daJ5l zOBm%{1T?O4j3ZigMh$C{19Sb0R9R0>8E$}j^I_Aje(+%FQ8|Gn-)DNE1qDH!a@l1N<%dQ^GL)-(BS z!K(eyER9SJk`^r}M>9P$`M)E=M%(_kk_6+p80?wcxqXPS^F?blwvO1hxLw-()4|h2 zn}CqB%7c-88d{I!Wi4(G@mZ^<4y$%)NQ)-j2-~AJ3B9>FSLq5jln))3y~FyJYj|0S zBbzgDg~aIidaaJ+gLqnU+qAVxqkJk~9$B-UHi(SBBvXr%8LojsNOX?H{?=l$?LBG9 zI;$p4*Aft?DoY1|q-Z&A*2rWU>3_KMOvd@ZVVsX+7xRTN?7rVqPJx4{)stXEy$4Vz?z7raey| zo*o(Yn{#lp?S?yLQ)n@p?3T3_EbaerfVz1;|CCw51bXA&kVKl|*!1STBH7x7pPP@F zI7VM=ck|buq#P#2I*L#;^SNp0->)fH`Gfj>KmR-$ABfLNxvfHmvZuk2FedsR%5i9qJPh9~jXpp$3;L%T+X-Hi6E+5Mc^{a*tY|Z5 z&z{73te>?3V;Tjx4lWvqUQ7F*G6J}@4OJd34;9!g=C1%=@wd^>dhfiUO=yF_k*pZ; ztn3T{vp#kM_U~kU%&(ZQPrGy-{c%MWd!;w*x67hDQqQ~7dRz)*5kZ$IkXAd82?YUe zS&^5i+Xf?U&F3D8Tzz;&;+r#+cra34)OF1Mi{^&|h~5x|lkaMq0J6+fnS`QTGab2a zJEhY#CxG`6p!;ZFZkZ&6>;|9FJ-&EaWqnATk34o`8D{x!`l0vyffVb|4z0yDzqjrZ zJIyNe!)$Rf1AE?pu&ylmbt;5=d<;-m7a7{nUR2}T~$ ze;FTuC_R>rtVdsM?dkGF#!laU-+`_9oggYMW1Uh&lY;a)PT7jH@dTjvCUY@xpS?11 z+*vYl9}zD~!FJNEheU*MHmgb;od{x@^R-H7S`#<(%?3)u8r>jA{-FV;bx>sK2Bhb; zSVTz(;?``|jrf1>h?})fE(7|aQwtYA?9GvC!^laEgsy$XbOgFpjZoB~xF=d%6^`y4 zadhY^3X<6ksE2wv*d_52ro-8Ob4C8qQIjFp%MbKz`SscJ(NGaqe!5fjm%af7liijA z^^g4;13e-r>6E)0<65*4UE23JDBG4Y$;-D8$IX>C zOP>dBi$9K}LVBD7$#kN+q9M<%s6?AeZMc|iJ?^T~YIT9QIOyX0m+2^@a%AP60*+3; zqX~@-pLa)eJBx};9Ayj&rbU}frp$hTT1|O=251gBh#7QWr`XBb!_E!&sMe%6&Za2Cv)M+c_F)4gGd<1~s3HPqr)0)u`*8{fFsyop*Bi z`ZDaCXQO!N@~`XtnBB`-ziL0KvVFBD7lw8rre zS8meq`7l0rdOP@XR!ooZ)CuM`sIqdX@xgHb3L2K4?JyK(=nOY!I9j#%6LGu86aK{4 zukb%qAAHO}>sWnybiHfKtHe9D{l5<%(7KEL`Y`bh8!oQ#w-W(Otuxp_{`&o@6^m&< zF=iqLGrC)FShJ>Wh^K7Fk z7rNtmQQ1o1a1sgacG>tmlC%`DTRrNn$v_v1>jL%}kEw}}kM%!2$eLq3=#Zz&ep&j6 zQZOvNLLEux8$J-8za%uq^~LxiJ#4;I!>NhJ_MvxOre1ew!1^QJ&US2GJUo$0OyqFr zwFVme*vkZO45z&`7Ef=_o$as_hYnNlHjpeVlFOni@bQRJN*3387-0%-N))ei4tG}O z=88=>2Yy}69bVm|Nx#=N+Ipa1W_Iq42fTa6LRjr6^xG{Do93~<&t3i3t-d-eUU>P+ zI}=MQg)nq4Bd&ZXGe61XY@MIjkIUJUZ@^%uQ2b=pXy^HZQWa6uF(8GtGVwj-nqrmb zIxR_^irF5+&-IGqREBV)o#r8J>UeY*ve421eI;XCEoTIkT=53^v)F@X6^5&l<(X|q zJW=ha1t0lZ{~(qS>C9efR1?K%8ZS&FFC- z0Q8dokwuL}=mQDX)x?0RfuE@Bgp=WsN<+6L(?O}hJTR2pC@N~m2RnAnW+(%u)l>VT z2LGagZLX;(j7F>WRwoy@hf|3gsNuV;j&m-y0+ylV2!I`=FprdPnzk8sEZ3W|`?pJ_ z%WvL7&oP|6n0fdiecxwK+~O28UNQ0?8i==6ZpUvv>t6wyth-RD!;dojfhwSYbBxTg z62m`=U);{v6=ZakDDo$CHS*s&+mKoK!y;$@$nj3Sz`kK~d8JK{8Fx{0_79&y_c~-L zFu^iA{+3*$S+cNizM;@RWv=_CuPxB31!n&LpMY84hH|;l&(z8WGl%3)*#yH6tO%*q zHJf}WQo$t5?R$fC7vX$%XJJj34NH9n&6j_m-a`E8OY}<^D01)-NEOf4{{5-z05*7Q zfd1gt#cF(>*000b7+wFle7uUg?aKHhus`*kYVEPQ9KO|J(fi-bx3>M`;B}=b1zP6= zO(9l$bt~T-(8FF!WF=T3^#=oXt@^I7xnmw$yPGj&x@FF25ts5L{{)KG(DLxYtU0Q_lCw03Ebb5cn1{m4Y(@f_)LX zJ@hZWA$b?khl&v23eu4mUYE>PLQLXg%VggvK*Y}@{+O+jJ%@v(~i)p z%mVOjsbwU~h+2?!#98{4U+QE>M0ta(Xx*I0=QvaT(F$I8)_CMY5bhY~k~D!&UAn7T zLMiJS&P#E*l4?#D+1)y4GZfUQZeEo|=e@}z<0Fmt$T(-h2|1IBfL7|H$5XrA%YS*M zep2!7z^K~y`)Lb**lHfgRo%q=Jc?`BM}I%om~1<*j@^TUdp#!krQmmpZ?R#Hpyswv=mFqbEvz`k&*TtEYeM^*-2T@w!9$sM2#1 z;R)#x{*kX21WKabvfkYhKoA?057=ZQ)>n8G<0PVY3Z!oHtZik$D2|Z@3|oRn@#!!v zSszLH3@+7vG-m_urpXmA882u)jP9p!i4M7;7MG2XCK{(?Ul1`14zCp9J6oy(1d@Pmq+>T7U{0C78F}#;YrT5 zqR9r-(Z_NUymk6^`v&n@&bc>W^Z*scLww(;U^l=`J^5HrqZQUHCQSntaPj{=V1^DAftw?VjTGD^syyE0;<$ zKy11<$C}uy-7Qr`rqDt~d`Irm(#W~kl;TD!F$814cxb$;Lx95byg!iRmD@r1o9`r{ z2Vzsu0|&-$*{+ojmGtfJ4kt>Mj(f!Z4Ow`vw2}*$j{nP(6$gR;4vQOGK6GZp7qKk* zux{@71f`+n034Xtyv-y0QmaQfzyZl?`*eymAbf7tPzR8{tMZJqqwUX_Jk6dlZumMz z)Wd!gOZDZBoHNV>kB5b3|7 zhQ6EKcqZ_Wq3UGRoIK(BjM;sKTRf6JWy`_)QWNzwswlV++jmR(_UY-k zRh$FxrQ9S&xJY%_i!%Js?B3L#=#XB^A2k~o@5NInQi)uLgC^u$ zYslk8zu!?-B4U^9y?>Vqa$)ajC+R*(%c_BvOZ=xuk~Z>drO;m@2W#;)cH~OYao5)j zhg(cp2AmtEs_VyNjgunO=GBlm&%GRTljpI5k*jHTk{Sb?2`9?|0Bvu-0iwAA~F&gR7uRSbPmxHmtDXPIT0q!i4E&m zPPc|Qj3%Cmho~ge)ZqV1ufaG3@Y;r`1n#*Y03Vr6`+|dAgK7CYnX!QK1HXMgJ*$=W z!Ey1(q@dYW@DYbWewOzSkdRY~N1(Fv+9ge;>PfAIeTkP+m)=(`-P!0_xE%wx_I1+x z_svGSQ(3H9Yq^iU*!R|%5PQVt(2c9Mre6m$>jV~wVZlGLFb`a2Le5y~37HhcgOax4SAi|yX_ZZ4xZ zJ%DdvrQDl^wjGPpqdOsre+x) zBVZY?FNgJ5u&`po`b2LkN*?V}|Mqh2S#OtDseYDWctL$?5dlpxx*()#3 zbKa%^xezilHoQ>oINxFrK{~VGu$4cZ8TIhlBKKVqq?D1@Ua;JpEIZb`S=cV@$Rr4S z=&d2xU)Ntk2+RK?wNCs;=9pbmr7T_F2Vr%F-(-c4G^4WMmxjW|wV!*hodUI>{pppY z_DZ8v&wHu6WSqD%r$TJ!+RdaED@k+)V>mE+vp87WJN}(-c4JYLAgmr#R!qeho8OXt zD@S86K6t_1xmo<&1eVnX&XrX0-c+;AspkLO1rVzp z*%4Mh(Ve{%s?v%!M^`h4xIt&3BB8Gl(Z}9vcaOG|~NSZ^8`{^0#5i;6@s7nKI z%J0CROSC+CE-WWgVk(u}6$3o&lQMPCu3&%7je%cZP_Sl6AT_uV`}2N3PA=d<%}&(s zwFE3Wz56kH5Bq`%^FE!IlU#jmb(813QWD)OUj*OZ%Pq^a#P`v#@v#G$Ig0)+%}Us> zIiHX6OUg^FW&bFaA9N>1PKp!$<_ZFwgn^!#C1#*sb-#00`&PFjjY5;-ds%D!`v()m zU&ScWHT2Qcf&D{4>s^;U)ZUJo{j+*=w?C$m`1cUQuhHs6D#aH|(zY40aXcLopUh{P z^aTTqzWqLM&QWLp(p87?8crB_RR^?H3_JSba3j=Q+NIVBk_l6G?vjud9nAXbTh)?_ zp+qoZn7Kh@!H&Voma>jTcEN)AW=4QLAKF8rUCoug?u`*-DcU-uFO3DqGOa8l^7@=L zY;am7HHGdJ`kS>t(@X189$b!mS`%?PtWVbimk3={g)BatyV z*YEZfJ1a8Opg~P&W5Zao3#6o+$-mfHbP6kdkP|%}ax#0avS+mB$UIdd%#TnU8$i^x z0jrVC)~cr=(i9;l`bIu#Jw`Hsyq=2wvzO+?ZD*(v)LfOMT=9n}NytgWX=k^gAlXZW zEu~EP3atnM<&Sh&$u5y8YQUv3fpGh|+q*`kxI>%izMl0Dn%UTr`PNNst2NQ&nLRh= zthmbkSjF1Q!LoI8IlSSnoZm)@u#l@mmQ!yK=K!!28024|6SUNSB|5_pTcP`z3`EPw z6C=$shdi&cWR1&ax}coMg%nfiP#!uU$50vvB<&ZA>V5;;_9XD9(T@7V&O_CoxZd9@ z8@_5R<~05xU{~^=hS-Tt6I{x!#-4H9{T{?PnP){h$H}uCTqI9?NLtPJAas`4n@S^$ zH`#es+fM(6mQtd_H!=>Oz*Mx0-~hX-|}eBQOP8H+A=nG+Rw8 zsDa_ePk*@Tp{i}Pn$U(q`0qqHy||(xxA7nhC32WGw(rgM$(lblT2-pCcJEcLmQ^s@ zqEW_4*3%6aNT$xL@a-Mp)U_KTmky*(D-U3tu|9*f_l(=C-pvsw0sV zOIxT@wa^!XX&!n?Py@Uo{!2LbUG?C0esk`1+T8Y2UAIES+1Ty_amM>Y--;^_Srs8`9lTQH^1g@>xYN-78?`}vg!{HdXFxc6ZfK93?H>aC`m#(by43)R| z!?(rgHqOOA`n`7H$M@lU^!edaVfGBk@KCC`;o8pO;jGAA&KechbDzg2D~vikUofjE z&{GW7uRk(x*NM^pL~IrQ_(Q5NCt2L#?K4dbium^56*x%#z_T0ztvQOWB@Km}L(Nu= ztS%`bn*3yP*>{k5J!wZiabZU{tfBE?r_5sTWk85_`C4*N<3NJmlH~^G)|PdqYp4lo&mw1|yf+H6d)*>KTLl$myjzJKtLiey5)zce+W&S$ zJ(AyTrT>cfI04r9qnB z8w=--qUznuB3@;9Tpx4@DEBjmX~I=uSYv;*GDTP@zDhTmVesmgw*F`ETFsyL74~Q? zUyu;J{!$+ArGXJ4L8Apgt3l)PXOggJT*Ju*?bINY z{=r_y+W#dyfla<$AeRvR-M>8>M7nQPWVf#NhiF80a}8BhcRP2~m0Vt9iehBRKV;tL`Q(;#T>9Y+`YrLC6mfCdQmflODJhx9h#;)F?Or0`W9GfLpi?d`#IvdC5 zykF{l0QKf@(zgMo{paW0OCf<3Wjs6 z7i=IsJPVSg{MMGvRpPQybsaQ26rk1_^svs}J$(cO2wXnQ4K$iy~+ zL{KtPIeYhLdS|9}P397dQ0g97qLEpT&Qp_$3r;KdF}{s8INJQ4=V_L=Y=S>S@-<3K znhV2nXm8`iSvm8)cYQkfC${t#9if%jm?@8o+6RfXu;T(nM@kXI}b=jK6cUf^?T_c56E)kC0Qv%8{y@;-Y%>e9!@n=jn0V1Kga7Uj(P9$ z5ySlA)y6FZ9Shfd^V)NO3cm-9VmNLkTcLJY&8)n@%QU;Ue5eynF$wXz{^ur6=q2#d zf#hps#Awp&hg@Ku-!0KUDYhR7?}dKT$AQn^RclP0^ZCMPVxEzVksw2i**F7s9ln#I zJV=IrJJ%p3;iIJw+993-Un*#E$)_H3tV(yjabm)fJ`Dtg==0H&|Jc#*iFVvXzl_Fr zcD?5uVy23 zAs#G17L$nsHfE|84{#_uR1S+G#Ui&BS0)CGyN3Qyt>yO_XOElD#%_*KxShduUd~f& z2lC0+!0+M6^t5P@?n%J8V{1S54BDDUazy?j9;w6)v8mD9?cF2)LELz=78n%xyY?R! z-T92(RqX_(pJ0SNScWRp4QMEH)kL=sEb2r?H@z<1p#k4jTSYvDN8Hj=9@m=4iJ&5v zcMD6Ly3L@Z%bfmicKFyM;owN%=XKWyK>tq^0BP8{UlpX++OEwDdKi5KGc}cB&XH;d zhknt#`@Om5=+E}qCcvIcDB zkY9Q0IwEX9uzk7`Ba&K_@7|up8z!amHxoz>tb&v1BI zKnUz$pTLN=h(P8psN;aQAnLrEVKZgMy*9pwY~S8b^q&F7$?5TmL7>^HWftPaWzK}D zt$brr>}5B}Q3<4`e)pD1cC#7Z4W+K?*?4tDWvjn9Q~J!sX(+H{rX2?28k4k=@2DX` zmYqKMM{}A9%ol59wY5X~PidtGRO|Q9Q_t|Wn|3}OfV}_iaB}5tx>>1uu5fb?-NbP( zwObHEl2p;A=PG2MFu$6RJ=*E40&SvP;aTY%*+4=_rk;8 zS*l1YJs-K`(7^QTBdK3+cYVLl*&xiiBXX!!QNst~cusEQvgo+?YKiszijnaMZBfB! zZL`^|k8(w{(LA$XZ+(!W=427Et~bgY%RfH&PLi?Kd>6N#fNA}HbNV8@LvDb-DAOu3 zQ)-9AUgvJFe${@V)vndWR_NmEhVGKu1z=#P)c1D&VvOg|_`_N}HAL5cC!ngk%Qo`-tTY(=LkCsG(QsciYvYFvt9m@<> z|J;3DJfdz}81tPHCNvtpj0t#y%R;ArDpQxFm5!y_S^a#Kclq41!hL|xu6*MO_|mfa zW}nO*KMDU{xlzcQz0mcZ<~n_;XLiD~LBr2gYLlHaFSwZn?^^CZm;fiMw9JORi`~oL z7?Wp2X??Ks*Bb~t1>P%nG#$;@C$`0Xy$FkCd8@S|zH`tf#Zh)Zav(6(&~4}-S`A{f zRhiap@$qkdr}jK~<#@Uk2yQvJ6tIJ1PnnAWf&6VYR}wJUO5hqN#Mdr2MoZf|v__w3 z4Zl=_p&FkG?5L10>35lwpPaC(Bd-ehG$92MP)8{*=?a3bhv$H{xxiex-=4yQp0FQy zcO@M4*e{26f^@@c?ocnZ-W$Xl6K<`MuY$;nuMcQ}ODYGlRbo9q{@+)XAk0?hzorZT z+!15%y_HBHij)cYE^x32(s8IfKXZuo*sita&LeyZwnbL*kk;oBxcpL(wShT6lU{Wz z*{(P^yA6P47O}VU6+v09$K<&QY{(Q~N47g6>5Bm7$4Kj2wAGhJyes!Re;(s1^d-C= zYx@o8TREASY-*0^)9Uud$PU@CX!7+TZ+tR{YEg*d#vf-`U*mq7BKeO1jPcHlf`wsD zQ?Wsl{C=0_T=vH(d*4#IjMp5OXLufi=<&PWU@rnKGcEx028sres&MzOtKF_JUcJRv zFMA}<*!O!r?wD8o;BBq*Ykds^1xs27ipxHjNANqX_9^!)GrEa6XG=Mct(OPyG)Rw5 zwvAaY+TADWoj~gv26*@fb2B^~sC&KdqY>jN;cxjcvmJ7h-AO(KS2H!|Fk9Q+F*GcAomJP!@mLyp zLkvGI5VPy$6E8h6t-d_AIq?HII3bH2Br_kBS-(lcYEg@`4%k9m1jB}r{I|PW8D$}e z1gqTyl70S_mK-&uZ>smsp*Y)rRSH#4*~8h2kUKx}7<7zPC*o}EJDyN?uN2i^NR#DK zpDo=r>aH?q$$FaxC_@xW{OW5w+N>$5*COgHYu9Todpu5NW_XHxJ@)*3S&+uUF;_Qu z2leq#h*A#iCrL{@lDfiwG`?FZ-f=I;!vtUOwX18(2eR?mU}ZCfHal^1{_vVDuc_K1 z#oo0OsYCuy);M_2bLl9~%Bm$-!Hhh~8s8R)7H5f(d88g4LP(27U*Q7$ojtk(g*ehV z6$5VUCtvqn0}2b?Yfk~T^O<6*m>w) z|EXR{=p;^x1=L0bYE#!}}U^)cBbep!oxJ3Ohm@mCc?4Ua&~sNsnd z>N9~xMQlMXV&R&zMUB1TBLVMR=Ntum${zl>T&A}X;-J}lWgat)kF4k z{%teu7VMri^k9m9Z2VSZJU*Klr2- z?x6IK>+!7iB_|R0wu@$$rK@dIp2Z$aOQSaiTAtSnB>wJ6_qNgiTF&OUA%{7y9+kA2 z&%=;o^EzZ5v&sO8_Omus5(T`>hph5V&T8qbvTvueUN9SR{wMPJSKJY6R=2e}HTYYY?)hFC#b%v5;Lk^Z{u5-gDIoWAn0lwUqo1rTzxv~Vgk!p6DPd-Rz2zb_Ctk6F0Z$IQZ# zH3B$(>neF|IbOO}3G7P^qR<4elcHe^L56uT-z`0o5dJfXwRC2}! zkk<+}pbE~#a-*)&Ed`6yJFq(F;n&uQcyx}1n;AbUXeW0w5SVJK|s5zn9wmJ`8n_u{H+4+g)I_}`RZt(u_!}Z@L#xzWV0ORlr#8n9A zA=#0Cbfuv8KpAk5c!O2QYHzO9CRjZ*^Si7`hSNjOkdt|^BZzrX2uRmce*~&RS-S9c|#S~&K zz$vOlj%U1W7%=b3h?ra&evA%tTIK}D{HkXYorvk~tUG~p+yMsEOq&2=0Ez+=78=f$ zPu>ks)p25R?ZwI_754-nPm@V_B8+Ul*!^&sRPmajtLfY=^;%o{*{wNlSC zN1GSsf(FZUyYF>*Jg1?Bf7>52#7w_-<>K&HY@|mA*NN`xD~;xRNJ^3IEmdSlzay9S zy)ePZZd_BpH1UWc_OF411(IVxkgHE`Y^4&a%8-#FG^B57xn4dx&~yH zT=)H|EM2i5S;X_*;R4}zMyW&Sn*kYo?3OPz(=v8kuPyEl(dNZaqH!TB$G;CjevCon znB^LZpG+Dep=&n2Id|$b(#?G28OC(@<6Xi}yhmI8Z6I~+jD9h~7&`b)-p5;*+tHQBky0@z1xd52_Pp zTgc3ttd||`@Rmmx8mA#_dOjF@cBjOLP$K<{!M2agWu)8C@Djnn29XoGf!^65$9->jz(DP6 z5IV%4cZWycPp!rhiw~@LiBdoUn`cWIOh@;roS7!yPL^AzI!)6#?tVuWtT8=J5p^z) zlz|pjV`j7y7}r(IRp5fc-R}Te6g5FW#nE{cNhTMTaDT6@N%7`>%BET^=z2*FmMt#t zx~IzMY3SM)f7>aWFQO9U&EY0LH##ZmPs_%3UM-Nl5zEM(1wx2yb%xPDg1 z_+r~`cQFE|<1q7KM1US3!UwOV-T{{5k*5k*Nv)+moVb1PmsbqUS+BS;MNT;mtst9j zn!UD;^magL^sZ>hh6s)|33*=mZuKfb;XEHO!@Q+D=1h6D9XqNunXnMaI-k2Cb?FZ5 zK21IDxQ;`+Hi56jIT+jf|7d#uc&7LN|G#p|>4(&j$j?)qlcds4`TeVsoK7dJROHwE zNN8AE^J_LqrR2xyC8dl-2{CK2`Mv32B8ITdhGA@MW|(bkW}oMIe=pzvT`p#xkH_=z zxZiL0>ot*(!YXRr5|LrTw%$^v$+)6a#AE)DdJR_H`xlf|C@%zWZYBW8cO7`8(Cp+B zR69ar&7Y(2ejQRhpAIiLP--APLGDI_AW=Ts?fD0cvuEB}GXXU}Da&Sw>b$+ul$Z4?7` zIN3Za&iF4VHd44V6U0dN)mEIu1IW7Z_cdgT+oJqzP%h224@o)9q$#&_TZd~3-jOnF zl0_|IMmbjQUDP}c^r@i#-*TC`ly3N1`_eAhyPs_wq7x-SKlLR`Zh%r7ajafHJFz*7wp{Ica zePm$5W&ZOHI~Rq*LQtNq8RB?KDREItEdK>BF9vEkX?J~&_*;1L(0x%q;RP@B7_lLO zR-;kwyzm1wqKcTvg|yqdWT#M| zu7D0u2@yspsE(aeC*15b>7cN_YMfITt)^IIW$jOvg(b_}K6%z4Flfa328`te)W+}q zns0H#c6IYO|K?)LVq+-P;Ldjwn(Fse+h~2wVMVCmHY#5`T$2?^A~ps;U;HEvJ3HU? z>_1)IBSo%-!9W8^EGcK7@Dd%NbFKPV_Rbv-VrJsGzw+Lk;Kg)piLt3)+6aePy=+{| zp*=r{PP!3+%=YBi4;_3rM)(2BgTqE5wnw>qU8715`@tTpe_B@@__2zpv<41%g9Ybq z15WxXw1X+&Y_xBAg+z(vx?j-)-yJm{R7IlCu19Fk7&H=7L%awni#>ES!tA3cGVW6C z+ua>qLrM0Bj4gTN3Vy;by}9w^w(nQuHm7$+t~htl#0c>~J5=LaC;Sk4r4aSB*MaY+ zT1&vrdUM~${cYs#A_`St$|&_b#VY|m5^#UzUj{S8S&E@j$sTr9s z8MS0j2Iw7Z?TtHoz&@fkUS2fwB7l+6WAK7k;}mr(%cjt(k6J|<X&mkr>dnioBK61zsdXOcxnhUTCx%y0M%eGBy5|JMq%+ zhH2hnUl-@_I}_FN#8X<&AE=)U+c^5t-r3;VW_?i-ZhK!)2i4G2P;}fx0GRI@Moyoy zanI{0cJkJ=duQbrv;*o=l^-SIg-W~vo=XBL|dMj%}oMd0R zuOn&m=%KsUFT$ZNZ`PC0gG5}*-U@CYtzrb+uRhXoj-4~!nox#ML@YlKk=hZz`d#IW zm3I5y+0I^hreIZ}*k-py5Ao6?tQ%%S;APkOJWxCHBw1CuSh85SEsuZ13)LjslLxx( zC~8A)l@H)U>6=8gS@WZOAoJ*uW&Q`Zw|)~mh|>Q2FImv~KL$}U$DgC*;ZY7AjjHs- zEWov%y!d~KW6Q;U0{$#hL!l8vpK~%CG%wJULMu#Sjzz+kn+VC0G;sq~V=g^$!GKj( zsK0ChjNm-Af?fsMgr!NqctZQ>Ps+p8Lc6JJd}_w^n2~sJFkRecePh%d%P{yiPrd`- z-$pK)4N&!c$1*M00-yKArcnu3tI=J9xj80pFB&>iW@?d`P0U}}-f!$h7xh?r zg>VP00vd1!T9_WPVsjpq_()OE7vPZ9^~?;o$KHH>fQZPFJy*?Af_5x0i8;J?xIv0H zHj;=*I@6rMA|%MBOT|Sq{jWhGJ!qk{I6Z z;VOu*a4;Z+=4t=&G%6DjdN3{9bu)>hNg|hL z5q{ijpVDromE|uUGD}{(80N~cNG<~gf}GFz^2ZS&fY5nu4+mgqHFDHy?Tp3?ZuZHH z&zrg#X`YV%NWL0GEjyM;YX9i8pj9Alp0s~->12L{HDk~{itZj6d^HUUcrwCvn9h~8 zb3Wu*p3l5O$~z&AW(8GSDh^DYdk5V{?WZ~a?R(<3C|x!H_J&crA2Y|6zTal+|Miul zZ(M-`x}mO!P#GQoBl(0<-|W&s(rm(e`$2HFm!`?{*kUL5Nrm05^_IL%{)T-F+Zp2= zUgIVT&!N+p2Qvn*ZIjV288KW*@$^#6-AI-N_zk1%Kxw>L<6rfL*b~uf4yGboS;HOF zcmOwxCwaRC0Cy77$*enO0=omoUZq;sN_Rmv!ofA_pQ#S372+5{*A46-T4EK;Kmf?t zXN0Q0+g%v|X=Kjv0KF1Ty$t#2k=$FW@^WJxueP4&qpO&&KWhqM8O2^LbtfTFwtw)P zGc?oItT$U8-yMMd5hhMu*i`Ke&tbfF4l~pPpT)PBWJ76 zk8z1%I~=k`lD%CN^G>@}x-GolbPx)fzE}83Q3i-WedDV3tlS3^2yCJtU+Ydf=e0VT zP+sjTWzZ~YoI_~LNrcrbW*=kcF#VPc8(f*=qM(OqrT3A}GjOp#FC$gJ=|7SiDl^OQ zgz!ha6({LFQsKxg5?ha(7f1c{KxTG_;~h9UQ#E<&wY-V6F~8BLaOyA)X=q6k(dKu; z-^O)iz&PAdgI(_fT|!=Yl4srXnKKrl-`__YYDlS)k=D+zt1fuGIv?{!(7I7QLlHn(5>;E=CRcg(3Mur(cQM2bybxr%~VC$>mu zZNoKYo(<(Y#p_s`0#?zceHTNR*0FAa?Y>#8?;kBrKKa`?rsjG^4Wj+DMK}*hM`*#5sJoTA=Yq@GiXtn~yPr zLs{>Wml$g3%SU6YZAZ8p0cyX*jET*2{nKzW&{!alTb|U2%`GZ;x-2g-^adcgUM5Jju9E{e%+< zPOI$#>fgt*6EB3^p-jZ%H%cMT7moyv`g^j6wxR6TvP%Pvs@Pl{*OK8-hgT*%NR zBevj(z{AQP#O=|~kT*<@IVXo)Gk6{=y!yy0#?&<*rDb_^73a~W(s$8+vQirDbfC%a z9MjZ%Mpa=-bnVc7WzH-POK#VXv1{N2XDIR&m0Zb(J)3VzI%C4 zWriIkLI2D9tsKob*3<9T-4P3YxKHDwI_yh(fxXgG{c=`)6SS+t(W6A0d|( zQhDbUcAMc=9p)tI_(|v~l0J72RKqt^Hq<#-OSw=q_D9rQ;|-(SV*e=r>|n~`X_P2) z|1$FENpRHd9d5Vh6OOJFxhKwpL8Vn>qt)o?nZ$4yQbvfPY@%|`S-WI8H%`=RAq@c~ z7p9YMGx&|ba1ia=?j+wPx0xCKzT)cb2oKgi>!^yz!CEV|L0}LAn8)t|JaYEYJ430j z6yfi|>>-p^8}p9ykY+RKwid1)M2gQWLW%5e(;V(Fd;+P3m`Sh`s-)~>w&ctpH1#D* zSK$w1J-wfF))5;P(OS5VkbP-*5>U`ttw~@qK&G-G9vW*roBA2dE&4q< zSpI)#G8fe>n4%o+MaxQhw0jnR)o}*nji7Duo zY{PNebn?A|j(53FMmxt@#f}gKZ-;qCm&$S0kk;!3ZF9L{x;!&^vz=9mLJyMugOj{>tb~dQzrx?*xb=nYcaI1HU4a)RnJP+^{KAdViWAm z*Id=#2`|fm2{fuug-}G_Z<=HpGxNZNSM-U5)GYJKw=o##PU@AK{6Fe{*zB!24jrIE zwNj{#tNE>qBH%11>Cx9+y5C%)u(OV6dS=&F=LZw`hCv^{fg~fClU(=_Mgsj0?gs0& zt2N~~(LVf%SS#mpiKhn{J+`Iv#?=?8xwPVBW*#k)u*$KFD&lP`lL=8h#op zeYMWkuN?ngvH|Ueyi6S3gSU|Aq#CUs+CV@tsjeqc`rOBdV-hwBpS;pH+Si&D-}Vlt z<^HP)1$BCj=YGc$$Y&TL?*x%mlBTSK(UZ7x&?o-P$g_+7<1wtlTa!k+xdu9w?wn%* zs83h~Nh>pRkhhg3fCUUsUbpF3mX{s-*RR1@#GsQ-xc3^KB7y37w^cPxuc_?dQ>CJ- zstgV~Y8N~O*bS{Y&j=qxrKfE4;nXc6UVTbweQjNP9*@1zXml-k2s|#oNl~{qiC}F#j@1}u( zlAMf{c+9X=b!i()^wqvL(Ps3VAz(nffO#DyrLz?^qaO%Bi!oyWB)Nnv=jc2QL9=lk z@znbnX#Npm@_}}P+s43!^4BclJHYI4;ymJEl=uv@Ok(ng=KODAmlNiyQ`G$xgNl%u zM<7}9I<<`QACG@+>iOD#Aip2{>BC&6eVE|wYD+>e;H}(#MFulU*sox7)@5>+IVxWt zqWb>PW!R%^;-KGjm^jevm;!Hqy$F!UtW*P4Qm=JoH6oWPxV z_8(+_b!?ui;v+LYhEYO(d_xvSBas#TW1nl7ad$zC%0u6@CW^LA z|NEL?W5HFYcOf1>6BDAlmd#f#vIC6=)JMjw>9+8Zgs72KXTQ>ZXILT=AF^V z1In8iW@N^G`U$DmsjA>noG6{=hI#J|hHqFbSvNGM=tMZfY3l$vuP4K$oYNgM9rxJI zu$u2ayK+mAX;)%h>J1(rfx9dQJz}`xw+F+3JlRI#g(#c;k1+ye=10c|ip z!F&Jdmyq4~_Icq)%Xj%C66()cz!@(X?Lb7z2qmKiv+v!R+FvY}@u-DAfL?l&k*Yr% zy*v$8F7d_RN-WQclBym!7GSY9E*0~-!(NKumj{u5%N{cu&Qn3M+F)M({Ulc1tK01d0%}NEf>&De8bc(<*zx>>($Po@ffEaz?wr1QB$xvY z+qSC}KD~NJ?a}6k)4EOh4;)sF4#}_OvLX*qBSnIY%~YsgRt|uNeCHC$y=-_li3Lb6 z2V=7s{AYtO>N}_Y^C?jUfeHt4P9Q8g=I`5ohaZ#JMjQqB!gUqUhnbSboMU4HMyxAX z1_Aqgm`($9=b}b0Is_O`vWg_%oP&_7K7;0^@P%#E z|55Wpyk<(l(_2@tyn9x%o0vPeDywixr!jcambBRAgNY1t1}=F6fZD9DHdBxj&kt}mwWG!~W@bP&od>RioY^3Q1APxreSAMK^V z0W7*-ett3(u<==^C#oVJ+t$`k8aQFzl&+iQdHPh(G{U8x|e|)g1SkQm?qIXT#LMG{~Hz zKGKq4jn9cUe#6*OmTP&xJXf(go<#;_%r-oYs4P+bAXm~9;TF)2x=r-tFPb681k2^4 z<(wG!Cs;IsIjq+qeM~0^nffJ*kI419RC?4J?^c$u%IPi&MF#b%CXzNsPFzdohl*MZ zQqbK0{tZsgcGVW+&_C9w|Dyp6pspNC_nt1&yH6ZY`zEs0lrYKx-~8AGm6yH(ey7Eqs9zXlLkWhdyC zXCfTXZrpFYa88|=O6kult~yYfL}ScPS+oJ0Fe6R&65o*dUVJZqfFlgG5Zthw33!IN z|5><*dg2_WPqSK!NTv)*tRgH1zg4Siw)|=$!Gx~-cwu>P6;4`za!8y&U2tlP4-^SR zHm0bMcLz(0aaWs3HG>`dvQXnAohIIz5{#((%7Rxmph=JtqSrIiZT!aT(ao?o7 zI%b2htce1zny`G?uc+6GOiE(rpsOCy$XMlqtJj(vfMAMK&)2&2^imj$peN`i-ohdo zWQj{4_*S~t6yYjIpDB)4oQ$6K_xY|k$!{iwdn%XiSk7IPiZ3fmtu{yiH!xJ*Mm<*H zGBg!nUzKfDc&D!lE#17l)s_uRz*f!3Q&PdA=JX|LTyYDTd#|Bu4^~lbu@%>}JLJPpzJY z07iQPD5Lov*Vxe8fqo|1`Jc%L>1(st_1RiW1J#!paVfn4;c#f3wY!x={f(6Th2di4M?78PrfaeX6y^k9to^^n#2v;2TO_ip#+EB1(tr=Tck_GO)a z--f>tr+q4Jj%l;{8iDSo+8bN+Nz34svG$>m?5Lp~sJby|P*D2F2wGHJP*1}7Z3S5Sr z+qdw*_ujAj@)aV-5QG`zgM9xF`9od19`mW2qdH^wpTqXi?30(wl9zDPY5!s@+D7;- zTY0O$yyOhd>Ag>iXG&6oE9oCDLGSKtR<_4ue}DQ;?s|bA51FoP*X|(1`q1uGJ-5vO zLL@B$z{i+{SYnq|VjY9gjEdf^l95Ocg_pB9I4T`_pQZp0g7ZoEDe8cc_rXckxDycm zTqPD+W%VkGQNH4R9Z^LM+jeoBF-uM&r$OGK0zKu_wZguSNI$0^E5)=mU8z|{{c1Xy z1{!O=oIH>q@)#U5!nG%0U$6?-#y>Pl&nV57i`*89Lj7x$?cvZsm?%{OFpX={!?lN6 z%|9jx8P4}dFx1-3Tv$d)EYWH9Z3psmWisfMe9{wVT#=I#eUpP)Ov!6cU}d|kb5o&2g9jqdM6I=F0T2c{+%%GAqk z?eyv_tZqGJOq^w?eC8!FTR78jLrKdmC7@LQ_>N9pPJ|F%Z#F)~dq%A0$e!h>zrc-M zR!2_ow}!a1i~K^Gmp0DXmNrQN`Tue^dU4WlAo(J7;j;rDwHJuxm@*DnfR$n^LbTcLQg-RdSq7Hs{y`FZ$#$`P}MC)Dsp z$94@~wAJD7mnh+`$gT+tYOMFB-dU_XLq8Gt?a7av@);KPO|-$_9)5w8|>O$ zQjzre6;TVbCNs3)2MD#oGDGZEzf5LVIJ1Z;n)}nSVEmv=mq{n>H zkZ?z5G)b4?Pc>&?H_T3F5r>n+Zx=zWX? zZh6|k*x`Evl!wexsq>l92cz^@AMHHN7?Gl(lzJUc0qqrGI5K}9yw#>-_IJr#Lx->? zukq47YyG0;($grST~H-43ToP**XQ(rwJC&Go=cA@u?r^*jjev+YMY|BU@gzPtbJPO zI~V__@*|$6d1N{0>EL<);h3)-j-S_!*>@T%@q=hSu6{M4jLjHxjs>rlsC2sJJ*~{m zqZPLJI^1+vU*faQ*Uyr6O}~Bt{0Vw_M%U`GEs5kW*{m4s%GXz>NyBEA^=rp|3^1{W z&z1G3o+2uyk1gsh{f~n^{sE>MM?DXS@n^>TLw&7Qrfc_SXejo*2Az5}ITC!lOqFHv z4vUB5wWObHsz{$>+7eX%Q2)uwBoO|RAUHuGsr4e)kZ@sY~F)U=`jumv|WM7Gh!Om6tk@q{7O6j@{7~IpV7Y6t9!qPyxe? zy+-(eLfN^`^|MS%eEtcqEAn({N{`U$2fWR^XR-4(f;4zqRmy)o6V|Lq=d#fN zh8sb$sV7Jr#;h>(`#(|$*0<|tLs4;-b3-P%if=e{SFrmOEh1FS;rUr?f!F)r_ZQli$i zPpvnQAQLH0tM_DYTH&HT{Kk}Dnl>rZb0hrZArs+w+k>m>w?7QRutnlNqjdX8QBn*J zd?MSwJx>wqr_$nqrAHsFU~%h&H7ElqUbfJjwCVfSYZW*nlC zUna(iekUb{8w>3DZzJ-_GQ^e)_jA?VFjO z;j#LplQ&xYjL=TI4ki)GZF&E62ko0^1>Hwq{)m&T?9$oq44XH(>*b?EY=~`xp2I4> zwZHy6_;0|8upNPOCb6cO?`1cvBhg%-R7afuQ>}d2?lFg8@7Ks&9vx zkIg2zfiKQYXwh~J|>uA^RoiWS|<--o}YE14VX@*o%4wN=I z1b7fw4Eg=cPcA*UZ`6Q1xuT#--U%MP5U|)qQ@wkYo;a<`8+J;~EJ@OZpE@2n#!LPs zzI3N>NW9z>O;bFu_lfjaH-2u{zmI!fvaggZbs4%*gmvVs( zwdWYeq5y5?P~KxvL>IpRVpwSWPh}NygA*O7e)-H_QtC$OOvCNoUCYXbjrW(8tbV;= zkc=X@Wf=q*#rjMO9WfxL1uJ>(BY*%f#7yofNO;ywCmEab|AQKuaY5U)e z+1*9E88sf_CteEZ&!b+gJs?VcoH=A=f%i^kq{qXg>kVgii0!zYS+J40w_b)mB_Yay zRN8Bc<=K6H8yj*lFN?N1dK&<{!2>+If70-dYELDu2%HvY@~6L7}DS#9zXF zRnMg6zP&mWaP4k?J^iJ4>Qnerwvk|CC z`;641f;-g*MzOkft8vG^Ill&`>QkMCld3%Vea4ex&TW0PmCRDgV#`VmdbKm*VejL$ zrl$$PgRcmXbn6cKC877~mBQengRtpNnyrwFxo-&;ZVs8{BT#x#`Fi%&x80m7Vba{V zKDz!z36|+d^?alcMYcM5RZiUa9#v(95u^-p;u-U;Y1mG+YHD?1!fa{zbj5mwb~8#} zUi9}-PQ2X*$Dv;{2fUZ2#74OF%xbP#<#luM3O3T3);o10jB~BxJ??bKHM8aBS4M~J zYW~Me)kEx`YhG z`Oj&XepqFf4_**aW59mB^pyLMh?2ymhe$y{J%sN0_WeV0LUf*K5#>j{q40eTn(=G5 zr6S7INZd5JUilA0n1KhnfzQCfZZb;CuhBlsblnU?%Cw{96*>+rUnR z-A!*S_FpuK#yPqsaquc<$WIW}1IEv%_D0D+ykj#a()08RWWiCieruP1eQv^g?>;3M z^o{^eXvn1OXar4XP@c7Rm>Qoxlr*2csq&KD6?Hm>cOzi2*%?eUd{6i+bb8>p=y9yn zAlezqU%9@MU{Y0pk_zk@&Ifo=#~wz@%kC}R>?Ya?AWkU$%aVqwtw9A{G~7&b7op}5 z17DWrxpUYNx9GlK=6RHlKIO&5ockoSuT|eKXlWjm4$c4em{6}6`^=S|6gSqKM=?07 z=}ec^!nx_r8!?%aC}C4%Lxw>kkzaitBtVOCPS#cRjHL_9zJ2>Nd^mq4yj7YM zP8JBr{fL@eYOy+(87fS&$+81qHOdcbw=17NH0GXrZ=jQgT3I+5@BB4+WkF{qAM-8; zwK61Ie(-9@u*2Kr>MoNO>YZ-IU@XE-4cy~n#@&OT%Gy!aDH3X9`%fx{-2W~2)x`ok z{c4-PP`h`&PXZp4Jo&{dl;7I6JasoU4$Q`zo;pb)QW6(GyMIr~z0sXgCBN1YoJB2# z`2#EQf@OzmGI8NDl%2{pQb*ATN*miM6~+PdGPf5iLFH5M}~B`P$w`SWWd^!+APDmrN=t&JLwx29=sMo=p_5 zjLj=m6qVv`Z~sGCyDhbDt2L1Kp*vO1|Fn+VI=u2TQLzSLha$2v5jkg@$Fu`-j2jOn z;leru%a3{X(^1EGt6Kzp)-qk`Fcq(-OqjB@bo6 zks(%N<=Q=Ge4PTJ-;ERsWsvzXzGoWcWf}go}|utfOw|(VozPUTd-TE-C!mj zAH(Z28a%Ad2*(gl6@N+ZKG&x8lf=aRPvmuzg?;mwN#S{4=x*wK$5!E$5lhKKm1oiw zaK>0pWiLskvqJj)<0iT{$OOgCdAis~+)L*bHfR=We?b=cD_hoh^XqmDd!vE4q^>K* zGjYG{H%XBF{os<)=0#7GUkK*IsgIHsvB}eVrh^=h!aug9Fm~CG+1k};u}+QasCsO45cLs~8|P_KL`?_8cO{?l%N(}_JQXo?at?nr!cU*i-bcgNZ#~^Mu@>AJEN}H)oK4 zdaiX8-)qqPOa2RC3-_jBr53zqXggfGS?oX;E9MNp>yPS%1oi4sb>;l?(CXx0PSmb? zob|6t1v$?*ni@nqmQg@{2d^5o#6hDS`MP~x8Ksz{E`iX37B_$BZWr7qdypY}6l8V9sGf9}dmHje@tmIo&RBGE_NoKufoe5z=Kpt}CZ>;C_%hS$6<)>s-i(E6Z z#p)pldkYREvq)wthf^F2yO;rNUHfeFDB_zZ`li|o8Q48wg`P%E7GUtWQ}r1#RZ!1D;0bLms8grP3IHO8UH{?d`96Iu?~PJAOt9r zZ=SN8^B%NIuGUyaIBz7fjGbaL~fcO6*_;3Vc4(syI*t9Re}Rz5Pb1n3_$u86n0HTPBz`0-V>>BwjI zvvJRwdbAyqT^*u0De+x8nWILc*2YDTnE|6rPZe;ldF|UQ*e%{Z>|>A$WraPD4S*rc z3?!{-kQ}9%uc>pArgM{rcB}Jp4SY`HmF%{}X;-!S@`*xies0foUm=4kEw5;yG1P~C zIL9=&$m0IqzT({cb)--Iq`vU3G5Bnh)2?AJ+fy;jr47$c@JfYEJ9%GBeDH8}N;rog z|N6r=cc9Qqb1iwiaPg*hw?w$aCo9RiHqyVb7u>qfrrqd(U_1FP=!XMG>wL`%y*3@G%|ESW9IXh zl0!s21F;gyb95=OEG{}K+FNMRXohZ+hy6h6FB&|sI#9J*@k6P+5MAfa^cHr?Kjc)s zXT%Tdf8$kJhOkAzWF#~1Vt3r9+Q>p`-4$%UiYKna8&6vR$I(j`#9SFAov;T__(I_L zb69;GKbsdh^OmXfX!Qq45;3t&86@7ye}Jg(D9~IU_coMs4^777r&(JG$n{S>3hyum zpq@94|9CIj)lrg|CGp$AJ2}sbtITtcT}$`O(Bb7|iQ-IRj}BpzUh071F8@YozX;&7 z9>4>*hW-P+zl1xLuA2E}gU0s7nGU-0jl4+KLO5ADBixmuSnyfQz~R*NkP*x`3j^QS zq;$qA{vFmX$$G!w#$ITQs+LHx2sD{IwbyYdCSPgNttqA^byUSnBZYLBYSgminpb{q z^Aj87ueJEi5bfq{mL3=jL2^B?&~G3I0{|XJJc&8JbHCi3*Oe}0hx*wkslJKt{-Kj-0xlHnsB%K z(;qA(f2gh^C850*F9vq3la301H^K4u3$09#A>aA)y8<|Ib?tVe0AGlhkohtTd*U`^ zyI@cFT>b-RL$R*n`Yq+pi(a>&{T%4b$xjGihxU5RA5a1p)}OVVOrO*|9Wg0faMJ#+ zc;4Xrz|a?kuqliz44zXMBY&MK{4<0|Q4YpPr^`v9+|-8LcE`#NbUVVUL2ubu*>3vp z*B2VPX@5p#Y{iwYerOo*^9^tMq8<+@V{4N(7)DCVA<&3cydBalMT%QkN-kW)<8gwXP2etC~_yFKG=^4`pHZw;Vi;13ff zo^=35#P+<8ElnWM@$Y)mBct6CIhe?B!`go_@}IBXc|W-Kj2Wwyg+wKqo)tyu@?xW? z+~F%A=O2I~jo~VF*&{8yM}#1W>Tm08`H##2 zMYyo>K&f3j@RK6^rmC1(mW4oA9n$j3N>9F#9zb{Rj_KM=jfK7FDal-^9Lt-@vtV6o zBSt3`nqoMP9O9v%$R-8D1I71sjry)g%9RrF>%U!;U+|Ilh|h)8qf2Z94BMb=xqzOc zbPTLj{ntme*aP%^$4vXvO7p^PTPvQ(Jr27Z&$j$;;7Jbg#M)%&(Jllp?Y=$CCy9dwa&!}*M*eYg+R$h z^jU0gZ~Z0aRL|r5Cc4?; zyUPn8Q@GJfTib;2NuaUufn~6LVK)CrqVV!3n@_@5rowbtB0Xj^PEPh|LBTI+o7ZEvDfCj^#7g*QL1 zFR&pk`dVUmZfyEEaO!LdM&E*NVsCa3NmDY_>2adJguVvP*8{L|Q~s5$PBYFgJ$JfA z+k>LHwY>%jWW_r1hxb)APyJ~Z|H9N%H9nW6LF%i|DX?!dDoKzhUQg7jh}%K^qXXDn zs5(9Mrx*@PJ6S_8u`z;ZPG6%b(0lWHL5$0Th$_Y?VsK0UN8wz9C`1F89jN*eE`KDU zmi3Af=e+MAf0;};&$XJ>wzyw4C?`<`8LqxHAo_o8Iva{13;z^)rA|)~z;E6tgix|B zMjbI!8*h|U*CN5cJ}2jE)8ka&2D2I~zIm?>i}KKx>LQxZAtqec#!QlZo|6Kw3i4zP zDc85j3z1^YDwylHQdcD9PM@OKOCjwn5={_0zeQs6g1+j}jlauI#cdo!!O&~bNDkBD z-jc%=2VYqaJn*sHRE+~(RPQ;>rB=Mzx8A9%p`r~1_d>WwOa08ErIjv;bkXZ#wF+=J ztJ`5&4LpT6MLZ#h=s(6>7}mmam$#o5S@1v~*S?{fA1YRww2HReBSep1yhI*fOLbXE zg`m~)WcBN0wOFmPSsew)SP-;Wjuu-|mkFz_E^Doj_15GSZOU4|sjA;Hd95RP?K{xc z#jY;_GhktyN6u#*o%tHFy?!U_`(vEeHue&4?iTlSJp-Ub?e;HOBC8PfE(L23Lcn&J zzDd^x>5b5ZO*4%uuT$vhCz8rEWq3QkdtT^uN3k#w7K0uFF333viQ)f>_OHxq=uH%{ zK=;m~*sR)}h`x1;Xi$p{m@-wYKA2arYR&h$L+Lkq%)}K<`cxnvCdeLZ?9+5lKKMTn zWP|mVWA#p_>&`FpqUIms$g*i`>n$qY$O_9+AjQSoj*q*WdLW)d^p&B9g||4e)3<5) z|FFq3VVoQ070|!w6AA+gW=%I{Zhu!DIC6&s^OJ+nv6JU?A?hVtTG?X$MAPlD0fEo@ z@rN~94OBIr@PxvNL*S7}aLjgMCoKh0i=KPhC_e>I@1?o-KJ6Yn*yDdD*%u}$^CcDL z`%8JJ->P--k(DLVmJ78_Icj4c*HDOFGv$Ss<4^}i!d~~;#esSeUdg;#RF`A19>^sp z0*dg0I15^ z?>qT;J`!QJkv(6r`UZ{#69jObsCMRN;~#IK{DeVHc-aXc&L&9e4V6hJQ29=kE-UEu zd3*hXJP1}A=ZE4`(lRw2_6q%jdbWi`U`=$OQgqElC*ntzeK*^acs0B2d4lc9=^dM>Aj3SeBJQET-Mjl^EW@iXw=63I%?g- zT2GZ7Aqcz@ybM!|D5^^!(O4^%B5|qx|<~seJ`n!mkfe6t~s?_seC|<`B%%@8&KuVm-ptP4mICmnHZ^4KGu9*eWdbF~%&2cUe4%yJ#0 z{-Iu&@G64&jkjikqDmZ{emkR7L>ZZoiR?V0({%L>QPKlf)OT}Q=M4vr{=3+o_f5ql zU*)|44ihm8JMQKmRB21PKB5tP*LLckHt^tLsm(4$cLL`Dqg6JWx~;!9R+f?w^@;|B zS$v{qyetF6IAc5GPi}_Vd)991?VL|m;nh+YPOV8DljP>_{5G3t)XMq_yq_O<(LdB{ctLV#Nun%>&2W|`^x(svD%+++6|{B${W_Ho*OuxEEqeMWxMu4vj!%!?{;T=6CPUDWJYSJ$R zUspv$ecBG3%W;w^u!r!4XSD5X6X&}kE-8J#(9A~V#pLg(SZsz!phSi&Fn|KK)bg zDMb)o?Qq|izF9CDcF#KmwRSc`a+rVFxeY!#)2`SRe3%{?`Ri*4`p17yl}++0GFdD} z>8O*iP^$KbHg_X#)BH*6&k{GouTK&^67AY=Mq3Lay!Imew^wp#$Dj}o`^oDRMt>5G z9ZOr!Dk6yR59Cu3>%X05WBOL{#p1?wo5nbxp z&@iln_fugg(RKWOa|*~Rwuc4WFETe$t6(UAj#i0g%R2i}u{(WQfeaSySFZNSy*bK7;c$_+#lMaVc3Qnh?$2HEJg$Cv zUvh(XzwM+YO7_(y?K|x87qjKn>CGY<2D0 ze-SlhDZa!ts|^SCvVe8vzDnT`U6NLE7gBCp)TZszK5tqqGq!BAeFg`Q1mov#Np!ty ze<-5o)*PJ0KZs2}1C4gr$(mStuc1-e8O~guYj4n>%`&4u>`pDF?6FH^rg)-oZl>+p z;&6+ZBv-nozjTnPfdlQnsivOK^Sx18fP6eiO?cG2xX`&@$CzkG0UC!WAsbbOax=UK zgfX@9gyi7b@zPUOqyl&5_BK!@xIgV}c#%w44Y#lvBc$M2qs->;5kV)_cX6aio8i&Xa<|y^uru9NI=i8^qESJm=!1>Bd}lq5|G_J)Ntf?2vTWla zbm|{zck*3ax9v$;4A?p&X;b`69-KJo7E~F{wV_jyX_*~$S3T@L6V6loei8rvlLKnV z>B204J@9Cl<{{6rb5MK?MPxikh587TzcmB;hUSN5?D`=?*JzcFzfvBYLHz@d@I5F& z?S0sL0t?aQ0?6!<=e(l=dzhBlZY60Ywh*+6bDdGPAO5%gIRW~Ps7)G5A=QXHQyD%+ zP~VMg9cWxmLEIYTIgVRFOd4`mdO3rwGgFoo^WJq;V_ZyuQoJ8gtZMBG1sXhJ47hear%IoDy{aUk`D3YYd*S9H+0v2P#g{-$-4+Zl z&3gcz-U3%D627R9xHuHfkrP$Bm`$v5{L3sxv>QwB{v6cJK{Zq`7yU(2Rd0Xp2Iau$ z_iY4GvSmIrMvFIT*UficxARB;JnB+<(MZ4_tudEeTV}Gx%$#yp ztjwA=Ev?+eWg0a^G{lW9v$ArlY0+{)D?>*SHE|a-70VQNP+Uk+Q4tXlP!@Tg-}ilw zu_b?j~r0<2&nRw>uB5+ zwl@8K0^4C`aaez+&Mr@Fqh{%$MdlW6NS=!N)FhCGTK(Q}?njcgX~K$^UiB&=QN1L` zxJccdvtJa&_r)KU{L6bnwSdrgTwu5kNl_f)r+fvzGLb^aM-b?OR2#) zYkog!Ego%>1}?qs0{V8@c!;NeW@C?J+wvC>k!K>cJxyRt`TTR>x;`h44XZWVFONH0&_7b}wX@fAbJoem!iD*jk#w3Hr~_DN1`Un}3nNQ|RT z*>@(R^7M+6nGQb!eY`W`eM>;SNECbS5;+Z=b(+zzcNEoqRcZ3GCdhP^l9_g#z`rz= zBCtF;WqYR?xz~}e>eHUp_925Pp$E~jx0~A@jesZ*=m>9zFN8W6%cwTpj+4wckDGoo zM55oD`LtgD3D}Z~2t{_6`I^&h-A_WYdMdsS%PL588rj@+MNLmKTVvUME|;ttVc#1A zw#!G)?0}|n$mjVUya)hZQmbq@djH)QfJEMTy+%R>5@O``1j4vCuhru|nq+C78UKdR zE)F>xo@aE{mz9h*ySO&SfyvV-0v^$8`JJZiQXv1Pq#Ch~f^~0~Jv7Cj%GzOWD;~$@ z+;@R@O6^r7Zs732LqUcuWnUW=9s%5t=+)vkJ%#c=h5zS*vvS}@^1WZlLR_TupYSdb zye!bs%j!JNVKyan(dNhjWsH*CDp`90wwcUZAF4IRl7 zA!LC2ASc|#B09HBGpZ3lbCBM;PXIUg*Ak^@b+Xmhep8WuR+8+1~capt4 znBcm0(X>1HHT~yi?a960hMA<>zM15-M6+ZY%A7Oa`V!RgAXxOMfq{c%8=KY76ZD0wV*$T_ieLM1r`NblBJhZj5_1ZdX-CkL5ZE ziRE{gB$G7K*dh#6qyHcSPR89Ty4`hi1lfwzK2Au?8c)(=;v#AB_gi1}cpUVHA0*U4 zE}|S3F^i3CH@oTA?lvPwmOE#U{KxYvPX_6yn zI;coZ+&Tfmc4(jTRk(}=Q93J7zvHuHM}N@iImY8@?k5X%GLXAn#D9$lR$S2cJ8$}l zQsT+~62tR$5|4XJE*bE8lSd1lLU`%6g3pLsgTj6Y04c`9)y zmmeR&!9~fVZ_xi7R0RI_cx~3ZwB&G_I>;y0$y9z;C&UQLe)X2Q&k?zhAm4M7c1060 z9i*;+`g)7E)kj1vqIZ=RkPer!MCKrZ@R{^Eh<5x3jhMFXldNc(HLgPcIzMcCj}dR( zJ^pvye0$xvh9XbyDqEXuC4N^5=YgR^e4ySm>QtU!_>lY^N^x^6g7R`z5u`$Os#}$8 zpRP|A@6h+8)b&4HMT8RzR-fm-2u&JXQ{q!q#V{#Vm1nIJ+3aTjTh%saoHW*V89^L} z$rhd!`w@3llzvpLo{cnUw|%@pz1S8ff}}sT5f@>rA324or@Ka*o^^p#f*|w0cZ<;@ zh^(4ASB&vQ1(eLBtRxZk#OzK5lD;l3)vh`B^G_E3U*SEr@Gre=959`Zt4PibWAlbexql}| zcl#nKI%iSa5?tqw@SG$!e0~A5S4ZlBa)5t$gGYweC#LILY$wi*#y(1@H`9bCA^!Nl zyFcKhz%?s#(H8z43(em9=TLR+wG|a<>Z?{0*FT|y352hT#8t0C>tutfGU7@ZpC0?K z-t;L~;cX(eBhAaF?{oEp`;z9Vere&wBPqhXtDtQjRac zE-#N7q{{R@K4sjl@CSEjN>l>7PN$eTuP?t*4e1;+PC`DEBkO|&qSf9VVUp2~gOgj?#CM~#B zTwqaVngxOMa&FU%ZPv*tq}Nm)ydcWe##^6K%5lEIlZnQhh*}4j1U2UI?4vWg< z-ty4A0p?l7b^i(k!9Gwv5p3cbRZWiNlF*kh+wir1dgpnKL`iD1O!&V=g$&!Hq_do+SIGLqUSn*t1B(ylwc>o@!gqY z_ynJ9T-1SAUox5@b~>$BFHt&cV_jvOvF~po-wK|qyi|s4uE#eG>liOf^4%L@2~XWG zb(02wcLk#_t&`5or`l z)|a>AHA>EI ztD7kQU+J&KNZwKd;#ko<^Mo!TO;pM`e@2&T+{W#Fpks@m6a2P~5*Nu;U}el&`%lq; z5+Qmm0B`Yxctd_*u^vl6TStxRNq#c^n>o%W(@ltgaf`AI`vxKdGCxF6%`{T6q1;Nx zpJ*f}qz80;$(DpXG84q%Viq%D!^;yq?fa=P8!g(e7@JOYu)s^LP9U;yb;z-kckLLb z(zRa3LgMZ^U4y%;iq0}pH$nK)2BXL337kaxHc3ifEbB=3?{-hdvyELgC|c8j>hgj> z$v#h|-AYrr(OQEQK5C{lS!ouj)E)*Tn0K*;r6fVxcdKH}@c56j0f}o=LR_<;plt2p z`Q5|oJI{m^lkc-{H}=QNQ7X6YFcPkcT-O&GDi**m#T6vO;wIsC29^8ETx~k4g@f&+ zCA%{h5d@u{;aSd$mPuZ8sA;Ohi=U7a?7@lFF+eMEylW2PNgo8Sq{L|cOtKa45*V*F zug`+PvoUGgxg!?2(-%3<6u$veX6m*9(Ryee6YV?R^Yb{Zf$P=a)AfqXeKMYOrA5s^ zHp!(iE{DnSo+iellh>qg=fohV&v-fDE z&9mdXq%^20)6%fW$6*esQ8&L!Q2dh1L3WXQn!i&-<5Sqjgn^ZyGLyN0Kn+}27h!j`n$MCIzs*zD7kTkoMs(Q z-?&oDqkX?lsVho@R1p27InU-Chp74?$3ZXHHI~-M73X6{w^rKc_!~?7jTJmripL66 zkZmSZulFiq@@G-Fx51Pyp&^*qAvQ^g(iYiKg00(|Dnthtvqg6XA^3@?sBmbiz-n7` zS&(mV68Bc;WtR0%$ekSgOuaM^Z`p-t0&m6b^vp1~yW=4vx?zK(Vf$w-`3*Y3VYEu| z?5clchEED~rtLcRgN3I%1fu+<&O38VPVyOL4*B0pS_3smU-6z-z3tpHOTND+27_>g zW8aOfOhkXnSSnntkGt;5(DagZ7i`3U&q7N0I}|Q4_~9Gq_Bx}xY~3&Df{18)ilRhK zPA|fW-=IGLQ1Vz-qgEO2t=WcDZ41)}w2y7^>&IuzPKKrRkzkfMMUA z&5O%{2Hh&t`DDz|jsrUkvN{^uHU)j;G-Wge@=-?7u6v``daE-sf`h&FvLptHWnTNB z0caSA*UHQlALzQfYcYxYH?|QI)aX$;MvweeZifkiPKZ<>_tE?{vYreuQnrI-+E^NP z9$3i^OeRvDVwD9`Dtf5DPSRunzUEr@`wtnHe<92{VU2!Pk>Ax|gV5jtKOTdnTZrx@ zgWMF`;_5_^I0Yh-Mgd(e8UP= z;OReHcHNkEC8MLhCI6GtV~r1E%Qj<%_0%^D<8$}X{*u?#QKiSN zYhq=lNICNFk{3Hg=oj1P3SPX2d=Ji%?eoS<1^`=JMfJFyDD8Fw^%Bc`j(Cf)_E28@40LHB_@Lun-)@^ZLBxAuMA$L*MOlKX9kaod~y{8 zmC}|v(!AVbYm8a5miOr8X*xEU>NAg$87Gc&+nZR3I(4F)n1Uj*?6|K; zikG^YB7QkpN>X=)FuA^t*7KVjr)L4})-GJWbJ%-Vk;dv+1M1y(n+Ik)*HO2e!*qe!PLyiOOyn`yx zJx9GTxVfVEnO0WK9mg+HJ1mEfvXe#5vgJtt1F1rj5&vrdGzC6=mn`OKBgRh`fqiUd zGMW9bRD2z=Jc`^Yk@D*WemBi{S9$xFG#<%R&oQ`(sI}!U>nL;Sq{riA9oWB^ipTk* zs=hv=D%Yv(+(y|8`}SeavyE5O_kzk>Jhx_h40h-ndxO!obc*@hY4G@W@`@T^vkN)x zS&sO>s6qJfl{waN$tPc0n#x6X5TTxBbS`lMnVO5SIk9-7Lom$bs{f ztO@8b{6i#3KxEjtDvMoaA=ocN)an?KavzYYxWTfQHI6j}mPumKurvN}dMsk}JaMZ| zjbN10XTJ*)OtT<<3yYX(`(Eaz$N1o%<8eoF5{Pmc)l*FH_B0-RJJZZn1nM3y>M2v{ zJ%s0)*gbIvphKdDsQ$;6hK&&jj{uEk}F0R%h(YLK}gfbE`8#+cUVJC8FXjLPRv z@63{{-!v#<>7)pN7P$bj#n@t|bhNCQdI$S3iw4`Z8c$&-nUU?Mo&E$~8mV>N>XOEY zX>#uPo!W^UpEc-i&@r~kY1*kAc$Q?>wNJ{oXWw7alMaWasD&2e;J;hQoR0+qsL`!~ zex-b%=SrPILfu?YD%)*~z9agXX0#EHO%B{(f^yAB$p&vsI?9u=g6v~?ihA&@_05LD z_*{lz>8OolN3TV-CBNUEc#3SZ=#J~z!dxH~&W@WzIm}gzi0pUFv1=1}@72AtInjLA zK35-JAt}!j89esM(ouyA=cknzZYGWcY++>N2SGQ%zM{gluJoMEq%Wk5cUg7FE@af= zAf#m6Lp*;$k@{sShqu$Bc>oiv>Zft$2|yJh=ES{!D@+WcK>{Ib$P=V}-xucvAbO?YI$2>|~FUFXTBk z(ILN&xh^F9^~L4B^hu}cepJ+V?PS#4EH=N#b29%)J~2Aa%vlsNMrRG*TFc)hsIk^u zEZ$Kx(s~%J_M}<2mqZA-w0qXmnETOk;nP3#1u`-}Kf^&4%yb{?1R`)#-#KrSna@Sf z*(4uZ*h%k4ien3OmnJw334Ulv`<~uzO^@_RPT*}eh|fJueU>(wkmHlB$Mtap$ilh& ziBL{s^-$Qyq9jrn2G}PswTXX(9=J^S#ByP!&br--tzg}Ju(g*i0XUE{v@z|@90iW`pcUeVY)Em;~ zj;>t-RMT4NPjVmC`f1%e;eq_u(t``(;Ab(wsgJPL+e~Ma+5JOWPhoz)u5N5_rUr;$ z0#>g;8PZILVk>*|3Im85NX@E}3<7t8WF-!ZVBG(e19b%!2MT5p92*8M7(Z?~3`73w zk+TRx&w(a9jXK`w(HurzQ+);Na1EBve|D4a!2~}vn`iOcMdt-~nSpY9TbKi(h3VU`WAAiNSxd^eMp0g zT`k4V*))c__a!uJaLG?r?S^)?HS_D)5q#_}!*tH$d6Y{91o_2BFyYpF;8HfAWm+n` zajd^N9?k#f!K=}NJ!uRSZr*AXy8KUy8mjzIW1#dRSFdz!nd`LI4(2C9n(%91d=$I~ zTfbgSENz0xA2?vjF6$yk>QjgGNfl)xlNzgV)PJKEA7C4?p{Bef^VF*)wH;&XRS))T zq}DmEoqeuewC0%mKikP@ve$z&$*+WXlK_`810&EO)HiCf3#R2VE`G`rZ$76-0fYV+ zeAY9eQPow$_jK$iO~f?|ovcBg(dqJ~my*{uU3&&+VMQO<`QJASaq?H#l^_3eZjItX z*gv1`fg4sm<0hjP{#Y`)zXi<@UtsK}`i>vZv~(5DjgpfDsU!4_^WpR@O9z6>T#0?% z*gmaEX(9s^<>#+WonCA@d%ZbFOtZm!07-KrX`}|@vwP^<>BlGVR@F3W7}~DdVMoB# zTK*oZMmbMCIuN3e10+ zx#zF7%ZS4CY`qxYg{#+=e0b<4E2Dhw#GlI7DpgHUDT!*}yHMR&j-6_Hci~@*V`=ji zkEDGJ20Dry<0@M9Vm3Jp{X&CX3$nlmc=!-4Ouy!E;c30zspn9N{gYmJN&-5(r1c5o zVS+p@aZiqXm1HI@iY=?q)njVQdta#_y~$@+DOPI?r4+1Op~%gYKWgCbZBgYzc|tv8 zX?h%9-bh<>zeiDwQWQMb`NKIO))Y@w&{^LbEXg}63?r=)kH9V%C^in}fr~zTyqlNh zt1Wq@<>S2?aAGyUl&(_xOntKrPBDO$x?Aj;ff|0$9?M1+D{fT zQHQ#Z8%RENM?Xni2yY895P3YPwm3DR>tge$E;kk}<=2V+$P-e>$_@h%=@S1IMYuJlSqtq$iX0Ia3_3t5f@(#=erxRWGO9yp*C2qus)koAhs)ALu*Fx_zl+t&Ch*2-ls%@Ct#)SW^H z)2RLTP7L*_Qp@_x(F+$=4_Q`jG&A=`FK#6Wsb(UF3UMWd&umhu$eY5#A|yBHL`J#| z2P*QTESUHvW9ai}Rp$SH&`t9BVdXP%Z67PH0Co+{{$R>nbXp!FaOHL}-F%fysaORY zsWy6L#GBPV_S75(6rt|zyX3%L;!B55b~hoS8!MPrRt(%*hiD_4X~7{a%5mWKvVP;g z4a22*;;kM8`$c3B=tFLkV9XDVGRlOi#quScMU7NBdk@UrE zy7f+(M|P zfpr;M0+Os2y@j0Eqp}i@Lp|;uh5Qg1FBPjn-*ss9rN8er`RUss##zr;mXZ2HcxfE+ zcKBe?9-$kh5H5!L0M-aXIvqr&M?FV>goKq*!&vg}J*yCYWBpxr-v^&~Rrn#RiL~2v zPOhj{i+hd_`HzhE7HtkU`6>TibEc<%jsBSSp4$-RKl5fb)aQMPc-4TfNS&|+S6KQu zff>wxCM=JB_Nw25JyVUA#NM*_8Lf|&D{oMPi|`yzx(mzN@3blZW7iN+y%9$bR9U*r zenX8k1V3tY!^)&gZOCoDenKH6VXI9!{vt?+eQj3zqmrwXQZ`nQ6bX_=GuvKGcV)r% zY?R^A_nOtLOV-cj8*N*0g3?)}2WZKrP`@Lhe@D4V0T2p&)lb_pRngpUhO)UDA8`h6 zLB=ByqHd|6n5FRFUAhrav z`@rva=@8S0XA{MNT!fl~$Tnlbv+NaylUN}Mo44N>H(@^{)ExjEa6yK4?BZa5An<=R zn0|4*+F9naXuNvpq~f{k;R9|_dXva&SgI+R(xko;#pdbHdK&@L+!k6OKsM#WAG#>2 z9}p}jG}05-#!oY;X3{EBhI++WKS_>0U`vZ<6oWZ~i3&o7tckcM(vJW{IOXLYs?_^= zo>kIY7aC>}Jq*D6qv zqt115?r(<=v-~py9J*d!((?wr0!WWE+Z^oLISgh0-Ro3@L1gFVxxPbX2RqMa-j{0r4VI?SU~l8xOT%=n#WxyOM)PuN zz@mIMR(@srj!~(p{W?o3J-9T!L=dN4XJOBr?kPxB|GakG9&-i9`t+&iTq^RjdG`>= zJoMS6l2fy-7Ha+|oyWbL7tbPf+{>NfG{jeLs}&C&nae4mRIeRo+Qp{HytVi@M}PyHD;l&4>ndkgqxGU%0;zPhp!;o zNxhXZk!E)lxC<`GrHS*FhSONt<7;{qBm z%Yh|c^q#d<2t)GEDSw&fDa&9G{J&AWHP0JgiF0oN9IIxn2qS9{VgmR^m1x$fO6J@Q3KZZPrJK0j>H|!!gCU+H`8|cMU>KDU3~+ zbH#ZN8{@8SkMlc==7hlz4-kJ$G0&lcZB)f!IPo>TQ!M5gqHP%ZXPjtx+NUX|%Vf%T zYn6M4#iZ@>#9xZDEO-)*y*5#two&#jYuNTu*F*+0uKQWCL&&e*J->JLU8<6h3o<5j z%IhA01kbt;JcYjkKU^s^bFA%o_pE2K{0Lb`d+rF`m5cT@z+nX=`#DDBX&xu4D{vrT zUl_P*{(VFM!#hIIEILSnuxx>evUm0mtGwAxYCZ4BV71Usa=)KztT(Xk-stADoNzxk z!H9=|0GUQyJ13=2-Eohh8)y?cz+Bv&Wp$@xX0_aJ-QUuMrIR=|E7^=n*gkq5-L^(T zZfT&F6Db75L!i_CBE(YfSDcgg8(VKE& z>}lJ(0F1MgdTINyYWjHNQ-})Zfo;`Gar^rhg>cuEo#9=IPIAn?j2QMkgxo!kEwWO4bYdJAAR|RUR^6-Bb;(EFTU6P&^lx#y1(%O;gI(# zloaK69;mYxY7=BLkaLH&g`5WMowoXYE$Fq`Up60ClHf~v0j{h&4i$D!#NAB+tw3#( zA}_WS4ZngA>wz6P%n0y^Vkm;^50Ldr6k-V8WzM9xc1g7yXpU%9R9582|8YaPFbJcN z#RjaRrX1A!UH1lbKS_26fD@Tmb;9PS3`T~~xWQ-=DHnwKbxx5H{D|;IUbcJG(iyYH zr7WWQ7z(D-il{Q<>D9~~A*o8{FR&-^e=#b|EqgTD!b*XCNKDh5Zw8tjfJ7QTw5U=G z%Oe#7%Ojx}{4A@dw#rzq1ETzRCgY51ki%0MKc^>VMB)rIi0MyqthNv9;=b&8Xw+jO zNG-^H0hAg1krVvw&}v${!};CPwMcq_GmK{-8`1cB;CauubcV}f zpBkw;?f2G@tZWM;kMa<~Y+g zi=0MQrY_S12% z#H|`e38PyuR$hZcMiJG(pP=dz=z-)=WAxJZC6m1!o_cUen3rF$>D;rBuI%xtys^J; zUg8=;t{Pcq0Y_S+=%`cdQ`B>5P6tJS5Q5aZ#91ZJ<&C=2CAbx+^dHk3ccej?XJnxEI9-3f1Z}SUy+LZWa#px*dlLH`)jHm1yct|3DDMxz9)>)3un zA8VFYcnd~Z%nEta;{&#mHiSGq6T#nscDX;bzowctE+1kn8F_2EP9* zPB%+fI{gkmCH!U{L%*oTCK{ku+##F;HK5?yli|Kr!kpq4=_Q=xp|u+?%r3}U6Xd7# zLe8_DBv;LeLTIM+c(2Zseq35#T}-?6+Nc@LlnFIS)eKEt&|YPh?MZknicURKW-D`R zc-2&i{JVs3=7|N#l5<7TZv7mvE4rhK4Xh&!N3u+owpKkcrT`|CLq;Lbko#u{JcT{vlOjp8aS;`d>f1%=563ru7Bp%XN{*t7anN%dQsi}#4{r8#Ht`k_ z%eKw{zFa@ObL?gu=e2;GJxGXpEIm-;c8{TzcRx79@Ue)mpTpF&nSaWVPP{SJRcb(L* zTM!F`0i#oFE9dn;Ukh_6SGDAM;Bvhx~br*-t8nnz}1C^O#2-74_sPa;?<|D4Jf)W^Q87e!`Ya?qGkP zozA=Y-iiD#w>3HTe~XfaVO8c1qsYcS!NvLP->2ljb-1Ll)x^lCSr!164UtG#cD0L$ zT68O8{P>fYna@CVy`FH|r0Y=Qxe=ma{OuzOaz!5}?`Nx-S|F;II+^O^h5ge7>D{I% z+8-|8`y5B(BpGA=Osl3i&nIg6a6jAyz=`DJ9`YAIKrv~F6Z)FbRQ$}|IhbAT1Q}Gm zna*J*#!II~JsEMszgvPgD*e?83_bUu#>|2|lVvqB&n{EDlW9rgm)kbnm)uyf=3+os zoVlfH`-xOCy0K$r4q_DAG~w^gnLZxFWALB38{VM6YY>%MZOE$>CIDHm%ChQ^65@DW zkCzNwVyLIA0vJ)UAk#M_CqT`PL}e>2hNUj+c5lUxJ?%SuW82sJ*YI)RmSI;x-u+T6 zuJ28npW`UWCaN-O%tqD_`=IPFJ^nv!7jwO2PR1PaIs9u@+8(M!vXDynW~XS^aRo|z zUO5C4ZEg^4dAYHvYx1{g6+e#v%3SwNKUsP~{guG*uIlHYr{YeG=L~n;v4I+&_9Yql zAfwtJE9#t`Iq{X-v$lau1Z^4KWGCXl{-<0R7rEq3 z)q|J1w{uQC5*h<{$AW{7r5)-#(bb#qv%#;vAebHid;r0GOEYP%-%F+5yH;L3a|Raf zd?zG@xG~ptb=1Za+qTZ6t5yxga#Gec*-XZ^<7r`rp{ecqojW+C+$R#exbyyh!F@yo zZ0wbNh0qGOz;qm%w1_N&40w$4Cx`N4u^0TDtBsO z9k>{O#nR;_#hk0|lPuP2NQm4`f~N8dDoTeOu-g83a_qs>lmrO+c@rE0BlOFhEU9)n zPGHD3oKsmKB0#oN&i$yv(A77~zT_j`Y}2jsg@G+;ovv-S2l}? zvnloTRZSO6+bu0o6YPQYPHQ~cIl_Xm?Hfr}w{n5|uYpD@Bb}Jy$1br4kOAud7RTgjaFQS_yF_Gb zrk5GDbs=SrRiXGA2eB^z1APXzuw6W}GJ`&_SKib&!pTS=-*J*o_aw)d7_YV)-V7P# z`sVif2S@X zfo5h9dH>9=8(5!JVE2fX^HOfo?sbK+?03c~6YJ@c^s{KFM?FR|T&G8ajW1{-eq2^v zy39%2W97I?(pZ)D*0U-FRUR?W%BYB#UUN%o4AB*`4YsKDU7UzSI0 zKPf)=@nF@25^=XlO&pKa>kW`UE!0k;G)|5X{Yjqq1)5A-)M4PrpLAM%->^#QUvo)?I ze+64$L?SO1(=-=Q&0H-A--^{dM`@$6K)W4dxHn;A+2NJhRtMEVqh$eN0a*{HZsjE$ zElxMHU+?;6=CqGygxTE5xq`~0Y8Rl$(^)+u)-~(#qv?u&hv069l$SkKalePLZMHYz z?96*OFpMDw=td8q)EXBee_L2CB+*GpOovH(!eJ}0sMKdH69|r%5-jS-3)O0zDmV*T zfuO|~p7My3VT42KtD%P>Do8QtQ~m!zLREgk()Jo_rQo=G%dlg({dpeptBXMX#ZcBn!1yTWC^ zAKGXcH`k?j!mYXBPlFG<=xIuw1LOpyaNMMmspS~hl1;Y zrDxfItdu$merbT~eG>PyC$57O1^p>!MjPsno>wr*@ICwQc||Q zxWmKgX?}?Vz+t+rBt9Sl^051=BA+bt4)pJH0Y|AVvQ4P}8b~nZSSLz%aF^z(rP<Wr|^x(>NKNSXil~CJx-Wx^r)cYiGGkiFKsL4#?*mrIV$L(N%e(Y!9i6n z-tgXpZA07U-|a1LXCO8U=WJdHSbEFZzbfa96dz&zEG?+osf<$`-3J)wI~ixxieQxU z5s%1_O6RuPq4D0DYU5mFO0<9WcxJ!#st@aV0{t%7!MZFWu*_z0zzwhS(Q>Opzr!6{ z7CAW7$e*C+f;b_K_6s@zbpdLRqtNL*$`2DHe2o4N%{?bOf@c6rXVwBnsr7@%@gJ8x z-j@hO+`QKBYI=d`oOhPh)G)$T#4t2sSY93+1}fm!qJw&2CuB^Ew{ZG;(_VZ$@SAn$ z4|yl@`e*^Y)*%KsuZNfgJ}lbiV419uK*iSDcK<1W$36M8?} zQIOuPG3`}fR-J+%pUzm^c*{Jt^2Q><*QWh!a+c5J#?8{gs8JxC_x~;Xx2fAs{EgPY zi(dTHBdS*qsFbPq;#Kown0p)4y*#m;(wjzG!+~DLxQ>feg`xuDUtH^DBCPfbLNWdhn#j_(B+zCq|wNoFj3zJXhrv7vQ!RJtEQgPoAP7DpQnRD-&M$Mo=VJAZP~kQ1}I46UpqM;}he z{JUaT97L`$KBoatXFk!tx2}xtK`~yq6fRx6|BpcVX$lxV2j}+nKn7h+Xh+bNy?OVJ zfT3q|#X}7-vh+aqU+CvH;k;lDV&5ur{dZ&Gb~I?ywEjZo2YK}|ibdx;U`@(Xd^9@~ z!`ZCZF^l8_*6;qc=_+WWv{d=E(ULUIbg>NBll^~@9N8VDNc;~;j6{ZdNHQA zIwZ23f*85dVWoEtoK52T+KhNRPN5!K^lyRkMpWk<)R?=fE8(tl9MZ-ggoZ7IXJq(L z61>WHG(C-UW}79R2_w%Q!^cTs`qZ6O6ElA|Y$1h#%S-aiB~SW2&nhN7q^QD-T2+&u z7~HI8DAXii*V>toz7Tez__=v_p`|7-!W@<`rym^-;P{ft5Nw`ph3Lx;sZ7>u5&-I#-<-;TauIed1Fc*OX~z4f4euPi4it2M7DZ|(4F%8SHE z@#JY6PzKyVT7NPB_b2R!fQ1~S*0j544g)!yufZfsblys1)EqV8J zz-;D2n(*Rw>7lbHX5+q0Z~DA8J8y4G)>(D!^fnfn%$>`2XT_k4_3Tqy(_$LsDn{KWd15_4B^(@`pUWR5Sd zmO9DWJ@2yPGJw_O%mt4B$a$#CiW-STAEfScZ>Ib$KZh^6qvYOLXECN7!-nchAEa$G@-4PmTjoV+u|v(I z1ajkhAHce@XY|tB1y{?3F(Vm7m6>;8u_1ZF40-)IC=FkBs|NjOZ6dqb);cL(t(BVa z0B(RinXbM?xek~ZDDn&?8^AFowQRh|Gk3syIaVN_{41_NjJu6rcR~JE_NKAh&q(^T z+EF8TVhZ!SQFYnm(H{d7f1$0^HWn*-PDYxwLw*`A`Co;f;19-sB&S_ho+&HS;aFn7 zB9!kvdm0d41N4h5#x+)QGdkWl*_=g6&Ni*5A7c`0KTD%A=NPgI%eF|z7w+LjET(l$ z)Kdf1o@Zb>RXwnD8x3?PZ$mx%4Z&Xw`5I-CMzXMz}c= zC91T@^Tf^E-p#2|dxY3*$rOOPL#{P4gcCHG1Hj~0KQCxqmj~<@4h!;n>Y97d(viVE zD=YFzRHQWgX*^9GC2q~kQS`quyPz<=iJ5-@SThB#0`b_nYh2;!3 zvW(Me5D7(nPHD2B{%FzzT%^{^y5Q4M$)+ZCZ{{8$*>$T}HW--zkoKQ<2GZQg?kGg= zX~uC5bm_8(OTDp+fUL`IP3F%C+vk$OZ_xScyy@VVU+*MNgfXI~Yx4{u7}%he5>hs$NWpia#GZs%QGh*%4;IB!Xu?xu=3{Mp(5YIrJkUFGrj8KbI`LZKA%Mh9TU1rsorW zO?E(ft76c8wiED{B~@FFi7`0tzm`TO^CbOeBgohhGMUP@Q8oCQoVZ~9Ly&mTXv@mx zNb{XJCiwY0jELMxZLq0hJvOC>o|_EBFT zshxJUAxmjvQ$ug*XsmOvecy0r!=M-`&-4>g;nzuaH}yt5d*eDMN){sE+jVeUHn$hq zI5pP&IjVXh)|_gBG|wHEcW3NcJ62Fqi9Q>JNzY?+n4%jl1r_|cC^-S7ih6Ccz#@_~_{!6O*(Tbo~ zWTPC?HabK<=uehY1?Aa~jXy&S=u_m|&39s49EY7vJ|nWs@+m!H9U<9 zw)JUQZi{KWsA#_CGga>&jdn1R9$qsU-^E7w#y{pl{M$s(va$|~L#XC?)kL|YH|kU; zu3Mzywn0SF;&X;dQ^v}$h@I9zfOMiCMel!q1-dUxY2ZI|vnIatySnbchRJa|a@5LJ zM58(qBUzk4>Pow!a#t%na@=zmJ?q4PQvNx|;GCd3tEKkuWkRbe##_ZGW7@ z)H0@j8$Q$Fv63t1m}HgMSkalG#tUO+GY0Qd$jB$PC%1lMbMsgJAX?}`glE9Kl=>lx z6Piw02V&*tkk9cz*~0v-(eM7iW2m~6mK3er*CH9`dbw0&JK?03Ft3K0&yI;u{%z{) z-LCitlDG-(`mZnG5BLg{R=eSuC+xBzkY{#qJ~lx-xGmMGi@Enpd_xV>D>>>cvKc3} z`B6TbmINRLA2|q4pIp`31<;8>)?mA!D)NGJwsE{_Py_7#3f9WM1&{Ri1%^8P=03#& zYvVh{*@5d3vw;jvr7D&uDM$IaaUfKjhEb)gc{JJ2sLjenJv=IceTF}anwpkqDuJFl z>m~1)>!MK`)?f9MT;!@|c-9<*sO1 zIa8BVmYS%P)VLs$5pD?DYN_bVX|r5VTg(*D6kGvw!KuVuKvXbEP!Y)xP!RpybI$8| zp4abhfcyS_@9X+}-tQ+?`%vpxj{7oBG0iS6-x&0b^iK6Plghsg3jZ_oG&G<&QhKJHey$6Kn5q92 z5!!)x*usC7A8x**VeD|(i`rxZ-B^<*zbU~~nFV&?FppW<6c|WDs^>W57ICjpK}G64 z@m5iN9ifS4Q=9yrKKXN5Ppg>AIA1Bh>zL`TBs5erKZ*C(xhXlXnp+#0=g~M|5#&sn zsX*em5L+$(o{e_$D%V`)lu+uJ9iU}_hg)+{m)pGNa02`!kU2}^VlsyqHwiwLHs+^? zUv%X0N88bmo)b77=(DuUM`6!F|AZ#q+^_^Sj64KhqwHbL-}|?9wq`Z@l6QjA*R$!l z@hFHJ0rRSLE{~J=o1Knhh)Ft4D;t&oTw{xqhnj-u`?`1Y!RNHlf>R|{6arVj>abDc z0Mo6jM3;FP`ya8>A8s8NuEOz8l#~{+Cwqi5cT$Ew&e#N|J0!^I3@kzTT3ad%T7Hda zB4I?%L>w+mu7d0tduFqH2fkf~PMy53G)IW+$mM2Sv)7HJ$$tqytJ|w-oO&G)PL~r% zTd`{8zEW#0jmvc_xAJ$ivroCbu4Bgkpp2OZR`|?C^vdafA^`V|U9CCzFCF>s z+{HMvqHnhmkZo1chScV_=9l_&gnxX^@>mh-t;+QlEUGqDhaTop)>JRGJoJ5@#<)Y|i_U(^ zIG65_@GB02ymn5)XwgIk)FxU7+ffXeW^>Q-c#BueGfwG;Y1wV`bb+zJwOE@5TQte~ z^j>+sLfKfP3~(6B1yN#O)cske5d(d_TaM0w$Ppp79z9;KVv#M2y(cLQ?uOL?>V87a zQl?YP0EdAo_@S!iU_3eDa_H+pBY#GI22MHL>ov?fnf!xkCaV9K8dgFaY zS(5zhD!a*D1{g8}DubMR7dKUU>wpf>Ptn%qF#krV=cTcaIe9iXjE6xt@v21lnzj%| z(Imo`X7%ycW!^df7WrQc9$vfJ<<@4#^}6^VEyc>c$0E|SJ<>F#HwdJ)WA*oJ=X+lX z<0Y$Zv(yEow`Kd%>~0$$T^eXu-s#1#P(nK6w@=PqghA0DiaU?LQ|)GxgM4`ITx2Rg zaX6G!A@F3uhB30#*NS5YUnM}+(IAzu$&G+{udG?*z)wN#l8z+Ril6ckSd$W=S?|&{ zh1YNq5KJGEH@3|44^B07s=(0Nn$>^t%?1{sFV*Qv1S;F6b|67pYUP-#p`E9HKjCDIc@L;9w6;H#n%0_RW9xBHd^;!^1(-%F*%IlznhMj zxTGn`$=r$j`xy_q8;WMOXeXMn5fw!oaBP9>m%{YlMr)h8Gwb~zmunKr%xszlk}z2c>e%+TUvApt*hAJ+h?kUw@#cb? z{iB>4e6>ko)9_;;Y0sfkU-+(-aRXx_vG3)Jj}218s%*yO{B5!VF4O74WoW95SjEar zIixznFo5gn1bbQ63bS$a)7t(dNZ!kJ6wW*y;Wg=7?1()x`4|F=s+@rwf_R2=^>qTc zkFX&Jp~s1WdLTV)79djW3DLoP9-#{TEe>&Ex#TeZ@U|tJ)vv@TuY zAC(08FPIl_^j%=VBaA@$DfRB0-saa0Vne%t?piTy`m;QT<%E-c>>Oqg8S>ua$ohLAN5|_icCUwaRWBEbx zAqd=`tPkB@@dx-D(A_WPn%Alu15O+ZC_VF|7Hq?#25j z`FJU##+dmtfY`V2-o{$$^g7hZ*~>bzlId*e%MDFPo!Evd3BPd`0Sy+i0BGy^Fl8^| z9ES{yFG7!^a@a%hl!1pq$#;`g1KJOcHz9OCm0;`tdvYqq+cGmOj02e4lwK{ZwcBTSTDzT6QkkAa39e&oCgY) zHZ!k5JA8W`#Wb5VJSx6qXnlOCWLvAjSz34U_;D05`EJ`z*bm=JwypMgpl2Upk0C1u z_)$&Ws@I5hoh&_F3}Tk>F;xy#-#50PlUMewYyI-mwEJIS9<)j#Mp078w9hp1P<<`{ z3@;#QED5q=NTbX`6m#6Uk%vLf{Kh*fdHw2wOlZ7Or`7fH13v2W>e{)K= z!G{I2pZKw7aw;Ba_COM5s0{?jI8$w*3OAIrguIGRG;*%v{#K|{YB$v_+9a1MM-sANk&73sMB>?jy7PUcWciODU=R8wUF8Ic{Y1i z?6C&EJoFN=tdaN@qChU&%)E4cN=|H$L2#o`4DI$AI6!2-Gv|mSg1V35Y8$GTK2*>9 zJCmXjk2M7me{0CdPQcn#gE~{jJ3-{zVFSrJb!(Bz{nipBo~@1{PmFp5-#LL0u$ z8@hk2<+NP7jh8Joujw;bi!SNR;1?!Zig!pkJMvAhGqcCGTLhKSTk}F(rQecGT6dJJ z1g%@XY$o|v&)LCjGZY+{hf9_xLUog01GJCUxDi`&Ji|T6&yykZpUyZaNwT@D6rkGS zNstgD3N);gd-3hn)I!(cJTAt~ zuL-ec#&>yKzxJNeQ9^6wDM4lPElY%Rmc5-p(Fepl6tFVxnOga8<3O5hK&hDHk+vcOZrv8Mo)1$s*Rjj0XcNUz$aV-2MpL zfH>Z%sFLoGRX_{Sl&*laG7DeKBJum+%ELz}%z|ljtmet&Hs&FrlUW8}XlV_VSA^H$ z=$8?{cV4fcL>an3rI)fP!3OmVf>0Z9)IrAGVL@D&%P)SpUV6Pd5UU>r@`I^OyGR7e zy^)mHZnNqanJWZ%?Az6cN{ThEvo~1faZq!v279-gUVQ?V-yf2sy0Nc%pXR>|+0V>n zfE)WvsHF?FS#B^r8tc%CZAOY@q56rEWSj?KTFTw?jj!Zr+n%b;dV+c1*IHYzl#2>J z4u4uD-%6gSN{Dqu$DForKSY}~14UexyS2KL^g{i$OGO>W}?TJJz_V5)b|te{b1ZnwHHxY0%kXTab3_# zj$!tExu8Kqg*g|kn2HeCR_+^sqT*{2jwTrJi`7bAsH*x4^)!>)%CJ}P)&jZ-;9J{p zirB(H;$Az3*u+|~puWQ?{?6A2PKyFe;-jwsyK6V$i(A#&HS7%a> z`bRnzBjEvc88noPTj=qRxd04Cb4xS)nsc@wGtso9fXK>kqv- zmZoh%m(otbU=z}}h#LJ^ODQ)v!U74Xm+yRw9ar?ME)!Q3bx)bKAB-ROmA;%*ILvAyUy}gzC4T>}2X=Q+oV9q1U>s<}WE7$Hdyc0L zwC4nRLxtax7MIps9d-G!g`2El@m)eC+ak^xlH7Ma#Z6gUcKB!LlD}ivZDhop$DE1b zwyisa8o@(9pcDydJK*~@Z5*H98D^7NXXS<=bC1FeWyr1KYCWU<;Wp5l%?~vJx>~&3 zny>rTlN?D;@bQ&}a2e#X;)sD@b@1|77KG&Qi832^n2=x5X_P?J%#JK)2L%=E-M0lb zxgHGs?YHXyV1Bph!l#YOLLu+TM)rSz^20i-+%;;7Lmh z%|7EDa~x;$Yv5P9+ySSQp4^rJi^?^^PJGu(SS~Jf^o;y|t61{;E{bz|y#36_wNur7 zMlnL{CC~}nhg>&l=lU>(9-?)96|_oevwn((DnyyUgXcW1d$Z=$BhUylUWz2>mr#wGha+i=eX4`xfzqnRi^>#tLs)a{OsISb@!t?EI7zii&;Mi3p=RmLKiKy%{<~^v5`3;s8);cPC*(9Wzwo{V;Wiz4lkh;PrnkNz zyrzh{?WJYuT$8T(Oum`H3(3_Q`^((wLFSQ+DG1O#D8yYZqU(!2AIW#T?5+QQ&$LPv z-_@1{ZUt4s(wE+}>ZMs{E7xi_B!IVkaQP8gSixqQEbtxuybv|Uvuv3Ee2GR=nwSHW z7?z=7h`Y`9O_%|?Rj-g#_slbTtlE0XY}x0m$S3e zB58(q^Yau}J@s*BVwBYsgV!41DT%sdCw=p?v%&8ZhZ0~_FB1+C)wbyH!$0&kINz-0 zRV7TIf1SKuVy)1OT_&#++f^XWY;srd4G=#_iYXt(0P@E1zI`PG@ujFbeCFs|{e_n& zsuE+ZvE(c87)n7)IFU+~0omeGxe0$X7PKS()Ro*%9^jlNV*An2y-?lsVF=9o2fDgz zqwGP(*tC+V1e*08kzE}rf8DmS)e^Pb~G^ zV|H_*t>RLu0D(6Ng7#VdWCH4>x@5$U25Gt}XX4|^SN>2OM;A?{B2GG6OE1=;>lU-B zfu`_@gSXQFSVOnx|N^y@SxD0`` zq!rX{k)Od$?JXcKe)$ELiaMG-R*e|Pe`WlzP$X@^xft9wMtmqkw9=f(C5Qa*A*nc3 z|DJJoRNly<*uJ~G4&&AC(@U{`D<9=!=s+?|474@+qp z6E^zOMoof%|H1RD<)M>R1{B9ZV?MLw3>1A}W-AOnOQ8CQjs)rhIYgz5A2gcC{nc}p zeM@LtmuDS|pcqxrKbkO}5?<5ca?@*QL6qlR%pELMCwQc!qM+`P2T~sldBL3DINLz` z0;|GG*59Qj2tECF`BV}Ncr(}+tDD;2pQy~xq&oDj_s90FMC;_GB*!Rvc$I>UjX(fY z%6EawL2H=dei#}r`3&T8oBIjkv1Nwyrs^@9R9wQYuBA&mB5m<&iU6A(^QZfZpx5~I z$4?(ftsD*}S0fBGi@`79&=$ySVox@LWXyxbx#`LOL3- zX6G)w)gN|LO;rW;?v&ievrKda=#_0KOg3aC9Ij@$qvnS&R_4$&bPE0BUSK~t`ShhM zLO{8Z2_3WFhi)K8;B4hW$myOxg19kJ9?f#0XY*GH%J_FFqjBhiV5a#a3WY~2zth8E8p|S%GAO`(# z!l+a57wW5Zc~CP7(V5nT=nThJ`M8GeVzrR5^eH|5?pbTc-iBx0ySsJ^f~H!UiwmRR zKf=u`Xb>~Mx3_#9v@N0De;<2ifOd@Zk2zw6(yIz}4VZF2ND@9Hgi0K{O2X*8lH&0<<|} z_Hf#FBJ=te;w^Z$>zE$A)pmu$0p9&QO4^m#7pAPrm)PA4edv=D2PVv;sD62Vm6Z7G z4_=)HZglWyZqX$I+=vx%Pz2zCiec7hsUFYF8g>_P#oB}OYhg>hQ@RQODi$IT1mIys zoJKGarkW}93eowo=oQNs+OWSbdUK-2W}rRd>p2N<#{_n}DW*#GIohgF(|t!YpbSn! z#DoKm?Zl*Ok(T0lBgD697}-Tcm!dFsP6C7)82TM%{}8WR1x zl6}idZCGXVn)@3JotK|{Gj;y&XDX+ zA_%>%^nHu&83MQE=Qa1N7@m)>KoCEQ&1)`1{w_0hU1F3jO(znvhx%TeraNn{Gpqcg zJY~ZsMm0PqqdmY~5os3m$yNZkySTaT^zbobO4u|nuQmrVRa2db9_-hZTAk<`z~*fC zE{YK+6 zH0Sd8!WNcAI7CF-2amE7|Aeb^UN%SJww2Reg{~3S-l{W=`lD zXh;s#Lsv!)5Ag@;tTenPXT(*?!}yewO<-KKRA@RQqF%9z*nxO` zuPn8td5`#5q=jOwn+xg#1%aQi%m;DMFBM;hLqqq*_9CG91bIPq9z~cLYXJapv$)?c zWHk-0TF083*rbhczCZd66dLJ;6-`Qt%y;+pT)GVK>I-g`)}$op=UMW%)CjZNCu_pZ$k+w*(QQs`rcW4hgkwY7tvcDyd2E+hNJ(c#+m z1uurvgeznTQ z#?1I14$%Kj%b4qk`C<>8;|ypU-1;tf{9B(d^IEzFx67SMq}+(Z04Q6a8Lg6SKE2_yH=tS9*$Qt~}RcR$|QCH6BX& zOZ&hpIc3ez`oC1{E7DNiV04Wu%$cnG<>cD|hO_t`qm`=4g7`=ny$0%abhl#d#e^Sc z_~sd$m5s4a`28Vv)GDJWo$54(qc{k`Y;qg}RT;^Hu6t#=FSlU*3o0P$5_|LrC!>C_ zjh9CQA&%zC`9pQ{Rb#q8j2ey>d^+}{s;|XlGHSWK1wfb%$eOC1diTs!U2F%h41r#nL28A0R5aUWgiwb$1}rge zqbR1*FKuo;7iYAo=l!7GArixs6aMZx4s-B+W0=RW0~DLLH5Y9(8=c9Icw;*bf!)!2 zTML$|qmjh`^95I1q1!B);09klFcW}kmhI@w&yPP*30io4F$sCTZKL?%r2F7e^zx6{ zcI?C#XaP-5fR)cb?p)k}@GB7VY^)`l62h|xYgJ9$37(n8fp?M78f`h{KT$NBTuM11 z$)3a>#rSxR1Qr@nN8VY1vsTLv6&u9)&@>r-D0 zn1K-Js_oZtWx6r5-q7?jh!`vG#%$AtuM!uhd8yR^7bP0b-~;jBFc2}iS0$YFIgJM! z>K8#dcXJ%Pw=#E4)&zvyW%hm;{_NlvhShfU*^q&8`gTNJ5qWc-;!-A)Ns_Em=61Zy z-pV+jTrynT-R?wlk9hggm_5c&6$_MO*UxAQdCA(^cJSoXqU~xxxa*|p#5)A6E6Xa{ z5`h(!s}hIJ#?Y@Tz2F#nWIA09-j{>^I=-S^W&tPN|7Jr&bDDc27 zr2hH|yn!kuVVelV1=cR2=)_p}&K>mg2?B7+z2=!qtFpDI10xZ?r|NEhq$8|ORDLe- zSg$DY?n_3}^Z|<{ziiBX#+das4Xs>RJ6EGylWW2FQi=#iM(q$qAW~)is`vA=psZ@{ zJv{o~#bL5be%_1M{QEk+t`uQglg2Vyn^*XmqM3XMr#o=ObmrR{2w|rDQl4+10pVwW zVMmM|OGEzsu((2|vaGoeZhDZBp1=YRjRjw}ZlXW?kWy03-@yg&>G_}QD**s!sExer z5h{AQ!+cE|+B^#!k!^}}u0zjQj%2!p8B>#lA87pi0eHmkmDsVvDbo_9FpgoO!8E@U|Wc{}X2LLeoG5Z7ebv{PFCwC{nr zFxKL_6ogAriViuS=-@vN-3qs@N+4h2(1Ig@;N>AEyd~&pC;oa-B8+FaJc^dJaBx0r zy!uniLbl+F5c_aD<(S^h+rV^mlk~V>C^s{gG|xUWlC0VcVs%9u5c(V^>SgCW za3va6jnUi9uJ>6t7|0V3WbR!Li(gL8W{&Q9sx{2F9@K3BYE-7tUJE61Kzzlz6Clgi z1GQuIV&K_1c833Z_}FFa2#c0TI1)Q?B+}x>;oM@6ht7=qKhP=EFdN!gtfXXq>%=a8 ztk>=E5Ui|(F_Q`Ib%kt^BzQ4DvAOPDeH?~zJC0-Q98Q75`wTjPZ^@i2k$4@;&S&!m z5odhGxoC=%zIc#%13=a7hm;CZdE>{ zarElIW}Sf+#8j8{mEMRjEx+J6`ZxN%)Y zwxm>&ZWpR=7eC|gMB~h`f8TV-Q@0q*>BB=}hMOY}DsEwRy>^ymsk)v&d+NAU-sv7Q zqAPtO0~yX=CmXx(Hin~Ha(3vVsY7^)#hru)PBRjmVW^3u=^*Di-=vqO%0l2urL))ep>x3;79dCH;ELn*@w(H*(>)#f5MikIOFx} z#_pI_pS-ETFbWnHtG2&V`e=_aNRR4q4!$AAQyGGK*&RgKH?$Gf`|KJ-qIGs8xL3%) zxV{0LJOb^SYzG!&;{t=;(Qsw63Nk3ZzvQ1>QFF3`ej+Way1_$bz5y+D0P=N1o}&{% zs5DVYVvgz}gEdG~H?EtSuCc+}PI#&xL^*u@CWvFq%;nWlDtUn1qgVR2wyaI!admFsZVlOjR@;gTt(d5>rVD4WG?JJm;=ZK0^E=F@l z#}LHoVwmoO*~~|HY=mt(1FtGUU-rDIN!(1e@4D!-DhSAw9H~mUzH%YpO1OtsYBTfk zju~Xc@(#GRJF9V%nKg40qU;*GNNc9YPz~n_}v8Gh53X^zwdnGfa`W26hH5b zPs@7Ta~9xgZ2ti1>){DTe2j|sscz{aAwSUNA5*tp%Uaa`H|)M<1Ut2`n}WDL_Vq-h zk(#Bv<3t^60NFIn&>%=3YfGno8f;+)i=en@-V<68kXCUbKZkitq5HAY?_A=Yy{6{HgC3@#z#Z1v{ zod@bFZwg_gIHs*i4rxM)sQTh9ieEZGEd!uhQl(Xzk?msBAL4B{o2Pp_#s8{uGJ}Ol zUO9WnM~``NqJ{k6&p>VnFXq3PhPS0qJMP!BPUaTkbJ!zEXQ8p#w+1^yYN@8k6KT4r zdkv)yGSxiNdfwWaPem4il#YMs)15uI&E$A(x}^ai)LpWgs{Yb=3qN(#`s#=69;u|$ z1ty|*!sM9iT?MLAh}`YwSF*!Y?jY^`JoWX^dVbnH?bTT&{C84UjS+DN`2((!se2#K z6*%d+>;HYn2RZGMQ@w!pFMxU#C!Xo5vtmi%VDwI|E}BmDrN~YJ3wb}Rz~x>&$5@kZ z9JTXsS=?}Q4kFjz?FykbGo^!jSHy}~ZWmKfQsz%}9pr?Rp+i2q&8=XvI2)b5ZXz*TEr+ zDtL<@GXh^i8Dlx#SIF*Al68%K{J3Uh&?`JEs3ml9@x}P_t6npij4oTqmi#1~^CMqx zQD2|r?afU5gKG262K~a7Qu_#e)QFo73UcjyQEdRl9W8w8poGpq($tTum-5mw zf96ww!Gm^atyDRh5k3X#^z!u|1Ter$LBY)6(})Pc3(Gqqet+DVuTe#OJ#5wJ4c9oM zo7p(VyF2Xi13cTaAZ^#ho);la=(5FDi}y<{iyNvh<^JjCh*v*m1P7r1-5Z(fXl|Ij z_UmB^z_3~Z87$mlZIwksQhb>4(z+x5T79~94H6WPHp0gU6MBlPL;R414m?KYTB$Tu zR-d~CzQ@M9-*D3b95?6SH(i zY<-U4#Z(Zt`S#r7H1$yr_^+LW0H&!}1@PWjlokf~w*RVtQfW}YeWQDwqS#G>nj3@8 zrS-4HQTq6QmM!@of-z0RN!QdzgxaZxj|fgh?a4(M%X@dEdDkCJAzl_?9*b*Wg>J<- zx21xr@N0dmM}nMTvOZh(ByLSkhgTnkJIqOX4~GZZut;y8X_U`zX4;6co%fxVK7d5H zgnxq!Ewy^10gF3(aEHa3+bNP4cNn#>K~(IGUn1i;6Dhq9S8D4lT;du~!3N`6fY{(< zci9L&u)l@h&|S)KM9R`k;f&LYS^+2UR*+i^!Y;c3qD4(mNpts|sUwXk!f16Z`F7zt zL>rICSih4vfoYzvMS+p+OJHm&;V&#aoqCJX&|PP&Occ5cx%PS1wwe*|5||DO=h{+n zt;^!LBJsbow~B{*x{0wJDT95Di9XF^Hpn%FjPBD)JNAeADI1`vjLl}-6V*EwFjDPj zv58{MN|P}yy--?0g2{du6U!FA1~@b3Utl}WVmW%X*d8;;VoeqA`ihjP9fpL6%1zYA ztMuR=&P98^e%EaM4A35RGsaY}r4M{y&K9cfei0Q`0q!2QIY=zqLoGK}zk%h;bynaxD{@s+ibzb9rCldyYk5X z&mhqEX+v^bGK<{f7F`sis8YOM8h6HLaQYF7Z7I&1i}eK|vMe)W8zv*%f@xGn#c!AOMF0zc04N>1KXYO#x-ew4E8M1h_*|D_1T zvwgjka;TS#+V3Kq;jX7KEbrizfZ-FXrWiZ{@wZ28$)_!`%i^SO?TcZczNZ|%X$wPr zDS9Qq9}4#xKJqjrDouAq0&zZ#?CR8P5jU3=j3gJ+H!l21?%qDyGjp6cU=cjv5u2ka zXLj^IlXe#U4NlDV1u#4OoyLt^NWu4=dX>gkHdo#Qr`)K28qv(U#oo)>vAhlL!J+Me z8r%$jAVQq_cG3J<0&*T@s8PE6BGVmjWHA+4^Ifkkmm0Pgx&(HlYRc`V9@u1;B+NZQ zkGofSbX>@5qe;m+F*XyUXRYd#ULj3E)dAW1z&w;Q$N=Z(#v>ky-{F%xSr#@6*vvk2 z<}>yH0z$-cBk{z;x-Dfr<|3e^DE2&5rx4x&xZK~5sQoSZN1kEV=A6LZ)0NwsL1K(q zm1pMp+|KRaDk!>{7-MnMa54A(@+gSRHm+^at`)LMbGwt}dwnGIt6iWj*JN zMo9iVX)|3#n|iB`>`Un?TmCm03kATrHEwLFa*eJf`KD>S)jRKVBk~eurZQM-7xGfa zx|*vQZTeWg{q31@d$gDL1GxB74{OcMx={coObHV$@$~@&*jBB$;#bKDSkG~O3qNFs zR;JrXMHv0yAxSs0%vT(j`A?0QwHwGc!{1V5o5iFt%!FJ+xE2fLe)8nLkAlZ`p0Jb! z#OVrM#3sDTBL={Dm%VYyLhi*+;>=L%tq2w_x!<71~DNjP+QeRvWb!usT_h zPZgQY8cv4p%i)V@+CW$phR{U$st8{%d#-N$c4C`zSA4Dqsv=#v1EDW!<9ppgaw{K; zt6_zzskbi?*K`knK5ze`%z@OGd{eWVWLSBNwsIPGMbu)KwwoxL5q5aiezN-;eh@c` zoz}HlsQ0w)P>$x0qN?Km@99(Vfz)wlZUOWXyhZy5rqL8PRcM9h5mN_6B2X!6k@cm; zC#X+;M=wCPBD?%HTY;qzS(&bq;P^>= z=TYIGzK(BJG+s;IY^Q+)yJb_wBiA?@-q^~&!}wG1WPC^}U%-063&j8uF$XI&UbG55?dFw=4TDjenk z52;W9hhkw%hGdHqJOHbKm0&U(yLU2y3VrsDo16eBrRQUiBfR?)X5hNd(NMx7$h`3C}KMxi2oR-p`GI?RZjzdFyb>B5*-V|Y( zIS5R4y87HSgg)0BSq4KOBDRj=(zBJ%cZO-Z>~iQqxAMB}S&p2IlCi|$=81arB4vzF z7Sc{%C)Jw~g~AK@y)o!_ZDw7V!YKehD(x?Nnq1U&TERg%QqYT+Tu3WYZ0664&PKDE zqNvzdHYM$-Fm)3gtwF&gad`&Wes(fM1sxare;%kPBTnR8W)ze-0-nmSOk4L<`$>Bi zMl@leb6*18|xF+eJNkX-pxbHcXvqvZ{Z=M%UKj{ zF=b`OGwoa_XF>@G5gU(&E>|B7=`jH*9*eeBG-^f{RL_~iEft~Zx%lvm8<}f0Lut`C z?B=c^?DSI@J%Q!qJQ@=m6S?}zM6Q2DKuyn<9QKZMkh=n7@ie0S=kWtEh18~B12dryUCIr$M_Vbyvw#LA(+bD|b-<$f9_{3C?1OWyG>kH&FzhGeILCLL4%B9TF zq{#4ES!1K*de$U0(&Ts3cNKqYuuNA6fM#?`A`1!{%#Q@9T}9u*&!xMvFBaW6avyis;tBQeJ{jY_ zKPGlF;b)nHOIolu%f?pT^;dw~xz$IWA0p%C><0y4QUhwfS19&hbSs?7O)4A`2Im7} zk+C3R+iQi-a{dEq-3d*2zk0j&0c`tTf-Mvd5CDH_5rS_bAF z_cSHw5$60=Mcj|QPx;W*a_7FB?M-wezI4Ql3Qu!CSdsWUg7IYLR>9XQnAgopk}h%g zeXyov#48%+4AIrrQDO-)Uqv7+OnFTy4k)O5+Obq-@vXbSt?LfMjeX8mDs=64qJRF# zSOQ>^P<>W{VD>!G9295pwZ;i|lkzLzy@BV{^do@^AIX-Mlf%{S z$R_WFESmC>r30y~AYv?bh$#LPVDBOmM+>J)V-(+|p`xgUl`l(o8@;eH~|+&@opwW0`8r^x)LU}lM1;HYFB1nH~1@h>tzVx;t;)& zat+}+O!1Fn*g%!!68CH6_B>R0^p9E>VDs*9a;VRH@+WbTSa=N))5V^D+~YcOkmb2i z&7O9fZFX0&=)XV!G6gWLIJ$g$qb+Z3ijI?}q%x}!KWS#Jz-Q}eHqI(rtNxVmA$$bf zBb@FQ%O&?Oy_TwyeaFK6xFTlf6Ah+tM){0SoJl$c;})+5O$=m)_oREHTZopRX#twI zl9k5-QPq4%F0K=2U);uZ3)Ui)iOnlb*3kT^x`~3fddgbL*ZT^uvx3wYO;JMnT@n-9 zx5#&5B%CPJ6sBbafeAADNtljYGasX86;%<`Qg3=4Umhk6DPahnJ-{u;4bq%qe;k$q z|3z-+4Nu;k+SjxZnKAj7uxM}r@TL+2M?{vV$ z>&X2Z6IV0R)rFW#HKmp~**2vIn0mSLwbHXB?1XN>ig8*8T>ORZ+j!gGRd@m$>CNN8 zS{mg>^TfwANl1nypp)NUN^zyUZR%4>_x{tPK#uI^l&#!X`5>G9U!_D_C&YT@$!{KovM{ zozjC-r%>*Y6+p4ClARg-xO4squ)jc zQC*e%Gqpy}IK~}eBxs7hnz9ZXy%k|PjQ1=V{(8Gm#eaujZ$bm2?WW<`QQ(heGzGOj z3zF!2>+yR2bF~xLgZ#)?{R;e(*IHNI%XnrSVI5azz@H%`J~Ank`kGpzcCEnggyP2c zl$m?@AyOy4?K>{asHgFp_uhs%KArWf+*}Y*$7}|P9$SYmnXigr*t1Lccw+p$Nn{)^R^oW7KUQyS`uMM*VVi;v107YPvFX~Y$;VRKZuCC{ zQ=@SZhCIR(ehO^|Frov59!)(q~N^eBIxN+7W5!#o4`P`kD z`X3V)`lxuUGr#f-%;157Mm^`?aWIVd{z6*KU(h&y;;Yex2!I4oW5@4J@E$@nCr+}E zcpwp)YDHME${?VnZ3Ch4IjVp4yN^~pvUeWbJY~_e-7y^V&wfs@+Wx&Q!{NO#LzT82 zVhl`GALtBMa**wqUh@?e=lg>pLQ0dBfamOTcd1U0zSY&nt4^W+~C zU&tO={PxNte!!t=WgtnJ=@jH2{Fx-kU)c^3Jf~c!3-*;Jbtb%~IG!LT1~UUzYy@mQ z7w7`na$5PctT6cLbw-Iwhb4O;mUO#PrBwd zxj#pVvivmTa+0h3mrY<=4dCvJ=zekyW0MbpReQ~oSLf6ogOS=(ov?d+)5VxY`~Ut=C`l|-%55V1bvlydZfvVma&mJ%U!QZ7+fb?88)0{d+$2LgiLlk_ z9F7x1ax=_LZboV&Hygvm*fcgXyEEgr^Z6Uz@AvEVd|%h~ydKViJg56-CXR&FeVN|V zHrAwUbC|BVF9at9uR@2~e<=`e@leDtR^5TRhu?S1gS_`{CI&Iyw=MrluhRQGWF_7$ zAhoQ$upFZNWB6v}__H4bCwA&~t@fuk^b80;W|L`F){U)n=ktwT6}aPnpNhKMhb|cW zy9QLXHM54RlwFIg9!|9=$D5&rWz6kOAr-p2$qnA!BHK|3^N{C~19AlNB>H;eiYk1P z5rIq4t4MuXnlKm6u#HZgY^XgIX;1bZ47}uqKHhuZE_${5j`zkzo34OkE^ioKxA4aQ(Bk$mKUW%JDC)_A+?Bb z#hSiCylNAeC%@V`>1{udkJvBn%2V(MAhiNx5Ac=jH2xQR?YZ8%ufz=DGVay_f3C`; z1_+Hyst;ZmOvi0kSfe3fW)ReGu4H>(F~BtF8(z`dvsGRLU|z%cqHljs4FW>{U&yeF z^wROrE`*EROf%(&a0=9>5P%je-8j*?|D>gT{MDB>0KsOd3o$oAr9nd8rxR zs7PENO-1859%0_&%!T!xhHwGq8a@CeAhoZIZh(vCp~|@8yhsy`du*Y+wEm) z*7n&PLp|1mfy7o0-o=mXT!efVYTkS(Fi70CH0$hW)^!bLo$@9ey}jCz3ryvd(BT-0 z?3n^wxf>AZKvI=el^3U(f|gSz4^ijH6vuf+p)=hp{}5`6`MOxCMI|Vze)SwL0J_hiVYFBi+FuR{MDb3M=HQVE#B0JS2&I2owQ0&H zr$Ra}F^jjCdaa|6;5!P6-tv8Tf6>zN;Q?WYpEuq=VlRnwFX?M=j;TU6P0iHNCh7$l z!fS&{#&+cDU!|dcxIRW5Q?==)x8)A;W&+6;#X^Z%T?QMS3GRVRcs)Zv*33uV3PHRN z80pCY7zKI1YaSQIes-b<;_HDPC8|H%1hw4UE;V<0x8q`@;nL`%2NnQx*mi{_taWyT zPbv08aOOabMa{E*9lHH`cNdcdw(`Wa^b$8hp< zae*4ox4t0P#D;Yh-#7@n^Z1paueg4xQl>5 zN32wsB_-6rrm=LP$&<5J*fuF|-v-g{)@E(@?M0fwkO4w9^gKPcIy;v#iuOhIqn8#9 zq|2WoDAcOWG8>h#Aa(hL8t@4F_eE_U(5bnN{*xK0o>C4@z4ku%wOaxqyerE^Y5`@R zbvn6f-Dden{N)ij)_P=5TaDf-8+phWPN+x<`y|P%#fUbO{yDPi{@#1rrHr^jY{)0E zIx^|7f{m0~Xk$OH?p=U6>uG+tvtWju6(E2`FRzWkxUCz0Nr458o!e(mqMwz98xMU$ zPvrqj=la=KP}2T+vj@pJIM!2fT;#*$Ht-!)!1{gwr$ghG^ptMI^~m@u&+(3{J*X?Z zkH7g9oswwtdR4F(kU!~6d)(Ye12Ell_s5~0Tc1cuHqy~CQE3b0 zgBH=1e_Y73dR}hgo#@r(Q{I5u@GdCUAe&Y5X{WyK)QnyZun@-nV_I20d22nUM)=Cg zu)?(RCf8DfLUS4w8K_bR_CqRK*c{$GU5_=(I_p0(-Wv!V+c~b+yR&cm5MzOwoZ-0c zLSu2uH$$8u(!Er~cIMo>zABRs#sS#QqKmjQ_)6iv1Z=>&=( za}30rM}w1sfhiwnTdTOlGJSfZXSb|*#s}Gl7nZb8Ed;jJTzQ%{3UADQUO@ znwO}{kuc*mtPfr1@$}NIie(c{Gp}*bh=$42R14`& z^+$O8UD7j$(u@42p#Eh1A=@c)pqE02Dzt3depb)goguXmPU+PDE@~)Wqwqo5g_ziyQ?1c`ePr$f=4LV++@-exz5A5A1E0~oX?s4s zGmK~;56FE3sk82@bGpMl63D20MX?brmSEE&Lbxcx8l~iae39;9XES_R+9`{JhF9m# zZMgam$bQh-`T~hLIl6aw^3+*b;l;?;))3Y&?7oV`)@#b(^BYBb)nG+ih2#M3V5u_> ziS5WZ9n5!S_=lHGZIYHX#65|Z2RcoyMuhh^QlFHsK+G#5rm3g*Je>^wt!Ty8vOSB0dv?qfel75-z| zNqA6iI5}!lF(!1k93+bLn(4j*xK}7#8;gGGFo(r5onx&m{v_Z>tp?&u@FxIv(!JSH z*j8YeDLiNW;B8C+ttswq1cKWJNNtWTlW!igA%r31dmw>T{o>-G0;*5*RmoA(aByfVd6a8MZDHBd(n)o;J z4%_JGW$eQnhb7m+YU}PhE>Jl%exJPQHbd<^E|gFr2FBt^cuK_7bq{97Y0P#G>JZ=k zdJt}6bI9?K5u{!}=|nc{$?1ZKN3|TeC}wv+po6r!-KDpNH5w}wbEic1!DxwzQk{J{Kj(c( z*}rd&KCzK@2YCvZEZwMI_RIj})fLVSh6JcL2hF}*I$eSIWVh7ByaT9Uz%(~ql6jy& z({u_fbl6p!+v0Es>6FcoW#F<|2WtW2kpU6!ZmharCSR?I0cA_>>8+P+&!$oxnhmm~ zr(cH24lM!xkDk+XabVMss7dVooslxScOggQc#dzU#@@5KmOYc+noB`l-R3w;Q=FGl zzOsE^i(h1JhE>p9yRh>y(2QAh+Sw)~MgXfA*)maI1`3E(>hbDa&T!kkuf#bGNoE~4 z(y6}v5u4aM^m2M_aVMxpR%yUuT7>tpSubBl5b?h9WL>7@hmO=7L5IT6>vj^=mlQnZ zP%i%&dGx1BcE^s~&W$kW%Yo~y5)lu2)S*;!3ap>?k|^}Dvz)aMLYM0 zpfT#E!9plw68hPGKp})zdRow!NZ+l)N0^l1#`mW*JWECiRdYWu`?`wnQjabZeh689dOno)6FRX z_+D)%b&tXrl$EmKP2KxFTUtqgs*b1&!~nt`!2=EPRoXB7PXIj6<~c-oE0+i>lqjJo z8~-w~tsk4-Gch#5nBdi*V~=dXH$6kQZ(j@7s507z@6)jzIx=3_;y(YQ^%mBY8(C?x zrOqEnYzyK>hJC?CI{M15Q31!-^j3C;?A%L2)5__quG(_?oN#{nI*eSE3or$3=Nate zeV?n-689{Sh~L8--PNKY3kXL-QUeynGcMMoE>+6%Y)P-FlRSs61;u3_r>{g zr#FbjryPNj6NmyFyKm)I+(%jZv{q*)zVH|&QB!u4W-+wVl;E9Za?(r?5NKVPs=Mx2 zld9rm>9q7LA6Ml2W=;ubs`#D)PMS>oG!dW#(NFZNaWr#`c~>Z^gFPAa^==>5GF-!7nAZ>h^SK`|X{S?%6R7qL)_h|59%Lo%_VA08ImVXt58r;Qs+&(4D82}pvkv4_i-Jr& zKw?sG7nc8lzh-OG@A*sPsY2Cnwud}y0@CSv(pc>hb4b}y{Bg;-O9V>l-juqH4B^&y zzcp+JL>*aL9Tdp%iZ)Ji?d7$jdDcdeLB+H5$xzPt>{A{#{Df+ev|^|10oC5=NZpdIhd(hL+|LSeTyce7u!?f1y)lO#v-eqZ*S8GJ z05}C8uv(KJ)v@lDN{-vF75jFb!5)I7Snt)nZMfh|`27|TxoJJBDQ4s5WeHTSf_DVuW7;fer%&rQ}P`dfFeIBbb006W_R+b7+7yTF_$&>$dAr5liT$DyKmmuD5d zi&Iwo?6sx_eeb9A@icYq*H9xeB^%i)3}Z#>fYw&;0ZNy`)?MGfVMMj z1mW?`;$@0KP(QI{>rGTyOu`sA3}6McH{I|gs=|k_MXu;QU;M5td^jRb)n}DWvYnb7 z(lN6fM=Gj9?eCC11>TOqCEq(f`Yz@pF24#&E!nmNv47`&!1uM3V0W~~`E%v8y2f@o zex}NxXncis0rV%+^|&`3`t_H$rQa7`?o>&PskQ1fr-`WN+2IM$s=%E}QMMgRD=I;v9=SU?}>JbEJfIWSUY$Y^;LkijQO2H&q(jhAobk+=yI;4i&RK|^{* zi?p}Fv?79&yY0#fj5{GaInE23!HTpX*E0wTf|?g-(a!sk9;3O^8KEwX-U)sJNx}Sr zpCe^e*O@HRb}CWRb!@{bqkKdpi29~tiBn(r6f6^h zv8}#gP-OC_f02aD0cVp|Pv{B0%TL}A`V4m*MqN>zIzbS^G0`gi57$Hfj4-cTzd+d` zL@6GCJ<0YJ+#g%yPD@IHh^`{=t7d48B>TBovpTzOrSnZ{upd z{eyu;$)?HZq{+DK2epBEcyYzDVMCm~@yqQF@wNf-fULFi=Y^_pZA1?j!+lYL%f{{o z8nIoTStXT-&w=iQ4$q2;G-$C_gfGRgF?BZTfNb!R2~`34F8LMN()p?xzwI3UPs_YyY>D64%j6GpDjsIQqUOUiSXZ`05%#2&?e3W^3Y#bj8S{zw`k#oW5rowd zBGIcnlKEv;G%tBtf`j(U+j6IteF_=`9U52wbuUiqnWE<7^7QA?MBY&(Qi}zhNIpXA z)U@M|f3fYoOu}9)00XeRE68@!&cZNWIb&lMb@_I8)civ50JWRPc!cvq`7*h;(sR@9)(3eyrc}e}}m_cdT8-6ugpcnl@|C z%j0`;c^7NQR(d?*O6$7-Ed*T!8>J`j%JZH4MtjD0^5yHu8cM6hEdAL(mB(>A<-ZOi zF%14>ba~7t*~2-2DdB%!VC@X*_EbT`;xTzTJ&bCsDg98l;wZ6My5LV4a59YaZ6d6G zdszEM*lHif<;5>SMFS;t!f=PEk_M6y?a$lDZf%&^Lc7C}-%s}q0P=R;jK&SA`ar&C zVH(v|rP2%=Qw(umXcQoqS`z%5$JZT#W)%S4BN}oyA^*@k-*KIM$3tt`c`1zHtE}A|cw&<-cSl331}Dl) zV6Z%jxauG~7HLeIPx`g4^m|M6265Oo)J);+G>CH8ePH?+@82T}d@H)nfMa-1F?KWF zYU@!w1M(Yqkw&P4y#38@b@}p;J(6T!d#_Gx?cG13#yWb)@8dS^*1b>F>2i?ci#HK= z2u8SCC5Um%GVryDT`!9v-kiW=n+?i#epNQ?HOL}i!vi0}L&jkIqE5aTIze)k>|6*Y z<4Yde@KN`f_ulKko+3W|UJz7;7Oa)bmkgPVI42FDEDuGpu1#mVVAUih@R>*TXNdtX z!w-X7gYFyKC1Yk&ek-9Q_0M(~V!~%+HOy81!atOIW$WM)mKUZHQPSrj&T*RRw#VyG zau)@fYr@Ra%v>>Jfm2oba5Ob2HFm@Gpkz7@gOA@U53YDg@LaVpjDq%mP=3>O^NEh$ zY*bU0gri~XhT_(iUF@1NlsD`|%{HfA?Ov=p#BlPYJq#Wwi~8y?1?@_D^%?lUOJ)Ya zbbaSWQ_ge^u_yk$%`*QDm3QW^g{%TX>cKO*{Om5_o36*|k?fD+AAK8U`TJ64^u7wj zBHTH?q9k6Te#>HOJJC0D7aDfm3!N6F8@?db|Zr_*80fBC=2vsm+=Q9_|-XU4%{EL$qEPe za4#LSe;9+#M^qqd!&VLM<+(wpGEgd9b?RccAuPz86pq5ZMgar#;gHcL!gWf=jw|j| zsw62@GWNf9p zCm7|qCH3QdMP=5Kfvtc7XUXI{=8eme1=)Xx+b~h9h9$7yO3lR$1a81ozQU4o>N)$r zH$t&^0~Rd6qD>m^(i34P#|M1&KiKrQzOFOMvfeS6VOjqlP3UqZ+nWx5jggE!Hr~U2 z+9|=?T^eY{QX%P1A|+vWZF;Qj4_Ce*6Q*9*&emBD;MY$;MOjfG?{sCl?EIg=&7H?% zx`QvAh&l3!I<&|e?d@I;OTzgCZF@t$eS%!__MH($;07utQfr@@0NPg^VcX(*dPwPkui3(!=-Yc$UTInk@nDWlY zh>C&F8RUChvmKsNIsfAg z6H%3*kbi7tJ;m(9Fm*}X^UiFY*Xr;O-G|2@lW)8aHuVmrJ|BvCywhxwQX!na%#KhS zoPZZ}siau-aO+E?ZQ-G=^5}r2Yym69rTlTWR|9`|iPl;;|9W zE5m~C4x4&yeNh7XQn@t_b%ZbS1vx&22ZriT7qp&fV^W~*>wZ?ZcdJ|43u*k7;|P<| z*e^#p^dbI#)k%t8mf-?ynz0`pa9ovGjr!+_v~w=x-SC_QoJJtG!aNg97W^zZ=3m3# zvWqcIkYC0k8d^<}MW=!G^=k*ndt{dWu?k?5M<|l&P>yf7`(5;pL?e{GYhqsaRp1?u zY7*~DvEpP%WbK^o*&8JZZ`gWCaOTFC|BXed`|VGo5JODjcHi&THt2hHeXQ^7kzZ?* zTuD9!z|~$q^U;=z)Sk{}tWb%tnExNbBGY9&nI7y8J?M~*Q->Dnr0)N0edOdtOm%_p zo9Gh`(DgaR(8}ZiZ?;UR#<$c*^OSj6vjO0`-<5CgcZBs9A$oO_jjI!9O2jA8kN7pk ztBaT8D_Cle2tGR+3_WL=&~G{KJH1M%H!?NZ=IPa$W#X`cHor)q#AsBEJ(@JBQ4jUt z8nuv2>SDb@6{p;9(5CN0m1|G>BP|tk<}>DUdUQz(N!~FQ!*a1iw{4qjC50i$tvb%7I8v&<>LGvT1gSwqol3jsg&b|3>!m znDls--_dpHyL#)S6s^< zMpHRd8t{ak+u%ruh}Du#0Y5s45zh9m1wai<8S>;I=D225#Ndq>A7g%QzfF{8Mcv9V zepdvp1b%;2Pgw|K5?bQ?vcC}a$+kyE$05ot0R6kK1<(3NGL&Y}dsnv7b1V)I{j?_E zx9JugDc10Q*!2`KgUj}fRAir42l0DyPm_J$*o(aFcw*UXM}+C%n2Pr#Xi1R5Ck@j( z>1)En@yFTAQ+uUV)OnM_-~%*RApBVxd0>k*pAxmu%QZ0TT4VtH`MF`rT7C6@yLFI; z=#h;PVFm@@($_h8oI6cj1X@%g8agu2jUlN&(NC_h50DEp0IT`5OZnYxRif;UB4J($ zC6D^wn70u(Z}wJGEITx8n{jcPHc1v-w)*)DtFHQwxS1*H(bzQ~sPE=ZgZITb4O$ew z`D&X3y70nI)(L?nY2@AAM|#s0aEem{@)YIaq&NIm$b#+XA@Rlu#Zz~ zE_z~#lA+MqJ8qWtsNOlhn|cXg%>G+U%3$UkO856oGHNdL8j@ z*hZ6dE=zf4NHjsktyU1ndmBn1(xF{lsxBP7NhjF@8G(OKef4PKZSMD>0269!sd@rD zujkjZv<^)t=K*fXos-~KJkn6apIt`z-Ni1Nz{W1Ed8Q&Y6?W3z%0jQvwB(y8x3#8~6 zUNrAFt~txK-b=dminEnycr#CO=P5IJ0iiCL`ik;bu@AP&4`Y7$l~)TaSpY+qwELJv z8t}4htMn$1_?MWt)&G)jhMNxO4$X0A`U-)xmCsu+zZ?i(wyhqU9{v>70_S%tF420( z@hbT0820@TYByZ2RNiN|`Ou<&6?m4J6PUGqXz9{)n`b3bPaIK7-(8OI?H2P{UNN5Avy4gZY5u*p_+q`lq{Sb788?0K{+ojXciyVs0ln-Y zI$M5?3n(f~ro4SJV+FJ{CHq-c+Ich-btgY{?NpWg!0~%krI_O9?iw@OXKv9d8Qb`U zfTDMHaMS6RMrmI_dWazF3iUz#sqd^$5qXlGGdXURG$6^dj$1E!h6zaP3j2F$dZ5Yq zQJMLy?bm+?ZY?_xS_IX(+9gQ!8-hGa-TTYVKJYawRpxP9`U)M>fDm>2SY<)qV2ZTh9bi<5*u z&&`pa-O8ZZ)ZSh2Quu6V$vJ4=`H7kMd&m|l<`m)XW4e!a4yxS&10J=>iArkSfbEu* zcYAqbGv6UODALB7f%ltzGM5%LT75qIDWX&j&;Nsa3wQbRQ7Y~tHMaphEc({lE`z3y zNxthG{}AgZ?le?uA3gFc7?~zIS)x4*~qRa7kTem7a*8 zINre!!qT=YQM?hSG!y&CUdfO5G7>F|8&35N$gZf5Hb|n{LpPX{X)%Pd^6Nor@Xl{D zm`erGaH|-_t?ZaS<@?S3!pey3yGGrJLc740HCJL;te>tsgPXmma`yO(xCEHUSBKanNc;jlY*6HRHEzDw@ zjxz${9$BQvdL5mK=0tI=70$df@gGGF_NMG4Qt_GQV}#%yS~`e+Pcii2(q*f*8CI0Yz&|&XM@y_5tnP2IP3Xi z>qhM~noaX9mCj=K7~=-BMQ8c#a);+&j(nb~Q>sq0tH?VxoYWvX9MG;PNh&DoLLG!} z!>%eH-EYJ5uv2yO^Z=5jWWUthn?qmuY*sGJ5fx!1$1i+tPw*%QPvx4k3 zHe&+sL&Ii2I8;hjSAf)ymhuJ$=`B4=3Fr#<3G6ZvO7T@brdal^iHJ_d4YD23-<7$ed*-7f z3oObEE2Idtd4$s)jl5l}?FKPxq75@Fon^1QTpr?X^y0OhV1vdxP1%$5=onM1OPrVdTG;ya|iWvs0;tN{3bWz<$nQ4v7->mm3bkDW1}pQ8=| z?CyjZ+f2F{!HyXIjq+6KHA14((ztcjSlPTBb*`7+M!E?INji~Q> z!!G6D@8G3?y+*1&DEV`S9S1<{{Vg?P25l9sT=!bOq12gq{UaGseRpw=I}a~}xz^kb z9rGS>m1u0{X0jwMzLLc)4$!?^@{fYKmsr^mUB<;273k=z9kHeqzTq~6VucKESrUN*;~>#$EPNBYCGBI{k^!VMF2_1*W>DG5tpXnTbT zTIT4|QpzZMc+ka7>^srC^jWpix?K8XZ6%AhDJ)Z*z}eDdyyva^xhL?n=kWB#=-}P> zACt8<`RE28eK66y*{Qfq53@&-d&RBpTtBV^IdsDq_GvBX7^4L-d%tV5+x8!tiF^J` znWvJQ5!4{N*|pYF32df5McHC1Y!*sbA*MeVMtqT8LF(ddUqy5tR^)X_^YH%*upQH5 z%FliASKn0oT+4KTa}zvQH-GkiR)vaLCzI`t`|GmcEo0qD>T5k2a*=eOzXN7PD&h_?Q*z8W$SI0`_Se#PV(oy z2)xswfwy^y$7l}>8@fx5^`R+8de{e)UpeKYa~!YM5)HxWUYyb)zVgn7=c?DS6_lFycZe@$kyTBbe@O}Yq_Y_WD}FrKG0KU5Wk9m3a( z`Jqoqda2ptjzhU;VF1?UO1rtL~ReGN?b3V@cwsT7!IVXFN!=K z(H^8f(_;uspl^hRk>2q!JIZ}kF@t9aDU#m&c$j^R)0&S_O(1$H+44Qk+9y71ugKtL-_6GrO($}IOqf(NB6%9GpPiMWhE6USRPw1WVT5zenD4EQ&T=y0?KM>dJA0n?bY5RanF|e zUhLkf^5UQ_eYR&JYllk=%H}2i&0(83G6O3+%6>?+OvgCcOx&**f-vg{J#^B7{OPVm z{fc*TK4}@45Jdy>-8&ygkjmN>-^LIl@h`0iqUJqtyp{a!XQjpGw+On#bDq!Jopp@; zsXX3eC*)IzQ-~>H_18O}M%$hVQq@^W`DX~*jI7AFUa+W4 zwH*L-bllp?&Zt-Z^SowxPR{eC`)$(Z!j?U0$qvgUX` z$3ivQU84r?9PQ~x>Ko^mLGG>pq=QkyC$|zfwtR)zuDb^ntGu^*>=;KY6Q@j8djViG zG#%tkTS<{4FxETIP?ml%{*2?Wia%-T$|juV+s3Hm0(&^XAk;aVJyaz7EgSuqMvpj9 zD@ptaIm%N<{IHh&%ggBi2crmGvi0lG;ozs&;_o%6i!+l4J_GBWCqqqPWOgP>IQP4? ztL*Z4^Jz8~G$*VX?V7po9;D{N3((2IGs7D0VhAu-S{YIW&Mq799nrh&S+^2>mb~?_ zd>FD8UQst$=DGVp(j9a&G|ama(>*aE8m-XEHM7niYh zdlz2fPJTA#M`VipbKIs)_Rv~z4QtQpSZ7+*nRQwWW5chSk~1C=ZF#WZe#nq zKTs7E>e{-y^YPRUwggw^<6)ujZff-|Cv#paBFkFC@W_z{hds>kCEK(W7wLPiOqW9y zJq0$0+LemXS6{$c%U z=#4H<$#JIgA8f?6k6ny-fOuW?88#>T3HAL&a=bq~<%Bo;J*8P=m5@H-%FfYVWh@wp zEBXSy^s;Paq>mrMN264pRY4+qDajiS;gxMJG4eaB z!b}R}4Wd&MVZZbi6X8>(DAgN#^cpAp5Lq5M;?!&-a%CrK%kBI-wI-vOI3MT7kT8h# z1xQ(sFN-3JG7cy7qkV8neDwcp;NStkgr)s%+7B*9iraZ8-B=HkLXLsljHBvQn(9En zPLH9L(#b-(x`x2@nFyO-zIoU<=5ld9J!dw#e=g;?zgw{M+Ig|zY52Bu$z!0X>d@j% zcIfAs7|vvHgY2%=b|HBt;=;JAeV04Gb%Z-V{S{uXjS4nIDtG4kQcT|X_I;QmzAY2) zS3o0i|o{4A@Ve+7GKUmKpJEo@^J{R zW$h`8jkcw}+A5z_HU%~0uFOn+>uvh0G$AeOJJ^wb+S^eU)E|u?BLcc8(hw^cv#hXz zy*c)k{ncg{q*oKjWqq-U+M8c0 z0acKw;gZgitkvX_&9WH!wpIDkMHB(Jnl}^j{j?)>2-pXa{b3943eAHqt)LnD&T#4) zLs+>s7VE6`2(Y+g zIkUoC55xEp%>Z$o`~5q5aq`FfTR7Er)UmP#_^u~&nfI%xnz`lOnBlR5`J+2a>>I2aJ@VA z(~t|zil5}VcD?KP)ov2Pvrm@&*J)p*&iC{v9qu!3vl<(zUsYaKD?f0&eHX1)F)3Cf zUmY~vGk~Qe1Y8V%P&1r;gi3GK$+e$wcw?*+ARZ z!{yW0=M&X^NE|;ECzVBdTk3$JFN8OhXs;oC(tKRLr?cU1O#Bk$QbHdnwXaRD0UNH1 zY@HjD{l5LW+nT!l`>+lgn71F_jKm4&rSJ- zdqIeB@Mr(`Mr^Js0W{u2p8uT3v{st49(+ zzH`7YznO#B`^9CU_Ujc3FtA3%8}*XyWY0#2(F_y{|I>IZnDAy%<N9@OclQ!040AJ|!Jr&TuuX+JKP&9KN*nD=7TWf*q z?@dl{-%_i?mvcjQOT1H7nPM%PMOJ`LmkvplhIqouBVGyzBi>KBK))r2ZW(m!u0=q{ z><2b^HeLTstHa-!EGE zOVW3fy{(*G-!Hv70U$M{!TcVhfX-lR>Ju6*Oh<5l&oXa4Kq ztEfxsPoxT))_=G=z)CM+A8k}y3&cbNR?h#B>eU$D^;1#CCvCsN^ ztpcOQ&&vhdRW)lcZaFv#J(^n!-O0kNm0J-!-$$aH71 zA2Y>Ekq6pLcttZ8M^cQlP4LCy{0rmX+n)JP+b>=46|cWA;=LpKGvYrz$?Pcp_-g>S zB74q!5}#=VtSoV!X9$k=&cG)Z8xnzS7;;i9k}Tf7B5_`7D8a5Bc&O{Jv@sKYt~H$f z&;~OV8~N}g4(lL0IV$2CsHWK0yA2w~;l&R)RsEelGs>BDDHXb63hBr(edO}Xs3!m- zcNpu%7*Uo4c-2h=d<5E~OpA-f2jCYvU-BP=u;uk6M5u`=KWcb@8^b%K6zoXO{JJwSRMNjZQf} zHK{U5?t+0P(bBe;R!2eT49D%C=zc1YL*Q_$k;N6Ew{mP#O<+ZZ^2;w$=qd`VrgOad zHi%|iIc-Q+3Qtu*pnbbobfaf|WwrPkEiRgIXmj3%?m*hKjn$JdzoOGYsRZd>Hb>1uEj%ULz_;7Y(%f@AHMMLi$W@ws@_E#46n z-icytKQJ#+UsVc?iRE`62W(>TFNcg>Ecw?MB|aGeRY6}>gGaU`KV0AS@TTI-d5R-# z-t0Urr#P~DhughRqcAZh(f{^W(x+cd80%MGM)3YZ-82u6d@3*shS;89H5`lIgn*a+ z(ROq|BPXXq4|WEzt0zBHPCA(=CZ>p?Ps2#pF2Azb1K27BQek+ z(ys9un(i4uxta;uyzIq)U;)Y9TaatBdCBE{g9w%F6U5o7A?8v@hGMm8^fZ=b5yO_0 z+xELS+S`>R<$s=aWk0pR80|BJFFZ!Qr3zi7`u|TFS*M{F9J)G8Z!l4p#GgdF2(cLv zue12T6xdzBnrV5)POdrg0~&e4J`_uqtFyYT3-Jc&M(M|H3_>>b1NPuqs-d{A#94>L zazkh3HYjz)zzicrSbUq;EXCt^x}$k~$v!qvf@2->Dc{xL1CT z{NiQtiOV~biLHR#FOK5XB=nxh3NIiR3|@D!RCoG!n`>>DYp(l8xakTM)$f%` zS7|;JOxr)6vR9lADR+21jQg`-h(_ap@0qv&mp`;D{|=~-IHtVyHqxd0ETgoPlVXTqo|xL~R&cJs3boKU>cn4|#=trYoj_Z0!K>+tSDZyY%_~9C z7Bx7O;w1CDiKm}N=hQU->_Uf6|0ekJwurDZ>7Ub=f>`cO5%9pv)FBJTQ@AgT7(yyvOdW~nd^r#L8eED)1KreJTm@=;d2rwzB8%!FryXpNpyF+Kg zlIlor2|Gy##+}Vu6g*&xF9k3ckFuY#JRP8g8*ffSjANJqJrFCy=5T9A=W_h@)=y7N z=`o)gLzuqq9T5p6D=5iq1jOK7M)Hm?$PL$tnmc`t#i(bjpk-Gq-|GF^lSS|MOCQqY zLVAJ+wJv#q@h33I|9XOzuUKPpRFM)bFJ@~eZ4n;_&G_6`Sa?eGLim>JrSTOfqQe?v zP`xj}9*-tR1Y;dewY~Fh6i=^6xk{A_u~viJ#($jq#WjWMkxgq3-z_ryJ5m!{5d*de%n{+fh~YW(Bhst znB$zIKKgn*h;PZW_GL%bm_x2mseTIEm%`biT*AZ-U7#Uefvk4*-+aB86V-KY%IeWQ6Bm2a16tJD@eA}w6<$`vuf`#$ty<8 z;=``zVF)j~p)iH%BBa%lB=u;VE3RMZ`t-r~+{ClA#IXn+_xu2dX1T7iA8Q^|WuUb) z-ujQSW5oA=*>0;yfRo8>;zlLMfjri0V-NYo3>~)7TamrAS&8sf@!fc&;CwucI0>m~ z?>ZOnB3l=^jQC3SC?lZV5{m(l{AOAl!-{07>Cxn;+YilXufp!{00PL|n%`bJhv( zFuBrOOE~yQo|XuCYi8ed)VZ!7@%aC9bT@BjZlE+PqKrz96k9Q$@8$#F4kQ=I4% zc7De>MLF&k$5-skflxZS+p z@4a5n=i`2V{4_$slK&zNZU5u?#ZH|c2W;$?)$>TxFJ;{O>}_Mug6Plp+|*aVm31!6 z+;GphuJ}I+3M}L`D_yTMAZ^%vspWc1%Rno9u;NT6G)r6+g`kZ@VmQjSD=n-^GkJY>18mtm+N5~SgqO|l1t^>8UNEPkdgaA-&Jbb zJ%*rpyfNl?$nLnF?B_E>>kKcf0OE*1Uw5=G?C2fAC8UkGzfWpC>bk^l-L|^u$-2I0 ziY@9b-nk89(bk$Bs#u}pPE6ff8*nvNH`8vdY$-N(&urE~0~!$aU%jl_eA$0lDUUlg z&g3QSncK0{cPzW9HC+*@8F}#XoshA*Nryh8ailEqv-P(aXK7KP*3HLHZH{|W5Agz- zM;Modr|3hiXXor8{=o29J4tXY_Vf8%3+wUrqv-edPNm5?H_XdWcSvQOlmUMIXMTl8 zJAUyV^lZbKNwBpM*qb`gpb^*j9dvAdd-;g`!k7E&PSyL8t?skgGXwR);l0%`A7Q!j9_xEwL56^|R<^vb@`){o zxWc~}+UiTtnlEc)HCDyy78(}ne1xu!E8LV}1HKvf_m5QMzgc`F4h*$GH z716Tv2nQ<)Z1>Ica?xQ~Z<}ZMLqbg6rnE#y+Sy%~yCc;o>$Be7+lMNBo;G_|khC(% zeV#C(34JsGGeOqu*>OAQRAIirjV~Je(#xW(cIJn>w0Eh=InnFU=A?xkzrRXiz`l}j z#<_3d&_U@K%wa`eYQQQy-VX2 zqPia%@-(ySzmwkP#_~Fc-D{%8&@;yRyu&-Z^ZbU0aq-pxM*il(#-E1TC?Hmh_oE6i z@6sH3I+yO1CowDQSk{Z?&E3CQ zH8ILsLms{;53je{4fr%%icW~=8J*&z0+BBichJ_dgp&=7C)Ui|Ny3U=&5TM}()-N3 zq=5KJ4!)3Z0+N!EunRK?z8tmm3V6CEu)E+_;J|stU^Wu}%ci`2PY(W=ru9tyIN0qD zxIy0l8}}zcJuItwFX&kHg(y~!E$plBbHuz>Z8`2*rhV(Iq`Bf4)vWVrV8@WokFfQ5`?*a)H0_@A0pcd8!Ei<+WxnaQH%A#h8hgud22mLZCQm@LAN( z8A5w?WZyWb)qD&B56K%7Yoj{;BWPYK5DWUwp z$*^e z$ZCD$-lh}x3hBzW{iY|>d}8>MQL~=RmGQrgGUJG}qd3Kt%eIkH4(f9tvgr>xWcSmL z$AjBF;&fegaPWq)+VgxDb#|ny-mj)J*xf&)vb+w$>^I$%;Z?lpkh+On9X13ZdvCqv zpeHvpsvbI2CQ<^h;azIQ!mD+~{POjviP!ems$;>2NtD^kI+cAJ7w8u|W^Ri{)M>(2 zX|%r??3{L?&bowg>>M59D|KF9z8A7Ge8AYr9(C(t7C-QZqOlHkDyvB)meEo>S8o3r z{ijetQ%{S}`#E}qUDs{9n?0vUSn9O3Z{RLkB^!BUO;l$}HHAvJZJps5qvf1JFeZy^qIT|vxAF8i zvU@NLiS7^NZv$qa`3gV^#6n1m6$#!a`2P-?{tdB5o4Q*(&eRXeneYFh*_pN$JQH%% zNGE`d`$_zR9W8V34&Oqjo96x4@$KNWy?SA>`R@G$(@tpFr`iM7oxU}uMN}3B zP%fTGTvDfJ-o$OjTMgF?WGEcN=EYvlV8`26G*i-TgH^gWZ$w$oCg$a#a0Rt9C%Knh zTTRkj$u4apCfxOo(Gad}Xnr0W&`UUJ8`@7bol>v&riHC>QpaM9$-RfC2!9e_Q&i}E zn+;W#c*CLqL@30+3U9xidu+Zye6uXCj~FY;p2~cG2!k)^v2_Daefjxuri}o7-9S7T z8~u+S!BlzEQ&+ceH||YhMCFV1d+aKRZ*Wc|SO zaG$L%7?FPvZi1(VJ(^7rvJcG33D71zjzP-lE0OWpqw@dJ23D=KJ$1O1TDN2KZ1!af97j;pZ}{_ zLh^hV(QkGUTSJAo9@pbn*!;S=niAt_GbbnhsZalGH&*OTX2Jok;?6phBq*3 z5xeu(TQut_-mkqiQ$2Pj42c;tPETe3=S#OOLrk+AD1`RTi=HlY3~IjB9!-6@w-TKu zpGjg*{Tme30h_HCuqx4rkR^^HwQ8{Oby{`En9c~OX3AZQSdo{1m+j>4db({sp(N$6 zw0X+cB&m%rF>NdKr^n9AR&DpFfMNA_VcR+os8&w-W#iM5Wc8VGOv--0j+yG|<{sKR zJDaUT7+vm_mu$%H!;sV}1G^pF8 zMqlrIu28A>J~xD$3~|tIeYKDti2pPga-|~KJ!Xb=jUz)ZUc}G9>U>9#HaZO5#`2L5nWzQ?xBun&@!6My(`nM zbTzsY^WE3iRLpdWz4hF~_#oktDYR-Lwo@LWv6<+}EM@;{->w>mi^xM-N=-!8%bBr3 zk+1$BH&o24CaCNVCq>GR5jc}!N}*W*1oAz2bYZh19?K#ug<1JKmM=QP+Lia5-fzs* zzvos2bWw!eW!vmV?1H~z5+f!Ud0eg=Ubg5rJJXzA4dfJlnk}Y<71Sm?>JHD1Hx4Be zReTRMo~JrND*~!oN-O5H8EqSpI1VgnB7mc}iuuuiOp<@buzy6 zMR9fggK%<3EZ#cEE*okd!IV{QXbabW!>EAiJGvhoA7!74D$IVj16nqf4KWR+fQ>DB zO|?2-{2`I~b`XdL+$=f4yrILe{-#y2>9XU-r^$Y-FoClOnt^h-DdSTA7kzhgqI7NQ z(~9ODCS-rk@;JxH2D@&pOgFcczRU&nOz$@QT2mfX*>-XBQ&*W3tn6 znQ!qYGS~e8Z9?OY*Us`~qdv9T<+pFvFGRF1`oBb0?Viiu+0>WKr%EQy4L0QXV3axL z>|Urw4e~Jc|3bm7(MElaZP9s)#Bm+Gud)$R$1BuPMthy~#jMw$eEZ8xn4>$#{+~fz z0^Lpu8Lt8nR5TdYTW-(1c!W6T5I=|6oYoB*nThtUSJ`&@+IBAxHIvK^T@Jrl8MaLD;i^rHxSn_#WS=uLBtLuJPiP0N3U>+WX+fd~0ypKY^=IGh6b##Lf(&jN+HBP_EUuuhFR8>LTDu4L ztrfRyK!mhso9!n%#;!2m9pa?`BYAhkc;-86v@7-P$X!Lxx7uMh#r~|Wl05Nj4iXhw<3+5wxcYRl^-~D7l>r9G56NMn{+V{%g)RU;C@+~+aDeA0ugX` zv6CHrcT-h9|M}C#e{PE}wV#h%$}B`Qjhs5#K9YHfzMWBhIITFm^v_qU(L-R;xK$i9 zn&;lVIq(XR920nYv#{|zVl+|!dy&{Z96GUe2t435X%HJhv)!D#PQNYxIN!_`-y}S2 zULe?*xp!3GJ6;%15O|~H7mvrc$v|Zg8N@oB%}BS34U`-8eA}IM3Ta`f`(p)0sD;k= zgV17-&D_*2@-{Cu0Ytp$w1D`ZF zZ&BB}iAZ@AxO-%fB+u!`#COf|fv@K(0oON<`KfB}%n((T6vVaabZ`1{rZh3(s)GPnMAa${PlWtYSl z&g@T7!nqo@ok%bC5L%|nRpkj_QGo`FS-e}Gta&!7lz&*HGh;D^_(=4!n_pNh{R@Ys zG^;6ZUVUn9>xxa*O2RTjzTO-00rxa^AwN{lT*a_%MkIYP-_+*-7qB7ryz^$lLHOX7 z{`o3u(89mLf&$9=>;qMPU^a+z)hW&XiLj;)9rNhj>Cl%SAwlKBn?1vI~MbUanUJ&qYwgmYs7g^En zCkta)YlMUowBu{>aQ;n#jYBk$iB`B3XSTG(Xg|OQiFMuVy8>oQ})eOXJV_zlv=7s3j^9R*#O$u-S`8+I~m|``vaNQKDp^4yXRrVv_b8+-;J`((pOc-EcTl>v79EN3Vsx zd67f&KLE9LiPkHZcbO@aDC+tNi1SBtsX{9&M`fmyauzZOn?CNAC3ggDp!?8 zfXMD?(xi6tMA0WR@*<&NTrnT5u{of=-C$ZWV=(QGz=7q}_NJ4qvmcIazbRV(IkSDn z(cP6C0Qo0#^0LBfK{Ji+-+rFA>EIsG<0e_Ih}FIfDnnt$Q%Zv7B72U+5@ZoC1?qB} zhBHmZVT^NgiZ{=zv#WxLzRtco5df0k-;h+wg^EU!mAA?ree1pPzP0^DeV7m+-5#W0 z$_)ZsQtLFR)7~Feo(=P}GkCv+d}G%*C>XCW{J}i~{~4#p5(S=KxFd+1c36|9D&fqk z|CB#>{cf*&w}Vg|2%5R?KyUbIp|=koW7X#V$jLK-+tr|Lvn3(cas!jh)@c}of6w86 zSk?>Xs|f_2<{_C!&|z0_N9zWpM`t1<;l|f{7O(~g3?A}d+&;{}blsHA^f3YPV@mod zW>Jf5{lVt{V_KJeLXY&+P2fSogr$~sBKAAP_WL#*qybxWDgR7C#+K1S0_d+Y0p|v( z!vScsNy5-r;-hQvxIQ(0&Nv>akv(VV4SQa9YzablV-d^-AX_JEzQJSH610|*$A2ls zR|FEO=YDUv!oR^|J8>Z8+zeDrn2_|yuR&gKy)}_-Q;10MuhHjBehzz(URc$cq`O?c z(pg=)2>+N!8VqSfGVP~7g{NY!AtinvUvt>goil{~9sIdH#312!s-e~*0+!lVX1`gV zz^~*auDuc7$m~5jQMh?&Os&DoVg3V{$f;2L3v;eR@_`7dhj9~De@G|DxMu)eY^3?;rh9?sCmWCNR_8J?mmLf0Py795t(&;O8kQ9zwF0fcxop)4fMJ zD}G33aLZx>AFcx-FplgSjVI8Mmh6aU4pcN9GSW3fY*kpLO-4)^+YLYWWnDUWfw?)Hr(GcH>#@|Xz-U``bDLp}OTE4+JwqO6#x3QxQI{Evr`xeA~Niu=na zKDR!ov)V+5NI~!-_OrXi^(Wh0!^`C}g@l3QW z`-Ckr!4e>Tg+B`#4X1uX1UI^@{lAPcGP2(%&&d-<`fKkkB7YIoU@Y$BS?A)sm5tR! zN2*zGA)ly?HGi<;@g3d-oDYvFtq9mKF5foxH*YvzQS7^wN6?am72d~>Wd=e@q;_!+ zN+Vuio?&w~g!UicXvUo%Qn9D|Z@f~cCFY|veRTH2y;v*8cTg+HpdP0e+RUP!2}fVp z=tZGMgk^!DqS9`dVoEbDNOfj4OJ~EuSx7#jSL0T^CEc4+o-&O~>*cpLn1D*D(7EIb zaWO%5u~qM$MJ7e`B+H@Yiqi(;Izo+Ih9GtLr%ez?H^9`P9i^`>yGvReKTHzcW?B@y zy2SAMaw&}R5qDO|Z3wg{@3hccwq`OtC8^gkpuU3MuxqR9cBv#tH@uN;-U9=Gmbyg@ zay1;6(e`FEb*cEKPF4cZALdSkBs|7NH~;ZXxK(byRrY%^K=YTw%!={NyF^6D=R%os_p-)wn=jcn2fP|u;``NFf)J7nRUp$Ts{hk)(dO$f z24H@TXYfpGKJP-V5_k=ltluNE+Dc1^J%~R)p;XC9hD1i-t!z9eBvG&jkrw(26T}p^UyhY25?~h8-Rmwmm6TA^MEyhpuFbevcZ8 zowRmvr~kr?6_*5R4jGQtL@uq|#T+DOsv9s{(ocG2jCBTyrH!J#J9lQ8us@0M3dfPO`FUbqY)+Ox61o#Z=xI@z68s zkDV!lWih8Qdg4v9sh^@d@h9tXX<{H*XpWn{;=bH!?3X$*0L2*Zon5T8Cep4T5uFs9 zhWNa0!JT)-Ev*(z5RshG_RuPnO&_2*mGe98$Xv7pX_Ck7NI7gXdU$y;Kf#n;UA)r+ zei1}gDy=m#>|;~>&EMM*IgDDM{k;NH6n4>ryYu9XTyLx$P+x5x*povDI$-0E8UMWr z3yS+$l<7CW5^hAzE2){->N(PzkqDySwWPmBq$63HL(S8Df#Nxz>;IkGEQ~0KesEK1 zI|jjNR)#BGt3EYtn04uN^y^11%SHjHhwF|RtSLdS&Of!^I@@PF>2%rOdOi8cyfu@I zG%_2b-_vKjFOJzN+1;i zwqVSWTHbH`zr*Vy9m-K}Q`VGZ#TJ-{oB9tNx?|Fw3%p=!ZD+kw#}ceIZFOJLAr4&S&GQkn2g@>dyd+RW1#{e^TFEFil^s(#Dsd4Wts5n@ zY>4hU`de~>*UA=bl~Os*qUIIM&veYevi#%ZIqP_#G%}qG9s}yczS)`*t}SN;m1bS4 zBvA(NozTEX12}iPa>J{a;XWq^%T9Dp2Nc316bTVE(S7&B)5GOgXJcQ_1P|Fue%65~ z-BMY<)PWkJbmUCviQE zzPkmo+gnuH{$4h3ugpD2oW@$Rz2@IOv3HBW7iJv;j*tqMq{mLbG_=BGcHpvO&R0RW((oCNHBA>(WPI~m3j2COu%-E;ZbDQN^!4r zRGnt>aQ|5&jIht0x4N;^iz~gPZd7Qzz}!P#!?so*O*IMP+xjME=m;imVXSm#U>k&3 zx!ZA;MCV|`s1WaY>u0KF9HMFv7sVENdv0e1-Blb|R>3{)b39>88W8ikirVEVklwzn zse@OOet(MVh0fbPjG@BvM8B;c`3I+a>zVYXlIUkLfP2^(Y}o-eQ-hEy|8~Wt}=ey7}s;`?v$!=ZnV3yO4caVErhifGkE*q z(j~_td22{}o~wNbZV4R-G3NnB)V-s$j`NvpXAz$Nc@E>fX}#jlAvUO zx#%e`xuiZD2bX=lkkeVzRR_6o+uI= z*iJ&=5P|myKG8nhg=Xo|aKKiJe6$4tnk|jb!BkaJxhFo&wk)28EU(k?3t!#I!VG(N z$)n}$wDU)5u2#zY4CtQc&QmQbYNOjnIV16ketY!V#pn!c;j$Ac&130B1p?{Hf|h1rFpoo_8wVy^9B=VL`SkS zW4C*szTB@!(K+qX%DNpK9npR#6*;o|o3|uY3s;8ac8-J#&?`hg;`=U&-Pa~z5#5vO z9~I9wC3HG{g;uAQvO^skF>V*8n6d@^XiAGPX~6cJ)L2Pj5c()LaQ#EKPu@t9_NqclyogIG ztKw=*w;>kH4P^KXW60tzMr(Ng@LZiI$DDVG*9^FeVsH;;kkDrB-748LQf13b1ADj^ z2DovBCT0v-zw8b3f@bQP=Lh0Aq$iDT-$XjP{6$=rV=CG$n(Y+HMnZ5vX)!1g zLPe3tr*9I+>76nGVkds|H)t2opL(6BI+*d2+pm%ZT~fcy~3uV@GIv3 z^w!5luYAJ(_s^T=;LGx3g0?^Y;@n5Q&l}HlaSmmx@al4XTDy{kb%TdEaAE0Ko_m=5 zqMUj%J@C=(emtbXa2!LnBq+@XlUj8D(V7@K!T?R}0{jqUe8{Ld>Mm2cXz_H}U*P$q z=_Y$BBFEleaEIk4>Tb@d>rQgDx*^~LzFP6WzS^fy*z20D7vX7$EG-?x^;hfr;u52} zt4JOEJW;mfVk;}dSiI}DlktJ~L06qoKSdCA*eW_zB6No9^J@_o0xvhU6wOXPP?gr0 zKV?t>kMS@?ThOkvMqBgEtk68#wh;DZ9CXFfvO>3J(cS>!X#+ zxVCKX@XZ4gja~IAimPE1fVNJBq?74}*W~JQ73T4~>q``Y{GhuXFQ&2LZFTM`_d=|* zRWBmDHqTm?`dD(dij@GUtso`O`Ch@FS+bv$eY6GUZNPrBki2i41qgcauOiDJKq-t$ zy3M&RSGwws(GZ;Wq5@w$U4=$IayiYi$g+_PL7V?zV^2scv-y`ic-oMmtP}kl~kOk^uB9xe|UT0Dkd4w(VJurmi-dj?y(ED91+{tA=Fu zsGR^NfBt*d-G$Q(`%5-kZg&J{8yHkCY_t9A^^S6NS<;&P$G}3&Gnxd;DZMTFP~P*J z_g7jLek`r;_o$iia>26&G|_S}A=*c0#F}yB=1U++OI?_z3l7v8fyp`coxp}GnCA^o zT1YMZX(Sdb@|bSr=8=RcngtI7Ymj0S{Lu{3z2t>tO(``q-B4O*6yU_BZx5`4HUqbi za350j<8dm)I9hkXWLj>ts$ukSC2G&-bW4o_AykTFK$l1540X68q zoiGnY(MVOK0$XuwmRaMAM4QDgPZWR&Yx;jn#7{bI?Is=9OLxc%>VL&K=-}M8b35Aq za`={*2O3U1!;Exy58RH^iWu>l)jAcgy%bDxm=lhD0m#XLKfQ5g4%(~z-=>3%&ob*x zl46VnuCg2Fl3+1#T5T2I*i&ZWK$WGpohMmPuzwVq;-q`g|2J*8X}|$GLsU{~=9Y>j zU(*(|CROq#vY52LS-QuDs_!Lug@1>I-H2)j<(ZCnrp8Yo^X;um>fD3w1^CM0RT>TT zYSSuPV^O4BCpa=j$9K{|tna#$dQkEoPn*Ro4bU0LfNy!TyRQmiyD0Y z*&ALIKkxC4(&B0A7ujgeP;p+7}H&ut}GGMtN|TO72RzfmL|Vc*b6s{ z`|Sm?t7B#nw&LvmY7^4vB-%iu0VHZ_Fb!@e^J_z3H`a2sl|=hC3W(}ES6OP9V}|Xq zf3}|#OWb&{b|2K*X#DKGoIw@G9cQ(927ULcoq2mequ(PTEMD7Y?m%7%?GRGY5nh2) z!DsRHZAjcbWoS0#@vJ!9NFxwbZ(qZqZ@m<4nFCShhdNF4qDgEp7}1ACE`we)cE|Qy zGqmZt%51h5AFl`i&C*E$Ii(|`Jlm?hsOBQpto$?V7Wl5S53fqVKD%+qD6#Hajf()C zuSjhQ{qNrQBSYsx6!R*95Kl)|js!L_dq6tuxuIl0X;IrcIS!@=b5cLqC+`3;xc@me z`er-lGWBLg($tf{S(4CRgMIB1+>to10e|xTD|CZ9=+V60|9UT1o^m6NW6yTz5YT-S zhd^S371a%NLcUKWP8oeUF2yJ>8kqJw!r?|q>T>f67XNrzqrjdKqEV)4&I4?FrxBi8 zDrW19iGpxPP00jjF=O|N1aNU5*q>_w5k($5R=wsm%e(BaNl2!b6C_ut~$C zED^k>9v+*t&;)5xYug@;?P@rhq1`LUVI60wmC1|ayB+BP-%2E2tmUS+q!@_oT5CDP zv(2v(bO(%Dk5F3cZY|&#}Mr*iWei<>6yY zoTqrfJl1;%KXUE7_Zl}_LpINyX^6`EK z@WY~5+Sx{AEO1Zf=@ni~4NLqV6;wCeKw*6r~Ch{Ji z&Cp(Cy@@p7x=Q0YzI;lZtRf)NG%0>!{p}vmFZ91SMB`NEA7tmrEB3T38O!B^o35#9h1~C~*1^ zL_bH`;od{nCeCU|MloIE%@D#ikhp(#lx5zquRH+w1t?LW17&n!R1J90+~1!zu3$dl zJ@JKU9gvT3-BMY7K(D$nV9XY4Z2(h4SR>Joy!Ac(abwA?CLNc?xsnc6?Asx}1&2Y*`OzP#A$~0@Ip~%8eM=KhXeK~8Q-8P?LXy*8&TCpr`j=Kp{O^?U zv7k#ak+R!JL^M$EMAh8-$M#ZBN{R0-jwj&sIt66vrSpCUnwaFppS)R@J6Qa%y)@#L% zexl}2#phLE4g7I+RVJ~+6~33_XQN|9M~g!b$;+~U2N0*XtRHvB769@euB^xpNZj+h zgkQrU2FdTUoYP}|YgrPR?Seg3U9Rt-?@$^m8l z$t&3Xby(qi?@Aze+@Akh=dwU_fm>AJ2|d|gt{xG1S$ZTZ3`tIY4^G00*wt$_YJD2= zSYtneY5fYxfi9dSnMJxpdrC3_HoP;y&#c)Xp{Qk z4tr@uxY>O}hS$VEO3+)t&Xz4e-Uh=B*~T6VinDdvuq&A&a|8Am7}lh%!;_Xgr(2Z7 zSnWTAx;A7D?6F!?u0AFSk|qTz-HJ0$0km#{XTq?KD2+A-Lakz3Xq$YnvNI)> zdLGX}cPC8?U5rzwavD{EaUZcUe=)^1H<;(eTOAV;Gx(B=WN9v3pu9YrA24W3o);>W z#ioILrM@q!vsj34;nzkU;btEW^Z=sdcjAYGNiO7ovZvgu^h;k}^KRYV$ZNNtb-vpY zZbrZ6N=8i`MxdejRTLA8_*4pC`W& z4eeolFI@*H_`YnZDVPxVA#$zXSq>_1T>)UPe+4{bK*00JN#{q7qM$T}x{{0fL^YaG zx1YIWANv)l`)jE^0v~gO3j;c5M8_nZFaT%}Jr~%x^P$aw8J&C$?$b+6I;AxF*|axL zDGH&)BYjo0snd7XHANEoE5g z!fIWpmi8C4smZ3`P(S)OG)`;C>agjK@@TV!FCIbH5Cvu($?vaCQO$uWgiDc9`{c4* zIW4obm319#L^>v)jy?|#(v(Gmwz)K0(Ve}aCeiFou!OPuY^a%Cr!j3;%XETn3~zG% ziD$d~sRvTFmv6w^v=xr$%W)SosnuEu1_DFDxC^uG=-p%UYNf32%LA0sc7Sk8ik+SO z_X!KCuI7YmYQ4}5U`Xkh@2~OnILZwRXl6MdO_LSYDbJ2&wf#^~eQ$@zq4v5-W`X|| zR_+ad!TMJ;L3lO?r^%b{zd8TZLJsPgI~F(oXcD(hJe$-G z!SbFti4C&bmOiEK_}yU%@sx|^HCKgeG`;d&)BfHYcJjjd2r6;}_==miUR2fngd<$< zTYOfC6ci(Y@cvsKNIbK_XH69vCdE=urHy=5-h9kZ3z+!arEcl6Ox&`W!K9gbBU!O7uzuIX4KHOTE%Q zZk;4Rq#c++7;$?SAeeU6+jrD=V}YYMXL9Q3+Sxvx`7Qo#vdem~Dj*H*(CO}#J;=*m z?f4-n9vRb$mbj*YI4aPO*WFnuwYBswrapOEEFEcXf6DC?`h6dGaeTIE(X+~#Gc=O{ z4C||#{RZkBlDl(4ciAc37~zpOnffC9Tz-5NW6_~*F?}azQLCnf^)_+3lFqYk@EMZc zAG;52ICbWi>V3{?eB$$RIwbw(vW0GQkgETl@=p$2zVT`o?|BRQ=gk++n^(VonZK&i z5*saK&Ya!qcwOo+w?7H!4u95NL0G;PoaRXXKH4Z2Yx1m(`2-jFlJojSyVsYSTsx2c zm0iTt_eq~yHWKb&XC=1NI41i!scGrn4q#%lj1O9z`O#h4d52*pwSYM!d7PQo=Tl9- zc+u5mpPH&~eD#Va8AyKGXqf9cRuWnpImv;4DSKDT{H+eHY$w#h=Kvc`suzE?I9X;4 z_(;Gv#zmPf2T`st8s5VribZ4kPS5C_lj+lCXTOKW?FbBk< zlpErWCwZ|3LM_VlXJ$ihe!~ANl^X{Mvj4=Nr0%B>^g5qfphzXR;gew#N80WOEJE%? zHGAXS=*Px@D!Rnk1KR?a2Kx>=Fk68cXIGeLUrKA!0ZH34);*zxbZASyT2M#h%%l68 z43s&iNYk-=rt}mz*tCL)q17L=QD?58te2n4Z-M89`FLgVF2%Otly;d3JpRkY<+n!` zx?mLV?)^>k_h-zv4$zXk1*FL?n0D_u6!M9N+eNv+Q> z4;gab&3luFnj1D3YDfA1X=W0b@Ok{YhAhTADJb&&tN4pyz6wMqHw-~Q=i zTF$e|)}_bVl_K!?jGG2JBU#}0+0ZshztacXBBBfvw3eRgaMgUfA z1;K#83U@KjI&X)N03DsxE@Vi`!YABgQ^&Z$p!nUXk=V|9r!c;YPMHOK_~d=DS$7Jc zN7xD$92c6v8-Cu&I3#xQ;zZaBa~-5tvOoTPSdPVS~4JLS%lkTMvgin z66ChChDp!8H4_w1pAWju1I~Q*ihDHfjdxbmW1zD>u-D#tgTJ9Rauh7hR-l4hWi-O( zKt15zTR9s4mf5;)Pn%YO@lNa>8E2iMzuU5R1aBN>IG`6Ol$IcnKck@4*S2;DtX$RD zkMn0bur?*zjyjW^Q2*jkl8bQ+H77;u#0z;7=i&O5kEikln>dSj;~He~(pe#3@@GVw z?*%I)2L;bOChJi(AbxU?sbZ`S_Ys~>A*J8$Pu+&6Bl((zX9%}mAoG{Kq$M`f4&*i~ zJffSgG5i{Soj@4YoNWYO$ppiqz81WSEZxhVT_O@^>$xa?{}Ilqr?p^TnZ9?*KS)m@ zQkcen7T0vLTup;R-6 zGWJw#;SdB+Kh5;K+T8>4gfB&=+i#iWGu1n;vKbqPF4V*CP#n8!v;VE`H-_28rSqlX z<;UnHUvTiqq{>9-Hx0rok7e&eNtT7 zkvM#P_xJSFk7eVWb_~Sv%CaD^t3+O7@HeYUO9tax`+jSYt`ka002~LbwHGf(6L5*f7tl$rswMYQ0V!n z?(&(ky2#tyl&u2$E;jQyDFT$VR+Hu{_aGIy5R<0H(^Eux7Ze`bd!MbMJXw^-Els=u z!LyMpxNa8HQB*V6r=z#Gp0>+O)1}^CHqMa)ry(j?1k5WxAnO+WdcL)B!ahoSqrXmc z$%j5dFWQYiojc-46qmt|hsyDB;6s6py=B(uy z1kIMjO?ab3fz;oxI_hJG&Nc zeF#O!NCqY@qqs4!HLPM}wsCPlR@b#VC@Z-&;4h3hGK9PD6E*Va9eox7;90~4;)Quy z>>HiC+dv2eXo?L8OrZS7QUfsV%P$?A1P$b%Q!f<sdZ*q*u+UX5r?(IJb3lE3W-z$>%L{(DwRF8zek&qu zIRIFL*)ue0QP45?R>zH3GO4m!2tPY}e-JG2mj@*hnaPgKPA zHy|7KQ-m&7E(CP_PmJ@1G?Fcn;;;T?@R2F|zQS#K+gO$E2ln3LB&oDJQAO7Uat&l^ zxiSA!J%nk^N+mDfbhcw21-Y?W*_>vew-&5mIK=F(5_y5%!8`$f{4#MXh4 zVjc^Znm-2~vzGsT7X249^>yHrA^X2r&SrTwXT<`_D5u0v^^QbJ_(i_GGp%jPAk?OI z%Zm%mS!wNksouS*CQk~4|MV+Q(wg0dAUsFIZzbvMx86ahr)|6oQZ!vm+E?Fu-s^ey zTlE=inFV^}Vzf_QdH5rUuVh63Rz2JydiF!ZsaIesc@oj~QUYZ~wBvQy0l+_TzB;tf_V2j04}pe|Rf ze$&r{dIxL`fOLC|LaM(!!Kv&4oooG)VrLidplqG4Yw#Fa`_>C++o2_))}luj@Q(tA zhHWS%n5wNG+Gmy*^mtopMy1smW~CcV#dG{nfxNqOdt+ajdNiB?(G_}y>IC}6R_9r4#7sTD&aL{fnLn?W7DHf zW{yl$bdS=k2}H_mZ>ce69N?F)CzS=H$C5{!@G9UP>|CH%=t9bpRzw}5zM^;_b;r~s z@$%YzNfxpO_VMX}MEpCj-fs^5<8S~(&dci6~6q=PYlkXG~ESY=T5pHB#V!q5vgGo;X)VCp@?s#cS^%$EQL*uH1ddUf99p^na{4%f#imw=3wWSl20*jAZ zui)^C*4nAC%2%>k)wpId9a{@}St`vooKV>gZp+S}K@yg06LLo)VRtJZhUq6@+bvBf ztwA0`yDNoI_*VWgyaH%yU+oLBx}O78H=$C~d?OOxj?$RaoE2trpOUY1(vQ*i429gI z*bDE$vT`@(DsSkZAll8|^SxUw0Bx6fefQrUC3f0g=#RRgVF%fZptA6?=OU@dQHdn2 zP^Yt5zB9*`iSBGpr4{o#N#2T~K`Bf;+m*RP(FvBj@!2Pm%wkBcp-`LIHT_$JOl!=2 z@(aX{>4XY=^4Rjq`Vq&ph2zFU7Od=EdV5TNIFn@5xm&R_IwQ0`i#%OFUAnhv@*HW! zK*ICIeGYBr?h&&t-Z*X-G}X%>JG)xZJLK4RZTd2v-=fT`I=Y3`S$to>4EG3!~l670l)?INnLvwnqEOMjGm z%HAQ*@zEljcq`bHXzd%fFHV`MA+(GYzp#TUr-) z@o{vwxaIR8ZQl4ooaZl2)|7JfxR#5oR~J13_S8E!oe*eH8@jO!3g0w+duifJOJHyg z80sXW^{V+)x$MUL{)y>EkEB5aolkK+&RZvEUnMR>Uwz3=@C3r-TlxB~p?)8WARi+8 zV)fRpPX65|{~LDF&QW?AQF@(`s#4v%kn)Gufch3lkDUhR8O%$5jvx>Eyseb^W4=jHq28xjIgyi;K@?Ove`O`ysW_B%s=9Uol0vtFg^ccj_*WjDR4k`6-C zzpRorJSYdhc@B3s*+YE0&)^2&Uj7${LgkdD39Z&W_#s@@02P0B>^||hSNx*2GL1e` z-*N^pldSMFTh_VC5 z1=e7Ot2|z)b}ckZQ~E|Pe)fY70a)H;X_WzmwO_%^E1I5R4YE6}-MiA*D34q$^eMdD z>LRGnrdWLKS1af^=Qo4Zy0p5k#@*i_AIhFp+CSz3?~Y|H%_cuhs&2H~IkS0#NZ5Ju z*L?Oy5WA&YEkW#M%;-8Y{#2OztSq0>37jQ8Ts^lNkn;=g?H>*2S;>!Q{b>kftR0H{ z(s#(vsb~78poT|0mdCQ>c02$6vCFH_wmVIgg~?0DBhrc9a0CCKg~E(jvQ$>=R{>nY zM|vr}$KU(rDz1S-E9_NklGb9@-Zsd}npBZ05|$<-9|s7|fH| zTIZGZn>zmZH3u;8_gYb`*dl4NdZ7LAXIn?cOXj64WLD5?xtTjKhq9xMu#J0G);$8` z7nVE+9?DDO-1J7*RJX@YSWynv9<8xLakRDr-hx6%ulUAh<9vn$qD`)_SQ>MG+DpnnAM|oREDYucO$~Dc1g#l0q4y8*gM=eO>i_%e_52iTfA+3#_WnqdgxiseuoX>dC%+(%I{*_7VfFN?2(OY z9oK5jbHvJ#+Y>Y2Yon42tq#WJQ&>8@Hm}E3G4LO!ndC!j+~0Ogz300SUbX*hJZj## zC)fBo$bk9{y+e!1CN=KxZZqHwBBK(%2 zb~^kVLH${bwD6933GrZk){VAIq&*-7y{|MPtp@Md!2P{lz6i)~m+BoEA*RO{0Lh|* zm2qs4n61ULh6vms>@f54$d0g!_)-tksqUu*696^o1!7+o-+nl$YB$$`)L*}vU@ZWx z`#)LqZFce4hwlaqYR$tgQ7e5byUC>sB?sMkror?&pcAEYWUC*$Gp?QhYSFmUZUEIT zj}II7YOPNK+MoP}7#+qFfDGqd?l_s4HYNJSr9%_9ziZ2UtPb7BVSMoCka(lAcq93s zc6>FKQAJ`u^M|vRZ}CdHh(rJ(URO>Y5hM_;Zn;dcv_w$hHzzCm-=+~QW^CNI=h=cC zGs1z^ka}p^{tmy+#m3$Y?0)Af-WzZ7q6v~UQ(xK>oTR*8uW{w|lGe3$(3#%9ediL_ zcM4u;5!63)YcZetT8&`i;*4cT(z7Pv8M)6D*nLw6Xt~YW){)4}T}v?(eb;H|fPBvJ zOXrZ!u)x?yX?2l%g3>2JhrhJ`uz((ej51G`rUZ5)?q$E+#zbq)yMDhpSzT(RFwsgn z1#)D>r;qWrt!|r%tyy?~N1K|j=YWx)c|V@FncZbi|K5+^GzIAC+4{ryEmDX0pKuNw zm?-K$k~95eSYO9*MK!>T)~BVcS4NiOKPC3QjHf{r#cLj-p{iQwE_qnc<1v3!b4BC1 z_r52I|C{&Twg@n-sxjk`SMvFP6BE}j_yhjb#vjEz-9f7FjB;5H!?ik`4A~}_l5M4J z3#+b)WJ9E$6(XF}AB zOY(c5nPS?y>^*3BeI$zanD_m9r1K1fQ^+(1BQ?RYv|f_z9~-yB4l524B~q_BO;`q6aKdC^@lU!moqG+&%H;xIQd4>Rm@ zy>B<3UMj!I>RkM|&#JLnQs4La4%-46-S#y*1{??d{?8_{ zOA#=8YUjFUiY=9su-nkw>=9_Ud}g<81|*(;H&!RzwDJNo7J6O)m^DzZ$yWVYp%v%Y zl~eOP^Duq(DgVI#dR13EeMgMZ`K$MNe{$>(%y>p_Qn#a{t7>nu7vttkyu+la;Z`(5 zZ~GK^hz@M&a!DcoQplcqNU(f?xHdCoE=#JrADYWq)N{%M0`bL`lxwr@W?0F7g8X&< zHJ_FCibuEulT`!ZVqN3yOl@FHahS%TI4~E z`6c2Wm}-x_z;D1AOp5C3HTPqpV6D}|ciKKvUG0Bswgm>sUTN00DE_63U{A5jdOTcn zd4*}~g$wG8-_h~58v`PMljpmCA4}4~voF{bgyH7i_tRiE+P3%Ib%B`SNTa86*lTJ#G8zJc3fbBnW5U8&WTmf9Gg?YkFHQ^p_g4#N)& zXtICRs95lo2>(|sUHkuvr8WrkZq}wt*PgB*u}qi&Cv!r(5>EkDbY|j%=-PhEnx? zJUF!}u8hw|kX#V&+H3YP=`eFHbv4`~KHA((Y_>YIkt50l>q@RP;rsFVKn{+&iGUrn zGMB780bh*I?RsfKqz!cu5M9*T#Je^w%ba?xbZP&d{^t29i1#opcoF4dlNT8`>c)X& z!hw_-aexzk-^|@9^7Y(Dabps`8=%B^LAb}O zH#0Xa4;6aGOa^xVX}G~_cZo&VVYKq3;^0%n?fv82l>5j^EiW+p+!uy%01rS|@NW)A zj<0l`L4EJ|+n;epk=fxemN7=Z)ue?Jb4>d7&{CX33?&vxIZN&Z^UciT390o4qPw=p zXjZamwE~_nxt;gW4>}!LL6W<>XhEKBj^Q{etpF*M{U*7nZwS&I3M3Kj z;>N?!uZl!`qWpq6s)?zQ(!hhbwmU~3N;BCdKTRj^bAN!Vx%dahLi7kbHrg#qK=5}5?@-s&+goY9Y%@oO@i0M+9qG6OZ+3}rn6l? z)5s~j0C-T5$)ZuhEgfH1cdn%mTYDfdL|tcOiTC()%LrgvfSYoU^8ErnUjE++X=ty?W;OO{<_Q_sy}71M%WO)Ax>3{Xoow znbN0+7*u6|fan9m)Kgd>`qmFCTMhr(J?b;M70lb)j1aMnewW^OrY3n{1I~c-e2szo zvexR&3QLSQ(0KqdVYFk-b)n5cDj2VGG_hOQ-Zw~@d^qlvT3s~(5I)53c-plgW22E8 zBv+~>CF+sS8>=jgHY#*v(srK67OD2j6=EnreCM^As#mC2JOQ%aX;v4VKpcSo z+w>2a4U2+Af9}&rnJB_M?46A75^>~&j6Rl^tw9Td~P)jEai0OxAK2@+nleBvZUKO&NL=s%TkZgF_$1y{|63T ztf47apj}gHB~VE_yRpZKnjoy$mF|~?G4CSg?&-)1c}~CZfGDYtY|kgj4A{pqA}pi; zIao>D7s9Nd-lDx+HozqIYb(psCDnw@*J#_Wk2}8>Z*IT=5ly>3dbZi|)vEikuy=vI z6j6aO@HzYCrA2^+d#lRFAI+6C_)70USl$|7(%Rm}UD?ae09fF7(V_9)blg|N_%AwaJcW!LD*$fwJe z+cL&Qi?#C`SA(&Ks8+^h!M?7a&5<$TKok)PcrL2$hes7fhVAkntF~)rRZeX@=pv0b zb4P0D0EV9*gkUS1>At9UosL}4itThu*YmDm@8@Z~E{yF_wofNo*Pp!D3jG+eS^+Se zQCY?2G1WPeLi6^g2yG%`C3K&IEx`DEiU}$ov5LbQMVEWdQD<8~UyNAF zpUcLW*Q=|wg51&@s*_9!>G$V8>aB#jXfbb@Z-+=8LiA8cHqOUA&H4`YKjGT1vz-Br z$Le6+B|*l@{8WrCS%<=WiXb1x<03}c$*Y?EupJ*_D~0q{A->uP?~}+T^5ishea01L=L6e=U$g})O+nb`KT>i=EN z#gV6x`)v0lN;Yzw(YNCZh-JnEYUU-Lz+CO?26t=sH~yxN+}LJi?Bp&#j!M7zB){F) z)qCtd)9ASS8@Ere@uHI^-lB%N{!M(wocZV~cHE|8YY-{wzm`UB)6bZP!E1Et7UqK# z1CF!s^~zS`FG}Fp9myF_xYE=S|2lks{e>y|%aZI1KTNel65=~*NX^V|^6Hu0EMJR3 zmy9v#Kp>mHrM?}LfE)9OzKGi$!+=2yGgO&YXKEJgCbJGdl2$t~CS)li!PBv!6I+F4 zugV?{TRE?-nB1LwRT*A#ixi+P>jm2mUn`4JHBHJVTRo4m5ABlYqf>*+W{VA8ueRoc z9uZSU;BwoVzAzapvm-Q!w{Ec&EV0`&?Ge_QtuT=9lU!{y`tjJgbQ`JCB-X6s7!W1! z^QB<`+57>}NqNifF$r2eoBi$=`2J5PXV&g3pYh=Bhg>ZxoO5fp+BPpV)|f?0v;?h? zW>w!JBJOg_9Yv87>tkYW3MFf}Y#;ld%KeV=?iaGCuWo5Cp}RgBFY@_6%`cizCX4JT zFf-DugK-rsOfD!sTxd^)wEYR$QHVJD|+$0{qF)MtP;zo$G+*R0EjP8;7cmtW(J?-?9qczZ;x zw&PFY#Qn2oo;!%?#Mj7dNjN=adar4y^5qmHyy1;J>1lBHh{_PSr^P>FX+`0G6lXV@ zx-Q(Wz69~1HLsgClzx{THfvDs9UCPh4?rSQmFU&%6zOvvzoxA9t(1CrI`1_2LDl*V zbLCm8A^9OBx;HCTdheP4U5Lf1{b}03`j#82%bB#jy`Xrv+n3XaeS_&n#1*}HRRc}l zKvInnLy4R$!ZyyAmgc(G_|0HAg_T&17oUh@POX-`mV|K zBfzmX)I7-y%5l1{i|crF_|dgA`@Rgs^$k*xrtP>}3#IMRgR)a;=SkMB&idyIy6`*L zhunb-Z_M)Riu6ORM%%*eOhY>ZNf%c8RjW3`tCS9NEdKu7+KThVdT-9;C1${6EX>(c zpBbGf;>L-Gsbemy{jr|dLu#+a_qzs_V{FfrG*VQrKY!co%vbaJh;}JRzbn^GPzS}P>86EtK0Jc=CH-iNLijQD`nE{| zT)!{L3HN}yN=EobIF!5%AU?)k`u2*)Bq1q=B3F=!skktz1ekta4-PtI5#M4uaQ6f4GW^gCy$AWNM4|KtFuo})! z?~)g``9RRKc0Z6b-*ngrKygHqk5BgYSN~W6Fq`0&_))uFTw?OE^iY(2 zxR~g_(KDZwUbk_`DtK8sYYWG2z}V-q;tvKNv@L$7RQE>W`EDDz=SzpLxGfowY;B+Q zJR4$nGZaV)_QKxR{^xy{6iWaI%+{*FzQZirB7u_K)G^)Ac5#>~d`@znrQXH+SiZ5+ zo72I5f~F|9Yl;TJ*ZLECF0lZ8`L2L4_#of9)3)twmWwJ2o11pS^koLPwa=`YB9`y0 zcVC-K6zDHcAp~c_mWi8|=kv;SrgjbT!%3&*5##F(dEA|xk>d%ym{c3_7LwIxsPk_( zb88}kx*r}54KPi?^u-1LXJF~)7S>wz-Z{j~)Vn?2f%^Lf@@%%3U6iPJBnG>-+a!IW z;`}SKZ`DmE{aT9kipY-qCP&OuvB<6u(a9p|0 z1s!tHidETi04=Snpd#{R6Xa}vhmqyfUEK!dJ$Bt4y{2(Ayfm@PEKsM+?)!rafd97y ztMr;o)O%y@8*iAj+3XuWj$f{gGK&E9XvX(Un3x&?E@#DKc0wa+gBWGjeP)aUtQ}Bj zCFn--+mLRr_a?idc+R2EumRnAOer9sN_zr!fDG-C?vnxrbDr%^r$)@0Jd0W)bN3Cu3O6nup$ZH@ zx}wy$DZ8|JtTY9j;Co3dP0sEuaG^Q|K=Bo(>#}E0uSDA`_9fTqA~>KLNbE3o6&OJ3 z5fkChQK>29>jQ35Zunyvg4m=|pFWPCsFY_$JI%Ivtn`GA$G zRYTTwbJ-AtAC;SWO8ez5Qj);8QY`&uM@Y!A*~dS7y`8{!B=F~w3lI-z!)JDoLXO2_ z^om>Lm&;OoBnLzUMY?+Zt*7kqyvKl|>KEZGm+z(;dV_D@#q4piO~5>Pkd{Adz((4H z*XTKetNS(Ik%_mW%wCDDI~SOjI_eX>%niNp`$$`|#r|iHqb|<3&byme2l9ll)((v_ z0|%P*INe)%yKEKLZU24bHU{QG$c|}tiOwM8(vp!^CoeFbGg}4qb3$y9Wkp(~XEppM z#vBs?)dJ|$dSjC@V1>RcJO^um%2t3a)!W!7o4^sRG*VjvkT1@zImt|1UD?*^(vdF< zOx8(T=(!qJ0|JVFI5#%e42G>Dx7OC&{B#2ZCjBrmWMqpv6e}V2Pb2S{tTOp}=Bi;L z^ayYqJ6ElBi<2m{>GckkC-k+bmi9-Id`Iqg3KI5hc$|c<@=D^uy<>2#0*Eu=Ado3{ zPQ=>g)`=Y};s?`PZ`Pk{t&lV(W5Pa!Skh1@O9!v54yDm2^jympM>8PDN6Lm3yw==4 z{t49?QL^%P|GtCB<%|afk;8p^{dY2n8~4HuuUbRz8fIBTvujp1R{_QKYPwg#Ex!!t zbNjebiJjQRqFtFM5$YMWhNMkG9`CV^YJ1 z@|WNX+o(|Z)x<>;;2_gNmG%ciLf6$bL{6+rB%2riiqtSoOX5yGgTOK*%QK{F%YTZj z>ap8^H71?4gP&xPN)|{Td$XQZxJ$Y(wR0@G3>9a0i}y2!z9L=J1|A3J6!!m8r&HFL zulMkouZu~L4LWCo&YsP%e>k-5quo0*+&nIU_D9uPK{NjBc9)HIqf?0x=3%YrtlYZphb4+>y^ zSVuqPUpii~$QyE9f5+>mPSo(v%Iq#2i~(wYzTAU#iQ^ud*K#J{R+)Pm zPz#=qYNStl=PUtN$C2_3JD@s>_;_oS)VY=7?(#l#mU&U?%Jk;c&kJzaYxjxyu1{T` zn+M3UN&(@orLwsF;85={q7Ug^Rvx)TxrdY_9)y;(yreP5cMzF%K9SehiXK15=}2h0 zjzOK>1 zxY^9}P5kCu4EuJj)ns4bnROa^Iv?@APO90v-x&?N)X|=367DuC`pGoU%$e4gFGRfD zZP<}}C5xZa_Z=9%9py;3F{jX*(4UC^(yV~~dqWx9kAFr!nN+7Oei$34*g1}5S2t?J z=QYHePN}>mi=5oWrzypWjKnUhZ}c$kp2WlWFCy|!*O$#M(cKDm9%&Sx>!h0jK^Sh) z-uc=c9BefPzazsJgmksx_72CU^1~s9l4{=(OAeDV9{3f22iX&Vr}nVA;@Uw{vn0JE zD6fxIQcj(8W7E92eUKZI@w|E9aOC=bxPOm}dXy%&BayjxBa+weiveUYt?x*Y zYiW zefA4Kax6&zLC%jkHM?y1;UWHs-NYQ~qzy5>bI6>s=4N}E;6s|tN)E(nBvgFnAT>X6NFz+^(Iw=emiFDMy;AcXfh_L_7O* zaxj;w0e&+&dGl-$P%+y38VQr?cT6PY7C9}2gNpaSWnmSQ0#Lu9{1ovJ5I6wci+ID= zcS~&)@jVW!5A=x-QgP~B_k=>D z+Mx^Nu|4Z5Npfn*7LccEIT*jG-RP;}#?3MVbw(9~{iLfk8paurzMaD(E|vNY7?@LV zl0p+WRc7NQz2PVMpU>J{t^PJHUcMnZu%j{kqdoH}WG;Q)Y%}_OmM=zqY2%$49rXk- zob}-|U~Z;ZN_8=f;|Z`XqQlt-d4CsFXH+hdG zrsN%l+DgWD5j!dd<5Phne8;@3<~UGNass!;?UudXEt`q|8b}feotzu`N@7gs_D(!$ zJ4SFPc;W9)XqY96+yXwGwRBLPV=v2V7FyKXBy25ze623Wi&6!#fQc-@8{+{wRwGgQUOfzN7O`V7OB;3m2;-h4D`n;a zwO`q=m7BL2o^EAHVWtW~UyQ%>-bX`}9k#K3*^VBAseHr5vTNHBy9B;_tQcZFOL+F} zN1|?Qy*Duj;+TN$^ed2Q$x&gl{UP0tm=yp3_Xp=;<29oz*y08D>3w%Hj(vY1iGuHo zy_{!Lw<83)+3&GAVhAy@Ys^?aVKC?-+P`BI`l`jMy!uCY*{fiH`eN2aou6FrXdm9# z5_}N;^G))`jq49+vpp{mv-R-X{a(u>sJ^X)ExG6%_tOe}^cSNUqLgfOnfreS`nm1_ z!n%#BE#0Q&s&PEde+Nl1(2=NYVuJVOXi`reVVHDHzIN=RL-wy|OB&J;eVtpKUvX{I z%|i=X`@OQ4_lx|CwgCLZ`2uY2VH6qJ+_Fz@$QJXo0svAv#re8FV_?;aj~u@371F2MG_$j6;s_V{=s zXamugx>$81AM@!hzeX>bS$5s;Vc70!(*sqzyiCGI$o%3 zC`!6@ggguKc3ylTZnR#NY$hjGw4u{W?S`t31k-l;tgf|+TN17Qe8cC7mk z*ISMt#xxZI{YH7e3jW?8}rcn4j3ZMs+{Dj={(MMfDBN=5F9HxLwhzB1-2Wpvw}tWuK@*r z zvGYHA{pRAqb#$SP2n;2xB{mej8eS$na3EMdttD8tc0PT3p7Kn*!KtJv?Dyd|5>P)K?u_TY(AEoJuQb#Tc!dVc!1)^VOdF!z|D=%C~l4rG@km>wy^Y=WNCy zt*QZ6a|5|A8<}rBBUX30PUibckGgT_5Zp!P z(ccrla^^HU6@qLfCx9^g!W(EI<|uU!d(ShI;9hn_O8=LVD~V08vmJefi@3FxwSdvR*~%L2gSRb4HWsjeTUuYM2?K9JJ2lk*#H_g z*78ndVy&eL#o3$YvC3$kHwR6j?;oCQeOdVv*b`rHYyNK4Oz6T&**~s69@rO>DX`}7hkX7V4GLXuHbAK>po>W}t`qp^@mF^X; z|0S*~)Il){J$Un*7MnY6=`g?3gpNmmg{e3`JNBN$-ksP5A_JAC-mHfTuPVh^%k{3d z&<^3^CR6ym4fDcz8)xYbM{lvAB*+1N_gf++-PEUjzzRnF;s5S;)q+S>FHO3rmaA1X zf-LBSH-6;1(h34k-e~(J)=lxj_>N|6>YN_?V$LTxeg4--ib9 zW4W(m^O^ix#1dgwVj3p)jZ%r+L>bY_Pg3cMT-(ANxPu{&b=Sw0nvj{>k&U9L4T?5p zKVzbJ5FGC0PR>Ac;!LfqGzv1+lA<)#f|jI#zLi zG*OM3S#FHplT?HD#}A@c^40kJ;L~J69|)|SM-x9--zu`E!IR(@&& zco`Dcr@VY;+WqAtpPt#z`!0BZsXwM%C)&(Oo}8x&@(SRRO7r55tQ_p?E~5tq0t4=P z-t0X(jX4hlTC~SfuDW#^l}RrPrj!i?@gPlEqZW}==5G~-P0HoO`L9N=0kZ+&q0E~g z^oAY`R%bL9+Y95hMA_gQN3ffET-E|9b*jV9CWkfK8C&`Q;Y4m!8ERhst2a*IpWV8i zJH4#c_lT$5iBe8(;hx@3>8FhZL9lv+uNbgU)WKnr1KS%d2ONn!=$3kM0qw~mHKte1 z%n{8_gvc7;=7chF2DL$4BAiF=BWX!ZzJ{uQ1}+|Ln*Zl!jtoJ2oleB_XKwqLWvZGU zP;l5S@)5%9SKZtR67gV|OsCI+Hh$e?1f4Q@8d_AaG1;nxgDk^rIgdy1`sL{>6M2E* ziZ{9Njag$?r^Gf)rbO{67mn}nv=Jb+uw8l1&>y$3dv|}-^Ih-Sc_AV_A+FUnBW8Pm zraWvTGc6W2U8hXCRUS{y5B_gct231ScCP#_ay!-3aLoh}a zJ_IeYa+_Z_kd8bArH&8&cnACC=fR4e`^x-|&y%*O{p|=C@}xY+5ls?wS>FQnP+-&J^Q{NNJ%6 zZ0q`YxtEqS_;mVv_EeIX)esfI=;r?-SKnT_#q*qoZI2x&G%8!wqimt9Yz40J${IAN zWSBUPpN>br-xq#g(B|(q#B6QB z%YJ*q!7sQwz8rr5R2so55(D7;FM21;qKXp7=Xr_1=MyLKR?{vJWQLehG~C6K`HVl3 zliGVS1|wzIADcv;F6Q>i1VYIk+_JJ|lZJoZ>s=e_N^zv?Cwp)7q4TfE2XAcb+olnN zW&)$0$2r%RfB|j#-j9F6bB>4~QydS)N`J8I2`lJj{FMGUJcZ;j=jrUZo+5gyn?2}- zQ~O`xA9Ng#EQDsC43GXwtN)tBvM!3-GD=Sl+rBIdiC)@t2iHPfULRsFF?d5QhtCo7 z*p`KLKCpz;_=kvvzkFoEHs}c%X^L-dMuNaTRPkzR6L$ix10I88f+6g7Jok+CordUB z&iKQj+)UQbikGEc<{SMDS3F2wIvlF!fwGmHYhw+NudYKi%G2UMW zcHPSivU5Rnv#7Xn_Apt7+GxsvPvsXF+egrU?!1+PI3FtYzpMJ{JtEmDd&_*`#ryc( znLO;sj~=t*ugcpQ&Rz7o{=f33{m0Xhb1-nkDx*YwAsNAF*mk0t4(K9`t-hD8JhHV? zkA5C}8!9ddZ)V9^t{t6X7XaGVBQ^W5jJXs+VqOAS+n6RT00s;5lcCq|ufLR^r#p$jfT1&Mtl ziCBe8Nn-|gCr=&Q%~Eh+iu2D< zZ82Yeq!x9n=Ys!C!LQxDqW?UFFlvp&`-IiEN=QDrc9r_8Qg)X$(8p|?BJGhYN1cwP zZ|IhK-vWh-C4Vos;i}K^zv~UG)>mj(TlE}a)h@Wc<|Qv*yOuYg{794m2~u7g8=w%X zcL_9w){VwRq}fEi^`e$@P?;gVQnIQ=vHz7(ljz;(H8$?5#Zu_c>K%A2oG^y0EPg)s zb;Z|{8Z~HyTN;ZEy`9*1ik3k}Bk>PWiqgXjulaY@j8Al{XJvWvze^4Ce1@2JzU4cO z7?+&HL`?NXR*wQ3)XG~Pl!(u%mF^N+UG2QEsw~uBtLfXO$c!HJ;E!a%)sJcY0`qIi z!gIE}J_JuOT3OdjYa@<|hs~}qY0mGe^G+gnazkl|ukqjPVWF%1m0Ut*gdzi!Kw)1| zd#^LJ6!lgkxWC4|=7^;E>yE0O6C}ztb-qbEF0p+C#U|foMk>1~Q)GjFCRjA?s0UhE zpSStW6(0;Z@(yQFV>bD4FOJ^WR2;Q6h$4Cy2CKqtQBDxzt-R@a>+yG%3tmwoQmaZ$ zJ?pI^RAWf_N`WWtU%75C#reY^N_P?3z8`{G!KaSAb*}p;usNWFwMH+p36|AUdR-nM z44X2)@%%}<|8>!G!sIKBw*tY9;+%VB-kVL2f6K} zUEuuX=gPc{$pL8=FhHH zLLab!A6`z(o0^wAy|Eb@wT_Xk9l`(Mcqg=rh1+=O4JIy=gQgi{$=Jg5_9Rg+?H(z5 zBa!i|LjPVVRT=my{*-zD(Nrxa)yi?r%ae%a?A^<2JYXC`w%UvOD*XFHxWbD%IO%z! zLv}(7$rP59scML?cp1NySS0eYL*3cs@dmhGweiuPXf36W>P#ytjMOtI+>5icjPP5Y ztex>M*gtoir;mxhjrYjw;I<_DpI2T*6qiw(MtRP!CVhXZIt%|mQCSZ~MSd(D8|~lC zygXJAiX?u3QduXlw9iTSrEJGUj+SiSQdL(OJOQeFruQ1oFT0DkYQR87{%Jx~Y}Mek z7bvnaR$Ez|`uaj}oY_53*R}MYCW=)4psTif}lLe=~V^PlGGdPA1W>t1lf zx$*lL&G6Yq$n@*>G{qfCmW4E3pyHc*TzDELC)&$G~iR!Fov~dmNS5>H=6z5R&247pIh)S zzGv!*_i_rv)s|k6WE-U8E<^A{Tu6m=kjg9nTQ-i~bJg_3x#b(SyKbp=hVJ1XO$7@N zNk)SCcIw|L-r2mNCurQSU|JFG2i3#a;M|%wm*BB~&ELsEZMZ9b`%mdWXmh2860F1-u<#yhtIsPrt9u<1L;Efc*;9E#hk4tS z)s`PhQq2@*P2==yYurt_-UBRI(x@4(XA+`X^v+h^JL=FChF)j`jQm;r&4qZL~H> zg(Y`m|7!piyR-5&1H?k32v)g8SgWbSbkV>5f*$E3>!RFL^^4&#Msb?IKB4%-UFi9> zmP9`5EUkLhzZALSw(Y%mSe3rgn(FpbebBODmFv_s5rFt}c=s1M9QXCG_>;46EaYyu z96I1@T}UCy?xk*$yLr-M3bV=a+!i8H)v~-zeA(7L_OhQaAe|vph5+6O_>DhdDeKe@ z59DxGXn5zK>)jL8_f*$2%7i}uk!eWgX)?S}9t^$L2mbsLEsjW+{nhE`Ed6W#T_sEO zIC~7g+-1NJ`Hf~^4@J^7JQ19FZ*iRlgE56&^1y|n{QW{RmzMO(#?lKJ>uws8anq(8@rNI7!aWv7jCMl?6wz4cQc8cG%gQs$HD3=o zz?v7^`NjVSFBdxh;GAG@ldYub=M5^ zMz^}7NPX4E#<1>+;LXsJvzTblBjTlp|6*ol|7gzgW$*~6YpOVVKwAIex40sfQ=M!M zgWVXSN2}XJ-|RG_1v&fXgXTf{EZ^hG$LLY7Vu`{TiP8$_^MA9V zeJ@s%n!S|Z``(v*2{#CNbQAbY=A7$+zKNF6tX1JlZBQ0C&kJ-}of>b1#Jv#x>AxUL zrbz+d;NYI|S#KU%xNw*dTu{)_b?3igcp<6iysi7nk0cV_d>v`3#QST865zr3rIOEm z$-{$&jPl9f!wZE=>iHUtqTS9?+}W>Ps-5v)_lsmljcu01`G3rp2%ECKD@5h94U3P* z<31gceKQJ*I5Xizhlz@6QOCqyszLwM^^oE;IlnJaPi-er0NzScnt2#LPTtHm*~C!l zU&qV#on<>xWp3fA-{}L9SFG0ljLqu25?=Nzw zdVhlX#WmE=tX}4Nrt#jl6ZR+CO_Y}Z@e1GzA~z3QX0KigRwK%PnjcD4Y>K*-gJ!@C46EWCgswIIG=FW{?$iN{!Fk@2wDrpYEJ z3|0e5_z)5SPlmX<6v3l#OK!v7E2YS9-K@h^dyxE{iWHx9le-nvHL_6xc6t?2#ETM&V=5&_$*fOkLv*+?UyvmO0_t?d5M444UGE~#lQ5@ zTiHng-d(Uz0PnWgac$(v04ryaMjze_ykmVl*XI*cQK|X7DW#dN$|904O{e)+#~XAW z`o$tEQc-pAj-oTMK>M7in?5q(h@{`dOrL(%eb(j@<%2-uyT@hq^Niid{qyV{Pa%7x zFvTc2D^p_NaU}ZBmT~`9nRkImYyKu-{?E>C_><%H?&s*wt__`RRNPq2*{9rVZ-#&_ z4}`oi>krhz4g5J~G71hpX2nhWiJJ1wd5Gl8Lh5`+Md-;$thQl8Zo|-Ioit)y^vhUF zDGBwujF%Z^^YMGEZr{orgMRpZz1O&GW-!}OuKHzd$oLy-cz3|6YszEDkU)(3gZ|;M zbdLdTQYQRU&HGkQ-l!`3#GAO_POR(QBs=~FMffPMf=6H?bpUO{FJ-39>*x5+A)i-| zq(jw_YgM=TP7XC^k@xCRCtd=lu;y<{-mN>6@pX)@F z>!oDbjo1nPDuLOS`-v*D6i!@WwUZQ?h4!9^zL{zm&YIPhUKti?H3h_Gn#6WZWW=Y6 z(2$7VrpcY7u3DmL=+beKdC$vIzr#hsrQb2XE!7wGp8ahcebiX~fJzREsBW+BSZzVz zs$QgGPLpKEr-lbdWjo7J^Mb2$A7F@5LLr)+)^~&HxQvir$)!u%Kf(&>-~U`sNk+J4 zF&yw}#P?bT{=e^g^Pv?LE80Wk{3_l(7Yx_z2U2qV!Ubl1Q*J!{{Q(K_T{Y?h35ofo zh=TDX>X9f)#o5N?GfORn`;6YENCdM6{YsUXrXIr&$eCG<9zSw-+87wvoXWTG&6P2U zDn;PY=)p?mfM!;8&%l_m(XYPf=N)@LmM%Q}z`hZNM6UlQQCBSO*^t6#@Uj-pp}zd$hWE#k>aPhf-`7c58Olv2DI>tBSsidwj|%q5SdPP zRbs9XFwyFAB=Q6ILzC@!`&U`S33r^@G6~EZ?y=%3{3%ZwkM(hJ*S9 zB#RJV5#8cspVD4sruvRQ?=f}bt3RWNTPPB~C5X!{hM4ilaqR1ACA#@hb~kG8l9jCV zZrvG5tv_WbqG0J~=BMgagT+Q-j5$Q{BMG=;q-}?MR6JcsjKOyajCx1AS2X)T_eeo_ z!mHSi1n6HoqdxMIWMWOsNaOVQ-jA>Y4M$6+Y8O7+@V$q)^beV-b0$Nm&FmtxR#2*I zV489vjC3~CzUEFdY^v(i%GAO?KEM*I@D9Xr>ug1RjqEK;g=lwnp=~$g?5H^C=-jWL zz(bY{jkyv&r50CuR94C>xw29;{Dz`-dL&5!RgV5M?4vY!Vc0GRi=YNUl-ja_TkdD? zOk%m(q7S7?h}47Kc13pX2e^9uUlNY(=;Wmu*ol1)HmWFE>Wzes3c^z~ihS?-Z(3%( zWZhO2vu^~qqFEopl%n^wz^33En#gkAHa)fbig|l)!=1oYW@g;h3FO>aXjG%HC;~}r za(~A7v=t}cb8iA)(_U;o5`QE9Qx`)+j(bCyx@{x79je2U``(x%lF6axmhldc>1P)C z{jfZ_X6)D0JhWH*YZO$_BZB(tN6BH{!nQG86g6(ax z;KEVGh_;1o%CPCcGd*(_=Vz>bfR1ESsI1V2zNa$*w#8JV6d13<`@Mfh_TR4%elL0z z`jPLI%8UL_d!+)hqE(I&-KDD9$0EZ&*;ZH6|>sfx*N^#h4c$|4p zRmg`EFYDNer55Ny=T4tLBZ;5Wu0$dyqnj?&46#{+rJ`m3%phH%BV2qq)F~tH5HNK z6WJU>Iu-BO@zvUsTI4eEc6@gCPTW89x6;N7R>-W+SwVU$9jH$FKXKp5qP%nmF1JP{ zJ6uR1mkzZPmE$5k#^tYNT?>`Vil1xhf$H0X|9dZ-gMO53c>q5yz0s=YREvv)%xKN9 z2w%)44rTlzz36q#dg#drqRP00gf3)n%C|{%m4e&8czqlfX{P#7#<89sZNAy9nAEp3 z*@0%phx@7nRZ0>#Tq-lTg|y<3N^m#)ucla_^t{~u9r9+qU@hW%$& zwi!8AT3SpwGmc|vW-houR_atwl38iF;4+OGE-9`cP+4iN(^y%l;F77ikPDg%prx1# z;tK9mDj32T`)MiddRz$ba3Cix~x#Yr`%1bzA5G!N1M zQWNe#9YVhq1*{0VJ|t4}DwR-bVDvO3KIG=F^j_ zES((a$L!4!Cx#t0+I3k-S-!f$0amO_xCU4lBj>FCG9DI9zAVChgbv`FsEtme>hK?R z_)?mEzFTI7d9{lK3}ufWRv?S(>8snw87X`{fy0s1^rpp$=o#EfqTHq<^wdR2bdAzq z|4}+p-tvcG7}%R2XqSDeBFpca=2?+%(3L!F>hp0t@2ooqqKz2WsC)0R`HMW`tjLeEm)qv5w*h3#A(Ou>HMR(t(zV*a6PP8Bdhl_Xhd1 z8|(_A;TFnR)?(1pRYHFu(IzZFKjDXPTn8h}dnrPrKC|i#Adp-Z%d76F!oCN=@=y?4cc1W?~VI`395g19#seOdT?tdf` zUpQ3e?Gk;CWP@mv?xQuHO+x&fiEzG#{a3pj24j|x%O`ZrrWypJh$wTBVs0-~k@; zFtPmrJzm93TMOpB$20M0Mmr<+2FYK4j8d+pn9i z_tqADw9F7W^}80)-_dte%run_0SEBa$dxcnMcVDO?Ft^@sM%(>KR6`a9m{vb`VMD4 zw}{!)@_^i*!mYwvL10fHDQY^wP!ZWZ;UUOr0O!pxbGc(0*Tv-!xdtSgxvx^as)y&n ziXw}WLGrx^xcV{E7NwpfyRpB}x#q~K6mo8n@F&!nzv(}@z@yt6t4=bA84;v+L0$^I zT6nbkTb zIJ~6dTn(*?M?^x9JG8fEiC=T`Qb+f!TVQdAY1K6Li9sUF@=93Zekw09sLU-w4IW@ z%<)D$0EqM0FUO7`2A_Z7%$naZDp9RGZo$nqr78P+Z13jcqbIVJBYH)uReR|}3rnBs zS7ezSr&sPhHU3KCR#9+L8eOY{7GOam7y2*EKv%qvV9V({(bM_f4~62$o4Ks+qMI05%Zg(vXVn|bkv0U+UTxU&6E^FUJL-`vBx7PM zgj6;1GRNm0Wn`PAMO`uJ-VYg=ED;`+K3p67&PiHcGoraq@Un?m$LRw31Gfsk?A9x4 z4s`y_jmxT`3DRwZR~Q+(pq{vM)c6QdmL~vKfQm2qtz`x=6DU@NSZm`cx{9SC5SqJu z#b^+4?OV=48^|?iwc!N&p{#Ok&!VQ{6-L!k@vHCVcKIde5P5&nKs3#;>lX!&$uAA-_!HCL%6udecwgilcc0}9VOKqR`e%m1V2^asZG0#zw9E(65%{3h zedQ7Q4`tDlBGg%D5h(WR1}|oM;H~2n4^|!hkF+WjVpVq&r)rF{aCr?Eg=q>@DKEwX zbbQTW>;=!&A@m`H1*a-}I2_$@NLuM_dF(B7y-QgB&zHa=JIRh_o#2eS^anyuFaT~j zt*^&imo2^}Jag2GGNCqvQR?fJO8o}}rR=T9k{OHOCry*MZrDCophT8PZ)mx5g`aHm z7<>Prl%Fu?ycU)rASuoo8gOPsXZz45>9#aI3ODwr4RlOJF}UhzUN(bpL!)8skvBHz zSmWI3dSMYv&P|{2sz^tez9`subOs}qRx9oHWNuFfjL3N-S)Ak-)a)u1>#;2)3 zbiIy*c)BwiE$)U{BFp~Vn+>1s?CU7id6h=}R|B}Q2f49-3ErZUGCOWB+1u4a=BARa zeW7r-ZF~*HZX7Jxe0Ce9z7n^ux9hv(?>cYToP?H>)NI|yHnSWEo)0TQ9ulWhbpAz| zb#pt6W1LL>n$n4$G<~g20!x|p-#V51rT22}%{$-sS#Rq%54_Rpqig&v-h{2DShna} zejKqf>*>=GO+quNlNKO*U{rHb&I5%<4{^PBgp3MH0~@k2XkrHFKu{*l8?xPnzB@Q< zetbajr=oyUl8#Jn8fS1W%C|GqJfXl*iv`)yFtZUB5_UxNK?gC78!KPaP6y4+Z%o;r zYQNb^NM&aWiujl1AlkC3LHC9SB@sjYG#wAJ&nd1J1aG(hhj2X)!T+Ex`q1fo8#Zcj zqXDsECowH)>A-Xw(Fv_hiv_;rUv1GNo9*md)5T7pu)~(fcH}BvKnH9tUwTvDJ7wOejmm9;KzoN7kTJ=?fM_;)*Tei6~XY&_D)46Xq zn!z&r?}3_Jib2RJ#%^v8a%SW1?vEq;yqSHYHh)H3-JH^pVc0+0Lq;24yP*`a=thIH zfMJas`xjMAsmZL6Qx>o5ewisnik@UG?m~PH4g)hYz|aL^D4LnJyLzXRT2-kex+hCW zcTbhXoiiQp^#jUX802-YiQ4F8?^}V#5Xq7)B$zqx+i+?`TIEgP{i!(lAvU|84(2t_ zG}locO%t>to7g9wuwb8FTv$WzSbp?mK(xGde{UQ2*AobTlDIuX^IPRrYkepxUXM!&i?rKUrN{<1kp2BtWz|b4_x`V-TL1w(TVK9 zR2~qepxoY7^K!~bZGC_KAu2T|_8 z&99{O3EMgX&vB~Dsenk8y!OlXEc5cF4O-^YsXi%3K(#9{ZYER(NW`*TAYh=Fj=82a_ zh65H4Yke_aGQFmSf2KoF;+_$*-$~DFqTa*&KYlOCH(=ORJo|n-?$*xJ|0X?0dnAHK zwNK>D%rp}0>}pCC8`>&7vH!Zo#{h& z?q4FgLHAK`cP3hL0M#*yH(7~|sG(cHiwx(Zk?Iii5xCvyhFkm*9g8d*fDM8ZroAHK5!UZ>NEH1V>cDwvSV|u%mSl zYf0RPh^-Sw%6IB;1NKORS!E>)BUD@cyDvqSG53C=iM#(^p8q)@$4Y!b8ee(UBU@(F z!NIItXtFxDnnIABF3Hrc)T}CpNJ>wZtYrZ!$Y#FYcNMU?sR)P6g<48=e40D1f7<>7 zDg}MFyi}BzMT|A+O)twsL_}42yZrwvs`HQv-SuLv?-zyu*4(7;Szl?=x+>*1ON!Y5 z9=NcZI|SfL9x?{$L`bj2djzVV5?|2x7qf?2cg(JXAGj|7x>YPR&A#SIA5M_9NeeQs zdvmJ%INtcU6i7kd^XaLa+#gf5au|@2Ne9o665(gK!*}jAri5V=|#E~Ll zE;b914$Seskyy>VL=l7K^Hpuact!>uXzIW*rX`hq<++2z#$kc-o!LjeV>1{9&a;Bf zd@zN|Xw77mk_}{D7CE5rqIWBCMrWswMBafEOj+NJ?imlmToN`SDpx2z-@R z+A6)@y{p`C`p&mM!IbQC=)Y9Vjqz=k-Z)fl(PuBdZBaE-2wXV)naU-QW8e+WjwJZG z&dKRNgf$VKUtH@%fKkJbx3QuVio+d~lGtINyqer7t2;ySW;&KE4UUgE{tc7z+pxww zWD%~jB5$$VqoU(NM1yqw*}#mewqz=w8Tjb5DUO5+*jJ$ya9HAZRk(22k1|>&y!&gw zW{P%mqn)wz+jfKObVfm}m~A+X-U1>$D9-r&<~#JHPQk{(($5_woKQf;a&dij?r3R; z&jSm~A0%JLo!_X`6P1{UMgQE1l7 z>r-9(cug9seO#|z(E&qZnb1RJE3lci?dubLaaKcYjkpGU;xR)b_y9qY-Ml;6yqU?| z%eOu6t|q_8a%t*Jkvn)W0mC5SXzlrpG`n4KmKpG*ESKT%WBq>qdb6D5=z+q6#edRE2@BwfKe_)<4Y^bN>){Pfo}_Bog!9Y*6}0&85LP->eWLl$Dk(ZOa4Ch&Ri>}r zexMjt@u{I}Ql0D8k}A?80Fj?L{rniM(uE?6h1%MbKprVr&V`qswYzf7ci8AGro2YTr=(co;KSDq*9 z*f5_tT8!y~s(7q|+8t*BpTP${I^RDzVv)pul28d)t8{Sz;XWn}5)q06A2m98Z%`(B z?zbqQy8(KgaVtV|*AE(q2S}8Ui%lD2ve#4R`%!8bkatMY_LdD>hF?fCRz-f$B2sSK z@+&>jPka=lCj%gz&_#8M>~!QC_T5~}@Y0#*i0H7;jpXA=Tuw*2a_y%?iVl|BTWROV zN|Ox|0=eve$QGU-PRab9nVDTF6^sT3^^H9L0=fpv8_lNgke!5XZT~q{ zHvZM~A$zN$+}3YWR%U?h?B<2lZMrS&3b3rQagrRoKP~zWT60;8evhY@HhS(6+tVa& zgi6_6cm-5st=fSFgX~oyZW7NrJnp7^N1u?96G3Ym)n({~V<_)0!bFt`PfDy;lh>lB zed?30E4qH;$7;{N9WWP7E>zkdnz4c&zjagvK^`q`d|QIJodP)$90-{?|uSo2a`{sypOQ zd|Mf2jO>esRq8BA{h;i>&yta-zo)EQfdffB<~X2E5b5KWBu>Y#d+{1Ov(09Y?=W*l z_^t<=2{##(Mkk%0R$aFXmG@q_6pxx|6ueeD=;0Uz8gt`EJGG57AbyZ|MX`xM7 zD06L#uGbqn+9aj3tnZGE=gqJ%*|flPUb*e1)%Zd(KLColW$1#8T4Z_2-oT5a(6#P& zN+kc3s8XZ}+|`Q$!ISZw;=HpBF>JxaKx0Lpt4K>V&Q0e+Le8bYK0Cspq z;5O+lT)}WSBDbIO+hAiUzjhlk2w0d`eWKTj(UMji0p)hC71iJ?Rfj3B=wf)})HEdS z=8(`pp*)%QMO72HX7WGjJQrhqV&g~YzKtEfU|P+<=+O}uaymkjUGhF!vaB8}-xh-T zJ?BEsvW(!-6OGs(>(951J=L&gXqin)6^&QUv}|3&iNE=D%ZRt;j{rNOJGE(85oP4B zipeO#O5V5sw2r#@%s0ue(Z9;ulWCKMtTJdZi1uscu5>r?^6hd0B!2zKAW$4z@t_Fg zm5RK`8;W!0R2BpgV4RgY2C$m?jHWhXA$`?J?r7>?{dNOB^D1ZYrb)F`aZ_Gme5I?J zbO!Y!klTH#?@lF?NVeUIh`bVdzgyFADm@DreTQ$f*{8E|LpVu_k6}ktUR~xlye?l~ z9*grQmLWo2_^C44IrJ;HeNW!f-0F^_>67OEi)^9KmYn7GHNdiOSkPWyW2vanl&cD`2{>VA<-eyHPWEIU`d}q%c-0yqhyG3kHeOtjW?T5HZ1IyFIs|uri8L zY?g}rfi(L?uK_-zTW$77e*zU3S>^J9Nm$vPz-_A?Q}))%eVPXe0sf!PiGE5SxYNpc zpp%+la+*`oVqFU`9kp}bNUOyWH|XRuhCA@e&F7antxc${$e%L}ES8P~v5oOf=RPNa zpE=}eXWrk{{p)Ww38a&Ef59az=Gb^Wjyx_)f^2-Za_F3{M!3xWFm*iKb=7C4E7Jq7 zr6wy5?|TBmEarHaIzHpqe%Vp692_S706|1HfRXLs$|NXDPxARlS>`8qM+kmb4R{z~ z%67`<6TZ4FocHc$-{Hp3Fatp&YKZ-;rWE4EqxYSTR=){!Y~IRtb*B^_JECH^w|LU4 z;^&OWuZtoJWtE*xsP|Ue@`SMMxy=Cj{snau%P+tIzq^99Ye9zp(bIM7=*;}>AXCGm zy3Kl%d^=E?5>sqnDWG3WU7sGN*VQOe*N3C+x{U3T+|umDaD7|OXlyhpG(%6gHnqT&SG8ew zlrc*NF**wv`VIt6#f1{7%|C48Q<4}jC8GG;$WtR(4ML!QhNrjRB0bdJw9Irt_9aQU z(x}=mtL#EASmON@*VPNvz!!7kwp}B62`<2YFr|0&mM(le&c1%n&3C5l^;C|*TDsI} zrZqacau;;nCnA-IBZggfX<|oIym05cpA8Q{#q^X>yRZno1~N}gZ*bMYC_PxoE2x%y z&-<(0>6CBPRJ1FM$NEHN_-x8X{tj39Euox*ZABBPo(dfxc&^yF^ zLG#}%YEJWdb>71G5kUH>3h0W#wOEANc+s#%Fy*?vD8rZRHr*ln+Qm5_GXMCS#}`@2 zTM6k|Zpc^daXvgV#gh4veo)PM02{p5+R8LS(R&jxPNOBe*g_@@WH$~4FgQ}>ylIs? zWw>vn47fVZa!o5cx(xTU&4zj5BDAR7xwo8$1hYOUWzQSH(nP9jNc*+UR9BO4{aHgj z6o1V2CZKHT{I!AXp3BNdS;v-~OV!#XKmB9=Gd1-By&aM7ZesE5xGCyHM(*YkU~{P< zbpX36R8EEK6fu4QpcMaART?%Qo5Xir+Qhwyeqe#5=id_}jL}fdbi})8tM}4z24OOUmN-i1WskeS+}Lfmcy8jrg*UnP)>>Y=^~FY4-n^rc zpyL}5X1@g)s<-+9h#HMUFsR9B_<@-h+C11;_!?2Y!G_n2|3Ur(_OONee2*6VjO;(v zB74ED@?}=XB%4KI?if8-7ETXRq<|N-mgYc*i|Ef7>nZ0rOTz*D(}b_=ES@a-!=};u zVFH8_I$17J&0ll>o4?vL4gynl0{=;-=zq`vuX&a8Kb@#5b2BP8Co6Z_536=@Dd-0g z#+X`41fTX=rKAaKK<%=8zz?enoXZMmh$b^l4<*{pPJx#x%lEIUc8#7!hI#*N*1J>5 zo(=lj@hQuU>Q^zNvKlEhxhdys*VCXP=*L5NwU4CGjjInvmEX3H9}-Kq$jXE&Z)#zl zR`4m;K)c+H%jnc-{OBly(lL#^K%lK(j<0#MdUKP23<*m(C_(#3q90Q)38)rONmaG! zc)rDl%|AR>UzCGcS|4EyoWWA`4T?5(aaE|AkOmmmW={B&>YM;R&Uz#klOphHUd~6u zbF^J71(NwAF`6S5oMv5?(h|sRs3|R1%&zX6f{HFN1(N1}0$A<^jQPMbXsr%8F?>7R5ED@ROk|iII`&=Kt3Tbe{JKn6^#G2EQXV6 zi7=P>yyg#=tS5x)I^;-)kY!LoIYGeijDYI7gXS<#s{6jbnt6fc5ZaFziX*0D-$e)x z<8fC*eK!cLlWF3mi|Fi;5uJ$4)@iB23u$Qu9HiQMmjm$IC$UHp zr8GYDK%5u!dcw=9mh;?Qxcs;uhfqU_mMdXl^0F5rvC82ROZ1hQ*H(sSDTSGqPN9a3 zzxB^D1*B_-qSG2S3~>vifB3=*X|WLpl!Tnvu{kE=8T}L z5!tT78@4S7?gn^UJq5|Msa@2!+Wp2V$Wav1f^;ss8l!l;OuHZeTY0E7I1*!VXC9?6 z9)wRP&E2CHueMUk z*Oy8(9i`dtW(#&~QVI{=ivp(Y z;s%Lr{YjC zru{w@0N&Au=tgIHo7adMX5oTjmjZgC5~h$%{p&j2B}K58;D(+tVlgaA41!7HV94chxMX2p)mDUuZUA{V;artVY-_T zb6}y_lDeMtq7q$Ly%sKH-#>uNqOsOB`5^a6^IR#+BOK=2D@(0sJAa+y7=CmD$hOEN z+XeUe@J@k)f|t^Glo=SnXT1i0DWqRVi*kbimjnKpLd{XTI@hHn85*BY7sed>*my-G zXsp8_m_2Uz`-56T)4arKMHx%^&LRiEh-E%lWHk5^=$H9toZWdt=-k=A)KS+qj#Xo7 z`2P=e+yM+~O(H{btxw3?_9e7RzKGkqFe$d^-;3M;+>NEsTriIaGLijGYp^UvKajc6 zs(LONHbdJz7c~pL9O*Av(2Fv zGhW!RDv~YsuB66tUf)A*!t-n#Lz+lEv0P4KeFlcLh;i7gENHDtFRPfIK43i(82TTM zRFjv#JhCUIy-BaUwd=QWo=AMSrKzgG;(Ps$sHsiqj?n{t7?FJe-b{}(zBXQ7zLpkV zV`kOMT2;;6yU&IrSPLmJypTSFKCy*OB6&cmbyaL4cpE`T&ALBmt zE|g6uL*B`6<|F*=3|28K_VX3tbbr&`WU(6B zsg;YV$gC0`_P;uit@VBIItndWK5>8t4Z~@1gl~#UU?%IIg4&s>H_-32Bh`93ezgf%8`RJt%r4IH z$?6&H)v+@6k0B7KtnJs6I)ve6g7dQ?SmfzJ%IEP7hR2fV^HA;VSbhnVZST3jwNGVi zVdM0~dx@Y1!@peJS%zQBC;RKk4Z4!yz%bK6@-S1`E+cA$G~iqUpArhm1~n0VP=6DJ zzOkW8y&=o6mslvcNH5r$UKy06stFSfwiJ_P!vGXsJ#yvYkZ5bd`r8@!e!qRP6XdMX zB?9g_!81A)xeXieZMY;TAVeP?%FVaAALi}&TCbTK*vDotT%UXT3{2~urY{bS^HSmX zJ!i223H2GWD~N}DS%I6E?JYoF_^HyPmblk$p{uLA5urZU+|kUD)R+#X3o23eDu;5G zu$+JvkaL$1C3+aWH5=bK4GUEXaZl9p|O>;4CVBN?NIp-8g zNXWs$Z*N|@%&aW;@m}RlTAYRW=f;d#3^%OolMU=S+h-@9LGX{&JyU)S_P$qcH}*p1 z26m6=K){X&ap5P}ODQ{$ys9qOHmSJ*Ok zX+Mckj&}Y5YTr7b9x%@tgajh6l|vB45X^sNG1~1;m#e=&P(xXIx)k6Q&+AtaO#h6MDXz9 zoZde@J=dHb>n4D(CbLK*j?bu`d~VR?I|%j6+1_MdUG!}N#72?pZdf6>(o0lUX(iYp7>n6j4w-8UcE$*NP-Vwk!l$`&1c4EK ze3D+?LZiTMqnW&SO~kINfJJru5JoRmF*_uD^7+ox_(gn{N@c2(!1s^&z&#%hk@GP! zYfGOd1{s{c_?Ph_|1pw6o((qLW3zG4L1;?~ImTQY6wbrHTW+c-o%R1xI`eCO+@zO~ z+@-`6NQL+U0y6A@k5b$pUIf@nARV9QFWi}+Ij@i9O38@F#|k*xWie41F#4!9;vxBp zg7!>Y5k{w1R{(N1+FPjTY(@}(H_-TZ_`zt|=Q6_?$;5gvK*n_kMqh_;8jkhLz0x88 z)KcsdP^^iN{hU^fQf2XeTcz~ z7G2=bE>$V@w@40(w0b-?4VMD3XlPo1B7=)61Ph!Mw7wSUMBqc44f&glkhCE8b{Vg3 zHDNz4Dc66x&8rwL;H!JOF*Xkv&z{a)!#!KKG>vFjg`>mwXL5VK9yXPZkq^P&_K*|) z&Y;aD3{(M%IG;xej;7Hb=82C&7UD>nWwm!dd1#uk_@D&~w`9poUO(*&0 zq`nHIF)d{3>i%T0l5Jufkez*9fe;4W_{c!;zo)SsM zj29dSveB|M5A^`m)icS^{y14akj;Dk=vbPDBCY&fC+{x8kJU7l12*iB4ew@`YX+xH zvZ1dtktt0nNZtvsTTt%VTjC@`1@$3+Trs}FPi$1|YKlG0xsF~9%ENuBtOvc2IOM|J zG-#A>vAjL~H>IHO?zYzFB_%EFl?}=Kn*#|%W@m!2uZyc`&V{scQoN1u%>#bAngmvC zmZSYPTMO@&CsV_eB$V^tXj4!(#17k7guyj`Ap_IF9{ZG|$eSbtRsA<#rkXc9ObMFM z^`Nl-o@ybYlRQl%Ex=@a=a1aytKI9DRKt&GsN_1yF7Fbj7`2U2V#nP$qR!wdY}_lnng$hsH->ZcaI$ zVY~jQ$q*0xUiMpm0Gx1@;jFf?pT6T`e3Exea{mn|6M?m4o!NY zZ}m|=OWW>5XrfJVAG7twSzWa=&1U(V<+^1;qs4cg$X9DpeLa|GfG<3kQSN!Cw&-=y zb)QN<6lLxYVyu^|Y2F3&A3Xhd*xWFDfEBABkvUb4k==Nw^bc#LGMfe`bFTDu(KW4- zhX4y%u2Z&kfLZFeON2B)A#ruF3_6*=s()7iJ&P@lehUykCniddwyk9iFD8^7bpbnK zi-l>zg8D)8Eoi%Ng(Ns3G#T!{p0uU^mJzK)Gf&ZUE5C8$&YAl9-C};GXqgk)+Ue!R zzW;r0?to4aY2o6Mn(UXp*UBd+bk3(l^p>^xSR2rv5z#hVMF+WWe$V%=YYbly_kMkg zTgV=uES5u-(_K3!5f?SkVZBpDI;|PpmILKM4ZmGW5*3@?`~GG7&)L}avp|EuUc{2A z4Jtl3jLn^_rRy9|!iHYb^j|8mwBPTn>9ma$cWh_$q&CRAIouS6>bj&#EW~r?OdaP_ zuec)HosOA0Jo8KcM|;3&5i1Yh6ojL`ojKqD)s!vm-QUOT@llbX*WDoP9*?aPbhX+t ztwVk7{W8*V^Si7A@xLltllvOsoaFeUBa|zM#vLoiD+E_9ojg!fSuH(h^O=mKr;aj7 zk6y&ddi#Y+-ERgcj2~pli$Df`^mSQE z6gfe-R>E}IS*7!7PN@QnE?}R zL9W)Whfm(S(|M%9PB3T0G@3q=5=Dw}j;qNlrTjnyF3MXsb_GaoHaRl}(6d7$SC z!)M0{o^G={r!qY=`+=1DC-~b~qmId+V}MbBL4Kz@mi`d@NmnvBcx*rYNyK)v{J@U~ z$4Gl6HUAQ`6U9yd@dis3owF%`eE$zjd=dO(J_)To)7**KAL(mQf<4teX zB2#ER{u#YP(P+hYr$hlSgT}NF@yC7~0Tx)5`5b}q$}^j2Ll&YTq@&)bRjI8jqzrH{k?N=N%PAeZu`mzjsJAC8LeO({^CH5MY>_QF)gC-V*t+%_D22a+ zi{^!;Q}JUGZ5lK7r*VU|^+a*)*VU}igTW>eVk~(wgx3I#>o%n3k*Aa00lWv#g>%aP zTqhy!ySQMg{4P4DUB{Oo+V{2R-un`&D#*wxW8|0enZpmf(@2K5ty zx{aJ0N7O`JRoEAm&7^CYMAo(nVJSr(J*j_v6E`pzcR#e{AC$M&$ZaU((0lez}tlQQ-aN{ zy;t|fBs30xFH8aZ$-mHhtW2C5FMjS+MB$Sak7Ats`>k#btey>r^i@A+=89)Ke%5LA z+J@3f0-)o;3rUJZ(sxdLa--JA-#&L7<-Gr=Suy=C`s&mBW{ zX4~t{U@AJ_;u_-|OOtTu6)@^I@z8X&JR@?)PRpg1{p{rEXVH}LrCMO*>8)np4y%#5 z%Vto1h&LzA{}jI^74%m0LZ>400a>pk!@g{Fua^O9&e^{MohM~(Oq7!&`5o5nx@cC{ z!0RkUJNqt)s3V!ODheDhFFX2n^C?&m;8;;ih%m%DCFlrzTh{L-(vlW16N&Y*WMyiT zG@=M?NvXzY8s(eTSVnzZ*F6{!x}X_gSwEvq%cN`-Q1Ci~qr``eP44$Irs)gm2lSNZ_y6a+GzM>bsr+eP!x#evhA6f?m02d)%^_<}H8hpH71o&1o_(x337>FvA&JuG zE(W~8UknReX*Z&)*4|7T_(UK(J{Dp)MPn`BfJaxk=M!DHv8nt~oDJ??Zqya{9|Y_5 zkOk?+2bBd5WGtM0E;CPZYk`@|2$|Kkuh@_g58hAOpWAtFk&0b*O}_LYrmkD9PX&!%LwVVyudf7}qgt-XVuQ^vsjBQX?#JfQqB4 zL#k$JrSeZY1-Whb0>{u&`cx`0#A4@-D;0l0zEKoEmH6b?lrG*VYRc0yhEuwpW#K=I zYOszUQ?sIgY#GO&NKE=4=K|4sCnD(cU+UU*aS>m2yOxC?`dM+lp#Jn z!s{Hy9oBL7`YGah`xC9gJYADm4-r5|IrD_5ueH$8d+v@yYa7Ht1MGToAx1TAeL}iW+YjwVfc$55( zx^+0-({xKUs%*4rZ8h=*d6{$m`6kpwdGCcaZ$^lb@c*oojcLb-#q%(grxz6g8C@<4 zpSHqj&^vMu`nQ`G{s#IAWepcvf<}Sa6}?@V5Z{vUzAf{`zeaxz&aAB5(#Qy-p97QL-B6%Qg_M&JyVGBi;(v%)OHJ(QM;^EmT@pQ5I z)Zu=}KP@qf{wxc||GnADN!(v8yd?(}uwsv^TnFPVf&kRu>TheS{GBSr0z66}?6x+s zQaobK!vj&{(;f{;Suea(Wi)3fhMc=?)Beg`(EJ0te$pG3ZfF&A-`XhU`tWVS+0Cr| zJ@oS>bgzpx|8E6wcg?Ruqw$C7V|iOMFmm^rT0$YPcW@oErH7Hk@b!5p`&`9pdrify zoKQTiLErcQr^_w~I^y~@s$&B5`K#X3UDc#lRCk{OKw~_x!HJ16*n!o(eTUh|*Cx90 zgEI^9id)~xj!h!1FlMk$RWitw{~x{;sOkoZu`JX(A>N5xJ}Lpt84>Xb14jL|8r1Q& z_-I*nEHb3(rJ=$$?r+?LyZ>Ey&X<UJn9yrnnF^RG zr1zy(8yb1rT5;Hw$`|mqY29e5Wbeql1`k?Y)5O>sDjC!7*KHGu_cl!p7?6=t9bOP4Ig0>n-PWszod<<-5IwD$biZBCol2hAsN{Z<6d4n}3%E%Cy3AP2q| zv@~<(-=6bMkB_W<>*+Y2{aox~q8$I1!kdkJ;q%aDr`ZCXyx(89jr>&z_E`0=M;Y9L zG05i9fGLJ=#?I;m+8$Tl{x7x*=5vENxw)BZE&c1g4->?E%tOrWL{iX&%qh^P*hm@p z=iv)==BBWa7D;>x`JJA5GFl;Wqn&GY`ybIJECg%Q@v-N_-k<q%+Em|&A&WvN0=9mjA*s3$rC#kI5 z!OXU7ytOaA@iZ#^a=}o7F<%g!} zHZAwnNbc(jVZNjEVZ|15WrI=8WC;nY=_nl4ZcO(84UM(IY+B)yW&+%bCrZunvCd9# z?=h{bsWL0`Se^74wC~j$O&P(!J{?G{{Rm@vMto|>4@_Nuz^m5c!tqNX>}>_>UwLLj zx#FMfDWQeH>PSXoD;()z@?w)QrtM8le%j1e;i&Z6rJ8LtnKn1RkuC8+)wBcS;J+pF{@N%jGA{BR{SB_Ld z8t*9}6K9>?Y)T&}j*`cRN}px;DbMULa{=u2uUo>&Lu*-}6QDO{*Z?tX0C!7=H`aVv zl`?{>c*wgag>*DeJ=%PEZ~A`B5Td)&9Ns+ARMItRz=3&oDWLJ0(;xIz^9AN3?q!>b z*Vo(&nS;0qqq$WQP#$+5pWpVfqOxLf4|~XO#9nq*#Jkqj$ToUIM{cWxB-NaW8VGUc z&`_Uqf#pPm)Kja*v<#h8Aw@I%HHECJ)bdNYASR3SPHYyLivM`S|J*e`qs&v8^{euz z;soyss-J;}tIdofXyX1FsnYiN3T3&Q>~=P{dyN-4z_rysx{=1Zk*$B-PbXrzYgTs( z$%@cBYoxmE{o_o(I}-6v%*&uLSq4SXNf^H4fLh&>X`~W5$l^f9#S@jEQS6l4+elnP zD_KbaNlI+~y9h3s>dNhh?cs1j!=r!V=W#cBB}ZpwE2+HHB|7E|(N&}Y?&Y4h zw;XfE5b-*GX}^4*w#L5oo!H|7H&2q%BUUJP zB@hCIOB*7sENH2%>nU>KD+a@Qxo9H}^Y2&)bf0v@-nRt;_nHj4I z^?|5*JC;mJg}ArO)wP_)j`i_*Xavlyz_d>>GCrF1tNhmMGxF*DOBzA$%iCgw@eCj; zte#O05H7KkLnmt{S9_lV-ht2xsW3(!`K;>oa>g8Pq9&pj&HSThXVALOyG*%+hq*8r z#=Q@NI}g|NXF)J(nnEgyknH7mKq>0-cTBd3{yO$K|1gYU!amPLNa#eoi*9tH4Sg3syx3 z{srN0tRRFLnlKWXDx@w^9~XqTC#moq}c31wF%52TlikC_E{_$9&=$2tQh zC7P1fV@c~kz(~Zu7oj*V+uwXTb{hG|F%`3s`)K5A0i~Ol-~rCT_xE+C;VbkrO&G~@xzE|kRr%KQJ3DUQbzC@ACH@E6JH0KmTPROvb=>SrKMym z`^qrYqXat8HrEvl4ORA}!t%7LFjBbJ86Ry!$iS0PYLH(41f`7WcrGv7$}c=(=fL@k zR;v6UaYtH|Xm3uFm1SuC(X)LKRf*s#_0XU&F|ji+GOD8x@yf4U#dc0pvEW`DQv z(nVQ^;gLoArqcFKy2xF>YpG`<(jvY81h@CQV3h%@-|HBBIA6B@)+jk*hk^K9F)VE+ zU<^8^xz@-1HfH+$sLi!L3313qKe=6l;dlH$$3oa@;6vgL{-^WjI~WVQjJ+~jF7I}# z;(ZN;A}4oKG+L~?c*@g87gLEd(qHtR;zHM!DH6|Ti|IanC?3Nn&vEgkZTF(_n2YHb z4;T3b<5sr(8z-zRvT4sFjtAn>3Qm74TfTqLM!x;t&jXy=Ig zqhpsXBs`05nvf~(_%nA+*Xc~)?nN@WW+a& zZ&g399UAeIA8lcEK|qkNp|ND-%M5+jkn&jz zneH(A=LBg;D|E4w5(?PR!mFUW3886`K4_-+%!TMqJbRPsTQa5mmFFkPc7eXDYyzN{u>jN$-cZ zV<6md*<;_ElbAhpf-c7mOQIO~a9irC($a|u z^#~@N+k7T!8dL0(Q16iAjP4Vz?wfip`E=mDIoz7v38XbzI~5;yuy99qv|9y(ubRRURiC$U0|cmU*HVQvB)HSk@vEHMS5d9 z0kN2fXlR}NMb8*E^C!G{bLLc%RYE2^uAefdZ;F=RA6FfhLw=rHjUR;6y?~II8phF< zuEQYGly_? zg@u}!Bp6LSShRMSAONXAvTM1>rU^f&ECDj`{YW7nH^#-jJ*|z<`-lS zQe$9)TZkAaXLDcdCykhGfPXOl&i1sk_~#tq!|DM0-u2R)XLM+d{#j@!LbO+^ zxW<&Q%oOw5{`TQ=fAjVgo%bxvAssNao2Ma}GZnbAUnnE?gw@flqI&g+dSusE>h=qp zKt}Gr{pswIhQR7c8V%G>u4g2IKQ0{!7jdqyChEV0Jr|I~7 zl32K0SPmT)d;-3m*U9E))2gAx>(i$qvEmU-#Is$N-2dzfnc>hG%>?76oh=uZ+ zMyA;T%?i)Wy$F%`Y>*?ShZn_qFF_)?JStt zsvw~dPsLdeWj_f5R9_#3%X>`1l@8@_^2Kpaejsu@i15fabb9FzJAnf+Nss?e&&E|4J zH&GKUl^h0s-vW<2VGulKE>>948aqt(t%~2L2tJI<+pEKg+`%)1AVy0CU{!$Q6((^q z51mjRJsFK%u_?wLq)386tfFsVdnXB&*!mqS&r-S%TCL?Y@glRj4-=PW`4R2i2dU|* zOWX%umZg069jUfMX#ebq)LV6iW@JBho_|(3tt2F$qnFypSzVlqaYn zt@+3lS>QuI-VYgkcpB=DNyQ;b1UlNPIca7oVQzQo`spO%|ltSfBeSwn|o$@ zui4oxGAq+$N%Uj+#q6>24x^Sgn|qbpiMktmTNfK^o)AnrcM_f>so*ze=rD$0p}SGK zEo$*x?7@2`x=J6azb4}&XP_>o(?i`EZ=LQ@rbW3#`Y=C2ui+#paO%Ce^!!!X7h*BM z?alTDSK2l`_C?H910}wJ+#WM>o-7Lc&7-NgcYJU1XhFAu^%QWbnflM{kte3(LUV*KDF>^w5!%kSAj{_4Oj2tee&$~Dj%}y9ymE^8cmH$s zzx@w{7^gV@!W8_R`1kUu4`ZNfZlM4+=(V{5~=2}&n$=Lk0d1ouX5Z4k*lz`hpZ9*VdF z{djD`pJ{n7Fl4G#rrZmoWm zj0*i}WzD5c&j_>ri57da06F-bdkw2N)2^TH7_>)3j^%-yRX_f|3auiqR;hc9h0_yz zZix)zdoejovLJjYX{Bf^GGCA{OAM1YS|_tpZ7e$VgKmhPO)4}Sv-U`yi6wVN_JxXe zQbl?NuS1*X#QW!ymTaQj$lgGTf7RbKlPv^cV=76*JnMjm-7r=_I-nxT1>Bw;cfT14`_B8M~GO^ zHpY8-OxmFQ!PEPdJvox2%@@!1{hIL5hlNMQS;TA8eT;>@s8V^fjO?03I~^o zo@m4zPeMz4+1V1nZEJ0G#C z`NQ&41&7VXBk#w4Y!Vtu#SPZDaj1rnp-f(WpW*>#c`Ej6BtfU0xj5;Ewn9&7!*m#Zh-xp2A*hZLX*hH5E@t(?<-kF_^JT z*z1V&tEi*5!i_3p+p8T!pKD4+8!12L2c`ot+oK%X*ebwge)KPcllr?$PP{Gnnflo< z(xDjq_a_j9M?ATxg+w=h--;Zzg{{t8b(X2#4j8RT6ID)L%Cljzqay~wI&?r7d#YJY z(h)Kt-A!c9<>$7ie5uPUT0?%5`UqVHw8=YRHg=~^Rw;esJ#CjH1$gW?LDgFG)FV)weqU*%DZ!R%Pea!#ha7SXJydl$h#@@!tAAXmtKfK&VL? z-QWDI9q0&TitK z*Z=vvV)BeAzVX}OGmm{USz2omwPh-;5bxNad@9G{@;L8Sm=#R;==4~MVw}iGRZ&*d zzm|{thO|)b#?0)Az3-a~_#B+=z5Ar=r?CZdlE;Br>Cqs$f5v-~5NG1Cq@#fNG5qK~Zo(&$25XftU(X@gYlpYKN9PiHju ztZtMQ>AG23#z~m+ak<%$7=~4|0`alb63$=G8%r$&T zW#K+RhpXS^ItXLjWr^<29+CZqgsH%X5VBwHi00p;x7i%T9323OA;0{r7|BE3`+|nK zb<{B0ZwAqwL6k#E`%LK9wlUjUvn4Ib`(uj_nG8xwaN8s_E+U;9o(`N$838?E?xBS5 zR~2)0H4l+2k8*(!mxXiaFjtm^OU~s@IjvlEXBT3*A`gGQII#Q^amar(@3r)%=JX$7 zpKg1DOQ;gw0>9tfBv~@%&Nrh+KJ-`++?O8tw0?Qg_kX0BJsy2xg#DlLE1S}CB&5T} zv8&>!VvJ$uUq|mvWpoSjnrhAbA?2Q0_ARSvjkHc^N2+=+6G7?gl?MiXQ&5%X0d|`% z#vvqn3#?HKr2}L%)rD1FPbqE;L6C11*h+L1N_pQ&tCkB zI{tXq$a$g*AsMjJjW^x#XX*J8CP=7(NdgJ;99rhht{u_NVBJP1E z(zO@(wqcJmldoT(uPyv~%yO%06EMgvK^}B(f_-j&$+U|7QK6jNRM#~Ofvx?V4?CZk zDw!ukov2R`Rz1GeAf;J-aP|xA=YtTjpc&0Lge6rV2@y3(aWJg!`zSLBpCyfGo6t?OgzQC?o z4G!{%gvO3Kv#3?#sF2+rlh;Hd06t7{1FS0IK4EO5QfR1{n{;3gG!%WJ@8_P*Sfn@9 z#4jtJDDS||OMCa{p|OikfN3k79PIb+(x!8uE0+_}0zi`37I~U)e&c^p%(Ru<@)vk0 zUuuQ@Rn6^!Oow2;;1{Yx(@H#;5$|_}CDk18pn9Ys;lE0yw$z|7z(AQrjxrR- zoQtLcCtvg)w&0p}9(1|o+JIrx*&y9K^(IUb1<1r`eH+U-*lXIln1 zjV%Azi!=tB+9vRP&q9o4M*jaE8ml`SD<8C;G7rK?Hu`+kH+TKDg}-0of+Ehn7utX4 zlD3?bwTZiJk8oj^5Gsxeq`0jrOx5e?$mSI*k$x^lLSdYW;q^Jkg;Bqz3}Pt$_S7n& zCX4X8$U{725Uf@>WOrKQNO{yLJ$9)h7kLA{C(NG85hd$>u4moNL}p!%l@Hczbdiq!y`-8D=hw$EujlMVn#8jj-O7tJj5g*IYQN|ApuT zN#jTQxo(bH%3v$_7hLx#QAUk9d~D+yQ~I>gL#JVWGDS|T`byuSSX3FW+GdK4V~TJ2 zQ?my6X9-CaaIrs@-n@lcEc*vh4 z&3`|NuX>O;frla9A68ZjC$)r}={w{cJE^fsd2*Za4z>aR_{mhw(R7V`kTo&4)0n&v zf19ffjrr-WVqt$tG5g!U>z=uTr~i02kJm{b`exomlG5(`hmfVptvuGQ59uRB>hXvp#2Yr-&!q_<@p+`r2ss9A8-b zyK>)Z#_!$)0LX+D?=RmBWOo>KRV)5fWIR(T7dU*67&mH-hZ(y(p*1|y;6NXM9fYdNR%Yo+w~UIHnk8x}XB+9?zi zWLB3qFl&?bua6H^=u*EuNLPxcXQGG31O?L|GBlxfZ|kJE8$h%x00H~|coCk0FK@i- zv}z;jD!P4L3^2`#!qS3ur^uD7ZZ2exsl=h!ftT>E-Q!tg<*t*_n?u*Qn12E(9vdEH zZ>HI*)4F{o_IVTr7B~5Ui=m9T!|pdKevM)kpP0Zbi9d~XjCFfPo>zJ_MkC6~;j_j9 zF5qU(Br6;r%PJ+scwJ)2=0Kv%u+Fg*Map`Oc33aCJ&SW>dKyR`dgk$c7Jhq43Nu@B zA-yPNR;i~X3pV2;fT5l$6ZDG+Rkb|mpl(=aDCXNY_Z(k}KUmIvsFtPsI=#X0Xtoi8 zJotgnKIx?(EG3F+&!Fs<0h{xUWSITxsj?6X&=W4=IHW{lOR67B7PIgwWrl<2+1QIn z;}f(Z$Ieb$96wKU;1r*Q?6attok1Q*rN6d&UN(`#dRxNoTsYvUFZo0AM2d1ji$)xR z7dWk5xU(+24d=8_o#~W*n)tR#k-0qpu_5)yEadZ-NAlVbJ?z{nX@A7}S>rG7?wz-= zq&K&oPO^Fv-Z54_iyx|sv1I6q=H{DJLaQ|m$8CM4t247kkb2@4%b_`tp*6xQ98;qSAC1-xZ23|1A&fd6Trk_(rcp3bi>3aX}?lILXF(XGwZTr!T;n#~l z#ix8oKcSzH;UF)510uG1VMDmcx0$)57dzM;n`{r>S|cd(_D_EI8{G~jF}rGXpboih z6Rof`U&E;}GC;cEY*QKZTZdC+*L615b5HkuP0i6nvcFGDls#*?QpaFvmg$9-7gJGN zfrDG!85gm)kB)vxmH4-HIyh>@gdLMj@IUc)(elNCWdNM8irZ!4$&Kj8P0ze&noaBs zMNHY%3UQH`-ij2FvZi+Bid&j}k}jG^x>m?ATeT24DkjWH`VSQ4M!YduUh2Pl- z;~W~w#~08*>W9njnmi>BJE+{DS2piJfW}VoSQH`HpS0?`B((`{kWTus=vP2>WS|y_ z3+^+AZ7NP-k9EeAIiqsXJ-eV>l-st|@tnPXVd7l!i4S(0HDOl{jTZs6H`rh;F3sjN zEm@L5%eUv~4?O6u9+@bP^7S=O$5|=}(Z7dX9A)X00fJ}MgsNcbJ-_KN=b^{gPUY1* zx1T%mSiXh}imRYCdVXMdBMFp4U46e>kpKW@b@)w;Dn&{v9kFu5R$2W?C0gylyU0LuXg+YuiR1 zZm-5zmg-vdHxC@9w$#)@4=I$M_lK50CtVs(sEFYW95QQJrE5cCWlvcxS$WWS0%|59 zW8}2e9P7+?`0_S2)aDig6mZOy-3f{COH+3`a!)x zu|9E*Izb|rrC=tTF+&b>jWNN^{AsI(IOe480=1#Wev;ij#%WG*z`<)ut1)lG)vqB(I*6>Dih>Od z6$d(t55$fI!fPBib?R=fnmuJSkC@eVCKMq}cZgr&2jUqwB)9xF{kyZ&7Wl_9(#K27 zMoksQ=0c_fYQs?(Z3$a>gYbR(Vtl<+J(^V5^xLrC#mUdGb&YyvyL120Vv#Kn$ubL9 zu+C)Mk4ST(x0+|ylKml=vPwIx(4LBP)EiVQN3WJ56x>&ta%`#AbmBu?D;qi{`@>SW z&=8Ei5GGXqkg6<+W28emV)X^LI|DOCn!wdIY2Dyj1c=fLv-({gRuiy~k>4$+KB^OJL6_*w$5P zU?v2=rH%!yNBI`czhx<|d%eIc6io|iJ;j&qE|85k$-8^42M$Q{E>iy7m zV4;B!=)P-fqZSdsd4K{mBMY%EvJ58dBw_-@erYE(&{E*-dH}K&qxHeFe z`wb)D!op$;wA5_hAMRDEWFZniR>Ot>YY_W;;+{?GzNBV7FxH&3; zRZmqG@)DiuIN#Wi8x&N?_=5Oy1tVD);a@VYw?nea?E;Gd@2TpQsT=i-B#s==B3j-~ z7Da5!t;TvGT?u6unsU0G`=ldwApTpzR>d^|CM|zsuzSRPY=sgGi*wkl77DSr z&Ga_;D*283jZ6ICv>MWjjNeJzYt&-sam=y$4(iHNG~-5)J41Fbz5m5HX&-m(IMOLp zhi_bv2+1vFZ~G&og1wfKH-3OuI@#$pYA|QCnKiIIFNlQJlm;wZV7&8GohLZ@39M;*H(qpG-Ue_(88o$DzZP| z2|J=bs>$*`0Bnykm;MF%bbn2xAdS{f2I=&yACx35e%6}vtnbLl26>VnbkL!NZe2+y zVt4{~NQyNL*y-d?o%Ic}AbXr`C9ZCj9)sJau7|%a6yo!VXY*RZGHDb&`Sv_bpWQ9B zg0HpV?$2Y2rHpr-b#++-vhmzh{MW}G)Dbvilvy}A{2b9eK9((;nrpujD!Xpo+Lg_r&;Wep&4hPo= zO`9xv)@~gR!jpW?=>ezkW)#1%O7MnxW}2k|$8+iof{0jZU|)mV^JRtjcAL=-$l!45 zWtWqD?mt*pz;#lZf2$*AycE)L+s&IP4uA?VK&f{~g^XT;d?Un!xrHsgs_XpOtS505 zo!V~@b&h~7Dm_V37}>v=>tf&X3yw&+Q%G~0ym7ErtP8W?$iBbVT=OK6`m({{Wnr7! zp%+maq*(QJcP8TZE!kHBbf#Jkt|SZ)+X?s=e``Y{T7#jd+?a@rKTJXT0Sn_^t!{_5 zFB|3UE(=1=pfRG%7W`M<6USN??o3BUhLmC)`(!?LyMEr31Sy@S=7+ zC8-{+Je`vT&x@X#Z-T7`AO}#p%8S8MjBmi`UvR8oGLeNbf>FTY@6oPmpNIc)gMe)a z>TZicF+*8d!QN)@fOF%DmvGd1Fdl#B0Oyd_aW}1Yd`3@ymS;&A^iG57FJ4bS!CH~I zxt7UHS2>OX@dbXxQ-Zl71h;kN=RvFXIvBJ8C#`7{EJe8_lm~)(pdQjrisDLF@*Is~ zG_yrILOHnT6uJwY#m=XV37m_3GkGBuii%w$AX6xwVfHr3#(p~>wqaH*rQ$IJ$*dOh zlw0xEww6K2>mvOE(3{N$^Uma#(kiGo9_AWNp>tZ&kY;hBxcyW8yT)~mab7=)G}>mKc^o%B)_%gBIdZOGK=#TGaAWIF zr9~~~Zrl$ROEieL-2iOa`LOaL^0r#)IhXqNC&1$Hcc~dQuLAFTUX?&ifKLe;)lSHW9{p>!+tY-izDnt{%KvSo46y^*N86 zZ^U8`8J04ja^)j(2EcH$MI6Ya8wfW#JHw3^hF)>GUT(KvNne5P(6h*(ZBqwEV?Ir+ zhUp9`n)YGK9(sVxnDo=l1aqi1Wbk!T*5A{sk`%}O%{yc`O0_5USxqYbh@e|Bbe@pV zIZkxY4u-XAMS`zh_2o6X3&7>d5AhdtRe9 z^=^dZ+m>tRA5ulc&r80hz5ES!Q^R`orO8sAy@>KeDWgNBSbA%|!|EfL{-maK(F4ri z@x|>}tG>0>K|GQ2duFm401LlFLdE{jJQ)nT`^6 zvg7H@(`iMjIFfZ>bp`eyy&)aP+@TCOn^e#!V;Mo&V3!4@rBbRrQ?b^ZGW}h%!R*o7 z><@RTEyrmUkxrU!H@F<2Gw7yMKe5mXjeWBnOWHZ89At2WvvI2O%!fzLu0_phxt|WIpf(O*f9-HJ8i81L`<=Z1+-+ zD$QyLCtf?)zE%<3h3o&*`Hg!J940+BXj2C!e9!y1OBn6EUdQZxYa2nP-^f4!Wb|F6 zbxNNk{D0gvJD1zCxxxJ&Pw##5nRyM4`gaE0|DR+YxwbT$?dUVbfFbZxeSx zo`O}wQgD3$oc!0QXYm^?>@A%FV17L^lvYYz7K|u4kAUKE7DiI1eytj0uYF{J`qp<1 zMs3UOs(*GNcFs>`D7WZIVY0tmZMJirbsCDDhBt83gE4Eq=LaGXWaB*fiEGcJ=hkZ| z>-rMgOo<5hQZ+L=#ycudMrrl3)*m@Gb%I~^#@wG%?zOH6Mc}WZsd|pX#ESjnprCC% zqkg^V9_!i6e#0NdO7@$#t0IBVRG)+mnbzFVORMNGSIp=j}s(xCaz zE6I*RkDlG4Q)%{|SjYQl$?-+P;6x!~?^`-5J>7Yur~7?zPV6{ulV%E|bayHcyT#jf zqNjTLQ|*YYHazh6_0C`axn~O*oDK?i4O2v25U+V@7A!Ajnp9R@bJGc`k|yXn;pbSX z|2uw9&shJIy7(Y^qe_Fk8o$e>f}%sh<@Q`*u`n2?5^k zr}L-e=fBH-wy{~hQqwy8Jqnz*Rzttr96+z+|C*09bz0MfIU zYjD^tPDeJM)zsVZ^CrZ&H?&BMx|^_RC<^pgsY;Ftz(Wma!}Gww})V7fu}Q+D2&R;L@Nc2 z3y`YE3XawTsX6U7AFc~T`CMjS_SS#<#bchL&Bjq9hNG~HF~!l|N{&CWLHd@VyRdj} z^tW~*E44uUQcB3?948YHtEHQ=&w7SRr+B!kzzPoJ2(5Mq$-CzH-ow=`i!(dkE zgRt`qq|j5~c?n}x*!yoRDe=FaL>+M4#`o{Fa={PDtqC!FpbXAs`V1R1ttz}$h;0@B zu(qm6aGN(u%N{*oT?-MwkGb6#Rv_=Lee1<+X`UK~t&ZZ(meoPua)zYoG4|NvrvnHyJQ>N_xyu|It6B7J|gzvpJ#eaQlLNj|gZbUbk z{{w|xSHgtPhVI85yc3(>#<)yB9C_PVr$F0dBtHk51i547iNQi6_Xdq7mo(2MVRM9_ z{8B;WC-b{f*%2C|13zt)0<=wsviM`S+ikA&;1Z4CP{w(}?WyrGIN2;ud6Ed$wr(~h z!3XH8W4WGhQiOt155#gc@jBIoP?;@wB34tLqn?FN*G7}hGNG7&a-iQk1;+C9pKm0r zqJc`~XN)q;TOR*-b`B5>e~?%>Z7dD^yIO;AviYy&EjzzPmg^Vou#I_p*3v2N@Zg*W1C|BBd|%8D>_hxtj{) zW^@QInHqg|^Kz4PesH2D9@T47sSzc8YC?dnOY{3}|n zkCwu8ri!v&h?NKAqgs8c76nGBGG5>nHbRe7RYy^`s+%{a*KHb6mWBAub?|}X_F6gG zx!|!>QWGE!^1tD|oa-`~>%cxmv2*ilnoz4850sH(sO;Vw91)^9AqGgQAf{3!j@_)2 z95<`tY{fD(0mqw(%Q<(ncOF4gzFi=okLPqIFa}G{eA#1`pT*zB(xMq)Lxd8=k#y^% zM*lPNTc7#$HX<0dU(uHJP zLw70SlVe_d%D=4aJVb+04g&w3W~tLW?wB);6kRATHIYh;Ma}EExRCUbbY#=Y{Z3EH zak1^|zdO-X6|KF*$>G>LyMs=(*}rOcwWf zaRUp??8w99vB_sGjEwUnJN+26Pq%H6MDZe;#3ZTJzeH zsBixZ_9Y>=sD2!-noNtw4}%)Os=gvh;IYUf>c8U4Tk6A)s@JxdR`DKG7_;s+SKnhr z2q!T{asDcxEVIE6lL`FxP<|gCU5Hy8!aOv)i9HbwnXR9_%ey)<`LfrX=N8P!=tF$; zz@(!pz*wf;+Q=+;Nntw{yGP(OL~Ql(?t8*EDF=0mY=C0EV{^jT+{v?c@{#PU&B)Sz z^0-Bi2+(rNMv zE|+dbc{1mLoVKTiPOMz_&BX~#N#wr-Q6as%YwYE_(B)PVGMM>Ce$`qP}`TAhL zFMnBoOa`(6xV^|*zq)AUNK}svHcvm)c3AmEPM`J4O4QyR>6oi&i0NQTr|zOiy2|ZVE+5X7MSpSL!0)UKvSE;Cp6Wmg?XwdmAnVBh8{;5@ za5@K<{-x;eF4*#JLX=MX=`evo`Q5q1wXvK!yLU~WT9$N{n(>UDlv8l>#_gYo(Ax;v zPSC-Mmw181RsFf?VMLbT4ukS=qc|T;6M~*D|UqZg} z9sR%X)UR5Hfm12)!w7P0;WFYL3bvo583i0&x%JaCdT1JIyMhzzP2~km3@JoED}EMyi)ZH}{ zs+TvQ9KUZ4_2|XS#YS?yu&Gf4_zc-ki@Tv%*WPo+TZY~=VS@IYbTd|-o>c3Sh}RYd zQF9b;+=+cn4Bih^2yXFLrurz~<}(iuKv2B6q&WQiq;mjV@p`-PE1blDt zAG*03$n#{VH@EuCoR(34gZ{SUb6%f|VqE0|8(+wkMMbfS01<4zG(?B9@BsRiHoj4o zUZ;=MYunrrXESWDKnasL$Ah*kavjjsKT!!Kv7{rM8{t-Q%!WMeo*&a8>6Ng!3dKkc zHFRzPr4pJ|aOJ4J>R5X-@}u39R2Woi-p{Eoi@oOnsOcVW3kQgX?UhQ!w{tbC>Tn;c zYHwf%xhf1LgSIB3VGq8DSb2`@t8pPkZ{^8qTYkl!+QUv9ob_SM%avqs z&gn$0x-TYOPqeyy?dO#}Al}771}kL_`^*kdFkdg1p|ye@UM7XHx{1Q0dGdYOS5LzU z-wE|j&Dg-zhnS_ki+=h4ZTT&=I zuzjfW6uQLT-M0f#HakKrq)Yy9BJiwB&UG$vZ6)wNG#7|!&^kDi=#`pkfmcUS~`62*$gboGCe^eYw zkIHzcXxh#eUD5Qi_na0sNj{QyT`m>>MJkrOCby3GWo&Cg1vX=)j}*7UEQ@PiA@z7O zroHPU8U!}~WrkxPTlzYpZew-UZ*n)fX||~Nn_D#g$sZ6?Z+5gI1zqmXtj)C2pEREbAYdO8P>2!8g&fl{6@zeP_j;WTq2O1Qb zpTbYrRq_`3VVMe&Zu&kL;h5=XKO5SB&u>}(aKREC=g5w?wNC5Rn;P^;BrmzO19*ZD z=Z&n}6Jm~U2UlwGTNy)HkX7p>_3C>H3Fp;>A$$`PB*L4{-L^E=6CU^BLShI9sg5^) z0bHqgL$`6+neSk0hM#j4kvh#?WmTWS;wB_KZRU_p6Qmtt3hkruG2(RL{`n%L{Lq}U z%hox=Lt1vk%9?$IPg<4JrQ?VyAV={%A9>E6)-vqW05l;DlcL5S_zbO{Df!$yl+LXy zvWt8I^chc_G6uHxhpe!`{MpF~MkpO-ZP_E~!;mkuikM3%hR1mE`X1@ZL)7$rNA{Uq z47S=e%@(KXp;?Uyu$>f}6PXg820A*N!Yc(WuMRpt1KTlseLipe^)cv}Bmkqc+MGBO z>>NXK&jCe~QyWgDZRzx+mp8BYlES{I!|@zspVEkcm~%cq{eWk+Hm_Y{s5ywyIhhn{ z%#mI5c6U6Eu!GNTuU*uW<^Mi;0WF3^g_D{563wX(T64M80Upn>(*sdu;CzlRw|?(m zn+X#tF#|IeT52}wq>CzRf!HO%6iu)yf^)ziWHB7gGpHoGy3_I32xKT%& z@^1px>1`ViN#HtO#d+aZHxmZ=iRnhs0CH2oom9tvi&X2OH$9>|D{@9_2HfTejnG4% za_FDxKhOEiP5)ruQ-w!Ftk8RN1qPUwfYK5RT1}$|LZmW!HNgMvF~^(A`A0#O0eOvR z|4PwBzf`r4XXfn=OSX%&*jOo5&x}?fg%^=S(iAf%J2qJMzwiL3VGR31>~mBVaQmew zGH|8OObVuaUR7tH4{EVn8|PT1;lue$ALZ?eX|y|^);tnEu*suM`1DmpIME*t+Ki+s zhbAb`7ZeXcUUK|CV7W9Sd?+TZ`R@Ko_$k}PZ_mnR%KIPx-mGt(-I1NUNmlilE9F%s~^H_(=+Z7&%5w}<8>R~&u&Gvdvv^Dq7 zvg2KuxJ%2%KW%qvh_{U)HXC&4_oQOvC#~8Ku6^I8oJBs_BKT)Ow)R;kYm$> z78S)Y!&1*f6ABUBeZ3BNm8<_+p_i%e*eMpgP4kQS=HppK>f~sk7vZc_SdDM>Gs7ok ziJc&C8r)9G1^GnygYqh@q{KeSbb!Vv$j)*H{3V<{QBuzVZH82ye=;vRxC}BFMf%hb zeKwrG)fXqK6z*Ppy4*_zNEmaUqof?slhdScfyApzP&(mzv^m=9|HGC4vH@i0tC;PJ zpzPP+=rv%)98D5#>JaN?`bSo3&7$_c?LxX@4x9N35B5PzP$JL**`}mCrgOK#LJ;TB zzP^(bE~BQ9cG^NqX=>+0`stqEo@2d671>z`|1kLSBbduj%@y$&j^zjB0#?5kh+VcU zXI@s{*dY$tjQGcZ+I?T8A-v4|1dZ|oR#O?g*GZiIjBw^XX(_WvV%WK7+WoQ*ChR(WwyRLYw6Qkk0=KNEYpVAC**9z=4lpw$y}+1TOXXdZFD~LAJ_vLB%ylpE5q#%$FRkxw`Mxc-vxegzVyj0#h%EU$XqAer=k5NCn=jC%&=e-K@4XknWArjU+rh%^YerkSLGecF*_%OPdGi z;yFc%Rh@Qs`z(+tFh@R}^HH+RNiXO-*&+hB)nIh(!b-y}R>PCr+_)Zu!RoNtIq zrZ<#?kmVs@&IltpYH_5+qD&gJ$aWs!8TDmN+Gucir!#MJc;~uC9;p8I1W$dK#=0)F z<+AP$m5S5Q#3me1jkpKWP0Zk@7(*Fz@V`A`Cp=s^vYW9dbtZOAqMySu#x;k`8rEX~ zo4ZlxF8~8j%F|M9YeC&KYB{|23bklL?D`|9U|NWHQuO~Y^(J0P=Wic(WsQ|3l@*p- zjTJSP6tEQ6TuKF0l0*Ro z0TBV&AAa|JpXYhb;Scy8&gc3p*ZY0F-oiruP*s5Xl56jU_5*RfU%cldEhO6ils8=k z5AIpyf$7WpHY~7VX@{(c7I>qAh&P`*25&F3P<$VK__8kIy7c)YY(3zWEn-Ui2H`(=Y@l+h2fH!ZnX|ugTNqwE}zJyNtL{#XNAbH;PpO52BQf zx{vP=Oh8~gNYrucNuzAyJJakaUW$&*_BG-B=KkzvxxWNFQ#=mzncmp<9_;BPESFcm z6~8g|dD+S~xS0`|Zgy6!|G}NTx5x6=1^~t-E2DKUOudlwin~0`{g)v}iCsQicwFq| ziMx8@jkZ79og*;QmY4qDC~&)hp9A}4^>u<1dfsb&!2H}9vxr=K*Ly$RPgF__m?usw zmQ&C^GJte{fxn@(ihJqnLgw)EmiZHcbZx#NI551&F;yhL3INSu+vvg?guc|h@l~~; zgCg6E!{6TblZs11@NTt#6TL&%QfihQSLy@mr3}pbQ@} zf^p1%Z$;kp%6btzdmURV%F8+%Bet(sCN$R-c1c&8!*`fWjv2y~6c=|Lv@q?Q);LBX z=1&r6_vHk6q*Ey#C_bwA(L$XrVj`E6y~&<`;~{L%l13aEpF0I8;fT*L$$MG3btPHJ zB(6>Ot2yi`^*SceUGv*z7QwI4`OPP72-$lvb6ZVe6>twmzrw-V*L>(H0G)!>*ZOY@LOLomjT zQZtiihI#By4~hTV+`#O4Z!S@6B2qB76H+{s*+U@oa(_t%Zi1l z9)`cI%dLRKG=Ju54A*bKvcjdHx_8CQkqXUDPHDY1(ZcW`1lH2K_aSUDJ(@Eo z6ov0#=CIe)Hg)T+S`1x-FeIyg$-26Wxa+SRd;-G1*PaRddZtf<6XRzsbpJ_)?;bAI zyf)9y%9rns%d%0z0(5l7m)4=&${=F$;*9{&*aWydIjm3CP@H{gwGI{5P;mWPKR3k0 zjQR*+d7_Y>q6V?Z^N5&o_=s>`S$*!ueUBk~bH2Jg>{NilONRSt_D5(v%U?uuhdb)I zaty73Uy~ zFT+3DmDa(8U$l=Ye`97fPlEE)77!u;pe~}6irW2%Mv9tP< zI?oXAf9hxZLOx|bu>rx}OSfr%goLVH1)_h~&NYJUfNH8 zm8bpoI@JnJ>%F}OUG)zL*D625YUIS{Lh_;2u1Bc86R9)jd0X#CAJ}Og#cf=0>PDTR z4V&)&%{grUZY@XRF%=@%hMV>le`{xhf&9`;Fkq7ukIJ+2 zGvwhj;j1wy+JJS-cTiMpK9B?4+a_3>P}bPo4KeJ>)8;!Q5kUjo>1(Aodp437LsML> zIY8J+ao@X5uwF8V)VI2~)_?S*Z_9F*3Cd`2HSDH}*ASwM|IXD*!~>yGpOShDDMxmf z7hHc)RO#QHIjR_fCcEN{pS#I$VU3LTBI$ix0^74-cGo>ow5#Oo#(IXxa} zLXHR1U5tHmdy0ci3p-LxRX6c3G#mPo@e8$>v4711mgzweRNe!~gs77D6}APt8J~)e zD2Vg0%QD#55wrpGIaN=kuh;W~hKBt?N__9=N&O^7y=SVvv8%z2JM=1ALGRQopw3{s zt(M>y%D{5jTo+^2mp6A`0bfI}FOcm{GLEflFkKCDU9A_Nc0K(qb>Wt|13A!&?Q_cw z-o=Nb%)-x}T0pwj!(J;Ot<54= z`;;FXUqsjKS^vq5ux1U4b?Nn1*ot6PbFc4GArBTAGmbFMw*?rlM4Q5XiAZ*Opw%gC zBJG8p_CA0TYJ@Rzr5mmdI?p+5sh_ z{Eph6p{C%vc{fw{Hb%&vbm&D!(xc4PAn zV{>mw@2rW$89h2mA7OoQ8O8SU73K6cVSyQJ!p-P~nfdnonPw~cga2r)oD{~UDZpb0 z_nGqiquiBamg&qzbJog1eb#^uj|p-E02N{4;dXDmrc;|GzvsKh3|@&+-%0PKmZy>p#3m zkNiDn|4kN8aZ?i`If8xs+}4jq?cAR=$@Jy>7A5E*56Ot^`(7U{6eA7Df_SlVSsF(c z3xIfKshw1!gxP>%7?zS(;ycV~-a$k_gIH|it8Mf4p0e_>*EVy$p!3{N&a&CRHjY$J z7X7RC3l6@CbJ#Bty~b3GYRysGakSE8QXGrR@T&u>lOkg&HN9=h994Z{Q`!S8F0=%9 z5hjsu@r)U@d!6GB*DC1J`?q72PSc0j@DJw))@8+mFM!frQY;gKCIFLcE5z zWChSsaA;|&~5BPs-{Zkvm%ABsfg)T<>x1P$qAP8LGWI(Sk za$3YTGuGw~aOdtk3^bzyqy#T#?eK%kumX_x?*VnQcV!=^XNVqwrn#<&|!Z3*m0Haq5c5 zIAK;o*$scK!uN)Kft^sK8QQ~3_}m-)hp$JxIi~7_Z*N=lo%zHgj!i6KOqh~+Z7n7q z7D}hR_~CWX*Bd=oI7=-FNE>AoJUQc3-4Dkp^z2W_dnE+?h4vUtCGCH*@T3 zG{JLI+lP-wiRj`gT=pPQJN1b=GrGu|cKCS-3@Eq+HRS#Q4+ab-jyl5eiyCx8^$2UG zlvKuTcm`kcwL{o@OY$BV`4E@AVZ6GoQnMeQ(7q!_u2OB$W@-isV+OgtAalaONb;KJ zw8(lSu`44KL>4vW72FF*UZ*%))=&I5B(I#M8f#AeKkA9a3OZYru>t?$ zQGW*XzrO3-I0j&DN&Y0p!p_W0VALj5^z2}%f*L&D$VKQYS%VZehpdGO$Axd?otb9> zU~e>qx@^uYTHuLM?-XP1A1WzecAbFD6@yx+62?*p@Q>9oH1*0x9UJK)CW< z5IM5BvIR!76|xY_d}k223_}dXXVB0W0pn*@O8gQMo(CE_mqj(%Ym>tR%v_6#_2VQU zcdWbl9rP6bd&iEu-ag)7(Mc5OCiAfH6Z&G7Z9~#-&~;h?uX|)4oS7#Knj=FJc606F z^qZ1P!AHzvy#FyVr^4<@eCUf>y~-WD@dxQy_&bKw(eCj-@DG-ARCHV+!CP@FU_Ab+ z*`WOehKqL-9kRaV1gGVFug+UCId9s0NENvjhR4N$TSEFbPHb^HxHC!nbIms*wLVCJ zUEsQV#`5~ajPJLE%Fma#=e?XGWZCOiG%+%OS10Al|MWM`eRZ^@uDZ^hxVU9~gD&cK zWDfhh^IXpcO>phpEvNcbGdsfq&7OlS*pQ<)s5~J(Wp)xC*J9Yy)*2Sxd)M}`VY&ld z;DBj8ylbwEx_x4UczhD`*&ZK*5|{%hLRiD1n&NSd>OAwXz2*m9)8zGP(eO<#UII$O zp`IofDuRpL6MDm)T0&TZQ-B%^t-ykLOqo65PXF>8xK%wf}ysFmL zoJ)lkw!iPmWa9W39#i)o^yZTt#1Je@(*^aW{DaH7;VfJD(rHq7p|5bR^|#}RJsTto zhw}~lqe!tk-F`N#V5gKQznQi$qi6_{w*2qVlSzr+tI2Db(!}~f|H@Pdf^5F8nxh#= zPU7W8!FAV?u$MCJ+Su00xL76VM^$1O>5uV$b=Js6M7E!$!YxjkwT?C1o;go#KSehu z53xQ;APdtr!tC~uN9*C|3+o|9Nvx!%qcz#O=&ZWlmqDm;=&%gWr<*5|8c-#^17{yl zfCdPP_wQW7Uti63;)_{yS-y9D_y0S4vBB_j+{x_*?A|-u^j#L{g+^T(?J&4`oVk0#F&{=6t|E3@~^yogKv8Gn{OA751hPNIbo z_`|l^bt(5(rcGm4e^qU3kR49tZpD+xKt!& z>SC-RZp!2(7myd}VyZaxg40O%?d#)%`5FAB=zhB8`|#UI^ejGyQ=uw(-bADEL6j?N z;=YpVD=)fkTgF(EHnzhRVU4gyAnwUpzsyc>H{REy`SeN7pjbgyvy>pXwbp%wHzzw0V! z#nz!~-^8K5+1jm$m>F@~^A0I68{PWGNuCw?qNuoLXXiqr18Qb!iO78|Yoia%WtLQ| zJQu)iogLePh5eZvR=7u^D6-2;qpJS-koW!d=!1Pe+g=3xbk@eeT5JzEezacGc@!MY zTGF-Qi2ORd$^(ulWHKx7<)jzdjsNGM;>jWEhRh4eq$wY0g&4^yGo}A94(oV~3NL87 zb)?VTmafBXPo60#!Pp*&4UH*DbAt>V-_MbrHT=9|=fn%H9zPAcUc1i~XcPn?gH}}1 z9-3}Z=LL{3jUCYQmm(hRcD|aKTqmbwK#W#3)5`LIkKis%ri(A5<%xA6fMrad?T~|uQ=4PKqwWoJ=ZYf6NAorkM~RKMtm8wACo5lf~a=Ai)a?4$55hM>f=6CR*@ z;2WXtd3J+ysS?GwE6D0XrEba|Y0ECIhi`MEHzFXZ{CCxD%R5s$4W9uxFb?{__)}&L z3;?*j0Nc$B9zuO)EqQhw)tzU&>-uG|(Thv1BQ)4EcA4xv)Vv*@J>3m(?&_kHTXjzu z{JI)5qc(_hMw%7AwmPLV^rqjHo>JPMTXb(C6&ID)4C;b+CG$g{B80c~V>^;7jWKI3 zQnF(%kD#I~M&gzKHm?S>079M1WYV@@O{!J%?4zh+Enf~oDk`)#MUfQx++l1@t0X#t zW(1{mW+?d(*ofWz&kAN+usy7JBg9vXQ8YUS&p%dQx=pDgZ+UIT<4RfsjS_5cmK{Ep zMcW9Gmj|-K13GctBHVDU`qr&V4_@`&%Mwj814`Ji8lDnKW<~Wm+y;;N5v-7 zu&tGD$xfbE#?Rpo${nKSTdJ@Q@ zLRgEgb!9yD_1u46(j)h3d&D%C5`XHo*)=Vb{J+3`wb^x%7xL4<8=ERmcOB1$KKLN3 z4xCtxnpXbKl`Y&i{wo#ntKX{EfvJK9q9h-Oxv}#ca$gsj%-oq>A!gWGo~&oSL4uok z3w)_ts<+jkBYsI~mrlJjq}|31tK<8XW*Ms?m8Og~1FI4Hk$!1Ps5HJ46#2)e@nN?; zNh@+yPB8G$bbwS9o~3F`U_;N*_q|hx+f)GQpWGf>DUp}B%3sh55v4qT#5)cGM6FRK z0jf5jTKaA8Tf9p19onDmc+(I1-D{-g04b)a- z{Ya>y=5kx$dW~mE-SnKc4zp3c1kZ7q?f~68YgfyB;#m%zziKN6nyzS$yqDP0UREK{<# ztEOzP7aqUhGsHP$d;$r<%VX~FQ|^b4fH>?qPo0gl^3JT!`fFaz{WO{Fa{}hWhT4KM7;P--(NqUh4`FRdKS@P25( zWogQov^DGtgh;8TiUu0_HB=u88m%E2GiApf za*fJOm!0Bo$fXGZuQw9h^N=(Es?)iNu4~D*WFJ*loqZ)=X6CmbNQAUyh_KqjA)$Uq zKX%G?<};+Y5BUQD34=G_LR_~;^Ih)M`x0c=(tsnujZ>15;U>BCSu}kSY{<1-vg4Pk zwrZ4vPm1{^sQ4qSp0twIrEq9DRmhmde>e;7a3tt`aF(byU|MsY>}ohd#ZpeaoR^r) zb=Vc zb;g3JK{YS1937Jq@obv#tu7No3&DRDfrAZqii=*z7Bc2epPJ&ds(jWqdf!av9})J>Y^Gs#C}R$v&EL|7g)eY+K2Ejj+Luek|Ibf$ga$9 zC$di8&G>ny6 zxM*6kkjup14>$d)b7&66?rLc~n)0FA2txGaH}N~-5M=GQZ}quOwOmO2X8e+tHx^XK z`=MCj7;`Ur(*mCF^yJum%aE3WKFs#2@6E6IoZe1VZd2=&4R2L76&dI8M^2Ysx^N68 z1=WXyYFo+aB%68VNAZqq4)qp)yY;oX7ZGAtkKnK7ZO6<__}PG>-wHJ`{|@-1T1P(} zwq3~E0pJ;yds4gyKN)8V6YNH(@xP3!#+M=CF%C#^YJ$~emp0=hNTNfX*5-a?iObMWRoXbWju=F}6ng{D51wfO z*7l}w=OsH30MFWuC|C6{^2Ds++RpB}3}oOO|~y<4@>>iFA8So-|VRp39grMnXc zMJBsp!jVaEd*gyVykwJX$%ha_Yw2AM^lhKKe`v0^miiO%BM6VK1siR?h(ZEBJJ;H3 z1epc%p$)b*I%8zfe#|z@jG|&_qwmYxAypbk8ZZrg9GnzeZ1~&nQfy>sK5c0}%_q97 zKP=9ea&Mn8`zU8qHd!AOD?DM+oYghAW|Z11eaLgpZ?WYWF`&U=L++99gR8B0M{Bh% zj^5DViL=3u?c<@em{mW)u2|vXTJUL{eDja(G<#i$ zR8peYR&l7hxiMSsB!7G%csj^X4lD#u6CW~xz=C8EO3)4~;eE{VBslcvfUEF7B+LyV+u*WdH z2slE>06L;m?j7=7I<@&%pQF*Bp9Ds^3${L)d=YEc1)DC%Cq^ym$uV14ta(UdOAT7V z(3aoO8YZ2wL#N^5nw|;;-%4Z0O)1CLKTS|x!}Q4*Bzj5}7D!CFiQn2c!g5I~v zuJeMxjmuGY=Eu{%FgbN(0r!9b(KGunvQ}+}udJ*{yCkL^H4?fUJf4nLt~W7z?OM7( z=6z2@49X(a)YzeZD99TpS}7jaR@TeSe`bsPt|SK$J}#h76&upK-CJRF4MW|eb9r37 zsLLu;tX)4OFLRWMDzx#iWk}TxvH?0|-$u<_UKr4033kL(PJs9Rz%#%lm7n;-aIp71 z;45g#!y2 zUKC30uxMb4^N{kB;OWX$XQrhZE*D@Y6}dNT?WwE2ymG2^$kq$%0m1m_^w(6t)1>P{S_ zMb0YSs9WT~W+d(Ob{ymZB$?Cj|k z*G)bUB6|Nk0<&oo#TVD8eV3<=>CT7G{c9BBjY5+@vE`=YoMe7q(qSUZ85WdFP2A=X z`pI!{O=#?kU^4YvAjWorQRyG`1z)L}{ZPFqE%N^HFFi!PRl&%fOx;T@gzepN$YY$; z;6C(Wa3lS8WbUC_(O<+-lp&p;1)@U9uwX?&;6bkblmm%cNaq>XW$3X*6vriz_j|k?9`9U8&6~ zXdLm);*H#(th(pmr+ezzdj1aMls>eG$DMiN#45T?@xRndNvLWYUq<1IeqaPPM~tM1 zGCF@$qx{V0n)N@2u}sA>hiZ!Bhjmp;y!NRsFGWF;z^c;&us=Tm6t}6@Wm|*dz?<1R z_^Ei<1J$Cw|as7AP&*l*;AFjjv2=J9R zDfZh&#?ODqkjjR`lZULYI`JQ+hyWgM>#>!flmlr7W!@v^2U(A>B+3POYGs{&g8de* z)QJiuP{o1~e_oX3xDO7E=RY!cgC~&H>Y;(Ck zfmE&d==)EvT#@(FC=X0+-RA(0B>Uh+&aPqKM7>J9BN~Ga^pDb^gmMlx6lX?zZY2u3 z65pU9#{JwnMv32rP-1BiXZTBedQCW8(+TobUPEDGB(46@@X$;}HvX4u${}*w$PqVv zL-rhnRwQ7l(i?({_4{gxVt81E1n18uL#KPlv3CHxo&F8a7=jI5w|g>z5P#EB?fQqG z+RO&hvZ%Fw<|JBoAi`|H-+4dPhV5_u-{Yb>_oz0Euor7rG-}Lu)%|T^6;r+yjt{Kt zsM+qerm|UiH{40%pAzy8-J#+Hde`{}v>uJp9 zx!XHKt2~EYuW2?>H8!7Y?+=07^7Bb-0{@1fwYxYuF!m(w%}LKyt6(&FL)G8L^@_b* zx5lBHyKXY;;kbVK?XHG))c~uN1@r9P;)C$TZe0uOiNv}PE7~xX^`$-;w`miYhm2lf z!hlr}pbC9ssM$ISP&p~rMBW5I#3a{x43jqh;EOWQP5ybfGu*C)D-7@(IFl%yznj&t zCJx|&uE=0C*#S7z3KnTczU?ZCyo)vO@E9m##Fy*O&#xi%c!9*+Pg+HgpGu#Vg3^b*x`P6}jM@Nc8C(e+z68@~d4f-9K>X zoM}01P-D$w`#~;Z&ilM3OIkA^shF?LQY)QyG)Vu1Fh9@;h}>ji?(}b=vYNUS?{OjF z{vEZ>spA(gUSp&TlEvWC22&=c3=?a*8v4C!nNbU-W9n=Z)R)!j7OPd@esoIIDB*O$ z?7+1g&pb%uoR(-(;EgKYYt!TMPgrme;Rfwf@P_W2*}*3l6#{+_;7zLDTCU$Wu&{BC zcLC_=0sljE0{3glbAjr3fmgBmi!HciSl z#7Hu`)aio7(Tu~}X|{FtF*R}H@k_k;yFh-@Stec2c-^)mdw+e_elVp@a)#Ry-RAY( zY?e>>s4R{el5f_GSQ!0}A8mV5)&rs?A{^SS2c0!Q#u~R`y+c2kJ(52+4MdFCa8gsd zH%liDB2;2-my;+$y~n{HwHCHB zEPpjowqK3mWR1uz1Lj}Nr@Cox2du+P+2mi&S&Ekd_u}m@SNATvG2J4=|d4voe!WMql;=_I_>?-04amcJvSbB!K_5 z!Cddc-tJ=edy=sWu#@ar$wrTiU54fNuvHeYFxc3RI0cxF!t^|?2nY}S8DASc^fVaZ zALaK3ENw)OY0X@>u^lq?qTnhvlq-sj`-htN&<}9b%?>y~N=k#&VKnOoLTDrlWiC`t zX5NhdP#F*ZD|+iR=WnO1e2bLkeCYHcU**B7esR6tkaiiozV^yJXG4Do$L2%L{932Z z&~IcnbK0%xSO`|WL!eD6-&RR^h>u#&V2N#t;z{p&e??F$Y6!Pu%)63S^$#tq+alcm zybnSjJ|2qLZrp*~n!gV&YGmeoqrTLY=_+(c^{BLdQ`{SjyR}|5Vn!rwqUwV(esI`? z6*W8=Z90IWqyKkwS@Py@@afWU?kpwaIu2{g_?RtO{Qz3FL7eGYE8B>W*9IeAW1R=j zI#-OXDZ#t9Xe}>J%lk-`iC18S?B>_*X~g^2Tvo(a`4w1!N%51)X5sP191-e;JZ(c_BT(v_c9V4v$ln_vmAUgrg2%BwGX*> zko8uUbt30g>UKamGU42petU1wS22jI+VIr*(gUr2#4;2)9mKVP(5_)d z3g(ngh&QMl1z2}W((kxfv3TIm=bodSdEyq1Ug^i!#Xe`;J{ofaDn(yZqjh%#MAc@^ zy0zwj_fLj*`G`MvBX|DN@-W_CY3iV?0aJ_qP-%a|rBaB~KxP;xw=AH=)Dp@e4K_B4 zGe9GZU^g+jXZgo+M%K-m%UtE<+dp0%c2B~0UWJBT?A=Djq}FyrzKDp|>d$dCpb2h5 z?2-q`SVES$UBic2t4dZ+cJ#=Ve%Z!>XzJMzGS%5hK+){zQI~QNHrOdHv&?+JnYB=CWM?I|$!MCrc z$XiKZj%`S&AtPVcGMIwNf#=vv9r#j{SKUMvA74MzLPBu(WdGGxStGYI)*DK+jjJT4 zD8c5tt8=_lTByPlT|=p^@K;q8DFauX9h z8$IIY6c-xOiLxa$#HYRYDONaGev)k~mU2>tZ#!r{bFggcppcSx-Vn6~ zmy~Fu`H|aQI!^xF$eH`kZN$n?A?oXmi*v$Kq0i?`>y^M)(y8CG)3_EbqqJ*HPX6%xUO$l0gge}U+fd*_D z=z8h@fU%JgN8e=ql;VD`T4+G7oF>?|-T&!~;E|4;gu4q(BV413+cxZ7R)T$P^N`Z^ zA+g^RY2pQ?CGMv~@2~M2e-MZ)1d#H>sq^`ix9DGI6$jwZfEgr0j&JP>*zAy_k9ny5^Tldch~F1MS?sB= zXTl6k{6C9kI+8WWtP*d+Y|;w;mosszC_>XP|Qh+Z>VSLW=uEE(sOyz(I} zjJVjNBL0&~maFB<6_?!^AXy$#9^w?gy|t>EDuqD z7P`ehW%;%QdRTr)lyoad#P-rwbH}6+;p&R5bmzsSi$Q}%YjtvkZ-s*S9Qw6~G-z;f z>LVPTiTkttZuB92&qBz%RzAnrU+lPMRWq)BW3%9i)f8$kU1M%$_?<6{g;&3^Oh}>* zK+uZ)NaH0?e3knZu59-ZapsE2EcmSp03XKBB!7lBasJl7i+7W}?Z2ajUIP+cZ&lD- z2at=hDpUkG`04e98ECG1-3`JB&b3N7BJZHhPngz1L_geS0@d%$PvKSgw9minGn_uwoXxouch&9wuIk8blv7vr;vJZ^6T2=AnrVW`fu`kf8`D@M}NL z%yUeFN_fwaE3m0ZIxt_i4!3oE3-Y9vU#|#fb=tJd)(9RNa?`%#2Q*arNehsU-_^Ed zrdu+BjmAHJF6QH?fcuEQ0!j6g9~>9liT@(l0t~gB*+x*xmX@}i^(}LB#iw)v;4Jl$ z9tzZhf~xe;{>U2~>j_jU0vLYRt@_f1!5;M`8n&Jo>id0ray!KVzHN!-dh-sS$=d0_^; zWo8=q6naNh&D_sBd3sWQMds?#^*4L$3a*1MG6MD551y5zyir0UX-O+@V<_40uTt!` zeP*`z<{saOGa2+}vqzO#HyuPruxmb81})P=NL#cUX0sTg0R* zm8Yv6r*DrBczs@vjB*cVk0hjBw@05nBa6I$NA!7C{NCUJWO=0rTMyA%CiXzr+Rc4F z=ll7{`?%XW0-Kt{~thxZ(Et- zYe*QjU!3`@YggQxgdO)v18$MWKSvuj$NfaEW%+V6jM;X&7IZHc*|_Gr(!MHIuX<#L zSNRnu26PJTyHzNeef*~$h<>xG$fNt%6)uQY)&Egp`=vHr)uy3SJo^t;1c<05GQ-84;_eG zlg!>%r+7%!`>B7b3O;hhbWAE{SkoH**Z5I?O@z*@O&V5uj&77W#{Q|29+D998sb)XU^y2b>)l?2iHm&tu?_B81p5r z75foiFktltdQXB)GH1*e&N+M)a*m$>A5j~3Z7YJJpDCt3TP??bKH9iR>98LMF1^-v zAT4@#=a0O-FY=)Gm@MhCQ7vNEV&Z671BdwwIy{uK#kAbIQd^x3UGOg`az9=WsUIx+ z)`&}95i{);hJcBI^hGHzyvn#6y`AO=6u$=;_-d*JCd}b@n|A~yM}>nUAYK2S91wCt zwDJFr9ItudFSd&I%Pc*jkM!xCDf3_K>sx@euaS%QO)u9u=merS9pbjbhCZQen3<@J-90E zI^M0>+=sMU0=izKtg1)CFM)%h-VF)qb6E3-iulvEEo0=vZR*)wqtj-cg3J>#CIQC1 z90C(Mqo2Vw3tB3}veaKvx9a+B&D&4MMxXcV%*ebwY--_9b)p;-dTGj}Q zF9ObCUhqF3g>Cb-ohttAJ-`^rzk^N*O-no9PO@>U_!LRvc0e{I}J|h{n5NeVU z>xYs#?81^fN?igwrOpk7vn29Vb!mCXQ`z#PuH`2T+2^&YwH~rozrpjgA=gcGEmpigcw-yMz_SF{Xnya->#rk=;3sYzd76d~iHwAw)0HN)m2KBignYM#QG zhWOWE@$2X*_xIqvd$t6;7lcaojRx8KqHdz;arh0_4jtyQEtVF_6uT0TQ@_ z#;Hi1*3EVWoIa+$^%8h+6+m7eAuJh>H%UfG{tXy^b4~qB21Hw;q&n!m&Nr-3@W}yj zL!cTrd8ey97{T>=A%2TG1SMiqNsJKM^P#EN%BrsLXQ0S|8erxp9rhRE@C%~RriM9) zu2my~xbw_k8p`8~UWfeciu-oqUJa-Z-SSYNlnKU*(d(9aW-@c z;x`<;2xTiyc$4s+dbh{&v?QfG=SB^|r8dP~(_+@iQzfk2$&5b6)(Qn8LdbH;tArj+ zoEwZjLFdnmfY7zAvm?i&+CG_c165s(`stxG>xu6=`)!fA0utD-JsM8*JO^QjDr*P} zjXl-O1$;{{ViR#Xtx}=7|5u4-`3wtL3qt7mOCcJ>Nbi}R;qTR+bPTg`bVO%o>BEIy z9QW}L`r2yF5^y!Ya7J4zL*+|=Gg0Ff$2Ynb0qO@Hp8${(-`dl0zqdKXRsK@t^3;QFHF6nw(>nlUXf zuYsN4OjkDZ!R7294WP%N4=VjE;eV(wOa2lbdq+tpe=-{svyBF{I@$uek3-0XP|btD9D(b?mECq#?TauS-;Jr5PSUMLFDw?v*9}R;7TDc zn1>_pWUAIGUUTc1_LHQ-OC!%7?lQHG{fJ`uPFXb%UrepdLHIq~jc)qZ{LS$pn%!aP zcz5o`dgbQiixN7W8bkK=Y& ziSazQeSERWV7etO<__&SD0fk9}R@S;`0&8K1gyVe37t#~*BkuE&Hhwpt>u5B@)kED) zpAF{}_}~|D`@O2>U3(*i#M$bzcnrIdCrzoe_uN*b%*Fg!O$zWcMM_2jeEFB*){t7y zMiQWE7xx&gwT6=1y_ufSf*n#1L+@_P#3X{Z@Q zS!}9w=yw`s-#!nj?YCFPTB2yR*6(Rk>yc~gdacnM4#MZdn=7p3RmWK@rbX)F5-eM` z8$J1EbtWL^8FbU^7zv;Hnq~p343eZ9RF>xU$Z+xe>}JPFU4GQ(@><#pXlOM2rTX+^ za$U>_tA}2Pgp7cH9-AF}7506U+3c7hai)9y>^MBL3d4dY&ff@)ORpz46#&nRnmlePr*o3mCsxtZz%e!@VG$ z$2QuH+tbFiRzsz%us=Ck1hIHy>$G4tkC2siCky`AX*M@zwVPcYl&D?Gho}DbGX&BV2dO_AY;Qg%pIlD=S7aQ*$jkhPPJ|!?kRd<gbo+hU^#w(!8$H)-{`sEK#*VYqQ=*w?DN;w$+BjBWt_r*#!`JvNWQ}f7OkyN=4*E zpIJH`3kDp)K4l*;IlfKVbkKLZa_d1U^F$5=3OMJdpAEXZtNtCBO=B?Ct@}~?VX4hZ znLc&}#Lstg&y(2k^n8`n>V0fS(;IhZgfp+n~3| zc>;#m8PM}1Z(m&2%(*CuCs{L0J1AEsDha$|#gMB`1!~9%P2`h@X!O*U25LmmVgk^*0bQfN>hg!J-Um0l?a0!zYMssWD($R!!;PuzkSg@$lz#e@H>yb8Sa+_4Y!**P0TjxeP zpCbu0h|a(mwXP4_KzDN-TgICX4R^hM9z-S)LlW8sLc-k^ds@FraihMoX?vRy6fn51 zAN2`)e+XL5Fym?Rs8IGKiSj&u#1;bI1B6+_P!X)f8c~FJujdsD4}+%Qd;)PW=8<;c zE9$JF0pB<2@!9KZGuw|{OQ|u zIei)yFHQjl(B~04Q-N)8Q6ICGdLa!Z7-cp9sHB@dkN6K?2mQ7Q( zH8L_lJ)oi*i4k|FJhsEevjTSYgbR@MmQq8?CMVd=UdDfEEh~#vKAB#XgTgF_y9igp zG(hF)9bKatBB83(kp@BW1BAv|spqt^6hS=o2NejOk`F#{k6 z$g;HU;$j2nt(Rv=k6}2fJC5a;N(V~( zh?=8rmU?n=a03RIVrutAVY{V00`J(=ysFh5=Vp0)tAs5hLW3w`FZ<-KGoTv2?sgP+ zMnexMcO|O#0k`IkR+H0xM2}lgtTl+9yzc6vosO8_!P&nuQIo414di@+l>cE?p`&jKraFD zU2pY*k^m3Ze-aWl4Z;6Kq zo!E1vTGVO$B^!g;R~&K=lEw!=VuVIJq;%e_6>7_Zma29imjB9t!m6^w!KsAbjj;mi zE=&}1#%Z7rd4Dx*E^Xri(1}ZqS~>7~_-(Y!@cHS99S@SBs94>$OeYRK3hT{0a$ z)(#H%2Pyz#lFj$pYR4?I$MoZaDT+ojYH}@K#p%A)1K()QNJ(EiIllv zZD)>ozRu4Sqd#vP^8~(yuNLMj1m+6J&fUs*)smX**NDN!&V=NW7^?sH*`yFDf3aU2-M2Gh*gdMt?wiaz$k; zJ^56$%DyO-G@)p=*AK&29TnyWTxSkeuw&>5&1q240nTfEx+`Jv4#%Vayx|)|D2vI3 zQYG14oI39HBFwDNE_fswGgX|GaF-;tM$yM6I9Rp{(lIQABF3s2AtHPAIXA;v8w??w zI~)+^J<9*8M)^J&iwiBpOpfMO?H1T6|Cf{g zE>x&nKDm6oasTLHm)^zw_jb+REU#;by!gvKUC6oeHDaj5kVUSWZm=A-G#0wN1HF~zom4$5U z7;63w1kU0*s48BK32)efg8h!opX50RCU7r59r&q9Ir`pgX`jLm_E^=S;*z*WdZU&w z=I&%?+R35T?X){wsuw0fp1gRgG}zdO1qG4Sb`D|kk%iuk>v>2HuXUHCJ}FrIVD2F| z!3d=2%QM-N`%w5Wk_0TZ!fRSnW)Jvl*k&o^naTBxAi^d)=J?#YHdj=p3r@yR>G#IM zP<28dIfO&K=PGXUBPR%PHS=!Zf+)0Ncot=}lX(y0)<8qtgDrL=kvD;+88-M#vUH_f zfL=b+H61D_vXg&EB?U>o2aMrltfq6AZO&F^p%Y@wuAF$v0D4smcx+qR;v2$iLRE^_ zB#0e#!sn{{vfOeK{YF=&0LEH`BK=Gf{mt*D3+osfjPu^M{FkE~<;`P|Et_qNDl4-?Nda6hc^4)bwA`;)pnz*uRrE+`yT;yD+|CU}|53H-W%eGdRh& zp8qDUeOh?Ghg)pICmz!}9$w;C)kY3lEuM8qm5(T~^9z#8is;9w4hBUv`_CIl+o^pt z_4u6`MWSgdJD5}`FGFf~7gX4pdY$$aPsr9G$k1|XGBxBrE7i*c5Ja;Zn1=EvA>lo5 zs;aXK1ghhMWP-BlV6n1=aw^FqGI5s=za)V8jb)bgQTsGiwKe)VE-LDH4lyO$Dk;%- z`;3&?Eo)x~p8~5|m#pEHP-RRx7oVO&-Rjo`?zA#=vg#CFPYu%g9o;E)Z|@Qu%ALHd zlE|?$cG==$*;aYRRjfU0A<{Ob7#@a}5bss^40%^5I0~P)KQf{nE~3^pk3?Ko%%aRQ z1@=P2XuHMny@={w-jlM3>p=61B z?k=c9EZno-J5abGxSTjmn?Q~7hkX>2MbR_Tuzaq=$q%`1Cr$Bp*zV<~FIHsG|3%1# ze>K(0B?WW{YoM8Z#0xsRLM4OO4oRbtTWU7KFDNC%Qzi1nmTCZA0bx9sFNR_gTvnep z0}h=6E6KHRsB0!RIzQg4fD@q3w}I_XY}utey%a}+n=r8JCT5X3oWwk2ic9E|MmzY| zIQ`_Q13x3;W&3^u1yA)huT?FTF6fror0hBEG<=|oe~#34cqJ&bNe7awNjdM_o3DI~ zj+e4hUa#bTqfeO-`wZ~OTF0;i(b3u^NDogDwyiuGCW4z)may8&#t~@g4d-fXPf(|pF8=r2`REP#USLh zCS5)Db9UmeusHJX0|}X96TfoW!wu`18sXS_HCtM;jh!VI6ZOze?` z9wTkF@qj1c?m$ksRPuAngt>u)=o9mbJ(UJxV)<-kW)JR!PlOPG(pn4Mux5=&=ljJ4 z|DQpYF6@+85#t@`@q9344UWG|8(fm(qUz<|kaVCfB9@uv##xt1VcrsJOoMc$R=3J^ zQEF?Sfb$=CJoXpIWZ1kIWR`}$VV~;$z1HB1Vkdm>9;6EubvzYTi-p>CmRnt~{Fl|~ z6KY|XdfIdk?z8SNY}bNoT7w9MyJG1TI(xLarKqtSt;jLB>w|VUKXk!0RR>6?lNq>q ziHtkQYdjr5i7In?ACn6yne(O^){AU10WuOg?&h_$CBV>P1vgN%sHJ?+?4v5Ns;_>5 zbH3TN<;R|)=$Oa8xkSNtF;!)w}R%~ z*LY=Hmo-nc>DN}(*fTkIRwkP$rH|lCP3+YujuWxMb#po0&MTEv1S(2U?F6aCMXHIL zCQ42fi1e*6n;l|5w)qCfZ$Z7cB_d<~x}D#}tj@2kQCnvsKxd3LrzL6DW|Q{gfmQWZ zzf3>oI3(=n68cT~uq*5?T7^o{HrO;Px>+m7IOWxO{sp~P>ceX+X)ehK7r`$dpKDoH zV^xdwC69f_JfVsF6=kjHA6(Bui8Rt%wS)RH*WOy-l)Xm}1sk#Oy4)SVe^aIJhHhlVE(;D`fE<#)8|Z%$M61SE+k2+{r|LMJ&I2 z$a`^9o!mtne`f6W9p-i`-!@PQaGYE2pY7T~V&h zVrX3zcITpFInux6KBs_-xuYx(MhnrO(_hw~w|w^syn$W&AJ=f-ytvnY#s13JPS#(n zLEe5p+1w>QT7Zmw;F9ae2redG;D}euW#vbdqex>Hg1#nO;(i~pk6Z26&#>sOf#y$P z`UTH6#?udnCKW$+Rbh8If4K``kUo+PkDXrzy|4LF#t5fCA3iHhr`N{YQxv`-lQ+$x zGD+B^qpvC6!MQEYk{#UDZH@Me|GcWtoK~0{1(C|C5`N25Tl>5G16uIOH97h=kn+wj zdaV2t{1o7SA{@(pi(a0iuwHFdI~93v#>RuUEegILUpW!U1j9c$Q3R;TO44k@MdsP? zo_nEowrw?IthREkz={T&4HnA(J;E-;v}`LU1r}sr4mZKiC*Wj14!C>e27}APb2@GM zUFKSBafr?gix&){>b2vLZi8q zc!r}pN}Cg?QFjgu5nCTfFQ*0+0XIgm-G4XerO#{x$ZwW!p^NY-Uq^Y#h5agqk($ckGp!gT7Pjf#Fc6n*!ta>acLclioqROg z0id2G?WD#(97*rfzVS zQbuhOy<%)IOpAI~uKoQooWEX8=hU2ZC)8sD5P_U|Wn=T6Mlr6hj^kMrfv8(mB^0Kv zYR<8-2Yxg-cS5 zT2cQ}P@Zq_6-d}`F9!&H$*=2FhpHDOjHJctYO(I;=p4u9Qios?+TPGEy(Y=>XA1g7 z01#&|%3lpm1E+3i)1b8WL}T@V1oRS9p9S_uX4XR%;jQ(8w{^;mgjd$s=Le#W2w99| zXR*_Cc)gflklduC06xYj_up5N`>O~{s0@TiaZ z6O;u=&%_*^v%@{$jjbThrTclpHsBubi5g0sJzsMoAwF-}IZHJp79{4ChY`LXcuiQE zyRQ$uuWwPc;9?X94WZmeuDu(*4)3zIC#x=!tL~Wi3+p>n)xJwF6!E9xjSgzk$3L>pbR9z)&L;u?k)IJvjAHcx~g<%6rw zW4yc%wcSdWY|j1W)8g%W3twcwV@OM*fu98|^nF~>v7*f8sdMar@zkXc+&@NAr&%6b z{cCGxTHRZg3Mqoi9I!~ezjzhsKDefP|4_$MJTrDkyP}ip2QLPPpRGaG%vYEx@%-em zn!FrHE?LlrTz@(*P-y5nR~MX{Gf?bmjn6?7uH}dd8^v{Ccd}~WvwU+_24ivWN+0NL zr^b}bWolhmR$b4JCG?)+2B-AK*=>j=H^*n50nI9mDFvNbp*DsI`67dk)RI77&G}38h2mQ!~=&_R%t+Y<&lyx}~(CxrTu zj1K~&$ytbFjfmZ(DbbPf&W~lMsKFk@t^P@#gn`3J@b~-`nrQ95@mH7-RHEdqm$raq z(uEvLh>FXdK@nO9I$Ofu39)Mt>_c~gekj^#(EjxSnVYisnc|zMeTQLag{XjhBhW~s z`txYXruEM5@`lNcwkl%`<2L>${g%|!$-v1Dg$?}3WG94E+z;t^)fSDPsp{qMMHByU z{jItWXf`1oTEuvv;&dBhPpuER?VSUr?Z!X;4T^JYFn3iceDVgBy+_QA-_77i{>mVj z)bz%3XQ5OIRl9~Q-RUV*NOqDd%_kx0TvB8}8hfboRP34-Pe{a4MM#;r*7Xb~YRCs( z(+YiKnP>q|+IiKWQKr+>1-AjcaBrK7i2puSb%tet?4vUImVjvIz}lMl^+bKu zKPeq)Gs&huqs>63v#~~w&#p^BxDa1gsc*qby^<2O%nTx-m~yl0CLEt&n%`4)ZkV1( zitDMP+m+LefwkDtF7qw1o#k^|dBWY$q1J_vnF#clgs48?!SnPVZD)pnRjJuPg^lMU zyEfl<%;l|w-Mgq%M@hqb4u`%B+FI)YPbDdmU3Xj}gs9lp-zb0>+yBBYKJ|MQ2S0(J zQ%&zrDEA9itnLt**q8UCGhN=J<=^g8N*=B3a6w>JD~(KW@QE)+vv;SCebT%G%H40} zSllJUkKoJUq?`5tP_C<2wekUC&|Y&(I$T^$w(74V%@$K2vygZ`LtU7LJrL^`yPQ}?ARA}k>Y(p}g%`^!ac z3MH$v4u7f}c1b{O*v#z-)W~!{R@Km}qPo`i$f9n<1GR5s4{jQCRl?#NTsEm`!p`Bj zW)q9UGVjG2sN*ZK{_VU$%#cj>cLrXV>Y!&QAtKgDc5hFsm7tSDZ?Yn$Pv#niSzVnY zez54_)@U#^d3CaftVvgA=4si}qM({N{x9Q*@(M3B=>R)F{86b$KG93b=w7D(Jllo* z%6pO(0cIH-8HzHW{thQF%WpC#s-$3D`^YnvlQ(Lh?4}*u(x0{DwAnTfY%ei>kW3xS zTAkbmjwOP^zO>x8@dOD0xOt@Yq#}1XYfugUQSq3 ziKkl;2a=uN6!jvKNrQbzzhtMu8xr0F*Ab7~Om;ecIfw3=+p^icWG3}qxfPw^IU%ks z_b5TAABQx|Xpe)%9@n~}9MwVmpj{2TkR`YKAZUc)zz|O@I$hB%LJJ$*D2$0Ph3ews zPm^xsg`fQA7#DA_$Z(-hQnf<2puigYiW_CTGdHL)cWLPqN8PC2 zy6I5PtV(*-^u-tE=ZG0QJq!GFK9-JT5BP{Cf0uVzzODTKy(1$b_fn5EvwzMWrfeQZ z3^}{%w=CS}dc^B5t*IB@Q|PS?nBDP$`RykiLO70rQRTMLrl1`)3!NVa`=IWy=o9$( zQzg(LZ8VVxSdyIYn7318`oAUJ0;CBbFZZm+H%!hxEsk7wSpRd&Wb1(!PM38TjyELa z(oGV=g28a%{jOx^{$6K-ZtU( zj5qB1tzvsG|Ah~UoX-bBCWftEGu77EccnGpq2>KqgvDzMkH^@Pj|i0oAmk+l zD&D(5at38vRIr{fB5O;|#H;J_TyYk`YEcgVd^t8YKuF{u$4HtWSP!&Y1g=0vp z!}LJgE992fVw-gdD&*ER4)lC3F=Rq*>}l48TV*ulo=Y5{J+JQ#E{Rm62>u`viS}in zC|QU{L=cmmAL0Dw-DUR|V~5&YYxdL`TK=S@3i5i8-g)MKEt(cKTsl)Xgq>wQ-jE~? zkUJ~O1IqcYUf`e#yUnVflfu0fyVQ~e%5?{GJGr-yQGCVMf zav*m}=I|>xfm>B7uj`3~^+(7r1f3qyt>n%4XFd@yz3=9=VV`I^qr}%xD9p=;)rm1v zJ|B^uqSbh%W1ED1?qfCStlyeh4DY z^`|xr@K3a9{z;}(1DC-dOkNQx0JT_u?>M|0sCD8%8J4cRG09+uH3BWwKOHfC*!7UC zA2r@%1=)koTGsigJ}-vHBojp%)VtHpVxI0iE$T)!L&;w`5YSFvHbc`rGj>x5&O4wa z)ft<&ZAD*|Gm)?Dvg<10bx(Ze{v6R&FSLN9nXKg|xc~BG6CeW1eWHD1@qJra*2YYv zyvjuz-{s{VJv6bce|Jz1c`ftM;(@(% zZN$H6j?l?g`(#)YSDikbQCbX5>sMW!*%$<|^$KXIuCak7HAqnBd}r!}%>_<}v=@G2 zeY{~?IiY`Yym*uT6&&QTH}5J444a!u%PBT87%6>48dTQT**3iN#TB#0AaXNb2!J3A zcGMb{QG181T|Ac|k8<*I($g*Jz^PuHPbt!$MH7MtmNNP~>#CuUcB<`FtbPyqdTpE_ zYW5w{=z3;R_fIAo{r1QFn|tJG+P2CyUfYQsM>#jbMbL)sPHD<(@+s3gq3LQc_fg{u z@I9DVqWio+*c>q69o+*iVoqLRV`!*$dY^x~gY!EkS*@~=F?n}+VOS>`MwDk0#BQZ>8a+P_AyltCYvlHh;* zi26;p|2E3$V^J{nc>)-Uf*g{razN(t25iS$Ha9cL=w4^}pCJqu9bT&-wxx;rpZ!u1RiG1X3 zKiH4-eW5sfZ_rYoJTO*uvWGXvq|rUE(DpW<@0k$u?1ob=-#Wr;CZ!_wj<6b)B7Gx9{H?g`+x}G)pvwfxr*k7C5*SQ`h zS1jF&WR{+c_DDI;U66gQ8d4M$3K9sN54ogQR%p-j2zD}Txi_{?&T@*oE7^otZt6lr z;FCPwHK_8**d_bZsifc@{w*SHe5IU`$7}#RLt?}SVCmrB|CM?8mmQNvYOV0SQ>V^z zY2rbGhJWI50^Q#Sh|46eLG6f*c~ZPdr*2JFh~IUUA>##3<>sw$4rA^gaGBEBSJYf& zt0MNdxdwB1*YS4Ll~lw3b=S6X82zhH7OEfwewaK-q^)MN;^QmKioBM#-X- z;?@K_uNn*eHLuKcG8VnW7k69Vrzzsy|6e53eQHZTPn5SWE^K?~7hQOe?f6kKF4*GO zHwH<9%rqi@K&9?@fnDM;sf|u3%>!QdSg6@F@Fi<V{M3FnkIdcMbW-4s$^ytAY+s)Oy zP;z_$OXC&rgwXpDg@(r(AX~K&;;w!Rq$s*O2mNQ)Nyi%h2o*T! zn68yK_|RevCr)db4)a}`a{;@)5wLUQRNxc6%)jsO^5cbaD)0`S{Tx7+hQ*lqgx87h zs8>UYYeGt(6nZ88{jIMho2Og5hU=&@w{fw#r8ari=9%_?Sd;iHaD>M^KS`6hcvUYy zl;ok^!UbQ{*4xikcG|hcaZnr z(?KT@$WKU_6((`)6-K^>MQCydC*ziGxYx52mOsxgz09j*-iGN8HtWo`0Z zQq%!LNmt>^{?xm7V(*Ko|3D0H|3n{7(hla!P^&TH8GKvmk0NpW=Uy&*sOJY(akp4K zt(NM%S7V$|hE0r-eaF7^WeC+>8qW>}hz3iz<2ur?0qtN??0yCRnIAzYE(|L8%o0Y% zuKdGtr-w+gNBnRKV8 zdsFBxXs-yUVjvs~)BsDVHA$0*$#cR5iu4S~_#wRr<#&d#TF`YPUi{oi5<*yBV3D=+ zjGTLvXt_u$_Lw1}Yxwa%RJJL|!w`GhNj8}eT9DVVQRKE;OUD~)JW_ z=+3}>Cf<9Jg6OV|o#~j!kFUvVbpC`XHk_X2AwCTDK_>ed7cDNCQ33~HGMNnOz=)Fr z4A;7bJaw(>#leuS&Gv6d39r|Uq`a5z;F=$~PNZ@4+0f|jf4P9U)Q3yJPI61g53H=& zn{nJt5#)RdTX-F}T&lRKYb9FoHX@pn=lGgrH7%aJ4qnY^Mw~FXT^m!6E05Z(Jq`S; zk+5}-fY2HA{fzzL4z9yDb2D`X5VLj#{%xjRIZYYkc#+)u5h$e4j&A;K>C0eY%3KFL zNuh>iPNxZUR{e^11%4i~o5s}r^1(vm`EwUfKO=EGxY>%Zx*ABW27p^hRhfx zb@8XVC%kUSEo`9^r}=-BJHLfbx?7ya=1&gOE#K53Y}ydB_B};Qc0RLD{Ldc^Ca8hv zr;cmn6~XQ=UM;^x=Ngmi#3^DmB?#yZoDO+!n;ALcheB8=h=rPLyP@T1^8~bv|^iAFV%3B)EsBb#}Tt9TxnwYAki?;C{$@_MUo( z_B+^nfen_CV?WoP1LT;+mPOI!5u4_DHnWovp&_MxE7O!6OtyG!$4A3&Ya`rygqEVO$?t{Ys( z*z|&W4ax2g80G(tvTtFk*KzDL`bN5F=#js+r6A;eV(itCv^{OLW1$~%6hzWk_lS2@ zv2TVyfoY{~Sqa_VZnYpWxpxd8zo?^!0B!qijWyK$TnjF-R%H*S?%BMUuUu)*H7exR z_LgAE94SMVooour!B-1y-#)*S;9$WV43}C5N1a*LLG{qW$6<=W9+H*TdYzU9~iflTm zkfj8#p=|)I%FM92GjgNPDSH~@e54}+KK@*Ze;qcDert85*3VCKt?lby{gb>~zd4)X z3#`8T?3RAzBWl8>4{YRwrdBTR5o%}N8%K!^;fE~hz9H?+i2?V?r?tAji-D14xYDoi zfTz;L&%D9iFlGmDdxJyQb-PJSowh|0J#P>Ajdp`m)Il2AXjX=zi-RVzdMXwhc1(1* ze#T&F@m+r@1ZA;04`u8l3s$O_bYHTT26-a9BzN2*i_*1D(__1D$L_#`VrS! zUD{M%-REF;!1C8Hn>SnS#{L`!`}!HdW7;VcGtE=?8L|T(*=Hf^lV+FdET&h4szh1F zmx%}~Ii&Q_Nk^}xk7YN5cGtDeOY9XlRu}krE|%}b2et%(BB!hB6)Wco4o^iJe5k$W z({l3emx8JdbMk&0CtUw(7bGSg@_J?24cI1y%W5=7zO4E@nO#HUV;qgw!&^F!ei(Ri zo_*mzHRh9WN9QIC9DvxDfK2dz={4?B=~Yrsl=GbIFMUA{+)fB;DNhEsOz#OV*+cm>^ryg3Z=JJ3Z__K81 z<)nlz2Dh-n`+3iqS_5yGw8Nduf%Rn8`lG;6b_C#lVcFSgx&mtt*FZp1KV~D^Q%~hc zlFZg{^PYPY=wkAzRG7bZ#A%OvpfF?yMs+biA4aQ0i%sD@D{HI67I$%KyKS0)>0ijd zyz2i|8h+$;hLx)Xrr-n-PF76)g6kk!!A_Prq#~AMMRkP zLM7SYeweI1&;55X|DLwXbzs9~?#8gC3Icu%8oT)-7$NbsPyYOaqajCFMN%3&~T6=F9;$nr=?Ig)r2%!siGNy zwVsSOfItq}S46ggM&K}Fz%SRE8XLPNDOK>)-Fm=IhzIi;TiMdJToYpQ^zI#urJwu> zz|t}_1f@|->Jq&Tv}oU3B^1nV-&qf9sItS@r=gD!@3NgZ6xoKLukz$STuI&5Tj16* znR;Z%negh;%!=isqD2qxqKC7+6IvhCv^@jKu2@QAPjAbrjM_D9vs-`J!#}^DpMe8H z_Dtt~Ob>7R@6>&C(!SH7mtm0`q=~Svyx9&Pu4#zC2)HDJ0+9Jhq(+P75QN0T&Z z#X^Q!oZB|roE&~(GLZI)B6V{fxtiH?L?(X~s~%4HvXVD8y|FTpX@0s<>dN!t`plT( znY3Z%dg(SG_))|K*mr(SFjcx;(N*rf_F0?Jbiy?8HyC7}9}>NCResDi=g$%B{ibL= z>(q|z|7tLPnftHtH|XlJd6%76!>(!qO_w{VyL8JJ(g|tDP)^3yGo?=Z4RF|1&5Ho( zR?M9QTv&pDjP9bT#V7Nar6pX|pHbekU9SqiSqOTYQ7ZgbXFMRA4E)mmEtBK9roO0R z?3fQEOuxCvC_0ezxb0{jg6Mzp>kp(8_&b|V5FKEdn`-@D&OP2oGr`^nGwPg9&fzXB zgKfAH8c*1PZV5~R-80@|@%fhY8Qu`A(~_z|M%)OyJ8lrX@qCbdg=dPyHr3;V~J&SNtdRfFs!PsUDRQ0GT?A)^~| z6pNuWTs2@vzFx@Z`;_f`q1@bR%yYH9P;euIJ=Tf@YSl=8G*Aicb&DC#l)Lu4Mlj;X zCF(!^v2b7bsG4PJ>x**Jk-a|z+~wlvF1@^e*308eA5^2O&@0)y%902_IgiirT*z{U zdykEl{BH}Ef;Sbg)EBVi1qAl$J-;MHt0V$6{tuFHBx(1AwleX%%$@7!)}n@5k-!Yu zAND5LhCq_Q*Gt>ZImeM2GkPLE;T~LDl4-6CHJo(E?#gt6>dH5#@lWRQmfJf9-7DdQ zsFI@>iIg$BXOJZ=Sl$>>qBo*LCrS!>k=nd9G8Z6d^TuiXflU$fsV>K5nnku}k#B2xd+nJL;y>Urz6A0cXG?#{kgC$RHb)UF64 zB3f9e+hk4K(=x2l=_Pq_L#aXh8bX~Wy222tYI9S1WlNpwv{utjC)S<@djuzaO7BM3)58{t}+2$;RDm;lZNRk@Eqy z8N6lEJHyY$CGG1wu8_p<__z+XnSby247+Bi*!5hi=lfq#vAGTSB?q^+8C_2ccD%;zNL6p_*O0~ba1NtLM4 zkz(o{abY^sP(-xCU<=wtX1cEAiCSkC(sM9BU~rv9#GCeI;s=rXxW@Nq8$RMhAWN+e z=m=C3e?f3|w|PmD(Rbs!XBn#_i^>jzMa|y;QAG;pAKp4=C(uu8YWP|3*hE?TjqgFD zakz?)A;hPkXNA3ZtX0hn5bvt+hS#b_2WhpVr~NB)TN+ZS{P@34rQWghr~X>*=-+Rf z>_iQRIKPRhG}t4Ez#6}GJs0=9XRnSoc(y>`@qOoAuG4-`Ol+-6yw7v&b^#ELAM|w{ zZC?)xBX=^+Vk!3a)ETw!_GCB(4GIM(E8=j;$mpoF(lPK`@(L`xvcG)&3{e|uKTcS4 zGH>Mk`NLj2{Oe%+Oas%s3S3M~nvU5u08g2M#2eZ!q3QZ0! zHQ_f+sD1tUWhcnq(>yf$8}mubrWeTD{Sz2eS2Aob#&IjFT3$9XNcNyNC;Q_Y`>@N{ zd)xMvZ}9Hl7WwuZBT+ASs-i5z(iK#}ypBlN4T7`PtG_g3@{Uw@Ky*5H%!;I4m#~KN z*dhNXg)myn-MvAW#qY1SwRp=LBH^l(AC;DYI*3%U&!J1|JJL-u$b@6YUc{v1#R5oD zPXMlei}V4ayF5ZL8@w3ZXSi+Jgk<19GjN{1mdp)=y_1X+hESSt6Uz8|jSEhN} zN$1(6R(b^RpanI_So{@>Fh@HR=q8 zR5l5yBWb zxaPQsrKQx~DM?vX4;rsY1rZ1BYABJE)hOpZggpk7MT_F*I6bc@a~lD#0IijrN+ zo7w|jb&Ns_gse^c7@{5U_;&A$o?Q74xD%)Ga^iE7QnC>z%tc=hsFOJz37qK!@0!vD z%Ffv?r&*JvopGty_L%MZLCQZ4uu+uy!Fknc z<}UWs=wP%P+N=JvI9yxYWaFW@vVHZXBZOB#miQ2hnf*75wj7}s%vKue_4_@Q)VImb zH7{EEuFiS&IgyzOd9%EygcQSX?*DX$I#W3Z=2(*$B0AjJII`vNOzPp_Grmr+kJ?6R zrri1B=+17umQO7caPB$1m=DjISKk!tcZSpE@E%i^%2(Yy-2vHY_SN`BD0F$r`!IR! zHuam$S3uTexw2N_v2_`U))09&eoX}!dE4mr(JX!%naMz1Chbw+Alf7T)q|jy0qE41 z&VL-!W=GMkaTCrC@#1+2W3iYDqwXtvvGH-CWW4&&s?lNq|Qi z=q@MZ50yjGzSEwvveYRPC45b>>VCmjsFx2<(GI1;el*<1dabGKf4?1cTLHaNl5T78 z+DKybJds0iPkmhnBkjl9liMhYn1uX0sfr2* zN)Fqb;@VC5_jS3BDjDFLU$r8e&s(T@ZoMh1OI4|{*J2a}i#ht0Ddp+&(hoH%IF0_` zjuXm-;J~`2EkMkKC#+Z9-1E3+BiY2O0vEB(Z<}RzEQ4S<*(YFqClhDSOnT;Tmohf2 z4M~fC1W||1c5T+Ka)(wZlHbS?WWzvy^#76ptf!P>XVHA>F~#v$h3xmRC&I3CY@3LL zlx$Yb1j1Kj=an~9gzx|x#1bV@)vjMhtxfvD7vr2CJ=~yM*hgTtT}V)V#}dzP_2b3< zz|~w?{2BQw=o1Jp*?cP_)+sz?)o;otw2Y121OMfSyACTymjzFbyaa0tdul6FK2Pl{ z+o*ll4dE9o3tu_GqVB<8`>VXosdW`reVf@OU!`VrQ$3HI`a>_Fu}d1G$STL>^u z^9n%936h)DjNJsUvDDRwMM-ya>)1%GNTdjwkq-OMdM779xOEBqBM;rqWqv$OdT?O5 z$c~yK4zHp-3u2sqj{b`G4Nla@Lx2WG?vOQUNO+i_G3W&8BU5MJvK9=AHn;jcaY)H_ zBj-iwTHy{vH#r=__3-OzcM5Q5r`?o=zyQ?`6(4DCiTY=|d3bVy67RJgw_lg@D(RlW z8frTdnP{tK=DKF?1YE|uld%bp>x`lscSDCGOAp`zYxat%l4SDMSsDo(7clF)Y&4;V zWONq+D63$7f|6Z9x;FBrnIuTObdycg@LOih3TXj1L=#UZBom&VcvYke-s@)lA3rdIbb>Jt%n;=)fqYpN1b6AP1@>8Q@COuK1H%}fHww7 zCd@7f;fwOx>31H-Wt03{3i_C>_TcNoad&0hQ626bBPpt-ZgMNv^G2bhNN;fI-Pi)8 z#f4z`>YfwX*6Jgk>j!SrR<+5phSZd_eyv;U`5L}@2v@_SC!jIid}Dg2<}g++iCIz{ z)X`Z!yLtx05|*=jPBq@WIzrl3a&)}ilCCXa{>;d$z)D|OoLbl+l@3Kf0x77>;dOCyApW@zL@bvBlGPA3(e+FMdw$2qd`_v$Ho zyIJD9*xhuiSP)d-O|je$Dk-uVIDepW{AuB=GZv7_{O`+>^_X%7km}bcR}K|&!1eJL zaD3Y+I{~Pk*JUlc#VnK}FGBC}@1*x9J8ot-JgBIyVgN@n;lk{r3usngwbvcZC2j+Y zTj8-;R6RC~^m<|M^71b5gGZR1zFGzP`L+|%q`;6DJGqucu0{71-C|nDa$e{@m&#c@ zSzdH?jZFJ{FF4o9ANTW%TUNQxd$O#opIdF;GYBTV?{}Mia#H>bj39YvuguRieeEcD z_o4g%@+GnXZ#P+Wi^-0qLBae>L+qE#YfzCiEk{beM-L(vQ*ttLJZ4jeOba(~-kqzd zkvDVKMaO<3wk_P7+02R4kE_SYk0>z^FUZi~$s8@|?VnLGh+oKyRzRn$yg*|uz)gH7EM)47$ChgHee?B9(E_e}5(lt5#2w|jle(iNV4^(jX>W3D5SZT8OfY&XQ zg#`UW5W~WIy zjL6ty5ugu>!w!nWA!SzBZ+zfDgH&T#9zJbhP)wXqtYB%EjpRP4H67}0%NbzTSHjID zu9EYvvwSq$9vlJd&5yjN1CJ|qcm)h+c48|FkTt%SbU<|Vb7GVK=uSp`MbgsP8!H!! z?h~#*_5E>oFK9qF{s{O6CXca^$p4{#2j7Y1moJ)#!R$iz-baGLRG_TpACk8eodBbI%sTl{_^DBGoz|3^VQOF&;-4}B}P~}QEw*R|i+h`{ELRH(B+MAu5GrDp<2t7{3 z`du7@PxrW(JIKvBnsRzLs;15`Hk(bKpQt&Xx2ox7k_IgM*qfIobn#Sr$8G6USvf{#M10{f%{O zJuIzIvl@#4>2Br(FMiUeamv0b-!uL)?|`j+KrZK(8Q7Zf;2YFwMV`a6N4Wx$pCPp7WgJpZwtwuj~3=pU?aKdf9pHGp~MJtNef|?cPD*LEn>@1sz*><+Xk# zf=j3IvA^B==E6szUMQ;UH{`p$@E(ac?9LIZs8$&^vKG5g{@p;)`cR=Qf#EH>+ZB{O zR8oWNv^Fh8Shc-cvO`bhLD*>!6=clKCp+A&`U0~jFb==Tz2E%fjh=k3eyr4w!p>aT z!oOcruPMJEm)&v)E;6K44ba2 z?^`F!%84Fn#zZtMK`;bz>`W9|j75VblSi1dA|pRa>Cr^7?gep`>ee{I5dlTN=Z@xLd96kce5ff5k@% z7bjj=IX4w;6nxi`d#nsSAkMDgBz2VY0OfJ2M}^{3Ptnn9yVC-Q?UoY3Hsn*04*qzEz^jrf2 zcv!S?d<48%aR#&IPu^Y^Gm-eo3XCyK8=!G8k#1H6KuGC0HF+TFlF+~MLZNojczTFH~ z&aoWKn?yYTTK}9>nYLi8_|+OhzmlUldy=xb=du#9e^@rK2~CrC7yEfw4u9Akur;*a zfJg`1Q!&n96(^a-@gAn%?0S1GcFwb<{Hq=8dqaL0#GB(Y+A z7PRfA0TS^8Q_UZZqc%^qJckpM6@Y)|U#Ps1c+U+wop6VVNsQq2@9lX)wO+wp=Y_@R zJqUtLOxLvOJf^cFb7J0uii~jL*!FlXcMCdH|M-J);t*_pyu`Hn z=Ik>wQHpFukU25bB~Ah4VWK|$YD{(0Zppuc(k5PjRSGZwkN0CJ9`&s$N$Xk_K_9E7 ze0EaEtQ${q)F!-hk1cN|+z<5$~_|1tC1vp#`+k4>?wFqLj zkic&$Tylt5>Z*iy3}4`FlpU=THP%XxE=`Kefj&#`IY4^MUN3E*`#@YycY=P1YE|)l z?C|eizJt(=b;f2Q~LSbpc0hpiARH z)qq;$NCTV58=)j+^LCNCYS1NuVM9|Ze4H+-ODNe6oe18nZMnGQ2cy(!p;%0!*dAM< zmOfrGj)*V*k63OMv`~LXZ8Kr|$olN0W5P_($lUP;9dQ;G4bDQRIlc$L;32U(h5D5% zBAE@Y7(luXj^=+RvEmbF6w5*_5=4^qA{1WgZ10!Z#lsA1Wd+2KXK~NtZE-33ouL_{ zgmh~W=u*NyA*;C2OtGtf+UtdA$(wC*%-qEtrkHA&kRQ22wKq4zJUM!KU;wiM%UDL< zhD%`o(frJD%;YsF>e2w`D*}9+axXZz>PR7mwHz0}elpe3p2Qa)N18er7swZ})#Ke} zY8nGVm!(EGS%fz^g9#gFV1yr#lAS2=GU?gQopCX6O&Y zU?@vE6XI2Dqwk1AyImlaO|knl-wyyf>ogYpp&fLI!;rC$9KSRh{M*R6yt!`vR%t*? zJ#vB>Fs)si9O_yOJpx68TTMoj=%)TfS`1jPTNMa?+3?M;Nb&>cv+Btf7pFTGNs8eD zruiyuU(!XB3{&Tczq^o>+Ixgf9=f-Tp7J4;@>;7rRDt|V*l%jWSd;J$qpK+Dg91y{H7%xbFn(z!jUwT!Q0{@ma z$v@_n87lQgezC}*k?QS86U{j-e>2g~IpV@Mm0Gh&%)x52&$ir0p>d$4rnF+S9)@4cPfhd(6SRKWfe<*LcF(QbSwp0e3snuR?a4M@_0LoKgiFCmC zx7n{^?i?XEze?O26=RHag9j#T6`RL2Lr#fJ8q_oQc#?P@=#xr*o)(WgCiRy&|6}Yq z1!r&@SPE~E?^e1bleI119&Ui8i!$v?nGhyBv`ii2$=RsgL+|90Yb|D&qa%9 z3O-5SCceAr6TMw6?a#gz_w{bMrziGH;G7kWu>+Z{l6ej7pzVJO6rr^viD6RTguWW^ z^vmqt^~0)d$d>jQ~#;2hC_AQZ+=;6Nf6KHmEY|_4;IJ-`DdR4POX?IJ>=vv+qXW?ZYp

      F4i-PV3;#-h zcf^N%;uf#`D!6+hz{=&?s>iOt&m}MN{i0To4{t5V2M1+NB;@)*+U|T-*T51w?+T5@ zvzE#_JI^5(ifQ_eb=yma;!)RV}7%=@sUenMf3>is|0goOo?8#G|4IygKP&E z6<5Jgc#3VrZ-Q1Af<0}qOiwXmMbZ{V&s9I_GDpdyn*v7&BxYw~6O~A6;WEF!TMBG* z{u!aZC2-83*WJw9;Dht6CMIkee1^50j<7qwBs0dlu++I-TqOsZlsnga)4#ESNv>D9 z)bn;vh8}Bsx6!opz*+CPQKF8U4d;`F@!Q8aB>_tDNBjt)Jn@Dt%#y6FmaJj4{4BvH zAotWt7rs6qTbYyH&i4@(%-b({K%rmZRKkR!DQyfRpyhL(&}xmSlRy0Tr`rmJ48VnG zK^ZkTL&mm8I3K}5w)wxy3yxAUlQ!btb8eRBM3?&Za1PegaQ0D`W+@3Vp6mxp?@|2z zw^Uu01LV8Kskx`=ZuG-=HZpc5nQH!WN!e6By*spFv1z#4deCiD#mkC>UI%}uKZ0kJ zN$MAT2e%sMrkN#PNU59XIJi-v3Hl;glUOTsx@U_;XRU*_wQDxLA%wwgsH+O_(>QJz zQ$6FrwXXYoD1Es+3)@(5Z0g>as1YY16*;i+J7{B;F0NPTx>qFQco=3rK@k(oX3IST z4Bfk>{)eDZ5*DT(Bl9|+bk(=i=qT??0 zVW1uUMz6ekR**x>HhDa=~NuzmZ6LN&H zp-=s_yuQtq6z$8q`gn?S>i_m&Bu)MR8^F)gX+lQw=(@`Ys_Iw`;6s^VVG?0O?GEf1 zsEwg%^QEn-{0#&MuVc1CXwb zq0{7@j#(JHLPRTQFrj_M<}biY#%9Ggqjog%zKQj>&uOMx4YKD;_b)7=Y!X2~9x=BQ zUL7#&3M7qTZuw@+EVq6l@{T}Ccm4x-7p;`{1&^iKPD0>6p{^tiBeh?evz6}`i%tJH zVn6F!y|OLS=K1Qi{7EOa$8stLA#c9n_cWjJQT* zxt(<>{%Q`z6IWI~!^U`{S+lt8E$2~TL%9*3od+90_kGc2?mzRS2lmW{r@Yx{gi}Q= z*z+P@PVU^a^aISodfy#g#i3nm;)Mtz3zB|Hsr1> zq`i`?xR*Hcc{tF^%Si(Lb*I74{7T|5eT(vVqMCopdd^GI!C?%mR`SeoZBnZjy??-s zhJiVjO#x2%i99FNCW&A5W;KX+b>VtMBY?jkp%)w${mJn|-CQ7B ztak2~SeHv{;uROXc0#}S@UX%(t2o4wq*OA6@$&Ye0U*^5e$TBIE+hY#XZ@fmsnNW`O#ed7y_T5sKyu&!98i z{>R{USiDK#R3tpri=p3%u4?0tTOg&;4;@>B2lEZzkBVCB-sIo$FFlN{TzV_$`Et0r zjdNBqsfhZm!d~~C%3YJm6%Ah)r0~kCAGaD;TW3ZlJ8q1O33;`8yLhJ3xSM|vlr+d( zGcs5;b?6v!Eu9p)*w;KvHGdp~4vRknYm$|r5Vr*J!P)mlIIRGcMlelGjr)b%C*R)hmEyp>fKim8?m5sg^wrD`T{sAX6yrkad-zg z;W0{#oy#{bboC$G8LyWfu-}|F8ep#EOf$n$DU4105N=FTnDLbH%B>#-DHp(l_qrxA zG08gWMr5Q+Do z)m*_}DVGB)HL^RvpNHIs(!=JyA4LSnfZn)QRjrS_B4!I70(=zDQnb$>e8wI*`W$R` z#rn6uv4d=rcF_BdW@I6MP;;y(4v}7SBFubKx~T&sp#l}H_+9my7WVnO%w>O= z>P)1iIc#W5BwJu0vuk)WGqMs`CvxP;D|IN|FZdfB`#1tz#-x=wm3X25Wc0Naq!tsJ z3c;Kj$Q2lA7L_3D;Efp7RIxNu2V?I;Nf}KHlkDhdZL}fr^STkh4vyiYa02rETu*U> z7-c-7Zw3$b?%U@|MrI*l=+Q%$ijgbQZEcvZK+_4GF!wzZO`t<{!2D%ACVaW`yMg%C zjLPq~8t1T`8CW+h=R?TDn(_~Aj;6xnI3pr6m}en8ecymfn|U41LoKqB$A*YG&4B!k zH3n_)>cb00;fIs>Mb7ym!u?+|nb~i7iGH}+M4eC-dK;O;mp+nc$(QcAeXHZq#-#(< zjGqQ*iN>bR@Ax>uOU2C9OR>i@M5Le^*rh2Ii0$u>f z1gHb8cD!Rf=e*c-XBM+V!|qb1V*X>;r|bq@Lg2Sz2Qa;B)9FtXUPH_jem-_pOX-Jm z5fzI+7Yn#mjy}~C`g8z%335Ws;SiR7m~UU-mH$C0pX@RhnS1aSgMgkB2jVs7dSuik zzUHyDj4{!iss4|$gI6UB)$UXIw!~5&$*Z>p=yx&w5VKidAZLgXipnW3Pjso#D+9$& z7(!a`1KVZyxR#cS(9u&(V!cCp9kRq+_C7!PKm@eEt;e+yPdyRqvM1}fv7Dvx|G*f~ z+vDDaJVchN5_Sw&e-gAW+2PiHyZnD2zu*_^`Yh@{Ot{7ggiY*K73)0rBcK9f%E61} zd6eRM@rmSaVtG|b;*_hT$JNmo`df){O~s^U(iy3lX>0%zK`OTPJ<(Q|wy(uI3*?xX z{%v`Hd2GwT(kdPa$SU_%+(9Kh!0m2jsHoJCK}!Y>FI9 z`N5qORN|g`W^vfooP2*}el6%atLVbZ_*gDX8XC9`n0{AS?VmYhGlxIi z^h@;^KM&(XZ3v0+vdMx;S<@wB$B;J|D}~v!!A+cw#*r(c2%P5E^6rqtHS?_PoskWO z4dBfK_3fGvZ93g;yb;~e%Cl@|N_DLLK5@qLN!{h&nyN;n^Z=6bv^5tP!ZVt1cVeOG zg0(jCug^^bxPaHXx~8 zk5Qd>glfpJi5_ZsIN)5rjS!}rkYJ9IBw_jik73E3yxaTJ>xQ}hyyG~Zq7;1RK)ul8 z;~$b_s;TqZ!rNKxDUje~>NTE8NzAHul~b2^Q!?XI`Equ{PRGX!jHiuoHzRPUonshC znmQL|VA_`qs8mYC{aF5^;wXsw)FL*gwg}Wx6AWMOBligHGo3j;4@!s1|R`j-^XDR+jUiIZpX z*tCUW6qiQ*_>gNTlMvDly8v1?F?BP(bu(pQ(P%shO%$&u@daOCqJ3bpV9O_>am_n% z1J`8X6C;>A=Lv-IVzg`3kJs_BB{}onQ%9$o6o~l)B+b%FGz{Aow@NtWF!H3(KPHi^ z3~#%=H_i+EfPs#=Y>c=$n&ViNhT_(fb#6(}KZwMK3Pu`qA!5-f z1Q+&bo?%WTIy^V^`3Tiz7ZB)gcOg zCOZl>J&UPT^@@?@BSsn;uIrpNOI`&C5%3NltC!xO`8wan0nn)R|E76R>v1=Y-P)ev zT(OnVjj%Tkxx>rqR7I`ah*wel*J(lk)VGfkzXUIntIN48eA3A+{%3N*7k_SKvTKTw z_Ks8!^O>PM#vMez&x(lyaluCY(TjS;58_ig*6gznz^T?*U8m8lGUB9o-I{FxVHUvM z5YPXXq_O7mR!+Nsk zk^%1loL>RJv?mKU4QDiMW3=9t zGFCTJe^jt*Y{OJE=$$o@cI*p&rhgs ze2WLqO=RGA0wNfG`y35in4;e)V-(BS=;Mj^D)ZlopagmBcf}Urt9eZAXS6hj(|KYT z`QbJ566Q;o$RttmpU2ZSQ6CVQm_rheFy2)*HR;)e#L@>I7{2?J#Le5D9dhWB#Thvh zmEq7Rx$}$VoaWc30<+NM?EZ5_f}A%ms(0wnoSHAg6xN$FZFdvy`Ha7HFe5i;_L5IC z1F9}z(GMb#Tk}AjeKgWC@C`AgxT>q8ILQDFzwPXf5@%xQVCgc)804m!wvKXfr2{PK zm;FgiZP(ss>%G&V`DNHIPczv+44uS2wt82GT~pxGZ&L_h?^a|N?Kt5?@#@(bK7gOH z(GRz`+JEl`84tqcnV;RkaX~NxaRS$@G|st7YM7YINJNEc^{Xdbl}3q6j<#TCB@*iF zB6NI?-t4h$k5E8wq5&|q_z}0#OoH6l{vb{USwqnuMv=8nJY)TNzGb7T^LSe>ZR6v3 zc}7ZR8j!Aceq31&n;NiiG3CvLGsXM3_UcqFcChL^xNsR)8CPzp$Zc6Z;bJV{V$Ac-%{|7REfx-*-(QQ*GxhmMKLk zi~KRU%lkdG%vmYIYdr8?-;*camfbe^HW4bAnR9zC;x`O7Up#k}ae(vhgnIk`Ce*1g zfGyx4;G_QgmD$y`0KMZ=l$?lMIs*q>5CrO|X{42jsJi)w-i>bLgic<8#e0N0?}4Ee zA9Ep1);ST#2&l$kqJP5&Y6+X@Cw(cPZaA<^!P8ClXEvl2kztJ(I_#qhicq`{FyQj zTn^LU5j{$%zFFD96AfvwPEFw?+NC)a+XNk)`(Uo^X4G$xwjjLiOfYj-8>U4nS+|X8 z$awQG~&mU;r~x86MoP5F4;EIJ-f@y9=tW~6Y!N7-NU z759j|y){+a1QlD=e(Rmsr5CW5gUy9+E`mT+vsF7n2m6;v?7QGMlfM)y-HA5C1aCDLkTu z4QIE84i|hTJSt|oMVQ?{-JvN=&bZj_v+oFw5L6viBG-v}gK1^us5r7Q?HJh^2x21Lq~{ z3%P!d7d_xv3jGgIh0$!z#$1|e4Z7kmNsSF*R^N>57N^aN!$r~Xajv}L8JAly&SQ@G zt>5cffI;oOCOY5Pu;8F}iARfPkPhSz#>V;pKsYtyzRZZ2$@Z|y*8Zwb^)RiD&W-SI z5-*SXWa09Uu64Fm`TZVBK+-IljT?ywHHIF+Ns@9si8JtoIk*Vy!`zE88a!s_tQhjk zf{f(Z?>)vm7cb?%;pd=1;ubiANLu&Y+FPH#F!40%XUU!&_0!_xKi9QiE4_eGet2vp zL`5#lcKf##x7t5E2lAZZdW>wt+o|XFx+c#mtD)*ae@FgwKnE>OtV37Z}B{0b+sO6Jkgn!gBNtHO*aL_3jI?%}{w+cQ}19TA=vw zvH66#^*c#OD(0qQCoS#7EGR1B)~*^urd<}sH6Mjo2%kM}Pd458s%klCZ;jp=aL!tJ za(#??vbG}S@Iiq0bNyY7o$f@LJ?ExZsdLny`O~p&p`S$Gdyil%+OIWK#0?S@3E5Vq zW((1mx>_AGPABF0d0nY<*;6X+FqaxlSytZV$fS%Rrzbo@;i1-`r24^EZV?f-f%AZji#)b=BWz=8O>ODIp4Gi_i3>mBiW(GO=z9qDE{_M8dqlRnn*7#iuDOyr zHF1|6f_z|9T8D+r)>0U{S#`?}U)>38?v?z?&mLYai3%a#v`8BfI!6$C99#Okle5kA*dG6|duOy+}RME*J9&Q2$QnTzkqK7 zeVtqS&&BZ^R9Bq|(DFi4#gSvfZlzpOd_V zFogs&R`yI$F})Z(r*sR%@8=0ogAK6XXRWx+d}I7k(U41tJ*Gx`iz3B-a3gM^Al~Sq z4hDom#m$*%NTee(=0Hy|WLcQA3v;k4=eT9TIZ&w~{IVLTC=;0>O*NC?3L0vv1RQRx zkEJP#MMJZS{#*Wy}sEhx$Ucd6a=;gG>o6 zpn=neYAH4CaU$@iN(yL9H`ARQjAHA~d%OpTXD0W=TXQ}3x{@^Y@;g(*#v(qC_}?3X zG2r=-NVeXf6_i?U4%$qAB3@-tzif_mFv5(HC>`2VeY`5S%+02;d~D2*GLg7x5VA%s zXeSr$k7MHZ@Q#*i-WCUnGHIT-;M#TVpwPt6?bpn#Oqrk$pQYOhZ42#%L{-st;oIPo zUKN>>x=G<%G5C+nmK0L(p2xH^F<}bNgj-?MY|xtTnZ?fcRNsp8-)dPuzB@Y28G&xZ zn7=pzp0J43=I%rUS+*WlX9Sut`Ym|MJ*zt@pmA>9VeRMU-$mjVZy_J7(h>wp7KadQ zD2vhfN9TxJDGX!BIs&nC$?7PxcH;C_4>0JyM~(FZ2#=y(i%_T3j{EN<4CsPJJVS$g z2lZ>ZU0rXGNgu4MTkTtb7tCS!;(XMYG<9OAff!iuzI9=i1&;v35`-T6QL?qJ*R-~a zuGjDsVg$V6P45Z9K#mOM$o-Sz^l=NKy=HGzSjqN9O9>Ewh}Qn80K0^TQ6u*EHP&(VuK*|UJ_j)`zOAyJVZG5x#}FSu zaRzbXNsc7=D4)rbzZAAuf-f?H+09?NN;F#v z%w6XdLH|gODr2xI%)Gx*nRAt_D#!AL!wVP4le286-Yi<|bh&eZe@P++$Bl_|iN!VE z#B+90b(*cP=a3xpA=c4yMWme~$C_Ua!WXm^5fX*5P!Ipi&%uK+yzWcb6;fv!sz`Au zo`?3x3YGF-5qDDx`sq*${Im_>8JgI(yV!lA!>RFE7u#)PT0qRf-l$Z}$hJ@_0r?h1 z2J>R>$@2>lOZtD7#WncqZbNn`{GL5s)I8%3=w2~r3QZkY-{&+}`}2o8ATEHLvuhTD zyx)*90rNRQ-bzmBkK&KAsvcRF?dNT`S}HZ2e>OVl`TJb)G1GLKEA+Ea!t--Cmb4B zSG$(>_<>=y<-CuwM=A$3V8T%%PE@ONvyMl9F?dOH62{65_6B2}k8+@A%bVgy#L(u+ z=Hi9|hbWbK)Nhv&!EzW`WlxfUVS8(^%kg&`M<@eNA|m8fk-ar2m8E;BH9r|wuw++e zIaE#7#aoN6YTu>V88x+B<;Gjfc<0XS9awCUbG((so=^q7SAubYav|WT-@-KiMbrGZ z=nJ@=6a7);U2yxHEKEGpv>GYem4FH;b3>>vyra9m>^^l&>Ht7;;TYseS=WpYvH_Ts zNZq_-6_M#+!;mV=0_X{@`(0v{2*$#1K4k>{?4+NS z%m8U=D_g{%D=2siaOzisq*HmBi7!L#uS=*z>~D*Yaa>TWji-H@xILE|bZCSSM;dEj z+(_**jW?|AYIH9(tc>ma(kGrUTI^kuL|wdufhxuQ0=dIpa9!*jymq)Y3%vr-T@zmo z`3IPPrp1Vf?Q$R_zCZ>qW)vg0!l6uEDn9I~7ds$OjlQxD&G4-&Ge&JTyO0XArgj-Z zp&@P|SY+_0xxl@I-CE;tjT#j0*JV6O1wF^UDaT@LXAHxPClRCT;;Qgl>!*~v?!wGj z&eed-&t2Q{Ef+Y%R9S0t>P>#>W<3{fag zNAbL?$;TnYeE%rq7BWhpR%e{EAKhlZFYP=T^zMts!{6QK)6p}c2GMoY5X<-nJN3?< zsn!IV21UXbm}$aFjG}W-Yx!+6apLAAKaX!aBNV9xEpHu3$|p4W^O)T|oKr1Ez5N3& z$h+;P>ZJmhjE|fYe*dYWqq$tFIIH`iKhIP2##FEQaY^815TKF{{0eYrb^DH`^R{vj znTKzQO5FO_A#_ZiB?T=>FKPT`ON`Bh;37p{Exbgt{=0@vu)`c&?djX#i@v=#f3t0| zehO9iz-#O{Gqc=GG&lTNU4`5q@AHO+;ezrqwU7W%x_v=xUgo~E_dT}+V`Y}SM`bZZ z8j(5OUSxDUjGW{LhDhKu@MTPjargUJlJ_mfK=D-Ec5}T}?&Lt6JmG1hr8+PI1bLe) zH7pH)9PKzqYD(V{wV^7crQkX z-+`RalgM?fV@^aJ(6l723c_yZ?Y$QBZ8FGnXsgb3@<8z=m1V;N9w{xlV!K5-tnJbn zURWnO>h}H1i4#WW@&9`@FP96-tP5cPhT}DC`RKY4dm{|EJT+6F8dyv`^zGzht^XZ| zwbI=os12y93IG7*%n9xd?85EFrrR>@uekD;6$ykPX<=ehEO_@2TJtsReD-Lz8sxaa zGE|c@k}bfz^Z#mM`euoLDc^LJKIx1WHo;yOg=X!+wVbXkK)Xr~L$=M}IJEp!?aMOI zCTCV)QLF_cAPM{70(gSmrfkacF;~_zDM7!P1MY(kCrsxqY%sp*AWlf_q_Li*z3z~` zHyK?+J4C%}0xeLs<)jA^3ueYeL+i@8Y-6x{7#x-402^GqB~Pyn?PkN6P3JO+!dFX; z_c+y%_XG5(!6!syBi3R-Mlq8ntbD2o1+8q*E*tK(tvqn93 zC2U!^`)8Hze7u*JYupqiErN$P-`Qo9tg#SRTwP%Kz;I7RgPY%2cbYI5iq0>75)CB# z9k5isU_P#VLY#oPgnuk9W~^?bi;}InY&W2sV0%$l2l}KvCt4z`S6*mLkg?LVe^Rgq zXO91_3Q{f1i6%$=rBwvEEWbF+bS}RIpMM*1SA1HMP`Q1mrBiP8Qu`kQV}@vkB?BzX zlRR|^EiwxNgjVb0?*&43nPuJyQ=J@}+|ef&eZ-v9Z!Q@K@_|Sz^TT>f3mu}L?{E;) z2$`(&T_f(&V{I34FN3Gj0zMq4#d}7V_&i=GBk}@_)?fI&V3xcj{9#)U8DhqGN-Pi8 z{(k<94j{|Jq#Vw~QA(V>6GJzl{qCPVgBN@*4vRnuPPU|4l0TRvDiwf@Q7!KTmL)Qt}L(Q!!%fT7OD~Kj+nup@NkhnvKAf) zloCS;TLLW}r%~`Gn!X*xI=l7HJ4ea@oXd3RAQ-QT)7mt;R@5CR&`HB)P-uPVCLEZ${##}xJW?(Xj zx>uHiF{m(-F)=*%mPQ0(v#$=wZ^sSPhn{o`&83!4jP`D7A96}ceBr)!z_mX|FFYDMldIB+fW2>=ZwOIf!8+)=q3!ZOa&fek#dZvLNY@ zMDRFPz)(hurq)KM8v>hmEfqZU9tP&3RI7*Sfi$TR$YJ~68Cv5y`1AC20bVcbji>AC zTE=t8kc+9yKedkk1cvP%X(+4i4(ur~nZV2L+K-ia4iRIE#-L5YkC`jR7tv!TUiH>; z$S+RUnu8+MY#T0sH}>izWZ~+Hd`z(B`!z7NUVE@&+jN^upL-`p)zxk~>*rN#`~Z#4 zUOvJSXKR(ut;G(r${&gYF3ZElyt9Hg3kw-B!Kab$Il)_9g(XSi0~biKRVPGkQy>huxBk3z+vO`MkMpV8(-7++rA>FU&st=YhRH2(t7kjS zQ21uyXV5Ez@rI`+^XGGWUf&8ULBXvdMk(%HSA@=Awi{qH!M2!|G#4f{o!cKc)fcMW zTB)b%qnYeA1Bk*2Be;W^YhQ{N+~+WjMi6Zn?77os`x=qOBD~yG8CnSx5ZplzmRf_b z36&`rs2BAj*LyEP&bII_z1QA$j#?Xfk_n}C-_wbDO@%p_eNplXL|tNtn=5GWq#=}( ze*|KWehqxF=sM1;Eg6V^vo&yPxOI0|Wvy}&z0FrNs5lxnXt|;U0oO*Sh00>R_RO80 zYtx3_ZnTXJt}*uuCWO_;{Q6A$T3dkK^&+3ArqUvwpJ}@UonhTc;B84C=8y9yB!lGw z`$^s0%v>+~_u_30Os{XV9yy*kVIS)#(q@(~9+*2PopcDTvA5J16$(7B{;ehUZB0*G zL}}*2d)e*T_6Fs%ByEb4x=nfb6Fa9EB@%fQln;lhSqA{$!(4NPQ*E$m^gS32=Kf{~ zTGOgbfm!1gG?k`IhfQs~u}&i0sUPg|rC_7AHB-5z-%f?a22eRR03T8H9(C&6lR(qW z+{BZm`NsLeq+$=bjItT%5|77F;&FHaPF0o9FElm0c%7ev2}cG+8y)1@G@3-hFI`n5 z5ior$kax4f+Rj7Y8#F%+V;h10!`1`sv!qt0-m!XMVu&2PqToa)vy(ou46tT{=jnsa zup_gKZE2xRgnI#5tOEVZdWZSZ5s!aNg2+g^UvaIzd<43O;zph2>jISXz2?`yntT97 zE%?1m1AorHn=nkvI_vs!maX)TpK2vMm%v9ssb$6)-p9UX>&t=^ehvATU>CQY%%_~| zuz6#!d2Y_3g`FK^`|%G?2-(z9Tk$y?x1odzQSE$f`X4JIe&2sq+e5GS_Rp6+&!?&d zTl1&6OvR?YC(}8R>W_r-jrAC@Es*&O-V-x()SN!3Y^}R`;8je9*T=ViB^<22P`3KI z+0bQ$D=y&AnrgzG-b5AXppv zSJZC+k%6sBo7A)(t&UQi!uqK0@J0-sXH8A}!>}p&6s>bmsrEYlX$>>$Vwfl9CyB>- z@LAH%3qj8cO*M}8)L^RgZ_#lWHVKejOuC2vc>wTDLO%|Pg1F!)b&&72evXJL(fVPs zG9@^x9F#$Gjfs=@WHL))v*y3MzFUvpj+VzqrQgUFzD{uO_t#8Z2YYOl8IgN5b~=$q zI-G6k(X_f2Tp@;5ok_Gxn#vR0@Y0x-Fb_YVuRsUJw5?qd7v8}L-}}gXpLN^NEo~jO z{q7gGiqaN$(v6lbeY$q3JRV$IVb>8$bu-C$Wp`3eE;#an-mwpkiiC+Pi@*GZJwZwv)~00gDP)G%c*uD1*l~*L$Mr$-VoinU@1`2V(!Ukn%uhi; z>2s~kd3n|s;n9JHh9eEal&Vv4Ii3ZX;J+|0N!ZcKabQ?XP)1{Yha)Lr{-33w2w10W z@S?4g;W`1JzSP(a-c7H?ym^|5?QZUD7S1^*y<}55R#g?L!p4cE!EUix321jwvF+8?0f^<0E$# zWcKNN!AlOr)}2wuO6Ch{%Pzr(Vq0|OY3@=hIrGv z1c;jY(j7T45%MD?U&hXlhNxCCt-pQ3cJwI@w#jo>WHZKwQZsDLMJ~_RB!#6Vj4$di zb%HJ}^PsJ~Y56>6`T6~}R?KM=GRrYLRA3W#qWyxHUy|Rj{xO_zqI^i|WA7FH%S@jG z3?Wpdo%Pzmm)bn8Z&BFS>kkUu6UsM5N{D})rl>`%^s{i8?2Y+M!VrIzNg#MT=KGN| z**xJJC8j-|fblISFg|rmO?KwH_mAIwc~-A>Y>YVO{5j8G{YTQuOhkxc@#63$dC;fh zBKEyfd5!x_P^staaIISeiFGI9YhZ-qcVBakq@dBhVTQ$n^K`C_y7`vCMlSERKLIU( zFTvbQMQcdWT-*iMQt@Q8nm$)oS>FLPv2y!`Tn23pO6xYA8`js6ckj%@CO+)boLnN9 zefPf^fZ?~Tn;>46|HXC&OS%))Gd#CMNEy@luVTgP2{32MK5?gnRG)Yeb@~es+R?_h%KS1IaEs{ULm<0e-WI>)nkfncD`9S}Uk$6=cqTauC{w*yCg)MM9j0gbE*g$7v ziHaLZvp&hP*&n|^w@U}MuaL zx2GQ?^*0W zi|L>Z_8jbqxQR}>edZW{g4k5tjm%xrcO_1NqB$q1I%B8xo%}O<_h|3NmJ5%o?k4t{C|(z2 z&&sg-wqI(HCYg`vzD1fnx7I8}#SvW-b+p;Wlp0Sy5BieD$lnQ^2EFhX-_jqE-JY2Z z7k?GL3_WmQ40lBC(0Du9-fJ`U^ya4sHIO1ProtHuR&c#lN!7Cp)iTbv;na!7@7*pB zw%C@AL9t&GE6am3%uBFSqLT24oq_ZDutaCnkCdT;V!E`nPgI!`^?^<<&|Lv?;%nvh zKTPEDJj`KGN62yn;Z3aItM$it+#l=e66?95@vgFBY67(Rsp?>g z$1(RIV}`n=3twoG597Z}qRfeR!_96lqj}=clB<6o9vYl4WnABx2k>O&odd7k zCF{1~=h5aonAn`G(Qa;=|841SqVUZt0?G8RMS7lYYv z9MSCb@W{D|bb!N^4c5KueyvOR_+bx%qb_x|QdEchdLSjoG$OztEh(&bzkF}w^bLG$raEvlNJA!+phT{224sJwETlQ*JINbgs?mJ5Bxs z0^RE-1v|}TOK2vz}m&Mzk6@406&fvsy=@MwrbNu4yWvW+4 zrh|FBex*BkA!@{a)D^2KbDDq20nDHxN0Um(y|g1Vq<)JGVRkBrsE|KSszdy0SgETz zl+8cD*Z-j39)PGZ6dS6{q$Liea~!M1u>=R~3b#=C&%2zCRa_pM`tjqrGY@(?FY7;c zcFXP0s1i;Rj)p6u?mLLo9sa!xoX-qZ{3wmRmVKPlu(2XB_iupqtMcyH*Ov-^ck;A@ zr}4-^XZraJJ{_igD$%csv=SPoRa`Wp@)q#U>|Q zSo==c!Y}T1`4d^WcQx?6A?^$;_=AM-Hp1f0%`-mc*uU@e!s>QQUXxuR0P12D!X7e;m+h1Nv4UfpYDcNBInWP7&pQSR6G#A^S z@oLIAXWkIebm(hX_NN&e`DMpyT>ne^q4c*~$5&-l<-0SCw^6paI<}Dg_8K!8_R|A0 zy!r%Tp$L-<+gtpamts$!2udt>+?{f>zG8Bn0$ym(V6lf3G8B!lY6y2#W!L6VE!~$* zl><3#_V7YQUBzPS>xrO;+Se>aU#)?H;%G1g>|2Cifg~ zz-_lR$o?Lqe0LZDxt#bAUjDRMXzDh6O5zN+3b1xf<6sX6{K*h5uR>O{RzKKJx{tDc zU!A`^P+QTkA?btl(C@X#x`4_mmDC>KNtn%7+ZKTdy7XuF&Ai%!Z2B^1c8UIM`+1#6Y_Y_TrM}Bg=4sxnwp;2s!@*^k;>skyWi0L`M~Bd$ zcGd&GOFqqX`C7Ux>XH*wzn!PCHZ{tBB2RoEWx02WzH0fMs0pXYsl2k-xcBaguQzQ4=ox-LX3QElj(e6!INQOFl<1!05E!E^bK6MCWh z*m^YXeaX>aMtjy|q5hgAZvHU{>?A%;@Fe`}B1mP^4_cQ~Y12LZ+7*~~1w?6=#DMpg z2`l~lrLTI=!(^>{+Y6ZeV=jL)Lk{RiSW*Iv#9f}{ec8Q|sbfy&FZQNkYE9-k>P1`T zFUa;Jf@n%F_T~WVvSUxO61TKWr>#@&idyTuB{y=B4pfA0f0O;~eaaI5uhpa1ck*N( z7nRYs?1A1SOOrN~%oY1Dp|%HNrKt5DohCoI)n)Off<2v_E8#`eQny`O-Kkf8%=$qN z%8yRBa{?1TwH~uusxW+F57t&*Suu*AH@>@GS$k$?1c;7kz;-95(Em}oEb$&DQ3 z+&-M6i*wK9ALXtM`7JKL2V7W8th^0~gd*t6EeSBYX2qKfq}aatH0FDks3_=XWo$kz zt!HEkp6wENh3y+ixoZjiA7^bXEmBYtJzhZ3$fM#tdo0UyX3%_)&M|ci-9u2=7 zfpNYI!(jbz3Ga{$frUkcV&JmAFW4D-qBS#jOt@e3kl74hJ?`N5?sQN1 z^5-|e49a2=_Rj1zp3HM=`T4LCs`46wbi5d5GsN>a=pz2PwFVrT_Ppf*Q8S@6Xc#YC zOr$M}m-t6pD3734Ef>2*Y&>NP$!kn|cBNK(j4Gylo7^I**hBu@qYWKx6|Bq_j5 zanUW+@_oq%wxr0~pBcP`Z7{HP9$W`;bC{QX;Gw-aa{os6Q!_0O9rYa8#$x}#OVIz+ zGlb^lyYo#Sp5V!(db1=AO)Ik>(2~|?Nb3vw4l@JPTMXuBi=4$RWjp$2P*iF&7dVc> zQTj!W;!V|yOH-J}cu?&a4&#|!y{8jSb6jOu&6vHd8=9%VV_Xj|QC@QRiqhe0s=>l!=$y?*8;bT6Xf~99)l-Bxm z<+1R0RBdSJn09{eN}G$6WGHu7F4DXfi;%o&E(e62TSH8@Ze z+OYbG_B9h>hogL!3sYB)K+!8CyZBR_$fS&&$DAEK`d}lYPg02Jf=yD_0Gd8?smUUpg(po91@Ar+)qC6gAoL zacY$*KEx*Jolg=U*Dn}}-D18Qffpf@-T)-vRpgn1e2OI9#1wHVX6Y`n!7SXH!1!=_ zI~83Sood$RW-S0@9eWz+9JqojgRoNnY{owMA~ELNe`bqv7EdH=<3|fmm+@w|bdm<| z-b9dOw+@5c*j1vfAtoE@6NC0^)4FPGpm)!}g6MkyXLv1|*jJSg48&xI(*?0D>I zuUh)rzo)F-8skm8&9Yv9b`%lnT%&|DYU(VV72{)kgpb3rCzDJfxHSLnCT64=b{KL#m4q5n5BWe6|yt|FI=N+i<@rjhK&VK^;x6!hf zR|?h-f%V19?Q_O+PWm712L9oJ-Gh^eN4_N7T-YX3o>HetX@_R^J49;AcU0_EEVcd` zXw$y@p^W=50~8n)Nf2~UO|M7`Ohq@{drmCc=7+QRyX|SQtAd@Isu`@_U=T2_I>ikfLoQcGj=50j9TxO#3Lq9eux3o4o zIq~AS6QrMJrU?O8L7utRU=urwG9}D2+IHYhi@Jxa2dx$}<_#b35|_EWTiWkpd1xPd z*u~$E5blliM#T^(A>XVN2M|Qp%FIC7$9R)KcBr{GNs*_`46aKSN7LnNCD4BUBW8qV z7zqS2%IOY=>dnVg-w!jJeX(C?9TJP_1@WjR8l$)~ztjfrb@{lucXY@d5x2s3RnAq0 znKq70ZG94_7&?X&VqZmiDwEM>D3C{@1=o-}&qtqwnZZc3zoHZIe&cJQ){P?w>=%nG z-Z@V0Cfej&>gY5GteHk#jd}@fE@gGfH#^F7kuNS{UC)YY?gi-1dHpB7A05t)fv+TA z1w_02w7TIr5daHOUX5}UONX5Cj#Fu}f{-W{q-k`ld`n1m1VClF7I0eU#J6dGpRxnE*2SMAKg{~ zx;ud{b)W!Hb>Ea`lHoi2FeSS zGzLeJ!A-#thts}Dh`U0idWt#-nTMZ*wr7Et4y>0n?^&7#BAmsH&q`H_CJX6M_jc|N zeMw26cxs8?Ee{}Ey9ntwv1<|9YNsa871kox8WxY;m=jhT$j~8J<8LhSsQ||Q+8q-3 z;zY$`N>9lvop&}>6SG3G3{5rT2)>LIm0+;Gfd_ka6%3Wzk*R$&K+xmJ=l)uC(q-Mj zYFki#9ICW3kbZxNMsA`1;K6GYmXthit^{$&^Ivj|=Iy7~+;GqR_B%}!`ME|_u2!;d z`9<7-R=`(bUsWeUNMHX0-N#5%k6g^}aqwga;$KQ1I3630nM@}GL4rEz&^a164VVZD zlth}*gB0Cf3q9w1E+}5RvW-4RofIx&(+l(MHoUvO zLTAd=zvLIxm6{H~lt0R*IJru{Vf$<)ci{{^dFzDK0uZ=r>43YG>PbIZJ-rsXmhyNP z)nNHBI8Z$Fnkun0P)SO1e{rPVO^3=?>)e{(ej(R-&nLgiRy5R_w7dR}ZN9V8yn)fy zd}>PJt~d*Yj6?G0=W2V}8b zTMNHrreYavn?DM{F(DC<1EScemG2qPhmN=UAtZAV-*W$s*Fg!Ahj2A*voTQdYdM^Y0~M99P1~jE9=%I z4FM?1SNK|!t%tASWV!ga+JkW>lR`R&Ac#>Enec{XAJ{POtbf^Q+>Q_34^hRD!g1mv zjZ%p77a#0|P&R-`%_+>C;OB#M$xu5`D_q$d3N0vf>&=9~Ipu*Dk)1rXasIQ4?IDIx zRT_c8ot^$DlI5uH^^6>O;KbbdvXxnT3+jLE0$uP_Q@ND`u8r=mtRV@{Ej2%gBQF4UG?V`WT~=hJ8r)c;4|7DF|OjWt|2|C`*9@~1FQOr3o zVKTcrVg|N$P-V?(ZK0=u?-eDWbN5CYpcyea-7U2r)wI%R*vb~v+|x;}#SSB3E-a>O z9nK(r?s09f=L{G=xwT%MIfVQCta5!S7~{{SgSg7{9GiWULzsN~r{HCBZ*Clm`b&cX z&p+A$WDFpR!#*-z+Aq4qY#D~5Z4*}PcIO04o4<*;CjL@cA1h7lh|nDMvVRQ91U-JS zZI{LPGsKTss+^dkpIM#=%JS|C%sTu!qDy`VH@P_3BDZo}5wCI&+c(G^qFW+8haE=c zh~NjrJqxXWsQht<|HzCHCkd`^XRUM^K1yy44&E5}vGTaM?uUA7G_kYM@z-_vot)vI zPhq{miYUfxf~Q*YY6fdoMfG66t(g`EbjHkFnoQ2`U2j2N>gqYAD7Kd@s&zjDrjiA( z!WZR-{AJO_aAeu;5Yx<^n3(RoFMp4K ziAgVu>8^KM83PIgKIQKdLTB^%clPFm%&!Z5CZB;R!sDZpLff$I&4HMB>FGdG0eu-6jLB z!6X*NNGX3ePJ>`(q0Y=4j_Iw-UBZ5kU{=T0Uyl<~Y!u4h+}Q4ckdw+%JJ{3nlZK7c zW$#ifOonx6y(LOH~LltiA zg&KIZ7yoEA|J{x?A%%Bs5O}RJ^5I28T)FxWIy`O!;5UoW#g69HorQ%fu)@l^AnR+|f>S#At|ODx!6ovb-;6 z`3)}Q27>!aCg~Ix%_K*;T)~}T*WhC%vLef9My~pni|(%!hJ;`0qrOP$X1m{2*K=r)`LVm9`hmhMo?2;d&*$0Ssl2N4wa^QMr}lg(YF>HX-`d^`&X!XhlLYnb-;o=q{ORFl8LkHzA$L1Y9}x@g7IQM9 z&ed7$VEid8+=`!UAAcyRIFpdNs2?Jpn-rCKE)M+%@Y5x7nfHZrf~!x1qc%7>-n5ya zNQTJ?FDm{*s% zTYaPiafYQc7;SiVtGJTsopYxeGU;+vG2PEsBGYz-99|!R>>nLUO&H+Ruww9!O^)(Q ztaXb>b=rb5Z{|hmr%oaP^6f8Tge3cCLy2bhq!RnNFc#QuH!Vbup&sR=R>Jdx_c=E! zI!L{Lv-1f*u8BjJUYw6#>-+)x)>W*y(Z!qY&+akoz-^I`wsz`QPkYP1`!xB32@ud4@(&X39R{{0J$ko!0 zC6*VD4_C1gKWu2L2QG)+8HI-15dLW)yK966I}j4&fj$xUK%!*dfavsIQh1(63&aH< z#C1D|+!xw$(IDvNkP}f?Q~12XFDLI9i>h7TR|bSKv4gUoeb28X9WM;&qc<`|i-P;0 z)AV;2+}GPh`cDmiu4X(>1V^uWH~^XJ%ZX%EpqRh^2G@~-KC`q1R#n8jeb2Uja~O=LJQ>gm!=1Jy9Rf^P|TG%@KuC@WN5YzAU|5I^Ts zqu8XzfltNeWnztT`3yltgM~wJ$uO`POe=~A#6Om<#_zFb7QURA9x=Yf^DV5$;%Qo| z`ZIFGo2>DX-MEP1=e%U;UrR09#FW|XSy`$!MjRR8g8Xqh1mrc-;X8PRw?<%eEyRR` z+@c7xDh>ncA} zKTXP^XC`A9LV(j(O(r1E^$<_E_;SddunsR;bG{I7f$JW2iiGq*^cR2|{)v?T4CSnA^K@q)PI|8#T4_qntMfIf2I3H(J8*~Y zkG87g5$LW5vj6lx=RYjNpnQmRS?r!~gFaml09r>U^T8cksiCyd4k|CGvo(+gcj-+0 zMJw-;TZi{@+iOG|xP8Dh6W$d~#g>q{IA^~?D)Y}zfDZ;gr9w=hR1)~7 z&Z`kygMgCPftSdR<~B`1?maZ1%N<_SGgtMd`hukiC#X9#5fIOyV81g{&;+A872ZLY2oX%=JkY!&?82(d? zKIcC^LzltDpM}J0WW4Ovn9u49q+gaj{uicB>F>b=vU~p%UWSW5Br;y9JqLbVy^#{c zYp%?2W%CE%Yt$YKian@C)I6l87}Yl$mFE|fO6{M9)RnAOTx$Y?KrdqCzeTfdo+aNR z`mpn@d`nZ!=#oDD2w4p8TTDu6OX_^;g0%VQAwm<<<>qfN9ssSm(F_<3{SZe}-@3KX z9)z!G)Mtouj;Z0>+iJ~?d>J3!BlCM`k}211GX_m9ws~KwL5EiBmJ_??GEMfC?xw(| zoEvG7*$tf2^bZOC^9i1{Ue(X}(zygr`gp~*z7y(KLOcDkI_n;v&8gdqL3TG|GACVg z+;l;MC)|kg&}}UNMZfTlrxI>|avr^aHxJ*Z$mrw-4;|1q69Fy`%#d^U2){Z>sU|rx zp5|VcZ(_pmgxK>aYthJj;uiPet@3F}I_U3I7@mDOl?@H>pdeRY)b1_1b~PupWCJsb z4y#tNTtwfWY&6h1-8!9Xgy4QeFEXqzlF@DOH^?@5 z2ic6S{K!_c^#1UYM%%NgcfphmEDja0DJpF{#7`r# z(#rKzX(F#BXWGIJdfaRFx?8Ul1ai)3M>hm4*NW00T$2s-$Sg2A3Y?ko=P7&}A8hm4JMwTJ#e zcMiYsdK9QbG0pg}hIx)mkh>j3{R_Nhd9LUcmQ(fqNnL~jLRk;3h8abYt!N1MJOIIYcuSDAv7Zw ziSV8KbgaPKo;Y-uhP>aJYHFPL1+CbCkg87*?~OFkkYy6jrM(^EuUC<@yG;IF%nG7U zU=dW`u&LHZwA$=DZ%;IHAG#lw9e$JEc4$oTj06njV#T=SOb=1e5M4B3I+7ihnmN&q z@mPxvo zjGH((OZpT{%5tf|#nmMNz9%4$~k=A((uJL8Id<__58K$AW} z8J=9B?iFgMHE=361lGxliTaN8r}OiHZ@%mWHC^2RRLbyTVto2vOy;z$jno33BhvMfB`TpjG*Fky`Rkv3p+C9m@8f z^(7~OSKv_6D9DmMYHq8mA5YLjixbHtb4`$~^6$$!^yOfz2)kPY{ywAo7bPPf+0 zG*oPpkoP4`D8^-odY7$;G;|6KgFx1nFcHvh#f_A@*1nkIXq=vGN;xcJRjYG&N*{7W z1ToB@FWXP6H*T-|5#~s)c4!bp-|Da-(*N1`dlQVo0&oW-KD#6=+f&lA!!V~zv|HG0 zU3Gw4mVTK9tpB$7<+qi-kK)&=J7XCCh{Kqy_8}%<;Tf0(AO2H;9o$mH6iv^kV*rsN zMv&^H==2>Dm36lOWQG&x!R&sJhGI|j#h=h;g1k6TSuAeg`cr`ZD`Z$(*>m-BD-Aq0 z@mq5hc=D#G)8&v{25(EYq>0Km+B z#FmY6`>(QPCtqRB%ftt&F7$R3);{;YG|9D>Y@SkF_l3x=YF_75#|vEgn+?&o7bq*t zd_(S3tZ<2YzeI81ihuR&OYM%aJwV;pUYw#B5L{OM$6?RpiAlqO#9XyodoDIAiW1uo zufd}2=IEY|O#P76X8;YcejVPzmap|TW%UY5&SS=Ha$p~^-GoC$>|;OD75KW|fsjyx znC%K=lU4MJE)wV=YQ7-Ric|!6$!z~Jo%%Hhw4BWjd3vu|n$nFSeI_i!f)UZT`No5N^c*T=oBb9OCD$R#fQbrs)1<*mfwk1(H#C4JW!hEeW zv5xoYB~mL=&uKSVVt=ZKjluz4p1}^mL@SzvX9hrouBWTWGZ0nL5&?u(V)w zi@P~}-KMkWPGczB4aJ%y#<$GdRM+WmKLPK0mIi(p|&P>xAz_8%0VxrWr0{lDliI~ zrwodu$v9weCCdaurg$PnqkEqPmT^wMQtxn?d~LeHK|A-=sZHN>WY6(K`Z7g>8w($Q z(~>MnJ?U^fB2X%+d3vO{`#_F`Q87ZgR7?gf8aL5a`>EhuJf1IpRXwXrP%>BU7ez$W zhpgHNG44cy-_xyrbNRxg!Lcc+BHkZ<(taEe=pTa^tCG)J^<&|OR$5k;a zdA9Rv9U?;i-;Tf-dtnp6#yKkzH8o&^Bn<2OhBugg=9CE*AD^}#Ba7bmS1oesNV*Bh`o_g9laKA2^t1x2`-1}60x2n zAlQHTfh*PiR&Zq`2Y3uuZg=D(;m6o_jAs?bFJ}^9=4tsi4?{8UJh;T2nnIGYkhF%@ zE-*E%9(M15-Hjv8-H6c{ z^$h8dHig?QO3ur@qvWml&rtrAF+x`3!^ix93hl237)Wlo+FD#z`xU*jj?79yZiKV; zvPcc3|1y+VD<+$MfBU#8{#r1|eX6@%{S6v?X2wFP zeijH_Y_E*?u7er!<%egZ)3@Hxp!k*QKb?BR&d(1ocfxDf+h%Jmn!xedp6tK31rprV z%lrCMEv%W6+3e;mgWl;hvviWGCBu?_dz!I7loZEmToB!TwZgps)jJ)*# z*zQXB8zMVITJ09}PBlcR6wzCTgd@Tn+(&6NyLNa-DC(!;^Xp_#-R^hX(>TKJm5yLf zyzTq4-gHcqo9ypwM3%{kz4!I!s?H-9yEB?mmqrgT+jDOSI7hs|*a42s(?AG!x)b-g zqe;I(=>rq?E00~5-X9{IEH5FrJJhtmAj^!`i2_?*2qHALJi&e)zSfbV{wo+WcjQ)2 zV$tfUIYfh)zZ7gy+&zeIo&85+)plLF8NHqx(40t$l7N`GG=pN(eKoZRlqFX<9VqK- z&cZJxLh9w4XJ}lT_5TUY!MWj#O(@m!_}mR<)xMp{M!9S3-4eyAc15~tLn1%4VOpf) zo5*=KC!~Y;TBm1_9~nANHrCBThL9`9`30u#8Ea);g(8xLveyv>X=@aSE}%T zmijOF4J-cp$cz8?k;e`n#V&tS{XUa8Ak+ofY@ITVZ`)hauty$^@?BS4MZ&`&4DX!nI+N zc1f$L2DxdrZ$XuF;2|4vx9arUKGd%JurqE(CJ!W|5V7IkJO8dIu(0-xx&(7DO2^I_ z52k*g^hV;|--9EPBfF%#uIM0E)FgJg=c*7CiyXu-(6O9 zmyP9Ha0i+NE_2rCYcP#3rjpik&-rg6f%tjoA5)S*@V%H3C&9TgAPPTDhAHx6jRViG z4)poi44BSp_Mt4w7FQ#q{g{-07p@YHAo^4WF5kLQHIOIcem?n;NjTJ7koJ9bY{`BK zaL!%KT|VSXEVJwNfT?4XcRuysGwIjtWK##Q=A4Q~N1Oi;RvzUwfV z`o$Cp4Qs2{_@Q$^D)t58c9S~Qmv@y|#cKgOoLXIXp!BG1Or>p@WPd zen+8to?pX1-jAYx&M>@pa{(KboX5Rv0r|Pwacy_e*wiCQf92f#CDIO;+ttCcI^(A6 z7GA4=Yn~YHD@)qUNB4*)3z*>$!C{`@8M^5_HTI+MR1%2k$oq0@)Cf^?g~!d4&pqqbwi8_1^LgHZFNjTsU25?7CZQ3B6{qVsUcn!AH~e_$mqB`90~R>fuwSK)Iyc#@y&urf zZ)lCWRm4*#>!Ro97d7(xCQQbuPrb-Oi-z{)j1ryY}@5ibA5L9j!{bZkjxr+b#E+8DpviU?x5IWALzrV?r#qiX;nNe7QuA z3K_ny<^HtZqnTp4|S+e<#?}@lmPr)B+X{k9nM3f1HLX*}fmhKVm$bRW) z&>zWR-c42A;U=IW@K{w|Jbn^WY90X?5!rKOJDyxiv}RF(2i}2<_x(q`g}P2URL&>s zA;ES@>e;Ib(KVfPa~eq;x`Yg9BQc*xTYk?-f3CV0k6iy`866Ih47tUl=2|ZaMIA2Pg8sD0*z6Al^xmVJZr`PPZ=IK09Ejsu%R^0h08^RoVZ`vRk$$hOUry!&H zd3$I3P^LMd%d_6*#JQMreG96deD#cOMv!~mH8mxq&n2FGWO?WeP4%DN$DV!%Gskc{ zF43BPv5&8;7wObFx;i_IO|FW`qbBz|D-6p~Q1a?2bef^_kh0xi_*7z{BcsDyVX@CL zmpjBPC|$o`2Xl;JoFN4^j%bj6qv2`;uH?be)XG==uP!5mGViR?s{VTv{K-J|>2(VK zlW$UU#ysoCSTZWtQ{8OAIpAWGyEr(T0hZ{nszT?-(#$W-f`z)5xup;=LB9x1d$L5_ zy<8uRZ6SLEmL;Jn`PIgJl!BU!A0;cxs314-yi{;}b&mLJ^~&zpP83Sc9uFjsXywjV zKVH|v3X{G9vIHSdQ~l;xsF}PTH#f$t@|7oDer-|)zlHcR9VCyMKpim`){QWW-bZZH z24Ed#=IbGH_gCxj7AB5Ehuo#1^#J!9Neam}JI{8;(LeAN?E9Hz`w06+4vs;#c~F($lj{Mb;L?RN~ueO8;Z zDM22ZxV1CboD?FfS(@5}Jph;hwD%KUUfjH%wxW{cOQ`jW^4ZFdNiH)hVdca%HW{VQWlenc{PXfhkl8;u|Tv>n%WO-OX7L zylx@uZ%FvOB;F^{vQ$(UA(d2S$9!D5aEx&#llyZhv9!Eo3*&?NRD>p;77D$3i-OmE zbS=4H1iD}!*%Z8tC|&U3fU<9^;B(oHBgf`ez*;s$}9{UqDl)idN%SR*fHsMDi!yEr5`UK&1@) zZdGnn=IhfWGX8}p7VfmT*A4akzt8=p`M3_(F1`7=t=OH>L{Q|ucNMh~Go;9rZxU?3 zY*&^RN(idP>he5p$@5r@n#HXL5_XX;e!aVia^A)>syuM;>f3WJ+G$St34(Z=B+<({ zB`ystM;?(~%Sqxf_Ld#Xq{L;|7`ZqcM@fs^OgjK7gPZh;PpsI2?kF|lRwL)<%+@s!k{sf7nlmef$hk zym%mIh#or$y&7fzR-B>zpG_)$A^0Fx*k~B0YYFBm^drgq2SvQK`_D>Ja}uieD7;a; zOFyEvWVoTtbEb8-+T? zN`4TvyySkr=V}kU$6t<9{pwIm>7F~W3m$v3dcn;&k^)*NDh-qAz0%80ZR;m#Mx-T^V|zk}tkRpV#gl6BU`FHJlvvtke` z(?LM3>@spFeyR=n>mdR$>5M^SB3<+Ty0baP#h(n8QrRrC>n;z2P5CqATV-v-S<;++ zm>GD4da-0$-OlW7P}X06r(Djeeha5wAYO1eGfs`5&(|GL$_}(`A1cJ#q0bfWdB{AT zpnk;OD|}(|D+pi7N*K-PPUcO&ioFpvnNVVN&&@WJs}lx5zv*PxS!`YC(3I*?bu1sz z$EoYCM`!Y)j-j$jMUj1od@4Z{d501S*{|xpeVe_!k9!f}0h^e#;<4?rmik8N^=prH zNS>8dZ*04`9&9~u1^XpyzNC7;6V_8y%76-%<3m4)4_i2nXH9dO(1eIkhTRy0V-n)0oU|tSGNIqS z(r4QGjBF%3vEBT!G^lby19NWk+RKvdbhO@u> zOjZOZmS=b*9ClRLKVGWqcm+D-i3+`I4H8_+y&5QfFk4h#!`VfHTw2-EV~jGF*Rmc$}~MXDbg~apPhi2#2OkyCxHg^y)M9>S8N6 z;`Ux8j(@FsXYQI+Z)2B^Zjt~{|w z6)(A;Ln_ZFFScA!M&9~diHY;hm7(SyWSKmT!2P|>U){Du99OrGvQIM1^YqDpnC)}b zltFj4Zp;`%`c1Kc43kV?CCqwrYN4p-Q<7utaV3Jr@BE6VLPOa6ghETASc^&8Rb z8kry=OK01E3PyiGKTkOhzNxt{3q+2UMz5{%dw1BD1pA{Qp0tTf_W$ zI+oGI$(+0ZRbE+5yUV{U)NqD)uJ{{g?n z_TPKFHI#niH_6a-|9Ou;!t>Hyp{INX4+8@~S*)HO14cDbLC2&XfO6Z8%ZuStUo7n{ zQ}mvJ*VV?VlSiQ8Ps2=n@mQ9kB#h8+jt{qNb?Gvi%+IOF&;yw`O{B9uLh{T}Qx|G0 z^~U*qw(tm-A$=DP5cDuC>U~A7*}B52mwLF*D%wtv#uEsGy#H2WOX~lW+vA@cWd(1n zrox6*L4;2|Kn3^D7(a@W^|H0Lo40BGnP5rjw?4p^uvSM2EbMJIP=QdXu8a@2Qyzvc zd~T^(Y0|g5fdO`+=q-FZIj6gN27RMpAYZQX@pL+ z0zL`n_rBAYeH;-QWeKT=l(MR^uP1auNCca2j%BT^rPVvQ*bQ;LvsprNMV;qu&8jiu z*gFTP>@+d7ep<{qE$C!44C+fI_8&G(U3BRe&gP_(RxeOMHcv7x=a*r`^)bl`D%g$i z8x6`@Q^#nUT>}KY4Z}FVE@%$lZEm(Gwq<&8d$?uF+LSuc9J-2fkn0sVXw_?wub@j4 z6{2(TYbOw+59!$o5z-Ryh6e#rPq4qSHivIeOHMW)qruvL(uDq$W9ft`cKM?)-(L2S z@g741s8)7dsomB2oHyP43ks5UI)?7DIb;-%IZk3H%61JLWo7jw>vi^4HPoBVA_qg4 zYF6&ADcZ^0=!MzhZHvklZ)V~=-<~N4wv)}Ei9zTZyCUW~Z;{F3B_on~1^z^uI3N&# zv73(}9BvRKYv-iTQ)3e&=OTG-ign%UEHtrRdb$kS-^^M)wfqN=`O>?Q4%Ih@8H@N1D^HME5}ji^?7!FD^tb&L%pa?E=sX1u zZjF_#!T$~1$neK>qr+a+iVYhxQdwzXSdabnP6IYP;-1OsL$sbv9K!-0edmKnYZ~si z&$thI(d#;2D5P5bn=%f%-KE$$+xgR{4P3X86Q;AL>kYaUkNl%PLpDn@xGCLV2;UV( zMA;`0EDI;MzOQpU@@^1%OpqvA-=bkmERu0{p%wYAtj5zvvQDB}Ohzq}HYd#s%XXwP z$iFe($qV-O0;7Ubsx@h;&REYDxXUM+mmPkYM@ibP4`KyZ9;~oyJqAV--oxB1TN!?d z{lF#lB;40#>N!ex$(*lD6TfFrudp8`8T_2@C(Iwwia}a&b=g7di;%}_cTp%h7fysrKbTD;zg9;b zm2Ma+bB^^%jPsAUGSN(WlJJaB04M4;EFEC3MOJ|YQe9#a#`LOE{~O^Gn%%5a8-zhh zlBu}WbX&#GxvIdst8R^BE{V!*CA`uqfw-s!lIa!CUH&WjHi6h$r88|!^{TRTlY6?j z9bYP0Y@wwsSsc-}tW80k9NElTb+Y2!55Fzip4QzAAA3?|lE=3fbQ59N83vZ^)^*d3 zqNXy7*v?Q$$X44b?Ivup6O(aOArlP*&~)4JI7is))*Mx54DA`@2e9ox(wSK^Cg3nw<#JHa> z?dbMT49^t4x$+DW;Y1lE-l1xP+Uw!7S2{OH25T-Y$m|Zn&G*@S;5aTHM%D2Jg`ViH zbjP`u@ZbpIFb$0-%sI~5e6LKDw2|?jypxl=W9axc=IwuOvnj{Pq#N55TxTKbjQ+r3 zw#BSoDW=GY1UnOaf+Vd|IM1PzOnP-gpmL3FNQS?aET%0Q4%9~DP?xnz540yjWHs@O zhfEadvUqprMs{4C`)kRmVP57Bt+uL2sg}c>l`;4VfR1^|SWp^1K-kk-3T+>HGG5id zDEngh8$gQR?NB_Y1eS@_=h+R`|GSUWieXp&eEw(Nggc=zc(U)a zdmw6$;?%yc=C!8;8(7m>z+CXM#(&Q2DTVRQ=_lC(I}-J>!?(*$PP#jy&Cwfk;z855 ztw}QQhXh5^onC@?Kfvzh@$hF~rnkWuQ~SQ@#s{ug+1Abo#+WGRv!VmRRYBUQXqo>kCza1LGDLdc3T<0RjD%F|SL|VYg1#;-$V{M$lmYYaXz2!K40} z@N1)4Ygc7n*Vn(U+WSF8A&oP>l-;7qTS$6KY#*|$A(^9AHiQsd$@(HR4TVeZW%Q3+ z=>q(S-21J+8eB<|Ir~6;M-z>I`tSJve^b}+P;Akyim4K&%Xrx|Css{x1`hm zjT@e_vc{4cE6a__DQYyCYSi4Iva}g1vYOOX$fc}Y$XyXIv$7&{E2-R4D=idUazla2 zU2_)@H{1{rR}hue=QF?Wb07EpCvY5aab55C>wKNasyE?b*J9t`BkqDjm+z}`2yy9u zPmtR4B7%_5A?m+xik=nUyp~o>Z9T%B_O_1$-#;YE&1W$0kdkk54~wN3A8%Q+R6BxHA~{+{1&C`hGVmtSe`*g?|w==6{qhQ@*F320)c%)}u!ouFzB5>jn(WK;bkM7fZf~VMeeC z)v680M7vtJ{2;c#UAd8VpI^xPSz+@7FI48@>Zp8+ zjPiddMJDJHZKQeF5>&>ju0{cIpN-e6t=F~bCxCKA`j7u7%DdHXgPA94xc|a{bC%hk zm7rqzW!(CVB{IUS3+9$f>aiRuTc;X$Kx)-?Qr{kz^nZH{WvR2~L3+*d84|Q}a%Sn) zXVrvjjq(ad+cp?g(nBEnD?f5IO6W6A4ybOaJ%@`G`M4u`V>%#UMU;RE%Jr|TUtb=P zFA=S3OFzZ}B$)||Za{m|M{0qOf2@W_B$Ld~5d@o*Hg=LVUKhJK&U!&kQ}r_$C$ zByY(LWYYl+Ka8EGJ~*fXM{q6|EmN^sKnzI zNh2zH5KrU%k~W`GbJA(K0oV);y_wr+p$3Hi&IwJG@}otUlntwduhwp z(M@4@rEG)3HAsee!Hku~(E>us?71-RM~TrI^id{lNjrhR644ftrk6++c9Nv zj)lB8!39BQ8$I8(#?olO_e$B>4LYL8XY>R7?k#UucR@3OTNqE@GrJNZy1T(*xdLcc z^|9O@rytErN9DuHWsbOZ*9^nH-6v3&=j!wGnuQf*JErY1lkKL;eFvdfQP4l;!!j*b z%?KXSW;(?EGR? z1p3sRmzKIgIm)Y4PRSO(>>C`GQ5KsHXQ`>$fX-A>rF0ZLp#xei4|o-;vzycb11}20 z%cZC9`F@D)Mfb9o3OLt=GQ_5cdRr-Uu74KepZTyh_MEvMAU%Z95_DNkBw{}OGl{h?IeqH$bXy$4?T2sI?!qoO> zw;9TQMG0(pm08X8GAf>p2r0(5&4TIT13rMfw`1dFikx!dT*vI#TyQ!g^T5FnOsi2Af?g|&S=!B>+%m9+ zU~9~kjlhRyNKv>~{FV}>$R% z>KurR>I^;eaLwZK>6)NpUvi-&O+$Kt?DzouqfldpHS^%%7ps5rGS{gle`#3NG{seI z&{c=QSFvLfQN2f=qO?)CeFN|A*?YFre~!i2rdHA>M6qv)zce{KZVShiy8K!{G`wIG z9c++7k_evj0M+Mai|E)-PqMr(hq!U z5kD`gwEqFuVNo{?zF+F}b@d;7(j|-7{?y&lRuk8+)~|+TRT%9ha?LR?I&AcBO+fJ> z)qEc6HCLuCI#@DSf%tmIKV)9|a7tC$j=DA@YT@eAM*m*EEuQ43tU)H=)eZNy2v^!R z0r?Qy4ZZ{_e016r^`RR0+t?thXQ<57ooP(}qigr3@C$AlzQM)CW|Ja9sS0XlCzcQ@ zRJQo6g$9)OnmhFyiM6~wKMxl+I>~?mEV+cJU8czyYyOBUz_r!T`e5hs_`jsh5Xzc- z`XVjz*?129HWJ+8pt)=px$4oIX7v)W8L2PT%O9u999gJgESiZI?;T&=Kp!q&M)ztUdHGxbU*f+ z$kF772j{C#r>5yK!C)Rj^RjAna~2)D`mY8Kld+2p#j8pOLPeg}qu50jMIMY5MOjh` zJxqTdlq*TLG4KRZ^Y8VfK{Ul_NB9d7G2Oqjh zdI?Rbt(SPbd~k6E{3TlcmTVp|S>GR_5M0HJJjXmK}7dgj|9 znlE5n49$rLw6mkn)LT(k3@dN%_?_F&EmD=l48+j_q%J!iFaXD45it-;`rNWDl22y8lL!9T2N^D3{1Vx8X!3(?ykHU5Ao3JRy0# zFo7+Wmw)uuMjXpjFr@EwDZ&lm8!!T7WJ#0i=KTHg8PJCDy|}QbPs=sKKIPJvo(qxl z=j58G!!EEAS7*Z#8brKhG6E3A$R=!TQF~kp*SyfiW>72Tw(N1u^PGAgR&v0ew~W zwjyw6&4yocD+dt4Sm<^=h2@44;jKm%a%dj}mb@;SX@{I&ST(9R6}K(%8PR}CR-4Xj zf^!PvP^!!HIzGj^1?(bJipnn?hFgTdSrzyAUh-G^V~wVB{g}Y7$6~U^cG_B(xv!TL znGW~A-|+?V+@3G06+x8-)|^5_nXQ*|wXjyk+Wwfl&W+RV;RP2UmG@^e@8e#xCzstj z<8REDp}11WK$KRd=e%CQc$NK-@7%3i`4G-+CZsKktl>8NG2};k?KB{H;e1^6knbiV z%Y7@pb#!RiNS~<-zKgOJUMsAe!ENsInGO-=?EqD4?;Kg4zbBlAx%`4waYmfC*ygi= z#MMh>G?};oaq@YB=(A6Vd{C$231wj?|ENlI-QHLpZ^NSZ4o{?aCM0<;P3-9lkALC7 z^z;M$g`R!;Fx}PK=f#~YQ(iadOa`f+Kj6cm=r^(HH{$J%n_hDTm>E~^mwdl|>1I%| z|I1YZ$WFRH($%nPuW*|SA8L9Fdfg{xX<$C3wQaME`SzDSKQ!+X$TLJaHMcj%z+Q4T zK$n28BO}uYT0c3@?(TGgPsQ}j8evaKY?a2^z8?%=g9P%nX`S1sZS{Zdjs-3Aetr@@ zDiE9s#&9~fVSa?K_^n(Fljyxh1>G?Yv)M#%a;#Fbp;KX=-i#GJPv15uE_iVT^RKou zg;ukejuIp-{*AhXyCk34kHv_7O99(V!@Lt95JSez4CtEQSFqiXE;gHnw1c(PA5O(r zYIiOt(?aVsdAiN#@P|ig8(!ICcI>@@YDzzvA+n#mcTN_1Yct$HE^0yx&qYqUuJxrl zRZUWkIoqQnl9kW1g3NN5M=RWGMU?j0b#;d5!N^X&sFU4huP0(MoL#~eTe7j$+WTnJ zt}4m_6t}pLo)O)s*{ysD+!;}bFj|apUu%Ub&42gFV${n%Q`(%uBONq?t`#sr zyewlk6rh?5{~t_vZRzq-;(E~0G#`{n^UCQ#TN7#%7~3t^gmGxiEhpZPY%k(sLN^QI zx{%usk^;Pk-{BNCdyE$XfC5h0*sxyLXSTQe7PE3gNUq;@oHsr0k1Cy*LE`mXC>d$F zuf{XyUjJZiApneP2GH&#r&;Sb=I3eN75&98)wafYP(Y`*NpE;UHJd&{C;g&a)=P4R zT~Z`hJ`(ktrLV!6k>2hJ-RkrSN|v2!%D8z8qyL43y%`WxOiuqbX^X=Qd03$0gBHwV zXj9pZ;n!Zsh-)mKUePG3vP3sQi^h%Qb7e4x%jq8}MaOn8 z#v?4zVZcg~V>vuY3;mrjUf<6U7*APCP0TQ2v9|_796~&EER}nn6?})c8gB(j2j*8lwM-AhHcW7)SSu$<11&}y6Ddq-VH#l)CW(TXP2g@?_ZG4t{E zX#Fu>8VnW%lV=}&n=aJuJVNng#o=dy{6)>`8RQDLx=%(7nYv%;xb5JyqhVE<1%MVG z-<~WkX75e#dj<-_E*xZp$WQljr(UCIUo`u4h@$Unv`eea+v`%a)&#mj+v2HR_H&Nx z57dJ1Zgj=F6#fa6U6a9=V1Kc%+Xws9j@hcR;*-*z;DsvBYKxNj{_uv`QhQ3&MK{Y; ztRG_aH{G97Ez%mYj(TIs*3DP7J$lI1uGdE}-F(;g4&CMg<4wpJ(-b!8U=7xeb=YDW z6V~w+32z{8`2+SUD)=jA24k=Q5@>5=V&|WVXf>0BJPGeHMk7tG^_V4rxX@XUL5Y^g z-YNRU)Y0qX=PY%D`O;?U!^a9SdLkKvwRq~D1MvOL_Jv; zkL5>y?z@>W+}H)Q`1B@yhLMPLcFpwx(#;3#(R=6_3l zn@k3nsOb0|v^=_dhP&Y%)gjPC(6IdVCFySMWB@_}G6W`g{2t}^EKShwpd&>teHZ+T zs+<2(mvJMXeq8xGJd}(SB1#B=6g2HT>M8E-uohwN~9Pi_@7qu6`D3!C46OdXR+kEe{cI zoTQ57Rl$jLnegBF)6sISzbi+W3d4?6zn46we52-fij2T6JH9bobZwZkczoC?X z;uC+;7I%rh!}kb*UaSqm*F(auJ6Q(T!xp{QeBJ{SR|JN4mM*;&EF~}_&zMr$``uJy zq8|5$@x^y&9XUm2ZMCw$+wp;38-c=rQIXSdP0j9z%#4bc%vK=kO`chqW^kGc@!3mQ zl{LFi$dmm8Du+4m9Sp6+2}%>t9kv;untjuVE~}1Cfy;-E`ajD-{dxTwvqI&%?B&U2 zA79Iv8v~`B@%_P(y?H@CKGDF;KSy4B$D)}M{3iG|v})q~Co?)T_coC0`dvU;Hh*Wa>Ukn2c15 z5ZM){vgne2_s%Usb^nCX=EgKsXM(~F_3b+7-P*5H_V;n@fqF{AW?jBfQ?48S;4qUW z`8NGKx?p$=dfG7K<803~G;@_>ERsH%AcS@<~$|R*#JBXT*_Mgyw^vxLHrwz0PMsPuWlHVpIERfmul`)$-WIO|*V z@5Aixw#>x$2)`wxsQM?D>o2DLY>}Q8@DT2s`}{g?MD6VaCCjfIj4Y!`PP%`!*xRbM zfC-FAm@Yo)nbNBMwsgOd_6FW#R^#;3TnNj3jkZiarVqW4^oF+$`>t^yqJAO;>KpjQ z5h@kF8}D%nUU?h}{Oo(qBj?<0ZO%j$R?K^TxrN%$6B|Ok&MW-@8Hy8qsQp9_!(ocu zH2=GPG3n!1n&zEU9^pd z!z?+!@;RWS!fn0oO1slY9B9RHB^s8pw>8`1fUvY1%a%r*0f=B#S^{LS(h4ss6_Hj_ zeVqs58DRtP%19tW04OQ0ms4A#pRbFLQfB&vX*OioT5gAa05enOAmaLIJLx8&hBPW{ zPiYJ@o>8Mwl4m*Wm&IzW4jPFL-iVue`x3-Lp6^|3{Dk zK&iRprQBuY*Fpa=z0>@Uwe4%|weGeUr)V~hVQNfIX6#>Ep+|{ItBl8@r_D3&u=fw~ z04QK`Kfb1Hi&0z#nruD{q*a*r@X~tw#gx+}MPh?Xu%yUC+DQLpf=^AD!Wo!O0P51^^GWr{vmm- ztbaZ4To4~AsU?@dXLo(iEmnK-PXE9STm00R{UUT) z`|FXA?Mplxq*QElJB)-5h!qef@x`X|AD^mSf?r=uK}dc{8)K5jipJGviQJG<(x(Va zXN`4_DJvL*bGgK*DLEJNCHKa5D|!sl>?V@FWM+SC>AOc!Y@V7I8z(;$MmuV!EW7TY z>g~081UXb4)Yjf)?!wNEJz@nT#U}*C-7ARWU40=MbgLI#QU9!wu(jMI&@Ck>{}VDS z+q?dhlpE!*oKtRpoF}Pgfdn-IBpsWLZSJX}Z4cQjv?#Tbyar4(nuhRmY8*}2Ed3J&#`U;JW7GIjW@aT z9b+-|2ie@tIgP1&MB?%f4v^U`X%KFQenE{jnheot)gUviTDK z4pWHjP0+Ha5y>3pHFhqaw~l%XHcJAZ>kIK;dN?1n?pXS+)#e7!li6oMCDF?V{%M~S z5l=+nGfu0N-2b9ngHxopC~3|zYfNOMZOL?jm#h0tiP(~Vua-CIab3>);R~3j+7pu8 zZIZ9rXiT3suf{;a41=~2>dA6recJvL>s{DXOWtPBYYBSd*VYqYhWLV|UrQROYW$$B zXX^kc7wOE(8+~UXi1&=#?8xzvfWgXdP8b!^AcRpB*m!csL30)XtNaGo7&08eykhyQxTp35GwmPJnSW|5M zUfTag-E3fftkB(=ag!F}h(|kH1s;eHo~v9Gm8ndU-LoYAkq*FK@e$TkTm5a+Bol0j zwlPm28x*twi;I$Y?TsaV`yvC=)H2c<>l@tQ-`zkn`pe$@v+~p~)pVvG^dC09hi}mo z`xDk%ZL*Ag7j7pou1E7PggBBNIh#Usp9X^JCTf?e578Gd6xH+|4|1Wt@gy@QWbnw~qd)f(b`T_hPLh*&{i06lhb44<M&_Ow~+Blf`2{cYeKP~IY|znwz2 zo!|K55C%qi34 z1qm+#uei~RXq;Pg8zZIm%AZb7Y~Lf1k1Bk_BokKWp>hIZQM>uNISs-{Y&$2Li0YUW zvff}DGkj8P{?mB$@$V|lyWP|7i0}IUJcK!e;ry5$b{2f&4ask@i)0+*FKT^A?+VyD z$~$uwWWwkx5*fJgBIu8ok&<;twh3+=;_dt5hMHVfERqc1cHZhie*a`0j?@=e3(m1Z z;%Cet^0*U^l)0rj%17=U!!HRS17{!tKyRp(U zh6R)mXfogM*EEfSj*L!- zwP&bec7?wE-k@h+fAY?IoiP7vGt{l=CdIaDbZ_gB&f+=s*S1nZcHE9vR=-tfYc(M2 z{?(oNuKDaLo;49c%2TJk5|8Jr88+D$;PuWaiwZRH(rML5&l}Wx?bmVrRMf%*DgbjO zdi5Ak`f+!gpSYCGIO({emSangG=12|WP0=y7<19sD*p_bVI02547FBNJUrzY>7+e` z`~~l2op_?arqhM?`Z4eXUSD(1od)>V`PEIJ0t%v%<~-uh-7Q>e4ok`+xx&$fg2EwB zc3Tgs&NZXHrE4pKnzen8rOR$NF{% z4L+8xUNWe6mpw;a5Vvjn**xozDFbU137kT$lP$29k7kLp$ zUYd*aLkRAId#|XWbE+HQ_aWBP9mem`9pZZ8~f7aX@0C-OG8XkB9ymFFTdDx^#I_ z8{4zX>W9Xdy<)HQu(@okr8+nl`v5G$_g#$&P?jxF>X_Sx`Bt#zer(vJ!OIcJ* zp|CrWRW_Cq02AwmW>v4WNncF-aXnBCNgpz*|IvXS@lhu8tZ1?tQyoDJ6%dtu&VXNr z?4+D@h-i+9UtO1lh|E=(->$|9Fo~3Hzm@i<-sImLF8h^KDmJ$k)Ky<&ykI^6#qUom zTwC_w54AeVG-{?=N}|q~p*$$Q$4cDgZCYf#IUO?w&=Dnit++^$q!iYqeEv*r8bnP< z(8|Wv_DWbT%a=euBlBfj?;PL8yMB=uIWCUE#l^4PcGXnyeFa7zf@gE?k24C#i)l1; z<~*yYyaA!SLCYxR*m!19CZ%rNw%AZ=SN|uYgt@Ni_u8Q>Tfb@)W^ztBbmBE2hPuyZJ@yoi8Y6weaO%OeM2c=lrPflnvn(4P@XqzWYN?)i?E|p4u zb#0YM9x(Jp!rDESJN*y;ZxFdg{>KbWXPq)$ydma$tf#VqlYL6HJQCIFk6Wk$d1Hl|C+`Gv^?q8NU%JI2 zyevC6vOnR+WCq+<{WX2-?OgbTG#AofP&a0)EH_J4%aR}LsUeJSgQL_9ip5s zqd=^lKbsoemE|9}**mo=BJN77NLf7Zp zqdyFzeoXT<7D{~$z-HGiOvr6y559Q=P<~Y=_s$xI=sVk713^Wl)cs15Rv7&}nkT)H z1th>SMaYb_ab1!4thSIOec8sHfwCqK>}_Go{OBF;U)M^q6r?D*QBgC!<65yyj~x9q zE5>`FL4y+w^wUT-n(rQzoHIkXqnA(h4mV{Yj#D$V`sOqJOh9~c zw7eo(KKs)HF{|jx>;U0l$_PU{+_+cAK2Fm?D?`7FAx@d_AW3Rgw2ZBnFz-hoOm73v zFtZXoOHZ#l9zRSGjo9i>eshBD!`(Ltc7Jfu=Ok_xvtVS;{=q5E+^FhhCwR$oZ%hAz z+MDLnEK30cQ$EUjrrLgi(;8=!sBLIbjd4?XCZ8MVcwJ^<7n%H;ag6aa{UYsfmW}*v z=||n-W*|C!Z^-h6;((=OQ&UUDD)vJyeUA~LJX}an<*aU=3NfiC*;NtY*VOu{N%X3$ z)&9QK8N#_u67?$kWmQN9@9HIY?U6W5?pSJqoc8W{3>t}U@kp{+!;(RYd$zoX_U3E# ztz>GoPicoeeyT+9ZdZb}t9b0=)t?{F30vcUQ98oX$Y>4Y^b+ySUNC6zgDl>*hz33E z^Wb}gj`qW2u((^LOHbyf+^hu+t|-z<29=%KjyG5ej?&>i1){u?^V+v`;qv-v`|QZ^ zesk`g?a}@@8kT^(Xr>uqkvNO1qRD?1*f<^zGX&P#6mZk`69=SBR6&N6tXAz?P0jqA zS=CfJ5S(tDhMTk-g14eU)!46#ZBd(^EOGdG)=RZb4JW=1kE~oU?}&3ex@==u=i_7G zvf@@@zvx899uStrh9s9ExiNmqZz%@GaF;L+5}Qm}W4a76tBM&vWUgyKw+K5-S|l_w zLe$7~QyI=+S06=Gn}_7g@s(>U`g_?z9Y?3;)v?AZlTQ-)ft%<^rJS zp*z09nKSK%Sr1dzLx%Fz!{WBqC4`pkvDz9b^|;iLCGttjkV?R_YTTOGf8us+H$veo z?CWiL12NBxv+Cz>?tIooycAf!IF_#+NdK@>n}0*vN_?YvNg*CTcn$vBa^A;9tHX=> zOk4Wu_FUp6repe&V3bL+8IgFBv|q^&T7KyeO(vke`PMnu8~cj?&*~)E(5$sOkG6a2 zS~%7#R#fgD0_WETAFG@BfM?-DOB!SYoJ|UGan-)r2`= zNktcsK+o$};Hq)B$}FsK>DbzL9kVczJ~6XMLAuJ#ygcm59qc<@f_R?>ThJ;Cs3|Fn zvZZ>kC(T!ijy)HDP)92g71J*Ep1*V7XbTG5ox#n-5gAQ%KN!#y4U4#*#&ecCSFAP& zqj1A=Q9tg7Yrv^gE(BHI=X2_2=?00&e z3cp_{5fOGxjpVlaKe;+R&BW5T$nKQb;m}WI?Q~%tF<-p7Gs)a4dLRX)-0$P?vhHOg z7;J}?hQDNyLd-XN*&(`U-NU!YM9NHDyYMT8aR75&@IytuCE^hjyQQ zze)5Ij3*UR7vtr7CvxY_=vPCd$N06D+_91rNM!N)HRdVk8*x1vUr_2EX({-qJ2g3Q zm@&8Il|S~H4LPgJQrByx+H@~t$t=vm#EeKVS3#^fOrFV*N4H zTK%xz3z8Z_*y>tPQ`JX2Q{3YY#EfZH3{he5;x%(?=`X^#B>TFXt`ZP!waOAjOElA+lKLLTEJEtK2LiS}$}} zrz>kuJq?hZ$8Q!T`SD1xqNEE35|U2y{sDS;^6fIR0= z=&NmmIzwvi6|Y^zE1N6_);=a)!nL3+7xxXf01`3@BfYzN=kO%3v2gnT_h`<=wjY|* z-~`;>@gaQnM@tW9+xy6;jGE5a(9qQ6=0a#)epNA)LMu8$TRnxmU7S~HVGd>ez?jE` zB+(cD1&=ckhv#P;QONOm;!k>F*nw`-nY|IX%PkL zf)ZjvW)=KrwYm^h+#UT61tcbAeTzmjp;hJ0Igo1=fs)bXkR(+*aN<)WE-xUz3d5zN z)6tKaw7@gs`0BtgO@zg#(hWmdU9aOLTL4x8II(G&&E(m#nAWHk$aD5oY1Q%a9V4hU zfr$w;3$dJil2mQ;w0oP}<=1e1mil01N8OSMK$Kb!Lkil<&bbbxSYv(gNd-Rl|D+_u zBiLKkx^-dA`_>v9PMZv+@HV2Pn=FN`7{S=&_A0#{tMBF8O zH<5^m3gl`;eanNU2EVfDG7!u>v>&eW2;LBtQ>wK#BZD95Irh-HZX7@pfxd>!gn|mq zVAI5B5HQeD_z72|Q=z@I-730r%j&hOi=3SlY;%{)GyqDt75~rz#d#2E({6@8{vjdA z0|EzHTa|`LnK7cKj!7Fokfkd zO_H3Z$KW_2IdV zus=Roq+v}_HoZE}cXXe)9UZ#cr~^{R#U%d+Ndtk&CuIbBEM!Qsc=j@#`3rMbIl7h6 z)FCsU9C$;?6P8i8ci;}rwG$Vz5^;BwpVnf*HUC4I1yewzdXt%zZcRK>El9A%rU_=# zyBt#`%Q}^*nl67i!Cco6l82sm#{ndVY z0ZYH<#1d;lp-|bCE!gXEgZc{vOqVwO=a<>PtuE#2ix36-qp6&j&wCVxW>0N?>)?`i z1xK$MYYrj*k$4@A%!e>voU&pkILBiObYik=E6yeOV1Ods$w{4%JnI z%Y!Tr`Fc`#s4L1viR(tCwW*i5&hmjF-7Z7! zKuS*Qx;8K=Y?&{Mk#jgQ4+#+{J|Wl2@(edUziQ41@>Oo~i%+G5a_vz)}i zVW!I$Wu@>SnbrwP%Wz#-^mnI@zgpnD|p|^vLeZG zhxQ2N{X5V+!k03P_(-&Mn8?eAivUg35i`+T!7po8fY6_I+U7i5SY(P?fuwU$xRL3%Lx=}!dFwkHplG`=ccAPx>da*${dUP zig>oxW)adR=-W3G;y zDwJrIoJR39NYHlO?k!dffM|LWj~*O8`nWYZXLj#jE5;J+xlHzQ_r!?yo)S7Gi0?Ly+u^!oK++SD@L6DXG{)R>YUy` znceqEe>OH~F(b|e)MfC<(V2k=DjL?)X=R@Nu`aLnf??227o@s=ZYcEh>WynwPb+Yz z1iH-=`ImGbtG$3eZxf_hrFS}{UJR3(1mH_*oqV8`<>lw$X67`H#yDsN@>S&B@q?gg zL}Igt?_YeQ-%1&~Vk|GWknkt>VLl&(2GuAI^i{MQ zfJZ||3cAVPbFKYqoypWM(CFb6*)}AFA=;hsCOsjS}s+} zhs%1yOW&1|Y#f$tPV-d_KP4j{dFDWHOHaJfRNXkgsI^A`27$L; z373plp@A+bNgzK-kwXf;kyG~=hXG;Zm|vMF?C)_=C~DZOtt-Z2WE zv1}**edKLaRb8IKGNIWCi~oKD%a3W_z-x!th^pg=S$YMnz;?PN1)6^y-`^N7s-s+r zeAknE)jh&nnSc1w6g312U41hBiJgAoVnmQ*sdb^FWrW|L8iup?%B9O4!h{`6i1o4` zFM+xn+j9g>C7*+;7uE}Oa@y@YpE|^WWW09xw6)7x{1DoYcXRdv({iHX#(M+G@a$FV zYdGwiiuQ1NNs8KmTtKJuFTy5nB7XX2-X!MiBsDCW2ytQe$&N%H1_d2paQ4qbB1q_1UJ{xCURrlY~Y~b)=4((Y0^nZT5 zLMXUESpWKa|2aXTS-O*QXcfEVd)pB&G~XVC9A#+<)pa z2P2EK+k5tZhJIPCzk{^#?7n52l|I9I&};W(Jq};}Bq&K&bmr%}&%~&povv<%K@V&t ztpCE{V}d;ArBhom`iJ9Lm))_Sb7OTnM+tOC#6(WG{>b!R4yzV@_6hn!Yg}<(eV0|) zwKSc+bCT^zjTFeFC(+*bc=7idHIj8py-t$9e#0tntH2iP1yo;up$PbDt4_fW@Q){Q_(-Yaf7|CS39(KeLEV7^3c22>)sFM~63V zx7nKcL(ke2y&IHaEtXT$az6?fuvE)%2CPZXTQh0EH}O0i(<6N}^Ujt%`dcLkW5*S; z6`oSG)P3OIqTkWmq!)nPFPAJwz$5t@AxH9GxPe04~2Q~ut3*-P&0 z^LCjhW36c!K-aS^{(?rEa!S*6zjUa|_?gQn!>p*?iR=br{&K^z*e0v!s@j0xfzalp zqq;IXi?WI^69zhuG7bl5V_LeJSp* z`(dvLQ#St;eAHO#dj-m9zb+*2Dko!i_Yxt-m)!k?8-aakEFOYkD+pS@9 z75JU0;GHDBY9B|RBY{+gkZ_|lzQFge_MbVJr$43dLG^#J2EK(wO1%cs{rsm4k6*6H zJU87LrSP02=`jrv7)d^cc?Wp`KXnb1$Rt5VQcBP9w(<^a3Q{WiW>BVqP#`7{Qg4)J zMfp@Fpr4ss66^%Gbo7Xgi9jyj=JDp+u6&k%ermvj~#rS)HM_uhbLOB#apt-GFqh`YB1Xm)9&uV81sRi>HC@VvkFe3y+ z{_$MR9N~_nOXfCsl91LY(FK33kTISIq3JL(R|uB^&;q+LuNZqXxKA;Lu956mmoaI> zEszQ$c`mc)=d$9SYU2)6hc#x#Mr{!j$Fn{~34dy1#MxuBHYHtGMtjdc9G#h+F;v%d zXo3O+Eb%S+vpy$(U%6oV{NU}VZTsa$6DK^ghRwWZlsqcSR%QH2J zE*4h&Cw4aa-(cg{<^8>}#p>?5Wr5&C|ITl)U&9R~iG%7NOI6h3t9Nn61zv9(?`6GVPU@Q z{*r|Xv~(*LIQWMq|J%W8fxH48xA$B$1W#Q4Js~I;FkE@|LXIu{YN26 z(uHH$vVPjWthNL^&2F(`cQA~^v}Ux$dvne#i>7W&&n~<8mCvc+=6F}sZ$}y)w)2Vv zO2-VG?GuMYHzQktD@ZrseEmJTXF%tA_>r1s#(~vKl*^dY^KKo!+|40W_2I;|BH8Lt zVX;z{{qh8!1sB+_x<@? zmmVGV@Put4#8QXvE1&8eJYnRFcu)3AR@)d&1v1{d2m}ZJtK8myJeeI^hF-Z`XqdVN z=$O@;b{0|;bs6bdNaLrFHjA$wz*j{=Es>xS`6hY*uQHsZ_~44I2n)we7uVJaoB*-4 zf`Ca^YLKkRbXx2S^0I5M3HA=1SxAzdg7)tLU}JxZE7id#BJyKy+@kqa~T;XlY@<^7rZ4v&)}M6ICP1H|TrwdtSHLrW<`UKK1XX z+R{=V#n5sb`U{DqQYN!ywl#C{=rd+P*#z;I9NW~dZGd(-Aj;ept}4AIjm>`)xfGlk zBID|azmlq`b{qSIN^)TbxCDgG9%hwe6SQkpA@wMS_?a>|W8TVaC*?&%^ofv46ip*p z4=e22^j629P*G>)T~#-3+RqOo;4BA$?h&hU7Nb zE$BQ_bXIc}K^J+p(DKZ+!or$?5!xEGE`q2Q(ge?)UF7~IA7D4gkg~UT(*kg~HMtUN z(p`$%au8Hne^pv<$g+@2@c&Qsezq&lC~LW^GH>Y9@EB&{+mOEtWQ1gnb>=&laGEb_ zo@a8+|1!Oh$THhD{nKMb{wJjw{t38A_+_*F_{=YpV^?POY<%Sya02j?LNYjUfcHta z4mnya%W5wMGqH9^&`;v%&kZT?YL(=?c4h8MwVqp8Y&WH5m<`!2NeiuQdq2`R6_@KX zwSu$o2xDc;Qp>YSHh0~m+C_ezy;o0LxzXGC!Vf-JpfGEKyTiyyk|=-YEyRqH;Qau* z=u!*NN!z0cW^jxW%>x}NjHTpvLL5Jdj7}wGhpmm8@lE8Z19Wa zchZOBk3+~e?y|2$X15dA-kPmAJ(N8fltpQfXUrOxd9wGCw#&AlDDx6_3$RBQ^_&Ec z_?4-22=ERE8hIl)!yV&!iMw_nsqg`cY?QQ>rZ zo#|DMDOhOL^TU013@Kxgm>-oVoP2%lKL$f}`uKGXi)GMMRLLFnyBblGOkeP}K3pNB z-(CC`4xu&;xr*NEyBvI48GdrEHjrGSCu3%q_ z^Yc~rVygp1{?tG?$5BEGpR{fH;%R_xv~uQO*p06X?0Ua^OXNqiXQG?jp&>uSy#F+^ zUs`jMz5IEvz(v=iia5Nu(A}_e@Lv!ic#+Y6@sZ*-y-4~?Ks*fp#RuwDr;40^*2@aW zjS;-w1k#bAe|Mz|%askxBs=Hww9kV;;#I?ykP2QsGrPMkrdf5*ROE~MtI(Amj7oxo zN+w#%F;8&Ie-yp1OXPWBizqUi57*Dpy_N)gSFt1EF2``518w!lhiNI}7o2fR z*ib0L=^RSF+e4h#p#uYK`N7ugTi?LjUQru1@(jX6RFymz8lfGXJr+_4b2R zk0((++GVG*l=j2!rR0z3;_z5Gp)ESHey=qr0JZ2piR71lSL`=z5R__~hDti4L%`Fx zw%C@Bni|9@oj1@=UKUMrgz|KdIv$c^x11;`ku@eQh3)J-G5Du#|YfKISCbQH{Ama(T=HNv9}?F3=Vx@_Ub znd&JkF5=2vFfi1Q7~)WXsQTwy~aj{3k!W#l#2S(t$${F(6crWz} zB>38s)ms$^X7m=DU9TI6DrTNa) zlDX)v$S2#_DEVKy@DMsO^MRti>=#W87PFW?*cACOvWlFAuk}Hjt3#^4D_qd#Y znUR(7^0>0MRpp0W*`__`GpWVlYjDcfb+dPi=-1wX2G1S-;Gr5YRu1Rqz8V+=4o7=o z4hN_@f0=ROnuz7EDKAR(cqw@0pX6KT^l=3`z(An~9laW2AJ7olc{M&|a&6eo`FOX3 z(=x|#1UK~vuRS?wb2mjJ`NQf^fg-KebVP5?KrC99UA7s5|KLSnfpN>p4Fz*=H#7!j z8&#uS9mb1e7W?jb!0{1I9;Jv>uz&T8@crherzq$TX=ba%X$s+YGmGp_bP?@d17os* zjnKqM3T-HzBXiF7O@9FDn)2(z3VdW0_%1h=d>=pJ7ucAzg%C7KJ%(K3 ze|A|47>fg=p=*2zcYo9ee3ZK`UzBalxE=e}#@x)36wull*-9#5;w;Isd*=VShF>P$ z3n(8KUkS*WI+}@{C^`mD+%Q?pnL{oKEagHnwBl<)hUs&o2%{77Uv1(f?s9a&9e%gW zAHNAUT&46J5u%T)B7oj7^U38WuQA0~2iT3>^tFPrjwz7N1C24WcqKkySm(pZ;7G># z+Kt6lEt1A?N+i9M)1;s~l?p;~0Wr(8C-mUY)R7gqj}q?qMR+?AyIUJXh$Mg1q-Blk zNwF?+U*+3%+0=L9U$~Y1hl?QtCIy>QbYD5iyBWKh4k_q>fFLQuho>hn+j_6GaH`xV zXF*3ju*ygDD&a_QGN9GQm$t$ORB7{Xl?BAky?U5KUOMQ=h+THH9BhsY^l8!B9<%(5 zi|y#%HP{18H-X91>xV8`u53{{$GX8|Cf0C+gRyOd^1543UMqJhu}I@G7wl7g!46`j z8hiW@dYE9%mBhnoy7!Lx@&6&tV1abW7r`pt*K6S%Fs5}4G^ny-od&uc%rc^yzg)RJ z7i9iXTu>i1eKc&o>#UiXdw%~h^8q&KX^k~}H^tC!(bUEC;jZ{1!`+5EV+<_=p3TBm z@jj+QBR<~`jNF-FW0GGZf8IW|4Q@CtONYB)K zhV&BBU7g^IySdP&VL7jxi!tfhM|skux=f4OMJ?qYd(&Db3?=Au)-yd}ITBC*rBzjF&XkwC9O%;;fcsc!3ZJkgHFq zgiW0G6_wE77I?@d6sr4au|0h7$`my_B~L>r)O=FWHr+zpg4vZJ!Vk`h65vWC<{}oY zi@YPkF@=>Wunj>GWjE;S)ZKtj$W44ZMQ2Fvs~5Vs5*2xy!(nzpvjbv#yN$FZ*@yqJ zYkiNoZ+MQLQ(OhTO{oTjc)=o;2-jZqUX8;-OPc0?OlI}L$B>8**IeUIYY~}#M{^_2 zP}2ZC1;TvF6nYFT-Wai15?eb3W z>e`Rx?+U^4()HqkTMWQtv8gnrWHZh&0eP;n8)7w&9jmR*T~%5fZ{+y--CQ_36XL%# zu6OrdDbwo^_Kmya>staRpUjk4QIV6SsBH5;Ru2@6%{^70~=l1|;3-D&a?Sxg$=dkR38 z=>i;ueg&xkyY&_ys<=LzP;%L(1+pr1#tqN1%2iaT;9aMzn=?ksvI_wRY$>8BOmy(2 z$u*-Rk_;|X8~tKn`qxf+oJ_Xyv{6>s~1pIk7}CKwy$CDH9Xea?$@fpnT0q z?^z5^W6Jh~+<_1>$$Ro1(*beIlU|2@0i2yzUx{G~NwxB!tO=lYgYb0GykHDH^m2=_VNE5vUrwrTP&a3@!~2?LY!0GO!~qAafQ>r?D!#I^iu!u zxGJ}p9;%1cQA+Z5tPJf~t;HOWN24zC$^OebwV2$2Y@k3)-NLwni4nB!b!OO-WNp#- zG;Sc)4Q2h<<(m-JFMf#Vj?E{Q;$T+984h-BMd=zbJzNr@d$s6RBwxnMbVTKG*GNR} z{3aKfAU~_|sclbf#5Dk$-FqpyS*G+~JyE(UipH1|=BYSYJHQ+jWwa;yj5(1dAN=gh zJ{89Nz=Ahex%B^@zLhRtN8*``BIrWF54VUCACwH1mgy?3GvrsY{}}i}qp+QHNIsXe z{bB+73@Ca_=8rlEFp_3z3|Hs={lA{_mX!Qk9{~No%=9J1uUz&Wm3?DGt2&RUwSTt?1JxRG@OK1%e^q3X@GwKKL>epgkfoMj zf5;wlBhoFUVM%cBQmAD}>*Q~OM?zt|*TKeF(v0FZe#62Cy@5<(>~8W@h@{^%v43MA zNmQ6sa)NAlNrZ>@|7e}{t9H1Po-u@Sa5MKOXh!#?+}?f)*EMq9;Ct(@XE z3Cl`fHtAuje&Gn$i#iM>n+g1%iuWk;M{%_IC3bzpia)OQO?X;Bo$O84g{6nLItY=l zL5Tb!H8@SehMKCGlz@n2X=+Mh@!Fmx9yLyy09vcvQ!JS0zG$CCnLf&MMW{nv#^n7*)I5zy# zvNxunGF{q_&??wml5(@-fO7-ruZrhanF^UGVBz0&_?in<7GswF%xlUV?Y3_T9%Z5U zJoBB0p3T^NyzTd^h_4$&20$C+>(Q9oP=P;PXJzZBLceD)`=}2*Tu=^|1See>%w@g#~fdFxg)7Wn8(FN+?^=t?6{5l z3p(i0`osCtjA@D4hRIo?FJjE}h?CFSC~Urc7VExew$ZP}nKlr>?cKi5Q#`XkF5r^62b@H{KS z@nUpa-rbvN_>;7%^$nAQ7hCAMy8Jc$YWZ!AE;f`wla&gDA*YF~W`|1)8I;m`<-{(f z6@oa4G20fH=2m>xbCi68=dEppHKKy_Sa5r?YIl9@J>*u6u`Y*l>(ZO>NHA%9KMJ#r z&;qpjM<>Y@O*Eg3Qh&9gHu=Nke!1-__;qlFe4obbn0mD4=;M|$Ot=hoMV6K6DkV`#)>(*SrFIXC6c-Ush^;?Gx0w5Nke)9ohm5J02;!fBP`OjjI+pI^f z{|>L(avc$b6ESm@6gM;Z%c7XkuK%jC5~Vmu0l_5KU_V-xnrTBOd8P|9Y4_N#T5?j7 zau1kA?zC&~PRW=G6uH69v5e2nLFNkrGkPtNh0G!VL6$$FTKU8FqFuo-JSb^pYrGMp z+ZDE7$#xf7nDK4cRh8@L0uRM&Lda`{eE_mcp(B>{z^)>Z>l+-+cau=M*XKdE6-&c_A@|eR(nKplE%Mu4%+YP zVV2uHS}cenJkuLaxE*9L$k-T(TAh3Aoi`1=wVz;_4+o5d&*_Fcv|>-|c=zg#`=OEB zn*O*N-#&hNBY85jMr4!W+F*tFXxFcm zlsvB49$X(Y&ZjsE4;uxs=gKOH<6^15k|;7N)5W@~716k_Yz|D0Qcp@ZE(-c8vG!$5 zcSQ#z#ibB^VFv^Tp%2m9^Md0lxT5ps?Qz)Mhcgk&UKpdX);#IQ%9oCKW|%#xcF8ix zaE8I#dqL@{kq=aQ%XX9w#&9ruF)UpY{O}go8M9`$sy&!|{RYM7m>vVRx2T=J-1EpU zPVrqhYg*RW;KG46Pr0s@n;+>^s^pF#dtD#k0_YM-H7Pb*Yx>yq zcT=atfVFAj;qM%$#uWQ__XPT6-uzFlyCoFwA`J_(4*&c$dhG7&yFUA(4>?iC0@s+` zNDL8#Cdr#J39zupnDjNTT%2^%bURSMNnUZo*BtY{d7&tkcj{wIu}7$md*8PTu37Bw zYkqZLOf33^f6w|t)w5y61+rI?7n`%HFC|%cb&aIh{@iK#V;OPal83&y=TRwW(Zisu zKC9`ykz_;}iIW~fBn#*3j>|*l+dyQ~$Wbq{0Lqrty2g~h=DZ#cA#Ce6m@2JAdgEoW zxLGGEQKr;^QyO>`s<00v{fha?YG__$!>xus>LWjotDm7!nza?wy;CY=T+LF`{<-GI z5lLPH^1$0W3MdP2;=B*Y%cJHqQMCn%T3SyW_CzKdjkA3L+8UlVv(J6ehQZBsrEawG z)ifuQ7XD^pDeImwlj@^dUjRrk?98fiK7|yGn(!a<0EmD+wU(1{r`P&R+x5aFsVURr zLx_^wG;a{X$Pds5{e3!gBo{mmxLR%>r1N@E=zmYg*W$O#nqGd>Yu?X4kDuXLBR?qv zmQMbA$a1(ejvO*e&)u^y9G>RG(8LRk7px2&>EfiNf9rx4SDWO+J4rdD9ZmKZ;v>VI z`mZG;{J$Xh_rgRYH%iF7AkQhMn0+q|Kl&@ftQ{;tVVjx6PXrC0pqXv)!nIYyVlK?N z+e;$c|6-lh#laUlT9*SD@t)O^1Yi_s z^$k#nU#*sb`nm3nB>39qz*V_(VCgt3cvErZZL}=4tO`@7{I&I1PDi-(7pW?>(590l zlefLd;kt`)OZD^e%ik}QMWh}PL{h8WPXbo-4zfMM93#!rvg+qpD!>y!`79?v6bfanj%EXMWS|hdY;2ROjO&nMnEbiP9<`*+T>~1`~CaDF`cS zHaqrjkorW|23_v0C*FbPVxK9jjgc1W5#S-Vf!mg+Do>(<>m!@=F$b>jxX_7sx6*>nvr+Yb8KTBe8B3?8p)wsF8ouDyN9^VX=|l3{>KTOY=rB)q2a#%%F!G-N|S`zT$p)VT2c@9g!ENF!E%=m#*`fM_yCHB%Lp%AlbhX<-^&*Kxrwc zJ!QO<>`VBpVzJG2DnI{Ge+tEldaJgA`!!=$LJCVxca7bDKxiwc-6ZY~NDirpS><&S4+%fN&*vX!O>E}mpI*vavR%NNTGwm74| z_t%PdD09FU46{!`NvRq)dv~X$TvqD`t>Ca~a``|?1UcmOOH@SUamP}w74>6XN56YC zjA9|5T|-^R$(JeG-lZkd*S)HLM0hz#-!iKm?vYP~*CM@W;@2Z}gb2Mn_A6HHW4NLG zJ@f<%^4;WLM9$p$uxEO{$eq5l3F5KpwW^&G#ir``u*+vj?zIVzM&3FpD>D$`wdeGG z?dLY3T??Ug9xvIhJFUXC2cz`b2(^?FbW$MS!$o_hBjx1WZ<8U7r745w^ntSX!%hfU z8g#W&NIN;eE~DGwslV0*PW{u$HKg%vuM^?Sj}2tfkqvN|&iTB8-KD9keCvIB>QmE@pVvTW1pPQ_OO?HEZGz=?S3tzixJ z8C#xkXKWlM1d~lXa3M!qU=K2*VdXoJw<30*6Tn;1pH&R$ZE;vw55Tz%XJn#C}p04f>mm3hL-I`CL8Qdp}g3 z379O5oe(CJ`wTW!wJ){4J7P_BP}jfn=BDGGMy7=hn2znkH#~<7ZWq}-vwBk*r7TOM zkgYDcls4H<89(X9Oi-uQapR9g(){hz7Pz>Kj*#nUZit`C@6!O-xA~AGf_L*DW$`{h zlkLNAzWXM|1RE6tVIcdiF8AEz?j3alAD^Vu?OcoxLWG_t64N6A#`aUqhHJ*cH@0D< zMiGtHFeg<$ZHu)-o$X(Yud8Bo&3yngpgKwTUrMAN{7j1i{Mh9T;+A+qzfu$YPX*fI zU3&&N8hfRSQ2RvX^F*=herG_%N)b|?fsAE5w-r8MUE92lXc)=EP@k;yrQb zK3@BP#%5!|@_kRa+buWw>Vvx!5Z9$M{t}B~f~ts^2wiwm=&3c1Kws#DxZ(#rX5{1A zsS^Z@pP9g}*#m1ryr`Yz;f}Jp@juVo${PkaTZ<#-EoeEdl6BY&h+MtTzD9DJ6R!K$ zJa5q<_*_b6VGrO-VYTx811zr9kjlPO@vl)&$~In@^rAZH$#MI3eVrZ#Rd)*hS-y^` zX?+*)HOV)pG+6e%8A}9dn`2zX`P{D^R^u(u2QRq%t1{BGA}$CzEPDb|wl5jH<;Gki z%IMN&tL%tghYyjsqfFgCcq9gOQe#7PcqW=^1`Me#;L~hxrF68+VZ=S{up!e5tCnGA zQn%B~g4u(Iz<^+6A_%1R&ew?*}*cjjoly zVe;{v^@x{ifKXxZ&YBm+Iim=bwb1Z89djO*z=G47#&!3CqGOQzh+s?gObIdD@DC3s zRX<8ofOZ8epw~D39Nzx6JvqsK`L?j(hWDx_#KzV@aUrffG zL4XL+X_>`kUzEsBty*J7mTPE(bhqg=K0)Ns6uKWKooq%MhQ0BI^EPrA*$dFWDDAEPjPIc~EGF7;O}QVPylUOWiC>nD8T}r%gn}&W z;~(uQI)UZ3VtLYYe8r9O+Q)^F@-K=yjqQNDcQkt{VzK~KBt1LB`AVuPuSyG;w??3| zxgEJ$mf-1dJ+VeHDc{s?`eEPjj1&orG=FPZrn(oZ+yi0e=G?aHDhE4LX37N*F4beY z4#dw0BI!4o9!&{t2U1Kcx<$z=+y~qTYIJGkk#YbBapLoArO67 z!qa{0eIGJ2{RDBfFK-F7^{ZrVCE#s|{dytt`>GxN_x|T`bp#5*HYURlCW@yo_MR`e zwCD*z>rne6^@GmE_=*r&OM@zDGVu9CXK_=GdAbo@F?MQO`SfC<>}4+hUVPg@E}Q|Y zyKJ@oAEb0`>`#Z|74?su5u?)^b<4i-Xdc`N*5sS41Hcph`KikX0zUarWjcuC3|fAN z{qt`ls%+}?3$jhhJoOO4(%#EQel}%WL=^UWw(9*mt7lB$hbu6T`~H!srQ{%SVzf4`DSvmA_UrAFT>K?Nu#z7*Bg&A8wJ` z9Ktpy#qbO;*ZD}bb8n7A=TH3h$hjl&OUY+U?J-Mvfeh;5_c;}7>={}9XoksGFZ*3v%jigvGaJ;GMTUx?6&pli2=Z?w0v@5I?p#$eMX1ihSflkQ;WXuTj?`~Ncd z$GkN&lZ@o~j=R$LExf(90nE)=l_?{}sy~Gst7N`__SSpu!1CY}!XRwa&9gkxRptF!|aNLHK=0exZ9N2DD!N`wxZ`)z#a#o>> z7ft!?5N)I#N{hSDZgz|rpoMrZhg$|#MqZDfZaMrSu6*D|_;-NOF-r(DkMQX| zLiby1p_2<|dfl?Ynq~(ho3p2wUrZ6|jy#wAu%lBU?eQZ+{F6*sc|g8wqo^J;Ifsq z!!z=oi6wk%u?xGpJo@fF81Ln1k1=V5yhvClw~#N-Ox83kK0RAfBcH`oOkR<-O;}y_ zrgH*L2AEmYhRa8TXF$ul4Y1Q4y)vC9s5Y(*M zFfR26;~jHzfO1dUi+>I7v7nfgqZ|jh|-icg=lE(CG6ah;Lbh-nBcDfVWTe{*MC2uN=x6n+zP<0Ykqh;sj zg@~OZwR}tXlhD4b6jdYPn?gQLB&_9v-03TH`}F$SzqGjqNL+-;&50AY-&~P>Kie>R z8R(V$&Y-W(r`h(1zxf&auBH>oxPwPQ%yoYV!=8}?zlRRUAB}$%>hkHa5;CePh-}-n zFD1-Q;$_|}`L{4@mz}(a(SSczH$GA0KEC=D@p-w6eW5TlUVq0ZH8Jw0D=P?>*VqY? zdokCw>J5l3F5LYvdZ|oUF;xR{=bfSq4fNi$eL=heOUQCa7oVcUsQTuyzOL%OB#7Ux zI=U_ijpKexp?9sTCEld|0j2kkC~wiK1*}twz`U5Lk5v}dk4+(&wAXvV4$STb{?*-J zPnu*{u}gghF+urFh*HTgkvb>C!fxW^e^Bzmvr`O>HT^78_QglVE>%L`=qv&O}Qg0E`X~0ta7Woe1pfL zF{dvW3H9-dQQ^Sf`0|hWrY9@No+O?>LvG`tQ(~ zYd}n=A2KWUU{3i-!@2+FHlER_nc6lwD3bS2C*Xqv&nmvd;8I2<)g@fjiNzVmb33Or zUeCLC$eOl86oX@}NjV(SgyQbJ{^e3D`N?JgNahJruW^(MFKRcGI_raU>v;IukQXb( z9*Y<&#j&9QqcSXaM{yxmv`<&+R|%IA<-Nx0yp$iK2mAkU&=vfs(I_R`2ks-rt7`!rpj_?CeiCRRm`|_l^|0mHh&FwkEc0pPHi=AH5!l{<5pg^ z;VX1?MoMTZe16Y^rTdbQwfMGn7qn2Hqe!LGc4UcM%Zd>eRG zUuKy72bgce$|5yWw$Bk4Ok1h4z2GR0M|;2M8TG-=VAf4RybJh+__~B#7xenUzozsW zuN0GKfr?fXgjX=)&?2jxhrL-g{vS+u!BlI0hu(#yjW*ovZ2Q6gPJ*+o6#FDpX12Q7 z_ngD1m01PJ^(1BFX}Qa%D3qA+NENW)@q$}=HCV?`J4^KzXMx)Y`}{bp$ZLev)exP< zPxwG59toni-Q_LxWe`IWPklW2f^Mx5mO=kRDdEd&f|9+-GpD^Udv9^aPl23$^LBWZ zCw{yNaR5+WvarMqL&PoX3w+(Lg zNq&~OV%3j@-&%a@gLoBA9R-uYMk34FSmvL*>zBrI2R?r+w>(rQ0CQI!2JzChx;G9p zEMdEPoPNc4Flq9p`fN$*nrc^**|)z$ea8&>0iwSTCmjm7+c<6X&Gx7~MEb^cFRac# zEA_kiE8TgDTJpDEsf>-6+zY#D{sMGKH>VP%m%paip9_c>h`3TGbAuRH^=D%znY=di z?PIpK-nQohKOR_C?K}ka`{GxWs{fq$+))$Iv#_$Q5VRNfeh^J-vik(uDuico+$5z?QDpA) z#cCM+Xkp+SIo9!+5%+ae#4)|;a%tK0ea)iVZ**l21P~kgL#LL~5p9#~O0cokqt+&$ z@W-9*+Xmq5-Nn)Bjlk&04zT*yn#aLX8_*iK`(EbFKTWS|KRjA>KNyJ%c3Y{Ln%)S6 z)vLCPhkyzdLQNd!@%JqO!MEW5!e;`@IKGCd2TDi{_y;0q0&nvItp8UVos2G(duv_T zy!|EW9bAC23oRG*jtm--B9Z0FquR4|>V&Bo0q!z+lyprMX*fIN(-9qFelZ$;#p>Mv z!*ST!%2GR;G--=OzE$-XMAbSSmg_gIcDli>(M=bb+s{*0&KO9dxDuGJh~BeE*!NM} zWL=BBPp~Guxqfx|@1m%KgMEjCRjTdnU#YLrrSgY!zq?nR2k2_Gr(;;zXPKMJBjK~4 zUO^-*U&_=&L=1|r*`liRE={8^NW7eZ;h$iMOP%FEDbRj>OB0%NHsLk$Q?t=%dH=pB zh<%}Vsr>Pbh-e;N!x9C)LB7#feW+jF*slwk<=ED%8dL6>@&Jtwwa6ytqeJ(LIFSuPFuVc&N!F;`$6{Kg^68P5LX&s#OO=@#wbShT!^nT>*6$Scr}fN}^HIjM+ceX=??s@x4rxQ<6pQ9UcNJHvZqEMEkAxx}+ZX zn>xgF%COU(Y1m@l1kau}X4RA@ebhe=NHV;A74U0zNahYvnCMVn<{ez#c>d8&4@cD8 z$9QTvw)$PE<7g=*>w^`jV8%cw!artdJn$UKz9`c1Hs03hj8S*M2fy^mqvR3| z*JTqz({(NWNB_~xln%C0zQ#tMx@`K?AfoQCUA4L_bhu_y*KCVVY~h*^3t#F{svg77 zTxmYKBhP7<=(722{eNZIaOP^noI4|cgf29dDc#V4iW#K2=S_rSD~!4qdl9qr8R+|L?Yd;D7VT-&jdY44c!D{5QZ@mdIP zyKerj{`UQ0{&z`3!?F@qi;?a4GElrEUE&=jZ6p3d%N}=(O?~Lbko~z5CtC#%liMADLAz!YM2v9U*$Jlz+K)vUdwOtOlN!tZ?Fx*Qu)^g_Wj~K;Uhh~weEdbyrPecc>DhcE$?|%|Adq*)Ox1UG=l8=b zDd%=<>m!$OOMJ_S##hIU#8NVg!I-Y`pTLS|f->VRQqePYerHdNxfY6#2_{sUdVFdcOA?(xT zNgG@N)72^LKJTlQ7RA_0PK8%IpH~=!RMKnJefG{Ww-|TjrV6WSkWB5SOpolN=3!c= zu7Hm#U%58rb2+}AmpL50YyfTZ%Byn(AXJpnyIlIMLjG@+HFZ`Ch|po9 zY0qPYE=OGyoq^Jm|I!-A3(X}~{Kcc8l4rzN)hx0WoUVt4e@2%IEX7%RvHPzXKMJWp zz}S21C$CI=(P7a-Zhj?Tp%5Es$8G)@Y~5&Zg&_7}uzr)PK6CiEl{;AGShfu8po{V6N@p>U4|BbzlI5OwH{cDD{eYi^g-&no=!_Bq7jYa<% zedQkHi>0=Xn-YdAA79|dQGLRu*yx+VLmk7HMi@I7QN}17-|+F&&TSDs=WOUP$|k_* zu#q&3)6m$Lt%};2*1e}@PFv7M$0Gd2#co)@d-UzO2fX|}blaer2acHXx`r$fjGI7_ zye3l*n&<9uDQ|q{YB!DoEnWvRXqTl>hAXqpK=vC^k9XcrByk@O4h}n)93z~&I4-)X zS%vs5a;4|Jd5?vwP900`I85I_ud7Hy*w>I^J|3L>sqg5>%M7T4GYVtQz*a=B{#uQ% zz3th0Mw;sK$(Hqe4e5xN2C7^21ANpo?P_n@P6E6(#OPbIW+N%g`uYvL{3CPMr8fvo zl6Vk}xQwA`@c#gsVqC+jCHIny`m1SCwDRbNEm;Uo8B8|=q3~a4c4VgX;H0Z+s+&)J z#op$efp&$vf1%Oz>IQ>6@K^U}PXNTEpgbReOVenUZUtPe%Od)Xc66_}51-mHz>Vg( z=*GGAvrZc_$xvT1d&WbXQ0pt7JyI_Rj!S;p}T0?QdvQlqomQU|oyWCj%RAkW=;Z|34I6ND+S{dLG|b+j?L`_BOU-zuF+mdLE%NYk ztkpZOTuO#G?*zl3eJA4mASX@N25o|O$|njjWDLYQf;u^Ty*2rdbLA3ur;Zv;su;Z_bYZF^B$04Rngkr%Vn}h7U|Ko%cQa8 zAH`=Alh&*R_VFceb%@sZd$;HB%)eVv0|sSDrGAMrxJ$5Pw$ya;<_t)Wk%3TK1G<2+ z47pz>F-$?xn)VfD}@Yl@TqZGX) z+92a6KX}^7Xz$N^%358h5eqKPOr0lMGJE#ih*e{uUf5Yc+ni#x7z16A)VND*JWh}h z>OMpta$P?n?4XbwTf0AsS_{?rb;D)Fche4}pOxyshjd1ia^>M-&!9{~0KlVs!Ldqa zl60H&33;~413ge_0EZY&wN4<^R({!==%yv!HArk)z_U44PrYX2O#Z?a)ZMG`s<9^q zJbImAR;7sjKD4^Nm=HPEoLr4)C!qO~a^;3tXh|BiS%UAoo zXjO~?pO9hxYJbe1T{WG1)9K7Xh;OyS_|pEQ(p6xcX{5;9@uQ&ZXl63j8L=X05ZQWl ze1R`-Q3SflYMme56}>aUMqXzDEpy>Tb6tmhCa>aN^(Gycs`9JqPim9D*uvO))Iy)q zOx;o;H#bhMc$8E>A+)`Z>{vtM5_S0gDatd-VPPFje@!mr%ntb%CL$QHo$zl~rB!Ayx|A1UAP?#VIM|+Iow3E% z@0LI40G!1M?yvll0)b7kiu3~rE0Sxc0p-sD&oceKR{lvrgz+mm+e?dUW5ad_z(yj! zx~kCNdd4f|_#TN0f~kFSI{^H3dm6yu(wiEpQG}S+U4H?VB=A0~p1GJe-kM_6h^!6r zW_F0KN}Au!?n^i7$&g%YK>(&@aKH|pcfe&l=2zLiS9aq_Uei76Z@*C{Qnx+Kkebqj_l}`cmmCYf!_q3A)@!#v=ksoVg z6V~v45qmXQ5$@yVf1x@;)%N!BHuPY|R8QNtwoK-H8Tn(FG)%s4+T#r9=Tc1f&`G*X z7Eib-4^}>eSDYzv(`0h~=PY^7p#+wOL}uEKkCKjyc*`o1B8&5!r~I4id=xh9{%4K0 z4&xZ7zSA@MW5B;c+8SGl+_L3xZ0)S$UOhh1CwG>b9g%Y-H+al*nsk(GyPCFAIIM1l zw4QWu=I`N#UCOWF?=hqC&h2-pn7nb-+aa|n94VTc2)OWD%#KQtsRz0z2 zxrNPeH=5*xuM*3BV3$XoEfA2`?H2;5;n@z{4Rmv9i)W}#Y+1Ld)(;YVu$9G0SZH() zT=oO(xm>z^fWh)@Ml|##X_id1=q6T~~zfGDy(!JrpZd z{*-PL+xDY>Yip)a5sl>R?|7+qGl7h=dx>l>WB&aKH>KZ7eaWk^wsM^0s#p~bR)bb0 z{^v%Cg#&lk3x5OBD4jqfNFMD=w&zJ2^#t7RTQ+@Wo7ndDfo77_movCd+OOVNhGRGo zhT|j{VrAV1NjGxNK#nrURn(qjzr^AGnwP)LH2k1FijUmZUTpPK80sl<@KY~rA>d9d zR9mGEBZoX@U8m|PS)gnX3Z#L1I#HM>8iT$6x zcpOdM$=PKxV;V)R?*GV~Y+W|KkaC+!_aO`Nf^~8MIL$kGn*g9~u3t+sgNS6&(pu@q zgKhhA!x&nt)mN7~+HX!gta_A75I4ca|Fe1_I7RiYi7$v7T(zaj@pv67+Xp)lnm))6 zR=3PQ2s|-ZyZgw9e>!%sTKoJ)Wg)pb9>Fq(4=6#(UJy4b6Y*f78Df#(gipl-UH-`%-a~=KbQBv^%&xv+ zFr{JWx!i3mxv&(nL+-}&vK?>p52;ffRo|GyO}A&#OnXjUt;!Gkk>Y4R_NpMv2X_~3 zelKOAG0Y3R-WTnVyrbGa@*=+l^EES80m(prV(ug);2~~PGZKW+VgVCAKMY-CKQqXn z-^JVr5=om8krxjC=PK3(KmiiB6ncW^pDF2ifd?+^-B!YtQJ3JfZG$s0v8XYOx|fUH z29FIX5$Tn6_``S}R#Zvtz~_$4nk6y%MQb$|woX06y@LxiY)bJqq)RpiFK@IV^bjgi zyrHLv@Yu4Mp#xC4Hb^hHSNagHYOZnYN=b)p9+4%j6YKB>-#gj%BheEb+NOSjg!-B= z@sjX#^K_Y(CAzBC9Uw4jwD-KAvO-$r+L3gbLkguwZ*z)Q?|iB{+H-N$_}0Tdd>A(u zFqO7_X@%ir1|8Tg?w!wZC5GJpF~|p{I2y_4h(}_jy#2Gu$Jr*y3k=@rO#kK7jubyr zX-tvSiR&J{rV(cD>v+xhlJpe#TW`2}KDoqbXQ5(En7dfm&+(d^#`mP$yOm)SVz^=8 zW&PRd_gZqFhUi5@d&-JIOA;N&+9QP!tRm?N{ofI2*T_hVz1&F8r5RO#)HjG{<3 zLfgjpSZ1|z7Dsr$D)t;SDR80Jbn)~L^tl}Tx!rM9tD?e=2G-7_%M|aBylOj%_knwe zP>3Gn=uT3@iY`!0Bi;^br@vJE?b+<99c9ZUrfM9EdyN%AYy|*gw^)v?bIL~9Gh8a( zSpkAZmG{ueVTW19P{9XBafy`ZE@wGte`( zd6BZ`D5z`|1?tn=ujh0_oe76pR$Ig5!qInRa>#;s8xR@%FbLKpGZ61+N^O^^i+u)r zT^-mmL}D(OH{l)gfj`t8+hgo7`Wzv9&6O{{@m8~%4q~iverOh-+PK`?{R9ZG^ zQf`Q{R92d1YL-+gxKvs$xa2NiC9WyCfRc))fC4H4qJS)4KJWX7`ww^>2kUdWuE%wr zRiVvyE~5{LWIszL_z`nB!_bh!`;H;UzrQ?$w7iG?9I|TW)Z7$*X|UHU{*9)}mk91^ z+g}Gk1kZWI(tC|(DOa~wBcXqTp-Xk@Z>KRfqTb*zlf#5CM_adszPD~1?CMS<5`MZQ z{=UY}KO{T${M?x*y}On$g22#^d9ZnP!C5l=Bbi{MT`k_Nv+p%kbWf|`+O@P`y7teU zu#-#n#uWAOck!Wgd~z;hKWFk>Z6#q>cEkY^QItvJcNV52Tc#s$wSrlFS`+S0;=^TMuT#_jFbz5FNf9 zd3Q;8AW+RQf|PnS#3BWSbK_6ddHig=_QXa~uBPB1P#I*M2I^y;Fb=-SLPDC2)Jd+7 z;%J19lFIL0?6{!4_MkF#0nw^Di0Q&Zd9gDw5?Z!8p3ef z4vlLutFu)EtgoMja&$amIAB5r@|b$dZGumXefNeoc#Wo}0%EiexUi}3uc7j|$YNS{ zcR86sn(UdEmhvKH`#pjNwf)V}5ER#jRG|_TqV*&k8|`UH@>(`MUiRXa45oN)6NV|q zNg+0v7U4VD0c}@5l4`BJ0JFDzv)nq~JRmFm-YqE=SjERrua+j{tn9Efb7Z?Ke@|q6 z^UDYi`8f*Scf_RCa>j|~n4J@vP7A)et9gEBTij$oQAjRQqKNd66dIWoYjH_YHU})t zWSHmnJ64Cf>>hFM%6wu>JlYtYox*hS^9)P5=2>JuljVp!TaV92 z&LiiE_!WKJOXc+u_}&h|_@to#Z}YOjdl0I&`N+wArY77T6bde3p5Tn7BPCt76?0G7 zPBkvWD336ugxR!ZubZmN(7)!jS$4{nnGPQg{cO3ror}%U5BaYby4uYvO+5l#+|HvY zQ-so&TZ%tLvYOOcP$1C&f@lHyYq?!4lfv2VR8V}wcJ_q)@bGE+F*2gtV5uW+goyi^!Tsi!7HJ4c)XEakGDpIjAYP)9k>?H61LParNDf$eF}p_k$Nuiw$f5{`qu-NPohbjL=2O?Ow;DcM-f?fSAl8YWaEqi2hPpbet>qy+`GoL!7lKW22swf)y0)r3`YplmbAb65$=LkC*{^hyr4m! zYrKX4mKxU^Q}2A5ul{QCO3#I+zJB7>0aF&9Kn{T{d31cGlmHfijz)-6p4ZqE!pLVY zBDR<1K(UWYMTlc@f$63BMuaV7j=Ao~ZhVx>(v-61nn|K=K8;yKpFy4CHUw zk<8c^fAmulm_#l8#Uw3I8OG_rU^{w%yW|awOD^AW+dF5n2dv2M!{*4ZdoL$kLg%Ij8(bS4vZ5;oQLYfbXNA z4lt{BJLmmoU8i08*yz1LigH7_3)ks6V{eD{djP2n|9Z$~VM}MBgR}f-ZtU5VKzlMI zibnu(6csUNugGxE5TiJ#01kvf$iN%4loqFT-HdU0LkBK;2!E_*eEAP_u?GR~m2=+N zxiFghH5#P2^3BA0J|y=`u2G9OuGrQ_KQYw@VN@K$2}S(%yaQTRCeb)|PO&L#x4 zq1Ccu^qhLQAIj-Ui>w4H2YbV@A>$avpL-r%QcU|8M=kWQmqugYSl*4&A@1bVV^;$B z)FT9JvcWWoVLZt1EhF~Iq?ewVIzb<(T=mV)@45%&uN#BDnGU$L#!C@8IYOuTvY)0b zhitB{XJ!+do7%S;4vJnaf|l0aXs8l!S`BHFOx=1|DHYQLYY2xcCuo-nS=_~+U{p=s z$O>S|;c@=HLIpk5!*Ir$$_)AVDB>$p`H|lqQV+BfgoC?|K=Zdp%!sQwcxzfz>(O!Z zt^`cGG&!$wc(LofiaDDrvy9WJH@zV%yRU298d^g)(fzT%0fuA?xW%Uv?+cgDIya`q z<$+ai5G-Z#w%{AnyjqnHtFb}Bsne9^5fLha@Sy`xD9kOcQ>a_`q%_VeX<1QQ)MZ(H z2j8Z?Q8{`kxi4qaL7L59K<7H4>k02Cq|1>vwuV4$Bm`nCp=)`AVAOdkQ3yu}0yvYZ zhKTy5m9U)&O4En`#|92e4As4<_H{68kiT+Wfgn9;3E2a^3DH>Bs~i+K?lU=N0-ZAWNJEv?y zLf;kPE_(H+x7B9b$M&;L9~#F6ttn|A>f%-1;qn$@UP;~>3jg``1IdNWXMinLLFK?- zm#e;@BxWhduMBd!%dENd6Yv$=py^xvu7<<^wp(70rEZ-$#xt1^lEGn5 zFeP3lUW}7rgo6})FezzJ=9s^r8P8FoU!KeSmbn?<<=&1wq(b(1mu%iREc#_1fd8r z2Y7&4LKoLcL1{OGi`q4W?{QCrQ{VGI)AB^p{%`)TqSdD%N)y3^OP}c^!a}C{xW|5v zw^SH70k+f0m(%Veln*9F*&PWU}RE*M@x0!D=X5-i*g>LEb8u z1Am;ZA-UvpXuQ}v^3PI|x`yNOrgxIe|4Rypjx zLIGE)JD6z+y|0#H95H_oc8Bf{8QhWllfM7kLvKSgEp{Z2IexnWhEAJ4cZ1AiI(^BB zRCln)gm?{ECm%`!v4ZCj!xldHtNmo54-{ZZ?k?WCf!cDUpaILI9`=CA@jEuZ0dZQ%~B6d>of zvUq;;m@FD@!df=}>mql=72&AY z9Y0oiZHf|XwFmMBYdn(_y4E5yvSHl(u#zD9wY}TGphl71Au=<2Mk6XJRUA1+&$S^^GZq;`{wdA-_}) zv+9s3HBCw5@V?h+XFJ6!A;!GOYjZZ-xr`-9$m!5vXe7}gWF!Bg=DZCytbxFH9ozPTa?4!Y{(G!|LE} zaEyL%$@ae9d`a$ebw0#|698}_JAy~%O2I;c{>BW z`!6Ki0UrT{#VYl1U}*9Z@9x=u8!deEQ1sus&ZdEn`#tVqb$I)Y-6 z{o2jt^db8XM}b%3{j|~ye>AI_V_>Zbt6Qcc;pIln(qh)EtOUtC4?j;V4w*drMLSJd z{0$!^v+-cG_=Z*Wtn~v#zK5>+I$(h915%D9pDqI1Pw?-~2ya1?=ka5%gd+!`yF~ij z64&e%a$|D~%wc@XS9W4B{ZXtBQge7g6uN&L^CmM*edN=HuP{f_LU5fv@_djMd|Sre z3CZ^j#b=bh^r9T@%}fh5Dgo#of0lcVrjUjw;%(x|R(_3Jf=7177_;4KCugTGU+V!J zTDee){21Mt@4O4$h^%iYjP*C;+E8-qj9L2US5CFKkFvh0`37YK{rs4(i|j1Y*FiV; zBD9)e?aaFes3e27LZKqO>(Zkayh8`!!QiDr?0J@41dZk)=QgQMRAWB?PCBLGzTiNdtfKs}y~AIjn%uADj=2a0&+R$~AeAvU0Etk6Fp;)E`Xdb-+-&zDR{ zgPK_xQ7Lq5NcM+tSBMkHIrX5;F(tu>ii_VD_p>k6)W`tD!RFIEp?FA<>P>g#y zSch=jU5|O}pgoSxGQ@{=q=6aNG*)*6Qo6~j9Il5awCU=Y!if607odEO$P>A6Xz@Zp zn_JWt$T2bsAb7-#|KJ0?+XIPrREctj5RJ-XOF7F9CuI=?@SD&c8g6^xO*p#w<`8Z6 zi98BBXjZwf7&|94DHsTm{o`0+_v7($lW+XdFDmbW7Y}=WWf@nN*|-!flGVF&&l^ju z)fh1JCBPb(?y2rEd2Q`DWckcZdl`N8OU*;+CI5PnO@NcOBwwCQ3iIKpyXNC69j(U7 z&VhJ)Jr*CxBQwAsU9i=D*i&`&EZ*{iFd{Kf7F8-6W7pm(za{GJTxxl-L-MQ+v2z66 zK^JOIF?O~d0od8w#9vzRi6>xx)~_-6TAP#T{-VrHpCfTmS-UVx5w6UO#8uGoPmWE( z*pu=O|FCI4)G;+T2_MXnfuGv8p{=2g-1zn>(is0*U{70I-HJU)d+=g>~3q3m?S4#MQv9g(3Z;;-4#^#;oed={%)R8Gsr&b!;ys}kGeB)ONos}`pQFkjroeJ z_bkYpdB|Pfw^nA{6VWR2OMbP<1?R=cah^2o3mTxqXkVLxm!E($cI4;e=WM23iF6O{ z%qHj{275fPue9+OO3{`Y zCd)nGdE)ym6$C@wWE4Dq{?~L|$kC>VgZnI9DwD;SdCv1uzv+!0{Md-|G~GXoP@N2_ zdrbfc=N}Dk=ka?_*6BXiIswfjcXg_t6jFGy32U*Wq-pCfW^!vEl$&$m%Ae4%eFG_1 z?_+jXVX|dSC{IcETSvuBOk-$0IO#OaY2SE?^a`1w799w*)+tmC&~KtcJMfs2ksNRY zdZ9)qD>>t=?egknF+U+0BbVm&{KtmJ4-w#jy(8d*52~xI*EgxuVWH z==e8}Z2PJu^t|{Wgv-pOna`YFJii%AbFUN`#wShhcn;L7aT?%x71Fqr*4;tYL%2~p zfC2tL?6wut8M3Ft2^ThT-u67=I1A6X&ygn#7Z@!?*t^#O&sJ!KUQ~8>NyvG`x25+l z^Itzn@{EwQx^gy5@#}CUSFljY=PpR!X~~ytc=KWz4;`6`eAA>IUo0fuwIr?Nlxw85 z?cXryRp6VOMDbe?AQ4!r`Z-v>>m}5yYGDsP<<6aG;%yC?6bRPsrZBNxlA>W>r7x$T z-itJiV1N4lFgvme@}&=#mD)thJpO&e5jk+cLlj#aX@rbc+}8Sj;iveRH_XOgN8EAG zUn*U)Z(cfF)f?=HnHY$K@1AxKLcOJcD>FRa7+WtKs1p|W6Xga^Se=F0LCePqqic2u zQXVdx*Gd+LEix^4tn{`{?rNO%Zr^VhS6p4YJ**|p0~0N1XBkCx?Y%FhRdH`mml0@7 z=bu)n&Zcvi(`2Ra%lE@&y}ef1rzwA5AGF_^M)DsqeHKEaga8AfbdOGbosLVfP2s$q zji=@9tfpv5lUNB|Jn?^Hg1V@WN7>Cwt4+yw{<9D4Xb+DV+V>YL>3i(Rw<+=Uzxe%3 z!e3PLmP6N<*z2S>4{D#LVYT53zN%4kO}ANWXe=^_$e!(nP>y;na)`H z@7%)0?tgr9ZPcewSUaS~RIlG+S-u6(O$6Y{TL>J0-sEekYqEEXp~JPNlLI2`1NC7# z;xPW24|pQw3gT(bhTc_BXQdZe*U;a4IU?kNI{Ybiox-XFsOWfgA9MYDmDIK>XuRQ? zMF+hEy375}LX}akMHO|cFlSzS(SZ9EQ zD`k(8khSrsRmY;a9)~xlZTxUy{>%}n4UCbL_nMdIBmA8J99tBn?3BH4Tg=dp1Iix~ z9V{J))5A?Cduit9T|}=Q-@8l9nH2Brg3ZNU;4uH>tgJp{pO|W6a?Bw<2Ak0=Ho@PR z!#!NwnL=@Rp8b6==|rGE!i5mZFzRY|MBH%2$r#t8r`&L@veI<(()?w&v^WoiY0%2Q zU!@}1xYMoN=H&vE0WTB2)edok(v06a307n=P9GKEyROX13Am%R2oeUf+Dsc)4x`2d z8h=waAZcS#oSwPLmESu_xI0bV{-2E79Nl zSo1u5ak%gJ^gzcW=c@TxH`ZLByr{9;2hQ6VaY7y9VOWVIj^8{=w!1S@=#(fC8UA9e z<4b=4(d&9cRA)dViIZ6+Xyvo^I*y~_k@T+nWw&-;^N8o?o@=GvwXvBs)ML0WLiL)V zp+K^jZmP?i|3@pb*ounRJc=5hElinoyW^eqwdrQ-vh#qUiej5lv%G=Gc}Ne`x1z<9 z|64??EAG^+a%b5c4<1u*u&cwgd| zr5=CC66_=!FP6@fa)c1}!;)-h(6QjavTo!i_UB$bVRwC1gF4Vdq&s)rm?aVReWzW) zy6ZO$J;zYhU%BR|pMKIU{&~vvB0C(u?05P~^c6Y&XNVnbcF02-H6BLXW%C9opeTL! zbo0CL$?CA?B460C$ObnOoBn;R9ZY=!{)Asf4iv=-C{|6* z={Sa`e45s;dk{4&#tqbOC09B)m*wN~V<(3RPGCp8CU4sClQyNjcjL!+Y!D?7jvmY| zK2CYz7CP+~8hP=F+HLu83&FqUk4WyVF*KisQ4{b=0u47ab%7G4kbK$S;FNwGh}$ej zqzE@aTb_>2lt#JlMn@SttqeCd4I-59T|vc`NeqzgW_jBjy#Qi`lRoa(U)no=vGmh? zXm7*3?{2P%m@NL$@Mn>Mbx3TKKbG;~R2~fgo zdACy;e3s$#+}QtHHPPO$rea_KH>-b9LE}lS`%!rzfp9v@UmFJ(JbP^9AAhvA?w+OP zFCG@0S6a!t?JgmWTPik4J`0abzWAa#2z`J^RlO_XSUCDyAFL}gdRCcMm7nrezx1(y z&(gF4e5Jnc?Hq*ew;7qf@nqXFA(P7Ct-n#)HQAw_{m9c?#|zMKp`%1YLHC z>6=Q!w|-5bFs$ObM5w;VggV^Y3&#Aju~wSXN}g;(XY#7pY*SpEGUfm5u|Unw&_3k` z2)%?eQg^y`Bzt`CWgXYR4i{G(61FiEbw~3^PWlS3z#PTYV#{+&yzoscr6|H3K$N%M zFEYKTG}O*+SlYO<+o_RLqEUYnm^sirR1)di`>S{6P5)mUe{&BC_ zZfNldlhXXKCP3N{S6rWZ;{OJox_X->z4pefX?2wVt_Xh%RG!9adoic#V$p~;Bf}-K z)--71(^F|3zSQM~7P+XT1`4{dGNHwh`SJ z+7xUZX1hnct6mS=rA3@&tj&wIHZ%Jp9o113I(stc+_*UztpA;Ud|y}TvC9)+Mo6RF z$OqlxN?x0>Pd024`+(oqN=1gkyz-o}E&9>4O>Y2P)&3y)=IxmB;^w z1$ab_nkjfRlVy#KIb$q;qi!7jvHUl;%32;DXR5-tsnR_`}po6KS)m$J_!3MZ6h<@ z+QQ+7?D0Z(palgOwJ;OEB)ro%A86{vIU8F{Tr0yqy}GNivo#}oOP2-rQH&=T9#;aR zQg``pw$)yZ_O{gh2?t34_HE2iN|a;|O;mwdyf{@bD%b(lr~Ye)7Pdvs31)5gr`eY> zFwXPLq}-%l#6*k^*CE)> zSZ(>OMuLfi1)V75xr%J=&u%NZki%PUo(fE74_qFn6y@m8NpZY7^uDHsy@^po#gHBx zTSXa7njPr1MBG=pe%ryt6z{XkwT_jDaU5Snmswis%igTsbB?_5`7lw6b);SIjwSAx zz2bB>Y&yfX;|%}FJP@zEGRWTNU6Z-;i5__7@1uk70n}03ZEmBzf2ty`SeqQRp4Mk^ zw`278PuKF^Gp%^}kd2Hb*YA^i2>3>Y{BBNZj(p@bR5J6z#FA_JYB~)9RooPu{RbjH z>5ToHkov{Y!eu`3NW_FcZE=0;VV^1f5s+?j=G99~$`=^g0IyDl^-^E|L^6qv6)SlO zfwk^OHv>D&6^Fo(4DB0h?}nke#TdAjKby=x6F#eXKaR^L{e%#hoe%L>U0ye2tYLywiS=~8czj_>?|I^>4 z)$)oVjL+*;2dS}&8#3Rk2(Z$vbEYK!bqc{#x?h)W(s+XZs?_ozO6=PGm=Z?Sx0wEK8PXm7Xr-yPGtq)-(D%-t)53}z2#M0E`-)^0=q4C*tw|gY%Z?tH?rv1K73r#KczKe#IQU9&NedqEX zEJaL7`>&N6d>(dQ4N+v$hM6YW@u!O7*itrN6K{YX0xrGTmDso>4eBAs&elPqX9*9n zf?eyjMvB7TTmW}g}uZNg%z)L3~8)OS29G)8`cC{6XKtEYqD z@*m5_uQFx1V6MX)z|Q@Y9;MMAZ?i9n;Xw$>LmZY$Ka`j0VIPf?GCyq#Xhay2_Eo|z z{u1Bft))-+cv3E?PI-r8o|8j{fZl?Ey*Z&Ui=)V7{7Mv7#vU!~5-k&TnmGd#jb~k-&K9X6=hxIWXL78eRRXG)+j)9hXl^ zRXO)^R8JNgh9M8-ciLgG18Ct$FOuAUYb-J!@JaX}ST9V+)^-~WwF~u=Yx0rm$6!NBl1Ep9o^;H1do=G?%Wk+Jm-wv2(}HewH_kVEl^d8?2Z$h}^gR-}h(r6H9AcYGv;7TH&; zGlN`8s8=fl;U~)7Av`^(@sa9@NoVWg*C(AbtMM37r9;Q3om_@D^_#70u=<)P*Q@9c zjPy(I>++EC$V`9A+$;Tn;&-;-bn8>&Z--#V9ID>;Cc#NtmQ=5vnlEgjaMc~Iz3a&e z*6i-+YI}nJaWvt)_^EmSr}mM?m4Lx<>A||V7DG$3$mnlFhLCuV;V|5JofTf$^@v7o zo_AQ}^ao{vR^ynHXNNI0?#vV*3*sv?VRk;kKNsKZK|LUO)|%OpiJTRgfj=R7Njq;C+fD_ z7ikVh7ln9$>=~rFrJo-13A8gY2iQ+tNJi2gE6y(!2=wJ_jS4ZQ-(@gFX%l){+&K*? zvO$m{&{K(A`d#^QC-@mmj8dMC^$$_=JGXFUu;S^pbargiYy1034Q99RN*lJw8*m8; zs&GuftkTIp_-+PMt~M(l9I|IjcVWWw1LU7VM$(8ntyrfW*9~pxy}v}&Zuy6_(t8G? zUzd6yy2%<+#auvsC{nobv8ubYl{9qC!d{35>&^;`r{;&8qQ>8-+%-N~ z{3(g+nix>ly9+lM3VRM*I8Zdddd#HJpn@*KziQn{N{v$-PLv*#f}iS1WKo0vfWNY< z_1~#ol_*E-u(!ILb93+1A>esZ-XD^A=O&w)W2-s{|w>x1QVEf=+8)^o`|4ugvSe(^u3)@!*0=Z+Tfy4l3dk^%0 zY_B`?$)wE3M4HAO{Tt<-^_s^76yC$v?5^mWP?unmT4znB2 z_OaXY28oreFENvDd6#0p@)2jH$)Y~Dmses6^p262lft$|Wr4`@$u1(RXMFNx9FdN-l)qz)sU8L*H#Vjp zrjxeCqeoN`hnu9br^wRtI7v^gZPG?k8Fmc&C9S|+1abPd;|C{*TlBKm zC**CVFYnhMr%$9&!EaOrU9X#~;ZN1cukg2Vf<)~u&1wjyVK3C>FL1w8V_2=-H1V}2 z?g`SdGr}f^t?BNk8-!iy{`KKq$8TT~4t zqHHnQfUkOeD>~@_eAy>PcziXsQN0`>yrx$%S&a#;Jk)Yf7_1|1S$Q~dk-#0HoHiFH z<~Vl~i?*Z%7)!@d$w#2-4C~MqBS|X8D(}m*>g@H4P0b4fKimSt1|AP-N~hsaCd}}w z{GH{+I{3o1*~o|Ew*D(~A)yuT+QA2*t!a+wju_7Q=+44F*Z^DKcH87SUv!mp4O+NG zXnV>VHwma~mfXc*6H*ZY&rPa`rh_JT3e;vL4FS(O8&NSXH@*SdTBAIK2>kt>A>zn0G3(B`P zCXP#(X@wU2VAk*3jw`d($ggQGc??>O=BHV}tRrlu23dWCHfIQJs&kV#7S@4k*#k)E zRRp6jjp_$@W_KJYo`3hOZ(%^OVW`f*=Sn=}ya8}G~R{ULm0gNJ^So4}gs{#5sm5)$i2 zDzFxT^aY;42l2l+HnyBa&ZRCaj_xEwF^gF%LYrk{Ipib+cUmy7*l-mvKHQYTHFLS5 z(d}WGCeyX57QHis&&$EccaB#yUZyhMtGBTaQ-1gyZ^_iya5{$zR~Z2D16b-wN2meMQ8bC2%(@*ZaSc=iIPFHMJqSh~nue70bhA|e>yS2mD( z!<5}#y2g}O10{yJX-O92Sg(ES@EV_;sx*(p^0;`rh+k8hU!T~R*F8jRlAqh;E)tgE zS^#dwxXt!H@r;t~i=s__%R4ADw45V#*!io`0PFT31d@5VdhirU%eicf)56jR)>ntgvVYE9RDC# zs-Z@ueHOtVj>l6OfA%QLJt79Dozj1K7WjMDyfW1`u)!%x8<}3f` zm5Q}2IrM=*KRA?P1Fs}i9IKVi%f3w`HtDfD>z3k}P48*Ur{p?5`-F0cfQgS$HHgi# zx$YQ>#C%Efi!GkwbM+;`ups0d8S{bul6ol)svtj#sNx$8cNM<=tirmflqsLfvt=l( zP1Dx?rUqZA0Q6Aaq_V4(557n8sAPXr_beaFej3i3g`#R7A5cjb2z z*Bq8)xK_NA_XedH}+4T7ehDmz1 z2PS3w-X`^<9(^;l&d6Y;EEn>}*N!rQ%!`WIes44mZPgUk9fa+8yzv%(%eeCQF8124 zYyIZ^WF*M3VG%VBlvP`@v5>Ah$L!2&Ay1Mskf#8zQnEpoh@0~o zgE-ZEzq!10Sn^|Xl(%DCc4dI(yg1tr^MDICFfZLYVR(rUzu!)${;U%C@l7*it|YuO zBVGS+5;FQZO7G+e!r76U9>pFCN_m|qs+MdjF{1UG425seb%`6Bp#qw6`1KWeRlI%- zH;#{)9+y#KV7?R)8MQFU`bl6m#4vp(iyRlrD@DwP*eOIQaKcRf6xuggj!&NRf$Us< z^{Y(Sg2RD{v9~qBG#8Neg7Mi-+(Y|Z`Id()dqU5F(s0pc@rI%HnmSxH%%+JsXOTSf zMz>*B5SUGj45_f?Xg-atazHsnI-%I7VDXS+CfTG04b^$IS;#%$g&f=9-ee8i5~JoA}oyCdLl0EY4cOwu}Sf}qCRNs3@n;n{sSL5%xqKj=cIMe;xc7=U9t zh*BpX|IlkWX3`y|*g_+cd+lNdIz8mh;teqjlignZNa$l!P*OX~b2a7)Qs(BZmbt>` zWZ=4{FKf`32Ko-!5mTMJ%1|bHH_uCbxG&9p87O~N;?v8#2z+v8lfV9bCmrz)-IZ!5Ynp600~7tSqbwlEh`(96f72=mXD(AMG;+u zW(o~obSt_vXdu-@Ls~ke8OUAc9w4t0&c2 zUF63RBR0;0W_D|Q*YRw7|N3JxEDOfK4Y8Z8C^mml8xXl=f(xmDZu~Q-mCnAc42l<& z>uhoZzw}z6?@Sy>OMlAv=#c{k;RNzW#5J9mjow2>~H-5 zD0RzD0rsRs0A4G#xz9{cAnPFoHxI-xoB}9qeEGV6kqyV;BeN`6t)8NnMXOLVjhx1} zD}=M`{M5C4-hUspt&E}5QvI#!|HH=s+rr@!6Zh>}LFUG;*}jJUW){Av^Zlqi$LARd z+vJIpaCq`7vYqxt^f#yCrYDkrA&XDWSn^t~N4Er&Qi8Y3K9#3tYb+-P^Lwu;c?`(s zv~8H=Xbsr{p}6VWwJv%3WIwR|{Mgk&9jN*YxN~^r**hKMJR&Elr#9!r#^X(ki))RD z)87bDSEC-kuwG33gT#D+|1B}@?l9G`eF0(<4ZxPw2ft zaAK1@wSyyXZ4n*jX{CxXpSoC=&^Wo5F2f212_^CTj}2^i*&0ocSEQkA!ABr!)H0yh0L2WCh0kqqZ z4I<_(&Y9)MpTB<&G$6uHv-)7W;Ersv%YX)cvN=0q!1^fDBay^I)v8waID~t8Y>e*igx-+3?V7McSIl|(&PBY}+dP-| z2ca;PA{&Z23g1$~A|9pw(V4o)R!+ijydMsiQ1+ju+$i)fZY!^Jp{g>D!&s_IrQjp)y~NKM*^fNOqBChM^8KIjj|>~FRO z5o=}Z8D~5o#UVCX^})=GxtPqp9vHRCgGl07DZ>$6d&l>$5S!2re%8mR5*Ht;QWW@A zyc?0RlN`WqUrgJ{EZYhODpmkUZMxO4^t-#!{5O;w;ARlX~33q8{LNxZe4dPA6 zDusPogfZO@%4bGjgVop466!D~Xu?Al;yWGt#^eb;F<6R%XF6*Xe6;{`%|tk5s;D5(;gS<)#FqbY#~Wsxi(wtj8mqAv zZn%5MhR6P6ygKa@Zc+ee-gVw%?3U<)#2%D=^MFYbkhwg+RV6sw|E1U3?rN0XYAoY9 z#a#Idf*3d0aMuUk7Qr(eeoRk`y(-$&;056!!z>kgHn}1tYaEk-t8avTq~QGlh@Kxp zvmsV9wL?SG) z1UQcQ(P{%#=7|@2iAT&L(5`4ZkNh5X$GgU^p3xf=wPoUZt@ZHt$%ijK3CqIOGpVS#yJ7LGLaWucdC+|P z)*-$2M8s@5Q@eO!#zKR&uPvg9z@s4%5+~fik#^!O){Q%k3Oue+?KkdIMN@*4OXooWWtR6f^H=?M! z>Q>&VXYa*_XQ3ivisk&rrMy9G3K-Ja+Cy+&oQ7(rpxPB8-FqHa>c*G98^&~R0-LP~ z6&d~BDEy}oGdiOF))u0hNiB0;nM^Z@QJc}DQ2kAmv(}C`kBW_L!jBs`nBC!yS>%Nb zz6u?~Q~vWz1J`tnB^gS8NehJRuH8k{F4~`RDfj{$cd?GtO^}-fK4f+N%F9^cJGblQ zxM4J!>Gm4|2=QmoFNHDo;c)SwmBVAXP0;1A?uVYox0-QxFGn1OU-dx@3jsRLIhT)Z z`tpW3`-5xwjrb1ZPA{B`fgLMKY6XpP*LE4fwEWbYNkSj3vSgcem%YDUOuzRKD!Nd3 znNg0hc5u#b237s}l)KAEE;=eLe+Pq~Q%(D24wcNgjMHC`MW5YI= zc*jsCPHoc!^F{FG$MKzH&Pd!XfMj!Sc8K^#Hl~saTBV0=>u+Vc3k%GZpGKNevVqNl zx%$TJcwb;=iNkZiYH5$tD5kW~rn%FuR{5-cY16V<$csM9+K_)&(&fZ~tIDrz0`v2@ z(2*cZgaKY8Zl81YqI3arBPu~5d#*39E?jxmlqfstdG$ph#gG}P=4aP!QTT+!qbuDg z?(BsSu?RjyJw&*Q43KQ5#q!P+Id-4bsLsPO(2SEga~oDW7QbwB@enYJxN@V`G_I9< z!^`R~fWl_C&>)6p19$z5$7U#kbUw90o41{|8!|}m-QF>HcP4K!yHLN;ZwYYO&q_r} zxQAu~AV1m;4c*q{ml#N_e+!3B9H6P;B>il-)Bo;Q&?ikB*in-2E#`_9!eh7HReD^SByx5P3%eADSA&-xKM8=3g$ok^d> zj9&Qpuc_*jkYRUBpEzwn6O^Xr2Z5G(k`(Cy0A$LoMk;zX*}V_oED2ax7!E6+oN0pI z7eOJ2q*QRZ9wmMMT~@@K?soz5=IM2djr-#vNlz7Ocjl_L*&cdkyM-5Ja}jDE^lsYl zpjaVIm$fBes{KA^q8<<+3->%&E9qo)cGIa3br^3z$AaP*r{<2x+jgrHno-joj_piS zWV=y$eI52tOkUh!5J_oD&~XeR92TtbjC$~!8N-OUuq{pe$*tW<1V-`jNT@18US2tZ zk!I+%Slk=;#$TRmPAM_dY=E#|O!Y*|#)nG?#;+QYF31>~5k!jB+%gtml3%1TAETy~ zPj{gmQ*103sm;oI(d}EGm(X+b^=H7BMx&4F*1(QKwuI%xBBi8>wpw@oinbLIm}Dr> z{2WTFZ%(bN;EWRaVHCHN?9f5gchL6?OHzHpVU=*G2!dqORTxu!g%FpvJLJNoQ~a%CjEE*bQxoD*@0ms}b^7 z$hai3LQZIo#`=IQ1EU{<2@%Ei`vYU<*TwQXayE^`75Nlb2f|ew*isMLcjgyE$YiA0 zAx!;SC)HQ!4GeVTO*$;jiW0qY;yl1Q_a)~4BkD}tlFqyTJuQ>XR9aJM9# zE`VlfGgjzSF1b)@S#C^netDkf zx_-aEfs6O&obx*8zJ0g17unV}M-g}7BrCcOC#++`mtSbIC`0?Y3iP@LLk?@)XCKt8 zb~jv?dgxh-{B`i-I}N4oVQ}OY(M4R#8C*yfAhOBGz}J$)&G68AI8a*(?9HONN!K*R*!s(5R&Z~ zwWCrZwGi}Ue}-J`Hwv@1ubxM)jg8b}eQoGtg#ntJl;*X)BDK!>IpW^5GZ%US76kw) z8WfLmi^PvY#K+emn48iM3eM=MU%QYR6uTj-J=3X1xNLkZUveP+G0oeMzkBJUnp*@) z@qh{ctZP7$gD+JS#gL(~)5?1U$)i9kbGxzRFlJ?uG{4yTtMkH{Vss(81d#-*mKoZ} zzNmf-)aW>1<^qStYVJ3IXT%`WmFJOPmT&h3uHWtQ8f<(p_u6C__Q*s#7;2`W*wc&} zeLrg)4;Pt4GqXn#y%Sn-TSDbQS@_^{F&Doj6a9Gi*1vb(AR1|V<7j;@pkdd=RLRWH zyX;E_oZ_64t6_9$$@?Be+~>TuXucI_SAW{g+d8GokN8Cg-e?O;488bVYzRkPfc|S( z{$ZE9)i~A!qBEEXe>1b&tin(Jnp6N688UsqEH;Pm47jTJUb=15y6;~$=Urp>DG)bpC(&cW2LVUH@KM`&-_xU+ zje7gYrp$;tnK0|~p$UdM39F77pg2&eZd&f-*d(}J$bAiwI@1G-Cl56yhg{jhZVt_q&wU2?7*4fiAfi|5N`n)@2`o}?01c!wAl;$xt zmJzFoTvSLdarZVOEYT=ghw{N_m0(*V>Viak%gp?*CjdG|cv!Q4m*XM_m{yF;)cr87 z-f})qjXN6D7_%;)pzeupjgLKKWLl4Ug4~m)S$4$}8`}gaev)EBB0W62Yh~^uig(Mh zGC=YsfWq;x$iINz!QtcYD=IDd`3RG*P{nwHIyI+4h&QG00a|o}^$y>u3(+AkqKZQj zZGhR3&RLt2wRANq%wGva7>zNI;z)U zSsEw9Joz99o)!S9*Xthg+>v{nJEPXoE?z|KSCE5-R^I?(rH)x=Y-5|X8f&WXIRAuw zKFx| zA)j*LXYZ1`f?qZ_-&rsHgCjjk;D45wLBVhkdyDO^W?@8b%uE z=NpfBegkU9ZnOk{;l0mVmg=i_l>@TzASQMo^_IkZU)M{uPSxsH)l8gX>C?KY9Ty|= zRz-|PwIFY;a!jX~7l7wg66-~=0ja?@iSD8!JYY3qwF(mST?zVpUtq^>nEllj4xY&U z!L8;`I!eZk?1$bktn0EY$xU}pc-`=wmsF6cX=q5ybR}fUc-nO6jIZ_uXPZa_To!!}<3Gkhh# zkNi(bJTD3 zRQE*7?2~UPNumr~GBDm3Bk{rehWh+dMsp~1X6<7)NYll%$1Yg-2OGtP`XTuNY;p9UxR#8oEEGehvu)9OxTnl=3genn5Hl< zOnP4Fz}{QUqiT<4PQRO832pd{>>wUy!$NwtKnx`0%^WVSK?^TF19I?72{0#rs(oxCg7xAnnL=W`y<<`Rjn1`y@Xp~-+2`zveGxM@@Q$H zN$eiGBz9N}r-R)#UbY~MWJAQ*6(#ZhIS@Xa&rV9cp4-2V-ib$TsRm{1nq;%hN@A-l z+A6NpFGogK3J2J_xkt8AhPcmn z;UEY*#I~Tz*55Uv zt=cEeP_sq@mA5yeq7GX0bb2l-4~EC??eQ%K-6U1BB|9IP*MbbOJ~4GeU*gXU0@%*Zb{p#tJiO&asIH6xZ-E zk{Rd@_?Q{~Ef6u|HF%_Ev9V)9&IxwK+w_h}tj-C}A?7JH|3+^nXgG=B5BIH9Tw^LL zw;&l_*0DiIm>9YyJ)AypJ89g|RXBHApnpzDw|z7>b9GWeHa;~1iT)3jg4+W%R~ms< zSb_BxidQg8RNiYq+4Pz9Pi;CBJYxJ9bwTTGY0Z1KH*QIObN5{4?M=WMmKv)c?DLG8 zg>Va9EvIh9Q$sDrDF0fd54dT>&mWT6lMwV%bA;nsb?P8wstE}QpIUl45|_C2roEws zxdDyIh8jZF7?N(Ge-vK7y&3f#vf3*hX~I5I5{Pd!*jbQaard2BxBK4|-s!>&oRtp_ zGOC)3AwBmNC_P_#)Tx>N8-O73HuYqZyF;--EI~Za%h4fw5jYTnZ`tMQj@KKA)ZcNU z%GtAy1K15*`Y8}fhAtG2(rY9oJ)@XP8Rf>Mpgp-V<%}qp`4e%`V3X`n(C4a}dIG*h zz5(=RrVXsWCa*8*`B&W3=#vui&0y(`mVfsbhN+?PHOT!*t$u8*Vn74aP13WCe@>U! z>#O%~c`29&K3#mkN0Ux$5OR)_uq5PNeFZRvO6V_O5rHo>kQth%@4&VPvH?jKqQ}bg zeZauPQs+A2Ilf}` za7~m8XqZ-ChW_&3%h2_)OPC8k)MS`1oZH3-qwIvDw~wPuKY7 z)Udb9f52~A!glZN`O#MdxFjd<&IBvYeqa7>&ZL!M>HT-mPx0ozvo+>NXC2K{hlq1k z85-}#eXq=X-NI{A#vH1q*i87-O!@HeRMA}Z&)oeE<*2Bq-_xM|&E_cI@TK-+(W|V? z?Lu;qOR+)pFT1b$spg!~Z;aPCtp-aHyvspg6=kgJF;1ktDNQppw^XY)BlZti?iIVk z(b3#IWr<}7dSp|8WyBxO@CT{HDiddgJB%6;!h1KT1?KV{(0Ic!N1+2&1?M`&xQ2Us zP~FQ^%P87iLbO})7KKE8R$W%UPc%7NoI)JuhM^Ts^XwY5RrT0eTS)j!X^Rm7cQZGqnPu90mK^ z6KP#KWqo8`8N(Og9vxLznDUw(a2(Tc#?Mz&6f-lTU4gEwKqyfB`?8+6?ptB_wcQnd zv1NjYCcDicq%~GSvt=ccuUk#Sfpmr6|1=B(lbd24k-doADNb-GvreN~2X0llc;a`1 zDP61hK%+ZBAH=#2n4O>6vQD*n4ZZ8`ou6I5Nf2Dx)Q%V?sqstPb}--m2V z8x1ZqnV(yMvTwF&z_EjSQ~au2F*c^!zP2%`|J3Pc zJ$OSXp&o9zym&dHmI3-6_XPdnMk=~%T+8KRUosQ>gJ_6Cf>ist-Px0)amKT#pJl3n zh1I8NNtE>-Jc8$RLR?plm4Plx?8-mXAZLrD{Y~k0ZXi94~$RoV0Z?mE{POJpa~J ze?`&b=r=#tzu;?1v|z$}5CKQjsK%XmJ$Dm>?>$=FR8ZG|UWp@!01mwom(;y?*nydh zG*oQBjKK^#dViUFbt+wWuy8qziB2MqW0zI@?Bx*j;KX~mMV9HXn6W?P6GSBtmsonP z!$$4uI4QJ5web_DY7u@Un=nj%wSw?VQ+PdW=nOU4jwDM?B{MxUpq=`w8^u#vbFX2@K!4BadXKk7A)jhyf13!D*lx3_ zN8nz!d5aTyJ?I?^MR=&C5DRPqnqi%2QY$NTm=SywTdpWWV#9cb*2mG#u2hH#I(7YQN z+~>#w=9(QMf6`&lJjd^{5eE22 zP@5IHZp^GZ;S!cxmB_2AaBm6j4a)jWv}SK+Rp)l!=TrOFt9Z8@m1Mi<&mtdj7YO}N zSEP_P=s}(NE6F#@DE3;AkbQlg*zzwixXRox&=*9RtjTnt)+`^+JwiN?Pyb@G@;VD| zLw2p-mN!bjNazUu)Kf9r67}Hz(?yW_Hu*TtyxE_1TZ8>fK5!Lx1bXpMBxq>UT3mR& zW$mzso#oh#tlgoS9L5HaI4!*5A~w+9II8Bz?&cWeQNwFmJ*Bm=Lbtk()G=gLOT;5c zQ-^eYbG4d6N*&n^QsDa_Mvx)}WGjy>JN!x9RoFPr;B8Y-!hd04Z?}|c_2g%z-5pWC zG=9m3@2xmN()aaGN|Ugnm^L18Y_er!nN4E%A2@JJnr{NCj2qWzRgLF`stuRiC$I7N zCC=qj$+imXOi940{i!k);NfwWYV@baug*?D>5L` zVyu5TzqrP$9QE?`knDqBvU8u#dI~E&o9{jQQKgFaR^GbiL#+7`MD<;Uhg7vk-H8se zz>`F04mGhpTjIfV*1M!Y7Poe}(DuIIRdbRLW%xB!c`!@V1^zpJc_V12VT|-SFrFT` z8g@vT#EmMDbvI#bg$nY5{ukA^^7#Zb{UI<3ITGQ!;B z+IGSOx@b~Za$Oa1*M~&ARYpf{mOjA{wVVBXznjE&pbgo{_$$f?(ImRBgs@!LAa?^w z76;sP;?-oVY~?##v0ZP%i{-vJ3T&NX%v2p(6~r#*xQTc#jlmZy>IHm_Fb2E_Xp4$C z7Sx(T5<`x;Hz}H1e3=SJYbWPdq5A7?MyKJOO}$@%|9T^kD}R$aVjYP%)suM`%yEtG zj1<1?WFijj|77^3*30j+bt}*OC7^=Q;VgYhmAy0}KzG@(uk9G{4+Fe``K`Jv%|v!q z3TbnZ^V|PsN+kN-FQ|)iO!E_DQ2}=v zyj*nS**%g~lW9|r+GVqrUh7vif;d^l&NFnn3Bd;)4FAMICG%T05OdR|KyV~! zhL&TW&2^MgBPO?KLaENr{->TZQ^AM+q#jkv#CL`UbRy=g^=!B5cdVv_Cc!nVS1j8& zz8lB)SosOLqFZ~KT_}FrpTqTwH9gaJ|HU}?Vmv);a2x1c)=!PEgV4noqOd!=&)^yI z`^lj!d-81)LmTgvK7OXfyVx^iD|cOV>+a?T#Sh0c*E2#|^Ws?=`2Y}p=tzQ zDMFQz=ha?pr$A(mzV0i*LMP|LmDLIAZeI~<`GRvuv^{|33?^i&*X?}grA-a4mkEZg zurvE<)k^;*w@{(0^|D=DVY1%nMnY{f(!cbo5BgQ2&ys5_Ekr5J)>`|}QV$*wG5@(8 zGSXm!AjtnMQw*B;=+}CH?Z!IQNXuVFFta*jOiI;f3v4<=chm$*$QF=^ag3x;@dy&# z4k=Qbj34!u$2?d*Un$^rhnsPenu(sVpk1Vil%A_?<@whAsd-dy8^v?h-h5<@)`&Sy zvhd5niFxj3u@y!MMx+Y9Q08~fzq4gm~$*8kBJw}srtD(l3#x4JbSa4nIEsQ}NMs@y2Kx8r@$^~T!J2Y%10sk>}_awd`~n+IlUAoIKNmbSFk4bYf9`HY6%C{A;cJM-PId^Jh)Fl zchd2y!QWDRarw=*e}P z{oO8LD$=d7w@O7e&l@6a>>&H+&5qUB$RM*>q4(d+teq5xU*T80f zTwS#4kQT@&k#VB`{8_&%eV*0h&Q!VgQCCA9Y}|y44av*e`HHVLzv?bm?3x0_kNM`3 zl~0PK%9HfWm~^HI_P(NCLlJUGGgU_sFf9&&EafJw_7Z=BqdLUim(~z~V=`L)w3rEc zfYiy%jH(;oJ+9MU>(Nzks#gyjS2g3hJ(Bu@h#rm|OfI@&z0vos*7St+=fih`{8x1M zfDJ{(;fiL+=&1$VLL8j7&0mx{bK7@& z&_=~|T(##KS)xuKTAH^pnRF|?I<*p7sxP0ic;#K24FDrq1thWbAYNB%$rbsJ)ICU= z7j+Wp{|<(_Xo7SU_9%W^qYqJnEQTJdr(nQ|nXQJRpG}i`!C#%x(dv=j;)*QGH)o*0$hEP@{?ZExJvXzuL#3Zw@|x;&Xn*1~zk1YQ zinfV9&c1X>V{%yOuj8VY23D%T&(sY9d(s00(BNds|L2P&7$!@%J9Ol{9+I zLp>kr9u6nungr5jMv^c*Y_@JjL3K=FBBjyyOW>A(czx({T{aZiHbVkGFhs_AsI ztxmPe+7{D3d-a9Y74(1@xs{in$lGD7Sn{~ch55Et5Q{dUD5gw_!s_KhWCHC1?O)An zet~fE`50w0wKKVM%Uo4RAi!g}64O7l`({tk`{f#EoIY+D=rH90oL+nZr*#=lh&Wf{ z>w}c(uxZ(|sa`{t6~4%oxC@-D`Lbr6efThwb-Og$`dJrIHOdmR8)F0+1|_CT&crj< zYOKKtdfjLG-EcwEUhnv6D201sW6Q^2PpH34@!dHrCOZXHuK|oaQ)O`o^E~3;3MAak zSDmxYY^wn9v5_&)G+-(+r_w@b+#t3pGdm5<&TZq|Gbq;ziOOGDT;FV^aqJ4l+fga6 ztXd+Nbj)XK@bz^{b?OX^n`^`LVIx-S1=41j5W93Vpt+hpLShW#(iuFfhq1U^RT&=s zvYw%Mm*xBz7N#B_JTY7QiFcJtT#{3r9a zux_$Jk>>ic&(tr&GtYnI8$6vjrBj5iYQDLj-vIPQ)}MyhP)om6jIn55ytkmH zAw*4(eUpc=>q^J;q@;nP!%k1e|LL`bf8pE-h&*e3(e_oU=538? z>)5O}K+o1Y6s>iB5~eDZ-!^)ooqQO*xjEx~J>zoy`@FLsCe_W@_NZg&J&sp)HQJ0% z4i%Us9%^X23UCBDEW2v@>GLLqEnBD*rY!<5B(Mzoy(*_ zAidjAxaM^1uBviKNVdVAZTPq8>K1uleo@p-4G#nG;fYb55JUBaf2^u}$8{>F@;-jM z4CoErI!Fo_t+kGK)J!%9lclU5BJ~R?Yk%cu0&|yEVh^lDP64Ys2 z+%2D8(42{3Z4CDR#;HT zH0QcGS2zKDTe1G{$eNV&evD2+GH#@;{Rf;VeQdV}wr3v{jn&Vpn@$lH5u}zOr4xO*+ti$Rt25W4vMJ)S^0w zw1+_XYURbhc5{gthO0~S=`Bm8%$D)xijEiSti6st(FBhe32*<~q=@kw4g&c(X~v1w z(2@<&SVC>imlhw&P(}!}p+|=@$4wniB^#HTt0f1@6^C$Di6J)?yC?gy!o&D4gV&CY z=LDs-2(^LxZ)a+`Di8ah0Sy|yJ>NJ87!kSYdRfvah1eOApBkgnX-k3!d^a0h*~^1a zIHK|_km6{w(&e8K#VMINyJ%LkE5CMS@3UG;_$t|D{V6GS^>iA_2bnpA@`hrR*|WQ~ zED^&87(5DSN}`+D#+xw|O+{XguWIyD_aXT@bVy_qCv;(hED2*DswEmbT2tr@X38{- zLBRal$$VKlv9oo$9@vSgQhaBMzl<|tBEOfSpBPq+bukSV4DoMkJUkGm@8WowO_MY9>69?WiWuU6XH4l;~sf5I6lR09%HR7UK4ci(|iAOM|6=xSWC|fJy zju4QuW5q?Fl*c7HYMC13{&KAN$BS{qLzTO2>>pWxnUP~xK=lAOv;*?$3+_lMYNMeG z**>%y<};NJZDmHO+hbAh?U2}WD%#54$GRj%W_Vtrz-wOIrA?nzK6|LZXwTu-OLf(> zv;T#7@sBKPE%Pi(EfFfqDow|vP1x9^yIG%(XhbCK$<}=BFRCIgYyHtAcaqJ|_%EDe z^%qiKfb^A$^S*(hP5Nt`uy3eCk;I;DO9!VqB9cebg;Td%4?wR(Os6~#v#3c4YB^T) zI$LMiKNc<%{e9`$qEPgX$)efXMU|1HyUM9bWm|z_RtxRdV}w;O$m(4o29Pd#i-`9g(E8! zTHNFsaH~lFb{2G}^ExVgrA*f7WHb`o!Pl>@aN6wub_7rinIAV9H&*6|dxGxQW3Fii zvct`=XL;^51}iVeZ<7F}Ld&9H3yubBVXIof1h8@O&|($Uv@&lT%$4ACt+NX%kvja4 zX|p%=O7+-6YBJSPYPccyu7e*Qu(}y15k&?(nZcn>U`6qc_eTmn%XJAuUFPL!5~1`& zlZxYpe`w!3o7{RURu?LM*o>XH@5Tq*@^wuYPPe|Upe4N`xV+%4tdv;eW z?mpt}$sCt2h}{iLCt^nlH7_+j zT6`@GJnURQDYu`Zihmgc$SXj|P}ehuP7>xoiSplzVo+6?NvN480)q#VCzz->ZTMJM zsZD8--;WGofnmg#QYQrmI%YKEc=xuMO>ou*jN$-|FVG{@a#ApgWzah@1PklmO|3yZO=AdU z&skwtZkBt@kk6~56n`=GO={4q_`?k4IFXjUVwcg~!y{HWRyxEXqizf*KSYU3S^H zJxw0V>TJIM)w>T;SDy7CY&G0qu97Lg6(E@1tzPGXn8;C*u~UWFxB~KSt?pBkJ{jXn zz3hPaxiV(WJ#m4d^j%?+{iPNAxC(0g^6`*0d0qTcQqX5}gBfpgu6BG}Ah_GA5!f}Q zVQpHPADIcL3!Nc@Y=?m#S6`y7_j;cIb+=vAE~7CGm^r>pv`pY|r+guMEM`l#&eFe~ zGVj@wAT(&M^a7wMpI3yGhe3k0q)B0C#MjL!@5>P9{7{nIRJU?e_l}YvKJ<6&t{(*& zf#mu9YT-N-x6|PCogOFjE+`=-S#yeYqfM&8aY+c1^)lx?Y;Mionr7&ISN=&P)^%2{ zsg2K&_N3YI8ed&%`#$>O|1YL0b<=x)e;BC0lQQYRgL?mGt7Qbb&MI-FCCuCNjP6t5 zqo=9$0~<0I4gLz$Kdb*HCQy@OevbUW(s%gw27Kd^lWNnyfYN@HFq=t-P}X+Cf!>DAzqgwJW4W9*a6-%U=_CRo$4g>Z4N2dKPvEXpA{ zNt?C-Wn3lwDK?y9`&FZn0k?jcX$`Kw(wga97y6v;77GKrqW@w{p86{&>We3;YOZ@A za`7GF9z0<&B_WXZnlvva11(io7&AVJicsRR0T@z_Co6&FRD(%M#Ky#3~gFogT~#jrFdP zepT0s+98?dpK$T7R4;v6?E-bX5mBH7U<+5rijgnraQ zg&nd-xWjbix?j4Qa4@}KBiY^)bi8Z_2K_`zviv6s;0`9JLMw!A($X!jrVhmuPL(HG zd#|*XA6f5(8L%5HMl7ddmR>n}GB_KpI>@4LYI`9)e&w?CA$C&F+|oqMC|I~&#}7aQ z24UdBA!3?M_Ji$el`8Zl+%jQ&CqdK=1-J6#Zk9(n;nM9G(bM~fN@BZ^5-$(gzX`K!YCr& z;80|geHRrw!EC*(zsS11l%3YA{e>l?)niRuS?~O%pSE8cVS?Tm@ z$Bq5I*831w7?a8E#m6N# z*vDbUERUR4Qchfls7|)MIcXWO)z?CF-RJ&jaawNG>bvdTJKpOGTB3?Q21Lj=J#io7 z_rO4~ipmzXu_wL+k@4;A8+1FoCW&>8O;p2J&`R0&*W2PlpR@Nk*vwal zz4!@lSKSLmMaDfMOpXnBRmN?flD(38kn+&ZX0imJRvz$$098#kHN2L_6>HJ`GoNnA z{Zp>`_ltGKi%@cPIH{Ucm7xRnNBA9*(dB9`3dLrl%`WV|h*BN8E83NMBZzuu*==o! zD~S98FtlX-OM1_ZhLwUMFrzc1$Y+qlhQbHT@}Eaj9CRp1&BZ`=yNT}_>$>Uw-`xZC z!TSwUflLXP9uTmm%cTs}1g1z1iTu82cw8l>OxVptvbTn-$UM~}H56Re%BMMG;=M2W z2^-+Pb{;j!XyZLHVW@+?{|S7aO|>#C-?Qs89J6;DYHmt8msAV@sg5ZP*M)}hsT3V! zO`2vJb-W%yeLUN1X=CZv7u?O z@AN{cLghHJnw(|0A1%0?^_O6m0S>Nm^VJd}O-A3Cp!vM$FDJ9K{5>it$VmRiOLW`J z)Eme?g;65wAoV1#=K=B6yvqj6oM`Win|ZM(`*&P~@w5w?Rfe71N!%8a>pRZ+|k8L#0cq?Fwfrx}{L1NN+#B}rE{ zqh1M$_C3fl|9fOy9k}YZRiwnNl1U9jZPR9?;_C=>nx^I?uqy?Z6y?lXFGBhn@1tBt zD6q{4ubO%MlYpLuZc#b?v+(Anl@{scrgiof7}6Cb|I`^I3g(O7*yUcZ6fWys1jqLd znIzdBg=q$=7O_*YYDSq|HSvTeZ+l^pWn9%RbrVrkueKN+s}zW{Ax(Ww;O|jemZlo% z=qJR;VZ~(ZZ*n6s>2#}KuL$pFXJG@$F*_E|K|Mf@iV`GW^)*OM&G~uCyrcP;>fQMD zH3gC6~uYmiYVUY8i0SAuVYkpnT@20Gnx(KHEh)i(1~kGwxcrYI(9Z!+HhD z^Qye170O-keRMgR{My*|{@f?sfr25XC(Cn0H`?Fw4XO6Mg8|)Nd!)%{XXRBY#&2}v zlxQf0alF<;11A|1-kU^H=0pPDbQh`+1Zj+ULYO9G(Yon5;Zd(j8&q>>Yv-65R37U4 z!Kl}O>JB^>NuxN6)0s|(5obocPwrgdl_NM6xp?w4m!t?}8q0W;NND_%F~^Yj#+eCwj*EiAgzF1U77MgIwbbr&d#Ip@CUDmc04`$z@oX4MKC}DONaQ-3kNtB4TSTdAl*Sq0f`I z57Z`=d?5yxBUo%_1DVOntCqagk;doWYLa-zv3lLkFMw1mpuej^#miKA8#jGW&WvJH zI_rb})*s1o1A0dyEI$=uO&dXHlcM9btUS(K1E*iF@u9RkEjH3x4R{yqKA#b5nD*3p zvWx`jRM|7a5umAOUe8pS7G>soeg}Pf7H+zk#^nca-b^UR1 zN`m_BQxn<6_^On1S%;OB!skobi1g%Jp+njl)EsQ;9_xO+LXKvr#w$nsKFL^yuG(1o zKA)wdORM_tMh!VesfS%C~&~ySK&u77eY9PQj z#F|^(E^H2WkEtz&jnjWejN8KTJy}w;kLI=-7}{b;v2EA#-PuWgYyN%NAPn1~y58)@ zRN%t{YSWEXjQwJsnV-~NaF_VZ1Y#p47c{yAK;LK&Q854JxPpZ3nPA@37(jFGTy)0@ z`C&`9l#?*rR_~`Mi{4fDWyC`_Mu=b`Rwvmyeo1Iw?ohY5s$Qh!`XIMX09_FpvR05K7jODT@rIAJ) z0tb}kauw_CI?n$2ex{c)~ggq5V1t z)V=HaHkLPvdht>__7Yh7V29zDr){(9BH!80V(fZp!~D!!n0m2DIjFcdqss)AHoIF& z|HcMRjopg;Q8do=0PEK&mJN*JcT33c5np_Wiq`?ck)lcYDUT2-?>aSu=wmZ2ehpLP z2Y=#^#V#uE1)AKk^gk5M{%M|^nRK=TYy55>dC0U$&Vjc}^}dl))UNoS{HP6XEfPt^ z>}66*`_o}JGu6{Dv!DnRu>?=FVoBfO5d)l&$PJ3h%uG)SZ|~qN@^YWmZ%I(@|*h;S3Z@U+N(n^Mjg8ACqQCiLwB;6NPdnF-b+Fd z)k5pJ8vMF_eT&sHTC>;NO7=}V+xDR(+qs;Xj<5CFXu~D^=%st^I0h~D8%|3%J8fdc zWZ2QLi~@hZ_5c7iCBj&YodKM-3J1+`{#FB+Q}+LOs?)urV&Q^?YtvX~koSwOo3pGq zbG}w}Pg)hj&J9^i9E1*1iYI+|Gu@I7|L*f(M()Gf*HZOv=w8KEFf zd-h(CC0J3QA@$N%6P^9-CMcRKcx*jU-(HbR3Q!gnoe*a>pt4`utK|^8y;1|oY!(UqKHkCU5Hons_ zYl97HzfiAF^R^Oow$*G$_1@qs&>L<_p{%0$4OC}Gk}HSl}lm8c)fM>d1NW1?)Bv>M^n z&*YtY!&GK@WEq86`p1N`x>CZ?aK%X~L{VK3WbPhI`7=C_e=5$%u@xs*ggu{Adnu@_ z5$^y(dQDHuwt%b-rB|OcgXC{a(Mm6MNSmwi$Tk?PdeLr=#A!k!_O`uchPKaSO^Tb> z(>IhDI*5a3Gy7z}17kzY+|KOZ<=6OKoS&u~(aPn-uwIJG-B-(*y(^|M~U;GzV)S_tOv#5|~OmTSbB7M}xuyg{M!64UqHS+_i zEFq&Yim4{c*n-@6!-w|Ja_&;weZD!j3Tr|xWj`!o-B&Z zXi?}|THXCdoULmRTGG3})zjfOXK(uIDaSqr%3i6UB*>b1wQsf(x1Amxl`mV8ov~}A zmC_zd3D&Lj?XrNN#K_^s@1VpWsy0nN2qP-sY(OSx6t({(e8b$V7UP2-HEgVqajK z=H*%O0n|VBkL@R=x&e14?kG8WzNmq5X8AYkClSK{DR0}b)>`Q=b0g6FhKOgB4+mQ6 zVNMBHzB}v-t+37*?!Y}mp?U4PWUY9U zSvz^?6h_oYZPkN-T*H7?sB3GK9N00Zo4O9jRx94rAMTr0v5$l9^|>z+hS+J{3Av2e zAms^N1$nk7@~$7)5+^Eu5qyr;w*`lx?j6k-5Qp*wGHvij4~RTHOF7U{<`kmjEF9rA zpDFBgSI=2`fa^vAqcnJp_f&4%cn3a7XQYB?Mz8aP9L7f^&JQ!~z_%83MxY}3KdS}1 znKrS;44LiJvBud~n9uxPez!KQ^3@gVFMVy<<|n`#RlLNa*~Ymk|N1@O6orV}8w4Ha zv2oFaWi_%UrvJd)`LRHa?4CYcWgQxe2BE1mFZ%3fzY0j5jK=t-HB-kg=*cQI=LFOh z+&)S)vJpP>P^I1~)0&|TFy8HevWGD~S7b$NfVT9SZUgd@9N$^z#-AE%etI1ji6lFQ zl4rCw5JV>g5m!hJ$uM=b;R$}A|2<=9!TJW?Zhg@;PJJgN(#_X%H^+%yo5WM5{$7x< zok+8f443j-Jz~%CMPqAuNN>9U#eQ;-hd`#sGk<8Of#Dy4_I(kx;k7^C)DgT$35gr| z@ZM1@@$kznR#{RDYU5slg(E?pV}Gkmz03O4edz!6NC7H%&7b%k-3dROU7^p^v}kf( z%EQFkwqujA8jvJ`5(Yn3II$r~U=;OJc}vg37Wod%4L0zEaE-)G13wn?5S|Y+%&mhn zJ0h2!PC59d!k6CQHIP4kVkbd$HW(Ake@1Q8C;BwhnZOnGPPEJ&4?{&}n(IzB^Cbjj zk9Qa)rwn{90n6YWhx&SQMYA96vD-;@yIx(@`PaYlDu6du$X6_GXar?M#Ri#ZSc+K8 zQwZ zuD1(k)XCdxT4Iihpd2ke*u;;y*{99b9Twb;9nn%g;wP@jK#Bt9&)LBZwGU!?$yzaP z(cH)N2SzxEN(<0fA>vOEP5df5rzMi>sD_VU^j2Y56VPSypiP2F4zw2B` z-2#x0U_(@u)#<$jfvEF8?)ec0b`MVNQ}{iEyIc8S1k2<6Ou`XAn-Qp({YCi@%cjLu zGp(DadhEj$o2Dy1j5?_T>+5CbXPsAS2?y}NSM%#C+`4!~zmq`qaxwX6vc)&fbR7Y? zGGaIW-bT0Et0FiwO>kvkOwGJ7wDjK8&(-K#Jfs@BHNE|QVShl{9K6n0gaxmobn;I< z(i8saoXYzC8d}Rd&{g6Ba?td~1r27MrYryMV^tz7KZ**NX~+GO$_tvC&$7A>g4acW zbrJK7QM&C*M?x}|w@L8eKt8J`!x$Q~(r08b9mk2dYGN1@sH-sw1NYL7;NfH4Zklpd z4PU&+!MdN%2z~)DiB_e|`f@cB)v3~;F7<0rr}%rmkHSIqT{yM!^^IYRXp`NUrK>w; zR9*Rqr_Z&TQ0jHAst&-FHTfX{x;V+7moWRHOxU%H#Jky}<=YMbqBFAn3QWSGpAmqC z@ZSLza~C4Eh-F(aaSYW;3&I2daMh`FnD6?=zM4zkrCW8?k^l1;uecM%Pje3cMsn*D zS!p-#gOBl(NcGZx(OH0D@kXi9F%x5)n+->L@D;QU&fCV*&jMgDB?Z_jvwGQM|C*lY zh4E75{T8Bd6R-$-Pj7O$WtuxPD-=&swfCBpHX()rw78IT2b0|B0k}Lu!JbLp4M@ z36*xsjJVl2>X50)F^)*If3Jy`h>b^Id_h6ISO9}?vJjjXP5>$z(Xfpz{nD~}`!*%0 z2HkPDH_dNp$Jh_y?%E0nEeHBpg_?ioVJ=s_a*6HdKR+isRy#CX1MD^Edjg)b9yEol zJr4}!deo1~=n=hs6~!xWtU=xu{QbI(K1J>9vi=CY({i1o zqKP|@S+FQkg8WnBh}go3{mgI!t~fS;@N90@8|nu9J)Q!HBlJV5O*M6K$p_@UFF^4s z8LB7YO4Qq+tH2KC1+){V93aY_9QT>@w}Sc|+wv*ICzsxZgBy+UHixWwt#~t}v+w>ptxwP4sZ%o)Jw1K%6ib+HU`T7Ekr%=q zF~_p5ROSy*z`7AgN>k#?RL5@#lk50bZ#D0!=Eo~-FLssFTo=`|USH4W5)tjT#yjJ+ zlrOkV`*@p(0|%sfOJjTEqzXZryMpCm#T(mWWqZCNzC$ImV^0_^gbq&}`3vo9SN)@{ zg;8pM-8LK5uz+sl zv^f+OdNI6Z&Cy0DWFmQH1NnHgaA}>!;*X|vzM)Fw=e<3SIm={n;O=};cileve9qq0)_X6U z7b~1b_79JJ1>+=2w}P77OD}RmCUhaxtcqul@gY|JEn67|64{Pow-r6_kSs|7jal)$cj#^A7NM6T!t)55mwO;B1|Bt6L z4NEfr-}W?CHZ79VV&y{Rl(xxOqYf&Nnc9q%IxT1_lv*@tI=LZxW@e@4R#BN-R+bws zsks0x?uwWTifbW=EQ+iGqCWioFP`JzHE+0&FQ5DSxvulnhy&LEs%D@2^DSZH4$b-+ z-jGG7)A-^`8GKpr{#>~1^`zXY1j_W9RCGse$%fE{1Hm;~odS7D1OaB3G+<4dH+vE} zT?x=<1}hA9#Wp&~wnO&SL*pLS=c4;|Y%S)AWqbBmJ2B7jRhtz?k{CnEYxl~{w?`gb zpnoXz&?a^oHoy1a1ya;qlpQxD;B+#HI?BISoC=$2H3mLOb{v*O-EUW(9ajwAD^-#v zv&AjF^toCVTXuC~a(L10ro@%GUhr4VJ=wkz#A8IwQvmE!dBB3E&+f!6K|$b9!nB&b zaJuu2??hHENy$GJsJWH^7=&*M*&q_qt8SC7YH%m2f?T2VuUdp(1~n_yXcRc}NL$T4 zyVaG6(=a=`$EO|!e^jqmKZx1nw6|I~W4rzGe`pZ{pS0L>zyFWP0NKJ_9SbX4CTVV4QPHO)hnB49gZ~7gH%W9zpV0GWZocQ8@Gbwe=w--;u;k#A`4_8h z%uW0oZIbQ+jwSDg=#gaQ4&_Y)K1gY{euOF=jPFd|q=&9=ncaYhSwobqiB{b80+Rta zWe1rlwA-GQr@9>F;*xuvA6dNiWFGQ7QTKD8qYl2I&uLN2c88EcMhjC>uiLhNYm?*# zA3A&9ybMhfagNIaK~)KgPP?!aZGC9FeE_)GpDonuXQqmxW;2sGlnFzi?jRJFLYzN0 zY%udnhq*TJCnFLpMaz7zab=Bcxbv;WL-LE}mdooT6ZKld*O<_H>6xKb!lScC+qN{4 zw_(NY0e2O{CUspM`y`%u%bR}I+JusQLHk=~PB7BOG`7qLOFxj!ZkTfZb6v)YEZGY!usyIF@* zgA7OgYhDkXB5#7VI|IWCWq%`ju-~J;`}G;-ZK`n4H|HvEg2eUUpDQ0)Jpw!Zww-HG z0}O$TN;MuT3T$sT&Z2-Bglty5Dc2u=a}dkcIQJS*2OO${n~dPU5%&*Q>~k;-mWyR{ z>Celm7PAx$*26?9GY|o1#K*j$qJ;;2fr#HH#|qV^raaUV!7$r^JGuj*8TqpWpca|* z{Z-oz-`dS~`&5fa3N@+nTt0c3OLfcLYL{`cFBXz;SPUdf>njCSWtJFO*3Chm1rBbL@FxB|qbhv=mv_E29?8tu<@ z>Zpl3PHQK3-Z%`X-{}yGZ>p%zcJfcXLf{ptHShOFg1MHX-0u_rd08&3C8GEFqyL8e z980MX(0%}z)<*v5hrYZs(-SAc)I4B}q&{n$F?T|B!x(TuGW&j^AKUDK#w}#{Dx1fg z9$ZqHr$c4L-(so1x*i@#8($0;Pi`%<3fhg?#g?6e4X~X&AQ_})cK~mI9K`8^lZRQe zS8zGAnP$VId9&ulU=StT;a* zYs*R-OJRv24pn)6w9&;cZkduS#1U#Oytxn0KgSQNV{|C-aJqtZ=tC-SG2(V_Mi^Ztxe z9mYu8i%X23IDCOe)JuKvwC3Z{#ajehMzQ}MuG7u?fjWKysQ+-NeRNy=kFI2KeFq!_ z^B?VF$baEw88xmU(w^#L?$Q%bWdzQ@Da=9j~!(jMVGQK2%+<}tHOu+5(Dz2p@u zt-=-i5#HI6JiT+*&Ff=KJlN~%hUpfCZb2h|UW;mX>}6VnZ*oE&+rF?hE-V(iB3;pP&+DX}hOOY;`PSZ1?Fk6C0>v}17JF^-)c>Q+(7 z?9Ob`fYyeL)?1UHBC2g8gxvMyh^ei7Pu+cI+)_|PAd_1|%NW~Cw9BqGfLap!Zjn_G z_<|>P@C4J>t5neEV|YIY5QQm1F~}cvAM71!jTEt~Z*@8OU)~@Ubabr4juLotQVR}U z_zh4fkWp=Sn>tS8-}?nplOoOUF?2S{fbEkF8>2d<62J>K(qNURBP$K*(@)rBCgSm61oX-5%RH}KLwWNx8xIBlZFWO?S4eWyxEtf?PYK%Kuo~2?c zn+KiFTfA$U7j)@O*bn392QH1>KU+}_bhoddy+EOd{u_#?%X|lbj{~8!z2Gs{kT3g`Zdd@{okujlb3i~GbrK_|FH zF2?6w9SLU_ZrhnJWHydaQ@!AGbALxIqytxt!{#hP?RV27Iin5e^c#B%CjmYjy=(kg zq}{?k&xO1(?kji;x1aikKKO+Kw(v(gnK#XiX+v$GomTDfv;AoYm3c-$v0}aQ(HP?X zmO;aM#hL@a@j8V(Vs$X)BDrb!iHSvT37_-CH8ND0waWjsm*xOp!J^fFRC*i<(izh-#JT96KR>g+qg=?d$`{mFr5STjM#tAcIT0hl)brjZ{4{OD5%?l?g zUL(#Y1!%a9^r7ZURITZx889Wx0kN1caKD>3dMQ`YIXm|Y;x+7sKQd0N|AU`+x1V@r z;VRDfqLCnAedyxqhUnaNHW9&JQB*m-5K#EU55UI{pAKp3<{EwinE2gP{JtFkZc` zD5j}Q(`l30(ZTP3ZtmCRN35t(`6bz*qq2#B>H^K5hQfuyb!9=9B{tEBl3IOv5XOmmW5C zVZ9n*DaC~^3ZAK&#|NXveFL@1yJGa?bMoX8`tXZhVK^{Bxg`XEnbkbk$+2YLr6b!vw296^v2ftP-)-cl?)LgTW?W@q8w;v9 zdN4Mh83DQ*Cg``Vg(b^2P2=15{7l2nVO89I;6Fj55wJVhr`WS8vNDzX??~wUxyj6g zmkO7|!PMk|07P^K_#gCl3h{owyt-28feAnB?;4C{_$Tp@JGrLqyz>at1#^Aeh|}6} zmReT#miyn(o?M@v*4Zi5(T0yYC;jHwC8oF+n7-L7lDRw;TS8E#Vh;H?3>Q3#$LftFY}Z zNyrm&3URxgHsfx#b1K)=;;in}EHc~g5zs%wdg2z+opN&Qh%m$jOQ`>X2R?LWsl9P? z;8EL|&acDcXYRG-IcA{O>z=@ow&SA3uh;8sTB;54RcLy3MCqjWVXU|~YBH+bo0f|I zi0pbGnY&nphXcMRUj+`7+NhT1vuq9mG4EQQrE!&pUJ*VETJ818vX;jN#cMTPg=X`D z0$Ime7pZ0r_|qTQGy(g_({JRk<+4+^w1#R~8;oGLm)JD=V;1)}vt&6LFn9sls%7E8 zv>o`J9qQf3$P`r5whPW5xd=+HT}CjvR`u6Kago_Y)gJ&a+lwnf^1Ts(lmeg0Ov+i=(ijrF*HusQnt3isk#`s6<+XI? z$NV5q;G z1H_+Y!Uh)ccfhZzac13e%cnays}N8eXcbm08(Q9riBq?nbPldOK}=!a3yGU9G40ljjY+xh z!zJ-cJ9c4^^61er)#5(8PW*dMd&5oyoDvhTAiof-sq=O1bwNaHbvjFf4F{+j2-^)57_lAq`9| zh|@g{t?WqA#q3L6PEHgmr+uN2Lt)+0W=Ybw+%@2VYHc-$ z0m)LI>el)*)jwC=_!ZzM@nvdCZJJcOR|GY%AO#N@B2ivoDA0iBVyg;GzHpVja<@#Z z7~4%_e{+kRWp`Vx;4i}ES~xViK+SV|G!F-M!o+4()U9(mt=G!0V;?=!5!VT`^7^f@ z#Eh`EBC}WjT{Vd-F(_L_q2A_{^_15Y#Z7B|SEV@b8COi{*#vvIVRLGUL zG+xV~2m-2_ivObg=7?*zU$NE*k6bjF5FDY&>Q2E^?>AMiVog7pjB8bV6FNjJ87+#H zIzO}x&x$HbnC{xZPVD&)h2sAwZ5DKy+Oy_%-zA$3ORsJWowD%VyCn&T-VTxbrx{;0 zNqc1Hq_^+Ab>07HtSX~=(U?j2;c1L~be>c%Cb+!y!eb00)1;sCDw_t^bL3vY8Kq^K zu^Q!C)YKxf5P39XFO~63C<_PlZQB0;o$-^{3y)apu;H!_U-Q({$y@ zGt;^IkWCMgn(wK6AL%f2nqJ&d?BHXH@Q{OL;P0xhR=0te8Tas&zkqf%hRCm5wuoM$jY?l9kcfxXwWT*sKMHZw%u4Mfc)GPxitZ?_}UP%1v@~j{;P<& z>$%-Q(k(p%JR249I;~X0Prhk6@hep~gAV-w$q)5Hr)f??$O7a*7FM;MH{k5de$$A( za<#*hLQ$KPkn>b_6G2Kwo{nQRN*v2@zOi(dr$^3U`7Lo@g!y87Iyyu`z8vguFBDk5 zsdz!!@30>r*b~W&#jcA5EpGfKEnQ4m+?cV@gzHJx+{JH8Sjj#%Z+v7%rP;_3OrJw8 z=xw<<<}}HzRt1La)T?CA1q?5((zd`uRlIXvdq45No&uSE_YA9#=08JUJD+Uq60P3OjI zk>+t$w-&JB0$H04u(3{AwwOkHHv68xnMD+_!D6#gwq0v7x0c|+=}+Z8c1Etdl%##G zf2}^`uc-kUf}actCC(uWzb$@GkZ|N*XAF^?@jb4r`0Zw=Z}TrJJqRlY0+H6yJCY#X zjys$-I>c7#Tpgt?@)Lt^#&`$bCbzF?POHf{yWBp*1%ZJ!C5Ycj1209F`e3$_^JFcf zu;zxad_?+H|FG5WpuO6etIcLip5Gitnr%)G(agTNLdf#CU4#z0fAx`}vc&HDpjTyC zYEW$D;)<1i#Y*0y?*eu)GReD+;lZFJP;0_~R`7w3iR(32i8Z zaGZsvm%@n8h4fl21_ee4x6#8i$Mrf(nDGoQ=HXz}zO)c!0@abx@+o3cY$tp33ihs> zXN7Wnx9cHuavwJGEE2k?Ig0I2-pPjMg{8=@xz;TsAiq!Ap2y)sYvZItZ!c|r><}Vf z51)9k5{jY{BgU+_6b)niR&=-Wwj?cY{&`u{Rvsa8qoH{6LB>AWL~w$?A0by z^i@Vd+#Yr-iFTScSBM*UvZ0EBDnFT8SU}!BP~A#Ve12wuFgV8~OFn1le4*=><`y#YvVoU^CLC zr_5Azb&<8ao0uXp5MyfITjk(=7uY}9-iFl}ECoGwWnRK-Oa&ZEV$1ua&6E08q_`_F zLhimA-)gX&PA!hmos3f$2f!FoUMWa5c8rUe5rZT_5gTI%H^ilSJ+^o(d8Op_6CN6K z=ReRIL{_B}PwE~G;g{?IEQdU&v{ad$8hr0MejEyYxbZzDK zNcZ$`Jv?d~Q`>so0)Oo`!j}p?cRB2czKO`Ey+mB$X>9nBiLF6aUBsAz7${@$WpNSn zb#>Q*YYviEYJ_?k)qXvdWko$j)lf{vG5BYO(5fuYrJA`hcJ$2alL0p^`(a?&ATNQ^};+DmKp$ov1yvMLl zCE>B-gO|q>*J=)!!S{y5F^*y{5(sT&KT8w!1BVl)&DM0%wdq+1!J~b>thAe;sv8 z$WQQkN&R5Xu?F5|mcur;c;@BS+yWKpEHNj=>7MMwO)SK^PJ>m*xDe{~j1Gebu0?8Z z=cyADHh~01rbiwK^k=j@F~UfbX+TB1lBLz6*&t`=`E3HpOT!b@K5XbjbyLI zDjb}x zoc<0Z;12S~?{iPQrMJE_%WpC@#zf^eif-$%P>rV~+seyc2p62_9f%GGy-{NEdUc*;P1rZRBa z=+@J0blo0DwXUO}@gbmT&XbsW3etnNTZl-0(dgBHQoBS-poPIVjqtJ>^i554+mEhs z^8SgUZmF=uxrE+WzN^^a!L~K3p!;=1!Tg(r5@s5);;Tbv|F{@Yo~Bmz1X$=UkZ2-L z&9~}n20~8K%T!Q-x?*l;v3rB&N}&y*j2tPb?|@aX@m5y5;`^vY<$wk+E%j%yi(>6O~4gw&<7CcKLv6g5(#DftIFn%pRF4i2)ubb_5g6&eaUv(BoA3rQ1hVp z9H91M!)%hppw&@5{fLnUz5)7V*5P?X*aI@f`e=Sb(sr~6c7CVuH_b++Q#kw$nKj`} z`PG(O)PoiLm!1xjp;*kGMf~CNxgKNz>c|N34+rQTs&xRd*^73`3YU1}44_5ye7!{X z=^XR+xN6UYw#$CG^92ZS(d0ckG@kKq@E`U`x$XN&D9`CYxHbhoyLOki0W*&z|4L{orYBoe- zFClqnB&}hSg*OU;tMoaQGPAKEr3DB!2o$3wr)CK?E_NZP(xGhN7t3>2$Z4H2Kv`ZG z3roTB7glaB7`$IN)S%%cP~!%Z(%>78*tMEFdZ2RKrQdkuJ-BZRw-~Zoh9ud39g}s8~k#VyvQ)_sWD@&6r zJP=9Km6qIcdfo%rt!He@{Cft=t|7Vak)`olcG-KY%e12 z5J*24E%WG*JxJhe;Np3kkZ9gNsbRtl%ww2NHmh%_FCPy#1_!=o={heUmY-EE$PO*5 zfXyPm-eXI%;C6@6$ZDXf0O-E>>qf4yy5Gb*vKJ6L7!|cIG%qD?UGoK0jccqou=wUL zAm|6ggcH|Qf~#dc65r8vEM(2SYB~fB8Tmh&g*gbI~<4l3y2PPj3fz)14TOF!$P?KT&nK8sJufw6`(gSWa0+H{gP< zg6C=!^yh*`aP~LK+J!`*Q1@=iTi`7Jsd;&9z*Z&OPy|cT!`2w8JQ@8k`?PNM{V@Ki1IMdpTJ~$iQfW>FaZ$>Z%{|Q(fEl=(=ZdL(eH8M|1v#4Hb zrl~sPrJf7?_L3T)xHvcK!<483iI6CtvG=UD137Q2Kk;FWVQLC#mTD2R_B$^ba5>Fnkc^k6<{r2D8`NoE zI;n^JF3Ix#Tl!QpsyD@?&><y` zgESjbrRY$C42hK`N;HCFJAbh0xeK|dkI*k!D-}&8!98^W+NK{nv+Cyj>Yiqez3ga5 z89%XtaF5NVM8EZgn~cvj^~BWTmZNJqc9M-F0bNND@Ys&_=U1XB(X6U-CXG0#6i}8t z2V%zvhUdzrcsW%6W|z@smKlrUb>Cl=#6YK=SiFr)k$vSebK4(~?&f(# zIYVZjzej1xS=eji@}y4V6y5{w7sEWk6lJ`eA=f)t6ej>mI-&L&>cdJdkm(9yDDR%t ztEGUsVExU*{eO{))YReG1F+qQ=AsNH-j(@f?og*kFtwI;l$yZWEZH{G=LbBMB9e3r zwPF*a5dz^~*2}*J0HyFE;|X337I}priL!8E25${FQn2M)c#;t}JaUDVo5M3EW(AuO>dwN%FEXqvlwT-#A+^mX#)VfS^kG_`Dd~#W8O7CV$=B zTX$3yn1FTH-+?aV-flXk?)!Wn3vyvCk&iSWJ7GD*=pWVC@omIz8I9Akd2*Ov=akRC zw0yh`XGBPkvMZuHQ@6nJ)WfjIrB~;=IX_!~aVL=xGvE1N+YO6XIMS>%T_?L~am$RQ zGvu*VHhxcU9S$^PnGevEg%^$uqlc;mJH_=b(_+n=w4q~}6jm$tE8STzWO(u-^frp& zP_@DX&YZ6UgE>R|&(+ha}E9PFONaeGIFnxw988Fb8;yhek z5+2O0e^t2Omc2`4N3UCnzLYhHI~p7sOmM*~#oG*&&bLRfZDgS7_v~CIz;sy{1Nmkd ztE|(toaFh~G@k9bM^ZjW>h7vrE^fr84sMJ*7=iWYFZm}T9rdD);!wFuP`*8jmdZ!uNSyJiFVg23|KN@?=^NBV%>1WXC!AygiGj9Duw=QXH8iq_-QsjtC$)>UqDk7cll`9)+9`**?A$%@tv>iCgN~Rh{5c8Gr|3~a_9cwgxe{!O0#NDRMZy}T&V3+WJ9D+wtQ^q zLt#V9X}B4&b4_O@GpJz}f{<}Wy+X0man=Y3nsjM20$lIGyJR$BI?(or5HtOCUF-BA z51lIFE*5mI?&E|;y7c>vM|A4%Aa~7uiUs&RI0t)Ivc#DDZP{H)oB@Y;GLNkiP#{~g ziH_}#&J6Z#W#0+2`*iG}zgV@MgDhQIgQ!O$L-e;kiuQ+z3!N*5K)gvF&>f~e5Iu9! z{2_Vh$~~R22=+#F^wy7buo(Bt{h3(f6IdGvIUkdB#jpTllIQ9S^9&0(tw>K^NB_v? z_3vO>+aM~3arG5XBgh|PG;UG{iv}g?Q0}GFgA>OdP)`oWO zWqT|J&aGBQuEReR?PF~CdxhlVjGeVqWKOjdk}g4oh6f$PG&65LlmA|P^B3rdB2`(u z-01_u`mK)~r@^x@5He_mm)dSTS%3(S2v1W_p%3&bUu~3~R6Ux!aUCX4>P~*YJ-8+r z6_VG)e@aodxgVD0KF5BI^>HS$FOW6DOtRIhbF{LqZF$7{6IGG@TQKoU!%HqY-cSSi zS}-_Met}Y^nIHSJXr^v*H)7F8r@dn@IYnES61};?O}SYeABXP+x$6{POKNNzMV1)w z6L?i}XdQOQBluJu;yASPm-4)5n|=NP-~jVDR1&wJwm*p>3c6VxN+Off6!N9jRi;t1 z*x2od(r90VW#cl?Q&LQMVCVr za-pBtqsslmqi2B@c6`F5$>|S?C&*E6KwBAEFmh$3d2vcy&yH^q-b%ZTxIK1!({$Kk zRUz(xX|LhkHqycqTj~ur<$5)|F<|qOb$t{2`-89BDT`rC9rd`Sefh~9aBeXoYLyG4i$CS}{b zXpqUUl7a~`An;_a(b2Xf>>i8tkv}ZyKCuu_>Xb>=Bl;#qPB>9h0wdJ6*r1Locgdfm z+E%SytRbA#{XucZ>O+|8u>0rP1Lx{Z7qj1(4FN~nv5R+yqIxIlie!_!jDMS=TevQ} zEGe-2Z`**W*o30xipsvUe42~_T3H8TtLR{yhLuzis`YnjG&RKJst(tGn#zKNi9;yI z>s~(1uS5iBc%X8lXOnjAPQW4k>#ybOI^AIE@lryq{v@3_q+K6fORK154592H1|1X1 zHMv35;x)0f`y^bPkMq7?KB`UpRMeit+K+jLk z*4Rb6f0I6+4P*?X*r$+yhl#RTv)>($N&9WLdvxQavvdDB=s{f1X;mHN@{h}PhJ&{| ztq{SLDUr>n4T_Tbj~$=Pq`{@`(3vT;>Uj~_Xi1sex5eLFdyYV*G!~8d#VyPw)bP%k z*>)N{^fGF3LDum7_c570&z2-O17&;ro$(}~7+ApE(GV{dL zsH-A6{~dK-Bc|-gSd6NKnS||7u|He20Ya1Xw`p*x=87U=G6k~R)j8=!@*v552v9g3 zxcfdL2^gL4=b=bZm_0I2H*z!C(2#T#){5)BW~gB}h~wlT$kQe{&H>F--ye;u1-(qT zUG%s5d`9CtLB|HascK`8KIl~nj|fdJ&Iym{1&Cma(GCvR?{W&Fo6j{O)K#s#xs}2Y z#m}G6$n|jry@t#?WFxLy@Pl$Q#YZ4~$!fn^-Y4A0wwU(^iEe^fNr=7n%bLuaUc)yj-|kq@-7!zBI=u)X{x-6)fRc`5?%_wQmUjbXzu)=DMUzxlPkYS^ z_D12c?Yn9pMXsSK-%Ol$#q_pOrgi6G>v@}mJr_5HsayHkOLL6zB9^!-74W_7*vPTJ zrrk!P>XEF6hl;d!g{jWM&(ncv>XY8Hvu=*odS-(#!^iBg^OE?=R8f-RUyrJF2+dET zCuQbhXQ~y+y$MSqe4y2OW-qn~32s;T|0%h*VmLJtuMf~Kb1~4q#F_;2LQy00x5F!a zC&bAm241z2^yN3BS!LjfAPj@%&YlMJBuU22tVQnSme{u9U^}_(+)v> zmTvO^#2vXjEjCW?SMpNpb7#ljM<@rcm#KuG41y~e9ilBEc@Y)vSXSds0x{!d2m2xp z$25fY9x{nqnr^e6%r&gE#6q^XtCaL-yuWNb9($>HaNYf}iB*_ohC`BC+<(&sb=T?| z^ELn6&B$sxb;GDr!>lQ+Wtcj@G0tW%NIxKjFCr;r(t?RnkX-17ZCxw%qYBf#Dl^@b zBWCKcKgAaT5558JN(I6+W-{u*CP>Z9IoM&&D6rX`r2MiDFFO*^H17G1-fG?M3cXK= zA{@ta4P}WQ6pUTxzRZ>K!M*M{bW}XU6*x*d&zQ{{CY+t=vLvyT(BC2`>Z%@#&IjXK zs_zPS6uCSbk57%;gH(LGGtnxULZ#z>JTZbz zG-20C-r@ZzlAN!qC#5mT}NGRMU>uNetF3r zx$}m3=~T(8QYC?(3Qg)+JMu*z#4k(S zBkjJneuSp<41{!K38K)}k&=&5DdUu!or+Wrn6CiV?3bjt6#OZBsxQA~liRdCfci>Q z{MgHvIT*)~X*R1+(FJ>6IUI7CIq>6oB@A0PBlf3M-5Ob_~ zrVW(*P>=gHClA+jlxtEWJ{S$cq23$0nFf^^cF_4jw|bMe8+v#L^_}`7McRu9R^Xhw zV@17-o&DRkwrOu<$+5uS)*dZ7G$gzi)@%(b+#znz1qzAnI(goTE+Ie_a#^xi#KCpU zc-{%2neE-;1)BxI5c@UC7JtxIo(1<#ElRa7sNW(U!#qn6TrDC0PIza+)g`}=jSbo% z@_gr@gm5g!b>HpCY0k>b$s2o3l5JqRr+`imqBmy#TsfXU`RpcE>wfJp&9|ixo)VPZ z&!-UkIvfs~I4`Z1tKMgnQTLXhT7II5je)a+v=7-?Y*<5RqcS<3V#Cbl17_JSMbJIq z;tj(Of?u1iqAO-Wp{LAtY+C>1dSoQ)y2YOrO-NF)GvGWIM~pvmWiLPRj=a zy>u)S(_>VIv`_e%0ZzB_bnwLyQ|hdydnb0=)zz(Y9$i?3@`Z?_j{nK+-0@JQcSN%P z>EQazCxETz7}Ls;zyqMWCV6KoGf4BN#X%>u(d=lek_=dryJQ!Q5}WkG5rk zoHNSA*w%jStf8r9s_pi8Z=_b#G{~VNHK|Yf$Hzb{N(%-!Rb7-O%1>ZFv+^pCa(}Xz502S=5U6 z$H1J)UEJ!`Ek{;v_=ZV}*~554OtD)yckm?Y!P%JJ&%uYnL8mjwzf!X-Ln6j3 z1}x>~BFN;smxY{>L&Vvd29YVo{&*S`+6gO;&7T~32^i?ITu~i{4c?tkE?P!dv{>iO z##>ZLOD|=)GV_dO@5wC!jeV`jw0LGPTNV}`uzp%us1wG=n+P^|AL?{Ugb))J*p zyhP{^@2pI_oT;Iv<4a+*c9i1}A!JXs=OOheD%g0><{3;8e`9oPUt1I@n!XrJ2hFkd}GoUQ)3%AWQWZ3|^+(9H^n*OCgi0qFRr^CPgu3jpH^OOHWc zW;?gq`TLeP5x+$M#21*b`b&EqAr7Mk)@hMPkXYrL9dRu^NQ`@kb?L@p15Tp4K*^)P z+WA=%ZcVMJw=gUUzImunJMa-I)i)~@eTh%9huQ}HdjGmcvo9lWFC#~U!?F!lre{U6 zE3^HAoqJrP`yE(CZnjnNskfG18yxba>8b0Vt@D<2m%6UP9I{6V)0V&YQR6x{bRJo+ zNf~nfds+Wbok6|yF(=$}vP$vETM(9&Ywy4#9G$#Tf#^RXp*uBUhdorM9$_bUu8ZSX zIha_|Wrxeb6$~gTXHeI>#R;Ojzv4~Q>@PuPFSdHMnoQ2wGaswRqufPecD^_}IWZh$ zjJVbHex%AZj@O^#3ytGl0Gd|D)>>?Lnlvf1YAWQa7pOit|j zocN*HVJS>4KC#abZ!1gcONzW-Y%tT3tiEOYTpy7%5?Eqc-kUnQAc4)y>1GFWlOMFp zk4e;+Z=44|T7sv926TlCzKI=&nOSoOLemL@$wv>?R+^Z{>Si9)n-Sjs*suv?h4^RY z!ED!0AXB25@*mFC*91FBTAVXfBjcSy9@bVd0zk!$CTr|(C+Wc=h!I4~R9p23`QY@d ze&6q+EFo`g8uxfC(GEeslf7`S3`6k6WuWbX4AYi_YXfUp(`ADEHA`X518~SzS91-; zNF*b}SE6yuyU#)fnftkh>MLo&Rp7nBB6i6&%lS4#f^9W2%*^s1&!}c(4QmTcWDNXN zhhmz1(Ld)EO=>rV(iecW7dFOeX62n1onwOr0IGL<7*O!RzU^3B^}Vvnr4xhIQSG3k zlXml2v|BfSl(RwYxV0>ktybXP_z>Qz>Fk7C$~_pzALWxjI@-?74K_5i$`F6Iwi0Kf zy3kBi!w_`D?1VH6!XO*s?d(a3HC@aaznt9A4|apDF_ya4H-m1{Sek8lPx%#P>=`SI zQbsG%Tpq%vm_1!M8!LU16UY15;N=U^yb=$2$#2{dIRU#OCLFnv&YXXzdydn@I6l3) zZ@B*757TYX#juL%*oll7BY8jO*-H{C40beTLKe&|A^p?}?m_aeqo@m;(b<27tQ+v| z?g_H|l?=o5R&L({z$_Fb71`9cyXH>g;W(P6SRcAbB!!e)(5UD3#0*x;eu?uwd!Hzc zKavS6Zk^i){)v9S3Hr?-=D|J>%P(1Z5aZ2(cWIykA_O&i03JSmWJ@~OkI)9TBI`S)MmY=#qE>$%lUDTCg* z(R!msw}cTB%nClb?3^8`Ytx5Cf^&$p7LZ9hIj#{M&8u;IXE)#x++1Eid>r{GXc&YW zqbb4fuSG3}lop9iHGbxJ<^4vx-j-wJ!kF_!L0C`MA+*8>p3BIhyJ4*lOFBiUxV9`-+uWPnpSqA3VOF$+)i2Gl-f_}aIch`(A0b;U#Pd@ z6t^)7dt3|k=I&3!8ke^wT-^5WL!Lx|``j*mM)kX>1A9RZ(3IVzkieC$GiJBgazQx= z^;?oyWMI0Q*Jbs+|7%))(@&tu^zM;oFv~Cep(w7A(Bj58go6oYq9OKsn|iLiMyuo6 zM^1qnXA|(=_3wP}B+GUe-EqW`X`RCFcbSCxnSQchlBFrij?n5BmeU>%@ei8MjQzo) zXd7^7+?jhqA3`zWd;d!#u2;$p3JA|a*Z5Ua&*Ott@%URevrMbWmZfH~78m)gWiThN zw^l71ItsMP_YI;an*Lpc`OlR9i`vptAov$f`HtM~4A5q+mq1(iyLiv`${26Q)r`iJ zhL4&;GQoC^=hh0?8SU*qWq{DC&Ho=&XC9Sw`v2`Iruxd2YNZ)67UnhK)0plkx7KK#DVd4A_S z=kPcG03Yu6{eHc!YiL%EJDPR{q>GY4{`ww*BpY4U^fdzoS!ze58{6Wi>c6FftOLj; z6DR-nV9EcU1h1%dg3b+)p-r=;S7rNS--HJ0$T99r?W|04{^rWQ1O|CmTu}k>ZWXl= zoo>Zk#Q8}>DWZ1(|F5iD0Gn^s{6_wnU6E-wFvoRJ4#*c;lcmienzKyX{PJ05omG`|xzUO0cbQn%Dh; zaHk~G=gA`Pn{MTVKG)(Z`b*U>=0`SEo-Q2KDvs)iNJFjmGHOO-?O4THy@T`}r9c9M z!lrLrLJr?3F|6e**15=COL7pw)O6eHyw3gI-o9T|BgZ-(?-+(yh}aXaB1TB9(&|mv zq-pTPtowpTtzQ5Q{vMW%d%DGy74x&1ltJ0zh|2{Mu{R+Q%dXVoCTh>(H zFJ2Bl!HR40;Opl75W-0IHwnj-RMX>1dSZnq_IKv5-%a_@7b^sBAbZAxh&S)d3fGfV z%D--kO*LngUZsf9zD@t`A3F!=4v^@zCow9M`YE!>O0ub&6bll)AywM0mQ=EI3^Oz` zbUwNQUM$r8&L;i=?8+=xijIcZS7On>Xu!rx(i=JCi}*pNi0dA@2&7YXyl1s?3?_4- zulHAO1HY@IuydxXj7eWYAv>vxOdRW+)n!1{B%xE#ZOeMMmOkOPWNhOrV^_sWAQvIG zjse1@QhXOp|6&lfQ&BFXoZp1@m&B_QmHo@}7&rB@$B}VGDOLYrC{{l7v zbEgM`Sf>#~dk1d%0z0&EHY;rYg$e2V56YISyCS_aO*RD@BmAG{=3Lfqrpg_RKw{ZL zW=s+khIgcAnjb1~BE$CM}JriHB659GV1e0{#jqD zvOc0F0G;1zJPTfpj_q%=JcL&~y%g&hh0o^aF}F9i&APL=hrC3MS{{AE@k^KCX9b zS6e>8sR_T?$I$oCq8P88SwpQQhBNKRXqmE#Up-P<0!889t7L5lwr#DS>vjybF>1oz z>%kFugK(3FYda5ztQO-o8ud0@4^BAYz{0*$5p$v-U-z*s-lx!YzbDrc>T`J<-*&AL zTJVMAmJ7I5Nk6?45ZCG?{d=L6uiMA5`0A9vqD&tKDRrC4@JVrxDjF%a9=}fS zSWW;E_x*P-c_Ts|;Thi@IH+}%OaeP^DF>OG@|mbgK%Vx}HWni}M{7gt&wxE-gw1%w z(8^TRHd~0Ui7p~`)gx{u%hap#%RbVQFc8*!MN>U8F0@JsMC(jka9) ze7f3aW>72{_@qNa0HV0VhwkupurKR}8LchO1z0_$9pIG#8NV;{E{4hv6{3-M<5szU z)LK0bYH?a@ePa$p3?=>ZwEDxE*Xu!y<8m-uuLyL9m?E)q0h_TH@YC+V)`6S-yAs@@eY@XLAhrr;mbcwvGm7l?@_3Qb^8aRyYiU+a^|T@#;MJaF?8!C zA`OokCs1HpviU2MjE~BOsJ!GnjUw@}2$!eOs%85(K^91iSy=6t8FO#T-0F>QT!VMj zU@GCVVV^s{QT_AWdK$O&J_bX?1c$4ZsdCXmcnbH>&Im?ip|pHc zL`q7$Z*Tl2*feK+7!98bsext8L_()@(>?uPF6-GGvYM$sp^m{dEcA41m$H3#De-ew z0>J#{ZC}LjU3*cXHCOow@T*JsH)=`^;sDz_r5Ti`{HK(;I4>J>Aig9{@2jKCEf=Y@b5eqUO?t6A zzg`B;|2;bQ{I}4{=IC4B+hAqV-H#jr`zFP`sJO0z=r9=_B>DqAwzv>L{~p0rpKJb5 zveQ!#*&elANk^+te9QMd9N3}%=%{m$)k^4I;JZ%jMSGYuiz-Xp)zQ0P(NJSTEs#W0 ziyQHG<3#L>P;f*ss|oeh6yIS=#O>!6uhE%gb*H9@p*!jwP!+aFXHX7Xvlxg&;R(AD+WH93rk^b){c<&CWK5-$l9bg#D?p9$?G+Y-_i=zje}Z`y@7KWADNvs(Qi1 z+dIXq`j-Tm_EqFDyDXlwfQyDk3zU*T(Hrzc(3%!kQeyQ}?|?=Di%o3n7o4F5*~T9sDX6!ZJb*-vt{5n^fcO*-be71xP6mu{Ebgls5STi;#< zcO5b=B8Po1lI&^pe@cp69}LeVg&l9N?n_0R&GwPy5$(si>KV@pHD}?j!O;;>CSkFi zZ-`x1%vtCAgD(){N;FU%xJAJC%(O+amJKqI1;1C+mz*JP8di{Jd5OhVdcv2R#(%7N zPi}lAk5hwN{!_7p=nSXkFe0;YlS0N>tC zmdf=7-I>SMe}KtE%oEJmneH+|lhr3S`hPQI#2*dp4gM-Kcx~XXWdXXc*+F`xrkqa3 zsqQo->Q>B$IpA0Q0)t;cbHhXjOtUfgN_0eqXQQ@6*iUuUdm1dAVGe78Uflv2Ek-$A&S4-kp_1ZH@tnPv6Yf@lGtUkcUoX-cip5+x`_D^XX^%pehl+E4%UYqKd(9`Zo=-#rF(LrgR)}m@!@G+B!?Tj)2 zE}uC47QDpL`FiDc^K90#4h#{DoS4cQZ|yBq$0-BZ(M#5C0;J!JPadUpI%6$&+r&ts z+;!#GL=Tne$`$C)nNH$PYv#(Y)ai#MgSK?a8Feh<#}eFGKYn*>C zgnxj*kHoyIo_L{UQ(-JNl>E;aMHRaAVKGQ=<#bV&JHH5u%q`ebP`4B_A$I@~v(ed6 zv$jF=1rsLO%Zi}Aw8nPapKGM`?>ciJqsx~!7oHO=HSK>+@?e@$x#)dg8a@7eniTtXafn}$(8`#gdF97_r{!*qa;zuYdLTD?zGe>B* zc5bqD=Qc?38Wah?m;jrgD3-iG+eo1UH8%1J(k9@46AL2e=&x{oK82%#n_w zzG4&(kx3<2k1wdiW&3RwQQ!LWlZOs!c*S<6=dmuUS@Xwj%_tu_?2FzYAaf4_=TR-p zmXO=Yq2))a*yxOc)#*od9h+?-KEDFYXzJC{Y)dMkL9NH_xUO(FBjF)a`(~!|(8~Vl zEGk}i;3!~0xn1FF7<2XFrf5K})yi7aSrJ=6EAb3`ZQ90swO?w8kmF(rnnznk_-1*olE^9j}E)jf(YNp%gJzCCNZMTYai`R)&~o1wSEo_t4zsHLlNqXqkj zkb|S2C{{2%np7k>zj0JH``HY&;rVgF=CP{^c9mob8~yPKJw39@aub_e1zE!`J) z4pO&#J&?k>8Dty|E#60>=dLJMC$M4-aT>bzU)4W!RTkjR^+?Xn7a(=dS(ir-y6){8 zv*f~3yAA7>CI24y|HjWAyCMBRjuw`?T||YfB$g$cMHIaOP1*clK=l3F_vgTvVMytG zy(jPPioAtC@L(pf4RQ^1g?tdsNUi~dLw$KymUuzuHzids=r(zh2D6LM8xbin5GV9@ zrF&=BaBD|lOdGy(cp{i~C}?%K-`YhaB>C1}u()U`4%pRQ=wT5ie6yFTufF>Fl8~2K z>9V-Gsp2EI;?^Vo-T(EQmy@PZnC`!#n5 zt>Be){}lJ{*Ux=L%NF-E&c+j?qyaAVXJXQte8fQ(WaSwSB~+i$Bi0%62xS#9=1hIR zSIwgB!z~rRhI-~mc*R?1f$11qG>__w$X9)yr6>Rl2ySb|Fru^o(4 zAXk?@Ew^@oV%+Z>?9BMYrqO8AH$n|F{*^Mt)E!hfK;avg^J&`7R@0XJSWg~I$2vq) z+bd$5?iqRvF4^pjCOl8ZM4)V3)5EL6_es50Z)8R57liL4SqMs{zhuW%_t~UK4V2x|zZ3gI5l&9peMqu}uV@9KP z&Zsn?2zxnIF=CtXZWI_CW`!|Noanp|jr7{svD$i4#BPYT46vy@3L<``3)#{MJ7k6q zA@=W4+_km)_yuzuLz`$D_C?R8BQdw90TZv^l96N87(6e%QG__`)ckfLsTY{EP15ms z`4VAbZQJn+p&Qc!V>ip(J0{OMvo1?L8Y`c1cn$zT;z&z2sD5ldJDD(sd8yh?*bt7h z3_G(zmD3ed$d4tM-h36eJMl%;d6y<-E&757SZ~9DV$8s%D*UObP12)ZbuRlf;S*Ft z@7QK)yHxll$J!8ycOaJbb9PJ{uXd)Pj&;4e$bdUVL-Vh#T)302&px~}PW7Iz5`d8$ z`S7;q*QDE5(?emLB6#oMJz{}=`iJSxR-1lM6ZV{YpGt6tMW`HpA5@%9 z$ZGwk7|FZi5WX81ecN!|_)_Und!O779+gFSZoo1qs1Zg;gF>?-i-N`TgLfus-&4Be*23@zqD z-ED`X)wcr44)%Af6EBeFO3_4)HG;mp3zy9lY%?*ehrb;dzd)bwbl(-7yQU|EE!(UY z5MkJMq^B6u3k0{mp>7GXTr6uJE~B|#Edgj&NvG$zZzVCe#35?FW0W{v{ULq`J8QVj z_a@z}Jus*-Vl|a~zP^=qq`BlFHfNkutNbA&?*HAYAyeS@m#6+-GD?5|Ko6iUs(#_| zKkK^xRPvbo-|| z`^Q)M0wECYslvn|Q2@lnBoCh+T?qnEQ^vZqX&+`qP>Pxyq?TGAH=WU;9r%F?T_5P) zmLoU|sO85bg#<)aTx!IxYwW+GQ{NFwZ^^c8Xy6E)K4y z(#uOG6+e@Yd4AFX_R!9U<0Hv9%K}NU_5Y-n;n%K>2Vo4BuH^>vp6P#iAv&{iD_7F)w!GlYTN-J);8t*g850@2&*|HFC!yciJVdAKx+g z{K<4>o|H`h2L+e|#NVLR*xd zxJN&MaV^|9CDmp57))3GBWyADz`*MO5o?Ny>;moLHxrLTA$3W)z}JwPyEdrUu6|E@ z#euR;*dR6+y;txqT`R*W=vy7e3vo8szRD=h>RlPmK)(89N~%%S(E3YvUkCMf=gV5H zvWZu4^A zxOTI-kgu}hM8gzwhDlf37$aRrx1^fSU4pUY;vHe(z$o-rJsIzc0bS>FzeYg)=TKjY ztku&((%{`?85cO8ZHf*%;{fQG(^cGbKVDbjw=i5{Gu{xAZUt`z=Tc{;B1_0n$&`Hc+$01t3aT`P%Sy z)VIQe9we>lZZnd=Ph%Jc#D6QuqlFNkU~e5`_z1TBwY9AG6a#CHWAQi%9I6dc;S?e1 zBReu)|0Z&AMr%2^(AEznXn7Nt0*Gn$rSYVs5G$uup3id11>fM7v}FEUP#<&WYU}0j)|SD-;-L) zDgIN>$#&loMQ14?3!;CR>lqge7cVG$m~us;1Qfk{waXa%1MSWYWv*5OY~CB`7n$P} zRe|@U(&Q;~%AY#Zo0!QpPOJO%!X1T2sf90IxYQx$>cu`ypGFX^wDXC zz_bo~7-N+diFiI}j%{_EmEU64mRxebu(4d7sA|57idYC20-Nh>x&SBniNxp2N` zvr)qXji;|ogo3&4`#b*-e!bKejH8uMz;6?!iKHtt#=EGPVgllUtK;WSA2$lJ-+ZWmVN|FuvY%E>e ztR)saQx6?4tiW8AQIw*s@Kg4As#ByA07%2UB)*iP#$-EJQ!s~x;cYa}u>B-bm>Q$4 z*Q`P8vivg{`o}AIGBie5 z?{n=Mdkd7$He_LhhvuY@ndcQD%aX^t&4Y-Kh_IB4QM|fXtI%=rk4radBSe0uDSnt+ z+|rR}!?3@>U$o8hX3w5ukv2vecXaf4qj6_V!7`te2yO_=E@180nbj^EG=7CwI?hkp zy{jvHNZM(8@75cSnWu}Jk@wU)}$8!oTX{cd9B4Zdw>v3jx;IM zM&P(c@syGY(hp3D4iyT+`u9LrT##w2UWQ4N6QQM@qaMet4z0=shJD}_7nB93HH&Ih z44&m>0F6jrT!a-$@=D#NDLP0kRSP=Cl0a{dc~}m3{|{sP*nb(@-9w-L0oo>JIQ30U zj)4vn{`h%CU0$-)7n8N_X*IzwSiiOLCMRfqKY1|nqBK-r{;HQ00`W}?g=#HgV+9!z zN2LI8Uax`AH&p`{Z)3ba2jX$rqO5;*|D#c0BL4G5Fd+=|t1kRF6z*Fa_RDC~@K>GM zq$d`Qs24*6!>&z)e}G+NG-B?Mblv|#93lRn^JD{DxXsJy>X|~s6638maIQ)d>j**C zXKcB5ZBr@&O(c!Iz!9^UZVuT78Slxcv0 z{Y%5z-ARd(Kef2h%-an7wgMP-)mSZdaCC_N@p0YyDRhcTa8Zm`>sb*M36Vi{jrX>*uXE^-jfCcD?jgQagEq~iyzy(n6uuPbwWUse@S%~Ry#@H_ z3EiQ3AGhuTfU^*phr_`{g?}H9bmIRih@~N&KPaXOB=J4Zdw{-M(5=F)K4l`6+tu+;^yT2u+rt-+3GNq}CAr4jdRPzf4xnor1SJ(Y-&HT^)L{ z6tDdH#<}U%pYHUF>u#i`7lX)(1bM5|V%dO4rY$^K#$YPatl+kS+e}^^OUpo|dK2UZ z37v}_1XnHgXs_h$-U_RETSuK#YVkf^^|`a?jZ1Bh3dlA=9LGQnZ$V&_+-8?r={-Ev z19t^oYi&fGHVBsZ05GlS=g62=q`WV&I@5w+5(@W2nyG-Cvt-DE4>(`wGFNf1f# z9qpI^)~SZkMrAX3g4g{)*|_ZWgL(2bXq9)K$4i{Fzt^I)PsB|2h>`{#eL5q`sRLj4 zwP?fcmKl%7R74`CWX9Mo{_K|nW%etV5X1L)HZUtGd2j`BC+jQuIVWB48Vo_^}sUpxp?Nwj1Y&yt?N=@afN z7vNKNhQ%nEgJHTgb5FElK3}>OxZa|vxJfh)p`QcYE~8EFtfEDzTTSNw4XG7={&xp1 z$r12t*a2bwa>knblHQb{UX`wyK-K!h)rvJ*IAaXHNcM~SL2vC#bF%Pbc&A+B>$P2R z`VCLzm`ox!?8J71$_pTp=4WP#p#3U3t=}RF8+Nko#8vb4S&?~M_+GCUGSyG$Vg*MCvbA*MoKOj1{BF=A9xFx2KD|m>+Qv2|_tsy#9x2|}irWrW?A5ti7h73MH9H2Kgxi&j z9=L{M82M6jlz%TNP@|Gl3)5Fe1y-o1p`MMVIT4vlwiC-U(hcvGy$jpp0wCNP!fuHj zi?Xtp)qpYG3)UAh!TWbaoaI3YU^nY$35;6;vZZO%k& zfG{1Ko;%DX5!bJ#a6w`!&1X@f}$+^Nlu$_wHf&(MWG;HKu`h z+5BXNdhxePCwz_zx6z1GKs~-SvOaD8_NV(XOZg0wGRC_9AsPGLX2ya5QpmefgCi4S z=|4rMQi4IN1I)cW$)K&S{t};b_#dX*O&EmpphqCz(h2iY{D#k{Z$XM_9l_0*Zu$)u zvIki*ICkP%FE29S6yu5dR)X1J7AN@5UW|YeU<4F*s`^2(pLlfa`ucW{&3#vqIeD3N zD4Ve%BNjJpe0fS)zkV7x{{Z)%F}DvfuKEgEkgD(N%;Tn)k{&w(YzJQwPJD67i<=eQ z$Ez;`zg~t1&%H>f-ct??s<&XulbA~&-Nt1-YEWdwWYem^h4IDv=gc^?+oq@ zV%B%*Q1ikk>Pf{`rJ)E($z~)e%_Mx2t^UJ`)?GFfz74j97VX^7PGpv)r_>YkC94TG z3^@T6554a}m|f&e+MURgC6xIz=^U7!jy=-T`l#j1qTH;I?UjSQWq6fiPpnNY5g(qk zWa4X3BdV{DR3kIAB)rC3gh%EH{ zeljV{d{X)S>K701M0+CLLEfy6-wy=X2gOEcSNnbx0z-n#AZh~1i%I{A8K*qKQgSY8 zY%X@&Fo=$Q*s(xUbj^)w*7`d_HI~Tu1$3g04VgZEjPf-wAXG;y2B} zYj$SDuozK4WnaJ`yiS=LdVKS%&t#fvelHEBS0>h5MT18Yl}V=LK*dpjV#oxI>PQ!= z)~2(|2;1$8maz`Brj%BrfKN~=1$~$jS&4Nn9p)BnN{&sh^29F-*SgJQT%OzHfh?EU z=O*EnBgtWfRHpN9uS8=L2QRXsaoVK3F~unSX=20lBVe1^UX2w6-+P(xHaEF11iC2r z!c=_*6);`~$}8w<56yS6Mrwvh66gl{m>KN#+I@L+Q%8HIDyvl5RUio6ofCT2t+t_; zT)UYZ0m+UIz(1gjrwng04mCue)Xs!VS{n5;HkQ`B^+vv4+NL?UHoJ=}l*H{H-YTWm zl(b9hN7AkhjA}<2W|KEk^W1-!i{AN5c1y=mdY_yio*<+yYMxXdDyZ#fGtpTr`OJ9gZA9?q{ExOW9EgKFJ_6%1~IW-y4 zu-@l$plLJ7iF5rlYe|>OGF?Mbz5w4R{gkgw)mj0q>a3#O#uGMDuBWsBDo4?<{08|b z>bnhPA&Z{e5sE8j2*wE0b$r^|ex=}7p)wU}NHB?w{o=&C<@4G*v~^*)!vn$POz83Q znEvlcoFy*?C}MDbR9x2|x2102k+`7O&^8Ho*OHTTs(SPV7tJagFh^~QjM4R#<}B5S z2XZ8*Kq9>hWtqj|X!~J;cfjUC{GmuSdN%CLQhGYjHY~uyqD}6ccIo(@YNd9ZwD`c% zjjAv~?21Zs(PCP0E~ZXW|H@Qr3!jys9KBR4Egd^mWi~-`pj60ccy^E(tUpwAKD5(#EMgiySTYXxXqG%;8FyCkYWalsShKrbOkM+_ANt;K` z&;e0Ip81CJXKSwN!=~RL8a`NJ;#?HcR7N7M=B1}w(Zd!OXBzGOg3O&^y=0Q@0`B2m zcm6+Xuj=hv{51W^rUd+*?xi2qYsV@a7hF<03^KtB zy-unKmG3v^p&8wuY4rSrmytE1Ru19Je&&z^x{TL$WKvM{&|e+0p8F<-LMw|MNi7AV zxRT$;9|cNY!by*rhgk;HGzha7`oRB_2tA(=NoO=q>PH(u<5nqi|C>2evoInKEYIzk zaH`VmKf{h|Fp4GL)x4|bbf$07uiq6WrFP$SvoxAC?^bJA8*E`{LUmJz14H1>|`D0=Yo=SBi&L zP;$fP#=Ge?2kD;uStP@`^Ba}0kpMb-5OwXdU?H!mjx1ICL3(~hpEDs6PPro#uj=SO z#t4d>gK8sMLWIfMqG-M*tbgPqyAA?)38gI|QI%g)ua+bI=W8}O>lAGnceX6vcYR#{ zO(tTmixz%I5R9U(uM>_JLfa{N3lwcc2>@m~(^s-hZiZ%+WBxUJ=vlYFNNfF_bTa{; zResOT%tcp9ew=?^jYBdcS~{FdML)JSlcp^kMaeO0GmkksF2#FGCxg%q+dPB)e1P-z zfUDo2UbR9%1Xz;_rM!Q2prygo)?OU0cEPz}))k(tP51avr6K}GKZ)XAC9Cubt}|dI z;(ZVD5)17qE0Ed=he+edM9H$sKT_m379O;5??k`X)UiJXe~9pIAI1FZHPdrP77?AK z!#YcfTYGXse=b(|pAcQUYTLMOa3yWl%%Cdl^yl%rEsLAmZ0UA^mwYSu$EVd1zQ!W( za)YaFvLfSBr622`Xg48b6#Dw1pk_b7YhVye@OScn(8D|Z0v=UwyygQ86kWhB+{~a0 zKHOGNj+DM+VDvIf?hLC{kYb74K_qk|tqg%m%Z9qVygd+1U+ZnS~IOjj6nRgytw8Yx3}5w@#NIaa4AIw*b zKq(P^$k65qO#X>3eoO9ozB{$95lTzL2hm~fh-tdmU3M50H1qGk!6l5b50$H&nur9i z*Y&KUD(y_e+@oBgF^@lCHg4g&45rC5udMP!!ed&4Z^L^xZCDrhVX@CfN0W%S@$kDZ z>wi!3$%|=IK1U<&GMAzJi0A`w7{32Z>rPSM4RIOk;N#A6rR*4~YAtuPaXEe&`m!BW zj(4n4H!w<~qR+DKDf21fR@woI-qtU=4SKG9Dh{$qdBjb4d;VPwHr}wyCHB<%pVTLm zb(D~o*v>roB#H3SsSf3dv;L+dXzeqx**n>k+f^g=r;^!T<0|NvGlN@fcSES}WxUv+ zfSpoKQrDTT{C83$_y5uWI-N*Oc;_^FgX`h~+8<%_yK40U*;aQHC*KF?(9eYcp1OsF zhkYO18q|k~^M4FQqOlT_yPBEchR-_;>zf-?^4|(4lT$TIJ;S~xD~%zCoEGl_83K)U z$Pa<%3q1qz8CNt7R=Z4a%GHG&ecaKis41CC>~S&bKTnc&O=XeEyWoq+N8E0c!16+8 z!cyyvcTFi2jn|Vg()YPNs|&!chww(F2YMjrcB!dSV{yS^J?y6lXqmfN>QI>m-Ty5a ztTF=QE~3SL!PKbNg|meGQ_}c6{MQ?O$pL0f@yE(Czip(5;9O zvg{<<;fS?mPNwcW*%~bx<L%=*%NqZ@E#m17M@lo$LEWV&(^8Rx-W)= zZLi#8hxlTR(Qyn%r2SrW?WMlJxCk_f3e8nS-2l{kTf&HGhpZ+#@_HJA@#}axT?Yh)Trej78K%Q5w~Co-1zj1f!?2+*DcQ z^?P_+<$^QJnRQg{S4qu4Zrgg)RiLe=)`pk_MlU7nP-J%B2&Sag%n5ZM7d;;gnX;2Y z%1h~|`ZU)tP3$H6H`N=Sd5ayZ1JRoj!>QbY8GV7h@EFEKOE4ba1nuqW4R5Qn5!h=k zVb0PH=G(nmAN;_uHJ$g)T>a-Vy4F9ED&3I<{Zm<|H}1M9|8)zi!+aK)wCf9S_$qSJ zpBxJ3co4Ep;Z~>d9Pg-R_pOI|TY7_@z&+F@n&F&5v0(t=QC+N>1$Mt3JUM;Rx+>Fj zv}P(={GlTo96+>pB0QfB{a#o_X9=hcYELjq(MMHDvNjQ{hJy-r zWaQoBINUhC5`LAuRS{=`9@9HE2Lgw%xMoDmnNhqIb}G z#ncqBEe`hpy3A>bM&rfoiBDy9zx%HYOnf)oW>PSC;!!&w4xV}IjVZNnpINqk>#Aa2 zzYwjDohD=G#!%>tueI}qUg3WtuhD2K-_qNP(oN-`sf7Tu@gUs10Yy@9!LTjoM5%uH zMjuF#jG89^S|6&80V(p{PRexq3B+)GY{bTU;w$MLN5d%Moehc2=~-C^|2swSB4%<( zUtM!44~&5Nwg?p;%$B>vp<{epfHmaH4pHyX=ZN23#tJr#e_5-<4JoE`=T%PYs84TE z`vcYiyg}Q~?y}SDY{SEuP-4wc8b>2ya`Q5J!}MA}9PVNwYf(X)S*n_Q~ATR?$2&Xr_gn5VPB^f}6Hx>E{9cm@{nbIX%7@t4r5lbkNgGNM_8O+>ey3l` zzQ*iTRHWX$&1x=Bkp>$_AxzG0eR*L2>Wor!lUXj52anP??5CyhlUITDl=;ew$gkD) zpYt2nAC9b{5Xtqm&9YaB^w@`8t`un=6z3J^bZ3PuNJ;mFDO^O7dqdr?o;5$54CA>& z?c-4Qdf^GG;yQe{0s&=%wiz@u1Mex#h^!dJ`?c#SFE_(Kz7eAY1(XABZ$=D>11EpA(iN59pm#EHGG}^aRiN4TMcLbQyKX%XYEqo z{K+Gvs@Mmr1jS$Wo=6X9UfX|o6^Q+uTQ?c%<+fGp2~HxfH4z(}(nG#Z@VRGqsR@Iuzdk<6wWVP z@2MYuo>v|YnBtjI7wyD$%(+OzFO_cxp6{Fcfa$6}D0de8r*B5jZa`E=Opmo{?FMsc z>pcW6O3+<=%Tbh_sT#Uso!2IM>VmtTS00IQ07^f^t)F5^=;DbFo5_B=!fWoPxPl&mkT@BpPT-iJ z;LG;E9pd{6KPolYKKh4Eo1uTNH(R4AQe_G?Wb*%QQNw>=Aqq1*jlGM*PvYuFIeI(#7Fi3sWedx;ABUSTvDYs*Vs^kvyjyZR{Vt;e@5 z=^~z1)1^K!iK2wUjar%hO6GYip)Q~5pC0XUZB4ZTMF+4*c@2NyfzyRlK>%NO zkNehA!UrDbM8IqF(1!7uR%<>$fLjlQke1N_hZ6-E(E$~Zkg&}snoU1sV3>Qq>|nHd z+D!Z<>mF_5z*^!m)KS&w|3by6&VVt)h>FC&06KYE1VFXbbB(@jOW&Cae|hUfaZB_g zrb!w0rMn*Iz=@XfKIETdwWaZNWc;H9hh==AlPMCP@viX2bYqXN|5-+0aIYO#BL{NE zhy@g!O7MR$8_XSZy^n}|)K=HVPmVJoLX9CoTPL5}pk!?jo~l~-O9cAtSI@~_@Al-- z`-0l?t2Wu81qZo}Qt|WMX@iqVPz8sn9C=n&Q?LCcakec9_5Q3OEb68O6Q32N-a!?Q zYi7XvNw*G(@iN^KR^5??V1*?n6s-tGcRL~?UXaoBTgR9JrzLIT`zYSuG@RFhqQeya zG!(%@ZHUgyhN)c^4{6xxddaz2GO`wH#tNH6>4G>Bl5_SI5YyM>X_@YxWEwsZUl%ub z?>v^bSANADRX^}AfPRaVxvwDirETfzQvBHZ&z_S*f=evN`l3rI^q95hrUj-H<*Vsx zU@v*?Cp=N@U_OH!k(wXQM0SyyN(>&Sk3AFKy3d^|hr;Sq7T4<9%LaUZqRl4Dd6+V- zfW1gBQCcvr^1ZEtyTSYq2L`HN=dsklH^wxfhRL7^l)65XDKu5c z;u+#lB+7{IfYbeQ9z5c*(6`aI&=v8c>#^$k(LRxg_kr7I-y7IbIcC^|su02^NQn8ZTAf!~1o6I9}E!*qaH z`8|&#zB?l3=A0lNXLR}M+f3Rz9$T;2s%VyF0$1(Ki}Psy(*yJHeX+1bQyX8!N+F`z zN!9fLk28igq<<)S@uam3h?lCkq}}M@x=?3g%Hr_-l=#qNwa;#ahbREIdRHZV)yuJ* z#_4$bkp$Ic=H~nI#8JBrcWkd-&eqjZng^nrw=bkz;YE~qtK*?a|5qtqTjjeBc3Zt} zg!%Ee24k|+c~k55H=pqvFD4IOgKh~Nno?Hxm6u0STl)YkI;)Bm&#L}iJqGwUZc^~- z_ase!EE($blTKw>FdC+#L*^63EyG_(uN>;cmDN}w7|+i?(em71UFW}UwmchCsmyc1 zxn)+naQjZ-IKxj~bhk5LGLvr;y7CA`ru98IE2rDHXIl57bUSggSJCTkGk^xS{=#wz zic%)q4#bzDzT6miq4hKQ{2HmBG1cufF8Zob8&8r!^jPVJy&8DCBni1}J zhPWr{xw^|fio>24Wza4nVhYSKqu%$ ztpQH$P2{~nGU=Zokm-#>K=9)S#oF^Vm6QzcflkK3mZ!jv-qeWd#OZ?6P zzJdcbMPO(w{rKZnbgZu9=2--xP1%&Msyez>LuQV_sYPVp*a1IqrI2LGdToWqe`X~j zIucW2W_h3a4?TPYM74$I1$R20+ms-gjmiq!$FC7;ZVyM^^6kZuM zrKVS86Zg9#UQOOB93k$U9&B%2@)oH}M$^^v)k6LG9&MAZ=!W^{J2=%Fb4THTuLDWbQY$x#Lf{#|_e|%{;HcoczVMW>L^>-&clZq& z&6{Ax|BF#v(QH)yN|idfEOP?eWPhN$JV?X+AQ$M|qe~mJ5!?ylimAs-fINvcJ@2#; zoGRZni#Lw)zmj~B0KY`2UH#W{DM_d#Nvuayavx-{lDBK>aMr4kQa+sek z`5J>47CKGA3z*1qi;M-)aBb>ZNe6MmhsyKrh##fRMozxfI_EGpE`&&ij8#*v_ zj8!=Srcj5n6zs;-6Wf@SDZRB#qiD!{0RIq*4_rYblR?O1BozPu5Ot<;NhbQ=uAFij zOKYsCT+pnnF(or~T!6~b=2((rxeKKhM7Xsi2u@DdLj5Lgj`lnk#M? zf-5d;DhT*+&i}>po>$x-xPROCx(*`FoK!6~(tx@DD`yE??8UyedktLAiCM5Rc248| z)r$^V_0wH)VP;G&zKO(y+zG^<1C=RGj?9WWp9h$+RiR)=190$rvY|!z@r4Xq6G6&Y zJ!$A@%RLf^L!FPXUR0FLw%4ey31hcWR+tmhR^5_RD{1l6^_$EuioD;wysp&kH1k+J z&;*-a)+{puFmeol+jldfipNHw@}01=5TVl5P~VyNF7aWi-NPnH4l)_w56m0Q_~G_l z1x9v~eN%)c{7+o@J6>7SGS*S?QS2X_gnjtt257Fvn72oqa+o5etMeyC@dOU=A|b!) z;QFNx;{{jk0`Ke5oURfYZNoujoF_Ti^tb$L50bhYc8Dr^;U1zVsF&`J5zGs2-v=6) z6*D@K2dvx;-+R6~tUv-hgTFd}6LK^^WVmB+tiMY=8e7@6 zA}!Lq$iQC$o1Pd|KLC+p_jKlf&bK9eZ$r3LmsxUM)wryksQsc7B%E}9_ge!CvvEal zm0MBjeI312L}U}~MRvuKtt#T}CQ3ng>@aOqW);~}IM-Ca6xyV3gJ!$X=zU8{;3Al$ ztBL06C1e3Yss#m(()27)fVfbwHjojU9e;<^ElehwUC?#&Y?oVZLS-#l3i+0Uaj%Xo zFpZg2NsFpD@(-(96uItl7Zhd7a3w<;)&o^2dq4 zf~2|)Ls7eFz{ML^Fw5|d(TvP%G_xfP=jGL2BnD-&Fg?@JdhCakQ8!`apxnyAOql0b z;R}23&jrsJP4;ERWH2N<5h6Csj+ft#4BaoqOcy^|&Gebg!a;r*Wh^azh~1p}lS}`R zp$1H8taM3~-P5dV07@zK=KQWYOHtmcgjTKjf`N4=uN;8%EC>R=ecbw%VZJhrJNZ37 zc9dE*_IW4A)GUfM^lo2;e^dwigl!;AL{$W}Y(6}IB4A`Q}gn@?!>8*vBL^kp! z0`_ic=P^cK<C%xs_GY7+UUnXsyKLP2;3-|g`F|0SY`XUNjoLDMy zcqtyKKiEw_v5~d$5~sCf_cN^o!yCy=%wDw)eU1DS3PS#2p+yP}ovf^pDxheOHdM=W z3fn2pOMwtMEPk&nV&fnIC|h_X2Y`A$otTf)Mu#48o2J#j zlcN{qh(?Xa2XcM|R>fijWUc3KQGYo}P&zduQ>SjN`ow8q@9NQdl^Mm`tJ|{GpF-}^HDdg)lclUA|mJ^y#0g5(l}wv-oHxb;mD_CLuRXh!q(bYDE7 z1iF^1)b(w0`_d#3=JAK0y0`MY!NtLAPpG2H1}d-hkFtO6dKzrMu2CAs`?A+5c2F$|`R3i0BdBV-%7-JQ#Lb&mQ$`1=O=}(oY&3+4W)Xe~*uJ!Gn z^?~DqqxhplC&UdgSRri4KFRMc|7JQ&jM)L_-RkzcVlI@se3qiSjaXefo7Qe*Cg{(h zN^p_SHcu_>J_k0-#l!MLgiA3QXSaLdVDz;y&Q+;8AKh&F1mu{lZwz=xvgDe1V;pbeaOVwQe8IIX;*MIte%#AT=CT zDnID$1{v0Ku)+~jN3jpM0C7Am16Q>3O+$8ktT{qls6-TLjUQchqMan;*C+ahoMs?} zEZDRT$FfBaF7R-lTpcC3ONW;c6_W(aN92t?dI;Gw&R#B^t=6Ik71Gc!-{v( zCd3udnwgt9F@kt)py6kKd#RxHb9HdSeil=RkL_Ogp{Mx=1ZUi`)Sa$M4iA08uZv78 zRj)Uqcb!7yR!1^;B*2P|uZ*qbgc}<{O-JLfy9{rESLx*jvFovoV-=v)u!W_=pGSxt z3vX1T!tSzk5%i*Fz<*exRhLtGdk`G)!5fs8pQNzhuFF6Han1$WWwT5VA z2<%PXY<)i?E!>a;kUL1~qr0}*_BdGA#+?J+IvI{ z;^S{7ZSDyFk*4rR)VkzSNHucECGl=fG9I`ZDSdeCei{vP*yy|I=bDJY#XxTzx2W;0 zt)Yff3~?6;H-ByPok#~UwQQ#8GHT}CAQ7)AkHBhWjwF#7AsyQ7EA?5eh?E=q7#%>k zsIK<0j)cTnD8YsqBc>5_y-8hfLeFwn=a%JFy=bCNO2K%<;}KYHTHqIQx|Rk3D0)V7 zL`Kv8$fPCE?jTRA66YaaO3h1DI579H$v ztkmmFPSrr<^oWexgUFYvThD@uqEebtll@9eqk;xSnWVN$x`dplw%PSbIx@#@)f2Vh z7e}cBSl~jBQ8P85e)iaVs%xKvgei3sw~UXdnI!voc_qcib_Q*|jtUBo*uG8bH}^oN ziY-+(axy_1*43L4Kel4z3dbMRq@)mVuHHxEX?FhH>N91mjQ(+e{JFzfeR^PyK$hRB zGNec0rQRZdt(=zB8?r6?pG{RocOhYvO@M4mc982Py1PcQ4dy+(eqk+Kr2MkbJbTcw zW{j!5bf!tyU1Tw-0tx&6U-1#{xW>iEzTJw)Io}q(u6$ihz8qVXp%xn!b#-7SE7@Sm z;7M4YHjwBc_K+$6g^IW|{O%>h%~#Z+VE&}T1AZL?>FJoa@i`T=ccAj4mqCVsNsw9G z+2o$dA`>aMpc^4a`v9SiZ*`)&*JC3=J3Mzp4%TZPYyFk?-G=!oaHBIW`AXFqHO*kr-X+AGr?umcX*{OGj@TSxz{ zu65?(lcsY7&qCeO5JZa>A8(A(@zeixQwwz3nLp5#S@rIcO5`4Jkklb;NKyFqCSfnj zY~zHJKidEh$=W^q4*cC=3-@v10SzjTMwI%j?CyW}l4#W8a>6OUayP*pPX6LO*QFLz zMZM1atk|X zD)xR72ok-?#}1Rg2x`k5K}GmwJ8bzHcnlEA$2-)sTTFfvehi<o{wm+sKrB|=MR+2NK+ej2?d|O`Kt%>Lv_>>gJ<ox%BIi^Ns5cwM!RVb{^IGn{$H;W*@kFoOkBUsS)WEfH z>bly-jK(yyj#QM&?lzgJ@e$xf^tyR+BxOl+CpqU6HN00h5qeT}D_1r=4@4tm)I^~>qR}ZAKd>^-Q*|H-E-SMZ>b zGwIyz!BYG|ksVmGEtD(>>IQ7ChHi~)`3D(KNUesP1D6WkidMiwxQ?fG% z-L%zKW%<(Hzmtzjj&ETc)67L6-MhL@hbZ!Pu~F(dSNB7u?sgW%qbb>KARmDr=6&_b zhj~-$EiKh-!#LkY)m;&|a7y!HvrxyN1dgiuWeJ7(akJWtIK|{q9BdvY!+*}IqGjGd z+S_Dbe!P}6BAqkK{Wq}{Cxve}C}vzSdHT|$7VQ+}^<41YuZA4PTD*i0Z-mr9NV6RC zLhv^IvdOJR-8FlOpu2K^s0MzM8*akJxiu`L9zkgsmR5V=E#>^aPj z4*R~&6^bik7H^KYbL2wZ$kX7rUJEeXCdsw{xFFG1z`wcmYW>i+FC#R+hI$i9TpI+eVgtF6nAluA9 z1Lo$9O~1{@gB#|UE5aRM!%=F%T)cYVMzqIP)YGU19zn~lX|Hc(1sgdM!Tvehz?WZD zDF0uK=%0rxd4o>}+41Jy8pFzuwhzhAD<-}*flNItMW~%x0MDo}v#%aUF+Xe;LVxDU z9$xcP=UL0%HN4(52Gnd0U)PtQkLJT~wPsY>zJywmsrUH57lP7Q3PXEazd2+<|5!>5 zVLekVCVwt4+gi`FeM7dapYCScewMvfl1plY~_+>-;y8soo?s#x( zpDosJRiOM?ev^Y;h;4xXvDq0IuH!2~{Z#lobo84z#fGL+VV92Z@|Iq8Qfvtb?2Nwg zk{Lf^_8BxQj0N#ff&T7Wn2Lmm{u5q$DxeH}lWhB!rc3>*z|0z$sqTd$`1A;zTU9=0 z6tdx-!Z?cAhNP{!lKRH-P*t zvuo#%u2_5cS4Roz{GNzmu*$G!zE~ehKERO6XD={8uz+5D>>mg|RW@khJ?Wwy>$!Ai zi&!{(-R?R*Z?os=s>Z#!JWI4JJ|pnDrsL|~E(Ek8>XyEn%@<2*sc>M_avY=E1(BV| zu}xsld0~lUQIBYE2X7!qjZu4O-j%e!#Ey@j`}G|l^lZsZ!M{!tr!Zb!P%Xd5e{MvR zQa2SX6CA@`f!xJ{m`$%p$%*^f(W7XHg<1+fx6)#2<*YO~TRSH;2W&m)Qip4)-0n^7 zeQS**Ro;gJMC+Pgbzdu)fql&-p&w6-A~iF06Kd)gsH7lg_$Kq{!0u|#&jV*-XFJT1 zlQkS&wip2cW2VGNF`Or(i;xu)!2wnM~UVY!FAOtVZrq2 zt?{dx!`E*}@FUj~SD>;)A9f+~o^-_KHbPi7r^wZ%;lo9pcPN5(s_xoZWsj3EQ567n znkGM#y{guL5xIR=A|^5igX#uDukI0*gtAZI-?1EWitsz2q9H4^=#S^duQQIzhb!mP zy>3r+luiVV7~N=#l5d}SJSLVCkGqaUYn}ex<|RHf(zRsqZXt5La_$TAU5PXw!Pw08 z@h5Lwf}-g^F#<_sj8p$TMMqHy10n7lNF;CoMw zMwXWYC>U;wp=+AII`oTVi6UD{4nzG+*w=3*kL%?@(>*3OnI*9E>5*E6H2^tTA1+(I zoY6E^toT#AnoXDShHy*CA>hlmZk#8dpn{GH+q<5Vg}ZWVmTkns|Ewg2@n*B^OlDip z1T^im3{exw3ry9&bvu#Z>!xngdQl52mKvgAKJTZk3Wrpl0jDKr_%U5HrDYU~)C4eETZ8UAqlgyCR&GEQiddOT8@pS-vs>?db2{@nCz zA+@85w>w5{`tYtJUS!tT9K)IH%}$h$;*LeN8V>`@Ye>SE#J58>AhPI(=SYvddTMwc zW?wfUQcXuB4Q2S>f@wL`qE(VM4 z7ar_R7{`o!Q=h~k{JJIXtfj*^>vR(7VZUpsSnvl-Oa7}H<-ozB*id0qjD#2{U!EkI zE12tKhqr-2^Xx8+FmZ7~VroLO!FFcAgQv_)Eo_$TX}5Cg9`K9 z$?(&TvgWpD-t2bGmIZ?+K9{`ZTzYR0JdX$AG&$=_eh#D(ENF2xP2TN*OumaPz zZld*$9ovGxu3o+k2@ib^nYCJ-k2{Ef2=mE0mbYo2b8vNUo${SmP#eahIvaM|m%O7C zwJN6E*sn>8)IiJdDlyZSi~Z!{ zHJw;|%zt-k>I>CC&ym&j%x-sFD_dp$N8YNepq(_;QCZ)@atjb$Oiw7EIG!(V0`JG< zufI3Dtu&wIF7OI6UZ1)|2|E+TJl>T+^1Osu7rsZfPCRTPq%D3jIitB4^q)48-1ib* zT#T&?&&p@M1I7RKQ5R3apDpL_4qju!RmPxo0@L!4kOBQ8xXrc0n3C+{^O8NXXHA>xMzC7En6%YY4b1$J)b-^$pZHoEiKfM|) z1g3s-cuh04TXWqFV_VrFNVMh>)RO+hOyhCR3`g4RcLq46u|kpD3*68Y{{ej%a03+C zr!(id(IABAC17@JVP_*&%+vBlgLN8(s>~{63iR;~N>DbOytdG>TS$K5M6AJcHa`wv z!ovR*(laBw8T?*&n31ZR>{`AlZ9O{mbH! z=NPX$PSt9GGw*NhyROTTM5~aa|F>hfpnhq3n%+!(x|EChYBuWehulbxkg+M-Ta+lt zrLk|5Kbt^GefRsIr)K*0#D;@3G&s}m|0!y?Sg~;7+tT+%&s^9rLR3}JQL=pFlCc;Fv?+YrxzcFA+TU6-Q{f_3n6X9T{BoMQMMTa7&}D9GOQ0B%Y? z0FncQw;gCUv`l0^?bMpi>BZeC9>%LhN6?a?0iSAU*w%zgSL6oycrj4r)2ZL(L4BP- zvq)1SD<_<@Mq({~IbD;m=}9qP(s@rwU$7xF%P_e%;(1 zvDLj3XxkLLmHz`WV1vbtCI1@lvRa&=p%MPt>HtOjc}_zgA6AByn*d5E!h0pFq_X;q zE8M}s>_%*p=(X2vXr8c>S3pS^nw-;hWvRSsw=&(ZMF{s&MK6XKvw+pT^nd+^tFv{^ zO!1~WWExWoC&#%jrk=Xv#`Ajs>4ky6;>GVM!;EXyFj~*4GuCx^y^1V9o7tSzgDe{v zD^8l!Rj6nh>n(_%6x}{&K55JnU~v;py(eXBqi=#DFdvrS|Hv%HvqLyy_2UPlymK>V zb7C-uy;i~K;2OMSHeuh3N3RJ%^jhp6x?Yc4O7N%)@5R=NEw4#igV{Z^S>W4QVeF)C zdVhvuQ`=XV^m7ffoVz=3dsR+V$3A+9rTqDtl-=F><$+#+@Z0R2fV{@hxMeV7t7c3T zwDBg|BC9ll-38moPYuMq6b?AAR+H!h_Q@L#)e+jOVqG})4=4UGW+mI8;a39e@sbht zaij`;?%7L&2FaC3oA$=WcUESmhz}VC;2=oixL!qs`^s#q4&t|2_O#hUDAOqoayTgH z?f^0d0tXvf3wL&OMQSYqUoTDe@!hB5C`^|Oqt^--JM+kb?5=~Kbs83100TzPSx*G1 z&~+@1)n`<0C?uMdrAFKDLo>_%f@WP?U+7y6Z!NACCz)7-UAM#7zb*XKmX6Bnu!si8 zktIghS^4s)>5ZwAoAKh)gWZJTes;{8n4X{VC&%)_9-etKIa^jsmKRNO9fNEntxt0@ zj4pTfG$e9610MS##R4ri3$Q|FKaYoCq46oIAGRVm*s8GEqd6w3M5Q)N?J# zR;z+$k7f_3c7wP)#RyK&|A$Fi)sAwMSm_-p|=w>J4@bL0_(y5R*}h z0bUKzm-QPPv2Lgc&pTa0eOQr7PBK`HHME;kOhleUM8=*&PgXuSR0zKvDLR>`h2oAb+lCJU?H2gWZ86hdS5(Bx5(A2XyGgLe9|qqH4j`UyMpxVRU$Z7eHOls) z(B90@1JU6C&x{kb-mLKiJ1%?v@3Zowub)bp(tEeT2Gs^yI31kO3lu8qESOk=om4dG zhsU!KjK&Yb{4<($N3VOdULNi{bq-qI*3^w-&`ot>K>5dhioLXd=%^r6v$V#K~_t_R&)2T7v39`gmQMFYSPw zY3R)Ugbe=S3;foYVO}S=5HG02%nxuU)>V!<&vZ2*6^CrF%k@acObO{suU+O#NKe|OW`N*-Uh^?gAJjk*Ql;9nzTv!fM(*TIYi?@B?!I1mSnlMF#kqE&yP3?vlO@f$PzOuZ-eHSjSi?>jua-5 zzpu~l?I@o6I}G3(R2NPpt^YFr#mUssSthLOb0EJ|ieP&I)8>jF&wLgCRn5bc5@uIZ zRJ@v~j@`n`$dMid`ye-AUSFRuMPk13mk_x60B1FR&qxH;i8f{}urf(t8`IWbjHT&z zqP2AiKY4sQ8XgP_M)y7CEWAs|P^pe1*RPn_XWzYPO$o~(4hQGx_G%H{Fb~xjH5$bO z=ZriNfgSU;zT%(V(qZYVD4f0gztzG-u6%mOL+=Bw#TwB_5=MWZ?2JbM zc_c^gB*Zdi8FJFLX0z3QlCcMM2<8_a25e;(GupK12MFx^4Mz0 z@l^MruXg9Ajcx<878Nb4C2GW>2Zu(^ID!ilgEzkrmhHK6{DX5D&R!Z5tQ9Wy7GJKZ zQa>SK9P??qx^vewe60q4VSYZagqB=`|xnQNMQMeL|@CB-K{ykxYJxP zV0^k5mbl3o>Jtqe`*#fuhhWB*WJfACgqfOz*8b@A@5lWSHGA&HUa13(3Nh8D+|BeX zS;9_9ao*8e(z||mpf7saCbFk}GPXf^f&AX{9ijxj)aSlmE?;$2Trr<^3NriG14+R~ zelPy>sb!9u3Y^}~;J(nJBy#VCIBCY{jz1Z}L6-I4l29#*S;-`13+B8X+8amU>125kumgvr!2Cj9&pmFc`(X8vq``xBhhtie^ zIjPxGD_&r?zE88PqWZPPPnehNy9Nx@NrsqpB^FBqMu}c-{-;;*GaR$=Dbx^LWsT`8 zo@y(y#43+9dln~?)tkIlA|X<;?IQV{dlw#9#J(jVaU?)5#S~_Or$bUZ(?;!C$ zh^y)+?YU6bu(93%E#IY4Wi6%-S32J?b5wm6asBjj2sh9J`2HG%r-1s^0`VcrAF#6Eb0<2i=y)Q1rYj34E3UG9$=tL*l$p?u z1AShMfuC5sxnzJm`2fu-&IiR|AthVi0}$$?DQf&?Q;Gy&L%y4Isp)PHS^D?D@Eh5R zRg+Irpvu^iaHsIkx~k)YgI#kg-<}1W1bT(&fQuEqFTo@zqx2D>iohx|mF8VDwaIQV z&}drYXn|7j1Gv`{b6J`Q&gOxEhdChB?d`;&|FpYrN94^l^F8%VAsotEa07oRB2C_ z>GUM{QAj3`9QoZHv_OsVAh-Oqg|?Jg3+T*_uH&hPfrEw6 ztUz*$-h(YC&_Op|3OTHeXwej`Rp%}*x_r`T>*u1L=#FgCU6F{%;a11!ckdU!fs2&w^Z4bY>Fl@+$xWEtOOn7_kUoefuXxDeCCM1JRdxVKMZv3*q zRbylWFN|(})vf0)P+j&#GMk#Pzbm8`Y;BJ=jH`E`SicR7J^K()wPQIdXz|tX`LN%@ z)R6l|z$Y%aMT>qao=>?rW*XkHw32$~DTLy)#}93~Sec3OEm~QG#gd)bv734A0PqFx zNa&6r@2{2(V?F_;;T3+fI$P}hf-x`A!zuTFZGhBN8%}+D>bsCazD{h>W`+Lj`YF0! znyrn5MR#ymxA#SqdjE(PtZs&WYZI5mv}M4xMJYM*<%7ZhmJeQ>%e9L6!{1i4Le7V5 z)|X+zmO!lR|pm*yYGX@O}(R9{iM;d<@xAA(rDJw`w~ag1I2E(Q)v-k$-rAm zKGz|)_&$A%{+4}o3E<0}#NmE)1;`gkPtN5m)`~CLC3#+&<#rZg+z3@oqC+6OJH6!E zSF|~+@)H4aQlW;@N{(>pUuUajR@pF)7wwJ21h{L5 z3z-yTr=mQucWfs5_-%Pa@Sa!Ta#vM)BLHE@P&p|O1rV)yw7Wpa?4o6n<~6 zD{8L~e_OfZ^u|S8g;F9#i8m5ZZDJ>#KRm2_w6d!F+CTmQ&`c+-jL8%kk3XXRn>@ZU z!Q<%FmdigcQvI;;fzr6Ntr4$_tp`&c26?cWgX;Jr8$;udBM|**93JoN%Cs5UT5HZ7 zX-fT6Th&%%lxK8>66v;tdDw_dhA@lyI-U&CKy28Y{alUNoZG4kFPE0Q^%7)aVuSo$ ztx4&4mfWWmqz7qWiAkwiVitWa*8jDJJ~J}tL^FI{$cB9sjq!?mhl<`-4A7HyAfU&p zRHKkkHM09)Da>%TSsbTC(7!OdGzWWmw^aR-ZwX}RdPDeof#~xC`|$Zn#QqW3h6W0m zdKh}F+J37TQ^)d&Pv3UNzBFWn zwfVe}!)C==_(^E+fQt9%Ed}X%^t&sRFDez=~~)BjiBRqt@KR3V%>MO<-s*qJI1ALP3^?zd8L# zhI`LsQ_9VUcxT50H?bI-<> zBQJ#`6+*~m{v{yN;x)X!Nj)jAsb*b30)GHrUZ;-(1`vVX zR6vV{cyEAwzY50IUbsv+S?HTg@cTCQ#wz@fYFvV>?KV!&f#F_tie$G8_4b3PmC2ZV zT~M{@>DMo74`zWaiuk8Re$DHMr*g8$cXmQm*i!Qt-3(j%xYXd}#y3Sq>;LXV{w-{N ztb$iARn}9iQ)&b3G0-ALTWI)SrG1-Fihc}8u$sF66y2?87HbKXiNDS(MIioOV_fTF zFJ76i_{IoZlNJtr@$PBJ#b^&lJ<9+Aer3{;}|w zo3IUI5-C*=OVhU}O;I&+;+FUO9+mqr>}R?R`IU>tQoEX6{~RCMory%~9a*PZrz9e- zp}%W@K4-0WY`5J3p5k9rnXRl_*E)9HK+x^(Ry86EEjMx8=zxX2YPgUBvFt%2{f*%b zLZ>~ih$L&SYr~lL_w}e}Btbmi!r9Gs8yH`+0Bxy~UcT$R0O2iS}k8-JOg?&jyHVmMv((e<|SCE#!@ge+-AbTcm>sJ; zcfjyvxU_+IC4}v1f@_E%DX?ilV;eLnspfRjz+Rl<6(Qo4x^v5 zh}hqgT6}~TILW?)?XfaB5SJ$$P(-(=5gAWFy&S)i){4f(m$C60ChdX~)KE(l*R-_l zvIgra9v_xkwTzvrov129SGTn~@AIC&HuRgI5|Q&x58&&d@y#-ad9YC3$0D-3Kd&pj zUfe&m{jP1!y`0#HLxGc1B`v#LPbP8NGa^Gu_a`pAq0N>sT;Gnw-^6o{*wilp5D-?1 znVEk;aLXmQT1;E(d+D9m1M6xe!u7_g&?tTVsI4<<7Rp(Lb%g0oB*ilQNE=wOXY#01 zps0-7T&1$W@0WGyN`x~LwN8xyXB_d@adfH$;o45p=UWK z5!m98$igZrrQCcqbAld|JbDvgRypcNLo3ecR1eTT*7`nm56Le+6$m*-{(Oh))2cA$ zc}@m4omt3Ggf_YDh!pdR4ky>&uQBd$ir~CK8b4!gRv8pK^rk?@<^EcxUFk%gxN9eo z_NG}k3u?Y@4cW9tEj1mD{}lfCb+UVkm^pBbwK-e^+AM;27U2@RKyH#xZ&p3l8X2?E z8egjJ#wI}!%dN9c>H8}<<*UGzFt|9$<{WFlbWdZILTKZ|0HMJ< zb#j)>s61+=@xPjEyjBsWsPQ()CB&>Yj+yrO?33v3dy_GJJ8uSnF6vt-FH3$bmzi#~ z1EVCOr~L`4l)i%g`&aQQC;Y!~AHuft` zf#)r0JtzJSrT+b*JPjM&t(}`iKn)(ziEmd1n|vL$oDTH(Hi}vQ>Tc+yI=GuUJFIoc zDAUL3hM!~BS4df!KFWUmR>eP9H2@Ui;hgF7cG5>Ze&>BcZ)b;X&aw&!3b*6v4uW}DSB1-wA~wrAjKb!_**Ol1ayTZDxy*kJAuB+Fv8xe++K3#c!M z(RsH1i-y>5x3uReB7);jo=qFF9x4O-yK5}OEZ3B}t|w4Hna30IjSFbNhP&?m6-|~V z^J+5yQ*70F+^%Cm#Wrv_mHhaD@Vy&j$_L!h|8zLdc~mDK9-JM%pdHbA3%(pvCNxOm zqSIX(?4^Up}&n&uA^t_sjI!dLvnfz?6!WI z65Y>$;~eF0Tyr5KncR@x8Z?(z*ZQU|>_;7S#DZW!5h`3D`Fv*l_h^gM6!Vy`=f-H9 z18|mqCC%0Iwc(HoZCq}K`&Nf2?S9eZd_|Ve=}NF|g(@{0@Jru%*4QJY8k$ z6S&n{^rE1V9^YMsq(8*@4v>2@CN^~euXM*DiyBV?UPJXoyQg?`0PWOc=b5QD@oELd zh~8QIrJYNmWt>0+4yp6MZ7Z+B=6 z<1QR>Al3;+KH|PyC_~YccV+s#KvQnVUNa$ZJm`qab$*H~dzN{;;7L zj?GbnZV^EhF|S_0*?uekeU0hDMPJ3uOLYi2{w~L%y=~YnCn9hmV0C3!-cj^68dYrb z6r?NEm25Deis%tCSW$&c3a^i|9RGFxcJwTF9%);WGa{blCkV7%BJYYW6&@*{bf!q( z>&s>Z4Zfqx*j9u-e5(X`Oo_~wG2yfxm?sWZJzS35}x^n!nN6;0fI;*x4Ra>4V(HYOEa>7!MirWw7% zA1r&Kafg0f^Bi||f&~#3!g2Jwgni*&mnqPu%K`MKISv~_1 zr&MMKhz4WJSzUmwv9O_!n^cm!=nLdbX59X(g>Mtix?!k#i%OLk--DuCH+%vq>mW}w zEulbN-p3iMTA5Hcb~`SeI|4#7%aN7#y(~*#?AN;h9z8+bqIiVA5Nq$hq-_$htb|_c z))5O262PQLgWFE8HPBs!b0mzbs-YIzr^~^Ob1*Y(tk3-CVPBK}*;ELytrheUb-wpO z1WPMxmaPLaOZNqFP*akP@E9KG^y`}y!{t$ryc>1D%fr$ptumB%GzdqlB{vA|~s;MTo-eXL1=b_m+ewO}v=mO6QzYwLzk| zcMZOPpS!)BJ+7N@+($)>%Z8KAw`gY{+S4|^|C!S^zM?)Ih&`fL<6I|ZTBRiSs$r0W z_!w%fH1DP+L)5qtA5;oFlUS*=@U=(vGH*8L>=p>f&9)IUQ6K^6(|T+)>y}AAkG^%| zW{wN1DhJ!!zf#?6n#%}>ca^HQ3}^1eq!VgWaNJ8huE3sNvVmi@NDz6hPIJp)TT7Pq7_v%(Lil(+nu~ms!(~tWpiL7dt;0 z;j>$w3Oar~f-YK_xgbIU5ZucoscXqC{rNSImvZo9I$9(3Pj2h8%^%D+l35=epEWNHPhL?b zSv*ySKJ>C`h*-Pqz3EjK?*Z)Ab%StxI(9Yqoj4N^;ks2Bb#P$Yi#jEIrArfb zl|JSM+#I|q9iwQa!~1TPX9WUzG{Ao-jU6=%`Yy6%Bnym)Yx3FI+P&wtTML9j)Fy1) z_)63C1Z8*L#oK5+HkCYWRl>y}KYG7)u!GK;Anvpa~ZKPEFQ_K1Z5utgSs@#~OY>8T6XfyWCY z*$DfJ1i!}5&CEsFAx^pdO}r#;_7#?w;Do6ffm3_O_Umo@!nehT`%;1$fZY~q?|a*N z6WZh%bWv}lzomX1Cmp25t}wh*ml>44x$Aq~>^Ys88{K<=E7uVJ3iFHJb~^!4!7crC zJx#2rqy!hDg*>;1+&Xh3$nIT++eT`2WqnX;l1alsL{5R|ndd*x&7;^orsUC~Dq)Ha zo_u7~QAMt;YWIe;*d%LU(e{sbi~4N@IqX)}%M1q-H{TD4bIbj5NyD<`A(ibhZ(?-z z=fj#?ta`7t4sNomMR>IVtHs~LmDY!+9`UGfy>7~EP_Lr@0XJD|DMY&lEmETTp2wSl zbA6XZoewfWGa(jF45jnGA8`D z^DIMUpG+($quf$h)gVJm>aG$hcWl4@uA$h-92@n?0z}a&=ek{9AZe>~Kf=a2Z=}B! zI^+9*yFjCau==c59PYZUJCR*sh49bT$U#is7&U*ikg}k>*w8c;H0o>-XXg*$``#c0 zRaE}|N~N`r9$S)C?%d-t4gqdNzbmgBHj}0hiT4dpn0NR|ZY8l32t>geq4&Xs#c>Oz z6#H?G7WYV`kh&+_*bA}mR(8ijQ?gTwa-<+KgXkFC^^_>_;fl0t)_?Tx!I%(Zvm2c3 z8IQD7F{RQOxJ!?2=TY)`t75OdsvjXo(ep zB3%yL<^i|4z^HXm9tnM2*)z^bnO%;{Z`DXx>O^GvLg#1n<;z3vtN$-l`X!e3w==%E zCYrYMJ|`D_H@e))0*+p57_FGOv?~9S-d1<1Tvoh?JLrOb1tJ@m9Eb)Dh-s1H3op(^ zDnCMhxpjk+=Q*Hg?h)*9+CZD^esMD__Y`6x1$&iJtESN8m*;r{lo=;=<+bMbB$<(m z3uW-X+vr6{JevU-=FUKU@}HyjH=aFjQCSWlpYVE(5C@AM*x>v`=7h$&a|p-Yse^cy1W zdcUd%r~}CmXzR7~0LUSaG2I^$He}W6 z&Yj&U0Gm>NXY?&fw*EHr%;r;#X~k@B1@e}C>kpS#)NItYjGSQ_h-#RW){@v09sE`E zRMzg=`4i%<i(59e&yRm~j0WKB7`pvTuO3g2nE3+I!P(T4PhJ^;>+;44-HoAgD35 z>z1xxWYfo#kM{2+7A+$HxO`xYr<|y*4MaikiOUH6OkdM}voykP`=L4J8%W0N5Vz#B zUM8G$FulU$v##E`E8yw5E;;b=I#XXFQYnJvr5WkT_q0nGna>ot35{WgqP~t>*rElf zp^&VeE-UL1Fb`d7{rTR&)5I%g+d>?~TE}orFZH1ERu_=PfM$AryHUae;NtvtHjdaJ z0?MRa{9%h93J{@I2iHarn<0j_OE{u$g{sib+@3Z3R+(i->riboc4!y)**z&S;Xm|F zFkszjKy{Wk?4I&Ezel^Qiboj!yHVOq3NDL2T{$Udx|3_8ttWlqi@4a zDncQuA&1FI*!DiyT3(A2OuInWD#U6$YAj{v$F)<0@&JrV_lzsvwp z#ob|GA&C{{g3jRl=R!7hSam$FrOx$KU%jz&gelQ6;t8!jGcK02T6rEr6RhV}hE^x{ z=Tv0XLU_LYa}0T4H_5b6Jlk`7nqp>Ifw#FMR}hvVu^L&g4tRpOuqZ=hx0Fl=4T296 z)NOn(W}SV<+52e=0@4ihwqBXwq--z;97$XMuMF;ArI*;P>k9dD-QO2$7is@}Os3c+ zfXw_%JC~C(6_i$#R$I2y1X5|3MHSFEq1r7e%pk7paC_bRA|V67=tcKc&B#S zqmodG71zV(^?)3xQ-?&`wCy}YT5V?v+n0qf@y8PgGQ{WF@6p?%!2py+{9#b+Ni@n*d=~A(Q>u2<@x;#nR$rO*fM~Gv1@1w z9=ls_v5q)kQ_Jg|)QDmC+75AH^SFWK}EECSy$TUz7mzZl(QkEw|T`-HoxbKcl2-aF_i&J!9HSmvQIF#=ll*` z57^mYf|xFApL2(J0Z)Qff3k#WCiBNUewjwDouMSwLhuN`2nac5JIK9~KRA}&P#^n( z`lGAivQ(5@L;7VPPZkDmlIT&TY`2&&O;sFj(#f?+8{-Io>0h#Vt`IuZ>I9f|H(v&;K=FWGt(K z++`+sA+c(bKQ7~`GOt|^X8uON@dDqKOuu344h4#MxubIBv#;SjpoJYJb?e9Qo64W2 zt^Y1wTd>3w&(E-72)E^<&&yqjCJz%tb9!E5K@SHqLC&Z+8G&o&d}Hu2AY4{fxM(*Ov(Qat)+I4jyhR*{k0v>4^VNroz zsf!PCS@~AoQ;WlYx=>NGUITYDvIy^*K6tGLoJytOkEkzIFthn9Nz$A@6R$g;ufEnG zlp~K0JPehxYh{@&E7N7xl>K%t(+WX34nkC}{S|tY8tYzVXhao$I);o642^b^MRAj3 zSspg70^&a$;!1zVbPekCY~Ovq4;d@5@6Ao=2=U;S;Nfn2eI%fdSh?G8+t~bHx51hx zp5Rz(88)Dv&|icrfozZYOrL0JDoH6h`w2pn;CA;Oz#jW^D!!K-_B2X>Y6p~#UFsn9 zUtT>sY0pZFDVmhfF1Jgf@?~{%+m&^p+b>OGOdCpQ&StFsG=y51#uD~PbBxv+%VCD# z`c{L)Ih{pNC=_7hiDwJZwd}7+D++;!w+?Tt-SN9z;e{^U)Hx42LX56|JL87CgMdyD zObS~R_&Q24bq#!Xz1_~2K~s}s+aPLZk*TEwafS90zcbS|s?22%SdRkB>L~NJ!JqE& z?c$z8dZzS9j9=bsP74&HKYjJf7thl2V&NeN@-J6M#Zc ztmKY;zEXif#>|m0(7~4Kpd74xL2wDU*q~(t8#$ZN#{N2-suUHGakS0rxu2a@_KrbF z^gmsvo70rKP3yrNVhk-0FNw%e$M8ttcTOW3=8|% zbEt7({Tw^vjz4$6pm*yD7B{E$%j+g!XP#&s*1tt_~O)ITF>x}9-nKO9mSf^=L3FGudR~s8o!%KGc!cAw7|BUA=7o?9Z zMtd!7*1j4yJjK+`gey%(o~Wn)VnW^gaa$_<3~YokV;&VOY3OZ6+`(q_d(5J8N*${- zLi^t#8L0cThpt48t#Dv;)|BMrJmu15jk%13ut_8%=-^DUw8jr=J@ZBA2uq}QqoQL( z+j~kv0B5G$4!S#e4E4?~gfy7TN$%r$+U$%i-b6*E*GRifpuvAa6R5TiKEWv>`cW?tbn{yML1tB+pbHR`UnK66nwq*Lh|E^D{@vF)`AJleO_ zWT9~m0v$sEY&;BuxS>_CQFr|A===rfeFj;2Ud*oNK8%@{vpiaTmRdq9G45Oyk({z! zV_#rW=4jRDTS<9Y^b2Gm^(rzvE+faHRH%Xm=uw)4xO@;U;#VTAk3W{gSuQfAuv&$O z+UH_Q`einVdOg6h1~1Xus>@(4J!IC)10|A?3dG+|q^ukrh>AYA%45JDKHIqkpH(SA z?Pg93%Uu>{pSWf9KfA+gZbW`qRo&Z~&BBQP=P+c`5moDjdKbWDSj4R($nLTIB`X)v zR)Vxj(#W|bba#^=2PI-os|hNW5u@#nZiUlxgMwOpEw;--rm?R4tmqE%P7NpdaC1aQ zu*)R>`VJ!~@)gWyWBs}_yqM208i)5q`91w?;;bq5M#-~+5%{D4k?} zxv<|zNjC(SlFR~}PrSp&R|#ik4!i}Cdsppin#OoU4A@)4;J4RQ1(z45&DUC0^5p%Fu+SZ0~>T;+kNoRf7q_>99QL=$<^%nijZz_h4NSC_v~2kB$o$DF}# ze5u-}?n}I8YF$g~xrZ{E`TDgYM8C^nZjGUkNV+V&nYDOQMH#)ckaEF`WqaBEkSN;b z;0JoU%9b4>8T}!1#zPhynkw0x_#j*fYwb#CjjwVO?k5v&40Kf;uo2;!nR>eDcxg63 z;e$b79HNur`Pfl|ciIS^)Uwz&z<}Cl4Pw`5I#p~PCP_P)$?{Zbh|m6_5J~&6!u~_F z09UMM*B`|MF69!o*i0^qOKbETuE}b?q_ZR1@AdA5x7K*9I131BHRZ`JSEKn$w7g>B zv;JrAG2*59?n(`{^;;PK5;)QM8)(Y15n27nOhouHc7^c{+z20)Z_7GW0BOC$A&nZG zsoS`LIHV{Iwk*)y{fhjDV@6#(5o1t^=bfpGk(Kn0i;-nvbZ2u5I(Qfazo?&ru<@vGMf#n#~xZFeh_Zm^4>7y$9I&I5F6#sM9;zzZ@wiIRDxaI&t(HW$7qz zW8zi|NS_&c*d0IV>#%XeYq6gk7yZo4$iU2WB-7O@LNFxo)9NZi>ct~E8&95t9PV7U zbWRvW1s~$v0#b!P7#@(cv%B(>$Fx6r6-#=`^vpuq&QX15$E6wL(y{OA`dJrC+^s)Z zB`l^ezh`L_%z06Qup501Z>_V~70IgKYX~9Mr!8o2e6myF4~l)JQ8{-9oFIe*=cKN+L zx4iW20__=i!&dFv`IRi{*WLW7B%!VGKk^vA!hI4H!~(t(V|uqUhqe!U%@sov1?7MO=0nXD0#a8g*DcT!T^vFq-uuCn=dntU%%`+@KHp& z{{Q6obh}o(=3fby=;ua1FJ6whY>C)>W50BuG&vTOt7Nug@X&f~YteTxIG-d-K2_m7E(+G3zRnL@DCC z37~V8BXc5cvC3~aA^oa$qp%<^+AA=8V;1{9R^)&8F8CD@y8L*fj9?py$X6abX1sXz zShw=V^_cXq3nkv_(r%G!l%}Eel2K-?7f8UFSbw7>zM2oJuW`>>ykKUr zkpzw8RN2SQc~NPM_?_B{$?#xZt@yE$MLjA z)pJ#|GJw40pBxtaRpHP1lUn96Mb8)`C4b+ju}85jZ3tZgQ$S!SXVDQ>I&qhS=OOm~ z44cRQv(y}~I2!>qzoQcrIuE<+581t66cUIx02OPd7Ta-tKwOLgpST(t*Fe3Z_1L)5 z>P+NO8?W!(=KwaW4fjn*__8Bky}~0f^nG0I13*4f?9}I2Y%V)x4ej1e6y!XQ0Y$}l zxAfbfuWIG$gKPP$mEJ|(9mm2|Ya5vW{=H8}+<)s6aiG7XMm@MO3TlQ6F|{yWmqCs- zvTJ>-Y7RQ67yJ2VCM*=Zc3!zPUx8D_~p4IVzW>t zr^{Wb7LRSIq|lx9kgBE=b#`w_-;)vHLg>Q|7n|B)og0;AS*U&1!JizX?QAidhSs8V zm8}PJ6}PN@WT%%ikBkS74qlpW&t9GhaP(na4HyO6j7hSmQEv(_F4PtGcjsJ?5BB7x zO-6N{bv5k{MG?YV7t4G}Rg9lliiDqxvK-~#?+Y5J96-IUkmsgPqxjF~Q!}E-N*p;J zdsG9SY&D_A4B72gi9{QwY>>9#B|&Mawa*X%wtHV`&%^i|R)j>qGcNU3Pb}?Pxj)Ib@67)CR=3y^3NN!7P5fx8PF%4B{xgqs zo-R4)TH8ZGORRye(SbJcD@ET+{1PUt83FpWlvT1)aD_KWe~oE&vPyd& zOU&f=aa3Yl&{p%PTQ=zVAIwP`#jh~hiwXAZC%-#xw)+)n?rd4!qZ+@9BM83(U}zb9 zVq>S|OaeD|d1a-jKW6hmIPw{|ait^Tg6TRpxX(Xweg=6@erM&_$W9Y7Rt$-(p+gil zDVsO88zR+JY=Gz zlA{H@=tiztmA^vU=V>U);Oqzhthwg%V=!f+?!zQ5 zq>rqF^fb(!fRF;vG%86g{qVCaMQ96mCM1OBt3d#dSHPs~m(RP4uiacZZ`nn{bY7Vo zH-_iZKw9x#-*CoISbjmW;8-x}ZF1PfRZ=0)l!p@?^0i@2dWqY{g~uSfIZbi<{+QA3 zkVlib`#nI;+eQN}B(8lAP9^Q|F6~h#X)0KxJhMyvNAU(fx5~N6OyNx@crY# zFfIOK-gG!Y!>z__v{`LkA(rqS{4`j?`a2;K$Mm(C=H(2e=C_C(L39EJMP7&@6RZca zl{Ktwc<;lvAGbC$e|6C}-_@D*^@K`;)?PO>Bbj0etIr*^{8cdZ{eGg5Q&J3xy8dMC zFZukv59e?Y8!(JvI5qYjv*{Lc+%)vJ&Euobl8aN@;X2{%(_$Lw*jgDDV(P97t?{mO zF`xGQFOR7E5Dw$QkB!Ky0LP+z9~75e(VKm=P{H7w{W{52qG$v0Ke?_wtG}0;0Lv=*C<>U1&hHXzsGZ z6kBdDw*O8*4e&q_A3?#gJQLX3dt!nr-LYj-`P+me;jlWp8Cb@6s0_Z2v=4W5D?U=# zl`_+XHy5oJY90xOeakM(3*mo5&Mzg4rjiip$%$}{UMyDGu=50wxwf^W`Igyrg`i1c zlU=sxEy#;xLNNu>gCPrg&b1(9F;>fQO5tX$^s>;N_1f#um|N(w!uluIk>~oyH^l7n z_;%y=a^0BVf4AO~^>p`wn#Ad0!L>WmoW65E>s9!J%!P}M?_Ii7)){B4BfB2!w>c*H z1p8%p`t5FgxM%I!*~}PwF|T8p^YQ2jJf79AAc#O5PVcayiVb2S`A3W0LQ0!UnSG$| zdD`RgX)-U3N++2dT-L}tUS310PL=d#;x%iN5RnHNqGPgg40&Y!fF>A1CEr%HWMrLE zca8cS^CO&``A^8pe>%PkauafWDmBI?!nRdBv--}$_qyg5t>|DYJ}7KdqGvgFux-$@ z-l1<+ct~iaj#RP?%MIHD)gF^w*oHz5^-=$8mmkk}3^Y)~P3Pg+Fk1Fbuo<2ON$n^1 z8ym$QEK1p3icD0qPyD9sg_7{>5gcI7{ZO>S)<3gHv5`|Jrjcj*1q_n+1L%C>W>Q?t z8aEJY4)zFW4X**Dl0Rw}oNcDJtkaK^bg?PT-r^+s{r=Wy1Dyav@Y7U{F2@L4DZeI> z`G@$3g2&QQ{|!IkZwf(|^Rp24aOTLkT1T@&_h%7PB^TY;c|#KJFmMZ)FE3B zpWhQ3&Xuite!$0>uhZV1Tp0K3)X-|AF%m{=Z__@dZc2iRG|l7g?e1<;_rx0C%V$^m zO#gGlT0Rmbna5*$DprDC`DD|2QcdIkYyW8#ZnO36Cp^%>X6vX0Z|bhU##N;`@RqPF zaL;!nWmJ3OY>MbX)IXLBl)zq-ER882)EI933T{*!(R1 z6ME4{V9?SUDB!66r*orK);oObqEEI#mBE!r_Defp%|6;QpUBVNHLp<5jKwqVIK-)M zIE_M@ax9|asP%gLc@LrKz@v%o_eIz@JxyvosTruyiR%%h(n~Kbv}@GLM9zs2ExN0# z2KP$W_i?|VcP8?tEQ1bCm!nh65^ezMhPqI_t@(ZP;hV6k{1xGs&DOvd!T4Gjl${Wo z14autOsxA}Q+Dff!TS=yo1U<^?h309n&O#C*e)X1v8&_Q_8i{lijs8GGn_&zIyD92{RUiDLIl&-f8|jgZCY#foU`bkVMaBxvb=eMF@~ORIVl}pgpTBKcNq`(*?3nKXCwa{mj`ycX z#xm4nLdWsn#{Sin^|vWYy?RKc)LC}DtA+I_WR-E`JIysLoHIH{Qg#&-U$$Rb5hN&Yx2#^O>@l{M7Y4YrzV2WiTlFa6Ct2gZlxyO;0G33?ea`p|^Ls zzTU+hI*wf5ptYT2wcvW}FZS=s{u?vGs&82*(B^g}K#PMzTeBuV={&Z91`9>X9jCz9ikwH%ot=`?!1oCJ(y1qzV$`f%FR<{ zZ`oVH11ibQ%#qXI#$RlHQA7LjpQa{?;gCaDfxYW@i_ooPr6^FZqgU33r=EVjlJz*M z-krP9Fcow|AFHThIn(gsd*Q&j>_4ZQ&6^nxEh_;Rn&!I5?n{6+ugV3L&YF-AQBUur zopeTcXtY7M?Tapqp4V({#FGfVYJGE>n7If!4~X}@tE1(s4hkB$=&z6i5PowLo&K2l71+g@MFT^|H0iJ}cVgAq)YZjCy}k2!NTasQ9-UU!@(@xY z_5h0|oOdu6+MrLVin3OL=w4hy7Waf@@+7W!V2;shm~eg5C+@f_nfY1ooJk0p;?%cK zv-Xpy9ctaA%l@RCxb7u48_RB~$Z;*-nV(Xzlj?q$Lv2p!xc}A>5WPNm*y!ze$&4Lr z96Z?Iuw;iNtJ1Vx&*+A)&H6Zdi+?Sjy0G>4mznZmXiws)W7OM!?93ro79SJ0GD@32 zd80z2j$)QkYoA^Jw-ZTLHd4yIvr>&bX!)R}IrcI4Kjd1Yn#JG~&3vVH1FMKR(Wf)3 zgXgj=K6MS*8vGzN2#w*tlsnP%?{F6pY+k=>rc{$-7Yk4DSa6gFINO~59&qe&ftICo z3U?Yk^5!<0ivSiVNPP`fcxB5y!_A(z75LWlXNML5X4U@v&r!8B-=f2{J|gKHQ0VLM z*3)4_ClYR|V8rh&m!)QDUIv^Lpsj#z0A3j8$~jBAmgentBoSxTXD*EP5pO45{42)q zdmW%s*rfnIeFGKM3C9kU*d=t=r8&0ZjLBWIUOGl_f};8y6HdihBs77fYkkAhCY-z$ z#$$~SkFuw$&2uSn_c^^poOOuFZ#bXMn2_+Bm}TGj&TbveI~27ecyTDYv%*X*Oqvbz zvzW`ZjY_xe?NkHGEJV~vIq}hiV1u`dpHzKyHBIXCk=MG8my^|A#td0)e|}yZ1W0*? z{zH^YA&*XF&Y}-Q__bhc+gfMTTVKGwh3RvlJK4^nlM33v# z5yQ8jQec(}D;^JO>mpg*x@?8%f+Gh|0e=k~!qa|Yl?^B4t}6mfm6|fl@-tF_5*`;j zAjS&rhYGbRw54XJs(AMFrTrFg96MqFE}%mxOP*R>GXpJC3v6FcM@waNdAcGsGQOtq z@fT|@A^;mE;iV~br&6bG(0*7^h83;pE7a1uRc(0n(6O0682>8Cu02>Mt9P3&SKfNo zjJ9%8T}2Cd#{D+mYP@*M$-#2A=ra!MOXcBBSG8s)_7o7iZMJW%ICQO1_XHD_V~vY> z1B-vOl2T>7HCw#(V5mV9*?~^odP0K`av#^qkv6VJzfz!rv$aCw!!wcD?9d_EV9?B89Ld3cZKXrZnheb`w zCIZ~nJFv1d_1!8NY}sR{0q?1crS(J17kl1YtPPFX)7~D4;Jj##jRAwJTN0iXF-JwB zo@+fyzlwr@)OdCwX#UmCep$>)TipqO!{dqBT4KrdPKE%gT@aKIk|f)RBGuOy9dLV3 zXBpC;Y=lQwb-&5A)JArcGGki7WAOyuOocT6;qKV*YC&g!RYD6R@_krq0JGIKV3uyM zuW-pMF>nR>>FuR-&M&*Pc9mS^U>#3jSM{v(1TgeT9Wk-rffS{cJ7fW|aAGc7HEzqQ zl+0bxOUWA*scJ>Ue*dNWnbU#6FSFXxJHwRNg?26KQFH1@mxt@b*zP3F^Q~JiX=M=2 z)8X~H>w5B5>&w@g&KKSRx9Q;dqddd{YD$(|4VB)fwJ0o;#qrhTcgLTx^}WJymgAxPEla(`?Y; z?tHEI|7nK9H43Vi5I&(w@gu1cCEwKB0DwzdwemLNM0b8R;a|*tN-TJg@ z^jlVk78*W58{@bu^6F|D-w^w>#ywjlkSGJ@vJUR9LTqYc%$5qar&_tslXMIQmZ{My z3Y8)2oYW8ZDWIH##eQ$6l*cnxCKkvno z4l#Z?QAcwz-1J_KKW%EJDj56J->yOirpvfL5)$k#x=JZw#%ml4$IrF?A+yc{UsNa) z)PJUf3Xq+1gcF{>hq{!Y7KeTCeId@-p%y}<(t=}8YWq>k>k;D)pQetv&+W&AfT~(} zR!6fTd34G;V6F;kQPB`pQ|pDSCC+#>a>^)V_&#C+-J{aJpM0KenP|!y(5js7S6@$X zk0J*qxuU?iCXARzC-Ro2jv!a{Xh(h4zPJROk3%X=3g5qhIaS3Wf3jqCWL06VIQBXr z(ms1EIvuEa=igYb%Ht&Dgb{8t?+)BHh=_O_pa6q%6vmJz0le+Cent7T&$z0|xJ@sKupG4GIw9xQkZ_* zjY>BynoD_X=l*H>ry|c+3>mRWa*%1CWGzA5U&jNj&f|CicER2yg?iAMv}v_xm`0AG ze?x4gosjXhd{!*mLL@?ay<$`;!M;AcE_qa~+a|4)$pqaK&@#gG69&jO*f(gnbAFL{ ziX**zXQu+6kE*%PC9U4w{A1~c70wYTgSPmxylW4z$I2HKf-=5(eJ~Zz6K7f?V74KcbY!^IcRDJ@ zbPm~!@^>wqkYwMeZ~CVLE7Nuonf&E|Lr{S~up zee}5Fc^O{#>U>qQ;Y~m@Tv(iek@7pJ(t$nc03LJXRcP_8sINNn&SqI1RmNAY3Ds8{ ze_5+?W=pZ|u85YxMa#Ul>xi!VePw-FpifKS%Pl(Hb`#F*g0gzE_>+IkYh?b#DGqG*%<2JpL#kh`rCxbn=cy%~c3xxk{t zNWOY%F(#cWQxN~JE$K#$f;(E_z1`$K-fzf#QJ*Z=ETTSJ?T_^Nf&YYCro>R{lQyBe zfAfr2nw=A_6Y$nGLVNr07jodXQQ8CV-`h!DYo)8dEGk@wy%<@2Rf^-apS|}QD%%Y8 z0X0lh-N9EuH+xx+BH+fJmU9&fEe1mdf6oRv$Dof}Zf~JZqeZN1rZDwjKYf;jT~W8A ztpxhDGo@JBbl7g@H>f%si?MBZ{?((>2Ysi)BsGfFg>Qs@Txcn(8LCOZflRI#zRg@2c+e0f|W5&b{0DL`VB{tHqDkKwz-em+tLV$!UTITTZIZV#s#I7?9 zA|c51ZMO7SOz7;xxfet#|KdW3Pi_{J_GqtL_UX4G5w3GO_D-;x@}dprhyLvTwf>_1 zGw6{QzdNWqlDxWQ0kFvv6CU&v`=xJ^MW`X9JfG7W;cma8WK}bmtgchdnONk_5RH}7 z)%_hQ=IN!e+UB>5N%r7hk-L)>ogX(Fr@p6CqAw>5tR)rA_xqWOcBi(Vf+Bnk9Wvz5 zG0oU`g4iH+%3!=Nsurf4~L97}LS7d;fN5brUCYGa7!Qwvjc+ zT3fN6gMefI&AK+HDaYqn9rdVL%DYkL+mGCddilIU9|o^g-XJSoUG97f38`n*q>fET zu`jx87aiIje<4e6Kh7eiX`-&=moU6B-?Wjmkq@?D<_TE9=+?BZ1He9$b++K(jYXFFcU41Nt@ ziQ-Q!87wqER^UbFvxD&}D7Yqhnl%qyEDD*Dg>xVa|Ll7Ta`F6$`Hx8D`HO;n=JsLW3>R98(?6pnYw@7ed6pppGaA4= z{#m8Scm-m?%BRT&&;2FfIi`akqe^NfT{x{`=&s6%PL^L2MMWlMCzOqx! zK^A;Gq#^B!IvRB$N-c<+Gc-`HSgxGWHECCiO{sj|92ot*@qrIwPWCiA=yS+G74Q~t z0QaazE)1ju&S>$DeZMt|*%`&4uC6+zvD1A*QQa`jY^PtkI_%%mbQQV6houCit%Fp6 z{ObW_BRr<*ltB&lSXb$D`swWr&oZ9>7me{)Sv{rogD2e6r*2>aLg*x!Es_WlroXXT z9{~Q^;QMc}BShirh15ChsJCfPh1!cSYUjSrr^w)JD^?mxEZU#Ut7$#e6C;8ERkqs) zU!RhQhBs!Tex;u78BvwdpQK!mYiRZMZauf{y?)sz_;wPVX8g(rh6;z9z$X6(BvHQ<1%VxfY% zT+oxPdPh>fI(q)b<}-4gnhknz-g5jhmGaet%ZpN|k>gHTSCiYmPC2+0YGoTvF^Bzn zn3~+8v!mub>#7&`b0*y4YHfi-$a6BL7v-t`Y*21kV!D1YV%B^qLD{4VOm8}Q$~DDI{ot_Kd0x0om?-ME#NS?WU0lN#`#=pYI zeM54F*mAN(?B+$VKA1wA*?|T-Pgy;swwzZrIf9GZO#mGK(hVW9mvw}=LN)fcmcN28 z?xI4Mna9didu!}exmd#Hspg2FJ-F+&+|L!EWAGQ_O<(USzES3d6btM0%7ebBzV3L0 z>dc#z6da>^HiVG`PN~)wa4+PJuU@{eVRr6l+6n)Pn&*OBPv9@Goy;uyhn-hG33FWz zQEvPcVV>6hn)%V98dJ^l^1`oS%7iNLem?

      xe7^#FT_+n4PP^+3hlCZ(#96sbFZ` zcCJ4RNXUTv1~UDTR858s>G7nNjrJBYxX}bns<|U;|K2@a0IBtA&_xtsIV=U@Of1I? z4$KK&Zcs)7Wof$F>!P8V`-%R%gn=u_pO{}nQ33FGN)@os?TerDKv+kcsz zsf!XLDjFxAa0+*X<0ppJVN-C5;skQ%4tqxduk;nE+TP=`OUmdAJ2XefXC^ik+xj|A ze&G*wYrh00q0bqxt=Qul))Leo;rYkBEu%`~_qB*J!8WU(TpDpUK#p(a>eQ8$zZ)Ir zD1{{7|NNYQkNqQ$uKqH)0t)WR{K(BMU$uUA_-g-lW*on9p4Mkp8Dj1ZGVQFpKwb1e zz;lUOZ1!SeDFlpYP@r9L(O8tB4rYE=rsw;Bd*f19E$^XfgDy9iTM42{#{#(|dAb(= z?75q*ecI#~X8rl7`i&fOqbYpzHktbMn8Fz^?|nqooZ#Xg1};5BnBrUv&nmF&UAKZ{ zn&bbuyms#|oQmiyRnkSLUNVZ|UV>}J`kYjnGdP}#NG(kSlz^cC%@cQqi?DEiY?4cj zEO0NDHff-^WzpP0eQ;~MZG?y9^pB0dH(&go=TBAi1Wt3lDwjcx*qZ5oYS2#a%~WXl zylCghj|nnoR2(HfuVcITEhYv5;XQh_P=dkaL zlGzkl0jyihQJXtZ6z4IuiQpQ3OCeHF&FD8lU%@#K2pOj=GloQ>dwR)JeEatkiEV;-=H28 zA6zq&Ww}Qt`bS@h4h6L^ru&hi`^6>+Z|8&khGOO}9o*Br-zV9Q<0x369MM`cJxXz1{mfDHeboUCF=sjkxfipa zXU);+xAn&q;k^xyg6L>H{8UHVX|UlM#gxP{QIKNac$3{J@;naAnWm!@!X$N@{RaWo z3-?*Ik`EZ2lK&Uxl6LJTx=t4wQ~7wlZ0CB&$tX}di&^=RE`%edP@gKfRe-k=o3BY`^zd&?tdmpb)SADHbv9Bc^GoR;S zQ=%}hYy>)&@G-JcjZ~77aiX$@>9tgy*tZNlCYVWElreCfAi; z%NWB;o%~+Qs0>ZUU=nU}IoYt-;GuM3z0U=w8sv>icsv++VdLRo3M=cCfeX$)hD({) z;0~|9>89?CQ+H-l3BGS`IMe>1Vy{zsvigGjoORVXM?hZmN+(a?GvExy?+0;O0xX?< z?OY>#H~;`T!Bkaooizw+YtN{-6fbrQtEtat>sSb!0XcqlE#ldPrRo|sfIZ=)t-gh- zeylqMtzC5FJcV5$=7T~KeyZt$!L~|+h{Er(i8qG!ba}bXOG|RfarntPH3QxzpKY5(; z(O`{^4MW$m9HrfUvjk;2dg+;gxrBFGoUku+y1>;GcAi2{UiN{^ig4jgtUoccM#Q(! z_?BMWF*JGXhLod+30C}mV8@9KdZ9@3=yTt*yeeZ5wWRxnceuu$y}`Tw(JDl&3W@e^ zgd~P)K@8A=q5d1JP8aYfG7?_a?)njYRDG3=zv>e-p5?^4LSOqS_!z_C_y^ipC|KQk z)-o%7^CyVu8T@iP1Z+g~sSJ%M<^NKt#MAhOl;?)|m||wL2@JhP1YEf>z-?78VWoy! z>EScanhI}cJz;=e0}qI}+t**)yqci`9r_aFS$~q(pZ4|p%4F&n?tmYQGcs6j)NPI2 zd|m_?A5T_&pBI0rJOg|9eT8wcb==Ung(xNSBYUXjul8p1O<2V)yH^G^=W;*~dF zc++&{Ye>4{Qyr$(64tM>f|Ga!n^kTs|Q1wHNo9?TkfX z9b34#8wt2#-(FF>0z3}{26OTbJ-53IJ%qZyuFPA&_E-%bQ)n_Q(2H4e8~|q*8v5E~ z6W@NqEL9CqqpL-zXGn2UtAsO+s?Ff8U++CXsO$@Ca!ZcT1B2ZX-dpf%NR7K(wk50` zPKph>HCgML^+YT>m?$C43qBm^Hro+s2Rp~i{-uzfnkhd2x}ixb&_%vhM!ZiUEt}Ul zCV-!eG9(xJIW7BH3$L0>5Y}BC70c#vxhY#LYJDVet-t+`i?q6r5thU(&xTkmeIP8V zW(o7&Q>IJ;V4P#7n-C+8`sci9g8zDF?9S7?`3~`{_)Nn+u1&IYi{_hzez8Mzhy z<#i-AEXaI`4rZuAkjmR+@|;KVw6e9`k>tOEY9Xrt7sLbp0O zs{s`;XN5s{mbIpiZ#oO6oSJcC4T!WlpmJC38?BNM!=Vdd`XxJ4!2R*Kd&h{LuYCM= zIo=x8rag~|QMsuzck`_N(^FcVwk~{WLOjQT^kI{L-xO5_IC=INeY%R4$`!-$_lK2< z65hGO$&CMZT0^NP45Ab?-M;<3PtO@^*o+X;?g=Ya*hj$BG}yK`ws-lG zPh8GCW$YH<$0%-g$l;eY`IU*`L$;_`c@jVGr;P>3Y}BYje9$+dTwMn_Mwm`Aaip8T zA`Bp%;BK;cJc8p?Oz7DC?PmmuSnCzS2)kKjNmS<7JFN~%>Ed)ji{XT9nwm3c}(0pSnM@vG&x)XMYAnW-#V6S?fIFGW^J;u+JxI=l5l=R&tBs%UrY7 zUhd8T5Ug0p?xHR2TDoxOqAG~HS& zTbSMzHP~R_&yrCw*Aj@I^%D6t+Et=6<1)3uH8k=Se$_YEFF2KbjrwAEXvQR!d3J!D zND2b6&88##%B?@C)`Gd+_Q93;tkWG+XJhJg^AV*H7ZM2{dyEHdrKPA2M?y;M6Ye@S z+#hEU*SHZHWE047Po%j$iMWcph~8ZjbZkn}nS-_39g9AFEM%fu-uvAs(*fj+CP)FF{f{gDLsT=%K-6$iDLQteyqVrC1nz74QrY>ZD7c09&)i-5{n*mSy@fg;*M-VW)=2ZZ-+;F0 zax-8Q8IQWce`salH&Qssd(ap$Y5Ft$y=rgWyvA63GI+e$s~AEMS5abD#p$6{v}>uF zSCn3O9Y5wO9kqRD5u8&ZD@Jh>^Cj$+|f{w&a$^{Rr$d-Y*fkd9i!uInWKp7zp z?ma=VVfQE`3X`Qjn8!UXxQL(W%3?gn*gQ!;yMxH{>qwwVW2j`nW$JS`znjft@VsDz zK_ll@!JT!lmagBAFI1HM=F6i|5UE2JQECQO;YS z_@ao&0`s;U#f)o4>V@DPUa8XkcX(w}=1T5Qb1xhtBJN85>##4!hXB%J)3N#%;t#G+ zZy{&ee$44Dx#=~Lu(x{I3@QIBQo!uw=UMH=~SYuw$dOe-e`fg4ZRm{RY22ac- zdk3d}(wGc-HFw_Q2qhjFS5B!pi$})=vciD&oMMCjkEeHWWV#Rk|0|Wc6_v8eVGfnL z#iAQIO(p5Rm2r05HX%$eAj(`w9d4%?V*hTp!Q z&+q&F3wC^8uj_SP&*$SwoIm1KsJ`^l}=KJc|vWlV4Vac_YcF=N$WPIdIkJCGY@ zp@siDd=Txw7f-B9v{Y{fNMl5@b5wRYNlIjP^F}Es@0a1~2$EdG#UJ)BE*K4!J`iMA-6?_o3%zGZ%?^XOOVV zRg1;8X%)_WFzMPZqGj3jzk53(MK0q#ua_Q}!mT>>a(du|7HJW)C=DD?Aw}*n8HmwS zrpSqk22M~hm-zkn6NW@|i-##l|KAOhwbLtI8nZXObS%RH{sa6p^s~#OU3l%urya-w zsD=c(W6+WTeEQzXOy-mC z*WpdUsq?0*L5x>;VvF4RZ20p!HjXJ4|XbjQI;GIVHUxT5}?)tM8@>7c2s#U@Mo?GQ( ziX**f4!#@D?y0z`K6-KfetmCUqj9KFRTJ2|cznHEn{4Py(l3*Uoh+VgW#pM-CvN9W zf;Wmu3IiSYN$U3^dPH6ulV^>npDniMCvP5=wWRDpNL^(`xYQNLiGoGM-37#p`L;8C zI_rxVkn=AsLhTd-;o|^LW-_wNkrY>OD@8$^o0+ZlC39S&r10yJ>^%TMXq7VALodB& zZd{2}$nslO=EPU7Kjm=WtXC5p&q!m0q&g%j|-iyq8(&TqrSTxhm*ELzkq)J1Suk6e|At=jdwvrOTtoxh`0{ zC|O)*itgDnn9f!}ul4M%fVtNt;g~YHqr??Pw`}}}FyC%rJM@nG9L~yc?kdONN^+({ z^@pbStC4e;+v7)FL2`3PVS`Q$gSIiGH&wAMFKjBD@456P;=^m!p13z6PRuxxPkL3D zQ~Ja|GmAkowQN#^i>+zvlcF}J&0QL_$0SU) zsN5Zmd^(U|lr2tvxB=*9z?P>-Kaw9k<$9w=%`iTZY8FM|K9e}9mr?+h)lqh>Bc0g^K9?=zUw+O03258>u&ZhpM==@iJ2d z+q8X0IqX<8EJ}Ys(IqfUbn&C|s_6aX)}r0V-U=jp0$}3Rt@YnB)d7WiCix#D1W*pP58QwyPK2`;KC0soK_EMp6v&v$~YE(|02#K22rj3 z>JYFuBB$3<+4Y%n49c$K zHa3q$yqvB;fJr}@V+CgsV~~LEwVNTN80QWe$yzW!Pa`{#2qSGeXFQEG@}Gozu{U~P zM#WQ$u@eU+L+KLjs~eanOSdFTZal<*;ZlkOyDh?QOEu-JC6Q5xd>_;cvT**z{AFm= zVY40$LPqbswKz_Z_uD3M;Ulu4%ReDQ7sq?frDeKCg8D}Q!djLCF03^`-*>C^9fj$7 z=+_4T6ew($ebXt}g*{k_ZfJ5%Ic#>A^YyrJH#mC?KmuiT;*0$kI_i!m#@;ldW-GF) zl`1FQhAc`JWqX=780Q{uKzalb%ip3(YzvYujqtr@r^t=mE<f(Q*-^=P?CLPVUrh0 zA%9gfq>BCS&P4zUdh!#NG~7ij6<;1xF|dP-TDLP>2T!9r{V1AyB-zH_- z6V5jYY&UQK70=p#z}uWO?c#Fqdtu*CXngv)idtNS;hE-%)_!LKfsRu!Za^W^imjB` z5I5TB$zg~<)dbwRzkf!iUl!iDaSy@Pyz?&J$S);ZjrIb!i1Hm-ilv z{>Mpe8hy)d-(V3eK{cwj@49fB(skXxs^9b&tm>?Z?g^jZhdRtsa8xOHL~JkraE4(6 z;PRF6cK3S|>8R=;C$d@|&ANTl)jbkf_&-J*nEy#{of9t(jZE z*)_9Vvx>F3wKB6#&6!%WyV8{AYoWWtUt2Wx)UwXL+6T?c&!;-&0>K;64Q7*A9ozV5RLmFWDNdyYx(Gb1Ub`fl`r zk7R-)0}fSxC7|M&NM%0YN^sG#YAoI(08=g1aj~wTuG!h>Qa-p($h7R8;#+@2ZDgzZ zc)2d}tdyqisv)lU)L!F0yTy$$G3u(@yLj;Zk_3-W^9{CcZU1sEIvi&VcHv1cGGSAL zKh>hD9cfUQ(uAXu#Xd{3FO9d%5Sj z3ygdTJ1Z^;wzRZTy8*1~_BgQGMwq114LqGY@GeOBup#^c#?DJGH|D?>tyaVp9$O86 zuxfR%Ah}x~dqaLneY0D4aE9D_gndn^|50uQ9%eEn!%!|=)0MrUHvGjGIUi|5P?PR^ z*DW_M{FANX;<2ldKB^M$K(7BH9g+4KUKiUUd{x`~DgoWU(QT1Wz{M<<_68yzqBlLf z%Ln`!6khvXh8Jcp*Ip!%iZm$$sYyk_Hy+O=Ktj{UWPwQ8|EX%H$70VumpA=y#pF)I zq3)*(nSp&F`_5DthEQ`Cb_m{0qT{zNLN_gw#1KS|HWq?;ZCli-KdM?IT{ZugU>=3J zj&U?HVYEmuhZW6 z1gus&bPt#6&1=}e2gH5W98KvD;+6<=&pq!9ZTE#rJf3V{h2P1KQorLFWnNE{??4|U zmRhgTuCrTE;1*^I?FVf_h2&olZmYtSdItD+ohed&tgcY7}ZHTR_mloaYGQ$Hmcq6>`Yf75iBFOl z-B50B^U!i54P#{#8BP6Yntm=0kps|*3|p|u#ZoV6TGa(#9+#tOY%{*!?wof#IH^@? zHxW8q*a=20Uugm)GERm^uT+?pMe5wC4Xn zSj25W^Pl5R$T?47rA=L^c|9`I&y89d14dD`-IimUFr_}VcVtWts|qMj{e#8mkVBVA^y zar1IZ2F#QjD7O?A-=<}yhHPpHa1AD&_1@i>Prf}ss$K(*ex6nkg z?kqpY^;E$$Cb1&oM^*yq$4J;q@6uZ&(pEWWr{C`#%|Q32MvS&?Sfp+yb`4d$Lf10KI;Ld&0)Mo*JTzbyDC!lUn66X}0{3 z3~{w82jv61pxoM%yHq1~Uf$s$i(MQ!aQZ!x3&EjVWMT znP2wB-q$q?V_efPV|by-teXns;)JM4s+|vs4=wKm*_krZ(QAl`E2bk;pF;x~b-oii zO(17-xAIHXWz<9{slYFi5ebca3o$^*sNFZ^ohxaLv8*5WIc&x*g2d?^AH@kiNmgik z@50SDYx}p_6oDp4etV}fR^_vr=wky{X5xtIdxdr=@vIbiT%JM@W^e!B@S-h9-@_^U zg$IlOEq+;iw)6#ZkNJIC^S{csvYvqZP&;Ypm%{s|nxH3q_O1YbK|lsmek6@tI$RrX z2SRX;7Rx;X(UI_Et{Z78&3ra8oMWpvb@frC=YRqwCb4n^(Zv;kj4V|)p8wrF*!gGz ztzyFSq9o21Cg%cuFg2zf#cxaf*HSQDbk`(yZ0c5-uYKUq|v7Ky2`L@Xjdt+>?sIAQ&%;hx^8;aFs^wGUW|;|f2XN% z?Xaa+9iWza9E%ksaYvr>2C6=Rl>Fn1F#Wun(Sa{{PrL3dJi6uVS1S`95}S;KKlHpKJ4vHK0JUdI-@=nMq!E+bc;<#-O zAY{|&g`^~3oGztftMpv*I)DIG_I?apAXQ)LZB&RDnnQ)k`??1lz6cyoK-Nxl^Jyk} z3d;vLn&9>j_kna9*u~eDOomp;9^I|{fn5!&X3e$8#4M0hS6{9~Mo#sgtUEJLt1nF_ zMSeFgFqgo%;^IH?5tX+Q9BOJb5*!2mrDbrKIML3qAL6}W9mcMUrSkS|Np&wE-*QVh z3H=}IFfned?uNx6wO$IM`)+BmpbOT2mJK0M3DGq|$~jm)ExU=+clYA*us|!C9*11M zv8c=KZ{{DUeI-OZb(!%-Cvjb%RjW$e_N;0lci3LR|8aAp(Kb(Ads}kMb~9)+n&0UL-*qclHKk0+i;xa&&!IWmn+A~+?cxMwZp%u;}QakovNcY61HZ3OLwMWBZV(|IwlxSWoj5bq1< zxISYOBD9{KYabxZGTL-zykh{|*bar2ad)|^e(!g!* zA!o!0F(`odzb@GEWNmk!nn^s!d9!v?enH`0uWNi=)!M+{XO0e7S5-^{7Wr#(t!J@A z(R^DATk2LVCPI($aBM3g4sQGk{G&T_?arr)_fxhhxGVue%cByVZ z_~H4s_`G{dF*i+$o&nN}ZjXO1GOul2wB)-~cyuUuAD~=UNJw{!B4$As{=xdZKjSSm z+oajVRICo!1sW^e@pYN0P3D#C5fOZs4oDxm^{7fGVXvS0uQ*F1#-z=8@AKItS)R%p zTn|GBbth?GqO##q)N7RC{Tz?$$Sj~#%b)|kp^&9$0-hb;yzD#aMTY%@)l=4q`x$K= z!@&_91MIgG-ug93LyR2%XGIWgYWm*vlv$yhm-vAlHcy8BRjy9PckM9I-CoS<1ZcRa zEnx6^`nnT8H7%S@G+GGJ7!XEb+wBW${>We2*BkXpSBK{xeUQ7GB&MW8HuVr8hm_Mz zz;F@!wzC5cHuSTKnU;6J}$uyZT1O4Fhpfykp) zTL3)BB-mQ45xt;YAP{fE9`Xm7+~r^S`6aHrWZ%U?q8O?n@)9LwlfziLKNaBoBgjXf zqmZNSj0EV$AFCsonDSfH?SI1z*N;vLK;_a>X6nlD!6>XwILzc$7xR5TRiB$TxivwY zPFhH{G#${I<@_{-<@xtS=tiOjd6XES&BiXD-W^emO{0ZQ&va+V)twE=fnE8(RAqZp z?>Mi&ydFK=pV>$R-AocL6gldJ?mi_R&Ud{4ldTFSJy|SgbX4EO;@ReKGlm;tT&ZwgIjwxzg zMGfsv6QjBM@z#@63sJmV()ewUJNyZsS&_pac)n8`HFbRgJj>sq98_p=Is^$mq*`T* z$A4uo8)vCSmvF`AiO_<8_XDOib>CbqlUP<8#cv|&&fPl{xsXzayl{prItJ~1J}mOK zT!9`ed$b^Z@HBGEztUXY#9I3|1z=6>@_=(dlMI?(WreOny|ZKuuS;gzbmGVc9!!h3 zo5{uccWk()WLjxWN(3@$jp5+J#XaSg##ww{p66Rnj0{7)+xNQA!WNQyuY)^_Rg&5> zVud%%ZCQmn<#e4lwl>I-p66Rm_q$kzz1M?>>L3wDi3%s7@c^#v-nlx+qRv)goCW_d zDg;9w9Aiy)**T5JOB5~tf_9^;NuuQz(Tn6Yv#%th0?8nGcf-Ba!Rd3UY3>)IH$MzX zjfYTS<^aKaJHYB*D1p397C_&Vvu8X`-&4gbP+QKoad zI^1)od2mar&$4YVf@eWyNNI~QKCtY-cNY_H>4I~|a~QMdpSYH-(Q3@@0Q;BA3}@T} zjGfUvkEDK(sf^&Bv`$~2Yc>*keIUeqz9su>c4D1*i0Ya$-1wtM8P+F6I9(TU4~D!} zKFqlAO7hIf8x1lbs3B~GtBlczAn=U#A3|g{ME_K?-cg&%Ck^XUaRN02`HImnAayOo zk$AhdbiG)TnJoO#t2P>-mo54Isbc--#I2%6^>F`>&}~huz)d{Gb1bJE6gLnG_0BR8 zZ{Sh&4WfPs#` zhP)RbPUfVa!i0RI9#L;pFHqND$oiKi|8%^a zPK>SBCk#$6T~CGQcC+t87SKQF`=Yt>Wnjf|Mk+Op9qGxCBimwCJkY9O7X=c-hU06i z#Jhh!sH`1zuBsM~ni8^P$s@0|B6Hi^>*uuUi{7x(9Tz-03!H!1gvBeoMn0%J32;3r4N>y){@k_?D;+jBLOi2*z~vIB$Tf^!Hl{0C%e#>e2=!gV zL|lLO#XxEg{951VG)n9j4Vp}-7T-E!U?k09!gcR`Bvpvn|EaahrVE zb}b{(mFYqi1@6H`ZP37EGd@>~dhb-q>S`v=k&03EJQw@Vvo+DD|g(EwOw6vjyx6KUZo-$s`X7Q$>r%jJCGks}d^G3yWUT&k)}DGfea#SOkkkrWOA;hD4Mb<%DDz4j0H3=) zIMJEi&i}{Pues=W+KD11Nf=-(v(UiG=+0oZuR?D@RVGaD3(a)l;;kAzH2y^*CFeZpZR^J z)4B3o9GxKcUI!nJC7JM~&YVZ7n@gX;AkIi8d94i0F7MuIjb9yS7wkNB#(*kG#wG`4 zN{60?|D?!oe(26jadl<}c+1yJPq`f&8x`+^;%EDN@4@3hDFKIKL%z2iQRRsdh%Sc! z`>re4XoCk^$HqnfFAS;f_l|jW+@k$R^Vshv6W`-gsZZVhbI)+q+nk}-G+kc%J^Fk0 z!upjifR41*eYt$b0&qvxc-yV8?_t?upW9zUMPo&3zZ>Gknz2Z89_1U5WUGCj&j{sy zP13C5o_DqYLDY7Z>_6O3NvCqT1ti8%6}|>4$meHJb$^hk&G$ zYeOFMBX2uDVL*gTHU_m-=o-m@V_7G(0)=6C$MDBwLxNGM0+3BCtPbB574Rg=W?HmY z%s3QBSIJ>Lv|=LR=O?B+WIx%$|3wMnEyfj!5nmpql)af^V8#PL_cp!pJ@^w??<48N zC~mrLHloH)BOJv;W9*FVA6QA|3*C8_7vsc1oghovgli2UM(~w zm)|&rURJJ(jsG~1c zR4;9@l3FxLJsT2s;1xiv8toid)o8Urab>C$Z^zKPu6|p^`z&DjjBu5jK;8~27gLjg zd~XfR(m^BPd{jOnL|AJSG+e{%$}H*hgF8j7bnc9Cn*3BbEL3#iewK|Ay;jT>dMvj! z%zrB|A#e1=mxZlnj&MCP<5`%pES2npFdiko(LAO4NYJ?T9+C0E%T4evk^ zA4%WLkIv}u&Sbr4W7uooh0fM#ZB$M04QO)9( zpBH~LMr2i^h%nfYb0;<%VWd^{&D}DozOH_QzjOX`2*n+Y@QS-td1pQAVca;YcZdX6 z-{^K~*pM*-7>VYhs@L=BPD$->tw|TD{0q~aofn|FD;1|tc%3*BVV!Fy>$2FFuD}3p{t zfw8R-%&oHBqW3)nzJVWP&zdaD*%NV&3!P{B9vWlw&rL~z7n=TQY#Uq0F+qa4x&?t} zOKNn0AHV~m-s^?w$k4tx`7Uax`oIsLXv0m9SO8b3WvYZ?N^9NbAqdi=X`{mQvtQ)l zL`9*OEG4!i>{o(pJ5>CKWGSLhSTW0b>bt?RFHYmoe}{gz2`LuRe(OM?w1u7-t!RjV zJ1}rBE=X_ObX@SMcL_IKaZ|u-FA3~-ecgl@7nKrU`s){YMP@6L-xW?{WDyY)X)u3m zXOxmfaXe}PHg*w5R-d`)k11YytZ(L-H_Evrm)A>qHr!EBUnFD&_k{RzJ>3^Lt}MAk z#+xm?@)w7mp22|AE+l90qy|xFWxlL8{TUcAv)Wu3de6Mx1Gl${d2BRUP9Xtu)48ug zEv!^!tpPTeXsLVOl`=(nJl9;_JqR}w?lzJ--QF&ffH(ZB4MPy7``7AV_CegJ3~fn#I%x21M{(%R2g~zC z6IW_j62`umn{*f8#X@ahkFh;k; zFT?tuC%ye-d+imT^C>rP@fLoVkM)W2Z;h4ouXjDAeHt-No$c$@{!_cf4<4VWp_(Q) zkr8fqo7{6K3e4ckYDS^7p`Y7K;N!orZy`BSl|=!(J*6%o{l#m}W6WtIz$fmA`#8 zl}QYDKee8iXk!^3-%GAta}7qF9F@s87T_)<&D=k{eY}wmnMN{-ga1zhkQ>-7mUb zy9$(N6&g+LG!GBVH;hNl$lqUExrtL~lDGlq8Tk{NUK1*JJYh1q-rZo!XUkplW~EcJ zPv`VuwW6L~_xqdib()lQgU-XJTx^5G7&!KlD zsD^dbep5Xs;21<7ZRI*%GUuawVgP2l#E_%JG!7&}%|&rp5G-DhK@h*oO0SNh5~S1Q zw^5&zyoBdcSlKRXj)CFoJc=W_;ETx%vsV(E#mv_B7mLlASZP1^zg*hR*)MpY>FYxz zE1ETZ&&Oou>F3D**0u6LIW?_b4#1Z0zejEV!JLc~J;-cScnp4TLT$J#H3W{xshhQO z)Fsmz;Q4n8KLYlDP>=+L&vZUYa=o$IQWpF-F>Sb=WMUd7j`xv*$7Z>?=M7Q>nvAcJ zMWsr3SrjSV#Bg<&x9(tpw5$4j9We__JwSTn`c>~2$>|zOJ@^EU;?6oe&g#R+y(_-g zo%x|csWgvEvD&-(kbgHeDnUc5AmC5(*(d^9Cuf>tY}6S&`J7(pe3kGG2~xe`dLyYR zZPo>c58RCh0oyI-RvN-z%Z>Q!4_);MC_TQ~PQdayvqx$j+aC`|T4kLHWfj45FYjSV z;iARB2}}y_F4;RrcQ>t0TzYryr*HQ>CbqWbqsN2P1Mlicoz|#;gNVMxP6(f-*d^mm zU>H1BNdH8q)xfS$(5!Cfy4zsj4-Ts)B^jq)%YGXD$9`KdVTHeSG`MOB3dfB*U> z4QUZrVBM=eU)BsWzE3r7>bY!W2Fo*Zo{7JB`rYK1za4xoNZt$H%jhwF(I(v>bni9s z35^u})|x@nRa|KMsjM8?h^ZJA%~;{2nI(m#+PWD#6Ge@hlE@Hh-mgJX6lc~b*Toy zQLuwt&(e~P&uYIIQB{>Q@(Oq=o3-0N0kGCsWo@jy z4`MDAtj}ptjWQ8CpU=hnV19Ql$0rGq7D5#UoYC;3Jl~9JZFh5Hc!cE(e5)3UM*(HCJmo8(v>1Ek%tok$}0U zXkFLn)&BYO>40@gCXzbyGYd`TR!EMRvx&1gXP|a-C|OEyuyKWl)5P>3Da^WI8z8b0 zg}uze0l(`2zq`Uzc!<8*RzVZ}VhhR()rN2-L)7bz{`@~LkkK8@55V+J$lM?aZ1mGG zHZzw*OBq?AsA~l?^O@j2ZKm6VD97(Cw4UMFi7H}FP?&)!5_(g$tRdNe#!C2kWnAZQ zwCJzLnMj}Di*{J#^6u8|V^Fb!QO%-*zA@HLf8MWW?y5=FMU>~ATbZd4DFL$zO#dAE ze#x9#Ub)$y|9UZK)c9~s9CfeYSvM;KV_J`^=hMi+eHoA9P_=!a6vXKgALjRDrmN|c zmicSo7Vf_J!l^U(hU5dNfGbc0#ipRFDPR6XWoZNbjZfs?x{X6K=oC>vrmXk4xNFkw zRsp*OVpP-mVCnhhzK%~L-#V@_q{)lvuA446X{Fl_woF2;*v>wSerNHm(6;%Z3$wBL zi`+Hl?*&`!!8oD(mfrOMc?+;gOVf?YhbV<*L}lmR_qHX?x0#godm+hg7rcbmj%kZt-0p4ACaTwx@w!jTYmA!NO1(0U5%mek4Eus2Fmc=tW(Uu;_TJohqv*ZTfOF=w~&<%6BJ#D zCuuMPvCuF2cM*NgL@@k>`INzqbp(gtAtYC&)}WTpd+8rQ)Usq#!E-kYwo?HfBGUY(bDg@5JFd5^ zQ-&`wJ@0$#s%b@#Bg7J#tB5*!Z|~b^fR^j1+@xfPyqnHeO}v;7udrwmJtJOz9Q%pYPxEc_AB`(cXJkPt;rR`0E#H8A zkLncn4@>VtuyG zm$$Igic`Wr1fyTdPtYlEeBtGWASL~^f~WXFsX9&dO2c|k@1Ckx^nY(sG*LB?UxLp9 zjD%03)^Itd@v(WxF8l$hrFa*k3ERG6gSD%@_6%~}R?nbEJ9_bM%PZF|43HWNxd3fs zf1v0vOPqwSI(t){*wk0zYTVL>q(*yKTb8{ijQTZrIebs0m8m41o41PCo{8R?v2301 zw$t}5b8$%<7y)JTeC%`p=EPICZ;I(x%cq}Vk?-i1x#EDs%6+w1^c5*Ik*eS&v)Z1Z zFgID*VEB%SLV!Zg)Y){)C{qSzC;?i{BvSTxKpC`~oiuxm1|idF-;Z;X-cykw23neG zq^BOae|YJ<)U;b4B5fWKeHC^>55)$4cMeB>00bNi*T$5Ny~XWiyO=Z1UI)+3qOZ89 z)%B{0*qBrja>^rrRC}Dem@}>|&4GNFk}oX`FHib4vF-J^wfkC5KQ`n<9wz=YEa?W1 z^L_wq7yj)^I}lZ9Lyr3FXXiR{+Fz;K@R)5Ci&IW>-k3HnXZ^BqWjrc&{*}Wo{~h_C z|L@AU;d`lGhZ_Pa?^(c0*F6WtFC~v1^Jqy;EYi0bMQ5GH(l_=dhU+hcbEJ%oU$GVc zyK6mZT4wg`Tg*)1;>%LG7YD*Oe|-y%UvGYlIhCV#S1?;Y+rU|61U%X1wgID$m~BP> zyLrKT;vwTV9+*m!`yqRNN=|FaBSV%*(`L%a<+z)+{Q20wBU3j3vChuY58utXrv(7~ zT>ke8<1a_mh8y*1HS?8#I~bXNFG{CM+I!7suhLn^6v*>K);BOWTT;Siy?|IB(Psxx zNUmj5a`&YpX6{BfB2maq3}-tme6*uEE^6xMO4aSGE+aKBo2{^JL%(uDQ&;xa2x5^8 zYj~~Gul7N)b7nssv}9e0@iU*~Jy!g!jqRG(OQ?Ix#p>?H$w*=SO;oi%0TGJ_!L#`D z9l+7~t06-<1tuX)WhUAYG0nxjOV7=jXR$7~YkKch#>ZM9Jr7wed`3;9_Z*YC1Jt)+ zSKI>LZSek-oESZdNN5)Q>smU~rBYRa(;_05#pJ7C%=6(yH*)>w*o$Kd`!*N0@!aVW zh<0RtAh*S-ahg(nN3s?wxz=u;E@Fx0zt;jS$G9Ett__sk-JcvKq1UE0w;aWNYN(gV z{J)`jL)QcC!8n;wm`uj~=ZK@WP7S4bxc2#$&S{;p9!I00^~`ZI>{4d3SYxZF|I@uS zvu1l(60DbhEO;WPQ$FLipj#_sC10aQ3C|~9+}FEd7Zu3*&uHU!**dYnN6=oAsq_r!EN*C44Oc}6<^}Bf+MpJn2aeC5q zy<9pUrM*r9+B2jyRo;{F7MnJ=hXp{<*M=5q$#LgE{$)!y-4onCoRXMT*hw%vQoL5R zH>ldy&b-O$7qiyEr80LwDc5PG<8V$%35oX*9!O9~8hT~o$qTTNuzXahPZwl1rbX7t z15dF6Vxs#(XPgq`)=KsL&6V`A72(-wmVOG%RmG#?l{oBd1AfoHxvUEnz4BPf9@Yhr z?^>17{3BN+rDZR9dhy`$-&5P-A@WvnD+|}-U~YsaHo^~EQbxvFpN-(!pRym2pAJ~Z zkm-9@M*(50rVt}}ubbGh)}u+HqmDeU#UXI9-r{HE%z79$=FVg~$3pTiwNkde?}!EXCzaBwv~}X@7IByo|_R zRJl{E0cMk)(#ERltm_6u z9q>}jyq{UY$%V;QE=baEFS|wxR?D;|+3D6|#3xygKz8zi7O7GD5=@+w><8={(lp9f z?0GTaH~97B&zLM(iFcZx?mvJk2k>Ec(=S|HXO^3Z`5H%$S~A??4(_?6E4|LIKS!oV zJi%RAcZJI`pypg9N5{@>dPb5YiT$&ls9dv{HUEY1Y)h=+*Ihd`M{$ADZWM%h?`Id| z?Pz--=Os@XAaf^+TMoCCJ(g6E*l**LPdb^Xk zy|r#h-p6e&rGJ1;JlxNkSAX33XwH&5->Cw8yMYVisZx>LNokl=2=qsM%z@m<@GnxF zNYpbJDA%jA5?u;>+2C3`AF~__1HE!Hcgy1x1^ngc({QT(f^a#*t^#uwX~0>INY}Tq zvm4>$+_7=m2Z67sLLx$A00|Fg!o&- z!}B&%qsHQW*b4gJ6G09E3?opS;7RabzRRVzp+OO6`bK_14$!=UMR3qjC{d&S`&ZY? zDh1(@)_FpYl`g>t`zri?rY-BcEJ-+ge8pJ@+@jjwJXB%SgAq3g(I9AiK4Mx~_$PBw zhA6R)8Kc`x(61d7I|PxF?lpVyW0P_NC;GJg4zQtJl%u*Gi>gsC9StaQ?Fi-jWTrJC z1W$O}8GTg@2`i~fvk95#$A=FGyQ97-go2xBO@cK?-%8V>rbu=Lr*==61?F;g(>{8+ z=)*Fry{)$YQbEWhj#>TDy5QCn@A^WH-Fo752}}-!nz)xfA}{s5a)p1!@sP}c?-AeG43J_a|ERz24l}~KUJZ7c}S6QJ0l|@=EQ9B`O_|))5 zWPdVqqt=wFIJ{nAw5c5`m2yNH+M7+zkCJ{Unu#Jqxwp+7B4Wzc7NAMM8d0;|-VPA#X=9L<-J)u9(e?touo(VI9O0^;FUee%{T&swHQoW$$xz6@C2firo z36Mg#@u?A&3J5Qzvkb97F|ruOK9&VDSpf-d9H6+53DXe7v}%DzVq&u1h`1m0s&w5{ zdTo6iIJEOh_~lw1u+Q3_;IY7K_>Ll{L5=6#-H`RKnEEOZr5LdcyLN(PS`S9== z=|ZUnRHb9L?ud0rWL$zS(mbw-S4E!1Z}4^cQW!Vyy=|NiiJA@Y0wx@zhk|i`qiVV< zlD-Pl{Q{)r`p2ls=a=h`*3J^1L{;ZlNTl^g3Gk$N+N$xa#o*RHE+DyfNbvutNF~42 z{!#6cx05aJd?!~d_dvm~Ca#KLi#ZKk-O!j#x zEu7U!`6^^QAiw4BXUDfxUyDNkECTfFpVdwePrDolifI2c+N%q6pO9v{n(^FO*(VD8 zIo7E|rczcM@XN*a`ckf9nhj2lQEU?eHP_?^05GmKtUurthMo#o_u#7@*X(ttK7W)- z`j|+^+$aa!^x}Od%hkkNqt1j^^LjuD>t;D>Qp~#lTA`yN?4%TnuRIcPOATZ>*ExFp z5fIwNdrE$io;PCYQD?chUpD~U#~d5}FyP)YlM3P$d=OmscRvb>w@psJ#He#;4PQk2 z`Cp%cGjEzQ+;V+;E3;q4If@cpb*f@9w zXTvr${;^apfE$(l4QIHY^;?z4Z!G^Z6StdF?i`GkWv4G9Cf34b`BUVK$X!iAWGhOp z+Q??WL$#lNjpEYq-JxAJ^irozNu&IzwW6X?ZrP$NCQR8RiBfe@m*KXjYo-|GFqfb&}*yipAEBh z8a(Ep*&W4!`MM#Z7xNxqHDyj`7Cu1J7F&i|vz^$Q90L9|u^t*Ba9}ZuRFe7s|6f@-jgz)(xsX{ojVa@pyFz7U zjwLmfmK%i@<(exhij;?61{>W|O&f6o85=Wx7p zUDx~le7&BJN3AXOA=FRsb?e+g+Y=Cv`hm?6k(aC(PK090OWM9)#?BCi?<|mqE?G*w z;V=-g+Fs;JQRQ6y2mQA9Cb(4?DddlW#(+%+bH+_eByZTtE)MSuIQIQk)=pa7_#0SO zsC0nqr2OQ#|4XJ`8)Z2yHI=Ap&p3QS-!z>&XLU-bMxNaH+xi>i&e^CIx3Y zD1~_O&ixXN7)tkUGnG6swv@aPV;Nd^*T8+z#2+qN`$b6K z;qa$9Az@_R+_X3U_z42j)o~rCjp_m8ZifuoL{?v}ui8p=S|)(ZDKWXhL}lLTe6KXvslc+|7;L$DFROZ1GzveOEd;nFu>Z1Ng0b~QkYn4RN` zbqkY(x41*=u4x3Tv+BM)TVexLyLpLVZTq&6ThhK z2?W~v)X22G02M_RD!JWnON`6V3q-a3R{fJ+`YZn&susHL`J)7gQh zU-8GHtvE9qCMUY#7VA?EM)(`RXF)gYh5o7eb>#jXUjARy>{)+8Cxv}A(NC9DP-ncd zz&ZRJDvtpT)cZCs(x4c=8V~j@Chq@ybXuK4N4b_-{{)e%NPc+ z{~$l!#kt@v;%@j)+w5Nb^G9X*YmxaTtJWTg8&~;HrR`l6iZZqV3ceF zDOkic0lknFUos;`Zm_kXm#qXTBloa1N{_8a0`jcAfwHEXoig$YvR* zJ}ACE2}suXX`;DV)mJ`LGQ;w=lRNDIrX)_9jjG^?_{(UK^aB_cMeR2kz(Op~*q2y6 z^Rc>&JU~+Uk~gEuMiZpRKl?^b!xKnsYE;saA!l%=uw&~Budzfu!mKMsUJjM-Tp#S_ zY4w{=d70I7C{O9}vnuEEQz0OWM;jh6Y=ry&p$K}$m!An5`%t?!UFQ@|Q^WK%Q$A~Q zH%+CKS9qSP3G{minAa&Gc!WbDpse5BN&OS?A84Y1KS!t7qr2x`c|<^De|_}$lR9rL zJ^q^FL-TeB?L5RZsFwx^;IoJ&f1^B(9__b(Jhwx?IL^dMNz|SFel)gL1 z`hDXn{$497F1szBmsYWSfOuWzzT9c@x-xcBtBjCggA0Y73mU7Yz3n{tqORP4gZ#eB zpcdD79_(lu;OlS@Ecp`>wT-wDLwV2~uz{-~-ykGjE~_OWR7j_TnPomcg2_hbS&C_R zvzJNr^`cI3{O^xLAALrZLhI27u>GPdV>Q?fYXBTh6{lfRhw1qbWqN^4dRn#QGlVpwZ z)Q|nsZ~f`)Er$w~2-~8ISh9-ktS7HOL;s-#KtI@{hLk0BK2J5vNB#Qtqle^%dbXJ0 zfUy-O%OL8LJ`1jqU(TXUZ`6bzS7ErCds3W-*F>%L-X29};b+|IeiLd1ksqd%qpXf9 z=~Hir(q;wgWSX)()H_%ZC+BZDe|)Ohn%(21pHXTg#qukuD-{m z74`4fgEQNL&bH-S-vRI|OQb$fgYsJ2B+lT{$mp?Up{YTga-Xw2hPv{0f2L{g8d*A( z3NdYWiu(DstLi|ChNWgvdD(dSzn0C>uMEA# zE4dIg>^Wszof@=9t=LUD7*ulMai!npwv@2jU*>=K=nAIeLcToV6(SE)+54aH22NzQ zWWcvdhTB@Mr=GU!v_PTl9`vEJGeocLJsF|4drS^NGO6|#ybOX~3pY^hM0MFwW&t=! z{_Y`ES$C~kt!`!c6UadoNyo7ltJaK4J+*zulA0_DxQ2x9(H+92vT}mpzt{tHwq!vI z2sF@n%64DqqUO}J9b)BB0+X#PGvus1#E_pIJ1T7}>&6->xEGv*VpLI;Dgv4xt@LmG za?A3c#3rA7+)SbAKB#-!2lo)7xes#V2j)i|qV>Aab+jO_jdT5iqn7GPnJ==nHE(l5 z?;L7|ovICCWoen}o-~^@(O1k}BZ!}ob-oymjOe!J7U#Zkn537)@GAlBTcRKMm>;OL z3gWfIO!$6R4~JbO*-$>kO=Oj44*2Y^DbgBHx7sn5?ewhxMVY&<4nGS{`C*DnN1*rZ zUYTpXJbYPl!Xt=|-yY##u{JX_c(}*2Yp<7OcV?@n>&gw+!v420)|w82N=QD>iKgUZ z0k(?Qd#{|yxhR|z)9*45{S#ESo&J6c+N$k!%=it!GeB=H5s+(+!dD)i5#tx`k-3Z z6tU_mrt1qDYao|mjS;O3lYiNg!9&Z2BlO*i+vdzlMw{2pXbZ|sqGRt~jwMkm>U!IA zFW4=#FC3Z>iv|3Bg$JS#%|PQ|YKQ7fznlp4Tt28@A&lc{y2fjMo zSs@$fEAzn#k5sVBq6|#{6XHAw;o|HaBBgnX{@GXDHh;iWxR(G}d078vvECl*T2>x- zb^uUSc@Fk)X2(cDA3o};pVh$UoI%vQoKLeZ(!+~k-R8~}*b``nf8?zY?G)F$(1ytj(pjIkK}(Ao2eq|^s9)vr{k461 zE;$nceR*mwr@EBzqyHT~vVDB)-q_xK7qf1#>MN=50M#23ICEv~!;MB?zErnCfv+#& zQB#>$wG=kx*MMExExA{b!M3|9y5h*~q+H{ZK#a8;l1>2K+YYbs9iCzsk#m}E1Vxnr zx@vUZ$2CADo@IMjLdjeEJSwK_p*Dq;t>Ap=2T$p+#PuhrQ?`p%|8IM8 z7U4ZQlqsfnr7$x^)9QtouGh5%QU|hOWKLqvhLP|)LsTiPf$!io>zieAk4C=@bwq&E zDUwCS7O>02NdnIM%VkU-AV1($F(Jm=EK-VEMwMwn3i!u4>3i{0`v%Y-)cMM^4#YE3 zC!{*WheKBctilD8vz@;xkY%f~Vw5`4H$4%Uv}*sX3|BkzDv{xkMod4kiMET*T1Qv0tONdgG6 zgRm1MUsQlSP$nqkP=B^0L*)VTZ%_mAbc>VOJVgGAWRU+ZDte7%-t=8vo6d9>#%nm>}IxKGqFV%a`q-+A&b&s&T*-vrhj-Q*VCR8{-i8(b{HNTXJyJ z-z}kvrd(*?;7piA%R*)XnGqpi`j4;6GvsQ0lj&6pRjf|Etz;+zhrTa8$cd0z9yBYPp zBa;i}5G-?{eg-m^SiRsBAsmp5im29#J7QC=@9?72DjKkq>_=^~gzEX#r8Jr$gCoM; z0X;yhb0MD9R)nkC-#w~lm+Sxgk3n2N%HTfVND@fa6*QWm5&v-}s_G?>zK znG;7fq|uXf{r!B8hp|#Mk(P&)-9`J@+jQR^#c#Lj;0@)*TUvkg+dg?V&0aT*lo7Pe zD==IztQZykF_E7sMD6O2>IV%g>ShuIto5-3!Z)7QJAiUe+|J%;`CX5i8015lHfL@9 zW8L50o@S?st`<;nokLx_Pm@nCTYl@^7SWs!wdp{;?;hW9$>I~O^sp1oi6yZSVdB#> z>Qu9#DGE0i4>(-Er%tbU;!eHIr8-bW-T4)!%_j)>b(~9)6J?T-_!_V|*``^k?Pr*g zS&O>IdTc=T&AViJe^+J*xr3aA1Xu`nK?s0S11(s=V?|8c=X#f=KMi)$l&mIIr_~7i zUXjAVbR#|rS@P$E817{=hCOwMwJCUB-}fs6CZnJtg5estg}glUkq zE)`u1VO8V?oE^+2lA=(>mUo8A&!jP|LG##ZSav6rmxYV9Lid(iMrX~Tv;wsJKHLVr1N>mzDVemHlNETl=L2Pe3MK5}Jm4>dq z)XX(;xB7LD#_kIbns<@8^i?@XaQvySC#`jvhpy9XTPooy(esjnfQy;Q;LC*uKUJaG zD~%}!FrGYWsEkG=@zDth)uV{1VW%d?CxGh_V5#f-nCrYDG!N@A>V;-hG0M`7HDO{6 zi{&@qr}D;6xyneuc)FSx#w6({F3imY`P4Pl z*kXjZ+`x-}Nd8lc@O&E*DG<+3)4X4Ya*6=7fpYpqeY$)3V_HlPy*f|OW6yBl1bq15 zI+#E6NZUv9K2hyk;#G^9!{D&)0}1tGuI=Fok*OwND_Dzl2JEEy{Wi|jb9@e%=NdBR z5OtKF>IYrkKaO4R+=~&uzoP#o-7cvo_Wh8-fI6tX+Xd?wUv<>WIc|LEM!jSr1?eqp z!<$Vrut^vD3b3ZTJf zO%viTU;QMlbp465g{$0J?~|z3LJNALs$)6~{ii9Ny0&lwG+pTt@M38QxH0+qwp!^W zBFZ6%D3$|BsA+f~=u|;FdC^;Z;Ra8uPqwf&;h&LV!w*J*noOqN%ARRv8Q;>1A(l|R z8OCcY5Wq0r1QjUoZ^Q#YlT?_&4-3FeQ+)n(L1Rqp1h>PQu(uI>xFiYr^adL5krXo3XDMvjk1BY&eh-9((o7| zpwP3_*I>}3R8dOhM;^^y@<(K4Sgs!S_oKO2T2))QOx*XoZo=#=4zrqacaLASBIrN? zumDHM$l{7-0EXbq9DAh2^gyKW(wV3S)eHNGt6>lcZP3q4lmF{&dJ!)+ej^)jc3_HA zKMA^}F%s3b>ZJY|6z<2dr>a7*)tDWa-g9;79UhV+k-eh;_`uQ|iDp>5=)+S*xN05p z{yWY}o&j!V3-=~y{cIRq>D1gwW`qGztA5k`(u_!@_s|B2_kzO4SF71`bbc zvmZ;0T$rzqo7+E@30;$?6-9yUEpQfrsp%bwHATsAFQ5B6YY8oL06>_(Hg?Jyz9wsV zNC^L#d8H!kR|2Pb^PrZWRd~;%*xC28&W8?Pn}z%!q}lX7>s6nGaS!H<@z(mL8!1jJ z&rHqNeuwg}1D{%%AEn=O0}~ir`_||!vZpg!+2dt3sgbyAKdU1(?X0CI=X(|UR#<;B zobNK0Y;+X&xjdyT&CK`8H*ENu1?$)gqfOglu_$t^8=Ms z1TZYI2HcSq-fCQGLMwFe;OLO>h)2kkob9WTTK3`m^(?Hd+;6@AoT{}4IL=no!FpJ>yWsU zzyVa7;voCScIODbpf)yXZ*jS#e%9+VIPFdm1s{JY(Z;vb#ZF!NXgVLbsHB5+B}e8r zwmJV){U`ORFNxn6fmnsp-^56u!YkIlzk*}&QKj+RKwt1ZOx(n8zo?Tl^F^i-Y zFNaHj)9Ir5x9@vgA8Cz2<0l?~R(*98@?#4#oK)TZZm%JBS@8C8*W#9ReFI-lUz^p2 z0oSqu)<=;2xO#x3vKcVeMCiYno`H>}T{zLH1v=;+TbjO7RDEewne_51LNwIpsZGng z{@k}lV5lIPsvI1JN>rWfk`3#-!@g>VW`u@{etfOmm=UaTR-G) z-0PYOp{K!Pz{FX*X9h@QQeSveYKUdF>dE-jq27huVmELE^=n%0R_K^wEC_0a>ZhgR z7EGFmcE!*LdnO>u!WZ^H5KD@dm z<~}i2%YVIStQG}KF{YKq5gDK5Q|{5!ypmj#tzeSuu`zN!^em;$lHYzRVo_G#IB2>| zXge}O_%_4XE)@OfD}g%34%-nkVpoaz)%Y!U9rHcAIAKye32%f*<>iYPq{H2YQ>h-s z3%g)Y$B3pnojLgo{@{Yv;!dgqcI{6^A$XPFqSd&d?0BdNeheipLungkwPE!dOOv&= zu9`QA_B+^MH*rm%YAZ5%R3PqeO*I%B1oG}vtDEaR9}fN+bDP1>#r{22ejtzMWMsvoE4nvbq4i(ordt2u z*wF75h~wIipgW94iCAl0vR!$+ zasm)v5bWJQkWbw`r-i24U!iANg9Fax6j}~5I?72U<5!_}`~&&Mtfm7?H-c7o6iVH} z<`r&V)C?rsl6Ef6oRM7uMlD_Vv;|s~gHZBYHXabY0cfGa&f6kJdp}s*)M_%Zs@<}n z?A{H<$^Wx9U7y2RkJuz#Y|-l`ZS8nyi;@8sgThR#M!7c$j`>qRj6)*j&4kR3_~qfj zx5|MYZKq;!SWUE|&A!g7GG}q{z2~Q6^;04b{h|-@!s{K`a~=&2bJS_((Dc_Z^ zh3@Jts(rK+w)$)>H^88&aXWLttqy5?9c%FdNK+u89tq-wg5mKqlMSJ#!3#HiK&5ey zAu60WsMdqh%WTncNc9@VpVZe*@j9?D=En7RH zaA)<#uO1h$GPZk#5kKFE8*@CV4hN;Ssr#7E1&5_Qq#Z6%bXJu+RU*=;R%VfOUf+I^ z=>kuSXXfikwzHmlK7OR?bns#aK3iDkCYwT_RdcX__4DhpuROORsX|%S{X9ta=_qWM z_g4m3Ur#Pkrt~2l?ElLU&t{iaLvO{;yH9VPh*SlJDwb5^v^w~S*%y+TJ`ixrIGn%$ZeLN^jk1fU28J;eufNx3s#p7CO*hua#x8Y+S+Og9*A$N( z3G<&(+jM!K>T5U2eXiF=Fy8H(oJ(siQjxe5H6M1U7xy$;Btz}eRX$`7{)vH zJtmU(-8ZK>ScA;_;zYtvQdayjOYz+|C@m&ejYzgc{T#Sn6~JJr$HnVStDlzJuVBJP z0Nd?q^Ia_;j_jU&4VkIz)E=tJhjSvDF|%0x7eiCLf&0$3&H-1q|NQWdYeB1Bq&G16+}*_+` zK8v@Chc)6~Kvs5e7Fe+H_XaVdMkun?mpG72ik^h7OQ7*{N9-+O6M(}CTKiJQFD&>w z1VgF1NB@(yc{+c&#e?@$r<}3X4$SxG=+y_bX0)E|DA3j`CO2l|Jm)I&l-v%2xhkJ> zD2E!r1dv3iY3=5wL-a8xhVkmnk|-)sJ)#+vvfuhTc&_;Kn`-H>1>ZsTB$8vq4l~99 z-qMijteOZzH%Wh-XVJwU+CK#B>KIDQdyQt{@jhXwraN?)Jw9O9mZ@xtyt5nLVwVv~ zh;i4AI6R$C!Uu(2UdO}^RA%VVqumE`P1L0wf-9>7fvkFDmu=?q>4gSu9q78_GXI4| zhG%s}%eWn+^SSrrHBh9zF}=b0!mPMIdTqMN7$5VV#;d5S_<(hsoY+hCYylHYPNCDV zK<|)S=)*IOAoI#UwM%m}Lm&!`K%3}u^F`%J9)g>G4!`VUQO={k>}P3-nTV>`?}I^v zl0o+K1(yhEA@2%cTKR{sVD+y|S+O@Bk)b;JA4DV};=uMb*)`aL{WZ96j!w<&IH@CN zrMNE|E)Je{{Pr{wk<0kF*t)PGetM?{)O*DsvXil~Z()b`u+fO6;$(}6j4)Vh9uzhn z<5zS27SW2EMCG>wj{p7fx&<6m{NA=-)^QI3CMF+~&J;snB~kERz^fv1#o*O!RFH;! ziJ51_CCByw=am-lrzhwy28wWVEmUzXkK~z}Tv*;v*xvwf0TP;Yu%li$+cmi#PkEO` z_HJ4tzR-k<6(5I}qwX&L26)Jv3UR$}G;>y54mYvVoVt%qK#LqtEh+z3!&zUWJ~Li( zwB`n3`cgi89B-wSUp0-+05EUH&t(9Ay;Cwmx#Rara+f;ywQH-q6{<1u|N3oLrpw}M zB8w>{QCT|y2Qa55{pcF+T>EaTBeP;}@XG^z2{hlFt|RwAX1=?8|HbHt-v$H&Cw%?Q zMBI~DyekU&yBW&VYxw@NOf4elb;?Hm*bS4T>+eC+J;w4m^&7FJSYxx8!-88tX3)xS zlLVhwY*Ag^SLuW*2SvTqRc(g%$*_U2lFT$QqYd>vwAxl(VZ$j{shZZZ_nZxH)ox|# zt%c7zjGa8KTq?N}7M#&JbsV^M-fpUi0YDSY$(__#baYVfjd^rT)80i%q0|#uMU`)u zP#(>9LVl|R0dO?sHEd_5Y+Jr^>6?dn1Ilij{_GjBqphOq=TY>@aITtK2E>oFg1R zi>KhdzOzM>`-K;dj0BF~KybR|GwvfI<0mbs;(CVSSAJ*(A71YL!1p^fm(3m13Rw7C z8mO+Q8pow0gJ?UKnn`vWO1SjU>Ke%XetUv1Ws9FezG00RxDAiWZ*0qre|Cjq$#uel z{ZL`w`)ml}^L|O{$IRA8$Y)qAiKX+0}`8b%eSL<5xT~OuB|}v zqFDfVjSGyIlQV^z!ekv#6zgH>yNTmDUfvz@4{nPutFAJ|vgSey^b_bIpr8qxx!4uH zX;v(6)4qOADy*8nvWe&cv16q!y=rJyvqRnB zF{pC-jrAY#i(4A%;nmmYbQ5$?SweNC7}>dNtwY;512yZRwZlZyh4Q*wew(3%VHu7N zr9jjBo4^EdvB>CSy58{re+dEB zMQoN{0a#O_jO{prJL;7NxBe%%Nbga1kQpm%sM&Hs8iG{%Cf{F$Na+k< zJ{p$&`y<)MTqO7%N@PUr#NKRoM!uklOV+mFS$}oj68Yl!MVMHdCYD++iS_SRN$wQbcJ2=Fk`P)B7EBX|kBBG#DB9bb#pWA4YrGmMvqrC>!dH#8 z+Vy#S59{dqB~{kT-_kcvaT%naP&x(XGv%f}aqY;)cJ3QhrwEKr8so9Rp!cd%x-3Qt@55WRzJyR3q#irgDL{`d>aMt$#9FrZ{J#;jEqxq%Ersxn zeKa0Q-_9Q>RCsv0u5YuCkFv9;ZQ%@%jORRgzu2=c0X4YwbdrG=>13gfBN%_oRN#Od zUD?_SN2J5c5X}12rk*|_)0uP7u~u+6M$jEGFyh9n9dYa(Av104!Nu^#M3n=whW3@) z3^F&f(perkXwa$-3>0jw-U6EbH8#>)dC88=y+Ztw9s72x>?^=zeEco-jr_4GSoSMq zF|YAq*X&AChQp9ojUpfzMB}ECWVnZ(7%cb}_G0xe1aN2J_01l$qw_N#pDNCv))D*T z*F=Q)IV0L7Vv!4(xEqx+Vo++{(z$-%2B$!_s%L0$m&wl@ z-?06PskD{o=sOQGrB9$WF(J5Q&@^^8;gbISBb|opvW5lKv*Cz9l@jsd-o!C~&8CZ) z8J2#w15WWeFR_lt5vDjiFzQFf(zfuTkcJX?n;w`(T2h(%8Pi*zo!xn@B{n$JW-TO8HZ_N*2k4X=+V4)a39Tu4P?5d zHkdl(S6zB!W@s&W_QtIt++U!jYv2$%H~XtW8gcih^oZBavK_m%&;_C*AQ+Yg1mn~3 zwWyLsn9!xL{5!;ad>bop)#tsgFaH&EBoKZfF)5$$zn5P=*Cl>SapTl)+*kAVU6-xl zAK*W20F+X5p^AoT?857G{H0j`cfClmgq*2M8SoBX@ee%@ACX^$GLL+wa;fGen^yx2 z#ByJPZY}SkYmLT;dXvS3Z|O$~G7-ap5#ep#@pmH$RoVT>3dUu#7#j%QukMFoXJ-gA z$W%~Qe%ra7jJ-lJ>8m#?^Mcy6eX!q6Q+5?LHv8~9=~(p2N05+7J&@POaa5ZKq9{E? zqZ^yq6-0pbe+DR#^MlTm1Mf|=D+IT)wQ3Z6C-d|HexX;O={oBM=K%8hN>Bo(VCiyV zXI|cy5AyWDV)yqL-lZYtp-XP4?haKm_c7Ei=48~OGO&aEhVgNwORsD3c$T9Y>j|}g ziUgfSHBR-9?iLMpK8|{O2S>2U8M-ne>FD{8fL;9kE%c(W8&lT3?2v2h=r^e145IA< znkxt!n~FklpgGXP=q*-+S~uB@cUBRCyrx1c!v+6$9p0iXw~xF$uhHc?4_+66wUW0}>J)CP60B#h{2NALw}p47 zc$9=$<^b-7WtCUtm5pQu!Y)A4Wral?-yOWifVU*g@E4hS+%jZu+{#HY7i)$)8z&LG z#2)Yv5wQ~3*U+2z)+aA2qrz5V#z<%qCfp1$9v{{1?2eHY8${;OhP{mDx7;fF$QFG_ zH)<*x79I1bn=mMT8R}5%VG_Gc?rnJ$OI-cFrEIUUiqRDDU!Cypk2Lf0%5%>6mAdA> z1FD`#t;Hh%fh`QYka*nq`Wlo$>WFzP`AlTJ`a{EU`v;L6GPEyC`40uMYDCcUwr4HPGUO8C069Pa~i`PwmY=wu(j$2P$G8q5r9%Qaa z$O3<4Xcdsw0)HF-r8SSF>?W9fUU1=kEH^3{t^_HYGQqJw1?p$ef%38pPDds%j!2%x zUc(t$!XVQg5QTEW*x8%zpLdcg_ zIcVNpW}?+POM5W8$usJk$J`myrY+ip1V(L)njb7a#J7dxmOD;H~z@n zwBxqc4;a(h;9DzQx%Hwq#0&}RyoT7?EZ1nD{&}fhP6XyaXc{Fxan5&JkW!($0{^B- zGX~J-m9`U#sRf+AtQ1c(zE{6$NIYeZ{P@+;!}Ae@nT%}5jXRE^N5TIH-Hu=|Cq6n8 z%y6UYQ^===W;2Iq)Gc;Kp2EMFY{S*FcAdp`LZAFdc(EyzFVUPCna?=E{`pW!RP3;P zVa(TTb~e-I8jUWr{f?}AgjwFz<}8&(7G5=ubEMUK9q3Wh`&r4hn{;JV>fo|FQz${b ziILWkTL-o(Vt$Q)ys+g5qDPbL@<<@qPs16%3yCKRiEB4W^L|mgiWKyo0=qF^stdV? znPW!7ZCk@73cIE%BNkR(#7C*Bq-DModP7UnkoFhS3LaR6(BbY}D1FS*>6?o+RVnkr(9~EMMRwzEwX`lF#$#?dAX7i z4;faRj9}f8e=BiP2B;Lu z^dpxpZh#;r6}Mem@=y)lfh?nA5D@E|PkRZ{mE(=buzen~{59rTyq&n*qHnF+u)eYm zi&ndrPLJe?pdp)`O`ELoT)4jW;*H^U2KjpACcw6(D;He^17qyUJho$J27cMrXMLNy zpOR>wx!U)8+5|%rf=a@~UiSkS3*=&43vJz-RM###X1&H>>cz9aIV^~!4oBGo%ecXs zg83|R1uyx9^CI67P?g~QBk}7;s+4VARG`3c8{_Oeqdp9+H9KR_PRXP#fw+e@44k-_ z5)u^e*?75~YPpnd|0&!4T>5nA@lD)n3EyGqnDbgXkzoRO2K)~Gm6?$%-KS2Z&)>n6tOUoVAFMDc~135^@1du z&L_P0@XP4}_(YnA^F%lm9<>6Q4LB!D_meaQGQA~RXQzf5=XwmsBi$woNg=wlT-Ha7 z-uTuaR=MM?%y;_&oYq{<7sirh=){1EI*;!?o||+ny!8X^eNR-HCii)q=Y`Auq8$z* z5SknS3f*^d%E~p>B;&-gmy%XysxF@!*vjjA#SR(0_HsDgrMy~>pWqd^y6xduZ@Ft6_Bbzi7Moh3xLtU$I8Z)ceYAN* z*O8-&Kr@kSeSUq>{K}D%u;(6#+qOrgdz>*7_@?rz`NctFG2LOjyF(pgqvo^+sh z9QZMe+N&m}zxK$8l;s%li|44#nX2wYf~6g+5w%GokC>80KTWdeRsL=ezE9HSU=POIEPNEKIv0x7JwzXrgczJH5=r7 z?)2H2+b)%HdMj2?JYhb6iO~1-0CG(;p7iT05cyG|&2wvaiOc4f9GhIy7}b)IMObn0 za9*SB0!4m1(+lt`%%4E??4J!N~tmMWUi`TOSP6u;kgu zU?9$iI9wpfpP+=+SvD~&HsW_KYB22u>D@k|+f|K{ng|DblseTzmg>cPkGVT63K{&HrhJ1RP}Jj*?>0eiGeHHE4H)f9JJ+f8V=20lmZ@vz=i zIP<$r61?+3mLD=02dJQGD6C2|5^~Zd_{q1x8 z&PouWd0aZz%s9{n1r?K+QrsTk=#=d5X8k@{WhbG4Rcu%G#>jYwQ%4z>k&Dm4Ta9+i zm%FbHL2AYY^KOW9tW&5lwMip<`Rh^Kc92zkMWp=16hW)vecom%>u|D%lz%wVvvw_w z`zB-lGV%@Ab-rR>KodNQjxE6yCqdvrrgyPJX zC`aPX*|u>PIPY75UJ5{ry&_$Fyp|y{T9-&HTD2yNBDxN6+Gf^&$Jtt!wOsfFNGV9<}`ct0uk-?Rj3uJTdLVYAvw z=}VnOD*Loxyd-#g`%9Brp`lWGvESOoPJy%b1Law_bm~n)i)Tv1C{5l9e$>9A?y0ko z<8KL|E)h!XeUdW$M{J9YiI)>*TEMD(h2bT{2cvEK3VQ~QZw+D9J4A!o*x1!hjg`@K zzQ;SyhHAS!W<2wB4c)AHYR~!%9#WxOOSLlpxc+bNC!I*b$xyGFrGHh;I+f~MwLG}C zvEIh_O)5{{JGyHNqc9Vw$_`gl6qpHNWSHdp>pn&pkZE>S)dcp6K%UZeO{=o59Lr3v z3WQTBX0a1yYmw90Hb>}|nT1*#fLGTyW$Jf|`{P{X=S6R4#-G}30Qi=nPslEf5wy(v z1rzEGn6}et6t)#OmfZMGYq#Glci7;?yBHW_ix#rbGDPbK7B6XXew3Nqq?g~Jp(SPQ z{Q(ejlRbb4Kn2%3gMWDHM`2Vfm+3v6da=)T?t*Zndf0Oe=Tp(7H@)bq4Qwk}J>PrU zXLZ9{U)C4&CL%fZ(UsN6%1|8VeLd+2s<}|f@-*q|EU+qZDR}KL@Yx5H6iaC+61~d_ z^XW>3An#;6h>;zZmr|oTw}vur!QB>Sv*)zjVp284lV`;)f>Z|B1-!IVTiU_5zk=hv zhdz(G!|-uf8>)`+&1%6(ZPvo*xjx&h7TTL71j|{hk$k1Gkf0= z?#qyV%HmCQ;6zD?gispR%B50$UE)a3XdEY@cGJ4%xMC7$L*kFrba(ht^CJ|eI1v-J zeBYu)`C{yCj_B=tY#YEay1wr@e&9X)gsz`bcJH`**tEppPaf>o zI@2AhhhmXe4_#V_l<>Q_8rtS)quX!;&W`y1I;Iy^65~~$0p?R`-U@Xt6FK?{R(8A6 zw(JdwoA4kkLQDzb3;nbf0M_ELu%n7C`E}Or(aHx0mRDUe-E5~)wLaxkeTrXkyB|~% z@p|99J?+iljlPs9(a!^3>ZbaE|BtCRaZ5UV`@hGW#%cPdl@*l>m6bDN%J_BM6>O}m zv81LFHzc)&5|{9DxTPd!I24OJkG%wCYs+4XyDqkF# zdUqwMcB6gh`2u-gqw+^YOd&d@@j9XVxRs*=M`r5cm{VFz-6v_zYrz!K$)+`?KN&D({Ja5hZN2TU+f)hGVPwkU5z}H zZ}}9|N%^j_*3}<5E4}hl8!APSkwWn=C_q91KA9{!L%oe_eH8am9>S%5RAC>{`2%J@ z7M@31hU72F(ACJpCg`PIA4!s^DKy`t59p#99#vZ|Y7D=^`QU24VES@Oa4W_vqGIVn z8d}(ca=*Rgh{;4gG+dj6p)+NGZ;^#RYsYP7Gc2>8&st7i9PN8GsOf)Z!zlNf?OS#~ z%A(ab#kLhFYj=5to(WoZ!L;FLHDTt8g|^>!Rat{#GB<@T66*fVW=u78Oqpb+djDg_ zsUVw=9p`2R(pIk~(XVm;?1DPvr=UAIu7T9ebL`~p1o|MXg+CZb3LUhsuU|$YKNU&M z{&7!hYcD|`SCkiZ;=YejdHL@#g#fbcq$aPbf#X@N)Gdxp+5>4+NsDVL9QqC-|5vsh|HHX07V@Fh~A(ECQ?o3{p73aW=ugu#~lN zHbEWpJ`>>`6iR0raBU`ni);pie}FdzNJc$1HYXktHLr z&{Xt<20S>E(bBwAUwo}??76ot*j7fvT|j)rXQMP?rCi0b891aK+Kzf@Iy2gpJNB;3 z{v`10a6oZdBVR zzy<>Gt?5AvG333d{L)XUyE3fuaI<^5pLi(gNNx?I^7&3HLuJY4K-a6SXdYBrOJ6J0 zwP))Z@^a{7hez87RWC%${oT)wbm-i#`OLLNf>Xwpii&!i!X?oQ z&+d~1Po5$W(r$)i+@0*u(_PYfayf%Dz#G@hP1*R=WdM4KuC}{~=KUBW$tzw?;p)AV z2oB)>F&g6VS2~91#JuqX$w`H9ksEAQcU%l~zSeV5-&zkf^+d`%;oYG}ZPAyY&bX_> z$ZjzUZb8`#KLa`4&)EA6(!y+&zLrTzi22NMu$T?59jy!Hdy~MG0m*H~SfGHkGM=

      zmZ48l7}rH1B$R4Ql~p%)Tfy8Un2)Gf#(n?l6Qu6=0&Ny^GS3KxB*oFaF7DSmS(UX_ zbv3MJ-y;e0oCuIXu|+S~Ql*f<3L6~GA~KB)rTeoZ8hn1#m1jDg#U3}8yBp7T}N!@iPu$9rt zQ}>S+EWz;-^`THEVDs0k6ud3xNmSjB+y~?)sptCsHr$}qa72`*-0U-3c`zKd#kDM= zkW78@?hLi#5ztjMW-N(FPpVrogA${Y)xPIBN>R^Ti>`TKT)P@Iu^7Vsvu}Mzu6a>M ztE~4tp1pkyt?x=WN>c@N18hWxMz5teb_Ch~0aQFrX%^WxAp3)AE=9A4QgiAWe7`jc zEC@=}`nAH(WVhgu;Q@S^&XcRdoa$* zc@`2l8@hOx^QvTd;GWH;zKr4SrQeLubF$EdyTix-?&v_`XC?W&SH*qXL4$;J)@Hx| zfZJQJHq#gjMPdlIw)Lx7hkd0X?|kH}BPFYh zD$_jJFa06sP7(U7DR`*ZW#s(GZu06s3!ayRur2wz5ESmv`N73qh=194iU^(cJk#?o z1o%6hZ`G@5FF`~q&O!(k`IIGrQRizUw*rl`4_@n@!?Z* zv!4|^bQ^l{3^L!yMf?~BdGq$Ba}3Xm^SZ}zItOSQP{vk%t#3RA$!0D3BP)YA}j@&lDM#p~0P7A@u zf0G=~OL2IKt`dgGmQ-*H$Anl$0N$?+R`csmq~YbIZr4^ZdZe01c{bE$e33&#GNMn!%>2mOcf0@;oCp12*iYT_aEVQp8nmAzl} z89~=3(Vu-Eb-$?}HF<_d^x=SiXr%{E;XD|YaE5mM=!>CIZbhe676H^!XJlf?wALM3%)(-ZPlE$ z(ix!2Y)SOabdowyaK4x4pEdNt?h{ohPqjg`(QXDSpLvT>ZK@3rWe?(`%{m6!ae3U2 zWD_O&L_@+1`3^cD&O}Dpzv;G!Kw}j>j?k0tZNS2;a}Jg@@-{m%a#JEM8FioQhWwU# z%zB1Jy_Usg6&(_7td7a5wapHg7_#q;Q0}tRj&_q(pEG-wo~cJVp6qZOU+AgMI^Wu1 z+=9Jl^eYwFx96~`5oGXds?*9_`F5&^A5n%kwMJhk-sLI^n*LB^jt9>s*_4A$ zQFhZi4;k`{B^$_Hf!>PlGFCvdP}gJVv>U}A7FYZ~A_@UG__ehtAL096Ed$E1}>&4MaK%>y!TEVkb{A-eq>iWfi#sUGjOIDi1 z8wszR<&*J3yC~MK(LwLjs#6u2g`d0NFtcx8%CTpsly`B%;yoE5gw)Ed#aV%(*0EVH+C)SQh-y5VYF1gZ5Y%0z{zEDK~s{(b5F(T zL&CoTRxEw&uNoEprseMX2%OG0uhMfXH$X7+NQvVJ)#%E(EfxJ1{MngYNOPR@sLxA+ z+NAbkbZAiUF_KL_?@6@qWn+&4cjspY6TT3DRs0VyCiwrm*1`$2jW#Vd(Dk4q!UyTH zc6}KF{{F3LCiz;zx$U0~XXBez|64rlo%Ms+h8|vR_d`Zv_4088X~)VxVsQ^35EYRL zXlRR*^>o)EZtX1J-6(-}98mshc#}72^eOm7n_JsS(VvLOpVNW{OpOKh;QttW z2Z?fST)yj3h@^vXrNW$2$LHQxEe;1r|1AVzTTOQNj;ys}Y`l-Df?EjH*)1-iW>8IcGNjWIRxv!~}!7~oK!Q+CA7tem&3qwBaG2E(Cu<{#T!RU!fR zHvyS9&mDSZk83+=zV9E~p|OnctQq zM6Dhq-&Isw5Fy#~16|Fmkv-Q)r-E*z5MUlAhy&Rg48L&80fS_DvHN20Ai#>m8mHiP zajj;;UOnwlTr~gCymx0yljWrB;bpYolWI%PA*e%U=OVOu^wSt*`Wl`)oFvK>*hs|%WF`28h(0^M#H+uArL_K!NNIf)G_+}{>H zf%Wc{Dp5JJei(%6RqoUM*_`UqmUv6tMT_P*#oKkx;Vkki2D@_lV`{Z#9uQJ|PqTd! zP$kxP8>&J_Okj3jGjah&C|4sVl5WKQ6jU*NOR!}8{jB?=`3{8OeGG2SL();uh|ApX z6Q2)4uThb{h@gVe z+0~vZSqKP7OM8!z_t{<1^3p);#q@%1cy~QcG4KC-nNv7-OCsI+!#NX-Y_RJ|l-o&V zWs&;Pf&#@}$;clIuv|2@B|#Tsuax~%7>$m2*M$7+yzKwc0wRK5CmN7C1A^u-2}9os zs&UVA!dhoLO4YKS>dcn5{=I;%X7K3VgLHe4p?`-FsiRprot& zQ$(exHq327TLC>4w=E4|_F{P*y}a5R6!qnW4mf@KdN&~5Tiycmpsjfa4Y-7WEalAO z)YwBRspE;}IRlB3Sey4gZ^t0Myb>>H)ULVjE>w@_%k%J&e?e_@-;wb4?uIVr#u1Zc zSF!3+m=D4mG}(Jn&@tI-XbDy>1wBi}Rf{G;7%f{8A*!JjZPYCcd@wMn{&~D{y03vQ zM!>^x$@TJ_H^tykttcl&4K#IWxRj+^e14J>>T5u5tLu`x1;^8=TwZIMZ`;z!|5t1;&z1;q$efx;w9#UhcDrQsY4&#j6JDoUdt>r>%H z)K;)OwL_W(e*k~icYJePbL%MfL!w9(<^jR6nx$Ot6i_gF(+q@g#~i4+q??rxl)H^J zeAU+ZQr+g@2=?tjzrYJVG`=}t9JK$vh62MRBbJGRS11A_EYZES)8QGuHeHa(qj{axO3!+DzeWI_8sAvGR z0Qt%ROIaO@vmI#9qa;V3uC5U1CI+S}=l>I5p70>rh1_M4-!ZZmzSY$hnRNjR_FyMn zXD@&_?{==m>L>I>jt3m@Rmy|j>J=$g$UbtCQx3nvSafPFC^$gG(f$(mvnJweTdU%# z`_0%lh{fmLM)Q=M%Yta2*nr+zqoO=u$JO2~)EcsOjZ6hN&|>2sRe?b@2#t2j5lWUn zDu*2s32=oKHQYNTVECVAQCW81r=$~G84m?r1=JP~w%u!Z3DL%V^%I}pwB76ek|D0= z?Qu=fB0p<1*>}xG4>v*MBn3}0Cg)TE&XPd4+3fa<_oY}z5gkgMeVj?15WhuKUUL6l z1krFf<@K6v$du7r7N;=6Gf3HJ3wQQCDY4J76Yj$?`NRrAd3%kUZPYRR_qLR-`OJ8K z3qJ}aG3I?{SKc0Ct%T}|?*oO8bd@BLAb^`R)by|%UZ`HTtDh5tMUZLb%zU^dmO-}|!mNKyP+bnxcT zt!Z`y*07D9iqmz|tm+EUdK8SfjGpoA8OwLt0RlRGd7?9pFPsw48D~-ypMV4@^XHK< zq2^Gj`@tAv%cw~d^Ro*$F+Im1Jq$H=e64OR|9jw4xc?S<4dPC8GizqhF&&JpkA0~h zXjfc|%-_xRRD5w*KNf}i?n4_(CddJ09d3yBdt}ozg8gA;+1{<_1y_AuUP@D74mOma z*#R@v$p1D}&q+SntiAMO%^k%O;gYlDf}PbT?HPwlOaPI{BVWuNeu5zOXKykLolss{ z+*F?VDVy@!Cl3HLUnj z=2~ob+R_9qGj_4UU7OoZn9Ly%xmxfm?USq8FDW#3^^)^~TS8}xvD|-urc>J820@Lo z2rg8%fon_i&ExXIbHkafwo9?s4azOw=k*!!_L=)}KTS4hZ{Of=nrcIIe5WNP^L=62 z{EBo-FU;YG>Z0J8M&xsL=&)r;aCHFtOHzzXnZ-_s2Am z+m_&0vI{2`Z@cW!XHc(6B~1hmQq?)gU$FaAc5SE;ah<(meV+N8`y0)0ie?xnlrGjr zXHtKo-}hc;-d;g17gqOHIv1yw>LNY?_PF=38(ZBcOL?{*h*mqJ8*EH+{1`C7X>Y)A z?~bd?=4L>kwaQS4Ve$(MlGT9JXy?6|%;!qnE~Ayh{Mv39zF<3e?uvn$Z}MI?h=Tkj zeBiTT(#jQ6E#XQ3@5d+hsOI;eMEJdqEAyp`6y26FM59?w(TXGa{J9-Okv)Wl-Y5A^ z#k{`l4VHch{ysWL3?y_2kDuhUQxgxmg4{v>WE9|Lxo#D3YJXX zcDfsN1j(#01n#*uPN7yDP!#$mr(PoXDg`dvEQN#etyb`Ztpi6Gz!Bf zj&DZsYDDz0rj`>!0XSWvatFBkKDl<9B*m?K$tjrGm7hwzdIysVRx7OZjhU@E%Dvpa#rXBE@N${ z*U8l}M;dqmxDdqfk=>g2Og410TGPL_`nX!~C3yf|e8$B!5Vk%SPs)5^i2sW?H8#VL z%tx(c?q#1=MJPKSW;?H@V>{4ot0$>9D+$)_%j<;wmn#;Hc62Tbd$kU|LJ;;0mgM9& zw&|}_bylis&O>QiV_?q&7PH+9H*K6oOx8-H);>U!I-Zc9#?A)%wDl}c_0ySq@yY~H zo)=2}-e4Z5{o^aCexlqRBCK^{67k6qF**Y_2)Qn@1yUo=K*yp5Dq$6s03g z6>vDUj$Z-7IP7<&W=`5&qPi*ewNsJ5T(5b3SKeo8&S#d{!3y2Vdd(o>k}lr}U8(31 zE2!?{6NGI||1c}n=}A6rbYn_ZTMFe%7=an<()^7@&EO585jSCi0R4Q2#k3{JqRakrw%e%y6OxX`klLTgfG}R z`v#TP^$Rc`Cei7?k8>B6RL0`MsIWhV{RwwXxY^v+^<2w7?*ae(|2h8HP%I-Bta`V< zY4Ph^deB>9x9Hz28;GXKpPh^zreFI{Z!_cvCGF(_jqO$KAMY8>yC_cF*F7nOI-&)5 zG7F`z{#>{EJjvO^7F(HytP|8BcQG2P8QF}bZ4T0RsK}%XAiQW+ylC=aau|4==@kSf z>Zj1JcsF;?14vqqoEnFjHjh?~i8I3L{=;wZQRnIC-JPMzO64GFU0S+Wc!`SnIU*49 zr`O1`CO^)wB;bvw^K@D+D`>5|Qk`u1<%8*kajBj`^W<`SH1;GYrD%WhOUz?x@(uU8 zt~Q}Z5wG+Wg9K*lC~6s*mQ^9poM`(MAG*;um>12mvx^YGuuOYp*!S!ksh$KXID_V7 zP8M~R*~chLOAQNY)H5s_o8Ba6aj7+;Am(6uwtF17JW~T5iB9R_)WET5CG`L>Qup=3 z+hQi2x0d^!_FL=Jb!_bZ-;Rw3U_AO}=9}&U5a1<|2)VB!M%hFVgFtP;muzZn8Y6NG zZ`+)bYgXpNJ~Zb11TqA{@V1vg-{RDq9+0m(=HfU=loo#r1tQ4rfWYGD|2WNK{eOT9 z7bK~c=}_fuH>Qp?c*%kh?)xqF%e_SZq`BlhtF!^xfhCJnn~vPe(QSZt@#~8~0>?LX zKEMzfU!7MO|7(3bb>=dyBD230@qWZ8Wh?V_Zqe@0=~-U4;q{#s<{n)^kswr9T7xri zE4W5Ayto+RyrkpK@P5YaxNQyQY_%OaW^;!m9nl+K;2QLF#eXpRaLB(+JyFoTiHN@^ zbqzbUcJg`HX7$$(P3Iv3^OcSkBB7do=YF9Mlk}z;Jk)6Ea|Bdtd{OM%%<9y`b zRQhj5a@A$@KBf`p5kvmO=~EpmV-JGLt(WO(=0{VJ1;qh(WEZ_T;ZaS#Uc$MjT}B8j zH}#L2l!Y{G%_W*7v@%+0;%c%+t9V3Ak^yLTCq_i)mkOODb$AJy=C`P;t@eQtKKc5O zy~uT;Gk_@kr7kOCmnx7n-Fs08JDC#pQI&!;a*CRWDECy}%hG2x9A+O)9-Y_?=w9AQ z&1f@)IkLt0)cFlUK_M;tsZ&dcU=z@3e!1}bvy*P;i(VCB|0(Fu>JfyaEH8 z_5>l$+Kl1m2bX(SGH*?p(K+R79j2W=g%Ga%ZeiPgsq)8!t+e?s(B+?&_cg6tA-nTZqa}?4 zB|9|#U$057E|h3 zQT@fI{BZA^Wn0d-8b(=Ap|#T0Dq<`*@lg*F_2TYWBmL$b_su%n`S)xQ-ELG+hklhq z@_UfeiHkS9ku}2N{UsfJN?Dht<3k3Y9ocoxAmP%&f8LgX&6x)t+ac6(d{x+0_Al;h zY7eXc&R(M;GaduAyo1@hd9@!ANFSPe{jQmdQ6){`6?K%@&S6s$j;kMAJZLvIN? zrViGN?=h3^%7`na8#OzV{t{C9lEK1M)o_aVmzD(0;?rRJ=+gshdy-NyLA2XW)4%i% z6j@@9W4d|&Ea>hHhdMi)0ck_MD%Kw1z@#|EIHIGwql511e&5mH+fr}#Gi@^_sUYwap#XEuV<2T z&bM--BC>p%k^x&WCkp1e?9)+oc82sb_sj7Pp-nlfn%`g7GS_Yxh8W09bo^p*TR~om zGn)|qBC~u#O5bXf!~5ijPoDB(7D3Rw@>kxh2779`9gU}hSylee#rnP7@gD%mF&5$b zfI%D!b3>eQ8p8f_Ssnt6*RG6Wyd4%T%utEbWrl&78uNGAQaw zRE~&|v%Ay%yckf10c+dMhi(~;C-(hD<8MdL*R0tDBU2Hg_g3M@q|=p@s_11zh>Ur@ zrIGu;E+*g!h{B+8g8DJo13P+oeB-G1SKcg-hiFnl35|b@Hq8WGYI`7Nj?E9T8u-Wi zc~eF?0iYwve5`GySxo=HBJp<(=(r{{y{#_zuRBH{lKNnGTM)Ki`cH9}&uLs5)%m2? z=J_s|L_Nsp4EjSSE66JZywJ*SY2$4~u@}+0Kc$?pVn;0cgU*p-K%UJpu*}AaoW?!n zJK^?2slk;_ebtrqnpi6hUp;VlR)BqlQ|>@mdBr=jog<5+7#lIBYN3~ST@xoDCm+b?9J?}ZTI+yj0$W&PvCf&3?R(BNrti{h(!vZ44Q z*lPK@ETd`r?1ct$p`=Bq+#sJ1nZoyBTU}4FgBbsSDIjq2QqS6l3A@Af7~(3$^(*># zgMfkzcfMP698<9Re)-q1m|Fzloh=B_56(?1TTeqkBnPBqO2b! zVX~5_#ddzZs-r$xbH>#l+EGIWLc{Nw0) zmAd*jqrSXAu!M#jF*PGFeN2lDm^i#A^*ui(MA&p8THwQe78Xr*&(2k^9opC5^>%{u z`JTJ0Xy%bm=r>@#E}NXCJRZ#Oi%kgbm>CWhSw+P^I@@6%J`ZYdY) zI_DhZ|JiDKigAoOdx1OeJ@X=X{f~W?8qPtH0fF~BG|8mf!pFp9L_~x}#ti*;DZswc zoImuC#?RPq{#*7KFP{-$J2T!iFfi%1%Y?>2&AmF#QF0H%Y+!FX^i;@gf z^sJ7h7${HgQbtlTMNhPrhMmIF_1rsU$}yhR)bTYaWZlD&usmZmv)u3lsNIWZ_hq$+ z8+S`KbBzlAdlOoK%5+b#JIU@*m`4$qBFAJ)bK{WuD3mXmH9Tn--^YjI)BkiZ5#aAOt+WJZ^7`o z?p18r_UT!>U5m8hOX*(WV99du64r0wGGmxU4@$a5NjrW6F8fG(K57xx6qve@z@B-r zi&;9Mc-0k+omw7j#*&Gc)^Cf?gT(%3o6O?BLZ;+-W_=CW=j%RI?|qkqEcZLxI{#v4 zso;5$61O_}X_X% zK`PyUGj2CBaGm-2`SWK8QhO=^nGSDy`%oulfEG7wz&+@!dl0-nPcfVj830>9{x8o} zKj=REPsEp7lOH#Z-km!j3zepx(`KF{&b4(Ur(ezG*9E%;{Ig)=jT%in)wt4jI>3?E zn$_l~zQhKe(1gB){NyJ*-e8-7s7UNLW@LW!{+xM~mSg@8ezt2E=MtkI>9UaFUGdC& zmgj07{P+5B)Bnh62{H`9ixm35p0KR7L&N|R0kpf!!F&{kK)ymF z7RhXvDnYrCuZvT>jdX5>hArA+NN4yQA-5f1_L$EJbW^e?cBGysumr{4T1$Er%OxF& ztV6`Ddi`L3v769z!prc1k?rlLi_aQ+UnFvd1EQfF$XwuGsej%hhcqGcY3>G-w+l^ zX{4|bE6vz_Xg&IXxO`GkC}^Q!Er%ZAu8uaMu+a~v1_KC={H)3KXWYz0swQTRq*anq z+}0+yNEN7@61P#w@f@ALV68G`VhDYzYXtsR4i(LV_k%*Dlbdz%Z`tZ^=|qL}J>6%> zNHG6~0f4uU?)_kemq=&QhBKT|`Dh1aP@uYwP7a>i-Bpb_h9R4B4aMj6o9cijCIN!m zDN=F^b)Dlpy+8>QZj2mEJVWFBI76RsX!=3Dpz^CNT5-po*PX zROxb3SI+xNMiD3>koeLTuW{O$@1bM(5A-(}G?v%K)NLOh!C`W0N2YdI==iJHE31Gp ztL*~*48jK2AP6)piZfN9BEw3IIeOSecI>Gu>^|Zy$*IRRP@tJUB3mb+LWMdz92d7 zkIZ}u_x#$>2aZQ>XbBz8gUWgDN9tm?!w~qPFWT#OrL+_Ehoe6ulinPin2;STl4lqO zVjnJ3ck)aPlK1C_!-G4eu0mBnpS(9Sx`~rUe2xXk3=OK4-AHUuQFxePYNIb`!X-yj z^m6rpCL%p~!8N|=njR<_AH7u=F3?!hoGt+BUU%g!&l`%1O<<}{=3tQ94~XjFB61_g zI7oL3_3J5jU9kJx3qA+Kn$i!(ZJM-viqNAnAK=mBm6h@@S~DH$)#`uO__Q9xZ!obT zyh9pPAN*ilYoh_}f%jgbc8?$Db1YOLVg22pxc&eNX+@~>cs)jh_JYo<5EfGJcZ8qi zoODlOOua1Ma_zq&F|_scNl#^(YxrF$)hEl9@4wdc>_gkdq&(6V(KbWkm8c%*bq~*&$btWe*ZO$<_RHP%xMmE&1?Bt{! z7UuMm_j%ICFww|%WmQQgCH~iY^#$Vq;IF;e==0_;C80JCGmW0%p5>a9j2G;Vxh-Rw zA7uVfXeLP&{IU|3WeA_poz8SKnWicsZtKLm^Rf#dboeL7P0Uiwg6DPxiqY}e*Lu0;Xds6T|d^Rj;d3!6b1=!W@)pYgf zdLgBk{Ith2e&{DE2N?Z`BBk$VKK*{#jMl3+S0KLanI`$$`C8zxPC~D!M&K7D&%h!* zc#yrmgZxG9O{DB41(Y{YzAb;g*d8!&O`AdfNf|QiLU1fAgl=$cUY5R(`>Xo>+=M~~ zm}{SZfMPc*=le~cLf>us4bVhPahcySU@>l>0+2^ZS$Lim?p3W@@CQ{^%cEYam-!KD>Oar8MFI%3YC5&E)WWyq6J{U|S&tv{|MTg1_$>7E#DPhQOtId$vHNtQi z$b6Ez*ug1vNvEd+LLG9l?PTaG=Pp zi%78Vc1)rFNqUJ4MrbE8M#RdAt`g^=0BR_E5P(0gWY`!p}NT}n? zHO&nVoEi9X7^2vU4RjlEKWRkk^^x2_pt@JhGIYrut>!yM+0IN#<-Pi;FNjbwf>7pJ zRj^T#UV}ACXuFDWA`s_irl?%jMjinPzM@(F9TYSYl0`&^JtFnSamT`^)!3rdRd09p zqBGnUyQHYPH{2Qby2Xxr)~y%_U>sAqcX9karT6V*;6A>dAg>lNDXMyP zsT2@hBe>s(6sW5*4T4#UbKcbZN6#du8ndnNt9|A2#&{dld-gpPJE-S%rzzYLRjj4(q<9@yK2Z~7D z$@jh?tsp_OeOID`7YM9OSW^^LnkU#;XmyralJtfaY487koh6MLJ*bZ`*F~>N!!?M)+qU5fHx+Z~nu2|xq!A4p$(dgjIZxXiG^ zj*Z&jM)AVkOh94mA=#+(Xc2+1+C z##_tX6t+LnOiz+t!cL32Up2|?;pC8)RCE?NX?BGu@5&{Z;Z~ zq?JP_uBId)T)Z!*IClnb5&deO1|-JTPMOl;I_g0H8T9awckx#%3BTsR4ba_o ztsIZk_gy$%V7~TA1gR={VbNd`_K3#Luw%YE78CY)&8{eVt!zcptmr^xeBkuzR*QDC0b{C%F-5IH4v}yCO*gC;Bvs@RMNADYO&p?AQpkk*udWmK4l>KBT>lS!hzMlXi)T!Mz z_fmrr%rPqZK2Z(TcEQ-Et~hUg-Zc<4G4&*05*iGj`4U}y10*O8is9U*E|(Gfx#o=2 zATc?oRILn&j^fVd=ayqhm5s~_{3}38=#=v!#AE^c3i9g)!$pir9Y};!ikJiEGYQuO z-~7Tht3*TMZQ8gBdah68+6kyl_*6X?MYj zuFnMaETqRIeZR0cca?lw#+e6L6duE^EB>3k`U^xBBgB$jq!nplZ9248?`U@}*oJps ze-ra3(14#|jKO+GT_;htbRx7>?g6|{(Rx^}^K7Cy6Wj12$wT0T)RCmaqMj+=e3i}_ z9OKpg!KP*~sb5J)h+{bVm)$y;Z6SW9{Q28bf^zFsQe8wH)2h0Xp43V251u8!%CP-ki0x&KtICZ&*D~YuVSyuPp@y3*t%n9$n9t z)?cIA1ZTZ#Yz3o>Z5}B}+qmj$rx-1DYRd@YcH1RpWEd}(=7i}~@XG`(E=q^dfNht$ zz=(tF!j?O1Rl85H^r+3`he_+0;A`3sPm2n2Bcii9u2>bRFqF*{!sKDrvCks=e2 zqKWua>8|6g4;R?3?CA=fFZ+aXOW)fEA`phUnwJgOZ^gE$skTv~iaaLtG<$Si^k!F% zQ=qXCV-i4Bga9oiQqkX_w^8a_F>5bvRCuqx)X*A>9wLnPX>K)bOr@wU^S%$NfNYvT z2X7uX;Bu^&6#suKlCXF6R?H?)5U#Iv^APBwO1nFLG~pb^*#uLKY09i6PIOK-En4E@ zo{7s3@!M{+9>IoemxwxF0a6`)^99ezHoOpS9P$n#nfoCiacyy`X}@*pO+;(DpIS2b z6jTom{Y=xY(X<#Ez#n9-Qj3qS+$9^+=J(s+UFI%=;(v#(>w1$;Yo4Veu@3Caixcw( zqo|t*&^NhLOqZhW{n6?@p!lYj+_a=laUscZCA$4QROCJ{+Q#N!)I|q9oXZhy_>Ao zl4%I!EXb$5#sJQ>0tZ& zZ=1nfVfZ2aTIAy_#JDuQDZEkD=Oj`mWe0>UuZzAV-IJROeO|B&10u*zSz=2gu%2a_ zg=WctO`z_PLpBcAo-rUft@sz<9I_$(Ip^&;-G$6GswoTDroIy~_Y?+@oy%Ez9{QR_ zxPDkY$j00piJ1XfVuD&Z7p%GcZQcf)e#~v(i01I}&UI19nr;RCJRpt4}V^_L@*~YyD!E2|p!N=Sr z;@8~`c~xJ0)GWo}Iem9<$BWF=_@rA-^BJHN-cizQZ8Yh<&RbQBD@RNCKbwF%hW_=G znn=8*M;GL`C+{}Bbn~=tv}ZXYC&5l(%p;IZ70Y}NpV&+qfl;)#F?ZtTBs6X$8qRx- z=#8mh;hx(~jg)7?oc~(Oy?_<@c2w5K{H@5a3QW?|EJY!k>s4g@XBgV)B1P_8*}xim z>2?V{e?<2#&M&tOoZ2>|!OS4Ev+5Ilfod zvUZ~caHsrn4PJ?zIT7&ixeFxK%jC2Y22hKIei$Q~Tnln%<;}tvJE#$*)mX@(htLC5?QDJp+=o2K#)+@=1dk0;10_sqwY3qdlf@#k zbZaj6bPMRpyRlnaFty;RfOVXuZ0*1C#ka#Cs2d91{X0DeJ%#Zl(2oGa7+CFbvvn6E z=_y?iSsz#kkl?0IjG%Z^1e0!3mW=APJ((qePlRuaZh8WkOUi551-#VKWK+?${Vc}K zWcZ`}gHvS|rB@d*e)`{t@y}rRf8ic4yK@_FX#SyVmtUpyEY(D}Wd^V}&R-emPSHH1 z!%^_@SB(Qfpd6b3>uPft=yq`N+V*Ng;pSw${wF4ZVJ-n5yZ*Kv@e|xe1hrn}ygvZe zhR<2}mlp-U1V66B4H~!XtzkX~l=^v#Bq7Muib zya~ZBc#hB%tKyE*wh~k?=&*|SJxy`}W1=pNA%L|PZ0XkN&R zy=$oF{9b^UPVW}T&BZ3sp8sZ6ttYiR&OzLW#uqU-_M#sYY&+o}U1W zX5dHc6qYqk6PJ)^q5X4BgM!SJPX?~GxkcKDmcgM7v#vN zw_~T2v2RGYyX7t1mpWHamtF;;#R@tRo>`sTGpX!L6p%uzD3f)<<+rp*!pNl47g%DA z|4okDhp|DGN*6Aco78+s;W+Cx^UgfSZcI=XFE5}Zqe{a$8#mX`xD?s?_pVmNqo(eF zFt*vuo&ZC-(EmtkXdWrgXY~f;bkggVavdv=UN}Z`%GOUjA?n<3@}0KZUAQlJwTnvO z^g!#US$?Pg@@mnw$;Mr%ODO|ukAs!D^M3I15X_EhA8AY{Byhc1(qZ#DDS3V081O{5 zKbd?jYjnDNCy5>Y5vsh_#-1euo7)X+SR$cGd#k$8LWt|%mWp46r0q9w*o1!oaRt9~ zrBMNE4sUijC3z*mrZ?fL_0)802O9K^eA5U*o|rx?slKXxe>t+-`&&n|J#~gVYGvu1 z;im!rZ~Rv1k`j9mTzzH7b5$2)VRHHxr6IsQZVg zzJRJ&s`YxgoR-SX*VUFS$eMJ)p&x`jQ$^^iz(mD(Q^(%wN~{$537`UaY%BbABFO z*rCsun1UMz0MoYFS~-3s0tY}nWZLMUfn^ky4Q2LDU{hCtyC zcSh*tB+B-CJHQC7XPJGQhq@E-JMG51k8Te2hanF{)oq0awvE2IOMIR9V`}h%=3{!A z-eTbdXM;MOdw1TmvF)&!CHLO+g0d@SYm3n?+m(YXId@Y|cy?IOcv<*4ykh%i8rgB~ z^o3du$I2)nQJ9ZJEc(_Trn60@Jx5!M8|me~^Pi*Llz+ZPksY+kbBy_Kh|p|9;8sB( zHk48LVf`xWS$ha0lsYp(y(-LyLVXt75Ia=UTR@V;i;nAsc(?G(Ej<4~gbnkePv~Bu zBfHT(nu`DU3iyvS#{Mw9CNVt zojJhxI+~S2s)K;zZ$X>o&8jV zSG^pIaL+V~Er%z4WS&}Py6rINsPo;7LSK;$ZUh_qnOyB@Y%`pDNjV{diMRCJ)wu_U zVU%@dOHFmrgDKZm$+qFR_rm2C)B5b|n!k`Xy%CSHly_vuX>GzISO+(|xkV*QzECyi zY!K7pr4D_!`qUYPOTPCrupPtL#_mov^DCpR{uyKWbnyAGnCpLdf!nzXrZo0hs`xju zC)`$-i2OR%&n7qp>v=8$lSYtbcz?V%yNvh#iuiw6Iv2MV`2YVS>UM`AgbtGspVaQ| zbgm7d+)?PJbQ*=xI#}o038BMOh(fhV2p!gGo!dw&9oK2=+_H|V)>=EXbH9B)-`{_* z>)N$lulMWqd_EqXB5$f4&Tq6f{+WT_;s|mw?1C!Cb7$)?q;h!NZhiqkTe@y359%!U z2=K|RJqdF(MeRi2rAI$8dkRXZ`CI8;iyG*K zwSbl4r1jQ)hdEg`H=KGmAtVR4Gb4Dvf7ZrEUV@lyc4Z|#gdDT7=$?sQ?b(l9=nCUi z>NmZqa9utyL;V(2y{P}qd`LH4QzYl%ykS`;!1Un~w(yJYu}vvmCovh`;jEzg92x|&^m>UKF<4X|FU4(@bcVsUzYTdr5 zd*GjAO@0VBO9p+$Ta9;x3M>6?P~fV@CEj8cX<+JB_T^mDyYTs?WfW_E(VA=Bh&QMP zx0_=pbX7dkfjA|S$X&Zqf&90S^>3ak$kt&q$%=5Y=3=FN1WZR{boX=sAz$wOGeKWb z&2O+#+34A7XdlV?%IY2i3}aRKvvte>jExYqf6bU^2K=tGjdiO8((|(W*J*^Gp;${M z3*zp!zb^R-bzN)>JIIK>uri{YA()^SBqp$W)je!W5L+u&t>F@eL46eH+{kc-`W&S& zHrI9T?p0f$TR{*TRp!1RNj`K-ZQvmzro*rUc5&#WMWW{N*{1hQ^E@}PSJKGLkv;2a zmBV*)F0<9t4a)T@41)W!QuMo&W2N!=8dP#c@<{r{a zPYk*!cu2Mw9my0GS%f=ypl0(Ge;r}<&`nttx}ZYs7F)`5lj|x%fE!q)Ptp4yA0l%( z!obAm89Sz?dQJg@t|?b3YvRLp)%CUZ>>9DpoS(Jt;>UI*h>l8cSl7q)U;1>KX3f45 zsux&+$})%(9Itl!uoaf zIO+jm-rb>!Os8679vDuP#V&Z{!HH>v7=dj;3>Ty({!LgWj#Z0)6D?@4D>+Mkdp*)I zG2L!yP zEnSa+8O#6CMh)Y-DAnTa;SBcGa?v-N?I2gWD|U8LGh#Shlsz%5T+qgyj15d@^?x=p z5_VVm;iVE2VqmY&Y`L^j1NFNYFkPxltQV`Ss{mC0Al`_&zIM?T8u)!r1{TsUa9l@W zP;cj3j5mCu6`Nnx_d*~JBRcmuS#~+DKCvW3d^69I2b*-RXS(ggOGl1GXRnpmvVJZN z80Qvj0uS{!ssyt`(>OQ2rl?Ewd4{IS)bSp&*oM>s8x@11NiZSc?62ExbqkBe*;=>HN@ zvELo%N;x5oI*^xS>!H4@i{g4HCV{F31Q@ePGRb10ZcSq@hBSkuStznSoy|rUEt|Wi} zL~fr;-d#4CANLUPoPahCedHnAXN2K1tzSWHt{IZ2srg`~h3DV&E*NCBb2tu+3X?!W5`_dAZ4SX})gb2HOPq#c7hwXW1d*_En<>J>s_O z;F~hu`na3u=UIKm_1>E7y8|Fo;{wAq@u#&z(BG{yZDFl|>6$aUb7ITwhpP zlnBPZoy$~nVCtxxdkK+*@-gIH0<^yUGBmi}J9(2}l1ON%sdfZcpysVyVM1@{tASz0 zkr<)=;%Jcl71!;d!ntifbGCW+T9t;go-MD}(V1fqU(*;)TZE>2rVM=(jZ`IWK*J)b zb2@(Q*5q+0TKFQX{v{dvfO%+5(#>*wHnfA379F`~mh3&myLWLxF2sDdQqIirVSs*0 z=!Gc8ob^DLE%H4V%~7~QOgCyXvzwu|;ONNTNht|q>^N%SOei|+?7X99Pl=not9X@8w z#R(Ku6d8U%Js0R?gM1-7SrttUPVpNZq0HkGH6xl{L)Z3|hTSedoe8a!@r*19Y<7!P zh;%Uu(q>X@jJlNxlvvCdyRI0n9FXnUAkT~rXry6IyqU}gs@u+bHIn0c4d`vzZ&1Hd z)@6mY0q%9Uj>&HOltErCU*+5nUZd-;N%0!JHskfeD&~`IiQ^Y z5}i5TXbK!wxxeCtMa?I|R_q7J9)}_Bi+i#z-YD-P?rwp#~Z;Y z$Y%cO!cy+gjma9$(C-#=uFcZ*@zC{^_;k#%OqzU#=3Bj*U}4Lfd)sW#_0j7!(S9(& zy7%Tt_=Tnitcj#N3!8~4*WQ+`;-1+A-^fvGdEhk5Z`D;`I&b%%;-TKsrOdeT{6%qz z={Z@CviwIbCUQ2xL`Oc?l2nrGLUdr&MMgDf4SBn#2kJvHiKSjW_dt@@Dj2K=L)$x& z(-oS=GYPd7uMc4~HNxR4LvzMfFzSRx=MG!c?`fR|ZbUePoDA%4gYXw&&MKXtf-?qB z4F)e)7VmcK!0(ga2w-~~yVmfkPNzYciL#u;G*9^{;q@uU@$XnkK6Cu{i;6VC;6#Zh z_QnNE$lR7Mj#tR+^iC@?nj5L{$yl-&@i5|ttL|2jL{Ft#59v<)gt>0Wi=R*{)gKiz^i#QZxF*2k3@ zk`bTtLiH1ZSV0$E8(i*NG^627R;jGzO{nh3N|~OKT|FE5S>ZQCPIC8=@DFplGze0U z!H3yHZ*g37s;!3nYTb%i75pPfbr^Lsky+!6SILg|x!K+Uw5M(#wmmNLoc^$tVX1Cc z+8!{HUxQL5a{j-DbRTj@(aB7c>OsX#0aMBOFHo%iaL5>SXnN>u5%c!9G0mMm?)?LR=?a+mN&b+Momji0pvCDZPHvV*kG+B&9w+gbY^ zwJC#-U9o%Tu}`+Qxr6;%Pi^^fgu$D?-9;Y03eqi<+;+2h1E}WtlII!iUZx0oRTmR| z{bjQxHA{{bxY5zM1^^WZqXZoj?&) z3}@ghA4V^9{t%7e&Mv@_hbssl8$91&%f`Un?i#@X$_nEf;E|aL>A0C633034196() zSwum3ViVep@96^LjEjhmr6ZWb+ynS>^$5g#_H8J3hnq7IjGn7OtknRJjJS|EOG|Qj zaZzP+)7Zkk?E_xmF`=wuxz%sm(nEZUxb%~wN07XusJl}m@jS8qndGQd> zA(A)hBCpLa2qzEr!a^~V^mhRxpc7J%_8S*qty%*y4%_U##pgZ)LD@cGqo=Gkz_hx@QPE z6qnt5ShCIpZ)X(R2y$&&yV7rEYbp?5EuXKFy?1Nzf@Qp-WDoWIXhD&uI7XWC^Ve$jl$QC!9`#-A`2jr2>e_-iHpb>*!IN%N- z@o{R5h>Bl?98ED_)@wQ-=}w5KU?nDK7dto^x5H>Dyblh6MP^eJb3AjNfWHQ&mY!oh z(?F8N&#>~jt81bbUDfnk8=22Fk55OxAMsQ57Q;_kg~U`Q3|nu{PQ;km0{nkNx2pc; zgX$xq(=5-~vfpZHxxLSFC7F|7QWmUq5UR-jizl&&c4P3!&Nyy~&6K-01j_DbBrtBu z9)_Us4AomcNiDWfsKqQH|8gHa8|QWxoHNyYoO0-uqbjht@+TE_*zG7j67~-qTBmIr zUi3riCF|_0wjqlTjjbPEqTvHh6ZA*AD1(w*V;cS;>uo`XK)jTCr|&vxPnD_+`CO$% zS^6}d-jLqJDQ+LnhP^7`)a4eN{f7gc8cQzZ#{$A@RGu7 zsA>={vpQ>%fDdIWPvw+a)M7Gc>^4`;`;QHp(*Qs(i|^(kh*{$|@U{DgIZi(8yGd`@ zHtuys)7Q6>x`3$)OxK|O#Bn28KDDOK2*R2JK^9hCB*+Ep-4L14*=@ea!*j6J9~zWL zwEs3jdKRar4eG_ki+AdKl+h6OW zl|F+QXCuFJs=i?OTo}x$P_lMP2*_Q_qtM_k2%?nZLWX*n+vRJmhk%{o3MuYPf|LSgsA9ydFwy^TqOOVqa(N zPb?S{&Np^>ktK&t0@hILfd*v8O3}12*2}DI(_qsMK(D8LZ$h6I%`5WXHO#4Djpr!p z=a!IgMyMZN$TJ0+jDg=InlE%1ag3J(u*=SISsoHR++NncGc!V6wT2kzKY#V8&4K3W{_1L8Uj{`Hc4sjSaI1G; zsMZx01`lm~-9Qi>uu zuZ`^4hk0)AD8eJTN>#pNS+a3~(O++dmDH297t9-;M8XEIM}2P4ae(Jw7v={X{;kI& z?z%3>y#ofy`}N?*Gc0V!){l)zw20=6@Qb2R>O(y<%TV-elU6iWgul-FgDL(!B+Cq* zRY8kNg-aT|4)6R-Q-p?CIUM?`Ve%W);ytuu$u3$seikuaXKt41phToWqtl}UN|!^4 z)XP9&fF?urb1yLaam-hxx;k>M^x5?9tRbrsPt?~Zk@e`lXs|daO|>Rp9EqQHnQymS zY8F^#&eMo|S5$$_bVs~vqsIiq@4H5>;Wov5Ve<{LgEB<)PmBRy9s z!oum%{;OGm@2Q>Hv;S-j^D1Em@eIbR3Sr+{NYG<~kIgiDf6P2d8Zryoia(IB5GrBTnsn@5-8>*VPbB%j zb$cf{vfmm6RvJh#a6bWKtgEtoZb&g-7%T< zb@N&L%>{>%2F>ZxD?XB!fnAo^>E~TDp=ka(TM0nY<#f<;q}n8tZg7c-LV9LLMAe%W z6mV0??QsK1%-9>mP>|%WOkxA2e8}EW%4wG#lAhsYr*|D91TD`;XG8-fEP@}?8qvMd zS9Q~Z#jGAgOloLE(Z9;y$901M;1ND!bN{SW#S#6>KgT&a?8R>{%*nH;)wEwDy1vX# zMZNm`OpQtb-T@zhHD2?vKX0>;2}j{Z%y-YCf?Oj;v=-#Av#P^NRU6U1@?clrF&*-4 z>Ge{@2H1yi@2xva9c48&!NuEWJ7xcLgECdum)-xTU>GiO;klu zRNwF8tbB6MGO0e`JC3a3PVcP*_!gQ5QU-YmBxUu?hE>+?e9aRw!FdXb=SYr~uLCwR z?6D2H&X5yutJHQqkc~HS8Cdf^x5cY0_6-ly6kgdMen&QpL6 z)o`u21>=zEZlwk29Oy{j5H3cM7MCv@6%CsZjRiwHP<;2!HqB%;`fG)>4LD_0_geHY z!tx#MDYjHHs^E=Ef1ZM@D-UL_*Ov9#T-FHx4nQjl()Ug~S^`z)3sV5>3|xP%z=D7} zDWB}M_2o%k(v-d4&o1fpe^P#^dF)qe03AN$@P(kzDmIBwGKy78@2vR60^;E{apq1`||^qiY?Zk|-BRAG7{30#54cr!*g5KwPf>OIrclJ@tV5=HA3<_G&cU4Ph&LGXyuS1_YgZP9)M`7)F8W~tfB^j z6yoN$CRnf0LQ)zh-KH`oX|lL3`i^q59i09*a3)Ike&wEC<7+jsG$~XmQQzavk=@C2 zFSaHz>3;TL)-5~$xqCIH#msfl5q7#jUFvVcm5YgWUlj8zM&Klu`eY~D{KctTZd0Kq zzHm`{9DHS$H#nznzWvCyrZ>cx2a@-nS)zmkDwa|J{S56^?X$K#R!;6&`G!_Pn@R$9~bprV{9N zWlNO5mzqcd*VV9?i*<-dy>7kX=2Ti$V-BG&{KoDFAN0_eMX4@WCEcj9ue;a&le2b(32 z{6E%B-T;4G-90WT7|$iquczK`DX2SoOWY{S2Cg6Uh(%OhPgMYXt_s+iM!%4}ls?Dy#MP_tV3S8wdzi*7#1&zNoduLiz43(+)GV{RrdN)V~eBKlg z7p;s3ka7Q;41G(reOVtOV@0a^w`nm$OWPDt^GLH)`$DG8E~91AOMK>Q=%S#-m2zV4 z?C4>Av7oGM<^wkqG*dXO4UqGMVH4$P5D-!tHVAkTvky1Y?$AFwqS>VRMLY4@);Kdk zZ&@?UcJUYa`yX9`^y&(Y%^_ipP@Tfk5eEbLPE3X1`(W)LkLNG=;2L+i*(A{b1Kh4K zs*#?>DK^gjXpe(d2XVAj7lLCGMt-C11rC8seAmGj9>~k+&K?rs(vo19=)YZcO!6kG zGdihRyX?S$m-L2>7N#>OEaF5#h)%Sm^&te4wAcSDT9_Yz--Qe}kY*V@^#2CXAMtRL zomb^P{d{!o;b)jW7A8k_r4>mI9XI0hiuG?egai(}y`Ce?akKauLT?-09r@FtF6M4g zAJ;4o%t`T@xVhA z)`pS!N070Pv&G@P;Y?fnbfHD6<~Djlh|lOn6gza=LqfjgUg9ppppfZZQ6_Kd_!3j% zu+e(mVj!CD9WQuDqmn3ym-Oq)nY4&GD@vv05sSQ1S1mF&$XQ5twI6Q{U5_-Q`%p%! z)O8F~GmT_2pS#Fr>C#`HorV{rK|_&*-O&NP?4@2&5UZ`LoTVXF*-!v$iun5QjX`W} zV{-HK{64L^x`e%aPK{+35GlFkR=8?%3OEIdmil-9+$X35vYLPmoe-u#tega{iJ92# z9Q=W&gM6m!aRsFODHu$xk$v#;oKMVXFXOBYK9HYzQIuH>bM zL~8=nPwY&qjP_!F>e>UXzKRVGy9vU-`vr9sM=3KB>esnNMVxe)W6VNFyD}?vZzxod z-~g9lJCl$Y6JRi`tv*}wAQS()R0w@%gNRb8H(s2Ne`A zWNf+-kR>L;Q02c9LZpXW>HEb7{%>a0svcuzlN&r|9xm;cGT1OE+?Rp~-#oFMGV@+p zNxY>{S6G|i1=ltZZkVn?Z-)B>rCusLRM-_=0#5dJInA@fx%rT@4D0*goSCo|ob{~* zdk}Mb%Zy#SN8$8>N^PG&uaOtMge_&%j zdQm#06*Z=kK(_wysaFHy^W=`0sd?|u*fTR(&*zYt)sVUB5%C>p5i6fbix`_`U5}sN z98?_CaEgL-saxHdGaZt$oZcX5SXCvr_O5&y8z!d<7%k1k)XfRxNOY#4Kh5f=HkTgJWQq$WHmVLTzwBWQzHrM0vn5PONQU__S-r!!4b zISDqS$tJFHgE|JnDCpg6LPXcE#_HO2SzXBz`5r@8Ixh9y#AvJ~s48p~lOH-p-YGq) zJxFi&<)x1G&>cin@Rm&B=PUs?}QsE)n|MwO)q2j3JJZD?57bOk*DB4 z&d!}(xU%%KbrZYMMMHG3Fp>xNW%$kc)hlxQra9U=e!Z+sKDDDoL|5%d1n<*;=IN0H zC$P%9bY!uzGa6)Vv!vP7Zo*@|a*yQRev{+115}2&!Hi2fhR4JvUi3;cY7jlI_)NHn zp=xPr^Lb{>cEsBBCFBq;6%bsL^eIEe;yg)FTdbK#xCJ9}vdpj#vZS91ObLsu%I zDh0W4=3H+LY)s!KKj&&3$H75DN;{=X{-e7<#plU+y>uq}!WD44gR)6i{}4ew?X-HTO9NxqBE=hDeVYUZ@s2rCU6% z)!W*VTJ>bQgw#)dDPaCCi1Z{_iDq;&3Sfus`7P9}kPXMIB8IWHUjBIElC^@~Q?^i? z59msQG0bOcxY{?y*?6a@_TU!zwCcjpvl4>G(%v)n*M+SQXV*mk0gb7HPSKu18m)5E z^0M1Ot`E6Ou|={@AO;CY>U(F|gXwlczI8&`R!@CY>_K09%$E# zxth-E*=1i0bKP2F4cj#8k7(o1Yr9t>!$|;)1(QRWh?EP89J&X=5Pkp&I;8{Tu znvF!l^GTlp^7cL(gsU(&dyZF1Yg=*c0D-1LwhyYJ`2Gl~%;FQEuRQ$nW_g`EgYY zFl)0XZZ>-PAEJaSt@*W0TQ*d5bDq{-)f z%!EW0gl=m(Kjk>M{K5g@A=O__xEze#I7Aqub~g_wniAf~8NIVy8kvaI)qA!(6rPgTd#0cgK(FTpkppeFm zA_VM2k1=+_VloL5Fq%Erj8;sXwMw-XM+q;ov5OOw@q7-p#6JZ)x_DN1Skq*EeH7|N zkvKvE$4c6u+)vY+i^dR93&1jq%5!eMtH`$6(fS41)0R$5-)~6wRifP6xOk5Mw;Loy zn1uL%C@8i^boOGo19N|-=9~N~O4e;vLVUh35;LZu9GL7Xwli?$Z3@;k@EhK3^Yv;} z?*5+5(gCi@y|U&1l=R(a1=~yy#U-`(0t@6fUkUu5ng(_6k9X<5J*tt3qYr+1hpEo| zWTyAXB{O#I9gu+T@os5t|K;-IHgm1^gr0VJW!g@@G(w~?qEfr*#jyn&<{b|!!Z=7vKEfx zkKXNeaW(JQwrSHA%=rU*DD!a0B0+K6{rG|mN1Pwjf1dI%VGpZW0|{L76UpDU`yCIE ztRA$oq?B2d`E~I)LC?hzPp9bmCLU4mr?Z$M!)=1WT`tfquuR%V{;0L7P?ft4y;7VM zLkC#SehmNixy#8PTS$EiG%Ii_mAH6N_Iqkf=D3Kzg~+>;T*!g#34W@cey9mS96a`| zs!}^hy0%TqnxehgnoB6Qwd3M%_kv~%Cr?^6_3#IC zG9B~_`uw(|M^9Y4!#@!|>3tN#M0AW%~GV z%kP|xQag20$J)HdtWI7v+hQBL^m^U>mTqgPn{pm%KlDA_v@nEBTnhtqMmIB6`Rm>! zx6zfWThq^4<~9tY)rw$LexF?~cOT7cZ2DtpS1dC+5-y)k$7h^eO^A-AW!c#R1x@`K zc?gi4h(%9_fAzczmg>unfsR&hkcx+;K6!-z;RO^2iF+o_SQucIk#x{O=XVfMr|qc`M+RpN^}1Wkk+wm-hdCqe zcyZZuLQn|8XM8hIL@NI`m1?0*rtYTHh7{AkzuC6F$ObO|YWKHo5^ z3a;{S?k<_jx3g)eUshn=kxPV&D!R!Xrq>q&;kh5Gw=UdcU5gNg?@TFuUoLm#t7de_ z9FD}hrafnW{{33pnreA5rM6`4!#vcL(l_LJeo(0ul8uw^j-FIQDu(HsN1(^KMxHcK zeQ(|S%!v*7z9l<;7iw02#aEW>9WWbB;NOEK`JdC|OSD!R`D2;1hcpfzVz z{>byAbVnR{v%;~4thp-tY@4*8s;TcOY+*k(Uenl2p=Iac}5F z6zUtSwBpdm0Y7fTIe;7b%6PXflGF8~dagya_V@x@MMJ_pw2vmFBsjrNU3e7E&6^L! z=XiPpyW5V{p`G5gV=YwiCDTqGb5+BRlF3iFv^Joj#Qv83{K9o&Qre9P-svdN{g4oT z$oO8SbyoSgZ&@`$c(H9EMNn|jvXj0OCHq{S7TAG@#EKk9!dphsU)%8jVPbgY^3?$ z)gCGapfNv-(aS%g|0iRiY&Oj?LY#`?)n+R;u>UVH^Q`vLL%(3OrPS0PxIvW_+B>(p zvkC(OM^VeKL2zU^FC4qC2#ooWGgt(XDi>` zRY)ItdrxJYDtM9^B{YL!WdZ-O!?f)-syzce9?Lon0Mtx=QYE6#8GqJBt<}82taElN zoOcyuxv*ZQnypdS>E1V_f2kFkJu)BK&tS$_<4$?#$-Ym62ssM9s;&^)rX*v^nbfR& z8=swj89`CQcC#bnY$FHF#U^Go$DKU)vM8W?Ht*f(1uuUSGJSsL)ZAgXTho_w^hJjI zw&@=HZ4c9r)z*ohOvs*#lJ=_7SX)GrHpH75SP|QlXA8?riEBy%g*(ui#ic(2;6L+g z!ureDYFWj?uD4)^4KX1;sJP~oF=ISrC$KSf+j>M+KnuZaqT7B1^V=!W--+ zvyphssG@VfbxebCq^?GS|>V8Nv>c3sw? zTj?Q_#t`BF7Dz9KMu9|eHfB71FZjmFHqUbTx-B`cx0dZPxd4y>bk@v8AuQ~n5OzQZar zB6N8Ot6m(9l!`MlJ?Z~k&{g=ifYA4&K#r*UFwHPk*0i&4HvU%@_tJ$AWQLY(3nD({ zw!Vfc1GTVXV35Vy1sx%`y~ZnkjOi6yhTUJ1hZThW86~KNrAP)q*LJQtK;G|G^;Bi! zsZ8ndZKbBrD6hEgT7;|_D!f?*JB4W$^O)ryLL}^GA`^ACmVz~I|Kkm?GQt)v9qL;z z@35-;+{`-&Pv@%e`7>-D)#xD#=9VAc=vusT=u%KNyR0=6tTTz~;a+&7MSN2LcfBxL zaB=l|TnU(0;(_*9UJoavrMR4~^;(d7c%a%yG4y6nm(YhssNEZTPQKZ4}=D#q9Kz-ENS&8}*)8_GkCe9LmcE z%ZEa({ZQ{(L{M;PxDLPznXJvg$PA!3BC5##H{IUTc$OFgT9&7t#H5#)alI-#KV^}H zaK7;`Crq;D!0P;wu6kHY`TV}WW;^V-)lUTjkT)ZH=9Wi%*P(>EW3V?Nkv#)mMu@vx z7UvE{h*S8@%cIeu6O;P%(=>ZDwuIjTSi3apdtq<`gf%f7jk9wy_KQ{Vj#|*f8m9P; z<}k`48WDb;C|OJq_NBY57THKPxXzrm;pdvll;#9ef)22EJ;uPafHEmMX@Vk%^o)-H zB|{l$U3rL_uT`th9Oh(4(TJw@G@BbP1FI_FHBxrf#5wB5sCkcH`OSsdS4!;<%FL&V zjz+7o>8*6fBKmq7qeCqxh_(Bji&wx%Z1-$HKn7Oi70#|Yw?YpmOpJuzDB|9hqS`!s zhXLW#_in5vg87X#2e<;1Aj$Xe9c(u<%O@GpFQJOeC_x=x9rWw+t?i-}0iIIE{iWI6 zaje;N)v86LxLHwm>iCsW>GYq?ZU@PGSq^NIXZ$f$4H={UzX)Mn z3iYJ?Z_2vb^9Plj8DTl2vU#>#S@Zf9%khg^^!eqtamF{<_r1*jP{YQKQuf)~U0%{= zzqujHe9jdv)ewVX{TLuG8|19?uNVR?{+a>yQ`?`+aodfs-(8D8W}Y%x&IdJ1%^77l zb6?bCwr2t=Fg<0=OV$tSX)AgsdU5SIg4&u7ZomwAUi6|-GK<1b-T%m)Y`-25YKjT_ z)N*IxZdw~r(Mb2|q6hS4! zzscmQK2C68ob*v)Rz-fFeSh%Xmz$BeDulno*y3;%>*aicqx}ILrOGm~4v(;CF1IX}5F$fw8oG!DmG#5tHR-N!!T;^mL< zsgAyQp|4LE_X6z?iXf%09pFpLf&Jv)9UXcYQ$}Z%MC-?73`JlCx^)27hOqQZR2{5{>Oym~-nR0ol`LT$khW{n?PY&sxit#cK5jpH2y zFv*SrZU3b6$=5LlqAVBNk5Q5&VMN!Ig0E(YRLbBDKR?tpCxv(yAx-og|4uaKJg}eq z7=kiLy^-1wDJ@8VSv2lQd!A-(N?DmQzDJ9@Q*IJXd#%`$S9==#<6XFczAVsL95JrN zYctBRRs)_vt-cxb=N${((EegB6J*-?JHxHCX$*F0H1MtddMWbAPP4gP&}Tw5ubo^` zv2~C*Db$Spg47O^;(Rr!AzN3niCpa^OQ6aDY=tH*?l*-26~=oP2!eR zl9)e+?S(gMMoHWc!@ulWJ;;Q>vO!x<7hs`pmWLubh9%qxKYyby{P~;kCFD5kvg|Rc zn440ii&QDNI1*L(id%zI^DQdHbcbHd!mI|OqjMrx_udPw%W7Kb>|YbE%d!s29tTYZL9hvPp9|IN_s5H&tD ztvsy#rP8JI2}jd@4ci07NT#ba95eGZ2R~^D-nVBwi_MG!IMtgDb;s{`aWn1N-sO%- zoz?H6=g~E*%Td2|23WcJdxN@f#-kAv`wag+2_Djqn?C?FV{61Uhncsiu15NaVayC@ z*yYK^vg_?ubwkO|E|WkBU*3^YQ9j?AS5_uWD#eRgTH4<9{^8Zr+us&+IRgnOixxHT zpa}*Lj1Kc7%m4cJ$t?|gCavCj#5<_XLdMZV*RxJdP1iu$N)iBJ=Qt@x!GG`3M3OF> ztq}D&XD3DJm2o7nOH5F!o37+}o|oulyZZdu|74|*>NF~Z^i4mSQ@xPrvd-V$hVV}z zU!;j7;SCQwi$}d8J3E3u1}=*bKky&*B++kt)$JhNDaw*W3=U?O@B7+QoVoXMKsY_@ z-lR8^baV>FDc78$0$A;qU#c2H(&p1Q@u{CI&Iu%kL(%meUPKko@T-eiFuKz9Bss3Y zs4mf=jL};gNIjLN`@y9++%#2`iYyuIaO9Q5_b2<>yi*emsw+={7X^9Fv)4O*i-rd6 zf3`j3X+3FPYC8lyf9hFc}{SgDNtn5~mc?rGo3@z5A!32OJ7IYql9p4lFydkJx!ae}CE4oL|d54aBiXxF2@l)mq96 zsH}s$%Mko1ti-P?$D+z(B!BVs&kr%|vzPoLT3;n#YJySkE%FZ!=w7Ls&jrvO$*h)v zJ$=m`dp1~l8UF2%|Du#ss^OK#QWKS5tv{-4TQ4Gx`p|} zV}*k|{KbL^KDlUPp3}ZaQQdW*xweO4TgCt!$gL&(SdRDJysmpI5p|j!eVh)yNAVxE zzy|G-%NO78`4t@+gWpxf(8Z3;s@6tEf9KXeQZ`2|yt7A659Vx%=LH2wXT9#XTaACw;-oP-=+X(O?o>=b>j|X!wd%ej4{J*Dh~7lusYW z{i-x-Ex|GC;#a3If9x_Jx|JLpPRRE*GRJiO4Vw@O1)4j39wm@7XFz10Cj3^^WkFv|cz zTcgx*S)p+;?8Jfnfj_eMmT7uPyZ(_eP!p=stN&T)^!VsbMbY8$P2e})Ix2^NI|{Q` zF#*VPF_|wrJFzp|EcSt9VC(-R&9aC6@x9qDWWYOzqrMNCrKU)!sh@p781gp{H{jU) zWN_1;I)Lk84VMm--t!d<>rdT!pl8;@x%u5Hs~Ha21qAy7{sL$K{wz&;;qdni{lNtU zJjLOURhLutD}uNOf_0u*yywHEM9%tV@X96gBg7);wq^(MrMMJa9bkd}AFMR6JG0tl zUgxVJg?ceR^6!ED@Ya$}D5l97Ln#SVv^fQ}&d(;GW$H=h*xc&5SD^nu%6_4E`Q?#} zmsWt`!OOy zK1xXI|7e@sGAx{qflQrSNnE+;R98+M{f4Y>XTFI%%$IsfdfAe2FtBxMC%(&It zelE(&^j}V|YByk1Kk2c9w; z_Z%=9mE4bP9r-D$bV#Xfzr4yCuC;8Ofp_W8AHSRO@B+*)D@VW^&Xb&CMPv*O*Zq=2 zR!Sc%VGtSYK3>Ptn$48!{gzX<3ZoF=m`g;?^j+FVC1YcCi$gX4M{0?wAlr(9XgoM z(L?Vw=pzUEc^@A-U`)BypKEcb4yI0At(pf+9kj#+xA4{xu$9q(yVUiqI#uHh?G>~p zoflewm+1(LOE9#^P?VnM=0@4OES~rMVpl+FJBQ%^K3GI%DPfSo^U1 z+U{gH=fwD)j4FAwv!x_OgWK$lZ1tP#h*TdY4zz62yGwSckc(7|M04lQsz0nPC#w{3 z=%}Ru^|wprXR46jP(OTo9SrcddK#_0ms(gePTr6a`Lc%pWI~$%Qz=QX;;lb)jyHI- zye=6UH=V6#J5^sL9G_Qwe`ESqr3~rMC#DTP)pN>?A<1hK#w7AuzC^U;Zvs>r(Xa8^ zqelJjOF{1mTQ6z8DwcrroESv3Mnr4ySlL%5zGNm*S2;gLpvkR5QVwJ_2j&ifk<$7+zrdoI>2ktOevU2r>*3=2@6nmn^0?Ar(5{Yh z729X|pd{U~;d!jH==ZyEp@;o@kT$CS=bd8`{|R@WMeRC7>FRP{a-N3CPMv-HAQ-V! zxbpXdxcjS(@9}g9lWOEtCTM+b)Pg}QztFdV{wvJ;1K8@JRn|JmH~35z{{}(6sGL(P z?u5lX*vBnk2>p2MUCN>M&lvmI#M^L^Z2@kB9W~)sHwdB-h0fj`SjQ9}!$$G*-7Irb z4l`S|)4e>2qGW}m)${2pZ60PXr=9H!EcMWeqc+ISc*`$=CCA4_HI)wQhuZfzyhFe29d4wDlxow_<`bN@iExjH@%|tCQyn4#91zW)~ zxp%tA{S~&f0wBPZ#vW3)^nzCY;?$hZ$?b}h-q80lyu}nhq?&&QzUWWJR+5TL?1H4< zhp1DI}*RoTtkrz4%gsyX5b>VuG{!qzDWENLOYirg*tSb+}x zotZ+~t*HAR-CvW^n9j|?&KtFVHfJqzat5zg5L&0T_JwvyIl(u~|K|G4#q*brS6j`M zgzA^(n8Xboy@Q6C)pgxhwX{l_Ep@s+&yvh#3q*=CN+k}i{b@_U?7gj)c2SuZwudmA zuwPhzax6!TZk;S%R`b9*|39AI#4XAEegB@avKdQSMRP&3vc{CLM$8Q~E1R(*M{`$7 zElW_xePOY3$_34>)N;$LG!@AO%ne#Z!QB)T*Ftc`1ylq?efWHz%7kM zbv_x)_Z>y=vV=fvaYJyY@+-Zb^-EW?Efi@6h7FRT;ip{=mh!}gucSW$9vLr8eNEC< zB%J(VGT2aFMFIlcy~z<{ncSJTh|VzXvq9*6@W&Tm3zE|}*7dC)mM_6jTF^5LNfFv! zv#Gu3Ilxy-41P+tP^XpmfY8iyY;9%a-L4UJ*5d{I+KX-fA_F}mCpcE{`ep#_ZQ=FT z{VuS_GS!;GR7^QChF=q~Spj2X7{t)G(9IHNi%mA@oTyrbbnkw&bJlfi2=5X7GHuZ9 zg_2fIJi&qF7Apa)R;QHpur68h6{l}`4(pp-5v)9FXN>>R_B7^QVH3pMyS$Zv7k4BU zsOIe_xBUHHYG!Ls>OQ4q8eulVS1ZpHo7GKa&T9M;>pQco{$aP}if`9EUY&d8-iM|) z;*TMMuhJ*xAPzBw>54;sTuE_;NT$BW<#y2I=_{01OApH&P5X3YQMH;BiePX5Mk_sq z*8{;R--#d&BIawOX;ew-dcK8u<6i#e*fx=`C{6RIWcXacLCIzK2A986OW8)4Cy>iyu)tKx0OqanPOW-oHS2 zsmpz=Z#jgi8ol?z>#dqI-IvGFO_>Q#423#c!&Ny<8Bs^94C2~pE?Jdjq zwW^?jnCk~V?yw*>@Y?i#R}&+hTHjQ0HJ{H&&Y8`85@HCW3>==dA!jB6X+G-KqOR;v zQdbXYcbA`1q9$0vxi2%UONq;KVZD#8Ds|X!-4`WtT58Hy2)Boyqjf&R&9_r5izd#i zi2qbkFh>Wr-0{NmOUA7asEd7Pg^6w8b9-Vqy%0bcW4X&~<9V`&*<|audz#A*Kwp=Z zW8_=VvHmmL93_1K@qYs_^8W@P$Oo*RJ>cayb^KrZhKH87u{)-e&HzjBRf>3}Ya>cK z(u&kU9^|MWA*?0g;KYT+-NPqcn=D^{KM&TTG}KNW)ji&!yfsWXIr6PV;ai6z*h%ZS zVI-tIPD@Ku$fd9EJ~mh6q?xqCc=66rVzjIkA0`GHn%+{FzsaA%D*%rA)hB|)eSWD} z01|ww`NWU(pU#B2l`nb|g#0yYQ7S2Z&fPM`rMk-&@vnSw+Wo@atoh?A&)4YbD*gLW zw6XpbpMZ@73lLA&soLr(JY?_8WXaNH-kG4==CL#%Sz0&>pnN8IjQF`>G^VNbp%MnT4(nwo=IjJ~yy>fFAImdG5Xj2x*GbI(M;_+{?|;~)6F3wS-~P?|HY>`pl0-d>`g z9hTy*9{EYySMJ2QSJ&J>ZbdVM21fvob$r{lz1DGWzCdfI&jGzTiUHC4Lqy2akg3@9 zUnkfn;*uFU!5U!W?839n82ts+iuC78Qe;rNf%By37xYvfwfo+N zR(0gBh-;jI*sqz_1V@y%eLMB2yX4CZx@f(`Q^6?RhIbm^xD|39PF%SJlZ5E%Quc}$ zHR@7l@iua|te6qG^iRs#J^nd&IT~fK9LS{_Rq)i zR9gEq!B`-?A=_}dg*}?NkI&vcy^DcPZ>F(!(z$-f7L|}nGj~}8x%%+Ceizgjwp?+F zHp0G6+4#0XXmoX_x|pw{zR!-E7~V6Wz^vw9x;Be-N6?PzC0XFAde}i2=6y{9!b7&l z#|R~(?T!j-v=fXyz_u|Pb5*$=TH7I~Cs31q0H$J$)t-|I1Oi4fqqS(5)u@t~O5o{K zNAaK6;6kEkYLGprafHz(bu?@tIt8%s62k-kd9TqU8mNQ+f!vwmjVx@H$?2o_=!(8;tWE4 z%WHPix^65P$+32*YkXHYq~li-QQqTQYxV4zWL&?qW<+AVB#SE4t23&pkxU&v+IC1& z)LEzeMfNo+;Qzh$K$Fb7aTD*}hCd3w)A$e@ys-O&B4S{7vIlN;=6+`1M0_UHJjEJj z3Vh%r2vgIm18gu4D%A^TE?%KMs*aySqHk&gc7dIxQ&yJZg&nijUx6Fk7`4NS!p~op zcsH+o*7An)6EugMD%K`#qCc)bcSnAOO<-TMl8B042$$-FQMSurbogi z&SWmp{sOIbWbZ@s()RrbvV>@9cia$-=<#lA@DLR!K^x>g`)y{vcR$!EcnFL-TgDqc z0f%?tiC}ei0Gak51biD0YdM8xyqFZRCti^u`3@U(jq#Q-yoQLIYh`0lQ>p)bP|cXv z-NM4sW_$hY5Z~fgKdTlr9M$W&I1kY!SU|7R_ z-tSYQ7ejrbbTJTRfK?paQvrn`*dFSPrc8i&PpiY(k0A)Q?6+Bj`9xQdAQNMH>2@W> z?P(N#e!k?R^B`4l656|1j3@1w)wbBE!=~_k$iPT>GY^3sEU0MDswFQC58N~q((VYrMtL^rDyMn{bc{i}4KQnq-|SGmez;rNPghc5dx z;&$FbemQ_Km0OXsx?M~v zFVn6gG$pfVd5y1*u2$n^bIz z;gGm`J5+U_IMq7LQ})dvrTy|E`a3{k{H5(6Etz4vp~a*j)XY$#b%_0-(^e*X zfTsUw#H`%`Px5olKTC?!aR1jwA%?y1#R@Th_j6q5x6exXV3p=eAB*>BU7;MA;oStm zulb4vX+_^oZKSYU_1C9npK_F2bCu2pxtp#X`i0w3xb6SBB-kSOUF={*csA11X@ZkF z`0duF+_l$`pnM#mS?hiAbF3NXmk7xLinJ*^Fo$QffRHjk#Se5h|LJ3U1n&X!<56y%=K^NmYEHYhNx< zB`mj^D9PTimVYS2{v#Np%k#GQW%d~-^!{)P-)|+%p8SnP2>*r*n5pj9>;-n(Z;W{9 z4MH!<#bk>J-j4#Sg$3C==kDHuAMkm*07?tv>G`kss>67@xid!_jW%-i3jHrWz;qp3*xuy~M&MKQwrBFso`_9f)R&(5&KMl-4N3)* zTJ3<0d(QX_zd^4>ixYUKLD%Z|*)Us9q}Cd6s*And{dipku_GzyEOVqKC!uvEMbkYhLMW z_U2t^lpB$iXC3`E2_HPHP@CluOR-naeuh`g_Lt~IMhF`H5R!{y5?n8LM58x6D9Kz? zWFIU7&j{QUwix{mNTZr!#JtvcB+;L`WkuCkKZ+@SBq|G;k1w$IVV2+R2{CSaFE%8Z)Nw!s%6 zeQQSvd5}Wy12q?h6wgVV50f)&8U9_QQxYZu#ufJ|F0{5dZMdBEe{ikR;`ZiKl3G%n zml=(j)0DG%@Ofzce;k@_@nZg&NsaoO+B5 zAmv+c@)V+_-4T%xciEc|B6QfYP(2fJ&MBMod*RIm>wSB{)NINt8+I8FZnww3Fiq=i zjc_d!nV;+oZJk#@CVq!KH9$So%x|JSxo1nZHUfk_53$C29pJ!e;rZ7b>+kZT$a>Y-BWP20G z4vFU$L(hRrLT4l@N@j4?iC zLvc%}-$=R^BE~GUHv*Ovy@RK%O<#b1-}8C;FlU7}-M(Xsl?e!uqL=V?`x~g`m+Rm5 zpD&JBNUB-uOvNFC_TOCk*KPitK?z4*2@5z$=3lZyF@2I$5qDQzeF{5Uos4;2%Yzr!qyd2)nv{)#{Md>SrX+1&?1 z`x_Lye#jr5b2yt6Zn$}2*zZ6CUtn$Mtq4Q#cKS-Z5iqFbR-VoVxjD}=0HQ0szhSpp z%jEBbRgB5+w`ZWRWZbe3|E@zU_~d>5o7LCL57%}-Rbs!J`7(6UkN+LTf4qL1on6{2 zR)}seyr&K9e8O#cWsqH=>M^u&+?uR(i)sp8ZnvYxE4xpnS7m31S&cG3$CZL<$sOsQ zTQjQ%81I7thqXJX!I%cIaQ@4a<)r9PB`Np&ymi41Ty0lXO;xRzr7w^7)4fn@Q+S5O z`bSx~VEsEH)c@%ac+Y9Qi1vw3zzor^(T-l+bW_KD3H!|5=ZE<-ORv$`2l@Gde^SJodZ|_H0p!rR6P%a&zdUf)T^MqTK!3C8?|S;q6zT^jfmexQA$J zR$hXTMftY4SIlxlKSaHTurb=$h?X`;W0W>!j+YnV)WJR*J2X6m_Ykv#|~-We)R-!h`qbCo#YHz z&W=em6tnf9!*;q!?QgDB5G3L@0*tjX87tg)6oO@ zUs5gT+L8MZpFtZ|m1tn6;KOAZOTNwvC-Ddw8dx7WbO)3^-G+V|X$Q+#Q#^#aB)bJN zW19Y`DOVZWJ@!}Wg~pDQ{=SmU%YlN!&&Kc)_eGqu2`5V4@`k%;H5v?s=r7Esvq~XCM4cyw{ zOc!p2NI(+hs`AQicnc6py~2?K8`SaW>L=9>UE;3_O)QtO)!DkGjxV1)~u8<;} zz&9Sd#VfszC_l9qVL?&Vh4)|run|RWU%PceMXxO1PDFnqAAr6E4wM};1Pr-lH|8w6fGKYV`e9E1w)M8ltBtFn-ir>KXx>eEzxg~+@@c_V@Z zMOaALO$RStcs_YN7rqO@cKdCu#)1EDc$T(lX`yCqIPM9`z>7g#So-l-77RTMjbChS zyg|e?t&HVmfi|Y(R_SB+si)N60UFnr>62ADsks2pbNOqS3oCA~<7N^R7fgYnJ^2MM zCA#{lAv(l}IeMWVV(I1L$AU+gO#N|h;yoSH1MtbPgS|evAny1Sb#35Y?u~k0V*`gl zdUedX1H%JVdt%YkMpvYz_2YIk+)RRhhGlhmD)>gYN~%$9q2W(=z51D&p2`aqaZv9P z3}lZlX8QX+X#6SJh{2^h=#b~FFwO{A;M_uSiKA>UdzMlbh zC`O_^-I&TtK1z9m!#BC7_Udh6g<2Tu*Fc6Pio4k2S^E~az^?B^b( zP3!KA=yFw;iiqG6?916W&AD%^e$D=^+whd6m!1dAp8jk&AQrDv!98Ivztc-gQ7T3oMptcu6NFoUFQgjs_`iP zF!c==h>%dCPJ$34YNM7N#O6BmVr#YE;OM*V-QK{|>-9^UzlcKoPI#Uxig{!j(p}xW z#BT)T|An)#H5=^K%?X8tdCg=RASf0+GorH{i0QP73oZWpxHCE{;;}npm$_Zx@amq_ z$Y)!;*OYqii)=+4zWCTMhEpSs1}dnL`hpPw7$I zx zDzQCs3<|<3`QJj9HOGPbSUOm2yqe2AGOc1=xAQ%OOfBT5q1uM-z=yQUbAqDhhOV{G}*AE_F!Ikko8 zdzl)sQN9O%_~{k$+JiQ%-SZxyL@Y9Ee4y1Ka+7dg&MBXVaF8ZE!SdTwWw2t3;3 zi4MSuI_fUCrz(-tnzHDIKTlE(wuCKu%A0ndvs@r#*^YYQRmE5Fq{L27uTuD_n6FI4 z?}f}}QLXQ5l}ZiY^+d|o%;p1NciR5hQPLA`=6?Od98dPY0hF(;qTkq`F4b9nhd%DM zC1)2L*q&0YtQ-#a8Z+52w7N0kI${<-b&=e$J7cM{F}?xTppXHFzy^u9wS$qD45LHG zE~fz^5j~UG2&=WOD_hI2`dNsrlRw}%dNb?TV-2wjtOFQpDyPH{#a$01BNrNM)+r`a z)JAG_)hz`PL`(jf%db>vc|c9DKg+}n?s{2n5D|QQi&hmp6&YHrFx5XY#CT5JIy4Zt zZv+fYvqAnl*?mv&5Vva({5v3m3}M3uhb-uXm;}XlHWUd8S*#gHeieNWUD)Pe7XXRN z5zp^Sues43V0^0h-MnPc^JApnQnly`ZUoIGoL~0S0wZ`i9_Zu#6MsSw21DoGHy)t} zJd^Yq$~#;5!2jjij{MJ{7u8bUF>O903{i{g=+AcA3O#1XG2G)<`r5lowSZ*)Bh`-LJYK)TC9V6gs5ic(ki$s8 zS7C`3CpAOCD~0A7w`<#|FzIyMt- zKf~ha?;XZy4>rvsTX`o{7FcCN+Bll=EkYm9Dd(linU&C_~*MJbI8--p^b<15m z7wS6zDO_c2*ssFnQ6T6W=N|4e>e=%Vp*a#OY>mU{Vvo#C!`LA`@^ZKIDpPDV z`+Dp`mQuaHj;%lx_-tT*?BMV2wC4o=WFqZCG_-{jK6t88V4K4DP%b6uDWFkfIX5kO zRcwrE7+JEL=ca}MW8mzE8asoBQ@2ikWA{$m?eiU)wo~qo-|SWUqYX5d>=-HKxp-J> zOx-lS%sZh-HtX4&s=1PuBC7FdSQ4KcQJXvOPEN}?Xd3)>LhGm=j&vAd{2%9%f5vsu z_oIa|$0iZphih9=Ua&64ueB)Tq-S(Q%kfx&8gYWV0vIu&?xK;J%n^-buR8&Eb(=Ux zZK7>3rPsHQVxM#si8zdVG35YwHS5te1COy6sdYEwNgGEEvg*!df8Kf!6cIRRGO)Ev z&Sb@z)pb{xfA$IlMNYjL8%f*ec)ltE%subbb5TCdE@4c+R>Cc$QuWYtuX`wN5Aa5o zj+&B23;FsydOOsrwO3U<5tXz%-N@N}p*^&XQ(3^fZ%}c)8VN`mQ56`p6};g2Rpu;5 zYAy?VA{;BFT|B%zh1NJU{sp;x1Z;lrz8n`2tdeVrQ=uuy>QZN_3W@ymt|hW>OO~b2 zTQIfN_ZV^>Tx}0xIg54>8>(nHN^kos2b(7M!&3GYoiQ$Rx7b4-&|8~rR1L{*Mx_-i z(BiYlSY<8{M17(rTPci@jTQ{B6r&^8Klcsi?W> z|GnPK!)8Z2rjLrwC3*bqnecjz_afG4?%cxnJ%Dz@VMBMo612qzc+T9=3-H@O_L=5S zFYTN(q=plQ-jjycutuMH@p|5h)Oa%(_Vn9Atf17Pele~d*sE1p8h;b4XX#jGOvNl@ zJ6^5eOVZf!E>P_WcG?o_H3qN#{U=pg%z9XeaaBY-bA=(2f3978cXBY>aJ^#(xjcUO zMJnY2ubdLH0Q-4w^i^LMuyODd{rV!;y>N;|xA?Ajj`N@ zW}jjbK4t6|42?KW&HT{huFUJ%gpic#Ur|mr4GYu! z!3oQYS#nyT>v_NOm1g5pZQ!zd&ai^DGf`_O2qAp?dRK#H%cZp@^oucdfE4id#G{lN z9JDs7^nAm)tIDPI!+R^0{r62R1Wdo(U`S>v>(fIZz&ALg9ygYZ~92K!HH zW6m9GG5?L~I|Q~BX?xX2EG15|C?xL=kNNmy-SFAUZg}*ElOWO<9F>;cHXbBN89IPK z%HLX&N1Wo02;=u1dn`}iKz?}FMwV_($8Jprtr4{N&OW4t)SolMNXhR7}s~lWo5QMh6hN=V6J_pTvJmdFv1tNQoWd=}&gsB;%8>McwI38?xq_+`Gy6tKme&-p7Nk-&PV%C7X(#O~t# z#`gMg8Sdh~{I{}K7a`S`jLn&yX8FV7(NBH=I)-5Cux~h4?vZtuMn~IC@|xXROf%mMeE^SGzaS zJg%21{NwKPM>eX#(xjGlQMuY7j}R$pVb*+WCQfV}1TXhX{a1Rf82#BDvGo{7`Xl?g zQ6>@UD=dPuFuMkoXTY6xij1J`*2|G+U{fuZ0PP2thjxXqnQx{9PN`U*Xd5FzTxYHg zFAHi)@FSC!&#u?of#6+Y-NRLi9dTk3W~L@xvr5MYnL)t`Uti{A)~r7nS6i05Gg?vY zFRqzZ)sepMk)^>)iDOZ>rvqbW<)O8t9zZcjrfgVh_@TL?p!Z!U`1pX0O`#^jODEeG z7z$7V_yhP_!_bcs@2+o+cCVW7eTsh~X0!pxUc(K~8&RZ``I?hjxJXJ)hbN3`nP$^@1CtwOuxXjB4-t{N=XN^EgvN_(t2)46K-tiu{l>-y&czCtrrTX z*!tuH+rz)NrmQd^Z@wA+quw;d-Wj2-xl3R(iLoICr3Oj|#nYJM$TPf#0(z7CL z#D~zs`eim3u|XKaCBD@XGmX>0pxZr?;3f7_H)z8d0I+&xGK zn?<35pnbf3m@>P_OOcTva#D(Cr18jXVq5^hsC0+GEH}ng&-r*xq_Bj z5|Gjmx+Rkb2d`|cJ+J4o!DO1SP>OLX9;W5nE&bC=ji|g9#j$*prx8>zGJXEBIQ9tJ zt0CGmp(kdS+4A2@<&s!E;Zbqz^rD(I?-8|%kRqLZ{o-zMv!*=ITNAWxgCUs4teW>I znTbV|EW~=#3jb{Nj_&N0@2R`Gk4rptDKk-C>$Z+j+yj<=sTe_nLYcbjR=%J7g282k z!J+^HpE0>*PpU5QX{3x!s}FUbLVNq_7LMuC3i*{qE(1GeGR{wo{nxM|USM~EV3Jz82^?Gf0SqDJEa(-2R%>(u4Wa|0O-iN+!IXwcc0%W^*cjjC zmb36(GP=EGnICBf`JqQZbiDV(+JZ(xU8su}w*xOH4cxres8wn?h2l4wQ*v$!J}RN+ z{Nmuf@PccCKW_lQo|7Tp;M7f0qH*T=Q#1yS$7XfuNoL= z;2C{kse5x=hdWy{c@2Nk661JQDLDNo9%lrEllnO|@fmh)O;M!N7Lw6mh)Lv-3)fx- zq&Zl+#|hzA5FYGH{!g9J8!0R91yRyrZptHmyY?3Co~L$!0BSxeX;#Yd`=&WjQ=3!m zu4RQos)7uuIsHGuh3vK-Ky(bFtueat+J+(tH`V)C`EQVQ16T4 zIs1dNV9S}r+-wTzV^6;2MB!@Xw|i#1N6F=fm)W6%P|`T>t6Wq+;JOjO9?QGEa;LE# z)oZlmk)vnphb%{QPTf3RXvZt@tY0vBsyD6(!T|p-fTk(RkpAXrHe5cvmA0Z|I>3AJ2PLjV59zKI%82ufva=`;jIhu5Lo=_v1-_rkovCKk$u^7+45s@ zW9jVb^3_N%M&5K~}a)pR%g@f8ZqqT-wd+E}g}$FFJ5EFzoLDf68Vn{k(`6@~FBYE@6%6eQJ+ z0wmkpy$}Oku9e4Mpw(_Z(3?`E%>v%IIfZEU)&b_$Y?tOGQIwII&A4SdX7Hi0f7S-_ zuE7h2y?+lv_l;M!ikS%&(wM}{C?^29uazX&X^v_HEkshP*;%@C?6EL4ihe4#uLT9NC-M%;tBHWClE)*J8WmgrM7>+LUH0|C3P}PM zqN!ToSwWp)^t`eBPldQzIqED&FdlWfvHcgZLH;=4-2p6J7#7S`SpHWx{f1JblA0IV zXGy|HMGzRWM&8=mRx%Qr*JMtJG+a+wsfj$?9EQHP-u-YIrQ`R^fMSMpGcwCfu=LB< zh^7qP?m#~TwaM&S{})b#Z3$9iWvz$xJtJl!;Z~9t#aUg=@EIpNY$-+fH;_0?@56c) z%o*M|cN5Dkx+esx=b}EDNc{JA_OoL+_*)&Ksl5_?r^&F6TL@IhVZGzIno#C(R|vg> z=x6^&{ERML?m2$8v1rJAw zO3r_G%Xso)8b--k{xS6y(L_^;omXN$HwfVrIdrvfCnWskq(W7PivQB%3vc{0>h~Qnk_`1X4j`DC%wJP&I&)NdHS$qmXKRMXinB?5nuknNF64@vqmqn0 z%kmh|sQ=rh6HA;bpZG`i1UsNMH=3C4S&fX{Y!)g> zZmYk5K@s`8L&r|a=A3m!qy>Q}Y{P8iQL{YW-R0$12-wBV15SH@s@1|p51SX`IFpKU zJ(G94vZno+N@soQ=(hLoDz9zG(3qXLE!_y6!Y&)5oc<(4ck^~M*vNKVUcad*TPt}M za$uuUefdSKEUfxbnM2H!_*Pp1keO$&$vLWTI)5q^Q$N9U)PIjDk^$8bc7jO5eC93P zsv{#p5>Ext^4M7;O*Z#NUFkQeI{fOM)I!Y98t2Z}sX$g1OM~rOt%xK_Li|A|3a?xE zUT@MxqFK}E57ODCSGKHzpmXet&31|3D5#)&iX>;@Zb3)A>Z$;p)z0=1F=``M6p-dE zHnR^R12?=;*BOLPx%9W|{~wJFzZCXfUYYwk`_K0V4bKe2)02kxfoD8{#W=tU{YetM z?ebjQgYAn0@fO=jpMhsKz(9+$4S%vz8Z=1ug2e0iAAdzA<_)!+PW4{)O4TFa2{>_B${4O#xz!UTqU7stm$y#Pz*s_P#|Xpbdv2YY?f8EDd%$j@S0$jDq;W|*gM_Il8{R@`+ZR~`jz=xd8HR5 zRZIL1T=JQ^xg_~9-EFJiP5X}$WsbGE^EELuYk&Af-rp39bnyW%@+w>3`8f45<|>sNcFT`Io%o7~wrR*d9LIhay$R~pvtfGB@|)sj!M zRI+;NSv6!n_Lt~4t&viVj?3z)1{>p0TYlyP#L3)1DbE&UjCdw0(J)7J1)Ux7!=unU z!DU*sqN63RwAX1{`c>RCjUncQxQO(dSaQmixYBisEiyZFc*A>G>j(ojlX9%Zm;*Jk4p1G}@fsnQX)sWTI!{yn{ z|F$i2^l27OC^Nr%S&)h7G-QF6Jgiv zLAT>>to=cbm+t(Y`hcl1lbG)rZm2j<3Z)UJ*oT0WW9dI@EKB5Xx{aMjb5%Y(5!3I* zb@}h)e)d4$2)tTYU?EvR?D;bu(RC1t4s(jds>bCs0J!=$AXb>LGP`=!6}dg{a%;#h zqG7r5^Mh~GW16dgrjio(lS!wSf8}Xc3dc0&YuJE! zi~w2bF~k}yi?c{-t`~A`V%Mzr{8xaf5#+)~_t~!{h~%+yssBl*O>ZY)_+w50?0!w% zZTD-;Q|gk>V88$xx&CS;aVRL&N;GsE{EuR|Lm{ikW%dfnfMD_1JE<&s%~n6#(^MO4 z5nkln$*@sJjZ51J9%`NuYM(1&G!sseS0u@}E>`uZzcNl!v;5ka*f0 z34k?qEFGo1qC$Y?gIWsc=q1ZluI>aJ$_cP@8kfpF1fr9LR#ymyu@uw|$gZxQ66_=;l^1jPSen8MW3wWn6 zf>3jOCi{h5is9&is&{bPQ=1zYiZ_{(4;E)-V40i9G2tYVD!E)z&G#uOcBe*NZlUUrqvFiWbK2|N~k_K z;pLL(7}K6`8?|g~Ke_{@txQblE`#0iOLj3JaG%XX{G*{VB#aVw9U4EV9-AI&3E1`y%EF<4@o*@Y0+50PybM zET9ELexYZ1xr~d5uqeNY(M&>E<-$YiDtEHIe1rBvPQ%Jf-MxWe{KxV74W+$Ni95IO zV6(CC4R=t*8!*BCW3fJg7!<2J-Ca`y_%d~%o^S^zd~gGWgcWik;#cGEFCMH$UzxoN zn2B^wIZefgUgn8h?_snm;#sRSVV^pt zw@ZtnDwnoe`N9$N*A4PQ0edy}tp4)2jDv z&p5O^z22Mc!ic~@3cRg+XA`L59aln0Om#5=ZO0DutnRo`HPde!b`kf8xH{<^gpJ_p zsi0Nag`(>lZU&k5<(R52r{G5{3(4Fm=%#;{7nWjX!_U<1xv_Rpl8zq|2wkts8`llZ z#lpQ}?nr2Uyl8_}-;i)HoS2m9Nq%@%Zsu;}+kO;&RxArLDBF*Ynw86gZ@RNh9mm7i z2R1S-2`**Mf-7_OutslPBBAn&?A=GwJ$#p_*iDB#bkryOdflt$H?(K$v#mrf7&I<< zf+7~mn_Y^hD)W&+8*sXpaa>p>!PoxNrl!p#5}7_OueyvRKcYl$?0vLZjTX$oBq?<= z=2*R09^0cHn>1eZIDsszBc^oOVD1~f(I;~A6{gASYE9h$ww0Ggw~6WcVNJi%^R~F~ zGLR*1$S|VUFKEf4N-l*j1bBWHC#p#LzZ>_E8|e02tY4;>P`!Ip=ysZ1mx8V! zcS55ssnv46?47xt26kz1J1BOE!3orC>{zWq=3Cf^&jAx{4HICHo8fnyM^udqWyiHl zs}ent`@DanWiPo^({|D5feYVXJkir~l^iKnc_O>tWm9brsly@VcsDRya!QHt!gzaL z-cQu%hq+1}#v?2V*rg^ZrxQX&EpAlTi*(rqljDsWhORO${o|eF9z{;e$q`V1!FPsmgOWtIM7PhHe(0vM+?xe-Hl< zeITkx_|9Xy-UhG-gDAVt2(MB=+&&9kVcfR?nyAT<71;(t+B5pP_VN!aS~J8$+T3)1 z;{b6Yu2gY{rKt_{CiI}InXmorLeGen0bn?d3?O(x=}E<6@+r=AE}!{Laf@~dFx#d8 zxq0rUa>(>~7@xew;lX8+yC$ZPnV+{(Wylov`s2Y4oBB&UI5~&T{BFat!_rl3v~4HG zbxS;5(GAAS-jBqUr$(|;qhqj=68Nd#?@?9|qo1!l=T{ni*9+3R3tSS~BM%S!68`>? zh9eBeevQ0t(k8W1p1E5rkrj8?LCpnayS*EwLjcZC#OP{+!zgIs=<{n;k(K6(dtv`5 zh-L&Gz<>M;l1Mq;Eo#xD}Z83kbAYHjevHdccqJsn)yKBpVRz2>zka6TcJv z8r%Eob8Bst@iVWY`WK$RrLY5wUe=L7{|x1-nU-c5)Zwx1#*_C@X!RAO*K z5|nXkorh5S+(^E2cYFKFbjV<3b8-^FSl)5>y9@HFRBIS;*J#(_vI@lB$?XR#HIiZ%T8IGT z`Su6{56gtM9{oSJk0=cwa7NZfPvnQ?HMhsPgYRgXiV(N{?!73?XFsC={CLs%st|U! z@{v#>O^4ilbNZ<=#mGHBU-w}V+~CO zf%(`hNK5H?w*GYd!DkEC10dJa_nw0{eRlvj4>A?E8g*O7LVH{+8_knQqt*RxuSHjC zjV=r5OQF|CR`D0lM;ESGJsP71zB+e%^{0qgy7oE9umwN!pZ>-d#ijpyMNWL7jqcW>9E%Uj zjZ~X${KJz>zw1AWe^R9q{<5*x6e z=_6RMIUQZ^bQpI$lu>mVuw#N&1}d|`zSUycQJdJnY@jK^E%7{zQ>r4v0}%Q+<3F!V ztrT@n$qR~V!x%ZKEteE$-9a0j!&P5mjd<}I!qE|cZ#Liz&Gg7Q-faq z2!>{%<~fFQP&5Hk|K0|sPMY1BD|Zyk-%5@ed~cLy?OUBm2x*U3c@@uHrcdeqePzO< zfyrpNfZR)rM)C{=wknjIlX`&>753r2KonSZ~_T z5Odv;Xx}y-J;Hc-M>Qa$)%!Lv&*W)JIn?_+jFtoLeKp_YpJH$99onPhQP^?VZ|wx} zY4?c`sJpv}?yOE>A1Cg~pGW2T)cO6r9b^tVAU1*r&I-Nm+#P2aRLV5V7oJhSwlm?d z$0T)dZRJO-i{`3h?gFA>-$&}|u4>umb`MD;bk?>tdy9B_OQdsdin!?ks~=wI#}7v1 zo%04MtbFb>p+>lEc((NxL+2`J=%hn{)dV{RxOUqP z$G>G8nbe@O;@<}--n9A)7`RZ~;VfC@?=aGhIGA=6L>&v>veO^S^maNg|G;01|39MM z#4YJGY{Q;%${I^@EYV!BtgJC*v{5q^H7jc@mlknDN-a%L#|<|?%PAK!HOnQp%t}*n zN5utl5;xop1=m8r4K)@~aQk@Q_xQf=U*I@+e)s)6*L9w(Yw-a)UAUo4f6rBMv93`t zi*gxQJ(cT(j&LP4g^M#&3|I3$uib2LbxIMLm_ul)gi4|KJ=l)0Gqbxr6Emuc2Z*{S zW<7uRf{3-Ddcoi`{)WEx%GLr$;$0d1MOsf5_WDi*SjB|;*>EM&wRc1O+%qGD@G-DA zW3v6G{CrY!Ua%Y`q4T+6*CV4k?yD08I~^bT;&;}H>`8_MJ<%u3h@^h3)bZ{P<)p!Ot^FbPm*~xadfWPaaqU_^*;wdrVcO0MQtzFa3H?Av;(VSR3gHc8J33C zCmA*~-hp^e-YK(g+F|NAywa}4HE_Xl^WulYeYJfn9sgi5>_Z6Me_>BvmzU}gC*bCw0+|eTCZPd7i&5AfuPtaWVeLU2O-g&3~tw<7;P#0c=3ss0 z)X2CetqCM#1Qpawp*IT-{f2zCywhh7sX4qdv=TU%ua>0^???V>w7PBSgv^(PP*0*5 z=O58sze6iOY9p5$0OCsd{K))*m4o4k5Zd2V=>~qPVDVm`LkQ)#lLx#^FW4!XkM7EY z6HXLDpBqudUd?b7YaFBPzLZlJR^qf(lucHigb{2y zTuA)2^{)77F`ydO3#(_j*SL}>`}AO$Rmwk`Po>Ys+Xqd8ZJq4SM+g;E_!`GaYJctz zVTqScX!d)^ud$y>yK;kH;|tKd%08n%IEz;vfqsuI)=+>`XmJM(JLP9wNo(tr6pP?w z!40J(V>8MJifs!1qu&>7kS10j)A5d!iq)@~kzUmJ$gh3TlmD=PS&=YgGg=yNWDcq4 zjMlmOF^*|l1Xp*qo>wmJw8QX&&l>xOP?9opol&>6s#CSVP_HY+7cP%AzST5v02#{C zT+AeHGQ2%5`c=(dd_0a6sh_bV*<&ztQbj@m3P(OyMBs1u^ivBa`|c@%O40gK$?#8vi3yaT9pR#3stE{o~veVSXY6^2O-LJ^F?P&H%1#k=BCoQ z+E~)&95a@5Q~&7hM_jR3nevDpY!p4cv?Sz!IqHAklS6Mn_(m8xfy?l3k`RjNk zrdU=-MyC?KLzzHt6V_m63*Q;Iyc_k)&F1Ufu}XN4ma6FAyWaCpG>6{_r%gK!GJJdU z&1Y2Nwgd|;k?@5V7p*sjl0R>xDNhz|pJl_&kUyEaef;Xc2uc`|n4{Z`lPTu%9MT=?u2TAIa9Lx%W5JQJ}Q zca+r2E0m{QCLwDX<0^BNk>Xll_eU(D9HvCuVITE6};P_Bxql+aCAGl}Agi}r+h>ugTR zC6qg#lyIwxEAaQ~9jj}L0!fX@v^}La%mgKu@VY^)=C`k&B%fo}l9cg^*DSu98SPKqr#3Uh9ATJkp+a2OxT zK)H9qk?VV!5uiGx|9K9hXwKxjImHyWE<2|mtxzyAqyL+@CBfb)2Jvy(T#Bvm9pYRj zH{Z}H_Iu{zf$T;iB@v;c9gu<-K*|>~(Nn>AFREyt$%pCbY>{aSzu%(?JztsP_n-Xx z%;kg^Cc%Yak5ZyVh0`g0w7`F|E?>6!MtTam|1U03Av!x$?6*XY zllx5Vf4J~q=@l)CNRO|y72gIH;J#574f@Xvll9k*e9Sb1SRjvgh7{tyW1>q!eKGzZ`sWeuz7JrPdZnuBlSinKgpIwryXMzvy|%Bb zO;Dw7X4s9_*6^KJ<)3AzW46*2bW|7O>Ybx~7b@Xf-ov`U*A|%XDU;(kOIxR#2?2(; z=V(v3Doa|J;LMFWJ2&mH5+zRgXUR2gVqsK$=I}(+;#|?iBpeu$VQ;6C!ECO66Js(i z!(80=9BtHfPw|Vj!y$#{C28JBL`^fp>VxjYqK_W0wIS1`kZ48wo9qeO z0<7fS>ear?cPxr;UO9AbNO@tx&6{7eKiKNa{@=J|xXr)aZlMnMuy2R-$rLQdYl}^< zZT-}Kj#XZx7*DV0mh>xl%l_;EvWr{qw**IU%Ce(U&z4Ia$kD(zvP5r3O>KE1ROZTav)79Gn{BX~)xfRNVr45N zt%hC~A#92>TAglo4XM*a*ikk9s0da}A++6zXYn>(gLd6im#ix;b@iENq3g%(nXk(x zlM-*5`1Reh)onJu_AMpFuO~xt0M!f&yT-h-pM-pbauw`Hg$!3xwq0O@}KqAO4_ z%KNaC;VAx|j=V(X1)BoA)Ot--1Pq;<^Yn)q+Y8V?9=mBrju(w~HYx`$54U<(Tuc^F zoOUlOGmMe%kna~6S%(cB#<+`G#B_yb!jE`#^?QE#Luq~Wt{SDZ4=_VBViq}{4Bqhc zyH&Gq!8emG6B&E)5>zLSZuqDe0-5T|v`0%hHO-V8#$=?oTs2|Ml5thSh+{rq{>pLd zU2=0X3+*OU;2*F5THrmexsxnVu=o}z-vu`3>6tSQA;Kqc)B)7dQ3!Ua${^K4uxhE- zY&?CnMOEfJ*o?6upO4gCeGFlZysb|eFH%Jq;-E1Prys1%HM-btgIz8aV9OMK@u&!RRwcvnP%i` zpXJ{ZLW1UGh`|iApIwiNC(GTN48=2YuM8-;QeiL3O73B2+d)M^pr5qXx)u@2GpYY(08`-?R z`m+9`<}BgJxxl-V-J=!wk9b3Om+BwcHt48n&6xJJKTsI_r8Ux9z@>iqn(+6c-@K{n z%n z>>T*tW}RuHbCdg1x$~0Wyhoo?<%wnuGY==&z@L2fQ|{iC6Gw=tgbhi8e+^6$3xK_5 ziNkrDOUi(~czuk45C_lEi_tiFpq*2r9r*G^b^Mb|W59m6S@!Cl;Y`D=NQE}42HcT& z0%ffqYf>LQ$WuQi;5?a+isemZhSC7!Oa;Q1G7>8(E>D67?Mj$9(7+{8RUF?FYPL|7 zp0CEbIzU%*iSp!H<&v@_H6_Ofbpp>8Gj$>U`X>b?QS8iH@NYkV?2FTwL6*9N(ZDuW z_Ak^@EQKEMBkiO93Y(I#b5J@ zewjC&W5zpN&l>#;1POUG_<8=Z9Q}e+d;iUBwMfV^$fpV{aW(Zn1(b{@r%&DQ^&vpR zgM5pU@n}o(TH+To_)?0Rr>vnK{7Ytm`MB)$bpVljg>r=M;?`Z_wst3O@s;_Yjj(Lw zPHPhUmaxt2C=@$OtAVY!jc|@&;h{yOZwU2o|HUK19JP!r%M)h&O7ZZUQhJdu`_o zi@HvnV>RN?NBB3&(13%Nz{yW`k}ZfOwT#*?+q7+4qtu6ABQ5(6)a+86&NIV2ByBHV z1Z^%?#00Sv6We5${ud7p80X}gHz8vIlh`Ati?43V`mH=NNlXMcy2BGd&FSAq z)OJIysHpXpOC{AA0f-xwwU)(MU26e$pvp^02iH9AThtt*_dxRe{M5inz?iYR2)0V1 z{vRWyz+YBkWDya?gm1Iax|jYjjf!~02}=h;y|s63*` z+0xCu1nr>zOqldl4U|*6vv^d|BZ}s(UY@d97Iq?J`_sUv&fkIO+%+QqoW=@()R@zP zf4z{YKVA6jGzF-G0%hrED~Z_BPc`HPGMMfaa0>v-Ax%=!49Lt@wt88&3=~IlJrN-W>CG?2)xQFBwm0 zT|sa3|JS%?NDh+Oq%Dp9-7CIKxdR)*DvhjH%pZCb5BKShHXAnf84w2CAkocr^6vOR z0~~{ZZsCd5^zh{R{`(c~O5RVgS1cHB#Q*Q3^GqS`iYi9dJ}M12_HmBMjXM&0u<1)I za$C>Ai!V&2strHWi~9D_clu*aF7>$C28_8Kb~EP0ERHDrI)2$)xpukm<3rU*=ZLJe zqAQ?3DBL~&*#I=)hY~-^+M|Zv(*-^^KRLhX`+Ua>^BR`W2?yt6ctyu-{Q-23zb&aw z*m^h>v^g5|@JN<5vQT6r34SFv4Br$+&EqOB;!<*>v;b_ADaT0 zgr<@*wFs^dow*JDbIg@pQ0`7IEC65W$c>s$f998pU(}2txoTbNKBfvo8&Rbi;8gH8 zm6K3VHWd~2_j9Z?q!@u$JxcAk>+UVYdCe(&*M*xc`s5{j&SjikS!5o~5F>uDrBVUy0 z`$5Qq&Uu5=D&tJqpv!9xor``i)iM4%UD>t`=sHe*i8$G!b#a8~Z+|N8QbROkkpHT$ zLMiD)xs;YlV}4zX4{s6H9~*g!47GyfA)?K9kM&V*cTDo(}GRV`Q=lnU0fWzHg1|l1WRm4&t5LuTPx4 zROaf_3d(Lzm;s!lk(xV|?`3vKXpKfpP@OsGC+%J}CiD{ggPJSi$o5tlWty;Y}Ia%pIS z@Dzzl@8hh|u9v$SogglDk=L$xR$>`9D=+!AsZB&IzHBE+IYDy=x<6WUye`V^I$A{M zAC6$2JEQ3}-E@WH8W?trx_I6mksClf6%W067S0|gb}GuvkG%q8&w{ESQx&CJh!YZu z<)~|^8zRZaPQ#T)(8d8DT1aYAD)Z@d;u;-tc2x@y&)yg43g?AzdsjH`+tN z7#Kowt1Q`OpivuVHL9yAsFD;iLRaG*R6VVcz&Lm2ip?Qcqf5ZPbnslCtdPgBdk)ws z8vT_GpK;NbMK}4-XH6|EAm+V3MXtMq9GoPY0*K`F^?|n#0);UcRB+2vU zZa-dEQ*P_O4%t3j++loV>QP;1)Zs9R5AuP7?BR&1P5Bm!+lHNX1kMam z5cz8&rA5k#&2-gIXdWH2;!DlD!HD1?&avfun>4oAYcuT`<@7wcuj=Z`|(F6X^XSc8}8H zzNhX0g;S$`&bS%n?y`s|g``qx#u9G6^L}f_`LZFdeen2N@V<@I+~cgT%3YdG*Ui|e zd74SO?>e}5uAK)*o#7kb{o!iA{3gh*GEP1UAaWDCdamH?DMca4Yy`KOYy<{jQJ zHN&t3OFNnZ5Kvyfq>pdXDvyu8a+G-oSLY|cbMHP1=z&JxyxI3dCg%uwvM^&gIB?)K zRR2T#PxOx^i{@b}0{oHk;Z_4S1o=9B)H!#Nh6}XtEIF1CuQqt062)qDU&Yj{ooUAC z*FC2+A5GFJD3pX_8J|(!eSzCAMy#j1gD>K(ruVS0rG_{TKbJLQI)@g z27eTpTFOtIW_D7YA{(6eN9+fdR_>s;^Jh3znsWe)?pa{&Wq@}ysi7VBHP&u&C0v!T z_>@oeO+Vv{U$!bHDX?a0<0qv}s`gdARoHDf)>|5->EI@msg)hu6=Kp#>{ztP-F2F2 zN$a<$@>b?&4dh(ImYX6ZYMPli(-_?d(%jsW8es8_5QE#Z@xYpDQALHgExY08a(rO$ zFA3V}zI}DH9Cd<%eb|GTfmEzlQ1uh~HN0t6H)%8%qV9Dzg+sG!k=C9Ic2t@pep1>j zOfW}4%yiwLyFPadu=>ZWgH{D@9vs{`?|1-4pNEsByq-xln_&?=3uiRA=il>VnZHyg z+}qg@9dBmz7=4JRUuLO}#4%lC4s6ttTn#7>CrMYtuR;tuD5bj73CY6tTiPm1@9hWZ zXrGU@b%wHh^f5rIpLNFe*89al*J^1ItF=s6> zJ3O3=`5?#gxjbBG6c3ZT0>x}}W4#agbs7!oSJXGJcFnt$HOqdJO)9!r7;!(+_J;_b zT)S?!bBv@VkVnsfSfTzN9@V`in}kDv)9^4Gajd3Y;=j{VVq^QHl? zw>lOANr{OrNL9zpH8`}VTZ2DoTfe116#6+L8oMlp!7=_V39!3%3)bRq*Oue7b3A1* zf69to{u&*|^++MKB0|^n?D}G1>I}2XDQHoOhwyGNKiP@Vh@PRnAKe|F6!dDGiuXy@ zT7S0QMjEl&uKqBvzg4w*$}~3o=qdwp=VD9*bDdikUf02*C7%DiHn;sj;N!Sl9NZQz zN89Rw?y~OtyZ<(^`~QuCZTl3TnUW%!LPfzS{pQe3+n~%^vBsgz_pia3z98qQ2-TdB zp(x*o>w`gQ;f(c<`(02AkEOBYlr9nU8*71GU~kX?t3va-8*<$T*UbNtJl!ApXM|Gz$O({&F)m;~%@UjCQf?G#qR;llRns?>#0 zexc>T?%q5*WeNWKQ{&>Qq|4F&TT7{>?vTVS>b@j&|N%$rh54Q5a_NRI{8 zldu)%e^9j3Vg6?Rukn5#Kj9zv9AxDt2fK}%lMN5DGj=%}GsOP0+04fUM=zLMuiXBX z{W7+fPl-HhrDQMx7-9>2Op%pFeg3)4ggNFq+OTj z=N`JvECR)&mF0}&81f(^XscfDbnE*sHdZ|XExv~jga>A6mHE3LmYLZ4947j~8IEdSCH-L} zqE(tcyD8XMq~a=TPc(+@r_z`{+-2ll~Wr>s)nLuTO7=-)G2u+5~2D`{!st@pb}%1rQ5piqMUs6 zIh9$xX%BK<(9^{H+DB{~IMS70;@TiWnm{)!oh<&?&lk?8g5|wuu1a@bz0&%3cn$@? zxQ2d{UazcaDi=94@)jywxv*4Ltbw zxZ?|RGHHbq9;4E!QQTioFO$U(JSJG|SbHP!==s03-vg!jbJOP=2_Ucb%&eb+Cj%Cx z9)7p`OSWHuy->Y-@}|IxGAus4LRf0zD{Z+T4!O2JTB3A}-)-Q&mkeHEpjxIA9mjK2Ot#k?nT8 z9!L4KAY%7vQ|}pts+@9qO`qL$lDn&P5WpKh(sdD-e{GTp2c$jWyGc1)=}$)g#+A15 z-`}rj3N*LoZ;bOR`@;2&`(IvEl`+}oB!iz2xhF_mQ~zK_C7?TgZRp~3KY@&|CWXs- z`NvqsqqfWPl*_f75XwIqMj^5hW5PVUnWgV*Q-@t3?L+J1JE;Svh*kU+e{5%XZo~r^ zUSLIc0O<1%v!!7G&m~wstroq2OkOIM3oY=5YFdJC7O9>{}V;)_hz2-G7?B^dCx$deHQbl(<#1{XeD&Q9)2hTQhfaDZ=1; z;eQ_BLnX3*>-(Bp(!0oNQEfr`0>DOxc}rB*TCCTAjCPDUdgGTS{ye2RGhxwriq|VZ zRJi^a+2gep8WsC0&4%bpCCVPpk>;PUU|VTCqwHeRM^}Hy)_d=yH!qax(!{~<0ko4E zrDqtg;>G+AMJpN|9>d8eT>M2{X*|kX@aJ+>F$~T>z#ma#AmFWa2YP|3e|7GUSzKTj z0%ao!O0B=}5WV|*ra2#Wgh|G`!WVs4JCIK6{~(fH`9u653B?;}*w?vO0-_uQHt`A@ z$sm)$63Iqg-*Z+W*GJX5nz7=~+0K1o{njXj7#1!Z6DTJQx-Gnpi+Xhq`UPApNmvOsaA~sJMc9FG)lJSs#4;c7ifni3fXzSI&e9j35Gey7E!z9PLh7Q{Sb2c{ocTO?pbUK0mbh zH>$td{<%CR=;~rR=zh8`F(FOYEbOOAAvn%eb*DXt)W{QmHlp~!c+_IoPrwwlUFNE+ zhhchw$qpJd#JBIvRqjRbdU02&l^4gs3;*@3gedpmVEV(lfS@-;)sed2-0c z66d;-HEn?Ss5P;g9O(iyIIFG+j$cea+=#*{bk!Tv$C!z>=&g|-+Mk%c_svxPhk zw81+&1aE|n7BWCEa4dGQXkOV4FnJ)Wr#&C7wCY%_feJc#}UCCYlw*vF`fqmO*uVL(Q= zhz2X?GIhk9e#o#*Kyd*5s#IMs!SZ!BkbkmLf#2{ zWE8~#xs_%!rI7z-<)D`!bm3>_VRSH;m5yGO$sa?{W$Kwjx~sw0bYZEg*`AM}W?bIY zfTe5liTex#0^A}>&CS2Nl`}?WTvuDv=p}m0@_Y$RrkW-hyrsQ~w=sz|d3{TFP`kkH zbvbH%|6=}?t;BuVxMKTEJOS39j4Q+xNg4cabyo6xO^9rYo0n490m1| zDTV2CE$gDlSBKFCUsBfnXLJgsw&4MCax;MLQx=wFP`p;yInUfw7t!UirNu>_N>)<`tyy%Mp9cz?-9AzkKaxAND-2 zgeJb%^9~u;i$U>kO=lj^Fz`6AdHIRFNj>{~e(1(R+n#ZzKD=DAIQ;b_psn>Uk`mn_$!HX%GOY9l^yZqFR_y8V_mU$i^1tb%ya0oDIEhB#T}B3#`PbD=wH8iB#=3vAo{+l_4r3n- zHR?EGLG&y!vH}&HpT~7OYm9Sh61$KuX>RaxiXO=9&w)>v$&~l5(a{44h(nZb2s34Q z)T7L3#edxwJVd!H`}t$^H_TFsL+RtY+ucrcXxx;`QH$Zuc+Y1{f6!l@PVaz*XUL+r z0~%E)!mF1rd1N1`VO&%l-}%#HEBqsBS`EfWLxR?vG!pR}E7K1u1-TjwKXPQYHaYx=%3O!Z5_UbGnH$+) zC6Q7eY@P=ol5=C`x`8(^UufabSK%Iv&}(M#X6Z?Q)%?8EX91_2PH68^tu#bE>|a%sw$ZAE%i~IvLOi-a~C|*&+mowmEqsAZ6FR) zQ*GD%DRQHw;g_6EyVnB-rxnPi_h4=z`htVZ!=8vf#yIFm**>??yyQ?SKBB#>avAm; z{hgN42m4I-f&3lBKCY(0LbnZQNKwYSmQW$0*)QR;Nx2Wmjr3IenC%LPCf0x*SCg5K z8NXob@36X`b_J=)LDo>7XHnzLuM9N0hgS|&lbB$_}mPgX0%x!%*3b__^$+PTq2KdsF03aM}0 z#MQRXK~+xPBR{nF@=F@&*2sHzUc>5)j!cY;Zk*j8!oCh-SwnV(s9as|Lrg2rvQM

      Y1KztBkln;CHj$9Y!_MtY|Q>Na^%=2?V2dgXnvwX+Y;VILEoAq>; zDKtlB__6#$#hHr*YYQtEy6GV$b5F4YA4A3E-lgDIOIWH?W;s9{~3zVu$a$V{{!kYUK0StRWY>~0MN#;EvX!H6hRKf+sf9`?z~o<1-KdsyOV#y2B!W zrKUp`s}$O_(L9KolKE;|B%4CkSl8@^#CRUL6FIxS*Ym|jhu0mwv(4Ls-+%o59J1*x zgSm?~eI6_;5bs4-fBxK*XzU$-NYzw!BZ6~$4!8hq<_~vTJ0QE`GLYb75=$k+z?qU~ zBGUPzmE+V~s)oh#;(wVo6j&d{CItek@vObpx{>-3n#(E$Y~!C9%|Ml^rIijvUga(9 z=7NzP$iGoUg`#nuZZOR;SK9vVH^u=ZLmOUq(!Nsr5JXOHOSH-t+D>Z*x24bnY})CpaD+46ib|3he&U!$asLjcwWg!>(1pr`UGK zn}T3yn=@qEUn>65YF6u)!#g_Un$Jl3l}@Heg31M)-0CzKrYn5?7U(vQPB*Reu{RQ7 zN}RT)pbUV7@(Z%@!WR9M-PX$Q*p`AS>x$?rAi4q6{~d%hSAagL|D)QCWIhwUQ~TM@ zai^vrP(*wBG9!7#(TL^v(m`+Q=mob8+C=N86#D6rs0<*)WxYP5)i1frRdKa;TiHWi z!B?70WLRSl%~`v%AL!OA9VoD<7Oj-*=MEX#z{$t`UwAivC9p5Q1Vh9>?vPtQ?nk~# zH)h`Pr+lAMeh5sN8l`F60S;*3Lw=}$E077NCp;_Vh23TTb9+IFI5ktDPyu83Dllvx zpMA=Hc7vu&FCr7a?;+Dl-VO!k@3Oi(6yuf0v<-(KORarD z%iHrVHZ@$9MHRuQ&qUR8X@_opT)3(-KKX*c>U!-J?y!nswbv6Z>m7~ypkBV1uFF{Q zdC0#u88ZG>5~nJreoWu?bl1qHtYkBN zzZ|r4ZDD_(;#}MZcQfA%YSzDX$)kc z$nR;BjPS&+csNOrj|oXT?q?hTpyZFt8Ks#GZTnvozaz*pl9u=JXa*G~PyFY2ofTTr=3n+}Ajf%I20hI)7#o%#M% z&4q4)L3Q~8IrD|I2cRx$+juDvvS{Ap5pL95NRz{p4Fg+~#UEB*n50w4HRH@jHU%$N z(Q!W$?njb;kW6K$2|^2Iscf`f$7d`eNhYnyxso&b7sEZz?uK7 zw|=U0d1nT|8@Yf}=JS0ceP^CZJXasSzl1!*eW&pSFE^|WI!1;Z^{MA)x?jK6BH2n* z^(W`n?pt^}1582_I=@u`dH6`9?zNgh>>oBnAFY^o_uT61N(|$I4g1Mq!#2Tji#_(6 z4NX3oaMVw}eZW%UsFMiwV%SX;-&+6n>J|@RHv z*9&t~c_Z0l%zFTTNK)~}&)NpkJ7=xnFV9U#KV?YU^yx`L?+nMeAQ`6ZUD5gwM6|xN ziWwT8)&x}m&USLT8jM-*uK97EIjJXGN2V{wRn%Vo)bvGiY6hFJ$@$K9)7i0X*l-2m zFG=T;UXCNCG%%{$uU2-!rZRP#2Cb#F4FI2N=WyB^MT*afED2FJnGngSz@iCpM zA74$f{n`rjqiKH2j}@?y!pZXurv)oVybqbnwFj?0(q|R4E{5n;WxO zSM%KoZ8}atRS(_OyEM%p%UT1nk;2ML$+Yyt!HizJ)$7c}(rV`oZ>j4~mx4f=5LsTYvry;u9iI{9Wfh+DOVV7(x!6oifzj&X6kvGmSb zH|j1@+>>u|9h8R4G~+tw38@8kO-MdqE$|kuIyWltTmuU?l2>^vC6H8#2^tz2kacr) zR(V~pMuV*9rWJ)hXjw9TMK(lvL_v=L)C**yJgnBNLURo5bneKdUnS1LA*I> zA#zug-A)`G_u(YL)%U>7HuLq2A_dkj?dP+{HO5_k1mf)VlbL>im`q<_g>4;JNAw`y9~Bz_I7~{T)@A-8ZO}yjlJ!-a zT7ZhV`KL!YmY`{!@e*hPc)?#D?w40b17kwAM5%>fSwOs><5aA=+0HzV2-Z|kL4&iA zA|NExa?5+3pv3-kFa2x|t9{tI*}1;LckRCp7_Kv4=~ZX*6&uL)etuVmIM{hc>}d0$ zWAQ-+0T^i1tprr1d|b87CL!l-FF+L3joRBp$<1`a6SYlDo2S3z!Rzx~#Q+)4KcDmU zoVtL`tafNius^2G(dYBqH})d><%n@^JHXpm9;5r)LOVJ5Z0c-nR)s~BSdQ%wPzJ9U z?V~y`X=K}iHvXuu+Ii3^v6uExTlQ^=X7hiD2Jvz|XMA~d+Asn{G?wh0%vxR~i2hsF z&M^b|eRw2#u>KFcD_bUbv3!4b;4Nv1cmEU2WVVyy+!wis-RuE#V~Sfjp?UplKktEi zZlAVPT`)>H*zHkXp=9K<)sK*jBjF&O%&7wbF__x0H1s9*vBl0AB90K^|2+7q4xkT~ z4Gpf^_GYV21w|xjaor@^Nd|_h)qxis+ z4$`evK_&*IqrCVuY%da&ly+;a%&7y7D-K8U5*xDcvd!EoU3rs4YxF`FkWMi2?vk3H z>K9|*MOEMHAMdx~^*jkcXhZbRXIp!hg;+pvwaNtUs|idJ81?1Cj2a1IvEj{wLP1?! z6F?UUbF}8kt2f2G@d1xuu>;UseHNVdL+f`flG12O#L4jMYu;bY^8E0IV~~L5T4^iU zMIbtq9E44^&Fn)JBO_O+o;1PN!Vg!Fux-dRTpXrBr8KtpsS6;BQ3k@z^ZSaxL~7)8HbR zm4~k@wQH{6^-D?JKOI4=j`+=PlJ5)xH`f8JK)yEp3+m3>Rlk3snebq{ym!%3-#Wxi z5Me*74U!X#K4J^Cx<)-a?F9%xMX#uGb$s+QPbbTk1SuIBeJsXF-&FohEyX`v~$}OX5C3uw!j7HGIbrrI{z~!@U&t3Nn}Z z{}M96O{~5l$C(v93CCgG)nI(72+dolnu3+Zgp{YyEk_@$ANST)d0iRn(?@VGw z`98>3%VERuT{SN9yiqbX^4fwgH6_=`Ku-g6Dgz&Vy<*%d@`;JFDMyI!BYhoTWppdK zw1*r1^GGro>jM+Hyg3}{*RA1!T5R_*jwhB4{KcFd zK(9K5#-b(2dmy~Y6#xYRVZ77po+L_7M*06sb%*|Vu9tsya%a&Ja1agrkg2|V5XO4X zJ@M_?tquw!Mv2OvpyXkUU?@Fw<{yh~kNQvNdH`OyzJ?TN^pH}0tkqzR-mm6rsfOmj zCfQ?qA+^n^0P|m6C7yH5z~6QVLWY&+8StmY_P}7;$t>eBnVSXDj^k&D$HnMsCGBja zp8_UIY?FE`s{6kVYRuAYe@4%v<=-{jycbH2_3URg5bkO>ak@V*LH_BZ4o!~?cPqsp zKid$iXkS%RY?t-aq?&I-0^5(^jTFQZ z{Mhg1=RImFHH|c7$2{E@&R#KQ(`A&&>1$@OdY$!vk3UN#Dq?Zl; z{!oX^@YSoEmSSjLAeLpK?_k-=R`toIGRtuuu8hYiKC--QF2|vqz5eT3O$=8HTurhJ z12mU4YtK8)EjEibl#DG(cJgnnr>mjGJG;`p?q)JtWoF80Qj)x+<*OcU*MA^s#MLUw zQX7QZFpcRf3=$P8*SQ7yy4zmE|JRdEojX1FXij~+nBn#vuDYb{YBDQ@r+lkO;RMD! zRO+)>K6mt0^Ri-1P|)nZ5gl${+3}(xVqVHG(nt6l;7(74S#agr!Rv^Fogte9Rqu0%fiue237O1Hv zm|=KVnT-R1QEWF4p&J72U5@QfyF`_0cQWv3zceBTcer4c`DeV1wE4caK+xmYliSY) z23Z+i4xWk-;uMU)-iHt}X#+893FJRJ2J-2mydpKmpZn{(-pFEuVx9Tcf&SXmGbZ2i zYk^c+<0aLR1~_+JWKXJ17K+bL^E&}<1zU-6=hf>c#t_Yo=_#5nq@P`>aFZ+7CLP07 zT{OSi{K}~TB@xUPmWd8pgrp6r(Kb~d^Bs5C8P1+CD}AIu&XbF-j|exP{{Yy+-N>W3 zx_d8xe;kY3z8@H|e_jwjUd%-(c-uGE7b*#Hcu|Vxu4^4BBMI>8YI1kNy5~a=g{k}K zwv~$Q(S1YbWD^?d!y$hGhY#BGGd*~?YH_jB2A$p$-a`A7ps{ zjvFXIZc9dEJ5S0LTV)Eq&dY*-+>Q*Z4&9^6d>k&lFuX0Syt@4?5m#qBO_{3+t=_cc z{!SZScy&rq2>YZ*BUOcD&!*1+>ow%r?@rs~=gYwl#o9Yfnj?GKa;XzC6qydXJGf-) zwf#rM1d_c8G9fwwm1NWzABmLr&jW*ZkoZ22YkQGjvo z^!D|W_rdG@X{^^o%f*fTUZ_A=s>zjxFohzcysnE0IB-q>4fx47Uc9bb%}a?tleNqY znxW~Ky;7n=jcZ8oZR5LK_HQ(^ysf(Z3R7}53y6iPoYv7jrP`o5hXjtGb1i43=pbKw-Ge} z8KNf4$LF+6tk}l_o@!wd{drX`T&%V0*%9+;U$!>1h2m_{9ymamEuM6U#`&ChegOFp!dsl8FOwA2&P=2A9 z3m z8LwhNM9L{zcNn2RXZY+azTn-U^UzH}s;5=dK6ckkzYa`TO2`+{A2%AAp}Rk#itI_O z&~6%WxVn9nHu~s}(t|8yF>timf|w)wRT=?NFo|8~I3iicbsAY*hyq_f*5c$yUbA$D zvPpn#aIs$Lw+)J4CPEz*#yLo`$qkcalNrcelFt%Q3{|U=$_Xe2Q36iljqH%O6-<)f zPswcu%)&h5O(VTrn!@0GwW84Qs*?z9yVX$u=Y>U#W=qB9rbaIFfuc~ao&0v~fF*c% zAZW_I!ci}!$}qL4lo_PwvdW>I%nK4Oh5L*&5dX>W)oX#6bRJ<|fC_MqwXsB!rkAge zifBv8>{ciEO2vt1BQ1vl>~#FeR7T+$w^${Z_qctYmQfB0b8-4&xJOsDlvovAoK#M# zYq_lyEISkTsON&S@phObeKYGVFGX#=f7e!bne|7WuQtn6P;Js8LAWw*m`)Uthguvo zY4hrc?;qD6Dbo*p(vhc2DF#0-726j3UW@%b2ku^5rveR{GjEs$`t1x|Pf?=0NzFEt zZ$uoravQAu{-+lDw zTj!)T?~gl%F|5^jBR92E{sHX{OXyK9z1CV!UsERw8R1V2NPGC!7b%tGU)|rjHhXTfm(*ZZ|nGsn|$74 zu9~*tvD^on$Q8z@cdqjXiLgxA-~T8*0c=Fm={DfUR^`5&P#xdef7*~idJ|t8st`VI zC~tw|_*ep3OF=O?Ky%Ur5OiEw$Y=%3ss=aS)-y^O=Twb47CZbv2YNY}ME8sVBuT#0 z-+_(Ts*|-ND=1U;#^303cB_X>FHLiNd`kSWU4*;$sdX8(q(9Y-1IzCTNOUO|flI3B zdcc|*h2KsVqE7<0CmbCpsb@+#Ce$(ddV1H#^_xtl!|LKs@N$A~Pp)n+5z;mEld5wI zVi|KeuB&c3=glT)yxTw?nR+uN8{Im!Eg4ovq6j9mJjdu$DgIR|0*Mk-0*d}Io#jNj z67zcd=d;lN1%T9c2>5?Q&M8_v>?uZj580AgIQycfGgsQ+P3V{UJL{>G*eXj#q4WIN zV6%-!NDyi&?S|5Etq8rLOR{dcR=^#~9hEATD_UaAUq2gL=v4=@Tt!iX&*WfvCg*(D z&klbx8^)_%1GIpYb!TKGLcPQASW`nDF}cO(yMBsx2GqYAX2na zlaUSwc}}T6*tX#iPyUDK0tk%lq{h}Y_u{S-=~=N8$*_t|4%|v36cDyG;OJR8SaCu= zjB|@BgnLvtIsyzrOZRJ+$Hia2;3Z7Q2dC*6sg1yi4 z+RI{akDX2*XRBf9p0*9MMYTj#R0>*;I5^~ZO*GZz{tfNF*Wg11=i!L4GoRJVPG8KT z+<7$MbR%Z`;qPG{^YV7e?t!ic$SI`H1f}xvF?`q|Lh}!&tzyw}`P@yuYeI`E#58Va zFmih^Qp}NHo2K!}*i#F;iH;`yMUWBBI{>5cRK~T0Q9xLu>}~2B^9E8r)z#j`-`Qwh z>V>FPvx5Je_m!()^2^hAo0+i%=X@1)E_OJ<5+T@?f0gW}+vMI7KH`jG)RiRWs>qco zji>Si|E&PqQT?5u!CdmXgTW7neba*m4lWV&5Oo%m8{d`93|~|rG{cwg1Y)y88^RVI zY&Z8rS5(JDFp0l1TdYHq!ihnv^&5v%%vF@oA9|8d`_}IyA)10y5qgQZWK$Ix`0VLU zkYd9qZno0)$P8aPXmox%?7uR`KaIjsvOS~I$j?-%#96!61%5U%y652OmZB|^^3`=* z^U%?pMGVH6bO$1Cb;tupPOK4RNn4BW9#`rXA-XBW8LgjltL&UR_kN#z0Kxup7Tlunizs+ltIQBbj;fHW@D7OOKO%h-32!)77V>@Xpw62fcjF6m%(_p(cqXgy-rF9wesKN~r7jaoTES^;bNG?ZO+G4efrbW@$lfJP2ZOSsxL} zl70e1qTcqTa|t@qjIRijfQL!hMj_+(mRtIrdoJW=9J#_eaWAi^73qS@trUwOf}~Qj zZ56~T>nq&8ikrbhL;VjX`7fh*Ndu)JNV`eQg*NZ8Y}Ao(mj~up4DgZ3sySr~G_(4T z5~(|J6w~bYcWuOGSNR?C8N4!O^C*@GZRAd#kYNRwF%(l#2Lj!qx{&46oY>cUB{_E+ zH2n?iH*TW-xK~Gv!8|-Kt6k%QfuRPI8ocB@%uavQ8R(UVi95m%GTMrZj1WB2#!NGX zKcux&+?=Nd=F80VgAZYykI;ny>urcNrx3f%lPcHYe52#%`*ED#|m#%icLH z`MSw?YcP%fOwx$irlt8{6Lv*|)SXq+_CNgs)`kSC*Y9!;wjwF)n?f~Q8a>hN38c=)>)nHbQYhJ+ zq85<9`5flM{1e*?+~7#%LDSjA+8?MCJF@URQMEqh4n~5~z|E_T&D|n+d1#HZ zE`|DRdu2LBKpvYtUimvI6e{?9)pU`CRt;n{ZN4WJg$PWs4ezwCjMwXNHFgEn+l#*k zEoF6vf@iMwZ06J>tIeo^JxW6HN!JE8|KmU)4FK8B{}KZB8j$e@&PtuuK93s*4>VY` za(ufF_L^}=G&cj}3hEry4c(4ric`-IV6Fr5j8Rivs!d`we^o&ON2*qqL#J#F0ushv zZfo4p4H}OxaB2ye|8mRUD>Zz_1Tj*TYcO%NI)fUZ-U*0==S#M6H)1YtMPrwm;17Co zWm`q{y;;2GB$m zOY~k4hTfh()?t|hXY8YLhu*6ZHs?Hg(m`WhZON;i)W*pOefHH7bvF19i1xLRcW*sP z9Sr(k)(Wm;y>RN8bGOFXukqT;nY-Nd=pdH$g~;34^W&%Vlr@_LMOfkA2<2Kl{e)B_ zQ`^)L^}uN={vT+C;H*jIt*Montfi(`MyxTP#`aCR3u&LLp`;+Vm?=mI`;K#WAB>S~ zjf_`q^QAjcU%Ls-Y#vfps26#d{2*(px{BW?L2T`Hv5`LN8eB5IQw1QNAS*L1Zi7%j zeKNdmzx8$@x)S2jIq0{bIxf_Yl=GXO86IeM6(&qt1?UGWvpRFk;}Cws8#yc8QMwnT z7Ph;ygcDjWD>ToZ(WKCx-sEh+kF7&WL1QGO%1#RrL3PwE3SKlePu+T^W#E5p#f!fB zCwLXDm;BvFo}W`DTvHQICD7|a`^|%h?;gZ1zDNEIn7F)g-Z-EOYUFzS%hB*G9OSth3b&OB27sc_7z8;Wl$GT!Q z_{MbMfPwJ5ye>YE{hICYJ|pFw9bNVYMBTW-DJ!k#;dfr_8IC zSfTk3wiC*&B`CKPz*Ad$LtSKyQZp73p%<{oGDz>(QwJ%D2hEaK3vN_7^0v6M~zmOw9=+t@nw# zl;1ZJxy$|LoZ!I1WBmZGoP#||IM}nnJZsd-JVlg2mU?RM&G86^>Ue)zz{zWV?L63w zoR*nTZNTmi(h?O!uL(z*<%TXPNuo7vp{AMM0QsV1Hc)Uo_*WN?RAb`%2tWE7Q0jKPR?gfI1nb{1|2NA_n#(RY~7UjXSM z(wO&^{S3ZOJoD5E{PWX^jblu$`XHBI9cAFZBM+xJ{4FuCA7~1y@s!JplMC|6i8!~ju95=`W^DCe*zZ&9Et7QO z(&c&FpTlc2YUBn;SL%Ed@tHNnsAaV`eD&LjfTAD>QVf-H9b%vFA!9dQVGU>Lr2rut zu4Bz?I@vdFRIVEUcpzo04QVfmAi{R&doW_8DnBvWO7kl|3pLpIyg^8;M$})0J_}NH z{?L;wuHkeOMk3Vzlh<_9*~e>!nNrcKV_hV}PZj()i0WuzDA znz_yBg9uY;k9zDaLl=Nje<#x*MPdfGx(>)Ky-8$?K8K**Z769Elq#_(U{aQ~cGkcd z0=QRSmZ9|h!Lu+{m-LV|!_)ihVxrs(&oQWIs*_SPEmD17{S_NRJTM&FMhdd=_mE3r z8PqhTSY2V*jCpv!#ZKq@hpaKK?J)jotkf$ZtoShE{cf8o-ghqb(Hphx{?wB`me`u9 zEErMs8fB4`xYf_5qKh;S3T98wPg^T6Gn=ZyHGhIIyXAov=Ilk)gdX_Ocpc@8GfWmWZyl#rC$(I-K)e={q!ZO( zPGpRQ$VwniBvhb}XX!C4UzFR^+M8X4<+H_A5QW5bdL>I|+~n&8=(P)H<-Y@EDE@{~ zwS0{Mg-gEM>*sGxSsFc{gM=sUQA8BQajfU~eF&B|fRI$Nw};+#!QoO%OckC8300mOu-xd7M9LxmZ#Cy3 zXgN=%SxdFNlg?SVS)qKZ`Dggi#^)Q+58MCaK9ers7Cw5 zJB@ z#>1;g{&^rKGCKUe@!W@UYqGt~d}g)~Er}LVIn=WOvz4{`-QLQyR$OpY0TP=H8RyFK z=8Z67k&S7+O&4^D`Sv^0IK|U1G~q#?oO`8ML-+U#+)MnTCI8TAIR zioEWvFgH1!uGlcKq4sR`r=^rJxh#+L=>o2ep_>JrhNNi3c`lUgtk>32Dy##Ad&opc zp4IV;Q1_!h{hWVwoR<*^lk)DMK(Lg{KYem5{bymrxT##O9pTjV5XdguUZ{abE>r~m zl?2mBqU}^~*ldAOZtIipm@NuV-E6RHjM1B zDH%{w!y;lPET)cTjsZBIUBcgaWr&|5-I5eHG7Pm=%wk|<2tN1Z_tezD=a9Q=qpd0~ zJ3}A8#VC|#Ze#{LqACof9;3XCODv20biL;kOqTKciY?WiB<9~6R=OtU&kAP@=%L}X z&Sn>JRC3w7ki4qfvezh~B7u+p%FFz^_*fUzyOHna^O_Y*HKQ=}QiIP}+w3h38M-Q^ zb>VdR!HIT_WPwuz^5ywFmRT4#9u%&bnca-^*(Ua3Z_>w3b$vRv%Py@(Jq{P7_mpg_T++M3$a5m+ zK!cZDE@4&-rcmKxk;-+AIOb`$4dafYx zV>z7rQ2+h>_n_&D$Ur(mV}hDZyNOD6(;sysCTf`;pYLv!G7iBrAw;hl-E_;1I48Qa ze|4&FxCHUompqocO0pHOz5^=Vt$r^r(tbKYZAvtgU~(IVTUes=kcuD@{8EUU(l5We zXPZPk6I=h|IyGR@m#|NUd!RtKDfL?Zq!cXjaD4R}JEdhQ)>H`P>I5EAzqc{xh`(9z ze)6oIwSHre&~{iLbG4wmWW(!+%Xb3Vq~n6~l1b(G=o<;@n3o<1SpUBubXL(O4>f+T zdU}NTPX)%D8WuqqguNkD3%ByeVX_v~74 zw3bbSa|P=#*ExgMIt#k$JmdU+3U$>j)|rwZ1s>;R0^F8y8oO@&efyj-_y$W!l{#Wb z@YlO!T1D5zVYnb_rB}`mJjLZC`v4>&4-%41|ylx@p3wx;2o{^t4toULc%xs0x&?&QU z=Ab`OjTr~7-%V~tb)}v&sQ9bo{GmTuw+U81QvRqp@aym8!+2(@14Czu+7$I=v}<7@ zIqrK|uAGJh)a+GoqME&a{^3e_bNMs0ioA+|Kbf42_BElI8JsvqUz|A{;;;9|q81X8Q!kH-?3}63a1f~#jVdi?MP1Roca_fhI-UYDBjs}&S%PJV< z-@cqVt2cnhNnV1uE_7952WCEsX68zZ(Q`v>^>uhvO9^S%n!l)9i%-R(PDuFW3MXPE z#sjukhN>W`j!_ZU>v{Uz(dPvokf(enhCjrEyb73Z)!%fv#H=oS)2tlp=Da9oHG}C+-m@RAI7`2#$~M z+UDzf7eP%-4I{?OME*@T+ew>T$A-CzF*fCIMp|mA=t7S^`wi~Erl-$JLBM&03CqTE zKB`1x6v@$miV;#E6VktWLihzh*f1GZayqMAIqtxNZ*#>Q(AGP!k-YT%r8aT#7s(+R z%ZY4fpZ{4D@+S;9kzab(%IeVq{+_OSo|2;GRbX3Jq4b0wW(}Wa(b~9jynV5HYNn=# z7RoJ?3~nIP*}t=x>BewN7eV-RtwPtpG5xtkK#&~Oty49}OU+^$x81yvt|m2QBt7Oi zA9`W)eY;Zg1c0l8vbiHa-rr%oLU}g#WXl>nDXpy@>7FWl9sacgq?chDPonO;?>byD zuAVdF2}X6g4zO#x-E6il@0@iGSnoS9oFf%#E6Kg|NQE9Bo=s)=jTi72ve(Sv8&`&w zObRxykM6Ze;IWq$A|=6L8)KWxt!9I(j(Mhmy!3AaA>4Qe%Uj0ucW~8l9WS3B7Oi{A zrGKL{fRU~=m^}&}xS>iiUpy+Bm{IDx9(*Y>0NFdsiV^u1`G+vfI`d8u+wDTq9(_}g zBn*D0gX4}k+|ynVm6Wc-8|_(>7RJoCCa&AX+s7W{1Km3g-!XN9_r-U&7_c zj4NPV1y6BTm#6zf!mA}wqJ@cG(Bmois7%=8bzWr`eyD}fc@s8r4sTt2K+qL_JM3b( zO`Ogyl3ovZ#X7E$EB!`UTeui~z2{q%G{cX&EtqVTWUw&;{ujFzJ!Q9eyzI|Uths5Z zWpX6Q664tby3>5Evfax2=;>;;acn-vV#Fp<&Is8-iY=>p`xu6EELvmjZ-9>gXaVM* z3E_ca_aeOPiYmJ5TZR5O(v#Ee;$5Iyp+x`nvZ$`(Fuhv&reukbb&u^j1nb=G(1TF@ zy=zv0P%=K*(a7z0)(zoD;F`QT#I*9Y(-m5seW&W10`-&g3co%i*3j#L-W1v{|%}hg7fC zO-PV1hMxF%PL5N;?IY<qMS0aREX{l8507Cf;l9buzPXfi+_nr|qJX;g7&>I2x3PFp$rU|? z4d9OGj_RAt)8eIlc*u8Nev~27HHuNI&M0gC^pE;WltrVBVjX1CnCJ#0I&Z>)V{tH^ z;6!TUTrUcL(!(j;*gK=N)NFfa^x0xkZfi=U&qi8Rcz_LB+ysD9y)(A}G+y zIw9-brcXt@8uekAhb za;Hee>-1Wzs93k=ad!onHN|m1!l07$+hr9ue(OgN3>FgABNOSBo(tu{^Oy1P{Q+&G zAj(B8UrK4t(2whvd5~iw5qsik8zC-Hy&krg+G;B!FVAyI0XXe?`>hjCr0pUmbCku* zh)FBN?BUMHv`+^;diJse+1M?zzxF7$;fYUUB=14b9u#Sdh8EH1$4!t_HnsU!gPL$L zn-pog@^%TlFyg^l{C!#dIeggvZxHy;WrGGm+Ekti*2- zuZl9TZsJzf>P$|=$gXXBB9z9_ zLsw@7Wt<}Ad$YR9--q)yV*AAL)eXLP<6&hBnh`n5nlKY@xzk4ru-*f8XELOISU;YY zKrtHsck;HL`5GP@3hbVnZ`|XYuXRs(&G|X%u;AN&_$PpC4O$LUR~B$51DuIkog&Mr z7Ftql2q5SpIDm!Fads`ok)*E!P1mBX1w_MBlCP3@dxYhOCDnye>&PQR&u)o%5!W7+ z!oTV3wdZZ7hBxpR-c9cPs9fS;cyTKZQ?>r{y2&27;ef%k0YB5_aq~{&Kcr6k`)JOr zU9qvGj_?lGKd=Byp>H;x>_A=^t-nnT?Gd|NrPGt|idwUe7}H=F{_K=|Yw7L{)}@cd{;Pc*e*=&Qc22sL z+{M1D%NLSr12`ul-APPCB5;|Fb8O<4J@RIQQ!TY6x09>hCTr>RJd-wGMEUjzI=G`^ zM}r-{JyCKKKIBNNGMQLhxO}$WyG!?@1RQXsZRt*&v+SbX59cqnVzKplbDSD1s4=T# zFNP>6x8HP!YFGszGc0xgkdAv%7C7UynU)WlW9cj=?Q0NAd;?STT!odA^B$}2T2D7s zb2f)vnh7%}*z$3v&j%ygVe%p&Mf-Uo=v?5ZdWPqsC}zs;qhl>7%bc^Xv>;JhNYVUI zYitjdb26~c>muY1k)WudFdMXHy}EF2j|R0VZjsMJwD`L5cvo>IIyt7MSAQ`JafqvM(pp(~z@rif0dmOqAmpVcMAK$XS(OX`Mf-Uk_uZxST~jUB;{ zCZa1f)QOyOknDc$u)YYnCVi2OQGZmuSzZ1>I+z}F)wVtg?0{;|U61{H3U||q){rlO zu~olYG%=#R9Nfw#F^V9*aF3p?F3DYQ!0`~bZ8dy_K~cCcM5@PFJL^l;B-m z6zn-9XFWPm@CN*$-LDFYYPfAOL<3z}y0eyPmQ%whXZPI{Ljrrx?sUjcq#xm?dxA$x zVX~w+N%x5i1vwaB&XUthGMSM(yP{(B@<`62?Mk)vE_2Ub=fAkm6iNt* zX?8b$MQ6>kUXUpPg9ougzSg~gFqH^;Tqjnd;Gq!6JKQ0A)2Q(?am|6AO(++tQ7mi$ zGJh<@$y7qr{31R6<$t=ErM84WhhAHh*7_+sfz7mCYJjh6dN^qw%2{SCd1 z%QTO!`WqxJZT*k42Lq625az=;m|!(}X!XflA!7b>M!goAmTPPrH{__eJ>gI}$@z-k zQu-US@*HI4e_Vao1f3G=F3d;s&0smLG$l%Sh)vbmZKWn&bQ9{KFzp(WSLvCAX@LOl zf?Lj?bfwU|7Uc6f{g4wAOnTT;swlUVRs{w#?I+FJ5nrrT(_`tsorx<7!79^9&2<;rcOl z^9AOU53H6t^8hlmIj^>zKVAoxSXxW1QH3Z-*@B|P-CiQ$U7MAEwjWv8@?zT0x7(C& z^)&yt(0U7Yr+a4m(Qz2Y&{D&?&EROQ!bq}9TPirfl>S2VXDFuDE?`#t?VfY=IQ%yE z<#mkaD8$}51jNU+)bTxB4->@Y@AgHf>oz&gl?;^ON7%Z$6)9*HbHU_w_`dMqL)!v~yY(Q4cE)PKWnC;cB#Ue+XA zi_8O>=0uauywpb#LG5d>m?cnm-j08M-9+{g<_dG*&pgjkuf`+Cm@^tJVCn?j$lx6hfW zcW>a61Kzv(37UrArmI^@$jQXJgdy50%z14#{n0a7BO&Pmci5B`5#(EQ2z1=kA%dBH zc@8at*@QWtUdWM?{ecx6sA6&G(>-O>^(kD#P`$OBquKbf*0CtB@O7?)L`V& z146!}-HQ9P({XUM*AYZ4N+cgtZKU_I8a(z|kH~$H5gEad-nDvLGJ%|7H1YGtU~kFh z*5x*r`D}!X96NK|^z>E-W_UFw>6B!u*;8g3!W!0X(}<-}765u^ts&)G)em;sgt4Md z=yAUq*P(h&RZx+Qpv zJDe3okY!md&P8Jbx?;Qc%+K$B??Ru>lsY&t&wLNjRb~utb+K zZ<$e{2hI!QWGj+$&eJl;!b5o`;ev4MT%j4XfZw9io=YJkl7wD}?92Nm&l9^~@Pg?Z zk~}8_jFV}FSa0)I7!d-k=*>sfdh)Ek>(c~L3PMLH{>Jub2D0`Cw*H2cf^~iJUjZV> z`fWkN!S-Z3!JOITA>y$PZ7k^`c@Fr3S16@_kk2XXx!{yJQ7=d=;C%5RG&_pN3XPK2 zTjd>+9Rmea#D~>I3|`S+y|#*06$+1NR$E0)23%-P7lDT&*~3O9+m=>H`kA6qU-X+E zeJB&LVLa}}2QgnWil{V;A(H}F5@hiiVC>ibg~v_5xbrQvUahI&bEP8zkwACYIpKdT zxU3M630`&W=#zi0``3H0p1PDY+-?*%o}>5cJhtov*SjUqRWawRs?yCk1IAN<$~P!K zf2n6G9kda*i2|1QHcKbQCdDRS<f3Cq?+sYOq!Z&PD^h@oV8^}(y0=F5$n5eezHYIGxJbO>&bs_QO{J43SaVpsR(Ja z`dA)8%+G>iCxdKuTI1pi!)Vj`P+%x_vLg8{D27yIeJl4J7#rF?ieIytPY@ArD)UIp z;^0db^SwDSdKY%&hQ-9r$B1qvKjnT)3R>=m%TI!AvE>%1Qqvc$9X}p^YhjvyRtkPn zc`jj!z|2OcEtuD$6s(g1Ub}|xgLOZFIZn$H3(te{<}Qy>Xlr@!4e38b7*FJwW2%oc z>!M4zimU(1K=#R8wh^_-dFl0GI;7~V15HH=(OPbxOp@Z4ZWyX{c|S3THl^_fr)L$gP|x`1LjC5{a>5|^-1w+D zbIg92yKaQ%lG-+f3yT4Z*(ZL~_w16aDO>M!K2rJJWhYmlcY+tq0ZpQQRViU1@Bs`>M28TTP(Qd|E8cRXXftZ) z`%RzqyHYxA*RG3F#o%mt|5&a?-=1VS!VT zrS$A-vfr5F`?27VBPmYtKHeX0hJDro!;O@A93vyS(Z!3etkKv~cQ@1YX?+Zu#BTNl zzXHXb{|abR#g@P6La4o=-p6_!?J&x_h?@Ozef?(FUg5-d33wn;ReAO+iSD9(O_xOI zAl0Lfn~N68k@MBAie-p^TzSEp>g>C{Jt42|o@4SHT-~~aXNSYR2&;X`?-wxO)dRw4 z@#Ucy?opvp5+uut48?_dbfq;E;$?s^>X+0J-BLj@)&WSp+QE;JXh zo(AQmD81U?6QxPowjm8omaM>Q zCsTd$_G|?)w8!beg73py!u9MErt%W3r|T+fFXp}y)Ox$pP#L{^;(vw0V+}WcFT5WKEtNHHcsp zFDijedWTX7VP$d{AJB7&%w2|0$LdyaX>aZt(%&UQsk$$J+@-*E4*IM3*J#b>nFMRy zat%2uKQa4m7_544v?Usm>+D0)ZdV6W*BF(jx`27X^XF?De&G(!>{B!r)JW=MYpoZ6 zlGd#w5o#QOP%~Pg@y&p<=7DVSTO93rdH8LrKUPauSx<1$Ky$`#WU#x<32i>B4VfB!#xzp0O6&) zpmc8+lxI~)tuI8@PVaP6A>X^=&D_!{&59oG>I=PF+a&)5Ga_(>7|4kyyfNnszHr0; zWEFOfudrpfi7U3Zfx&G#yWN-`+W^)uwxRpj*~a-aBo=}P35*KX(t|e)Bzdb4r5x7c zZ#RHz)fPROqm9QJ@U71V>to=f!P<{uJBzP#3rC;P(_BN_RdOdjKwRXZp+(q-Mbo$S zW;K0Air)gI^H8Syls6ev_K9TBjaoA6pkaUq#%@sYpFzXD&Vt$aPtC4(dYlXf%)}*G z>;7df?dkwCT>+J{RP3|~gp!UJoqT5R2+(W}Dy{ZM1ke>SnFp*JL-=X{ zaQ^^*FGJ_w9lly|jGQEl^o2}+9T_-LY!|jtz5QEInSTR|quf$gHHBE$3(=I{WVEvp zfPVGT=6MKoB#~ZT&RZT}I~r|uMCP>Uv}8uZ9UIqi$~1@J?(0kMf+Q(MV$Xs*Ry4@t z>|+3cL{v8k z!?Oxe9{$#C39dm`K3k*5uBA2;S__61Ou0w5MH1rXto(rXw86U*1MG|Ai))Jy?<>+P z?@0*IS?G0h1|SnLoVhXfECTSO|9m@OW-@cUCx7h+)#xSqTn|5=ps5aa#B&x*&fN+b zx@n`uxeHvQ-`7AdaF5c?>J6Qh5~(V$#49eJy#k*$$`n^MhED=}{)kgQS4->yT9dkc zcLur;At6ps#fPi=xB5p!9#&L#KQxm&AKNCm?k9PjatGANYpgA{CQ$+h8mqSt27RB# z`658d9+-Uwla8Xgdp)&txT2-rOCTT^pP ze;4-v*p%@{8m4gdi?sFsI|zJIRd>7LPJ;&pRUh=HSL4yf`_50ooCUP=pMvQjhXoVu z2Ya;zPp*ucUrI4|UKBY}I^8Grt*Jv1bbq-)?!c*8eQV08&6S5UxX^RzZnE*glb>C` zNwonEx->PNTTulE@E;}TATzv440XIS`mc|%KcER1|H3iGHIr@HB+OL^DQ#70-?`ph zH`3~4QnM*^#hY$(<>IQY3dge7TGa=Y65KdvWkHFON^3`|q9|xxIA{^@7-%hd*(|D% zu(_oa{JhieXs3KhFV#+|wL({xTF2~)yq?Zn-V2tu zVNM)|HQrX*ybfY1KpU-Ujlj4StRdQTa=0r`S)OF;dWo=$Ka(TGq{%T z2PU&|>vvG(!mJ>xYNxx3FdpGO@0ZkOQ`Tmy0&#+0c8MF$#<;@HZXL4L;+p+Fq2Y`D zPU@LLaTpawfY*6p(P&bT)`-sS-&toZ{dyGQlCvB80Ph_Uca`GqY6l_m;l!ji%Fy-E zF6PtUk&5f3?vqi;Ezgu+h&WBFwaOWQVd+Wn$-$(7LBMcNF1cB1)?9B6ltDGL-l`Pr z%M;H@xsV)pT1i`8-*0WBy&yXf@g5gLR{ZB|T?a3Un5VPg+(>Gynv3OBrE5xNh4i^l zJ0qyDEl@VKn$X&F!GMNsU{!C>8-Uq;&Fy-=0gErkA^e3Mmg4!?;WjYObwo9 zI`�k=>MG8j{gbfHFU_SY4A%hd}<)k`_B^zowF})-<{Vl^Q@L*ECZ{vnFh*iyr>J z2n!SYCKqeG9yyiUk()ZI#rg*$m~Hst#XkPEAhzj5hf9RGudm30vMH_WF8a<|N0DuV8 zb$?!PsU(Jz5Rx-{ZFQ4zkneDp?~{A^eU{QxG6q3HVDy9u{pWE+Ree-jF4oZdnm*jJ ztZU_gFQb2F-uPX4cmu;w@&1wMQSNd=pQsIFx?Q}&DR_ZSGv}lc)&o6-@c4}6A(sDs z2;ln(K+V{uB)3|#rPYiyC$E(FiQU#iBQG3dhM-hX<;l#kK7E9;fber|)@@J>-#)81 z^?00z-5-3^dka0Tyw!xqEUcdZtjLoVTW!kn^Ky&`lD3=L%S0>BkK-Yzvfz> z1<8Z#)FqEr!zG+j(ls}$UjcK5`1VDldn)cpURoP2V!emtEI-0HMYdTR=l1~T6o#rr zv#Ea`d_D+%q9=02Ali0fCN5Z3IN4qVOz#T@PwFy5AE$&$Q$)rwwS0PTH&OK<#V89^ z)cMH~sCEh5z$rMeDw1exZsy95m5XxQ8gKbv>1wWGNm?3PVcOxY&Vmo%@su~6=dXYu z`QDnSL30cxhDk(E*(VNZON(rq#QIjX5oWrV7uQx1m)qu;PTmg|H@m)xT(VfBLbtS1 z<&|`;j%4ysg1O!@N!~Repd!h}*b#M{pXYmprQ_=oY3n?{v@@nVbSf%G9AyyTi24_q z%jix(+?%T3A4Fdz3Fc$xfgQ)5^cnI=_q*5c!)CksliU_ZY<~8xxJB+qj(B zohQkadpB(qeZ^6=;x=m`_Ww^FT0fDCS%{o|>X51R00;%>098-pmFB+HV1bqRL%_dS zT6%$N&Bk?avaBi6g)$kk;rJPT4boGnGw7b&5QVF+tM<$8VLa-Qil-vy+dGwx%P2v4 z5r6XYSNb`Rssq+c_SCvK2DT#ZPz zhionx%6}D6w~B-^f%L+>5kB2ry~W(kk;-KQ;7I2+XrQ3I$q|3pVfl|? z%ZPep4!hkk^d;b}q~K>2{El!JugnL(5)~Z57?xVJ!`60(soTR;v9Kp{XBV_?3p@DJ z9g1GdH#}RMoR@b#5DraABo^e24^=h@p`~z@qz3ktFHx`no*t?1JAp*PC=@pvD`bH(`DZ8gPt+E3D z+ZFx2nDm59%(;8<;EfnGLTM^wNuMTRG0#$l*lXE~T0e-V*H#P(ZAfp_;v5iFm0}%h z>Tj`lMt9a3KHXAW_zm#t7}CYfuG{%P1rJxG?2r72wWgoxiU9#O^5~WD$ctlBUFqgx zl@tOh3ARo7%YWKEJrC}yIQ1n&y9JR~j*+$mCP43@{Zl3hp|yOod|9{ep^z=29Zq`g z7j{GGlAphnbNI@G?M*IZgv3y8v8b4~TGz2o(rmHX&y9ytNvyY%-`Ee8>Ct{Z!7x@E ztH-6v!GglxU_|BmZ;dp8Sze#58n_jhfQvBttbS~niA%7mwJf!se*$u4Q_iT@(B9g+ zFXDr=JoNq;OU*pDf=&GP5v%KG-J!q5lUzhqH0)6%uE@diogF@-Zn{Zjg#|baBN_UV z3E%V|P`Q>^(t)m<5Pjt31)nQWQ1AlJP0dslONyPKQ?Og7X`FV2%!`VFtQPaOIZuFq z!pf~NmCDk$y2wQ0RQClxArA%1qC$DwRff&ivG|U>T)kcP%|P75_KC6{%P#3{HQlt{C+Z;b@WP0_#Egzjr$#J9AA_fj@UmRIEi`5ej zEb(UA=Vg(yL`_+VXSr@G_jiYepH8fC&MTJ<|J60M)hSY2cM?Ll{oTD{wI^oPOM!5e z^HZ4AFusn{sgLv3ezR0jqIa9>L=rx1T=GnzgeK?SYkk-q3I|6DV3)pHh(Co>TJ{G_ z`33%S@_{P`4Q`%SC2n%;wH*JiD`h4xb#}mMGN`=ZWOTSFbT@x-H^;R|w~- zzS2-bxeE7v+Iu12Elo|T3zoGeSK~MHVKAHY%v&9^laMv=F{@dUd1>YbJn*j`*;gQ!DppZd?IcUes3pspwHL+uLy? zZtGc2qUTc1P2rEHJI8jP0VvP@r^VWje}Ly48*~19E#jd^ftJNo!2G_2oAg49?r(L# z7%h&t>KEq=r_35Qe|=$ZH^>BZo?HFviXPLV>m7Wm2sc<4P9{B6>X06SQyWrK@v%&> z3UU06bN!m@-n2&H#0{k=o(ky_;I^H72$qw^GJNmSUBmgetqwFh^k)bLT=F8@%xazU zMOvP@FHcr-7;eYZtzTI%P5$sepNtEfEak#05i@qm5hlh$Ilv4MZ*aq<(@OW>TWIb| zX(l*a&{_@x`-lH?6k64xm<9yC$HN*Jj@hlYWnN4iirhy*)=t~z!@hq$IiYsNs-nrp z`^@ftViNVQT5`g>hLaX`WMAqK$Vcnf>uk0M&Kb#UF;v+qx*F{yIbIpkYh#Vn%Ksmx z-aIVnG=AHjva-gKno24cTq>I}Wvo$i!_3rXEXk?F+$gmyK^<3I04pmOa?6rj(X6yw z5EXZ!Qrve1#I+P~0~J&h6n**q-sd=;=U@Lq4)}84pU-ujr$+jCuUBW1g;Zp}sS`<$ z=e;+Jm;GlWTeSPoVbGLDrdwSYw=J(*U-s?Hq(3J1w;Lsgh|nj}VB!0OK10|L$B|wh zCo?f4T!Z20S=W;mNs77wccaZ*uLYx*mn=%oDuU^at~lawd8a@5d0;$|Q$JR8C#a

      yJ47P-c{QcH*2EOR*?j&sY5?=GdRW$}?&6|! zeezey4%5jK))!ndk$SAA5pI$9pUhJws=+gSQ_-u6`ePOsY($-rZ;xJ7MkT$Ae|w&~*f`}e!{{H09o)>VaX{=XIWtf| zbX>fQ`fokQ`2^ld7Zkh#8w+#pE5~i*#?!LSdpH_$W1$uo^IJy3pco7lq zqPz*Co)C%8#mpDLb=%6GZhV_|Y49S`EDLH}jLv~qWUF~7SUDNHc^@(4Y9f}6Qz~>G z8Vov9of|H@ON$W~JVrO-?^0_9Xrre{P41x?`AJakb=CA9palmg%fpNsm6VYCTD9yF z%|@rL!7?Wi#EVad&)d|#pL*hRPwiwTZnz1m{mchAt66^SdSO6idD)isF$)*8_GX7# zvAI;)ZtJa_;g=)fWH*BB=|d~9cL7|W-R76P*k+_ik)uW}m-RA{r{ULwyHe!LHlvZ7 zWsQ$|eFRVaAnjJuTQp`yr~i6tWCaLyb0)#H)+#hQAm|>t9ZhZs5^SGiJT&(4AJfq$ zs%klzKgzzxw>Cvdb<pmO7y?u)0 zF7=q&Eix7>db&GUO;ZQFDvJ2qdj-Pd{XvvIE;(EaJwvMaY_Qn%x_?H;G>kS5vJRoH zpG`HmzY#vWo23$aG<|(bmb2>>Qu^yPav~23{OzyP9u)U{1wHdfg;K;FN>M^B zqVAH1Mw1_6KP@M5Lj%6yvcrAPNd;3Rw7)-@s(oxN7|w8kuhHxjr%n!9hS_N-pUV!D z(B4yfUvVpWM4nEho%)h!f{_=#y*ihVj6qrj-W=EZGil>7@q0&HlWUuH>>0P-PdO+_ zTRLMg{GXV~HMx=QlNkl0Xz9GpC!gF!Y2K5I11iQQ*><LfBg11av3FG&%1 z6%6L1&k3#5f5yc;u+E4;~OID3SMoA94m^2a5JaaQ+>$ypBHqQ{!BEg=)|(F+40!O^_&mTNb{%Nr5&VUZd)FH04|h}$N|R!6 z-sm~LJB$_ky~lS`wkF#LE$_yW%~K`@=)T1mYiO7e+^=sdb*snCOpsG%NJe+=2p5`K zfH@v7>+N&ly3?t+4dz+kw~iQYTI)-4B~x?yk@RXwBZD<-OzO=OQ5)@AT&pSytdqw* z{?sEjg6gPUDR(nz`Fp)H(7tPPW|krIcUi9bK*S!}(74a_p6nN6su(fd{9%skcKnNO zk6zdc52rfUS_En@0T0o~%`A9#l?B0spB1)%4SpgIcgckAU?y&V2xqSo|E%9BR@nKU z3hyJ=dUb=tA)1{;IRQTt;nOo>#64(>{pz;MS;_@{|&_hW?(S!uC@g z1|vFSkxyxg?!nUoABiP7pw$P07>rm z20Q>+20l&VzOHZRLqm)RQ=E#i1!B*?hTqU+vSC||+2PD5lN0Z43o6?6GR6L&0tJ?w zAY`AW$+md(jud_$=OIyxx+kp(Dgp zYh!&YxQ!OCtb_AhJ@8|!nvJseync9uE2loaQ)^5;e{;gu}NWNC5-OHLp zzawJjKC~)=&{~@tgQk|YWa?Ak{|28;gN?z%HS&_OH zQ!YWZPEF0rwF+~00(T2gv}HBzF=2O{;0O2%NW~hn;UH>EI>1d273e19%v%n|NGbb0 z^X2zrZg5PZ{;EN}^z>IOtHO zCss(b-jeh`h3;HAR%)<~--ohwpp?a(`DHqt;IiWdP zXdpvv65Y2KFP#{T>|q@xN43*j#Pt9kJ?C@J$9HY4QGS5#`^*H%29GtlD2Ez`_#Xjz zWjT0f-Dpd^lx3}dsUX`SBHKZoIWgqSNnmb|2&F^6oza_4tV*{rh8*kTc%t+~R#87i5v z=HbVv8I`@WEIVX!Q4*B0Ud}lBjq9qLEN&Uqn|c6E*!Zn}7sh}3ALPGfA09`Zkz?m(IBibA`QE;pPtC=S(QeiA z*BEtl@1lyl5-ytT-~7bTP~vcb%lY;)K%76te2<=$OGggDcMHjMi!m%I6<4l6+ZE>E z=@foV`#1S7RT6}qv?SW(M1?$OSFlx8v7J}R@|>TdxHnY)Qq$_HpzCg`C?BGR^v&?M zFuB+++&gD!RtPpU;g#ral7b#x=Q65Bz6$Sq{xYqj#hj1wjnST1dg`R-Rt%Q5jA%Ey zF|F(R=TB0<7uCvqkZnwlRusgAn9Q4hvy}6K_uk{Lq*cKjU#;{7KT2NwODO+tB%Zox z(`)Vh*|fsxdy5TlmG+3ZfKpasApdE}Hb(eJ`)MR&``scUCXc-!i{lv(C_8SkB@A2Y!p zhFfk?DNLM z)jQ(~pA`J>k2M8@O@N^KFttF;FEWU!bP@zAtpAU^u6c;dnjQFy+j#~z^NhY!J`wZx z_I=++-T6}=nrzsXXOx24*ZUR}E&!ZP>82)RfTThGxe2`!lrEsF9U3W_?}jmrfo|8N_7%i>b)l% zn)VXwVSOWCLa4O3D;K!A4SgNVRp4AZqqYQXAv?Q7=gBT9a0=3ExU<5-DqCeI%-=#;gzvFQ@ZnXp7$maa3K(nD> zywu>=J??5hV#^G#lKO& zQ{?Ot#@~zVSq+MbQDD2@u!#WIJZsxOiQVM42DQ~Reg&#Nhcy-%BSBSwxu`Q*rK2(Q z-2D$U`U;X({`^hfmI1im5DdIMz+oy0R0k8?bRGDnn#T#4w1o3^Sfq$f}lH^ zrYX{l@q*f(xGM8|V3U|0QcyqOaCVHS<|6Z=0)P%xY@TqN!<_X<1q6^d=u4eFOl~ij z)l+QYHLDl`y9Ax$t9@wFqfQ<1v?yK0K8N2BRv0KnihW&^i5`y*@&>GUJZUl5Q6GlG z_Gvb0gI0$Z6%ArqLrLl+(%&{bpG0k2@nYmjH$;oA0lj=darMkIQzsppP+Yca$k1;0 z$o(6{mm@dF#I|8uTI$5ac@1y0FpzUmHP9hq%Qq{Qk})RDQ>5kgpnqsHA;bxEk*C22 z+g26o)@|+W%K6a-r`3FqeJcV}9V7xrXnb2Qj$>}mDX5cLwY9fJ=S{bAORNO1@kXOz zUK#mvVzAoEWqHe$mbIS@I}kWom%_ur`It1T7WS;mty;t=QJflN+($|(_6&X1%>fh0 z$^cV`fVT?&T6vNOOWh4oS-!UqO<5TipC6se-BMRqrq+b|S)MIUKysDuB&quA1($p8 zuux*~z7K%8%j-|cb(_i8Blny{lvKz_X~mur#?cYD!}euWK^-7;saWOBMdvn9^I-UA z5b5sN)C)41lEH+uW4*Wk4juiEGx7A``&&H=z}M{)s!j7TC3a5ZkEAE5O+EgvaLAXz z?kwySbs*^(ww!}dS(^WWqO1x=UHEt}|4mi4kypjV*_<`X50wx@T)~OugtgAkm&lx( zTQneHyAdVG@?0XgR2BDRlHR_)@9uK6}pfd zC7S)l?RmMi;dkA!UWmlYVRi3brFx@KW87!M?edW9Eo&VD=otHP!-Xe!jMQy`+s;gC z+htB6^DaZunq9h*sR>$T-AeILzqLVY7IUBkTkYtTurQ6N04^`Nh8*B#Op1htJuNI9 z+cy|r>FR(6^J1%Mabxz@Z+C;tHzQ`OCH(O6GD!Ty=sh3nAUwbK(VX)veI|m}qaQU8h+N zJ`Q`1NA>ihC>)u~*K@&_QS8D%diN5sLFQK@l80jSe5(X)npM*pp>?aW&RX(nE+)~H!^GVOs0Q-hz)tVew|Uw)qIOfPz!rPKr6qDvTT25> z43jA}U*;HXD#{!dMBfl9|M~AaGQBZGaDNwHavPwFyq5q6*vRXa)?qH+LJKv(CoC1}99pm+k^6oHPoEizgE-T``D`KDv{Cn;$J~%{BDYx$l z+@2*hJzQ9PK$L!>A>hqW;CR+|#>347GSV_s)7Y9;LN1t%YjXQ|w&%F&W}xf=A^bOH zoA!F7ElzEx-G}}O(6wk{$l_-D`jQ5|+3hQjZWGY);U0x8&ITn)EPqVp{t<;E%Y(+J zcdDsUK73n%O-k~(epIx&`vqB#SM_HP-|2=D>&C-TK5zv^Do1#e zjGu{N7oZ{v4*6&h^M#p8)P9$AMVdXDLBf1C?(_Hmnoa!^z!?0WqdETi%>4(+#(`)P zK+nGK3o3&_`^?~d^C<4BRcKcAqMawYyysoTfb88jf7bl-x=61w>gvy&dj+O_@6gRv zVZ&?r=jPMfY(q}V(?8YmSWF}Bv)j#jz<}kC5N;|5-x#P4t*TG)J1u{Ke*E>|zyrJM z+?D(2^}Wi0W2njcvowVb#$Ew)ydZ}?a6fu->xc5Rb~LnL?T4Iyh>Z9bcQ^4`{kj^`1Sy;Z`K~b`U9JI_8FuFHhOHH;F#y z&F8{>hjl<^qU7P_;q&e*X!1HAfY8Po!%#w*zpI8`nKi_y38Q@@sKhG_Xca&W>rDDG za1MlnUmTB|Jgu$Xgk3wn(}G)`?KmFp{U~AOPJ`Fr8s&*Z&eGubiNN^_&hTfhIv$o?2pvlb^WGj&O#gr>f*=RHGS?4`1>R#gw%kLE4AO^ zMPHmQ9Wt?9Y|W9+hK8Eha%bZY7*ZA$0tIUV69QV0>f1NDesO5!Y!uJC$lErQwUV`v zQ_v*(*YL7lPB!myXnaBBr-lu_-nYSlUDCy~4GHOLQe@wm8TWj7n(XPfYF_{4mf@Pi zg=8q&ne*OQGd9GLb8~^(eCl4dqwSSy{@eTI|uMNKH_Mdr8gUXL} zrnh_LvfH~&>t_u7znI@|Pd?!7=2o1jt8wcvzZ~&ZmiD9l;??~V)vnxGfTJpadYg7r zW8Q9{9XKA$UZts|^Qz?Ky-&;3l;fw+NKY_%!#lLMGUzs`&o)lcb(+4A!L!hBIBc!l&q%sXu`F%P;U_sSWSq zi=?kr4a;GEoC06P**@#enBW1cr^ulikq948+R|(Y_Mz=5u?;XO%6146+D_fxH2372 zuOC#cyO+%~(7n6eoaZhHuB+fZ^?2&zDDB)^o^LI)q!>71&Fbhb=Q#s8S3G3Ua-oim zaR;HzD8YnUe20`@nD9ov(|eeHYd$YdpfpnY5|34RO`S>{v(uvbZX(C zGOVb_qso*jTgIG!#epZX<73R)KAMRd4}#hp))Rx)Jb^FP^ONU<%8t*u^{rH3(Z&jlx7xf{@Wejg z(VS~?E6_G__m?EYQFLZCu`Sf`OHqdS_3#MFCdI4|>zItM>4-Zd$^!qmDD`>L{13(C zGC5fbd(LPr;R(FZQ1$hfi8j<|8oTyU~U@=7mM7Idjr<36iJ)19Ny3!}E= zNJGK!E&TkO9j_GA3CVjIF6NNWLqeIBeH+Ahv)cQr@h_~m@|4uy)55wf+W(4KuY_fQ zQI!iTzp|or5PGf_I+3l*&5m6!~aOjr8)Orc0Z9NN62ltRCY1vl>6zJNH_))SDT?+IVG?dDH#f z?x-xRH$i0;*$FZomy;xP3o=!>kOC{DQ8~u0T5zBlCvaV{agMi!v2`xkloK^E4aR z>e}Z129i8|v@-BF`PX(UfuBRW^SNuCGN9rb&`T>9d{%H9EbYc6Fxc}}3+2YU(x>v1 zl(?@CF{{EwMF>dS34Bm^K37J^JzVj)9AQ%at_JZcTfB4pHO9} z&Lje+;Kg4u*Wn!D6kLkmTgj-DPF5TbXDn`atG2t!UUoA}#-r516J;9cMD)EZU+f)lpA@DaKa@dZBRSnMmjvvq_Tyvzv5AtD>Cx=>dKhEpN%K}PfmYy~lpFXX6NG(QJj~fGG>Dl^ zH)@SxWGs(UFOeKMU9$VRrpeTzcp8rL5wv$4X*b>B9SaJu_(>n*cx!L_Hg)U?xExeC zmIm;!%@yTkVfPZz&$TDs%Z`1lmwY&y*-JaRBfBw12NGX8U&x;EV!BIt)(X>s4=NfP zx8Ivv{ZKJ6jVwt1yXWL=dJ;3kyQyYau*TwLw~Y6tFEoTy&8BM0ifT!*(i0w(`okM- z_^@VKy6xqLb(4Bg`qQ1T z3HF!Ncf-t?XtciO^kVn?-%2T-^6{TTl#ar&VO%JW`&2J;JepH*9J=NSn%xce`0k&0 zLnI#bj=_-P4}8f7Rcxdx>~J(~BRE!2HO?)2e$xDDhQ}92-Y(@So50^K0t8?+AxDlM z=gT6>MtB63vg07=L60gCU*Uqsv3f%mx+7%$X832ffX;kZQw4L|(P>_lc4f(tOnQV1 zwk>{Fe2kwU@1CA!^stBaiE8_6#SE&9Yay5u&nZ3zkj`ueR>L|*lk$+k)G`^dbpPsm zpIzO`+Hge;Y&r96Bqv>U*yPDO^&Byed(j!L!@ML#(?6~630keBCEoMw@e2}L@neuD zt0AJ0z}SSs8Zvu!cyK&*v8!i~TVS92WB9`uh$>8b#LEYa~2AQPAg9mbpm6!b?E`hP2bmkQbhvgoxZV{VUWqd6yp{1w^CO}#kPtV^(77?zKzz_T% zOy&JI-HDp+Ir2|w`1E}Fqb?}os-d_b6f>zZ+&4wG;HhHFB9Oy_h{3uwG~bQ5QWd~_ zX^Opq&8?voT60Z6J^OaD0qR!0V-z{0YZ+-EuUAo+IJ~|YYoV^3((B#u-zGb4T~@fI z{ZHZ6{kIV|KNIK<09J$g<0P7`#Pn*5d*n|S2$U13A&GHicX6@)F6O6wTTasNN zl@8mTcL=ZaM=lKw);O~VO*9r@=1j=AyU*I37o2b~o*5Pg53v#>d-IUbE^P{Ny_B2Z zVV(1LuP3lxD%*x4EaBL88}_s}^hW%V_~@>q%N*t5=RV6rHaAs9ZMv7j)^Y>>bkFYY z&pNTp_P)XUws>^259>3T0^Z>{5_-%`y=2a0k(lJZ+LpX-tqw%}!}q*~?F1*UTuLU&66x?+xy1itkT6d%!{lIO3$8&=W!oi8(lgGsXt!XYf@ zpjRkAKFE?gC7eiDm<)Ydy{CkKv?>QGMb!uwR$6jz=ru0?wOxvA>orB1O@3>c7!mq6 zlt|utXd&RiY86MP%pD9vk;FBXM|y8ftVmqDtR7NBZpGyI zRXvwrxYiT?}L{X2I$tJHNvYM7h$AWJ4hgJVx}IIB`o<=V!3pUSKd@*Okn{pDnHdzR#vWL ziZ#HA5Ub=HYO~9h+U9MJfg^eDT^*iO-pZW$2+r^$YZhjfQ_68MlON&&s9q8X% zWRR1U(FE2rY|ho)N4kTm)L%Ed0pwHcm0mdnb>mHEt3e%kGZ2VztqHKr?W_G-E*K{6 zC;Lh7|CWh-gCPCVcC}ezK8!H_n1Hco0~>$w zoz`T8lF=Xj=U#4<86Pt`jngg=?e!wQ^Qo|$7>Ph3Km$zeTgWLSd;w-9^r{CMa)rNB zBqJWNhNaeZ2+sphwZed)Nty)vu{x;wMfQ$uUd=Oo5NG(*wD#uh{N?7& zs`N)WxN3dD(m`U@#fgdpGk0&w@M?Ri7W6FP(UN-kxbldkeX#qXNXuY0vEA`17(QV= zcHgVwt|Bt_IH{d#sBCHR4|ZW_+?fDUF93a{Rwc}p(@+;K%Y%qxufGAUAUOG5%ADUU zFCYi|2a@o_tz&>3LunYh6nX9J1$XD=1bo6H-`7vkaaKJ3?<-;4uVD+%lsr1@$wM}C zGu4;M0knUMkt4Q^3tof-G9J3g+zx(duEW0-zz%XyEOg2#+g1v`NfG}9e+RUGDH*YfiujSP;k1exTy}zv75B& zd%*QreGvqTi2P;s*}aLFDah@}1H14DpfCI^TdwZhk<87@A0xp*+l$d8vjM9O?$bj+ zgZD-JDdMEO3D~hkg8sz?`PU*Xm-3GFe&$;rKv6teGs|zfLU`rW-wjAPB9}t}YZO0q zE((WNh5hLgGgY*2wb}m_Xw75xW6CS>JhjewP4FUbi+u;lzT7E4qO#nXnPajSyvj>%V7D;}D*ICMmUBw==FpAd0rvNTF$^u7(c!@&>f(wCr0lOASLl zD&Qr(->PhNfIH$y5$|9C{lZDl0kQ= zYp=SrBsUek#_a-a(5Usb9I`P?j#L|Un8kgX(486;!i|Z-4#}W4lr}eR_Nd#tD72{4 z+kxM9+n>TBC&nfk2bAMwy=owt`6RJMbFCWop2syc_4#gJBM>~k4$Io82d@>KS-#=e zK-)u)PIxOX5{w*mzM2McVO+IGCYKntU5W~B^V4nb2v|7lho*?XS}LZXAWXz1Q0 zo2y_`5%4*GOna-0*#cv*BwQ;TbmCIq5$_qY+3ahkkf3Ox487fO?_j2t4Bwg80$mX( zK^vBjHR+g^Z37bs+-(P^db;NB+T1WUqRB#wLgcv-h!PDk>R8pzuQ2V~MA2nmA#ABg z@Ju%dG3e|Hf3k$Ws1VQ67J4u);msF_~jK&y42_SGe|l^Kl{w^@Dog>KyzA@7qI;v z$(X6QII{BZc~0Qk5q1LJk2tupNb`zbquM)(yWZBh`JHjbnZHZz(y{j;Ju{nOXD&QRIzXF{%Weo!hxn+RDNJ%d^Izn$k60Zdz{>gaTf<`NiP|%4q;2o!y|JP)#}+UF8XAu z><$wdRKq`-;h71b@Gg40!AB>oXo^!xRx`JKeFRztDK6weAa!i$D}H&K{t0|()1lny zOX^x7gM0HH0Zv|NTG;N~^vLZ5tA%@Rv+ldVv5N-VuUud&^bZkX6EzB(8pnT1Y}4?B#gWF#7QZGiTYoDH8r?4pnEqZ}iYN+Au@8hEV{A{oy}kvD zxW7iYhee20`|d^@w~FjUV>LbhWTMTSGT8|%AEHeWK&N`oILmntcfh+B9eD>AU%ir{ z%I*p|8@XN1JQ-BgUVAj_&dxK^#ZhSrULnrcA^)<8S8~HE@mZ$qaBCm1C`r3G(0UPnF#H2#To8CK6^sD) zU|km~p1i|1J2oD+7};`xMzrt~e4GyMCyIq0@|8Znk!>V0a;dMT=gL$n&Z+GV;xx+J zN>&}F6*XeZW0Hh!dJCiJf`g2KJiA16fRjS`Bj$6JFApWjdVi>4O2XpZy2WH{n@ViA z^ZG}8!<;bs%bhybh%4=GP9}7ZS2Zo_bploFW<1R+OsI?7m44LXnHRo`9+Mrt^|dFD ze8{M3^|F~yk#Fx%d?wN`)xTt=AW6Qx-_GwyuNf=WZ9NI&o3Pth$OS)Wa#kKyMqcI5 z-8=MZ&Qcd?F(y8f9O(q%sf>wHVQ26O^Qa@>T8nt(nCr7}($#zBBS(vp3_n?%f=fma z3+*CP8Rg63SHo&Q`n}(IH4y3im#70ilTWYD82>1-@bspg+%1d*57MI7bPZjzD_ZsfbjYux;_*_x=((Pn-#HWN(i|Gjk2IzezHfa8N z7jw6<;qU-p>zIz1@xncPprXa6eBqsHU@|Y^K$~kl%Sjp>O4(wamTgLOxWQ|vBv|yS zAQ>yl)t7oPdL?IC2{j$8cL1r~MtlDuF?>{l#!YU|T}(5$P%TTg7AxMLnO!>Zs((aJ zX?S=S94Y$iH{eOst|_WH-6T0R+7+!ftJ<$Jxq8Gc;Oc!(%KtlR)63KAFTio!%gTU9 z0>jtJ3`EPT`Gq@`c%TAabyYp^o9JIUE~b+tt1WLV^Uf55)U3V2^kgT$>x z;xT518%5(UCjZQ@nXPL}!OJ>~v;CI5*uQbZpE51J>a>3J7-FU!r9jN@!CeCt#Qiqx zVmXS+P#87Lr!>tzU~0SY+>G zaZUdpp|7^w`fw*b7^U!ivauMnte)v?a5y?*z3GvDdXb`JYA~K? zQqknM@C;VG<*&+ykAv)$_>v7Vv^sR!Y13#z0v)cEAb=BdV9M)@J8mw?TLau$vxOI-_Ntl}Qfk@d z!1Ci!tvbpU1k;`<{a{0;jkn^m32I#02>21=msPPyUHrYS$8zRFeRLMcX3Z4HKcl{2 zA1}iF<*i^0yQU(Zoj6DR>UYdAv^;RJRMtzR&}CLBLl;w~YFdd$(cX|0qI02+vA9Nl z^Zskdq}PT%V}N$+qVIZK?U~R{xa(r83@s{XMSv$wwqG#MXDi!&VM~5$4JlpbOhCN8m zS~l8;ZdlE`RNO!EY_-JnAH}3sVcBsQ=EbviXPxA$?(?mrzOtL90<>W=dj6S`OZ{@` zPEx$~ZSZZRM48zl?bzYI?b2bvoEl+!n6ND!*kAA*^LJOMj*`^7QTqoh8L!y+~|23Ki+T$(wO&9bZyoimrP`V~v+T zCv{n3Q>|`-{^w2WhbX6Y__t0u;B#E&Z)efsS62WYO$E`dj=g&V?o@Q=U#j06m{a2= zdM5E1r$Pub)Kkgc)G)!y-SeGBJw(HtGz?ZVLVOKyat7~q)sbIZk#R!qq!gK~TP@T$ z%JJt9YP)2KUH^F~EiFj^ohk}nP%0+{Ttz>n)Rx$8ZGCD|^MQYBaRs&cyI@&YkTX_W zqWbk(hzxG~wp~EzJ#Cg&{5H+1UiJi6G zg5hp<{kPdKTcG~&e-^0s+!CpQq-3{7wU<9UR+|c`_tw?<-#E~ z0Ru@9E#~O9vY87H2RZ-1s0uX-cX1sFIgt6Eaj$6o3ctXSq3H;5JC-sV7l%F!4^TpE z&mKFvNqgPMKC+rS`!Vq#J3nK{R{S=pZf$QzPo8zalbY{B+(itA?10CFbymoKK2g~x zi6^7Af&vZkzK;&hm->l6zqIpm26>Xyt5|bZd+MDpcn$6fq9wh0N+B8V;pd@$j9SEE z4D!9HTHBGe%|z>)7Qews;JrcpsiYX7Q+zTt5uX7G^;)J%<&Na3-ciLMP)85K^ezoHK3-Or% z$P)cW1AO`P1HD-hS`l0qJB%RH(+-krI5qGr%vssXzH{I1kS{ryBfOY>z9IGGUs-*Q zF(vSjSS9)%pC*{6lLbHTjG6udyjJA5MN2r^b~Rab_>$w$olp8a%4l$Lw_&R zbhb&gBrN*?r4B5f1!%8s2E2*#j*prNigP#C_*2iKG9+YTbd+MybhZc7P(wWTQD)*-FT^n~C)XG%!-DI=DYZ<4fXkdgyR1#;JTg$Ya> zhs~9D%fmU3?6a%6f%l+U!SRO#+M#G;k{x!fgOt^-WdIBcNaa*yg!WF6X#46A_q%LS zf3}&9n=3ffKAL+t=)?<_*({>G#v)SXB(W5gBgyhX!lRkB zb*msm2Vhn%z4W_ML}rxkrdNU~QP~bVl!sEl4w+rB`HDB#UXR*Y2W`3>+Bnz4i%Tux zy)96RBag&+&QuX@9Gf4+eNRnjVGrdw-yv$7R_|Ojg_-}9Ak_rSk@IdRjh%yZU09X~ zV97x*f6re$%Uk9rD3_DRN|wH7tvx7m;vaZ(Bl5f2oLjFe;zofJ?&1l#37wPDk749a zxS7EHKEDmMpp*0Qp4xzmnP5Am4W)lvCitbbRO*8&*)phaT+Bv38^?wHyN@f5*D?Y24SBvg8&zv!S zrvt!XBbc29#(iKeACXr#nBTO`xNg=`;&!#lOb_(7083JybSls1WKz)vG4~!E$rS4@ zGE@c(T7jCK+a;crq;HaQ6F8v)noB$}^%(XNEG5hE(LSYO$sCcev1TRcG)B5h<{pC1 z$Z@}3y6d$wywqs7Fqy@8*ihE+wtbS;@%s1mc>*?oHQM$ri(GBX^T(J)60(t}2G`Wo z3s$>}?nlNTYxiCFDar>xHtzhdjZ(X2RWwx}7V>kfvs~fOWXyzgM>T!n0{sdo+5A!C zX?01P+}Lmf&XFn)#ky7LvGknv%T)Qa8)xg4wI8Jz>#yy;*YyckEB_pKN``�~_rk zx(Wx+5L6ADuT+oa>PJc(z_)@cp!Qj7bMHC)Q@^_K3boS3k^?h_mgqpNk0TJlK;l+ z{*0|~66;y;d$h2dmbY<|uSK6?U%gA&Zpl!|aUHg7QUA1f9aBOIVgVb4UJA`|%Z9e6 zfmm9>L$nonmoeSu{^otos8s@932OE=)%MMGVJskdT62<9Zv2Axf~@?lgl4^EO7)a# zOB5+O^`V5|Q%0~GCIA%0yi(j6c||nOtde)h-?~h>7g9`+&f5F%Q_LsDgSMhzIMP^7 z_8A>w4UEk21|A$GVvwTxP2uP=D73g9D(sa12M?D>g#XwUZ_rn{CkZzq*y3ZJ zkx${G@-sG74hsicrtZO_mQZ#3zeHj?Yr`=n4D!q_Q)IkWz1SA%WqXKyfc?!i(l^s_=KSSa{|VLDjQ+GN3x;CH%n<*QRKOUMRy|i_8V2j%(9sf z`b>fJ&h}QJu1n;n@>b#rmuipkx??V$xkp!xVAA>g5~{jOcDwCdCio>n%c3l3gnKi< z2o=Zcux-!Oi5gPzLIs3W-+;KtUIKC7oap#H^{4h0!8+*&*`$ZGf5Y%)Vt4f+-c1VLVg1Nf%!|H) zWpR6P0`EEcM>Irv&WK=-xm~h0w?cfF6aC2Ziib5TPZl*}!WZ_n(4xCEFm14Fisb~r z*P}&Y@hs;Bt2*vV(6nw(0?Jdzpd$JjvrVfp4yEr(3+Q%zMSo*CD6OQY?pHgg?9=HoF2+^a#>{`+n$4fE)@|&Lz zfD0P6W-Dzgvi)kW;$T~{$Cu*&LCcl>7^ek-b5s$LvCn|o@PUnhp%@>0rd^-B7EmJ! z61=&a3f8D}%W`|E*Qxiw6We9oUU#*dAN>Ig-iUUecb(XxGmOBCQvsGU6=pbvjTU?m zFhb~ISgJ<*m6NZ#g7?TJ+XY=?k; zJA7BEhIl-PJGalUnT737dL_3b-WwsNC!Mkq&XsAu-1^{2G0RJP1<4ei|J3Fh@K__$ z3mC@xVPs3hd`^qcYa<3tvk}!5?@g}MmWU~ph6HT^!E736}dJwLC!pn53Xsg*H zM~Z#!n=}n0`jkm>Z|oC{Cmr|EGHhVru1gu8OblYa_`}~#e@2LNr(}G|-wm%#oJheR zH8y^Iy#7SQr%Hk|^{e(XVQHu!^|7mY8j#VF4WIZ3TlxB_M)ph2t_~%M21?w-*)e>p z75t8Ea$_L+1$x2|>3dUDUK>;bdb1V>X@M#WwVaSjcQ7f%i5PnwUoU3SM}-|)8iiI&Lv%rTG{rfo=WKaNjx zGr=N-#O1?;@oA(|K7*>XwzCF|4hVSzQmrzCW2+ysT^0hb1`o3&Z3!|q!h+<&KGL#h zW4)d7Ow_uQO!Ky?W#Xa5RBO_P`u`0{A)OFg^3voybWFLG?2ZH~@~yU}EjYd8R_!~v za-l9NLOkH7`@}u`5mW6Cc}aVGyBf)x7mjckV`;dIg>8}K+W+zgk3uneny{{GU2Jw1 z+^hE(yjBwvTI_<_ZCdiTep~bn(mT7eLq>3WdakQWbfMVmNZAWGhEN!B+04n*c`M9L zof`P605fpFW3-{E|kt+d*9#p z{@wS#uzf!7&+Gkq9v)s%hf>h^X<^ZT9mM&z7jW(D>f&u!OqGXFbN4D`;Wzya%O;9z z{Z8Q32gL9KdOZ0O`pvG1#<+%C*Z6H@_(R{RofWvy(dht#<8m-=B-s}N91<>Sz`?3J z^ULe1Z|0F2bSm=IjY(0Qms@FYVSzpaQ@$JFJFlL=b2iO$>G27{a?bJB~&g25D#F4-ryyr_;2yA|dib}N(*(XLEAaTQKP zR{a)O;^U0=uQ1*ya2#6ka;cSg} ztYqJY1z~f?plkUJoK$G)Bm}YB4+a~v+H0d)Pw!Z1!il{2#^P_^9EUSM3>+yKTxdgsi8Fqh3Fpx@u>ZVrpDG1Xqms_-q-udOg(K$f{F3ca@4CX z0GDn(V@wmj#@}WuYd3X$n|RIl!a#c->2M#s`r;6ng@doD0Nm@pL;=d2*%W;k%1X|D ze~FcG9MLHFg-`zz!sf>csQ)51nR2|>-e2r8Y9_LzBhHzk}eTN5;25xji{ zC}E&=3wRYL|6uNidd&KfDy406(@>=*@5BkPY``grmDiY$C|W7=lr@Xaukwg_re@n| z{H23pd3+E>*x^;r3j8iEOe<2%3AN$N%EEqd_N?BJY_VJ|#LPA+l4s?cT1DdwdcvW>M}<$gyWGcc8&L z3uKUNuzj#&@cCF=;CGL@-69nEMvO4_o+P*C1T!JM667s7fHmwU=HEc~WF4%xu9O9Z^3_$8BOQ zd=62|UvR%zHti&(znZ|WkJ+x;;RfoWKR)7i(XmOT`<2&xtFB_mExItd$4!6L?cu8g zLm5Yn5iXSidJ55;*J8WzRp(_eq4~~~)Q^nY9L&yS%zH+g;C}8n`Wri;**#9(RGF{t zg03EN7g}Gbtf`n)oQckx(yVBs^(*gY=O-T2HDtrlHSq9a+ss$sM-KMx4(gjUYtwE8kXm*yBmR#II*h4=4?DkHH-bd z{FpOmey9WeOnAg_VRea1;lWV`8VmC@2Rs*XipaaZ!wF$2cQx8F-PO9CW&g}9UcPjACUZ>q0 zP<)IvLhny>*=f0ZESyAxTNprwaz1SkrSrJ^YdY9?&>z|IIh`g)E;-F5%XEG9ZK}T- zJo;saKcUy>xL?aWlq*+mu*QCKRD{|lr8CEjpt}jl#;S8$`PXg0=x8T7`>U1VHzNlX z+oGxuF@`OdYqi((0`1>wMH^Bt*rQ?Ft&D=2vCn|m^=dcXW&>_%?Hwc(!i?v=B>*B9 z9EeJl^o!zzFI$3F4L&Pj{;9V9zL;yri5Goa5<3eHvDsfFrDmyvZ>YP0(eJED7a_tx zU+5pVw-YW;rFn}5FVS;UTe=D(AVncwVndplOc@`&Yhhb{O)Cr3yA|Czs^oiBs&g6l z6I(c6g?koFT)CDu%`>6pZGBR7T+HKrwz3fM-@?X@QLremKh;6NAJ@k*#_t8Etz#zz z5yNr8g-gFNCrpQE6zjEoURARf{GG=*+FJO4@wx#t_0V~-I;c-_8u_);DlB$PNT13M z@~Ryl2j(L1)7QFoGaC=5oTy%?-lxxn^!IccXwUvSD`KQVvJ}GdoP?z&X^jAIR4{)L z<~sT%int4C*{jhaHV;sLOs2eP5%MMhM#xNH%slD8V~u;M9&!_9L^_jL9M}8vZp=Bf zVBZpc;CyE_KNHTu;+lj`3~~3Wgli~DnhAlw)HxD(3BKM8=D_-DzB{fW?AE@(S5tbG z1D7|!@cq_2`K~%y>bG6xghM$vD}hEMgEUF=-k6D{t6=QyO(yQx3Rl|DLM~g(xqdSZ z?9m+_>>!nd?z3oOX4l4L z{;!EQBoImp3F47?gdv42geJDA2Yf*OaH+(lL^`O*vwZ+G*MaO9Nb6ZBE$4;_>(`<1z;nS*W{@`V* z5up6wcR1-;S8(!n6LlnC^OPIkB}aX}PS%^>SIKXl<6NP2k@R{rLCw2qDZp1IEnx`CX?vc-D>uZOVeey9f(0SV?E#q-yN094dqX=T% z)?#045gw!39Qy)zoFB{6d_N$0%Kn>B18Eu~!C{3J6qXr>%{XZ{bHWy#FiF$dCmL7_ zo#)*`K4P+PsEe*Ys)XOgTN3}bqz!m0YpVI_>)i6@){W=txUIqMqlo|qs8i#QNaX-l z*sI8;NQcc|JW9z~uO&t-ipXiMf%Dt!BdF+x9qk8#D{jZ5uc;G0YIBeYHCfe)x6*c~ zi|{7Wg4vHY6{F~gc7MPzt@_~B(^V8(n^Cf~?y>#y-{i_rVlc|ZNq%=7-_4vVJ^67T z|BKNT$LRK3`4hv7Vw)3>Zue{K(h(lluJc!lf9rd}{y~b_svxs0c(1FT&Q^Yj!CvwOd!p{g1Os5V=4( z+I|lr##bE!wi4+`$Ee=+FPVQp4I(~>IsZHUZO32h4JF0D_tEMY+7EdG`;n;Ej#I-x z{IMY#kA!0+`BbgU1Ie580C7W3V9bMDTlv&yk|1y zJ6$qg$J2-+oqFdbF5|d55{Uq`cZG#lKP&*(>hA10)~%2Ljoz&>_&<}^FdrM=Aopt# zz5a@PtFQGJW4;5jVG%ZNxl_;gdPd<*^r|`tCAQhU%Z>Y%Jgm8oyBSW3H_~P#!Q8q{ z`t%(SWQH8FV7cCPfudp*NGi3S0xuBaqb^K7n3}oDn=VM>)thXXeAqs_cz@Pqw>f&s ztt04V*OZa{@x5^SGn^;Z9?v}+J#?{r)^G75K+ zQ@GD91s$BBnY2-lM6O>7SWhWgxU-+uu!Sy3S=s_amSxoG@%HuAA0deL<5=ZCf?}GU zw*;^)&bOcvs4*EY{IT13yLk6KcGaL!*Lim*IqiNHvCFIyph)+Lv5UR$?ZuEi>R z(Y`sekPQ#zA%Avz1^qe3md(;Ry}E(YZ9MPL;3(dskM`v&KR#aG!n>#cH_%iLp&CU0 z1+P@IKdu;2y-*vv{2#k^*@trX#xrB*9CwxRch9#rIJ&f;LgtL-g1n4A)!n+!w^8tL zSJ|zqjd3d%>sT9-te%OFGW*1niPlTmzkkxSiSr^$9;xsnL)7gtL;1~(8g33Pq0i0b z50uw&qrNuy#KHAe^4>{%obqb|;^;jawAW$Xc{QUomAjP&OF7ahE(WIx(LvlTGKS? zZx~SX&)GFB#CO^unsg|KBRn{^!A0*Hj7Y1B8Gz=M^jXxCk+yjEGOLvgT(~W%RaTB_ zv64ND+GvVY2`!@4j2l+P%mH#cJ4)ex{7Y7?9m&Nkwrub{obY+p2BZDXMM0UNuW7_Y z1jL`n;Ar|s{<}_B0tHkKHj7+}3Se2D zaIXP^bQQlwcLnAQTL)8BHx5%mf2x2@6DkbmRr+FpnnX;77JHBDSc!=GQG!Y&V{XC! zSpd~)`=i+0hE_aZ16nnl7R37{#g+I)y#W0-`cBjQazyr9;16KQ<(tL=N@gEwJJ87` zZ7*>g_(bvX_JVlz?WsYFR9_u$spvrZ9~M=o=h9^`_of`J%8!-d-*RFT+~g+w3Jh zOZjSn-IbF6SQSFg0hW)R66a6GxnE z^p;&H*E7SaPEtK`wW?F6gPAYZ#Swjz(&N@1!ui31C!7Vvb_XQ8#y{$}q}P3St=Z$y z{Yr&1pe2D+F&I*Q(9!c!rxrbU_B7_Ud|xg(6RIK>9((b9e4=S{tG&)E>$Sedti9C> zAw`AugO5bDl4*AMk-Gk6!g|LQ|G8huu)+uHugrxDFEpdR58&^j$+Owj)V-cHms3P~ zwB^^3`ft_tkBO-2?YEP|`LO6+jp*<%@JLpnMl)|c!`JOV;ARlj$SL_~(V@73c|T*F z*I8gWErA?d%{kWp+e)&E|MmFjYLk(qVoru>L%*{CeR^v~jS#$3IRJ_FsOKIW3MuG1 zDj)^^RtP?)7!qRF-1c=r+)UVChN9ZRr|3+$xvwHp*60gwWe|WsHb@IKR#G+yp;(yD z3HOR)fwHQwsFu{y$>taB|D@PApf(q+MR4R<^uOmN)}$c9zxF@}ERZP*k4CC>mKubp z_*c@78Io@K_L9Zh^9s)LUTgUAmsAOn+Lp^WB)U57y4T?eb9PyV$K0<=gP!TWLS)** zLT&F8iH@(aX++^$z=QaUlN60f{*&W~B#tIn_$zpK`BX~gUcb79J<=T+^QOLvUUPJZ z@739$VsH@;>XNm9(p7ogUo2O%Zr}r~4Atwj-6y6nXR1LhQ=(E2n%=oWZ7Mzu;7e$C zxV~J>b`|2|i;RmRcx?jAW)a@?IZA6t6#e|zsDr#=frh1w6}lLFy-_Lj?SE%5(#*m7 z>gIbAYHD=8Qs1Rohj(j#$FYGVeE6^h$tf?Kw1p7weZib^`H#Ks627qLn3f*~g(SO6 zA}XgcezR|K+>yE86?SAy{glU=N`5}M!^n8qr5Qm3|BB;a3fvn*f4r&-f9IdF?lv;Z zIhWb5MC}h}<+OE{e?sKjdQIf0JMQsgQEO*J)>dt~8P7;)we7L7LO#^Git3twF*hOE zY1*K`v^l1T2xHzK=3Fr0O=$PKbLMVsxJ=(?bhGaIPJFkfgnRUgHy5SU)w0=7<9P)a zW^VSk+FiwkKQjp>iOG!%nvNhhFC>?lyh+)^4$zfSvSP6H+&5U)15&1OA!i2#f5Ai|N@l6plutZFg&**n;|D|fTW4yrV;p0h~OU}hfr4w9nQUT#PC1rOc!-{|R=V^byV`})Xj4Wb>+tr-|tqkxoL z{{8q$bhpov5B2xiA`j=oRLh6s4$Z`0{W`tdY;TtK8c?A*}g++1Idsa+Wf<<_l#w8UMN!WjbnMK(-pg4=|J)PkKFP) z`C;EF`Bc|w`Y13xBE+1R*X(_OuUl5@e6%&-74UArG0J1@U7WW?%a(7uJu** z1Fj)Js&OyVOGlYMct|JH2ccMqw>;1icF;tPH+(G{sKVC2pb1KnQ-li~x?U^D< zY(GdojwB-V$5PR{3!X`+Z&ySX>aQ+Ksh8rvoO$mtW!yYgFteVPwD`PGf^BcuO?($a zg5Lq%K`y&YGqk@a9d(WR8rX6;a+!EIX7is)r+09Jy`=3|MVGZ-l;(x)&5Hrn6y6wD zAe~x#+Gav4rJ!eaC#S0iY!|;?TFyg=Q(KmESN+WLf$fl(sQ9k$5zAAJayR$cYZ%Qv zRHkhtf|Um{?coEHqMzA84RmC08$+w_qS&?L%u3~?M#BGmYk z=WZpc?Y!d)GZNTDV?Klb+5wvGQcNO5c$VmM+FA!|ZQf>;A&09e#d$d47*X#SkL9r6 zZT+kh>I{>D1)6WwIBIK{+_VmGu9;bGYYZpv_=C3>n%wWY15~0+E{0QpQ+oNY}i&Ta^_#MQM7)Jk-a(@^bs# zwRC*)^l}IFlXU@dvAAh0UgylNL+*8!Y};*+U(5m#!(~e>#1Nmr-skLZC!ts24n9jX&?y&1jSQX@6n6R@^H%vaXN!RvibUWNYcfDQ%y=%ZH z-CnD_uGHAxNhs!jt(xYPS~6;5B@Mi$>#v%`Z>k2S)l4=≶-Z=q@nH52=z7YhDMg z{c&H(u_FL2}r1dI*8rhMGJs-R<%#nUox_ts0u&)#&`e9#UEvl3S6tYV_X@u^t zxT_%L*2O3fnbv8a6OZNFlB`lpx6Iu?`#I%bac1RjcbT;K;yyq^m|>Dg>)H@4Kft-s`-+-n{IO{UNX2`v}^3_c)F{MW-+J4 zK}~J{2YzY}q~YAb1zcBzHVP08U)ebTJ?Yy%IlO)I{0KQVJ~kc?ZJc+>rnZ%iU>rb$ zS0>46eB>!OaBYPlQ3%*~nO8K{ewqbwgS?TF{z{EIQBBf@3KfrugnL!mPAzr&$B&Zu zV~U%ONnJdp>*LwR|4G|cEsW#=EeS~&c*|7pE9D%<>*bzOFssY5gZ+98fUHdDo9`+s z1X`Wz92?!=d{GFz<}>a*+%Fv@Si##tq!99^s5?E(VYj& z958M&jewwggzUuTka7Du)Zs>MkKX;JUu&re?`EMc2DJptp^vwxYw9?;w;SkIYm{K% z{NZK|A|yBe5Ew~J*Z}-u7}m}5#L_f(5Q1B$@QX&5ew{sCm4$VW=OxRwOp#vofM?el zI}mL3N^YvoEFuZxxj?l>c^OrU+zjrv{RQh{`4h?qq-%u=9u1^)I3dwi*nTcdL-wW- z{tlcIoG#`8ov;8Rvbr8qMHXXxT_zKw9Hj&aS~tL6hS{FW8iUFirOfXfL2GZ)O&6YL z^*RbRzCvb}jk}An_$qnaapQ$e*NPO!Z|H)(mAZnywvOYI+NLnt$EORcb?fB-ocGc3 z$^cHE2wk?1c@yTBcg<^rGaS^dFv5|VwY_fV@2m*YL*l1v$cbth;Uou&N4<+ml zEQOBa9|;iiBckH!X$QTRY&EgKxpKq1i!({>+42fk3ktn$z)_6qGdTQ5!IZM*oM!w5Nn&^V_&X0wN?*P&O7Bah!|Ffh zO?YW}y+b~x8J(4rj2kJ_*qjItA=^9VC$JnHcm-#irlVVEx`)(@XX88@v$t~LBLA=( zaUt*cpUF%h_;hZ$tV7oTZ=4XodAjv*0q52bOi=vUW9AV^kvTM(nuMSn`6*(89yRRq zUwhNM`kPN7a@Bp78n^7-cOST0y;TfcGHXJ5XF0}H1sMO#hfbIAGa8%JoMu^mrpOrK zqd9tppVKTJ-mM&hop~B^ud*KJ?jk49Yzf--isMN1hcAvRtmj;xiMZZBkrV94%AbzvG>?G9rzDCMo*2Lu zq;$WLvJD~2Mn?yBzq#Ny@Y@D-2G_J&MD$oT$#MxBX3XcT<>Q-bZCs|!D9Gsd?l0Ko zlChxBFOKy^SZN~@PP-;rxPCj*2DAWR*Aw;KgebRWiZU2iFh}dFfgIplL#vSlKZa_n zYVL+891J#H1?S9$JZcoQd*;>W%yq}wa6PzO<@E^P{9-3cbq!&onC>#UK;ctq5V+eF1G^LmtN1!Y}imi{mi2XXA2?2TC=ZG?^+AzYDw&!P&j3Zkyuo z3+XijV2}uL-+p?)lg8FvcAKrj0Rw{5enO0@>T&}%WFo=wioYY(EW+T|m%QK=3474% zy=fm8ZFK{RxLxU%-1ck}kANMzPA+V6(9GPv5(5TT4^*dkq{lFZ1E`vNBSmi7#>mg%XG_9O{Y z@{K#L{kA+JP%hqJBAZL83YkJTtmHRkg0-f*vW4?XISYqoX#XN|VgDqHykPs%)fq&n z;vcHbv>gl*Zq&U}?hsX5;|Dl98Nd7lCVh3*?bDp?(Ej0Mt;l>+-7P#9;&-GYq0j_? zeW+7m=NqBt-=Y-25NE3CGC$omo=^9MTZL&yG3&M`$4Od`L^LJNUG%~!?s7={DcHYW zH%6VByQ^OGih5nfRN3TZUZ*afqht0ot2GxX75k6aZaID*Z|Z~s&PT%k=J-VSJh`R9ZMPcB0Y)j z z?*`3bF{fi)+pVi8<0{n-I-isF904-Y2J9p=7?PE%nJniB4a*ai_c99R--|Yp{NO7w z!h5DZlX;&NT}T^W-S~I zcp)$X6(BFBtkW7eMwOwq!Q_ow0(+Q^n|q_b2UHNxa4olV`SRTF1_2x z@v4kcYAos-A0CUfTWs=@MqZy*L*2V{bu1e>@M*?$FCcqc>BFp%U!i5J31q&=at3dV z+u~G3FdBCft1c&{AMy>Tp|~#Ec?2!4`a|8vc+5-IkcieeZruyUA^X?v55+hJlPXb>M{Pzg#8C|{C zgB7j(U+?~BRvE8lQl&ORR+O73J%E~C5g*F3h75aw(#GFNUn>07elMKOdOne2fG7vo zyRW|R{TzR%e#AjFRHUeD%!d1z{)Z{72;baUvUHTkmIxBeS{hQvXBrkt>&qIl017Aq zXA6N*ID%LLmVlK@c>fW()vho}7MIhe{^vO3A?M%VD=11!16>b3MfpMN0@LbgYvK^h zE5&SmE6QkY;(CS8WVu|Ho*8raW_2p`)5N4x}WE2(8BmPRsjyAv)8qW&2eGUra-U@KEs zCA3=Vxsa5P!Rgo58It&NX?C}1h3Fn4{f1&r**w@hA)LzZ|5o0Nb6;Amtiohg@In9dcO$Cz)C%@}P z;?#;}w*8KuJSHp@bKwkcXq}20i#ZE^As{by&cIvvlH*p3hiIxl`%Qn+04$8M^Gt_` z*=&fjap^}4yy_dG-WYK43JmHVyR98QePT5Q;N>E*&W~RF2iItLdPFLH_k)++sFCM} zyh&Tv$SNNwx}G-Vb+c;z9T55SdBu^4I9~%^MPH$TUcxhldgKX+pU%0I&Uj+IpzL&e zIG^ftt|j8t$EK6}M~#AIJILh&oqsUpKlr#b*_y?0{<0&E5v6JZHpB*l%4kZ1Z=N(8 zO5j;4O`<|s>S@AD0qN*GMkk*^GrH+o4L~^P5X9*brITTeZ2dx9$2iY@!EH#BIn~3k zmB*^CTt8PTOA-6hUFo^?p+=DP<1UCGI=eRh?_f6P_I}%3*zajkYTGN;Mt%*33p8=s z4cZ2Px5Q_GQuK|sR!eHUhB0sZ;RiMA((H!dq~(Z&@Mn+HCtV!1Re-O4t}t!iW#zez zCQ7u!6zR&=ZbaeHJm@r+@~p{lFm|`~M=nYUfJ#eRdQ2Ixg@wFMw6|lv`Uuqbh!_<| zclo=%#&_&Kk5!Lv6&D6xN?9ta3!m?B1YGsigDbQrN3Kac(v^eZpZHeaa1$AJHW<`D zZX3*bmV_|l*Mc!GP6S7LFE}PMRVK2RrcU>yG!b0-965}`3WQLF@)*w0`*&*PNn@Q9 z`;KpWWRthxis`-V@&7t9ZV(9fM8}#3;XP`?zY91_{I;w%!ne_O7voMkc83;hQZ2{+ zI~^jsSvfsV{b33lq8$mS&6@8zmWxa;Ed+7Ks6?(Mq4`Nu12a8k=krU4-A`vl=OYte zc+x4CQOjMXJEkPv_NgdK#RU+Y#>Fw;C(ITfe$+cNQU|nPPjqWyw9;|D${|Ba22-ptiQJv z2K_fo9(w#v3NbrRr8HKLEB@Wj8^(*%@I&YqjLc_POM)4BUx38XN}~FC%;jyDfBd&^ zG<5AAx!-VQ24&bEE1U-Xx-@xUgG3GvJ+fYH9#Ck%=hb3d^sQVfW`2)sWjbF~=t4*f zU$D&5;?VkEX16cFUkP+>_A=j;tk$okp(8BUH8%I@9MjxRNqlURiW#o^S3?JvwPY*OecwbcKKZ(LJ>f-?OPB#+TaaGwidn{ z8h>N~RmvO_!!J^X1lt$C`mJaH(MvTYEpzxunvAH+X8DYYwubrx)!cAY_1)K0&rafq ziVmS=srD0J^mz_>qE*|iDzf@S(RH#4&@6AVYs?yRYRtAJAoQ89-Vnjh{i5Be9VKbC zny%z}_uo5w#+`CaBUz5<5H1Pa!WQ=x;?rFCs&kBotB2&q8E@deQ2Mw%fSr-dSI?Ep zsxo*hI?6r@9}1cJQT1VlJlf(8??cFIf+Fp4=brYv_>A~4;m3tTApZCAd)?>40{BTd z#YxRZ1FXMOy`v4Ir!xQR?#~tMev)b}ua6>PW8beBm_KCif^#o#`G$@;IzA)1b8d5c z#^5dCNh5G)>a!SDyM)iit7`D0$4E(B5baEm-SqT~e`<~MiNmgj5Bi%okUmMA>H4Mm z)&hc;ug(%@wf^U>_QqNFR~8+}LCf zs3&07%EI&wr!lmGgY`>qMX@dEsK-9%z~|6tM<`NjbJagDiL4&ow5PH))DvePf&cV) z`;fCK3(tMHrtg**#(A~53Z{Q1F_J^qLYvby>%3_$hAST6TEDV)=_CI3OIbk%-WXhf z-m65+^~hX_A95T#VRf;DUQ7ilJ+* zXm8+InwQ3hbyECYL|l>okFD~X>!7QK>z_33caB-Udx$8faH-A09d@A@=cBX%Q2xx4 z*$oH+;{rC&wpuDqUK$jyb}iUJp5AspwH7zj_Su*;vXE3=2lxk!u(2a*tQc%h!R_xc+|ZulM3>^<{cwyU332$=qqpvFV)Kt7fY$fJj|P%#*9+0&@jtw=m+bu{qtV^ zCPP`Gt7E@TArBw)Y1EuUG;=gSS!Q${lZky%UDRuDsdWa6O(T;w~|@th#*RH+oy zgtZB|*Vosulm3UQ92yne`PI_;dbF83gg2Gm9Jdws1b<2{H$Mdb)c=d+MtZ;LF3D=f zX^KhDDw&v4rT+onE*{IvYyW9ly!$`(zbHWw%$)YX=BoPcIA@!|2}4 z6DLa|?^#3}L(1!Qp7Y*B7>6#`p2yGkaz3YM_r!vDW7@jsOFrTxnRu(cd5KztR6YFy z?(v+CpH}Ty6DSj(7X6?ArIUb_eWj2S@BKUds0V7FS%S+G{7k^T3G?-T=IvHy8dhI%ivxbly?SFC+R6GaA7k#JbJbo1!Eg+HqRd!P==vKy z91%Z{>&M3|Zk)d7#k$+;xY5nC)TP<7e$xD!0&Q_)mG!Otc;EekkD6jsALyB;Qpl7} zlSuFu4NKk^Q=HF%2Gqj71<_n5qs5|t!Rynz2~G8QK>qGb=~52({9Fc$`Czs_%vx#t zPy~wSKRWj z9wxR%lab&DzaA-#u2^vR4K}3_wd^H#zVp_!p0DCs_VH6jKc+9qES;{y+&&opEBs3!n(VhaB_!pvFZ%*&6}<<=tXBg$!#^Kdsq@|bI$LU6-~u=awj?4r z3pe3@+`n`d|C0#{jf@!DF#8k4X)dxPwkxXxbmysS-!T*VB1#l^eoupz6@>h{>M6s5 zpNKj+O3y8wBUeOsA4Vst<%@t|2CFqy^;`4{k956z+zc{iq2XMq10)=t(99kc*ZCrK z=YZGe9(~9(oML^w>n!)ATKYwU+5q#Ex)b9a`N4IiXX z{qw_CMgPTl_)M7zp(<^`aedvqUNzvWBkE}gRo{OqKmGc|)`NJv-CJny0Y_u4|2Ae$ zspg`(8d0n-@lex+l!+0xrroz_LsBlvKu$GU$;YH3 zY$~sbhz2_DXC$Fo%vr_mk)B=y;OFxcsK|#NPJbObh3eXWAF(#BKbSDS)$hr6x6=pY!;^SXhJ z%YM^_^DJrh5t%ZIoy;SVuPn8*mQIPEF(5ZbO;1E>;j^9zy(fqjxKH{-IS;+L6xZm0 z5f6zW{r-FS*P`$+LagPq2tMx}la7Pzd5>78DroVMN)RQ5rHcugyB*%XlGQ1_{?LWk z!s`MD=(CMfR79#-lG&sHQh1&7c#AuJFp`HBEZmhmi3?zBHXfm>#c}l|KghxWHpGcq zAK--d#^b&r<&E{P1NiwaC!fG&b3>+T;F^Soz+ofL#B}FEAzi=H^?6_-`$YNp{v}*1rG_72=X|JNsQ->eY0rKSCdJ zx&ig<`Ut)8vu-MF{aZDHuR-5YYdta^kbBxl(GWMAH`|vRW%<1!EeskZ8D3diKC zwzad%-z|^{6Ow09v)8I5)+Y+mP+pBu?ZQ>Nrvr~0rT-IvXOd3rl%|6r+r)0@pDo-P z2knl9(`xEyfjg60XzJUf^eF+&+p$`WTU+037Kgz#tPp5VI_Cvohvc?rA8^OMsdbDH zoYht7Kau?$9SGdP&DT)&dfp=(9|gsE&oF`k@i0 zLM^~0u)fKI9kg0YK-7bsa?}Ax{opqp_{oU-blB89sRqQYX|o5M(g4B#Or@v;=&QCG zTA*d=K=85j`e+qqnFq*})?+7=E zQFw`_CHDwYBYR2knbF;1E=XNxk68&BvSIn-9hQNbfcf&R1^5qN;^PpvpN#MeP1X24 z!6aePB9xzziw<;td%U5GrxLZCy4<7(8sI;4ioKfN6B5Ho{xZ+fF#0=C!RC{ZGQBW~cl%C~Q5)Za*rW-q z@+{wxilO8PQ3=*24W`t-!n1>(@WSLOP{OV%VdaNO@Iej19TA_bS3C~-Bk`^Rt2poG zHl%s%RC`-x*ev?wnt?cC`R`24_nqkahQ-u?FvV007MCg^2wze1UmYdRsZ#|s-unyDHB$8#PHXcpjSQWyWM!l(Pw#MPNqgT`zDQe4hBU@w_TW~{5~M9p~`EG z`a>ONk4R32HX;*Z(S^VUQ1!LU1Mg4RM-;KM7_$N{e(zAT4Z79zdEmV|WR7M(+kz#Q zi+v@S;5hRpl;zH(i*rcn8)f)*d%uTM@+z3>x(1_{?$4RXye$sZNse1%?>F}umtjjB zS3KwC79&(2Ir~!_GVQaD;gv)W&phA5y9xHL?EXIC-8ZqykF^(HbG|~rZ;A4f2=XO2 zUm?ZbYvG;0WM#jjQqV$Z#Q>u+%+Rrt#Rm6gSnI^Q-u^4bv*4-F+h5^5hAcA8*?5H% z@>Y1=c&~!4J>RTnSXXhUhzWzoO#w^RKWRg5xk(Rq?RWb3G*{3Ij>L|BuK`T|!%Cmsom$@g3bJehYg|yYcIwgZCefK`9}4-cwLe3epq-JdGc$PH{m67i+Ebb~>#jeJc8^(o58oG%?#W|mKkX5Hp4fZ+Pm`Ve)rx<2T_8BKQ?I>a`u z-btqbVY&N82mR%&@$A9_4*jEox zy-5}tu(SZWANBSCSqDwcBSegf#s+&4_LH}xL%>Z-n81zn%eMdR@0$TFTZWU$W+ylV zuyiD^dOXS|bVoXFTW%vFe+WO<&w_r>G-*w)nF+dM7d4jn!k5<|PELZJ+8&ds>I6s8 z8Ml-6!pX97)8%_U<+nrmS*o!0vsK&B(frKoRi3!WA35riDeu#E(_A6*w{Pqzt;9Q+ zruH& z+6e)I6CFH!0|w{H19t6U*Vn=VWBr@lhk8cdIl|b%Yb0UQFO0ONlhIXAlEMlU?kFN_ ztrH)Hq&9>cTqZm31@<{s4dPNpoAj;*PDa>(mg;!e2%RS-j5%?_SZILvK}vIDU&h6{ z%8)fk*RAfa(+8FJ4b`@P(y#rH>By;9;o04XZrdM!@O*xL&&}nWs=L?St`5sRZdflI z!aA#7=Ojl#3F9u4jUqyB!9#Q*vyr#Fy8H%GuZPe*eCahLZIzlJ*6WhZzZv@If3v0? zPmc89_NBZ06(@;pMrVSkeWCb&!-3rQB!<)&)Y~q%P`yIbJE3^-pySHr&|d! zAMfY((3ebc!JmpEd{NuopHX;pXU$kJOKES6(eYUe z%&G!I=J09^1m3>>sF1q_i()>%OzmR%++ zC97`DD79N1r6!UP{#X4h?i=awymbHfu%PJYN%eg>r~|%JeDaBbPbBd(auJ~9G^jy? z@eY+(9kRV>Dt6HpmfKt-;TsF|JGj``L;3$1y_#UPJ<9N75O7 zHKe=k(&8W@WsUfaX`9GSA6Fc7t|~FPLn$M>idUa~O!}ZrvGH*^?(IBPW?Zca#~MKR z8JH<@%-p1WtQLC0Lcr{HfbFkfI_(FlE@N5(2&>yoO^H}^j)k*9!#4nD^VlZxyM z6pf+}-M-#EcpF^*c;xfC!29Mp|GQT_>Z+X^$>+E;hue#d2@IB{PE3_&L3Dv2@3wTi zT0{Ct4}^RrG#h>CpjWwed9c@frD@FdG)ZiPXW*`WQKRNV9q z=JvL4C23+Q=U77rtNo^YINM*r)m8VVLU(m1n09&MZ4BsmYQX**v*44k1t-a^8r4y8*{Z9bGca?#xC&N=ll8oez)JB{&c&&_Ikfwujk`&znj;P(L{z| z&!%hiz{Cqq#m0XC-$6Up$?f%B#!ZP+qy!J(w6Nv6gc=8WEeo)$oqR|#LKfioMj?7( z_>zEwi{6mheQi;hg9vT6jlDsC3ZBNF7KJCO#POFbAIWO@DxLn*(W~%!HnlAPOIUGT zIaj%Xy&iP7aijjRYj>x<4c}wjPXjh@LK^zMa(XW1v~Iczk4Sfl9Ysg*!% zI4xNX^YVr3g=(VHT^>*5LRvm~0k^*zF&<7H_3YGIl&a_6>PgrZ+ zM48916eu#ajW=HlcB8XICF6EkrE+KhQ)xNa!5 zQ8yQ5MBnay1%b}QUludhjB$fLx?`Rtb3~2iz+oD`*o?F}uE76ioZse#T?0RwbvI%q zDDu5`W#4R8?NTcw4kx^^Hlt(`c;e=IO>1ZMY8Uw$#qRDYsKXHJ;g@%;DcyhfLgB02 zt7fC~Zu6X}Gy4w6Q(jFgvHqlKH1{zPAJ@aT=Rj4_C`9GHR zJz&$H!p@O}V_#MtsSJ#+yncIe0JbPo@P5{j$AT0+CQ7OXyKG+ZbQR-|EpIUcNE$Ta z+@$8{$NP}xaFuQ8pP(IGecfi=SCTVnY1Y9uKMYhU|3T3J>Pl%z(f&?YSAVf}b`2B^ z))UbltHks=&_izUKMp&>YdhD9RKSaI`sLi%cMGh301O^7e*E<$#%f%luIO^_a*y)6 zs`nAk_JYl=?W!@u`kDIrN2XV8_T$1^6y zhO3;~rzzXgH^7C$f!$c*4Y5~2O{>;tGQG~*U@PQKM~jA!c?@$~O18#imT!1WSPyfK zm$P4NZSunRx>CTS6Q2j4&XbnA&-sStoc9rPbU!yY%@%{QFhgYSIZ6vPItz76U% z4PmDzRWzsX1@MyWw-PGu0dZNVc!_Yj>0Mk9>R;EM&fdh+?vRCB+7e+NxGS?D8han3dF5C0~6}wa?oZ=BMnB|GU|>jt0nnL78~t& zeM?GTXa^14w)LBb>P+3|qx>{eZE0>FIc(2Tub2v^K$2nLcjh;6VodVqh~hA6)3uKD zh?x*g>iE)#Vf^xG2;K}$w}dK~3?VH2)=-1#p+!rWtyg5sN_N%3iNI8PNR27;_bEkP z^K%&gkjm=pmxZOrSCXOoJ$~A(OhEWD^j^a{Sbr4Q)0G-0nm*;;t)QQo!Z92mlH)yS zx}gliQ)yf*;GfuW25m0OS`x}=MMR`eSF2e%%bI4suz4?Ut zL=b?(UF`=&^bG8nQgW$gow=?ne(SFsjK)dN6L%38B?LjJ0%1Qo>d`p-bkWnEARo1) zHh1u0ehB_IC0~-0ViosR9ype&{cfpiLh^TyYuomRr4!{BIlr|`JNjE46)aOW=87GQ zg#j;>hWrGfQQTrX#1D!8#&0|jXCc8slhe5YaT!}l&8dxc)M4 z4?>$THx$h+$gNUmIWT?&QO?!2uFRtX+hUDeD&&d{FaGi+#QhsDgL8Ny5AadLx}U%I zYlEP!&upzkWh4cK?EmgeVQ%$+>&>f#JJa2~-+w4jvVS5~P1p(fa;fBrQ@7*T!`B}k zfwawG`s*Lwqz+0pteHvG6)??v>pP*GIUYv($o@omxb|VMoz<1%JZq z+j_@Zo&|dqUdt^H8g8nsb9>pn8L~eM6?arzm-fm2s|1!C% z;=f#$Y!<$+1sE(ytAyW!o))q|b$%n9!UE@Ii_Rr|*XW=7l|H*t+M99iAH=6+)gW|L!1-3X6xZlTJwLi4W*d+KYG&pnUrb99Jd#t=m~`gPphB9aU=ItKCKzvTvtHVT zbSEbSY>-sUxj#>w0InG(^oMO6)t}M5FZg}bhG|7wWk!UaTTtL05(M(P_?D(Z^|1Yb zlK2;$)7J!QHhcrGW66>0bt7r==TO-$viN4?*VU~_`kcE=X63sc4 zLzm$>?Rir{fmc<=ej;|wOdy*fsb*C8eMQC{9t`k@9xVd_&|eYsPt> z@(`yu+-qiZ#J=Idv~|>mXXx%RWl?~1?;&8na*hI6VZ8JF^s^0{V*Ebjy;a@mMbWAj zouDr<+TxWL!wNluuQ`}O?uMP%(UoO;ODBSAEMh}rWP5#@hox%L49_FZ`D8!+IQO;kC_5} zyq`HTqq>N3o!YoM=Gk?ckDoi$cm z37JSCtY~u?)4y=jVfg)rDsJlLMxgifR%li`qu(zT<}I%b#ypvU?a=Of1B+bawtn)r zUaYzj`(Yr$LSVJd6GS`PtaRKai5x<@D&`+}B}3IKOZqT5aH}w1u4+`9`8YK1Bv2~P z)(EO}5B5K`y;3??dhVZVGi$4oe>tk_Ap3wIeop8|HfQ{@TJq>2Ey8>p|LwS!jWJ?N zff_UZU+n9c=lEX}FOMoXGy6^+bEbD(!7QoGlkrY+J$@4vJa(xJlZsr^22#b zu;9Vmoe@F(NnaB?^EuSr3t7c68xAo_zt%Y2qkc7;c6zAB0&_(crg|cuY$@j-yy<0b z{ce$Ne;S&CiQt!o)IJQkSxY-_ z*`MZhtD*#NHKU5A(dYZu;mu1qykF4`?v~)qj}bHQg%8BkH4N<>dy{o~G-|+IB>mLk zzL&_lqP_5+%G_sCR9PDnEvigNDj7YPeWMi`gla6Y>Z}(#MFx*Vpt3cw#Ncb51zuk$ zd6UFbCn5_Bt(HNZ%yKK?E9PlCX$(AN+%7>KaX-pr*O%wo?027F%f zRYl_CHX^;Eyn^`Sxi{sgK-%rAoZ*ajY5ry-CZLn{wtP*F5g=(rvUhermQe%QT6pzh zMW^#(l!Lf$g(y7WuHA3&BF~v*oAPn4G?{POm`6ZfLC0#Qh;XH zkBmJ^He33O=u?&w?TYpTAUzxLhi&Ss?eu?r>Hnhe2#li0^!pMla~vcbc%B&}Q`Vvk z<_ISxBW$^7c-z}f0(W_$+m@5%A6A zNP+R!1{KD?olFN(ktP=WM?71FsGv~5W8gx5n3 z!XnwRuB~LhJ^A}@>RUFW@)lQl{pxUhz3?HoVO0wnbMHeQ+V=OB@Xto6?u7LNYwuO0aquPzgLZ5^=RorY!1lmmGsWdD|lmsIcn_g2d~8kt}^|)MjD#Pl^25 zhnZH;(>0@sK>W_iQRL%?;X%oy`mD6gQdNf1Fs52TuKb~6N%wdK{f$CCH`la>bsZP> zmkHCCzfO8)`pagv$tR;c>KfJs3@ushJ{~Ulf#PiwWE&sPUb&THc69ZEg0djjqC+%8 zm2cTMXdxoCfr+7)c|1HaN-D|Fc5G3G4z3Qbre-GchacZbbcE@0!zo3Lg{LVE2SqoY zNPIhr$jC5@Uu?8L8$cG6TxO5+X zmwbfxKXL3VOlm6aCG*=CrHegp`1;X{!sBi`qTZDBh}3wuas5?#D<$(&$A?@rY^*%S zGVt%Wj|l^x=kl*yRZhXRavPBZrK!v0bMdspd8H>sDIFs*C$ z)tg%|GZjg_M>wyh)1~1Bc{X-9?`DAqsp`O|8SSwO*9uT#wdQw4E5a<-N$PhD3U|XV zE8~8i^;t=Pr^7y;oQN42AzX@5i;=h^qWr!ivmv)H)E#Uv?DjKvkEZn9!|+kN`ywWq zPI~xD9zV{kiGUP7$KVw9db8ThIl;MKM?QD|xG2ifC!O?$67Gc0klv zL-A}gEXBKYAdUhnOKgt3*yk|g5k;ssXXhlJPx6S54yBBlx*seFC~*s8ZbPz)q3!7# z$C^5f{&*87(JlaO$N$s`ttTlV1_hIK1fIh-(GD}MB1?~a=6#`CPlE+muub7}mgL{{ zM(LKbvQxg%d?)@rz6M{txQxfSU!$_ci%1URaGMfKv%n{a59C}bSu;SJr+dvwYyaga~kvHNN_(_%9Zr44Gl7);t-wgJv{OKPzaO$XY1yLbC+LX777ebqy3rx&r zEdiJ9lQIxh2{q*u@NKZ@E_~mC9_BB%RPYTJewoAXnoQd#npEfdK?ufgxe-MD2=6De z15MU&Iah`CIUgFSm;;$72rW&=AW(U^UtbXT!FKm^ozuADs7|TeJ(WR?(jaA{<$jL_ z(|p3(X~gY+u7{q-lpvQ!!ZJme(WFNxibIKx7C<+O-y@wRu%o=S1}-)he7!Q?|HZWK zYQljJTv%sl4O;H8c75(tL}Y1qK<)_T!=M3F*hEIRsuM$(AFH?`x0t~#3KHW6{YR*4 z7dvxQq6^yOzo`>PaWyD~G_$kSE$yY2)kTsRZ@KGGqV~>0&McyLDk!$LQdsMc+^d&jq?Pe37876MUWRESJfKH{rMXXPC zrhjbj={r$wlHX0->^n-SzTaCRXY?bNJ#fB6Q+B40%g#~K!hz{Qf%n$BtcxspI6!V! zykQytAA_Z9aQQ><3y(1gqp7gvTTy)Wrg4J(Q>h2JY|Q;;V6a*t&41{ejnDof#Q;7SGg!txeod#(!Qz6$quMb$9Qr2{?Pv|M9Tl%B z}a*M=miNf$*oOP2j{ zDMz?jop4c^&jYFai&5z56aTiFS$b^$tlp@^eRO^`U2S~4PIoIbR2ZP5blbu~5Hmtx zdxPUwhMXYGEXd)8O3g|bUG*b&*-5KfjnxN4#2{Ai#FA)zR}k!^B&Hc(#`!opXmQlJ zB)lLAypSjs??OC4z3%*VSJXsfpT}}dM<~Xynfc`ptgqtF2!FEypCO8;zkH>zqw#@S%qnzUIwPb-TVBINW47l4F-M88R&jZlcp6@lWbIC zxTJ*KT?ovZ~KbJ>p;=Q=Is zETWdx{B~G}vNxLSA|~co517t^!*;9LS7n}NMe%`+1!1xrbiDp5yy2Y+fb-FPD>!;G zQs}O7Y*gfgd=BK$r>l+!4WTbtvf)_hcu)}TqHwI*olin0989+pO$ALUF&_9N1;`i1 zs0WE2?Et<+U!Az@a-Q^EV7oBHRIe^RQ>-yN+jr@|@R9b%=BS;XArJ4>X}EZ$xf64&$+)|TXcIbw=7eiT;Eua&WY^ERBf0#BziuW zStbeY!Egc$e~X|n^{9SlpSsSyYAfhBct4SlQM{9V)htkT?7O_{c9=(8=r=2(yHMe| zJTIJVbKCw0C~(L5BdG2k7*Xd>p;_K<*`%82d1~s~U70rT;EtxrlK~+^&b7Q=AwJ+f zS3Id%J@J_+)Wy1*C-4+I#QeTl#q9iS%XKef!or^T>o|U;WRq6!Ss3p*MI`LQ&a}Yp za>I-3_W7G%-r_hSFW1=}NmAqc7w;PShPG{v@WyfU1;yctEBGZ@+L`}sF0!{?7-oxkw6r9%k45G|EKtH?Ikjp*5>EO4EnbqjrQbcd~}iMV}ruBE9kbja0~Lj=M2Nm$?Ld1;wq zxWE~P`K)pe1TugJzjx2vH+G4OdYzhO{8fgUh+9g{{GzlRUTvtU;N?;1F)z~Z5yo7 zo}j>^tpb(%gO>GhVR2&vX#Z7_i9&rWbjK=SCpQ05eI zB;##AXO0+cafxNp67pcoT-yTXqH+slVilLiw#6{K(V2^VqXpZFds8tXJfPQE@^NPb zDb&Iq`qE?bkL|#0&AmGW@c~DR^St^S*9Q$RuRPW#85MhY0!BA%YOikbPG{_@TI_yK zrS&@qy@4*;2_A$)zGaf3D1{rSXy*MxUvjLsw90aIq_ zxVj^pME8&y$aeIHEyw@b`Z98MLdLBhk4gHo5{3AWnqi&IF>!VcBSkk-L#`|6&gsZ6 zI#!WYXI^EEot{hJrls}5f&GLr$tg8s|}KkrYz5&3UaJ)dy=MjaKWD zX$QbPekS0bSd-&rbD>V{vm;gNUgGd;qE39`<%0_Yrx3IKsU}gP&XydrE*QBKwv|yx z2)R9(smv}hJd5Kaxqw`aAaKgnme~vRvFMEKWz~!Uy9_pfJZ! z?@+G=oOW67DJXg48=|6fpj(XD>X@{13bkL9ms1;91>=UBPW&pQKBOo#*+9|a99%Jx zFy@_~q@(7&HyU|m0d8@UJ5U{7I_#;}eyUX%YD{N+0B{`h&-K6RSbg?K>49Bw=Jn!U z3=HSp$YPvOiRsfC9SUkC!D&WKvA^_%43@(Kllk8^oTq^S}a#9>&AtD3&N~@^1@eOlO>`TbuW?R8(37Pk;JZiin z4sw(66x~y!s5|Fe8-Fyl z>oxV)=Je+#BR;s^v0$ISxIDm(lJl~C|NX%M%s#ww zjnmJ4Bd^VuO4%-+Tc&q;F{L>bJ!*w&d%_wy#@$k`S8?y~$dBm6HhrG9{^m(5s~@L0 zT-eo;Tag9Mq+>O^z~t=jhL9-U%F9g&Px9Q@rq|QErh=c?09A#8Q0*FDv4l&=;F>Z| zNjmt_DudE7HaIW6v}}{?^>2^6bbl7e9DZwr)0Kw27cqY)5gWnpKdVkdXn-W4s_vuS zs|5=nnybn^Lp0qvY_sy(ZYA{k89F6)l*~da&5bZx>uf!Mb-cT%UeQa|v7VBk0f^qD z#oehjc;7_>K&Q+2bop%aVx9(7y>9xQ_#^KU_fH?;k5JA558~dxNPvEn< zC1i=aONYP~mQF_te(`N_b2FA`(P5`1kub)4(Lo#TeRorjD$8sW~(i_3ZlC_>U9#8jhxF^&Ar;{l_-r+FpfcS?YHe zquT|82>V3Jn|;RtxSg26=dM=I3lhbfCTgf>_@zI6HBgsfCW}qceYRHO&n!r_I<3I3XjL(h;^XQKEd#`~wMSA20>C>3yp!g_bq(`UUO9Tz_NcDfGeFAXV%bgpAvqw)ON z#>Ze^Jh9y>5Vucu<+8#>d=OZILSzx|P3qL&(y2@sewFxTle6@8spEW-#AN6D^_`*D zfQRwm+=;mL(7W@mXwv&DHJh+Odm&E#JX*x^e!%IB#P6;BsF@4Xt$%uF-lI+tMQ5%o zc_*b|Jwy{!E7ZL+wte`mQYz#Kdwo*&2v``Q?%3H>8SjqjZ70XXhwhwGLm~2_0qd|v z2Z+tceZr^D5ugvDJ71gZj^2iJDS`!}iRn}7;!REet_Z6ZZBia-CRT7V!o-TQQdC`n z)Q@z;CqCoN9qF^!?k`8KczraL5TBdseL^(m;pN9Q3ti(Iq%0_DZKjj6db?wAG4c`aR_h$O^;6P?v>`mE9vz>k1CMSA*Fz@w1Q0NnRH`KI#J6~Ps;Q_mf zPqya1b2S%YoOE-YB-IcHS9AiSG4|RCJ3cd3VQoS^G|tllPEa8;7iqVivhY3uiho@3 zT&4NH?jpE#n6025a7{!cH;g~?`B%PkQE>o>@^cbkP5>$EfQ=884f`f{y-uzE@WGLx z)QIiGTx-VeEUnY}N3<{Bc_RJ%D%Be^HjcD$ll)qdN>*O}JY*Q_MKMzV%*`CEs#SEe zRoF3QZ3ChFA6PDTDALn?u2Y!g8UCMDe3d@x>Js@7&A3^& z;-)>^BMY^l)k@F&&*ZRn%fPK}+VN4Iqxs3h(c@Af0906Waevk|;&_t5?{r_`zw%1# zk#Ufe1Htw!Bl1x{^U`j7Q88Hs*nfRJns&w-brP=o7)!`JZ~#CKXn&ihS+O;&uAXBi zS!+5xwK==Kc3Sd)H<^?M?;guaito3<-Y|&i5P&3@hYIC9t`6;jZXF#h3z_sNiB%d9W+X{Kzk2c3NA|Va*(emliV2I|w!mSt3 zId5+2jmvDY#x3d8H9Nz|sx0frj>c*iPC)HoZ|OVlZAl#PQ=_rW7<&b%JG&H1FHRdGUD&g45&On-XolQJISo*;POxlKA-Xt68xZijx6C-g+7Zg zr!lSS^tu<7C4=}EhEX+|5n-POlj+f+Ke294aE9xWtrOf#yX6M@H)|7kXJI%{6z`z( zj2}ZK&Mm4mYqa>UeKQE$?Cnm=)__-01A5se(`!qH`mk+g25MiHH$88P>9$NdD5AoV2+zInOEqMMhQ$-QS#4-96Uq^B;^QMk#hpKsjX^Grafz!cn zkJ$c#6%0X@heg9S$C{)r%x|>ur(dho2%N1y2qdH0l^RF~*0^pRPZh)oOgqH`L+jlk z0l?^uh3Mi{V}QnCSswW!E~SqVk!+$ik0begtstl5UqgO>(%w`!qRu%T(Xu%%yVlU? zI9klu8qy0)_A?G~{nceXz(_r9Dg{!Dv?7-2(JQP&@f3bjuQqgoaFJoRw8Aaq7O2OK zI8KfH6JZ{(_@8P(=rXoO0Wi(lJ06r#O+5JhNP+!Q=V>*IDlqGONI?f_RzG<(sPauI zbxrpe0@dZ*_b|XvsK`b>wf$#O)cXH1CU#WAO79pZj$i%ACdHfw!~!~1AMZSQ1v>W~ zc}}!z9Ni#LJ)4GO%6+fGH`PwWwNJ)a^|Jp|d5{ZcOI8>rU%m9pK{wtmRUU>q*q8o|6U44-KRmkch-d9=j!f~pT$cD9yrqvql^Z{ zcFib%U%)8Qy<48J1c~})E#Y5kj)Y^2*9n>ZVGU*r&Ixwf;_8&3QqT|v`RU@KJK)P^ z_rv$PdAHB@lz3M2`xgo9*Tu#KHXctT)h*pn&|BvZ@SMs^)uBB=?=3e2=hXm)j`Y)o=`?Tr*jQ$Xo1B)E zv(o>L7$(0kdcwD@T~Hra2baS6=SW@&{bpx3vjjnUWu=@z;}=J(8n?)szb7EKAl78kh4s8wwH#9ih`_zUY=(vq1Zk{W=j>5l5-h zCSPo>s2px$750E3fSAsT|1ol~*-l|FU#`&vC(J%p-HHDi6GF?%cQqmN;sqxu7u$bc zaBp2YdP0^4>XvV^vR?6R#QNyjic4=VZJdb>tl9De5>}O}p35Z*s^>%;iwGFczRXxL zR(gI7ud}3VFW*oU8P5BR(fn0#5%QruGn~J6h71#h!>hkmxL-vKHB=pBF*71UjUS2h zvDX5;P5n5|NX5XU;>=&jkaEx?4#SA9@=2KzD(t%WW~_Q<=>fW-;^tH74N~sStm(9p zXu2W$h^0ngirsu}vFBMqUv1KJq{}`kbze1n)m& zcsbv`WgPasf4Hf<26y^%8ZUIfMCKI*2)*MUJNk(Dr|3TgW!C+Gf-#c|p^3wb|6rO<*+09|@kTw;Ux z-r3Yi?uI8A*$@!+gX9{kyc~!gn^!h;HVp9?^$Q3s)R*nn+fiJ?dRk?U6yX}*cq*ui zIqePDj_FZ?*AT|^i)|YuR(~BYtYOIR}Y3 z1zb;oC@M7hl+>CJ+uX8Jm@Q`#e2ki8u=V|z;>pVO|Gu~9Ayu#+!_UT#G^aSKWT(Cc zQQsc#N(&Ezg~#d>4?nn8xUb*@?8y2(O@vJ86DzT&r5DcG`#i4n0_~@5Iyia_CXzGosRxQ z_l^Cd)p~W}NYz}_>mW7tevQYty|*pakixusX&xb-ocNEZdxY zutq3eZvrpoGEOu#dPQNn`=(xsdIH6F`8?a~E8&iHNKy2?RtRJF0cUGFCz%silI3wV zB-jLcCR_JAFDHmk63Ak4)JQ=N1mHKg`w!o}GM?zv?uK>WMS)`G&dr*2==Sb9_<250 z;G;6ADEmkFA*?61m;p#L+ATk6Fx)DsTLy#6*?vhEV9z| zM6Djr`|UDn86Fa`^yED|{&=HcZDnyoZ!xvg*e5cfpjoZ}W@8-XYn=#6fM}=%*OF`? z04K)LygPcg^}}2Gp4t33Q%W}i0(Mre&^%CHLEOe;EoiOhPKe9)cSP^DyN_L$9k%DS zT4I~#`|wgDL$Jl-G?}y_)<`m)pcF@csvLmXxS|q6Ous$X4K@X&>&7(1iKy$oRD$20 z#Wdp9zsnQnGFmtLr|nf?64s$*4{UL2$o*+AQf1%`TTjGj-8RFg{W7E@*TnZ3wPLc) zS03+q7!^0_5p(0};G*KD7ZpcRJ%q^O9}ci_o8>^s#?KB*jaM#O)8bFPm~VY?N2cv+b@mbs z_&kqUv}&6@KV3My%C^`K4ou9C$G69Z$Hg6ujv4bWh=^Mx<`+3j9Y)WDL(nE&Y*Iy} z@D;ugOs!l!qU2-F(nwBzHjaP}&5jjd(Zsq-w7Yw|T}uI-?-@SDa%UUr@05m+4@(dU zB3IE;B>bPAwc=>@I{|z_zbVSKQ5e=8)^7Tz>2Kh0V7^YAsUa$Od@#2|x#u-zA4JGwnK!D5)l3zbe6hLDhKavHf=WdnUw^(8IANZ0_Kw|Qq zO0yZ4YHm(#o_Qn+sl5k!q0n`K$No^GznBtP7+ETurX6toN@fh}n!3WF!K(noT~&Am z!EZ{Q$NBdaY)dbPht)%;06of$8ncFfs5ECX_B^R6h7>cSL*_ESIR352oZSETh9$D`&t=p ziFKvxgNf`UY6^X6x_~>rP0UYDoO8Yr5V7v`5Q!m;H*bXW1q;iNv?tXXzFWGf=$SRe za_OS>iu;YQSsn?WA9lwe&=@0MPw2WO!7t;yIW2XwuUj-@_pLve73PBvH?#XTp7_2- z!I%0z6cM{$Kv503XIH)Fdx}Tqr=`ExbM9}@QA9aUCqad8-x;sCX%=le^vf;{kspkS z!V~77bVd|EFOH8HTe{kT_z}jqV!IeJwX1#N8-MDD1sUOyoF9=abCmLwthQN06=+JS zb!DqN1UdX%TkkMw*+ctx*DSS(s51x4x618~y%!7|YU!OIGajPi>%_@%8KxH^jX z`H&41_N{ozW9((WOXy%}0%p0~V*d8O6`rD;sQ};MJi)~%d`dmq?IZ;i-^;fi*U<-t zCPzvXY4rb)>j<32*O60!g1|^Cf0^l3pagPZ0+F?85J89;TDLo5XB#b#o&Ty#ZAiqM zk)>p#UC5u1M3eI9{7*EHF=^<%jb-TO0 zgbmQWt;e0a+sG+J8K(eiT-UlJE&Ew}$tKhWoMh^T#s5Q%&QvrlSJ#{FLWSH~ee#3?J^h9(;wKrVF+JDLcWFIj0Ayw^4oLS07>3`^vvUHa1 z2bCaGA-@Eyg)S>gxXx=DwOM=tGLffH9w8t8ueJ^QCt%XXyKo9QekY8wDOKCAlCy6} zX}*3r_xvL}K)us$(x;e&*mu2`(*6Y8!&1PX;uE8DR*xU_Gs0fR>5x%l@S#JC@xN!} zWg(9WZT=FAPB?ENO0oWi5BN1VRcD0ZMLk{+@jYgzey4f8ja6C zT3gIHRUs;+#`Oc#7cH5-TCQ|ETnb$-ys=M+IpqZl$T36UD^9|=m%#S#qF1j<0-SXj zU(Qrf{wGgQ?QqzsdOEJUI$P?kzfDYOS=pS+TeNbJ3RiLRyzpJg@>%w>lyOe7~3VGZUu?&8%N$})QB~rTVunmVY^C zZ!n4Drs_;|)cRUM}0)OD6pC-Wu8|l~f)F944qCJa*?+nW*i@Y}Al*HukUAH8v>HUxL9A%6qUv zYa<-`5si2V{?vCpuJgmR<3`!^MKG%gC*PI{>=klbs{6tKaVaqr0d4tGmO!JBvNg)> zTyS>n0eKZb_E^bqGI&()vt6p3dGRGbTI9euzc-4}*ayCiu09Nf*SK!{A`h7Y3evx{zTl&wDYH`%6KOxp zK{YQ^-oivY!;ZCKBEZ5G9UC%0I-(!NaJW7$%B$(HYZ|(lU5=c9&KjfR46SYr$Q8&; zN!r@N*+)^g|8RAw^Zo>JisqOz>B;gCx_fBf3&lM8UwOXE1@u-e4??{drP=`qJxN7g zWRz@88`Gb_Y+DxUT}y(#u1K)-byLqn^k)L>iAEG3@aTLq$sx&PTf{ zey~Q&ojr9^M!&d5FX$!(0_K)x6M-#XR z;eUD4H|55y^oCffxGvoDuvUINTeD?NVDklWILli=+?vS3uG~S{#|ebo%z+$px&EXS?`lb=)uU^kyQAka=JyP;A%}u&&Jw01 z(glVu{&hiJVwBJ=isiYalfD2|Mi{XWhl-)VN{9qr95(gc3ujZ|Lq*n8+oilC@xb%l zDc7|!jLu$y4kU#7FW(AV)1G}0PgCE9&?^f`oH|@s3kN}6yNmidyaxdL)Z?0*Gs#G? zdBo9liiGc62}+dGF3+c`qYwOVlaT;E7p&ZFE{xY3|Dk~_2=%iU)9$J zYd1(UeR_K*jxCbUT~vFDBzKVHq~2kFHm$c~u+=Ho4$`i5$&a7g1GH;caeOFs%dl?i z(;D%e-CrMVDdTVupn|zE1!TIWHv@Wob|Jmt1H_Mz6g*JoX&qdXmS0@?q8}U4@aY{C z%58}LdCYHq+*zKleDr25QdIGXhgC))h1q=s$d7T18^z7*3OdVCpp@6hYC02G;nj4v zIH0Mc8K38-M)URwN9{j`+xrK#=vc&cxSuQ7=9BGvZEci1X4(KqTrV$$>4dzX&b<=t zceeOoNVvEdkgCWFBwyb6Q*QJr!l%9**g$P)nkkH^E#X5pP)vAgq~LC1sh_I!q%5Y< z1I{e9V7Id;4JHBxZyEEMM`2KH()!Rkghx){rET{gWW{IlD>{`ICp`EK=!H$e&b9!! z^&B&%mAbjmkQQ;;S>R>=w>Y(O00sOPVLDrr)rq^lGmfz>QN%o|eSW8OERE=N8f7cK z-d~+RdCy=f+75XPd2{!t7RTei`+h@d(WYK|ZeQ8I4ZzQz=^?WK2X5Z|f&nQGCtD13lR^(4_yw z(iE>`7ws;^D0&#fC@)i#*1jKC{JLBxFIPaL{yI3t? zv=@wUKGrLxV(j+Kscz1Rf+rBFA5mL;?0QQQ(Q!Fl6t!Vrxq5g0Zk ze3If#DVraczt?%-_c5H#u=Q>LKP zm8rW~+N#i4cQcf@735T_$18pit1e9r5kdG@shvgytWQrL?P>r@)hTZr0MJ1IFODg5n+w zIKM)NqB&2zi4hcg$@rR;ogW}aO$8M;p7Dhg=){@BjibI_4u3)l8YL?_3M2O2RRVaf zE7mcPUbbR@i~-$7l&WKGWQ@{|i2|PG%8eD|_S;(e3#dK+X$n5mhALu>y8}0Vyifv{ z>0m1@vI)VfSL%v{c~tC1e^07(nQ*Sep)NuB_FqpHr@@Ds-sLMQn5dQk3v3Q)u5Y>Z zgqLci&VHFo>8+*`7ZefGbx;W=FO^5|`woYaRSK1b4%@JIwg83IYcrGOb+m@x@t4XB zoS`Dfr2ovcxQ#T+_qPTpi`05G77Q+{i6R^5`p*i+)&L;RYaGx&sdC;eIof9{8z1vO zaIgPO*Z*zVMhkZ!WIwr9JIJ{Aj^+}Ycf#K=e5k;5>z}GDY3>xV8QA8nFu3+=AL>TN zeX?rvzAFA68c22fjClmO#90&6)EGv7RHYpy-9-(SZW!= z;D&D6mCTb0KojYRmx~MD*kU|xwCp<#Lf z|Dr^rt~b8mF38 z-d|yke@AvEbGXn@xT)WS_g}h6&KY*u{|{B?;?MN||NTm(zCKYOMdh$c;geXDNth(5 zk0KqMnNVcI$N8|Cq*CUXN`)=?6y-3dO^i)t&Zo$1bC||9hdFGsvDvuxyMDjxx^CD1 zu)W@|*Yo*!-0!=kRS%kLpoYJ5O6Ijz`=DhZ(a*l~sn1$nH!`|=Eqtxu07-;8qbY8g zOIr9=5i9V!+(w&8%^VNw47DWZq1Bw4v%Tcj9z3RO$6HDtg{pm_k9dXRR@k9H3%Uz_ zi(lhK*Uo-_`G^w6_R{|OSUIW#7w~1q0{36$KOJvT$OZi zHn7Av4&S^AJ7<7v4r8^2&bLs#*7XM4ZKX?DCq?@p-^I?iHzmGUOQD!+1r1G9KpO+Z zuTu|KB~JC~y01UA{!}&ce&dSMSinQ&d|xL4>u%C1zfHe2t?3x;(M;&|rr6>7z%fGh zLdG7Rts3K;d*k~I{L>&#nnq3H?k+7J3gca^7UnND`u$UW$8t7b)vOu+ia6GyFeM58 zDJX|XLUN_j_5cpBWj;Kl!8gjFtqe$f3;W&<92pB=O;yyFYEf?>t^kG zf2v~6jn>MoVdJnFVDf9P8eA`@`^|WvY8c+8w__6CUa`ktO4%PTY4cOl^B`1Bbz_^O z!o^M|q%>FJB<3#QOMC~%f}!4-=(>@l;A9-Oc?T_od>b21d;%lZt{xy3W71a@Th+f2 z{g+^ga>;5AcWyd`Au5;{5@mK+%xO~qpUu1J7&?mXa4Z3y_mG|5TU`_aIW5l=E5b zobCfQS2JQV?2XAs!NKc<&?A#PKa-5+M^o-aS&NPGn+rXf7x)1z#i>Dr!Ub zl7OuQ>bZlX^pRxq zIvmrsod4STg&DZ26A2lt`b*a&__Zcn!t#{*k<6={wc8ACS$bIhtIOKa%X?7SZDam~ z`#bk{7NR;RL+&Za=iVDCD6kxvM%fV&Zz4PGWu+;NYu&qFsc7W!y8(Wq9=AD^V$Q$g zfwv29_(u*uui#JGTAL_m6e~%x$MD0@&kcSKM$Hb;_H&S+b+XMT&O2|arBFbUpH=eQ zwdrbIB^5=bsTuOgPY))iR|^^I&`cFR8VY}AstB9WG2wNqgcy1_3_m1k)uxu)Z%_@4 z8kxb6QR%GLezQigt!0If>m6jZ1X1!F8Fsj~HUZ$Tk>3MDg+;mO@TI?(M%&8zH*X3e zUY1#D%@(7(yGoUi{n*5E`Xf*pNf2E97_xax`;c*+F5HOCO8zn=Jh1$sEjh!qbjy~_ zm8+L*Zleq|T(ThYgwkD3E)85hK6BB>wM2@RSU7GB$4x!ZcKO7M<^79FxGW`)y6uBi zlIzdIRyI79Din|8U8mwVRA;Ik?hDQCOQ#=RoANN3P>J0!J>CMX(ABwrTBI!k!;^AW zF}=*IYERf-wg!(C?xHSi{xx?B4_Th|rcu-PO)jkW>T1W|UbOK-?V=e`Z-7=9ys+I(V}qr>vNjFa|7)cVlwV2 z&al;=z;upaeLT)z*}P-PyFikXKfS(ShKZ7289x(*ziIqY_@H^cFeu|Fa_vWdC0L_# z>gV(2G%Ky`?3#N-^OueZ;#rz2@Ddux!|kj&8rsn1xzSO;F=9l7X55Qi2m_bCse^sC zBD784#hC3^3BZu_n_;>R%7@I^dtJ z=aLI%p7jfA!1L;{;-Ndh)5>DoHEy+MGhYs5&B!k!b3D6Umr~AUzv;RaQUUZo&#h4q z-`9hPLz)%_S*FPE1{-$a-{{B>0l}CVLPuDFXG#zUQ!3sh$?3!X2^R$pOI3pPbo6o; zg~c)ZPi&K0{4dFYAwuB6MLC@jup@us>Jlc_83Ns0EVP?&hR3h&?hXROIgn`{Sgb152kw}Lc4ouY$AK21meZ6 z+sBZz;jfq= zMHWRpz{#*MH<4C3fEWRL_XG096&S}DA?r<{pXVldRu)k*DB1YeVrxDtZHo%O*p4f5 z-%-<>WW0UKZ%oYh^oel#+IV+ru>bN@_9A@*`1F;0*uTUS{FqU+F6v!4@U9HE6?e!+ z0)it#@=in2XV;Grf$zL}U>!yWv|M)e+vFx{;N<7n(#mO?M%cZSydzFoBlXF-I^`mnQ&n_O^o?q=J>FtqiwY0Y6MTz%A@w?5zWw8U zQEz6dmKAi>uj!QTgsDL-J9ci;I>E4z1l=ec(v-p(!z;FeG65qT0WZMA6u)v|(3$!Nzvy7O9Kr9#@?619I6}Y5o;)I5Q zTI9gKouhj1M$eO>V~1HfjC^}&si}ARf}to&v==nZ{h6b-=Xq-iiEtgb4TR9vG`{t-rEv{cNdl!lEymeu*$r`1UWWm zaZq)!$!(INU|N4g_n=;xsi;868ck?bkXFg0q+?4q&qf-zfnRjHp5`<^U<`2bHG}(? z7n98`{g;aH0!N3`-UyH!zqyCLl#nHE*XjQhd1y8;WqjrE2=kQ_-1kyRtoAJMOCfc7 z*F373fm~l$+7x@me)Y@tH+50xHQKKL4Y;YI(Zppf=5%fSO1ZdeTWd{m7(gV9rLR_6mU|MLgLgq`sb_pi4@u+zHJ7|p(axzfS$;ZzfxXws~pb*fA4lWeBh@*IxDSQ(C%dN+G6%_A4Z_p5`=8lmBoof0*Mo}V) z`JFq2T_R{BBJ2UyL@I9qn#$ zV^D9%^%qVYQBlD=1%cC*`}b@xkV~nKsB^@Cm!})`8()h;`FiFq{5{wGkgE>eGz@Sq4d2nQQ1L6 z<*4+tms&1J0_fLptRY>)ovHSaXS{9_z)mc8E7Uq`wca(dFxy%E#R&qQLFJcw+*Sd1 z9hgxwgVWN}i{g>BtSbK!x|+H>k#?_Gv&LPUMt?({ef!oynSw_Uswy#w6VqfEy8K;s zV10^*L!aQ51@sFrOmwp+5I0#&_4PlHVoCitlm~%HB62Zvdk>gxLoVL{D;(lgI!#5% zKOW8cN!f-i-IX8{N2A0LLGSRf(q8qmavTq$9D|z6-i)AH&IP)L#CS8GL=A0~!SZzW zJAsO%R-BEmAAqly6R_*2?MFP8xnTuGW1vl@V`h>7cHGswgFno2`6DO1b*J?NV7?kS z!8?NS05A8}13rzwKbW?KshrB2o~iw;?Kd;Nz2T)C**c_V-+xn{^<05tI`CPyQ`%Oj z-Jp}!md^lR%+VW}jNhFTs$mNqQ*G@K`Q4c8ISu5-`MWpOs{8P4%`a8OZ%>q>ZG_j2 zd}KI9-e!Ha%;CnVZgptnsLxn|W$bBuTW`CATChNt<{M%JJQRbQc>8KkGc<0(lY?1} z>vxj%*)Czg@CjLvKtC@a0fOo*z_o;JtQX~IuKP`r2-o2m=8XZ);I;O84%Z56)iKfH z#G9Qen%hneDPQsmbd?hWUxg%e4k{)JBQ_X-%Va|z&Q95eaI1x19@g@g2ejWnc|+iA z)S{cT&uVX3ekYs;2j6)$eMAU1B3=W zhQQg$_}O&>M-#Gr782Cr_41m?*$rH!;X;x0*dMR#IG6^Fyd1}Dce>A#lT@L}dxQ@Y zeT21o>gVa`>#N7tA6a(=0gdfrFb!&51pGOp3k#1Ov0>>eRv-$x$IZhs$3IH$ z-bRQ$Fyw8+J4{RZ%|;8KBc6XV-)*G_N>=t3^LGsEY^(0Vo!_Rhl9pGFr`v>A)0z!5 zpkG{8f9W`1YH=^V)~5aNRqN?|tNtf{`NNGg{Ov9HwcCF*%xBk|LE@S6?qlcGdAId}rzOGMP)H(_;e3io9o9 zojTfyzNm4gNUNEk?Oy%WwW`-X{?{O(`t=AOPkIjzx##3*c+9^p=Enj`$3lLZmHl^^ z?5oDAY7ElsBWpA$}m20xD^4I+G{W@~|_>p*@Qi2U$?;#IpRz&gpiRQCPD zo`I(%bzQ}a#s^T<)V0Nd`4(fw&TB-Z;s@IXpkuc2htaLmHLan@l@YaN*Yx41B!&kE3LY z*)zaav?g^Nd;ziMjg-U)Yu`4B=)c;!DL2FOZ2dc8K+Z0{AyS0WxAvVy?upq!(K57Z5~lS&vfb?oS(8|&L^I#99KX+QGpJ!hEuT<0OYhs zMS3SbX4F%1aYS9_A)Qc<->)Hy>UmxSWOvJla@pWP;40;5TmlAlDC?Bx!U=CK9K^P3`}1|H^tHpy~A*){dZGUnn`6S->GG7c#;L9qb@IsjRlzKW60B5VL)zQN_%K* zrs%Rn!=UQNr?2@s`Fo598CD^JB0Zn*QQ$%YYfIF)E&1DP7tJ{Xdx?ZT4*A*EVx9fK z+9fc8-6%MgD32@Y8GtrwAckdS=Vs&NMvRQ%mx(fd*26s@+G&6aUx5ze-??4}#n(5MG{|HL_CC3Jt zsbfNp`{0k6c72^hj^lcnFf~_V+HR)da+-EL<=R|_$E zv>=Q#GIm1nC}REZoiRpfDxF)$gE(*}SG9h3zkU(qzM#+(qcQG~kTl}B1PhM?z_BB- z97K4PZ9Tk$9!k>l)PRs;iBv(pCZXfdNeeT@5u~PRH492o+Ej`P5%qtDW7`R{tz}O@ zAM7M-7!mA7C=lK&1V){|1oKh;1QK;TW!x_fOIZXqpFfxr|9Ir?lSW_e-DA4`Qlp!a zfL`3zJSQSyAj<8T4ODqX@R!rC6VF3TLS{VnDrkk|eUb5#HH5nc{%;{9kV}X_Npqzvi=`qCnADJ;w zWe;hl}Be9?|IH%`5W{2_jXxWt}=4D1o+V%5l6kn-N5h-`R=e7t{4 zwgp2puZX56ETK+>EY&tlJU7ZGe}9df$6(Q9JP+ppd+c|@RVv2{W^ECvC5G=$iN2S$ z+_wT;tgz8{t(i2>hg#DBx*v?XnOi{FUUX8Eq8|)f<}+6%Lkulx?N#uD#>b4tKY8{KL}MRY(7MIH+oXi)vlUzCvwL8 zx9ez$*AVI=@Z>IdTwYOu1%p^SmY0rwV8b*Dk#5@B>hb3+hTto zZ`#^F5=uMpd@YKVy)lA!u1V(aH zkRA8UkKpsWE8h*EsJC+YQ18zU(MFCfw$p1S?aB@4eIA=_7tnx9F$?c(+t@Ry%)s_0 zaBxNSNbL!onEnonU*5S3up9%9-`x?-7aAH-U3zcY>qE$!&^Esq2_F7SgCtIDRZDiMMH%d zh8aKR8AaVa*MNc}#Cho)I;3qLVZKs>hYc=PA?NAl*vcNf(hF z<^8ee|CxfnfH3IjJN@E5h}T4yYq3MNSIsEWF1wIYLTQ8&)hHahCjLUR%|BC=LH9#b zABT5TSM0fhK~PsuSU+4!j{sa+Jl$6z`X^G7XcR^I27E1FKS6>SXSMZ9>+sdD~1xCdJPR#t-Q` zO{2%XJ^$d1%Fzk2mheKW{OcWAajZdF1*yT+;r2N0*#hD$mQg$OTIpc!PhC|~1N$2y zDt<1t9bD*lYV(M8O^$J52jyn;U!P#d8aXzq(%S4j^O7W9_WX zUwT8gRXEr9V+ah=`RjsI&^`!i(HNn;;(C*Xx?D*azgqm46- zNwRrJlGmWuk(Q^hGqDe-z;9khs5S9=sUzwK#1DR4o*eMaN55u(B%rI2MkZR@iV%ys z>C3H0`edgAGn8(l@*AH9#!Jn4ui1sS=m2!}dV7#h|V0gYE)o$>UWecxw|+(6xZ z4orOzuI4H6bv!jqvn4-U>3yE#CHit=VmF;J=~{!3osoApWA6x01S~LUqMG+;Gke7%OgAX&!V1$nIPg_5xW=doqw%6ep)@^zVtHoo6jT30EOO5 zYMRNbm-cuHn)BvHh=h=rq5T!HC9n5@^0MlqAERHb(n$|HVuV@KyXxC~7jGhFXk0HU zZ_cXoDHO`eOY(0v>D5zlRrI07KXHv*iaJ6Ff-3WvsNKSAI@EB{F*n)37_+M-cTAN6 z2+$*1B6sk|g!xDjWhB!qbxq!sdT;!1eT2tSH&|im^(qDYGtZPhVJ7GxTp?QCfIk8? zv~_aw`ZMeS@lFdi3;QI#o3kpvTNPaZc4Hx1o7k^%VFUF|qp0 z=*AtQ$B}N(pZ-FfT%YyZvHKwhYsxC8XI_@Lt&GA2(4_^Xy5`)DJ3SGondjY>vMNU5>x8=YLEqN^mTU&JBm{q~cA=lj`fi=mFtQ!(>@oKR%#!>jbR zlMKhig>c0PIbXD_6Z=p;;tYierx@`;UWUc5dLdJV>j%6Nqk{@hg^j*qYz%(jv4AdS z31rBBJWF;p-RgWWm83XgFLAKaiJbG#z$yo%dQrjh(N=9%O};WlbS3a5{1G7?Z*euy zjq`?(VUcNdfI8P4vBvJR+pTlmS}uMmtG;=fgie~FTOfR|*S@nkkd zV~LWMP(eVqLDJd{!(4ZHE4Zd8UOeqd0J+GgXUb_6jnHD|HWBr`=k?km@9{YDE`raC zq4qQOMAKRGdl>Hsw5j=#)E-7`F=w|%%7(=o`SP=+aWC-CO}d)iO$_C2HC2Mn&!jHn zhLbZS5!p&{PLdv$(J9W{BYv~^fZ}m=vQoF_Tdv`6E3s0BEAiZl_5V#;4D77W_oB-6 zB+nSSEdHcY%|@;^2pS0*1y9o+;y|(aO}6i^7s`~|K%`v&o^5;b!?mc>54->K!J+M5 zRrfFU)_}d*3=iaaON)c~fmv8$deqmmihcwhMKL_;;d4a{py8sp#=U9aE+zSLWqhQ# zG_*bhjV}0QRh0v{qDTd~IH_N&Xn@_G54L-4DE@p)JvuQw_6DjLwOgxcSO47w)Sywl zhln+nWsN3qoV{oG-dbJ7V|o47V#;{)%1et!XopF~upF+0V3Li2O%JS*+#lvC`;VO_~1sz*l+;eZ(V`;tz!`%;%3D z#53L)1{k`jQm)LWLyTdX8K^MMGWBHU#Gwi|ob<&#Mx*H4u)0um&_9xS4E3-)S|bP5 z+9*%Jz+ICw_<#Bv=NRBi-}Htgc42_=lN{HDcMfXP-!sp=2Uw?-agI*7PEHvt@9tEK zltVayE<4jl*dOJDHVsuTYdNTb&{$9M*T4TOa#uiEw2&x)MlJ*xz=aw==6ogvZ?9cS z8W|#YeeW7?P?Bm)iH1BA1>(J79sLGf{roO73nwC0neQls^{8i^j~`h#DNo#%P-1rf z{H#t*UQHom1y%S5Rk5Ib!aepJ?`@>fXuTvN*(y9B_Ia~ynyZBf6wBGdo@`{dEp2_Q`+XXCl zcA}bL`?Jg=9x~4S?V3^V!X8{WG?lL&i|pL`_L+9$2HD$t&A(kDv^5?K#Eb{uH7spz zNrm(z9o?M>M&R1i+h`Ar;9HZRBxH?J z+d}RlU{SH7aBKhD;q_~juNFHtDvP*L$Xv59EDSJ*0NI0Neixxb@QDpO709W8I+nNR z1UK6$)%w@Qaj-lg_clskLxgX$AON4Nd|2TYbTSUDaM>8&g)z zdCz#;a^Eza5;_I5jZQ(34N5AmQX7KAPQPm1ybi_SDQ(ir!8ZtXCbZ|&Z{2`@6~&>I z!lF-|v-S5op8ssD1GT)ZY+fn8^6CV*h#Z8=uW-`vL%wre7Z^#O)AbueXf88xz~bq&<;G z^ra{N2Xb+8UlaXVjLzd%4y24uR?m|UNmi4`eEXixI{-DR@wV;XSQjE1hL&#l59wa5 z?7gW3LMk4BBt8hZ_Bt_j=kmhEp>J)Vrmm4UDvD1jZ(yl+k+cB9!C2L$$?pt@Z7(4L z?{mGi-d>2DAAz>ebc|DrJ^y}cGmP0e#r_ah`QuNj{>BaMfb~B=|9B&l{?5Idk{Cb6 z8MFz}&RH#}V{L;~K@->bMgTW{0v|@Qq|o zS{rjO@Z_qWN296zu&(vde9BAHT<;3Wq^DEdyr(7W-yNdZrI`r#Q*vp|Gh%f#Zs{Z# z(tL)w*C~LA>wo}SXKdqho(T6XoCobR9%dY_!r`7UM-y(B_))Nq(-*A8?El(HyOsoy znOd>?>g!khpEbZPi1K=@d9LyTtsO#S^a8jMjN6Xu3VsvBv0IqMxssB_ zVemGgw^m4GThwxz#Ur}jey4CRuJqLuhJjcZ8@~FE~Bzr7T3J14O8>FTIb_ zvL?Ukqx-zAG8u?`ga%ke*SK;Iq3YKk#>TK*0d*NV`jm+&=7Z~0l>)KHlBI_9d|u+L zu38iGCw8a&Vc;CQ3w|N?x#-Uz$cm!Q;!A1NWkoPIn$;i<%J)|~l$+}r`yZ)D0&`Ui z=Rc^lT($3RM!m#pcI~hxXb{ZBql%kr?baJ#1z**FE}hD*=UjzYvRq-JoBTCaSbA2g zk+O9ozo>0Ihqg~;9d}~^q=NTQUF&c|xx&at0%JgGiIxfEiNhD*JGZ#wsk#Qr5fxcd zPFC3Y*#}46V`gG7cEtTRRhqaSiow4R#gP*5H#V{{(p=l%-P0YZ6{g;ieiRp=zN7g_ z8enakN$FU&q*PBFHM1&xZSPc$xUYdd*j;>X$X4ROdVVpS=j~&a8{t-}fI;X?QT{An zutOMP$nu}0ni$2f{Gx3DB$meQJ7^#EWyiXe047ihkh2*5^<7#W``ZQchnV@Pu0nmZ zbpL$Yh?Kw59Uc-Ur@|;k6s^&0+oo$%_0;DddO?ljUlyX+zW3%yAC}LizHb5r{tLqT zB6BMK;V_EarW5@iv5O8K-I%*D<>5B*vC7!Glh?d~bLAM6OPO<(jE_m%M@n#tw5IsS z^IsUoFh!Z}G4o^i)EBvBhyTTlN6DG|!DR*! zJB6|n@Le;n^Ve-fI5zbLAcSwFfLkqZ3}oi)Fored-x9RAfFCui=`T0Cd3vTuJixJ` z?I?CyPWqd&A6;Rvr65_L0i4Ez)nz1O(VjRb$~kTG{tCe`wIGn|9+z7AhX(r2{1Iz? z>!=%G+yFv$1OUEau2!;|U6Gj7T4V&R5)ZK9J#vAILzSl($jfin|<*Yo85kGdu){{%?93X|0Ad)pmm-f7|4E2ozgIp}>?2j&w?FVbAG z=p7BPqKJM_wm+(pL;F}72+eG+P}KgiffEm94JNaljgRWMGT*qxr(87ZZ-f+9%?@w{m2Zd^S!FzbP z>hhkO^V?{->2Tc@)W@|@Sn1a_msqHemsMCucut5+ShSn8b`jtC+WI7sf{m-=)_ik{ z{%tWz1FF5hC1uang+4?GKMo1HLo4XdZ7~&5y|o6RdG zgPz);OVm3#u|iVH@Kr1bv&3aqguO3$IwO*^v=VktQ@b|}20Q}{%8AG+Ni6Z;Z+3ac zsw2oF+aV@rtgH4_vjhqVrg@D^r=ihm7J#`hf&e;NTjO+uQ?Y7FBvO#M7`mO%vnz0l zudB46GhW?M7Z`1%Q4jdou57i0I1Y|EJgQhH+9_8l9$kzr1soj#ZF>Ad*2lkeka|xc z>SB`{M2J>R^?hBfTz4|@JEpqq8@X-D zFFkguAK)&me*J>wbiK|&dLR-9i~-SproA0!25WH}eRckYoU*D#+Zl5#q<{@xlubV1e3oz}Ch=ae>0xxl zGxR^KjNy-x?fp-&-u6e=X>?@Eych%lY)ulM4GWv~#wWe2&3mV+2&Ww_&QP4ruZOJr zbTyQY*X|p9kmcbiiJK6!)#IAiOR05hiA%QDqfDIj1HsmLlu?K6Mu!hwJB;zyYoSIp zS@dU8-#1CH=JYqb+pH^~W*t^zfDF7)eN@zQqW(OKSpC2T@ccoJTwqk9T63r~8CxpQ zLoU#Z>T7!2!wQs%UqL=oZ1Um3K#lmypnI-JL37JgZLML|h-8~!JlawnAxLa1BCP%i zqV<_|7>~u_F`13H&@$Im1re3-v5s*%{PfApfQ4DDardb~lFp;tNjg?OIe$@Lh z@PjGVyRk`0Ze%K7(rcD03UdDcqpKuirVpD=-19kOl)b1_{=cR0@+~F{n6#;s6r_3? zbic~o;veb5Ip9>tOxqf0)+jKl$hIf%rtCC5PkrskC*=lW`5BVBhQ26BWqTycYXer3 z+^YWD0#>K&Si{dP`4OgaPHL2t6A!LU-omgfWd5Z*#q2kltLhDG2y*sStWjWXoxL2u zH0=jkdt}4=KXBYCe5Zb4K^bCwqZWfe5Y=y_cIj=5^FDZ^-`HBW^?Janc`%Pzw$+?J zd#MPC|K0Twlm6xd^XHQL&nW`pMt^aGhG$G!5qP8R27*3UkYq@cd(bAF<(M&>#0CBk zOZEAI1F;~pBpE-G)PHK7yLFxW*&f%Sry+^zD1~3bzv)>$dVeGws_=w+K(%=~?Zke#pdG)iZy}i;#db$W!()mpv*{-w*Jf)1 z!vwYuttLn>O+fWW0EUYPT|^Y~@}5i}IxbtwLq+w0>9rIHq?1N8*m$USBE1dP##{BCa?RB4-V2Y9n1k*MDn;aYDJj=QN59)SL1} z4@EnS;jXw2$0*7oU4q57ZGKtnJ3ge3Zok|Wj&YUZ|3U&~HNMdSy2cjHeQqoAYSl_U>>7yUDybM+dn6n|M+}C+h>czO zA)@7sscv=ry_8VX(hWa9y=GQD+EOW`-|Pi6{s0OecU}pu7S;OAsXFIl%GxcBfIVM! z=SwdjX}6N1`?U|f^d7**L?r;7g>GWzX%%*MH6mL~3B-NVX$NnMw__f=bsa~BqC?|( z_x2Pceje3RS+a?+GKhKam8Mbg2V86igZ8Gv28LYq%%7(+f-jf6Yms!{7f8g)!v~k< z@aRVk>*Z>*xt$Pj23fvNTYK#=zbz~$qgQ7J@<0(bSQ3Xwqxc%)l{oiwUadp}1gygj04N%MjTAItI;H5^=asm09>rsB*>Zp z@^Kr%qy5cOi+kwfB!&DqI&RO)6MBo7sa334y@^*8W!emf;*qYX~{wV9h|dIs9`k z1FI$PC^wjr1N#fp0Q_bHc3s5ZmjR?RV`sJ}+$e8z-k6t@_6l=>mw5r!`NKL^OaJyO zFS@Y1Z4ea-)%Qledd$S?*^-?r#HFB8Fbv#ly{`~g-O)zBUik*SV)Vit{{Qk8Ri7{Y zV^+L2aJg=KNWkP4-VO>xE+|S8|5t=e8u#D_{sAp+eT$=%3eW`=c*@(B$R>TP#w z?>kr?3aL3XIDc`w^0vg7&KJeqq50rvVv%zLdFWz{)~O7Oo=3)j#NQtlZaxLB^07N3 z?w^4px-i-r!7i`>*1rq1DwMpQma4%Flt<)CGywNd2+Q!#DWGxOb3LQYu5W@Fr4z!N z@FSjD+0xdNY(&m*O=?2rzR`{|EG#EEt@=&E)Azkde0i2Uy2$d>IFt$t1oY@da&W^i z{~>iO64|9#(T~IUh<;VmFY?$r2ivpK1vpD;6R(K(UDLX=MTCm{9Q|;*rU4EL!t{RZ z-IshZNq<)8Q}d&kJ!b9@Kh*gjujb_x`1_zV;aun>3N9@A&?6(;x>m^WuH!L7CTJI zK-G}15KC-$Rs5FNaNjP;?h#@q2#a2!{YIehy86Lcg+xe`*!kC2i$B++ z7Hpnbtycl;W#0eV!yZaZ?J^=(&@k_xib-9hkBRxjY$TX}%4$kIZu^>Nn$ z(pcwD6^W;rz6fm<1xcM7reBs!lW%J3GotoET8!cof`2@fj4W|1}pOjtt?;L+}~WSKNr!z#208`ISmcB zIf;~`8oYGD6IUOWOIe>4v}pwwx2xxKQcRfv@^t-nT946K`24mscMZlHt^NtLe-;!| zZRYCY5XRX@Ubyx7&dK2;?;AmCk=u=neKOw+m;kEnm z{|JqkISy(*owkuqD+gTe%brlY^h*NDW(^=tAfCtO>;xxq;Sj{rpcr5S7MVYuKCjZV zuH1(7U!pbd@0ogDCM#}kC8RZ#l)@j&t$BADOBrS7w!wKdOPcnDN*NY9AI1UvANIsr zxPSJUG@u!N!75_X;Z#2S*TEUK0?F#EyZ^5OS@TlUnEH9haQwny!maFRV%i}Pz-0KA z;TNadQnt;avnhS8w#;y&*9t6OI*-Mm$6q<L2vfSKiwiXYJ<= z%)@VYGp|1d2*a8w@8ra$#77aH-@9GoPgN?9Q9adZqi%JS$FY$l4K>%*hLz6R?#s|0 zX9iZmw-s-DaqY4@Vhk8CD`bwpy2LHD8CG-R(S2O6 zl8N6USWPpg#YZ$+KXX5Iocm^V>%dpbx@l@HN$lK8dRe1FMKg!GuX@*U@2CjbWsMyc zR&wBUxsQ1@HdOM=DBi@+ppSVuigtp~@Uv5d=f;DX^KXAYkDe;SGq(r=SmjQcmQ`9T z^-lZrx#wvlPJPXd3=jZ$ti!3g4XB1+G1GnQMDddOUekRuWic)-?`N?rTK#Q%sjjuV zu!rB-LN(I;S`T1kJ|-)e>pwQ%7X=#!M`s)2_RqaVZ^^Hc+Hhi zfQsjt6=3p@u$n>x?zH;7NE^kU_ApaQ7Jh?mLn`PwkypVDf(XfaoQP9>5_WxCHu(FQ zr*iMoeZ?p2y!NcMVO&AyuwEIfR&#cR`z3xukV8B;HEW+SVg!SAs%0H?Uiu&$Akega zO8iiT&8ci9>O-7UJ&wFnJ6=F|#ZnKLuP)ob|i*$>D~E`DE;S>iZB1_=0dm0KRepNaPaM7S!*pU8pDh zGc=gdxIbF|fSLENt@n&hhMxB`>&uHjJ#ydZvj6$SBfrx0HkB*=R>^tzf}ZN3t@?{m z0z-)6dnBKoW((0|cXTOX59=|0r!sSk$`~iIfHCL)DV9FZ*@K*(asc%c0e12#*U-nQ z!8FK5)URTc4&6cTZJe2Q9eD4-DOZ&c^P+`X8||60A>1KAa>K5E#QfG1k=62*6&SON zUn`pcCPu*ar^J03q5t$@>|K&vkd&1eGTM4isOQj3ORu{&F$J0;8j29NdT3GLto}O$MAora66}&hETfsW;qmU$H zHQSoMuh96HagHm!RlXd+Dg0w59~GlqIdS3&+fOX9>X)~Op#lk18*7SNcUYGnaEGAH zsm)VYtSx9GAixuEQj~ZlGlp%uo@-Sk`$llIw~VS=yq~o81F*5did)s#a3yVGKfxaZ zW~HZxN&9j2`>}KvNKoOkT94a0krLKkYx9k9tJap(>ZWOJs*m@6AVb3Z%gAy&&q_Vk z6StgtbZ$`PD(r=7YV)lLnS*=y^H=GXUC*1`_Er7BCk|_m79Ql;G6Z)qA)94NtESN| z@O~^Ov!+6KrS<2VF#UG4#qA%vzHB`d5?%f&PJFx;_o^1;O@yDBeVvbwBwp8uca<6TJ{WNy`)N~j+5)*#x8N~46wbOY% z_!Och^OeeUYT`7lew8ZV+ASjeRHR$rLUl3eB}DdW6nwJ3#9X2Q7onMP7h})^V`bvl zy{S?)jd|Sq7Zq2KCC!sIe06d6bPY~~-_z#6Q|r$9<@XoF;;FX-?x$*uFP#COWdt^7 zC{f#OxmcsyCHyUhe$_m;#Do}@${*egZ%NO~JxpTwIz ziV&*-U&aQ22MnM3ZHu|PKzR{jbk-h7!*!-24QoR8nqP7qL%VP8N-cybynW_~OwTvl zX=qK)&{!$<<83S^Rz;7;>QZ*Clb`(p5x6g*{mRdOYUXE;m|D4KX^jbEO`028RyJcr zPNn7o<`N|?ZMKXNeEjb~Nj$Z3rq83J;vw zFy96oi(bkQK1s*k%r-E;DV8|cQw>HgD55?ZWG<#Z@N7dehF^R`xJ{D}GrI5!eV2Q( zZ=(6ry_%9|mpua`AJmqM+#UGEyYK3g z&P>17`7}C~+b)lHm2DP_cBjrG_s}0TMbxL2YrZYL4k4KZrHFVa^cIlOM_nis^zX5Z z)F^?mkN(j~b)iMDqQ}%^={kw@kUKo9xEBD)Jtx(qU`140<`3+zO)zdTCmt|fD6D~PDmRC z6Ti^VClIxv2}E?Kbr57?gIVw-aebxQ9k+KybLj+j4n_*!g9GVt4{#IKrw&@PgLovp zo!rY@Yx@z%MJoIIR{R(?K%#2V8dg{`U4p20Uok-3261Y)pE+t%jF*>BbAwt(nSQwb zstcBnUZ+rQjeGmgHI5Q_4^yoZJH9la#t+EOp9ZWQ;}7DOH}z4b1uf&2GLua^**rLI z`zLK{A^1AZQz9-2N8FUalQ?O4zT~f%JOX+<@GKA`+#!_{tG>}4b0?~u!vk~A-T=r5u6cVq5>k+K=QHWbEYBiL zlYs=#wYtoNaqYzCs}KXMKX7ukn_j`pO@6t;VF#foleDRmttkEEPOY;t7S8Ji=?q(^T-+4*qoTg@2MjhYh5e9SN|y~5T!Gju5hiM=Y4x?jjKB@Q zOGblCR)E%sBNsk!U^4JH4ASRrCf`!f^*59t8)>bj)a;0z8=oAB*nNV1f>6biRB?IuPd8_Do#`^UO6bq+wJ6x47qc`~tT*wvf_uBB?GdLo8dB$KYNP52xBFNkt-AOg zQYhSSa^kR!Nf7l64j#U7Q>zbOU_Q!pTr#u~(T#BjsO<1797@IY=Un~gn-^sZG^@9x z+P^6s*+Pox;k+|nM#N2@4>!l@*ZNa!dMplEYy?gsb>$h!lGnw7k1&S-A)`)#c6_=q zgn?m5p%VF>O!@zdRIrZYYBpW9271mP4D18!MSt^QU+`87G3=;MV%7wG0t6EPW?p`M z#v%1EywYAfCNabMWb-c3y=!C@A9$|;_eFx$LDuc=u))Mq> ze>jdQyNUSOQW>EwuVd)5(H?VVA#`b-GEUi>mZJU1lWISDV!vH$>Cx5AmAdh>e}2Ur z2NLH0H3z!@HpQr}WR*2yz$?$Fh}*%b^$9zzy>;cq z#7bq*i`k)tLi)F!*IzwIxnQ%M%=D11D>}E_X{nkrRjS{ z1&q_=u2N7-cN?QU+W)2E$~yD%f_G4CNM%18i(2rAo5A;eIgGOv(3@W!Fe{S9*6O?Os2lD40zI*H$E;Keno?xPW|&$ybAl8vD87W*VBdrVt(( zIL@_}d@u_9(9o(Xx%UZj%A8P6wAVPdr98ExB9n)B(B|&hWtvm4`-|a(5G|j@qU&12 zS6vVrG~ZB}r)>8IrSTAiugQ#?o@GT(hinw$Y-KcTgWH6wQER6b@Qb`bz5182XZ}>M z(!8n45NX$9hzvjn)NQ%T(?*~N``IzgCJv>xuB0sk=CcFvv9`x6v5Krj%Ftb9_N-Wc z?HI4=RlX0n^sLvY=E3EI?k)ZKz&f#J^UV6gfks(vD>W~=8CT>})b5I?@%db8Ji_LQ zX$#J#l9$+55F4Sr=3E0$1hleF==;X^FR}hPu_bQMvrA!8VIYvNLqmzbM11hLSWjP}~{0eqd2i}G4i)8dY6oU1Hg>Nf};z|&S;F^hRNxna-6 z+P77<_}!YfFuf&0Wl_QDJ0=I){~^ACkz*gKPE48W{o#t@+(^83ZdyU0evWKexNuu* z)j85c!@TRhlb#*xwHEen3y1E=>~oaM3Ep%1VOw)+)wRN@5pBN^f6fzQEs@-%M856G z{2Swo9}t(UzBr*UU#e+tA*08@-E@$yJ+ww?vA}-17LZG$W&GF}Vm`tX{~WlJ zyW+>=$YtB4HptI~(;Q==+@Y-%;&xY->+43!6&8oqoy6fI0PBftrPydXiQYIX`wxNX zs{-Yq*K!>?xq35%X!b2w!^RUcOq8=({XIPg@t<|#Hv`v+{Bh^8BV&dKCE_oErm>)P z_g#`djoK5@7xkbfE>)<$BbjjA2X(_C$7Pr0n6B5LIOgw9Q4W0lm@cROsgqE|kT^yX z<@o74(IOZkxk#Ivf8J!ZaQbV&b4`Xk9wxunjuUpw%+*7&4YyIL@jAylmyU&LDS15r z6{{V|ZrCDxpuV5|{mR=kD+R2oi)I~PITsq) z6W;{sK5J_#K!y?uJSOOov!`O3IUhCLHKPT`+n;V_+6@b@Viv2X6Y|zoCA7r;+AW_L z>AaDi7Zhs^dF{me|1V7FRc;5>{(u*`y%;G@wbn7ed1kPF_(f56zPrs!<(m4c z*F|Q?gSgwt=XUDy~ZdzGjF5y6t|Dru#gXP}&udr=S z&m${+8|qtFfGu(BAcV>TIqeDzJiX+e$u*I-j<^fiOgbI}LU)1ExjIX>M%i&@8f2n0 z;QNUQq1RwGb>>+E^(xtHn|ndJk(c=s3m(>`W1h@SYre}iHM_kg_c;r=&Vf^!S&0a; zN}69gOEnQaq;jGwO~FS!H%1QK*@5fFPQh`0ka*?o3Q}lAqUa$oD>t-`7BUSy;i2`v z(+XvLt3~91YOaX;%9NvNq>s4mqWY*;Yr|BRP#fBk6ikj8EY%uHa?x0}aj#4}xka2m z$3A>f>Xg1L4N)$Lev~%S=C{-uIMAHJlO@l&ky~fyA6Z&OsE#r%66FSjE8Ijs?ggrJ5-bf4lWU+dHKZN#kl!Ok%dyzgma*QhaPWlILWOe za^FM?MyxtzcgVHY-(s{AOB(^v4*x6>RgJ%$EmdS{%R|}jahtwV{I#5r8Y)`hWgI8Bu90$wDPAhM{ULaV+ zFt)Kepz=I$4+8ygWzfb zJL0A@Si?~3ZeVd~wXZj2k?$(Uo|(s@FZVB6sWsyg%5p3SpK};@id&-r|;U z(C*f>N2x*mxgHWZ0f7{D!49c8U;RG@wLC|E#cut#pws4s4{A4OST8>rEjqp0n!c%c zO)FUOeqy>4_5hT8K)b8*dRx-K#B}wLD4YEae*Hd4 zNZ+!+MWfF#%;fp>gxR6`SFM4D1dAIGGDC<%o$(+A8d?=XNy7PGkoPva;SCd>{2z&a zxr%1x8MWF~x%3B%b!+!Vf~15`fH)fcXdR%6DrYwtU^ML}0ohVp-~+G2la8H|9q6#K zS?B!~z&5lIhKeT6&gY0* zSnyG5pK*ygu6cuMvz(?-kZNO)Ut@mJ?8#KfhF2FE*3dR}0!GNJuUBB!R~%RpdU<@? z%{=+%ePNOw`iW2Zbw^TdWvi4j8lBV{h*9izH?HWVQwF@Yc{OL?zA=kP)woIQMIzwb z+J7buVgS7}%R|cmGAs;e^)EquM^22F*nT4I@f%gRD23OXzjgJHePnCOlT}P;>!R43 z2g+Ht74Jpto)oKz(_2d|#T|hKc})XPs^ViN$G1t@-Fi^dW?*uLPVM@T(`e2uOm3V^ z?ANyQZs@~`eLKUtv~BHvTOY}jI}(shOpi_Y{%sz0OWh_!$qPH8tK0J=Ff35dAH+`?X97 zl$?4^oPP8Hzqj=0l^V%I$}%$m>(Kiu_88Hlok?|kfD*btyP%BHq_T#FNEmaBscz0Y zj)?81#JajPQ?91_ti=629I`*2Ty^K|eVXYpL$bGL)ufQp=GJq|qbfCC`L;?p%O1eI znR*d)(3-}E7_gU%xSzY;095KulA;$K^s>GSk|#V{=2%TJrx`&7kmibQot77I$%^Lh zp?reaCFCm@eF<2(?a}Vq7>-|PCLYt@z5%P9B_xHxvM?B+Qs-g)?$u@h9mOY@lN+k@0-SvkAS}BTG*no(cbA9-I;=6 zmA7c(3GC{q17YbU7}F65o&~o}9jjZX>{*?=G*jRNmrijIqkP3?9GA$*6Kko<;k;2_PLj?@387>qKnY9{Rf zf*#aoS8*_3SpP*hh$ZDll6NKJ>jz)ABa4ZE#8zSeXe|wf3n1g-tnWZ*3#~FEyoig}AfqeDa?x;T|w$z}gK=}zkmbIc)GMwnT ze?QgRvUnBdfZBtO`9|f@_jJR3`#M?wD8}vgQCS6ku+eLtnzs@znaY%Q*CtiuNdl>} zc%kb0O~mXIJul{nriq@toNN<@_=!Pfku5PjSp`;+SCVa!n`5)Lbp*Soue*%*MG|Y{ zODQm?{Q-mZk5^xJr{~Y@aM>LlyTYR&mU# zbr-5G&rs}%XPJ%B5NH0JA{wJ1se13{j?K`n&Zook@!;rpP5AlZZ{k>Y+(NHOg(A zPU#ts{B<6tH5bd{+^t|MN|~))%CEt4qbjv+ZPa?a?Z1{a@lj#T+Ua3f{c7Kuj>@Q( zv6gDV+6cPG>(Obg8Nn$R9x;a3)KWjX;qGyRlCM`cb8{mJ6WfXUXdFPwp0fD66Z2mR z^B(?iikwFXCbP=2NEzF)iM;&{5RVdZ6spSR5sveGeOK6g?H$j(b)WBVik_qt9o5VX zmDWT_m`CN*Jh>mFQ?4bO4C}rEQXLN{^7ozm2D9GiT>8c1M@-D~f)IoOH8jW{8AI6@ z-3w%gc~8I;7Fp6@cC46vDStwXC(60LtNWPD=TzH5VqNKk)v}iy-`#TdHnyYEXo^|v z(Mm~T9Cx5vUelO(^9sy2-+kN&)4M>0vvmbsT*2iX1W ziCg)M_&-{8HsgT5MLB+O5A8lYVYycadK_`8{vlys!gT`H>A#WBQ~x}+DrEd?wj-C& zUgFSx@8ZP!)Q+JG_6>S&8(5&(v&+|%(*c;an}R23UsI^Erm0=D4okvaiTZH_p~`Z& zbgd9bRo2%}u=->EjvCs^>rbn)&#!H~(lag3NC$=Ss6*ccjHHhDE`bJ^WUY9{P`}aO z3G7POx4-CaIr%hIRUJx{y9{X96in2RQfh8CtnFru z@#y)#5z~cZH_u!>%^5pvpcTM;Vbz&|3*v11wE(@_bdy* z-8f+}`svjsvzk)kgh%(bb-ddA{shJO5bws|YcHjhtwBEaWyXHX~G;+0PXB>y` zXdJgC#KkSuPQN^0c3UewQ#5>j^>jc*(60W^0-QGhD#%j$9aE)38K}cleo|X3P@r9E zvGs_mNBcHkRVjX;2l{`luSici{PkK5m*~_?M#D1>N{o6+Sg_eeUq$cQvdn z*2`SrT)n8IZc=__YU)na#|m(Dqj($myDL%naKf+D?)TdzfpwS7M`_9{8PcX(lAl>< z5G7Y-!)jD^asm3DMU{I;x`*yz+h!YQ|Di^Qr)iQKKfUf>7^v1znfqnCAfct}_C!Ix zSw6=J2fV#0qAl&j$p*>;7{WauY?g}e)seGBIG_!6mz)K6FQH0s5*p6j0h%7a8+6Sj z&}Uk6UYM=B@}#GIEY(o5pwXpn(Q_k)z^+p-zaGV$%ZbO#aux!ZkjI>!<#(>AkF_;q ze!ya{Q=IeihG&;S6Bci#m7aDozd#9MRdrTI-x0U)m~*b}Hmbz@xr{&8;Tf>FkyU6^Qtr2k4#kN;^D(}df-0viFoSa-)Fn0+6R(C%hC;)cVX7DN9_kVMZqsw%?M4yp_LsJGXVRCMsfId~k6_xyfeaSu=81 zDILim(XIOi(6EA~i#DdZ#l6+&w+L3-5X^M;aeb@s!eV`LIQz&1dS{ik*Fh+9A5;nU zg8Gm>xokptymU4!!cO1usqzuabQRh!1jnq*Hi?hHEmILcb`37!_NA=PBK#MD7vzmn zpHM|%eo^d)B6oE}vot;RYRj|!clP)^5~8|)Z@HrkHTaj&sN`w%qAPiEO&;##krN5>g`B1ePD>{eT*5_}A>(|O%j)?gm*{RA_GJv5y zb%t7?uvhftpDF!|oJ078ESx#_Q;6B4Cgq+&>K;%`=z|Iike!!6uy6Xm@}lMkss)yc z`aZd~yZqKaT$!mibiwo;LEZoi_q!tX6NZm(l)1kiZHpD9WPl1bwZ+j>$w_ui3nldZ z1sXpydL4-)F6Yhx+Dx3D>b%^f(ZG0O6Kj35%-63aOhN-1U2;*9Kw~dP#Ro@L)8qAa zQGQ`|dO#n{exo0Kv5#5y9Q9*5t15(r#GJO`gN|<6jo&_iklH0<(I9g{e9 z+w+OMN*!d;*$&L2c2SA4Afz=(jjX}&v>wzB%oEU;H#rZ3V+e5A!*A;Xs6mq}A7ENA zGhbUzRkJ(Z@SxK4Y1O=I*9e3cVCP4cx(;+lQB5$fs@+U9L>LamZDSz{Gy- zTWcc%T#0LTAWJD59Ud{HG!Ii)=Ldg;N#ciWMqBMm+4Zg^Kq_{CA=Df2V) zNve3@kBwtRhwIv*O+nY(ZFbEF)M|UPF{0zQyrw#~#_i??3A4=YVTGh`?EN&z>E*KJ z0kKvL49{Th0`0)tg6!nwj<#Ka&%UV?Z>jGJvw&%q8+%9>W|mYoh1wVNHE9i^NL z(e9!%+2ekU!U~+}IdAeg`)pkgd70yO!fH0zY{78xZG8%^;GH>>(-)_Y18vM7c6Df3 z_xniOGj5Z-gIdoaMH*>d>LmSEi+$tBKZfC7U=K!zCpVlFFSw3sA3FQ{9y9EOr|;V~ z%1c|(#BBP3OL3>{QoDDFQwY-o7#V8$ylk`fKp?)QG5xS}|Q3c zg>!kc5@T69a&|BOo`vzZV5;kd0=;s)FS;Re?d)Z>}%{ zlrNb1TWC3TFTXJ{XSl60)xx9V56H^Qv}hkg|0_K)T5r1NEi{mMV8#R4{R=W*?<%yC z0&f$h$mqIS%x-hgV7IQdC}WoKCdeyutu1<{N`csG0-b)T{F~vmPw}jEm^k;Rg$qpD5>~x)v<0 z^qX^#wOWxfceyf3YlofA)owv;QwH~O;K1uR8_RMF&^QXv5v)5eJoQ!dZfm-9cU1BR zRzyy>B2z?C%xjb0fi_c$$E^USICNc6biij+n1xs?jg|2o9L3FcA~sxxI|Z}$>M=Z+ z?~Iw8UnWm#6>0OEm*oG~Z};MGh#(Ba*7wr#zL@~m>d+{RO>*o<2m52}VYWmLh}ih4j-MC6d^y76aNGF?gkvStK#p@*(<=h=XRcqLuf~N#!UmBZ0v`6N@}d|ej1ci z4ceo&mQi6e_s+8s%gP`-p5-s=OW!`6Yw!b)sE~2}TC$^V{+8Yw*4P^s8I*Tw5y^n%fS6u<~u%yf-AHCsdAnWQ< zmJJ+%U4z~iPhTT;J&YfJM)t|d7SiI%^T46KiVOjuW&80ZTZVpSD#xey2>w;H-+BXP zgWW?u_rXX?`-4<<2h`PFnm6=)$Vu71*JfoTJZFo(+vQ3Hu`E2_W^|#%-_8~t)^UcC(aldV?x(Zhw2Y6rE)ZRK^hIN&-M5|{@(ELI42|3bL5}RP;e&RxdM!pb zkPmI|vxY)JWs#dnn4$P3s9g4D>Qh?3bGY#AU_l=cBU}BrF3uo^mz?c@h;=6imaWgM zHEy)T{r6}hEoS*)-7^3uQ%{_yvZ?X4^S+*SMF1CiTvO=7DdCCcvS1Rww8{-^T-~^T zCp$O!mL5*`nCpSM#BxVd$PW_HE$Va>y2EHFjr#ul6b-4oLBE6OoExzujgz{MvmA3BgSLuTf)gQa z3b_mF(+F;d!q%K?`_eRCD)^u>6Uzgrga@8WD_3jVdJz*ViT5$XnOA=y+-~sW)EPqek+GZvxqr1{T$9 zN-4kk#4RL7w5@YoS7i5Av1vaB@3vSy66^o{)nM`R*IxJSNdcN4dNV;GM8#Io$`W|I ztM{)&n#wTbbNX` zAHYXG{GJ$4IDX!Yw?ZSp9l)Z?G3g8H46ieq8KwpFo1_lF-Ef~ro$2FT!)6*D zb0|&QgL%E-XmtU`4DNuss@D@F^!?gmMbPM6m!m-iS)O&wi%Q}AjL;UTb@da@1gxGA zq{mN7OiqF{H>jXiuia_q%;i+m=l@JI?~KOwl4NqNg6-2-V!uOEmy&u~+p9d4f`KB; zpMB3?nOaRhgOWG9EVYmsS7tgM>egMD$O8q~Ryxe45L7*+5mrF!#QN{7jD`Zqw^AT6 zV$I)Lmb#m9LBzCI0v*KErH|brg-Jfa94nU-+dS>Zb>tTvOE9=E>_y^c^0c%Uws}x* zh}L$Ih|gaM2#(?Tao`rjEO2nRmt1-HjRpB(*IhypxEQf_f-5s>VYG0f<#FspV>F;n z-32r!6e>%MbC-!Tbd|B_WPh%of=ZU!Z)yu;Nj4k#t@#QpF;K7D{7PVbB97X&3-SEn z=er!wdE0a^v%yHBh?0vQj;Z6>JhRzAOeF1?w|4C_@SRoCfgU?%`3(_ei5=2ZKvEv1 zsCuloW@cHC%HAa531vp8Z<7^qF?Ula@6E5awT&GrrN7oWL&Ge#MDmtZOSela^t>gX z@C5<$UM+DKI5xLjiCwoHYmXYrgU4`2{WqQXt}a}GTk^izTA1z22F4rwOoS_J@qmP9 zdEfBa=f>Gyl+67M$A`o)(3|oO8lk>tP@E6U)nZ-1OVi$fbhGMZlk7_ElK!Ui$*ys; z4EeS3g^IK)zA3-7{k;ZI>mD}{vo5twt14~sY2ptVlw8MM|Bp-@>HMOdlU^kaEL>kK zSQxmspo!wtMUmdkA-Oo`*WFx`$=o|cjN3pO4%)P^4!SAb6Yq$3i4yL zefrD$wO{xVz$8l~KmELU^}u_-b1w}!Dg{+%ph)^?Hp^jZ%JPA0UZ%+Mw<&h-#B*x zbtpXCiE@!>w&8B3&trpfm*U>-Cal?O+v8h0{Om5#{vuI7Zgu8dv#dP@ZRvKu`SKQ;#H~mVlR`U3-g4R6onaicI5t6z3TWo`kbfRd5z!Wtc~Dy1$fvU*PIOS(#fPM z)+Fr2>_P#nY@pq>aY2xtr$-By9@0u<&?s?oQ`72;3-&km7d83(+Q}Rb70{|;o_*aS zI-4JyvdAr4cm5>D4SQ|%CaF-X(K-bBXaijf!S{pDmfz#sP=>UdF2@A+-5eP7{3!Cq z!|chmvTwQuP;|xTnS@gHMD))S!&@Qv;FKwW9InH365sn@WJ}BMXXiCXT+mGfT{-edW$-iEPXto7_9aWKuOt*kMx1j+(_Eb~Sk7!wuj z9{?O44u^rDCw2c+oSMX=gfq*V6>YF}^}5We^aBq-?5uO_=ux~R1mK=C^|1gATei*Q zcfZAXd6Q(ZF$23dKIgntnRVa+^5ZGq6Ccy&5~90+KaWnc86`A+#bPKKfvFK(6J zF(R3^JgC@q*ebiPHX$!Y)y`-5m|1VB)#Jmxsi$qXP|OS{s4qh``+UCLKptDTQkPJ8 zj@hO?)%#vJkygykl&F@(nAP=e707EPS8T2h%s)F|quFYw=_-^KKBfHj;RBIyLczx| zf?v_(K3{6QmLr8L&IMIj%r3c%vMohLhv(LmeOu@6!jRQt z$=2@B&Oz-0%P5g#bj=e@b+vmcZZBi3bbspy95N|4vc(1ru^u468V+aVVI$5$tJi*6 z$n>z!;@;^y*Lo+;8^~ePBWo8^e3~pLwsb;lpeX*SHoFuI{~17i&YLL~T#VHj?22Dh zdbtI?BEvd|D>o~%K|eAOkE~l-17jrN&k+Awr?*yGmdR$jVlD4|)g~#A5ZdE_&jYV4 zy_n5SU5dC{^Zmr*6#3SUT5U<(DDKt_;bTj&Nw)t%P3tf3S)V)hN-xJJ1N%lF#7{QS zslx73nN}R`8v9P^eD1PEJAS0LDlp8;jk9#o)uC?5py?Ia>@^H`!z|N4Dd6#xYfwOT zou2yWZ+@<94$UPYg6UIlwk>LBd1*0+9j#rp7*0?)AXicmMeFrESr9$n0S4v@(nn^# zhr6ZrSA@Lu+;Tv5#cjR7%jXuenxY+lk!|0mIzmwLeY$0C!=CQjynvf_9)9>SpCE@i zmS6u@Sp8wm{)}4*{nx!NiZXzAH_BV@*%5I4>aL+vx!MxQ3YRjlGbr>@Kn>ND#A%#; z+qgoxZiH-oYiQoro%USVedKB);58MDHp6OW!9w3BEI9Ci<^9tZZQ)W6>eWj0&mT63 z5X3&NcB#2F}n`Ky10$QS$Ux?8@Rj$9^|cXN8)>&1P=ucxQ& zjlzWbXOchR2TX3o1+C>J4miN~PK6>p9=XEUtJ>mt7}`m?F@a*mo#Ig15Y-0%f!yerznKOT0;2cl&QQ6 zpcPVWhtJ&I(OSB0=aBZ3dmR0c0_unx{9RRAqF z-I&?W1-}pgU|!4sE^K+gKG1-$V=Lu?c38$OyJW%loLx(n?NVUlD#r6VBmLImqmVYn zDpHYanQmw~S+H*-nOb%<$It<&^8;)kZk1uIb-39c1jk;B9)uM^RU+pOx{;>coQRG2+4&`1y7yJ+j^fF4 zPg8jVc+bW#-dvBOEFcno)5CKISsK_k53H-b>Y_Dn7W<@B!ii26sriLZH&B;NJSw!F zAj0kL`G-KT@Qn}K`&z$zA5#OT(DtdWZ8Hf}`-%KXp(F3CbY?Wuo*KT0Vw~-7 zJXB)igi5FLAwl@UfD+a*4UUTa(#|I87zjYuDEKm0_#dr z@o9BQ;8&PkwDn_lCu7XYoOoAge=s+D@vn#dCwt6S`ri{VkuEsY8#s5JUYGs6mblgV zlIv%9CZjf{uz|nBnxbq%YW6_N0)P6ey-*CBKT%)jop*!UBRvUvS+&%Se^XPti$%Y^ z7=r)@p&7?UbiZBXeeO?){UoYg{kW%9j~Q+Y<;=Q_%L+X|S+jiN@-;az zZ|H>g(oWyR@n~t_P~6!v32FyZV_jaavL)<&B&f@JstJekxXXZ#n21c z_Sq$@mzr8jYm*OR>ZXeqF4HgH?{m>~$-eGeMg@(c<|e=4t2<{_CC4(gbw^R+Go~{D zv!*-v1xLsHZiASknMDeI)34+?4QySjS*=$erJ)57$-k3{3K)5X*(5kSLC4DEKlk&J zO@ChrMFDI{Q#5T&KmGSe3nQh%wQeDKrF@ZYZrLn>{&`~$L3e4+u@e=uTtceu8W&;aKFrcN@u!*$c;2p z4}rq0hh6fqw)q~CkboeytyXTizkNPcBrVauaqed+@a%e(hEE3BPP_tQYgXhxgS1siLuUNsxGOlQ6C4l826!l#eVWc z{xw>U55frLi^fKTO)b<;!U{!)xkmZ_pq*zw&sIU?0Y7Cs3bmYKt}yTBMAQDT#;<(0 z@k7>Ps#8;^KcEw{zNHncbU<}(qaJ))f4Hp9?)H~sUce6*-8TNSMvSoQeFNj7A$2;- zhr1?AmMGs@A#61ih+ptyYkAy$R2Mb^Swz2Edo9+h8M!-zp*iM15y$fO!u9NQhm0FS z=aBLl&)WIsvKG1ZClWxB^E8WBX<6e7Sk8Q@gSp2|rS8)!Kki(UWMK1J>S@{G=+KpZ z<-bFG6XdoBSY8PHU{d@Ieni}#17D^8ajr0fAbP<%Q7yz|Q!mq|&0}Ze1JvCGo*{YZ z)nhkp>fk0#o93Dy65sf10n>M%DTrKq(dukkvCqpUl%XPxsLDY2U@}LwcS6K4O-iW@$B_Dp_@UCp8F^VW{ZnqD>P z-1TA+M~{)^8hTqLsAZu^CQ>jFQZ#X#|D9@Sb1VChKgQZ;)$58PuWmeU(o=5z^O3{3 z9`l$>os>z+mmMSTe)`PyszId@=M`EZmsWMefJDfGc1u5hx_DjzsmEA9=8(26J7YTP z?kfxvgp~suAn9{(=Q>ri*)MU*n=FAGsNt7@L)CzdZ8fuOq=F*%p1V%LXct7Y-+H>1 zt#Ba_qSvwCZ^S6ZTu@aIkmT5T^b!rU9d^k}9QON_t%Gbr?c!dF0_T*GIaYO*?;K<9 zsOP`^Iy@Gg;N=AX4T;^g zhK{}x=9(b9z%b^`=;8KTW15tg z{J$3KEq@r>z6^=t0yp~7iU*XD__e*>ipdi(Pp#r4bNSsHf5VPQ!lo-)>Rgv8O5G28 zvs8l2`-O%O=$Uo?i@01+hREttlH$se3&oYWueW zu(>s!_U}Z}v~Msj{u7(t6#L`yCLpQ7YW!RkXlu?HK4x94oxaZCdg;`*U-8bA(Z8U$ zonQ-VN{PQyQbRP$wlYo#&76WeeJp81RFc%!{9|l$=^}jk<##P zRH%Q&;gu1^z+iX&&kSZGa+y{Jt3E$>E<3-Bk*&C-!RxF)vvPdIW{b{X2zgA48Eeaf z^@q8>@QJgJ6uZ?!BtaVE&+m$S4p%VS(9U6>vOfU?eZs=30qOlLA<4uHLycCp2W{+Oh0ddLj`D+ zq@KE4hWFZLrchn$0$*pVK?}!Ovx}!RE@?3QDmZz()tI1|- zr+1G;uo9M>(w#(7$z2$F-O4#mTI`O>&P7!mxofrb28PexZT3bjq%cu0!;zMmzvQCm z8(U?T18C(OG=a`PBTHfJsE^*hNolMZ$)!OX>rIF|$Z}96*CDE2a>+h!vCym4k4`;y zBnYh!ZMhlfzPX^`9x@2Xc&Ej1n=)j&`n9GLCV>IA*t>QCsTrH)PEG9Q*T4~<0V5Av zkHQm^5^cFBMyYWHP#VEOeY^xBIiD?z{O@ppM0|~ zy5E5~NNX^Mlw%#SUtO)HD23oodBzWo5^}PX4k1RvgejaxfrsG_17f5|}Sj}U1 zCwZKnZaNtyAp!_y5nV=q@A;s@oZ-|a_DzFZ2CU60E|@cg%FMX<{|>ZK zvaYRNA<{C&1HdjISoIi1^j~TyN z;?o-pf9~3+>Ty+%@m7-|*F9C0-wHh}Z1}?nH{qRE8RhHIq3IiD(r*5nL){2qTu^qU z06}%;&VV&8G<~VAhZVXTN>OsT+3H%;W1oxj8P^r#Es2Jc(WIzVcO^`vg_f4mnM5$q zPwoHl^zQLYH~t@YrBW$!DXScoRCI|&nVg1P=(?2YQaM`S4j8qhJ zY~-|68fMONnA2*^aSq#2Z-Sp zE7K9GFSj41a}eoX)dA}Jx)!jp;b~*>(zlDQZFJb)jn_5DYVo-EM!}vfH7(hCdX%6F zya;on{LWqXO;W7-8E3CHO0oF-K>sQIPj=1brtXP; z^)Xf?K7VO~3mJ}lEDE#*yQ7}FyIau5dITtz8za+IO+rx2C`QO1ZHn;iA5^{B%ehop z>8bWh(>0Db^bS!iV7TVe$RqTL+YX*`12jyj8)zmw9bP2hw{W#PD4kJ2n(T>|8 zkNh4$(4k{tOGdCs#auk~j5H_$%`4XkVPcWhUKwYk%>bY2MCGH1 z>X~*)?L7*^SC;UU;x>osv=UPyBw=30-g$E!v>WKKr6eIkNg-Z*MDB%s_--!cwAMXv z-Xvt*J=<;j%_l7Y+Ti75BGn(Ty zMf9sbsH9ELKM2~H%QIp{_of-gegIB(6v5%x^W!7vB}+OHUc3pOOHwBBIS*EO-f+vbs$#w15h)m-i{%HocRW(u1c*-Khyf>x*Qa%pC2Jd>o+ABc8U`s8suK*jG$ zo6Dh@naR=gl%Ym${Tn{^t*Ev1RYKtQo1w8a&9f5nUq-IHiDH_~%mVuycnjrhBeGn4INej2`0#aW1By(n`v^p)V}C$P zVP40euPn5Sb+2TuZbRQrZ>zhA;DlqnD#?YsP&vSK^?VfUug8Oz5^vO$xd#kb4;7l6 zhPel#)|$etqwb)+i-Yn&%VTE~JC6q~S+<)=L!s}iZAr(*wcNz`M16RzG?iFc>*mD( z*t0A39*sqIv<)bYHa6%!8R{+gpETsx8B9%s*^e}yT7|>s#xWG~;8JMjwdFC_cfds$ zowSRCmF)Ae>$>6H;at6~?&dL-AHSzpuyQm8KK7-+GU;GG&(nvrkv7mIyXH$GtfrU) zW@vX6Ku4emS00U8Cjv5)oNt(#lHSPRVtngjj$LqV zb#!Iw!^jOirnF{Q%CFryq8{(oSEQQCF%5dhfN_KTR_NlHDxzzHDQ}0-Q-ZG zE2gZkfNK!T8-o3UA@CF;!L!lt{k??`?Zg~2*WitbJ}tYa#JRM1DbW12k(ZaG%di*9 z-ZAb&UNWy(y(er9*MBA#khYFdvEnMuAo|Us(d60~cApSQlzfl!CGi znUw^2hVcL)$vvyY9hOUuX0t!*w^iMN_sAz5V%#{KuAJr#%A4uzAb)xcAW6CN(2qW5 z>ZhQ%3&7D1ubay`fUH}I{IS$C$ ztt+~syUD$0y@GX_nn+;ByE2>M9pqXFJEv1fmcTzvewnt~QYntn z;38w%#v|MOURKmqE01bB@1`V52KG!Ac>BP3XF`pO52xedfFQ(yN1W`$Ic@rQAWogu zCKoZPq_sUuyD1~)1sM##$g3XqFu?2g0XA2#Aq(RF0x$c=u+Lgof^P!q^3Oq@Ia^zNj?jinZ^ulKO|A0i&f*Va}4$3*3WgR_> zUZ&l1bNeF$y`LbF4$C@M)qmIHmW@PvmXB9&JYY2#L308TyNO#<*u(iCR7Q8Z(|JqM zMVbCRXiC)}dgzpByudd9sQ8h&PR^7LrfKtNbRd#uShC!FA-&^6Ht;mWn|;D`)zMHJ z-N;y$b%wC{)~ruwqN`6ud`8Af*DrcKMHbtFUJ~;uRw3Ag&a>+u&dvi_&VQ7Pj^?eT z{P;_mKb@6TnR3Gyz$18IVhDhVlQtL`H%~H^66cjM?;eCB*hj8K1FlYUQc|L~09QI|=PgrgFq!trYT3WR@ zBayrDRxYklz85cHCpt&sIY2Lg`y-vr$FR))3h~CKybfkXeN?#)nudz&a0r>reopFr z*`Sr*jo5rMZ2WA(y~l>b%WfHp%R2um^g|UcVD4-fno%s($VMufnjViBHCi$L z+)E`)ba7=UDod*ZSf0SjF|XSiV(R>vGlVeOWmx2%n_p^tKV=>(E15Fgm#nefLyFs+ z7k!57!0x2e;fC@1EnY8bC~MEI7d6a8%Ae4RbdP#7XWug>B;&e-pVEKaI6r|O@cE|7M9ZzJE25!YpwxpCG*iildp!uy*4vll4>%dZu1a4Qu)b@6z(2o@S?LVxsnxW3o{rlW zmcTlb=_T7D@Zr>k??6+)BfcqGfZ)MRUu9g#$w6$CU$#Yv_<7|7n_sHe@d znq3CS)arfvAN1OGA#kQNqFGm zBQId-vEe{**dTq(ZsBoQ?f5G%$a?lp!v%qBlRcByDH;1W5+A-0ZMW>%m-ROU*dcVk zxV7%qyS`Y=_~bzLC?LO9=u==9a~^bmHYXK0)veXIuN1xF6kP{jB8t}?4Kpg=T(11w zM*C2PgC4$E)62RZ4A4Bj)uUK94+adQArZt^3vP1WJQH_@G{AYjLyiox)1B(xsa9`G0Sv|KTufXp>S@Esx2`*xt}@}4iD_ql$!tZ|Q>z0F%Q zc~^K>V&elIl;Lvpn%46VwUxF6RnDQFRr_a2~S7 z)SGrE9W_^~8YAniL}?clTJ$;khlJ6xa%+2Qk6U@h49R-DCoI<{Ph2GJdF*^tBO=PlOx6JLztuO@jAPC60c&hFtIM)xtr=unC;r~&RD_qmN} z`$2z9b$yf8Q*l|K@5hl=$^r_f9X%fZyi|Kl8ePp(csLQBChx*q~q$U76M#daIMBGU6n|NcmH{!=z z8*z+sM$4Sp{ng*nDkojl>vt!F0-H)RG9p@6TN*HHLjGHNXCprC9yc9uaD%Xb_ju8z z6*Ztk?DLQo`XW|tHEZM#B`wP~Vk@SU(7j^esN2&phGBdFeqz|${UqQCvf^6r_m`U4 zL?YtCFB)uy^>SthU9!|OXkYPo(II1{!Qo{Ul-g+T?h&Pzx#$|ja(dW$lXX_Y zde%9hH^;AXmVi$UuU04H&(I+p^p{@DX4^j8!6W``y_)Olgn07s8!V0(#WQ|zEvI1f z7wgD)o5t)^_C~hAD*g)M0YLZ98 zPy+q+)%a~ukVP7&A7H9i(X!hS+<5=9yk`i!SQE{|RJRUAeKaEv+h?F7s36y^#eqE! zaTdC?8ID?d+Nj{S!g4(N8q4$XOjE~v=B@VB>X`LM8J>_gm0)t5|EoYi$>o_-Pl+=+ zmEA3vp1ircOBJcOK>u?fGu``3+(Yb~J98U1^cQO519I&cLs_j_ax}|@Z=5CnL0IST zDO#AoZiXFbHdKD%+nDo6#-xqeU+Cw7OYrO8Io$l_jYVd9PX%-ACumAcm9tPs>UBS1 z;dQ|=!x;#|9C4%KgP^=%Nz=8@i#FzCd603=E2Bxuv>P?KA`Dx{j6-U*+(j(5yI$^Q zK#{8T*2eyspA^VFsj;ITM~L#zJv1F)s`)8;?uwKW*evewAl;A*)q*xNi47d*k;TF~ z;T@Lok$AI>Na&aB44~WuVC7JVsF@?jT2HZ>`wti+qIQP7ltltN&Bq#1yMi-31q8Oz z6CqU&^;l~Xmw{du3Xhtu{Yg({?_Zd3Lm=ix8>^+0Wm}ED89P#tmxq_*qtWeQWoPr1slu1n>#tjP|Tx)kN zfuVQ^(G7oSr0sjCe06Jm=x1|xQtiu%iLDjg;q%OVseKac+nrgkg4N8 z`*A~ZgZ)y|P5Rjm+8)~Z@hD^POQRoqu*5w;@pwRoSGcVYPXJHE1!xGCK|9B3gOz%; z!}c}q7(XY}!lxp0Xxbrh2=%t$b=gx|xtEoNX(rnVg&GJ#jcXlo4kzhP7Y}!v0pWO1 zgeYa3=h-{ZIXoK~dMb$nYdTT~s<%fb4dF@aKho<1?&K=4Ut-vcAkXvLFR!^6|3U$uG%J$=<0b2iQe>xCfkm4QYR>wf6wSg(@zfx zJ2}p`0{H?Jy6}r~D7+3)FZoxD2f9#MS9n|nf}=$Pf%Lg>kjvlAY5Fkp)3e)MW$9;3 zxW&=f-eTh1yO!C82dfV@Clzlg6siEb@Tuz@3h+Dk+B2<1*9FN;@i8Ifd0b)osu~TU zvq}{VDg%Km0&YB#HP0Q7JW;xNuljcJ;h=L6q*@`m23e#cYXBs<**L0FN$daLIdWTh zO6{`zouty%TXX<~=o9Q1nQ5YGI&Vq0y54?9s^ckEaPw5xdyoEa*&c{ZXnnCoywiBc z+oIIh$paa&zoy7H-2xxXmS)MSVvqmXmC919biiDz~K7gjw$8bZcL z2_?x?+39A=)$=#RAzmuocHM@gx+}!KG3Z&(FVz$5KTHcN)7&_$qays@;a3uRPT>e_ zJzO^-NcZhVP<{l^5T@#{1rwaBM1Ac<6!X_Oia4U%hBy{7Uc4L`GwUcdA&#CNLGOsT z5y2%0!!n~z9w)3F953#;938ABM@}=5tG%IXb35A zndEFeNUY!OiSBBriJhd2hm4(S(mOO8Ln7Nm(*Ojqw&0+OkI5?6sciN}#1IK++k_om zlG$rIWCAR8ql_!;KtEf1PrT@|BrtG}qi9aQXC57_d=xl}?vT8%+FElu-)+7?Y%L+; z)_#<1C&MtG;x_^-sttYH-xx(Mp8!?rzb$!>4HVBhe&H=mgK7ZM$FLWdt+JYDrUFno zMi)k{#HLr#Gd7JxTCdmr1iJJ|E%Jk)NQb^^(6V7{8c@O_gc$**S?u4cZ_6g*rW%sz zQ$r&Ik#%2WgjICY^ifMR!%9f&t4U8O%XitxysQZ9fgm38F$t-u-x{u_9fU2G^-Lj{ zRng3Bi;ZHPSz?uCPZ7tUSK&qW#ft5}zC``#d>UzGvXGqVfY3AuR3o1>;%%7L4)qJ# z)AUV4W}yzlWqJI2i4gPc{hq`j8}!h16@t9qbl$3LH%l4D`R2h+HYD+Ba66CgOl!u> zVDpqb84+jd1224ldDR#wU4- z(QTcL0Qu2hW#U2?&6@lEJGxc;1%c(t%m-a1#@Z{=%)0R5NN8^Xzgr7aQb{&~^;|U* z$3(1~uD;Q1+W0dNOg-oNc=Im+d$i$5MQY^fy;m*J&q&;`tmqS<6c9N+$(f6rw^{oH z21M!9$IdUdW_Q1bR)GuFd;nXDcS^#kv)RifW`okGY-gyvX}Z~*sN7P_+fh{{=|PEV zMP;=LujfkYL`EW3fSFq;d%*u%No{FV^1{Cz&U4>;@RLGIz40i9%P~802@dVz1;%{K zJMl5eH10vD?aYErRcN>Ac3ybT<(X!Tkk}oYW?VyQQexcdWsHm0>+!ba46o0@-#d#~ zV1=c!Iqi6R%1(D5N5}NV>k$vU_wlW^g+Iy;t-kv{w1vGktew;p{ya&^^@wN}>7gBI^dZZ&Vv#RhI8K^G8J@9ebJR5~6r{Js|*_ zXfGvD;(+=a@b5VND(XF~Cw8Bjpubn%6@~vYYRx)cyYSW!TB5AF=<_LCIw+qF!=$1% z3>5^Yle#djti?h|R2U_^;kJ_r5`X~h7i6o%!kv_Oov%G5?m97HmMC(mL(4-y=2g9a zo?Z_nQzN*u9NirFN!WR*nP!ajLhD})bE%|NSp*+QVzJ!Hfz$Jx1)FYvn%+uS_D38( z-<^o|anSwYX@28=Mc$P+vcL~OvCgVC#o&ioL-8s^_LHt-WNueneEs(SZ~LKSG);uAnV@yq4k<~qc=X- zHz_p(?{ix@(}sOpt7^Xwe`J?=`13JmpZO&WkSUcj^n)axDs}U<-d^3Eu1oDQb1f$# z)Gr}Y@{EvG_|-Jao@ylT$<~ybPl6O>cQPF^!Alqc2s@I_`*`W0sFla+QVWH}rf9pW zh&v*S--~*~vdvksj7s$h{TUVW?)XP2*cL(Uqv?StLU;6VOyJ#RUKfKrqGvJ1!Dj6@ zokB~jEDi|vNt+-|;yB(f3WCenm>36c>APEu(h$6jY&=f~@_Odsc2D>4BeU2h#6q@) zef`GsPY99PLai@ujLr+@tz{frwvQc_MQuMhWWflpGx4YN1y`J`6MRoEL^rV0ld(X= z6V-W4s;5CnC~?^s;n3Bi@s9pl26fAwM`OxR&TyD}nnL~tH4XPR)o;u|Ro5w|^)aBE zazu(?S_%J#1Ct0=?cel3gnpl(wnRa_y1#V_^DClS1(SMyYq&|jMvq014E+<}mc8!C zg`aXVr;SF&g$}32vop2qE9NN2s^x^J;kS%E-n_%(thZ5$bjq4aB~iJ$9XzJWg`Tx& zyQ3Gqb*CU5UXw#sPHz#a*gbYGcXNqDlRmF*x}sEMGu7mO8lb`qFUB@LFM6s@CC5}M%ZUwI zy8?JwEr>@Ryz*x!qoa+a2NZ-#*QTVzk;)5>mHX0~n|-ldR#GPZ3&4}V>ogm3Mc6h7u#oo7s2h-e9mPup*^!T0>ny+-zR zx7BHHAs=KK8wOr?j6Ceu@-rlycCT{oM{HrQRUCL=EPlC`vn$+cw$s=D%!h*K>z`Eq z$lhG&hz$?U)}*6Xw{9MM21QuolDd3HJlMOudjIRKj*OP@mla5Cvr5Knli5y?NJ=9g zKK&E=H2y_kc%hbqS$Jpsi&Pu%G+iJ)VDA54`hq_>+KTwy7kdAJnvW04n1MMy6Y@1u zW7*y+sl*synRM|uD#mk{-szv;dWmvn_Frw<3gil{kI^r0!+l~wCqg~7g`SrfIwfti zJxO(Djq@ERxUKSkq=Q?K&*Z9g(ppM4Xn*QOhkyKC+l$jzVc7Z=Igpnz7q=T~h+jGH zZ`WboQ}=(e0qvsc+zz$GZR^!^!-$Nd3X@*Ehvlynr@S79B)egUt4;c4InO-MD$d(( z+{Hy&&B{U*nb+o>(pAKIz)k2{KK4y1KHPeGh6^x^-)h6a#6vYPPeXJnGw@5RoEwdT zE9QgRBDP9pDpEPp*hMxV;`Uac$z0DOF z!Z}}`zSeOhQlQD(MEyJ6^RQ=UBl(}b988T zq?^+#J#g)Mooe`K*}4ue8~dTcE0juFUasF{?FUM3Y+BGoDOw8TdwR#Ysmpd-&(2Tw zw60|M)b>N<%M!~yPuo`4`gX~Bg7cuuFd#4AHQyeUx!kpocijTX;tN=LcgjM$M7y3j z=lRUPR>DMw3YN?|g9J<2)+h!hm$=!0J{G?BH@kIj?o|EO*9BH>8mjuY`U{K2d`Az| zbMNi&2Mufm=2h7Z05jE8c7anCpesG=&SbdEm+dDCdc1Vag~C$9fjX&w=0HdGw2rwM zH>wR;rT~|Nd5N=?EHai|J9_@OPnBEGZMA0klEMS@b}cy{G{+L6;M$0|-9GcTojCBT zPn*B&if3s^hLg~rC7K2c{y}Q|MoCA7WY~(%J-xyqp;Iu=Q-TetpzroM<`Elg#p9d> zOJ1$B_)gkHT6VV=w+(LXUhA`vGd_0OKdtM#8Bz6f;dSt*vrN~(8Ab`Ps|04gj=|5B zBXn_&fgu#)vD8`_LOnR&lxOP66(5nN_S{4JpM$&J7VPCE%-ESid+y-Go%9}M9oeYrOJ%D0o}q`9)Iu&Gs_}aFk%^euQSfIYo`%Ed!m>5n+L!`lB2lr(aP_kA-8*5=& zBVr^+TJJuR{CBR}mta3G=I6Lc)CkMmdKrIILe#O8(1zUPMEJ;QiT$5#d>_s&4|pk9 zIF<@n=2}+H9f`)SB>lZQ9|uHMplEjRj7Xk9DRh;B;@&OrSn_BViusVl%FRze4&%L&#=9(G$#!wCm#L=#H(?=RH!h=09~Mz}m^>C(3w^pb-!5Ee zUv*qr(~}OBYwMde*BuTe%TzaD-$8KCkae4H+l*l1ux}oc#@$2j#(upnyA0TcP0pmNB0AD7v$9w!4#bh2+`S^B9AxXH|R>KsVJsa|Y_p zW=2Oe%`6aB$UoAhK5*K*Vq9QAT&StnKMDcMS7Pibpx?Dej|a(*aXKoZ%}Tq8%AS3$ zeuqA12G`JBAm!=fAla?ihlivCE-&kWe3w=t*1XRxw%4*3OXv#hy=H*FcuD$tFg74T zTHAJ$``?`JpG4@AXh)RPGI4Ubxa`yQUqWzq!YfwB+UawC?bz?B{T?O-0-jW6B)MO?5*@NU zkHF-C4QzQ);D?@w*EvLiPfaEg@icDS)TYtRtQw(HHP^gYiOavmW3|~rnvf?Yol5JG z6Rubf^k@X)Yn#0SF6Cl+f$_#I1ccU=Gx|{7^yF<`rWq>XZMbb_WQD8IYJh|!63J*a zwZM1f`Op_wxq#Hy(g|->ST&;lRleopu%vSBwbXOgUw}MC^FMp178#OJpO7jn8VnwfB z$l8rSW|Ccc-bU3^zx$pGCAEYdp{xOn6uw^&+}!s?e0Ut{6BtJ+i#)1*Yp!FDNr)|djYXm^Ojk^}9q6 z$^Q`%R^1$Ounh17C*5p9o1X}DxO!(t1=OIG#q(>o^_mCw>xB9S#kX5%2(=>I<0PZS?sz?||vb`;`wJUT<5qa@{!muvFSe9erb* zx(}G1ANF=O!UIY6lwShDm^bAYGUXQDXgRAo+MoTEnJ@;&DECA?)d{fk zv%?M-(s8{=E0gj|U&_Sbum(RIk8+E{G$=7Qu` zZ*3;4jSxICa@I+`@7VK_xpJWG=A@gRc3kw^f@~IhNR`fcn@C!^rc7xC#)=%Qb*1b4 z0f_svbAtC;EY)q)&VtKVLYOzZvpz;J=Hf$>W>i|2SNRwa~4FG+V?#qI)3B=aEqUAk(HhQDE7$UW zVhWCl*jLJ#38M>g4QS+WW!f0p$G7&?P+mNb+U*g+gcAvOWivmvwas?CXv%APtjQ}p z@!Vc2I5_Jx*%`D{N`G~|_a%D6|4=9O*c*UKF8-q=EfcN3CwQ-T=Ai|8z-r{|KS4Jn zl%?sTrk~R3s%~3a;~M$H$m+V9O!KgWcJ=ad$e#%9Db7{-;fNS^4av-a-^LfE{Cb_8 zl!KhhXnbTG(iYZb2utyqw-xM-drWsb?c_0}NczIjx%WdlRu7^(&qnv^%}>jyH6oLk znd2MX%E-Lb{*@Bmz>4b~YgF8S+64qM7%g!FqV&V3Ok;(?ZI``Z2Y%Hi4hIsGHPyUL z+T!%R%*!;6T+D@M*Uz;Y|4HBG#!Gs)x3F*dK78A-Pr=RhWIzN`q86yunmq-rgX~lp z=_Pp^O~$v|y13f|3TjK<6g!9d&-LUwZO;qOr`i9ecwI>130yA$vowGV{0e8LIeI$! z>9<-svD&#=b2NM5DZ`Rx%~%tUUu*&uHtfTZR=m9Dc1-g6@G|j?BI|my&-~Ia1Kzz} zg!mTsh_uQ8At&POy4OvQXO-HxS;57XBK(OKc0cew-*fujW zou3(0H~KE=M^*SAGJlY`H!;wpc(6&WyV6fn=CCJ9I2%)my3*TCsMhzh(iNP6Ed%g! zDzm9l<7w1l3D#_2u4#@K9T97re7v%GsJHgc7JesOGgokM(WhdJ>ze{af3tg`=5zij z;~D*OCjeMFvBt_2@ zRk;tK^lRf<)lR|tq)&2Huk!;2KhjU^@C0|NNyV*~u%4m*7Y{fiye*ex{IaP;m$Kr^ zljM%tNz;Gnx1tmx6n<|woF^e`wN?vcRta1F{Zj#D_9l+!{k6X9q(=?y1Z~3=izDGU z=k>B!|EosZmZ0NY{L2aE>*Yo10e7k7O<_yr0>~=*d_;xeBgQTR^1Gwfbpw@P=B_yl^Vob;TY^cOB`nHm0RJNG1%Ea`=q4jrhG zV|3!o@=WdXHCPe6mlykbZHb?GV6{yfgr?~va6NLn_J&@M=4mOG`D^rI-uG;1^^z9G z*`t3?feQc{0_{M%xMQ~;Y`td3Rg_zI+;xgnu}xZb*$;g{qqdAps6Vu%Aq14h-^WqhQa4**@At2d@ZV291|D9IRKFcBlD57puiuwE z(3{{dNwvdK{Yn)$=Mcb1;IdHC@}+LubK)4@$PG9$q6U*zPI$5}np(!ao^=u8$7J|n zlRI0mQfzWZxbm+^;G6bdy;H4~=FfRZiUKg~l!*!y-DSmX>v9Kqzqj+L#6X)ujolZh>+-|S@Y7!0`Z(Z z>GHaf*RpUbrf|_pwyRYL#a{ECH}1a;3IGpdi2?#{l9dn*uE8GsdA7KFN@?bLQaPf> zbFe97^&criH7?RkUsJ!M1@V_>9PYPt;fXi=2zH!s%u6+*!|B0X_6|~%NDsBSu=rdB zD$iL+`!Fan{8ym{c_gViYH+7?0J;)Z2f@H$L`j9#uHYIO+CN~yu!2PkL+`29c@mNL zQVf7KfB)aNn0kN0Zc<29*uDYE)5IPdM$(OKV^2VeJ^lUkj_Qb7z<#_<#)BRr7|x)f65xn|M7%jIIHla1u0e4CoA;_6r{$T+bQY#jj(U_Y*dk* zaOsF@co_>TjK2Hb2|(Cm;yKI+ZD=^$bkg%bW|?AdW=*qo`}u7FdG`p`RnV` zS8-vEH@I{(9ZS19@iH8+~>d=Xg3)c|)d$7~J*>eHC#be{AMQwf=7I zy5=o?6?>C7~b=NBQR?PcUJq{Z(8IeC>T*9Ox{2 z=kb%p^jAS>zU>UH3X<=%yv4D1mQujT0R{4Zz~UfXziqkts`|}H`TN^wGnL%5ieu~SPA5|BpDl23`dkW|*l(JnkB(kzU{_7%4POS5;T2y7 z6PVnE{83Z+y@H=xEpN(cH@3*s+`8`QPlc@}=dXS} z+xHDKla(LBRV@np>arEntKg4OdvV?vRi|MAH^k)`D#rd4X83P$i}sR{X@N_HPls;g zv0liz5*Ln^%{{rsp3(V7KBZo_q;2M{8nzgf{C6`spgg@!Svd4Yty+V(=4f`hU@>u> z8tJX;bzd^}PuqkIK|#1Leq?VACZS+sew#YrG zRUDm7a#%W;@8rh4Gxep{-jTIIIT9qW;wj$5hLN#QuNVK8TK~#7&#vCw+&bs30*bqdVj<+fdR&!@(kB_dTkn-@ zv)C`8C2Wv-?});a<<_1`^Nt>}Fwt)ZgKHM0#UT;dJ=0Sh)x~L*O}&318A0Jehs-X< z1>xy2)*E(AIWn$gx%j2hCgkGm59U_Is>+YCi}>p>cVdU|q$u@J!`sPR@^L7pWTWA& z$!kq5qiSZo>Zwv+tzC_G3W7e@u+F4I)j{YG715$BrwASK|C1BzN3Gwt?prU`dWV>@ znxm#k$nz5WQ(Sp>*(fZwRbljkT@UleQ~Qrp5RkUBIkkc9rClTwrQmD^xCuDQd2|;k z&wkkrH-tK%N)?j$tu{n zU7KuujZ@fLKz-BA@E#X#JkpToAd~Ckt*X$US)Vj=J%6~NJ36upjuBek)xsQ_3gCuG zFe00>F>og>NMA}XY#bbU1W{ogaf@u`(=0Pq)dm&okJTickdO<( zvsp&3j~_W1%;W6$8QDB#F($RFIpX5jGiBAn8PTFMW<~`t^2j0L$1wVqCd$9h#K)R6 z_ud7p-m%Hqg(Ei-&O<}-q$rj`$kKR0W9*k>GN#K$#!RKkxW`?&#Z(9I+F|uaLdyL? zJep=DW*9r6jOhx+VuYzmMlUiaDE39OF<4+tnFG41{8cX*8mZIbPZxWveU9omX#wVs zIK~w+G+~fS>)Ss=iEcQ?6Ti1D+7ioq(skIoCU8L%DVeZkcQV$#%CO;nAoKU%bDUvx zFI0-YbrE2OFv?+^Q0WJ3B@Vu1{AdV+OKY%agKp2&DT+F#XyycTW=jp?nz${)L3I6k zPS@OK=WkEa@?_5v!Pl!fw(>28K$V{7b9Lv6BU6dulQLmc{pjYNJzFfy&e!86&stt_ z)8|mEIPLiLQ+Jwj6gCsMB|zJJ>)E^($@}};p!jIZ>I}vB27sNJen(Se7u+Ey&xG4u z$?bowgPz;k7WZz8d1$CKqZ9LnE_^m(dV2BTvMRIeSd5WxNfZ86*_mh5=1ptEU+D*N zrEloUY%JdIor2KZeNs2dGRS|Q`}BtI!PyvFiXW|gDQ(1Va+C6CIL|E_S|?S>M$Y;1 zKTk0ZgH9vVk9r6D4<^lcrGk=crP~nyNrYK6)2@Q)+A~}86127NQ#B#oOcQ@@;uuwt z8poEl`~{?+a5Ke6-C551T_3fcaE<*|tQnCZ2=Q0#NQmyxyR;eWc+j4#HW}=a zZ(|UN4!77d*&Xd2#WZ3?c|T{2K-d6QfbI{%(iaoycHpRUL_rk?dUcf|AtfSjaU&y) zp5nf$3wZzBJQOoqiI>7xGp_dv?!f$(LAqn6r{k)BX^37OoNAjsAG*p@|JmRiFiNcl zPYJv0^(|Jk4ai>$VqPeXQ#E6IlM6{P;+br9My<=JhIPB^?6sweuil9cf@56F!-IbS zFKG??r>98!Erbz;xSFs}1g`R}O(M`or87~_l-%yXlO9-vf@^jBhYrF0*W>*UgOb~& zcw*Tnx&G)kW$~GZxc=Nu>_wk==1^zByxQO6o0yKKtFg8z>zmO&bd!^GZ`S7Ua0=3J zicoo*byWH%b+=cpNmwI4`f;Xbim@2ZE4o^|9G$1c}FWXA4e(k`}ES9+ZQv>3q&)v z43>%xS9>Af68Aa*`F<77Vf^~zt$#&g4TNa#4>CqUR4XXOvy1*@8!Qx1;Ntnz6Wy}U z5-az1+V@`k{VwG`%Iui52^kFfow;iBz+0Q=r=`5L_4e_>{B9c^htr^DueNo;`FchM zD0g4Ssn8kAo^@)l|G$Aghh4J097g*FmgN5VDW{pca4WXqmP}uJ5ZaprqL8yCJPp$s zZlbge*{|pXvZr!E@ZkC{1*@;`t!p>nCBSv{>Uz7b~j6fF7R2jNaz*&Q9NM<6y5;$A% zaPEUAH6#;2%xUSlt_vhrfi;>kgW0+`h{eJ?nE4jlej844B}MzElCcV3=co+>fFOpw z7Hy*!7BO90ZDwH4u@hvGqDGan-9$B0vYG!^*NL+{tN`JB`=;<=R%rD$iu+s{+T6YH zcO_fvNWp9$^os%Mt*FdpoaT%P0I)0M%bO(w@bEj!r*!vUXj@AG;BU3-?wKkEbYGZ#!JqL+s z`6=@!vh92ZH04+tsG3P;ZW+3+wp#xoKc^$vecWtD;bqz8S)xg9*Uqgobu*`J1<{pD zDam-pULmf`)qs%pZA?G|)5;u1C%w!_M}!yRW1k@`i%t)abqjT~6xkeZt_!e_2Y zs)X#r-pb#kY?fF1cNKi0{j96&Ff%rBcY-MPS+x=H4 zneaJuEBTiE4Ccu-{r+$zk!4OoN&*-c z)}`f?nniGk3b{UG3++EhpkkLhsoIzaJ&hcjQ*#apFIdUrw@SE|S`A7%b@SJboV~sH}?F;5s9( zUK?rGDeqmsVdx=EnOD_=X$!ACCdaqU`8Po@(n#+qm0X3fJlxvzRlmTkh@jhplctX2 zp_ ziy-vJNxqq!tRA~KRlB+UyH|Pz9v=bgLW2urFWEo4ner ziny#98vAu%^~z$_H?5H~GEroyPD%q1e!-62aV464t|!il!W$dEJTvR7EkJ4nW37L_ zkG?TME+Ol*5k4|YFxT|-Zb*$0Yt#R3VxePRGo7hw>{o+1#f1MJa7g|yuY)^fp1&s~ z|J;2`p;Ygy0#F+`JKqNyW<2uKsA$96=$|tC!mccU3@GTpsJDgiTka-)&JyM;{P149 z!g5=`hhcyFw9`0B?Bn<=G5+)iA-SshWGN(-K=T|odRoOh3>54ybKjPN0nwp4IQm9* z`g-N|thJDG^6SO+prw4+k@fBkvm;84HQzk$*!^2#x zSGdPJY)l**F>j3`SXoF;k@!Og%(hXI<)C=cGE7%+<3-R(O;8N{j;82qjsQ}A#Qmq& z-_j4kvgzE($LY`gfL)O5e#z*TrL6uXJv24GCU+ zXHE)m|7~p7SD_(n!bVC=Tan~nm;7}pfR`XY6VsMx{CSCRU);0JSqzdBigWCD|36H< zd05hE+_ybtWiysmmSiqyR@Rs@+Nk4(nUytGW}6Etg%%~Kx#9wtS!v>$DY;TPrMaWx zhDxONjlsvZScAnXPkZ%l4X-(`4|&auQ`J8(xV?JVPPt`-V$Y?o$GuFj{!?& zuIM{BY3EsOsM%ZmCdpU4wKVQiY^iMyoQp-##W->dV1!@uhWV3xiPQ-{o!ccx1g1`BTM=qi{{=wtDMuEvj}njdzi5cJ6}o$4%$V~L#EZL~ zx?Nre3=RY!Qbj&&N;6M4ewV*>}@{O?(p>hA@$S1QP z>KR}nV5&IKB6G1kxR%7yahQ11zs8gEg1ftu&48#qkagc(ya!hlnf?Bu%|pv}A6=K< zU0|Kc3>s^Gd*M1na|A|r0;;_|C9QZNRc;L>7` z_1{|kF=M_tG^HOjvx8Bw{0XjMy(M<2_3Z_1gUsI?VyfSptmGt4=XMS+K!dqG)dnYi z;B(h0{mJ6!7V{QSK%%((KuQF546+bK^CIn*oWxpcz`<`v9^sx-VBa3-W2|XToVizW zVB>NQ0a<8(2ScJ3g?-;$=M&d8=X%o5%xn~-=Ld2<&d=z1HHgZOo%pLx)T&=ca;z}b zzd26g6&MbOx0mtDZp(zzl5^~hnUqCHNfaqiW|jti&+ycbi32v zz@Y0JEO-g#N6IF8a~eF>sE=DCbtK?D7UOx(g>Jx%I3{x+A#^qc2#JIBT|Bv(+MDk! z>r>?99|{wYWV2uP3?!nl8?Qk!)XBuoY$_@^y~lj>~YH4^Ea%+ zLw`Fy`*pf%Q5g6O^&4vG(dyZ--;SEqOf?Q!o@50JQUmt^I%d+73JD7bLQ)acIrDSz ztPf@*`V^V4V!`}Wf7RWgY}rfiE4b0;2w1S)%RdcGsXF&zgY zSiiSpvIP)pVZtR%;qDVdo0tv4;VqkkUcK~9%G1KbwqG(_mR(%eT~rnhFNxh&tr3F( z6OpD966CWr{AvwDP%{v$^+i0W)IBLag#At(ERJdBjek*r7J(io7;7EFuAiH<_Dx1M z%>@{KW@3YkSgZ5R>`Ht!@$F=O--(dEvyoG*V<~N96nfUtNc{&T_;0dL*Us-8xc9=I zkMhOBgFp)G@y8Ie5gIJ_g^=;&yxt z{(G{WyGl{Mo+Jltt~MDe4v~+m_uq-Gj~hDf!AN4mF`hVRi%VB(LkXn5s^l zh=Zub50YC3n`@VWGYGuOT%9(n;trjbJ)M4LLDFR6-2V_!yjN-yR}?zl_>8?j*f{MQ zztz=Xmmye7h@1kb&~W3HQC^YQ?l_NIV=TO$%=gWh!5ha~JRA$1{naPa8n{sy6en%^x9$+6oJG&<`5tVydMRk~YB!Q%Wdl@8_bcJ05_q86Q5 z_LYJ!?K|4(CSMU4u3LGy@4tjSm7eqV9H(FGK0wqayKGW_!k{UK9Dd&b`gm3ym>*Kz zuwtM?iMS{kXFiq8xJ21K7`*@nQ>`G;J0@7;uCpMOBPHpPO#334`iO$AMp=WI6=XF7 z*Uy+x|6JH&HEMxWN&ixyaeOonH!>;NArqhK0+Hw7f0Sso;ok4zr*Kf|TYDw}ty=|~R&)P>H?~RBzczf&I}^?PoDo*o19Ab@TZ0<$(;>#cML1�{CcXf6)* zvUuweNs#-5zAM?0@)Vk}Wm7NURX0I(E!NK0HkPO4Q%EF}{pwZS%jlKF)AHn%jA#0S zccDEkuq8d(0U+?|ZT=pcry48c?wRf=#za3ZpL07~Aq~OCFzOrq_RcyWYgR3D=1kE< zW=CFNIPyHpbuuqw{;Hu(6n?yK8`%7!$=xxxbNFb{K&F-3`~hxCv}NAUUVecwg}pC* zqhO+WXuIh|u%pq6S#zP}-VphS?Tp)1 z(ni2s-n4XzCYVfFY`!U;D7*lB3ah~KAlMjBfzEQ#h`cT&#&sC?F@cFb)fzy8ww4BBDfvQsxj^ zR6f^54gS8IE8KjMA0an|);w*jYB8VKl*#t9?4!}&gMJFeo z08^&kEY*O7&FIBDl}nUb5~97$!o*B`jz)y>gSz^oXcM35qhU*>d8Qw{CmJ7B7n;^W zr#x2$ezW(Y z&o<7#W1N7{{)z6J==-_A5l7Wp>dlQWOtOzDO1c~bXHl+Uq>V7ZZ|ify{TX_;bD@el z((uk(WM4U{h4>}FB8v}7{nC#=Qy5idontTEJ);-KyV2ZK{V*>OgZf~40&=>YJA}Vt zTXaVeOx+H1j$OFMVe{+I>9@^8PgJA~Y5V0DS&KTe^jrwGVN0|-)hF|F-_|cJ%jF$^ z;}g}sU9f>Wa<6ZGUOVb#@)oq2uS@)mtaI_0nP20Sh{X65J&(|$lU*hM!I9%M7u%sT z8s7&$B3el07mMC3Q5QTLL>?@z8P=~>9$OO3)LoRvL{@TBA6+w`_}Z&*Z-7~oZ=Rqn zHN0gZgZx;eF+082zt)RIez=g=1Atop?>Q!)j?cnWa-yz(7{2$%l)&-|`MjoBxtYe? zHh+$(f0uj^Jwu?4sTdse1}`Yp;qLEM0`HKWS-rU>HFPw0M0|7qVO$s+r4 zptx%Aekb^7EOYLDF(3zRFB(#td@uD&3?cEh`Lwamt$z5pwdWb2((Ajhf)KDd^hnM+ z{ZZY}<`p)x`m~6$ym7uAR(_E|&qnOe+Z-v!ACQzK`QFO&ExE_xig+gq^KC3L1H{`V z(W18nRHv}vCij~B&zXV`Ypi&e#5ri{1#^cTtR_=vwBz)D(Zl*fDFm!ggezN{31~ve zM;j$X(xb&3PHXj7ryAo|x;bdSFjUK!y$O3JqHY19B=UIWmY4sMTW~#>Wp`bZgtRmD z3xISmYL|qijD$ zRMQ6=sisGFT|kGA?}S7dBXqae70|2iB7c*iKiS!SUiv1TSuH4vXptbca8@uUr43=q zl3B|rWyL`U0^vaIgp}gdl9RQ^i?FzMd3dui(jL6bF&Ax}i}QkYgT~A3kpbf6~lH z{^)4XS3}K7uLaC6javNLI1{Elpz94RSl9~ESKa2eV=n$(6xN$&Hk92l9Hy3|3U_Vp z!}lE@V#OUnDZiqJY42>%!FHuzOh5{Hfr1>v^kcc(4pZPw*hJNigdS3x9dsH?e^77RlvNJ-5tWMQop)cgv z)wVs7XJ}$`|Le?TQe7V-nlMQ(9G!TtD7l)vcznZ;FjX5S)hGcs$X(g*edMh-WE=yH zc@#-jV-N;?o0g+CiG4m9-Ef`s3mDw$UdmueS92 zG0dV_dm;R_sB-%E5@jdiIS!#R$c6t%(=YemA(emEjfk&SP8j^igc%z>%Ve zaCzEW^fO~lHGgW!D0=yi#ksHK&}ef-r%g5Ln@#<&@*dH*CccMkR8>T0Rp(FUf0%p7 zu@6e^nXwZ~+NuNcTKiC3>!~x7^Q}e8PxIz3a;+d=w7e@S3^CxQZVPi7e03VBO91lE zu3khLy}oG?pvC$otcD}12L7=jhE2Y9l2ZRmN*u29h^+V?;9--PKKx$jbaAg-V<60+ z99|iJw{Sydqd`>|VZ2NZomkH)vvGOXR1@wT@j!#=XH()l%GZAas1E(!bELN0QL2f%&KBjc#z}a7nqwIaAjGy-9_U z)5~QSrCcukxThb9E78Rhe5kLLZRtCw6|^G$0|G%7X5Gf4186fr=L|sq-`b6Cvh*P? z#*4&7Aa?oC0{TK?df9Os>6a_`${C;os=mr)gbWZqNtJMg=Koq5cs(z>u)BZe?8c=% z=J47f@VawYvAtQ$-p`7`kd&QS2=knfgt8-siFloLD{)gv=z4-5Vj}o8ly(PPXS7YF z_L`F1_zu6kUgo+qx3xB%mBQewhIwgg#I;2Dkqlk94I}U?hOdYWh9(Il=y}J!>1`@K>v5u0wk7a{QDl{=qz1;#~GQt!&~Wslc+ncHD&UrwLmdd|Me06fK#L za~9lQhB+irX#vFUJlp?v-Mt1pq(I)15Vj;+>#ru_u0anL;Xq6KvA|!bt%Cgh)?pk_ zhF@(v)e+O_vu?$dMjWytNsA93EySjhm)n5mYkG12qa>%KVa6q@Z5c^y zk`u130mf1zT;ZqNFjG!RkxWh=26jN>ma5qjbM|!5u7}m0<16#5mWO}62q97FSn~%J zhb`f+M#B?1X`c+$f+fGet?A_Ia?p0Yz>9L#_c1V&m|^(>!|(yD_6@Np+=E zXHEJrYruKmglF>)8ES!h-(k67AHSah1tAkkfEP$~yrJL$lz=w9ZvSw6X~o4~*X6aB zNe-&PC1KkMFNP~y7pyciV&Dsa43*R%`+MHf&eEla&KFzW>0dO(i@Zc>R+fe<1xe23RrIOx zPYwi6EzPzFu5|!uc%;z%ZowIXb_6QU%EcCp^pbDfTO50_peE}x0gE~lC}+xo73Fuf zlY|lEP}Mlvq_?$vue*An&JUO7qu#T;yiV6#-)B9CfRLb}ssR7Ry^*5c*v!rLov@3@ zN4(5=bj4M)Kp&Kk^c;Qn2C=_17rf4@udhNLPdN+8y$o*G~z8d^kzNyqFaBD3^5 z{IRrl&G*_xilHqY;*)L-=3Z#a;RO~*Bnx#VUXv01wQ}b=2hCEYA}+ZT$!iY z^@1sKj+|b4lFL)%tQo66 zEbs}oU(>z$VHzk%W0G->V!5LQr(sr(PMx$~sdoA(>2{)6W+FD1V}8Axs%dBY*$i|g zP~Th~=>I4Qx0_VTl)ZO?HZL^(meZVQCw|f+-9sf^O4j24p2Hh#F+5Qp)PI+kCPbnYuyGT#y%=#xyFP`iG812 z4xZ6h6PFw!ujSjHJOO7-(iX#s#V6(9Y>@k+SQT@DVAZ9nr4^Bfhd1b#KH_Hys@aM6}$seI*Ck^=rh_dHAy zQoyh5hc8MyA*v5O-!(9nM;;~-V3$$rB^2=6!y5bmzJizFT))jR6$Izy-T5lc6=KT# z^d?Sq-T(R8`?__j8IK2q=%9J1*_vy_`anya;xs!(b~+jS4ArttU7Uo2uX=|i*a7>o zldI-$Z&Jva);40v#Xfc8RC7Rapy@Vo+wG>Q{gs~9u)qacGw4gM1NFB#|7OmzbJG-a z7~ljy!1BqB$+690>)iyeagTaiGUD==i9n0qPl^%#|WJy=!9w!TDy_Zr6v-Qk0>G zvJFx~aO5}lIDZ9rcA0lQ2zzp+ie*2|c)C`Gdy}o;-R3`=aQ4c~bu{wtU6#{&;(20z zE9|Q6YlmgRTleQHES^%=RwtmPw*Ea%6wD`tyn+&(%-rMj2YSV#FL%U@VJT$559{|R zz@y#eL5Jj`O|0WR(H)?_t-DNqCy{^osion)kN}da#%MG^McaxTCYXy}f4-29qQ1Un zypm`XmNWy<`08zyBZf8%m1E7`@~zz(sXsR>op7UWI{1YJpYM-aR(Cesrx1g`$hZrS z9U4$%C0vr`zaV#YZzi_vpDvbl^MXwa*SjUy$%uDcOha27hX9#y#VoSfc*MF8!j^CyJZG zC8-3LJpz~D8rbG8J=5D8Qs?uHy>I!s=b$eR_aFG1;B~hirXFJ+m`8P1-v*xrPqIuug6c9FbW~0Ic0C-O9f2K6 z3A7I4kzFZHoA)HtqyA{=oUdR`j^v5jMi(dQF1sWCpnjJg>2BQ=>YkZV{37<)6jor4 zo}A!)+eVE4w)so(HTzi3*f`YpPc>s*c@(0*#f*|fC+uB!zAE<)=giOiRx;{VTJ~T~ z3UjVtsM|j6waK~LL>dH5hU2rLR+T35J!}_vM^4o8&*Uwwu}JH8hZi==?7aP6dxes9 zsu9|Zi@{FDXRU+sJ>&7pkyUPF;p6*yM74krBDi26oKP_5Dbea6(`+?@0-PlFina-s zv17sF0Ms6>^p(H zMgSz&L5QM{B{~$-IF&+m*6n~FOh=Rj+~AWPfrsxC>s>U@st1jL@`%tT;+C4?=h^2qwTwJ zhVq6FUv-qCSTUzoAQ7H^Fz=a?>UA){ZrH1OOT=1qlQ&4ZV@Fk-z`cWY{d3I*1ixUh zu0<1_m6^EypKYbF8YMS(8p&D}8@~svo#}Hitm0#oSFpq_*lWKa_C4V3R!>D@8V{1= z)p*ux&-Axb`jI|>@reC4O>22MQnqgs_Ps&LPGaZHvLRA-LW$|wGQIZ(yTTe*tNSY? zEjdS_o@@7V440=b@+t-5rpl6(jt3G`6>4HJCeU1QdQS6SMXF;(m>(C4rJrtS_bI*| z+7at}93@)1Hn+UXH)#;`!j}dY9OgjCa;&j))Gc(cKqWlr1#ECcbuPkaPSIrJo5S?* zS22s`1#a`yM3!0qS8aMTXLHs_w)o20%BPJePB4t7?^dZzIs%7Blu*Qk$_?&Br<~fV z`hPrJur9t3qVcw7w5p-2blLcs=QhV*HH^Ru0U6ut{%l{9#C>a*A}Z-r8))s$fvxP z#|kIiXY9>%A)VO^f>H=s6f*;_fQ%e6nZhnmz_m z`%@>4e|!;67Z?6BTE~J&#MgbAUTc4cT5#A-C&-Y=oYD8LHTzS$ABef%9SygrRS3Il zq&8JO0qlMI-I@zS+J>Z|&kV(=SwJW(XFyObu^<*=hXGFq7$|` zl?(3PkKRfD%Ol6piD|LctN%ec%iZZsSM&M4_uFVJEwfC4KdY6NE0xoFRP{S^t z?&`o_5vQRoRw!-WZ{o4E` z-#>U?jU4{vKV=ULxX*N$VwG#Z3wI{HX?5^v6xHA`TJtgImYeldH`KR5-XUnWEw zN@gA?->JY7%_^W+Y0|y*&K2atk|>io9UFy$(~)NiF9?yRrNWo5j?dXcp$s`q7+uW9&lKy}3k_isO#u)!i-U*V@HJ ztJ@a0kGq9f*(a`!zwnQ0XML7K(W4~4mWxr!@+^{6^_a^yI?JTUN}3o*;!BP_;OcQR-p;t46OZzO0cq5mHn;|54?HE@!d zn=1t?%>#j%4&pTM$VS)xrA|A6c+c^u;1Pa>BqIPU`QUSQH25{PzqqA-sBl%?TToR1 zf{XsDIMJMbq^|FC*zC|5KclU1=lm}_67ZANz<$}dgG;&3Q(BWb`@!LReW~Y)O;^Rhe$$bsLKcA!bFXq zrBz+LR%LZ!!@dN2MDiXjF}wTaypiTHW&94Z(HR-+q)|{f@~G4uum`g&Imw^7sr@7_ z;i|u&k=fO8p`v;A-Bsm=rO32j_qRt6gD?VhJiz^+(!X~o9=xQ*_o3UC(>=o8!B1I9 zKo6>7t^km=#ZYNc<5RO}pYONvFnj6Q2Z*x-Wi}b`49!(#6SqxYSX*&6NzG&boea$( z=(D&++3PRcZdi*5u;H%p>sx)9;D>4B{A-h5?_9K~Gkf;A*fRZ-@M@A-1+Acq+j6FspEJ`7gX{6AWn@t( z{3y%U)gQ-Zn#m0wzZW~w`ldFOtq9id3G+n_8JMq0eErl;#U(96;F8z7Hw^yFqQ^#l z8K#f6R6UE|>$;9ZUeuLrIN08sA2UP4^qXEK^@o{0$)GfvD_?Dd2YhZ0|ea>j5qj-BJn^VU04^ zgon)kM4^Ko5-wQoj%;5;jE!Vch~y407CdBhB}N+>41P}+0xMio53k)Z z$4Xorh^Yl+s7W=%n(@rK$}C>nDum=yQzWyi(=2utJe#U{OIgQ+vizbusk#4@y<1Bf zHam=ub9L@_khzNF>%g~}})I24T^8rw%yxpR^+4vyzFNduWa^Sq{-U5=J zm%k%jN0Pt1!aS~Ox+{pih<>F4p~llXW?7y3P{s{}M>#`#n%~-pYF}ZcUV9BP{NblG zO1Y#$d-=gqr%59X{RX|f?#qO^A^M}sJ zs0JEx=#B;sTf3|x>fCsSwE4zPjv=hM6JOVv{edvwoQadp`6#7e`d@E?Q=Cj)Oa1Cw zjv#ETcCYy-tE`tsZ0bdQ&tF`q(I+irOzfX?Stp-KHeB2@ZZ#!GissMdo{F{s(P|H-U&%t*F9nfknHKr_A0>cOMy4A1u z5yvLY!nIktv9R0 zZ*}|;r!{o-)pC!>j|up(8v<@2Q)95h9u_~;8qBsCryLaJ#@h_wg9)l_xVqUi73K(_ zwf(@)NAD4B0p> z!>r~#I^*)bzsUf{UYkw^ttQenD;zDhM<$8VT*Gp&7{6fe@{_Ss;H5@Ea7Pa#4?j^) zfN5$D<4xikK0z^|lj+g#9@fd$uejjTQ%3N5eI45qi?v)?Hn5#_GKx+MY_OBu)-&{) zZ+}x3)CrVtd^v%u6_Z>lB>MSl?_p8dqwpi@b*RYpbbHCRV6JsPeV|Frto(zLi3aC5 z?E&$iH&^{o9LD1`Bsd;lv2RhoG~e2~1atk{5j+Qs;GG8Z-z=Bf&~e51N6=bn)hN@= z;bW+sd?a}gMKq6Fs@+8$+I-v|9;1dbnO>q^6x?2f4cAUlFQ72rhQ(D26@V>q9YrSo zT7K<1ST0e+qh|kr-M25D>x?ap=zqKRwOvrGLVvWrc+v-c3OoPdxqxvcsd(5RkJ>JL zMv$8TOd((&y@`>r&6zT6s!P<5EXY@=75yK<<9*l7dTs+`XT$n;2cvOcSRZ$}oBi5u6@NN`FuqYajMtErT!9At_@qD? ze>oSRMGC*9JexirE;*w-Mc4)sjnG^5K>TTRUafN*1$F-i4t%ii4ZVwXL}EAO zHV^6(kw;S_EU)i<8s1H=-Jrc|hy6JvJXM(QvYLnurrSBnclG5o^K1p%@FMr8O`W3B zI~>OLPf33W_t9Kq$6AT$2WU( z3Q`g!GZqkasT{}s8htV!cA&M_YD@qVmDuf|*Ke>3<5GqXzxv(0{lm(Bi-WcVdg!$9 zJGu6)rjB-&ds}-lsLVz_66s+m`fq6ow%QqeA%ZWn*vL{5e(3x+pOK=;f$tX^7$qi(NeLn#i$CbNmiq{cyUJ*cVpZuJuv%Nk$)EFUeu zzf4cRGGtA*8Kh?+B>*@vvrrSFSF_3Le(=|cR>iCZcf(idtAF_zE=6j06|VVX=NNG? zU%!OvrW&7;dw1hBZK;2_N6tOct3|N>j-Gwh&!C8?XZoG6%Z9Z==h&I+N>j`}kjC3X zD$yfBMP^f?c?;7DahZaNJUF@+NF1WcDQi8mA?>@k(3W^r|zs03;cBP`D%;wh* z?Q^Tge{0LUhAvk6kOCMraG#`Z=7_uYHThRn(V(YfP(=#E(_An{-#gprxx06lx$RH z9isi@K+NdbG!H-71|B3=u?(bqzp!*L%Fvx6=&86C($V<>ZFpRfhxCL%n}Towzzge| zl^4S9uL#zP$I)T)@0d99KZBlL7&&QeH15FW=wkcYoKC%|CoBN-g8j#o-rW*-A2vSM z&}Mf2-VXN4_c8o@UzOK?X(}<8U!&C}YqeMnl|LukEgALj*X3_=&rrwk6Fw-Jedzoi zvAvz`7&}WpnnQz{vJ1CrlqlS{)!Q@lz6LlYu;f9k+m0qS3MZ|uTUYw6C|g0bKvmU( z%|Gtcx$_L7J#*7hW`5F^|g{O1R}L=+$gylmN^a47NO7|$lj_6y^ust0QW zEP-ILU=c~kV(~jX;Z6m8OfEf)^0*Q|f5>FKbER{8PFY;$Tt0C>IFIz@L1YEvZ(neh zII>}m_38NvEuk>@`{4!FN6<&~(@dbHAc^;?bi)##7kp{FF`zBghFAtI(@bq(=w_jB zk=rZHIxQC)Zzj@Nn(|&t6d(A?fjG@k$LFZEF#t%`;5!BTE zdR1VMoUd-YGz>n9M+zQBnXQ!=NvSOB(tL}9k!CtJ-r!*;jOg2U#9julK~#58zM1js zJuHrWu1qV3D}M=nNadG)fuB)C+k=g{7qGr-f(PBX^^q-!tXatk#MQFGCSgH2x3lU) zJ|ksMJT5W#d&^zi=~T*H)T6+TX$~G*Q^kG7TYt1E{E3Xlfj%%N89Xan~mVzi0sM<)P*@Ei+2OBuLWQT31SzVdyIn&)Nh*y16JEB#4Kpw#_ z)_%wns@g>+**B32GSTySnWxn+wFJM%j9d6e8~sd&8%X;6cZemMF|V>p*R!fsUlN6uyM_2U&M0I492mPdhCILpaj6^G?YW{q;DqWEJyKIG;yz z)n?5%9GV3~SaH6Ow5I`9M;#RH5Z~P1rs(gA8m!(Qaq;N#T$Rd*uZNaIM?oq9sRcXY zcRZ4q0gxgK|8W;y5MD#wp}gU>W4c;_ zrvvZD zYUGnSW$vFU9Q2gA&8@5MTT<59mF}C6395qB5gB01H6KWM+mP|QL7g9Xh3fAIflAEb zr6*`-eq1O9H~ZQdeI?J{+*`8q5BZPw-#T}*i_)`R6z1BY(ecHyy;jIN?G;@z%L~c{ zWta4qXWFdagZ`T&86D$Z^^&3Yg=Ff224p(!8}xs=7T+HxOr48JGYlA5L@)nzY@(mm zlBnZ46kYj?|3g@{m5C~%WrNY1{OC=!0N~xWR4-a#CJ1#I`bWvmbsO`QuGnisuILrg zK(-wDc|&u(=X0&&z4f1m77v*M7dHBKHnEXfx~vtj8^3aM+@fZ)VIJ}1$S z%y2-w)t6g;bUvf6XEYRs+xL&9Pr&?6-%;^|?p|`#&v< zC~l)ICdnbl2Lt*IP4xTZCgt}5NdMq(9entG;k=|OptKp@$Ml@np2LkL<@tvi7=f8* z3i}wuM!rLtFwJJ8H}}{ctMWh|^5jESE$sE2z zI@c*Tk5*aZxm6Qc4EyKMz6_%%PuFZlk|$h+Gm}TlPYXo3BB;yOuEi)}@zLffXgHfA*LQP*s-Y{W=!t5MRz3{r zkwe+AkED4BmXgHE-)f^ph%XYRBu&=$8)muh5$etsETkVJmQ?XcEan?)4Q?uU%ZIGr z7@Vs$Zn2*%Am8jVB#%H+`eZ?;`Z5eZB6Upq?5#~Ym+}4WKD--Xw!y`H4xxwQ-W21E z|J}u$%CV6#-kTOTuND#;E)b^-fG{`0tVTx4hAzwZOL>H!sc&C>#DB`W14NlZ>I*X) z87=oPZP8{h>W>JENYG5Vi$m3lpeE>>zKf0AhA<4*%fd_uSZ+2!Q!F)G3U4safFU$j zq?=Nvn23BrktCzvJfER0Vtoc0i{la}QUo?2VV{0+ei1);d;=l*SbZrvZJh1YQSVw% zvi=Nx{{K7cqEbEIK(lPnn$M(KG^x=J#rglq9Z%A9XK}yBm3Kc$w6DcIR_Q>VA82ZA zim=AS)hT#VK-(fCg4D%&Pq%vh!=HG(gxVisN9?88%Po8z@}#EvdHglvf1|j#F@fN0 zZcr$*npzIJ*tn)M$-C`W^TeSxvJ83)iAJfroMD=6dOcLCHP4KXzGZaQsO!P8KCg{m zX{WAL&DDF5sCF;5+TFd6ff^Ey1E-dqK1LqaPuIe>#dPdauewf9p(#elkZLO2(I$^h zeV5an+qWF4H<0m7@JmU|PhPCXT2NLTOaaZoO(6i>g7(zXTqqPINSR&eY{m1ou zDU$2mu~L2CW{%I$-qz6DARvW0Bj*e9zkxkO)~{YN4R?h(gENI49R|l7UR;I04BkJz zC?QtST+x^>#kbeRZyLN@&0E;_3`PV7e>*{~KQ9O^mxr9kt6WZFE`^FWCH>Kx^O|Dn zUs(8dWck~&ifao=E#UzHONuDalL$;O`zC~wbXm4S{c|%2au^yJS16HJV)-ExF&j6V zzmB|sl2j@}*6gNmx|_8wTZMw7z?ix3U+d)$OPLLg@mv{T))(I<(9(9j(pKt zC87!~Z10U?I1kh*HZIZzzSTKcYIHtX1x7&;(cANogR|Jd5mZs|Q@^NcvLST(oXPGb z!8y$G#?$cBGd0U2nv^~o`z+5@bDCDTJkewc7@R6hu}n!F8+r)}<#ZgTL=N1m4(PwfwF5ymmMOXr9N*Gz;9xrt04C`EKMXM9ElIc`l7{`r6gY`K#=SAMl>3Sx_? zr6LWh@C4zRiz0m7FMUXpIR@{|{bw8qGb~?8*uOJOs3=J*IP#wYBCaX43LZJN zuE|b$x}lq1|33>jm^N%^DTC2(+4W9#!XYeDIkDvUfQz>f8E+U>c3fS`zFIq0Q|9fn zm&>VkB;1qce#i)3Jj&ZGF;okq7K1nHpud*(x5fM-g_&y~LuTD%%;AwPWr;@4Jdi-LW41 zuWOr@bTP{|R*d}94MlI{4g(RsF8o7v;E-3ePq{}uCj-Y!_YQTB(zSSqy&sm_Z=hf` zaX3>ArRl{IU1@SpPbKJ&4jYvsF+n!bOFpwNR}I!KQ(V=|H}%!!BJ&)N4Y4af7S377 z`K9G0iR*iUE{pyZQ5`T!roQV<-kcyveDGc`i!mqj8bAG6vKkh+N5Ux$V6SV>yjR81| zhHS;Mz^2`6k3iHx0OWO33#wR-kaO76-V7&IydxcOI_7`ufjD7$D)JFA;y--FRQA^I zvm8}<G*kW_ilWWV_XyHNE=V-6x8g8fV#^~prfAV={^A`m67M>%n_&V%Q#`ZfOrBP;>FT;3ryO2dXrS_LU=(R(HU69j0 z$H13VuUY#9P)!-xW=#7SbR&MU@5HeO{P^(EbT0MP1moVL2%PVb2Z-*%aQoJMCQGas zU%1?t@)mXoZXESs$S~qBul1>HegWp)HB6Bzzy@=k68bjhN)UU0Eb!s@@30^>oP*4N z4-d_e9&`a@qWC)Nz3PR*kBE_|h2+*=o~n(d`A1%yzNc%R3r*Pq@f|!=yO>}{X+E-q zYBgbs$U5+%k&eIwtD zBD9cnh5`HLBc#p<-k!jTZ-oF70C&hV&Si6C!`CW3)kX#O(`nYDYM6R|&veK_Sf<}K zJBlR|$&2X#XDy_;TO3lVtO&!_ulSE`r3|u8Bx8qsTr}xVCh~7j-O-l3iuIfI&b=Dw zKhB&%_GsTyHB7ynqWQ}njuhG3cBuVEDi4xxQo)~=iQJ}Q4B>8xmAyj0nw z7Angsnaj?J(^CO{!-WMWSOu~2@HbM37`IV!@25mn_Un$Duds;M<`OC_j{t(BdXFq( zIppjWbcT5<;%aGOW;0{hbq{ymMaX+cAPDukfk5tf-sX?X*QD~C=_)0(xO_v9=ZRkC zww0eKb1}Z9+BnVmc0q$cY?vZVL9ATehH^La5FSafU|;R3in6fY=NtDS6u5Ox_;i}w z;OnzTPH`F^A>|>>>il)BSbyV7`99u6IlYikin7Gq8n;pGJQwI1Fq=FAJQ-mE5L9ie zYd-09Ymd`kbq9xLVVIZq?+asxz>|;f$K*x?pDb0OE$}D_0jHWBUDV8Wg(n!eF|n66 zYag%w%2-51VdR4T0 z8@H#FYk3Po%EQz`96Gxf8A>ieyh8Fuk>ip@}ivq#>&qR6KaW<%wT z#9^%>$}@_$C5g9}ir)%JqMwGoO=+CvI!@GEm{lp}MZty&IV~Z(*l7hF*DM7IiZ3se zu>%rkD@ehpV!2z(u@+q|zZ(bNP2LmL>F+PnTV_4)jX`so_n!Lex8Jr_E}yr%#cso` z!3#!8J%ht9ZH<%|-ZAaF*xy;6ZsA>J16q%`fKV1G-`Q)!-xyHZc+xatKu=AA^+ILs zRG%>|CaR6v|04SXd=H87_W@v)E#@QBX7tE$9AEYwzKg4Mvz*Jl*YZz^e({TZPeEG4 zYzx9;toKlz{B8^#J(Jo)6|Ugr5V8NG3pdn!u(WVDB0KnT=)P>!$t{^&FF825DXyDT z_Q2y}D`LxIZ;yU>vv=s{3-R@#{)^TFivwYUCJClRyd7^q%7KQo z?`eRpqO@sY~pV%j7gksH?KNDsx^rv|_lN4?Cz_ zr7Y)iwvj}b^M)`LbBqzj<}eL&HX9q8nR~zcz8{bK{tx!pzK`!d@Av2RdOnAo0T%A6 zHA~M@5xUJwC(4`HM^=|Vl(oqP6{$Q2zhKWjP!7cck>RY~s8h$?G!Y#tr?d{>ZARuEefQli)Sn;Uwrl8k7Vf86~Gz#ff`Dmv<2*mK&w!8*E zh7Nk|&kLqc)|wXZ#d}zEBD@;8dsP^;GM0)nu-0QNoYF809VzLh6hdm(nCZ6yXNn&4 zR>Y&yBrr87HA2C9d+sGO@;+49H(&9$X?!p7uKHaRfBd90m}p3iib%hQY*oOa291)_#why{@Y;Zf zfG+K*`4^bVK0b;rGae;)zC9`7UUX=tS^4A)mJy*yF|9TIt(lVnW;!PFlh4rYTSI5i zq&p~3hZ1LDF3qEUmpXX&5#0y^VNjDBw|J zNHbS=?!#pbJMhTyY1iQ@$}elmv>648%>p2gq&G1+^YWvwb4+lU+5I;r#ar5?x%wZ)sXE##ga@Iyu z3-VPHP))o1bX%v?NNt-y!{R={k__&w*Acb`^ z#&uQ&?OQ5mo+TEt69>+Yb8%HGkhs!hA98^N_# zSYGHq5>3*FxqDa<=CbZ}hYuyX1cV;(?)HsHRM%Cd|3~Xp`(4E9<*@I&1rI<-#!n{F z^-d3DtK0z<%N>p4KYt(1(m8kDKX@iCtvqh?Db7D+S@@YsN;?er(=2P|AC&v~4QbA0 z(1mw*?G*TuoQJr`OmDUL+dXpNxQXT(Jq>z^au1!mIiNYfuvfgU!OMxd7IpWn@Fyc$ zP>=>elB+*7cFaXP6z}lg_n;<}=61P>5s~`K(T@RF)`q?mP}7>`txtAZ>TX0>vYw00 z`+I>nHdf}%?MC#&E9TWgL3Ws=xSV8AC)&5&HX6g*B@hOEk(%nNWui%w?PFeJ%$uvs+b+%B2Z`!0u_Q{vaa7El^IDNG4H~$M` zl7F^*Ht5=1QfhaUENB?q2ZvXJh6UaFT{@Yv)j$Sr^Nu`L;-aT6k(w}%GhE{vl^&OX(@C$T@*TVHqAZwoU{%U z2ec}MaNZ$OZ$=F0w4X%{GG3>sHL-RX*DB?04*q)K65^CY%#+&5z&rH#!sBU~ymC-e z6!Oz*@o{4h!Td}^NPZSGZtt$~z%%zyUp2m0OT-O9k^9CBS&we&4t*IZ%?bz*s9g(e z;m|)SAh^R@o@W&5li?+^&)l}&mt_wecMiElLgn-FwTvS8__kTa5zm|IB?l0_;X{q- zaY7qbk%l|xL@9e6`^J?=iBGLXUn>MvNJ)z&0bpPx=&Gd4v_oNJ!BHArA%>rK!>qle zLU_dUo>~C+KMK!FKf0H*I#NI?C!X`X;&vWJ$xUD+BoR|BF0Gi8Hd@vXXAMuV*JHoW zcrCj7YCD^savKp@MnZed{>Je8x-6ulN~{9UaqB;XE7IZ@0~M=ZS}G}^+*6~3&Caci zb(wK3^8Sq&ok$1T8~vUJJ@nSO_9glWV0`P7iog+N>tl-NYu1Z2$Hifwg4q+t^O3n> zzr!m6W}iziF>KW1jg^3RX!xr}Q*0kjHzy~lGJQnXBA~jq(spLZ!Ga-%J(`)vy28v` zq1aYg_dup``}DHfVrjmA*~!bybxIX?aJZ^H0nGG%SW2Ggmfjkkcni(xD7n$9uz(qk z^;%3V#YhgXN{1X}!%tTB&0lK3*Ij5tqBQ|n&-)?$uKF88x7l)?%peE#pZbDZp^yh! zXEZJy$s#EJ5&Fdwxx(!zK6`?+SwhZx}XJOY=L!mepMVv6ykAcc{$1LH}h5nq-nvh-A< zjma|;Ih}AUM&-RsvSNiTc|$d#Y*V?}c#n8S@wjdMzRK8fv&0MS>zO49WxjpzlE%Eu z@4hXJ&Bvh8jcSGT(TEM80gXT{Dx8<}PX611q2Nt-nwE_)=fh@VzL zK9iTFTXhOUoX6_RDtFkb3!X8$p9O?Wh)u82ZQCfn2T%L!&g~Vwj#nAzwBJ5&fnviN z^Du-6vZkAK_2IZiyRaMF6|vl>?}x*)GpUaw)-R^ZiRO>_NZyucsdlpb-8TD0wv?~& zBKs+vEGpD2g_iCrT2CZLe2l8BypKI^zV_>Lv;J_*dtY+;55scMbv<@BS`!z%{%FQ8 z+taLk{##q!$Ve(K+enY;lQF)l;_y{o`q&LC?EA$~P*_JJS#T z1V&Y%-rO6TYrFVrLiIl4=JSh_zPH+XD8nR>0H8bvKDMzJ6|m;~7JUJsu->?Vn6_G) z#_GDm4-9_Yi*F{^`9sdMO#BlmLWNV8TDBjKD$j~tTRo zu#L+elD}0$HWY11vE~h@$bs{6RRVWHI{k^oxd#4WqYkVK=|@U_OzU?g0Qym~d_$4g zGRkKVoUr=H>+X}rJ?rc9gfem+aj3|wXKh@=zsU&5EiCt!k90GSZfLu1$B2ujP8VyY zE6X_3Tn?h;AGW&~UVOYgp%v6$cEp@ucp>3oZ^UQ>&9pU?qiilByc|K=Q7-rgQCcwQ z$RzP}zt9bXf(`wIcPUVE0E_F(U+j$ zY4s)V3jv(?ts2C;qa{@J$%0VR3H;IQfMfprQ_fF3Vt=|idk#WMUNM4+;SKPgvS6bG zni4gL9Wj5xu#GvppBXe--9YS^U<@U!gnu4cXx7X?SV|u8r%Ir8U;bTAgtoNpx0ihz zwsL#r2KzwC#{01_P^$E4W4M&|c9o6|2``iph-(i@AMsQ5Xf(9m*Xl|0wbG47E5Y2w zRop_=Tts8wVTiMZ#Udb**~DB4-yXiW-n5Z(p~&>L%h!pqt+9;ay`iSft%=leSj`cs z-fbZzqD!%=Fs^v}9`0YCB)5@Bu5Vf0Tj#=Fq;Qm(NH({Vye_T0%#Z^qdxUQMu-Pv1 zIwU&6s51Z>lQtj0boR~O;+_hK&8seKJkrE_?p|_Err`?GyP ziE4j<8;Q}e&&yZ7cOumGm)Fq|IfLyg_&8d0PN23NLg}9IEO6_(#Wn%?G4;+8yCKCG zU~Vg|rcl>Ms3dZ_831#bUw?J6KFNxDSG2^V1Mb?Zt|4|CW2zNqppB@^l+h-`D1H(ftXX=Vd^&g57X>Knd;O=rOK>B z9%%{SrG9vr#o^>5DVK}y!u|?jLZ~9AM5H?t49Q{dYM{y4&KHg zGa{w@19)M$9tf`<CHew1bU?Ul8(WaK+7gw)ero zr=oQsP1N>$NMLOD@z5#zwq=QouhevmR-4Pq+V!)pnB% z-9>Hftghek3>*F+dQi>k>r(a}`WACsB1&{4j67xb6$0H%c2To4AJn3oz4H$PGIe_Q zO1fV4%)fDR-quzX4WB!s(Aj65$M}|#GgGNd0<7}h@PfQJE^FM{LlE>bujM^D`MLL( z%`W!Y^OA5ncIOo_WsFD8r-+`e+|Zlgg*A$EZ8pPnxs5sP_ZY0H>A_*)#-?nx^gy}v}f1EoH)OD*oSv??0wd0BC-Awj9LPw2} za?0kiuD}c_eQcHoa&(34VGTwU`ET{rc_?Re_$SZ~)LLh#t3fcEwg+T5$F|%1xcm2z z$eXKEGxxy3-OecQ!6uvRJ8Ho-!8KPtsjS|qtin#8#JgOp6|&cdoO*JWSxL=f#Z-|D zsMUEa@N@6$+eOU*yRr}&KtEEXyh!a)8T{NOdkE3X>TMglb^p?f0MvaHt0w`4wW#-& zrCpC-IlOScm%VkVzuEz@IrE;{yMb9}uBmhLK%zXU42E-bON?y^n#~xE?6+PRF#lRj zhimhSPOcbKOQKbVVma=%)1Au>YDMtJYdU%!x*5|-o&2(Ov8QbE(|C2sqnX^x{qG$$ zRQzwv=T(^S`%_>fCuI-AcWHI~WhHO~z7_{DoKx2yhC@v%NVWDN1~U)aZJ;M$lfY2S z>_d+i+QNl5_C^;uPch3Dk3y2s$x&5Jn_X0B5ahbxhPE?|?o*cDoV@+J(X7vGLuTVI zT@AsHWrLTc=rutRdgANI8fF1v%j;yNRXhWunB)I9k$g%00$WZzSI(_Rlm?H z)lcDfIR^OYxl>@!Fu%n0k3s=+0uaPE(mr3fiPEgA>N9I9@o~xa6>y8Ed1(x-8D3k7h;GfU91X_f9x6>$g_MktHkcb8bLsaMj#udOpK| zR`vcMOi0mz>|q@(tZuyAb6i<_D18&lIoy}H2`Y$9txwfJ$W3I52~p> zH2WsAu!JaNc)Au#Bpb~;jCa1h52uz+b-}VivOGY_omVkOgzF<-7Jx7-8e0LM9o?>c zf!wiBF7{n_J@aKu^SZ)u9Sc{Rx%qte5r?X&-xgZXG3l8hS3V%t&OSE#I=X3+ZgQuj zz!)_5iBmySVE5DV6)KAwYi4ZhV0r{O^xU0j?;beWT=u+1Ur&_bUQy>c*b=2w_ti|v z-O8#rU7Bto&sj0+{*umj%6~BV_-57s5a<5z9yTHQC2{WzI%x2m45g;hx=nfhG4M-n zw^4l{7C(+V5HauX5?qoJvh<iY$g%K9V6=Lfeue**%Cg_jwu_UjRy>J#@*d- zjyVNEd_EC&j(5Di;264rLlvx{3Lmy_d2Hm9^bI5`eWDOsFm5*0Vohz zz_-E0(2NtURA+hkiYlGzdY6lMc~wf_Y?L8tJ3^!JRCg89{j;*sgJ4UZq*Q2&n zhn?T*I0IJd;NB6VFf;DdvWx!H{JoAf#8=_`{5GsQQ}P}iyUSic%EjaAaJ_goH+e&T z9NlM%Cx>qIO!NqjZe`L;8t9te*5n745Ivvj zlH+NOT}L1nQIAVD=NW4ZeA0HJ-hHdBA|yU4E>CGGsS-b$kefatzrMy))}ZX_WO48L zuHOwrar1T01uk>jP!2lCGGkJ*S3CIkoWlL(2Ep5vUTTJV0K&*jsVmr#d^hrny?C12 z$hXxPQpyH1;T`Qa={wO)hvckUC9deH6_m*u6ZD<8`|s@>a5YxC2O6+U#DGBO z$b;o3;lMH7X#~!kCt@vTEXjYc4i1A=h6<-;o|8sS8*4))n_umzZh`xgA+mgzmaZ2V zu%?u{Rf6fJ+6zMED-~0j;gvxZB;l*2H&bPWYFg5ztl~BeYsaw+TbwZX$e~-}oJ}^r z)<#z6aB`cu-{Yq&x3er&ZAG30%YZc}{$}TE|$|q|Fc{N`p=NmQLT+P|e znuW|Af>aebOg=?%2Szjj*b@AY0_&-6DT!r~W=bhEpK$5pI5vk4y9JHHO2@K(d=OJ! zErm?@aO?4#e#K3WSmxFN7GGj=@5@#=v#ERe?48~xA+z1hh#hUj`pl`1RR;BN{v#+7_ah$pQB{ zJvCAWj|Po8CmH9q?E9HETn07tHjk}r?C}-1&7XxR!4Q-9@y&8Q}(C)H`J&4(ao`t6x3Ae*8a^Ar& zfSXV<8hw0mxJ_g2#4xUamg_RoN74&6_b&=BkyRO>EM~`>!B^hlwpbV2y#Fap96x^s z*7L|m^=CxYE=Z#ScvJp=pVD65KJX0!N}Gnt(nkpDiu-XOkLL*}-_&YcO4PA2-q;0GtyGv_)zpYl z=#$Y`E(dCh(hf+w&|fIm{Xa+OhyMGt;o8$hc%e&Iy$i^Kn`TAsoEg?!nq0nO2g;(i zLsbLS2bVmh4KW>+ZmTi$Va};xoB8)vMKIl}B=yKUYIh?kKhw8!+lE3u!}of@oZp@Y zQ1FeHjXvoa&lKpsa(D8yh_nKAAP~90PrSQ20fZ*jVXad25g}`AldCngPF(m32ejqF z;|{&c-Ym`wd+C;DA|l8lnl`-*oaq-N?)uUWpI%p|n)_%FdFvS*cd+7yO?Uam1R$UW z+PRBo?RNnqIVp>=w-<{R;8cNzK<{+g>~`Wo!gCXn_Ok5sl9fc&f~cdTp|5lkpt1%b z!9AwR+nTh(S@#WmCX`#ZO5K{d#C~-k!LEaSS}2+yYQ7FaWSdImTTg^^vcBt97%ITy z3_us>eqHLO^Kkm8=t}1wi7ZQlTA22SHGZ8a*h>!_6NjpmEiVIqMrFmsP4%#cn3YbN zoI4@i=ZrbGdAvX48!ehVxO1fP2>&EBApkBCU2g}M5O+?QNM9lkV5i#Mkcz6EW0A9R zKOqxjhIt>kY@cwCF`YS5YPX+f-G-U%e!KFxXgdS=C9o=tA059*`C4vrPRjOO5o1dt z5#nVpik(rjkVf)z_P-YD96IOe;oI4ru3i~-PH?bKdcnU-=spa@T=LeIo$`#_cNi)5 zYwBdB7`9ueBIegLV{qRB^KD`BMJheBF)p6ulhrpb=5r7 zVp5^iv)92*9QLUsy5Z$XOG#%5QKdoV+PL+4iQ<#_{Iv~tOnkyy=h?WO8&uRW z8a$NPSfGjb5# z@Jazz+wD)NUG2)Rg(x`3G_gKVth-}s3SFUHa4sUcI-;qyVf&L8b0A?yI6V63#!TB$ zmPMy$b-h4=6R{OAo2_(mVA(v3bQxe015%bETW3$ObdbWLgxFfLlO~v9)YTlhIAw)7 z45qVl89q>@8M%Hfc(V`nyRvQQ`j*R6{}TBk)N~lF6{RKk%GMVRgV8`9I{h zd?nqxI(2nB#S+C6;OUCcNro#r2nE#wJ0&bS@B9-K+?_-= zoHwu-rPriB%yz3EW~EsyjCCtl3^YNaf_|QyDjanQ@ZN?0@jtOo7}v>m>Z^qmS?WrC zjZEC2dgs5XtNM8wOGCQY~^S=pvtvs z9SeQ?iyg9NK--5RodT5KJ&|-p}h-Sy36WTwk;bWO!$gRT?h(j+Lb7h8Uc?=QdRAbS}$ZS8`O9a!Nx& zNYO_&=p~{meSheMOcc`6)$qz2KfCGH-cN>$8PcrD?zOg4wjA`1 zQ@-3L!!=5EAa3zPdLkIl;!+BlMje`_iUL3X#44hN<0rDlT+XAMbQa}>a3jV2DR`47!C~W?(J&IpoMZ*o&r!~EoA`otl#K?f9`(BR?BLye5-chAa=HlS_vPuI-P$}=2MUyd;N~Lq zMdPhAty6#>UT|NEEj_;V`zsm>B}_Ifq(Vb%r3~=RKiV0rONF=b3jAL(9r@FTUGK|J zKQE^xn@6%ESE{5h3^+MJn9^V70)Itv%JuBD1htNA-L*5{aG$?rNE7kuL(VIGor=+= z;u~Alei^raX}+)A>VG%}{+|o?wd=*L(!^i*TOy|*)Y_1O1Q)<_&u`H--Y$wqtok&?{67jU8_LXRepQ#IPEdh0*!=JdQRzNHAfQzmd8gz{kE_^ zQwMa`&NMW-7r8dkPW`U4b*<;@tdInIIq_!VWw4T}@`CG_gja?Nl&0LKEIp8=+YYF3 z^Oy<$kHE)p2>x@n{&K_2KW+%kE!kDgPlD1VzvlFH`q6HhT!&F%T-5`=Fx2OWJu}^@ z5t62&Wkwb!veCYv zVK;|u_k#-+K||+8ji8~`amrOUAP6H|Ny+V)9GW#AwP$nu(0tL^`tw=SQ+!mv?|2EJ zG8=2l%qE5zEg)LqSctC12|~b{k(;0i!sg-Q)>o6j<{>NbXPOZ+9?P#C(esIgF%X+2 z^eZmPC#fzj2^^?A#z79|G6r`?QJVgo2vL;z4r~sTr#rgURY_+?#s4!i`u<&!b+eJ7 zeTMmXNu~r~v$M>UEDtNwK@XpJ*nqmn8`Up^puPgeT&Nb}Ug6?zAswdsYrvO?qn*5AYGymem64bxO=b?P^AykIeXr7;X9Nk8p7tTNx06Oej z7T%QVeyHBFeit-9G5aBvuyxBT+AXvr7j@qmRBW0hTIY?rfT8|C^>FswZ+Pz*lHc^5 zfU)d;>q~NhK0#}L6uKX;b;wed-ZX&0s?JvDwJ$w)`7-p*;vXhOI=+}_^jfxt@b zjZf5ghgE4rPTbh4r==ycw5%o!B6i-tBaaMzCcZ+cbmt^2T$4|J$qcF@-*n~ zu7!(g(U^}_Rc%w~+VP~DpFj@LKJa$Ppc=w=zEat+*X=rdO>1p>iic4y*?1hyiA!>s znn~+^-y{sTIL$fAXn3r@`9$eYgnw^~?{b|G53zh*bL&*A z3nXG}G%DF!);c*`2hv$p1^de@=GT>b+-_owOw`5 zxhbxOP~@!fiGYg2vxQ#TNTMc;fe5uYESI$z_}pEZ(;&i?lVmyn5iJSk^c7!3avJOl zVb@L(lI+lRoPY2>^cwy)Xtnbl5ED?v4Ej=^auY{J#zdWE)H~*^J-{KfLZut+&B1b| zm7^Ww-*fO9rW8xJ9MP?>ZpM2(^gArgnvmQs)w5Xu>Fua$8aBXici?=|u1n9fKd}t( z;)SP=Mso&i+LmTy>_cb$0I}MAj%fWAMxN-oi_a0>%QWyY#Yv*grly5Cl-+2tB{9M? z2|CjN8fc6Qu>|fG)M6l^SzGcx&R~eg`Es_>^o#m9ou=@_xFy6+SEai7qnTf#pG?Cp zs$wP;SPBC%v~c2&qt!A**e}M@?56U>TdhWatPl%b9TRWv*%XcYeyv_{y_(pBMeNS- z-fJq`HuTw8UwLXYGOPQO$|KIDuQtX>Mz(E|(GxYC%O5@V z3gSbp=ib9L zuhD(!DDqq1XVN{sQ;_;^4}XLT2EtS>52F8Nr{Lv9^0a9qyCSOm-U^Dpj<6OhN2lHzd}IeZ$Tl6k3%j<->)CazIXc?Ta0CD6itJn75yks(Qc}RF zmhx1)w9K3IJ>K4ic>YqF*_C|> zfOoee>gUej2?SGIf$~R{U^?< zJQ2cDw;uPtEpH??AAZu&)Mv!>p&qFvxs?669IqCTo6xaP=5v&uRp%cXczbUghU zqThh2U?X|*@}hIj5uuI}Y59?JA>uS9cl)*+H<~{w_dJsbgK~(KeFOet>sWNushKVk+csY>qvhwZP>r08>zJGn9V$fslWOb5SMG9rY$fq3z1kkd zpMmO6W@+n0y+a=Zg4fHWA)htoPD^innbJ~cn*S3E{c<3==O%9cwXJSs8EZZ*t#0m0 zz$?}@!p(q`526Tjl0D7$?L5|~$ig&l|ccb4g0c}XtlSBb+U&3ksC zyeY?dbeL*QQu0|my>$~3vR}kP#qtX~K%P;)F3h`_v<)TyzzWH3^+Dv{H1JCryC-OS zE?<1c=k42#Z5o(=M8!&yrFd`4n-dgZg{)|z)q5(O!r~8Iqk{c79L&*?t2xp2e*N|x0;o2Zt7Yso_IS& z8MdzucmHpJY~p_gqKi2A|IT9|N9C2myItQon_q+oe%; zgmi=S=xWv%B}8T$`d@+OsKPt>mzdH)Wm)OgRWo-+YQ1ep+v7`00=wy_{IZG%k7->} z|2Oct)HZd@QP`a2N<`|={rs(sgB+R--o!Sh)tfmgJ+yZ+1WE$@YY3r2UjA}ASV zgToU<_XIn>)l50~ym67z{vR_baSL+NM)`o#E{&|BxfCa z79sDA9YP5S%l{Ko_U;Ky`^1ykZcw6wVycMJR_BY>47*TE4e2dxSfwCWbefuGR=oH0 zaP^Z?KY~}Kl5$3y@Ji2f=0xO62)NddOKY zg2~Sm-==+;sSatS;*E2)V+1m3_lzIo zW}V<3pk*cKl}JaKWxbw+2^ns_E;%g;TT29f9o?v|XDj>2oGctRSbybXD#fUy<;%z1 zy^^K=)@FiNV9A=NDvd3zoZ>3T_(ZqB&c|#2IMC7UE`2xI267q+6HYfSYSb2M%pmS!Gs~K?Z*wR?O?AB{ zP+=&+>^^{87Ed!~pI9t4Jm-U(0Lv9|ua=sdQZjbj-=rNPl~~Sx#!0s$b3pax-c!3>jDxXw0T{~Creu$0iy+e#s z2(HdQTj&}ogSDU*s zP~${%+o(c`Ojbfz1QjS2w6n;_iZB2HsGGAbUw~G}_bdtO!_Z^l-&|^t zUjkl-ZJfpoYk!X(Pxv|Dua_kXG%7C`5c#_Gnr&P%UbGEQs%-46KE!*XTfBFR&AnTh zJ`fu=d=+oUMU>4@{oge&Ey7J-N*vPtMgn(Q#ea&v=`b$hE3$s>HLp=EyUj>=C1rssd~bWWcGkmy z^RK1vgzqbmQI;;t;Dm|z8AjI9Vm~ih?V$YS>AtyKEA?|u9&4Q<_s@XK!*;UJ$Tl&5 z7c45owC;*{h+y`j(xtmWt+V94%=v{=|D?#@IIqOFkKxTd+ym|~9Ta_tCdf0q-3WIh z!wJ6i7mo+=<5qjBchOtrgk^5*w=+0gW-U9MvIoKQ1)um6;8m_xvzY}6MY20&G zDjfGQ>}vDXdWc1Mx=ct7ag?x2>)6j<`tNFALO)xx(?kafb=pL%R5{O}AlK7a&N#!R zCitX(wv^GN@@5wvLQM>-ZTh-}z>S@5zFRl7UgKUDFqcobp}+Zogzh|f-&VMqq&Hoy zKR4xn`+FCbq5%hzsC+%Ao4M4TwxP5Rr+~^rj3^v@KEpq*YF8UKR%XGdImigo2W&r| z1$ozdR5$~)Un${=jzRSK2lL}B+#(t8U7a;2daX6byJOne%5B1zI6g6{ry}TI-xZgR z1dx!yudd-yWT&}hfJSNBvN?LmwV{I4V+%Pi)hV7&ythNkC2#ZrzD5AIR+*V+Wf8tT zr`H6jwM~$l<><5O*Y&#EhOCfw&uClzkctGlg4wJ>)MQ%lT#hY?sdlG-|3!s7+ zct~_K&-^8j^vrIfeI?@w_3D|>VCwbr79hIK%yYa#sOePkE>9gt%){a5O$>x|Km7K& z3-T)WU0CQ`E+QEk#lPR;+4{lNlx=o1&p47@{b*VAVINh^J7+%ehWz}%S?1XLdAU6C zQ~DnhD>4gr`#ScHlRqmujxpr8LVrqR;kE%kaR} zABh9!v`7Ti;t9%oKnM7DVUGd;cN_m1_4sOU;G{t_gLe~lamM$c$k}vlJ$j^dz=UW& zy;d7YDf89HuoY`MfIs5>#LuWpUy09Rv_o}5 znt$kSOsgC94F)Xy?*9WfLX6WoZ`7)X33!s09MhKD9I6y{3$)|2cEhN&e6`Klw5?zC zL?e?K{@pnnyPndYOovy@{_6z=yNtpf`Tl1*F?(WS2`=}Z)1$tyW0(D}Z;X$2eT7F= zQ9zJR(DU+r1WW!y+lyB|%}Ndl&r5D@W;u&RkA!z%X3IxdOQlaN41qTALdH!>sp$Astv_q^^TY3CJ4wr@ zLy$&p+(0)(Q~~ZdU4J@sO!iB=u#|&aF*c-XIKS3#{%U_JzwM@X5t!ZTbt~p}Xsq@q zmryx74hSwWh$19i?yMTEuJDnD1@Dl9TL)dZ)7_?R@)-pEVmm&iFS~BAGvPxK=eod5 zTQOv|%MDXA^Z+HI^s6x%PbcD~N$OJOQ@UpT{#RkqNQZXj#qVC~WC}{b6Y*&Cs2T(!-IR<&sA3%Ic9}Kv= zGEOdi$rpbP*j~!V9miDXjJ4GVSb~SzgTB@ZgRf#@FKio?DmXY({wvODjKr)`?j7nQ zD->mZjf1Kx#GatfN@4x;|3dMV_#=kS|^+(Zzpdr=Ttce(bib zKL+t2RI1=`^&)!fO)@YeF^p~|(mN)vSZy)>t%J&eL-%1e6e-z1IHp{{wGH!C4Bx3)R&m(KN4PI#mx)vSG31jTvq}P z!h|!Hn3FN@{q3B6Rb$whX)&R~p5@DKT#KPI$9%2>Qllyb!`d)mG{3g7V(k~hnuZxY z@2Pz$ZF~lJ(t^T=y(~xBQoiV01w4gHbp9rTs+imDQQ~%sjX$cq4}{YWmNo6~I5T?E zzj-5Qc<Ow%!1)rF26ocQ=jK zeu0{ln`$R*Bc28&8f38^!bT(QEkK)=OMbdZmlMH`x~`#BXW1yPwCu=dq?1N~GL2~< z+M&J&?}ED2#-51<`uh++PK?^pVo)YrzN$|r;Wo+_ZVlV-Rl>hNOe?Ch{P9|v?J$Q( z9j)DqMtK6Cn z(`65v-jN!xrs}`!?mN(9N2(#Dp!mei@S8$6*VaOY7hta-Rht)ZuDlN}lv2dCO)-Sh&@gN-uA#(?h+~mk#vQwh16ch@32z;_{ zV3I!Oj69(_kJGwNxkbZ`C205d^uAsywSYfECU6Q-Oq%e`f~j0bY(djCfOH{vx{on> z(n^w#SZxUl`?K;+abm|gcuu6idCI$0nchpISvg~dj#Gf(FVjPK0Ga@QY368#nXig*G72h* zVh+$!4{p24wqls$udSOt3>01E zA>mc`;8jqald?|SSc+LQ5pj8s`ZM(x>InYUPcM%FqryWJ#dR%xQat6R##y;IB8sp? zJBth?*zm3clAo`qSY=rSURn9MP;oXvPo2;w zo2eZ4XL?^j;p1hzxNWDn-CF|U>#$&i6M=P73}PSfpS+S1X)MfJT~u2mGsxzQ51zdwFsVze;%c%gYIP-b0d ziKfGur@9qf#aq!&wjRMxMO1c;JF;%g*)bBXwh8pNkYTSnG@zKFTWT}kZR@2bH3j$b zFWS)Nwcitb>q(FAf}n-qrrxZ!E8xHIFx@V_qyAB?+K;(q@~YF*I$`_=aH&r_5rae% znVa*OX&$rpJmrB>nrh5Xk9#gdBVXP){}2~>Eba;3 z-ePY6%D2@1(F&bzCkM!FxS9H@}3;K%Cc^uahc;3SBf;~5J(e4J>5V74+ zDE0Sf1LdWD>1V^~x>Km*u*DPw9wEVOZZ)gSr6(z`TW=g^PE8949XSL2F;rplnYcM_ zfKHvay<5q(jYo;Tw)H-@e|vsu%^l3t@gN&}$|sZsfbDH9ei!cIN%vZ&|933hoP4_W zxw%n0z1CP-qyz=2rYbQGb~5%P9deQLP49f_n=Ay;ICnS?=kCn?<`YCqUi?$DI_AyI zpZ_SQ%d3PA3m5~oQf?1`F{yq{{rrr4;Pb#=RtFc9%3JQau!%*$lY@*pmHGQVm}2GT zJS!(>#I${=kG%So&Wn8UT#RVm)j0GdRQW4*P!V6MBK&(qGsN?0K4##N zm4EWf2<0S6+lbRVr%}3Ux+CA28DxB<78@I|+;%MnB`FPAJS0xkDQ8(pEy~B%v!a9F zmOvsItUo}Bc4u89bBKLMrp0BEwroyz$4Ghe*c8GjiW)sd_N zn+jZ^cUf%V6gef^z0Eit__0Elj`RBZqs15P5^%L>XkT$HP4-@-h?0drTSN#|ZC|jA zOiGUgZGDHTHgAsHlI0zzv5(e!#zkWy9IXtkX&H^im)J&8m9L2=Hk2<_`&S=s17m^s zJ7YbrOJ+Gf$o8ImAK=7H3$gM#nHD)L<#CwlA~2dcGgG=z2Qm|CiR8#fA$dZC^)Ft& zb}1lW{a|YpPns?!)uytcB+Q>~sRdI{SxyVrKdFk^+DGfK~ekpum=opfLmlSz(D#777`dO0ba_04Kt zW*e~&-N^5LTobf3X-P1yKeKV|D}=lo$s!P7jhe2x%*)BpMdE)<)V90R_GT^_62v2v z_kf$jMaviHP8}DTyk$qDes28^B?kn!z3@!~#=8y}nNg6=mv}=gL$@)NI4cwWkxAW` zp7u(q?UDk|@+J!7^>_6ab*n%~jl)D&>z3B}a%pXJhus8D%MA+(3Dt<2UC0`)1=0cZ zRdTrUiqn(0fgW}|vm)TX5+IshH5dqdY_r`B8$@QM!$lZz`(2ZHj?ak;_ zBPA~%?2FY&m%Y@PF-+r(J>w5M{?`r*`*XTiQ+{p!fAMtg;Y|Pk|F2Z)t*CcJa+p%7 zWDA*`CQ0g}$Xii{oMK~hSdGnT!^XyD`0exg zUDx-I{k`iN*X#LwJs$V_?MBqj*J9fu1X;V7d2O}*5jlp0PhEw`W9gMHYyHETOS)lJ zDto<}UG1UD5*8SWcQzN<_V|TOpSB74fMJ>QwZ6MY+3bF=0KLnVr(sx5k*j46*^vyBpsGI@vrW_aeTWyMSzJQ2G0-qAkqzy7lHD8;$p;x9k zaLzk{P^hpZpJGKVNW7Pl+=e{92bo)MLunitD)m%F9*le!FkU%5yfv^M!&P#cYD+b(kR-+xZGZ}=Xz5PBzKfCEG zMU932QV}nCvXBCW@ve8>@s%T8(5WTO)VR;RP}B*pP^Mod2FLqHmVw?sKhsXGV>cLe zy$iL0u5$OHt3%xvB}8p2MK#GaS3Zq)@aN&{z9d?Kl|jsX9{c@)ctdgC#p#-E=F)Vv z@@LEU(RjD;$tCX?_IauRtHj%nb4ASjs*N$(63L$KtdVNixBKa%kdRoFy}9)F%+d`u zi95p&4f=Txyp(m)|EQ{DF6^IFWQ=uFR$KCiuZlCdjqtzVN-I~q^3ETJY_L~`FSmmp7;}E|`H& zDmoNq{fm-goe&G^;PQLTsh74PYKmSm3^!ZVsS$(3r_sLPJofjvzg=?uwEQ1*d6;vr zzasdF=Wt2bN#?7@iB?6 z6w+B?>CM^OAj-M3NIw#>REF2o2JjgZzdY-R4J6a`@Uk>J%SGhF<+^27@&;sKd2DuE zL}*Lnhq=eLKl_LRX}C9v?V6!s8C7fTUNq0H+~1D85ug*^`~|`FsX;Twd--^vY{{Zw zj|D@eJut0G*R8HyA4@4rC(UvGLo)m@SXc6@+OrnxIZt08nEv(lS&k*`ZIs;U->8+OKYnD70b&KZrl?=hMgQ}{Tf;uB2C z&3{t09dCKNXOTGyDV32#ae&r?DwVIaF3&$JBhy99$HWFPE2E3jf3A3}v&2#AJz2>5 zMr&XH#Z{mGLXXPxy1cxbg9xrvx$6QbwOjQj{n{*CJ>BFzemOG69rCqdX#L9pXkc8_ zvRY+$Q;itrA0oXBU@EpA!sms3M!n9rf=|6LaZ2A+5S_(G8qt$Q&OlK^T=?MiePD@S zq5C8Hu?+8IpawgNFuTjGaOSx3otA?z58j`^pdBiBuRx=4$}QBADc8@f#{FqU6%K}M zd!7wMuM59GnB0^kl|awWOVZSa^76TQzZVNdy!P0eSGOO5%b&L!M@AY z5lFwT@3pwxT<9p}y&B{`bAnh$&kTos>OqS>>E8o)D*eGOr)G>!+5?Jp0TcDMx$}}= zzd+l^h2wJC@DO0cj>bxVFZF934Ew|(k3ct8YQ!{smPHNxZD2wEQ;&M7S^7#)CGrPdmY=X3ed4 z`XdiUILmb__qwALGr(vg=j2;vr9pd=DnQ{Wg|)5Mv0u~0Ex=D|K2?kk&$e69YDO~a~&44iL4}>Q3>_cFLr&p3nk>Zc1G152Xwqb z^nCY<#7tkQsojjj`Lz}DewaS55k^xE+Q^ocD366b&&|yI)QX|#@66*>Ju7&?U#8jI ztRD*SarHl@7CKM3mU@)iKWPuI#*W#~2gQHBK4#_Lw6Rp_0=3>^xjwy+_jy?ow$&eZi5<9@}s&oiBT-kj!$ zV4r)ADR#ln7q0b9tA$yjd_tqk)65_v#(mhX@{csxbQE`FTK z^Ho-&`4UO*p_+KzahcEsDSaAWF@&wpi3C=|?qbVA4B4B;Ymern}YEi9@5e5+0?-d7ebL}_dn#dO; zv;lX~BOh)sZrG>mhnzlo}E#4hSmsk46{)fu%2%J$J6T(l>EzNBos zsbTnep6b&qvdKUY2ZL35%OKV>RR0?zvTSI`zy(q)i{>EjX$a@j{b&SYH&wdFUhwv7 zl%bB0{aE%EQFD)d0dXiNDiRF1p?Q55<3vHY_hdDv9GuX2PzQDbI;&VozSZQw(OH)= zh7Nu`S0}S({PKdHCx=M;ItE>Hp8lkp-Inp*vXwjapM1nvY+Pzjc^C5Azr9hs6Ruxh z-~Lt0wvjVAFN|}o1eB$f)QktnvyyReHM--ixDq9|ji_?48hLj7!TK{dZL1>5AUEt} z=}3ncuhGi6WL^ANynX($vChWc486hntlJZ6o})E#8UTQ3T?319oEe73rBkL5v!14d z%{{6GW+54meUiHs#k@bGUpmx(s;PO3Gx^OAix0#cRh}pV#D; zbwb{U9BBdn!Y^{*YYWgiAgOwqHcB zEwRp>D`pp~O71!V=F<{1XVj^LY|1X~*C8bFz9-w?w8_1R(q%|{ zj%^J1M-5ZACp&t{HpI^f+AMR+L5vIZ=)x;rm}K`P;g?U`(!h$C?e!VZ_{Q^kO&Mz| z?Kk!vea`(F9kUm9VznfFWuDENv-!7Q57l?YU&$_gs|q$3Bhb;Q=ok zx-R&DD=;%?K3Do|xvybXiv;w!3y5jXm`vOaF+Kh@y%GnySfd0KKCVy-tZZ;)&{)L! z%Mf`fFPYY7s-~_Ra~}D%wYThJ= zGSAJxL7OE^>AycF7NbG}o4xrJSu*TgM{+d9IS=pql$EDS?-7EtY1i(Br7u6>z48UO zFiq4lJ;!`R7aEUEdDhDK1o8>Q#t{Z_+q8#;Q+2JZNTLx&Y?3_UE98d1kovVOzMJ=K zQCzKFX06}1K3cPyYp4}D+$m7ywli&;hL>Il3KpApc>nNNt-ZCd>dcpuXcq}qhppDo z2;agX3}D4xV!(Y|t7{nU%D|cL8+qJ7c;TI7uoiFw@N8Rq7Hh(WN7*(}VzQ-@b`6Ub zj8~MXa?(Lhx{WItNwUFAgJ5%h&!}^nNKkBNz5S3{71&5s5u1;t_o$hP!+muIZ+B{2 zPv2Uk#|)+^$5?kra~e<;S75l^hD*D8U)Y;H*sI>0a8;DL;^MSk691Vb&$Z46u*`L1 zF0CNW)`+sRDu|aaUB#!xn6+VH$j>HD&F;&|TMBjxa#SRt+ty^IAj4kJxX)y8>vmE zPfZ(`QxLTp?V3w)-4V%&A(b>q0Qtjs)4y|i*j=xKRc^0uiI-Cmmydkzikf_cVoE*) z!-(;3mdBW|jB|`a{T%V2Sgj&AOGz%99agM-kcu1Wz(zqLNbr2@l7wISER{wi9m+|n z3Vf#J2gzmkr##+GyhC11aGje~8t~%HV$C0Oq!ogwewb0%}`*!}FjaUAf}cC$)bYX0flJ%CfxnZy(;^~mWq z*e+xxM>{Qb8mn7H9DDQ1>BidP@Ikysk8Na@&H3%Ai%L)hq(N!W8ud@w#y3USpZ`K| ztS@Pdu!GLE>u9(uzEXI<;o)k1>&@`BL({`6%%6-3oA=-m@Kq`Jfx)We!{pzC8!gnk zk9QdXj==!zis3&4Bh20lsC5kmuUMb4A3Z-IJcX@!7#$IGnBD>sxqewhDio-K&O)dSG4sT5&N))#u`h z$W%@mo5FaD+;JJ}^iO#yN>i5*#ZBl~`D#>EgJvCY?Y*B6JFhV-9k<`be8oCf=yTZr zYB28PQQ*8BM(cO2Aw#VB(sz9mLBv%OvhpT#@y)&d>8M5C!*ynx+c-t)l|l}A%`3+v@OY zdzmBuRo#%p2bjKcXXFsLn>%yC{7?70g3V`^T^sy<*>-*Fc!wgr_bWhNyiV3UtiiaZ z>Z%4VVq$m(k9ke)h*hm)%lkfLZJa3WvNMt=>}QHt4bLY>TkXd@=dlv8qfr4U>|IEY zmf3uH+*1^&2^qs$jdy(0QlzxRQ$XLcjhFW0(CysyjOOZy$OXaG}}! zUV}%DJs2k20@VQg4&8Q9FapoUC-I0m9up1PY> z69Ly;D86zdXlaS|NJVmhoL9{-1=}l6@e-9Men!=T?ITfzyhxn~?SDp1 ze$6lNb<%Q_VGWlg_8KnxQxr4p5kOZ*D8whF)djH^9Ya8c%;&kLa$}XjfSyV2Bk(1$ z5Vi{lybl7q|E{Wku-7W&e#4&gq9eM`*D#J16@8XIP)jC1SVP^mG67~)bLo2HbeWSu zD;)8B_e&Nr*CQ+gP}kYVyruMk>$T@PVz z(D>ZXl6^h*kX=e{E%Gm%EI#a@0^jYj|4ye}8j9$ihmnD^dJ3V#5e$E`()E2p zPs`=eYCynpuFhaw5hn*t>@K>s05=Unw;LSj-1jSyFrfpZgb1iAyc{J&>fYQm1(2mE zi)EP-GPq~qjcsQ#;@wgvtjRAcCX-z0+*lqu4C__0AV=aZpT3OP3=l>v)~^Hvp=>I1 z(Ef9~ofgyP4-t5r;6< zb|xU$FDEskLgn=$u2q&`BR4EtkAtG+j;QoSF-b+{Hd^^s`)0p_cK*`zCm4Wb8GzdwS-i1Ly}BMwmQdLzigvU@OWgpagfiP#o{OG$xFck9)LL&| z>u`Zt?#(Fb^p|914NK4F1nMM_z=^E1q+R7LPJ#=u%mUCwr!?m%%vjb0!}c%~s)!#d z(PJK*S}yJLC%;bH8|NU{Tc=Nsao0DGrd%KKDLJMaY_i8`na{J0J%MF@m8TYTw561a zi=SS1YD7XT4olbW-8^zAb4&yFGu58|S;(NFx7ZE8ZlFuxYfUSBdOEMN2kHnEs4m*Y>TkRp{65yIS0}!TvYhYlHzuChSehds4H2hpb~Cg1 zZu#kJf391nr0ia?LA(g=iKyv|{FFOMj;gB~iXNv0vxtfjD#kx9^&Ib=*X~Vs2p68be#}$=`u^y7R&0{cb&RqnkJX9Q0e_CcMtn|9`h-O3VDwZMDc7y`SRl*WwY@5( z=OGynSacP?Ub<07&?-6hpxpcW)TWVwvl<9XNUbWt<@=?TG|>-QWBsxQ-w=R%oAfaq zyQl2%VaxWuv7EA3u%1TI4Qr$GPvo%-)n87R);e}pBo0pgJ(0^-yb{QY>+kVL4*+gD znfp=vJ>B<(@m^0lb-i8AMf6-Wnb!J`3cu>6@_9L7O$|Qq+G~7C2gI6JcZhg%n zR)x`WySOjRW9g`a0`Iq-q}n@oG5XAy@j$GCrQu6^!;jG2RqFI^e%33cQ&9$6#Bb{o zSjGcy?hCLErq-X)>#TAi?|#G6yVkkLnfWl9v3FpsW9wzLx>ULB6@M~c@3)%qs)$G{ zJ*cCO#0$27G@R}icJ>KfUde{Kvwp@#4;7i`cFz`pv4dhM4EE>bbH4v-`jL%yuUY^49*v*g%`I3;sv~A0WdVY%Vf<%)v2Jnm z=CAYBXxwlBZic(ps+%4gmJsNGvRGRpy2ia6h zxBi2kOc-rLUIaF{%kQ8`zdK#D8kUzItKOc?ER}A8G|(xN3h+PO7YW4K7+>7(`tVk{ zfpj*dp7jRgXg-|{Z)ATjYyoURTV}}*|BdLl;5G>KI>5yKxk_X#H|0QelM*jr^yZ6O zi^;HEoII5<=Hu6r)98y%a#ry>6~+b07l>a{U6&O@cGI}Iv`5-W=huLRsX~{L99IBG zA;n4m3D?GYSV$;qKN|I-E4;(ndRRqN1s#$4K?mt|#3vJFfiE|F81)q6jhD;JX8=5k zbf}PKtH!wHQD-_jf8Kv>mh3FVu)l-4FQZ7;p5tYdhW&FZ77H}#*ttE>*^Tyf4baQZ zsOYRtSM=D_&S05cUD<{nHqEVU-D&Og)P$OPNmDGmsgQrWNzpyjIdaSBSluhk9TfNp zy$RKoJGJ_#+3jB{(`hj=rGM<+*zGBgqoBwz&cN6y<*3TgldgdmyK@5pzkcXn>VX@r zeNM`A;U5t0G2QU_wIyF{S}$_0=M`G9IId{-uw`_V1R0dZ8MbP@1w@&i1cZrMbalcZ zB9Q${&sSSrR|k_|8Q=+jXLx_sZIFHTN%wr$EOQ_jl*rCdz|zzz+QT?94M2B&i0wGqjGagO={5LDD#?6%f zY>P#Y{nVVs_5NES{Of=C2Fj@BA0hL@+dAdSS78gazUzMa$NxD z)DI!ebsu;tV>e?=Rs5CFxT)tG)AH874bu zJUJG!X8;V_*e%a6{stJNlz?M@*(L;!VhL+I>7U*Nm~Nl{6!kSO(O!GH@GW7E()Xqe zCH~(1jrrH0;>1Q;P?~q(>G&6^5`FSkjX~ky@+&(F`^d?|YkC$LBR-tWCi4=1Agfo_ zF+lFQ(+k7#JWoBLC9Qa~=15KXcFHvVh{|JWC>b7MoG0~AFnDt9YkCd1m0|of zTRtX~-n7SS7Q0xY3?6d#+(`F}LO=5`RL`m^kcpIUSPKGW6Epjm(Ajmme@FM8@4MGmAsM>5If(O+lvh{%er}iW{Ng2)+8DhCv#I{Q!G`|2*tR@U zSi1J_zV=UaOQY?iRJ^HB^L3%y+-K1o`nf$}(iY$ZSw(U!Vhn|U7&Bo{(LGp+=lD#^ zrLet_)%Hn+c28M=Lc70wS!37pDckb3uY(7~UUIdXW!Gn$7=I%k^|q)YlJBRG3oYeK z;c6i0its1o!@dG)-~T1iDM3NrKN|j=jyJ`(Z68%BT&LW}61%jSThnrSveALb;fheT z{ff}!1cfq(zw(t;hR%79>uDtJK6t>bI(gTYM(IS3oCI|cfq-bqqN&my@nN%spYM^q zw&BITF9B!3tUsZgH^$p7QHr0EJmFVskg1Xbrq-Mj5JL=%EK9L(fPf2D^c(&gl*=1` z2iyld>3L{j@m-JCqa6Ga1>qugGkIUy4Z*C|^EQq^a#Cuv8r9r96rjyCqH{8PfrVEh-*cwN-0)g5a zm!MLzao|^arTS32>QpDxk+YFcKxFGm+@t#y!j^1jN2CFKld;WmhxV}MdstU2u56UJ zlbd4k8oqv#8_mT1+BdfHhxt^MvQxjx40bmDE^S-(#?3(BF9o9#HQ{DS@4e-Auos+U zG@LB64?a^+0h{vVjOjcu5ubP77 zuza{VRxq6uXPv?{ZI59Q5lk2Cye*_oX2QzxS)J>AoJT*mPTj(Jcxbq0^`DOb$l4#6 zbz_}^d>&odog@Zrm28Q4xYaV*rLm%1-@&4hi6ccb{a!Xt5Q`JE&9AH{8G z%^O7l?~e_iJ6csQv-jp7uK1AC^@;`Yo2OnQi|key3=!O$KLRD&#_ykQro{vX0}3X*V>*-dlUKx!(e@TNcAP57z|rJV`vWyPsK|V}d!RnC!eeR+G&BG&*%Jq;(siw**xF;QLM2x|$@v-MZRa{JNxR0AYKJa1 zba#S)ZK~)P5|uZ%=(j5_yGEI@4U7j=j&a*E@Sk)(ArzVl{s=>#$5M5r?d3UW5=M(Q z2qX_tuz-rUX*SSqzc@&zv6*44ifsO(6qfRoh6E?#eKzr>4}k6)7(MOZrctYsL{!j% zgn1A?o6PwiPvQSxhU~CC`wGB$dNGz0Uj<21>u2gU#+ct&NoS@^2fzK^<69ClVCSo{ z#>3WB9Gd^+wM!J(p$vRkMvDHK6{zrI{?1nr+K?>=4;4z>jff}Oy1sE8h*s4WyrBu4 zBgy>S%1E@Wj2lq3nbMLB!OnaIeAxG;>P;5^%syW=8r}Ru&CqK(Q_|VouTLxqG?;P2 z`7L%Tj!`qT13cCPfc6IOlX0+@I4ZJr-s}QU2emUXVXVW=e~~d@nu9_b-t_Nz+FaXO zBkGVtD{W1pQyQXYCP57hDjc#p&C658Jy#VH@6@bR5vwEj+%}KCgA@gq!u9fB^+XC! zJY_KNPsc#oR2AfLytk-(ZGAQCki3WxM}N>9#V!6MS|De4-hf4B#k9=MhVR5IE;g1qei5+;5 zx-U4fXYAGRx<*+y_aC_9Sc9Am*M;>s18V}&ReK*tQ?f>W5j8+lH9;6EV{_va_05RO zZn4?UVW+vBlDO|08(m}aPxrpc7u}>TPGSA=LSR6}Yz=9qBv7t`p2yV%?4siBq+BMb zi4Yh0CThLn@uWi~dcU1tTh%+K?Zh9yjEn3jH@!F?U_d4xJ{p)uZoa%kI4yOqw!Tpb zh={VKvd5Zs3Mi%xG>Z+kBI>dlW3jDbv&h*f`g6=3Kq{jva=m{()kWhogos(`dMEoW zxcl??mPouk{D@mMd^7uSR#0889^7;Fuw@5OU5b)?O#ji0u1ndS?kI2tond*_m^{LJ zqt@fLFX!r)$#Q)0W`^c1!bBJvAyw6wMUh~#!Wru*GoAxFrtnneM+lsf# zCZOcn68(Yn*7M36NAg3@OEJ9ObXB(~kw#&fdSnx^0EE(k1m6m#9D8~uibU=z|E zu0N+DhWkgChg2IHUd2Zz^45Ghk1qrh=AWNW-gSi4v`bz781K?FyW@1a{gw51|0qr> z#eggP)W2?@orvq z()I;gst3urveOBqoeB63qS718-?E1f{qn9cY``y$sW3kJYs-PaPk`zX?Eb3JNtK=^ zGoy0xb;H6me7yn4EXFN4U@NDn>j{$=_7%5cxq;pxN}7t_nBQ1ai_m)yZL&3d%Nw-c zLk=YLe!tk^XNFM<`cM+B> zLM>?S%CHR3Ed@mAoDI_Mv3Wi;{XNq$`Df5?N?E*$-kS2?em_+|B*{5ieo==nHToDU zV++r9o-|W@S8w)v;seMHxyW|R4ibR2870(&6v-XOe~R3*u6TJSC?C-U<11p!frmWH zDV@hzl3$rg8o?yY&YyvrFAgm*>>S~mP7XQvub0+~<#*xD%^c3{Ok2?=a~^@bs#)RU z(H_22;Gv$QFG2KnUi#X3$*}VZAGI0N`r1+S(arNGM}^F+AVR7D^3(ji6tO?-vVYjl z>EpQ5x%l~+{rw#mDh|S@-%mJ)E~R2SFRfR4A|*;vPRgA%>|kY0%u;DpGT~$JHA_V% z`+>nymBs-KnlDcL`6{Vqox+r#=A78^0Cb|gvgEl1B*poL&Zu+zaX#0Y9 zU%gWf%XY`$&9wYd(}5|;R|lfQQa7I9Iy_5d_-T4E`ZAZ)eu!X&@^idKAM4grVboW4 z*{;nm(ZTC!f5g!FUL-`vi$vcZkB_M{z-!%F?K%LjHP2v8UD;mQu-|%$K-O!VwlO>} zGFHO}uK5iVLeS#o;(dO`TGepxpHG&5txj8sY?=X9O$}qdMq`U(cNg7#W4kTDLyL1! zjx6G+sJlir<%^{)a-DBFXTCl}*pTJLIYj|huSeBT<%1(4lBA+umFr{~lC>E0j#AqCzSE@zUhHfy7ik&0j-orr3FDQYhKT>&Tb<=#s*Dv(1K?Ez5}I$5;?iEZZW; zNM?Vz#Bl>ME=rw4-Yto$)QUAATGy3Cv=jyPIPt2FnR;V^0Ff1(UmSvxg?Ac1qzw-Z zYy`)z4ii8dvezT=;IgI*Ec81r2k$k*4C`IIwTlN|+)UXV?JOEY_kwbGL0*ijMUj(k z@sn*}7%tvms&i+1(^}80lN9S_|J3Dn?bso zlVKoWMvwfGN8M;u5PGj>G~s=>(*6##wEpH6ipcFbelR$V=pY~Rt=|uc(O*6gsFkWl zhUP4M%IR4_K3NIxXEoQQ8A_khhlhM z!c1ixE5hwwwOtL1Q&BgJ%!W7hh`I!KJrLB-kcAgrT(>7$akf$0_H?f2nCF=ys&n45 zzm41SmL|TWEljUMK8F3L*(Y1q$3h~OdpA~+0xlKZN}XQH_W}dkEO5nI8i-(&D&<~t zEv0%ZEz^T|@_1y)O@E#DzS^%$eX1Il7>BWhXdX2wG?ABixS^sHfLuNjF}%9$<9|3-j6Vf0tO zDYE{zg(Iv4Ro!;yaqkyy(}=N74bTdmVE#L-<1BTTDsQS*)G$h)I;W}iALXM)%1@Rw z|MD|GL!|zZ5+#w(jwpGaRdoZMhAHs^pTA9;Jaa+of}oW(;`Mji(FXIhy&36W8}lZf zq&&X1#?^sIj0xSMcjizP%lZJ$Lw@Lk{N;puS%^qe(n2eUKtFRz1+Gb%t!!1svJ3YS z42!)EZ-nZv6Tg9Bh?~K(>jrJL(fcv$UNdpcrZq@6#jh+Soz-y9Oli(ZsvM}tg`JLO zjH`ffCz{cV6g#!*y&qKI!?J!49TzA}=BAvYI6WD6msUKP@{?;9wD#Je28_jrZ1o%Z zqP>G4I{C@x#B;x&0)|?_6235^0wUF5?MwMs8|l#?`!^;E-IqsV+L-)$4_`bIbD4DL zvFLnX}T z^OMuin#UBHI=LeoKZ%5tk0xnv&tc3SrfoZv1*-AMPDW9i*VE%=MRhW7`l9iz9*^+lZI z)TCyU)RDkae6yMKYgueUlh)8t|FkOT7_DeXAedrnV0D$KpU+uYxHt038da?rI;@zo zS1vv8kwcv1f^1~nYX`?>_lX!+wVqlMI_ffbNPj*QRD?_bdqFhxlBX_!JJLN{e=tqB z@o?XfhQx{eDk6$k#V0pqyc=?>hRfyTRI|D-4d!b-8xrey{%&!)c&9uAbcG~JS%4~l zO>5G&2|O(|V1XBd13wH-ViFXw{!(W_0@y69eT&8&e2)Lx!o)NA9=!fWJTi2mABK?o ztntUvhf43dU=lncfZ0C%l?{-YWQ*p@$v8rI@W!*Zc|bP)^gue`K#$xFHGiZ)`~b3l zSgxPiDfRhG-X9!RyPpL7qu*qDO7%`y*co}|)AVc&A1mv&qFqNg*NTH0Efi^w@|Jth z(^_Zcld}cLQjjRO6@Uq2&b$CZG^*wcoqwwx!Vv1{&PX zc7K&9V-w@;Mo%sGyO~W6*Q$cZI%0a&3X(Lm>T(ezpMTDRP3 zE~tJ&JJ|sfz)E@hz)ip{ePvoM_dU zX{V!Hd3gkR7KV^qD>BURP6~SD_FR_ZFOzq2t|?C!DY?J&s+7+mb6^>|6TUlJgP#K} zJWrIQ#rQ5N|Kg29)9LbCNQG@9S>Becoz5^g&Zh@g$b94sgpMH5h4%e=00~t4Mxp3q zaC4(;b|84AuM8b~rwl}lojYQ3FB#Ee9Ah~&nZK*SXHF?^qV02Vj{L4~Bu~SHRHzav zVnPM|C3X`jy8*`1bLEeiFW?qr?s=W35dR?Z~;R0|7boGG)z$UGsvj9392 zHFY$2WOa{CGcRUoiDA=3W+#Q#eFiezTjSm&ajd$MX#}c1S&sMaFj%M&2Zshn_kZ!a z4WSj6ss#3k11wq- zoCtA^#MN+nnb)?fx8$n`NaTy4ncQ0w<7vN|WEocjw`%xbHm&2?34ZIv9A5+jRI-2c zpvK;3@YBXm>fIWK&kLt@dm=~+^US0E@w87$j1Kf=y^*@WE=E;D{L)y!C@ZfJbvw!2 z7IiZ7>Y}*cswPDxP)n#pIb`tbN-zg`auTM$LU=nh9F?~@zcXK9#x-p()W?>R;#32| zt$fc>8AZGpj?ht{PGq0Q3tu?JnlA4lXE$23y4559Jfj`T2sY@ymYpY~RLus$g81j3 z2lV9@7o0DOyJ;wJQoX5*UPxn{M|`IP+GgDJbrdM0QiTS|TQ`(dl2ebaTrZdz6q0dL zn?y@(wp>=Un%~-duHV~bte~zy>kc^@6Ee7m^~MTZ(sUt|eFuUUg)_JRF||gncamkD1V{=YZQyXeXH|g$m;s!Z2|RamoUN)U zS8C2-bM`?w$>h54%+G+z3R3mEgF2p;726}7=iP*_!$&WC za}xZojK_OIx}Q~ty(VOWjdc8Vms_S-8|%w3{BCW;+(brNhL?tU^*4A9-G1Z!?|51I zhG2Hn31FD=W5~f}&K7mWJ$}|u@EGtg`!F&SJT zKg|p=Lisp)PE_S-t^U&b5lGCLp47uit-_>~SDxS%V@K6v_MeDLBeykXFA-h~+ZBIT z`Hv*01Mg7U{n3fdlBUlb1wnhwq;CEl2z04>+AiA9eSW3gUMURj1Ze%M#6JktUiD_M zOrC1tx);u*FSK{m5gqj`PK?=wGOk=o4XCK#rl->7Z{ELtDEg`mb1G=7r7GB{wWokk z=I4Vs!0hF-aQUjK=m?6A+U*OV+wdl`M2|P1@F6ckrSR}=|kQitW^=G-@|u*3J6^-)M&8!k+XklJy?O6o=u8m zoc6Lb??zSf#yf9zOS&!@QEC^Z2|ehj1S|3pqxK_>X(!E=b2++b@b(H}#5|q?BB!M{ z2@5BiAN`=yclSl0-$WH1aj>`KeZfkzzJQ-v!z=ygxtll#t^EpL{~S~d6y%gl_WAEJ zIUoIXc?`p;0^8uMk+DKs2w_Qm`-@4nzUfB&4WF^v_8C)p=CJ=Kkxe`B7~!UG^90+W zrMa{PlbQqCz}w7LK!(&5SMNYxtHlXy4b`EFCT{UP_Bf^G+ZSoiEqPK3!HaXsHRSMh zXsFK%=-Z@XYvyZHz}MNBV_~Ao zE1K))ltub7(DP->x2{U>G%t@fG#EY*@S4_6jGu0)QPdHeE2v7&PBu>QJ|7QHTZO4E zf$Z{axvl+PLAx~K4c(Gw^uZrkUY|gq`w;B($Vwu4WrqTNw3^V(cO+eH0OE5 z4~J({}tD?_ID)N=i;Un|se8qDM@!X9wkM9$AwdbnuG=TBTpo|Td0 zv+G2wp4!m@_E|s$Ep{_`^vY=Rx^$4dzPPF)n6Q|t+0L+iC-^6t?Rl0=%2~j8!{4R( zqhHMJql^DNkiZOA4IsbMk_ojUxLfmzv)1rKXwN3-`~ zTS`>KY%uF^x3cFraI?r$Su+5msGbnV<-3njpWo0)_I8q;?dA3`=yTeqH#T5Z zc~*9nQ9d~;4b*yzj@2*xNZ7rCr1@j7M&%=O_oe6U$)9<_r!!DBmeS0Q7{*xH-QlLc zrmOmLU{AHJ5#^76LN#P;{3YkQK!kJ8US{K=<Q{EbE91CNQu4KXDxRoXMq)dnQiel5_e za*tdgExx70Ud_p9irt+vpN}Dj`KYuHfCzSre*z)RVttL-4Sf$XwJ&Pr*)9((QDei6 z6jZ?a(>_Ox$KmB7VMx1J7T5hQ%1&Y}Rkh2vMlh>EMrSr8cLt<)T|tg*FaX4IiM$BCP{4(`ONcivrshkg zPY{RCs6_&s%EvjNg?>*BhZV}^(5;pxt?7#4W95<7E5D2WKRG3GF>%zdc^L64a4~Yv zN{^@PzZf%u%C8l$S-FixZ>k`01~JdQKk_Mhtv{mHd=v6ypPHWXwj3QfUDMKBGnLV< zR{r?Mq;`F@pXO!e<^RXjc|Rn*#(lrCvQDLWEXf>XR(g(uV;waYWac=>3O$wPf;0;g zM@}4ol{t#snU#agN)2&u6dGb~Gy??(rQpCVf`W(-_kI8J{14ynb$zbSd%UhvceSrD zFKCFViEVfE_YybS^vm;$N2t&6K68)gzwYLh#VbP((lxR@L>F2Djw)lK=YQpCSemTj z9>6)fzHiSJQjW-oJl8>if=6hB*B-6@Rm0IYtuS@Tue0PVe7j1kr2m17Bu|>UubZHH z1s-bPTa&l6Uz(bH`@p*KbxxZ}?}YK)Cw<1v%SL^|Y)&YK%7Pmu){z3#74Ha@`6q=N zw*oC6rud2+OuB+itVS*bPn*0zKiQLjKAqc|-F>S#AG3DnUIn?r_*O6%BIv3fKK6SAm2G3Qq zcp028BU-*~I5wm*zdF;Hr zYA6kON^u0<#JfethIMjpV+=Aq+VmE6e?Sel^wc2p>H&~bgQH!Q4bi@Fo387r@z@v( zAhC7%Z-Ag68s3__P(^jzOFK@rVcuJ)4qWVnRzq*TGUdc?2_tJE&&(@EYI^UPmJ@K* zgeA|JGS>ss7ZEnmN8@kSF;k&{o?0RDjk2z5Y|EBpA`k|+kq=4jEMoFiPc}-Z%7gQno#TuX=@oZp8Q<(z>Jw6+>eNRY?i9Twig1X=xB$$cKN1Uiegvy44tz%B z7$A9zjPaZWr?_ZbK4mxk{mRL4p1xvzIon$Rpzoh8@)#k`*@gkAk<&F{_o|{_-JU%8 zDjbK|?B1++%xYnJNyTi-U~=#qk_b-ey)lVIVUoB+;-@4t8Yy~-I!22H71hDvYGXz* zGG%yPNyJ`s3Xe70;AGJOTEhNP{XS2)riqW6K6v8|W1fREQq@*v`cUal`lHU*@X z$Hrr*ZdxBwNKw>#?2y!vq>m4WM<{DKK*8cg+CkOoO{?FM9s8KO`RJ$d<(}U`Dl6to zhk;YwxeAp->K3y}t=+P6LG9W)o>+eLsE5PHS)X z$w!vu)X|eB!gZ98%?|4A+%h)Wh-V}CtKu{b0%7@|)Z9V~zxkkRY;yu{(+vC-?f_H) z`04gW(hW5BS?^IDwf3nL>JL=+qU~5NH3;S*$vI(>^7%aMl7fq2+30sxW9ZZm>jTV+ z@f91Bg8%;nVx|AoQS0uK&ow36$U5Yt+izttgZP?(gceS z@8{v2;Z8>oG41<0-YQ(gV4pf)_P^mZGhN|+qAIDDovK{fvxrOu1@_5DN$_1&pKt$PYRc1&KPa!1-hn&fp{wrCDLz`R`cd5LR$U$* zc@w|%-VULKDK_hO47{d`nn~vd4DKGb2lrZstiEs8jV6}?-Rf7I5f5Dq@uC-uz9fd1Lts);8nR<%ft{=Q>M|MTXLY;;@_jeM)ry`F6&^zv302(mu^ngi;TQL zJQL z&22E)4nU##?15Hn>#_+t&-t_DW|B3p$|aDIF;4N@7601xG}W+?f^lK04Ew+ zFR1mfkEu-I(ID$k!M1L7$jH(s1UBwlT#RIG-T-)Gvf<`;3LmNWQ#BSKXw?=11DBGU zI%2ED5L?=AKhqbXrEK!yigjaIJHVz_?9Vai%*mM05SJw^Zl1bOvq0(4ysWc5&oY(# zyp&o{Z&k|rTLl_&{(w0Nqd47CIdrTjC5~T83o--XguBvcjAvHDO@04^3>QOsRxA3h zsRuXvvQcpAt(I7%7*|&c4_ukRRT)9%@cNti_*w10$O}T*RX5vyO6tFRBXlq`*g(dc z^HQzaIbZe5EYyD15>e4S9fpZFYkrWloXH(DzqH{VLcmS)wd*aH?~^+8C>AZ+`n&X?GZK7SI__fIO1#Q?lwZdc zWtXyFUx-YhA{AVw4|Sq-)<4VR{%2|3;$zx8c5B>3b=CR)KGhM4#xd-%2*2SOZ^fJd zHH*XQ;Vdym%V!Wuv+GQ{LOvkp7N)VwJKmG1FcDcnMI3(Sf1jl|uKE*bDkr2k3Vf zCQFk<8&M+NDMOQX&P;8+Ra}NByzL?=mij4GWO$X+`K$Af&19>UU#^r}`OS@YZzG*r zL`m%>$1}4I%uFMn1RAsw?|d?aH5(%urkgF7d-hcOvuZjJ=Dyxszy_zLlm<1^+VVXC ztCg-dU1%qw&ZY?Jtgfw1L~pYQ!$vyA(g$teS+gC2i<}c|r!p!wWB$KJ^Ij@EKeW$v zcQ5^7jNhG{?Z-OIO6iO5S{}raYjhOeF;vW92wCUknU4dVtNtd}hT*cGFiRu!$ zro&D`A8BG+*SiGY9(m13q+ikec=WgVQH&`*O1vq3To)U0n54AKB!3%c?BfML<76gC zyx6hT3_nGskK;-^uV)v2SL)k4^aUm~w6G zP$3*fbxIYLB&Hy1K=w^Yk*%+ju$KNt*7zU?Hc^arL6lJS3Kq-4d)95UqIwW%maS-> z_RsF7?o{$726pMG4N z$K^Y0-_XPt#|W88{)P74G60Pm4!a!-- z8&8wsiU9aFyfaa6GFs+MiC}_{(0mpwiJup0rmbeSmdDo$Ual9MieK)}3T`Rcm<&F^ z&0x>r0t{Yd*TfAYEda4OT4uyn7dG}!(4=svV|)ZQFHa0NxjQM$;%Q$E8J=WKw@s@5 zHO{}t-u{np?xco9_$BnOyT#Fx?50U^IQ_%Af|;Fm6BAk3}me-MEZrRYebkLj`6iEt>fMgf^Tr->RG1`{KM(r7VrF1e4l?R!ZoT#nL{jhgPez zl}}!vyroa@_+nYOB9kmEn)*h_&$Qh1S9I;;P4`(?(|Si;Hb zQj+I<(zr=ydZ|IdhH>3>|sNPG+wwoLxRgmlW)u4Mj0d#PAuQKE5K;T^aZ zHzp4bqZX8bNueQ);_6;SZE)lIq#tm2{le)AxFuBuSZ^Zc=_sslNH$4^z<`>BZ$aP= zcSXorwRft%2H4Br!`002*G`M%E7e|h8*)`afw)6A<}Mhz8K}{B+<+Rb>g=T@w5japRY<-tJ&XsPYHV)W73u|d@&uI?rLwG=%Zw_N)2p5 z`;Dr*$0?PuIU+9QSeG*?jEJH=RQZL>GMe71Dp;exf+J<~sL-+QMeJGk(B!2GA4O_& zXdPQC7HMk1)O|72UP&&P@bF~5kDAkqTd^iwone%N&*m7ij7EhMgquY=qs^yDnBBgy zktoAIr}s#yydAM>-?FYY@>3>>2E$DYHj|-;2#RVWfuO27VL6e?OAwEg_qKcACTzDk zq9%Tl*$O%oX} z)`D%}x<_8hShh`k)h5^Zt)5pSuR@)Bdt{`YOr2_onf4l=0POgPt7*gR=1vN}-2@aW+@wZ%abQ=3|+D;;yL zyi4_!MX5g}S~P8fJOT(`>jvEet}LG*ai4sgonoqs{ClCO=t$}<4eE`>Hxx2cj=wVb z&}f1t-oY%%oB8fBCT7iZfKZ8#;o|12cP*VkeG|G%yi7d06g8LH@$&1nET1!kv|`vI z6q7nzQ>X$h51q=2!#lQ>*%BMp8$c7<=n!P5VDyO2qX~WRI~po9ijd=pHrgv}8>!ht z+%usEOQy_usk7Qy4(I~2EuRhr=Db>wK)${6=wLQI$DZ~8-F5E{^$!)_EwP->W{z2? z#{sN!2YZk7^excOh4ZIKH`VShJT{fZf`bgh2eK1ncMsIm*Wy(+#mEE}J8PKGPH5nB z!$pUeR`E_(9ap}xVvBmYyiawg0SQmvMdk=+v@0)<0ApNFE;;c@NxlRVplN|cVv0`e zg2lrAs0%OhR8A)$Ktk2X^(^1cx}}D+$i2hL=4$gb&L}-}sMGj7OId8`l_#uOwCR1) z>2`t~)wc(Oj;wC_>jf%uHp8}k#i_mq|Lg_0psDY47~M(Z<3liouGsN7{O#uD3&^O9 zfagG?OoU?af?5&pu)8Tzd&=it{)sU$Q;)3M#A`u*hSBz)R1BESI!dX3?RMaLP*lJg zdTbiBjilYga=M5cbt^C6;DDbibgM_8zw8-}f~k0oK*1^P)ZRmi?xZ*P%Vx3T&44Dh zc##>+%6GuDx%Xa-ux9$;%Y;wf9QVAg_ZK{+9Q*^073ka5|M)mu2fazsB0?zpWNk}k(xhyQwpAk>YG;{w+N)lF2Fz@g_|-IYqLiva{AY)I zKDXZ+r#b*5-0s=j!I#HB^4ju=JpY_uuK+q5*e~8FIi!xSm{8H1CzB1VmCFM{4JaVn>?=!C8HIZMS6WBazFb7(do|9G2 zI$2Mku`c>5X`WT&D2+HkEZnjE%6Rmxv@Ju;sn~LN#p@UbumBt5Y~+!aGLnb5oIMn2!p|9jQ2^B4f&X9_c*NC<#OYwmhPbVoF~ z`CZHlp<7W!Fxd!GP^8S0I;MK%CxzI-425OdiC4hKY^tF$A?rK^9vbhnQ zl~!>7PUhh1wef!0pW=t#@K63Rg03Qt^S%hbPWfX07&RJ|b>(j(b;d9S-hn)Jl-5?o z#HDV^&8F%SyIa{*?BcIHX)JvcZM0{d`;PJ5$Q?#D+&Ve5hRc7H<(eYQ9vU z{8YN~iUD$~(KWGk7PfuH?mC$j8JnBtS3YwT_>SvT?$T+Fw^&7s&iwk-iu zb9((+Sz~=S;plMJIk;J)a&5WK5X}zV0dvr-v;Xy;eeB2kuy>m~tft+-c}i0j6~eL~ zI=JO$sI<;BBWV`{WT+cC?4AvDGY?o`brx;Dvpjh_1jVSik`!cl7z)4e>Nd1I*~?(r ztFLqAm$VD$hDLUt>E|{e4s#wp>!w)F@~i58tllHPKE@x&A8!;KQKoPU6Xs|yTT^xpjA!k_ApZnXsd^}>()e2YS69*aucGG}ZF=_i9Uo@W}aV3yNdW;tV7F!WKAq z#5D8VBI)J?|tmaytQuZ2oP$6{xL{m5$q!6jGrld+_5vt5g z3XgYFHcan^Ciiko?W^Aa@m7))H~c{it;xiz!)5LP50&I&KOZXVX=@g!2xhHD#D z4K|8=>Hi^nT$kijkuS@hrB-3Wuv`s+6$DGfT1>}qT+R}vZ${<{Pq%DhbeSJ78c*^q zgA`O9bBDrzMsE|f!T9-0KJhH4p!;`TD{GJQU>3jrS?p@JSuLTlQxJd1=t!||k()x) zLG~=6^P1PsRIR3p+ntX85H zskLf}Ov}cW{E%M2&kWT9ai>2nmRk+@%o{hpY3BEAhF+ecGY+<2Iic#XF7)R9>@$vA zNbrpWpK36UdwN4{kFX54WibK;-x3(QOzSo6X&V1FQE6`>!*R+;dJc{48Z;5Mbx2$*GOPR03{#0Pm{UI!*r z?AQN`o*a-f$Yr4!l*9IaRVd6qd37aZcQw;5xSL83C4$MgEcmLiLl*14<__dd9fZp&N;V69vXOSG{Px->8i*p;uV2(c1zqzq_(IX zr}Iiz3QRa=$iU8h=NIC8)V{YSuXFf%XzrZOa1>8wa9V~%qhjI?zgkU;)EHvCrz$HB z*Vtbl8V_{%rv7RizF83x!)aY#xWf{<33mb`Ozh_yicyeC(3{2meci&dvD8IG%3yF$ z1%GFpV1VJQm&jA3{}GpOj3L|mv`;DvG?ZUOp?8sZzxr-U=_bE<#P#dQeo?&0&Zoz& znRm5#+98z-Cj&Td+aIEDBRfo<%lkDHSa0hbS?ex}BFfA@R}cNLY3cXF>0*F;OvRQsrsn*u@&)?}3#RXR`7M}JVHa}=4nGApk1w+R|NIaK&Am|vq5=@h=Rs#Ax(x9e(B{MQGmhctstopUj_ zw6_$j$Qn*woaWl_MUr2s0KS_7fN+i|Adfsm7;bW1>}eRz1Nb@edyAs{wF+a_PqyN z!f0$f?5hJoyMRJ?S^KGt;2o4Eog~$-7Ro z*y{Z!$2RmDo~NV?oIi!y?EEkk`_t@Z%j{QSp-4|2?WyTGP7hQMOr1FiA=*2b#(ZJL zu3m#Q&oxLKd-n+Go201kO`*NUa8k#*a40y$Yb2$YsNky;V^d{|6V&lV2IQ!^oQe3G z42JM4-Ho}X#>R?FQX9_3J^tRX-p*Gr4>J$WuMc7LpP=EBni=gb53>I zp}FtC^h44Ei;L@zKV6LpsKhK)i%x#kb-F12v{6`uZ)L#Z zxG-3Lm}DT#bZ5(aO|HR@Xu=*d4>bcf^C>0@|5n>o*jaL|DRWG{D?hOAqFPe3i$`Gn z#-t-y6k0EbK}UD9$7%&VkXJrwD%2g4_g`~vW*om$enWXu!&X%}O4uHcH8 zLkL4UkpZH61z?^+D#Gw@7|a2%aaw!Pzi13=Ow$}ecRk7HDam|20|}xvZIjN|ax0}p z>!bYfO?Db^!{?N|?15GneP?3J@Ox8pZW!1}P>RX4o@fezoht5SWO+I)?h0P`#2Nr; z`sD+B-^#3$pt$Yqn(?^*QL_L;Eg8~op(7)?>9!CmZC~f|LO&A{>HO%^T_Fe zc;C4gVJlg`d~6z29XG6;?KdkcGK$+B&5ihxd`8^g@vMRoR(-?WYQ6J&?!sGnudvmRJnXQZX{x2FaO+t)H}+D*dcAH{p$8ENre2vX2+ z3W#)iGL%p*mtq*Z_H=M~=hOs4F+n3hM&E`jgg><)`3$X&01k_a4@fc*+R{*m<@Vxgqg8*fy3t)=9(AD>2l4p7(S2(_|uloaGu7xp(rIsqret;^>+L$O=lpLSYL3oZm zIE4N2z;bPL>D=?Bbj8TY>1|>6lNJ;I{207owj_J~9g1;`lGpJ8?pYF*tF34yUo!e2 z4{>DSoKs+Th2`qtvHG~Vs*b+@R)=WRd|8eC+W0buFsjm7m=9R$jhJ=?J>5E9GZ!*%iP0_``~6j-4*o9GEhkE>Q+LzQYa-^YG#2IL zihQ}|6@JDQGq-Ot%M7)fGQ6ohI3Y|;*6A`K$y(dQPpW7K78?&+Azr7u=R(MTFMe|VK^ysG7H$|5;4f2T(_EG z1eYT|Y*26Jald0#@C7Z@Gj=};x?R92)}HNCCtd}7R3u?4sKKk@zgUL}#y=K4=bZH& zeVrm6MJ))#D>i4tSC3LWCwIcGKU>u^xgEw@YeSTcJ9wEitPVUi?z%dyy^Hp*`5P{z zmA4apX@2Kef#Yg;jrUa~IF@rfOF1dxxxL_zrO=BaePMxx@8x32_u^tAdl(%(1L^`K z(38X)g)3ceaZw{r<=o|4Ry$!)bMh@S@ru}||EtV>`SAEB>5y)1M#7pGOj7(zy1SOm11tg-kL|jL>yGF6^z6TkFj*fCh#@}(<(Bc_?Q?5^T+My3TgQD()Hio7ZcM? zSX74PWDdODz*#8FC(b{%NEECmPBcb6-JiYr2s?MUym$Ui@ygqqvi>h7Q=}sjH~EEWO2QeJoUrD)6e)n zFuiH|TL)?vk@UNW4Vufg3b&Ib(@lV7B^Vrd$faGLhYliui4nvuUaR{z+?6)vt8M# z#@{1TGgCUABm}JQtIxWI=PY;O*il^FzC};EnMXsx6nE!*a%-G{9w;=t^PyBZ(^|3= zldG&2N6Zchb1uQR27G)%ZfPrfk@1?CPbW~oPi;NC+=C}mpzy%5hxKL#YEh)UtkyJ@ zoDIy2rM-OLui^GeRWUq;KN5ur z(wv3uiqVBTn`pT;R!<1gN8-++-947x9T$>|3IrwVHf283P@IWS){ihIL^+e)YwNro z&D|CSU;3cpZyh(CdrrE)oG6P4D!Q8d)(LOLPo&LQdM{WqCHH!uEz~-G+yQFHA2aI` zTq)`@do!U&0AsJ8R&y?a7wFaOZXFa+m)urm+xp>QSXQ|e<5h1WxmBU6ZYj$oceS#i z-nBL@S7$`@wO})aZx2V#gH@Q*D;>DPbE?_j7=fi5CzyU=N!bQTeQCNtvFJ!vOtM#g z7x7$l||K=#`n@kCJ!72DN8bySXka-r<}%1dhRs0X_d@GP z(?K)`fkAzmZ%2}C6d)w`93|kgL|0ZLWpcyCA7NnV6$lAE?u1+`7Smo}WI<8IjY9GF^dRvF--(C*>o!#CTA%7O# z?+rO?Xip3=GDY2+9;UDBcQj1fz!d_t$lsHA`-rh&KHjbhbRu{cnCVNB06MM1qI?S* zZK7{z6B~uA!3!;pVjq_IG{~X^E%Hf|g5|h*5aY6|+(g$y-C2uZ9CtVMGi>)pa@_FC zS%7>TBP9-v?aIE|R0iD&_+c*!_B=@c5bfL2;_pz=T;#JOl)kTmWw&YQS7_PQ?Ou)S z!H>qK63qVm(C%~yr)o@juD;8%`any%Y%r#|GvcdudH}cba?|++ZBLxa0)xY<$7c*8K28p%CIAk?AthT;> z`^>gQEp{YpfhG)s-)*W8;HSg)Hf(3j9<=5H(^`EFiQM}?hhc}8W>M1ettj7oz}Wuu zm%&@2-o$h7&QYz(W3^Z{R&Y^KH@qHKciw~?C2?_FonMx@f`!fJP#{M|&ikp*YY5~g z6}PrTi}Ppis&xpz8fyr9IA>GK!fi(s866^Meqmqd}U52fzr*jRX`BX13)1C<5Jg{0G>uNPe51;$D!t(7#^48(B zXC?vLka%8bl`uE0VdV$~{I3aVWxRdo_92S~b1_|^qm>!WZ(1X5Xq*4C7%PtYn!AXK z9v$5desip>n<@@~T^_IMu(-RuV~!;a$Jgvz9FE<(-e4@MJF*qi~` z$50`#D!0ajyOW9RoxPsppWYjgK0w39h@HkC%Ir}&aZ49y`@0lI`6;U456)N!PK#e_Ryw6a%ISAm>$U*kWijgo=ijlL-E1Bs)a%alpQG1!Sx$_G7!$EFXMl4-q4=@?VO4wRiJB8R zOY^WTQxCxG*h}v~z}Kme3}PK>(gxMCX3`*eLz5~~qH=LT1r`98plQSH{m?KExtUjP zO~kpZlyF{6_=b*=A);iHkXtIQ%z2d(WvpyLW%K**l0>&?_|mw_k4DrH=-qs z6`Q+WM@|mAIyjkAKK)ayYya1h8#B6!mve4p^C>Ea{MS3VHR9NQF|B>`0Xin``MECq zhEG)pL_o!@pF|z~q7Ao-uBFl25$n(MW;*0w4SM7<=sl<<-&Q>U&hW=NZ`Gz2HX?5{ zyP_SuRNJZ?-!i=6VFO{s>v|YvnEg3KxE4rHvJWC}&3NrTnxz@N>6G6~FW=kRpT&{b zp^X($8WW&SIYydU+2wKio1vJro>-`LE2=7m=Y_Er*Da0Fhuq`1yV~cO8ERIhBkY1E zhX8D~5kihrPy|+XFo>cW2Sa$hj4zP5@R)*?2iuYvH|*qqqx~U4gC>ER%)3YX4Q_Rg z>gclIc%ee#Bs$)`hm)niX*h0jHO7&i1G!z-uvCJPA=K3MfRo~8QDDX3h*4{JLAsP} z8}gLif*#<#3H=xNF)(&Ban5uMZSW$;i{JZ;=T&B4Nnh64urPrR$K2XPg-MU_iSjEO z2e)rD!AD#DG_AOtFmBjCjHaF8;(+yNclhk%DFH1e7J;2ylG^w0<5b30BVHLnE{v;w zh8mx5kilM>mEe6caxa8GXSohe%q;Ay;yv^^Mm<8|-=V#V8Goq=&L6@A4{bU`!+eKy z6Istj^y-fDor7z#0GRZ!t&kUDO&TgSpXj^BzmfK9%DO_mhX8EDW!8)!4sl6{>hUw( zan(HNUdC#`644oXyJd869C}eacVC3{7#B6Hfh&*0H!-3||0Qnaa@?$$L zqh%#V>kW?6jlgnATUn$gE1qrH*2x@#XID`{SKwyL+yy+)Z26A{UP;hd?YGy`YW~R4 z8|9R* z&GPSW6)xfhV~Fp_96F#iI^2;Uh_w1xxxp#3Z9KBOWNM>b`yT$jvuE386c! zUmB$QVXL1eK4n6Qig8H7LY{T0etcLytcH5R4%MSXc>t12*`af888)%|t)LTp8jvEa zr>L#LH8v#tk#mE?>OH1O^si8$^=kM8*Cy3!nqIUdhO@0=ef@vg7luOLBv+F1Jyt3Va~51|~wC*0|l=N@5K}M7c-bP>_ zD$WrbZqDUUz)J%@5ryiXTlifw>g<}Ln&xAA=c;Efhp&fkhbN*GZ|c+-o&k!E7S(i) zDOZr)OjWjppI-;BC$Im;@gj`oO;5ycEU1zsPXuI z*LHWV%M`Z0ym(p-^B%Re!-9{FvJ=9VqA$&^?(wDS$DNI3t=HMD-$fNS$0icKs+Su3 zdj<9H<7Qlq>`ifQY{^at{S9h@I^<(g-uHg>IVoaTq+A^=r2;6Q*OLZ7uwRuV`EmT4 z1D|JpU%rz7wB3q(7E?NW;CtcH^3sFH3ZJ744M4gbr(J@)&f1x87y>J&8V>x{@%`)4 z+phKw3g}bYgqr7ba?i5ddmI5|BH5|?&DLxgLA@Eax68w@RlQ{A>EKh7v7Z&$ zjuV2jw~kc6o*($)(W+}j&MJbPB;Z=q%QDO#V5&G}i9EtoOgxVg^#9wMQtUw!<*9igZ#ZzKNxI^{%;>yeK-hCC~lc43tV|-mBdvZh^;aH?u|Uu9_neK zt76fC6%-neq~OX3$kOA4xWLb&VeIaYh|*&*+$J$_dooTUpqxNyF5koFMN4dY2R6UnD9q}ogiRQcnoHJF4Wmi_4j?Jz2vU4%%{H#=gSP@F@x-$nK z*@z;6m{y{Lkj`?;@u}a-vF6>5I^*TD+Wghjg5@mrOsm>xs{RkxzKV_>S3&nj9jPww0fd=4_+i4Zb?wv*aa1osN$!GixHoPm+gi zALJCc$I6G8rk`e?8yOpbl&?tbhF*<{u7H4{VZkTXpH)TqpGARI?#*}qy`FP(Y{hPP zQ;upgZV|Ko*N1QQh>M=P1t(ybi>r4D*t#`^G5&=Qu=P8br6hASITp)-0zqmhBE@K? z8#8wVy1)?ZfI>%?#6K(yPui^ho|WQ!nM_@?99D~PbH(S)9IFA)NR6$!ny^br;Mjic z`db05{BYOc46KF1PE^ODBlIj-8K94 z8jxDW_!|Dks)?4r5%5~g+Ay4u3k;1Ee6rjX8WL-=aWNpHk;kbqV=IB#BK`HyGa#1^ zR9FaZOcz+a`Wf_XzCKkTFY?>Ih-GaGM*z(QftJW0(i*qznW=V;`}o?CCkY^(s(d#FmocqT z9~sdo-?}b<_$`-n^WQD)9RWliV^-2oR-XuQLWL(d8F;{arH2p456>2%KJ?wRx}zvk z%2Et7)4x%X*Qrzs?1q1IMORj&^4?`BzEK-UlKA4fvc^;QmEqzqJQLfbrA1B6PLWxcn z!wW-o!MraHZRM@k_^MXc1F8U{Z3fKh69aOUc-cmA zqEa1Z|E%MQ?Tt^{w91-?c`3ANS|X$bEhL1^-MD7ucjXM+2v<`Fx4^9H&-0zw9ozvk z-&A>lftU16GqFLwcM#rjFJti}P#4&318tP(j7^xX;>X#i8zVk<$qpSsc5iU{BC8BP zque!T+8n$=^fD^&3mIB&^N^fM^0EE3C}Xm$5=b4XeOu2w@dv5}B$E;vEF9yt#XuW^ z{$zL?SL=!yv+fo)V^#V2t?b6_ z_42nPtYmXjlKrUsVs5J=E*ls#P8FsR$wbCo#Qp;=X2 zgTL|v5jxpjT-8E!4s+6hpKu{}T>}y7+*hBhD)X9-QTIrl!pLgeTd>jhbY$vBloGq- z!%X`}c1-a6yg!763n1)&D0rX!bwqt8sm?1-w(VZU>BJ^C%n?Y9A>M)|%a-1+0@ax_ zv8>x+EtS}gOjCQvug;)Ju&jGDaRaOfZL%$lZiZHKz0$WXZSRw|xtjZ13wHeSKz)0; zd0BK&tbZ3#wl1pdgN7_S&6Uui<~Xxc%HKcFp?8_RU2F^esn(@BoHghb3SP9t_kC&a zvt8+~s!61U{`rl!3vmsjSK)-;xW68?w9*i}q%}3J$4QvcI(!YgfksJf1r?qoR66;G z+ND%HwCMGq06T*zN9mAxwh>RMAH@8o)*Y7B+=Z5cpIm!|_EoOj&aHs1(#9dzs@_RZ znQOy_WKDgCDvWk1hWW+^00I`ATS^fgYAd>CDDDW39XPj-+65R(34U%9+l`35_c+E6 zgsFHo`d;`FV-@waYbFUfBnB4Z?+ad=*2_O|#kBjn4w>h##l_Em30@#?Ol*Fg0aV=o zYr$IRQFcYXp!*v@Wt$%-rBS4=MKHre&P; z_w^-NJ@91Uj*g+5b_vrx5B4#pkoW#+>hU%l z6s{RS@1cN@ADtCB57rXP%@5<}ms@q;gP`Cxf6#^U^-Qg6NUQGvtKN#dRryfYoQ>5b z+(~48=*K1W2_x&W(1)Ra;8zI%yh9KdA?r@HmVROND~4w0VCm;9>q-Xrx8|wI?B1%p zPQe>Q|8Xumnb#2gv#62zgq9msP<7-4fA?tKd(n`JNj-N9!OHQ`&TMFHYGGi3=9f>%T@o6RWd z@#i0~Q{;GTa6i<=Q&%TOfZqnA(EVBsIve>mjF^953!x4<0bze8F`P6Z-hnC`bEw(< zIotm5&gUHd;U5m?zCZ8fx~^A7ym1aSR?J;lKinp-!#)j~7@l@atU^l6uf)gr ze^xMOcdGBzZT}$=!sq{?xZYxcK(wp5)14^+OC7%PU?QYG?sFu&;a;gvVyA(-B%@N| z7^u22c$sqF4Vx#r>C1XlrnsNA28SsRfm{sq)nBN|~ zDPUY;QfEg7{5cn45j-?Tpo{K=I?UY%}?{1GRbb zBIsLoQRa?44h!~u1ob^v06s^3Ge|q9$cs$w{0JQ-DayzuIpDpf0{mIfqO5I%QbMHk z;%3e7{>qU80Z|!D=@_2lyFtqrIUQ}Qn>KMUdUjD)7)n}uWTF^;Ye8wd?OiTouovc* zKAP+{57@AzY7jd-kY`Bm<&I@XI?o=2R!xVh9#XNsl=>#wi58C4-hG($UVr?64|`{d61xKog8cF;bl-x&*W=2C>eLBkSRiW%AxrSVs{Y`_z2G0j z!!6z?5SAUkw|{U7PR5i1r9;frh`bn9x-fXAE-ycdci7V*zp&@4Fr}v@t;eL&H+czX zM`vaS=JiaTY(Qkl1jLs;Hyf5Bc@`}Pyc*9RPBX5J*z_69a?Fi^@15-ZTJj<^V8fo6 z86-r8Ns(@2ICVkXveN@Q>$Z>K_@*|NlU|x*(N@|XOsw`rOpEcWop%_C=*qKK#?h~& zt6~>7<7Yx|=uPq^IcNlMj@y=pQ#8PzLmPT)6s`rRTmt$&>R`E&oi(4c8NA{)#iS2I zQ2=?+Q-Ejn!Ja)(O_@OAp>ZUvtQ(rho#j^3$Inv9QgOMl3Of!;Ys@eluUMw*PNhkyNtg4+u^=|LR9;lxVv^|sg?E^ zXJBO=&`s=^tmm?!=UVURN3(|LpO5asF+6ce@dH;P<@>aFLkXXl(;9XthpW6+>M4a5 zpyFwsW$9mG4b?dwR^ZJ+r=AS&_(ZdtdR4yvJR+(C6ViE+l4x$H5}u9{C+SRsAC(!u z!FJ}J!RA^an(yiU&C{^*R?Hh-|IBWQ)1aeHi~2WuAJ53PYlu?FEJQi z2}ZUSp$Usz>&40~T*XlH$toGBcVf*LYS0e1&3xwJ%&FYU zAWx9?xrH~Z%9lTE$%$E7Lt@_;7+IMi1Al6N?5#=nfU%GDDszw8hj90+c|v;mY=W0Q09iSwW~XB1x4(gNYgX7(I`CvQD1!u@@O8C zEdjQCA@aLnj3l@ZXc|h^-LcFB?+&0N-hFs(zs=jWyVK-Vr{mvOA|pnn3dqF#{iyXo zry#*8oG);7!&VZxG}#k*$%-0QF>O-HJ3}Q;rdXIa&i9=h%prDv1exVZ0mh$9l%9h_ z2OPLozsFa39&I>O+U_tR(AVvESn9tiC~ky&JSmb;qK;&%TT!b)s*}iwaf=DfAe9s8 z=3)o}@#OodO^)Qn57f_z9Je1s229>mHUXko%y!jm>BP&NxOV^5bc2|!RA=xH{)BiV zLShYKLv-JUE@&Y?tH$FPQbq5rvuwEAYG-Quk(D{nT+Rma$wt*rPELaHboOCXLRGx( zY2485!};?3Y;Lb2STO&q$nsys_V$j0X5@VmPA+1jGWvN;LkZ0d7D<}{RGthIubGe_XQ_JUVLBd6w?j;CnJlp^DcsSu8$8(ISalOX%)2&I5PyXA z6}{Vali}r}2A}bO>bNLrmQf~;X!+eew0OL#1RtB>T~YHQeEGpV+1}0miaF@_{SBbc z)@V+zBhgEEdYP*_1fKMY2zNkD2E7v{Z3YAwt^`0n$628urzi&q)D*!6eDE=+Po$S~ zo^yM{Psrnw7T2rpPRu5YY5!LNjim5Ru+FhNAJ|&Jn)LKFkbd)al9eV`Gov>L1RX(t9MFI4;tp>(2~6;mCsaJL`H-jfsL0!Fkz?Va zQ~&qTJLe2}PDl#`4D=8i6^5oqN^nLM&#jYm9S`yNUGWi09N)gG9F%F2EMMJ`4r}mR z>f3s?tt0_G0CwO!8jiWKLQ5-6C)aKcNV>z7{^=FVe4rstgrzD%7L*5lF^UVJ#)CI| z01a$@!_2p)9qml}T1G)n@pwVrD7=z6V5;x;yQQ!m`6;7?BUdZ?nsMJo6~A^g@2Cn& z4xTZ+94;@l?MTL)gC1u76r}2PgkS7QRCwVwv1`Il%zg5@UEDaSC`-(>zTnF+CMd>d z`d7ZS%{))mNalW>t!BUuv`Mz)Y#blyOi@P9HG~CX$nvJYQkzJAtDe*7JX|4)96o56SRlN)xETAEanVYRfD+QBs0OwhIAb{ zzC8iS+7r{@>){=Y3%9VmV!zh&Muge*zOBjiF|udU)_UFK=pkF&!l3G2MvWNgMuRpn zHEUx{As~G0x7K#ydL^oX0aNGL;u9fqx49tMywi#@%^AX~?&)TStN-hI^*0-1$U4$< z*@~)}nlcl;x>K5OnsjqE{iV>tMSi4 z+GVy@uoHq)WD;Hg5#K&HB}wtMcS?^1wKg#wY-cNLG6JqRt)10mI-$x*5bEogrW zwZ(SeTqnAH7?(8HD4%a>PtR;DNt$tiHi-$*D;EdSAuTJvDI>m08dDUH`O+ul8^49y zUP&_*I=29adG8T~yW>uL%v&lZKe?w-_&|8CC$H!DfV3)#OKhcI?Ptxo9%p$KOK-KC z;Uk^m_xpN8$?KM^R90$U)spct%C}CdAi!?sJeDVR&3*SI#9wY`A^0Q%T%{F_`YUHOhtwPiY`0wxey|7ZDw{GeW6AtU^uWF7*u+M3U^JO4dpmi* z`+y;`*FZ(zO4#Tou}uQe>T~QUS(uzdBue79?9|P(xe4pj9~SM;DfO;gF^G(5;$H%+ zMv^L+B@McUdqEvqcPi5JyRORXTIpIV7P`}&rPQM%HWcfI+~=WxE5|?|3C6BdPXjx0 z4~G$YC9^d>$u$p~0niY)KS1)f9V6A1IB#We4ICwv&6^c+stW=JE#;fWM9TAMF(C;n7YGY?#q}Eiz??J_jpU!UNq>b72 z*;y}193@4>;N@u6%vL0J_AhVVIp3XXMIM8H*ten;n4{dy=7E1?3nh=NsTs>BuFvdd z^QFFL&zG+2!+2B;)|oCC?oHu1;QaOK```sU9s8ijS^gQW&r&bnt#wR03H?=&UIR<`$t}35f2Nr^7buKqEfI1G_`6K{$C1~A zB6PI4NUzX*!8E6TjRJkuWsJ8vwv1%8E5P2YWNd`}{YLW(<7>k~&o+K%HI_0PyfU4z z$O2&{<S6 zQBhe?%$w$$;YV;)-nKLNG8CLOVs|MrV$4MoRw;5zW%Wy*0>AHDdYlM39>MLEep#Bn zaOMEwXLO3?mEr#^04lpZO?X<^iRroAqGpJo+pBB(`VHRi5WxYg>d~+hyeHL9+|6`% zKtz3Y9hIL1T@Uww2nG!`t?wP1+9x6$pw0;zm-@J->mi!ZYDvlRmA0ZCPl@MZbdm-M z2@dgNT9eabb2vbJtSv~+7fmXb)Q50I^`PNtOzI5^{MaQ#b4GSoebrFAsd)AS(C9zj zD;ETrs`R=cOc8F=Oy}FkGI;rn?jpZa-96LvhJGZwk(%XG#XeG+A0zp#uE}|rbvhIS zPnUh>@ z!FUVJyN+}y4E)KA^E`LC!lgicw_EW$<{b$8T~a6+L!qFO%LLUg)0|%WZ7Ca9ht#SN z6ALvy02I}_#G!HSM*srft?y6Lbuv~BM&h;siA+|N1n{(=7UP1{*H zR+}!)+ujO^x{Kp)O`#ga#-}}T-8A`;!5c|8mP{Rh0#W1>^%cCJ@-N9ipP*9DTBUxR zaAdVgVwgC+j>=ABzzby&h>|70A07u{+Stqx^tvVu;_G5w9i?zp9A8-s1*b`F= z$nwiIH?K`2sH>c62;^PQbMxLtWbjRL4r|fwx(wNi3EeaVpXQd#5opT_wZDU&7TR|h zlew9cD8W?=dM&n;8dl1VzPdO_d2VW9r9CiltX6dxv3}H;k?gjm#2G)oX$wxDma4jD zJoofuESi#c78K6m^iM%76m-=OfZvFnCit1JZX^!+y+3{7plWnSXEkL7%W;Xjdh<%Ru6<&Uxk}m$x3@oz?enrpeZDYC znYF6AnRB}_6Wi2kZe5CP)EgjGWj0P&c^$z~5n!81obL<5jvyOLax{(tT9AjXb7p<` zaCL?+;3*8CI?LF8W2s%|=m&sMezYU1T4^=O-w-hvX(d|Pt&dd4vb&bgcr+&H%->PB z_?y->RL0av*8rTB^H{7J)^c$}OoIk9gGVh|erEf$0n2CeH5sS4#Kf6tlw0V-l7FZ|9!F6y|&|VKyU$8|X ziao#jYLXQLFUR!odU9Ovo)c-wNmmf|)p~!l1occ006piF615D;G0ybX+9^s=A0Dfl z7(2(puAA2+aJDqBqunB^bGN`UPz9c~iNWTbzGr1!B?be2k>|VRenO1x`I>@-^%y#_ z(&_5Y%#(BXpSRcL0jmyEQ52_uRL*w98G+_a^!>rZ#LVt823i$vLI=Lr$1$I)7Z5Ua zh}*iBg!&_qtaiM5^OYBb3JUm*PCwtd?c7^V_*bfaNAhD$jB3_GRGMui%VXI7^ld{u z+Xhs$RwcJa=?+Y^*HF%%8l09qBtnliDg1Ym1um!MKdg!Sb-cAa z-w3p70DwMW{ryJ@QRuUU-Ycp8=Sjx~z7@1K>@$^)en^zb3(2)>6`BDc`K{Fxx22s5 zw|LR-{Jn;a;U2?DA4QGTf_#szu&e)tLbk*kL7b_ynz07#muwNw-fOTbT0asS^^y|K zgEEO3Vwx#oQF~pM?)8_S;$Nf(iXamQt=6q!uBc%v0^$nM$FwS?Tc7J&m7*C!|t3gV9=Q*-wLrh$+`}BdAopqg-uLN(h z(1Jk|@aIbaCoJ$U+AZLhz#jSbN1NrxSH~)+hSS$vxac%%K%gB9FrQFge5}4#+Wudj z(qrK|=sYIZ^p>VTRCIEWp zYXX13ffX?^GByecaaR2uzq}zdXQj0hSD82Wek^SQZlH+S&U&3oy^aCm=dbwg)Ypey zuc{LcM`IN?%z~U3G8m-l9I#>?F{z34E@t9YkNyTgldPSK=IC!mVmr*8%{MRFJaAq7 zv>wn1QJ$ElJ!u;ve_y^?VjM%@HxTEF(PP}QlJwuuM5c{wD{ zPA)ba(xlJi`$f3ca#fDotdc-kPNAuMyD>#6{&lu#zyfCni>eMF2UJJRWtf%Tyv8J+pP?qNHo!*DZ-rEUbw+ZK$cUk`3R`1qo;P$(h)#}=XH5S@1fSa8*{~}^; z{5ASR3pX2lWR^>6S{&>&o~BIXr+J_>p<>k^&K4dCv@6aOqE=Z6^ws_ zI^Wo;HXMH7`pewAI>mH*7wy1AtLAx#J{qYYuF57=zL|4d7|}gEtk|3HojwFno2t$( znGCgAYt3gIDR)_jxa5+$5sj(pZ+uU-?Pr(`qGvdpHSKK~)DocTSLUkc0)Lqv7EQQ= zhJ8Pe?0gz`#c#?5o)uENHfcsc@?URF%>MV8%A~6OI=#GRX zv)g&m4%R7(1C~yU!%g*r#SmJL(PeWaBX(j%aYo;SO#NoLH=H87r*zS+zdsZpeH#}| zzqvbs{I@3{C`cMBST(LRCn9wtr3@fNc~4|q2y5cZ6|6Gs>c1ZA-u8a-Sj>9m-RKq5 zLM3#2;LqBkXc9dm%bsOh7Mx(_B5TGRwpD1P&(7+4z>G6&I)Z@!P-I*eLak{w8|A#f2F@RK0#sk=?DBG^v72RL}0LWc#IaKE2o8lm9sL$CZS7%B)O- zaBb+8<;PcF{wG zO^TQNKu?om$fR$Lfi08z@n6z~K=G&U10S5sk$VHQs0a$C2#8O5w`3&Hd{KWqcdN(K zh(CYsPsgF~(6ek(lg=@pNh*^edBlj=034H$t}=Fbmlt z?mImC83|+H8jTgKvaqrUEdw%#o3-QHmy$+S}gq z{YqWuHHWeFP1AyqsF1@$!vRLSk-E1Eo5m(t`2y`?7j1fn@*%ENBqbv?>#=>*hC_7M z2~cW29Auh*buKoN&UkI~I~?RpICiei(s|wD73)wcwk1l}OM*iO8oWI9p>Q8W<6{8V zZmTA3`Qx1p!}0=+a$7by94YoDR-+%HrJ(>SXcw~o$m$h2d$xR5IQzuWbgA_SF;dT) zVE$$~!RxMd=?6F@P_OwyB!d)(o45h} z^h?QH?%w{;Kwj+pld&?a6gHjqWTcg|wG$;JoiGZP1h~dvl||OTS*NddipcY9nTlH! zSMi~(4vLC&1ujRJnmmpT$T8p2wjJ}0&z-S0*E{(EKoBc`;;(iejIpn2U%x@@?JK4d zJz`!jwXRd@{!r6woc(N_6Ti8=9O`)!y0Ax_TC-A94E8T0|62c3qteH;DE+PJMo{CK z$F_yqscMf*h$%VeXPBf=_dVgC-s=G6R7$>+(>IUFW6ueBOXnPE3j&9tf@^v%|igS$LU0h>1p9aAvhZ^zT*UJ0rF;^{DAC19C_Iw~P z)B7oNhAXN<-0YR=tRQURu@A%OH_Mz2%wlqm6A(Vc%lMS?ByVocqd{<6m0PH(!%c@R zY6|eA=u?oLph27@W!KfHmfMl~dRyl8h2mQEy!tQF#Q8GXHzG*f)qjxUgQj#|j|nl~ znkp)@r*`5NcLf{(SiLK;T>ejiJWXtRg8M)Oh@RHoTY7z7dAa$`~P zl6Dv)y}B*t;iCJYOXFdlNgob>s)lDq${*Rxc>c^gkD#Tue2KAKc3rMAbIQqorO)wc zxjKRRdCX&AM^}ROUMyZ#9x?1za(VcVo=089uX{iMLac6FD=>8yx{w zm?%Bj!zDeRz&6jcYl`{&m+BYZcZ|^>vmtjv6UVl81X_nTyp;B1^2gKo05cui7=>Jz z^^|2cv2I{a_p@FcwoqR?v_JVv!t%D79JFYZ?ywcLvQ;N5@ti{pjU)CoY%dkn%krpO<*pCrk2tCei`o+?u&F{v0Ca zX;JmX9@b_RusqMjAPKm*6hDz3mym$#pL6+b=I-lF6FmugKg10n50p1?ts@JS`M1$m z!W;bC1Uvn6C3R2Q5Hpumw^^!jzx*23EAhZo^862KBV4wGTJifxdS$s7v=RNVlj2gE zWEp4ZP(;8LVdji}OUK5ul9lp9fQavk2Mmf=WjW-!wm1d&v)tx;mZSO6O6AGvxy+?Q zce1d{pPhr-pBqc(pPH9-50<4WY%FHYeh?59L!I~^nA$R0A+^Rckuap!EOg9pvI*v* zhqEUjf;CX&pB(voxf>LH3cDGheWNd>4pYF7vEoM%!`_J4nwO-v!E`TToG(nsc~6mlfHJx-OV5}YKF z%K)@p!y!qxx>FllK3S@!str)b&OMl|+z@So%O6MmGkfDJ-8MH`;rbls<}iUSg!+$W zbJ|ZIq9h@|89Fm}EX)aQpvYbEa=F6os(1jf;BSOqRbwt5;ch@(p+!IftdN79bZ011 zcIIt&(lFDVB1nxpfLmz)Z)eBXv>c#HAfTKl3g5bJHd}^zGPl}%XTT`&P|I}^qL&&0 zPzNeFVTAcH1re?E@nZa)Tp(wTf*#&JL?}C}(I?V{=9ViLW`s7$v03%>GH@n zS8ldQANYxz&(lcTAt07XPcSOK^9vs6P#p7@?tRZvSXQz?_;W4o4PyNDT>XruBu?~B z=)43;z>P91nSpmPRtZo&!Pq?#5cde~s#Er&- zyB@sG9JvM@#R*+wmx5g5q@4ij9WP)&yxefMlbDdkwi@t9@Y><(F#k!n-f!x5p>@Ta zldly&)n`C@{gNrtzA7cSZU!P9QgI3!$R6K8p6#*&SM}YT@~|kn&XjiwpYd`qYzv`h zs2R>^!c=WD{bXe>kaX3-AFQDFn@;3mKzw(nM>Y4_J}B>`D&JW_LMSSGiG@2dl!Wz# zftdHuM51IXj5^>;(EuM+e<6L|WNZ(CYJI_z@SF*6f%#(mz1S7oDn?uDhQXTUyACU3 zosfcLaZ5^u_(S&mSxY>(lLU$cmN&_HK(>;wXzk!T+=%hl{9_4WtkQ5(cgmgOD1RZG z>zqxN(erluZbnT>qX?_2xJ=i%?H-a1PO;Rxt|E(e2Ws?0%&>Nr@~7g-wX>-^U%8}k zTL|0Jl10C;&GOnfLN}K7Jek+ALa~aieXCCQnmARojE*bo_Zr+@Tf}KrRJuK(_r-vc z0FTCzVWmVq(N@RYgSJYR$-cPV=NnFB@V4D{yR}rKp9?;H)nDejP_#tZr$L>9xi)m9 zK%8c9k5{H$-tt?jO*xO+Kd9+*5>idyN3XJsg(Cxi0&|J4{`Jp)0jYFD$oDpEMi9aq znN7U}PW!Y3q{2KhN1WFAG@ZwBE{FUvOiC1#XjksZH!!hc8bbU(lO#Z|d&pzZ*SiC6 zLSx_5-_!o9LaZnd$>h)VXIv^8HFprH9H`M7gMl9-v^DdpnA1x~xvQl|_X?r$NvcM= zLedR$RVV3vS;Z?{VtSLN<6(wUyM6WGg}_G7CZ4bHYL&R?$!xhG3Y4q=KMTXp-Ykbj zKPxdk4fIDnhx{?T0W+Wek;)`QF>q=+YV#?>j@&0$#kUGr&u(<%7vjum0&o7+ z(NFND%BHTnkBwa`_Xs4bbb{)?G@oFE0bHGgUpm}6?W27-koE}13OoA%H{m`xn-Ke)z!qkkU!#^uZcg284s_hLm7N)*e z^x*5!q?=aDDT{)B#V_p;Tm17=K_Ev-2{7ypgRQF*;g_@?Ujg@YHKo$lyvX?Cz{k;6 zj(yD0^sB_jiP4W1F^W#o%m!3E@1HHeh@H}6xpk?|{3{4N2zfv_q%G5Sym-ObPa-`K zz}-LOY;b0}@+z7<#dqc(+77|6*W?+|CHSI7JvL})t`rLLaBd&6-J4#p^GY33FrD+% zeot*#^I(JE-{Bt*O+Oh_!PNJxS(>tm1qdqnmw37Mg5OGO26JcC5vUfthLqa|N}!P` z)eTNf*R_bQb&qL}5E)!OtrQoV4K)orqtNeBEN#q?RxoxqHO6p1! zxj3b@y;uoW2V7st*(}#@0EwHROZJ~^mx@PAX_F~nQJm_8LU{q3emPQ+r0w;=zc>h-BGSA)mM{=ET~$lCv!3VA>E&8q2vl46rh@ zTvjyg_+$pCao}HOWY?h4`16bhC}mGA+#HF2{(QrHJ1)qyrvU_zEL5K|yzC)B7bWxNj-fV4 zPC9%s^~*u%I*tS(T}aMJ`ApAnY3TghXdX#g(i`+Z5tt(RLm0%_IhNE&jmyBmZv;V= zGKD43I%MYk_Ta1L;@L@$hPa_U(&&4!EFjsXQ7~?QVB)~CM)7!(H$0Nhz=J~?i!q<@ z(O>$3;pij!a5YpR>O->p(-K&OZAFbicX%*7olca5|2k$+#qy0GgyJ?WuOmG1ze67H zFou=U=#VIZ6Mi!ehLwG#}QB?KY( z9=cNL^7?jZ=UUAFcj@3}j|u)Awb#Vbuafo#QYhU2F}LEVx|}>)Gaa3DsWDXP&{#a% z5YhOV^tj5-k?oBSf}!X4y(F45XxzSEG^BS5@10iBZ(QCn&8m5%oTJFaH?6jAA;` zI_Y{DBsw^kir!YO_KAC)y_>NH-_&`Vu;$34)Oo|F-i#=xpKHBo9Mj7PWVV^~da0=# zGu#@>|H^;(YUKbmb|kTOPjN!7cMB}3j?A>YH*dfysvOUt9e(0A7n6>H{)faKJL?9d z>;8OH8KsowSN{D-XVI9iXeJUSfX0}8Ii@vI#gxU64WK7klL3N!8)@;DLG-s4{$ ztlZgt`f*q!>@@<|mF<2sq$R1P4>I~DCp7w*xi*Gjv0vjKu}|S zRoO=!5UA&sj_=mi>=QM#PLVL@fS&-@7F4rM-nB=hn;%uu9hv{5B+A(a(YR2ZT~_Wv zoa=_Xsb3+ey0#yOTeI05p&{3X#W_sGkQ4~j*U^b1T#@>H0tTV+teUN(Gt`1t({1P< zQoYxt=gdrE0+HbXdc15#hb5ex`O^u&4j4B?OK=e5mTw`94~+TWwA%UANrH&4X>DFh z`j{z(7cxHeubCvARJDZb(M-VTuqUiK8Y5mrPb5>#ShuyakH&Aa5?JBU9&%RFN5IJ} zszs@|eNK>FFE2oK6eV481wY==-f|0;zA}X*3NBnsn*o)xk&Jx`95p()9gVPY1lfN<2D;DH*-GY8b))k`?|Ot zdxQFL^UzJqmomhRO-fzf$`%#rfNdBR)JroFZ3GWW%vX3n&{0NznRJP{6HdV__?l$! z#l-0Y$=~g6<)gDA)tNnfVfDu8d>n0EC}tb)NuG_+3tmy(rRsZi1ruQYyXWi~#!SY; zMeeP6=xM-1m}M~VxoLyzfBxL-Fy+4H66@AzLpOaSEea_qjtoa91kGSoz5t7(R%R9s zo^D4(x-W$}k;qq5&#B63)${ZkWWuKJ`})0>j*DEp$%ZvWa-yHg0RiDVf&P4v6h}XK zTTY|gF4d2~F`|vy6c^ERb|-Ubp6-rC^ITr}0LO|t(;00bFaFmllUh-jBU@eSn>_rZ zT)*I5ASe@gi=O9oZ{(6~0lsdP9}s6Kl@tH+nE(GJbli~HAr35{go+6b z3+dZ(wnu0ExhLmwPP%S#Vc)+G4>k1ihK&7e$wR@CnF4#y+@cMgwEKbQgBEQs!=`2T zd$5(gU-Qcwb}YM}fVN8){w=>LE>q22cnA3aRSbS$tM9aY^c|8TZiJN6pkde~8qkhBB2GtVSwBls4Z}iI zV(Slq9E33OP8&i}45#}A-m-Y!JbF^>3NIe*(pw@kcE1|Wc2ljD>}xD;EFohn*GLAh zm%tS7;782)5vz zq&{6GDG0J3DYUG)T#C#(r`wa*XFS%ASLySxYA`KhGY0DU_XgpBWZpH4ucP;Bf>_pp z`H;pR+1RQ1LwWke_+8zu%TG%hY#cC4%X>TFAYaB)&0=|z*>2)P>}x{CQQd&$}|V1}ep zctq4@(B`F0Gt?Rn{!-YNr#tE^rOQ3z&xVtq;f1{(CNF*=XR__%Rw2I-m9BPY2O>+jlK->y-Y#lL{ zluha{xe5(M(GUY5syP1MbQppvfLSeGxAh8TWBV_9fL#Sd)Z8Tlw=Z5{XUZMqm$KPg zj2CBrT=tH^Ru2xNIzPlYXg)ex#MFF73_ciWNr)=tHIc7Avk9Uk75R^GIsCgI)uAL% z=c-o%Ym3?lrPs8CC=%2`%>~!(f6~eUKl%fbLM|PujeZJdgIpxV;LLLk9Yy2=0Ov$b zjWzl`fPY(D&>-#+T>iYvG&zpf6yi{lS`a0_0-rN^3d?mIP5gIi*f*xWVL=_N)#>Zj zU{}?H=k{!LAM)+<=8K12lD`FHAT;Jnt!l3W<0C_xONBJKncf7VU@pwZtX0lW7cwFU z9)<7{hM}KFQ?PmV58}oxR+v*16f^$ApI(wxsx}Ywi|Uxp{O=Qa^jBxD=s_*>+uK(` z!2E~Rzw=95fRPmGeZ3<{89YWZw7k^D_F(>usepw}_e|*-KD(z$AEwI1MgvL3+x2FA$EsSJ#rMm7IrBOTpn|NG*{P z@u}O7{T*KPx^^ZJEzSy}+{Fb)>RP!p-xv`IKgT!H6!IVNjnK5trH&uv?f`ryLI1lu z`pBw+lgkoM(_zz31ett?@nWs6HC;)ozPY5g-qZfidVlPy|G53U`{!u1X=bN(VnzR` zVHu5FQf8(>=93LY8#;Kr3nIfx-FAD=P+8yHH@oS!H?wc~1^12oQY$*EJCmq%@%z75 z)|YF225!92Ua(IqF+!35%}iLIeK@Z7X}j;?LE3&oXzN0595zE$-2-omo=#Z)*rs_` z9hde{$)uRcKj*wC-T)=0hd&wlsxC-|1uvdgOETf$^Qb4>U(tzk6>!BzH%>ODQm|$* z$mrOEU6w3`dl%}SvSj9se|)JY@C12NM|ilE2>ETIiS~Qs^7oht{48*EM*&tEkgRHB z2=`!|Rqw|9N@F|iT9S@as@*j=aX^No%uBv6K+L-U6-zD}XADNw`kR^4=j5gYveQx1i>1){-LEK)j2^o2f1y52HKeMV)aQnZ;kMB)9g`jD{V|w> zfy+a&iw>>)R-CDDN5{TWRzDi~My>}cpqIPeNG72B1?WPL=~pDe-Fe`nT$pUVKx(}O z$SP7+Xaq|T&f#)~zE;Y%WDh;>v1ktHh7^z#Dgbxz=gj!6lS~|K@l8p@>5}?|>iSrYuQdS`UJAur^JS+|P<S z#4HAeqWbeJzy~IHdxne25!3?oSisSmeI5j*sS#SA)}W$ zju$q7={q4^_=kzSwVD|cYT#_ogWHshg`iA>AW4}yL8P$gE6k>%v)6=IrW?;iYAfQW zy*pD-Dc=S+mei@oNdIa*u)weUd(Rzlj~+fv&1guhA~oF4Pqikb>lZ~6-9#bJ+>tFY zFAOmFPYJ>5N*1R@CM%9IYvo1l#Fv=W%dhPH1=f;R^E<^(dd*~opvbwsD#bc~4O^X> zsCn7h-SE400}+etY*>CndYg0y*YmG*osyG+06i671v?kjI*wgbi#HK+r=ACNw!Io> zPAmt(V}4c&1KY36ti98}~D9q7||2{l0 z$T^tPYqJ)_k{=`pzaM~VfeyLXHpn|*wSD6iuGWA@Ghs}6nzxYhq`)IU?7-qD{G>A&Lq-utVDhnFIk0Q zOrJJ_=*i`bn<~B1`hQc25^0u^NfmKl#^YxH=xALv^G!@-tjw%v2+7*N_!s!mf}iG} zrX%K!ze4wqs65z!53>@~!%d7EGrz@tbVifLxkEq3Z?JQmbmv!Abkr3Q5qL@SLm1q= zhLa7t zS{!Yu3(N{E6)SK#^)RUgjZvx z9G!kqGGAAh=(BBHM}Y&_HrKmD{KJAK0a(j79r6F_KE zPGdlMCwr{n+j8gW1v6XZd6Vq~ptQ%(l_DiBNcR!Z1K!TOGw4n9pDONWh9A}$ywhsy6iNh(P|q4bBta_`M$e)+as z;{qE;m1JK+CI2}k5f~2MY+hU|BY{=d)9GCQCWRGL(@N_|&sfBxKNZe=ZyMJ&AI2yg zvzMN6BNXK0=8 z*_3Y<17Y#g;{HxZ3*dWAt(TjXK0?6F4|ZK;6W)_Bk~jH;J4a*oC z&i^VSnK~zYdIjnLRecEWno%DFI_F=W%YkDBQScCqr?LkNuS_Z?6>D#WwgJCM@x4n1 zGN#;O6^HmzwKiu3Ei5P zBLj`(ztgQ7HLa-VxOgLpX1zd^0lL1hVl?8$yOV$!>kRu_5t?SD0r;MO98 zo5nNKwi``ft=uaIoYc<5VwgWJ+_iNWxM5yOs(4K24Rqe?EZfl6X`okb3659UF4;zL zf0Guz26HiQr2n@z`^sKJ&1vj>VT|R4_L!~?-@6}U#eaXQ$2KI~DaRx^k?ZMPoKCR( z1Q~oR8RWgiHn!3mU76Lr-q>xo}A zA~ypNkW$ZIV?>=vy3PBAV{PN>#x!+poa;ObTKF-Y4?ST$p#pl^zo}?ER;05Xx*1ci zmT`T^vzZxg5=4OzyKD_8d=#CB=BVj!# z--B<<&mEe|7)GvAof>M4BJBR+g)W?TExc=+ulSyKj=rDT?Q*eT{LM&D2m55+a(hPp z9Iq931i5q$wF?jWek12`K5}WT+4kIO_d!-8TR57ODkTBK8UsG%<6;*}+#^n;KE~>g zz6J@?6(#FcWuDyB^P+A#i<@7%WO+@5=N5vt8aLRn-snKey5!|Ls;=|s5Sumfd_xDK zVTSp8JrjyY`<++Ybm(-15p4QJK3O4^LS6(W8e zTrEEsnh?S%%Y#(0FLQUy3I12sciHe2WwF;yl>as%3^~QiIcI+xCUeDtp;KjDBZ0qC zK2h^>r*a^2vq2X8-T0V6BYsL9kgVKH9EmQsJsO%{`VxKI>CxCS)Xk)5JOP-{1;)6l zCC`knHtma7-6AqOS6#UY;avpMXZ8N;KCeXi19n*|MB!DUP%bL}f~5WsN0cjyf)2W@$54WR^>&lvYb6?l{{d!RbpBX@a{L9TU;>5+9tFmkgD2dePI}LT=|60M$-|AuP=?+C5WWnw!(7< zP!XYpq!EkQUL)JrvmIDN5B+CJ*a*g>o1r5%qZP#fu2alSLZ-~UZ4OH7{jY{bm@0tIF}is$@=i@JD{{r|<2)k)L_5tr}%pJv@Zjz(Ml4tc- zE%!o@I*4ONQ6v0oj|CQ~%mHy526zEIf-ZZUBPQNo!UEWYUvGlD(981!0)y@p+HF*w!*{({+=!l|THNS+R37uz8^;%EOS!BaeYsshSV38XVoh}O1qxt1==I>L z#i8%9RW0b_l@=s7NQU~3;n7c5Eb`?C`>U0{M5z}vL;ZcYtGuRu#IrfQMEu)dK1pSt zr-K22DgD{bvFx*G55VvFmpj2o^}ER4iCafpknOge+HU(Dd>_5@2-!}dj<;%~xJzzY z>n}^H89yMpcLkP#;8@vK4Q5_FVWAzigN;x8Q&suASGQaifpUTl8#Vo zuUWQSd7BkES@3)N@Bs7bt*g9@2F!b+j}L5MmGx2$?hWRC&Jz(XbBt%>UwQoKCt;;$ zYsn6U9jA`{@?Y4IsZ#B(4u#;bXm=01iaUzI{sj%=@^{o3)*IO_^$ejYOP4}m-`h9K zv@DI@AjQRQFnCeN=90ixWUv)o3|FnXx{Z?UQgB@()eCcpVY<~w3ti^V>S6${+Z4x3 z$2;1qFym`<~q9|iB4=bLO(Diip(QSAc zD+-y_B)4r&S{%PoCY+X)DBxw*Z}RK4&AbWw1Y@V!%fKcXV(toy4>M_(_d|~+ek=@I z<3o2SA`&XuFFb!fS(#%E?^}6zg)(+SGhdTjl-Kj52UNu!s%1QnuRo_d+Q2o+tMON{ z`yzTg!qz@6jBTzFUQQq{8uX#pTqMq3v z`z3G|@DK6K>+sFN?fJ3Zo3zqC_9%NCve(&h{zkOi!>e+Z<^>%3-EH&OoZ@t~_AjPU zg5b{*n04A080603w=f#}-W(ALS&hY9aOrG17)A3j&Uu!1&NP#Eig6oAJAo0q6Bvx~y%0(h;=Ez{_KVXMtmsM9*9# z5>{JVhZ6{O)R1-m%bx|cm=>6vNVNK0w`YR#mHkcc3=Iy?tQP(!oVXGZhaB^ylTxkz zCUH9zH>XCpm7uFuy8RL;l-|5YczpKQ??6|DIOi;?!1E|DxMHs5*Rp(b9}qrHQPhKZ zj3}E}g;&LVIp8E-KB@aQ3-+-GE*9>eA{x@Z2b7gRfq|cTgJ25e$2&#!&)d!E$HqHa zh|U(Y6K~{xR>2>OY0Yj^C=+oKOM6T#P6I3l|Lz-A51v zRZo353;Lq@a{bJKAZvTpbbxo6m*%rA!7%Q)vQ%tm6`l@*7MbNR2{Dh31syb&O2)G7 ziQW5OmZ>u#RA9OCa9AuYOuuDLS}P{#@W0!DFQqSw#!HiAhYW_p+%R@zJ;v>d{vnsR z43&~cAd*!mloUWIepN_gWLDPqbyH&>iV|C%Q2Sn`+b(#I5!A<{?Z!I+z6d_hRnD^b zNSt;J)IEWsc_p?yccdbAu5;3R)^el$bWg6WYFaf~1XDwdLjimb@pen-^-+a!J9DWe z>z0;^QKc1`4?&8G6}pO|B$LxJh#l}R>KP8AokSHrgr^yosnn8~YAde*#y(NFHIIB|;u?*f?yfFsGk*TIF^_baia4AO=n1x2MCK1WSVN|V-5Pj%J@~;Ylr}bc!~Qt;N`9P;nqMn6twgji5|dB z7uo{X6VHgkrU!2?=X$R!egIAlvD#GGd$s_M6#42eG>50^FD|-aX`aJLOxe&S(NsTp zJa!Mlxl#`d$v`RK#A^LLIHXxb{LrIz~#>3EdW?<{p@ueG!|LUTIVOr(LaY^b%)>n-+(GA+&eiCb~y? z4tp2^8(byZ@vVb99_t49*^pbGh8W-Vt!tI7{hL83LeUMVE9psG1U(LPaiu8y?@o6R zyi*syDxvm4wM^E$QNL|TAkMx=KKJk|Q}uoT6Y_P?|1K)_nkS{y(YQ_l$J~pfkj)D8 zjV-eFzaCIq^cv|H2;Qdhue`zaEqrOUolw8L1~;Im?cb>I%b9cijN6sf)%UVbF}kx~ zmDFc4Rnp9P^+xT6JTh0awaWL-5gZS>^unnJ%!k9jyUZLPQ?+Yadi)8?R%ekrNw?E9 zA$nOB3vSH7TPI?Y1lv3f+IMoW!@BSdWOO-Fc2P9vig9>mTzZSxKk0o~+8rW%kSMu9 z?in!sailSw%XCWFU2X|-WdFEWw;LQlwrKZlCMr?u!072#vbkeiq2WTY?C3{Wq zd9|H_U50B-Dy)kgLV+Hyb!4qjChV&ULrj0Kt53CTa11b}Yv+)+4GR%v5XzKp*7UzE z61CgRxnB`;e}0YiSNV488vVaP(`zq$+5i3iud{*w2FlrS{y)vXBro2r(TfMsf_lDb z8dJZCAMLC;Exo!ADdJ%{f9qfa?o8K4J~{M`8X8L5)ACe|_hd=jav zfKXGG7}+fhiQkKfmVE@QbI_~NY$Fj-zqq4hDWbSc2UYkHQ+n7}Pbi2?TXQn*9I~*Q zP(FH_5_EtNaOO&C=YAY=vO-73vbGNkf!q#!t1mNqZ0=v_1K*eaiiR;pZyon@hrAxT zF*#o!Z$4JMBxoPl&2;&7dbaCkS-m9>5z8K0oLVc^+u6xct`VyF(TvrdfO67Y2qg;> z71Z)4(NMPe&fh{#*t^e=5Fx`Eo5#pyT!8&O@Pr5!xkU5u4k3$cuj8L0tx(VH4S$%Y zc$W;`x_}U(N);C?vN7XbM>yf0&o39d_4x=PmimaTU=h4t7QYumw{X0*RIY{ z)x%B7T8t8FV71V1?=kYEE{uQpews0P3MwyLdN6n>e|>wGMv0zi%mRMG-nP_9G&~qq z{bLT7DBVqheE}xr8S}yM-7H^56S-y;=jDsDc30ktq~E~?s0>qN*n6aQ3r%(S)udTi z33^S9$2`83iKg@sT|0`_=3D zG6*kT-pdO}<=oZY&qm{JpGAc~g^4yxK7lj`A2H~>(@}C?vb;(am>wQNy$)HNmG@-_ zDPH6$FVPa&5(}aQFfK1p+Qehht%s?C4+m5~^aWaaVU)R3$c?cf@|{FUB;(HMY=}{$ z#KWg#S`lsqh>@|V0&Y@0!|(MIt3OQZx(nlJT<^~&8e0B#JpIeyRkDj!*gEbR7?f>O%7+iWVX9VQxz;oMpXO^Ji>s?Fz0r0*z zsN0cq96w|>5~-Ex#{2LpaF6gcQrL7udR zvJdE$3qiDlsz&8CuZiTwm!U>6NL7fk2yJ(KikqDfQ`3v z)0D8Lm34~plhdddXAxV#H4B5<&;VR9xB4E;6mwDEuW49v@oXB(^?Hu>w}p#QT>hAD z)#3n;lC=!ghkdGT;f(URc*Pi7X666I+Z+dGD@^VYYk^n3X@k+kp0V zjYBX0U6-Sd&EWeKbb&eukR4B%d1_8MI8~UfJX!(>u$xM=*QZ}%#nxg5VfbWGxu7YhNct4FRJtEifb(lm?X7ljlie*NSK4tP>!JY@C$o&5 zLapSTZjOWXM>Eh0dn%+BHH$1Ig7ww6&gupylCaH@kBFQwdKeCUDjEN0n{J+eEVMhH zw&am!6SKm4qaET`^v1TsYn}pKwwmrVQL?jyNsO17&MrS*7FvX}haFwA_vcuIwj_-K zt7K*qfXWB0gt(F@>B=9GsTh|u&!0Vg%+IIBcME(qM0n1o@-w)tD^Jv&6U9ZB&&9tc zTW0|7R*um;_*Bsr;#p;><4@pE?AL%GaK+CIkanK3wEzX}tx|3=*WCE(9=%(lgpc=gGm}+H>NUu~v@0 z#dSP(MV|h2!LneselF;cPl#rZ(10H~4m?3y$wY<;Jscu1RXOa5Mbpzkqx5Y@^L={+ zd;>3zWb_a=lV?h(ZOTvqWMm$_gJSA$%|pnw!fds%U3;>5Y}n8|$l zB|U%eANsfiwi>1ULN6u;qWsX^J3Fk+3Ez1Q(*ol|c z`DG2lvYzFs{F_E%`*`Ix<}TA|(C;?87UT}}&$UdkuEf&vOGsF@Q$FGqdU`Bu^RtlX zDnlr;Bz2ygM%%at@rx-EdoL~Ea7~*hLW6)ypzg51WBLt$=cuv(=ubSj?JuJ_kxIur|`=g4vNvk28 zj;3MfZqWY1_pLhGOWkn$<2GKbGytteMZtaGW%W4?d>tCi_&%b*oX+TIMRYt4DHCSM`gQTRlK9pdWX&4?i7_-xh!M z4o0>59zL4;t2&;~tGnEIDJrm*dBbp7(ywow%G`?8EwEZVp{T^c9w_PLC)lqq5gXv& z=zF5sOTU?uM^UZ|s~g8t+Gom0-Zcwn@UUaee>8+=#(ps(8SVqr^jSZLYK}2khAT|P zdEXU+o&&RRw)x~$7RIdI0;urc`Q7_ZCLSC9&Ehu?6NQ`1^kRquKR-xtYg<%N@a*o+ zXGbV%!rD0TT(w`zk0(|msCC@IU61V{++W0Sdd4lqjsffA*7gaK*-n#6D|bc&E<_+t+(p&1_XaKv`qX_Kb4N!9v#XjvYrlhpBEDx7=gqy0`D=PTrt=@F^|uS=JV zFT=N8f}e3Z5HJJy*T6~NPLax3=OY?^S8+;v9U(oGAO>4{@{3IZRi-``e)e|BgLmq* zo6G$haucCP4=zpl!m*&A9_$^82>NFS++&u?evEVF7U`?8%Y}ebQ0kO#dM@Nd^*TSi z8B#urdfu5U{TTLNys`9F4ucSPyms~~)=k-Rb1pm9VB*;TxwxDCu8s#e+J;DeJx>n4 z6OCOwJ8c@h-RVgkK?0veZqIjG)p5i`n*bsNXy-RArQwSvUG59VI!#VIsMYnS$Iisb zwb7zI&JkMfAnhK-fIccXsp!}^G@PU)>@i*~yB>5Q-#$aiyqrWz>UI4F%oF;lfc8L`d|f{W;{ z<9-YQ@}5Oi89Aj1Dtp}F5yVX%V!0?zGKI#Kc1)^#y^P%px1Ce%+{?0uOx*;bdFS)u z9s2SZK}QmefgKgQALWjdK`|)ibm-hgI%-jW_5%;1x6en4)M z2koz96!B3ZNH!cB^6da^eS)bE?;kDVKdiH2G|_8FmhMD_HMpwQD%1B+gb3ETY_4Xz zZVl8Q5P7R(!45Fxe`%!p@&L>ahA%AxuprHNsd(F@{byx22lE!sE$*5urmr=ba=2;w zdmeA5a}|d-RBO|*o*!A#9nhou~oCr)Dz^xGrolCWkYX!bZs9(ebxhL5oWxxaP`qPy3o91b36 z*MIB{MqC%xRgQMR>5Co1#t~}hgk0qVH3_+ArKM`(BVQ-X1b2= zjqBR*(p)_iXKxB)_m;JCAdiT|schOZ3JPpr=uE>!cXjNhoQ>JGu)SD8Sg^X!nE{Je z*I6{r_lc!xU^aBwaY=s=SGyR6i;18?IYtQFu^{Z1Tbm=iwK9zKb=H`Y&y7dJX9?6$ zW21-r(@ip#S zGw*r4mkSQ*AB07i|ApV1H~}i|!RwE!w@Z!g+e4hibAgOjdARIV-XN^V0QJ?vAqef8 zIv5a8PQE!QcxG&huj6H?H-rkEF0J5yt->6(qYy&L{J4qA9*&XWL~*^tN2{m16HLpI zuXN;*ThL)rw{d@6>_OgIg>n<08=`qZr92DFh=1?ukm#O}7G0Z~IgAd;qL$-UOBbIZ-Tvyi~G5I55Wv1N8MyK6*z1?~8-Nt&!YH{Y} zDoVSC8l;rW?CdwbfLo6FZiKFq3!3%IgcoamZ_qxLwynqx0k9{Q*7YZ)t`^K!=+ux@lvkCQuAN)CKiz14wmIVGb^Ce=eX^h=~ zh0y9C(2nbUw!7=u<}sA}^{7$j!MlqnQQQ1=jB!W z>l}5a}=>$_g#7QJK(UDqyA`6&|+^zU?a$xj~<%0C$$tS_EAia4kPKUi6lI zQEr9q27feEcf5q=?Phxn`hzW#VzyIU90yaD8EwOF4X44LS@1Oz(%)tEPmN1|&kK9A zYjU8QeCBCn>^FO~bi!3p6~=6N{RA&8zS{WU$ghPBb{NopOSo{t0yf6vhCgk9bS z`Ke8xl$N?Vnu_Jj?p6sPG8fvrF8F4y5tAq2Fuc?m^S?#X#M|w)M&w!T8v6ucqPy)K zhJMlES@pz+2Za;^TzO@kI?$f}Q+f09YLpOttr4YZ6bLRZhN3^bSS8wwN$4pFlyaXn z4b;>No$&qKfpOzv#pVt#@s{P&f5XypREx^`(iVb*L6?3~y{@SAbN#khTU}H~%AV6u z9aX+^T1dQ>N5za9(TsjPyhB}Qrx30z4cA?)?B|2aoE{um@YakuvDZn0GoR&=<2WBS zSNWdX4OtK-p+Dl=Crx8rn9wV}-?|@S{?X2DY?wpHb}0Uow7suK6aPy_kPz_xpO&Q~ zU@N;nNP{=WcH=ipUE_#|L%mXSl9FIS-4B`7cfl;C7F^uzIJ}cSWuMUxYl48BKGthFF;sU%{ITUZgxM6j@qW@LJ7at zM!mcmuTqEl8eq&EbO&tVEnx)kjo^Es6;YeT-^rSqPNZXZ1VELTJU}hQbP@ex<7;9Ku=t zY2l!LNbHV9Yp$;}LtXqsuf!Hr3qeP_oSYOwO-oq`w_LvTsK{lhqThto%=U?yA5Z=bB*M5+vpBvg98$e zm-2$5r=6f<@bR=N`ux55`{7mzL#m#{rO_8T@lOr>3iEL08btmcL~PjKV>D{{eqoOn z@F)k7tp2HkuFsnwKXGLGL<0`9aW_zWvpZQ;gP!GE<*}UB=`;dC-#uzGc9%V=-p%LP zWT86NRZUCwlb+CDN;ARRh_^)RnTo?CW@D}PuXVy1i??l@RzKDBDJ@iOQ8X(U7jJ;p zl8%j!SU5b0+wQAHCqBdRBW# z4@v3t$S>vyejGB7wrGclJ!%freqOwGAEYX-E8QAE7ZElF)%ZVII(ZIo1vT9o^Mh6I zJX9`B_QGyqaYq||oqw~=p_dAioK)~)W7k&6ib!jJxSg))ssI<_XSc#6I;Wt;pnvz^ zp;r2z1^V%sN2nUh^z6=);{`OoseIB#@EiS@siut|hNphTMA1Ftn#V5@{;~29Un1OD zJ`u_d2$bap-PXSFHEQrwY+B@tIphB3<&}j7HB?4Sq-l9BEGVY`AR1 zw!s`^&F*no9C{ydn5FxY?QRp~dt>$`t0lghy|ny2O0Z`;vUlZ=-|%P{E|b3C?;?1{ z>#(^2Ri2g~KB=qJ+W(=?JHOH~j7x1^a+pu!eeOk zISe{M-9%pQrbhW?9mIviBA<U7E%46uEgL+7EwKm{ekI**S0+BzY0Ig(oEtt(`~1DbXD6+4m!My zUCZNC4shXRYWUxi2h(c-yyVVy$%lDUlIV zzX*KU!C8DdRyO%=dG4lP&OvAK9`Z6d zr+CTUuVH3`q6=|hG!S%&+Hh(`XjWV0CFhih?qi-=j|6bSHK`mi=A~g zGxPiX@iGtWQzo zOuQ&d%Ay5Fg8DsrLU>2%wpo((%TqaBijMcY+f%o)C28SdO_K@#!$5PMsMhbWpc%MMy;VHW^Czg|Rryo8!I<@vu4GUpzi?M4ZCH@$&}l&{K8dmZ z*fBJI+&mE3UWvJ6j+@|ZEUTm4AU=PTHuHLR%CypAy5nlR8SohF40GaXgmtQ-2aegt zc_;Y`-(P7kJ-F?WcTr>oY)l4=3_*p;_MNw!Xc$@?9AyVDo)@(>25Dsvf@njdo$u<+ z8K#1Y(6|SSqsVoN#~ygUS;LHprMw%UzL-2f{Pyc1WByDVi{};l1+jgxLDURK#T@>~ zFtN#)Q(ytMl#Td7s|}C&5L0{Cw-`FDI4y@#igal8Cv!%)yp?SsNZCzfq4Y0~Y@!nY zttSkMF;!t;i#d3C46HX`IBXL$eUpz?mz~uCaq$r9nG3T7i!5jXy%fwI1~txcO1kk9 z*#`Lk&|Z~mkc!k~%A#40jH7<|8u$H)yVwc+3!cJQjw_NP%ES^{eXm-OVjd;hF=pF3 z4nSGVjHZ?&);TqpD+gO2jMfmob)3`i@|P&85T6UDt z)Q?+<;Kxr!f5D6Bb5P0bBSux7uZEvHrC0@yUWtb%;Q3cIxn1t26FZi$);m*Z=!-{W zSvnG@C(9@%fu<)vduJ*HrkH+$(++NH>~X71R^A7GGuOoz*8N5eYtMFZj5EW}k%o1Q zrc;!evLh=KCvSUr(CQ3T^$%T%hr!??j>7g)fI7wslJfgCZ>vGh%H3M*I!E;?s2Zfj? z1Di)+r-F9xgOD8sG^BZkYLl+-G~G9_t5dw$7cbtY(ur{MYr~1 zwq8<0N6e`o?r~|cyX0gekKNr^GTGRA8RE=OPFv-~shz6V!f^}RR(jZbrzj@X8t>yC+NNFFT(iQ9bgM9Sk5tmlX_XyI7$$l`%Om?Hx}n0> zE_9P}L}4+7pIjsC1`h|_w(Vbe_HJbZU;S2B1pD9fMeVZ8-=dgv9cX+>?&>BT)>zbB zK5k_wi3{9EyYM;ja+P*};>s>H9TT^+<_nW$I&AX3)e3>r36W#&V%qzFb@VNQu00X> zA9ndoB+nj_sg+|yO)np2_cQZD(x#5C7Y$YyFg2oFs=nlCLZf_jBO(J)8~6BP#jZ4_ zqI}vi&>_-AcvTtP?Ab%XRaty#n@%lH3SWa#S8*i#cTK14fdr+uRZI_YEA{WVAyO=I zo5#3r$g&-T4jrtNPs;`&z5lR+mVQfH&Q1Dw^ANjJVcXfTYas(k8!^4$UGMG(RQn`t z#fRkUC;`z_N`b9Q>+AsW^^3^WD7JGBD$BWO{9TI?sHo`gQYE~qR8El9;C||m zi2sTz(kOva`(G)c07_^sMpB7hKd73vtlR%t)(SJZfxQ{cBB)^)N#E$_MWgY!V%d>L z)hI684_@VwaR$QD@1@oMr(lYGu9HO;Iz_Rj$9YcxGI8Pvc|!M6j(!YSksI!hO%IFB zGz>ip!j(_Y?4^J1SsLH}<;LbQ3q>KqJ*>cni5y9(CFRg^M9j!X{@uY#u+`$AvAT1J zOeEHIK6m~ALN5nXwiGo?eA9~iakbhSk^0fF|5|eY9h8T~%)?!UHcxH7QcabpY5MVb zkC3I;wNu6K=Z`_Y$$lL}{8uK_%r`isbYI6lUNSgHclv~%`koWMvOM&+`@z=p>Ma!T zN0P!Oic*}*Tf2+D7#W&pRax*snJO0K>{^b*4~Z+RTXOR)I# zM`1J%&_Nx?1MY_>t_Ewoo**aBtAgpDQC>HKI6nlo4be{mr!4V^d$Z*5hwWdVIA2oq zfEv5^YbS&P-jIyI<(VE#&_NSKbImh%7${_WJ%}Cc2Q%(CVS!w1jvN>RP@IVXIAOfsw zyajk@?x8F!_FV@bpH@j?W#4lD=Kj`EQ%@iceJu72I*iVR()KM>YG2ns%7Xs@a89+I zYW0P5TC4;!Ek4y=F}ViI4tlk`$2&Rb!#~&#_Vy%jfFiS^tbw*0Wh$_TxX{+v&UgL( z5g0s3jJZEm=xx#(UU4>T1N1a*4`+GsYLK&e&XnS^=3V$+2IQ%pX(zP6$99{2;2H!j zUc#~YkGp;gmH2bN9_U!I!uK7GO@Z@hr4bxDez4Bi0 zJ&UYDJt)qXsP0CTPpN8-=@R+nx+XsC?qC`sS^8Xw_s+e8PsEOCCRm*?vj6c*H0BdEofPx@SswY2nVD;jjAsybTPG@x3tL~A_uQEq# zQ7m@dyQQAslUGF^Q)mD4eZ8DW+qg6zF+Y}o-41vJJG;mC0`<{`!~z_Xih6z+xaYdV zG;8MUEM1U8aH*vce3NQFvT}x;J`c|{wH^Wf@HUvR_lb4rXd?RESSfn~enz3)Lw$eM zAfRu%G;qIrKRA}&H+}OHb*>umV!!QcR2~o&f6aY}p3(w(S>tz1U)B?R)`Al^D2nY> zN#`l`(w8vjPuk4!CDW%^&A$}l_`?OlTuz&FR`JEt_n{i-yv^XGXTV$p)aa(O|3GcX2? z4jY&GyZ$FXs5#*)%8$oB4%2)U*(Ah+768JKIdbre{ED!g*dkS-lysIB8kS0;s5?#Y zjd*mNY^y(SA3B6S%y~E4&52v~c3VnQCgJsENC-wKDf` zM|<{WTAVb0T6qA-fG(Ac4)J0q3(K;%(x&)_7hZq%YB#Kv1cI<%pJ*xPYt*fc%dB0>VKUyXM@&<$YEnP0T8yOM(?B z1aROFA6*xsCFsJX3J#$jcv5w|1=tw0WyT?+4ih-R-Rna#7fj5rKDpSwJb`X_`ZMcW zyH6l((`$hx@3t>EaJ)s&y6$OLR#44Aaxh6heB>iG(1HxG3mu_ge&mr4 zop}Fzacim6VV3xt=D!CYl8VC45(Q9e=cZE-TD=9ah)@yX$CkJj71%nnVeDadyne*e z(@A(nAU#zT*~&mDBdQ%qEa^jtSB3jHYB#W>=2;O)oCncCg33?wvk<(! zx*bie{jzS1IJ?o>t~zFGL*2jK9UU{1gIW8_B@-cYbs|^zGAm!nqP4i6nRiB9c}pJu zP-ld$uAUAkk{tC3i0^lu?l2c~f422%Ew?aLkoCg6;qR9jXO5!B;e=4|}G#Z^2d6C#ovNA=g4^*2pP zrt~`sFOBFSe{`5XqEZ$1@*6cLL!OQzpo9A(JY9sC0 zZ`Ig?$qO9_9YtzxcPH=`w#5%k@uCF8Q1A;o<%$Lz0#|13(kGz*6c9!n?k!Z8EbcM+ zthUeKyIJ3!>uKpX3VS9!P0eQacw(x?40Wr+F+Hw-PX~dGjG#xGOJe>k37Q$T>;IWG zH*D*hq-sL20!p9BhVi9-@7XCY|DCUA;Fo2)=LLf7FEjp*T3ezc6 z`DNO@hzFMmTc5GgWi~nC&-BidGNEc^H8zyEz=YBVT^~sBy15VNHKrKtKEn*N1AD9Y zL}0G8g=q-^xMOrbc8-0}uf>Fw11l#Y(;5beUrT)Hm_PBt4WEK^H#D7s+35e6sRk41 zJ)m)eoXFkRr>z2AQsgVvf{8`_P|}6u$ONm+B;CMxn9J{vMw%T=?#@fvM(uh}DC~ls z#UlHOdALuD!F%ihyMrf>CA>6NxM8GO_#aLtl3?+Nc`Y}_CH>I=klo@9Lp}%}0G@d8 z5gJwCJk<;QN=wX`+}U;H4^wn4M&gA<+?sN;l881Ybp!jZw((>e-Gzz#tgbNCR~Q<8 zVxnS$a49&X;?Q$b*~xpPKTzsNAF6^M!B!LnI)$29#dYF0v};o2Lcb;PRQI_+&vP)L zHCS6+l4Be&&<&x5r-5)~1Nmhv| zq3|D6-j$`DWOb4AVX6XttLYiIn8d;$Tk5L-Q}!;x^)q|G(WdbSTA;V`mUJ+g5$3SdnfJ#*&_?KNwx zRPnV$F^cF@U)SeX>*qo;KU~zdI|rP4Z;yuFwFWLvU6qP@M$z9jo)q$uV4UwI8j=+` z$_f!q*gxLy9`rTb>ZB9Eo&d7p=r9*A2X>nvv<(U=9=!W4z|9&#cWzI(hH3MN@qxLd z2$Ggo-}7LiG2i3P42c zH+m2YezYo1L%Y_jAKfgpX}d0*H2z2dIfFmKWxpJm$>dwV#4VWN8Bx01%BisXW%W}h z?9T&t!on}53~C<+o?T3xd$>ynAuyU*aHU`szUC_BxyX8*4$a7|q$Q688J{MS)O*?Q zELEcBIq5_zD`~Ns-YTn1K$r&p;ERnR++TGug!+yItJZ+*2-WnYy&uf8(ly4K2fjhj!F0j2$xer69Z39Nq}8aF_|D+{ExUK^Bpzdm7+-R!;cl%YwOm zxCcL&6|X&3Hn8B3G*quYAW$=r5R{P4zZ!;Lx`(dRu9L4Hty!Fj+;rourTdbfHTRd8 zB7H8Ger)VvmT25!K6Bj0Ysmndpjd~L)28UgeMb3?bwKgf&w2ekEiGJ8=BC&80vw3=h&`%gSM(BlqOF*hB{Wye)3oG&s z48nz#$7jjGgaK^|3>&;RdZ>R1BRd};it5Jf;@-i>iwlhnQ+0IKm}oe>Okv9YO^gMh6013U(ZPS;jja1s29oTLtI! zaPeb~x>z4wS4MA}jyy-9_8h36jdHeDuGSI5<&hoL^Y@jy|8Kh%#gw@?;9CHUT6*6_ zk{21=cIrr+xUaQyDR^?H3wP`@sxra=; z4}zaE;&K%d@_)C;GjDcJCI1k-(}P2P9C1HoIP-gjHqyZU`q41hXU7)pQ@x@yA@qrk zj+ckXvCR4k&M;f#VI$h9Npi_kCGB>=*SRexq}Rdg(Vx-TgJUN{$L_S!Q;xHL8jA(V zn9Loj?76_(A03cV!SPaTdzfu#*kK&_ILkiR!yVMSm0|KeZ2sIzVcon}ZOjr*qYHlO zER~?`^{k~R7)a12@42iECNz?e<+Gh>XDeUUS&lGNZnsc_>(zeJ8liH?lsRA@>Q;T} z*y(d&q8|6Do#8#x@;9F`Pf1&UE~%fP5Bl1o)4>CpgTp%BbFjFv!L)BAjBKb?p-*S4 zeS8(i#R7yVnnmFqyTweQ^W1S0lbO;$!>Ky#mI{cie!0M7&wEFydA_!F%RohN;2byV z)>B}4I*V7l`%%E*r$xImb~SVSFk`QdY1Diyp7L1wgri*Lw6| z=CQ`twHv;r0VR+cw|~@sH=^7-UYRu5Q0~$qtD(<-{;Y(4(v)hAocV34eH(+}m>Gp< zHF6DWU5Uu0ad>+eNd4(1Z9- zHAT2EulReF5#(&Tv{+>hbC@_=hxNt_UFVGKK{yt>5l;i;#ASP%2C9D_`A;iFk|d@eTQEf5@*w5 z=Erl*;dzc37%y8E+I;1lND>w(>gUF)lABNW7)TD`PepY%XpUo9z7WhaV2a7m1j}1f z0FRt%4Ki3yEJ3O#rZ_tqTWyFwppR8LBe>11x;n9<1F=Sj0RpX!t>kb0_c>6QdFXuZgT+`pj4aJpDSACcCY){(dd~`J0n@!I!*hf-O#^_ zsG~PA-7l!es4*S(K-nWuh;83S{@jk{rStEg?&$U)=SpN$ChrX9C@}c@XpnUP9goJ^>*v zwg{vdfj4^Ef?3A;yA-vw?XYZ<3f}} zI~9_d8d#;!gz6hx78!oVjdZC&M<&2*>in|?FTb&t!GPw5$redB0?(4CMVTP9usgw* z)!Rb24IPJaZY*txG7WHY2D7?FQX^OcoFUcMF_XZ$u*TDo>Gj+V%hm5&B;%6PVO*%# zF6y(qa8kY3vm`n0`Hw@|9>qvJ?k>YhFm7h!D9!nxNo10I+!1$eUXG9d6D$^C66}`l zKU>-ok*7M^tZm&E(;vuWa;w=#PQns6S2z<}I`h9I)AoN)Sy@k|Ih9&&m6bM@OqrS+WR^B#g-(rVDwNt- zZcJ_{Yi8vhnw6Cam6euTYVHD+sko90?uwy+f{K91j$fYV^ZNb)y!ZvK`?}Bb{XUN6 z>i4uM(5aQWR-CdOr?lmh%3gRSuBWhcl~;%(ArZL{h{OJHM1zybC?rus)ciVBPinJj z!&F?aPBrTUImz`1p|3Q>ovf-rBFk4DviJwq8Q1zPC1TajgJf1CpeHY)*hxa5A6Ksq|| zMdyAKR;wUPnWeTUC9=J&d24CfyqQ1#OI${~uzsD2(A*MLxT+r9iQqTrXyhZ-KfzmwK$#fKQ1 zkis|k+--MV&Jx-$HI5DXG0M%tk9U;zE!vtX-=O!Y&bipMg`HjyWbdWF)lQ03 zcz{qhkG2!G++LoImQ>UH6Dw!(w@I~?%DrC=%bfoNlwx;*ln2);zR6+Vt=5LJ7WEo{ z`+3NPgt~sVrYx_(0HC|g1#1ez5b+Xe_B9! z!n81m)1{l&kdcWo*dF~yya2g>`P;R}8J-oOM)Otb#JhNaSGc)C=bu->YyB|5$lX3%N`Mh){Inqs`WBt5t_cD1t7Avvmib4TNTUFcKC+)73M$*uvxjQ zu#x+RtxpW5c*v3xM7=fRu^0#NQSNdIY+iwHI|xLn&Y6*5CPtt?A3+PSLO#QmV>fRfqM!j_WzM1~#VVIis>$ z9>NnuMlRQHD9w32IKgF|j0hu91DVK;*e=)$S<5Yuy|Zu@RHz3gq=Ol=Ayy3I!hD2X zANRdxB+O@nezpzpnnDHG46y~im&iqZ+X+%!n@s$rW3Qmgq2S-)45Dz%_}flhJG%n= zG3?a}lan~6tK3t0aI4s~;@N!exn6-(d}=)6i=*iv+!wpAFj*S8v~6+1-Vu_|H>t5} z&B+suI;F0ie2%*^r~c~JyAXDwG4D-+f1aVe&Yv{HB&Rn{$5G+3r#2xi+LYD~a%0w% z2MJOiI`PK}>o?9qQ+4{Jqgfky!>$w)6#wR$0=LGe$U~rjj~1!>apr^O&CC}we9_&| zqaKxlx$yyEIC#GAR=2*;gbS4vjA+9CjICAYeMJ{&L zMIz41UqfaiM$*%YLL;R6Mb6`O*k_)3k*aPFLDzs|P;zIaXeZks*F4Xi}Pqn3EvP4^TmoGuqgj{=D-Z{^Tp7Yo33!{#(J3dHW)$oov<$Bi5$ z4z3YA0MMwAytn#3^Oz>nk%thx-&rxy$Ms90ZyyFudo)4cGNf-s_voX~wz~M^!efG) zWt$;b5hi`z@KUZ?ey`|dc|@cSLvHbg!8wtCUrldmEr)Qpu4u=mhu^29#j=Ogl)RvaI;!n=ri6h34*u zz{Iml&J$+mdYXu1TF0f8n?$|*Dec)$iF=YXO}yD{i>e>0AEe_ZF?MY9t87}xmkKoNt!@Z95+}8&Yr_}0i}#B~$xbNBdjvXD` zV(=f9Daa3P&Ik+>WLR*l6T=J_5JKzsYP1@>xZIzCFV~7xP1ePHU<4_3AaUA;p$?C;qS^Bm%E-_7iTWl_7t$t-SPs z-KNjTVolQ*MWbdAHvKUzs}CJB(mYcZvDl5EO=TaQJV!29(W{pd8|;SleXzH0lmWi3 z1`EFDjxTyEGiLK1{g;7>`&Sj-2YMhu&cFX>9!rY;NZ zpW=XbZLzhO#FPmum77Pn;|j?j6#yaKmMkR=9LzW zgHHD^XNOg9vRmAZo9}EO6f>O6`*mF`d)1SzPcIk)7xNI2INEc5Qxs-HbC0HyT*%#k z9qs6Pr1eO;w*w6{cj z4D0LEh^$k8LC-VOG{KqwvnJyVO`J{Ax1KOKZy=jrNz8)i| zyGKP{0x|P?*$4RN$$@RG+=sp)?1WZJaAVtPJQi@r8WX%0eH508_tNRu0YwMj<_(i~ z(1-o=4IYM_UetZwkaMwyg^(m*{y}{R&|7Yu67_G*R8mnt$EK|N&Mlh2VtKa!&k0Ff ze^mI19Xl)b>iw9%aY1LFy#@v(+|tt_KRUmgL*#nb%)^Sq#tKLAN zMwGmDx~4+v9?wSaC%>rc1%1=-7Jr;~r_latcv?}36#bnUn`LD1y+1Tq@yjSHmlV*y zF+5t(e?9apz2Q?^O0@4${8}04H}{6W4Jdj}ihZ!g-cdE{7VS@Lw+Q1J8r;$g(dp?j zsezXE?8Iu=x>}<*P%;f&eyxsnWg7z$zF{zWoMt z&d!K09~b{s1+I@fDy*i(hW7abHEs#vWiN#tog}#qKAf>>n9T+D^rgtc*yK_u&iB&LLzX zn{~K6#+h;2A}~0{ZVAjkGqo{uGLVHA{sfll0I4JO;E6-3;CwZNFlE(TUHKXSwj(7+ zUT_R*Y)2CLF0H<#sX#>)m^eGA_;vkpuAAig@9i^}w+X&q(!Y@*ePn|<$cf;^0bh|* zkUqKyijQeIKu#Z?c((0Wskk$S-gMK^KiHud3>v)K4l(mmtl*l(;8K^Uqk%SA$I%NaC9Cn1`i?8=pGs<^h)*?~}oy=zL9xYdKG zb$t0iW5SOFL7VO@FL-$QyOpLX*}rxEW5e-3iI-Hi%;Ca?<$=p;trG zaXFLBG2p!O{>iY$SizB^l?u#^QIyJw@>wvvwDd<6Poc3)xG9%&mGccF(rcs*Ara<0 zPeH*g4UDl(8opK0ZFffaNkgTzSgyo&+xraeEx(u@Y93fv{X>>##v|w6ZeNfD^wKR0 zs4vVoFOHLzUiAi=&wYrgXlixB+jzk`x&>LWUhVdklfDg_ZqK})P8M-ThSZ3F;wPMbLD21=t90C+_8RQk0UmcF`5qvS0T3*61NEvn5 zSF)wTN|zFy#IJII-80@3U-Vg7UcPb9sL{A*p}e(NLmBk}l{Q0J27S4O$4v{wdYUx{ z)q0BVdMyBF0CpZ}ezVn4rf>h&(#sxCoIojUP=SIM1E7Ji*H za+*Xk&z%S7;Nlo8jZsq8d>+5Xq+2PfZx8HdGzL6s-I@^i@Fr>)n!0DMtMb&R<}gbL zc>zZAr`>(ojq;fdnacQEVJPr;pCTVqi;_q5jimcH{x3s1=EpP8KZ>j_ISLt^jeUQB z`Sin}<6mx;MZIMMod}^Y=upOjbY67iFjUZ4J;59Pt12}R+d7xniz63iwVRbXGrXA!S3zuDom@r=?FdE6&mAP$}ev2gA3jQ*tweQj3$!D-5gW{2G?X%%Fu6?zc(e8 z>im}SsaAtH0INYij~v!q_sg}xcG+q$mGNr?BX4cz+!G^3@0U;5e#}67lVguJC)E7S zPU#s%)HI=TRf{MISgYGP)kUqg{|8K|L~%a=Mu+T?UKck{7%Z)qoQ9Db%&I&hChrRu zRPUr=V$<#^r$o@h@(McOupdm`w=TLdsQ;&t82Xnf@*P+e8p{i{t>WygbQ5PEB}UJ= zI6I7vT^-i88{LD->(J*`=#BVwc`xO})$HXZiRD^CZqp$2pOo&7g}(*;7iorm889L} zpm%W(^ehp|KeHK@N&a_{U*6OA;;6%~THiH=G^xUVclNoUF|EY$_SKDMvr{%tu(G1d zaPfKIc!?K&WF_D;Z2pnhS!`Vf5W2N)XE$xaO5Koyc=gb=3Bt;SlaQ@u?3EpRI#Zly zFPn&aIX~(f4%Cz+PjH@SK-v%I#S@>)ae`7A@|%$v71)s!kja+cIkP$p=Fw@xzaFGC z(nASH9S$aIGzSaa73zmPqkb?)BhKpINmv2)u@N!b!SUdg2X&_R3P3EkC`P|cIYHdd zTBj;a-%VvaxGi!Q8watYbnYcjf`%FrX4 zFjCEc!r(~$0tVqlOVZ=k06%yvF6EHq$81+Y;k_$nibE|EIW#HNK6NKcTh_!Ke@IfEP zd3rK?-Z#(SH|@$++o*-vYvc`9g)n6e#m5d6;vcK$xRlTCT#sLTfq@d<$jT zk^$_?e+M{fL)0hI>z1t!(*eJ!&mq>1Oj_@W)`sSV2Ir-D-h~2ASw|Z*Hf;UoI=^1X z@{CssJjnp3;x0-?MFP9-Fxlzx{7TiYiGR#xm;r3j9e+m^gH~k6ij+Rp6C%jc=8-su zXQId+a+eK-Eh`#k>9qbNnwn`e5C=ggc_r!)ZDtfKo+L02Z%AXce#kSg68=iWL#>yG zLx1O35#8Sspxx4PgJS3Jr`cZJ%+pxbP52^*{Ts-#U3gAOO~y3*eVO*G0Xd$be5KTP zTVh@4eNf67-iza%>~vi~PeTeDCdLpORs@5Sritp6UvlV|f3G?&Bqi?c$}N>I8-(aB z4+GOvN_n>gZ@9Jx>cb0FC3Yh5<%{#lwkBtFc-0s;mEe_KoQ5vg?XA#bZH-j1cC`Y^ z<6_Pe@Hf4UErEN&|H{U>%lfNcOk%|86ipqQ|kI?xb}MHz4d>zpdl zt#hPG#V3UEzliz)lCEUNvNLZ)8PcK|^^yi$`MW0TG-J6*aM)qVq0lwoM}ZAK7J+JS zzM=98PNSzh(Vns*ynYnFq@KDyA}Ba^r9zKU9ECGmITYz~1w4(%l0P20GP6XgJjEg% z=M|au-O!!wp+oS1`rE%Gee66M#Qw-NwJ-Vp)QvG< zXBOSC8aVLMSUh@$ozPK-V`h|@HYDb;{CmYIrN(8s)jJD0zJamSY{ORb@E(J!nk}Op zafN%!GCrXipGUTZ$-+(M&Ygzhzli)CN-J8q2V49n>jYam?CQYr9eGpBCIz3w@T}_? z%o~gGR_=qQ2jYR3muTW+!{{;^kJrJ5{AkjPDlL}$);y)$hXwkM|nB%Gu$`5rzG10qto7ymAeS?3JuRKi$Jah=-2Nq1?dE4_>9Z`j< z9~f;hrFmB827UoLKprzYozq|wq<`V(ofXQL^2)fhAhIB=)>cQK(5~Ni8A_OsLY7viZ}kaXJn%?M4X+~Cr|5F zY5MMZSTZ9UT60cAQ`+;$BOh=Qd!Nr$O>6(;=oW&csjx|O#6O?nb@r!xG6N_L3e|CS z03`WsAOG~fJ7Q0N-V(o0+-eoHHNtoZr{clZRLiw#RfTQ{%I`}CQ$g^6TBpM?pHwm$ zPJPTL&uGxhy_M9Eo>ZiNkN_?2dI68Cj=T9j7pna#@vM6Vx~nERxjC5;kSPx;EmC&U zV+7iL)(^!S_l`cU*6XBd#4k%gn|ObxwNEjt%J&RKuxXB@yQCVsd+pXyO7x9k zr=NTF1?4?n>V6yCg@ z2zE4>N58AHq-BVAM{ajoOFtuO8?RPeU@SisF`XR$6@Q1N*CpCP|AR1%#0WIobc+4g z3TF*qA$u|(FZG0@RWPndYbaJ9R<;gob_W#NbX&EjFt%fVey{#)#BFv{hHO7AaMaAb zXA&X`Tq|=ziT>8fiZ%bz1y+Qkj&Y%^OFt&J6XD0dpAjzTLIqT(wd|&QF|E&o9=1ao z2Ka;sYXiriP9hjImR4O;$qyK=#?Hpz7M;#DdX*J~(r;x^W!x!^A_(b&Uv=IPBkR{F zRGEOJO5jKTB^H2Bauf7`NxH(al-Y6&g`Gt0sUrom& zm(F90p$A0V!&aecsXaqJ4+;LA!HJuQ1qIfIkvqF7TOYbt8?h z8;-Aydn$oV5glU{>n9h!hK|4JT`GM2?3!s!RD=#BROIiMz;yXJ2FYk%j9hGJf-R|U z#S(?O?-z)R8R%jKIaGcVY$NQ!q6V4?1ChAc;d%UP6#!6^!c9bhxDjKbqQt?5_3jPn z4YJ1|bwOe4Dwl9Xen!7vEaWmG}<11R_qFJ0Ln>GL6A@eKTs4MDx z$xhHnH|7=(x3`;e7qJiVY;+}J+2mKW;Cdlq^C_xV%8Q(1PAOS#?Pl(yjxQtLFDM>S z+io7itB$`PF$ps{X%eerJNsrvw@`;fUa&JD0@tE>(|3ag&4SgfT@;7sjk9EIX~zy+ z^wD9LQ*)L4AG>C-4n^QgVDQSDt&fzb!>u!USub1tfop=S%?wK)QlE#Cx$4}Lk!J>+ z_c8ybg?^O*QL#4kh&a%`Xuse33&FTS_TTK7H= z4~-klm4;ij6GFuYqMO6KbWgO01JZ~tYhTDO_L;RspC9r)x~p90C_Ih9zK&t%nSKPg z(rR|#Kf}08kf92}OHh`$xi^j-Q498(Cbr@q{{jPl+{}RT z1Ehm!Npiv!@(%>gU@pnNfmaKhiT|?T;RoARITEJR>b#+S%A6B$PUCTN5iePVq+D$e zpOm^oOykwNvF8vulUW$SLHMN2Cj<8~NRj#h8t6UZfLjz?XJoKX508xw$dXD6jww9) z)K=OEo6t**3t0)hQ%e!8V4bFvP~C(@fj8&9&AzIC%1l0;rtc-8@_W*S0Nv5jGDG1Ji{>ys>a<*36tlCh ztam9ptZ2qh67gE{%gUdT#e|QQip!X@Xm)!eV$08*K29zm7|D8W?c$i@yCO@S`#azC zY=W2b2F;)aymALX`=+SkZyOJKz0lPF9p*3kH)!w%SH}rIfjb2nvND&$KL-^X zI&3}^Wkj!!xq_S5VlYt>NfX4y)O3d|`b`6@ssWSv$FoR}reWJDFuVT$g(D1!u+S zS|OKW=efTi!ODM<-Si*`MzT2Qk7VMsjRq!A2=6FyFvcEcHn)@9x!3`uM34&iPtF?T zwF3#Vq5zFSUDHfxI6LgFD;^Ckm_X(bXwf3Ht2y>O{Pyq{p9OK!RX67=QC9YpctzBA z5Bey1{P_@e#59$GO^3i&{X~B+tsYakw%&<$UreD+06E64lX2aG(X{(x!C8Hs@!)g& zQZnRvbIfC0Vr5K|dLQbuO}UL5vESy5ZC4Ml9BS*J^^p|7N`qYVs;JuEWnsd*L)k$0 ziwyfvF72(u3<>967Utt4=1~T7FLJxI{?2aGNhQ<<<}T^l$&M?ob?E}?RZD<3m()QlE5mlFfzh}<8}}16($L9olQWe zcWFO1z=o5B+Fa`UmjkYHNL2J>SE=zRDl`)r9Ps8cQ0XV>mS+3Q`Vcu|85S;TBCjdwzmBI8NAO#-7i37xlf|Sgw>BBVM~>=C4`ccBEv*iJ3{t z&UcNiuZaOr7g#X=K>(}Q^kd2e5Or>vjz{m_Id~8G(1j>;6^_1qW%`3Z`Rekq*077v zwbHt%djS1ix-jRNH)5d%-5-dxrs^f~(1R5VOPlAR$QBE~hSM&0gr`}u2l?&&7PIz~ zOj|s@e=8)uvZ^G8x4(THeOgDeqnhjyvrXQOOV4(Ylj*Rlgn%~|vUefydX?XFn%1}` z$1B<%j>}m~T`M*|m&*~0 YzMy&oaU8q&#}7aKe3W)@esjm{Xy0hVyT)`IrF*8o>TI8`|j!G)7u zqr0~DkH++k$hgLfrri`{x!(3TP&Qm3>N0Rb99a|JbEj*fobmu-0|Mv}2btETD3WcBs5*l1kP7!;iKfk0nXC0%xi?wJ zYuF?HYdf_Ox>v?2RIYq+1VuC<;viNO0%*E&f003?HLL5NnRyRcZfNkusH2CQxCY>h zlX|0%&G*2(%9*cGxEZ6!UV57F>yXWIxfr&XV6FV2NddtkS_N2cb-i?|LG8MJ68RU1 z{@|6d7wH{rP5LC|Wn;b%u@YMO(=9S6zOEdn@;+%=aQ;G~MCT{HP=3_C!5_X>l43mT zN(SEP1r`zTm9(w?*aaAU-sYc6h~OvS5gCL^%e~k<8-2BOvH(!pb^C^kRVqA?2si}G zFH^}I>xFb1*nfJmjGRiB4uCvy8%FcAkixWKr#|GZMaF5k2UWdO_y^5tZ7cDFP68Zc3V%hBAL_m9j9Rg&z4hM*Z=t^yF}g zJZZQgX{B@X=<*SKm_74}Ss1K6xNs>!eseItw@En+IcUFOrLJx2K0DiFy2N8C%tm;Q zyxKa7XbG^6?L7Y5T3GKCRi}G2c}!j)HCq#y;S@d93Y!CUhiOHIY@|n&b**iLvdm<8 zZ^vrE5ep@~OTV-b^dBr7>ZQyw>NmI1oIrUMwP;)G8wT;@gqgKzZMam{GN(&EYow3- z7Io#v-pb1BPW8&vKKy7M(S z7roB{I5hQ@{`01_?rc{KtX9DC>ZQK^o|m8#=**K2U3;4wIOw`fTo)&2{td#2KTx#v zRtyEMK7nDsbAm-5%*31Ha%Kxhf+CJdXA_u@+dHL}+P4KL?G$!|b!>WuZpYQ!bEmEC%~3R;fP)ZQ{X*y*IPZuk#9i>!5wjuaQI`uSm0*~f`7kk2 zY@FF;(+S2kYvfSU(W|^Y%zRL7(EJf6b13ZzLAly)Kr3!UMa_~k4I$Q)uwFCM6CSL8 zw$0MFEaWuL`Vyj7U&^=b>Kdzdn_XG{mg6@gYumtt^cbG| zkfb2-o6*{l-k_Nzaqlo$suz%``Lx~AY8;2B*fKi|oDehR?@&k7LBmb}JbN8KjdGr> zCj2YT^b~)&33HoI#APQoxUYDlG~f9cR4{2@I4k`zdY9Vy^?ARUmg;(&$>^T(=evZE z1!m{YF-n&GKXUq0LS=(Z_vo#+{AP*Ao1XU3VObvh6-^f<=_T1X<#u$AH+0xjl%kxn ziIuwn+bjX!i2?bn=-ai~(exXGh3we5c+LkX)qQPw zuG7=l!N<}Bob~yJde9;zmDvWl)g~b$&*vwlK3Vg>Y_RSsN@7be-Ay#-I#^IhcsrjXWc=I9q z_LQuGwH3XHg#^TQrlNQA6A+N^ruGBPE%MNB%rUS%2JQYG#~gTUDf8fxAGq}epG4>~eb4 zIFYRBH^jj`pV2k|mgO5*_yw=f_u4^Hb$fWO;aK5rX~%Hy{IQ|K zd!W1G3n&(Aa9@~)o;GT7J&tJ*p7_HVNW#FTS2eJv{0NRg7lW{p>BYy$Sb#C(o}ayX z3r#yB;nlAtZ<{o`*9bmky@_Bn;!;Pv$&zEUz(BTh=Z%=)mcW)kH}SV#N=8^p(X)T! zteIt|vjDCi?hKjWMf)*{U&K?P6eJZXb|r*>9qgf?3u&BBdSHru{V`+c=@h#_XD-XwQPf14My&pPVt_?l39W4UTS8m%p}RtQxUqoQ zx|c6O^oO&T%iV#3mp>yEfC$z%5G?4~fIsED_0mJBSI>OaKt|X(*^D;Yt$KgDMXd`${u;@< zUD*k7wr$k{&Q~i2i0T!8Gm^z*3rc4+B8r}?D{)R-EhyrLg~ZNvHgN8|k~}WQM!>$` z06&;ZFC?Sw4v<^-0Sw4SO&RW=WSZYcjWc?aSByHx!Ne{?uxh<`cL~szVaz@BDJK^z zc_=)x2`da);coeH3~_tqYxUdUV?KgR<(_2Qw{;^mGPd#_IsgPAD%%486PqpPk!L#VrAGmK%L)PaR8Ke1~Y|e`u&sW5ah@Tu2?smD(VrALcg*{~Kt$m85IP>l9M)a-zx};3gFU!&- z<4Lry&9-mgpehfEuDjgBykoy&HIhh2$624US^!UKzo>()Q|+^_MZc-3)_%i`sL<&C zWGmm#ut#m%Xon*hR1FX*X{Bu{0G_!D=cJM*2wBSm4V5!>^}Ofgxyswur0ZFy1;K79p0JO`&emo(DL3OBzJ|x1j@v9+{3UkX z4kuIY^hq{ttl6!{5+8jX@A&28mSyVL_a528r$;GcIb#Z;ubE@SJi_or4nJtRj{#$3zv`bJSQm)PWe_N=NSoECaBF{w7pCK-rJIh+&X9^oCCF<~d{?DX zI*o@P_u5wkQNcggyb;yT!zU&>waf8MQ_t9odS2Te(|{@a z{gBr=U|&_ZQIu&brP)anpL8WkSOcp6$R2(xHxj|NDOrJ6an}=Lt*!ZTs^o5Ozfn1~ z5v<%y5Z;^pBzNcg4La3)rinis-nVsjv0=W>&JpnaF4_^^XeBm>;Z~xj9^Gj1;9O4J z-(W5~BN8%>2Zr`PoIjdA>;O?SjmnyckIn0~>H&(Gcc}kxb=`tkd0<;b$|Ekj5Sdv} zCcE@Ns;&B|H4l-CDbNoCeiN7!lEaTA=3V0+NoIwFHH}Z4L`W&5v+Ri4yy&G-CAl7i89 zXDC*6QY=iJR)u%v=~4z~Y$7%N{!rdj7vn|uB#}%DV0aF;P?QtZEV|R>3E{LB?Iq3; zeZbBg+o`otPV#5Q4=<6kJfKU$6W}46kP5OT``J2Qs9pK1e_jozOFiIXBWV@ld^KoWq(r*Z2E7+H5m9BM$#*>hA|M^ zWWJ@77NsjAE;5i11W75@_YZ=YZ-uWhN`c1l|~ngdI#A5VC=uC{$gcwy9z<8r>?Bx z-xO!0Bx~o`^1FUZyjPdO}Zp za%!d-mUjrn3v(S}9jk3H#N66+LZ%j1;8YUm2VJ7>?H#GC9XG~*GVlk7q_Ojc^P$?& zdF|pHQliTVra>|g6!!1y<(AD{*$uaLsyn0VvTpxQ=Z5-eaYfmD#<>Tb$z;O(AGBHt z)sjfi!hEKcgx=?7Xdopqo!TciIezhhD!&KU(b9}(OQEz_kj2WVL{qNK?kH1oE&hBD zCUm7XH~9;K1F8vh~w;6n-#sSD#r8>d%@x3BaXlMpXrLM zCW@cLGyjgi7K8aVmK;}$K!595XNMJ*h#t__bTIczs^jJUcpm%&28ArwTWEZdcLx_; z81ufmXRP6;a!&VkuRp@jIdrQ7NSMu#^Nuc*o||8J_|$&`{amQ{T3qWfk3=JkwOcfm zT-_hoIr$w^j(f#1-cZ&f_t3SYnQS21ypoJ3eY3jOSKL&igA~D&4hXp&1emqB$ zYkwTKKZ_?u{|m6|cMUroYp-L1>4QnkR*eRljXU%L`5DmFsruZ3BR)i}Rn`OK`{Gk= zUZ9c;5LqL-%ypif3f1lOzLe99gd^Xx?rRH=Sv0y(X1yLpunzr0Oj#O@KD4vNl7D`x zn7}&%qkEWr*K0B!3|?`T1SW+Y7bZV#FM1YD2W?>H@||+5pOeLj13Qm*W$-Pht4lnt zkv}`{fU7j)oCgtmTgJ|2uy${yD`r{HiMCm9v|PLaj*9wjU{3Me8vTVPVRmd{YN(nQ zSKqJg);KoMRFd*%=YZ^q@zjF!VlBF!CrqWp_pumaVQpJ09k1S8ju#uzB}1+~z{_Ah zlRHGbLj>1X)g%Yi*+pG45N1PAg{1#eq^dN_ADr-~O)#Z$%}~p1w!mrWaFa)++x!?< z7D?L;i2_!yEPhamwrDh0aI?8Z(-B8h<9r6rTeV1|20Sd#9WP9fbw0S@(rZGBSzXRC zrQQ}Dvv=$fMM`ja$Gp#QF?ZwAv45C=9eHM*G&*qsDUX~0@tjmWr>o~^?jNdEF zQ{_E@XS|%%cgPd0@8FcCQ|_{TF(=~X9R}1Vi!ik?kFg^327O7LrNRwL$SY5Y0o2yt z?^ZSjd>r`)k0iIDU#)o6be3(sZ`PMN9^S|lSXdN}gbAAGu4Wv{!v?&~2bwVrE(4r7 zQ%%^^w3SR93VrHb4h2~?7?W3*nBp*Nq0x@mH;6hkmUELEDVmyX^bP+gaV@zr>&{Y7 zp=3*1dpQR$?Sy~VcKMub29mw^fK8kyWUJ(sh+rz14={_}t5~>VK$_Z5?s%h&w05~{ zd5LHcO!D@3*he1a{w=$LH;leE6F8$y9l49X8k!3iO{FBv-8CsSo%XnXV}2D&&zD** zAX(sDFO0hO7x?GKebOmOu6^otOtx))FL8nJY4vAMD6L%Fb}eSh&{9XO-blb6C<)07 z-3jvhtlV714@@Wt;t;0H!lF}US&GDfG0p`KP+^VkyxjxkF}nY!P2_S4Fz7Scs$;na2r)#EmCft+4*9&rnEb?ra>l*GvL)=}AI#_FCg zozt47abRdZhdafA{=}(wKW}P@HM@|f%Mak25E`nfjW)Mptn8o;3!Dw_wDRrWCeOZz z5*%n=-Ch{;D@8$9Umx_dBsa>BUz$`~{M%FTZr00G{F>&NdYMc=OACD0v};PWpn0$E zWeI1UoEn)`i@=Qq0(VDdN$c|^>$Xh-4<8yLq#Z7B4t~stzDQ{zc=H>RQ=V1CY;CK`#!>HAsU|V9o>~|w#rV$ z)m*VxaQUQHg$&HlNB?rA|GJz!d$h+eI`Dx{RX^ev*}VVrA@#F%c~A+V|Xieu@k3xGQ*O9kwBjZu4ZTdg%Q_ zW=P(p=DG4d`RN3WCXv5!^qks`!V;zFquc$BM(R5Vv-I#u#qG$FqPSO~s!4(?*&pUC z7*=nGbr?jCIM15au7=5HQ8(txdpd^^zA9n5W>W_7%`aQ$O15tciUVmxiGX1Kxm`5r z*}cL!X+O48 z5_2JH&27Oe{6wRywrCyjqs~qB6(gocgeFc8%%bDR>R9hI{(#H~)+LXMzOlI!n|4)K z;`zGzeI9mAYuO$h-tn>Gw>D{|ahRxs$t%+AWC!SD=!i7?66xfdAbo&Ch(9jlerHy< zqTl5Yn(X9y6W$VFDQwa}YPpHT%GWqtwYID%^tBN zoUrE4J5aDPb8d7vmws*s|A_ASyeZ8|RPukr>ic#tJezL4(~cyRIsGULJZfyIKF!i~ z(Rplrw75$fniBrGaYfF&Z($G{%eX^Wrer!15#h7|+HBb- z^eV}X)df@aVlhuBzR^nsRhvj%9*qlU)KBl=r&I|FWsb8OIV+E;1ruL@l5|K=fH1)=o{|;ghw;_jn?l3a>m+ zyI+;S%2^5;hQ#L(GnDBmR|_MebV?Ae2ytC)h$rmzDex|WGH@!_Pb|N>^fX zfa1b{LdPvgsoiS$l!Dv6s_nW~qxnnAiODT|9aaEW#=(h1iMCHY$pg0O4MLNz=K-LO z1Jf-IBco)*#;ULw&VHLla9kbFjM#S>g0Mw=EJhuCtQ#Aj+p(S6e+*~tBDotoke468 zVjYDfE0f6R5&gUZXFbCv_#MYa#-160A3(Uf0}Mqcwqfs`ogDRY;n*{%E^q}jqB67f z4*C~j&{Gsrs(E{|2+egyO~YKGr@LHoFG|9%xxw{lo9R>os)un+!eN!*0*1Q~s8^`0 z^@(X5j{%PUD2pE)(`-9PF=6{S;V6x{^KDcE9Tk0T+zjFZu5A7NYVu33%C59a4V^`_ zyDoP?j$t9;Ax->iYU*q?e?zugl|1aq)eFQtoXr6iit|ewq{-s2E<6Q%G0Wjw`4KspnXaGxDL8X*)tK;^fC;v^q z+yi6v8RA6LW%9o$M9#&}n5L>(&-uVobPiG8x!Jk!_DNA8qLU9fp=uv`K8#|D^b}1MO}<0Un9P^ z9XER(8}Y`U#%7Rvd#{3rtW9|Aa4qR8-5z*%tkLUJ5nc|jm?!yu7MwitaZqZxx3zpc zFv;|}DaaW8K>FI&G6y*-NTlL z{S4kml*46le_T%yPQI8p^yX@#*B$T7YXvl_EAK#11Oapf+;5RwMto?i3W<=PfD_6q z9a*~Q_@v(q@?7%{<|XN@2|fIS;|vvN0?D&M@BSZ8Z{n47{=e@}Ib}_gR909nXjV3v zGUlY?29>4FI7v>WmLjDVjT^ZyY?+l7Dw-LU37M6aTWV^GLgkV>Zm4K#sfd7zfFK~t zkN4+y&i5St0S>&L=lOa(?)$nxJUsr}nwX+dj^kNLnnQ=}6NSH#0!s?OEElS^wW|G~ z#`-QMyk|vn7O&8WYPw8+p_gc&y5Z$HY({Sa$w%W!o{UXIYX~$-uwF0Z6)M>L;B9g^ z^p6Lh-5Kctc5BX}J6IG#a=7p z>%P+yhYjW;9GkXq(=zJhB=CoWt4EqDLI%tgtmUu7_=N<=O8Pw;h}^0>T<#hk7#%KTBeT!KxUF=oWNDTcDJq_BL2P>onX zq5{Gg1AbK%hRxEQ?W1wEvqi_S$h+tV&@{Cesu80KK}E{sSJ69S;`pZ@3&F0Z_+4V&qXJUQKeB9%^aarP^0Q|PcK9JAP&T_Dl zR^ZphXUi)+zE(_AcjQNEfWv@(ya14}9hW!@o?1ZDipS8_S!d&viL|8{ldI|Ap7~{`gNLiWC?mB8(BQx;}0c{!ig5=9*bP7GZ{~ ztlny`DSEb>g<5!zi#J*BgrX^nJuK&Xo4keNIINzQPSE9N3>g8>B0I=IQw#Jecj-R6 zMTFF-e!N71ZJ%V~Mp>1yq9Bx8Og!ZeUE1R7r9Y(&Q9UGiSwa0bzoJ2PQg)_-d)#Ht zJs`;xiGBZA3)b#*!(sY3sV=mD75cw@0iGr;hrC;0RkPX0p76mF({F@zDtpm zn4UsH$=5iqfFC&(Srlf*GV0flj@my)sfu@PB!P`uNdYN;!Kr^&q!359+Byr#?+x|y z^wRb2&b8m0GTTM}lk4kVHg4+l`v9QBahp9TDT=p+94iiM&d@fl)2+|4@2ofZ^Mc$y z?nl+ViFqeX$2pthR_A`@)6yOw0QR_J6Cd>yP21u+O4Vh#(C80xW{P4#be@=vnVmZ- zFM_JL_9AyLyph!u=Kdfl1_<3Y^184qjM4wvlZLy(cQ=%_o;nv`{kv$M_;L<@V>W%Z z;4v@${s%3XXv*!8@s!)qD;4(?u0D{cO79?21V04Wy!T?N5f#(1hiHx7&k2++RDmZu zmmB)b9A-|?N=q&_^2&V1b;OvruAZv-8TpEHMhw9RmGx1cLe_bN4y_9LgDCQ84D_*| zl8FSDvaWsAB`bNy#m@-!PQqp+3!_d71@v{g|mk)=!d{dr{AA<$8E2VO!Sb4 zVuLE4AMv$FnQQB!H-`E(^8U+sz*6XY<5jMFWod=QB~k8O_Jnd^Tynt9!^cD`n;}?| zM3?XigVI4)%dT1*O;!LOc7+lEc>ok_W^Nxy#kk!Zxf;YwUHr-f_(&fKm@K)rYcyOB z8L@`E!!7Sg0e#a`PH9qUP26-9<^=kZGso zOD26rO#7BP^nT5BKego^H1=H`^&L42NW#W%Y{~&oCCo_-){O@~ws`tXexcBSw@}~F zOg*Sxba`K>Gkrh&)z|VhBjW}P>3q{~_`=n~kL=@s?2G13l|!xvGZO;uSJ%!hD1s2e zZXx$=)1S$(*sT8TgXm7JTBDjFKUb}M$vY1QiB7WbFUzeEieX`r$&ED@^@;J&6y`f0 z=5kW>ut*_f`yP4Uo2dt{x!+asv6%cwXDUnwE;n^-H)_#wl-u*Jh3+4jym(>j2{Or4 zvrTYvA=J=n*yju<2YzT3Yt8!`s>OgIl^a<4p!NvLB`P6C46G7cyA-8fodL|M@m50>Bxt`8f41c6Va?X_}W2*=?fZ}wg ze0p-@Sm8p|#4&AeMf)S z)h*G*@$YB$u=_|c=7}}#Oh4S5On%UQy)jAeXjaNM|NYpj(y!;tMHL^|n-|2Pr>v8d z%S9DT{f>)j^wYadD}6z!764WDmg#DOza#Ts7i;3&w1K#*+<{kh041;s4EomCa)QaK zo)|0emoKt_$VD&J?*i6|nrgw*842xF%x>A1BtBzMr$e4+oN5rNL}i5l&b_j~bkr%vSx_Jn91zcB6-br{4>4iT5PF zzrFylBleHSie=Nw@Gxc4Q-Kz(Rc40IYD}DAY9FQdVglwa=3bQRT(-ndl~DpZ;c(LV z1`Z2;pl?N9k#~&b!0Vk`sr)VSa)zPBlpp%&=vYCl;BrD0Vk(PKk>%1U$RRTQChYzF zeCa-!JfE6RJh(rrJdeaVUmi1jUGlJuBDfV`C*A!~@Hu1q0}3D}ykDOzYfa9l|LFMY z6X_~q;-_oW*4{qgTF_0-+R`nC-n*hYdY^1F=1=6eN~I|q@KU7-jYDz$|C4d* zi~a5Gj72>Tr3gFBpE>j3A0sJ&-yMRw#T~?BG~3=yv%S4bCu3UTEaq|Ch(16*q0Ge@F=_$#u0%hmO(I(UEEBA_T`RLFE; zHWgF1ll^(s0daypSK6vWzboc3EV@!QN}IpyV0dgEhJTXl5kH1`G6Jn%F%t5?^c7i; z{SHKC9zK$lDtc^T+@x(@H5W}L*tb+4EFobYm_uJdUA8!i&imB(_z5=l=~Fd-4}EKo z7loWWXFMT({J@w*UPW$y$ ze&?fa(c4Spj8G8)zpw%5LV$cg-k!Vr|004Y_6_p1 z5lC1}fN7{m`g|lcikD(BATG=hN2z|U}faLB_aBi}r5PN-bb@~YsX@z5) z+S(RaO2KRpDgNty>{-=wU>1s>WBXVaNB`C&F+5Q#?}z&0CsUV_l^4!`w7C*J2P`vr z0J}YllZN9F>BhcXF@-T*K9Ns?0d;_Sv&;M_FC%jUf|t=F zlrDSh4{$IvUPsnHd+MLqB_(UX+H1?NaP(*+^=j1BL)?j=HpKHj*9j*H>x-~*HW zFB^7k?QA`Bkfi2Buch431i~ujkK=evqoRVG2;nvj`wXK!Koyfc8pg}0*;3~557bep zU+EK?Xdr3x7nHV^e|6i|{QR4E$cF@rlkDvLd}x*T#{&Q+mktV@wT!cAA(`iqJ>;T` zpyd+d*>w^^3Aiz%`mzZ3(^3*IEg zyco*9CtEMp5_q7=XB|?Ra42PdE7LFHN3UNI-IVH3?kPohHDvSvVVF>%#26ys>(4&d zSab@cSFV)=(b^BHEI?k)?Q=d^l&FwQ1qRB!!)^snMfC!{KP{Ai;>aq6`j;^0@vy0z zD(nMc8(y&x5k6mbuZv+lX;@`z2e3rD#@V;^=(G~>U%R%<30)htL`0f8rE%us4BT)W z)luq&n>Ga3So~y&yyKJ%{YUQAIhuF^cz;*;ks+t|p;3q2ITvW&#BcIPQ!(KFCdr*Z zhc1!8I%pz)V<#oE+S5ON-K&7mV>xCGpP+^}Bi`hIg|oV9pnGYDxQw2S(P|iDg%=sZ z=`I(Q8!d-GY#FhT#}Z>{GyUgX)mg`;JtoNXwO5=ez|&dLV($-P>_ohL1VNMK0DAGCPRjRv4*Yuh`-$`jO727^^(I~rjTy#&-3*2mP(^Ga|u^7wNb(RY$Ms!>Yc5| zcEMVKIiY9c+uZW!?bTL*W88|5A%8sd3351z-RSJ7_zQ4R-{ogRdq2CdY6jh(XP>8> zO*sOYWn5Ox&S7?^2zV@IH`6a5EudDu!G<5{Fm3h;$>>e1C?en0maawB*S92ieA+z< zbj3+@2euBg*Kub!GcTWz9v-VYHeA?K_@|7!8$40tVG;KHW>9dncvEZI{40{tH27}J zZdelims)$kOj}8<;vwd@S(IE-LSC+BU>1Rx{t{Y|zc|M;GU;n_7(3$z7O@}y@Ux`G zmz9IXjcCR`)il!`uh4MmE?{v|F-Y>WH%My@(G^eUaiD*IH~tN9*80AjE^waql)U|bwE)az(jM(TygaJ(U}uXJfky2%-REYB>x~R z6=Gcfz?ki>iu!qGZUQr7zt0p#p@+?1)R_orjYb_ua|)U>10aRdPsK3K+`Z*#aI5W? z%tLr!#}~z>*%DVzz+=!bP2R?O4lbvc1Z6nuHk4_(d4=!!xnI{l184*aG+q7O<3r`Q zp6IWw+ERa3Y=Q-nntD?AYXqierZDW`Itu#9b9wv3%?l6 zzt1IXIq&EeiYbo6lMB^6Ox=w6;GU>a!33ORz)&aa8ooF7VzU`|pqgy+|omX~smW|E@&JcPm;Bjt| zytAaIP3=1=O%SH8u!kDcdH*?O;antpA5jtZiqc3nZ3yi9F>-C!taXLT^}TPFF9Mu)eWo9_P~IiBn8)sPS+w^jz9U#5ouHflGfLLUuy<`ZY1mp z_(leSj@LR28H! zIvkI_VBLm|@OW>xMZ_)wBs5txX|bUQQ}l&y_G`+ocAhW9_av*Qew1HLTvPU#u|#(C z6`u-uQ4%ECCGSuG4%nqB_nZ;glO0ztz04nEt#WzxxDB;8V`uEuhdaghy=mfMAT!}N zmW7{|(+S7^Bj}av(DvH&E-!EHc>b3Z8*dd~-g^LfMm@SMs=;0o&cwH}7+W`Wl zql*d%#QFG&v=<2kOdPPC9*f*L#T&P+i>|Z_qdgJ_Yu*j z>TJ#M*xkI`?bC*G`+ZSEj_{fW^N-NZ&#L1P$?r`W#Fm)y_*FM;Zz~+XZ4npNQ}L&= zW4r7(&FjG3Btgbt1Ly%762{hL|98P-)hzK7L~8`Mw@V0HIW@Vkd<(Niw|U9iPx52f z`3YT+LBgy=n`dDxSfvhYK>uMbqczXinVlIgZ%rt)@K=}T*$*=y)g^uacJR~6X!N zBY;__2f)!KPVw{7)*3+!Eq3_FI&AGk^*j;_-*6(4z^LwWh%p>IF^o$H3j@@4RV*i)5A82mEt)y|x3}NW|W!WgCbl z`HD)1Th&Ig_d7JOdpzxoyf0;UY zR`C)^%bFkmm(npD)f2(5JLo!I;&!9=VBp#*%FWnvb&e{hH)nFrPz%x_-gbaXtjYy2 z9Q~x77C)K6u4;s@E?v+WJ64MGWzlqmFR^X%e=6j;b#7GX@p|lfl|`fQN2gs|=d-Ep zOPK!>&y^W+N*Z=^BhoF_f>#~xB#^9mPM6T&2HH>HFI0*+j2zb7NnXxXZf>2DXHb3f zODrG_l>FDrzin*n5Q?iEdoq&z@SlxFwFRQ;7eS0T??3s}_@{z^@?JmwTt9|gEdEk& zOe~MrmA#rt{~|D&jHa!I&lsR4!n*nm9Q9SOpPjm%Q}eUSm{SfNkVgniWK}DP$+A?EMsZh9>LnBt;F(JMW-FIheTAM=8+sXI+GVIC*usTcNVE&SaTeUSP5s z44H6{?Hp{^UR1$|y4~hao$kb!Qi;Az=wM;>G3l?}txKx!K%VVOonRN+V_k66%ION( zy%oaMZw4!@nQQ^|i#x*>V(hEwVEd#8D@$QjQ9m`78B2`V#nzPr9r4BP%ACO-dbaUl zT<9aPT~a?aMYdi-@Ujv%E4-o09)f?>@>5YQ6=0^Pw@HGF*44x#*7S=Hx=(Uwh#LA& zPL-mk_?Qz~f$&@orDXMvyh;>a zBH1>&!EkZBfR>Wyqu^rhin>UWGRaGW9!gT>sH1j;l?=LDvo!%_Lpv$VcyD9hHZ7{& zP*v9P5uFk{L^BHzph&A=-h7)x~C>n7W?LO(m~2(LB{#?Pqny8Gd>M7@=6(o}A>hc_7*oFN~T44hVC1RvwPd;{d= zMwbPn{-_j3{@sstz0`Zt1=E_toorpG%=-VI9N#!!Z+Iz>`Ld?+Z1?m0=8}}27E88!irAb8l&=Z!Hv@+i~T8|JBgsrleV^$U(R!Fc~X874K4+!`DJ@WL3+~-A3M6}H*8^)sgNsT5a(UP zCLOl2Ykt1p0>ieD^TKJzcQ;+-Uq+i#hp%GYV7^od^?zuD^WA*(wVM)fyY$j>?pcA& zO6JSJXF5$Wq~#=-sgqz_k=UG*ULljKTt-KGMzjuq&tqzr<=Gv-qF+g^hiFo`fP9Qy)IrCc85$zonho(|fQ772T)I5G?D-Ve$xB zr@gVsNRp^S>-uk|LNk}q`)-o3u$|1Pb}&Xhvh8(XK3!PYkpg~Xg+uO7v~kSq&d2xu zE|FCjly-n~ku)!ew{C3Pv#x&7H>Gf!yqVzKzN%HhIkS96wls<=h|FQQ`>(MZ#fpJq z>>B5YbK9I|76*3~_MZXD?5?KnV7IPccXnh~DX9fKKp3 zMLa${C=XG&oY7jQOTJh|j-}jpo5dbvJl>iHCPitHQFnOjm2>~|M0|vN$q;YO^HGyA z0exN;4VB=}igcjeoMCwn9Qs3nd7!dP=ydv~up9QnmXI1(uSvAeu?7CPr+q2v3>o~v zSKXO68 zLW%)x%KL0G6L0ei`)q0iq;+9(n=o1W&nv&@fvygFg{zlR9MW=}K_QE)b-gJHfPBzKRT%BLNmRrW3O&qhfS+Inl2Y+a&bU-UZH!~(zVHMcwT1XZp*hebV% zIe`3($=xpGRP?FkVETp3{_}b_qnohE5-8WT!K?9oq|lILx1>KQ({9NP|L??c|JL)S z#%6NxUP_&4Zo%k^-V42RM-7cX{N)-)GV-zBGSo6fL7*Q_1{%!RZ(8Iz;*|~}Y(aRB{?U{%K zk-huzkw%ZdtIDn>7I5yPewP2}N~WtzuJXyr*_j_jhbvrSe2Di!nR#lj*xBwkWBU|md|diP0~x7g z%$w>@jO*CDuv*{>4<8o_AZbn!;CXfSk8IQ8q4CG@k{8M=i`%DKyUNMm-7Tl&B5z=v z*0;C%ywG0b(UrLI zy+3-t2l_feg)gcne9MZ(mqG1z7UHDyvBOmLA@wNo=s9S72C-cRC$m-Lz{3=x@%KB!5o{q-VE>z$qqmwDrH-eVGm z)t5sE=(>w#P^sG!n~GqW?IkQuchdv7-Ho+hMN2GcW@@016VyxEM%F!oa7pt=$#%QK z-6AFHP8>5Rz{vkC`sn7!d+8Gv*?GWN6t#$D14Qc**vO$R0wh%ZusRo|`ohVHa2BjL z!3GJkjXq)4wn(C5`wYGDZ{sc3B$d$(Q=fV8yukHSbJMHocDfQf7^r-5pJsmR$iY(M zd`YCrrB$t0MX)=#px}MsS!*^+1PUq^P9ekqM@aEhhonxy4oaTRW&g=sU{Ew`ySH>F zYJ|Yo?;f}OKK8+`ilG}!wVPa(o?c$+Dr%bkZ3=d#Xtb46*hm^N8M&0R6(lnSuIZ!q zBhV(}(&$n7Ttu&K73n|_*qR4&5KrK`5Rp|Vs6VvMg4y>R^ooqL;OqT&78$gj!kjts zNXHoBNZhsuGNH)E)@Tz4^9IRy$3ykmH1aBX4{uKv8`|k!>5WwR0TC!R>Qty@#c_JW z$xw6pf;{*u5y_M4#zU&BLk*)>X!01-J=ASN)`1?I{fo7Hb91k)+l9SqOjaJ^*U74NK_-|G%NH)E-z^e>yrw;UQ2`+y#Twug6jBQ#C zdsnRxW~~-L%tw)0=5s`8MaFbT(cW%tSddZarB)=5_8oAQ#G66(G%2q9?2KFXm$i&@ z?jnxVGsTJvSZ-mD4oKq6FKa9*`nKJm+JjC$B0{}FmeWI<@gE>%pBs?ehoNMEqo`D^ z@By`R`-w8X+@Qn;n$W&C(MOnZMk`sn$e7&_){b?5oUo->F(-2<2Yu*8U@QLzNHdOv=2{0~v=_zYwqUjraVIqISCp_+4qQUl+ zZ$e-~aIc9tDjdP<-Y1ycv8e99w0YsV88;Sub9cCB7|UUc)713fZ>1~wIK#8#{dFuc{pas3|O*(}V-d=8zj|;1P%UjFoJP4ZhG6R8Y zz2M$d=4t90xMK2jWN@M3ylJQwM6^8s6Deu673g`TN1gLHHYol_;hsg_1%a>LtmXYk zHKsXh-@xr!AEp}Ia<{;#ewHeSEiu|-0)2;(m%w7yVF9vL_%+Ig0GCrtD`H@cT@eEr z#qV3ScCO#s`nm#dm;L#OV#Z5KNzr?GIZof zom!wcN~C?MvEt*h)vO|)6epLR=F96zJ%-6(BW*KZ-l81vcu2yXe z>GHy^Hn|sL_Bk2T`IgKk>P>{S6#5y@D)%r)p^A{0+CEE4pqZ9a(^HX|-6UfMKwzp< z!K^=C@_y+2=&y))l}RQ=_k2qm8fxUc^~nq6Zv)Hq+pU+UNodKbGVtR%#rwq4$+pnR zz22*vxu_%CEdNF(3I&%LylaiG?MoMOwCUrULUC$82y@D?bK=+WSEj6-a=FQ=w%PEg z*-gWb!$#iQyu2BktRCRCgwBL-jUxD{!-RPyU)L=@oUZyYF#YAn^o|3Cq1xH=2=L78 zmDBJ;#zQf!l}pP9v?Q@BT@|!k`}VE$BpG){|FuoB$6W!+TUfQMfaqQUZW0MM?3KJ8 zZS2Z=&TdEI?A>vazZnYP&ARJB4ufJS=p^tO4Afsei~_c|C1AusEhT`kk~*7r_RPho zRNgLHrHQbN5r%e~Rpf#`RF3YeWumsm$bO$b_R>0r4a!AJ&*-^bu^g#!KZgt4%L>nA z-y3lXyVH~6DZI_;DEA-GiX{_+8rbiXSguJ)M}Uv?3|Mb3ogHpHkwE^BavCSoiA$Qr zo@fFm%&n~4!ZIA4g5jRZ-9Xv0-dsr|rhKInx#`jjIu*MSCh`S%W=+I(MCAG;>Lhrtd|s~~wo`b^LX0kwgWMKsRF?E5IrQtNvQw#F>2 ziSXvqiQBMP@KCNbXw9THv+g55YcX)7gR*I>o0 zm_PCbv`zLkuJ?4}vMX@3u(!|6F=XEVlq3g4%O77VPqUua@pIUnVr-a{q^(5kyX^;K z==KAP8fR~pj`*ko4J(oQ+3_SMK2Fx>5-<3YAm5s2nI$v>soMoEuhj;UmsBXv-lU#T2Qoiojgk6>LrtVJ~y&mrKW*zhW9FT6+CMYdlIsy^hG^ag74-xk1b-d z@gLMn3BnczV;_a|u!eq`Egb3!?ztKpzm-~KP-d3j?%1?patzq~&53D*FiwyvXnA#l zRH;)t*igC%>kzhYLo805>wR&M+@Z`KXX!^nSs~|zdbU<)|50i#^P?l zT_zg2%l*+~9H#i#?$mI`JMn-K%ywbz!TNt`8~25_>Q9=G>PzE#4SEH3 zM?YXbjc@(E#r9;ayrCU;t@Wp9T3F+pUU!rY?CX!sToLls%)=jFb%A=&gky?z-R#zD zuXIM+hs~ydXH!dJ_iv|X>1m+U9*T!A(QNef5?_K+M z3K&?wSGy7*GycW$={pxSl!8A+KhER08m-4-oUR$!t>~${d@C~%=ti4=v4VCB_QIA2 zK)kTI?xB*n$_+NmgVqRgodXVgw!B;sVs#zJFD6){w~;c8mba~~$bY{V<<2#SOqb{o z^L^9&X=jc|VmB`|wUcCSxb|(-ki&H=w?{D%IJYYv&^-q7jMUjnRwqnEd~B)DN;>;o zK#Zv8&9gP5y)%PBbVjL>>}Zviz;=CRMvh59DKOvH$))twQ2g(Mwl*z%;>#vR6P-0U z(`=NCvBm-^F(af(2$Yp|;D3v7pe4N}wbJpk*M+Z0hq^Sp^(H##H@h!W(4ksEp|;8M|D{epp#M zbMbd2@n89$PHEjTU~f=Pp40x%&RhwAnei69}FsH}x4&()jM~rs~3GFQm6!zyxR^K@C_5-uYIccYxBt1wze zS88~qq>ws+iyzQNH3N~e{JBhU5vI%jDQ+mbCV0xp8z(;%HZQF|1X6_DsVQ;ird{iX zMb!qgUP@xIh@>wTdrGkvjNWf-w17Bs{}>Sr6SNI-#4mG-J>+RC!R;oss8X%PB~9}h zx!99-Fu4_2!>%7y41{_@^9;==>eTR8#LK#N!$~Yf2V;&-+Z{@xyk=K3I0Mre+A5r> zDk*1?omxW`hnekJ^Wcs*XVo+QUb`;%ui>}_#mr=EG%MmLt)*&YyvRw5Pakw$bY+>N zcOIt4w99Uw=%NWq$EU_7GZXk)#M+V8-@~!*>W#0NdIn~1sl{c5#`b+?ShsJMt#fp7$37_a zin?F~d5%~s?M7#oahZsAB8HdSKjy4j9ND2ByEE5i>60K%-Q5*LA+qh=*(oQn4~C_i zgI7jtdRHx|=P)j;N%#>#C$s~%oC5p5qLj&1^Z#rU$8ORd3f!*ip?^Oivh(}oO4XZ_ zpGFri7F0QAX<(=7wtkFMnTBTJNsrWgtJyCDfS=l|!?^?<<;v-StA0!HKm7yzF{9aQ z>zgzu>zWhAHtutZ?x~X%EnIhf#}%g)d5^A377F-F5|*1wtO570x^JjuRqNMr_SYp9 zK%hGmDMj@J!wbNvBzF#8RiTjpG%GO8$~fLeQK8X()L+eTL$~K8_%jF%_kd6Qez3Xm z(Y}f(AfDn7!07U~l8e4+q;+)FZoh9Ki!4KCIx0BDB2{4qIMqfsF~zOy;hC$#$_o7X zl{Pr}1zmcUi-wz%_?Z0GBi!Lad?i2ChW4#h$BunxemVQscO3PmQ@F(xd8aH_Gk2SU zdV%VV$DWQs_YS|ur?*&wj*UbIsgpG9D;dsyQRd5oqzxCQnEBS|qe2yIqZDk#dWa^D zBfASH?Q7Ed*%NztgF7z72Z=o-;`_kKIT!bzg_?H9=93NAt6;o2TY5pQlbdrai z0@_=v4;Q&P3+}|$t|{N8VzA$J6~lZTZIK}-Xa|E@P;OrGD4k49cBv?(M`5AbYT3$-rP?lEc7srLJ*z86y~lAFsF%sWq)<9 zmx;1;)?!+gjJm;>)&SHc`;ba&>-^roYB4dMekk(vo6x43s%X@e&~l>M!mq3F&nQzW zu4SeuQSyf)crDcEWVT=Oe>V6&?HO*ip^iD#((Eik4p@y7qKJsB}ei#8y?!>z883T zcE4u}%w?T97MCvX%UN=BajM@CC+zO3iT}GdSS!?J`*{ZL;crLVuujK}E;e1B!2LN~ zJ!zS=B0k`zPM5^6Z@KIC{{@)uLxS%$XtOrpEXd2Gch^_Dr0+zBy%k}EP&m5ku828IUb&^Tfj9j9l@-50oP@iDBL}~W zJM5`Ss}s?V+>4It7H${l6G-U0>U-u{+~2&%mf3%Qp=cNq@Zke!Li6v)qh;2)U9J-9Xo+Ej7?5 zAA?t}ebA{=5Uw7%SNSa6cr1iFJxBaqrLlKVuKqqvO`$7T{ny5cf5T;+n>#n0aNwox z#r_zsNOB8^XpMX;MC2%%3%jl~EwDJimS~|zz|zV9JS*N|y<=2`9?mQFr}{)WX0gO_D0dHR?U_5GraP}OuVfF#Vq#p92_u$yr(xx6}GjUS13vuMt?n-XL8{7vj z02ek|?X|W@Po(fg7c4t#X^-vU!pp7=K#X-6N?=K6Jx1bsstc+cWF1{zJu%(F0uCyD zo^X~9xjT76ux>*1su_iG$uTE0U^GmdOG?xVZsl~bOWQp5Dx-oCMCk|#_S@P66 z>^t3qqWeZB0cSF0TGoWCf-uZ?+TXP_b}~*I)9~TsY}MLk^cF}-_GoCvq;B+;60N|L zR@6~o(8|4JH82&a>O;ndcUfw@l2{)CerfgfHy(`@X=8ir+MVFwphrRC;U2HJP|dv< z@&9dn;5pnyWSpea z0<@a{VFaowW~#188hh|@ZkIJ4y3WJcI5ZPn;l`M37R zAdVpq;)N@j+S^&#F#3o9J^Xa=8pru`J~fSjxo|!*LzG2~9~@GKX9q7Be}_f* zxIj(5VnkO{h~F_`YkXqNS8;xcz?1nIKv~mEo2Wj13z1O_F`T(1u15b_ zZ?N`__nH)gYt2<#cc_qhcz)wE-e3A+O#n7Hs z3GtzCpZBZKFuQa=WFj#GJq*P^nbWHQ{!Kkr3r3a)to*OJ-An_f? zGXJ#Waqwkyg1FKS@k4Q^&VUPHIsf26*nCHn{E9B?O|@XM?QBH) zaV>V+E^YcDY$$+=-hZKD@5x5R z+>uB~19U9Mi^CY3NR%p>fW*rvzyn?3j8LB#E++wTu_Y|lq~=k%*mFX1pK_qxK1{t1 zb)RNbg$y-jQ#V(oa!`ukS3U1h$~y zN({Kd*XxXCA30JLP+CD)S-s>vt_V}@5{=0I-zh^%7~47ieCdt+o?forK0En3K2;7+ z4ARX@#EqT$k@-1EOC@gMjDJpT5ufgF4aUz_*$D_o^Jz~mR|hdDdwYx<_27Lu7z6n2 zQHLk+c16lxst%u_4cYnq&#;KTGO+AnN>@7JEN*m99-)Th0`=^8?E#oB`4~!=s_xHI z+*6nX;5O2izadrP4NVZy)P{5@j(S7nB}gt$Op;jbfj992|FXwN-Du$$&hwD+Rm6jR z+FHyB(P`fI!pViP8$Fq&0eg}?`70Sc;2)_geP#L9%NgK!rM1Wf;c~?T&zJsM0>H1O z-9ikBf39)kSrL0s{7+rGyUpvx8A%a&sNf7i{%=5qDWGz>P( z_MW7f_}8Ql4V~IJ62^A@Ix2oMBVMd-A!S1qG2?z&iGp92J*J4%sLHwX-KJCaFV|k3 zhgw_FE`zHO^uFkgjZ{yKQ@dcmkR05luk}K_ZJd8nQ7#|QuPxu8lBkB_KRPUIS|hKA z3r5@Epe)V8!#x$Hjp?oL+_`rQIk$09VvE0r(?&lacQ#{2xKK$Yrav&;OmzjPLKuH^ z%yVr#bO{qz1~qGX9k`yp7)gMsM{vS7AiGo#`t4Av+*#NI){b*J$^&pyil4Xw>b>~r zkh9?Lm*OpMfa{1;(c2v3r79c2)7_xy*SdMlq6}=DPf_*$iQbZ>H(?Kp5H4*+duMYg zy?-D>p-1M$kpL#rgGu9)}fCV9DBr2w2~jsLB7c-lB?0k#WX+9x?3Zm&CPv<-@h0oz1) zww{!<6qAy!oplc&-*ukY();lCpJP7xYV4d(7;@tjvusj*NSiL{ zs7k>I6mvh7p$}$RCh4x;fkBtFW|UVLdlP`ZC^&frV5}0?DR(KUe*qpN%NNLSkI*$Wlh8X;rlFQ9wf2jXocyBvZ_@RH{o~t@P zBQvx4ZA!Z%ly6S&C|714N80~5-DvSQ&0LFG(`%z`Ge;OXY3&&wgj&voukm|T=S7$aAuF(9T>HE6zPel0Ol?0F;s(wWrMDc)-(t@ zcICOaV7J&hj&`$akaSbwSCXKV6`JR370l;#>iv5%xafnJ!Rkzz8>>U7pYMTp)(&Xu zi|sY0ZyH7m@NyDfzNmYLr)7K&$5)#B<|iF^9I*5{6Q}Z<@@U=4Y_y9>vXC9rJ&JJ_ z6oSsClgs>%m$_7{4{n@T{-gd6>MtH;>W#u}4 zpwzk49(JaeF?ZG;G28xhXrlLNa0WocL96ULZKL!m;~^4a-1GBu6PB}|i6$}e?;c}1 z>o8h+EKQsZk6-Tf4npG9#~V%Ean!+Q1VR0uq51U-^SKoPF(YNYNg>_z?cjYSZ<2ty zAj2Uegca}1z0rB#Lv!PX!1fAGE1(|z3^%_WAuD+96*)q@OeLgwxE~3PI$BwpF>$pt znf4^PP&|BeJ?bYytQxAat}$<~%Mv6`VOj4%gh7U5r&047W)ywlLbX+pHjM`jzJ{Ia#wI)WK}6Ts69< z-{rN_Y)#=7CD7eOigoDFr~H3Zz4>3#>HEGv<&@J@QrTpsNoHj;m5eoNE?B~m3Wn^Y`1kEn0 zn=I_s!wa6BqrR?a)b8#s4j()<+zn41Tm2ZH%t0M;|L&K!%g1jyLZg z+Hcl_*h~1z!#?sdLU+|4_nkyKL?!o-&pGG*h;LB-k0vp4^~)N@OOIRaJ*Aja@zCyE!pt*8Yt?H5J=dl~>k$?0 zTw^^(OyaZYdqn{*Hw^1}%~rpq4~Io#VsmO^2bOo^{R%H_0;;a?cj%qyoYX6?y;D$S zR@Cz42be8FHcKIcYW9XwG2(8c#g>KGMm~j6tq-_SS4=X;Eo};1J8L@ee6Q+O zN`8OZxu&;HPmZ>#w#rXD#!3Fr z5tgzw?a)@x$|(-!T@`;oeJXBlLx1^BWhrSQHw>w_^Q?M}zpU?!f;Yi-36^wSa}MJ# z#S<`ilTGtMM4^vcf{W-S?85L|q;jbL67bwV@ccUI4p z9cEY!T0JogH-{~eju-K>NFBj^=_?F(z$6zb>o;klKQUKhwzIg- zqZQGg^i*~vCL+*8%2n!JeXj`@*D?k<_reU3+JioL55^z(ujfHyW$q?Rk7~Elsp>yd zeqyuHZ1WJK<>VpP+YQ*&9|EAQc1GdhpKc8|FD=b`6&SDw+xGdz0y!hN*?x< zJ$9+)Ty&qvvS2f-U?ufD;8Nqa&qe1WmQZVD-lY>+NNaCCWVkCIVaIlZs1D+zJ{~~) zo@06l`c#C<3`gG)tm?~(FQHVreqfYyrz>v#se2V~5;gnGitB#`+e{bdHFofWgjf38 zSM=?uuPZCPdME|v^C(7V>G|FMXIS1WLvV;{u@Y0i_1JEw49br$aGEc3FXFD;beZvp zga0*q?2t0%I%P_^CnDyylg|fUUb!nJar6{(O>6GI@b^`i)7Q44TUlN+wRvOaTC zwbHBsu1w-JjrbMOiWaEjuV_g0+2y+<={sC7Kh}oU;-e&tOAzhxNx;jX97_lAWze=j zc#ABc0eo5Ei(VTNZx1{LtP~|!#09)nX1eRWy4GH(7xdJS8=kNgNu3~55?C`8MD2@S z&%3xQz@L)hJ6VYBQ?H^@zy z*?wSe51rl~+D4e}n(v>q)(X)CFQ7JQCpE0xJI_3~7(9Z8oU>_lN{WBX|2goEVb&-GT zM6EkFKegQ+X}&w!Q6u%O06A32t7_2~=d|;sf%PGTjyLGrn}PYN&eN9gn1ble6Ua+_ z+PH*K+da4PnvE= zbU-OT&4{Rt;Kz_U8et7e2wBiID5C14vWke5tO_sv2>zVxv8dzVA+i^6YTRKt$y>W} zcOu(q3m_JFPtd@egsit)=o9m@&Wecj4OUt&Eccm)40$}f#k_8)opFj?;Ee@`9Z9$+ z%<@saEPTKrPu~b~ZT>`C9jN_1a)U(E?J7-~5EcC0$reWjMh-3}8M4J(j*t8DkA8qC zfc!uB8kin6>iEL^xZRyYH?#-GJie2QKh4@R-3JnszZJ>Wu&OliH)BCP*vE&l0{FS*;2h5||c*(Adf!5u|<>&Nu8Pr9^ z;Qa#Vcq@B=IKrW1B!LUH0JeD>lG}g%3e`p!Cd?E*EE^W7H%2P3HJDOZAyuRctad0q zdj_|Objr+Tm^2)wI?OFIA%^7MP56%$Hpg1%l{S?dE(GFL?Qq>VUDv;|3|JA;wY7Mq zep^P@#MNZ=mT{+L2FeA@Pw{BEw3KmDJ%1Y-6*K1-g0GC5BA#R>o+((qJ@w%PF(C9( zsJEWrQCL)U7IO<#>!tE;KOga*IXL_LEu_)lp*OuKNqp5hC%wmlr&y-7EVSx6rq_jw z(9(Mv-6PR|oo*d{RHQE=;D3m?9nrb6W7F`e`7M0_u(coUvwGDk?SB+v;lwz7i_rZ( zwKUdO@Y&EX0?tmAQlz_Y`Z#^e^zd7`L<7PcPx)soTB{m~mB78<)s1hUa$m(spA9ts z<2%(hF9_>?1_P3ww%>11YK!p8Mcib(gQVK9G%)7Q26n(D%1B>Hc>Rm9$(Ne9^b5>8 zk+}z=2bMD+yQ%NpbzLK;*Z@y$#^v%j`Ld@qZ(|-jI-#Y=gECZBa&SauDjt3l4-zoG z8YA!@rJYM4#SI&L+p32KRAdL`HrrKno_dztp2pu(jzNidLlO&nQG%($SA1TC2HL~L zSQugbbkt*#LN*I1{7iZ(>oyy>OJnPYKMr=}8Z4z^4QWL3r=+;ZoCO4eQ~bJCuO3kwsyF;VBNI*hY$M2RAgy3wCqlS?HYK*cquy?eu6+!qnZb0=F|3fNxaf_1Z~rA-<0flvsp? z)@r6qThG%l;R}r9DZaCCB(6wger|uR;3XYfkA2XYVV^-Ee}cy8?*p<_0G6vRLVr~M z+?8pM^$buAm?)YQY4b^( zFZKhj^HxG%;ppY`j|h?Zx~S^@YJB!e(ax409#<#SUBSERwYe1Tm`A!#HdbGP;BIr}m_<5ebTnJY;>uklN)6F0T#YWi+4`+iz9cw3e)k zO`j{Tt(G~<9o9nnMZhoYC)_zS$=6}_G}T4P8*vU_aM@r(ph^|*g~ps4+CpU-7ygif zy(hHMJR<9#D(Ft=%K3Vza!W)MckmCV*L)uUy4U|v$)|vNHIIAen%`K1r{|k`=(?6!_boNr%(Q$G z<{Md|_1ToE?tTMJ{xG}x3oMC-;r+$FTHL;F$5R3`3HV`Z+Pzfg;kBgXB_S-e*8auB z?Tp9v0ex3P)K@wTO;5ZHjrucYCWo$+IZ`m_Na8c#U(N@O%@rka5K4nJnPV#+Og|rW3ce8=$Py&EV;A3i ztJ-T-*sH$pel2xi$I{d(xK29tTh3GLMQ4MARanQUL$Ep2ol=P@OWk$pY*23W5k2w< zgHD>tJbNO|YT?_oB{!V)W}9d;cu8>8HcRGfVyxsRLF|y`WNa7(bk((;J zN0g*KOV>192`<$JU4=y*__j>Q0jTtU%Z7*#VTjUBkzBYA7MIu9#yvn?3`s|-D7ePu zfU)7+Au_6nIH3W5hHb@>Me`6Ae3u_=vglLZ>)1J?XHh{u+X*qt>#WWiwo_V9Ntk|-8HJ2GV|>f1->m}GtMEj5$8skTG!u0i_I*s zGaI~v`SJWefOE#a&HN(d?G2^qG%8>;b?P@mo54jF!x@X}J>a7s3~XeNs6H|Jkndt6 zeyJpL*U(PX!ovRPFmKwopsIIn%cvpX_NAHDLQL-@X&3%F=^qgko=jWbnW+m0+q+kK zMjr{r$`7?0%SNP+A`{~6HRDgt-a>6dg@w32P-YhSOsNBNs?3XB{Hbe?)Fng`5efbJ z2n(+Rx_A<11U3#CNDd53@VZ&2=@xoJPHKGARsFfrK>NpiN+MlsLIA?QBF4*$V} z_QD(5-)vmY3XobBwW0f%nv<7DP!q1ybhbil;;mog{(lTQMC013JmoH= z!Hr#mTb*uqFWaO~Ft{>f;kBO!KW8zeaYjyX;BMrA55>VLCE$m8jB52T;8*Rc*BU|uP7|x=u$xVk6Yd*=aUU#;2sK3$;%B=uO0ub{ zz`#`NF6k1XF&&}`zBx5olBD68+Sz*sJJdW7%T$|&(`~UAn>J`FyG*$^=f}+i5fwfvJffp(!b3(rv zwIX5%-?tC!%vKoBfDVfj;Z*&k(ZHMU6fcRbbR4_@R|S@y1*`69tnU{Xz;jKU^Cq6v zK5(m%u_WKU#f+gp_GqSa*>BBWJiV!1s|mSGvkgzNf*+)RcIBWU*tKmN+57d&`R}q) zzMdRVSz|HE!uR?fA}H z&QCpq7!a*6`fA6Z_2EnQkx)x#z9EiOAWi9XN3ln{^9vV@bjtB_!5a$>%H^E^31(09 z1hkIL57zUb5X*>&g)V_}W7K%pPVgEvq0I~eNe-d2 zKl0z@ODwP9jZZdAw5~#Abk~ z)adSrz+KWsOB>!^y4%=rfG@nh=%nlcl&1Ot<9sAmLc-lbBUN^n6yH^k>9|)!dms_P zG;C?lPLCSIA;3zHsPeVJs+ZzyZ&IByhLP#V9Cc#Aad}y>P}iv09mVf-Y(r-nuOsPc ztKi*c5(1K{X-hiO89w!$ZmW%wFJ!yNDvV_3y6x?X48@NVq2l-L$PJdb%2_?P4<`pR z^#!ic^MIucO&^FKZV>2cFvg%ee{8Tiw9?59$>1{dhlC8K7%DQJ_4q{V&pCu&>V?Bq zets2!E8z4DD*xeQea$d+WnFk=r&oi0_(I7_fEsp$W=~$DqgBDM>k&4Kr0dwxB~dC| z<^f&4$3pjVL%ln`9muQZhDODbrn|i>Oa}8DtICEEnMisp`d@SnbrUQw#_^!|m#Oa1 z;{5kl!x|i#VWF|E&bq-Gs1q_Dzyvfq95hh;LxLVY1OF2Ai`R6Qd2dI znt4@#zZ?(|5q#*8=3MAU_r*-o zL?om(Eu&NL;GlYMt|ZH-G;nS)2Wk12A;TC35DZRqkOE~JJi~%X;)oZL@QV@XWw z#Q2JY-C>ZandV)6^y$Dw{Y>$%Lt8I3AN1}D!&E8{geJVnI^>{}t&1v8O9nY=SjcFa ze||vDZ1}F@?vba2x?}U{uW;XE97NCLM*kSLkeyZ8#tu)5+^2mBgLvvV6_g&{4x)#k zwg8qudi+x0p{ABetH`S9`uq8)5u8~8b~hevIPA_{?6N8em;el9i0#gv!e2n<`lnnT1~Ayyr|o% z@B5&=@5T(%%Q`4?$Bt@`O*#uVtigW7I~h8zN7cyUC->kcO@K2ml=IYs1)$sggBIo? zxhw2Evg6_hByNdd1*{)cc-FI6DmNzf)k+lGHy`oB9iD=F5yfdmVx@rUspcf}esx*! z7n(ZuLS)oG04M4}fOE(>zMQ?Cd*GTQMrPD!vKQ|x)||Klo&vV6Vy)k69~K1xC*qD* zTi57*bdaBWETV*eWS@^x6%7{z>Qr+9Gf5{BGP-Bo{cV(QU4d+9U)Ay<_qx4}iKyS! z)`v+B0H-lC*~*ss(EH?ECC7HJH}>%U3A#?cu+0i6?MsP445=Qt*L&%1DUDrP86;Q{Q{rq)o$-Q=bPop2LP9a#w7*-fD z8U_&FVt3ai`e7wD;gnD#lA zLXW6ET8Rcd%Xhyu6SnJ$?yBjFAH0#w@pKxPCNX%2*0$9;4s12KnASAK9lXp@-Oev$ z+;{sOj*|?p_i=bi7&T)>PYt%#Mt{<%I$?I4JDr*vzl-w!;GajJVDzj>M%zMzteShw z8xh+}!1J5{v(Bu)NjcKbPchAe@Y|hlFmHMrs`)*X{-XiQKhK5n^+yTve=8Er7NXq_ z(^2milb7AGm93FlTet&eXrO%I6(-l34Jk1CUR`Bj>J3EDw_gj5X_+<|jT~@s~zw%x7&U}(j$lt&q)0SJvW^=2K@CgtHs8oH$lfLv) z_sh}0a-6vtI6F2gPH0-Yt@_erf3x&My5O`!ab3M?(UJf>T`yfl)$FP1!jE2=Pj75Z zVI1#Jxy-uMt=g5)(mMmUZ7V{0=rbmyfLL}S#^iiw&}!A+j+xaQzJc;2qnMAi>p&NI zj=65AZo$WXM;9qanE%ASZBGyFbGowYA4A|gn{EpM$Ibp3{R9}-YT+w6iJ25QtMm%4 z_I^_wi*)PP2FB?k$hCe)4m;Iw&8{nBCNU#Y~U*Tv8te6P#PbRA3SXGiJh(>LT@>Z@XSm zPVfQr+CW`nfr$b54wUA}XM!n(=p5NmdNAQLGQXHw35-G zqCX3dsVGlfACUD)UbNXm}23Y>HB@J4w_KsR5K>U zWFTA>bkLjm*vQX8?yxD#=z?h=bG0DrRxFDwzwuK@F=|5AP?8;iWrzyeK~s6Od_Bj( z;F^l(8cFTH-E98MQpb3lz8zDcpCC;fx06zUigP*ip_GZ8mNoHij#~W!rA}c&N4{D4 z$BcZ@hajr(rJ?$VjXlSI*Ua=CKww!@C%jh9UF&Y|XxehhqtoUA=p za}W3k=~A?_KQaQTZKBgAK@9%N#uB(SuS#r>d5krI*~DS_-YXAH$~mS)Vy|&zX#i-2 z;-l>thYT~$r&twuAmXzaaP>57Zia?nJ#J8#1FudVy^?++ek_`!%7`4OzV$2S5(3j# zub?{%t>ib<2>gjG;{bFX^#guy@ThsN{!p8=aD1tpeP6AWIUPXQ3581&1S@;=2mCQ1 zpisLK+CHl1#zwv4p6clQL5<^w*lxGL+HQ9;olSn2zut|X@~OrDjNNYeE1BFX#CWC@ z@>kN~OEgq|*y!e^nHIluG6NP+wmp;2ap=fNC;DN3Vx-vBuK%D1{?NbrY=eI3KQ z8zV2zDNb8)1m%Id)8n-3>^RmxChL}SR&bm574|-$O57Y{EFk{qQzX1$W#j1mjSgc0 zLCbeK2Clv(mLo8b`WXwc^$(1%qNELR*7oRMk7HNa)zACa1upH|#`WCQp~4AFu{ibD zj#?kyCzM;51eaW)2ZL!i>yJHiWEHce7i+YWOn-cp4Lm?Dur9is=1mQ{FU=yjM(!$Y zonfm_!Ef(+rRO+UxJOy%(59IAu*#|D5H$59r`q~ya^R6T4@TMA$$jEVJs*pb*rHoN|#;*J(YN;&ssnxdhbL@(h|<` z_QRSU91aN{js7X7JvbA%yWONTQo<`c9D=~SBE%!aRb zqi;sk6vZz;MA7$bT4C!6P8e;Ypm0JM-2kC|UH(`5Am|X7SMelZ^4sGQ+Hps{*=C3) zXg?2lY^%Q@9liu@jVz6sC@IojpF4+$y~1zh>Mty>fntKdKAF07C3d{cHR^XhQbFdxz7gt*B9c+0~PWnZ3nCgtA~p7^EI ze%PkrguNo1|8Jyu7wggV4BO;dMQ*24y+#PgoU?ZdEvLM7x^iNArr6@C86{Iy##+V0b=V04Qr$-L- z<>7)3Gr-kEWy$_nJHXUz>)Al@0XrW{`6=jZhsZOU*YiHb+gusy91*1s-eXR_>Q{)cyG{O`oioFU|Va@$8+-iNoDH4^>%YW|FvJ| zHS6H5+?&B*l`lsCuNMpYqP)jVSGlzOxPmR!^C)fnIVMxvZ6sq zLY34pPpDgiV%6b%19A6H9lfg>T4)2$4D~gnOQu3rL2kh>O6fdO7%gw_G?LASGJR6L zmUfQ@eQR!SwyN-2-$pZQ`e108Ff^L4@f2~sOSo(--;=rG~uf_{`FcZyu% zFnDq0hZ{z`nioJ9>KW0u`ubTAKDZPZLS-H_4F*fjb+1Bsc=~^C=dvgb9<%y{2L0~; zSdvhEMhIO|d*y3nASLrbQHL<1u@PUGA>uu&wW$5Ici2GmFLn8wDLFGTx@*1j7{F}1 zC)sR4@AWwLOI?d}O}+EyFCfD(!#WRm6EFe(p7)h@%z6_$AZqGQdb@#`-0i>3zeZ`( zGw$JRa(GEXfe#ek$Tk3K>QYWjEO~HNwUu+4EcqT0sJ}~Ny5z(&1=6y~_AF9R$fP*r zT;NI%dH;3&Cp?SNyb%BSvi(wJEfiHKLhS*fUR=DeaH=%Q|L(Mgkc9H?Xl0wjF?-V# z9Rp6eDZ;=bltbR@@7|c8IK=!b0v{1+pLoPZu2?{2+kLG-kq*1X#XDs$AoEq3g#5lf zby_X1%?kaa{<(*=62i`|m6o`WSRWk(Cv6rdCN1jO>mBC|QU-0)AKTl($I67S8az)S z^gpDHv;GtT?!Cd6>7@rTWZ`mgl4nD$xqrCPbXX(ku1qzBmiYMAj}KMjCgJMcoqxAj zo5~T8F#%V0zHAe0Uf{+^#9GJD+t%m>Yo*0L7Wh;`HDOyB2pDPY=OMa}8nXASd)A*s zh(YS~;=r;_wV*@FcCQzHeCKy_-&2V15U)NK>@ zQb0KGwIQbK-CNyD7l#>=1G+|5Bnn&B!^B^=*DgQWI9)uH>Y3&dPl&l9ybY@39mOv# zS$_#Ipsex5k@Yo7P((pV7%tX?(zzgjE=@)p(o{$`iO$NK0EoJie)vgaNGpv1yERoO z{ZXSXq*HU)09mhBOXj0pJQq?j2?RGrxlgi@Lhk(M-;lYnq?X9$w zsYlD;2Mzfts@aj5`C<`cW@KpD5vdfOyDWtc4%gif;s<|t(+I zpk`iq3m03CdK*(eJd>@-zoKg&QbUiz+^MMVBu)1#ens8nj-}kyzLRh4L%0J@YvOCI zZfdIowG2OvJ;~Jg;)7b7$2;;A&KA(k8D*HsGEw~huS$deDLi=>t$XxLqu7LG_sOmi zCcT%vV>qLuU1BcCFc%PF;=JsXgpdQi(I)A<*iV#}7us7VBN?{!-;XU)KE*zjd|@Zk zReNsrw1+x8r|kW7JZ8L=GxO?-QPgj5%_#A)-S;pHYZ&`FukQT{a-;DKFp?{0uLZ*G z@E0~#1k=8&f(?dEbNA$enFf8wN#)1br@}39AymiR*R)$em|{=J7ewUC&qx9nB{!pjD0tpS>-ALayWR5N7IHEdv? ztMz_?Z}&+-@xnA?16yW@4?FqA*>~<+0Xf}sq&WV7Kh!DEpHh2kwyb;;BK8%z!nT`U zDXvU_PZ?YUG9^dp)KQz!Am`Z^m_ssEyL=B2KK^Y;WyLWrBaY;Nm{#xctY4Tvss7xw zvd&u{OFXUn!`?2GaB*8X$GFEUuktxN^6HYSW;zw#ZAy$O%x*l-y=X*Y5BhoAmvW^b ztvRMSGB_LpP68*k2z%vm%W~dAgf!o;pi&v1TVtq-F^bvmOOCvd_A-ILn}T^g?CV}r zdC9W+UGO_aIu(^#(C!JrWGW1{e%LQ+=mjXY<6fFMq6;Xa>6^?eSnk2M1|NluIBx!9 zTOn?KN7&)GU`>ddjGcEqcrpDpQPW50yAfi*>-O2G8a<|oM|f)AlA%%ACh_+5%-Gz< zxxs(%4io%z|Bi*IWVkKTN-zB-eG?y*L;C1tZ=Qw_e@(ziPvAmg*jC_>bG4iZuCja^ z>JA?HPB#}`r&_i3T_!LJ{5QpaR+@5$eqAj9BxBPMSk@gBP+$PO9AO=)75R3Xq$7^h z%^$TP>k(cUqh+)4hgT!-2{xO|EWW(B)buB&@}T_*?@~yT*5xBG6HWBg%Mp~Hhn2iR z%(|YANa5hKc8`dIN884KO=k?KhaPvBBP-`bK$$KmHKO%`R|PJLhgwy<^HV zen<`65r z)Xp`|p$2tIOyAsY-Inl(3J3R_5#B|%eN`N*C~A*MT`bX8(cIOkbE6FiJiu*=4*Nij z_`1fZ4IdE~(NMWmqa$bN1m$#s)Fj@63bM$vchW4IK4$o-!^=C7OC`(t*OmW~W|JyS zFZQ`@3#SE~a4cPTFtQv`7>Fm-KFyfl*m@C$QCZa0AKLD!>NcrrcT2inU0sQPPZ(WZ zuM!yEp%vG6Wjq`_S-k$S!*8VJ?`h;4yK_w`nwC4(;lvQ@W7u_WpP|p2PrRBR7q8G>JrEehZWJRIw<;0FTYQDf80(Q7Ii5<%gsP03mUf|9In=JhUQyphB zg8L=!t-`;z6CeWW!srRjht@bQRn`i~kRVd@p2PVmUi)dN6!jMK$UD4lY_<^ssBv?q zwY`aF|Fk%PfQSbmhZb{YuqOTTAW6d4YG$)B^wJ?X2TUm_EHYbsX;$Ue2Kksa^8=c> z8@e>nD0^o9+O)j0yx(1-Z_HIwV`N{mE4i^-iPN&lUiEWsc4f2ZneI0`9U}|c@TTkN zT203<7ww%@He|zTFd+k~F>Op1KNA{b@5hvn8oS)O(mW0GQL%qn8RE!*U-HPQ=;r11 z>IN51!Mn>qPIT{eQY{^69taRi?>q9#tGA=y zCMUv*%&PVkQi|7xdP7gtS&m8G8KSzumTF8W*Eeui6uVjX`#+$PcgyYTQ(8Oh@errU z)aBrF*Uk|mEupedbh_Z*TfE7>2k z2cov^IXP02nh?7U-g+grhte?9_O-JSnUDePqX0jg*4-1TMGQID>=I(6)(4+%X4hF@ zY4b{1QK@d&-(Dj_R@A_hk!6EiOezwW;AG8-zd>VGBuF2Gz_2G(Y(El9mN3cT3>0m` zITGRz`t6cvOiki>2OfY2%!eEzgpw0v>@J6XImQRhu=$37-k%s(ucuQd;4d<$;8NG;&Gg=SE>zGIwm=g(Df+q#UstqWkw?L`R*hwcj! zJL*)%>}#13QK}J4$wvCl_Td&z1Mvs^^@L6IcvEQLsTzq@U|c^AE9f{+-t-5)kl{y! zEjw{B<>gClk)1DN8>ByoTBm;v9e8@>zxk>6|LLFYhr&}}A8%&F49P|@4sLM+d3pUe1uZ{jGjts85P?GQ=M$&DK2^VwqhJw3P29GQ+C)h6udUBOpD0Ee;J#P(b8pO=F&z*5N0xqZ;g zk>!cc2%3Q@Ei&+i+tiH{0e|b=RqvFngP}(%=knsG!E}x#trozBP<&Dv0;E(G`Xjxd+*@(RI6*2C~W^;D&G%Y4!no;{LSw�{iZ4oY3`b{t3 zG5l`odPHRo5<8DlA$E(Ny$k@Aljo4a=g`3utuA12)>MUt=<&~)QnP0R7^Je%``GL|1oyp)!)_tidnQZl{3Z*{O7|; zS3~=2?e)O`-GLR6{n4Mzr^!cK|waq|)&es(!5VnhLG?XS8U z?o>O^lt=P&D}<5b7HPQ6XLaiAHM3il7D zJx`=ro+A6OcY~OmqsYL#_Vfm&UoOAJ4O`3)D|gRTPL@D(ej$P4CiX<*yb>(ygWB(J zgfHKzC$wfFv@hqdGdc^%SiiyYy#A~>dGSzvym&U?{J|a44YMp$)uW_=Y^Q?cbEGwP zo*gl~yWeL=73r{q-f@_@Y~$=3Xp1_q3jc&pz=-Q zuOy&@3U^CrGvzu1Pgw_zRq<+(wEU^Rm<`A$X`i&khtg?T6~bqFY-Xz1Z|tyLQh1MV zfFvsLFZnueAbZ=xRANTwmT=nAi&$Mbrcwi0FPk3sc>=&{3* zk_kk5q`8_l>YuClQOv?NS^?oNwC_0-9*RQ5gL_IG=J z$C~FLKq)%MTmGYMQuqf^0_vK!k*F&!p)LICc41*&B{PznPlxekk0U3i10qvfX|JqG zOOFv*y;To*0R;!B1m4y4gD1rYOkS)nb6tkjUBjzl`r#i{7{giJqYgd)=)WF|#^U1@ zuvdjD_IJ=Ybo_LU&N^~rpXu!R{HfLybXV(_kuL)SC%>M24-$mLEIFPStbLbfa*)J0 zX;BCIlq{k(sB;6bs;iS*w&=sT>=Od9R$y)L+xDbbaKgkS9VFU_ z*GP%7z<$%qdcH*a(zhZ0eG@5TCoAl7q2VBFy;+H{fy~|K+9jH?&F* zlG(-dv^sN{`Qkx(_(k|xj5r-(G#y`NszQhscg(^gtoa=CssIFhA^`9zTD>~y~;N%!2arHhoY}F7nY0E4kw)X;FYT9$jTJo8h5_;%a zI&gQ#;L>?!)5ak2OBnA!64uVm`N*=Mh-rjkzR%;755BP{=>^qByZqfs#Cvq>gVGP!j3%azN~7(hdJ!2BE{w$;0KrE zP}0qaOCUTS(ZV%uX-d7Q__q9W$;ydwCsk>ueh}P`4ExA5aB0v_hh%3i^_!x7P#J+^ z2Yq#UhEa2!hGFQ3*bd?VE&?y3oM^8lAy$6$IO@n&-t7*w$ZHb9Xoh{kKBR)^PrXXWssEiy#zm#ZJo5Ns%jHud? z6M5^WkUVO8t3^T_CGcmYc3uC1AyjGff6lQKyZ5zcTc)oYe|+W`zLR7Z)WCz&Vb_o1 zUNKUUnf^GM&mMR_c9m@35MZO$L#E7(g}W(^-xinDux!@KgHF(r70_EZ4yO^4fac4& zmjZgsjzy&`Tbw-X8J;kI@=?HC_M|KGXa7A-F`J{he{lGvu_0d{!Jqwo1adppB=^SY zT=Om-y&5M=yi*x^0_3EcFhxer`|en(fmEt4&^KorOO19z287Y2c-AFh`y`oQ-)3LH zS+m3{YL1yrzTZ=_tzmh`%;KHfM!?Hh>d9sBr2WtR>5et9?pLz5=kAzzYuVJpZDk1DP2olF0#?0b%FC`x^RGYk zB*cI!Jl|lY*8gpYhgIc`os9cdRL^`wD^PjO=g+0~!yDe5bcQIX)@yy420d`6CxN2tq|{9-LoUt-YGQSZ^Q{LHQWjNmUg?~nAGX$;ER)X8glCP(eney zbUoqq7hW!~4qEW9c)e*7)xi&WXW`1I-@w{9nPre^YgvOj_-R84bTu{o&uE+HMd$In zzG#uzG#y=#KOU0W;3d+CJ=vC9=%L-{zavbZj0)ZgSJKoBrYsQG!EpyniCUDLr>--ort2R^}ug z$dI&3B|UQ+Ceh>q-vc|UN${1T{W|s! zx+-bPBZF2=Eu{{b^PQ`hgOYi?TbO8FfZZU1Xd0|_m!=$lTOKo6*0KDc+E(OzeD+%2 zIr%KlHQaIP27-y?NSntxfqgq(0G1OS0Rtu`?+qqgG}(=v{jj>MT*Tb2+Q`@ELT`rt zqHlIz1dkUTHTHFvK3ACUEDXP75HOH`d?asf%T|eaTr64RloS(3Yw#>L>EFL1n>cG& zZUpHG(|-q!TAtSY|Fo$O{o#Y@m_I)JLepH1K5^sSe#_q! z;?RR}u~o*sYd%7<+I`DeUMuh4?c{w-$h4^RM^U7bboX3@WyLr$`hn(A=vGk6jsX`L zzq!Hr#mH^vUCT?1r8=>>0^%pJ&}T{1h579b?Px8FBI~F@zPTi@{QICOq#IJgF`ymS zpwbrSewi{pJo9Lf){Xvgo-tqbL(mgsoe9~$$um?{`KB>abzoHJQJhmkIy4qg;Bl~> zJi-dxI19dlJxQt%7nrF3{y>;Bj7T+E(!W!o#_OccL@6=;rUcWL)JaPxl;|BC{9tSu zGfcmjZm99_wDyYIjsJ1Bu@j`cT@pR{x|ZsPt5~R7rOC-fnuu4;g(eWJ3K&+}R5*gR zn$od3&iv8R2}B0qRdg^0wU)pO7_{1|p6;qbiDP4Xzw|Qanl;P5fjV}s;%gv9mm-f1 z;YO0&Lp~=(GiaANI#I*y20_5qLTZ%*ed2j2zzw1d0tLqLPSKBcsva(9mMCN1Gt34| z2sr#tN8Cqk#Ky7Zt%gz;h?{Mn$&y}!vT630E+p_K;Aq>w!tcE6*082+|B%f_?_}gJ zz0Wfr{tU++uc++0o0k8+4Q$X=L z9);O|ohou=K0c!n)-^23j$;y(^VBFEoFrD6#&v$vD?R-~b=W<>>Gw8QZ$mJXVD*Uo*~ ztrcvuN8q~PcEP< zZ4SPGG?$?Bb~<(5l>9?SPaBKv#Ssz2*NO49)_<>XE6kuL^*^WknG^6qO9tje4IYE z&}gtAZJ(X)N_>>`BvSWDZSQfbpBWee-r7eJe9j)tr%isX#dcSUT;2S;imz!u7*>Ll z7a3lN)Xxuk8$(B8lnmp_dud>=qs3(H7VzJOgOJ;Gj^Z*C7S~)>ofI4_lLpsS2GhaC z?AO{q*kKMSn8k8L95^#CEuENcSut4nd;lrBmsV_CloZHMO+W5dpY}$>${xT2zRC`* zvW!ef{Sk<_{NufAnfx=zoE9abDHq9HEjY$`Ff~Zpf}2lO4p#tTC+~~j{XeGOJS@qy z{TrWF$FZWai6$2+E9!BQ@oC%z+RL$`ZNgk2wHYf-#9h`(OUsnX$|e;uZOl|~$z7mQ zL^HKT#0^mtQ5I1V5D@(FeSh!q9^ZfYll!`_`}~}r%{tZH_6SikFgqRiZnyf#$&GJU zz!Ray=s=KzcV43@zEW5Rj$o#P?Fzd!Jvr$FH&=l*UHB9n zVTacJi>ArQ{Ly_}&E*>yV(Rs-?yJOZ-x_(aVhRbQgePkMy%Vlx#tVmnQX8Eb0d*G> znDpI?B2Mcd5r~vrQ88P;mwl-x&)fDNhlFb3y4uYRbu$}5orELSU|OGh%T{ZxtL-?*!1a$K4w;Vw@Jp z4|UiJ-b8M#B#%1!V-OkGd;Oa=UYh!~%W(w42+gz@SM-U)O3`x(O#?Y+Z!A9UvW&Bt zYAHVDgjZg=0GQ;ZThu~7{b_%@CBE&xz(69fOa(JCA zdL>qKpTD%fi>t&T5k3ByQlTpD4tgU!^2YilUTOs2G=T;r(7aN`;iu>J`a@)t#!MaC^T&HBFrykaT0#VI1>oRS)9FPVPraW=s(r=HnRTgQ!M_zVT$BL@vP z>k|EufEH#FJtfF(^NRjKa>G$ri5q0;=QIlKtOEb5(=#~DePf&Q)VSNn&i)0v7QSuG zvnyDm&8X&$C+$i-Qn=OCjlL>C^68L#Vil{b3QddR1JV8D+4LDh^CZONR0ljQL;aKy zS=hgQsmLnS^#rY34;yu~i7dcr#Dm;BBwO{Pe86&P!dVI86FRS5-xB2H8V(V-W3w4R zL5o$Saff~^xbyIusavOlM4Yx21Vi0;e(TnmoBl1hx?9(W^|LjSFU=PKz6xPFd+}Jf z&Xd}!=npJynE4erEq(I6VQY>x>kQM!);PIHVs--#NyWsln|%W z4{)0UGj2LuC~A<~pmSR@^R{^0BCFG{bs_BQy;jHO6hMbiqsvSyJ@58Pf8%0=+M$ox zDPV!9lm4%j%i}YFYNzh9)OX0M-DRq4q>74i@9mk0jW5uHbR=jvwozEb%$h00H>>L_ zya0n)>B@Q8dGAssxSXFp2r>t8s0b%)F)|)}d!unECOflJ_+{>Q3=v=9ayKLCy9Ggv zGKP#@G(R2#I6^+1%^Lg8QabMlmegW&_l0Wd80jz{?ztfz`UzL>bvvO;%QMY_sF+Gr4ICHu)NC~fJAJ%| zZ&>~g4J}7Bk=|bnC7(ZHIs+R2@9z0R=3or;G@lR`Ox(&z4XI33r-rz0?xV%}7)D|| zDkX-n^%z_DXg#ar;M+2&_h@VBufy}?)rxwUxqTxLX@RKT#5N(SBXei%+3w$ny9kEC zHEK`#Q^rkm*Vz6x8_57en3Ykguy&oudh=Sx;fa@evP$sxZ#40N4pX@p6usJwUFjX* z%Z)R>4_r&XCvXs@itDgt8N5FIKrkiAL2w zCJ-dr%w{k<=gB}C@D$_&@ussf)h+}CeZR|oo44Qmfv>2jgaUH{8lm9n%9iz9!wI!wx8mc)BVQD zIQA+`8Tj9~Su@LEjuGOk>PyJHE@;v1;%+OfP8g}|MsFMUC<2W zUY42nV2hQHV&_KkOSt-r>#Exk5@jwZ4VXPdY&kVx4aX*CMa4CuDpFT&4Zd+@Y+Nu@ zUemg2ogt{}3*kng=?eK!5^d*@?rC~S2S!$BNVU+lZz{c9Bc{NY*b`jLeyP`vYXPs^5&QcdB=pYc3cBAVGK?f7sdPxHdL$czkU* z+tm2XQD9R;)*Y^fAXQP?)l-oXo{}{|{184W+*Rby(sobZp!0*W8~@J13?IqFNBWO7 z0|X^eGv`BxqSf9bR3Clnzc^SQK1935V<_PV^wP~gYj9`tbnW+&gNQs9=@z-VBWP`g zX2c|^&y_=YX*thph5Co<5ZwvJnH09kx_WndY~5uUh6<(U0fkNW5f8rF=h{HM692AL zcKrg=9FTXvAd=f;{mZiJdgo>tkZ76p?8(XF9^L2brdqtFhaqYH14W76dj5W<2h)4* zEw?e_Mbte91wd-oa_L6Ib>xb5xpHY%camS%T#a%;Q44MLoh+N`RITdPF)8f++^eGWRWcIb9vs8LrNWJ-w8XJR3`pOMIm4AKOHuO#yUi zOq|+CdUBky)%uLvrP6La$->4#n_*msoZU`;D*F!m7B*%$9|3nl*YNI?gy#(n1f;5s zDU8MG*+om%eL*h2mib}eGea4m_%ck5F1sNfxEw>jA#2w<68Hd-FxT<2e1TsJPI{}- z??iYDKO`8PTK)t@psEir{mScIXJs$KO)2`i#7~wvCGO|Y-;_UgENgU)Ct`?qI$aua zw-aZtP`=*Y_d5_M{pV}kFm&4#^&9gRTKjx%6I=f@N{w`_(OC;~ZW^Ke7oRn5QS}a* zTOVG=X|4n_Z99Wij8eKgH@gl|Uea3;P}vvN@&a4M-YMYbrS)lW|-9~4!qU+ z|HcJX5gWZILR^MCKnJ~SaNpd_&hd4t_gdQf%*zSz18Rqv|0TZ~YFtIpya|0IX#C8|W7|N~d3^TGVq?Q!-hSnyqpuv8$)@JMDRTF{=2K-7&)Ty~it! z8?ss6<@G(0_G}fKow3*{_HT3!&UXBO@E`loO?h6`q1a*=tPtWhrdDq?cY0cbs4Fwr~k0LLOZT4lLlJ4m=E`r-oP<0IwI@$CZ zf@aE_rt8W*Oqvs)wN1qn8b8*NAf8_yXBD(kW6e3+b#s?l)e?|Y*PQg+uCTJ-bUNCS%KcXch&puqlLP85p)2ZOb@^Zjq~I9 z)eM=F;1BgqH;Y*N-L!3PH0IyC^8+{`6G(**lc@@V`*71oZgeBxiY*gAReOvXe+p=RsvL1- zi*bY8EK}Lt+C-v%nqWAPF0Vx*sux8-@>~TEuJ}%%7N7rWy(7k zjC^Kg^{)10@6tFh-efB0WFei1J+U(@E4+CUEPs9i6>%OLD$d8o+Z+D}3oN3w);CJo= zf>`!1hHj4~Uap!BUYq?~b4qHL2A1=hi}Vi)DL(4u45oFU`!-hecrCXEaD-RBII&<| zy#@QM$o_ZmWkH6}Bz{?9p(`KTv1pC^Z7v)$moOx4+`zEad^bJNqo`0o=l}e->~l`b zyBb%r2jq_~I0!YqpZi;$BeNc5uAThk(3La}&zI3i2~Fc6$ZU3j!L1skD9w=Gnv2Vw z!6>9JlX0Wo4-utXYr9%C0W^`)mKT5{iTd9b3{3J~(WGfKgn6>sqFL66Q#!xwj>n%m zBuk-q@7#ohV*EfceQ~$(e4tymp2;hRWwX`N*)5Pt@YI2mI^o1fBK-z;y(C1n8yK5F z_R+YNDs3z-2^TN&y$caY_(t1X6!n}FZ1(;6lYTVB5JofSPLiAKRgEUBe0bZs#}wU; zAW6F#@sS4>e&{r&fa%fRylf-YCY{h;w%y1PuGw8tWIPS53rb zhG~D`8>j8?h^P#wF3+XuvjT?`p10XCWl6FF6h8Eu@k5oAz1YECoW-pE7Kc8Ane7d^ zUlhZL20YEibU$0f9XkUqPhbSsZkCYbAd^f8lc!#QZa|kpMLT(SQteagrp5B>a+Lq{ zG#-j>4Q0X?{l_Aey!0yE*8U7Ns8{(@xwXmexcB87bW{Pf5508vb)2L_lTGf9QBZ== z3-=xW^~c!V^R)BrKG$Ul{R$$Eq!*D7*GifNRrOe!TaSfweHdI5Op&ilz}~V;CB~r+ zx!9PG)zF_MF%6P={U^!=8ylzkg)g_9BSnNtcH!7)U^PG{!00{&qj5#9F4b<%A$TW+ zk~W;iCHYAHCg&t}aM;XZWQI}EL(?qd{mdSdCDpTu>dFls3$>&bpyiA4f;U~@Kw?FQ zHP_nwUO%l4>f+rI?+459W|(K#Yu_>)ST4(8zPXE7PIEUmsoIH*0i(TE38$sio{x=& zprk{#7!pGB^eFSDy5GOjxU$2_21H&iZj56XLyT?KFx@-U;CcJH3XC5c;he(=1Hsd9&bBjwcl6kE003=Y}orpi)#q zTt2hoc$i#VL)pR{x!Z{te>j+W>$<;Fj2;HNa2_Ujz}u0HJ5lfD`ek;b!*J><(7vdx zQ!VowxVaehR$bp=mwWr{(UmS6%Xi;mnGPENWO&M6dq7e3^KWx`N0*~<@yxiB87Y|z zV!OgUu2kyQgOp|dQ?Ye)x-$^bV;R!3eRb5`%=E9OmKW(2wbyqpZv9}dzxnt4=uy;2 z7zEbqo@s2$$SLoK1c83bP@oC;bG6La>2^uzgGZ+Xocm|p@S#{-RJTRFXX`cuIoV{- zQ6Xd08zsB?DGbFuNGu`hEwAp|>_Z!K=tr0Mi&fOGQp+!3#cR)+)FX7<7u^AAC~+?> zF-8M>^NUV&mi>rnKX#)V)5apHgDW)Pu99%3@e)B4PUNQ7@jAGDi$1JmnUFw{O&2Gb z5Pi?p>4sBIlLMhL$8z;+tKRHT{A!J5Nq7pcjPyvMmp6GD0vHHnjnWH@*kk75-q1U~ z`Xd(CM$(+50evqf8Fuug+lv3`w#t_5o3?&y=v{&Ed>9t`X>itZ3et@X?=!P;x*VuE z5`QWYrh}kIvRTa0$%f8j+zIb^Wpp>Td(yry=8xs>EfooDseQ1Vb@EeV#ax2$zu@Ur z&=tSnTc=KBz=o1Fg{85OQ1Xh zJm?LX*&-fv$M0bqH>xtN&Q`(ZZG}*3`Pgr%xO3z*&+(rEKr?&!W+LN=;EVGLsGMB# zRdrNyYs;A&s0T>_SWqWBlV@>$80mTSi0gfR`f%9%O2)u!4`#?Lp;%}sb~1bsW;Q0` zH!$dWVG=*d|J3#I!wkB@0rnA1l**G*G4X-8*QX5@x|uZbckCz<#nN15U*DBiWe0Fh z950C{d>E+b3A34V*@wNS>po?ihaSljX*||}1JSP{4Zr_wrKp0L8|p78OI9vvdUKxx zbAIg`za5T0#QI|I${G^iVJu{;EIGdj3q8{sHV1Tsg!-rQvd6mEALnk>U9Zn2$ih6| ztgH0AYDewbyT|^M(Rv&tDMC$zqM)tNqO32AQeEnVj&QtXC!%8N<3w_G&NJ}8-b$Yc6P-S@J> zM!%(^vt5~g8E$5T!|}qO`uiJ5TLZGD3t9;mqt@3f&_PB)W1QzpD=z?txeN*Osjo7B zKrSuuntO91molA(=Q)A(dn_XC^6Mh57?`Hn@Bd)dZeLRGTJVPl8-bh-^(MS(yo$v; z;l#Cf9C1LN`z$_{!2chRW6pXIf{u}AH;^Yn<~EHTlC0|LxC}{&BARVx2Y0=v$TJ*n zsRM@8;0xzno^&MNwXljQ07idf@47z!-_I0^I{?U2E)!CTJGU9$V@knS(9zn}w{qsc z$?pX0EA+>&-(i0jSL_5BE~KnxE(${rd7^H9PmfC)1kv0-m#C+jZ#mmIbF%=&7eldU zAT3d60qpN@` z#N(mzq5j2{JwML%e2)$oV@NW$2RE06Ef7j)3*Jzo=dKLqW>!@jV^TRSHXSW^=@NSnP0S8p__dZTXS ztED4e`f8FYgYX~;;cSO+@W#TXdY9VQVf5=QT2#Af?@_ejm7d68L;r#g zm2gp;(iz53H;`(V22<^TZef*I(dA9=kLhh1ypbbR8%{M!$Qk&ACn{N0Wr(_lMYyGD zFxiTfpM;%#uUXcsNdXT^KMSSl20eQGJozxIAJ{AY{I{T9s?X@C7O4N}WVRY_$3k9> zWx+>er0>RdZ{}GlGvR`jVR(N7rjD^u+cxcB?)*+mu6w4M_`xKO#yBS+su?6XmNo_3 znVM)A{Z4tcq((2Pmq=R_q(DTP$FQKpg%sMoqgT$W(KcQ$-_0wtP#-Z9Tmdq(4F`-GDaA6p^Vd3K`i}u0vm_w*{>c` zq#h(l-$?R+vvbNO*`+%S_uJ`+`h`!SaQ7%1UF_#H{lb^AopwUSE!+u78e!$k59gBQUKiEEGIJei- z4avxH57}5%+|H>eM>TFa26&0q%iz=s)PbKsQL?{>LFS0xug>y43p>6;Dl@THyXHoc@RD+|21#~ML`0c;+b!zISi{E^+0;; z706v6Cv}lZpgp8vA@8Sf#q&|49G-7D=+DQfCdH{W&f1Rx7QX*q2cBH)N<;N+_z zMD<+Vcelswapr+|^~eV>W=KsZjcP^8!#6?Q8sS6pW%Pzh^819Q43>D;-6Kue<$1n8 zF}_+iNY)qPGLG1#WRS7FVwd=)v?QXCU>9R3u3brnCamd~<{RBXdN+4MU2%4QNBFSr zRs2;-OH&~J!ND@@O_JAc*tT7`(~Q3#9u8Fh0OR_|?fG*(ZcsCU28(Uaut4WZ?@GZh zi&pk*zeppv%T@#v*JrVf0el*6Mc#`1E$627Vemp&?|J5jR8V&PbC~N!<5cs`%+`sy zv_XHTf%9>9@|HGnw#qD@geuI%G?lvoWI4Z5V`mDJ=fmA{cj^VI2OOV}^Vg4cP#E^KuWRUq4 zrW>6`wNM1Z0x#pXKNj5!!4Y#iMY3N4peF&Q)n&S{S_`Q3m(*BLDfwQ*d`p$RSKfl+ zbrN@HVOCDcypH>n=83oenoQk3+0*UR>rp`2$*hp94L?J(??W=vXfsN0>*h@E8{`p~ z%OQNP1veJ|YIiPmZH9C`TF4odZs}RVL5lp%X^(2OQrB*gc#q&-vVxYx4+@ox4vbH4 zd9#Zy-d`gjXcuB5{6qC*z=Q5~%NXIzE3kgK~EoEFA_EV(Lsqe+1gE0yCD%B!8S*bUQfNb~!lL)ljEeCa>@weOAeW_;6GNW+1aXzZ$7X{BM0pz8>{Pp;q>$Ma74)+|= zFCD_;KS18i-IuMZ!>Qu-?`_S6Jjef{Y<{4ByQ*cqVWrE+rqpyfswALu;yvm#OxNy< z4ANZAEE(Py{)XRM2p!qay=1KG7d$o8&3CsA(%?aLe7NPmhEHc&7)f1E4Owsus^> zun^ubSE1j4mYgwcE+G-ryO+Usl0$W6c8-T=o0=_pk&)1Cc)A1~A(J{Z@}uG~B>0E( z@@Q8yJDfqz=tolLF`jiYJ-z}4e=llqQYB;(c^^EBVXdT- zA1kay3;XvV4E2(jXxXJp2J#47^t>fcKy5=Htew*<^pwBm-UgnpmlW zFTV7ha?rR(>Twv-vNFklzgJ~H8jHyKeifv1xj0CikfBa=M-Io>Q|Hw`j5}Z+R-x|1 ze(?P2Wl(sOkbme*`T|qrqp}vJaCe=H&X=Gr)cOS)XL-IRa_LwnN4(;|>J*S-xWi0f|%yCRZ=6htccpZ%Q;++|1x1+m7-`#NDAt$ba zj6@Ck5zTT&1n)5!yP$Gv<+#EF5Zf;4m&9|tNS-^zr&zBI-3*xV&>nN52JCE+ZqGyK;`Ejzc} zrnjakC#<4IjBuj5e~jKY^9J68mDE4>0RD01e<-p1|?!;4a-rw z3RYWlG(Osc8l`SDZIWQB*+`hFRVhrW==N($|43cCEY*w4SVZ$_8-QE zqYJaiOZE>Ob&r%HFpIq)Y5o7DQXvq6mD?z6`OS12A*xqbly|SFc}W&D>a8M;pW4 z!S1Zryoj=*C1@!&q$x0)hRTJ`KgN{Wt7m1e^ZI3YOx8Jg%<%y942slEg14QJo6c_9m!Ku?#~`%$;N&_ilO#VjrQ4M198-`m}K=XoKM zsd$u9q!!T+$KC0O!4hq-YC?Z?10@lQ7Fa}nOi`;8UpMRnu)k6DowNss4m zYIo##28S|Icz-I7n)=~BeR0eZx_Z$6et%z=u7oi$0qiG-7z%wgwtYJNA^e|Yen*C7 zBMsqaK(e;8%VKs#pdoZ6C&LBP-2yGZqqPp&_2fYv5FG{K=NRSZ#?(4x0w4-L zdHk&Qm@I`EmNMArdcvFVISK&Ws1&vG^%3erQ5xxR$lL%5>l|DlxOW!&G z&tVSQbdjRonq&B!V2)bqiPG5%MRm~C>J=A{&jmpJB1C1BhQi;Vzm8zqKMSSms)IxH@f+d^v;B zkhWF)>v1L$NO~3N$xRdJQpnmLVi!ICRotO@Gh>QrC|I?qYBR+V&26D*x_ANyxbp&% z?@@S6a#0-@(PuPPd~YwF z|72V@tD$&j&;zoGWckjeaZxMDB1e@0{6?-s-zvMN_5zqyktOJHZ96!ST|}+mE6>ns zkd5nR!w|q;8Y|Q)FQ;5Dejt-lSBe_r=%gD6?{h$_*GgrPm&k7G~scqtvLP`;;j7vkd=^{}S%gqgyzhp_0E~S%Ei>BZ7 z>1?a%qixCYkd*hQB}XfOe*haJ%5um+e(eJDVXC?lB43sJhSO1){TcOydEvI+XJ(^( z7aJH^K>3+y+fi$g2O~X1J?EQ2MIr2K$$l@QNpRtT4=e@nh`mL#*mNQbwx>LK>~$+l z+DF;CFtf{jf#((rCEAUp_x#_1dQCqSb-3yG*!E*KQ`Jq`r^u}%hqSCemeTkMXSjsYj z6F*hR=FZOS6sk(1I`i(pw{`C2bORHc#I?-5IUp>(FZJv8nxK2_cn_C9lpFbhzM z>ah|`T`n-3J(OTK9MPd}v6>&Jrj}S`Cs6iz>sHr1{qkbzDPv}wtwQw0WSaLuXEDr* zyAkCEU+vwZ1?9G-E0h%x8NBA&?;4Wy{Ce!hqV5^`LH${?@N}*i#Jj}GT*1c0RB)~0yV$G| z2Q#XxA;X)dN?uG^f+~1FY6FW|W$jJ2b_HEk(znkhczyP&tj6KEu5vF@p{FP847;R% zXtqDhvwGfPm%Yw&`Ut9_%OwUEw}rQ@i1?`Mpof?d){<*Sfhj2!(r71l%(oV1P4i@{tE<((nYDwIg7WV7>* z1P)Dn(Zzqj7(X76G?Ua^E$DL#gv)S^ z+z}sEIvCxc8NyW<$6-x$0OoTLB%Y{r;FPrqiQ;0|Sf>piQQ_QCJ7?KX7O`O%EE2;` zuZCOpG(NO{!62)iGRnCdheMvl>>4~8SEU$E_YGr7o?v$^(MF0)<}rZtf5w2u5mZXx zdi*uz#MSv7*W@A#?JGWKUh((($zj4pb{jX*L(BO(dGx!lSYHD;p?uBnsL3XNvx1ID zUq2oBS!fl*niXYLWe3hq>1H@z)2ox>)|)KJ4)%~XY($WI(+T`R?T#D6R9+1{?d>I7 zkl8f0@PqU}48NfWV(io^C}_E~c(+-s>PyGpl8 zz(b3b?^E9$XC*#1(M$4iq9+t)qBC~0Qd!mD3bf=UjdfIok~$v21YOpBNnBXr5t4t>U_#MPZ0>{Jth3NGiA?WJtyA_R=Ahfh;qDReMpGk2 z&)75b^BDDy&zz0gr|z3I7ZD|m2J!Ime8XAoR+o2wJ7y1HlT2!dKj9Zf3xORpnxFUl ztn}x+7m9leAKG97hmH(}!PBW;@y|>%k|xw(=*Rx41DXX)tbz9 zccVw!0mnm^cLbcQ_DdLQYu(qK^(&~5GPr0>l~0KT)gB*&E;C-|76lS@I_LrKq22vE zi|IGk$gFgSb8WJiO}Ctc5uEn}V|CGrTGzxzO3K6_H<3DbSdA*|RyzJF=>i6Pr-{)^ zwSDUFUqM%dq`*?LA3LKlrl}LY-Jl7TJVaFAp0!SxB}_XbdZ`E%PizQU>{$XXnM;F$ z=YeG4Q2IlwSHNaeWtm`S^dGb7^W~&;o?rnyBlLWc;JiDr2Y>+h9y7>8Z+ay9 zs4L~-CyADt|DLqai^dLsJVdP$aj#W0OCFJ7|3{zx%$Y!d<4r~bZ#nZNgY9i>>*qR{ zM23+s$Jac}VgQp&qGe&~^)Ut(sO;tNZTB;j`X*knDOz?O^v_0|Y1=b+KEEWy({*0F zA||O8X?OmFaCTXZdRaKsp`<&zC;R&E5;Rl+eGcaRf@JY7LIw_d%J2kx1dy4nnBmM>gKORmkLowA>@vJ_S zS&GPhyhx2As_@@#5EIClJ({(`(c;=OP_19-Ip7oq#E+Wrv6uC^ISIsIr@OuJ03NU9YVjTgt z+$fv2re-a=e}n(fLtFtz^Jk{>jS^qo*Ik^^7_?>d0q>i9==r=W%7SC0**J#0A-NH6 z6I=z?3QQ$?HG=y0RCbd3OR*1(H8=lxF`K<8rr_bU1#AO*1x&kcHzCn zyB}tdhyg2tmWNc82xq5LgTL)Bp+4@qr4MfTYe~}@nNc#l3K!41=YnD>8vQ>Iv{%a@ z#^k^C4)jnIQ4B#X&1Yvawm_AsP;dGB;rb__N40u6r_R+A8a17${f*0EsMexKAOQ3^ zP|sUBbV4Lg2AE93+OA#keMXT&a0^8u96OVf8=Ku`?*A@(d!;E=$4q5PjoD z4%h&0(oKFhpMfDYDiAu%x?x7+!*U?PC4yD1Qpd?Fzbas=#*Hd_;NX>dsTkxp{ z)6m? z%gU301fRP2#BVoFrY*IDK2>wK3@_fwP>M4hsU5T9jhFGBsCGSr>OHC-=OdZOm(M0&rLzw-h^R}ehS%44QB?E>7U##Yt z*T%tg8+bp^m}z0}qVV;AF2QCJb>=-SVbQQhB1WBb(T-jYm+xW%V}9FxGvE}jsk$Vm z4CkM4^8PLy8qHIzII+}2VrmYquz-K_7_dcG7jK8_uk#9UfHEJWwNkhT{YKgCxJNo9#^$3z)G472~d> z_+}<|72HF#=WdS~G2Le;Rbcj*_LBWh*RlF1;X3GOaZPNi@)OvbhYcOpY=VjR)cDh{ z;J0#i=htNhRn~CM%m4TdEi8wnyFpu+8{?gX=H3f0*mgswRay3!KBXvk>OsOVj$)Oz zt1QC^MWO0c3)8cwvq6>!!{F9K*eju*v(h`3VZDQsToKO5j}yZ>wIN_EW62zQez9lB zSYUWtFL^M1(6DCv-%2ySoIXx1(pZ!*F?C%kEPVX%9F{T#YlciOlsvky|3c9~kMvRq z4IK5f*%oKI59}-D)G0L><*1~GU^Zuf&mMX+`+ zTJlIjGP&bjS&Q3Pq30BOY2QNaGdpnLe6;ABg>8uLSvufW7am7iRQoC)@V0?zU20A9 z?rhaQvQEcw-25OS#1;sDpm#f__=kmZQ(}PNA@=Lc;%b6Mg5gXO3dS%DO|gaCRFg&8 zwo9%qdLiDf$fjQKtws(0#1cWU`Sxi54C(Ky;!j=(Vf4t3-r3<_Ugc=oDX~cQH?6LGb(q_pQxAha1Fh4C+H@fM(oM7jg12 z(_`Ea`vAUOShg#V&73Gf`w5{DYt8=OZH57AY;bs=bAO-s&2AZ!^d&4={Kp~ZnF(uH z|K@(iQmdkAD;;{P@wi^ouZ|sCu|&vd6k2J(nX$E9i&<8l&b*oNT6LhI`U998V`!>_ zoe9cE9jcMbv?=1Hp9m^97&al7p+uCco1;HWYc2W0#WH|yf{hI(Uff(plb+VLOMEsX z)UprXU9c5ow3jQOw$<%_Sr{5$r9VnXg3jV5-TbR&J8J8#E}zKmrg6R>_54*kQIZK; ze*sPxcfjGU6{r;E7JR?rHGkj^X#Tyg+w39C8s-VruIRC6;2hx9(CUr#y5gg2f-P{M z|LAXSV{h?hwrDGEXE2s}E`at--lS#g$c9?7VJtbV-ZKrbp)P7JU|LgfERF|OUoy0P zIi4n0B%?@i3oj3LuRHd!3)nYXjSgLO*I&(UoASP~&)$?v? zknjPH(?QdF1^BJ)y*`*y7VdG7S(c`v;K6nuYPC)pBC4!N%$1OQqYhPPP3PH>U0g)2 z@f5ddN=vM$ho{=&#Qa`D{kg}tn^tD-(7CGtNjr|hjv4mH6Y`D80|V@^lS>DvXBh(l zw~I(4Wx{*I{RJLN(XmZwx&hJtf6EX*j6hlkh8 zl0t4Q-8>BXA+@39O|yM&L0-`@T}jrP<`F0J z*?5AT=0yX0bM}e+E(xsN1ikGLKjHIUBqg~}=+Ea9V!ZSF?BMO{ep@Z3N_QUdIUT(z zhPb_}kRb0$?^qQ(l|aJQ)5e$cr_;NO0;k#(+#>Jw+E(sCSB?Ic!wsAXxzeiP;=O)0 zGq$7KP0%V>9KAs+$KOJ*uu8u!u>IUb7L{-a+t~fI2&!z*%-~Z?dWf!UNUyv2Ok%cp*Q`#QTc#&4;Kjh;BqvD*5DDnFrF1?W2MN0%mC*jN zhQ7rzNVhd;{5%1lc-S->BotfmCGDGqM+rV$Y4nh-E;SF*tK2sc9Z=<=p@n$4RsMrq zvUW9D{x1{czmq$j#h#tt*xT_syYdR=ZZPET6az7`0#Rem?FC0XsPO0UkK$kB6jlp~ z9~2IUAn#EGok}sbad!44xnKi-;>YV>n(MT?8n(`TSK=b`Sh>+^=L7pf3~!FkNxlOL zU}t7_X~sB0?n6_?9a!51KK)*tp?_-*e}xCHSksj!m;RYrUnf1g^fb{>7kaYAX7*|7 zl_I5ItF^_GX6gV^{Y4fG3Qeo0dVuD#5%wy*)8?p0oB?TiVu8PSH7N&qn)^X_d_21( zWIR49dFdw>D*@^N%)Smv6>JN(*T&<1 zbNcsG@7uL{*MI%fl76d|;Ho8!(CTi&K>CKajRQ70sS}DR{g(7q^)iR?Mv~1^P~g%6 zb;c}F9{Qs%$*>m9Bh-(ylaquK9L_)9qrJb}uQ#$EV;op56(?!kR8@(EN_vf;3U~qu z^!ic;*i<{~Wqu^w&S2tS72fG{W#op8dV)EzM>aULaBoaer*y&IaS8}A`qU;}CXTH& z7r`|2mc2j!+2;PO+Cb!6VhoBpF7nZyZ<#emW6%h-B<@Q?YEt<$^%SMZtODcb0*Qfc5VDUyb7kU&I9$C>jY@u-Bv?7lX8i=ZpVcYR!@$S1xL z7|#&TWQ6dpK~gATor~g;4n#)u*cS@v`G2zy)0x`M0W8F23Hzl(bbKzdhZclM^E4-h zTd}Uow(P?&!SmSWiGUmu51ku<745ytAnly}R9qw#qZRH_=h>!li_;SD*O-DPf?|-8 zX)NE%@aDvM_u#tECgr(xfh7ODnAF|dYhEhoTH5-P_WnzHl8(W<#S_f7#hdPiYI-C# zFSW&1>ga@X(dDSMCBR;S8-r+$Tb}i-<^4n7nsop~aSqCzwN~*s#gWnBpTa6U9+x-F zdpSw6#}A3AYex30@sF=H#0BJLU>{FacYCIj-G|hD4|MFbu$H&SfHNDO$N`O(@#{LwCo(fH*@fj^rNl|fY7@#~m-EOQhbItbl}S1}<^SppH6iB$f!+W@ zAuz_F9@xyh^mF5KbGPx7X$?&APnmwY_$t#lJ&;c-ZYx&h|$ckM9iXEfsgT@!fP`LX~z zS_FnoF8pu~qqtYDDuXXr!rnhBWTX~WSNO4B*1-079-D~XMNr%$bKg>am&amT&Ijry z7x)J0n%)RSw|@kY7ZVfrrFnw1u_kdqIUyh%BM^9ddn;yUKk0nuS4X9|KWikcr}Sm+ zYe%1E=8uK42*}>}3Va}~@uHBLjL7v`a*FgGKI-A5%~~fN73sy++@F5sN`-{Y7~Fb8 zJIjwf5s(TKgnnsq`ThT+>dpU>!1}-cX{;Qt7Au=p%≤+8lsQdNQxm2L zrIn2v;Vx^tC8?EDHmQ*5q^Y20DlS0ff<}rhfE%EoBA_TBARzGN`ds(-aX;>Vz#o8f zJm-C$ujh+-z!11j9+cu0jP&#hmCG#~+o<$5fkBJdHXjwGW~E3Vn~>o{=@E4L41GczR~)-j(+;CwZ0?V>TAG;jS6-w}|i$e6h&Kft@SgOcE4SuBlR9t}%8 zPoWU)bw4D?8(+@-@EV;Vaj9n#f#}QMrlrp*vO2L}+Mkt5uJK8rH@**;4L6}vnS8eK z)W2d|KE!(3T2L{r(>?ujTRNu!^%-T)_514!-%pMGxPCt>7=qowBrjQx% zs#c^BoZSR&{TXh>W*cZ>8Y&2LyJC@0jaT1H_=OLa_)VN9>pvaP&TY52x3oCUAbOfW zU~?P$c3J@PBDQ8WM1M=vk&J(@xhDyuzt>XYWeJ~rFe6~CRjG<+--u%kvPmft)BaBQDw_(9jf!%=gbD(uht&7Q`j ziB8)Fw-w?6yD=a4<;<>N6q-`wHn|IwOpYKI^}3P80w+$%g`sy0zaKBR<>rdv?A+9; zBOpEbFSzhyb#42A%@f+U@buq9s$bC`1Ur5gSjtTNZEN7GY~&kDE+00H2c+D`*4?WJ zR?W6M6oBQ?%GABpJYasl7nXlM{`lvR1N}=rUQc<1VB51+(HbP&GGE?yGBh)%mdn)# zDJe-!yVj2Kbn6WNOq`4#O_?N>&ZEXRESCx!-* zAv}Y@^L4Pkyn54JL_CzCS<`i^#L{?I&b=D1uewvw3M`DFvo{AL{LOgvn}{xLvC6&>_=~kVhS^6O^ig4!=&SKR_hDNiMhMu<^bgE^>s^w9j%bPAeM4PU zwE=CGbYW_4Sz$aW^bpc;rZ0HkQ+Xl%;iAmN+Z|IF8MO`ex~C%C|K1Yk=fR`?dWi2@ z`plHaj2-lZ+n890yRYOF5kCzQb{36%H#u=ki2E3M6Bcm7RCzAHdf!@&UwZ!<%gajf zoOANp0WlI+(2uB}tP+?{eAF%3n4^ssnuhfOY*g*~{DznT{WpF?oXZnHif$D&Ip=XL zuDaR$(w(a5OeqH(wmKy{rHFsxe>Q#30uwv8$UGU^x0W?aUq|cLO#Uj{IaEA(d!f$> zVNQ6!e~Ni;2)1Gn$Q6q|_(K?ZhQC$(Ri~|h0U^{hTLbuYOQDXdTiKLLApEQ(JA(Zc z0)?Ti^3LOhx|WUtMRbc7F%GNBy?J*?{$Y4iHM~ea)pw*Y0cssvltnDj7#HN2_sM+y zNY-D$4`XWW!Jy?_+i8*tN*ciU3;Vm~qWwGiJIJON&vGW?DWKQ98P@65KMB>VL6di8 z3gy=0-%)FKQEl=Rn~f1S5hwnn9fe?=yK{$>vVypCqiIXvo=uQPUX&7u#DUUhm}10- zn|%|Ybo5@-i3rM+hg5iy2nJmT?}u74?}yP5;jU(KZ4Ei5Deb}k!|iN9uaC&OvFe99 zUt2X+ndsX34QlM__%R+eWw9#HdZAhRE9O++yLQ``+RG%^dnejPbl5Ifw{iW0%rKp3 zZ<8Zub_MMr9S~{gIj?YAM)G6bPKkdI8?tSF^+S;#;}#9?e_AaM2So zzjNw7@M<_}Am7jdgqJP)<%&L>4hd9Dez4}afpEa;61Q9|v~wH2#ilJ2q|&_0eJcJZ zJ9&M8ch`RRldF69`su;CSJx5Hli;Q!F?6Iaf_&t4<50ZD$@umq5cBnVGwzU{l?!kT zB=##oPk$IvS}*5*L(PJ?wHdVY9ylZq^C+RaJWVWn2d#Mqfdd8w55VDODmPZcY71u5 zQ?6h&(F8cLZ*tc%bWN@a z`jF6nMRZMp>hCt@L?mv*+0d#rA|!s{exrr67N>k;s|yRkDZL#biA&P?g}rfXKPWSu z9qij0dp5*N860B$7#05*F4B$rnV(Xw>YzBzA27A{G;q@rgpuxJ9BGwhXKfGV&Bm=` zZqiv77zQ%&FHFJGWPNOK9o~)K%}T_@e2pdA+bzwmfQzV7&k>70#3IR8KQ~!x9#Se} z5MSMuW=4z2>2aIww@bwt!4loxlKJ@BBU#Ey5)E*K)hl%66a$I?NxE!oYq{&ZHAkWv zVyq{PmZ$tZ=+tH&J8S>RBWs}ylmYD{|7tyfY##ya6LRYH{`H)#$UCdAEdnW_}1N8J83R@@7d3A1=lI#VIBfRT5c`o zW~z4#oi{lucg=5XNa?Y7m>-w|abS?NS7EQ>rDRt9nXl`nAVycUX4;TUfi`kVAYsyj z>GT@^2#n(#BF;41A{zfexTsp{=QlDkKY!m)pG&$HU+eBm3^JLbXp47Icip6!zcZ^C-Dz~Pu<(r zf}O4B19}gP<`;-)z&;`=Vl)Jm6%!7Vpgg%`M9RH52^=in_wR zELc&J`NJClAzcj{$hoe$Im4R^q}KNizi$M7_}h~qV+&X)017oeCoXWzRKt4oggLjo zLd081>CjPO=udzj?wbZzBxjXAv5%D}Rc204>`GWj@{{Q<{F4t3cJ6Y2LdmxQomkvF zzzp)Kbd)*TYj?Rio+`q9b=tphb^BR!^w6RbxYDsdT6?D#;6Bu@`6k`9^IOxe!5!E0 z2UzDyxN#{#c9x~*#Ld;&A%Iqyw~u?YVe6p}JCk(hJIf?-!(wsF@v@katUs(#(g@k5 z;>Zruc^2%qM|o%9R!8v(W(DYv0_gG?1omE5T4G+g`Ek6dvntAqCWX$qx!{~#DyX0D zRWmqO7*iuDDOswHOD8_cPd`5vG56h6b2Gsj^i&~|LbgR-A>zN)Y|a_kUjq*Bce1T^ zS9yXBQ&&@#_TN>niDY(hIO1wVNV7r{H8NFW8Bfm6&G*f!W})OC+!-a=U{J2(B>te% zu2Rxxv12ie%bHMBe>!0)0~+QY%Of25F`G=l?|(P^9wG+^&l;BVDxeAuFU*LtJ;efqzReMxgk&p*REh%oVClKswM?$eJpFg4sTsYK#PZyY3elT2*s^fyvR>1V<#NbuaN4D?R?{&oIR`2poXyQKI52{ZW{Shgpr zWjOHDDg)+zpLoM*d;MqK{e&pSU?52KdZapK0&iwp^i1?>Ecz?K^a%>XMyD*9{}VLI z*KN{Yr!S(0^Y2mH%idfrfO~4Mbe8qYGJ-ni8}At2WyAU`N`OTvG|L%gdA@Vp#Ib-p zjNCDB`VgC-`6X$ogq1M+&#*=uVo`@!diX7$g|_2g?0XaR8s7nL=CJ^uzM=EjoG?bb z@kXltknu!K=~LDkRv|6(%IYroo?R`C53cg+aF9*lmJ3)&b7oE(71S#Vb0kLNUaSga zoR3Ge%}wo4Oa$I_-|itFU@ zgfeKK_3xq7WG2eOEx@Q&@yyH9d+0Gr2rlp-&lHyJ$N^0TuA%Jc#JCf_9yx_qe?6#HYx*wbDDEwH)n!{3BRS>NV$Zq z0{#SMH07=;+=rKI+T;&#Dd)tirxN%MggpqAOO56G%9TeM#>fO{rW)Jfz|?MQLGKiH zfiZX`JNJKY?7m&F8pU+?Vd!8RHQQ^!3)6czUHmK6K>9Va2tm8I?T1#DaB3{Q+c>M!zW%3m@2N_{s!Q>_|ug5&hx zGGsTnc3xMOW3+Jc;&V`H@q}D_2cvo0zBC|^IO^+gp1DmgV2cWJjRB>=d$d$E@cK5I4>@zIihI_^PVE!8VDZy6KcFY z>ZliD$eL1Ojm3#u`*7?gs{pR&()aJI1NDWJQVC9YQ%x`Tp?P~?i)QEiUx>6iD7mA^ zl{q~2C;w;@C68?wRTkVT>6qnj$2N^*UlkWsz@4m&mo=<@?)XUcRIkbDdfQsg#gDP3 z4@Nsq;a|cfSLO;5W}CGTzShcuyN@U&3No}iL2jeJT>_s#V+GW4&y|!}Lyc#7K{ZA@ zJuHOfD%S9i1^KoBb@ra?TNQx9m=+N_Lfrs6^MzR9p@=1h^5b(AZNaR%G~qw{9uaN6 z%bU3uKIn{TgKXhM)Sxl!E=(I!ySE|aeh%N%Jro=e`FqK#td0V38t>*5s_X zi3ReZ*YYw!Cog5^nVXHc`9JU9tW!6DjkCr7_9X?MxG0`{b;P-@$&YtAUn>(fE&b%h%(EZQQm4b3c|xjJQWxa|5GcOpj%0 z!yzLM(}WfD>#ppA#QOaY+-sta%QI3aX8`lZ&T9yoKg~M`$@{_AtVaLl_6OwkqKJ{l zU7YO8a2oquQmMXYc)V)IQ z2zF*Q8sY?cPVfc)=bFa}sPW-qx_Q#3C?zrQQN=S#p0MvBxb^$+JWhw4H?2{zsMWNYV*%<1x*4k^Q<+XVC_|Gl`T<5 z%@lnfD!Sk7{}awOL}}^@@x|dco4SN+bT_6;=jg?U9Dkk`HHV|8MO4Q&xy_7J%pcrg zN`4x9vyqIG@QdH!XwK+&J7MX@dP;r>8EvOqH_`PhQ%ZSBT^z_-uS*uNGJRLa7#G$r zV^Fo9SJmyu+KXTc;|1p3ed~F)PcX{L+KB25fapW)a(`W!%?Wh#*@Da#h-{e!wE2wh zD_(d1o*NE$+~g&38*5h$oJytBj0je2%X743=Z$j>$mv2`1pS16*-oL)!cnwu`8xv?YTv`(y z;OK-)srKP;+RUp<;M@d_{9Vy?7vqQ6gze zNq(3I$3vvV?sCinFU&J*d~LYO7_El2BP;MSr33x7{IqCzK=_OJMOuvJkJI1E8&Kkm z{y@Ez*c}W|yOqSw*v(i=PXg^p(ZnU25yLDBspnPbzaV?lv*s|o`KeWUp?Ysrnem`* z^Jgq4xD}AKcrU*rU~RalVM2J zyge!r>@5V`U3#zsZ^i^MrVH>r)v;et_rOUQqLXxDuYHmKnPZROAf5om3H^E~C{kC( z|I%RRTK|hP+S-k#Jnxx@NB>y3uipTM1aqK#?H+FHX!2k9cm$&8OL*`C=K|jx=sVM* zz6myU^ZgHf1;1^X9W+_BCoF&@z^tvSx2BF?t4}8FuRKgK*?zYL`6f24DWhF=xA94t z_^>Uti)Z75Te=QdyPw4o?m^ODy=(dN&C31NLjQwHPGzZnN**|EIA-qV)J66lJttH) zq;+;A1>Ye=+Z8?KEn+FVQ@n`6sqym}0JmwO#mrOvDS8nU?;W6la&A0_~N^FU#?k@4Xr zEh#`dmeUj8i|ll9O~EQqGyLSt-F!asAz^&!|_w>++c-}28Z(d z>{D6IP^9mBO_r$LDyLweJ~wr-E(uFt zoP{4W`n7bqjsX8Jfd4P_b;EK{(x&o4PEuZZb{XwCg}e$WHt?79(D@O9?AP5|Sq2|- zNpp<}Lw}kR+m*^E`Ni`q>~~?yw<RIU3_ z^!;g!GkMn5krAzYTn2izjA6l0EcYpZ(2_a5J2Jp_;qe(f=DDE%w&42G>|paKil2X< zbNuaeX0MIvpmBQXVFBqO7<)pNf@cs-cXivGF`ZQhJXLz+Mu@4j;3in|$X`0gh7AYy zqqtcB0A=Akak-M*weC5Ki{W_`+C+31Ko=6_#vRRhT<~DTN0-=``YxvniD2u!-TIP+ z0A0bwcyYlckg-481Fo2#)J9Ow1lkqq?ge6-qL@YDwZOd)D{^0BRtZ{^ssx4ki9TJi zShO!GLEbfNjLh{lo&M-R!HZR|G;3y^syN|62_cW%Yv_8_=%8vMMcm6hOX4yNgv5{T zdwEVtzh#O>iDx>Mt`tRpTDeGTH<=E4jbolxz-Gf~kI zdM|-r$Tmx~1AboyeD>YZ>GuZm#Wpu7BE%{jFh!jSO`B9tjGz*c9m&uE&CE9ltX;g@ z$r5tM=~==gJu3{|!)+Jyo(BJ?Nc=x4;{Rg#*>6{TB1FG-9GF6nmw{W?Q3OFVT|Rs9 zyKyESuD)r?m#6w0Qs~6MqUv?;<^K#4k^rZ)F?P}m?lyXyg7gK6m_yQyW?4i^bidFI5N+4G&%}9gF#>Y(S7ObHh9S0h&h5) z***+5t*l@Eq*?#Muk0yiqVA=8DmM;dANUI2O&#RKF}9usejsmR-t31$jsFh$laEuq z<1+zeuAjP&2aqP#yTL%wvoX1gdBCIx*010GUTuVWPl%Mt+vlHz7>1-{;@)g>CxS}n z=B@>Q4cz|_Bm3UfxQ(-X@ou=}{%C)xdD#ld2A8|Dm}-jl6S4sKrZ%n$GJD862YaO5 z>^qO{P*}E)xRX{eNFTOGX|@zu0}ot;F_L5@=|b$u2{ZcEnt z16A3YxuxsAYpG2qJz0Ryk89KPn>a^5a8UK~Off8PxnhgYCT{lE!syQ(Q@0v#x4{zn z3FKEx8E|=nVZI3#rL03;i6T8?ZTh0Hg}%W?w7o zvksh$)M(=BTc=ns#iEI=H1hQw)_tsv6fAj+547**~P)?2sx=8^K}Zxa{TNBsai33z(p$?dRu9K z&*Y$vCUXkIYu7C5YU*i!9lM{lKZ)_V5%4>>q4t{--a7z|)A7MRn+izIRLvP6`GD6+ z2KMfX81=gRfLv-RY;&-$!T0bz-75dC1Df74n19Kta-#a)v0}*}*2|{}Ps@!Vv1dlw z1r2|=Efgo%m*lIMtMm>5-u=D5*e~QAPcV+vzBD*w2mKOUu70(|`HmWRMAIf_Gm8b4 zp_~%yBfK0;_juR7h<5!Cx4_kXaQKj+26d&k*V2`C@$u$AC?141oQ&r_p8?HjX-fY%N)?pG>GTvV+?0&SAzT7{9FZ{+dJ8M|c>Q3S;3x+LC z^+I}LO}W$_2MWzEvueNPJk6W@Wt?hU<>dI8#yP}|tvz&-qB#~z!+?8y6Rfu1fU_cB z;dbFHV4~1;+**b?b=&%D61peVosBWXXN%6BwMV=BYBhvhD8cWiN?I6Qy3}@k6lLyt z=3O`BZ*#))yo$Kek%$_{F6%91N})5hf9qs}-aD3jtFPg`yHm{?U*iV{pF8ENe6_tm zV+HkrBAH8goRHC9n3~&T{+>J6W~Ffd|HW<%+RQN2OtkNt=wUn{@^IV{ZhvO9bMn5sw(7XF9TtBm&S;B^+UlbY1u6*=$jSTDtz1? z@MtG&lg91bUxltZN~z)Nr|d_wKg>^_1`d}E=EXAMb20$M@GWP^IW+5|{?)te=Y~VT zmoe>2)_SK`iTLSV#smMrm{Pwgr|GYq75U))$Nbs=);UBc&*pjlh%+htbxT(d59w){ ztOjGgCbJvfG8oGMkw$#9rt}dFH9zCM&E&a0#q0uZH|lCYP?2bqvFsp2^LI1sKkYi6 zE6?hB=R|wfCMD3W^Vx<=@H#k!fH|6Fy$QOLz-Ig!(G|ARN?G-~GwP7K(ahIf7t9l@ z0<$rQ`}$xUw}_<|94!PUjJn^oR+;8`EL^u(#dYV#?E0KYevHqa@bhd5*)_es`HpXt z7-r9Uh~-Ha`SG({R3wC~K708rsVCXZ*b87Ld~KpVHVO z(UcYXONqn5uhpDZ^uM3#g52=z8l;m_WAj&wWPNZ==;TKRG3pIuj2Fzu>HNRYO1?Ul z4UgEaw^wx@8|)lY&x~hJX*b#f_RCJu)?@~T76Z_EsUMH3^TKGAu30(T9?(XKb~?to zj?0}D_HTVp+yy70u)^R0o^4P+!JK$1E8xUBh~%*30IkB;N>qpz%AO&MSZ*PtJQsT0 zy4Zd}NadCakYDY*vU;sgeR=SD&4)jJV|QmBHNIN=fJGNa7iN#ua8=>z>*QMb5oYD) zlm~5sB(InN&=Fi1YJ+GsSGwpa`PW`{e@AZE>se~rei+~i;QT1|(z9^FgQ zj3qD8sMrRaHuGHA&%8-#$rPEptyJ>)gMcOU(+_vuTme9&<(B84{zhpZ@v3oCw;j5!=5J-a} z&f}1WBgC0QbkuSrs1&!7ZtZL2D|?z=c$o$x8kP~Y-!1eZWh1UJW^E|yWHrtwKs@z+ zZtyFB_79{vW~BZ}HR{9o=+(VOOTf@7FVJjR@l;%wwI~+(fgd_b4jFg4nhKjyj^8BA zxc1H-0xiV5Nx99~GppJHiuZwjHCX=8lvNV_E1Vs!07U_gcMZm(L|_TQL`yr7;{YH% z3rJ#->}OD#^PX^ZSLDYVv({=wOSDhAB=XA#hu8jIeT3|0Q`E)$m`~ofX27Z_YffF^ zHV?cL+#5R!&J-U9ztuZ>SzcgzRrs8k5ympT7IB?EXnp*rrX{Rt^SKl0v^U#3Z_#%b zWr=IHD&iKDzFyo4)LV@1VK7ud(A4U{^i(OLkGGPHzcG0`b3{xUUya;J@D=z52hHM5 zebstdDUI@$Xjz3!WpSQ;Et~x!GnJ&VWrC~ffyAJ_Jck^h7h_>EbHlvv9Bhg>1qvIL zX#aj24!@r~bTiiGbN*wyK$vrGGBrP<8mYTi;2D_YqhHiO%R-2U7wT!N8C3;%#Y_gnG{#6Yi;QZfEk;4}0F!Kvc1O~9X3UKj1&VdBM`4$-C zy@TZi6ygI%hYbVXR6NFPN(CPkZVpX3kIn%ztgbguuLCh5@=$VZOceghJMATl7pwj? zv^+e8nl9e~n9h8FDHy<*e3DMVsLo`Fg#gF=x1cEd?QPcahYQK_gK5A{^z~Kf1M=-{ z=kw==rDtFN&DbXNtw{t9EO2ROSeF)(6+1@>NT6(jzOk@yX3buFJW!0AR+V0#7mF{! z^FU8~Jm9E+w605DYb)%xz+|)p_t`_v;jBK$ZvdBxw{CRHn>q8=&WsEEj&<+kD@Y+y zo8KB=abOc3?k1JWHbC9I*dTs?>|?XJ&ifajh>)Ehpu4$wtwCFZKt{$2LE^1b)WLvF zm=&V2copWq%!*~pd+1t9QUcgeNg)QPt{ zz3>5P4k=B^WW@fa?qP!8Qv?rO0)HF1LA6IR)rat> ze=E#wGhUmSlp}7yB|aNtq1U4$J0_)28odo)CoqGM!l#FotZmxr;yQnB;oi_Dmm&$N zX07U`Cerw8I3urDc9tk|w4x<^P;8_E9B#?;-RnMKt9%(5NtJgMShk}j;@~^8(p+ob zPnY}1_L0-{RL9Cv{K7 zP1C1fL-u9;hnvdLJE+Yq%oa&j)3p9Y?24;%J4CJc2=M@cCafmG**~TJ%;arpHr;Cw z;C^Uk9H~SkH`%AOYiF`wo5x?_HfugUKZ~9I;aZ57=7W&fht#gdkr?*|Rn@12H_|E< z{F{F5eymgWrGf{h~)-$<5}Rc(^*)x_Chc!0TU-Cb5dBzC15GmnNVf4k*?H|saX z!)26od1r(d##Hozm>4V()iY6ZRO#citg~QVgBwK<^|hJ#=xd<2m7ByJ4Nd?raXd(w z^{ST@`@CucijN`xc8X-hetc=~GNKhAPfVA#azdX+IE=wRZs&I+W|2U)`$qLH{aYu9 zwk_Y?O1N{2#KYrZ8Oly$m^F37O=p&yw#*494DV*640F-?N3$7f_lW{w_j)Q8Y>&VZ z7W7F=PK#e_S7AC^u=Ptt85d}cPvqTEP~y*)9gcAQ=raX%gQECr^J0_zL?ZrVdwo39 z(6Dp9dnb45#+70?7dwb{f1b3<96WHyrSPr*-|xGh5Q)MfTev^w`L#y1 zFO!V_**+of9N_o)#kZxgT{#)>%&%$&Ta`?Rr2K!Wxm*k4~Wa8DX@QuBAUeJ!>~-Svls^BLdYAK|66 z+gyEk^ouYIg|52n=F&5QlmpfcSY%aJKGwr3RWLb{YjIX#QaQD2)?svWxQldgoqBSy z(}slcVh`VghItd*`A#ZN`+kD#LOcUg4MZyuuhSj_qa<4xhQB>=&(SP9UQ_)63S}9l zr_Zj-E7W{ZT$`A-%3B3jaQL(usCj|Vb|;cK*%F@TE}Y7>f*Q_+bHg2dHu}VVbWPI7 zjIFz*&N;rbViZs3e6$CTiQwl?7o*_Uc+MAG`BcjJC7Qr=_ z8iJr^d4#m-82O}aYE1eB#;iyHkg`hr;D#l%$+Mm zNtcC$fxlAL{(fA!soGYLuk!;TEACHq!r;kD73;>H5zx3`N6Sla}ziVZ)>+*W- zKtoG?Yzl5hwpGNL{NYVn)7BH7enBA{H0zcU^72#20&!;}Mn)lVM)ju{Qc|74aG2*j zzaHiP`iBvnL(&NxA{i-f#r5&hcN+7?E9BO|8)?Dgf}~D6Qccj%f=Kf<W+YpX#XE zy%BRqeO!lQCI6mqqFAd9L7X(E`^AFn%0Jf&CkHh}C6)H+fFYmDX^19YsIW`nPMmn* z+CJW^?M{2hp4$B+HE(o_AQ^Na<(9iJ*~ea_Exx6p8MxIJug*@s070D5f8&(ZI_21W zl=PQdKh1ZYwJe3P4Gm(&q~`x#(E=@x%}2uxf5kowdD=_~RR(c5D5HzQ;E)7EFT+Mo z*eqsXl`er3>NCKRUmMrUWg{lZDt&C5e@#L3rg%pD4brX2-7C4een)QD6&%wl2>1B! zSl>e%{RW5}i@uUH(M%_Q;S=U4MH!_u40>DC$YgssTDdK61>Uz9_Isc4=_mWYI&BVu zqN`pN#RW~qHe|z+u;0!9JbvkKt1S!F)-tiHkM*}8D5>4A&$xSQo_%CXXYVI`&WDI7 zn80}8F3<(PlmV#reU$XR8INgl)vKh}*G-&e}T*v9YA zfHqb1#^+!|GqAcF7J@>B5SS5b0+&lfbmhv zVL_fFsbAS|-vhyzST9}E21$%%!NQmUZwG)VOVlvMXgb{L9=Tf^_nMiP-sM*!s5+40>Vdpz1$+;>V%+_5M|4 z!A|YJchw7Gk`Pv;Vc!0YW_5RWcICTz-EVT{$NwfYTUL=w%Jq`XqOGF9jH-uu3_qh@ zhqvfLh@3^`DHgF>b#|X?G(RO)vOT0J^Q#-_6XV`!ac=5f(eH=Y4{2a&%I=Un)aCq= zGEM?)t@mQrxeV89S)T(c*L1EhmPxWb2I^@SQsxtdlSg@5l716EW__Vrqixm3Hxw(X zlOm4@l7dQ|JxWnc5Ym*B6EPELofW8V^{rV-0;^hZrTXCx%}CmAMV_M*OF|s+D9tL) zKsc$xEMZ)R-XR@s;sZsQ0qzKJjWBg0nWnTl)mnT(dv-CBL0vm9NO+bP@o8i5xsL>V zPSi$SFOZTMX6}xAMf4+x3pTP9IMsxDS7}RqyYir#JL80}U+Q|>&zi*jGBbpg3Vf4@ z*bi(p@R`)_};`u7`2q7e~bD57}L+S^xP7bQ%~$NS3A0kv!vq=Jiv;LZn!W z*A4hLs6CuwXl_qKkPpFBC`)g>3f%r*rpNv|f#i4*m>6~R0x-vefY}6rIGa>o(oU_> zo0sbmG{*#3I0O}@c_Co=(6;FA+yIww5Kx*^xV;1HDQ&Ou%7s2SBA2$8=~=i`E-19A zwRM1&7sf(O>v{|On5*A*z}9MBRpVc`*p|e30>(~MEgN>r95|M9+PX7*JTUXcbz+BK zS7E5L)cHPXeg$;OZtM={hrl~=ae(uA4PplE$EJ+3#{B;=72Q4pIH~{iO!<_H@2alac3Z6M2mnP3R z)W2*7W5cd)Muc3Iox_SdxFF{ukV>23Za zclyH-;JpLXI_Y+j=w1UJ)H{8s-`)T87DgBi8s{!{DqUPb)?LA3jYe-QNQyV)I4v$T zyEQ3QosCTk9)zVQtWp2oW_5#lQd)dH*RBYG)hA-=?^ZUii4HX8*uFG(Wd!2h5E&#sC z$;KBK!>F2+k(NGtHfKo?^2g+Dd{+jyd!QZZzv!iK?ae*b+zwWYdMlot1?X1L&`@2V zE}+aI>zb7U`0;3E>|NE0$HJ)Q}wbj}E*^Bxo1!T!yKs;ku=sVi`%Btb3TC2* z`4r6TE6$ted1%&2j_{tz1{v-l?Q`DMLTcwY&&l{M_AeWV<}0GTUx+)Z0GQP^#|9_< zePr$1OML4ZH>{kpOZeD$8$-l&bW?E3PKTVKMHUB@Hr|_Y!St77QbOkEsCIp4m~-<~ ze48em(Yu}KZjz~1k$H%gv+w)$0@}qn=;|S0&Q4^MiFCMrcAVQVipY8r6O%NPF)5NY z9jW6U<7K0^KzN(ou=Kt#XVUVk&^_$OzMWkatsir(g;Io)Lrc}dVuZQ0_^q#nl_B=Z zq2X9A&zMCCfKoBl+$U#QBl_+j@d|8Avi^qN!FC>=$60nFg-I2+tAF`;+A7gO$MdN> z_+1Ve)`Mx@k_!9bKy%|e2R3Imz-(1NT#O|7NzY#EgU)@a4z#vhCamu7YZ)as%x+Gn zfs~sacJr+8TC&yID}48V#a!*}m09oF9LH|&hr2N_@z+t^sAe zmx+%z$2X$ZYkrQYEq4@yHeEy@rdW>^ie-a~hRqYVhgc1^t8s>3C#)hLX!7UB1;DjP z+Mok)X#s=o^~rXP&gq)$A_@qYkhiaFV}otQt~aNsUkkvk3rn(_0W*gIll#H$l>ANQ zxHBRskH@jC*rxIoFjuc`ABySg*J^hGTcG}7Hh4l$q%*{8QbW7KXvOkHEyg+d$Q?|zfq#|$G z-;C?#UX(nKX0C(;qYA9n&^upOeJhpk2|VLy#{$>x0&xEer2-Bcmr?DZhCl3o{!Ow1 zEBQ6+Y;)yGACR?jDsXWhGE)9x7=q{3HNqp$gAZoqMrJs7#~ZzpK2Cbig?lQ@i?af2 z+^-4qh1}P2IoH=b1rB!|(@hi+gC4iM$cqGn!YlHMr^{bkqaWS3wI{fAd@bjj zNSpd5(qpTKmGdnUdWOwMoAb7fE?Q41M&qwJeSJZM8uIMW8>ZxxkY8XU)9>mDub=h*`o7%djDdc0Fom~F(C;W!NAn8`x zL%&UYTkC7bsoMj+lY%&encik`&`lGM72EP1bj9nw_}isUrLqnKNwLd(;x*${&H7Y) z;$GXpJ#g>Y^^Pa@qmC$RKHI;r7T3DH0vrjBoOP{=bVd8<5dZ$bPqF=a2uXD7c`-cG z9Dk{PDy~|vz~$T^W%j@3RwqOwuVp=F(NXP_P+Wj!$mvgTzpb%8?^v!#=HUd;eEP>- zLy0{a?*>?RI)N6`F$Ci575GaAt#VZSRtn9=(jQaSxaE24yr_fYpFsNMH$6wM#l=`m ze!_iwuvu6AN!pMvqxEhFKB^QE{Ql7W`>Xl{^XdItr1MT;lI>&FQ*oU%HCHOAqY0kM z;B|)#n1ZW3a3unH(7UUd@?>_;Pws7!M$>Yz_eeGvBkXMiO=Y;e#_k-Thm7xevNu9J ztoHw_!@pU=?@pYd5HuMVJ?V^l9^l5?Me07?RNvh3O;WGWx)Tr@K{WK9dw?N#vX}Zm z>H}YMzRY(zW+TN#){u!3e4a%wemAT+SE4_QF!49bn^9*oW}Qw4Z^OkjVRAjJX5LhU z_t0?6hSy(|uiT~go>jM{tt)ihf*`KrWvrW<+#{L%w@yarOIMzWvC?1FnhAFsFLYgkb5{LG4KLV{J(8MR#Z;_tcltxpFGA4JD3w={oJo*V{tloz6b zm9V?CuN#_N4R^DA3$#t`Qth^S#|7L^zuOC7MA|L%ftTu2W4NEgI>(i#e$Lld^K9LM z{5mHklU6QNd+G&1S0#}izH&GL{pLwv-2q%VtuhQ;oqK%mpY~m2yhtSGUO4SJF!c8| z)i&)z>UVslyo_K{aVnM~b;~}5Bc>blJux3$MfX{|n`wSr7XVJZV@STYN z*-_8;?u^7}sjq$KF!Z1cSYYRE*2vNHIq4y7ZQLMqiC*Q4cEi5bth<|%@0sv1w|bZQ z0US&7_878Dz&!%3J)b>!JzAUj=p^VUd?q&)*4c;C5;~ZTAy~bZ- zh8$(C?B6$tv?P2XDwli_{;B;%<*k|+sz1+c?AF4eP z@YYuQSukH%1SDy{q_}}%jAU)5;lS@Dnw%2A+O&Xt&dp;XgW>{Kgy%2Lv_b8*6D5-= z{k=BPv;P2&bE5kJg_-)m<^>8q{K40@JPx-BbR;M`H+U{mtgwYN%^cC&RlZV}3Rs~( z)0V&XR7G7E)pQ+bIudUASvRptxvO+@i^6q_3on||_mr&8O}d0k^eD3YI;gi2nukD0 zcj*>}Tb*e%Yw=C3`?4S~^lfZDPs7)!Jg1FLSsl6hf03xyu#>VG_b4^F^l4Xao9b3I z93F#>3ch%g%o@#N3{tyP^j?wcO)ifeFv7LZrC?3igJza~qb)`iS!4f~)8d?Sjqg-< zwp_hYw}X(%q4T_Z@cDc89dzmJ;ytk7Z8I{4_2s)jd`AJJUeArD zm|;`2c0=XZKTj79##?6e+g`@UGj4ClM2|Ajx7+{z%iWW4+Q4NZBs+adk$iuPfd2hR^JnP)*9`p5N&Z4QM>MI zC_9v$Zn0b3+LL!0Z#;U`y<&4^(p%QcmAE6`aU&^r8TL<2k(>PPK3nW^+a!Z)9y>T< zgS-BT<(&44`5k^#^D}lEY8PH&*ZC#uT`g@(m-?YFwBGE{Y861`mBhHP-#-KO;@FJC ztqWEPH`pvsQC@CycGO&yfT7jCFuOoF)KmaZd#mz+^F;-oHHlc?*c2b;|0L`s<+j{4 z5SHFLgaU;We3kZXfYj4SI#{4$oo6PahU{AsNAc-zEgZ?wLL99dPjQV%o8Qr;%oDJ-6QfEpK<+#7H$9z#|>)AxM@g3WB z!qGieBlaCeShhZqT=0K~LyF|KKZb;#YiI;sso7KsA?`%2-64C>(UTnlV(*#V1F+U< z^o>AQUtbvNtnB(u8v``&t3yo=QA|C;`cnll!UlkmE37BLi=Vw~HJu3!-Z>JY%tUD& zoB(4dkFo1z^(&pJHP!ZxQvG9c`_ybH;K+!*wQ#_*#3_~9B`cvz0q=UbASdNR)IiH8 zXt7|}-n$m2mibJLfHYm^Vu<0ZFop)q4wyb_ycu^4?riBseTIqbhH}o;ktZrBOHwB> zEJ_{ile9t>PhU_@+K_qL9h?U5UdZA-w#GB`k>WJ%B*N>paIs?ln>({vRB!!zSF1li z?^t|U%4%Y=>0Cmd`$haC^1FZ;!DnB%i`Bkp?KgjXt0cQZ5UlrvC+7#+O(~y~`)QX1fnfw&5^*A44q$%t`pjG0ySl&5(1_Rs8q1{uI(&a8L@ogdUz7}`q*b-_)lR#g!5 ztGV#TIA?6(SCK+2n75doExL`g520;kbT+!S@K@sSteS%T_1nCq3=}of0!gCgLzeF= zr%zly#>Cs3EET~LZRuS9Kcv+OWYzfzAVmQE?^uztxusz}xV<&0aYe%VnN^3?>42<( zD*rhu1U&@IS4D5z-9@TU*{^Cd8%53ZL04L7{%XU=@jy7m-5fTC5$GtA(OJ&lSIsu0 zK^|pHo`!WEYRb9?vKAS<|uqlj^wZ7yQbf1^qsv=KFEb!`W7h+G^nGpjVE6f z`YYAzGbj`GRZGP&2VTx1+q}vs*Nd9?>qyazckF#a0z5**+{?}E+WkZONd zX1kwdS*oWq)L-nDcL!k&fJk86>DzRDcw(#W6NPNX4sjP|z#k0{S}%!;oGN`Qx2Uy# zL#C8R1XBWJX=t>_Sv`_BwH$H<$=``>Q7(UZ8UD*Qf=G2&n(==NMckkW09?C=X@#ltoKw=4lj``(j)p0sLP7TU|TR!0(UD- z4*U6%tWO06h(ocN-l7Fv~emzRSAoh6vbcd7~x z){S2_KD;`Fde^JZB@3~RB4YHJY;q&B3MzLMK`nq*YN6RU5*|5}EP2T3)qa>;t5>(& z2&Q@DpFpZd1~vU8;!pl{%CX$Bh3)^n>HilUGW{#*yez#py__l@`K@VR(~6rj$Uf>s z>*kvzMJ-_kJs@0t&% z4Y3}y>GZIfq)uLVwd+pt0t~5t!)j6P%g_eXMSA`qcT;QJ-41O}r!VR5RN6C#TYMPW z5OtO1YuG6C|DZjRhj1{oKuCwlr;e!nQfg~XyBBikn-h>0%O~gJjns^_%YI-QBm+jc>!cszUoou@boy8qu zd7`G~r>TlxB15|A#*yB8RZU6vsbaUC_OET6=3*;N>X+<)1dgKdLD1nmk@oePCccjx zS6%%%MdgL9>~2BVtLNKt8OykgnJ(LWwluiX=W!mMsNN(F5N~}Ozc#@~x|L{n)eU7m z>~^|8+;E`2K~4Mkj8$pW4)qnjuT5{D+=0$k;LwBlsY^*wLUVytWPj#x@8P9@rO>cH zNrq+5+d|pq)JO&%9{y!PmRw9sb-jJ>y?5%;m!g%Q2!L%=iM7xXg<3}4Ao3-+Gp9@}Go#4c2RajE2HQCdak_nalhUw%Il zx&QWY3&lherC3s_M0{9AKD&Kxo{^$uMYV58bm$!pIc zTA@otseUdfn|iB`2`%EAgD94Sx??dlhj};N$y6m)rH(JPu2$nq1$)L?YG=SNG|Nljwq8I{W#6JVUfxh%dD?;3_ z9|ZTU6GDM@D}qoJ6{30WUI&I%l^Qm5fD%9i?*MnRcT6w_#v5;LAVhoqKirTGf90QiuNLd&g3V?#$?tmgT1-ul)h_Tfd7MA8G3~63Ta6^QnT{ z@a)m&>Kij%8oIN0|9mC75-+h;9(6-eC|4_>RCoKKElkltb(cju{k%sfA#Ts4B<0jVG#iyUn>?JKIlU%@FdKeV z-~6b-zbTt|b47w%*wWZ+y>6zjb(4Q>lzg^!whSJ(Xt#f;tXVW0fAm<7gXEDvg12RQ zCgV#{+1Hb;%K%n#$?V~Tr38^SD%i_&PV%NK{dn56A@xvv&SJBu=zPk}TYgch&c0WN z4do(Wc=9=}pie1;x~v0L^$JnMZQ?<{XOGljMGo~2$vb=45hdKW;4&8Rd0u`I&0)@^ z7F4pCOgCmZU5y;DZuJ~{k@3cA-{e?jk+#>NbLDc|BW`1OrKtO8a$#`N*wripu&2gu*XcWGooGzK$eAR)7ISR`j;JoIh2)BHa{hjQl zTB8n`$eRmQbqy{tR!;D3{j{IG4Y~Ubj7u$@ z@LfpFQhgJJnMth;N$$ZrKh2eRjq2a)kr8RQO?3jQ?LwIPt3Q^mnf_t}O~M z`fCj8KbAv-2cz$G9lmomQlD%8Xu?8~;Wf7^nnf&?{qtb)+~>@>WG6IWY<_O*X1G?0(F*k_1k@7W}{c50J2Xx zXjkkj>JE7cOMK_O=BxjmL!lrdLz8sQq}zsuux}yqvfBpDZ;Q1+P@zPyxNnPeCEPmO zoHjrhq{8{gf2kA0Oj*o$;tLRJk|VHmxf)T$jlCq4Ah!QB)rRsXXnj9PEs|ye99+dQ zyT__2E-A;OmNj0CZm3a>g#lF;RaHFKYkgU_nx%7FMV`21c#T3lwfQqMg17S+2G|h3 z&OVyD*;TuOlSO;sTcD>0sNY~RHE4hqGt+5qSbNQd?L^Dr30O6VDjhH%y3@(kk0&3{ zsx)I*NJlryrn9lZV7M{u$a#oM9-Mm?uQ)H{4?T_&B0KPMdi|q9_YpK0MIpE4E{*qPTvGQp1@5^NmAa1<)8SYiSELZqBoim_HT>SYhiBC50r&jl1E!Sy;bq{2?ElQ zUCQ=&WUa)rIQ%bKhsNbyAx&en_y^~wBMDj8jeR$ zXNI8xydAS27R73e^EW*d3!LiGFzS{W30k>X2(NRzQaj!?ugDE3C9lU zGUJV^9SC(&CR{Qqt?-Ax+Dz}2eA%m;OIoK$;=e}~toJl&a`aMuuNoi181}P^c-Xw< zY1l0gC^}wpITH5U9N`r(eiU_{gHu9=?)%h>-GYX}kxh%PZ}VM?SdMd4DXD=C8M9;Vi2(yLwi?{WMM zb>rbY)_VVjCKc8PFs25%BhPv8BggV9eUcBj2(xs8g2-X|Z4Gp&Vg5AG>M-EMKHmh* zjkDUd8X$UI6uYMf-oFZ7)W8s-6v&upbfg~I%~ZDp7CofygDo*=p)`H&XY`EGP}(fx zv||Q)wO+C0Ing493SOE^o}fybHUxF%B0_L=^lb(p${)x&XTPNMGvWzU>15HRZsvlQ z5y}GEM8>($g~kNy&DUQO;eU$U3S&fd`4W;1ax znM~Ah!kz0`+J8xQw1A+)hs$9vT#T`8z%+J)vTFqNaNNFg81@q4MCE@Q&S+A0d@D)M zUVDgWMvxw<?VVr(((35lavFgxq>MCD7D{GUVH z3-gSD#m2B8hj_lv=r&qIO4fwBcmymgqF&71<}(@SmAE)qE$`zVZ0pY;PaV~r%f{h~q~c*; z1$p(ju4!6~EQ1f90t=xnQa<%zl`(Iww@DLBij!<|`Cu(T(TVhQB%#;?Titw9Th$U0 z&OGJcAl%V6BwC4C-k2CA-*!D%retY+wTJp1Bek`@1&&?@Rmg6kHmdL&!}pIRf3fCi z*yUNE^*fV#Y|cUEFhhzJU8N*4Xa2rc2q`3PZ=G1l%A8eLV6>&-8{<9B?9;9M&{{XK z(sL;Y!2rXTau^UfP_ncht%m~6EBu}E3b^>SzsD_Iljpn*545C48q{C+f_z-y;is)% z{NvCov-SB`9bVKjXO9z7qfPtMp7sI0Gz1cDE;AL7qc)Y05JwL{Sh>r$bzGjeZlbyc4K&*-iIC zaV!HpDM9V`qA`xTh@J0e-By{g7cBc`m~np%?|n|${H9T~KnJX|M+VGCB3=tlrou(# z)^|10w3_r`69YCmpP_nLmq~t-7s0b-4 zYlRhsinRR4Z`3o^LTGRxt?N9=lQkvE5!n{aDA@h)2K6r!9Y-$k=!G!<1uul-NKEoA zw$wc%o&$9UwaJc&s4+_SiW4}jwu9?n!5fxQ$k+e`dkUU)Xf zH`Y&4BcK-6Qqka3+N&Y@`|cZ$EOY7u$s77+JwvotO9xgBA7o+vT$nSv1+pODdMoOT zGPYJe$;F%lcs_`NTil6%3X;~(hW+q5qk)4^SjYT0uM!{4PQ%AX56|q=?mCgFspBoS zzd7{r;XLygWRvzqXlYn4GFAHvyD_j9Xx{wTzh#C~U_~3y?c%3as`|`-(30jq`o^p? zlKA41`ydDYCeiq*@OYIAJ$pN;bH||;@@CGHT=jdXDfCX7etJ*vgw>*=Ep-dI@17r1 z`TmQ`y^N796u7$@(3;JoN**sCu!{&=IMKm#_~Xtp`*q3sww7Abu^KNssfO0cI{G zn0WDR8JbQbok?9~lv_U1DK8Q~Rs#ug!0_V>z{8-snS^X0qu59!z5~t$MW4}s)HD!E z$q0VW_Zs&JQEhD0V7+$!%#mG)?wnLIZ5?I87#fy`zldAYbd483LM}IqQw+0;5lwp~ zI>d#Mh^xq&IX|JvqrTC;k@wd6XgZ@JXGbO-W|Q9pIWL98H}k6TyvgseOXu7WMfkfG zUbg+ob?P12#ByD#Pme0>tnQJ2_aPp5+_IJrD)BBlqW0gtL`gv?7C&8QhSkO=v@DiE zT4!p*@otTr4ZAMs&~pcP0qx3#U&483r(f7?V`Z)FFVJgTm7IXF>iX1<*}pqq9fgl> z!;}9lUJq^WC<}iYym#`RsWNg7n$-981KTqtb*DWp-kP9lb{OpZ%O}M38^EGW*~-!% za!JZ#I-D+PeR=!p-L^Y%4hE)4#WoI7^jwOb5PiC&x}ahI-8i5Rv2SdqppqFoKc!g` z%oeW9u3g`DPd&5m+p)1SA#q4mNFl%BI)J`rY#+84W;tDt|%uAJWAs<3jPehgNwD8EHCVZZTvb8|?#WJy$47{AExlLHNop*LaDrgLDrex4Co{~yacFwExwG|8QOe51-Jhm(qt&jxnw&4(jVT(>o5L-MOqJEx zHKh_}b4Q-`;|UOe_|SKDCK~4RmmD*Y@u$olCrU1wq2Xws9sY-H+UsrJp`<1tI%*gCwKUpTm?)OK z;eszAMv%89kFd(OsGY;R_#>W0L=pIY$2k#P)W2svVcPM zo`0P^_q1ul3s~O5T6|-Xn5G1-xkPfB29x^^Daj1bhGe+gdrS2eZY*ziVPchw>ff{O zBT!nQu!QP9?2ucw<=voNQG;UVmG@XThLXB**`i6W>jl927^x-&xAA~p9k?W93uGsv}D-JLbW=eLlC zX~vn7cwT-fTq423Nr_C0X1h1c*4)&~yR-Y0QQg7KkKyb)gZfy-m27zUPsF;no3a<) zu%P=zvAT=89o{x_q%5D<{$@&B}1wQq7hY3E5QX1{7S`O2`z z>ZIwTfXxNhqN+nDeU)UK@VT>ve}&f2rZ~x7KfhR%!Hzo-B0bq0_J)fl>Du-{PnDh6 z{W?P{(sVGxN`TQ65F_MIOg}e6JNa-jDdNBo#Ps(5x+2=o-I*b&Lt~k`qoxpjt%9;9 zzgI8FasEQ(i!|Z@a}5(daww1{6KNf?vrr2MQ;{BLoQtjkjUfGl_bsiJ%gx)yN%vzW zXn=;R4r+Cop2f)(O^+l2wSe8&F!+ZADRlXz$=3KI?_{goU@dAV$9wmop30KE-N&t2 zN^(taRO(aR)hNS_xi*sYeNhWQBw;nPh&c3zaIzz@gXP(f`c`y+w}HrOT1ARZ?Xbcx za8zd-n_`w~Yj4u`ki9J+6EQq@^6j?{b7k`zgM`O^}_U?a0UM@H<{na0T{d|@`5}w2DaJuq15Wpp#|EH zIM|}9g&gUiIt{Xg7dAF6_HmDgvUHMdS+}P80xN1geT{INbKPY?>u)9h!YO7!#613v z8W`d44?a5m@_CB$neOH9Bcm!zHbLgxs?=nxk7gTR} zB>C_k8j5Y=QtLt$a0jd!l+BM>_t1I2_j!D+s4@z{0!(JNE~2qo2C5&InL{_#V-_X=Ka=u@a;Jk+b@=_U#_-5`C$nczpx+QR+5 z_%8KlO8h)g&FojI%0ud(eiThtcAlreEgP6kbLzWOMY8@k@J7;aKT?)t%}C&4*vwFNZ|`$q4<#c?eNjGi|uT)pgL6`N)2XF_5OX zotBli#dnWbe%oPwbn>Uul_b&tl+3!YBqTh`YnI3xQNT^ub`*QJ=@S9Z`|AHm@?~&F zY-i3jL&D#jM3AN`I*TSbW)!zjn!Qk4A{^gZ=Sfgl5}2i+aVJ@vGypQ&5?001Jdjw_ zAChQ;C0Vc!HUJ(~A&eyrOnfJDHw}ws?W6Gt`nKfiq2rMUOxxe0^|AXERNH2CByBqz zS_vX4iGFsPUuRWs(8GsTAtx?Yw-3_VskV8fJ5eDa#mQmlZ%X~fPGQTIPy7P83G(9k zIDa9$irlKZ?e&4>az0FE-S(|1IT-=G^4Y47wqFTLOAkyZLGRjIHJ{o2TXnfSb!AF) z_d`zY4q6P^En4~#D;Nw$XhMPq&uWLOEi2qo_6=FW1DlinaUY@nQVNA1XE-;m!#X#BKW1`l>mOeT>vP}vI^!zm zL9^fWr3)|)UN`^EERlGjWYD3q%8z)vIq6^O6<1#GB&j%;@!E4Va#iTI z6hE%BL)+ut+fwt0KbfGT>adxT!`!FF`u2ZD1Z@RKeOExW{2z($T!W^1&NvUa3kOMy z4ds4JYt@|p-WPcB8F3D^)rEp1I+7b+Cd$3mr!gDXdnN>M|K879{B2l$gm$eZzfyuZ1+p4Sn#L87+LTNP$J-+EnC5V+TSn|u?#RQv zS?c8n`TL2H-B$7n@HX=bZ$xp(fW=xwo7Z4*s~dOVV}W1=9Fc=?kVvq@3+WB!{H0NS>byV zJZ`x2b?|7S?C-Jx4-cuMNxko4^R$GsVP4!GA2&(c-)i2jeQ z&Y$~%NZf>ng%*=XOPJ>U9M$_RSDe8k`>aW^XO6(HP^w(UQ$#+iFF9k1QqDM|2e-us zR)ll`SyqNk971_2e|b|*BCWAfW35>ldbcvNfq&8YP-+>xx(%Vw6Dt&d6Ar%-#I(@IbaiP7>o1jc&WS4?Gv`r~ zC%uVr#Bbv*aRWw%NK5A-Pk7&6QnI`AbI2zmcU|&0ZvdPKfy14t3TsFpyU=SA*d-LM zG?p$5pFewEj45>f%%T-5zmO$8`IGihCI{DqHMpG^B=Q+7hGWXrlmhmgc#y{(c)jfnNR%pz(N_B+W$iT%%4P-riD=T|h}S`5+a5({r!8>x z`;WQmt__)R<3sMy+B+g`dHBM1P0fxf1N%;<=?+eKX@MmcM#FD~J&$roWSrO0)|sH! z1HBhHxK*iGi(lFMO(Dj1S`|)h|H$1mNU5cIWvt^JX^XTQ2J{;ejy?8)YzK8N$%en) zU-A%@#XODEb;{I|(7Z^!gLwta^J6&Iv^U5QV1h_8R+NImoK@qRBUo(Flr!Y%C zH@y%Ay|xpIc^=-X+WF0{v!+pPOPiyXOPmSxJ(KvOTHrxrmT?B18e7YtAFLbS z#v<1*cOzXN=WaHV`ZV93isHqcvuxx%rBhNoapVaFcL2Kco^|4cxhP_sH(Q`S@mhs} zxbPXLVUW7+VZi}({5|Dq+s|i@*a?C{#>>`te!efbkK{_7EPz-)8eW-&eL;~so!5!Z zYo4I`QUSk_QfFa|7!sv*^`oQhnek-%1;FfX1X|{0*z58%Beg_yR>H}|o(*YGn11Yl z^2UD`qCZ)`Hn`;z-ENg6=P+Xo(I)Xf72Q-Hy3}d6@H=~*6V_P!Ez9)7N7QV4RZ|`s z@?xhX0$VJKBl-dgFIW%EB(7NQq8PS#`R6sqxw4~{&=^|RtEcRRwRvG&Y`}}`g_Fh@ zG86qkb}?5XZc0Y~d_Ek+d%Ys|!<*nwGNy@ZTK9Q&|IIb1yy0>-MZRvCcyJmk6v zRKi})d$X2l-sCX-l!^vj{G9GQ_z^nO<;b=jT}TEfOxb$$ zPPL679D986z>O$QP(;1WuBC^yr{5#?rB#DBIuyYl=aN68GU6xy@gvMkwWT!ho*x1& zjZ4DH1WAxt)s%K#hCHm>^?O@KCkXtwxqxmv33M}lc+u)wfr+vcXVzk}0<-rmxYQee z^}xbh4#O4~C6hz$^}1Lmgf~axZ1a&$7olH=)=J+Nb~rxwaqP}(+mnT{Z)?g)>b$Zx z$lTa^PI=%Ds;ILlt2yu%vOu*VJZq*fF*f8xXO^E~2COV)C%6b$lBfTi^rx(QW9hQ+ zFKDeB82uZ&8eN?7k@8)g$v%4bOp+=#&*Wtq2t5~Xa64Qu{#vG8HTb)cQy1+tgZ<`O zMvW8^LMka9m{s&%=&wTCCFrj4O(Mb<*6OyvUS`Bu>}9(Q2`Jv9$ z_;R<1f3_?~o<0`|`#jgwUTs8iO?=Z2o%bqJ2>|@@%+t8FZ32+=X=351={^aJ<=6DJ zxSLQ({3nc|+C~0Pv&kJ3?Gw2dm?69Kj8G%4m$5qmjkV=XBhKUM*6@o(n1lHsLgg@2 zesXB9qFyx0W9b@aw-K}62>Mvh;GpOw4865&B!iAzwJ)J-Y;_p9cAaaJNLMvR3*(nD zp9f=W!JvJEJ}YUV)A(bT5pvn5ZCB>rmwCh^w|9oaBH4c=h&n_~qvdY#^-Fv4-h?~n zg{vsZ^lDIvTCXROaJ-{-!6bTa9fGnDhZ%JlasAgw+{?ywVTAiAgBp z6mzz*7dQ@ClNFZrTjn3+UQ_*wdY8d!Y|Eh0@#qCT-=z@BTycx`4~Plgk7bVWyFSeVocMR z!=fkm*yj1}vovM&C+u5nrooB84C*Cw!VAwE5S+?cHR`ErbfGXIc#>3+-br|yJ=U8P zl?jFoqn00-tQl-la2T7JiZ`tB;UA;{VH1qKbA#5NP3pigDs<(?mOt8v2e;VZn9dEt z8?^@br2D$1@oUJG|H!d?O$^&2<-7JCcj0%$CX#!!4u%d!*MCR;`BL_K0C{Avl!_}v zq&!LPZcLp#&%BPEP{V}|KgwX;xVo5vp6$H ztWs2)P;8Ijj5k>F^kw-XXLEkD>hd1RQ1agy`YzvsB-|x9{UU5nUrZIyM1Fg0Qu?NF zv%5dcZ+>*^a^`JT5=;E)rAN(m7ew6pup-1wHB?rMQC~e4m^MCwo(c|2(6>)pYB`E# z^*Az*h4==k@r%DYt08|;pyDWhu@_jXFPLNTdCZjMUx5`fY}^Y?%OrC0%}IBHTT@+e z0SSgILo91N{)9tMfy~-YQE6~u(6+LXMgrZyr)YkS&b&2HOz@04OsU3^@3HFQ8zsog znHuc%&P0VWBvO9_;TW7soIzpb$_qqC6Rkrl%rgn9lDgocG3mm)_T6gIZP;0IEP*^N z6oA@0*Gd<>*y1JL8fM^O>>s2GGwvpFgEuV)TL7kfG?PN>yK8+t>Sq~PpzpFrd=_EI zYISLJ-Os9;_@NT?D+Us1_-M&L4wpmj;!`1UL(Nl7v;kqC?fl%x7xE2cQ^d{b>gU7Z zwGG3R!8~StQ&E6;C*zV{+7#YtAX*=v2Uj}o6M&)<@rOPgz>L- z0kSK5VrsK1QdQ+_Q0O($liRh?VrjHV|zj%1c zPj@EyYrwL#9pC;=Z@Xlu=LvEl4A;s(PJ{d4`UU`;MDgdLHg`&x2dAQpef=fE&K?|p zSqg@-7Q%(cje?bP4o7M~ep^26{(2;KF=JDIVTn8-f1B+wjr4(uZKyY?>x25FF5#x~ zOo~?M@*o#;l#_pi`-H8JML8J-hn$gg$5ztqz?us}w~1E7J0~OaoF=iQZ@^D=g}HnA zHOq?@TRLF|)772l6411mC<30ikPderZMI7^Vy~OJ4EJLU2ed&Q4yJ)~k_wF${b1=K zG?E3z+704K$yiCMx#)Z&%J{>Wbw$V&i9HmV!|Jj75t+rPxMGF~)X ztQwWS6`IwWUnGO($abaKN9&v`z{16NLI$f zggkx7&O;Ec5buel*OImQ&oG}JH|N;^y`}sTR{Y{R5Z&TI?lF6PP#mFQOw2X+AJTU@ zKDPET{s!;bLFu916Hu*|JG$5&SMADQ#&tIl313pq)N51Dei?EW^MiT?XS)QAVF$*j z%+0Wn%6bGXVwd}{dcm>Ki=Od>f4j4K;om)ksNot{3b`p%vx4>TIAu^vM|w)GCehR5 zuQ&+a*|ltp>z2LpxaoyLNA!xXI7~?fv09%dV<5e$md8XDYC`$ll&t`C1j=UH~0(WxkF?duO& zct{-xhW*nx%>xc`&j^aowOiZ%W;~XX0vZhM6{a78kGNDcFJEcxLb2n>)wor8U~xG% z*ax^0;+)0FA1q<)!Zbo(<0&(pAeVwJMu;MDAo|otZJ8u|M!UM-X8f~?YJX?gjobmA z%$3HlsMrg_oyXUT6H;Xh(@d)^+*hg!F8t5V@VWF^yf(;1E*j|kr-F@8{O#u|x$84~ zbxQ7(0P7*VD;9a%NaJZxejlcZ9G~!xt$kfs-!N|-*RUX8uBJ|*uOO!D>gT_88=tvd zN$onaM;)mSo30X_s(2!ewD+~b{YmGaA!|_BupDMEbY+APz3hO+BwvutUbLn|-2zRV5`cb#h#D7Hol z-no2sGd%?=mR?r&v_kiNBmC)Y&#O1fzKSl?sblY)WIkE`T#-l9`W{<|pV9VN=%@HQ zM+mh$gD6QSW(BwKt0LHv8{K-;6B#s8pH*BN`QwxgE}CTDD;}y~j$OXDeI@ zjH)?BP!+v6sorf%d5So0}XY)J{G~mj#Tpd!okp}bzJI%6WZ8)beH*g zQCPgMkh}w8bn>O)o4Wjz*%=Jcp_Tz^-mJB9&qVv|mi-9u6!t#6&2&1merI1}1p5y5 z@q0tp{vj{!zTmLs00xuvG43AXc35K_DDlV4E`kg*%ZdGp9Y*yvR4Jsv_J9U-fxcsq zBijd^QoG+nJdjKS{CYN+4LL+nAP<7~fEOG#sx0y?vEcsC2meJha4;K%?pH{16$j_Y znBnIlSE*pA8arQh{#h5nTeE1G%j>oy-+^Qf*J>SZ63^Kn#Xmb@0GVo^%ZZY%0&^Uw z)8Sd`<36z2)e11`ST+1A_xv9a1%cp338`dM=cBoOn z-06CGVMjY>!U>w6g7U;)<+dX@{d ze$<_)O5k<l($k`uDX3!s`6Q#Y65Dvo3Gfb_IfuI(%_m3o zQ={O_C^BPqN2sIKBznYCnWjJ2Xp{IOEM(a^l}j5Z-eY;}j{b!5E^ZkpZ76kpb<=4I zEJ+sr@`GGA)U6tZe$SbxhHfm?Qg|wnl%JnFTctHKbgA%tkb5cG} zD+)iR+8xI;EsBPb({qL{cn_u&{`->uB!&^sWHQ8(XSop34-O;?<6<|oaWHMV zx7wWClIScwmCZUsRv%DrYli;J+!74aF6Y@Qr-tSdx3XH(2fE&lJTuta+tSAE=Yx?y zXL|;VA^>t_v^KIUcQRMc|L1i6=EnL%d&sWqs_7gC)$NuFcJpzbU4)9+viv?%4O~i! zO*~}u#A)8T!jrM9d{SH@IcF;bkB7|>kkz`;mI+HNVfzbi9N(m&7-^<&Y@^Vmt)HOA zuGXJ3sJ*YiSC%~%-22ss`z&ndn!d07{+|%1#Bqo^e;Z+S+W0-%LSAER735~tpS zNlKrIz1N;)tFhk5w)0{bZm81Ro%pwdiC;X-HGc*6DUS3lHMQK2uCB|;YKhP@)@+#F zESMXR31>;yQibN?2IbPv4w?Xs=b;O_3vr??H6aGn@<*S+E?wEKXrc8M_xhN)DfT!k zHv9Bb?Dbe_B5&ezQao6;@WFjputJt^wB}k0c}Z~>u? zQj86E+*g=ZZGHh}L)tv-b8z<|gfX=CxFxA>t>%`wO0{A*?N!EQi2%(umpOb=+;ZCK zViV?o+5VytbSt#29rp(hMSEchgGe0o#AWUWS|N5}^1Bt712nY#3(4=Wf6d#Xz=h!T zGs?u4yVNi3?~6cIIapd268AKHx~5z3rSm@K&$GRP(tW$u%(gt46U-G%UwoR9*s3f^ z>^_U1k9`R~)*3T4^o9vc*cShN$6oA)mz{~`uK#MmAF-?DV|9h3bdnnclY?w6luSbf zt)9z|O9<$;Cvrt*{TYP1>qsctqJ)b1P0d{+dPQlQbC!+CPbxrgg!Lood>>kZo>s4L%Zo#a0 z^b=TnIsvjt?(vq@#eJ{7D_ECjQ*N8L*{)&vmg2e2o8BhWJqVe9<8tF)Z3?OHI9$7(ab9*Y^EG^<3{M}>^6NEbtr?>Z4IfxBD~#GKf6%9?<&-zhb>@)?@v8a| z;x7lDhIR7L1(vP0d4Dq^_1krmU&N%tZW={_ak3Z{74Wu zs1-6Vas7T|pUa#-3r@bvX=7%aLq1%xszo`^wt$&|@^OLC4HAY>0tdVQn+bZQ*tQ>^ z)%~4(9C(BS!*8PvS%zAc9+fNjU;07rpc04#M76yyV+71v(q414) z$O07QUMi3heT|?NNbv1jRH!w;wG8>ma zsx3N$Lk7B4?ZJDm)9DCy4qiyh!Lvaw2IJP$K0EArxvCRcXN;uU(ssM;9Mp2ysqV-I zLa=CHRPAncmoA-lU!&Z^wd_BG(ZP1Sdfks<@uL;b1!kXoQ#VZZRB$m|#0xlb zDPon^L^`^(sk}P5bnmSD%N=@g+Xj~A`zCAC{aC-)=5ChodUZeACMJ6cgZVAN6m^XvR)LAV`0lvKeVe;5;wO8(6C zmIo6eSy@06st$K_{xLItr{F0tiVlf=>}93$a)9TxRWLCrvTI;ut#~S}GW%65%Kck! z3$Cj~BXC}RXlln){y(bT{2}SIZ~Jd|9H*?zXmTN^h3PS6yeD_X%4w=`3Y$ty1xlN- z#3lCykj%=;)XIv+jdq(9al;)b6*V2yR6s#RK{Q20Kv4GQb6xlMhv)kb_yclszR&k@ z9IwM*!F>u(i>uNoo2wgh&`RklhnJ$~fTREIfs`+F!zYI`cXd{|BU?B&iv=w_A7%%` zEdXsiH#SLCnMo=!RVt!S$e0EnM44BQKZnPnkLq%Mj)vJWa4`lxy;3$gHy4xM*{P;- zJ%)AJl!(=Xbm5OuL4N5lcNDGT5~7L;_By(-xw0ZVl%b8%(cS|t6%G=M-^0LN(o-CO z-M<29WUUC-z|>^8e)Xh#Euo37epc3Eqwudd-b9T8!)Bq?MoR`+VILWyxTV4LmD0xN zP>*er76t@i`LI(f=XC$+nWo9KmzP1t^9kGHzbIbJX5`e~OWu}vc1XI`;UFyG=xt^2 z#SpySZIQVuFZ(Bbp<9zhdl(K$h>R=vxpq^6Z5n>-e%psR-iKF?ICiX0gF=M28ZZ{a zx_d0LNwoRDrZkU}=4>?=G-Ef`^Nmx7ZF{!z(m1J0`sdA{5zjhLBC2Gf^_-0`sbUW? zE42}uu}LlroY?cR!^C`?^E23e4Z#cNf#~69gTgSu-P~+~Kibs{F>J_(EeNMrs&Ex*yQbGQ+MX}X~%aVo^ zrh`jNij2I-VNQpfS-C*V#?^j~J7A|p5n9EDZ=vW>=zNT2`*a!k9eX346oFI6fPuCN zth&M{GPeRM!Tc_@&IFktz2cCEz=zXM^$QYP8Puo}qyl$@A^3IO2%}YbZFBdwWknP? z3>^;sVtDIal%Cii$nUwA?G`?kIhITv%i|m0luFvJV%e+LN1dO*ZFur47M<^sw8bhf z*)}Kfc-WDc2NVzLg3W3f6zOb9d_(C~)z{xina>{j8?V1X!RO<5w4YcqNrZ&nEnuqs zr+tg_{+ed~1^(Lh-aJv2!}&*F&bz0sO>W!om`>+hv^iqJX2o!OTc)01`mAD$Eqd2B zwr_I2JL9`-ib|JXfWn+p>*Sxfg5KIX_D%bQ@}PK`CV_Q3&y7koL2ZfU_!Xkcm318a zeCf|Im<3<5q2qlX_zR-Oo7T9r7Yo~^I9DU$jLMWw0qHZl2*ATk7!+b72$evx%LuV; z8uB6FxNxMu`FC=v>qw#QP@fP3#<+zULncKe;WB!wpn}q24W%Fe1i#u+J@ZjBlttdF zeVT$wu?V9nB_&>cDjfq7UZf)&(6Z`31Cz8e}6#VZ)Jy}#{cEJNg!#DH_nAKHgmqA_jAW8^Gat@XP z)OQ$wKDDX_!w5A2IbRq9!jlta{-Y-jnSZ2B{fKIIeHM2wuV;PQWA7&zeDmzY`FtGh zn}Z04N$JZb6U;#NwshJKyXo^}p$o_g{i?*)z;3U&TUr?KV1(huzo&cggB7Twg) z67~D=yyNkq&=@Fk2vQFd1Qq2X21qF}Hvb;aVY$*;;<~t<{?+a`HLL7aPQeyP^vomT z5!&^~h+<~_7NDHsLw=>~TxQr0xnDh1bG5cX{_6!DtZl9dqb<*8R}*a$=he5SIW4U= zSwwUbj}uh<3yW2jc=2U$!kNm2n3?^tcK|lmf<0jW%cn%{n-6SGEZCbdT^X19BJp6f zdxR@w>fER%gF03OHFaI#?XilSFE-yrNylin#4{$`dnWS6Km*Gp0h>Fn zFbbJqx`In!mTHIYc&4*I&+Mo0P_fuEt@fQc>pd_h9N~YA@`z>+@~=1U%n|(%aT2nV z!*Oy%e)M z=e}HTE5yq6_v!BJuu+dEKH$W9*Plzt4BpTi_=%}g=&>;)^%N$kLTI7k{EAYueLt+7 z`WU`>)w0iI>TD+diFp*~fekwTu|4c+bOZ+!gEtNmG;o5}>XyEyLWn=SY>eS~c7G50 zk`+-Ib9yL)kyx?iA&~8=O$u@^I;YDyYQ^xt|65~wIqyPcdXA#S@d;(p$Jebia? z>NMK#$nTxoDKz53O#eIGr1FOXU7`?wdR}gngson==upKzzV$X880$64dTAS%U_YR`n zU029^ClXse1?3;F1J%6~Qx@kX^>tkLhZ|ZV`lrn)!@8ZMY5lRr7hbNNOg551kLF0{D2dkjRsZ}?$5JyOT|6_FdVMU{dwwjuf_`Nerdtq z7-uxSz5^@K{?-a9OiIl^PG7n}5JS48`2=dnI3g#9LKpp7Ju8Th`7`X2`yjqGS%ud9 z@ZXu8@tw;$@5oHEr)GTGrFYnoV^!JM$)8cC!Vi@E@+LS-gYLD8Uea^eVa zU(~bvg2Iepm+yNfKRsW*xrb1vdz> zM5GZzWoc`-!c*Hn)4U4v1i!_9Slnk-3v)}3x?%fa%*+G2bFs$>Gbng7ocD@WG^~sG z6XSioF^YopB-dpv9sKuoN(DwSfhx| z=45ru4lQe2;A;~aGLuI-~7J?TJ-vRaI04nI>s{Ipeqt9BYcV2Wz>;FT2wL#a2O= zfSGEHobjev$6l)b(hPMlE-)qbBPv zCpUh0t&YLBH_(WjVchjecK2J@$8$Mxyb~AgkJaNsr$P>!(8(m~0x2=k`m1#?0sE!X zSAV?9A8+HioiWNf%VL>*U1sksp@}~Bx!>Fy4UW7Q#QYc+VLE2Uet7_Fs|B4e>RgUv zuGgK!2?y8Wi-iA{7+Qk`qEM}yuonzkpn#lA4_Bae}d_$S)Yj7VLn2&2O*O6-7Bq1TFBCXeurzax~rn? zwn6{g(3T4IB?C&R?2CeBs3 zq3cMmbnLB*De+_OUnxc#G_E_@y=y`74;U5VniN(MRn?@)iOB(}@yDuqw2$RmMId32 zpqF^O4shP+d_HODq1`>x)~2&H8}$jNW)NM`F>wpLoc)CRjO~hS0{s6|#?i>ywD4Ype;VH%&2VC{p2E{@-zjEhCWHBAn_Rb( zO_ouP?PTyw+`QTMC%IX)+;g43_vTui5!trfOG(0D%ALnOmS?A~ZJ}*A+YBq#%}ta_ z*9)dUluYlr)798or?g1(_me=96K~dmoL(eB2`z#CWxFN@3zUC+NWEac3z3=jArpzh zi4kVwa3s)d$R4si`_3IfTQHvR*bTB2U+No72;obba4>-2^qCz4?xq5SWNcHfvJ7(LXVVdR82|Zk4V96Q z4fpuNCfEW`ZR32~LzE&KWFT48_=a|FmSzRlSe-H=#r2#fU4cAYEd5bc)_{~8Z*rR> z+(vwNIDNJ?7hP8=sa6DmyGm~9o|$kcVLf&0dMqo@+oLO_OWoV9&pQR9J;Giw)OBD~ zB0Fzy*Y~PXfeu6|O0Wvk$<1&;c^MOWLNC?jOX45dxNLDT8HJ@XKN=Q65>k8Or=9Sy zKYT*;WV$ExV54^@t)VBPe7qIE)Cf4wU!z!0&9 z{5-<0<5XgV1mOpZy(+3J5&LKFF89M8{K=%VgKiccdn1eFzQIK@9}_AR<+YW3@p;V` zyx&0W;8wAdwk%h%o}=i+WmUVZr#G?M8oUyO?0bXh&F1y&-1XoD>+4VQ@KFt()6-Ki zZ9J(5QQgCJVrJN<-=#S3(e%e&HOz(Eqx+!p+D!{IwM80CHH+UxzB3(xycbJY+8!?P z%d1g_QGN|smV1nQGp2ww!3XthJ~OvQft+_Ey|MnRiDWpHM@QA`zpa1Av%d^{sE!p< z@!^?Bb+lvGvk=er`at9;#TgYcmMeNuwm8qP2q_;=P0m<}lNK=#a}M-qTjQSAKmYG> zzMkHy8E;q`xGi=x$mezU1d(ZhfEVlvhHQrf>fE9$axZgBI!Igl;FWZ-Sfoomvj5@*W@o}jx-m( z0&x*{OB=*@sAd0{448QcUpiOdW@{UQ+Hxjmj*hKQFsF$JkKux>ZOhlgM5uksKf#wh z{|YKXeXRWF1gx>FD(!=1X}U`++0_U7P1`71a8=3^s~`)9iNE#=(^8M!Kw}^#8Jc~CN_kvQ))&K$rV#PD ze9&oDPteM?pI;)(&Ll#_hY`4X02t3of4H&n1EH^v^Imon`ouNTA)7s$Ee#CEGN;XO zm-PcjHB@dZn-X<2rnn56v7q1^gt^&0jGe-ZHvOH0Y7l3|(rorwxK=RP!LA4y_4wdG z3rlqurp}rkUJ*_*@m1DbaC?jJ$f(AV3&1DwW)UvtmEB@|mF~w=5mpDNNE=2x7htx{a)M z_&X$sui0?xpY@^qvIn1GV>@wm2Fv$-l(e0*^3Oh|n3xuQ&gpth4lPj6c`pd$doWLb z)%BiSF)sGqqG?;`yH=vK2f#mT`&)k=CTESfGWxKg^6zI8K(oeY2Cn}0 z;@eXSj8A?g+Z7CcIe&4PIb2w~vd;a1X)sWn#D0gSkC{a=lzwtDDsJW>_}ZDc55A{^ z)Ui_3-#*VxCQr0?0tC%K3_eZr#m5|z{ua%Mh8(XVAJg; zS@EqW_y$v?fs9b}*Vo~<9%#5hdsg{(A>N6Qo)Yw0_cdS&Y5M}voW?#i^c|{S~Fi)HLrj6DdamKk{Qy zTmCphZKI;cLKlE*jY-^)II3Z+2YNYG)2mZ84Pk*ud{kUj9hD*X6)8)DbC;<$t|#k% zoSyzRxW`Y0`zH3WH?cK`dnYtt9YcJv{j9g0F^U)#Z=!;0n5D9gMeBe*VkNR9dw!ae zW=U$Vkyw5`8nV5@k?!-UhmaUs5v};d*+H*@@c?Pe@;;+QIf8~^q@#i8;aGj| z#o_q>^CaxgM@BY7r(E%}#OmudEyy9o(yg6JjM1NdrBiMEe;49D8<8#BmyU4P6F~hm z)0Rq&IB4-{r3lm9xO=8P7Wh)r8@dqJtE88ozL9)#v5BrO(vAKicixn)*@wnNEtpPW zMyq54H^5hOuv?`s$9!?lpUKb_4wH~q9}=;Ty{}`v_sje;^R&3->ep$(W>s_V&)fwR z(P`g$*C6MVmtO>bEVaHMTCxX%EM#(F!yj9m1I%eb;%!-ZXL=~aKgr<^*!WT9KK8l} z{(wlb(NDPlH|XqYL18L}c|NO2Gy@?hq8zSI37q!R%47f4{8-ipBBtKrY@Ctj@3~X^ zOk>BNyClj$vXlyj!xcEtzM-4Y08>atZ`0ps80pH)^)Iq+$fzvT9pkA2EC_sb%bezx zM7ulLT3JINdSYc(!Dd8=PuhT6hWLz0vbD(@Zh(0LEKAoWZUM}Qjx$XA&g>OHzFuB> zx?mv}00=~V&PNrawP(imHE6XZm(`lmN2O90^EbP6D#@G67}7N5mFd^< z=rH9CWxP)uT)O)y(vRps(`Vw(fp3rYWU#!8YqKUrdy5FRD+H~;P|u*ka#h(G>{=jxIJe zaC|21`xX^P$a8`)i(!ugoYAyQeW;PUA2ysCoXyE}#7jhhJ@wiEpzwMEeFz=@LvU%G zdFotycnKM(C?)@;J^iY$)LI^V!Vsh~d@Na=>oRYz>lpcPmUOHZg$)%?X1i@Jhy0RFONk{96kVMeom4)U;q z3YkUJ*O4v(zJG0Q@{HaRCL3K<9-QtL=Ayf1>;-efY30yU2*bWHVJ;|TvGM!mS#-72 zlE>nP2rgK7Q&)(_RlbWS$VsL+^Ssn3qIvRIj$NTh!(O*^J~%1Lw2$jyn4V(MvubdXEm0-|p&Ij3U5 zbIGFFi5mAvY`jIpCyG-5JP)ah0o?TP%G3frlhZO<7>57oW~wBvuY)pVoJYpel#|4% z;LSO9;6Qw!?LZSwXt%(qI84%kBrB(Y21e5VTGS3Ufb2jYZROazkmcmCmXieN_0KEUf1nLlWvWKbrnD7<=R*|Dt8cP|N#6D5 zIqESSV&@q2MQV9pZ`jd3g5*aR{cm+*dLURQ9#c*#354BJ9UT&^n}6+3Z!g(9R`FIQspojtYK|o} zseGu-t~~SCtkZf=bLCfHkg?``@ID>-dtME0wi<0@9}TN&Ch&1by*ox~=gyV!_Qt zVst9PO<=7Yw;$=V=r12!8n5QAE z^Kx}uEY#W?q;Z|p>dM{~*ZjUXG!{lh+u5crDxF6|1T3@FgkBti%j=;)T~2{q{@Qr| zpi$f<4aL8pQkeA&VA=W3;hmx5j_{ZhX{i{%pnmgTUzz!FP<21EXJdbx&4@|5CRBAS zIW=T!{<3->R@UOO&NVBxNusrp^Kt%!PUstktBG)u;~Qz-61{7-<(L22)TkKj6u)#o zgCF2YM3m`|^`kl2gK&>r-TjQYjAp}}bpJ&t;%@3zL+?Gqn?&e0AO2pNJ&Hz0|7h~2 z?99xr%ajAw5nsi(o-J=HKt`%r*;~G@C3*~@7FW4<^1mkI{2aeNA+Z@!_w(Q<>%zp zZUN9pd0=*GT(>V0yy%7lSs2T5CEyBJE{HC?I8_rrp6-Pf-y}^n>Gm0f$wiA6!obmC z1h5SOVwa5yt*M;-40E~YmZT7m*-UBTln@?o;TCJ3`Y<`wn3O7a7<*0fSO%esl2jF9 ze?67E37CZJUs7ABNI_XJet|7rg$zHp2d2MKAY^hMeaMK+%tln?P)N3_!2U)bAirZp zTr-Y4nOI@8UwQhX54?06vAN!ypXC+}Jk-_+>_JvFdK?iWomsF9DvaWThcv^Xq<)iK zohM1G@r>HeYN;gistLliwI^<)ds_k7aX^7RFZsNXgh-T8cs=XoIa1bELULDPIp_B1y(WcK;QZB^Rx zybT&Z+QGi~yX1F9e866s+syscyO;Np*ZXw#*W4_??{WT%s9i*h5Ex}r5vYS*=Ymh1 z_%w@K+`E?+|M_RXnd37B9_$^^iN)m0Q8y^7s$TgT!F0bnziQtNZjl8BfKZaFyu2mz zPFEn)50B_Mp59+Upw<1Asss$8*?l)uFr5*Kl0!aPt*At)u`$MDI;ulViuy>Jh&$@K zlD%TT!|#5My?58FSN}V0zE^e%6s{%!Wi{FM*(^&J*K0^oPdes1qB#dLu7Mg!!fC@T zmfds(D_4y&W+x!g_i2wEdQ)bnZY`_PhYRs;vDh_`6(?+|^|Tet+tW`33u!ph%;-8F79);`?U zP?uGZFfSy>yIMt=&+%3>o!*p<6|y_7iXT|TsOG+WKznQ65cl0G@g}WaPj#QzpT$TV z_FLz&4p7XW9jCJesR2lK9W*Kppo=l>VY!i>P#G=q{Q;FG*Cbtqy3wDRs#^P{XNxm$ z&-)sXEz8cv#}HcPkl_tu(%lrVW1p`dQvcI6AZ0x zKVR=A*-q#@Rq_J85Q!@=Dfia%>|klK*p_{C9W-F2Snqkh2VhE4eJ0TiqLIB&1d_G5 zP1pw)Asp}LNxFrQ5Z3_AX$(SsuVbxCYVPn5Fh*Cb=Py|2db4NyH*5vj3&78!DUa)4b6$ zqlo5SsojmE!s`9lYps!8QA8t;G*O;l#QUi2Fp zc#;LY2-{dcZtrh~fIssECslxS)~|7lV-nTVL%R{?89!?i$^x?Af+lUlJ^V zZ(aFejE7pVeBZ%AGt|-KY$1Y>=t6hX8`ZDWy*qH(?(_Jq)ubbo0Cz9ou2g3 z4nzg)P#>!%{d%W5q9)4gu%lGG21fWHyQ9bWIGv&nHcn|C`=3b%1^elMI^1=V`bL+T zP-W~9y>vdC)j6J`T>4kY9WyKNJcEJc_Etsql|^l?cPt8RPpY7n z=vJRwY@u$$Cmt@H-d`triMI9k!zNIdWc8Q%n8MQd7jEvdPP_32YyWi2CBpARzvh)0 zVaK+phrV%JR!>?=Q;$Y^O+(-_*D&jZcX=ONKUpP9js;HtmZXw+b%uY5?^-%`yJgPt2TmqBq2nmMlnU-MVz22L>THmv-a; zaBNpq!rzHD_sec;kUJFYXj^^crJ_T-DRcu%hVaK(d!8`?%ELaat(LMfS($ILQq3D| zYfpj4hgUE1QP%r9#F-0>8x-QEphoeN%ncr|Hkpspc1Z33AoN`7G{^55s(ap~E#ffv z>Nr!nJIYuRo{@9@gtO(|@Q}E}uBnA2^J4swA?csK7>ZbOd;^vcXG045mzBNa6;%2v zbw0%7&YZ+;(Ry{EYC5Z#=-loHieV(4$a@5*7$~=g)ycLf3@9d3NBV1HvNtiL`rg+r0 z8VNl8z8j-;I#qdUI0%}YUVj@GGmo*ZV}wAL#OKClTanFFWMsuccC6!k%q9*bq*$hb zWP2Kbtg%LFg?a@-jU5{JD=h76n1}<)TTfo#Gwm01 zp`7T`qlo7EXHZn==4Q~;Abv_SVpe-%bXYj6o~IozB<(El)FxvdQg|n^?$}(_llJs3 zRJ_lzZSe#<$EbAi&A7UB(=lG{tP89>8XsUnK6{LTt;+Sqbo|u^n1XnPD_I(Av&6p( zmDkYSB$6Hj{*kG`L$Nob#B|iClj1( zxJ{m1q@77xvF;+QP;{(d$FQrm5mi0`L}ix=I6C#;)7~rup4oF5|1UgBlQI=~Iyo;g zcTdtbw31CQT`W0XJKZ0XXA}Le-%9tFrZ#F6z7oHc@3G%5SP$wxXN26fCxl^i03X#y zY))XKdl3!<>K&;t2+&P?2_niNkLXaX_iU$`azv26q<0Ce@B!^Zf zeMq22v$A!yk{WfLQ4aiQU5Y`TGT@$tpM8+zj-H6udrTAemdEH*=xrJ{+Mp>umqUe) zL8h`8se$L>X6l_odgmw4^(qe@F!X8}phA&F9ZWBs5{iAR@wdr&F_O`=E5_W?BB(lI zvrC`fx)Pt`>UxIUvdH9PUqP+oWp|J8J$RR4Cm%d6C`@+Bi>JBXdA+kIn0~xTemGs- z8b{891v7e-|GZ=CO$|dvkP)@2|4EZg*sT(ZewbbB&-YCPv2+iRYY^2jM#x91d|d^# z(>Q27DF-odrXfZaC8l^$Q)?T&-8P!GW{>TZRn0|#Er9WuJbnbaEvPeieg7jsT^Dyy zz(k#G!^$MzZ~a#OX>x3Q2HvjU?|Ufp!N?5;6`-00BiW;;pC^%b`hX^hfiY4 zE>PT+!Va^?)7|e}oYY@dVyjY=%WI!MFDoL4fAlTg*-4@HOH-##UjrAFE?9Wx_7>QS{e_}o&JL~j;kA=K1K=f>M*UGyqtgT0qhH6Z$<(e zVa!e5?6`uEe>RB#L6NDkw{^oqJD+I*wb^K)r6la;A zu$b5~$nNv`D&mDHObe4!?Q+TXA!9b8lh;u#ZkLty#?OG=UFS1P7aDqPSLZ$MSQ&*u zU~4Wzq^aJYQ+D|gT&A`{Uz|@7IYy6~QHIO3?TppW(wIl-7#zD$P|{o>UXJ5{wD-!= zo$2y5!7Wf9=SUm zMuRsm*kRPQo2<$hjq^TCzNaMnXE0T9jR5Iru?`O*ukXdNuZ(8(7-c?&PNQONjrV~- zfvP!_bs-x6YLiP7Z2MsFIp@Hiv1(Nf`BdlL^cGHaxQSQ9DD`Zx7wd#A?8Q^;%FI3z zFM>E2G#>u5%LHkM@e~If#7Lm5Ue|`+doFz8+&rA}(;3wJI_6wEEpDuVRUAeJFAEqz%HQPuOiPS($nmVOS0CzorASq>Ers+KjCEGVYQk+Pj+h)9 z@3@;V&{jr4R&9!_efI`Pt#GPOk_7OFF$QsDi%WyZ-+P48SB45STCG?FV>T6s7xt)6 z0NB2jqVn50W9|;!879k!Jq9bSMMwn?xZ4rFa$yr}U!+5sIncpfLld@kv~@t`!DsZj zr3Uf0J&iJ-<8)bh^!r;^)~qoupZewK`6G>p0mX>I+{MsQp0i=*T)&`7U61~j>DbAO zp=)|*Rs9XhEjr?iMRJsTK(%k|XVL^*PmoD({}(HgbqRXIOw)e+@8#>i-!!{WDB``5 zAwVBl`SUqHU7TNKMis&9dSo9U753NTZ+f(i|2~Yy92E|&yeP9gk@m5!7qu?s(Ghe@ zL)_J#i{3#+L3PMZw_)rA=YTDJr0y@TpsU|$tKSxAEyfb$DW?A3w5v{kWuL?Mz9rW* zsVmkrkA}|WN3_}aT$?}cs~F1a4U>hk!%q+Aus{Blj{0{soTmASSM}(%((z89(V!w`coZi11!nUsuiJOyZEYS}d*?j@5(94)_ z8_F%$(wl8>5%g|JMNfPTLGCDny}wnGH8)gIt`|2Cx7bfI6XQR2-0EqR1cG7gt`Y~q z_0)=lQM7Cp#x=!!_SpDx>2yZUK}6VqHRBlll-Dm~v8|fJ9B!)$G|Q1v zCYYO-g9jm_9<6geBd9I{evVKe@|HS2lb&n-=sP^uris>d!>j0|bokPM!@xgZVrEbh z$AJ3yG6v2ShOABum+H<`AElRNc8n|~*?e5f?X@E(#s$GW$nf%4_LFZ+Qtv(#!ArtzRbHDSCDP~!0>h#7Av_|s!suri}U=x^RaHYzY<%U_cW6IEepd1 z!4up4mOTya4WsHZcGawJjheY$Sa+MVH!@c@bRoy844QD5!*M!O`u)bb2*-LC690~;ql?~leG~)D-J|aQ{Or*1 z&x&cxdOgnLuj}|@Ud$n&?*`3hbBS%d3n!Wiu~8s3p&BYDoA($I{wT$8?A;Y6qb``3 zBo;D3)t2?TOE}R8f}lt$l3&E?+4!tNpK+q$w!EAcwx;-;9Rm=*T9{u;`%E;&ZJIHs zdu9XK(t<~HYkwbnNEsA9`p~$5h%qpS!ZSnVeAQcYdEfu<7?)0WNdw*)@f>Bp&U2xx0O@JlRHHie)>{8r0B*;$5l!%@WS^oBCAZgTJR4?{h6*oVohg~(Kc!ICDj|IK^8IJkF zn>YwwnhB0{z9-_RRUsQS$79W4?2WE}*%|f|HrCU{pP%WcgVpv|k(7`2CK)&m;V3s2 zgWEs9`X@GHyzvO<1irU;?v@++F)c|6Dq}b$M+G5)63@Gru* zBCM%UKFmKiKkoq07pjQ?Ld)>PvNTR# z2>D#+_8LKkI$k(;5~98BMy3jH&eD#$ek)o_G}I$cb8=&%@+su&4E z$u9ld`)pTuUg7(kyLKac3~#))f+p@vUvzYWJ=v!HAFQkP5A1QUIaN0=TbSVw`o=?8 zw{!B0M1$ey8uqB|S?gj^zwCW)#6H}@UiLtGrLyhQUueIjrMz?C)$F!O(tt8{D0ORr z-%mu?C6!ZE-s|bBqbJbx8)%0GhIo1HAJ#shk@z%J>uFNoVoq>y*dM3a`HaL%F|^gj zT+9gj_xl&>Q#@d7XkF6&=wUC-r3H^VjNg6o<_@x2Gu^o}Cb1eR&=GEWcVvry>yG8y zlZ5$mw{s7AM`D2|<3n^TsHcX$FNBteB>af(tc#^4hM?CvTEUdUJ+lnDtrSu^hsAFlM90WQp zMPC8t$`JIcJ9FGyi+Ox~2vlVb*Z1U&`%!hd4(Ilnxx zjuovW>VhIjj7mG6GoA(ez23u1W)g^MwZ05{N1Poho1lL1*+&7)s z0RS{AJyJ6&aHPsQ3Eykc+7TV*@R{()0SIjY0@|k}uFSsDcz8v_d4}cA{FXvKcrRH$ zNV{_O_c;8AYf2?IudfVH=Rb#vi0e_KYvGK-7bZw`hov#x8;EjuNZ1%3{$PVwEeSmVQOV zg=}8o)+W^f^?}(J3g=+PJ=NZvkwxWOO*ArlRdLVknGel{woCg?^>*Ry3lHI|(rmM( zyHya$UJ_mig!YX37_#|Y6(FCU7Y!O5N~TW`^TOAH^rBAjp34v)}(wyo@lo2)WFFi*Zn$9*hN$p*9jh5fQ!@$WnEiTHb2l)%1Y z-sV)7Uj%6%$jZS@Mf;lZjG_jYl~;%Z{pGN4_z21O$tqlocV*%RdZ8#+Vam2# zTz%#7%=IvrMcklIM+95k6~vbaG>(wSNWBjBvJrqDby20~>r0L>Qa`OSO`t}~|9eP# zCN2+UzS-H-l~}Wy&=#oGB%B@19-Bk0iv>0o14rrN#pw-_W+%S6U}TaROy3aU3*B?q zO~N;OY0G0?&G{VHPcctfVf_8Z`!Q!m3bVarQ92cS{!Y}EdyN(@UTnlz?8>o!%wHD^emOmlT3S8w`OH_Q zV?nr;Wt5(SaG2^vIXnvE#K%*1_>9nb{`Ctv5nsUhVR28iHclww@vS&okXCfFDnztyQY znEhDyxhn8VUi|Ha3tWh9A9!lzsgW%1)pDNZ&||q}y8HaVbn2;w^p)h|L(j5qS;hZ} zzchnY1MloDcTZs5xvssD6ZOY$2zW23I@4~dI~oWsKjSut9!Je=;(2oY{|!w9K6!CX zR|WnvB(j*o1FGvf#lL~Mxn=v2+yS!F7Rl%764X4T(Hc7X{7Tg2yg#+C#n%&fY?7O#U$8Z*s5eN)*Fzm;)D(6n ze6w5oY}rd7yg#05!hU&1_&s^%a8=xWLHxVMK=T3I2XXhSg0_x{i$=Gjqa78Sm!Zii zvoJe>SbI)=EhP1^XYyUY!YSYpEL5Oza(EE7IU3@$D> z&y%QZZpyJ+?jfIUl|y>l9@^A_U848%>#`Hrn$`}=p$BY!44yL5F(x`{Ygi`x>2(~{ zV>1s!e@MVE^&^~tzg^`GSALnXite2o4(cIEbJXAdH?oiZ-!Q>O2@#~v`3-tzD5dY-+?aB*(B}=v zuQdI~U;T=(_fj9DU|YiqP5eti&cPs*LolHlzwjotAS~%vXF$~C1#mIZngfK4GU*3) zEwcsaxKF4;Z#1w|H!_oD7rZ8Z^6652CM-bF4Pgxi$zV$2b^Hr8Ju+LGK#Y-HJ3X5Z zACA9toPMP*d+z<_5l%Y3m7|a!OmbgLac|{CZyB)OnWIQ$E{>iW28^Q=Ad^uTq!J58 zp)GE05d9A%9$el1+U0%pAG91hSe+*cx6=x7s2o<(A*t_5+CLg{tJnF~SJw(S$LFH$ za6^aEPQcD^!gEy*VYMa3ljjGgGa}wFQUN>qW%oHWsv#Xfkl#0tM34BUOYCRtrSKc! zVMI?o9&zHucFVgc*{MheO6md#FJq* z14paU%_(X!68wz8+n$(MY#EMRs6u$`lpTV?wAIt$hwAZv=l$un&}jTmWQf2IR^Po! z+KAsb)ZMK3^ys~v58gw~%M|9fxmnThuhWL$Gj1u<6YCSmriJQCKBB-3X8nu6i;80& zMys_yWe2x3wg=lL23ml(lk*y%Cp+J}w)y^}O!G6CO7M|;&UUJg-tf<_b1Z}%r_xK0fr8L(izjnP!jh;MjoD<6B#%+a2B ziL1|L)yr)v`ot!9%?6KvedvYXI^#sBE(Cz15z<8nTv%h7@>R<4ZUmTK&}K#wiq3px z^w?;|BE4Edp8;$)DMurWi`iVMT1LE3d5$)~1GVDpZgQ zHIp|)zl(KWF1rvJ-&Y6tng1KYwfJ9J787;Xt7S1W4dfOE`t56IGPDCUi>hNHlIp}G zu?-*tvjgB$F)O00Mm1N|Fw>R}@=F(bbS@_-_>8N6wRz7`hRJn23u!9-UJ{rX zfyu_btaJ01)PB;m3Lcv3{#v=6nVsMJD0(?m^!xS6**{PI2=|cLPrnWrWs{wWp5}?~ zYl!xRezq#qzvp|V!=*(KR`Fp-zYEu8&4zLc$cA=92x|X_I1!w#9`g6b$uP4g)x*r{ z3-zh)JNMBOf}q7M&;KVH*)BR)ljiCAb@fT+kyO+3{0htT#;-~Ef*ut{^ue5@*#qep ztsd---9JhX^0b|e{;qtH=aIy=zJHc5uv!Ni2^b12o{am{QC{vaS^!cn=un29&A6ez zW86PuP-adfT~~4g%r#wo>IK?V3GL(5UoFzhkGd?#vqFI#aj^wOX)vvjk~%o)mZcT* z$zzlk+@3@Aq*~2pc8^G|E`h?gB8PR_JfprElP=+|9&K;H(hG(I+azjgRWl)q4bP^bT?0ZL(=;fRM5%$akbL) zAP(;<06W*6NEQ&@o%^$3(KX4HYRF<+t>X6ar=jwdR)a`r^1rWVbK|YrPql7~AMG*P zHYzY~9`!fEcCXlBt8$CutKSz<)rwT*up!og60Ps=*%+w|Gb9NNjXxLD zzrYKUHh0@T^OyDpNCz!kKSMGWg*%i_UM`h1xYa$Nv~pNa(<J4 z`#3Ck)ADUQ?}mXdW>2$x)(imn!vW8eoZV;l)+aD{RFZWQN_z7BOUtj81mxzm?EEr~ z16!eIV-1i&csBogdy>TjZ%&@)SKZV^TA%NZKGAZ?l znXf!#-jis3KUg_*3x%{1O`HRKaC4>EW!jm6;-u5pjicyESf?A&F1~Y5SL{)A$Q^ zv$;mlIG6{+lM(7x#-J9A-)gk0S-QW%t4QukJL0H{MKsLYPS(CZd zDZFd?MQckdhN5HX+{m*~BydnU+$$6;=`WiPQ5%lhc5~Ag;MW-I={&vt2kMt6SqbiI zqJx+B2|;uU&tQR|U;5KBmIiJ+d${#Sl8aUADL(FCaVIVgpYE+RvRQWjO-LZtfc^(` zQWQ3n*15ilI0^r-3~L#<*0-3Z1%l$yMn!{TlO~D)w3FA^KO1J0a=(a%99XY!qb zrq81ziBre=>zDHO%KztB=eoMevN8~IZnJFtZ%SuZ!@wCE+H%BalgUtIw6yzPkgyKZ zyyu!mO)`slbfRtR{vO+`HhBGv|M_ zKDpDci&yP_0bJ6jKrAZD%p->o_sa}sk`Cxb^7_%KkXOcx#9<|>Xcn1cWfsK!gNE=L zF_?wHTI?4sICfY?sWA8`$;jnBBilx@YT_9i+uA#6>i1b7QNu}+jV!irLFbrJn>4^k zVjqS`{s89bkt3PptO07*h)gFv!b%MGjJC77)TP5CP@G~q;SWN<<`1u`sfRrMwD(}Mx(jV9_ag~&y7yqoQ(%66_D z_P3nPlR4k(vOCFdB*?aO-3cLL#Sx#qFJ1=P1Qi_f>`MC5*8Xd2`Uqy;Wj2388asQa#!s*Jc zV*KfljELg>_8r0A2N;kz zhWqBFusc~+^V)v8jZCA06+W(m{vI*lbMo^nMdcs6OmJ1I?7(03RW4f-rTe{coDGT2 zFe>QRKdd-{B^ z<-jxeJp3h*RpYsb3HzakV?~FnFJsVGvlEZO{?zB5F}^mNqQwQ(E9W3OEtyQkr$jj; z6CGV08{$L7G3QB4!Tc|}s1u^SCHfQ7vFIj*5Yoczf>-FHoQXjb-8_$0e?IECHOA>E zXb$yf0?qFB{J@~W9^pB~!>*WH_xdoW_`v?P#8IbGPL=2SjH+e=Z}RWNt_fMC%pswl zIR=VHIaDK#>J;?}-DmUdPCILM3%q6arM03J-I>BxEbZ3Xa;UNwXyj!j*uuGA3fMWY zNZM9I{+(ZK-EYf_EGp`L>&oOuXGQ!u)A=!F3ox*qNOH5}rGv+*4tAe_N4(7b9W$3? zdlmy+qJZY>ucjgZT9e$k{VycYgNvxcUYL68~h3WK(2Qrt@XPOm)`Tgx1Q2 z33lPH_>!6=F0CdQApI~0PWPsDVgUFAVT*BU$XYqO5=`x!P7690Y}yb(*|fETQMsEb z7f`!jRNjoTvfwd^gLcCbSd1O%6RF1)Z8%Y>jT91Qdf}|G97K63TKw2gy zil`rj2R)am=_@7n(e9txupKbZZN3acJTPfeq`FN%*PmR?ZlmhhazC|XwZ%>^`cG8& ze+Mx>VA*lu z#CoToY@Ww^VP|Rncgd2u&_Mr`Enj?(hmD+i05u)u17umis3c0zcMTbE&WGApq` zP}A`vEaj&+aSu+7b$#JgKi${55gWl^MFoRRGd1|z4b8z5JoDT@zEV>C!mfb(s$8k|JYRcD zhoP>e&!eNv(#7k641drh>Z|*VqA55^vb?9aAewR(tQOU$9gQ+uNNiWGFK$v++nXk+5<$me|~9ULE+kt<`$_Gabx=&eLGYu8&m(5_-gk>Jtpm^rfeKj!dO7#IAcWhYj;a+Im z@!IeH^6#O(;mz#VkSDu;kIB!5{N=+WMtm++S%`G@2UQjv*vMQ5lk?*Y?B*u2|8)v? z#o{ml4P(^4-{XZIyB@j(GM}P5!;2(AR=;k-su*z+(VW6wW^<>&CcBfR$09-U$2L^i zf-q&V!8=vhmJ9R7)Zq6B(`stOgX%DzEKN!{>ls`;RS6+37b1vIjU}6Ot^3?{2hd6| z^C0ym^13d=l<(c29Uj$FBjBY+%l?_Ab!HZM72d>wg1lFiha4BNih40|+10#<+%$FZ zDKt*={XFb;Qu0h4=Wnn+mz||#EGk*(iJV=}h84FAQ{Q!^-i2fNUnIBZKHO^>YuF>S z>T}<~{ZVLUW!|=UNOe$k;rVHgOG3{=#zNHlge72u1@e{ys>A=?Hg7Qhj2nshcK#>H zi%l!H`DqNIBn;=RX%xXhJY^6r0F&IikOZCw0ZlVh!udP&6rkpOmul5M_NO8}etuWM z=&Soyc_vrEdsAu_QM&VYb}-``U)@I`DX$p^Mr)b}w?SZ!0&!?<~5z!%KcF|4)t;K)ay2!%x%3}rEJ_IK2&2YgUB6ulsRRN8(#a{!~~t?+V#S!OQ455s~`&bG6Sszp{)5za0K`}^I23-STZsD8Ilkb8za zk<+cMY+q5}GQo;k>wSNtq6WSsZ*x%%2zQ8i_K`pIBXCmFcq^j~pkqL8Jc$Me3v)?; zrzbna+qnkB3UlP8AMR!+G7C$86T(BiA1-p-X0X}aWAAWe9Mvn!S|>&tzwBxaE?es> zwG~a}*cQj;jQVfYtI%N*!@qo$PZ>PV&cqequ#(jI1;4SCU53gc|HIp%eoOpHj*gPo zNWSi&WLHOw^Q&*C^q+hdl$>vNe<&NPoYkm@Ul^ANhHfL@d%!B2t}LJGfmbTO!Fh0S zM%#08vYDxteSFDIi$42nOMCPYMS69&__naff57M9bsMJ84(p}J^*>2e3{z0 zQXhyIXH5@DR_{t2-gv#N>jh8VaEu%!UXuCG?q1|7O}&+?Y?kZ)P5B4xA5Z1^{DR){ z`Hi_YWLb5)ph?k815+Fgfd7_+;Q+OSL@iWx=F|g^;TdKGyr*xw33-%aH*b~+iB0i) zaq1x^S@f-y$po}`Irc>604$UJsopi3ES81pndNn^ryGLG@+!D{qo@Cw1T&L40|kCy zznPP@?By44l2WW|kom~LorA5EyY;^}!M(TH*&aHLiStP&n>wXWRbKD>z^f4F6pcp| zwF&~L04`)X2uM2}b6{Vv`n5auI{StgJ|CO4ycO*_ zNQpbu7`qv1tuRZ}wP;&wx6UE->|LwtGU`1um!fp0?A9P4&MQ;zW=aD81{PmCx*7mW zoQYhMoqpjysB?0ZJ?d5*p6NNd7sPtB^2J8)M%_ldbA^;k>Oq}eR_S!!BC@(;Uo zht!izT=4Evs&P(Se~`&kYiR?^EmPV*-iM<(j}`^*Q;Q-`&1SrNGgTEMyJ<@)3WMVm z&oFr60F5_L5(R#{;Qlfj6Dal~jlLWRv{~fOMQ8h5ll>LEdhjRndVxhS`nU)FOwqDn z+3MxJn!#t{^@xPOVEPCi{lI1re06{Fpr%(`aRG8&R}KI-ymgUI^Y zV9l$PlL3_CFtPD*(m-rnB?FS^m`YLp0FJ&dR!r8bNDVPKRT3dRNG$ndylZy*uzPil zCk_0!IH%$3c3I|-oSSzTABYJk4xcKb$AEpCrjj4Q!Z8(!dAWRid2}V;OVUaVC!de9P9r zSehQv1yTexC?bcw_BOb!v6@X1XCdlUNzAez^VVjBQ1@+J=q5U<2h<5U8EBjgY1Jci3>sz{5+PXs#eeaI>o1?c>F0-eg!rwEz zY+Y#5oT)+2W2ZJJ()#&}1^o2ChtY5E@owD}!3L27d&~`)FF9onoB8eiA~mVLXS4ZZYH)-c!b@?6~Q^s(Ams1lR<+Tm)pZDiz9 zUAO|s;%dIhuVtH({akwNG+(G>x*;)uWd$>q2A}a7SSP0ddXdZ!pzLrD3$JXqAsKTq z`X@x>FgxBPr+zVph`<3~{Eua$%| zWh0SO>(O6d3X>Oh&d8LohfFuje)pmL9G-{f=Q$RmB08S^wp8=0iL&=jVAB}1^Ec10 z)u^>M-3KMxOPM^FS=hXEUVgtZG_I}WcUxat+d#jrEW6^t%OKn1Q1z#YkJky|e=%d} z_e8{@L2U({+ScP#WjSr_;K3&iGpay7lA~Is(Oo7Wp&g5D) z1$>>f){z4}tMmRoaZ^RYJ>3Tz#v@|~6pcfO?PKi_dyHMO81Z6F&E(v8uF&ns%n`tn zT4^Z$dfxLdn8K6+^m`Z2!Q*a=fYY7GbST5$lIzoPLYPc~>e~<#+Nd$DBzQPX4|nIv z3(3h(gZOD$B=A2rXkVFVVY=g+|dIy|l1NJ2${z{8RdKgOpE zW7}tnwotrwh-b!bE)1MMY+FZONh5hJ*4*rj#w@{8VY(AEMO1NbV}WBbn?%%G400=3 zm0#P51XoXsshe?!uw5E@z*3OGrop z#fv7clx0O~fEINV6B4?5$r@PamrQ_cx9ehClMRs2_OBUvbUKI?Oapw6z3JT4#9C^1 zXBp3?`pALBfi^au@-<|{IeAZUh+WgQ$fyU>EF5h0rD1bXeF*^{pf$-A4TsCOvC&6gHaFS?y)xjcm?(N&BB` zOU}{c_w~uCNd@w^sR1jJ%^yqSZc|v2ANjloW>l}j?7xk(-uhD3f?3&*>hb1d&xE{B ze5X?gvg8w0v&CIi+`IjpCnCx@awLqSgHce|ZPs|#kpRH(9eUl#%2}k$Bl00+OX4wG z`aK(;N~0vcr5(D)4Nhe4L%d0rO5li*|iD&?K@HJHK(hr;a1^$?;GGqAi}O#q!M%xAc*HH*eT|2c z9FT4Hr1(ID1FNR&8;GBv3#w`^%0c}0lx5qf)Fbh^CPy@={>A`oJ=xPn;K^%g3$A@T zb*Vw>vy;%Gg|o_pw4Y*@npKEP^$8PF*MIOUR~A?ghmK^~aKrL|JIixMgbwq+cez)- zj*qOZAtFFEjVF(TLNBqN7}7{UJ2}729?^q1a=AMZWjSmI2q_r%B&PMJU8ir`Hs;^Y zC+2^K%p~5KO?%{G8_QwOVk$-JyYSZau4P_%S+(MYH+-T6_|yluHtB(=;L;uLYX@&9 zS7xDq68o=Wf%qVk7T`6$m5;?7qb*VMbdE+!0=RInpKo$WAFZx;5#3@X{cH#ME!fH# zQU)!LdScA&G?iDJC;SABOMJMxdG5q{+rvYmZ=HC)#5hF8v85@WZ%UWm66(scUrJ^g z$~SmKF*U+$TIX6i>&!Jev?YC9m$i~5MvWm$@5IB_u#}Apxyzvm!uF{(byLFNPcP8u zLjTFOoQmY*I`8fG`?PI-Bz@Z}!h}Ft$`RJ;j^o+QSwW;DE3gqe-2?FCN{8lLBy+)J zWY#5{Hi!LA=K)~{Lu%;K@IOVp@G&nt%OU=X-8e?GlS3;QX6_qNYQ6_=l26tTQolZk zt9{^nPl+(4q6hKMiL19yZNzvk3B{X+5QBrdRD*!W40jM>qR;z&0tYiYP2)9}hj)Cs z1_YPXUHC22(ET$o``Li&qhh}6a0i>hrIQmE1fpith_f#eyzkzi6^(OQm@;oOzgNJJ z(@;x{Ef4hh0ot^Hk)DFGmw^Mvnx5VYz#Lrto~(m>8v0m4%g!Nv4gY8^|NEs!E1lDO zt(!OIN2wX?vjAg$4R_)B6`-AGJRV|}6K?S@=tr-CJ*?Y1s^KG9^ zn@Je~MxcYbAPJhSnVAl<0jF{+w=QcEyQmIDYyr3mH@%d5m#~zTuBSNaSeDH2N4{Go(}0SI#R#OokAO2YUgXmOxg4o@*8+ zL`F%MEJkVuoK2#tn3{dW`A6hDWaC!Sd5#=hqfLxz=q$y zj8y=S&CPP5+Me~um>U_x|HW$tIAF$>6HX#VxF(`8Yx1=}XKMK4GuWX2`d?#5Ogy?Cw8y-<@p;VJxiuUDDk)W;uw_0>Q`kf=1AuAT8CTmL zpfZqXEmB`Lejf%nmGiw#wdB#UKLfc~O4R<-s_1|3qGKNS-&u)mBKL8(ir)BI8{y2P zW4+#KxrE@UdC#*xwL@yU!3?X#nGBqhTBx(O7^%ARf`5(Xku%SW=suKU3;o^m5 z)5JVC;{qbMNOu9@JyZ*n$mq+j0^Xkflo$Eu6WeX+;gvc;;Y!GzBp8z$Vhg%hOaeq~ zdMG$P0hasTFu7LP^0LE((^oKUVPTHf0cw$OVR!Ewd0(=Byd8IiOgvua%-8ySe%08G#h=2 zS4oTPlnGEjY-2>}FIg*0!Au&^3Yk2I)ksUtU1e-7AgH&u0u1s@!Wsj6UVak#45eC* zS@LlS5Jmy1-pUk3;3~8R*xMq{^D`x}05w<$DPFut_H_c6>pK!ZLCKj)$$6jW)V4X@ z_eee}*!xBnvfiD-qz$BtNOp)pXV$?DE|AvOxc1{Z#ritc_pTfAsKLj|wSHP9ixUwJ zcG*Pd4G@m2uzX_{co0JFWcvd-+ke?*B`H=<-&{b72bX5&Jm}*|A5h`-tGT*M($!7> z-*s&9J&auOh-rK7RyNb>g2!{H>bQEK^GC?+9wxDj3)b`2BfEh}@wC#8v}-<)Rm(e&SM1wvv!9}-8w6$P<}+ZH$LA8K zP&*9>3E@?O&K~iuYFcYW9i^q|ddt$D<||7q>=2x$r%y|Fc96TX{2Kz6sxQD(5*nT% zlGPs$V1hsJ>cYvHiPI*rZ-RREBT{WRil^bo)kApP9%F@GQiIiexmL!iqsHjxfJQlr zS-7ITN88TA4;#OyKFuWp#pvquM&+m+`bDM+OK|0zX{Hn1jekU)S==`c9T$XhhK-Br zkFl&X)^g0^%5RVoPb!vJIBb{7J?Ev=;5xQ*%#g!sb$i!RuDERHgaE}o9jz0c%K~f} zk*|_}rP$J08lHD#k&^tn-YFze9CVS%_UCvvi1Jp#5~QS~363u2-g+w}F0sLBkJV)s z1gJHpONKGQ0Y%DMmNCx@u}=q8-@I$y$01 z&g&Fh<-3+f5$}jHLKeMDo_m%&)rI2lFQ{PtR8VoJ9LOSUwr!XPkyhFc3svB}=?=Ce zS%YnnIMP+3If-G?%A=It$npBskQJw=+&zMy5FiZ2@xXw?pD>-LYfo-vB#<56xYz;) zBS-K1_I@isNCmK-;*=yao~*BS^P;Cr^Ku>So+mBzJx+c{hg074$s`X*5Zn&s z)+(1PYc z?dDGe`JqKR?6ZAp5I0OrITh@wHU0WpxC5t(A088)@YEnEM-%t!OP{i*{>5~6?z&l7 z=eD~`au4H4?Cw_AKU?y5gv^5Y*O0GZJ}k70Gi)!QH2v2#mjz|eSRiC&$E$NN#rBSK zX7cnbU+0E>kv4uwv(M3KYh}C0h>3BZ zD|;7Sx+}^>d&K*CLGjJ$H^LpQwZiJrxchh2v_dfY0aEyz04N50So!40E9%8B5cE`| zlEH%?#5eI903r6;OqyD9gBtd*bmx8CUc|_P)5C!);LE6XgroDjKIXp=+Nr6J@YPbc zAYx&)lc}~wJ)9^8!8(WLDiHlQ&6F5b+u2qCS>}mGN{y@=`2?hY|>eu7y1o7XehePkDN91)Q@eqzbS6T&g($+1pZH}bmfr^ZCQ_Lo4PV3-)o1SU{8u+_0P?Q@)1r}oV?3H^MXk4ZA9?J zBCUN1+6nEz^Dal+6iaS{>_&5A^ozmcSs&Z(k!)M#Pc{n${T93xi<=IXFc3qvUo)RH z9W-CW0xC5eSPjI@M-SV`?KX7KAV8N}EI~A?rZ9drd;(CGo$(&{zKky%DM7pQEIW>g zo=fpp5Z`Lb?;e5okZdOhJ&7RS5h<&VIMBY9T9Zp8MV}2``fe6w+aEJ+rQkAGlJ0Yz z_LSLMwh~|0OM{KE3{+(C_qvV~%xBYy>UYBbS8Mk_%Ri6aajiL%aPFRC$}0o>xB4D@ z3pa0*d8(s8plw=-edTXd+PT|RvESa);!d5yeu(#al;KL*KXm}~1$@A$7PW7PY(ga;=k#MAI0-vp z-b2}}fs-yKyJ$}tG}PjJ7&-vO`CQ|%jA_oziY)GQlBQjxF)W{h-#~`&|9OKuORRTu zBtZy8ipMbMG<6Hdippdkc49^+XOUI*~aAgNx(3+aVWRqj-|d2EYvb)V)QUkm6{ zx|VXVEi^($W3bgZGxEpSndz6p%8qNbkWe6AK~;CGJOR-Syku$mGDt&~-G(eid@}Ol zID3q_HE;j|Omc8+DDf<*!In7ttte`r3uz@m3 zhFlK%T7o!q+H6)FD4Z185A)VZIe8(5$t(Zan%^L%wrTiwY;x8%-|;KLxWitCtN|tK zzLg8KrczoQwJ_1P4}2JkhLH?_x;^t^QN3Y^kya*6+^9bQA1Ayn7*N0KOhk)m6-&>v z#XzwTjlP8+0a>k9^#PH4E~skM-AYyv8ut;_0MbyfErsGlAhR#2iyD+`329U}ON3^Y zv6yMxhS{_~G@;Bq%#Y*siY1pW+1*EWSJn(V@}_p4@k(u!Hq#n6+m1kno;@K#Z{nN< zh+mnC-crnjcC?mNVNkBrEP6!c%LEANvE8;OSF(>gM`lr*sDl22SM^)1!E5rRD)f4T zTgSJ8#nr;>{AuV{m>BnOaOcJ#*s8vxe50@O%*1t#xVEr#x6UJJfi8Pguj>?2Tdy?URn{9^eFH{e z?mVi&oN;Sfl(a$1-ucy9j1qVjWM; zRI9Ge*DQ;dG1ab-1fFo)enSr&L$63?BPG|VA8!5xU46E%Xzm8}wI${+WkuOAz8?VU z-8aWM5BtDefh%;RxBaH{r>Z7h2Y+Y9a6UVfd6$5p^C|?X-ZyYF)y|CHB41EcNpn52 zV)B6O&dg$BkX=-AM?zeLX`}W7*{d;SbsYJFXt3;yHaYK%xz)R(8b3Mk!M^{SAnj2Y z?}i~k@$E3Rqsvg;`&sR;G9>b0_Pw95A3jvXP>{_wTihFDb(=S`pI1N++ zV&;{1StLS(X{3&}9s)Co2M#wR@qkd{t|}z)Tmkzk5wS^`u*tbt0LmjymI>wiD?H1L z=iY)=MCZjsLPC%f*6YEHEPezy1lh3%ig`FGg-k%Z!|`lHyUJ9`7%cFXn3CeevfA$f zw<0wmc+9MhW(Q!HyJYJXLBXSvq=60W1WMwjG2wwu^ z3v0oHy(C6lEnQdqwcQXh0>*#)-$o1gj@j$@t$2&SOKQ0Dg7(r}jb39T3a>Z$0^xArc<{bu|0MZ;|Gs53qvRMeTY2HB)ms z$3!so7Bsk%on-r4esyI^!}C2_k+!h4ofXc1w!fya=fO+Rza?o3B$q?o$$+TfJ7+Ca znYmzN)-mvpXhpTE@dx7C)-C8cb5TT@Uy%2aV4UYLpbRh%(M57swyP6@cLNbGtf(G6 zMQ3smgtMQ?N4zRV2WcPeA+0jqFV`+*hcD?&T{xNg45S#IG(_!k`&QGD95+qshQ4w` zRwpxCv^;_y(yXpUo{gBfv9!J{MAmqA3j4F zf=Bjgb!BHLQDqYpz;D*8*%FPlCK0>oF$wjM821+c>^oT68_`zvB;)OyOwEH}z*a_e zd|ZtIc3A;N;MW|EB}(W;Wo5;X%ZTDANkj5dsjJYQjDv9h`OCzpRxWVokKxwofj$Yr zu<-IN>rkEX?&7ZD&b5*jlyQx;n~C{bbje-4V|Z`7Q26iHE051v%>b~5?ucPKc{Qr4 zxT(*?}XOpKMTAbPYZC(AneO;HzcS)zkO&R2L^M{l9Qz%I99ta zYXL;HRrvKfz=Ln0_>?@R=E>BT0B=9vjF;KOqb?^A*r@4$m<3s>HmRDsKie_}Yi27Tl}XNg?&I;bLQV@VA)EOfy;Q?rR{!ME!Q!ic5D2iNp|z%3Mg zvQJ}8S)ef|?1iwbPS#CyJ4`9DP%pSedNS8(qi%ZX@4_e%7zuVlVTBl#bWGFkG~Zq7%V#cx@%7Gn_h_(4Ye4t=Qoan!BA)5Ada>^@iUT>?MJ_rZ2>0yLyer z9*d%HCTJIZM^_OmrNBuK%&gLjKokFs%3q0jJikY9;+N$|vfKRiaT8&@^|1WKG?^n7 z$)UCIPPnqP_J|U#rRz-`Q`De^GQlD48MUrCO)`qTknefCz%1Me`O5*DL~y(||8IEH zr+R}fqVd%hDf@2zo=KQ={qKa1deF`@j$6$)1+%xo=8G^i#RtpZ8oeqka6fUns11>T zN8OrRcEDWMX#$)qf4PjCeDDi%?oJXrxtV93m?;`Sol>W`_nX}(gJ;(+Yeip5`P9=( zLM1||IG?`brhDS9S2Tg;2W6-p#?n(`!Y^FnYb_Kqb$PTz^coYYhX+UaSKVM-4VSKy z7T>ipiI-pfWzn;gdo7#uLOw@A4ztOUu<)e;#}#6tl3_asw(W8C)n;Lkm1_c-Frck+ zbN)HnIv*KMDc4(koez$v9$@ZUBu52lBVn!S+Oj)VacF?#3K0)DluGHfJ{r1;xC}N; zY|w!h7ZBJhtB2s$a}@_Ln+`8N3t_p50|+j?$vp*p`h6>kLswwUh@4du3a~6oZ%)5+ z=+alIp;hW%v#eb5n7CGd#VnHz4<|05Gwcal zU6_{X-hcCb&x-cGGk*bb69mZ}@@`qvh7%h!^G>OA&xKNxRUR^u_4WW}e|SoR=)JEH zU)vamX^Pm~H`c-IfM?*0mjX5AscLm<=Ge~7xCXcUa49tkBHE4DEc~)SUNF)3)wBwK z*ssc-t2UNJ7pMm!A>>qixK08%ChP{9`8!}K9&46W^;6rykOT`_6~pcTcRhN&oHnpt z^19R?r57D^*+Hc^HJ{>b%A}(7MCD$<@AcO&k&*a(!t_du0Fi(yiX6WAnH)47>U>lu z40T7W;pQ56y7Pqnkx|GpV_?paO+i5by}W1SNrhOO2uKe*XlsBhzJu$OBu*m*L)iDc zD`7G-O=C^;XXPP^IH)*4sLYn0=V}46hWmx%4fX^uzD54Nw8jdB)e}<}0Oj()qSo%~ zd+*^yb;RNkmX?cILa_9muhW(Fn?Wdjn-!mCLqQB$N0Jd@sPkc-k>Wk?b+6nz6y?2{ z2PH^v&oA@o`lBR6j?McC?KY@-67(z_QlVF7i-Ae3{(FQb(y-e%xhg6@xR^+ruEwd_ zUWNZ9O}c}3I7C4nAm|s*YJ8l4Z9|uVh-msRnuy!;G0A+YB)`NA4)PK^){WouX(=@u zfjT~vJ9-1l3P1~%=(iE#eCj%b=2bvQ_bc}O1YPQ%i1LWxNS6+Ex1g79UuC=Rwj||; zfPY_Zb`PE3&)#MJshdcI(~~Mw*Orq0)VHV9uH4I@W@7|e^b((Q?zD%vD+FBd9UlC? zAy~RTpFRQzmD?F4|6^XA`EM)n;i}90%4Zi`y146>0HulHH>~vXLdu>GQj?mao6guZ zSE6J8PXA=zX5Gne=uAfbQGUdc<1-ffb#LZ_r0aOZu?2ExqG1SNIa)Ce5J_1CZA5nX zY7A$Bz1m`L8LhK}aBg(JJRuH}t!E|O>h`*c{lErych=Lx2)DU_BvJ*UWaDeAX%{BC z(3Qb^iY6^6jc84aT~?VexgY*5{uMw%kFSJ~eH|W96CTtX1dgrgYWRKNB6}O_zY)N$ zErG^4BNUow7fgzr|L0vXQKbTpeuv< z3z?59(p8_Z{R|9OMc8aN`?AQecupfLD#soAmZnU-fGlrQUD1eUn2*e_FPPv0bm0F? zN}`H2#RfotOn_vlQv31L+O>`io$GJHcbl7vOjp0ZjxPJppvQmp(rR}TOMl&YC(`uD z4N8#N-&XIVma6)kr+L;c7g&{pZGLg^5vRz{Ks|_@ogf6@Bk`g9OUfAjwdR$!j8U?$)d!9k&K)))j>*AUB)l}_aJRo> zuP~V^D;)%h+6mozdW4?T0zqbSiD$c#pr^M02HUyOB}K;x+7mB+RchdU%;79$ngCFe zH+sO)B{ig9Nf?JA`m-_+-Mn+prk|P8ZxVk<#LC+V$kUcb;I>sXm*PnvNn5yDtoSC2 zUvR;ZLaC%dFMxWH!zQy_SyFXKC^%~b_f5#4LG;=s~uVs@EdaAYC%W((jRFY0F&9wAxSonB-7vU1E)n z^uF=(>6{iZ$*2|4MGSBo!Z=U4M=l7;YW)7k978r*lk2Sx{!@DZHn^ZKnAdofpRb0Kt88 zz%74OMH}dKdVk>dFSh@VYJFC9=V?}g^v#>O?R=-VyJ)xFaKZJPw7{tEG8Y_a{7G2+ z-Cy1_3?5OLPX49VskjL|1Q^z6G5Vb6h(F^_n$VsTIH34?%eKy17enru5s_B64x!u z;@d zpfr$5oN6gm^L(SjP=mrBl%f5?olywC&q3t{W1yhMzs=Q;8ueqbLEfZJMOQuKMF>l20pq|Zr<+*ud9%^!%}Et;ekdAINb`v zKRlDa)Rj+J`lgC1R7|dzN)Ar3za`nN=2p~2ARpSd12>__)$jT6KeaRz%VW`ct#EDt z1$hLi9cT4=L}C)S;RV0m!&(t?jq91*THMH25zz9&x$nk^*+_~Oc6?elz^VbOClgn} zlhq2lK`q@J9KCg!+_~!xlb6*U)J!4=E}6huS>1OyJ} z{LhPX-tva)`f)w{?&rS0_vcexik`K52j?xgx6qsY>ohyM+VZ)l>)&tvWj~I<+mPSS zHaHSW$--mg>5-B6$FGqXF3ir-x_xyi-(Y>MGD*{ccO33tdk`zGJASi;{!6yqsCSt> z(I&i11^WS6uV#;VfR7cZzKivN#ucX-&<1#jpDlecaVBs3xLW7`5{J~it+4fJb+V?6 z&8sr#J%JD0we}BMGYfFa;u&y4D3RV}rO`qSnEj}Ad%VFwu^{g>|GOr2TxpUFsdaq3 zT;3eN#ll$r8~efqiyQL6iGbF4eT(RgCEkkxOOMCp&yD8Uiv-%R;FB{?OFqnfaM{Mk z;$-xJPpqpS9TOx4GQF8l%zk}V>^Js59jvVS1wGkte|#1imcxolZ@JP~yR`jS`!hp5 zo?nk~zGIQ?p6MP|*U747-GbD7!$6D7eHHO#dlb(t=4Y5uFG4Laffy_L5d*p}LzV(_ zR}{}AJrl6EG5{x_acSIoCq)cY z9nyswIr9kU*!A~*y6qZ$?F4Q!VeP&2R~hV)X|9k<*4(UX;SK*n0+nrCgz|^m;z5EY z#wQ*hk(ZC@sQ3EY2L|oP^HP*mARm4WK4o*ytXTUItFZ$>bl^-1YBU$jypJ56aO`wz z4b-~i{o`xyi+&-3Z^-^IWtjAnt_N+%pq7){QZg?s$ zOb8Fdemr2IZ4A_?W4JeSG98`=<*wr#TFBa`Y2h3pl!j*&H*fEP{xT7Lf-a>JkKbp( zJ^2y~n#N#wn`Ew8s16Bom}99-H2wznXT3dX0esdEJ@6226fVfXq$=zb-!j5sBaQLH zZ4Dr6s4-Y~?Q%8`XsrhC%G6d9O#M65f?`3*;ELChht0=$|GLL8rC6!cbvX!6tex+w zd)ULEM&QOrPt*v9kCV$^LW~R3aJ(WSNsLfK?m?=a+uZE>{+yWJW~SMQo(3jrr0yDO z{NAzF)pL2OL4!T4@exTnVd z6)@SvNkRmK2g1`Ke*EoSdL<=R`NU#KbpM%zvo1<+--l2-A=K&D-fYtoYs+bnE?U&w zujy${vbdSS?J16{;%7IH#SvfmKIs^xHmoZXUF%j!Qwxo~6kENSB<&#CP{EGjzKKfi zs_PA4tY>h9hG%EZVjm^fEqG`v02NllYFyzX&Y6!H?W|5M>q1$HhXktj5s{|8{h^F?pcP=XfWb zz)z}qAFvR#1AGVIm{w6s_(9A z-2KBFgcTO=?K&C84K#0$dUl=FoRMVx5=F9p8BJKs-RJ0oX+Dj^SbZ9=TSROq*T}50 z5%SQg^_4ki=l5Nz7G^ilTjU!0DLJsa5sJt7mkU!6;&vEmo0n!U$}LGAyte?CyEbcnUp;$O zdTVm|OHkm-wzjrU0%J`e{hrK81~ooZ?$;r&-K8xzzutY7Sd!Ed!XPg7rY;7*h-CQd zvQpbj2j}8NB?m^4hSLGR$XWq&wIloX@G>2AD<)u?j{lPJezlQEzumNO){1DS)3((3 z?;7m0s&s-uKV1^Ci}C@hpk~r)>*qBuAbz3&BLWlNDBdI5#u_cRK*+0b-^8zH+N%6I z3ak!C1@w#)nh-5q@gg8H-m6ut0izlr{u;7?)fcC}@P$gD!bhgX}5sf{$fPoU$Oc3gk;bj2Q;%ZNsY-+UXkX-g-b>r8%9|i^pUfGQ$lbQNUX@G!k!ntd{Hc(ID5!tuG z>VW0x7`cg2PQ$ME1?!^`#|MVZie=o}E3ps}09+h#Hd#uqTPbiSm)he}E5c>Ln7fp= ztH~`HZBk9U**`Ww;}gvQA6UB2xdj_X*c(N)nHdx|C{sgycxkvf>S1_;N?4`3TsxEK zRYa&pn;R^Yz%~j`NT=noVxA_H!#6^<$A=JUa=LdTTC;<976(5exB`cGyEAL!NlIR( z8am_a(Q^0RIGm+XfyOcfD!q}VMwn${1?FGK+Wqlbd7;Nggu|*`ke5wPT?(~}Auoa5 zNUD`ax02y-mJe_qwzOPx{xu-q@jX+ycWC-+F`FL~d}HFEI_-WT^>G}H{MF$@FzV<4 zv)s^~l|v{|KE|cfYSDLjXA%ng$wkUT%92~y2Fbb-n5{y%D&VO4wJNmUOn~tA$!$f} zZg*T@c!QJJMu5>qu@8J=%>lY~+yOA--de`zr_4R?xsc&B1^n*ORgFHJw3f5STa%XZ zOL1`afp3M!CK9RHh%%!zoU(0<{4L(*9f4NGlAQsi%#q6{&eQ~UsHZ;>|0}+V_i}c( z)7WE^$um)PE#~36YH>qWl?6HNgy#~~e8DNIYg-~Bpj<^IG|@BeD2Qku_|p*5^&Q(f z4iFTtRpjJOZCik(e!~iB)^0XM4Pi$MQ`L~#3|3d#l3fydWt?}U&xRO!*Ku|9_PlX2 z93V}fy$UHo)F*n(B9l?&^^XsD0F8>0UW{wnp#dz}29#CfKYTOUlw4n}4={PO!`9&W z%uTeSCTTJra9f?hDyW66`wIV0qV>-uWbuHTUJm=SR+`*psKP;Y(j5SWB(ynGYe*bY?8@n+(e{FS}j>S-i zO0RDHlBL46y0$i=_>vJ^M*8QAsV%=`yCo~z?i6Kh%sv1e2t2qAIAU7_6>BA7TsMXA zg%J~e^ zxRA7~8aPnJ?0ilOp`3vQU@f+3Mi|^F4|RjBYLguVoz|ebB1h*&#foDVd0L~ed#Fxm z2d8(2jV<<3u5N>AfTru@bN1I4R~TkbcqED10;L{BH=#k4RC&b-c~*(g{H{TeB^{w&3&BVu3PC3Q z<8FlQPhA$OtR=7AvKHm~;9aiAMAEpc+lI(|IE-AaXUJbF|z-`m-0^&?9ZaNj+cg?0q$IfxvE>;y1DUTKTH(I zX(`2^pMbbWrX$%D8 z3O{{ zJ^89_=#MgHuBzZP1HT~u{YeJvJkV!}%+vA`++og|Q08W1B9AZb=%yGR>SjO*`hoG` z0`2`~-)NEjHJ=MZHBJk3#?>sM>EbQnU(wdxuM2w}mCBES@Oh5Aktnek#?wche#4`_ z6&$9!M^BD1nEqyT`o0>{Ze=ECc<()izw;wjRT$ZS8a;PE#)F@y{zBkF4zAVgv7X-9 zN3nWiSxWX|lsv6EJDKQ~K&n21RGe$nuH!Tca=`iW=YB|u|K1^U{)T0%S8t^@%mcTv_GEG~9FBCfe> zPYn8EogYplQj32QI#?hF3jBMqW#YfYc5_Zm@EAia`To`~0#DQ(MR}RoogvF;Tny^Q zedLg~k-~GIKo)$&h_iQrb-L+dvgGyCs58L8xsT?WYr|!R5(yZh8IR?F5X#S#(KLCO zD%9lyL5@A==OW}XJC(aNlHI<^kN)KP@%ok4!8%(hbHq`iavyRKzsmBxiqZJY{g3k; zh8>0j0$h_%=>!X?pgfO#qC=-5P;Nhy9mm(}c*tk{WS8(W4ETg?HsJ}8y0lJZd#WQs zni{ZeV^q8(4o^B-aB{gjD7~hv*MxtTuG0Mxe;YKpe^`>{*SBp4-A(7`8CA@XyYhWv!$IMlnZbFaSU&f9(;W#0L-OuA0q>sqH?E+FJ@^!*weK8i( zYd^&Tg63Ob-)9TnuL7DAut&KR$1~|}Ms`z$;D2aJw-#l+^9y8-_C?2pm4s5uJZYoh zv-Odlqx6m3NIJITfr)Rrma-h`Lr~t^0fXzsFhzeai7hFdxDlW&W>ut~JC9g00tZ`6 zrf@vMi-|MkayIx`5BzToJQ|l3@`hZn&&=c$`*5FQlW7%$#cQ76<-?Hn{pjznQwSUR zdOpfZRwlU|l(->;fWFHk$osX(awgb?h6Dj^F(cA zdVyrn;Xhbe(v3-TE+tY@PC8M@Vz%8K6Q6~d43N{IO&JBu)p0cS#MtlUGB~2=0vKMS z{i*1h;!zPPXB_!-Qk|qqkSTx;QGF;)t9R0175@c>(Qnc~MhMF%S~SE(m@8|vbX5CX zBN&*_+nMw%f^@31cI)B`uI${&)G*RcXsMWk-${CPQe2uVp)+ceQ z5Em>M>x}6o?Tt@9NcU83TbvDETD$Uoc-+QTUWU6@g7aJSh>IXlivZ!P-Z*{_$+FGV zKv5IxyF`DQNfr+?O2Al>f8Qt}{GlUTZ0D-%DVSKV*-|y$wL_D#+EI`mfpL-R$wASC z=TW~ma0d5A3Vx%WF$WjZ; z_;(vY^BrNulqhIUVXyXIzazv7>Q`2g3w5`#@ah7!+uCZk3r7uKBwsfr4QXDjndyel;YaQBQ8uuXG3uoQ@>RC-|tr*K$F{ScC-=vm4!) zHfaYE&SBc(cR!Z->HjM>sCTr%iCi#VkfOcR8dmMDQ8@gv5ls%BL6H`&}1yE4qd~xx;tx* z(`bC`j=)NHg~dFng5>*)^)(NP@s#(C6Wa)o13tarvF+>~)pinfk9u-F9HC&XF9{7i zaLvL#Q8UMaqRK1E;l=98JL~{`J)>)SFwAc@0(uAyI{oME0lxVsz2c9W=cdA|wwR~*?zvbO`V*W3jZRGiB&>xb z16~>SKk_T?0i-NL7lFb6!{U}vEzVg%j)^cs{8!P{Yier>(AQND#=Sef5C4|4kO!5Z^7l_Rbj18Zaz20vu6UU9kUwXU^#AbD6b!k*Cuc}Z($;=wx=9{T! zi<|bM=p}xN&1{Szladp{5Olk_Q{gzlhwUyPcd37ueQ`gi&W7HY=v=7Ca2g~}1{Y+(?;%uBSd+(ybgtjBTKM@+vyQ8--hSv?va{>A# zAd`w2o99_4H~F=?H#tXrGvtjJ{|pH2Z{nPlUexMo7Q0CzSsz z*zdOE+z_XP5LtueL$HKW4Au&PQdmXZa#EO)N+Sp<6DX3}HX_-~5)hIXHTTZH4Fx^R zu=Rk9b03JH%sDR{di_HTl(eB5FT1un$$Ql}{jNaxo$Y1WYyXMUvUkk6#O5~U zsoX60oUXuD*JMrK#_#8_k5CCltx}Jb78QDuo88N6y{7K5flLsNu+Sns;Q@N=>~zc0 zVf$m|T-*`Id**$PK>^)*;z`))B4t~%MdBOEUpsM+8uLgI05i;myEFGK#sOGwbA~>4 z+e-XipWfKtw!+edFO7j0OCeGXEp?AIE;l+za;6A&SpMl(TkwP>E1=y=3GkQ>X+hCTf(^Gnfa$!SCpCChd_+~)Ov}V zd9NjIrlB>q{OpPwwO9;x6`dPA%;MH)e`J(JV_?CBqSj)LuQKJ`@P`Wjk$r37$xnDr zN@~sD46|n*s)4)Wh!>j3ejqH@>WZ{9p!;b1W&d6#+&jMb6YM}iwBPNI;zEmIM3To} zxfk0|z5arq9R;(;&2WmF?^8;YGNkJrm->*elb%%zilp=w(_E15vgxuZ*Wo~K1V!NM zICoRala~*yl9-N&YzUxDK!TDCv5FPG32@Zh$xpf9;D46?4O9g^?Rg1f#D(=NWVkDP zXdQOD1veVqgh6wZJr_I`7YcUk}A{ zx{Wc!2)K~hjxtpL`HoT~u~4;9)>>f7VVF{*$C-0TjIdcp$GSyQ=9GQXi}2?tw`9P^ z)gi-8+0yf3v$rYy%k}`?i1s)6Eq-F`;D=0(KE#n;6o4b)et$BcADU=U>^iE8a(Cx*C$M9%JA7obV-XQVU2H8(hB<5B4 zpV01zuA_-(i)N5Nxiac1UEpu8+QQ<5AkivvO-Dctx>iQRw_IM={E9BY^6Tm^P-Vv8 zzSJJ&;ib`fu0-a1f~a^z7yuQqQYLCgzfyWOdx;mXz7+?1fm|JA_BC#aq$3afb_&|` z12jTR6rh7{UbR=NBUxY0pX>5~6ri{}1LA$=!)XDn`*q+2JUwtfjp0oPlumnMt z6|bpq30P5KzqZj@>}3r}PK%}eiSpBWi^1A{uOA2Eli|zF(N5sC*$r2ZKSc9>2K9d! zKi$U=et`yF!X0=cQsr49zL15(gy|f|p|jm($}`ft9c9(jKWlEoe};QoD{)bH)$&;# z?6c>#kL8~Z0GZ30df#Xn4dSFdTM9(|L5w8!YmwH7faL?pvYnLcHxsM~76;ClNM9yT z#emDYds;3PftJglqWpFP5RmtYT~V^yvhpf;_| zl>Un1zfg6(fLZHipB1{@k?(Wiv-Z#y#X_TH?6@COrfLc*v(PycNO_Dyb@P{gda z{t0#Y3?6;Wk{30o3mVPFxz_6AI+QUNMpV>;G&7^csxdt3T6RoWzpTQ;l}7u5Wu_!v zxJR4X4xAWZ>XY;h5{Dx#v%;XN-VFYJqF zP+{Nd>pt)*sy|itOd9to{^m6wWm?TpPxV&(Lk-iRT0TYu(b1jC@Xz#?GmICJOcQ?l#19Uj9xqycD&Nz*DK8aWC7G;He@yJw`YTscc z>aK33Y%=WpVKIJ1`A=RTr_D51B92Hj9CWXhL7&$41g{9S4k&f$lLeH@NgS;c5U}>- z6#y=`*exr)*g$zYt_4y)*ii(}x1pSFjg4FpZqTDNeR;h`yilf5`-J=?C4;p!z%A67 zKFd5CJbrJ_%aKCci=pf-)AKL!r}d=C7LjCnl|Opt8G%X`^3EX#sh*{#onDE>J-5-jT-;bv;5p1{jeJ7m`3XuG&Z{YsBiUN;8EeyyXIUj1 z=2@rx`~o@l4E~S9Oa7JxRxb_vj+6}VP2LH^e1Sa(-0t5_E23<7xJr8!o#;od z&r`mzoK#%CA6E66Gz9qEyiXy&=@NO3AouiOByJ9k5AJh!Zet2TUgnscB~ZVfVefQN z&^O#UDMBql;AA)6X&Q@B$tm&v*55oc7}!Ai#ztf2!EU`w3*enzZ)mh^^qk z!{hgYu)T?-74k5qjD7Vl)q~&ES1Q#gtybwt-XANdB+o{QEH_m!iml@s6s^@#B%BFT zc>cvOcx+}*U7qrNON0mO4hfiWR-SdeRBEj2*XaDR4$et!L(g7p>}6_myN=S1Q=(tk zej6h>bUyFJ>x=cHS<(7YD|d2XwZrGX_h1KDvz6_6#n`?mOK;qLdC1+AaeO6Da|lOOtY_(N zS&E`WD*<>|L-^WXjp7-*i@XoBf7t4;%XMD;Ayp>S3H%iJU#Zz27v-4<7c|aN-h4UdRcvH}|^B&5xlxath7NcqJ>R%mg9on|&hb^&o=rb)H z+BWkY&!$>N+)=sOPXfI!D*RlIMXlc$y4(GwP20)a=3>asF3dMl@|ur!-A<$yl2)kD zYL`@p$$j=mgS)3=j!6NM`+(My8JUe|OxM>9@~QtY94aIkhBH`0-GH@$7+dLO3vn1C z&nscDMm6>^>I&v3a9Ba(Cu|PzP&FUA{3XEDoiG+O)UH_q7gUpl--FZ%Kck%MZIG+> zdlQ4bGLfTIr?d?lR?g2Dh9X^5f_E&o zM?ES+iiktu-`2w!-oo9&_{or-k9!+DI^d4WOxRwVO*E^CKy7jWJE4)K$YQnZ1V6=N-ltX)Qn}ZjLwkTKh%NrrwjaA2!%uj@YG-QGu zBLXHab==e#B9g?GSY2R2)1~GrbIBP*N!4ftJZvhfYzP`o_BEjyXS)MdaW7F%5Y$_( zV^7Lik@}phV8uUP5yWozOu+6@c>!Gdf~>zVX5Rx-*i{;!?8G(o^ghY&OhfscLn(F) zCME_dtzT7f${qH?uSGBHwe>%b_Lq>NKnpI7JZX<0Q($qCBI{WOjAMVAc6t+gh%zLf zvU^Q7+kkm5Z|V_f7~8UcB)K~@+XydJ_OqFV2MfnRr#Rb`LFpATbd>w}jm$&B;ZcvU zR1fu7Zg})ez)MuKs2YJO75XGbPigH1Z(WJMLYK>ZbO#hgjKMniMd=UV%4=!YMeuds zKy1iQmQ+-7q*}|`?`umkW-m+CcVJSxYSa#iS$5{Ixc;+$*#k<=kauGGPx`r7tjT?{ z>qc$rK>p|&@;UX^a9%Co0vBOFUy<*Kx|mbEq9bR@&)Dm=!Zqq5vS$XQd)wF-Wh*M1<;;^yHRg`R>8kgE8(6fb)u_9yt|+Z@R50IhzeatehON_tt(`eC3Df zsOTSN#nWQ{PYCA+n4du;>)zB9ub?O|=zI3jd11|e1I#NTq8G+lo;n`&=e|Q`lNziH z@}XUimlMav1@$*zDZe_8DZEvjX`+Ol|4c0Lhb>@tj_5`w8$#_$$(`FoN5MZkoJB6t zBhv3P7$Jd1Fd?D?0u-ollen|(h?%}DcNxV zbdO_lQ%&`YDITwzDoiIX%3nj!6q)k>3_>Y;RX&6=zU9H=wi?n`aOpe25VPdxlh2EIqH38W4be zrGSe|K=>4ol5~H`ARiq$la_}ScEn}N=szhc{fUnlL)yNb4_qz^wr|2km)lI&a(Y_g zzhVAAG&cGlqiGmRka z0KV>7|7+~kf@IRh>ZHV2xot$N^U-0#;)6gs({#6-m=1%5w&I)GnOCKQ^=96q_|}OI zb1rfPK{K~#NAjkOy zmP0zk75W%Xfqeq)q(O`p_ZAumSlkZ{)&7bTnT16-(Qh^`;q>Af2~@d~)#@+aY{dB? z(vLf9KTfri{_|wj2NR$H0(etVVUiVRMsSHepa5hd z{j!~Cn{_!o$X%n2o3jTDKL<(^cQZ1zh86~mFDdxO(Oag_n_b9#cT3LVE|$ENh6)0k zwd3ZFtub=Zd&ev;MsWtTf2d|1x}<-G7T?iyKU|&Sex*wH-3v^f4FU9uZ7!PBwb_#4 zcic#1>T~P$exDhy?g%fYEYi7R&mrqj6$golIB6zJA2hSR$dpDx?)Q8yWl!$%alvrc zj_rpiHjAsmh>&T}ekwvGk3$9~h@BQYtx(Ih0WQv{hf1@e19r~c1wBz=eX<6_LC>TD zhspEy1nNPDll|2SEe7P^?0HH3=W$nSXgha1D90M!?3Q3Z2jemnZ?dw&M&Y5~yz%mv znPmInXAvQN&a~L{C6PW+a==E>5H{6mFn(&#dy)qMYiXuup1pQ(%uFCQi z&@vwq1$J30nwbs3H<>TmgtAu}gQT+mN*H_g<+C0Er^o7va=rBo$cA=k)^t5~Bars! zj+a!>VRxP}g@3ARSvbP3;fv`4^JU?K#5#<%cE~qOw!|4+8tu%X;vdgL zjgUyKGUmx9?{w6W2@CZ8SNM~h7NeJd$7@qmKwh7vbDUKTqts7bN_6qLMwkt_Ch*eS z)RILTj5Vo(z%^SlGwa9y#v0Rulj9thZ>E95CB3n}s(6>)7>hr6a0|TN#*y(uRSxE; zgH(&0&cI`;Gsp69ynnmoTciDq6T`4hsJZ`~@i_)GawVf`L)3U7miwMP-x$?opOYlK zZ;=S9v3D~xLpU2C99Q59$Y@VzZ)7BTSoeCy+hUAb zCj5Qj)&|kaET~HWum{@xteBA>W#o@f9T3aiiD8IoQI7PNCpzTJWx^T<{HaR~-Tfop zl|`v-$KZUDuBV_eHoA-g!j6DhpI$ovJY?7z{L)JBnC#~|h;p4zj+Sg6>xA?ShDm=( zcZ*+dOp}q@anqXKZe%dsUjbO}sxgYqD-cbMoE{a?2UTdKME}P!$?pHKDAcc==8^Jeo8>aj; zIgBRum!7mw16lTs<7zuYkE64NP4Z(S;^W1^-+gvSI@}4=Kw#CgsIMvVlBd$M;HK-G z_+Kf1)uqMxENO$#k78HT0&!n9qE6O)yGueri9|+rRu9}{#b_qhi|RXQ(B}b|XBck< zx|f-)D?j)wrID9Ly~hCI>mAR4-|m8GXK|?fi){`+IXd_`ditIBcf7a~bI3NN49bx^ z`K6otT3km-Z%oSTyl--?IiY}6!!{dp?loT3-{cq~;ai)z9HWUXD(p#K$8IGvOTKw-!y#Zc$`N?+wz+Q9iOHke3 z*Z$0CF63Te5fIc}F=fGvNksWeTk7lS74Ib%6jc3y@$K%!kQQ5Zl-b{31a8NoX`L7p z|Lb4`C$*dx5`VM`sArQ}r)#VQD9w3kGgBYj{llRr;v4qp_bjq?fy2KksF*s( zUcNSvt`G@8@5XdlCX-Tg%|Yp)aK02JW4D%8JJT{iWnwJ`Hv@Q}WIp1XA@Vf7kAZH$ zripQHh&}MT8!(TZYdF^{4|RKR%tyL>nVF=l=n-ajO9!?~z9-PUDh#^|F5x(N&{p&{ zoQQs7L93QxA?!eqAh!2q7_p^X^`r~ALUM(1t;rauMG2fYQE{5@Z`nICcT0zFq<%*; zytr-*8BkpJa)o-d|6J!HH#;iXF%nq~ZKt^rJbX`xXlVS|u{JLz_`&&uh$r+;! z>JUR>!rR%WR7bTHtrYBHj~MT?ImiLdvZ@5LCk*6~xV5YA0MBaE)|W6BlE4&9qKDS#fp&eG=UOKOQ-h<-3@# z1cB#l#j|&ws-9#pAeLqUCpZ^aMuZUvnQNHp3t62M{Uj&iIFsAu4*nRs*j~zWSx{78 zLo)x1qM-5wyI-mY`#&aF`yC(n4rPAyUIFCD7fV>Km~8n0|-g@9{bd0#i}Fx6%#Z zYeD@c@%I#K?m`|&(NkN6Wyxn)RQWA?thCTp%sJGgh*>1Q>ZNjI7e2=vdK)Rnb#(`%RW319?5jL%8_QfJ1 zU?AcoOE-~2O1E%Q5c(fn(|LT-nt)=FD;uhT$|g^ngaZKVBxOFvU7H}ukCVtp1nhey zCDt>)k9?AyMJaJx*rU-aHw#GivgV#3uciKCM1s^JM`Y}&*Z%pMD>TUJE8;ICboL!l zLcQto4_xs%pg0f0DQO-VcWB+K5amXKjr@|Rm^Wnw#`E|Pibt9wLfXxK0+}MGh7@83 zpi&n{ju|jag+66)NS@L&GVH_{)~nc95ZUkV3TpuABFF6hcq}FJl+aA1yVnJUF9wd7 z_&#u&pp^Ua$Y+c;%1=AfO!p0fst3?Lb@>~49v+-h={xJ0wyZ*M|N1~=D=+eSr2O3K ztqiUHG}mnZ&n0C!;B+UWKcIKrY!P_qJaXj%bVEoc1qoW1I*PND+(*SypSVbn+-=L! zjNeh@)^PsT?o2{3kpw18**QE1-V-$ZA*NhGDcG4tESP2%=C<4{-2||6Y+c^|8}LS} zuOGifzD43__E&@_ivt{0mRG%~g4Z4@V zXJc>Tg6w8cQ89dF#9wqh8BQH@^@1yY-JdV=hC9Dxk~qtLe1jZp2Nj1;bo~Jy?~0p* zG2`lX3IyzC7Yt=Sz&J+>l^+3~@?9EDkFhwd>o|XK&jQvY6~EnDv4JsbR%6-6^D$i) z9!gXG?g71n^81~Bu80(14;N-V)^5Mx0J4u+suP-XO|mn!`>J5>sKBH)rH>z3@zQOg zu(8}4`5Y7^%M#o7a?&nhuFM#sNjC~lZW=+JFKacm%RcfinFDuT!!LnnTrbsF?l9jT;$ zU-~jcgmcblzVMI#sx!|ZzaW`+3n{KfWRx}AeFzjy`6C3lx8QRHcs)zY8ZHq0bdQOi z5(I4;vMEt%T1(hGisA_@-ce4>3RnU}>NG6bU6r20tbb?QcS?#>)G_butInmk7w#8X zKin(K*z-Pu&B2Ke1*E1skwGJ=B$hqYdC~hSi?poew`kG~06v!K6sBu~r#)kYk{le* zl7lO3!re`?aEhv#RqDbH(2WzeMpYf44||ufJ5R8+)^lvp!$xpN=YH?*PdkLhrMEsR zPjJIe;rrbKiS8`TV!tqn_IgRFL5xealhy+!N+zjtPhE_Qzv`4=pSu)mx2;M!3Z8RY zE+!R`6_|4rI;i++ShnKW;{fRnl*t>$S>Q#{2WOJZ>ni6dt&?1pE8AU$m-jBnj>wxH z70tukDcr(CLkQH)z_|H{f2(W|aEprYSP(#{BWT-T7cw~76i#_Au0^$xRMWK9y` zk{>d@icNv^ub+wT?P1D2nDea7B*FfrPSXjy#i|M4%ik&Tf zh6gWM!NDc3Hy{^gRKpt%!Fd4=md>B*bd|Q%@1r7m;zB7l!HB85ne`=Y8RUZf;z4gN zlGk;bQ&LFD)s#y1-?`1Y67qjg+@6F%>ICif-nSU-rM;M!L@Gw4_`feE^pq^GFE)?o zcnPk}S3D8rzFBS>E_m+ZLz*|64e)ZF{__&F_RTm!Jz6=C;XhUP4Y%lcW#YSR% zDZGg3k5Gmw1mw;t$y~cSXsR!=)E4uz-=cQ?=z^$Vw={)>@=dSW|5jj}w4BnXE2bhT z*JEKzL)2Gz`!y|xdwzg5;at9j*3(2l*V^@X^)LHi3H0{nA=$;wCk!cdxfhr|sB+iJy0} zjJXWrP5+{(jH?;E_rz#U(&E{E=@GLb4aG+IN+J)y%Wux!M>&7*EP0ng()0nP9|JK> z_GVFGCq|<7$X#xhQk(?Z53v_qtUpZz*iZ&BhkKeGWy(Z~B{gC)J*hX%ZBbsrKP=bp zrLU6@EvufbB|YzD&3Oa<5Hys#8+ea?;LSXwn0sqSb4=d2Z*mBimfBtfO;*hB4Eb}H zKoRf0-K2UTYs3M99BBZJ#LPSY_0mvzA)EA=q1|xKg}ikx-j!*Bp*aOvLe6<=*e4Ii zb%kh`@b+wIj>A>Brsov$@XTg6eU?HA~w-FD>N=} z%&-8&fUbJo_SX?rlF8orTxgSO9MKLvmA1%)o~IZ|=DeZZ!}jzh9rovk(z=fbl*i*k z?TKr^dfp5TC)1+5D!oxPDuF3Wtnt{?r$-+Lo+`CSA$Qo4+ zXm2z9eHdXXCiUj%tcsZr8`HHjP{f6SjJ_~<)Q;3VK*0Kr_0=$@_atxIOtl3*6BGU% zh7ZKOziOg9_(1s2E(jaRP{$zAmTFmzV>?m3~1u#%dNz~cU=Y48eof6eC=;3)8g z<6;niSjBJI6PcdJkRDO3G}T0%$&Nzr6kY%O1s73%N?@)lT68Dq)!28j{fe_B(4ye- z&XgUMAGEm$m`Qd#W)HfS{M>{xsiz4Xpf7b8L%I*stRfjef z@T4c$56OAVjA4go%1}xiXh^nrCLG*r{}hD@)dpN0~9Z@l|T<;$JqU4ketTjZNKbNguln&2)GtsZeI$pMgv< z>idi#4~d$QMfG#CBd=iTauBwVWBiVrHg?;kh^&J6zljV?ze)?*oJl)J*Q}z5R`J(s z$k#nK*V}|O8E59#CnX*q5eF02UD|OxtB4s}TrA(U+f6Ac4#WukmPqu7y^%7XRxnO$ouVv(`;-eJ~{rlvVc$x0X&AuNfF2z?R*QJT)t-h$CAn^uzY;jHF zS40-)9{GQ<^`=ot=l}nAW{oXV*s8Y^7Ja7RG1 zG8eSQN+%UGYsg&COw9$*QcM%kR8Ul~P*4z25s=l3@9%eA=Uo4D{&%=7$MfOydOzRK z$K$0Zm@HVKDHkkPAM3u~qJL7r>2)H5^EdATWK+JqX>#Q}v-b%?&$cMch2&+y$G!fppQ+Dkw6xGGh7AvZ*L?9FseMAa0dTM9a$SmR{^qTyH zyMRv3fyYBwW41j+dz}u>Nm@U|@m>3l2OfB4A?g&R!f=Bq}hR~aI}AJuwSbQ-!>S5{d?sU_PuCISxY#o z5FhTaa&d2eZ3u&q^XyQ#Dx_Fr0>P2iaRqeElUco1BTv7)_+1Eamd1|J3GIa4sD^~U zYJv&=bK#nSPiOoML?76G)$}nF`aSOa`1-2j&31WSprR5m7Gx9cj0`MHG~sxU0hUmc zimdLU&yZW;wP_et^nYadgB1zZTmcX%jo#s^lvsFtcutB~j2A+@iqH3_$7!== z%|e^^y4>SUxyVcWb$#*@ZGZz?v*u2Uj5SAz@Rh)npKG%;`5-?e4En&>9m~mBTEPB6Kp-tD(CQ~qBNH^$w zmj!cKk;i%t_R<=smYVQTkuR4CE2HmXF!293IHrzi_GPpHejhW_SVBCE!!*~kZjc^Q z0mHQYkax07zM=Y}kh-xHdyigmwr#BEGiP=tf>ZiIh5E@ffD5~UzmD=w+54_G_0=#y z>PMDM*2Mx+fGg$WTn(M8nWFB#F4ktHQ6FYap?V&fQx{IOlU|(xRA1vwWgN8MxR?c6 z?$@%cL>XfQWheU-Bj0!g6qAQ9pUXc+5*(P@K>n(_aJ2!kkASS?+Bp}ZZsgHFw4$zZ zpWwmfIX8T>Te`>i$!41WTD$_~Y8Utr8%|k$(V#yj8{ctb-kJZ#MdB%EZU;lDR8dTs=kA;H!IXDT&vH?Y7i) zr6W!NPn5<7ALN7POARAVLqkJuMKbs+SJ(1bnB41czj5f|iQpwt`=Mp~6YF|KR}XeA zVts+2{lZw+FtEz7k#*9mcw=DzyuYnAafWYaQ@pZCj<3<>;f>ViT8$WIM>0ULw>!i9 z7z1u$!09bCYL0HE>8F(uQI@LMTmO}swyl2aTqw=!vn|97wwP~6?W7w9I|>8$XUmh^5b4td3$?mPWyZMU?o-d2oD*Bw+vS3lo_OVR7qfRZP6;HQflW zHb*w$?Xb89K-AZ5=`z>ZGRY~PYEohW)RtK02j`lwgl;bR$(@+j87lmO4YRprG+sZl znb;6$ZzA}sXFYPnbk`xtUHyyYw(aa&%#W(lr0ba>sB5~osE3?P)qC5W)NJQeeM8gg zN&&nw*uf>zFDj3AI=ozT;afLZskfj`{+tr7t?6Z>UCq#bsMkq;?Zi5a(d|Pv{S{M< zGV}Un{HOTvnlk8=W487{J41yTP5ebedGF7oDACLR1vsf&JsxU2J2J1Yd-keKAtOm; z@-IRwjW-tfeA_hfL9%-A2jZ?Ay0K-&d3gN5?2Po3ALY~UHq6v)v?=y)f)8@MhaZ!_ zm%PXGTUG1?XElivtYkjaPq*ml@tZxR&nFtgM~iZg3K1s;#!+-~7+!TSy+y0Ugefsj)G@CX}f*Yw^Rq>y^=p zidtnE*?v^rz;r!YsG5D;M(Ky4+Iy=)mO-&O?)6TOCK^47G80}~ zz&K++L4rEg7OJ4j7p0eAWn{_-2V++T)2Cvp97IpzV(`0p{f4%t+1&@n{K%`6dlxWh zpJF$0HmKO2*?gNlyfrn(WBio1L_I0fb|&T(#Kf0zg@qH=Lw3iHFoqg$n0%chC=RdR zDOTUK*3>P(oWpALcDh1EyXx20MU+)I%5dd?xVYX;)>XXS9e(~ZKw6W|0bp_)u%sMp z$a^@j%Y!+$4t?yZF9M|QSN(5S8@jHCp3U6hPya477ybMdvU=^r$kZ$NIk=^iAENfJ zi&?pi&rSwIm2dymnJT7l>^K=me3v-xI_nFXU0TS-j6HsXis97i=PW{TOnhmx4S&q4 zGy{<&Y*tO#ANv!e%y59!Z>GwB;{+~#HsAEDVuT_%$7M2&)@$yK5Zzu)E&njWCY+mZ z2d6E&bo%?rXXC!fj-z;thZ2lG3oa9a)1a}YajH1zNB$A9anUgo+~c{7?--woaNSIcl@}93qK!fJP*KcI zW;^vfkgP9B&b1&}d342AI8M!1bZeUhE?mtYse`tVZ|!VuNeeq6BcsY)Q$};P{H(w; ze?<8Zx{IFpN1S(-unBdfKv86|7P~=34QxZbwSo z*nB#CB-Nk~>!!%ZYIyd*XR-{(1ILhMQ8mLYDL=WS{F(Ov-NvHV5MtjygM2TJaeyOJeL7m4>?D7!L~tA>$@(8{`Z)u} zMT5wia(gE~ip*B5uQb4tuSxewLi50x*Q4N-o9W@=3sY=AhzmFpS_{+1QIsZr^Zkki z3yX&HO@Nkp7v0__%0>b+(`Lf1di#L52NiQY`HiVc^C;v~mDDxM74H6?ag_I2J0Ixh zaF!g~mj(6~QT~QFK3Taa?doNf6kGZ=)g)KJzI~%5$X}GK{egvzDSppJj}=f2mnvd7 z?z=I-7Bl21*J{*1*K6j59lv_eki5hh#-uX7f=@Yovvd>K->FkY-(M|VSUqyxK6F4; zG<@Y=Ja@Agw&W#n|4EX*&|D`!JwRC>H$iM_gWu8Vxr9-mZj`F>r>1_dD#R)asktAa zTH^X@p?*mn7TMxE2N9~b%Cj~kyBg8hOg*4g@^w3=SYk`n*#tB-$yiir!8%csJ4Tz3 zRKl=)PAB0sZ$y=sOJ;17CtOqXgL>%PX0@kb~5!LlURSgZFT=b$#SqUlKS0zYRl+DdOU9r zchaVlCw6@{f=r@Ak^MrhyvjohgxC2n%j};Vh5^ zN9#@@Gg8K#UU|2}v6}|!B7{~Yq#Jgkj7W%U&C4dC;@dL8wCV)9%Z)T+N}LpqBnG2F z%AX}mwcM?|4>26z_dj^^g(4ofjY~ z(a2WJ-vxvs#U;RhXIOR{Yg-D(t7rnKAW1AK8OIp-DPhbVuARK3i6DO?Irov~t$r;3 zQFR6IMbY{Y$u-=DNVyS$4wyJ7l^c!BlrpHPJ@AL&Cj`&zJ)Yn7|HV-52<}-i!E&x?6VoT-YRBFmqxqMqxD9tg!KmxR}m& zALn*b`bS$>6>lPgwU?>S^BZrOM1{ip+9C&5{y-V=OjRq8Y5W+T(1o0kBKCIp>rLmh z3{gRvvK0`3P1zj2Iz>)%W_>zi&up*PZxV{36t{1uEIxrY9OzH}v*qL!o(LJ%9TZ5F zt4OO#p7gT^r%>f78rdl<#qK-$7=>6OSCwQ&^k2bKcS1TD zTolbIu^cAZp-#CMKN;b(z1eKjU97oi~EvjgCz$h80`_%=k<-Da{x>bC@T`|dd z5&|sC6beQ0%zuFgLltHu1%7>NFlCpIz6v~f(DN|xtZ~LP)nP3K!g24aM8I=(UPeIF zu{;p@rW9a@aiu+2%{X>api9s4SeycFT-_(MDwlS9$RmD<>IR$fo`@wsyb&daJ^IQS zO`Lh=8WY_?i%+My+K>`FCExeXdo1+S7jZ*IO2^PsuYk#9e;fj+`nftr*|?u0`7Jye z$v`6-|77u_NM+W!^X&*^db0Tw|7q{Mut{bhrIDuMMe zk<8oq@{A2F$~OfH7tyo;1(YPTOZJad&f>Fp%ijo;1c;Ax@d^p#&`~&f2N^jD0lN*dfuS7#mcuY=1ekA5-IT|?oFg^)5BNBt@grn zi{8b`Ye-LR%2U|#8%meLY6z8(*Y)#f50xpi$}qmM;1l|yV9di3jt%cZOt`SVqf?lq?aSU z{Wdgjy<62##WBhKP3k2x{cA*UGX!34kGjGwSQp+hk=}6pb0|XG7G0aSCOdpOyaRC+ z%^D-0OdBAS>kcP}?8SXxBwqJ~;TL_eT}i1gr2hIvJ#b*J6 zW9ETZ&s;{%xp|BA+D3KV#f5O-i1z4)rRy~tF!DQTm|*{B6)EVK&a?Ny9d_%Z4V)1C ziPnE1Ba}J40>M#vBG<_*GK7Vy5gG+0N?cAtg1%<_N|~AY@TdwgOr)Me_Z{ajuKM+ z9{Stj6nIcNT)msw_q-O;M?A*2<)F5Gxq8QG$~~nU94@^#o|N?Z($xyVi;zeD%ApBT zJ=)=tP3fSpLhg3{CWxzPllZg5Ps0PKfq;>~bQR&N z=iZ7~m(|Am&;nhM-Y_WfL8ji(5oiHzU|0JE!;f5YWg&kV6qj*j<@*cirQ02{K@V*# z){o%E*Mb}TIhN+e3-azsh*xO@dL!9cKuT>S3~UTWEwvhF|6P&;kS zL_k@R?KQ4{`Wds@O)UEWyS9UNP(J6r4_rnBtm=Mry=(7@Lf2LBJ~5!{Qt0}BZzgsG zsPDa6o=L=#nZkuBZGd5sC}WUd?!Q`9gZN6{QTmBS7<(sXk@u%fvH4uL+U1)N!E@ls zUHRT}r@k8IfGoTk6M*&Xc_#JD_4iYBy`iWiTN>^8J(#{xSAiJN3UJsnL{U9?sjg+@ z-FCA%dfB!L$r*AC12E6}%Y*uQfkG0)RuWRIy6j2i-w)1-Ehbjuf+h+kZ+~R_p_Q7n zVJ$DH*r`!uINBJYKI>oik0px0>UI@n#0wEIrFKl#&VgdZ-B_Gyd>-DUtie~@e06Lb zC9V1RJ5|K|iv!uSimL>w_|Eh5}C*JVprUuprhLlmS{ZD;g3zKSS-w2Nh)YQy6AL0vsZ3vTk9{e zAEm|R(NX$&0^DI%p|d-8drp#hDVMTao4LLO#3+B=js4pD!RSmXsF%B-*nT?fqxS%Z zH&LbmzZm7@OqH5Pmw&cLYUBq8{71Iu9uW z9a`(GA{PNVCGvKb?@bE7kZG!wO*ES4R8O_EG_pv}z5;l8Jz=K47FD_UB5~xhpWE2G z^QBUm()igY<%Rq(pfE;i0(R7o7*$q(t(46X)eF{+be1s^P!8hCbO1>2#`)nI}_czhE{gO@i{>A2t5#N5!q&&}`lpnMl)@F%> z)BkcYo`m9clQl_8G4F+bT1WM5pWrb+4}5g`vi&sG%IDqXu2r)-IHZrO6LWR98Q-0@ zmiOC7K|79X80_yP_Q?`MX|oGjv+)VOuAmUmwYIc+sZsRTq_48Fb`1Npd z%!WXMfhr*`noD&SN6nrLHo~=LQ1tqUdAMBGtcZd#$1a4XtOT9}9hSgpr zTw(jC#c@pkL<#67uit?Bv7?#H{x7ZK9g3mg*VOZ>%b4`8xlC5c&C& zd_iIwM-)6t_Cr*`zbU^Ctr5F?X-<0(jNR?N0K$N56nLwUeJ#9?ws`e{MAC_Fetm@@IL`PC$*n1Bptu-lpQ>aQk&Dlv zkZ#v80!(`7eGpZ)zwizKq*i{vq_lZ2D4*85^k@*rhk?-l9&P`>7YXq;>g@7S>Gpkh z&0tH{#^djKjG2y2)&vwIPloqym9b#aDMw+btEKPTUd- z%2==DwXj&11)RA6&zo~rq!Tb5uns58DCIM6IR(Q9g7v+?6D(MZ` zTRK5SnO*nNsURqqF_JJz9Nw^FCn^;BR0Xy?H|JddRLSz zU2cFIz6=zP4q+8_h?E)C9TmT4r|^+#|KPKnrbZWEq?dMxaLbLeViqMsuf&wD?3UUR zAx->VVynKY9tHjMOW{Q-q_%mWG68$}QSFz<-mAvE%l1s-eMOth>Jw9E%$_)veBGYS zq#n>m#D^CZZ(|sK#mUvfjl7#XXXaX~Ib+-2_KZg5dpNG4`6z@|gmNd){a=Uc`h2gp zF^=uOkJ+_&fvLS+koY4@wXc0*`AD~WvE(n^OUH1{(fcVB#eSW~KJmClm{k!GH?p+- z?5&o?b>QO^3a@7G-sDu5u4qZ_K<|+C-cFs}_4wM}{djPSfNVWzWz#PLUAl$Mq#e?? zr*{uwUe}boBG-RX#l?j%dqnyc(f5|T6rW<=?`b8I1p}W{wq^JsopAk#Wpn&C$eb){ zlGgSOzd6;#&pB>NL^N-%uSU^f34Z~qWi?5ppH-bV*L~n!j*t1bj|?>Whic)mE5W5o z(>m@11O_^V1b<;{t83P!9v4-7Xi7j-77SY#9n{q#7HoTJJFORZyDReQ<43YorngzT zZHl=qwDKzJ{+xx7Ln_Y79g4W+;M+{$HEEompJXdCvc0{E3kfo8Eq;LZl)ZEiT?j;G z$pfu)lT=yNVo-poJ^u!HblKn{^u|~GY@s6r z<2qYd_&}#SU{l*T*9=A&VSY+;0%=0~?R|Q09)?W%cbVtwM&k$lg@F_NYqjqZ;xJ!( zIh5H->PtZquUEbkoT;-iOi}s703XcuCB+~%H1PwRNyAL--0 zdlFN=m%VUTcsVlivqlemg&6n_CQ2Nab%)2mr)#fcZS2}%${&A__@~y-se#U%&MS`R z3!zmHiJ*I_HP_IhhwA@fL6i*6ijR#XJ9nETdF|{3KDD`vRuWVe4Cgv2$R^m7Ff#df zl2?@QkPyc56mBPi!cmnW#Ug+6@F2Zpl6(qXN_bJS@WjLh`l2L-=QiJ_t%BRqB1?Ge z;s_tVCUOEHteU)*I<9l$UJWiLJ;&&)S2hT5KlDO7!gc-xnWvWrs!`npF}=BrYq70l zmF+k3XQc9!^<3-nqH%qQ;(`THFK9ASwdGr<;_pxkoS7-?pcrVW=(OLxMpnR({{t6h z>Y9vFcYmR^-e>Ae7v{B{ocKWNB^z|hj*AM?UL~e<^5ZX29c)yo@|2{3P|gJpH^ddA zRdRR9Sdvc@?Xx-Wvf^>Lq8c6!hTq_9F4gbb%w=XcC-0oL0jAq`*R$g=f|?eyu0Ma#oNQ%o!2KjQB6zLveKuh0Rr?!{)EK+ ze^2%60xGve;jSo-;dD*BY95B%T?^c=5w$^e%lTM^OMPPq{TG9dT%eKe z8qi@z4O^dwYQJ#T)!6l%wRH#6u&EsFMo8*eUq8riJnv%=bDsCnu!kx`luh9sZI=-2 z_=@gv9y*vPTe|4I^d)tgY3MON2TdIP}ms9A4HT72vp|!t+zl3B9e&CqoET5Lq1&zNFsJ`ZbB(#B!#)J+2V+ehb zA_^?@kPltWMnsi~;|BN}_1gC~*{Tmb_u5FauFhdI*OIL#FoHR~=RP(Zr;3xuJ!-Qy zGhyfr30gu@k6@FMEa)JYzN$eozD$J>%FK{n62!^Qyd)iag0%x_-|Q-zia^+g!R4=N z5r1)#PGWj~jn0)WCeNDEe=MbD#GAvE(<3=Lb_#acEIzVX%P_TgM4=VwQNTgPd zf0)&KaId?$vK`p?PlnFhVFO?Pq6hY4Fw6Dd zIIMl~-hnV^Oio<=bc!QLD&(EkJ6kJDwfklc*qf8=eRhO#QWl7F|LcHy7D?0$~;#bNh*dp%bo3oSy6z`C?Kzgz-vh>7*S+*h|Zwf;H z5f@dvmmUb53-W8dGlgN36yG6LT?6hll1~&PlkK_ubC53=)?+Y))b;=JU5C(1dOd7r z8Sw1d2EqQGb`fOl6gHsUP^UhfK6xC^KPI7d^e(2TuU{0rqP)4-jJ|}|o2$)DJ4j^H z_(lh4uN`OEKz)aHkviA&PMskPcDb*Wp6@X_*Pk5wrEn!rTb2!ITYLXEbzZ_amupH-c>wQhgiBUKUg1zhaA9 z4mreusT!HvBDwJNcN4n#dxDab4u5RC3j2g_EC`Hw83**C(vCe<4x`m?1-P34V(Q$h zA1UkKCHC16-D-Y>fpUk4l)Tl1zP360+BTr{s2sy>9o_B*xe-2Ny{i4a90obt*#o$| z#0%c;?sn@}U(&A3cg}@Ku5$3)aN^Op2jo$|ZzYlKmih!xL&{n+o7Au>x9OOMTtM=A zgMF9V+Wy*l1O3*!D$JHEh9eaXn9WwRGlo_Ex9sE%)m-;>%W$A%Ee1<0qQ_?^zn0}; z(QjG$MM3&mE0$+0DQ2H&YpUhGtZ$QuS;l1NMg6==4+M?3DxMTzH?sk+;1&mQhGNl# z1^bZD2OI8YPh0c2k0-{m%i^oy!OH9y^+J%EAG=Arm(^SnSCh!&e`wi12C}EAZWYQC zgg*VvI*xjDDy0gBmPxFHHf%&ytyKR{{ngD#dg#sapw+bUt4Qe|^NTF-gSjMLY%06g z=oFL@e>E}uWdgdyTOvC7g_u^x~mKW?)H>igfILe2v$TLI^` zX%~hQ!@92YFz*I)lUR~sJ+k#*-eedAewPL~x{GSwooQ4GIM4LhlzjFM=q+?8r8Fie z>Sg08mg?xCRnkSQ2@ig4>OyLizRp4R^s@1- zLcdh}xwP;tJaQ%dsh+~RW`^;!Iv%nK9E-`iwKHy%!q1oufM=`gA$tmJP zWLpBcPCUKOW}!D_vT#t9H+Sgkq;#Xm?m4M-FBqt+-ayG8Klr``0(RH#T6t$gYK{$U zSKS#<{KB94i72^2`K0vPiQtTCVACo>@1;89PY=vt(dE`ogO2+B==JNuXNIfS*2#ny zf~uHUa!MunjawblZq+FKwcS`ulL=w%eI+JdZ+=F{&#Z*h5U!lI(1U8*Q*K{e6+Bb4 z9(1`yqJExqS#?j3QX5F$4{OmTu_0usP3eINY}9Eq3pP=6QhXhK4aIIWXHDXpLy=?! zZJzC#I9VirLm};JqPnCxAz941hBJHLYc7*OAwwRe6M$F#bKRH|mSYvqYwI5<&{F-c zfo$9@&(db?e2+8%&UawBPo~yT6Ii)zu%orhs$0!5j9giWrM5hw%e71MV0kmxyy`6{ z3)k?CYoc}&gn6^1p3f58r3`{1@%+U}=?eMO>i(yWu~9+e);04%7Kp_H?i;6hBWJFv zQ-6IVDg4ZNK^e={t3!S&^%gl8v53!p3%?qe+a~UIG(>DmKtBuAZoR!!UC-1_ma%#i zw>b9#?3k4w_1e+@eJ<8*r(!VMB$FpK5wF)6MJmGQ&DIw^ehyZrdjZ*+1DwqH9l*cW zz8iKu8OgsanRF^LdTp;7F^krP{i3xh?xDbxiR5F{7I!1T%(5B4DgBWX>v`nPWZ~wk zRm;^+Ojf@%!gJkahWsBw9Dwh&m%(4L2XG||rGU=0>Ft9k?%Eei!8bG$Vw%?YboBa# zC=D?|xqYMO-djb(_TJjBdb?TrK)GxVaD^9v7S}E3I1IGyL5=`C;Hz^QP!s7*eVEmB z#o@K6>dDoWzMX4tYgvWHO&ByQVWYeHSe|UrMEwhZBC^K?5ZFZ|3EO8vU*sPUF&#IC z`@fA3dhNpB)TI0NH7{ZWIr)s9SVaOHgh1@?5(3ayxu8%kV!WlK)UZ=)L+e-chKUchi%*S~NS=%YFL+Biy(DiCw9x7?x$K`icJOorPXZD=#Zdpn-d9Z9#V^o+hV(ADuX8eb?WMM5}k1s%-hO~Ic9Xs z1sPeQFU?Rno&vLn)8H5qrP+YN<1boa!As^_WegFEs1sIG2Jg7@fxi zNunJayp)U7?If&Wr0UuKfsp_E>|z}H%)BXMYh|m~7PjXA&d+^VGew_O<&-OXCo+}4 zZ)ih%Mup;-Z9}eJzS!bnbRa_`8#V%6t47_YWeBp8_`>;|NzLEKNrdxw)kB;uF^Scc zyaN^=b1Xt)z~7?377dVQ8p5m5^*pos^{XR6{MrAwI${F~eCzitjF&4ioQ1~#4?h7I z8vo7Ax3x$I#T!UneGZ10>RAo;lx|dq!{=lZ_`ThYEla*v{QG_>tmdobSsUZBq5(qzKQqd8YsKSRvFm@$KAzHUfVzQ@JfPMoT&l5gr4!4sVYazd?`i zt=t(osz+S(1z_Do&NQ+wU{DNBA4r|vGIl6OZ+m-A`dI5yTbn= z9K+8LcNTEO@$W+8K#46n*FYU{xOt71oqSC^GYfuT)o%ZYk$B)J^`M}q#ABQKi?&jI zd}-K!BzbR9F#%xEXxOr_ec9f5khK1M_qD|~EAY?q<2z$v6FLQli0AmX9KwC0#|4n7fiU3igY#NgH6Uta8w*^ z-$GB)$<*rd+UL3~8EEzf#*5`NLTW;Pb6|1vIM`DxzBY7nCrP_?B^I`p%O4jK9*qX5 zFEH;wEHr62fp_yT%lO-JeM zK@BN>RD989KsWL)Jp<$#q?*dsMBC+?$94%m*_ypGI{^$RMGXB}+gRGsj5>Px0V2QH zs5C;@_8Kzda|HzqV7T#LoJ2P7L0<19#*zlHNO#3yA+H^rLO7Oy{K6n-?#di+G(c81 z-&Y_cK9RpkuJg=IwY$)(hU!>*_No#0O!4;pJD&l_Ezb(9a;vwy?F%vB84HgMq~MJX zN;I0y-uyIcs5J5a@*oPiOD9u5W&^EdU|EEdR+eVB0qrM)Ax0b`QfUjJr5z&jPazoKpCASm*l*Z+U z<`bJAL8r=1)(*Mg7e>ZfpIg_7 zTjS7G@t=zeMRdkP){YY12T*7PW#d#&z9;0C6R=g6dniXogb4GeEW$81@Y|BCZwn2l zgaIyviYFACAqIP{-I*VIM32)B4CxS=bb~3oaDivc;)iFn=n~OajvuIhSjj&NAgT== zC=|)yGrl}xlO;lLzc%tBa=89N3nGl<$P)+Q!tY*accTfbQ5&JEAM%$&J&rX&?hHKp zxcIw);#~Rwb)#P2uSPw67GfB=bnyd{9kLKi#^`r6A6&ahy;dC&2Cpq|Y|d8&^pvcH zNe_1v>DfSb=qIn6mlkKZ^5w7L>a&7)&lk${ z)UFk40U`V&-Ti=e*((oQKA<>>S~^_aJ;`C4V7gR(d1uh-J#k~VVvfibI?-hf_V2pW z)&9QUl8qV9%%vHz^x5`{5&x+iu(-Wa*jRe&6Wfm>{Mgpg#>A|c)S^fcXqSIgY&W8d zI(*flIYLs;2hHvq;JjC82X>wJ`jdrK5pwKhx zngvHQg6?~YQ=xoyrz#4bhD!}yAJmAyjO35}+3x0xq4D0cKiy7m@Erb_naIrMscdj*R+ivxfiq=aYr%=-&nPjef^sq*EH$L+{uf z^lQO2}rb=mI=3r_(iDxGyy-U?H(~-MVK&aWTscQ z_XmJt8!AzKflJq7G#ghwoqJ(#NFN4;Dk7Z~ZIL^r`tq!jwm)p4H^0$M5Q1R52aN7w z&}4jlq|5gNtlpL29TT8u8}{7c6k2Lij?B3oXGC^No{%82>o4R&pI~*$-xq4xZ_UJg zS;Zl@TmX%&wfS?INpzuTG6-rZn!M7ceZ`FrnBbVeVmq{1b&6r_-JK2$zI*p$8MWro zg}rwo9`pe zM*K%VJq5*Tx1#dfElJ!;|Jxf`<(OA@60FWlm{!^26d{fY zK3AJ3SABr9aeodF>VR6@ytQ8Ip@0Nb)?8$@pnjGiNMBPKd+Kc8h@R6ar=x;NC3Ve- z8olt5^#R~9`Y4f9AlofY%a2W~QFge#q9-~Gq!A1tcO`}RTpjd_an#y=biOp=qmFHK zGzKW&!9D>l(Uc>4F6f43PX>IZ@-_z}^jhF&Rd3!Z@?1EwiI79WXy`#$k@s?Sy1Ja| zPse^Y-(IpxbGBb_8rnJ6Zew|2@C(bat(>H=M+jSDq(z^eZ8NtiwVW`&rx_$vZCgls z-o#JP!;m3EF}&U39Zne49eJVy$I6l_o4$l&XHAUpNBHd&(v4iLgw1$ZgtT`MxJe>T zhvo|ELH?XCz3a9;RqyJ6*U`CApIa+0CT=th$-Owh&!;ix}ou4Nm6qBO~L>cIJYW(Yc64I}RZk;Bu1i zBvIL=DCXM#Pn=QQnQ4Ww?alaH`2DokNAD`YSudh)Z|;-@o%g{X9`f2WRrS}OcX5fj zZCZ9=Tpsze>&!7|Y+uYIQ(BlGuIL|EJ~zbO3)Gr0sl6sP+<|6$SET_`e*Xp%x0W;3 z;OPp8>&JP$kjac$Yy0}aF_EgW3-IC=7kg=~3}GJ{JV=cVJ<{bi@I+P8<&lSr@{sxz z%k%o|@Ttz3$R46&0Sy5Mj$h55{2CJ5H>%8{m84cpfWh7AI*)^^4wRPmr+%y;$8iJJA)|lmteUWT!;1I}P^%Y>we#rf zCy;uGBofp^9llG6x&CuGva8cpB6TTk%A`*1P!6ci+jRZO#PNvkkWL)G(dX>|B68?Ir)M` zaAIX(x6Y97m7)&~iqdw%*J&tZv{h(k0nU}%y8({bx%PgTV8l`_=UwUavsVA>BJX;z z!TGkHWblL!`dR=6>~6CwoXT{2pQy4i@7Zoo*n5yiqain~2NPe$kui-=3bK+$a1X z`cOZTX+XiZ=grfcsT zIo``l@M??JuJPcMUOTfVs*LnTp&*)LRiIcxpy)p4f#luj6X7F$7}nd4`RUdUv0gIu z|F>uAPd6Eb(7LtEJ=T{$Lae-k^(x&;js+&IbIyKK%2z}4^@iXzu^|>oKCNcEMhdGh zJgQC99T82C>lllLpro2yamWVp?XOSvwtqwTtFJ{68M4}UbH~~NOvh}%7Nv&?Xm+9y zaI%iYtotb$C7&`wu51w%0LMP;&|0=7FZ_-c*ug?w{E;7N2vWylrE|d4{I{zC=>uyiK@L5jhbr(Im^3xd&Y?BFMni+#lg8Q zg~{g0A+H1h5{bDuG}ViRAm)R-(CS)yS2*|>6x1J%88d%n&ztw42Tx?tiV~&nB$5c` zKmq;JCb&Q)Hddc`#x>r{W6lL7FiN?p<&?9Q$1)*bQ_#D|Qf;l8Wl61pRYe25w zo4)+ROIF^M6HK$gFX8r{dcDMet&X1=DcNgjR1I=x>KRaYz{h+JUdU^0wOO5bHvk_R zOXRI4vzj-Skf26FuvsjH<(q4wKLulkeYLp29i5z%0aN+ch;MBk(GII_x+^>QkNJ?T zldAL!1ODcA#XMVVxXgX)STpEWh79{$uXj^@D|Y-F5nQYY^g-8KZ(KAQsR2y;r?U(F zo0!3Va@eg>W{I~NYbxEQv1|~TFfl&T5v~Qjg4D#;AK$mv#rnV*r}|}E>5`J=QV;n) zTw?WHTgnS^;sE2jSfaUfo04D2 z>1$B7?xidSiTJs;7@@V>4803+KOhpR{xpg@+a?+Rjhoq7)Mt|_T&GJ4{#Ua+-5tL< z>B@5Gf?*rrC{TEZ@q4xoo%HL9~0S z)Kx|#G|`eyE*LKZzE}N)b{14&u#fq-q6OL1pJAwwr6EQOLb0ebWvb5Rt2-NynY~Z` zH9Ehe#Oi@^d5AxGg+({Yo$EWJ_(4{$%Pwk5>0ye4;M(XBB8AUJr#r~t>;|<6M18(Y zE30~itUkNl`1V{NUUf4{@G-<5aY}^05!sD5jib|3K;qx){%Nkqox}F+fGM{x+ZYQ* zpTOivpZ1U0tz7hG%JX7;2cEgr%qm5R&zlNjknfpk>@RPlOX8wxF92R9JL{gTdhB+H zK~g^08c_k7z1#Ko_*{by$(Z;9dyQRHb{4}${bU30ou%|CaI_>H%colTrzS&1S)GR)11akONG)5 zO$B#E1X>i!L|j1;!BRm%Bt<|$90#9kd%w@~^^)qoC24h6cOSX$y0!M2 z)5s3)aKH--#i3Q2m)+;gf*6T^K5eJMA222%%g`Sm7$|=9MQA~dIwKZ);n8PT|CJ-$P1>jyiOY%w(W>C`LMbGSk4Id^VL5idmRF- zubW+`{PT7FmG}sbs6)w=w} z+j3g$kG&_xYCi@~1-5dXn(~V!d1>t9+uHCHffTwSni2hfr`TM`+(~a2zLmG-)Wln`%=a4T z4`sq2sfmzACx)*w^~`N~8hRh~$@EWN<4}Esm9De8Y*nXK@lT4?Av@gb^sNr(1`Vu_ zpZSoTgO93=OEK(eTuLSpM|cq*1mNx>@jNS^TY)sXG>fSAKnnfKE5&K02QSGd+*u+a;It9b?;%gYIuR`mRrQai=yV7jGJ>IhQzi4vCLd@M4oU zW6cV$4d1Ug02QKtRmQ}*2LH|hlarH~Vf#z7J@m~Wn;YJLe|j-jKr&~FZu zV&OnBh{$NpOZoziyS^RXI6dw`J*i%6jyhrbRL!^oT>5Z7Pi)mLwc&j!dgidQ59Jf( zssL11eON#tP^_Yd=v(};_f3S_u;Hj$(lk;ZMY}QWqksF%kPA|FV^YQ7#hShCecfWM z<4mEST(E0kMHK-!r=vRru|LY2Ce`bHG#yQaEc{8jUKduGl4Xr9B{t(;7DP^!C0;#g zR(xKNBuo$88NPuSGVC7jLlOuS{uiRKIzv5lJdk|YudbDO%ZXyj>$9ad zloH=+q9Vid0nVw;J9;d7)&3Ti;a=^IZ?O~P?%V(m)1PQuqso$pjo+Sd-FRoIxW3s4=gXlyvwi=5w;f$VH5}A zR`PH^Fz43bYU=hyE8Uy1HJ^A_3pY-EtWY!=mKksJ zzFtV!TwD33j(FQSJDhIWeu%XpxkeyUiZN%K?7`=v*|PhYQSYxpWsu~exiqGByJ5%* z5`80xwG}75qtoIKO0z~^(_kT-4p&X{hIi4SkdKIn@e4R=vv}YUyG;0-?iA_*YTx*N z$Z)IdzV?*9Y0~=bHWKc98`6wed8?NOSLM6Y!iDFE9^?D*kra<%nLG`c{0$6`+q$3Y zaVL4eG8OyK=v@K<9TS=sfa(x*&aIr_EglnVWF0c7$fA%BBAFDqzFSgG`(f=0BZ-zf zwZ8B26xVSfCLm-h)AnxklG!KLKdMdn1E7SIz!vw}KTs zHl?gxA2|e_xWKA8q7rmTW_gQi&%T?lit7Mai7~AXeIjOYCU;-h%!{|f_&g`CPEFAm z$UNJEVsH2_2v)dE_}=B_Zk{jxh;o)d_x$m@d$jz6;Xm5N`p8W_qU?Q06r)l{rCSr5! zJw*^lYMq4d=5Q;A)*735AV^3M?G!po;4c3RuQ+>5D>w&`t(5&1A@<>6>E(==F(+Qb86y)%iDYQ*3q1p04~^T68bH(cg(S0pEbLjSqejU``cEI*n_4 zwp45*7z~&=&6P99wCLnueF$rk219)M?CV$C6g)F-?-@-jH>Jw9r?*hTe%76yyO+uF zRG!WtBaRqL(ivg9R7I|~6#nPn8Rs|Qh!MdGk7u%8n^WqAw-#!!*2_|`%p=dyC!a9D zDfVsQ%b=Y5SRraOY-Cnu4*tI;O0v`a`H-hp@9nYMcX(GM{bBsBI8lnz!mO#!5 zHt;lxOLu~y+{;vq`Xg@0_qz>y>$bKH()Q}s$(UNLAIOfbE7E~s=W*x~VGCM~X_Q+{ zR^on%d@=U2ucoiKP#-1e;P7HO$TVM z*##zR+ipB*nzkUwEv9W!VBT&^cL)f@R2&KJT^dPC;yJWIXp%>%utV^g^?PAuK{EkH z1T@0kYxvr3y8xVi+{=T#aQsv|SAT_TvLOx4WeGHl9?5y2*VDKRGf`etFF-Dy)+c@g zQ*(V|ScdKko}>uTeOC`Wm-WFO0>cte^FQthIP`|1&^PIb3fKY&@z177Tt2i(*hKJ)06VEujuK*QHgmTD7a- ztRGzQPS>K#%GDbW;Y1z>p*~)f1HPfJ*acB|ItM&cT5O3MU`H>2b0N&Xw54UNiZ_L#AD5tJI#Pa}dC%NBn`32I&3cI4 zgk7YecbRA4<{9;7?(AZ$akV5ct9(UMov&tGiuwW0Sq9K#>tm{GcW)g4o&T8A8ht>Y z_)omY94tR5Mon?q@7)sY#V@M_c!Mzt+6D_*qVEKyU}Z5w7&x#}1?Es74{&GwwD2l` zIcVa4fWE>g8DKJ6nLOjUL7s5eJ~biVzlWR zNWuO`o|Qla53EE3Tkxis_U~)E^OSN@R9;dLpm&`%iStumu5zcv?VGvjyX~#p`lK- z_-*MP$BQAp1lWTWD?c>2_s&-+ix@jZBU!APH+)O|V%6EX3kg?A z)_IC8T@ax9kce`VR^h!ngC$eh+E^9;_!UgSfP4c~wImQ(hPbv#PR&j~H4zqCJjZi~ z<${bW7kKVY-w%K(mKQ*8q097(xA#Uzog)4Ms#=Ct7#>yEA#>ny_>U~o$W>I?6;9gi zX!FSuzOK$A7k+^_O22C;$62Ei{*I5~3=W?L-E*0e)E~ve!x#{ezJ!R$k_i?bM%cTu zP`WGYz5{&;c$rk@z#^zq^CGgyOBf_w#d)dx*wjSyoZ#y2!=$8hmt)(<`DiKb>n&Jb zMRsltb$a=?XR@bS7xM|Vwm2L?Iu8&q1~D}PuL!7Y5GQZmpd3S@Fp99KVzol&0T!(x zIbFn)&qCu~$2((%`_RUtz9|n<;koc0IS7A4qRzh$Lk>Y&} zTjVt2YGy`k4#}b(kd`yc2JLl%xvIJ6IKCt7?i}iKm5H3_L`mYh!uxY_XV|yOqpsz1 z$8Zhq@AnBm*uq9fFom_MjcYK^t#UaZC+Kk)mHi8}k1YZ(r-e%p_H!z-=5G4b&i5qJ zWo%dc&M^aN$YVg6*;s(H{?`RnN`wUzyYe+}vAn&>c#X0n@ z(LWYGAndWWV>j{+aCOA+U>9l-cPK{aW){ePKe~a@T#2Ocuz|xO1pxQ3qbbe z`wr7ue46vB@9K>YbzSo^N0Aa-%4{}o7dRv3@8)m8_TyF2#-5hhL5s2Eq`S^K=0dUvwLqz0A~No&}k|lIJst z(<#K6jD=1obC%7t(mYeWc+vt?gtJhkO_pqRXXVft&9?g^h(}(g4sePvPYv48(#H{dWjAGTb2W=Y}gN)hF&n&`5yQ=H75kVA4=rJok|NcZ}Tv>Kr(ePGIOrxpuQ;|x3VF-Z}AVSVFU;R2JK z)#bu@xB)dF%S^w|&7T+zf-$t0I4t39+T`O2FY;S8yFW^$*Lhth`3eB4VPp9_uJ~qgwD_pEw8+&aGV7qE2%0`X7Rl?0oeSxGt3(?+g zgGYX)NoOEBr3y)I={K{fG1Qm?DK~OQv273vLttYNlHk&Y+<=BIdAfQ zKoox7#p|w<0gCCE%kwaKZ~OAu_W~1d)SRsd5Xz4hVS~Riws-7{6#*L1AL_1-mYzrY zTUS~cyEy1k!J~#vcjm^u$(OHLz05%0V6#Wx5L0B3hZDhmTe1!Q@ zn;k&Sqz&;`tj<9aQEAYxf{&CO%U5Iy`Zsu;jM-U_TqytOF*Whs{?!!f2^dm)+J);CG`N56=JO>?}F+hX-PC7hb$Yip_;hTXV&TG~M8v7)1 zjNk~NWIkXNTcS~Q(7h=j{~Dqmlc{xSSq=pdt{!-YA7^o_cZnhGJaiPMTznpeiP&6m z6@3Wkx5IUIV6*H%T?^?-BpJY^RmrFC;iEY!98FVzClcPx|I7d84u)?|V!_6H56^d$Gn&wucO$NsTo}`aQYTI{xEhrrQjCmR@keH+b|2ULmZVbCZh>3|brh-R!77 zk{_k^#mkq6HHM`~$XZCZ)^w^ElgRE@Kh#x0>S;?jqPA0uCsfUHn*5aC6ga5T(zt!n zcsVmb(rgcBEt8M&bHm)t4mdu@o`t={CrBB(ef51Q&PhCVpx+HPfy z0K9c1i?SJZCvVWACjLr^#2&Y~J=$ZYTOMQ!&d)Y%RUtZ;s(KlBqqRi@n1yDq(+5*U zT^GxHs+CgfufFHH#NuRH)aq3F&_#R>n6>V~|U*@?djtvpPNKcws)1M&jR!2@cZ%?sf^;>Ow0 zaN?Q=F%L}46j=;gJaf^HYsbwkRAzpn9tbi*K9>?ack?isJA%H%GIxHacRuWIny}pk z5MBlp&M7%Dv~VkRmuR$GROI2MkJxW=WK6X#IH*)Vq5aJzDTXtbV|!2~tOY!2I{29StJq-mZPc0%rHkc{~L6GsdZ<+z^C;dDBPatNHhL zgu1t6&M)iP2cdla!gk{jwCY9x=)wOStC0xS4Lb%}MTA(5iQt;;aPfo!9Y49TY#9N3 z2^5sgi=FnkV-~gGVd+2fRWu{-yo$hnqxc1FY>ul>wz)Qc#CvWG(6~ zDz_(!lN%uOdEErbi_Y=M#c9h1 z^|WS06o0Dsg2ygLdiRfBM!aK1qaO62UdVszn18UZ zh0i}31+&O^8p}ndUC71OIF>8Lv7H=jdW_XPtZog==J%xzYQ^%{HMA!MZ2UTno0)oN zR`E#%aIe?(2X<&h!BbCHoOkTfo-n(NE$D3@cvhz9E~OD@hBB1%WRQt6U*`QKV`QR# z(qlKpc9x{zlrpD!e6RVLg3uV#4CXvc^B{3g3v?LOjPyr#=&=tUC>8%6ylL~iK38d+ zG{`95b~Ptc={8OY009w1#4?Q0X5gxrE)d!@L+yK=x6WSDL>HB@&|`Hz|a4p;y>@|dQ?_u_LVRm0iET^~3Mh_O0d%W=N_=>h-an@2@bE*sRzor9WbzFp5 zF{Kr!)q=uVGS`d=AS;wm0LE8X9H8oLudg86J(oF5Z=D2jT;&mc< zok4Fq?eZ>=DDQpm=rz+2f>E(&;&&;=yMw*dpr?jv5zad8z#JfhMH(z$MF;IXekk!ghwo@6;_B zITSnxsjOro^>^~7OK=p4&Y!4N)H%JhltMm_T2g1b+%exg;9SJ2gkH)9{)6+65)y9* zY~mlc(`f&TBF5d`7rHn%PTo|}0yA~POrVez43$lrr5z%7=#V!slkejyk>{EG$qO*< z&Qg;3%LT8;ujO>m;A+VtZ+e z*ak1;cVJXwCndY=c@~4$uE7TY6^7yV=$KF7KB2CkK%N%J8d*Z`}!JQi& z#E(&;TWa%*O#+t*$7 z2silL-D^2vXey7^x*NTceo+z}o9G$TY;eGqXrdpglW^M>ABFUL$uXsU5^U$0|HGSl zD*w>{WT-Au;pA%yWb4te3{^Ke_Lpy)kWt|Q#OayA?%JxD4@tPcdN;=Z0_bLjUgTKh z;@>NB!*I^o!ahkEf*9#|FhBR50Xq7Gn~c^6*hTCPZwpB>&K^!vVb7ieGk5ElX8;a_ zJ~1oP{8=c1IL4M+(eo&c9kT&tP^vP_YGLO=d`)(cjY$}${9Rh@+K#L6a6@&{odt-I z*G80&G1BbV!7jCIU(*p2XLRXjDXKl9yz{%grf4_drstE;3C+1L8%oT(qC#^J=9&5U zGy7QpOG9n~rmpMfi3=QazS%sV3zS#AdzM?dFJvvX@`TkZE%+&0Ck}N4^7{8_(?i*F zGd|Z*ZS)O?q*`aNRs4kM$|6y|@ynta7xy?+vF$bk)s zLWEQ8S2fmC?H@>+46=>3$IrK+CPpIF%NSW#Vs*8}(UM%JyofPf1iSz!rgx|fx2zP; za;XJ=o`8+>Vb~x!JJrKJi#muI)?sIt<6(Ci%VSCr13Y<ip{toHFp1-bpsoQibhSnT7TK55Wtl>B0bA%3?O)@&0Y zE1uQ-HS`gx>W+~EoKh9S&+}TOL8)2fpNTaU3E|hXGgn2iA83oeg3dSBYtLTydf4ag zc{5L!;B_cTjKk~fF9~_XgGBCRfT@H}tMVwDI=Y|>ctC5<%Sw0Xo7+fC;g$N;Wmu<| zdRIc*OEsI9ns6Na2cER?QLUejT3f2bvKpuzeek{<0ez{buA*lZbz|?w(nZ39xC6q5 z+kP=7bk!WQE+fE7h3kxaq=Hmo&qs?()0w7ll8M9i2)8xQ-Tk9!F7NkkXkjRv$0o*KL1 zKtGRGQIMBNDVx}Q9oNi_*nK2c@ud6}XABv)a^!*oHCKIWX~mq7ol_k%kX)yjxt8Q3 z2x)Xkpe9d!Eubxl|V>G{iHPft`LEh}@9YiKwEWw>c$K@S-7{UGtZ2yEUp8V$}iDPf3o7M2WkC zb_-u%2tW;59&}1=kc}sK^uIV%BJrrnj%TP!J<9IWoK`+_~saZ(;`_JsHkgzfP8A!8Bm(_+a=y~G4@!*(gwZVa0muuQ2&NbeJYx3uF z)quWxzURw{>*~ga01(Sv(9&l&s}J5Kaals9;07xDZ1Cqs)>`D+<+*gFY=v0JsoH_Y ze4F8mq5GK)k4bB`5hmz~&9yOLY>LjXn+GQ{QT<|893*+NDBLTiGr|3|pN=Pc;Z z+2QK&k5UmJ)J~Xo6$+5i5yIB-pWWa>tz)S>{Ri2l!({{Kh3P7Psp{w&Jp8oaYCe}P zaBO=&=HEsSfq3*s6E7SG^dIrl#H#lvh@Lj4xTgWTZ%J&95y`d)rjm#KqP8i_g5WgA zgtHc&I15Y<^;0{%iyd_l%_(;@4MstU@=~u?w5_T&f>q3=ruRAA>oic0Z`>}`7Y14* z4tZ6lWtFet5Bh^`S5UO6*mdJ1KVx^iuu9qGqGb8}%-?iGop0Ub#$hav^T8<#)Dq=3 z(Q0R3O;W4ihS-1lOd)H28Qk?4`OwgOkFSs?oim6HfPWwwmv9huL|<$2HYM%d?6!i+dal#dP zoWAyabv;*L?>MW?9zUA4MEFP-A1;a4eDR8HlLj`$05}i4UkqG4-xl+>*~2Tote6>O zb#rUmR3{u#Y%v_DM6l{^c4dijeep(*JJM?z&9(eYnK*~q`Co7ucycW9$# zyW*HoH`!M&@bQIo_;TW}LHAH_KSZR4qgkTGxebU_?|h#GS$|}rL*X&Gr~tfeN(Agi z*SHm$Gyckx)=P@Vz&g=CP7=h0m5)MaR=gWn0s=m|g{9JS?5eXz;#JM8n#=?ne1rDLZ5h^`1LJg3zu zw@0Suk}sBSDoYVV4>$SFl<%csgsm$hbwX{rto+mGzv?+i$nUgGx}T%GwJQbJRYjh1 zdLyqBsITT^#9S$vd}=JT-5$G>+SLEs|YG2@nvt^hlQtQeH);SjVUf7eksf|l? zeNbL+QkoXCH{Q6fbN;28hf*MkE%DbTylVWe9FR*O-Ai)AgqU!sEERoiX8{=`YUA&fciJ0zTd+P2(BAVUyDQJ#(=81KIf9%vsQ z(57b&zGzp;H@Qh22*ReC&0>WY5_O6L`9pb|ZAbj}%-SC_92Bhzv62MbU|Q9`2{;rr z7yWlj;A2_1iPj;0B4sI%~;)Cj|g_2JQL>Zim?wbg`LGF{)Wn;X&QmoBs_izB#yW z4mw(&|K1>-UN4}?$#>f^f#fPIn!Yp?nEV7e=x!ENRjADx8sg9?<?*x{lUK`q)RH^f2Q*6k8PQJ z7GOJ^gmKL%j1#o6WbMs?;uMNaa(o{or#nHeq@(+13#fAn+!u%0So8O{G{LPV-zT~X zw;Msmqn0DTgUV1P(%?e?ZrIC-sw#?oZOF&8vzG~e6P%0M8>gA@_iMQSf{TOSihN9w zkoE+(?UJ44=&E$_?Oz~!S3QVS8Dh+hA{t|ZQ0RSZJTWo^npg$L^B#t42rV4ro{VCm zrAhMe8mJuW=_{1svp99>r!FcV7z9^>AysqlYS|S!+KsobmW5GjI7>Fg;kAbvL912o z{KWyoFLBQdzs_!Nwl6Sy<=EJ#6WsyKz4RvO)?lFqg6^Ml1cgs7k!Egov&y^W<29U` zNZ!&RqCgX!SdSQA>*OC2V|{RVKRgY@$u=&26uKn8sxC`#p=KLe{bJ66&`DbmXUb4m zig{hX>s}D%hMCsBnAo0g#cZ=kKSZlIhfE9T5k^HNtV>Z}v*Io8I|oij0_0EV%M(m~ zOz{b$fKX7$THi~4eV!(Kn~;A+by1w^)*?9RqKvFbAKMcUP!5ZqCJ~lV%K!g=CX9RIhv5&p)Z)YZlKDRAt4miiR_$2JPuAE|4F5Fv3ZHS zsHuClZLgFPu~XSy>t9Fj$`O@X%0|XxU+V-dg2a4BAEV=o0FOIl$a?^mt=RQ(-Yx z?T5Qu9=#-Z{FR3?J`?N*Ei)arGObv>T-S~q5)`ghf@BxFUtT^arp)(3fX>2~axMbeNzoqyG!%7j7QiJY09ZxT zg8dRrboj+VBN9b$o9*~uF5{(!b!$pa44w#{qJr|0E=Ub0&4qjA)L#63l9E|-RnC%- zM;s+~ELcyrOi1%ADGy1v1`|hbos%7`h%N82dO_1S=x4fJv2UfeA?2Cj#O7Uk$M0$; z31+^j2)jVenr>a_g+#Q;?js<-KC?PMyL#!@k2V_B?7Ff6(LhTHjl6`VXDoaURuEH5 zCkG*Gx^X-#?jBWJx~X_dF`;ncLOwex2Ey)cr5L_AtV$~t~u#rDL#T{-52cy`ZT>G46{+a;s+%eTdsN%*#4xM z6piOFK?&2N{{HgM(J@vK>tV7kw(C6)tNGF9}S}~WfdqR!DY#Ag^uTp7yjDpq5_uQROBM;>uI}Egq z<^>(uVXRxy3fu)FFp(Ot#>Kh25ph}6ei!wFu^h}QQZw8AMd|dtuuE{-Jn9{np5M8($vs7*`y^H>Tz615yQ!_+QMekuwXVKuCJnB$rUZiXiz(~%riG1tc*D*! zQDWUr)kpc;A9U|slM!m#^<^<5{R!7+$=82G|Jt`!(DRnJ0js#8S=auz3;ymbyuyat zx>A2%Jm15#F%j<}A*_SsNvlm5v;75+-T~!eIQ|Zf_zx-<2_f7yNp4P(qHx~hiBeAH zF!8^z#5Y_QL*D!a;dr;VJ26otU&$UT5|))o!3ivuY~+d!pZq)HujxmEa>kCiAUt8?X0-k@O{%UFI^c`x<@}&EE^nId zdOT}s6wp2)K&`TUG2NWwN=|`^{R?CKxPGjEE@j7M%yu7CafTt-y5Ih|<|(kBH2kh7 zn2rIhfskl7Ex0pyU#S*bfX%}#wDP(Bk zV)C0wg1(ybKVA|HR1Sk8vychw$t$DlC@-?&8O{9`p6W}`v;*@UvbFTTLX zA?`9vTFkBa#JJgY+&FQ5@ucMyOiAbrfA2aK>J_B1fW4^{B@%)mQIhgX<>=LF%V9Vn z*phE_SR;bHG@yJ(K1_uX2^VVzkMjFZ9nitSEIG?@@SsWIM8pG>^Yb6uDp3 zwtvw*vI+a-Ck9WX81@bHN0G-Okn@{c zgPS{W8E1s{>8wi;xW-F7!QYDO0Vv@g7>2t{t87$Sj|~EL;%`OlRCJ}h^{0@UNH(p@ z+sx5PB3qt~?E5=w&+5;7fxi9crHO0ypR)3-+PpF2bIUdtq)K$6>iN=rTR*7RU@w%u zHH1*9xH?4B+-E`TIMgnn(~Wt=79W1H9YO$Q0w)0)rC(DqtQO&~f>%;cX51C1!+eK814jm-^0EGhl@507=f3qLeK z*FA3#{ic0RC=0{yn>&ZXX;sAbW^Cw7hCC_rcVPw4yueLw{_ZINtT~UM-TI>wm%nsM z&LbyKe#Y4y)pczRx1IPog_;HX^IpTh*_8udViSw&yt|_xS!gNHGNlqT<{EY>E1JXan;8WeU*mU9Ab3EGn7)x*Q7Awl` zi!ZIh{V?5zyO?^$H?M%#sMv2_8Ohzk1D6*SlV56#K%phyF_G`s;k}Ho{Fc@HtCy9{ z22~NEEw{8jN<6bz_4u?@)X$@ulK}!5@ZmT0d+O1uJV-mxjC%MAMslAyS5Ax z&~jpiQotZxA@wArA)vgU4HX|l0h(U;_G2$5OliL~RkYgB36CzM!f zI9oOtk_+%h=%+Zkz{PyH!VB{!LqTy%f*`(6y!QtNm)!)*1wc|xm>gY;1cml&bO{Y3 z$yVd35qmI^LkJiyVx{usa2gA0$SG8+{M!h27E}rwavsFgAHm;=4Lyc`PKVEj?cVQ> zZ;ox@Az5wO!^{wND&Y#1))%r)__&=`Kh10f(2aNJsIS|!jlOj`D@|_}dEmpaaGvqc zyilbWR^LmHNYq$psP29YbvRkjcYVOTmUwDe-j^o1ZKsVhNz5(5tP%in&mYQv8j;)X z**e>A@i&U8e0&n+dnEvN#lWnSSc?KipIYD}%lpp@k$d?M$3s^(D+~U7W6m10Di0Vq z+S>D^RG+pDD)w5~1M>mB#%+`2^`!}a>&3#z;q27dAmV+QapT`Ympi082E|3)HxU$G z^@?O`07zV>{Y+?Hbqp*u)}N+H7c?UsT%=h^Ezsp2mt?iU?=7dEyS!--JsscXLKK$6 zOnyB?t{d=hzv-jjqG(VvV3nZD)rF-Qp3@$%QAmHPht{b)rQY%~yRc`QHQRR)0gB=6 zN~bxUWIDUF=cPgc`K^;yT09t-hOttRFYY#7$mH{_aZ5BGpMh{osD@&Av&&78!Q+^6 z5!-II0wf3An+CqiZe810zw`A&9YLl`w?YlINX-}mh0f;s*$(7YjB;9+OkQ}N@C@14 zk}q9XZF!R?DlfbpL;X5Zn7}tM4;<#)q?-l%=3HTIwiijVi-5Qo%o?g5&E80(g`$f? zgYx-Sd&z{}{5=b)rQYyw&4jSFvor)vZOu@e0M$>UIg~uvbXa6kJz@DvuOO!zgD$6i zS4r-(x2;nugq>Jrfs5Y@nn!a&$6qgLtNaU10=eV-9}{1q$!2|~adb3ysOZi2tt0;> z{$f7a+8C4TJ-SwYywa&9llG@k7cw}_P)`D2v{poMr)Rtpcr%9`;8ce_X9U7ZE;;=H z`@<1F{pquC0gl^VOCE6;Bv-|R5mP-93B6yCx~fa_&(u5gS>Y0dx=;>i3E@g`YhduGHfr*3*(>fW$n!cy2jM5PHq>JiFI@y~SL z&HSm%84Mf3Gggw(y#86QG-oPj!%3$gFSV7tL;kf?9v=1DcffR7dOg_zVbEG_?NZ zF$pA~8@oPt zd3}I%`ZcKzv8vC&Xmv20H5`|YYaFVbr0WoE=}y85{b*x*Q3G#PuHPF~R0fjqo2D(W zv|0+k`K)wbBq`EZ|F(qeoNkQr57k``Qc2&(IWg+mkNSmgv(lHE&F9f`Ot&V}no!g8 zfm&T^qA&VaZMXbh+>y`{FEqSoTL7?9K)|x=_ z&DLwEK`^@!Ih*%R(D&Te=xr^NE#(q6x9Oi%_O6@Y(NOpEem7lugvHJspI*2$Gm1>M z+3KWlFda;eaDtzt!STk^XWg&JCg&ZvZS?}n34$|*m=CW@%DiCl28GM@AU-Wks-}6# zHv3IK&7{fi+?dRQx2Md@o*;Pr#i7Y|PwV1MwSQsr(T=qz{FP?_6{t9-RoxhNnjzv_+sXr-v!+|lMgWx?Vwew5)hM54vEUMe$2Q4Nt{uR*tdKc;^#dK1oVwaw9oiQnW8II~Yson?B;7DaAsQ&CBh7sh zUwqiFvl05=-HiATX*QZ)n;R+h1^gMDXn?ZUNds4kRbj(5?n)*%8kYi$xW4?>pXf}G zjWxPHN^DZT1x+pQfs-#7|5NS0C#5Y1eg)WKO)O4>2zs+754nNDu5* zoGAlhOUSn2zy`tNj>6NX-@w!eJ3(%qqP7Jb!FHhwdu#W|17F34`3?J>mib>zBj6vq z8!zkjh5E(B=kVplFV)+*+mYT=J}`br)wp|pY$E&9I^KJ6*yM6eouI5FqOCrYj63tL zuXH|>L6&7c&%orUeJThz_x473`**Kb3-dwEh>4A97{Q4 z;1j03_WrmRCW=8C;iPg3YT-#Qs&mZ$kv_!#9tZ6=oTTo_CIqC_y001jTk)zv=9a?$ znDpC@mmKKmYjT9gfqc|I=y-?^&PWT?0xO-ixuP)X8W%WmQ8-O!fmtcYRsX7imz7v~ z&n^D24=@Aw1bv0RSu~|v_>YiM!w0+8Rf|KYI>d9&=P{4%w5&|^#V-MjWMEnD1!n6T zHL8@a54G^EBMMOd`E3DdTFOj+L?bQ+w(b@*yUhGghY}FNy(Q`$Nkz9Hk<-1J{+o;E z5+fVe>k<{iPoqQTv;K&k%w*`F>NEA(H$}-BFL7y&Rf!)y^eP~^*T6;*W@`aS&KwUy z=ic<;w=#sO9#~ep>|3Iax%i@nw14JG1bO*+D+dJsk9>)5t$UcNq8ED98IFFgv9@(b z^Iq)1zl`l)p)98xTrji?*ADP&czGzQ2LLmB z%pi1wJid;aj=8nqke(l=-If!-+^DD>{NCUI$VLp4}Bc<&R_WP$*nav@8d!mEM~V`grb<{+XI;ST}4NUVAFVX6%DJ59}QSD z&wx2frN>?EAkrILg;Y<)w|L-vgaBZtdOyyN9pNBmA&m%3=VtR0Nc}gVi!mU%q+)v#DCR5uGH=6uFJ# zS)bP@htu`PhJWilVT=pv063$g$3dEH5HPNaBTB98=3uYLgm6<@{!plya3GhT%Ghzy z4;|9n;M%Ki=p>Qptw}n~I*131uU-8KCo+^1|NRJzAVsuD#@q!9~tZE@pZ0t@H&- zIH5kndug}uT5)_|qzvZ9djwU5hM}%#`%(1(n=@o4pn2gMH>P_oh$P;bXV z*{ZyMnuq$GL(NE`+9uHt(1(L}NU4bT{UrB4WeK# zA5iNs>untHme7-bf~pS|={=?botDl@pI?6lc4R~JheYf;_q+--vgyu2Z**C$EV0o6 zo4QMVHv%Kgz@Nfwb7B?m6ib0S_c{>F5F9@FL3hjd4HEN#>r%mWxf41(4S;e^wJEQo zPr*?eoRC#BX}+iYBtnb&oDgk{ptXNxujKS=(0R5i-cIx6fXBUr3nt#v_52=E{YuNZtHC}Dkg|$lpw@+h*!$;UKGTN{gtLa z-A{o>7f;Gd4sfIdcl9zs7-%fQ?~T@xsjpT?WYiFjtW~!bJ&)r_3DPt>arX66C$YYG z(~WuTPhkbqZphRyD1ZyUv14TT8w541YkkeySIjR+BJReyS zK`;)w3vAJ6{qp#~jo#{Qwj1ytgaYMq3CvHvrI+cmrtH@WRBvfaGTkO`EJw zXp$|TN@5TYxzMK3>4a2FO5IQ{ShhM*P+{rqgxh>;s*RDFaH}MIO8&LwSa+d?S$Sru z`fV_&LIUo`NJE=l*Hcvori{|kyS2@gj{&8Da?YZl9XmQvMcGHr1kLu_Ap)zd0g&C_ ziZ+%#<0cmU_K8v%P122L{Me!_wGF0cht;@zF8fp{PpG#yb95k=^hWkp9W+y4j|Bt< z_xEpJ#Iq48a_JnW1tJ6)azO*W(?$i0foTbJ*^w2g1h-HlZ;*C2MrOfIb>MhE<-2&J zi6kqXn>qnmejw>qy3;h&G)?pV<#jw9_<}SI+?1BLHNpt6{10WHK`Fuq7vu@{&Ln7h zt0KZN?_!s=)U|UF?t~pP&dsvZt&O?Ox^B047vZh0BqSl8a8K~#eA+J6$&Kv;d&2xg z9}><>W1r!GGxSqB6S3vLOSl&|Xd`M)i%W1O5I!<`F|=lq<$ zO6?v7ah-J6){UilR* z7nZ1PpO?MyEZ0b1WIGiTHi)>aDiXiu|M0n@&8yxKAiYf@y!~-W`THBxt(niDW7-3` zN5ti}Jd#OWy;#xpb0a0&0*(q>DjMy%Z)s6Gd|%x_K0>=(zT;b3v+5t3A~bgZ!Noj? zyuCo#P(%5=Rm6Kv`8AR6T4WGbCJfPvmaOtjoKIr-El#<7m%0%i+k`=EKRI##2*Pxf zvM^4y3eh-M-!5`4C&x^SW{Ou|KW_E)R^Ms;g>?(>5dxJ- zw-V#{GMlmJEMB4F=3ugYr%5nVuqed9zQtQ*-oxKWi{EH`pfTA=ZCF2dtLN&^=Gd8G z>u`)xGgl8`>j$Qp5kN&ybJPymtHcl0c9IB1Ih0+WV==e4ZgW&TZkA1<2}Bed&{)Mx ztOY?LFig7c)iOeqP-vx*w!woeto_e#4AO6=s&Eay$7{YS-o6|wA?w^U{qh=%G8McC z8J~uhi05A|{uNUcJ9#PJV4q#O%2RQvsnF{dz$*E0pXy-Ta80&$4SI^|_DJBqlvQtu%%C3>Al%s_*%WNN!V?d%v$TX9hezF}%{!fkKVp_n z8ARh8M>p9!*3 z?Sg5(#9^i*-X zH86V9?R7rjSJ?1`HXow7Ipkje*&w>w7t@|?cAf1zt~R&DZDQO^OQ;m)kHR+h5iJB>ewwJrnZYP@iox1WRIagNlC4Yk*@uzv3c0IWp`0Tw1V{xYo z)QZP`jUKNh5-(pzd#bx`OKXez?+35!oB89rS9w^^Wd4etJR453*KGiH+XeTdr{GUn zZrpZKl~&X{@6+(G8`zoak7c|*Z^)+d9XQle%8MPqCcC)Q`_{;Oi&NQX&-|`(9GbI) z+dwJr2sp}eUkjY~GOy3!aiiak6|&1Ksk}^JHmkMn zD|hiH*&`COW28kq9Q`5q2-~(?P8o`j-Cgq%*xpvUuccE=gNo~jD>mx%vFO_z!Y8v( zYvw-_MWRFCX7PiQpFDZ{R* zxNA1b?tnASsKEJgU#4nlsmNuG4*Wd+xk0l1sijzPS<=Pti6FhQ#(XY_&=dLqSbCm+ zyAAxy)A%y`@8e^oWPxjKk%zot%)v9B6!-7Arg@5d=RYyIgx+mG=fH8B?r&m@wUL_rC9c|h zTW|hFRrajvZ<&qck1P)}-r<^8VI!m8PfOelg`*r8!f_Y?6j-tKr%?NtUIGaE{tjtr zh7EWBd26Ty^dYTivG2Mtyz!N~6^}bMgngsUsa{V%SPWI?T7>zEqLhtm{J59H08F zVzf$qc-UIAWyqZOL>BdX)WG9-h<={p_$1G{Og5)W)h!oo1abpeC#Bz)T0F|RgDtmH z$CqZC6(1WcjuRGG6l$yvDxh4m+gS>~*<;7PtPXAuOr;D)X2iO~NoNSLp>0`;f2PG) zc`LAy?~jePzCV@3liSh)F_>ox&^nn``k1nYW`CC3E@Cy({z5)bq_ohtMJ^CQhBGZ2 z{EUwAUAj{u`{I%Kj&|#;v2lIg$%VVHn;Fo%AJdT4O;Lh6kYP{;$Kkp1AeFR*mL^DJ zV}IW_sVgBR?{Ahfu3ac9fs3Tt!s{3OgcY`A>_zgEu=S52!JtUTkJ99ZDoEfikR` zxgy1Pjnvd|Y3;;+u&ye%v$yC6MvgVpq)AF)l`#hMnt$`p_%(o|uzFxMatM3?8&QW? zDyWZ#!?2s>+)kh{-U`o9-|V(L*k`~^Tpw;30A~o8vPwg$cuYMQ6nHVYYB z-6i&FuTCHw?!q=1VoV%BQajL(B$=0K&>Lr|4loqUQ7ZnU%KKIyV47>!!TB^78a&}; zUgM?MR-b|16s64bt-j6BUoj-FnQx}@aX;kx^QRV78wTpf@AlFT%_fi=aOz6ym_Dg} z`!D-r<*`dz38hfnad0yF9wbEpjFIy+Biz$YxRb*7X|Z7SjSKYG~1bBea6v@8&g~~k;ciMD}~Sb!hg0jjI4GAa+!YfiI(H1 z&|@15xI5ILeegnW@1b!wbR^adQw~x1m6mue*R0WpSdNw0EPPlVvTw~3c*_k2@3H?v zNADi|kSJ^&aEy^SpPl3EQ8zo%v+g7)c($lr(uH zug;I=DlhoDebNHe$!&ia-xU+H4{Z8<_h4edPNChuOtMX77@qwi1oy$5&-m!tq|z~T z=vwt}7UlbP_qUBxKtK=Oat?D?Hi4f-$QrCs9@b_X7T5~nF*%Td+r0KbkA0If2^lR# ztQ&nQ@sV;2o5!+8g45w;G*Y7-ZgGBoGLARP!C@SB$<<3s0jrrf4OD~FEG^x}x8<(X zYGwfP7~k>?Mxh9tfML@(t>I}2v)f|=t1Z3$cAeK&{@d;S^Y^LM0VhAEGillV?s|2EQsxMW(og{@aAyTWA>a~4NRg89e#dLMpPpl1x@kr2I zMDI<3#c=ak%!`4>NRb|zoc@R^e{^H~VniGJMya%z+7Yq?#`e;=nI5LR))5)#8e~R% zmsb$C@l*0LYV$s>18}nCLyJHUfQ`@zHsWRpzJJxLy34&40<*FtQt#vYzL!~!> zM5v8U*SMNzyj^V0cvguiB@tWbSGq@wSxUPP>=l)#g7|GMyho$B}7XQ>N=UE zUap?~7(2H6-hb)b+p^gFKH|{Vf&0SYhg|=sKpl^$YX=8F#CZmC0(sIVQ+3xnHOZQ&(X2*l)-cuMx zN?XFB*{7;Rebu{s18HLzBJtmJueHMUQQg0`7j2hFE0i@7<<`t8jZV; z{eqZOhKAb5Xg=l$c&?(`oVx}wW#AEc%8_6?N6Q9-R9*4qA6whyd%=FvYeN1)d_y)o zF=)?LE@AJ7&jS@^{Ll#`^f|qlAdiX>@Dn959^v>btiumVK5q9g{F0e$4A%3j)`(lD z%Pd2?(=c-?Cg!3#_FM=QNF87aWv30r370YILfn}{U`u&FV60zpc%o=CcpYiO26})9 z>NdunGeAgR2{Z^XaZPtfK6cvM^o~x4Jxxv$`G-?XH{~e*xeNAA?79}Jekpma3KHF zbS~(^4F2-kUa>SZVhGPCYrM=0jO$*q-y=RnO0E{82Z&g~D_WnTrziIR_E*GO>gemH z=~P`HeX$p_=&3pzR-{_mL>HAYlQM9-rMji{4tKaEJ4n0$J(jkAKO$@4L_-YV&UeFZ zlw6RLU2dk1-(KpDy9f+RmhZ3;uf^|p52&!_Hcpnef5>&N6lY0Bm(9v?{KA6hqj(W9)LQni zZ~-mW7FnV1rGFiyT&~Sl-jHbS=-eYUG}l0GOS}<`B398cdLr|xO3%7Gn^6d$9}bN3 zllZ>n85Hr|FjV?=ZKoUnEpHos-kKJFBlQ%I((78t_D(C9mO6bVjsl&s;ykT@;?}!9 zxP}BKpJVj_eKv6tw82|dO;{v#t(Z4Hq!_|+YJA|)glW|ST-znS5rgbW2!mW~ht6SN zOmj@Ct%FFX%Sl2HE=6csrZ`MvlPYkPH1@sgxd%1T$og- zp3Oz1k1T??waw=LxY$}oEfHodR{*U4IWB70kN&PN7-C0^AV>XVWYyf*&Vr~bnmf@-ws4-O6y z6UG8RU44J;VTM^iP@d}Bj^!V&JH>PKhl>I11r6f|XHTL9y~v7GLL04OfEu^8WQD%d z?MO<*;Q3Ml<)_>oAe@~jl8}sd$uEN`ex?lsEADbtMt_3dGJgF9FY&IB>Q`$=8C(#j6N3KCezsuL>Fu0#KD3daqGbVL*+ASqMs zBsRFs<+Dn7R%iQJx#vY+3l~Y=);ZBSohz^gGv0*5%F({T;=A z3ey@K9+6%-%dcQ?>Y*40*xHl8B!e2E>)k*#`|3}mTLj~I0@W!n6$-giM1hF&vfLS& z%V~#(i+BUEe#rcN-=?GiCB@u?+0_)Es)Gy{B@_&PfEe-TbVy%%=V@$%RYs$~8RV8S z>?(v6pRV@Gm~CL&w=&77%RZ%zJ?!bQ{iZ#Brfc+3VBgXgBkj`ET|!)LwenuuD*KAv z^Lfya$D8VFQZOi?P8ZoO`-m$RY1ZL1R(Uk!D{SwsM3;lJvw7#_gKg5hW9=nao3NTo z#d}K+l$xhyP=~}96cN7!x3uCM3Jq5k)>}w4^ zD;_9Z_pF{VzK=dN6mz5+P3p_vqU@E9_vyBH-!Z}5_3nNrg7+gx+vUGZBP?a{VSN^& zkEn3n^nWOpY~?oO5(`~Mxj{-^kJ`7rcdv*WLsm`XTyMXO8>#L3l6J}k2!qj)*k?qR zkn9sD*+U0=YmTh+CT8$Xr?5%!`@F!@Ci;oY_iZs~ct;xB6mpB+f{(XnOzz?9Eq|KV zUeE0*CTpJBBdwb7nj4TPS15C43z z1_tdN1Kn3YFCnpPW)b1F4x3z{BU9Qbu4Q$$Zs-%M0S^?8NF1AF>bj6shyGP^01D)p z{19iZX+BGUK`#mBDG=C}tt>e!qK~%yf$@RjE;@AOgu#aZ&_Yj+U9IegNIMvHb)k<% zln~Pz&W1NLOinqm^C{_DI59&x;0P(76X} zX+z@HTxoEaXqcd^$Q0LCy%WX1(eX81R4k6=F%0!2Ph-q#DjQ_yAYJ}tbwp*ErXW}A zlDEJ)?8kQ$n@cz6ox?<8$}FovD7V{6Hq5WA>8*m{f7@AGZNFbP4&01*y+?l4a2yol z9}zQLDfYF-FP={khKw(5bE-7W<(~(%aVb^=kUv{|I;fzXn&(!eBvrM~d~g0Cn3!@B zt0|LJTXIhgMT9mY+L{23ZVEU&vc8+gy&L8fLK-Qs#_zx5HQ!jmly5F3uuHyLGQD_) z%S9B6Sw%qdBT}8$s(M?b-aJwMrp4Tr93?QQ-rxBCrRi7#Nn9D5iP)#Du0t?J?jS zbKb;)F)GZd&hoavKh~xHojIVz8IyI)Qq7oLc-%HBzSHHZy=I6?FFbDKv_ zL3?+tQcakp;hf#b7+TE*^g59;ut1!~%i>ufVt}dd7tQ$JIXMx*G)A0{>X&6L4^#Lf z%r`~UXq{*^-|JMBaAx5stPZ2JBbgT@oHxR_WASH{( zt}<}Hduz;sA!bcRod+f$4_MV=!#yB2Ub;*ORTm|MGmqqiHV%2HD_^3?)E0$11uCZw zANFq2;~g8R!#n_wur>Dmx?|B^!GAJLz9(aOxWhH@2^_F8##gw#qm8RdrOW>apkh(_ z5jU}OnAG_dYuQ%J2stt;Bfbbre}@=T?p(&3zdb?H{C3A36>c~07IH-GoFjO6UH&>3 zRYGfGioND9U5a&6-xQL828j-?RONh7<7LG)s?{sS{8*=+y|Hi5Zeq}ARHgS%yM>Le z+0OaxQC&rrErTX0ShEoSA77^8Fg#H0!rqZs-bJ>NB(xD~eT@J_9FjtL;BV?HbKsGF z(De(Gm74O$ynlUWszU9UldDoyKWE(Jrfk5~v&3`{MAC6}YO533B8c27tmJ-ozGo@P zTaTPYnXNP+O$YO#x#*Bg0e?$lj%-*HOunHbiB9k9z7KvD$h2XbrGb-yWhuUO zb7Ga)1i0`BO=h_UbB3S}#3E`GUla;-St(bB$^(sg8Ldnb@Jj=TACnI+UAhFcHWBgiej(K_b zxCv`_AFELRj{00!FBSHQK@8{@XD}mp_{*LN7uk`L$00~KU}R!>8n+YDeQl} z^WuR>72m-)>m&vKQ}S5rbo@civIz25-wOE#^+@+Q;uL6+aIz3xn?x}0qFMMccF+3T z7sZuh8Y-qyJv89WL`xXvKRI4Mff8NPq(|K>W9{AfWSUM zDzYrTc~sA@Mo;Ow*i7CLhEFBP2jT4&5Ag+eEM^mq*qd6jd9iQ0?kvEz^RsDLHJ9q1 z#29TNSOn8PGnymy*IsyqqAdKNgGBcN8Gh^#!6qobo5IdE;i-Q}W%5YJ6gCkbhJ+eyk1&P?w=br^k_Vt`FjcTO>6) zU=|^@4#e$FJiquI;OV#~X7?pHTAFlN{6m;+JGbOpw|kJmK+1;z=d6O$L0 z#y1vNy7rmwnwOjsoSxYwd}_%#lH(L)Hi|@HfB(>i*#hEgzt?B}Z#5C`yOzvAaTD$L zm!odi;~W;?As&$L>U9LL$0Z!Uv;k|~M1!1a;^?jZPoS}j730j6$zDVIy(tMvqp5b} z*M-Zs>l=0FC&l_o|Id05P|foyzgcE6?p88s7+Rh1Q7yxS(inE1up zF^fU|Rw=<|EO960?L&U~74Py)R+*UPh0Uel`~2xpWA^s>GR$#dNdd-He;SY+ZI+xA zDTfX*^y^**sw=tkeTCjOAvz)9fulWX-A&RV#W`T1NTf8wp4F^b^y9VxI=rmP_N61z z0-C=bx4oC@35?M&z#vQh`>==N?;|FZQrCqpOh=YcS)+sb2nXmOh*L)33wQk0&g~!k zd0NwLGFzzHVkO!&$lq3*oi^0+OX5?MIPE+etKAISRP>=mfzA}xKb*?9)xKQq2jKyg z74@A1IuM(rvCTxFHWb)Y_L}UmNCzJ6t>W5)#qV5y=0`3K^+XLHa7E$aF-GT6Qm2vi`NdOO4{IzX zVRp~Xp+d35cY3^1x1d&nGicZgUb&VX>azIU!c>m_z0a4)-!e#g5bqfpd46m@d!&-a zup1JeBX^B@oM-p$MfVbJq?_}ce@q4*z9%3m_Y#>c#74$S$}!n_`=&(H5y{x^M6tOv z#lB1FXGuy1k{|)$s^7;puW}Du`!jgg0nWFf3sPHBAb5W;zVhHK*MA__^t}tS+Yy

      o}eSDKbh=R$=-F-AbA*zNp^W<_rf(IyCm~6=i~f86jeoyoiA#npTA9#-}>w$ ze97FeCY{qXl}%(gmQ|F7V>}O_z$~rt5b`8jf5nGinP^~(U<X@q$l03U-m)Ejt6z3%#reU1s_!t{@;bXbqn&>DyZN-1mAy$5Q z=8%9>)spe4GDCrc)Qt@n{Y`V!;{8uTpa?GvY%2|PL9srxJeAN4svS^FN43RBfsOhw z@75Fse~VZ2&W(TLNZ9ZNX@(vqK}TO&;Nd^6H$VkIUx1qBHFk@uzc-y{(?rvYkyhp+ z2d0|pXASdFeh%gFw;vS6ZCFO3VOuFILTWvzCD)(eA z8~58`Wec`loJ)B^^F~5nFwRQNeC3`7KDVEye3Z^Fl5Z-N;MU~0 zH3@oMaC!}I{-232Z4OAS8OEjOO6NydDvKZMKu=bb9~Yhslg2>s0rFTui0b!)fn+mZ zgR$Repu#HP1gpfzLL<`i7Vq7*Z5|@kM0GQC=^V>PaB@%bg5nCdki+cetk6f=2Q=6# zpN4&Vn+-1;qc5IkOS#`Wd1y0H0Y&v#>CrED>r_pmv0tvmX0=`)?e%X6`23`C@?&+3 zz8?l{$KNeY>nM~1JAn&aJP>m6^D1LaKhM3@&W{V4cGhC>uLsjCnpXBA)X+NJvX<#7 znlF)mp#ErR<2Mq|T!%;X`s55r$`%wwAkn3?M&J4bf^`?VJ?8llgGaD}#ZRm7rQdGQ z1{KdQwCHXsTCDy|_J9lbqtZtaF;=V{?XrlX6n+F`O9RwRl1fV>u5NjDig7LscXn#J zJk;(`flkwucv?84$;KydpcgLvrG5rjOPBH}hit=@xC0W}N$-l8vA<%5^~ljXRt`=P z_VFe+j?eG#UHkFFS`-*s=S1dB}>4mhmk`5xIP?=amJ>itzvGDzjfuUe1XVVHZxfy0;FXzoqPL z{%pLmqV<^7^J0pxJO+_>ws|*rpO>bum)Ic)k2&~9INZgGJF!Pak-{)N>)^qFAOFs2 zrF*|w+lUH}VV2d<3gNiVxPN(o355TK%pr}g4#h)rrcgu`Z{z(y$L(kDi4-e|V;{2_ z{5}8^7IYYzt08oLx#}JU{#aSCfsQ}j6nDCS{Y&2cr8s<}d3u)Y!M(61cuU9fKRhz6 zRAM%Z`@IhwIy&fG=Q*cNIHQUt9qZN`8(m(A9hWeC9_}rLl~aXz(6P`iSV2__Crv)z zB-ds*T2IAh4ygPI+m7*HHs6pdmV9OcKJ(KFAk5~PLHxv^zp!dITlVzD-c&|gnHp*x ziwcbo*40xZbU?%5Fg4ST|Kmz2TRTt6Am(c24UuI6&M7INscW=fCJgu&LEo28E}Fv# zu!FhC5MW@T_E2YkfsYCQ-l;{44AWupYn6sAo z7jojnn)fv9)3|EbFk@7G@DFUk5@gn1h1q z_1+X1jF$EPi*Lgh&%`90E1F;3nZCf)h`5^70k03b&>CAal*yVy}YyS;QYoW6e8KOE+ezWF=P7sn@Gca+l z8P6~Zu#Jt@De4J!$e_Lhw(?=p0_){bR|G3d8Ij9H(Cy-&kDIFe_jShUY{?B8DWHZ6 zUAIpsW^@=uTJmf&?Sf%5^SkncQj~NGyyFn3%cw8^uYRbSXB!r4Q+HMsc}4Je);1{N z{zcpwCvBAe%=;Blnsf#qZtNDysDlRUumfqlXr12laguFd;UmIjhOOEHns^$19Ktq! zMLo}l0*iuA{#r;DV!@zDGs!x=Z|2;mADDx)DlKeX6Xwb-PJU|z5kK=HofkxEc!~P) zLio3a{;?@X>5*2mV@~wykM+Q1cze0N`Is5@ zpBSOOWZz)C{LPeff}8-7ny(;jY3Sc@$k9~SE%z_+QS9qyk?Vrwo28STakp(m-hpAK zD=v}lT5M`x@Ik9{o0|^MQ=~+ibs4DU<7jLwCLe=PUK_(vQl*kP?5g!C+^y+7Ytj3~(zZoQA`0D}zOuwqJHs-3b%Y;J@3{P2ny zXJ?=5rX~}fZ$6Y@gKW8`%{!)j0H$50U?%B)kpJh5iebhq&2)Ckc_0q`=jix& zVUQUax3WyT$i?0o`OV-fd&Qh?jX(V}DMVuQ1{pqcXta)ECLdPkWi^%0fapJT!%7CcHa*2&GsWU9=2``=EmxQ-RMc4L{;I)4}Z>I zhT`^JFr&>&30~}4p?*-79!G(OMklD$JJt1Qf=}G@=1lecW>S z?=6Z69EALAfl`>@ICnwy*o)z!#ik!@w2qxDqz}slijSF+pL?&dh1)Xr)&Dy4D{&Gf zPuK;}r(5U|v(Tfi4rw8#y;NF}B!64(|9EnwXjXX)fomvnt#Q_ZLZ;}SyU(wPdh30Vd--Kq2)AQ;@=nImG+R7hxP>M9gVw|iVGfD z77DDi)l45M`at)!ZfwUpdg>yl7%SuCDzD)_7?s(L^D8rMxP7X8fS`5lo>x9kLW;$P zs*FE)4M&SlC1^(99ZjK)s!J=ZnO$vd!HDv3b5>Bpn-&K|)@@8z|h7~_zC_`MylsM{KP{3^)F#1aQ@N4&M;cB2quH6tD_d$MSo_IZXQKVIuRAqDqtfAi{ z@v2N5wU>t$73&fk_7Y88yb{~Oc_d4vNVjx$SM3uNrn68v+^lhZyl=>DUXQW;dtJBL z=*Ld*`{j@$VZG1sm(VEJpgxLem+f!fTx-08q$b04boKUA*TAD^h76*?P|=|7&zcT~ z49R1=r$K(4fEP$YAV1Eq zXzH}9#N!gk`~2R?0_B2~bd9atEveInIQTxMOiR0-6l)2C**HjN$pU~3*IcKnAmiH_kkGWVkU7s&x#!1e%;I7^v>k8&qMIKgO~TQ5(u%% zQ~5z3G0WhS|4EqMNe=0%zoYR=rQJCK$z`p8`YD`*_QDAFssOT z4)a>aC5i4{yC461U12GtN0RaGqcHTSa04|yz~}@Vxgls%e#F9{9hEDR=mz2Ptark(I&4`nON@SI8?Tafzhj{y&K>|K zg@w{k$8l%Tw>@`E|2!p*pF?_TtiJd(HZQa$%q2J@!)A9!Oa4T-&#c4oz9Yo*597(| z|Allf$$L~u{W%fu$3HzcutNQ9@ULapn!0^W4q08y#H~tt4AAi0uiF{V{b`@_BvBhB zS~TfHj?*K|e&s`uD2(&IanTBsVtQ6ThHjm3r~{T85qTpN4SEH?Jz%(PR#;)OER?R3 zpIuuxl~$)4nkFF5CWVIHpV`);Cq*=Hc`;D4g!G5+<|2+(FdaLE+m*r|jwEUa07i(e z$pG>gIxR19(jMI%~RH<>Q^eoWvP6=e1!b?AFCi$DlwAxz2+ z-Z492SgRQFG&!Dh56`>*eLKyX*Qdj5euYuyZFe$Q9gbk@6}HlQeHyP}p5>ilhzs-a z&iBNu+{=FC?8baQpRpZTET*0 zecWAWvNwj=Q_)d+vrhp_F0 zy)zy8E6=!+LPecwdw5LW>cUNB$Nb*vutIzJ+gFyyycg3v_ptr@G%dvBmJI#~F13^iS&M7bxU?8JaJtU0px2g}72rTK$^ z;3FeSn`TofEy*W~81KyeZLU6|zjN!P7`Yw2gYquw}xLya@o70vyD=LdGwy*Hu3brYEw%uFj zm5%lfk|}3qPaFK-;n=CzzvVfge81&kHwH3%`WcLfO>TBL%hkQ%v8h%SI%ifr?4#0A z*|ejrb%Rv58niKeK&`z58BQi3Zt5Vde7%46>l(cR9?Pnix3pFAgI_!jh1kB12yik1xpe9m*^ zht|AZPxJVvLQ$>u?WG&izW2V10w@A2Q2thH^&F%0b@Xj)!qg6h&2bEsMv{y=6z9a70AwP+fIu=p^^li7OI6)`D{UA)LnLpIOx(>P5!aIQw3@C9LxiIgwkJ-! zUw!ziJeIxkE2PTNYwhBO&ObywEgvRUKgp_@`42J^@Y|>D8LX#_iIT7s$L2!}kn8d{ zXI)1EUMtt{lD2g2Da;RW+lD$F=Q{GOSm*u3`+hR`lpuEVyF(D}nS8dTuq@!ueT-1&TiPkf&Qcq0irD~gwGTd8Cx?Rh68OBZq*Yf2k_MFAji!uh&PinrPk zxzSX3LsC?Vm04YK2pd_PIBrUoth$y>UI(uF*rTK>V(dje2;|1{oqVZPPKZBYoZH@V zF6efT1+!7472JNt4{7Didg{Ui?3w0b)3b2erig=QUt6Ap-}>3EVXrA8ATPevW7fT& zdrTa-KGI>(qtrsG_wsY<9zl@>TK*PhKP9IcHmI$vwVQyvP~C)?e68FFQ}<#5#A<-fY+|N%LvsRR6WUWC>5ah1p+sKsIRjK-Wp67n8<|h6QVsjs$rb z%|>0Mg^U?G+0izh^Chp_fACQC@GyPiy2K9`m_c`EOx9oI7pkos-1uKDKQI2S8+67{ z7jP(#$8S(-`d%CN6=?TaShcS@r!+3Me!z-)^63s@|8bn09Tz3j4(r5AZJ%%!YG_QK zp-bG@7TQoKO>;9kFwJHx(Di*`JxwAz;%C|^ciAo9!c2~{?_5vgHHBN7l<#OV`84OV z?=chwF0*4^Dq5au))umiio=DUfip=tv7GmSm#=7PY8RB_-nUyXe>XkjyOxs2m0mM2 zj#oeKr2lFL4gK!sc#5u`O1$qLgjiF9L!Au5aS1mVe{*M)*+UMv|=7i8HvUXIpyt_sSOKTSN$Ra zT}mQYCtRvVJ`gYel*}{YKPacV0rgvva)gjebfvG4Z-HP`n!51+SJ#<`HGQRf+!mEq zMpI=dC|mnDHMLZcB4B`!idL^3OSCE=TNJ7h10qBSkPQXv#&SET>#w4tX1xW}o36PEKH#(iCbLZZE|2gOP*LlwNJKOty-c)chnb)zqh2U>UgreFB zblsPO2=_xOTQt`k`biN@upiQE-<$FL^t9x@B#%Y~KP~R!>YkJQ#UG?bw60^a9yoGd zId1cgz*d?9%&Zv?+k<(94p8eYT2KAQi;~k46XcNo>QU2{V=++da(@(&mE77ett|77g#q{%`T#`@W(1L~JQ~ zF(C60n%q}9wQ8dbOkqN-+yU@JZg!sUg0MFeqggIl_xcG3@_8A@YW*?mj%Jv-pM9Q4 z+fguev5|Y@c-bgZay+%@T4AN4#6`mTTDBq3w)X>EP|~^6!yT;?(OkD^PsN8VRE8xw zrWH45i>@f9|AvuK5b@}^;s=6=n%!`jiW>+#ABF@G=}(Ix`6J`EaI@v5v?8h38@voq ziYCytU$faoBQd^3{_=cvrr}uwBEA9XPe0k&31q-)3{JW%Gto6NTjUuh@bN8p7u&R9v$ z_R@%nQDW5UV=@Gp{fdFG3^sui6}tf7)vX)3MINTw&Hf4p*3L=lwgrs+2Ml7hwRj(9 z(xLWIzf2=?OV0 zl8G~Pdc5cvWk}ykjJ=Q__%(cFk+QGKac_xcF=gY(cQ2)!3;F(sI9n@h6t?kP!NJa+ zh%*5&LCz)Z@$S8y)A9pikDM52JWzgJfB%5%TzI#SCViu38TT^W=E{9lY6b)^KiYf`o0Fj8;YuGsPG(JF#RL9Ky%O?hojv!OaVd`0?J?w zPrQfXi^Q^!YDRHl1*qIXM6gHZd6-GJ|Bh@sERTi|=4}p2kZNz2+^UdZ?}m-rfQFCY z?)BOSBJr<1{%3+KwL1;`!&S&}g@f6Dst?nmuc?h#yA%+RfZxMqx%Jvh0pa6!Xq%H) zkEpr`Y&ar!U&8PN2x~JqT`1+&!oO&vh;ziLc_SKluza1Xrrxiz_ykexd1RCEf!6u zFSN|&942pM*wBDGB0yuwe!p1A!h4jHMJhVWm!_Tu{x=JHDGAeVD}W+Bs9V{d}wjiq!yk7hv&p zgnF|o$Z)RElVSY(i9I(0tsf@yZ!>HVlCe-|0c*jlX)xC_e&lDso<~{-mq==B2gsgp z$vI1BVXw6opu)ae_r|Up(y+JF!b@M9q}f>^Z0q$`{WV!kl!6lcG%n+35m_fsxS=9pN7PZZBd;Lf<^ zzx*I;+y1KdF~_k_51qf$stw?5i5?TtXb-)R8~fO>&o2}84prZxuk#Z|_U(u0J{7OS zEZ$(~y8WtkfYN8WPxk}{6ycD;nuuTPnQV=d(4ns#l_<)AVI}3MBb&89d%qv+%B3y9 zhy^SkWtY+P1<9~TC-5(sN0ix53L$X*zB8V-D}Yvw{t#tNM*ZH1MDQU~k2k#V1%@?v zsxrxXx!6U7{T4C2%I9SSau!RWo~$^VPndZtZ+isT-~RiT!>F}KVX9k*Lwz1^?+yX` z!j`s&i*A=1H<$)H#xRBkB)$J4s!}!hi{tF{VOdzqRli69teYJiE1Sx+aSC}U-4ybL zkOj>f!d26P%Vu-TiD;i+UfJOQ_U7}ueDD&(^KggJ0FM|~--M3gePbeIVCp%q=#3Xl z>a6nakJ@8mu6&m)&=-|ivxb|fI?beX!|4KM71hOX!#gO@vQ18C!e%_|0f@ZvA zvc>={OBLsx01q%4U4g@3bhGtiFB|DbLut+`uu(DRUZ!*<;zJV{*Oo`!NIexccHTBM zSU5q4mS^X^YJ5x4-Yef4&4LncOT$%l^<% z->wf3dv8-aXHQ%_Nj2vnzWc#=Zr#2ViqqV>s#@fe0dKL*rJEDE5HjpLHZtx8J1gr= z9ZLR=6XmHHCGhrR<MJf62}$NG$r5{b>_TIJs3r{Mo&n1U^~hZH(Aa@aaHb)MyXz zybX0DE)5wckzJUYP`4M5o5@M7>x_;>FR=$%+dhF|K#vj8zX<+$Vy=I8ICQ!M%=2!ecbL*-p5NT@nOC11hviElb2;PPu+Wuf%Glvu z47xvqF(T)6Bp{Ev?oC1XZMvB_ec#R+>Jt)HB<;Xs;A;f9mdT5n;U+j6cGkQsVJ(BK2ibSvG zNg+mO4N6ZH`jZ!N&JiFg9SaA%7G3r#4pw4^Ybz{qWrMcAe?`K zdv3nV&wNVKkXI7A8=>HN??IBJ-A6Z8xj?yiffxb<*%+Bx^}S$-gVBH)RgQ%EBrDFLDQ6hw>Ub^S2uNxrt$BI^};LCZZDIi3U6u%y-O>dlWV=jiX!)9$c;)C?g?e@jnnFg2A~Z zuo7ZA9cIy%DzBCNF4&!S=cNr)$ESdmspk2TnZ$0xmL}!SjJc5;F(|)^T1FeuF&a=n zYqaKddl2``<;zXCo5_KPzEPy{b={edinw40BO7{TuroI3YMLw##D8*b8PFE^^_c1%@2>BDXN_3dQi6!2?L@p zR6US-IM6jG6Cx1eQCvTR)l4_;KMQYw?l|;2J@}_mJ$wCwulBG`pVznzniecg6-&!k zJtrjYP|k1jTOq0_de6UPit53;VD*WWmzqhCqg!ECAXSDkwH&JA8`|wZ5qqT)FH;3v z&lif>H}{rDB09}k>wOPn%ZTx3+pz0alF&X@sWpIvC7d(bd?-aLC5?v5=irs#BpVtb zQg^CBfKy(;_oaK!y20it_h`DtxNh%6)6NY3>ZXPco-o^Vmt?-=N2nZlV@|o{2@-sz z!#_8=3slsn8Jr%;ijBgF$%bAs<;z+$k5f+>j}&$bD-MWA^j;w2kw(qKZqeQIz||>t zee9mLD3PLegLtc_+bJZl#ZUFRiIKf42A>9IKIO`i0WdlQ=OC~_lK&;;^|u28a<6-; z5%P7Me#G-6(ez6HH<5cZI6XptmY=x@gItM7MHw?!Qe1>S*3pazRi1HNt3O3f>k!6r zR@1^GaD@7hSjdC-NRX(Jww;q=519;Oz+7*1gK9H7N{%4F%hrjQs$~)zdFG&QP>*ru zThBH9FXe=dWr34StHM%QAnABRVvX)8gq5+U@amuYMoO0sdIyEEnE#zFTzF%&unmH#c z-D{D=i4~G!=F9v?aS=)~guj}E{~R4v8>8u(xUIEKWo^cz8lw3zAst=_WV?-KqpTl) z#vnoR!v}h@YC5PP8?Z0oji`A3_3ms`l7?a_wbY54IZP*UmSw@ivW@eqQ71wz`z~5{ ziIBvvlw$?V8_36V@M*`X3F6A!l*cbHBwZj==E^Pl)0xm2UhvEflMH0nEux&)bw)#rUPU zMq4;XMfNCz=jE#{HdkIu0x4DqxU4HwP8yu~yk36S&RC4aUFYNeal(26QaJ3;^b=I} z#L?d1@xr^95p~L&1wls91{K2^E#eIQp_JUW!_3=r<@HbcLQey;b_5kH zgs7ZdnEca>f6c=GNMo$J&;Gr_e^mXSIhM^ag%t0)3&RP0YArh1I|4P5f zvJ4S21A9#OmS5jD4d6`!)^hW?OvAXT-e`(`mGWCQ^FNyD_fJ!^3SeEbzGu&FTOs4R R_OG$&$TwjJ$)RVi{SQa=Eu;Vd diff --git a/transfemscience.org/assets/images/lyons-mcginty-1941-p4-stunted-mammary-dev.png b/transfemscience.org/assets/images/lyons-mcginty-1941-p4-stunted-mammary-dev.png new file mode 100644 index 0000000000000000000000000000000000000000..6f36736c71a5f897a33ea059d0ac06f1787b2ba1 GIT binary patch literal 865556 zcmcG$1yo$ywk=vX6z&P`E`_^8a4#eTE1+<94HBFX+(HuEg9dj9F2UWM;O>x5_TFco zb6-36o%`SaZ?y)s)*OB49J9|^wAF}EQ;|gn5&;1K0J^-Kv<3ixcnts`2q8ZY0Qkl8 zbDuv@9OYiS005}Czkgr=A3wbS0MMANz`Cxw%1VN!4t8u1GY1nWo2Q-QZ!LhZn5QGe z)CTHGVFI&(&14CDLYC*Ev@9douQiEDqvG@8&d%@Dlt(CVNbzl z19nhX2!*Get-Xt&rwG*_b_JjBe-E=$QTzdMwGp9``0bEFS6Pih%E1{*!OI3>H3fk< zDfk4~IC#0ac|j}`oFGmRJBWv!gOinmR}jQ4$iYYP*G2X0&DqRcP(%9FU%sB7M5ruX zT^$A4**!cw*gUw{9GorKIRpd**g>4^oSdxB2v!#_dsm1jtGx^LKP*T?T}+*=99^v( z>?wX*gqS$Exr$IdNBU<9c8-6WwRiceOwR>l_k=jIbFhJar}PKV(bB=y!NtqrhglEbaS@-BVsdCcBn1X4r=e}@{Hy9+re{bm6iX7|JzvX?EXf(xXQRcr}0-o z{w>-C?Bxh$*MPb>xH+3bW!#@VQvV|x7gr7FKkNBFP=AL1t?X)L{@>{Smi(6jKs~Mg z8|ZJz-%v+EDQ76e)xjC;;9&cY-ckEU#VI&B*f=Q|bgb;n96VeYf9LR*0#q8}3KgMx zZX|A25Em;K2bhyXkegTV_amPm2=pgZ`MEXCAg+*q3lkum1@Bd%gvw z9Bdt&l^x8U82(LMpDJvI*SAdn9huefzfdAPJl%JE!^!eu5lo=Jp@7exs z<~bzD@AdUZ0sa`&{oQr8ZhsE)ae|&Nc8=e_|5AGWALRcOYuQ^pmy(l;;&;FNS!>N_ z>Uu6VFAonF&tKzeR-RB>U1_W5>bU$F2p>P!zsg?!tBi|F;5R$`vut3fr>hdg3+n9h z7wt$wEdIK)wW9bZ?hlL##O~R<426WPgFTe$f0h0=^-n4Lf3(6(p~g)CV&mkYuzT*4 z|HaimjQtnT|IjA?e>C_9;y+o_vUmNxGNI4Y{cnT&r~E%zlA-t`4UYd9*B^-A*4TgZ z^`BG0{!i!sWwQQkWjQOCXYTO&tJs=Qr+=3H51tf+nEu&{rvJ$0&ta>7vmpOxt^cRK zhb8p6>HjzE^C!&3!Q9mY;tZ9rcwQ<0k=_2Kj{h}y7l`}sY53oS&Tq~qVEViha+;Vx zSxwBj%~<(4pysR)4v;wqhY7!_sQ~03`u{d`0YOfVe{kXdN$7vYW@-tsw}3t$CfKR| z&y#`hLOFRrJkQCPahbDn@;xU5fpT%N3h;9CahnL3n{spT{fA`!N$mfZlQDI$cZWLv zu}J>({aKU$rsMu^Owu33@h1(i|E~=3=d<*mm3;MkZvHq6 z3I01S_@DOR^WjMFc`N>VbN+v~jsEH1;s5J){5NC%%Zc|NB>H@e{(bxR`ThCf?{5H5 z`{$MF{CvKDDTjm&Kxc@NmzDr~emZzm9<^U^A`2B+vT0ipsK+Wo<%(A*i}(5rHfMx= zubCzTV9|lbR>3$YGHD^lMGHMM53<$rF%e&rHW|6@je*V1Y z$H33yec3Lee2;8p5J>J-^8}7ZQ^eOXA8*NfKjSa=Zr$e8&i8umSahSiXnq6ztHTFB zzunvYnm&(|ceR_sh6%*y)GbV^#AxbjKEa{@@h<7u;uxw~HvLGE{As8(nkbNgS*daH z+rG4>TMv*!Poj|-NX=Fl4%_tld8quWV}hy=YBrXXCN?5)?PWl7;}vqJIq|)gwRIAPO&$y8 z`YG;BCS35xMNO>KmnJExeLJi$0gR;5SD$fd^QL$a171a&W#ztyzQ2Zt59(+cuYA7S!6_Qg3JJg>j!S$2jwTHQ3v7Ag+ zVdX3#B*P@r8ea><hPVaI2$&u#d^u9A+a=eS`XhW zNUlOhX2}M>BMQ|)Nv-b*s1;ZWI<86bhcM}h)FC!!iyANw&{;ul|QbF+SJ)!G#1UWsh?_b9>zRRZ;J zpc*-93aZ_wmnw(&3)hW02!)R7alk}7tgFrS2)NH?&Rj~l+E^Y9^yaeo0cx2V9@xfG zl=-?M(f}hpLToD=8WA^-YY*}cwjAT`1%wk zc(Zca;PeL^VJO(k*VkYlqj|RWtoYLDmj4{;GYjN^F;*{XoC$ioU%7`NGi)^rQ9uBT z`uZ+1SF|u(es6^HJUv@GJDs-JlCZ&dWTf#~GD3A^yu1etY?-pNr}Q#mC6?OWv<8VQ zwdYOFkZU*BH#esSSG|qbW3F&2YRW7wlq)r68Vbqm3<0X8FX9^ePlX(GQ!E>V!eZ(G1 zeWYf+S60ec)D)Yog6@d#@ThEFZ4oqvC$IC#-4~DX#uQeHS$=Pno%L5QU?$X(skQ=Q z(IQ4Y5>F)ciF)P##0)WDx2{NC*lhXW%s}@^Y5qTm34hjpE$LAkiEwI>i zHE!AmMO*ROU-8Sg{V^?zY)a%$36Gc5C+llx0qFQlK;hQ)L+1v4VBSZ$45~|~@*3EXT4l5H zRSku`ITQU5z|s;+_^aBOip5k44<}vhN|v3kp$5*lynFg!b$n}9mRXNAQX!bU^{J9brW)-Ij7IUR-p9)gX0NZ2gbPuJ z_Z&eXOm-=R_uqSL?Qn~jsx~e&9umZgk9{Aex?^X6w>g;Cy`=TcvsYrtI`~_rDJhuj zABF3E^{)-u7ha7%UWNgib9=?$PtMlp4d2@OJg9-&w;8r}w{ZK4_cTtFG~Q6SjcltSa3tKO6A#YGW#LnGF6d{@-Q5N;fdk@8 zaoUO0Mm_mRjN^*VvlAoNk7Dd&t?eGWSf)QK5Eh1qN4ENcXu+M_rkoL36m%w5>r9_8 z*mR5gN$8k(9p|~DJYhl|+`vQ2p ze}187XHxbeCNoDNZdlNz^^xjqTHn<}pj{f-iN>f=l-#}y+k(LifU!U4KESkbXbg~- z(xNI1N#?fGw}a@efXr4(K)jrlR2tA<9b0SNuSScf2sf@5<%dUl(Mq}um-KGoHPoUBKKhtL`(7GJwqx$ zId#r zd6u?IHJp5>PM7GSV8dLfwd?B2UgYjUKa(_U^^`C_W(?jhF$frR_j*Weo{l6;2_y6| zwHoR~U{HDpcs$D#hZF$}MSTyt2bKM5r-xn-gG0lGwGq-1VcVWMu8r2Zd$sZ+Tg%*L z^w^#d`!~Yguo4?vmM-Lo?OrXD6L_oFmV&Z~LSMfqZ{m-GMMkA)Bu1{qZ8b9VJ)l+e zdt4K{UA{K*d+6@DRF9CU)Db_$!CGCjxd4 zwZnrrJRR_p2D+s6c)ox2`;gqZ9*HHsD%sVZzxQ63prztCO<*uPyojT1b0^^ll4Y19Uwx}YC^Qfd0Ph5tWfK}TRZwErGq{XIu zI2jq!Vq0^J4uK`?MC{qO<$O&djvrbmTpWI)2u^C5j*Mxeu55J=C{lB(AO$OA8ThfN z8&a@*WNH)>)dn!w#vx1%D+I#&Oabwj-pnZ->#V9WeN7r*hfrvCWHbS=mTXF!#BINl zvH1~PRC?_`hFd$A*P|5!L>FNagl0?d{U!WLwIsGW5yD3bZZAgZAYKuUUC4&VF+qdh z3k||=z~3AqIr3Xz8HnNEYZUsNz^tkl*{;E!oSoAs;%HRBF&veS<-#<+K5{Odt)jyk zePmI?*Fs2xMISJv!!;!UMA+&a&>_9Jq4&R7-|+u&ku#$}*H5RxC7bY6ksdSDnimPw zLOIYh)@=8cYZhyrzb;KQNxn9;@q5@vAuk~eJxHR|^Wf^44{NZ^YrWgRY-m0oS>U&0 zH+uVEdaTa|&&p2G$&eR&L==_!qPR0Aguc7O(zIgEryJ%;gTZOjd|f>*G%1epvt;@U zAdzH{q`aw#T9J=-EIP;5l@~D(1&x6*Uxrd9%8~$`_701oXFU8C=ERC#@2g3+c3V&o z()}CwdJsqMUh7PxEJCea4mlXafh)(XFjp(76e68i4PXdPNeP=dTQ}K%O*xuTcvjf1 zt>9PM1RSV!nxSE1&y5UdI6<}a180KXYQW5sk=06qYl0eVZz3XL>0nbz6T^US>usk3 zRX`J0IP6Ydx9e3p$%;h?oyQ;!Ub;**2;GDr(fg~@AGp@6A&L!HKbdFODO{)DpgM%q z@7Z|uhK0$ug@p~~f&Fe~2UDJzKV)!Af?NR|ejS#{c1TZ(Z&;Yp#Fwd-1`-`DF+sBE zlj4RiZWzey^wOzBX9yuT+lNpXWv&RLIw~BP?vb)p^hC9*$RYZc* z$01dz>+FU-Z=1DtTUECjIuHFh=}Qd9mZj~`CN*q8_Pwd!gQ->#Q}#_n%yrS&_K!h# zY@gC5K)Ry7jMnNsIqXny(4F@T&^9IIVXedf&y{gYL${d6Y`+BRVEPRvx@f9*=Ke!i zui|z@p__+aSG53w+NC-kn725e%NBVQ24HA2SF3?W<+hlJelbWTtaVqa9$ibbZHA&WC7KD)ggu+}?X z+FXJ_1SN{;lc&n`_ezm^UGs$+k@q9S{2OvmuB2}$OZje;ur{AF^G$AI@Szp0$%_7O zUUaV4wsp>C{K^W7R#&5J5;W7PA4P@9$qcv{dledp3NAiuXHcrqXR1X?%J2B-1;0%d z*}_x^x<>gy*wlvYz(O{I;{si%Z$=JdGMc1sTXQbswpsn8@5*OT-@FVc3K%w8-|eKsRJ9?pFaV)0F2m?}NBr~@ zqoj^qtn5r1=-b-+nRx>`F3g z;B&}ENzt-!iO9HOAxT{TRIb2q1fg~y#MlCt9_^^gw;Z_JljzZ2@1QL)TT*{3qrULGZ`1( zzqXlUBgCh}N3I9Y?QLN2v@G8WaHtvmY;AkXeW;iPzvR|7OOK!31Qxd*v(|2tJkh26 z&=Ya6?ZsRkA)!^GuvF4v6clDYY;9x`^SHw{ElX_cRT61j{+>vcUoLusF5a#F@|%r>87~O6`oYQoZ7Q#b(hOkWi2WM zPG)1+qEgiUutS`_^Cq;#eDia>INe?^+V7T$HU=Lc35c{V#aAjU^$rCPfNrp3?)QvybWPxbC9L|_>DOo^;b z6X_`85-y2{XELo9+yO?Gu2Bn&cQSM5>hY}A#^XVireu)CN~3%+Mn|RTrzG)UkYP3qfQ>WOMZ+}pIYG)1gAY2(R)dR#vzK=t zP`pHmx$8{nZU4#4!J(D9c#hesR*q*gC5vCtEge#362}S2&Qb($6}Rs4s%@WX!?m-TL`qiW0L0oq`@uY9Lj* zM9g#@W>o`3kG;&wb%y-Rb(#5H8t{CzE7a<^U8XparojSR$<4>$bbU+P@IGjag!g{O zN20|=%sd=|P>}^Pbr44ZNUZTz+d8Xi83I$B=M*Ttg1vI;&Mfbe1h`>a7-h)FO1xrH z*_1{}i4m%zJ>0Pa6z8x$y*YJ4VaF58{Ah16UdVvW5v5(E=kd_Mtw``afUu`|jsn(Y za6@BhvfvI*3+6mZ(Q8L4E>c5bPN8TTL%9SB+NClaDg8W#BK00Qe9qRg^tK6Dk2+-{ z7d#=OH(K|SMselKQu&WLy5SGlwmLn?>}JVtjpzEYK$jCkBExwuB_EMdGo{c>yIDw@FGV=#mxj-=5SaBjG0F3+;uZ=kA1M z6Ay&lb=tHTkg?@~towvPsHk;;d(N&Xbl=C65py`1Bon>-UwD@Rv?h!t#PKyrd~?DU z=mC8|mo>U=Mzd4nQP9An(F!*VhZaZ4Jkj^0o={5oUXU^sxG%@gp#RjZcS_ z@M5Z5yQfp*gajZ3Mn=lw64Aj}`pqI>rl1;n7ICwDx{8vFb4}7v;-R9;oYasav>!=t zoPDSu$7Opn7hWU^+pb+3ZN%5boyksz7Y;UsH+j;C+pdcZuuA16;F&~?3<8?x{`k=Cq3KY~hN8Y;qX@+k|o!L!>;I~>QU;6;TwqvJvb{aKP|KLuHGG@~l2 zRG4*2HCzBT2V>vEC+yyzp%&6P42XkO*|r4lh6Cf#BgnmFQhBkBna$87UlD(?-rG||ju|hsv5!2U(Jvd3N zGAa_hW6%j(nMt^>09Pc@sxFno<49QLPE-vTljDVbtWDbBaqh#oH67_E=hnf zp74?Mt0)f9M@l!07g@n{Sb5c#y_o^p@Vr<`2;1~^qaF^8sz~#Z5pSkJr%UQ8_RcmN zfro9z6F&ga&uP!ueU+a!pF#dAfC0QwkwcVZ%xz`5qo>V; zodrkl|J3Aus-hhTL1wAUC@klvONO0$BWyTzwT6cF5*(d4fb0iv;&g#0XE>b?NP=i; zL|(rj_~1e`2w95-1X3=*G4)-V^`e?k7jn%IZr2!7Rj&3#r;(X7T-(F*YS?AZe4mXc zo&kx0B4tRZlfT`WKv)6csn=?)z~Umg>}i_)#c@Sf4dV^D+O;fj`ZktM7U9|%g*W7k z@f|EDCzf3;Hc2bPST@aT_#u5f_+{JL1!AH!-aegf-DZ4oqFT-XoL7VerNkzt+Q`^n zP01PZFMw)>c%T%??$9xJ>t5l~y@`QE2|sVfOa&}_P`Dx|DsXarGp)9Yv0{+A%@cCE z-X72+U@fvG&A+!~(lbxljGu!yP*chGr9DpDn78D%O`E()9O{q-ERuwpK#esA6 zc{jZn?9oMFn}?w5Zrz3t!UL8Sr@xi2g$~uRr)bO`hH zRyGhVCR;OqQVX?9J$k}bOz4!AqQCqAFGY)!ED2xHZ5me{y%UPh^=602erkYGDua4O z!_(NSq_{*Jz8blFo!UOnx+*{ClmwLKU!IhBV&=*tqZ}Lm(mUH)=-U#N34$=Ogm;}z zOqTh3&UCct@6?9{;_8&`uevA*2IO7zVfbphiD8Osjx8OR@@-zgGjPlvUfMDJ-2F*n z%C1!T`c6u*NkvVO60dX~aF7K16F_DDX~|con>JpxJqNbF+z>6<1cpK;&io0)XIN4Y zrIB8JlD1Ht9sYo1%mjro>r2@A2DRy|qIV65-47l;V*c5LE07lTNUxWW{}65du{qV0r1G=d2k5O9V$`ZdpnA!`Qf zjq<@*S5V<+^fE&!{{jLf&SRf=5iIuH-jYmXUr_Pe})EnuS`!L0#o3U9Dj(0D^v$vu91oNYIrmjU+n&$Hwn|xZEwn{FCfe{&4qgA>rM-y2z zp}F*l%_?Q+jL|=KBamTk3~~^2-I}U9@RMzGlX{C9qqfd28h*eSS@X`=kKEZzG}+;p zC^z^IDG_|z!)`y7j~+gDC2Z&(sa~HYp7IvMDJxh9Q z+e}l`4$(xkuvar}peHp!j7YoP-xE+vE+^YEeC3E>CCUV|hkuk%oo1z)1%vLG@%Cb= zi|7M;i@{k0C6^>+PjC)mtwSbQ#W$X55xt|xn;>`QlpR8;8Mbs$8cpWE!|MRtu#7Xg+9TA#T`xt zU@dmp1viJ6+UuP6ZUYc8Scra4H8sg1pLSfmkUiK)R^}D*{F#(0uDv+_{q>_2LNN1p zTzu~Kr1N*nYYL*ed3h^8*;sIWWM!82codNkX|BfDkBIMw25sO=tF!XhzKDA#t-W$E z(9BwVGRx5RPIjK(lWIxc3GEj7ls@T7&_xs3;E%b%??V@g0_vD4S?}|P_g|!IIpzR( zOf`r}QbgLKmT|jP6TKI>yA!Pnk+4&S4aF#DR78ijSl7pAo^;5^=Oo5)@p63eE0I63 z+s$u2!>lh-s4k&(OJghxMC)ewvf0ppTDq;!Gj!JF^8ziLhb*FQ4^d3b%=aX|0^=71 zd=iz~2;s*3k@GlmuiK}xCMt+LZ8bg4D;%zfbeRJ?)dv8m>IwvW_69o-(?dWRtw|wx{5=ORT0f8EcPJHKLRGV z7wn8sHFwNuOIMPtg{c z%e?t@c4EB})%|p1wYRN}r17&9bY$^56<+U>(Jzp?5Pn@k<&Ns{J&NiJmQt5{{Y`g@9B`j&q1Wt+Cwv@h~h`jqKGi?X5Z4@kwaS$Z%Ru)1$2IquzQa z()?y-Pa=;+)9uH3nQE+$1x`I`xp!TJ6tZN)H9NHhKM&{p48iF=r78+)YF6Iyb_-O; zq)}gp=9#mY%^K)8gDe*Nurh3~uyWhc6@_b)9@M2Rw8Sx6dM{Hpk=k~Bg19WL2Ct(iinrj zRq?Um!uYx5R0k{K3KJO^8!Pk%XdGg=3KsO&8uC(>Os4ca4xFu}2O={2;4KM4)eie;g+;2PannpJ;dnx5e@Mug29gSsi2lRcr z-$eedHeq`FGP&^lk${plw9VSN{?<1!G`Op~_BH$*QR`eRZ|xFW+56drX~th2Q=M%Y zFAb}+<$fV3UQ1Qhnl{NRF``IocdK?*@&^NH_*w3)o9MOM<0xzW30X#oUZEmUBb}czRNz)moVoZWjqGUM@B%muH`-3J*h{c#MPH&HA>9yc}zBfY;rFMt4an zAj&~g4qT}ta0r62yKnF3MMj!!3+K&!p8`B=q)qIy~(>b7c=I}w>g5dBya~x~S zHfwthSH;VMELUZKJz0RT>-ZWr=ld<>&JQc1IjgU~FKj;gzu^&VTM@bBidEYCLJl+0 z+0Bi|ZU;Edw9#|iK@lB{%-B9)t9jSwOH@a4p{!gwvOYi!XJm7zDmf zXUVi_e8deg{TDZ99rm>KYPtD0Izvp(W6SRX^7k6JU)T^6>Q!BLLaX;2-=xaI(N=N} ziri{fM!g^+-KW74kKBK<*5b9_w#r`vMhj@id%%;t?-CB)UY7bW>q=IlrHP>@eKa6E zh;wd4X12byC5AY?0^3TXJo_@%Wvtu`RhMKp$8P0Q+SyHFwX$9aVxT2(Y#z?9W* zlHS!WIBD!3TtC_-GygJdaj)uvC*i3s{Jz;O_R)4`l-PYMJtSS$*S8);V)$dVYRj}L zdeN6Rc*`aFjK|6_UrBRHD3a|wJW0K+zNpsO;Q%S!E+cZtY@KkBO88#{q}!N=UD8{; z_0P<40HvNTy|>C1^*-nTBgwB|;y2Oi^@2flKh0_`YdyvBo9@L$O!}GDAJ);^ITR}C z`O?^;%1J2>R~%|cmydmz;{)EulmXlN-O={=Q@#zeBvv%e z*Qu+TrQO}a9V8u`BbQm1r!MhPz_5OdgvA6X+{y3)>`65%Uwm+YrV<67h7Ap5q^#OI z=bqB8oBhJQX={(-SB@yxLsRU8C z5J{G*aQ_rEt#yT3P`Us}maJLFYu4&Z#>zqUQQ>NM&01&t0g3oU>5hKax6a+y6H3eP zuT64O2vn=<*k6%?in3%}Z+yP?qNC6_$?Ydt^5Up$#yi0(MtL;DWge5fJpP~=Kltm>aC-B#&^?IE2^!_TmYGoRL9ulK@K*#2Y^URVPW0iZL4SFd9 zS6z+(#o|6Uu^QOrvjN+j)zP zSvWJWsC2g2!BP17-{B*9x`gm%7 zUpu>!M_*r=3%_ar6qAx@*$m!W)1d?61L@V(+pCPPqLQz%+`oq$#I|~z==1o9I-R>~ zROca{1mt_q620M3IotM(#xhpa0s(o$*HCcwi&ew((-?h)5;qwozaqyt4{{?`Bj~Yy zR@DmINn%od5&J@A8FNnp1(kDtNhtT5-eC3$Z2<)o{Z#3uf!f{E`O=Nur|9KN(j!+V zgQab{3{|B7?!>_?BJ|5@hptjv6@NA{vTPsY@Ef}of^L7p{%*wh zI#(5GI8mO$3_&$de)Yo8Bb_A2lzk(Q51bWK>^J`aWV480GUA=aLVnCc44&E?uM9l` z`uhWieP-W&K?~cp{6I%~|MMe*bAZ^3K0S;GiwpC7URS?}qac$on&XZ}#_tA?DIalB z0`=$FiES_ZzJ2hxH4hH0AWPCkgd^P0%r0b{6U3fd`xtE}HxA#e@~)DOn2D-=+e(Y^ z5I=xkT$91hUK~#Ag}YMNMVFRHHvz}N5Qm!IMUEd)o3XT@0K!F9^;e;HDxqti%}yK@ z--Jc`MftrMViB}z@~sMbRi*1s#GwHDB3nOw&U~?l`zeU3cE_vq#+sD~k<0p<9&X58 z#{E3nprzzZo+>weUq$h82X? z)ebD5#|VHNNmNSJyi!4LUV4U=fGV-6YO*V4oof19?)>w1gBRzB6F;LgyM42JWSdC2 z`lX`?42GNCEJK2i-b48YCtsB7Q@I_MKKx{tN{QgY#p;b8V{stH z9IRdgZMjpMOG~NyL_*IhJm0TAm&jk7!|{F8y-A-WLg^J|omzW$A1SPY&+w&r2;sW0*S zRi^`mh)c4D^ik%PQZAiSomc!b$UVw$9mHL~RdeY&FY`9NO5|K$^hf>}4%~LDy*?mn za29hqSW7^?J*W}6_1k(=XXDA11r=O`YoCxk(G$5B`3dUr+gwu=+?L<-gc~)7kr6}d zMyf3W;V+be**E3!x_8PVSXYa_YC`2)4uk23gQ*x6)Lx)U9dOeZfJR7IRmWDbBI(ha zGkAnUnpM0aCtzpN--*Un#+?3OLVshubHH2WU~;;76MO7!FB6QP$T-H9wEJ${Hw zdTt#z9;Tn9v4_trvR(R9p4OB>WrD^k8y8T~(qrfW3(ugG{B&);^dj4y$!!>7X_!f+ zv}b9G%{D~J1OF;z$FjJ%5+R1pdg5uoypr>R$!pQoy)W2ri>uPk? zY;{S$3cqXg!BVcp=FyKjE5lv0OU}FFXZHk(TaD+;=4@?`oa@M`}*@T zb4iba3<%Pf&*A_qObOjUNjReI;W9}j~E;kMQ4L-ah{<((L`|h>I31c|dDY2$T z|5>A|OFGx`6w{P{X*@l;(qY;rr2RICP~@ap6lQUDBO!7=V;`&&z@@iP;#kcyB0rVc zJ$iL+TmM+~6Jq+gGilWK6~qGtqihuyCxm|5>0Yid&rsfLj@D5n;@l)up}=9zDPJ@L*Zv&n^wBhjfU|>BPH15vUxGyr% zi#uFICG0BCW}#{I=xMr98pBjO(a^gec!E0{kcIav!3Xp*23C`w8+NJ(iXG!(GRtb=#^j= zNmNS==Ev7e74hU$pBQJ4BaZRM*p9ngq#N4Gka`!vnH1fx;4j7SlFJU%h90xt_O2IT zzI4_JlzVrDNA>)op|iuMb%kPOatFeVQqXLFd4uA?lRVxVVOm=PcdQOc`a^RU3uDUI zWWs3J$4lI90(@#kqA46zN$1vB31Wj+V(2mrL%MpeN9L8uw)^;3(zQ~;7UT7L>iX|a zyOMU&byYo8R;;Un<&h3|Zqk_-TFsK^N@O z4}ycTPZ^=k zr}Z4)e9-vN11~rS#~Q8v^(ArCAy*{Qn<(7l0|Nr~Xt9(8{rn=qw>4W6x(T5yUdf0x zYRri55doppSg-QLLR}3fEgCdA9UK~1l*mE@N0aU>%!J~xZ{rAztBy#Ha93E#Y`GicS4;GFh>@!_AAyv%aB+8 zVZwau<2LfZuXpJ^BYli#PNZ7!kP~p38)$A&5K`&VuUu^FM?huKp7i>i@ z9;}k#+<%uP6}aS|`vEO{NwFkFjT)KC4B*m$w^m)k zRLCsvM;)QlY^nR?yW8P#N^%S%;K5u`@|}wMDSrn4EHNlJ>1K#&FwNAsi31^`KWDvI z#onOSS+|ZCg-FSd{4)wnvU%*Kg^Oc@&C8Zj4wrl!KaV5fzCD`)Qs;MwqP64t0;~Jl z^VwH(adE9L2HZ(RI2(Y?XOmYr7;B~$8Di;_Qd#e6IrXF`==zMuiE6vutgpVGc()Qm z;ded1^?~tta_AI|B?x^FVQvb>Hxn@UrQ|&mWfQf}8#VfUGebG8aD9R8@vsuUVj-;N z<1#xn{LMH166ZQ~OUQPq7o#zg(vO{rjkV!F*l_3u%b3px-`2mwaEte=y+NP+~ojNlf>XIMGMUE!dS&09oc({N+(*or&1vO}t{w!godj+^UMa z()5zS_ddQv#@|G@K z5G-9b!3OmpE7*vHMbmc9PM-PPTHOj{mFAKaIn1HvjrYTY$TGAiG}^tmNuP*%4&VAr z@PDXG+Bq)>VXQr@B2PT+!%R`fi^p** zHhI}1i^A^fO|*(%3H8Xt=7L_s-b0u$;%Sap*60BXCmyHKC5yC^_xm+sFH6?WoJCoq z$nQimEvA}WSF}h8955nlhGijAoagV>wUIS1yE+9n?p8e-k=7&0U6`u{%u4%cgJzv{ z$r|6o=7r;FmVAuusg%>lzLgv29O`pv&OqOk3f%bQrHSID#AQY!{4OYt!HCtxTtRuw zq1x!p2wN@pV3P);#k~ZfL(RIL38O2*h5Z+vIxq`L^$rP=ciHEAnJP)efr&Bapa|5K zZ8aPI6y}!FaRJ$(d|*FY?IDBPglsz!v%y2}IP|s(7`vujTOt%|0w)Ti z$}@uGn1z4%vqOaTL;Tt>;?J5V7jr7(gA(LY`N%}BWc~=`3-P88vbceVC zkJ-G4NK%~R%Nhbp@FZW3jZ(=*(DR!JI?$aLapVT)GMosVvnkos>EUz6r%UjqFhsL~ z+N>9D#&})3Id;6W6?h>?Wu`(y5U(OYssq+K5f0apkZ&orHRa`9QK_$2|j)KuND@!{mQ`^Mwj6=Y0F!`40+_V`8l{nz6a|!|rrz zsgI;yQn)^2&ARsbr5M$z5^R#fkhe}qpT(OhXY~~8PyFXEAQ0xdjyT5f}j6Rkz$Q$%Wl-#oM?g&6=}?z z*Iedk*xs$D7VcM)nfY3^*86MINAp+HO>_xGj_D}G?kn$bnW$8QR6`JCsvA9wW7c2G zM*&AazyrhUK*FBY^#YUEX2`C+f^9M%8{rFk()`o3EM0HRKKDq{rk3zp>7C00g|i}w z4V42tPen(QcLw--VokLkHAj05&6{=^i^AK_cF`!Vn0w`!Y&nm{aEVJm?O1sRx$B;*FmI09fglB#Dr+RiW%&L6QC;%kdvpAe`%qrbGM!i+xmv1Qhcy2 z@7?EJ`=}r`T5eez^lehjN>ck}HC2wO?lv77(q8S+$-?pOy^mIE+=VU>DuzghTqd&! z6pK(fAQ*lBod_sBd-Om~rEN&hO-gNJ2y9&Ofc#jWp1D5qDQ$~LR%~#s6;rVf`q?Ok zL9tR^FV|0Zfjv@~aPPLW}&2M!dRevNUnOTN8?Lb%8(C;nwCs2UA4YdMiE%#R>BS$*@4yVgwcY@4eCZ9 zmkNI%?)bT?d7`fF`!ftN2Z-#&{azNy_4daTqYY%JheV=hoSRd{WvJMZJ$W?#ZSa-iNGyrQK6T-oSdRZIhbV#q=Lclb zHhmLo{dI*}5f}{0h{q9VaMy%8=&?S&K$pw|rx}4NAmm8UrgvnHziBB-S4VZ>wW7*G z31N9L4lhVY5rG9mQ*R*u1JsUU@{18GzCvi9_o&zNi6(0huevuJJxBwWnA$$nRJ2`{)Q zE1>a>2#(phWObnLra7|&m1nKRxuxD`7ez#nblj2R72stZpgtH~1z|D2ZXo$PrDH8e z9{Z9{+**#%!Ll_=Asv>8(ZSR?P0NN%1>8e+ASa~$xcUQ{u+)cz$GOK;1D-mowdSGC zFs@!YECdGXz&dKl)G6+{qw~i1>PZ8c^$h(Y>FDTo zGp$+>pG#{(m?pjg*dZpz4y0t0qT3KgoTx}T@Ea1b2q1Z`hw0_!TTsv;LG>X?5eW+#o;%$FHX?PDt&3zdJz3sV)X{-tb*!_%@w**JKYhI!vGA9Nt zimKz(O89-}7eBb^RquyB>W|NjrrX@)+I8y43TWA+5`7Qb=8euXi2m975Wgk(jckj)FW`0zYBQlKzg=9XZQokU{Mzc0h%&KPURgLthOIiYA2f4P zzUZ&IKnI2v2s6m*Rqmm1L5sFV}7Rr_09< zniPtnfy0)P2jy=F&E`Bm>gf*S1U0zM5NbC}#vClcRD|VAQ?HqP+La=5@YI#BM)x*D zcrK&iP0dx3ekL~Hi|9x^zZ9Jn>UDPart7m9Y~%C)S!k8b@V=>9WWHI46MHrE_;WJN z*RRB657GQCCzJZ^IsD=NkJ{!XI=+qz>cjq+iw$yvwQpZ~;Imx{Lewjw@12tAE9D#C zNO{?~()*ZvR3&P;eKqH`keyy9dGJJ8gr()U^`%Z4CMJ{c1J*alDWl#Q2z8zu>L9Ke z*V6qqYKtuG%*USKmuKD*T0rO&IZ{ci-6T(oEkj4|ZQ6Ow&x#SA8ww}x&4#6Z6#7Qx z9nd=~e+&F*sh&pY`PH;z06_tXL&yc!wpJg#8xV;CVHF#rgK=U0l$GS**Qw9p%^|3G z`Tclst5!1GTc|<-LwN7YFGI1up*F4F6ECuGZyqodO21i(5JclbJLr8=?|%-}?b_-e zSE{MX`rO`%a^2tB^;3K+ExS!EsJwYo)6kJ#E`yi&$un6$R#5n%3gj{NL`Nek(E zX*}_Mbb6D=_zjih9P)%|fMd?A#&G~5odlp`#i0u{1)+{NK8WWrS zOyV$0Sex9#4|F%xoG1&1u^kM6gTl&l&T{p_iV<9&WWC|eFdf|p@*7h@&Yzs>9_76} zRTQ=&T3AhTahj)Rp-H)e3$#hE3uM@j+E%eM6C5vJP z)IcJ=FLI?bSR;57BD%lbpCrn#5>r^d=WkIhjUS}9gNxyokw>~F`+opUK(fEwJc6_c zmq^3b_o}+=Noe&-^$dJdG*IsC#rC3*Vn>CFia-^6+pd*NGU4hUWa_)gS^!MgZ)ZLT zZX4am_eM{>T>ucbET(IU?5tBa0;+n*_YaTZqN{4kH44V?e0wkF?B#{VHCTHrEKgLy zeI+Lzv7E#fmjusW`jLPaJR@AU4cOUZb;^QSpkiCn{GAH(CSLJZb_;u5ZXDeV_!)Fc z&$jB1^j6{I>)1C-WJ>7YY+j$MNnzgdi8Hazu4zAa0u9&3^+pxWN^cwFX}$=+7p5)7 zez6K7QAnh);31{zt(A0R4Wt89TdrM)9+*M(Mo;O$TCUc^3YWub&@0Lhvvq}^rQ$lx z=nl2zmuH`(l(AArPQT(t`>ZcRSvw099q~4#Rv$Osg{nJSI;FKTz=g*E_ zSe`-Ki4mzH#%ot7g&IAb1>Nua_^62ev}x_O!`rM<1+m_D7FYAmJWDgB0#w$mZVl)B z_;w-NP_VxSbD>f^)+HkU8N;>(k``gc1kwsoVzE#@tx(ZoDaq_0Awo+WVPgKVh3AgA z9)Y2#Af=QT!kevqQcBC26SoC`st^I9qBRUlLP6vT>txclLIEm%?-VNox=+l0Ln?6r z0jjl|PDvxzC@)3wh=Q0Q{i=^)oHZaS649yS_f0KXRWA}*z_Qd>;i)M_MF12cKnN8O z&l=W}Xf&sc7X&J(_7W;oAc`HlMaq9()Jp_2O~^^qxITzX(?s>ejE zHoc0)6?-ZSKt)x>5OPTO(^*M=e1XA8(6wv6K7$2NM`r-fi>n~^k;_(D zg&m{QRQ99Zi#)*d&0dq@p0hI)oWVj$Y8i>$>h4Pfo~hWb5V89+z}8-Kvzl9JJjbhh zf|Ke#)Ucr0DXQAkaTRJCXX72F9Ai5At+aV4!{z8HgL&B0r0tCudmOhX5l-f4J~C|u z)d?Ud4YKeM`ppymBj+v-ACm(GF)X5vLPTIh&*gOGtSy7p49f>llr|QIh%`S<&1Zt_Q!u3d~)%w4B06;5q z6QG!o0I+Q@eC=_yghvUZrws3$ zOxyG%`mb)xr}@_4d-c;SGM0R%a;y{#siyQ9_gH|2w9ty2rJk@Zg{aEh;)WaDfwD57 zIb&8Uzz+G1j*)Otz<7q8$UDFnNy`kEa%P5S4Tyg3&cou|hZmTY01z?IJSIoWVztl8sd_Z#fE=#+2N-rwuG=Sgajgj^RO{$R%5UJQ0bNA4(qOo_iLnzm4LgGyc3^~ zu{G({sGIG#UQPc`=^{CkJ$-4Qs~az!o3)uGIeB@0jLo(i9pvq)V^!#O1LLEvBFZ9L(DNLZl9j$TL0O!O*!n3pKyKZ zE*S7h=Q#FRSi|1SW!W^D4*2fH_aK7C*3P5IpID(0({PEBK(a)BB8O;!a6woJ6Hupbo9jqEN}I zR*2)bx9e`~t6-D2mfJxyx(1M3uj-pI;U~~-7$$-X&J@NQ{E9ycX4$FRdrt_blf#d< z7!LMyB6ZBjRE(C9?K&sTaxXwq&&_hBFG5qFoi^5iCZ;{P8DKUG4d*^D=%9|>ur(7E zfT)6T5Jjd$3In2cj2v;;hfk6*Nm-{2fU2b{zvo>6d+cGVRBnrFIV|8Y%vG_@{c|XX z06SK1v=vM5hYz$k z@05qhbV?29w6LFrZ!fB|T=wz!$hNzJlV;LnET3+hnw5)d4_s+q7^#lb@{}YYH^xFC zjI#{Zg4wL6I-N%vOh|dK zVDXJk5`gVAvJ-7MBc^uhtW{{4U%bcmt8isP^%MtBCTV7gpWb_m@;BI9lLwL79;=`- zcr?_-*_Hk5iNYb@-d7!B=<>M--XX~U9PK^(qgcSPDClgT$ryyX8U=DJWi(^Z^@(ft zUZxv*<(k?Ic*0BhL-u=R^f9jHvi0*u-HxFQRum(k22b7T=TAGAJ!r>E1c<>@K|v%7z#Kj$Q=jIUV$ z*fLCc4pw*IyuJ@lY-ki=hU)P$0-Ssh;dnFF>eVmr+jwtqzo8)&#-rs z54LmDRgVC7Gr-2yCrm@if1%GPC(XsAHLN-nyfQ{o+*`zS~@O5<{z&Pl8*b zAX9h+jf2_&aE9YDCjL|Ty2!VUtJB3~k{8>ecQyuz5#LY5L?EsJm*&jskqQ*4*-nMO z6c44ap=Thw0@o6>_rcH@;tGS2Tsa>z=t#_;aTt?7$df`VY@;mOsX!8I4hMk4zdp)6 z#P$ZapiUZ&2~eBrlrX@&3hqPIhsv(?2s-|0({7~%rt~=ii-mt_ko3LCT9BmfHZA_9 za+w|>L_VpJIDC&*r9+orSv6zt#9xyZ8W#A?kE;H!%uA6Kdy0@bK9aiusto zX}nVb)uVoJAI_OLolA`}KXAn_oAP?L!L=wVI=Z`~M66`2(UWYCL;3T(Mc?t$6P?F{ zC!q0IobBSeGGS#>pVGOk;Wa$1e%G1rZ?Oy?c*cf-MHs#j zw$FmW#2$Yiq8wV@UIYi$_E#p)nj%`ac?Qt2e#v={1`3hpC;JvzfD#HtXuX#lTYa_* z_aL)rb6B3RKD;sD{mY#XM^+Q<9pn=mfI}XVz#DOMYt4rQV^j6g+K)q-XF_)YEcSDe8H1RFj1r# zf`UprYW^rEhny3L(~&GA3@q-3Z3jv;#^PQ}@rhRr9%@_XET2x1jiLoFxv`yuUx`(dkpd;a9fEaZ)cyJzI0G zm8GsCrp7ANR#TGt?FF)oVpL4*ETkRVyAWJetx+2F6X8)4L(K zJcMFmk3Occq=qhy?aa2- zfjyHSl_LOyE9N6sa;qAcF32!bh&_%6O&t%GCXXoW$GP;fDiA$U1|duZIXS~vdrCDQ zD>uDRpduzyE5ePUcE=c?xo)jUCXo+Az;Zr+ys6 zc-cDv#VR2{X7yV~i-bIJ+FGOQ$^<|3iwss3Xr--dKuQo15mndbPU2d$irzfL<<9_F zGQE~k>ka7XD$k!ACpv->0-<$}HbOqWn^W3ka$pg^Y$8*DpT{$NGX3e-9y^}-cll|Exqx&n~2;u#XS zLW6m-RwXd++-|St(4#SAV9MXsKbBDQJ5n53v8UtPuegmIblLQ9UN55;+=pD;7Iy{~5a zKD`B}bbIJEJ*bYYzSRSb&a1@NeNgKc?+RGEj|TqJkUCXLAqxGz_OSXBW?f_(*jj_k)w%F@V(&^Kf+oEk}OYfQdM89e= zm_jf>1sPiOuL>PzLWi%dPLo_@&s&*0zRzc}R0=;l4ow`NngFk`@OZJ7w5?!@zaQa%6b zz*RIppO-SZA}U?E8uhOx_>RTfCl(}#b9L5?Yh=9&(4nGUP;5tjq8JD|)7kq6%#}05 zRh`*tfX4@gqnlU!U(!n3s`>`LC53BZza^V*fR zh)u~Vl`w=FTcrQ&7jF?(0x{N;tF&x$wWQ@V^2wDjPyW06na1e!Tfb+_=;WRvQplNv zpkO5yJiL;{y7GM(Rgt>ZKzD>gBBbGUzAbGG35Bc*<7s_#kpmULI%$QYl3_J=!FnmQ1)c1RgFowgi2 zO;0mlIM?v%U1^a%L7D>YS*(yDXd&-pvb9kNNiMpn?VLxzbedV_j1DWtPi_ELE}Z;( z(nZ59(tA#*eFELzqImKtop5NKX5 ziM>LWRH=++$*gL>r4bx$=0sO~7q)NQTt)#0hgo&1sz&B}gi zn5i@Q7T};-aUO z=0SdUR$8j@SUXHQebV8bI4AN6XGJ9IXizj601 z+4Z!el{ZPyc1gBpGYm2GVlb)hbsF+?vmCYR79Y&{$^Loso@kysE+oURpfl98oPjQm zXExajt?a->-Xgjx>4bXkL=_j-JizNPA@_b+@?dT_XE*1TV3;KzVpW>pQ9s?ZMpjy3E<>cI>|us1k#3nuY`mSPd1md zt%9c|pjy_C*7t36sMpJL1bdgR#e$ijlfza8vMg za%b&XD9(Vtovbi#h5z$hrNkVm=i&0Cbd=5OhuxVzhB>eaoI69Z1Zw+!t|W!akFRae z<;5<8mer?706W3X5~fO1@SlK{h%eu9y1Hm;CMf35(`mOds`*g^nBo_5G# z`}Vlo*{MsFwMo@kP8WN!EXj}A8OLrqDfO_EMqJ?4gtWW9E8wT-`Yi-4FQD9{#JT4N!)4ZAKQnQo?0e}%5Ua3NB~PFacmA(LW#JR<;%gm_{0VL zXNH6Y<>vgjhwcLw{wxqdS>9~n|43=MCRUIAIJ&$3>7XVG->S>;WZ(La9WkBdCB5@~ zEId9xI-+|R?Azm=3e0frg0>fh0b*v$wO|f3sfEFwq=%SH&=;mcT6+r7(JR*4|#H zyd-H#L6q4CJC$qy>|k>1E z5xMkJ>zT2_)w22^`{6X-wpnT5h-vR@Xv}vkm}O~ch-`Nc5f7;?ZF1P)WUX1eJ6IeZ zI?ZP`a|8QZRU+Kfzds$2t5zl%GqsoIQ);~%3>M}Z2sh%8JPnhjjbHwPcSHnNQ|?d& zDijl1PHqrt{1tsMH#QbnLKZzcI{|6;R>+B|k2pArbSNM`P&|f9y3N8kkA(Vx!)AXUJ-h6WjavJX4WjyBRlh_j|F-TE8J(;r1hw@s8kM!0Z$Id-f0xK%fdD zJ3e7l6NMWpYPsP#I#L0y6(~y6WUMKZ0*mTitH}^@1&;-y)!p4>XV+-AMwB)NJX$4@ z0zjdZ6HF=m^?BlVVq=pKY`w!3h{GC!lW>1e3hdjWJurx6(@G{ndif&kPiS8E+B8Xu zX(uXB0SjA-#0pq$(I}qV`fZl75=Xsg2b?*npGCJ7Y#T6d;JXtGI#8eG$r$lgrk}lR zZ<<%owU+z9jluV5>e?|tN+1A>*@}d4YumT(-WoNOYNFPTyIrwYb}2Cx-v0DeF!5a` z%b#_Z??8Gvy-Wu1jehBypNW{e*^}RloUnbuFkJOVI8jzdNhA*0j3MKCwVaPW&OYUz zvz3_F>=Tc^%e1z9PB(*h!DaDGS9dJAp?1@0*OaKMB_v5w> zFE2|w+wWoPb_Fj^6Z51wvo_JpinD1w&*E;M>G7ji$%RrX@>WhF2?QuzASH-x93Pq3 z+7yC+l%m$iGUTk6f=^Ke3!|3txhD1qV4)3QY)w_uU}`!{f^dle6d@|qB>W)EnyA0U zXH{CJ&tS`U0?%i>aUjRw*yl-{I|2eUtZ!jWxlNF2oi+)NU+Q*y#6+ul7jR2Rxm{2g z5UToCb22UHc;puVe(uI#!r{b+g}Uu4&h3GQ#{iN2`#Hn_$~iOkBYW5w*&yj5VKMq?C{4}9JRk_=+WIYKWis9o>(nwfyjBN2u&AmpWq1zx`I^6(T=gf`{0}X$_L;0ynjh^ zS8{-=Xo#yeyKSzMSKR8n*p6VG%Z9jHg(El7&^MuX`CFlW-AxDZ0ILfVvBcJmR1t#$ zPiK~b$KC?EPi7aH>zF8WeUO@*rk!~uTi-c9YN<<J@hQ zS8P(Ro*12eGlh?TJeGOx&O3;~<|Cdr8Y-@ARnqj}EmD%{RO)4`EWCgPPh0g5-0?V7-ZT@)^Ipp@%D&A?+R?8hTkLATjbn53RuO>~W&1`{9pLd^ozThD61a*&T#Qy5DXi@mSCDP-`vbr6Z;il&w*JZU!8+ey&QIan0PxKZ-pvIM zm6&c^Ne>dnh9~$O`(6Q3vJ=M?$VvkPj$8i!vMsBtO6Wq+HIuKPSq7^QDh)FIYc{?w(h!XdfmBE zwHaL|^lX-gk$IwCC;$d=9C|5}VGs9{Luya1`Tf@HA$|S;{>Q0bVv@wNGTmc&epGa*?TShq z(rJiDQ|<(iwn6?xC|^B#2EEj9t=pByXz}(Mr4%r83TqkE*cMN_EIaFkDP~xTkR7M7 zf}@A3If9FeV^9M4nB{>z5YPVE9($BmU03E@VJS`K-QL{T5W88!Zl_GI&?G~UXJ{oF z#5h|a!gosz%SVtlw-N(F-?TqIi!T8HzVS{wnTZak zAT%50MGMJyM$P09i^XB4!`uCkEqi0&JPI&{ z%1Jor{VAGb-SEC7h9MwlR?U`JRYQ$JuW5Ls247I`PZqxC%r>D~dDN zGDepee+e^5rU9|F!v3J`r7%x@mHN0>5-9+-M+ORr$L150FGvcv!pZW<26Tv+^@DwZ zWV}Q|?u~rGmdtq{v%PTWk7*heLQx5kXzotGb6u=vny?K|mpV?DR8v_+cBFbEOu8(N z1Pm#@|KoZ`o`s>Y{5AmKQ=h`8z6}7s|3~jGHbHir@hiXK7k>Zuzx3H({cNk#uY3&v ze(hKA^D))q45szN`;SzCGr9x-DpLAt7yAXmI7@x@$*^&DEK}$s5#}`+R*l zYA3y;X_Rke(CeQnw&6Z9Cp?`98dB$GF1`aFSAdSq)Nlm!L+%b?Q524VDDy7w2^xQ1 zJw%Zfzs(?1i){R9WRL;3bQwQB_7n*ji`Umoj&x1{dvT%lSa>DW+B!{{%oG?!^Byi>0dpjwaT z6_JxyO>CcxD8#?35K&c?*qg2rVxqK3rfL;%V{(t!AnYILH|Y=$s?}7iUxU7R?JohYS7lI;Ao(5t7o6 zx4WupjQE=Uc{0b1ZHb5#(j}6>W_2`{4JaAPuw9u$MVC9TdZjJpNGW!f4)es{`ap9a zX?ilUy>MnGBIXFH5s}Fw*4qkI6%k061k>l?^Po}Ng4awIRk1z!)>dXRrrB1q2$AIu z;yETy>wXf~`|V0-4J7h+pRLA=jOaht)kfq~lFE#L>OVmd_XkJk)dfwX2{ z>LL?3vL$C);|ADPmOy`~pa7`Y2DG7l+Kg}+_V_Vkl0N!uQ}F{eX^0Thw4o!4p4A=8 zS)9A40{FZ3^K*hv+ppjK)zqq7Q-Hqtb5ogr>kq#=m>TqN|6aQL!56+6?|=K}J{Vs7 z>i52imZWS_c9}eCPMYe>o~=#|Qiu#AWc}9`qK}yZr~@u(eJeV48JOY>h!B8tBoe@o z-DQf_amn}Cg!oK*S1aKAp{E7U3~DJK2(VLkjS89$V_{-pR|q2r(h-U#pDI0IaZdSTdZ$rO{_HP^*bV|G>5J6aM?3ng z6gwj?bpE1Jpt@tb;L=~W4-#)$wL+^UmT@oEhAL7kz{~>hgZ|);|IrJR8vN>U7XYP1 z?+=5(>m^J?5o!Z=71s+w_W^yUzvd)z~(L7niY=bHy zR%@$y=fp%9Hzu8$A|r9@1B7?w%%>XqvL&Dym#x6nS=aHBfC(4sZH4_heGLHc-lu?1 zeF^~Z5B@<1o2I6I`*WD-YhOYhnXi9seBm4Z2z=UmdQYDtoXk7)jY;}T;sip_a~C+83QTG3LQh1cEWy*?WNzG^%Rf)WA9RYMTD9Z0`;An`b)M~1s<-6?`1n-Z#D7I1_HoK#uDbH$`YonGE zy9U>-Cx9uf6%h&4UR-wA*AtLv%`IiyF3GFT3$pglR(~}_K}5$YJ4V{75}@iC@N(WN zEabh{j>J_ zE8oZl&-=i8zwy2AefJmr?{C;Y^wswP0PlU}5C6aa&%a^UzVr`g8RK-lO-*0Bc6UMc ztw}#yJO-fQYt%}-v!4xaKZ?Dph}VLWRcikjCQsotNgS#DBmF@>>mO4uGfR68jh!)h zETY=pe`yIdCwJU8?DhJ9t|=+{35Z-ixvc3OT=mIBo!9iNq>Q`g4l@xIW-2AUF)`9v zFm`)-NusJI`(}Op9_9VCrp2TxTNZ0Mh3tulxG)iMm1`bj zTsAP5I#sbf;0>u_Rh1+wqR{PC-4w*_Bf^$#MR8>UH}Ga??~=MJ)D9D)7GDE+G8*@? zs;BE_c?`|s%;n0#6jIX#QY(lh1*6&L{PbjRk3?M#$r^&{>MUnAc{Vz8(n{5=x_ZaV zc@8UKjKm2@E;hjr5RTKAzBFC<#jhMc4{bThJ`Vt&vERS_#dbTGnG^-^wf6x4@BQ}A zLh<>}`_T_y`pmoe>!13@yNW;mm3QrX_6FYnO1np&__d$?WdLR>F1qZN&TeyT9ORoa z#Zb0UmzSza#l zE)W4)RaBtm+RU4C#GH%sG5R$H9{T;}2yxQobXJYU){+FVqROrnK&4H?@C_vL)xHb3 zl*@~9P#v$SQg@*Ox2PM~F5QXC##{DrEa;?KA|j%7wy53`wW{7`G)uVNFizDe+UG6S z^&0>T=4?RcKm2_F0CU%-t@>ZFKYrUD!xujf0C@jvxjyfH<6XOH|9m@t1z)p^pEJAh zYtO3iv)ld@dkaVt<_RxGhsm>#)gHdQ_`tQtdj!{630>B|J*u_VdRRX9o3|g8%RU z*@cI?x?2s*RNC1{A`N__L%e3RW80X98Q6&oI0h5@q*PUjaWf>cw~)-*CV`#OQHXl~ z(3+yZQg^CFg2Ez-#%d`n%|B7Q8eteKT1_Xi|C~-ViBqA7sM+#Uch5Z~ZSuI|Y8fka z4=M1C4*##RsbR@rTb4B-aNrM9@0EExl3k}UbCfXcZ;qT z{!AJ;jhTBy8F{--4YNasN;69e7Zz`+K*s&HL=O=ak@}?0I+MayB2K&BII=l!M3aO# zlFyCY;xjCe4X?C+0cQJOu=ErqdV@s3r7#nrH$?1xtFwuV?L~YVHmFR@>{~|C(9l}2 z*-GH~Xv5y1@Rau%X-KB=tXMOB5V9U177o)m$5QU;bq7$)Ffk{MsDg;dOfJ>tj5r00 zr#hj7Rbxlw-Z2cz@HTV7_WSFF=}0)dsZUkk)7MqMVb?xq#kqs;w{b8(MOD9TKfi$3 zEcNc^0RZ3r!_>G>Md9z+-|qv!2lnb`ANH{#P_gEBM+mfQKTWmn* z7F-if5`oonhz$o$;_8wH%n?ET(NKsz|5`CW+w~@?NL95HPOn8X9&YhDn}7occBBB@ zK&wqZy4C)5)Qm^Ugkhw>HHFTAIz@-s)=$|q83s(3!)O(d01%`X;E$@O;JP`<&E9kM zQoB{eD7JuYdkq>A$1gVDH}FFP=dV*0y^>GEh_S+jV`P6E;QnJBxHG^`ZxNsWy$=BN zIL$Ele%I?WuBPt-06v+ne9HcLKh1)794~m%C2!UWRkcG}-m*8_MMxQ(o+~H%1CBPlzc=&i|5>4#8z+5 zl_V_vY`G!v)UbeKbKH{Rhz$Z;3Pbpbh;gbJVT}4>pqdWrel(A9JDJjUFbc+#aj4V+ z%x6TUOpxti;d{<;o;6`=X)TAsy~y+uHR0Ru6Bv-`Yyd$-i8b^4SdCx%6%6Ld33K^9 z`{&c~_s{(;0PRqQ-j-4Ud;kD=FSX*oZa+UrCBD1<(31SUWv5<&L#(%+lyln8UOq;{ zt-qwxUv#TZ{X?EFZTM2RYwi;8G@z=AA;(g!(9|!bqMd(TFua(LGsik3kd;0Dimh8I`=}yV6Vi_q!m0NPN z)VyYMtfD8+vfh=zI2bjijz4CVE z-{veBb@<2Iv0SW{D8b+NQXWmJGaw7tudU}92w(mVZcu-w58H|d7M=uXnTQU zHVnu4eDE#%_vbOv2mhxpFb_Fw4gpm_KP~YC>K}NwIUenwT2ThUIF-XP&6nN0yq4@Y zI^PbJ)bI~6DUE?y?t>%jJwcB9lbD=SEONxn2##}*Q*bSU!sih�@<-o&e!EdEsy( z7lF{TueZ(%fkyzhO&6ppOl`7JR8ONyeI~U8?^DwxgeR4ly2X~8r8Qr-cHIG~3Iev% zO%ro(r;2c~9SV(mC;%#&E5@zMG-`fiS_}TH0Nd6Yc5dVNDcplO)tNn4Kp)!tNMj>& zJJ&?H`|~e}!iK79lU~i8G?NXF1P)BjlN3Zni2%;~4i2`CPe)Jn$>{wd%@5M1PHzB! zNbcOW8#eE&|7Irjl*H~zb@xi+G}4)^Z_QRJ(oV7!upL$|w)LH26Ex6-d+X17II#?{ z!`r+Mn@ts|h+7y)7Z5N=14K;8c=m^RK+D{6^Z)CL1=}p;3SigA9hV2o7qdO^232qg zmc=IZM))B7@?I-Xo~fd~uT3k*2MOGhNU5+uRI4!#?p;G!CI~E@y4rR_AU2w`PH=W) z?6PEe=pi(=Oa&~KWzG8R!UDA{pgsLg@7YPZxa%S=Ra<|pcg5#K?-z>GqI}&#sb$*n zJ9#Y{w=eDNKF$T3jBX6Rxs7e_p+K1X$T{?X)8_>AAU~eVavbiI1}^Guz`!d>Zgv`q+lt~3WX)~O2d#!Ohvg0n9{sW ztWsdx(kF|_j5?bU8F zztvHD#oc+~t1!eKLDgq!BZC%>6w-nrg7|!wx}J7V`miWm_t363cl#$783_qpy-C#> zw8F%z6Lz8$4o9^;Z_aq9=_Drhh_Sa`$&Yv)X0>T z9YLy!0?)H{{HpfTug8hg{t|6UBU&O}yM4!0yKgp{_`C_;Ci~165@R`T!hn!Y2QELM zPET1x=hZ$Oc5ZU|>I6L$u_)fxmd+=aFS*o5;5@v$0qeCm+ETsFT@z`%g?eIs@1jz9sKw=Lg;LEjr)72 zohl#og1VEgq)~iQMz)WDCPy24%A_~0)khZo`6HtNs(;qnTror0O>S-t!hZ8IQ|Y%0 zSc)Big_b_09tN|B?jAh6RRMN>gcK-16-DCoN(MwKidZOU(uNw$XsN&*N?cE-=E%8G zx6@`gd@v{dvU~0yGeeEH0KwdG0EbRjnp{Z=QbUuTxE^#VshZK4OOu2X=gQ~zsO6-e zU1biJHUrP=+fqb*a5h_=8Wi%DD{uOnPyt{rVe!cwAcsEX+`Y zpU03&^%DmKr5%gQH%bHH8U%E*1Fs_w%ck^N%UYXHaQF!kZ0RgNPRi~une08D zOw~8lR&A0jDnUv>$+Nw06+D4aPs(2xk8$Pu&>vRw^1!mUMeE8p5bE?yaf*A!F;b3g z?TplO;yLhjgQ(dHgZX2fUDyIf6oQ-wJrJ#fP3^TWq~)ZI0R|6m%%A5o7rolNT(znh znmLMxA*>AOUj2AHJ7b54HVZW))FLn!x!6__L&=8YH^@EDhRMnLtZuJipj68tT&gCC zdHM}jg*VpR>?&)eb|Ri>ARze6G$L$EC?uBeIO zOe7pJ$_T!3joKu-)d+4LfHly$E+BEa;Voau2V}f`ZLZUa2V*Tw&mOdn)5V=U(uC#* zxRE(!9@O)0)E;JFK}_=mw)VbN*{6$N1Nm$}V@K5H4+{x^9@5)U0N`8yl9CRyL_T8kh^5;H@cfY_<#i>bN z=dthYpA)BV@F2!kN;m`Clil7sq1rxsi%+>-IG5zy&r~{Z1Rq<`{xFj$QcB;K#m(}ct+&N8mx_%SG%cPKii z#j6KHG^eX6J;z9fw`}jVIFMQkn{fZUv-c-Pf{E;tzM+Ct8zlGoX@|S=0r@nP}RW&+WPdh^u;PUXWZKXUT z`T5fZ{|Q;H#yN81wb+nBW#9?S%&R3Gh~k87EBQ)J&Zm_N9CxsZg9{6Q6k3 z=o6p##20(&15;02?tOMF?icN!_rHmuaRP|voPPf^U;Q4@?|uH)?ao(_vEFs{-!nt+ zgMazAAo%)U`v3s&=}%+uGI#;B=vq~CdYJ`k+S!QnR}n$kE|-VP*2axIny=^AI-5^8 z^O)U56!U{iu}r)AP0^P?H!t z(TIPK2Wc+KYjW$GZ<8A6aTasb&sO#269+M>dYZKU=y~q5Os?UKylgAP3>B%C5MIDk z5au3&TO55Gz7h^;BfV`obMdwGoy8Kf4Hy^qNwIv#B(=u5v;g1-#B;f94~`yh1zd`y zCd!Tz2`>}J92x3P@emZkG@cqckp~all98f^#oNEDKse@*i?U7R3_xlzIpE3uxOKsd zUE3^YFo8T}g82`vqEE^m66H;2$hk8;U7S#|LugbCuI+Ngi97T_R?4^D2LQbLnepbk zpEfh>_dheZ6i68Fe${cxe7fJSPw%hM#DCK>qW$J?_G@1PVjE?@7%dpFH1k7=s?rj% z^b52Be#D$zC3ZP_Ykckn`rL1<00RRy*oFY^4xYaHTCn(a1 z=SSN(|GAd)YG+TF_?q9>5t$G}M+JaX_jV0I90yx09hZWS4CP2!8AKz0MNc3bzN5(q zdv;~MY5#mae8?hZhJ4zte{J!~=f8Tm^ow7dF0AM4dw=_I>2H1#@B=r-CixF>Jrsb5 zo!zC{;#$T~e|S$t9^NSUN{z0s>L(nX(9AaiB4c#Zqvs^h)7jLi3BFc+>JF;k6OEv=t8l+FtPm+l7jY z?Sc)2YDXPZS#4VdAm$$|1qh{;QKh@eYZoP9ec7r66xU2b zg;WBAsf117n~08ePd#esZSp#I=tC`A7jbBamO@Wmc(7S#Cz^9>eH<`ZqZ?D>JTpuj znr6JYrP1m|`CCiFxsOeS=OS*25=}w?fbN8s1cFu(;jL?k<5^H~-1y{{QHYkJ5rQWc z%_rb0*b3lD!$1X!o;g`8s)T0Sd9SbPjp5?q6HxAfdE$2zVt|~ zgKK319})qW-^r4$G#jHD^Ajk|vPA*Z*A$~bQUC_Cs-;8%gK7m6LlEiz)KSTyjU8VV z8~u&9OMQ(U#qyLHxJL!BlNGnk5mfYZXwN84RW$85K8OPc91eI-y&@u@Vqj9Ca*o(C zb0p@A?m22st^>p|R;dG+c<_!|F7YH)r#hu4L#DOjN;!;{-#I!%&WO>wX!d;GxtCsj zX%mRzD28``9+NTrlYiBI{BGh7Z9e?f|4)KA@tJRZ@%C4}qM!YL{A>Bm-~XkntzHeP z9dvL&t>-77qQ`418K$TX-&>yT&iI zjq1|fv4Ez|NLVCVM`lk804fZM%!hL_cLA#a#0A8t+q35CNKGs+Xq_m@Y}IoC;6||C znyxGbC?H$6mA#bPYCt_3UFxmZQvRz#g8*6%^W{T7JG&!@sZk-~0Oj zfN%ccyRG!}nJ@lZU;E%I9{~8wXFmTg0)RpJH$X)|-}~SF;otf0?*PE3KmD0c@;#EN z??m9j?8kMaLx|sq!bhWFFCG<79V)S?*RjymfSjkSuS@)9EEqLPZ?L z%Hl4#5&yR|4{mCvL6;Xp|yISL`rYG-uLT0q$G!$#!xtGH|_W~w)6fSThrzLQ=r%{$gpv?fER zq7_h0haRe{R(~c?TGst_?TTvQK!dDMOV`sM?V)~ljxL(6Vv{^g%NQkiQe7*AnFv}f z^zS|fz!s;>?1`*fj#*~NfK5t8*}&wxEN%C#ru^IkqX?zfMUf5+(@|c-gQ{rPwRmlTQMyPQ=*#~fEEcX!U;{rMqU&m+ClNz0nk-q#uMt~MyGK`UNxV!pXtP}wh zy9CS(GhY>h6K6ekVzI4Y83(i%-xqrfW9{>WR%K$C&Q2v7Z6$R;m&q~Iw3>qYzI8R_ zWa@*wWCQKbyN3GR2XkqN)Zm^`{c8$7g9%kcwmxkA!+U2ioh3WYX)CO;$5d#o^_7BN z6e{T@CIA(Zm4(DpySi`-vAD@xk7M^DBU<)bi%a_beUm zfwtU^(paS@s7^}WBA+x=LB3med2+jYocQXFsNqa{<4GS zdGlDq)7ze`Gr1VvbbtvbcJE5tyozTyF9BF)NWhOlT!$5iw}Zyc8(^fQMcLUS33C!Y z%f;AhM%rzdS?!H-poq{Jt^ge{qXnBJ^t_i$E&Wo{?{03|SaY(}_s*X6x=0=GF<72_ z0LRHzfhUwOlAAIrSE_N}5x4Q=ZREJQM-ESRoRWHe&h^Y+kywN+s|u*cKaHBatUvZGTiQ6@U$@DPDq zm+n6CjuiwejUuR_1}ee>$3a?9&Vo9MUJcRo{i!!H@m!A&< z-@fvcI;WawzrI|Ty7+bF(4~eQdiK05_>`33hs!Q$wNMNXa$F-=UbF5&vy=RkDJl?~ z>Foc{g|E22#jwMLC(C81VaKZ?1(e@zScl#HD}V#W0j|cx9o^qsKiIp*@POEolvo5o#^Z< zhngQdb>Y4AGG}N-IsHW5X|W#DW& zW&!Uk(>SD7?HLcV++%Z;ss|TWz9V4g7L}D^IcjSQ6f(f#Q?Ar{_-yp!fx97vUWL@z zQqYdD2Nssl(pIO{lkIO=E?*A~rz={JSeuUbO@9(!ktLF(+fk3jJ(F;@d7^%RQ`Um> zNOr-X1uB^-In}1$7nmIzJA&0`uI~m~9YT2aS)*ipOr0pP6Jjac6-$lc6mWS8F`y{w z=25@6dek-s^+Sb|CVNV0B_E>~77u&2`u@qY;xK)@M8S-dpL12Y!3U)N)r@}F;?!Y) z&&TdAQjCkSU-dFM?U%{Zd8lca*D&4fe#vKfJ+7Dnq?psPXZ1u-A~mhvi*tuUqzbJ( z;7ctGVtf>^;{;5wWLB1*BzI)3XZ|3ouM$U>v%k0ALdX`9!Vp4%hSi;69-&Z#MQsll zA#4M#t{4ShQ-G+%_)P|2`nb|La8;R)hz>;;OBPgF%-8)9e)~G5UQ}xNTAsuF?xkVPKQmbNULy9h zfXXc~Zs;M-Q|;fNRrzn|FkVm+u6I~OJ>KJPK=hfk9L6&n^2eE;=iFVm14fYdDa4E1 zc5j{1*>vo(%g>0LMT=JLD0Hi%8Kow?R3hM0O-sl0Xnb=hc3=Ye)*`OO48Bc;z?IuMrx%MxshMv595PTM=w8|^B*6$bjx1yqgel)_0 zshr`Qt2LidSnj%2Glbc*_LXWo&SP`@lG0jS^m$VIr7>SK5)TdNKeb<@q%4y_wZ_?M z@&pIg4N_9#mVqiGf&RzP;}lTWn@SGO-E*B>@bN+@A0gv-V5QWjb$Q%su=LIPosPb& zgb4Kqp&+HQD1Lm!!7Dkqb`Pytj&tk$dzF(BX&krd^<6mUdx_Bc=c(c+QrMj-0|YxS zE8QPV;0C9hZdqB>cJ*l68Q+VibVRcb|HLUsEu7?Ex8V@(BVWNJ95aLWsjwv1ylZFEt+B= zWC0wJPlg64qMh`2SncD8F~_G_D`~1u#fb@UZM?nOC};We;#59CsD75Grv3 zVafg@h=NcM`dR~tLs-mRBnzfa@xRs$F&oyX@ysT)9V9l8njfnt$jCcsp^olm@f-6R z-k!YcoH~;uL}18F>1pR8^wo*S~EUtLAmR?jBoHJr5ni=D^XUwve-`q^0Lume|!Ag1$Z+d^nvb+B;5bTb}z zW-)Q&Q7pn#}4Z*m80QDMkVn~8ma z<)5<2O|b|R5VZ(HrsS&AQ8o~oune)Ny~7p0vcx6UvG!=HP!?e-g?wWww{OP$M(8`< zs@CBGuvxi%KsEnJ-t!1)reSQ4C#k23ibA2pAX6%0-nzrm_frvK;)Y$;jk2Xk^M+7? zC5I63z~oKSv9S_Q-xy=5LZBfU!Q+`=`L}8lzzL=b&TQ>xK(zLKu^Ri32jd;&o?^7^ zf@&)~53AT7NpfQZkY=%MP*eyMrSoBnN3*tRFumUPLZ(9suvw_+B>TE*$uaL}!JmkV znwERp=*yzfj0b3gE(kOpU_%`P^NG}#x#?zFT{w6}w_XLCf>gl!iY@GHx;aQHu@pdS z-Ii!vE0Zq!zQ20Jb}275L?AneA<7lQR=WxiGhIN42_&{1RPFPY$*8Jv3=<73;;-^c&1SRWc`Km-fFBvuHOZ;(xHSl_d3|-DbS~cSK2I@sm8k4k~cOf><3*v;F{*D7tHRZ zF!!j}{uU)<`B*Q?NW@U@TP0gfl$vk%;HT8dB^_BwZr54SEF$!wGiQNtO}1*AOb2&M#QH2;`e?f?DPZy0B2E7DwAU*i65^DGw{m6_03tRq=#H82CKSa_ z7;(T^1JrrFN*T#GUb{==C@_X`mFZr;q2R)Pga&-!^4!mcy@4FFv?E+n3Yv!B0BmQx zL)c+$2VSjY$~e@(0SUyVc|o@eZ45|dt{#*&zi_4HXG7hBQo&F$f77(rRNV``gk4s` z5aAjcSXNpfi;LM!(?-Tn>52-Jz&L$MGiHB61EV$1_#-Vu_30)!M0Q4;FvL_us$byt zV^LB9--CdqL>l|EXpIv_eYXNTq^PqhWtXT>>a)1UzAS0vVj4AK^Qpux4FWt0AYuV} zN-bkqF$azc{Jfz2Vo;I88^}_7Gl$X?!Q>566>g$7?oaNgx#;Qp^Rx3H9R%Y+h^Lno z?F;QEN69NmH%uQ`6O`GVl8PRH)f`< zjD@+|oLjyNPP>ZBEwc7dm`B?2v6H0D9f{(HHvMo=vZGEBToE_`SobIm^UwA9K;tz> zn3u`&#xsqWHdwlKi$}6C(Ydce;bl*CCQ#Ag9Fp))6R~i3U_3oXa!6+3Ff@Mp;#Rm6 zf~^+xJ$u~We}i9H(c5`geM2_UTGOo!zup}6-0S1E)gYD8nFaa66u zE~2z$QRe|8pi~CK1$b|pJsw+Jr-g?w*~WosbL50{wJPS>sk5|+^F1WC_S>?zQcga0 z<~^H;uFU(%w4CpnGZfm_dR|NhC}=;vi-2%$LU1eL{5*Yqq6zi9cdmkaj9wE1bGUsM zhWAs7*t!RaSS9>v(N*o$w3Y};e!6R?R=#$ZVCtnT4=RC$N8M8IQ77Jn1ScB~W32cf z{o9eBljRe)<#_Ejt0M?s!_`N-p#VPFsI$2v=mVIFqs~CJ4qdg--NiNTWRV`<`;QIYrZPYs1)jc}Ywhh_m>o|f# zt*5IeCW~FB1L)Hpy@GQZi3hidDyR{hK(a<(?gd4iCfZeMzw?tAwLz?D^Q=MPM=L_*l7QM9QdJ+LXUu z*+uPpjc-3GJU?gbNMNCivmFGrm&RJ9R_Wr`J$_|WJ67d7BC5^4vNM%ahuhJ9>2->2 zN<{Fp-E&JBq81NIJaDVxn4Q^e#NaW|yuD8Vr@W0@i4gpd;Vre*6|$ZS_)_OaVB}p^ z-^2Y=FU)eLE5tvT?eHWvmrH3?RCokDgt?`%v&=>V*JOvGBt-SXd2}QiUO5m4D;Zk1 zr0#n(;W97o_>Uf^?dW~DX~Jj0e&2(k4_vV;Xpu<6R#yp}k>(6>;X8hk`iQ0tj138CB+Iy%yuGdLQdXi+(K{^dtYV!J{8 z&^5HWw1%e`KMT34XPwfH{%GL_-8|?$nO42b&f)$cAwd~NDa~hNfQPRSKjrA5iobRI z<~_#_jg*=n@;65n9vgHvEt1Nq8V9wM>5-97b|l~=iPE5dXKTrhQ?t_pWA~m{U6Hos zEGKc;@XtM2`Q}@4RO+@!YWDY~YOnoMBtjiorz@9w%qoHL4ao>So zR^2OV#~+REy^j4X{d+fv$&Y2_6#9Sd5E&rZdFG&?qkuN_P?Y)}<*80;Z&GPns{KrL zGl)Fcfd^KUKRZAG_owgr(@ygdja0D8@$}IXrCb_sgRY3!kARYy0h`$aID8ZGA2|Pk z-hQ%4;G@?7-i%T=JZn0-$%Q+%afUX*cOp7G)~OB7N8~&H%9qaWeDFra{`!37m*4y3 zXV=gE=5GPOZ~fwVXymTQX7cmL0S@E-%f7k>H+?+!QqmG4YX{=$E7 z{;?l(x@%#bt?4lzB;0SN4X(ed@PblDPI8aU25fk(^73PsVyR+;YpEqIrS$F=Te3(^ zQ6MemT%pFv?i){+o0Ae)ga-K6Oe0f5r0MQVI~ID_umr% zqM{%!#10k@Dy9XkLIE(br44EZ7Xc-*n~1_hV*#+c-5=>Y1h6=u#tn)CVBU^qrxax| z)1fo~s-pWl1mI<|dL3Dk;o8_Z&UvT^eb&zxBcN0VZy69PA%!+cE3HM^hyfAHnM z@3+2=FMs|&co&e}m?O<%&q;cM&CSjZV0cu>L^(3u&!(fo4-gUQ4F|!Gmu)LFrcl>h zOJnryWb$0P87!|;`apkG0i}y}#{}RV+aIdNfZ4~-iqB)#z!ie{woit% zi6(+VP<5?LY_A_gJ=b9)B7tZe#>OK1>sODD33%v9d`VhbX+#@L-F?@dGzS z1(ptw(Dy2|rKRvw{?08Mt7kjylKfJdr&^nT9mJL4Uo$M*n(wGZtYpuMWawr8xb4k@ zdrWEWZRg)fTo#ZGjU_EgNp%R&@PWFdR|_MM5(}P`P+U?FnRV$>#8M?Gr3}w=a7LI=P$yoY&vz>w}b{|hv1Yx+Cg_c6`P&E$0#sD4ddIsz*0 z1RtA<4%1=mB7)0uhlVo__%qI?{)+l1OxZg^omURs0swsb=YQ>2dd9$5D!;sHLHiK!t6%RI{>~r# zZ~w}0)3+rO@YOHpH^1@Czx`=5WB@)9d-Gne3e@Xf9Aj7hRwrG&r+= zPyqLH_RlYTg5etw?kiV)?z@|)t*gRfs#*l0`HPK|rVS)b0iLTUY^S!cBv$EQy&r#M zWB`m+U#Rs>E#%Lboj;>{n6Dft%K})TR?fvIPAY9YLnFhL^ER_Tx5!0 zR5ep%;)gqV&&Tk_*bWU|Nce^h$l>WFeHp(B*G(Nvz;C{P85Di_s3dmt1Yis^nQbMy(HU(%u{@15;m{x$%s zok$gtfACw^U-;Hn$G^Yx?@kZcMEUk4_5l3SKS8Y`0{!lNb$dE>bi~>(_1;sR@BTuq zkB_h4G$ewI13Q~}JM{FKv(>%sy9mq91yli6^Qs*epD^0VAYoDIa9eFFze!doB*&_z zLdonqYS16588&m0H1`-(;tXv>s*HiS1?owFoWrrx4ah86UR-G9 za|D_FQZ7*2xJPUp`Qo)i^>+SSiH>P3ppCrd=yY6gu* z;_R+4ws0I-A{wj8;Kh@U;12x34vsnHd<)}b%@VW`LhKQtZ5Fk(cmyKS>xSV+LvASE zA*xba8>Av_0PQC85)HVU>~$YBRmGFdKWby{xd*JbDL~G#bBWnTXuNjY+#@Pw+yL$P z#!y`%3(9#5k@F@(slzC}&O`N0mGm}=s>%cs1u{UHnEOKE3|k+`um9%v|LB8>Xr$ED zrTo+L2}A|Bk==+tCGg*n8R-Qx**D>fhNK7Ews|yF%2l znwd}ECUUL^XChhT*6}%b2k5|y+5@A=vxdNr7R$0>y&mGE*m2vh2vnUts1k^%xFt0+ zbQ-w{w8?}VFr*N!MYx^pINE#_>buSIHlmx7n`rJ<#obqWzH&EcS$)muB!~($j za0u!r{iPjn0Eo4cS{h`T7;XdosV6%=>2DW|U{huyOGt00e{OI°=yLsywuzqB3k zS1AIN#r;tuK}Pm7(5_NS(qatDXK+^b<^g?jRa|!s zgAeVK_nJ+9+O|)e#KV`qJq8h(z5H}*IoF7RIMsT7=&3SqSS@2&z4W%GY~Gw%VTP)# zhGd~5+BFV-dIAB&nA}Rp6tv)~z!BpZ{w2Ko#V>yDn|9?JUrfC6@Bc?PK4)SNfA^E% zPygM&_C5go&X-%33Ohqsm4442`&a)r48h;{^uGcCc>h2Di)PFJ0RX)F|FYv5X9i*v zZsf_}>!8PqL?wduFc{)1wtAH)^L`;UPSB!hvd-qw5@)Q!LP_O@rRpDbIzVHKm=RAk zBHY%q=PnSEls~v}!k7?MwW?u0TiHMxGnGvgcHX)JEj%CyQ4Ivfx!^-;DNDsQ3}N9x z)8Lr;0H_Ikw=%UzVVd?ZmE{U35YS=GnN_{Vn9m&u02P$e2HYTl9lE(VU3t0U{4l!y z@Rj){=YlVrdBI!Da$?c=%QF>;ArI8TKc6fvxc$dNvz~8L$bH#fhfq~BkpdTq(_>Ka|nXJ!5Rqrj69#ll1jZ zzYhTThY$%g?0f(7Wu+2*9RTpTPlCbk{+quF03UqkQ*qcsg^GfRzHLwcFI0#?pZta2 z0RVjWF9QVpX8?eoUX-3%7kP0Q!0&wLcL4m_r#=k;_~3W`-gkiae&KWP4e$QJfBHM$ z1%Bp#@Ynx5%z70yr8%)Fk&l9s(dw!itn)Yy3Iz~HhK@VO4M-fv0qwD zcSRV}0zB=>6LBtCqcI!uDo+X0K z{ucmL#J3|nA&0x~CsYBHNPR=YY+M{)^RGVjV77z36aiK%t^G-5>*80^+LM_d#f}4S zM@u!I$q~I5K2~3#Fc5;h!_MlQyo&jo=d{8&*XDB6B|iNxwkxJ>1OM^g0f1lm>iO49 zp5c=KNco@psuk03ZB^_!$5Iv%F^yRI_wVxGwCy(W3Ex|K9(&UHZMh z_J9B2m%r8i{OSjPGk$*ef7m7VzxSX1A99hg<@%{2f}ES!T<^WP^4H;tH5n-z$AB)y zfp^`YVf)|k4~${S*)%!KHdk~ul3fd72gows0k87A8^ z83csXl{!Y?PB|$cVB5YJ04n2wL?y$i_p>X#?_I`yN|KK+P z;Jtt2irjl20Pya=AYg^yy>I!&=1TB{AAf_O|I3Kz5`PUpZHk2n&-Yr&_Mz^;uw3zb z|C4n0+rROx@1#G!{>d)@5Ya65fdAxwnoCT}K9lSI(*Fhk@kFfldEvf$GtyxuKY>xP zW9ZeVgRP0ZkBT9hJhXHa7NPAXuiS7??2K-o5^)H3lYJxwej-dm$x}%(T>|2)+^szR zQF*u2T`vHNoxQFAVc&#n7RzDc5b&WN%g!hzG`d`N{5zx^xPZxgwN(o-sgzg`k@-sq zDk_)3$J^Z}kud!VH^Y>O=%L!*rn``ijkyM92Z2LVIWs2_0Dc5xL6Ohm1Rr%;KD8x!SMY{_8Adj zPrTN8U!&fF9Wfu7O4_f+ArebTvexD(qi_Bu{|~j^>reVl2?5FqAhKe)rh#5bt;u%+ zfC|Wt$w;LVaRh1(J)XL>n4$*;UK=XIfy_{1OaM?sBa5DWx3Fchr&heP*BWRAH7Oj% zin>zl(}}~G-P;+pG@Aqct5v@2>kE94*>uEPxdFRL0y2C{{jH;ZhX^h zw)Z92EC2u5`@2}%w(UF+`daH_&bijw`|P{VwH=@!+zY%?xru~$^i}adJ&-u1NGMW4 z?4VNd0FLd71Cgq@E|n8_KvWXq2#F#|VJGl{62&ffKq?`w^8n&0_8UT^e5+D%?E7=} zS$prb)|_*+)_7>G^`9}voNMlV&b1R#UH6{7=A2{n(R&}gx1X>5DT;!rc%>Xq0cV`- z^1s$U`0Ky)?QaA4)_?hr_G5EGZ!N{(&kw);Rg52h%0a9@|DECM{~+e6V8i5&Rk@rN z^wg=ZS2QOCNfrT6Kv`s=gSo7J1N1a^Dhg7lDX17AP?%6D%mibd{RI;SHxJ*>9SF6M z-cWy6_H>;F307@FtmerpS(J^0!_llG-E|3^6bVy-!MHGyD2P80C;4LSLxQLK27stA z0Iwr)t{-)8)gOA0_3uUdJ&iZG+_;qKpP%gI|I{}-(Zs5G_lLe`JZ$6S`1M~Hye3j> zuKCy%aqCyKQ*rO3+MEBq|NDmlE==HG{bd07nQyjBTC&<~zXjj~qI~ma7#vOzyf^OF z@{{q=Rkr`uFMb;U{=&chFaP?bVSWyL>-*pT>`%9Ee)_k6`~UgJVmRK_-;N&s(7*TF z|M>s$-@nw`m)}gyOx5(GE$7!a_qO@sQ9JQ^28x!w#y^IZw5)3e%ZfYa`gRYXF$z6I z<>iHaQdLOj~2>c1k)t(;Ov}IYj@TaZP|4Iv&z)=>yC~`Cp#j!_mvD(J_mjd>pr}0UFmYlY6 zUs=F~9r9N#Ohc8ckMpqUl)#fU>ows{RnHQdO0p{^^0+J9BMq*izWy; zn4CFLk&mf69UUWGhvT#16yL8GjMe)}9dr}nyH{o~(HV|$_!V8Q#el$?!VUoc_P@P& z?w|fE`TL1bf3|Txey#oKH~#M*Mo|Xv=FbAa*Z)ktxhw$Xm7ZSvKR<94ksuCd6dv8b zf5{&ee6L3;0pK_PP>*l z9Dz!3PO6Lhb4unf910LJ)G~SJ8HR9`k^IadNm0*gHkQQcdg9$=iF3JjShK=?Y=VWw zV)^)n*Pec_7ifdBFwiF(VjuXzRHK=ahH81!l&h6`WAS0%PYF5U7inP@nf zh3P8Gi1;q3#-Hb?AuYQ9bo}{s{_z=rizog6{ty1jo4Dtj=F|N7HvsULUUyf~lJV(p zq4nI_=NOOJ!ma059G(2hulXwd*2!r8BK}O?m^9R9680w&WR55D)OejEVs6VCTO zQz(A(Hvs@&`x^``g8$xk{x^N+HU9V9oA+1;1&5_-u}L#4myV7pwR=EK3<3`spvp6? z*-+QB_^f3-?jE3xY69pT+R5BUD$B%P=6ykm3LMENHg@O6Uf)Z@OufTSL{A@2IKZ6R zM!Kh|fw^C=s^kDU>OmD?^?YRG^OD(>*2&q4O46mVgSexe>-90mRG9|TO6X(ia*;9_ zX_GvLo+4jM{I=X_tq42!TP!WL!@QkNgy>9_5D_wda!ujPX1(UBd@5fJAHzwftf<-9 z*>cIXita<7(G!msVx=soQLDkx9@OlAojzqD7U!#8ae)cAXJogiS=q|e%cGBjf4C-&;R`L(w}ium#M#pgHU5n~>F!hYSK`8w0K{MPAs|KitwA|6R(E*I9}|118_ zH{#<@`uBgtKYb1Z{(k)OngK0>|IxtrE`l>a962NRVhG)=EnX;l3(Tuq6Eigk1So2h zJA(mJm|C$!y83rZXIzuBPk&$@8s9J0BU^P=gX!T|ku35$#x->87rZWMTKkNPNkb+ei~ zJc~L^dq?Nz*-Spv)vs=EElU4s!=rm(FNcwG0k3Cl@e@E6k+-?xSEzfLCOgjP^SdBH z7rh7&{ms_^$nbM-{8O8EuGyN89Ea3Ve~KeEX`JP@w}1Ul`oG`$3IC<)d*Ap||El2s z_m-%|k!i*!m{nBTV?i4$Ie(Izv@Lx7qBtgew7=QDapUjYDo`zL{#5s{i8gRiKfG3BZn(3*vz#SxL0so1n8Nx0{(UjC%+;UsKd~lW(bH zd&CFV9GDa!RxfsbuCjJFx@B$?;xL|$9_miCt0+GXIKEPq!YaB zMN=Nj?vhznxmZec)%XKi8B+GIMZD(|(;A^ON!fakB(Q2dG{0<-mVR}yJCvYNuT}~v zD6mP8JYCi6w@`o23e==49_*#!1roJ`9;m-+LN!aMqlB$ zK#NPqMm_dbxnw(aAw_;D4Ac5=>fF*45bM-c7D`TVqE>VhUiOk~oJM6epB`g4+ub-I z#i=?OJ)LS<$gsB%>{;;z04A=2SRfUZjsd|9{EA_5+_`*N%Yo?7?My9Bm&=Cu6m&%E}>|HFR=0KWEb4mm+q`q!_2Cnhw!n`A~l zDpORY+YU@(c z&<2|_2oPm5Vg)m6&>61V;Ec;gM~eKx#Nd#FelH`l&L`AZUN}snDFd!PoqGw9LE=Nx zkN;=wQZs?!Y{91gto`0LTE#${c=N+=dIFq|)N4h%qKH!e5N36*b%N<<;a?l(t~Vc$ zpZlBNL^bB=FTMeQe{b-5HU-gHVvl$rfXeqe;5tB{Uvj%0{@tJKZhHMQ=-$)opZZ?| zz? zCyrK7nIerwA(sKYXo6;XvQnJ_{8sVs`Z*Ng&g+?`4&W*V@_>?_Jr?(Hsu>-*gyN$ZR$xC%;Avh$%nwBWNpOGgDVo#}tuSB2~LOF&l}4 zJ1-i`VErHIL$x}Q0TWLEK`=Sa+F?tPZzSKor(II0Bc&_@pf$5g5;KcIJCfYN-z9Hn5ZtC*8ZD;|zDW48+M5k< z;Wr*`spqwq)syBHh+sf21@fPsk!enE%uE+~4hf*xY=Yv5Cl3mgFN7=1X-w;guTMe& z!K4PD#DOLl1ein5u6947Jb^$~hF0*_jpN+0Mgm|0C6E~egu)CiISjTQ8fjJo>R$gQ zJIaOiU2f_8yJ+37ZY!!l0OZCT~%yZcgkRXn9RhT1kyZ{DM4m&6#3XpTqWR7!4PRvbY2H1+gNnPZ@ zQL0V_{>T@u-lN|Xr zC@`pJR&^&?EQp5f%F#ts{h2bsO5Fyy^g4}T3Wp?(tg&m2wIx64 zE;yyjiUrN+x*@PGC&-KImQQzqg4!mmd}DED7S1XCKc1S(l&;1v{P}i1FObOv9lDAgpjY5oolhKlBa&RAICXQffpPngeq0)OgH-iy(PpzU{ z*C?{PTX(Al&r5}w z`I)+#+l{dZ!7wQ;QQBSMCwqM;O_m6r@?jvXu9hF{W}n=Ys}5L;Ba_FH5I_v2Qbhp< zv~pZEe;Mk+j1SkKU}aK@++e)hSLPMdTap1(OVQ@{n{G<_zqy9^?x4M znzEE2Iw@Hi27YuYy$>;TQS{UAJYQ*mD*zIVMxBzZMO5cs8f;+oEu_pzO(<9%Hw$D- z*IuMKAJgtOE)gQW4j+sABL?52lVB!;&;=&Nk!)ApujNWeHeieoVGJM9$gUj^{LL7K zmGgEbHKN$8?WP}+4W{xu0@Z50v|uOQv(=@N%&kOdz^tX7(^WCxUAxsl%A~zk*S8hY z%h0OLcFhEV;;t&gzlW^>t|vQs$$CCwcYYA(!dV}r4{2+od{(0PA#Bai8n2vDZb4H@ zg<)Nv`!a?W?E}coANGH~{l@_SZ(OnZ#_FZN?k+9g{JV?qzx`_f@LRw22V=E=%fJ2_ z&Mnd@<6pF|{RRMh=gp_}(fNld&#ROBSOUwJ44&1-Oaw$qt#zy4xj4_$uT9*sia6DC zTfMCA2qwaO@_Y22V~=r0!q`O&x_K#Bh&#Y6=c}rwCfcQr9+s1t7!Xqxg(qz^&DL?$AN zwKOxJ6fTUD5b(1tmgY1d7OJYX;57rxUY(aHW*BJ&{OvH8Qk=V)s+!HwWS(acQC0um zCu^#vlKEy;71LD9|EhW}+E`GkvCV3R<;*CCUbFZ02C|Q-iThl0z!tG9`yhKUGeb?I z(5Xo~^k$c?5f#sK zTOprr9pW`ze1Kk}z$aPQ2>xO0+vwmc;f*nc_G>XWNKj(LAop#+uD5{Fg z2J<^?xY0q*GiR}uDtFdtzBFxvKRe6yYlzyW@z0gl5p$iL`hQg%2`4W(FV5L!IUbLP z<9?oJvHBKORZMk09%sw9t7ahQdd$oali-SQqHk@T%uiDv`Al@K?sLy)t|skQG;2~x z469kv+k=*Bsvn`g8xZqyJKFNo1)k^69yZyCx~}#~tuW7tbbIaUoUUUxX(#wRuET}b z#7+V)8N@iNOAReha~Gq|%lTcajIYbjak9WR^i-!xHQ5RG34Z&BwsY4COMJ+V`z8S3 zSAPR$SrzE@H;{+18|eS=a{ze#HYPCDH34# zVY1HZlAdVi)i&#F7Olf)=XcV^Ef|JlM@?;!lhl`CC4y=l97U0+_Q(}L(7M?0kL^V|A!k6#nEp$1Zhf-J4_}?J`CGEu|LB3S zDplz!wy5dIIZCVjhn2)LeFx)`tPOPKI|9J&r{s|G+5XSpzuE}d=inXDem`?3x$>sk zm4n83a8?z}I7%WXH(c9JoVx*7lz2Wf)U;b)UNv)96=J}?_IZAJ1Oq<;0Qk#)`gF*O zpZHY(z@PZmpTf6)$zjf)iVgBt-JbVd0KhN(CIH~gf1|(sFZ~oNzVXd(0|5T)Z~V;H z_1FHYn+U)1r+Sk@%rYj#Ko?*UPTO@w82H+c|2hDC=jZ=@0Ki}UwY-xIHQ#YlJdhOj z!uwE!v-JtpapJPNw&8fP2>*2=uggjU{Y(d!>eb^E6f~xDj7$WWK-9wZ%=vM)s$vTEB&;%E+%A@KcxP$U zLdNMr4xgJWv%U*fGoJmPHbr$XA6lmAde%$g%Waq9d9Uo@bfnJ;6h92Ry5R~i|D^rm zFP?nmm5990ACd#WX!KZn)j#pI?*PD?F2VIr`agqo`{tLBG+%Hx!cZlyLIkX;|{;knNd0IHP}NLqw#i9{ns@EiO^#$BMZqE4iwn zh%DgYQ4qqRdstlgK6E5WeG7juCSzylW{5DvwR)C*Oa;HyhG-UwXJy8#yIEeIlj&_7f|{O_LK3* z(nUAt+m)E(sMHefyI=C4JhM^}*+tetQ~ge%b>ZU|{hIFk6jR|OVO^*4e44Mb#)Yt>d+R;?#0HWgc=In zS>C*Y6nEnvJLN(pc8ZP`7tM|@v@oHEO960=FUv|>OEG8}YYyi+VO)zLiO8&?)u94v zfXy<`$64e!FkdG2z#112#X&7~m_T9bYNPKU6^N*s!n}8Ln_*j!(Vf79YnX{V0=GBK zAni_HzOK=;y_#hB{MBk$SW`O8w4S6qRj5uHR!pKBC0zB9&lT5;wBe&T1w&wu#es2r(l zzjF4G%=k;+SbY1nzYajh{Qo`7$?FU;y9EBtuMJ;C|6EFV2s%F}Mz{neF~0OVPUlXU z#Bp72chf)A!dJlkHEivzuWKs)-|^zC>eXDlPHoUlY*CeYo_hk5Av9{8uTZPUATp{% z!yxr&z@)VRUVRJehkjIr*#n)qaayaRtst4TXDjvgq0SK3_g(=#&)%Fb(L8deNjL)_ z*@+QnFga%;z4Vu|pB1o)*FIlJ6XW*i3iCxr-gjh{HLM!9x{H_icwSjjC5bq4C`?3k znl@Z-ckR$X5LNTc3@UO&;n4SHnU4lgAt`-nQeZ)F!MPp3EW3CI) zT{f$rGtiHIncCW#q5h!hI`;>s+_|Eza{58J*yMN+0 z`ftDSH~yg0w2rh$u3*xI{OFYvwEqZv?SK0xKX3hg>ve*#6g6xtOC?A4jdAr&*G`P* zF;Mgnz;Xk}*t``Qwzg?^tuiuZyXOoZX204j0wJhA#3R%}7~X7qf~%G`^Z|00RYOxU zYkkmZ`>@x;P2m8dG+9-4IRU~P`G-8UC-mU3m;%foE`&mmLgvZLIvljXGl#K5ObSqO z@)=4lkQvSjn;3y>ba>4$Unvt{GArNsH|DH{p%8;kV1_D*Ki!3!2xcvn7oJ<|*#JTx z&Y^(n#2%Mj1U8ofnmjqi1$fi3Fz&oV+4KKvg1_|%4K}mPKm+3R!J-oENOCxcbWf1^ z-TnKAPd@$h6TlQvLBwGQQ2|$c=4op7LhEQD>B>U&pg7_eM0f~U8Jbm0TYww zR&l@F83KVS!wAgMQyg)Lu(49W*q4I227r2I;fX!P0t4cSJ=~HE7$C|_s<`Ebc?8sD=$80Z53-yT1vtli& z0>_)r%etSEL82PEQQ^08T3c~!=L~4_~!Nh>W}@c_N%y=U)i82>=}xdd+qGn# zI4KK~&Ik5X~=q(oL`leP^39mk{?e%fnTfU&e|c{VQ7{ zSZxjRCAEp>_5GryQTL2qMb=;V%)t8Zp^H47U%agskm!eEp)8!+(#s9v21Ls=t5MbR zgi(*#i#}>nmOiQ-&7i0dv8u{)4w$i`>hxbE7-czn1@IF;@k_t;w*h?PC;pYM*AaC0 z6aUBO2TK50f9B`@+Gl?S0Dk5xf2II=Y+Ch_4{8kh`rrBXZ~h{HZ~pk7so{01GBV{% zTU=9Youh{*@e6+SHG9rQ_rZoT9^8>OQ|^ofl3Ud{fQdVQR_*Q_n=|OjIZjW{0Ez&h z|M&fS`mq-*&Obd?9h*9m`G8WGOBT=c(FK=O^$2xO89JkaoK<}2Q>u2QFzc)VGH2*6 zj{DXi4>C+Qmz2wx0TVIWHGPkXncZ7;0vE^#Ky%a0)_j3_QR+nBgJU$z3a_liL{)-c z)AxeR&6?H}7dBiWhDisWj+Un!ofldmGs*5c={i?ePym@99v+ULeC5UMR8!GvT`EiG zA$QHB!W%$EMN~1B!VFdEiPeVV%|oo({3im6b7boEJt|ZJe9!;n3mr%(nHpM(`09wn z9!|*c==TDms=SGEBqD8IF|ckI^#$IN*Ky5~s(B49Jr=wbZVb{ZnWVlKbqMQ~LG8>$ zV`markClk`xK0dd1kT!NiI3w=id0;|U~r$i5a-x@ODsJ;Xq-M!^}Ugdbx$w?5v!SH zcwXy{hAZ8-(E^gN{wcBAU;+fn^@#b4HdB##4`yQGq$+*VSxQ94#wmp;W0EIkS@E#` zZ~bRdw4 z3E*|%hLsxhJviSx!9=580ZLy4Co#@?u>xpY1G75A06{9>JFH`#g^6HdS_&~(9ed3t z{iaRL(T|ftJioA0!fn-Ijb7}w#F%c5io#TrO9ymVTgt8IlE!PKt>(%M7w#Gj?`k`% z4<_yUx9r+`@}dkHa*GZ0%Xh$_(3ucOne~i3;+~G@CI4rHm>@I0*T{#4^iEv1-hinb zsB>1P0xFqUAI(_1OyTKQvvuaULI8^GM0dBli8@blOL55;ZxGyy8v|HT3OiaYO;G_u z1)`{UZ&dJeo8};0lwQpjXCKs> zfph3ge;2itJ?Y6m>hs8A-nO(n*Oclp8v}S9(U}0^g=*(r_*bz^%lA*6M0JuObdVp? zFYx)+S^m8Kz=@wUpqLu+;B$-l!K>L*@8FxSfjrxBolp<}s3{wnYP^df*qq zb%w@`>7KN~QNfbN)F$wldDbr(`)Ms_&=}InMOSQ_%j3(m+0PCGPHw1dVK;>dP}Nop zp|QP_MjSDcObjv<8BGeagud63{j6m0=y>sSla`PMWhK*svkyVmrM1PYUT?LZzDo25 zw(DUDw-xD8d4 z#^tr^RiP8Cvm>pV2IvU^<-uj(!p`wRpVaYm>mYRHk_8NcoaAz0TwErF@U26&$FSvV5s$QfCVdQxAo4&k%Nr;bj_n& z$qJerUr-atn%nj9RpWy&sCW=-Eua7fv9ij{AWgfC9L0vifQnB-H{FmKfJ8Ay%WMjD zh@DE~Xf>gvBfG{@CO#IC7$x*D#ktL`iBPrWXu4`X+mYRn4KIjct3NsS9gn8#r-_wW za@+WEWu(gztae&ksQuV_$`nBQ9J#erz3^-%2v1*ezQX`Fui!_kRed=9-1LNEEFVN* z6pU$i197Wp(GsQg*RABLdRTf#C9e(-O-%|*!x@Wdcc;;cNS6w_lxAk2C}j|f;L4Ym z^a_hYz1@+@93*+(h={lY%&Knb1XFA3enb&^CnTD%Pt|ob-Xo`le0&w(`3nH>3;%|H z`py3{0N`JAl3ZL(A3e!qfNk1L{Bd$a)G*R>B3}55HTsxI{;zAX#{Or3MQgdk+GN!2 z2O5tx2e<;XQ5J{>IvV8)O@)hVaO19Fc6p6EvjSI@GUZ>(Io1WK_cxsL(i!aUQxr>V zvA*WSSZR^nBdrBy>*_~MgSOh9l|ZOEWM)}EL~6AT&j`j*J4{RrsKh*dH+aB%#uZ8M zj69yKD(V0-@mP{6HL!cKGDM_0G}2Y%j9JWaG2jbmWQWvJ1-#bzRP7|(MHVRSYEw?+_S~h-NBWso%ib-xdSGX{NqBft z>z6@Ht)^^#Swa06;`sj6>$tcdS%2lSErs;U8S8`VHTh+M-I{_mM2aePYM8BA^FVPW z$$8GO*g<3zUSAY!&z~FP&9rGlS{wHvn45Q|J{!o}Q|d0>O|hzqQ!+kz+ivkh)HNj?j4B@l>2o zq&j~?;Z$m-1}YE|;4q7e#pJ8gyD1w(P}oCd(sKovgiHk@Fr5fMiL+idQ+50Tn3bUm zS+OmS6lDdQa#UqLPm3++abD}3bR2#B=uI-cD9_tZ$V^hAU?;$qiRTZGpqp=$uRpVI1 ze)1rScgNlnxt_2ir|)T-J*x*$I+mP~^j#A5&bc~+T$oCIQaMAZqr_IBBZT%U>C%gAgMMU8*{$ls#*Z!!d zVRe5gDBMNGd1fGoO0@*SMFHj@5lgoCzi3I4Q4t6nhMwYhR%p zYnPR%pb|=aO#%lyH}v{#=NxpRb$i|LO8cx% zQ?2Kn7UD{Oz6!A^#LiR_{5UbDcCVG$iW)Id8gWu$OAsh!b^!1Qw>D_UJaZ)dCgbj^ z${VA4-l)K~6QKyzjcf)R=A%~p)9=e}i5)9t;$!f<1k+eWOq8@Jdsr9@g*Lk>1`$Qk z{Wg;h=j?+Ye27|Kz4otx91h|_>CYabeO1gfb&2FzC+xniP8HC*b?(;BhAUhB>*X>h zjIi34CrXnlJcG_;GM=G_xxxe8N$pYOs3`3UU-q!d?fTJ^oCWfhqkrxyy)J^hzLQZN zCRm(A@}AE16~WTuXp)z8qdC0~;DCNZhL)eJ%6-RaiOKKf87keNRw(q_#r(Y5?I=^MOd{;`+@?fIt+Pn2|S?Pp97QP z*~pex@iY}s8s7d{Z)@7e52vldi5F4dk8aN>asT|aX4w1Zv%UV`{p%-;@9+NM8B2wh zgI{)L&S$MWzlZG$zCTyJuc>|zZF={9zaxemWsABLb1J9Fs9}J(&Or>!RqQq(&4du6J^RsRHFdZy4AD3Y$HLi7!g-BL%>{!)-i4Yg&*_Juwthz$->Ig1k+| zM>B;$yhb$xk@+GD1CmO#VUxiKGjjw9rnW}_%P~PpMv*{~iJ>;b02Ef3Fc)S~OhlzX zxp-9+6QIPM%2GkGf)Y_n%$zlu#Bwiy-DirJtU6t57rLq7;;x=ilzEm?lMaM5$_>b4 zio~^0b~BsiO2#4&sAgaJV!`b=fFkt%QVN7yx-AV@;SHtKNdZ0|qf)`^m{Tu=TkU`= zHrw@D!A;+bzJDF=BH{dwBjcAXm9kUCDvKU4(PTC*Peqh{lb&J?LrU||I(RbDiQH?1CPd~$6eck0@CjfGq1}~g z%Rt}oE%91bfd;Axg;Q03tO&+x#o@s@Olnjy7;+|ML{sssLDRd({f>&_NL_3pGILXn zND@FLRmc-iLKU)j2fwL~NXlHOK&ruk0nb1NKp=&Y)S^H{6uiO4=CI9_ zSujn0&e&sWMPO12CJnI$2m+?i@OVr7WqkD}qTo_$P9Y1^h!PA&L;#B?1qCU14oc(! z$D}<9)upREmpyU#mRJ7rPYo-p$5!f3ne}7r))`_3S=Sr06EgSp)J!eo7M{xJY8vQa zHrDMSs-AFZbOF0$Nd!_B6UF8^S-56IV16bSN8iW|tJS@Q5alNT%W6|Kq3Yo4N`OgB zjv-lYqj#cBzUObR3X>(L+K&Tn4FeRU%oM1Yk-?-(q0zO{L(iP9QSFQ{SjlshF%hxC z$UXR#7!lT{V>+GMTW(rKhXuzYLQ2lFj53d1q#ZP;?AQA%U3e~}Ur>v{&Ab?pv@GI`fFmD-VTQuXacg8u z^c4!(j|&M>v`yDm0OXES!PL|DAq`P#f{6SJ1dxkHPVKGC)n#KujPi znV$stZVjM9;GiF|>|uIk@2QAKD6)F^x0d3w;Z2#My3l5esSuaV^M|D*Ejd+?SxYB7 zN&f?Y3_r}~w!8D@1o}6W^X0U-gZltGQzI7Jj#D}-# z8%oio2_KOy>9~!@JmLfpeyoBk>$Go)4|%g=zf0weT7#0|9B=VvKE$Hy62oswy|M=d4yk9Vv=a z5v8}cw#i;o#hQwS3`K)f};xb8UGAH+vA>xK&bzBN{q$bRm~l`Cxh8(wm~3!Pn~UX5*;DCB(KUwolHe00|xg=Gxo zm(aAB!`ZF1t=UV{?a$&c+m~QUr6R1|ar$AkFYJm?P{e(xpCd2~&ml>R%8}hC?WOif@V>GM6$rja<18mA? z6YRPjfJ@_~L%R5myW0^gS?I?fG+QK6aAtlp*p~YW13+zs?!ZU^e4B<(^ z#E#*6#&dum#X(1b=sbvSW*{j@FcQ_OcDiSzfEYB}u}q=4XouLa0;>s#hR*6%{6Ya(V^j%}Qg+5s8@nedCn0*KYm*tY3lH@haw#f6h@{i&@5W3En22lsh~_J^ zx?LiC6K0+oHcdN`C4i*B4Yeol#X%~rJAi>K1vyImHiI?{keW=-6#o!KZY+J|J!YwK+!3mAkeNj`?EXKMf|HhO@>rRMwPN%G{crKnV&9gZP zJh66-%%)2ERvNii$~DMEr5ywO=wdi2gAvTrNiNaysdhSwsDndoA zS-(P>R)1Tm(-62rNcTUi}Hn_qF^e*tSyuXa=aTkmczr>81nJ;CYFb+UEx%Oq;UoI~IHa5I9|v(bGQ6y4D6?CvyNY^l}8 z)fdK;n!CSy?jPaYtzOx|Hbh}YK8y3lj5KUFx^fCn#uN;Ovfd;5GZOLlTF~st0X)TK zrCxcBn;KQ=wb3@^e!$^3>>0PRdUh`Zowptg9kJEkW1!E8D8s1FUhDZi7C(Dx`A{fp zT6d4g?B+*x*LPExJgdd{64%8%M4UfaQwcTdkDlFHy%@*QVXygDV9z2&Fjt9m0u-}c z1OHwoJ9I%S`{0)PURPlmo$TEml}JO-1BNHm>2#<>i}V`T?6(CSYlLz6UhMoIi`K@_ ziK_)-bfSt3BV+H3xp`1hO+FM>R+A>^wNs0*z*k{vp~wm z$MsBAs4t^6N&fs#=qECYVHDMv&a@un{cuKfMnCGlOdj;H8Kj1GiFmAz)LaMwRN#HwWgIJU!fNdT}3}%K)kxp>hAi8B70*qGFv;f=dRW(_fX4?vHZS>S4;1m z0Z$)uS(-z@)_?28KZJ{*JmFysm$d#v#gV%p$*JsXyj^CwgJWB%naG955e8f zYykobz!3vbSxeSATSzw@N}!4EwjoEVoBUtZ9+aB^d|@9}+*&hXW$lhKdd?I>Akbnm z%Xi=uGlbNARHMpkKq~|<|Q4mQ6 z1t=3()dUW%le=k(!{xnKo!>#oGWHNMPgSfyqI7m@=5eWPf~;!}eu7_S8Q; zA}v$lGYpANQ?Fk;!Rz8KoqntyJ)F#$QoIkdeTNUSCMK2O+#)|%jXBDcV-8(49Q&kM zco5RFoW+7S4j7dxp36SAGW#`M&lC(TRoe&{&jSh^aC3N8dwHPeg$`5H`mr_Sb8QR^sGG~5-!tL|e|Wxn%2JS&RG!4f zjQMT8(gj=r`4&ytkC__8uQ@ZV&?7SAAfJ_I@`mBhj3z2bH*(L68b&o5OCL`v`)L-D z=iQiSZEJ_wZp_X%+-2N(<}YS>;b8zgEThw?GHKCbsJ%36(9yp#qJVo?pD7rwk`8C^ zbOzS{<4MZ;+5k1#@|mRASrkhb+b)wYyqZb;-IrplALpA~6I zf~(B#I9>m{_#O3t>9gLUFf!?1dW7Oj6xjFy3h&eh`LbR zQjXP~*n|JQ8s|^!>SnF#7Z#VES{1I;6-Lc5sL6oXq>&~Y*Wm#y9!7W`X!M;LD(OXS zB9)C`eD#?DOtoFGF1>W~T{=pe8!`$!s<$T#Yt)5$F1R9hi06o?B6^z5>c(rS*%sZN zj=4^GIi!}Gug3%%7I@7TS2)-69GoY?3;i>Nz{-Rr0Xk_e_N_8BDEs@ar6WDu+5)7tl z>qH3vv=|`|;J9A-#AI%{YVhFg?#GrEw&q!3=g~ymgoWITar!Ks1Da=AJLe$>pPXu! zYsf1QT@)zWX`BHpQkJpHRf0Z>JdDYdqwM5dH}Uz8^7#Jqhr2r{Z)zlDHxygO^&*j% z^auU03|;3gHi}gAIj#_37B?9X(ZA0(t!v)Bhl1f|tD`rHGP5hK2li=o^F@qPr`vST zSi^TbHTq(YY8EggjJ@SUx_j52RP$!mw|*km)=Rk#JkT3z-&;>foum-XEPCbIi(jQI z2fA#*g|gBt1DO?YIcObZgBHS>1pGv}Pbn$~W&mBbv*@rj4bHgp)Ky~94GNynqF?^Z zYVDrCq0!~N+R-vEcUwib_J|LXA#)h*Xe$k)98`}8o6AH?tQ^MLMfEJ@OLClsZ^+tE zX#It|P{~jW$)l2DhJj42+FYmaeWo`Ipxor3;y3nU@Lj<4oK6-x6`;TrLKBlG7K-&S zc*ZixtUH>iLOlfyqY%VH6bz9fLT4=WUy3JobTR+vMXrUxl;P&F5ah`YV5A#z2ul5e zajI^aj={{aLbvXkI@qeSVMG3sccdL#-H5zIuVhM=+^71}_LZZSJ%A&f+D+wcWc z$}~ZsswSeCJqymPjHd$TVT}w1M9`#(0)=db2q)ty*w>4Xy2ZwItPNC6eEi}%;f)@^ zgaQVa26vY%m&Hsd%v}vNL8&EC2#|f5O7~)Po)3p<6OkN@_oV=b@BSxmjxYARn@=|G zTQ3S=Dk#iK60cghczH*sPojYNB$>Go`-KG!pX}A5R2iLZq&gR0YFoHQ7cOu%g-e9J z7I-2LTgV4F1|o*lRCa-c*7t=ex<}U)$XSuD3A;$eWopNoyD6Mh6o63)ZKy*a{CU9@ zr=*mf?B^(UQ%e#Ug*!`B zCmQ6C_^&HT-7~v&r;08{QnBUJP0%}a3<>|lQz4on>c!-WI8Is-)9#*5aPW6pNj-Y@ zS?9fOyK`mf%xM}`Usx2_S^3=?-5I$OuWUxP*bFe$Ijfj^ zVJ{0&8^j<VyGk*wmO>{+FO05VuG2|-oZ(-o^kvhT9#^O()h`7p~7^E~6daGB=PFkc$mJ z>LNLFGq2z4G0XjMyQ9kRlGx_`*vGm3d#@kJ_8K3)hUYX%{8F>5+kM^RuW$X;ZS8%@ zmdyJD1LdR3cnYJYYU2tDu8*~sQW&vyyW9?y0i7{sbtJTRG>V%)a0bzlf)%A^RETc@ zxcl6RV0Fb~Sk07l!PU*&Szvh#J8Obx)j0Di1Zni^5cUr5gcJ##JeicD=TzO7D=pM` zhi`mG^dSpQk{6I&hkQ~<;Om_Sg&*6+D@S=wf6PF22vRGplyOB)22Hy*O8WqHd$@7C&JLBH7US5@M4h(o z;ejeHl9k~9AzoZVJ3}Ao-h(XNYrt|AC=S)A|c2=h&Qq3IFkI4Xl zg##$DFk=XyM-$wZ%3G}VCM7l(Stj3HQY2rl*ox{fG87OKk2EDnVThTs<19xM4WTi) zDj=BU;bAX;9ihiVDN~V%08%QZ?u;60sjISvPNp<95D|oPg$Lr?zxxL9MY8GVUtI?@ zb|7?w7hlOwK0LUv3kO{rNt5&92fIvFuX%nWa#WYG{+BvgVO-o=@b^Po5Akw+=Gkcs zr`;eBu}%NGGM3oq>h09Bq*}bgkJb^?kJZTcYHz1b@N{7(P{!hChTVSj8pO6IQ5v^l z%=>ZL9M{qCNzVKzoz7uItf+bGJy2{>RxbUh*P8PL0}wgDNEfJoDlWd6!WAIq63z-^ zIn{pnsi(S^KT3zBU(?pE?RS&sVKUQ{8>U-%1YpO_sz2sOips!ntj0F4A%!2Wx@H>= zO|%c{mEi0m=u8z(uWoYUEv%VfGs44%r?D3(s4c5@pRO4#Q-FHsD^su`Zj>Eil)1v< zjLruou`yzOE{3J!zojqZ!v+@d6RZq16_bL(7)n{%K_1`VzXO07v(V#<+0eapRkLQx z%1P&=(=KPG=kjKKS#5BJ|DitV+IDR?*+(O~AFU5R-$F@PgC?G7{+3nxipRfi&3E0Y z2?1-X{tQ4A!syylp4o8Eyx-u1;JmiEC}>%r8dlex$DP zfua6&QUU)@@f@kTQa3hvgnKmkW5~Ty3d5x2%p#i9Gp<%lv8H5bOJXd&W!nHU9?|$&^-Ml#hK$(~UEk(faG<+taF6I&7<*pk!_SMtTVO!UL z*^@UySJCywLJpE9UBv)vRV^AMic5Dyy|a-zv?tT><)s|Z5gJkLbmv>UJ%{I>%lU)) zL`GIy)y)rPUg>;orqIX}i3Z19HPF7L?)&^Wta97j0Us?Ecw2p>p3r7i_YYegldJG_ z#?mN7Prr_rZr#Qo8C!p89{un_(z8U%DkW_SLejW%$)}>`T{CTZ-Gh36V%qh3|JrG3 zt(T{E_T2{ClkkKCFB8Y)lU7gG+O^%euYLUty$}<8`fTE@f2sn_N6yPb*{|kG%;hS8+%EyOyzx{*9BLGOby?yy=HxW4bt+JY^ zI{qDOwq*#9BdP`y(}^!zwo?X+S_^Aw)KA*-0?jgU*Fv15Z4Xd;9>1V9n6rKALI02h zhXE~yR;x-~*(#%J8BqiO3Qn;YRV%W4eQRUVN*8en5VrAF6o&)HafFxF#oIe2)1kZP zW5F@(DPH*t{m8lMeejqMX2#cJeYAajLUq8i2p5KoIFcs5;jXL8=K06Fh z3bx1tSpgNgkTN+eR{pcHi|P&dp(K4hvG8E5XX2*T+cFQ@bC<7tH{4w_Uc?M0E+jRk zHS=$T%5$o}T-P)R7Yq^5fS?IvmoM$}ejFO${j&SC_3`GqVA z>Vgov-n?iPjBG`7WdfMJ=#F~H>P~r#kiNuGwLb&^3XGjq#xBrYDF&qUMX$t*ps9dZ zXCMkF2HS%ie(;}uA7u*wyO*zCy|}$8c`N`^6V=!!RQZ+GtpWFnm7;8!)PE^v)uC95 zRB_b@N&2H;l)1{EJ-5mBvd+R4&kR-QERadb>zclIW-`iA0rq*9#S=0Zue49-apJ#d zi(9T~hB_vPw`vgnh5Q3;KgC6Sm0f-1{!%vpBI)Bt>U$k(Ij}_~5?XK~^|ZR>BGSnK zxR75&y@gK${p#e%+9#%EF`TLwmXsdDb~GgSeb|_iJ6O%2NGl$ia&g2ei_#L%eyuT-*n>A$}P^ z0C{qOi(e_Q+OhuGr;%Lf*dN*qUTEB$ZBnp=>knS4dp%HS9%byd&bXik)tqK_$Ee2H z?2(78e6G^SGmUJTRDp@JCO3*#Ia+`;S4qSG>VaZ7F4Lb}04M?j=7|SU{qXLed|vLh z0I+@a>8sn_;H(vFuRUUwyn~fH>;9SYfQpYWCw0&6Si={@#;$D7SS&wa7$0Y-`@-oW zFSZ)P^uaeWKy32yukuT2w6>^Dp;xm6fS)n&0U#<7{6&qDLDxz8)vb&FiSBwa$(YEc zi7%QWGYE$%_YSFR-r(a0SG5UhrtAiwz-asC(Q)xIzv;7*NZntaF7a8Q3iORH)Wd;{&&pT-Wav~vA_D6=~9NE5E%~S=u z#5oa)>B*5GV`1r3MDr=89tQ~w#>`9#1fXIb9XcUrPO$ysyZddKC!pNi+}zz2sKIlO zYAqi~$amM&5k_a)@MNC^I*%i2vqB`G@FDEWvpmKvo=KCRl?P+1G)0Ex3Mu6oH*M~s zfxMkJ*!cBVp$P)vfA^78MsQWcc{z+V??Vr9NSP^$x$HwE=%IzTQ;M z?v2K2IvvS*UA9|Q)L4ITFUeZhGkxDtAM_>?T)~QTn%av)ajNichk4$t$k%@NuGe1Ya?S)OpS#{n{Hp~4f1Vg$VXZz(A`EUE(%+y^zZy~f2&wFdl$yyJS15a%SRoBU!|b)2;<-W36@ zVqeW+Lxx&M8~K7y4^0eEqNh^x^a_lclhlwLpuXN=3_uqA>xWNa$n-@G?;T5fhgw)a z+&~g(#U?eJZ0{rkD>AP|m5v=K{ z%UI(3yI7_pY-fbiJb-Z}2<`;GJOF4wm%ru!Pz)aZWRCWadJcfz1du~EO9?NY;*+*)&x%)^t_%`R2}$o3K&zjaBN z6yUKo3weY=D{w^CG7(#74xaOVsQPKaysWOs*r>GN=|(32L~xdtkZXcYvE;BORnxFE zr8z~9CEkV~N1wL~_*yKMOiiF0s;g%a*3t9l0ai?Fj5TD~ea%HgX5HNaz;qDNd3&?P zF^MRFCYT!W+!h0bv6imytx~%VWg!@U3?(f%>53(OMX*KA#f=@OsjRFD2Ho5?sC!1i z1SVpgBYh{kSH0ie3Dvz$J}|%~N?rev;0S&^Mp_yM2yJ(2@vu8~nxMJ;83I8;!2|}8 znTn~Qpop^)0A9WTaLVU|OO+<4(*kTgvsfW!Ru%2oL1O5lm{LI{Vt@*aJhW1BhXpjj zz@T_qNFr);u2WPxCo5295ErPBmB``()qN?YupD*X@4>`6KknxnpTM?&6v_;nAqTnr zFK+G+kDF;DKX`Zl2g_ztsB~6d-xu(_L1Zv#c(`%|GpZ`K06>5j59|m=_;GIl^EIgN zyFV0#-1nwbwWCL+T?KcF%g$y@ftI>$y;fi2AJrz2&co-SlW-rQA=MyJpJya`>i!ki zHR{YQ9~4ooR1Gby(^_xcy;DTNQLK_yIA1DcjUYE$nfftMRb_WQ270&JK~6&cZc)L5 zsVXy#l4yUL7Pm*zujNt@h&}TNSfPTN!nLd++{#R35a^a_CsBF=+B<|>EFVLaD6+kE z%F*!d)lCHvj;%dZD0aFkSuNl!yN5cuF&T9Vf~9~0E$k(< zIcAsjrvXHXjCf2zv7n@cLNMjyEK*7Zrlh6qs9I;YNjOCj%blAu0RWZ98#P=}eCP|d zWIVQ-2<==WJB4}vS!m3o`)w45v=4L+Vi0%)GWG0-3(a!^$O0(8`bAX7*=K>GX;T;~ z`=_^u4Fq_xyDY&QA(#Zg;!eyRx@=_x^C)EIRcSItEhAsOh({GTq#=6or?e>6rzFu2^3dVcJZsk>c1SCRB1 z+Nn|GpQ$zxl}KF!c!WXAbr5M)PL_O7D=+u&={?j2oS?U0y1!Sks4yRW65LhzgVxsd zlWSh_)!V%y3d`@i^h>qV3E;wR&v21YR&PeQ_iA;C8UU3@=S{@i_Iq3@MM>2qrJCPA zpx7$u^iQIb0#j$*th40)-W6*-zSp-2-PhOWh!c%GaDjjI{|P z1D)R4&%?;zDZd!%C`?5!s+WgdAlSZ?%o1S}wFt;^=BJz8vD46}`$3fn1YoK*qcBY= zu~dKmu$s9DK6uRi+x+X)rd91jgM)U)k^gUd;?H9o1G zqh@?oXL}Two5ED!!Er;vx5}>iaR2d$5db!g+JW#AV{x05D2u^ir%6(>q$dDFiIuGM z?{4jl^)IBI!=pG@N(|*dQX;Ra!oa0Ct1Z}W2)aMKz5gfQzkfW+i$5^G_=E|>OpvF~ z?`N@cw=27{eSCNa+&|3<51(mOWuf!q!%=y&-R*W%hzO=l`U!8amMl^$QR(ehO=`Q2 zoUZ6B&GHkIBg%O0hIM2+qdIjOT8bcX&Rv5Q;cw> zF;IlH*}Z#D3{F-*jx#MT9#NneBf8dZI@`v#95br$?)rGi9ijRa@uQLeaCU>*O-mKA zPU$SkV-Rg(cnZC|O94=XgefhO<)ye{wcE24D+8U*l}B~Xg~6#wLt1njjhYjIg+NC> z=mwehgJX@D$J#yMSlF2d8HOjxR5%>-)N4U2OSQ^Ho_@xRc@4^v`fy<~%WMUW`QMAVs^C<`1|m7rL=1K3v^s%)=H zh6)xFH}0CJl$OYidishKu*Kk;a!KCh?MzML!)bU)493%y8^YLPl7B@7DM%z9Gv~VQ>I?eIfjrMVvq;tJf z44Be=F26V#Ro)E{nn-jV*CXn(*e+Ub~A9a>-G`X7(MD{y>J1#h?8serwd-p~R(VPl3mF;IE?-gMr5@BZ=TCOv7M z9`|J`TbgD-4tck9iLWMLp5MQF^MiNq@ba}{8uN7I?yU!lExe*XJR9`NL_0zKZ72HYMjX>DNYYoHK)n$+w(Iy&A6u_ zI(3qINT4jN3aAMT>+g#dY@xa5@^+j|Ts$?Ah%G1p<5*mL6p#t#NPHQ#98YY*nG>ci z$BdQ5YEwRAQ-DQ9y~E?Ym$JLr?sgNE&Rx#ktGR?7)>o%&%J%l<{WQ&`;PJEX*^8Gd zz~kqiy?r}Rw;P(u@o@kCh?|#ReX+p|c+xrsp~(F7_~x_kfB)^{@s*a%Zc}LT!BD9( zX;g7iz=$0)aP(ERy}mV@S3kM_gDagD8=|Qu=VRe?l}ASY9UgqQqQ~d6Eq$DC#p*nx z0>w}|P&8Gl7%QOWsR9Xb==N&z%tQ<&qjS*8DP(D(F{B?}Ikg*Hk8@&yjklLJzO%(^ zs;_tac@5!C-HQQR)>j)ZR(N?}vSERdm0gL8$BOW>_!)%~*iB(w7uGn^7purHFowEW z_Y_u(DxGz9K_s$dESPF&UBb5kaiy?H1T*zeD(h;3wx=4mCwF6ErHEAzhjFqlFMbhZ z7O686)IwmTg2FY*lUVL_(gvo>H6H z>Ui6FR4`&NE64bgT)1kkNXw<9<*OG3Iv%sO8@((}R&l=EC`zq7PjC`mT(%R&XXN~j zSv~6ukkGE3WOHYUZPqBQ^nEJ>BI@@Se}5IvHbH8V4HC7Le$FI*?_yQ(MAtX-~XNO-j^3!OhpcF zpYBoaK7DyxAnLBoUaUyw$M1jlyT5aPcsw4qyBBx2QXI$2aVcdWqME{r5{=tKt5(rD z3q9KuX3CC3)ocY9QfZyz5K$?n-{b9uwZ8hT_c1!_Iri>_goYpbBxD34^HY*&Xl7u& z=HMXScyw2=QcJAg^`8E#W$d< zRL59YdD5>ha87Fk-peIas^YBuqv0gy?p*(j!FhikWE&y8a-qRI!X;L20WGCU>dCp5gH_jkRgdPF5(BKU5bCl2 zY37c?XhG-8!eS?b^isd=c=gJZ!>7pr$kYDa<2>EHy1@&h+$x&Gtny+!sZ6&o=J~6S z3f$oR?|wed!2aR!```cG`yb;CAjkdN`^Qar`6I7(6Z9}8DPjW6?|<-*e*3d0JStv2 z?2pH}1Pk)*>08^_HE9Tn!N6I_QK{|qYqh8F#_LsNtMp)4nJ(+aI@|Nw3gZb|CW2eE zFYZ8pri08i(_hyTQaB}P(OgI&@Y+TQUpx&(XXVy$+7X9^*g0hp4!(ZV*``pmv;y58 zJad*^8e9^;0@ElxPTi&ccCAso^Xsz6YQi}It+z3lD20ksm{%jg&&8#;cEjrY-0yIS z^z~0+DA@C&LS*{v~}#KY;Hyl6p8OFiOEY8CgtKB-IUn}d&Sjzt~ z9+x7)C$!*Xf~)kfRzG%AF|&?7boCn z(!tDe6rfA;;58($3f5?NZ`U7_rMq1g5gON_k#nwtLjS@!5P{)FS5Vj#Wf;^75AOpB z7V{re>1O94OF`6p_pbxW409nwW*vHng z>SQtE!o-rwEwREg*>(K2m*k4pGupw(xrsT_YlNxY>m`S;2OD7W#07=D09n0%uZE}t zTV)szNpsKFB%YJxzB;1Z0T9ft=~)ZIQUDaC8l~wj3_^<8(8S>Ym_r_tupZYT=W;5@ z$jAy_9rUw@H}i|H9Od!m_QmaPS0B z82AK(3TO*6qvpJ*ZQ`I&H%lyyEI77XClv*~J4%v}1Ue`niO{vJEop~d7zidp0LX(p zU@*Ul@{)YOz)rJ+#g?XatSjAY1q$F=J_Re2oHuoK^k5+eYge2+G_D|X;;MA#Thxh0 zp=R4czhyvzw{|5@#5;;yGQs4BIY?@jE+DD)>yUqC>Xb+q;{)^jg=RiY2Ga!9Dmof~ zspEZ>!f91)2?&!^Z^w)rVQ#J}C|F7R9vj7#R4|!TwXze%rn;g>Da2q^_0+Ts*lAjA zMpD84ty6qvxKSPem@v(YyZxS$mm9zwqlxmA1mdEzDHvK}5+cbvncNArz|}4H7_IZ9 zV$ehCc!5Q>Wh+_$np6SMhH6kx%4Yu39S0rtL9TjPcLL1dLZi8-UV{b6|7i4U2$s>P zP|B%{HN|aE!wC>E5GF7Yj0)}M_bo-Xc62` zXGpUbL^AA(#{R;ZP^G>W3icFaah|)-7h(vuxBJ@-<7oT$nC=dTm$uzds(PFVt_wW| zoq);YKlft7;Q*9^2Oq+2H-`!=03HwXeB5Iyz@*Hga@_B~``K^*1 zL(ga+mwrxmx%7We>Jsw5Rh#FUlFBh;ph36EMFDtN+ZnVV0sPZnx(L}Gc)Yuryk!!btIvFfVGmj<5 zD%-P=e<}kQoF5v=v9|u^%C)Wu`nhgh8$qmGPylNs3AC5Mi5R63QNNJ@7ON2p@sb&y z(xWbzKbaP5M4SU8wi)neN&I_<2Z|9z`q zZM&f&P`vyjpRPqpJ=RnEscXt+;xDZ@4+$5s)ZIIOmBmO;+sYoVa`3?R#?E;8H50px zu)3GfoKBU)*mDxPrYCUlqK^~w!AG)69cX}FEC9G6`OuaoE(Er6wtRxmlOsWOr;m@1 zHZ^3Vtrm0^4xlXwcXHFY8Tw&#m(0+Iv$K3w9Px5<_wv>8z?*{O4Ba2++s!ToV1SFS z7x}uePOP9in@#vZ88@s?Gk}R-904fiS!c21!_(W%aa*th8}xX5e0co9XYc1S6+Gez zK;enOD6U=@Wy$$QvOzRG!&f?FVEsx@%G+;TZqlMIbTgyz#U@>Xf?OY|WOaRaesEif zcOF_&gdRd#1ynl`@52YN&K5f$(zG&3R&bAsjy#9;ln?;&vEkPx~T2rF0;)}~( zHHv+9T`n4>d&WSrhHHo6>tP&>CJTj%iP4Hc^! zT>RtjiJ2HoMTR3byY4G#*JA+UC1ap0?L0c&JQ1$4wZsQQi}#_Nw!GyMtR7$n>}>rg zF7=4RvlGxj)X0-GJ(H#DOl8_(|Af3pK$`2-VN~_{@oj*#0T-vAMUaYlTj(6KgN_;- zX@~eK9<3=vhuUlmPf$(!z@L#*ui1Z2W@)hoi1bcCl(i))%prIgJd?D#@;dGAzAC#1 z>^9S^`_H#udHUpKq;Q!~K*h+?7p%a@ieP#%m1%nUPJn_3IUHoWy}NzS1cBJo;V?hG z`~D5?rU@@~njrJz=l7rg!-oecH^BS%0H*D3v)QWam8duRiJ=te#Lafh_KIDLQcLOM#4WDtJ6* zoKo;bk##6Q)SrxGd;T|dS1=iM!N^GvYZ;HlK+mp-0im;4@YE?4YPM^t5-OjS8eC{+ zB@|?kddQdyR$m#Q9YAUq{a`&vUQ+U@}zg_A4W%Vt(pj7~fs#*lFhbBPjMSN!V>$C}#kmxKg%W+5uDgGkG8#tA~TM(haz zOsj;BdXVJwSqh3GNYN?x5r%G2?qtMrgBdqZa{-?#0sq!2Adt08E>>>Zqd7htIbA-L%1vell%}?BD+22jBb00^DqlBEXBgPj2tF z6BCL;#ZYK;{RtTM*~sZ<*q)#EUJx1O_kLlzRcZKV8k3p@_~Ue{v(1x1>6xuFOzH}` z{-X|JiguUU_;QpRO4hfJeEiUb&mtnL{8@YC@z zV|(tNE`BN%2$Kn+Mtv0d`mmeaw2?)_PIhSfbb0T5Azk8DlERtbEtv0+38Iu3?RfVwRH)#ho!7Hu8&t-Jb#YZonCUvV`^Q$ zK))>V?JcAuC5e2ARj=Tn>Q`=|B;9R|{% zXHZPIvCZva51FU;ayZTt=EHVVw$oNN-~or>1Ov*hl)5a_!J z$HTPQxEwPd4*Mrec>e}(cUu5fb|m{B{NQ`vzsF74;#LmFn@_*;qo3a0PM%f4M4`n> zv-NmJHXRB1M-f#8D~eHdI;(;C3Rqv+#j1k+O7|uK2zG(gMT0 zXd~C43AexP2c1Abk87Jr^=O-NsR|H zAR`33`}52_1MU!|e~&+q<2}|CGZgCHU^}hP8TLy)*sld%t7M4C8&`C!ac3u~ncSb{K zcM(9Rf}0ru6A>|}i~@8^Z#HFlR!xstP3~WfaKP1uRaTW!Y>xbC&KuX?P(O?GKGT2vzBux-3|TPq(ovcr~>8= zc&ZSXLN^La)0Py+FGN|H2~f{IO8|rtF|E&7(a$@*lfZ})yHHkTvgRzHDUeLK+uqKH z+2;A~zP#N(V86e+Dcjw=l~Sh3{p7qHjqcW+u?{? zY^G^{c=OrYCv3`YS6JnE_oJWw*y|TJ8%ho>qAU{}uMdIfD(UojX|l!VM9U8b)4`d` z07?mg>cti$pc~F}+Q-_U&T@g_JuWr*_N3=xz|!7v@=ylrGcgteI~hrBiaqXqL+Kp6 z(nI#qots5Zr+0;-n-!+x%(;-k&;Z6frNXJ z9}5=LQJ_Ldce>P-b9F+Jy=HtEN6>P%oNuY`g+?~q?jI(&H{n3-8N_oDlv-;hHe3N2 z3^ULey?1?X3WfYx>qpZwS%!(MbwNPye%OWuoW-{&U_3Vqgu=Jbzxjl(o%Vw2*aZMk z_GHti*?kFQS$JXCrQ;hh1w*(C+H8XwbHocwRUtF{FU2;bjL69@Kmi10ipo6h;cAc! z@6U+Nw7Z-%PA>%FglnX_PiTm7u#D!Orrl2FqnO>kxZOSM_xt;=?l#-I<7PKa(-sO~ zGL#`+zPP8e0Jodn?z?Xf^DNs5fE}Nna09%5LJ{CcCjySghqnj3DBGLuT`2{(uV20X z%FA6LK)tf4c#ysqwahdTSCsbY;pX*2!tn+y6HP^mwkpNstFflFsJnnOu<(Ft)|(UU zuhc~5wVg77-b`oId4skM(X?0wJX1OWP)30#OHjZB z8El#2N|2uJg`WBsk8MFVPOzhHYSmy<7l(Ux0u-VZhPB?D9rdJ=D}##a=(=!c_mqgv zSBO_I19HD4CK$9Bpr$1sMs|ui^=*Zfbln>umq3bKHw*0UWM4QXU$^g3@gTZssm4)q zqYp@3{d-i~aU}%jWF*(nqm|*(hfSg`4HbnFz$-cAqT^mzgPKBFV5+m6xPpmg`DYKV zZ0v4)`o&eq$QlCYyZ5RQSd(6eX)>7wxO=+&?dJX6&2BSoUjXm|=uLd{ zYFptwG*83;`2pUt+9cUir(!7(eZcKmAfVR4}PjWMQ8_@XW2)Xs3Ts~_}5j^78tbhLIz z&UlJF`&`Et7wNw|hVDyTV_ZK)cOcU7e4Qf;DR#F#_`@NBbBTDBp3Q#n@_hK%!nKUU z)8NcIX4WjAeIlryvs-^T&6a5Uvblwc7GPdDwKfl*{8;w!EV&rblGTo?)Vjz@p&m3-+ImlBDj??O#XG{uRSZ`E z<^_xdX0xcykc_%x1ymJk3NBO_GG^Fv5{#BUag72ws8byBrHq7At-mg2I!{~(C`GNv zR2cimyiS#kg3 z@!bQkeYM?w0-$VO-hQ&(-t6vnTLy_inb=_S9$N^&$^zBNReIBBK%DE6$X13;O}trF z(lAdYB2Vq;NnL$t;z#+Bkh`dvpZb(Y`{aJ+bivyl1OpenV!3E>ss|j ziLNm`*3g;3sbX{5qh}iNHSJd3Q`2%jGYoUew0y-8K({*ZVPIn;3(cto15gzt32^N% z(edU!unh1I<4}WmR-SdzmMHRtR%x%8=X)Y<>b%yp$MzhG-Ss%=bI%sZsmL-hF)gYu zh0zxY3aSIt)(^&y+3E=%V809Pf;{C(BB2yX9#<}zrWrDURZEcw*7F2J%%JcD_7_-{ zOBGM*k{dAQRgM4b32QY#T|@N}*Rnw1*h3j&iIkO_XZ6w@)3k)$+4odv(#Q_g#YF1P z*09n97|b-FOTdHv!^T#5aj$1pIjTp$BL_Q-9M+Fi2N7)`MBT-i5QY388$e}{0Xg0g z7!Z=7-MqYgal4&16GMq;Qei4kJl(&! zIc%owv|#}bDmyJ;5SJQ|%lY=(x~4>7)e@9@vug{nCT$SFCGUg~w!4gI7<{@q~?)*T#cQFmR&mj&(i zqf-bP4_}Ckt-xf(e*LP*jT>9AE)wVXs`;w1eXHnw9k&$AKq7*aNNkl`@r3sROB>0M zq$#ApwEKCIh(J1##wvkUPYEAdB8?2~GhPl)Pocvkm#vB+QZJ~GC1vD<#uGT-S^Y05 zD=5J{0M?QknzHiDL`21py?bddx0{)EXkP_Cd(QX;~k#lpCy?6?p zX?qmeZB%gAM&j8;6616*24&I;lnG|a0>PY;QvuhVCR%NwLA)BE z%9w(Vo(P8K&R3f#i^0%7x9D6Q*P4<#-Vb4@nz834G8kGMds(@~iE4V*A?QMXdep>| z+xk^SpdG*FIY(o}rZ59@qsk#li>ljEWq)}1!99L#!r}hAkJH`jo9V@laD3PwK(`x` zr$=mx=w_NGRtQQV*?<1|6Tf&Vn+-9miq55MFsYdwk2eK;IM8O|K-@KWHpqaZxEZd| zs~}6PMF=oqDZ)w&&~AJC;^phFe*XRA?aSR%vSv*iiU{c$sG3yxq2 zAMd~OpKgEb)u*psDs-Or*w|!6!KJ900;ZT)O&m^MC`YESuC(P?DX20pu5hQPQ7-zC9#etIX5)|w~Xi(1e+?=s+>H`O-2kd zh#4>Bk?vIpz*J0C!6niV)E5dDEu7T&qb%GAN@hN4${di~#)*ikfEk5AUVT=9B9Td| z-jj5J$rPI)CG()NaP5*+Oj#gL)UZXQjKQL^u?Yd-pqnZJD+HK{ zT9G1zG9e9*5{#n)LeOB9te$I8Cw7@x0WBzG0y&l~F$zRy22ct-D}3S@K;cM?{>!ki4LaPa) zJ`!%VG#GqAxb{ODh0t})we0_)Re=77-x5Ng0@IXxGGF8RlASLW{bi8G^%EYP<17Vu zt|d<>l27>J+hHL^eoUh^xP(s<19eT=Xvj%35s@dnTlab;n5cr;vt$qvPo{&kOP-6q z1DaG|kj$|ctv3idaaftrhZpBh?kJv2L zvNLS(R&kWjj^uDC8%7i_Wu#~fWq*-O8=EHGfdDx^JsyvHOfcDOH^=t^+}^!@_3Fhm zW12SGX-XlBb@tE&F`19Y+a1Z%OmaNzfvIe7?rsZ_x-z0nN@5DIa7O@qLyl3@&%W>$ z3^OiCzURxv^8PetFSKr7a0iKUV(wbGZk^OnbaLi4tJr@XOb3dhCK_AY&ldTtIi260 zYZY{HOf`!ccF$Z3K2bKR8d^eD$akQe1?tW{Fq4iJ0SYn1^2DvM0qgQi<}ACX`xjlK z)ZCjYV^A-csg44X2RRsd9S&2YLZfG7lW>JhR$S31A5~%l^lZ%GNpm9D_84WcJwsJl zGM6p`)E)P6plxujITvA=ILp(?_lc_3B5V|z^mVK-@JtP zs5IalaFs|2?3S_2cx0-kVTPI*fI$Su-THGxkAku(EP^7;D81-H3?^11Pa^Dli6z*8 z_6F0AS+2iZC(q+=ffH~R+l^E}1oo)!e!&1bx0qw|&2??=yo`~_Q$0R3yjhfyQ5mgY z@-^_>ngBRz8!MTq1bm-YD{wqMzW@IH;q~oiK5S+b22ADf^!DlgAAR!4?)dmvzJlGY ziBlyAo<9HW|M>gZo!P$n?Dt)-A5d#p0dESaP zNQvE<0HiRJbwlKEUs~e4B81gPpqU4jC&#(A8oY?__X_ zl|*w(IeEB~05HdDX#DP`vPgnRLG~4%<5AR#0L;3=->N`|!PXYorD>2f16@VHmcwrT zoWzo43fM8l(j_i-e&Qs5Q6DRoJNh95aq*OtT;)ec6sOvg|Aek|AI@o>mF>C1fT_VQ z+?1^3wDl}b>nWou3e~jO1rSc#z98e`HvXsyfT^5i+DuTHfdV=nXj4jAWFWN?HH#Qw zBs0&VU+o*wIz((8Q4RU(1UMsry>ju;A9W#ds8Zh9dg~6dgVnc|HIJQ3EyAdnq5{)G zJ`R<`l*!?1?SyPsQq_augnfO|2hAO9x{?uUDsp^yd;h)r`&TcHxVbS=sM@@LynlT2 z29WvjII96>s>%$~+3vsl=KXYdcsyW|B4OQ(lIg`$uy7%hT%mAJY6wvVip4%A0t$+u zNYQH8g))pMa1p~6`=?pKHt+ZE&17eU$)jq73~oeGVkrQMQ33Vg}BBA}7el&$-j)~N4UEi9f?^Rb@uhjdhy&;8D*jO*N!0Gw4}BUsqlh2*_z zIF;1pSkBITb8@i1GjzDKBo5kizQP39`hHJ4=?;KjT1}nK46mz*OYy&8dp16|8?R~; z7)}D z_LsqcvU;7oFy~hAB&SxSrV>s0kV|0#FkJ~{0C;-jvYj?d&Icgtm*-opJ${5R`yoX- z|LJU9q7OpH*}x|RbnWFI-a-z5zIb{u&muBEy?y)c{cgM66hU#zR=l(A3;@&J-42hk zDO1V)mlRWu2HM3pAKYAy@9e(CXqxfFkRzZ6wg;I-byqxRxQ?06<17^b#|FdPhyb|R z%_#dLXxeRVwo^Hcwlfu&9Oqd9$o%kh|MuaypC`uVE1!f<zdZ2+Mf>&tLod)fO3rYm2XF9^nwC5_McAm07fa z&M0BZV6R4NI`gbs7)v)_D#XM}1!^GT0K37^6Tj!{+90lRuy=~U16NHb@WQ23FnFw= zw5YVp3MehG{WC2S7P+*b5l=J>Rvkofn}!Q+P2Us$n*$FHbX6*tD!E6Sm!7%Nvddg{&?+k7W zV!ke5^#-x-Ew?49AJ-@eg+A3iYBb<=B2lF9;qw$Jx5er}W0wu5WtF;RkO8uEMw3m~ z*_*4;ms@uu#W-R|*CWzEUWg0Cyq2mzDlv&1HpG-F_mtIh9)O6LM+JW5#O%S6K7HSK27HtSiinoHA6tbZGa>1 za=7;lP69N8ra{BE05yYqje!9x2Lz_(kaQ{V;0{b8$HNvNp3X2n@TPb~hnt%w?aRxv zFfp-$_*ejLS-v>$zq}yr=LYYe6mz0Xo$bQ?RD144{V=#*GzlQHcAA%Jy@E4qJ38H| z&L1tS4>`Hdnz`P@i)1;%S-f<#X_iH24i6(n1e}zzyM6iU%}oIgvc123e6cBVl=)!T z+}=!51a_FV8v+yrv8RW3hiS9J{{5>mO9Y$bwji75{eh@3FoO|iD%qaTq$Wott_rD< zX`s~|7!bO{L^BaE9}n}L>@m&Y4P-()6}@~MFM}okEX0PR&9j0_;akD}h*^%CG}IOV zHgVws0Yp^}v-0+?Jihz<`=1?3+3g-t$|tY3g-yfFAR=tUS6V%yB*X2h=?7R)xpS@I z71VzfjeKFR=q?Igj~Yv7+3^r3gRDEDrPnXk9jQWYS(1j6OEd2lwclzwzjF~5fC22n zMUiJuNRvkapcM;f`MWcz?gATa;zJBiD|fVbvFEIxy~L(rHB#$3=tgIVT>7R+SgMPy zZjKVeeC*g0g@-!mJ^HY&bAJ>KxxPq{HKh2xnjTbFF40CeP~U zK|Y){JE3m7PV#i}j6??7igSt)bMdOz46qh$Js~oOW36iG=>wXop=ZUpphkAqUKM00 z1fNuFUF7x`oms_+NYZXW#7rnQVG6&Nc|RWo1t_c1qJ@J1VAD>)T)^BbkA;{)gFz>dv zMFc1*gR4I*&F4UO)Q)lx*#o<&Oq*$M2RyvE-F9+L5#A6JirU^pjt46@FY)f(XP@26 zi|yTu&t&)V)r;E=l+`RA1!64-W+BC04_syi*MdR7xwF*2UOz?JXYlLPqN#F{bK8vT zE_L+boWmwJAnjw@rKJ1KPFb^$rmFzE{deWbuHu-J7T>SsBkT@tJFf=2nwWlgQl|vQ z@YE`AK^~Fy+-F|#(45kRY{pa-;AP$0V6aOk28CH~-5l6*Awu;44dgvix4Y{wu@NHD z8JVfWR7z3qlb>kSbk-c^=Nu!-5e)l~{Eq-Y0?!y!By6RQBd9yvg(K(Kr#3VCY2)GV z$-|SS=$vJs21lyYV4n~CX*Y>~T&v`;yl3r-6x5THdjU!bW|((W{{^eVBr32erOZj} zn7IkgG>=<1Y+wLQ(;3BZ<;HU#zbMk}wCDHC3h@OSF*8ach}yzPPBEOa+1&xA7obWF1CXl_75)(RGN-o+(8(w?qB$bGE=T*tHMOVh~Z1OfVxy91cBsIH01O;%uEzt&SDX!H8rm{^ky7%p2mCl5li& z910Y^!36muh*)q0rU?u{R18$6Qc)6usb=CFg^A4+A$2%DO_SIGyWP!`GL=H``jL;= zVtPsQdzNwlp8nC{_FwoHUcUOVBX+x2h1^|NW!Cxe;bFf6?*GYG?{0VS9GR2??&HJ5 zd)Q$^@?LhIyx43?w_gYVN`aa{mE8%K$TE3GDW)b0uqnIbYrgd-!T$Zj;pzViY+ilk z)r(Cjy&2_T|+}K5}vQXcaJ_2-M{9X%?O6 z?(qKc{{G$l5#{!gwz84;Z*QgvMf7L_0w#gDA-ZOYa^ao=y0xK#a+`nV?_k#%2vx>c zqb~E3Ysad<+@Ram-CTn~EN&`RkGAy+ie`lZuM)w+b7Cz%11_ z7sX!f@im`7I6V8#g}Z5Xgo{pDMb^`TvTMu>*E;KR3i=etp*y#6)$}p`D?BZKDx|~t zqkLc}d%o&pj_+EdJF3ceP$>bX24W)hJhi>po}{8Gj+r$?8K$#`5~XJ%SGyBu*Wk>m zM3`NZWPq8~qiwCZ(icaeCN7Q(SL>37xy61l;cRAFMGHakq@D43@-0&(3y{ZUZ{bS9=gg}&ETDhOmqj0lv- zcPQEEX`wAnfnwETn-|l}+JhG41i)|%KT~lbgEXF6%g8fU(b*<%M?*}FCu@4BpLNB zVi9S>%0dP)6araMcz}za(;8JH&{EeakDEJ`mxIE}v{5b!*}Z_y$30EJW>YXf>NG#u zIYowZ-XKi9E=SFJ-oetFZx;8ZOZMy>ZwjWG-dD}6;|k#r1u<#gcJPHTd^^lz>D4FBWx9LHG-LhWqbUkUxW5l zD`Fq)5T0p1fm5qCEKw5_F9>XMUbWGnwViDV;7B5Gij7+Z;`4B?vPr#ySiCKc`mo-wJ0J4V{tq#jW`ZAds@%}aYQlfNburuP-7*O zbmaH&SqEHU;7%GKupoo+I<5yG66&idtkhf}!Mw>;KJy8AQj7NbhP{(Y6X$XpKt!OR z9j??yxFrL`3=Of+a0+}F984wxn8c;QCWCp|$5QzvCu=QT{Bk!<0~ADF%mx#m;6rt( zj0e>`GJhjQJmQxqXQn#&Q36oTGG61pFERn~#qQ9QANN&Bx=w_v@&V;GVvl z)uwXONuBds!=$>Gx`~IIF$(Zz)|TmT#8oNSvhuGM97<{Sh~6F#hO8SIKP6+)m?+!qR7_t>!t)hmM7 z8>D1n_;alvpj#%WJI8LnBPD|?*jxz%YZ>!{F`y_B%9}73fOKz!DW|}bzHdYfEkdQ2 z(Oo&#D&RHtnM4aM)${5~WF9cJVv`N;`KZnivyIV1lxpU(EZm1*Xje z%=3PK|MrOO-Q8|?11Zy{%TjX?+`QUs@PPT@VLz`Nb~!%m_pA>OySt||gL#(IEt={4 z?g!uf-G|PKQPRWL21{WRFBza>0C+B#-~F!Ke)1#7yJ2`N}kIiOVwjz+H$Ng~wamd2mWtCH9Pf^o#xHUE8bV^o*&eaykSY!+ZFz&O8 z`lXtrIA`N|ZXli|+}01-59#17AFy6NcG*7aJUJk9qWzs6N_~o8>3f}rotzgb_oV7M zo2hxJ8V#@v3g~(z((^;JI`4A!$FMdT?BLbfZlT=<5J({RYnbdo{ zl)*anb8rw6&O8&%?F541-t%J~TG&-UAvOD*F1lHu2`;?zYBxDabzIq{mH|j|xHnv} zs1s%v5hDH2YV4VBCp9sV1Y$sn$iwDnlc$ArZQf9@De+o{vfy={BGVmAjl&UbTC{^9_gIMvszNh7wtKA4q@j177xU(D3GR@LD2aHr; zRi`wl>eN?u3pT~ocXyPyc<8Bnn6iOPpaxCH<9-^;LAh#gQfXhu<9)4tMxM3G9|}aF5zg!KT!o?kPRBiuw|L#3Dn80Oo2SF**Eg&-Q-)?E6Wip+DvXCVT z?Y!LIOd&hXbDoMBg?trc+1XlFmN{h?nUg4OyX}e+KVMPQn3Bw#S=&orp6$Fpm)TlM z#^>H?B;?6E1b@(gWV=zlr8X;uGtBJaa3evF=p`UX+8cefl(kaJayNri@A0T@g`!rZ`P4EE1WGv}R<8-_@PT zA{z^_2TO;N0gh6-LqKF(rwmv&Q5M(1=J|Ly$np3z&ydaQoheYtRE~%JaX%ktlxd>P zrhrPBLN`+}mBaA?n96nwzT0gIlc}=#ih{s}3NXzRUVL(Mvt>RJaB^PNhI&mXKT+W# zz*gt|{&u(9Vv~u+GNC*<0M(2g>a34xN5}pB{qg<0p&U@mA5EtNc`iLBxLe%7!)cer@09r9qMKv z&Gh!IJwv7a9JN~rQ6ew8Pd^q{W|7WP`Pfc7DoM@U93FrS0WeW@Lv%M7SNuGQtJbZm zpe_xTi)|DDl~L_=DdC>9$ZVx`Qa;gU>da;8Wc6%TM^jl`Ev;d->s8tD{9x9aC%yCu>?EhSB`!3>a^cl#eoAd~nnD*vl``*+~d7Ym3O| zmiC!uQUbqAisT?ogxKbbT@cn-@yn?$6i}7p5j5%H{kzW(08EavzIxrRF<_cD+PTzs zPClypr-#pRi!Cff76w$BDV?}%?*vWzHzqfc`4y?c3b%;@;=^zbS-q`>IgiqVfC|XGK7v!I(LDEz2)?$E z*HQ>3A{2wP@LOU45)oR9EM@(j3gh+ECMvbwWL)dR5h|x!iBfy44Bph;`w6@#vv7S& zyKAMOL;ci%8na#^mqbMgEjT0H9^pbd9!g`@?9g);BmA7`FS4XEUPtuH76DJWCxEcW*rA|}GNdJh0LIaYJ`;*RyIvIX zK3$n*G)u^zC&a$lsn0!Oh(g)RgfCGO)H@>#o6xJv8d_bviJ6&B^fx9V?qa+0X2T4~ zW;`2NeCHX7DHUK_W-$j6*$&v5xThm_q6x3D^9VD94x(Rxq&~>VV@9i4-WOjv;-fW^ zS3JW_?q%&gL_^InRfO{F0Kn2Qt}jxgFvaoR(}Ue?kN5xhKY7@_+D%g-Q`jtGfH1@` z-A;fUL{v;!i)MU~0)RZef0F68l-pOI+)WchI%%D$@XZZ&J3ek+ytr8@q~Q{)1YNpP z?qcGbyRW=_l0pUYgwM+M_y;~=ngA5WY;lo0dDLEWkIc%u*VBuyeD&#J#^K@q_y{@P z7EBxPG-*nf093&n%n$P;3hwxB+Cnhz$_B?-9`6-T2Pr=~?`{eel)zSd;vq%Zlm`Jg zLD=yNVj4o-M!4Kh4FOrIbh#rvUZ|b8b4lLeK%bok1jB z5a5Ah)yHpPW*HlW={d-h7pl}^YGiEiAQxhtF?nEorYL0$j%@|xsY2`9^k6uH0%GD+ zE8OS8QX?CtY(TMFu{nqX581a`z)5B$}2fdaQMxJxT>f`t8fmw z5=w_uo7FO1U^r>xg<3=YTt9Qql*w2&0kHwJ@OQBw)SYALc!VsHDSMk@N(JfO*a(2Z zlh6ejmAq;6QCcUK>n{ABLdPP=R1?rPtr@>v4Dn@4^x422Em#+9$^1pJ0rOPXaYY*? zPo%m={A$c~>sKFV}AfBrka zbG*ULZYpJivNu;z0n8IN*ve+Bki#s@uGNInDf{^-$ESz)H@lZ#x!rAvEIsXfd8gg& zs{){uGVxR@9B;{}0eEIGCYBgugOxM4AWFoAE3tc^Y;HbzP@W*i1D+lqc8^cf#1jfL ziY9)*46+ly3IXk=>GqSaKHWdeKfvK>KMS@~+1>(NFcm;yBJ)8Gve}j`7Lom zKYO(LoEn}!_8#Sd4InjD6I8E5Ghk4gud7j!*vNlXfSH*fUk1#b0lMTa>wppG3!(=9Kp@lCUx8*pM#4IgiGS3_imx=&0 zpujw1qEad=rh5EBWYa(o*^Sd+0CEH~F)`ub>pP1)eE0oZDR=nn&3g#;pS}9zcC*2I z06R5&Q z0wF$v44Yjk3de^)4BBjBX(EXnRp!W`A_Ry84=9+#XjaD4VaDAp)l$M`|MvFfwB5i| zComHiTGS&2$KGK~rrW!hM|tz+ci(>R&F8TB__V?8i+BG8!Oc_%Ci8qa?C+lhuWs+k z)BSOS{j3iUe8UHt_IP}J|G2+@i+Q?%>>ug%7Gj=|m*BZRH}wb$uvxxvz^W^o8MR4M zCLtu7V2uJQ91xxTrL1h9mJunWi8G8ZK%{XjuAlV*Xf=Bjs7=iXP`fdf-5-`xfp zr;_U8rs`3yNsEf8SI{O{=R0|HEimgk`f6_=?njpEOvcICQr~kn=LvY) z3VO1;@S*Ep9hXg|Zxb_w7zM>kITf7NqZDXl`*TzF90^!99>5wlKGP%S2%^iIJEEnI zl`_cGyvC=hd%}%x+kF$`Z$}EK52I;9QoD;&9n6ZzQ&Qg$Id}^-Kny5UD16dOw|%=V z4Yg=p$TUS#B4Jk@WuC-{kg8OISmLN7 z-W;Dy>#&oxTn8BCW4|!s8Wx!7K3SU*c3t|>(z4c zR3Km(@T%@L)|`hHgeV^pRHrQ&*U6kQ0x*bR#AQ{ zF!$AJwzw`cO}D-ircR`aqY&H5ISmV8;W&1oaeI5i^qcC8{%0D$7&QKcT`3V$Al&51 zbJ2#YE%i5|Q^YCp$aWQtNLx3a{!h*voSi-z<%q0-2Q90l4PgO`_ingYMQOeHG&}ou z=TgIMWtHJEQbXr0r_Q)9HBoOW1dp0*qF-Y&S(9UZ|HA!g3Is4C@q$4)($Y`4P~~RF zHVU}WPk~6nLP(t&%7LcPs0M65)pv4~Vkkv$0Q9)o?p)rT0UR+yW>-RGzds&|?+_u| zKRrFX-P;kR>~3#&n^F)WsXtIX$=tlZ|LlO!4%OK13eV{|H%8-E=h76 zOAx#OND)z0GxJAeWL8!8IlHIl?0(+=|3~)B^vrhm)FUb*{HbR85Fr8V2a+P9YO3xY zk=ZjnyR6D^HC1^~C?o+~02k_73kF`kEzO7H@szf^-F83(a+$ExDJ7iFIb%8>WWPg9 zVb05SXwf_iPVqt{)SvC7PQMI~q7Dpy{%PxIvuU@;snms7oI*@qfU zBEuY4zAyu3+D#+i(gRkD(;0ZCM`n*K(ju(pzSNWp2FTje|NhW+N82}Nwvy#1f`k3l zB)C5R=5-b3pislIl=#YQnRRe0q}&&`DXvDhR|J%^3!xO^EJPtQ+HI>6u2!C_>>N%7 zZ)oWzUJZc@0Gxi9mGhz*iiSoF^j*J$>bA1FE0pTP7Y|g_v-OP$SbQ?2>~N!5FTYnw zxpe$)-$>lJN_vO6Ih5B3S(EgI%NDLw`R%#%#JTX>5;cdpFC$8V$`oAu{NI*vEOIFRE08QhO;DLkzH{^6YYcfUTVc5o*3%ZK;(j(-<{!89;tOEtC>G|J(-5-AX)1QCBFtd)Dri1DsWx&Q$cz(pt^)|bP zj18;$1!qE@V zgeYNyr>8&v!~5OPmqY{OS2b+vL>UVUyIA2suhE>>N0sgw)e=mvj|Pd@WH(U6Fh>pd4Rrx_LXz?)>nSKG$=`M9Vh z6{O`lwMrcZzOdp7binm;1~3}qwgan7od%dQ%|Vsdcxk1_CjyspfKrku<{E=Ej}tAk zvc9C{{nGlHw_Cej6MOB;g)H4GDet<`CBfG1nQ8SxB2{)9F8u92+wu*hZHP{_`Pdrw z##M)Bf_z<8g{xbb3sG??_R0ph(*jgc)0}TF>t;JwiEeJDbMBaEjQ z;TmKUTU8^SrVQz}+s&>Q1Xx?e4LniU_%Oq_S#Up}1P|0fq%450cR)1;~DsA)WYp~*0Cqg2?nyep^>}<4^#DMI4o}@r@8AFY_92E`^1X~#J{~MF z8aRPPC4krzExvR0oUg4MTkmuYS90>z_X`Aghu8g9yUT@s-DZ=L8g8`aLPsm@?6m&! zN74qrA@0ABd^3ZB>wAi0An<|ROFj#i;Liyn4u;QC-HBf*? zbXIO=uQF8DAKbL=X0=v0*GfEIPj76QCGE{Fz`a)kb9-!SxPxmGd&QDfy52Lr%&DdP zK)oV4*e*@X@=#JLlvtyiTB|p6<@6TKQ&VM^NCqsqCPq};aa?ZwZdC^G%C0UGiRO1UZv!<0 zzaARqqi+PAUK?D0uQo>we~YW|y4^9=N|fQnSMu#w`+Y;-i_`;V?Dz7PO^p+hm9{}H zrC8NGX5W3dG@ece2&VH+6o3rd?c)}cYqIP2F^w;lattdIG${btZo8pdf-P=7ouAU@ zUp}0Nw@*K1im&rlT9>bHN(5Ls9MAi|Ze!jJf}vj(eT@S!^zqf@jEnvF9ovD2r*J|H zJtFrw0h$iF9e240bVaj$`nQ)!A2}V<^m!^@ANc7n4}W^|^TY7%GROu%Ga8v$4Y*v> z)%`$QA39Tb(vQiR|BJW3^AqyCQ?9H;G}hC?g!?*Q7d1iPcYw?6ZNs~jqOd$w>BJp* z_xEjWjnV3hZ{4-#L{WAusa67jsQUqSzpxKxgAlUbIy%r+&ojtxHmrdEf)h@{(Y2J5RkFOu2 zo<)reW7gW+u)^IK=1_A~9(i9y5Y&!XgKWxFeYJbkPl1h;zyh>{f>I%x91PaBm2kMB@>YXw4lg3iJd-pJ1@SfFQ7pcy<=88rc76Yn z$T(+TUDz;Gjw$6(>NxT8<=s{@#n~=qq^)}q7=XKmYWVY&%iU-H-sP2V@U~q&(2eE* zOqNliOLuOCpUtG1;}=le<#pVlr%h`sv+c z-`i%=b2`U7DpYfV0U4O`aeE&7&Y5B3asOqXvZffj*mXggUc$>$5)d{|(-_2#XBZ>^ zIwqEYSH64HnXOk}DTmGbKX()4Fz&b8ZRY?KEYjy)+DwYgZqscyeUwrKe&+aX8`EWU zk`=+@CDc3g=+F}!S+gNN*zve}w?QC*Mf@E0T_@e^c+6r`i+@03;nHnAifG%gHP^x`&peC0dHbqv z3MDsO=g+S$9a_p}iT1Nbq+ProK%RZHv&$Wo-|G5`Goiz6yoswz$d;?ki0Z|j*{s!y z&DH%g5Ers*USbehzyi0tF961C7aBLoSBtiTo(<#oH^oP+5M+$~A95 zE;lDE&)ccJ_K6Z|fm~Wp##=9H#`1m1Ss-7=xy5s~;xcnMW)pk!tGQ4Ls0u!>oXOIn zjO$SbEIw3&qOlORxIFk;tiE1eMT~ua+?HmI6{t*hzEpF{mhIKEcst~6ftdjSL^NmF zt5|sszHoU^>F6vE?npjG4Q4R_Nt1&D^33+JE?D5I2|^qg=BhbQS#<=7kg#Ba^z)0Z zBZ}1q*?=;Ibh|%4dBo}K=S_;nPe1+ie%p)dG<8!<_Vrl-AVa~E;uOd1*}n85I_^Jx zcsWdf#7!4tC}qeTjG7cr!lnqjw|>e&pHG5rzz_u!ha0nyDwV+cClWX~?taG0blksu z{%zPi?I>_?gzXM^fS-U(+=R`;Zrh0fzDm4BL{+C(_i(tIye>uUhMCWty75yt2$LQiT<4K!7zfzX-J|4;AwQovU`T z-hEWVeY&^eE}SFW>cqI{cl)bZDrE*#sxjiq!Ly>ULF*Ez4vUzrKn0~L`2yFhYa(@X zL*w3ZYc9uT=`3tns~!6XJk#b?TPN_PBD@bDH7<1xP+55e;bd7VEf zqW;HhRw5etdqcRIy?n2nLamp5zmE6+fNgp1>u35wmgkC7EI65g7hb);xqp9fTm8XH z6H3?V$4a#?r~XiA^y?Nt%tlgTAyokhGp(GVsYb-*=L{8Qnho~#>ms;TC+yPqCddJJ zD-CM}@GAoO0$T9GxVJ=X6;y3DkqRZLSI$0^gflhQ!dF8EcSjDjsA5y;iD9PHDo+?1 zUq7Sx^xWVjz0O$SCLYa@FM)ik;p7Ys0btMOuyi^;e>sdNgxGIM0CjrYZ42{GFf#*l zA)g(l6NxPz;XIUPsfm{p$M{^jk{JMN%@65QB^hZqKCi_!oYrBZqj zvJ3Cdr{lZd{`zsRpFhWZ+Hc$+?5F|#77UxT56r~O0m#fqr}2!?Z>1NZ!t=&jAth>B zx@gMgITWH3&6)xBoUjE;J9^bzEhi(WZ zEh%&W7shdFyfc6rOo3U5*0)(U1}dc=XPjmEy-j_pzA-YS7+Id)!DwNIB$AO*MP1&v>q7 zm@lkf6{~U%rDRuonQld17l>Kwu$Y;Fz&soAJij6e4nU2`JxzztzkNQOp1OXk@G%*0 zCW=v*4a~Ksv&`0;FIB68b{q)EVHh4&L}DKUA%HVe|HB*GB?M`Dir;v@9HA2_Z;8KA(7d1~yNB`T6~B%OC?W!&(g@E8YO5N+X2A zGgDmig6O-`8T7Wv1kUv$Ip9&_o1^uqFyrM z>oCd!J7>*BrxAi@b$GG_Q$YQE8qq(!eH!`ze%~SX+uiP=mkk6u=EtA${z-xmfWTcq z-RYStWuI`NEEWXfR3?vN&MLA(=t|s@k}r0%BI0g=n6i9FRZiToPs{+ZR;$hz>%D=O zjMizeSrtl^KY~{MsNlTAz_Q4-2IE|`W%<`s>#N@z(ze)+l~vPTAN*RXuVAaIhgnWC z%t7_98kaM<33RW@tDDv|08_8!Gis&hqL0=6eA(WFiq6K2D)&sGUP2&UwQc08F`^J< zaI2xoB-$-~nkzqWi4pOlDqVKm=whsC-Ycu?>ITOg*GIM@#%el31CGqp)eYSOI>_vW zQKx!_O+{+WabDFR@YN_YxL_wsXg`|2)#rgPW7@iO@lvkHV%k#xE$8L}XIOtG2hTik zrUp2Li-I~O-C8duMB(CgfT&=z#vR&C`AE|+iVg@afVn&bjt z%mL6`XGY-0!*(?qtIzie^j$TxwQOi#7U~s%D;v!UpRfPgoUF(t4QoBJSG!74{0K~7 zUi)3H5oU0EZH?lm?IpgjQj`!fn@Jd}oYh7PsVT0;Ia#)<6fE$PvR73sl zGx*%F=Pnu3fqU3veY>b@&{x(~nSL#_vaw~>-!As5cF%9vl{HS|Ugz!hQ+VYI|3OHp zb>$Bhc3a)HT7pDWZB>SwnVA9b1b_l0lnMs`Q%mtJ^zZ-xlC}I^caw-s+*E7&JlCZD zBGnf9WWRW6b8Yu3y1qr|)II@=_0d{DF`Tal^+Jca_`xqWEnl|qvgs^U+cDp2(S%BW z+f_@6f_5lg6RX^LBq}DTiQb$GcM5dRv^On))Og-RD@HQ&bHlG~L}I|if#v(FUA_** zY}?)UyRI*Cb*}@K7Ba?+diY; zJ-vUk83g!7)s;I#G9dTc-TR+MJ4@{Pte8&6Q``bQr~~p@h@ebA;Ux82Zu66_~XUXqBKARd*OH zfrR25xyVH?&!Kz^kJU8Y7+RrIXl$ka%`i!3atNS#e3lyy$GFtjRzZjCL;7&a$IRkfvn z@J%BR+$aN0At>cIDg%sX1uRd~IF8c^R_SY_g9BZNg6p_bLwU}dh1cq+jHByP59lLp457}IIrBS;qkz&YMAKS&ZDA3S6NPPWkd%lLKa&>z(bFb;f zMKPfY3Y1mI^SR$$Y=lx-`&;qUH1E_>lq+auuBK*C zADv`iAyzNiix3wb+2DYd_(y4;vj&$g9VTP*QgmV7w?O3_hKbgI_SG~j@raEr1OV24E`eA~;fr=v7E)W6pjZtRi|@)_Y~{Rfvf(=h|tVF0*ILP-+0Ky4M_*zz>^y zW!qb!-nWnOSBs1LH)LGb`ey>+%yN#NEJdIenGZ|19c(Y^ztSgc;=xS?^2mz7(#-IAkD4zOK} z@-jm!Z)|bmfKihbW(2x<8VHRx^Cse8rABD$os>*vl=tuEpu%kyN@1hmUY(~3Z;`yE zU~$&0>eJ~wo+bc_bV_NOlExT`U@)};{Ijv^RX<9%%RhpkA;d0}7ojYS5K5R05O+^+ zpLU{vr&Bs8V&8?q`pssHhNQ==1|@(^v=CpE+(1`4zkK=l^$@mkgi3!6s{mT4_3BQz zj#@PX!cuTC10)nWMNSbWw#VtP9}v1sL6FX1-6l5pXM}wC_Yd~gAOv@vbzmc@MbyjA z(j$>!GFNpY5<<>U&ko4;VH<;lu44uQA`I-R5Vhimkq`oNb+?sBZ!EaCCj)byCPxGi z+;j8b))x;Lp;~;_Sf4K2jlEz6CM}MX+im`#atO}(zFwWLs{>YGSe?5+#vk&HW9*iq zwL*Qqr*AKeP?xpk|CZ)OQWHS#UMmKW>;V5hkauzP*d_RznuH0Een6i47oOYfU64- zqeNf0ftA*&_U)9K-dHH5zY#yyez=erP1#wDnM>%V7&>7tly;W~>>JMei>Ad#dW9(} z2wWkGSwAT8hcz^y2}L$y^J}>F@*&FvH4xc~D!X#Q5@W8UQ&_EumV8HQYI+;#VkTi` zEUycYm<#=wwD3J*WpkJ)Af;ph8#GUOOlf*PCUA(^PnHau4cxy_|vFyPuw(h79wZ^Wm6x8_8}6{bSxJFiulaWiFjE!w433 zQZV%8%h%^U08CT2bxV2T!XfJbkevXP#r~;tecU|h&>(A@C>fSG7kOfWakiJW zCrB6pfg-C@fDq3Xzm_*@aJXj8Dm10D@lfnpEpCSOJa!n9fy@=J7$@fKfiIS_w=!>B z0f@_XgKVO`=jLQC+Y;9->DlVKq+9=S4D9}{U~LP$>SQ@yf53`ktFH9FTk}#Ln%rDX zuUy`iPGcBl>v;r~Kn-bp`K3SePUKBFw)G=;btjc$XD0$mWF7!mi85SmbvFCan(Ox7 z<2I;?PK)rrop^Z)r(;&T!1Ry$vOE5ZO*!fLa|!eD5oGBmNK~cKCO6@)s>xdJ6Y{tgq z=9<&t)5p{LhB~3?Q+Ta}ezUb#7Xm;UV*sbLSuBuhO8l>+G<&{zJ$6G;lfB$(6*#5D5{E<7{ zzqJzJu9ns3!dE3SPY<8d25$x(y;azySq|}ahc6Wp6v0zN9mB=&GND!?Z%Xyw^MRJz z-??m2#joYu_Z_ok%h1)43O8RTG&CvsV;6kgTp57*?WmSJjh6A7Pg7lXV=G!=k%2!V zegAm7F@=9{vW6B|rt2585H*G$7EdLTmhIADD>dM?GLlu(T`Tqppjl=W1HL9rSXEo} zb~>p81~OhT85NY6VeG7i>Z>Y1n6WQRjiH7dO0n1PHwet=`2rvRuz9>gIDW~={w1R%kB71>UQ0QZ(XHYpZrZ}PkA5rbr-vjO}N~aqv zyO&z6RuPa49RK~-4gSNx++n-vvMj7k-8 zYLt~t5pXoc_D)+aSF(BBT<_Ub1iu<+UO)!3iinw|rfayO#4~u2Dh^_KRpi~9u~Ged z7v#_F0a{g_yZ*h}!|NWyD@Z`A!!AdFn`WdJiIEF!$7T89Z?^I}SxNcw>jITkc}T18 zYW7E)+6;5L3^HE5yjs!N3UpbJ~-i4$fKS|9jS|$Jy-Gr1i zY&U)11z4JC&mrx6~zhZr7lI>3(OG%Y0-yrl5y`8d7&Hl+gsM^0}a;_$fXLtaf`54!rBn>4i7Zk|_d$vE`Co5@$?zrkwGY`H$e2n38D|C?+( z#j)?rftV4zRLtX6vZ&&LjGEiG($?F^O3ear)XEN5mBX)w#aC{gZ;lDS=HFWHbXJ1s zUJn&HU+%7p^ICBl14Eei4VSU6DM$+zM7*)_9tZw_rN()RVto%0wfS#IMFaJ#U3 zn~JoGZ*zP7-rDAKzlV)Dn6y!9+S*brlZu?@c+ZPodzJra9Z)8CWk_XMt2cEqNHa^; z3b!u{sL;5sHNV24F)K4v0W=4|1}QKD0~+e3f$^x&<_F}>?&;l|?WPk=>1+t05gDku zxAnC~-f6ZPK!ByJrB@9*E@GcBKNG+Tt(E4g>(fjAKqUzzP>g*ScU{LM zGHFgZ0`TcD9Wo^Vvh4>kw7TnIj^%E5qyqbvSFJgRlwUr7{+tfz5+sN$Y96bQ6BQDk z2y-o4@jRRkpmdGts?(2K{1yV}aKVKYA>-9iRmoM<1lV*mc=1%i!-CdgoG`k+}dm{|RT69|V z`1`W4M*16SnPZ1nl-~nb)BZXC@0)2zj{^u~rc7*Lr>ZPc3skJD+1HM_dZsF$PI)mN6bUZ78K|0?!ROqjeBvMiMy}Fd=l=izl7l+{ip)Y%!V+{< zCYY*~yH1E$IwWF+-6-&kh5IYLlMSGPpt)T<>}!q005>NgE>zdH;Ha0Q0DvnU19vdE zR)Uts2wn{Iq)t5`TC6;C1SzBC3|NWJ3?ZLGFTzmg{x}|wK#UvOblZoY-aI{SBEv#@ z{?*^Se~1K3W|q8+7ofmcG&%xA+}tb&5-H1;xzKh2Ai+=Xb;?AsE6y|lTfozk=qZiq z_}HQQ6CnM|`L}=k2S}hGJ@N77`Qv`{)2H8_&%@*Pp%)$f>8T$!A+AhKVwg&quL=mj zBE+OFq;i}rP-M+oyd~p&-dKo*W50Q~iJQ$v^z?!$438bA0UzZ5HI94Ty?x(fL<_hC zilCEXrp+@wosTErIaVCL#u?S`~s>t!QS*YE4#+ZM8n|dQ=fChq0AV?8=r4R+u4Frf36Ja@&0_jFa3}lhAdkfrD9! zdWFKVoISr=W-nxB#LR{94}f3S5+w)$LCg3?X}f9Jc!X=Q0F2qeLkvDu2+S(-cD$LE@jTy1=ZG!#8?!>cn z24E#d00wk*5CsxYpU0#t^UVMel0w3D#kyT%SLJ5-2rvCE!MPk$jNxUh}oPk-Ywe&HrQ~)Zy2Vvk_79k@U^mpuCf^J zp_g~`(AK%vSoM|mRxBBw>(*bHh}X&&!-})R9hTKAxHlMWoXhf{2I^0|L>q&l(DWN!{!T01+EARJi6mvCc$^`NhZ z>e^?xQadi5sgC^&qJ2XJZqU#7j4PWDCOA1;%_0Qd$7BkcXqUy_F1mgrto_w7t5Gzp zrM@+Hxp}Suw!#H-P#raA1dI-OK*aD=ASG{+*~PqEf=8~?qgRgDCh)y(Dgc)4cCBf@ z8VRrX%i8L`yv^!|8Xn9|EX)oz0ty7gFfLWGUy*}>VXP1p^`-A+otKS?2n8=;C|7~G zx&kq1t~bBPlBJ_p@M8I@(Oj0B%_t044$rwt`kXv+W3Kqz*9$FrWkj#2Xy`_u<9wlc zOfIC##pkQSs+ZBlbxvN`t1Vui)?&b@&b#Wh;>&o>ML)k~_>wqkf}X+M=ziVVo8LEy zgI99^r5s}2UaB5^gJ|VO=c;N>^i5vw^*UT$o6Wg}&DJj%zpv--tSbY7vZ@*P8cYBt z?jI+Njws#ZPcn4fHV~AN&gbLEfQ}T2U{lIGb@fSoezh}@x8B(=g|^Iukj7PDKBO?7 zrXv81K!8jFdHE8$*r^4@`MCf5=>$7!+&%r}=Qo2Nj;CHks$UCiQW9@&#B3LRmzWD_ zYsnM1-W~!lICm4Wx+;Q0(C;D}xIag9gGx?$N?RfcuzN4YET<`F%SkgJ+sxgR27SAM znS-R_k+=*kF*i@1%?u>W07wkV1cI<}&gYjepFZx#BOnP9V_+&)w3Nhm*i7r@1t?k| z`nCS)73jVrgi0_lRlm@jY@qN^3Q5ny_OSB^QvxF0o*(<%EMaj6(qsbS1Ih*WkHG>zz+MpWLG9lN4Sz( zv^)+~p?XW`-Q5LB+Wrr$)LLk0zL>ZFa=8R+BY?H4vhW%k2!@=_r)hWt5eG=5A7VEt z1pM%x`z}Tyz%(8AhjF7e9YlnoX&NCri7IfdK5b%v9Sznjbi^{_P_+dJpk{_bcteZ_ z57U^=F$gBWkr5z!gkiHw8U)9~{;wZ^FrMS)r$7JsZKu1#^Ft?5iVzKTL#@edi=tLi zgIKsQ*h^@kmse_EAf`ZZ$g1N(bp&B2{m_%gesenIVNzfmUmn3yT%5NPCM@Tiri7Fe zz`e+Jny{bV?F3p?utHF9`L^L>*5r;!VhCV{ay8eO+;n>R`0KA957Sv8h~4%aB@l}N zftpyW6^e~3kq(MRca>ztwY>7ZsK*jh z+O1Blwm$$f3F!P~GY_r-j&{ki+5W&%Dh`5Mrm468u2))VS}?B+A5eGSui{11;M?iitvcowSHCaf5<>wVQHSGJlnb=d?kSOyB$`tm-TO;i(t-GEZQ z+KpSSzvkiM`QdKwM5{m}o|hKtc48$LuQaQM;vD-QgxFeAU^V%wzot}#S2nnL;nje` zxRU93Gf(HlMPm)Ms>B~`O|q0}SoJGj{&6T(|G*mJcHmmctC4+wSm;%o)vMH-A@us& z>hCL&;&j7(=EZ6$Fi*HVp|r&rygs?TR|A(aWS04AJXdk+6mrnMB}#6^Sgwge@ecF(Crk7(mRx^Ras}^eT+Qm)}0@5j)kmeSCWR zR=kg$MByN7A_xM2_|~pX(L{%QPKxn#f*@?VA&PZrm_DoP2B#ylBRW4Gx$fI0bWl&19Z@!$UC!wJwy zpvl#>>DnumqE41|hKpbEDb+qUN5UU!-;J5PY`%74*3Hifz|@(kW!PL?)%~?4y`m^we_OsRVSAVP z1PyH>xKmM!$;r&EI%fTcweR%}%l&zE_q!CG1rJ@1ww66vEUc4M;ff3B#IKT2uAb|U zi@jy|=r)H)OBcV(J9^#jQsDl0yLLulK}vwjw|akNsAjdkd|t`Dd5M^Naj;+QJQdt$ zC~5_$JI{0TYij^r3j5CP0dj~ z3dJrbUtGZkFx2vR`uy?JpP!V_an6d+c_=HH)i}fmbDWRQUrvx<&-iV#$vcea{W$g* zB6YB;G%e21k~+Wa%ohi4fw#y86DTX^qm;lYEqXK;tCKi{NP7lCA?F@T*+tIhu zKTTEVO)%5}-&nufZM#5NJ^9*<(s4YU(gd83+ns_#AQWOMMTQ<E}denK{Be-gpj z=*l!(wVU6+`tnNb&F;<1b-#RcHn{zmynbcw5vsN5Xbg-OUMFioK8~(hb506^>ogtD z=TxFG&Jp2!$~h~vz$4I$O}1EQH=e%k)34N7g2S}PJp;gkMut^3xDvNgtKyVNUm(-# z+f;tfo8vJXM;DtGu>lw5oT08P#vo^IX-x)z%?%1<0q?waJkUp$+_89-kn=N6G~hzt%8QGUx>f* zF4U<1d%~dJYBm44#5t+E8x!=k;9ETrPyEL5-`%fRSc>K7Vvj=1BipDBP#nM#Du@i5wG1j@Yb~m^ETGvvzy<5Ik|{pFF$Jqj zQC6rAQ8dGq6bK|Ny_%*8r!+pjY&e=+WB#uiOG1Gj1n6nl>^6fi4D1eqT`0>sj;H7S zc?8a19)5zvKuih*AnTaUU%!0(mtQ{{Lv|{%*=+k^=*&sVz}DrnMB2DE@#^k&5kcek z*qi2NHS6U%pP-yx3LVM)?Z@giLY1GkivD&sfNz;*XlVWNC0#A7f|#zN53Y`X-REoJ zeXr5n_1BjutlJIbynVd@S5*T;O~96>^E8gB{AlCbA;8tO2}<@tFR-G>uK?PGlBmQ6 zBfi48Kn^qWLcga#SD$s+MT?{^wQh~!C|)v~g&BjWB_G~4hG*6+THXz+58dFaN$e(O zGEc_hSo9@TFKaA8yk3hJo2qBbug(}M#%{HaR&_78e!L0;`<-n8Y;ERwXn{M09+fIN z@>=l03W4>7V48EZ{#cjT<}K)AP_df-tzglr|7B0Vv22*F*%fQOPugCP<7|LjgcMZJ z-Wx&O?_#WVFJ%$0bg0=cqIDZ6Pt-)z_pV9+jGfF{>FG0)aUf=WZ!*?dgrg=&fGb?Iu7>u^?PQ1)=YEB^QJ*cBR&G8lOLX+E0+N-bM7ZTbDx`w3%Fv5U2vBE;F&0EO!6eMN0TQR%+vF5W%Q@v_+4b*TQX$twOQ8W40 z>&1(qUKF}pH(I8~?R}oOWVthhS~zlZ7!q2JrUDk{b7m%#iJ8g}R z>)$Z2H(JSHFZ%NzvCrLb9}@!VyssMG-RO2ObF<@-KIm>JU;9;L+{rSjPqt}b)4I?E;GYWs-e;?W{n?e zztg$*JKOi-M5|Zp$|5Qj;=T8wZFBh>dw$RHPhKKa&pbtP$Dslx(l;F5jJ#$4k+;_9C!V$6BDG<(RQ1+Pcc4rr{m$vrl&y& zEX38VnTx$%)F=SpRe4+hO5|#eOadk-0cMNbBQ6GxFgifJ@A~e1JX27>J8+08NJx1C ze;H1xijG^2NQhVf?J|(z8Gusgx<0UJBgeYjx^te6U%q^vAcyDfcuo!`W@iHV`Qv~6 zufHiIJjC5@v)v$UHrs9A#{|(**?m1>+RD|67rM9lgJsSr9K`e;%%Rcn-0*eV>mm=U z9}CR6Og>>kt+S8mAYFXp*9 z1Lg>9TvF$+9~0|U)m*G*0LNl;)w0-9T#^iim|LyO!OeBxw>7&0GlYxUNpplq^Ty@& zH^EAc4TYsrIF_w?)Qbo&W~K{RWOWl(nVmhg8e~%UuzixFo)4S!IX#MygzRSk==-N3 zK=u6jm;d#j`xv%3`}pg}NpRi+ei~s@hkoeGELEzWPB$@zyF;nv>bcAgMTJ#0K$X{A zAqa8%Huo>4060+J4?`CLXr21TP?SCdt<+wc;77 zAb4T`YNn2ewV%zQwdSdyb6}YE5Izsv93x1EM?^Urj{B#VjstTo8H(~u0)eYT$1K5B z$ElFQ_~?_mz^%xf7VOcqIfDbC8+LD}GbY6_#1b~+<%-ks<#^KUS-Y)l9{=UT2hkknufF%cst4JeEN8^`VjcAERcA5#UXvsGK z7IKFc@?Qcf<_;AmQd4z(PCd}L4Ve-ZvBpny-d28^u?P|IzHzq)B1#J|CF>ncbdayh!#W_bD`Tgx1o(s z89ckzIF~L~-IFgMWGnD=OXq=GyMeE+Lqu+(05dNj=*`9`WqLh37JkmTKPB2Bln6Hk z)CnX~P-?ca7npcsq{IbScA3J|rd`qa6fASct-L~SAbj@%hUM9S)cP^*AZEPmlc&kgJ|VU@h4oC_^H} z#n9Zy<+g2nM+voH9RQHT!LXyVPYT2^Y_<}`J-{@@z**0qzfO?pvughswtZF2*4^2lr^7vdASOhBW|G?`RidChKF4r2@4n_wSj7yHW(u40BSdI>5jYp)lyUsX&AQg;P;$?K*FDUO?7F2QTucWPmna z%axpRGB6-STs%C>!VE>U8LCry@ol%()LdV7qc)IMGAq~67v`Uu{@+emOU=^tS3p?J zYYlTIKtq?Uo=Z-P|B_ant#JqBD30;k7O}}NEsUzvtQ#;#F|6wZ)&0tq)J%@GMFurQ$czh$jGP9|MIWn zpMM_uJ|bn6J}QL{*&IR+F)8|nP#s(j-k6ikP_^+E`6bojtV^=8q@#uD3INaM>NUb( zO2%>M0sv%AP=^5K1_o&j>LCI9dGbv_I-e7Fc@QE2D6oh^i^C5HECOSp>X-zKjVY9J zH1*Z5oU29YAfe)-Y65L$@>*tQNoIKs=+?==m0-T6I9=6trexo1u@BJQ{@Bbfa403aF z7^DYrz_|{Y=0x0QC?p6oGXVARc(P%fwm`ST8ABI4D6&JMNC-s2O&_4&GoZpOYgagj zIAADxxO7*WbO;d-Z!iM9*@RbH<2PG2Q#FvNa4EI>-A2r!T1ry@W{MCxiDe<%0y>q5 zge8*olF6n0!4iVN@7|b5=z7)`AVx%bHwg$51R*j+nCT*O=66;d{Qs|35;DFuEn6t% z-|9bdNZdSru8!j%1aQ9txL5QYkge(`q=0}}K=sWzDeT)IF9fx+dNnfLK$7!$|J%R* zt0BH^$LYQ8uTUG^FG70*Wwt^tL%5X&3V@1*1S)IFR4sc5pp|=h?$?;7&W?ve>M#I+ zI$inm-1FV6z(3OJ<6iW{%L~79B)ZoaO1nJtdzb$^wIy70wkhu^so!Y9y+#1tbd*y` znF)z>EOi$FFp*Rp)NRJh@poS|Ogs_-b7fqRnX;w>$ zMOt6B5V2XQd=tB_k8<=AGBo9p5Jf^p=%NIH13DfLr^M24`zSJuPJOq5sVHdsxY>4H zEz(du7K=NN1x!TBOX)0Xv6iKxK?p)Kj6%{Q^wZH(0%8mWhqMgdM3LC{o9)BP%MoGo zejB+KCvpS3i4q%wbY-Bd2P0cHhahMm22@(4tKl*b5Gn*POGLLh<(D&_-lh$J4BBjv zUye|n`oz`rX8a=Vc5hli41)VB3#Rm z2@Tt)J;*aQyREdEf5uj#d4z>T8(n;HrMNDFy>Rtcjqy?^xms3ibPtrcJZTk&a7ACg zI_i#?xqyr2FXs!iY?~X|+uvxm0CKll6&Bw*y*44NT}u~zUVX6jKjqMRg2c_+bUf}) zlPae3WI5^6=IQNuN`QaNwWlHcdzD`mZWeo0=(x_~rm zD56#*m0Vz)V(zWg)LZvm&3yfFwaMnoFW-4tP3%BCq{DBFGs6C%m{76y5?%_|fhST{)r|Gzr z0O1e?geiDVlSt+0tu7P>45p@OG&4sJXEUIrD1kVL$SYH@-I$_x{m^fY(2j+PTSWzc zXtQ~esD@#~g7FMuCT7Cf00fF6a1xsH*G)wm98*#}>lojkr40c5fwn|BV0PDC9pH4w zkG+2G%Q0`~R;fc5n%s9fwqTzZGWqg=GCA+A(sB)P%mmlvgbN>stu9Ta=2h`0RjFqH z_m6t`^1-L`1UY=^LOR6_vYk(dQ_5pbnI{D16DT+WA`zga7SF1r#AOIe_0VzAn+&Yd zN}od5#?Sxy>vP!ek7L2!&2B_-ma*aLcA2GC{k$OX<=HL=#*G~{^P=_1&9sz2B4Q#2 zvjIt`6iPk^iRDj6f^GxYz=Pp`&tn z-+POgA8UDJFlvRtx!P0PG%n_Y)~Y+oJPXLxoo>#-m29a}^q%6lx{=e3%a>o!_DM7a z^9pXgY^BPwuOx2J>yl2Zb}8cpO)@N@j=x8W)fk)KZj{9Gnwz;10q*LcuGg4=p$nS! znM#r_EMQVLZ5qzz^ zuHs@UAI0yp_pUo}@1FPNURA6$%+AY2IA1Z4SKFu=(N)=Nv_~|*n&oNvZd_KMW^S|iu$kS<$ zw@;7jO4V9ILrWxzi?+F?)gI8olv7Ele!P`PUoNiNW@C9-wtlGydUfR1s)0q0t3iwkg`$8oW~$DB=|ezo6AH4Yk+qRM{|&(2J9*fu32*q zYyy@6yPUg{mbdaiu}0f_A-h@jdkrXZ?uEx?K{ z#!(Oy*MjF2-WfLr1=&buZV^hRYRX~Q$|iJO7dIFpz|!}%P)DI&B4ReE7}X#mS<7J{ zGO_}~#F`7BRQX&CmkiaW7C1lv-)TRd#`API4AOPO0}x2iNghKN2qjft%OD#oJdNXc zoB)8)1F$41BWyrfa}t=FU6|!S5hEl~hwZS9a>jW~S=C$_=Bkl=r?cscTa;kh+MTJS1tA5sKVp96ssej!W(X&oZmqy z=aPA=w%B`Kk;dQeHdr*}KiUkHlN&ZyaDUa0x*4hzrK@CDH?gNoVaRWO`jdW`)D99} z{LGJqHnGb9M$*(3y$i)mU4^jz!@#kvFl7A+z70NhJ#Dmi>Qp2P64OJ6?x z6d@3nJCG$Rg}1i_$%R4!D3PV0GM(=X{z`jwAGB9&8piXE8Tf_t(>D zWQ=?|(Z6@YmTf$wG@XtL2*n}xYKD}v@^wKg#yut=nvZBrVVI6zKc5j8(}yi07kuXS z)2OHzaEGX_REmF9Eu&eQ7aQa9*)(N03Mx(YJ{_KqCk*|yD{dN3hf~fWBiS^KlOu*s zNFabFwJ8X~?Qk`x@0(ut+bhv=$tAqB*VE_!xVbIW%A0q!reJ=vT@OkyUnw=MRiBQa zsKQz*Mb1_&2qa3ECw+H4tn)vAxUJ#d8>Qpd&r?B8sp*qmaJbqp6)p)f;bQx#da9Lj z=QDGqQ!T^CDNW;)4ZJl~2$Us0PC_9U^T%>AlxYkdhxp`p+K-TcWJoqaIrN(l5JC-Q zEObki^_k{<#!4|jwNe+l;KAfKF63_xldHOV-PR2vhDQ=%aMz0jqZd`A6mG^&A;MD_L#Y9$LCwoc|yh^t1 z>Plu%2SHU;l@OyMGD2p7o)72nu;DAIk&Y>OmQs0cN}BpmVO{f_Cp8F%zzk$9;aCgr zb#;u;Qe*PRTJf)Vb0<_}kZ0R!8EGj=$0f}Ois5+($<7V}$$-D|Dzhjrf{u3rIME@d_<1b;JS z!z;(+C8<>PwwHneY=HSSr$8OHV%(Rd)d(735cA{9;n@*l4^=RgiV4IxmrJ`jjEHqK zVeSFieHuq38?!=3$->Vfdf6AASV}I0{Js#wh_L-Oz`Otf~p@Qe2`{n?Nn2{MtYvLW^Nw zKncOrQXW72*Z=L`ze)%%_Kc^WpPWSGPM(exF*cLUFcUG1xa<+xn4JLDwV#FCett2H z=FgT@6LX4O;*Ti^^mE$1eTp=Ytlo&`6DX9dAJJ)4NUU+*rqh%e9a9hjYz8&j+12>@ z-Fz)&H!DWX+~rpFj@N?E3c(W*^P0%u+xE|DNQ_=No9@|bw=TuJEUltj8T?zsNC4n- zfPQ=7VeZx?n=4lQZ(gVFg+TS{Wt1^K|(51sJw(0>C695Q2G!q=3Q_5L{u*8U?*0+DkwB zNmUE(#=;>;U}{p*fM5)&n0c|^lobq9r~q!<=wjNsaVtc}R<+4CL~gFRyv0ItQdH9N zz;b(_04x&#cDc)`=ka`=MgS5hMr^7ISrxC@$GtKWz!dPHPrCtG03ZT+g9rpSRrk!G zYTT%+XwK<;YW*aZNE&l5Kv30lIzQ?b)h2!23Vy3Loe#$`Wi=2yr)kV%f)>h!6wz;h zSoVP!vKW9kU`*5XmS0kj8K&lUfUVV|0(0TBt79F_!+z1*1^D{L0{O#So)`RR-_UsH z1HQFL2~-N*-%i#oR3+sC)xYQD^Om`OaKqe{d!pM66nDM#ZyzRvG3B%eDD;p48-*go z5JCvOlLD9!17J=Bfq<#}pX(K{S5x*3UJ09v$3LIWzx>yK{rJ)kFM1lb`*SiN5K(2> zzv@~`h-x9L#&fij8M0e&Q5f^$RHTMx@s;C90l;laY05#H&jdm&$mh>r_PZ{`R`P^l zNEs0H0Xf7Ll@QzfhiP+^`zo!lIx@%?H-CI51xKvHtbcK2;a;=sCf@czoK&-Y< zH4}-zpbTpz_kqu42gv{g!xQkb|BStm^t*mDM9l#8 z?0K93AHkfr;4XGCfI79Gx1YX#nYt}T-M)MCgqLaiQ22;6XH6JLGP^OkabYlG^k!9; zl=cLRaFJTLp&6tA6e{3=Wa*eeL851PN&w&o^lu)vfNCA?D$JPy@-%-L1d6P#UMdm^ z7#wmwfBLjXH}oG*LHgb9aoaJMQh;iJvJ}l5y+|k+jgX5#j|Yt*r*S+EZyzm<+lSak zoD+yS28OApM1kB+hvRuOunZDHDXk9fx+t9-pI@+j+6C9A-NSYl+0_x58fynJ z^4Bwf{pUBk?UrMY5ywxT_PT{3D>MOk_-WE()rZ5wL!b~l41a#uc0?jsA{&88Duqvi znmgP9L+0i?snzy9+1LmqQ7Rma;mlrmyOwmhCr`^?>AH*_T*K?3r6 zxZE5<(g;a)c^(6}gSkzom&5a4&rknwm=xH&{SQx2gCHx|QZ>tK9UWf~_J#Dzb0r95 zwQK`yfitPupJ=s)baAH#XhsN_(&@C{e?9g;|Km0W9MzrP{N;2!=k(7}^+YPWs?Y(z z_U-=jLHZ#){plZne%b}7c9KWUd3yf!^k#Tc^pQcyJdY$O$x+RtV@QCo%esWAqRwXo zHrK?ZEMaT3{Flk?0tv^=-BR<7Ny=tYOdl_WAZBdij^!t{u3J_D7rDEroNZGeHL)QfbeLZha#z6Frb zTj~h~LWw~rp>v~NbRJV_o?_jfbMNELEW@-?NDtzKm ztyvj$QD#)Jw;paHm+CT^A=I2oVYV_Ms1OR|y)}+17d^%Dt%g zrp)GYOSd$zHl42&>1D#!t(3q<4#H~c&AB|y4y-!PeN(L35?;j~U1-&>73{hTU;RL@ zYp>5&cx99=Vz&m0S6Sj%SWGTa;YH{>*23o|h*jLV4#SQ@z|_MK&gXo#F_#eGDP=QL zbvH9r92Lc{CxO^(Hj$|~Sy`x&SuGwP05E1{Asf%KHN;Z_@UZR5YK2Qx((AR#6&jaS z5k&PBtCkxDsLy-+JX&`s=a@%;SZxZNBcJwqo(=%3#2pZ7R?eCmPoCZO}O z7*hyc7u3OVx7}{Lx>c*@l+)??D`D6e%%C{~0eN>N1 zwJpr`e^wK}Nr(Ayo79?jnfdeuV4E)p6ovIBefxY1Yl;IGwQ{}g3@CMnE}dj0#9%(~ za;DwBRXHYzNYqdwqY4PhqQOv%^?O0u#B)u;`mi^TD^++=JhT_LE==3RYs$iUkli$u zea4^5kp{o?<_T!7^8BsVKx--YEA*QRcak2& zK)uMQo^`}|n)-{eD72DSQ+-9j7a+|ZEZ-?6oDab1Jf`!uf8^K&5Z6$asuuz(Fs{>; zx;Ot6-s*TfP7?%4kh70^hU;GXT_5@k&7=8X2#Od7f|PuG%hhDz5JQJPgyr!Kb>uiKZw!!k0f|%QiJ& zQf)AEZ=p@MrN!;A$K}f!va+zzEt9&INiHw-epvM4W}$k4rcVDZ@6AFOa<{yLEj{Pe zSM{3(y=`{h`f1AEw-ntgOZa;p{6c|8V1z9**mfh*KSTA9;4D5JcIRmlb~57P9nJuE zM6S%%D#91y1Y^jhg=*_hED&M$EdtAC0`Sy{5EVdbE+Rgsr5nbSvqHK)f*6&mtHeft z1ei+LnP6RW-n_j`3YbIW(s)J}c{-n;kEi1i&xeC-C_9+L=H2Na2YuQ1fNIAG1oz~c zMMxwBj+<>i3?T}`Jg1~n8c*ka7#`t@oYdDvcANU9D4{L|LE=yFXbZqb%%(VOF)iN3mjTlOjmx-^#Y%>N?Ilm zE!a92Fuy{w-&k~uo+e;0Nu#H76>jvUROl#*-YOFN;XF=xI`30_Gp5~R2Zgz+wWw}A z2Smxyh+X!Ky z=s1&;f}M&^88?W#qo?!f`T6B+lXY=AWxz)LmA8+NL(f1Ovmpc-91?&~_`s7+>R@Jx z-LOSJ^bigLC^=L~n3!QjCo#m`+k8A|KJE9XDJM}^1rbH~qabUH+sDnPUq@BJcC+iB z1f|>s#~pwvfJ8zC%f0bykQ8XR4Gr8_1%@T+@3vaCLW^E2$koY0PEw}2Qx%4F4%7OS zYcIfjZMra??#jwLjjkc6^^Ix@-kfl_zHPnp`sl^PwI=a=FaN1|<-ac(DdW*$MdA= zu-|`7;UT#pk7sa@8JKFXF9Wr9L=hHTTtKkdU9#k-EhDy)Mm%q{x87YHgh~?9yqc?j zZYX8zSw5Es^g5AB7XR!nn;m4Yu0vP#+-r@n83w(UGs^`8!~|AitNT|V5m~KQ2Z5O& zR>BPLJ~|c2y3sHw>a#S}z+Fj77XTaz=@zDJKsV;o^GimM(D!jwiZV~E zMdP?V#q8EcwSWbZgr!pg(s3I%#N7zw(bMVhm=&u$hTCl!sCa#UKPK8Abb@@|Jq&Nd z_Vxzm$RvTX3Nv@1-|47&KI}h#`Un6RGp2Ex_8t1V6`lfsfR1OcITTY)ssa+}wi)O* zTgoc205oP&4lZzxJG$M^8cxV*dU<|%+@x4V%n2FO@nytj69TfHA>iHHho3{kdqJLa zb$eZ^kg}*tR(E=K3sb4xPLhe9C3W##{m#==|+UA84;; zV@=ii!O91h9lx4mcS5XR=S>8HNFmfPz^v5UV<>-%ir;7FM%g?BwtklO$$`QGbxrh5 zTv24M^~8ChrsTV&_o_ndR=skitUZIRq7`nq6OmW@B`u)3r zvNI@5=K+6~9weN}!6l@lq;aW(!K?}}MGM=URnz0Hm-Gc06hx2Hc?!d(iy;KSY$D>& z1*r;p21B7KxljzDf0Te>+eyxdVP*y(BA%I}iFfaEx9@@T^T+oOg9i~2!Ra}r?&b4` zQ~!2&BIy9g?%lh$k3W^YivU-pRv$F0xj{^H&c9!jdIMn0g)Cqe`RloLYmu%9rLMKr zqRZL!Rn}_u_0<*?j#vM^fA{;1uWxo^kz4|WRyBp!%6oMavca{|y?L2Sq0#)UxQFlI zMPRGzoPkWCb3FY8NsW~)je7|9ltV8Dbx5}3)cMBWq`&~26l^ntR$0lbXENAgX}Uwl z!~U;n%#%X8ZrHuw?K;L>@XqT_=9;r6#qsOMfBP~%p=a)b)sP-TM$V%pHJ3p`xZ(OO zLE8Y#%@n}6-+x6vZZRG{9;U;j@-gkkrw8r;gwRdUlfX{X89llV(CKj8KOZJAKq8xA z2nH8PmGba9N_1^wEz@BE^<}>N#X8|RWMTbn`*3qP@cKX|s6g9{ z4$NTH8746B5|b)-$`qOM8m6V{C%IT76$ufx8Ygw}qp?$E6?anz*Q(zH*j!Zh`nEHi zQe+;Z7_Do|@f$+V%M+DE>pEpC2E`1(#ERIeJ5a+zJ$C(YlH)N$fPA9q6t_X3>7efe z0H|w*Iy?^q;B**IDFbTf<8(^c0*2>v0y=C!3^%6Y-a8{OOW-?}nd+-y1wbMa$g@JH z#}tU;kZ= z7hvUHmsg5u{a_b!uLO=^*&C``yM4BLMux6%`+H@6jAvn4ZA1#T{f}KA`!Ay*j{tWY z$)RJ5NW#Fh57S!=v7_K6ZPU-Y~*3J7q?rL_lc~;Hi`FzZ3k3GlA>$uvgN}O}aJ7~_9bpHAq zhNP0m{Xr+_UJtwDKiQy45RPvwk1+|SX}^s-02q(^&oBGKXvRLG4^fa+$LZt8!x6%# zm&s1Ym%}#c{?msP!NVM?K&U|LJQfas8jfGR)uoZ&HPLFYq2oToQ04Wgb~d$$scOy4 z?Y0|w0r@cF2P+JJKI=m4&FRCdZWA|=IlHiN;T2o~orHR7m0SS^b28M-CkR-8!q35X z7!hiDMNnn@zV&?6Vp7>&@vJnLO2M1dp)6S91ufoO**^cLm7nL8gE9k1lvvd zahp;;{4CEuNg!6!bUMd#mj3wxC<=-m>5db#M=dKdwWitPc#G*tqK$|~LG zj>f(tbW&_W+n;iG-Y9_~CNMTZNk}fK8mlM?pItN*Snd4s>6c$V?tw0Ln}JFdilV(EZ`_0r9OWF<7>$({|M93#R=eI3OWCe|R|@#t8tQy9igCj>r99f88I4 zhh7!HczBUuUp{}92kvStO8{|8yeV10BwP}ID%4XMhf(*>_0+nY&C5o6t62#XAOk`v z&{?HK5eVxU&A{s*#fA6)C5!FKt3^wH)?X58T-JK4Ea^3KHqg~-T7*|UjuwcudY2Ts z%H}4mO#C8u6M0$xhSCbIH3zR*g;&4-5%hUZ+WWTWg^9I|51ZEQj-dvH)?k*#I|~5f z%p`cx&BM?|fgb$_xy{_VJXCmLh;nn`+tBY$}ghLZaL>CC!FdYNSCZg2h8G z2%1=g2`*O3yEM{zg$#Ti9^dUVrmr7%z3m=!N{H{`Y0`5P$nf<3J)O@_r!c(PK9rr= zD!Y52&azIHVTRDHpN3FbO?6qVj+r~)kG1&~Uapplyq+Izf8dnc?f0!OS|PYT16`#s z!>cR1o1rUWk6#B+l-3~jk_eQOB{lxj)6=`3{>wk(lmQ9xW$@SmLpPNBoxbAnO^rHO z20~qo;d&7VvEp+jM>>7^?U%oP$>=b=`^UfhH2nM!B#>)9O?{~$nL&W3bexW-lfK*L zKiL)m=P|d)V*UEB<9HY+i1ep8plC$A>^4lyjCES zz$F!DZEe4z>iAvEvVYfhbAP4<7WwY!m+glhX1;&&Rj6VX-o(?AjaKh*bYOC!cb_awy*+>>(XLTz{nhKUuy&f)~-tA)f6tEQYyjfZ|1f}ZwJaLVa?X5_F>k0FRK zFdZHzRh5!TSb2@i6=E~?`QX$eZeT=t>F46;EzO%pf-M*uu~o}D$~cW} zO)0OZ4uP16tfm{)7iu-(2q<`qfr(la@9nm1wBKoLvy=03G?oKi%~V1$H&+LhM1<8Q z_-aA0H8hl02NCm($M`FQ?;>Noprq8kyV!+M{nBEn&?(nU9Bx4D^#6;?Ej*-Pk^ z(M1*pBW~k~Vqv1@=L=AT!Msr~#R5E+D2n0~nM>87U9{yvnybxKU1l3~PV}u8Gee;Y zuto=y!K_5gv*cs7THlK*Y_2T*@c55-+C4;!(5LJZ@bCal*-Msf5Jb_JQxFa~eg3-d z-*$Zv91>y&pzq%7#tigNLm#<$BrG5H|Ne}(ecz!6blGhhUM=&RYQG57VFVoy&-?vh zoUjf3(Dz+Bjicru(C+OfU_40mJpv#u95w{6{GtV0^Pl{_Z&4}Ur;UXmlq zZuhi_a*9Kw;AX-iUB@rm}e9T!P!`5w>`8leysD^*f@Yliu>$6+i=Z{{p5_nk-1qEzu6YamvwNgdI z918%Hn2Onqx@aZVjc3%lxn5S4__VpMsjWs^Vw>wRWlxw1)8_xuA`S^ouW)glW*U&7PNdNX)^8&s7V&!(6~zZ<6mMZXU7UA3tw(+{Hj1Vt}y|_79-9$mIJ~OnJ z?grTT>&qcL4no3!JiI)89zS9yr!*qOO*|ha2%JNt0EK3q#+;|~F`tqV505|L7o>AH zDIi_25##vjw_iVe`2q@i*`*H9{ULBnhSO)+ZBqnL5~GZbLBUCiU@jgo0)R6~2$%sx zBFH+4hIO`ygtV=IHnC~hm)N}+JtZijVY;EsPF=3)#^%ssTh!NID3xusP_SM<)Zq9l zJil~^s`P4KR@f*P2bZ)H%jGWD(xPpae*ypyktm};-CB$o#u_@jyi66&w7OOiFFxOR zj^kNYU)fPg7aNtBIS?WkWFqQi=V^SW1h{MC{T4S=X1L|~#ET!fxI%ml?J?L_0d~ff zwmc~2N{Wmcxkggx;vI?%H>eC{unB_fDqa6?AMm!P!Hxj8KuEti2PaU3 z@Fty}(+Sw%^yTwm$B)u=*kczrqT#83x61}_7b17Fay%XX{eRu#|Mn1a_vh%@0A|*e z%b;l`>ba=gq_E^L&0oL#`kY2pkr4VmJWPi#Q%)%WanotuYv?xOS=E?{T&)tl1c*dp z)zQ!AE{MRBA|g*GRRG*c55#WUAOFjFh)<6X+aS}wz8v50HUj4;6q(?Vd@?iP(6uac zf&np&8I=9}@#PEv8<8#E1por=k;lUJ7KBaHVSgC0i2`QyvFn2v5Q<;bW*ZzeiPa3q zg)Ryb`lpa_MyGo^iu7F!T@W1Qr#Kw+n4Nox8KH;gvpPW1bsSDH0MPT7m){Nvarf@$ zclmLcXKv*wY%8OX;I6Z<1>9yaaj^^iDviAOIIKpEuGQ1JWMnxIO&%8B)=C|<)?5XE zYh7_oU|m!JbAY5cKpf-+{b*|fC~}ipNKKtuVh#mUr6Q=8LG#a4-n3!|xmhW_YQ>jg zKsHTj$_mivn%uy`QU@jyGtZ&pLDe%5j13IWdP--746%~{MY6iK9mX=?=})`Jc}(N! zx$6V)r=O0}OMJlQ_+fwk`1I4C-#vEc{;}smvIH~J3dJ%hpjmbL^6A+9!<&t$MC9Y= zfBkPS{Pt_(BA&V=0H!o0>!VInI-hfX{}d#r-~RJgY(C}Re);9J+48U}?C;25fBDb9 zrU`tO%_h8m_kI_kjtgVfkptYm{_p>Cc>fQ7-ozk^;XOe=eE#tCq&iOF@h`jd;jsJD zCUlzt$RkeAzkW&S`0;c&?@!4CBfhoY4*UIK1j4&8Df0fymk)<8U!w@7r_B>S95g9n zx9i5y`-e>@Wy!d)v62YLOJM07FURK(UB9UeE&T~!W~78F_|~PJ7G-%!-foye5wXkIR>ci#NTrZxx@wUZ z)m74LF`<>4hpR5fjn4H>z~&$J-2DxWiq3H-l;(Ff{;?~CCMbW0!((QB1U5oLBp;`k zbKwjEg%qSxx`YAJKfL?t&6{orYzkpncdCDP`gqXKpKu@y!X(6I_hR5mH%rt>)@e!z zVFS=^w=KqnbPfOsfR7q;>T5zT3!v(g0Zbh&?>sOScYwQTwTS=#aoD``!^bn>EU+Dr zUxFY9axh6TKPuD{Vyosd8>tSmFg*Ue1%MMs@igDE-+*D7F9{K*j{9vVzc*r|+W`U` zJ&J0MImrBGEQ5suB!qy@%)laC^7C~%KfmlhyyOWFQwRv#(tB&TMnQ>c)4NfLe`_n! zi|(fg{*Tri@DlTzT~%w!i>m`Hftgs@1vd)>W!AbQGO->+J6$J@axj31S!5Vu0FciD zbbXYPkdu=EI*t2|tl!036GaPuq2}}c>;Aw&w?Q{Oa+(V>cHMRuLJhlg#7$(I4$p_< z2?&W1c29q@5#vemwCgvp@kPSMOXyAhzPntZ)9K5H6rUyq5YhERFTixF2TUPPKsV2* zG(La%teO=v1kKYm;Z#P>>3P3DoR6nzmkX--W;2~9K!CoFePd5Tt5C6Op)6^I8r*M$ zyEiNit+Wkad6z0#&AnEUjPJ_}tJD0R!}rJA-^VezUem<}5?pxlzq#la7n0u)9hD^D z2OD!iEf-hu#RVH*d5J|``qvE08llg&l6e=C;MRCi*=pV0AO>fHBS2R*aM+k(It9Qp z#tfO#Q3W|C1c}@Sate7o8$caGC%NCn%@!)%17q0j-o1Z%>|)4nC>6ivp7d`HyLkGH zj~nEt-EKnyv(<<%i=cWi6@+YO&FOqNp0VjdAG<)92#ydy4jfYsIf+b3dt-_K1ml#) zvu8veXpj(z023BwaSQNlX)4=8Qb5Ay3GuZ5JlT0VJn06f<8<2ZVg#g)jk*~a+=X7G zy=n6rd8+dGzDGJeA5)SEKM4pB0mltI`vee7lVvR>EfD%))3LX`@#<~y@^Wp?%FS^= zr;ssO7cq4`q|Ha2&XbE6SR^n*-M|!u!K{{!FJC|HzwA#5`$_t^TcRui0Ah0m%N%Mi zt2sMI4-UYUXo-2e8as~7sR(Z#lJIVnIq6~iKQEbP((2^+LqFR5@sWOJ~xgz-6AW#NqsBY|?^dzInw;q7QAhhprv zyQjG60)UjpvqGmd+H~CfxyviUjM+77!f?x{mk*ylACL}DLw>U(oyOCYEIZ=v>Fu`f zx`1LM@Zd4$FTZ|xp3sGJCvp4!f=s3bEU5B2Clzq!8(b-Qy;-@apOhCt4~Y5;HPX9b=}DqzqJzrY~EK7ypVH z5zWdd6}N1QYrnMO>I5=|z(gI$e5VrSip`G1z+j^vsEg|b2)rpfF7gx_P}|5v?^-$r zB3E}clxcn`)~Z6b0(RD}O};*safP>(?+dN@b!18{V8ypek(KjUlmU{vafm+Ow%uk< zubNB9uvNDhE*Anh_D1=6So57 zLAsu&_>_jN0Nb!Z+`NB!_p}RyU@bL3-W(>PhA%Q&kCuN?Q)7#q%WP* z>G^b?6!CGh?RvI+Rtu&Sgp*>_E{v1#bGHF|EFgnTzlXxx*PfzTZpjiO~#ozx6mU`7#^ARuDs zI)A~?Ua7i6W^b6C5n_pnDg9suAuuC$n?HR3Bxy!M|MVVD+sH`c%i)xeJ)I8wr*7B` zMgYPzR-Jix`0344-wC;8Rfq%%WYdR#{eZZ6d!o>7 z-yTjWr`$jFT@?7~%Uju6&Zooalt(83T_1)}C(6YblAG)F^7)rvGdAy^ww*d zwF(4W4!9xqDmd(m@1p$Vb)TZD*Ajq23B!6*F#tfKBwEmC%okm5>Ps&QxeOIE50$vH zial^awTnk&WmMZN_m*q2fl6`q#`Raj>nhQK6;PQxr(C`sp=rcs*dPS}j2sG8Cpak3 z^&NFvAc&w>5$U%N58KTU;aM3336xOWMBvG7n$F09@C)L*T47ANAV612yCXv#ID9>P z{Pab!*}i?+Zu<_?QJ=L3c@F@2N-E0f~%$jz};@Uedzyb7tzuQnIuG!>bb251_`-I9MJV+FPJbI#^|{h zjwIb?f-00mRmW+XMo16U5Qk3KYV|ijAQDUCtY=9wW00A9HM5pm| z$|VUMaBwNaVFb(nU+Vs~NvhARr6P^47#Xl0RsC8AeRWL%U-}Y^_^8?hgjjIRX4h| z#*|=YfZg03B*a1p9uGe}_tZU2Y(RH-#5jhCJe`lHjMZj7pFYWthuzjiv$@}Otvk8v z`SX`$&9Es7^~G0k6Z+1gqSItF{5=#fM<@tnu&^aOWyWM`uIm)|n7nXIN zk6m`v{Cxa;Dh@DrUDrnucKe#|=vLG9A9VPatv^q)zdU9rFR@3-oF3t@u3U8oTq6jK-eD+yFOGrLO`|Gk8O3i z1cr&hR8?WNw$_Dg#I2y!;O1)AK10+R-oUta3kAPaU~Axuw|Y2pC@KgWHSg&k9{+s14zO_{U>dwD^`Jn&tBYvX? z>vmA8@m_1Qvwg(@=&D868i*Ejhdu#CNFk!4rL2eqEC7Hob~WK0hn3?l^<9e595umr zcYD(`%?lVnHiJ}j;p=k7ZKzqnmtT(m_VZB>ZxZ_5(1{kGKh0g}x=P?Ifcm=9vX&Mf zI{0 z0f58})P*i30P^8^HqF)nAc=vZ+iHNWs_v>@+m(e7uJX_L-Bu-~kPvHaCN+0Yw6@^LqaB>DP}(#dm3~yq0}aI5bxn7mz}j@eQ^5zjkaqmES-9Hqwc& zUdUf@5%s?tjsjqn*H9(9&D8*fo`LA0#9MmL)iBpRlcg0M8_K%O%bHS``WP6nqLv|o zzydIa{rCAH4abk?+;#nKk8#%nn$Mr6Vv{Sv9OAF<4yBQB`R;$Nx}1(jqvW5AO~`0*dRZ22o~`$U&mKecUSmk}gUHJsjS3Tu$r&qv+GeUp}uONJ!(j z8!k+)ub#1%<>~2}LjUuFkg2ST)4>|1wtypo?)71PN~27U#BEnY-~D8|BSm zZ)MK@PsmGe_LyErPHx7v)zntVc=OD-3EnVnv^nppHuw${Aa zs}2rorr`1+B0*lxYtE}?AVMDZ`wrO_A0%?9Ed|iqGNS}7kg@A9ui!xlU9G)VF{#4w z^-8oJ-NYQHt8PqVf64KcNc8aCoJTHsQiz@cvAhA6Y zurZ4e2zs+s6SVaKmXNvt4r6ybPPzyO4bll2D2f}3sp+!h2?TVVFcG6onaa(*K`jXI ztxl(2Z?)1283IsLp~Z7CR6TGz9rvf9AB4>pEl^bjVvyy_di?bB@obXbA42H&!)^#7 z(CX(_`$+^Kg4l={{-O?uK;LZWb2A!@@Xg;}_UjFPBmnNUNm>(A{%ZIJ3%*z!ZQgEC z=~8q%P;E~n{K zxOSjoLMgf`B!!j&Nc|y?-R?ttTI69DW!!ZMrJSFS=UHbr6c6_C$Mr_8>OxE)^*m3f z>5ML#12&p-e4IfsDIzkNLH_CW}*s6$l_NhyZ;`NJ;gI;M4cKA#mKc6^R~g39jj{)c@^ z>?sYWA?vn++h|%6+)@ z>uuLx5yaX^(CC#OmzQg+Iis5Y1nwb8m~Xw%c!N@b>pBOnih^EIvb#*a*X5{p&$Fq_ z*S6c$%ON;zU~JRvXLwnUc{ytadU^Z!_$Ju%NsEs?C1y)GBP`H@0zgtf78DC1DF`T~ z6cASp5M%evppnGB4{%$7b$L2=F1F^F#2H}aeDfL61sd-#_B+Smmotfs~(2u6ur|4TTl!b&GW2s2XxO12eluG!#jCexx*E1r2rYF>&8AUb3ra^to`O$pn85fjwZrf%3M}0#T*jC{CWEH>&FRQ z>i38KFpMeGaztgX*pK-oOJdIMFY9ib`u{hl@!gdE?PcDu#QOvNR(`Ke_^))5Hg^;4 zXfM9b*X`!z7oF{{g8k)TZ$Iz1I|_x?vlzMn;!Hv+P&iazRV;qXR1ibhLIL0!^`+}uI6JkS}@NJR{;x&Q)_Anw%qFa*DdOgL1S800Ei zRCS#{{rU;k0gNPslFPCPL>&TS@zAS;Ziu_%DxED|*F`M8o~C*6+}cE}Q`YP5-lzt_ zJ?Anl%aT8ihopuxvbe0cx3>l4)1Wq}A`^%+(^f66&TVUCQltn+!Y@v!e> zWCkasg!%aAfBj&HK)>7VcHN~d@{6bJ0H_kw_^0E95DyP#=sQSy`2L57 zB+?{cQ_?qtMLu@RxmN^~XL)IP{Rnf#B+h^~@m#l@M46FjzHvh8sN{ zSe5EvL<+R(nt_O2<8u}mH91NE)UFBjVKP{2Bt*C;bCPWMqP2z`bnWT&VrpJgR+>$+ z-{UP_p5?3Kn|*D$^$B^+yqF6dX6g>S!sq-yb$BbS{vR(MZ1LV-RYUQYhOP5F8Il6S zex!;M?;a=$c`0gVWI+YZg=5{cTV0#3V%Ox=&8rXNoBb}7GHZU0kn<<#vi{?L`OWJn zkvnkOKki1!3@__)etJ5Ur#Ty}XePO!)Y`gS)LFFV0xhb`*^gGm-`zAjC~oe`weZT# zOk$t+j~@tmD=JLm7zkjw?Q~yCaZuno>kG-29d!tVb3V;C*S}QXo>6Y5Uf-`S_`>8+dhdu^V=z0ph0Dd~p zi+=ueTtmyMds*kRA?;F(!UTu}&OU!WP6z>#hQ3Rw`;E88L=psYZrNYahH-@ zqTm7)MY${yY-&ybKzyknx;uSE55KW4FBO5mLu-~QVe8hp{f~{m&3X)4O36VW-o()v ze1qufQhCW$6SLLhi&(<|Yf8@i#R{%zQS-{}2Q@*sO0)>9TVV)9&7p7zdAV?M3}7R1 z0i?1jxBf$ftu;*z4i#Ix*CN-}n*soFE!l4ouA)??F95qt5rNd%Mpr_p33*j>gb@3h zr@0L8==@RhibDGMhxdb_{BqjCB&A63oUuFObpG|k1L^X7L|K=opN2o`oIei_hg~lM z5ol5M0Ju3t259)kwl8Kg@B1IKkK{pJE)6kgFRb{?O&27x}bK8Q>Il0mTt*i-2qLJHU%6 zR1JOT_wT-cd-!koazYsPZ~x)Dgwo253(D%qs%7<}^5#tkMF|p+y*MYb1wjNdK;Ct~ zte>79%feZG$5Dg=htqk^7`=ZJAODL;3IVPNY^8#)+Z3mU7j6wWI_9Fvpg z3cRRWhUdQW3!%`ZPFDf}<{;F@QP#2$H!JztsM!Ic3ur8OiF#g<5uiz6R!XAZaiehs zZw#(rY8VQ^x3=2V*CjN)77!}<;{bu$Mb_NtE8EwWN~~6R!

      gu;?^5x3J8oPfzD^{P>IzQnx>l&&OYu@$LAJ??cB94q~j!)5l}!Pg#0k zH|`IQhrZs7P!;8B?^q3@BjBd%^BTp#OL#ec$y}Y^=ZL-J)Y$7FmhQXLO@{i z6H5@+@W=kk=W;#+CB%odNXJ$XjCYVU4&^x?4L}He-vMjR=Yl?Y3NZ)~!@04JUD2c; z;i@QL4zLV$pyU~$OEL(x+ywV9w1hs4E0vy0Lsdv_a6bY-m9@FiJi(!RexVSL$LRuYG^0xtc;k4KQV5E}+`R&?H<`ziN8Q9FPdV{8O}DPq@H%s&E0- zuNc52%*6q6xF~Y1{0wG|BXGOaUfR?PV(1$}THWO8;k8fPe&}}Dwm%wf%Meo9k{giA zTC~fD?P|QXUC%F*yEd7sH?A-zzH~El6sX`@x9;v=t#!U*A8&v6+f8YE5(Z(IX0`Yr z<1rwkgf0!k(3eO6F*Ausodp)TWJON7tW(D-Wi3CH<*ZWybm(ebrMgE`z{D8f&<}lB zAzhG&<>_dqJrm6;kTL!!|H5TE3AI`@`fo^#7?l3}^bP;!@HJ_f( zb2i`*A5h6sVqO$X0w{|yMIB}Lyso}1gM%u+Hghl0SX?<(D%|fjB}H-CpBzhL#v(6u1!! zYpsi57SaHPdzCI=(pt?>lL!oQH*DgqZN}a^uvd4vR=}`vt<8DOW3Ky%UkKo|E#GhY z&&D9H^}6J^X{UJGw32R?&%MUO*Mn|^LFrm<*wB*e;$gq+J_dLxmQB|=&(GQfeLG5l zNJ8a(TEk6S*VcwVFUK#x9y9c)D~7#9oxl8|pFck#KR)c*ebs9ZF%2)o@7A*7lWVGtAr6wAD5HZXArAr4rlb&dsHmm;#R zMZ58FH`G!Lael_<;(mPoRr`n0jwi*unu^W2 zKb%w{LlOW+Y5@!sC%7T(W8WUwx&BN3T!HH6olA~yToOk=T($SAg;M+ zxuaHAbvd%iom;G=#=AvH{)*Bz%iTHcYgA zkFha4S|%S=Pij-bZq|>Sl&j2j1@0>m$KZmi8&`i}t~ZNI{d&@Rer67Z0TY-~3%Qy; zCvGyd6;<9wtV>D-RBf`?Q#k;m+Ew`Kx7My*U+43kt`F>WDC^s85Ubg{Pg0_GNrf95 zlh?AuqFS=64xI?swEL?;aX^)d|5nJnMSB2XP9nV`Vb>Ks=6D$Q3{V{3?Z(Hggowlt z`(eLE#B_F5Ac}S}t;%1ZX%QUvvOTzYLKlvCz?xEJut2vZ)*(`S*0)Ex2k>RJ#9J5UJCfeT)Do-fdRof!2LqBq7`?l1AGjFI zZTW8At>&eu!j4G8yWZzdAItgagyU&lGsCa>X?#=UXH0}xG_wYCM~Lx&T_;*>UFKYJ1WQEdmPO{zs!|ZBE@S|Z5JGJt z3v$oT$0hgp?z@m49^Vh)Mv&E8ytj#BsB^augpUtd9zvdF#+nO+rB6Xr<*Lb!%s8zQp+U7wt@6Ie&HD8@CeMY9dUm+QyqN`Nbjhi(AZA zbvN{z)4tJnUNJeZ=l8C1&RbIg=*bku${Hwp*kKaudxNxLv^9V3N zu4bB-d0L+G`^VJB2+L|cnnLb`wiIoW)@Wy?T+GJ=8?m=bPtCI00@WgOZR4* zdu&XSb`K>XL|IedP`E3Ymi1f$pxrLS5}0eZ_uCr|X@I0%e;DGTOP*yyH9R+$D|RD* zOHxrNY&;(6-o){|oSvU`!Gs@4z#zopzb+XZItVLh_>Lcjh~qykssq3wY-M-kn6)U- zq53~|o%}&}@3i~w6IMt9Y|&{jLrMTpPCxzke?4Xj>+YQMH+tKd=y*Uc`Uem$PCOMm#W@Atc*3zrDNUOpRhLwFc= zxF%`C43h3K9_n@Yr+gI$xdv%k9}kAm#-MSA}pnuj>rN zA@<*SX=;Z2`~4+Q%t=ImQkX=XMDMg%2!PvP-)!=4l5gXhYC;prqTjfPSGVlHTJ$sA zBqg^xhL@30HNue1HFbllImkt|FjxLLGPqvyR$#!5j?QR7po3qgIY6w9>~p!Hmk#EZ zB)J*p=H|6qZZ&I^U6=Fe^XH%PkNE$PR^P1B|}CjN@gc60QW>oYbu z2a?{>94Q`Gc^D1?MchGCVuEYU8dB`W_c5yovmqCqit4(ot7f1KJCQDiga9r80m4l& zz3(^`S-iprU?2rXC4swHFs2BJWn6XvU&?yM=bbvVILh>N z&H!TouczlpQ%D`2{yYQyA*(t|<^LIBDQbv-h?dKnP&c6th!1}_ozLq8)&)ll^C9mw ziGKO~r~m%H{=7&Zrt?zN>U-Q$4Grc8iBsPX1g$-1HJ8E+3g%i?KqLf$v}st?SQsGA zK<)nf^`vHz7&}!gi(omXC_$KEiu1In0+3|AHIFcVOQuzi;p5iuK)pb_+P&m|=V^sj7a`^-J~N zt{V_+k0uiEYMh=>WTcLd$wQfzKj zMa{3c@SQpUvC>vC^~$jAA^7bxt6;GkP}JQ5G2m`$x;%gQ(^DQ67USjll*b6!-aT{M zM_+$(H~WyARguh=)fZ9pfzdr>3Ee&dq9cqGluARjnA4~+gJn!>K0lwKYv~Y+qGYW5 zKCZF1h~_TVculj4bRi!0-4Jt8Q$yC`g;dSltZLDN3AGM`1QLm^2@@ziu6MmZe2msT3 z>L~=E6bHZ|C15?R$GIGET;(tfp#%<3@Pbn0^N07}Ki)mXnvw2YQuuy7uDV`+3gMU( z$Y(wsk19Txdwu6Ab#Zr!fR%z`EU_E+sd81_6*`|ke?DP&^TWGCANvr@py8sex)BHr zP{FK_ zMl8ptr&S@CDTs7kOhE*&OMUsP!y1{-T@oB1XWnkM#EC{l;{;pY9D! z+aUgG_Fm@u0DzShs6}|-OQMTf%T~HhKhnC`uHa`q0M+cz-OW>tYM8c6VryS{KLSym zj@Y;po1Z+-$MGIL+noHFcdh&GYP#XfN9??OJti+kVI)k$yA;sraqUh2Rlf>41?xu3XW<25F*N& z7YC5FC~GnI0+mRBS>x~t6C_j>7IJv?=a@s`A|ZzODIY&Z^N@c2=bt`y zYY2klsi5#Q<)R`EBZk4E`c1>g3%LMJLL{o=?n_>CK|r3Mx-7df=KucjUq79!+rK?L zbb*OBbqBA)G#h)CLg>e1Dy3A9r>qhM#ZJd*TE*2>JFb~Fz}4IVV!7SWZ(dbk0jpQi zT9FK&&LZeI)L0RK$ndZm^|Kun-S{xd+Y^9(d^ikv@(Dxgu;6^^iUa+-HxEN-HF{-B zvMGw%&T5%Zm%BoX=0sPp3s8ODS4*^Kt*?QFkoN3I@NjQ4ojSSs;fVtA5cL_<|5a z5W%{9i80o_iuw#KDMF{E=#(d!&skqSeG=*^;O+6_3`J;QAdz(4 zy5x!N`S>KlKq*BiFu3avXC&5TS)m2e_lL2foUYl5e);(8lMaXP-akIX*a=`Qh-$3F zX7(Jes>UP|tOrENQlHAOo|iR8U5y7+va{)U{+y-kYbAKJv_QtgxJxnB#alO%*DPNnVX?81T-YFtdc`%1)^v7W@D{QC^JY%G zK2@q-?fs8HPFJ7ox&~fcBY9IbBHZDt_tpm+>QaSquSfzp6BFAVHH6!LwF0#=v0l-S z2(>kRWAmS z52D7vYF-p5C1=DmByoV#IPM=5Phk|LX_~YeLx8%tXaEUzp<5VcH0pqoEAIAe9Q*xlr@bh(=*G&jPV;Kg zcSFuF%|Pn=Qq;7p#$i_Jl?AQS83~gh#3rhS0x#RK5MvtqE@-KWEg696wC1Pjc-VFS z`oDkq92Y?J<6tGEl(<5@;syf7s0xaKnFW>S#ns-bh`6Ot1}RoDXuvr?9rr^&{mawI zdU@FY;bGj5T^AbUtY8CQdVvW!x-@oYtSbW%<&4Z$@ac;p4MPX_aP`^D6(E+DfNe*- zj1D4DvobHsvaHB}ViAT&C<+iKO>%hq*z3c2J*m7+`{5r}0ONk#b>+C6G447o(-*<{ z{IsUO`~C-kaM-xdU=T4gTkSE(Ey!`e5Zt8dG;Q5WXqxjBM(V%7!yvR>p}!5Fk*mDX8~68XP+_b-WLJVXsX2mSm)zu z&bL=rCFB&OczgUe0I^FDaV24>>N&{bpFgkZF(j15ONDOOA>@?%h5GxnbMZt{}~khXeVF(~%^At?T>l`}y=R0>}$iJxzz*!|-99m9;Fg;=jy_ z-9P-{?bvSzA?HD~v?#n5f&?(ub_&r}C#3*7EI9G`xRVvq^8x)~9LB>#7dDd5%fUd1 zHygf|Wq}sVh+{uKj6}t%UwXXOpc?*EKJBT}vzxs3h$`01!eC#E1Pb;*4jV zWhw}N4NfI5kHnV~w{ zHzCEY9|eGp-3UQmmL5FpI_}5FGb93_P^+lRFn$J5R!lQ6PrU*Fi-eqn0bTC*GphXu z;4Zsi03@YYb>jh`Cc~jK0$W- zT^|UFI|t+biEm}~RTP9N!b0c{=RvSyYWT3s$4|!;GkP3~Z>aH>^_b4ne3=iXnu4*zdYQ!nehFUKzx}l@uZP#nHNOu*>$M{%Te9*23+t{ML)HH3*VR zmz{3|x3B!}#_a#j3kl6$Zd^|SgZ!$+x9J1R4chA9TK3IbpQh`z`W@_Ye}OH6etBi& z7Y@X$mu{Pdzx&~4oz~-@&*4W90yDGgVM$ZLGCR3JD!TxlZ@Xr<5YAY?VQZ~TCUU5n zu@g+ClK`c;-X;Lcnn4y(MT`Mrh}1ljq_NM?UtBGeB?C_@ur7rKJz@oXO*PNcye?2s zF_;#Rq-20maRbgv8R4N4&VY)siL@k>wTG?%JO_!0HXrwB2pGcoq&n;II2_U$5Rm}Y z_>XJB@OSSHLuXl_wNM~&76qtEE0RE{_SUjWl@ubVW#pIw*4aup3OXJaKoaM1=u^0R zL45N{2^71!w7~(W_o~jr!@e6+lG`Tq%|#`ujVc?Ga-A$~izr%h4fg;*4MZFkAQb>< z?8cq#m!zd+AigC)x;_mNdADNNMPH}WYR~xzS@V)3s9kP7yD&4cTBTZ=*0{|oa#7(} zc4ZTHWd@4o^@y|{*8u4l z$d#Zj;2x4zola+q>J+=KBL~z=UYGf&4<9DYJmn++VP^OB$vWmTG`7UYWhIf*ob!=?T)w(R_XHH$` zI~SplcDXyA1&abprV~qaMQN6X0b-Mu#WlXXl56~QxeEb6EbeS_;Y@LKxC!7|9Fo8xHsj1?R5jh)b9^-%jXNE>=vC@JH;X1@gR2K~` zu3L8J-2m*yVLS*6rx=4E#)8y~htQP;r><8NcULcB2-Rn=6yuEsW(I-MmK%33LO0CL zyYYf-R;#z$Dtc*^ZYeG=Bssm}Jzu%rvKgYgbP8W&5Zmg#{L0~Ew8+rq9RYaXHP)q5wm3!Fl52r}yvH-prVs5R8?!TnvE~F$`=-eul}1 za>^74fDGi%#(9vyfe8>cXz0?o(_Bhfm$=MFNlqx>Ub)OvP9OjM58pqe_JphNZU8$h zJJJCi0W8e$z`A_?aO|x+9all@sE?BKl2;r$BzK*PFU1kmvx3~12xXp@0)ixB;gUb0n9V!|=<)P?MgX)MQ)rx7FraV)VhE_p z6a^Hzz8erABw#kUBm^_~Dya)sUy+-2sV*DWdNYMq`2ejGp~1|x+m5Tk)e8$eb8TXx z0LhIG0_#MzebCaDMra8VwFZ$ScIdYXq^9JQ*0!ew3DCl;kLUtC+UT%~+)yDEmj)eE}q zyIRF8%mFJ}3?iL~r+Q$n9DlAMAn#JbL_ zD#nNX5Q?4k`|mqpf$QwG0ba{-0j()U9KSE0&QIg0zYu~*7Xy7-OLwTPVM{OutE<(8 z$^baQN-?j_QDqYdc@c=i*Dt?*eE4zPi7p*hpkxF9;SCl&rImJj%#W*_yC44k&0$C( z1qpyzBC9&`26Lk*zNjIbXgQ-KFy1&+X7~ZD$E;v zCV+{AAsEMm^$&md5C7}GFt8UapE~gKe>;}{%lmgKJtcuUNV@Kz=|R4Hem=Q{PkH@^ zTtYz~AMpR4k)J>RbQ*?`E|5T|Q;l?f{<1v$XB@Eh3{VUfmp}bKf7%TZ=Pwif{P@Se z`=7oa*Ps87fB7{3<3GHA6L3BvpvXw&sVu{&!hy?r{Indu#P9a+zJEN7_g(IY1!|X& zlLQFCU^V(SM1~iDfuZlh)6ZW3*enZ98T6)K!rS+M{C*799DfGsy5h|raWvpzG+S36 z-;6^7++eN>lhp0avXv)}iBSU;gwSSLC7}n9u(@h!Vt=Kqw}om9FnL*_DC&DwFT_-f zOuZ^3*J)}{zro0Elq>6$WP-VpR9#Qa^=Fl6RV|uSQlL9urgkmvth22Nr&Rrr?3W)3 zg>6Ps4SURy1PV81cB=)A##`501K_R(umo&hZhbwg_vYpCwN+VBZ;Mr7&7umC8bWZ8hFvLM}`|CS@w?jIMKbk%hQ zN+W4Rp$mr~gxX;G8|SR7&c7~&cK2Zhy_itno~7jSw`k+} zT8#NWJgTh0YU{Ghs%oYN_`*)ob&$7z{ICD%`-dd8Lj!%a_C+ZZ2UB>-O5^XH#Fd=`|j)@{$L z#p)6;PZ86c5wI!$sa0%C4G8bk!~X4?G2#`duQf4gqd?)HmUMeDLhUWoF;rV@UyU>f zmkv+eFz#grHa<2BsCL1&?Nu^_&>;~3m2b?U-<+lmGjWM88lhG@^4HK>ZU=byqvE-?5lxKmUVCL3!@jkuE}~!Cbp&o(|D^>TzD}^Qk@4+|zdJltf9D&N zA`l?qUc1cd2?1j?&{1BuGsG~t%kN#8Z)OSu3E)_DAQBGnR1mK{=voNt8aALzujHQ! zjGH&oW@`m&H7JBI0qibXxkHTY4-s9SemS9gND@O7fdCF-AtvMES{0O8Sh&op%Y+17 zSIzm9(&Ic1J=?mh$F*bwpqf!~L6Ec?h72H-GNZ~?s49x>NrI3>=0G5rspk6Pwf^A> zf;y0wby^BSSCE%!MWi5DoQB=u{hN2Yp$ilw2m=Jwq6!iw=NjLNM+%VY6>h)DauP z4gfx#^C1>r=XISG7{kN&1D9p)sCr&j)iJjIb#UV9iucy{gQ@@sX-ouPRnpMK5af=~ zacMtPD_<@QE^IW@dOVSoBwl8mAQ$Ok3gn$@jN@S(BF5p(qT{ZQA%?&#w)KmxDoscS z>{kd4i3D&pdtLXT(TLm>u3`*hteXV4D+ar{Lt;XJW-y@3)5o7bJWnUU*PNxO=DbSL zFcvHy3HWq81wj|c0fDZGO?4?Hqx*5UJB(why#jCE7{Ni&ZrEjRt_BX*o|jc8le`3p z1tIPZF^pXw4W8$mwb3xOsI8X7ii{6D0(Js+OMytNW%0y7cCVO$^8jLU6;zk1=!+BK7T`)ttGbf_We-LLD0XdqG9xJ0jvP3@C!&bwWMx)pU2$;f4O2NA>q zhyZxwCcp^{0=zfBR#M z6l=s%I0^{?st&8z3r9homg$^x=}OV1OhC6k?7AKKvd&+wjMJ$U1juf8=$-)pD|>F+ zur5L*?x4s-RT9p;xQ6SpYe=mF@bxrh#HHhDofRT6#Z!)Hd^o&)co-6Ifhho6SFbI+ zY9R`Nm<0h)F=Aq-PJ~nw1Ui5Ee8eG_d0ppKO?T4m9z>@>TvZe>^(J|X=CT3=0V5B? zLoR_8GVTIOURHVNx|Ae*&17Vd8(D*kflG(;Z5D#1>vy}M?~!At5 #*ojNQF}>UE zMwQ(#%@$)!T?oulb20!b_y*|^N(K;vfUCp)`W&PR44Aozf{o$U+_r1^9Nz;5RmFiX z=8kTS+RZF()9S{fw=E~%n(s2&>bm_l-5kU3ezqO`KSuDZYrH0muxZc(RvU&g0JVHN zosXYSSqn59ITixb+y1*h{`mJl?mJP1fCLg+tkQad8CW_t7LmX}wmAN}K4;AJ$#heYF8RM2y6z5mFd?{AI{la z?NXnVbJQX`4nIxjP@a#c9ixL6bv0cXYQH4l8#0?Fc=Ce z*h#iX<>mHSYg}PqM=N`&%~gTg?up26BeWnwLJ&76BLZzb%-XrX3QMe-yJnp>WT(zr z+E#@(({+(Pd6~!7Dn)qvL%STR-8cialVGsznWF--z8zVc+xY4NLo<9<|3V-jNGLGD zRWhYP4R;5qN-Zt$dhvV-MC2g9LX~%Qgj^%3Tj|t|s8>mo4PJQFQghu|T0fK)rfwUI zmy%T-LJnvab&y!1{-g+{THH`+hHmO0t<(TE23Sp1S6j-e1&n>?VXH3$gE#5wCa%0C zDyYuA`O`mr(8JU2kYX1d07@_s0?Z1~L<10jk<6CT;WV9k618JWt1rI4Dk<0ZzM-WsYgw z?{*Kn{>r;_M$rsP61=w8AwVEC-ZK>wktkAmsscTQ>9`Zk(>kxY_`K7Q22mBn*dl|M2(kzJJ#Tlm!9-vk+KwU31=? zNq|Ts0swcr$LYf{Kb6H11@keDZ-c7p&Yi)QKj^poa19gizSVL8uQEN3>L%*(=Yc+>Ct zB<3jma?9Q#X*NLBf@xVH#G+RZN9tynb~)nBo9_-(#u#-jn9uWS4hE~2`SWq2!*cw5 zJg*3tW(B52jikmgAcwg%?j^Ho?F&Gyq4oW+ZNX>_+!$MP4S-u`aE?Y|H*Ujm+1D`&4gCNS!>m|eXf3zVN{h- znj&{yC!6>9YWQRY7bLce>Knkb(v9>x|G+<7QkEYgS+8qLR7!E_T=V5 zF3(&wm-)1`3Pa3%Av^xg;kKN0KF_L1%#b#W76;2=$?=K8wiTd+LI&76oBrg6BcEg8tE3$M*m2GuD}*Ff)X)Qo-lV>hOVJU$K60)#I0DFh78 zqwIHqnN>8pIv@d;NWNCoU(Q>5R&A{u@tWs+y$J%`1V(>@-pH?y8))OV2fuJ`|9?Cj z=B29n0{Qf1KAsc^w}k}#I1XbMM4ZI0!gGzy0OJ;{)Sm`8cz1Zay!r4fM=A)yGy2b| z@1wX`0D&aYu-~n-E<_xV%W0kr0Q!C>r^zCtWNa1k_5HG&Dk;{_HmRYKcO>frR ztx>xCRV$s4eRGNAH*`ILn^*Ohhu#09TAx?5cJ!BLt?T8)xBQmBJX(l&x$56MQPsAD zMHshUcxH(Aw_M#?A%dIVhiW25(&|A(NBjYghCKgD%I??Sa1x+X+{LJ)fq1r#M9^t%w~VAgnGG;SmEuu|niDv5yTjX4W9>=?kWa^R2sY=ZDNR}5XM~}go)!o1NDgk zqClcWn`7i^x#B`ipxj)G)(x7gB95Sv4g`0ej*7wo4sc_*f{j&b*SyOzdnx-$OoW@< zo4v$2Z^vD+!3Fm523C5-Iqw(9wbH%*d6R@doq%5>KYwvtU80tcuZ?!hOuZ-+BqTt7 znpQ;+j+3wv8%P*h@_Dxe0=TIN8AGkAM^+}^=8tOthk;_+mBZUl4_`jdB@h;T0(Xg# zU_}THaD04^#e}>4$m_c10_GUszI`*U=M|3+VPSzN0;sC?npts3R3Yfo^S}MsfCYLu zk#lP0M;*9mPMm3i;5thX7uAjAB2IIEywK&4KNc}OIeZE z^Mp{;BY~W%njlOOM1~l@dwlyiaPo2vTFQD_76l5MtIp3Ke>$yNMS)lB1d8drs9yCF zDr*C<;)-=WPYZ(d5Egq`xamp^c9<2Z7$l)K_omvOv|*1INlpMTc2_aDn{83yE&ccf zP;r6f;Vr4gTMDY;oHdTRYE0HVViVN7Oi}>!($6#S)$-K@8=I4}Ran;CePcS>^$gXm zvYRXY3LOEiQqX}xRW`I*r*Eo8c&(4+uUkD4*R1|GH~}O~ZujYih5Wh#5wz?cLTh*i4$y9sn#4!RO?Dgna}5CDeDY$T-y;abXBYY zU`gFLkRuvoh3wwEeHc<`E_I+&R2t1a7u6sViKxx(Q&2VywFFm646M4(k@ z1rip8>`(h%Znt7cZ?#;Hhyfz7`G($kZN^ie)a=WXwhPzK;whY=OwR@hYoPlU|&`Fa7}KJx2lqcc!H@m57$ykcI}uM z?&c0k{WuJfjFrOx#8|65#R-6O^>S2=g+X9qhL*DALJ}p2nL3DMgNE({e9N`80MX6Z zSecs~ZS6PNX8MbXU){MI8QA-~y!m)rxxOWYn%?y#tFSdGdU1k^z4*+ zDx8zN?HBdrTs4CMhpCs$!G#G}7X_pj^xcU=i3p5&dFnI*U7e=}aO?hEXVeXcUAeFc z21&gRyLaDx_;OscuG0)i5Fi0jgkfrUze<)F@!?_6ITs-H{qBeFzJK6l$^9@c62L6( z?TNXo8^9?Dmg(1zUuFd$J9+cI7d;61up1tG(J~bY=?@5{oX;9V`IwirguVN^K%l1* zy4?_j4Svnywuj+nHD+KIz~SpMtaPS>JT~9;(KMFFppvU!|v^FFkYWJ6fNtz z7PDGrr|Z+_Pfs(L14I&%ta+KIc`e1^t&6V%URZTiwfXtV> z46V=_TB#>axQX)^XpOQIH3HP?JP>Vi2(QhOi<8#CMK_SSU)dMllHYY|*A2U+evmIq ztF|BCXk**MtwE`yapb*eCe}kR(UmQKTiV?Ml~>FY&`iAmdVwXwr5YH`w>DE;Wu@B3 zHhDCw(9?^9*CXVYKd66UW)SJE`K_5tg2L2A33%OT0&v^`xIpFHRSdYSPoDx(C*V*{ z2q}VUDQOiS*~mJ8*IJbNpf79?RrgYWGz=qhYrtme8i?xLVW+CdCfIxy5GeMC!(lGv zdCF?A99_%+mLNf-ZZ_stp7V5`PHR@3fk9ZhlPClVXa}Tj9D7k}c&mwJb7(H>T9&c^Ouo#gMN>BpV`8WZhX^Ki zwc7o%3M{k2R9Ee|`klVYeh2eqc>~ru_z`7nHakfUEJa}o9`no zzM1OR`@4SOD{IuC7H%JI=B8mSU-^XeGXBH8&)Qt|dnoHK0#{pi>q@J+UYNtoHLnt+ zvMm5a*(E)NGzo(uVSVEDT(a(yM9%fzxz_G5l{hZ{%`MPks{uZMTfAD^b>>1PE# zNMs&>E(8J8^qt~_8R6|g*0mTAckjj@zkl}_%DPets{m3nU)E-l0ihs7l;@`mXf7C} z$A8+Pq#4tY#v!p<&Y|E16 zgIm#GzI^`hS%>d_czpLr9vCdLwfGo7`@>=Pkkq3T0A6w~Uh9agXgmNi%<6+F;f7nHZ!_R=j-_|E#Rvl+uyE!4>ybcugKYXRXp@>72)`8O#Stjr{|Os zz%k${m8^}>`i-$cmD^Adg-+As!)~AN&+*$^1jXU-@DVt#3V2o!!PUWCZD`nl-Ez$N zbj}Jua{>ZNx~N_PfJm1DN;l>%1O1qoMTD7QL;!J$p(BRrGjLH2XxRMAzEZ6pid>wQ za3?LiVtt;@Jx8wdtWN!amw`x4b*XPWBQMyPC(<3{mlAQ|Z?B*5)Ist23~-Dgh2iFu zH(S4!T1Cn-7(B0A643pxZFFg_rmE(p6g9Txbb1~VrLhZK*^ew#fr0y7-(Y%|rYZC3 z^NihIixY?? z1mqK@NhL6bTWU`GKNHZpoH`7JAr=h>N2>ax5PTg4qUrwtc?g5?V z9twfP2wd7v-Q2sWI_Mq@|K(4g|NK;jFX!)cM-3#pF2E3ne(2=Vb*3fvT6SKw0K~&? zH+B)o5wNlpbBB2qT@e7TWm)Dt9Y23Qu98>%@%O)91H4IAHFm{|{9dD%e7kk~Upl_G z>HF%hxu*DEkujSvlSN!Sx^_fz4eN?5Z_@+(N3C7!azz@37h_q1BD# zb;)x`5v!&lgb)KJCx&7Mqqm?T)1fCu2jE)cSucgymM>pE{ktM{hr^qpBT1-l`yP=G(HX;bVWA^3R4P9V#Nu9k{JYrs*5-PRftw9H4%io7sukI zNQ~XXNwhy4VkelV;|bm9T9WGg`61fD00fun@6}jFC0b35Zq`Z=usEnLd0zyAFo1Up zRw_UdtO7Z%pCAF}SrxK-c#k2a=1Ypz3L5|@%eqXb90bc}M>j4&HyTbUbu6Za(i|{0 z6l0hvoWudPqNM`J!~`qmR#AXt zw9Rqf=J=*012`c(#gpuZL>?)?3qZo$Bp28is;eSI zHnm7i0*?l^vVY9eqQ|%Y`tkFZ=Xv_bhhf-{U4$>*J*;QdynH{@^jSZeY~QHe@S9EvJ$%wx6$u)D#lKo!+# zah<6uLJ>;ENQ?_@GryvEbC>+#^r0JeU6)d*O_oKp6;i620Bo#vt7(tIiOeCpACbO%m!`Eg`?eK{ zBS|3acEb>%^V8F(e^=GwnMb6t7PJk>SUUhAa)N3uz^Ww{g#EbdgRVfR&1pFhU{FRO zYX$mNG=>zh@E2}$oEVRkTU5c>g*=e`ir-zOuGT8JY%Tg_ZwH6C) zwuYvPbRK1$GyP!J)M|GqopVLM)rsV5@X{3D;bR z0n~N|!q-8cU#uSZ8vWKlc$4pI%jzb8d;zZbi|8 zcMyQ1c9j4quw_y7Z~Ld&b$Z4TVMwJcuJB^Os!Pr*3XSz{wm&PUOjKu#pti}?b0oH; zgJt#EAO2s@^YY9m93IE%&?l(+PSSolSy^V3X*P!R`v=t-ecwq4w4t)Z1tcKVGM~y? zrd)u~g`{CQ0kZ!t2`fvj6Gtb=laQ{S=YoLKX`WG#imvAofThPF=ar-ty>S!B001Md zfD1rOB+!@>cmbBqE?fCV(}t|4ObR*=%5|Dc($=8$bqP zYtEV}yy;5cTZ#&GUf3>$GZke}D6t=G%IgZ1l%S?a{lhrWiWrCeFz$q@l~de-h7~9(D}*A8 zo`Qq|sJVMZTYYEQ=ySB*Z{b7@`aoVuG9brO)QZxFP{+ zFAJ!tRSIVisGefq!jeEvRG)q@u9}C0>-7*CL!a(?NN-~^Mr;sA(>c8RK&7p0ao46> z_!5ug?I;^C-$d@OpSU-k-u`?Qhps5y(pkMY>(&O{ZnU$TsDV7tdFi-uywIMLjS5T8c3-qiRis5R=5v z1!e#oy3}zz><(iL;zgeqEt6FeT20-rwyZNUVDp#h+zk2#&2LgmZiKre6a^*% zi1=EC^fJPEm7U+_daFy{WJHXO?>ml4%gW1TUkB6{PCAE zD%-mJ&77YCwaL@};J86*w^$zlh+-CXWfDMoj)UfibGoRjhJJ`|-wyA)iocdFA+TY! zdEyXass&T2fQc@ho4ENn0s%DqD1|?w>y`z2Gyv!%Eut8ao=+?Kz$13M6fndXV~VLV zmLcJmv>M|0WqtbaJjdZXjJtyKr1Jgyy{oOuJgo^Rh!TrVSZ4BdIiKgemb>RWVF|+_ zh8yMCrUc+GQ&=qo`2HU;owLKs=~FOBHOT=^fOK(tRG}N*uBjUj4-b*x`FK2GnKt$q zAiz3hT_MnE{V07enAg1g_+30C=+lR3?m5xJ!}xCBhwJ%Yyv8y;fBba%ez%J;iL2{8 zACJ%2zhzJ*=7ZUaD*)BT3#ui4uTARPDJpGO{EOM{*Ig~U{|Bq+Z_aE0RS*X)>-N`= z+wZi^HLwT^V6Xs~gYBzE%MAcAynslkvF%_4gTGeH>s8Cp@1Gn2aPw;)plY(I8tvN^ zPB$BfT{#fufOtYM(G!&d6}xV@ijt=_B}qNBNTJ|*V>c>DUDjNdF!)^70+j9{=|uloO;)hsN%qCMzl^i0^NwsEs?e*y)C*K@PPe(JRuET!XO1_ zAO%s;qBxzO^6tm~)a~n*bA4Ygrl?lWm+fL@D^^BH$71`>P|OG{npdFPzYP*XA7czm zQA7Z%+$|=Cxxw9-3CIY>(kFyPgs^zdS!yp1+rpAsZnwb?NV(>JV0^8eb6d*1run#bjjuOVd5u?hk?I7y*7I(t64mu|tsDJKCsSeW zmcIG>Z*#*y&I;53b<>-wc;- zJ+I5@bJul)1h80G$>9RuNKLX3cW8L4D9_-$PN%HW%Wh3Eh5@E3I}ych=m@dr zm_iU?1Edy<8)`*%NQ3Qgj=ExqDFyMd8~TU+h*IY1H0J~qNR-_bH99#A9KXvrKjnp>>#xJ23cyqVmC$vm@B7GrlJtkE3~{#` zlZdXT<1Z(WqgP;70KH&Vy;v8WRc&6U;&cBw#XOy+jC~wC=?+6D1k>t9wCuLP2+*?5 zzyAEE56cheSOh4V&riqCKpNK|8o#f?H$OipcR- zv&-(X&KLOR@;|{v4fihKqKaek-8nDeA?zkP*=Sq!)?1p*w+rS*)OoRLnsXg$p$`mt zNd(-AG;QmZ>UsJ0PA-UW4GJ!g;l+96E2Vn|T6E5pHG2`EtDn2x+IF;>Vc1GH+V29~ zkbyG*y{UDC0jf%|@6`$k3B<0t|7>tw=4md7W6^a104*kVD{x+O{I;cQ8^y;72G{d+ zp3ViB*LlH!ICLN8HS3upG8D@*&VsdEY?2^#T7ZIFOtqyUW6W69pb7|eouDjFPi4+I zii2C})mB99q}aM0HY&s>=?wr-sadgLyZytmb`&F0h?qPFKoUw`aX#j$d(8Hgs?AH^ zOaXLYYZ94F@JK+T+w^o4g)W0?Sy>@LH1vI!m_eZys{^R2mH>cK%(&4@MVO-r0=VRJ zi~53ZYU8E|zy0io((w-)q}wieZ4+A8Pn{Wt?LtmNfs`9J<; zJ!UyBWlG415-MKR0nRMUmyRaHtc=P7uR>9EN-DY3Qa&f++HtO3Iuo4SE&vN{a!YLq zT?*ctOX-zCgDt2ax*V+8!CF}NTaK~YS1JF<%^s#?? z7?j+A&>Xqc#Y9k$B)p+MjVS`FoqqlF^Bjj5A68XWg=7(^U?)N`7)U1<@l$6`WcX&As7)oA50sB9JE07THGBFjbCNf3ooj5}RTp*ew3 zRIyIeIV`0XsE}NW?I{42U32#mZwU4^N)kB8hBx2Y+;;{E0lAAPi-ZzF7N|isfa10@ z&kIg-dsbpx(*T?NMlg2R{O*h+W^`%*G%w|pAG$F_W~&lw?f}EKx&SZpT1*%S!f=2& zAP~aYf*_&@xp`6bR!7>N8(hf&VX3rIa}yGXgc$o&AEvt*Q0uF`iK4h^)vCvq`K0Y} zSunUR)A97Df6p^GLC^gT!_+sO9TK-~?UVSWyOsc#ItK$_1?Y7;qKF@C$f~4d31lc2i9L9~~DtnAhy)Rpax<$8IF-4OM_y&dcc-`rN0$B0}tO z?7J>y5JEicAKwp;I{^X{6C{Yh%Y6Fu)1Stv7z=vRWj>cV?EoiX1+y7cuytm)ZhRBU zf~U(?Qz#$%qQcn}v12F_YYysAb|t6HwREeP8LOmcFeDVs&CjffU7+u}t`kuS z0T{cX7oXp~J^%XOutKF5m>lx^IKFw@4e|QMMd7MNU!w5_2Lf~?FROf*0sqp!KMWFD zGSHVr0qH`36H6DZOEE>PIj=u|`nONO(D&n)lWMLUJxHGpL+l~vN94R7%gQKg$x|r4 z8o+744{=OF*BlsIbq(XIb+~Hs_xq@7UTR*ui z?gs#UA$?HouS)D*i*Ns9I24FE(#0K{R`n%wifRE~u4agiqg zSsGm8YpR}%Qsw3))f@~!(90wZ1I&@auX;*#Kbel0a^69rz&u`qoGWfH zPg#M0Du`f~4Iv3oPHWLfGP6}NEcCnUH83`Km8$l514DzRwCClq7#LV`DNSY8jVr0` z#jLD55FDmZ3B_%mpFf>8(ERqJUXd14K*8bF!lEh&u25m8SF_?3$iLjgYr`uE?e_}Q z{)KhM#xFL7|G?Pf;sG=_x4>#Sr00B^zWmzF{a%M_CS5v-=#h4BAKyK853vT{6avQp z%k$~euYdZNAsb>~@#XyVVU}?c&=3r`Ew-(1j^l2vD5C6SHGlBwV@ij8 zU;>D`LwrQ{(6dO`q$8uXUfkrDmQ?}=y@e6wioS5G@xRgu1&wHaEzZB9ghe@iIleq1^(@nz@UmcT8I0@aPP zT32{A8k#N$pRSs#0wb=LrWEuNhcPuda}HkU<|X8LIiJq+q7Xt}CyNCzH@!Lmu57i5 z!_75sWsFh)6az!Le!oi*hTVTT{*o1P_`8R9a-NUpRSQB10ziTwc1x&8iFQSSZXEXm z_D>?RN|b&G>r)V2WRxWrl?ugFKe$qywyDM~_$D9t^>yGjC>$AflfEJ|GfbD5A! z5D0Xz)c?;9hfy}S>@r^L@8;gJkzfY-HO^@%kn{PZM^z-`<1eQfJEPPE*ani@o!WJt z^K6KMAOXc}Htv#WSk6l+JyngV0w{hQwv^_j*p0ze_^l!`B#<<^*pJIvfTgT5P}QkY zuS^rO;=aAjS^{TK^(L*Xnsr_K9RTSMhau9X`)y+uz)K@s1T&yX^tC5bowMRVq38g- z7MlB(q^?xRD+aPH^G#2)7Iy(mjV0VL#<~`8;R9_oV%`waTO0Xel~o_(^-aOPT2(Iw zUA$Lgs)}gM(^50-iD6pi)8{Xrx?y!NajOgyiM>jcaeV*g`$MW-=|o}-F%YbrPp9LD zp9Uax!U)sx<3CTbKah0al?d>rzSd;SN^$0x2`kbtys?56nsuEFP#_~35G+HdKrsgq z$sC2iN^W2QoQUD%sT+6mG9NMYdj5Pot^21pft-aCcKh8BSj%b>V+^SeqJ%*IxSmhP zY=C~o!(n(BQ@98SIBMlsd6A9c#4+UnSYTuD95f7nAfsVla}wU z?`b}ltQ4feUwJ*FXOT$$RF=|<)<(eu;L*37<`qxBD8K@hP98K4q;Hqy3_)3BZK``^ z%Q82y?rkR3G>EHeZJz30%CZN5VRz^gbRgjkGrIcDLR?8P#9HTQBYe1_vWvuCar0_M zZc|@lf>RSdy(~YcEs@=pl5Zw+`v}+49-<8t^=~pm+mrhXp73wGqYdi3HnC;^YDLxE zVP4Agbo}&T=-)_)$sB5KkPwn4N#nSGJnSMen}I_Nv1gdB>+|t={G289eJ>Qw&%gZp zCpo-N;qZ_k9374bpsl@iU5zcEC}JEaAWwOD(mYpeufml@Pbp6LcfNek4e+ZL7|Sx1Jb(FFl7uLLYo5>R;NXgb6QqieQaOG6)1MZ82>ZuDrDLEN z9K!wX?VI;+#;!VGdAIN5_u$8on`RK)DL2>tKH`fB)1o{=5&Nj_P(%AZrMr zfjAEH`Lv#w+2O!xdR|W<-k9R12E&cI)uyU(6HGNQi=_U+G9-k3|B!;O@bq4vh8Z!0 zkVrd1S!ZAjDTo9BA`Z_0Ahj)B5TY1$JY+!FJZHpA9VD!I8CFCEJ=hx*93Fy^kB>rWi1ox|Zx60M%tVJ^gylkQgIUBKT^? z5|c`Z!U`a4Fw6NUY4hGMtuDKkh-NN-3y8WyWQdKo88dWz9dTo;=}Wo`E)$iV#y9LW86XP z+l3H=oIoTjD0w~|r*oeoI1y6>wuH4c9u!N{|6;Z5p)EG0%EEsw5_&OV?tb6w%oGZ6M{r-jlj5R{`dnUK6;1EPWLZK)WwXa@K zKc2swPe<+E{`h9kg2)0jQv}+@B>4>BxU4g9i1IOqaTp@tgQU=f0J98KQ{e^?g{xbw zX>HET%*-mGs@)XksQUaIlR(i8<4%5n&bsE3@!kLJ&1efpArP}dp$e<|hGm`0@$>Qo zc?fTYC|)cj3YcO>!1KrM`*%1_r&ZJ2@7|A?Bm@Z55ddk%XQM5N1XRV|y2qvhK$oW+ z`_2Od2*d>T3-7YJxFUqi%jZwW{P1oUG0n^Qr_bpBnBEN2=YRh1rTgQ5{jY!6Rm7bI zrj?GOhAOHotsDi=q7H%xv=pZj`DHpNkaA0lGt6_L0u zs+x3hG|%zc^uBmQAv6rkH>OaTDqlkw1EH?1)`0jH1up8g-_6Hdj>YdQYc|8T0grGyR8>UwgPM7G1c1z{ZW<*jRHPr~cIY9>!orOB zuQe~{^ChdD{^Qfv^#XK5|Mb)yx-kGi0;)0zbFBtxvmmhy;q>R9@BW(zGHT5^ub;c+ zX+<}_Kb`KhI);G-#~>&IxkH_E!uq&AE%^DDd(@l)gg4P2W^A5qT2-0Dx2dToO(~2V zx}X2+|M&CX@zGbo55AXVp z;D~BKiYH*n=fC{t|GHKX#qRxQUzEvP=@lD|7We0zS*-JXcjR9#qQ&5fO7` zk^tcri~`NmCQlcP{m_$;aO3zATp<)#vhJBTiPv!8`^^EcL(IJqHJQkEzk1h-mOFX1 zVpd>J>4-xsz=+VBK=<0W~I}Yi(K)B+Zuc-jvqtv_% zD*It3;rj9K=6~tcU;CEtC9P-#Ha7oZgyEYuy`dG7v&jHI7OPe?F924kHr)YngH~PZ zT2V-%iBxh$DP;vo^AAx4bt{I$Fpen(Y10Mo0YsA=1zu83`>BdYfJCsV(;Fc#&(G&Y z5$e*r&MP=+kEWZo;b+n#RZDq6M2rH|)$|eyJU3JTMZ(-uM-LRp^R}nAY98JuX-ROmgd?jE0P^FImNJ}bQMK^yps{RKu z=G({qFzZimG9=f%W|NO<_uSx)-Bw1!w#5kv8HkhT)Zw>L2(`GRF#|J6ttAhLA4+XQHy16H!UoLK(QaElFM`K5XSLPOCsr}Me+1}xnw{~ zpJLPzz)o3)g3vdQ z>&gyRHB;+q#TWuue~xxd2ew^i3Mmm^pUG`tJDihj*eA>Xes)fS9^* z=)%SvW&%sAD-IS3q5u3`@wZa}#ol~Z&$?|*Y>0`j>?1WLS6I{aCf@2kUZH=j1(3*% zaTQ%TCXF}bTbjH1@_gsMykHEQOV;*8cEbOU=a@fe?OAN=#&u`((vx2yq8o)8;(IYb z8*96_PP!w2Z2pWEaiiQ#oBj9e z)1m-KAaAP8U|7jz$AzBR_WseL+*pfmIk`=%(#83-Xt+fD{jZ?pN#zP%5 z=DZGzIU+avq!-iD7Lqur)^d4#zFc$|rqjYC24Xfwan18`S+W&V^$Nt6tqNfjLN5}i z2|(=+cIz}7P`_6y?>E4Ro3|5_>+(ERA*pNbe{u36EFu|L*R|xp8||_U5GRIbUFIpT z6#z_Y4eIXZ#z37Gj6gU>+^1S_`tbh4*l}@#q_o#F81I##P&mw0OD;>%<*ZdDxLbMj zyOSPY2JGAJrhu5%yw<0`OzYC)>FeXAhXTGLPugkhqyreFZFHLNIfy+7+;(Z~tnPq^ zt+YZ5z;3pqAv>mcof=+a_8V$K`-Y3IAO55EdL6wPqH?7S{O+>HuTP|Pqu0PGLuf-- z9e}lp=9aGwvFqCrDuAaY2>Dtygut-LXG!Qd#BPinQX(_W*`>cX1yoh5>*aEpmlahj z4qYU5bzoO3GnlwAGo`+lf+tB`qC@B{4_$XSU$XwXo^wH&FLLO*vO0*!lo%|`#BJY9 za3C-wDwmJ>ajGl~t!wi^G1IEGh(y>@%x4fJk}Hr%%~krPpaG(rPMcrB_Pt>2_C{{$ z977L=LA(3$P-6PhVO^Fqugmk(dC>ysru@9=GLWQ0jq!B>AcsTgUUMew%~}=$fmvW$*)_wQ0w}QHC0qZ})RYAwMY%2_ z#9LMATgt_c+x0zuSvRg(E4oUv{@#Hc`!vKG!nUWl`3=nf^8K6B+e?B7TY|{GXW4}S za}_lZOQYw!&9&`W$ZP6hH?jFg+Lrfx9oGHmvj(t!O9&-4Vh_c@P-E~8QJW%(qpE9B z1~kvWEckd7Q#F)zJ5*l8gxtw(&GQ1GfJ%T{9Fg$;!^h(|#8$~^76=UG4R<1f$lH@= z070Y?P5h=Z(sM3fC8e%uGM!>UM8oufz5)TYt6Bi+x`2qHfK7|eC6qiUxD4Go<;SV} znrql_plud?g3&I%;|f-C1p*jarY{pzAV_1)N`PrpT^^MJ!$aKCU=3`7YR%L0Wm&BP zKrL&CW~C^^@H{!)jf@y@f2_cV)9IMVeN|9XLfNjB9e|m&0Iim?%$KUqpWqad5Xq>DtK}g~PgA}dCk;^5q6h8AL1Zh)-NxB9OYzd$d9+GW2@tDL zCJ!L5p@o#!H3-|#d)1rGc=KG|v|X<8%sv2Kb+MbDef##!akur>a8v#JrjdjEb$aCL zoO^SEOhj;ZGjG`+b9HT`cj=BR10f-ZpjZj0rV4bW6q^h{4c+Ny3?ZiIR!Uh{j95Oa zVqI5=K7M|9T5NTo8xu3M_(ts61t|iAO;ay518KZJ4XMLgyKe0t%K6_hdj`N5;&8bK zM4~Bipxy78LAymT!P(wVYmG$`;CTW7)ylbQK}u|V$xB5*5ORPCot6_g=_H{^?Yc_K zNO7Y!wVmC~T=uf;A&RP1#5i>8F#Pum=5uF;^|vn%7cpqwLLN6EhD#g^hSPW$gG02; zv!UnV!_S9tJfsMClcEq4hye*9N`zmQ>0vAw-k(%oN8`GAd9=R6!W@_as+DS7E+9_K z!dD2&?MBy5tAayFA;kS90R>k!d!2c*YYG@IiRIf)*@n-{Zf|>aiwkeLmEQ+4475=j z7&|W#d;0Dct$6uU)9u%HE+9F~cO&9AEdWs3tqA`hi}`zJ`+sk{lHy%oMIS7H*e-yA zl7WDG04o6n=tAfe5kQqHFk9AjIS8y>I0uZQynBB<4BeJ{X^Y*f$>5tZ6k={#R<#8c zuHZPFe#%J>rxS%F0d)=~9uW%w1W6Hy9WyZwRhI&A=nkj)^Z=AVYrmw^db!MoN`OK# zj(ItM`YaD?Jp^z0?(dYsm=!-iPYQj09NayjNht%+yj;#t8K|gL0h9<1(xom5%Lbu% z-M3MJ8UP`?V$V0N$!`F#TA^h&@OTuNYtGAh$wmKeu`O|V*@s3sI}tG7R)LbfmLew z&fsCZ87{tS!$WuQX8*B2Za*5F*WUU+J2JQHwfZK&cL1R~Y*SevpbP3NbXrOVY}JdF z6)O(E&;cN3Ep?gJj5w}&S$Lghh@QWGUDrl_A0op`bwlZFrwNDvK{UjKvQ9{+0qF=z zs@>Y9d^y8xb*(_(^>a4#y?)=fv!Uz~Vjn=Uk2j-7O?5pWq@X5HjS7*?O$QYFym!{u zt=Ulj-W?X$x)w;}{^tn#gfg8Kb^7gZ4|BwB%l)FkEOBJL@460^P^U|gIGj%R_lNMV zYh|wOe;nAh8ofJx|63285iavuUr**{dtK=c-^3IU2+&f%^RLt=5ip~1+uiJT-Gf7f zLW6d%2z4c@e!@&)9Uwsa5z@1l_#`l+RqTD3OrY_01C z+0wn&Y5)h6ieTo;y4E2G(9}061nN)k?uI_%T9+E!ZI`BFGzQS?P}~3(;w$Z&t$P<^ z_~}u`@h}Fh>w3vCW30IXsT;e)NC+g%j6w6E0L0RV`t&s{Se}-<7zDtAhy|C+%V5YiY<^YhfA?x~h_JumBOWr?THA3xk5#{OMo5vW^D$(H%@^?X@3 zZ?KhD0Hu}!#Hi?~Po2Qv#0X*N`XpFGs1}2SxCwu4)tg?ms#-v;WtpB!omO;!>TK&C z_Av3fg?XkSN5Qw7MY zg2`b}f;Qnb**dIW(Xcmivs+Imz6~?kHr@-}=2*Y^5`NU^N8!rLH#ZB2o94~-64_xhk|K-60BwZ^mSUWLT9zUJ!}mMFvTI-K_XDsr{||E@%{Vz z`%~A^A;mzt(XzHgIaC2o{W!)jq@j+IF;W+T)-?cM|JIGCuI=T> z*yY1^@(e2E~*H5dn05tn*sBlUWa8h(hbU0zGT3 zr2;{bQgh%jHX~OEz^zi^hR9)}TlT5Nd=9jAu>FS;g~JEfa=8@aA=Fq=Rn@I7H7w_c z_aBerp~gN$Hm$iE^7M2*Usm0PIjmGQ%dSEZ7!kVEC~i?8l0qj^A`&6=QTXb&2dz-3 zRdrW^nb$IDW=ITxKB0<0Rdp3)RtZ;9;r_rtZU9TV`=!0qDUxzb!|7l}-Ywd_8v<`U zwMuwd`}aMNZ&rmxTcGU~yTjy$h&uK?!8Iqsd)>`TAKyRVz>6xz-n+g#M*RB4w=Z7* z{G%aB-&!4c%UZwQjkbRrZsHDgGcz_aI7tUN!BOD`^dh#@>GShNp{BLewJB2>P>W#A zx#V?zI+su9r;Fed#*i;_E&$@;*a5EQ3c+r+=*9{G5s8GVOGaKx$(aKOiZO-tr@Lid zR|9i|N?y+A(=r&`U7=bH9Bh*TE#5F+(<&mToN;=8Y)gWoR5aLwSQ-%H1Q66gEF1t4 zU%$c|>#yZxiH+@Al==FWwNzQr`RU6=`(aEG+UK*8|go8u` z0kmF#>C=e5nwd%sjk)x?3D7(SVW#RTV0n>zz3n|)qHU`N1h@i}Zr%I|Kp0!+2-3W={^_033aH}krY^tV~g zKWGFZY*ev7{_G|)cl+z@S~d@mjm{o!KI6tvD`j34;11j~p0YZS0!3zH(l#mX=N~J1 zg*u=)qYGV%AqZ*f3rxZ=+5Ji(d@CyeG^`&6V&!a&GB4l&mch77A>ldO$J-9|2WO1 zaJ}R0>CGzI=iZSR9f<5XK&2n{Mh7zOj~T)q*jkkbqoD!8$J!)xbbA-%z&~A+~0= zQcE@OKGw2M00Oi^((&|;A$K)%KSV|)sBeblwrz#?44gIXva0GJCS+jq1+=YOY^1Q4 zz9KCvaocyW3+4E=e=|ef-=ao0IpdcV_|@$5=9B#G;<&$IX#2g_i`=)LZuF@up=sN@ zRuC8x5$|BGUfdw6%lYf4PnV_c6Ldg_{&0v|ip#SWUDo;h*ZJ}3>jI59AkRes?)uX) zswu2EkwDwhVs6YD7!0jBX8=0SJ%^qVDHR^y|MF>>vr0;b+Q9r=t2^LswJe1~vWU&; z5hP5^0(3wH?tl6a0BBt#7wUx=5SB4@QD87*2XS<}vs#1X=UOX><5eAy*m$#Se0$fd z!5L+q&QEjK9mYeD;r_YgCqUgauR(PU2m%PfYkO1_1i{Ms{P^o%e|^SJAAkPvaf}4- zB6fbXHjxg~_E^I3iy!~=*u8uI;WX~RJODr!Re^{|*pz}|iUA?AmaM4fXN8j_BL_6?SzPM9UF!XwSWR!{IY#?@1SiUz40RdE-|I$lUc3h z^Ncq~-E9rL{pd?%dvm1i*NEWu9V5`KHBQ4nv5?`%aPR+}Z4ZpUiMZ$%w~G)SLzx_) z1PQ^-O||5;ngPrZB%r7_`Gq=lKnNl5RjNteg4X=){6ORmb@ElE+vRh_lOV<@y!!O; zmq&CdHgbII4&BgSuYDsF@@%GnHKAplBWU)p8$mZ zbe|B$wR%X~7u>-1)^KsZQD)7Oj{?edh&A-J^% z?j;yh2oOiyQ$L2M_37a+zy9rcwOT=tfPs(w ze0i_RB3vPWR)B~JB(U}CZ-4*Gr?1Q5r}sa9ICTQGc(q~n%2&oK3qTacKh3{&VH^&9 zc-3Rp3S|L>tGi*?$B#z7luiv_f5{bWangK1w2ZLW~QNH^dTQ2RN&7SiXEB(>u=tsA) zMG_1*h1p90tuTiOfss-sRX~u&A$*w(GC(AT46h~6>$;)?D6xcyWjDOhk}(JogLotT z5Q(s{?UZA>2I#jZ#0rChN{xu(1h%5a;25KnI(`24zns%gr&LvIknYg+=_N{(R$?PU ztRU%*=swhuOVAOW(QGI%50IAQ}G z0ARgp>K;Q3)!=14LyJBQ5jgyt2Ux(Sw6nEYO>J2(mlcHR{5Ti%5@3)a4IN98V%*5= z?zUC3=q3_DaNb2ZEw`PSM9HfN37840u%Mx-w!A`I-a08qrC}u_l+g())LKx*BwS2C~oDGs`%~m*Uz6mpL2z-VCq7M9T4B&j{yb6 zCj>zA^XG?b^8(DB*V+S|Vi?9gl&Wk^Pr$9EV;x1vOaS-N3JI`C84(5uGxPCJb5G`o z!>MuxRCmjJE$iic4i&;7n1BQvM7Z`tQVBtT`_mn7verc<3E&1v=wjH4mqid<8O-si zu9q_7RJOe=x9<1-DeUFm#u!92=XFMx`nxaC%l-CNslF1cnetZ2z=25^b$$Bv-~alM z?ezY1IE;y{Y7pI?rL7XdFm)4QK%^huL2f0X-}dj9^S=>U5uh2D0_JKCFv+)yjKK_&HKh>tyd-Xd6f|Oy7+S{Ch&Mr# zZSbmZC@Akr*Tf8N)}>bqgFIRF)7qITl!0LU4(UG%F2sfDr>1mUXCL{N1S zVcqKYsk_f>2c+RHtQUsn+*1fyYo1F{>ZnH~38;%}%ZpXT{P|=5?$~*i<{0DDZuw@6 z`GR7#Z6>!2Y2(wI0USk)wOs(akQeCk^!3Yc5A%@A^bDl#cE_lNV}kY_;p5l>j=kNpr} z=2a^IN#i&@PnUuLAyMoE7C6wZ=f=K+G#a6(EyUWMB5rJTplv^$Fan3{IWUMkNVAeU=c1yJ7583Svf-g0xgRK-{Wr+l^v(gBZhv zAsgl2qY?~ZNa#3F$U3jbwyH9#ko(% zKcB`BgdCe@a4Ib=2fZqmsey%!feLLTSSFNGGKJv6Bp^1c``~O5ZnN8M4p_TT;dPk4 zq{?^Sq{gT48>qp3PwikQi{GRgZU#pKnTU43+ZSxf-RWjx+Wu*(XFLCV%V;)$3V^-% z-fO8Pm*R<0Ab<)njD>?bx}fJ@pDtlM$XaSuSm@=${qf!XX%r?uYJOTudjDXLPuwHg zWr0>yk^b%wV<$l!6l2$|Y|ch*O{Yy=YdC#4Ic>|hG%k_^fkPE$)E%IZ)OQ5x?#p>nQKVx!{Pg}#x?xO$ zTxvJAKt+NSGxvGE%+^mM7zXYH%qVMd5m*#KQKwck1py&diYzfmprV2RRA_xXSB&?^ zV}u-QEl*1| zm>AbRBfPywd-*Rbf%TQHUQ1Y@8RY`R*WKFIKiewnhF#|)+A83!2;G29y#rTxwUNQV zuVO|DdltbrH%?*~FbK-72wR1xLIjXzn&Acr3%x9#4gWK?mK9=a+WfwcF>MEDZY&XC zFT5g!*b8*jhBXtE%dRiKohUJkuH%_}lSv`iZE}(W^rA;%FA5fTwUD}Ed#EAraxFmL z_5CFSi6J3`Y;{?)Q{otc2q9}W7V1#Ra-AMNc84)Sn{DmRVSu42Gq*JF{(SiL|Ldmq zR5veh3J!S2)8pggRNQjLIdn+F-Oyd@OBg6lV(ic+hTI``Y9Kew)BA^~zdx4G6$mlO zG#{}3^|!x2{p+8OK{#$1bTE{_GXDAWKzUsRay*p$d7kV8Q_+&=wIBxxL+CJN>H8p* zhyp5_?3k;xLRU21Ks8eZSYHA=c~RwtDOG zQ&g*}#Z{qF&~?0+GO96x2ewxG@lSQYWxj%)^2+9Ep^kkoi*S$!LV)19^E3S z1Z)hImkEWf)!p%nLN9<#T~S^I$v55kc0$?{Z2P9R@ouWCxx0egQPJ?!_9KSVQ$ks4 zclzZd)0gv%*uOvg@>4$^hE~G4tk1J`A6Kb!U>1}WfK&;0hf}1`!HoOZM~SvMe#5{F z*J^V3@bS5rBGWMRsj2lqsFu9u1@kh8E}q7_G3iBAN;0kMGtI~BLpwAI_f-70}lt4RP@h_<8eGw9Cv^$eM3Fc7R9oe_lv3;cd zCb58oa81||H#O4T&K3+=TTKS?tCPjX*?p*tK>ipFS)pHOOh7zY@QhB4=L96Ax+c?|nq z0x2u(6%}ujl)D=6vbE0ANNjt7fvRCTpU;<)BM^UzarkiTyA<~N^KF?C<4u)V&`D4O zV3uMU=I+;Jt}6;efMpgf>uKmH1-AeMYvn}(36LvS;yL)S69h6HIn3_#msHLHx;6j0@6I@X(hb(_oI!yZR+0><$;%R>fGHBrEHT`prY zhMj?`5R@7y$hwvRkdUI_s%^jDz1u{6n}Zt!K&>0QI!alWH9HVu2S8i`OV5HbgF+fQ zA!ZQ=xhhE@fTieK*URGs=@Xy`q5<7_ygLqkgzkxV+zMc#QPUjI7KgcNRfR$f24iO4 z_h;_rR->ylV3eEq)s`yW?NT-j(hq3Du%+wH;WiEhpsUO;*6{w+?{{2sf9?oF2 znTJiF>;e-G1cM^r^b@8G03jVyOhLFY5K|0M2wtl~tA%6gVoZTOb>sN?^KgIv?%mMG zcmg{KLVqf?OW8qU9>>#9HjN+eQedlPzLdn#L}dq>S)uEE`TFI8jfP7k&7!R-J+#dR z1LienHDFT{CW`3L_5D%|jK~B#(0ho0c2TvjBk^9o4NMXYZ8n6wrH2XdJ6 zYw>oFUvXTAYc9x@A~QQ+ZgS0IGn2Z3)o#sKTkpGiLF`@6nkT_4YL{$?${%;`{S*6{ z{y{pio&2^lAka(PZu~ZX9=PeWxEXKO5#bxFhu>>koyptG<+o?(En~ta|G?RQuQ6<% z&;1MA)aq4HCz{E@6cCAW50=mkW7okr2v5xj0d9tMKkKqA^HUy&K83d@{~}Fu^JwIo z%M`_RYT9^trl|V-@acKU0MP#_#O`o94oNmF{-(3Janr9C1hWbdwC~^L;nVZOuWJq! zk)RjJHcOfRm#!a%6quVaJ0t=Dar~(}ozK$(0BgwtOHa%BZ=atpA}~gsa$X1E_@Ui3 z;q(%{YRhNA05PiynBRi_FSGD>^3o0@3o%y(7Jb;Cgw(emEQTeDDr%4wx^@GCq$Y?V z`+VKDMOTfM?=^RGwadIb%@qi-JD?gM5pp;H8I}TKiU1@w%)SI=AjV}W^ZDs%MwdE3 zCB`C1%+9U#6e(`InE)?Fc=02T;c8PZo$=s(~7fx&Xc zLvKF&4=tH*+qL#XYH4OO0YVT(|g`=4c63J|Efi%EnHY6YOsSr-7WWq!WX zbfhk&5J_Wq(*O2rJiPn(;dGadu{r&4hw3#iwF1z9`#etF>D?G%>-78uhxqF9jZO3X z{B*wANH8}@uDNQU37=Q3`H~A*Jh+;G9o!*xL#b+TVm9S69rIjzSXLlg+F@vf|NOil^`}ia11v%+u>6%{FENS`@vC(&Y)O*cC(Y)EUmyNIUkWnvah-B3 zF&>eNA{mfzQDiwtMO@W^zy@{wy*!&)Sv93yP;@sO*>+~e3fDLJ&KGXw{>Kk`uDrbe zKg+}VUNdad^zY{p0}F+~FqOSZ;1#LQzy0%?BmfN6m8q@ZtgL`+YU-^e;R;^2%cx{VhCCzzy?=Hvqh3HY&lpFXkd;hbSVI#3WrRt zjaGqb1|hhXIz63nf7gY8m&)Hg@@Ivq`3+^NaVlT%STJ^H){S_?t-;nC1ec^zLL{fe>R5CTftJ8yZmv$fjoC-Bz~U z{`xy}u9;hc#b7{~=L`Tv;DZ z);CnEK2G^O7sL>{qv~Q5VviI{)(ngi7;emg%v9k)m{|HJU7jDOxkMyJr&T2;boYnD zkRrUu_v^kD>;_XP7;LK5if%rDKmeGeY5%!d5tuR?gP0p7d|L%K4Xl>aei>QUOTFcm zymUg)hN|!%E|{AG)f-}qZ+XFgW&w2QZu+ROsxBHJ0!CqjDw6d|Znc8rIP?gBwmP)q z-Kpy%$j$QeTFZQy(MdN>r&80tFmC;5=uf zq3;i^qm)_;VmHn#fhuZMaXHlxI*9?XKUB!FESKl=yW{Zjl!jmqNw}*yraY?^q1eCg zjfX?*q)d;0{WRjVD^*ylU1N11gzFt|MRVY$xn~W=W?FQeFLUA0k(!$cgdhZwxZ8E8 zqn;{0%K=ym@>Ei*uBm48bd&(sWzC--{>%UI-!JHo_xHz+yb=P4n2P7~XXCq5>JkKC zd5M^}K4b={5W&mz>Hqq#|K$v>`kWrVdLMtfPqNNHs;H%Cg_A(R_tiiw45)l(;bYO} z@2R@3b&frOU~XCvuboSHtNqlQHI830&{u}brh)g3w6WmD{PlMmtF)PsnxA>|cm0Fm z;7VX4dM&u=)UsE$C(Hxy0^K+5`-iqyf4}58w`-$KbFfueY}e>;+hDbA$#BMAqi4Qb zN&A*U+$wryKlaT}I!lapKFeL#=irdCT@E`So;=V#Ygi#E3%HR<4 z^JGtBwbpt*uWJE9NFhol z1d+r6O^~%JYUY3trK+M5hd>aHB35$&qzkA(s47VPp^s5q+XlaNx0mOwt#6rqcjchQ zIo-e?ck_xuU{Ud1=Ye)U9JeZiZxqz7Jf+)f#%ngf4@KZ#KC?egf3x5Fh7tG2t(_o) zVArUJ3DO3#6>ui9QYttOeGiDPPpBac!#KtvIJBaymqN=5fYW-)xjffUAdGH!_tVFZ zLqws3C`@==H_wfROF%l+(|g4@jA;k})I4id=@08AMKOlf8kSWNmxf`+>$O$F@2cWW~ZoI!Jv?(FnoZhXFb6qdz zXM|(z0KiSK`78sbN(mflcTfbq^uUy{TvlPLwdAGNl@Js2`gD2v`(OUs-#+Km$6+MY z)zC+CGPk-s{=LL!Iy55NtEa?GIZFX(08E!JfBjFNFW^$o_Hg#Qlblo)h&2MMSA+FH zNoB3(#B9!ZBP7zavT&`St}8+++x%dzo1N`Og77BU@n&T~3*c$b<+W+ujp>!Nr1>B0 z#jdT%ceR+1D>RHW??~mguI|)haw+ee6eVAL<*gg-KfAZcLlT$*WR_ zir~fsZWxM+5$*Ggo3Q{+FL_hjhd#f~F9G0?2A&_5)9JV*CE-nFg*7(&>L@!Ij6Zn(3z z_Zl0Q1Lj)un)8>l1E7$Cz|6HmMu;}R%5~0w3?V8=83jVoOyZ#3=m65L=@Wq12@A8L zO~BWU_ueu$g*JavV89}5ux-Fl%Z}CpV`>=%vKL-v8?)5bJ-c1^=vw1&b9@EgE_>f_ zSiavj+wIrQX-mcb^JvoUM$#00jU~b>5qYr!psE&xz8^0D%JdhGg9Pbg4B{Kvz#M?Y zLGCo?%UWv{baZ_8^Sk>#nbsl^q4E112B@1~BP}N&98NRv{;rEb0CmkJuSkdCz&EIL z&1E%mCrL)}|A}(R5Y#$<^^`J%87#yEb5&m>Vi!axkZOMV+uz>*^e0o>${R=`oRPYB zwfhYh0Bg;;7`t)9Won}tx^XS}{4nD^VoZ%DMnDC_pk>O;OC{_<&yA<}Y8q{P(~9^|xmPq}2I(Spy1p5zxAvAO4!<!^K&jo7n^sCyb60@c0%qpl zbhox^XiMJ?&tO~i-mF4fP0&BkuK5_^#`E{@b@cBwH?p^D>&DUFP?&8`&%}%>%7E~X zDpjthe{)EV8)*ghmTA46^uD5QSh4&A@#ptHA?a`&^pfYhr<4TTa>Hmuynq(?DjUEe zfp*>x1(FcrvcPh^?%PDVL2)y)f7T z$HW4W5UyL)kj5n47*usZ&WbP~RKVH{LBr|vK5~kNw-T(cYHzleZsGYqd{X2=ldHV@ z)AZ%MW@O_GO?9WQN{5=)gid62z_4~K68B=ph6MOc&-!7fcB?hdOP&e>q9g`NS=QAd z0~GBS3*<4}Su=lFu@I%0ISQ`yWgle%tn^za7xj6bT#zswoEm z%K}3|6dA`u2B2U16hYlf-wLrqhl((CqUA{dAV^5*Kir*;j8$ui(jg=jYrmzgZpK>{ zP#qOGd>C*#Y&kDiRn0)UD~%--*w9Cmr@J+J3?!X&|Lgtbe7-0G^c?z#iV#==PFI{iOtfE&b9@ogEb(x;#0sXj(ruc@yX`Q}) z4HjZ22m`0jPXq8I(CKN40I)p#^xI zUYv%$Nt@&Ph>AM8!yQm&to4$8MY=nQUD6@9`Wi+We=2(~DZ5M(HFF>ADFK}8iXgJ@$3Y^S>~wN65g zwl|f?+#P;4ut26M44n@0Ah>Apc|CPwiUSjG^fHARr67HeQdTH1Ns2L0DODrHq)UhU zL*OP54%mxj2Maf-cH6EKquFw(@FJ3lrE_Tp*lcAldcYnwUd# z?lB6wMGIjAg3)+G8;DD12Algo19QstcpfYi zsMd-ui3EYx5KPOungvJ`Eto% z={n65vZ!JXL#$rchuF?Fw86S2&0R%Z~1g`~hKv~zx^Y|+KL&7uCm-OGlA{oH{;#y@XcKa{qZQ-%Gamy-2hR@)y#>3!VbXg zg^j9a-Bx17b%trp;0Tx?K+z!$DT#2iV7M*pcW-vYMA>e;sX)MKOEqGNMN2qH|7(B}$6&Z!%Q1OYD4i(1L0 zzw}2?G*k71u{lh@AxWK1mzsgRpz~VFw3Gp5iLoCJcY#=1qU43H`qD?lUBRG@+Y4-z zk{?f*ZIN(e1gN0D!*f8kf-Hcj0U<&Y#~@lu4ONh1Wq@N0(!{8R+fv+OrDnGE?JT`@ zVl&j7FDnp2NGu?q%Q}~eE@9Oq2^sUce34^+R3=ezhSf@}-oaChTxQJiI_6y0HHi?5 zG+|iXpKJSFH-WXPQ~`)xya^zZgdHboYBGSit9TVy0Epda8}069tpNTd>#<)~OVhu( zt=4Kfu87J%u<_;Cx)HErR3uJtt6C2rmH;B=x|Vub(RBcENU2|-0_pn0 z;V=#|uK@suUg9Vwhyf{*0wAQ}aQNvCuqVyc*ML~Gtv=>ZQ+GqvC;)UVdD0lsOA;}_ zUDZkjD5hSk0U`Dxed6-`c!>sK5oSolI!&qt!;*6?z%XzH49tT1@27BVimD1Uby}@g zK|1yfS1q*w-N9!@&CA?XX5BNM?$rx~x$2rrLF~FH0PmS-CI#~RFqONH5Rxe9lTZi& zn$Mq&VlQ4VE0%MeBtLz6xO~kO(g{N+n^0ENyZd3THJ=~PD|Upu=|)`JR$s+{8duE~ z{l|K?vX&YEB9YVSh&c@wvsDISe|Z0K?v^5ec~yom(VOiJIdM}z21FzjsOJzG>MgEN z2?h{r)AN7LQC1L$4Mf*v&kQ%}Eic{G48fT2$BZr9_GsFRMt;BT+r96$mmdt<3@k$1 zz5GU?5`e#~*v(4*K}-4|nMq z%kyz95rV+maR}sQ!Prbq_wqEDs-Q(m-UKhV zmUp`cRN2?3&z~-u`ojryJiR}R19=Pg9ekxZ?n}CXah01UBtRi7%#1(?T~)=Qral~c z=$erg7ocL4E=#IzwfMkIuU1rocVm}=Di(&Qtn+z_35b%0aZC&rX(A%r(iOU06FInT zMA3NV*Qa@XwuD9?`nI1oz9UgO;4*G`Qvrk}L;?^baV(;ub=TQVF+|#9R%RH{e&aVx z@O8UZd%IVy6@fxic+sVnvO<6epaW3Ks^@^y>R<(vuxep-h^Pq4lp4K;&?!*0<|Rl# zEAh7G?06d#viBgmxNqUH39HqrnNjy$M@9{P?->8p9EL( zj>Axas%t6gp{qkV>$1+r8k|_0^qrYnfiSJ5Y5`cnOWnH(Go-?7dRl*KI%(X*4(h5{ z(&w0tU1F^C^%9>m^7-L1YenSl&?UiQn3gy$OP&{fI?sy%2uwnN*V}c^H)%-#t|--L z_z<4Ua;X5ME7ZjZVL06plmw=xl?fKE6FT-%;>{?67&Qe6BvnBOUq%{+ekZ%GP*3y)O z*e3g{IQV{G2EayQR#i60tf8dx?*D!IfBpY{!+)OYf4Co$poWO8ADC_`TO!^_XrdIV zsR*%0zWYg+C4)mJ7wX4|I$xAUC+&z)z|mZlB>*dcfZd)I3JCB1fdQcQ;02)C;uZkm zeHYa3oW{HR!`Kfgkw9liU_hJr0RR?qQ$=wIZn()<1wcgsq%(M{Cm8?y{8&XWp7h_I z9v>baFX{1s_^;T~)Qd=vXkL-){PghnI4K0U%rIy{`C4+uho3)i4ZUdvS|RuA=R*K{ zWg&o@h4$5HTvd%JL_ncT5D2ydPz)e9tF@}38+xX6nkoXgKg3~(LG;2{)&Ky5tt-kj z1L#g4-;IqO((Z^s9Pn}-1GEkCUHgHE0dXPKCBN%J2iT%(RnV!RTF$2rB~Md6XQcNs z1}rJ+3P&YLqr1384?s00V3{YTSw-JKf&D*!kAI5z1L#+8Ll z0Bw3E4OJ(!f`uD`91MQ7t=ue!wnxYtDD}df-P{>AxZb=e3bHjV&Q0ZlRRKwqtfCiG z2r&eGOi}*J-*dXpr~Y5=KHhy59>Z3mvg&0Kkq|m!LLV*_(7c{MmuJOr{PQpGf5F42 zzkDj%r<2JEAfUQ}gjuX|Vdm!XrH9A>2WBRQ*5z{k{Q2qA`E>tpWBvT;(^JKtK0f`Y ze}BCH0Q%`??oFFbTmLiU@A({m`t3Z#kOJ00at3hu^7p@-PY>@;T?i5|#0zjZ9mG<{ z5rSHqTC{Be>wSY51;s#fBg?14;a4u zpZ~|A3eX@TFOvCtSXrBmg;iArpnN=dIsMze|CfJ%UM+H2pZ>2?K7vs%Q`0L~ z#*qQwrj@3F*!9Xh*)7=U)d;%@`8S*s-)k?E>lHWKd{Y}1$!%%67DHXXLi;TR%vB2t zu0la@uee zfRP4c^5IZoodi(L2zYuP*on+?a0G3@b#*lN`3M*k1YBxfU~~5bW?X#>Xh-37yHlI=B&kS{kXl~Tz3N&JDg^@2p>j+82SBx|sR3Z-Ei#1z6hr7HC=k02 zd4_N)btyocNTpk90EZfrH3v{&R-v%*CZ(% zQiy>VZt$i_PE9S#)W9M3z{Yfj0jkr}!}B?7NHHGgbA+UXyv%V}^LiabB+`w?*?~z8G9$)*I1F82K^oVS=7JhE8fu{K{!jn%FCRyv zAo=+7$6mD7#|M!(;N7VchE*-wey>5`Ef8#iRoit#PC#A&L$JDh`mgdaKb;>701)?G zFZ+6BO0-KhiM(Pxs_O1k9%2_$m%^52uzfyy(@|fymyOmwQ8Mi!Z*3w`Hzxs63woO# zGT&%*@(tzYt%>?3l}`dU)Bq>8@1Mx_olO#k+A;=W_p2UN^J#2F7h4J5elWIc_Nx8v z?NDuK$PZDJ>tDfI=(=xhsI8>GC(MDiN;=?PT420=m?@;ghw?ZrPn`hhQNH_i0lb*j zqDu%}lmJ4q7;~&}K~s`77q+=+t_Z+f)lsSWut%~#pv~{~N`&S^P z)BWKz{y~LkyF6kB5y5!}zX1mYxpLkVh_|eJ%_W0Gh~miUcsft{Gf)VqF>L8`RAAM4 znwC{XVhln%THe^kKe`Kgy}4~q8khr@A`U`PM}cvu9SO7o2q9)bQL9?>Rbt|8PvZ_S zaY`tXx?vo$7SO0#dG+EoVp+~W$x~#BkpYppdTZ87)Ui>EHtoSSoK2O0 zNc$4hVod_wtVwhOix|E$7;bJ#aKECjPJolsTT}(uY)e{Pd3&5~yT|y!Yz16F+m`@) z!@1dPSDrEAqhb2 zZsa|;=PF?==%2$we(Gwd^TRwVB8JoW@%`PQ3qm1w2b9vM`I47hLmYnk_~CRIjpeS4 z?}mU{)*0!5OMLgIL&wH-UJ3w~%~4sXWk}rY`oQ=O<>_2yF=j7c{~8`p&X*NH2$IHw z%*)yav=g8f$K-MJk{0b3xE(4k@7X|VcSgiJ6sgn`#f74#Pl+Wx9f3ZQ~}r(@O{F0b(Q;B zZHw5hrTN{lbesQ^H<`^g!Ct@k^2V#d%H~$JDikIj*aQx?nEJc-wLU!~t0Km59pbn4 zy25OxWm(rebzL`hF*1c7Io7NO4`_^Jz@Cztc46ae835Of-nnf*+IEj`vcL=@s8^C3 z(A_~j^=sSGkVxAv3$qB6*;JWA!;f}Sk>Bc}+$2?RlEq3rG1YpHbL{$F0ptPmm+AR< z?7L8dl_)}u=Z$o@ezR#@09`j6-@QL}B29SvM>C&no18}U@?CjdL%W^Zx~BkM3O$XW ztfRb>i!V=hSe1vOP#L5|Q{^ zgF=vfJ0I6B0u`Y{t;rawWhrU~5J@l)T-D4NB%vFo5XR#Wb6HDR-F2C#b$%Wb=1Dvt z%Xr{OaPyk;qzLFBEeS5l#>RU{)Jk64dDynSWQIGu0?s?{_1bHQ_K~rdI9=a*-GARS zzZw4f!guSmiH$wQcKdrZMUub_386CvuiZFEHA6Wg<>k}o=So8w?>>w}jK-?koKW1%!40(l zcLZrVm@qa2bk(9rT||JSbSkN?O95(Kin^`A;^7_cs8)C_0H&v$j_y#{78BH|#mA|_y6wUk^C`$K>&%hT7-Pg#p~-U9a+vRqd5 zry-}0e?E4M_40ICV3vk$s^2Fb_nRErfl+Jx{Ip;epFZh9pb7*~Oeys^uepY<1B~Pf zdv87{Fm4Lu0w$6`t{rNMse?kbsA0rS`nc7v-{$+jzxK2#BZlgGf-PPSG3jj6``~BlB%YTEK{-J-bJBb9t0LyN=$OQmU zKKD<@kMH^sQbdvvI4=bVF#*W?w}S!Q>Gb~ouuK2_USsSN9RS~HjM#en3&MS~?^ReX zIYkJeBaCC;e+}cb7aOH;&25)?K3_7>b%)dNhkMWc>R}2dr#+28A}F)Wfr0?xJyr)Q zR1iA!>o`plk^*=smK4WTRfj`J1b~HrQbWz_sy077JTIps)@Q!Vm*K=cn$JU?E@ySp zjMTj_kX|;kNB$638tAQA080TH?cUc~Fe#$M>f( z1-QEUl~C!%o{Iz23jmh4fxH~X*b(j&^Ce)KD*#idu1!~^brVU))d|(gS}|d{oO8;W zwo%~?88mP@PPtz4&#YHVVX*V0AIh_6)M^OJ8+`1^LQrUnp$ zxxp5WARL0j)N3x@{lTbx=`epZ)vy5E#EjS){`UtJ3UA*dB0wGg;6!q>VR?zM1EFOs zpzN?c+GD)T&$~L!HF6|&m^X=w?=N3BgZBD?JzsNsCVw>X-!xW$RYXEJh%QC>I7CVU zY?0av<0WqSk=YMzai!!&$+#Bmhut(_pjl_3utjH~T#oVKZ+w~KgF2C$AI&Qy zM2FD$Ze6C5u_nAb2%vR(nsM@a-ByWMG&oe<9E{NQT`Xp~_?k0pT_;(mFXxqkgy-ky z`RQNNVau1-b$NO$i{^wuqb6oxi-@-*MB5@Ln`z765|jCs2^19q5xl`CZ}70!)Yw0m zDU6A(b<?ryK+8H z6#$053we5+&WFo~rwMqEByK7UpautR=1N{GL_)0yPi)IF*MyJ`;~2KYov{aZ@}>rw zmsKUI1Zo}(dnQ1-)X&5Hcsz8dA>{|dbSZ_AmpNX>B?<*$1OTC5tmWcnS*j9r(U4FI zP}cc!DCQ1ucX+>E<_jKhN+|$rjW;9?Xbfvb1h77x^YeMaSapP69zXs1*UOUaYj?im zG|7D*hW0f5T7e~93}S2f3O(D>OW!LbpoyLsGfSVKJ}yxJJ*1z0`EY+40vmB839JlX zkxsw7<8(T9g7Wt(F?yhm~&zBlitKe7K;;kYY>{Q5L{UngKj=pZX}l z6d-15Q<`n8K=#^dX9dE{6hcI3R1%o0s%o2ouN0|277W9-LK)m4Aa=MlpP{A#3u0qy z`MsB%(uVF_CF~mPc02uoy_praf%UR0{9$twFpTI*C(Xga95q@=P%RIrylpD zNf59T*oiq{yUR%T<6-QeU9Wh`^Sl6Fmy7gWNP!5U&Brl1#B|MF3gjIY)tckHW?-79rIbhj zcgMP7Uh-$+gKm=#H9U$D0!%{yCjT-&UuG;7OR)L;@Njuv)XzyPC+&VZ9_}{Dp?yLl zA!o4?j=m09hhB?SpcE|K#DXR)XsA)jGR5)k{reAhU0~CyZ7W0o_;CO3KE}g9VrBaB z_rDqEr;n>1lBm*lzV=GI%qig>KoB`d6o~?W$t!SyT75VeOB9$owKTqfH^E@p_5sx9 zG$Qd(z1hIFWDKd132bMeG>*n?kovujyCXGzO~kodY%{h4v{kpWG0Dahz19fWp0RGT zup7u+eKXM`);(Niw2FwEj(s~cnzeI-6>f&vmfv%ALqWjiv(&iM`#EfLq8qp=2n*br zANTLnHn$@yyxXA-W7GZV*2vD<{YXTIQE)OL!h@9jVibU;+u20Wr zL=5M{p*HgY5_FYW49!A*FLcUgP;nU8D9!v`HWKY>IEo> zK%@?W)SV8;z7N9N7VAfJqAfVt)@iMId0f`DAG>3-Puq$Q8FVwZDvUdL2n-mBF({cI zRDcpgmpXw;h3RISDcx{?I`rLU`M~O10_+vY@q#Ri`qSgm-`O1tU{-4_1%RSPiE#u7 z6_7-ylf;0!9%qlss*$#*D1f;aL>NF6VmGAoMY9fdMVHDng*t)z)4Thzgz*A89Fmw< zFSX>$`SCoj#|}s>%wgzD0zkdV%9-iadOLdA$`AxqEK=JA-Y~~sXWwrA+zBwR9?A8d zZ1CYWx$f$2uUq@B_%`%+KTyBURIis;6F9jW;MC*~%)!LW2$dKxQ`c%udd;;?UoHt% zyMyqMY7UmmWr5*z$?{wkM5J8Xju@VcvDkF}@|&UEY+e+k zIZtze;N5Z9_%2X@L+bC5pgTFsLX?@22JQJU^s9w|u*XO#s;-l zxH}v|8iShU%fsKkmi{?CJWi)$V#q-OMpeC8_gopttdvsYA_obmnu~>MR&!a-IxFs^ z3-G#mn9Hj@iy8KmhB=6c2yPXw1`=abX1+qCHzwWR>8`I{Z0m+!eUa@YYscp11~xV! z@*RD6p#?AutZgEeM*7&SXx#<+A|dkKMW}IQTJl=Owq7E6YW(9L0(~VuIr+G3_!$$H5G`E@D&Pr^W#9B*J?nURY+j; z^0-47bt$myB|OI1bu4g``0bIt%^(UxZt0{Bt@|>mEk}&)!rLDr5_mI_XrHq0obsFI zI$yrxATnqbFywqmBLEpAK?6`{L!$2aOSAZ?FC#%D4E^D*AHqL`gVW6)zC3+BKTc`9 z|M=dmmsV2TT#|1lPlfc+SOhRuQU^l3Gto7Yyplg?>Fe%zIvr#9qb{?zp!W3N&cmNV z3<`49TGq`zF@!kaa+zksF!aOyQKCTmVbrkBMdFq|BWjfl+bJ_qOqi#yms3{}foBC` zIuPRFgyG$)^7C;ZSJIN#WqNuz&m~86N2KoU*?Fee>SbmnlvkmvS5Yq{`gm@iYS>^{li4%DY_p4`sr>}7Pz2bM%WKb_b4T>4)tz=*Vo30n*R z(r_BOz)+pPW>5WH0%C|M9ghc!K@?@aeEIqaT=di984?PtZH?w};VcO)fVKh`(*;CuJw^$X@=t#Gb^g1^^m z4OgKUV`32f1CyHWC<&`>|hzErHLfL>(i`%VCl zwBfS$7PS6OBS%@jJ|GN3QbH-E%qb;EkPaO|prx!>LwP;}p(+s#}*(-|3t} zsMufxm~sHvT1~Eh6CJWN;_iyz0tuiF{{kZG+- z4l89@s~)0*)wSf$&vu{sJC3pY%XuAD(f6nO56}zBx>7U$a0A%#S~d7OKbC!$Bf(L_il)h=E}U0<{Xj>jF6+*P>Q~ zZT*`#IuS{T*)8dUCsbPsY`H8;uBsvyky4i!>zsGNX0x#KUl|)lu`Gfpf}8;<%VL0l z!f@z;(`gvOw(;4CRLzJ2!p0~lt8k%Oo|k!@|5iij1B98uO(09_*aZo~RqOI~&HYIr z9AivKA|%2Nt?Rt3L7$hj%z08h)J@h@>+SSYBtRsFl;nAc1CTFI%g<8btAZ&=UM!Go z6i04G^0qV6HHChzrcvY!BtX!+U(0%5KB7o5F#%m)R--u+y=d>!)aV zDaG3c41mo8eiJqkB{#2N7l2Eg5c3Y=IRNbC zLYtu&8A8iz;BEQsewngg|23hc4cBOR+m&>No4D2(<{;itVFQPjb*x|qgjCo0ay~yV znG;f%x55C_tAtwC(63+_HhWO6HO z5Li)di5Dhm72BKJnwy)paDdH~UVP6CXk(CED{xs zck-$uxz@|Wuj;@%3g{PD1ti2l$Wgto0Ay9v$-oH6SOKgh)C|dH0E)G#* z7tR*IF>y1FVu3;1eE)+;uhin}G(F741P-hD^7T=NFaTHsfNBa3!#F09zzFaNNEbMg ztGT*5VlXx(2~o6GpoZAjx@f{Vu4@(;khCBBl%i9N!VGXwRuRAyQE<4A0)6442p|xL zHQjS`t=bxJ7>pS(B^YOj!&_D4+YyPdu})hj^EP$TPJwxq7+|97T=C{T0IqEsYQar2 z_J|Z%s#U>(yso93B5ART?l^vZIHw+Cz|%Z`S&>B! zT?oSoco^&y%OXKUgqed@^Xi(@`5h)afsv!;~IeJIffJj0xWf1=IQ+K zu$*%7c2^+gZqD&|2ysKa61|_7MhlL3yyN-lfnwa~WUZ`V^B3g`f!sYmUZxn691@|b z0$`We^><^hh9Ja%qEjfSm9m9Xr>OCeFX)qIlzyBFGPKqZqWAYl#`y8B$12i_YB%uS z06@qEia7pRpT_KL6X#AJ-5Cq6E~cNi=`w$hp(v0#YzCA1m;k?$MJ zru=2wfa5(q7XWGs$}caO5Ci7OMUcnspkpnOzRMY9}->1B;G{%^)K0YI97ei9iQd8G;{j#iUcJLSg z%vHMzouxn&=T7>ehc7h<5E&pwaD{EswhC|4uK+v2xvC=slsx5C832t)2?|(yK#WcQ zM=VqUwi1xGt_JRVtn1`Yt90vJO6u-T{i5|SoXcDw0#yklFgI>WLa%bOFaI$uHH=s< zPxlC}DEadA`04%e?%>nqy!68eUlkI&6dGqy+-%|`5Os&rnmG=FnxA8goz+@u_3@{) zsH)1R{dZJ8ocb=hm;@pMu@E_>5EG~2)Z^!OOj`kpf{7skqztbCA_2;p)xgRIv`bTT zSkYWj`K8*1C zDwDyrn6{dN_9-tCgA3}aeaD`4wZn(?@zWE=fBQ(&=aTdcktp>%D`ffV^D?fNuImN~ zsnG=~)S7c%WVkzES(bdLPZ#uuap;EVYc;E?a(V0|^hp@cf$|?%$aiHhhvKq>$HnSzGD$d6hv3^>XuMVA|D)>sq!jFN4WAbor=CJ!IK%RJ<>3geYuAFbc&B&a@xMPlP8$185IiGDVtcB~ zL+Xe-nOEtxb;Mu=92j{eTqaGYy8r}efl2clQS+Lsq6@4Pfa_8Mr>#3X;HYiK;-HPu zK~2H4J;c{2=@q+p#ggZ?JeoIXh0QmqSZ3Q(UEIctn^!2f;c!e>Zv+Dnni|Yb+?2Lm z!?rrhra(EOrxlfN^Yh-+^8Ebp>tB9-Dj$%J&6;b*;sELj zL=lZmk)hqyIF30*34m$lw1>+I2PFy>fN?j3cqB+jT>!M8DpJ12_Ko#)y>tJNPq2Px z?z(NQ0>S-z8OgV;6-Q4~_Ud+-XQYTM9NJHm2*d*9W!{gS+8OG4K~9~j{YVn)$3J9oJE3B~cZp4q2n7A(0pZ`_y?nR*b5D9}n>wPq>&86RHm8_`5E8Tiy5`HerPKh( zK@|lk1^t(~6aclZ>sB2HpxajD?c+(3aE#(Wf4Dn#ad)BII+kWNw&yZGJwNA+1|GY< zF8A=w_YFWC@7^5_uHB}nP&JpU>0{lnD#1q9(lQQ7paz6MP(?u1yj-T|ryaVJ5E`A4 z6rR7T*0}({U7xn$Fm?lG(K@_;k8VVL*1@Kal9a#c$`!5-u(+6E%)^kbW1U<0)Gj^J z*!3aoC~&PAnrB=q?-UB@$Kzc$za4@5omsW$2&<`CO@Mv)AgZ|qr&0h%t>i00&TFwM zVyv%*Op{S4Q?)M99)|tih^Om6-+hwQgf?G+h6%pSZpLTtd&ERTYUvUPiF4ObFU;f*#&+$V%zCZP~u6glV zASh>^(1kc^hel-(84n+H1Ok#Tt5^_$2+Xx2hM={snu*g1DLSu144o8+m5KwowWKHs zZ}M@pfwR8h|JQqT)1ri7N>w1rscArcL>JFwuG7sv@ZPtb$$}^z3PC!Bk(Lpvm)v_$h01k?v*jU5g z-p1?QXbukZWx9~A({w&xnjAL?R3ThV5&FLG+1&wC^@jDp(^7}-{!i~a;6f}hNhE4YlLQq-t9MitZJ}vx_zWvl z7+C?P@MidLd#*+sR|VeKn0>FgUmx1-Sl<`JTQ0k~T~Qc$rRj40>DwEOtxm`Q^IE+U zT$`Y8BoRf3J?auxl==K+dU%*Y2?&Eh3-Y|=Qb++2lzb`GAnE|IL583yg9)&*}nHWob-@ znwM2WJidF^_bG63MAY>uM88ZjcA-rMs-V!{olbpNy+XZK(_K=_fTVbS#{FG{Atrd> zpnUib$0YJ)HAd>SKns8}7xeQquU$}b+EaP8CAA1OUmohpNg!qGN_&5M%OR01#rHCS zUE>pDcw6)M8)(1b_ihH?Hxe(iyIaE#_p%1VrsDj~GD8G#D@)rK&sUQXOCuqu@5RP^ zyCONv9mW9!`ex;8`%9-E1d!f#p>JMo-)JeM?|f+oe18}R?4N-t%+*XA<^TGtTAt2d z&&vWHkEc_#Me})<6awm+lXT(W38`U(41X`(`?I13_zVrvLDaIrB++ZZv`R0DljIs= z6w#v4%POX|1lx6Sw`C7#6(j(_P5s{O?R642(_Khgxrn#fhNOw`ZV#r_>Co->X?rFL zYm1_^bYzIo`BUhF&cFWUN#2hYRSSZUP=y4r)UsGZ07S@j1r!&}8HcL11bP$sxS9G( zK=(p<^JEOJJ2Px##vK#^q*?Wo{5j!^tVk$ThcxG!Q{J1eB6X zK{RQQHri&1zQ6F9InXi6^gLRg&QJ4`LK>3nD=LBl(vMw=x=;VRA0&v_%m6pb^W|$$ zD^k}rqpP4)fq=(WoDoD~iXzO$65s&TwD@|NJj(rtV~@*)x$FA0)kA=xO>c>b9j4~C z@v+hVg(@Hb8tSL@z&4|w}zTQ!2W8{2GLc*A%Y zx1V-ySwL$;Qd^48&}?7>FIo4s>8ghm%uPh*XXDe zU8^CQc^viUf=_1!x+ti4?v7o*amoJwto_?|BuSDa2of`kh+Yh4fL|h_GOM~~ruSj? zY5)IA_MCp`sqUGo%8Cs4aJT`c7ZG9ReGpZH!5yBF)n_$N#)$w7YI>0iGcggd!kGau zIXOWDmXG&Omy4=Ifvu{&m-+Jb_uoE09XNmq!HK~p0@Zx^?f(IXNa&>XQc{Cz90$}g z$aqK`a{co8V#{>;CH2Dg0^RK|Y-av{t!fbRTD>kybxH3|hp~%buL|h; zb?LB{?$GuHd|h2XVjcFT1V0CGH(e4+nO7QL=4}v z>b(ItZ*Nlm#3+`IxPS9;uTm48dB)sFsn);0hQ`h-C`f2DTg2ud`4O3S#&-OhdnFXlJ+*1 z_v;no?=Bt`TA;U~_w92^D?u95OmRhKLd}yp6ehd z0<=mM1X+z0rl^JpNC#ACY#O&ku)u4nm0t5k3~o1LT~^Vd^jbu z(1B%NwVCxbUQOcWEf9zib_AgocvZknYXU-yDWEL5ZcQwjz@_b=Kcq;<*v~diUzh3f z_?#=c1aJf+*MOm5OhX?t8G=4z@{tHT;}zQqQnQbmZ^Zg0=_ zF#&B8$glp}y#Kx(ul1Y_Hn^EOzPVh#PU-gla=`HVy}u0Jm(Rf4*P6MynJYB53CbiA zfDodsi>~YC>B}^KSrQI+cWDGT)DkgY@?4%$e=kGH0jc>Zm>Dq<`)un9gpj&JFWu@Z zBy^{DLno+Zt;?#|ys)>-ewohGvQ_{EzIGL89719<7*z8LsWo|keJDsNFDP9v8DID) z14Lr$^&8k)$m*^4f?kdf^B1)0vep1!=P#c>|Ngw7(Y;?5cCYK@*Z(PTIK&W=1kt(V z6$KDNfC5EJDf#?#k!6{S?)_6joB-;-6mlA^ktYn^s;sbJpz%@^%0s^VA(AT z_t~zxjU=t1z5OC&CU9LJfB&`SyS1d&h-@pZH8%d6({q1dI}7DXCV6`@w*h;d58tri zeKSB;Y|Kh?wYO}sU;?(?H-%oleLwar<+=yIy@!SGlfA#=_)iy&{_cYTw5=cJ_U(em z-N_Ei>EZop=!9zD3OuP+pgv^80CFr57G9RPJpKxIJjUAo7pP;1-=zi#3Hn$_7K*I$g-e2;Gl#vqZ1oX=0d z^0@NpejbmqHzlc+60~A4jYFU0TjW$|TRHxYn(BTOt9iX#_IiTrG);q+o^DiO+rt0m zSzGqvb=k^iMOAO$YFF76{eK_`0zm2RaK<`A*7MU;L%RN^PN+wuc=s?g6_q<2uHQdk z({=hPr7moFY5G5r47AcVb7*LkLV-@rwbrGs#pb6aBL+a1zy5db52qR=@asoOfNL?R znJeT)P_6(>Rh96K)6exe>{n_o_J{5df9GLsE%=Vo`Gdo^O!9U+EP%+%6*GsgPxI6H z^Ygjryr#SNAK%3xNQC8Br$>~z29?;S0ci6IUK_Gsuw+F*5GE0XT65yzFeE7QvQE?V zLIeZQUPx;Ru|MSMR`>$8d5OlOKAhrVKZUfPLMY?(z?@n7J zS^!1OPv@`aY}dxyV1qd-^7QrdUmj^FIJ9)9mU&(i0ClW$UX*cGEYE9|c)He`aWlEC zZj6nV`-Fb%?@p^E2@s~v`| zuE&)p`J;jN2b0~XWjkBc*#6D?N^SG)Ef9)X$V`_g(_+4u*yv47#~M54t7u0N_- zdi%>C?X$XBI{xTo*QF}bLvr;0a5zNa&^zvR7zWW0WQ9)fb?O2hj&bM$lQ4pK4L}uL zstkP>k_d+&s~?`c~?G^?Kb}+_JxiMmV|t25WwP{QYrSKmbA%==vP0bBz1v0NCr3 zx^B8B1|c#~%Ty%76m=RBst}|bTO1rD&~-3uEc>?(4rw@?E{o5oHX%j;S*YcEQ!dBh z?sPf~q(v*lfX!ML%qDJZNjb3EvMkUNLtf`n5GepPS4hV|KZr!}yc!BbEW)&sQ>z;8k8OMJzELpE(VW`< z6OqaG$no}6VQd3wD;?6yr@#4R%OlCmO$`*#Y~`R#jJlSM6y~#C35$ohUM$0-@YsXlG6Z1#`5{gyqZGdEBYbO^{0nZmqgfr zYm3A-0+^Zt+EqAcI^KO9Iifs95<0Jg+0XGs72Gw2AXWMBzFxaLJ?4>*L_t#cSYe0;d;B1j0R z@an}OND;a&Uw{2=8Y%GiYdf3RD}-IKx3=40&Nl3JK*1Yp0DQZ3m>Zjb*ez^@@mIAH zSBJUnJ;=q)_f8St%#0gwl&?ekW**pH9BVyW8(Mdh4=@uEBY^08W{VlywkExKvsQ2X9FC(%5V)11MRo0Tsn1VELe;uXPv_@pfyzP02N0{9F{@~69;*g~ z=ITJsuHRUjlM}0(E5PkFqZwN_F*U*5&~R&Q?6lh(W!(u3FU0f;c9JAOx%B7)4nO_r zmk(Vj>L6j%vZ_kz#!w3);6=+^0Q8Wti^m}a2EMbhvF2goJL`?HErJesne*4LUmj;g zsG!gvM$}0vQt7rg-*hFf#>UqEmkrG91nuV(WI&o>>l~3&0EtKx0wc{^i%NlYxcf>ElBe`o32+1f9=^XUCX2h zRYYpWa?x|qH20;dtiR{wGF2cU5Cqa8Q3wOsyn+OM7gKBtmK#Kr&2*Wy094(frW}u6 zD>Qc;wB!Pe^%x{!cjjnO95EOaLO%T4S z3Dqk4RHv^`mnuNI3-I|_QlH-GiqNg09}h#?>BQf@jjinqh!A3TT-h)~LdURL=IN;b zQHX`X)t9HIGoHUZKE^tH7`oKFF`WcfF6S?g%jy8E_4sO3fL16I2wN$r)-8}A1lE$P zR={e#q-uN@Pp3oq)Q@-Xj(0JHK#`zUr&@tdazb5~FaLVMIF7NQg9J9)_d2#$%n)nP z{HvN9pe^NV!#9-!{EqgNR0)7Q(_r!3>4 zJ3L5a14~Nx0GK%%vZCr-b2S`Jr=Q-PD#6PJz6X-$zoK@>_uNwya#O9PYOT6r{r$P# z1+DA)be^V*s_I$(K>>m(n$oE`Q7AUy$Hv@w{m5FAY%dCLTa8M)ZNXLxYJX6J3!tjs z;iN5^Q4lwUTtS3{E~N!XhhxC$PyhVODdZ&=fPpeC7mcUkFqRnvU+X$gR*`^iyz7o# z*NKS8H+=9GgY2)iNz%7aAIO*K%a_OLqKJh;e|mRF1t@grH|7X<=bOr_%SK~-GK0{S z7|=0lEt;o@>Kc&}VvJEF2stTVtBgMwWE7D4!v_d^&^kSR{W2LiN~wsKY5L3O z|9D0m!~MMI3;WVtnIQ_*9AH)z!J0}*p%v(b0WWBlL$6=*#vEb5SP2IHZcn>?4zk4t zub0K5VfqQa)&;t-Nx+DfEuR+jVcpU>GO#9 zE>TDQkSzZ`!Dkb zaY!k$5CfK%WnDmr&=-_4fBB+AcXyY>tS30^Weo-Zyi_l*mKW5Pg0@c@yfOORHc`90 zKuWL1?haeOl1eB!%(Mj$(r60~(3V=5&vhP@cOjOPxIE?TGBW~ zz-xJPmHok8^2P~@txucIXl5}1&6|^mjsKV!#l|6a;{*VRu>^j#NWy7X_2 zVgd6U@!(Jg+&=5XXSA>qKG` zoLSfPhc2?gODzbk>jxZa$eCqRm9(IGUe?Q{blH3b>eFLhvhG_H0O}K`1E%pXd*%>C zh`zmD%c$7B6@)<&qHH!TwT9)X>)soHy?LNH)SQS25a~i+D)QX*07~@=AZ^Z4RTadr za(T?pzn?ERUpnb!Syu+opBN#pPu>0TzFzS4sX{YC5c!^Lza5I&?0P^!I43?5=)TbzNpisH$AcIxQIDkmR}>y|t%o&lTXtdVF(an*v~C{q6Rg<(b4Qh>~H9ts$?UIKdZs_XRmx8F+~jxpQ~f>i^6e$83W|94E?{MUNy zFc45J156_*uxVb=jZk$pt3ZIXR(cSy7y*WUlLHB`Ziu%cVq24hUqW!S0&`$NAh>5x zG@DprL(eCVL6862@Nd7Z|8*G0u^an%i9M_oMG^cum+tP}$Dcopc&K^0tk?x?DaI~7 z{BsPQLb7+w zv{GChBmqH)Hz7u|G(=<&v48!{|Llk|4tkb*HCsB1sYbs}~k0aPm={xKF?=P5!l zU%CcQEB+Eix-m{DF`P?&ddlE1)=$5Foe}O1GIisC`SH`^)QzgB7lgidmCeKsk<8aJ zt(SEHxe8S{u}{h<< z(=UTaic&AITvWT`h@z&9%lXr>-VJq~s)Nw+g#7#;|8{;ZmwHTH!u09)Swg_{m$2rG zmWt9i4BarifB0}14;>?P!|6QD3&w|)gbAvZ!I9kZ`RVuHX&g^OXG=B#cPR*Z{co|T z9v?XM_i_Ep`upkFiGcUmOW2jU7xK%!NkSM6?`t>jW{lEP> zRRnb1;m~1vuJhyb^V3YnyLXAI$nZ};7X?tU{^?lL$74hhZ#`^;yfTxotMyvk5K{=M zDgdYp;a>|de)xy?@9(@=mm~l|QUtP|KmCt?`G0<2=NkX+=n#a^ zksyc&vSWQZpXF}W8uM@eI-L%~sh-0S!~_9s3T0BS6`TB+0B^;eealhDX2=L>1sXU) z*p@n1-CEg0DT1Kzox;^dYG}z&+j-3J!h|3sLoPsbszhu%PDOJnYisDP8s3+(O>W45 zF_`w|DUHvtA7R5e(U{-YhJ0-a^0r+yWrl5qyYFyT14uRw**9SJi4zq-G$fTGz79i>Q`$Ht$f8g1vZkScKQoNzkRlo&^=m)f`q8 z5}L)tkc8a?#<03PKk5mAx)_@amkuSbS>s>hDPjsXQV=a_08!gM+9kI(Mq5i-0Xgf- zvtfzhx;lA#A&#y62CYXfPP4E7zPO`G{0yxV?c9)m~1;QZ^MKjPzKzW%jYi$5ixfF zAkaniPJ{G)3JMdsNz;m}8g>^hCO3Du5rGlAZe0~fF$H015^bP1zFs5zZ5o`L!NS-o zmjI*c{Pf%J6Ql<89kMCHI8t4!hK}U$OV@|cZiBb;NTUGjuHiH|_ej3#dO_`a1fb51 zo;K&y10}At#4;_H#lXlqx6bu_2N`c(RA3Kie9a<*M-`wa*r25Q#|`wsB6m&pHxp0W?aHv?ujHVAIZFXXTO4*TnZ3fvXd z2`Y_rF9bk>P?Tb-)G^ZG=U}m4kkavgdpLCxqg4|xi&vyBkWkY-&zHN zGUq0LW&m0i>O#3JamfW02pLrY4pI?9*L7^#9Z!d4skO}WJa)1r(*#&4we_50cwqqx zysLNe)T^pSNeAf%f6{qc4?_Y;bdn$tawleV{oNW%sa*_A0W4Z71PC$2NHF#M{P^$x z{a=1n=?_Dn4nr(9E%WnbTCD3&?~X}C0u83sV-2BOLmavjOqqn6RtX?h%~>s1mma&| zn?#Zns{sGT`yk(5c}8%5#kV;(M13utXcykaE#ox3jv|6Wkoz+zKC|mgXcA)msr=!7*lLv z7(;mrkI)dyn|9ngrNkIp0q45V+f7Hc);W?lk;66;n3^^n27yC2TjsVvgssC7gLVZy zpg_cpDJC)67$*lC`73a6zsSu(<<)GusS5_UyNd0%(-PRmCzY4ekl$wCZ5wM=yxuIY zVNlxJ#QtDPZutd_=w+L~&S;^y%1lF;XirY)Yf1vSe(;8!#gnC~00%Q(%!euoq)#XqYfZ zWFX~fzNjE!$=b7_KP1$JDbRRYQZ=FgsOAdO09VsO4iFJjs4#1rpZ1-*gxc8gZmuv8 zw|MwSF}6*8wv=1c^%l;G22|D?Nn^k_<^Fll|ld( z3Ct|aCQNK6i_)DI#B}=k?$nDw&CK)SFo^Vr3IqvSl@rif7!}1bPem2z`EZDh*(0c{ z#w;lT$kxac!|8B34t*CB!|vA8J5{#0PV>43xLPz*HU}j163A_Zv?kIhgS^W|bsi?0bg8VEOT{zy9_$LnQQv)I}*( z)s_l$-FP~TT?#?Sy$D9{#$(~orID__SRlYyYhC9{DV4fnKs5&&bLdiBv0|zwOu}B4 z*%MGQ1M|F0lZ8-QWVp8W9!(Ha=db5;=Hsy-Pq%H)HV~O5Bo>AVH;)-2xS7k?_bXuT zWvNz5m#}es8p6XuSeJ{)vaC``ptBaF!+|ydMl07fT?jnOSQw_u(_jAWaTz~8yh{vy>$>Kg4)5NbMy>|6T(b*t zpCW*MJd9lm&0`H)Ns95(29f;Rx5|LT)Js;?g1zk;)Ks;OjnE+ypx8093@}T>P1|5F z7&RiR^!@Nvqz6QwZmP(AsWmhoZ^adC#S62F8DtD|ot~%5v}7wekeDeTsl&QXlibm9 zINnJRf{Ht|%~WU9Elb*Hw9JrToL9j*MTvc5cZS%DA`au&tvMs*XyC`$-qySX|m z5F)w{%RB?pN90lvxdOG8+REc1!Ld|T*IHopxGF+3a`F;buzT72eydE)dVUY_exUkk ztl)2HYcHh{bNtBYrhU`ZS%GdgKD0lkEhqrPOe<5<;%{)4NDwhlpb*K+F{J+Zv?8SO ze!S~r8}4;lfLysBP^(h_@+yf))oZC3uujuuG2-s-a5tbBLP%`un&RP*0|2%+1^RSH02>iSUtgd}QJ-Q9qy zboa0_E@oQQR8`VOIcsSt7^rz(fWwqUU2wtWg6>{JK+C$YJK6#we6#Vi3YQ9iU?fg( z!;22#Hs8A*)(U0B1c5;sUHE$`7dGbHcaBi|{Mm=RD{cMQ4d3P$xONcQ4>56Lt%^-d zY~jrktZxcW)(+Zn~%$4j{SYKK(!+D^jIoXfnf_4%?E^IB@T zh$5#j#Cnr^b3l;nUNj=~so%-t?F(dULYo&s1=soVc%C5Ra5o;>zQ?4)x~7!ZvDY%M z(}aLIe*L#!7d-s(^IZ%f^{1ilzoi0s^Hgik&A}X6Hz(*HvtgPWMf=y~{P{0>0{YBg z3P5P(LLeqIEu6Qc$3rAwnleDK3xKLsTZ#h+H331!q3edYlXjasO5p~Tby zy4+F@pha)+wtyzMAZt!QB5yU4MTFsrqr5Au2KO2t|hOkyll7H=o0+5HYVVY#O1~$@1D2y`4Dsw7n{>$*e|Z4rQa z1!4p$-1H^HX6}y4uxtYWte1=8Jl`KrT^I*-Vre}?0qTId#BedFF3;!3=Nafv$I3v7 z1l98Ezkhz3D}m!MR9I;aog`!b{vUsScj}V}iGs}{Kx~k}{#{aFZtK66tnx6|QbMY_ z1(ah3P)e;1!19zA1!}3mmak8f0#2=1o-^w)p=^(=>XAE4*I*F+K1yBkQ69&TFt=mJZ zVA5@|`vURrWEZO8@N zYra}1K|wzW;;(Bm*5pc>X(5fEFo z!(Dxw1g;H)@=ez1Frcxl-OaTqXav&fpcT+sC3c)# zk_ejOA_@s7;5cn*rldXzYRzhus{%59IGs)%!Pl>!%hwC^auM_poWgX0+zIN^E3=}m z>&n7Ja3|un6KZZA{>%+=Ehq@GsmI-$d1qULcT(9_5C6|m+YGlM?vGp`zWZ_eL6cZx z!>Y}iyAS|vyDV=!SO5|@1;Eu2Mo|FA1B<|_s%kAu1*W2iKm|kds%8i*sJWK)a{hWL z6_idu%}YiHcm@E~5(ls`k}B>1(LgT0-^asY?2?F(NbC+PfOAG(m*#tBFjTFekhG%K z8}+!GDXEoQQF574=OtU!^XWdMySrjQXDkFa<0MdV#Rb*Zd77Ut5Ka-6bE<%AK2J+A z06}7`w#>PxB6MN6|EHh-;ePCc2s0bl3_#qxV7E3nFVO|DezsMyRMX{XR3XA5DIHXS zbzPTGOKuyC>LR&3e?6~2Bm)P{>-;rG5jNH0`0dwUKi9kA=bwU~!(w0i(|u2XnX$oz zNTj%>aXv zZ?QZPB)nm(-~f~vZhLb`1MrTn2o<;c9s^*CJ|KIIArQa;oiIX02qFc5l}lY^sy

      V&2A}8{H-vd@=9D z5c7?#W4u)f0FZNl5FjBUMuvn6fgVOi0dfJNiOA{Ur}w9a5y*3>%LSrKF36JN>28{g zKa4OnB_c2Dx-ckEYsFyOToPar35~GRJo5oCDU}X%lSMzDD;d{Y*p}JD+e%iNiiVQ9=!tZj;ZgH@KzEa2_YdUpq>K+O#`_q zL;}{@5aTxHR7=j&vZ?~L`{=^~t% z97Bqc5dsP3vaXj5ML5K}k01Yh|Lz!HJ!Wl|o+hn-IRa5yEL|Ro ziB3=G>bw9c0$QH^Lz_#SA&!ndHlwL-g8ZA()$;jb1OSg>mGJPD{blA%W?aRTD0pxQ#?1@6WO_@ z)|f+ZIM|tjlLJ)h`t;@Z&+{c;R3RHc)tc`K-}YXsU=w(cm@5YnfQ>_4V=*v?tSu!| ztiNXkB;CbsIL0A{$gXK2*r+v{cfjFpLIjo=LnM^C6kO(20j&9nWz4<8UDb(%3FaQ#inm$1uyjEHMt;KD zC-5?(nj#=!0=6xLg*W?-ZFO|rmgFtvcs*iR$YVFYhiIK2&&wu$^fhO6%rGY*5>%KK zL=vGGB*3-Z8^aAIZVYgM98YyEWxDnT1O&42uMN%eoqc1bv}>`g6^yxRU7M@eIE)hs zP*q||rU3e5AHz0*AX^vClBhUV&AtH9Tq4 zW@~p&`~PL15^opyXydH3IrZ`Yx4F^+9By~})(N(BevhcPukn3?8Jn4EDT*Kp_zMG! ztx0}`Lllnyq%%ha62nwYvw;YjSHH~5j9gcsFN*b|sHUblFPHOq%Eq0blvx*544Au6 zfnak(zBxn!PGjg(6c`y)OI>TN=+H+2AQ1&1o}{{yK-KKJraI)hC2TW}y`KIwpTmUw)h7T#k*XoYL1Kxx$UNY@V$>nQQR_OL zFAD^U0bs1pK80b3p*%f3Ykd6moR5d&=_ojaI6mU%%@fq!pu}b&4X69F<%;Uk4Lu!2 zvxcL;d+hoehJNh(l;WN+aG z@ex~>w(T&$jeJjy-W<;RFAQj{790kzcontXoDkqwL7ZMs!TV=yvwplyqPD~LvHo(# z&6B99O27#IRy9txk3wIHCvVVO2(60QGPBTR5;xY5Z{7dK-hUgtefgZ!HpgpTF6Z;( zwB!ZCh$4U-hH(G_ZZ{UKt>Jg{&}dHyZq$I)zGTR7I*y_h-RU%T{r7d-YmtN{%5^u9Kg6%3lPECD`RVfb_0zd1o=_1F zhZ7Jc~z1^<~D2fCC_4`wj0O_<=Oix#Vcn}E^T4!K~;%_}3vs%BNmpQ{#%XJ1w zRCGtAez*#38I7F{hgGfLo@f)UX{{BAk-BcY&+}zo^wclYtdJp|`jrhIfBNa&Fp@Lu zKAirnho|TN_Ei*YCyGfA_)H z|NpRl*D%XJm`QIQ#z3uWtss)Xrts?K+g`d8t(n;vt&_0MHm%Zi=0zf&J0}lOZ$)&7W(LF5{R7RH20=?^lRLEV4z=FQRuN!kY zYWRigd72o&S#v4Xc!2zJ`tZ~HW8Vo|F=sbdwbo6u;b5;IKxUyd-v95@?_WO6SkH43 zNCdkY!q5qz(;8x2C)|18gzGx51=25@NpjWsb3WdU$dA8Yv|lb6p&L69#)onITJP@1 z>sv$x0bw|v-r29UhLsMdW9o*oLP9wn&`CcW#oz4dUFw z!tIQk9?$$`Qhn#g)_mr9i%F@S&8QJP-!^P%=cSEs_gcoV|L68Y zxt?OxfCMywS6Se>>1R}Od#H~a&0OlyZ;=Pr%0$qrG zj6zNH+~^jq?HIGfE?|h`hiWPuyN;t)pntdZ3Pk~D6O~uvWmBs8 zZtuaypdbX8PRn0DpT8~(DoPDwR#kS_5L1eTT8+1~S{N{GZDK-~kTp+hJxW;t2toi# z1}LeTHHe}OP%-Q^NZzD`uSV{ci;$!t9mOuoC*%YGwT7agJ*s6QYBU8#5Mq$qUhTcj zg_T0;oa>sG7()gkN$NPHMw+lI9L~61ldzfkxkJxi=1FBFK^2%Af&>;2IQB_Ucj%qC z_4HL&-E|D@e2UN_9krT^5`u^XtVwjSepI_;9EKQ=5-RQvR?&)y4bMB%$w1q|lRaGDk^B`91 zrROu`Fm@qOln?m&?yTsbxs;q$QjPtG)BF45p$i19?jl~*Krb_!(I6ExgieH_9X`&2 zY_+014dIa4RjpD0qpXw9Lk|ri5`lnK8&kP#%r6vtnlGmj>!pLt7Lk)^4A#v-$1eOjjZbnr(XB@WnU&LglS^?p28o25r3? zzwL_S8;1W)1_*4M*hYB>L<}Qkh&pH!G;s4@`u?JLFECt9B6zQ2;978Ovuvw>?dhbU z$LsRJvi66(QV35IW)z+VU=kB)1{FZqY+z@CMZ} zh#cgh-S8HZzud5pG-ixB3`7F8<^20!J}nu9VEId~F$p3d(rg071O(@;Yr3ixEw$DX zO-qSWKz_-HkRmALOXw1?^>=Nm9krLC*2a(m#!AdkX>hmnCy|~J*Ux`Jr9};KIK&K)W;+u-&l9ihM>2p-D(3{+e`&?UDjoqDh8wwLlj@K>N>5eDUGN1 z52qF3^e_h5N*b>Z*iJWX~`u1u0fnt^fsymG%o$)UvM% zyPb-DFWS5P@0XP8WnXOTz)jJ@w)@uGiaLR}$OLHd@HN4|LO&Y;$Vy$Z2WD%mMRUN3 zg#)ZAv^W7`+LVxB5JE&@D5nCtQJvg>JKNu(>!#EYOPf-^Xves7tEz(aCf*L z^%7;#GAc^5>YiUSg)iDKuE0`%%D=`GA1rmmc?sV+>mT*}8@^An8 zDTXeD2vJF)gCI++p}^F&s&d>kolS6+QfCGZAs!CkC??3~{-hy@i2mcE(PI=V%cXYV z&>!yq>2Nw8x=qw$#9%fwFPMGgwKdLKw#VdgIA9zSD-gcIB5KriT>%2B`eiW?0we%h zVXm69<`_#>Xc3^4=W-F0%SBf=9t=>6fh0LAMTRsbgSk3E9bx=nf7NxZ#)tdk!K(^F zfA`^xIhX+zh4b*o9t4y`3pq07RQ73mgmw=*Ziw@bmS$E zGPVl3wsyzXKYlmD4Z#bVeWEwp-3A*qNg5MxVk9UW%*FzbEZKtWCitWEL4Uk>Hi5BDDqr@Kx>s~S+N7EeH+Ab=T|xq+A7 ze3guiA;b{y6LNm|<4dFcu11U3@#wwJn>buO1#5g`IC^Jf4e zas7I(<4=uZ5JdMsH&!8r5vnG*o3>i9vb64Z>vTC!Pv?xshXkqU`V)rF>w3X(`uNM~ z-3J&r4QUf5Lc!*%repswEvp_n4h`JH(Xuv29^~;fL}*x-E?12A9nR;=j97*sBESlY z1Xr&*ATk3j1;=fvoDEInz6Z1IO_}aq;tfMKGa&4{B?X5oF_S3vc3Awf>ouY&HfK5m zqcLf1R}Q)>YRN5tA#EvCC8H=IaxGWK^j2N8Y>*V9be8f0gup2Aa2owP95f@0;SZfI9zoI#cD-a*J;U@{O;#+ zzRWhOYG2p6A5-iu%K`*jE_2Skc(srK0))a=1XqKWMNZOB|NiOuITt=2?@O%!(tEl8 z|Ni^)1>*-T(2u58v(}1)%lY${i>-Y3r*2yESx$F*Ie z3W~bzdWsYpwdQ5BX*@IoL8V(^9q^-!&5!I-6$ zNSL=sR{=+XfM4@P%~wEJoERkPtCL6&ZG5uOh;!c@yPe{#*(8Ez%Ud*ud{N>Zr;#b7Wv_y18^^JQ0ql;3l&;! zjMvx$0Hi-0$8m_;1K2ZvfeJckUxp#)`eGmqZN@fCKX~H9&@pZv?v|J|-ubI%_$@O0 zgM-_kp>G#k5Hpd>54&CdjbpO}XXY3D8pK^iTf`MDRR88;0Z{Y*5<*1i`@`{W(bz3b zCh9kKA_^o_vx*u3j{P`vK|+)iLo~zUVdInETvre855wVfniH`4szB)`YZ#1lwF4j` z9B$veRh=)8yyUej2B1I@wxY6Dt!9Rh0t5hw2m`)4(&>OWcFXmm&GMoOAn@TZvq=6sp!)A9>x3Q&X)pnF zEv*SswU_z1oIfAUdSU)<)S1<_u8KqYGs^P{>;;?ejv1!Ks{?s`ddf(M{b2(ovdpPN z2oeZjA!_|&e&p=Dr)xic4FCC~S)u$rwdxRh(Ml_iBZ|irvXu8=Y@1v4$pY+)*CeDcqa!&3=7*vjGC6XH6mW-MbIv z^5vpG{g*%e91-t8Of1Aybr1P(zKEM;E5N~_5QQ*@qU*X;gcu}LbrMd5%)wn;rAZ97 zQl&~r(gPS0sEGg(n^?j01%_gkMq}GfBo(E8BtUM5F&-Toe=;6La3UH)uyl8h_+%4dnNd* zUC;fd#Jex(sk`f+P!pwe7=~aQ#tQqvRJc}|uLNCkgT%1}UFU-93Kt0m5Yfh_-wBS_ z(==(DYL0^`B=xE5->v8Kq>x??4`Uyo5?(JpPUhaQ3I$A6&5bF9AS^^-Un-X=LIe^I zX@>N2y1#!oj(y9Dwx`mJOgKTc)}d70TCRwQsHsvU2`Q+wq-q1?Ya)>@#V*8FauA5H zKtx+rNzgEW4H3E;q<;Gp+pn)B1Ol94je_3X%Qj2T)@Y#R+}PWA+BO7ty4pVW8n|R= z8Q=zZ2CxKj6(BGq)J>7WkN`Jty>LJQ%}ZWdIgx~o$-CqH(~5QQTKl1c&!)>^D+*PQ z64jPvb(PfJo$d}ppHl7mrK|uJ56kL65OO0oH&Yq`_~H2er*--|<-GKlc|3?Bgb-Lq zZ4A#8Z`<2AQ0fB7WzB0<)kW2s3w(msbxAc>#G&gE*+gP0tn1n3IBE(pe4Z0hU}o6U zvdjgXqS$F(LVtMp`L4N>MQ$}s5`=H#kL_i(#_mw4*5&E(_s_q5^$7iVBAr%X0y>Ib zMFlwa(CS%N=;wBVvFGOUT1yFtKxK_!2^D~@=U?$*8vC(FY7Kyxh%Go6by{+Tgz! zaN$=sy5~-t^^1VnLKP-Sxzyhd7ya-LKiwxZE2*|(Zg=%+huz)}hy;Wp0Cj{?*XQR9 zNnK(CI0j==)DW7!+YC-{bzY|b$9%|q3} z*nB&;zjV#({4_1quyxp4i!v77 zp-R=dER}FYWf;oJY}~lI)@ro8=b$fzqXtaH!}0VP;2yz2z;vF;MnMYNPxx+IH-`EdX2F zXxoY;O(VnYRqVdkZ4mDDjcr)kURF?$__b2R;0}gbtAj|I%3Ire-S<5LC~yFX;4VOY zmrM7QzEBwsLbD3n@w$teVBcA~-@nIxdD;8L&*s*7f9CVL#AYnV|kE4uq5 zvlAm~VDssWZU`|*#JrdWu|kv|m-Ac@5d+uDg5mDx52wD5B2li* zsTQ3dA3uHi`h*1iNPd|R01*V#=m2nk(7M*T>Y9HoF?AgWAfIzq1RylqbU;$C0f6}B zua{2`@9sa`A81#>GOI1zt2(sjv0*a)nm6{SokeB@L~baC@cOv}s$VZ(Z{m0hNG8^Hc`#O~>#G z@J1GVX|=a)%Cv3QdS#)sI{&M*sQpB(bu<%ZP&9@{7d1!d_5HiMV}L{$l-z*kGO4dM z1KeH)aRd`M0vtm1Rp-kENU7@-5F-IAOlt@mITe7B3P6EyWo@_zyJX!Nm3)yZUEdNUH@Jclje#D2(Yg1+E`3{_3eI@?zzFWyc~vvfW~thy zFfsPuw2ZkeJz{%J!C*J-P&S3PQTwu%y1}(co>5y986n>2S;SHpo?E>U+c3cnd^d`x z?)b86LbZb9QqcQD1DE^$NTrk&;^Pj`(D>lmYY@UCe&;C z951y@^ZD!f>4J)S1^^6cl+G(Q*W1H=%`ydD^L$Yiz%rKSFAzxsVuGHlrPdfh0l@R) z^XKv1$62XuNyJ1Tu}}s1{N#r?bV)xve6EaT&ZU{Iuyhf%)}?4o%m4)hCipT%kp-G< zi6Rg!Sv3z86o@&!jLw@ah(IkdX?+y7B&n?#Z^UokEfw4TMz8X@mi{o%dMh^!@@*7( zv#GuzYF+odtE5R^Z`E`ydS5?Uv8nAS+!Wcrx$^H^*={ewh&F)i?>esGC~nDnH_zav ze(|~tqF3NkM25akZIr9JnxcDaE#75o#1X{7z#_5u3d~atim6yTaVG*duEvDO`~G48 zKwyfE9N20o%-H+=@*yo<3aE6xAzC90m3Ad(_MM z{psV$!)rZ+mg)Tam$il)2b6u+0|WsiA!OubeU2RkY#Z^94>N?l+}y zIoc8}N)#BVJK=-G<)$E4(2)NDLw~$~cQyZ5qNW$m^-Ej&jr&EGX8P^D|i-*GjnEG1z@ZsafcZU}rj}R19Yt^#Ws$#^(rsg^a zi4cG-4hu?o4n^@#NaGj?5Fy;Scn2^}AAdPB$L@ewGWwVM=>C*wB2PAMmt`+lq5j}rdH>ZXgA#wQW=ZE7En0D?a{oyOvpq}g6wg&#|mlV?} z9#0)TH8_SKF? zor2-HT<_%p}*%)CI)9JLk1HnJ`Z0mQO1PMsRp++nS( z2eb| z+0J!yH3yh$+iu;kr&62$mcbdVnG*Kokv2+jVgmZZ`;|+vs<|k%BxE4@WBD?ke*#md z?$*{THv{FT=ZkV5#^E3cfX%@-s3*}%+zUnu7bd*C~MysWh7vONgzZLVzwkq0B^2G4SCsy z!OQNs-2?#N=8A2P$h>*W?X^1F|J>N%t_JdJZwBM5bg3cJ?b{j-j#$^FU@4vf1U~d*B=ERk4TpC>|8y7C zO37C3tn1*GbSkr=!i&L=OUV9s_qVV&h*=wiupK`<4P6kt_KUO^N= z#KI&9U7uqA)mI>;(~uyVQ6vx&m)<4_) z$~|aPlCB0*wh*4cz&8N z%%yVclIm`GDw$jQMH#RSusI6ra zuU9&TtFHS`MxLp3L`ag*u$wnSImUc$x=Xp5cz=#GY=RLwQlf|3tVRZ~5m4~U05 zG16>-yed=;Y>$tN+##OE4k&QOL@Q7s!OEJ^gT{Ucoe0Uxmic;kZ@6vCTLiThlNf?Xl|A3N*we9V% z<>oE~psRhnlj23Lgl6Jx+w6dO3pAWsaBBOk;n&gjR^T&+xtSGpo!dK7R~ED`S}IC` zLv?d6jpDVHM}!1Q?oE4*+SFVmv2$=jSkcwB&MSH=Jpjb_+y@7`LtOCg!@E-ltn0MQ z%UW!MZ)%yRsY76Du4%W+VLGhi5Cg|FcHJ;^UdzVRb2C$D^Pk0s5)10)8FaoVLKQ74 zDGC5C1(4Ng90J3Xz<`(O%Qc<#vYWrd;NNPTvnil+V`j9T`yQC1QkFOUaG2EwX70kAh!&Ju0Q?!=U+}^q|%K~ zcsO-fae~(Kr&KNz7C7}#o8t|8Ytdyu zkWd3lKMW6}hUE-E7diJ`%#Xssw5VqAl;U3TRm_pa1fC1|rG@ z!<;jiBLH#=26-zjZ@GM1Dw;_$i?G?@Fiw!v2WWMaymsM*mQ2!G7^}EiRfn>ZgEl%S z+Du35t=tAW!(6KZQMgG^&^&8hU_yH+3pSwE)}FDw*&UN?)Imi&WYempma2I|wdMJ| zTym_n&Qa@nSvy!!U%g_G=L-%JhtmP23UsYNN)bR15{Pgx5?=+S#Fzxo8+va;^Mo0w zup1G~jzb$P0OneR&8%Ed5Au`hAEOj|KDk9bExz$(5-1=+07YJ8N`V1?DJ#D|uTH=H z^%JBU*2Wy8P?qXN4q@n0kmgDDt-GGLmWXXnVFUsq)lw7^L_+0F_>hKLV5>yIF?NSz z*F_Q303kTJ#+ynk0Em)6q%t5ZLU0EgYt7mNFbEiN0pJQEuVhGm5d^R!F1)+4!U1=4vvL6oMA+e? zUKK3jgwTMonpXr06bT?^5(X4rguraj&4ignIs`>T$WK~I$hE2hvBnTfsfJS-^x@%j zNM)__I+vXDnyWW`%Q8)!kLE@&ca?SkKbdUJ;W+}GsL z4VU>>6o`hJRQksFuZB8+#=GGlsIB>Nt(ULoQkKi1NY~e{>rl=GmoM@WKrzilb3wX0 z9iyPJ&lzgAzdpN#mNtZVFA0eXy4v5>51&6RP=JTSyAStwsF(E_JoEuUP*h8;t1qgG z4jl*?ou2;bAAfo{^nvaX2HYJ^$b5p=_dTA^Gq5-?jK`js2~2Fvq1Nthz}M9nq2?s$ z1#_<`3I;_ISmUwyavghCmYfk|Itj+(L$8>=Uckt5c^W%LbP_iHMzKLV+${l{lKAzg zy*)O8`8Pj&BTeD`nr>#@3xfFaIdAxwSA{lyy&D_^l`YzByB@tNnYW5y`wHSFpk1p8 zqh$wgC^6b%WcG(Djh9;{a=q5TT2lMX?oMnVVt)NZ+T#D}8SfriTG#pM@$;v-ASPXK zc%BZ#X=fAtF%;dp5RphAPF>dx2q}rSDo@qZ>lelh-bCdY&Df-gzJVRF-OD%aaINa! zyiNBvZQ9gfEuy*kEfYi70m@#hR;^mg0M)g}Viz1jK+emT-{%3EtIwwRaD18}hhaR4 zQk+|1>P-WKBk+? zAT}Y{yJcJfo!4K)M1YyUrAP$!7xDT5?|OvS#PF^8;tw#3>xUW?^8M1%lo$Gg2k}RT zFDxdk*I>sWB3&z+IZ!U42EP`Nw?Th}$bILyi{`$))UG zs{{a=^Ljhfx+p;c42VfmpXRO~Mv6fQFQf%CYve2uq+tX@wUy4lK1Eb;$`Ia2kqXR1 z=ChiM~RDr9yRV_f7lMDwDAZ2;?^Sk>Y5il48hr@^%PB0BR-=$cA z^(&ozdDS70LWqG-o>rWC^l|eJu5T;{^UIT7&XXd^`@3)sW8dkp+0m%xY3$a+MvI~! z-e_CD-&#oimyZ`>+#h}N&DC|&tbb#^_yX0x92?Bq>}w2)ni$~y4Y$H}>(}HBPIqk1 zWkMB-t-o&Bsu}{|znxTSPO~AUG@7pv2nBht+Glci#9x3~*g9zy4qU z?Ng;Ld^{XZKOZ}ZA#tl?=!O(3;I{DSQLvL=r7%@!PHq6CD^B$y$pG>EDOhN=7F!0%4vXyW!z@h(Q2veM1^q zQ5~3`p8q;$2J%yuF2*4KTnmmr9gclq16LIe+M!eeH~?s!6i{>o%u7S!OJ3Y0bbz2jL4r=9UO|ZhxmhJ90ht5=OpDDqCE*AV zt>yd#LCzjV$DXx&m+swDhN)T!%ENF!4nTVM{=meXL_o}eB9n8$ zGRys+R8?YkVABwKnw1V#4dBhsfSh>vaKE(vtT6mCxX$zWJYNp~%m!U^F{Ck#T^9&e zRm@>pRi8gqr@kh_dY&d+K0Ox<>C?m5Ex&#FQfoS#{`vp-X^fHUDvF?Hsv-y!0hoKU z>uI#T|K-yc)zinH|LLa=D`7%@Rt$#^$FW0Igf1fIbb9#ZeIH9% zfxCy}7|G2lACD3vIiwIvfA`D(=kzJy_j3t=q^=mjpr$I~EYq)Fi`*aLa#6@(V65-n z9S)d);oYC&VLsK*gM_a^0#Mgn%lzf9zkMxX9u7kUnD2gxA3uF5WqSPd>-~qr|9MQQ zV}_wLbG57Rt^%$7ueF85y|DoNTAK1Lg&`1=)NSas{I3O!u#LtqSF?M=wP}~YH!sx} zuYYh8gL_p3#E#oO6*g9f+5QP!%dju|oo_~F?GVA(2?Gf3c3Y`!urX~aGd6At0TYNi zoQxrDE#IKAwqkBGQ`v4}T6@)w*nF$)17HI=!Fj{Qc9w{@lF!Q~?PYrW_0wkyW2fox z;lnYBNZ9K^-uefMVrvE&+NE17NyrwH2r~#2ox7|Cl*^3#rNmsupCnO;UcI2{$y9_l z(VqLB>9_7=05%H1{;Ujp(Z)?*B8@#y*lUc&jWZ4q43?Rq8APQyRzf*QYtP{YZh)!Y zKfOOs$FA$QKzhn~$q-3`n#Qivx~>`_K|)N`QU?)%SE*i2t0JNT>zpDpr?8n*Z~x~l z?7Qr$<@w)^gFflnB>LyB%{e|mJag}~t z>X;+6N&tn5`74f#+Av-_mhVqY&8Nr9RAod+VFqFcE%T&^NPRC*Gto9_w*3L@*1S6f zU^m$Y7&T+PhT(SRWt!)?QI14V!-{DQeHQ>>7_@bmC)FME-Oz8gprWj6^=Lq|NwB6N zF;`Rrib9Il5-G(ND1l(ce(g=nOhQ}I##_DnitjS06<+pzaNFB%g6Y;gt@SOwF(x&z z+_GVrt|jSLk$8(e1#XN0m)g3Ov@i0t&XYrWO4UiWPYc@8!^~y{#6cK=rFlr}QaD6r zIDFN0DJfJSCM;MbbONo-aD?UbkjPd*Mbn+nEP^GVobLNxQg=8B1xYD}08|ntR)d?- z;dDBjmvt57A|YsSY0g!x*vWgL)dLq{QxOfC1UetDIooW z#}A$U{+Dw+4PEOyseo#QL&5;i;doG#6J&vUVef3bYk8e1l`&NR}B+(s@|G7gVgduIb}K?k9V&hcqOf zLhM+YmVRBQkW{?R=Pws@Sl2S#sWo`STXVKOLTKx78>q~H9y>HOnS~xHX zHcb$iyjof6?2wQIV;3r-uUOZ4iha0Ajc(s*d*12*DnS8ZcpG5bU|qX4vEtS7s?xBH$=e&-YI|sKodYbf!O-o`y_UHkiFl4dMVdmW z)#r(wr0Gm`E1W~Y2p)t5E>TIkNCA+D3_%nHqZH$j(I4V55l~@EEgh5qiHi>1@pKUM zg3WxLiP_-FtS|=)$Btn0^qjR;1;7;8wk{N`fV=LC;kM{RU|pxYLK2AzN=S&QOI;GU zn@*)BEc3J~qA7eW^I3APMQb&!rKl=m>Y0!4?@wdDEmYUXXxe&Y!>9%M6tI;#6%b=$ zZyazzJTOG!c{s!C)-_ZV(^{r^S*m(1_ySHn zIQIAj&;PNaE+pwcY5|RCDnST;TY!H#Xz!=6+kUrYu@P0?s*LcDu+iIC?#*ML4?jd! zZz#}sv5snoxN*b(u9GFS?#ZC7r}Epk_x4ZY{xAPIocHZV0)Sd|(9uRV)UD>VZbGBO z>EU!3`qV=0n?Kvjg>G9|@HRv&O{xH30RUasvJ4jy3B~}jx&e{^bO`l3lRIfCaQojb zZ{DuMfVWNY-aLwm7D<(uP$ta?F{X^hCZZ-j^fJr`UD5X)X*s@o`h8lb$-q6+Ci<&s ziwA(0M7{=4>qH+=6k7K?o+QGK5?tpckTHDo4b#JW9+v_1S}V|{J{8nz z>pabuQ;$D9Hm~{i@89+?-`B5K0^9HF1jaWRD>=+TQP?ZoP*Ioo%_-WktZQ=*m(XE1 zean?ul8~^#&E9OdvR$Y+%;EOR4)MF%wbK>G!7HEFS10Ccw~cTA92?{d;sD8@ttoM- z<>~y4JBSob9RSot0bHkbM^+-vOuRKLiwbhQe;-O6<{LBBpG!XO6E88{q7 zP!S*_ICiZ8|e*2}k-hrgTBiKsh_+>C5@NY}HPVpwd{1?gp^5-iKT(01myQ zTk~+FetbU&;6_(}zj*lN|4io$s1>U*#^HGCa5;Zk;_11-ynHLm~y&R@@$WicT} zQ4HOEALH?G`h=ymzW$e|KSLsiJqY}Eh`o8}jwJ1m0E#!3M54cco%~-r>{=<@Cpg1s zL%Lq>Be=O*qqc169djegv_Eg3me*U2H)xCrZrt3IzrmDiBSp zPAYwj8~D5@7T1HJ4JmKka_y>r=g{4~dsNA)5KMD1Fe_|%{B)T`A^2%N1a9fJZkluk zlp+jUKV^o9qZ$vM?q9W=&^dS`jYiC zfz8!Sk=Igy$Si?ja8oxdYoMqikw~0^hQ3xKYBc}?SiB>kA{+?{!y~!@%lUCC@vxv+ zU6!*#VgX>frkp2H$bkN*pYI>~t|PZ{`wV%Lf@~@;(ABy{S+#YsDXx*h0V#>Z9*0vO zgNVd-x37WNfLWx5h%>Po-Uk+t{i0azFI4-`ICS z^$nWq^ip<*zp+EQo9;fjF?8cN^kWxp*_A+Z03)DvdVQ&wY-PRM>!sb!JdXL{akdrE z$Ehq+CtI&12^|O8EH>TTUba27V$>TnzO8Kf!dkrLKKf=1X1frdH%k}-z&f3O{rAUu z`tadC2uL~wB14!FBqTElU0|rzF_udQU)BpoMQu2B>wFw2K#&2gP|Yo6MF3D4nzM8g z%n(R7I?K(=Xy}4D5w~))xrhRU*dISW&Fh*WQjlSrcYjSqu&A7$SA9v<+7spt+kaV- zK@>vQ4as#CH=rbdIzX|mopl_7!q}9_ZJ8c_`~7LToaYjc569!7%uip>7u9B`wIu{Q zF?BBxuo{@dtEb+)TV86129D#H;>{`sNF-vAD{sK8HYFLnNeEcA0NP4rp++m7dF$WR zCWWHm3s!5rnm)J}H*>6OC5M@lIJj<>&bC!Rwy3yCq{s<>D-Lcq&h&#Nr`5s`S38l;aY2$MSu7Pj`66poJW)7LLRtzH&IOu%~ibm4h|<)tXj zN#$~xo-U9+r}KGUYu#3U&82{bm=1jTe3?C^}0XKQ?yp1Kxsm!u5}!j^=c^;jAxG;J3can40>l70s^* zj9n+5y%ZL{x&ED%(sq?Cg68cvJ81a=^n}R6-Q5toK1Kiqoa-~U>>4ht;2 zZ(lxry*wA=yQkyBpVy~PpJoF~pW@zs!FOvC*48aV0S#hks2jD8zO7vy(C7zjBExuh z%CEwfE{6T2txPAzTZOGvEPYj%Dps|c5wlcNdVxVV%xf<^Xl;;zx|y4yu8{!=PAUkh zt;r$1RD@rO`uj@px6z~)qqJq^H3)j0p8j%%8{D1Tt+in=m;mI&-k7**YPl>9R9!EX zrO)D3)!`6{E!I$g#H?|*HrCI}*;yzs7D3mg>E@z_hxeyG0+qa$_TUTV#lXWjy#M(y zvP~Irh@tgs{r{2nr%iI?ShgT|?gHpy?nXKpjLfX6S1mRDp=JL6f0>bw!o{l5}%5RVaYFoqG<5g9FzyYCL}Y48t;Y=b+3|1>8Ja zZdUHq^9w;(`}-=0q3a492;rbj9I3*vW-l4(c|w5QC^e&>I}HHVW#T+7FqPOkMPH@r zyfQm3tNZ7OrvK z42~a{skW?|{N5(XNRxFeXE8aQ*yqhoVh;A#mC-G)9>@)^{u7doyNDj ze7A=CtoRk-qp>S`xPKrBE5Es(*^Ws%QFdzYPD4C#i!0B42N;-UnPrfnZV391^9h|4flSU=A0scGQAw82xLb* zqP#o<4fxnx9l7>o`Ck9pfyE7R*4V4ENWmP06)=bQLwM6)b?AfS`wO&>$irhVF3paOl{b zI4c8)(pv_=SI=R?9xEXTX+uPT86p?sE;uDIt~=d$9!o{DgC9MwR0Dli<+$P8i+0zu4h) z1`Z$I-;GhXgn6T3``rX2nsH&>Y!~@;SN&+UZp{tfjhhtVkH6&izyIwwH2?4R7a9TP zt2C;zNXX=+88L6u-9$1sY|;-XnQ5<~wDo5Dt#37TXE^-rPTSLmTYzx|b??F`xUqXJ zLaN$#xuKlFnz1UW(W>94#mceAp2Z;2B_&GDu7hetW z{k$ITvc?dZs-wcHz{{F*S(bB_5%(pYG7vIAIEXpi3`LrZWl9S)gA^i=t_Mo8>HJwU zjSuhNR}8m??`<=Bn{;dSi!jvVqogcQq^JKxEq7R6Cd;#*&M!D(7vNx5c7O#AcMDrr z3tEpnymIJQ(jpQZf~PwfJIY?LAapU+oGneo&eQyyO4zXDmcse()8o^G9><4+5G(JD z?5*5D&C7Q&^A`rQ2ox0H6>e6VM8~!Ur0WjHd9fR=YiOq=*i++Zdh=WXs-8=(Eu-gJ zXiX&C%)9$#X%VB1YV5 z#SV1iyPv|!>nYx)6kSBAHu5BpUhGoY(e4De4q?b}c84*vkG%>isMuN@cV*3H6&=Ho zz&IY?jW6Ay$MHNv0GreKc|o@GY5-Avm07M$#-dTQQ~>6=Qim<+P?xek|BwHiM#LDX zlE64<=-Ngg5KCo-&C4=xhn-3|9*3UcwJ0;J=@23VM0-ujYeB9KV$RgCJaB7uUPbld z%&|X|hpAW3%X%8-6hePEzLXUU)>5#hHHN+=WNobp0J!Uh{^36g&~d{c%kW9=zMk?r ze*Edfq0_Bm&$K_`_oH$5h+o>D9AMk9iSi>`^?ROO!^YeHWwW=DD>h)-R)*LHF`C?i z+yW}Kl}Ty?tnWewSDYeTh<;Ql-#|0M7c;8#CP@7eaI;>^O4xVle(Srb1-6!uMh+Ew zgkd-|)P*tph9aeAMw3HE+0*>(p@sQX(Zn}g0E2=GX*^_9^IA&wRDqXP{9$3FSH8hU zgwujaU{lg_*bd@qPqbXW=`shk-edxSw)R~kwsPs{o2 z4CxiKO$wCcypvgPU7e-TmKs-1mYYl)i#9u2E0_d9BtTdoK_WP0#G&t^pmJpuxwRa?2m<7DM+a9 zZVL-TC}@DXH;)Bfpk0h3OLWCBjANECV(5pY4CK5lXB0ZGYqjqX2esB}vO{kG_i74h zni@tm&A!9}Fs5-7!1J8ays*Y`?B=?bQr(bp(5}6j*>Y*!hb%FSf2#8; z>Sn0m&Y{EboIZXy-VcG$ys-_}^27RbTZDG4>DNm$&X2^?8SvjTd{o(5(ddW3mFpFL zFXgd?zfCi?HeuI`AozAV-Tbn);yx-I+CF-zTy3{lO<$)@>VEg`*bz;Qb7jA~o8kiP zWx~rp5@gE&HQ76FyRs7C4#S1}m;j0WyZ7l7KOB3&a#F%&)wFwSSzThwjjd(Rpjwko zll|s)ja=uJyb>!87-}xX)`B&|a_Y=b3JBbwcXHF;1pt_pWL60kB+PFz zvCal7Rtezh-o&6A-8Yj;5Yqd{$(LklMuA{TDRx5)%)rW_BTwtHBwyFON*q-3$qa%J zlvGGjfHiAIT2u90ww{EBEH=$HO)uwVp)-$z)vc8q%}AvdWUv9U|IasaIu_~ghM19y z<&><(}w=M$~YQS5Y{R;Rn4|NO6GH^wFaCVRlLMP2NKnwJ?Ar0aS^^lHWS9=0tm zBU07a4O!O&*kW=R`aW!IlMJAmHDVr!s9Rd+Wra!LC(jQcVVqF}p%*d9{=aprB{CrsM>%P(qfSB4< z8Lk?@aPx};&SI9%Prv+iUH^v=~$Q7x~}&rvf>SVWF@cN*G8a=D(G zbU9gX#Za2L)4fr87r21{9ZIVcD7#b3hJmCyyP5l@D*^!Fz_|PE z85%oadCK?qqo}T;a!s|i&Vo{~V_XRp1tw4$-Eu7;xq9HG0rX(vhK_}5UDuS?oYyJN z8C8=620Z2R&{Z^MK&k+mB%xGi*8;TIug=e3zn;Rsn1he^_x+|M&lRkg8o%N1@HDgMk&OU`^$e*7Hk> zcb`5UU~aiOv}0)v_)LUY>Pt;V?=U@KK0ltjKY#r9PrX1@P#v|TR6{_?g$4oY%in(e z0+aFKi0Oa)a*qG{zx+kC%;)6*0O&Y`uJc?=S)b=M0~nMPD**s&M**NtRNc*N?Mi7* zk#C+^tstthtKEXJv%oSy%>f0_&?tJ{cP%U@sm%kZz|~9KxA=Y%wYA1TB4V(!wd7oF zxr&@iT9aX1E!AayK0TfAag+$E#qGnNYj#y3!65Kj96-(M^Sq!RQ~}T4i0Da~<1kJu zFeo?xu$<)d)YBj_0v32Fxcm6ttpZV_hDHX^AR(7jQcJ*LV?Qwi;cx%P<4?Vfe>ofn zcIH~lHXB~^792rT6vfO{M2TU=tfmmF^mn5wBb`qL8p321I-(Xk8)6hF<~iVR-%e9< zIP3EAGJ`wdzn$&lLz}$9%z#oyA?-H@--u1QqDdV%4D+|gua8gj^uLq+`Tn3tW)g8F zKoU2lV#{cGn$N({kKOTor(FzssYkIeaF4A*$({kkt-F?q;Z_QIAiGuKvc8m>Y%!or zSvsuQ?iRo?DDwI9Zvc~OeAkB{z?@5VV8X-C15EzyFaP#uUsKj@h#J+kh=jwZ6@vV- zMpdq*6}j39%cbcTOd!@u0^~|9u~r*r*9{9<%X!{lT)>%_sHp+*PExYtI!H?eAVH{l z-Ci~|5JD)rmzt#qkxY;JIEM!w0|aASR}d=RhJ0j!CYl`pVVZk;1n zccA@u^Zi=!*V(VmMe~%rxoQn)$WSJrf+ZZWo+q0LNty>_mUAi8geNy)KyGj)Ha0dQ zI2T)%^XcmsyZ|z+PC=x-tqr17woZ&2FNbAgH8Cxfv_Eq9?!nIYpX0Z4I&*?-T@k1L z=bt1k^U#k03_uI8$QDxCI%QUr9m7E=Au9lt9izPDf*~5fI6l1Zg_#|-SOpn_`Jye% zcwGvv?zQHeQZ{6y%fB1?cb($?!^h+O@H(<>OGmc1jmw**df5QQ3{qw>VYl1k+BUBI zWH5v>0LTDS|L*6HcglhwtzV7>TY3Oh8Z!?A>-jvd7S_~>ZSR?x`HHS-ii#Zs4$VOr z%CV2KK?Pb!C#A7h)FY`*!BJPw-ZHKm^cHS zv^3n!64+W7u00%ddZ{#Au{XEra4QCS`On5P8*zfvm)0OAT( z5|Lb>c91v@hjC!l5ZftKy-f*0nBbc{7hNyVdZ8eVnPQ*3WwHu0NGAf;007(_KK^{l zXLC$a0Q3(qTaesfc=&06cOO6WT9|c{ZF3OCN)`bTeMRQpUJQV1^mch4!u&>a=y#Bx z0G#){;rB{TY?s6P2ZOLxm)c_SAC=H)$cv$TBVv1#hppIkXZPW^ zKeSDb5CAGQ=tv`hX&%ZCC}y~&H>;CxG41B~dh?H%DZtIDNhC9q6$+3B5u#V;bCVMH zW+`#ei1+GXw-zP054NdrplLCn`Pi+hPAv95%z|ku>r*eCb`i)KOAIXBY9cN4ZL>fX z5My^QX`R0P{g=;YK^WfuDfFG{mHfov4HFL9{5h{+7u|XeS2)W+z1c^c4;_5TD;zAa zd7Uf9)6_3>io@|w0_^4u3Mf$QC5Qs003utXt^pEIfMT{j=M~|I80Z1R$9MNZ2(?(X z=4P`V4&p2RF9RKq3!`S^`(Xo5G9Mvm`XR=1K7RxJPx8em>T`um^%mp>f?kusRM1w-u3v8>o@*gQYYbFrb6tOZuV zwC6*~!5}Ne3=+|Gidg0~3J^oo*0%^|5-16DwbjYeWZD_hv|7k1oiZZqsI0nG;)t1R z%Wp`$o0&55oyOmH2Gn#McAST{;^lqlsK*C!; zFTBMsCcFm`Ip@}v;kP!q1@NLFumI>7=Z{N!0Pc0H|mb%vc!W9Mw3-Q*9 z;>v!FMH{21qgrz-8b$72xd)h7Kvhx}wHOZtFa+&~J_^5i`AzTCqJ#3wxfp|ZJt`U-V!5P90!rb_VH>ZTy0k&G!^W&Fa|Hqe? z0=@sBAKtsgOC02GsD|3kXKXjXS{2?{Bv4s3I`GbhAW-~fWmO>Or|0MO?o&6zZ2`iw zwB~t*a=%r7(~~qA67CR?ix}06qOfEzL;8lb4m6Hk_u}30-CcFmc!1HDUr) z-kGFfa3f3W{OxhhZ8P`HLKQ^>OpeF9z7IFyOLL9@62`?d-WRX~EHKYGY7|Q*7{?9~ zQB?yf>RJpyDVhp~Abk{ov)=#tzx?^ryOC5|;)ei+vwJOD_SsQUF@Mcx)aSdj>07iE z#QqY%rIfT*?l@>bET>rm(Dy1LwVIKz0Lp+_&Qr0n7VT`B&r^!^G@s5nr~K)72)x$a zC3mT)U{S+OzqSBdbR<24V5k*QRJazhO5&F?LVbn%+D?`8qicfhLHpC0WK(N`P`W90ay>3u6+fgn%LR;}FIn2$PT! z)zaJ`+Iqj79k-x3-%pTtW_%XS?i5a?CF*Yv}; z{bdBUR|4_3&d-+FA}+Y}fbB9!%q{=Dp%5;kHmXomlXf~fP`q(5G?WccQPRq4R*S9K z@owz;7{goEik9nS+hRWnYF4(2vs&vZ2VmGcOlmf;v|>P`od*dZ-3-gm^V#rGV>gDN z0v40VRByZJ+bdy%ST)ZnP2awJeR^KBvo4hj^kSc%V!$r;-S9}lfK)J7HwZ^22s#%4 zUA%jl76dHcP}cSR-G@JoWt!0Q-w=c`kOE`F*r?c3piV@Eg9d1E6AQ?oQWOQK6A;4v z@owm>gud(gAn;uGq`GtfkpQx#p<8MYfE(6z`TF-SQ3P;JKcFJ>JH~FmQmJkfBmoj{Sk7!|C;j4c}W>NBAZ_yC4#LY*zTtS%+RLJ zA|h46R1$;%wrAwr=b$4}VpvXiSpm^-I38uOGciyLSl}tC;;K+mu`~3-5rhRKRN+=F zH?r^0zgvGkF+RS#QzAhHL|$QGND;ffQ)r-W9C{5=0}&GwaWS-gz1f=v?D#(KM-Z>n z1d$40>E-W#eLfrhZvn$`QSDkT|WiRntd#)2Pr0o(z7I_k2Ti+}a1X z0MD>7*=-BxM|O|5oEW!4;a-1hV#zo0-XB#2fVM4f6(0V}&pPT+u`af}QJ8dP50 zoK(W4SbF(y^C8^I`t)>8fCxl-SZ-d{>1CZeIn62EzKT7MEkk>|^ZlneXfH$H~4kor%n zAGhWL5e5k`ln5|bF});wFUv}-eHU*2Aszy(lomF;4Nmk4j3Ovh3-t;|>iQ`91S+y26-wL~2Z8?4U&uJ<8a0f^ag{7P-K=B}l z?qB};@Soo>y#MLg0SE{n2$cFTL}s|Oe&m{nsja}a?tfgQdvzbMSJbfIf8rlgP+w_g z_mA#j(;tleD3(9|*v&-s(hxrUekpw-j0 z$=D!RRB>TqVcH?HATSB_<_7-uoERumK&b3NLhqItWLGviQdHFmn1wpiy16U^UEoL zLw^7c2h6fKY{AR(nv1?Xr(&ie$_KrjZYair z7`vvJT&o+{3`$gsIeeX_N`N{LAaESv`8?AQFhTgJCb9{@$q6ih#A@M@uOM6{zm&M3tZf zMa?X+JG|Ew!>CXWJ%TE%!r08*@R&p250-8D+S-_iy_%bW zxmL4`b6ySc5bwH9H!4E8X+~)`B&s1w?7E>>xMLxu5ZJZaMk}yEcPdrDZrBeixEj@( z-E+%Pk;BUR{PmZw=N0^D10)pKd7i`4rN|M|y&JmtxP(JTfN-FW0)!o57*ra{gL8Gj z3xlhGwp~pdi9UAFO0DKwZv9e~6Njrw6Bxy2I1SiIJuel9y;tp;3EY=6S#3~F0(;#g z+ct)V{eQ%6*lfh^stfqXcF(sNbl}22R>5#Fz9|X(m|v?2|LxD`0Jz@BFx_l)ZkU!E z^&f$6ktvbbkIWv*MoPU&5N=PqK~lH^rL5DsuEkkwTIQ6^i)aW@-mp;!YN=jV%Ngss z79IOz2x8`7MDv75!c@JQn6~-f9BXGdS6Gwit|aKd+P^=q&uh(q8IUv7Ee8T`RqmiCFAk9wa)>iZsT9KAC`RC>A+bvnb2|b{VJ3;4*>SOD84o`v zE5G7jK7|#Nn+K787{@N^aa1AHoXa{Us(@MR-0)&%1reCswlGc!UP~5=4VX%7!CJlA z8KGrXF3YejvKE@Vmp`qRy5N%HpQ~*RQ=Ghi3 z1vH9uj8#RXW#d>CH2`%&IH0aJghBg%9W;ut!^GWSaHYDLRB2REaOAX{5yUdEJ{R;+ zwN)4|8O3c8mxAh6kh5D1qGn)-yI17wtp>2&amH*Nz%hy;%}%O{JU`d-uKd8!s;4Fn z`8F5OCMGSdFG^aS%lAsfHZ9+qJzzgy0bCF;uQ@|N^+t-}dn<5#mv#GFZAX}ym4>~q z$RKcp3p*1L@uAAGk^F=X9aIAwK}4iu!DKNn%i5`^X2=Ld&h8B@W2i;JGLB=9Uf2K* z<9Od4@B2PzWoHtGXNyspjcRq0+asZ+ZXFI}Y!a@hX`WNEwLc3CIW4&exbEJ|t1w8+ zD_rCnU^MRSHod}tw6bX@i~@Vi6ZfzTH5_2(h7bkC=ed{z8szwK;A*LzyZgDevo%(S zL7lxC9F-_gDJ9{QmwA~NsW9S=Eb$c>kQpqZOrj!zU}pHj+Q-mWsFy2Rb$@}kfAqmLdg|1_i_I%0x`2&b#JM1v)0W-!YsUJs#Fc{z&*#Id*+>hODn)9*%nP1CP?#-;1tf8bh zj*%3lf`SGnfTeF3Wg9W{>jcHn9q)hcF2Ddct3bWf#{dD;!SI~sZ*nXt0BKI%--iyb zun&84am`p@XH4e_kS;9R34m%SZY~V3mLZ`VQ^u614r4%=&hs<+c<2vd!iyZWK+V7o zbIZA`R&I&uTKf$Qm=R(K4B>2EJ8TuVdIh#^|F`enZIfXWJC+Oh`~6p#W-26U}y5x~>D zP2VlgSGJ<%{=ecB%cAft8u@6X+ zoJnytN0+jy0cup;tyEGl*7Irkd$Q@*zc0((;l1$2@^sV7(8{11M72W~MGPgUZ#;D4 zP$M=Ld~bJO+oR$p`Pw*$ZC%qkBlHo$3AUcUeSSKvfWIgPD<})iC+WHXZUVl;`+R;( zz(Q4-0>H|i9U|47#TC_HCf@w0y~N+x_&4*jwQ9GHwr#CewEn%u$g!XDjRd3Fr9EO~ z0&3o!{MU?U?A(X}uGw;cwv1jgo7;5CZ0mIK@B^4y$rk?*_O+WE1hxo{Dy37sK1a$3HtH_Jq>P zLHmqA1eOJeaYgokt~(s0-n3s<$3-iod12f6pOzUz0t%3e{2rlr8Rgdpju1 zP~ie|2x*Ktm!cgM8Xc$<`aTHCG=(k$6|zRa%u31Wca}I-su%5~wu|{ke&gH0xa2pl z=je7$*-^k_^ z(F8StBhs`Q0HnO>yhu0nN`M*vSnUn9TC1>Z)Fq5OKmLCwEMK2Xe>g5b{H2@wX`|#c zO*-5Q1^J_l^>w(Xye#QO93&3F(z-MpmM=?dE-f|tn%6`MM?2hXSr#eSd#P@og>~3x^ulf&kUF>Z9}3CvNVhkPsZ62u!VLrx)6rb^7-8Z_g6Zm@DC z6gVmb>fwJ~PA5wMAX1*wJRQc^iwd!Wy;4K#xC50$R2gd-dNVtBUwSG-Bx+c8LSCk) z^SY`Wj>ECh0Wl1XCknN+Ft=el6yVO`7DTG46CZ-2qWgGX@+Xxj%y4H3EU1TOhanDv?%k^oZ1@#p{Yq0`$IPhwSKLaW1V?y)p3*vgRp9n$i3)`%3WAVRe36l)<-V(%0M zA#{UxT}sYjxH}#gBvqPWwo>dSklef`Wj8Z~=Q7^g^l}QK9CrVK8bbp!A(v88TCH@` zQ+hm|abPZ_L78E&0+C3_XTr>FEVyuZ7zzuB*MeAo9;M5E$4cClA3&k$Jg zY@iM~A%SZ_tGfs|06~Zuj$8|@qHgLNv~8IRz^Vg6*CHg82@UyQv0)rvZC~G$w%BQZ zdAE{vLoRPACx>h$1mVie1S{yGSvBHFfEN^4DuoAOugkfdpC5P#g7w>ZP8Q?w5P*^c zfK)L9_#eyZY{O3jhZsaita>r7rKagTBRcNyOG2qe$1#Q=kg`z(b1}2=;<>bkqE_yy z@XD@0ZO#@ck%V{u8oyO&&PDsji9T6Y^9Xrapo?aXQ2wfk-ij)FGNp=`QyH&H|sG^Mq-@(?fAfzbIU-I(J zK<8iYkMECTWFY6jjkrRuCRF_a~`S#_P zFSC67=>rUi5~9%XP}kYk)B3HW3Q{0;ArQmOFrB`BJt4d-U;ZB$kN3ypVIWZKHNd{`ID>vVej za?+?hRR{zffFZO1p*5HR8#q-UamcNSXFg$>r}4}E{kvly*^3-hB5jG?YFi#egj#2F zYkq38nD+<_66b*BxsjBZCCo2<*B?U=FwC3~S~_FU!0b zgcI_fT1E2*G zLX0e-=rHy}Xv=VGZ~uWZs}Pe}1%`Yc?;%r4vBaQ4a8wtzV(m6cN(PwCHqEEcQ|bUu zEX+c!{uMO9(>yJwuhS%5htvFo;qG7F)y_TxLl_P*-p3A4hR`wl*`oSV4Wfb10D#os z2->>4AR#c&X!77*!14+k$W5+~YU}X79B@R8jjR?M8v3%uH|W@n+s=HUe5se@#^rTV zt(yc%JDEfYPG}8jZm4GN5(C4A zM>_vD{g4zE8K1J^Tw%fVJ$hMIR~$SpcgU-zY?Xt9rc=6 z`(e`51%P=<^W$lb2;I${C{wG^U$pL+!LDG$?yl%;X;=)oEYoRx`1tP7>A*}vt#bg* zl>~sY%6{8hMV(*8>QXrjceEPjk_^Ba%xZ4OTD$v8{%uS1^nD{QS*GV9uB^;e3cJ^7 zI-MRTXY`ic%dR^u-}(^GGX1MGEE ze}22CTA|3?toSaP*C>oc2m&KwRuO^4I4&5wPNB6Qi^%ca!>CyR)a*-2i^1};6oi+@ zBflG500T<}1?t8=`r35^0fwB`#Hg+;q=M?~wc18o#;8X1=H*-$UyJSypj>Jy#oP)4 zqyYlnM7}$$07N1rL0Fn?@SRHKG70;%5EGb0bY~i9Z;XZcppps^aXb_eFdIAe2nMyfn-`~`?76J-x=aGb$<3A5TDbl;?=# z;c&Pc=2siZ_nd;6nKkWqu7>Kqm*Z+NW0?CT-?vrm_z$$$x4FMWi9Z~E4VqrP*!}U} z{)w^oFZ_VcrhN}f3qLP7Q~Y( ziJKd}EPn>JepBT6<>fIQG4$ir@X4zNeRn8`8?_6pKn3YAp8@md)9~fX$DcktAnxu1 zU7C*sbmfa^#J2F)bAr%=59jj=0}2qms3nA|TipNV2}$DE+R`jd&(LEGQOr^{oKC;} z`ce?Xnk|R@i~eCoT!ISUzJ%+Mc0-&;5g|ZSF+8`OoZpE5d4(0MrQ~uU62C>AY?b3T z3&ErDQ{=s--_W0HRU5EKAPxV_b7hOK#Bk>?P)E{LMZeW5nWRp8bX-A;jQ ztGpCSYqFf|HDc)Zb`66NL^#|~75v^{lGv-~)?=`h=b(UeXF~xLA_uI=zTK|?ZD2ix z0G?kSpK^CNV6ayGzP%&E0Rma_i`TzmI1Y_SJ-1vc92Hiqn3W6#-10o7^o)BQ@A}BQ z>fj%p4PMse^zCKVQ$mZU!Tk~UmVf*0X<6sF02+>m>x@ocfBW*%!kBYGZ$OADZ@;1f z&YnxkVA2@bYrUCyvyx1%Alzp3nCaDf{NWA%Lm}n;M!)mz{+V%uYuWCM0lLU@VB>vn zfc-Z^nfM}}V_qxpx`=#xajqMC4#U|EwcsXJ@b=>hyR`D#>n4i}^BV2<>5bLl!f3+m zj#~0OEiB`B9Ike6<3-wu)+(7Os4^j-J21NqL)5^(H}z4*1#%7NR)(w&(O4xkT8k|)uFc^kCLtyQapl^x26Tz23twSk8Lv?t zX2sV8oyVL4+UC7EJKZ*owYP>3AO+h)jL%h1)VsvjI7!P}k6cH_v4SG>fmG2&+(=DndLS4?~b^Xj>br+?&0@4W`T_#44;I z0Aq+jWaC!iy%ASfgu7alz)}o|$mcIyv}Pu0rjJ^cmX?LR#EfjxcV({ z;=1n?&}wD{&+9a;OI|Awz$O7&MP0I<7D^&Un0D+|g%5?hWw{-u3s5F!5yW8%i2byy6?@NJF3~bE(`j| z5J+hf0d636H#0*m=6e%CYs+tJD}P}5cF4<>8KeC(UjNzJH*Mo4wz*oX9T|4HPzw~V zS8@PNL|UONDlOgP4D;#`dTS$8&c! zGOG}5{Sv4xf6Cr6KSA!^AI6(_j~c|cz|2cAlNbSKXMsnDub$@t2H^qce40}(t4Sb% z2!Siy#Q^iSbPd~hb&|xWfiW-1Rxwxxp86O{j4E1h&LZauMi}e+2U}Nz6P2>?%RUgtV88 zWb0e4cPnCP28L-3wcBF{-kAR5M9Y1q>OGO(swFnDxX{i)oYkz3(zZSGt za;YUZvxhXFA5RlPMz);IOUs&?RiG$rp&eyh=OMnoJC6D$-eYWO!5{52Rk2pN?SgU> zF14Fix^@33bx@=%)&c1p45-?G>Xzo`ufP2A`9FW1X1yy5GLF^Up?KH#GqE;)^7~xZ zO}f`=EsjF3&yiAcX}sYKxHE5cg<4Qy?fthxw_~d=Y=D%@qg6D;%*I3X3fV%J$+(#Y zV)q{dmuqb;i=|j4;&!VHkOV=?Css9l zpU+SF>jZ%)0DWJ<(9m(%YI~cqSt)s0 z=Rp(7Jk17t<*4X<8pIxp*r`CN9)lMFqDG!7BS%K~?>EyJ3v zFwD|){2HJ7^$k60b+2AiPS2+z<=AnvAE+>@#OyG0xYv!&atkAvwiNXr z@TN2{3ggGS7Q4^q^vb1ujb3Yi;vMEfb^F&Jh4liUZW>M?qPjWse(82;g(lwh_n-n} zmu9kV876P3feZjU8wq|F|GwQi?-{gPr+qVf^)ef`Jl-&8+1fvdyZ1%^{O*2;x9>>Y zfs)KpTGm3xaqJ19wVP-kG{oKuVt*`8kLTH~{B#~N7!s7!fohCW%=NnS2$zEC%_O7c ze-VdVUh-)x8DJ0z#JDnx238?fo3LgPV7^I|)GV;P7R>V!x2ov1 zg8_hW zz^hrwZUt(hVK~YX0^!7qr6DSlXi3xQ^KZZW`sHs=vvpxnPr$sK?^sQNz#w4|AyerV z0G*+fWSfaAwN>>@QN0*6cGS{I;tEx02B&v;_nkxZBXzIlcj@j7S>+6QK zw%!PDc;p*l`t9Me!O7feEmn(Tql9a3Saw}3L8G-~fQxs5;f#`TxYsTaRHYk(m;B-5 z`{QrFJtby%T~qq|Hv@`7|+0AC0wm8TflR z!~rp#bLe9~bP-hdYRdD?q zDMT9|#&ybCGGJ3J2GI1@_sgi0G=0n;K85Xu?^=of{YU<1$HmfbSYbGTaPNE{KYcoM zH--7v^j{Si~8C1?Vf63D)1rTBgkpvZ`lrcD3 z?PB1+KZhjTsGRphLEadw%LmbzA*laQ*0n5Xx{KFgmP^7gOnv)8!;L<-wu88u-$V=C zUFvqq{o%tYp8-1~2sFP+R~V`hxKguuZE;}ZO4yVbww1S@zW(QLv-GU3LkP80n3N{N zur2kHrYS+YZMC@eB z!_wc!AR;lZ&tHH0>*uGlBVv4bKTZkAk6pbRnLz`vFHqiQPRm-Y7$CK@85g;{ozNdN zw2c-3x^FTsQMH##3-CYcEJcg74bQ=54$iPAh)aPXD3W$FC_dWt^#R16e@g#NtkkUG@Phx;**Y&N; zAVSu>;Y-TodS66R;OEo&G)>dowoWc3J)WjD{$2^FwIr>uxuBlEotg9p3RwV}vT6S= zYfZ!P&|^6bbL_gqmRh*yIw6;J$ygHrn@*klW(7DN-+O=l`s;swebKUoh?_#__6$uA z7a8E#Z+9i^j8e=pSkXmTE;%pjRElGrGtlFF8pcDX5_YHM_a*260I^r;fcg13wcHCh zbjs`YyMWD)NC=}M!zv;G?vMX=r_+2oC7jPE9N%8ltK0P3x8J_tI6@=9kmSCYGdDtH zhI!c!4g(14|Jdxo{`kkhz6x0XxW0FLkspg-O{E4#eXU}qM&Hgyog*mf(+VVs9Z32M5h-t{yfZk;_{sCSuIDwaY4J3Q7$Qy=v|;Ev z5v`RNw)5jO6(|Opa`Y8nL+W5A$y+_JWw*`2peFUfE=CL%5JN2v=G{6IbP6}BI5}WV zX+cWsBCYgS-I}*X%?lz_^L#@Lanb#DILr9(oRQ3Cn82i^(f7042wOAN=2tZZQaD#s zhqpeo0>k<1-+nn+-}h%*B&XE6Hc-6)s6~PT$m{g7^mk)-==)7}c^f2PP;EfK>w4mr zwoa>b>-uz>yZdl(GdF=*!#z=jan8%Kc_2k0(E?(JXUKg#ja?_w<>~bJ>*vRp)V)Xl z@TZ^T^WSGV|1v#391nxG#90MU!L2~dGA*T;0akQ2QG~78$qe0axEtM2*M>LkOGakx z2knKVC9}8C)tkfMyoGDq^KEWK6S2B+d(pJ8=*=$XjpzLJsHmv5ddoGJ(CYRKVo{V$ zuUM|i(_6Wjr5lxqSd>(>D2XatTFd$%6+sUDcnBe!O3Dawp4SyVFF1thOqw7P?ac-4x-ZG~p z6+0!fZ{Ow+!{O=$Gynku3AFl%!j8L5<~2;rXoiqhOg^9CtCy}K0V?8 zv^G| z0d8R&SmW^1Up|PPKYu&x`wz$CEdw`zTC1DQfB*99Nj!6m24$cYdp6Ooi%daqF1yyN zwSI@U->fE{#`8Dpd^%=mc7^wNAKcM8k$i_9)UEt$^1t%)XfVvwR+6qW@w7idf|n)|+|HpR5<*ZX_qoX$GW^5V;q zc%Uxo09&~gT2%rQ5fQE`R(rwswm!>SL4rg8-=>(c?RtI%zH|pMNCa^xEQSiKx9_B& znk6i2&bAZm?YGXC#b&piD_aW60k~5f-cRY2@(O3`)1R0Fdr59wzfrVGhucQ6Lh>5Qv*d zlh>^Ra4lvKT4U-JIJc3ZeCO7_=~t*!`3J>X+F#?guBvnE<0S$pTQy_aNkg&wUPYKWwhyGsr0Yr3> zTIXG*>h`{aixXLzPI*nKG|Yo7#?#A`%Im7sPO{tXu#~i>r?ahJPxJBp@l}<3r>R4B zC9n=g)4TiQp+l#L6=6^@D+xzClfzOz2SB8cSijk?ivcN1htpp_pH^@e1VYSB=@|gb ztJUIv$)7);7h@`8Ka9%ERDn93{`T49$0I&fcek8Vs-+?qNY`oc^SA!~csK}Bd&7)9 zf%`pXgtQy`F%#wUV^BH(01I)=%XD6vF*_a8nU zZtR|H-c|MK*Ds%^aBvA)tP$U*d5KEQ5xl#$6(D4IWgzSYs^0?&09M~(T3(NBrN2g7 z{=n>Qp~;1^Y|mGI2LT|4F=$iTvCBn>z+P{y(e=QqV5iF137}rNWBb>(e{;D$^EGWI z5MrvEMA{Bmew%~69NT*a{Q9Ijc^QI4uOxxkZX~FvRq4;qPoKX$J+7jEyHkaERa7q} z84!X*4(DmDJc2cZRO;;UKAQ~=IDDPHPMU)|7y%pXr+vre?MbsOjXT3_T-T*!c&YP{ z(_pUzA%N=a%(ypOsdy=12Br>!iGPq{U~o@W$WIo8;3W2kBek@YaF@O zK>=^DU#`r1kyfHAjmRNginCTwQ0H|qOVd0=d!^#CVIkp7s^I2qz3oKdaQ||D3g@K& zon?VT`inhkoC-$Rz!wgFlZxE*Qn2J~9LKxH@QIc)F9Da3TVTa36>t~2z{ER6S*v$A z)YuKlyk}fU7&~=5X2CJY6gH>T_8=&gfuj7 z(06@n;4R4$ZBO>8HAI%NLrTR2B4y@`$tZ$6A+3-oP_vV3cVRbFG^2_OE8DDE?U4}SnN$WhNuP;75Jr%4Q1L);Qja%wOz`Xd3$%sHw-7a{BwP%b_G)gBLeP>#;2k1c)yAG(0D3%e6Yxn+tv${kMnk z3WV;i?kjvK$Ix}$FX8xb7@AkOtEq4$ zz-@gwO$)XbLKgvSeVKL8;J776uhksvPH$Mze<#oWqn~X^g;)Q|{s-m}o4Kq0y83bT z|1L>lfa)H%T@JDBBXm2V>ZLT9YS^WX4?UW5i*`5)h_N}MuQwOWxl!lc#<9MIY0*Z=zX@Y4qsbcYdvg%q{%B~*7X6Urr% z>F9KP_i+5>zpWjBb$()W$|5WqaCIxWl5}~lb6E=HPsvc~e9FFBynok&-LeKd*G?nc zYdfiEi>ZKJ99IEvjprLyDv-GYs)7Ze#zK)YLzuBOVQr8TMLn!9@^w88nx+*1JWVB? z&4Af_`m=~Mg$7;o%sx;10e7fV7j;Hr}`Fap-)@f+SB-yeq#P2OV* zVhlhO=sVECXtL^$=)nV(|BqDtYhc0v-);zBd z$JUEKP3bhyG@UX2>%+$n??2p)>hJ#}KY#n}m(Oh-$R_^k{;lCQ>@2v)A*U%#Pa&V? z#~hA7|N93ikPr?5W!AA6(phy(;kwf%#Dd-lBR4l2Wtx5fzuOvLuM(zAfYQQaAqVbzp5z}6Ki%3i7h z@jk4@&R;+O{S4$Ui1X7a0Wn5A{-%0=9G{={F8_KqIRfRbKR(Fm^jJ8)==tGL0TKvm zx*?rsdaX`#Nv!d~I$fEceI$;TTY+)35&rG#&`+ zQ+)buS%AaC!~6SDMX}2Smz>WT5BdrDiBWxp^)Up3yV=X>@wZ>UL{e z32_uy&gK2G%rhXqT7tX|d>mXBG&cz-*&N~BPyKSru+#q&;ZOf-Bc7j-n1 z|2_Z5eTbO7Ma`^?;^-ivqQrzoECZ%mT!}YO?PYYWwubFwX~{K1EmmQI8)o}dTB7k1 z3RJX)@J3s+by`^l^d^GbbBA2RB{Xxi0#1D;VC#)nxmdkxsqZFmV0)x>*>G2=2zKkAw!Vuad1zl7kvLanEd0%WYp%SR#Nm7VQlWw3$Gb8v6H({rgc! z(F<~^PyvjQD=8^9#u5c{5DtJMLwsG+!pcqKI$QNpya-EFh!fZ#jWyE(6Zi&KE9ef( z@h1%cS(@1U5EaVK?0WT51g6Xyw|-VJ0J*~$;|SPV$G(w6y>eKr{jYijgm{~E1DIMd z?bSxu{>-}Lqh7g$0wPamr8MW&fE8VfMgYKUomVpxYODj>yV?J5zcUB+q#tHmShH;8y=1~At!<_d!400y`A z@%AE}n@kvioh~_I>{YKT){A!p2w}rIU+^%5N?UD(fD4b?&BdD3m6I5nmlmWQBB&;4 zDe~5o)N-shiI**DUa#>PNnk^%c+7d_=a?1%mdyWKsr|?M(2;mz+X)6 z<#c?P-!7QF&cROHzS|irp*wuUl2-=@C`wzL^RzkVxK;;RqNe2K{QTS3#}_-nkun0{ z8Nv+bvW3X6CY30FwD2GHfo4c`97;QQd*GVdu+i#EF z9pBvzK>k*&tM~U~Ut6(Mx)0$LEiDW$0G4GH0BbfTY_C>W(TMfkQB7)9-f9zhNy(fM z1ewLzkkhg*YcT-X4Q$|@hm#u){3hGpvOG-urc?b&D|boqeHYa2=h3A^c!P7gto3@+ zVtj)PwJjNP)%gQj<`-8=t?T#R_BL%mnjPwJxg;*e^X4fWf;YB}AP^$Bc)etoaM`VI zF0sM#sQ+P_mN*MhM6R5uj!WjTu`8clE|} zWHrx_N+s3)E(m2wbp|LDRh2Ek%Eca-Q{A231#VrL+}Bezk$7yNa%{m zF6T@Yps@=BP_n;|L1@cmFcI$*KUTd~cc_bV-Eh6|Mu-Eh43OL|hNcm)t(8}cOrWb>36{+N0N{KPkH-w>&owo$8MDvQQ?Nv1{q$W7{s`6cNMeep0 z@@BM}0eLI`O8p)ST3Z$1`VU@lLn5^~zoG)hMyUn>o0{77$Z=Tp3MWHLN}_V5it4oj zBt0lTzf3a%96(+S&%jUdV~DXY&oE1(D0yMxZWxAVl!dfAr<9W1Xh7__&da;>tuKpp zIHn*WJgo@OF2V~0D9akdo(*$c)~8unmU(`DIi&>#LkNmm2;6#UZjY-*L0q|phR+XR z{m@MeU@cyffy7xzVfmcl&tJ~ZR@tmLkRgHPcsGuHY!0VyCuL@Lv=b5(D+ynN0L!`>ER18<8NU>dF=ynIi@QO%LY%iE5d+jL7SX2E0*=F-!u7$BDLVI0(aUUQ8>V4hS2bzO3GGjBA!kp;ZDNT--=FUuj*mcxwEzn5vYLtp0HH`qZa~Q~1BMXMG19qYWUWi}P+gcqZ;sW%cJEN> zI_)~Z65dA*;taS`n^6J5VAb4ey(tr$0bDn4mS}5YxK3l_J^S~H(})8J#{1KlPqqo6 zbS-q2K1P(3(jwRZm#zCiHg|syj=a9Us5naqu@^w$mgXdaDq+r&*0jo%{kL_KGEj}F z$(WGwUYH{4BXd;BROc813~MdE0FXujWg*m@!7*qEA|eWExB$8Mc}9%^?ef3`M&l5a zeh#JU`*G-quzRA+Tw#{e^7Y&27lf!lDMiFk(t2AJw=952AL9MkMG*!m`tI~>=i>!y}Fzg6>rVn zCA4qC)UQF(*NePOwp8avYVCkEYIf;_7-nX!``H49wqUVIU&5=uB6%aBYG&@05q0eQ zu1+b5K*a2v(-*}2u24`Oq77NVz<0`t~wsqOy@7^*!YH)BB-8`!@`>7~r-(pH6?p=f`B!4F}0- zT8o=9M6?swg4KT^1y9oqDWU5QolBk&`&4W$=e^&VyB!zNZnl7{K#3sLD=6Oo>14Jn z=a(Gn;qb2yDo)H5_<1>Wuw_XILa;Rj0p>O3L}@icXek2%s+D3u2~vBmo>NL|POZpg zmcd~5lIHU%iMf?(2C3zi82pdM%{pxJQ~{V?enyqpeuSKCsE2AmV;#SAyuS(}Z?KfL z0qb5b{Fcag)11|`B5%v-x4DNK*r;dL-GF~52=(f# zwqL5ZHzB0({%{uq4zmNWiMvMrF+v*!VR;6!W6e2s_t0>JD6pv* z)~@#u01|_jEQtHm(H5}^BdmwRx}0p9X2^3MN~yqYb0Gk*hFI!;DyekZjlF09YN@er zjBLCm0%GZsyj}Spw79jO6YYH`E zz^1BbFU&oKA+qaT_we!4!>*|CJEKub0gO(-B|!CQHKer%03Fcua<@w8YiF6laG2(T zlrzF00k%Xm%@Wk_oCHQ~@Fz#mg07#+`V1^HU=3=*3ga`D^Vic$rVIM=c%ff7OokJT(g4uItQ)HE}vC{4`oa?TC8Z z!zyC17w9D*uZ0EO`+xUukJHP!mhklJv+*kkN^OEe)tIU63*L%Kw0V%%N2Aurb~_)8 z-9dhHTKVfJ7!i*E zM6f2AgQ7TM7uC{qM#$?)N2}NhMSxpnD;6YxhzukkcIhMx-7>>Um{*{i+rbvx8n35p z?zRRkT9AuDBp$+WP>BlE1QBWu3Ik{|5v_3LwdPu2);x;W^t-h6VZKUeibGuewdE5q zK-wQ{JlL7Nb^fRYh{REgq7*ACXe?sR6%B{h0=+kHsg>I*LE_=~^EW$Z0FGomW}4R( zDdlpD7N^UvURNMB&cr4YBVYj&hq0KII=i)o2CXPSQbL!sv>mtu{@(0LC)&E3qa5m&y+@Bt0cyjz)iQ+Ief zxwpR|Z+>0@uWvr&4TQ!3Ob`H7VX&BNU$zk*3bkm<1cqAcRvVH1uryTj(n@^Xaeg?j z$RZI~lvRsjc^UG$uFyDEAc)MP6-exdJlq|A`uWeF-XD4u0udawg)^6DWbAP%0i+PK z4`oUy7+Mt49UsQ6GD)q?^^yZ`#J(ooa9ZXHM3r)m?W7{cE$a_&2436NW56R=k-CU9 z&y}hRATfqg1fJ7+p7RJmnWYP32aMyf56S>a>))2GAOqlYK2K9Sqr#F)F108`yI~9h zB%Y^b&C_xQYc1vw9STxDWm}%d1PBbVJ9voJ5|Xl~xR{7wd090I!r{Fldj%9Z6;T(0 zI_`{-rPyuEF^GUk-f$uQ(co)<#TNvD5LelSSznJ<;@p3O_O8^|_U~rrm|UWS>!2UR3avM? z)@yfw0@bU_CGiLV)da+3($48k+Hy<#y-v(lCueV5H{0{IvOvSt;FUGJz$DqfOUt|- zTPELc5B#m`oxm<39ttMK7{VYT+(+t|g;8Rv$@*o^Ku{IF9B*qq10WR%B(|mnrPw59 zR*4}S2~EzBA;uboXmijRBwnS9uwpnbSWVR(HEO9OBuv~mAc;iabv1)%2*cP((10Dn z;}DP_wS_FWv2nF}HD+W;pmr?tkxE;)=N^~Yc1v`Me!B`Uay*km*$Nd!?zy=^^a>S{+fI$vp#MS2-d z(_yyxG)x6r4BeQ0tRx_2Cf=$<&Zww)I*T4)B4sTG9{PZim?8iLqI((d-XAkC0A+!| z%6VCqO1W6|w$m$sb*XFJnMeZ%0`YycuN8x6@RF7}|(cUUPsBc&k*tLAv#2+EH zv1PWrumj&qe4!eHz1oIgz2K4R6=1WC9qU3H_$x~`j0V-3bu0E6`W=V5-FreqKWi$J^BiJNC7lh++xJD_rj@~fI9gLkJ84>g;k8nQ_WkN<&MUq<#M4@^ zCWI)Wd!V@86A@}|sr_3t7n^`2RvLz(f6C`&%B9tyT( zkQPhU&@jww$oc$)uu59iYz7$~KHc4+@}lqHJ9oX;~A(n#*d|)LSc% zmTC}42mzMMdVYCcW(;XLe(W@Ga~)LxKZftn}SIgePIxkJFBGt%7#{$)zC6AL)VW(*A97@mU?)| zDJ>Z+bV46ROIghSt1u)7Kl z-yDNXFcd3L`P8TJ^gKO0DG>M za!%PQ^}gM=AuaRtayrkxr1kdYwYdf0*=~^20AS_%Jpc2f;)kt5zyJA?QUwJFL5T%~ zYSn8+2N7!S+Fo)0!Pr~cE)SptfIFANVa;huggZT*P_WDar&AmyA`GH}46O5W#yEcX z(6!p$4Jpu%>l<5A{M`V;4Ex_K59Y z(@gxHaPnHsig`6afzYu4ECTEMHFMOy?}y{@zB_&ZNLx|=)oT!q!(Hw^t}mz4d07DM zB{U4DfH@Aw<7A|LQ)RIX6VKE8hxgsUCjnsd3G142Li_+?$R$U$$+J0tJfFX<-4uL% zIj|H%6p-6~aF(p>Okc zyV#m_VgOuei#v&cYSiS`Z?9J!V(hiya4vUrap`W->(^g$t3a#7{NBBBi<0xivDUy~ zn0YQh(>Po53JDcK0PXtN_1ushL~Kz@DyaZ$39%0(3PeI$W?+s(yU!5DPS03@wJ)XF zAPrdOr)kw;Flmf8*!2@cV`rwt#IV{_VAd7t9IP&61u&~#OIfF6z*s@-IdBEMddQ44!_H;FB5Km7ku_h;LYBgwWPxJ5(<07jbAhlt2L!|mJEt5^O1$Mi$3 zu2p@9b22jqcc&X^20&Fsq#qP88W|p$=Tz5A;~~?7G{P|GAhKo4-n=z0?H(H2p$Z6d zXDaLmu~}6!M4M#UUZSFgUQCo2ViJxl;R+yHPstQ;P~^@e0V%`SL|Ne`pkTwjEq4U~ zASpi0wW3%T=evDh1Sgn6`>eG+;dh0E-j*RTPoXei3hA~+91tmj1kgq28AMxQW+x-c z6|sL)ziJ>2AaRW$!&W}8m-~%Cx{pHBvMiU3(8iIttqRp*P{>V{LZ*Z@pdikdvqB;$ z=5}rXrNH1)tJY;+*VXSF%mg85)Ae$>oafm~*-V)z#lBLRIS8dT@7lpI1KhhoJJIWc z>LyFI(@lEHb-OWa6Ry{xzrXBs*!s=tqS~6Opc|_)F>k(5#E|aA;V|>w)4K@-xEajd zWHV;mU~vOL40dBlh~d1R0g)`S%vOh50oWx;jv)m>gw?`OI=q70zzOB2nG?U$akpo zWvtvRdL1n1*L$(KbtFS>FVx;%c3=sC_s)aO<471{U6KZX68AE&0KLj~jS(GiL*E=< zP)(;UFG&!(-mW>{)Eu{pkL~?RzMb05n{K-}v5Q2YYb~*CnoI7`vOb;94nmFq=NRba zNw5ke^;KDaREjbAr9I6K8Gs1X)>_pR31$5aG9A|Dj@E(%tXMz)vKAQhZrCZ8=v8D% zCPP)559iaWf&6@4D39Y|9V6QenAQr;d5DPPebm)ce>DP8QdM|2`rR^l?|?EfnFR?F zWYbjKaxX*|VyM@qy1B%6JXx8rA?@5BshYVP6LBna+%#b7*btC%;Afp0=bEvLknfv_ zcAz)!Blea8#3CwydQX^AW$?EM;miKj&SZ!aPMv;urirzzozb(L|qnj@a|9Z zc;Mqh@+v_#3K7`6Ec3EfZE}y;Y|TGjYJezYNXa+Nia;Uw0^Fr^{CGTT)e{UVT33Mv zVbn`4&*$goOTj;_muV2GGK3Y-`gEGlEdvxq4UGBt?oU5GM6GSrR$BuIc2@GI#~MGp zAI2&0wz|^}d6HnWd)a6AF8kJT;~TB|E-~oaXE$XQ2OJ9Duu$|JL=6%lZgK!XB0>x! zbZ_7uYq^=3Zaa+uyV(!h)`HAE$D^oXZrs2`6e)OJA?u+93Hjq9@&1?sq5$9^EYOC6 z_>hW7^o6aYAb8E`+nv{Ks zP?Pq^TpsU}oBl&#bo&^{3A2pq8% zaWl2%O}k`L;n01%T2uH|i7|*rVE9-Myq>>)`SRD(nNgnqGS?4BL_-|kw_4ON2CZl@ zmfC$Ars+5k2ayVBIrn}Sy?nv5+)I>>`y{~JjetBHA5ULZppQ#6lEcS8AA>}+3ouEf zY88^l>A9#Vs-d2Xe7h_v0IXOp+MEDePN!9;cX6R@Rb8BP zIk$BlrrZKc)6hq$?yO?E;g$4jCx78qz3fhXd6(^141=@7+D>lYcaiVqXm-9Hw(2%*^@{EETh|?eD2rT!cka70*t&-d?^n*c?~U7V5rVtI zjFntK9QKh2xcBl3HsGw65w5*%z5#UJUbtugSYh5vu)V&i#A)1k^-N4GzC9u<%kvX* z&N%=Q$gIjnVH6E&Ko4f+eKVaB=)7DiCQ(QpqRsW90kVF3`gaU>$gO4+W(mlGr&C#* znzO{v7X@>32q zw;JCg4ywCt`t?P+HFX+#T4it&^gfm@*x^Ky#%22Y^m!R&v^4>(J%7W;_ais~sv>gD zPZWVfn0jS+13Q`BdgCC;_z7nq%5wU4P^L+Mxs{?baGcVVV3NhE1=&(<;|+oD=s|-B z6V$tGn*kK?PS2m_`saThwSq(hFjI%F_5AepQcif$wZ=CZKx5LL7id10Q_y^5DeY*%=;u^-xrAv zw`~i>7ByZcEBdAxB$^|PFf)j7cm3-&@Ko}ayE0y!!%t6QCa4;EWl}Q$T_lB489a3R$u=1 zKj!l8|2`dD)mmAXg2Mqn9E0SPgNR65&fZqkW${uqA0wJWk&_U+>E<-;4$@xC=Z+h0 zyi0zAP`W{JMLcf;Zsh)7+T)q6rBYuUCv6+#;@Y=?*Oj;^yI#Dhbff33_Y~MD$X!2p zkM#x8jScNh5cYr7v4OL%`}6)$O{3qGs6enPoYVEQ->tt<=v)`oo0bXgeUVxk_90@r zO$}&pe+CVh5W6Yg-&+Ot9`jrBTw4^uyaNb(D)0iDQHLIZda=97E@(x|<2mI#0#L6o z#d2Qr_($Knf0>4NhvV@uj?pn+>$P;B4)1^b^N$}N62AbmSFw+dF6)iD0-&Zdpi=AF zG(@8~-M#;Oz77+S!#fOz;oW@%hG7~O0E4P10M&KlA9VSLw^wbgVqMl2`fSK|6#y!X zZR2WjLbw1O%>+f{JnpuS0MPXD=LM;&jk_6;0FG0R+*<|BLD6XlKxk;^gfZ>r9C%p; z{{Q?4{@tPYTHxm&9Q|=|PwlqYvvXMaMRb$@LFdAj4~GpbX-IEn&o@e5jWGyvli!jOg-JF06iZx-^#x?=L{ z3eI6OZQHa>?M8^HC+SYmb-p~!mwdcefwq!Zc6;V4F7~E%E2VL%b=Au#(};$PT9wPw zu&ycGyzNe83NHbgVM7Sansru_v2T5It##xe-M2K?VSbuIszT@;Ut6VCw2CpvVYe~W z)+gftlL)lNVK{!ByOvX}MFB{YaU5Rt!tcihaP@3-Z;rX~CX;mkFZn5@=Fc<4AqrP- z>*d?Gujlo(stwAvx?b353d11>(nRSFF-f*#xKUxB*4yZp1d5Ra@K#qX zt-Ce{!k<s;pwh?hbHS5OX-MFGq+uzH>-26ZUd9BvM$7jZW2b|V4Q2Z?Mm4n^y8 zJ|gBM;+=rNco-ksTvCF;GnSqLmaKNV@r+7c*kO<@P(=TTLCf^llDYD--uz|@td3C38KwpIW!f)1a4`gq7}-~>ip&;RqkJMmA88AF??3`2-x zP67miD-;n}Q<#RF!|Gb@?~ZARy?S84P96ILnaNuoNB{3FOxfjEu(|Zys%YHc9JeK4 zeD@PCAK2Gt+yDE;E8ri*i2?q*#-BY`!t37r+fQwkO7gv4=ww#{hQUGX02vrydtv%* z_wc=Na$mazi00aWAP5ClQo3vj5L3|95J3_K;iA=4xIV_i;XYC@Bym))F!ORgoi5Ni zU*ZuJk#Z8goXUJwh)7H@Tjz)x>%lady4)`Z3TVr+2~2d6HWC;)xr$+E$F)VEa-!Zq z(AXT!JNaWAI1DMoL|%koP%E~zY4-A(Z%-riLZ-(m2JI5z#sX!v>IR8UsO|Ff`SHvB z2erhtRvRGHn>(&==k_%c!)u_5aY!X$UBol;kT((JR;fx#q9Jv!hX z%D>!IFb0$X7Xoi5x*0^_?#FOk(Q23_#NaTk+U9S+ef_+?qVxr6+|yKBfdeGvoVb`2 zLyR$HOovjd19C_yh&HUJ=f}(C`Jy7@G{zuXwl10u+Ezs{AoOV*^25X3M9AI2K>%$P zUY>sW>(evp>C>N&y1A~to(R4%Iv|p#YgOy0F^R+2R_`nXCMJo)c>gV6sWzWQ zhKP(Kg%qGv0oeNdZN;&vumR>>CAEY3ePs--J0cD+wf@GxO@bLcQ!~Ku~ z8=zdx8G+FpCQNK_=1oA|Ly$~BTY-${(`lfC03+Flb3FxkZ2;%|@t?=>kj0zYczE~2 zdWIZRd%hHFsEA1e5sL^&w*-IzqBu+`XkAMM++54zOLFvx#sF^$$?vlQmvd_sz!Y*g z{`BW}Q(!Y2Q+P&ZiJ*sEr?JfM_@e2R2?za7gxV7=Y{N|I6-QCpxAamQkGi(MVzx&dDSFh+} zFaO^3f@uGTfgNO9rOvU9Z0}Q?&FK%XK!Vj6qVA6xfV6ikx=MlI=BZWtL6+6oOb` z(zPZX0JTdGQqRE3 zCmF{qX={eP!YC_EjV4ds^Y`jC!;V>Oy1C|IN-YbW;Jf&l5y#>(lVyC4$F%YlN zTgO)IqLA;$iZD!fJRAlAE`I)^3aG|B#a?!P-PGC*th#Po=;^|%a8Ba*4&i*RXr&}= zY;|30JAeE7mv4~6?f6RQd4r-L10lyTfjwm)1PKFlEUi>kNht@Z6>WXGT%MmQWIRq| zfC$5(5QIFTG%O2R*OWqdc=s@l085a_5Y*aWPfx%7{M+*iU4FZ)oysgP6U#xctu1~t zQm36>a@Du(W%Ju-qOWmLdik^4=SBe2RZ^sLY&UpD32x2xrrYMVnB{gD9O7ckBFr$g zR-aZCb`S@Sl%Cq9Ec00p9NUV3qBmkVG1j83)v`(_JD~?jy=dRbEgjwvXt%QxxU0m1 zYU}w+##qc;SsOM30jw3^7{N?z67R~pr&BrO^qdC_L-Ii+GXWLqTA!avUTaGRxV!b` z(+u2#L#s8YEwu#&)Nt?l^tG&aNKg_wM!?6I%R_Os)1Pr<=brHZZjqg8v ziKsog#lHNV$8RK&^KuN zW=UeNQ@p;ry-wmf6T}E$3)FvL*s-TqpQX3|3~vk@wln_jCx3kWVO8S){ITEgA3>wS z;8q=kXn?NkrL@am)B95LAVAXwZxt(aIe-1_%eP`Nzk?hMQPCQb-ku72S!XrWtst$JQtJ8X@p4AuTS>Bv_0?BM3;}>9K!PBMd1|Gs zm5AQNqcTnRc|VmyA#w2gQlKp~fCDfbjyd&dml0W17sdMdx8FWLRgf?9Qkn{F*3RD< z-T#@12V=sEiS+A><=wZ50Z2!GHX8YVs)n(jT;L{~J{W2#y@fLb3OUp>P|h<3GuJj_ zRZQ2ICr@>0fUdy@dRfK+zv7(NYCKwL#)7?=i&o~RI+WWhQB%gZ3doSV(57TP)~4}v z`nCc*ja`oJ)uE+Ul{W+1*if|8*3h)oiaO8ba(7IB{i;i;IE+9{DMvsH7_~Ly5QA>* zsBhWvg1p{8Jk0A8pk}TEP5`|?LccMJ@an1!7+|`ty~~j0?*91c#~<#F zDfBi6sL#JH05}Q&)7Gj(V$RU+Q@nQ*l+wcc+)ilCYMBSU-I)IV@hVq(<~@wPAL?;O`TZGWsm{OSni26GCpB?F!IbnOqmr&~s{?YuJEs&CgOhaJrAdJM0( z>f2Vs>(5_p{+;S!XbK0U5itQo1O~H!IOgsQgWBe&r=sUmg0?9G=(ej4pw5sKd{N_8 z67pe4A=*##Wt__b$S}q@MwI3?Qch#cy|J`bjbnWiQgctC2?R8SXqNTrDJEH2DnOE@ z8&aBar+q_}EiefKrs4!QSFphvS&+R*zoF6!UDxOH*YoM}|L~Yam-Ex-uixV7`2wup z=7y13#B3i@_B!KpkOilswJx7b<5T&zvMdeio9s_XmU2&W@@LoaAjPVCt zE-KJc<#Z_GP;fboRRgRSdhBX3U<$ldqV0(!gMf73S~;~v$+rPicvw1aAzZ!!%@p!J5P<9P280`ky~P zK9)2L8G4yZOMM9ADiHlrMRo-?JH77pVcSf)B9$-Cgm1B+E?$32H|eYh-tQFJQyl7g zzt<1`UV!O(F#v35zKMpN$RXUvZ$gj|gCrzDQ3Yz#87f*U?%^tIrPaG3B*zd?J%sLI zz^q%6w8ysw2f4O&E>3xHH9!KRoGxb+a7aRIE{y4gdRVBygP_B zpsnl05pteLz)ZB$m3Mf88F%_)0p_NTdOAh>(=Z4?6oRB`rQmM7KOS-l#KzG;;U0+J z)+yrNFAFe!`Z!FRNCv2Fr5y-72}8ZCzG79GP`{o^9i|^XAVg+v+8V$?Vm;U6VQ3UW zzW?;_)1Qxr+{x`oDC^Ugco&Wj??y(^wyx(oDu-zMYj6<3*7KK>+}+_Y#8bfeu})AW z5t7|a%3!x8_LuoejNNZU{VF)vD_#TvksFB#-Ws`GN8UD!^=47)3fCL;;d(eWl~>z{ zB)uNWwoyC3KeCAd1b5fpZLHq~C2vcQ1Tc*K>L_uYzuVZ_DskX$Gx8<@xK6g4uaUlK z8XVFqJZ9Fqwk`!Xuo626%mFODL|vNJQkQvcv*}r+#H}!#5D6h79*=`z&Eq&8-ap(= znM8e=r^~zo9AijXR7+W+TtdnzL|Cb_we(rn>}3H#*p>SDPuTV)A@4x_1B*tFH@LIysY!QELByjT^`RZ zXiBPhB{=@-HHiRe2mz{R1>!iQ1T6*m_-+v)pez3cx#nS8;BBVT0Vmn=v+hWf9`y9( zvZ&TM@Og~qb4kF{J2k`R(;l{L!gU|yZ-!I@jM*UhxSlSvAtrTKpn03H6qHieoVdIG z@@*Vuu;yxDkg)OAsP+=Qt1)z0F4HhXlp?LxORKgPNy*ynR1q|Z-E$>j$T1T0E_WOt z(8|JyTDi4OZN-E&2XMu^cXv|=O(ANq;sMMgF~lw^Ob%obA!@GR(f~tk>*ed;em*To z!@Jn|ubwKfW*7kfUMGcZtjH0Jnep{KR`{{=tj^XM4{qdL>)zdP*S)y2x(a&Xgmyz#(*&=mrMX=3CJ-I zDjz<5I^-ZwX||z#1PDOM2;NQ$p7UJo5Z14DLcRly!zBmS)hk$XlGtKQaR@2r_Ya?b z_;47zvA3`o^m58S;NhoFqd>K_Qft`#khdD2!s_|+uV3@~h$)Ixl+*l9n$#o#bj8JA zZ4x&Kc?TiL&D?e}i;3=8pZ}7#sZo#r^NsX z?6r1^p%-iU56*LYk$Bm@Ht*8DwBE4N*!*@{-tby(9$lAsbQqLaK+4s%JH|+ZfW`ZY zNCe>?J1%Cet+lRN0qCMd*A}t>DN7cNIoCT$&*A>~;qLv%yD0?nbsWd}sR9J2oB(Z0 zfmng-D2#QkHI~-b@h!;Ujok)-IXDzeqL{)s0wA0(Pv4%98azZO5rLgdx&rkEI{?Pe z0PAk*Fbk}Vu3xh;9u1|fm&d>U_20g%KOS9@*H$-uD=YKmGe#UnbC|y!2iGSWfG9$Q z`h0GBftcWA4C#7-O@+9-6c$r~870cAG%UEk zn?^8o{}c7~s=u_|Xb-pHZcVc;wK@56Ieq#3`P*~h<9MG`YEi}3aQ>3)z?eYHP`iRG zn*kSZ3*YZl0DUj9>{6GY+fYHs83wpBKp@|Wf5ZTLUrB$@OL%!w@wP^?ZNg{(s2Am2 z)tQ-zg@C3T_@FIT*kVNh_*(0FmYmZtMgm}}4v2OogBQ)iox7uDee%G$OA^J}w5H3NZIAqHsgwk;2O zc{qpJP|q2sBMXz8y9%HM7GjQO+PeLNMHVcJp#>I^LGIqayU)xU*V=q*d*eRN?8noo z=DX*0%?b1T7!fX)c|aqenSn`StRbYF>o5$5<8*g893q=Kx+135`7Yx4={Sj616p0B zZ5s1^l`=1^)!k?l3G+8V@TN?)Gd_M-bh{n+ zZ@z&xlhD^I-sZ@~N>{bd9X@|W0r>p}d)@c0vEB7><1MUwxxyX9yn&%^uH=fd$o5tH zwV2~}+Fs+W7p)e6Ht}XNsDQv;pXXM+NvO7BbZ&HGwgSx%3ifByV=eZ4>k5dbE&#vfp+r!R{ zxOrxKB-9JT8}94muQ&kqyGgbG{G~?3{So>8bv?J-;$&j9m(9)JFk|eB8uf5UDZl|C zZjFNWp}gObAZlZ&4U4s!w4t`T>XRN1oO1%ODf+x+u(^S8&ZCryVsh7Wl(D6CR|yKG@B2_%e%`te@SDw?kR ze39I!X)R?$t*Q+{V2yQyuOWhIc!DIwxKYTpJkEhcDMm;~> z13+6;2m=g&hy)7)3@XF>!!T~Qivf+{fkP9!1}Cn2o$4$*;k14#7!%QfKr)q zS?Gc+5`Y!ypF4qndM7C|d2_ns-VoE3sFWNC+}OI$I&iz{s8$jZ7I;1V+yCp!I{a`@ zZ;ExE&&>^7Zu72w=TTwe@vtp&-m+@C{+~YwbQA#@a!(;ln?b->hL6Pz0i1zv9?R`*ckGWM*4w(5|nwaaR)Z zP52%FK#_TRcb_k~tP-+th(JLe&hu|~e~Qy6+R^&`^&8(dj8{qaEXA@Q$Y?o()WMGEIQ!Y`K=M#wO{U*@mhPUW0F#Iac4FtnS$AV;@V=VdN@6ebW` zf=V2JFmQ;Nfs|C26^MBnS@m*y8UzVi&I^{mJ^lN~!*s|%TU}8<|NH-Z{OxCzak?L; zAMbNI5{Nu4qF$P;l6w}M@&A?mv6`MIE|q;9RJJl^mMV)=_JGb9q@Ge zB;$bRd6pES0PY=l?dKH$++jkP5WLh&>(4 z1gI+Ch47d1{&a#28UO81qKXVSIcK8+#EHWz9u1><|c`%gK?ajxrhpfCnB0cJ{hkia@$zWnu>6P zAMQW-<8Pl&Qx0fFIPL5_cfgufCmDjs)m!UY<|p9+n+OYRSLI~VZ9}lVhED)GMexlT zZfGLC37-MT%dXKBDm|klbC_)+YTRuGY~IrQmxDG}*S;_9b82s*f&YGMzJ`z3)@DN| zl=sG1Vud-#iT1+h-jei3^fCY5FRm&}tXs7YTcff%Ae)5mOUZLBr^he9or*|IP(>P# z4^xWyaG!==AR%CS_u;&98it%hAh#^w4K^>RWt~Hwup&UzS_{t#)!OEBTw_Qf#w^4e z#QUOq?3kTmCy^ACg<_hGg(7O18q@q7k1i`b>hv&`qi}C+bOaCf^NZ^SLw7tA`{AaZioQ^keu@v zxAsroIlsKUOWRBX&0B5O>hkURDHkPTnL-FGILrU;%juUX1__xsD0Dsj_Be+Iy_>5x z;l0I8(kRfwwJ%=6Q^))0>g$e|0MT$j~ediMPR=70(n;dr@}^?A_x`DtFC&PyW%mOKn83cA~q z*|ILRMuhP$2rl!t^;cHcJJw|lLmwf;X573vg~LM{4#PAKhZF98^>;vQoQmZy5Zj39GfWM73zFL!ZEq_&N{##5f-$+mCXa-#s=cIsLz6Fgjcckh1uaJ)~TcRyA5b6bAHDLtP7xzEB0K%{Q2YL2ZSK-8PvSP?W& zV+>3Zx73d3SZKl(gTA@Etrf=5sTDWi#rEtS2vIoPUbB|xUxNUMylW~cuyGH)rxpM} zdohxQT!c8J!$YfcZ|_+%mM7GCMK?m+y1QPvD0lwkW&`Ptz4F1=(J&lrw%lIywmmxlA|lxN>GW9iXdsS^X3Y@!u(sv5LrP(E z5a8yQWxjyM5rDNo*V0EA84c}tDJcR#y|6FCP=dmm!@f1d0hFvEBCs^m(k`;$AMSIE47jNmFHhfQ#Nj?44pXwzsVd4N${~pQzDc5#~w(1xZxA0JYVB7jGcC>7eQenl8c6bcM;Xshd7*2T`QfVZ}2JwMT3k9P^$)q=EY zTh8aF^SoRXI1jaPiuo`bf^e_xz9=b}nH#LBg510T;mzK$?^ZkhXl&-b>#AJGC-$8S z8--GbVXY<&Oj{YZ`| zc^D#b96}6znlS@eT|pcI!ObuLw8a$xmb7S9JQXWTt!4FjGywJMI^`Im z7Hv=nvj|&{EH~YV>tK*{C;X)>_-tjV22`|Z$lXDu?}HU%YEZPbtQC-9oTg!jF$9th zyD_257D{k%U~JY81PTmZ*GoGH9JM+yj5!6uFx)o>0VP6;KB2A4DaC}}<{U+r^LfP` zAVKF-s$oFA>^$ykE!6O+2HzJWk2Evr`5E;(g% zn1>hy@S4Z*6t!Yqiy@AQ1JnzN*7NyvUeD{{T-9o8&zIA;&&bDPnqm}kXlbQ>JAL{3 zbzRP?ZQ#43WjVZSU)G!hvv<`8_a0}fs(F!y$X#*(e7i*`R06P@6c9UEM;Bf)h%MRK zx4lm7*dR{tGlT2}X?yvzw>zwDXp?Ln>2AA=r@3w#Y5tvjPx>wNgTe?uXU$02?Cmyd%WKthO#2oeHCCPuIKgwXr8 zH%{3NM`nOUZ_O14)wZ73^STa`*H%%VpE*Pzj^kY(hWnw6FbTM>I~?<*u6Qe0T(=_f z+tm0!d`QX<|2&0{A3nVsazG*s@t0+8z_L7_k>?n++*6immq@yKHWGH&T;kosY1z^q zR6t58SKm2)1vA^V;ISWy+vr>!kQCoEP840v>WGsFu#>nzvQd`awpkESZ}{Z+ZuQ45 z?V_5X%kQK{ULQNrn%LmBBjm)wTNPS}#V@C)(o9?D+Y9&K1JH7Yq>j)+9f*Uabe!(S z6l609lYR;P#NkDIa6{$-(4gyKI{_q3F$Aa#Q|l5n(PCOwta(O2z~d5gves6^*x`%i zq+_$2O83n!w!gp^wEE@d9kh4v^?Kd!XXw@HTTGT5g>_lUN z!{_zLe*u z^Zac2;p5;*Brxi_EXyyKFON$xuNA+xbo`JH64H4ak#_4fP;ArlC5UbYtbefPy+{;X z!S3WL3?;uQI;zhr|z>e)#D=EzChgHspP?fkRh| z+?v81R<&twVN(Fe&|snW@oKHhx-NB@o2_%5>k6=~$a$RZ$Di&8)fAOMq3<;Y3Q5UZ zD9|RtfwsnItSmzG2jU|PK#AS|z;#y;#t-Ye@b2BiU5o;OhjltE0fc(KK; z!c2sFTZ9`xot@F&sifokbD2|SyIQbR>Fsr0U-fngX6`BV?KR!3Dozq}9KtIl46Ahx zLdhu5W`wIQE`)UdVN<5Mbukofx~5DvS*T z@epF0Ps?>g4oOhCYZFgjr7)mww2wsi$kM5LUDoKlcr5NMgtpC3Oz zPh%W2pjfFc^V|>u2OtbmzUmxSmGHFCr9x8r^wWxw%_xFeKFbzRl$`NIr&oa%353m|`zL_1i(VhF%_&h&vQ+8$H)~ZCl+nrzIH%ky_^m6@_0Ibo9%r1 zdf!N63|h4d$3(H=Iw ztUR^@9kvy?^z{k6wJ3?PDbFe(h0WyTA2H-?yhcrg0GGV<6%WO zz8gtMVi4ZapU^evRlRkBF@VOVTAGIL3PkWg*sTMJP3u@oYxRWIF7xyGRAKA6sHDSj z#QAV+V-{xVI8{?e3@ioErjQUsIy9>VK%nr4sWY4CAC^0rkkEcuJN(?K0ou;V?haf~7I!O>$GrY+8INSaz$qkS^P0P)>qCguYkaV5{`|J8% zKXw$)%?*1FvOP3NAhgTlGslRLyds#Jg2IT98(OajbrIKGH-k1uhypb9nY=dC77PYtXalrFTbo+9&gC7CqYz1Sprw93!e~T}=_*rF6lk zcgH*kz#Q{<%$ehmQxN98dFFa22tynp1ozr%v1P`3dMa^9V@i3V~V)g3C2^7K^o#A@SlEse?I~W*ErSKFdl{&ghC7f@MVRj%elc_buY@004%Z1 z)a_&-YQdP@3pD?6DzwUa;K`Bov39VM1#<5)t01^#pkjNp% z99{xPRqePH1y-2$;mLr(6>Kyhi5u1i2nj*e)m#Fa>RQ^X2Zl{(4;%uaqsvX&yj(Gi zD_FY)x?=po;C|J}d+h@0$r0JBDX{&?%WAQozjcbvMiuS3v8oyZ1m#*HA#4qZssKc; zg~ly7+)8{RY@tV=0s{hz0P4oULyIjWOp`8hNJuf9D`FIN1T?62{L77q&0*b74`!;? z`DG-^@eXBCT+U}nP%BGWTJsQckcay*39CTzc>nP3X@%(g^~3wt*Cll~MPvp+LI6hq zrnMCnU)R&Gs~nCcg-B>_-q4_BKK<>lfBpIx5$_+y44a?Fhjw~w#VI3>gEN`5@UnA8nMAB<|#t!yeum( zr_XxUR@O_1pq*3z*l-*HyDIOL4=%U^!}?SeQAF`nbf!}NYai5Edb zQ)sJ!(g4$)VGS0Eye}$m7WBOpmKCa@_j>A$&}Sc+cC#-o!!<2rprvkRgiv)6k5^5x(E^0%c$r1Aa`VGK;~AAg2bk^qS* zpsnRJW`4o%sQ>l&x+|d zg)g7Ko{!VJ;~*RuuB}TqP>`@?%GP?FfP^G;8?#JIP+O`(L+G)4Xd=D=Vkz{3U|Rt_ zKQ`FqqBSN-)*y!gf-e_E#e7=8`4Dl!<#Ky0K>=J*jT1DVk|53nKcO*Apl--|{&2?f(O#_0r_)@D;l_>-UenVC&tx>J^c! z|Mfnb?FCjbbJg0}ZSGwhl>}yPf^Ms`?QPn_L%?j8gHU${6K&pEPEyUlrJG?gGqh`n zn!Ae=Gm}tAV{KtbNHHnEEN}>yRD*83M-^jtwcX*?&D|&xh?(SI%ePe4`b-+U)^)C{ z>fekbHLa~Ngdt(LyF2_^+Oo8Ce@G&L>00ZGR4HZ%_qziLj9DaNDHj0kpipfLYazDF zw=e(xm%lxg1kOWF8NSvL(;=b+X)Sd9WnHQ?prJ(!NpZ*_bkoDFwNe=__QAch5_ z)RSjefyESH97F3(1>`WWgaD|v764tbp63fF3~3NxfIydWRzTKSA$ds9b1Y3q%+H@6 zzs1}nXIbL;PycI-Lt=xXc|{AZkiAvG0QA)-^zH@*%N8g0gQcrDwU?a7e3R3E8STC+ z?CZ{Y*(o$v?9rGuC}aop^;MR5-D7w|5&LL+DVc9YZ++P-gS)GO0$^-SeTOq&mjPY3 z^Yzwb*I}qG~&hNDzX# zzSKsf3(ItG1tT`v%1;b4^!^~N@6XQ*LqtTOj8#=ti<}_#?oWQ`aRZ1!hTt2ekcrU6 z6uN%wcAfI>$6AVpI7W!*vLu-@YK+?i-wDnzAath>3#zGMJBx+-MjH3bog zKsj?&WI?Tp^{K^G%bf1U_xFdKq+MHvoZz+JrBWAvBZ^(jx56RfrX0Wl2?_zpDfK?e+Q8XMw%R|K7kIY@r8%3?^pY zSaG)_>vnbl9p?jeEfG`iG}~4T+=RH7UN&jg05A|48yOoUT@bD7F4W8UT#Y#cOp#-k z)t9ZVWe7eZNL-*0)wvd=F|5TT5U7}GBLYGX|83)!yP7pMm1%nI}rbCDVKmYY`5XlThoi7DxV3jCB)`cO>Os&k9wJ2bVoZ=+# z1vSRFoPYi8Z@)e-E0*V{iWIH++RC!#p)6G<5?mA&z~T7u9-u)E6EKdl#pE3TVK^M* zVx6vuHa|Z#fYR}fZCTd)c)o-&%2M>BE!GspxP{Yir;6Xcem(x>QjhQNa$pW_Do|5% z)0Th~Q$#@sz3L-fJAjQP^mK1+LI9XONN$0F8o^+L4EIIHQ)?-qoKWWV0?O@fkiZ7E zizEo<>M~`Sjt2mzb9p?}^4rsj>F)Uchaq9EAO490L`!W7%$F5m9LHR`tB1KUbqx&n zj))83TWNS(-Pynv05%YIEp_bG=#7W)GHg2^j`(*O!@hcU3v(fEDta?V_MMX91XsWz zU62&40dN=rrdJ>mA>zJzd3av`m3$}SXvqR)&I_@5`6d6$Jn>`rDThhN>?#2P@ z4@1zGMcG2!&3^OBUeQ_&U=ABuoFd0gz$U<7h!(p*!M67U!Z0J40%j^4D8sy|7Jw0m zI#Fhea9_~JP1CkDt-8%}^eR8aFulWaIo`kf<>%+M;LoRZ zas1cz^!)XVAsy3vI{j_>>CbLlVxKEvszV*KdSuo1Q|a>!{M|5)7=!SMv76W6TmhehXyu!3E(y|6i2!W zn0TAdi>3Qxfn)%Z1>?Lf0HAXDwKglyJW@VAetLNS!!e5Xz)Ia=;Q&K}n}}93MT|*g zG^?mZ7kxjOLXFL2AT1&^-RFUgy{yapR6c(_m-Hcq`Ri{d&N=Wn9OP>#xL5^f7!&1Q z4b%CHgt(?HLX+gS5 zQ*YYS)dcv48~3@zEGSOw3K8DO(?Jl{^7Plg{(8pY@SqY?oWK&yw)mXQ!6Sw`E#(Vx zd_0|sV)~T)JRVs9im*z|u-*&OWxo|>P1O_z4#C`>fBv?B@;_fLU;pR%zxi~By@PYckYTbUcY=>G35_Gyo;@zo{rBypTh9*em$LkD$DtzP?ZVg{PnE)%l+`2 zAAb7teFR6g%78TkE{it~!y%72Q+7(svavcD09puG*7GGFQVKDER3s!}xDkk9G=7?J z`Fi-xpmnZRRGWH0Iv&VzzF?T{j`-Wpk9RSS2MJAw)8i9`=4B0c|N80p@ZoNZ=*C>G zww~8x`}#kBtMSvn{y3dO3<;I1B2uT58wO$m#LPOJvqKV$UGu)zk2gMv^K}y;2JfYd zj(f=7Xnk|gM(R?4SOSvT-Y!NjwFEQpCQ;11^G*UnYwX^$y^YuPwgTmF|2w{W|FPry zh|NE!EZrQNebYav0=_x+2mPOLD+H_)>%XUj3IH-d*QVoKfeuoe57P)jfb7eSK=_qD zS9qaHNDJFu@}2K~g@oJ7KfiY{07Rtme!%_waXEv5b5YE-v~?UtN#JV*?DiIV73^HJ z0t*94UH_x6xa(Z+&xQhpv}jFMt!&tOh za54eKK;1+KKu~C@xbUzp7!e6J*QJYl1^^t>5D!VTEP6tw50^EB?~$ATP`{^>K>kzp z3;>jSinViWAz&yg%*=>iT8a8M{Jvf4b{DM+0C~sCuitTJ(+~*4A(IG)2nB|G-NNa6 zZLHKAhg!S7ToIH_rcq-3?fJK_GxB-OH-8g_0m{dp(qV0<(;290?Yc}<10DR$h09&L zFM5VZm{JHp(^lshm$@tkActWZl8A(1yrfis!_i;LQ5eQCWve=TpQC0k0JT6sDc{$M zIOQmTe8dG5fK|$@bDewZR7cFT@;bbX?5&1t4&d&5ZcD&&|GTfdezr9=0C5O`A?^q- zip4~z>l2zm>{^ZvhvDvcI7HEI{s=)FB19t4v{V2g9-vj*r{mo?=HC%HT zpo;xDZ&f8Hh{}IplwQ%t@BGRfVf*I)sDtePxnpyQ+wMTMIUpQi^v4!NPIfK8Ft9xU zf>YOU@(re97(m|p`&4>u@VlIrj@|Ch(+q5V4t)RdeD|j$5~ME?xAqsj|KE43q5Ic$wILuP26%_n$P`#rl%S@*g%YZ|3OJOs)pz@K*hcH$ z=yq`G9KF{U%rLz2`<9SnYT^F=?l4p>%d%cB1-cYFoxXm$`=?I>D1f28W(je2B8Y@6 z0^N5hlu*{CtPtpT9>|UbE6A^G_AZ0O9HI>Oud{bkvun9rO2hCWL4qJr z2xwC4Nd@VCM4QX%h$-Lwc=s?xfx-oD4ssZ`j<;+C88x6#Ai!C~fi6Wsm5M-;Odw(+ z5(y!v)}Tv$jzF2uxP!pg6@vTh<`e-sOylu*pv!Yb`I_=$U(B!k6X}n+Kd6_{y#1du ztjjoO}-RRB3mIS05y5g}d2t=BocgG0tu>sqQN?N}E_dV&a4 zLkjCJPmibB!*GtDQV{8OUd#Yw`Z)aXr)B>6FTczvb)EADL#YBN>-6Gc#Sr8p9Q+LM zbWAy7^`h(LS=aSEui!k6$Gb7708P0AIdLe|=A>#Mr2KF<4VGMD;w!7Kn_&x#QNiTI z#1Iffh6xRrreO#s6tPazvT$ja5^F6A33)^*YpaFh(oZK$LTqTEH8qYO3+C3abPpy9 zv=2dJ?IU&dwRS5~Vg^DS7+@0VnzCq5kHCUdo1+*Y$YVYvArT< zvH_w5agZRu(bQF5MtH{ux1`4QnX>=>54NiBB{OPn3;6Y&Pdj9%LdZv38iM-zt z8wo&&F{A{jB*lm{j3l~V&H?dtcG0QAz2v#k+Z}Ky;H|q~GKVzXuTWkfx-8lP7;Md9 zYr8z3E{E}DB>KK>yBlNI?uLFaw|NFhw#UTQ7-HZzv3<0_EwshVm{H$hB+q5j4wu=4c zxvZ_#vdm{lyT3=w`a;gk9D(D{6!fjESqm@C@hSknt-S(NjE zIZj^zozktm3t8Z1VX*UzCN80I;XT5kig+ihM>hMpqx%+1cya24$@UE z3~@Mqe1D%JS`FirvjB>Pu&X7*N?9O}lIEqRAqw}GW~^EiBuoSb(?%b>9onxBzW(}l z31aM2&0D8aVAIgs#cX>HwFx%$cR;U`soN;$2ubl()RxEm>q4(n6#wUD1d_4PYCr)=H^S5*woxVBl_$P%4n)zzs!2@*#Y9NFfEl)w#pM+}mxmlUxD- zv!zr`EX2+ty-p4WR0SLoGuqZJv0a_k)_}Yg98j@BYXK6*8W08^KYjf0aljcxF<}~$ zFi8(@VYClZVABzFf28=eKt81Aulw>Qn-vs5>t9jNl z?0&0zxmmGX)^(jvGk^!>+}xF5fVwp`+xrg#kPj9UCq&_C=mX3R2_iQ-mc|S>cGFhQ zr|0rRYpJi^e%9_vH9;>D1^{ThOs%PQIq#lk38a<#VV+g%!^kt{$R+ zH|Nbx_z{L%@5bC{uYf5iNWd@*DIm0Dic&65sEALfz<`+2wx)6J*04E-4(}_pfx{%y zzCL=lrk5yDI*U)i<}h_=trd_a7n6?NI)uQG4RS^)z_ovv6OEFhtf)~Kr?1cJWiHd@ zTz^VYpeR5djvs&eaLh6431LV92CS8xT>IOFs$pHu^K)pqOvS(+k%42i-m2#Rbir`VHNRwY>a#3);VX zyhMwy62cw(6oz|W@d)JHEqONV_q!R~Kfc`Cqqpz=qfh+@4}1Il+tddDkcfoTTGMxC zs#>eBr*AI{-nHG4635kXQ19J7@`=dkB)crBN z)&x+DDdzjK9KN2G3V-?qN!V`~JEG)(gcMmSriUa!5(QcQq7Z@&-wPYA`C`8(zrqU+ z5~N|gYw6X7DLs<~I)L!KEARQt-h1 zP(Xe^za+*p08z;)$1Qrw({Oh$@@C+?=~M)V2DG&e65~E4xL2vXi2+PE72NGu0rpnX zplGczfG_|NNQZRz_~GH*h>UiKBgXer4vFpi73DuzDX!oq_*G*ozYdyzf3h6``hJMm zgX-S_-gf;vb;ITS?eu(}X8?~j7Bf|}fG#TC4}}5Y2H|?~HtzmT*K6+95%dnCms34+inw)ErjYaa@a}kw@82B{kr@K0yF(6Hu|7Y)yhUPc zy;d9iSDO|mK|7rha*_Z5l|X90SbzBRX2F)cf{}*dC<4_i@7ZZ@2eD38=s)YD^`*t*=8%3tM4PVXj`F=Yz_}2G)=UHnwW{Sl z0jjPIXiGp~b89k4jDlE$c6bo3(q@EZIUlAdRfR=TVCF7z&*egfwOW1TLe1D~) z=nkRU%X|P6xDf&n^H`5xCCY|~K?Z>uTF615O*L+2K`+gK#;$nL??nLEf&t-veLtRc zy`YFxg>Vc>*mog_7x;px`{76@Z+XX|nR-Ev84`wruY%T!XsaNJEDSnAr{kEZtk0K% z`#elT=Sf^8&sA03y5Nn2Awsf2n}yW{kO-3Q1fhUZsEXzQvmen)+zw z4h0k7ZVq#GF!xf~jboYm4jJ`&gAoXhs%EDz&tFe-U4c+ky{Z;M6o;vGsS?%h$|8W5 zT7XDU1qazvp^l|^@0JB%&{Ed(`T1!+oh7qtE2=;>fCt18hae)Wx3B=?bQzYdPz*5K zh{O2dpBKb(S&ahasjeQHUCx)f?h7X?2~=3(s0!#=8S7fsRWT^gkPzY!b7TgwgyTfI zwuIuKTtZU;BnA;NVkWt!GQCskDk=emG2>#SUq65TMbd{4fti`X0g`b3P1mrwN$8qO zhNQ7(KK}Ue{e2q7i1AQ2{43k(=c)$2vgDTn2JI;~Sa4pWHC zaYOw8XU=yEBDf@BIE}~qyU8)v6}{*QG=oUyagqd-!};#`aCd)v7?O}D?9~)5HI@BaFQta-IdwfVtVXHj9&L>{BsTXAF?KAz-}e-qlUyQdUF7-nf-&tJx2Oc_g|Y>GHmpa2)7R?2;k{(vplW`vldKra)5Hvx2= zO9es*>GxtX)WL0Mz#s_Ry(ER)NI)T^gB}hdp+Rc}bdUrsKpyU<{SkJF58pC|E1RW< z9cZydRi!txDFYN?A_SLGVIE*X!BIrWjjK0!A6Sm2 zt<+_mFC`sL+dEUvcU8PQ7sHN$z-yXl6YV+&VDhwMo zNS%b#J86mmvvN7l2*6s+x=Q-i7bAO1FOx#lTUp9_InU?QQykg6)wQyAbtSX_VG$0q zEln{_Q_j+<@3M!*>Hfp1mUd~~E^xiC5vrH6Of_5~Fg5|G_tv#lto3j;CFxpABAgQU zXhMEG{rAKu0kCyl6^;-&WDydD^f0l<$qq{l>P2YZGKTZQ_48l;?UARv#cKj&3HmU> zfm8sX$|?(SKEj5d{`u1bhau%51%RR&fj9$3@0W|5qd*NTL}aEr6yvpB9FkM5>#u)Z zr@Qrtdq@g5y94F-fLF{16<9pH`*eRl=sZ6;K(GSHaQJ`~(->kPFUN9!9LK|uSzrMq zP_tUswxwjDNSqD_@bOPS9Dr3tYRj=L86Jsbd)`E{X;_~Hi z8Tb97uilLMYI1CdTrYZTmGJB7|7bSsN8i(K{MLIH4+2F-+qF?{%ipwP?Aw;Z=rd&V zDC;9YAjAYwhCz%#;^qYBE&%$S>vD80PX+=Uu&__n@8h<;KE@`mMAg(hSf_Pusm#kt zA~z4@#j+dy(zlB0OM330Ef-R9abhFh!UGW%kQYs5;fhrO6{xEu7KtEcv6fp272bSR zt-#YXMnG~?vk(j*VkUvmX4NFGB*69+{?!HzP}0zz=U-14@9z%+1wR+m21G@~<+saa z(Ywubuy<=RgSw*TGlq4|6}3IB(1_uX_0_(&zfq!%;9>v?NDNFH`Pn4IVVD?^p`|$h zNhksg$K#ZGJ*V50>;BZSHO*}MUnl!^7CUN=V&wuY1OPEc;r>y}jxa-sSuQ+7 zO<^q{4=jPaL0U8M(y<-WQp>u`rKU0FC4|t+k}*OA7&8MgPWR(D@3F&^JDU}g+L3ZdOk0!W7F0@amy9IYW8|NQ444iJePg9tN;iUtOg zLR*ce6?Fxe1L4K_Kvl~Lc?^-4^|#-agNE!fbS`Q?nuUB6tWUE}5a=)--yh$J@zak###L2UsI|PLMxZEQ zGnObpg!c{W3b4IBbaO1Dx17n1!qOY_m_&B9E=FIUUbH_Hvai{|%?^g&cjLT0Lf>HD z2K_{og}%oo`Hvs}KbPM2(DOglvZP{4fV+RcNb>z}+TqndICk?w+(5hGV5tD^*1Y!W zy&8liGU6NHS?gJGUJhBn+GS)(xr;l?4gL1U$ovoPnIr^@sGol>%du zr8-jjj=K*4oR&dL3aE1h>Kxbg?>?68qTteij==!LLLnxO9oN6LBnrnd<^R}Ymo2bU zNka}mU8IG(?H-x;HacSZhmqUMg>py=EbZwei#71N?YlXSIRNuzUJ=pdNcMW3ikexs zvA%99%!ELIL1zF>5Db|l3M@F2t0^Q21yglv+O*Eo?l0FpUL_48NB|%q=a_RQ04#!{ z0IVqp>E`nH(D(ayO#SkH=Lr3ej?EF}S_D+>S!KuIx{hrtPLW977R;?tbZFDHJ)O>r z-7W~tYb9e20x*-gc}2e;)mk^EnC|!Xy%BBIT5AmeE|<$;fNQIL=2SqiHr4a8Jg>D% zTT5A6Rc@Q;rBy{DiFq0?{Q{GC z;`9e|)Qe%12yV|ONCimJknk$%$pFs)N2sR5G)~74wXA*L3lftY|9lLs&Y+NjsO7^U z#6&k00O)JV0p;N!!}0ySR0SLtz{yb~0NHjMdRu?~gB!3O>HYpGGw5oZ%>33B?k)B*1(_gF4D6J&_>xZ9D7O z&P&}#05nAxi6Cr@KCVqf7)7nd4IE@}#I^S#V8dkBgr24s-I$a+m%zg>DXpUNO1*w3HLDd_4*JTTHQes|7+`z#hcCBZ<(LL~~;{fP_MC zrp&@{L-O=r@;YBm>jDu@14>ymr1CgEyi0!ZmN!jDuyA(^xt3QIFzuSbAQG+f+9FU? zaS=fON+B3`e_-uB3LrsX22|P5b_Wdr;Fsitn|b6QmyqzA0ti9p;n$x-Eb=S?c)~cw z`w#CTg~401P0QU|bsh!^Bh(teOs)ht6U*eau4~BoE_Q52I6yBIKqL_{5X{>d=jFK_ z|MltHBVxY)@ooz9=^V$0ksOGU*xRgAD1cQcM-es)Y46hTK7(9gt~-y1dM%7PU>De6 zFnZZS3~=vy6uvQ}_M=0IJq9Lq*LLOoh%hWDgxMe<3ZSG|46bh6-R672!GN+Dqny5c z{olUUTIN{C^{xO-$q zW)=!Sch8*N;U2zFg#7=%g0JMu${z0S%ya{&s?3UvaCf_?8XwF(GO|$Uo;@O@i2!wr z^ze(hnO?pN*eQwwQ2+$m!bkaO0hc8LGFbZX&*ywU33pK0RuWJMcl9;Cr@=enIqUj5 z{xtpV71Pgu`M*7eX+$x2(Ziqr%j+-7-XV)&Ivk#k)3SD1Y$poU)`$dh2cWVtTzAz% zUFX;53({qU8;(Eks70wf@S$I{q)n1lTCphF^WxwnJx?-C;r{;N z{xCRjJOE4>+|z$jc!;=#<8U7YuxVt&p4b@OSE#zNc97<_LNnAlT5mq)U=D1?fG8cqWFX?fW?t)x(BGxQqOJ}K+ukD^M+3N zbn)rq5pzu*nrdbMW#VXnYIT7;6I#`__r0$t-k_ij2Pwpx7@ZHJUn`JRvcsJi6c8WA zdz}e*t&6{J!JG=TSwksnaXtuu6@I(RidIck!CmTf7i9!wE2Q zwIFBhQ4Yjwp@uLGqKS#3P$Lj^a8zr62}D@|)2>tobOCyv6LV7Dy|>bFdr2%$QOq6P5jRI{v>Ywp)jCtJGj15wr%l zwweC*t9+m7wcT2lmJayym zwu5Qb7i?)MWu;$xt81c07*vgD{K*wofT7dF{0Y#yH#`roo{?5WqyZ zFSV2kIKkp$2*Ck11}n7yvd5FeUR|uv22kJ#H%+EiUe&M9pMSx@fN9X`%wWQv(0bl* z)qZW?0$29=&O6AvzihHYF7}$nwgA2@zSOJ}#;&t`J4O4Zl={9CKx|tng}3HPUylI5 zF^Hub)9Ox6LCK}|@+$2B$L+vue6>qAy46;)x39y_E4-d-qu;;V_V)P=rng<`ZBNm6 zlL(F*L4|m$ulG*DZUk>_Q%BzMFoHH0$>*aE~6gL!X?r>TFDaEYRtI*mX_JSMser%`kI5c{2 zU+XJM(F%o^gRB7=;}oEZ+8Q=AQ8P4_t8F*!R)@OzH8O`V-G{KHr9eSSsfuhF`Gz&* zrVQJK)XgBa%^hy&!m!u#CzddZqCor{5V{VG0oD1An&qZdwf2xw!F^pJQ?mv&2Llru zi*In|GC?(wFTzcYi2y<~khMmxwb~ml3aHjxsieg@zhIE=XC&eTm6)1YrPgsOjW=-E zm9X9cKWu{Dgg1&Y0o1XT-o;m$?z6 z!BWi{3K`UDZM+(Qn$D9uh;zbF1qZ8Y23FRZb15)wW;xf^1&Iw?6hi`WfDt<@U=|mg zm$EEbVOnzyQ$=3V>&XgAMQ_mN47jSQ=_oGr>MC;Ut7fd4mMI4S6#N7o?t^QlzN;k5 z{uUX~%mu4z2w7{3G9Doxe>#p4hAdr_JBAP|T8)VAZWtVzs@cBgI@L9qAEKA;HvYap zGDM{NJK*C_A0{8Y2*cnR;zK|#tH1Jf@(I9HQ>j(JEFvsEFKgi@q2DVBF?p@?d`KQ< zo1_l_Q!NQ2lfWGw{9`Q-VK1cT1$bdLPB&qX5;UE`?tdseE&~J7X|Es6Oj)! z&2z2*JTN-cQfK|L#vzC>ATiBfPtVU6j41DpR8v}qtO-n8}vuN@-S!}j zuHAD6F>^T1DWgEka0soyR=^P9Aw&#VYPGyIt2WdK&;eSyvBJrN2#Cp5Xf0J5K(@oy z0JLTzN<=+d1xl@|oR$+13xW&)_VuEnV=+wCF~H<%FnK@q2>gxL?#*rB@1eoIRlRIC zzxfaFTl;Ik)KQvSOnUPp0#u+TE!{L%t12!jm%PkR_aPp3fh(HKa%~Wib)7G325L3c zzDDpn)luONq3IVO&WqqQj6dYTnkw!id!&~aT(ndG-VcHk6qwI7z4DmD|p>ZOAY{o{oyYkd7MVZR(jcomihCqfZ*Xs4OMe?S}TJ= zLO_@_XaNFSBrgKMT56@J0gY5a47+)I#qDm>IlJP=)8%qebDV#C+^q<2X08=;=%xGb zV-0>cjM3Cg0kL;`)Y~KcN6qcOzvzGGXB|kyqbsGTXJRx%PI(g<-rVrsbfTLQ>&CHY zO>cz6Ix&L{qK3AWH?6g9*G@OgWrrU5Ftxq}GJ4&L_zG&-&X`(h4ZPVa_ETzaX`8}X zuS=TfE;+cPd~R<=Umnd|Q`na9_2}ex`)!wC0}=0rnIQfKblbqu99FYtT|aLv(As59 zJTMgD71iylvb9>Q0ur3u#eumQgt%8;_5G&b>4)FcwE%0{WTb-}1th`@akZ3GvZBU_ zK~PU=y@ZL!=sk&(`}F0@r{_}Q)DKa5A$1jA&T+9#p^m=4-U8R%zH4MMAcCQB{(2lP zKwZ7~;a(#Gj-xB4nS9*u7d6;!Fd)1=0hUdKm5AZOaJX9y;=6Bx=6Nl>kl9GFQ~4R) z-JyXLYJeHEZCo|(hb2%GkvL8+oU|8}?(Q?H=04ph#9{D4W>zeNgs2fQw{5yK?I;T; z&4bZVsWH|HSglSCC@h|RkMtXaApko8=A)iReTojtkJ1sklHwOR}y2QVy(J3c)fB3mxtIyMrBABVLmAT<+X1rGOX-4Qy} z*3;)@%J(G;zz*a#Ng)E0Bt=cN3{#vAAldXs2qY}FTv|XifPG|xKR*5R<3nVDG!iGQ zls}&rpK%DS^isT)`Jz1DM?y0;*~_FkmEeO2`TOc3u@kWKH{R1)b$xxl$noGkY6cKP z3Rwa~2m%ik^?)aIp;%KhRMpZzjW|O(s#2R;Q3y+R&i&i3k^uD0cUt!k^-7X7WacRhbb+eP7;-O9BXU;?HaG6hqYBzgzQ-;QIqC)HV6 zO z;^NRRQ6vMXwd}?Hy*y>;cz85x+)TOw&h}tsuXpw{^xoZ>^o_{*I67SbIK(mB-yg?8 zh)u0(7ojk@c`cjPVgRc5@J!qsyuL}h)TTf%cfpp?}foW8{Z1G#IU}4Y$5;l?vb@k!uT{?kv~M|u%bNIp*r#5Ai)D#3yLe3aEgzo(=j?!1!5q! z+MxOD7+~=<6fUgAF0bhr8aW7a=TkAPRV^v4mt{!}G}Zz+JRPHxW||8^jm{T!!@#Jm zh$z~ER`33|)~sy}AT6&im${U~Bp^4E13D#%nL(-4@^Vfd&O7XtJOEAWno6x})dq?V zBE#Y1pMU!4;ShqW#NGC3{q5^(NWJ3Ufcf(E`O~xF>4y#L%$q`2Nd@92N9>0WaVX9D zLiIkUsi#+ua74`+)s-D?Nq~Yqk@c>3Yo@I>vsO_xH4=DJXhns>OtmSR-}_mn7p;h= zmnB&vhb75?4pM1*g??+Fbsx0rgyP?ABR3_;_bJM4m+S3!`v-2t&-T(<|3mv-O|Gx= zMjK3l-@p^wzGq;d!35N|J%x9{(WdRc*`W2OXni@>zR}#iS_T1#AZ_=W-}-1fOyqX7 zR>5@L#JUzE%x<>8cZSRMw^{W$Q}F*w$8BGRZq7HZNHob zGi~3~;vo>Rbc46vmwBIifdLk26@W0gAu_C}ZsoTq0<9HkR)JJIf61u<{{C=xFWvJG z)Wu}^EhE}*&6SY(?&datI99mBwquH(TZ5@;tw{k?K&_rUghxM)PUZE>^C=6$5Nn4x zC;-t_mRBeB(9sE4*w zyl9xky6=%*g;}jW zE@3|XGEIQuKE}~ISJ7InfQffLIBzLSYNykR2$Fv|QFapDsy(F;-I_NAH@p zs`+9Zr!ZaS!V;EN7K;tWSZd9wG!tdOYSB7h7C!b;JO06yUMoX754`Dx5*W@D02IGqPN1D15|CtHTHvR6;I9k@0Mp9=nX}4`$bon z3h>sl{KK;A%|1fc|NY^}fTc#v!Vd4;c$#t*Uc~SRhI96Jn*SaA*<~kx z7fRTcDKk37G6c&@%G)tP@GTQkE+ixL^4dy;BS;v1;Wq%~ch6}*>DwH$x23HC@p|=I zj2W=1wkG6KYpH-G0A+;3+RjUXh`-U)G%%p+#XGMR`?mXsV-KnL=7CYT|7p!QvGZ6@ zH45CEaVc5x&>(b+n!Wx^&jSgJ-ofUETD77JmkkVP{^q9Ko>{G0s{u&Hy&?Vk^JWp} zWSoZuVZ56TvBn(OO=CR9I8L2M)j!G7>q6J-YFcxufTRd?Px#(&AaPL$K(DcGItK=Y zww%(MOi>_kaR|fH(^FOn(>+@P*ilzS{2F46gjU;H0p+aPx=zaemi*x)R0fo~i}g41 zr)ITx8A1nH8VqcDjbZ+N>l%1x*R^@CT)#mH&{XC*<)t(27;%5B-iOlL^%9P%n$&b_ zxC%QLp>!AmLq*-Y_s+JpyBPpsKMW$H$8yq1rs$4@rsUkzbc%i?pp|?8BLP<0fOXwk zWPd&m4`cM5eKc!zegvFP`CL_BzpB5B!_D_Lv#Mp8m-)OT03(p{1VGgxmvvr&I6ls& zrGLIEZwjNew(DN4wE(cRz}QFlJiL#EbDh&F2!m{M2LKf5^746wAZal;XMo7~c)UME z&piTwYMH;DpP!*4ibtvI>*r6;FY8Kfsem+eYAXQMqT_HE8~}D+zy|+qkKT{dh`cTf zN}3fOK6>t-(pr2s>eyuBwP>%aUKbkzY%UpqCMaZzg|@qy*Go1_%a%Zv(r=S0BFX=G z+V&pHlJG5U_jU{X$J6A!Vr~1(puPS!>n2Zkfr z^Uz(x6U5F(<2tRY93DO%M+_yP-j8?jF!>PP%w9#Dchnj&3y3SwOzT>TqPYk#n5kwp z1%)^SFQ^+Ho_BIxTMRlc>!O{wN&|5B^rs&$CpX<6P!gPTf#HzmbC~X%7X@+x;8Io< zx&qqXl@eOFvAlLvt%EZ+-?iI^W3`q&K{L}X1=m_{vT%0_`FqX&PH5@2cEmzVH<&MO z0!?Wyxm;>(06eOT0MhfXcfN?U;)#MB@&z3P;S@6XfMI~@(|u$#rMjDNG%!~c09Mpg zg&95s;bV}+X*&iVCe+fj%A_743NUBXr)d@x12FvO`OA8))iLMe^!j)=I-t6mvyOLZ zY9f06<*U|t#=VTC7lgPsH0n;1?*?>ImV&hUibgq?nqE^o{CQ2!GYDpoI6e$sV~UpR z){)UAH<>c9;MIkRhGAQRs87BSq{Tz{`1Ckd-EFt5)%p3Ce?KMX=2{HZ1H-x=GiY1N z*Xuxq)HpzU{#v9>!a zY?&3ew|8i(b7HGpf}ve(ss$(fMs%{}1 zLCmPHm&*w;#u6si_Q%|5{|XqIHI!U37!v$OGgL-D)prT-RX)eShSq*Br?YXRh=JBn zw1L`fj>-FlQD1L~)eOO*Y2LwVY(j8=V2rMYcz?LeGqj|6@>_eKNthW7{iY?>tcU4pArEeEV>kmfAqnMY64KeRKkZMPb{< z_XofhMe9L+a9|b^;v2v>6QilNQfkk!nBn}`6wB)`Y!5$tni(PGdz=XzM};4PbI?va_hS{qQXo?CFof6t}*)3N|9UR`Ko4$j*AxZ3Ezd zT7Mn;rn8-#z0D)te%6q`^7I9M}K(5|9uC#nMuV~I~SKkkL13B%! za{Cs>U?s7=%-o>OV2ylh#v7`@YNx`pGC?+5R=ZwrCsj9UfTKoq;i>>ss8OskH?W6+ zrb7f&wOmjGh^ad^UZK$YiX(u^jUAO@$pZU~n5m5ky|KsjV67nqJS#su_sM!H;1$BBp!N){t{*i0lN4A}iE;Ck-iA zjYPdBVq5>zHpohsn&)rc(bmN|>H79{!D-EFs>UQD+RUn=nSgrDMmJVe+i8%uWtq1? zdxLnrdyjdB=Ux9LzwiX=m!MnudC0%~3jDWmvhZM6;)(tJLptkrUdQ-$cH z)M_=LRb&xQOfZND^KLWxe)Q!SJ6=+Elv7toVaRPq@0*ukOTpg#?d=|Ct?4)4cy*H1 z2H8Mx``YS=ow(Mq4OS}w5|QDUkeDH^QBw#Lt6ulc*d?f1wMqKcXh2hL+F;Gtbv#JB z0irZ=TRtZQLfAT@AoLrJYZ@#_UHFw?Os&?-=l}ly`ET?8z0PM1Pe1+X_y9DmRjtB} zaUga^kO@V<%yKv$$h$2c-9g>lSwo)TI&)tQ;7;6beRoqpOI2ud!D@vBY|O8tBh<6OsPGtplgB5p+ zEN#7`B>nUR3TBcCCHKr=7uym5D)(!do^_rxjt82eXv!CgU!V2ipMH$C{DKKnNv|(0 zlY^H*kn=fFv<`+%;=Js&1Z(JKtj$DN1hh*Is=~P@EaC3Q^!oq)`WYG7&){J_uWn$Z zuXcBcqSe5fwi!*3wuNmyl!|Jm@WJbH@%IzE*ErsPcr8-Dj_kR6+ZYoGATXrpT;bX}6xbb9@IIV}rvoq=Jv8%&RPrKa|3NiLs_ z|LLEOzP{iw>t_s)kHhex{`#xRc$|bCYBMMc7*y3Zq2qniyNXcvh_Pc&n?ab(OjT34 zyrzU9_z@t6XKdCjfa*>ifvG}zRlv}!RfU)%CN>3$2zlShe#Qng+bn1qayc8qFxaPu|NUQ1|MOo@)eVP_KRt{! z%@=xdx@3r8)yqqBC<*Y3!bk4`19j(XbvmY18rYAa<@j_yz5d&I#?znw{HMv)%MARx zuIu{sa>?20I)D8f$1q6#HC_Jqp9j(Oy3Vzk){I(}55xV#fCQh{2I%?o^WQ$7@_+v4 zfBEPLL#x_AXlC{6zkQkhAGoaN;rVOA@qWbLGVA$#iVO$R*RQw>ApQCa9(@>aE=XTK zoz_x)^h3;_p8^GGmfa9F&9D4V;Rl!k&Y%zyVSzPJ69QAS=EBP3KgZ{Jw#O>AmSwKn zY6S`|mI4nC7;FFeQ^El?pc^ zXHzXmYM;mZ!FjY=2gfYL*UW2c9bc0LW%bfMZ2ENV{}(U>&03e}C1%1k5o*?~*`~A# zY=8>^HlAvOwxR}n3-IYPx|Zgha{^*!CvyGLZ$}RW_;-5m`>?$O^9K!tc2f=gUmx!a zGc~WT^9A@6@`@5)WGxJ9UADUyG{MrKpl|?S>DyfRKjcv>3ZT_m8f8-@e}L;v71xOd z8wTOZJ_UbseXL%G3fBOv)QIK#*Pk4*b9*e($3N`a-kj)Ap{<&ssX#W@v{GuR3OF1F zna~yG)}$rRmySl<&vFzQ`U+VV1our9_;5ov!_Jigv2jlTv;no0G|#y}vDmaG;5(DcwB)qpaznV) z)*#`Q+w{#)SV_6DfWy>!8ZNhUeq;3l-Nir_sO3^HxXZb|9YrC4D$42Y?|d1y3tduG zSP-m+Tt&71fqFR56YMt#+PAo)ompX3OYZ%l@4vy{9k#cfn7Hjl@4XrS{)-fl@ot{I zf)PO+xtFv0$Qh_wk3#^!)`9!CfHIWqzNvM!+Dt(#jx`CIR)rg}%Kqt1PBU~}E13rXa^vCX%McF7$pO$(+v$=4O|M)pmt_H*@ZmVc&i}qC^|U6=j|2JO zo8+a=r#S(a%c?RwmZRpEHDHC7R2!p~%n<<6`T6tYdO(=g`L(|5g_rZ145%-^{qp&& z*j9;VJ=rj}QWOpd$haN4EtUG?5eegjxr|tLf zhgwPShhKNqYY_Zyi~9fPxVecNkFHmf1e|Ko)=t#k zYwGt$#Q1$fZ66G1m*}M)?h;9^>*?$BQt-k6!p!wGzopRAX7a^^+9Z7NMGI{ZE9$ohNYZ}mk_j|iabMsx@Mx`WMNgpyNK*wvjhnGS zZsQ*{bK$;}oC|sG(|q$;%ETF}`SSVn;pun?#=NZ)KISlJUsLij!;>RMg;Suas#+7PB^y%MzSrrEe6A3C*8HZ%nSw9MyE=VTo6(tx7Y2zh>;*Ti0& z5nKpU9LDHbz=)Na=dJisSHJbSc8bCFP1d^DJ%m{Rxq*;wpSv-hVgXAOJExH zV&nI*B(zmd_HSFIom?HxAB zHieO;8H9;N{x04QxZQ_3o{RgD>Uv%bj2C}6Od6Q6eqFwt&e?<=fC8j>E@?g$oJM3p z^`);pa8K7D;5F7(^XLh0RGD|ttbr6@y@ebm&yZe!{b4$|c=)_%UJ|_c!A^DgQz>2) z2C!_v6KohF;0j*ssa(!^0fGc!ps7_+ZLN3fx?W8!s?dBnJ^yw(Bd&6G!w;q7THMY! z0GOMW^>X^(zK1%@U^GQpPtPZv9`A=>P$7!6kqwCi9uS6E z1B7I75$DVDx;7f7xSp_>scN;F0jW9Ui=N`$@g6m=3%~(oMNw8jBuFh)++2ORq^ViE zQ7fRXj7eRCwgbHwJC*Tm7VPhhX-R9TfD3->i~VtJ<;wj6sh>^ zZj4$$kx|ou)qU(J91%0)nk5Aaa;$`UIquyyU?IaC+}Bjtw+y$y`O`;ci0a zb4Vv^*Q8Hs{(o| z&nE}mu>oa1ze0NcqoxYI{EwGQ@sxl0>!&J%FHm*Z>CFnHRpGsN<7)!WpA=gHtAv z=zLIu_xF7KaEyULXoQB%Us(IQF3RG&Lx$9Z;v^n>Sx|+gkI?puL;f zZ|XPun{DV3*dKW`k%P9Ty+O$aa6`-Mk`qKY$Pj`rD9Zxh;DkM3ZI1~mII<6~rP>CW z)eR%?_hsU?$I&~V>&q{nKmAu=xO>S!1_q1FEZCd$eckSrWdVU3X(uD}maaFbQLR-` zZnw3TswyDj=#&-0!PV*n zDW8_S=2C%YohJvtQeGA0A6#uHsKESbUeiMkLBz>*QF~vT+H5}FuB3HntAmIHFN3E~ z=TeFnA0*ZD`Tsgag;wn}%k4pH+ZJ-&piK+{tgR&h2LD_F@-nM~W`H3*^C>l@T+!y| zFTZ|yT^R#PTW^Ai4FL%<)Uv$%_RI4D1%OpmRRLU#6c&g zWA@_RVBl65FoL4R>Kq`_gJ5ya4Gw7O_1El&hr8#`fF;#ZQ(n7jH({Blr&1ltWrdfP zmx^$Drj&!2?71)j?pi$tcUcX(2^il{mc5x_S~V|CLEi7BCi***TsFPn zjpoiwosqb!ShsEq!v?T&cNS9#aClhf@^}~z2hq#AR^PG#HL zM1*0|C8`PoZ5F~kb0tmWNl;bIbFFHolF(3!7Kz94Zwlz?ulZpVT_1SxLJHIfFgc7R zvcRmU0ov60ad6W?s{>Yqv0~t9nt~T84g7cyKi-8HhQR@?*6Ox|xuZt|;KYeq9k8r5 zB8-ps!{8dkS1j^+81@&jl{6@@o?q)}94GHUgqBteFoBg?Yel*I+v%hd)2HXt;y<9) zQr=$cR#COOdx=Ptg^0i+aKiyQzr^6B)x6ePC1r#lhvRU6h@LM6!X&bDmbO_?p;jDo z_b+${8_{Of8HlZEXN31Ot`zUbuI2!JsRv>}D3-_C1N2nV7-!rjxKE zE_bdp?r)L1$+D-T5tPT5V2nGbx&cL7`8bT zY*GC`%wYZlzrzdd8LrYb&R_`QU2yKT==(C|%_Yr{;Kcdw{_8&+O;h^v z+rOOw{jdD=@u$bTD3qUHPp4E5h|_baNnN> z-z>H<<-T*)TKZu>N;;Lb&?Q z>pDz8Jamt~Yj-7t>3BXY%+Uc_)eIEJu>@*5V5ErX+~9#?&>>QY<1{+X65m*^{YXqI z(mL9ZeCSdRKK|1`{dn)FDG;8#p8qzEqvo-9X3YSUOHRMM%=Zizhr>}fN=q&C0hV7k z!S~Ivz|JR+f!dAKh@WT(NRr-Wm;?aJtLHpgS}STTm@GkPic=i+SW&eO_ivA*)T|(( z+qT$kldL=Y7|a;0mYQ?H1ptdcbieEl$NLayhYut!i9be}usKxKUX3v}K*eNy zsPS0p$A0fC5C`;KPk2=+t^!pxc?btYGrxgl?X)S-7f(L*uJGjjw<3_yWDhNGrB5}UY+D1-ma=i#bGb_vMZ=Xu};c|hg3QBP>7Gkc_71ykvw34(2W#=50mowntvxutI zq+Rb@h^@|6E*v1ZV92Mus>q-&+&xZCb3qMI*OuID!$!ZMgZGe<_t~{C|8LRL8#tV~ zM;%V~ltA8p^k(!pu-PuBYu2=H|6RtmqQCSCM~%9(JBb%U7#=WAkmyiTTFPZTUoNFq zl(oyOzj9f^{f8>>qChNuuq580z-6FiEvMIEJj5UX1ZwH|bV~W*zjU;_FXd+d%Vk;Y zPD3RU5ujPq3a5@aj?>e{tu>6kuEC=vXY886oRF)8+ac$H0|w{3+n z+7z<;Glhtc$AgA(`r&x+&Wwm8*n0QF!%{@2SPZD9Wjh&dfcSV+^|OIPMp@R^ROc7? z42hgyV~J7LFAl`McaOVM5`qh%UFu1kI53OKFd7&qlxgU0de8(0*hzFlqwjd$_hZ5HG^u&c{#tnF1WZj#=|)DjG(n{Smdm8$+}w} zAl~`HMO90KbEI03@P93U1-2HVD)ySK0q_To_iNH8 zs-+f0c76bNBCsWuRG42$az8N;5*2RAaGTAUr^W`+BZ!^~|F4V<4@$QPw`=fEoy5bG+ z0D#>%PGQOGikg5R=mU{kjdR-K8p68q!;QaV>I6jOXsIYfQd`-*wHJ7@%49+v2!Zu+C#JY3P!h*ME7t?_1E!#2(_w z?Tbw>@qE9te@(niu!VzM8MeRHz}|LsY^)3gNgzUlAL;M`5N&Fv_4NAsf=jg(Nx=>% z=bG>_S2?IOYtDzTN-yA7fKgt){&pIEc)A~>V<_tU^4l-}K3{$ur^6vSZKeL`fiLB> zlle@<8&AYVPa$F#1F&a_+!SsMz?nH2kmdS2mlK9K<@r!UI0UR{R%g~o&mrK z#Jh*#UY5_LI(IL<$X^>AIfNi;C5pHTCmtLIKv6!wFl^(qY026FPU7g897@w-sOz$% zQn?vwK7FYJLTkpv-SEc9$(E5&rxSP7ez}}pzPy~W7SF}|AOxe{$Rz?dMr%^{`9+d=0ALE^G){mV#-S=3`7k`(KRrD?jDTZdX2&Q@%+z2;!TDQbQGR1$ zgTOFp))ewiq>8qP&bCidZ|)J_XzAgbdc=l>+5Y{z#WkkBV@Xfa8qB!w4L7?11DowT z6~HMq+IKJpK>%u->NWA+TBY4Veq*NFj-4^Itv9%j?iFc_Zx+#;6HwybJ=|=D$PDh_ z$HTnld!3hML6{(0yT%a~lTZZER*DG+Y?_Dw(4`6uwbWddra$;n+y6%-VTeFH*4lt_ z`3kfQ@cr@e;F_v}1H1zO0V)I3te}C!K}@v(;t<3T1`mDbdADKoi4YWZaV`W<_}%He z8*kxDuYdPOuY^M_0H9vc)>^ft=%5(AiH`?SE0=K$=jShe0M;A;m!YLpIM}m@gL+Sx z>a43G#=&3Lzi+;t-zwPqnJ}T#Ia($09I&+Z2ba_5V7aqEA8V zP6FT%55ZGp^T&_J0m#tO)&am|Ol`?uzdk?Da8sG*0)iXH>Eq+waR{tUaV1$pMQcj) zdZ{>wD)gcXImW}`ZtS`ryrGT-t@X#k3N-E7gz5Ye6_A0~0)P_)ZW3`MwZOWWFi3!9 ztt|wPloqRuv2!f?5fiV@)jU@mrn~WFS=ah{(QrSYj_1b)Qyqdsx|FpPv_@dsUj9zU z>1qL8_o7wo$mbh%-!8Yu#Nr1MVMnqjdHhHF9=1k%GcdC$VA@1ChV#ZCeH%UDa}3kg z90Xo!sSN-_9^UGgi3?itxW~~XxdnuctKaQILb7p9g}84f-Qxi}qvtRX{ieofT@ z3hxFw9H+rC@fiFx#b+$Smgkr1K7U3?8C8qc_Bf5hgX^AN$_0C06^` znt0#pZ*Q_;0ASkRmUj#S+V>Q6#_G*K{b7I4_;;M1cjND-Duj)G`1e2d2jk{z8_4^h zJ}j%#w!F?5!P*H^%z_26R3$W3V>JMd-dJE;3D$DbGJNNYz8T%R6#S5LRY22xU*|dd zbBi)ScWttLH|pTwrX4LP-2$em1a>e%p8w8QS!-JUacAac#k>9;IZWHUozz7@Ybq*e zBnCMC;LPgbFb=Qy@;yw?NroU100gdBSyC?Fk3_DM?DipEf8PuOMySIbj$uJv6+-p$ z`JdL~?GJxL58QFV3XtpC=N$ga@!l_5p`{4Ipv5<8d0x)XUlR|03m}|0_w*PJk-B5& zj*|jw(^6X(QWYqmOUr-@A<`}o@ps2OcaIn?K-c%u3GeP+CCQ9=nX!qECC=YiGaE3@ zSQHIzToy*YoNGW?()jUdqSh)85vT>f2VM74xiQGt%T6m zOmPYxNO}J9cB5{rDfgGH7(!eqdM+YF?U}znN4hs=6 z=f%op0e~_?KYx;AT7h7t>GV->S}$_Wjls-N?ua+1j8%Kiu z2A6j+`e?v3jio985uYu4{@y#$rm89Xc`Z8fUP)vKZx(BMV)wX^eHmJk^e<|QLL)Ot4!0nl>& zZe@enZhoR~^E+&cKLX?~pdfNM{q55NH(S}F5+ z$yJ{R(REe%aQt{YPQi69jkVnvrolNwYucEVpmn~a9G@@$GmJm{=n{}FX@N{~a37}V zYBD2+mR1X!;q>zS>o1=#?Llky!J)jKUe*F)8RImJSk_e&IHlJqa_6fQ#Av5y9JJPG z8Ov$L{Tu~gB1f$QT+#hWagBA}NFb)Y?jq=F>!_-xnMs6+*xKHOrQ70-*%tnZ0n#D1 zD!TJPK|QH6?23d0wC*3JnjyP}8VnR$12g1+SEO9w@RASH-6&YA1%LUUFONSQj}a0- zjQ6kS^`!a!F4VbwJ;N70{jIk00|r;}m;d9x|FXgzKK^iUErWb~1Trq4FX1>Ycg0%O z`RnD95s!z1cN#J0B@V~+^RE}2UsUC|oW)5ZaBD5XYvkznmAW;^J@s z!a?#0exfOs1d)%Y&;Rq6g!1yY<0#Pd+m}4yQL;ysY7Q^kn=)94FC~7EN?ZMA84@|fhs$w&`5$Lg#E(DU13Vm#_k$0?31ajT z{e6#X1V~F3qzb?m3BjXe0S3z}aPnFoNP?)E%BJkpMM%1FOx3o@mbB}M!S%gZ%%i!d zkIM;eKq^bh9j&Oawq@Ro9`iH+O`)hjYbZtI;TcsR84B?M>+Jke;Ez8&Jn}DJ*VFTw z0THN3IR51?Pvf0O>n400d);0fYO6J`=VT69Q1S}-@R!Fp4&4V?tX0KsFYNl8S4U7Q z>t$Ip+;W1u$KhDTr}^cjy6KRn%280j?5R)&6pZEc>wo|C6>{gx*BHcVO{p|?(Z}Io z@MVD$0imWRODoF=pn0V8C!LWn9RzFAQc{|XOsGeX+w3RamBO#P-{uNT026__2#GaQ ztst+&!Z+@lw;P|Swgwi#)t5n`n+y|Rpq(A>_J7?D)1cPq8jf!Y%K+eg5CA;lVm#bE zj>uYaS-*XYptNe@#8;#7^Ty92&1^ed`Xv= zm*-P9&GqqEKb^i@s#{Jz9zBAt3;P(bHCzk|q@p$)#sYz^W%&$DrWaq%Brz z#k}+_siQ8c5RhkMpuI<6ZXmaAStvc^yRM>b@4@%=SiuBUZ3Y(Fbj-V~%wEg90oy6S z!qk;!(Tq3PML*o$C1MlX8sZLpf^RsPZ<)(|W3uf9*h?Xs+0eJuv8!>s?bl&@FpFMY z=|~;y5=qyRW?$I%91tt&!INiDxn+I>(4u7!6o_}t0j-iMk}d1HaBP7DHKQxN2Gec&Wwog!|!m43mfN3l<348UPXQ zs5o}aoBIxli=m=u({4)2FzntjMYPmXYR~FqLyBB0MO*W#-zEm@zJC$#o3@CXbo9Ek z5g-5jfB6XjxoMa>pjuoQ5r5nc)^Pf*3_e!0Bm$tSdchDhp_IJ%bQxpqv$Tu!m|5rC z5gLdfXjNM)4T$Jx3I$m*udmDLR1$#5FoY1jk1TtnMQ{B9Ca!s&6FV0MK?ay597YiVgZ0Kik#@W?qgl=K z>qTAXun07jk>WJ7Dl6q`+NGOKm^}c2XgV+v(b%t3sKK?J4>>!$=^0Gwoun~{V9Hj4DIER zjrD&$h25l6ZlHEsE(t(HT%1Nrz)u#2gTMvkU$j)LuhXgBO#nL|hXrtD8LJiyi$_^r zr&JqhQF!OgJK^1X3}E>2;p4ivE?sA;MIAYjJxm8wnTL<=1fOj^sU37W$Rt68T4f1( zxJ&_ehf&juw82Brm3McT#PvotGp$u|K3(R^s=&#QY8~X+Oa>1f7QN3|wUdbNhNs8l zT@bge9wOofNDP-VLZD+?N8t~$U9V1Pe-`1z;1=umT6QZ|slyWpJwYHQ0i zIwv9rCfi)Z9U34`yT%{AlV$n++~%#)uxYbz(5qdAr2!1NIt;yUyuCfzF0_JXyf+4} zeLiXcHN4-{-uL&u@4Ag+V>6s0C*Krh!+Ci0_ep7 z$XI|Q{KlAp6QG_xJJgTE|AA%}68bv|V`{qV!x@!pRi08N`m%L+K(`AY&X!m1FF6i|NNgnq5$wN(tcU& zWki>qR*<^OT53YmE1^Tey)Rmzvy*4g0G@cqFc5r@s_pa7z|0;ubJfm}{c^6TkxId`zkJs?1c(F`b;)63`6_Wn3P%X%N%#rY*?l)ub}h+6heT>s*- zo==w)5ucQ$paK))WE_1Y0RD&55JRJ343n&YF@$X?wJgD~nu&`(s{ao(oB!@$?ZT`K zqCc<>rZ-o|KDFPs6czh?d*6RG0Me~aw($l!ZY=TmgPt-FL{*{AkM$P-z&f9@p8&vx zgC;PRFRm)WQ7@&ugdY;n*TX^MFx)nG$PZ8d8=hwX(9Br@ALDM%Kmt?|e~eLFzNE6A zp2MGi_~5}C16D?{Jbwy@(a&E{Kio&Z`^mlUSpq;SbpZV( zttx3fCmn0xAZun!-aY-Ne>%p91ij3c zTmlDp=XWwQDzAbt;CJ-xe+cd@A9n1R5hR*wKZ-G6!RE>2+&&>%KcFdJAx^yQ1(Sf}a zCgK|tLa>kHan6fDv5w0DfMCQh`UYrO6rnWLqLLaRy6Pgal=Hl{Ax5YwFz6=;BmETpawP)unF`K zk0*S1`qP6|RgkzYg1`)pZbUQFW`?!mhcyG*5PG>3k*7(A1)62S7h%+HL(Tv-G&Bou z=2N27a=I)_(nlFuaGQ5F8w1kDAL^&)q!7nLbZH%BPu;f%-Mg1|O*B9Z5%0rr0e}@b zz;~&Yyj}`U&!6QvFUy)5KvDsLciua~PHQFrOe732NayF%Di9F}$Q|yEhhvBv+Sp9D z+=qL<+|xTeu1xJr=D zo&*5xs?cv+n@1DvZS#%xNqkEzGF<1I_Ka^Qm>A%0QE}a`*8nv3Q~D?m8JKW-IbCqz zqyIUt8FFA~NemN;0~P?K5S(+q=vwM2Wusau!dT(P;61YdP8<CH^?~qA-Dm2xyT;|gy zs{weyc+MpPXsROQ&7mD@N~!}yj{g$;G~CA^LMjjyF=xSoSXTHU=<3gx%e)wm^C5?) zaU8npUcaHP!`MriU+2rRqAo74B_qHw`8c!4aCZ#Ir8Ymt!(ob!wUKxc9fs*Hqr8rn z^7YqWPXOZc)7SCmpByne>4JKyo5+^+MyA&Jw_kt#l7nB<4ZzP7yK6Ev2sr>uq1V~f zau5QnoJzCk;Ks$&bTaH(+}tJ2Hk8P>5E|FBALj0+ z_q&v@|FKE8zcW_}@vXbo?Aittm3tlr$GsPH z9bstm{hUkI&ix`1hhgx6RZ1%5450WbwWe8I@hX{JOY>=#>7hm~##DPK)3(yh+unEm zeSo;1?jKKIPtE` zInVcyFdc-TwG@R!Q~+hJP6q4UtG*$0eP2Uk6UDny;SE-4nQF0ZaCJOm$DysqNpiwIU12ffYzdmX9)5LRfuJimTTsD}>e z-`e&DkPG+apI*)joErnz^)m3Ag)@LHsp!~}D+$$w;DRt%kPV8woqR55#pNQY)HNxX zVu%Xw1yB<(u+z?%dj2LoP0U>hL*a(|kH?3}JLyes(_2RgLg%tJ)pgAVMgfpGpM3t& z<&x66E=ZpqFLBJJ+SP`jBE8OQDu9aj$4keedRfQ`1Qk{$5Ag-!G9*o z$5@woUclZ{gO;rUj(@oAT_0-O-CVelVBG*Is-CzH{;dUHJbtEK0XvRn3_4^I31=b#>-g{9rLp&Z2lN7fqz)VcR%P<^rS?HHHmL#_?GYWtxtEf$?bVs zyZ%BO&S6{iHm}3$*KgWoP-|Pm^2*KaEwoJ&m9}-u8rZhN=*C>?d_a{aa-LCS4f!peb1t`G>U|}EU%4XLn}*TSE++Y+U-d

      &_7 zK@hzBbaAlfi;9mCq6lF+q5$HwUQo*V_~$?W7*R?Rm*y(*ft4q%nwHW4_}HQ&fZVtQ z3V=1C9zIBDS6lNAcHN>Bk{cU@n{~-Lc@6?ZasnA~m*edGPYcR@C8s?u z(@v+?Fxj7;PfKM#c+1P{DD2)vP}gk_yT>A+;zEoe3y>8F5`2dl)tb<KOR5+ z@ZrwsS}?=VZ93H%ZL#4$+W5A*^B%ea#wNm7{FK$=w`j(e187rI0!}GRJ$^V1QMuKjWXR&&U^2ed0*4j zvQjQN_q(M@^PFo1EX`j|Kl;hR`3_ccV1a{nkfK^`Xn;2F;T}F5GZZNV5ooarKRkVS zdKjI+lKA8-t>>9dmB-ZP6){zy)#b8&9;Z78qgq)SXzNvNu~}L!pFe#~aMGa^-#l;v z46?=7?1-&x_?y-*577|o{c#){j6*yOg9EEpH;m(jqIYpT_z(yMA~nw$;*2hpO5A`@ zW?)C6J3c|a6(zf!*Bh)~loic(JH5VxS+7+zYSxS!wi;stHEQpUsn@cl()Hk*p*i-1 zi*JM`-|A@$vEQFnHh)8B9dJJUIy1krQ<6Mn(b7xu7eU13-1W6}g%BSX+tF$UvK7yg*Dy zXC4ih4uF^7gz?2c2$w>@`T27G^zk5?fS43=m(zryrulMtEfw)_Xw63e?yxv$Rv733k8X2AFBHE#-ocj)EZoZ4dtXD#-wlVbEr+ zb;U~w2%}D3QFg;CCG*w_Z%Mbw&F%#Xc;`?t4a)1Kk z4<8;6jsdFxw6&W+XM?r1s&H|*yCmcakkrL5n4Z%7aw@f=etP=hz^V#aSAj#-TIbUR z&V#Xh()eDLp;iU(>8e)1`|XwSc>Ljqhv;-DO9o0wmBarT>eAZ<6N?a}cXSMv4CKPC z$y(FetQf%XY^=L+=(>3QOx214x@yi=??Rj~4R24(doMWwaQF3o^nfNT z{`s#5*HoB16etbj(^&+9mgb-e5%MC6Z$xm3#05r6VVqu1Wz^^T^;g#_9^m@B#|E^T z%V{b2oz#V@)_GAnzieH4fv!ajhz{v1efsHV=liQ`w9(%nfD7^FSUzI7|L~aC*94%h z@Cx|Dk3W3);V=dVKpUzqr!S|WX2>!j4v%XpYeija{jWd&7y&H0iiisit%%2#}ke9xsgA;#)i-YI zxxlB1FNoMm3oTVRa(xG=Ao+VD(0k?0M5&>*9XPNd(K@W*UAg9u5A*l_nd#kD)$yEL zi%YwU-23D3-kd>$N$cuxqFYt-J6}(2OPX)K6ojj!s#$Xc7`5&e>sBsL%_03<;1$=HQ4hAnk6H8%K0FsIUs%G?pY zil)sJ0vs4+l}my5VLHSpD3;I1>G*NY`H~&#`dobQ!2e4iZkm^6P|3^X>nY8O>6mtX z8}Fqi$?R@(~7A|&kGc)y1~*CWsP#PWtytdANu2A(HLG?lf+0|d!8?Eg zSLd9+d-~yN5>1y=!Th<7A3(&+%(PX7nYuC$@vtT+3IpMIJl;nD71|7&KFoH9S%IqB zYC||Yye@00Gr&GMS@2(;8kKhA-8~~O$1xt1=e%jxl{i*+*@ty-r0CO`Ig1~_osg|V1!@D(} zy8$C0h~^ZqqPHjyx_)yvYuLV~e-+bBQ>I70W>Am_yQpRmSmGBv{`}!C0)}MsT9&ko zQxIgWql@f1ts?3V0}gi{HP;4?kTArs%`HbTUA5GbOI}j05HEwo*bU1;0v7KsK+P_W zaftmXmdh^z^U#ck5<&a+cEF`Tljx<7@f%ONI}^ zQi^5cmNl)fr_*8>4{7$bfryA5fM$8Voa?-N$tn>UqLNDi#Sl@e{q5&}X6Jh6rnO!e zbO38S+(mW-0)+ayxx5#0X8P5!VT>GG!%g~iHC;|uZ*$| zQr4wWtF`dc$5VS|b}>XBoS^dO=lSbJF&-bYbJ~eQ)=J6XX#PHL2+pGqC*-gOvBJ zZ~N?~R%UYJ$%m^C9c~(X+gu|6-82(sO}k#HN;81kRi9=@QCl+sH34(I7CM>WL|mBW zn({El!ILOZTj^ewqgt!2v|2H=3R6|B?F9!nje~=M05c_RU~~yKV(ZwE-T+tK=w>bq z)3J#{+&CVOo-OA~6emc_>1A0a(R%h{4)|Mj!*E#ht4lJk^Ox6FDpE!CeIN6VQMJMW zTG0RpauZz5q*_tZxNdP8N$XGBOgF~D7AJM-xTY|JqQRP~f;<5VX0=^vm6$++3NkbT z*vj@O>1rbG7W$OUoItfzjuiHRUVxMr<|oF9VUihAoy@StW)sK_a+#GjthoGYGF9G}=t3hMs4 zw}TiBO2LLTc<~{7u9t*xcRx6wu22W7d09`F6}&7%QUk=bW?)mRIiD}<=k+o}w1Y~t zf=S|(O3|0+)trEKBoHxJK_X$gV_^qjcCHq}nieaj0?W+Qj5CcuPxUD1bpf_S4jN86tzCp|S-|xY6Cnf%U+^GT5jJLl2?{A2qx@JsG>{`rf=qrVY z52|wvG634JKno}iEVwf(>I*4$ghXu%AR+o7>JZ5^izq*uxf~)j+6atWnknHh#e(FZ zTI#-TZiI||hF)LAUSDCyy#=AB6_7yzalw1QkFtRLa2Vn=Hb_&T2x>Dnp&f6tjiw6c zgGX|?y5xpwh>i`W+I1+c_2wyxz9l*U%k+3Tmow0t@xa#val4jktw{tREr2$?q~)|O za6^r{p}M?UEy&tn*3=4LkYWht;d4z|i%CvvX;rJBnZmW2(wwkNS%z=jr2jy3jN0{I zw#V7S$o`&D>z4>qv1^D4sMWP7s1qI)wSR1Xf%lHY_Gb6r%YIw-_m==@pJ82F9O!96 z1e$-qa6igRP4ngD^m57@bWcmE2l(g&TJtc}g6g9KYF?IXH2^5ONpmPlt*e%`R9&@z z?~`^m9X8YhSX>AztbxLGI3%z|-{wz%hyy`u$pthVP|wS2p3mTa86%`MQ?l!l**!tJ z0lR}|AtILp(ptkW|GXyOcV-r?%j@Z~W>7BcB~(zTZi8C1mgn==UsKJcZ+xN#l97EZ zAgGq6BHNa?FTHF+LcQI_&Ri){ms3QB9JJP2s`GxF#xZQf3{I}JsuKLCT)b8Q@ymS~hsjC!AS9;!B_ims5qz<-K2yf+3-W?4Mpzb!@=-T1E&C%e1R6)b*~jHHf&)+ICA;NeE_WnPjsHhHmfM?g`leNwS@sHuch| zS*z8$-L*A10h|j8Xa<_Cxh%y1xY$6|kucX4>uLSBe?N@((}bYIQ6vhIN zPzH?vU#ZX`_@ ze4wfT>Yz1{~xm=Gb_E_(^V{znHiDpVFwOX><5^~kz`fR%9=>G zWCbJqFax01a}1|B;LEb(eENp$I(J zbNc+3H6^3F5c>J1)$oD!@%pqqEWd_#LeQkm@!$xCrfOQZ_2J7y#yI}^+qOLZ^Y`D) zA}e|UHQ`HJaug&%KC4ac5=R!mc^2=~FT{#pS4{>KwkTh;pP<){snnVZ3?BgX-C zE5&Ah_x)e~XJ3e^70h?lEY(tM_;24KwRj@4y0^=^K3(#@{S`8gcVS@8%REKk)8o^! zfIJh-s+aQg1;g~=e*Uy9R|R%`+J1a~h*(zuh0&w~3<1Y_8{CLhB z-%CWwyHi!5Tpk`V{&mOYp(Jo?&I-^!oNf#`&sj^U@*_^aecjTJ>G8|2|NGznhyLsR zUEOO{e0qBL?x&9!Vq}FX7>=php|7Z| z7W3q~#5GygvQ*TcAM{UU5RCs<`1GJ*em`L=sE|>R9xf~5-TCa%p6Yg8|Kl%ZQ+P$? zTMA1I#0l{vwrddMCAs;tv3pU^Pc-0tP4Ti=m3X- zmIKfnu|w10zVs!nhC35$1WGQz+xMC^!t^ zg5iCn3{>o?RDj~hWs||PiO>$N%;2iYU?py~E|<&Z z+2e+>e_p9!n9doJuqDyUFSX9|U8l!&k#GgY(?<;Z&c#~WOX1#!vxCcNibE2Mj_i(< zob&7f1igt4Wo&6L3L{h?Bd&TFC(#qVFD;EKpn)DB8P|a!2CHKe4;~1GhCfZji zgX-a})ek=d8r0yK#yzj+uHz)tV;Ho%4_N&E{uE&uNvjlS-t)32;o!%444(1cPZ6n< zG+rtJj@U*omC$P0chkc%H)EzRWhs>11!10{_?|A%F#{lG- zm3#;VIc+y^5__N~NvjhB9Ji*)Y%c)7*jZHpfe;KyrtulB6`ZBi zNB{)E$uOPXjpxymkycV|sx_CC6Hu!8ju?ip2*54|?}#K$)0chUcCEzRJP|`3`CR~Q zD7Efo-`1kqz=}%XUi0xS-PIeBMpbj?xB{sE_BhX+_s369!g&uH1Qh~cJ<`*(4H>$v z1s+z+Gk~pRRdb}ZHs=M>3C*2({*4d1``tfaW^aU1-qdD2%>0+o6#&jP`s0>r*9N6S zF1q(Q&Dv`XO&p!6W^`)_H$cI)!@}*2{!fo~t+z~G>5?7wURRT9)`6%1+5tRl4KFOd z;}0Bw!%Dsx8LaPZ>+TM~4UGvH8fmRh8x$Ouc^~jdAhUJbHh({z&M~q>Q?S54_tUIs z+gXQz_QLpOI5N>@rfOB2ivY3q14M)v&9MrRLFdz!W3KCJ01dQZJcsJ@CRNL_Hw=g& zUBFIf=TXQ>5x`1~4Ne;185=a^+`t?>fSPxQ79Gf_yPv&z;syhHy=|s=mX_&YG6Pxf zs`sX7bKquX=pw9ua#KQA;y3S0<3G*g`}@xsdhw`LO~K*7tt(Q#tQ}WEZ`9JG)AuaX znxGf(_9<`o@%xE5977=h{w{rlPk&ZTTTZ!fn%!` zwm)fY2%!Q-WAQor$^wZDKozxBvzr2-al7r!Z#V1PS^TT51sL&x>f+~3q?(3{UZaK*&AxF3+hB09MzJxr^OKO!}lM9 z7skmKBdM&My+hWttP4V|mB-U+t8xhE4`UZ=aNeA2W~JoIWmh1_)8ie)Ka2A92-2D( z7{_6HZ;IWNPH8xCyYn6Bru4AaMN}}m{R~Wmx>55s|T=a497dZzD&VttyCDG z3a&`nDwKi(YVe4s)BU^q`F;*m3|h1`RZVH#DJ+*=xi$ zeUqCVWx-8(>yPFG?q$OmVD2y=KK`q~thHv!Z~yiXL8fM{syHwh)~PQ9c>$^f$p!UWyZvI%V86KqhfD;WFA0DOQqKr^y{8vtQkaPx#6M^vCDG#wm>jNF^J z*NMv7Yvq1d*)=$b1DZP^$sls3$8#W%nH|TP0D!VNI5HwrIA9!3=l8!|E{j?-Rqe?q zy3{~gE?*@u;ca7^nTh>yw^zvLwC?-Er@QGg4zUFRtTjh|D05Xj!8Diad<{?!B|uf} z2+Yqf*AFuhu0@r>A^2SphDerjF0EETD^L~kfZ~&nOv9ugw5F9BnvrwlpbUj-E!(m# z3NRx~WAyA8RsbjBySZ&oxV4N>V7x5Q4Cx?APMQrq$A3 zijg>EurS8&UC>$sqo!gAo>^)P@CDG_nPKog0IHn*%3yNQ#i&TAtyHlach9K3a2mfo z9-4bI1a!wh+&NO`$N^Sgf%c9n5ag&TNvuR{R(#9(x+9zG>Z{dN-0ZZT(E-mB76kAPc?!=_~GNp z!?Zc?i=d&^bz7cR1#0+hn(7b$Cgv^#3&-dR@?o^1%FBX4cjFxL<9se9RaG#yt!l1r zoG|@#n&;>VzH!F{8g&G$1E7owRW&CO|2%(Zyy?@!5Qzf~Hm~V1_5JCG7@&$x)htY- zl2ujEkii4?ylp88;Ms!*Z2RB`0f@g{irTt!t^)k~M`7+h2H?N7ijm8o(%?wO|MV8)#72=F=*uTUy0iHgc`F zlyXWN3!$n8W+C*Mu%dhE;twuUGzF9mXnI6~*Y(%S%767!g0*fJF1IZKItbVxbG;XW z=ke+hyYvu1K0e9cp;q)~R-e^0yQ+xw_9=bS2>V;t@iyA(w^W+H`4@-Ar#%lV`&?i3 z*7)scP=RjC=S=~Q>o#J^V-Q4*ZHN-5FbE3@9Cf$Dx@ zbQ@DJd+BjcOPHy3{n6J>T74kVRIQ_rL16yoXuKh_;H)P;hiyXt8n;<5IR+g%4HDx0 zyUX>EJ+akzGamDe~DKnE$#3Yr-OG!xex zV6~RKUY;7<9RQ&~UcY#lqIjU2DT3Iu;=sI;c!M@gr8Lh>A&@(z)1b%zBVY`y%;USnPWpf%I>hADio z0T1V1`0?XU_wP>?fUpqiiY3dywV>;pt^5sgVxmNw+nKu0s~{OP-RxtEk-2V+160@ z5DQ94dl$ZL1yxYCJtrfm0}B$h4Uwr@5FJ@#A@)H6Gd=gu$W`tWP)(Mc z2sFbez!Q7v5r@E?a^kuux;WwfbGSafG=<~wJ9NrKYLQ4VdNp34TXu3fef*f!J7Cql zgzo_MEu$ihpng8pt;ZyS#Gq0tnpayi#NWBEzub4+P?68H&f6^YHH@kMC$oMMyjBWx ztT;@N8v;jvPCq8Cli;!gg-Z?+hMa>hmmwko9F!UMe)!Y* z>^n|JTqD%9LKObtKP;(&!-@eU)BSnA3u6d3H6miLILFlEZ{E|gxMgE+!Ahgn91*z& zD2#pafqd9LfzKfTsbT_?xMy03jHf$)e$On-P{h@7O7?JY!`(kjYp&~4-nLYzK)}pQ7y#03d#eU*T^U}}o>i;X zQUOVJt2ZQx(EQ=2@6ORPAJp1@GS0E+|(eiH$zQ)^WU9FY&=-QnK@ft%eNXVUD#m{e4YLQ0bVKes?=B zjtmVA&K*zpmDILb>r)$3gF&0N1I=(G5e!DqnyqYi-v9O`GmyOZ^Ne)&-e1R{0e&QT z(Reb36Jn`i2(wJ{&!6_X{rR$KEgxnEX;o__?Uzdf5?u+puK}t+AmVrOdd(dfk*4+X z`OA)xJpjQJPN%Ru1Da92ru}L)%I%5CF9mqY8(o&)~d1 zK0d8a4OZD8leLg+k!a(b%pXW3@hf{QKqI^X;=fOlYOm zT3?^C?8wp0MZ@_9hf+kXZcm?n-G}!l#1o>!QT`HDpeIQ$6OxYMMZ+P72SYn1#;*xz!wg{iRDM^MJ2B-Ekbx^WfPL6iq9`IVV0$(|M1j zy(0bnK;MkElkkY&N6xXJkRvy$!X+n_k!*r+H^_QnocL0XU z+EFqD+n4LM53di(21B!2a|Wz6tLW~L0E>@A z1b|74yLAm;TbIbK>VFgTw5x>>V7)(A zmEl<2QGqB(pSM9fP!u=b0vui>SoEMT6JD4!?OAf`^*%Q+;9P@aSnDZ34_pfFS~2wM z^&GQA0T}ai_x{5$osW>x4OIM>eleAH+?j?rP&0{ zcR?Ih1yUUS_?<83d&y5&8RJLxFFo+yrYAV36yi9a=lRp;Wuu?5rt;AQhEhu{TQ2p$ zKeROf89<1^kNwo7LmbxNnjx*%ub(bUP~ja$exC16!`&Gu`TFp9$)9g9j#8e4pCU$< zId~`iU@(P3jZ}r4Kbn0tfwZ<-)bdRbNIOi!u{d%Dv!*rG3{_*OWyOe4D#V9Did9v$ z+EDkDvTs`Q^=q-35x`R2QN(h3fM8owO3w#Dm=S=ewLdDSc>%n~Q{Gm5U3Pr9UIjov z06#Z8no%F{zsL+98|GNKuM$pj?T~wSWLj!zdekv}+jimu$iW&TIH;;Rl=boP^X`{( zy%+Y!=4YluXZ86#Zg|&b&2W>rt9_?BhgUji$rzx9MbM&fvgz9DQJ-1`yXORSYcE57T?gcd0fE!ob!KYN6^JcN_+HsFg8*c#r6%n&llB z!DAFAjHVUiFrS8L01T#0p~^-FnWsDAz2L$d6keu}JL0EBm(M&z)9q>71f^mOF+{Ih z$^{A*lm=mzI4ibauUd9R^yp1&R)CA{m-Ewk^3SJh-#n(ZtSbO5`M|yhAA^scM;_*n z_xDjqGdtEs#@;p9VIgcTHYiZnZOcuZ~M7>Kn5oIg$X?bop`tW6#@V&o#1$2nWx7tt(2YiX7w|n&7K2`v7=m z_BY?|cY}x41N_vqDffztD$v>+NYu;K^k9{+_Fjb@g&)w1wwK+YulIp#M;JN`WkE*W zyrHui+!01!Fz-Dc^?JYm@V}bx0li^Hrk)(R_6A}4UtfxzkN>R>@9!>021j}*VL$)$ zSvgk$G)G`2X3y+-y1##ae~RA6Aqt!a(CRnUD*zAQYG6N%PhbHw@3lrP83@Bj=RiJq zFE45BL8GcPxkmf+@hGG7#XW(|KrcDCyn1FPEpM=e#JVD?H;*_XyrQ--|sI zG<3g7@{YNm${CVTwOIj}h+q{EGcbhNHMM7Yj4G@K+x9l}tj`Z4tZFAW$=w_UWh?9c z`3Zo61JrM6O%hM<&aw0bCLCY(Co{%AQbPf3DGGRpQl1hQ^;$OZPJs9~#7lpFz1ao8 z%UR%1wv<8gH+QfTv;wpSt?R>Ol` zr}uyU^;#an6l#51mv-2;kaz)VQ3Xpxh7;#O23k_YzJmq<(2^KsFtil9Jf)IfiShJj z)?UO>4TpSL7{kEI=kxvj5P?!b%>m>EfXT6*Ap^9alu`f}LnvTJ(848cSKQ@_HLjy4 z^#?D^$u#+h7`l0>u9wrqGzb#_tJ-$e!7+jCpa@&Ne*RiKP_}iiRRC01@cV1J2U709 z1Z4Ji5DG4WILyy0nqda82$5@gFxUUa+|7C=X9P#wM>c;f2K|TEE$jjR2SLf+QWg## z!ykaC(JNKQasZ)-4<9c@dzSHh&QPC+n4sIo=>06`$i4X1JpcIbd>bQ$_9`+EU<`#L z>85Z7pm`HGmf)juygS|BpQnJ}`R2~5AcGz5Yq)hx0TwvsR>h&TvKK2Qt$>W9tU=}& z$FA;sctI1HcE*RJV>Z=gCmo2IBQg>q^E$$LfL$1dAOKK3qhehfJOVLG>*^99(Wp4Y z8B;-0+_*6^c<+Ay7!D&@QW$QklwD=AKLtT$b-mu}J+syfP%@`bYi6bpa_H0*8SEg- zu@}nw^^}ox4+xkV&gb>oF6)N!{^RSlR2>A4xQEanRMvuX*-H6$t>wI|F$&C|GOl|E zH!!g2qQG{_bL|ZXCcYIh4cNE!vaBh>%Z30BahL)*g4W0gXK8X&F%088$dMn1y!pxEk1GZ{GvA)#~Igg%tIIh5Q3ftABGS-6MX1{B68e{ z8UzT(0MXEz`!*H$=5jY}Y(RUDQs1x>8eAXm^^sl=@jdJj;EtTF;TV+lD)5clNxK;_ z9SazM2wucO061`0p1Tzr1Q58tAQ~}-qvfhS%-|?ckFROn6b9m$6xPa{fxW>F8=@ny z;`jzfRBJG86^;ysO2>9nbdenc$ZGY~)h6Tp8vXSC{rTM#xv|LcyLv$So1%AY=w@($ zF_>OhmUN{mqms(Z<`HdHSxXxmm?tejR3gsO#z(M$;r%}gBK9+=u~VnGC@ z9=VKr9Imx1&%9t<$a!HZUCEr-alg03=b^T9mVu$`)R!2=Xc-E2x@=@=S(O+y zHDfn_cz2#-$nDq_P%(q5DU-D>TM_m>v|(>ov^C{`eXkHT!wDh%oAub1)cWtcpW z(gZCY{7RnTHhSuq+ylVo7{|Dw@3$kBgXXkeu61S!!iTWyv(5z$Z)L|Eti`H+n#Y=+ zu9tJ&eI;h`EbN+9bGS{9^%y)H@7#UC4)x#OGN%41JDapOzN6X!t+MWm1cUf)2*%+& z=+7Aj%fUsuKLh2uJ+T|^=etpev~DJ*HPbBTcTW!w*IbK&kvFtlB|?~QuqXiJ8b~62 zA6rgWvK9LyPIp^=^f5-NONc|HPR4971$%!?nON~^&P2`7$OS_qiCQLBoU!Nyo1HO- zZC4&xQ(1QfkMk%DRjtIWIp#S1>3{e~9cJFQEj=MbACOyCT%Ptl5JzI^_y~cbY+wHR zY2A0twE>7z9EM?F-LTJoIt^4-MOd79Vs;QfiO5eyccwwh=3GWyuekjDfLYS#?ddMG z>-Ay;$aLbm)`_cYt~pQRILwO?QrU&b!8BEEp4@E+rdqhOMhQ@>6)pxXNq9uc%NTtO zgtEW{P~yM?m@#l(REJr4@Dr8bw^+k8O%n*>g*`IxVl+a;WUgsHf9g$G<%n~jV@OOO zN3P#3STm?Q)F=*NVp!*2y=nN}Ugfy7-8z`zN{Gt8X4CFk@Ew+gpwW*>hE7P;E6)HQ2Go1+l8DztXKK{iy>-U4<)XbU50j6Y9s|^llTTrHga6-z{bbdF_-n+(57_J>ei<_^{fk<@@z+qLz z`*uw!RbeEwTB>SBMu_{i3Or0pIOAL>?vvKwki_6K3<9!Xj(tU=v52%48YI}2+>>XQlG=FxOOlM z4aCGyXfb&28DwNE8jQ#X*HTjjd~fh+1qjq~UkX+YMm+d>S>VrM?^Aj*;ClJA*Z=s_ zY3LC7s>-oHE`ikCz&uI=KSH-!7vQ=r^X@r){q%TwGJst*ty-R*R?PVDPaoz8zzYM8 zO%=j0O;4Xbe{C}O^r~j@#6*bGDepgJGz?xZyAA;4bQkIq)uv$YBijnVTFsl*TraD^ z(w+n2`yakP&jTYn=>i?X4n?iNIc5^^;`cbY#+1^!mr^I}dm`9UzCUj^?dzv63Dn)2%Tist`e7J_wctrkGoHSt_;}V*;ft>N z_#Sc&qifr>{)Adp7}lCQxXy=9Dyx}-;T#C$`po;**(L|))KK^B>%$7U3o*EEPzLq! zrp)HZ!_XusXxuHHK5jW}PnWGMl`+JTz>HjSb3%q@4HXbrQLs3MLC6%2j$F7kJ@h$E zn;xS+=RI0I8lnx<=g z{PyQuar2=Ky zqlBiYCFMYlT|+kk&_Za;aP%ec%4|ilw+b**eFb^D{h%xM`6&iC4 zV~kp2nlRnnbr;XMYM*Kc0*DYqL}0BdoH>uuSrqMNqu>a@4kji?4uP9>(UzNpC2&X< zC=40^L62NF*yio(QSKn5z7%-PNYK#ZyP~r=pXu?CuA##UrNe-Z9p3`P3jpg?L?r#X6uhGuMz z-q3t+#=?;2*#tYlYmHOmuCJS0YB_bWEoi3ZV$~|D(w3(<+Ho&kXv#fg(_yh;xCuD1 zYhY^z^1=cINZ`klE)}I&jS=E3S8GWrA`c0OF%EkLU=RQl9a?r!rb9YId#*yin+hMb zK?h~Z5}4C zOeDldLeY*PiDSZiU)FgaO$m8hvMj-G%bxm?&3+iqy;CutPxBmlGNyv2rD|hXN&B*9 zMbonCf&g5{DYaoFa`0M(zFYW$Ib;AMD#r79a@@s6drJilRME7qC10P`V&c(#Mf-hf z_0S6HpB)D?r!OKVb7DF`eA@;uhyyE=8^We4Mo<$oh-vRBo(Yzmw-4`=T)JKj#Rrz4E7}PhN}huJ>I|> zp3PC5K%SSR5ui+F2CEDQ$2MTZj%xwn?5sh7IgCTg=-)0Q#H@w}Cd;M%Q`G00aR5^Qd`g8*;{n@6H}pib)vm?&3S&8uKyTcfeaDp#jwJ?Wsf( z!s)#IFY)7irYW-S+m;KYc)l@*jd#$H7)D9<;`XfF!Q`CYsp37Pz(egW5hIN zMOh&@LrlT0pQ6^!Pl-(ep{!4nS9eFu4$e`?DgroWhYYiv>hS&e^vD+-#*nKYhVgFZ z{kYXFsdB(DP4mE5^PWST#vv$!??xF$Pq2onP2p6j3NZlcE9B_v8PL0YxOMrCB#(}e zp@6j>mtGFLrmS5zigDwf9Kfw_p5Pm82lw*BmoR9Zp!)oK(j7RPgB~{I&Urdk{Y$v` z|M6l7*?(cn@a^T?&42p!n<^;`s;Y12_e5kfg}93!Sn%eXzkbnnvsUbPn;ikZX$cCr z=o(Uu$x*K`0TfWhT6sK&cDcj>U}Zqiys#r{t-Knj=#39eU08>n8Ja{ioXpiya-I>z zp=eVWk#|EYfEVx6%PV=u(7k$MKi;OT)~R4EB4R-mgBu2gLoohbYin9Zs~^%Q`Bij1~RrC(7bPZCohS_ zd7k}w;!w{Y-`(FmlkE*vi<)TL)8+b<0n|-(M^T-gMuCDHlQ9c@kGrq%;}(L>CHD@B zR;kY{64hK$V=C;<#$ilfKsk7cJhYYw3SY-$Fg5PkbN$Lai7 z#nx@ha|RIhc#Wc-L2m-s2=%N_Gh_UR_jjzwy6yb&JWrmA5ZB*HeE*$`)bTLg{qo3n z7%;sb{g)jm`W*9^_$FS{TJgVG8H7w|%%RsEShHLBqre zx?vp0aq!A;=h=JaW~!=94HeG8QP0F3a8q?_3h3W`AgxC|yb%YEQpCK5b*Et7?!*1Ky z8Y`fkLtp?LQ6qAW5roy>5jjsp9UFfWc0OJk8u|>WD722eA@YcLW~h*OEK)~d|bisqu=C_ME& zBt+b@6$UtJWG-A2K;hm8jlCIfeV+G?nt}D=t+$Aq0o>SwP*LsRrgo}H?;0pumw@QS zV@CjsfB^*$-|1;pxazlk+4iacYe9O%*LU0aZXS=j0#Yj4%xWoKJgUJ@it$N-yz9;t zc}cYb%p!g|&r=xalfM6OKFz9qh*ZUDtqlcrT^}DVRT-^V+CV7>iDGlH9;G;Z;Bi9q zWegdNtT|sp$GeJF={m!m>vR3QKV9}zg|)`e5iSil^x4~yH~~gCRyHv?Py-QbOko_N zhA>)S@Z<~Iuz*mv;s=dr|b_2b&yfyj1;2-D4qh!jSEskWR-1%ju8hDAmofI6?~ zSTN3!SAf{ZX_|{fC6TKoSI<+9I-%N5uqBx zr03PD5OR*eZmgiXZk>w+0F^jv8A3OOXSAfM1ZJ((;F-PfyD7x@>6-U_TLxi>GU9n0 zB3KBdhG$V3C$PIz7Vtm$pk?0{WgpISq^iuQL&FoN%XyfuYOdLyTTR0_#-BVcBb1*6U@>+X4mrIgVj@VAUO-HCGAaI7i8+ zTyoY-CymmNBUUucsVc-X;H9GOK)LEUh8X!^xm08j!Fg-z)7nF!a8Ur~@uzVbrEZU1 zat{>+8-|lGlb~e$cp77fmEq=@n5aTERkI8>ps{ywB(8VF4c$cD*bbdnX@F5X3K1Nq z{qdY$fzkU~WH^Free1dotA9?SpQDey{GGc|y6hOI^>dWak8C@1FmGcpy}gQqFduYy z=jgET>&>C(7w?leM{l#R9&#Ft4}nYkedK0;DFdOoP7cSRx=nyOdaI1oVD0$kJ)$yE zlXiTrLpHbB-zJOn-VFiFLd0ED5w(inN&3iw2<)(G-XTp>ekh$L>iccs7#!p~9B7$_ zflL7>fnKClxK^mBfV^i1MQtD|I2gk0eeaAp0JW-tnZSV7shOCn-s^~ zQI-QBCNz+`?z^YjDk@w9T&u1g!MU~0S_5EYwHd%5CIgxbCuP6oilSO;P0f@6(2^d1 z+|KDcppTmRJ+3wF+ZsbaxvX9g)@jYE05a=d8bIVC`w)FRj~q1!sp z@?`=X^hLE&vBZo_td)Ztr$7S z-uALQB=EScIp?xt;NgdNV}x#upo(30?A4$(tD-h5J_PS0J17oXb6#tuq7_xG6=sh^ zyF@$2-xRJjJz!D2IHHDE^$Cn#YP}m?s-%j|@&*;`}bo&3AjA7KAf!eLd*_9j{8S6LZ zqSg;AA}7HSnqv)+2H0WkaJyBnOy`dP1%jE8-GYdN)l$U3+&Kxc>+`@7*j1|lJ11fK z^%EZqI$Z!@2*LADJ5(DK75~h-D`W`LJ0Z>oky5)Wl$y2H0H`vwTirAJ07uj-##&kd zKvFqDOD$<_<$e-1gy#CQ==c8>hWvI+@=M2p;mNF1&#>L<^N#Ro{j2xnN7+cL8T#}A zO(CQi~|1})oq-IDGoMY95K z1fq;H19B#uboy=*5}0(Ax2CGiRF})c=gS7~qeIye2()eMhQ|_z6g>zw0sy-=p7>?vFk?@)|3;-#G`u?!%2X%r6^9Rn>0YV*@}P5$g!STB=R^YG+*#ND$(n zr7nA_r2!r5H~P;DB@3JtZ{vO+FEo%@Z^NU%v1E3_E9gnR2K!MR#+>5?7zQ~(X+2B;igmX74v0o-66VL$++d2>#NeA)_@ zA&6Zb9|7LmCUzxE&Y{U^qsrsHLm`{4ijAv+=v8(d}L{0m`9pU6$oW z0;@1fcsHGAp5lN8Hw_NAVOv6l7ZFgnbE?~?rR%wEwrAV}oV^(6CJ73-#rzQ1Ii3pA zetEd;+p^pF#~&@f5LMR)C3;a!D<}lliVwq zPvbOr&#w|t5@BniLaeFanlpx3u_W8~^i=Tihwnydic<5_<+o3l0>@-PjKeT!*My9I z^gnE0(&f4|xDPtkeA=S}{<>_oro0rr{#G0OXn<~I2Y3K-Mi_^?Ddd{2t5!&e-gmAQ z8EPphDTIPA%*ZIMpm_XsnuE^d8uHLNRAnby?T(9wC-(e-9$yb=O(T-XhZFt{8oDY1l(j@U(}s%P)ECM zRXkS^M^Iuk>-=rk_0L`+-%Gvs5&?UYwKct=cb{z(dKA3jIo(0rZ*X$!r*(kW-)U3+ zS5@2*uA2Ux*ZAGvSdV&dUfaPrFj{+Qn$j_|>mSzP_Z}6mK4v@40PwAS+6+x=&0FzK zdTE283=!82z)9!xQ^GX3Jy!;_09LV;?&jyio&l|B1sFnlD!@1nUATc_4BX66Yo(Ib zHB|u6Yz^=PNTklwgsIh+`JQwam9l86_X8Zm6ZLA%Dfq2R)bqW09_28hnI6bHBL}q7 zD*aCI^SCVvz{xTD7w@pGr2t`+*y_IQ0DOgAe#s6sPs~0t3(%V7^~l!d?UwiepaSu3qVO&N2kXB*4=UBtvTYE=VJruG7C=SP$qoT)VG;1F*1nHE zgrQWZ0@5-BgrKobH{nZh_M+5yJ18A)eSljo@La*(Zpe1qIE%pLkP*)reLFdCQLKOk z`;x;j@;rN#b=o5!K8$ILo&e7d902$UmX0aN8_&+OK$@GOH4x?CPVJuE2J^y{DBkAC}7e*j3ts2eDiKE3j8!0{Ix@5X8q`W$4l90=H<)gK(TaUv|8YHKQlqm+@gs z8-g~?+w%DJVM9j56q9~ z>|U3eif3`N7ysCAkOqHr9S%F@UgK}bj{kEEg5!3}37jJ^bpyd$YY+~d@~qWV)j)#Ejsf)DmW;)CB4B2q+JO0%d_F zkjPH^R~1;E*bS!;fV~;3bqa-0A|+0waLi^KZqrNqZ~HC zd1Hr`*98zBrV+2DA=GJaM7x%mSQS>4Mux}y@rMt?Bv4eKx>n%TI|*vjR2Kn29))7) zN4oQhze&P;&9>he@gc_|8OFHj**W{Rc_5Mc&Po53{Yl5^-l3@yvP)-a5ScjuAFjDmOv zG6Ykk;z}#tsLNkL5rzYG;3W>?!W_JJF`VzBLlE(q6Q99q3GalV*Rvjsq9gJ zr^j62rahmFZePAWT=yqKn1*n^d@17D344Z+O1vxE`Si(i$Xk+y!oXpiYfWQQE48Y^ zE5PiVmYfuTg%E3?pin#T_YG*Sb=OR7rl9V&o?PDzWKDT{>#lm&(QwM zxYuzlM(Est{#Rs;I#rz<69KHZ0h%M{NREzbXAtzSi{kh;Dm{#h0CZ7J9CA!Os1r2r z*J~L=>_iYE2SgSpoj2NIOz166Wp>FMIT3m#Lsq=n#E08Mg@NF!uy zak8Q7M|za4m5eg5#8I60*sqUOeQyY#SqnT+e5w+B2qH~=uU!q~h#EO!w5*UQcW2Ho z{w)Fy61)TvpsHyDtYx{k2{e8D{yYz8ttBX+mB!|{sUPNfXD2;%;f_B*w}I{yYwi3p zDBQ6{oMS7^I-y5%$^}^q%AWUSm?8%s9#tEd$U|B-s}*T|@+$Fk(slXtpa1K>{p-1` z#sj+GDjdM7@En5!6nW?QUT6s?OGypH^yRqAMjJ|-~qnCOhqx;%wz zNBYa4raV;V6#mU@umOiLbvxRhjf~7W67OSn!p<|`hVy9(o*W$@J3YLl^~e@`*TtUK zR-YkS-BPZYKy37~uY0lA)IdbX0n(b8YBB)cqZHd(+BNS5K8&-FDOfsYhuEQ9HR)-n zeqwUOFyi37RECyY;Oc$pLncbti)*I)_0w;^d|EIK08;()?otlJ6em5#c&?S!UErD< zj2c`Q9en=uy>nF7$1j%)7z_`_L;n0}(FuXSpM)g_7J>L?WUg6*Fr%Sy&k0(CAGa#i zGAbN%EoEPqxwe`jmh0o!6%2<$fDoX=vDkz6zpPv0XuO--!Hlt>bjWVWsg?>J$Gbbv zFd!vVFrz|5L>M7B_;7bO$3P&@M5daTWF1@<2^p$~CEz71kRk(*mvRBmxmmoXFTbw4 zS_WbI-kpaB4kHwfxx!>R>%Izrux)7rjzuAGzxx-@pdAR%bw*>tZ zf;w`<+CgKtP1v-zQX9+;)?ObTJ^K>f8YFK%2K2z)*dI3N{`l%eX)oPKZ*+4eIxzQL zp~Q9Tmgkpd!=ZEi`l8Nu>_meG7#GI#BtlBfb<1_wU5AD^@8E?*xD(-=V|Wi!f3jM2 zFIAVX{^`nvI2?t(0zh7$F4w(=GVp*M;CYFv*{k7k-9$AKIJ>fkhYwC8bu4LIcGI@8Y-hGtq* zUboBxhiUYz{vqy$Kxoa%zHkoBop=VwwVIVBpk?$LfF&}c`O~CHp{$C)$^eRA*M#V! zC$vV-r)h6PfPkt7@jh_q&{SgfogOg;@#LDJHD%R`Dd-(y`2KtzsIu#8K}*$+FRbE+ zVIk=t`&%B+dEd(T_C9I{e>Alln-BF+{4^~J)p`!mKLV&2APAeUP({hjDo<0`koUh{ z9-n@g);a*tDgZpdVDIA0j!|-$`8-KI=ev|NRdJDqu|gekGo!TTcFgx*Jxc=G;izHM z_b#>P2GP++By$4u?bcW8r}yuN?S@134~~Xb52rqf^E`(jL<$2d>kXg%;;C6{e>FCM z2_UrAw61GGi%~Q%-TEz#Z@hK5j>_&I>cH6fGs;#ytRdwJKMaGo!yZl>z#*gNJ)=q+ z+sKV#@O%#bwKYl8UINn*&?5#zB*&bVGDpYAbg4@cI6SE)Cw$YSm`e96;u7 zV}qVSKck+kY0b++g76@o31xfwE!)Ne@UJW}coK$m&sHM?Gt9t7aEve(P~5AnZB z5hI>~4(1Cq-W76C1&7aDsu0lZ$D%bypqaAw;)%U$X}6kdD^)ZKgh{D1)EmQG@v5-F z>psSt>qZ>7(FH&qhS}jF?I4FgukF8kwQqjG$ZjlV7}+aoQ|_Bfp2$WsC0$SNBEdAR>$(B;Qm&`-c%Hf=f&&wXtsx(Iz^ks-anGs{*bL2_ zatDXzoVBPm1TcH28Kr@lkrbZE$4J^5bb0#u-~aMp8@}T1{rmf=u0c@uPtY2N`+q&x zuYXxE{Cxl8_h;Agb^G(5KYjkXW4@dCw+as6P~AWOv|hhFK3vrBX`Jr{>`%Y!kJEQE zs)6F+0;{r=TiVy_&;OAZ1h~6^GMrCi6sIV++$^DiJWB(bgx>t9(3D!Pkl@|N|J(X= z;_<_j9|!gvWZ2UJ;a=GJa*SM^km%Y}rr{mgx-JXi>Ez^HL^W%<6i?mJiV05?{NR{S z)vPKIn~1=wmhJ1;>xR7M;IQxc`|qdOqrwZvW165)b$skhio=H=^z&wQEkgj-WX$<` z#xO+>$WT?QHAe#FIDXwOk0dyKxSOZ*-9K0Gx~vaRI*u4m@9!u3y02g##>snOZJ;1< z9n)haRg}>1A!>zpGaml(&#R3hsLkrWEo+teevZfK1}GnT7S_6&G~!)AEd^n?pZCwd z?8y{_^*PRG+}?U7*31@Wf(`$b9p3-*Kh&De zG@J!r>!CYBGU7{d85XAr=sDPQCUYN9_qyW-A189?`sX(V z(dRK`7j{0r`R9W8rn0kDb>&6g!Fy7!u&k6Ci{ zNjZqF5k6_vwIOsh992z5uzg?GlC`R6t&kYCmMWtm#tG0Bpcd}ju{Z#JCF%a^5xHAu z>JX*ACG4%4nrTNTk#pTC7tq#6UL+2vrRDwc%b)-9u-$nDpWlD@FjhSe5m4+ZG)!F5 z<*DKE{__v-Mr>RD_3Ks}pkQ3tF(Qn-M;yj6#C6G*2OogEXl)?rjP(kD`gCTm4NT>F zeb|>c09wrPjG|29J^O)$&``}9oS48xsp){^DGGyyNrPcvf@)3c{6Y^b4E`!WPr-nyd@ zGaTaZewxqUP4hfDXskQD2vA9UU!zXKd_T|QfYpOGrkfGl9}V80XL-lO@7Y6wakv!` z%v$w^rnf%if!qRto-y78N9sd8<*I0zfsDGYTY?1#)xGS<*1%ziOmNc8w?GZlJM4DD zO0z@FS#zzHQXcw?vp6(Xf-+j|b(8?HPUHD$sXfK8x>p)G%`&`f$BE=M z$g3+3>n+W2VLZ*^7*Xb+wWU-6sfn8XzutfNSnC`Z;tj{hs&jRZX%L7bOGWe8uX}R< zSdgDEiO0`h1l+k(6DsdoS~cY`1YfGAbj&=gCPX5RP|N!OEpWsfX>c539EKo4pDU2G zU1Jc9LgRNt9K;LvwjH2(-7dgEX;Vu8qN-s8P*Fu;Rrd^JeY%7JPR7*>K~n(=#K+3q zT6187IwA~!?EiRrclT*S2!sS^LIe;85|*k$6%{RQPqpxxor~4l3;5UpEM57B4mcjY z{8!+0r~mmngz0X)gaZW9af!E6|5dx1@S@RU?uObtwm_FUdebkHek|Y+m3?)!J_`A! zkxI{dtH0#!KhyL7!>i`&tseP9+rj5IYA>UNXOaeSZ$xOvzfz}QcSDFj92#2dUhIcr zH}$Rf>Q@C04XU+VugllZ`zDjt;8PwR6;YgrVXn3CB(b3mhJlR>t8QB&OtEU z-@iK#d;R!ncMYYf4-DPbr>)lX%YUBFCxRjE1{V<>^s#E)PQk$mPSfe`yDy&~uaBx_ z^mWb%m07syq4HuNp_bR0;IaMo%g@)n0acuc9MUEYAYmbbS#1D_48$Y`-%u3{?lNS| z#3X>Vyf2q+@AteIjZwJOY6RvZ&pQUg00CCDngaes4O*e#z?v_6zAzW)5(fCoU$a%A zah}JsQD9$GOGXJO5U&X}eLp8jPXEkNs@ zQ{J97j32%`MF-czC>YMQo^u%#W+Wr@VtL_hixge8qpj)Mk$k#dmJ-3dAdaWgG;0AE zn)ViCn5X-H{3y?-2OR^IW?EIPcButugJ*Ir`uLP`!JU|7M_*uOqPyrHEn?dy_~jE-Md)!eg+W4O@8#725XGYrqb3ly0irXr5XP9OH*jfb>Gy5 z*DwEC_Q>It|DJo>T6rF9zxg0Ikk-Ag=?LA(fo@Un_~FY3dS>P0b!qzQ1DiYi+JWbM z0Nr8|FvUUPH?r2cJy6$%|NYfmQ|d<4ebzuPl_t>9s%ov~{OL>j^t58~Y_%Lp+yJa~ zL^hi9tvLhSVVPJA(DJq_WBKJje|b!* zb?COxs({t1#_ZVvR;nF_mCW412To9-EUlR-$O|)?mhJLz$&8>{%I4os!Bx$!K^SPJ z$84IMcgCc-Wit?bI~IS-Y%UC8TOWq~X&iyf$iY8+20IDNFrMf07}~ZzEla0rMn4WA z2I+P0z|-9{#RT{e$7%Fb6*)B3C70{d6F|)Hah`tszdULQj=m1R+&0K-@1W-*?ajiz z1;JZwZ`!&Muvc<0D8#6b`=4Lq)!tR`pe#EaLJVH&N``-Ue}4kyeO=b&(_bz)|92V! z6Tuh;5J^1%+S*{&zyqm3cU;bCq{HZ=cZuwlfU9#(;5-bijMLp(7+~a*z|(j4KYsl1 zUZ9HT;K*^;=V-09S`vUIr&5i@u@}r~y<&O7KWSO<+n@jPo6a9I58eqB*^x5&;SBxt zGOtd=suqAV<;T$=Ty4KIVHog1!DS__J!QkbX9~Is~BC#A0QlRyx+V$ z!CrJeU(femyfANFqRwFWCiDE=EdKw$>zQcraz6}k+-_AZ$aS_U@OP+szkki=S>y3T zhh|pxwC$gNT_0Cv3WNT>cc{%8e`7z7vR*!Y6&}v_=Kv>l2+`Gq{1x$Ccn4F)na630 z%z|rih#Z*&XH-C~0_)@0>dIPEd8`nWk^w9LgqZ+tfEF*Ocpj>&DP;iXGR;jRz?$#} zT$Z;NwF6UNHz_7UcWi)ZIc`HUe*H470wEy&^E6E7VH8gY=le@7d++#d_VxO8x9tKW z@zXrbgKH3Y@xW#AwonW?sa?=x4KI{wEsG&ORq9&IrIb;o+SY+K681|Htr zYjKXDsJr@SMIz^+#?LFbhkhRgK+S1gawpl;oGk5IbqX0m!Y~3J%9` ztpW;22wPruEh7LRL$`&yY`~Hk%;SB;imbzU4gh$P`$zG|2OsD2_jBa5Uyldjyx1vN zO?5?HcM>nn#o_Ke`5uc0!_)ECj{gv>^s2u57Ov9t064sKX!^+XdH;U9Nf^S8fJWo_ zyr#Ao{@0JYL2};K<@)vKM_kT7;c#D92EbqwR47ts^O9%t0Z=Upw8Jr(ozwQR$69OE zF&sBXVTf@6;CmnS{L?@G>p9LtZ$b6eyaF&Yt-Xn#^P)xK3?}EtIjxTuP(Bq6&V{4GVa;3_$KYR7?B!5(1a<<(E%i7sXlN4tu!g+k13{j<&Fk z?|%67Mf~{$0PLk1fI?^m{%I?qDG2(}#4nJE=LbO$K;k^j%mt9(fl@SgkY1SMMB*JZ zKYs`pA~?PP+j`ED^m18t87rCt`{2j(-TMg_w<3~NEI@78%eE{H3>@$xQ)?pwR&uH! zptcIB3|NJNs+Rt5bQn7FRx2vY9TdZ^T2*Pmpkv~x~Kd#rk8#({JwcDYpt#{LV*`#%UdRR&uLL6fN zNC>29y)OTGIpY-Gflf6{)9K_{E07qGys#URYHEcwz^^q=3{8qs@N}@@72p_HV5%)u zAcP?fI}7rbfdBX9-S_9a<`~$?9X?KP3cg#@S^+q=-rsmey)cLbd`w)~Krr_G3$|7{ zSU!sfc>2>YjgxqXrme{k1<4B|ule$I-H>2fOExo9q2QxO=z7%IPqPLGCnB8pb)%B= zsuf@lt*vS`P$ks{^5S?XjDl2hEsDCkKs;bq1!^;E-FR7HTFhE!b`t{)#s-BU!I70} z%<>$<396;kTt$Fdi&{~Z3TT7Eh+S+zK-2DJ#Q=n?nX*;|{CU_>Dug}vZW8dmRkJ4n zA>QTgogn;v3=v?S;=Av`>^TTwxO@NZG+=i?=0TegDuk*a2ll`nT7mQ8LtT>QvYFC& z=jUS?|6acRfZDfXqVY`MZDa;h>vBuXVhmVw3KQjLgyOgPvjahV8-Q`YzwFp+zWm#& zKtL`aF1o8IhnV{;L>c4=3`HuoRRC~~gO1Z_R|ZOjn-h7so?SnOJ?+eOa*Ea(GYR8lb+dXF4lAY@|c_k(Nh_hs1I>p(fY z+6VpLu2UtBrWk>wp>>2!d!>wV@O!(QGmOEvc1$;Z#q;F-ro-7O^6tR3xWi=-q(|Qp z?p4@(wbNgH^}b`!wz3v@^ z3eQ2j?<2z(gvfE}&Ai44wJeXxz`=`<0g#BioF6ZbOJ3m15RWUk57l>G0 zExBVda)GYUnkz=XX*mQ&z=1t#E!cO3ckCEwT60cG@$==~_Tl|J2G(6zZZNc0OXLW9 z%_+FkIs0s=^$HT~3BCFwm^+3OJ$xDwhm&8w1GBsjLkxsk>U!Na^@LiAmOU)%wkbiH zp_wM3G7K2Q0HDCo2Q$zn037=e0o%C>0f9_2l>!P)Ytilk$sVQDWhvFn6>{T%fJF_^ zqE?$S2wY%AtyI9pW4AOdT2a^3e=oEm%Baj`{rlwkNqz7X5FjXZN z04v+R)HUF`<_ZSDBps}MOwfb0A6U*C()Dvxmcus`S3gGZ=}d8G5pT>(_@b%j|;!Verw%frVNZ1ZXe=E4O3ddi1~uweFY41~)`9 z)5G0yoKN%kn3)L^PqF6HdA=iPYOGAeB91VpS~I{A%Tqzs)T-$j#gZN<=r9DQ1+~>J z!$oPeNU5dcJhr^7kN5BI#{sE&_j?4yGa#@zfYtTE-tFikI4=xXQ|C>eu@Bt(fX~QF zJS)I%iqW&`{(vNmn$yrrduWAfRdwQsn6S1|0N(@zn3h(xqE=S` zD4G{xCYBJVamnjbsz9V%aw&vXH8((OLj~^o`aqSQwGnk;o@SO|&?e!$?=JfJG-ZgOG8s+=armX(Mu?ejHDgMz0wylIqjr zwiIBV{W#DZr1xQ8Ki6)6fEWKE0|?H+^~0idDjR@q^GeVC8aYO{x8)wH3vtj>;u z|9r{Y_BeRdiM)4-*a=h(-2E>57?~Z{TGRTufF(|l5Qg^%ZDze*28=rg=JpITW&kK? zRf2k2pRNzrOIBbUVEcw~7=@S|yn~@B5jn@?nyS{k@2UVO%=6$;9N1HI&JrH-7LW`f zkoV)=7^3S^?#_Y0ig)Cvf^z-qr%Q3LY=AH8$IGsc6k-_WGgMRCOu-sZu_pi<1Od6EQs62S zv}XgfG}rQ)%LWP4yOM2Gl*L0yWw^V!xfu-5 z%Xgup<<^HZ969XO4*69Da|D9Jd=tIDs0|&vsuR9S+>Q_Zel2}@0{@P&!GG7d)pq~j zYrc8YtACIIho1N0m3;f_-yL1e(GWu*9!?j4Va(6{30C&Y!>7mX|MYSFQjkw6=2JRE zm|o8B1^Luf?I@)6wmuyfvNd;-NW9#g-&`+>{d1caW?oM7-NJ5c0tv)SfyhmD$T#gz zR`>mGn+o0<#*PXWiWGr@ZCJ1a73O7I8wQ6`KR>4Phxd20q<_Dw%65nfyi5(Iqdg5G z>D^(k^&Yixm;q=HOX3JCmtP)!`TX$UktYWBm24~Zc0U}dZFQQ!ONJU!Oy~3avjA4z zH278w09xAt@SWJUYvCyY-C8YdI_dW1x6hC3<@2wXaliFjlOG@?KNJwcp_iO!BpEs2y&^68XI`S4%boEUjOCJ z?tBit)qT)}+x6k8B1 zjjd?`%%1jruQcQQW2)&s1L*zlgmK@EuUKzW!%+%-6^nkC&wM+~93TmR1eUyfxm-4V zWI*4}@o*_E<(enl8cnyW+}1CT1u2}s0N(>MLVLdaJmG#}m!$g50@B^UDjL3gx%~F? z=PNKF0q;!W1a&874sf^1l7=Y!!B-nRpws!on~Z&5W~L;uTb}=NoduYIIr7K1Z|)+{ z5RaNa7^fij3ftfR_P;zdD*z+|`)}BAy*`y~HQCgxnSWDb`<77Ez3y8Ffa~*<%K22E z%g`~M^X~w+uh0|@g3<^(5rNha@18HuKuVEq6fj34w{HMIIYTP|2nz=~3$&S)jJB%W z1p9g`B{Tq0wGJ`GxfNhEX7)AYX-arr{g=1%JVP&+&)Y*$+kgG}GYihx9mwf^d1!!2 zj8mF_fN8N}2F5OYAu;q`)6wd2rS1pQ9q?M}e%-fm$`f7ZA{T6%?^8w-f z_a3U-O}*8G$KdhY4p*StQh6gIIBrEx!oZjYda0n^dY1v;J%@j1*?zG|!naPkfjalY zG!Ag`?nhy@|FMH11wc)!o5#rHFRt6(%?y2eMAPTzPoFP)zC*u)VvdnnhL`=T1C1(i zS5rMMk7?b5WQLofI;9YaVqQ+?%BYu8Q=Dc=DT6?<@+12b%^Xsrwh;}7`!<>K`2tQ5q1VTs|JTRMbq7ufwQXf;+BydOgWVj4Z7PU4BAHF; zbUrOvV66cSeJ$$T^r)EEV8zN7M*!3IMgZ*k<+q!Stg-@SpMC(RXyt3|gr|Z)+u>vSi2&yb9DC?H#m6hG0mu;+%H>M!s?9X0n|8BT=FM~vfCIvzhNIR> zZH!j;=6(8D({)!sf)J~!TOXrac3^&o}1sS}Rs-(~>YP7+AG##*UH3kfIzg(`HgJ#7%7v@Y5 z*wb@e^A0ttwHB@Fq?b=WfBw<~x_L-x$&s0vf|G|AT+3Kt#c6<~Fyy#y7xMQ{!0=oi z0)4l*E)468SM&Pov>Vkk3gJ+$IwT%n-WK|3*}ZHX0x+|gvAtl&j_(R!;o;pq@_6=J z9C*W^;OpjgE1z~BkWU}Zsc<@EL=D4GF1+YXQo!(*cL%`&CYUXEZi zp5DBFGovEsEQtC|UGCEoIkX=YB*Z8e%Xj`}OHstARX<fqQpTEa!MxpLRqQUd|s;_wBME&q=yN1im%hpSP_CN&>x~msw>BsXWJKW=N;g`F>ea z1XCbF{^8fZQ6R_mY5R1V)57)Pm%n{}2H>E)EQqH;hza44QSN~PIuzYlj?$(d59C+6 z+}K#c%~1<9^cfClLJvR>-H+ZHUcf~dp?^mha$w!Nzr=$_XXi+)2;SZE&}tMAiKxOj z@OTIr13XE@`E^f;_@Kt&g;9uCJLoO9?0~@n_m`4dxA0PD9pWK_ck4nR9kLl9SN3t< z-Nxkzf`A|aXy$d3xra#1>JCBxgHa`b1A|B(ISQLT{^wubzHe$+@+k{ct2S-GZ@;1# zfOMaWpXc`c%Vpiy?fyrJfnP+@jtGIk>?~fDDfABcp#rCwpF_!+gLf60&X7{Cj}H~; z&5VE1TExi_hKP8F4(x;jpdJQ$HLI12#2Ke6fc*+chDvMzGy$A~EFkiBEl=h7^6Ty+%}_}eOx6q>lGv*e8r`P3_ZI4ys^Tz)C*74tmbt=qGDj6`qG|MV|sth>|lamnXA1vn7N z;LV6*jL9CpJmDPi*e*r!*81hA)M@TOU$vI)@o$&LlG;UhZUlXn9VnH{@;~PLh2Xkh zpROwo+-|SvD0OdJEj==`L5tvRg{h36cY{_{rh9V;zhQc>b z4g$g8Ewd5a)V+OqdfIWycMAhxfnP6Ie_LfHe*f`@4r?;rwF=-yq%qeZNM7ut+Lamv=NfZD!3Whr<65`KNy z%l`St(NHQN^?FM6vPZsu!*R~o%1$XIK!;*sTzXTZ=hc9ZKfR5+_I%G2&>bA_ z^~2-(G%}uaA9d%(-TR>(Z1ABGy;p7J;Wq%7Vg%oJbuYab-r&+MpDzw{4NP={h8gvv zPE3Hin%w=VKGdzH1VBFgaFY7-fBM(!Ty`y#D%i|>zP#wxByOry{m3+z{?#NGn{`jWk(|z>qxBH*B7U$*u-JA2A z(4AA1{O zYOw$CcrSbWE8NWg)?sFkZF2*krX|kWs}(coHeOzGoIk#~pZ4-qx2W6SOy;|v z-U1W_rEoqsvW5zt-mR4Y$aHs33}~PjUw#)H8@}-|j2-0MTfTeVVr#FEaA2kx04m9A zBJ*f2m~L07quALKfp0P$#nb|zWiK6HB`M6n^y(-fgoD#e90w}I4(oa9+?9X|xm9}| z45ah{(ygPTmO;Gt5lOOBFu{ zFeF3-k*^vOfDP`%Kop|n#(<%@nz|N1D8Kpe!~1zK=VAN5Gu^v8hI7a_?~@!)({2EG zndbAmcjwcc=pP^Az;ga$swUm|w=lXzY@@#T>RfJz`%ZBQ0GOxwD4Lt^_42e=e|q>l zf6T8we>?60ey*2dYl;TQ>Hf_xPuMKqt)~jf?ndf+zx@30^W$pwUGKm9!qlPw$7;dE z*uX@@L&0b%Kjf!XfwvKD?`p;zLm&^y?>@?Q8BHgdryS8sZS`FmG51SJwtH*48j!*1 zgz8@r(;!K6=HIhLUWS|1x~&JK6cWz&_ous9_aE)kt>yO3@}vj-k6$XLhiM9NNb_lV zb)|DY$sv`>%jwMJg|g>xcS@7focUySYTG6N1oJl4`;UM6Q|Q~{_;t^4+phc6e}69l z9BN0mF_dERa(9KKs(j9;hkO8!Y_OxA4x*d%ik`6$o6Q4h1$`UzQKfTimq*0c>gp+oDoy_))iaKl4fR)7%XAKZrjU56Z{)ZdL`n|%Eze|eT( zA!%N}{`G$kfJJ{1;Kz-p5MGYuWPvb1)A){G^9Mc6k>ogDj0$?NLp{d$SSEW{EoJ?* zn*nJ`=|cc|Q-^_^0bWk0{KMOcQ`^=aI41b8Lw^OBVE_l^KXfx#IPsjlmtLxtem6G@ z1V@(l+CE=9^78J@%qW2*Mk($XA{Soa#D~41_W%jvF78)(jG38iqd+k=X+W3{_f# zqZ?BIM+63mx?fEkwe^&2BhQGZ`@4B5YkYVt8?+RJ%vMY_$o#Y6Y79!kB?x#R620mE z^!)e~EFn!1?YgYj-8fQ$stCZa?>r-8~ z+DhM)6W;ywr=Q*~W-%*Ni#dQK={EhfqhUlR-COLvlDiKebsxgm<~`2$?;h&LXmUz< zN-^drdTa2%-mC~OXwKs?`u0KKfgFJ_5CZQ8xBvms-8~rJcB^2c3&1>jA8;U8caVFK ze7C;`Fi|hsyllIw?w8N^&2BrYvAY9qsNWHbJJ1oL_aJw>LXpMxRcAFyBosJy!apsK zc(5HQvakfU{d#$xcnFGcck}=^ZQ5!9z=+cswN-}iXyBYYEvF%~LjQ-Rxq*LVlX=5rQrp`w*bXph(KWGKArCqV1`ngrR8*DY}F8P zzI%7()~@S>NTv#R%=aKU-3f>2`xo9-I5PI<{qDoZpJIPnr;WI%p?cXGW&=kZj8m(Zy)ka1_r?XjjY+RdmWgZ<21g$F0YP3M_chL z%q-m4xO97=J3A2Q_a_@V2yp%;R;2)UyG^x#(dly_I2-$zlkTOKht{ADipXD59%rH{ zHZaoZd_VtiN};rEtGrA?N9)nPN+}GJLWBF!Z{#_ha<^K_(+;&}TVP~K1k{IT;O^ar zkBdV$ij)#cIJ9o;0uEE~?#Jpgd^KRb?bi$AY5<5O21!|AFhgZVV51Pk(zL}%cc28> zfXl<>pZ3!SOOlC!?$yDG(e--S({xW$9|)4mjx?Qn@D5PmK!FcKw!`+=(LhK66C5d$A?X!C=@AIx~grGbK`<+tO_u*2tW*n?_VAszi^w8Twi-Z zqB#N~NU_>L(|rR9;vrDD;U*Jrb+=yYbz9XzG^ncv?^h6HkTPIxxR-lj;h@^eUQ1Ch zpo&=nfab+kC zLVwi_KR%2O0S5#o^9Ez1Km>FXqwZtT8I<494|2hQ8ye2&4xSYe%_*W@H5Y{l(AKA> zJfx_dhmwEq*4Hi0X!^Wfaaz*yzRPshg$-7><{g0oIjrwb|MnlRmlZPA4l^4K3yX;r zF{UV5l5hYsxCIJK2=0g!NpkaU-b*d(Lr1yJL~e`_!|A6?tvmrhd5R?y>gD0{pJIx` zclH3Eb~82Y2%?3o+s$iQD3hp(#N4g$!1@`R(25eo2-n z&5vlOdHCt#1|h}4_82r_hj)jA2}A-+cV_{bqnJVN?q@VLOcTHT_`@68+w)armIKYV zG~{$X@svw_s;z;iDdm;oe1Cr@92U2>n<~`Wh6qjx%-cvlOdH^4X5VPmd*j5*`FuVl zCPznzOaTZa6qvv

      7XPXbyk{AvP%p@%-`KG^MP}F@lK~W3;X@CW)hu0_HTIvC#ma z?Zz#j)%!Xf1fXJxU1bV&kef6Flbv5!p;oFSog~vyl+p2gSIm?7%p_~tmTv)WhXxpBrfqWzE`3ooDW?l1)E z=KQjwzrJ+?9QxfAAoLF7SKUg$yHiIG#wH<KsO-?G1X+f0Td~xp!??s32#1rJZEjHG7-nhL$L!u zVUK{f5L5%egfI*@EeT4&jv>+|yd-riFz8}n>)yLs2d5}e0o`H!x>?nGYk5+MAa@HC zC3e&O;cD=pNmrJ<{vNIY+1 zma33TR!sBE!`j6#v>yU)0lWidrn@URRseijmb>LNEzubwA1|Iy3&-#ce}Mu(K8_Ry zk`Fk1Cek!zG%u*lkeB(+yf?nb-B0h|+*53CSI}u16?mEuTfDmuyOgUXvj$7^LVIJF z3CS7Q8`xCg3ef3{yxQIbXstGDuD{b-ENwwM6OZaEf;SK|6BC%(%G0}tM<|3u zvYO_LcEr24DTgjhAux$3g6-yDW*XMj#IeusHHw=>c&R+3fpc?!ctW?*dhf%G!TT^Y zHop0fGs3s4`b}JFgk<X&+XUZ^*6r0>3FPSHf7CUQzt>8jf6%-8 zhxQ8p)uS5%*&q%4SG=7F=sn;Yhw9g*)j&WuFIxjZ!_-(K_?%)xrTIGE$0EWZrTL9< zKFQ!-eRF98Uh>!j<;jfNffT~z3UB6M;w-0L{vgpT&;j52?jo@YYkKtNN@+mr_0l}B$4{V$G=`QRe-`VRlF9s zK{0_T#3%y55LgJ!YHxL)Cdp{04`te&KAg`JX$X#?jRG*|n7z-bJNfO$(J)fcs;v}7 zfP-TM8oaiOBtS^=O(532aJfD`JUs6&%_yh<(Dn0n#aZUp6Q~1d0SLqW#;dlvYxxR| z_Qr;E^TUVpa!9>&#RvlranhGB#O<*&SY3}P#*pLgnj?jL`T%~|i#|uKt!|ez z{rIX2^!G>T-#(r;3?YG`c|XwgK%kM4^snWYaBCGFzwL+;L4eFMu|99xirT{*)A>Wh z>8CgMt=*d5-b}%;ezZ=#?5#T5m&>&#fZqM{`h2^r$K_K+j5Evp?&F8MFRxB{H%w{5 zwxzn&(}@XPBya%C;WaQxUyGh+X^dLfxJGPQ~U}| z2o$G$e?ILywC?MYqN22zEH;^d`NS|C)GXupI=>!2&J>VzyYZAHNQ^N^VEXfylHbkK z;n4YCk7j@!-efUX0BJeDeg9$3gwq>c_&jF<0?9dx=F?2ea={AQRHre$_NU8R&3Kz; zaNM*23e0!+Z&2y$#jTsc+V8Owak)R8(j<`sjY6A_q>PBcguD9Tw@;4+k@F-Gy?VQ1 zYoHvU2(foCiviURv!0_r8X}f+6IR`&jafyYNErws%QF4$;=Z~`e{bXXox}G34nsme ziq_wp(f~au?3*YD2)|?5zLqI^`Sd`p0x*7Y777R5Wqg$nP-YKwh~a+w?Y9!{t8b$~ zaAN}k56E{1fbJltU|@vquIsw(mMKew8>Z8nj~`Qnwyn0^4D)@RY6=q4f*#Tw5;F(- zCY&Sqp_z9mHh~FhAf)IpGtG{e7KupbA8~2v?L0^-t(JtUK%fMNyafr7HAOLi5yu`H z!IF|NDw_dOm?3(DniViiw{5MLx<{*}3GVCld7PEM`7j2_%F_9t^JPYtTs|9aXSyZYtAhLEs1g7TD71!}*~Hszkyn zLP4hId*$$|?@jX@sLMGgc^dK(5CAQgFP|Q-l>rJ2Z;zQ1w(a@(dWD@TKm@jf z_W_Ur6u<=3re$B%6q@FhUr56MIEeBz-@SW#KLzb;ZN?e_paD^G79R6jt$@J+7^t0c z1q?_O!!+=MRt$jTGayg&HBFd>55ks}%_mZfg1hXNW0B z76jOfW-`C71A8?s2;|gBF~A{P817+@d%DbKM>o#^ChLERi_BJ)h<%O#N`#vC#)Q zCYH$j=Euh?U3rQ*GOXEk_wCb%dk(4)gfI(&bVpZ(bQ};6VhVQGB1+q8s}c=}Ax{K` zNS^LbbCNc`k^&hUIfz3Dw}Sm20CQe83pnAm=|RA4@A!SZaUv5_H)0Avr`Eseu-#}cuePJFh7PYfeKaa9BXvDK5N-r@$BmoeG(27d;NL-L zj$iZ*QikDyoWZamSJ-hghwzsUv)kTE(VRHJh(De`e0+amczgJ3gzdJi%d~S~a0)~z zf^H$v%lA|0<4nJ9hKI!@0S@T~1w!V?J)M5wbD_us^W$v`?dY%sA^{M(dbu9e2!=5; zAYdjw+}kKHi-ryoFbr1+Tidp^J@00$i5#GqrxUYTeQfjnx=cU^BEp{h>DRygeBn~G z!W>_IeSEky2JKFfV{d?&Yqt*Kz?57=B>-ORp2*?d{Fe4Jz5Qo*n(pTurCTSNPA6lz z2B?|_3M7JR4Iuf~)4R2vcVUDHfv`-=X^v={;B=mm2gS;~J9^u@sR+xg5vGESN!&$C z&*mQUM0A%^=+(g)TDy7gJ#;rM#~d^^R6Src5zN%BJbilnt+*3I0NAG`Cn@WCy*>d~ z>r4z(hIv=OI0GC;uTSf~UK;@9I!#wSw1mMEaudvV@7~_etXGsnONR&LkPk&{0iXsz z2o8gH=t%5ic0y+!$PhGeW>-BldTi(!iG z0=quG0j?Ki)Ca5$#gbTr^^lhPJQ-*rW**R70MPweiOsOCc#6;AGfLtXVNp{{=;)Dm9k>c1ay z!zg_-1`7V0>N#E>$8TEgUtLtb*^~nvJ5#_*Z||@Gy`A^b6QT}=ck}-0o5n`{ZT>zu zJz*dq?PyDTcXEVL4q}6QsrtO-MWTVhA3wZ*|9%#D!*3OPt@B>?OJG4rEb-7FVtQQ@ zI`)Fmwjo03@I&2lL>Fniivj{q9+pzkt#p8)rPn|pVGcwg0^U&f>+^^Y0fkJUkxyxZ zwFH2Lz2T;4RM14*wyyPB0m>E?z}@-X8Et!Lt(Lk!%`k(&IHvyeum8&@ueGUFcz^ix zd~KT`R=kN3y#cCj-a4cM!W4RJu>nPynYx=NI&7cO<( zx80;R5Qjc!5Y6pn-(vx?wo*y~B*v6d1UNFl0!59EyYqQjq7_By0U`h+7)V5f!^k4t z40cR?Z-&;i6(DyAA&-Kj8aN0;(c*mKJWb0yr8Ksw{tZ(P4zdGI{D-w4YwLz24p`Nu zW}G84Q)DK_AifS{D-k^S4I~E~-EhD{L?B*@=a??O+J>tEv8icoFYd+WjS;*X5^Al6 z32EEWw(A9UeaO0A9(TFcKj}G{!wm5>6LUjz8;soEU7_fEkyKk-ACPcfey|QRL5FUS zzy9sF>COE+Bn|9+y?lP!W5a&McHLUM|L6ARbRtSD0^9RHDK0B00uO6`cWMkX?*s^8 z4)Ld_xP2+=4;4Sbz!M;tPL;#|2lh(O+}yW{KK1*)s|SA0H)Y#qDV1iig+PNM4aY1Ckeq7 zJ(9t?IbnDTcZBYU`OW%-XU;i_`p$96Wquo2p00i>d23 zDl7-W>HCj&@;^!#|2}{3AC8x&@~b<-zgznru{hc+>;} z3!uHC?VGW|tf3+PFy;LF%kHk92;xDtJ-z$z7Ar2WD}b~@9rso&Wjy|` z|GLcppaD&v)?$E`Ydh~#3orz8^JWg80Pst&qAJVbhL&FL=!ZXFFO}c@aGtYyH-KYg z9T)@vQL+#K(_XgA^Lo9UQ^fxOfT5C8PH?kg;DpP%U5!Q9&*bPz#WVuu!}jV_wi`a1Yh3BYiX9|gIswy#80y&@uYGxPEynG7{|)P6Mom_X$P zMgs_9j>1PtUqE7HMbl`OT}XRn!^qZe}B;B8tpHjBlL2h4vL)C%wOqy z-@vphtbvyW0NPeoy*%FA^X2o(yRGtnfcJn7PGem&E9I4^pjT~B!1pcfz`6t8yMk1o zKL721`t-gy=PCrY?Ydnp0(JYmZ(9#n;y^JGv+Mkf`Axmlrv^k^vG3|eZk;f|=b7$5 z>@!0FOv6HO0%KwZ%-WIbNPbn${yG9r9awHRrD!|g6Co38IA}v(uivPTbu&Av+%KL3 z-D(+BVFiFgqEli@^TCV~=E{kADEULc!b0GP^}4NZfB5i5!qZ2mB`1UgiXwS#3ePs5 zb9PK$Pej#b08A6T`duldqlsx25d!>$=40@YA4yv7Yh;=uw8AY0Z|mjpekm&~F11Pr zTwAR>pT5m#*!d8L7IHx5)9H<@$Z?)HgI~>Da_T(fhK|Vq=zr&q^Z(}|-AzHvEO0mL z2wf1zPT8~jO#~Ofs7!+F1;7S?y$@Nwn|8s0l)zxyIURJVua#6i-gLA?f!1{>B{GK& z^A2zz4jn$hy;(;O5wL-w5;zEKs%nNv#0>9&`(B=Y`OklOxSr-bzkT!5d70;besh19 z1x5Ey{~xV!Lb6Zm|24GMSpY+F1DJ%#tq+%C1cO5aM2B^qxg&J#h8_YjkDWuUc?dE= z+kRbZna<=5amt~?)gmZ#1PH7|*t>JNJU(8kfv2*!lkZQ@8xkhK`)UjzgVBJpR+TtK zs-O4TL?tparc^#Z0ybxbt?M9g|33{3*yZvZyj^}izqy|!{Lc@Z&amAsKmWM?DgZ(b zPg~BX<%EFVLP%+D?W(^ORI~^Xvb$MRd6UfIoy_;|&Vpe3}o<1`=3ERgsrDF(+uTzIpBQ zf53;IA?mQ!u-wV5IDVtO5Mo& zj~S2U?(K*BNOJy>SMmb?8QnOP_UZig|8dU(l6;4?*6rcxS&f0aJ@oovoT z&v!qb;{VE+PVe5VmrqYB%Xzk%FkS!cw;*_H#nKO+7rA-&au{I1q|%$6c8N^|h;QGW z2mndw&a;ycBA9x2>vmh{%p8dEMd)=@jI3UM{a^kI7(9Dv8~tVb*C4XUmp(L9MWVP3 zPy4{=6ax#X8ARU6k2{36Isb?AZk$7&-xC1W+WKyT`lyNj?@#sVvegR&#@@huN~xpO zhhLuC-P`&6r+@jd2nFJ9T?e49TR4oA$FiT_PCshdni_cjykFXsLyo@ygFt-0l?>g| zPcA97&~^7PC(hzpL3~tlPpz+ID;#;^4e$Q>&mVvvj!(q@ghIY&W zwI&}v0e~IQqwXM3pwOLItfO}zgx&!UW&tEuOLc-SKwL6Iv?Ygkj+qb`W<^!aYI4m1+7agfNx7Bvxd$1clOYI& zzU`f+7=DXFg4>#C3zD;k*1n(oOk zV6>nB_z-K409dp?J>Ip5nleREh%f{&`^Ba+O1U6gJ=C8&u0WJXAwnGLwL>Q4_f6Zn zZ)hzBz`9C*AuSAw>j8@QKT7!eC}rN{X}SRvNGJ@$bw8}Y#)C$q#c(VSrrmBqs(?V^ zd0yrO@EOQ?PMJZlT_U2n>R>I)JWTu43iM$GMOMU+uuroK1gOt#K@tMf`OoY1$@tCN zQ+}&C%^PHz3{0G0$XRVD%>+ib?YDpXTxgl0tMR={OulR%xI&+6t3{!*pUG`tqB^9ND4n`@=OY z3vacE03l`eez0hPfF3v;|5C&g&xU}IC^mx-Pl*B#C*|mzgy3q?-nHxH^Mz9$l*Qv< zOI!&GKD~W^UM6&mhsl5h@=jk}wha)_o?OxlFrhmIq~T05uFUI-9vvM~a*Vlq`zyUL+XEdy zoKdU)U8(XbH5}jpYyNKA`zn;_2n_35wpPb+y8cMf!Sx@D1JX>z_ewP*ev(shg<^;7;b&hXOV7a>g#x z{ri9Vr}yW~#)NLF+OQzUIVR4OvrUAXzjsM7}+iEZPEyfwlZ7)T4D?n23Z?CBN^keM0tON74kCh;WDOWR znFK*s9^#J7>f` z`ngQpgHUq>2E`nBsDnu3;W(qMqC%m<#^NYQEgI9I2gd-%kWRG~M)LvyW@_Dsx5B`S zIsH9f<=(q@bV?bKK+sxhQIyoX_W(eg`Zpr<;~&}`Y(c~!pg_(LW{z&XBS>U03vx_3 z3AtKkBPN)Ua|B3yimq;M=I1MdFp>azzog4mbK-i*YL;RMVfnG_#Wx&ugvb=6&1q zo&y4TCpfy9_Yk`utXjVn-l;={oe*fOA#Ch*y_8Yo><*e3-k$3oGIAJRj<3bWLI}f_ zg1VW3m_Y+Sz@Q*BOn?D|6gWy?Sf6`q%jy2X z$eCG2XXy}R>l7lAamZ`rA#c_Z1Y5scwtW;gY0zW3clbdy4IEQmmNU@W)lh0FVluDw zlHTSR_yzsplqh7t&5d7ae-S|6r)DqQG^g7?C^&^fIOX-~{D=LhSG(TpLJ4kcG^cLv zqZb%}Z~J?%c2qlPp1(VOpi!9q?_lt~?0SDN_!VJdKwtm(5DGVDL5I5?XgKq3)jYzQ zVtK3Q3(g;Z{HGt@FH?A8z+tU6yp1vCd6Gzr9MHW$FPriouQoP*GYFWh0oGxmTY0*y zJ48~RLPULfe0bcj){{2Opi;DUgp?)UCy4=+PU-WtY*h`WD3?#?yD2F^dF1TYu#B(c zYJ(BdF6(=wetaPW+ESG0l=I@Jn* z1q@)0UD3wRuiNue5eU$&UWbG9cSA_5doo)A2y=H+F#tJft+dV|Gh=2c3QmxDWW9kv271L39V6@<~C z5h6KLJ8%S&%fcwAdh~J>24+;QYF}CD42n~jxYcLa;c4h@-MBlw1|JVd zj80#z5cA#wbv7LA^&1Fu{Od5|;2GoiU41Xtm1V1zKc2#?FBO3OZ8^7l?2iI1TniL{A;OSGPXd6~R$5at zq*zMjJ}*FAr_o_67h&m&;SBs(}O@0pt#Fe%Cnu z^02kby6>&fRoeZjDGKUtcqSY|=RVMx11@;G;O%nV4ra)+fD<7e@Idb{LzfPNTKBGS zZ~#I;_t8rPn==H8{rR#Bd_2dT01V>r=hNx!T_CcTv&3ZExke>bBMWx>o?GtBqUQE0&4lC`qy$iZ%#BGOWOF5OrryEP&8;2(sIT3L$(c z@$vCZ>i`AZ{On#OYhrOey;VcH>?(DAo)Zw`RzKa(Q_b26_DLT`3lzr2_qshgM5x+!x{He0RRT%giY- z9IC4MpOJIUQ(|IfI+OtT;9`^Av_xOG^asYdGx$JKz&g6t^|!zMyz%LDHw(k|%jMVK zj7wjwU{T-q)>a^8n(xvyWk41Cr~P`l)U7#C+I~6R=Xj!qh6Y#Q4Uet?#a`;JxKi2s zXw}>>GzMad5bmvTbr`@rVYiqJC9>|Y9f*UO+j~PComT+m3O-GzOu!TvFjcG8+ta?u z+q<{jK@1jvQUfUE#4PK+UN4tD#K;MV@&2^5DXW#@C~n8qs!aX!f1J;66Y9EMuC<0F z5q1GC8yGC8aY9FF&(>PKY}?+9GV89*DZR!7V=#>Zvml(>hP?rtv0hgwxRdw=z@scF zVFH!n>2!(=#y%k1vb9uKcGXYGD!|}`1_hX1QA&rp z1DY;|l;X?*-2y_4l9%&iflM58mcc~ z?#&4|vvLQahk!5;mw#_L=-ypUj3fl=we9;3E{Pg5Gj~8<7StCepIHa@K=A-J1a`1U zq8+^xM*xwg)0Acia1}|tcK~WkDKW#b@Zk!E@Xs&PG2;B@$H#SD(SDiNH~V>+5;6%7 zqd&|k&8OecE|+VEf($$%GGr+E__mj=+71jPF@WAN2b#cSZ$8{F51;VG%$ok2sz7vm zc>MIB*U~B=w8_)cx`naI9E(*L zMY8&I8LXDF!IT8K529!HHufjSh_!n~G72C=8&RAWz9ru2$W^ z(+_WdQZ?rEf=r>nbnB)xfHEiu2(F3j)i?ywk=jZFCwdPM{ zK5$^jDN+Co$V}cGOd;HyMrl|+hS9l72ol2EkMFLi!y}uqTYh-_q0}TK2UJ;s5N%X0 zAn4ZAI`5yZXqQh(?lRBOF4wmoN{;E6g&i*%3*I2NXoGJXAHEHE#U1chZt4KK@$X<+ zuUueXz4s_|^lzGQgSF8K#{^dIAQ@63w|uV~nc;=MZR0uno=`DT<^X{FkGS{r^+%DT z-?AzkJD8hw(C?TNVSFyo3jrex(D1inYa<`+E%X4s?YXyKIap7eC0jq8SYpf(Fdk1; zAenwZmYgETFaTg32pkSR{jHwq_~t^pf&DN~G@$oG+vM`|UoPqNuFe9r_4(o98F{)k zY;Cb#OWm&qCP|W(^GpoGZ@-jMYip`DlZMuGSu)yyIF0+?pcye+j;Kbl06-8X=Jy=)JoyHqK+vX`r#6G9D9JMPVA{f4z3$f>fQBAmrq&#=>yF3~2pkcKj=KxD z7Oa&0X>)XIDVnub0TQ0mEWp%@!8;&{C_L5_rv$TBuG$GPVo#3s+6rRXFm#GKqt&$@ ziBf?6}!L*5#us;vj~-P|D|Fvr>CPzGM|5zM}3!~T)3E)YhU)4F$|IEo=5 zP(WAJN>0p)<1I)$nj+pAaO;ZTqm=^qA(t4!n0dmH(HwzuL{~RXeU!#JlZbF63^6Vu z0O`ZmNr>gN-aS8FxAj_T*>pcG!G?V#d|+lRVtaVp3Dm*$wvLo$=&h8acWv>!HO$Kt ziFkq{v89=CLc10KxUgiz_W9Fq&sSY{bHJ#z{QUIzW=6Fhz%bL=bCwA(zwX<0S9QmZ z_PG(Km@>$J#VIaRjze9IUW8DGf8L8KlGn9uh>3`V5y;)W3>KxHf)OKWy<$#5WMw5&g^s@$+qXU9ze)FgLxs+{O0&n}iU3c>i z!BE&Y1VRYWdjJKJv}~m`YgMQ{B++}$0$5XsjD)HKfDZPIRbv3%aFm*keDBpud_#61xLcc%O_lNEd3f%p7 zea4qvZD%y zok5{1hUPS0Kl!XHC&#O^|D@#8Emy^=&lfsQT9FbAb_G@yAy;_Yu#;cigsmeu?s>F=>F6& zT(r9J4umY4UpJAPSy8R35(%?bgO%;`!v*K<%=^`W%|T$$6H=|<^ZemoVXY$Vb(RW5 ziRVB4co$!+e%Qo05ILOB!g>C*U4eGMhRl!Z)_1pE0hlWvO3)HSV$O{t%due*1wY-Fgox0ALE7S_WXP zz)7Shd|gtUI)*%5?`k}(ojU+)T_M(c#|{QUU}h`1g8=oiaZ-#dkeMTAMz~p1I>7fw zJHWx{X_{hSw9VAkx||nEnG?r&FdDtJ_4&(}J^>m446s*I)84fzjxRdjuLaBbK1Svq zL32RN-eS94cS2y_f6K<@%a?1}OJK0rRpXIX0GK*(0Z0=_^h#E39oBBb}xwubV)lEjJeA2o???bPnj<>gZN< zhd%xG`O6Lf$T1pnssOBR-BjJ+_I6%gDbx*RtE0OWL=JV8fwLocAL#{kLf2sNVA`?; z66+qP9bVR|)ePWtY6k~65D|zYQDeHPtqi2FdB>4@FuDWWmv=w4bh%=?i8@#*%{l@D zY0*GQvImZnqXxE<|GNsWe=0Vdtb{}N({@wdN&oQ(~E|G)}se9&$)VJHXNca{~yeuE&#;Ybh$2$TZIBf3Tq z37yhFP;^HMOaLe7*slXoKp2m2U^=26vaW-x@84c(8YW2{-6;f$LnkKYX*q2`U3a)z zZ3c<&&U4(XLSz9<>khCz2IPq+W_)@EL|ZM*PbxxDT$TM-Wlp=sb_9S1&u~lM3erDgQty7s3FhxFp`00lXV^csRi6Wc8y_+PKnBP8bMIY)2qekoS02SSO z-WCQ)uh1x;vT($dmpRUpgzgIG;Tasrv3tpqF>l+@0t+1oIRV9>rh{us-Ms^x1IMO5 z5fF(34WX5h>iO+y_%^^DPqDjtjuEB+@zm?IqwR#kk{tl|ZeYlmq%R*gm|AlOPeND zS?_jjf(pd6U6;uRQvwe?2f=$&>FIc z*6R-b5T<#KcT<+gM<(Z^UjE`h>VCAZ47jONzMA7>v3I(mJV&vfzxNCP02;mq-~0)V z1AG6fdh)`FW;mPy;u~`0Ye-|=zW#%pVS#_Q-S+N--1gs&YYC#P03d<>;8na({KAV( z$nW073Gbh!0&+#E%RwI)#k0LY7`RlS1~+ZKOA4{ASZTWgF#$p^q03Fi z?mK#|q?d|l)O8rg#~UPrfpm9we_pTx+f}K>Wr3CTGtBndv}2m4lwoa;=5wB6Xl71= z5bv5|czrvp2V&NJUmF1ER*_DoeK+`Cp4)G+ZP*%Sr1%kag}WjZ&~(3-4Fy5aLIw$- zZGVI*1cLghSB#CXZjemg0C#e8d{%+4kSxaM6+4*bVhP+N2ou zhPY@>3>fKg)`HHyn}PFb&#??HyaG980g4tIWO<~LyDLDEk`IeU;XuSRP*s0#3Vt^s z<>)$3o>Fe;ioym^2!S-92Y|k1y_>2wa{#3nFrbNb2)8rfTRfYQm$fzra&+auNg{{u z&}9e7C=j3k2{cV<@x9u9;c1~be+c=2i61^2^FB&v8bGksY%f(|4G3{sV!54RHyaEM z2G}{B?0%Uhrm~}T9HHHSqv$yNWyc6$AP-SI1vshteqB{D>Ge{!_2)|gm}NR8 zIiQ(fVq;M&MfrUH`jXODXgsmp63m-$>+5&M_~MykxanTK{sA1PSPNo0`X&@ah|#$N z1ENnIs)wX003uSDg~ag=VR{e%kdXB-i8)qd>KOgT+qg|st)K{OTH~@Tm`?M%Iejx@ z5~`~qGQZwg93cDOS&KRl;9$Z{{N<~>CimU}B9P&s_yYxM|fC2-|Y)(W3=?CF1$l&j}IXDWB0@nBz zCIn&=cRR$a4Z=2VBhj#9Gj|(RTC#6u+YP1D#|H)&s&l?Subx#1WUT0jA|h8t?+$A!4bE}OHPr=nK)Oc|GWcAaL%zLu+*qr-GbD zk1hlvxWl{3Q6t0A5DTVmoHB~8?fLSwa5~S+%>1%5bRfB#^$?=)==3pxhB7nRHxLw% z1sbT)m)#(|;9S0ek^~Ho@NatIVF;GFeG>}w+p!p59gn`t_lRxOtZ!vWd^LWh+n5Kg|f3rC1b3^o|N_ha`Qr67eJ;28l3FJzGyn9a)$?W6}^m>40S z!}8|KL%Sxc;KTyW_bGs<4XA~Y7Trh2KoRKGfgA)th~wTcqk2IGN6rh)DE)ec(0W$i z3QYsrDPW#B2@o9s%=R6x(!4>ww7oT%m;srb=LZuezB>uW31(L6uKH=mAh-&KWG=}x zI1@!n*|>obiDCTg+vU@z=WBJmP2g&#Uhvn4>$R6mD1Ev9a&f*@>%||ZB3^cRr9vMJ` z84#nxv@1X zbmHlB|F$r6tTDY{0?@Y7ViXAtG6nRO%+?muU9}D{$f!FgEJ5zue_kLRj z$A`i`A!JNL-B8cy4;=l=@C&|v2?!Hi~KO%i)|ZEY2$f%XV>Sgyjk3ul0bA%r_(8+UIF6M ze43ZU_RD3vA}O-9f5kHGwHnVGr_($oRBKlV0d0TQ_y%T!Ih!KT%5}ePd1{xs&C3sw zah*;g`Fzef0_OX+Kh<;9Z3A+il1NTqqKr~lX!g4Aahwasl^zp&qZ0J?+#>jB_7-TnA~{_^nUaV4Ma^4K4qx6UA*<7NPgxR&em!;e4A z9K10(0&(jhiR1EbUml*e`2HkcE`ScnPNWZaOF-|Q0ulP5cjfNd_N^%JtVpM7rPL{% z|LLbUOY~A?ApHoCm&L3P@pK3%cn7RJ{PMRQAD1Qm_0!59%HJAry<&Rz0d?Ol`wozQ znx@57uh$*vSoyn!5y}&o8g8o1y@T1i10CHC(gC%Rx7e|=IXckV_T}N%$AToFt-`j; zmty~;T_X`eJ$hHgji)@APq=mEL2f*a5*XdzmpAX<|F#-*#ofmre>g|jEl05Zk}XTG zJ=`sFg%CnWcjd#s{rq_K^x>y>bC$F5lG14kpvJ}=C^$uq=;q!63}9q*e%W^e4~=P{ zHxP3Gx^=s~?jgN;BD!(+j;_W6M(AJVtiBGxVFwiepa30CHsZF!m_g{uvi^rJkL}gymLt-?e?&mQmUX`Wpk9#f zKE4Gjo>8?bfGNi%N^6|XDbtjo>+_|ZPKMn8nB7r2&#}S4XQU~8BT=l11ZZ?Kpl#W# zCR76hv1K!Bc;0LK{+ECK=dIt%97j;f%o8TEQh|6F;q*4(6y6=$)DQ($?1emiTpU+{ zyf%8nVN~pnQp^Am19N~XtQGU4qXN{ft)urwERJUw8_I9jYa4P&%p=}-#d6hd=30uj zW&q8vxErHWu4To3FT*h#SET0F(d#;|6*R$sLet*1IUaslccKDRQ{GwGN-?N6-RlaG zw~)bL=-6Mbn$-pX4DiL8&Xuj<^!3N{@8$;|7vHrSS2aKoXGv2gkVhcISz7_;ybu6) zcLa1ksx|&co%_ExnCSJL4=f7w0xm2(;PB`HUAu>Y$FTkBla}Y_st{ZNptYw7X^Mfo zlx@8tFmnvCGB*HPpR%})npB`$^~T-07h>)(Gbird>vnngRn480tu zd6>fn^xI0)TG?YX2au+tqm?*~^s^rm(0WJU$Uxn|n5HRjH$p;kf}pSmJzmSaHtNl%|^mfscITwxHJST3SZ{ggNDwU|YM*gMU0aOw09Jk@$Q+ zqduR3d0Wr-cZ1Aw&+9W^$bmvBa_KSR1$`01aE2T|>%V#uy#D&8t+vC{-ZQ`_%d_{} zYUiZ4b{@Up{%r_x49PX%sJ3>5yzIQz@4n$SIr-Ip0})fMHVz>3e0Lw&zHbNLj_`fs z`sH2!T|fDIu;YK{_~U)=`+M=SF8~0%2l9~|y*`aTgx30PyB%ndSCoSn%AFtdjTe(l z5FKgmz;nM0@*qYG1TeuEGLXHa0zoe|@UIx-Z?3%$NG68;d|<*MsXf@aFuW#D@&PMu zAmhIS-0=X;0AarG$bYdV{q%l8sOuFQ+>iw4`{krO?eTuDpxAY*Pbv{;>M%5?7zJ@k z^ZD)gUOSxlthOyf&}&m`6`MA*G+{TM7zAQwv`Z@;(HW>tG1keF69|oK#34<<#6#R6 zaI_A(&t?q}AyhSMAOUxk2DDPNL>UrWf#HWuK}REK*MsRtprJ^~IqV5o_qvb9HgjqY zm~O?b1KnHb+G}eRLI_d8rc+I*>zA!?q(BH1odQHS42}@hx~)-AE^1XPO)+gpSQ29B z?trzciY{r23ALH#y*4lPdWqN7(w(S#>4`5Pvn#`B@@&>k(O{K%=-TP?wkag>3^T(H zpbtR}B0@F5m^lI!=AL4!Lm&klEkV9n35@{}n2Nv~0+-SeAyXE~nF5<}E^6)-NFto! z?nXVJBM^h&c8j&>d!PbvbT)`?&k9kv#qJKuIVAvB8r+90637B*s4jQn0Bh^x&ux9W zR0E?n0DKL&pHx_|U7wye%PFVGmJ$rD832p-I`{5fh@dY@Fn;JGne`5sm;LGC(`PV? zCMe)Um%rH4{T#y;c`yU>v>)B2W6`YJex=+?L!4&vrj3`#_miM2Km(Mc7QiWG(!C;a znx-6caS%Y!4M;iV7*mcplMtg5&|I67K0Q5O)ObqM6af?foTq7;PNyWM>c&1;{GkKv zwm)B2=2x$O;_V;9hWVwL7Y=b#GWxH{*{swE0FWQd$Bu3=ci8CIy_~9(lYdnJ!q^6naj^M9f5Az?Z$7q+aQJxu-${m1 z;K6?$)k?hqENeE;E`tjw1U4M3a{-oHDYN4J>ctcSMb~ynwHZwN`*$d9Gc#y2 zW`nhrv7)Y}?t8(t3t)!ohc{oXrn=Xoz;A#w2y+~ssb-})%we@S!k{|_N&ugx;qFa@ zS~u(E1(9a8Y3UP8i%80^IZN)16unfVsB|k{vvjM5y|(6vP6&x~@6cXq>i|4Bc`>Wz zY(|aH*KOJfwXAz*3Zrz-LLeqVw{F3GU*{D2<+la}1QEZEI)+T0J8E|{HMpH(jLk~% zwyUGp{gbQN#IfzQ)(K$PGBFrAFtn_##a4#b1~)B_mlex0&!S$Q>UQ0BRX`#Df;TXR zBI@k>2zotpVDyEc1BKyn7qqG%x$*OIe?vcDr$NZMFKe z{2-uk-hlCy-Dr)e;k0>QmIc|g~;uh)Gd&;&409S`;K z?c2BWv~w0#6NyK?l*V-hY`ch0xa>XV83t88YyPl|5WwL?0j*>XlC!`YlE^fjiVX-Y zQ8uSJO(HDJDdDC=f&h0{b)X>ga(9~21SKHmX_-$k3e;33Sfd^Y-GI=`_3_hV0il(3 zU284XQR`Z?_iysOuPcJXzz%Y9Slus|$D*0u-X*Xi^Qqx}q1CR;k{6TaZ4VEO4n~k~NKD_4Z%?K>(8JKE zI5>ASY#hF=O|(G{9;Ylv(CHXf@L`~897Cgw2*H9K$iCm9>W*+>fFe3F0xzO6-A`eQ zHk5`bE(^au-=|Ysk>`ov*4^B&8Y7|?RfF}?6@a{XZ`T!D)!rNcqty-ih`MjB?FBnV zo3|;9DFOSw>p>(ABSlQ0WC!TJ!MMV#^17AU-3&*>nx?P#C82J$k5;Fm_^u5quwt0I zDCiKp3V=!jyr@wWfIv)OF>O~ybyLW~1{hjVm^ZyeEM8hu2P`PNE3SRZgtj-MJM^yT z9chp^6e`+LciOH|+QY93NXD|@YHW?CY2oIGYT9iBTqQR1vX*QOfL&2};xyY8Rc!}g zz1+=Uu~Q0)b=%(B`cw^Z`Tx=OXU&l-OPV0~nW~x@7Se;UoOAP5R&{k(SIa!l|Nj#+ z@6*$jRhf4=v5?_(EViiHJQ&mI^Pxo=LoC9~jKzG)4H(0^qzjg3{m`4rz7f)|zv^H~dYtX>A4!G7Z7=;JYif zn954VoiU`UV@tv(7V5P^ z5`uFLmMe=84+Z|9W~8)8#6*JUr^lyroWnRxP|es>vmq}-*br;Y!w@}P+aQD{#LRG{ zM$Awl0i0*BXO4utEtluNkMDndf3F;8ZweOfw;;nG3F&&4DzfbLE=D9$i^B1A=Z}$m zUt`qRON)ba5JVV;I3L;)z5#B$A3XyQ!l6TAkbp`iG0rn$nCDZB#mWYNhhdz@k?R&W zFGt?hA%I%f$G?7lY<|?IT9)&&U#iA^+f&X%x1s5Q4*YtY)G8c{anrmlk7woRy^qY< zB2S7bsAPnB8VG86QD%M^fdt#v@5#u)ITpCRIWRScH#}|!w5yoMp%(S(w|v}808s~lVI9G&T@fMIR>N%x zzP|h4(Io9aup7ewhL=$JZ`6ucV9cA%UWbG?;h{l~kNF7$)qz(LIbdO-Wx?#UQLFtuAk&p*Gg?P}oYm3)~Px^Z~4vs+iWaZRJJX z?-*W6xRU)!@j$7yD2?ObyisEZkQ@zW0|4<>sw45CGU~Mq2T+ln0Am@vc*`&6->Lva ze1Pd-NqtWw#D-LhTG?9b2y-XFb#1iQ7y6iNmtqmH-J@K8Yk+0|oc$6B{Qa8(Lp_1x zLv6*IDt2v1T2f7lb183i5#HT@ub%$$a%O{>rLg}$6-2bKgmHHw9|yC z(*g-NAo=*ov-{IK_~?z?uBVZ;R`x!DD%N$0Q8oH|zIIZufx`p>g}Yey=jROg-e@mb z<uvGS>6?vb`1NhSn6ffYGhfX}%jgf4KgJTy*RhjVCfGc!+-6VW4`PT{F|B(1069|KGheYrkjt9Z~TQ9u@p6 zA;-1XGDv?M_uNh0r9*D6CFs?)?!XCglkIEVWUPb ziea}mSyQd8mzmo7Y=K%c;Drci+N^OmnC7=4PsIIl-vHTE`}fg~nXPm5Dh*KdPCMbJ zSJn>Aw=UokY#=kDT22odvQ|tFchh)3Mc*o!1o4LITF(=LFj?72nPAE?Ps13H3AvQc zfmP^^yj)=D{<>p~!yE##>KUx4R#OgF23x_-kO%<2Xh(Wwpk%|Ay-*zk85jgH)Bd2C z!uvMD6Gir_s1QPW)*`e%ut(=hm)|aBtB&|D8ikD2dz1QIP6-{a!#vMEt(b- z$q7($9KjWJ0t*QZ@DF zpN4519Bb1m%#N5^bqv=~mdaEdD}0PY@XQ^Z?Hb_FjJ)esqc6lCMRUDd z3ccNcx2L*abnD75FKr$exKeA@@>+7LY2Q*Rl)*6zYN~)k7afO0OrC~`spf61fWx*` zY~{Ql=er>X8(fAUExK>`v+Api)ZnG z4h{)%89YX2pro>CfM-S|4=>d~D9_-K5fobYONNi9DR_@ASxn9mWDs&J{_aB<_N|B_x@_}zvioO;C3_`uQRrv$Gx7SUQr@fsm+)0;LxP9_FICFgt#9s89TJz75trD z(J{`WYs<8E?E3#5Tr)VpUKjmpRZDGvs}5>at2Uv71V?1B)_TR>4wfUmK6e%o?|LRr za0F|&RL9^BVRm`J#5RX^q#19sjbjvOtWvN4;=yTybJNH6PHQUgr*~tV2k|YTig>2# znt{ks5HDmc7+4aTi_`t!K@L?*g+KvT&DaV+;virQr#Q`?p*4SkruB^EEskQ=5fKWl zkwKAxZX2f+`<|2*6r>M#6432)fi7Ha43LbzHYd(nQP=N*y=N@70uypB=6prw?!5{C zL_R_rsunBF;E9=-hu+gHu7FksbEQqIZDg<}*^D=-BIhJumY!SSnH0U=`LU<@)Nlgd}~P+}-pSscL%OB{#j zdNZBawWem-1s2CpklD3vs{lKeS4?$>UXr_8=6C1)QAp~SiHGyYh^6_0^t$V5fHk}#OL*Hj5JCR z*Q_ZyKJc6hWON;!24VKSiE8*E8y zY6?aJSf+>dY&n0c_d_~AXGJ|1kBsU5-A7u7ar%(rFZ10;L5frJzkZw#Pk`E&nO;%V zH-Qh<9Cfa>JDN`~i%|#hIf5Hl$0_eQr+VJXnp#2CC9mrO!CuOJ!~t+K1t}|cc7%bT z+>AkRXifoUCS!^ByglcHv@P5i&;weQ)(WsEtqNw>i6HU)8j-WQeEt-tdK!+sck^_> z)LJX8qE#aY;vXdR?A3q|#}x4JKL-qESDeKwsG}omo$39Pnibck*6r1}nYj||74Gqm z>%F6?54<=p^g}Xb0!$3b*I7kB3I#x245s}Kp<^!r_$?IG5g6|1!Rp(0scEgM6>ycB zsCu zqb7FL6hs6$?Rih?@8>a&ky(8M0nJqFwNfSqGm*BYMMc6ix@5JKlKX}61t=95!G7i- z5q|XJ=;aWy+@8OGL8Ixeqyhl>D$_kEX#rqbTSeN_hOHK?8q@%3XkZq{WDN#$LIMR4 z4W?BcfHOEkYAGpBoc3L*b|456taiwFfK^~EIl##f*n>Hu?6q#kz2>~c(W5r2BF%Xx zK>|yph}r;SFkY5cLT$xLZLRu@DE z<5?hrk-!|Gs#G>WMY;QZfRz>1r#K8z2nE_T(oI|5q)Qk8okI%e7^N}f*zaxHPgf*g z>zt#GbpaiS@#}+Q&C0f?w3T%`8-b5W>GD?y11Y5h;S`7HqL``rp#Tid)|P?u!pM9) zY^cen>}$(8s{#V}FmTn3=dhiIDMcR!g0<==C&JKL8=MbZQ_95x{Bd3+(GOJvpn|3e zc|C8%gE@FF0rzBDbE>5P7*Z+N9)CMcGQ=UG7>?-=0f8BW<|mrQXkYWC!jEFf>dh`J zLv7#ks&NXFFd0f&bDwg>kN@!JJKEO-scBu;ja4%q%Vv0byga|Jh(i@CV1Qt1l|J~!Q^-xAHx03+?cZ!Zg@H>~FdGj7!V;q1--IF2=qD86S z1==jWd-kYl$9A9RcZew}&}C@*Kt!9Vn)cgUxCe=sW?s7%d2oDP_+P{v+7Ie0I8sBW z4S-|!Z;iy46^yP}|e*q9u*`a1#q_QG8H-KMX&52i*C<~Tn3uqt;Q5NLJWe69!jI7t%rK*-^Mum&(`os!i+wZlY1PmyZ>=Ey-QWMhRJyYX3$r8F zdgIIk*349_^d^cXOo*sRYaCh}hOL57l^x`VlD$^xc=mz8!Na57ie+-dUK(nDPMvek zdto9L>cO3AJpfJ)zBaQ`t(aUd=Ji3WMFHOj6Abv(JE<$qe*4_XT|I~4AieG53$$oI zv)k9SLQqGr08#vyQ+Gg$tk_X4%zGFs$3sm4C|!`fZv_|2d5qAi(`(`P-)EWJmtw~V zS%t}wYk*n{Xs~8=iO%<39Eu45L0h-N{-2t8G(}ez*1XiT<*n|eyvX}MJtGL}R+jzb zoz5pE$EH#NYH%35HAbDnn+Lb4YVk#HE+0IEL&`?Ww14wqih|ne_-E&tp;}s%P^9eZ zx?OGGO2GsKKUla`E?RZ(V;>eT2)?$g=qs%@Q@uPr`U4Q*4rEV9+)H1KJ(+7~=w1cP z6}!AVELxF@rWEUp$;csX>xRKt4IfVP?4XJOgg|@07$2foRsgzfdqS*CZH!|zfu@xI z_S^Z~_vt^Olr`nNTUU0~*6JTGkJnYmg)rVN7hOuSy__$5fF%}+9T&Wr!Ct%3{<}AJVC5p!t9sIH*V36AiLsoQO#wp3EF68gm&KC|d;kQ2 zcKvvc7__k>r=8$m7#wBId@|Ki<=QQUj8i}@&e2cz|BDlS+5YEdgnzjG z_{CQAB-5xJKuae8nl>YJ6L8NU79=pG{&TTu4UiqzbQ9hq5? zi-MW4>xNVi8zX(mg&uwx2VqpbwkxeqryQ|0$dCj3wZgRuhO0p2^v~)0c|jBgGJsa2 zREooNnxV_K-zVZYj1TXoX;NLc;)Xk4N~oD! zNe%rmXhy9&gTjoQwpvQjX6BkQRIAxtOXJ9Pu6rh*PfRWbWaOOMqN#3pc>jKkEU+CQ z?su;_cqHDwJ%@*XJU!s~^iNWAuNI4zPxtAp%FHZPHE-A-1N$*d5^~;i_(z`NfR>6S z@uOg0SB~3d$>zi9G;dFJ9<-?H<3F6gfFoJniLnDbaHR3R7N`h#-*i2H9Rl$FfB91w z*cyZ^adWR_xXg(d@^Ci}RmOR5GPiQBkVvRa#`)Ke4ABGtx;;N7nDY zj|flevhV*_vc@sl{(Y+YF!05IMC`azT=oTLroeH65YDB!_G0A^4$fMKxO zaw9TT%|#0+_%Vb7y`WHdVpeNr0FmQh41+U<&x(t5BDz}oo&-YI{GcwRS7s8a>tz+zZ0YXeNvl2~GZ1Cvb)g9o5KJtO?f z^r!#&zx~5$(A2b{ImhbJjG6(>T6JK#S^{-Vkw6ZB8W`-ZG&X{he$|znYe$m6 z25Sl!gXkdWzsVhyt_wF>hr%|P>pH8ig62!yv)g3s_=}pNIY)C{&cU050J?G1+9`Hzc&jl1t5j341PLW`U!}UuFBb3>J zu~ucjYe}slcGV(<0W|sn$hChRLUqSqPBx#M?-cy&IN1~ea^Tjjh{;t$J6V_3^!)sF zzbw1feaQ&&fqY{l`qKEMGDBSR#XlHV=Jp$%6V1!)AZ{k z9Qn9SF5IFgFlQc60A}{W(g=Z&u8NzEs5{L<^vM2hIsUa}#V|9W>gbRTzQNSUZip{* zw3ulvC7T)b9!s-ElZA}3%x5AW$MJN!AALV7j`0m}wcVQt%wd=k^dt1W#BETVfZveE)P@k=U zhy^apA3x1O218M`<@3LMUBc-;#TW_PmMTOHm9fScP?vPM6u^^i;e3DDwvmy_rt7vX z$~cX8rx|8VwN|a=bmtuuEb0hkT^SfnTW!`_iB72X0=ZeusnIa~LfVVwfuBat+O&(zv*QNPk$nTrT5D#ebuG)1_KLgH$NS*v%D)1b9UpzBZt{KrDa;zI z5gf@eDvnj5&uLZQ;bEc%W+tc_L%Z;p>$_Fp%9QR=hn4&CJk}U%0wSt_T^H`%a)Vl> zycO>Z#!Q7JvJaETR_qZ7Pa5yv4aefynz0i@6YHwVKvPe+A|*Pfoe!MJ^$~!(0_p6E z=5c@#S?jv(c03*2e|p6;{d6-T#}2L??D*pYjwQ8OLq{9D>EO`u*2Bz0o4tx=?H0Fs z2m%0NK)_vT6<3a6@3C3~*+H#)L+W#cZmv$~W(7ZVk%*PGV_oDHms>MO4y2B%R4omT z-*&)XZ9lE5yU&7S$aS33m$j~n-hXlgOlqiN_PR%EuP)Fre!-#dV(4y-%7&|Xd+#wP z73OZ9x+32Vw_C zURVb(M;)YQbei4M^kL838NF{0{#uetfGeshO`+|O%+Q=t#@2P!zzn!~96|&<^*qTe z?*-?rELlOqMGPTRBOJ!bX4gBc3J6h3<=&&}xqGFh%`KmqmKgAG^Gq?aZ;sIPioeRwn6+TSd;C!ct91> zfUcLt6##i=W)Y~8xOskfI1MqdXOE)F-6&3db^UHX>=dL6kZWn0o5@vF1&)1d-3ILk zKIj2n6yjGs{`T@RBWDDFT5FnX(RP3tJQ=g8IXH5DJn=k))5HB~ic-(eT1rv{?(YY7 z?JzjFE^@BbJ!PFH_oq*PzMsYJ9@4%s0Ep*dEI#Z|EX9|Ow(=gKODE*A0X}c5M@qV5 zn5GP5wQVa|k@h{v-RK0x&ne|49VYg*Xl(!wA@qV89)`<1|Lr zVgOV*j71dSVTyn?wW{E8yc?ybSG})nYSy535P-=u;G9EK)4V*N7X_)Nea}z;#RK5L z%xoSWj$BhXCkAFmMAlpfD8a0#)(X^A@_IR+pVu57FwSQ5dNFLb{~R|6b&rng>d=Up zJ;ee5Ay!2UF^oYRJG71)MF$z%flffz@i>T~o}9VXx_3dp`C7B1(`wCH_s6-O&&#vX6`K#p<4=cQ zJ&N7T#~lFs+3RjA^b7a(c*KBz$9zw_F=NwLOs`j(I#-W|>p$7`LgyeX^jOshu%FN3 z+~IueaMccbd+7dZ$Y2okZt2T=9a`<|8Ty}_lQ?&9gk48#y{O>4T7zD~TYdW_bcqDI zOL;|r68jq1~@JmA(^y(8!BG%f~E#P?6tm9{=1G1*`yJe5bxf<9|v8) z6L~KIk$DnS05YPBETUmYQKINT1+S!n5|)L7_wPTBK_mhx@AbUCIak%PnZk$rDFR8i zGjf41;2H>C4s;y=76cy*K%n=ZKE6NAvm-}ZVJ2SKJ5*l)xGN{Pfhc+~>WW-^3E`$Y zN))BaPi{^p4RGxE5ANJ%N8;tQ)|yi3_qj1Z5LB&=5XTedKTTmejrY+@5ojxxn*wqg zJt`~1HM6Rxna5sNypU3bFRmZ1e@l*z=aMR=RYp zb1m@0X^JSeZYfvPlJhpc55mxt%kuY9tP|SW1-)T0k66*I2pOdafMJ}XFr4c$g^u4o zJJ)_(&HDl^FapRC#W6-1=l7pJoW?O~Vghtq9-sYkT2J~gNUK`B4)7H3t)yp{OVJMr z?&A-g|9fKVcK)2PfrFAdOd2UIcmv5gxe_QtZf53P@_Q_EHVsNb2 z47^_D?G*xn*k6fVEF%iW2uxG#^PSRBhHnDNAI;e~Oyj&=?CXFP6OF^Cvfi2MgkN#`1j!+W zD{qPJespN|_Rl@?du>;}MW>7_In=>1{FMji$V+6gbq7?#X+AlZt#Fk2^#0?=aYAB| z=!joaWf|l=B+j$F`&QHX?BlxoRBP(unF$;Z)N8|+%4)GL%mr5a^N5`sp&wpl|!khT6hc*OUgKHN|5 z?f`Ao&{X3k(zTVwRx8x&*yIoLii6u zM5^nSz_9~SI9NopTC!;sLj{})K*fQ!5n?`A-k$koCjL-<=fZ4d_AxGj=O)*s?cV9pgFtb<^LMy`OG&tr88++QD;p zT`|3^)3^?0e;gsfSoYt~jpeVTkjuNu(2#UbUiE3)9>gH+odKccp_j(S} zdIP+5;eL|>Whvk=dgH;((!91W~ui!)NNDU$+&9R}*cQa`* zT4E$>faZNK5OVDJ2R(RU?|ngD_tIt41q|Wi_$)B<5WMZZi8;Q1e;30T0j)+bb&fqb zCxr}fUP8Auapal7?6egCp8Gmw1Y*z#=V1Ew5fTF+jyvA=Kz_IDciy38w_CHO^YfzM zVHkW6f}xofRUQUFSR@7l8qa73Xfvqu(L=R0Q?p$5H5bgheEt5o8qKFW#;(iy?dyhN zW(GXSnBjnJL9GnH2@fGCb}gyc!Eo%jFa?5i?Fu6i$QT&V%Hjk-y)W4PILeTbfC%Ct zgmbYfedIWn3LpgU(V*7aD~i@p3bkg?)=FN^mvysT7|N-_1wV-Qr_;mf?ml>LPzR{y zQd5;n!6^RZ5P1kO3amM2Rt$bo1C6KCLtxcyH$?For+KV0-%S%&O?ht}UP@%GP%Tsh zU@iGla%#YE(6O|Z1~$}vU!Io*-t401-GJKV5GlksgwWB)6%FtNx>dAhrcKp!fBxy5d|=_%C4n-M}Rdr z50ly_#7EXnw|N0MvPMve^^~l9)m#*z^lVm}XQVad>muhGKr+4`v!*YMx)(!4DWzx^ znQ7Ln-+cg3TyxHp$lBXkRyW^c7+ix<>ww61qrLsOU3o0mCY=M?YYm*2)|PX0t%hFr zIS)G`bd*vvy@rn4$Jxst`7x+i>pTY6r32`7?s2_qj}*2ShsWVw2Zp!T9YUw*Gogmx z6Azh{d!ocJLNnK;a=6`&&)gsM^2mCH{)0qL=S;y+UX|Ea%#XF}$v0fhH{ZO!-7ZoO zzmD{{aOw_xjFG!mYrPB}v?w!3G|Ub)m4z>5+2O)S;w$|ZKYnvU*oQq zSq*?=6LP_b(3<|i47&H*k7SZtpSiHRT_=ZD*Qejk8T?C(F@}z-Dru>R!$7H{^r}&a z=ry9DfxT<3s^wKR<$cQuA7uOfxEh8qN86vb^ViF{_&Ef?A$UX<77Dx&x|dmpnP|}l zM9PfR&>5I7P38yyV>pe2SH;04`E`0+{QX2J&@~}FtSnl^>$ViMIJW9K!RAmFA$Q3A znrU9w%f6QiNGZOQ+MEa^#Ce*>;MwuZ?OzgB_2V!N%-%=wg4P+C{|Khl7fR{VY8eN0yiV5rseyR02f@Sl`3jY=A1Li+nyAxNVMgWujj=w z#u$S5W~!wW0BoK*%8y#J)~wZ{ZC{@L_SZ!o&~!=9IYA`SyZ3hjRkrI=a{!#KI43>G zpzXMj?)Y!B)^f^VR5+k=NxO4^mSv&4W(rmx6wUhbY$RQj8X!QfnJQYG9#o5E3>>|% zh_DtPur7<1nA^2R1jl)VB`$l}Q^n*5hSm;}FtldJ6bfbpamRoU=(DrqNg;K(3KR8U z(2m>qr(5fCUxwZqZ}vlV_!7R3A%wNp5_3m%`RRP`C5FAkAotp$;QCMQJNTiEXlU0u z+Ww8I_0@;eKYS5!BY+(-m|lf;=g^(h8;bJyM{oZf`|)}@2V%#)0B{@uigMJ4H-}%~ zrI-U=02Qwz^tJKpfA)R#%)``R4Nk%^Kgsd-ykYXA`w!!Ax*tbjLTHE7-|He(b2krT z_$c0U982BH{kLx*0rMeJuAOC#>)|c*w-|*9Kexu}L6AhO73ZuAW!~X*-czM6wcUj^ zhlDKT*?RzKT>vn`KY)WoF9C$-l+*yC+Dz?r&{hyGlDEBI!M)!u#L)eA-Cm}ddZ8hJ z$-#M`Z0VQ^@<}!1t+BRLlbS(1%WY;4u7 zuC0b2#`Aqp+R)In?9bo+{faVH$a4DTJ!Q5RZC7e zVH^=o6J#9k=A~VJ`|`LIydV3;7l1?MDXc@tS`MoGRisipqHZQN0U~H_oQF9;fjcn! zF-)VIq928Us`Z!UVMT~q^!xRMYM)jWU#nDHXaBA4xLV08slH7xP1|~YJ})JqwQcWm zt$iaOy?;T;GK-gzl`vnP-vJz=XH?`07-VW;d?W*6h*7daChG$_Oz(3zJw&u^yIh{C zgegMnP`ARn@2N^nm(SlarjY?u80ECXN1&u-1J9a)e9qQq_WcwBdmp`8+t$7+LcSN6UUX zZw>%4y#lE;eaUZH@uaU~P0y&VzkLaE&3>|2zu8{Zdp&ReohsN*-t)VC%F)kj?yAMp z<-BfJ<|x02@nT75hi=(X2=*zTDcs=~rh4R@*SKfLM_teICD^}2v34EA(GTI|&{Y*C zhOtzteYs#|kfTOg04IMC_u7GUeZBA#@ip-E(PppA9bjx|wZnZKUQsgiRcsgZ{V9$D z5srFGu7izRgENBDV?0C5(6kk)Cc0OxwU(0hZFlboWq}`uaCeIH7#Io*YE2dV#^b3N zlj}qaapastO*5YEyet_amP14b%^3CKyc$rp%j4%58U7WayD7N?4Qy74z@7MB*zZ6X zuztuHso+}!P=V(75j=z(29kgrgDQf=KX)}X1_X87b^(*C(A?l&I?D#d1)5S)bJTHk zaIPMgu>sBv1Lw_B0xyf-##%LcAM(DfDFePJ$H+RRT<-S`&%1UoAoo^syVPyO);y0< zm;m*?+bEt80Bnb6A|xkCDQ(}+n~g1FZ*U?ElaWWy3hcrA08G#f9z;+wZ4Q9e+OGyV zt|jkoa>8DEql4fKmbR^s48eO3%R2xzuy?GTarEZt>$wf-k9`t{Yc31xIH{bM?@!;( z>UlcwPOWN1x)^2|@8Z;IQ_b$C2kZc_13}HIYK2w=NWk4_cgjqGns9cB)mXFm!~F~&nLdV2owWF)zyaRUI; zJzzuu(EpDe@L3p%8j%BBYsE{rod96gw3W;A(eO_{02U&0P*uQ5oTgK0 zTTv|M_m^)IH-eU=sWOv8fXD;`C@?vy=w$zjitrxc{z0%`mgmPO(ke#b=mQV?KC4seTN48@24Sp=+Xba8ARjIu2d)!T!S_T19ht&tu^O8t(V<*Tdf4a z=d_(N>-uz#6BKZvdhdPf10`#r&!;*#0|YWs0%2%YszT4$heakDu>@vaAD`gw&T+B{ zLPWWAd9z{QQc^|DrKlF)rx;p$AFr=p&9QYEfS2%h)i5AjOIYAa{r;m^W`(H_N!qJr z{k6#3^&j0guScTa4fy2MXyN)%Z(`3e_i~UILD8cXNVmVPlGSK1=Q>5U;iy>cIyw9q zFtxeY&Cnk1Uk5&e9rBV)j^OGo!Dg_+Npmo@H)geOH*G&TZ8$R0F1iXFMz{c=AUiNc zM_b`{8^3gby9)}v!m2XRs(TGf>gGsg-7=*dG#BW)Zd=}$G>w2}U%+FGAut(G)e&_y zt5@AsQ&iTT+)zVcsX8hKHuw$E?;v4?mYl1*f-r?6OWQo&jb;En2qT2QYvY-kO>f zWsq|>`vV7{bFb0Q)k^wMCq=D7_uHsWPKo4TrAp!X!0s=>^0Zn1Zm+w!H&jsUj ze-f6Ca!vcTYM3R&0j+8+ly7${;iV9;-Z5u*0H=}IiR)9vWr6~N;h1eQiwFy1rQlbX zssdU{r%3tvKJs1O&KnRtGlnU8gMm*p`Y@3fobG}bA(Uq0F!%y>!*uxX6|3IC1Dh!d zJPatlswRiT4q$Dm+Ik-~LoE2ZKt79@Vu1rUAG|$UGExWy>^;;FM zX8UA{LtYIt+@sRS*<0PQugoP&zow+ zW9At_n7pw2k7IWUWryw*bY0wDum^B}!RS>7Pt8(Y*EQvUp#mNSe_uaZ@$LEh)AX(> zfEb&S9Mk7!walln4aXFhG;L|&q`Q{A+W!3bbl$6?xmFc}zq=D*HG`Rg%sGak@*y^PV1C*m zw?=Ty!4dd9LlG8buOv{#R#Qz>=i_Ttz)F5TOX=e4w+?n68+0WF5ChtYha548O!K&> zknzp)*q8&~Fh95l-T2L?m4J5)&7$C=Lo7FPNFx=fw5*-1>PdrKxVOLp& zLE@rgrmA%-=kvLU4UjDP<&p4VVthJNP0S%6u_BKZx+D}40&2BlXj-AQ8so}hVC8-K3kT8WP$HM1jjKMXy$gYi>p2J!T zE8u|w;&6JHBDCghQ3XRWP4l1#)n-5550MDCn?-~e0vm)w)t%RUjzDwJ73HdE21Bu< z?WtahFHEGcEL7dGhQM)aYGq%Z9-p%|mtBG8V`XGw0IH6fH8_CS`_pnE2nnG*$5fIl z+xPGAVxk1k{0?2WxjFzGgCnF(5afOu2GUaUmKD$?pp=XXXeX28<^1`#uRc_OQA$pE zKktKhasZQ`vPW4Ls{|fG1X$IxutQVLm#=^QvYvn%!R=^onQEzd*Oa$Zv{b0>%5sX{ zI~Mm4w6BJw)vMrUM{rvg(Uo7Va{#G->80$;vLv;N2w6g23^jZuY5Q26jl()sX&yQd2_zE!Vwb^ZH5o*c-%8Pd^hX4n1f0f3o^0IQlwz^#WA?g$u#W0KGT_CK&tj(Eq% z@gMCx0PQf3po6EP3e~Eh0F>55gjGd+$a`_v!lCAYgzHEi>+!ErpiLW`^f9sGg<0LV zK3i?p0N)&dgOSWvG>~$wU25&->R>x{IUy~5yblM0xc<#)AGvBb2&#y+eg#neACUU> zua9;9hv$Ft^TYV3KYuvQ4nR|D)>;L#*HqW~pYK|&s#c5!_C%;nTkMjys)m7wc=zq; zaoG(uTWYBloZX0fNYJ`2VoNa4<7 z-Lkv?@Bw=oF-s|y8sRi&=0rT(S0R-{*=Zd*`IWc3y-Q9oqG~?U* zQ)p`{^x-r!J5=4lu|IpNxIE_bwq*DL{}oUCRGW_>zz?T+x*xs#x_|lleLao$xrS}e z0l>0(4pi|KUc5(u_R-&C9mbTzzB!7(SgI?tlGs$GTUL z$n`;OsX1f7tgx`7&Vn{5b(If~2Gv6lI6eODe>^IO(_FTafao#e{I?8*Y1FU3Jn+}Q z{dN2g|LGl$C<3hPJ%oE;&}s$RFfxIKe7qn1*Do9H=CbWrpSDFYall_bVf!oY-~Z$L z3SBmls=!_ViXJfduKU7{Td!M7X^6}cf_Uy43Tg(>(6pyN-Cf=_0OoF^u~&7FHW;cl zSeRhl-`p`-)jmc#iW(yK6879xRhuX$=_X~j75}Xy2oWC)iz6lNIXV5vI`4i9SM`^x zft_oHrU(7pwYN0C>uX;|o%nqLdV`n%xaGaBku^f=Kosp}MZJO3dU8QT1g%twZ>ZF3 z+5ATvT_F$dsDS8t$$Mj%9KE3IuAN{&mEn35+J4-s;ca7S46vzpVkI47w<~hb$QiiWfCC=LIqJzjL~wkJ}vK7FnAg2UWu?lcbs{pNR&yR>e&8y#l-VZ6OYV5#M zIg}0b8nli%c&k7oKhz<3PZicG_)1bZ<|nUJ=J!+0%;%zV}hTt8M z14{@4I2CaW(+X6z(kdW=nrq3e>cCnQ2n={HYyb-hf(RgJZ`apf#Qp$gf1hl zm3Wh);K?}$CSewKL{K79@)G^i(^{3C*ibv*yVY8mQP#5)BHQ7N03YvH@)P{sX=IKu z1}2y&6Qflkc!bd!GKc#CmylV6YY>M9B61G(X;n<8sdD}X=sZ8%&x7oF{r>s4rvi`E ztOV4&t?P#Kpc03`{!ro8qjlE5(t=cX?>y~mG6rm|a-OFFtyv@1nzrX9X@yMt*@I4} zyNA1Z9=O8b0t3*dYPN$5F*<^>SziQiu!G(JbH;Y17prQ}Qi~-paUD@#sx3|1(^5Xx z)u@Zj0FLP>Y3zkyVBM#W{5Vc)FlEMu1>pH``8-#t$U~|`PS}$RaeB9u0xfx6i-KKa z7}^c9yOx-)2drjj*NNE;#`zKetOH`~B_J8>?O`_eHq5_?TulM9 zPGm8lDK((g4jyM%bz~rGV27(v*qg(Ba|#aEncxjKbzOWMcTVC#54@g*Gi`9ta^p39P8ZMe!?! zfV|WtB!zScoxlkNWsXD}bHcW6=RAg#OReRYm!pb1`ZNu-HF#kMCToars15MqpbfPc zN~-AEV704b0Dx9m5o18LwL>}?su|~{WCg_#QBcwH-mFO&#?$FhAF{7L)!~o?A zH7Z~qM^y2X)MSX>lf)pU^yiA(Q&OHDCKdgEuYL~i-k%0PrCp5KTP-QkUKAX)0rpKyl3pVVE5&InLresXN&X0KP=DR zweIJ8x$FU<^Jd8rJCK7~bB+O{pMou}TQ7>}D0n(B^5DS`j7;e2&FUQJM)EUy6(@cc z_RxL(3@>7vud$`#oa@}6m-)C>bkRlk#(0se5zKW79_~2()>D+5BLiOHat=C2muBlE zHyrj0*Il-wUUF}+JO`%9&=l^VnI8(8%@kU-H3Jb$K~|+ZvEz+kO5bh_=8jwKwFR2(zaM!Ct6OMkU z#1-E}eP}?_b_F@TSy~yc%ZVB>!4RH(!HH=sTPTYjW3UiMUt1^dM#c&cEa&sG-=CH} zSFQEdU2kgQy5Of~JTM7Z%|IxCf&6%FxdTvUAA$!dBFO>DsH??;!~1ze&H%#%QHJ2fF!AM1Q zpTut|cQf5rfooMQRfYpy#XxINZ`OJfTiG;cFqxlu7zc)Raq^eVuC0949~EeOJHZ{r zoqP4e+x-*(ut5YFJ?@RHK-EK&-3tE5bv7QR}b~# zBOFkhro-hYFlHvyQnn={^eM0h(j}G(5{DLuMMRikW{zMKrbh67P=K7bVhv5TBw*ij zLWmKSr8;ngoMkxa{HJ$OlaGE7m<_0~&bJpw01wI%1+gKBcOk@7sz+~-Jr_UC4`bs} zzQ5zs`+0Dde_KBP_3uwRA}E(stEKe(ec8@uEO>Y~2SKZ4FGWE>H#}kh`8=XVk>~HL z4~)F$uw?D2bZf2Yo;EOqTO4Mb-hH_L`2KG60ImYlTDJ32sSpWu2HzD#Krrsfz5~!; zO3qPp#7xM@K-~)90V2TwU;wIa_59nHf_+_acftfmM!~V5n+wQ+!*FN{fx$=Iowm!a zp24x$a5qiue9o$SYMILE!xS8wXOFpj_&=Whg`R8OzTteHjo1J*?#lm;6iP>L;fgw@ zw<}QhdUd2-;-g(>gUtxdU0Z3LX9m|hjMrzR+10_8+|LCo`6$fvXK{}lQE$;Xyj4Fj z{DI8a51W>vZ|K&qYKoU1wm*va9sd7QXy#iN+ujH^B~-n+zo|28M)pSp5VF?}y<}HM z`@WfSLofAiKkrb3X29#=rty*7z23R|k+=Wm$Qb~+=7IhE<59G?@zu_tzTQK_|RrdF*&n+^eYR+gd)(^6}77~?qlq5!VNlPbOf!{8lME#PMx zH)SY{MaX7&iF=s>OMS+9+;6XPTmc$--*!XRayeg~Q`NHNR7!0b?#-Ro4(|o919Kz; zp#k3ec!k#Z7zu#)V8HY3!`2DI5V6CxiULI|8B3`OKzzs<+EObO@Z-B*9wttgwa#C) zjYF6QFWu;%IzT#AXWPoUq_kC_3ZAj2j(=*3ElbJc93Q}=pT^1S>%f-~EVM4P=IC}C z^~_5v%<``A-g!3!VZ0ix13&aIf6~jjEdV!F`ZpbPwg8d_I2>d~5r}7pgq9sVm|)eB z5;UJ5zZgPTkpT|l80AEe!z$A;V3r^M_Ag&La5Ca{u%?H&`(b#)!mPTNTmX1Kh><5| zh-;9#-@ThdKyE%r2ws3j4Gm_B=8#Jx-%M)(pn4#p2&O45xd2)!fE`#cz{NcxO#KN~(Y> zfOF*7F}=<=vBSd;gT-MOhxu;gvgP%kAAkGX*9~JFu_vv7u9wGsIX||=|N5sg610?k z>%m>2%m6%e{hC+ru|5}YpYYFd7zR_jqO=)dkP0Bucz<_4-$l<#OrAR(vo4>%>j_h> z#~VzW0?jFF(^ovV)~;e8)Jsm*MF9ni0XRHeusxr@T$*2&r~1iAh|$pwfT_M-8;xNE zu&45np5`5lL3d#KG^s1gR<>o==s*ABAEY!;fZiAX82`z3lm*|W`pzFFUF;ZS&XIZg zo%G4im+3#)$XquN)GGmsZbcPd<9=SMv)2#WF|@KP;PFk|qy8>3syBembrCcBL5=#b zSa>sgv}3>SXmZ{Ti~v|=MzdD00#-jR0CqGm-?VvO6vg_3OWYjTUBL}!zn;q$m3W%xM=7x9J@}9S1HV^ZN zfU*-2qb|@*ao!YE2Zo{

      icJ(_N{n^{;jR ziWt#nIUV{2fiB9hQA}MrSIOXfU_1Ph`;=5r(6#-9tMAh_~2Z6UQ<&=k@ zOOG}-ccdGYxu3CfKoE>-tjkCf{mWq{^ znK2`3?4Y76RC>w?>nC}mRiBq!!k14>?i(@YMjpgcR&sCgBJYG(c2axhn9*pnNZ7%t zY1t`8N1M&!KbLvxNENTZvzG79!p;+_PP*68Oi-rrZ^dGT`0xIcrD~Jspk7HVRH}0x z+Va0a^E=0#=Me{8D;EQjUw2eTPc2(iy`bRwu+MZJ+ivV3c}UPU!YhH~7}(+ase!mA zm-wO94u_N2%evLW>MigSX^xi{Q{?KFH_?XBF!`_PiAJnb0z{2QV1$hfWo1 z3+MmHzmGy+%AP+oLj5Ot5COZBm8ru+K$2#zZv5_{KSmfWICXt*_8>Tz>;qpm)kj4rxV`wDN zB-Kw()QWnVVi^*^)9CTm-l&Ef*IM1h%%la$6-+g6jjMkZU5n1QiS=FIBYSQZA2?Gu znn?y!C?)HDFV=wX)~q*5K*sjM6SpI#ZMGNEvaVn3y7uYkZ>1!E*_S^6mq>15+UQ4b zY{3ne#uBe@$5eX;Mt{TQy?`w?CuI}Omp(O*rF$xyk}q__h7aLpa9mK!%WA5=2EF~6 z@zX>?$=Lo)4KJ{uqmjXv76=bpkg!j23A_3Z<``@-WY*dd7N9kCUJnM%EMQj+LjF$n zW#N-&-xsv(I$&s?`Z7_q4J;do#V1L{XgBvI>{nP)yw~ZP{~gpwePBnhGSzm$hEaH5ZT?;9JX%ST}LlP&qt*k&LQLp?+0`U(tv!` zkBxRSiW{ZtoUxbLWsP^jR`$;>HPoha|DX3}Q)QKesU@ke@1PnzEg;B~B=(mJ>5d&^ zzp`^&R5R>V4y|F}ORG_MSwdKM3)O9Ons&{oR=khW5WM!b{P z>Iau@VHRmhVX0oghvvN(XXaYFul&g(g1&|g z%X|;Ww*x_LFeF4R`%5ytF>05?f%qbxVk)M)Ks!HEz}UjcDb?*tLtQVM{ZYrezf?vF z{dDxtNTSrBNBucX4Y!8$QgB!216NCD9mLLa`of_){9#~YY@ALB=H6=Zm%xcIN$wJJ z%Filo)~Jim1YT~xRCXieDXVbunTc1Fcmaal2IupScXLpkFD79t8ogQ>e7koAyb za&buwFtjBLh>^_Gepqayppw<8-MPnfY;Nq!_=|9@*Ku57x0!G)sKpMX!G|}vj#1bu zJ+UiOZ8a6Qk@HB1geG%Nw(fu0QvxU=_?D9u=TmUOmX`-kcCPr_w5+JN1uP5amHs)* zFUo?)lTCdCsJJ|jTz=RkBjOn3q0om|ZW|1P&`3%?88jZDE@&dc|C|zUm`rCxH-=58 zI!ZWqZN+7J4URDsM{sbf(FWqO;sM1TCVUnYKRUVo`hEOWFZi@SmyEkY4}4qz2;8_{ z^pg7-kuf0@$zAks>YQ_U9G=LOVo+^j>GK&Rd}gY?F>K106_>k1Aeyq`}s@Lr^pvmFqaW@_BY38u7l2ZVArRd z6+BU7AF5?^$d5IDgemMPvmAUQtmZj?tPQ$awvgn|jzCUZwLo`It1@m+ZD~(nG&*H% z5gtS8=rDu(m)egRR#;&h`7ewz^hPit#|xoe!OhA2S!vchqjBdveAB^oonCv76Ky8Y zC1T}kfZs3BZ=La~;MfXgaO%2NQ~3{Xr9qKl@LN(>b>!$+1Ini~O!nL;Uf&itf4b(L z6TnMQ_o*{=9M|hy8qTQCW7$fUt?rs3%b#=(>vW`)RVFic@ehH8?%aKeM9~lm!4;$z zFeQTSyZ&l*ye0udfS0V?!-gVnEQGH)fj0}qLnp;)_cYP)|Ha?u+P$!L5JTlALPq0w za0(-Ih4HJ9_){f0k-p569N=m}#mC~X331)&_7v{mvt)HGHWVX`a8PuW@9TFOWg`1( z&e_G;vOODPXO(+WvIdg248kjZZCjOmqP#T?fN+1EjMKZf##9%#YsX z9$5~J9LT({*(CBvJ**rqXK@n(YC}rk9_78(UEG&of51>>(&QOsH-&Uq`#*H5$w)9T z3$78yz#ba*cGfu$q(Ny!ceBO=ZPQhL6!htCFng@y2aW(B*Wv*Nr zh(Q9JVA+OLV`XM1vEbuM!Xe7%5Z9;(?I`hZsLAwkgDQk&)RTr$I!hJslcL3#1T2~n zo_GOv;Kc@Q^r;kfcOPPDY6PEO(rt_eHDYwUdSra>{D!G~0qCDas}txUrMfCaeWM`4?!e78^83LRTP)i=durM-0ZC{4ZFH--wQ-ZLoYKOPYK~{^@cf* zS$I+ya%XGGE+-seEq-)tM_O=O#QV?-ziCU3nbyBX9x#8dvGr=sU`AAT(@ zet%EBVY4obk6)QGJM!DmS8Qac;{AT^s`w6Z(!SCO9!!~^3FbFg6Bcl9G=XI`MF4iw3A?g7vGET_MyJ1;J#|}~ z{*<(ev9>Y`!sVELPlv>xzocYyP!~aaVJ}^)gil&z>@AB6w{e&zc``gF2V!oz)ITv>Kw0yXl(u!ebQ(3)oYU5s zPqMr}zl-rr8D?49rKqmpzB=PBO4jiLS*m2bNqDK5e|%?h^nj91+$6W?$aRL5Yizh^ zxj0iCgx&N?u{?cOg4-z(vq$tpm2mbLhe7G<+*e%gEN_E8A)g$^$pl?OJV?esvod>J zcLFnESP`#)Xwov*%D`7iHu1~3vd?qy=HmzvA3@pqJu0G6S?ezI#Vh9;MyEL|0TMfy zQEQK*Hsq`O_|(CviUx%^jl7MLlPG+Q?`}UUQ5$eTgWiz_OR12DX3UjW|IdL+1Xz#g zSuY^RyI0#OH6dE$qR;UMUIlE_1q@9#yjYbLOg)kA=$JgM({!!7 z8S3Akd}j9B`x@anMFRcct}Oc~+dBc!)lHBhkmhYB03(955IF8C%^mDJ3~TvvkNI2N&dTMLhbOKBg5N(`;U6SQmGKRVDNp_MNl42G?1fWJpj^Y%+J% z!hqHF4D}ZEp7xFBmm~{^4RH&(tF`;!b5p5(Tls%=r7FerA^jkkOyDkdMlZf@=@8DqAw;vnxc|^pLTbUsM5dfMzq27YC$=Xv)OlO$9^kk0K5jA zKO#~B^kiG6`B1q-K|DyRPSK4qNolsAL4quaJW_Uca%?nJDGaz_We^aj{4%#@`5_y( z+~>*;spPF}n&S19B(7MQu~r{|rJhxUUNqfLTy|GTErz zG)`r4QpX*LtP}xz-5KMOfYc1$Tn+CHfx}wf=WB8F=?M1+!ea|S(a~%c6txuhfjMJV z^ev)YSSRB|H;XU zW3gSIUnV}S4%ZtDePa{zde_jc9rE~=yXrsP3Y*;OBeFiRc1+c|**!HIdq_=P)Z6#7 zUi7DF_jKcScd!@W0y$RyFhsPZDZ~)Ze>+))_`&#mgY7wuqSw}LU(5dXfE)~Y$|RS~ z<-2-qU)HpC>c7xV8B_|-0`;r(&%3K`d{!;*SKN7)RX>B7$V~5~9_(}FYVWvsZI5~A zAK&Y@SR?54PFt>mEe>XnP%twCv2uQ)e*`qy1s(aJJeY>s<&d*{hX}cAKfQbUx_S(;$vn|#N(^mgdT?kQYiK_Hy3=kx$qB~o^C_c!U_&A?`FO8#ppO~1K{ z6{we!dZA^IbTnO-gY+kIWvH($%gy$nxr%Wk(Ur(EUHa4FdL_ZGLnuSG@Zv(msH;d|u%~uZrPwQp zpO`l;HGAl9)TrSC-+C2|KE7EB$6ay9Nh%EiJ2OH=}u~zIx@#opra7k&4O}{|!qTXw0hoNMesq+O?Ifb5xS~ z3@T!ZUN!C;{?%z*l@aH?PNi;t-NJtulS{Quo1TC^YRrT&Z#|ZSlu0W5ih)tX+ z4=*FVhw9x%TiDxd{Yo0FK^RLAA#x&l9a^pK668wKe`?xPJFAK=#0|{j8xFQM{R@{x zOIkD^vM8~Yd226|;m9!Df@>{xf*LI;zb)c`!LU7f!lUSMrInq{GNi0g^pAj@O&W)E z?C7b)*00{l;M%qF4#~HMm{{AE12a-T{Z1u$9Jdv4X zznJFdu8l?3--bw>fqBLKbeSDE?d3P0On7BJu`QlaL>eS45(+y=pVRA$h^firi09j; z$=#{VUTTx}z0ci@O5vd>!ocH%VxTS)Z?!SJN=nwq66=5qsZKpZu0(X69zp5@lTIFz ze)fHa6l7B-oB19@zV4C4T6kn{f3<_%0njnNmF?ghnH}$7o0mR3cy2LurIeoqqvz&@ zoal1@F|2q57uj!=M3~TU{B);!HUpiKkj`--9Kmrew7gv7>KfI>J+T5#Ga&8+Pr>Qd z?=KXF@dkM`GhrR!x*)K`9Wbiab`5v~iY=e%9YCbb?iKsm+{+QfM+gqHItrRIx0hYa zUfvl)B>Fo%o9c`nFfEF&SmWIw2IC_JQqXA?)|tq$X)mn8RrZ|mU(L2uG)%1dEBkqQ zx!G9vceZwmq1lKRw7n*B@xV_KuGO*w@qWNbQv29Tiul6H`Ku{nI{P|(utCcHH~wtC zQ>Xe1`gd(aQg;PW{6r7JY~O@UYD=U$_0+$NZS)9_g?c*9Njaz~j8IPBujcJ&p09qZ zA;M0;C-+=≀O+zIF{-#H@R8r&RkpqQX=J8B`4eB}W42D|#E_?qcEAPxhOS1)M~{ z+WfwJj`i$b@&hRPpi9J)LcCePcX#Js3UPO?)jGTa`}AdX_0NRmTw0TvuCddqlDa-E zGmY*bBAb}?pS{CGZOJ`rKO8WwBAmHy`7O1yBRxko)izsXstqiId|&FdDL3Pgjr7O8 z`aXCyZ_l#(n0r}yk1Ju`t+Y=~VD4X9ar%Lm+u`uLS^C${2N%J)kwT+^7R9b>N0Zou zbI>nwYs=ePiQ3n2ML{E%Oe%nGD}IG+TnJchJ|8|BkaWoD37qb{llH{G5b|FKtumYV zw_@bkxV{Qpsv_o%nkwtMM_3_;l3U5(Dm@3fYvbe${ssbiirkG{TNqzksDp`Tlinc? zKJNBu+KKZ2W?R*f0W&PJHYf$f8zK4u0ouQ|(;oNbu?Zi2f@Kpl@{PC{haZqOOi*Rh zIH;mM$C!eTO=(_O{N_3nu!NZf{hQK;^BhPDe1@NT$YLwX>3j<>IgUzZf4WvGvm@gf zJwWA?>MJx*jcP*~arXC~-8f8eVWCEPsrD938TF0788i3wjz6_;<CmJ5E9rhkpy|~FRS)m5vft^}DDOM}8_BE08ZT4%-+nmCoCvELLr4wFq1K%}Y1ErE zrHiQk<&sW0ATWRG-Z-CUbf?~D*f_fE4cF0&>$!5Fd*Z1A6GZ7&FyihEw?C)* zdYQdVS|Rkpm3v*o zDnLlMWN0IWEshK=a^h*l#0A&q>M`2g+vWghyXnjFi3KVoUgCci4*oFE1Y6lkiUeTS zUK!1nBA_qeidyyk<0FP8Dtj6F@oi>0{=Pe zc;@r&nKOWCPb&hAHOeOfL^=eevqbz`VaUw*V9uODbYY`wDh=)uFwgG*vBdDmIO*r` zh2&kf>%yky8^A~R2W6Fz)H^Uo&1@pHc!Wk>w@%bd8_!miBc=oHwl0|x8>H^x0VeZp zvx=_Uuum^9vJ@9gmW?D%d5ZbrAcwg0IEs>WQ_85yZhD7GS9&0|*t9!Vpr}+ukN=KC zFB+SglLIW-+|?^&XQzVm@pED8O^=%<3hgm+q-d2KuO!E>3gXvv*|2=z)uy#OmoPTr z>&?4Mh8Ho%(2ky{2hJ=_K4CyF(&1gpI5z>+ffOVd3Ed&0(&wPNsL+5J3;_+>Z){3t_gF%BHEWqMPR&DJeCz^at+*vEr4>jv z)H{{iRF2LuU>W$Y#(z_ttbfX?iw!XysZY&#$wLusU%)9PYC`rpV?f!WT=98iHA0xo zcm8*fq)VtnTkYX&uo)?2>rT?N={lH29V(!Vmi~W{Uj3wOg%b>Kl~w zrzE{nq&9;o9htPYVRAu zX$RR35k6?q6yAtgifco?BY|9U(tlOXzZxdU%HvgAM!E?P8x)I)dGxPNy18-XZHg@M z3r44+_=~LmD0j~#HN`u?qpo#fW19VqR|+E>?Ssii{nz~$mj9FNU$fl+*CMWTMcCfT zK;F8oC|k>6orX3&M@82B?;2=0dZ~l5t`Ur{p?x%;Psa}pcD(agzuq|4QNWW^S6q{#DVNc6??c#J-WinruHt(_Ueqv}U z$QF8{=mT@J^>hU2s>8!C*VbpHNwbfJ0P$Teg+cB_f~#t(~D~V zuMtn&iLRZxopxnqqx?n+_VQyg*x9Ld{poP7{l?l1laDKN&roWYYtFa)5jzVw)E6x7?Szbo`f{VzIz5>~o2twiUT@1vy1o3V5g!|ye;H?N8@kuI%U8FYXt2fH z%BJtHhq#V`yZ#L7_m#!2Y!~`mPLuCY)*&p$5;B6+H78HYWIrv z1;b9H#TY34a=3Xap_jF3=m=8%0TA-Oqb%1uG3>gwr?1dlr&fknv}8c@#aM{EOP*xR z8`2i+9>LIU^eYbyQ8`A>ofxW(5qXL2)eeTvP9#M$trul1*mNLMnRFsvGX#n~BzfQY zXq^#X2d(^?V=C!{hUpZTNNlL`fGgw^n7FxleLJ*7f3DU`QlTu~@pR!}DXV++fhb7& zTvG;`s$n@|*BCoZF=;WR!!Jyjk7>1YpNCygmaw+`dRnccv^n#*Ge>HWWwxIszoBKb zXbO%4n!3g5=1uPYSm*#Ybk*1;RQfjip^ck251hj}TX3<3cG<9A9zR z7KxD?8;=wHM`XJ}K))Q$kD5ojqR;IzTyrwSJ;;*pYD>z2n0wX8$rRaE{u?Zx4IIaf z(^%TNG%_AlX0*C7uBcA1BmH$9QfDwbODJh^G?{(+AqikTJg_vIC%fV*nlIklV~R!q zJZv@^$6(O$(;4BnQh+Dd6&HwyY`wQNZ-CBnC9TdC??C)yO9syKIOgi@Tl}nK2PaZr zhr4v?3iw}jp50ht&P{bNBv7A!=xD>RONy|m#4|gP%2b5(m#h5CIG*4LLFWPR<{au) z7XC9_DX!NXEI1pgoEjgp?kacw)>Zvz7QXbjd*I!I0}&T{0`7raEim0j!x5+Y5@mXL zaCnuh^+9QD!tr%KfL67wZM8(_H2~v(Z`2&b?pq8w+qKo z5-m$Os2A^s+yKjuASHxF?`!^#)2R8&q)nbBVf!Iv8X{YO8LSau1?2?fHzepV63d8K zlNOr1Q~#E(@!`Pei128 z1uHf_j%>M}vSdM&XX#hv5=B{8PF&VsoLLPFdVI5snft25Qpvty%9MXs$Fef&u^yVp8a?P|w7?pe@!I~~4ZLhL z-SJwJ{K(6!qT_*%s z^p8Q%13U6z|8tT3E&*LuStl_jmEso5tIk=bK>8O>g3#ktLC8-wZNB5y=alUf`&NH3WH1c!<4|ut#rVmBNd-C4f2sShow!2EN&J;X3Vv1)omXxGu|eP? zGMJU+Et8LtAQz+H03(&j3-(ao#Fg-e=*mTv8N4x=jo)z1U7i28ath}e-#)g#>0#?( zZP(plLy=kdWk4=L02}H}joT_K1VUOX949yb?l@$b-s_^|RO4>@m)bK@>zJ}Sha+pP zva#&TIORP8wc8@O^e=4WGYPfMxzA;WD!pdkOFCL;9go z$8up)(``G)=U<}W{P`!;VdhY}wN* zadE)!G`L&aMwSN5`J%eIpjlQn33gI0slbm8uW!XuJX7#y6AFD93w88WY*$+DY|?s7 zW&AT)!-a8#;@8o}yV7@yzo@q$d+v8`%MC0$u9UHX1K4_1`8*iW{71|{a{K_YlcisG zPX2r$cIx)1eXztIo3_)(HiznTPPt`lcj)>(FN}9QF|SKKx$SBTDNzI7hDE7NH zH)*gcdG*5#ZUE7~`vVdoo2T{Zt~sP72PFFb5v81x!0I8=cLfcadBCskJ$y}ao_>X3 zW@gci@ye{{-O%1hf*i_pjcA@IUr*kRKlGwzp3}ptr#933%j_<7i}YRWYrWD9?rQ`xy6HAl{0^FP0Ngse)oE$<|L zP|Zyy5Uro~xjztmsdt#JtF(dWtXHn1YcX~Q{NOma*?Jz3t-6;|cUi>uKkf`WWab#9 zD5>_NC^xM+)_DpJNIw@kkAz0l>d$?jJm`m}|L6`WyY@_iImNkBN>#V*t4k|b8p-6G z<==zjbeB7=4&%Ay<=^Ov$w8yI4viEN?<=%>3K_Vn+pxpy6*zaO zF65r9n0kU#TINndlous`k=(5l2)D0wud;8E7Oqngn`zlxr|Q~zHm_}$A+wl;wff`lQIv?udG`J4IMxp}0v%!}IdCevI` zXa_Yeu0QGBCvb5*A^C=X*XL~NOH8{v@h;cSU@TbYLpD#NC%6Z@Pj+oJbW{`&q(q5A zEH^G_P=wsfgtm4bFz*gLp23+?`RlY>a6hndtA03D5q4<&RITHXE56?B^bjD?2gw+4X!1HeqG_+If&C)Y1nN|Ms*X7gNWowBpy+Y9)roh& zN*s4pvi+);Jb0$)V8Of-e3z30*J)~b%j|w~A)~@f8v&;vJr!?~WuZEFY8rTuxEZ7C zj_ME!muue1J3#BJE$DTA8tJ^K0Z+Z{Uv;{@Up3f+u(a7?GjM$NdXMDh zSCdEG<@JFdE;;|G`PQ?0Z8a@V(^391ISQzYSt+E}w*Bw=bZ@64(x#30QUR{q3fjL_ zNiM({#ny8E3{xuZ%qB88`l|Sce$cdpOtXDnB8Su@hdvTw;+^9`Y&zHr?5r$>UPeVJU0oa_9S21 z%zq-8UK+;JD~YE&$+qQYlky8)WJ2BAvWZU;#?l~uORMc#*OyenfHhtR!302tA_XRpa)`Gc#=-iaHps-dYr3^CoQ9XoS&Tz#w}BC~e%P z+j-JcT%~mnW;}Q_gD6`N$rajj*46_lr>^9#uer3~@DK7vS9L3vD}}1LdQm?T_HR+H zD$jjh=EZB?lI2>{>z8xNq>hRDd!qxc(WyC9yS(xVND3SdXndDz|bSaJQ_wm2~x@oU94rm$Dj2_x{|stXuX;Um*?bL z8XT;EmALXMKy#TszsFyTn+RBtUy&?C&9wo^AOpK~&426@OwzTLldCCfGgs(EMjj5| z+fGkeuws2XW=#E7eQ;Q9ffD5bs-s}(@@DY@`{MXe*?QN&q_}Swi8PE4Iz9CqazlaW zX>M;6JbAq_C#%n*^fI&9(m-SRXh0c2!yHLJa6>JcP%{393{>E!-U*FBp)MXbtKH>_JF`PKqk^Q0wgS{cbe_LEj3N zgIQ`F*#c_CjGb(+!*y&^80@3uIN~X9)Qq-+NBRuokI$xC)2|GxF(0fV=4r6`MXSv8 zwU6CVI$?G?Y|n%jUbfb%nf9!=EJW~T^p8sD!mEkgj2g`7k5kj z(){#ZMT8PwWLg_9>rTGHc%26mS@P(sNn4B0Hxa=Hm>7O58)@$Ty|8*zC;xhwygDB@ zd!W^1dXJ#MyNGwt&z-9pwyiUH?q!3b*#>j+06BjVt!o9#LvhDhgb(hF`eE69ogJao zq2NnQ(7UA7{7{w?IVYf&pDYYjC-#|E|BWyS-K|tBTVVTJ{a*-JIw*xh4gVL>1+0U>86@I^YttE)lk^yWdz*3XnZ+4A_>q>q;>fAFYSMC7MD17)xz>yC10|nkAn&f$_>gYukW!7;v)BKP zE{?yMm8r^eMBbPh9Eg<;_WiR%7N=z%_~aZC3%avqMeY2RAPu`~C=EtOQ81nYNVjhFKF&wV^Pjybom;g1->mVZ^M6&hHBT08Ag1woEstP#LZ6MqG z)r;LCb_)%e)~BLnXuPh^yCz}z_8*6NFPZuw--JfB-Uu=XJy^Uy>%#@@iM|=fPpQB5 z{;fRR3b?RFE??`LSu4_mV`Pb*aYGj!9^SmNI{$g@`ULGml#BDSC@CzoH0}1)=yE6{ zMA&f&`91kk5-9jjjxS}pbWLg?#bt9;xl)zsL1KG@$^s34TnBS`$aeL5!lBh+s!NKo!LJ9j9`j;U<-klJo` z@M$#}Q}&*X{=_Y{(ykapkq6x(ML_;j%c6W->KI=9Rds|+c<#rrM#PJNXru6jim6S0 z(Y`1%JL@Ukac|7HQJX->Xx`vn{`!bo3@rzHi1{C}Ozc@K3@>t5+jpzD z_LEKhls&GU)RK3)z_>R<4?>&+VO1?~sp{(<#n3TOs`7C=5&z+D#$uO9+aUR-ONsN8 zXSM$+pjp!sU9jZt!JbEA!m)Y#Uucb#&t3{xqHGmHh~KpG)ylSIOkSAnr7z8raN?`R zjH-|-6MBj0bc&1-Lw)Y11DO=%S-O>G& zbv=S=zv2`wyNzKBd-h`Nu z*R{}~QEaOCyy6GE5)UkTC$W2o6cGw0+qU&IH}{i;n{74)F-ox^?d0sw%+?D`T;kwI z^iV8%3Hpzu18(v#Jn|MS!>H+7qUxJBTC@02<7K<-bg1<&Q2!Wh#~g+9$l?Kg7X>E< zIIT`0A(%3Oj^R1Z--fwX?wnyg9GR6Hjj9?4G!>&T#|FA~{ARE;ln822Xfr_3BZ-rb zy)>Pc2UyM3;PU|?d&e8sCNNXz7Ue|W+DC8>vR~fv{-osMV!EKPah7aakr+JURhtD2 z&jDM{z4}sCpxQ9^tsKtI*}7)?x9Z9Es!o_;ZOHErmhfr9B*(^W#V57zQjLW!wR4t_ zKy8KeV#{IP0eGiVNtkZ_3Um32IcA6VusVc3gMfW<{0&<>cQ&dTerS#T3yN}EH#L0j zZX+;`Zt9q;I}9qe6WVx9~@DBg=E$zQk$oPQg@d3N$E zMtvivY8nRDUR+T=>yv5j#wn*l(f-c<63&hsi>u(OcNP@kDK=;PfaJ0$tuIvO2SX5b zHvr~;KXd+LMP{MiUQ0<96*%u33Jb%z$F~0y6rN+@zAs=1RS^S}5Jq#I^PPE0pHgw= zI=44;%^-?9fRZr>y~*+EEUb6D9T&b@$_u;=ExsSVCzq|67PSd1)Suovna|6agQ%cN zhp6(>r0Tp`vumr`Q(9<=*!F%i*MH0a&f%_4fDj^;V-QJXjr3Z zHIiZfHa#iq5UgmBF*O@ZBUQKQ8{14^ezfJgv6xkDz-QYS55Y~)-^PO!-VW=F`f2 zSprXcdX_Mto}n2yr90~F0xADVMJP)t?0iCxFp0ZyL{m<=zM~9Am*36B_)N3BpWLQo z5RPK@rKn4%w@+}hfew4heZTUb#&@6Uz85i`uDUE#A3M^qIR@$LeehtxK%&gUjfB zgSUx(2Ah0-_+fqN!WoyVPau1?wff+<-uZshG?*!)tu zsrJ*m8}`A^uB7c5e;=KHz^UTkwEnw;oDJm@gu(4urZMYogDedn%+i7bZ|C{Xe$2T2 z)1Gt~UB4*xIZ|r0PwIHS=u6skbt?68XyE&S<|Y)d?x1ms@YyyiKr3K`Fo%r8uJ&e_ zLZ*rcGJRQaqA98ASrRaf?tjRjbe(krhH2Zj+V2Nzod}e9x{n|gA5zQ5+;DSGYtkC) zg=ZCqJw|5es5X;x411-WI}rDBp+MtQk^{iWcJF4@F8z!8jn-irNqnE4S>tu92YOgx z^L`v*gWl1$18pqKu<iZ#JB$jGYw0HFbng3U}jIn07qFedVVxLlx4#__Lq|&wvBzD(06IneD zd7Q`V`>caFSD;QgJ61GCIP}Q7uBW%If^DC5&uo`1JLJb3eIe%NeL-k)-w_4XEwW!T%G|KZm;0B9|^ZRhdvnxYyu z(nU$))W%9?x4O%)jc((~A%y!N#rgrlo}kE!;H=p>|9PX7z7hHA+m# z-Cw#tv2kyNbZKb-;aQ(*N63fVX)JgnWaS?1UH7CI*uQcDd#zO;gMGs@UA)@I4H2Jg zpl!xVVt^fIk2gHD1nMIB)6m(|6gOEXB9+i7dWkqpisf1{U)=DOK~)HD~u zTiG`}D%1~vcH9TVEnSub^k7d&0R14lC1iq-_}>Gh?j_)GMrEd-SArllPjswYSSyJq zuIdO&ik~^|4q$4jJ!WYn!F%~dHbA*-z_pXBsO!qdC1eo2`p@-*9rL^+m8DY4w3os; zNYDA zqE2mBThuzfS$+|26KrOclbcmj{o-Qg4k}rycMr#9q0~VQ}$ff*)>ohWh1ls;<&!%iwnk z`A|wDFrIO9<+120wBR?_rz@=B`5ow{$>6#fVC{u==0z7wAuF z=cM2PWNq-6JGC%$Y>c~-0`-a-*wi?$+!{8gJf6Md0B!PA+`}(01N(rO=48~D^p_dx zh;eKF{lUZLBnSB18;|VCGWV%g`s&ztMa=o^Q;18u4*Uu0lFV!tRYxfIXL9P6JMqU4 zj7vWmteWo|=1sHq4}E-4!s!0D72hdXjvcQ|QK$9N${C`u^IiIs=0THu%<$+=$V0sx z*^i+`h!$7r!E%U!;chB|7c|wipoL2xv%1!KL4ik;3D_lL4vsnaMwUqZ z^#G4o1%9C%cCndkb6g?XHkCw&2Acwz{PYf*gwcF=sejsJ*)UPEt~RFQ^BFV9?A)_* znWfjEOjLIS>(yY1`YYlmcT9G`R5N$^-jZE-gWyUkCuGc5#98fFS0UF$UYC08cgRh5 zhhG`_o_%c3PhA(1fCDMEm4D|$==eJ$9)?HD)Gk5#P`b)e$gJfc|5nq0M3*bzBjm@)w|)Nm0itymUOP- z?Crlv#SPGByMJHS171#I*po_oLxUn#pW4M=XARmfa=cO(evO~Zz?%;z3iYMe@rO)4 zCS}0_DX_}vGeBtzR7gKK;uSF~tz&$^F7+Qz4=Hcafto{&3u&skY2fGG$l@9MS4P-y z@K;YY-BD*E)0}SPq-N;_d^A7D>|u8!nM>9Tt{wD$Y%e=4I}0g$-u8T+dv~>#XOfo% z{~bSI|4gs(kOd{ScHli>7481i4#h`=uK32ej9wM2F?%6 z2AoN2-{7Knlk0{Lnt!!mvba6dl-Xw|SZ60%>NshzD77r2VUVnu z$aUyP{fJq%_oJlJ!Oe5)zkd<{fBBoK91{RPylWgWB&Bl1qe}o^;q5B`fNtu#Fb(l1Fzg{Yb0r{-qw&_8jpvJ@e#i0s z3-9s1$Mf9peO>37GohgY@z5{OH)4N5KL<=p8(q_d&uYxm$o}L|GIXR$2=pcw zr21QZ&u&)k{aWJilpr z8m1}sEZhxPD00r1-0$WNko$}YHPfC(&h7oKUNlM@$IoW99TDuj59qe=JVl74IKEL= zZWykiLL!O$#uqVj%KE(a`G*HLp`XIP=EO^?m!mi>%BmVI(F4V>yi_L`+fQUAPwD$_ zUW>#jE+RN%)OZv5lBdPm6<23th4d$q_XqZw2kX7b%< zKk0K~E~a5*-7nMF>Uq5UCzIu5VdEZT@6n7CQS*O#tn@4^{JrPvNa1kxOvi1J2A22S zvSdBXlD5{L*6q(8D`L*=1AVo^PallWoR*eG$2bd{CAFcRq_Hkv>s;Lf*}R1ke?S7_ zwbRg!5i3zPY`NZ?zJ^5DAEMRu3`0&yzv_+Np)BfLwJUkw6RGkkl}fj1j6@nnCx7EH z#MYJP!Zj##`izxBqB0`S+FLi3NRqgjq^5nd^q`u84K4NcbeS1&^r*303cj)ClBcG^OK)WcOS?7GJG!J)GGvFF75@hBXTLC%g-#c- zK9|<0f9KhdZ((2eX{bi3oX5stEJ}3j<_I#p@1FI#z(5v6G|yaSVH4%2LIhvczy%gG z#xGDU+Rz}sWb{-Qh17^M-Z1s}3#UQf(#X@%PZ=?Pz+M#f98|^V&~NcRDd+Iy>UD#lr_c4@)&Vm)E&Mg|b7@C@(>NbZf9;9tH z1V2R&COtL!I%Y(QYCL^swrDme_UGv#JPcBbz_o|7Gw=qL>MQ&6+>;e`nW)9!mW zxStg{d1YwpOs>X$<8INnSY8pmEyYT2cMS@cnGHDxiCHFxU+nE0wTHTV->bn$bY!CBQNWcMLQ#QZ9 zpasJgQJ-GZh3G;7gfl-&3r{zT*f*3BtnzjG5Fqrar|A9{@& z5$)JbOXr>Zv)G0hb4L5yZb;cwRqNfO0G(|y`t7UHx0e3yoO4< zA_%mQyMGQ863$H~okK-{ zym;nGPk0*482mg^qDQ7|=~x&FH7(Fj6eq?72UXy^5=*2AIE@DqApzd96%UKF0BHVIewY&)9kdkUm&&F%aE(!(fC>9gRj%cJ^wWaWGPv*oA41o zYEGf`SB3I1+1g_LS`t9&eKsX>-Dd>+?`}e`)W^yJI1tiWQ`h@9_6iCAuZZ@*1KYsw zx)YzYXsGYG<^aoV>8!tr{d4_yF7Gf)m_F5EhH*$Cz6`HjKTFgD$f-b|YT+V~Q!3d= zA=99tRZXNm@hgVHj5lFV2#RNOmvx4gI;lQ-5C;hAX!WSXzc*W_FWRvIJmE^!YP^)G zd-ap!am(I=!;?1X-Qv!|USYTRdj%ldj3;@F>0z0VaUpD~gO3)lmpu-0_ z9CD{1$d|JGTFnr~8`!MhCLbwvr5vmL>gD=d|9V@UExurqh4jFGe{D09-pT~nM_{U&d%vp3 z*=p&ctJ99nb2ZsuFmKq^OP3P@P_|^^-1|}#X{kM%Iu2*7?kQHaj$gv%r6;{bh)96D zU?3rhBq9?77mBe*zz4iznt?kEkVMt>} z=2u2w1gYPItPV8oUHwwp)*K&vz~;lA313r0d32+|Pcd2oq2vxon_&9MDCg&~8kQ!T z5j6X!bD%okd0BK}i$$@*grw6%f34rz{T`D$Oq$}wo{r&o5HiFxD&BYxwL_Gv)SdS>EzR<=^$F+Q>kO)|Kq&T7422q*-g| zGNYnr`{Y0I6!%8V?HJ}y{F5BphSJ&#u_Lwjo93Qg0u}XvPT!8NAw7R5VohAbKG!ax z(Rr@F8zy@zIb|!808hqA;$N;%`pT$vrze%sS%3~kz7*b>{6`fv9aUuR>Fg#Eb+Dz^ zWh>HKy?d$OOY@@bS6M8fRu-!FQhev>vIRHM9=$R{e`v6zwbTp7?eSDzgfU&=A#}x2 zJ(_cS`TCB3){Az;xI~DxFvBgItIdCpv8qP~U8=}J9s6Fa@Yle-*F>}6bvd+Wpi=$i zzr5Fn3ayXi{%jO}z*}(JMKd|rXGC`NU&))P_eEP|0iHFViZlY+W(FioZ(AC8KP7UH zskRM#kZP?4ZKJn-AJ>TR_U=k;3wJiABdMg2k8DG7C8qz(6TgXY2z{*sn2Z>2X zK>o|)UbqGKV9h5F5H?LIMt?ES%uFJNmITIJ-CG2ZhlJZq~VAk*Rk0=vPD9o3%1_NKnL4;~*%2?}i; z?(LV|i$p8n8;Bj#`3xxf0v_+7f`CBN$k@cwq&`3NNaKlc*3l(RbL0(^HR zXyh5Bumc3^RKQi_$J*6*loa=A4$}DQp&Y>xWU3H^)sE4Yn{WztbWxrd!${?K$q%fI z6@o3XNtVdr{lULPEM60SY;SheFgYi+#D_M+C2BDXy$r?V@|!_NY*pg7-G$jWQYqTl(XiXoTW$2}t27V*IASD$#G7Lod02zGzwz_P&w_-y6NP#1)X4@(M2YzN_ zQ07szyI|+`Y>-6Xs?S5^i8J7e7Jt+}SQ z89r67_rY!uwA^|KzPQ`C?nCT%U!=~;#VzLvc|3n3jls329J3U*VfnRvW~ps;L1efF zNeQbiC36&;09FB|B5-lQv`z z=4^fYta)BVF92Jy6VPZEodC-9-AN;Nk4#!*IKL5^#0gP|D8^*bhY3;WQQ{2d#jGoM zd*iFy;G94Ezj}{=`)&}3zp$rG*`anhSt~Y(15&1>e5sh z;<&y>YIHx0Ns76p%h!08DCax~fd@iCn!rM4qf<;DLB;oe5G7b~V;Gt}3{E#8${#Fr zrr0+v>Y3a~nVa32a|zYjaSaOxr_X!vhrD#;A1l_%&sEm_BDdM|0`7bS8GIaQ;V`C- zDw7fb2}4<=hu*U-zRRPH!ftfb<7L6`!6VJ-+)H_3w~_LISw}541&fePlG*9ffGb)6 zC!(y|*K*U}P(CB@GCrYa#CHYDLLzCAO4cG7vz}1dyP0iTht^ab*;`WyXzw|nSl!ZI zpR+D&9WPnTElx)q2Zj1E{Q4b@ugr@=@gDs)R z?NX3&>itei!2!oTMNav~G1D5qY)IUBsmMk*dgwynI63Cy9_qHtWE8HbHbqjaNS}tT ze@l;-IRm1PIds(Njt-?sL(#!TkD;>N4!BQp{i3*{>$|nTx^V|kUK+%Nkqc@2gj`B7 zd6@$TYBf8#!ka8K=a%FR>=dKID9=9_xx3l}79o$9rd<-W=jrqbea~nk0v1PsTvRl= zisC6#SAsK54C`9cn_LI^xC60==Et)TnonM^0h2%kXbc{7Z z5y?trit(UY^u>C7YNiON!M!>^oXpE$IfEs~)}=T8f>3C;V}(13#?4w!Q0DsCDB6$F zzG5?+tXVa0x9!+_h&952LKC@}!!>QH$D@k|3!@{tR2E5{CDO&OYQzx(VAVjqCM-lP zrvafDX4*zncsf+Juzq$IkG6xwjUC3_MBowt6*Tkp5aFCzSyb;qO|Wunx%J<~aABF?f972dLna63R8ZV1_~Cjm9U85=<;R4w@^e6`kY!2mk`(4%aWO; z14(*Zvw~>q_NO(gSx7JZt}6V$7jW12K&|lI+a;55(DkKWlMV{F=?s(n7ZoGF)`6EN z1H_6}h;tVdm}E-A2&vMRwA!A0wtDFwSq%CcYt9b6toSm6d(Ig^g%ekA>Gq&?%EmQl z62nv0YK7K>3z$ER={#C#<1uTxKY8H?%_k96ZAl9IiKihKyw}E@OprWju4O!H7&>g; zlv#mtNDK{*e4Jwz9yXK~c8iJ{a}0qiAGhnazl^Gz8KT9DFBNd>^xHY%i=TY3V|lR=p;vk_Z|i)%l)6#9rVFE#$`niQchN^SRdAF7ML zieDZ$7loK-DHe@=W2*LzN2Fc?lwPnI4DF_lIFU6Nk<}eJnhCC}EsXRjuwEGbVcR ze=1k~boVApr4@5llfG+Kt$tvo_0pSG&_S_mpL`0vXP(B3ua01EUmC&$#}TJ09k|ni zj+=``J-c7c?tCSjZBVEGCV5%W8@YBbx^6`V+%Spc?#+@g-e#}OoV|*r0J_tv>X>)2 zqBV}=WNpuTm-9gLWT(o*4~|y{*C^tGRKFZE^^C~zOIgTZPoz=M990(LRI#j~md@Sd zxh-WekV0^%Z)Y7UYO(IL#@`CxpOdz?q(k_KQJ7acJyUN1Z(6e{sf}*xo3)PSL7oQw z(ps5O^Ra#xBsNy@t4`zrMBkp%JG_L6JpClMEV^2JWz@(yBv zAZ%%J60wciRfMyvd~d!Y+7L6>{XND8VFB*#WQ~V#F9;+vQbv;zcZl{+SNLBU4QsOc zpDl(@Qw>w-{$}lN-q(iraBiU~F~>f5oT0Jy;Tm>~UH-&7CfyQUKk zUD~p})1JF}_SIDUaJYxh@mcS?_jTTMZ`!#iZ?OO6eUVA&)pdqp?w#jML`0qvNO~+kt@ya!{sIww2ZmjE_eHO- z!?UrkU&AdNift|^=G{?x7UQh=Ru5_FlKYWHS)QQtqv+_h6ZOgo+}kdPxf=b&f3)?w zC65re+tfawog^;!J9D)PA(4D+TM^YdKi?U5=zQo;=AMhmKA5&_!{KnsY_4kNJYSKK zlP1wvZ!hR@Yfy$7K9A%OJe?b6e9)f*K0g1H*HawOQ^et(rc=ixuVdL5^tH!jHWin=7_1rV!n!V7(^9JBGQv!=%P)C;tu{0<*bGLkjwl@QS` z`eJS{=Bf>ymb%*vzDHmiR)}}RZAR-V+Pdujo6dO7wRD|HMSb6}^rLOqdM4AasLfb5^vC! ztqUSxa@2ndl+>Eut@#2=q>s!;b_My4TzLG=?P(t#NV88=pAzV6O4RXqNn>YTGx}vO zKND5h^&VY=-n(3nBNtD;M#EFD1ajwMTXD8Bl{Z|&RoRbALPY4q{2b35U#QUj@`4~h zf6pywz?ow#J=t%@{c!8yRj-l%7&(OHTqrA0*2W3K#!GLh>gLd_eU~KpyQo?s~ z1115KRz*dwJ3e=kJ~4*3`n)LJeZ$OwQ)+bA8yn=VtsVRnQmD6gph{aZI?+%wQLyKd zKy)&MtjC{s-OLCMZKAyMKNp^ZmtK%}Y0c`@dki-xa>Cl{?0<2s$e6N51VlYFHh`H( zJOUg1$o^$NW(rya+r>=LZYG|ZYc_qpU|jsLBJb;o8H`rJR+OouUj0bjmeO@3?_>$y*}!|d#JqzgpBPF^dcmH!9?E*&B8WF3Us()z?F*nfLR zj<=@cFAE9Z=?dUJx@F8JxAGw`-0}hR$s|lUK3Eov43k-fWUE1X9eZ+l`-#ld0iiv% zfLG&5Y;DR;(mTajiC*rQizl&-WK>6l@#+VFqfRb8qT2G%pW5;EI*y0DNhYTx+Hk4HzmNVaCuB|ErVc=#e+#v_+dFl0=Q}8W zW%clbXzJ8THKlQ*`rBdVMsVxDQ}5FdWgqe!9NXcweEm5?qeuY^BTHs@uexL>L^tSM|aEieADM|<>)i;iVJ?!$>EhykxXM|PAATiK3p z%dENgI_+ejLsJe~8ZkKP7FjWqnDWI5rCYh|P#=A3=jVooRpTyul>%-hCO?XpAI^5_ zD}waC5QYs4)gS1(G0c&xq3fBUq_o4@c?AKI8X$*21f3XluevQ#KYR=3R~|xu=9cQ? z|7Bd4+;&Kx&Q`0U4a)UhP)Egj}m>G)b_iG4{$ z3`Ez!A4+?%7!UkS?#Aq1PQ%RLtE7&5G$y~LO0@%Hzbffo`=B>{Q#-UyeLlz^!O>c2 zzo1Cp$8ZeMo-fv-^V4id3}o-q+TwzPWnY2*=^#NLSK&AF)P?z z)_a~BS@w@4mJIg20c*S(yA4*o}2rP?tGRq zLNo8=){Gdj`w8FkRTbEGj-_Of0~;9)PS&&|(@Mps+!$Wh;{VGwX|5(GK}Pa4-N3bl zK=t;56;VAkL0$5IDWh)XP4B+1XpByREq$+;v!3^M7d!>EwR1tr&q!pb*tmvg;_H9P zn+eRVu#b^W34tCOU^&i%JLsgJQ?$k;ppdv=;pXu2oZ!ry2C9DoL`qoa!dOF{5Tqlm zLH%Sm4R`d}PJN;4xY4Sfp`_voz*s%6F}(pbHSZE3V}>)I6e{uN1@6B}EhQOkFb{_$ zA(HSbxIKjC2@Z!cqeSAr&ZX=-7R~!jwNTo2y*xm3#~r2)K)ry$+R~r8<=UUzp)}IJ_RuDrv#<3@u)A6Y$mACTJip zN+CBdo|Zq!o$YCur6!8DA$oW1*X$3{M^9pXcck=&^%?eloJ~-Dn@-sZ1IZuIxs^V- z#QUUGze&^>_OGQ&R6!tVumS;_H!ui9%=C zWcf3Mix<;D+d*Op2v6&xsIy;oUBY2ENnh%-U8eh*#cvT`_JS9m8MUt-Yb)J4QiRDt zYB*q^tHrj?B?%+PUAqjmpPcp&ttymEy$*Xl?BtL88HGBXh8fm=sv7%r=(%dD#%O-H z3nX00XNMNHPlTEw-HBP5D5XJEH{+9QH!_M{uhO-{I0|H8sE*%C%mDlF>B)(l`J%;^ zourvFTd75I69Q)TDqL0=n;BKr8ljs-_4B9cg{zBN+5DQBVvCl4-y6`q zrsZE-~oR)T%xT;dYRmbsnDtM9yM#3#J9?Lw zl{yu*?@&lDQW|oiF5dc^mvzS8(!YR80Z*m3(ROf{AXzZ=|2g{W=MD$x0qbLjWC7y& z{JYJb&F;bx6?T1;hb)!vK0Sze+`1pS$oYg+YYofU7xxFnQ$KV zSH-pQ{#maaLNl8R5EbLOoDPl8rEm;q^Rz8=dH1BSHT?nvm%x|E(W`I_2@%?7Ft_Et zG18-e@we1bogGz}HeozRk7TWy`8L=J6;t^d)8>N}VnNk2jbtpG(=YwwTMl#5a57f_ z_$2&YfzeCe8p3W+){!g7lj&<2GPHkirKH*3qSe^zJ0QYR;)tP4ygo8L&g8?c3*It$OUK@Z`8k%xcPBTapH z0u3ZXbzMjyb36|*q!-U6Rx(V=mPcnTgil#VS>_=z??~F}+x-N$4^^wo*6*b@hE^`Wky)d@BG3HN$Uqc=y}^fFF|n)i9eWi^S2)+XE{*4uGZ*L#yc zZ<@EQ?HV2v90iQ-HV+|F%Sy|EhuZFz#pbNXWC^8V=y2nA>_#cyH5(T`7JFD{UCz*H zcLX;U&Xm8FY=@d%Rt_}71kHOzZksv^Cpg=m!5ib@Z$o?Xj#pnjH$LkHg;BDaZ(Hm9T|+}Y{3Et3 zzMeUMg(}|tOqY$3VlPatW!C&QIvt^>Ssm-Ou5F2`@DgG^dDt94-|#eXi{2AXR`hG! zkd}x=dNLD~EU8T_;g+@wJsUx-x+Mi@lkO%&AJ7fUb^x8~2I0>H#l^ zm@G~dzURbAYFRhKDI=7&SB9lt$A3vLzu&V_XgyL+Z1MS|&2A@pg z@HusCFvj7kxv|6cKEkkTNJgEf1%UbZOF+aY;mtF;2$RQLow$_}}Y(+k&l2;lZ!iWTg zRY!%>g+?==;H;7|E@P^qCS(?k8_+?9PbN+NBo#=nU9e7z8=1RHu6TuQ6S`8y7Phn0 zcQD)GAya+9EpS{%rY%vmNkcH%EShk_3@j4Pbr!R1>OEV>71lsW=J7udK^$S_+#Jk} z`R}}mXIwr-4|+5O1zc2_J!% zC*!(4Vs48tL%C~<8^2%cb)0fEj&YH;!!qad{eVB=wuxy+1RE~e!K|mMYjYMO!Fv;M znNIl|MT}F8%gLNg3Obn8a$^!?7B11&OU4J7sESP34;hQU`Qt<%Z|3w(&MN$AKOu;m zn-G^2$;ac-;R_GvzISwenRs=)3G=l=$Jw+ht9G?OI}_U2;cnFY!m?=C=<8IhDmkhA z$3FjP|D0eH2hTg;9&|KtWW+0Xnt7|7vP}q zz*pW9;C};_CP~tt7cMo;@aN0GK|5<%Mxy1nkeig)L6hCRs5w}NZWKl3!ORbAnqhu( zKOg1a;@WQGKY}sy$&b0m@TrwwQO3x4+LSV45dFkzy}j8fOe=n{KBjt*DLWdKt}#?K$pzFO znL55=&72^%Tz!m-$LfNrYuI3|-02?KVLG`PR0MzQCG3;y(8C83B}vxO#=CLf&_Cnz zAFW<&5FJd^o3=|7$#ozK;HBHcCs9#79ZQ1CKKU!(qEi~`n;d0=&O>l{ntOP(1G=pN zy6O{nM#ehV%7guRC|2kLC-TWTqH*%}Q2(R;5cQq>TK=%PHA_`7Pql*X67{2N(G#x! z8M6Y8HyTV2`7^i(rdhG%w+^A zOMNOSBprZjT?*c|fNmIBd-#Q=Jff89r+)M}fWRC5P_h(*!5TijE4aM@Ss;9&ZfKF6 z#ZS0dL(vCpzfz^VzQ_pFOfuH_>*cjrVdL-{)lyI-1y}oD2 z(8zHU`;`2&UWOX2QwODwn~4_fcV!ckLUiPQxtN?Zc?Pf8Hn;tFV4lrvwelH%=I#Kb zzzPMDYbUki^omx8o*G9SpN=U^9vK=C*n_sWxB2o6crTB5RCVc9BYGMzg#owK3;j%; zxNS=O`^HJA`0zHYqII18mA1vSB1$vXsVrGy;HjuvA* zezKvhR%qiWEtB_Uu}02R=~NuFUo8I`>LRpINcIDA>+NOrN*y7v2Z}6Q<$eYXCZ9lr zU)!7;UbuNp;+#q=PbS73wLYdZ`tOPZdnKnHGHNI@=^&yc=62qMt=?DD*CH{swRjCE zggW}x9~;33xK77drA&<#g;_XwKlq&28>T@-bnFlRT<4OXGWG55!s26z>a}pcVfgej zsOs&dsD;pR)KR@WSi%LOS=T{us|7S18FjYaiQd|7vtaP6JYy_7X8&|b?}~ej(a{Rp zTA9s=ZJ%Y7n8()0Dr!9zNxjFz7HfKO0Gacz^5z>+<-+lYfzF{D0U4EdDe# z#nmw%>rjb32~jUEd>IYM@5_ry$jrlI&zoH&`ALF>r;o3OHkY4&Nz;~dtNi0^-md!T?rgaGqL=V&HZZ188)reJE4PF~g| zg4ePC*odUyaGuVftMjhmH7TheqC4iy^WK%t(-GA%Q^TV>v_xC;7q6RASLcpTapb## zB^nHvTlICTl4RA%#TE2T!(n3F8;oO$=xa8&)Y&IRp(84%acQ{Ec{&9Ir$4P(7cBsn zAM?N2IkM~<_ttz|udMn$W`7eo-&xZ!TcM3|YAGOw&Apt@v#u6m-Y1v3<@vj#ebPzi zad#=G_&dvt@!&$X!EI)HSJkWIEe!#4b-LSf@Zsp*7h3+H3-VodMWAM|nlnj~oa!6NVJN%0Zwsj6m^WBnNn}8G8E|@F`?DpTGh$(&A%A);hDS@^f8} zr8M|R>_>a)bd?p36!0Ir1#i0-e`qE&ZjW%q@#eHwU+nE@$?F~ot!RFTz!}#I`uk#{I;!GC$J^2YO zt`HlgsR-@n#ErpE>9pP^h3-uKjWb`_VN$Yzq*FKfdgw-e{+j3+*uq1oA3LEb?QU#V zf0=QMverX3BHh_rn{6;QbJR^5RNrvSB&PJE?Yig*()nffz@-{}x>I{;o;bLN?BT68 zJ&9x4aXrDbp}oB+&GQ{a!fEyS{{Y@Alg;XdWMqv{st)?k=PXD*r`+ZmoM1|fnQTtd zD}}Pwlm$0*R>n3DDzh={tPgA*&VM;L(?+R)?L#4KXRqB$TuUTMv8i~~`RtL!tN_Vp z+3ByL(Ip$RvWF1PsYT%YOT2k;)od~7CxgkDj3S19Ttc^`Nlb@O3&s0%CHC6K*;5hS zVL_obpZB7|`;5jM9i~Fky3VbINO!Wwx;!J324Qt6tv_;YK>R@ELq+;e%QhNkfhn#e z7eO7_*TiM%-`G5E*`TbCex)5Nxq;A;J~48LivPawtkn5P=w-xEcu&LLyFjYc~fV^hpYoBpU^Vaj05`d*nwDfDq3CNoknGjA`Dw;xglw%sMf^)vgLaX(GI z%Phc+*GLcgqM<#U2JHB3y$^Ro$U};{UQch7v$^gNsJm;@?#?RDH@RT+gWcEXIw~%Q z`>$EGC}Z`rd}oW?Ua;kJk8y==T{;v1OJ~1!B58`fJ>mt>XvO2j0q4JGJJi2Hg*6F! zfYC@&MTLE}IiS96{w-U5X!Gd1;V~}YM<6Rx=tX8G%Go<}+k}s%<}?)|*J8`GJxCo$ zHS|oq573aFHZxhAyP1`Q8NO>2Pk40cY!c%Q`6JnXOK^;aGeZ`fpR?8o8PP|^vBX?0 z0G-PdTZ!_&&YCtZ4;cHaBet!7aS3!`emxn-c?M)nl4Xdhg$?>Gtoq8PFMb+Gdh#lw zXF`8DyvKEujX>dx@59YEnhe!|(ny3g!|a;-Ym4fStuDls(JRRB?hzJk=OJ?wd0p>p z+5Sk|g@34=Vr#aslpWAf8XuV&%ue5)FM2;fHV|DpmuqLN;J)!}?RG3X8dwOQ=+hTE z|92s}Mt5`&@-?bW0kt}1lCULQTb>d_A0YqYs$&^UC^?M_`!rnOxc*>)?9~frdtRuH zo7@c~LZVwMZ5Y4AB)Hm8&0OsY(xuHc^j@aUFql36J$=-%0=li9UiX47*)uq;JWF%a zhuX2Z=1>a~GY`>(rF$^Y$G#Fx>YtzMjm7PE5$$gq?IHm?>hi|MMH6GhK9`3VfZ;hu z+050`ylk99`ut6zwXdl^{=*1O!<`BenNEQs`fDtp+>=*ffm+te1hJe%>)FMoXOEpiyZCOdqH;LO<(im%Qy)?l6T#x_PJ!Gxk zbD`f0TV5==gcE)D!b`7f+F=WUNgS^3P&*9sw0v)!PBeEDGe`Uq5pWi0hp)X_z*+lL zZ|Kf&+F!hRsFe`=bL;*Z*y9Cj=0}=?wD`au;Nv#M5Ux7*olZR4z#*=*f zAI`Fk`ce1e9Bpi)Ov+CiT22HwP${=m&xEz8Hw%=@kkz?>%-niCX}j;CnwjRV4%Uph zzBoADd-k8+?MoYDyjWwFed#s5+Lh&3+Y!#vwJX{2wbHeOP{khuquOZ%|lWW3R`nz3G7DU!Tryi}X|2f8RN}FpBJ9L2u4&mwCQjPc+ zy+1`!wuw#1^x==xlmoatpt++EI4H9Y;-T}vpsZr{zV?x1Od1s9e0Ks(k`|r&N|V)$ z-7yAG%{^wW`|fOO0DhcZr4MXA*2Kt}czgk9aTC;D6q3I)B%&OL$YY!g7D>-y=^SoD z)tl@6=?>OMbl%cJPX!G6x&d{i^}W*YOL+&YZilaoj97+_nn=wwnF7Et?RZHJNz^KN zj&qP~jwGIRwy$8sU5H5(T{!n82~_X>HgxD;$Akyma0-TZ(9eL8qu+X1*t5>aI$k>J z?8(Td#$V-yI%I+^ZZ?k%5T1}ge#WuRZ?)#*LCYdOYVyTUY%J?ldz9`_a3s(AP=s)9 zJQuAqzByL2>S~l*`B`dGg3!oOA3Rs9Q@4{%VNyCmC0*y#j9l01nyb3!K_^Vkcz4tv znii4t@~^2r^bT!CK=YJX3;u98UmW~K(e?vz-|E^*2Q4g#uqMX|NOKz~#`ZIe_JS-5>e#ustbX%iP*2~BMmRQr(Nea6`!E?K`Lx)3C1qmOt8&Em=(S9CF#`j<2u(rYM!5s zW;S5S3_P$n@S^KOzw)Y&849{kTJp-lF<6nP+FuO!{On`f!IFNyMRkSaP)Lw;u6tGaq8LRV__b-0PA1^$+S~v*)AdjE3H>1rtt7$8>!;pE?K^Cp8##L- ze&!2)9QhFxv6Xb^=q5KQCjLa(jkMCgq8`G68-Ey2{MwlU#_a>@2I=mb(lp$YM`p_7 z8*`CW**DDg7)F0?kdN`oO=LL%s(tqY#>g>4o8`lsZTTPF1)p8#fWH8puJO3!2GEBO zuT{0yw1Yw9#`f1KJ;^fx9VGQ&c+9CBt0lAdMtQ#AO)mAKEYHU8l54>w&`H&u1J4^I zpS*S%h{x6U0$kSV`Cm*;eBacDAg6T3F8Ckr-bRqMIfRgg6mLdeY?IE+6& zrawfStN`A{NgNmn*aJ46!M)Vbi|1yz`ysuNV8#@eid(jbz@JC|-hfVPR!&etymjO{ z^4a1>Nt~YzF{Jf?qjf^-YBC!tXdKn>(x+6TExRxTR z3Kew-XDWMdHi#wBs+)wz?#}<#-lcbl`_~@*mto@|TVYb82eFr^tDSp`7R->niNf!| z;q&0BOrUGf0Ps1GwfBg1Ss*cYJ6X_wJtW&ZdWkM+G8$bPm<>c46Ss35b(l@s@@Q~T zxpvu0UJmjmJDB1)6r8V1O}~(U$tn{4jQLB=wJz={9pfG%EYL3iC9FT6hq4dP?FQ56 zo1;gjr+C5m13v<%u~Wtz?APaT&2SO)2K;Ky)nCGAb!rU-qo#(k*fFxnb~K!z#5`3= zPXI+vh?uS`TUR>8B)p1;ARb)Zru*o08}6HVsZ46dR-D&8&;FpjX!(vbn6gp!KAsb1rkp?w2r*Sw4TO=B;E(}zsGn_AB~9?=V$UbA*4=j&ZQ%B>PBhMd^r zZ6S#+Q_NV<&?##4c23uX(|Exp(RH`r80y`#k^I-xTHT>|rQ0E!Je?AD{%Q2-6jGuK zGkxFs35fM}l)AiDn>n(Zy|>8+m3I^@IDp)FG217OBkYbBjA>maWy+c7spYRZ=OM1N zh?=(f;UfNpq#=WZysZzRh`t4t)sn%Y`g1zqU`m&}TD1Er$^Q5~9?$c0C@P{NJxyt5 zE52KhiIKd~00o^R1-DhFNJ|>9N***(FT4s@jq3an`du;Mlz*4>brOc(XqciqIJu!? zZ&x|_$8V*Ev}1o%c+0X~Kgg`2GG5g`w+<#|7)+2}Z6FO^~M?JVXf_v7!3EW<9+_+)V43?QC zWcp-?<}{T`eBipg#}S2_^I+bl4riRTQY+V@V1Tcudb*DKQquyh@4~3ciaTbrg~(40 z(KvBEPg!!G%qq85R7{7Db;EH zix??7K`q?rRwvp}N1j=GgIkwO?m^Z?vqKeTKZlw~y2r*9EupB^{Oz+^a_X4o=lC&R zQfjrQbZ70R#rt{lmmOiiQTL>t=%o3djd5A82FsZ0Hbd%kZfPy>nfp^b?rMfcXn@9L zvi4Q4F4R`A8z%T}w4C;?g7}X+glEJ7^#ue6%iij42E>r<@%W^37Fm9gKTX}YBAkO3sDX zi&AWv`COiwqUpLH&(CP!=qCqsftIkfoE35-`a@UB2@tzRBd^x>5fl=X{{`>O zuP<5?4K8%mFFXUD1b;kktz3DlLAwhF-RZ|dA0HKMeZp;TW!FAS_q7+T?4ZY*x+R}& zoS?u0o+A89a{Nk$`=5RDi~6cD3b27&=kW8u%yG-R_Q2|rEMV=P%)O=vZ?K8*W(3e3 z+5~X72Tq4)Bbyf20d!0pA;-^ec6EsImqiZHJ$bTF1;VYCN7rT7Cc4=hv#!_W4D5Vm z%sHOSr!j8wxo|Q(+>WJTGwE_iy}fv9^Z`$Fx#No?BE0`Ck~b|*Uvg&y=WH(dCwd_E zbOEQdgBHsJ531nV{qc&^431?pcHlhEMC`B&N^TN+GopY{Jzl1evNmntw109GHLR(*dgVyyEja{H|9JI>8_nYiAmpxP8sjr z8ql|93~7DfKG{Z-U%IItg-;OYj}_5bJ-qjANl1^qXx>m%;}BlAMpU<4x(N8Oz~ZG< z$9Jy&JSZW_h4a{PdyBpj>)Oa{w&PSLvwtgyhsq;IL`N*dcO_a(W{P*6{0knrwim(U z5KoQ0EOJj-pD%$WH?yl?d(O(qw^E3cyUJu+csG62#mp0Fi^7qEE`BhWcm#~()hdvm za!)a+fBR<#k6`LGb^dC8Wv{-lb+I9DZYQ_GrGN<$G{#A_^y((-ym6BW6 z7~9dJ^0BF^$$?kR)?2LJU}7u)eIxf%QFS51mNBWQp4vo%bJ689tNLHDV4$RLQ!wlE ziPcD<^c=Ii$Yi}R|4Qnsn`zFFc=@ZE5DQBHmPsgR?QwGa((K$p1Tib-sLgI9^;%8L zS1j(+%zyT~kh0|~iO&?7Bsco-Oa8-|jKH0ENC?T)aE2o8_@(lED=^p*~lba^``_WetlB}P|U?{I3&6S)8$n5 z-XG?(=7UC39yeJoA=Y9ZccrIzZrSPRh!p2|gHVDv^YFW5yVrqj4~@g1uHws12Hgew zR-tu_9zkx6H|aT`vYk0Yelidv!Z3NkXdsKfS|IHU596n2=?GnEhglhLH zggQSZhs+o!ZzWf@R70NXB7WlaJ%>vfBGr%qOXXH%4or3?+qLFhD(zb_XEsP*xSy_LeAdexh>Sh)&KsLyKK5XZ z59B%5!BP^qsI1sp3i(jz<-DPds-&(W)=Y>^NKayr^2;8j+E45rpQeq$5h`WaeZtaQ z6nfmCVSw-=r?|+=T0=2oYW02;znEwL8j9F}KEDbbT6A4me3Vz+^6Y5Tsj6WdU5cSb z@l_qlv@4hQCzuP@`u=hy%HA@o?T_R;y6>09za#wFvFIRsfBiHDTKM4HZ zB^cv>-@MlZ7OmZ@vt4UqafBe)&n@N|e+g4lGM?kPn{@9PxCW@Z98RdM9d>Dto`U}Y z&(3M%bTKyLvTNIb)7PAn5B3&TRaQx~5r3F4!Se7YP9Z<`VcAi9jU22+ajk`syV7_h z)~);yuQ)39bk(BUjUe+pT0T1~RZx_XtZ*o{^}+vxfyTAPgF3R1c^mpBb^e_;nOT)Q zKb;wa)?09bY>_ErXIv&+N`>B*sJxd&ts7|+W2tP>FR{ZV*y)t0LR8=&p=lFQq~4w# zbBEqEr=B%mTRrjpX0~4?!{I|a`a;ZBMI#_vx#h0hS_eJv3^Nu&x5qYJ^r72_3g4nc zs?;Tb{Muy1uhccGN|0Br__4`E#ah}7ZdSZj?r|hVMcwG-j=o>W>@Ml2o2OY$|>kdou2OZiF@-#M|%r8M~k4fzyi zB36_m9fvUTU?~bZ^838&nOM~QU1_8f>bS0^cJX;yzEodb^u*x<7ofWN*>yRKa(gT6 z;)wjwQuP?dR8Lr5e?fgreWZAk+V!E!50qtwu;)~jth@s5 zp$F>crr5eGIj>ex-19+t$?WaJeW-5f?&Pv0knIQ95*oqRoeCU1EE6E7TJ*QyBCSHx82FBuJ+<6^WM1eph}xi?ix~i;*W>pJB0!riu=>c*$s;{&sM?3QpP&y zw=#vK13IgY=9t-ByG$URuEIVXQLv2vNaUYp0|vkJkZp8%F{_v3kL@a}K4{zEv(OeB z=~k4TYSGv42NkO<3vpwGZT@}Y|I~_AxC+~{YTODhV>`k9+t$j~+Bc-rLtcpg5Dlxf zuyq6V7owX>SkHY^R)$QLd+FZy1Af%*UkrKO?s}7t$_W3yisFfW!SY`wA$Bsl@|NG% zB_8BiSPL9gz>xFzW6w(-7E*&hL!~=br z-7&gP=LI`gDu;-%`DOZvT*KRFt`Loay=Cj)A2Y6WrRaBg0R2Qah>I1gd)Ef)?Noq; zcnhiCQ5CYx%ZmY+TlavYzg|Kcc0m?R7+NYeA^PyeIr}HB$<~y__^-9SPHwF0mt%!J zNpdIC#YBEkNNLSB*_(hbyTiC3$^F{p#F!=52=Jd@Ko=@gS0e~hO#=yiI-hC}l$jx7 z#@nEP=V9_{n<47ENTguDdyfkj8ItY~o*M8AuZBf;C*BT+Fp}^oBpxz=FK#IuD)O}LvKs-Zey%^2>^BqhoA5YvQbS7F$8u7@3;{)^WT#){k%r&~{#oMx2Nyfm3iXHF}H zz4`&?daR#14XxbxYIQ_>?05BhU&bF?e4wO~<=F9uQkd#malaVA+-$V=r>Mo+cvVtH1mrNK-6;q@@-A$6Z zU9n)+AfF11KP*@X^aTB{ipb+>EL}NmPC>SHRIL8V{YQ^x^L<+Ekrf?WTLN~%Io_Cb z?g%%CYnpZR>fP?~tyzih6ts9Yt`Tike`F>ip==&Ql%q7V1 zBCSE(3w4>^_}QdYkjz9w#fZyYW~wm`ygA-}CBw-{uj%tfh|$6|qY z+^wxQT^dw}DdZC;K23XxrCT-mvY8<6BPkC}fs(edflAx)B2NjgukKaBrf>ww%snS% zU5i*fzfn&&UW?A3q|2A6_xdZ_S=|@SrVFC*yaQ%10_CDciJuvYF}(Sj1*=>2|#5lyhU7-Ub~*>hZaI|4`}+)tFO zFJ8sbI=$vARKT5Z5AG>ZQP*JUl14PlbAOe?)6~Q} zgmXcJDc)qrXv{g@SL3GxuiM*SiR02XP&=nK)q?{^_w~LiA)RC+^OfsI;W!SgD@HV2 z2fU;gTZKeNAw`qq{6H#}Iby3_c7yU=s`f0`PuxtI!gTjxABOB?R-$TFl z;!-!g0(yo+nrbiXF?0^*J+H#CPSn}*_>0ddTEkEVkBmrV-rN2F?h%}W1Xoiu*1DIa zC(IvmTYDsdc*uv;;7GH-R7`!ZyaIzYcC%31-c;PGJy@jPdOW}%?9sAvuMx>ni#c}x2Qq;JdjB0^z|?texhihul7ZLeQ>+uF8SF!H>-!M zIUEGO77%vzvN$UvYG`ZP$U2Z#93G|j11o>f{(D)9_^$Yw>Wao}cI4cP4yl)FK4+Ji zmmWPMnB-TZGu2u5U8p-)2kXJ}PU7b0ikTwQ{BbkxPz7Pb@@Cy`wq`PIknaVTU5_F} zl}^7Hf1J4vU7IhjlTCbCT30`rdWm46x(oRe1G%z|Ueks?;aJ+SNQ3Qlhniti@3d8t zBvSSg1G$-U%KGAIg7n9w(W|vE4Vw+qaOk&T)h}_Z9Aaku%)Ga-!ok5HyUSfTjd(-R zeg(`hQ*7;d65sZ6aiao1d5^+7BEkp>^h7HMWVLM;Lu6> z%%m}I)g2@Zf75HemHH8uB5HM)8%z3)8Tw=oZtHE4WTPV*iUKvCP`4WRlVKcdH$XhN ze$#5K(I%8KOsE*HX&&jQby?R<6O`f%T(&rtUxx$A##dY_EX;Fpo7EldaVpI{X1FCe zSbypiYrI{M6O=a=fXMmwk6wJ_E||bMDkW;g!Irlsz*YY(sxnxr*BeM#+$tRtZ)WIA zQ63>xozve|KL}&$%ltAhQ=;Lh)P+w)(Xltm7-%dONu{S6WaPxzrnn9_Se><#PbigE%IDE%x#%odonuI|In;P4-gM^ z9mf*AWlhmn5`C~o8PZQ@e}lN`?~i%Y(1k?UD{gzd#T~)!=)1XsVeNjCBO$Ju;R`hE1$X{+E_Hv)useR# zQqa@KeAiQrIig+yIzO!3FnP*ey|_|WlLQoKnRQ2`VNIGm39hE;f-at6g31lO?rK+u z_XbX;B^?N1J=#N~^h}QTOz*(#rKi&JG@4w2eVNf$G!4OxthsQ*76)bR?SoQ5y9B%Tb<}0f^?@Y}hrD=<+on0{x^YjlfJV zN}u~=i#tTz1=^ZXM>}cDkMp8cI{>Bfz?BG?FG9$b#Tl4KYC34vhgY-=Uz&2*5ujY2 zalAPhWl$Rc+Nz6MbdB>!wF#L@a(F1)ZT2(yiC|-^8U}kxOQ-v9D&7(GOAJLuZD0!ug z(X70kOA0+@t@8JIgO`NezIFqnNo+r3#F9){ngdUX1oLX)9etyyzlQP70!rd#hE*ww zz|l%8NVb?VYFzCVx<)K4hUUjIf{bBLuV?Am1E~HuiMEfI!;67u`ei9F^EA5}c+7tC z-5Lv9T}dJIj7wJ<_5TRnf;jCgVu-y@TtT=rz(9D|;C&IC5)`tt?O`@{;FZ03!T7yd zY0Sxxrui=zr&!LyStyM@hvXsap7&g$=d?XXHsI$DqW?DxKuKA4%N_9vf>VsO?ejVO zC^$Ohq*wGkx7Opyw;^d2xJiPAvf4YEBgxw;uEVX}v>W}rVw)w*ta;J*>;8JZyHFq0 z4TDDb@(q;fz`kLO;3HGpb~sN-bQ~3JW_&dS?7b z1|*OYB6`BU53@&YOxUmwg_oVOvJOtWxcj4qWbYe8f!=@QW0m|mp+zJza+)+94bsA_$4RrBi`H|B8u zs?gLO{)Wrq(1pv5^Nc{$L-6OO@>A2h}M6yk{HZ-u2I6}hh4si)ZH3?;)N z)U1rwof86%5_?u!O*k0u&oI~;&M$0{1nKAXo2H2yZe51M^6{H?^u$-fe$*h2yO5H0 z8^jOTShox;0=J@DM8!Zib1;OKi1HwggWV-(>k=lQEs5}+_&f_EcNYs=oak**d&>GpARMp$qZ{Ftb%f9G@9m(J3ke*{|fNR#n#(_deFYr@K8HK#JoB$=vQLf9LW_eS+F|z|g{R8{JML&(rmSh{pLP_UI zD$?21H|gGKiMQk@cWY9{&|Ale4A!#iBCgj za#^93%aUxNT79P-IjJbTJFQj!q5SYKCWVRW_n;0%W@!f9@ZAtwRzTzmFp+;Z?pL3L zY6*64cLkgE8HiDa4$%+tj$VYkrqDI2K{NTv%XO{~a6r!%PZK}ILg~IYA^0C0uOYLx z>Ir05bB^wHb)8)Dir~NO5Z4UYkv5*`?qvkKPVY(z8T>>IQ~`fIqB9q(bwHyQhu@L# zD3|_qN$`sbD-vv;MtLvug8ku^2WS-F<(xH|38cv&UXwM8#MfveV+!_pn>6ocWiiVi zu9DT6ocoT_3ms%EKDVY~HOa`E7|i-D0d_NX`jD^l!hby(TbO*a8Axu^JUVi3sctaQ z0gTO>v_Uc8k#!F6lNnjOE{>_q?$mO0W!4#|@QXL#A2<#}BzyRRqMQKP10T`n5N zI8gT0m5oAelH~7-Aa1RwbMzG29Fl!#>oquu+>RT&$5Rio3I|k7*`h81A3sRflRQ}j z1u8^J1%pA~M_41b%yi!f!dcz7Vvpm4=X6eUOF7Pm|MHqpZ-(Z51oHg$dofmDBJG{m zR^zXwhIct+1>us((WrC1(%KR^RrR&-uAL`}t%~-|@)q0;1U2%{x?gg^V=U89`V6J~ z0-xm-)vHYVbTx;O-qOZ)PdZApn~P59^V6v1PX9FjW1p}4WCz?%avKBdh9WfhD9<6k zFoVxm)5tuvX?k=uy;i4=?s7@lS7z~|?cv;2I%xjAR6GkBS_dLiucXd_M({Mk{sG4s zf)zvXh_SW3jwRoL05Q0kDN}tpSxBTu-c5P&RByCmfutf5cdQ zZxT1r1J9KqF%tM>A}+KkYQ6LoD<`{lvX{w9PZuC3=|=V|FfDJDQ1ah6>*p3TAr-zA zkg$5|wwxcu5e6AN6Hdu~Dee5RJTjC_Nv+W5hhfYa(Qn=b-t!Lq!~yS$wVLUY<1QDa z5c)v{7nWk2YTveXfJYBkjYB69M<$1}9e)iT*I92nO8F?^yVOg{J5j?m&%8QlrpO+x z{jdq*aUZ?Eqx{_#zKPfUN$bw2tnPI^BeBZI{Mfk>8ygF*THyLB$Td-W3+9YDE9C3+ zp1WN8Cb-+9y~*-Nm`|GV=F|@%1-Q}xrrS(B{=dG=oPIAE5^he*`a%!L=v>^cGs@Yw^CypTeYgC?RuUqPV^rFBt-x zZM-oqLQCEz{_4E5upB^MMVc=c5t=~i)DA=hH^?&rr~eXHsBUI;X|!zn25Ei6Ds;-v`Z^#aSJ->QnLN^&;0n9k4tL@vpmPwu1k4r3g< zwx@U;qxkpF^YpObYnG}$Tw8}=J)^M&{gLQVHr3}`kHpwV(WW9bWj;aa%NN(0NdtSg z{`gbiq4a>9yog^zUl1qXEsZNS8# zw>Z_2m=RMx>1$1Th<+>5a*_t;Cbni5RuyZyRmF}I>Ir%u+*5n14FdKD71U=9-AvIT z_P;b=l|6Y|2InAurFf;PlyC`731O$)QeSVa4yYt7YmV`06{cSVQ!j9-izs*^rhct& z>aIVjmAG*V^c7!;E1qklc7w<^;R>qWhmgjU_ib@=Kxl9$2(K$+G$nb(d5v`>2=;Fu zC5o;Kwv^-S(pl8xD@neE9HXH~Jmr}(L*H4tYBXtLKO4f4CFgc#kp#x*BPMp=7yV!J z)-9d6IGO{|;bBZK3x{6-_3J#h(d;v)7L%@)a4!hm9VJ?_Js_B_dyD*bZkLIQo(ust zh=cc~^_$6CvYMT})Z;Pc0W~$zoh*WVLlbMOa>z8iR7^jJMX~cC{_|dB%3n#mjH1H$ ziPF{P7bt3JW+x&=TVTHI1|T&9uO$9qK^78zuW~d>^a-->TGEVTcTDCtqFzxpJj4RK zX-Fq3Iw%6l8UV~5C(6E}$&D177@ooDV~i5M`dVL2RiV2bmyKvz>$a@Z)GP3*>^c&X zy83yBnvOnCt=H!M!rjlXi-v3jR83ZkG~yOW3G3L?dQ%+tj;)&V;VUAS5Nv#0>;m8! z*eB)RVJEpc;ps3T37Ff(hpMiguVp< zRvOJhuB9zpGGqC#@qX>Kk4%l7SKQwe-b!(5Vv48n|1w#>X8ZZ|C&Yu9$oCS?1Isn| zIc#M{5A|M@EHElSU_{)&DXwJhDM=2Y#C~c`68>=+y6U8Y&yqs8Zq~GWc?-9QG5lJR zPeI1^tV{eGwLZkCXyKW>f1?w(A$jW+GcmI;OjOrhJYZHgr}%ePN*acBxvYE(+qe8F zz*Q4P`*uQ@TdWeHEBDk9br(<2MPDT;lZBM80eBl_y@WtkG(+C8=i+U;(=EzS^#>N0 zUIp+rzT}q}{FW6?p&q@1IE>sl$qg-oNe8LytQ6STf%MX@(=lnCHl)_wE6yGN(*{J9 z>Z77-9{bhZW)+BZ9X3gEZ4BwG{Zm)Ml+=F#G8%GBF_W==l#w%<>r}F~om*Fy^=!PJ z!aIF2=2%xrly_w9p$f=qb0*;{vT$$;)qyEcEsZY*@s3LHOf4NkJKyA~t59s75g3`RuSBR+@i&7fK2JToeg2J4fW#`-8G0Am zwH6i_WUYBuV{gmG-3?M^;xf(s0nmN1cHmxaOJ;4WriC)6Ph41))d%HPYTg z;`p1qQVQxZH=PvHQBC!Bqq;l{^ygBS!y)1<0NQwSaa9Pg?(*Cf|)701m zUD11YYTLE&YbjmtBGIvXhQ=AqBO1?2r#zyN7hietAE5h#-Y5NZC@aqkRW0m6$7wUC zrr(bHmQaRcRFKJj%KG@*3*x!>Ip2;bgr|*uyihNIF8|kt(cIY7v*H^ySmrHI>vN*a z1<0M8l;u}a*S5_?w*BhYKyLsm5iq`Ko8sFjNSW+)unSxpLZK19s||4NY7Mya^bWKlpZO`v&zq}v7~Mo?9roJ3nTmvh_ODMBP^WL4&9ce8pOx!(6?* zXisOc`NUG>H>~tQIQQ9x!G!)al8-N=K|4^BDN7Fd(%Qtm5UV8jK0M`#bYo{KCeSzt z^0iWQR4O!vt%!#2)GvrH0bDlXO3HFx*4YLM@wK?DtdKnQSm+0>#}Amqmf50JOLLPs ze<)oaISoM4&2q4fi5}d~^n0W82tq~sQ0-{Yxb%72a&{llKHs08UOAg5*%5QLv?}~8 zxO)q8KJ=~eLj{-pXiI!zlKw@|7xFLE zJgs_3wPNzIGj0v0wTem~Z`FR=TKwryTbp=DGydYQ$~aZ6m=OPQ7zA3XZF>l;OtMY8 zmuqKU=fCDfIibs2D^@X;nfrD!1ns`BB}7z*bi_`iCph)Yuc=4yt4lCaRpRV_uUDbR zY63XXK?5~OWJnV^zrZl%a!bM*KdMbSUiz$-hc_z|l#Nx`(@O4yUt2p%mZTx*kShM}8 z=|@kqE|VL?^p+e^Kes=JQ7Uc-Bbr2}s4%Fh{n7)i2vxT%GD{!`mHlGVV_ID0Kh{E< zZ#><$G<=&fukmdqdD=GkimJ9tp#-RLSVeVRyi~Vk&G?YM0yuY{I1y&u({`(q^~u_Z zA=;NB+_(|cw9$v|aAmPA8!S+S%oX|te8_fatsXK%*Q=gFYe%9GkFuI=E{?R9+(~XT zud2;*Oj~#;Fy37nn!76f4P+~S8~UNhX%D2pxDGr-B5|%W4tz-d9MW>j9Yl?aNhUi1 zR@uWT)>}HG9iaefp{7)_pWQYy(;RNhJD&E_YF=`x2jovo)mDk+c-!|DfH9~BeuEx}e}A!BXxf?z)w z(vE9+#%U10EUd`KYcF`dVz=^^pG$1o8uO zrF{N~ioI<d0cGGe5`POMIO5V413x5ToTzw@FlZh_Aa4c);WvNbh^# zMpn=u42EU`nN8Ava&qRdBw!n|tjy5s3=XF%Di-E#o^za%v?kh~yoF2(CN%olxHMSD z^`}M50PNx~+E>OgzYbtipX$P9HLfYQ$sv$xaD&+24rXYLVwQZYCy|fIYZ*w03-tk+ zpI+n&xe~_qOpy`#iBmoIQVGj`#;$4W%t8jbyRcFfISPPlM9%ur6rKZ$2RHoPFuxZtJIrBjAqbd_fdEQk*>Y^UC6^Gv9S< zV#Cpvv(dOQF>Dr-E4?#fSpX38oxxoyG>gf+uokihJKNdZS~54yQRLW{P4?iQL~^sK zRY6fVq}TDtrHpTiD_@H2QchBYIx|JpVp6S7$&K1WERLE9FYl;aIfeb5zS7(lLRK7T zwjHjv!uiV77C@@_CWDTb7o0D%_*E_$Rn4l+9~wC0pR1xfNbKYaxk^4_nd*RwIS%Yt zv3gPzpKKh~F=&ZkT%e!?u6E45_wjx_KGakCh* zBEKD>o0hWP&R)M>V;V(ozKPkx;J1f;`(1c_|Dt6zbUAriPt@^8tF`;oltXF;Ww|z2 zk>Dc6tpn_3#vhf%Se3s)xqWftx+o$s`D?HIZYADk&g2G~`xK(l7B%Um`m-f(z8aMi znfPATr7UP!sOK75zn;Zslb7G$Q`w5~rrq=|tL39i2gJgp>4R zl$^cjRU5jY6G2>c_*$GMbTu@&^xQnyS)HXjant7;%h1=-?0#6RZWkFivwlHO8?)nKu!X?3wwo!}j2DPg ztm6!m`;wgO`qZ#>RTE)ma-lr5F4AsSiqx%lCiUI(SouzCs>fxEL16ewq}v^VVX3T7 zZS`gtq-@h9nDP+*hJbMnTNwdX!B4Fgs1_gLF7!bbp^-0^~R2m|MK4 z+L^7{}ixAkko(ez;6j_C0V3zfq;C0m|QffcB}2UyQUd@jt( zkza3kY)*?xQNnAKRo)sLt?;#ZB{exC4kNoKmgKm&dyA>4{>06GHbafEPfC;g0&A}G zvLKrDc!iI(M9p6<%_Hld+c3CeV|ZhBzTw8cnhW1n`J4Ujo5hJX9aWO>@%BVx2!Uss z2;B&Hkv$w3p;cyTnUE*lQw(0V+*!t3X>N!XA-TWF2qDZNSb#Ohuav+SL$ciYyj`s$ zassc%wz&4^sjZjqM878s>P~q%qPXgiA`QYs>e-HOSJsrdC7z>x1q5{opg_v(> zPhibnh8Ud2#X+Tg9j^ujU21+yCG?4zg$UXo!3uNXu~r(s$P%UJGV-;l#%Zy`+DoQVYzx zs_kaOk=A$c8$P!o2!T$`C>B_%lR7$7uL4WVEIGrPJU5PaY%kTSHWCgvu5H|iWG}14 zZA+^k_LnZRERW}08>Jr{E=nHDdo<|N27*xHCVb_7uE$f8KA8A)RAP(Da&8iW&CX;X z6mo`Au5z+fzR`MMy?QK?ew4a<%r!(!$JI0ak3*Y{z=JQhr6ebV@N)F8KFJ%q-+1|V zwkH>pE|$pXX#W~>Z$x*>&%IP{P}4t^Qs*52L!$T{);uMq0p%gwL5(VLJgH0)Qy2A} zp^g)wr!qq8XhRw{;N76OuCo)9Q%J?KP9dvVAb6>`uN0mo=Gz9qX-z)L&+U%7Q8_)f zvkPyW;f%FjeE3}qz&++4n9ajv!UWk%T3*$IrjEx1XWd{WC0D@v!vNb$9&k?KUJ&ng zT3=>kw`YzVe7b}op#Xgwer7%B4+?W)g`QGBf2>|o1mEn}J)nNwOYlSMLVv~F6~*+s zwzvX=x#(C`ikOz!X5VlodAyf8>G;&onwE&`6#M%a#-`2%4gVI9DtI4KW2wh-DS^P2 zM(h=lCD1Y;&l@isx15qzwpTmstJjv0n8x#HmhwOXzR{l(>kXL_^c>fRmN?)qU`!}f zIw(ms@I;jcsB8v4CvBoTL-OIyiXd!bL;4#~efR=$l; z?l_@D?nIMMm=`S=#>Plzf#ftsZKudAQes_slo8zk-X z%9Ez=6)&qaln!m=k~w4ct$B^2 znUA5W`2Pyz{k_9E1N@o!^VfhuSc?NrGgU*P|i>p9Y$u;qR+-Q?DXXP})!L zJvj|rgaYS`szQp4&Ts=$U-Ph<)iB{l<*r-@Rf_f$`=50c%9UJh_a^v1sdh zL2R!qlRDktl|(V;4JI%qq8hvFz)5AZWR_Rj>R}@nmT3m>2gSg9#d#*nkb?Zj3p=S(WhS>**N{xTGg z>SbX4o3ZZ}D)IY#!^*IxbLeJcFfjJ3N$%L67=tuwyTH(X`Y6|}scnU^3?BA;r zDe=F6n}+F!>Hwt>xv%bG=qdA;G8|aye{MHcgBi-SkqW3YPw)jAk(w(my2hGVK7O0r z>m{$RYn;;s2RQZ-)P?2pKDH@i#YqaXrkJF45m4DQO72ZT-3DnD@~tniLD;`>026aK z3;JIUz`f}LM>k}pQt;LbnKfHTn@#&Dn%L)AM0c3~QI4;Fav0i`6%C!gj!zpDm3)@m zQ)YCaTw8-(>SE2BS9e`M;&<|Z_`jvhc&+JwV+sG0|Lr{dD88@sLg%436m5wwJdpPGJ~cfTWiskdE}4%vtOlX-a~oLhR|(V?%B zuKOX(p7fU^>DzptG&Au4_Z!|%+eOIwa_p(euGW5au)cf&=pxx{@>!!6aD5w}Mu}e7 zA;XB0@V#?wg3%cmNuOslLQ*!4>X__4Lq30I|7AYQI{6 z$<>;2Vr#yAC_m!zJMWdJdC&7!3%H@bSGDxHSpeNz$%n!?z_RGgF>vm-2c{z0+OQaO zMfF1Z4KCa+QvVNo)C7_I!5A)B!KZ{>BeYDPcB{uPLa@Z6Z~XR7a%r{>cU|7KQ~CX@ zaa+6OhToy3)k&kYo!_&w`Uo_8hZ!~&*yNQbSDL)mjbnqS&gx&n zQs_PJK{~|%UA2>5*3|w(ZNuB*0F?OGGV5YNAw~V8aJrlF@KrqdqXE+pwcsS7Hg$yG z(qOq~b?a>(RhfijkN%XbUzZ1OiHD;sTC7<;CesU#TnJNIsf(H?gY~yBasS#}4hdSn zrRx-Q9K>7qAx8=<+oTTvb5mi+nJCde!is}~7qY@5{Tw-#4n5U&6LUYNHr*Eel6uC& zEq_>8xfKfjKI<~9XFdHq5p`?wn3S~ovV0aw_uY+-lZFSkC0vpDdgMt@T})c2j)GtQ z^f0w)+AOzWu?-qt;~;vPB_2|HUoeAwi2V6`x;jo6a-Mc5UuEJ-+SFxZ9jSfD4?nIF z6?_+f=$asO9{PHL*dEquZ`c}WP9f`z>A37p$eB9so=Sf7#a~ndikB%wL}fv7G|1Z8 zvy;>zeDa>;<<4%O>I~{XjA#Arby+w|n^yNf@=h3*TzRgw&N>8_pMu zUr^oPm}7V{W8wFWpRvVx7ZxdNRzxA;&=<g_n`nRb?IupC(k zTGgB2;&Q&9g_62LOb|=iqnNhg5Zqe+_;X`Fs!2*P;T13{-dde`7a#5-{z+0TMR7_g zl0dCVI&hSRV`nb;Ri#qP12+Z{1py)XRZ+08RXjrlE@)oy~t$;s6@_S{zU1LniI z3cAl6wg-Jq+9+7>)l2>13C??Yzb=9`@ya`0rOImp#osP~%-C_}K z+3lhaJF9bEd{0jnX1V(dn_q1I2Kdd-;_!_;N=#c7K9QZyXc;}kICQ8No0s6ehPLij zJ)x}-^pVutHS;NdnS~CSlnw8DvPiU=_9p${-guGcx?88Y1>K2$-}quu*pmTBTA|+8 ze(7SP+{PA}znu5$t8+V&5Fs;}F9&NzoRRoe8(bP5GHxa5u*T`JfT^tTW4+HI-s_ud z|Fkw2Amq%!wzN`UX#h)Si{FB7Uo5*fhskH4D@`0p4Y-!gB~D1edfxYIZ7QL{hYLwf z0%lOe3PN|e_FWcp%&8(;m}u^}Nu%d9N6Sky9N^Mve}g%TnzfeX%>yqf-}iqBj6FI# z^QKLK!lZXFVVTXbDvnI*g!uj6<36J=8}^fT!r7E(K5PE+9$lAZoKZS)@xr37MV1QZ z@RP5#Xb*{Vc}@N{_EpV{ZJKeAJySII;8`suDex3@1gx2Wa}aN6tc3Xa#~IxylGkRW zE(Y4r9X@*xgz&T)PP{vwY~6p=)H?d5dlimELm9Vv#*(2Mvl-x2c6TIjW?H@9S>;arzoi1pU=GiR$) zldF@7SSHDD?n+}-;i=iBPY11z4QS#`W1Xx~`T9?l+bfecUS-6sF_LAkx+)^>Utn*< z2_dvx(VdWdjZ%;X33hMZK^fb!O!O@?7sD^_raYuBWl`3B+NOl0EDJpIV|c$BG4Zth zO0hAPq_LT~cX08ssl)JTsm9;w!*5r$zBB7?)$R-jk*Q0>_E+g~o?gU|r}OLBScdU- zY7fD|G!5>i#@^OVqCu z5)>4yD|ir!j#=}UR&4Y4=`5y8`qgX0lM@~vPLVysJ`Buc_(w=1Y@k=+>$0*i}(Dj%rQMfq$YnxeG)@6Y|uNgIwuETtgIRzyNP}nvN z%Wi>qyAn#4C&yf!`ErM z&9a9?dzfn5`CYzFlA-#DA8hI_Ac3s(`%v*(dgDPqMZbp3p*$cmTrfrSbF!Zm7m!}vh zJ~|=7SwEW+4UL5=t6)*t@b?&FFU?7 zatu0sd;pXpFQ%nuTqw(y6+zrtoCVLqS20NtkWrlEhZ0oLTd9mL@i z=7Uj?eCR~lAr3cnJZg>~RN}VjJI?#Ve3@%2Ph$NPe(LYUzn2dng7_=`K8jWZCO=p2 zb$IQcoSmC@%{oGxHNrW@e9|j3yG^wvRpZpX&^<)TT;U-Mmh9U;Vl*f&(wBOFsE2~- z+pzQ;%lrDph$FGl>y9f5Pn;NzKGGcP-grRNPmKaY`##N}K1>%5?<1@7r#PzM&r~rY zppfaQ=!xt7hQ-;SU4(nfrjLVTE)6lhUu$k*#Kx`c?F(}Nd$0>*k4V=ac;H+&%Nk_Q zGI9vD<`^nA=Cs1*urV9MX5+ih_aAuv^msllkH_PFyIrq_-q%MFvAZTdTz2~? z&+>WT+aXfal}=mssH*dzlNiGjehe;}s;#qyXKDu-J?vNF+mbi6P|Kw5yH+|aKBI4J z+xxGxEU>DxN$?${VsBz}WxlBLT?F+ML*VFw4MKK$gZO0|!Yi)0gX=YR^O7`l3x*gF(>@)N}M@3_J-jz{)n%(cRv6MT}brvu?pvutyK~$_~*se?QDG>^Z^9}$=drvT`7{`I=C`#)2qwCK+qbiV-4$Zv#Lb#BeitdPego^x%B(rw zD{sMX-kAh?l3pHm&Fm>3j?b3(XawsoQ<5BYQJ>g*>+1UZ-*Z+C{E1sBEg}n@eE4_# z2d^BnJE41G>W339Jx@yGE%Je{6^6=C~f>Ex0Ll zD)KGXA6yDu_|=475MA`gwaiuD6yhWK8d%cg9Q<&sy9Tt{%+_04tv&_SQeVo?pk4F{ z4zr|03yNE26n$a)aQ1u)&;;EJQPElz1NmBsYMp_3B^%5gqic_UlCmQ1l4JO3ql!is zSh`08(M|^cR7+W6JIQ6nf7^t+kgggI!GlwUG{=KuH`E$AzY;Mr60cEsO<|<3jTyF= z5dx$&YA6rdXL?pvyZ{|)_9zRuJs9v!@~h*uyoaRNDrHn@3~U}* z3ZJjp_;XT9z?m4QgXZt$A&S|wPe$FxH05UuqiYz`}%zU<98ZCSzzWZb;oOga#0r`Gn zi~sAERvT{@@~Mj;2@t!mnZa@F|0Z6hn#rtdit$a&V#95vMZw3XNVCOR+u&j)9hc2s zo7sMONAX}fy9O=B)aX3t=*B%@Tg@`t@6Y1j_qa1nm()VMBcDHm_YVk1TDY7=F*p5e ze};h{q~9fQ$GCg!E&FRfDFn1?95;5PEb1Q!XuT$~cxF&{j_kIY;!NCW6y7{&gdi$y z-*majqWil#2n`*z5Ter?Qmp`udH-fc+RPHWi7xRY>b~Fy_kF)uiTKuL+Z&hjz$a|e&R}s?r2dXp0V)NrnT_$OIG|Tb z`|X97XT_$?2wfu*W&Fu|+YeUdO>HP#j37nIHEL~9-!!cufxb^hcHIox2Thx%i5=!4|BFIw`no_)F1$&PJ()UI#R5ReV^yf&e z2FdRPY-%is+9d59bUID?JYTOrfUgyQ%hNG>Xk`R7>`RZ?fob|)S9HM^6FHY#dR&>~*|WL2y03q-9I^$LNMC zBR2TsmOb{DW=q=9m1thq?$8(8onSPMYYpu!x>$wi{`Dd%^Ct8_z?89l-+kW>aB|b~ zv6abz{q--5O_p~bZYu0Uh7Nuj92>NHT0TWI$?qEcGW`xeI657+bsQU(2biBHK~3!G z7i>;vER@dlXiX&PnoLh2AY4rK3HpczY)+NZ{+E2%? z)GA`BXK%!4tvv&Ao9i?_7!&4W)2k%CqiF0n*S$IhSHp7@?XU1%Z3P^!yK>aDc6>gT zbE=_5FUNJ~v3lgfOU;B-VSw6dvO7*Bp7UxTZ8E0gg>I_8fib|uEFE({Pucan^?lKk#D^?cRvbw=P)x^4H)^*VM5Jq9T{NKzg3>?eMe^>m{$#P zV~o$FMICh{uCZ<9a0>NuJCyWYiBz_jA%#lFn|wU5>b_jL+jVd7s@kPNYkqI>deMa# zJGHOR=FsA1t0!4rPqrUdCp;ndxJRF|6+Sx3<7YZnT)3c$8z`!d9xqOwvWBh&e>6KC z>dTlE)!VHv5*|9GEg1Uio9Vdkm|Yi7j8N{UW7VDqfDZ|E9Fc@r3+D(sbLFEWKLCVi z>hoI!LN%P;3~W(xRfoow6TNd1Ys-rX;4&$+6J{KkIY3jfm8 zI%a$)7Z(>xm)a29_ndCq^5L3(Jim?~b$Qw(9;yx1hHyT4OMd2u_^+p)89MfF!%T6x zqRBy0UkN_oW6k-&OHnq`dWO11v*S1PQ5Rgb4ti^Hat3gq-ag(;3a6Y{LxhosPMwHS zZ``eS-Qh1L_yMrmW!6dqnss$UN|y-UJ$!6Yvy<;mdD;Io3TioK8twZn!#1n-O_=z}v^0 zh&lH%JSEf{8@)Tw9xcx)F+*fgI3B?iSQofR)H5eSY9ugg7CaS8d%062KUW`by4l_YtZa@iMmU+$=~o-K#=}RxW(MDFFIWCwE8;`+&y-Ei?>DxG=f;1tFv}A zMo&8Kyp6Khe%n;>qkL;$A;9F8=jL|g9j#>0-hCn zZpM65O35o88;24ZtComaK%&?hcbn}I`1RMLw6Y?5&~}Dt=c8);H*$pyTfYT9tk6UP zB781YYhy9L_q~%;4q{G{3|CdZKz8`K>O)T>^c<__A5RU!Vk%X=LF|+eU+|^wa#LsH zruOLi!{+Eo=O;SnvpR2Q-ankD*|erax3F-rup|%Ap8R@XV)k(VJ~ZJHP>N7hQDAu1 z>m2#ftuG}(EkYB6Ds-K`3LS^8anI2o+;M=1w|vu?S33xd{RYG$lWrfPfW4U^-&HPw zI=$DNJmroDqLfKiOSEdU;d7a4rA?g&Ns-Gszk2u9DW9CzK5p3aVC|yKm~kIbsQXu4 z;N?+(ALG;y!(7u+$aEJ`Zf-GPB9RWT3H!Ysb2!l0! zIT%(G(o)6`KGbEl>l^`5Gr>1uy{-oXmN;;S@Z!P+oyz#}XKBI@avtIAPM{g6Aztfz zUBtA4J_)q+F&UCh?{#T2*}eM_8S~0YjARrwK z8X{VNyc~{>&fA1Y^@h3-GEQjgHu2p@P(vPqoB!&yjZQw$F4T*%jEo3i_$jf?d!j;? zb&HU{5%zmMori~4uge5LbHhF&N=-@;pIb&$zs1}jAU-s>r!)n&D5OkoS#Yj)yaY{8 z13p!+k#^-jG~8{Qv86+mB5e5b(VSj0^>MrOXsSyg^^#YepZZ!6LRv_U&t5y8ZUsbJ^L!l6Vzjk-Q%et&fySR0+P7pNw5$z3m~ zvAMt9yN|R5PMp^3eBjBk3wpRKOJ;Fyodp1$ggH<>Dj&=do!+fLOo^rB!l@Z6)55z8cw%Mi4y|d{tH40l!45-C_c9rGB&t^0s+mKIUdu)kyQ&5$K zB#Ng22bDw;7O4CAvhS!+o_1aYjG%L|v2Qbg=ChpKjx4u+>#sgjPz3;EqrmLpE>Alh zXKu1?Qr_qc{aln$VT4{aQ3ujEt}+jYJYQ<>hA;j+6Z3aQr#y#uQBE(Z|3uHS+O_DC zs|1=Q8F?xp1hKoJ+#mxhGtwbloh!#KhfbjDlcto}w6o|i;Xi4~`DrB-LAYny55@@saQ40Vq=%2({=`KC3jIy*Ub5#kaZeu3 zx&>ZDC8M||x(w~DNjnhY(|b`>paJ1LTS=iH@<1AcAidbo63VDUT3kK*JV{#iK~>6GdRlrkmIs3tw2Ym!Y9NNysw#>jL(dYM){)} zzIvBc%#Z((E=@7C$jMo8gxU0$0R7Tzjpe_S5xt+YHUIdd!Kx zMJem*X&wlgv??k@H@4NTiC?-G>0N0;&R*~~`W2|$*MKS;iVR~;w0X96a;j(;Ku_E~ zUs#|g65cEMF@9Qp@yBd-HLwN$BIu^*cdWc*=1YH(pq?x>WcExr`rLz|ihcIzWog#< zQ#?%<7nEE@e#4{5I6ZKhphI+UmaTch3hf*!h(ca$H_U_lQPqIF039=X(nHIT7va3N z>(LQhVQ}FxmELyROo_d+otBUG#s4AN`p)u{Q=;DhO%+4FI;nQv3Br75Ui9b93a(u< zpRx}5HCi3_Y4=jHw9nOAbZ#ieo?-MOx2s4icFE2rMP`d?s~egf6?KPwoFQR8>q!Le zPR7Jpgft2ER<{-hv&hSzu%y)Ph<{p56nPbOl>0t@=Q);tBv!vBI9SGrL)TRcR)AwL>R%hDh zFLf{E+ikDbW;6qddRo;0j9Sq-*bGD;BvZP&B7EbLw@pYi+Oc{Ra|X6t^`Ea^PzF89 z5vZt6+2?4SLLKGi!^L-z)*CuGhEo}Qs*Pjx8)8&mjL`dS)I`RAfv3PwZoo?Bj>VM8 zMI%2P#%f9y^((RPHtX}rXA2thXTE6He2Rnq2febysbb_GM39VSwhuicLw|`r_eaI- zFA&0I8cLfi)&$)rnr`t)2PjQW(2OL+hGU&25B!vhr8Aept zI5YOU?b=Pfsj-2Na@{}m*PIxU5pWd1VP?SB3%UXLJ=hPurQ&fn{5WETW zdk^>2OT%&(ViEPbF*j_uEk_>cVOXch`&Hm5gKsJk)*8sHIoFjc?=s)Xn@I70Gq(5S zRtt`4gBQ<;{b0ck;ryt~v^mQ(y2Y6(vH2MY(=!!D9Gm-X@u}ZHO*PO61u8yOgYl{H zm+G$`99!@=d9qwk&M-a;ksC)oY1ybW0!h`-W|TpfPJhv9K)snQoK=S63YXnCO#QTu zo5R&z9Cp*mPhk2u+K>AEm6x*;mW9-_%cSd{Lc3#FDB{MDbV2m3v^aCT7mSY?7RnbSb z=9B_`!e*I3kPwnglVP=68Y_W%}UCQ*V~k95|i8@QxJdDZJW5uGvDc! zcGKd|R^k84T@C(x#L5V9&0&#q)$4QP7TrzHfKR>$v$=4bOLh0+*qoO0S zSp~6huS!(QH3K^>iB~uO8B3#CGA>%zq^UPpHGk!2^ zB<7rdEdO^76ENWAU>mV7FHUlF7sT*gT4kN*$29rNsK<-XYE8b% zm;kKp)Bz_WKAc~QUs3`TLU-tVbD2h9kC2t?CK`-mgw|^o{_sE9jPe6CI2WZ@As&F#>{TWZf^5@4*=qENb;{ z3?Q7v_PhDb=$c*C8qN=EaY4g)v9-uCvgkhnWA!fL{<0zh2uj}8Zmu8omdsT%HkOty z_oOJ%gJr`WMl`68H!bvm&cr!k>SF@ql&T=pju)nV_+|yBs2n~1Gjn6wK9)mF9phU>Q(x#bhooFI=cQ(s zWN4vxh#mM9gQ)iCuOF&fbAtuBG@(%cIE((`wC?6I+zHLV25FEr= zU0WRyfkeK#%5-ks5rnf3AW-7FzQTab+}_i2N_ zv(#%m{1OLPQIa=+ojHx!P=Ic$XwDgU)K4aBh~b0EO5s0{8&i<&!S4_#PFVCSEb^p` zG5tD=;*|0P9s0>}Hd;8Bf@LfB1l?*B-oPFzGU6@HDkbFHg87=`GggJ24Ys{KbWS` zu5Fx=ECZOw-ZiaNoJhGJ^1!(w&iBzF;ctR5p2pO>TBEk__QBpWw|#3SX3Iy?i}{e~f>#@;e1n z&drS!ToWl#-Z{*C1Tvkbj-0H=1xwz^wh&}e%A>OZE>}=;3y7QCj}^ozZ(htLBZ0nB z-QLgvnF+&9)!_-zD_Kdvzo?vY>zBLuGMxYVk)-nGr2=rl1Vl{(Y-*BwSf{9c)MMkL zhUpsILfED6n2Td2d$l861H2NDyn*aourOO6QeY11xs$>ve#`*XvS{8|^}xCl<@Pce zruoPmeFlG>BMKtV=M)*eO7qbLEz{0jaX7ee(w6zE9bUGfo0XBb9LIy195Vqp$7!A? zhCFr&WR5hnvD-sV%7iF@d0+aYjo_y?u zuWvk)sl{;SJ*CRe1!NB?5*N!0hPu`(?JqFA_gJ9SCcT5^x^2)_v!PdP;^WwE6RnlU z+WlN*dV<>{mHqOGyYyO}ZI*#M@0-(4m@GU>lMHMVFkasEUN_TX;;n8n7F%`EJi$ z$DZJ|!M}92rQYGJ1Rre&L4C$d2df=*kNu)&M4nf2>XrJRP2!hfO`cWG1_Se*#u$^ejEWzNC9&7E;#ykD#L;EDGa=?%&BPf^_Kk9ZH77~$ zPc}{CmE&*PRx)4f^1XaRlTx>s(-K#bo%ES$z2UWEUH^V}Ut#YWcV~sWBZ6EdMokcv zZGqQ9K4^2^Y*{9%M{RXv)HN?QJQ#YAO9DReiyZo%TZZUpjSSLqj2wN2ZoMBCk3q~x zaGzva>%@u-X~GZpT_e9{i`WYJ?8^Bvt{WMS0`62!t!5%grniM{^JB+;SkY>rRUvLh z;k?(Ax$-Q29dc|Z>T?i!bl27n8lfb`S_Jc^q^SbG&6(b~HcY?ckjj-&%umw@bj0TS z{ax$E`r9-8V^a%ly)Mvu+*P5>hVgc3*C1e{@ctAL1I5M6n-ix3nVk+B_$2Of@Jhvr zVxuHiwUvC_QSwpM*6?Jjuc%&)#KDka?7#}FabDOpc2!;IzE3E)yjK34){COGPru1m zf`*hJ>%N1IX#I(ec4k*80E8FXXU4`xD%)QIK3NIb4z2~rB_){&j$+(fT_)a0Au%Rw zT+r`*q-=7sPB~>$J1Us#o`%}{0(n1e6e;*#FGc!0!?#k>4D-uDS@w4h$D%o8{@3@y zY1s`U?IOPv@D6R%&C7$0l3SlmP$UWrh3-PPK$6BE;}+trj4 z*rLg~L@4C+Zrsyj&r-@^07BH5pEkm;v!_T;W4Lvk z_|jBeEOpSTZmYbE4~4b$L`ecWven=NJ;%9!?oi8>3;^={{~}HS0H!?M>F^Y;&LAtf z3SEzNept9d8yF8Vi`4yyTXj}(bVGwWvLSq$-?FYw5i6IZaXamPSVB`P@+rQZKuX{) zR8P9D7xCRO8GOk{MVeC9a94lgDXs{(nZK;{HZF6S=qkMM{+$5B*`U8L?#EXf3Vn|K+M36e?Q$*-JG#5#bPEw!ebAO^uho zvm&BRco5PlFZg7M7zPMhQR30m&SDu|yd5dO>&|hPeKK&0cY<`@JhSneyMHWpbz?8**F^MK z?H0-N3gKj9QtIJ2`R_~RjQ6^bg7!o!?WS{A%oW+Y>-)X&;Fc~E^%9 zeC`iImv|=MhgD2@)@Q1yzGbL6LG@nQuki>V69;dsoXJMM0o<|Xu))omv9!-_?UhI0 z4o?GgbxumUct3m-s}&zeA#IdlY4|&d_~z$bSKoSJ04efA-s$#0rL=)(hWT1=%f0r+ z9`#1}Z2Cu72+trMEScmkRq>W4$T;_~hnvz!2-U8Aga{hX>);o_qzT}2YUU4@_q3!@ z$Ba_iMobcz^k=>2P3Gt`5Yvq=FSb*X*jC_SH`eT=)VhF(#HD*y2#??3{^PTivS~KWZlL%G+KWaqg*I!#(4W4MVcj2Io z^;N#V3)WEA7uMG!Bt zNIIG2zi^iYg(c2)lp{BQ3;)+xpG?%N8Pm}g^%byWQp%r*WYlOm0ie) zV4JC!tt9fswK}WqGuurWov-AC7kZ{*dm03bn1576KBtf2gP4$8V_zmBE~XblZh0It zsEWHt-?(#KM*banjZ$ndjT$k2g@C13#v}XE3eiUWmWKs+&TFN!qs9$*!3`HvQLpAk z=aT7Il#{81gk(hB-JaU1@rOTYPA03AB468Xt1gy9i*6aL6pp{qY&l&Y9|W|xOvMy} zj$0YQ&ImcI{k=mfq_KV(GSu5kbn{q5dbjHkPO9aCw|6qo-TJoG4R5MxTQo>viAvS~ z{?tdz=;qQ6_hq-kWWSd9R00R)hYRt4Likl>WP}EGobyuee6Vh8?8@qo0oS_5jWZLy zBZ~XM6_OnDE6$?(z8B>JBg?|^y`@wLRyH;O->7$78Ijg+tJ^~gaTOrJ>Y(fnt7v$Y z7hy~XI6Fu8DR9s`u1#c8TsPm&UnfIrj4dQxzxv?HD_e)@*L>``gc5P?&%V!t(vY%} zYttC8%L(UN9?9(W%tOpr#VToIxd+;-z$*Q54eF6QI$Z~Z@#kc)1c#4I&SdG_%e8SFk>7qnKJHx>cOzc;p>aELHkDNeJFJP{8H** z(OMW+_sYGGHWOMC+X+!n#H z2{~9YQ?eD3=ySu)XB*Oa;W|<__`Ci;bd7(0zw5N{mqqVE-}>m@N4(+ghTg3^erSc3 zfzIG(g4(UD&r-%w-BF^5>B#GMgi~wNK9X|_qgQ*s@71YHU%Y!;XQ4n_rXWLZcg9&ML^;KkY?`dJPOH|~k1|w!T^g;sJ!x^iR5`G8 zMN)2{A|w6`8~PtYys-IE0kZSbvx=ygtXFvuIbyqa$n!XWUh|kkC<%#dj1F}f($CxEArRZfF=(Fe`_GP2^Ks zp7jt`aBQ%{guK-2gc}|IttBWBZ>L7RHW;uM_o$xYA)cxVeciAfyGxZr6dN$Eu1Cqk zGEXGeNbc#h)e4?G*P8bEe$A*+m%eXfwO9pb@C8~Pk(FUq6^I)tp5F^}@l!Dm5I1!S zl&cvmK>M#7?>)W@x9z+ZDr{9^kl9TRIBHio4|5{BeS>Bb7JOy=9rIZ~6gH22$$1Ul z`Iont*o5A?z_sva_IS2N{(R9??5b?w&GGEnNDJh>m2os)#?1{|`(dfx_PeuksaQ#hoeZon`vUm#8m#MXi;`w1?HJkF`UaLQH3UD%9druXfIYj@aw1Ohqrh zs6*J?L>=6W!K=GeSYe-O`trfKG)hCtXJe@?n)ntV}Yb4%S?&RglI;79%nXq zEMLtZ7r~RNkg5G4Ye55@Sja1>jq}`mKu}?gvg=yF=y)TDiW5fn2Dr)t)eQP_T}+eG zqkFO*O;J6Iz+l3ue#{^%EAZ^|E{kfng~|uOflTf6Evi%DMzwzVrt|g~X#LM^-xyUTP9odxnIk*WTrL_^G`s zgDfwlSWQ(PU7B<$d$-i5uG&gXGphpx>UhZLj0@aNPFK&2^nIBB$D98Mbi#@Nti~(k zJGv~NR({-M^kz0{IriXO%SJt5a0~vR2DCG*LR8kqb}9AlH7W)?-zWt2$;3%VCCJ7L zgfzfO(+ebILQ8-P=(Ix^&P$IYMKdvjZ`PP~_;218Du8{jh+r9M7%OCLZ&7=at%Izz zOI22bPc)N}e73sG{6~>m^Q;M|et$dobVK7qPw^Rdz0YZZ4@z1nedYrlgHy&8zm}N# z7*>yx*5ue1TfJbir13BBX%XY<45OtV{D&F#WsLwF7m;GHV;!o*`#v7GFFzDk=)Hc| zZ#Fo7CYB%KD-KeDyx#pfM6)Ndp=1EQ#&v}lono>x6_zRV_@*d-ReRAmdvBbtBZ<%u zKL19BF!nV_7`YO)VF=~u;vz@qfmy{s!qaR}4^7kD9n4eWAjFBW- z9_^|P#M$TzNqb-5#QimI@|3Lb2ldRhyQZ*pS$n z_;o7-M&$j}v7=#|7sm6R#J=4>{l9j|hP(Y#>T>=xrU3%yvt+UD8-IKZ3`^;vbeylu zf$x)uHN;7UlR37}2Lg^{;?!^nA?!>Xrd%obgByT6HVh%@#ernjV?K?u!MoGBox!T7 zrHp!Qzt!GzHPa}N#rpQwEENpxa{WQv$rc((ze5FdsVH19u!;N?INe39X`5g(AE4_9 z1CK`MeNZVi!q7`AT}e1U&LWAsV7Pa?Oz!&oAx-gd$2xpr?(~{<$4*I4;TLU!b$#^Cqe}E-e0QX^hAk;=Z2vPY^OtcE-+lm!6mf^4 z)iMVR)L+8{>|Z}?%+ZemRo19l+w5UvNWF}oGFJty+$M7!3{qb6DzKYeQaIOP8`ecp zdZ17AtBTJ7O$Gd0(2l2XjrXM28HE4W7w22~yw?TsDoy-JWW_rIrhdx{BCT7R8@-I< z(-mc6!g!Sw+KC75LPfNlOg{tL+OC{p%AhcGeJvamy5=-ivlD5HzRW;YWav6u4U;) z&Qt)b%@j4(R(14WazJ04;J4PfD((SqQa}k16WH5ZqW{5T5@2c8Q~+oX^(!BvxKtmd zr&aA(hnU5S|6G0KI9@fCvht_SlEWkUHSL`N2$D9Kl3s{et0;5^$Sz$Y;AtRcmL$#K zZxV7W;(_7Ml8wFJh78dH2BLO+-hRbL7hu#nJhxnAvl8UX_9oFU5IFnLVU*IqKo2FZ zF3kqX%93C2D?^S}(^Nu1XHa!L@9^wyqm60<9hsJ39YtQ_cg86s+*Doo3Sp;P#Cx|j zLAoEInA@a>RKimB7-Fr%n&cpL%A{i*)})W4e@-uP)^f-L_6)UA;I4kpdmtFb)g}xJ z?KU3iG8pl#Z9;t#F#Eep&FdE67v;F`qNhIlaWSTi(B}jYso??FdOp=C#CR4N$yN(J zXe>LB*=qw@Xy|xOv>`WWZ%-M)!w>R@F$HGVLFT{z$hN8%fk#Cc%3f@Zlr44tig3=B zQ$Z~A>i7k5ylO6f)MKvdlv{>q;LPk)#|3obEGu(ouw(-_7Tc5z_Z94H5!krznHa(lDI{m9nmd>5)ugc?k zTk^d?SX>QiY#KIYX-f1K>%k1n}( zhw)nh@1A2?D#n-5x+`g~0inxf7r-;mX(W&ru=2)G957p3X=FM{y)M2oK^Ty6k2#S$ zP}7cFgoZ8e1$lo8Zcou`bmV6b2wvmxbWw43Y{Rc94Eo$3Xwm*moZ{y=-*Dwu30&NO_gUg zb^?Fhf?E1VN1E0g&d7x6tF|O+@aii&cl`oz*b^k+J4YCbn%J51Si( z4g$?+B6?>8!rv6;MH8NVuf0)s)C5QKlcvToWMrV<*Xe2@1{`Q#7}PfUviN+G>Tz^*b5DEo2F+^J_Qjh5X{XgmL@!V8Tk* z^yh)>giveo!+{Tmm;m*?5>b45-dMjs>~<I2ql*<1kuia`nIIwIM$c^??GJ#`@Soa@)46?X;J;q)=6 znfo_}_^4U^)-p`^W}+=c9UsI}qWiH$kGN9Tk@QSlqK`xK4n+3hx$a`MPtaR9uDR3D zzoXBO3vE4|8o~|8KqNJYweY2^z6x_&-9AFg!Ts^yq=h=qR_pP|6}^c9Vs$bqu*5f zjRNiP5$yit+UpC0QaQuC2iEfcMvf;fJsvxjYkK*8-umn#OR$*w0pz0;vuAE3QCU4) zROW0{lVK-EOSq|g%fSv5Xdzig?D;{}FghbqI|Ldl9W|Cx;n?@nJws;ptC?^FpMF^q z>PvK3_~DLgik-hHXAtTX?+$NR>g_j@c%U^*^-7VJkw+U3@~!3ypk>XC6&@}b>%CgC zY$bBudILimswk-4=`ZlE(>P7u;NQO)1$&a%vqyOm2P*ZQ8jl-?r<}|8;XivX+pG2= zU6|>rS28oImD1NP0%j~+n_U8{_gvP&PTDrNQgD!zZU<9Atzl*hYfU+LGE&rePH* zYf=sgePlLmS;M^d(c%Yp=zG+Jy0u87)np&v5pX4^pn;?=(?e7`EiO_O9!C(qbh!le z>O`(+pvHvYi9pN4eQVPvtF&ZV2n;3+g%>d4)e+AF4s))j_&BCR^peWWAG;Swd=KWs z@oLdTTbjH&^R46ih_#}h-EXJO`zWWz8*r+V&1bxKiu}+9)z}(QTWD}BefR5%t%&>w zq>j3CkySN}jLwSbaAg+xSZw5*y+~zi*#lZw_zNdbH-XTK!FUVd&Y@mNC&OsyL0t`3 zOQHqG6@^z1Xfb}>Fvpa)q?C(lGoZR2`O8Et6L4Yn)Qj-W@tFCJ0CfjU)ZpbFpz3w3 z&io0YWUM-@Y7;*QSQwnuCi;yLWCZx-Zl|EB0hZ-tEgNk1^#!9Ptrfhw2u*+ZeGLpC@TBF4sX}ocscZQo0(>E zc<7BXv}`;{wk9uy7`?dq*>xBH2f`yP8o7S*b>Y{7-SLyFFzyeLN0XZ_c>@(5pQo)tzk4BDo%K zG*dVo(;v38>Q8ar%nh{)JaKWIwt@je2#S`P*yHaC5`XgoQ)MhkUmvAWrTNE7ZfGpI z=Ka!yG?~SgZZ%_ldta19uy0y&mPwWVlx~NZDob` zeCSK9O0o`o_wZ;}y7{%x8BepbkP0c;LGMmEWxNfoxaf_t14t|Ji2o!bj=Q}MZc~Bm z-9sS0Qjz$%AtRTJCe7&AT7eJ{>N)l0XkO>`@4a!h^U|+n57dZm47xkvT$E~BGxtKX z^(!0RH1(AhE%=`Rw4rhotFdOQQUll&p_(LDCyY*KQW zo3t<$PJVeifpratU(w>PTsW)Px;4&sV+aN!9J4+QhPP|3Abu{r;+6_$ew@FpwpfM) zLOiMGN}IU(bE^|ktTbN9i7}RzH18e$_@*S>FflYxisFrH6j{b~zq}lvR_ESk7bv}( z;Wp2Hqp@e>9Zc?;X-#Q^-s*CEH2!CU2BX;OcKO;?#Lkw;AY?ir5Kt`S4nur%io*uHt^LLT+wk6E-CcI9beiP_*TC;0?wb!EV&5$>6 zzu8mACSjU8802FI>XS$71RP%Nd?oLDdO!WNeYf|Wuo2S8Xco18*m{I{C$;3wFQ#mb z=;7iWR|%%vN+~m@6b>~P)=K7dEhE4u7^kWnx9elimQNY4kPHBdIPnj?a>(FgteKr+ zrK8Z*JWwFJ4(iA5IxX{$X6fh}ZyX5iy4t_(suKI+gALOg_gG$UJ|S?;89g%!ndI5p z5n4ZFO9B`h&)V8k3;X95iUa<9Ve8G$scB;Zd2lX8 zUs>p{6?bNvX00o6?m#?If3-0y7q)S^#j6A9x5hdq(fMz=20H<1(R$T=tU72`3!~M- zl>C9DPQTX9X=*0>7`8kdRoD3{9gBJ)jxL|bAus!Mvv;A+hmL|BL5hxg?Yx!AY%@F7 zQc3yvIRwvNo!|}geH4SWG(8goGOo%wO&mM|^@BdZ%C{bC`0hT6cvTk_6o!d`N6fEV z$A>lR(_5(SDtB#xt?XFa4#(%qOSD~XCe*FLcXGcAs zVtH01hbfhM3QzS!PLm|{R1VK#&J&7k$Z-xk)Kf(cIaQLw$g{|d95#os)holCg|Q6_ zo8ufdHaj?c_WpkVgU99Z!{c$k-*30u^_IIksfKV6sJ86B-~Y0Xk?Uv(F7FAveR4_0haAY+}L$WNTJpqVU8B3!dgaG$TBmXncKY8YR z(U^yUAykTR3ZeM6nAY{ah_A(R0=IMgGq(GVnyLnBS2%di1uM5{8}}y!;x=vcG=YWS z=^Ig9fO^jkKGh`7SmgeX+WB)5PU={2B}9?q4CF&RTV=VD#bF&tWqR*{CY)Cc|M)lB zGl$L_!$pmeT;)1Yv+&16_;B;Zu}+X>gk#JpHQ93gyI6DtIPa2}eCNCYzDw~KSa0AK z=3*hu3F;W6y*^8`BQ2X7(#a#A@QH;sQ8cs>PH_8*zeS|9X+S;BZ5wCsPJR}CnBLeq zdGz_R)i;Fci;)X79rM`y)SX_1&a(;2ZH}wGHw5y!IomoGy+$a0o!dl%kSMC^m#y%K zq{%OlVh`5UhyHF&yTOcD)IsP{AnYC)OGf;;f>;>;f?*EL7op8Jm9pJ`qZ8eln2-}H zbC%l5OLmZ=zL`FsVfS&<3G-4oe3jeTSeH+pyxf)rFf0eQ891Ex`58H*#hj=yRIAIf z9Htjq4qGN~l+x~b?!J8QuS`df;BeO$4UZH zqF1ff#Tmx0qVy}^M#t?DMs^dUv|lL@@kq|y{j*NIN0bka52HKJ-qi#fA4?RKSokux z?C2$7-X2Hi4=1lRU=R^>xvhvNi-lyrKVI3c!x(BFpbfl0$tnQfj+{KN=?m#y)aISh zJ~yoS2#wDu_M&f&Z|2pA<{R|6Ik>iGngqq*PaLXFqJRd`t$NyLaSO|4sH zp&LlXU$mMLUX9~g43q04M~o)g1>zgMyE0MYgN&GupbtFH@|92f`@FxZ*MNA+x1i+C zUp`0#)nH0jeVX}@_pQlFS=G+(w6-e&k@+Sm^@{->c1T{QO8J?_?%66UhUm{eWl|iW zt>1^|Du0QioJ~c6j2!@2z~!uPBX1wn$TyEq^ePE<+1P!YLs@JODd~fAN+K%E7Kvn z#j$j4-A|;Rp%u;{`YXVe?9^$m(-fQ-6QXZ~X@%|6ASH^YoAxsh`YyWST%relw9eTQ zPd!`On-Le2Y94p~;dQ`|M8DtI%(-&=G{q(uPT|klT);hUrYtV(BSY-QB^N~YF;Qbv zXNy(xxYa;V+pDe%KuQ~m&-lNYp+r<74(Y{a#ha#1s!whsn#Q3(HJ1p@z`(EU&Eb)?1@-Iw@o4ut{m4G<$smf3YYnrk6JRc}{>K2%7RI%@0e#iCao>`> zx{M|X`H>Ou0fDzx_pTh& z1I5kdU5;gym?ib%SJ>v{W_SU(@LM0Q?`Pjs@chN-Pv%x)eqN$?L=-V_VGb)&dTk#) za;}5c_5Qofgpp(+isX6}CrW6z2oR^bcuNY-$Te-ye~k`Y-u?yVk~-aOtoet2q?+14 zYH(Zj&fV3?xXyu6$nA-b+fWVU&g2zJ@#*&7|~#fA=cz%;6s%&mdn{?bw&ZdlWRAFPG+wU?j# zApE4fTtJ$`ZDxV&Ott9-z%kTU;w8vOiVQ=-Xno4{EQqS!>9SsLcplK;y{+R7b+W1~ zqItE5WVl{;G-lyDBld?lCH+er@&&hQm12j&Y$48s>F<>|?o7`2?FRa8&!fu-tZ%b; z(0ap`N2Fw=CK4N2x~>D`N-Z8r(_J5Cwc?4}CTaotfN0myo~xulS7zSQtCfk*n{Q^* zdgH*Wg%d;t4WsD}Q|6o{XymrK463-5Rjn5j&;r8i0@y=|8+*z5n}mRT779wdcYAQL z1jt_*m<+^<*)fQa(cjB)^b*Y2P1k7( z_te@kbR+1SFKK^ZoI$CjjZ)aZfuOwL#%BB3u!22gW7S6E=>{2Zq>Jgb6eVQ@tEko) z#GHTSck3VpAfUT?3i0K0|DA|sFOz2%QyYvHwkO}en<38C_8TDtY1xky z?k`W{U$u+vs4vse>(rA&w!%Z2K>rk#OW{^I(Kv8w}Ss$iWUlBj~{ zxjH{v$qF&2&`?>uO)=Km`$A*ndqpauhNyk?)D^;tgOBEwsfaGD%Cyi_Hs3yGsoyH7E;TKy z1#5?|SfSMO4~d#VGY@htn7_F2e_3>IU3D3#0k@|$5 zvSPl7Sg^a|;z}Rho_wbQ$JiN}(L+#*+0&YC;57;6qK#g$LD{$+^6!pu z`bAqIm2lLif)`!q?<%48KZ!vd_c{9S6U&h6E&+j`WB)bdUPjl{ruNhP=SFvrn(2UY zJinlkQGLrzIXw)Y_`N%fC$Q>QrV-~03n8q`mYVnGqh^Wba|H=~&4>rArejT>6IRZf zCWT8wrZ1c4%x36OD<8wWx?LrVLu1wF#J54a!OzVwV*5`B{_|#=;Dswo$iAc1gmp~_ z^6i?_j>s?2zaK+GL>wX$;NF}0#Q!0aHWFBd7!43b%VBB$GJJTVLO6|8W(2z&o|?Vd zU^xXE@Bc=GZ-EVFv#T9&=zh_JJexp}@$OAQb!D8KqPPfp$b@yPP1744@r2w)TJOhd zR?A7PO99qaKxThZxN)(_m28YM8dWJB?*gzQr?;!%2mH&6M*Jho0e(}C`kQ$~!_wF< zh6mTF@8ku&HF`8u=c$<0P~l}#tHZf3EFWtL&M4RskCveaZ#Bf9NdzNJ91UaNwv`YT zrw<1y(7@6^6A;llJ0MtjUp-(&#S70I!MRzbE2_QrPz@^&_l8_l+m%v+HlR z5wnS*Vr?__{C{P*o$||9eb}7J2f0W$GV?~el6#ai`3@gy-sVZySW1O1WqbVzbTtOK z?{K<`!tYr~Xx8?Q-kV~-qgH#H7xHz$upp@#I^M4W_|#Y_M3^Nm;+zW31z5 zf$Xrv(22FQVqX)7dOtxT{3APe>J1VcvgYI+)2T~vLQuZlk}f)RtMrY%as2l;P0Qdf zW?-4wOTIA%E}JVJ)kF-$Zch9&wsTtAYeEQ9&cLqn5Oe^glQf zIl}5f+pRYEVbT}#R;y862V2UvvdLy(;Vbau zcoFeS4AK5=?#0%dC|TU0b0r8TWk~Jk>Mt{z(ng6y!loJ_A!DI1d3Eyg5!E9$F(WE( zlH8i*>n9YP`AYe;e?yNs62&tmWq8=u4S6&C)^kxYCgh%iQ(Tt<8?}@b(j2@{R6$t5 zuV5!tl}s&~*8CkjLo<7)i9bCpu2yY7WodqywVxP;7mgVy6O8-(-XvW~Pc`|VrdRD% zFJM}6@bwY7qm5f_eGaINneI9g0mRy%E@~T>#0TnvRKKRamye|!$2(@mc7Ac`O?c(Z zGsfKRk2cIrB(=Z`hrPG~^KN0r@MXG^x#<%1;6Rfx7RqC*Jg{LlM%ztOUo^p{I!ZgL zNNy5~XSMe+gYx387l^ixm^&6RoK!P8Bzg)iUzpcP{W#%z3Fqki zOCrkDisGv25&Z{?jm3jBJ)s7}qc;{x*u3m+*P8#W?#%6OVbI&G+VjIGx^|FtO!6t@ zGr$t}GkRaH?=6r(oCdxIySHDDm2&QtalwC15t_f`7bo3*6$|V7{%~FHB=CRRxsB-E zP4sRlh1|sWPvhTofmo01XR}a3I$;e{TeY=*h{RtB_MLH;SBWEEs{M=wN8e~Sey8rN z=CGo%HKM#h-%}HIM}U0LQ@n_M--a8Wq)mv1g$5DPURqG5U$m<0^jNPu6;Z zV8tVzQUnbk5Z}4ct;wVyKN}sF18)9uFs28(t}Pe72NPv77fT(sTX0Qk*9Ei>PQL_u zP4&q|_~m2}-pSBej8pi#vc{`XFX1}YhyJfnnVod8mG9HWntKcCT4~SRk@RGU>I1qT zNYl0B82h}1BoVhmW4TwD6gz(cthO~BruWT@$KAQ$u%Y24-a2hGLsU5&SdUB_Wh7%o z^M4uZ*aa4BNox|r`~9^%H6yN#40*lg`py09`#z#a^G&|U)OS|+1RV&Gfcd_Io+PeLbxVvWhqsU;of+)TyFf%@w4on zQZNxlc(!J2+@G_`**-i{>4l$XY^MM(k^f%NjX@caejn!NBiAAVoaQ0} z^ogAP0oE7$e1)AqngY=T{-C!q=V;e+?-1TB`JL0&;#lEI=sYBPF%p7#G={w~?KDIi zoC~$$&Xdn5sqBr%9Vd^pUa<}xvF~pG2aZQ!o@dp#bzx9hZ&x&1gT6Ulcf7a|rY|BIv{)sp z$Shw3Gq$dphi`{RZo;aQXqhg&?!RLa>OYKnqYb>jALOEIqXeFbw9lqLwLL&|ex^;rFXZ^pkZ!Wq@SB$Lgcp2(xU{Z0Ys>R! zEk&c|BL%WIGE4pIc<<17-`pzWS7?|xs#fiN|3S+bL4tn8g%hRhefhi;G;&I%4iy(v zN?F8(-YkoT74#4mPS-|xbhqQqy8jne6}`zF)8*B9B8Xx2%Mbp0Rdi=~v!GAuKLVAG zMiw#ppNptp6g)Hh#&%wz4_cLCSm|{HNm2&4NhScPqZK(ZpHI@{2x+5smr79aet+l(jTeYG zZ*C{tSqhB+3sB{xR-4aZtG@>Hf>&o{hT>!J*Q>1w@N}n0;fwxc;gf!k03~YIxPPe%kyS5L4BdW1#Rx>Cq^K>hR+?%HVlsio&_+37TbWtL_hEjIEpfcw;tj8NX^ z6H`y|DonAq`VH}^qewJAxKNi7C^x0bggU85rCNE;9w8ABW>TTm3*PoE{Aymgu@*c= zblM)61;wQ#8XQTA9hg<5ocrXxDPprzEFABL)Tur&`HQrCSA9>l+jp4|eQ4n6VD4?j zOy#0~4?J>K|K&JT!&;HxotMojzGhJiQ#lX$Euhj3Zy!rl0p~Z!sZ8Z;mXsPyZGjtQ z#lVu-gihOt4jG&v5;mJKm!;6FQqd2p_ykp{`KUbI;4HOye+TB@@Upm9J~kb1Ty&@7 z6)H&YiGd&_1W$1Sc>;?2HT|TFB)`FjW$)R#`3ywIs4F}-BUaS=2}B&ZAL((191(k{ zo<3a~zm`sbco&a1D2o4`K45XF*BaE&OAbegueYBk22>TcbC_Q7!6&C?_Rxd*%5x0a z0!X`4NxRKmsy=y|2iu&bb!<{XU!NYv)~mRJbB3b`p2|7$z14SZY4tB^vIqgh>& zLCV@kb8BK3Dm6??rq3ij(eyE+Jn48FX_(Jg%nH+^bAz-am$B`G8acNJfs-FsFK$@> zhu-r|?6&hYu=zZ!g+m~nmeH+E6uG5q=Tx%iA`LctYR8RcotAzS>ADguwfpLKQb|5f zhHofRiVar#3Pp!jP7na*vt;$EP{DP-Dx86df%S?uJPZDO<*ZmXy7fe4<*VbuAU{pz z+26yU%G4T=TEL3rD%8ocTL%>$pJa_2T#>o2Ts)6ucbm8yK8;=kS6&*11D;qp_A)~!J;eYuK^=_En5NV+WN!#<{pj~V>Gk&VUgaA>Xek6u$ z>->emyy;y9XYQzhQvBx@t6_vX^134kys1D9s!pHCF;}rVb5xddI2e)cX%#!Pd&m)0 zr$Js1{QNHaCBSbHwtwy}@b4^Q+4{+51EP6mWY?JZL5mFhfYJl@^?<_GN{?$J10lTO zn1{hx7E4L_@?x1i?3;~~-jBgB2M7KygcQ#^8`LS8J!Y=Y12Te5aD(LUv?qi0ldH_X zSJZVg4MnAAC2)mCH2d>3sawC5YrTsb77im3^o4n4PN(zn-AiR zzo`w+c+`UQHXSC*5Snm>lLIQ*lPaA*?Pwp|*n{z33^MqHzKI6LR=zg5MirW?RalIH zg$T~3(r9?kG^)*|cE9z$A)ooW$}1zbIH!c;d00(uW1{fS#!{bKsl%_V2sSlZTX^CO?Hrxv;0eT3o=Bw^ zExK1Kk3=o2b{oa@hphH4RO1$%Ce{46{QwjVqa=*Re#%=M?Ta!CQF{s#OSuM`m>p8+ z2HPjtkgrr(WF|$88HDW^S8=cM$^cM%s|oIb=8=V4kOXP6h4)P>&ymljNQ-qM#EDSx zGWw$H48LttedD$uEuP?1dx%{3e0+%hf)7F17x%9CaY%oM#lE)>M2;$l#r^>3$~g*s zLq;3UWs>c|yCJAit9%KT+)1;$316;Uo$u{9+WDRF3_8=d>xu}_g@j$oWi@*Jyt5g| z3rK*ru6OSq7p3T3%2lS6;emyAMX8onKL+)8r(eoZSz=u8QIa;f|I%x~qE}9S!iY3n zwi8Ts77#~UCnqMQF~$YCeSIMGM&3SF9M?SP+qL9QAWQlW?hSvFBx(*ck=yP~w8&08fh~N8;lmUN?ccm^%B{i4 zohFbhF)qEPg-xHN*wBM+qn*_$dAl$+AWs+VJNj;=oz+5!_F_@rGx4W#4^JQxB^7t0 zX|*=`-ohiT_@gnJ6$z%lh$Wo&K5;*J8LlROB{@1GJp2$ zTrAzy3JqT~e@@=w7+84(e(KltGp=T>|8w!s8ntdpOb`52uzn{gOsuLc)Jnkjc3X$a zDl!0934+cTQ%L2uWZ;SqYEQM`(C%o4dFBTft#3y{pPK!$pAz(qMz~_y_!LIGsaWIe zoGTjU1E*ZHA{S1}KQOH4W*;T*>pd`Ur!oKkCw1k@^=%{YoC31icZrchF2*?eSq9@5 z2L3zAjRL#uDF>bICL7l%Tre=Q!|nUsW=1o4;-{J}WGfUg{SCl*dQC|0Gw{fKRM?%m z40BOg=9|0{wNnbc{r8JMAGeQCgR}^35#`1d#`}7GykGJ68%fsDzBx!jttubLFT?d4 zNKFnxomg9bg7rJ+G$({#%qny=r2%^*J=9uvJ^s^_hE|ruRz!(Jrkb3#A*dHK zM%p22f>ih@JTkRX4YeN+RWSxd;;D~@o-gOio-JK2WTG-d*?_(8#{t}WQ>)x`#mBPV z(Y=leTvoa*@MFHl7yWjeQHA5fUl((%mmy+0fOLLE-aoJ!bZL`qVnrFdjF{<#NKUC1 zuOAO<3PlFgrR@Zc*fMua81-o9wD5rE>F*LZrXG zfi%rawPaVGOwc0bCTUv6;H9dJcLFTB2FKHxjc#2>9b4?3x<`+$Q5bSFGAKb##ze=G z;||g1YDa;f#$m#lUsD8wadUsZ1RCusxvngFO)PG_i16;JQs29CI&c28`Im?WeX$qU zLgM0P1(oWej90iYE>xRdCc%vdj>UeLw73CNN8Iog2HGAqXK;k zS;{V2Yfr+<6gRWWR^M|9V?9+GO@BgpwNtkj3jPr z)Uy)5VnL|T{T-bki=F0zO+&Zqdpo)TnY|ezZU0CQX%M+Sv?@;guZ75$jKI@A5^0j4 z)B_vzBg7c#Z0)c7*blS(LWBe=|IuHeEe{a^OQuVtq2G#*n1j5btaz-ouMSf}Yk-&W z153Aml~5GBGsgDR{Cj0tNpGSz2^gNxUz3zYI?;)@^RSzV!H78{CYq<*khV1%n zKK0l@rW=C(n8QubuJ25j8K{J;KDM;kVq*MQB8o1kylBZ0(K@t=%$|d!iKcIpVx40? zJOO5NYzk&w8w5`NHJhbSq=f+Hn2jSv7_sUW3P}bIybXM^-jZEW^~7cFOWWPOKs@SZ zPwW@tdd|oGq!Ti5nsfRO0R3g>>6+m0IhsG$aU{QVK!bsPc&1JQw8RK#l%ys0yRG9D zS6=;*EMUfDg$`Z7iJZu(R|p9Fe9yrFm`o_n)E{z40UN zFtw?bT)UZ%lvkL=6IJQuZrM*46?l_hK-Ik;ZD*p^lNgS@-V;yA5nr}-$f<9T*P0n{JOECN41*Hyd*+u!+V-kcs>NBD& z^_IN*Utj^I{}2c})n(dIFAFV=hlBPtCQMK!$WqPe9os&3-vhBZxG=Bp2Wq?|V-zXt zYSrHK+l&jp0(OpwWoH^<(v@~S42%7`G&Q~^;-v@Im5yz;lh(gn3X_(gF16aJ!gUtv zQdyQSva8>EY`{aD&+c+HZ$IgH& zoM-2EG;&if*lUZLf-}=-g@|6G^ZFHfZoik!L^6PRz%@*7KlWCi#YRHZ_ zHKp`KtzD7c>$I(_kRmOVQRNNZC>q3+LnNF0f!Rm}%Wt{rghWtoy8_#O6O;E-Sn(gR z2JND&b_n4;{E>aC0R{cA_hn!O&Y;)2Ffa1++<~n7sR&fco7Sx-;nEgzQYol(OnwVW zP5%B)p&7>4HtBclx9685uWHU~8NN}uq~G_(dNQtb5<2qpT9s0(E#U)&(_O93OR<&T zor0{0)@82MQeWfKp!@k>zZ<+ecKMH~->wl39JmyFeqIL{qxr*{PK=UQTU1fY4D2{} zHws9SR;NghOx`cF64&BUTAHTOhOg|ZJ!flrWpedfGz*hF|P! z=B|H)?9jfxt5#h1%dS(|6B1t@jeRJQemPdUQ+2k95mBKjCf&OTzYX$^8Jn@UO18Tw zlJK-p(LYj}_7T+UqxgIHH=YD)ek9`^t;pQ#bf)MRR(w!5xC%kgNyA!4epTFs{V*W; z-Znn9>EP%z-~lh zJMO|4yXvviH*>kO!N9K3rXiqpT7u$_8O-GDcSl2&)pkPjmu9QPi2F7eNZ?fiwX8_h zetNe0JQx`MhFH+L)|fGDeTVa#$)sO7^7~@QBp5(G`Em&KdqYe7f?>NIpa1QH`7LNc z!T8ueXtCSfP2KELgr{09BIVcP9lxWX(%0+!&V6yxYqx1OY2^aLq+0L83u^hfVbboR ze_@`$rP0*<7PGs(RE~o9)+eu-QPO>mtMD_(Dv^sio7A6)V^ZG;@+TnEZ%=phSX`toRqCOeCR0;yY9{F{3YQ~r8$Q4w~o8sCA%Vs zA%3*;Oott*KB^+mEk(x%q@>361ddrirCx)Qfw?k9u@Lb4T~Jqkok^7QDeR)(-{_?vveCi9uRL8P~DiC)9-PwigNt8!D|33 zs@OE#Evejq;}IF(Npi0x^`-T_nrwYrT@CVMCpqraB?0)?NB)Bcu<3jt=jZ1#aWbOb zc-UquYWOH#IpC`L;-F7RVF?3g(3#s<8Md1M;R!+^6Rwkuv32R$O4Z@~0E+uz;$(0c zp-*XbcKgb{YO^6dMSny*AJ!@fms4xsv?RB_XH6?~8|?I+3QiYLUFHJ5HCi&4q!$5~i5r>QK~;16mbYfdcAof6hD#oV+ zqfqjsrHrk`a`)(=_?<#)>RD{-oVCnjVQ&uSy|GjVAfG&t=uHZxA*1R9FQsx)vVLJyDUqLhp854aT#_3~4&DGjgm_KD_Xn;q#5rmA;$| z{Z2ie%1Lkrj@nMBSt&eQBs(lMv}`tYR6aHDRnG)NjPae)kmzxX%CJ>mT0sG7HA;9L zEggy{Lopi;pM>;LyRBytzw0de=#z!N{lSVjayJH><%OT_xLgJa&DS>11b)>G4Y;lR zL*{tVa9v`g0o=Fh}qJy&L78fjM2r>=fs0V!m3e)>KD6L$a<}g zs%^jigmV(5g24UsQZ?d<24%|Vx=TSjXr{hn=z?NETK^}v;Szjmo4$@%;Q25Aua0)S zT8PHiE0avGE$%}pZ4HhV$$+Z1|5H3{#TChlIYsERw;u!aolg9k``2Tq4<^4LL(UhQ z`~~D?VPJume-nVqo^b|~5+E(^hj5gjl3H&~dN&|n#5KYIzm^f7KWso<`eIyaTzd!V z&1fl4dZnl)Ht>mybCc=7J^9~rp$2=)fsOMs@LO+KRpw+r{~^idpPA2P72Vexxw(lG=3fGFpwJnU@6-&)Tg@?Z^v-C`ZlHXhLPLiDmAcZ)JT_Yi;rA?^T1G#5k zAEQjyqp?+}7prc^)}rGaZ_Zv8mx;^9z*Rdx7GYA=AJw}r@NiC#(QbhMG9(4~7T`GZ z1!Y1Ko!|aAF;vndIkm$lC05UeaWVHpTIns9f}jzr{h8d61w_g?&Ur5DeQ^3yO{>=L zF|IK_X42eFAtLPXKwL0s6Ss2Yy6j-kRwIe(O--zf;aG1C{@c@a90)9&;;i^Adhh#u zK*r*H9^kyw`Nlu`Pq5}f<334ZRl>K{(Fv!?D5Y`@)`|<{pA9<~3sfysPyBu8Mkek_ zh8=C&n6v} z<5=bTjV=QuZ=hPAbHLLIDWQZ~%>kp0%hL>(zC;ZYG#b&ffAlED6S+A^C+(;QiM6 zIAZ>cBFnw}LQ}xNN=7?>2GEHY_!5n!YaKevS+ToUX<{M5~s+IVKExl ztJLx3W&xMcT7-bwCjb5P7cg8eyLK}``&jk+?0uIc+`Np?mf5;8Z?wb{TI=hD_H2t; z@3xW5I)R*or;vY+MlR$H$i=Wz;wSkBHu#UK=4vk+6b3)kj8jg}*L^#EFV)FMpkj_% zl9jNr_Nd*wO~>M9r?k;vI1}4I(gHF+ZCB$WEAmwT`;|KB@i<8VQ*YcimZ>Vf} zrR=I!^&J&?sfNsXvRee3Ch*7N={F{-kHZ47TZJ`~M)6iZ%shKbdh->%V+xm*q$7Vx zx5Cm)s?q@`heEvT3s)&w$m9-?W+BJ!ezb}szu^Iq)L841Uf=2ce1k}yj|pq4ldSYx zFr@M>1_Ko}c$pbemeP5aVdo%2k1vzTvOOzyh^{w75qQPT^=HaiOp%xkc$u!J6$t8b zM8-=}Ve9+A?do~#Yi84LZH&%?`PP`*F@jTSP_i2~gg0bO*+&h|DH-zG&*sask5~na z)i)sYgEV@cHbwN3-&!`qs&VbJ>-nK#;iQYcJZagxh6@_4{Rn`~uSP1J)h-HtNdxYJ z0OBd>ieS4xUnu>aSuL@tUJvpow2?eyvKT2s}n zo9PXMl}YK$7sHH9w#QXr%AlKrac&FaO4QQ=i{6AiV^$aA*DAh+HVO^|>%Q{)15!)5 zMz(yi*g(aildg9Hxi%gvoSSx5sv-LWoSH@WpryQw^F&IvzPsGjr9rd*a**3j6ZKaK zV--1G6?gC~(~#({SH|Qops%se$x}xkWE`gV-u3i3H1mBv-s6yj%Plf_41 zb>mEq5}3dkon3bUzO?hAb(rDXQ`@7(mKMfWI&aBTYoc(-xQ;@ z(}$G9lEugT<2L?x_f`9(oP;mynJ|b6P#{8@{n?96GU|l!i$lSf$8!~OZejjBESi@x zl5qHvvB4;8q#-a9WUiE~n%3)S)zsNdT9zp=%S3Kcdv9wxd2cNopt3a0=y9xX;p(B8 zk2~&f2hQEetf>^LYwXMjTLaMA$NFi*C(vIf~z`LbxlaE96X_I~4rj6mW8^HT> zV3Ppp^+g%x-Y=XqM-BYg7_s8Y7U^WZ1!SHwN{ zPxPfxPSIn{AMe6qxv4tj)&!X{F=)H+-iAI3#=z>8XDJD+IL>`Q?%mZC20PX0(&QD< z5va7jQEiiSeCp+AM!oXLFGd{%i(y;LVXjBitV;*`h&df6^T5SeZlWIlAn#wIH_S#9 zds;Zh)KTXCS^5Cnpv;;6j@^80v|>5h$mm{@_}{Hs=r(Po$v@EfU+g-)(6ra9t%zXP|T88IvehVaELM43Q=9&Y3v_+gg>al_B4pbboy}+(AA` z(OyA}gceS<^Z$BvGD#wCdW~V|7F4sd3zP6Zqy21^mCtaGtnsxF$-bOm;7al z@my$4t!#DBT0h>DxfN*UcnRVSaIg^;io7Y#`-inq% zO_ik6^{y1GLo1}>Zq55Jg|+k&j~laDaO3MqJwLp$_`6#~69#y&9YEnu{E43Keuz5R zG4xh0fJkZziW5WJ?;+{RNzGkvFafn-bs4wgbg7=}>sCLL>S{{akosRf=xOb0N|GR} z5b1*q{c@0YxsY#1@9h@^A_Vc1jDC-n2oJH4Ka{65Sc{vAeq3G)!w- z#T=8Sty~@V<=Go=LrmA)Wt~n%>Ua^g%!YLGNzM0KWJ(x_NLRLpzG!RYy-6ZmsdtVX zv?bIl)$3>aEK8_WW1PX}WMK7HdNr!%5obibFrWnQ9$c8ME1W(zG$vWJ3BSIm=W}K< zN|@(1aH>PmyGai}+jnXS3(=boO?v`B*!B+j=U~#~ekGutC&eSO9EG>n?7#}%66jP6 zL2h)9ikZ9lOx4Oyesf7)u_^F4LGGq%l|xfXO|E8O5u&TN``D$V`GMmN1s3`Ihz3yv z5g5DCLm)VzHkhoi^X&mYCQiCs<|$)Dl%>K?z>0HF4g5`5YcZZh&juzqA+?ZkaJ29& zN<#UYz>|3GfX@%h`io*}j3?)RohIHihNO!jKgkQF8>0?{Csj?ln=hikI`wwB*S5Qv zJi9TG>nbBQW%p%6XFDVAe|=U|ekAg2!&WRKsG|YUfT^Cy;OSTOmd{O}p6vU0bo&o4 zAd8Y7h{=#vl13I@*;oh*jXIkaC$CC^$1H70ZlV>7RnWEAzD<$jCd-RgN0A{oKG?hf zEc5G=L8pgQPh@-U#y;-vmf<->RMP~yK_DVz(*anoWIij7bYvfOv@GQGZ3H*@US1n9 zSCFo>{C`QvmHlu{^9gyazGMwa#05p8^YBPtFC11|Rw&V5G`3HbADgTfm+VsD_lII_ zKyyE@4g1li!L9a9D|hvzTIy%hXAoq`yHka|NoZpMPL3`#^Vz|-`{FvMYTOH)tkj~Y zd@KexT^@s#r~c487h+K}(5(nkt)atP{hyrR+^lMK%%~Pv7oniPch-IjyjQs~1Z`z@ z&w}R`KhWgS{>2%Aq;>0Y=T-0C1!>6>L(5LPuXFMlz?yhe3cbjMSX5eQH{0ODY5dBH z_Dwp>8mSRcvMt>E!;QyYO-IjWFLm@tw;E;xl*o9Bdk?W_nt_6TaPc$}pqRvvRgQ?w zuor(!YFN4s6!qBc?K|TE5II5qdo-G zzRZQ)417s?_ZA+#WCA9dmIOeTa-K%nToRSzU$V?Pm|IH6>ANr34Xwu0 zr|?*m$Jkg^sGFK@ooNVgj-rbJK{Q*r+xzi(%H8ZUi zUVb6)B<`eXHzLib59ME;B}*0-!dg>qG0nB}WLTH`R?{7IAaS5SBk#Y8X^>b5H&QtFA zJ11249pd$vkOdXBfd_V$o2ptl%No!j6Q6qYuuH+0m>*{Y9kc3^=D*BMFk4QfLn-^k zZFaEw7s-+2;+&9>c(LJ1WV+bzn_W8srZ?29qB-#0q|eT{ zHrG+B;}iZG^2H;At2OMSQyiPr`Jv?`jo7GoV~ZI}7Lr`OysFyH8Hy`j-4g6mjtCx} zBja>ldmd5yBj(u2vO2xOFA>nWj@`GEb1WI5c_6v$@iVyL`KSLoxldE|<@wBjh3DB9 zo)p+nc`ndBW}S;r@#V06_?Jge&2(dZQpEZ8Lst3pVq&UNEs?PBIdQD5lmaC^FTN{V z#b<3Kyq+8bl)s+zP$%PNhy`E#=PQ^6+Gzul&U_tmI}-NV2DsxnBWm~4z400o+~r#H z-d|?IQ}M0q{w^W33wYQNQgL%wVJgk|~6 zqkoK^On8wUXs>FnBj1JFH1+Gm5Zwa)9sdI!$~%0ICvjKr;%MhSF%gEN7z(?}Ma!<!dYkEo=M~7q>sE+Eme(3IHMb=W%6u>;|FTJkIo)Tl z(^uyLYgY=&VTJFvfghOarvOq~5mQ)Wq)<%{t)u|h2kA)bv_f&pcSd`GkUOKUIKn5_WmkHDL= z67&#xtD%vpJyo|=gm_My(ko)TiOWXrWm0I7aUtIVdFU5v{R~!HLCTjWU+Ws>phhEJT9I)MOYXiWX}wjdWgtNN`iMDjMnYizgZL1fWyG zOAWnbV#@~o8ZHs!E$C9rKcCPkIlZ;GSNw6cwW^7oAs2^u4@F-r-=n3xoy6z)-30( z=HCZdJ6Y9@Yd@?hxm&b9+-Ekx%C#llzvYr8>3B}_&&!!u96+s_AW&dJ=uYZR6Pd9L zDDJ>tm{+J6>R&SB3q9ECRP*RVn~PI2_ew#b$$bccr0vbzj?#W)ey}!8cldVnzd1#{)DCZGA0A5vaxUbY-a~J zll#vYim;h?aO;gcPblteuWrxTt$yOuEW3)`9hddQ%F>Q=?u&?D;tOpH??bG2^j9Q^ zXS8!3`T3)TN2Nn<`MWER;gt#agtvMT)KFc`h*pz@Rm&$LDjd{mzhS9*DQ5Kr;v8gK zX}Agyg2GSAdjMPfs*KCUv6=md0h`U+tvAvBy)R;xQ_32LD;rBBl-wjZ5ISX94sW5A ztJ8K?z{p`D0VUp8fhlb8Dig(%rOp@^o<|wqn_YLM%|&rq;KT6wmIGb7r@7I_h<}vs zYR+8$;eL#W6+d4DVa0?9Ww);5-q90*<9#p}e~d^-&l*)eS}w z&LKgM&_Bz*3u!JGM@hg2yi)IBQ2N-)suF0IEkE{OhePv%YIi9T3$YwhD%(Q7TC!@k zEkbUgEJj(Tl^=nTnYOW=79U2%PN4EFr)0TqM@4*}-&r8loF07Q|4^yVdEZu-AuFAa zUtAs3Dh*&<%>JMfaq{o_19I!_$q>U+;ZcpeN8xK!t(J6o(L)2~@zXnfL&#dC6g(<| zazQ_-?oJZp@odh=vV&i%J&tEI2V2_{PUM<+`x_<_82DGXCD4=dlY7;8^dsQc=|NC*4KKOI zY(Oco(FqyB##%yV`B0G6?7sY7qw0xfuFpXA3%^rXTY9guIM(9~$>i^I`TWJyBF{RQ z3fM4H@9nf63b*~q05v?-PBv!p80HdT21y+82+&aGB+j`-LYCqKaq`E?2!;dXWd_8{ z-D%&9uDs*UlS;$WGBe0u`Yc=MKTw6ep3A#_RCHTtGMEd~Kd!BY1DoLjRSx^Cw|9D7 zN5Aals@2WiUi=;Q|2R7HzogT)4Yxaur8SjSE>u?9nDUsT=7yP>HI`@_?vz?K;*u*O z0+mx*k8W_na zQENR*i0G#SH|Zl|FUXqNZF064#0uNz!29U)hu${-W1DZXM~6HWsI4ihY)3nQ-yei( z1LpFz$aI^f-j4V%Jsoj5M)N1TaWvODUt7-r|Ko_y#;kDIcGzcVv`OBBnZ=RUO9`}ue1#&=}@anA3R#mrvtcH!@~R3HG%PYFE-X$o9pe8zt-nH z*IVDwxZiy_?`t-#4lBt`Nd-2=;qtmMUTsQY^`)rp^i5eermMcjdpsckLUOPDvf81q zS#-Q!p`UM@+*{u6()3VbFS;ZJtG(2FPr6>i`Ta?FeGn0=aXZlfntuLnyAtc)t-ooY zTXway9_tqzy8bx>UELW|fn9u9xmA&LA9gc`;f?fC?YPr~YmA-Q)M%0(cXydJOi@p7vVDPcR3a`J@-fPY}Bkk51~$`HB9VCwpf5=Ghw$+0Z_--yT6TRVxq zHW7Y5y}YHKpET#&itj|N=4mrLk-Y_4&}^fcVet59PTX_?c@S9%*tWX;5$vAY>>Ioi zeZ`s1sBGY67u-C{tCWNr=_2l?#+QHKDA$Sp;T6|uo-Ar$ZQwvbyYUGJ_{^n%-rB^A zH7!@42Zz@@Ba3+&a0geXhvS9GHfM-dG4y-7|Vo%BbOhR z95UsWE!P)?CeemftXj*$lg8sRoZ6PQ5ACGajh(_4Eu14ciC~o|KW?PiH zZoZK0i0rQhU`7!4fv7_;mHE)kPCDDJ^FmB%D!v}Z(X;6sp&6HuK8y8Am>HAGJYWR% zkJcl2#m|r>^?YK|(eTSF z!5v8>(|^{Y7haOG73ad{_Z zbjj%hWnV53FTBLw%60{zVxpYBLeDLn^tvvp?VHOp`GhUHDajh`V5k(1RlXSYB3vOD z89kl7qq~r?SL$@!%Q|ye*!dM2t?WAXTKHPVqhJro>1Ot_fVDHqfn*wS@jbTdYIdsM zl`rK-C6v2-hL)%DJ_zc)Bc4CI6jy$v)xqz74+g#E1M(yg=tOs7JRDbjSFL5>gM%0u zDum&c#RmK)eyYP}d>8|B#jW-t-o;DLZ2U%5*6=iBSWG5iKK!p!HL7Heyy-}S(x zqs8@RhJ?i+K@X?EvzcCO5=2qn2^o!;ZMHRx!5Yv7<8cNnoaf|ZHzvg?qZPYP={;Y{ z$g30tr!WfD@G9}Qpv={hbcG;0!87J1NrMXk%p@(R?9Wn!rNChK^A2wVVLE(W51_1q z?`U?o?C^|_sU%)MtrHS+jIpMLu^EcJuhl%ZTR=%rYI6RY)1dGILrAGSKFG9Kb1lXA zP9RTZ77kJphGH`6h25Aza>wP>)0{)2Mz$09uvm- z@xDPagsn2$VE9;RDfx8+4(FWHvH+ROQuc_B{A5~Bc6Vlj)u5^tbVZ(HdB(H1UW_)s zQ(CPKt-BZRfZu@rxEY=FF7sN<${GCt7o*~0y6n^Tcnt@$V#;t&9lU<-Xhy#VGCaWg z1jN_xc)ogZ?Z40-xkn2!2oaE>j<}>aRIA<9eg4SkVFA~n#?8H6wJ88gjsB?jJm?Fx z4t+7c<@7CpdF5xbHqJ_$Uyg505sQ7?yr_{Dpll~&u9ck*7`^3HpR;fs!K(kRdD zX#p;oe@#(5G5wz@P1()8UHKcyY~*SDTCFj?Q({RkqJ|_L5M}vde_6qaD{}+VVm0H!}MyhHWznUI>&3<$w+#o=f6*Vybx_^rao&OIbVY zBlx$~&n<5aBv&E|lCa2G#=||b--C!fj4t%KAMp=MC#2W!cr`7Q*P0hY%~o~GjnL;j ze+Zp+u|9}>8RSyvHHGHQ>O5yKH2Fu{J9Q&~%sE!9t`$FgLcvTF`sB=g4A5JNxXi$^ zyg_mBeshRz5z$*nHPciM`(6=(lH$N-(8+DO(1j1C#$TrC8eZbg*qAuN>e>D?H13^V zX_7D*s)iK~pEw3K)?$+*8B?0zM%b~r!lQ51>w_MzrM}eL+y|t*D_Q3-F7+9*&PYQ$ zF^@klt$<@Z!$6{8EDn@;()n`9T(X{jT*L+CYzq;?b|jn~tLxrhJ{VV`{zk!#j(HYP z><^mBFiXq?h%eSuly~e(E2duARZcR}NK(lLUjaUy>(qcY1$PIocoL-J@2i3a;|d7A z$^@>8B_F;#cK>E$_?_Zlk#=pMFf7Nr{2!_5=4|8{-<9FwjV>QgbUF1&4hN860-v`@+%6 z+Y^j;;PoU-c$yxV+SI)h=utj?VCewA=r;^IUoq>IQyt;%VRAuKnEEaL;0LJXKGk}< zLC~cAwdo&1ftA9i10$|8?=s5?-gzlg^7&Ah;_>Os6$Lvz@K1OSR$wfzGvP0z?T>2P?}NK#Id zAls4fZa8?je^a2D{%sH7Qy^POS9cEGVPj=!K_d}~5#M`1drjd{zI7n;oO);yW240{Lr zJnot6quRO>Up9M}2Rhiy=G9jhQxT^~j*EZMn4s*j#oQn7m!_2)B`uP8T8KTR1&frr z8ec(ii!B zR)78X7!wVL@Vx0Byi!c=w2)ok0J04ceQpozfD;h`-uSy`(MuVG>FX3rA$=mU0_um& zi;NUuw{z_TPs3OL4gM$`YY0wpo$xGw(T@NwUs1IB8b|b?W4d-{sq(_gO+fdgt^fGo zV11U7NBrL>SrMP~>B9Yy&>^o3;h@YvfqVuK{w0C`jEs5hrPLsH>MkyBH+l`WT$=FX zXm}N*MsfMEDDk>9y9w-u*o^f<9jxT_GbxYmQ=bmkH^99qo>iP8 zv_C%@{fU)$Z&qOnmq0jZN{)X3-hi?Es&6RSfA{?T18Y~%qFhjRe^(T>vLJf-L=D!~ zl4BKtmSkP&{vxY8kkj860hq%{g6#=sI;P9-Q2;CHl4fOQb5e6rFuATdo9jEg=S3d; z(MHSU(P1#y4i&jp#!Gs&0__!4wKlg=HoGHXuV#JhpaQQ0F)Rb>6`QeD;m$Sd)6Nj= zkgu_)^o{0^XRBI+KzQ6T?3Q*wab$(`$7?se=&k;jmfKoFLkO60m~6@Z+$t7pYf~{d z=%dpTy3*grX=geUCJW;_t5E?uL4u+ebr;La`Od~j8$gh&QIK2p5T|x5DU#FcILDZX z`$uX{z^`c#cb~{7mi_=`_&+rET59LIU6;i$S!|Y zMARI!G_SqvhHk}OGsz9$W;_dK=c7I@S&kxPo{H(A>B?tA|GFqoN1?jRaPzWecJoJp zNbqkr6xvEYMqS-sx;))y_TVOUU3Mt`Wc!`f9Sv~Qbf9Dm{D7T@E{D0%pz#}3;FwYp z>!~umZW=#}KP*Le>vO@?G*#IpjC~P|0uyrzPD%Q zHf`SYBxH%Saf+jUQt}2Cza(U)1qarJ!;6$dNcjt!?;c!K5Ax;^@@8PT$#cK^V@!vyiiY;dM)QyJXEDjo3M@8$$l{e9t}Uo@GE(qLHuSNLnV$iNz?li)hm526ed*m{@cRZ`mzVsdJs(5BMmMg z%Y0%(jtzYw-Z!-NTW$U=T>QTh7ZBT^HYhQ-=}FH4D0S~gC4)nDH!?c+VTjexgHK^P z74}fYv~sb%!QPKK*bD>{>%8=2i-H839qV;7GQ$VxyjTlTvcB)Z(YyqRQfeMEvm<7q zpJ8QGk#)B0x(1Mu!e6KW?%P?nwf0`#$gQhp6osUm^)*=y?pCpvdA>mr!_lzp zaSdU8$LYzkn1pbXMfVU-lCg^PP-^_p-;Gts_z`3IuUS*3aDlCEmXaBgt53o6gBQ_{ zXX#*syOP5UP(l~5u0UJv1{<(86)3wmC+`oCnx{_F7AOBTxI8BA1L|jGjLs zUi=*YAXU3$@kSuRe7jfQ)N&6~Pne-@gqFOGY@!*Yt@oieZ}&2(NXXAYK6Uodviy%+ zySU1J+fm#N8zr%?!*f-a8R(2s1njeo5WobjD)5lCStS3b-)_L}v^N)0-w<(<~O_MP+JQbbU4 z=T84`F!f>ao&m7&ukDOKDT`W=+HQx1=B{mw_)OC@rH@_dMAY+t&Jo-A^2WXY_dvZPkaRdZj9P+go6QEQ-7WUK zU%U2BNo))W?T?j$8?dk$!#Z>gkwBvm+|HK0x`QU+PPn z067@oVE!+>BlGI{$8aPr+hQWz9SPe^rXr|Qy(5tH5Ms14Q=9l}HqgIVx%~uLXVczF z)j(r<5u+#%z$q00{vpTizqg5ti8`7yr+%C+cI>+ZB*OJg3m@4p_B+-0OZplqRqoRbPn&*V~R)zyf1 zATSRU_r!aBN zA8QfTWVIk*HKxFW32$4zNlb4cw@iO^07_>9*WtLbGrP(dj1TBm{S~{IaXtdIti}mI4YlH$uclz4baZ+Xxgs+ zy-U~8$-}{~8X??gCZ!t4LAVS>a{!Y?MB6US3MWIu7^J&y@>Z&}6kRdg4B^QB=C{eD z?K($4d7yKCI@|9Jt~`7!IpuKVYtx6#CI9@EGHha5>?)G3qUI`N`LWoL!fC@kUV6pZuHBy2nfCqV)!OcKaOx6Vt z^dtQf`=9WBOxphLSL}mZFU!Z2J6?}CJJJ@s=)W=95?B7qsWkLh-TSD9^P{&_4tLj9 zJ_#ebCLgOo*kXDASZtq}&7I?-IpgOid3rz2P-5dQW?mNu#Xf^1H5rCuF$Geqt(bl zblkrKlyr!dGfn&|xf!6+ihOMpy6d(VyZ4R>dXyjc5CUG$w(FmGQvB4lU;OoCmkHhE=oS;R8O|jWzWU zAY)KAR=Ujn#x<(ebk+n5jwWi65E}#JIF^068(PUe^`&ZfIg$TN3`ouh^l!5Hq&a!? z4pq>#VU#;T$i@4FHC6EaP|rk(=;KQQ2ISL9AqM zD%>nLW3Xf+9wAv+`NDY(e?$QG%7cSwaTa-00>BM5hQCmq8CG9dX~VTnY6h^hMnH2^ z6K0*HZ+Zps)tkHZgi4HPdq;My#>*@hG#z3y8Nby99$A>lEhMbYegOR%iM|PxOcqEI zaJ)uA#1ImHSkx-RYgrkfZuLY78L^QMgEwm>bstvSbe$SGL7!B|{mZRcrO9o6pR+eo z+$?|XU2?Pi;;eG}08>gt$9;RADn4BD!i~5vxU>5Bv3yNW-qCs6{i&<^)`++M$Vt$V zOr+Uu|N6gxBXi(1$Vis<>@yj@Q(`(tx61!U(4KvRS@+ZtSU?O?t69vEmDmV(XP2yGj0r^~1*Y%{A)UC~|9Bf3w9h_iUHH|6jE==B?X=edqtAr&xf3OB5Cw zBUv!;iO7ISkn(?HI*)#GI<3EcZdW)~r{el^{R66RRS=*b`0v7VBZjs`VeD^CCUh{_ zdsY+r7gSnJt^;4 z!w-pY9DZDxENt`-c=bA;tJdpAo}x1IdiQ5_cONdOB(sa-bD2w#E8@h`I(DU$HQ{F4 zqkhXG$R*PU(M4CSQajviri*L0bg$I0{+T}%d)^5t@oU%Fl%GYhfweBeRiSXv1W0L z`!(qsC}_-D@cl#GQdr>Q6sEAUzVK!#ec^s3r@7t&qKWjE311U@le)oXQ>%i2zLNx$ z#u&`EXZqu!u-W2gM4H7P5a?nmKT;Oj&Y2Xag1Bc_YB>#&iDB9mt9R^v9q>%;X&%N7 z?6g{7jMFjr&CE?9bi?uHU!j<5d0)*hguhCTd>T10@!@*&_+O*{T6}#7%t-=hF|If5 ztxk`%=uP!h1Z@C@Wk4 z3jFR_A$|%(cO^h`2Yr9e>TC#2GfBFIk(l>>$&)wgyYjcQdbeeDtJgpBgg>cDu~J#B zh`wV5Jaz~5+pvxbBAQuL&AhO_hhZOKW6N83-(4Oqiy!Pq&T#Fy38Mb%tU zaW_g_)!5Gh6Dt|I4uLIrYd!IZG+N_h-~A!H-pZ<2dxRHt0Ug2mz;-Nsrx>aY#b?{~ zse~qLchwawU2wiJ^d6c!j<^j&l(Dsn0HedrvWLlp zh@S;W-;u}2n)8b3)uMdwHIE{(aMY}Z-pEm2$Nw!Q$QW7< z4H9p%Vz7UE06EUn>B1f3HS0H+4s-WZ%C^SOZ@-JuZ5C}Biz`QAr-xD@F+BJSfOe7Q z@XYE(-Ve_PXQEMg^Kn49`=n!xzTW9*Qw3^;b2w+L}z}%YUTApXrbE04>V$tC5zC z(}Gr}3I-r%Nc=%|;(6R>jxVC!jSmoiZ+s<5X5J)Y*6dLPAWChegq!tNmrMQ(KQ0X+ z4GmPPS~x8bjpfW|AB9!#Hrr-@9QIHFwf=+YMV_W7%y&v~4msL_oeGBr;ZMm}c0x5f zX!S@fjVmi2S*-ZSJK2x>PXN`8h6!wDgr9!R+oV{`U$^{q^|DHJN`-0LxbsX>$zfvp z)U=Ucd(aKJ?ad{GEaHtiYNAQoiieZPo((o<+%_~$c~3^BSNEx7L|`9oVX5%<;eKXE zzm+d#VeqrQ@xja{&=9uoBIiVwdvMq8VR>9ikps0m(MNRgT$R5xnE%KUuAYXKUy>wI zvh_&n$J7Pgw9$s6+-I?(VXHCAj^tPBKkWc*URntGllffkv`UG6{T=Jy6`tT48|x0W z&c)Os)xNBX&h$bLGW+!AM}_aan3QV zonb#btD;F1)V^Z4V>u7P5AGZ=g|5^4+s-}bo-#E~jSG*w1{koH2IH@bd%GQ%V=ZHJ z=SPeEP8H9^A5xizt39e==i83fycVR8P$?`PgK^2i}Tt{WHx>pe0jt_(guUSIWn&fFu%{JKd z`DDO;g6*+1ty%I`8+1+q>da}tiqWbhWKI**qe|a(pGz~s< zZD%02ddU~c`1Y)w3Bps$lTNq#h}rW0b~#PXzZy{+_$Q=1PC>`^?fxl#eD-i=_gKFd zW9(OkuW&j;Q{8h!6U0kA8bd3wmkH>C_}b0M#~*w5S15s6TI>2!TUFdWN~fghFJpL< z=?}yOoC>e7{Aj}yz53T|tj@W21g+xAbRV-Q|H-%_94n%SFqRhSLuu_R#lP|T8CWhG z-jeJEYog?eJ`?Y8>a>%ekmAlN`&U85nEhH+pf1(K>G%4u9+y3`$C`t&>~I+SM(Ntz z_<6)eS2NZgs51%dSQvGdjP{*9^4jp+E>N$v-S9t?o+lIg&=Tu_v(KY*jH~q7m2Z^1 zBCQjd3EumBD3T2){N|+QFQ=0{X%O-K0{QiEOVHFDA*@1l&-T;EdWSDUu+Xa3S<8Dz z5y-{`?A8<~QGw-;-JMS@*NIbi)clZSPjO{JpfSw^C>Pd;WCnk|=*j`;; zQ?=G25!Kcy^G>YTGAkd`@1DG3O=0~T=3Bj3Vc_+}VFr2a_tlEz#AHbyl-J(~qBa*> zh57Q!sxN6mYUHz3@8bp<>2j@I*-gM4rqzK zPbNm&^?Vzw?1R)ya<<#e(PhA}(HT6(c02Oj2#fn%*5CL{a)b{+)vQ9NBDPXwf)buLCN|Y!)|Ll}!P{_}SZ8cYRBO zhY#!1H0~Fq1hl$``fP5j7TB!|k3d+Gm5VhD<&PlclX9@#TKH)zO=QY!SE|BX{gW|z ze$XLKpMHZ}lA7%031?Q^M1g zqT4tJQL7$1)BE$fGi|Kwgc+*TC41W|79B*;$W72%Q0mHHTs^$EV|(gj<7sQ;sO`lx zyN5cDZYeW+?^1i!@2f8yv-QYU=&M3}sRQ@0Ek(8LJK(OJ<%YU_gm432`QskRgjve` z^4blM5c@%M`|MzS-u8w2SbZ8W)X17_=8`fyX@fcT;D7Y|WPrKT8{5Bpk4#7p%-bxW z{N%q&y`K_Awg1Udn{SrHN&Z!oP~&tvMwqc8P5yKXVezS%V8)qYY(L_2g;E#ejD-ln zg1(Kb==;eT{ITiV1iRL1R$UnnTy9?58_r%_W}dyHIUxVrj=Egg(IihsUTKi{Zqwo$ zHg(M$c;gQeUsHj(HJty6H)J~7tjN`0p+K&c(bWx{xIkfh2h*+tdz+d&#<)xlT+yk53i~Wc zIEnYnS6@1$Tx^O@#j$VrwgzM_zPLzv8InWo`-v~^djrdptb%SHn*r5M(FePoM)tE} z1^a^0Z8(0!f70?cO;#+Tzx>N-q+4>_4MIjgQKQAlWPV&9v`Srnym%brS3y&!D$2qL zBj_rz-HL8vi(v0PUkG6HeU8Z3Bz7qaW50r-a_T%CR$G0 zdb{27=XKS$L53vmJL{x-uS)vMQ+ke1&V}El+U9mUZFH;v>?0Z$_@2D@OTPvIn``aR z4Yr#4TU73B+4g@*9tcI4^=R7x)@19XCZ}U~liW z-LsHY+b(}*FHgqDx%LUaKF`i>y0Ag{RrHQqKJrbs8q(MnMwy{oSvxa$;r{L}VUm2a z8EiFnwx&b9Fq0o~#_0-2C?dy<>rEgY>G?V7dzp)>OzJV zBwd(p{JSV`RJ2PlY~yly#4>!D5wkIzw-I!aF7P{EA7x}!kaTTN{e6A9>??)XtX%>m zrmnhHEWQhDH2Z|@awIbB>kFMo!|pVJI23t=2q<)NJzF2l9Nx7s2exVYAn>D0;+VQ= zz_-?Z?P$r6^s??J-HM1$4lHtkN&})Ms_6JFr}ZxfxL>`63#or%q}@>TX^E}GQR-FD zNNy<4-ROJ)y{odyI3azLEfd?!HlFWP`~kIl931Ud4&M`QkjdU3fK9N9nfy=}Oa7J) zyM-1Y+m2Her@ApFciV&CjXGYaUHPrm{Sz>=?-&01$|58aXm*SjPV>uB6LHI z@wpK+bpU|Xx8wQqUf=`zi`NV-miK4{j(-SOegr;i48<>fj9vSTF|4cp)=Tr&k$fP& zaAd_SVM(fz%ldQtjEF{jRQ8R6QrnCFSy zP_|814yD8|3)Lc6J|Y!m`@Z=-)Sz9gk(p}p`|6#T74AAQ(7&qsLd=q;a$vVUk6@Tq zP|AvH;=M6*Z1+AXD?G4Z;>k5kEq>`pDT`vT`Tu%xp^6ZsUI0u~bYJy0OB%-)(-6Pv zTQe^f0$&b6OXGhX5oCvvr&OOHc)oB^JKf8Pomv`JoxL)7en_h#3AKa0XTgFQ=UROMja61$AvKpa-T9) z40a8T`&||j-_y0myZhYbT1uAS!byunzY^sO0{H2`=Zw@OkX^PD=X1E^x1d11>KIDL?x4(rzM%iWhuYD?A9v=K1K3V62?6bBi&(irb}N zG(Jt2tILYqb!d>BU-={(Xl0ERVn@+0BjTRX-4M@~5w@mxPOCRbZu4E39{m)OXwR>W z*~sfA6;SApI9L*pyf|6QLGUlp^WX%gNkeVIVOv&uy}JxZ#T%_AuRO`92D3fEk1R!@ z_7Be5@g2#H615TJZ)6z-B+S3lWa$EN3C8+d^S=ds#J{U$jpP0t^hCAhnYaK*nD15$ zvEEpHcp8QSa1w2qXKpOJU;CsH=#rdt*4PPjL3@X^12Z!{F7MNwTotD4cG(>UK3f!D zQ`$W^zY$txB`K04`LvKZRN}Yiw7xIl-oD9h?OtibF1bw$f%kGx4>n=ND_Pb+Q0cbcShcpuc0io6$aJWGJQ}fJ z>Jpev6B-mm%~v`o=5B^AkpaQ0mXjNB(DZVi@@62ybywAvm@o6^3Qb?D9Vv0CSla0e zC=C_fRl`{*)34I)6~ArN0^qCdX!S!{cgnP*+=ec-+B*)~ckVQ~V?*gp3+N~fPfNI7 zogQ*NEB5yWq5?2k*r9rQ*alwhsoID=1yH_*>w_Q@{Ilrn=N{AC(u9wzC{d zzQjH0u~sKOL0IK3$J%-qK^R9e$1@1nU@agW-5z9g*<83qNI!;KJ*sDpOXzE1{!8RQ zNCP1gHeG5h)%?kQ>{pAtxeCNKWJCjQdjJY{RXs!}iVGIxs7K_0g;AYr=bran{|OLw z0|4ByN@wHK6m5VXbN390W1UW-U}-GoiKlPHM~3=ACKZv?a zHNL?LSxw+s@}v83Tbowp(S<~zr}at*kUCpTB7EZx-ZwB-J`~GgeZNU*MRrZG&V{1c zISTO?%7Q)T+~WFi`FU??%1So1donvt!?+e?bMR;e66siTXtJAkvkLtupY^Qu0&nj`NIwZ<1W#Q`P$TQp{wsc>J=*LD3FkOgYkqTAl(!ZRuHy%x|NxYVFDy~!m9{-XFB zt80}C50u{{>K5Y&vX_$30AIU~eEQMtfKClj;zS&%bNGgBYF_HE+ z8}MDccPl};Sw?yy3SQqJvpdt%5YFw0><1Dxcc}FSVBV z+?-VD(uWG?j~1K5qFl}6SIR{{XK|{OBB!N?B(oaDaZ1#O#Yj#4P%S zT!HUl6@{;-s|SU-NsnUnd`F`v;?q;BGxc>#s&!APFBEu{M2!SmF*cQiM9o^DonoXn zG&mqFzp?&9S@KWUw7E`Km4jeyYHF;u74e^`zX>fw^2n@ zz81{22d(a@em*~75(-!|eJ=bDOM|K>^pRH@P4+`wL%l}+$cm10Gdtc`@wI+kURe-~$KIa^9;aJ2D&&$9Pg9^Y=86M< z$W)gLh8^J}7V1{5{|<*NBAz<2zt^ldPy;{9E7a$isP**8%0b&EjuF=xC;vWq6q+9U z<1inQ2Cj&h7<rEwQ69VCA=uwT<+L0Wc8JIkOfBLDn! z*ou?lsqWiuZuZP@!^WU0{Uao{x~2xoz&JvH-X8ICiPzNaoJNSC4Qq%Qpn~p=keI`J zi&=;7^odIyINO$GZB2@svytndJP}EO;c_zGyEc{P@#&cx#qOO8N8m~xd%TmB)%1!m zt6GDF#HmU+c=@;XB`h)p`8&m=t2W$RevKjTEpVq|lcT4y&X}hR4O#DA#&sfD8+o`C zMFTDFa&bAl2;Uxy7F|{>S3kCR=diw=+yS!XpC|K%#+Q3n^~@DzUpJF*k_L*CgY?sg z?m@4;S9%}v{!Y)B3PBdj%?9$;aaG=a#h)+Ol&Eo1_l?Z>b^4sj#u9K;n z)@e>@RD;PNBb5one{$`9OW3l_Vyfi{PDN!e#WX9-a`}S^g50JAL}Y9E<|Kayv4V>{ zlKXCrY^%WgmP@bTNptM*tH!Q6Tw|wj+~5_pfX5`LKjN4zu~u5?Yt)xoSvjHtxNw=E z16VBiYH5wgjdS$1l_t&he(~)hA=Nf1n!=gAto@TT{!;o%p2gBzW>T`#@W{s5qT}c@ zmP6{GE{3dn=Q-Ze)hhsdtA$As0lg__ZDJqPe?#pSk~U=|JJwLcw?m^_`?n+yw#;h( z)1iCKAjvE)2^DdP;FEna_5V0J@3%odfoGP6=~Rho)8!Ywr1rsM)~Kq@#uML|G7^vC!2c-;TSC zdcIz-;0HUFbHxw$fKW%=ITIa!g>Ro3{5+RWIcscia%T{ge?L6!tUGg$<=jN9mtb)~ z13Y)s*602gGwhIeSeWwY2Teb%`mFZR@{Wf4iStz&88O=1aLs5`f>uj#*=woZa}DWm zi(O5^qY%mFNks}-!K?=XvU4IOr+g|#Y(T$w#2&>J{kKBTwM9N&lzbk-ANddOx|H&+ z7$MV7_0mo-{w2A;@KUhbt?;<5@V=%`_w-2RXukp_b;ppKAMZ32VwRj6d$gdnbWIo;Ff^V*d zfwQZmyKF1YtM_r|O|o}P2MFJ`dck9i99%+T6ObWUjdiBp#=M34KfOS21&ucUi~c&3 zv$g6(h}4{M6jaPfSrA3aThiC}UwvDJWT7K8 zdY?>>``I^cGM0%L@+?c{PB`40&;My1w^Bw>(>v6ACQDLKlQ93l9juHiJjHZVyF_kg z!bOU^;9abj>c3DZu(3QUrSuVF=Sgn{5HMWsebnmxrV&U)>zWpa6e+It%g6ByOp+QEV`&CWE1v*t#?r9aM0#(ugA zYbsDa^A9ZsafF1iHPq_-xnFa#B zRC_m*Wn59CeDWlSHZ?Io2sZ=X4&TgUy7#Q=5LWXr>}WViG3E^j62g2ld7qId9NLYpsdm?H1Y5XI|mL#UCWSZ-jyW(%pL^ z2W(prf}4{xJ4~j|Ty!c-V1?fz;IUT!OA)54wlQRVe*U=gIex)W&TP3l`w_gok=+~CLYm$9E(+jUi;kBws6 z88aS@?}3MDn3m+VTo;IBlX)ShiKTR|NGk;JHq|)ikgSz!Ka~Act9>-tQ+DWb!O|Ye z^x!uDr>TU;d8g=4!-i81n@z1QB{c7%p~=$ou#F6qX&;@ zW7i^kvTQ7)!vol!Yx!WqXha~E0ZE7B)ayH;-b_M^gJ6yokZkFA3E1&YI~gbv1!jfR zk+Xi_pBHWgf9uMt;x}q2UG#WfbpFkz6D3hgL!CLCF({;%;3Va;P(JB<^zf|qO#_25 zc4LM^84gPFI=+1zdvtUfeFk5nuNv}{?`pFs-f5EPnp={QF+_QduNLiS@$`BcYF)W3 z-ob=#woy(0U%K&H7(wS9P-~U>8zc(}d!ifo?#ZZ5;ErDpA%8tP8$zg(d`BY}8pv5yzw9lc(abh8Br%n0VP1P2&K;Q2Sccc2H@M?{z z?7Q3+O}9*p`MM%R_j$6IaNilT(h3`!bAywaP|1NwhM9R~>wWTi;gWqt-WvrX>-1j) z{#|f(+1sAWO)pAOalZYkBUYdB`KyzD-=^+!N8g&9@E?&sQf!;+jxV*`H7BoYN~u9^ zkRRT6yb1;xOQ>fa$grC8FsfequdX$N+lq+$^BitAGzceQ3hf2C&da~glIWDSoVk*) zR3`;8LwEyZ9(Q!#@VU&uUEgOO3LfrV7puAWyCfkOFlhE-92q#P1t0P)K4b z#jQ@YjVclsml<#iy^mp^95Pt{E6y^0!3_~8(GIE{SxWxZA-&2%FTD~N;6piO-O@NF zygTO$Rq4FO2&KDUU_?|S%CJX4%7vJvl+!wY!{)M#;S-pe`R|rFMY2&gZVWvZn#kJE zl>dWpaJZh6@wc|Mz>IE+R; z-&fjk%0s?1cHmG(A$2C6II+q=_|wt2LAWJETTmynu2iiiFc1+Z(effE9~IN4N9Vsn z)B2~OHVb#+T3%hn&xrdyN@yokmy$g2C1b!e9aJ1D8b#g{t3gXu5p)%;wNQof*NygPiy|_MMi=hpCJiQG22%C%g6F@%} z?q9hOI%XwGcgp2}4QjQTzAK_dvSwhj5xh>8C5x54kdz@t&wfU{#H3(@bwzgOI^sDq zXypQJuCu@dERdTUvp>XE?wC(R(PfZ0$wGiLF;u}mm@+DB8f(~;|FDaGARQToi3=iL z$@Vj?4$*&`M(}$@pSl5`Oyq49+4Am?s3AS&(=U3`r!|Xx^j9D8zp_Y9VZc&m+MJp8 z9htx+7v>*u!cyaaFLz^r|18tUubQtmy-@xeS_PF~ToDYKt;bS-B^-#J~&k_7Xl zs9^s}^*n6t-kEl$ezha3%hgFo`}MIUNxpvWPCo)^?e@dwn|q#r(t`btIdU(xGb3^J zMMr&f$?=?^#Q@fIFQoheZ;WmBMB(MbogHVG>4PQp8&WmjhTsJ|$_yB(G3|xKb}?g5 zDkqHc5uUshcsF}}PJ7mDXKUacm2^|;c;K~+Ly0wraG$s$N$k|aBt--*0pW1p!8 zk6`nIW(pgs4GYK)y%Z+)@0!jYrVND+$JO(aGmsR%lj_Jw(`9YkwhsOLIy>^?j^{D6Lq=OM57U zeT2puA8C;6Ktt7;HI=8~>bx4BSkH_>0WRppJ&w#U4oTEz-c|*axGfHlediVRrVbsG zJ?+FjOQQzpWN$|XICC@yoG`Q@Co&a_h~kbRWqMyNN7y^YuDa5z=YF(YZc8?^*2HRU z#w_*{pfJ_Jf}Aq%ta~SUXi+*K~v*Rq^^ljSaZl zniJ=!%N4S6zg(%k-h3LQ3VzhVjTj0ZYdTs}))RXpF1$#4Hr+vGd}7fH_#%O0Y3%%p zqec=2H#M3(nDTPNeXn8giqPGwN5eX}xn?L3qNlKG+Nd{gMEO{DnUnELYE27g9)sl1 zlf8H0qI#a3t+csvL}>KvaY;g=u4TVk{i0VB8|#*mT`zD``5PKgQ^MYB6rt+ps(6K~ zDOoKa3ScU~5y(;GYRc(CZRl&rFJ5L4Dy;koe-GQ^QjJ9*-^d`XYE+iIrwFoFbMT={ zVq#ZJYAk(XAsbR17clV|c$gY<4boDE_opUY*SFC59I=*=2gkK>M|+>~kyJ7KN=imW z<4S2;v>bi<^Nk%A@RW5Q|L+9Q@Jiw=&){EeIBv7#oN+Yd8!00P^F~WCNH9M^pDw$; z-jm?bNZLb)u3z|?4P9dxyb>xL85VD*wShqIKjby&!5gY2-$Z9=hi}BQPS(oR#SFU8 zH<&8w^^6rCGh81`z;8y*IFv!${%JxokxuM>N@s`7ymG6X zI_5z=CiaU=Zgb56&6GQ|JX^_~26rH8+1ZMav>f8)ri9Kqm^u+4)9^soLz@a0x@AlO z|4gfEwX5k+@+CTU{TuIrtn6VQiSEMr;u-D_X+C9e?etI2m}8YvwCsN~&mJ?Lz=wu^ zQo28S`}zk3or%DVAeusrlGS;0-Z_;7zl(VmF2+-?@*7C-7v9f>M9T& zU8_z$j+1AuuW{6aqE$IPZjGmw76-gP@~+^fp6`yy_dCAHCv@+{2cNrR7nJn9jV2$S zWHe`FsEw*8ay2}iw9t*$=AtVTQL48F1^$1?H&>EOK^!D4bC-JF&opa!gA02R$9}&a zHO|M)y}Yz{gdgc0KX#^Ya`iBx z6VwUxBh()t37jPMKEDR9X1BI`j(VCN!F)l;+sNSefXc2DMP#r~F)&&ZlsLs0>Mwa6 zzTZF@`vG|xjMWBdUcFr zg^`Rt6-@p#Vd*%z^hqJ$^@>!;bEd&cnS>6 zBNGoXM|#?b=}jT8Iay}()|2YJ(wSJ~r6m{Rst$bfFq}w|Zwp+pW#^ElOOOB^OW74mR?9I5W z;hbpfEvNZeBVvHiC3~)N{>q3~06iNa+pc7Ta{Jj`b=YC*w&8V`)A8LeS0rt3I7qQx z5Rk71sgpQ)?87nm$BD|FEpf#a7J`zcDb@8-l3K0Cru4Wi4*=b>x6Sy-6*~l>C^U6Q z*UVtx?RIE&LgJn{2PULZq|>Q|L*cCi=i+c<7Ab3eR(3#2nMd+WF~F7fHA+MO~^! za$;w&5I2U0T`STMR<|!BPKwDmT`m~y(q6>a%UTPOjmm+>uzDBV!~hUw-(vYjTWtGO80m{3R&}WeR{o>qDm1y6CV9Oc#LDA41m(HQ)9kX6r9u&ZR9C)T zUP29Uxf0+#7QIwpFo&t;e3dkbbpRc^`|j%BfPtCP;l}e(8Q&BhF((Po$)@wv&=;#A zuz+qL1>frtlP)ln+nemqepcAzJpq9K!x@^zKSu6(0X%&pin(9NpnhvuHD7BnK+(P_ zR$Xnz3>a=QyUhzG?MI6njbrvbKJ({2Hw?Ev+$?D8SWC@Y;t+9zChJY zd5rDCmTa&neEXa{UV0!{m@iGmGsD+BHO?@LkTt?h9?hYrgaspmG9G}0Osx278R~~u5yu=Qwp1xNCvc1 zW01_YiJl{15ZQ^kyH3Ja%&N`hCTVwGXO_j)P0~~~>(aC6pWfxBWjiRKLxU$g&~|fA zNaGJSG#m=pQ_9+_Go1Jj7=F84I2Ab7O#`-$8g=ZBOL#{+?8rWl?&uAvHH|4e<`z58 zefA^1^kQK~h~nO@DT@)aKk>mMMrJ%OfaNbqnMG^EPI;l-PQSexL(eNzr`$fryz@G% z7E$+H)IJ`A>2aCXKyOS#_2%^)3b%b(plHM)*yvg=;rv%=)B;hPyQ80aPRkv44q z-)$Y$)DQ(<`0;A;3#ML?NZ9Q8*uQHQXqFUP?DH6Xh@AywN~2MHo=a?{uDv46s_ zGx09YejhaWwJK!KiH4qY%0EO8!(SFgEZ~3Axc%VwO&@EPs$V}{7X>Cok#v0}=fz{t ztYE=YQsXQm%^q{J%}e8zj!ks+6jQ@X!Ad#!&~#vJQh^XImhCQoyJursdz7 z#{DEFGx9kdjxYJ{uEp0J&T6@SRrWjLB8e-%m!v%R0JHnIrI|+)=CINbWXGb&PITR0 zsl9Q1uwK;CX-;#?RrVMF1P)2dlZi|`(x(rL?COso{nCb3LciX?x7f`$G({zs-=5Qr zr00Gw!@A12{L#@GsUrTy6FboAA#TY^0u-0wCC5GX!#~d)Y4w0Z@ix!w4IW4*88i%u z+*1bp+5nrH?qE(_-Wnb=STIPdHfK+adAeu2Mc-1Ms@Ff)D3R@5pY?A1juwqX!zEI3 zqT5mk^v5w@*@c_ah6I6TA6dwd5)ahVCfRM+jE!cIsR#u9ia`F2ls5fcJYbcN2n76` zm8@+KU|<#&v^BCxeyJYH5t?cwCvG%;Xj$JgdoG_1_$fU+0H_UDi0tP2OYqFkVayuH zVX!D^IHQ_+U&5lS4}PMTV_dAmo;%#mqWPtE*c#98@QBi^=23qUXi{oy!p6CyRCr!( zsyi#!Z*QS~ynBlyfZ`BXGQI72S`hP>;$%j-$|z$#*bL)!y64_>?}3i)cVZ+!`G5-W zd-@e2??qGPi?DbznD9uD5?>H8sW<3ROo;5VS?76^=7D4E2wdE^IAP;9ZU>cWKgg+% zVUpbg+mn)_<-y5SdB`hhi7Q2Y$|=!2h#=Sr=8k}MXF5M91S4g~PM+v-z|XlUL$n&E zW;}oyq`S8Iwo4CUu#~10G{O(-iRZz(@A&Ua-a(uF&M&7sOiuA`=<~iA)R}NPI%)1F zeKsqK=rhu)*!#e0^NV4LB?$iyX<0V-K|5HIx^D9|OXrU&mk%pX+Q_M4H>!~qugELy z7898;M7Yp3`|e5ETusu%m#J5wtN&Y1tOB;hW_o$Wt?=z6@suD-?cSDj@a(y@42E!c zK9+Y={Ag-?xM-8eYc72-&ER*donCEwq5#Cj&V{2*Zi>wBCGJpnpSlImwyB1=%*U+`h635bUB*&DI+x|l`V zC{%ue0c%T+8ddhEUlsbPoHS!N;Z1Rb9^3ny1%8zl8 zSf-%PkC<)A^RzxgRT?n?*PHB8J-TeXg!Lm@^r$rvkU;e3#mk)Udi$)3Jjn9FE{xx( z)s>}}>6;dOD$ol)$r!bT-?gjq_H6ydJmB<2 z^K6^S6qxP}ppVJSQx>RPLo!xxA!&Pitw!GZF!5GnShLU0mVG7Bsde}u8#e;Hk-Bgw z#chP2KbBD*p%7h=x9@-U0g9XICpY048f8LhJ+eU=ug{%?-UzO!QEn$G&eEQW-ALUmnOB_S-no?$JR}*^61EoUM(tRzTwR8)tFMt{tJP2s z>u6nz?kd-JUAxGaTNy)9@#wTW5n+{PyU?44bUvZDE(r-;Tk34hgx~AC=Qp_h4EgP^ zs0$jNYUPu5QQ^lARfpp!2bXJLpYg;y{s;Qag}Djox=W|F^7EfAUy6&;n^aazi$BcnK7<7g^m2`f-UZ#!0$25U0lY!EqyTqpZUv@a5vu0E>TK zV?i~5@aoVpYw(7-;~*>bvy=O3jcBcvWD+6GB@w8>k2_`YYZ-I{!c-z)`0Pe<1gJD}@XngLnPi1+Le zW1X`elV7UqP@6j{Cy~=ds{b`0nV9Nqw56i&oxH3BL4FokYG&3$*8UyAdK-m{f{5L; z_!@s@to}m?_lT+dz=$dXuu{Q!s9o!Z>bUNf+G_b}?N`=ghK|WjI45l~IuqCyovzvbGf&8YSG1zQaWfrBL6`O2_EVTN z(}B8O1^9ocVKuN?!BoaKDXOBL)P|n#GYn|J#;CxFz)Fvw4Oq#02PtB^|iD$RWraVR>Nba1kZi@XQa^N;HgGI|nm#|e> zGJ=J_H?+B87Vd(l@6l~XtIU52Jf8oU-B<^jcsPo^N&oM{&Zffn#^$^cM0|Ud8!Y@> zE3sn@nWS#pY0F<7z#C)UaH{mQ81)7pYbF_Cn*)V0zkI%l{W;`Bu$N+jfeo}dzaT!S zQytzRgGIFFf%4s)iejt09;{x>RJ*Nht6)X+y|I340QjNn!2pI@G{f9y({m5hRbVZ7 zribM;SR8B0bT^dE=Z&iE`!@AF!6W))=DguUIftoP6Y{fUt=0gM`F=O(icFS&u%nq7b~1nN$-XwxnKrQw{-e`kPx0@ERicPGTBG^kIj+smKs{DW`Gd6#et_J_!T zBeD;7v7;DFZ(0JvWPc$TF=LjZt8h+%Y3EF2z=9VTF zJO!H6mf`4xSnof(qE3yG4GHXp0p~@!|$&mH8`M)oQZ#ialN;F^IiBsaXB&&;jX?JCv{4F`ueUpmz77==Z=! z%w(9~6Z@aND_noxiL8r-b!3NvFi+-_(aJRpM+eLN(&9G~!EEr3+hEp)qt3kTAW{$2 z6QsIFy=ad2Ljje-CIkn!>l%QFkJ~dN{B4Tp$arqxMk%pfU|+{pdkHh9|KT7WiZAYB^Gz2rc6w!#?} zBA@q34$WHqPcS<$5}TJol}wPS)|Sb$g0zUg;-;%{H6PhM4JK3s86ammp1e&F*1ESG zL!Qn*rUfc>k{@9fBdck+!zlZpMLr4t3a;z%P~`1Z@q>i&Il?^pv(PIRAJ)`g(xhF@ zWULevehi#d8gT6E41(vrNFNye2C7KaOlmL2qWaEi$t$)pM7J92p?AQl?qfkO7~|^6 zO|4vhrZd?}`nAgU{WDXxrI&_j-(vIyvWBbqb=}mrvg7VHGxyrVxWD@64=*0v8$`|Q zv;MQ8zT?H|m^^t2rMn^q%yonCHjo7Iu#1Xbd~kB&Y?a~uqg9N? zde84w+p%}@=N5hEzRmqQX36r5SjuaeC3M@t;pMCE(&xv2?I|@e< zI&DHu2ZnTax9qqyAI*y`=v;TsytO1sloQz@8=N;s)9VLr^4xKuW;qS1i zC}2%>Y&zOM_dCLjl{#1z$s1LD!F@{zmTjT1u#%q$w^GsvlcYWZ&+(q}QI#7U71DFE zoMK?;#j)CofeJbXujeE@{!!xbqo;fLJaXmb+7ZN`*>l~4<#$fcttQF;s%g2JpxF|mIMgqYr9ENj2gfDRC4J1FkV~GfC~Y<2)i)Fp8oI?_r0pma>h>O zOp6uSx5eaY%!b;)zhbV@tHzc4I(bJ&B+64h-s|f4FjW6Y)lRP0q(sK`M^!#MKUo;- zg$(U`Rw%wef(IzCaSTV$`2EXNOLJrmh6{yQ6`JQbPVlcT?dFO*(3YB&W%1>cg0|sA z`95NJU2cSI8;mD8rXKT8iyM|^LPHsN>^X$|sFi{tuBn&*%Ur9|mhF7f_)ub81(6)M zDu< zR<>q57zM9`?JxxCA0B+ocWl=J>I>iR4xoCp@9_|mkD2Tu=1!$2bBY$tsTDHuF3n1CtA znWHhI+ZI5Fo$-#YqD_dC$VuFfs@yR#D;U$@T&q{SgcUrX9XRT{@bNw}`9 zK;v~CJN=&KsnPlh$?_o~1oiP{{}E0Ty$n2M_168XB|LH><8V&k_mUP%E9?LS6*X)n z2nqpoKGT}SJmYUqVLBq^Cgj_Y;w@x1E~EeM&XzWFpd}KUx-j*>=aNT;^!?X?wASbW z>mchpiE)%rK=oF<3z&^{I^+9Y|D}WcB;r~U$%b`Jv;4HdB>%~BsRQX?7ioxP_EDQQ z>8Q;UKcaYy7_h7wpNFYN4-|Q3!i(Ls854=xNbx^CQ$BMa$|nIWlI>6wq^0u)+luzN zR{Z!4iL;X6)3C;7J*Jqfou0WG`;MdVS)beOLA@bV7nkgnupN$t*c35YAX&P*Jiryh#LK{ ze_w+|H))?HCiL9$%(*BAQ)|&4zF_exv?32Q1MmUQTbFXCb^#4QuQc`+crF(oGbJB!58x3xH8=X0@ly5p!-7M9e+&(dFbu^-FhCkmZ6cJI%=k#lL)cBhI`9m{DeGk|^HVJun)FmZM_Z~GU#iSwRerxRtc%{BK%C5SHcp5PB zxm#=Bp3Z~7oc6579iKeR<8(cs+T1kj0}d%93&~t(Ci=T8r<3Q)wk$(0^Yd_muDs=4 z4UTdnIzK-AU#*$;vB$PGnz8d@2l|fuO;Pi%=2YWfgB>*{tSKKO|E2m<#U8-nU zR;bhN9E$)=i5g*Or)KreJK-)tyA=f*t!_3tqQYoj@X<+)Vw#E!tc9UM?iCp?!B zPT~&?_NCE-*bXwW9jsy;w!+%>NS{3jgS;%PQk}G^JdVuXh>$5*mboTlK|_-%iKee0 zpnvxtcgPECL_RkDlYjNfOCXi?fs$naXF{;#~cEsu9zP zr=L`;W@3{h^6nu|0qga2zA_ONHFaq&R$5mG$DIC>JuB}u zVjEh;ZdX#^ChgqMlgFc2@R&2Ek>tBO$Wz=_zrBtjsaeZ=Kb?)iEJ=Z5t@Ex*ilAFZ zoYt)<{hLu-<9-z*D2W%L!Pqn-;mI~X)2 z%y)mP6*g0~>C8#z$)Mt!%obB>v#hm?E)7urZ>Y>DPG=AIbX24M8z$|z?62u+P~0F9 z9&X7BC9=E^2I}{onht6XO!71^Z&d?QWWz1E=LP;o0 z<9q@B?cV0IGOrlbWeRR7 ziq?+C^m7i#dkvcUwV7v#PT=uN@B=|>eO9@K3e`O|Wia@+V)b>!}t zs7ty!jKsZ#X@8(>FRosXHnD5D`^~DHtY61K zXO3I+TB^TN4b!szjJ;Pts<52+Y58x+}D^WN$vNF8gVevjO} zl~!?t!7=Li;2u_lOp{A|qtCa_<4Qf)>hu>!KST*ev?H3C97f%Z`+Fzru}{Mg1&x8` z0&tI^xWXE02J9x%IaF@tRbH0iYKAmyy&Bp(9Q(ixUzY5)W(n1-=WX<>rM;3F!c%A> zOra*DfLu=L)Ssph&FFDb(g( zgAM*3`_tzQ8Mn09O3Hi~6D!*h+?WE{OE5ax1=T%Ww$A8yfhIK-<8!N;lK6S1xpZwn ztE35hvkL#R!|E;S0%N7~UZm@eqScaK3o0UDlAEDBQ9g;@C44a7H_^#h<5SOL1POp^ zS}Bx5xfNIVK$Sn#k!jb2;|Xe-3r&UvqVt9ixxH>H{}xI{8r)X?oNAd;9FxWczv48E zmVzZSgKx0}G9xF&X{`kXjf4x}PAY!e zqtx|U8Yo#%^{^W*VK|0?6c7mz|)@?)i%>JrdV(@7ih#K4u1>XY$YnAW>#Gz&l73A#kq z51o^aSv%i`r|REAWDB=-`dC+3miToNe3++U&~ti;YRV0@zkRXn6t}S>`GxV~<4#tz z>Ojene*q+1by2NFW@ZG64~$XGVSqdJlk$qy!t=sK&M8R@9cu`Vdv^ciQH>)Zh&P zLkCLpcJ8mN);MtY#K1K{>*`44(yYg(j#PABui@4Zy?tjhCn(g%WxA-pbtBdM^sH&C zRdjUy>|($5!QV`eiY9CY(covrdj{BVw2+uQV8~|ufOfm9v{K2v2{)KtVD(Sp>nh5& z&Vt&8C&EJq#6F~-`1H_gT71?6VeH~%xGM0pOmsa*{3%3&K6cx!j29lUWB!yX=(i?O zQ8o9RjaOxBG?+}w);=?kXp)REro$b{7vVnRsemZt3HK9CvZv(T z#yO&&%0wujI9OGda~%0JxmE4EpR$t;YN`NoEaH9SoZ8hJd*+587;!{KZr5N;0wrKJ zpHVela`wTOw^Q2cn$!@UT))5gZ211{Tb}_&E0wUg(vh}sL+G8@yEmz7wlF(U;5M55 zf7D`Gqx}46f`Qj((|@!CZJySBHkLK&ogXTUjSIXe^e6V|tISlTYfEYu!Xi zM`3ESgbcgrcR&V#(w+Av6X-55^6>;U-{g%??eW&Cf#$9LWVam?Sv;+qEYzKe+Y&V> z`(4P$wO$OrynkV}W;3U^Wvszo!3fbRWf7o4gAOs}|9FFbj}883qSG}}`cd!;xN_-{ z;Ws~;{`*7bP4|{vp+o6|_-%c0*T25D&gOFq4v@SWWbk^DsYCbf6jOHnZyo~;S<{cv zPBud`G<8b{Op|<1f)IWwS*7$7@&s*KmJ9Pwy~9=PhHXV>xrY4gr#{#={T~TB231s0 zX`;#RvuufEOu5ekyJh}VpppLQfuLb}(609l0zYO#U?m%LA=1jRLlj?}4F&;XFLIyi z10v@%!|`1e?u-Q6p4T}&_8@T^0kzb1gs9b6|9oHP80Cp#=LQN;^3KOpCrt;PXy0-g z20AD40kqCWjkWPoPOmTQQ=Bkf(5&;TaY)g7`fxdzmv^Xtll-X%xV0T4KjdY{s-{L1 z<=pSu;+b5-$?oXRC~dO!&DNI>Kb{jihJI?I>%TQOcEgLWzZgVEz3!(NNKb~-7aXtp zbE#va8O1)w%5g!-XfkW7CC>w&N|EmT5GUK-yGc&gozYNJe$dTb{j|o$8$iG%r@%X4 zs@b5&SVy0>12p^Al4X^`p_;mKZ~qGxYHc_86)hZ|(`v{ujk+_*gN_E0UW=ewH4GH& z1@EM{(g%s>Eq;!gws~MM5-_5DXTA7Htf^L}Ak7ImJMV3r=&E#2f|`(;I(b$nlkY_Y zulXqcG{=x#pualY!WN=aSM@&Btgi1jOWsz^Zm1qQ+h~?Z8-6Hh`iz8+^U=l)h08zA zGwN+n>vwXP`XLJ)z>u*PXCj>f+^;8Nt9onDR4O*VpE9Hx!0mGL;*9kNk5<(xPk9X~ zF?2uKbvi>)LHDbk2naRGY0c=Q#7K0~66myAmEjA&sd1*xn%9TX_@zp_{VX9{PD0A^@V&w$H36+v$-qo zLS*N4_|Y#38i{h`XhUZ0?87Y4b^S0)uIP$GHvbdaZ<)=IpASd4jY%3;^6Kx?C)6{q zA8xoHl6SRvWb?F*C(+iQ2&nwn)ZEH7ECbA5`8E0=GI@06VswEFCN zYVG46pr_q6gA2`LlKC4&J%+0ahd)5khNhLpJ5D`vj(%uRl)+U7b zMw(Aa^L@|%PKgfk(#qUsYK2$kgOirkt~ ztZnZ2A3I41Do9z7Zd`iYE^GaZ6X>)bQDfqwc30>a%Js9IoTo*&&?isAqs^^8%RP@d zYCZE=D@zN)ekq`Omw!atI&otsw{69<&MsDfXUZ) zx@qIQJAVwqVE5s_%Z(rb@UarOchPONR2GAJv^sw0md?lu-&XAReiJX*xGc-5j@n7b zh#7p%l)|*+xiVpZ#FZ?nSz;ZwUjI)J_>&6&xe@f z482|q0oV?13P}hT4pYn!q zv0HuivlQb>Epm{Zw8iH^`gfko>guDp{Bq0j^f`rhijABTHdFd-7`2}G68&VdLz{;Z zdntVyq~!u8-JpG1L7gnDrR{^s%Q#R|Qli8lTl$-4+;jVCO#ABfSmZ3lp`2-p%zTLT zi~AwydPvM($Zp3~Dod3`s0&Oj>q_C-H%g?;y&2*m8|^`;y9y6EB=6mCIPrXH1;Rdu z5^M6T5j&yIQ=s4E&m|m+2pF}h)t@`7q1O96bEH`p+Y3X+)Pm@VjI^hBr95;np zXVLLcjffwCI|lf|MFclH-(ofgmNDAMye0MdG z&%8iGN^E!X9EpFRh>Nk}wrZUDRzd8Xpc&QHX|jd9%M8w=$Ek)Pq>#Ep z8BnCWJA`KQQe$r@IZoN99ntzUv_1t4Yw~hCQ-NmJ>WoZWK(Mhxa5A*Y`X7{kKmpYaoL;HxshoVbO0#-yN0UA>3yhFV6#eCUo`*!&~lFK z6JT0?bWlyZnJ;KwM-;J{4%AW#Jv&(WUv~KDA+GO^l}~g{vCm{7ZWHnxwOX>#!EdmD zADT6mNU1DeV<660k66KWs*PNxYmk39DDLbG68K>0W~y+ld98zI*z!)}bS&sR_C~gA ziUYQv(&G@*yjz|hYfKE#iAYU0$OL?qP{e^8*dsUp=+61e(%)xacm0R6H#cs4xqeb4 zONU~FEAj~Lgffsw2 zel23u>N@@5f~;Fy5u+h?(GUNSwlI7^eDIk-?+e%mAEY!INVZZWpAl>VH*52oHY{zQ zHx-5CYex$&hn=C~^!L=r=!!O)`|5KN1iAdYmsRPU)1xL&;>prfCsU5fPX32g*_1RD zjw@sORU7d3t&Bn5xtagYBis*BWICF32wZXZl723vDR^F_28Su0@kP{Q{>eg@pwFrv zI?+~e>Bm#BGfnr$d_tq>^6l){XGT^gS;3Nogpy;GNqn2%Cqg077+=^A<>VGj&u?S= zCl9_#16M%jcx+|8>ffELqb3WigwC7dB=eoiFKbRfO(!IbSmZ5j?Lzm+zA>rhzv)G<(AtPgfDoIgdA%E<5}~`ZUQ)zrJV$yi|kfXtYG}PhX|Hsmqh9!Z1|9cvz zahghNDyiHmE1Iz+Gk1|1D{CsrvD}48Ez6BuQ8qIxD;G2~D-|>=Ef?H31Tw=l#WcVb zQp63F1OZvZKi}*3f8z_^cyV2Fp65B|bME`0*7N+djmz5%Z7XjN9*7Tj+S#mFNOTFw zT#bB&M9FXX3_cP6uIYVXt;2a4x)|Q$YtXLpVjqMMzjq-!LfNVvUHEGx_1n+wte)*w z>#8^GG$(EZZg#+w{hzO+JSqBzs?O!%LK`cqqULK_zY}JCWAfy_rs}hIa{@|0{D3q( zb6i2k*9T22`sHV(%>cv5sIjpZTe$*b%__tZJ=*xQL4@&Xs-gf{!rA}bX)N-H$BBrD zs~Gc)-ILYtbxzb{-Veq_kz_0LX?2))fGJoR%H3>AUL(_dbWP)sJI(*XnEsM13GF_% z7TH!9PkFx{cqvVcxZ%Gm?gfT^E~TA{`k_wivCzJiCH?%!|mE(kPi?>roPvt`@F^uirM zr@@r!_ww@eh}!ed;hy=W8qXE*O|i?tbJYTqd`0kDmd)@3!z7Iqp{j5>ZTZ5NeeSr- zh-X{A3aBNHGao4f+EwG|7Tx!-E!gf-QvTA*-&Uibi`2bud4^pU9PsWZri5nr;{KPG z$8}1P0*+kqbBIK1E|DV}-n~aA?;)2k4iHQT$D+X=ihEyeASykR65aPcI+zt5D9LW6 zMbVwjP&(}3=7q0KI^zdYa*|i)tbP?Qf(bNWhWIk@Uk_a%XBT7C?=>>3#e+xkD@I^KtThI&N%xS0p)mTbdDyJ-q?$#}yoQn;_}D=Q!2 z_@(@Rd%$}Rb~L~vs`Cc}a%oeNUYvRfNmJ&ouMpLPAkAG1#$D6Imi>axBYLyG3NbGm zxT2>CO&-ASi%?PUPrUpdN<5m7if|x~0x2^InyhPmeL#rn==($ZJQ2KeYqdF}-KMF@ zD3b}I3_4@W&((_n41&9E3C*ZKrF-snxGyKIXU~_KkfSj4{Q^nfH`XbZw_tkqwS%VW z)2W>uS-r@NHA&3OXmX{Pj9Y9o-SYu{gu<6Y0dU*0#qNY-;bA09j+?D-ix0V=A%=RO zQGQStslG31+Bu@X;vE41YwQ!=tAaq{&NqC}|=mK|!@9nLba1|b8ghMs3>Lft?1bj=)^ve$4lgjJkc{22343j5|**9Yv+^brSd zXM0<ly8I8{tp&5XARY@$_|ph%}I!i zuP*FBSo-9^744!WrGV4q)bt!=U$<+=4@K?1Qs?#~`nU2CEts@rsw~HD2d2>Y5*70Q{QsT+mlnwnX&tf+atyU~vet>+9{q9j%`4X|^6h=eU-$DmP&m=>hNJkB z&0DJLxW&sSeOn=EZ}$wI?K3$p+}#=HZ(1Z{~c^>?9(LrzhAnw_K#H!J5@$^n4gS zY;VDJ^!47P7SQ%@gOX&EkSWz^+aGP9asTB}!d~b9{BUxM!@MMrGMs^q-=Ve2F`D4> zr~B|Iq9S-}gUiF&{$9kHVx!l==lX59|6M``bO z$P0Ji@6sytn=>fBvvucS5HY#nBK4bXK?p(TJI06C0RD$Gleny~x|uxt#>4Qp)#_>3 zr;28&s&0mrsPkw;7rZdWA=oHE^9m=%|bhkK>6-xcv;f*a9T%Y>)n5sud- zg)h43zb{6~hl6C>rZ|aNNYbq1481>Rs59j?;GFOf<-5ly*|%)aB7Gk${0@6xZZ`P3 zgz#H8Zxd;XIC&cZP%K|7uN0Nw9!{kRjo#qh0k0s7KIaKb_TCgjYu#LkC)Z$d4lKV5 zjISn3E83AmQTbS2c7ycy(uS4$rq%#K*50xl@lt#>bPe;sLpmkL!-L_=hT3*A#aKiv z!Hw<-PjqNL9~-7u{xyaY%QzDlxndAaiYBh?>BVl}L$*F3>sl(xY#A;d1U$9z`=-3g z@Kr3DgyQeif_3f9)`5Y^BCQY}wl(ULeb9QaGu%i@F9>>qbY=X3K0`z5e4~(XPjFm9rEDI>%K*Cl|)4*wkjn3C>X-oXbM=cY9O z-Si#v-8JY?!a`5c3zWWXa$j&znjs874?KZ5YQ4<@!fc}sMUT?vtJ-O{@#c4`e_P$5 z1q=xJ0vnr$hUX!ws?EdGbD-udknwz10{o|WSMZpT6ZNh`pRu=oOm%6HpLhwdcBDXv zzVi(0_^lFqww?L-^AVbTN6*$}`IBlN;}Xdg-Kh=bRVGeIyiXLdQI@u3m^O~smQNk+ zT$gwuew;FTP#*NyMLJwkyw-q}@-J*_qg{Is4M!Z5xE=7`G)47)8Wb$o{? zvo~uI=&6)M%t&T;5f%W*#m5EML~=bwVnqt9j8q6UqO7{xsy;?L*ZhSuQvKwE*pMG0 z{zs=&?02u&;QM>)eg)!zgx%;sVCj`6!}tb-J}y0L!PFPN1RO_uE<>Qd9)XbnV$@JVHuXy!} z?uX5vL$(aR8AM^nTfUT+(v_FjyC>Ea@O8mV6$3i|b91g+eOiPBk$@t6r-1gOR09^p zNu92e&x37jq@XgsP<4itXK6XR!K-P%{8{mC3S$?L+m72tX0#GAyMFev+x~+NEs3p0 zZ7S6oo_K_q`3vmW+4El3*ypZvhEkYieWMAe$PHrYk)1(;zwm*PCEQ-?4(XE?&;A!M zNBVPwa8&wU;IcLPG=m~r!acf?p27gom_5lx-xneIs0_qx>VnswxaPSW6GNWJEIBm8 zmlC2;;UKA3n!0@mfzbu1PQ5_aZ5NH*t+{gHrEfy2(|(ZNNf4acwc48L>66Pa*4$%f zx^Y8aZ5Mri;_8!No_K56Ki1U9q2;=D&CQP4XvEI(+nfvezYsiRy|JyAeR&m{pcrI~ z{aQQsu_P%i^zPwI-pa|obCnk1PG2HIEUhPd&ehpsH))0ag$}5^8RcsIqGVF!=Q!N$ z%0YkkfF2ESw1Rf(8k=gLurfRt_00g`cITj@Eo3fpqSZiB3GfG4aAis!kEz0T&EYpCXYK3V@ zD?wAz8`X*{${dKa({oJIGcBCl?NgfI$Hn{%Ss9TT-I~AQ#(i>q!M96)`K_$TmSD&n5q|I+&i~xhx43ghy2U*{F|Jm_P_V%E=Z1co9Xi|&Q*^$QAbVo8g!R6!e#x-Z%m`49bO>Awdbj5B z1a|?ijL?3m{LQf0$1SKOF0rqiVrydpV0R!MNB)LX7kNV12}9u3e`JQUq4k+E9zq$ilShskY zmwooS@<#=bR7qt){+jmlxr(kD9L6LqI|euqo7ov}^+`)->sL95@S{U9JP8BA_*%pA7ch2X&FA0? zvo+2_9p%x-C}9a{anJnth2CIG?Pkn=DSrd%pPVmVl^pw&IQ`Py(OFq)W9! zs+g&`XtyGM`>-$OdyWow4v<1<0)Nj!z#AoCXg~|vIlgM97| zVQ%@>Zj%py6;T_hN&UU=u0d~3Hx2#!JhoPmsua}-EuZXi_Se(>8WI-MldER^3%X*} zwTPW51Z#k_XX?LkhDQ%6JMrf5mDIUcqr8d1i9PypvGJi-1ss=(Y99G@;Ww(V1Oqy~v60XFf@sj&~A*r9z+eX^#M}bOGMz4LsYA?^Uj6_#ZhDK70{CUIe z2-vi1BY3nfgw}{Fh}Q(^yRJtyqL5p!tq+d8ZW>!ciL*79g$m+gZ+aW)u{IqgstLIW zEdlm}=d;!J5Ka4MvBHun(~ndxa_+xE{<=4LQK?9{Cy5qZaMVwZ)}+M7clc;US;i40 zoLi|az!!t>4}Xh_;y#XO+AV823(hGoCd);~tZl=vDJxy2Mbs=dTT}y6J6gygKdtK0 z*T7$cfWniZbJBD#&BCQRO&lXWd2ULxHni3Mejxu+gM&E7rKCP1!Ce&sNd0+Z$SQ={p@um1hC8hRoeN>&&T_>7Z z|0Y~2IuaXyh}X7z%9El3(1yzEs4+K6ty%LSwP1^zCeF&qOH!k7?nr@jz0xrf_v){Z8{7*Bkeon&e2MCG>vU7XG2JKc1d4>8Wd4nv&ve?&$2lVhlB7V&GA z>D?Qv$0hmjmZwRLlg=cJCG8;T?G;8rU9bXz8(W@%tjlw9&28WQ5wc_S>WPri<0oRt zf3~mc?H)U>2r^U#8Hc&pg#d5D&&S=_BP-mVlQTK1hmNYb*=DE{9pf7D<55`1BgZ|p zu!UDX_%G!>O-`eitLs9`NEH2x$wS(KQT1u^k12K4H_jc zZ~6PPDyC%x_cuGlqjb%Vg5Z!(hVDPwvkP?(5Per%_zz|p>}sIT^P{HsI<=#pi@Yu` zWPo{^kyQ&TV=V+Q+oP9MbIHT>YwyZwz1XNrD%Jx6+JBAWjph@On`G(8u141C;~zjI(e z92-?N(l*&0#K0bprRMDj1XI8{Oiui~!E@qn=7{_^%rl7kNdZQzOy8&8<;XP65g5ab z`TEJi&z_ZTQCG`U*m(c}<0KN0;|i-NXQiVT56}0+pr>FH^nP+OsA~OxHrt$px}u!3 zvNxKEt8#N>@YeB>qUeOpQ^Fk%bK$V3$Vu7dJBwc*zxrh|*RHko={*sT! zypEpVm>?-u7tWv883jdFy5slTj$?{YiDb2u7CE98(PPn53q`s1lRkMzewe_h<64TN zdw^M+A>$B{NjUq(5XzaQV3C`?vv|MN9}Z0IY#_}+hCx*uZI^*GYSs~i!@o}O@Yl>m z&fn8VExB=`EAXgTx*6bjgO22&Pt?wVnwzAB1fo1&cPf7f8HF}{H;QesV8ZHUexy!s z9+(uFQRAHv-;$S71c`Ri2vYduc)_BjhM##C5OrfAb4ajxnHa8qlK7z*<56roX+ofQ zYF1LN8cA&OF<~nIH$ZkikVo5{rkRzAqy=%~gLxgjg<#8KBDTujnZKc(*;`RJ56=if ze%(8g_tg)fHuQzGHpcZjHDByvzXNaefQ+yF@Cj%J2w8fnR)v#w19Ul1cEPA}nK-Ta z9idYF+PFNbReKU-GuS`kmd9LAcJiX}i_I6Eo6`pz0w zd)Q$(yn_D#3E9$x!U@*~Ta-tXkx1d0rJOj~4LepE7~p_FKSVb~;SX^!@};JOIgzD7 zfVm}QdwEJeQg3RFP8*s?Hf%JGkIT7k3YE(of;zNq6EFg8EHC&XzVDM=Q_L9;gh->7 zuEQ+5siR>`f{>Z4lB%lTK_cCO!RaQQgv;iO*BA{LX+^fqIzM?ZX-du`Zu!t__m|bd zr0CUe7AVmD>bF3-T?&&E0?JFaN=hq z6~$N*`vg^Bs>QZ9*1k)~cFaDK48`5G5^&g&UI0Q~#XY(_W4MQ{Z}p#!{|{#T2X3^y zxk(;+2oYdc0F>mns0RbMsF=ifTQ6t-ou@lsJ*g( zn0x|NGLo`cU_B!7fl{AWn=(*r+$#@@&hi&}X!_9tFk&%I@h+r3hcM zI{`-*9gh)0V^y0r@+1v$H^iFxs!0OB)SE43HQh?*I#!`y3-=|krR^xohan-@IZ~Sc zQSMOW=<;iMwv%H$K!|y#JA5?rv|UQ^>Si{olNuDp_(Vv?w$D;JUxf09_w@953)4f` zQI;bpLZu*wkfFMbUHryftAND;f7o`3Kh13UM!q+5j`2JLk7fKeSqt$gu6j{|45;sK zcAO`}-jbNw_yW#CV;kkDrxcWaR0A`2#R+hwKiGu znxKimf%U^Vm(h$q7FTYpedW ztQ^p5d@OD;mlPID_a#SOBT^?M-wCA15u51Mvt6H0LUo_qJ~oWZT(3i@LNM(luAqhz z|0zp-)^3i@7P=*rIbUCEX-nJ1VTyEy%V|*2PpGfJ^Fq_L(Of#7CBNUx%jX8G{t~XU zhbTwc@GNm1mR}k-uIaA4=m&4czY5w+)+YH=oT!9Q4Rg6|`ez$#OOS@*7~Wg+afo7$ zM$O~Bg*7iUftdw@iR6PaMi?onY8gD_94$56vPiyohLkW-sky8efA*QFc{Rnh$ZmWfJ@>AI|QVEKDVJA@~t8GKIUV$lU3yJfull+>oG}lbE^D8GPWrjG!;dZe6%uj z9OiQyEstwgi|$P(Sw35zmY>bXFU+zwAB0#1E_6Tev$SReRez+~Ma1Zfvk_}m@AN|W zPoBm*zs(7MMvK1AD6@(D%gE0PE3E}!)zb`($`K;1*c^ly`sZYJkyW3OK%R>V{-IaZf*n_WqOvNy544|tzej?d$dPFsE0Y9ZUd<7?ZT zd}eSBuyMhz(?6y^_>pg>%Kr0Y?Cxr}i%pC4ZLO@kuQZNONf1xE-%H)NT9P;A&q)qW zX61l%?trfgQg$oC9WuwVmUm?Ca_&8k3qKWIUV1ve@KqugWaSoi=_3 zokRVgbArg(hj&e8A`*77bB;ud;9Jz)OoLSUxPjiV2mHKIc1Vm_9d~Xb*Qvf=eouwn zrTlYg-plk{Kx7o!#QH=;re>jGrJFk(;oi*2vkfY-pu^4O*WpX@dn>ax+Tf$8ZS^$% z-J#A6&T@;Tqi><^lt=lh*Ym|a?_SN-6Z-y*L`}=BSxJ3i@sl2;h!Ut~b94pJ)#@FM z&9VRCgQa^0ZjKmosJ4V9Ow%cp+sAen=jOR+&iuDT2d>R`=|6ax@3S0>D#!4x)6sbr z)vRThZ&^(J>=1V;S9bJ4`%2M+nD~mVV{-g=vg1HPP(w&NvxYL}U36ALeS&1eTpQJG zy@#T2b}k&MWyi%zJu3RLls*u`7;;PCIA?HU(=LSAH=`$jv043wsHzCN{3CEPX$r8i znp%y%0Vi@27wZzLFM!51SscwYWyX&nS08Mz5ZdC-mTH@>e?YYG3JRj<&c1iD^a5v<5wq_)Ll^O-!GUCXv~BNG)Pki~h=kG@1L9U!vpB zV$8|#^e4`Gpja!F6c>6~cfJAXLMhtJ5)+~OxSn%o3Mr>3qq4jZX8JEXK@qrkFYdRcxbs|_DnzFY-EV;&|#i#R{~l<-dMNn^ql6e zdD+V1%Q>f79ER^Lw}XJ+2>X_Q)H%0TqOY#6?9YuxVD_ar?_a;Nb^o}3S^m(9>)Kp0 zyi>Ma-Kc>lII(PR_<%F((CMX`ukos6<5YUL$r}&OsK;mHDIivP-8e6bYab7gQeFv( z8A5j6cG;sojf9l?ANntMG3uQjZ@TM4Jn3|G@DAsSMhgLo=cB`imotq)jO+pcRfY_A+RLY_J;{$2`{bKMsm*2@ zsA5N7!`e=KOXHOMSjET(-KQNBe+nPScRWCba8JjwJF+0Q#j+=yiTR2A!pe}-W4Eg8 zNT-7S^o6ICDg$M~Yo@+j;Xb|b;*slo#Smt$;j={fS3Ap74WAe!U;zHKoV`ygVlsK>Vb;TfCj+vxawjr?;$V&=ca*AX}Ze z1K_H6aI$c5(~07qoFSFF@d*$pVvfDO(3_Uu#YyS`(lAZG<{>4AXKME9J4KLjLpj=& z(1xlOSBYlRyF|T_=%v{bU7p;vWA^>mJYT~{;b_3;XHMW-elAxWr{(k1%!EJ+mgD^+ zR37dp#Of_KF=zhZ4l7&y$Ee?uL;--*ta6tl;m?-lTiQnSL7jRmlOwE=@+~ic=)VQQ zMdCqY4LeeUX_~m%0$J+!{5|aHGVEktf0b>?_d@^r$ANKOFOmC)^Ke7oufzt(ob{@y z|IOk1tZI!(iCKE zd$N5yWJSdEg?Bw+jx0_*m9)<#*+|Mco`SNKj@~{WrKz4_b8e0KA6mNk4_4?Q5cHmt zK(23h!`|**6nIp#zxu&a8Eobe^n3NhU|f~?M7qE^R$u$^HC1rCwM?{0Kr`?6@v5pn z*9jpu%Fj|ixs~O@Z71haN)ZZKcM$l}Io$^$=ZO&(M65Vg5wFe|8&QUu4a=m3%_I0e z0-Dw|lrMXPFfZEx8J^bW`xr6r1|h3#55&DCubv57{wq0<#A5F32E8G*&nn{h)^dAP za_+@SXshFA{Uq#yEq|Cl{>fsGu&q!+sDj2k$nNR#)hV&tX1q@qB@wuV=Fv^%bY@7p zbBe-;dXYUn@(@VLXR}9>{oCr~W-O_KvKqcc(Ez%__*uS#@-vz}u88}j7+TF(>irNz{hg}0-&#}AJNnT$n!!m)d_yPH}(NVb0jEpjFl@efoJ1b%XznHH0-W63lh>G zMEXaobo&fw&ue^YjkOCcX!f-){~4_jGh1WPM~t~j{2_g#E>viR@_)f79JC~Dj#8K= zaZHtbP+`^Q6oGv}FcGfU(!4yHQ__;3kI`DUp9Ua~Ce%kxv3Gl?1SQQQS zKa1-Sy7o1$)f&qR{Y>8}HGc-v1X!%O6?G)M>7gOqlPu_pJ=TXjFTL;Q1Nm_hMuXh* zcaWnslW~M6MELP0+ITP5mn9V0!xTE4;jz5C3p*6FG|CcpVty>IR6@pL9+27kraMi? z-vZ0lObshz10INuq@$f=85C|H7tDLC`Ld{-q1BH-m>4}(PfZZCdU~A8f-^p|JUYNF zNV{j_tgrUt6rm;x`9{X%TysFu$CXGi)=bva;VrvUMX$tRm5`q*&tkHReMiVrP@gqe zmLN3XTu@OMzTn_t**BCcv|M7n*=kBuw0W|VvbO+tdhJYf&z@I6UY6k>P}Su36}oGV zr{p;$hS4kq=1OZ@Mun3robWFRiYrTT%dR1Tt}zE0&XsU-$Nsg@@*FqZll=%meo^1I z>5ZXJTHlSWW;pS3dD26{#v^XAk{8Aiqsq5^1?GN|k`URWFE8hXjKIjhK=l}8el45+ z)?++6sY?A#U*S_40p3>Qn?h`<88C2G@^myPehL3zyXu$}3l zhnGIh`#VJ|k}e7S?>_7{bPnT;pR_%NnxFl2(j|TM?yFzPI;;%T)coOn3AzSw9eL%L zuJwn@oCwtU%h8x29O_DTQr_$Nu&u?=cc4eQk#$XX_+2c6Ju?BaKda$nhN=P5=sP-t zIsn2Yh6M;%tQq9{Uy7;_7m_hUHqpQ!?S^i&)Cr5pIQ&2(2{z<4p$g>uNs`e zhn**E1Tl<81$}z)RP=_(=lR!Lu)j9*{}|dIvVYj04WHPN zzi}-@e2_e(njF5Nd`$fD9@a?N)Fo+HEy4a>emd`q*BockS2Cu_eX+2G7Qe|gTkE-Q zw_3pWJtTgb>DB+0c8L542orT_eE^xE=0jI2guoxm7l=gv@`bLB3Txc_u)QxWzrkZ! zgj`#47|rdNKMD7$g0zmb_9EHki;6+ZKPtu}E7jR+1IXp>>1-8i?U(u$LgYWO{ERdd zn7EI^`fpLV+p%|h7$UcbvzC`h$S)@gKc$I3Oi$Us@myI>Xt20|xKccCRvl4hy za~lKHPbXGDH*$1?9x@~w`G=t`W8%b4Z#J|o?~PcV8^l#ZaS{%B>Z=U+oGh;6UG|)SznBKWnJ-3LLLI259%mSGJl%o+r3Fh z{_Pw1XSRuL&8GZ``7Ui+&Wp>x2m<(;2>Tclwsz%`T;ME_eh}Y9>BjcSzL3Lb*??^| zW2I5=8E05~*+omml6|%ZQvQzVqO3(5N_9wmQU~unu<^8-QXu^bd;V{Y9M2>`aT@QT z-EBM08ho4M0J{{s)a7&Ws(SU0A8x*ZUw%#QV@+3zSJ>QpE}z>SC;CqFN^1J$=OM&2 z`(!1>&GrpBem7Tc>QH`Tz4l$jkM~@G;C2fx;TO6m7vNEh4K|>PYKFkSk%9}^UOhKE zDtW?51?q2sbw`Nos#gAJG3{5F1Qa@kq__whx-B5|&j?8Pm%a`U%hUgh*y_#hGp7rv zOiD3k@N{3m%C!pl`Y#y2GB_{te0oj?3^>&o^cv+2_ZtHbSP17{W`v4CRz%JP6nt^* z7kOK`(qh1w@qHScg-%B%Fp#n^M^*3fb&8h8Ik2|UlSaboJu~??8M&SD^O*Rj%#;W0 ztc$FA$nud#GYc8ZkAYcQW*`So=hHf>oT5fmMvYsPB)5iNV}PD{O{C3tBjve0HPqcs zcGH-dQVvV$m()IWvP#dQ?&p-xw)>Hn_vv`9}}lK9;xE z+4e9z$ud}@{SvTF4!+v@F;gqKVFRmE`nn6S8);FTMPjC{jvAlOSRQ&9mD)0cFb7NK7bmt)@X@Gl#1# z4Znt%t%NJ)ikQ1}-*4K}<3!|}3VVlPVHN(5_d}??^Z*923Nu&3i(+gtjx20TR(zZD zwE_iEXFKFG42M5xBX^=I>n(FkPy8y7Lm{}^k_ZjFb>ECn!onfgC54C$#CE}m-lM*$ z0^{)X+5JPlpP6nEMXb-WM@O`-8kN}6B+g5#idNTn&7r)Qn7Cl_L3cQYI>|qr+!xo( z+7{~4&WgCY!P9gVg4Phx-kk)`RntBCoH4qZ7W>K^8v674IF`4=5N^i9P{rx#LPzvI)DS7atp z_4I*&8J2iJ_gO{+<6=SbP-qxnN;YL6-TTNfJ^Cw(wSeHwY_(VP-p zam>>MS{!xN@vbv#_9TM47$)2{?$lM2sCk5iQzFda%hCIZUC70BV)XZHm7zOQJSz7O zf$x+Jcr-Szw$l+uZ>^Cws&mX>^n~i$W$EP)RPXEQn(AF0|3u&Y`QkhqA**h`wS0}R z-{)B`rzcAjW^oGA4cCEwH|bBvUI%s_R=%YVj!ak8S>lo<*VY6Lmbdbt0TEAj#ezpG zPoUW0x0Ow?DgHUyhOs3xype&en%>KFKvd%qhVfY`8!G1H{@}1N)cK3)gk@^&L0QE& zdqAJwx1Sco0O9!Wbrme7OKA>8i89*H!@zYUq3BKkjsFuNOod+Gt|c@C`WRI8K;@I= z&MJw6pX~~#uFiu*J=7upwVs~DS`O~22Y144lZN=$C>e$jfjw+}s@&QUk9IyaB~=q1 zte9A4EVI4L-96NE&wPaYB%5bH6wCgJ3W-yfRyCr-2ddI@05Fw`Y0XO$fZ3J>4@+K^ z&+XAbe1~6-c=ls1IQ%mAT&u*($p8DJEi9wQH0)iL87q7y4M}v@>vCR;2r8tm4A;ll zftMH+ zy6+w;HIwjd^Ne<;q-hhQ&wz=feov=*7_FeWF_(~QH3j`Y%&gq`wCXl*6c97+0Gs`%Ru zN~Qg6{-leFzRY-nX$A}k2t&Kqcjj`-dmR>b&t{$l@cnyju+{T_3MG8pob5uBrlc}{ z!fgXvp{|dCUz9P-DT8M@UV8`4Wk;=+I`#%GH0L<2=@kblsel85E4_;w^aGkaE;6b) z&fB~azAWxJ4L9CflO}z+d$IXN;4&w~3Un2M;Pl%iME;G1ej%>T#~v2EgfTUpkOIuZ zG&V{jeaH1rYw(unev94RdvsYJ8e-HMpM>ub9q=-;Jjk*drk*VIGs{oubIB0AcKGC{ zOMf)jY#h?zE;Ww4-Pb@lwRUWL{loxmEKvc#eS1qH<0C$jTiLK z8V~QpogCkNqX8A>T{Rfu*0uAC$JHIHv3Eiq)kWtbPusQ_-ks_Z@5xMzz-BZ!+N7=_ z0u*(w$yG*OM5_7AI-KhIWxsvYl+T35AHH{$4@}~%{{TeFU+IrJ$9T1kVnQC3HESSB zWC}?rt;M*aU;4#&rod+xJOR!wff#WUB)HH7s<{U?KFKg-T-DtpSn`bs-1i4HBDnN9y@}={qA> zuuoo$T3blfGl8qFI@KXUrE{f7-vrjy#9Kx#%PYl2ymb*Zh25$S}zvML+-= zbO|yRj~hs4no|!Rj)Z?EBYvgM`q6q_9bYri5111Wj6YdXKwK=EK?>3qu(*9yV6u&nq-8VPY}X>o4>Towi{X~Y+8(5YDdqRZF77Tm2 z{Roj>*?u@fP#U**L3#JCVcC|{9`t*v7XTD*``9a-C9oe}3Tb*B?61X4O641NR~hlh z1pGqb$cKa*=$pKYf%+*>xqDKRn2Bs#s_FxNNcRUMps%J^^5|I(!xh&?C$kxwQKh4p z8&EZTKUu)*licHG3)LC{nR?LfpwASfj2iLF3XHDXwM>@k$iJv3o!JF-E7XDYkpIxD ze-2Qr@>7KOdPf$0Q^^gc+D&2rJ#s!uI3S&|`|b4N%p@+U0JAq5($f zocWub7U#ElYBDf~;XgSwC)h<~>au#pNuuk%eVx8rPEe;N?S$wpZ*=`DwF9a&8>%)i zGuDSqq@c+?CfmpcQ~wYtwpVxbJ#@&O?;?SjQS3b;Su|wnBi4O?4Jf$R$QndL9Zue8 z7}0~>v^PgapMMyfB+;UyK4pQ#ki32!ou8twu&&gkc7@$N zjEq{k8N}&jC@7}~BjP^awm?$0no^tmn}6ym?{RW8Jd7)G2v`v*{=PUd zcJ|@tpLwk2q0^To6l#|PoD3rXx#tAd;qb|$p>Uoj&O1Yd8;rQ*7Hb=8O z5c3&C%-&}{X_7I1cQU2uOlQ%e>MW|}I6D{I zA=?77^;wx42!Mk01xr!W^sIojNWvHz?QVyRtb^&;*lX0AX-Oll=SdOG$QDnfN9Rmh z-Loy-f-c#})j^;q85$O@6M|eTR8W-JW-msIqZiziqhn2;-3@i^Q>rNo+kbxL6EIcP z#g6OGhsO4j7G6`iEfrxahAlOtagcfCq#LAk&}K9w;f8&}{OF{j`M=ygMc6_f?w&+z zn6%|pLbmLHzN%~bf^?^~_n2)NL?CNchkXCDfj<2$PSSOy8VDEgIL_|e#+fKjN~j05 zI!$~()Nuni=#CIS-T1G9kaQMXX>gUht( zo1-T#{Myb3TysK6N(r{Qj@mYxu}ih@pp6D>P7CLq8@x0bw=XI3eS36us~{15dgi{_ z3;P@_GD)#LSs0NA;b|NJgkw9M)8-{FwVnHtyvydCxEH^kc9iida#yafv#JPp^XUH~ zg7z?L9LZlxfsNvZ$T!ew=n03>5*%PNBD5S=le~H_wePI@)YxQBZhW4vFzcn@tn$U> zwe6%Ap|7*sx}S>A8quO9t&P-B;zxDGCKi zdh4#Z%lZmc30n!1zO=qiuO&=$w=N;DQiP1@AEgv3UDn4(HWI%gm$UssAd||5c4TB+ zc7q&=QvNPTVjNjel~Nwot!>}Q*b`+OOPj-Cg}oJ8wE-(8wpT|zEH%!Z75?odf`?0q zgw>qytrMHu1QrsiWhPUnGy|S?hnrv@W$Ta`!-V^WI zfd3FH4EXrYf+){*K@9q(E;S9Y)M>ESS$<1*5CjwZX+@-xK>Kp=>JOV5>YFyav?+{P zdoN9UKi%ia6Mc527CMMBiItJIuMKOC<;-vOuhZV%pAB>GZ;H6$2EM;&JVi80p#Rj=S(>oz6wdz|5~U(9F->$_v|suFc~FN~ zQ3w4{57E|MvG6L%JP>X?(soF;Nwy&Yx;`$%$$Dr*r#aZ4S5J*P29G_C8G(w*e&pT2F- z8!ZeQw;=|es*r+r2TuE!ln%|8>vnw$N&V(yoPpB(_?(lQGSJ3Oz5%y75CGU8Z~P*2 z?P(2$Y||AH6*%7e5FXiVFz+SFl+f>bf9UbHtOO(pRavL8&vXr=q^ch?9fp`v z;?~!rj+NO+N=357kliMIi%LuRlZa}CN8IHGZ-`}P3(I5JDSN(#_%7)~FOL?fYS;ao zOYF)QHh!!m8)D`in1RLJh(lyPr>J&(c!hXy~jfPcblXW#2z_>!j|!F>J%3vsP~ z>!XUwd8z(qmT%COk_NqJ;}hp2B^~vLrn|}J=&nzGTYO`w7lOY43go_oy1>*zU+3u7 zzbPEw8``KLzYoe`bxwfNKu`<36cjp8>dZVEC3diK2T#t_qr2$!O#=VQprN?L=HWpg z=AFrqcWq$L5#M9z=4?`8M)pUF5~K(M0hE$6G14ta{Lp*-3EaN60D^mH7JpZ^(CpAC z&P<9}6KHf3bo24~Kk+7=#_CG7)YO(~*Iyp)>LNfAaKa&L^{M%v(bs05g=OgHJ#$rt zyp^UAeWS;v<_57bI?i}s=FAP*x2XWPrvHX1-?PwFB#%7*W%)Pb-1BL*0NUsp zmcEl|iU&_7yh~9K=JNlF<+c6SPHnRpHg*ZiUuyfG@Gt&uzWO5N?KU0HJfpJRQ>yrJ z`XdNAYu2btPE33e1U0QI5`zgrYBd^yu+7R2dH(j33`sBrn$G4e1P!v$^Ib}rN@l=sAwg$(6Ar`xU@mvhjG@yEz=|Me<~D(%VAN+p)VG%SYEq+PZbKQaD>Lf-~cu#rP9{>Tl=Y#G$8pvB4o}hhf1-!hsgxqPbm}eiD?AJk7YZaY~2Y#(HB|JvCOmw5eSMufU2j zaGrP!+vXm93(@FDqEiWtKW`XcS5$I+(V&j8Povh9SJO6ywcLh0P5%Q1VnqmC^;!oS z9mv&BlArioB3qd(G^kkceYyDX%JY+Pj1vvsHRS(;biP*o`}L<+PXbHDS$g>i$HHB^ zQu9)GDu*3>ZPJ%4727`pxOo_%-(tQ3*%zdl992oq|1W?U8!_F=`-8APzc1i4Z&+`F zb$40fqf_V0WSGG*4=}TSwC_E5O3^u-zo&QJtHh+}MNBdxq1!|j+_9h8A}Ev+DYqv3 zJd_-iNEe7HkOF!{+`rD$#E9*FUDjR}8N<=ncDtD!32Mvl%^1Vmo9$DS9yYDocr3lk z97lZ1@A?m=m2`NU?uu$qz{|amDBMP%_^TX9U#g zyy-LB{joBJgB?A5c&mlSjc%H~gr}ntAL8t>i~m^IG2=vdN2_Z~+&I0XD*Ao>%{4Ew z#VEbrbMGiv$zR~-=$kOP-vpnYEF}eJjHlM2b}iWNz@WYuqLwg=xw*k_&I_Zg3l?j~ogxEm2RnS<=|=`$tKaZ^vZ0L9r>8B41Vga5s1)DfG=I;#z6A2sx z2@}Q?!YX;w2l-*qTAL4?K{Z)Ais+8D?lg3iTd^K?X7B<1fsNlAQcWC(ve0s!OP}ie ze*J2NWE7J$m0v7oNsc@%swe8yz4mFE!QBnLASJr%cWldnT$(uw4Ow}EU1w2H;w2@(UFZu%WWD4-lq)T9!86K-#C7RFHt zqmuvHwY!a~&3u~?Q6VZXQrQ#V)3v|VB9=J}6DuhSgt{Fh9zO9#u^{#?`;i6bZ9mO* zF1@a9SspSh8c4O$`vY-RCqX0JB>ZrNHTxUOTZg*VV>%w#TF0MRZER^!G1xHJpvf1b zWXnA>$&?~INKArnXJs2Ru$VzGXOpCMeT4QkE1G~ zxr1bkec;^PQSgt>S7BFVdtoL&o_~@J&$?Uv3=ee(DcLQd%{$wJ@`^_U;v0!_{_`Kx zxxj7GYp!pht;M*B+`JqQ*{|oQMM-+TloFaH!QbkDTySpwFWpUenEK3-G z@|iuTkG)qfh&StS>3=~s`uDkUNU8*!MIoB z>_h{?Gl#yN_mn#fe2>Ka7aC65SBo1*RN0`v_k^bia))cL4u{7jZ@*n?@kWh?ei#S| zYS)=%Z-Y&{+opm(ZTegU$Nsbt1Lu=$LK)qj7pg8k?paHH$*M#4nS(oD;$6fT#X{ZAc2#d6^N?;GLWDA1i{} zKBs5}xltIxg~*vYVrea%V*Ymz=Mh6Dq^a5lSj;C^`bfqMCMIy$W!-fsBEW<+}RUJrRSm^v9;qyXH^VCp-?0vW? z=4-iNKBr^{RIMsnM9Y4yv4-CrjPjt^z8wz7*jENyn({e(D=PX@zTJ`ZY3^z&R)xXHu#$#?)j#MJP*LicNBmTs0%V=xU^0B5dxPykPmR4BivkX zEy3S)Q9R|P^{*-N)l6xJY+lLwUQ1VoS7yv;cqn8P#fCnnhQGDj|L^mTeI6%G{4Z9H zN|V{QD5|&B9{$nizs)B3YMT@7sR~gQf8So`L4(CJAZfkT*dr2oVC5F%R!v9J4gUU< zi5X3?YaOtL(Z{Hq8{DaN+9${rX=TVRUT*ac^vDBcAin z?uh4Q-gY^KG?QWtznJZ3B{{|PUz1Y(qHmiR`%Qx`+BM_hKW*cIfpYWZq+wc%^-b6j3e zR`7X5doi%t|ABEfOopAQasxr9hmo6(yO%N<>7fy8x#6LWQvw8dzItzEX()`7;*zh)bB!4v8=6s}R^yfC<@By0QPo z;L%2H+>GEc7p*;y`b3JPCD&ET@uP$bz}RN83p37ty#z; z5e&=rr=Fetv)6Hd5m8=K)i*Z2E?iDB)!}sGBxfO4>B&AZcN}0?(GKgtrQGP%`>tmD z3hU=M5QH@{EKK4OX$1Dby(0wy_e?=@ZBIKv!RV>&$f4vfy#l7;FnKX8G^Np|T9w-3 z5kW2O(dG?&QAVU7rwHa>ooR&?!l{ZV?0QCmmufs|bJJdBA*$%i2SLeajtl6lsT{9R zQZHU*+m;f6ogQ~V!Mt$SQjL;3!U9>caLrAif*-R{on9u{<4`3}d|0J?H=O`tR;gBJ zNI*E{mA1lL8hKNtvLROd!KJ*(a+z2;8SODqFE}~FsENXrjg)}J7h+p8amOQ!pk=v; z*gBX=a2-xRcEsd0=fZn5@}hd>UV^nVHNBm5zhm6=HnG7<*+y8bM=;NNbMH&Vg#EhP%K!GLGGB%0 z?FY{;PwX87kK+oPp&NC7L^k8*ol6OIdk!;&h&b~AHeC}7rxb7^$FLxYzyGrD|$|%)P zHDdWzxMr=G?^=H74n)5yX^t0u70&po{X6i=#_a%N@9X+j0&MwO{`8g4Z~IiOi<7Wn zwlcl5V!_w=kutS-;m94$_*K+TM8_}f>oGS64?zelQ?+2ouIb-+Lyai6T{GKqf+6_= z9mCqJqHq*H(=K$eU(YG7jmT$Oh>ur&U1|H8gp|Ap2e=aLRQw$lH7Mrimv+XAM`UR! zmg@Y9hL8v8(l&slNePhA?QNk-Z}QH1Wz3u!F?X7VV`$xnD}GtcseS%kL!gR4Z4zR7 z5HV>}dtv&SpIpFs1Ij4*LBBNZ5*gz%Ir5&2R_0ShKk6q-ji1dJNpav!1!STs_i2pt z%RJ_DM#r}FB6$@%3CM|v0v+=^E?u#Se=s+NPv6irc}B~^T1I?;EZHh|J$Co1r~}vu z@TXKevJd;$*?orunX&y1Mvs5A3;Xfey06zGrl0aG8!p>}nN|Mx)T}VsG+TV!YDsEz z$r1@sXxgB0Ao5p=1_^QfK*)`vUe89lv71HJrCb3d< zmSEIWCH`aj57_*Kcr;w<%u$%~H+@;M`xgXvm$J2@Im47V&U6UMPjO${#B`;T($ZGV zx9q{Y${-D`l(l)7E%QNO-7;Y{c=>rcV ziI;I-kbjMD{5js;xwR_2pnhaK5|~P_vhhPuk&BP4Vs{K%6h{WAKIWRVPsCp ztj4QLI2@er;tlS6=BVIFoUk5fS4m7);+|&9q?0r+*G;3SE=S#gNu3(%UXArEk~DNM z%diGVWloIAE|EQP*W}vsIgru(Okj|3@+t7qa=Ol*Jjfo5S!FJ+=v*ZD|^H)QV?qFy$3P`tm`&t5i1UNGZlV?vnKL)O&~L>1}?N>=I! zT;?X&B11l%`sx!){95G0c@&2Yy;}n9m&QmpInLC#4?FSx z0CCzITZWjmKI`oFj!|`{M?8u-z{n|EX*xOU->G!Y*_7+oD%8P^pht+8%gm5H}! zG4U^>R@#=|davLoTB7;4$s08uvIIb-^Hab^Kr5x1gdvU}u&PUhX}c_b&9=y$RuAmx zs;-aKOBkkCWi|({99W%ti9F4kDlsQfGYB&^!Fuj$L!RdYm^&be2Z1hES+PwljbgxQ9+p08tbLI#Ie7X?aZv2O*G-^oHfr!SEli8zL8(gLl}rxzB7#%Ers#^iw*Ss7LL! zLscT3lE1Lxo(nz z;34kag88cKZb@qCPVbzB?(nGY79pUVt2y#G&`>^*y79QEAi(Q6pqjUR1X zR!S(#FK&~6#^?mztPCIwor&BJj@Js{1*eW?!21GnZAt6KXkb-n{=0bV4%J2Ajm^{c zT&RO}WGSrq$HujzwW0zw@hPnW1nm~%JtNz4dMB6vXegbqIhoesxinOywyg^0qqneT zY+=nhQWrdW=&ohbl;v!&*Z7{%_0BWU)b0@IiiB=Cu~7Eo)#!n>bQTD;)hm^*N`t^@ zDx=&x*ZrnlcEEHfR`{5Q3)k`<_%=S1!JlwDRR;`>oqD(E<39*_nh-8rwmu)yFTbm?7^Iq9WYN5RGgBH?KL1H4XEY&%7L08$ z3(hMEm-_EV+)cB!BZd(svu+pFk3j7v<1+BS4?wNzC%-zyE6r7v_3K!-5ZGMSVAZG} zIYdJTXI_w<&QB|7vc318yrMs^t>w29Zmx@8nlaB>>8U;mrXD`)jNJcKUVQU zl!3-4nvcgV8!f*QjpvXsZvwDO%crP$c6UQbmNBX+8iC>^V2hESer5wdS!91r2Q+G& zz3Z$6jC?C#G>#S>eq94sD2Yfy<4PsAMB;}o^~8>5QxbI#Uf-PESn7&E3GNg%e7}I~q!JMh}pnkr}c*h#&lGZx&Pc_n1c2dgx2Ghrf|1>{yePsU` zru^DydJxNK%Jf@W*Y+xufzyz!KMrG62aIIA!2YC#MPcdHPmv{fmM1vKp50zko3}eU z*{tH$yOq>mmxHFK`V)e?b`v2lz!YMbss7FKL;Y-Y%#U`KBmZUfnSKrH4?Su8mo72J z0F%Vbb1WMqtrr+ViPu|gy^wF02$pUBc#@R7m#-%NTaNe#td*Q=LUdq0UdZ)nyky!9 zvL8F2XWcc_R2`FI{p<_RA=xxTrg@<*Q%6(pIQ%henvHZ+kf0F9+!kcrK52pNB z@`h-7LIsmaf}J*q%rTpsm77aGxpb2ze$H5^L0+igNaHERPRLB##{N0GC7e;2zBQ-m z(w*VlrMaUAN92&W61RP1D0by1Eqq^c#AN+x*e~DI;hs_nI(emaeP>l&rK!30Iu;{N zJdwk0X65)mLHZ%H`^hiv$!QZk&%YdS<9CRS%8%Oy1q?AM2|citSIc)c)3|oD>?Y=5 z(IDxAcg~7kt1@gtnV|{`8(y(pNpp5S%;j3oX*(dg{G)jTIMHUc|@^FB>wu+cV&J@7W-8Z!GZ-hCs4aK1~g+$VO#Y9Xp2d~;UkOw z?^1xBwOU_LF|`||kVa}aWu=y4H>GSeqpI+BVG!QVH_r`KHD8_6yW}8~UWAwRaMD!J@uw3>&8CZVDabg z-*ieFQ{25<2aqS4p4_^kmf?MDdHm%%Jt?#a zzn$CUkw5<&ij*0QCOm6EcIMfcUC>Cft{8sgvwUAee8nRdV^Ju(sYUBQtV`rQQ3Xj4 zVj;M62Hpo-sS&sEdOY|I(rO?C=H8A!F3!*w^C`7eN$q}C$zRZkq3yvBJ<_hc^m%z0 zsvgop3a`X3J zSM%Tb&@w)0=Couj&V+!OYr?Fc_ez1)nz*tW(&c^_UY(WBn0i>|S?Z2L{Qt|?TLHoEu0-)- z$B<$VoyU+gQTP6E!7(Gh#qpd${hNC>xi9s{g}!KqhDwN(`Y@UKt`UwGG2R+q9g;7J z&67HJhng_jHCIcOgDXaT_Ow3d`S-fvitA$Oq8 z4c8z0%g@S*(9OpJFU+LZ6k^unPQcij_hzTZ2v5RB=#F_GY$2-B;Fx%Acv)WH@N5>& zC_{4-!mncxui5tZd}EQL=(j@w1d9b3LU7G6$|=V z9k6l(z-NYrA5Yvqunx`EJLey)rc^jgwBeM*34Fxa(!71^cz>f$qD42|A&_r#IX1%+`g z?9_RNNVi0FRq%)9XGE1U=y%D;n<+WM#=FhB1-S>z`6Sma6EkpeglDMGdYP`nWNOG_ zdNLkyz6qtx-TZ2+)8jvdM932@5tt=)m$Y8)!emID6BnT!D6NM0`Ksj2ol zF_4Aom!y9;c0@H-dpI{m?gN{YoS250yk2#aU2DEIo5d9TR0$o=+<4iP2s0<7SKUsX z?zfvSSD7j@|3@1PkJHHo%G>%FEW&4ZCwt;KpXO8-I#k8hzaZfZ(3f?xfWrebGyx6AnyD|Ihe z7fWoyM{T}uc9TBvO<)w%zI|rixM=@0-MJ^&!$!;KOGM;g?H%eFnLG>|aiwIod?qr+rZ%WTlVOwO})`Y{2c(P0SGLiy3IDMv%4l zI%b#Sa_2bKtznB-jU4+xKcc=}lrk{;C(d0mHsD)yAQR2oS7<9R1ST8c1dz|Hvq|2d z)*YkBXP4o?tWEgxnFP?=6+e%ZXQ8!2pHV+enX|vIP4}YXIh$8bDHi^fb8fZkw`{^j z8x05c21W7E2L!%zM(S!$?{@TW(yr#}?~-#mWoCZ7t@=8J4e(ze z!So(te(;EO&BTlnv(tKJSUyx`eiULqx$tH=@t7qaq zZIFVuF0Q#Nb}G;1EG54{R!x*{T;K&ScD0L#;&&u2FEJZ~7FeFj^$?*Ra@yyJ%B95P z%;ORJ4bP@cxp5=fp7| za{X~(pwk0hx|=-@sD=T)AFF!P=9QP`$7N~y0hu)zk_S)7#qe_0U|=A$pyM=T`PkE9zpiyhY!tP=Z}*dK!q)U>HVmSFK(C`kBpZw4oq<-ff@ej=9p? zz{Fb}B-t&WX4uS)>cua}?^|3ehmzpZjhYLtb#Owa7%jG=*a+1;gHN!hJC9 z9L6wbaBu0EqBB)4YHxaBiyv;Qz{=egQ;gt_%ee}k{8ui zEdoe!#&xnHQGOgDBi)Eg{wvL~5p0oC=LEYo&AzpS^4A^^-_Yw6U!J}0H`0jr5#r|9 zDvKNC=Bdg<%f@R5Rd`Y1t1BpP?YiO7Csxb4h-S>OXatf%9iP zU>6ohiNYLXFT~E;vEw6mRC&`fc3!V%KJnU>;`fofTt=Tl_uU~RmL*=n(Su3OZvj{NRKwT&yJgMs;ULz#6anFI&Fc(IrTFlCRDJKf zH|(*NaRXdiO=tXgra7XhdLnS{6Kt6!>%X*E_&R#jc}d@_+Oga-+=bm(V?h*M+D*Gx zSN?4GWN<~(f|12By+nI7{fz$lnt@*<_f6rVSO1~XN8TH-cp=k{qKzMQj9*5^R9HYY zZv3D&PYR#K?p)ah$aPsNUHBC4nklsd3!i)FR^v@ph{Q`yW1N9>@2=qbUdF=E9knHS z*ivn5AnykrRJ%SuZ7GY+7_)J)1`nM_v7B%Im}OCbmRD`j)NsWcWA#RE=Oc|);64}% zNaXgrXcM1iny>Au2->xt)nXZbrS=`4fTR5WW3r{Q`pa(WljN9?TRvBReSvkwHtciY zEzXvnQ_;(~9JJ)QM$~-1QVyN69Z?)8LoweD4`_qM)zEjvhsNr$@s$ZSWEpI0gdaQ< z_|3S1k2*R6tf<~xC?Ax3q3|h({EbzAMh%<7efm5TXMeiO+4i-CsXWB30AJi{jfZkh z{l+B3a}xyZVsEt?8>7~lEv%e*(d1oAAoc)eYvcLNn(r#xLR7w`WovXL?w>S%$T4<8 znhjx`siW~7pcjRtOH)nD6AM4cD<-vkXUp8+L9b;lqeSzxhB&Y;anC~eSabYjg!7zw ziqx)BKlT{3jAPGf7AHWCL`=GChSmt0CEmx{U-cHT4s>ahFF{_yfd$@OU#wSenXJ0S zmp7T|w9%@eKUl~wPY|V;X1jWG(VhxWB`}~HVe_=jqrsHkRt)F!aUONWmx>bH_%jlML z7ga|YD|aC0GJ3D#9(u7pGP^+fAx{lrbP6yYym1xS86;A+r**o%Ew<~*r`1DYS85La z?Wvy9ZQgS??Z@a%ttL*!O2J~qncEwWV}|#L?e;EQps-V*L25e#iNyXsCi~kHWv1D%YnR$QJ#EUfLkv+&EmnUSN9F z_ie2@cZTw|a#E`S3dnHZ}Q( z9pB%CEj=IW7Ev=?BSP*2x5i$&bL-u>gf+$CCB20nEKUmvilSSFU!@!h>CPshZW?&W ze%rD|v3~iY{f+Q_bq(HpyX%ZcCXxJ)q|hNC1GrZf&Fuvi+;3cNxR=st7i{~}} zc)6{Ism%kw#3RR|ZntQL^FBf;7P!UD1?efqun_dEbG-4Z=8EL{2IJ9Lz${ey}6K#CnUo$!yj6|%mw1EamTwjV#%`;!&-fr=k2ZS-xX9MAWU+pmGPn#250 z+h({yaPikYb>C;*IRsRR(n@0Pr{@FR$f2xZXFTqperm62z95k~Ni&6zpzFw&esaMi z-6<6Z2fFb`2`Eme8ck+W?EQFRQc3IUYHry)JQMXA6Z$PL3Z#go%=P@Mwt#IcJf&Y! zs_*q##l7Le$N^M0CIqD%<0P?2KXWxZMfd^Jdlc+N#e;~IL+08rKn8|b8H&>c$v=4O^HQu$+8KPR(s#+T&85Nc_ z`9`)?^mBh-MP2I+E+Lc962=b+QDc?5*UaR zXTi0CI}Ri=b8yyyGUgUZd(m*0EYg~nB^I6wv!(iB`o}&M9s0_zQ(T?BUc6*vAqpP9 z-{YHYWW%cguQ3N1io%ftnB#ubBp8~~GFuem#l|g2ua3h|kes zcu+B=X|=V>NU{%-)SbJ*Z^?6DX0T;?N(NHibOq3DHdHo2>{(nkh_l~)Yvp`#;FkcJ~9w@I!+H4Mdu&5PSS|+97s>ujSC& z_sS;}9}-&Aclb}$gMsgSPcJ?2cjR1>cMjcwVY5?S1K(IO253oQ{$NqIU4iCStAB8q zO5!s7>~NFW!D5SieSUXk?@ITlxSGI@a#vJwXfqchONCI*aU2rexx~1=`3FQBVghB- z+F=Ab?hgR=9c_ZVymG_0-^jC}G%L>q3t2-njWmGg7QS9zhH9EW$tz9Oz(|UepS~h8 zNu@XYPX!;K;47qy6!~I$OPsz_LD^TWKTdC(IoECWCVY)(1+P%|63$l+J3W3lcI?RJ zT$pvJ#`S=^*DKT4htU$d8-ccGQRn+5+gjc)z!v6`bk#@Xpz2Vr%+SvF7-q9#1Z zJLE$%+VhjI0MH7d13xbKMt4mc)Ub8O-9b&zLlQ`Z8ENX#NDT(B?mt+k+C?CX8Q|RV zTJIoLTA@aL;K+rqe�%-Ot#*)QIGa*Cy0Z+|1Rd?o;^Y`u*-_WHUAEVSXH=-1OtI zuVJU)_pk<}I`x~T-?ah0wFm{`9(Qa{R_y@>%p@7+hgiA~p8MoYexS>z-NQo?iNpaX z+U%oLXpvBfnCB*FIS6Q!2LB;z2M9zBIq;VgUUpo`G8>mjM9oFPi@C!v zwtp9_@(p+gXq&X)b841JHp72$H`B?+nf)eA=CbnNtPTKXhqcUwtORA|rOGrj3N@1f zN^sm-CRz9j?wN;(j+hP8IaCL*0CYHoG&Oy~8+gCLzMT!32AHsNaUaeBN(4k=$SU1u zeJ4ZzZ^g9ZgRA>ufo1u^SJJFy#OlX%?I#e~s#2JI0%;hxi`lDquC*ky)4^r@a1N0 zMYy9{!;&41G`dOYy@lS@ufZL++wgNUDK+=AFpR=7PM{Me<|WYuaaFjK&9^qY_~N@O z7Yo?PjlZJ!3u^AiK%pBXUHQKa+K=&Ys*n+2?nPCqt^o}zeihEKGpvd1fxquWTU z0#3bzIDcLSBqh^l8M1F%M*~FwSOzBXYeH#e@6Y8Je=gZY`+1TpE>-s5P=(^{rPA0YVHL+=UGdX~PB)h0xQ2ZCGvs15FGD*i zZt028;Rc-AyuN=#38tbF>uL&gz`1zi(KFX{*Xf^oe_K)sc?JpbEj3JBc)y==s156_ z8uR5U13y~^tfCwm?6UA7k(Q(RCfZid>&{JoR^R)~Quc|V{$gn@ZH!)Uh-rwG?jr#~ z)bd_=ZD6Te!>23^>T$30X4EYIlkfOcDOSrpcjlV8p*9G{Js)vjj5j$pT5r)DTu2G{ z2;;)%RIFs{KeV;~#-)CWtIosJ*!GC+U94bJ+^_4K6gBYX#ZkRvi#xJF!E{Z~nRBGne%3saxpoqY zdkAhd@{!GC-ydsxG0|3V95b7Y2<^lpUU{xIrSk@{s|oF~7KT9yO+D)q$~wHRU}6I) zY;MwuvD|~TS(hDtvdSDGc{H3~{7$LQIB+Pt3(sa0TKo7Nb26)+Ec6G*hB7b@sC**&T6g%tF0V<(Bj13BfXT46iWo`SOxJnlwafo< zdHtlb(gqRbLMrN0TDWj`d1nWNBx6@|Aj|XjAM=FJuZHQkD=*7D z1(1myj+_1i+St^Zo zELHoeMgb#X{mC5=z6nr_#U9kq zqjB${9Xy@tU$?ZwVRxT-U4526LjODdW#~WUS_R`gq5Zpzbm={%Y3w^=2aYg9&GS2k zkj^M;o3d9yFT)b%Uk6!tcup_|&irNhTP`N%s0%?dXvhY(hnQldP>TOvoA}7$=I1HY z_n#09TjFAMpH& z_dtzXcKmI5^6CvPJ^YL9K(F30Lyt)2-SU{Njq_L+is-&y#5qU`)uT&2Z{Y!FMbx%q zp67me`cc8#S1>cbZBbMBytNBU-R>%z1`UiiKC`uFc7u^i3e$flA~rM(PRjEs!C7Qh z<$HHkviMo-cgJxea&J2KE4UNq+tRw$2Lc3fY}&WekzAY^=ju_L=1D38=69R_fF3j5{jEcV)>|mhs)cb`CSH=YvnSfdd*EKGwwo zD+R}@8xeBNTpUNKDor=%Vu%KNl!)+FYSHTP9( zE}@C}lHj|(rMXBdamf2kDf&_#E1SijScn;Uvh98$?@m>zc3v*SSDu3gcqXp1T&V39 zB_2~u6D28Hv)6U=*y`n^(1aP{v+e~I9-j$xTKYwFyAt`QD$uWr%ZEzmu|~S_&!E^k z^MP>ueBba4Oy4_uMp@yQj%e!0ID^`X<53x>CORL!+0*epqESNMHdp9>Kl)nJOcoKu z9TkSjgcYw-1P;<^%~&7M--MG5MrVx}6}9B=MyEm8)X7257trQ7x_^`}xAD{U&Hcbv zYAYPij1b)xBXX5&>XG~t>;V_~VwliogUg*PYAEl~d`m)uhze3g1O+?oJ|-$&v#^?t zn~hA&Oe3#-Su>ZY^K$?l?LA9KU_NqST%17`b3@bmNET$omUGn`KIUxFgbg{)W>)N4 z8)43s&6y6({=U+_yw!W{860PsVdiD>w@_fT;~2SF?Kwu=#_LSYg9p2r4>45D_k?d) z<5FAoUR__2L@#gJfy94nMf@UaWr{`cOscU(lxSVWYqN%U+9`Old^`^tdQ_5|NMvo8 zalj#_w~0T|9Bv+5|@{{wHFy5ct#v|$&SdpT<+bf z(MH`i!DCv650Pa^8Y8Irrxg^q{?Sl+3})juQWjj z0`_w|@O?rD*u{u~qCFTWD$?UOt76UkOU1#1hsOiw;JfHyYucMLgJUzV#`xC+emOHK zdr95LDaaaaB^J9?vz20w*YEhO1Ouawj*?3({Ez7{2mSwYI!%us4%qk`N6*n%^B+Mu zod_;B`#8Kd7r&~+()?VUwZwQgN**l5Nu-b!r7{s;#UFV1=Epr+_9MoKH8B?aGE|sc z_{J?U3mnxE7jP#DgD%CzN8XL8p{s1wxzrS0{pkta1kp&>?5NsGbys7(+9@v8qgI%w zys)1?p6weTsI|-sw=?R-=HRE^d6^!PzdAmfv)0w*vt*DMLiu4Syt4l7<61*?)GZti%N zAHOS|v0QWny1T^~CB*)EbtQ^0)6(hdt)Kdyn9BBcio0fNg9!C&TwD2XdimU`l{Wcb zz)atq$RtFgPP=gfar?Y7R1cd+60_y(ZDJp`Htt6fv=DI@@SQbW(yi&CUaNS_r6gnJ zJ+}cMg!J*u$UWCdSX0&Bs{JEPO>O;*g}<`>8+#9T%8$zZ*=lN$Isui(a`Wh@Dow^p zku~U1QGMt3RY9V2aALSq^IG$wtZ!m-e8e{@^jj*fd!nJwRu_eMuxvQK^Z!wFF8)mD z{~!N$I;D=Hj!?ObRO$#v9ptj9B$YCbm<%hFGM6JU?4rBNa!aKWODZxmx6OU)V(u)l zvAHb6T(>c7HkkN4;Ee!ZU0rwrQz!|312vK!Os`2utF)|jM1x3SSa zgF^-qqZW!(&@mcSBf1#a9eztXyyk&3&c-A)%`aa^5XHt7UX*R6&Lmzny|QHQ&{51; zYNNhFek?*!wR_X(0$=y?TE`FV+{9Q;wOUPU&_eY#fc$5u>&_KcyGE%%;r4c+z1r`2 zKNCOH!cM%RhKY-K+Q+*>nCUbh_M==IJoQxkc4RT}@I4Cp&s05;@e{!>&-EhxwEU!! zbF@DNd)L}B&nUVY@95HS%7us4E{szYzkz1JK8aN8P+k=2GpNMs-<$w5IAqkXYjS`< z!ehAFfF!oqe!;%F(3%tTX>_F9Tg}{oy9;-+#badQiKsi0Y(lQm(;gO89m?PywXFP5 z6qRwTv7_9;(FoeKQeAimUa-^pNZ>{d0gjqTQHajyWp1=)EZ)CVNrOHwCa-lSEJuM} z^X9AbiQKD6v!93oPD@73;W_jBm~36NW{QkbK1~5$0s&YW1Xo4RmZT}$%sj7&yFZ6F z9Ljb;(`%L51t=QQ1=~|7?u-cd!Q3P`IZCQL-lgg;{xQhW8hY9S7?WNsP?*-ocerrA zGDV*c<0i%0L%x3uEB_Hd?g&?U&_OWA4$J{%V`cP6{F}xr=?)UH+{|gB_eSs!1c)!q z>7mVi=|A~Lk8ZL~6<}()_bcf$b=i2hqiD>I4F3q?nr6x-tTGdW|cf*8THqAPK9=|}6O;#c?! zDyph}%PXhjJ@|ym0}Wxnkb_uYrUk$0Ve_C(BV6uJ^KOMb%=I&70R$e;-;BJ$Jc)0>} zQ6kg^>|%sZjwJ2IP3eqUbxxD9lLdGC9A5X#_de#s$~F$kK4>$_a`xpWmrO^6HYEq|;X9R4)_Uxf3f(L-{Z zj>ul#4}%%x zyn^MGAO^FZEYWs6%)6vAQ!VJZzsu4xB9B!&9p6k7{Yz#$w0-Zt~Bbh z2>c`}`JP`~%6N5Om(Lj5nDK_>nw9W8yvB0ggP)eG6#al7uu@wT5`)Jf-sfOVkASvrow8 zQNM%CbYkewS1>{}@-sQ~k`q971R(ls5hA*vGX+(rT^(6D0RP~vXVX#TZE(8FDG#~z zij#FG3?(wA($shzH#JwPb3lRh#Y9|BmO(_jE17vtRbM$9nX3BY_&INYw}VUu$J_ng zS}bJE1i_Q4oHM%F5^9eu^Z#KrxAM*J4poHaH)A}eVQ!*~7_k^MSN}sC_{DXtH zRfY5>%f}pK7CzJY>AX^wsGzlk)O>eptjAh4nN2)i!dqWdvJ<%I$7Z<#)u~UNH$k}u z3Z(Hrv9M#R&=#$6jiYMpZSBHtylm&-(V`3fh{)JDfoL$4bPqAV)B;QV)*G>YklIvy za?ChSxBz0X{3$-Rn7eKHhdR#0q?3@mV=Yxn1I5*1asIAns~a=T14!GeE6;^N5g=m+ z)u{gw+k>2%^aL%n??XZoljjkdF}jNdl0acnQT8QLui>v7nh_DAEt4agN0J&ic=H3H zKpTrMrt^^#)w#-)FVmL6xQ><)2P)lJB@(=FPDAhyI`ycnNS-~Oqo2|?dPFZJYJ-cw zMN{W8T!_eIogvF4(4wa#?jTv<%>`rlX}kHdL%NH`%Bc^;bBtG`f+Ru4RF!O!cFXde z;;DuE^1|i-n;~s{ooE#EejbxLQ;VA^4UL|yF3c?FQ}nA5Y}Z@T*=M;qHbI(eI(mOW zLXJfuhM9lVtZggX0{Bv_s7x9%*8oAC&uW$$)L48y83?DKo?~J-F6+se;T1>0@;eYs zLOm#njqf34q!@_(^rU)lXz`jj5N(Z*Yn^*s1?hP@zsyOTwM}lJ2E&>AnEU-WqC+_V z_#}!Y49xQF*)+Tx8Z=}-uD!Xjb$rz``aARdQyO$3opcw!UAnS(fAq*dx@pEq^Cw#H z1$>71L31AhH>S>yShugg%c?)J^-5sLh)w35KC(EZP^Ap(J0tFgIxZC~rt0roidxS| zv;6fqZO)e=-9u}<$RcD4)F_J@EB#Q(dDXY(g^(jNA?hA^$K|T4@;`U6d}6i0KwiW z15vc+rEvd0W_i@TK9SSEHBQauf6$rC@5rC^yEC>t3Vh>ym-PYLq?RoyLS|7M9%F*f zzAX1?h7b{@^+x4kmBLLE>HUo^&`WF0IR%sO>YB(`!U6(1GA~K82_3v` z(r%)!NNtuYT+eoV&3vL^ch+>@ggDA-@4N&=&OoaLMz9ANMgWhe?ABSMs`!qjovd+( zS6HTQR+njG5C4Q|paRvVW;2zSAH;mtSM@q7SUi-SnV41d{aiyx$33e*LOkZHFoM8) zyhXpE!C1)pD8G{rl1L}H=&mK9>>Im z^oN+C@r-z?!w`vCwfk|;yfz<2ihn;@aLTeFQOJ9*GP7=;6QYo2uO9N|O{?WogdTBJ z6Lq8Rd#={TuT@p*WU6h`%-?r^ZGZ5eI^*FfJ5zS-zrXDM5&Wp_d%F9BvmtTkFz>Ps zxXUnv3c5J>N${oj+;JHXeNVE*SGh_~{?g#{XrRO zO9x`uSkWn9qaOyV3*NzGjT~C09i%KgI9WQuJWQQkV$_}Nzf6@45ebE|L%HaN;c|-WUr{#p|I@$~3+#ihk z2HUnkdg!AzK!y60gIDL3_8+_xP#+GPsPy%BajUpSO>uz zNkPMu2UrX|XKg!Vqp{AO1#OW3H~p>n&iD(*1^;>8=&mN$KGmF6|Gb+m_g*V+PCs2n zYn(1}L}nt?mNyoFb0_xBX{5|le#G_gnquaik)Dc%{yOzz^?+9#bXWOMcRjVPaRu<_ zE%aE3+p!?=hEU^Fra^;|Z4AhE)#av>Z}uSb+{h?oZDn7#?g^9tu+#!AD6tQ#eKP8N z02N*G`D9Hi*A3)A*!`D{&Cp<{y7u=!(F68}Oe3Yz9aJ1^i7cL!?#e`7$I(}(zUZV7 zNZz@E>ihb7XxuLt=ti5bAu7&QJ2^h>bKS0e!O=O4!=X*~{A%%@l$d4w;UMQbRa+S~ z@?qU~umDzP?NCcKvZ$`(c0YZql3-TT%bVR3rMOjDsn{_?#03rSg)^LCgaH>^q}7ky zP!c5PW7x-ZR||s()M_xm<|X$uzbD?9#r?UzmQrBVkiV}ZOd7#=oJa3A14Zk?*Tc{Q z?}N0k`}vqttTZN*SL`hbCtG%Ts)|&8ZqeTac>(ib-H|O%-jwX@1pH-Dd8;~)pI!v& zEOs>Jw6bMf7oJMmsy7}rET02jpRVo-Mef#y*rX5V%6eb70+-Rs+X2IzJOC7I72)Ur zHe_oVzg|;axSCRc3>e6+;-E0p_qwa-K%g(>_CIArgY(6efsB6O`7J)a&VxT&p^|wG;b>1f_Kjyshmsg zL02>u3U|u{UnpgU6?VtCy5BQ&9Vjv5FCtYHWk$R<9G=z>;tyshHc|s?}-No*;SnD%*PZLy&=u31)3<^ZoKS zpYO-^#f^L9$ViN2oRJ14%yQ9V-g|h%CI0-|bUdrql*29?>0E?hTV4uRu;zI^xAW8* z=6;u+*BK~^g-|IK|FkBj7q7NQS^fN2L82lWV$@=yiyvk}Mozg?-;`pfk5-ZW?hw*ny4SxeAaTzE)k_kr_PAZq|A7+g z!2t2^KIR!zzRZPU%oX z-w$;-(eC}!jS;_3w_HF?K+Y#Exo@z`-KpxfI!lx^JC=-iYhHHru_?#6-t=|6UXn=9 zt!@Gw9dWEGVb&`=5FA%9)40a4uO+Yk|NpUoDMI}6*2i&MrQRchFcI=*AWD0}t9h|J zunE%g#AZaQT9Ra9w&G?2ocd@vI~w9ifgORP5wkugLg>h(gPWoKXbEi?lOn0!^RhNU zN8;t!^LVWp?kVgM&{{$8TRFjcD~;7tnoQz)GP@pEf{RArJ_>f-9ZGvTE8B5bX|@-! zU);WuaQz6V-GW~@JSz73 z<-Cvri)NWl^*WWF^P^N7wCrs^tNL;5v50E(#N<(TX&#J$f6QFTea5nfuj{`j*$|8a z=LhO!H;PEXW>iKgaFmi6HM+P$BUQC_)G{agXIbW^*1Ph2Tln>ZWLy`1uW{17WP7!> z9A{GM%(7R63UXT-A?>$3_bB&mrO%Ev*#e}W`$*m&Q2+|4^f9ZPFA~Au5`#85Vro?E zyTx3XeTd3J?vL^fh&cPn$Aae>7x)!bV|_6yHs>}yZmb5tU47h)SvP?$z#2XHXRJmr zzS6lrWP{8H2Ftq#==2l3v;E^ClE1S+Or%?_Bylb}QKo#PM_7;LG z>zt1zL6+U2+dKzvf_q%f!9K0t#3F(DZHl)P5xZSKza+FWdg)fw4iAhGldFxyUB=>i z*|xnF4wJGSm6OZ()j$|Yw~Knb6|vEI?2VfMq6$iWh)I}Bu_%Y}a~5(U=Xb&@K+NE<& zc9r6HDWkc^3~rsi-fq9*u;6L=k6kJZWdnyL&Q7FOo_TNZ5VZKc;N*~{VdWBydUEEo zcYXhC*ItE(f>D=TY5Aard&SvW+jJj!N}y6kscj2{zeXjTTO)+l-!@5zH1N=?T)iE! z7L`6zkvdtkQ5q0CPxA-9Z(X?Qz)?XjpJKfMVP8kctW$TZNH&a1Q2Er)A;;3Vbk@Ca zk|{pG>X&JCTwkl3g`TvJ=c*u(>=O62;g=7rMxs@{JVxeQyDKAW zvT&1$g^CNsuMm7`+lk(!ggwsWWpC=+ADxGB;nBx3HPG9^q?J!DME zu|43*$E3y>(p*-)YHV@}13EWUz|+}ke3l5`b5j~+KJzYYAmQ~6SclEcTASgD;OCbr zbrJA>JFfn`QhD<&V6`&SQN6_JrrS@?#_Dta8mP z{=S)f7d0oq`6jte?cU*sQdgE`!HOD;FB5 z&c}r_+zU5n4Qw{Bq-e=?RFlj@X%Ntay}tB8eQ<-R`rn-wN8LxM+G+nF>Qq#=Ds;jm zQn)aZBj9%Q(hopYHtmdD0sn8H_Y zUbMOSw*but4k4+?DGCy4YLYmX&#M{LTKgH7JkD{jrL4DWsR$4TSHk1b7k*~idmwbh zv_p}IHNltJB0)F$<)Pu}U!sG$X$(boXe(%4daT3rDrhaZ(f&58MMA_$%fBRT8Jxxj zodwOmX)E%2I_hd~`>uhjN`&Ty%b69irQ#L5S>9Z8f-#~+5OUuD)Ja4Zo@5<>h7%CD z&HI;KU+$C3nC_IF@FTm)MWzblZ)Z*#A#KBBlr*M>oAVO3o*0dznk`Fb4h9=Y0amu>5wH zg@uO7{zMmk3}O0%>PMGZbADv0S0*kj%MyHr`v=Z>-)e9d{Wp8l?qUr27akP z)ex%#1ckExexkUQG&u;u1@&3_#HG)wUePcun9#lGxYA0yiMcBPYC?1fmHg`7Q_S!9 z%?<#~{W-3*9jiU?oU3{ykDbn9A4AJMID7lNENi$XBzVB@4W6P0j5b<`fJznB2*$$R@N-5tV%h+Ps7gDy;O_;?;tSU_6{njCW z3&VGH^+;1|+r^#!Qb=?YH))F)GJQem-Hns|RgS1vdX6}bU7t$B5ABC%pQv9QaFykM z7N1++oFutuvw4i$>wKIQ{~o)rpg$%e7SylFn!B2Yv(`fqO@iOYf*B7A{HwR{B%`{0 z#mUcDZys!XM6DFe1aJjIqYv}Lv-rJz_AP@#gROU0JU6aQoPp*v52_MU>Bde$zUv`F zC5G|*LJ>6K$No_Ge1w1bSaDeY`b+a87FF}uw~`8a3WXz{$N+g&q^`Zk?F4zQX1PY+ z#PP%O9RnPf9n@GmRl7{>pSqCwz%mqwVG6w!^S?Xo@t^Baw`~KjnSuVHgF=uuW>);O zdJsq44c>Ig$yD7-%vZn@>HC5cI-cS#rR!7;Vf)dXI4p89Q&9&ouZ7Q`R1%JYS-! z&$bz8IO}cS2K{^B@cp-YhmRPB4Gp~{caG%Q?cH4_C3nYeD>T|Z*OYx&av-> zoLpVX7130hW&Y$t*9?O^l3L4V?d;nbLK{pT#S+#669o0UYQLnA>j&E!NMKZzJ7tz_BnDfV%61Hu*xNzJjt%qHtT z6~aWNu}yV-Sx#2`b0-JrL@bVnoV`ikM2v4k%vUzpQ`v$=>RKw=_@xS;m9Cer*BJvl;ZTb_-x7(ZF6@ zbF!s6G$3x-b+9g!wVvLzhV_CPO4~E*W_URNc2^Nr1+2u)s18=`b^&iqL$6JIeVwW$ zt?b1*JPB%AQRNlU8t3N)ZUB!aaG~KZ&t7E3XDC&@&Uxc z`CZOsD{Sc8V{kF@_UaZn2yY83>kyqTSYU1&($V7TMHtSR8qPD=ETLc3%02#_DL41k znMVcd-`fl-%ZP_$GN*QeY4kSW1$DHMDnIIf^Mp9a)_4>nqtA! zH$zl$sv_uZ;B$*xvp&Kji_LbYL8SQbAGh;8j`L=D{d+&V+2l=|CZ=TqpQBOB@#--t znd%}!2Rj%Zk=rKnuoq@^ciL{XGKz!Z$2Re&#Ak5R!@75`@t^RMU%)Zz;9bLj({Ppb zqCkFdT{V#jL%!3yoBI=z!7CW1m>V$ShWnLSzG|j=5~hFfwJCs95=PmG#17N-6LmIB zCSn2OsuRfg1-Y*v&K%|CI|Ju`NHqp~JBzCuIv(>MN+Cv#HBF`=X0J(#52n4`oFd5; z#P5h^!7p@fim-QZ{Y_KDtwKa$y+FSs6o+b&w2mO7JJt&&$p|VEA=DOTjon_D$vNTb zLzQUgu}t%lzTiO)mN%D*=C~VrpD)DT3v!W$((Cr)U1X>|F_ncVlOs0K#wc@^;Jo0R z>iD&W&PJKm*L-wfJub_dH*H}r_U&oYTg5s=Lh(NoTO`3n{R;@%qLtLH7&<&vgC zv1)zwVn;snmBmWgGlKj5x6Nl?jtR_`UR!FQk)6$S&NSaVxIXo>{M||XCTIze6&fKq z-^9GWob>*`w#9=I4KwBEUf~x94#FL1@;8xUtG3L%A$1_)3Tz$#oCFouoAl+nc1k&2 zDWAaV1*42c-V3lIz5qvEPet*H(ZX!oZ zZ}`riPRe*jPeaMo2>7V6FDON!QOCWNuA`Sr9%4h%b8%xmkTMy2?h3Z-zKz|${>^#| z6W*rg1#cI-jFsWHb$K3?p)KNpf18KkL<#p-GQYrT{$82`N4|rjn{)Ek=+%r=(j*7W| z-Fpb#8Q9?9OBobvmxU)GGbFWP0IeAn5$XzmxYixjusc8HShM)wI5s$BXt$Tmpwokp z2l~boef&|wVP?x~#??CEv+$gcMeg}#d@~~x(>oP*k#6N{?OX;YTKXV<_G~NA>(+Y5 zZ_tuDnwfax7WXwdv$QY~4z*3RWs06Ar>V~o1J4`2N%}VT=mphgyd!YKV^!H1W$irs zv(MrUR;R;~N~xcFGm?>8uwwZVY#I`L+9!~~ebIvjPi^QN(TTX*Ci3a8h*7ER83OHR z=x3bzx%?58JB8zmQ4=jq7RUb*^ylN1XS4Y8!EF%X?Q)Fo263wryhpGGxu%e7tW$rZ ztqcSjj;uZiv9y*ndg_BK`3Y2E)3pWQKB*&5k=cYq?_-DV2o|zKkdW%HuEMKA-^q;o z!b|5y6B2ddSfa0uyJC!kgl#$=^rxOE_zzqJ&AdEZr?{@G;}u`@H{|VTTg~YDXl~0J zplD&SaW!>dmv^;bcGN4&4#!&bKp2RpB9FC=I<@j}%xo3T@QPu4*iC(u0saZaz^(^7%V5Sb_rewbZ zjT0Z!Y}e*2)={l18Tup;^MisI5oJ!I%$E6E!P9$e4{IeY-%6LsOQX!^g)F0uFXza+ z)`R*?UB@V7Teb;b%RG;DB$-RMMK|118;re&&E?24dddkjqoI%MsUgr(yGT&6} z7ivD7U3s#d41Stz_Xv>bE|QV(x`36hC;yCD&I_*JlVo=gFz#&50Xg9ttxGT^s(RN8 z@HL6qWXyWHE~}wxK6o8$Q=qEEASNim?HImUNbQDM)3b!)>i9#+%Cq3Lu#N3t(suYX zdm}?LetJ6dSL><<@B|{W>1RMA3C4iOVzv%$O@a#>$(#=1h|mwPmJwk!`bsaV@i=op z3V1y~!i-}UGP-)r#=J(%8dH>!8)gCLBhm9+l@0}siNcFl#(2oKeNh36q@Is$ag;gT z%*4+yp@q4qd}bXc)Q*@KGuf@+LCEXQ!b4R?plIxP`PHS4kBw1DdJBeSDxodc+~PxK z%Ztn~=IEQqsyruYZ)VVM!E*Ua+vc#k;HoL#{GXnhNp6Zp>UtwU8J4{6En{sXm{Ory z=6gb||8ak5c=3~bKYaIIwP>~Fm6njpeS)1!Z-_SX)P3HY+mm9q#_+*Qwsg#TN#ZB3 z5fpz^uiZ$-vMRS>o%zzr1Hb?bdJ@{s6si$ED`|Q!-k(K`%PNZ<_yo29gqZU9X@Tr#Qf+Z>aO4UoD0=F?9hXl8GmiE zS!7NOGNagx=vXx#!3E8!*BV|_=%g9QP;XofI7_ z_zU7}(ggdYWo4?L<#R>J^t;g0jaEiBBEbIT(KqnjNwY5jNZNmeFHu*JmDMJLVeGL9 z)Abd$19Q~g7a4Ouqai9_i1~7J(1~H1O0uaJ#%CNgxI2;2l0I0yY2{twyE()0udR<3 zp^!U_i0n)7zXGl2_CfR04>>W;K_hQX=c)5l8OTZ!Sfe|~%Y?jWyH!#0W)DKq<4KL3 zO?b5MDTgr1!54FU^CIGEQkui3oa_kFcb4=L|NGQli|Kd3r$c9@CSZEtT>f>ZLQ&Ur z>(*5`ElYWq6qdoAc4%%t`I;>YC+K6~#{?TCKLI|I9|9SLF?!vnH}GvTzm#U*X9?f> z^`U)`wes-Q2dJp0tP62%|4p4rYO6>jhT!|S8M?fmN$(#onL&Az%o9}&_?U=qW@B24 zKO9-<1^-Ebu-%Tcg20V^{-Y`?!ji>fB=g&xV5E3O1AJT$>^s()E~qyA+J9nYQp+c* zvdXMlE(6CnZI*Q&+R;50H|D^7})gjg^Ac3<4kXow`4jws)1nM|YnacwH$>H0pv0QI)b| z^DzVf;uh_#rOnVBXe|GK?G^q0R;l>~l^BFtOpseB+>6j%e_|GqRO+6mS3s7AJVhAJ zJa_svaXKL~za>DBr&X|;g%$1*FNY((g&WBjnND_5{;PPvH|Q@CY?4XovoypJ*Mu?J zxK;rkU0~S?Qa5c=GB+=(oPJ8~$VrRw95q><(+u8iqm=Zj<#YMe&;2Dwj~~Vv{N9Bh zWw&hxVW)VF=OusUGajz3?mpOsvo9~ez`+!KTX4PW8e7zPPRtl(pKV>3k8&fUKY=;^ z@Y*|WxuH+fHnouHX`rf4w6P`~%l4y4J;24Wv77kn56wXZ5wh9HOJ-591f4{8o22QT zNq2uR_5GlgKk$cX{(K|llt-jYT`WC~E^uMEb~#b~9Ph|@yQHnW-5(^Xg{f?q`@L6f zLS#ODM9L>V^@EzO>Nfhe8-qG^X__qg?-0q0F+@lW1T+2a&4YN$f_V6{RvE{1q<)e! zd(0;?R#mr1Q<^RI@(>Cj;VTUx_N%j(&ExCi+4;#3&{7`q8LOTcqJr6O!L7i?^ScTC zgf0M$DR=${ z=h3tIrqj(y@!-44^R~xffbQv{y`I9#k7Jq5t{#ZrKEOsvW9tae9nCLptqsqUhf1@3 z4BaNn5J}2;!LZ>yX8kJ~HCk1Siy|}H{G+qMIREHMz+%glojrZGg;S7YQd(5E?wp1o z*ESL;xv?RR zQRIi+(!LmB0fiQa)sl{utC)s$@|itQOn;9KE+w6m8VU+~OUNHyBcwO%uVw)U1I^v- zMV!6uHN^BT=O$Vp!Sh{II8e5ZQl9_czm2OOZ$OUm)vdfk<7ApghUSE8Onbfi`E0kP z(-svm9t6(y2)RZ>CFL7rSv_uZ^LakAw{_Q7^6V{>wIxf0?NOqH(1A79awKQ6(a1O+9%^Hu}3c!lek{5X{B z2zy6;j`Og%Q^T7Y**LDY@Hq*ISKPw^#eCLEpeI~wobl2rj~^N#UGTe^=~OA%(Xj;< zId$1poz2vrHQgMvU8bislbj!199qf_aY(^iCDA@l;pMw9u@}ngS0+wdO~xoHoNe-q zai=J6+K=jaqFP*4?C^#EVWflS7D~KgTG{f+%`aUK13%!(6Y5XfF%Hvh4SM! zO`KAi5{JR!7^GX*%{Z)jL_}3FIN4l8c)={Vq1OH~IetOfJ9URiKWvzQQizfZwg^9u zMHOsMNO@=gddu;P{hfY^+)<&)B}_T(Sr3}lU3258Ake9?6Oql=B7h`M=~z82W4>0S z!s-zpHaQ`y_pK+XVkV6M*!YVLnwDnZlJW?%eC>TJDgTCpCODcef1%uSSInYfK$X&q zx?D~@M80Ss4Qi^Sq$vX27lvUl=^w3N@y`G~Vz|Y#tFqsPD+Tewu>UG$!h&X{US(xe zFJeb)Gkw>-I`bJRLBq56-{_OI-I7uc{nSfLOJ%Sle*QTTk>Y zT#dypP4D1?aWP!HjUVZoZD#i}%kZn&IRt~EwY#YKU~NFMssN&S!_A){E#EEWQl6Wm z$wmb}@~LZq{-fr!LCNNzvWz|#u`V>m=sV5s_<_0!^ypUdS=uu{=BE2wirXQ{}FZHTgWu1qZor_gjfV=mSIBzT=!AET4I=5_U zUSai+U#5$r>mx4H&XUnlNvn=~m%*+Abd={)zSHlu;;8~lzRacLcKUp-kQua&3ZtD7 zb`}MxsFU*6tn^#UyTHMG1LuSY3;yRjshVp&<5)KWquP4-WJ_+h7i!x}r3QS$D<5@i zChan|6jlR@lmEfGDpNg*{UdqaHAToLH7a1K#jhye(t{&jo!HQ5{+7S~T3#CoQRX)@ z)R!#G5l?PO z98)O|@7jDKJ+`nJ;}JoQ`Pbv`aT*!Zk12Z3iPaROGa^Hf+N{3j)y1syJ+O@Orstbk ztX^>vrjD769UbF0bJ9(k1iZdpViSlO6sLJ)>`n$TeR}z={jGHT7WPnc9&KmqIwhl9 zH85c_9S^u3W})u+N_Y0aJwYnE8`WxVW0do+qRtuXnz8fNPW*)gCw{6tcb#DRub1No z-iqk@$lE2}AAGIYIn9kJFHFiM8z?{#xrs(6z;T`Dq60N{(&XO zy|cJ=BQDU%AVQ`5Qkf-RPhvk%E>)!-xmuxdLhtK)@nTrSvkjNj_V=~FfT!MuMSSrS zN4zzB`ygkRVVKu&$VS(V=b+y2o=LV&PAP!1t+}Wag2pNG4F9m3uC{I%1@yx# zlRNbGUcRB9LSyF#99Z*pLupZi{g8r6mfs-);!7e{`S*frlf8~Dyv(gkoW?bgYTOAg zl518Em_?F3;G~+N25)t{+c}{oRMb9v_Fls2WPLOR4_T#y*wN-l+IG~#lcm=ev zRmImR3gbic*;fChFRj%5gzK_`4S;LZbP#s@TITGVsE^p$ z5qa6iX?ST9ap+lk=Zj2|?)Z(ox0TD^>lwNa13bEKY%Znx*#*Cq$41^I9qW( zc?Xc3?g^^tfT82?I6H-i6S_N7(M!V&^#O_&09Ns?D^o`lD{0x9;+C3qjrMFJ^_^KD zpZGhn&(sJK&Sw7Gm=GfL?zW|xekdNr#FzG&g_y|pl~H2Pq~kMmOu7c<~IPWZZti>LAKU6 z3PTAJG6Eluz}bH4Z%n#TrA`Y7rwxP}3D?Kg74U$NYD=fHbmZs=^J9WSpto}BSnHkB zw7{K=vc?A($@VW3_=b|ljS$>y>COk-6dhW&(&(mKaE3j%CFsjAJ$o|h7@LXR!8L_W znF01JzI)X(?majOtrmlkJKJ;k<%hRc*5Sp9^GhVq2eMG#rgALRA{2`u)14|1=qUg-?sKdyL?9wODWSh*yaO`c znD+ZYh+%lZYd3PJy+IWLY{Mm9HaFn&RvxKF=ZLI_YY6kBj$t|IQjwN-vtlQ-$&ce(nelcb^ z^hCU0O0sC@@Efy&l{0bujGLNIRXDE@md{UcGOy2mnNyrVo`)yT|D5L%f zrvDPQ_IzwAN}p}bEw7H`I8AoPy5EuhnM}Sq@AS z26?Na?G7Lw34BTGqZWY@i`Z*L^84nb)8Sp-psA{Z<%)G*>r;#pQYi)XBqXtI&KYBZ zvcX%k-%JLto{4=HV?E<)5!4w6@7M~;Cu{*)e?P$i9S98!z~4Sj`%d1!`h63e7@3D7 z`&MsSco(u8859X}3j6c3dSeJFgn8J>4aGC_yBZ<2fxJyYx4VKKR>~qrSUyhcHH!N6 zI(8TfswY{)81R>;ucDC_p_YWZIKb{e=Hq}yV3-7q788L$_P~FS_)}_R9ku> zA~p;a9Xr+$i26%XJybU~?hu`o9v9xsJq;hxUy#qK2IP5FDdl&{SrIYLNFDCE-LJwX zFBze`NBZB*r?QGCoKL5>{NP1}2eZ!y{m*gWFsZ(US9l6@@4?_Fw^|T#l{Jn9Z#>I^ z+K_-(w5{?3{WW%@2mG%zElBQZ>m~6flOo2kR-6@}euy{1lD#y;#peg@_ZNkx{NKU&zgbxdS}EkPM1VxIUL+#k7H7@M^UCL^{q^hY&C>}lD{&E*I#$bJm@Bh?Zt@*f7+)BthwUg2|vymq_(kG0J-NW$$Y zazceC8VLy}4C4sVs}Co+BuRG6AzWS&sA4vJ2-{Fu$GU+ZVVE=r1*Gij(^bzpI*7eP z%+O_=l$$I1DkmI?vci8i)Bqnj8l`5);Wj?!L8kX;2LlNZ*XrcnH zbl)WW=!lhL$Nl)U+0O7Xh|tR)IXFl&!_>u?!IZbg^Ri7SQo(q^ z@~IaY(TKJ&WwRPGH_mjZ@#?ikNwtKq#5^@$Z$&-(GEfv=)uW~i`im^r&5@uG;-Hm! zf0*Gsv>^O>u^q=SIsC6Y+6oZYDV%mHI<3<;NZB+ZN*#qqGf z2SKNUruF(F@}G_tp>CRi{xci>HW*Kh2-8Kbkgionzp^v%eAd z>JU=xuMDfAi$z=u+h7qPM)F?+)Q!~7^&VUpe74)!CI`R4IuTjm7~Z?u<>fTILYf*0 zO=JG_g#&EdKZPE2m@?w@o*z2d@}*XXU;zs90wQk$^ZX{S&MfQMiR5;Yfu{z$pwoXr zzvR9e_-rE$SeC=_`(8PV{%(uIq>*G-^r~dD#OAPFrD~I|`m`YZuX8q;s>iX$zhMdz zT#JaQl7+VyTI+)8v6bT{_EQz@Jky~y*nJ%8wq>V@11oXP6&&~Ng{lE))(nw@D;u2P z6OeZ&U;e_s!Ke)~%@jiR7W>BO8qX5TjQq@B+Dh%fsg)OFTFmLWu6YD^cHhXfVAOE! zkG!s&{2r}mu4XD|P`)L`{EkJU=|o@NPZkS%YU*swxVJrVXUQsLj7I>SS-`N8k9L{RGO& z4xPWhrn;kSpUvGoS6+`Z?dao-JT*o#s*$?rVDih-6KvlWCZ=*@!(>IV2`Tl~+BguW zvJ=Ms_~|A&s(ZFvb~8BxBb_<{gAdl7JRQj!+R+-)Ib0We(OsYW^#o3N$7QbghH1fC z=~2MKjpf$n=>3B_(73M4$AZGZ(4593&!wA1z>oAN(?iP(QI?AIhUpP~0A|{RC9j%HYjBN#U=RS!I)SCCbsJSFR*egQ@O@DR-netJ-=>=81m4; zs||h+F?RSuLcX#+hdjc6Fh6nhk1&(b%kUVsFL&|2y=WpsBg$Sgq__)`S(D#D&DF{>0SX5f*M0^VN4mbyW;MtgBBMt(%$vAJ=?EP%|9n;T;m9m#eKU zi&amzucO@45xALU2E}=Dwz5!zaSqRmXZS19f{)@h5$%mO{9*<`I#_06YOcEtcDstC z)woto#9bD%2DlFs--{TLBdQSQm~1!TudR2Wh^8#fmQduSBy?yadk-RX*Kt+U|BJ?? zCFfKIe{u;Au;aIy;O1(?KL>e$)Ys@M8$BcoLUiTCjo?@j4H0X8?j58N`Ns_yEH8sR za%PDj$)Oi1$O6*V-g~`A2Bd?TBTqeT(lpoL$`Yy~ zBq|~EWK_$SOyE@lg3#|GE>b=thw6a!4&_EUR>ezq2Me=M2c&5ROO}xvEi6D>3)bFb z;0vwV71yyj>2lhc3xq~FE5IZ=%tg4MmvR%8%QHd5yB@X_2U z2!D$RpA*o;H;qy3FCtZnAW>7GuMW-Ni0tatFJr)>^hQ-wLjasP;VSvxB=7=;?j^i| zL~=6kJE4Su!o@MpXjK2lHiR&eGU~F{r|Vo956;<*eObV4Qc>Df9qYtq$r4*aD<**a zuJEhAVhD9})%6E8V?;4(vlbJP-!*S}S{ZMYMn&%l{*ugF+ZB9#;YJR1TYGHgpSj3v zCJIr;4Qh-ZDrJuLE%}+oEIBtY+8t9G-$YuV$W9GyX_`(6R|sjwREGM>Qp=%piWOU@ ziMfwpiy(wz63d?(0(y7Pg^mD+`=a40WpYe=rewc5bVIH3t^uvaEI1ghJr-%zEL^;QiPL0{$wYgeLX{%7mxXr5( zfS;B+38mPkY|QaIiMZ?WQ&3Iu+FbW8aAk_yu`lPW;g@GZoy&qwsjN);+d7NMiL+Sk z)8y{Y`_>sdQr*gAJQd;TE$9j|W-a}+K0d1HNJhAhT(ZBuTa+R^%@Y(`DX7;FFqMqvO7vq$oDREuVq3a_+Qi++ zyfUk>5xWK8_~%q#+c-~Rp^9Ea7>Cq#yAHHoH{Dz zB3xr^=gXf!%spaBK2t`9?dM{Hi;@l<`8LY}I;$&-m|#YHIpNaBHK8w!){$pk-LOSEL4P<+uUu6 zxiiH!8?(Y(H?y(XY~#1@?|=Bb-=Ej}^?E%YkGhNM{r3JQvR_Z0FaF8>5OR}ts-X9b z)h5cw=Q%q)d+$;EqdMRq5h-D>GUTjci3-yWmbFfeKCQSXobD2*o$SSgI_BimCf`g^ z9gT-=wYkHb?@-mGc5V7CLP{|o4H_klqytqR>UJ{(=h62OjJ=L= zzH$2$!h+QHLqeCG-I~=8RA)~mb{!~nRp4?>aSx|U5Dg`}|Co3HSG#^%EtVT6JQ~1$ zoe^Ebam4B_)Wl_n5+>@J^T!se|KQ+`AYRYz#7>O zGbfaG6@{*m8wFW<4ay|ZT5T#*L;QCDE*u{|xNZ`4HR{yj+a4Wvw!9=U;Dd2suDOr? z0%KzTCwp%%MAY!TrePfi>b5Vvx%*QkQ^#BblHRX2oKdY>ktQX0U{Rq%4-%W-NdNXm z&qWs@Lgpu7H(ekd7}02?`(Lgk(0T07CQG^DY(SynRNjtvAvc}SOoQxmvl+j4+f`wm zLtE^t@&z5u=QYj$N}(xtYT&On8yLXow)qrq(KU_ zD$@z}=K!UjUVmghz$1_4pRjZGw;WO1?OlGy%|>_^fU5g^x zg1Yl9#^taNaYE&Dkor>FB&v=ESE0Ytzw!BM7If)N()N-n>u0+Ta_mWx4@`UX2g2;V z+3;0>9!;&X8~;Yi0ha^JyF3Os-bu=-f;z$?;R#Ci5p_pv4Tatx*IeRDI5#6cfe7;? zNvDUjtZa-|n1#@Mnkj|~RRmhu*HCwYVMDtk^uh(T#xLeKHF+P432OyG8Ypxo?Wz({ zRu*zPz}Mm~Xyi@Res2-@N#BqC2^QAL@5OOKM!6T)Mu2#n67J{ z$i}ShTPH+M55aDNNuIqLZ0nz#oo|7}*eTGu^k4{I(NffIP}`rp`)8cO8P=N*$X%I# zR=XO?_Y*=FXZFCW0EH2@;T!3<5zWnHh@o@n*03oXO~#_pSnl7fl^i;rM#YbfaggS0 zHPmqNyFuj(B*3MwqdP5bLXBH`9r9$UY#Y(6q~l2{ff~CBy|CvDkm_>S(v5J%|xsbE;Gp|@cS1ahm;My)SK zz2xrCLZmP^bq`q6bbTv3bK?(S6tQ=-A;;Ky&b3fkzuU5cl7HfD7iU|Sp1-hfdv>lu z=cwN%L|`(a%Q?PEM9JT6d4^u~g|A2*D_hmv4#J%3;a_m)p#O zJRkg+yR@mY=k^$9!k_a&Xz&*-W_9VZ+TN)gUNqx&sVWq`N0Ulx`>G3GUo}8ndbeM# zAz~h5)M%-)TBn1^1w1j9YkUAR>lieE4Tv^7K@4S6%Afnhx4aj3H}& zrys+PM^644{$FhRtD>gZL;@b`Y4Rzx-QM**@8o1O8DCBv(g`sx^h@}?=VVWSTf>@< zm(Tt_{o76+^swllUIUwtq{^BUsy9iBoQynG_TKDchB5A95aXUrR2e=JhAX8rS@i_L zeICTcq&ok3^t7h&I}Z=(Z_8vauKW2ZDnrL*A# zPl^L(>-u9-eJqfO-c}{MB4i(dYGVAIA?cn9xLZtgNhe`He;?Euu3EKmV!xN)GSwZu z??O8%JQ-fT{)0pMHh@DaPn@)(87{wJ`wV2ZLKVG4Z-*dY-0CB)Q7%c}S&*H85pOUs z4E*aZk#TmrVGkaDCBUUBmoRs3QF7aQj-!^aLCcTgn7Pi{Bs3bwsE8X1DLT{nay!k+ zY+e|>5&zfXK=D!v3+}Tdgg^qoFL(SpAlmFeyH@ z?_gY$o8MS2(TYX;fUKg96}*{E{NKd4_<30ANeTw;_z~Pv`>?{4(eh+0bL{O{(ON;q zt^@mD@6@FBHKSpKf5E&9X|gi6C%b%fl@LrQ{%ECok<1%@PcFY}ZjoS+J2gbUfhRnk zA7M4hqM8?3Q&|#KXjM^5v3P3eo>%>(e%b>JYHIa3V!Fg%G&^3Vi(`4IupRPOoK3G# zH92wK$n^!t+_3)WyF&}0He84jU;4Og?YQg`gcWNPk^>E0df9%ivmcb)_cDC4qckfQ zM(xl#oVF7zJEwl5d1_?VVoD8&<`k$&^;1{K4n*b`%JfU1agVCavb3U;9I&xq<(QBk z8?-eYmP5kRp+W*(V_#ubvOK;ta!_p!&lV}W-OoX5{G;Xi zgCrB1W9zhSKOXpYc4IU!ca%5)LW}e{KH?o%H+%e7u3X&K5k090LJIsgeg}7>?wTv$ zm7a{*6vTLz(V}wKQ*Cs^$eYtPT^but(o*jb%wq^qcqM-?5frKc3_$Qf0f`Ocwgb(6 zRvuCPOM7i<0w_vr{U@B4P>D20`jf)RfBxV&X0cS( z>ABiEEn1Z^#G*MoJy%q?xK&gr zS1~J!D79N~+pdupM&|XEcrWYXhY`#vf|P4#Co|~MIW6+i zbS@|CG=ZTKZ(&3XD2%|J%)Z?yJrkm+s6uYHoOTZEJ9UpR-@7HwM*BpE7$mAb6^&fp z#uRTlfl$lg3j6VZ!2V@@b4yz5&IA%K$B}c}h}LMD9oGWE1oeY*=COH#`48gcH|<77 z(yk_?SxUUqLUKZpMvV#6W)stAv*>=)yGwxk3wQh5^^HtuA=(pP*xs9Y3*v~Fhq^uX zsy@@z)`<=`P7V48`1a{ABuLk`3HmFIoo{^-fFQ7@f8C)(4ddgW7Q)ng2rt7ceoHC_ zb(93@!YYPh&9iM@2P8Rx4RD9t|eU3y*ne0k$tKTG2S=5 zG{_294yZ(dd<1d$tT68kDS4sRBW~?MxKVb;lqB_Xm3t^ZS~M5GDRL97Q{#ppu$OX= zX;r1RX-&|Vf$BNNcG=UrKMTL{_u@ffX$H6UI}I0uxbKo|Zhqb%JD7*FSEjyEAGoc_ z`iMc#1!leEmG6bJ7AUTNDPf~@X#i~+eGsyIW9KCGIraBs>=Zn>ve}B#;bq$j9-pU% zAj5a|+MAF6%PC0YfE%pVRo9CLbOkNZ0ltvBb?>?65)sG^0VzaNpb;qkMGvvk9u)<% z7k}$PC#>Lk(EqU^gma3jWdn^`QZ!j@n)K>PGD=2Pe>*CTZZRh;wvBHPSleP90}^?O z+(*<82p{C+;y*!jSq{DhGmB8$Vnfs`Ci>iuD+7SJaBz>tX6r_1Z4?e<{V}zxaIuwf zHY=v=P z8Jclf{iG<*k6rR&{T8z9J33bDqueZ*zp#gRsLDl499N6LnjBVi@W8&|N6i+xj4IC9 zMom!xA8(IGDF3w)tjfeXE4al`$e1OUXve>w=cJfgFb)x!N4#^ei zpFmsNG~1&FW{5nzyLF}O&^)f+vEd5meXu1`!`FI`eduEgvppw3IlJ%VZhi}OT|Z_2;R6!*+9lPEll8N;J1+5N0|tKr~+dJ39DAM zc&-%-6kb=(c8Ib~&athsfnaCT@7XH%FDL9`zr#aC#w{g<4IoL07#~3onH(LL^2?X4 zq+GO$Y^;J;7H$@69-aE@E#GsoZwqXuw}bljKhl*`vF{ws^9VcpaRbW0qC+?`n$-2h zv)yx`g@m9SbR^CVvf$zHnPUE8(~RTdQ|6*_&&<(q`MG=CqWa?PmdV7s9%bpCQLvhp z41$#JWtbhb*AC*9+x^o&z_#f_kV_7WTgD3;Yx$?SI7TtpL}WrWM{eu0IcrXE%-9pQ zHcpn!Gz)1~Z>5WJ_`AORjQFK4>dm z0@)dyWCi~|cH25yu+WyO3wMi9tF_%K&9>6g(YZ1J7Z_S5(4Pf7f#+XPO(37SxAz5 zFI}{}qK)+Nfql+Qk>_Io0$Hr_qw|^1(2pB+maevHJ4r3ph~hrcPitz0U?8))7D@2f z!t1CN#<<@9wpKkYqJg&1XV_9&J@;9)afIplSLkSO4$R=-q6L8)0TQMXcXw~yS0P*dv}pVBWKUA zO#9_x=HfUV2*f5SNltX{(7W`BvpUzd698niKRp;Gcr1l3-AnfNnm2Rht!-`&Gju%9 zttd4d=RO3IV&AAJK25w>Ve|!ydn#>wb$L<^@~Dj~mq|;#Ws>O_P-Pi2a6G(NtM0jv zpY8|?^$KWh^70mU;#*CkPmh1^X>QA$vnXZN-{&Y@i4&Ml z%Z^`zBlhyAs~}l@wWo8bFrzV(=F(9gDR3DG!SYI*wsNQv?L49E3g1BP;$d4@XNeic zNUmT|UeYFA^me>YSFLz4nHn>XzsXCEGdx73MZXgfJb(GlPr5h(w@YAHr zYjsAONEg#8qm9MHDeYOW+1z5b*Zt+bai)(IrllwYHh?(rmd_ePSb(pQ!o5eWnpdq* z{E2DCH@9V`Y6y4hK}V<^x?p9w=oIuXCtI7C#$H+Tuq|sW;L~CtH#6t`6WnQp z^H}l|zC$>96je#lS-h_(J%rkH_gqk1iAua(KRLiwa*he##mZ^)NOV9#yIb6r825ML znKf!P6Z>y$eBZvWGF1zZ-@l~n>3U8Z{Q-qCAyr4M!a z|Ad-uw^mH}q{5KveRuKhgLt%ZVSeAQV+z_AMXAyQP@o{m{i~&?j9qX^G z@5YB1?z6A-&#|eU3)W$-l!UfBiSag*qPK=8yw`gom+cr*)$&Eq8hN`W;(ulJgPEQS zb{)G3>HP3V+1AMN|on&CL4Y&jx~@maD}g8J$o}MZ*2LX2zmev6BGLRW1pbkdR|Ps z2KblDziG*GsX{lfP@M95m8e<$7GT3~81H8;#-i|y5!RqpzuPDx5JrsB)r36%MuVU;BI88q?pZI9oN<6xu_*SC_>J z3O&`(SNhd437go5*oQ{CY~RF5BC3pS*CoL%j2ATX!NlwhrCX12*UE78Qs;Y1AuIf8 ztn2Y`8-tbV7AZ`D)*x1)X4u^!xDOKBZ4CVBvB=*gR@;3mp*E8&lc%E;P?p$n30qo^vF#qy-ER5~@iukwgQwkV z00Pbp+WQfki)N+Ci^oI`NxG4N0%q$us?-JFfm;;@pl@Zj%A}@X*hx6Qa%eL)m}K6@R7O=qG3!DS=E! ze(a~0>xS(hJmg%_5kAO+UFq!o7F#zhwo`GFs-SyG#@l2*&fYlN&5b!&x4wJEuw@=u zcr{uIOx=j^fCvuUCh+z>2EG^|9vXQve-CThjt=i2AGo`Et;_?ojJv+@6!_Wwzj+s( zuJOTyhMAIPJGqDu6yaN5%Q=9LE$A>P3US&=z2WiRW@iU;nviZ{fr7;xS0pQ4h?`9O zstKiLd7tE2JI{8mF#NWx2+Zgb=yAYca=LC5VfJ_EjOOes{}A7kx8K|F#XGAUx%%>W zrAI=;boxdg=X>?z;hyC=t_kQCArQ7IfB7{pQhjC9WfCf6?CmeiCx;GC!oiH@k=}9( znEbRf$hF^mfaajxOMM^e=RKZ78cXJBS}L(4Uc?Uap5bkV6J*jd_(3H5Nm6u;a=~Q! z9r$hLt@8DPmU{V`N1UH?E$!iC*ToixDv`Y)Vdl8S`Dp^g_fh4fL3L!TLn6egxk@w1 zd>Tjj6e0S0QIXkn%}7CBYh1>2zcQ0(S%AM%>U<;oy}!e!zNN6cQ7V`#7*W--mq%&c z$Mt;Cj_#UMq$AL_TI*;bch-iGWV*M`pMdk9A6Ra>_c54GP;nkS%N!S&~t|FK>CH_pw2+eJEZ zsJhcAhx}=`5{NOMapoal?A{njaxf0zCI}St>s8@y0Met=MvzYPy+g!Hu>J&13D~1G z3%S&IRqb}9F52_)*KFE>_wMRri``fyQE@Z8BQ zoJ{WK)bcDatZF_rfGDC-bPrbme>{=ruhH^6|HGCwhzql}#N4@~&o=*?74_sK)-mfRIP&x$eTFr`FqO_b0D(aNgji z7zQt(5Qfoe(BZdj`b8(>=tyyb9=5pp!;!zR(8}YJK}kvEr?Kle5$)Ip+b)z17&D3A z(w?C1XFg3OMH#)iWel~&E||9rMxR+%Zi7ip<&wgr8L9604|WbRBTj7|40UL^94e6?DVz8+YAu#{^ZNYFopc$ zPAkpHNE#s50J5{IZGb#^8^2^xNlXX05B*}Eqy8w3; z`SeZF*Rkolechm)Xuj*bJlNd$tgJjcl?M7n*rGd~Cq@gXj zPFgZraKycI{&{0jr9EC$w&=bv#5{`SEY9p5*18ArX6fzG`zPDSkxUK<4LoLrd-Nf7 z_?!nhctet;FOHzz)V%wQaL*cdy*6<-0ZjG}rtet_+6xwSr{NvQx5p^Nlcw|eUgsaLfBhOpGG(lA&~o!ZRTwriYaqP}IGxjO7#1E)v5P6Ej1NXqx5 z5F@W|BW3+kqpBXvd9wN6`?nvBUP+p&I6BL{+LUwFW7-Zvv_Exz(b+^Ds7t)@`HGN! zY9Qo%*dDzDj+Ga+oa3&6RYjea;Rj#a)D{TUed7uN>`O25RGvU%=~Q@#fA~A$CMweMENQ)t*AeIE{{qap7MPN9QdTbASCa6Ze={uMY|KEvJ08HaADX z&QDyTUWdZH%23P7_fep;*Az1#bKp&U>-fM zd`y=%=;w*z^DfQIHQ&=EKxgad8r>CC?|6Vi6@Dcay{NT5A85Y)^hS~8i7lfWhbvMO zLXxN?)sixM~M!j8^d4U8W|fo zsAAP2H`gCnytR0Sx#+(LmPv8Cz=*mtMrj}z!VU>&k`A8%gGR>sW zY9b3uNfGH>g9e_8g=blw)UUin-zyN<3pRA0RH|$3f~oO&F&}Gr4`S}ZPpCHc*SS%( zmPS%2DHfr;^{tT0Q42^}u}#Y51>Y8KosVCRaf4N%Wl;|pJxz9X;z5*mcX3|wv-N&Q zEhxj0d>pXGIExL+hJ{wfm9#`%ACtfBbs_}rf^KODMD?cLtUTygyVOlj_=5Ug|Gp|D zX*S|i@fI-EuBm};^viH$3a?cHU(YB?%+|7%Iz)HS$jdy75ZmW|q-PW8d2sx(JH~Fg zI7-n`O)qOfi7r!02%o!+JnNA{D2_chaWK3Jq*1=!gLa^c|F>a}@!v)7FleIUr1}<< zMX2g#u3U92+9*MK(571%#;Ev(_uF{?p1zqX#mhA!zF% zZv^Roev^df2|h)?XY>S=1V+9VpkJiV%2K*?KY2IQoUTWMymeiCG| zv&sNm*&nc*Yd*&dO_ec6-*A>~4J)K~$eJWPv;Fi#>+lcY;IuMn*!j4wVX*1uJZve5nFDO+u@fE$XoBZ45$&MTaT*5BP}I+EzAo2e%Rx3njA64 z^VM-t-AJs3%=+6^V$k=Fl70|OSh_`c(^0p*#o|q&{-XFFcu_>ZKQ^zi5waSyg&Ja0 zVxr0OSZm#WFN~^5&`&TtA8hnZB?{rxes6bS*l&tl&Z1Z`kPOme2`#*4WoHb^Tm}D;?J*@m)U|4X8dD<+l67VMtsq)-n zGCI(l&Wes;&bnxNvsJzmKLm#V{TS>kUIrnV`*^<%8jnMxPs{%4%FpMKeiIJH{xmg)o5dC!PlpWV`kZi%3>V)tW2$;%$LXXGI0*^ZK4+RF{eD80Z(y|>&E zoHAy-WA-;q={{W>CD)raw)PV|9`tEZm9Ki#^sm$p>+@-I75hS#k$+9cc}5Xh?l>DG zkg&C|bkZBnSry8SjU$iUi!GKMG%8_W|D2GnhbG@m^ff}srDnL_haGXGHzoKtYn9g# z&r&31dlTX=Y4I#Rsv-ZNL882TfC0a3o6OVx3eV+lRQ1>Z8 zEh;s6?5^-J&JYsJTy=agu=@^@+7$53QySFIvwVGH;h28I%DJP$sjeL3qM%L8pw!FK zguB+l@1OdRbslreAWY>qVVBJ3Z%IDPorRp*bUO0sBoCH~f+?+Fd z&dUJ5#gX?1EAf|4^fjm8KhscdhOnYP>?A78Y{&+rWBn18cj z^rPFg(jV^I9A2SN%Fj>FYIGLWN7a(t8j7U+`=X8be*XMP*+-2KY2C(OM7e&m`~Fyd zUd~!RYWcs2EWlSLq7MG9ck#AC_P`NdhX*F6`vp&bOE2bfRo(6dW6#60$V;r<&5lj` z55ZIaSj&UK->)E4`b$V z02@F%fANW>adl2A;dY)+!4PYl_0?-LI3-AVz?1;rq%Nn`i~+7sfg|`P!NbG4T@AB% z2K8BZn8oUCDWwP`tjaxB&R&wMK6~+m`A%s%1t|P?reKTDK~SixanxSh{+A~EatvrHx#k+G8t$igyvj%#IbibI`O9U>r14 zEwH<`oa}>Z)sji17gB#X*i157CxNQMY=o>?Uc+!BN!1r=na5!%L13F2h8Zvg9rLpr??xaOs&#Bi-Hl!*2`V9;+FjWgO1fnYfGK=2 z@ziH1c$ZR_Gvnh+3641upr&>>@yms%83OlC9PrXit>}rNulQGOV#LrrtJ2lK>!Qv; zb!ifJQP6a6&ChJ3Rp)FT2S=!Q`ZA_^$t>^Ij8f&b31+SN>au2_ zc^2S&5iCO)w6{b>r$C+0%jfjY6XTciH3?Ed8UUcZ{`WOfblQLKs(*(Kd;iTe;{z_D zj!pGuE8};Y>{EB;{*l8u`-;@iY`un-mSXa{E=zY^{CIdG{fp6FF!>=d)*P!? z88N}A-G{}6Lo#hFzSzfz-%E^JkQN`e3tt(>m}!YyK3Gbcj;3!i328~QASP~liHek5 z*SI@LD-0;sP&qynTVp%Y^^ow(02BQ|7by3ro{ujHt?dJU3s7?M4!pdTOLa2}`_l*n zD0yP~MfplU@0^@O?hG(}4t+79ud>z(Lgy7r33tyKR97+6cJ&M}pDJ_Pca58oFEL+~ z^=hr^S~Pct68386E09IBPD1Xk zCR}c_pj3pjDr?TNC6bfd^#=S36KNBVjFh<2F)Ib9j+oQt5Dq*q!bTr!S(@^V(WD$- zAM%Vo*qJeYTkEUm!qR`en3Jn_%aFrrYj|#py|{;9bA+6FnMgC1qOK~9aJG$ZITaRA zOeFv`-BBN{?2Iq<&~?f91T~tgspPPXO}z)Uo#Y1yf)%9L;PtFfqP@j|(GLG$DLnX* z{}i!Gx$r$f+H9*qXZO@>Z<)+JIG!#uau~-Cq(#slHXL>w&l%5P-L8p0XSGINwZkrD^^Y$T$lIsspJ|8E^+97&hIEI-c>5h}o-9$l{V1HR zErCuUl<~L^tomc@VmINlM!m?od85xfM?#=fW>MNK8M=(Bj0g77N@V#oV#Pzh5`!Fu zy1o_l!mTD0A=!jTYr(3HA-^J@bou@T%aOY3Gm@KS?Y2183ZXxZRbys!d z9iW+HF3&}=G{O?q5ZJ(R#A*qI-{_~CuthiBAUpZC zHkonc<$heSc*MDS{zbcij-l+5eiNgVv~bqDhGJl9BX={_zSJ!pA z9GX-ZIPfm)PbQtF%xife(slN=2_KKo2V*!v#zq^t>)IP<%e(@cE*dkK+ zuave7KKQvv+JiYgji35v)lk%+KhEz{SV{hx0Sc^wB>a1&MFAfq?^AOr@nsF}GumOq z$N{S3lvy1inXml{ClO`Cc}g^i;BTF(xMme+{v}vw_j4GEpEW&nUCmVlGHelw(TCCkZE&=D4MJrU?d8GMU5jD)|jU?-Os0m$o__D z4w*)ochLy&Gci-k@d)5>%hQ`Ny|@v^c%-3*b?l-OcUB{VW}TL;iD*(4|MmkfmUD7a z00(qOpLhY5(nlV9LrOWmw&8~$3mJ34uzsb-aOqP^_>MmPXO87DCIz(e#`f$Cnq`h7 zbr-CE1Zc~i^00rsJB&%gqEO2Dxj?U6;ywvon8A!4zBG^Da3mD81r%ThCF}AymonN3dAY+?pPimJT_EXyL7W>MQp-z3)=*}R{Qjn}%$g*M+Hr##-Zxz^b<6Jv;VnUpV7gLJ{8 zZivbF9}XSb`+R~}HBH{Q-MN0tl)46%u4KAYPuou+vB!n4yO;)mZEdAq%2_v~Cpa$D zSfXlX_IOuQ&>&#tW*2B7@tCQzap)if%dl4j7Nh7okCSsyzJHRWFQ&T9vNEzZ#E!P} zmwbX*iIpOX>Q7L%h*NK`?44Cg*IPG>(9jSHhNhtr@UVI z(%)tsj{8vZmyWJ{G&c#SOch!T((v2mBYLc7jmFf*Q}XapuWIpY$a7V%t@5Rr zykyVnyuDV7ZFP{wwps7VsdhZx&|9gdhUKVkI6DRDcPv&SZk3*isq!-CJS$3}{+?iu zzLZT7UJ6P{Eo;b1LDyD2d#7?Y$eupTi zFw^J-799$#Xga7MAjifPwk2UV{wtdNUHVgmA_rbvh5s0Fxcx`=sR#6FA**F)8o z-km9!9oyMLe|e9sWf7VkGGm1j*X5DVshrQxA zyEYJLq1l!@d!(NvcUd?IvIqb|l7%U%z4WD9>3-RYhi_H%V+x2q#Y0>T zg}3+_Sn*U8v_vp0oH^b9#kWRu6Npuv0BTXMjH1|YZc2M|iD=>;qN$B9?J_aP@hCh@ zDTj{e%SaY}p@0;GZIa^pSEE}0+w~8f3P9OS`egO)F2zFsG|Eec&=39~{hGq(QcFpb z|IVKaj@8eNyxjebHr-91f4^1{TM_n4EAIBHV>;y%dB5(2O+ULLY|f$1l4gXyyJ(x} z0cB6rQpUfVOH!Q;OnNWWM>PVQfKludpytJN)@T#Bz^~w6VNP$I`ZmSl_3m;f-uyWy z4}2OcjC-%pRDa{bb`ylzl{{3gsdedOKD6={820tzH#S-*uQ78sU5u%IZ40wDtJ?py zmO-1TlOJWD_Hc-o zrd%e|JVOhRiOQbY;S(8ovF#y-eRhaLRlutrI@9UW`JKop!wF8Q1XqV-!kab*n-sr^ zLYgPesx~`t1rDcHfK^_+uu| z0S8l$RJVB(lm+s*@tRc}bNT|RIfxMHAsdXIiSm>=K0qPu^@pnzLMO3D4Is^iXBgbd zUbCxoNJ9q7WvNzBOI`nUaUDq^-jb^5`u@4sGAg`?Bx?!IXU?;d8~8Z<~RoYi%N z9(B9-6b3nRA9iWI?!L2KTJoF&v$rxi2|9)Dd+==I|7V~5ae7r<4i!0yX~(?+B?v^+ z-*7n6*GK=bxd-oh#OmhYF$eq$>IqHO(Z1Dx2Zfn9N%xTe1nN2dKjnI>NLxIqkR9DSI>-$v5jk#MZ#c3mynB2$A=>}HlC z%FTsttNjg(L6M(DB!kM=goo9--Ycg}s?3+^v9~E*f+iBsr&M<0ILtZ-Cq%@9bsb6%ewJs(m)1z`&f2gJ8O-X3jC0(rQkC0}7 zaCi3={U2Tj^gn9w&Fa>Ys}W2v3RSc0lS6zwpy2Dl@|}yCk30`tivy?8*e6 zutoCyrKoz@oKX=zw;oi+@{!*I<5%ctMJ9W_pb`B~hQ}=+V`xC%icR(I_0kT}C6MvJq zS2I2}kaB4*(&(}Ljq##;_`>MOdztqtkrSZ%He7eg0OR)x=v3}v9Tp*|>U|M9lcSyS z3s^qj-F43)Iq}v4@`u8PJ)kvU%OvnTr#vT6V~E%A2tHS_^N`FX;asjyii897lpZV+ zjjVnoUJn%1M08ahGXhA$oX)F0B6e4}Dfvs#m5{yNTt=pKnKe?gc#fX!-dxsORJ9Y@~f%QNPh4t&$cLLvQ5 z3zW_n-f>@?=P07(!WC*+BMyzY-M^v)L8kx};?`~rj|TNpDfj3?oXVP4p<;*1%M9qk zSY+WXQj1-O+u}qqz}@T>&YN7E7cJ=Bq-+qGeowgJ)$~x%6`+?B9Wgm$j5ax`cPdcT z4)V!xwbj*7vsL3;sRO5wqOmVEORM6E&eV%D6x*uZz z|4|fu62VN$s}M!U4Lyvd9dyz(mu{0*XR#-0r2pk?M9+*_pq~Rd-{w>R-K2$CZFFr` z(R%8X25Tu;=Uqt135Z;;Yg`G1G|&S~t)B)M&Nn#s(I_@}#EE(0+vK%hD_b;u6|)bw zI7#)#rd{h6tn)%+Vmi9wLZtR#K}XqnD4Q*oi7RD`7N4-jkyjqq36`D@L?1_*;DF*) z#_iGNnUzh93%Wq3;zQ0Cl`ydUfEbFPgO@G-1FCiDg=*N<(1&y9?t5Z9(2@@xyVj6D z=C~PXVbF1Uwd?6TqGZqL$`AA4a_g*1=eqB%a%(UjVw|yIUqckLX5iiQkkHWp@#UGe zVw6VZz1>y)POv*#PeNicHNDzNCT|QJMStu3dJD<35i|Bo=5>~0&{ZrcL*|cwDI7Xh z+(+eiCX3(CFBjpxoY zW$Hz|PdLH#f6EQWBG4P5j+h-X{)U3Iv2F~nuN?Uk7PcMs(dKK}P`lL|-{_=i$x*z<3(}VU@V#$r#39YyOFDJjz8H zR7dmaQe~>yh%-ZL$**n9MuM<)!BkT0xt=2TE8Jk5p0)V+8hP;0Ty>L3eHn0NQuJGC z@Jj8&H0#aFVWkhRAyI+hEgutj5DVkwIOiy%+eMN@SUzAw@9B|SSxL3;p4NBQgCgtqtDMMDQz8uW z08iyduNl3aQt!9TZ-COiW!wr}d=FMsoUfB!TBOSN*KU83dqKn3RMmiV%{T`iBx$!5 zoW;wB)p|D$bYmOhBvxQFvm)#oE1^^8zNJW{vy^RmQIdf!2$p)XDG|xT0v_XGc~UE5t1(jqM4fRXX4UNbEbWsmrFIAhGbukkz|aZGzF=fOEp6nUsI&_kn& z7m7~EL=%d=spmAIu9HHqw?1c$?(aM}I?&SgXlMHlpR3&!uw4uLfli42z+~Q&aZ``* z$Vb5A_lw^3Y>dqa@ql#Gjth=2prVq8&`Y+G@8#IQPH_YL1zPJ$9=4c}K%sZIdnFOV zUgMjo-^MQ~eL>kc?OdPE!T|7mo!UE!u}+EVG{NUe`E$RKfYQhdS0A$@&$<%HX8^)! zk2+;20hO+e8!`Jle_8$4G1CLaXR|V@up8yRA8UQufvP_Yy|+sD0)1;j%~X=BQOsW8 z>qTa=t{vfap?H5#va2myf_L84ohwYPRx-uhS_qNMokfd1;}K5dw=jYpb!!3U02g+X ze+lrECaI}B50rH9DL=im5`hz{?2+d=a(&YetB&+}_0iO+)xT#n5uBU>HUw||tM8U| zSIc(=ZsscG4~6?`ZC;Vh&ZUt;EbiasZM}Hilhsi_Un@Vz#OmlohAF!q(FkDY38dZI z4=+!}y3SiYi&p(folZ0)d?}A+^a9XZ$)9kPQxnE#U&vwTy}C?p+V{ALAk=b5^OdVM z)=gIWRv{6p=2&mpC0(J~l=bSI6*y=PP77+j5_hW$uush$C4Q+R*R4!T7=u6Jr|k*0tUM z9_`8vW42!pFqc3(t@BStE*m*o4UG&w3qYYIMUY!92(I_6XVb!oQ?Z=VRN&|EhcLkb zHq#CX+HX=xw~FAilwkqtf!WGUbw|wWtYJ#L+^XY!#d;Z5_=KzYqeWYg@rNMc4zRpdw=gqM7!(4#l0*4?1#y9Q`TX<+ z9YmnaEa2rKh`q+S!y37oS9Ft_Pay7zE4$RJ#rEm_w_HaZ7*_*GV}uSVd$-ooY}5l~ z71NL%9yvR)xH(%bu+H1PDuU6fln&+8?reJZP#>IQPh9%oxkYor(fM3F4_f)%{pYdD z6P+m*AJymEY<)a(Ta}c}0O(@#+?xOrlhEmG+DGr8%h#@UAGGobUocul-tC;I4&k2E zg%u=Q#ph_7OV)pu`BxuGtc!Z0A8c5mpEBPX6`Eym7CV2y*6+4~eki27oy42-=~Ib+ zbp2dVah7&O`>gL-;l^yo!lfab$H@CdB2LjrVyN#WNjZjION{Oh(7zXRto7Mcx_r+) z!cbK@HlhZ2z-fE{hjT`?i8FBP?!xp?$UD!YU_j1|^ZfxDm5&so6lPFdUq&5`!DDt( zjQrGU$Zxf4ANaOW;zYh0f(OO~umo-slM;hw+)y?*g>w(<6wX+bAy^0{t)63q5=JEE zaZ_ml&XnUY%8~O;bcs4R)S=_rdupYe#?oesVu#(1a?3Xb9i2n8d8CS6@YWIBI3oGyUmBG6-hswA7Ro7f0-fUr35Ru{K zLHM_nuirKPD4WzFaxvlXlS&)Jel^QGet3b)i$ogWrl@ZNabCTkDrSZ{dG+^Ks88Wc zaPzyJwmt~yn#-iF5>YZ?tw1H_j5nD+;{AF}z^L;l5T+WE=!8fAN6~pWB%S|%{Q5Sm zE49wja$#9%XX;rOZmcZr&J;aM&4oE47335J6_BR{;qHt~LT&x|%pp?~n=3#q zXt;^h@Pn`ZO)_)#03vKLpXUe>HM$-%WC>l@Gh7hkl@TZ`nq0q?m_jbRzHI(Xci8raJ%ic zL9(-bVy-E{pKXEvNNlf6Ql0m%+3VriB$lFkf;9D`xKt0{r9yzW>R6*ecA4fC(LF(8`x_$chTR{Y1Ky(5H#fG~!{EVBF>vF4 zN9u#&xUXll@}qlO-u$T&uIP@^tYiKc=aqL*F~GKF88qiiOHb;~_;85pbWa={)J3%F zD6JPXb>ow1O-#$qz%h%dA7$mtzZQ5E*-;Dr%_br#bzNeAi-L zZNgW}J=GXWXmhjs!Vw-<*>;hv(x1p?Z5uzxH;A5Gn~*npHcof%8#1=5{-*u?>g}Mt zrE1A`@sFbsym??}N<+g%aG3&;ILlXXpo~KfN08{%(xw%Qp)w5)3866rVl{K!!q|GD5Mle2W*J!6{k|<>`{5+# z9>~r+p68iXzF$;kj0p*{4KgTvubV4*5}r)_RX0!{GvA$E`UdViv3G;| z0v~L=RURR!apO>(fw`8N^>;WK#tC{1WfQ>cn6beP|0I*wVY_-2{**)>(Ux@Ka@c78 z)!AeSd^`v=A2V~fqPb*$4#_cb-|}F@g%h4wt#IT}&vSI0&l*YJ64bSrNOrevM768V z&p6Jn_gx~>cy6Uncxvw3E#4(NqMTvy-uIds*5lZ|tG$kFwIcEv2fb|LsJUDKydgYm zKFQ(xNRH-T(W48dY^nlI3w|hU~X!tyaAYg4Wa2S}XG&i~5fe|Y>qMB~%Al7p^ z$1J{sksj4o$llnu!M(tIkEt!%j*9K9=9J^puEu0T2-IfoaTh#)oOf5Jx{182`u1GF z_FHUzK=~(4$Ne*bn6FFuQ416Qn7u=!+eqJ2Q_v@@wd|$u)wpAbly~mtf9t-~&?HKz z&Z=z6oBDwTteO3}ZjuD9?O_+Z`J6U5a6*ePmj|qCxgGMYUshxRzwl%v0tuE4h{(IG z>1pa6VMoUloG;w4szQFCT#6rQ=zl0nMO>SI&cZgfX0j%JjKZ-z$bISgqP=g__CI)0 zLBU|w7Wykx{`7AUJ5>T->QTtxcm*uwJ!aThWo+qIiEjV>+P22A*E3_-ixhLnP_kVfk^aP8!!qR=N^!pwp zXHBzfe@RgI@mBA4$2!;Ts#k}$X=k=!Fb*?2OVss=d~p9cfAQgNdh(gypcZpmkD?Y2 zl%?Y}0eBG*+TE3+q6zA#Rbit{-%Er6m#rY2`ZJ*oWJ7Iq+ z9Hvzr6?az7G$;gC!c0>k@2de}y)D{qjT zE(ObccOtt_7M&tYYm&j-o`)PodeB%war8Xg?%`A~tgW#kxGO2y+pGdwWhODh*bJe>_Vt1$ZvG?H?u$sQ&}Qj%ur^}m z(rj;{aTMnwwjri`=-t3z{>QFQ$X!vuXcdkRSElnnJDl+TAofCeD!V5eH?(<&blxI| zdJ%snXFkuF@Lv9t42ZAsN#QAD&CBVqOjC5#u?5p(K~~Ifbs+j%Nf$g}an3wP>;_`2 ziBIg*!fX@diUD|iZIWZT*`(xh{rfDKE)lX!nWl`@wx2GH@yP>|<7Z^N=Z~%sw?;%;N!vai~GSVEj z-?ij4`to**sVP0y^2PQUB8hEyIMnziP!MI7^8r+B2^sj5mG;Zm|&Kah7kBoUn}EX)k2FF`L|Y5y7SCGV!sV3A%h!t z6uCE947iOxbN}&I9 zKu@a|v%=)9ge-Xb(zGGzrXocXQ|&-6X$gg;>S{#=WDk0qB^5PW+uR&1-@*Uv!u?h; zsLQdL)fyll-tIU`Z1!Sy8ZqYCZzWvQY434##_;eu70W$M*6G68F~5sN;%Muz@=i&a2gdqI-|cc|w}ZPVNjp-&BBDIl(Yv z?p36hAVH)!T=m>(M%00R(%QcrJHgckU1yCENEt1lMw_nyH6j-zw+jEQLB5NBGBRkS zwJ}aG@bD~sA^_(YZJw!Cqq2ZU7Xag))I8;L!ay;psV-qdg-I_@MM=MQR9`c-9Fr-7 zfe4`;wSzl=AH$3u+i%0fhRC1et8r~h`C?*b}I zqjTIv;&h4sd5m!$4=lbbG8p!e(ynp?*1+U{dlcum(WkUuEbDA37pH4#YAyqOFFH38 ze`dX>#1I~|+Soi~{$TLqki90AHG?h^@%+Hi^@Fe9&t|de(AO5!*G_fh{YYu4h#llt z1Z`cS%8ZV+AW0;3F$`H}vv?bCjdl{C>q z9BR~y)#L)WLwfs$5VA~bOgCtfTZPJFaxduHztkm09j>Uu(jN2&Q|}KSS40=H6YI!& zo;KH-=c=~9`PLC0`+bLK$2R2)-ikL;X_hZc&J8-&Z52#A;uN?Nk~f0yM&6CPVK*Bd zxim4Gq4_vRIljC5YQnYhu%xBZ`)PCZTPd{rD#afs>Jo&0aiz|Y!70H25jEP zgSOS4_o{wI`)6M4n9*995JHA}T9WZGpcm3(Wfh)d78`?~60V*#UmwvOYJKN(fZm9K znuTNXhmg}O%&Dmd{i}ALbq|jyq})F}OfBXz9~n;R1lFp8vJGvT@a)w*rA?+cWZCy8u7E=Q{=R~g zAfeT*2A(&OrL-N(T9bSqQA0GG{lQ;AL=JqE!pkYD_s2J}9!9M-o>*Gp`Kt@5VL|>b zixa}fb+{@Nv-ghKNRif%DzyWh5LTm=W^%*nu1eSs4xbwa`VDM$Ov4_@uJxdm*${%} zxb|4VxRqDw6yRVBXB-g5Ydwe(02)KMzU5qsID#w-lR(?V?Y<(|$8p?$EK; zm|#;@k#s)!%xD@u6~AX0|D_zej88Ve5ZJPg)ibPEc;317k`KL3D(qhQNr{5%jg|aS zx5M+b8)5o!tQAac6#XMQ=+aj7db)F?#!FO)2In#R67Wv&!|`S+^!yC7J)<8sQ~#7& z6L;7g_eXsk2>~3YY1Zgud||vqsH)y@p&BchL9;1KL*9>CVw(*4SJUjQqD5y+NtSxO z2GbduN0gexOo$Jy@F>4t^?#&S?c?5uO{bZ=#YqDljz#f%WGAW@ytJvOJpQ;-(fBT! zP%jt~e(8^?Ox%f#{)zA}_WqG=9;|pbA&ZO z-9fEsYDUD&-OlBpAxR3wkl3|#vdiH6Q`|yMufg~h_+*gDbeJ1q6cxnIY8HgA-ExOB zJoUi!ni^~4_EZN?ybm{H-(0XRagg5kNyHnz3=A{xEQi)^`?;(@G0c47&?g++4ox(~ z%MRjBE`$|4o`1JR^>uFYSmL{rdQ(8brC8Cj|IPfI8tse(24?v%;F1CZ=SBI9!WrhT zkID}-oi-g|*yJeRGW^NuoCzbW8nSx%eEj1;@yW!ZExw!90N2`vd4F!P6na>-J+>p% zBv0H;{EQFTiI2%z7F#WVo8LSv5}nUStPd>oqZq5dSr?JeGgpyh5lK0GW>j?3tH~Ts zWdD_bEFo4P2QMQ9lpWhbNEdzl0F-n)WK;8ui`9@?7vr60^#VC_m40e!oSDEUo97}G zzgR5C!!Bs_ya0<5<`S&dHqMSt+kF1C5GCX(b?*SZ9yqgb{?Bcv#Vo=vluxy`Gj3~9 zU4Ug=A9uA>p#Q6lUFAiY>$0Od==AGpv>Ps7`o+#?ULkv1Nah%1D|27>s>me*dll5r z3fs6|cbw}&-qe}g7FWQPyzcm-e;`u&BmcFi#k(U_r)in;Yb))h`Sa9Kab3bUtI)ZB zbV_alf7XLtxuMi|kg2BD4fBDe9+W_TCuc*JJdVKL)#A75+6vnn?JCXgyV9n%V7f|yrH%(s@B}cJP1h&4eu{+`9R92e@qB3 zo-1wHG1sQv`Vtp8G0zNk(lulmvgRJNH*oKqPpCV@3V(RLnti;&MCcK7SGuwv^B(|R zoZa}k#=J}25mPT6kNGA!X8jtLRGLfB$~0~ju8K>*CV7Eg$M_x0t~7BH;lSjERu&kd zL-=d|9QCCp)CjUgqmb{)pY!RDT~4~#0C^);m(9WmYU{36u+dHpEfz^c-Lqcc}rP z>;be|XmeljnAhQP^<(Q%;oE9V;+Ms>eHH9`kVCy{zz&1IRe&Cw)Z(hRD^o309IqK# zcHmD{=DF5MjjR#+^sBFD5+kCB0fJ=Pq(~xiayrG@&PpDg$~o|;YeSp4z5d&%Vvn(| z^CK_F(0^3iUU7=}Y~d7-b0z;ZW}ZbkKZ>48TPRBcdrb3R>I}M}&}nDeU6n@%CG)>f zI~=wj!9*t{VV@1;c{j;{&-W)RD8c&65+sZ^dXJuo~C_wQv@`o zjn+oGcq7w9#dOVYon{Wu!lQVdDAnh|wcmC;P{o}ThMkNM2Sz`9Pk`ihAIE(&O~npr z?EKvmSv+2*(h$8B^Ux0P%89D@hXtm0W^Muf6RKN;3>Q)D6KZni7sWc!K2BfQYui#B zU!c_vOS!+obCnAph`iIaD6qn%qsN-kq5~HHcn`^i=^3_0`F^eVKvl9fNfh_L9~`9T z!Wz5Tw;XZbB7Dh)XNhSq9GO-zwr~<%=$@aP#$Tox1LOaUiC6{+#!76_(W`CT*C@U)1%mB)=MHr~Ie3IDYI5Pxax!>Qv zujj{2A3(ksd`i^H!vBw);a#`9E*?5+X-LoX>*kP_aem3SA_W<7ZO3eu>MD5L+u*~;C& z<@7nC)=NvEFff!6spD2F5pp$~ZUwki^iNyI4~}Dn>q_I3o!j-xJ3UOwDDI|!AvOA* zldPi~-0+#aS}!8YZtnXBK!l{FJlUvW;K7!N1RTe$-duyhau+cwn`af|MJLDJwR|;x z!{9C1&7i(BH%k$S_6;Z9=erq|$@=KGR-*X*ceD?CrL-`<9 zQm(>f=Qz)$?*Y)fbV@2TEobzgAE$`T)&&E%am@l3nkXqE{OtI!FfG3e8VR8g4$x% zO>|rxO8TiyliVSJX>XjUI$J_B%C#ayjd~!={?`&cSMY=vj?1213u>@^cPhsiI19_G zC1v=MW1IZhU8jeks$^9jp@=T>IpMRPLvUExpjdAcdp5(P~$iRFPYa{h!$+5SYuMIZ1^c_f;r87*YI9zpuwQwaeTc?#lKnI z({%O=k`HY0L%rBYUbuC#UQLp`>{C`TVwy8_M#J{@^7lr)9MaX9Ecvg@Gfz4QbF@~% zW-Zq^KhTo z7v}V_)d4U(?niGG)I;>Hbiv@y!AgU8)Gs>A!kXulF)_jU(wtEeeLi+zxah$KOp8@ z6nonwjIBI_mXpu8JW5-CWBoBMN#ms=uZwvcXq7R@j;&_-@~s`_;)i?WzXm6+@R-fX zQ0eMcd(V+Ip}arMTJknbZdbdtuc%U^`ZMf?Mp8=n^*zs6Nx`3e`N91e=ZOb$qf!L= z+@vpeVvcXzw-4vP^LN0NeKTh`Im!HB5t%t{5yHTv zNxk$)>BykLv6I;?mqJPtUxRWsMlac>kAFJ0qNFq0f6oRlx}BXDW#)kWuE^0SFMl;z zn$PTyI_scn9AwB4uh_{s(y*z`>g=OD)k=%5&wTdSD^bI|&-F?8d z3|9CJ8=0f#7d+8``E@bBSF49bo1cKDu3x0n7R}B4-VSr>6V6t2i`w(NoS$J6I9f{B2BP^xyUw>Ch+9 z73+GOpaehM1II7Unh!+GWCbu1v0ks~$OZ68413nD+nBzoJU^aYRA#XfnWP{sdFsM( z0SjMW^DWV-S)B;1*fu8LwI9-*yX67OjhsxsE;{?hT0~&Q!^`F{J)=dc{Y5@aR)iPI zOpEPGDf-&xXk2v$XZ|<;#oV!pO-&Ws?1&4D={Lq1roeNtg0_#ywt<@ZIyS>@29ZA? zetbT4{cn?rXfm{wrqb?#owR=tIrtYZDMe^D4vilS9{e$XKkuL^g~?{{vtff1ffdRr z-KW6}C`THo~(YC>VYy@s%1?{Z#VmJsZh@`-vHI2G8j=_PKEsN9I%>_) zg!aNVDtd7!t^Iy-OMK;Dsyk%ml&vvEGvjGd{6|OfmuciXGYqVk@rH~LA5vu%U+7(X zkOGHX!u~u`t&b1(#a;4IriCM4Wcj9$DgZIH^l(R&s5C%nUW+%Ce+jw$5cQPYuAk&k%=mecZXxes%R6$c07SZ}Qe| z|1aSD2my(RNZ1+xob(~p>p`xN22M_P`L&Ao86GTgeFKnOslRspcfWFN% zVKjBRfZuLq5-b&V95RY_!cK8$i{{<)>1|eB$K~U&duAsd0!=_Ygf&Uq)TZciis-gM z9*q9Lf_O0^1T2LUf4WaZn}cW6x^c;AR#)eHaC49BH9Y#eM+09GHSq^Z{Ozl>>HV;rtk zuRax{orv^-nI*!vDE*Xy9|!H03i%)r#d%c#urPdKMb_r!ML0^nB{i3!Pw zIP;Sl9>B@DQJD;c{O!2z`I#f9(Cjlp&#u#QK~0V2)fDr3wQg^vsHW4D6#4(# z6^L+k^K7);>OCN_D&-!k<`iQOin|x2mAg~duggX3U7V8bLOqz6Gn^268Fz#G+c^Gp zEx>y$&=D4qY^$AIv;UktcrHuMyXN8q{B<$(5RNZ0OfW7EGUw>(x`_??p0?z)fC77c z%@0W>8ff$MC597*ym5lLzxEZ=3V8+yB7X)pkzut!=A2eCMSBSfSVFHKq{P0Nskb3h z_ic2wJJRZbOKr|K&T_(P2CFV5$)7C^0X|5m1Aiy2r8`Hz8+$|PF0`Aee^KyHb@;24ltM{$;rnI(3CA{efdPO4R{+oD zw5j{PED+?Mogk|2C9_J%0WH-VTC?$1%cZ8Lk&+t-S&1<|SRi7JpRjDwXj*96Y+74h ztKpTMVjXW{>O-4vloND_NP{<3|uW?!b zOS?YKD}nKwcaBjZ1V&x9e39RfkC?B1KaEr-^-JPg>G8T4b^Yo?*2i`8KBJ)OgFz&- z-~EeC>1=1!IFAuDimSb;B+j4Na_ZgyJ?Y$&!*mR!mE+*8{YQ+B1)04pvU)pkJdg0K z^ljbwXUOMkDrDIoX-l2x`4Z}KUf4?g=|kJzd?~+E!ZRh3(rngIEmn>(^vkjHT?pe6 zk_V|&*@x+K2;UK?tpsQmh|Qydi#kQK$;D8w%#dxSP%%!zK#L! zr)p@1w+-Nv-6_(;JO!=VXQk&R1vg~FTslSchEBIe)>7vFeyJ*$imzK3t+9RlOmy6b zcgxSMs*OwWM$Lj66GYpC#17g=^5ggAg6|U%9h_F4x>h8rb zRF6S1qW%?&?`v-g{CxQAo+n2Set+HTAR?a*yNr^CXbfGwn6Ik?XFTBE(uV^XLLs)Pc}HN1f&mS^@DLOnZ2I7noyNuD22O}@0CX}0JfsXwun&{i>Eh#jsEJ6 z(*R4fGI7a(u9NjVu$PGVrGHHsdKQ}U|1;)FmhDfi8{yB(w}WvjZ&Sbgz!Wpw zziC&FS}vbOc`Ks7y%0)~$YxY>CIJP~%AGMmCty3>z9HHk#06(v=4=08{dreFhL_EY z7$(1J|Ge;_$WRO`B9#=SZ?ukG9Rf zkTsaq>s~C+aWUtZ$PBI7hU!+uX(}6Upjpi*+&fnPFB^4nWe;W$}e#aN3T$EegUeQWXdrQ&Wn&RTkZvnH@8+@EOjx8vFI z;J!uuI{nZ3MAcdQFS5!un;wTc=C_yNnZ4ttbGxaVFss<)DvqG=F%@LwIY@eFxwnZ=)Nl;yOI zKneXqy>BmhW^pWc*DPRrjgT3)&chVGdE zB(QSp8tvSo#6}b^(R-?;48vBNHgcD&{oF@8;KCI4XX)?>FMNKjx7-zOq-!JiF>jYE zbw_tHhdRJYaOHd2)pGmB?u#fc3h`vb-^&`R#UrkU&Ooc`T&4+ulNMl62UIzt8f+0F z7(AL|$EuvE@hIY`(S^dcB2@mr zWLFGmM)Al-8Y{L+)M~HoMTR+g0FAH+y7cY!=eW-{(H}0^b}p_RjoC9ajP?u3Nr~=S zA7bu~+4FbNRx$+e8eGp$t6OM-Hb6g_C72zT8nW2lOV=~-tzGD}i(25S53JYJW7M=j z+`$zH>u1^XveueRR5&1Lrahx?vgde-TIsflq6yd55{JqOlVstLg-)!WW+ zidIy&k|3aNPqku*kF6_)?Jyq@w{SFrpq@jR@Ma9m#nLi$s;sx)(XS=&9JXk#siHC4 zzPdW{xoK|)E=oths)$vrWq#x!OqWN75V_YCjMV5ut#s`$NLan1^KyZqYyELM$ttud zt=JD2m9sO4>etVqj*}pmT~+_DwIoHIF@?v^`t%0=m8kkhYPLVd3ld)biE1!Vo*m|$ z=h|9xvjydxL+Dw_ZQE&fMKo`I?1px5`{Ru-+Ij55-~>@2BGvZ~lhaX)Hs7-@8yQS_^7OW&n;7VMvpbwdPDW9L8otNX?2HVjxpp^vD{k`HFzt%S=sQzfR z#t#3%kjM@DXuA_@eePw!T~M`ds;_Luv}7l)niIyP20cuOd&hpy*y@8Qym$NxCQd_L{CRdr|N?#w zR)-_6B0}&3Amak$+)cSLL4Ja%YAxBX8=<=e?^7RVpFi;jAFgYIOv-(%S0fI7#wwm? z-DO^M#qaCd0r0zmyT*m&Z9wvmZWiu7=V$SmxWE0e@u02>tS&Oke)8X+p8|SPd?Q~F z>Jq9Vi{=25EbV zDKB;lsY3~719sM;Dxj`V983G%j;a%)RCVM9lziS{-kT^i*oGyJxZJ?KWN5zdY@jI_ zZ%bZ+Wm@{OOvManWPE-^Hxy1VAf^z9e+>J1<@%auACBM17WM5AH z;N!O(F1o04Erq;T2h!O)skFheo8`KR*74;&+{+G ztRq@bDu|GX=NvWTmzyW~n_sOdTGK@vPxCMMa~gM@TXFW1x~prNch0jnj=A{!{~hkW zwujH|La%(>{$2ha3Hp{s9|+|iaj_JZN~d>95H1AXr@3kyDapP$EC1gCBDXB%MJYi3 z*Z(JQ=MXc*tH9bOe0!@9jTPhA#Ig8VAlZC!WT9trRs+o6f@&9UV~{JNj`34^^272J zw0)h+f5a5;!A|$01>mu`i;*2_&_O$_mFUj*ZMDf8c6JaBkN_laiy(y%qvL_w0R(2)0 z=@YdB?psZrTOT}4*rgEPS(deys-0;3Q~%J-{c&N`TRz6TFLt(=D}Ajm3Z$McD<6g6 zZL?8`zabr-t?;TPfh#mm7NJ~8vrop)dxw|i2UGndEvC^aF?k&8T@9SlTbMg=&tAG) z(@77Km|pG@ZdkFDOtjl>jrl!$qc_JU7=W@1J#@Eb2xJ7TO1dP|$^zw!w}7K9RBX)O z2{ZNTfgYu@Y>RSpMoaU-hQLyF5h9NO=yq(*0pKNdsKpvT?QVyT6%zee-}{jm`E_UOp9^l3N@5JR)$Uv=REE{DWf=SC}I|Rz^ZBs-5(l zg32m|Q%u|&NPqfAF@4_(h1lVY0Kw!R$H)AXX9;g^vEUALGu=5vqIK!+VP1k^qcHX2`N>QcQ@~%|22-l4f=kZ zZKgEm|Ezed#JTP#;RpoIPixoss5)!JTFe03{k^B!X^(=k8TWiYC|x;ruKI2>vZ(Jw z!wZsWb^#!-y3~Dtua7J(Am~1dq?g4-VSZ54dTu{;iN`j5iQTuV^vjl!Dor=pS)0AK zyHV?iH0;VtT)s4$}`4jP%6l>0M{PMmHS0wD{!${S=s1ke-GN7e> z2%xona76ZC2`L_apiZ2Om@keg1KwRm{!_O!qLz46Ul0Z&Vrvo46h&c6L!zXr!dRA4 z6Z7#@o5uy3cWIOv@p>KFZinvoo10Nz?Wy-FjFnmsQmFTcgHeWzsF}j>EF$(b_;lr= zbp*1v7vK*hKo_>oPQT~|?G~2n`_Sqz&>O~+ zp1AhS+_LxX%43Gaq_n69I_9c#c=l+^kEf~?^RlTe{lHL!$<{4MQ6JpzYyXtmFryB& zwgINpA62|0solD9U@fc$SA8fNmwOj989X4|w^&(IEx9CYv&PsZd!h*3eOgU1)5}|0 zWkht`+9%nP{6IwO%S|KfMO2Na{LJR~db?efuq!|Mga{l=`O*=&nl)eRHgh#n(g%7t z648}_3inGZEu6O9@sw&|`Dl$Q1Z47;-U0zKFnYvk+^F zu)@JpYuKQ20Q%>G7S|pK7$2~Uratn-CHKD~a-ccN{H3DQJdrw0d5k$h*jF2D?fJ1~ zO;x%U;FHaH4>5t!=^DLiRX6(>d4+Rh540RMmFEy9;&r5@&8U+M@H` z=1KX!;UN1mCp~b(E&O&_%Qy3M-m*9ydcmm3`<#zsV^|2W^5cq*;~Zj{gM$E3te zu2H@evbI~AxX@oE(I~`IHq`uS3&o_qT22ZnV@wD*qSA$ z$-I0`B)lzWPs1Pu=UqJ4KW>l5}h9@t3WZC^MeEX)Y9@CpQ2|*tSH$S%NDrs2@<+@D1H~7u0}x#>6=H=E_&UaNnIWeBGl9bn)Nc3QebbrBI z4p++{MTp(vR$C1d9#tI4-sev%oR@d(hwRr5Td7UmTxi?=;!|rhj&femOqS zNd<1p95V2P_piNq+UvA24}s+rf;g{oUzOC`<^!sN4J?~^p9ek8EtMmjOMJqglO!)N zqH4IxIG_Lm&-~(Zt3BaH#KqLKFi$%lC%ulPPpA#Fx5yWy~f?^t4EC85Buzhp~RA-?)sOlI(9kQ&c?Z`c*pCcS7*SRS8IX~ z`GZQ3W`t?m-@284^qQV9%HCiGj?{cZR^eakFU_OH%Kw2+Q6euVKP9(&jy62Pn>CzAXOsxtVAT} zD6zpL6C#b>7`T8fai4)_=YN~%cvVp&S5d@R&*t-zC^u39X3~^c@?90PIU@<-=nUET z*jP42ind^^)gu4-sk=AqS8M#c27!ht%ZW6y8rnDx=KfxHKwjL@(qny;sG?$i5h` ztk$g3|C+WOuq**MZnUWcC5*iz6l|q$wcqsLn+aCh5cPf7TGGF(v-NFI={tNvcwp(k zvbN!!M}xpj)9JZG8_Y7m#^QgQzs_fUBsv>swtdwsdELSSeYRipD2h_BHX!}&UjE*g zj)dE40@BXcMxg%&Js1&|^>wr4V8O^t(OB)b#u#JN>e`zw-5W*yUo0SQ4bhY9ZYrPU ztH&ivRTuOVm5j1g6R2kg=v3Q_l<~QyT>ckI%ZDeNJ6SfrCkUBCN~mVXAyXidq;m@{ zrut5}Hih4ii5EL6bgwl_n&^JkwEZhBHscNRhbR*M;}Q-3<^NPV?z==LzqcAH%(CNm zdF6nwnE0P_iVe;T?^}C1`%QUa!dj$gpJcgA#F9kt)qUpM)(KF;pwJVua^&WW#9_Vw zI3cOQl0 z+^=cvRUi#+p#VMnbnX<=A3f=l5w84Wvu|H)KiZl7m=j`jQVqXAhD~m5G!9k}uYwAx z<7fS)tJ9OLNq+Ac5$9&?wG4ToSCh(y$k>UX#+tO6(?4qWaQ4bq|{lzBD_zf7aCy48L$K zJGarw6Ac`FH&7B??Z|jlZegwtT4!jC$NUM*##SvM{Q8uvNO10z#jwR%2ezSIg6PTy z^2R%tF+9+z9K0nJdDt&U@Cg)v=S6QKcBdTxhezecnA67!e&9$C~y9 zOBKoQxin5<@c)N5#CkJ9&-Q=*pa&ab+`9*RH~D$KJ0^n_E8Wq1wa>+h6L#N3E5*Kb z%rCtSnl>qOeLrcJ`#NpBm|@DE)BK1B9eYb2+ssZ) z{Qv+men5-D_dH^@fe)HqRQV$C#O*;Z+5^;8M+dX6^ROk96jB^{yXp zH}tl*e2DW|#xDhwI#kOR z;tM~WNFN5>V}BDKan}X2Dp2IP88*2yq)9ao-2raJ<%Tk;kNo*Q^C@GBJF%~4l4IW5 zk9&w%lAce90B#g^u%Dt!N(dR!2V7i#D2CiEkSy8Cx%9fx94-q{z7f-X=E=wV;n0%(&EaE zKZM;>cD3X*luvXWm!-#gZ+6Umd!=dxn>Fwe&zsi^wKKtXoOF9Wvq)p?Oa*CMxX9Vk ziKv#`s24|7efOq(mmmM zAgq+SkOcrWon~opDxE!>MeX*qFzHK292aUJ;#?HXAczz}il+-_uBOFTS7eNi*V`24 zwR-5(GC$PUl@MM6qS#Z?r=BY%KES^2x8tGargx{jeDzYJ39Oi5!Kzhc%XiOSB%J>^ zEjtejH{KjqO88=Pw6m}jk?O**@dx$3A9FdEhAMN`s5Y3#nzC;e8E|rCOE`jooq_x> z761M`!;WZ>0F2-_&BfP{$&g=*@^Vsg@>``*gc;Avl4ZFAwX*7aB6!=an9>Z6tkFP~ zYfk@BxWKrBze&f62@Dn)(cXNB1OnV%b4uZ<}A`^4SG)w^ld{*tQ_ zSo~_)#8L&Mu7P4tjRUcL@1rlKuCGg~)TZ z48m)0JQbY(EN&$~&%;p*v2a<~cYz3txoe!!+HCC<(=lYOv@vH?o@C3dbo@V#&c&bU z{{R11M|CMGqMB3bN?pRGKIXh7MO~HUQpm8dBHJvdIn7p=$~mV>H6yu-oR-5ThE>ej z6gFm9PIH(!jE#-WZ{Od4@V>p@yS?{%KcA1s{a%P}8=520`CZka4d!qB;u?^h+Uw@9 zQo=QPdq95hm0THoFgyAD`?X$HRgNBvnHeN9&E9t|`)sV(H9O_?4>7yAWy*;J8nSKH zSc+HlRg?5$%}VcOs{oeU5)Hh>^D&5Cv#Q{1gk?b91!JUc$^=T+iT!l2M`B?8d4hut zSa29i+}iKz#)*DLv_69iFmej?S{>V3501yz`r(J|@}D~G9SQ@gYzOQV{cLJg(Jbt~ zm^U2c5n!L3zsvJ`vdI!QF;Q3dAL;3z-QS;nA>6$F6(Wy$Fs%IB?8IzV-{MpVdi(6m z;uj0M6vB=ZohmVb{emR3 zf>wH?;^$-Gq>_lwU>zR(X)-Vumbu>bsln`ifz9BBsgn*BiH@{}A~PPzwUkLdreIWm zAS%fwmu^y4p1z~hDYTB@jkYg2Cool?E;Aj#v}>!1U?F?=M47Uj*YDB0E%bEE>P#Wv z8)cR4lZKKFg|(kuE--VOm#)*FXiR0;{Fh}^XYF)90~OM)QKj{^2SQHh-#JFozJ>BK zSuicvp3EJ=j|4o|4Y`7yU%LI=LrevFC|v?>wUiSUnB}U1(T&QNPDZrxnWzs&_j?Y< zZt+dPFMf>YhuBLuw9a`$XW?12z;ah+nbt7))v#)MRB&Gj@1{0guZ6ZbWkO@#p}mdy zc!}W|GHo+Tv5euVikKd9%H62}Sgb(J4l}k2&}A$eSWJO`(j+Mw zEmQ?mm*&zzx!?t>SE{jhxgU934p z2HH#FdAZ14E7wR%C!yU1E${x|*N#P1_NdRW8~Z&i$G=IRh&Vao{&9091JBYu zHi)0O;6Brq)@wDjpD_x^)8?oG58}Xf_Yz(K7dO(cYWTXEp|CGC9tA17(^37_7YIi&t%RbscPhCiFgDg{=1e}z~jJeLH* zy8E>=cVJf-mjL<+ji4=;cY3*rLz(Eqz%u8io7F^37Ldsr$ z@Bewv5qd)yQ6AMu_jyiStwcB_$G`hRN0tw=!)=qv>%!z_qOR3Ed|)towfs09ShDvH zknHQG)QH7b>WnxJmhWb!d-EMeMewt)uvwR}pY(M)SceE1QPIAb)cLdtD(HZvx(P?h zzQNGq=oJRK$v>l_%T&E&;@<%QQ$lv`ndh5`8d$kP*w9yT|1k=CODEDfG+7&+w^?I> zG7-v7t^_V<_ih}Ng%zW2*&Ot?n0^%$&H{_na3AIU@@8#nxAVOim-rMknApDn2x?S(Nsjih@~v&OxtL6Lv> zb+t04&u>{9jE3x6?s0b>h@MDCVqXYyZ68X}`^pY_i`UPiV{HbkR}_U#n*T4UuTswW zC0lOqWhvYy&ALxdXtz&dvd9RrZCy^{So~Sj!uP+&&$|4mCIsOhKKMVkc>*4hR7^Pb zfQYDuv-3M&t-J`mJ^eSPzk}Mus`m(N@LzR;tAKN>)D<01FgA&RH=WH^J5tcSgQ7aw z-pujLA=Kw#Fn{hgqOl80xT3u7JxPVptp%ML#o~9|*ZWNq9FbCDEZd&`Qb7I$@;wiP zu&gSMvjR_Pgi?~tCsy`55?gcR zts7@f8OooEpMn;?l>8qT#OJ<3Neub1-DUd(&>6miaut~lQXf3+HM7d*kN0keE(1({ zzePY(kRWqq5JM4b*Lrj4<^RHhIlqJ}CyLVQ^s1dTHLRyvT{Uk6XN>@?-UL1WaRcyX zx|I&?o+V@fv~f3q>&AF@XjoS#J2k{4EFiYm6qsEWQsOP;wP%o2u;JgbHPbV=cXkx* zM~+_(Yj;eKZ3JoxnR>F2J(KA+nRdt;ip0mQA>FFP+_uf}bS_GvSNnKcm&KBwQ$(p< z2Lg}hu4ehT(drNCaAWrT)U1)0AB~c>*m)hiGqA_j56D5V`+G1Ukyr9iW*2_AQ-K4H z>Z&hYFq6O0xzQJ6t(g856Jc$KO+J^L;+eZf9d?TfSYaRgrH|>>tfAz*pFF@}o9#wT zh?MCA!*h?dnq9CwXT=IU+ECeJWwQSQz)VT-NmOg|V)GC|d~5Cg+AK&9VXaOvxd~eF zJF9ap(5DopV$eMGb}qL#TpQCP(79V`R2cYc=rk}`d|cIRq4rtb{kAomVpzGX7;1c&IY)`Xfibz^en@JSYk^c6OX47^cOAX zj`H6Og`PhLGn&gLTRox=_^O@Jgh+3I>vws$m)ex$$L*TJ9 zXh*D@h9VebMsmnZ{h-c-)iY&qyGHlbiFz`}C5`DPI;L4W9fcbLP zW$}@dn)nLf+pQ-W3;ADN*IZ^mP+IWHxcx%j5RV~|uKU-MIjV*+b7jLdk-c72&UDNf zo%Ay`YRtoxHPIz;x+H%#C?b7Fp9@wZmVq; zM|a3qFWJUr)?ay>B({epP~#W&$+Y5ZEZxD$sUfmLsfGSc7Z%xFbt6La zZxsSWJjhMPnl!T>e9Eb_n^`F^fxw5YCX;hs_xAOC94yN_rm5D8R#Xo}c6j~?d7xtL z-sV_Wh#IWz23z9#?!%}t}H6_QlpG2t8 z_*W6bb%Y-8iflx1R)Ia()-Q$=4o7n)q>}blsb5L-gOUQt{KREmrjgFXI=$u`^T=e} z(zxT;eAP=^qgw!@gfcDX5O%L?AFonbQTqZ;Ygd(dQ5Bev{PnU3O#X1E4`O>*RfU)z zPb?sKFV7Z6NFRU~-N7;R~0pqMC=N zp>lFwX#<;wTB#t`#tf=7+$#)K-IKxpNNLI#u6y-^cO87fa4ke^6P&*AS3{4|PG(JA z^{IJ1d2tQP-4hTY=d3Y553#0|Jphdtl9!Su=JN!pIK@xdw4n;0g+QZm$u9D}?G2e` ztx7q#0+!!n-L5~>9ye5nn7`4c70~;J&#XPseQB7t>99VuaM?fhhhnU#AaW5uEd3o( z5o$pEvW!zlT-!wX4FfSfR;~IZB}jV|DXme ze3^A^{iM7KxR{=Ix&FgtKY`0|`)_XwH%eWf2cV2zZBsR}!b&I19v~OHK3@jNLK8MF?FsG~m- z-tK-|=$ETg>E^|iuXX$K(ym{M$JIWrIHE^Dj!ko8Q_BK>QdI-NP-Vt|0*<6mRy&CKx4iR$3nP z6;tt|kHVWNc&9+5oTiDrzmld5U%+exy@`NDwf|};TUV@NpUy3*%#H+B$)>(N&(?hl z{#1K;!pr*0Y_s)VP`5;T&=NIO0K8R`S|ESpxU+DS@vWV+tVRq*b2s9twAz--QcR0Fi?Y$%5vy`3A?7&EFK|EfzdgVP)*=~QdxB6B9vwF5xjJ2!Gxa(cx!5ziElCRBa! zpqu~B(D{H_MEh%fHmDfN`4FBl$zL^B<3SWUPYE}CqB zig)XMWVkVWh-qu3&M4~wq1rMGWknPETpx&PmDGjm_)NYc-n z-6ki~`mubuDqhBiZLv>1434rC2Dhl%tj4_A{;b`(AFcn^|HtlS*r|=eUu4js)v5USNER+7HyVeys$3BJ8 zV~$YhH+;?0{2E**Gcm8h_fXzury7I?Jm=<_VVZ|c&L^A#Z3One{hR@*WA{H3U;WE1 zMKWyF-wTB@Ek@bqCdQPiG&k)`wQFSWMvQYR)w?6hOS&#*mOEFT=FHyXdh%NurM>pz zDp~3fw}^bj*cKHwglM#BPI@GQ**6c2~?~5+YNsO zk;|NFP6I^9B1}J|F`{>Eo}S+v+S9r50;d6?Fup|WGuQso{;gfLP+QiwCcqsUNtX`= zm(|yK2VrV-8H1x^r&f{*FHdbeaSKf+l0Vq4z^vQB%$dWzBl2Fgx1G~BMu$iJ%^N3| zhYTR@4S^vmH4{V<4d;rHV8c~bt| zdyqi3CgF=!XM(EbbY#sXhBYzP)d^71H~f6oGGg93cm?@OH1eBBCuPaHDm@+>uq@1K zNWG@bM1`hSUNt_FRWj7`2(P%$n{_>J_7GE&Mw|W- zI1r^ehW7To>sDVByKCxSw|V4B+&Zw_dsT2g*qUTHbYG6^99fYi zX_$N8y_RDjgyM!${rwVqR5D{kHwRc0D>5x(D1znC{or7fIRDtBHI;9#^_l$n`P|&G zLIflORpwz*i4AM0X)PToSN@S!oZ4u?aG$BpPEt~6yyIUF{>2qNo(T}Rag}6W;$kVu zW(q2FYU+c5GjD{ZFr&KrKN@%Z{DWldf$0|A*nf0ddFBQ67=|_y@w0qtp>~p9ZoJ+A z5oxE_*N*F@t(F|!64{ksaN^no607N{mF-F}1@hF*Td*u%VY!|SD|S1nBY*FE6Q-WF zi1mQgzoRwZuO;PJbZofk#cYkL0|yL-SF?l82?#AUZ$|^BHCxJ<;~yjb3GnnJh2Y(? zIoL*4tB`?PomAG%m{pwIPCysaQvtcF0~px{0~^Vm;duq4Yl^RkU})Ub+YL1 z)!TF*+bGyDb3dcZx5C&aii?XN!%d)5*|^}>iiK>)hbmH|ZF(A31Fh}^I?>~1di?Y& zIs;5jp4118$4lFvOyU29O#NCVTkwA~KutZ7J134kN26k7Jkn>{dJDbKPeWyCd^i^ri^iu(~7cnej`! zVz-cleUdT)rS8bufxbnaE0(DY$zc_HlH31FZp-S{0FV5lzn}?=bd!?HH7Z&m=10O? z?0L)xaQ&pCZSgKJ+XRSGD8g*p%-^(x-K2CRcZ)KJEV>o)nz&05DpRpG*o_KKDBEl+ zZjco^QMv6eCyuJZ5TrVaIoWopjH)pfvHu6cWU{KZsCKS9&+}bQCsq1_-;!63ZFkFJ zGF#8DB{hEs`l_WFPg+~v>XKY@q8&L{dwPRy@c^->&`WT_J4CW~Q;|KtASev0Da(EA zX;VER@=+~IQ=5EeF;!YtF1|Dnw)LR^6i9mk!&U9=PHeJuIXj8rvP-nD-^7(zM^#ka z#=Yy&1T~cJ&|S2l+Vl)|0|`{sM?o=PZED9qm7#SKP2LwO3c4c`;y3+DjPiT8yr<&c zy|M*SKTh2%Jq!cQI!4|MGB8u3f~1D6tP||X?+Soj+6*?XTRCW1K6j)tLJG1AiX~w~ ztyK$COg-2x(|Zjg`Xv2~v|rUIEi+IsYvoiGCTJzU&d61+2H3)XrEUh94c3`$F&N{e z*29s>qAZdi{yZh(OZ#Tg=(rl-LeMNTSCQxow-;-gb0B&#Af*dubDim7$*IO5nH$K> zoK4tNd@6_O1FI&Y+?A(u{FjUzdX{VvqEgXWOzs7S9Ygb)EW?Xdbx?Ocf^jDg8>WK+ z9)OWA^Q_G;L=X8Y`s0It;(p{Vs!4V&!WagOKLfVD3|R|Wb^;8Ryz1L>G)O~W_@utPf;o{ly~2!wvmxhQh0m=~B{Y zpKj_V-#oFr?B#T`eu^wQ?^ga{ezHO+iU;bX0hW9MO~ZH*vsfZNSuIAg| z4-atj{ud5mwD257Ni^mp8IjMrB-1m8e(ig z4a3uuLm!8}ta`mxFV~nZ)$7^Rk2>17Blv%<#v8nEmfdf<-&Ep7&Uu1)4LoSDBnWA# z+m7lv!&W>Wm4rLq<{l>_@W7Lo8WTn)1&l>i~QS;@s&~)VT*(9F|vqzy?<9X^qGJ`i$ z4feoM=P%v)yziDYa-!y39_otD9o-jQ=&g|W%Zn%YF!IdhPpSX>cJ!~0h2(d@1i(|m z6T%hUy-0OHqCKGV@)P9uyU&ULBKMKMX*EN1mYVzHPk|>d2xsx;efxK|2cuno`I3L4 zkQFtvsqCJ3B|FWmierg!Iaq4@ZR9!Zt?4T{4e6PQgZ|X$<)@@>b86Y;@C(e3;rf25 z)gveC9(G6gy+EkadF(!t%5rhskz~=ZK{~eu%l99^nqT*W=W1i1*UGGZ87=P(8|-+7 zyXB?lZF-r0uY9=JOxKzJ2$mc_gTnLkQ8>Z!8Omls;Ad0n-nEQxO@mgVhdwok;@E0X zhXVZULD)a==Y|(a5Mf$YAAIuExpf7k#t1F%I9i-stEY3NvF%^7)#Y(-ch%Oj~1qA)x{;Q(%xhqn!>#_3lA`~rC4tj+KrN8y{>g+aSpwr#f*N_34DR`EXJ(3-$I7Gb}ACfX#(ObzR`=Eh4 z6qW-#WoXU(Zy?Mc-%jQM2|(fPf1duMQuQr2Pw>Ck$LwnDO>IQ5WZ`g%Hz*WTx!_mYbD7z?-h_ z^v2CfB0oqS>nD*Kn7{5%dzEQOpkQkih}jdS-NJdp2r-({#|bYjqhZEL!xV_S?XA*T z!I8wmD#vNniG)o`?l;?bqDeiVK%PG8Xx6_`IsHFvaq{Cup+F0h+ij)P@5tB>07Ku= zjE=tWu5ZD9)=o>aCFm`Z8k$Z)fLuGgU!XCKtmkd^yk9+ON1J;#>zU`ohmgYLy926A zCC7g}FtXC8U|5}&6p?S-Xd`#S$C2yY-{u(}%(})>oP*yu((5G?x2YFCM!#?~dkm)= zI9aaJx|kii!ht4vjMwRcc}>Sb^6=o@DJS@OVnn5~)p+2RThE*)H@BbkM_L=FMBw&c zT90utWxim&%x6>FCG6Z^;er}+3=D!z#c_QLA*{F1_=JUj_+QcC7wFGRV-yyG4_RqQ z+K@jo+l{PXMv&I(#Rs8YP`Z1L9_Sb8*c*Sv$v3D}yYbkAX*-Mhj@2v#NCd~F^E`VL9o|#)pf>A< z_ch%?kMzR$Vly_@9#Jiq*wY_Fz*~HS4Y6h~i zG}X%dXk^lsV+DxeL5D5rHf(QrX({+Bt@RN>po?MLZt$3w_e0j~VOhoj#HtEiUrett z%?0rzAf4XwxfQ}<6@KXALY8gK@WilMR@`b9EN8+%eWE68uCZzEN$N&Q_OL*Lu@5Kd zEWyp;B}dXd22>|s4Y+s0dh&9iwuBf^*1duAD&&t0W!s2}wSE1SUMalxLTDqia1iL! z_UzT!;yeMl@CI$T?NtG8g>BTchvs2HvZ%3GwAj#-G0Yg6@U~tb$Uff?;|1+|+T~#Vv?C-Q0x)?MzVlEvJv=) zT<&mzVlzMi{i)fOW?IYZn0^*=r}RdodE;0P8aro96GJnhGBoO|V)rvikC*xbG98)V zH(dPi*tp1k5BT2;Ee-DEsOqEcI)1=db7gqepoMW4&=HW`4Se`Gpn%?vK5wVF(>mdX zxxTrcd2-MZ(T3e+lhmM_8<{31nh|jPC2^$9n z;yw~WOhp+5uagY99=MsyOVfnC_X@)i-lcZW+vm_{TZZNzQ|eBZ*oGc= zi#=eCFwAvLNu9l~=BhAW@RiF@GEo^!dsV-_N~i4Sti9plo@z;($@hWpLwBi>?M*|0 z#<9`N!)U)fyb*l!Ft*X0QgjUHnzf)HnZ$H`iOxvVpnrS*g+2zlP(D;H6Qi&)(Kjd1 zu^mwxv@~(-JjcC#=}ju&4b^$&rtH`bZ~lA6LPV}wAQzWGmG-G64>xB$*H|t@Z6y+s zMqWGVb{N0?Qvc1Hc#g~c0*AN0EYcjTOTfgP=)Erq;dWu&ACEqXr7*}MK}P_o=DXQ7bjRDW|C{p$NQJB)TstC)Y{nFB?a%-CgeA- zFtF2T;QF7t*Zg{@3_p?n1S25Td2u^?J0-BH>_Z`*rT?bNxPjzAzpXW!BTk|B)y5h9 zaJcaNdbsOa*q}qYk(vGEiA{J?%tT;!S6ozuW?U`faqJNR?4;R(C*4GQu}D@_uom54 zvzz>&yZ_oqG)Vxx#J}lDaEW?7O~O5KOhd*L*`yFdiNUdhBZ|$Sv2ZxHYxn2c=E5kW z{uac(+2N&Tg|)0v-_Non-^|6@EJccWT5S4eXfCbvTC+wGQ4y!2(q>!j75$E84;gfa zXrWb`H*=Wa&i-0MYm0ccDF0!#4d(kEij1Tx6=&Bjs7AsEFVnM~c8(ji1U}d|b?Vfb zX?0AZZl!MtZ#F4WF4Z5XbEmT6pMU8j4gQvvGCZ^7@_f=GuH0{piyNG5ENNldbzRwP z)5>(IJzDj$ev_?Kv8-uVq3LI-7g~gqmOVX!NnLL*f7LzzfE_QjhSWp@rj?W8N?+~6 z3kq200ec4bz-RC2R&JeX13O!^Zq?ikbaznL6D`|L%G z6U-IRL<~c;pRab<%~U*G>0q1HwPq6r`XRPinD58pjuZBzm7jOmcs$>70LbH+m*;+J z;T?pglh)xjXmX6oqg=W_L$pkEQ>beTTv5}y)5k&*X!A*qxs1Dw4Qs{)-puPc<5Pye zZg+O;a~MvOvl;e*bLgJUB2#uqp8*UMDeQA=V$c;O(m(KUD4?RcCdDqLJ0G4QmxhR4 zS{b!hP!dDNW!w-%n1YvnVlk;hV+5{yl7Y@=`)sUysjI|4CRe~KA!=2A`)E^@rYnK$AOB%|HyMen+6efOoOQ!@W$-jmDSnb|j}nvJ9*F>pyb#l){F;1r z;123GQO1Xy$$XN42QP>SZFiEd_YPo8QD?73(*F)xF*0tHj&*IV>uycd;7l z@9xj#1B2wkZ;q1QUZ27t$4G*oZ2SQ#8+KiS7GOv@x3uV$@|(3SB}V?Txl9#kdoLLn zt1b+#5N(swo$ICavir>6@e`H6`T3?|KKZpMW=}#IE(&Nu(J3tnNlMO+cX#4@}>H@#7op9;zKBwM49DZUSNA1*$_ zRzB#7X3Wbuv9E1kq$Q-p3Lf#_kaZW<^mAXgS5}C>i;u%ZZa7Yv?TeD=rnzOqXXR!) z;Z=UAs|O{44I=aVec15Rg_qAIzx)YVa~Z}y`ZA_v;xqyes!ZSf6yZDdtT4W?U|ejJ&LdQzXFq>D0~v3 z0pO%dKNOzUYy4p#loTAz`aB(B5qs1?AtJm8td{Ja;0?NS5N_8QhPnA|>~~eW8!7(P zD{=lEw{m~`ZEN-FCA(Wy(fA9C@!B$J3P%am z$hMlQ#}b#^>wFhRXO)J?PKyCwjWO@IAN|?P6FMDUhdRf+MZjB3{9PXEAw14eY{JECtFu$(y7c>ceno-N)-lc2`R zD#V|10@lX=PHh6MDyViaCd3(RHCb}>vx3_6Jp00R=6R_)LXlKG5xS|L9znikAMOy# zuh`l+LcDI&5LTl2XRt4eepJgk+rU(;_&#e8sa{-h>RYPjFE<3G?qe?pZMvWwL#rrP zG$YsQb}xIZOPkH!!;XyfGX$P6`tyWkHa>)F1M=;J_W=i~)! z*|lYjQ2sVH{d~4+-DGMNN#zPsVK$VP#|I91q;srpt+9LtPS%Q*Ze{zL85@W9Q3e9( z9)^mj*kKp`3FFPcmm_o4jm1Y{Vs&p(0jUgglWGI{`WhCTa20&QPiNNgD=STJiISlr!E-h`f|I%Wq|uIG(& z>IcMz;OSv$RMJsm)I#J`W9o+6-HAQRb+E84`@(sKksZn+yy-^ck(+C`W%C2my0x_N zj8L%muMcX%r!}i8d2Kmu1BnE#H0(XS15t7VaoAO*fBGc`5%8kST?Y!?d?G}wqPPSI$|c4P#o zEj)cREcf=@3bS^Lwwb*p#H(uHNcGS;ZhckOPbj1$aUgd?GPp&1~3&8KPkg>SZJ2;L( z`%|pZOK4?+m%McUxUQ-KP0Kpop#(r)lrKA9aWZ6yp_b~(*1XbqrD{YM`KbX0$GnzO z6q%v$QmO{;h>_ea;1}DXjcFdB%>4?+Y-ORXgsJ(B6(d1v82$r0x18C;S%0OlgZw^E zS^Jvv`Xax>KXhuq%zI?1gWy>WVvmtx`WA>SQz>tE06SK8-U(^XwBH=y9y#$9qB*8{ z?dy3;TJ?Mf6;ZOeqINqu(4nyIzxYB}>1wa(ZV>%Ror<>c%H!tV*pe@m2X~2A^mj+k z)_v5%kVn=ISXKucH#D(4W9E=pDeJw+fMc^2!nZn1sE~;4YGSqlm;`LpQB8c*gQ|nV zJY@X=u$2gHA?h@l-%Jc$Akrpb>?dxR?#s;aw6D@qTH^{8r3f;Cei5S@I{fe1i+e3O z;NQ*jNJ}?t3cXNaO=XlNr$z1#ZgU7vSn!4Ui;|7o?=PA`@d4TsQ5v&r$mm@m&Jz%4EpzP+ctz#-MdCJqb;K`` zd@`j`@$#L2-u5GPCZA!vxx|k8x-uL(5;fXNww+kqxN7AQJ(`ahj!ME#+rk?~N$=`A zf~VI%C?hMjbt9&};luq(&U@5;bX3^}iZWv#(R-taio&h+GcLEkfNhTJ5pcj%sM_=g z*3XFjW#nda2&>Lr4LrA=jhAF|8;PsAX^XO#DISRpuHCP=$IL)}%xP7Y#(QY$`;d-j zo@@3b)|c}>R?OdyHL>=t$4B}G7?G!TmaP3=SXQK!KRAdsAuJ9jOXYnQY}5d*$Q66Z zx5HoVQL{Qrd^ey|>0hT5AUIQ22Zf61%^zRcuI=#`D;oLFye_#u7iVu=94Lq!)b9b` z0V)c8yyR5X#!OOb3j1z02&O2jylxBU+K+I1^+}kL_{rL+#AGe-><7d6`44&fjnX@N zSld3;*mBbZn5}GoJ_#mQuu~3z#&?hllhjn3|8?`G@1D(xmh_3e0cBoouQYl_2Qb?2 zusguKRFOTVF(Wk|zg^2ggH6C!nr;=&W-3lG-tzm#m#WVD{ZMf!q4#i0_ z{tYG(P`7HqR7hqTFmK*?(Iv-J7HGrH=C*jviwM@vUi}5~8yM95<{8fUzo}stk+x|R zd1^*v^k~#6D}(&p#K?_^Oi`9?(H}jz(?0%B`ta&)7XB8R;pHo51?&aSZ{A-KX&^J#K1O{L;z*KN4b zy|zaRP_f$bw*S)fyizn$yGGBZYr2RlQ7)O6fmx|q~*xDG`+}qv#j-{qQ6FM zsCLCA1hA##wpu{hiBJ*!+g69YsRqn48A7O!d|P8u_w#rq_JR>x4<}-EY(sUgUr6n? z+q`K^|M_+q?Ws~^vE7;(&M#4A+lrF*CRKcCLzKnYE=ntbipc+Ju}gTeryo;yu-H}b z^GZ(H+EM&1751Il3%kcq#y>mw2He~t24ctZuGx#Gc4B@WN;c=LgH)>L38As`pBAj8 zk%8~-4_&!FUwND&uFYXZU~lbDI{w|Tk!Od$*Achac7%(qZgU8RD^K-loonUQ`eRh# z+`*i>(ylq0)e*aJJNjKbrzc&28uD(V8lFnOd`Rh&4NjCX~TbIt_ohZMf(Ha|w_y zv)|@&6|n}+a3b7QOdPf3u9tRp7@?;brt_X(+GQ~lDT{|2Gh%nu70MUl9}0WfX1|*g zKF17g)Tg@c^&`YR#o?=3RG~QO*H*jMO`neY4q-*e&8(yRfWFZZd zZ4u6OfTp88SC{_eX=`?#*&!$k^}bHDt!}Fi_W#{~Z_f~8ZYVPLCY2ah3Ekgp@SFk8 zoduPP;vSFQSRxZmX8SQJZBG7(*m`Whiq{Ca(-80XD@(WNX;@G+p->|!|MhX%WS>tV z&i@^c`44Js1fqlF>Du`lShWN3xyrHXB2w9^NqP1Cu;w6b?D=I9QF?#eQKun>>=5Xr z(OxBf;tov{4!KKq)*(-sEKG{p|0tmsaxLAG`<21kqG-p@h^Gdl4|$2M5f#w}UCY5k zXPgEba?Td>p!!xK2#py4y+n!i872>s;W}?srQ(E!el{Q+{CRgnl{-`l0C;aeIJWQW zJAcOh##VqrR##xgk<8zhBzjHp7VkVe4T=}$Ih<6sU4vg6X;BTCH34`DU7oVnn!5Kq z&C7a1__rIu#(K5AH@JJM9gN^2LGa|m zcBTmCfn~ztg~s(>p8?!w&2)0{D_(OB9+%pwG-m?ljL&#KUOK>@X;xH!xE(u)fl6TC z3AIW6jl!NR#eBHmi(?)eIc_rAO@diW>=B{s)e5@-Kw3nk@Y7b{z8d$XA7^6hfn4Xx zyh$CWSocu|YHPJ3^p|wrs$tdyBPR@MN@{1#*Z!A>zw%tA)J7f!!(PO^r?=Em0<*xP zf$2~BVoooisnamAKw#OaT%m)G9N&*p+Ic()U%-0c(JH z1!Bi?rk1nvFfXlptZ6|L^%Y$ny!f!F;oZ~8z!+REH=A$1a1^3qNmzC2s~utQvh;h? zx90a8S3T$1ceK#5UT%EN02(rLw46aad>~i4+Bl1Dnw!LaxDWRz_>47sf~?t%{FE0} zFJ))aUU%F{fk(r>xtaW*L~1PDVXWpA4wo|VK!WtFPe*S0`oh2+zyQgm&t?~yJKM&0 zDVk!np~r~x9p*GI%_}*Rm9SxtlPY8`*$0hKlt9nKDv|^p<&8jfgUN{L>>BmT2*%4k z-%xuvrvA$^Is|`G7|xp6+kMzyor1Ql(UGQ(DNeax(l>(Rx3*vAUPd|HJ$&%@Lp{$v zTMl2ZtNkLWjzX%0poVd~Sh{%;Ssrk4-Pq52N^EQZ+6j1;I#N{iwCf(toxn*pNXk2l z%zrgN*E2Rvitzg%gk;g2E%W^=ZIbi;^KJP-oj)~R5Qjo;?vU5*)yLM&7n?wlzueHG zlu|#k3F{`!A=8Lo5!S=QOtva)IzF4V=n=Gv4joHHj6So)pGSzZ7XWimG zY;JW;IU~EX(uA~XJ{i+AXMgS?Wxl;6c5$df$(9^u6n^72SoNP!cn2&s`ijTId_cEb zmGDp8X*^a)SD{ygcc7!@%$?%3Dh-AVSM5CEC4Z#TIXSCUpUPC*nVNnv=-BKNc*OL^wcSSF>$aP+{L{}r0Sy5@&W zMixtH$B?qD^O}jf{#YC>x>sTeOgh?bJ5FPTHeoA~gPmncT;!WRmdPojk?|QhQG4?| z=C0CY_KnrOnO+ThiiuIOsoQ|yWM?cL*4VDM@d*Lzp1ee?{5E<7nV^q@;g-z3HUjK5-;5Y=;@h{G-2Uz+IR}8HQ7Kup7Nm80F2yn z3?3SE2PXn@$G<9Tx3!XXSK9#kg9uPF%KK+bFmn&RVek^^d<*k+*Nrsi{*AMsIkJ1dMw( zuk}dYhhDY$>s8G3UjYl%ZfBvoFHqA!^8Xe*Z#68>{`Aiigfw?*9IcZC*bZV`EAJzv zuPU}uOkrP72^*(iFIF0wRc)l+{|HLVeiy2%j>q`zs`S6kWN5`Iuy=vEWzzL4<$@+u zXWslj%a`HR*p5%`%aoR(mg6ytpQZ0mkew7g-M}2D;1Ai?D~?Rt13sxzncM9`Q=tQl zfdEm7pNOKn*6=eP6Z5wK>QagP{D*w}Gcd#SXmHlS9U%h8g>Ag#IKg;+pY8S}x8$}@ z-TT=;k{)Ymi!*E{c~*&&sOLIA;>J6@CxrgcROi@p)K~0Js;iyO2$eKca8WIy2K=vk z8tYPQ`>l9isx#2ehRz%^8^w0&pK#d>OEQ0-yk5019te9j=|K}KaTdTxA(=wAa|NX3 zVwcD*Vk4+jav9!#6^2kDMgIJ^A!|*A+h!2ccPG~dl4DiaWhmne-?*=sKs}rT`%Gl(I!$BBU%TdQ4_@v|YNmCy=+kE)pS$7m7=bDe~**9;IgI1JW5n}eZ|Mq@rZ{zuUu+Chv zp-!6to>!e4m7782y0+R7PkZ%Oy|l5Fwy@`79cXI~(;Abdy>}{C;FAr_Z(6LAscPO9>MBWZ$HJI_a!?U;9V{*TQ|KXF=qJ)P4;C)QUA8v4-#nH(3LD0aq{Z_ z6#Xh$W2`EBBw(OW^luBt1XQM&J!=L5AH)7~CCy)&|CApE-#5g2e^W*1mq!fzJ3eiX z@Nzu1(lAc3{iS(`MN{rrc-#AKcKC0S?*o}}@VxZcONH|H!J)|e5odI^l2h|FdZEow z>C3j<*T1S^^Zb~NoA{OYH9%2>oV(en4Z5{{WlTv2bW+fI5|H>$($Ojl;1fW?*7qqB zyrgr{BvS9UI-oo51ZBjc?ek-#77$hH{fvyP%a9oSGg5@SV)`Xv@InjncIhF(_?^J2 zn&W`1RzA-y*GsR3*PLj=3p(p{lGl6z7dw70ZJ&1RUkroBMvJ9`4am$hqhICTZDd7# zF>R?>Q6Va8(b4fBPva+`u=$rRd=DI}X~#F|c;7WA@RlOwdFLFjtuVWrN3dr)lnT_~ zXO$4n&wU+QBn%DRuOJw|r}2b~toU9VzLDya>7%<1pHQ#CQb{P-^a-DguN&*V;hLiD zQC;M*T@o~kOmt56Ks0MohmdZnW{-$Hjh5$he);}1i67r7C@-+ATds!pvTgc)PJ@pq zDeh+lIeWS`NV;y_Q|@}Bzo_ZOM(U0ijb?iKJxqjdVuj~{UuN7Kjig%8YyGsl94Wjc zRU^@F;8e`)1+%XR5S&Ctq)tA-7b$<|L_elPpM>dt3Jqs2zCF7z{%1sR|2Vs^{lS3u z8kgvA{b#Q4Rg*tWWaSm`gE8!9Ly!ug^ol0{ZKME6ol4%{?gCwa&)(Ku^V~Sp6?5O} zR|M>PXN3F$UZx2NC5s++E#$cboxxEePy}$RV!X`S@{Mi$&ft?8%5KPDk3|aY%@1Rv z#d&;EpYG5w=-X_K+*$?^m^cv$T!Wky$i|LL=KCtAZCm%J`(ea9de4xDEVZW&jo-WI zpFVP#T!PD6k2DA^SCVw|pS_Ha5I!VWN99e50*!N)iER!7);qaS!+dMe*J_&EzT=HS zLu!e>(foHJYVRJxZ)pvyg^j9i2V^-cmCOQXwM99$#%<1 z@vZwmUN*}A()5GHN!+Dhu-;Yuf7cm-r=P~FN9>HU+jMZ0nI3Iq{nJh zgn_9uA7S7vHqb#2^#52o6ThU>KiW@IlhagMS!uadR@Tqdam-!8avEzYX%!QN(#mqp z6&Dtp7Ps88v{WRsvQi`$a6zF`Trzh-0hL0*1pxs80ny8S-TOE2<#|5O`JD4UT8ty- zTL<$$CV1cFaBbEanW`fTEl;7uR914m!f4GduX(w9!vk;)n(VPMkZ#x2I{JBxpcC+| ze9|iASX$2c#M(@@-(70Ef%9K-|F!Kp?olt-*OKtF+8N-J1EVXR08OTOqDbiJrqTUF zaNINVE9QcZL!}`fago(Z6?L7TTN-S|FNSuZgmY0HkY61oT^dCZ$G%wJ-ga3^rNpuJ z@mIwNvAzjbarAsB&Q3|YlkyLJCy^D+dxr}F!@V!vUWkmCpdWAX)%ns23@xm8(M z1UZAtvs1GC_r-j(61Cs0tch2Pez*XU<6-5Ic*4>ULu`eAo}60I{808Nf`E9go(%n_ zPTzMeT;ZEwp{G2lU5=9~=8Lrq6wjLQHQrSFH_i6tcDbNbn>5=OIx(9V;nDP|5SOq& zvHy9<=6TZ0j{eiHimk$>mK8XWrpx(Es6WMao>AofFxA7K%1fMG8L;zVp{%kyc*(*c z>34r-U3%T`L%}eY-F?V7iB%IE#4f0ONp!=d z0vI@OOfT3d^y6*1$^7u($LEH$Q{#ah!y^B?##cxCj&P|ys~7)-A)>up%|KPbWJbYe zq+9*Iep926f^dhC5rkZNwMs=hQ*0)kKL|u#hgjvGO>HS?5PDZY7LsGM4Rm z4NfPjXnz7+xFH4>HWRdKFJoGK$q6T2dhz3u8*21UNtwgqwDd`MRNY0hq6Q*G@&D^i zb{f3TOkU&a8pIbL3d~)XImuz|j5v-OA2iF4{%`C@+q?1N(~jWl58RWw5^Tny9ow)A zL&3w3+H_(EH$)S}`6nRz_N8{FIyJAOcIuxsXoDIuSGqO}9-RWRWK*I?Zv=;*z_z65 zP+=NLK1?ewryUDB$Gx)PN0z2`z0t{{L3=N1E6vBwzC-azeE%@UZg3R8t|G?^lnDkp zAG8q@fk_Ehd!lE~ZdU#sYKP`H{L`C%-VwqG$4RVq$0%=f`fjGKyScAPm6s?9BP#M% zzVA;mHJyj*QccFvW}5+wC+${x%3lH;%ByXj>4hJB%o!`HsdzNMuJ>mR13Kt9>Q)?f z=yKLKclKPBbx8R1F}TYKHbVVy%eB$_bkF`T-DMy3z-h*5g{B(LPos}IrZ49=Lhv3o zM$5EF0Zp&li+e$s*F?xU8Lx$jel|7=sa5E>t46!*6jajr-;R+P#~;e7C!57sNt zaVNfBczO2lLZe}~LB*;h$1 zzYM|IuVSPX$k$rtJZ;Xlb?48JC$QXX`!<*Oz9KBe3UKRC>6o3q$Mj&OkCkhZrsKRr*5*EriP#5~grT5$*cJ;&Ai zc9bl=1)QJN*^t)K)Mc0`Ebl8~Kr?bAhrFl1Uw@)^^GO|vNI>xO%UI5Dr7!CKiL(Wp ze9T7?C6AWw`^!s6m@f*?cVyAlK1WT@UL-uXQt>EEddO6CCrnm-q%Uv;{!d^r=H}ka z2e^=*0iDe&qBRW#t=0=f4By*W`A@NymA&<2j_tp?AI&)6vyTC}q2GNRwp~*l0nXbv zD(^7D&VLIq!jQkJvKB{-97=gp*gGh0Ee(1Vs0n<}cKfyEh_;%nUOaaKP9&+zgdv;&{#8wGwPOMW`{g~JD0v=om{0<02keQ6iK#U~CDqEnzefEAZdJ#o06m0O3nlMB+pMQ9E9fs#mCpYZK_I81SeVLD1GZw zcUkGQ4^KbWeKaJBc?#qdq}qUA5cq4OMGvPVVzp_sgio4#l2QqPyEn8PeBIHdra9C` zwV`4q9H9azZfNp) zEjsJwIVfZydcNd`^W4g(rjpYYGgZNdG^NFumu`_+jN`(R|6J@iGV%k}eXqYTcWax7 zb&)N$X=fHfKA5iRvPf^?FDHXqSXw5b)@fP^m4Gc<=C263Fq7@E5w9Q=_v^o2e?h%NIkoro!ajfY;B1 z_VlwQg$)Qz7I)-B!Oh*4Ivvx52Inipa>azSDo}wIekw#y} z{t>t7;%pNS8Wxj`HkpMtU}$^JX2r-=f0`m-REA zKPh4UxcHmpsC8O|JYmiws>>!2d(Pfc?;t)cp#66AvPXdlk##y3XrB^zs0X{dnX&Nr z0Qem9ZOBPenvU}alKnmX5u#~Vk@RZVoVhQFT6*kQ4n}nWK>KGwo>o-GnK5T@HXIE_ibV;Q^eSdx+bI`t34Mhf4=gX{zu04LHlKgjl17D3j%YYp1wfz^xQK7h{`mJ zbcMF&xqy{^v$hguOlxi~Vml2Ru!Od?rPMAoBg7{8-KX`+|BVKEXgjW5tI;Q&`H%Ic3`#9V1Sxn_?8I9!Pc$sGSyjk~bYEi^7s zBL5@AFd;2PJ$U)7fO(bclPTPu7B5u$;^H~Mo5MVdZR0Upt-J5UyYB|AW546Z9 zG{RkL?fDDgSj`_*6T)kQ&X1!t8?fKpf1WWz2mR3s&xPA+H+R9p=yVnFh@KF%vekCHN*XIG0zShP2wb8KR_4>0nFj&WhYn?LUtR&y|Ni zk@Q&X42>_*r%oG#h>HK*FQ?}l!+1%0{lq3t5KHB&t=lS2C(LVp&$H|tNVG)zHJR6* z#+D?C(@%tMp=DS@j*xCHl`l=3>kyZ?wZSuizJC}2OJW4;k+v^Jzkaj!HuIqDy+V4g zyr~6R7`?2+SLJE-edd3G?;pz`MsXjj!)mD!8|I#}WOpXU?yQxnFC#dT?PH|#$&c|` zI?ZTj{OB4AHuoL0yZw5A_U4d)e75@4)fI5}nc3gLrWw7o8CAVU5IU6B2Jia~){qbn z&XLDV)f~O{3o1OCrkBx*#D`n$Ej9=huY&}BfdDgaF01X)ku~@fF?-wPGc2 zH8toib@0|AjoACKXBRUR4}1BTh^bh)ON21}IudjGc2qtrdH!y`)9 z>CGO;6D-`$PIytq6PL|N z@#aAzY(p1UIwvmvLoakSslY~zvofgJ*yQS!gkN%GOxkI+;3QeOZnR(AW%FkG1x#*H zda53-G4q3Av+2h@7%gurd8#wmt~4sCLwR7cpm(C2Wdm)&=|I(&EY~D7$4FhhvF-@@ zfgt;XY!s_VY$@kdJMc1Wt|6pdh7@?O+%_bj%cJJ~u7IS_VQ45Nz1+9`xpk}lGQWH* z-wL~YcJ6NG`Y%TffD0>^x*W!N2CndV_n$QXv66y#;X}e>+E&NJeaYWKA^e23#hkU} z9EzsL1o?h>6s;L$`x$jTzFT8hm&p9Z+UZZ?iLjk!C+m5$u_wl6Q3HeL9}27u@8>E8 z-)(I$i+V!(!bsWSOM)hlqNc7MTc!R(K5%@a^Q(lwBaT5hBOO2hS*F+snOs&Lbs+Fx z$6UNs941k+ixY2_^jZ66HgEO^2D<(QGRrvi1Y+^m_B(SDHiCEpMPr|*pvm2y9%e9M z<$6YcL(@DVIt2tRHmP|vKcss9T=r$NWJ619&3&@pK5}tRA;@YqJ)}objWO&?!kJjL z>!~=t&Thoz8x5_uMTE%jdFA=;ny@Rtk)r#Jb9F|0@*5)P{r1eFX7b2e%|h9wCy3{G z?ci&caXxeUH_i<^rdvj_d-SqoLdBceu*bP6HI{v$?&e(GqtxcZB)J?goipVZ=M`3y z<0oBs#oK0fN2(taE;ax=+oQAdoslDco?2+E&A&RexKkGbq-E6na#dIpmxa{6FzK%1%og~)LoC*(|&+=aDas&tJNxiJ2Qf_fb|@;LBy zUGS%{vLD~MPXrSb_;O!2kB$P=-7m>3Ygt^52k?z2o&QNze~A;>4XA(pk^bPxiy=NT z4@7Q%>@pLdZGSkk0_MKFh^l9wZLt%0wfMQLbV1x`|Fz=Mo#MT>aCnr29$N@C%Vll8 zI1~WkUVt1sQZGExGGE!o%VH0-gotuoCt0{FL*Z{nZXlIaDJu1LeTP@Clq^zF((Hj(5BU&`9Hus2dGwyP{-4luMWB(C8l@oc595>jFT zWssBsYW9!YmN#RR4P#Rn6?VGG7gm8YBG*ue?EMV5OEEkeKiyW@2pmM8jH=2iZq2tS z4P*iq?2Ag}ZQLz#K1H7(I5^}SppV(1)$Q?hG$F@5$ zb0F9lM-jjDOuz&WT_ckVux}GqA}k-5R#KUEEp?vL6YB(apX&aedGp*WEaBaOsZv76 zOw1@Eo+vPWpjC%+(4iMwE=qs*!}}%r010wOSCQR(70jImrPvSReRADb+pqRX?)tAp zZ^yszQ{dbo+{`7{(K~b6{P)L5YiIfE}B;|WgpJLj5()!aIw6Jffp!9n8btzpj0 zSH0~?P2i@^{z6Xty8zb0`AwT+cZ`g(61Sm800Tp(mgiYySH4wFFZVkkDu!!{#a|Zw zowz?bcj3Hg0s7mm;Jdfxu`T+JQ0)!}cNs9rz++8!!pBguj9*Rmk($~>+OS?G)9a75 zT^VLK#ylL({^8NhiQCQzop{lFqbXM${>GuC@UmkL>d-qj@6g%K^L51@jx`Rzmkxm9 z*u1T#KUvERZD*Ecgg7kfsa-1byF-HG`v@P-;J1q-uM&I$yz6o(jDP0n7)TJFMnD_m}#;ujY;DediXNNR<1`&1CF2nmjib9vxeM z1e-v>U30qS12U$*IZSd`j(%%l7Eg$+%8dIn0y}b&{L!;3l5q1ZBwV5`$lgM8gs3Ff zfyKREys{eQ3Zqm0K=Y29V5Oqy>X{7uE>M8al! zPE33Y=T@Red!Ur}E0spGkuA%9iC5}8e6sv2dDQ!bTUx{NhW&a@V*>b0;oUToE3IQ` z8MibKg;xV7SB%PIy`dYF+)h+z|0&!D!>6a_io8@e3!YBc&Q|KdXm^oyqp~t81ajS* zZM^3+I6}E4nytxj%VC;zOwSo)j` zs4x>i)4M)+^&ds=oGZrPS~iRk6t86+Bb)JnMP#qpZ6%0#i*;Z^*}RetJlrz3#m9pP+67iBrDF=6R- z?<#Tl(_M{hP5qDE@-z&xKd+kkUIE?yK|vKto=2oRxHd za@?-{Sik7t5S=;ySc1dju$s>W#stQ$v!dsL!!S~J##uM&&YB8u94LB;+XaovwZ|94 z){Uxa%I!hB$7Uy(rGo}`O#l1%o2r3Q)0c?dsYKuQ&fSUeW3L|QR8|IPB(RXR{qY&s z07r@;sVXK9V%F5B<+07;?anj z=~Ob&a30G~Ia!Nei~!u^UryZC)6~#sTh$Ae_f9PJ80`w$FjvytUD6Da>?g4gBrC6# zxM{$vproh2N%5bgvO4uc9&9k@bKLIf`XwuJ)|8Q1D0ppTqDDCZ6MJJYpjG{r4E1Fr z$DRFmr@G$}^v{Mz-6}6BjfOxKkXnYnsbAH3iOOhwmF7284CpW512cls8|0ppeTp`Z zAn#Ead#c=nOFj_Z2SfWkqL=1UQ2qU3^6y{!SNrxy;n44e^gii8VrNX9B74$ZrN>S3 zj;}s#D(gGx4WR^wX?R+DtKFHXS@V^y7*ep}=w%Ax>0P~lUg^%i?whp2Y^6cX2pdnk zV_+YH?f|9x-_55?zZ0A*v!`2}t#HFw)DG`?bZ%zL8`#2J8SiO$e|R+)hUVv)3>>Zq zr|fgcKW}plHM*PQIq@+j7!VYLt7xp$If%6;-3i^doB#UO=GuUg>8BurdJ;_V^LL8u zsKXVkNz7@pa8qt+Sky?y)^1Q0mGl>r{`+FY&ZiG}-jraiA$4*qe!9S)Sh40A4<#KlFBUJLm(vEcJaOb;Ilo-`3(}jBEkI$3D zLRBTGLMIm)8?l1_79WWlw47w>TI^iI=udSpN{EQ|w@}6YN2y&$%WNi1|3}~#>Ke|Z z_J^>Yhb-JjT+A@Y7!vG)F7xX-DD+C2$O zmHb#>4w-4}AEny@xg9#L;fZ{UrKx?(q5NRTIc7*rqW(7YYVq)p!0s6`ls2-b7EL%) zXf3BNU(d0a6+tsed#~h6UYgth*31t$!AQ5y z&BL(nijQYhe8=P;<;uPQ0_0N}1X(XrPwCo6dC%4wfD#S#gv-*i6e8ftlq;oq195GW zmiO?7e<|N<;Z0&Zi*AF$z2Jsp-7HRvK2#Kavh3d+`Y9BYq}}9fN|;*RKsEa2iXByC z_XwVE(1Z**-Gx%dGTFv%+~K`9>tYOgqT(WfiH~S!B9)H);4wma$e- z!LDJ*!XtqfhoAF?amc6e1Q`QGLw~hE?Z(cMhd*q@=L&{{-}?@W7a$8NdQ+50(AaQj zxoa}2zTISOf)&sSj~X(A$KvI>{W-26)ReIA?(cw#E5bCudO{M z43l!Rzk08gHvoDrn`(mM*tT-gZvlx-u;$FEPL^Jk0t#KAK6!8jQj-SupOA4+YTeBE zA)DZE`yF2Pov9>ui5>}MDK>G!a%>9rZTxRDNIcuHabOl>aBC+lc;*k&%X2H)W6$7OLf~*6WZTJ z!Z>Gaw1qCzYbKQhQjFBY%)mQdS)JWDH(v*y38~%~mDbCcv-?pO?wyUf_PXD|y(u@u zTGt;z6d{cGJ?ZYPVbU8`J6*FSU(DlY9xq)p=N=^|q&w}mz9g7U)!uuT0Y*loz)PT# zz-=)rOVp=0XBQ3;ZA2+yvKFQ+Ru0kkp~8`uzH>x5t`0f!j>f%%d2na24zh&Ds$1$} zKC{ps;@`Xim=*E}tO>pHgxdQ_vNiEB>=?Bgi(i@8Yh9!#I5e3VvU-$U*&pff#&D8) zlKhnre7TQd1GXYrux|3@Z?sre^}nJ`a~(B}F>uYUq2xjq*cYQ>*90i7+gq`C(7k@T ztMb|9E$nsBm7gj`NyZ_>j^TOqBRGQnv+0PiXE0%=66QSWNO5!TSpqv&^BS_+$QJj) zJ&CVyYkw?F`BwAr2rB#w@1!oaJ+8(PJ^I-e|DsoRl9K$M30(Nf{>LT_1?{oMF3AVeh>bfK%`*3#_sOPq+J= z!zIoTb(!FJze}YLBb1eeE>|NJ=aL6dSI`9h>X&zWi)OseO}IXd&R^rb-{ooBvo&L@ zL967rSFqIErbf?C8Z~G+!)r(8=^{U$sLjW>RNk=NVDCE_t2O-07ouv|{~qv>=pQ#0 zJR`Lnm-;B(U+(5N5KL><&+f0$+Xf4n+Ia*SZ~E(+61XAeC8eH6ywN*> zn%)*!(_!`G_i7sqEFyoj2o37wq{lK&_9*9 zNtfo*EsR1{8#3HY!U0rdKL&-p8v4d1FS?_=*DEds@xWesCXq93&Q`vD zUFit+FQt~@9B5wrYvtiqXYcZBoS8GOtqfg2(t@D{|%AzMX%YSOU!Z)vQx&L-}T+19Va zOjix0FqSYXtPW^O*rmXjb14b8)-r-w*Gmu?w6*LB*B^|8pQjS>x zjDr0u^UYrFSVmLyci{a|k5YeG;2? zGSnq6I`%XFgXCd}9Yb7d0^05rA>&Z&wca=>yHU*w*o}aFe-)$O(!JH&Z7S z)lG^lIPKxBzRC|o?lWkV1(LTs=w}hjGDpxH(%f}F(UpzZFTLv<#>6gKZa0RtAnxoz z&sgN;BqCzlJG~O`IGWln-oQDHr8tMix>>4v`(E5MGn^f37$Uekln<&{cX zlO_-UFqTwamUN4vJ~!GzM+kcLGhFjv>c1B}`?o3`Mx`5a62tpX1w|D)ZZEgJVwaRq zxl1=bWPR^%p#(5FQ^dsCTzW#tj3qzd_QgBT!zctCxNSpe;1>2^tM9}@TlC4PO8B4( z&Pn0I%w(b!YNbrnF*u{vA0P8!b_R5k`g7nC^90U*rLIcdG)@2?Da<6CpXtN7{hVNO zcJ*iTGw+ABCdUumMZ1;PiV=|3>)E=4I@(oUuL5x{n1z^ijEEQ<52rk6%+IW73Ph$Z z6gX-}9uXc{$j_IbV7c6#NFLNMFz?a8d6UyQCO<2R;E#iP-u7RBt-$;wtZ$tDi|*XRU{lpnd zRsvIBofjF(b1CFG5X1NlbeEs~zE9eH5f`jp^!t*BRSzS@y*Ep+D;`Q9%ahfllH>3ail z=i6rX=lu|W-ltkhJ0JJn&3KiCR!33@x=_7Gjp~%8flkmpD(Jhj2Z!nF`og4x_dA+y z9EMx_uM4fTS>rb7Jkz;);GL;|7DGDoNn!;+#%vflWqe^WM0?~u+6mJ;=@2bgf3YuQ z3^Anh+c$SzjeHZOz?#Io-s(o6J$7I8gk^JPJ2wsWl&!elVZJFLAgB<8QBd672n7fh zhFY?uOROwvGH$(f-lntaGzvr^&WP{wrR>cv$)O1+D0Kh0^1{AA!R%tDE3gl<*=t63 z+OtIG06h3_ia((-^aLt8m9x=>rfbkmBycCC?L)0=B2O2LVIVt;?ax9 ztr>YhD+qFRcD9qT*S)Esp$}y5{r%b$cI%b(&asd0@e9u?^Gd;Qf_JjR>IGX3VaF?W zk$f{C=+Mh3By>m3=+ls27*`ZV5A4NMNUMu$Pw}d1ojhR^GM-V;Kc5@IRMu9Dltcbj zrdHMfnX)rf_`1=9@`7(sHdYUO&_l8R_#1f#;7oEIQR2Oj>hIc6s=qb|)Ksu1gGvo1 zKd77bJDqHi*~AO(YP`g|3biz7Ea&nBI0=s+I>K?yMf!GS@F?YOFmQsuc~b0F*4Q?& z#+1G7y{+wdB!3RT2Vk_C<=Pg#WBpua6I=uQBP!CQt| zWzqOI_}flh^fJT}%fg`@D$5~pe_@1>46Zo(t2m#-t<7HHh_NFCM4@G|0H5s~pYT+e zGWR^R_Vc>f)5#3wCDH^ahE6J;vUG^M)(sx#MgSmgXHbPC{(o2J3Vl4Ij zAwdA)YUFq_YKa=&|E)9fot&1G{P*+;*b|7&No<(Al=kvgPRa;INhSa<>&#l)S__xkl7l7_vgTM`PjT>ak)g)6 z38hFAZdt+gI|+@+s$NmEkMV*BqWjT{o{E;92O7+}Itn{XWOMz9yy;)PU# zJg45GaXpN7o~6ONf)#%>)#_I|WssV8)oIrN-%So-+6@(by9x_lK#q?ly=N!IM_+x= z7ZmpkPIZ^7Kf}dGOvqe@x#XE&^!gAC3%=OTF{g9pjmwZ7d-7!R>-Y&pyfl$?i%3yQ9w31fefI!~Z1G@2G>meNd zAymM;y9U&-RJ-BK9m+()Q4dJmjKR0>O%MLH}$~^Wj-BYEwTtT&nb$03Q zHAB9d8rQpqG&8h$Om@1fJld!GBdfug{GF|LA8n{+Q8X;J>4N6Ph+p872RVRg?V=#pN2eLlWzd2dmgVLYr;!IEjA`!5MXxU zoMpe1tVq6;u5pf8pYC)y3V&){-QgFb=Fq?mjo;253k-?;)|Ax#wpZsaEG;TZKZ&}Z z&YL}W-{uo^%hGTtQk|kMO_x&}UyRk8A*<{E?`<`5vRKbKvc#i8a~?d-^6O0GpRu0a zGb>}rn&J}wv?d3>wXhaX*i~(mH9Y2CgtVmSSKS&$2}~PPqUnni0JVo zs!4{GyRWN;^H)VdUwTw{e8R70oU!p8s)f^0k>@_egq7Y4hwiVo{CO9Jbb!m+$zp!b z%X+XjtbUbGNLPG#M0?=6x+hJiFo9W|n-hrQHZ;-Ef0r&k_mp3_KD{JnlZ6^ID( z$M^kjd~c?E6*jz$Kv<2KJ)1`jKd!(iT0p_Pc_R%(>V$T`IFcYUS#KKjrWi z+uR>pQkqnmPE`iU@FJn<^@$dB87a&4HTuYcp6imv{LivFIrWXm`ev&-4sOmj;I)rV z;F=OP4Tx7K6tO`Z=n2(i)%n>>Ld$9RPt@_HfI*XM-??vhWs=Uq&m%M!lh@9=z~iLc z3$2VEjNXvq;;RRsDh?R#f{Z+b$af-n#_R1aPhcn?WUqc|BX?(^Yd?FA;eQBG|ET&% zP5MnwTYCbwPtpGyuwZo7#0BX@SIZgr_g81Yl^fID$3+^txV@*a(G{}1PZ$g7*QwqW zN(E0w-6v$>6WS~6L6VE)D4)pJ-f|Dp5o@Afe8`dAE!V3{SnFd}oXkVGE3voJ3^OCA zJ|0$)8Uzi7d}$&2{l>=1-%6K5U3L5reO{ExJL$$%bw_Ux1)qa0aIW{$6ZQ2YYM#OS z?KJX#jLTk}mddz3*nlP+RIKQ{o-9v~3r{}Z-b+-S1hiXI=FdD)>ugic?imPvLs-wnM z`}dh)uTTA)@km~w4 zaNM^p;C`uIbVQDv@f?aQ33F4#Z!L}PWJvAQv}*y4Qx-o?bN>BqC3M*|SHxP?{|=Av zLD#^yXePCbY0Q}4)Wd9eS@W*5>UGNs#C)>FpxC?CW~y!v`%X;P5{&Z?qu{7@S`BGz&oCIMxQ9#rB z@ANv`YBWFbghjVrv3&g#8&FIy8zl!rf9jjme3@?oD-v6%60HkBmVCx;OCn0~A=ggp2rC79fw%!hQ39IY$n)X+ak20D%0HS3GbY zJvGEL`u->+ALX#AI3#t{)G0@@V0Uui3^8n)w}mr08h=J33HT0F8Q9hjI}h zRrgJr9L`{`alUJj-7!uwnpd{`Rm{1O4UW*0Hb6p3IdicL)=O}r>&!`SZ=K~FJ#2Lp z9`niu5723ksq2489uMg;Xzv8cChfO5-tVn(R$-1BU&xMTmT=!iLMez%KiV%NPrJ}8 z`X(O4@?_Q1LA&wol8M#QQPAQWgZ}5g znW#VY*EL#Kh+VZSeh{`Ubd>QsNm%-Y=$e{*zQiv^_@^*?HSd#Xa&`Lv8rNoAW9lV4 zeNP)XX14b1-3c1nBQ(x5Pq%Y*nRwd_jAzFfEI@_oGw{1Ef%g=$*3h@fwaK4|jgB^5 zW`J?j3yC{k^p3na&Oi{*zFRMXtn#`EnEt2Vq#$LvN|Cb=qQgx?L*#)}HgNXvgtk@I zFX3Y{KqV-5`NnXw-5qLGW38L!8R}iR5wWL^pFAbY!-mOQeo=FXJ`sY#f~5&BO}&6i zUuUpJYCueFlrD{ROiVyoFW)s72j;B5w{5kKr1d;<%5(5VW1^5Z{a$hZ>vQt6+|5@l z7w9j4@ae0tn>u!gUKxSMbN{^U0-&o+WUk4kMOq*qw}VT$-)&g)Pt95o zvBY$jy_wp7(IC{X!N;EwqISP775c{)EVmxe9b(*BrJrRZWVHsEw|-+q->?|JSYcK= zfqoyLi@rCu_e1u=+_5K_Hrvf-*S2uf8|HB6F%+UwZ8Gk^e^nN9Bg>zHl`KLgrv3|K z-%!%cMkv}8Dg!`OZz^r9&Vi+KagSlNnuMpW4R?%ZEaIAsGu=b6_rA>6Xd{N!BG-U1 z87L@82LS?LdDx|l6RafS&Cs!#ieN!Ctg4rL8VDdK3+Ia|gzm$~$l(=bZZnIdBX5YdFr9wT0~JKV^Z5^g>UU;ltm$2xe=Rh;k7wdO;MnddrL6-#74kq) zyu6#KdZWiJyRGt*{n{kJcu=C6rs_K0F=s5)LJW;Eep16b6U8~4Id2f}pS7F!kyd(n ziq4qHY_ITsSncw$vS@E{1!VF~-8+EOM^Af8d;+VEN8t6W1H-T5M16msmp(%CS@2Vu zecs}`)EZm<)RCE3;$hq_i)ZZlnl{>4lEWPJx2R)&uvS=l)~1Ljga(QOuJxn?ekmUF zKC_wNQ~X(^9gZ`-fXD78&&GE#Q*^V}PyIPIdk6#y?Y*DT*4*}`uf^s%vTO+^OzXeF z|7E*QL+VqMPRWbNELgnBP3?4E*?Jl&{Tpj)ok%q@HVleaZVw{%>;Xm92-a=C_x?QEZNT$}A_b|_occsMXd3Io z5ndRrovA2D8#J7KIn{$`qB($Ime#gR&*Zm}ea&tH9dEs>u#auRtvB*>_>>k#3g9jt zm;cFmRL9}7H}Z*e7u^03Z@EDa!;sJn6a-d(3cd6N8+qmziqjKn5l+n0>id3XH}guz zYcoNt;Hxa|m%X+^Hv*6=v^$;A)Z7rvJ4sGKBecJrAED}f71 z!auoxOn6q}#Q{rz)a02-8c7M}8{p+jfy&wsgo4kOeV`x}Z7d< z6Lu8(!NI|2D@c)S^{4?xxU4C>`h?-B{@Z0eCN-p}s~;{PvvNa@bf^#_w*~0ve~H(p zNP%mOtxbzr6;5LYcE|N_1TRZoN$)(aZ=yRh9p}4jZ;={3RE>^bm`aDRW>U#xnUuXc zF3TBs(H`nsd#@*Ro(SqQy|~UovleQ5fwyzbW*+x+QH8cOXr4R1%iMdM>Z7aduqkkY z1A7gCH%W;W+|5gybpPv5oKxU6Ti?e#0I!I-ZEhw}HHt)<&6-4Jyx3%GP2{|??2q0r z%Y;}>2Y-j+mMZn;#`QIlHj4VWO^H*Q+iCTW7|a6suG)N;RRCXrA6uHrtg}yaWSfSj zzxeoQT&tOA+lJrhS0wb5xrn8RCx;Kg#@-hr56Dv z=6CPSmvBQnH_U6pr6)#GQ|yzX3?DenHuJZ`YlPjr`&ljAM$RN*CaT}mY=Q8~2KHWe zX^a!KCeRhFrT^ES<7&34Rft4vBOHgi$1vqtpwn#Qozhd|G#io}N0@)v$H^{hsvw{@ zBlao|6fZ&Nioun*sCdi83W}OUQG2Bh=@cdWss44UZENzPp|jKK#R>G?w!)^>dj~M> zjZM1i=LURxs@v|MoM)wTe~Jn#0N>Nw_FZ$}OxPr9%$==u@`3!n7wBqn*NgLdrS9z% zgM~GdzrQvlNZ5Wl4#o5=*G9j@JH<9;%7UQySBH4h2S)v(INM^RG*_1FMp!E{w_$|^ za&xMkse6%pL-A{aO$W)5k&E*}`fr$R04i@9NY1+bNr-JfZNqlIph^3o^H1>0oq9h+ zh;B@5N11Q?AImZ+=(BM#?sA-!4Q}igkn_9CB;`62tZi_;lVaT##2~xw(pH34pj`m9 zY=UtMt=#1Vy2sfD&Bs2!OIzq3#np-Yht|Tr%mVKng?qa}rASmmN9-&=l-dciQagP+ zyFv@F!pW4^FQc3sO8YL^3zX%8N4UN>!G~{n;t`d3M8nK(W6Ioypd|Wkqp3fT*UfFL zVBFD`D4G3X+*Gwg>AJq+)qnX^ENGQlMy9o9o+teKr1Gr&CDErAh!Noy7En6xM-C$t zgD(j@C@SC0+>7Vu@&=s9mdpQ%E#IIMB_>6wS*=TfCPZ zfPqjA+OQF>pP*J`WL;h1V-M1L#eC6TcQWzcWaybxc_C@UxOa# z1It>PKP83(kCS(_Fa80ya+SKL?iDdDtJq-QWKGX#!VE<+;ntdUqtkV57r8uns)g7q zSgCZgCUaJ;W@Rs7=fVWnghI+FC&YV9Z(szF5 z)hsh|1RF)Hc2pL(Up@zSZ(&9bwZ0{lizdkUgR6rBCPVHO{!unwQ!5!~&$YW!2pG%T zzsBzFm?*AI-r@4b^-Yr`FLRk&Mo|Ej3ntl%FAb;S`eO@Y*A%TSqLbvp__Z*zk998M zx23B;pD(VbrsrdvNIjW4Amw7fmX*-^rLI;`^w>}I26LdTfmh9yshgqia)wPHZoTQ1 z&7qZ{F}Zp}O+WN%J1d~H4Yab{{U{tFxSy`5`a8tpK)Rh=&x!r!1Y| zh!!oBcQBx7sEhz!U%k}NXA097NZql{K%S=8be7W{Nhn4msL(X5;GxC17iQXP% zn^%=AaUeBeQSN%xR=FjYY!JD!6!jbyb*=Jk@ltDc&g!2JoD`ak53wd6;yG1W`6xC+ zrnCen^IyJt9_;K=ydpIRTHS?Z)*0(Na~{uMGF3W)vlb6U-8bxckcM-Q?$dW3Daf38 z;;d%wse5PNamX7P-|nyWSgOR2eQYRcPYBIDA7n*}{sqAGSTZV{Qd!UNqCULb{k_hB zGy_c@v3mp+*XY4lHj#%6YzEZNl0#b?rBRvc%g=(0`Rm!c8eR66?m8U|dFm||j=Q$k zHO9**oc}myN(wE^u$-g1X=Z@*&9kjf=?1Qpq)#z4ME}2H+_Akj{g(H8YNT^w&`|Oa zr7I#2Ke?+%zbL1{ke&m`2L8bZj@uq@z?C$F3o2Xc>3rY~ev@jz7ZP58FESXlc-0`; zR2rLEzU%=3;M$m?7L>?TWGM0!d5E+S7EyNe$U9aE+)!-FFnr}KUh*DdC;yiiBr0#r zz{BsZ%*liYdYfGDWX&dc7vTy zAfg}y1bRJIfnLOuSO0N z-ZOO1RhM;pGIdPud(P~iUw22}cyDSa`mQJ2;3HlA+6VgyZfI;QH#sb&Be$C;)QYxA zY%bI+zgk+nzhfZYBg2#LVF0nsB?;Ruz|Ievg+mzFFal{UCioC6K?fD7d;>(H$`LU)8@U^swl9G(Ke)j=ul3jN1Z6N}oW3q~7 zVahKK`b2aIY@b^*J?$^=BJV7BFC&rXSvpF2`T8|6*z*o7tMI|j;F@j8rz`Aw`kZd) z5O|U->}siAs4^lOnAjsNJ@tP`dhfU-^!O$f0U4CAZ*B#0XBsT{rg>>3>;PE7%PSEcs@ zBA1O4gxBZV>aaWMwXsa3K3qB)p9}~wg_?p)m)x(`+ek`BBb47P|{A{UjhUy?`+^|a2JakO7eZ?>NiTC=cZws1sP6D zU7Y=KRxb@&V`92MA>k1o2wsCM(@0rz+m?tEKh%I*^a!g{!2Hc)tLHG7NanHCeWe%B zY8vvDUxynVBl#y|1;w9rx}`2Wy4+fAOEmOS+A{TAaHxnq$+xeD2nO2<-NcT_CpDhp z?fzd0k34wKI(NPL_Z^J~N+F zY~~46=9lRrtQa;de+JQnjVFMqG@zF>24xooSVuA&&`CIYvQ|SzR=3CS&$OFZ*fzTd z^HY(6_(4`_WAlmL-unUGtN8~t1w(OrX8&18JsRPd(dIW%<6_Lz8C9K(rkfgY8&)Sb zYL$nlxj-7%=^?H5iO9vBfpAFbP)z;Gs);pL zSE?g}`E?6JAP1jN@duD!3lum@oNFWp(iz>+Cjk+7gH#gVz)r&{5S zrUCAB`Bt~;#+k{AKWXR&%^~3?ZTt7>GUIO__fpyzrf-M6N{H36XzrQ%X>P)3Ms&&O zXim|}c$?I%GjwJ!m*dELM`73PNWf7JpuQ7v^TW9 zTrTqZRh~(g;l28;g1h$JrqHCm!$CW7;_sFg;jQ&CSi}bPf3MC?a6K)LBwm8#vwP0e zkmHR$4646OZRDkpKxu(QUdx%aD>iSSY(ni+2N1y;bEaBs=Pw>?W+#lrzXSB8>JQIX zYpJ|bn>@Ut;I?>*HPwjrvZ^@w}fEXiaBmKz;@^NF; zIQVr(Nss^Lu=F`wA^kni!CwkCn4(bDk;_ODvhP*Em(4be@S|03Fx*PXK7x|FnnaVa zm-8zN7=chyc+R$oluw`~kfG0X$)*0v>!lx``PO9{sf%hStMu##=h3uI^W+qw{m`Du zx=VHp8tU0fKQTk0Pjy=c%~%!z4HGR}(KBD!>z9dL)R>W+Nps&h!75BST6?#Bidv!l zTjaFMH3~7|J_gxo+Cub43dE(+J&3xd#?{jB;HbP&3icIy>|P9R_n2~I<<)^~m$z)3QL3DoM?&gKI#&B-2)8o7O4QD`JrG(d z6)(Kwb*gGVSxF083`daWACA6NH&r(-5P5cUry}YQ%D>tlfzP|1VHve)q=smda~)j!|c8ZMWRR!Tv1Q^>Hk%Y3TPmf+T)vg`x@4bzt7 zRB|;`(fNpy&Fib}l?)&O z{^g+?!H8$(%|qa<-e(T9xz>)cdQ}&N=?srm=D-}L(33xs>D=v((U(z`?J#eEtCCkg zn?kMMk>|Ht0nUyz=@=5jo53)Y@Q@zjC^oz;GXJNqZWi8m7mlfzA{u0)u0Oy4=?n za71e)CueeC@7G?@KK0?HU25Zku$A|y1(;Rrv@zKmlu?k2hSF1D)o5J1_xovzKmZ5k z9@as}=HHzv6@QA<5wYzRSv89GF^69O?0SGF8nP6c);K@~RgE=1HUDD;&-JF(+q|96j^p1p5iK4&Eh~v{n9VG3qcmuz&b)+ymz9_BCBHnBHH- zJ|#@H{yehTac}7*OawQ9{k9S`YL(g{`O?ArYK9BrqySs>`1(DMdfH(G_{?ogk(p!% zq5e;fPXpyF$xQmao+AHNYa6@j0n+r6nF*p_Tj`U#LRDRVoFu-?2Uh47@jY`qN)H5b zaFkM*tIYzeLhHIIrl#lg!p_KvkZPCpubeo#P9Xh&XZ#OE5jMAJqKm3x;djXzTblVFVM?oq$f zB%wAma`l&@E%Mvu+^)c1r_v2pF8}=5Jdoq%I6X9*qnjzjUNs*n$JTtmPA{W!+p*rr zC-E*kZ}0Opdw;kVNMvh}snyOqG!}I*#Q@kGKfM1_jQVMiH>TRok8=Kc>b5d)Fcgy`g((Y&YE z$z?bnv9Hja3i)9ctew8BEu zHC!1&uzW`V1QVL4t-Ft&1<|N-efD&xy zZz^?A>_FEPP?U>zbWF)+;VbQpck26SH2QG^s^E^2EQ&$6@cB$!Eo>ph9QcypJov!KTW7Ft{S1l{XU4fn z3PUg+9Ij*ltiLORduw?9!)-kcyOXdxv5Lw&HrIv4UTG}3G4FIqMpOTTTeRy#ex zMZS)2=ybiN>^~Of@9tyYZ-dC!4}zn1f)htrRbH9VDvZZkpodSyitv;#eT4D-AFC~z zXKw03!uXZeCT7^P-n3{(z5C3XfH$b{(wy?V*1p;q3t#Yx&{=m+JoA0$Jw{pVWW>hZ zAKM#Z-Bv4W9`x$RJrbn7ncGOn^d-+5*GIH|_dO~wIYHBv`J}bXH@>=opyE2AxkY-* z1)09@=-`6K{@CZWoP@oVMlwS58IwU7%fNf>Yyu(?q@y(?cqQ6uWUmQK;kvzD7#dDl zSc9$n3XPed%l^;$6T8o`ZW0|PJt(_}1r6HbIeX@;I(1(Qq8U4^dGn-Jgdu6Q@q83v zoH|1Alb*=-0x!hdh)*8tO_22_(IR8u!zu6qo>xO9)pHah^uZzxq&<(O`rT^)pzykg z*+1CZBn9jwBgxYQt~38e${xY5mY9~S!cNRgOU=u#Pcpc~a?kp#q^yzXMCW{LaOC#k z^aat-=`9PA$FPNvy2ybNP1`#=u&E|4WUV?5;(uf|SF~s>zEBrLXbqn+Msg2$Y+!I> z?H16oGwg@~YP2nWhr$>aA>gwQG)zY4csF?yUoDi<7pPpqHN>GrWj6rfz4u zoK|NZHGGLOnqtHHhwKXRkcQnCFclpRnMlO1%FuLxKh_RYlx5*YTbge1G>^SOiTV&- zwbJul^t7bBHDNH}@0F&v(hWykGTC~D80=CjZ+|1E)77voXm*D`nDITnxgk$bx~A%+ zoz^c8TW7avX+7X#w`5_$-3=3!UIKTHo{aaq4~69|50Oriz%EU%jijZa<@-B0Mn`bR z7u(MV)Jk6f-R^pWy}(bbO(TEs%MEEK74g66iXbb-d>@L9apLXjLv7%2m6u{G6$Tf+Z3*E5#00i6#TE8H8jgv>D<;Lr@P~=h1%EID|Qm<-P4eK7{;W_pD0xy4O zufK{1^}#n5_;B-u`MK~5j?!iBdwDtF(|+RxL9tKy-|zR3oL44?-{3V8Pb^VW6-5r8 zvQA(12#~IHIpOd2#sGaL66)Sr;IL;MttLa{R_*xI-Aa%a% zw^9UtGGX!UucAO z*i6`q2<`<*kzSV`w7!e%SN^sr%QyUS@H~BZn7W1d=uC|zGAH<l0UzQX6Zx@aUZXDf*zF*CcRlI4ORpbxl`2o=V9fM zIXRWuv1Tb%K0OpXI&13v9!6yR83b+)*j8*W$YSO|zRjK7bt=hncy(S)n{GH)AH+JV z^$Pc^umBB9s*Tj}E%hVZ^v*gT{!vtrTWxAq&s9vA zc=fSwvUhq>`1#g<9}GA?3NlZ=VzqMD--VznuLxnz)D0+6I_A z!d|=`FgWwR@w3NbryjJS)$^MC_cHE$u!USsQ4iek84%#_9|o&$m^<6F&Je%v-lQVP|6!DXf7W>@DLLcr`*CA!SCS{2<@5HGbcXkm2eGQ1=~6XfQc=gmIgYZ~ukk(d8voc^ie_9i!F0A2Lz!zG{C)5en#ra24qf>_M~*ap8x#Qi?G%Y@poiG1HYeN3kT zQn7m}S!14EYF7EkY=3cOYXWsupW3xyE3uzu9@!KvGghpZuJ(L zoB^dtL$^H^jiJY?%Zp+qdaU?oZDEy6$&e>M@zlgA;S{A>n_9_fyHf0!x%##=WVr-s z`+TwbH?dgXOO-Yk@9?kN#hxYOM4%9SfeY3vLaCZeb|B-vjF@%_gM9)kFezaN=X4wy zVQ>L)CkVSo6qJ0>c`g`nGK~=SFnBmWAz%Ibo-|}ioXi8b9)(y`vGg>=9zW#h*h#h< zM7d)ZCrhKkNxqL{os|56AI^l=A#+2mbJ=@_5Ovxpt3{pfE~EDkQB-MXvR@ZFyX12ARMWr7Ef;abMQ4Clw1ndoC96cz9HKi(D7$9W zd|AWSa#&5i_wWj*{SwloOZh&Up)q%!a$nP*Tf4THt7a}?{#qeOVqS|}Qe++FPi51h zJ3Yr93Fn4}Vlfv9Tc=+eWmD!?M!aJY{9u|BazRBo@KF*( zbZ}<8*-L_JA}R;$5Z>ieAr_L{y;(v(8Py1mm8(H-tK%0=&$K93g8)ZvKnOegW0BW%Gbj<^s}(R#sEFG%3^0I zdLEet_=|@wj(+D^RkUK~5nLBYZJBYm#B1h%0|otxg$9GV2%g1PC8MzGmyTC0j)=+m(N+k-y3h4R2=&goM*%|#P9m}dO!#=#mc#U{jZ2=k>tcb za7tvOXZOIB5`AyVr*ygRRRUg4HBvc+kY+y^aeG6E4Rd=A@70wm4#83+^UixpYinq# zCPTgNK(@!3(`#Ef)^4AAwDX$d{Fc{io1!q0owki^Q(&R$WO?r)O&1HZbADjhvt{bZ zbX2gqVgW6n9xqRe6Ps%ZNr%@=+f}~8VY+&CcX_&)D{>U3033Ld-_O&0l`q;BqXb;c zARs%T%0f-}N!#854T7#>;7TC^8ttznsy!&yIlp1`f)r0Q)|*o`X-1 zZfqN+Hs+{F)Bl)|6fYEUA_LKOEHWaNgG41y%=2emDsP%y5k0_)PUU%x8^Orqt?Q#- z5x3pR&-Y#*jH-rq?Vg?ZYvuf;6^87tw;FN4e8b{h!Px@n|C|elF+auz6YbgA z5ScHXojUZ-zy_CqLENAz`lk9NXkiY?N~yh|8sm>$#zg6=o>n$$RysS(#!vnhTs>4p zYq;X6wqJa7nJ&8&PW2dhJmV4iT{Vi3&LPvX`kbAKR;gK%|ErvtJf zEnRKCfI=Hsmmm;XDNMP~JHsd$K?}UBdjGUHZ029jB{I_$*WEz~kv%BYjSDbCiKuzv85a&d8x*NenoWNqYv?}+sN`}L#dcnC$8seA-aQI>{hDC3pGCG;A8t({21xkYp(v|j;wgJS- z52J5Wh>c5ihg2*Bv^a4+f{}jr9OO3z*!ri6q7C)GnEBjcm)* zGFxf?-;kZSR*IeP9-1k3L9P)W84rRRxYDxru@&5>DCY5SAxe0sD9$HX;ettu{&_Ed zmTIY{O;XRUy}rcL>m~;bjP|?Sv0@D>tk+VSwWa3sTb18{iT_}2f&7|YS7mVHJ0CPX z6}HZZP(=MCLa|yL;WqO8eJ~pd$WGdODoVVGSX1z3(qlcj3~4*w0X$* zKVk2_^1wda0|SQPLJJ1T02#`syQoZzO@wbEGrs<4V7s-&q2E>)NN@WPaSO!A?7`$h z)jW(h|B+Z7#SAK*p2JMB+;Reh8*hNowbg6;4($UduKmT z7izFyODWOiO>GnnWWO>YEno)1U@sb%(Mh@(Qm!bP`32WMGT+9FwfYfztnCk;muLqQ z{-2y}ectzLzN}Qe;K;cy;!wyk?ZDJ{qnN&?SknryTqjl@+Bh0^WbAMe`Zv*`sIj@W z3ejcJKlAH!D!-aRdBG{5omSsPyCf4Pn{>vH9l{Gb$`@+NuXh^E-Xf*sb3W#tCKOcr zOcnW#4UFn}>CSyCqCDRvFNhUPcN#K4Kar=0G*t$~gl|imJAxT_&OazWWawu-Rut2Z zo&C!K5SBx*DWX~x+!zH77AMqj$($Mwx8YYVu>6SyV<@@xpK{fw#>Tnud!chv#nLo` zgqQ&CC>ej|bb94pJB|#Hpmi#uSL^@y+RGwY-{YLuSyv*XA4s3|)M;7tNaa>i1poTo zI-Oh+D0n@Mn5bFv-jfe*wd=VzdvLbP)2Ic0YOKY7(nH>~K*DLf997FJ2UPFuclN!C zNa@<^nlQ9q=iRr6!tPBK@Ah__cC3hq)31EGcx5x|PhNfY$`jT0z_rY=Y$#j!X*L)3v`aXnT!O$EdF2#6K42+e1;IjT`VyH7okyktw#>BVOT~o`D_l z_)hE_%XZayxDODwMd zL~TPB*|1fauJOPjpciLnSSx+KT(@*%0DL~i{wSpUYgf=8%5b8(LH1@xS%(Za$IeP?@|D)K7G+~demhLY`58oY`iIla3wc{bBRQYZX z(TVJ7A=j8Ti56FxKv5mx9~_%0NywS8gN>B9w_Q-=4U7&qH1nJ%yjFU@?}kNs+Sb zSelkQV7InOYCnKz2DoC+)0re{l4w2dKT=n7ZBB5J&gAX%SKP02LXLSL@8vKPAy6Gj zE3EUgDqao&1U?0~=HTqO(W8?iLn>>sqLy}QS3-5%yU2Q-Mdk?>Dxh=krKVUB=8K|) zPc@*PAGdgl1H65)7P}C-Es(veqcGD1?e5r~EMYg}Zx_>;qhVR@Xm5uvCldIBd&U2V zu5BVu6P8>FfCkpLH(5eRgvRMM)3msB^DVeqsHe;a8~koOke) z4?RX^&_gL63c_};hX^X|*1S!KdpQJ`{{Y(pO%hN_kM|OHQ>@hf@ldH8^k~fy(e&}{ zEy(00Bv-{y>Srsst-E=}d8ACz)HbJ@L&cYDg39lo3t+k~KXhtxk=Y2! zbCgx5;mS0J@2;i$YjA&wX07eEmvZC#sI#(iMWl9?geM7OhmRRHt7F(ET3fUyAiqec{fAebw3%>=z^h zq<$ah<1)oE?D4V2Q>&;V#Uu1l(LUrNHSS^K`&h)X#k@=Ro*8a*d$is;^2E_by(=Q( z*mqSU2qo#LLBmA<9brA66}`E&R^;_WdJ*`-XF81rlzFzmzJ0}`B7hyE#yR+;JG=Rfr+wts2R};xL`F?IZ z%+4}cN`8X*!sO+_vm;Q!R*lPocwcU))g#g%g%iiTo{?VX;vJp;fRG~$7_}VoEY1ZF zt?H=GSk*#{%Bj#~9wf3%hecDOW+t2IHYcNS0*GwA^3LfRWNx^Wv$nNt+lcaY3Jb0r zKxid7JRLReP(1rCa-AY`aF!iAtNl%~X1F~m{&bCFkYkYw^|10P?3(xq+13cR(`1Kx zJ>`m#v%HNGWM{EKGGb)3+(g~3XN_D;`3Lvc)rIE8&C@M&%?+RrE5=LhzwleG%)Z3j zD&_|2i*Eq{t2FzalSoeVW>>P5m|e7zWRjNc7R%_Sfq(2l_^^`SSi&adA5>p9ivKw* zzv<>XqCNX$g{jhV)>H_*`ek1&K!3_0H~q~YK>2T!E=%ADCJ^E*zT z4A0UVH*4(_UN-CDl)rQLPad4|rEz=Cl$F2To!~RoZ1f#Lop1l>SyB~#!$xT%APah$F=M##%Jj4YZGDHrq+9g-McxG z;rN0pMVhBUvr?d5z+a^MvZcs!IVQLLV3c12`N(v6QKe@tGQrz(7mkl z*M6p&unm`ok=m-!g_P#l$mR=!j7m(d>BBSCa!BJla73$bn!5L9cdI>Zk#Um7e?TD6 z;;Rv;M_s^POoSmfWm>rjtI{#f8V&f?NtTgO1sUM?V^4;RzmYaH@ii$ogHL`j{ASx+ z>I0~eqh8>-6)QwTk?3)61M|NG?sWh6Y~#3ptEY zsKfpXGnk4GSNvyaZqDYK-+*etTw!3W}U3+0ye=No37| zx%0}i>Z8Kt%IkpTF3U%n>bou$Q7qEnWm^Bhp5iD@*SXxH94smlH??Wbd*Ro=A>IUH zFFL>p(PWK1?h%Z=oUtn<^75JcYg=J-%*1QB9f>_rPE3oYpRboe&e@4J{V4LXt67kt zLl$bK71%`6^0D$}(b`nHoo&3C_0!0NZ-sN`u7?_MpMJu>B(V9RlV|>jH9)E-j?)%r zflBej(zzi$4=d9R_Q{VNei>fum{;+QlRtoq+L^TIWp$Vb!rOUOd7gm)+`kD<%Yk@@ zubLuRC7?$g>>FLj%4@UuCxw!wFXHn{e(cyfPvgn3X2}I<#L&-DFr55a4>kSnO%2cF z27bG=2CuHcOJ^W!%9?73@bR4+8)x)ZjuU*7!wxBrE~DZeMhO{*!1X~>V;R+|=`#tv zL4Ck!^?8!u{NY}UK5XwY#U7P%1|V;?xD}^nSu7zmP4?DWj%(e-X0uHor-h*9xm!+$ zw&0YvV6U)Pl`2RI3aA6J{xKZw-7W0nN_K4bwmrnUi1e}2S!aT14S%8Dxoe-{!Wq|| zRAT=k!Z3%`8iQTJSqtN;%|2^vixu0`pF<~>7!o1arZ|*SgOdGVqnJ`$cHI5pU{?Z-Ob{EpFZNzR{ThTu5Qv^SWZ`-gZI4^xO6ctSICQBu}Pifm>$_ z9Z}9k;e~E2b5~rW|I-ZN>DGNfwsGH=@C0sjE{PY7U1usgIC}d$l3NPXl@2W!x`H68 zzQ!_{trK`pDC9hSojBagh3z~#GAXLN9cWhW2ERZZOpEwYU>5}*#%yqZd^-cPPvV|^H0rdk5U#+t_*DO{u6Nf%}3=bpu57tO%^3S(Ojn9R;C z=bLe7K0&xN6>Ox8vM56`JW_*D=P0MFIbnh2jmCsGd-ydWYwD0ouGhN^9)Fj`vXWDg#e~dReO)fs>I>~-t+5ks6T=1K3sBEWVRwn1ww#@sN9Uolp7Od zwN-+{sB#g_<5XX=p5Et=T(I~2aU=hjZ^fGO-nMD+0}^lFjx`qNZ5HTW@osYa1BJM&KCMoW=J*69=$wI({`D?rNS z*ZUDi(je;M>q8YKxf>su*Zy&r}>2xZ;+d>=2VcrA=addAaW?1tgX7G^b(aL>2qgm%w5R0d|PmVGm!`cd`?{RwMq~IyK72PFj4=Kj`!gq;AZO zY0qWWppWc`kBMXm%!d?P{gp>5G^7K2JPlEQf(WcTLD!eN4EUZFF%cQx<*ownjka^< zhLQoELmp=04>a!z7Q$%J&RL(GuQBS|U-yoqInYtlM!Qz-5jBVgdvHG2t^gtWcA=r6nI+wJ`#0?Nd zmOmden}~MX@ z2~-J~w7vbT^C)9+;y;6Uk?8&;L%W7gqZ`;^^! z_#_l6>55QXX}rQ*X!LpCLY$ZiMBl|UFLuR5fqc!l=PTbL3U#_6X^+mtk9-~P{T2XOyESl?5NDzw(^{1evi@WFQY zSG|@(;Lp(DoXPZ-tX@8=fc^@N8b5T#b;Iyyo8VZ zY!mA%<}0pRcN0kzcc(#zZ(G>EQJE#Lp-aEl)S|86{VI3dP?-RjNY#dcIP=eS+)<<> zaN3cOHZiRWN-3?JF`Oj|`K(p?9$NB(D?jcFYi&n4V<2WLiqs26vhl>oxJcRAlrGf( z?mX>(I>4$I@yoqvL>OJVF%Kf_ll%MdY)0-4&Y~gn+J6DbP~0d$QYtXJQ14aGmchJc z;z`1*#JW?F8N{hd8$2s^c+5a}Cn5<&E5X<6;yv~I1ctM2iKS`>LtA$U@66~qil+IR z;-PfvsNGH6MS#g4A~@2Q07ZSQX9712%dBL_{NdmN2>`{{!J%W-u1bPU$_l!v+wBr{K1Yl&ww-! z)vK0=4yz%xcWY!{AEX*Q-i4eg7umDU(=~3Xr4HjiUVvOO4#E{nF(N)JID@c#XPiqUacAow6Lj~X;URR ze99IeV>(_g-J!2mO~FUnikR1R(dHzAikNgI^=ZcL?cp&dkcz|8an-K_s=e&IjWzNl zD<>?$fgHcL6pNbd?=&$n#R&HOtXcgwUonx3Fq`fQW+w59yLTfs#NFOaDF%}8&4Cx> z6XhH8m)X29;fg+o$?uRG_ujx<6eQ7NZ&^AsDs*9NVA7Z$r`*>clTV$Z;e6K{ogi5* zo#3ER{@SgO{jM=SKOsYTCPbd&z-YZ}pMI&g!CY3`JsJ3tJSe5GvVN(|6VWu?_Nr=6 zlvPl}0?CUgWLSDfOJs&~Q|_i~VVJKqac^;&v`TI7_qjX0_{b+*`D_?amtpGL?4=DM ztkX*3Bf574TwHAojdP8G#z7-tcL%61X)^8TH%+Q_2zrOeRH297<3AWZIQan06RFb| zT^@mXVq_Yqvu4Dj@=Zqu!jsv=TkQf_lK_i zByMgv(hEHCC)Njfp_(3^Ptj@n78eHe#Nt1Kb<6*MIKCGagn^hx)P;o{$ZRN_Uj`_F ze%sOySGSRlB!;&isCH631JWvxMO>?>MwB4y)x*;y} z4YS4pv>U`J%88GRMLlrsdj&A8U!NDyJ zkBKX7GJDtg5^Gno5X$jD(D0h1Oef`jSo4B$Kg6FH5)`W&rlZ8W161slqfO{M#znm^ z&9{BntiNaupA1=l-5PG%1GpE^h>_(2hjdbKUqZ!Z%3|4a-DjF)99E`M9+^4@aJ;g* zY4AKbo)Y+Hx#s~y4|4LxnMuFj6$LM&2L?dL{GEf6Yg8OZBXDsqy>c+1-0=d90_(0} z`pqxK=RI}^U0s5~CqcqYCLi8Pl`b0(zL~9Q15#PQ?VzBsQt7h@Sh1LL>LZ}_4yLd! zZH6y79}Yz}do@s|zYGnIiLKh*8@ggR)%56+NtUh*leS^h)H~pv`1e6ET-QN}|7tw5 zn;co4Ho<<()E0ZDN4F56o@*0a+}0?|oGj;i!3E2@qX{eaD!ZkK=$R9(zJ~5FaUK$k zgmJ#$b&y9zHA)w@u6fqAFZM<5uvdBSU%ia91c9XC72+v05QW7~>G;X~e5$5coR9eQ zVWm`E>O<>9DG|z`GB{qQsj~bV^ z?k0KGgJNL&F4XNRwR2LjQ1rwH18r$KEYkQV@b71s zq~^5SugU+o+MNUf*vp+fl@FlBdxrrwR>d*of7%;ucLUP-sVRU3#_xmK$N)n;rQ6PQ zoXXx0p)lSF!aahB3}c}8w+s)L*~ueqmbx3Z_n$YfR?24FDMM-G7LIVAmsa{f^F*22G>X`L1ixuT`L`Nw zW-8)O8@oCyIliNp?B*Wu0&J_?R1HPm)OTodY(5Ft_*gjrZLPJ^Uoh~ZJBos=%Sdk3 zP%|Z$0vwS6%PU5Pzp|ec#m!87#w(m!-(QFFv@surUNisN0Uj%dPNFpx)kI*N_VW1Q z6BY|;lrh&)`W3}*;iEc%ckfcrHP@>N%jKwq$2m)eB^DLhk!^$08eCPQNgOnp6Sohb z6&{=BAB_+>RXbp&P{>VA1nb^REd`$27Ith=d2H&lZ!13dz3Mf--p_hVU1ATs!ON>y zRIr%7NH4f)RjTt%xBLH^YrLraJKWKW*0s6b=`-YWNb_6lzd0dhMP5hS*pr`m_VlTW z7_m`X*Q2~Dw+P&E@PDxp<~FKF0E z#64LOn1{^i{XP1vvGL-Fj>~Tx5r4H5PK#9B7sNksm+R5Eqd!P+hzfPKI?ZHyHmfwF zrQo!pn7%p%(hb<{E+Z=Sz1b(1{{FeCAO6#M?gn@WLAZ;JB((0YP&^sdtJ3rEquCAf z3wb_98~n7>w@)@cNhT?C0VnKyR^yHv>(nw|p3ZM~B}e~K^V_1qxF=nO>c7&hn96c- z+6e#zwr1pfvVo)IVPv+^iMhb8!@l8*3ci(UG`#&&P@Ekm5@v8A*a@zPtyTJ3@tT5T#v|>FBYOgo&e^sQi^aWi5I4K;yU;y^d!zMZ0Ulp`l@Pu5+cf;YL)~ITI})$%(D6?NGY!YTYsiP zM;QNpKop?f9`3P4*gnydQ4-@MN?swK}1IOm3aA_bcfz@EV9AGX&2p=%j%@X#A*s`3imY--?xKj=tr zBePWVA9ixexF0Fla4FgS*DEu2c)!F-kb%JAM2IT7^bctTxM!nF(>;7@<>u<4Gd%A6 zxfok!h~|Foo2#jXa`P|x%5Qkhc6?M)ofB`wxU*d~Ex#{q6`xLcukzi+WMtuNjyTmQ zv9BjBeaa~$!`@5^QKRB&Gx$kr3GFRiEjvPNk!_CK@-}`n3r?lfN1-&oW>@0As2k(Z zQ#z4HQ1FKQDa2{C|B5xPbxUjRGnfxTd0fsKpxf3tiYnw??v0pgU!|ufzJI9xjAFMn zG+MIHcgSZKFlKj(@^#Ndz!YEdB0ui+@cfZ;^qGIP#;!5JF5j}!aOjs2U%KoX7h!kX zhu{%_xwx0qDnM@{InEtzDfbI3vuaB_K^Wa=j1p2?e5%LOH`|LeAFD-H7}IwD(R_Wn z`ewi47e{4!%90UkpEr7DIB)4q%aFMVf*eqKG;ludmp@v(Y)8#h7GJA%p&JB9tbJ)r zq#ml`!wh}h2|Hwvq{l8DGvJ>k3L}E2zGslzN?Sr-;bgl3c-0*5&G2FMw9{kW(c$(W zDe|N*GLsp22!vA6_-4j3xqn5B!dQ8OP$Uin@5S?TckQNVkd{5nQ{ z-YmMRO#}XJ#1j~K$Ik6PgRpX(d-W zlmPDwsLiOVGxwz%Ri;Rr*T!z(?)K}tpwc+qJi|Zfo5x;C=Ionon4q}f>(-g51HbRr zV9L^>tBBtZFB)$*`01LPulknO=%5|&=M9xjvngzet7FE36GXMx-wexJHKAkrZI7vn zqL+t0eXvg+&a=gavy!$=WX%r4G-*Iw-VL`*W*9jeubw}ntMQT;sL~cfL+)A^{6C7$ zG%U&V?ZZ=6PE%=RX^TobHKvSjxhrN)nPW+1iMe6gj43YRh6_t(<(67GX_E^%Iaw;A z8Ez<4ie@I72JWH|ZYYQd$o@Y6?;HmofQS3OuHWxGSvTVklx8mySiNLVi_i-~cS8r9 zZx<=hcOW@r=Q~KkC&PhLxg>SVXSc{EC~~m9F@CIxwlm=%Wuxaim4qbd3+5(+>FaEA zmz@|nYwIoaCN?g^klUl}UVhuP|mW94^nw zq`p{^d11#@wVM^3c%N9*%^_Zc)| zoN%#Y$0P2)a3pSs>z-hK%RsPZG8g54*?4JhM|12JewA2n-ih2no$iMe9BK1i*)_=A zhSrSM(85av1dTwb5r8%h9R%+Uy%l0yJ*x2V#xLy@BPj{DM1LnvA%Jg-&{m-A?z48u1=7W%=q42SzAn*83SpR6Qv0g!BhO-rcPQ@6{#J?poG?+q`Ez|I)mcfcT)1xo*4xoXw_gB20*N?ca17eZG`o1`l&yb1!=9W)y-B zF@hWZ0s(~_*OYU4SaORf>JoQc&2URO1HS~n;~R>GgmZe&d#((AX|(S@IRANn$Kmw- zZYjUd{Y|qSuKC>8VmLP^_83T&er>Y*tuf^pD0Ut>Vnk?a++EeMFD%o}Zi7E3OU(Mm zBFy=&#Sg@O&WMk@{3ql|fbm(5uAdm~CNf4K zPTkq~fUga^*peUDCk}Xv-)b|f=K{uyZsA?Jk`^y!`Dys;AHWAaef~Z7dO;)g>A%yNU*AyM2a!=|4nz8h9(7_Qb$)}Gd^N}clj=M_~j{DTt1#!+q-;9-I) zMCmL(ceFLbu2q^8kNR@6*`bl~QaDH7@)QKSL>j~QMkVTp9v^+@MBialL=OPM7MO@*63Reg_Y ztr|=z3;ozxK{&n1A1!c?7KLMHMaP1up;SA|ox*K03!x7>LlEqXTue5qtDi}^Vr@GY zCp@U2*I9jgH(yf`fN1Ob{7Lz1;DGqLqwPq%>}^g@a{Pre*{^K5RTjNVir}suN~p_L zL4AxQ+Hv9a(crJ3?}cMj0uxGIX&<3+m+&{<0i^2U9HS=jy0`{!jIXY}yXcJag+6l0 zz>iDzoB9pmcd}E2%nm@d4ZjEK(|}vdYYd|p1J^=JgK`*(2!HGc%yC5g9OImgo*3(m z>AK@KC`>^l_!;=nm=ThJqdDlD_u!sa!1U|N5)=EU@;-P1%pg71fD_=d(TH3#;bR6- zKZ2cXpS@UxRZnC)tAP+A8?WT%I(`3ae^)_>_)&7o^WEE{M)GkTy?Jnti?t}CSMqUt zY%4N)(tbXzj9s{rG9^L15T>~fOFxde>cgxg2fiiWmc3j`ZGpZocT6?K-ZRL$0wJZ>6^+9z!Bk)?VF@*+E05{chn zV9@2(H3#S5Ay%WlwB7VbTv_4)iw_86RJNvyoxj9739Ya|y_l!}uHLj=KMU{?kSB2eORvVzTv3=q&RH={S5-OFClD7Z$S{=M zBj+co?=L88M+$iE`w;#hn6(*Dd>l$K1OqONrRlIf+=l&Jv)l?t+-}^FbY%U?FYFwp z0pqSi(x;e3WxU@TP@cF>$bZm`S&(U{!_7;B!pR?=)3|RS^mbXsTA7AX*Tp?~7PT+C zs8kY+tnT$@V?)K6uTGWX(6+=RXbWVAtge%l4l!Cf>?iEXXlFoT=GkEXy`h~a}N&8Ej#T!KB&~m6Sv|Q z`LPv;+Gn&S<*HNny{K4Z1#lL0&fl{l-WAJL9bIMau-=3eJ)Rk8URnrf^-E)o?)NFGSewdC?Omz%1d=`C zw19MeNId@NT2dBee7bWz-OJRyWfZuWbKG?UN4zO_BvWA)V+sJc^hx1U4suIw#6E~9 zWqdFQB+{~!4xhE)mBYu~>H-T%4)O` z&bqBgS!xJz7QKcO&X5oKk!Iwqvyq=`8=1qno|$_EvruaUjaufdV4%E_}oZd!~qeXy;=g^<{a zh2^4XyC}a1x{+IK57Ky{qH%b5YUO%pa>oQsn7|+oGt)dJSE|Z|`>~<7wVO4nXg_RD z)g@7R{vL#S^>gqn>AnN*0eSbB*-4`|SiBLxs@S!7$l6)RG8B>C%M?bi*r32ilEEtN z7zlmfoM1b;sqDk(_yaQd#OLgIy`f__#v*FseztktG=TbSawpw#t_VHnprU5TTr)s! z7o0t(y7N#8BP>{ByI%18!7?j$`zt$rFa78sk2OILHkRJse*9xM&D$}8pB={6VO>Bf zE-$T*($@yYwQW^Q_ae4QuWoEUVw=4eY+<)QdfWV6Iri@LzQy`(i-43Fx0CqqE~*bd z@J`<+>%bB3d4UYh(?U$^@Xu|kIM1y7fZ`dskMrsa$oXJKV&6Y@#Q51>%xtbu)u|u; zEwubaLh0g@wH#vDe53x_m;G6LolO+s-vYb*7^{_s)xoD<^CN7x0B8lGmHac&k(r8B z)>`i29thyPkNbj!`1d}`OZ+lu3wrrq&!#L=&lTi6zc4n%1>tcw^54IL>vb7kgp!yy z&|YGn>M7>7IG|*{%F4a4!{w}cr3}y-Qpq{Oe+FI{kWkG9Iwwq%FRNYrs+pHO89zDA zmTCVZh`-I2VQg5KBg|_P5@33=g#zQ5zH3C3hDbd;OVo<{4C!Xje$W&G6qi*r`AeH3 zyR*rlg-rV4Ri1+7>N{w2l{LG29Ezkfy8}^0>TMnBA2NW52NLFwOJ36K z#^aA8tcbLj*@L+~@lUj>cO=?+db6mZPrj|kz?v#?2iTIOWn}CFiR2f;oa*NeZ;Q=~ zO>2Hz;AoWW*tNWpG!sNk_Tu~m_UkO*s}-CWuTP5i4pL?>ezZ3oP#PpS&4s26k*iXk zXgDPrpb@Uxu}j$*+XcLfpBnmvPRf{_`B^oNL02z5dJIo~iRV(e*%7Vc35e8lPV+K8 zbaNcmaHs4kH1_hv65c51q-i9Us>Ddtb>x^_-4*k|2G%&OB_*7T0$Eo~JTEQZBdJem z*|M=2oi677mvTd<5?~gZgL5*Rqp(muvTE~=>;(1RG%~fZxkzC#uPr#Y?GC3K>}R~j zYq82CS&5fiQ9F<`jSY(6jOf@h7?`>^cG%JgEerRj!_N9ImJMGBk#{$@?&p5&fosVZ z+3oV)iZ!td=Mia?-(}_&iQ0AQglXs}?1V;nar&;boMJ!k053kM!OVDk4L_>kc#_mL zdNII=?Y4z!!a_d?Jty1yCAWs!Aik?p>6g-IMb~GZ^)EUM`n{ON?DmZh&Lb@E1vxoJ z%yFZ!+;TTvkW(;}&HHl#bFZt#+tfXtVQsOVth(jV2q4)Wo3yE3!vpuD?cP}$+GKQ5 z_i_)R3bV1(h1c-N%Wd!F(}i;e$DuC~MQ5Oo#_(Ls_STm)i9dzKJJ*5GEa|9YVgobl z-PobP&;5BlU;^ESmz;K6W*#H{Y0#k6LxNt6$>H|XH8j^2STVVLpZ|Nk@a-(YsEzDZ zhQoLES|C$3>O{xL#JPhHRE~0wS$L2<`$U{|qxJ|Lf0ROG0~-w0hZR!mS^kJCVGP-5 zza@EM#m76Nr$O8Jkz>GcFp$6g^e@8puoy~z081D<#JiQUUtkxbRz(y`UUr6dkYj&6nN zpXamI-gwG?^%T#ami8O?K^&Z~hNl2vsI7tAJo5ys?~uG8|DE3C0)fz)5*?p`VsFnG z`=Uio`=u`~m#V5z%0C%_uiG1JS4VoDbijs^7Gk)V_`t!?K79NM&)7xzEdzZvuY_Pb z02Ud!hI$g>N>_P4k2-mzKM^^r`7377meCFjbzv|p+8|`y_w3Nfj=X}Vu>3M(WQBO^O zHNb|xjYTlzM>$^+p>6e-Px9`*>bsLvSmo5s2$T^16Fc&6^#3_Dj0t^*HPlDY-;={| zgl_;R&%QUT=L+aY5V1h@ODkuzIruIbhd=U~hdV0@5TL1*V>!x_OTet@SuY$&I2UzQ z)H(5RPq0W*)2D@paLL5%?*mDJx3nEOhf7)AG3kb~~r(YWP3BBUCt^rBI1rmwsinSUI=s|@o?g#;PMIFdo``1U4 zk=Sv!G1T31ezu-mqCXFeIt&s8Nm{fU3NeS@%?vmj(M_cZP67T9t9iMv#TF_zPU{XT z&{^r(^p%p*?9kkZ2DR67Jn2!*ABSHwjq6ZSBmu9QCbF}cqF+K{?QQXaE6g zcgE6+fuMTlwK*;1dOs4pQkR`&n=2=uY6S@&5c2g=_GMOQ(Hoa{LMzDyIAxK3GD~I} zFfOeW=3#9ng@KFiI5K@B#}oYAYrnjJVrSi?1bMGblxxFv@jb8p0~NNsO(DZZU!4JQ zc0x=Nu(_-Bb4KZQNP&!46fNYg;|7NleJiy%-H*FNSACyhI)xHA{iFWrto--Qosb)3v-dwBWDj zyB>4&0~Kfah1j$lZ~E~CX5gl4UVyxtIJ>@ou#glxDt1MT?LCGIL6TOkoIC*fSC4l+ z%4kG|obG0$gI^Y59xz7fG5)0ymFz}* z)aLJ@UuxYg29h@NgTK{aRdDL3n2r?DE^sv=t^r@C5MCxC=)lRiZ3SN^YJIvI?#$C{ z;Omq&p>w0Gx*09azMOx;G0s}0X1%)80d(hM=h}B|xCzV1$0Lv)bn-7@GgkY>Y+|Nt zJcW=5+7VkOLlR}CA6=7mv&^8_NC`lPZknh_&ZF}v>1?dpbX>R=vptk5|38>B-j)Ru zXWA`+Zwr~3Kl<8OG{|F($Nv5K-WQoID!I28pNhCqG33PX$6tu9@vnyz6y1)M3jFv=fe87IKLh|+U5|N2pBc2o?^}2Nsf;S(@ujpF9&hA zbXZE`ro5xf_I+`rQwyM(5CmD)~DPfGjs`ThtjGP`rMT*vV1M28Ww=rle% zZI-duX145c+^~tt^a#`u``hrUOCLMt76Qs|R6K@G`FW_DQXaoEGt?+!m^w8+s0jZL zHYUaq>Z!9d{e-%cU(RjWAEIxpkJC@l#}D+JLoSxhm36#s?a}Qxn)?`b$YQ{!^!G`p z=NYX(zG)s);}oJwP~n2oCD$TKv(7p9at%lLr+~-mDTYDsTvIN5%6(5-Dk+H5d(UGV zL+v6l6xe8a%j3m^f=GjuEB=d|nm`p){;Q!>>K|ZDSa8eQ-01&R)RsbmCVs5~X)xuK z_|xfK7|V{3i-M%@jSTC#>}?$0kTHA7$l|GXmB{7wy)bsbk0!2nGO7+EB5>;rxh}qIf+|j~3HWByvUvltLECX_TtWdgccsU>TuSO1DN^j`< zr!OMjlQZo+o&FxLQnqHfJi1)!`J?p8g+}?pb&7O;+;XxsrI%inLsAF$T>ux=iqSc0 zhB>=$N`cw=*}1z>YLKbZpp9N9y3eW7UmE$hmGEOTOw2c$bCll$3l@uDvkOi)v9x-M zr6$}_RHS^RqV}MMUYHdi_U46lNXWrh!r@*t$hRZkBEq?!(rm+OF-R1mLzhF!C=V%V zl;5T0v%yy}g1e)o4w*2=n^)KwN0H5Q`@mD%hkmIJG#CLlf`=uusa(VJ|u}J{` z)FfIGJTL>vXlq^eLl&0)QT);A6=%60b~q6+Lh@8%)HO?97kkZtb&eN)w!p~S zsG0;o>(XrvXDnvTS_hLjn%y4&^xRCTNeMK1`F$fSC?9(}>YFXzEE|lUnH<^UJo1mQ zo=}2ofjRav@kehWrT3Wutywa+Kasdu8!eb7+@9VbGJwY_x8ASPS=#J_P-F3TC7tt0 zdhAw17`LQ~?Klk%(_1mf0`FG~3#|cUo@-jioOxU+*gs zd$z+`yS~=#CQ$zNQJSy=x>D?EtJaX%l?=ZgIId@~Nn=pCWsVdl-0p#oba)(rJ&wxJe9B*8VO1 zW3fu{p|0DgsN9afI=?cgbC&YdQ~ww2&U9Nv3{PiNm+5oy3?3M19|3HoxaZ-yCT;Z5 z`9?w$nckx>+IcW=ecLrf*( z?aN--%rC+9q?M;>{!&n4ujpJyRyNk^=9vDkD>j>ml7+hX?gk%w2(gH5rG7~$E%03L zkXzrBPyM^+Z8L-7t(K3dzQ27w(C2N=uMc4R<#CRKiLHAeM$2q;L9e7GAMl>2OUh zFhW`{k*H4Mt+&}?I(fDqZxn4rBc^<1*7fJ30`%J(h zr%LiBWIZ(OOXdAI_xQU!>cGD5pBByl%Z+Del8uNYA^0TRytV$uEn35LO{DS&Q~U*d z!Klk?kr?R#nOH;%YU)zXB1M2%eR35pa|kLtiThhWYn$~X_{NX=1o6PJRJA%HfB|$z z?gsk9>ZqR#@Uiq3|0=c$ZW-vbl-~=-B{=z)_Dm%5yjlm;daxFtsYTILTCnM0N!rZ& zZUfvAi{!-tghoN?G$PGRPmG>D35efLErQT-x-Z?N;+`(3a)Ck#JGh@;j=s8cb)qUr zGC|^0csX{iQnH^2K1@Wn6s>b;rPIdaMnd-^u^w%Lsn+dcmwF_)v_6 zj5C$}KgMD%b3wJ`QL=kpjSmlvUTUm2Gnyu9RIRK@D2p^ zE4rZ4=o)*~-e!RWwcB6^i%xDVPmSH4EG7 zH@LqCh)}RpGw68sO-YTGccTrRm?i(@pIpTi@2go_BKa?ds=gSMvJz^j&+}^&#`KFq z6OBNrCL|iVNjer~oY@=zd*K0VB{FSZF5`}9D)jMA`I4R0VQk1u}<-bI1Llbe_Y+}e8 zy^;9b3>-JkR|()TN*9Hb_k;iVG}9&qjzN*?NeL?)jpZUWU#iG(v8|s{o#$X&+tCzs zJhWE)sPVxPgflEj40qm`+q1E=>Al2N-)|sM9}hZCbgkGlZ=h))=)Vc{1r0w_F9XCd zTao;L^y6ZW59liBFZ&M+ohIF!Vde7R%^~f;n{*e;hn&~!7e0!Yk}@+!Aj21Lbvswf z=?iqcT=JfI0@2yT&zHW`9ftP1>(^-Rz5=lyDMdv4>2C0e^U6v{RP*YmaZo^SH?gIw zp1gcj;&!0zcFsCde9CyBO+{4T%eK?*>NxkQKF4(^@MZs(6WI61;N$~-ZtoyENX5*Z zsacAL&POBoY-T@ca>Ja?e*dM7KKUV512eG2rh%})B3$8P2DKTG1sYu2f>cFgnDO$1 zrHs3%&_5=9{ZWHUr(9@iW~Y8IhtP)2eATk7GxNp8V+i*r!6ZQ!$ofWco< zv>vzcX#=a70o4L20$|MSAB@Zw9x6hk0yH3r_=_M6s)q5rs&k5?Cn=s&Z>@XjUic*o zU%o1Rk-Qmrkp6K1(ap)FWn;culs4Hs9HX}L@GH9P>H9E=1u*MMMU#h!eF_`TCHm5R3m_cnHV zS9kh~?D`ZNq9XXOTFLatiPCFT()>#;an=9mB*fi$4j^u`-p=aoulwA6qtGZow7T^z zL+yRO*geFacTuq|XEmUhrYJNsCOjP<|2XiL(hgC=0iu@_8Q{vq33SYfGL zg1pd0Qm6^Hko+5u%Zq$uj>4p^BiMVZ-gsmK)F?&o{py`+qU^cMOBlqROfNEUuuCjV zY+Rk}Nsk{;o=4_9?{n^G6bvkEZ{8(1F{+ri5Y8O3QSoln&@YY7E)JSmE8M?_vf6PWWQ!sIXyorBes4Z#n z(w3^XMfQ6s^-BS;2>LeO#CT_`{PE0!^G%7N=r4px5O#sa!CQei4|w{#cfWaBBxu6a zyIDdWF6(VmAXDL$$~(~cQmd77bANfi4oG!v_E-t%VBgeQlwyi>S|x*go&4UJS2X<) z(UEzh!%?6MoOWT_+ohX+G~F1n(`kT&Jw*ai!draR(011Btu3>XiT5sI>*Juq|kxT zj@IUxoRQkD^eU{`L+Jw`53hRWFo!l>>o4$Y=2&P-&pFwA&w=_8#1=gF;-;)J-!v$0 z=}?J-Hb9l3&d;&mz;_?kELaSjkS+hAHM`YV7eNsNy-|!{Z_+0oB5H22x_of7H2p!H z1nko@<35mTy8`p|JBa{pw&Om7Zy&JUQBV)TnyPy2u&8rK=|WpfGfDL%kwcSUbVcoh z|3oYuniT#p95Q2oPtu?_Y5qOvA&XK@K$`?5y0t~VdXYq^?j`pPfiIwWW{xBN@*S=9 z>MNc>lv$}k^KTUb7(h?*5lEx|j9;L&2jKqi%=#rlYb zhmy>cGw9bd%d94eU(-B|5XT3oc|TT%9Xp=!L_9|ER$n#?16-e?5<+V z%vl9^LYN-|(Zt-&L#FCYtXBUsXb4Fa#IVlbg2g6-d0FbTHz_3!C2QP{jS_L57mad= zO}`Ivi$Br{C8&zVQ`*9cY24m5e7;8nq7r+E!y%ZaX- zKu}PPlMjgaXIg%aPYaiyeK0DhibXY84H%uRV*3rB(YO$PI0wekFPoEtNCFlcDR z$Y82Ix?2;HB>C89v_B+yiS+!-IgiHJexV7aaP#f#HmBjxN5-Q7Sr6+u_{3;`L-1V6 zFJZLG!X|MQLAX0v^(L)utx?Yw6&*0PAGh+)b0pP%Cze0jG@t6oxoDJCw@=x7v1F;} zIqz@n!c~lXlUn*4&56tF#Mf1uKs949WYgwdgyhVM*1M7S#xTjst@-&lTK*G;%Q%m? zDI)VloabtNSKUcv_n6Iv986J!L4{ z;b9K1`*pn7MnEYf0wvQ<$sa7e8rbbf(P`PUB`HaeU)rECKqodfe2`Qg1Co_;OYJW0 zvl5xbT{Y$&E_M_-RBEGNWiSlRA=*3)(A9iMSy!EekeYr6qFwi%Cl6gG-K|F(mvOPN zY|$ATHD-14b+*Gzx58WpPqYJfbdt1Tg}JA~r*%u48Ce-c?t~wQM5-Soelf^;5@*C` zKY2e<_|?c@++UpD*QEZKoi;UIaD;tli22^Q;8j~>E@?Y>elfrjRw*vE`p~62?;qc=51GS9BgVvT zm1G}x?9#Im62l#Jy$W0o-!_nwGL-*7f=r30e##H9bGpg(#q1Osc+bWll*DYZ!W~7L z931@vDN1X0R`UQ3VAn4m#@1U7{(0xP&G7y;vt8pWRA2;x^rGDlk_@?Fbq#;)X+Yqx zpTn__xvyVEU)tulHRX)-!$kTW?c<^LL3;)yVb` z(FOpqRU9i?FhVCt$bN&X@6G7deYxA5-ZeZfH6ATeq~bI;?RfhO3#K+88TozhseN_U zg!$=13tZK9EWpLxn)Pkg5G^Y3^3Rd`xf7xf8NCa=XZ}_XlOzb2>7Jg|Q5Y+$W%>?k z61t>0xG!{efn|0Y_Q?dF74ZYeb+@eys?6GYXvmw9jSSM|0G7pObd=wCPP-X?KdeDG z<=^jNQMx#YB%Zn>I;|^D2G8?cQ)2zvo{`;kOBGeGF6|qdB-3l0nEyV{G`>5jZvCkQ z?StqZ-Gjd;9Bl=}8;s2z+FP<;yQ)&`v=^%L_+G8u6`wT$i-hF>C8Lk-`u+NO)Hn8vsN=TK@wUF zVmB02gx=r;PT@F#gA?~~vd0|vJ1c~^#`Q?EiR?K#FzLdb{J%!(AQ}RUijw0BT*qX` zvH!xXz5VF}SmU{M0iQvi-D&pb(R}7l(a<|{`HNL`%A%BFkRfHPJA|8YI0|cN(=Z!n z{dy(Jg3u(t_Db+kKv%m~Sq6MA++(emu|?lOdF~N$`oKsO&7YIJ&%io3I*;E-I#MFh z9Wv^OHidoC`~J=3#otxN^LN$tGxa}WnOKVOmmZMyLx!v9?r_h>xq%%X10x4n^faS9 zEPs5p{XKRm#fAKBHqCS@=3xiy&JAJ8ImekwCj#@2F=G?UuEXc~CHl~kZCqb_-miN9 zmX1=<*Q+GgE!^v#tabEOG_65&{S!sAZrHM>&9{4x5&o*0bCeFQ$wPSiKn-XZt@ePaH z%G|04^Ctn;W5-Bf)Wz)o(UwI{2TPpS!*DjV0LY}7i#8Kd!hEm@pNe@et!#iLW+`{i zy(SQ9kv+{#s0k@&C9WoLK25S3gsq-%&>N2TmlN@QYdjoy)y1jd7=;?r6ynpCJu~)- zDQ>lbq?cP2_x|bksIbZr>e3=l<>=F=+pcVFW4Gy2xN(J#yGA35`7pwBVcWTC;s?b< z0WLnHq=`$L0v%+r@(a zRiPhm+-mp0H+^OEj+&Fw_K6qL?jbsZ6q#{2E+hHPhlvdJo#_GCfiVuV0@s9W;TM)Wsl+yueTws|#>5M~( zNAzzTso|J=*Y!&g5)VzrlUQ~OmY`qvnc7kIKBp@TO3d@6?4LnHTycF!Fn z)j~7sb$gwe?@*r;o|MX^KX$`oQzv5rP1L-5PUz(?)~B_9l*SpNRRJd}8Zf0DFZ#44 zh|?C)P2_%o!k|E=Slh+t?j~sRRv?_UD>Z(H*D5{vv1&o$EHL}k5^F8BTT2(nttCPx zB^JTN)+O8ET8-jLe}pYn*|KUHaEYAXq{SXhcc5zI@Jf3Oay&Fjqu+ zO{_qi1YB$r*9ZDQH?;jG8)heaR#J5;914{lszg5{UG+28`-!|qo0WpI;bfVkLg{#N zvQwTNEpZuxK2970-x_OUVDHdi-1oVpmN0JTiG+dYQxmqxY_Dtr2$zXsvojTura{#R z6guNH9q7)lVI={NitH<2wsGlMr;`?Xn_lUni z#ePfj_HCW?H<3i2pm<`To8=8K^IvwaLa)L?DbIBELwr?WI^66}DOBD6VTOIieCO+T zWEU)lZF|oeCB)p9?1zWyxY+@7u)%;_j*(eOFwo&L^br>1}au{Z|gfL?Pu8!gl4KdOc%;FAmv4XyQg7e)%3;0s$y-Nl~ zh*aSZUw<LXVus+ptdiqSJ2;5+w#61oqWO?+7#}pfcZdovJI;L>(V7C zf)7s|Y~4ctD|cJlB2pG`y=G-gTT%6YL;jX`8z}32x=bKGXvCrkdz4s}B=!9~OO0;B z%W&;*RA7gJwSe`)AkCIOY|_YnS{24VTHjrPv&^Wdv+dd8=D*fUua|R%_kGsRtefwT zp70O0xM6~g_wta{w#h2P-dW#~e`4s`Jy7s|CD2C$1WwVs4V??4rEhr+?z7<%Nh&CX zIWj8L>t(W&K3Q*06o*m$-%|jfOZ^d3q**WGrcT`2Md#CqQX|{5IF3&#yvd#)YUd5Z z$NCU%$~KiI2J+tf!2aaimN8DPpe7u@OlM}RJ zyrvhh205#HowZ_T?J@New-g9O*^@`sD)Cw&TlK$};IwJm#h9H5^Rk$uodB4WJD6qA zF|zlq-saOJZ|SSix-i%hVKl?9IQ$SRP`Vn_N3rer(>%qWj#wmKm&J_RXL~pvu(sqx z3d7yWCtk0Z$!5f3_CBW&k@n7=M-abn?KKD;NQyI6Joxy^`^{q$knlCJiIEQNBX?TzXeIpl#mvqXM)c;EYxUVDDJME|0qUcovo_ z%lja$C(#JHbx)xcGj}$UeUd%}kPs#Cdsa>STT6zW;kyL(K8TXXQLRYe=V!o55IrM+ zpKJfnjVcv#(!vcbWMq=2e-udfFCQth{VK7$H)9hO`7VRh_nA2+j!{DfNZ5`1#!?h( z#zVOqaRL43tPxsuI73#lRz0NOs9o@HtrQz@FuYlgJAlPU*-W;zDt|_zzl}PS!0L=i z;clVWn$wL-G;l<!;dUSv_NF>pLg ziCvvU8{J7y&^^MEFL++{|A0mxlj%kFWsC|o)1NJ0TAfb-{og~(v$Q1s5WL~Ory^x2 zos*lEkyBz=P4=XrGsc1K-C0mH70|HnUd}{(E9;$C&UPDg)&t@a}EdM)?OhlEe|f$d*j7H$di3iqU20^w5lUf z{6-T|<-Cg`bylTomzAJ++fz$N>mZ^pt`yO#|8H)EP9J#==aYa`FT^^snB^3^N`DyL zcl}FH-+ICbD5d z4!#9Sh;C;IP2d-18!qGdr6kGbxG~ylq1kiFdY7=iOykoQ3`X}!mw?qrmn z3k}`nWdb+i(2||p8qD>`H?SeCJzho5OH#OOvygSqr*aEJX(}kWed*EUskZhu|Fa@`Bk@JsAk`5Bed1giEc%}M8Nq- z3i=0}qL#EF4-}lU`&0_TCaAXmR%3eEG_#KEt1PSWjqmmL_&$PBQpCI``l7hkl~26Q z8*=HJ_@vl%^d3*YoTu~vA zJ{9-VoX4-ZrVsDuN%pSF*1bP2>~Fu1!|Ly&iiICr^*J#k`)2xzCD=QeY!3rBL__z? zPB!nojg4;X!grm*VKDw{ztKeSjVQ=2O9_1#1YHZ!OHd=sY;_iasPszxdGHP$6LC4} zYO4gb-4Zyur*Xa?W9oEV0nkZJoWK3FyYp!p2?_A8xXo7CW}+-lM&p*V{KkAthOe15 z%s4nOi%Nj9Yg%*9M6t-=Yd$f}az9RiIePi)nJznIZhx$%_+02<^KY;H^ibW6#%1b} z#P2(3%`-@#T!}sQ<)1)Qd}n1g&U&#b;4@<9+#*J!^k3*94bLspJ+~f2u&N-LqhJIWuuO3dkXMH#{C zkfJc+Ke0m|M$4IlriLlXX531h|4c_j>G#=sN`%ZMA@S!))s(LP;@tmpbncH#_y7Oz ze3H~9B&SM6myldeIVDNG#keZuuoY@$OimkS)7dE@m5QNUMVL8_99JL~=EWHbbDJOQ5-5B)wc4FWJ``2baToBm) z9YAA#reX1g;EoEnH~ppWZk<9SW376$MnV-ogc@L|@o9ljY~hNp-Q7uHTtm)uEFPJx z%Y_5zq!r$M(&IM7Lwnv%=;J3D-^2#A_fICx7HoGdHCAWM8=5MRaRW2@9z)`e;uCDz z%;%O}DbG}vZ?&!2_IA9hjGe*zIYr*|!HT}OG-g~=c%1zA3WSaG%|XmRBMpl$Wj)Uv zY_$`o%SrW#mu-Hj5YA)2L6wg%o_?&zuSKh6>P8OUjf2> zvZ^0m71JLK*uIXoe+@-IsXuYM0nv+9l1S9C#jKZp1`s%7`?%-EeUr9}tsjz-S2*pI z!z;O_yM+ybjo>YU!L^|1ZNabHVM6Tsyv(cXR}V2FX?xFS(sG7g<#>;g-JCrVRv>$Z z18k^OE|5Wvlm(jN2>O{YGaJao?k{;OAJ*JBFadaoVBfD46FP^bkL{2J>NK3F$2B3c zv$+XJPG1njpf-}Y<4P}2G{ex4%?pp%`fgGF@_QIi7Wp|Rg0=qhOusMWjyHK?#uvOv z^|--I-iuwALcA%0EfX1f1=DFtluMB!883dvB$ zFtUg}1I`)!1nS+A#t`S_tnsifg?$ptdg#~ZZC~LFF2u0uF5F3oTV7_>vego3U$@DL z9DL^#JgEYNw79`o)^=^M+_M&F5LUgFo??nniADe3+*(wKrUw~Mte`A=?nghFSMAu3 zUGtR9x>lK0v<}y|C7gB~pHJuoN8i&m&0hy-WyywRsl(HnJM&pf4A8=@BIWprO%J13 zFY4}}Z9&#aBy)4c#zE0@CiZ_$rhDY4$B7`>Yu$_PbV6EFW5I|DVf;b&{lGeYf>*^C z*}bDlCKI~*9_A{wKhwSKqm8FM4`zQ=vaZ0(n#N`82yXaiP#kGN6{gT58l$@;A+tWUMWzmI^~BDs%t^lj`|HM%be-9x zb<&2|6ur2R&XnAjM!J8?m~&|LmmS`!%I6 zNrVN~dke^~NMIhltZikq%;o&fS9fZkn7!xz&NaV&jU@>=7vi7Wy1LnRiqSm2bymGN zz#o23UUA@W$7=p?@(&q%*p4Rq_B;!bjCc<5NG~B-7A{1Lua3S32)wOFh(BJkkdNOuO8v`gp@dCyYFb%<5@|4t?Ehbm_6WStrFG-u zgqAHR&&|Z1*E#(niy1XgF!OiIq{kQWieOM%9D<9>$axgE;x%JhR}*xB=uEs`k}=8A zd^$pSUv3Vc33d=9cZE8+=jUWCt0qYjA?c^=Z>f6tPbyw(4Tg8Ml=KD8p*(KW?w~hc zH>1{nS)u--XEs#BD`PriOaco13vmWX7u)>mc3^fFP8A1TxXmF4)L0d~4K&M#^(KYC z+TJpCtaLjyjoxD=j|z`?WFuUKPWZ)4m_8RqPT$k+acM>hPm8!)rt4#G8a(?1$ zxQB#SjnimS@9}v-h^TC>IMI%`W4BoRa-IChXg%i7zIq8_a#kfMq*nOHIinR$&egN2 zt|2&p!fLK%=!@$`Df^D^oF1I^#M57WenQ8ycZQI6uX(}wB3=67sgku(K?}ciK={$3 zay?HaU=-%2qh_m$&*W=^N|dvZP{yCWrJ>a;p9T#XRhV+tU5~ z5~5_N0QN_f5#q-JOaaDZ6G4g=5#Yh{Mo+HIh=nArEyz|g{47MNCU(Mg-nnLy0g2#6 zIEIvnqZiaZ;Kd=)g?RU{s?pb_sUogZz& zJ46?hyGFKXDwHJ-*-c*y%`?n3>7WHqIIJeN^RH*o+LoQu@Jvf=ASjR1`N+GHehl&@ zT<%vQ%bqE*k#lF19@$e-H?Xonr!dN=AY0b33JsM!>DvQb{=QLfHSlCoS&P;G%cmOl z`xH?Uo>uDwC+UCl*oGC@F++9J27HGaaa~3_D_-?bUZ)JQLNaVE>HgY z7G(vqsUoMB$HS;eW@-@rYpgn6vU-bqhiYo(t9o`)%~cU3Vf1b$tTZ3kYQtxn+Qv!3 z%5TR$#k8XM-nAjGSe(QZaJolZjn`@JOi98ZxTJlvfO=Vm+c%|Q*T;9YOqvVdOEWE4 z8_4$?yua9c<;CR}gwzk^JNO5te!UAX#j~msOTUQk>sI>*TvqN-78M{<6T=u=wf)81 zw(||@)#3ZT8Ub;Wc@FfoGWXXlqJXWplC{SN63lppzf%6CjH!0?l>OxAC}~ec+?^}77Xjk;^{s+ zmm)c1c=8_7Z)R6!AmU-ttsG@ZskA`eS@5px#|1n89NyNzmcUij?(bhC5(N%~{uzml zG==yzcPy2h^s~H0BdiXJ+F6Z1{Y<{80w?cy3>PL;k0b`K0ZjK?ED}OUS;H(Zkm^xaQbw(E7o7F{{s@=FgRx zH_Fil=(x#^(=D|TdT8kbDTV;&qsP+3woQt4=*aY$Df#7A%bD7ZJ=kedoJe=~^fIo+ z=hoKv3ESm3k!=LrGUnu&+_C$lT1P)T&pF(1f~ek)1@a!tdZxyF#yt=A{)b?*zM#MxG3^(jx}TZ&7aU!J3atdMxwUQJux6J0)o0+8~%A?n|up zcb%~t5l?)8Ik+ZbR3w7$jL-Ev$>1s=JHpxJTTBOs-vyJLw-bdIK)f)9Z%lM1WLc#wXXlz9SW$Md6nasB)C<~d1ZWkOa$Pw z6$FUaE)&SQun%A#<#OYVu5+7EoKLu1IC>=8*s`^k?}Hh_0#~N4S|Prh9?Mlxi1K6< zXKrW(8$!LR`@QhnEWW9dk-ICiAb!2C+6OP+#qTN4pK>+1d3J8-KuPPL-2McW@bR*E zoUp&gG<@-rdsPVr{^s2l9Z34U(miNAF`!_PDw8o592;IE@5RG}TyDUHlS@Z;#D{51vXEz^ zjG*$2>?CA@R}()+nGjTY?jo<97*77yR8~^!yK!0DrZBcM8^FgfeOi3(0X;5OOhbJl7}-|I^2Q(JAf&xIkOw&+hmlNgbto%tit#Ol z$F)j2Hqluv$QI|U{^KBrWhdNE8w+c;ZhlBM@|Ublt+2`c6+7Dx`5GIci1Z>yhM!}=|)Y?Wa?QINA!2a+gy@J&#*JY5af5jj`~C5>kQ;B z{pgr3wTSRD)bw-l3F5N`3-gBvO6=19hOyD>TQ}6wRW6c~@j>acBcHg?7M$440MWU| zyJF^TdrL`gY4p@xnB{sW&W%=1C_j-oTBU9X>V6V?(%>ZZ-c;3XfV%C#n_>w~pZ8vr z?pGdt@oiFq7c9$q$MaoYswBu_ zNVlBF!h9Kl5mZ$~rNuV#`^sKz7WhWh%PL$8^%0;Q2v95s>pEoVGsrCE*`~yS~l|1ruPfg z6&)5()1Q;k^;Hh5jr_D(|7$4?RObDpI}todIJb`#Fc8mp|6TJoiQsuUd-+*?D_A#z zeFW*i`q7!~(4paTCb=U|E_9m+5QkXZG>!)c&wN;JHTIt?mQ0dhsID(1E>Ymj@d-3K zPommJe6%LZ`D|24gwYL`d{FExJ=n3fwKFPVzIckoyxh~VkbTm}p{PDF-G>u)Q+INc zB~MetJBk#Q0ct|8@n~hR19&=xdue(+81$%=03GO81S8kleBx(st?V7GZa~ zzXvlFDl+oIm8jyCX^9&Q)(C%w%9b(Z|lbi~g`si++#-NV1(k>ze|ueh2~ zN*ZMidPR0?UtgZD^zE)OprB?4O+Qx=lH+JWzuL|#R9FdR-t19SXzN-^Pr0Qd?zZ%( zZZmmm+r+=90i%Ob+eTGDeXb8)__t^cz_Sg}7uVL8TKFE^dOUaEtQG#UrQhkre8+Gc z0ATZtzh&Khu`X#^RQ`kcuP+nqo^&^?1g(=aKXc`7Fe*801crtNrp>$=f1`|@is%AZ zQq;KtYh{^$9}E3V)ih^B`u%v3T2)|cdk$*!T~lR~WwV}@iamtZL4q~$_-G}gTFVGN zFY!pO3EdjvMfzRPibjiQR~-E3V)oHy4t6zw+rWMTh`AmbO!1Z%kfbt~m}262LtSJP z!FalMVOD4M2x41zuefMAbGcxqv3@zTWp1kYLr95r&3#}6F|akFYqKL-MEco6f2}g| z%H3dNT5!J-XEyOcuoyPn{I=G8#wi-(A~v2h-k9QP|6@QgERf9`)G89c2=}hHoCO#8 zT1b1hEBk$5u=L+nZgrf0uwf@X#SSPi7{cG?oqkrEY56keRc@`{vw6Io;Ih2&iU z+*^1tGrfG*)TTvn0X$JY92fs*T6)DXE9u0tDSmA5u5?YyGz_ICARt&3*f;% z28}V!&M|_<>hKqwCocjd501HRJa*#z7^SDa$Ley$$7=B_RgD8r1Y|)uNGA;=bR#9q zYJk^g2cAvWg)p3>ex{eX3;$Mut^L9Jc5CD$TwFI&*GnrKmfThjs=l!|i~?AFacbb%N)Mo)jI}7v+50Z~+j$WiScp-($r=7-iNAb{ zIm@sOEvwh*DBJ$``mQO@(-JVz?YxON<^pP|Zd!w^V2-mc7x2uH%a~Jt`8ag_x0P&x zj_PtXgR69b%?9y8+Mixj1hT^2@;eSYLD{Ui>{g;uNqMDX)_AG8leROS4PL~FOi|HC z9GepTmID!X%SRj%#yMFa?$VEaq)aA1(28mA2P_2s`@QckiQHB4ePzipKF`e z9tb|^P_Zrz);~`%*3@d?^W1Owb$NPQEQ#Ox#=}asV&jB>fABF2CFUN6of)-}XVb|~ zaErzf?O4c2$BJEm?PZ6Pz(bXu3IYYLCi z0I^-X!!G^k7S%$^+-@rdWO!`h{>qI)P_|?6BLkp}AtPN9<9pbr3j7lRurAbvM`*3q zpEjme-|XAh=#jAxLwq9cbia2d>dL?Ozdx_{$5!LD&&=o2+VjX6;&hSu_NA?aThMU* zBh*IT?#c7tfiUj|zk3AzdSWE;3h^>Jr_9V+rTWK7Tf)aXSlQYl@+#9t$wog`cXfRX zFZjtY*C`~FQ|R;P#UsBGeP(1;G}9swb{y(2`zxme@lJIPm}f{T+DcXLP+ z7NhRDFK}=@ejBaf#mXyV^~giD$xRM@2F@y}J8>pmiBxA{DM^ErqY1CxYl&qa_SV)B?j8V=&2{_6!TMo)Jz09t78}c4E}7UyBqee@f_X&ucFu>hk=(VjY8PSGD}l8ZNyr%vlre?X~*3 ze08~HE?{Vx7|>K@35^nqS{7}(TuJWon6+Wo>74t0cLfp-Y1vFG2&z3;;y-qzGOjmi zit*CU$#~J&-oTDXCv*VXcI{Rz84UjDEc&Rv~_D6EP_N!CgIA=_2 zJ!rO64aAA1ScIMa(}}oXmc!O}%r>i|`msd8h|U0;PoXJO+IKW22ZQzVIzwJC5Hq?) z9s?!-r3{}+l=ZLlYi)kd(AXp`)9T0}L5|VR?;8i_Or7f6C7~@b&VufLfLb4gRnHZN zAl>Ec?K`5y>#y@m>ta9H?wTp~)>2W~>#HUXSvJE?0%K=&8wY6XeTRx;b)?o9!p6TYgK=e=#S zJFG7(EfD*HCXKMAjli(%%%dACfQ=P~;xXQK^C#4eL6^r{`d0t^w>Er0sf;q^6@2`8 zkkb^#NYgkzO4faC?*Kg)E1UXxiN$^O84I*OUhY$~>qYP94_%A@UpbzX7()caA5^hz zjwpL17Cf4~6m~+1%WDcq$oq}{u9T&_D=G9t4^Iyn3{Rwc`}i-ot+~w|MK7ljgs9ia`9lXF zky#OXF`%=Spf*Jnd>)lCdbSe`3ZsRPYKuUE+FzrlfG9s>9 zaBHEh!_mx1=GuHoGmL0+8Q-|QF@&)GluR})g!|%!b0+AsO4aDd6G_GBq&T7!?*Pt2ZUZd=~so5mc<(bk-jv-{Kf8&hFTZ=5{Ju69C*LW&cHT0 zwsLmwerDrly{6Hh%!h3*}wnJ@BQovtxTiem>Tq{2Hd$!w_=TpM=I=Yzf}6qb;5fhZ9S!Jc!+ z_OVF-)_giO0b)BG$~N&ZW0~X}3(0psD;|0asq6Y;`S;z?1eZ8BrTYDj zY_C91Nt|08y1TpTs7B*W)kdeL`Gs6tSjK_E6~OC;M$zV15r~`iWOaTz$i3&Q*&Yd- ze6H@Tzski+EzRJf#5uLC@rZtqA>X*mN(*tJV2Us+aSl>gpu!yA|1vU-9Aw0K2~9+@ z+8g2fbsM8f7dpe+fUBxhYE!iTYBiVK54TDBlM&pi}L17m-K0PCxUvZjA*gUD< zEc|I60UG$o5E}1@CfsO~u=85y`%b1{n=X=dQ!%aY0%AR#k>S)$^N4NuAVXIhDdjT` zT$a-ql^puR6v?kiUhAohtKW`1qfn%>w;RB@s%xr%Nt`&B58C;T4AdGNA-l~hr7Co86A z*ayQlbNMQh=cp%tpTI`g1M)>j{0%m)RR9tD-zKH6He0idBYX=D`dk(}OCfvO{@Um# zI=Ff&!c49#2OCoR@mYq_Qa7egwI-<Vz!v2X!I))E4Xe zlMUW?0@h-H{-@pi!Drt3%d_k%&=2Th6Uy}D8+njT@Z;zfSj8R4HuiR!-$ZH%5# zW$S@?){lvco-E|~3VVko*{#FkhYux2+vG-@LfTNlHNcY_zc$wNl9oaL*Idin5HZ&o z5%_-wlEh9g9Z^kHPWBAhOs6s+F^fUz+Db}~bG$`O*x%!|z-A;|h`kNw+}?|^`D;e? zLxl3^ctBwmvWb!uF&PKl-^o+9$xTnh96lV0n)6ewp5{~}TbJAZg>O0* zjq^&FQnxL^?|eF~&dbSxTHJgGs6401tZGc#JoL5Apa!wkmKRLDmrN0v>+#AHW4fx7 zEBrabxaurdDd)HZv)D-d9$`}eqdT)*EaN%XGCZ#1`@j0u$&Sc|e_=10wSK}+Mwe1= z4v+UH5!dWR3^;#Wg4+?8lTnPH#9H%b5_M#sox{CI&4%kn3D5LezaS>smQ`PUUVS=U zT(Ib6xrCTD{bREnv+zRC5MgPptAHiGP*Lgcy z{<-*)ziEi0$i8&ZfupdH$4^UV(lYp$ZcEdzEnwHQMR%zXbshB7v0t@mE=+qRz z2~CZ!o58@D_6ZwNMU|n4WqQd>T*!;QH*WFar?Xnw<4dW1sRhe2Sp9yt_+D%xsVPez z`x33Xu~MR_b22yN%#D7>b(Z7$rHyswhLlNcYIVCq^=p{Wf;)7%SoxZ_!N(&6JWK}K zG%6~yK$fURn~41_ZMo#Jp{P;F@3kDPxU#sl0okPjM5x6+S9Pt?Qdt^b_ul}FY9|3w zq%Y*8-Pp-%wV)dfdew}!{ctMVIJq$TP2$5nvBfR~)Zc5VZ}5W#hR`J;$O1?%n)VuklKe(D+N=G9e z+X%Ql<<_!KslGD7mV*4I_a{JSLC%Qv9C90Vfl*5+zGs)C`_iCe#e^0Yq=;}Y*|mjdFFUB*f|U$%abGqz47O6x5K zcGi1b@13;v(w^^ha1>Kv<1susH<2B677P3RCi-!@8297@udhbsmHVbEv#kPOhlw{8Gf;XXlzVs7s3Dxi0Wa}#g2ZWZPls?#UPC9MP1I|-ab3GL+%5~=6wc4 z_An*g7mId~zpSfzM;ri1|Hda4={VN|Bzx9A*P10#DYp5IiD~|Ji$PKa!a51S5$v1W zFq~jlRhs~L-G!UY_}PV%E#mP*g|j|?Rw7>}ofI8zatbd~O?dW3y3e>EYTZK_ilVg1 z#z}Zcv-$r>@p57E$e`VP7^SiO{npIAsOo%v{6v0qY4rO>N{vl$Ob@u+#t<5Ay?ma) zjCE$dC(u@4wSyidF%FN!1GN0UcROc28r7QzkHN4{Pbo!A1j7aD*QqHneW z;&WR*?J(K2X=CNeMW^dS=bC%UKiqJR_hw-@f((t&Q9qx;d9Msl+$pNyGN6}o0h;(0 zk)mgT=QLd(!<3)yD{d*E&{b4)(EzIgo!DOm-nC25r~7d z-XwAU<&`%EykNLy;Mi~Qm-l++KPrgzb`Ixsdqhqb^MfG2z>NnH%iTxh)6lM8M8|H8 zVNI&d`rm@&v?P|p+{jIb{NQ>ALP=wV+#o+PU)W3#_9QhyShm)@mQOC?FyKraKV+ua z6R#x?b98*{gW%bkp^o7l;DOLMzw+&c^M})J@;M*wpC)sj!R?)K}cP&?gKZ7;r?O2*KGA4=S>FBte zE6G10LO)ctbTVNZ-6h?h>9f}_Xgob)GH(M+Ed56IPU5uUh8^S6g96Gd!FtAP?W(TT zDejQHf>+oX1W8JHH!dh&V1LdOwHh%#Hr)Yx1(x;y%ZD1%&iK6KrVXD%LvX@4SF0-i zQ}WHmJmbjM(n|X>ta8+ON>Obv6&PKbUrcM@Tfn{miOGiq2+^g4@w$wGY0lVEx_Y{F~8i>b#ff<48}*N z=m~;z@E1f|#W_BXdRC7Uf6_}cPlss?P1K3*jvk8ljW>)xKew8FGEfj!ori~R(!H8E zQ>^Ft3EH#5c(9Uz(Ua>!9UO%1!wwxQM?WWj?>W5c8K$dQQqJ6|iBYjYZqrvFVrS=` zj85r$S9APL#l6_34+j4Ik4|TSb3h%1na)VVo+R;71`Jdc9xgdQ)ZS^waFU6Q7J@Ev z>!!ngvx^~yNrJ#Y!Q4CjU#M7CF7UhCbD+v?z3Wr20Gy$73-qd4 zfo-Q7`v>-2);CW2S6P|8Fl?_7cdCw(H$2uPm&j ziUQ3v;p6J2z&f&i%R(Iw>uy2jf(+YA;~plOy@%+{vwW`Ar(^s+7)11AzJ9n- zf@yw>j1GMtCWuR{0W^%R^>zLQTx(f*{4SJZ3T-i{$e3T*)15Zg zA;I89h0}olYGaN~gjXJRWaoI;*ootw2_GFceL-`d?vPY~PTQ{Tfk@vJ4g+hNu{}p` zhD#&D^Xs8UoUw64%i|j3Vfe}MY3T3OQ_p>FZK$27<a1Jwiy%VD%C^|$uUJkMK{fQt=Bj@(lV~H(9S$( z;a38N({`;pwDl_LJNf0e;JqWI^C*$@E-@Y4W^U zHS?U6kAJ1)NP*7sU~|T(z5~0@5sy)BicBv%FEfZ!0)m_0iO~Z{wfvtrw$)nPqJqIDHq5F<6RrR z4eX8@3`fNqH6JWU+~h!;2XQ2^g^LazMDvmv%ipe9dUY1qz|*Gk49%Kn9~kfIg?4Fn z%mmB$3101<_a#*G>;8835HA>_Qb9?MtK;uKcx^Y|d=8<|WDT8Q&_03j-=htB2r+ERwfifrRn@HR>x9fqunl)ZpdMoU<*lKvg4jf@~ zCq&~_`YkEII<{!Nf5u?++mN#sD|Oh1mm|y2@SeE>zY;KLn`P=PSMa4A-t(MmjFMQ2 zHEChmgzI|F(wiW;%}>JgF-C49^tD4@oLBw0)unQ1KUcBmPXQMm$byJT6nrSr0sQ(OfQS#g~>j^1szKLspYImZ~Rd4S6 zPI}x=@s%H==6PZUFYN7V`iiOl<~LmVo|5{){_st#gCXu^clDze zgiQiZj>9XV7SXHPM@imE7ya#LWAVrw+ObOU$B&jd-3w^B6#yJpovO$*^>OfLa35Qz z-(0}38Y9?4NLs>z>9rW93H5VK6F@(hw?JY5JIbNAfcaCkvL&oUbuplrqtvlrM{iaga%8iZ} z^f`Q(&GH#M%_cXhFXQ-am&@h2tfdR-R~D zvsG}qiQb9EZHJ}~I6;<9jmG`-30J)By>vJrE|#?B_87u%0d8pj`H&DBD2Mz2^(2fx zXfE)h!dLs?R8~-UV~Oj6xC;l_8#?!%EC=GjpB)5aX%vyqcqj#9@^wBbCBtobuu zJr*?!-XX1hLj2B#KgP=oWMvadjWTe9K`r#I9>%$b~G*x+H4G`JIyek^uVY-L-k z(eID;`WML>&q8ljJW3MKY)>gx-81ho5bXNk6@>Fup8xgyfpavi%MOgpvYYX5hk=mk z8m-X?`&x!#^%<0JS!DfDWU34XHYCVDJIR_0Q9GckssC3PpS?g=R^I;Oyq#Q`Xnk(* z`9-7TNp!Rls$fqxcYZ7^KlmH%HC$$LGFT$S6}dp~A%bJJGIGOJJ^~XFHo*wi*xK6c zjw1zOwdDQ-Bo|Ur=2r4mQJL^D zgrfmLFgIhIZ#LfJwa*9bt8Tx9+CmeB%Z1FQqRL#{o71|1#x@;z?-%>d&*$kxm#c{K z&#fwXN^jR#lv4&%*>{>-dN3aj8{lJkXT}N)^=dF%uY*KoSA;_!9OXx)Rr2JrR+RDo zTp=xpTxG?kDH$Q>K++F%ZE1U#XGD}4FO9;GF?vw@-r7+@va5$XIeL*gcO>#cLRfw{ ze~Tk(@a{%k5iS%x>I|;*d{M;{br%7uY5=@rV$r}5(b??To863!J<$4}bE_R+%Ufyj z+XWogjZ;hmZXz;#WsibMLXCY^ulGZ=+`8Hs2)Qg$t>C$c-u}ektJ^zwmSo~K10v5y z8#(J?i2XiMLiobPXnJYOB$%THJsTG~ymhbji+zGizMU2L^;dhZ_``tQdK?5D_+ocW4*YL3~?9OBE8TQ{F5>sM|u~Q zO=h;FOOHp(2Aryp(f!W+r#Ya#rMRz5+eir-{0O~5MFl5>zHXgxo2z~_Wn_SiAJqSa zr8iJk(l9Wp*617f8ET778w@$xeF;geUTtnGPx<^!{GThZf>I6NO|8)u017hN{0|ME z7%tea;x9HNrl<%nk#~igFuwRq6y0e^a9Lyjr&f%LV(;NDGwsXc=*eD!prhBqTa@ne z9|o8$oGX8Ws!mDY3yPtsX}zBhJq=#(MI!|S2K{>R{Et=1Kb0rBS-HWDJ_v_eCl#D4 zv0l5(AW%^sx72GjFQc}x@{+lO#&?bLJc-|7F#ZbyslXz|&oL@{tPXRh?uhDq&R1;U z`v=5A*q@Q+?y;=?Ya80h{gB{fpL2!3U+A|g5+y!ad(z^0h8I4vg+Od~Hvz^-zTm$% zA6>U8)PZ@irb0Ii^UcuWw)UO~6G*i9Pe7h3K&DE2WPo1S-Tf@Xy?I$;o7CQ8fXHDs zepXzn*Z*!wyM44^R&9c<_NsYMmFP#k6bM3~H@Ak=+;;pEy)}^^L6GH>BhMNA^Pju98G=n6w3IuE6WqwT`0fRf*TWG zQ!kkA9n}03olzgaPO*faBYRe&ozX{Svdf~5RhsIPyxP=eW z6DbI)wZx>FUyckVQ0&Cq(B`B&@B@pTDg@DSrG`dHZ*aNfcZ2Rcg$6L@_m?|aY-`{!HEA59AU9x}J`Gj?K$m~gWY`n^;u+Vt~y*o&ND z(ZiAC$%oT+o{4>*wB9=>4%N%0-(-xE==&m&5(g%16w~Nn>!1|8}7jJu`yN<#-YU)28Dv)Uy z{Ch1n)UjM8Fe-70cbJ8@F1u1+n3Gvzs!qMY{8q3TD3!wR`ft~1|zpymdVu+YW= zvYuo~iOh8#a~-BvRzG#jp?rgK7#~;1?)N#~5L#(mu;#B~cisI{*aEQLk+EE!r&4_+ zw)|2ypK^^jU$o=0f{enX_>Xt3mAl1sos4L+KcMhJ+uVDU6bmsXJaWY|?ZD<6-Dx_b zsfQzaeS8}iFN9r|7m0R@Wo1mt?6u=bLvXK`Oq^3@2KHDXQ>c(tB4#A_6wS-oE1p0t zNX%ra3dFnuWAHzds-qJNrhEs2J1kh5hQZ#7w*CROiDj-G)RLz9M5p^yk5@sW+lK@A z2Zw#+s5Cf?VO7>*e3xqmSD@pV?=VNmx2mlU;kEYRarnxLX*+M`YcRj>_qH?f{PqZ zhhR$IapnxzV&=k#4Q6e2DNkQe8RUYhwk z6@n>o{w9jtYMx+|LuDr72uBn|L5m4{5R~AX7&Zdp#@+F0Ypb_QGovRafERLwa*G3q zZ^*C>Tmz|fZhU(orWRUi(Z((ou|X|iDPOIf!ns@jV>S)_dE)3$6IoBYkFk0yIf^gU z{uH_^EcNr6fBV913QY<~I-siAOqp^jT&zMGI$XCGn|KSrVdPC6F1pynzVW#4KpU5C zHr|h5bqQj0_GIqWM5JgaT}4*h3S7yS)URJgb^9P%xaZA6{hMVcRA=uZkoPn?OQ4ZY z1y8TRB8fMW3G@l^HTW+p+jN{5@q2o)kNqF$S)i7+d?CS+zr{b#6`_xoWaKWb2UH0k zW-Mo(w?I4##S4?!u3*%_hbhh*Ja?=Lm*BE+qCwhC>NF64&*`J^GJj4#NH;G?pd{?L z&MMeBU57rJ!N!p+!bzz(x!V60b-Gdr%U8AHDIbZ-xO=2&_NeZwWNi_RVh&%X3;$W4 zN=Rv7;i`Qb-(U+TRM&W#fVNn>ZoAj|&1>YU2x1#pTA7i^f{EsB|Di==kF3{{?UuZB z#M}9n5tZ_%U9L(ne<~%9L>GV?gvgpZ0pZ0}a;<_e2O8q%e1m#b6IdD7-Glp3gxOlQ zZ;GBfFku^9aaZXq_g;>p@YW2$+ax^%DzQ3lWODrFY+W`fZ!wP)op=mw&^)uYyJRs` z4>s2HN#Zvmj4mcLx0D4-KZ-WyH#P)G1SP}k;m=~7E(N9p7L_Jvr{kXO3SWQ*`6(9v zzHMH8(kTzGM_G3n*jL4mU2m=yWu+$`8Pxz?tgp{=?=tz1nOyGx{LRP;pCkwr(}YG# zTLf4;eO@K>a~on=32etrqa|y+#(!6!Uw$~DYw?gBG*Ys{y$Cto78Hj0l<}TBO}J}u z-=2`U@}$jTPJeisD!JHix;6#Uo^%#0DApCD43o@U2(%9hE`DAg<?Lw5 zC?u`#DF0&6-)&uM&x5WfV|?)YpX>}PdlYB6D0?*amI8f^ydGW#kcTQvK%mfweCgwf z-FB#l1;S|T`F)XyQpQ#tDLIQI+N9OlAFfSMc&{eD<(Ij|-UC31w|U1oTSN7{6noHq zPcTY#9@*7)T!YvL-(4h?oKorivkSP(<0DGg4>;HIYq1Ppn0|GHQEK{< zg|dlQNJ?FE%iP#a!CHjb10=0{*R{Po+GjwO*{}_EwJ;S9OPX%NU?k(kFhxM;P{tya zviqMSs^z2hVvyF4v34R zJxDq%fEUW(j!LX(m=Y1@ki?$d$&hbqsm1AKNgOkR3o#EV|0I7aAnl`yP1B(537 z5jM6(r2w1eT&%cF2d|m+G)s!3j5j(Bm)fz1rX~Y;I@qL5(d*wGtExHm*1@KC&F*XT zr#1_ROz)0N)YMZ(*KwKB?JChzG#dp0blA#ZI_Q=aZEB^#QpsWuttfL8Y^vw4rLa)` zH;y~%qj#q{@(6fgcgWmltyvdaYAoBnSNaBCj_P^{1~^*|Ds$gts^g$;keR;VRi&HD zQynd{A2zT1Ez3CN5f(c*ZzqN=V%sUroNIYH7)h+kti$iav`Fct#8TN?Zu(`95KH*F zr3gF4e;QgNm5?;ac4a5YK~g7Z;lS6`-LnJ6>T>+W>kT>UY4}NyQ9EO8osKVH1>zCI>sX6V#iQX_H)%o|W(YDgq*5uCCL zCUtry9+}qaI_UNqYY>KRQ{rDw7Q|Y@?k?ojH64Tt)`&NVBW>~xMJ&o<$`lc)oGBY; z%Eu$@n!@hbmimBqoJlIb0#1(#DLy<2Z=3CV)Nrd-_&PIA-wu&u{~xj85Go?&qjeqG zB-F91A^Od^Y>Yz`C0S$`0$A|hIWn=>l8X-#ACT?UN+J|GuJB%vE=moClw>#g!_73W2YAbY8kephkk+ z(B=rkeZ>8a)Zy5Q(^b3{e7)$~L*wgA;Oy;p;Wgx<)}R7jr`SLrX!WHvGPZb9>rs8< z8$e}?hIl#`VD{QAx=Z`#R+s<{Qfb~5!3)VVZkkK~s-AjdjQrBhnCm{arFSWlq~0QU=a&gnPS zE$|*q<=lZppXWlGEq1SrxCVCI2<*0=UEAEY^%|tm*pNg?#uR;V2wF95sY5OW+SI>D zFGiiUC4!=3azAL41oSq5wsC^rpF0+1nDx2+Es7<0p7^9~EIn`0^XlAO34;#lEm@~` z!Q;Lbv!)8kgIhRT`Gf~LQoHjA6(j40)jLl&+W)7Rf z#@KB0-RJuUJTI61@Z95hf86i)+w~egw6SB-V5K_Tf~i^^W*a&=-up#PJ@ZR4K3%`Oabx?)j{#$*lMuWqB)Br~8G!T$F|i*TN%Ly?WMrC($8Sj1j&Q)shQ@qF`| zr=|d4k6YVGuUv_*v!J<5vA^&mqJj6q*9h*xMxgS<7{9FAIQ7t_yvJ7g8g=jgk%Z- zey{q?mZDn-Yv3Qz( z8>rpW`_k6aW?Hp5>O}aNch)~D6z2MzA)L48_zc?dEiXyTSkqj_&hJNB=C5C42#AYX zT9w#w-@yrIue`HpX225Tz2bsHY3fFk%PP4xUk}kXwgi>VVAmFTTIWfx_mOOV4BETK z^*LwXu31upWHp7RsPJQm%96i-{(lmddV_@GY512}%kY<^RmUSQ^5$u84+dih)|ERY z!{C;chw#RGMMW(|t+iA5Xt8ZwG%$woiM^8h>($g@PvLMaT=x8<-AUQg8Noz*>P%_E zJK2ong=4g#)|QUc`q#fwk@KJ(82l)2F zQ~NI!QMj7C4Oe-)Uu!IVCL)F!uScV)KnU@T)A*p}`X-MtjwE*hH%{+&YQ4C!FCuwb z^M|OU!8KS)b^1k5vvt51$J;qHJZb4q6EoJv5;(7#)=sC*v}bZ-E{(R9h+h}xjTd2T zJEVu5NLR;9TsB1yo2lUWvrdb0JjBM0eku(WD?lusOd{{;q@N*-`~g!JpjJ(z|QiXNJwKm2YsQL}~{&ECO!_u%SmDpkjbPE&va&4y#? z*tMsu%;(qaWd(43fik)qmT6YZ+8eC=U}p6s&HeJ$EhKf`t6}g}z;26g{+X& zcDX3lns;I1X5++e8p3Mrp?2vAMc-RXElO}Pyfyq38Zi}Oe>0w-il|h) z7Rh@%t>(bQ0y2 zYvsvR@jDXoYZ4x9c;|5)?c?pLoS*?C@MPRIixP|cU=zDvS$<<=X$t@eQkI}4?h)?v7V5KSP-k{C*z&gHVTZkvI z-ZJTJ>O8GDTSZ)vrxoXrE}vt)a(VMZBGgJBlbjUD)hpqV6G1r`VE@CHR}3cI+WWvF zy)Su;DffMe>YJrI{VaYC(^SZRim_;Es<3EK)2bOY!YVUcT>EGek!Yj0 zu6$UA4JN2UOO92zv^Bjrf(Qa=gt*ofxJI`O7e!bs3w*;xcgxmEmGO_bsh_-@zAe@O z6Y+Xlime4p5|FOJ)0`z*mY((J8fTFc)?0Sn^qm2>^?-=guwKp(&-9TFkcT`qCM3Tn z07c#j{zB_!d>;OG?%wGm|LM+w zwEhZ)rzkaV-r2dp6)$*S>OTI}5}YlvP^6O!+#+9~6Tju!v`__ocf|~t7f$B?1iGu( ztF}j_GCkIt(bfUJ>6_w%usbux5C6L-rwb>CPoDel*VM4BjMfkLRa&1kbT~^ zf5rdk>Ic1m*%9GhW7r-iVi+8azmXKIe6KFb;25d-w2SuxMw0xXoJ(V4 zej6?~dl2zUeEPU$;qI-TPQ9lr#Mk&KW6tbdg$QZHmK;jPPs=%?XJGPY0N_5S<0C2N zQBM4)IjL^K{&h8i#qawQK-u41D^zqi?!#?|fAf+ipDn!E0eQ=mszr<~Hg$fnI_>al zVq=coz!_rnGiSClrf03y5`~HO(3!+b>#z@o!Tt5rH8Bb&e8Y@3a<~p2YiRY-0F8<@ z)&uU49zotw_b~8IX$b4YSAdA#;pQ(UF{>Jtn|J;^gBtG5YU6SmqB%5kP1&rC9wcmZ zpp<%GW~j)=e$(^G>u%3N7VQ#tKY(=}h|fmQX1?_tA+0J0q`bVPwpORdBU9(+cZTRk z95oPmDJ0)qL=jnicJz=g69o3wiJF8SbNeyyc6$drDGC_dg?LLmB>DiVw4W{4AXywu z#Vv9lM*hQm`xrG6QPlR*vIeWy{qE&`SnpOJcyaWa+vnPIUrwb5**{alaUYw_Y8m|m z!&@P-j?r~PPSek^IA!CXmEvtW7LHTgcN=q$QR&=E0F7>aOXZ;sijs!||4~*RD>k(p zjScUmzXV5#KAWinEwwLbe0!@)f~^oOA;~Rv9xZjTM~)2kt@N%qmWx-8l(TBwH!ATz z^1$H`kBBo2-BXo?UMu{ucKxhb0`L_MXz^8H?ZzH>*2)VLgD`w~>a3+kZ(Z!ET~RST zZwDh(N+8HUjk%7_*2uTu%>}4`d(zN(*|rG5=Y9uy(7kzP-$3>t5HivF{bwrBs{qIv%88!`Qk7(bl)tm z#nNw#^~0+vXn3>Q`!8tSi_}O9P(>Zwe5e%bj5l9w84o?vyb~!pnTrQs<)4}iA%!;E ztRPb<3bD9QNbcgy$w}@xp+C=rbl}jW5}>J$r0`~XWaO~7fq8s~rX?#l5D?qH0vMlO z;ZL;2eLV0MP*>+L98_n)S2Z$ej1P|thk)gEW&?8X7O&?7i6irVkLc9-Nt}Z}0tsKW zry_I2METOln-3df|3eP+GIvuMkD6&mUW4g)wPVp`zz2*y6*6j%;E$dOh-^1CA+9Jd zp|i<+`I0AsooGc1f)AdR>=_!Megx5%o{hq55~Rfr2J z+XYT`Wvu&CuaPKTQE5)zD#eLh^76>@2DAEhTVZwQ@lzT}{96i~S*k}+N_7G%vW)s< zX7r8&scpSEC8M~b#rA#|9V7WTDR6WV+!TjgBzIZ|}XfezXKzF4&2h!~VOI@&9~ZU-c;)|r-HE^+yP<%!eu0v>Du08(-%j61QzJ(M6MX-&NRj>v(U1YP`ZEF=H<;k?ZhM`lr-*-Xq?Q@u6^>Y z#yCUe8;788pUh8o9IU4}CEEm5xyDv4vfXRERj>!>eKX=SPHFP|0)HNJEu&BZkl!+X z4TV)(^so-e^|dnt)De=a$K;zOO}(Nh%m0+^=vM4e+lBZ+C3&+z-ib)OIW?QTvzT>d z5fbswdJrf0*92pHR_*BK%Tdgo)yFx%Z`sm4ym8#GjLnd+aKg&rGya>nWn;gMAsWlD zIr;C7yb{KRfUymA!=`(!0@cP{&Xo8iZ}d!u^`iBTp7fWg(XfD64UTl@{;nH8fKCgV z^K|asSw|JCg|`nkKZbF(Ro+Fpt`55;$AAcnxT@80C1qR*2PyK;6~IW$O^q5S=%pKF!#Z zA6{>`g}Ahg+u?orNqEEk1=3e*g!=yHUzUD9=-p92Vfzkg6r;wwyO*;5P@sw}1dzTk zRf-1~?DR=Z@5tXytK;u86{uP^ZNtZqF7_cQCYGmEbP&e9=p263c*h8(I$dEi#ctv7 zaie`uOBWlcS@n!pv{#g9$wZe+q4}tE$r^{zvegQvcsJ7)zJC$L__3Cs>kxIk$<7EPsKD$cDS3vFR$+!=4kH zZUMA(6gDqm)&##k3etLP!ZDL)DrgldM`(sR(cFvl6#iIST-gLLs%}KejF*|T%5Hk; zz39QO_b2Pqa<;yIu;sR~(uFoe*2UZQNO~qn2~WH10OjYo#Gs5uokz5{q5vbNNLa{} z5rb6Am&5esQHQ(hZ$&b1qkPPuZCj@sfiB`B%TU@XZbO%m zKAXodKp1a0f8UyDTL3ID>^d4gH2lvhHOBat+gS77#2Iw|gFqPPR&dkgRAT}@sAzi$ z=dGDD=hZ|7%D*)Jgx-Z>J0adRP$0?x%dXo~&7OT)AtqXdcuP56a-X< z%Sm#5WznsIB)zeszGrpTe0~EJHT<=+1ROSWKe@OTI6C%ru1w(5=fV+DS1m(Of1xc& z;3qyUo)oW=*IoYTb7@1a&PvdvM$4dRR$b&1KTkju1+@d5`g^ zR*fgrS1Z=21e@aFH6jVp3Trjkn1B1b<8|`&u9;U{EG^GhSSHyIOzh25)@u*zro3)_ zd$VwQBUW#0J!GYp;-41048SO89g~Uz6}@6?|_unZN31)nq1(XePH4;<$F`Z z<#EZ=TX5n30H0sAH*@>W+4q48=I_~a#Uw{_Ty6;1j@q`*0%V(a~H)H)h=>p7LruUKF|8PNMq65Z?z&5g3JHghOcBlyyujnv=6mjV?Ehhb*Gp_aBps#{kGt}Nif2Kr@4sJZWF+?Q zqaKmke(5ilTs^lCd|c|2ay9r0{=_;ZF||ei8@zFNCVKb@U4nkCO52BKerfLD6R`s_ROYcR}XZ`#qli{=N9+?jLo}_T}mc-=UYx;vglETHhj64(5r0tiy z_3~AM+$70o&xOC2EGhmOJ(-pp1ziL(4RS(VgzW7_fm$i;f%|EKbCS;OEfwg1i zZn}_Pnp1;eNt z#&{E#>o8VPQBjPL{>zRBp1z?-DO&I)9>CL z7XZ)#o!^!(qqwwB4j5QTCzn4OSuH3K(>U*oK+iN^>b~WjPj~>iRNrPX55JnJ!p<&wsG!e>;Gu&{E5bbX9eM!_SC75-{N}HnJC&C2zJ}X)cTA50Dz;=`oAB_#jE=d^RKeC5r zV5wkwdBI*Z1Apu4iLL9lDDz?V_W~5m#-uI9rB*!jl-1%#g(dRDA zH*0Q4j0*)g1`m3b(ilG9;A@rc*Z1_$OqAg^0QCa7j^ZN9TwXteJ&$%tx^=#Rlw2U$ zx0Uj>T{#mWZzwr?_NUt;dnRE`@eP=AXjttO>Z6xDrsb{XkP+PR$vSRzZr>Q~!s(#H zfwB$OV3)jsktlSk%kS@B9LdmYA-b=sPiMM9rWu1h^+qO}z}!yAvkwJ1A%xJ|%HX2Q zq&8ew4#9$~lJL3xKwX3a_4$PFuAYU4uJYo&G}W2)&>m7;Zw!q)2am`R35ps?y( zOVmeQwl6%WaV;f0_A}-Z|GtsPeW|_d*?qWFaNl9npdCDV1dBS*IQ=sa7dw4~Nd95} znAZ6kMcbXt{;v1~V*%5TbBz<3-7RSU^ek3wU3PXmP!|T#uEp=A3|k-wGw6GD!nMNl zu~|5E0FESJ*PX%Tk6(jNQSR#}1h{sBEw(s{2l=Zpo zwW|Pxu0qyY9b@b?k}fTYCe8jC`z@zD_1-F&-`?{LL-w8^-&cqmm-ODJyJ4sY_=4(7 zb|Y)-li;9n>(bX$$>`$v;AWKo82nP8eGX^txV@i#f=SirZZ1W98gmF=+oRM5wMNVi zK1)r2)(Duz|L)@DbeE`A__Xr3UW8vSU=7CUR6SvU_9S{1`fA|^2qtqcplg(fIMMDI zKQ;_GW?LL3-UlSCmUaHl?ipWvw{%;2ap^(lvddD@2ovw|+OQ&~5ms#BHPx^yVc?OE zP5$CF*$U~-eO1D4V1hw|a>R+s|1p0#o-x=;d+FJBLN>$Q<*qA9k6CW{MezM$KwRr~ zmvB+~@%;WQTjB&{;$hQLd3D4fer2}Bf2jWH_|5T*hJF|PY-jNV{v0T)7Yq^IF+kof zsz#!aR`Y3#ov&6a2jZ`dcK6Gi zHG_;O_jzXaUQ;z{MkLr%#E2q(tJ-z*T6@s9<7pw9qyLkLQ{?60%BcBWq+ea8QcuI{ zsV2~fQ=o-c1FXjYJ*!;ouax2rtO@vDoRuQI=w5+M?1* z)|A@&1`DvrqqQK^zGc{d?xoSFD9UyrhtdClVRr}kr*Jn!hhoCi-NW8SPwYL3#8)i+ zwWZSoLQ-*G=Nz>rY6a*YPigAZL^(utIITh)C+%{=4iCOfRt)828@2M+{*C9;bAJI= z2Ic!D#1(XXt!a^9ZDd!G{5jAw>V3}BM=~Q0ND5s356)=}Zj<@ci5g|Uzkm6(U~+h= zd6C-?thzozz3KIM#QL4!J;%;ZIOs@EUo7AXDtOi7%~^YOOyeed)6`eB;#D4PaJkJ@ ztuma6a_ZG8mGO@l0-WMuF=D`EbptXf&eVdkYpQXk&+jp8MgOw zYs~e?k1yZi!OviQ&0g+ZIb{dF_Bxtgr04Ok6#FivVIyw$`>E!|(&Zp`JysT~a`b23 z>^6k(*3tkkMR=L1{Ox=?Y4Q(x%KUegW?yH*a%LcVd73_HW&zGlW^Rju;QdM{xzC6HXg1hs?>rV*;kC9{3~cYNQu17BFsY%PL2!{38k(GbMk&16kl)QFWUti4GV0RgeRVF|Aeoj2|Z5M1M6wEdGRAd^|&=&Ark2yonIp2cUS5GEj zj{U$;*WUT$^raRjd77*+I2@9?xq*pLlrDTsc+Eon1NweedB3A{;{?2=BBwUGXX&72 zA>@pASM5~5Hpz?&O0B1c3YcC%`QZ`A;`zmpC#Vr-EAw~t?|FC53CPwTye#mO2@OlH ze`W8DdB4FaX2ze$Nu3xhi62}vGdX%2UV5c35kL2uNS}PgE%1>w$ouijZHY-WiRHrTnkCV^^<}Dn z+VH(0oT(xF?x;*F6lOOQ4*X0-rA9rPaVfIU*JX&ya#DHJZQW*Vt@+l$s-m|G5>KBD z6y%V3^bEgvDp*e((i0#2?^M89p*oS+m5m}79U1cB0Ss+IH$LRTPks_y8WNYVs?>+e zM$u~$q5=$%0t-JEabJRIj<1qx%XEi}@m~Q@J?@^6#K_wo{m7LG1QoGl0 zlje{m$DxcrdW>UOMKVs$@E2KsP|(eHx*mO=FSyqJ$YiN;KMT!=JYE~jIvzF1`!L|> z;@qD@yHh<#CM8GL6$YN58|YZ z&4(N^iFxL9r?1BCF}a8FKb3@`u2xp%CAP+Pq!@e6JQG|k-oRdLK|=54PzsS2qzyoq zpAFqHpwP)=mS3XC{lP0cABitVDiXz_F;PzJN2@Uf{uC+CKj4(TU@pJInVLHJIz0Ap zSJMG)tLjL_T-H9fI*V}S4L3{%g(vu+BB_=8jDdJUllb~~hp21I2Du3_S%zbLYWw(R zLTMOp`f82Tu_j^qf9&A{Rn}U=ZX_>I1Ys7W7kSt;3)If9bLid%#k!edlS9k#?m^c# zLzXmI6c>wuN79gIdIW)6@>?(<$1zlSMxFdjmn0r;6m@&pO%J3uFItA&%?3-zr~RzA z`NsOE!|+d+`2*siObo#u@*RJB(&wgf*30y0`_o%Pq8;Srr&6FCdL?Y?WC>yDQ z>_)5BPp1l(f7Zj>+B1QWwgOYcjZf?cy|7FJ)W*WX4Cmx4@=3Ml#5u_cdGqS5?BpaF z6zKAb$HnD@Ijn3sy?dP%UuXR|YOeVHcx!N5=#p*x>fWWj?lgD@A<{6w64iYvjg6ecL8~$cb!9hs$;4H9d0lBe%8#VM5TtDj=P`{ z()Y*mESvQD+mAO*(GhF^9q)~|uESC6{|;=^^rKP5H2v6!mt*q$q;KH>|;ff(746_=?H(9C86-M~s(ZA|AZKJa`WS4LyIH>2bTT1CQx7(%Fw&+Be`ghY58Ap&B$D+BdS&Hp{cf>C@${aGmn(Icig7rrA-zUMam>Q13 z#=ji=CbbJ!6_}U?erZ^=UaWPF7k{YS+h^rl-H@Fmn?3#IKJuz<|Fhy_E1)KeqG_rVbIC{SAzRI&No|8jTT$;EIE>n0bXG{@6OV1Y zkE7!OImHR)O&$(&MXejS2L+y!GoyWOCi%nLNm^)l)MeATa`fJtv#`@BeT5#*ky#A| z{u^oQ|AtIUlqhSiTCc(TYf{$0x=*8elGR*KT|I%K9+PtD^TK zsqR@S0k_eo&rt7L&qL?d6*k}<*Q;Trte#hqCfF#BGx2C{gZe%H(<*Df40LtA(w>NCp>y*NCu@JyC4(1&p z$Wzp+w1-6OxuWWLWeQ^T5$H>bYAF|Xu!qAZ1w6usP z9Tuz(29`-*==w>g$!=Pi4dW#nW&9CbuIs3e#+>nTDUz!8^J8Zg_p~1Flgr_zXu6+N z42Um_zg+XFUuLZgK=2)vX1;kB|F1ygqXQkHmkWv-9-BQe`)j^KvpA9e8DZK`aBUR!*=l-E z-P7rB;c&t(%6$cR(y#IQ=0UQ;8Fr)n0!})!im7|u9kSk5>e17U+@j*C-YE94-|6A9 zBK|ww96;B70aHW)82pT|D@f64*tr(3eJ+-6Ug#~lbwt4W?q~5$E^%unq%lwcwrXSg zP?h{I=95zGQ7Q~vCcH<7tYub@ZtG7ey$RqdDnW?R>umMcQp_XC&qPT~- z;!E7Kb?l0_|J&>_SJYB0wt4Baa6~uOHE;gs+t7|97cPNwI4q4CJ;A18i9Bf9ZNfoiHHzp>3BtU8*N2hU_TzZ*cT^U9oE-d!L!Wt zo}%*RN$uT-|1k#hpIK#%#cR|ZNrt|lU~et#qegxU>h4Z-nscFCjRG)EGU8&4343_pyG% z9g?|17y&s_1DPs72wvK4D){WNLw}Cm{__~o^t1J%C$aS+EQvl5`d9a_`zy9(cHV15 z#WxEgHhtEb4oGeIQtTPGRc6+%WdiXr`1$nLaV^|N!&CS8u#$YA#AU7NJW{mR3lmc2jH(BRKC&phE~&JcC3Vaw z(8kBk+~5bZD#6I3BIS<_qm74Nnt~+>OXV9=%t3w2APMrR-1EL#GbgRHU8Yp0z2^! zoQ7M=#Mz{hxg(YbEr04h3O{6JlRLcLkbmU>{h`}cPS9J2r_(1&0T@uM6W&g)(u|G6`)&n4gDb^679P-ux8D3{` zDdbvH?9kG7jmGwq6XHHU27#84FHG@uf`6ZgF7uUnXale*CAQA@wMi zDBTS>vCgL4ao6m}D|(l{eKJL_q_K=$;^-sH1Isz|HeYAFNX{_8d-{;S!rL*b2-+36 zgoQLHl)}b4=><;ar}C6lu?mMxifMkWmvi|c{qh1t-2l0YXN^mTrAIf(yV$Np_ol9v zTfplx9N_#X%h&atBBXuW>zhUs&YOlF!B^?>p4i_EaUD6DXnM#n$13x^wp^REN=9-8Z_&rH^A~JRGe_o z;kN~;Rm>Z!Z296=ZHPYI2(N7B-oe;3ITbk8%8~3r>EQ{_9l|~kM`MBT*!D+epoBY1 z>ixa6{?03wQgY3)*5{V%|B|8?m7p^S59IqMc z+}2}+Ymc=g#X5uy87ye>JQwMc^g1*5{!QxsiLLrUQMYwzvt&kX+N+Ua_W+$2-mFAS3(Rn0Lw?40AR4cg2 z$MX2M_Z9~a5EJ7czOzUd)>H6Bgsb7#+xUl|$c>bZ&oFuL=DHd9%cHX|w}#rKTY zg^{=7&MA|)$_7(!Nm)Q}JWlIzuuBo+gp8K4m&x;u4M1!Trx;r&iQ7Flwx=Q9h4`|` zHP%KteBR2UUdT;q$xClj{p8z$fdNEmqPV)8TxHx-^wzx~?f?k4* z$NZYsL>%mjuicz0NVq-KOzFV99?N1c(ub>HJYqrBxzM!wokW-5qJdI#=v(l= z@iW`R;CCP^juu+HhDq577u;KDlqC2Ia0uFTxuR&ac{m5rJ4_N;kL`9D11PTb+eP(; zZ#BuyRR`?C-m9II545YxK$mA;M6|Bzj9Vm|_Qgg7iT!$$OmmZ-0d-^5#*@A@iyn!B zI)s$4ntibZf6ZSlGpI_G=A4Zg+NrQ-K5kSZ60@Q~WGHilL4! zPU91;{8Z4Qcy)ZX;hcL>CmqwinpuY!aBb(BtH9oc*F@dTQ+ZryVm`pq2&~)RL|9W2 z{T*tWxNhLG{yV0sVDLrJ7)%5L)7_J(!TP13p2-C04}e8XH+g?w;!(c6w@=TFS&w-t0P2{BHa z*v%@HTwjL_6H{*S#i%;j^ziFyd*pCy^37IBxzi=|H6aC$E{&?x+wVB#CLF>&sjxqQ zIB&T5n0B!3e_DnG6CeU&2e@v_Sf~c^>WfZ(rH~!>?nyJCYaxIe!uroje0BB$~SV>=z*4c5J%4IfG@!g$v-SPw#R7!y&8Wj>Yj2U zP
      {r$#>4+%wsIRxEGn;^3-6wwCy(J9(1vM`VU2n<;$c-NO3%kxE2Ah(uS5BVx$ zQTDR@g=`3SxED)X)P~qg!%~3K&c7o3zmM=iK%Hl;LpAbWzZ;g>0avYnCvpEr>V#4+ zuI3D1?u!c!Odj$&WZFYqS8C5pp1N~HC-k|)Us?9(pd3{|)b_|Xfr9V-Ne8_5=wW$% zF>`C+e_uHh#+;|Qhmxd!pGD{#8q3f=WxpffZ{&suQ!Y6c-C2$Gn*%8%aU0cV$RL;D zhhfryK4p7=tBj~l;ouTPN1ZR}R9CoXi^@USUUm3l*@`mXSvMrCxOH?^9lEX*hxa9s z%hAAkM##6j(2{YCf_?8U-{clCZP+Ak15_osYo=+m8FEMuy6dAeT=b0CI(3T~aQ?Q7 zHZ5uEBBZ_hNT4L7xK(Q4=a68H*f_6?N2u1yOMUm(KHbnsLf zgi*zm1t^}0E1xALEI|D2@>}9*CH*eJ^(o1v^g(Npk3X7vzlOL`M9Vl|z@%tWa(sv`S>g_QZjU(w<(wgOoZ> z`R_}NoThYN%Nv&ZQPXYr>almq;C1^POZwgKrQWsF34>YI(r#fJ!u+mI?11(h1zyUw zyImr0EA1h9P#XHwwxlFbK7x!X`=TF3tx)(nor84+SRr$FLvXw(+qx_*|xINq?H;%gZ- zT!p`a5L61M4~ywlxs^VImu}4k6cgXNwaAYI=oM&=j}3i}QERW04;c51IODu}cHA{_ zv4y1-+Gm(--+;qgz}^P#ssCejMDKMlFsmvo*7ILE%qw%K+~y*0k7@iptdL%Nx6;mg zlC8Wtc;7ecL(;*53LKa_#ws+_S}8Ck?ZD^}5Qm|&t8&YN)~d*T&`jL}Rk@}FSjSwy zsuen=W#06OtPv6IVN)k@3*US|qZBh@{{l;2?xA$>(GLoS9bz#9hH^8;Ep7hp;Jp$0 zh~u-l0};A5uiH5FfWed*R$sMQn%z%Lc-Iz}C3n7x!dj!(${NB|_i=ts_O07&?t>g9 ziSJ1tznqA>qu*Q`SC4kcciPc&mXk+C;1h~B*XGJOkSD8xL3*R$esC>yhkhqjjk|*9 z0ADa+iN?QHI&{ZSgOoy$G=QSWIFQw#{jJkU_?Kw@jgm0)h=`g%y}_WqMs3;bnUSy2 z2WD3R*D803a^g^wl!OMN@Y|Kn=6+&h+78RcyngxZ`K89|rd*m@ zm|af{v+5;g39u#U-;!u~g6kR#Yb3W6rfT%e)!hWseYm&X+wsC+z2`kn=0AF$n1p6= z3%DRa68BK(UEHF><&gfPfvv6cCYC=Aw@;70)$(?dW!+j#s1!|mD@bZML31mv5`3lC zXDrtK0hRfHs_A6eTEJ}gco&&Lx*Ty*2B`i%FFPF+Jtq%@$M+4uLyQw`t=K?4nmLnG z6loFh;wrCa%kJcmL!x2R)CW{3X(2)h1G+4Gv3Y8C$y~i2$y;lRp~i-hzRsg~YRQV| zp<`neTneWb{&Kb$DtnLQwRIMs@U`N#eZ6)!kq$1}{3~;1)qBe~n}Jn=79&?}iL1y^ zKdnr&7XP)vuk-58{YL$tse=r0F|@K_pjgRe?03{yEy&IWI%HcEec2<_N;k4L z9`vR~!x-Hls}ar+_$CJbZjpbEj|tykh_xc>t20C{PwLl~x&W>`>-1%M;DQTMqs zsxvNNVH@OJ>j!d}{htPisqC+6TZUG#T1zt9IvZ~cTOJ?N8@Lj|{@R-+u5c&;w*s~z zWCDb&f9qoUS!790q>b-u0ICdR>*CtV9q7&fIB$7jrx?) ze?ZkN6GhAF@ar=xtCR-JPFQ5Y(+U%Gh#IikF2gl$76cSNEIxpJ3J!6F3ZRY@z2v0i zf9`#+c-;dk3~!w)*v`Kf_z;$_;Siv}0E!gEE9Ad_AF1~e9V^4SQ=IhE0xq%jU(pVB zH&KO|?JafS@JbJM?kG+jG8d6dvqbAu@`1+4poTpGypHpV#x~P(1oie}`!m7W-3J<) z&xl3OHFQ0HjU2*x;A>Q2E6=eOF{4&trC0?$^0?QqrD9NupGEHxc?vYCp#XbZ_xlkG z@2rG;m6n?O>*@BFTGDz4i(dB?7_FV9T}0V@m(QUu2DvaL?xc|XWQmykkzxSwA_#mP z^w?lH*Qt~83~2GbEX-KP1Ihv&8M3Q`Wj3hr zT^=z&7U9uAk7fg%HP4pcSJtOdQ-i`AqxR#H&z%nhYP9q=;&mpsWL`)3_RnBM*KJs5 zfwTlMe=f>W1ZvD^YDS${T)ft!vH7tn*{bWWrRq7iV&G+mAEb$~N&m2Y&Z~bEPZuJP z@=Wx&ExT;%6fOve=yd(T^fEHa20|;wh4EpeM=@0VMDUf%!uM(hCIAL%kkjS2e%cZZ ziIT6^7;xXb6Pzs>^9)9>d2wzxa*C&usGL1d4fUL1$Y3+QAgy@!U;r|oa^lCin8T)} z^0bGnk|7uJO1hue@u{wx{-(?DUhIKjekSHDgqW#_yG}qzi0UI2Vf* z0$YWDZ|+8n>|8TG9E@LXA4n278rX&YP9`8`{q07#g~|HVdL4AZJ+;hYmN&SVb{?}! zG}8x-VLqu+)55AIht5tlIk@p~fP}oNICg`1ZP&LQtgj%op(f45tU_Y|EQYtwkjdI6 zWDtc$U(J}4=XvY%gDuYu-A(UP(Bc@7t~<3|sQhtP!11wzPp@TP))}I;h{?*#q;J{a zt1!7c^ETQSdR()8?U{X|Z1jf0dmJ@qt>uXi199FVugt)?yX? zfBe}#hrov@(!?I*h$YxzRFCL1-=uM9;)L`i*&Fb%seRHvHpRr^NI!3{cjdJo29^70_{@wB&}Y!>UKJR@{h!@nhYQFt14LZ?qxvw zyg__`Xl>B*z*4*Sw3|IO{IqadE5>{2wm3rUTpO23Al_retvV83) z8-Fly&&XoF{68mZhTT;19CsJqvg*gKuM25uPRid7EzXC93mnh3E2gB^AmQ!ZAk6$x zr#df<$UYrX`bAk!S=9OAw6LKLW=>OTiWTLFBz;D7ZZ&gE+q2y(iVur#h z#sn~Y9C1B2#xdCl#rn^38YF|nkbbm8#4`UfdBd%DEv7}QM2CDx!>-W|F}bzg6FG%d z+ff1i$3r4kSFVH>q30W8vq#gpic{0?ynf#@NETxec$2~)i*{knXnlc_4YUo3Be2i8 zdsok_sS;;K|FirLJeD9TF*+WG-(EjcpwwgHuCCd^k25}#mg9f2I^3rA44~WE)!P`C&E13711xq_;h-rU(_Ctr`IC)3Qrq{l{*|DiwVj1AzO zw$W%@(hx<|2o$1}OUAUDS&mdSt%%?~91QhR(DQy^-2n|P7Oq{iT6J+suC*|`F8q0M z)n;mS#WFGkO26XgEuKe+nVnG>6}UVRm9U*Yh^VZEm$X{iYq z{(JzpE8t6NfWAQme*xT=nG#{HuE(sDJhMMMc(AWblwt3n3IOD)=b$%g<0gN*H5)XB z6XSk&rmhukeL%L&RK-u#Cf63zt><2}{cc1&LNUZk4+;R%BB*}#A{8CQ{6d+``w{=3 zK~As9QS|L|cw~V7T_Eq;Hxjb`A4%up&vgI)|Er_ABy}k&WtB=@(k{6WW2+=}DNE#- ztx#k`$mXzd$yE+>Oi`FA$#I66<+Oduab(V8hGkAU3>zDpjo-ev-@mZ;`}W%F{d_(i z_j_XS6KKuS&k+Mf%p^J_t&ZVeN)4H<7m~v;--eytWC?Zb* zcG$!(v=2g_K+nu1{MLfE^?`D;xU7PR3GXM-VA?TLvI+Vmc4oitpY z|D{~v)pboyFFJtS^S(=s!GBo4`YD75GYw^=d;O)+{}@q`n_SSTeg+L|O~F&%`T1@d zw_t9R8%3zw0LtZwa{ShSYj$;BkSso@e8o$XIZRj?uU70%H@pY;4sip(4vSR!$hC6i zGL0N`*6Y-i$KIPaR&iDkfMpKh#+dJ$5KA4lsf3WH5znUxIb0_EX?e12s4&)y% zu>;~7K0j#07(uPfX1{cyXie%O_r<*LOv9VVewVbBr<`aN)u!H#r~0RAC(X_~l0tV9 z9akDoZvPPIt~%~(&YQ6S3?aK7`7>De7!#Pvft`1QU4Ry@K8l-((vlF&(ZM?7n^UD znYCr<(xv+i2AuB@Ib{z76Ym@m^g&HXp&5Heknm*3?(%4%W%bu6n{J)P*Bdd2hK*aI zgK8orDb&P|VxY0?gbazm8H5HC4 zt}ybsgal;5rM8|EUYrIZpj0l>*%}D#ZB4G+!HEglXPl**(fO;|$o9&H&ginw;$B_4 zq4z`UvhZ%*`W0@ycvXH_R=BBFSyvtDU%Dl}b-t@$okvPk@BtmK@JHvcoIdz9)2yHf z7Wb}SKzq(#k-{}(-^$OOu**4Xc+s2Dbd~cqlk7#zID2tlzsa}Y{JUjNrX`cqm7Rau z72e)9#ju69fJY06gykCyb5opAmSPV79a{lR^3I*WTYxCIEV zTxBzi6cF*G=4<{l{!WUSXuL)oB-{nu8$DfYu>v|5jdB|%w+I*Icj(!5U$Q$JTGww* zgm-R96;2-NnrjgI6cjj`;veuckM((Y4OZw6eXrvMbVk!K(dDX5F9Gdcne4uZqDDBs z+lv&^6#FaP&NBgUl!KnKBB)kNEqCaX>EXN9Zvl!lHD54_mSBziEa7ivs9%Oqb&5{0 z4&J3niG#@%n;$(7M(CnNqMTZ;ZY^_YLbri+YC zoO7JOiC*7Y?DXyzm8?3iU6a+|S)KS@$n!$X zT2+7>6VWT^_R&?plL{OkpWwun7RXw#S#Yzd_hY*9X%yhx25?Ky8hD4|YwFY}=t``= z>{Z?^Dz5C#J_yujp6U+?K0pM^&26a`m_UaHX&wXY4 zS4hg?tO)(XRB&ihS-Lrb*Mh76t@hyBr}^oB9AFETjlft(*yJxUFKOta&Q8xB@ZTLz z)}X=u`yWIjC#f-i{V~rZkDqn=5%@%jaB*3cH$l#L8i?#DP`dw?#2b9Nqk^vbr*EYo zk+F?lZukeHqRN2{H~DK!GWYi3Pe*WIIW1Mz-))vvs0tF}j-UXLs2s^KMQ5!r*eAR5 zMgPqN_dooV^f2-l*X}6Fu~h?q1B5Bb=KJ`1fz|{2i|qh+PuMGx=!sQ;cuL4bMW5E? zbSsmU0zCoW>c=ssT2DD2JC!6^|PIr%TNt- z2UZ7qZ@sY~1`B=)(t!Qh>cwj1`CRZMSrRf}uL&`)WHW%v$}Q8^^$jC=RYC5e)j_!E z;RhsfH2)E}w$lQ&Qn6DvaxN#AEVyI{udC>f{8Wy;GGi0^b)fKyx-R;3PWr=Jn{jU> zhn+U&^8~{0dP{1?A1EJ2$z_D0{p^4Fknv~qexSPVAZhdHgh^86%7rD}TbuQl9=Qg( zYfQu$EIN8`zU>?Ym6Dq06s?wQ1-p;C35XKGVMNuxBl8NRr9aTm=cqc0qQL52X8o{7 z;Ql(=G(q^ELA4rt*a+?wews6F&cW{zrs0{lTM!(BkDuaB>;v1v74AUL~}n{5;k zG;p4C-h`+hDZ?>px+FhB511IB(^)7RoM~Nfx^|y)T;zGef~iOE!L%!t6t7bE)6qX# zcT|(%m%Lz}wqXm}w6%#R0`0&BQ{!;JQcM@~IlD()6@u|;{s6u4Wr(t{1iH0!cAzx# zbJx>QOPnyqv-xf5*OLt=(%?K&eY`P{^YZ(i7;yW)mveR^5f6@yqh9uv|DIatUA znKcV;=qk+umtGf`$PyoK5P1C;((}cCq$HCR55E1WDZ{G6H9P26df#1t4`hPb;HR8a zU1g}@p2Q5LRR{Exjq`J$lSDeqJl27;DaW?+Mm-;U49gC#E-aPy94TVwjG7|)KMjC3 zB*WFhC$+SYaabGW#1IG-Tn*H z9}`dFiADM+%+`V`ejN8WxDMXCca1cB6p)V^SGNN-Wg{_%1nEOTpUDdi87p}zfF-fjY|d1un98m;7I^5i@5>szs>inuSeBvx?VflYKVsL_ro@ zY{X0>LFu(oPVp7Aud{`0mL>&?O7`yhI@v>Uua|tz=zOt0CL+PgQ~_hljM&==&CmQ} z55o6n*JDv-7Ib$VSKE<#) z1JD^LQgqw>Z)q?zh7Q>U>l){hBKQyFZHg-NJc7}u__6<7VvP>fuNSMFNp7>KomINb zekptgIh5g4nUN?i)0e+kWml<7o0XBs`hnkOwO26HgU4ZS?}*cLA3l>;h5!v8wK41qM?6~Eg&s=;=}toJzYI5XyGxY-cU63|GB z_vN#!put49mmErh*q0fZ~^-n!;W{jxi2 z$(os@f9C82)% z9*jI!{nwF?92q*x*Qp(*}$JbC5%L?UFXd2%Gi zRCmo{iTMLRnti(}ysWQ)bF@$m)PCLPZ`}e1k5t>nsir6}Twl6hZLSO8 zPUebVqeFo<@D?vOn-AWtOPDg)PHO#JObE5c@rr0{HX`4T@Y61QiDz0-Q+g?~Cyun< z7V+Yx+-~}_<-`=1SI@6|XQGhX+AXba{LZL6_zGQ*-kG&h@-UJ9$C`5o>8Dx)sY$rE zX`@(OkOq2kP^*cg!Zwi@XIC2I4Q_TddI#f{{*$B;V6|6URst#%=PChX3gQN-$0MHk z-c+o=9z{%?;h6f?d65grZ)=99S3AA5LEgT9qw}6mEM2LC=Ubv!UyS-46}^PpY`=$F z3@@46jOENA=b`uFIdZ*J60fdMr0y9p_+?ao1zf)FUYWg=RT%ZH6Qok`< z6VbQ@BBASCtm}`4?6vJB;I^-{D;*COT1sL_Hah7*)y>o+7DhWv5ETIJ@Y$tp`M!_^ z@I9TC&W}E^gW&HLKD}1I1yIE2;Rr~1S|{d-!6$n4&@`e*!5xec!=~In$yhJx6<3fV{ zIr5-hHCQKBY2XNZEi#UxPV(~al4EZw$#b~)NK@`fv)ajaE_v20+`eS41tvcL-zT}F zst1UgZ%E` z5Vs&hMO3DaQAbOD87pL?``Ec$7m}M1gIdN2HXq};V)=0ko*AlUH`eURPrTxpdW2mM zP{)b;oPOZ&uzu6%Bc+I?;06w5YvBPgc=2N5OUVm94tui-BF+Do#`V;2fu1Q-JW^)F zuUboS+XrL7uLPC0vmH7$Vj$Zsda_B+F)*-CC-P4iFpS)4)8!ZDxxwu)dO3)?Ojr))dlz6VJ)>>;++87reKr@8Iu60GtcbH25Q= zCaJdy$cjZu1TzSC`qvMmXzz1=*&+93MQE8(a-OVM%?_7SQIFQ*B%Z|( z7g!BCwx>8)kY%ScRLe0KFoBC~D_wPK7z~%e!D^-1Tpt=@+tgP*A871Hr>l`G=A0L) zwJ7sLt-OV+S-ebObUYC|iZ zaFJ7&BVw15V3L1Vn_6swPuXGPb+taLWzNh@P83BWnh6o|{|lXRfalh)`0Eiby!DbW zG#F`gX(GcriV!%V8s+dq&~&ZLaDtN=?0>Q&qQaA~xM=8EmPy&aCsKrqV+s$#R)~i+ zr`k~1zqndaQq&wbCwRB+h`mRH7qJli*rZ}zKV$HJslhpJYnh}hBqTA?m= zO|wDskAB1$wJU)~BlHJ>D$9<3?DKx&k2Nd}U+h(S5K$`L@0dug2oO+)DmHKP68yf- z-gr^?w=nf10R>d<8gd@m>imm5aY*lVhyLj=aOA zH}Gbx>GSu?VgUiwYm6cy8Xj6JKA<^JdptMOm;Xaxn_zpgPDaU4sfaBRWk3S4BAf|d zSuD&qgxT*1wf7HwGovbS)D!km^Th{`Vk?SwxY}}m|3rMCSbbGCYe3}NZ3h3XiG{xf z*AXeSk(JumVfVS-Hr_IwLG3esCWUzM4$Qg8*)e3RdM8V^mCrHu_ko+v6c z>N9mN^_d{Sq=pS$ai{pO!kf0Z^w`6sNTSx^Dsg;~*061>XgAbU2gY9i6E$j{HpD-+ zSL*p@RC>Lh@@{juZxM5uw0uT^N)w$qs^o({rZ3m)VL@o96)jQyGt18PDeZ z%^O>`PrJ{)!EtRLHuxE!eW-(7cdObd*2<Z0_LS^Zz zTeLkQO1EW=u^G^zrQvgU=<1s(OHu|;3R|zYe^a0_6=VK6l69p1h4_!fCtTd4$z46i zPxyu*1wG1GftWX@9B#5*Q|oV8`Qs#;8wD92z9uR83IING^?pKq!o=aVh^h+^d7!!h z2eTT;Bmm7|0Xz|*DAf>iv$bV?{x$P4CpugSu<$DEe{IzkF58x|A@{k()g1!XK|A|oN2*Wgb~G_?9Z-u zh~d5)2ZQ;kx&+J){H>A6N@u-O5+C&^LG!P=3c_O`aw$4;4Nb@1xUW<30XQgrv3Bl| z|NOlZ9p`*7rcheA&ij>&eU$kYTnFS$QI0sZ!xJX>G|59RL<7K50gC-CNv__h~}~OAW74pRE}>Ptmb}iznD%Bf+s@g16bd0vlD6?1wRyTq11HB zKO)WK$@q`_3Wr4PE^bOPQ-yg1uas(FIkSHyXUe?m8<~b}S7$R%%_0$6sm&HddV~Od zvkj$pRH`VJF~gYvCQN=fDdOj-#5n;UG}H#eU}Io5kow)edhNs@41yE7KQ(HOxck=V zfTMZ4;B$%!%||=X<#JElJ1YSb<=dw3%4j>9;2L?d#D!AiLF0Ia1Ikt^|oVyAb(k`*tfOUfz&;SLccV9pCwCK{)s)%-d&1uPbLd$gS z@sHKDdG2rg!>`g^)^{D7PsrGm{%NH5CQU}ndRY6q&F{FZl7R~EtyRx>-}L6Lco^3} zm?it?$OEmSNR&a4{$)SE!JBkUd+ObJ230=WaQx_!76bBU4ic{zu!F!CemV9z4%H5J zF%>syx9n=gantBr@I1*srSI-qlO54!^X?*Ep5_mzSV`&)uY|jOH`y{cmD8LQna?fX zWY%+|F5;yhO$jxr3J~}rG^96@7a8wbN_EMOpw0USNE@zQWZ-?zr?YmnKPKUV>OC)k zM4FJtQ#qa!q#tPuanPxzErasSY9pQYv%(SQ2ntv9Zy!v7{M%*zSR^FJqM7E2(BEg) zn_3PUaR)Mzy+Fe?c+&2uhdT?HNraG|;lS6|@vf#`*_EBM1esJo(Z%IrjtySw1i=Lrg*G%CfU2-X*vIr>t$jOm0d6p>ysdf|@P~$`ba=XHt~nI$i8Gh5 z3NpQ$=bmInu1pRIDoI?WJ@wn}ElsM`B^;$Go>cCPb$v}~MrzF2L( zrwa?ngDqrvSvBA+UBR*Dmz!VesK3oIe3M0CrRx-zVTwXGZ4r<6Z-Y$zHsyvJ;;8Qm z93ZIZJ3#}=XhYW^glVA%rX@y6#3(+x-7IL12uuos#Gbuxyzyy1{e)4}i7-|vb|JcN z(YznbdV>>3+s;F24^MCQf1>yUsv?MIO#~VmKiPF|S#vE8_QYuL#`GH!4LL{MJ?8 zLUw>gA1Lg5yM11o%}?JuiWq{x6SCd6I>XAiDTW`TsaiQ7Mk+%Xcf(zfV~Cl<+dv`( zsr0#Y%XZSSqgvK=tX}v*aTyR^UTbH)9Gg=d|6Z-XzO4LbXOu-(QmCU<|Dt=uYOq>_ z-`1xm_OfYgGuM-AadNxYiD=Xt=bGlurL=|94KAkq$6Z|Hd$c*)VL8DH-+*_$H?#Lw z4RgOdX9kb23g16lYG?f=bi#c>dYOgtyLNzZe0hGP$K*5mA>>ZKsj?~h5CWC!@^eZ} zxXpd(;gDH4GZfj|YP_`YAn}(rc%aw-T1}Z`i_2m+C4?;rm0s5Up?>8;@l9EgX5>M_ zJ@75J*-+I-N{0bk3zSQ_vxS?|B=Ga$Kb6dn0LkFcTd3okncr|t1BFohb+?2aN zaMtvCmTLK6gzeHIquH@uA$k>cpeVzXgxq6}x{p-f)tLkeT?irp&KZFpNtPeJyHN$N zQj0#~TEO$xW9_eNek=R5?l^sJ?Y~v^DYYj+j^rY3iDx%z0EjUDq6lk1vN!#V)C>G3 z`u5k8iHUw++4Ucvu?g9cHmgLTo_PBfMu&w-;sGQtI5$A8WXZGqynEV9O^%)G__B zSFcol>&2~#sub4-|HTj>e5XJOyZTV~4xPg%h`lybfbj0n=)|X_0%3uR=TWd@4$^q zt8HyP#~5tbu&VPwgA+Ti@eBB}V`pgq;B)os7yoK;Q?dDn(?W)J5cQFFt6?3a{j-Mv zKShG*oQfJBno+;Lrc1yBSGfZE6oM>FGs}XX*44u5r#;ZrKSgoWA-<1)l_VYV2VWA+ zpyk$jfaqcl>yHn(1b!b;-}IxAb>KnQ@ZVJ9t@g3sX_$D9)-k8-l8`sD2=5PQ`ot`k zsJX4}5C6R=&1tA`lj5FA{@UcEVib8M1`{6*>{cM1Bkl!IXPO4XD)~EdDYK2|x$9B; zolU!Q>Z0x-ZnQW>@PJ*Oxh~u5__N|Of5x!1j|TLR#0#f|p0@L`L%IGri3=?jh_#)Y zDhwZJ19EiX8)M7<(nY%IYkZ$SMhHEFb7@^CJQ6`Z0-A?STm`^a=m>6SOdq#vdw7qU z!}RUNcVII3&1F%l>YvxeEsfd~- z?0LB2HtO;!3wYTxa%c04Uf!x31}XvCxGMOWX!6FPt|G?;+xl(;-zn7CI;gFs(<@?q zbEnrn&3O~0X(FcvZuC0w*#>kdbP)M7kL+>2EN31M$iAEXz!ZRboyR$wA)`LOsTV#bv$Z>2)B=D z2#>7`zI79x7>=I52-PS?+bcGQ&=dk%vaW`Hu$-c_psNQaAg|5u z!2G5KakFTc`K>{09~zed-#q9np>B2NcNjx3ldbg;6&lbDy>R#0QQJFnzGcUIOLAB> zrpt^7+At93ld#IZ9m!?in=jZuHlI0Tu;IER;M4!CE(=rA&_iOVATCe-a-EUkQca4g ze?JgKT5!-6d1!2N?hk9~@TdH5K6Bd&!{5AFkAUeYSW3i3p0S{b;(sBsT(doHiJR_< zbyL>j48~aJXj0jq*^)yR@?5&e+jkyVX)80v7#ASDAY-~`wu-tEL8HH#I;SsCFGEp& z^@|73H@Le>CQ*JfbR3Tf6B`qr3yoe+S6QE8Px}7^y>zU6POh1lf{Z7q6@Sz1W>avi zEzoE36%Ug6)JYgPZ)NQGj|QRRmL2Bw)|sG|fR-A*B5Fm$iCU+1>lkI(sI|r3MScir zq0t1YBz(5@MAuB@U!CI#kHXubg0}Np-rEG0ql!Dg^lGrTbk#>_XZfmANfbnbWGVqwNvBATy97?4F%3t=-}?0uj830PoDd^`+Y(Lz%7i? zyB2tOoTTS#oJNe!Fr9$CwFP1ZOy-`fARF7Kp{1}r&66IlzJ}edA6@7mX-3Flf9?SA zapKob_3txcGM*5xbi~PJDapSPpg;!ihUBd3f?!-bDg6>>x4aXt+Jp0zj zDVTTJv6D`2z5$to#kVU1tIjo)0>_Ii3{UASCJtQD6o1r^zu?=Qfd(AX-ooygx40?T zR_E@2e5lQz|I(&OtNc`CfJ2a3b+MtnPS6Wnfq8!`okh4vOZP+g?9A}RZ^}LD-(#? z_GqzWc1MZ)qSngQ2yCtoTe{24hynt9aFtwjK=O$^B(&Jvr)%8*xZ?XUrZfx7mR2N^ z6inWCBuw5y!}gjKm^ViFIMn#VlwM>&8vA`lq}W2HxCzK~+HypD;S|AMpAiiTbWgSLq?f7wX2-4aR?+K`SR${Pb8hZC#Fgz;0_go;ZAd zpVIJVd+7+eTq;70m!OQl=$wg0`F~?4gA=vcZC}kv{!2U%*V~*6+BoU;HX?S29lIaf zwT!$zqxC3{Y&WP>)2T|JpB3j`VJDbEUVvvCzBxnbLHe-CeM29j@7gnO0S?<4o}adq z^8QRmra1yAfz0^?PuLxI^<;f4*fhDAXz(#ow4_nFHA~o>rB-L6!Gn%=G*dOIgCKr% z8vX6p8P>!4i`$XFWmtAxg4VeT#5S z#3&8^8;A1NDgd!EN-2GciMuv-)rMJ4VfpE08dEp!V5Xkr&{>u?vUIx}8Kog5=5j?k zDsY&$uK?LLjTTILxe8v(@L>>TFK~+hbt$6Wjq@&gvVG?D(sUYsp*8%~fTYPkfbila zQ74>{MRNGXV5P|)(J;_6Yo3~!;h8bKJJVGgRXGeIW~gS=Kv&ZcHp1eaP;gY_no9|5 zO{|~&Zk}FI)LPP2aaF(^nC;>gWV>b?QrQrjvFW&chAwjyqw6ciJpFG?|5&Lj{L-VA z<8HU+=;`Z1Sm63R@0fQpXNFE>@w-RZG+}6;bG$~jwz^QEYxOS*`!@Hi`F#S}Vr6)B zjzlDGwdWy$#EboqSqIlcnaR|k?)UOOb>zPBb5_$gKW-ASR=U)oiuds)n{(e=8fpvh zt{Xd73igE~46^Gd)79Ax3~#ir5A-6TVWsqWaDsja5p+qK z`$pyng*L9L0lr8b!!;m%q{q4lm3UAwztJ#pu8q7WQixx`1d!2}j~ z?xTYEyQAyATUCB7u|Gbzn)s@$!)h!|v_q>~noByLif%~$p@n?}uf|5M9Xp++^2iEq z?lK`$ud7+d{$11}{4;_kSsrh-0{mZ2(3W_rmkLN7n)6Tap3ef9oyjS5Dn%gnPp*8_ z^6_Mv*0u0IL>#r?M6_u+2iUvn{drSA)fPaTC9`RNx9Hf(>Tb?`HoCR-km@;=OFVba zH~y4Uhs;u@js_Exi_u$v?39H}>3*tB%~7mnvS(%v4eM)>V8OsByvY z?NXYNx<}#Y@lQ0#ggA4_W5(*nO<9(O zS*73?k2-x1jNix}k9T%Uocj1>vUnGJj^>39KGm1AzBN>*_OJuRH|^U#^0Mk|KA%?W zT@rO;_)ospXT@+#)#6T>+l{7%H+=h6BHVPrNn?emGU|R$M|59_@?G0PNpz=zVWd?@e1@>s8pw@! zR3{&lE*Du2yyVMPHFijDx@uS6t6!h;a7z^dfrYyV-l~|^p?|II+rc5mm@&w$eqAU5 z$KYU1$TTAZxH0|F^rKH)almH0j=A2b9h~Dbx`-1#QeYxY;?t5@1tA@$;CrBpKGTcC zGtQ!PKnJ=!1P4T$p^L`KD| z)2|)Jy}P@1Q$b;b$n7(-E~faa&=e(;MD?sC<69BFel`kK3C`1jwrRrj^9?#xqlsUc zary6E(K+QXYaJAG_$(PU{zaK8833hbSBHpfO`)|oN*X<%XjwUa+``Oos4LaiKjJz9 z^MB<#{wr4q9$(kIe;q^(D~W6bWsz3VUH@e*g`AhTP&iV&2e_)7fB#A=;pZ2C|Hi$C z(4p*~?-t_7N%TLaDyqJA0x9R}E(s{?uh(FJPNvE%9w2m|Y%lY9b_MOiUrA5X;5aSKMz$h~`LsG=H&Q;o`3<&FU>Z z2kLvC;h2+gk|v57`c^jV?8?XyrziJ@>QE0cH;3azPQL&2^nHPS%VWnI!%6dU&+BMjBZWH2YV zrZtUn>CPnwH&~+E=h}w@OO?-Z7Fg#vQt+exe#-#h)TLTC_u1go&xnOe>r0^?GI04& zDf~zC-1a#Qa&xsr_Uzl17aW(ooc7M~=Zqw|RZs@ZWAl|~QDXR3H!(Bngw&HPN^N92vxqc|Ac!NP=DRvAjhsptK z4y||COPsF2XWmO&peCadadpFnB$N-4D~-SAHnheo%4pgUwm!T(%fKyyd2iurbtajcX|MJca-bypAZSlAUbcf zkiP+%zj+CY$TP;KYk{cB;G`X#sVbRejpgHw7id{YO6RcKj{kqSZtYfl?6r0%b5xDT z;`}|Uj3va|>rIQs>+i%ygk?{_RytR=+c_*oJmBk3+$<1BKo5CTgowc(Co^c@+9B*3 zV&4T^(*(INAka8_1+y@tUV5V1KL8Uw7tEUmAu;srRKq&4@k#aLSC86%pYD1<}KzceAM>P3y_-Rv zO^)*Fbo@;E@?<~TO;JfHvJQUDveEPpn4oAq4(^}_$5k7-)HrC191s+ucof}s%CzN$ zONWmF8b!t+?tr(14y`_WJ=-b=G*AaLT@;H#fVlY@>9`ONC~V=kx@iP4DqEGf!ljyN z14!UhmKLw?$fP@<96=1v`8UT*ipOg7*5xGrTS*a zF+?$nCCE}0#f-HlCWutiD!^n2t1J8A&{FOphTo7-r| zRz_j0YLrAbIdHl|>YRp*KUH_{;yt~CRcpDyx9Gv%ciX$Xc0)n}XOrlmctm=nZvY>2 z>yl!Y5zr^!T>u7zSPQ-%<>-86W33)5k$dvwO1!+shW!fIf?MrDJw(Y0hl5 zB~}yppXv08w9ams9o9wx#`o$Aol&!iJjF$XKk>f>G2zekcPXm)0wH|7UzIx?Wnfin zO?p0;Q>gW;D!9*$;H5n4xpZ@*rV?U3c1rHQoG1ga1FaV|IaHU;-(w%oo_G_!R&#ug z8=_+~>Uc|xw+SM7<}BM3G*IW`WeX03{As@`VI3iFmBAkoXCU1*&Vtpd%f`amb|rwTxHPn(A3BKm}ToMKUsg;Ve7d#XXvvgZE0K-U2k zBujO+G(T&Oy1Q^l?lyi?+>c~CDYTYxHPF1n+(MAYnxO*G&nN%j{qdheR6xIy@@~` zq8EF+bEuCy6Np91`}Y)O1XP^TU!Je2qGM|;xLT8g7(+|<#=#bg0k5_2irjl6%?DGt zA?s^0YDU|T5^F5uFWEr4ILh4CkH6AMGQ|-o_l(1k@~p@e|4klnO9+hIu)e%0QUk;J zoWN&YOUFJgI4T7e4$n4DbHXZ4jOV*14t%rz2HRKMIh_Yx!u%g+nb>^0T>n|PIu)MK zVosHI5^m7c+i*}mCz$ZwET!X3m`sd7#8@ll!a zx~Gazl-QMp*F^cvH_+ZZJF(`)&4U{FTlA#KxesEo9@YC3~!|0tMcuSj4gQJZmd2n@~2?QwP3a5KMNK>eG z41sf8&>7zm-khXhJ~(8>HcW#!r_F-!d*v^yx8kRkwlG3zTQZ{%(%bkBUYB zO+V6oVFb4dQee1a8xs34!U1w-Wf7@*;BfHfV(F+^c=<-Hk!gUiDc%Q0sU+|DGw8;WfJ+1FO5C11iT8mgW})N$ytXwh4MSCD!g5z6@hq>!A{qVkd!;%314N7(!@K9g5)$C@Ca-D z1Zy{89-Vpz%yKlHH8#><8iM4d3o4x?*k;BfkKZa@d-`Y~W^U@*Mf%b$0*WjJzS+;E zaW5k%Te}MqEd%t-Kbq))bQ-?v*6GA+n+8ZrwwhcuTYSC}u!4-X8#51u+@G2fJMpS3 zSO5)slH;Y-K=+c+tA{@ zCcD4+1`bFe8n6;gzzy#}&r-L@02GFNSdTfxeJmolhw?1y(*Wso8gnQOv~qj#rj89v z!J!V)v>Knp%hfvbSh?7D7R2?tv3W^`;4he z_HOZHO9!{&#NnckxbhB<40MKzuP1Y=Liv%Xe`)*h+5RVAt^eX&tyXrg2)6zEX>z?& z-JadMhXc8>DpJ;`j1!9Xr+r6= z=TJfPdZR1Pz-2i&OPAYOm+_mAhwq$rZkNVZbJS$dSTA@$3y@k--LNO2H(xu4xGiV1 zCEtHPOZAAhhkfUpG&J@WIQ;RGli>p6bN1%VUUKaT;VHV|yC77Ff5n$Pe^?@QdR_9P z%zRK|PuT5?yH_S1wBRGsK;xKVy10~)grl!l&3Xbv$77SRrmT?+pj1~ACacn!teHRC zGS}v(FJ$L@Qe02klt05xhnjqWO%7+gU_SzKTs-Wt!aU!EA;wrsjW6X94l5~%?&_NR z_7w5*>LpmbNJx~QR1A@ipDr|nT45AIEP6n7`{Q|RyDvS|qjt4lJ&v03)x2w(ylwR$ z*839ec>hQJ+Q&0CHB#j0I{jF|C=|oXKqH2v-^7h+M72q<0<)lGtYsz`|DjXgYZ9RN zZon$|?_2VHI6u=u(H_sop?t?!(p^-=hG`|$INkBB4R~AvC|$lS-=#oWW(jfed3 z)e=z8a)HVq#1)Rogs9`6phAPaa~GSE8nTmzr95?=KOHO3;IW`U{Uvf#uTIIXO84_E zO#U=}$EXFq4_l$A{{G5nmCPHQfy<0DAaZx@Mz5K+IonRtG`?wt()wy|{$QA|+mxM_ z#63K?|M=mR?W%fj;`|jsth)u+Pf$xr0N;Bi^xTdL%$Zr5QGPiTfoa@yC+vQ2d{@tL3Lp(k`C4HRubDC zLS7Y2tkP@T8gU~zu`_4}wb1U`Qv!cN*Ww1x8C%m((R+Rr7jeSR?6seeW?ms`tF?RdSdVPO=I- zf`8DX36zWTyp+@%^L#~?^U_@`*yH7ZX%B ztED^ZB%{Axs%VwUX_;lBZ?o<9Hy0>xFx$f6yTii$OA!Gpjq)&AzP5qFOtmK=t66~l zgSeL8zi0*eIud%6DEnbiAagmToDS59v$KZPbLym{llRuoqe52$(;*iFLldECu1h-! z*0bF0W;MX~G7W_Es39HI#X6HAC>+_(_P@kWmU(2@EjK9-JWvO+E}GL(fVU z=CHlR=FP9{m?}Cy7|+-ZZ?SzgsN2wr=DokRWqD?CRN!c6sjms^joJ>pbNDTw)w$Y3 zZv`~<0i4Y9L`$*H;RO|(P=Coc3tOv_AbgAr7X0eQBgt>Ged_g4Pl2u{YDF*Vd&46Q zpM@0p{!2fkS+uatZ?DRUU@!gv0sY0U`RTq$fvZamA_eBXCU~nj&lyUTO>t1ditPJxT% zsR19emO|j4IV!=Cn-q;O(YRQe_u93t#Vm+;&U6iF;2Kt9`&XSLyQG}rUYIu7UP`uo zK@`@@v_NDiJMDOb`#{+(uoj3n!!s4OG5-c5wZZNt|G{20w*wK zKS$Osr@3EstP5N^rR9W<%uk5T+I05cItN?|3{ggu`0$XWsBh!`Tz-?u-U!#()C19B z7wg_E1fKCY3-T*8vC@k&nlE_#V`xV{F37NooF`oP0%mCyo)x&j#6L1ZkJ7`)A@xvyJB$flVAo&&GpC%;MoU~>m;HTHlU*4XTmZK_WOY-{NR#_i;t)6+= zI+V^9wZ_k4BL^9MjYayr;X7zsPD%O2=|RNgNBHKZi$!(`&zi)G7cTD}NGW(do7wSX z4yv;7w)&{xaQ{9vaCyCP0qLO5Cs9!5qTG!T(W{~3KMUQ87{r*;#uJpq)9YK!bUnzr z#PQW`99a)|skUg&&WT?`{Ynr&7XjdZ2&pJ0#$As85lCY0p+;GkF$40;nr|m&@^lo^Mow(Up*KmFrv$< zKhKtrWREV8P~1X%l-}v2SIXJO0dpO!*3wRh>E~mOgz+Ol#gUd5wxkB)93{dWnXLf0 znu3{H%4K9so>7GB6bY00a523#OY!U8?y;-rl!+nK>?I4{?&u z28c6@+{MRQjOi*3HKye-=U4H+zzYozALlTP;yg)+iHp?N{4X6>IL8{FCS@fP#(PRb z+TDoUGpBNINR2+m`u|FHZed=ee^jx+`!|*ai)jSMibLGw#3ld66ETnIG2(lVz>Df%d2Tw1Wwn0%UGyZu-Fd!v)YjETyj40=3P&N`<7B;#yL>q)|Dz;la5t=_ zhRQ>gaAkK|At2w4o=V>lX=m~v$oZYSe; zu4^aOz)v`&amDv)Mp{s%NT^kJ>0A;BGdB*pZ4LT4t*^7-k->Ue{_4p>N?mhG(wd;^ zOhs|T-|09zzn40ph(R}ejM!te*uH7)2Xm!u`;g7NIh`?N9RPXdQLW*nvYHbt?&=a~k zg?$ZvB|D>@ov0@LD%Ai-Nw!f;%zl`=g^FL`M}BDlN9Ul1jL7@ZreR0201n$z3=fzD zA??W0Ke(MvRuR}KLPc|1WvvL#6L_z$Q5mO(b(4aM(>__>%zg;R@uT!wzP)2w&u^nX z`ULLWy*vzH^?KGE_2*>68SwfXU^hA;=_m-p${uae{z(KL%GdMLDJ_+Js+N9f`aER4 z;Fg`11U$>H7oEP@=$jKMe3#T&1ua}&dl$ddP;GxHZ6k#7%=mtD5 z;w4tZuEGsE#uPOms!@libfewR2f2`(3yx&|o^01!y8F1>D7J)bCjn_8yt@NRJRi!_ zvrF(TwWj;(v_DlFW4cZ@N;swX@zp#FKTDzVbxI961$^%U_79BvzEOy`ubplBu}Qnz zIa2~H2$Y(0BDI}HW88-!X0SWKQLD`&NM^=`Dqf4HfB%?OxDwcg$+}WuyLlp^ts8Rz zORK9-vpun%@>8_HeAbVa=*M)A;5v%kB*BW8jYn$_E&e;1+ux*;Kq_U?p?hx%a}>jW9H^X^Sr52hvzz@m64vpavcPE*v%b^e~7HPhol!q5Qs+z33E1& zM&?TOl{yg#)}*4J#x?6$uLz!u#o2H0dyX9Pj);#vH{W*b_p0DSYem$&cAZ3%oJfO; zSm>ee4OgQd84Rwi@7QKAzOBl!+>xa6AJ#v&bFHDX{xl-aga)Z~yrf=KnVGAopFymLm&6>t&OnDoSHd?*o@O^L!4W%DGT#7?cU>I8C@5s;R$%TyNTYXG&WYLPrugIxt?E9E7@_@dQWT@{xU%< zefUOq{+H7UM$1TF<1X?T`I9>MQH)PO#IK(0J=Waw)K-ijo+b_) zEZ|*CU%91Y#qwJ}2n{K9V7xliRi*bqq#rlA)|pw{rs~@^RId}`K+^+!@XdjL4+Mr_ zNLC>=r?|il(QoKzCWK|7a5Vp?PH+e=B`hi-lZFmW08k@=F^zf>6K@@Z<+Tqb{IKPh zIk5%wLB+FH5#|qwWmAl&k5$9q#e!!U-{k*|Jm$NN4b#NOs*DfWF2 z2$r>4=SRJ#X0&H5{b}|g7Ge=_7*9GMF*F<*&P`TU88Qy@>cV9ZI zT;~pjM0Jmf#9f=p)9t|edwSe}yWG308lCFpR*TirXz z+p6()seWb8-P}&28E>z~8pKZikHe(#lSk_RJT7A2(aN%K{19N79nOHjydn<7Jf6In?9uk zR|A$eGV!(1dkIYfPd}T;VTk##_>&JU6Tg5r`=+Oi83w}#-^TwYBO5NRO~ZCO{VX|o zJbTGsiwA^0mqh?5kq;d{u+5X^JjWh6#g&hg5MBjJef!h_zb0SYn)j(tLJj;Tr8Cx) zwaGTg^P$KMm8#oLm}JyI{1zF=WFdIKXpEWD-RAaIzatF_^KVJ%gV&roLX^m|SvFx6k!F^gk6 zm);BxzW1M{Ic`7b(&X#y@lrvXEea`^oKmN8`gp2N`GT(-YX3nM8LhOxw00D%KA0@7 zYk=nBsUH1!(xyI_b128Dy+7xP*T+K%GV+EwzKB@6Qbye z{P72K_JFXnfWinoOK%iHLX3;qu`4bLWXqhn1{^iwKZ(kMS3Q^;uUsWgp%09+jdFTd z?=KZL<&W&o?_^LU^MU8l;pyP>R;39_5;4$cntZPe)y*H+(uDkCZ7X|TR{JK10h(*7 zi8=2Vm?0#LNAAO;c&WBamie0234ee@SN-<9hz`6!kEcidi3yGVFn6^L_!3KE=ScF- zZ5QaLXXij#*t3IGxkvoMb&U^3RxOkiD_`OQNU-0E%FlrP^+Y{av||^JSzX3SEwV4k z98p3w$7qYeY@?5X4Rg>?&Nj)%`23}&a#(1oy%l+Se^yVJ)iLzV0)k8!T*e0tXjn_^ z834R+%X z_!u$YXb;)m>aC&Lf+|8ff8zsUrT~3%JO4iH0s0P;WxZ$pqjwZr-E5znx((# zTik(*iL^6=MG|saq|zbiI32T^;E5}WQ;qH|a?N$~wIX*do+q`D zvmWwxxjS93;)7X2Hi~LYWiq2>lS;9g|6?Rj&O7 zk&n$TO3%d1;Z_NZnR3&|gwHt?gkV#=Y#6{xwfw6Nb%edMt876tzdnKqmtG9khneHe z#WA{#wV?A>Lqg_f3rU_PoQFHD^(TGkQN68VBubAhU3OCDu66SPrmCeHRivg&`I%~& z8tNI5-i?!*u(HFxfFnyW{mz?iwN8IEK6@wbS0uXtN1}Wc!Qxj3f z?KdGaSYUBPhtF9%Whv_r?4Tr+N=LSkw7JU;~zh&9~%;F?^QydA7o*K1A zZ@n*gAAW&tu#}f=8}&J%2{-t17m@Jw+_NR$!9hAuf4Pb}He zb`+&x;hfadla=C|9Ln$ByBE+%Yc?^E%J z2-Zm47~&QMrly2ChdRmUblstq@~-D~vXQ`TXF;ffT0|)O?Nae8#f}EdEtW|T&dchp z5&!;xynGyMk$`}mNO`h*AhHVtmOcI&XirKM%|0&YX643#);Q%ynNM|U$x&SzZvN?E zWVx?x3sOzE6--M>=2-LS}ZuCG~7a#ls4%SVgNCg?K_?BW<0XeILpKY%sVVs zi_pFg z+WD*^6ZcT#-|~YvnANvKPD30ulX$aImJJ`@?wldd+imCsBqYXjepFIubX+k$9g5pv0c?t zw3icmnesWsKCRn4bHc587%Jo9ZD2uO(xJJJN^B9?wHfwH^O)N=>Q3tICgauNu`Qdw z!@QcehBM|Y7sP5$;wu5b_}dkYeIOw7zoyjTNdB?CeoLy?mri|Z{ydZ&SPsqbeUDA) zw*m77LAbEmy+;~wOpLSxBkj*6v3E~xIBKjo=Iqu5K;$dOAQ7Ts=@%*JiER=qIx>`@ zyUL(3Y(* z=SihD_2)q2Y)f^WnYy`rCbnn2YcQLSF)AQwFhX@Qz2jE93J_rt`ij2@%q+WnXnb`e(33E#ng23Ts|POU!iHkTx_3R zAApuEWZTAeM+^Q1k4VeML~t~>umPYr60Z(X{&FIvSPjyIdWL9{f>HHF*kBDy-GPAr zRIfCpK22rH`%aI=us6E(Qg$qqJW;tTcIZutdf3$Sp(ilcchxAsD7%?G>pM2xq@iaN zE+tL068TxZfuu^#^h>@`s?E&?LLoOd33hb z&4j8MtR>sDPW;$2Ovxs(8ias!7Cy$k3|YO* z?=nrV>Mv-q5SAYN2M-kWLuyB+h{f1XNuP&QMD__quQ@)xxnZE?jWl*DL{YPqd`|uR zS!+t|q??MLh`Eomgxk8=)Lhu~x(*?Jip(M`72g7uy$@M&E8hxTm~qf4iAm@OjWm~> z`r>4HQz4xoT{BC_cZ`JU*+gDPu~XPU4G|=vw8JO*%9ur7wr=6JMvhO7IzKzAC!oZp zmsl=jBHf{1bVfrA&hyPXMUuq)a(_ga5Z$hLEWfX}$voDY(VCvCIO9WA_%HPrU``x8 zP0$+M3roO;#z~m_S&O2HDLkUqdsNb+LJQ`(`15MkpCZSV4f1wG_m|SwlviL9Bla`L zX3}e9N@E6`e1CeasM4k;VfM_2S4j}=pQT!YxN1SW;^5Di;eJT)=Ne_ue)shHUj&&; zi(qI-zMJ!y-!}B8R@)h+WQ6D&o5-b5_j5z9*0HPnhzo~az>gFfW*X0Zo3N?j9gpO^ z<6V7NU@Mh6(2eL0vIynx-%Jb$)QX@UGc%LepX3bL&W}Ae^5xZdlrc|&+V%7xC%`Ah zC6^7^IoXHS3+(Y%dDZs9E`TNP>iU0+7uMbo(S_5sP9c4RJIYPp0iV&aFC_JtPw!s$ zVgo|^m^>ovR7}gsj2|b}3Z>N_9ue<_cNb262|M8sQGP$ppwr{Y+=2#g@z?0J(#EDz zXz(Ss^68TR)a}yfZqW_XRI~A^E_eOOg#(SIB;v*nWcVxCCLnIF){)@(=Eu?1GaDg2 zFDOX$`I#*X-Q>Vj5YBiQH!8O}-l{hU^2HOSBuCh82CB}K$*p4y+4-(6#3kJxm2kI$ zey?pmM|fRo{_)5WW0FhAY`;rm$d?MukEU@AzRS~lV0+KHI;?i-qR_oBNDNkBwEY(i zkF&nTuu;i~9ZQI$voA2u@7^rCMlgd)PFpLp1=7JV!&*Z*^9r!=Rj{|y@A0-<9rde~ zf>7=i-p;l1TV`PLaBT2z!u+Iu^|C#gU;TjodJ^Y?2IQ;AT60=Niuw|*vY}24e=r9x zm`Q~kEtvnEP=-F+lhl9rKrQ;%m~XIVr?T!l8Vi1++@4zmFb;vzl1FA8a=KxP>QvlT==4$6QmI96zJqH{o zWGFxS%|DoLxO53iKA2@09P6uO>kTEe&V3O<3L*n{kBP6&jF@bE^kS$N*2WaTPyK4;_DO^rqR<|sPjLH`EIdH#(3kXnhsmbUy zo?Cn5=7PWZUy@COFCMGZGa3_xcyH`lPLATKi-`41IP7IJd5<*t%6q|Q*izqT1@2sDm&fzI>~9mgLJmp-J4(8!;Yvpx1@fUIenWkjnQdZ$gkVBOxa-1N2` z%mCW4G6@f8|L$d6lJTab-1FsD%}C}*Y~&Z>Sl6)z|Gl7}i4rk~^ty(+b13$7CFCd* z0`!P))Zpj&IB|5!DJ1r6)vF5Q_t12jXMAk$`GhMy>2EZ2@@Er6irWI~FMy86)wtS1 z{Y&jke^c@TPcVGkOP(CQSKV{>C7nh?h{!8dlm)8Dy*##`$s6`uPKyUs?`VXSQoQzY z=Kkaug&A&6+vAQNiRK8u-8K6GT*};aB0p`TT=Vh9bS5xr&SAqEFthNr`+fEff|Phc zxY0gyZN|a(U3FC3im(nXaNX|HEBmu*Rj=07T$Ww8_H@OkprIEI1=l34$6XBzmAGv>qby*(|Us zdZ>vh4GfofgxKZ}i~h@2jd~Yu5oviQWLKf%``FI750SS8LE`XJDFvzp9tCy<86$C$ z+^I!7x@o6oqPC2FFt!k7HLeNB*M6_m^>zD9uKbS$QJwOy_WtyIM0lrEMyhyU(FQx(XW`pr4Ccy+__GE3zIU3qWb8CF zw%l$0ddOv%HXudQaO%N(&%!ENNFX7;Vxa^87XGpsZyrE3ZvuRiw8xphb(; zvO~x*#HurW;rSDz@9@xp9i(H=6!LM!CO(9u%0KoLK$ji{C@UF9xDcb6Su?;

    7F)CEDQ=8+0~0i{x%)x$vTZSrk z*|&dM&pzKg_OmIw_c++5-VYhcdL!|6(FZ@Tz04k_U%K$#(&_(BGb3DP~R|9^3NExUuoGrzb2LK5rH=sZz zEfh@;XA8o=mYGpz!6<_RbLs+PfQXZ6pv;L3Utqvo_z7j>1(0CG^=$p!AkjcKkYHwg z9_TM&HwcG!J|6c{O{x*{atYQAN+}uEkj{q`Bq8JPHTm`>5k{y;`-x1jG4EHR5{+F0 z%Eai8-7W++=Joq{lG?BS ze#G|y`cI6Q9LK#qF#=*jl-7>AUEgM`>Hq=rsWRGXmlB@%swDUNBfsN%fd; z*sy=LH#u^9JKIAo0@s%4Z0{?8F0*}f_t5Pibq#$*N0shbC--ca9^=^_f`t;W2d>BP z$i!NqKI(*eV4)+*b^7l$pd<&3Wbq)28hka3UoSXXoKAw!Z2#0;&ingH{(cP^vUl#E z@6$A4%`KLV26|!Z01q-=OVJCis#{_r#N7D#^&jzI8h@~bPi*OvWJV^NS(sDJ>2wS1 zgC!)))YG!%Z^XK9X{C9THG!027#NuUJory$s_cFlIWH1P7@Iq0? z%otRu92y1I%e1i>kXBuX4_f#=cc$OZmpF;gKiw0p#CdKA=vnCI+l`PuCRL)|96d~BE^zGpd@IyvV;yYr*gDP zM46K6KwIq*d}j!LDeg<^o>&Z_lVuar;aHo;k#xVj{$j*FPHrSzWVjzvcc10>^{U@!8@__ORmoN z{4bW~jRUIkVP8f_|FnE%zF@wYVvuLcTxI~<3#Jcx7YA$?^(B8#EJgVdSNQh324gA8 zM6lgt*WiBz+n>Fbe|fzLtDQu&{GGu%2{E+2M|z+OzSwJcv4;^qQuema4bbtWz)m^> zLQ)tO#v}o;bz?Fw7UM(iBBESA>MLmJNlZJq=-t{SY4O8~^jaGj9od$b! z8Z-ba7QF;ky7Q98yat4c4+yb*rsSQz=QWJcQ1E5jjg6Gc4@s4!Ql$=o3jIi&G;yXA zc1UJvXebRI9TmL*ae)c_PXAhj$^A}m*CM*(D#rbeq*csFfT}koi2Jg6XcHH7MMvAs z!FtqFzo>MpaDf%k3y>I?AQ9@1;{GT; z^wHrXM|+2kV%8c@76}=kmH$!{r!aN=<;nmLHA4bw)v^!7;xUNak?j%RQ1`tKKa%@W zVL%XnFoCV?zglE+B=;77=x#XEN$dw1@Wvi%+Y196+jtJ+t3?p_vSFmCvQey;Nkf1V zI?$-n*aCDBGlNZG0O`6X2!%v1Ky+Y2TitI7VsaP{=;droek?jLY!h@A9Z2v*2OZl4 z9l{%&^448+Kv;8NVnOcg!jE}{wpZkyxDK2rej&D-kz&0HWfY*A`_?=$!vkjM^?J@& zCM+h~s_@qEU{6~ zJ0kwg860H{#8W}*EIc5-7vyX=AfC|rlPRY;jHr$NEY)L{GN_V!E34?%YXHVLJczjq z^nk+~2I&_&G8nf<0Qk~5BHUL1vc@1~DFT#VdBSN9{}&)NAZ|g~e;X4U5loaC^gZ<6 zDQ=&|UeL3L-d`?ZvOobuOH}%37!XC-0pz|M=&$7viF_Fzzabu0glsbQS(Y>3wuWtDCNg8j2BwG!*{Cn<#H1 zY%(-UJx(zYoAxf|^TRBpH6DNe^ZC8aSI?5-mwx@tp;zW#3%LF92WxLWDEU8nz4x_m z!qvy@a@3BD$=syPX^q*)jpc%Qu!~M3w!D0PC?|!D{Imsm_s@Xj<#7!jUu++S#7;%+ zB(X#1|81wab$Er=k740_Wd-}jFI!iC3oLXI4+~h#ht;CG(Z4q=mA{ts>7DoM{wevN z>~6Bd?e9*%SMtA*zr=q@|GK367O(^?|NiojzM^}oYfuj~d05lpCrpW-=gy1y|BkAi^ z@FmQ zL>C7ETL5bx7H||UF9Gz&%sH0$+6(^|z}T9gz3AUBC0dsaGRWTUmv)C=j1^R-$1mPe z%QKW;w<)MzZW$y)&R6RAde|=QijP1p;)=Nl2;h4<_`d+E)&v-)pQ<%EetS#Rc2__? z4^xLeb4X~5U*ozTHS3hP7O#w3d@IQQ9Y~bYgduZhm+^pC8J9LKpq~ ziCR;-Xd@V=p91NT0x{I!-mW72e-XnkwRvMCYAus#t;Ob)5@ju`swS=Bm<5SMmOY^g z_kyAA#$giTXZ?JMchUXMN<@pWVKuzhzRBG@4qw71+BkqQdj}kM2ZOK7f3OJ4O`$u1*QEMo>y&ZkKL(pOMPu@D{QJ48* zRE{0X(iSyftw5Yvxeln3jiT12K`dMYZpJ+&WU7g=Ti)R z>*zRV8Ak|S05@yGYZ(m%*hym7owenwI=`0Z_vZE8dB70@qP#3I%K4doTSx7;pH5xV z`L#AqWZ+yZ9UN)YQ(-V z;t*4(AH>P$u~*yB`8IYo+YIlmdVzc6ycMx8>?ti_u2njnDo-DvdgtL;?|W$H3%U)j zSO(+0UN2xloYy1vr4cur>-43yWslBZ+U~!Qukl{17f8v|zLq!fL96p?Rh871uNe>K ze$*iEWR$=5fLR&dyY*s*eA;(=+JxVh89RSv-`}F!;k{Nby6oruTGv{>vW(8JwN`3Y zg7aF!zU?{)<&WNdTZHPE@C9@o-o)?Ib!w)Levoi>$!lM&{6VsL*jMRO-#zp{-os7> zP2$h~9q+5_MGMjmtRZ$x+|LB-mwqXdiF2O?fM>=D0_IqAWB5Gw%%zxN=Wwte5)#$$ zJJ>JG5NeyHE`?^!X#I_skTL-#L>S)bKhM&3rA)~B5e=YtlUU5AQ_TLU>-;~j;stTv zHr&s&!3mhZ=X7#W=dyCInwNAZT>o-;fsaDecK%Rbp40hYJv1~o|Z6HKx zDK+gM#H?%I)_I@VO4_k1Xl-LVkZos=XG$Om3---_o61Q2zwj^rA3XeTnE;X!lK;McDffSzuYZ?`$^Ov~U?2hD1C0MS z_krL6@U^Y~#o_lawEr6S`#((S_^$-kf7Ofsf5OB>D)#?^{I@4b#KU`EM@vffUsH|# zwFu$=2ax}}^QE`@R0FRRpn=B(7-4Y+*e4Ru(9d3`YQ#92L{mMc+E%A)lOiRed79`! zLg;6l${Wr7;t?$gH8Jqr#xbuQKFJ$BZgl@~MpPnsRsqW}4^iX&P?CYU~A z0&g^BhYXgYy(u-K0WY{|*d&4b2NJyITH1Sq{Js)vG|vf29f1$~o%wd`XkMiND?zlS z9!zYSyhMc>)cp}~5n9S>sszWmr|?k+x)?d~*g;A=>cr%sC($-Sa~UuYD=m$Bdfbb~ zn$jenv;jx8WSXeNhfUE!mqm-TLTc{*N}Q@O`~+V2_gaga9siB#zCxZ>8BoH4CI>)U zwP!N&j(b`yMu3)vEeG?;res1`_|{AtoUrB_zWqxaaHp$kE?tc>n8^h?tP%{s>5l_s_@? z9{#=d1`?2x(|G;!w|_@rXo=`}0L1i?yy_$jQl^YdeEbeBe$l&+q-8bC9m^`-%`Y&6 z1Z3o3{=qRXva(U-t#hPg_jZb)5Lj4VLGfRfi5c9&(#qP#$=TJ--NW-)KwwZvXxP8j zL7;PT^YRNY*vhJETuozBbIae;3jfzarp2Y@mDRQNz5Rp3qmRcYr~kKE<+OieBp@Ke zr=xQEPsjiQT0%M=Ng{e)byJ7TFT@OtQhw28jqm0j!FHMWWHfZ{2R8XXi^<9^ufXnI zl92LC%b5kfh;3>am|r0Kr-=m;_$PST|3LpwvkGqhH+Yx7u?GYN-$Rf4yK@`$pUD3P z-rV{(?7^YokS=eT01AU!jGi7633J94e7j6aQMeIKv?*vf6?;ryBq0s-oGI~> zG9$?%E30^^BArqH4We1by&wvZ#`@5P;cdJOzrtN=K3;1lo0hvG$vkoPtyn|v$MXj8 zzW?4d{;Rv-u1l4oJ@6R*myp+n?01WhJAxp(lU?2B2OPmhv1{8*)=zSuJ(1IWhr0M# zkUK0E?z;W3L{N6(KT8*^u;`NVHzOQDZgey?B|hE&n6qjG8E<e4!O_Z(S|Z<%>B`SM#bX ze;$qP$tVQfr1O0rW#3ea6f%5f489!wkfTffeCjoavr#(q&f}q1@3pgU16BwflFoCz zJNk`j8x}k3SYo#SvfP?O?59+ZAIkmabxzi8^R}!e@e4^z!8Ctc$(Q*HjUrSlsFK13 zNcD968jPibqfQ}xPXk)p(h4#)EcBM5Lf~b)(Lar*^r;r@$|l`!M|`mh_0)#hf534u z3BqQ61Eun2&_!5>WuPR8EvQim=}0EM{w%YRx7bf%AGa#0rg^;7%1A^C{2{!42nxJd zH|MDWM*Fl>mz$oj&mu35Y5_T~13faQ=!+ zNk*mq*9p;Y`Wu%{a1H|OGMQ21xKU%(BMEKGDfcAW4R+%&k|GHN*Ed!B2-0@*mNYB} z>VN_n833?Wx;Z%;2K4$t%4(MO?WzYUOnvp%X+O=)THSotKY?RLAUvIh9jPZF5Lka2 z!@)dHhcy8jnre88S2OGv3rlckBTpNZU+kbs$Cm!md4?3`@cTSc1Wi=?y5aHpti)D( z0|u_KtC3ec3<`1NTF*A3GFN6TnWDD2islw&_+mmAV(6DJLt$A`H^*b-CquOg7V9H7 zINFo-&nnI7hnUCIBk(wF0X8tw+g`C`zx9KC$G-L6IKr4o`@iCd?2zv?@Xus_9cNhT zNP<^ThM+CUfZJYbTx(0QYdmTx#bkMVdyApMJ_WIZBb&&)OdjnH#>?^tJ!;+P=kCpTO^YmoyG%wZ((r=j7jCjVi*ivz?h`2}^ zd#P`_MuT+^^|L8>)baR*0|>pn;W1^Tm$HEY7eiR?fWuausUD=*sq4j-_7AzPG2A@JAT)SIiqwL{zKuV zWDB33=s4rL*pz{69P8*bQwwIn*&_CZ0Ur&jJ9pkFbR2}3vj`ae^yZ3Xm0xB`U2=h) z;AKMUPxA*-@otn0f&y{cqGtU3tpg742A{5?+Zf=Yh3r`nm5AG=Kx~XUaYjG7^vYo3 zv@Cynlrh0jOve>**G@ieBHj@H)t8J%T4o{&Zy2h+5JbZ--PJwMI~l(#nYA(L05*lf zTRYbE(~23b&Novs8*kAJqwc2#p%hKnED7RxiKz}Y1ay#U zDneor&czGMS3_0qVkKww-36v8Fq?w58Ak8w`hhxQA8{i+p~mx56z_}Jz3@H|z`!9#?ZpBLdeRLiLm9Jfbj)=MmNQVleYf#A5W;(CHVV^q;^Vwnp#gaCD~FWK&Xmxq z%;n7G=2EWJd8z@xHm!A0QW}assOU(pV%5V8pSAGyN;x!)rVcz48`e$-FasiiN02uh z;|mBLQS?*sdtsp^CsJnuMJ`^x;t<8uRS6u?O{x<@rGb~6^X|l?@_0!DOkEA!g_byd zoN981zge8RO2fN}=s67}o1Ov;(A(O2o8f^fV_>*f{Q|j}h{_l|9S*lq>RJ)4LlCIY zK?E(QEo>hEKQew2XCys_98gRu_?nQk+;co-`;}`O8qQIvbkh~`Pg9C@$x;8#!`QR? zTK-7uW85!j=SOX)&2T@>RR6s1R>ov1_d0vPo7G1QeBt)ojWg3U`*o7#UsAf?n6`lQ z10`mh23_*Dw=N<3Z0DptVuBZLeQum&apoWM{YCr_rLY`Xtkpz$3M2&N((9H^fBs1+ z-AL?y273la5(q6?R5Mm8IGNhX^My?{%~sUONlY^Of24X9bvLVF5qh&>CY;r=o`~RI zX+sgpt7eLnREIwAd`m;+cmE=KC+6rw08h&J}fbJ`(-%0~c~L_*H{MX|VkCJ;Mh=BLd6_ zNblKpbDyx!Mv!z*$Ue?RwQwTB&;EU)p5^Q2Kg3<1BhuCRXPz&r{*&Sd!##zAYW_V% zk_{)%;rYxY?p2}FIW%~?mFrIvo7?HWZRLm<#T@#RqN-6A#HPG%!lfFC23lm^1eYO8hN_|4}BJG zFKd`xaSqySF1BgX_nEGHX=Kg?pxQFpjpp7pu2nHg9uks}TnuTP%WT`gs=Z-;Yv%|N zgc)H@12^{52-&h;x~j@Y1zC#=;h^r>Cuesk!N)mNb^q~lIl9^7Wa_}*W|mG5qOE9| z@FnH=q?QtX!R~I@*56eaXQx#V?3A{aR!e77Rex`H>y|45Q%ufsewEW?Ndz92-(CqZ zh7}1?0X!*X@y?kt&ijVbR`mXC4|!j(YZ)U}h68<9Fk|+k#DclBL6>d2~^0buM9rPKW1&h zxj%pE{oHL3cp8}$DSfm3VcrrG`E0vSyY0=oxGJqn*fy`vK@9!v$1=fR39lcAejQa+ zWx=kCzm5%kqOPj7ofZ1fO7R~6Ejw0c!PE-1A@dwP^U#06i zA4h*c#f(eWk6AzCdEqy!H9UUIGB#a#CoSyCW>4{)pdnwD z-c9~@2_4Zuu|p;lmbN4YL!Eh@aeplb$xFf^bZO#^?2Kj98!b~ZzPbz<^6D)vy3lU~ zR@;WqxN>HpoI<=eMaqq)pB783=3AE}4L$YkLa3}}kGl~b1pCRYfwy5f$T%!U$`jDV z98lp4VDD}$El*`Mq8aS^zSi?V`SnKIN?(Zep(OPZ_@(Fy_oc=gkKe6_*xvG)X}{53 zO{yPLqoXrV+7UO^Uz+dP{aei=F6##Mz4XCy!uG?%zsVSfSuB*Twz?rn=_WZ3Hz>QZ zN@*QKazUBMzA!Ir+IMPFpOy%}cDHphn})j9;k}r8{Dsk@BZHRN?3zaCa%>fctSlY< zh=_qN4n&gT&^1?PZdDK=mv;*B)Ue?ZF@v^VWhunqwdJ-pJZ!hz=!+3b|6tmxB(gxs zaCh2W`Wo62Dmz_L`EZQioKP6T9izma2y&zf#Hz)E`P&Qir@B+OJQm~1p2qP*EJ|af zxzk#r@BOh-??pCFJ6?-89&KStpafq8!DX+)rb;4@qmbxc(B7o|2eTKv9X}H2m}pUc zG(OM#jhxzUvcF|(nCNXvGMsB2qQ2zkiiud7e%N~J_eImI>}Eeqy<*1NIG`L#2+TEU zBIO6MFUi5B`eDa11Vdfr$C#F5&Np1dHP_boaqjnA6XCI-EFn|l-8d?#+LIwVKaxQ1IQCUj+hcZ927>J3 zQur_Ydb88G9*a}nx=R|&5q~RI&pzJy46U=ie!Gz^c2)qs{va9SQT$9>iDd{h)z?{` z+$QpliMU%a4>5idY}b&kf*GYIi2bNHu|up)XNHPyND?$e5@WIsV!MD6{R^El=|Hg@ zPhh_>-WRpG7%Hi%5OA!Ui;R&9>w%$<@PM5Swfaz002m4}@7&G}8D4wDmVfZI#iY{8 zH*ul4q~rS}hkWO}G*XMS6A${bk@q-!uY z-4)~E;RgwcVExU**-soCyf_VSKDETj9XH<0Rs}pGQ;WQXPc}3iSM!gcOx~1JqOu*O z7fMD`JJ6+IId?x=VKfkrAzdS-kA$--wIqWx>tjqN3mOe+)G={7?4AD26Mpi3dHx`4 z*#5-RmrmmF%e$bo-sc8n6r@}aC}^x2KI8zC`ZLobR9P6g-a1X(CyNiquW zsHxfqtC+>__HbT}Ozkxr`-NmDz}M3Y6oC8xJ`2O&ReZ{m_mqhkz zx`hH@0X3uaJ3LUZ@qq&00aLI(fpD{G)7}GHxK$j4y0nh@gM!UuS>xpU!_ zBrFaefwvaz^hgVxQRGYGG_6^?{?H_X$YV@c> zIs@%}iSbhp-`dwLyqOkV{-8-H1bsjb5{l7C2@WWAffYSAXNbXC0c2M|JTm4VR$h{< zH*M%s;0`xGj<0eisvMiUHal4@FinkA(9{sphMgL5lSM&MKs6I$XOlUrJn-W8#WBC9 zT1FtGGMs=Lg!lYMqMlx-9B2dP(-yM~hbVT$MII{d!W!TMO{=Y3EpB%C!Iq((!rT@y z-Ek0ZyeP(g0JmR{%~A@3(9GVW(lAGhw-PNez&-|buHSs#P4&AWv3@YnImB*LPM$dS zdOx08gOls*c~UnjQrmbH^~6%1gGg(dI02cj4o0Eg(swW#Pm} zTU$hi_A_JedAX{}RSa9Sv09qzOSSy?=}7m+UyCj zJ(RqzF;lhfyH_Gr<^0{3&Tm_+?;0dn%Bffe7x%tY?Ne=M2WTTTClF*NY&d(-VQ@!p z_m17;{WD6O=XjIcJm%ZJqxxEYE;zJ{;tQ8h$!xdHhk4SyxjZxi%#6aejIl-saGElw z`8MnrNn=PWn(|-bkm_|kWX*~#nl4_TtU&%gx4xhmx8u6H$(A9!{JyvOZuDob0!jN@ zHxnArzeqX7=elJGtGt(-V|gf=qwpy+qO}0v1e$@yP5Ge2)_PCO-qa+&E*}JV@b$jb zb87V+PSyq?WGDo{_t3>#lSw67$iKSK{C1kKmv&S&HAAzF@Uw_nPZH88qQFu&JiFms5^q zB2E6Lpm@G;8u&g}*c3DikleYid%X|&O8_&kg&nOSh}`z9d__C?Zi4i%=!Uu5;&PTX zqq^GOqtWH{-lRnsNx&akhSh=Zl>}lzsT}r`zqs*Qjp!2qGDLYX7Fb4+Ep-?QX)Faf zf~@}e2xi9m<|~0TDJcVRBrUBQzb{ZX@bT>f?V0c=M!!FMK1bb_bR#m0>H11^uWk&Q zuA~QzHG1)7mVe0EE`L3pEb&b_&ho8*3M=x^EA9Esl3a*o_wY+J39*{L@y=}5$z6{>L z!z%NY>Vl6e9KR%O3y+O%DqmQ)VQOVuZt8V3xTno3sbMU@Of-w9$qn_t$-49wn*ceKGxqk*@4^8-_^k9JmN3FwSts@(- z<&mcin{PWvc|j|`k@UJZj2-iD9#w|1FFAYJgiRwnh>3FO!$TO%&FuSk zi%ClvTy}ShH_hEuS-=dGr%O)p*Ljx*syH5vVZ#GBDs`Obme{oBnZ4Y88@gs8m+8FY zH5Gh!Qi$C@XcqAsw%o4_A`9{gF8OYR8_oI)r;X2Maq2NaKNHF0Gt8he&oe5_5Fye_ zVv-fpz80CI!8##h1AlBii7_vy~(0Hb<+nwsZ&Sd!Jqz~O_|2=$)?4(MQJ;r(^&?%9}+>!VJtdnfI62f+)lAJcoC=tmwvi=lAW2?m}++2@f?@l(kzQ z&QH2(Q^{tgjB(eIk*_oo+R4a(7JV>3i5!iIcX3HgeuL=5_Puhc&qMB3#Qqs#xTdHM zV*5vUEq0SO%_ccf`wWR2FkS2l{IsDYAgWkpj;ee*PPWrUwkxyN{06g9hvT=RsLlJJ zCn+VCe)}b8@Xr-VZ1{?aD0M?c-0DS70()Rj$QcrZb+;meW@#sy@D9v{?v zxW1Ui|5)=mAwB+tq_u8QK1@sWX=z!YIajJ0z^Q}%%M0!-%ma`Ne`;f+*m3~kzU zr4rKp7be*yGPohF3OZ9-dyIZneUDW;Dyw561c*}2@E0no;eMh`^AMG}(k9E*(Y4e# zXmG;TWTs=k)0?h3M0H%;*UhwubmvC{+%cIZFl`d7c8Ip2Fy0pJCSlyAjDNOloOph6 zMs0t{Sgxb8%ltPcCy!M&Xvvb-6g#<;xy?n}_cu zk3oc=Qq^s1As7QLM%y)Au4~ZjB5|cAyr(dX=)E0xTFb_guhnlgcU&)Q_<*5Z2)Hqr zJ^-`xMv0b!HxBqgm=cf14c1mH-dW*+B<8S62>lde_9nvmOMmLG^Aw+q`9g62i$L=- zKva;A}c{Vsm*Eo?fBIy>o^L}#LUDia|=HW8ywGpP7ASjeQKb~W{`N2U=>Qyh2eky z2p|f|U?66=W;?f-ZWn674`oTm-%HALZ&KXL2oZ`fy=`2Oe@GYhzBcr8<0t#3Ku3#W ze+BAf)vwSelY$xFE70kDF_$#9E)$W4V#IV7AyY!J+c3OP?pM6~(;K{qBn^_DqK<#k z>pbz#9*Z!Y=pT67{R^7hvNJ7JZqk~d=?6^>oKa|FAifS;kCx)Y_Mu%PG-cq!u3ZafPUq~_z#a{b-;zz8aX@AKO3HBdO3e6Xtdrv2)#|7U2%8Ik z;lfYGy-`Q0*cP9Wt)DH1)dZGOJ2ndJC8|r@&i}N(6Cpy}nroNkGGwc{W6HGHXw-*% z22{_ydcI22pyXIvq}NSEf&Ou}m%_hvX2|(#Q-h52ccQ(NLyx-0L8EEe&)5#1fY5Ac zMz$rbY`f^ON6A{)DR$Dz_kON8w&ThIKWuaaVTWd7XMZqu$Y8~9! z*l|!+*bBk>ahYkbO~1C${^06PV!IgFvB~G#{U?X(ddLgXTZOC%zK=|Kj@`g(b3R+4 z(%egrpU=G-{QK^x$N0(gp7H;BJlYv_TqT+; z8QDBdCb3cR+2u{E(S`XduR|MxwE$kI6DANX7+1IWSj#Rwj*DX&Sp7TYmQYuiUv$Y&-s2LtSm8VXoSZi@% z_XdIGsqpt=n8a9h3Q5U~@F!}AX`Oc|j14O-B@GI+J^YqFt<&yHy3u52a2a7C@As17 zl>L6>M1uxfCb?$Oc#zjbG9Ql;*JWdy(|Iy5Uy7*R5)YJOwKm#{VkfX5%|xh+m>2xSbLMh^XOK#a+{AquJYnVq~u?IM~KwxnL0M(Po$x}(=Q6G3Ff z#CO|r#lNwXTm-?=$yG0=5(o1n(X``Wf>VA=$-k1a?S(D0wvh6B4c@49=MptUZ&oA| zX_UTuRmm~$JLyR}|9AM90h$a+1%OfKfqmS&;2w5j9@5oay+y znfHh78auC-s{75)I%028zD8)ad@6&x1}BROZFL(I)a(ev$dHny2KB2RIv^qei=^Kuvr?Qzj-XJq)%8xv2A6H{!2c@KbYS&OqDX$@QHP6Y!{K=tspv=(W z>MVBvqoD5&06t4kjAQW%wxTPBRPEVVDC3s-rQ4sFt9YvQAw9jvT*p_0%~7rshS3Wi z3NACETsdZzcpo4tO>*DLNjul>zA;py=3!FRTzpdlOpEOw5hou7?8LYWOnJaiwM|qq z2eIqDgvq8A{!3(Yk>sT$TUw7*pk*Nk)oKJqY0a=RYgGo(I_>lFhxaz%0K>za#67Y) zT2ye zSN7dc7s7eL_R(Oi%`E+PP;uXO@s4qO$ey#LSF~DND0MR1$(;Q|4GlAoH2_82_@5uG zCgz`hny9-&$~*{p*s^BKId<$YzYaIT5bIQq4D9{>tGDlQi9i&05H#xZ2x%2Uhu&O% zlvzb_PV)VypXG>Vo>sP zQErvmc%6}DbPdYJDe2<03bOLDZ&Rf| z#U@i#jM6vrG&Kz_QMgg5dw0Z6Wh9;`4%TA`oc;|+x1x)V|O$IpMz4uvt+g~(RtgZ4XB4f*k;#0$xJl+(@Cpd znkwhjMLV^p_@X{iUgC57g0Wf9Cg#roK(HrJBo#L8R4V=pHbHt@Ylj#QW9$Bu>G*Jlr1!~N#F-N7 zRp*PV5SY$_;SK|F1&;!unRI%$#KXWfbI{qJ)VEhbIb>Xgv{65fXrKOa8X6>WQcS1D z@#<55rW~W9XmaGAst%L`xg+tIWi2I)t@wqf5(>?NIW$N{Vv}dTN$k?%Jl5)`+cj~- ze$i=cr;Q1*s*i_+#IL7m2TGK%zJ{vOTOI0@PzM{uSo}}$$;T}jFBLJ#rBX?>M|%4tf8bIz^vZd$rW4Uo?H&qN_fmtTUrC!{zs^Wn8g z-l!~L_pzqIstY`a{9Y69c4r zpNuTop+@F56Mz@>*Td`np3b>86j5QPi>@K+AHsXzS>IWLwoY8(RwZTbymg-tSs(J0 z=F{tpH}NGTgY3WdYNq$@8v4~nSi|vMJ)t<$6LJz4Q(ETM9%2gNZrOuN5(Eva4{@aV z(FB(-Ijn%^PHDMDk;DKhY`c7Pl^P)eZLJs+KCm~k%;#QJXzN)<88poO+|%A$(IoJ> zs=SG9+oLwStHVvv!YV>g44QI+0B(|QkVe8Q6^DQRe1miUlx6sdy-q?)xm;2;!os7W zEl09DI}c)Ku9)H7OR5K|d>7QXyqVs{9;A=qSifLd%PbJ>qAoe<6AX~kV{~5E^F1Y_ zA|qqY);t~p7_siApC{2!BuKf?l_z-%GD^ylClfvtSXL}^w=qoY0CDL~DYVmT2{>Lml%@$(WuV^4irVKbEhWzM#()-+xWS~1a{Vc z&HHDGQ^h{f5Nio51e+3@<3E(HT!sY((!{r5>@o}d;!cwwycK+!dG*3nPe0RcR+@7S zE_DP3F{Z*$^73T_F)+PpFEHDWCS-UiwZ+z?!%;F-^{8$>b&E-$U){ChZL;v{J`0QY z7s|(+eC(PTFNx6xBXi%yz`9D_Q+UFLG4LPfdn^-0LjV*Zr)BkUuTVQi?|RF`YmIZN zc4rIUqL4huAg!QurAaB@vfFTuMEkbgT)9QCKRo0M1&OrslO){tv~`)s_VzniaRu?w z^qj$@C31);R!e-@SmcPfw=H%!Q{cSXucabECTJw0H*q1%yy9VG4dvY{4u=;PY~{Z? zAhz*peyzAx<_wh3`Vb8rpf!=BjqMdm(`eQ#0chY^>Cz8=talI!%ee{lud@)Yr> z5L>m%V%#5SXFD~I?lQ;DzCX1DEjWX9)gIzhESiGG3PnTxIH)ZD3{v1UUr`E*@Ko+H zi;;P(lqBw__C}1c+8X@UU#Fep=RV@jR=QQRDr2XHK>`~*>o)oTSs6E&x3%$JfzfSE z>JwFh7_Qk@E1yam*Ru-s^oOBIFOu*q$II|aN!lOH7(VVISUko4Dq_QgaWiyBj}205 zWXryR<*L=_mZy!BuxvF=VqL%{EIxp5KP9SHSOy=xaTK}nR{lx`_0lLQ#UUrAR@1AD z8eD(}=?x8G=NA2ukC>TiQd-9-Z(?xT2JK2Ue*IIxI&VmD?zl0K2 z_~p+N$^EqI18$kHLZ0yQ!wW?2eNh0)5UZIQ6g~KszCapiZ{gBJ zs@L__?S*G=DjBEYFF8Lxv9ac7-Q7<5>%6wRFEhg(I zCWhLSdBb8o>y=b(*KaD8O%C4fedrddg&x$rz`>O$ueO^8IWXXlqdU|k1Z*=?M+@H+ zh~t++u)8ZBZ`}H3De}dYeRxXu)3L}HW9Z&Gd3u8_?@h9ftLt*0cn<@NN=|KTmO{SF z)T620H3wZ&!#IMPBs0;HHj0p;NHmFsn@@5Ny!+0*| zkCX!*A%|8RMHQy5Mr=bLt9VUt@Z?O zSK?zuB6vJPpGrP_;<6fhM{2)^S1GOX{=LGbMrSW+YErMJML^d-^!}%C= znUFw#U6igbCZ&*^!8%D=yyla#%Ss*c4^k(ng(YGn*dvqTi8i&7%;jkxfaj}RNF#pi;w&ylE&FF>}|L(<77FyLrXvR z46>LZdOOs{4R!%=eua9aQ8CKn>vzm%5;|9?pFa6g+=!+&)q<#Y$9a4|RhUmB#=RiJo5pWrAArO?+D+!9 z4_svOlL;+y{shLghRm_)k{Y4~eu3huBuvPgQ}`+(O1)ghCiQ!+QVhZOMK42H4LgI4 zgRdNU!#vImuO`FZMER*cpt-nZ_z_(B(gS`4V{@sTGbv1h;_aHsXBiR_y30S3ARp?8 z8^8q$7wfas)GLb_irWlmrpKv790A1xgFEKscHsD#l73>5ZQq4WF>w7ttyNMk4T~5;U z5Vm>w)S1Y+h{!4n&n-BxJK8p&nNIZ*9Kh1xn#&W*&$_JEMeDrUq1}LRPN6@=DK4Wc zlXOl(Yi|awx~n2pZb)q{*1Q-!q3N0>pMF^yg6D%TNSCG+;~xs`fk#ZL%%+ zTepJe8k5Gv*UzWWbZ)M@FO*w*TnRP+SMs3L!TBgSs^ur@H4qj1X@^*4FaJeWW)*Iw zxJ~3kGkxIKDe0u|W9hZmd^~h)p7qI&#t2yrL48dynJk~8_KFw#)e3r4rPU2VE3RAe zIcx&5yPX@<*b3%tPXs**j;H*=bpvh*KzoF`jvyab)|vteU^q1yP{I6H@njANv$1BJ zSpjBT0%Hzqr`vcv>N1W5WMn)OD%LZsBa6FP7dA4k+_cyj+iua&QHtWiQy-_JHfR>k zc%^(v;(vlHuqvQ*YZZ^LV`Oj9bZ3-iTsIX2m=~no`&s3Q=CWqzl!%;ehG2_$zRAQ{ znfV+y9rpNX+|)2xUKwmIsDxc`o@fjc(jn0AWvzNFX;txXL>fB2BQumcfI} z?JlyarqZwawDF*C*QUg-3r+dWMyPWShiscw^n|Qra_OxWN%?fa1>7TQIDl1wc+$8F zlC`XPi0dM|ZPU%yvd3bVPk*ol_@64;WEG#Xt+EhinwPSf@wG(1(Ktr|||K$xC| z_4^8s%^1&9pH7xnrX3$;wk~94cgg3+zSItV!-3E3S@Za+=0a#bP9gE8t7zF&fKx7% zZeJlHy=7ukqfSp222*cjT6cj$DH%*Cv~WlB?(lwRb4DsUSb81{A z9BOgBLU@QL#qF_Jb`YT!)p%OdR@6yH?W{a3RBz1@Aid9VdBA5hmy0e$o|rLidP+oZ zNzI+GKerY-DHOwE7Qt2G53HrD`I;oQ`mmd((VWAJyQy#D9)-PE{4SD9D!I(Gmk^`@ z3<%&l;nV)6ad30s{nMkg~i zNuBqW%-910qV4xPpJ$jd><&A3*l6+QdC4BX&d>=iGzwJyyXa86X(Nx@W~GxD(op#H z6+Z;DLsuG};oxSQTI(>%+Hfl5ALOtwyHXAn0D=Sxnqe5s);}G^LR4eisk7nVm4^vO zakgL6690PCebF6!m?U15dv)QT=$P_YbMK6LEqgzvjV0SI&#CFB(g5RfZgGY2UeTSR z10scxP+*1o3HseBCkn$*IIhPq@}+d=T#LVafpQVk7@S^IoTzi7HhW^r*?-frm{MP_ z>yrB-j=i6|a9Ej`qq@R|Q3~mB_j7I_sd5qgbL3^RhgMhISj-!=@Gwu%1O)Lks;8}~ z&VNHl;!#<=9rlQBjgO{=?OW1J>mO%9ZrGqi+Ce3R7uL#9%NY+gR1t(brY zR?3u2M=3c(tFF1tNJCx9N52y`RlNk&QG7uv{>3wCrz2+8xtdvH0ItX^SV#N(JFhIF zZIgw8zT-&cG6^^LP@B( z>n(m*R9P%;T(n(NIko49;vwqE$e{COzNPBiF;ofeO(fEac~RUiG;8C40~zILqG%S{ zK9!uAaL&7b0M0hhTxIE&D}Gns8cLO3e);TGy}Ua*T5uy_TAlde@y7+Q=kDl3xDCt1QchR4y}^}3#_ z=nsCYx|UDDjtpR}xafRD>?weoG0B|F-$YWeZ86xRM z*rGfMX3Onhro8|()FV~~XAqIivr$X8JfK`rj0sCTY-@&sO;p1YV+$T=#g&_DK2cE* z4>tS7I`~W|ZWF#`l(u)d#DmOqy;g8U;Tlm`#VT2xmmoi0TWjSkV)m_y$&UZ_&Uyp!!i*wJohE)C;Hgz!?|VjDl!)EQQXG7n@auv~=}MoVH|L9*Nr~5ww+i;-Zxm zRC@9|6J3G=((!X9l#BVD2C-X0e#{-9*kTfsj@iHX+?8A{cKF@il-mMVt)~wQ^S*3cdVdN8)g%S! zBr3n>+`2Jc|pgTIDbr;8lG>pMR)Vw2+I$m zqi-d`d2{~lfwok96z@fuxs`nP);+k}pi1TF%t{QM0%zKi_gZ4E+p$9zWAs7du4*x0 z=7g}g+L<`}AgN(?qEfjp@0EwTv}FbG*@O!6Sy0|Zo$aIcH%#1`nc&Yki(PglFM2FY zpbR#%hp@O&Qx#ogmpa0F`i=5mAD#xD>?r$fK9O>tH_^Z_4p@>0i4J>qj+VY|=*LNL_-umj-V(N^IMyAW7DpO_fo=f$LYM4t~- ztAvhHKCAKx&>n%Terll|O1x21pFs0F{@7j`R|FF0BYO=rEV2w4s0Cvr@(v=0Q=L^O zNgo1F2ats4q>CG4Y!`DMfiSqo0}6iu8kmbkmHrbN0mcmtcm;|!0GL_Y*eH7y^zzRc z|8c!-4xPwUr_Adl&=>H82mfrRKIQk!rU6}uRw$d*UAO{fjk4^H>KSC=H z`Ey&nW-7P;lh*NL(W@PE!fa#gm+!)`7>$l}+49OFC~8+0(y5=QrZU_1JJJe@G-aOu$B2LA2fy!(c;V$WXfk zNKQ*mb`0ku%S7S7`OUvR4FfUA*qK4CY)_rp%TR^&YKJC7>p<;h8rkhYb?&{AO{4b) zL~O#Vd*_2G(E6LzTd!<>sn}FHFbwVsMBkVHk3{7;?Q45J5*>BuvDlE@&_`ee?o6V9 zI+!bbgtkap2fJ;YR0TkC4An>FVcWB%TE!T5^+ zBLzhyfGZteVMSERpTkag@Me1KuWJcx=rtM3b+gQi_X#ywx3PF}9>LHk_z!&rzno;N zZW23>g5hVzv%by36M}c`{yPwcK;>F6r-diYz?Z}EV*9B1ah>BBe49%NMh%9cOTYk( ziI|KnqQVGOSiGwgt~R`<8Z^^{I1lRO(kvXP1kU~aHGGs2GI|5gguAb;$ntsAcNm=6 zLV99(yqJo};Zdc#!g4n^)N%!monlpQ&2vy*4!$zO&4+2UDWRb$`nRrnq=XC&xRwF| z9iKiem=5_skuQKH-qF1{uufs~$}cwqHDj)w8Yk6;BPVg!fVjh6iy#?7A7laMbh>3Z zRy{kzeLG*~wU2Yfr*&yMs-QCk--AmXbv)k`=6fT>rz>k7uImMe9`_|_04=qF8WS7S zos%-uIDDdz^u55AGo_WGFpe9|@SLcsH^RtRrtBy>-ZtA=&ZuhOGONcy^W>>pyp%-W86(^ArePvU@ zr3M>|f?J#Lb$GgZ`-#%6&3!fOWt*#+^f^mkMYNR`LsmEU|Jz>jkG%cs0G1m3hS3N4 zEX3$cVlV@&;iX7a`trGcW+4V`5Re^E_!TN(0Wx&dJ~|K~mviNw-16^Ac>y+yc2bb7Ll{b^Bf z@Tju5oAFCT6~fG>*Z)+Evvj|h)zEvPAYY~Ytyrv~AZ5ypkB7%zS54&oXoFAaulD8Q zw;cSWP?o|&Q^eV`%Gnv#&!GVk| zabz6sK(zsYdc}L_K-Xe3j~^}J$VyE*U-IF-yK=sVz8tk>)U!uOt>oxI=g<4Cq)dEhDQp z1}tzR2x%@G^V5g|ElNx}UlT%`$O8v`X@vzM-aIcF#FK)GY zs#Z6Vb<5A9?UM=msHmAZufY;or6RsqRU&J0!A~jJC~u$@p5j~Pd)CXyJys&%GG8_ZSBlk+aksusj54HiJp=! zstxL!xp?qLtZL4EvfrHrpY<1O0+o>K@f`S)^II+GWn}m|!U-YSPueKdcJxX;O!VYM zvj1m}P?1?-j>b`i0az=*Yk~L_MjJj#Bf}@Xz%RK0B<3RG%v>%yRDxs;r~%UX=5omk zVC!uHTd2^SGxPw6w|e1}g4;2TvIf;gs5W%)es^Exbn&l|V94yj*a$tMaSJB~3RvGK zAz3Z7%UM;2T{HSR)B(^`uFA!AGQ4}+$}pvC+4l`WD{jyVRH>Y}XCj z;aq||W}#R#e<5U4syoCrYT$w{mp*C`3O95wUC>~(Cbz(2**=oi76jYJ=@hI#%EhRzLk4p!N$$vRe2Jv&eX!{kX`i{Nh4E-G|rRo>m#=ZeP!P45D(_|QvWo;Rch><2! zr+=g;|ElL~X39#+WQr~LlX6_G@ia~fj*w&;go2@095*wX-$@UCrPJamjJI}QbQx|) zl`D%UFn)S^RJN>>Katfz5pNaITf6MbMH{iJyV%BWRp6a~pgm+`gqQ7+oFv#S(jupT z)Moky;zQSt$4?hZG-cDZ@EX0XI@uK~Xr)Gnqx)_b%M{FOqyGW)mVCbi_HJ+qhoG?2 z3iu%8NXT^}mM~jaM=mMara~{URX?SVc!3`;;HFMaZ;gy1w%(vL#q$m@<_uT7?v+}6 z!Y|QSUu)X)Y36iBgvW!F+2tuy~Ybwoz#!+08Ujm?pa zOXnSYIrn8UbfO7O0QW2{-+bpxwfz#L7+phUI$Msw3Zx_ebjxndJ`J=tI5UIMmLLVL zumj3K-RT;tNn}vvDs}K7mC5()`0Ww@8uN|XZOt4f4GIFdQKo!q4S3Rm0=ZZgmY&w= znWeoQsBI_FE*T`@@iFh_$hSdKlG*?KNKnQ@Y)65MR#n_Z!S!RU#b%_OgBEH$p0Ay< zo#gu?+r9tOZEQg}qrNJq9UWKpP&A#~pZFA>oGkuoC4kX>Go&D87-8`5;W%+Nijn3* zyYc2C;c3q85AO4InAaqq8~=1dmcL@`B^DseMKSF|Nj`A^&r0IX$@qu!=Wn-94>LNu z58G5>Fhxex?dP#K{A0eAiF2uSUV}bb*UC3qgD14TL0(&xbQV`Sfh8vHlu+;T=aV0m zz`txf+kn|dJ}SdTI^^;ksbVXZo`0TOP-72bKhTW)&3YGIG(cCiO<}~Bx9l!X-rccC z?n}$Jz+GT-uPwYfoC>_SxDm>*LQ0z(HiB(zB@VmWBY<#htgFPJ?J#{|D_ zx^9PszbNEF(x+NT^&|UD4%1}(Rh#-nFyHDv$?B*uhRP4qnw72OH8?QS0Wm%8QiI$s zlrs!f%*B-I4PKr)wj0?z;&U9C^xB_MP3sKRQZ-f4I8W(-}IT%FUfNDCVU65bNZ4gDsnQV`RcqO-u z9D=YJ2?Zf3C*>*GO96x)Nl7`E-}9661NFg9^=kOGZbCR~K5Ho@yb?Et$(-_wt*1(f ze$92OR(kdnplQUQ8@14h;`LWiGT1U_;&f_icbyH-JaolL zUgJ`*ut))hX36O%XIOX*E&t^K--!Ufj}9N(hMuAHRaNFzk}>54;FIS$1g^W0o+N*r zt~okizBxg;I0D=}*!eQz)gY*KYw4q{Lx`U%IX%+yol)H$Uh%)R@${kED;Sra?! zrY^30%r@iBn7viw6xIJJRDtS)(~BUhFkVDF`37}6KdL6YSiN=7>Ro+cT&q~;nP z-aE>uC|Vj&kuiRduKv(XURRhbG3^D!>AsV=1$VKUiz$|sDrUyK5<;ao#n*>Khu0h!+o<~mNVO`cYhktg`4zPSYi_HsrLt0{BRwdM(muVi7K zY~BbKlv1LZ7>UyDw^e@9pEo+(GmNfxao`#0oXIaGb{Qj{!2LRzDyO%^I=yP8A{am3 z^{gQ$9oK3s4K}*OsXp`7EoaL{+9hLr`0v{dLIqBkx}Uh_Ct#bPY1;`O$TA8B*LfZh z5^%K}#KuQ$=qK-(wf*Gp7q~G!a0Km)MS%8%4I1!Bhc}Y{owUVJpz*PAxpX*Mm82kx zBd##aYT=#n4!)Pvx}Ssz(-zw@O^frh0TI`Y3^rK~A)cc!4`qQ|L<39SaOvv|`eN z?!7^kGqZmSQ#gsBYcT@69D+XieGd#t(sDZWe9iDFP)Oh}G_H9n!eBmSalo^Zn zFeE_`dhd5RM)i>ozzKI1M%~n4?hi(o6e{UCqu;KbT9YjXpcme?Q&`pHbd$rFC&jNT zJ}^mMnZ0pkImfv)So&6jvpwL;Loh31VjOp2p#Tq`ZL3Ei?akJqzU=x21wGoT@ z%!*N+?Z5lDMOY;LtDVi+wwdt1rBp$lI&cO%v_wO7?uAy7*fx*-K0&L|K zkz`z=y+at4TJ6RxD|ZNmn)mGhL6`SezQ^Y_Pn&xGhsRKrf%KpN0Y09Mk;AtnBmnL& zPuVqV#5TmCV-igd0{ka@yc{+Yhro64c^8bJ`wIY}y;z{)SZl*7W!gxs%fa=xl(c7| zf^KO!Wrkw#o<$pzFhM_qvQ5&kLgT;Rf5E?R>oCF3W6>Xx;`^seXA?-46uE}bZ;m!^6_A4CzQ=OJh z;Qr`bE78{{xz=EA%4@=CdEdsbmT!o<%qSq^ZRZ+7k@y*Y-1rv9&~xfZSlXnq0(Q-# zaAX>a7tgg31-WMa^@Mr9*Eikbn*tSWpCx#2FRdF&or6dpRQdIKKeE<%?vu{fj?J0} zYQ42J;}2IXOb6j1XXY%SwkjtK-F5%W&g7u8PAo!tzj0tYrltCA#J*)8CZVW=1iJB; z!GCOjJ(5)OhZC+Ye`VecR$G6w+E?!M7+`uYsjyRZw1S8)(o1tZ{H0H-n1X|}RRZPg zOtMh$)pn2?fYA;@Ce_1^vJCuz3hiLtu-Ha^s=5xQb~M;pjIc}*b%(W_gnVmF^HMx5 zuCr>9x?2=l(5r8sGQt_r96ZP``XN|qSsH#G135ochayC!v2TMix6Hgg2Dn3E`Bsxw z`TB9#)j}bwjjoZYs<_vRanCY%MhE9|SnSJ-+ zg`+&5ngp0EJizp6RlN2}wGaT@K?&_Jwrf`XEu!&@FHQNioI#+~2wH!!deR3C<;M%b z!z#ijHwEYOa*RRh0=?3lGfK^@Zu%|d@L0)>(rf!Ue=SSd{D9F*Ik-N|2r#br$Zs|Y z%V~97)5C1fZpw3N3s$aw*fzbAgDyrM{I_+{vEf*GM!4id)t|B&@ZN2@#MfSt?q5ZC zcZBtY-yQOpzUuG)t^Doq$KJ5!l}U(y(AN0!S*EYPrIIx-u>t{Oi6=`f4+MyC;hG1dnZ|OCD!0#&s;#P0DQ3^0n|i zHN|Pxs|OM2$Yx8L6CuvTG8VUz+Ik6(bx`Lz_c2Ph9B% zqIxkN=9Zx%Z3?{~QND=CQ3%g702=91*}}YG^pu;EvEiLFh%^wk;Nr~INyKvUmV9pf zQxaYYf{%ajCe?q<8aViQn^e%rOH+Po)5^;jG4rUjdkt&o<1$ixlVmW%|ugW;`Lf-GrzL>Ef z{pyU9OYmq>2qz2K$STTPn9Mn06YVQvQYT6pE5)ItxlhOy;CK3z2qbhl)uv~2Irc?T zM#Tt&lFimmr7kQKN?chlU;zawraLhSe&=y_F%4*fSBlUIydG~R5qkmKtf#^iEcQ8$ z&+*Zao;XP_&UD`t4UN+3p+*X_@}DATBw6;f)R8dY>B^=}MBE4ce?km$49u(ql(i@O ztp^1x+1*|_zB89y_N`{Wh~aCce-2OAt4&`1rft--sKWVXtZ=!j+j)=N#GMLq$w31d zcwDfuh%=jV#PRzS|F+XK984!a#OC=i1{UjHaQ$m^Zgjj#-X-tCt}*fW&U}N9)!KYX zmNyD$?8Z6bN|((r_}KT2+bzTk(e0KFb>Ys{E$xm?UnAjVZPnzps@EW7tZaN<-le-^r8O7 zOvOy7zF6^IFf$H=uU_ouH+$x=*~5?dl%@E<>4_L@s-{;K$Dh3NE^p#XdHa{$*jy+4 z9AM=B{y+IltA4V#ZIjXGW$CWsOQ#r~}@t=`~<-GDZ3X6F$&Xk&dOe4&#Tk8y@N5674HbyHSjGQY^-$G+^^7vSIkH}Ls{%y)|rijeAm<&4-4Dsih5aXFxrMa z1YypT87_Y`OM}|q@sLj`fE0>|t=VgSwZ~UhAwHGl;wf1j=i0l{zvvOJS@$NPLYuTT zzxNr-l>btD$XDD-D{Fzf%Op`k2bQ_$v^n^ENikIRJ$?Db&3bk3*pinC^|R)s9IZ)@ z;vWFQr==7GHW!hS22JcpI9u=d@Sr)iBnKwk=6+qWznho8$SzO?-(K!^YTIjIfOfsp zc3X3!?<(nXpsabJmmekdlChoFal=~4b-x35{Qjy?SoVF#>MC&-e8wF#A|y4R2rpFy zC%VWFFomutPbI03yVpXXmcXubyg^$gET7dR4DDS^+k?t0?r?T3gp^q!4kUY>EoUW; z7podeBojD*_kS<8I?s`=vWRu5$(;r8XA++K5xsew^+Bk5YLK(xE@QUgK@puOrv?t; zXi4e091o0!-B#c~qpSb43XQYm9+En-JP5C66;e0yoM4Ol&KB%jI+8$?GXzFt?=(6B z&q*FhYj{spjo96HxiN@bz4vd*Yy~<9P+GpK&8Q4Vfzy^QD~tZ`y6zfWGVCp5Q*1N9 zFfx(WVRUCYMT6NSheM_v;0&cwx28yEFSNI{e6%dUsH~AJ@rMF0+h#VwW^`mO32iXf z{{XKeO~{e{n$74@e503_06vof)W?9<1@{%1N|q;rW+F*vd1CQ%X=IE>w>Yt1cc=3B zoTJYk;DU*^G6sgqmV;JdYtdru*XJXgWtAK7~q| za-5I&!kH3o=uIM^$$l=boEf<7xoqa5_-cnE$=ZP{abe~&v=h1hpYNm%jX-`2XEq? zdntbkM;<>>ZC_V8J>%S2E~Bh^ky+{DyD_a%wunE ze=gL=hig=gXOJ`L*G-4mx0oKqIiHbHLRF5UJf0}oQ^f9g@%GkDvytLlX~Q3nx0tkU zYZ=yD>79?7+Is+k|GlxP#Ig5G`F;N}?!U*EwS~e87IR`i^T)=&T{xoI71YeaDqofU z6l;=)glFq#efr9`FF(##k>oB3n#h$rR!#J;lKN2`W#k#erx>@4@JkDj-4b{!d^iQu z+N}BVRZeFk5OWZ%?V`Z6(5H~?D-)WVP@!P_rc4!@EnLRO9dh8;5H5ie0>hR|830hy zaeTh3)OKZ0k(|0(=_SqjU7+3hv=_rAei%jo*-ZPbnpS4O7I;9>C#peTaL&hr%+}gT zm1JYD^{i>EWG5HLYb$zI%@++#3EOH_ZC;fOW*XV`)O8lgsJ6a+QXsgLd@jx1oYpbZgGI zBsnt$6d893c-m>Y_~dgBwG5<^baaMyWTS<~!jA^pVa`Lu-~l(_KeV0{#FjS5X*&ZI zchXLO#C%M@`k=pM;Vd(w-JS0`EjPsnSX2_tNMLyL@hu1A_mD^rB&eTiy6gZ8seU%1 zC)x#c<}O2ZksoDx2e57Bb!};fI@6?dW>V}cl}l~3TY9mz;d@HPjQ(2SGjz^FpIJCh zgA53PMuaulMp}N93a_{kd)|4rb6GSK-(e#&5S=PvCj-djX zzeZ7Xo3MWqL;s6c-fq<@#jznZ1^6h@kBrs3CjcSxuR$!74e7UhUu$(oC4-Apw|(1p zB+5uQvNi)y#v(RJvaGO1zjcP7-4MJs4RDQ4X;z+0@l{60`g$A-?;bN6a#XhH)Il1ANG?4;C`Ao5&-f3uk$Xr%2crjPN(=vEW+YNTOEe=*yt zwKFg<1Xw2Z+j*;z$y$+q3>ZyHkkN9#&~bedE>-PE`7y_GrO^UnJpDG5uxnpr{O+8k zpqy`Mdvq*;OdH;}r+hj?b<825HQ1uwPGp;8%r03!%kG;qlv5R*L4cDl?U*9Z@vf!W zRrx4-=%+oe*<)C;2;FD88GG{N`mWtJ$HLQL{nnzTauQ^r2bF6g5}s){Kh}R(Ml%4* zR+shs#B8k^mXDq}gcVgipV`uvD#+XkBHuVa{ek0}J{f-3tG{WoUR@UA+aO0fATSQR z8}`U)%K%!gN)`Ht>Mec3xA%zr%e}~iGlSS0aLA(uxAr(&$9O!qL`)JUrZPycX(L+4 z*(H7k43z^K_k{VL_Sqa1oJmtMnxAtL@=V~yUd3%$NbAQ%(WLmB;2y~Vay(RR7EwNE zG4t7g?#UC1E9&Q8oGmQhsw&ihRpw;n_$#j$oOLgSe{icF%nutV|LTmM7OiX;XI6(} zDs5oKvH*aLl4ms|1fL{9As}p8UR7VCnzV0($w+X-EB2RE#11EwF>ZZ zBLqwfO_Te?ZOiaQO*^ls9oRIRU0o1Ka zr1>d}cSn^iKu2$q_lKzMZcug!$8QBw>8)j5S%i$1jttvsA5lih`3QCI%!a4KUepqcRbLhEb>Ztcfm1z4~AJF@Kn?X6al-A6RB znh%wolSD?0gNKPplMj7vGHO1W{4*P23veaC6WQkhwO6uHEYOng+f)e0L(!dv7vmoqZlN+{^SMjfqA&5R$u(#{VU6&?$697WhQLJ%sE;R+<%?V z_-&2v?2Ap}WXMt-`2M$w{jx@maCjvYyfX3e3p3uJIJwRMk8m&@dA*g(#m_eRTPo{c3DrI23p*`= zL`>Ab!zI~eCMrUUS8Ufz<@OPBk?0pg^E#X(;DyC;b@40d2LXVr?*)lMDdg@ z-O)fY(P|r6u98p}#IgWdd;hJge0+q<%SOEbvOr&!QaFmG2)h0yzUte|w`S&>0yuJ9 zgU(eNxD;t#t7yh)I$x4@2>~@jr#mP0WeW8feM=^x*N3dQ`x1L%e(6u7i-v&-CB8ha zR_+*c#j0geVvr0m$6y&pc`OHn5-=uJ)_bXxf@-jvaeNk>p=FcJ)+{hW1AI&sgeiY-mIM0~&#`1n&_WteM;3{DH(oNIO5MxOPRKX&NeI4ZJHFRIz208kxtgmd<7`a<5)g~0s-@u+DkUdIi?(CPkcAIjtr{-j<>rs{Tf>gw#kKQS9a6dNcOVx?vuK#@U;ISE&`N!^ z5NiuR7UI*G@J(a=t?goCAqAP3zjGz{${1HJ%dQgjlG+8g_p6^c|0$h4+4n3nuX6TW zk}c&;0n^f?!1_-4^XJs+0N3PSaU(+qb-?{!bbXsN}%S`#2 zEckH$GJXAUXsc0I$v3peTa}(Iy~D}^T6XEcV=x-5e=gEEVb4A;kvwG@ItWUyoEeuN_QyilCtX#1{XihAOb4ad5A>35;{^_H6Uenb^%tiP<@3JqxpLMy~j+hNs zn#y*rzE@-_?T%fSlo=)@N-W-nB%3-deFCTs)5@c0c2#OEUV)7h>qkZ-P)dS=@W@;oMw2gMx~!EbL( zUL!+1ZbsyA&liPoIt-BdoQSX|%4<8<(Z|IJ2r0QMTJyi<7V%=8)L6}&qd(YBx6BD4 zEEW>20Vz6TSbI*iLP!9?H;opE!g8{_ zH+{#H?+of{wSr}e=}yXy>2m29G+4jtl0c`ZJP3F|o>uVpoq2BHnsVRiT*e#@Ng*X+ zK^D03cWd3M@UULT5S2vXB`RS{+1IHt;=qEgl;{MpHbVNo!U0C4@Qn}|8IA0YBgNWH zh1fx-z+#Swf7?{RxUFOf!2l+HXpvS&ls?SGCX#uPc>x9gn)s$6vH|O3);azmQZ060 zY^H3KLU zVufY*g@k1lNeJ7m>FpG|wfbTOJ&F8Mh&h5Xo)gfg$5uJAKlaGuZyhAZ4Os^5dzR4U zwdGw{mn@YcoXzyW3785HjiBf>Qn8L7jXlSL8S1c5kiz32{(aHD==|biEceK;^G&Cd zF=ssgB<(n+$`bYE&7`iI%d~?`#3%{-9pA*J;wN=uS*8GK5T0+z_oo{$O~i=!y(P6) zh~y3Vk>7GQ)1{2-5`VmFYUg5r|*p5}_+s`*lms<0G78n0n)rsc6_m7}aSf`&L z@n!(;j;za&H^KixpM4OK&ZkmNP!iHlY@4<3J_kRJCA`W`APsmdyi}GKhEKq#zkI~Kk9>Y--Qwj45gew@A~Qg;uVQx z50TN~=fTN;G+6Vg`mRF<8hNLg<X?7)<7%puFrcn z<9u@T_mT!zJ(zCF2r(s@k1V$m*y9KhxH`#4v+d&=MH+<>%T(-)HHsHY!8Avi>^hWH zdY@R3Ltk z&0|9DFlZ{X>%kbYP*i87^3GQ$xhd<9koMVuZsm@@m;wrxkt-!q0A-~!1Kl*z-(j`w zL1f7agrAEE#3#{51Ej7t0mIc6a7=mloxvim*$D7L7biatS0LEb*BxEf7H?+ERDa3D7A3vmc>ys#%mkf+tD|3D%&kjjB_eSzNCdnU3 z3h@mXy7L$0u8A@1MOn{Ml(L}RfRBY^HO8k8+QgI{h?;a8Zt5y_^dCMdPk#F{ETMr$|w_=*J=(^^TCPxxO_&h!VomV#QZ&KrGw+Ihy4E3|V^O&D?kt4+qw5nOXd2%9T2NRKf}HBF??ngzjUHwS{q|n(y%= z@INM>y<#R&_93#NO+fSK$#CDZ9hz3Cj7@9Z!I+%r#y@rOpP$CdR2$aC#;I3@{_-heYGtFFrI6GG?35Y}`#X zOz);@s}4^Wv2C`Bo&HUy7kendN0FBg%M=*vEK9uS&6DXe>fD|90(71w3g z+hmTB^33HBjoJ~4^c`FJB2c+2&~+rI)VFiTWMKcg(oz0i(HFk$dn}L*3Ih9}3+b{v zn6kqFnf^UUHWQp)pdBWj@*{w5w!X`c zgTqC(P&b#r4cMM{cawzSo9La};&9ay1nsi3@0rP7OdMO*&p?Z2+0w3LdIKCH(zMK`u=GBXjXFeS>FRDRoXdXh~b&%P9+d4&=&P5gOHR_E}lqSYxB{EJ%fG83wTS4LM(4XrJJmSrNoG23 zA3tSH?62id{b@jQX3~O~<3B z?d(kgYmG@X8KC?D%cbS|47&WLLgIVYDlsVi;Uv>>DGqY5S4YWV&-p!xH%K&+Lhx5s zX-fz|hONWJ)dsJ@mzqqlK3?);O*Xm8T0mFrGLr0#G^c-8OD(}VkPbMiG?bzlavmTn zdkba~glVLZgVQ&mcrsb$E&6q}9{Drom9Ye@%UeBA+Utz%aqkF;h?$6KbCHG1!km}T(&k-jzw^DdV z^*Wjmf|gu;PLrJJTDY2$ypVXag2rK)W9@6L<7G9nSH#ChDTyHo?Tt)EwA{jc|67ZF z^(-v-B5)^@{TMi$8czEUrx~UORz2p&I3xH@Ol@4eshqAc6E;@K;B7ER1s*}aZFX)? zf-1H-!pY@G{dwtrIaaiord3FWA#EIP`$|h+ah$$BNM;n7|2Eel3iZoRB3(6#MlR7N zc=*`0VL?3RR{#?7($XQJws6<@&T{k#%WGEq8K^VU!l$aG#mz#u$ZAG3Lp|U8v7y024JaIL3{dV3_sd(GZ5Ey zd|z-~1L96*izc|DXP{KkEy!^92}+2Ol=K}Tf7bRTN``t;7@}wIuHjDU1ZWd>QEok% zl9*}Lw5=28i!c8b>|3R96oyF)i4S~+#8t$X-`sxAy4G~O%sDk8$-*Y(LNk1CmFLA`ceI*H zR@b-g*NNSDsx63HFBYzQ&Cy%jwGvW@;f|Kih>_f)Gb+|hNMd(BGHBG&%xT#XG4blc z(i(JB76!!lkROGh=(eYhlb#x(wvN&Sw^y0O<0b#Jy?n0F$qD~{mG`9z1)rwamCQ&x}s){@R>Vs7hu zefrtH8k^#S_27U`>}BR5))vpRd|)XkMLNiRaiU_i9*!72zNmc?Uv@7ghg2{6t%^!2 zRNZ)zW-_710R~?Gi1_0*JsV9(X)*{`=KH`I&X`vCu1tC}ay;vTx_sY2h}T(w4_UQI zLS+Nxa%1i?^ng!`vY#&7dQ^6f_6N?1;yv|`Znj)=-$ zg#omAuVu{Om|VK#7RNtEhiLI_+s49-SZz6Wv6^b4^%3=ol$+O>03}t%u#ua;li^>V z3ivYXx72{og@rV0wqq7dyJ4HZ6e?>-y7 znKR3wzHyPu_eMi1MWt(dwzmL#_ zQSBP8V6I>to~}W-fq2<__3Wo?h*Kmf^KwY7v-^bS6RM;v2w4BCkW4Z;QHc?-M@uxH z^|1_KX!6z9R`zeyNm2f>XS<-Ir_4-cuXeouxhR4XBtu6q+S@&9{)Fy>6pauE0`)4E z^^QILpx1#{DR*c~{qhh{Cq>?qUHyS}odhQ&z4NTqW~f4y`uokuHn#ei>;P=q?i!DK zLaOu#cA5*fd@g*8VfdJ{2oY$h7q3Y*f|mA_lkzVJu|=9$R1uE*uU|+*QxET3?vfAX zA7o2)eJymz!#a4UmeVai6~y_A(p5gwo$N;fyu#Sc&pJSw zio@2%Q zzF6z7Q3|S#_7;~R%Nb)xC!+(R=Y($P`)Y#rltogf|Fh}@y9MRxY$biPv<96hNnYo&q5D*uUB+S zfxGTfmEmpo77o_+?j3>M&u4sepjTW0Imr)+kBHXc4k7Kj66z53(GL97?i zHBU)kE=+0GUP90On}^to$cUCqoNt^=Y{$XuZ9cL}i1?tg(aHMEx{HT=CT3W-rwG9Q z-UkY>{H=y!%ERzF^cKv)(z!FWH0({SV4{X%CleFzwQiyD%Cf&O02+j&E7tz;PKynE=2RWos-Qa z(MxLtVcKgAG;<91;{&FuBsmyH-Yd$uNWPe3vNGO<(B!p@zrgWTAR{e;xMr8hVI`>8WbRCC&|v&1zeU3HYeIdML9&>5@E%Sqe z%9j=4JXCF$@4cQplAeV|YD7fV27k!h`Hw}B{pVr zngupo1n*B&)A8h3d*9#{IPs87_sUwW>X-JO46<97iQGE4@q{JBe z>@ecdlmT95JIrdDM%9`EE$qt9t~2PohU)XP@*P*A#Ljkvyx672BMf?_%8PvTMWQ`4 zwr&pDa-5@{OSC*3t+<@~%9PH0**m@*7geDzZfBlH>Gqu`)1mbb)%4W>#moD67Dr0| z^FQGC242vgNFkS5%t2R%7}#=CK?4E>+{dLm=6y1_6>>Hd#Ngy>!s%>NWWKS&0Qvxq z-mg2%=JzCv7qrk0x+Lee_(AwEo`TG+zNW8gR_>t`@Oqntga3h+h5^h?Z7BA{X8dgu zrDJ{9L$tLp+%d||#J-xRv2#<^@0Te=_^QaxWzofceA2Yumx-Uv``!(5CS8nov!t}@ z!7KraJt%k-lG9v*m%jyrXlyU-P4ILy-cB!GZarv^69;n|SsF80Fc-#-f@WF>6pN+q z6yk@z-4ACd)Ir@(=TLlHn{|Y%)9Laj^~|R#3JP}v0i_8taqo+0Xn<&u9AXCYOFIYG zWXW0Cq!(6cT4Ufsk>|$f0_%Br`IBV2uAW%bazN8X|AMD(!{~u!)xVWLnAlom9W%ON zosg2n5XIBq&g*jqN&#TC(#EB61qtDdhg3swoA#FzjgvSJX_U9pWkxo6Hw~C=(_O4 z_3xKu5rDh^DN(i9H4I^~qx{V8V}Vt5(%>jtlefWsYTK9J4L`J15~p*BjHmy1PcmoF zh#JDVW;kW%3rX3#?Q-#pSQj`-Nrtt93_+VI&C&2!SFniP245w#XULOryAWN8t1eq5 zna|zUnIz3#U{3Lj+`Wa94>Hr z{@>vOqa}07|36$9iJ8My?wU3#(8ON{`O+tP6v|xMuw}E4I!$Emq2MWYSpP<;j$-du zRizvo7$!?A-1W?3I1;@5oPw-B`cE;?R@V!e5ot z%es@s-!w41R_gocpC&E)XDQEpQlWUEJ{G?QidQKk0;>?wees}|x{S$iTSk1R6@%nm z$>hZevD%!Ldj|Hd)Q9^y!)kD*Xby71)oO$A6<>C@|^8}HRO9XwnWLs5MVnd+t##L=a7d=5~MI#U3q2|=-`Vt46N z6s&|86LfZ7d6O0o>ubKyag6=eYjqfita}F}j5!;*Ods`8PC)a$796e83IZNcq#hUh-Up-7(IMUbuJV@@J&A)nvUi zYhgZeDyw&bLYH{=P+u#4~K$HiR%ndnx+BLK{?V=z}w$CkQ;# z-u2asIazDU9f)gR6>5MdCmrGkmYw+iH(wa2;|;Ig|IM|Qck`HG00k83n3fy@6WBt! z>fTr-3p>}3hQMt>`tf!Ii$lMarB!!w{brndXK)Y-pegZ!!Wx0K(t=e(T?FULqQ}Gv z{A+YA8Jn0zQKwFxseW4rCq&(f7#;_$k>*oe=2A@Nyh&ZYiF3e;PM6B{-Q*B-*jZsV zTWUlJBMX17DsGPFmk6{Zi|KQHO6NCk+X#@erVi$5aPZg4X|tyOAmSotbK$ftSPIa6 z|Kh?#GZ~RZeEGcpN9$Rm(f91Xg4_84^vrd1+%S8BCJN;wV=I)xyM~W;YR#$n&A$lAbdhZW96_fXW_l10;Wr6#F{^dH zz{{^fEYV^lD*uP0vx;gnd*3!Lp->3Hr8p!=afiW40zrc7;2zv%26rdHp-2*(;!cZu zakru^P>QtFJN^CnzQcX;9__W>wV(UBud4tW6t3dci!A>YG4_REP~3}6qo7#D^8j(0 zUoLK5$fCEd%wy%OIcB!~d#;#QW zvZ{nSu^#6@dul+WQSk1Ww3nEi0#|>?GCFi{Ld*M&7aCY=Kia}eNGIut0!c0reoCSD zS>)A-v3x#MyJSbRE5@~6n)-7`9aR1PI9siV^Qf9n!E$`PTc>F}C{>f1q$t~=qdoVn zYJVJSnT?50r>tm$|J8vJSXuD7)C+f!uCd(n$<51gjzgEgHnB0AqkMt#=V@(8fgIL~ zeIl=ZQ;|c@b~ibUAiVu%*X<}@9Zx-79iVZm>lvsV3YgCk>C?ISI`Lm@*<;`UGi(V9 z{C4m$#Z`>w&f3u7bT-l5s{p4}#7pa#DQB8yWdsP7tftv2B;@z7)=TRsdfUger2$WY zvEm5pIMfZPuXV})iea`yL7=D&Y+Z6+cJy~%A`b**j=uTb;U~{e>;=gm9<2J!fK}th zeZcJ?Oi{70_;M`Dl?tb}1EojW$+JTEL-X5ti8;C7Ho(RThv`1Y9;|WX*5xmF?%l?mz@CY_e6T*34T9 zHOy9zM~mex+Lto@2wJCl^5oMwEG<-{XP8g>2M#W0N5vF$nxt~BnC%~*^&~>Wbb2cW zZP>?3=36Y`mt)tU={m(H2W^}EtwnmXGsoH{D`taj5&qdd2dO2aF|1YXGvS$mZ0X%H zKZhAWW=LnH=IH-rz-6-A$kYoL7f89(-v5iaT712bGj(6_ViHWchPXwm#A7Y-dIx2Qyx=jvAEKx!{CQi)RQ?d&D70#@kIK8W;eI85O~ur z#F!Ts&<3jB!2y#0J9Ew!;AfT#XHI{OP>$9eVuJWLr&;k00fQL)HN$<;)A z!+%N;3(E%GQkSGN9M-3lHDg=IB7}wvJyAd?dTPQt@i5bOl0(+> z&4)|MSU>j}9k$CTu3{qJr)yiVrV=J-7T49>q^%lh1?2^;0kWr6&kQdfRtm!B<*`OC zIt=8T$9H#{N>w_Q&$U`UbN$>FZE|UFc1xE5v>;{8N@TeC9n5ptsur|Zn_Xw5NOaA{ za(UV0@#O>Ta6bolE{@Mj;q$J6rmK;rN1I&{mtFmYMWXZDbQ+f-#VPA8^>`As+4?S(QVQAUH;-x&p#eiECn*K>q2`EZpLxK!0wgv=Bw z+J`1z0M1{gyonQ7XRc@+(Mu2`eKIBg-rll)ww&642}ny^(}kxr3t&Exc*!WQMV6nA zwMHvExLBAV@k9GFHKELsEvXvUe4$pZ=^#{&zwb5HAtoJ zY<<_1LQcr(##6>C%Nb~VPfzu-Q|nNNInFwZ#oGp!0j8EKm9#;f(6;S*~uD zT4!v?DpELZS<28c z6OdbqsagoaynRA@(UY@;56&p*4Nu1x=aT*5WhW@6 z43)kWB%C`mr^HRQCM^or)9z#lh0(e8wdOep_QO7Gm({f9?84gw3fab8++K*G@9rjE z6A5A~P-o6dINNHRt{ih_| zRdu2vQ`-lZhDcPL@_cRwM?ts|0{bm7if_6Ks@6Id(Su^S8Zh~)b&k9|ULxne8|V>@ z89Hj^qf3OZlNCs;Yj2?mq{V>(ukua5abSi(JsTmC;i+H}FxBf51sjhDDuu40Zu!Kl zbuJ@zOx!6QHvLep|7q$pmthWR3B6TgzdzO*8rlBVJ>L)L~qy2WO^UuxE=vdf@FWpRw!Ti-k`k$}-Ydqa1kx7F; zgY}hIHCvgMyW0S71N11{{$^NBI?&dtMLyLQ`6oFPa^5UG)D>Ho=D%!08Zz8SpmXhi zEFzY&AYeZakn@v=&&-_WUK^Q)I=M|1Ya&)_u(yju@r8zkcTKA!gyXhiV1))tl zFA3y1rrQtWrk*$J756@=duID{{9Uc^UyaohyGm;LI9E+A*GpQWj?V_e0<2HOS@rd| zS3O|$L}^UAE+Nw$1~KWkDefcxw7I?$%~Qq7vK2v51nbylYTSw$soAc%mJlC4jZ3$g zJehOi%Zz^?vWQLI=0j##12xa&q}yCufj7y%jRc!^A8;4&MtrW{T*+oL7hNO>xc{bn zDCF{+LM&6vvWGk0-PHW*5v*B{@F2h~`_XE&e;|ruP9XPslJ>obfg41*@x4!pMs^(R ztF$OCKAxAV^o-rjmcrfjlG8H53}24%sN>d3grPNj|Ozj zjUV|w1nU)K%M}KN$oj&auf`{FU(c)p)WN8MN^ZhW`AsDuqCIE~y?W6rj)K@&h=hQ` z)b~vO#y=8%Y({+YrhzzfnH zU)6WIIrJ*%q3SIeK_l9HKeQVqQC7@RR}!6wYuBG42=G04 zoA{;Q^Wl26yf1NmGZhNgr6u;ic?Xl95{xQa4WmX19Fw`8Ko&)s#Xp3ACDu<$WA_u$ zXjynGCXtPc%4Rj41+yx+OihBQmM+<%U1fohQgWGT`N_N5eh*}(c;mQzAbAm^&P{|S zmog-cHhutYFqMy1bAk#889s|XkKX8!Td{@B*@Q7BdG>j#+#L$Wi&G7}*rbsC`xkGw~}EE7pW zAYycf4Qu`PUs!rqPZJMlJ=`Qo-jL;3!S{gBJn5yB>en~Ra)e9FXF=s&UlpU`o>49) z#5ss?Q+@=lUg>#kyF#tuR*&RF;=7lytOZya{Kt2ur*-BP3qQUFlqti~iwOOHhT8k7 zE?Sgqn0U}n1ZGz99UcgiPi4>DC8__Q@?ELcjwOWCQotZmKrq)E;{gAv6pcFrR-dlOHFv~=Yuae(9B}K$gmAf*$M$4~z9AMBE*sR!OfJ= z)Ka}}BHyc9KW+sd^IaHpPD~TFp09RAQrXhcF;}D}_W3x|i~-aV!JA7w8U9sU+Y`SE z4j-OH^vN%1fnBPp+D`O>-wPR-*>Vx#yfjP+!MvR!E;T+cJ9aWck)3G+T34>fertueyUeqhT&38$z#LR19Fm zX2^9O&$tG5mkS_Fzw=Wmb{v*-yU2`1QFd~eGgIBl*AQvLvoyjz;5x26ed={#Wz`t_ zB93%@j(6gpw96ak2$PYm=T_z#@qU$?lr?F}5fN1e9^Fgnbw3hT72F9A-ScRl9u(+2i4uB9W6%2)e z7Ywgs=VuwkZ$~o6ceeobq+x{W&;GZfaBA)a8ou>otxXh;8c$N$H?|Bk1HW5?Wbl1G z$-pJ=YgUWa^J~$q&DX%m7O4~x*3$xiT7oxf(#bN|Z6#jV!eL`$D=Y9MjbK@kgLA4%XG3ggmMJ5S(#|AnSx)31irT{YkL@oG={7v>jHOC5&qu5Dye<# zuru)H`1;G>^LG$5V_2GG0sndf)K_y!J@-A}$1_i{p00ZSML31oRC&*+xQQZw(Q0_Q zcv`|b`+K&5ewmtGkSRz$mX~AO=zRK_Xw*Mmd(fv|K$9fo9*X_DjfO_YDgMeF5Ga+#pFjTfoNZ;4cSkqkPgj&;Qna0a|GobvWHN;(bA*AcC< zJmD$-L4tzL%)P?OeyE2E6kUaC2MpyxbiIZcMu1a*>jG`q!`jvQ6BuWdFsj$|Oo=Rg zRSmfJv`N6Jz?CpJq1cL7BB`rOq*^Yw=Q8`xSLUgt>Y7{e=dxGOFU`N0owt{IIZz1B zKQijFx3=3nyH&b zQjZ#HRqM@E2jCtytmEOy=Q)0_xthAv4eoSPRGp-DHf!_i9J#WNHHOREGdn($;>=_3 zX`ehtLnduV*P{hb$=dgPB(I87jDzqa^WJ=_io#xVj24Zy#4g|XOpq-Gy)TQ_w>{5tCet{X-ZjmcBH)Hf2Oz4P&UpZ zsr;)vZ&KW~f=b;lH6bo1ySvd2^3-8n!)%!SY1-qb=hB{Y=v70_-S$2BJw1eCNoNH4 zXPEfV`M?_Aq`vJHQRS;nIddzTCzJH^MXL8%DPDSuHHp$7dGDncF4QG1(nqtr9j404 zKRl)OU;SuA{Y6FO)X?|Fbk>i*5dnLbZx_dHK`m>_W;KIjuN4O)u3rKn^9*&?;&rPH zJ1*VPfMz3O%?LbmTn^>+s*H4wZW&nWN%9rhGC7f4`R8{MIR(HpgJtlzzu-9e$D^bF z5zqv0j5pK_i#3j$BW*6ow;}eXd$mQ91tolMA#sGZ8*QQmUWFFnjF*QJ#IDw4#`CiS zEWy>4gCm=-(l;Qd$>rXOaNpspy=#+>1&3MGbim^%`BBJ-`X!!}7F-Yq;)W@u z-rlk#ym}h^-r3ASyMDr6G*EdeA+;aI^Lw=!r*WxB7em2|GKuI$*GoQ8SB_sx5;)fq zd(UDzIES+EqGWanpJpPV2AB0T%cMe>y-4MN^N-zoZmewGE}3!>kp=_i_<$5YE8Cq8 z!T~D;sM|&y6mdQ52JS#`4w*uDxD(=oCq}%;^btv%dLnl|_y!*!EazL}n0#QQ7DD2Z z4@ltqz4UP+ap|!HM%x-+s_NDWlcG3shq(B-Ybn}&u8lnKD{`j`n17Vf)C*?}-j+`Jn zTBSt^X#}OQKz|Dl|FD3>KZS6s7!-(li6YrdJHUt9R>kkbnae&1&}gkwo;($YQMWI*_|B zyEjF+lgj`-8S-?bcy-HRV~($<9z_s{lLeT~kR!|%KJdHlbgrUWC`4Ca$_fe5w@O3A z+{xpTCL%<+CaI?fX*asuF{V$R>b+1Y(HJ_VHN6X%rX7o=L)$)j7i#^jNrL1)g-X*i zHjfK|H`Z6tkOv>|LE0up@dRlSh%ZpmS5in74N{eMmCBDS+!N%b|nu zfjboZbqYVc$4^x}-H(x-G1&?zgzmJS-+y%|&<&ZbBn_U#p4&~o$tH#}g-YuB7QJGB zZi=42k)beqn#v~(!2nGx>^`ns?!8b#$*ia=zF~>ME(1+oyaYDOpJ?j8RB@Hhdv!Zo zaFTr^ZyKSryn{S)q&3#R=dCSJGQarK=| ztNA}qYlKs{Jqy$O!f1rv@+aLyPI<$nYG}SFo)pH~2T-Tm4_CmJ#5lz^LQNb+fg=n8 zO-Llz`mUhTR$``M--0Q8d!Snsm|vQOj65@cKXZ!fxxvZz{v9x>*|6oD}payV|wbm~j_qc+agm?JUa)7kX6 zbhMS$SiXZ<8@8I!i%t<#C*XloHg!5SI&49l&-4@%)_OBDBzYmiMnx z2x1=q;>jhP;6=b`N$zPgdl@!#0qTZ@z*+WJ{+OFA8c|m0WPi zhcF6~7b?wQ-5njJBm+~DV@r?Pn+*1&a>fm6`N*m%zA0kiS<^lryt2(1;aNYwy299& zlLo59f~&Xwr|7(@;|aD8K=&%0ul#O&*lu5(>rdY7(h?JVEr7+L)?`wBkj6mX%#*RC z=Itt}p*|>cOwQFMHe*{#Hp?Bv11_`02l-%-9g)=O+xouSGuS|i@ zYhX-s1j;=*FUmKE%uE9;6t!HdRo(s;-Z{DUeLqfI*n)4k#3`yV%=i-)e%?_IiIY`n zoozHVV8=BMUF&c>QC>9)dJPulUh zHNe%Xh&xNBFiPJWMlJbn<)ZR?QBQ^*7mH3=_l>~of7raWghss|Lt3ErdRq`lnGg=l zL?NuaqQV-u7l=P{B=@*At{Mq2$;ZC)WMvdhEK?8Op@2=?RT3@%wqke~3T2Wp#F=9X z>fUV5nQ8};rGLa4Hm-adw(P>dJ+5}sZ$n_ROmfH^skeMYTa~>f9cQ;Kh-yj#YIIy7 z0U(f&%mj`uaQd0x$lJL~ptF}LnV7E;VRo7U8f6ZA(f?bfVz&FohWp;BLFq3KWLmGb zHVYz`@?N$Za)YMe5*5Y%v{J!#mRYy$`op!!Ba81Ub|{Ft>TJ8+z*>nn#4o^E#63f# z3ineo5|F`Bq52c@`%HG#BI4Z33$W*`tlV>`5aPPppFpm?k9WYnX)_iLLk%07f7U0b zeg7`Zq-EBphYfNVRQGsthXBvwf-Bj7&-|K{Ule1tjg%1}6K*gohue6G1ea$Ll}Urp z)G*n(I451p0l)aAP9{mJY{vL-gFo!Q?l<8}rX#{uYKD|=$8S&1x~jv0rsOWGe7}bF zhe{LcB-|7loGA0pIECUQ?yw+q#yye%@t-l6gO+sds?h+~jlJ|#EOF@}I3$mH{q`+~ zD3uS%RWV#c=T2$={yck)z8czx#?sJAoXdZAOvKpd5Xh&#F{Maxs|fBm*+qHH*J$Xb zL#DOx$Fd3?mCp4AHfVtxWrt_tVc)bgJ-Mjr(AoB4`(7jevij{ZGG~9nXtm6Q0EBIX zydlepSg--~F{kvTlq1^QQg?usbOs}W0Bj!DTYchFe0$ysTs@&sL+V0Wvdn}=21>}s&4FK08fyWmh=YWstggIiyY+r4$d7c-GwbgUaN+eNK6-j- zX5O|oaEm&Uyj`Yv#Gr79E;Q;hIahA9QO6U3h<5G5I1BSM`#QUGlzj9LBTZ;)?pEJpJ zF#XzK{5EYml56+2t?57n=p|m{B9xG%y?OiOjwjJQk=@~@7vNy+1IdwLX=+2I9fEqZM9KLEQJY7`Oq;!ZYU6+lLUmf0;NKM+4qW1-L6^6%S@CK9taL+!W+9wZ-g9EZ|lO9dd7T6{cB8`H?$vwy7LVBPj0B_ z8%-LuSCP7UD1}fWG(3bxK1i^IXAz6Ikm6?NOhAB0^p_(1;}EvDTqztL)!eyAYa=a>&sOR?Y=vIY?B*~ z!_Tt3ufhRHrbSndB-75zx(7AX(i?%vmuZg{Ul z3Wb_r{xwnFneqR@H8u)lv^&NM;i)V{2Hxj<9&g+2=oy_Up7KK|3~Np|pX%?{x%V>s zt3PfMdc7Oc08dzalI3swux9ybhTx7=kEqxsEEE_WAX@G0!<|{vYtZ26l?n4@AFeaO zFt-?p5a>NmkB?6?!GRSLN1;YoJgN_zH?=W5QedH2@iz2>0iaaXN+#zKCq|^BKrb2k$tid7i=uUR7MEy-AdmiLvLXmBa=^4Y<2{^VprrRk z;0@>+@M*OT*yLEK-!Gy+_Wi|^O@Ljn_rqE>y zMR>pnjv_wYPlsmM=&)!Sc@9=KX}i$W9x3U#$fo zR*~{(zOifL;GPpXw4%9`;JW-iHIVfWL_;R2J>-3e?X_4_61Y!Q3_Wfc0e+R{G?6^AH~&u zb5k(sQ-KL#^%#miCX%cUtFMU*wQ;Dmo?IP{`kRGO$FRMn?3C9_(J>lx492IoV{4WF zTwM{R86{XvFh}ar8Nba!st453`W)%`u8%??ir8Ek0He7}zEh%g%LgE~I@}b*N;gRR zR=J}(jg(t9{W%sV%o6{C!cY~u;PI6&HVSl0QLc}hd?`iKtCM4*wYeuCk|$qy;PXxY zRi5lQUzYkMw{-?v0_VisIoig$0C92~>=X5U6?HBSXEgc$r(fU4Kx#Y^#=CV+Kg~2L zPtvKasm??j5TW;)%|$?3d(WwN4Xzyw>xj73V>^{s#i59^1--t~O!dJy{0RWOR3M4& zw;+BaDwyC-GfFD`es*tW!$|%86!)`3*(hw$06BQba(X?%r z9JZJ>Fop@7Qb3S>1hCQvzx$j_RB$3 zJP7g(qMGOmaq&s==DVwe3wGlj;-L2f?P(qi3qc>X{*L_O6)If&XjhB(`Up+^6G7qI zT4fW%!72ANRmCjKh>Mi#Jqer8ahu3{e)AW9VbdcJ`wVrj z-e%MBI}Y@FR(ItYmq3m1!4sS`w(<@t18**kJk}1!Wftg>8lV&O&&hzzao^-sbRSiT zb~!gM5=aQ>Beam#NyTp!344yP8+^1h;w>Cr6bVDv6jHVJaH7sCspDo-$i*(uYlC!1 z1L;qH>$UX7BC$2+@u7FWo^l~C zBfdmY&DTz-26B&ekBm3+>{?@hf=9vv{N6NEg1DdfM8mT?3AeuPB&$@M&CIBm4v%B2 zih9j4H`07e-e~F-V|TU50A~$Bx(I|%DG$A`#D7Gc=j~{jv7Wep{@;gV>tDY=}{O3p&p=}s|AM0 z9@M?$A9U?*ET$Jd)QD4p2^^1_lD}Z5*!|ko+CoKBQ!le%n(%l{{5cwnX>5ASD34?~ z28a)nErR=a8Tx)-ad?xTK*a+@#mrc}JK2hNt%7+|=jV)H>!t37aK#lL{=8PfD{8yp zu&V3xT0LDY(n2x}H7VT6@!TzCI`&uQd#Mn3d@R%B!0SvRnWpb=suR*>aB78Gi-b|; zauz?3El4($z~|*(bXJ|9f`8hbV|++aQNHR@8A1^qk24${T~=hVJ1e~j!W;bv{V1-B z65-9u!>Cno)Kx@gfqklL?%`0@dEB5TXl&#O2R^Y+>MZ13z!%AJrj&}18EVVg&pE^ zwXw&!Cus_l%X?5`UK%mt#6S|8;{&rmbJ_y#9yibvO_ne2=*?8=hblI=Z=Yhfb2OyK zj0d57=pVoo>wiREl7kQz|21wQNY+DA0zR$GFx4GJE_eER3UMniLNcZa!B@L= zjTZpW_65Ix{!Fl%;DIl#E{B6RJRVHWYmi%AC8ljJ3k_}_fdjN{D0@*bz8p0anu2ooKzn^+gs{#N!g8tkS*ukeBh-Z(9@&G^j_~iA`pRyj9l>p6` z3j;ySV@e-^9wObt`==h;PJKQ8r~osO04_BT85#|HUkq&m{~IC<<|ac=eJ)bnI+kn_ z-rL;YaK^PD7f@}6!WW@sb*|MKNX!M8yU(Aj8njERwK^4L+m_rOW#->pZAFDogocG5 z!={-3Y0;<1k}Z-Yw2rU%n7kRAU!{k7D6EdIIScuwS-B=vK>aE!iHJs?byPb~b`EU{ zdP-*3S)^POr6Xu8_NSw!%E&=@D)6OqjCg#C^WlYArUXzJ6P|9)TpcIol#n)%o6Suz z>stTbM2mx94kSj2m};3l7FdBB?6w*D7JqZr)R)dNnra~TvTpzEemxeCM3^J=e!^XkuibP*l9%%IlqYGXp-?K z4y6m88?;q>_#QSS8>|CeUcGUka|xSMu}rdK^MiVba~lr)gaaiv$`RCLF`b9iX>2^B z#l_KP>&ubusxig;?Po8_D^P`(5pV)iA_*>MTkuZY)CGzsI{may3>x2-O?A-#xt7J| z8?E@4^>x+T?$xN0qQ`AMe$Za;qn`{NPM`Xk$H&dxcG3D@`I5K)%{PZS11n#h{IpUU zu)J8-0jXvy3vq}b0hB?htyxwk<^d9${I@w}sU!`DA{&Eks;nBkJUlkfCCN%OBYPOp z=Pc_MU#2})5$OSruz-Xu(@5$6$TOD?vxjbGON9-ezS9hW;Q`mjfX~6@CPTmNKdtFE zt~YJ$03yyy8jqzj;sSB{#+nF$S?Cwj*t~UFCj}|@ZF7H8n4SlSP5yTg&_LOpneX|$ z)oQILH<+FCbD9KNgj*roQ1Y1%)!=W10e0nX0qNJmCWaA9i8nK9hz76MUVo*5_QCJm$DE0?!Q+{s%vDPh7!orH zYJnEc5|(I7^f$No-oomCq^ktzVxkhx5^$d{l$7_V_dPvZKZl8Nw=WH^1VM|mH`nuP zOX~c6zD4Bpc00tXzhuhPkz#b#Jzn&ROTLtPXJ!`^d-~2v-e;gQPqa?@4BIRe54)(# z>+ds+Qk;XYw1jw4E>PjI{$EPM^j-2g<5!wP)C3hxR8@P0ey(wAVAqO9o`AlE49t;n zP+MHBax|Qf=bpC0{;9f7UYTf%#)@ey2inGWP_BPio#Xj9_>Y@IVJ?Br5s=(@#d|j^ zVh<5yrbEa~Kmfh=XFlx&SmHs~gom^a7!#bj-W*1>?>Fdsja`1Cs~X}n`%Pxe?*8_d z%PytBB?Y*^tFdSz8KHbqAR_$tTe)`TDo@+#;4nikBhS_ot5jIO21JfSbdQHf} zJt3)F%Js@vN|wReRh>PcdGy(?*XL^RQT34L&~@1TcrVL2pPPX3`;7xbG8xs~s3DHN z>osm?hPa)VvCQr{>(arNc&Sy>6cQKHvAWrXZhl)?Wky44Fq~o4h?0PS@Vu+7 zlv#GHOm(zF{CK1EYmFv8pFj_;emdBp6ef{*zSjjsg2%&No0?MlZ~GH}No8xq?oddggMiWdyojx9`g_? zRvMZ#_u?rDe11kwDAz7RFg>}v2oiD31};Jg3`~3yekbA1kriB^wcq-r4ot&6^#=By z_@$U;IgA0EBhs?bG6~i;U@M=tAN1*5v&iU~Z)}M?Sf8b2ab#4g*8KUAq0pk`25%tZ znnL0bvLWACdB<__zcuPx6VR}u5H~K7WqZ8So>F=TX+SO(-Le2Q~9<{|p zk_L_W`6{FSojpfN-1eu-OQY&0ZIEev^dT1MpNjES_twRA{PX2T3rj_e@*7Xl#hO=p}`SqGN(46PKi{YCK&!Y`d3ZIOGu-C!gz?Z((n4# z05*xLuX=-a;u^!wy?uaBBcEfagZVe(uIBP<$N(7sH3ARc#^e$QXzOQkh}-`Nyp=|M zq~K%JlTC7AbaX%WR$Q>LZ2)5ADnpGFdy*Oz1Jxdi-y@`Q44&}2g)jSX7OSyvv4(^< zme(Is)Zb+PCtn@oW0~HG2T;X%j-v=I3L-FwMyABn^gNx3fCN(WRDxFbu8=+C{El*8?@z5rq;W4XePp#(Ths*=j`OY*N zoiqotzCV)Vr4aSUR|TJewpzs|!b{574A-bwz5#4*MBzq^`nl6^_eW8V`~XsQPj<&P zC5Eb-DJo~3b0|bJzAROZBYin6=E3t)Cld}EFncb^;T4}wjeg&k9;U4hdK-(f_oBJ4 zPs{$uadJ{>4Bu&zxAWYzhQY+RT_@i`S%swT(<@E7^Ne^nkBtk%c4Pm+8+seP@v3kS6PH@N#|HX}mo^O>B#(X#(F-o$%VT5b2VJei+f`vjs7VORl$i`@&KtU`+5| zVs|f_33ug@!+*YozEd<`iz8IT7(;CJhV!HSP!KaDUCe?`7{DjUDK?CA*)IJA-`6V9q{-l0P zO0`d_1}tE>7Y^VpAjXdsUAfKW`WT{9*PNy&DVto$YeZpEJuIFy4y_h}!Tp2~)5Odp zk06eyrb^7<8^o-1)95n&hoQl|Y7hO{>iJoJJJn+U8?}#k{*W)8BkB*UrJ)T)&iO<( zYX>U-@O4{UY)9&I(>A5<1u>rN^#-q~BMZfv&U#|=GY7I#yZoR#t`qf&fD{Hoj%I}@ z2^mM5YqVEkoA+gH(eym9M|5Z}KO?``h{8@{ARnm%XPA$(0?JLiCeSO(0P}CG;r>$P zy4Qw8_1dUaE3CKjquX$?Erg1k`JK6X-ePuxFS*sh<{x60Pm`@8`W<+!*HOS52koc$ z?C4*#e<_H#9-6ppCS#6Ir&yx_X`K#@SthkA+{MNfeu-z(&pxL5QOU2sKjSaCSt3&j z6{#u`P?K$Yr4#a`Cn~f6As7ETjwpBeXI-E~v7ct}yvNuzFH^k6&pl}431JqgZw?}& zQUB65+<=m=r+JoY27^240KfqK{WobHQho|{`um>xsEDbU#&XrELOP5q}?AaF_EfWuMIu1Y^atZ7DEJhJYtl< zF$pJ05U`~}GiqaQ?|B8L@Cg`m(CAf~NNA)p*D?O2%D-nD2IHw(?P9>6q643_tzQ(0 zT0IgTXxH(+21&5F6YVALTuzNi8-Q~17fKKV3@q=@uJqr`YJe6Ye2YEDclZzVj5 z;YPs6yu3VqzJK>yaED}qzu$ylpQ`UfsMa{o)th}CCEm$#Akf>JNbQVn=7Uz%fcsR; z%-o4VU6=XMGI(OYzRZ%|NhNv5zRRS6i=8N&-KLhS4606WR?D9HM`>(nFsUw}lrm3v zWSU)Vo!dh%6{*uW{CMSbTY?3a5j4b>Cu!f~ZsW72w3oqC|8;sACtt*{hwBFdF#DpDzDShsvAtt_0 z5Mn#!kIDPg{mL++*wf_W7m>WS{!HObyQkS&R4k1(ph*bvCqvT0+%Sv_b! zR|h}#XUaxrb#hYq=uzl(Bu*^C>t+4U8_)jjewvGLm@-6~#{@LnF|Xev)cz4Xk(-=8 zh#K3Wylj}S_A*E(1iVUcrl!L zeP=v<A}e%$3vV${ou>dHqU^nq9@Tg^C&4m-bA*0KN}Z#aLrUiAqTCKk`&*d$d|hA1lMU3T;5}>~MWut~ z3mQBqg9TDi(^H)1Hph*!_bcMsP@B!^?IdcsM67=Of`UdgqlQ)XjLJV^fjt>Nu;120 z-bi@w6h`+WD+qblBm@iOF^rQH0!#UT$VI+S?j);>lO+O^>wV&1IAALIQt#0!QLhh@ z1Ovavj5x3`d_$%{q-={VN;Hi`Osi-qJJ^^OLM)7se>Qu{d)$QoN!=IwJe~MS4b|d3 z=(XVFQ88A2e=M%xy?eX+)ZSi`i+~`IFo!bpS`p#aBs%cMEkm?zcRtrq$=FIr@IpDe zA_M=EIxre==Ji@mBynFeA#~6RI0b!^5xuhgd?*&9BzC`AZ z_eth(BOVF_s?tjc;sK^M_O766g~9e!ft|>7ELNmnwsdnrB!H^oetdF%av01lvKBeL zE}wK5ejhlcQ|3c8XW@lOdj&W+iw0B5z|Td$dA;Epz%~XR>iL1P>3Nmv<&2E^iMCjq zv9uLkAC)W-VyAjcF)mN!%5$FcJ0n-R8N>(cjRv=gI|APiC=T6Qojkt(u@q!9sG5f0z)I<;-8ju8jkItxi+t# z!9lvXug^3;lM2-0RxH;hcV ztc_eAglZ^r3vxU6dM+fJ$gKcap=9>s62K?M>XWtGf0OGT($aU!f;JwDFp!8E_}_!@ zMjA*${Spd)cVtGXbX==raDC=4)STsJa31RzM&xz_KU_t|;!ZEg$bfNQZkcEqzY>oi zoEKRN5>oDX@Y8OV9otYYvNs}nuSYH=e?YS$4f>EJP7YaBEH=OlvtHvHzB5s8c@?aL z*)=atoBsU^9=kB=ixH2_nK+*v1PV363T!CqN#ofPS`WxT; zf2|g1H~7)Bz-NwQ7WBa1>54Fi0%rYu;7>K`W_xhxEp2Famm8m(4Yhb%qTlD`p}>c= zFwrTl_xol%vae( z?PSl#R-Ags%zwEJ9l=e}7*|&;lwuLNF`@y-Y_#0sr!saHGX{Q!vNC)uYp;Ja|9)aa zt;Qsb!`GPCF1bF$JptBk*QLCMf}HFZRE`vX8TnVWE;96>CLreLMD#LTwobN zki1`O1EMvwba`H-Bl^3cBbZ~Pv=~#ctfXA?Qq_9|7;W{H>sI$Co5$yl|D*0LquTzS zeo?eIEnXm4gHxb5!HNfh2Q3sRuEE`YxDy^5(@7>YSBW5SWqj9&r8}&2!-iX(u!?;z3G}R3I72s@*1k&X2uqk)ss#-o zI@m16#Uzb|a%zSQcb)(aUg(YPnHFB8qVpJKr_mhqyxB}Ynpx447F1TZv5$q=THwTZ zclC%}3ToR;0@%=7(#pu~nhlIcoXc|ODAM(vwhGyVCIc3cGLfuP%KRa^KeRo+?UzJ- zCWVUemK^ci=l2GJJ}CZL^trjNA_@fTDg30bZA-eyHmJ}`g;H4e8iBrRmM?I~sVWN% zKC@GqIwG_;qKl=ivUiX3f?~UHt8COjoFE-_9r0usA@UR{r?794M@V-rE z$tB9GuzqpSlTn|?r3!q05^e*wam3yqTyFfPGSgxyyzzYBvN~RvVz;J>gGoA6sXCgA zIbG)u+MhYihZlKmmXyD6VB3hFjjzE`s1%^QDn~y)9E~kl;FNLc0O_o_n)u3GB95y- z%EOAiIgn4=b}^rr?w@)n?!&N}XfCSejngvJ8>((jw9<%-AG-A2dV14?m;cG^It&on zgLTa{==>Vn8ER9%Z#+)2&W|bZbnZO$fs4?|&Xn@lLNx@da^Qg*!bfwVE1FOiTnVNX z`bU=uY<#L;O=9YHbG3&onU{H7GG)*jK@Qe%5=~8+K|N4W?rXY~7!Sk&Pn@MGjU3j2 z@;FovMB>2gcDUP8qE}WHK>7tUoP+tg>2xT5@Pi)v`wEJ2Chf8{q9atG?hFl-OiLD- zg0F2!gTdtq!ANH<(q(;*EB+mJFqS~USLXDqRtuegx%=2|a@~?!P61U-sF1(1^d*M# zT6nPVYL1_kPW#pDA!9UUtK*Z=1BOl?A%C_c?+z{s3$=TKB{z-Q9y|M0T_rlsmX;F8 z6uB;=IhV_`0t)mj=ymOo7O7o$#Tmy%+mEPIiOPe&EG4q3U zmx|CIXBJ&Rp*41ix1*gU&ZrsUpB|K=|-`mlFm_x z3K?u?y4MkK21Z&I5tBz$AIgSyV2~>=mziWalXok9=iXdl*74fVGma@OuN|+G8%?V& zAsP%*?~i2eO5>%~vDt>q+=rFc${!3F^H*=+|FDEbNw>kJ2}2+2(-n&%bjZN zP1))?fVAV==1Xv_SDp^Z2R!LGl$GvdKA+ja*qosB;UpIN2>1w9Ca<>)IHidQ;Y$!7 z2*Uj2$~J5U(#!T3eglz(xHIj%9n~x?k}<^EcheNG29=iYq{>TN`EyWglPnBp=cl-9 zz4}4%1MOT}>M0?yZEI1fA)9@UaNxWO${BxY`rHIvd7Pazr&aw)7#Rc%_HI9@izovo zh7mAvD3sx6rqgoSe|bS7k`kVtg_PjZ5T!K@Z+@mq)5_^Qu|RRb_!tTk*b} zoRYkHt(igZshb_?UcY<{%O2X1Y>96o-&I?NqVHPerMOh_=(i{WnbbYj2yTqH>(j@Y zUc7$o?a949X{>@{_8R-$2=sj_ZQB~u*-evtWt74r6n8F(=u=us2|~w+dxgFIVNq$2 zHmqF%ED;jF*D@=%q%x^_A_8_UaA!X<=JDL^Aid5Rcwe4QuM^A9uFLA~GI|hWFR!oE z6iP8D10{c|8ye*+R{|(ggGfLD-IC^oa5=g41b%ClJVwr+SGiAfo*$|f3vQl0kGv)u za$QM{vd;?EYKZtbq6h!bD`jS3W$;G!ru7RxQn96-AybP$qw*mNcNtI1z&A`GQS}4> zY{Gj|(nFxm^|95F$%JIzTFw0ZPt{IOMHbj+Y+++3M zrcyUoc1|YCXWR=Qhp9e0-^-B>Z$qBkgz-ciDk;%LCp&&8=xwK)h$7(bG(oc_3Uf6Y z>n-JPnwsVqCbONDXmU8xc2tvkuEs{#V4RX7S*}|n5NvM5t29$e?b#7pv)6q#fcs52 z#ncf|w%LVybhteiTmpSX2gkMfd5qnPE94hQ#?jy!f8Tzt6a2f|Ogy zNJ-KegFiSk?e;QS@7U>Z1djA$uNrlY7(C!}he4FyFYyexI#qUL|6=Bb^q~%9OrkS- z5-HZ!u^OjKLU*XS2t}hSsHi*!EfXrYNE(LQ75A zTkj4$Pv44HtF{TX)T-lPCZd1b{T?kp!SvMJr&|$3rV66>4rvSz_P5V3Ye^|i_0mt5 zCNV3UHQRANm0y|sz^W_PRAhV?FFy2YA}u{7_XAuWuEw32zv)8FsYxB1EgJ*;!oik~ zNK9>k7M)m#caHX6XVmz)Zt z>oBlRyX-~L6IB~1r7?RWqwTZqPwVfH%w=WOf!J(OJ+!2sRVy39zM*O@stve)AIoH6 z^l8SE(&KW z%%L(K7ov7jtf-|oJW>{sIEE3d?2Dt^D;{`yG%pnE2eG8jF<}Q5LTYY zj)%w;JjH9EY{jGuZNQ;|NECD}`jhV*iAXDroN@UEh)29C<*5_m%ZfFL{!|+bK<5!F zhGaOV5u_CJj%5KRmui)N$tgf|$$gq=BYy`*e`b0`tDrmt!XFYZ>NCmuPA7~pt8QE7 zT*pIs4{|I^ae}0~(M}n7+IM9(I$p-NLJ)JfN5oGV=pPGXzh)7>xQ9#J6$H|)FtL_P zxvU?Te6~A?{lSy2P#%hmh;guU^5*=p#);p^OtzqmX77Y^OyDyooURMz&c5C(-LBV> zm8njo@ONEXt^jCp3b923JtG@UII9)nXaFs{nu$+nJt+{g>{IBTqT%Rfp6p9#JdR0d zN649`1PTgbQl|}HY=5n+2o)7!Wng$t`;Z>_$`fWcz31^ls>M#l*=91;;M&d6PtR7D zg9xxAF^-^v9(7~eJ+<7PIo#4{;b@2I_SQ>Y=lv=iq6ArIxsum%zR}df`7OEKrD+I$ zD)&u6`Uj@&A(1tn+$Wg9s1WXS&IB-oCMTMCxLW777^3~6iC&J!qt>w^8hS6EPP=rz z?M^Eo@Jel=nhf%8nVzsj-P~-$34u%fE>^!I&8*v;_KkU0qRlNy)Cc7B9*4_^%Vfb8 z)A1Ba9f8s`E7p;78RL5X5#_2H$sUWzxaFB+yVb9Wsflg|t*mjAJk_flhVDPM;3G_; zi}ZsU7C&+sIy)_z-WOF-u#IX~sLqVVa%jX-<{73nez8MEhsX5F2fNcLXsEADhGz-~ zTKB}pw-Z~s{8TL7*{Q=p;~Z%GzB|l7xv?tx$-8ImWU_iR`MDX6xEZYSiMIBKk(zLp z$2fHz^6JM|YFErT5sq3G24B*pOXjbi(*G7^|KLb2oTSq3_tk$GE1SFIA9KyU&IsXm80P$YN{ut2QL~84`&5l{1-Usi&URw3IalWN<1sDNLM}SCclo zSKHC@SS;bRo4ZZ75Y|x9xJ#jNEf0&nnvrBapm?8UB;|~)lT+3H!Jf$8E5TO5A((tL zl)#{%iOc(zA5(|u+jklTzcP}DrZq!IzR@#4uflZ`JtQtdnnOVbRgIcO{Qyf2N+!T_ z$dDyi&xjHYEWmytEGK8PvsjzutBiG3oGzJdb$T9?@a&e5M&Ci8p#VFn`dO+=Z77#6 z!NxY{s~10ouvkNjhR>t`)f4H_d^}GFZkwO!#%7oo7ndi|8^{`Mf{;YCtXnJyMU!YH zP4ygQPP4f};n@gA=XSi4uu=ar&KT;96k5CaBFwDpT*{mDYP!rV; zU4U-L2BV?5avBr?Y0x_h`%MSxs5|}1V}pnWJpANc&F~9MtRl&aWw=~9QfIX|XsUNM z9!~>eaGGZh{B1x#`ZemC04o2G{c#?ah#-RuEx)iC0tsis9PTz39IyCV1 zCW%cUH!ff;{tj!gJjs#GS8iv$G5FBNg6Yb_e)(OKM=}a~dhOzcp=>|Ckk`92v|N85 z@4{gPG0HarbNgd*dS%Z@!}&Mkm{ZtM>6WBZsux|!BRVTgD)d>tWEz%HRjk>n)PD`U zEZyP6lQkL*UV_G;b7J{l%4jhUic~mt zBRVIiwacBHvX{+$TGQyV@$olFYwHk^V{2XS2apN{A1+-xmG_@Ps$`pO*57>8tLCV~ zQxZ`idn-+{L@M#&TE7VKq3M_Q4Q~#$nETxCWiqb4WDQ7z=lTU8*ZIRYt9#l&)RFC= z?F)|%esn*7uXV)`diynoHFk5W9ScVb zSHfhy#DXyIqn(MvbdpOX5h#k&rGJzzVX?g z`Tt|<(!`WMXs^AmZylzPd5|lO)n3Oyviyqck*Q{Tk=rSpMhlgMvknFj?O z0ZY5;eg#M%rxydp>c~f&ON9JWRm&^obb7+dKJtsb{XzZ}OTu4P%1DtE?I$5{I?osP_|4b1hQi}U} z7QJff7w&7Lz8P?@6@9ppj0mao&xnBhRpGo+jid*^0Ii>h&jFc8Rc{*FBEd_6d&tdr z$uYvBdl5B0ocFo6gG6 zJQ+Z`$>RIvE zW!(O{ya*x%%Tb+FP5bmx7F*U}+ESf&_IS@^jh!(Uk`jG@$u+0&)MR@CRh#uDC!MGa ze1T_GF8i(SPg2Dx;0t`sB)suySGQN;h+jXxMrxK;5%CmW>!elk3J@qa={E2M zsuv~+Zw^vAoF`LK!q&aC>gAwGF931@K@00T`up%18&_SS$r-&Zf=-;7qTuV7g0b zoHSzkksnynTi0+|X^WRUi> zhrJkCvphoMzMKBe&P-WE^;zXyyJ$9Tn%^}!;e_qgSR*tEcQV0`OTCTWS&I=oq0z%$ zXW?viC^?3`T2cjB*3f#dAjy;j1JAO0CP)pl%o^R?HPi_)@hzj$)s$ z*tD30U>=)NDu}#G_^f-;<-#>E7WBlPBoUB7q89WD8nXYaFx~s1hX;f#$ogM@=tDh`tE&TfB{0*6+cR0~p1Fcalc~K6KE*$f4 z6KJ_NH%HJCyn(0S-1kKw|GRM)>bFG6`sr(x_!< zioBcTliTL%tQ={F~7a+ zIL^vCU^h#1P<^xWV_0;{L!W{}Euw#Sv1r>Bf%J-jR$D0SV}yje0iiB)Z@8pgS!~Dg zlvxKouWk^@_N%UVABUK$wzAOy@!jFA#EkF(ERZxLJ! zqwR92uE#ky*QM*rW$;AZGt|Gd&3)$0#EgFGZUL{g|pYzbi@d>xB1YK{g^IR-CqoNu=4+ij)3JWyLqZQ%_qDAOj zqbWydP&o&7-b5=F&so;3{(!Qodw!u_)$AkqOociavJ()>+fv$2n9clSFfHVJs2vgg z%MCr8XV1NUMy7{MaawUl?XbO35RPWDM8j6wtSP6xcy29Exa5vM0A)5OWDy9iEkhV& zS-o7};yJ{}SfM329QQn_+a--X znU;mn!h-|X`h#rJq#}|>xtIV-pH|h1w#dCoh@8uFmLKnpA%?3=%qhic!Dx16{aSG- zlNVS6XDwL>K9$eQWL|CTuHfYjk8U)6(n(?48>tp2Z5Xk<-w9d zf_jatQ?zHQS<2bfA3ok30*tEMvBi%YD@q|vf+3|MuN~6MSPMNmXSmXpWR%!KTg%iq zwCUt1>8?^8{5E{+_o7`Vp zcr>M{|9pHlp>3h-xKXI2ynp(;Y62qTOP%hF0;H%+VH=zCWJIuzD}jqHgsrBZr>{~f za%E@yN_#cm(Q3a>`@vErKl-(&$UaW@a3gSx!SbHgy(*~cA$1}#^6#whImI+-emec( zuN|rI#Fvukd$7wlsOHRx#5~Z!KaTMP|7RzS3;+L}G?oAh;8I^Mg?FL+JFO_>in(0v+%!@&JTN$9G4frll;d6GIeCZPN_c^i`u4b zEPgJczEDqru#Hn#V%%P2l2pFw41;f?nf+@y`H-uF^;suRsRD!bEqH7$1C_tyJNIIs z$GtDkcG6wEJ7asDd;~*e;uqLtQpJKuhs4rgRsWecVkm7`-V3LU@v)hKFY&{86uGQy zTCw0B@)zhht3$94J0JSTq5en%sTwQ17EI+it5Rr z+l%jSX~PgQ_M##;-CE@jDWl}jnw5z4B;`H-5e}Ut&F}LK!y%C(7@MkAvT1Wmm-@w0 zXevcj*i3^-GNaH?sHgC$X%<#kBy8EPl)ST694#7^0{IS{>QP_Ph_B)|*j%=HPxZdH z;0+`ErMhJP_t1@kdUFxlx_%1b10ojYPh?vxFmm?Fj9C6X{CdF)Tw$dJxuyix9~>36 z@FRurrjPB_+L3!FgQO7y8st>3%De*Ft+Qgj&rupsYhE;!wU;<0WWLj(L_dkFs2|pq zGbH4X;{DKa%~O#lTFmeF2G969dP_r0Q3(1$x+E&8OdCM9GeZZ;b{R2N zDGn2&X~)8jFa(g;^C5HG3KtGGdq2YrsO4`{zS-+tBfo?}mM_SjBoyX+9tC!2(8?UCVE3qEsFGN!U3}K z(e*-3x5!SDXkR3;pU&M?lepH%9&A<2Lb@144_|)v3rLgm1O%{mq-!oVPmcKVu5!!e zr*y|5l09dQW=Hn@FtB{ftyo#@8fhKK@r~qy(tgfCX$yQn9-(5OiQQTuUE~7Z;6`kE zRV!Kxs@CjDI=a1b)?#i-d4DQJ)*!=E`!>fTq4N^?swG=%kXVKem1=dEWX_r|LjxNc-Z}m-lh_E)sd0!ZXW{l#PX8;l-VjRjsbcm61&%EIU;)?gr5_f zo^;ug&YrUknM*bcR2Iwk+7ezTF1iYK3cnw8EEelX3Fmv2Ym+lt5|--t_yduvzL(k=!lk*I85K^26$A+=LyManr{{f$)J9&8E8>m<3C+&K91r`3J z5{=gyMQ!V4_Z26m!l2o|-i^Wf=sr(y=N~lR#3JC>Q!77|zsK~y{5^k>2IHPtd!}a1 zyL*_8_DEzoDDs;^`oG?fyV>4ae@hgCSV?l(-PYekFKd55f73;Bqw0Rf`~3#8(3d!` zUYFi!zfis6DZ=B~CDfx9ej1iQYy1Fe_Ph3($&dF2=e@@0oI6NVP*M1uyPva?_}acz zr0V6!xfnr9*}9m1z(0Q$|Ia~t=>PBssr<(uw2vBfOG`RZhkgB%u62t=falk~0kCtP z>TAoOzu2tycf?-!F-7?4`ZwIXzvX2!_1-L)1GcSKFf?hn`8H0zXP|m;blE>py7&7> zNpeRrGx7f8}h`GQP*Ao9Hdo$b^&cZ)WFpgzs50q#Ap=6{$$WuKbbaoNj?_ zHJ929W4!$0+#^vFGMr);lfnGsR*5>eax>Wt3b?@N+3=k0-GB~oov9oPx9ET59dFtsVm_z1UivTo+cj)AI}`D zXM1gGec?N^al_z-;Uu~E(XnlDMn$q{@);5Bxt!}LG}v^Qex*Vdqk?EQ6WD6cgX+DR z0-Zdh6tK~eqJ*pEZF zf_Xbbj+j48GZ*Lly_Oa&YO_resE%|QYVt;&wRi~VC#r@Wah}PjNA+AkH?nsosNzz_ zdba8P>$M}X?fJ;zhOqTVt>+!zqVZ~|bOMs-XSy{VN=|!evvj(7DY$eS0(B(TlUF2v zQF-Kd531aY7G1dv`p2i`elLQ2Bc!U8z?L&bV}uo7$98RRsv#+C*PmJ{@-v2MtW$`Y zXsuK`{WiPfZpoi+OWm7}E?S6`1(7}Xylvthpk%8|XfbYFRkxNZo-^_-2T>30L>Ltd z&l_hK(K;F_>+NlM&74ypI=9k*z8#mGAi9wmeYya>FoX(JM&tZHD?T&ssO8y^cXy)h^7 z-SPRB6fS!RD4@Y-~ot?Q(ZC^no$n6f1#LRh0Q_l zIk}X{<1Les=wX=7fg6Y?eK{q4`hH8*aBxl}g*-b*b6XnWGPbU&4@v0!WbgS(guiwge2 z#>}sr>DPeCq$X#FphRM3MtJRrOToK6Bx9N?Ue|Q_Qcu&Y$0osDt{dMuUw4O%V6_k{ zr0ZlD`gJ&0+)}l0RTVtxp_P*@JhccWH?GaO0xDxxI0HT--08gD~7Un5LLz;E*SqtX1DN2K1 zh=@?h#07k;UfViG%txM=Jk_CdXO7;IwHKeQP?)fVxWMn)T9BS~)IRrufuvu%-UE_H z=ykofNrDU6C&Y02PQ2D^6aeSb={*dFH?xflvdSUCOy5R)(tOa;nSjMGa?a5);3vD zT|gxHWoP)^ErWg!LW)goD)lcUKaBf7Wm|}9LhNcMF0-Lv{b5#a;}4o6ym~JRmry~wvPd~aUTC{N@;8hxX>f5U-duwwgHnz zE}X!?e^a6mlJmSAQ{AJ;5Yi-D7GsajTKa_@c)x@Ud5M~+;q(UtmX zN&U0mW#dpMaWhntC3~pUd1CP8^JUQ=H1!@tAh}|5mh7i*m$s=NFDpLvR3cv;TIjA8 zS(H-0&z}Xg{mzqfnmA3MDsp#{k&3!}I?hmv+-#)dL!Z5S&#T#^KSArzN0LfH-u-=A z_QdGI3+^u(_kMg>Nnol&q(yMYl}rE-8qcd-VVil8An$oLGTw$rZDipEz%K$2b8ajw z=WwvpO8w9ZF!>bbsfcp$S~yyxQh@}*MveiA!grk@K%!9~$Db-9xzbJM=#$?h7wpI?XAo4E{>bC90O3 zzR+kvp6n%A6CX(o%CX+JWgV+8jXMbu=FyM4eJ-D>=0{D!htzjviKSyo!!y9#-;J7S5Jdyh>JfHntv&0=&vj z9;jP+p;o9yJ1?t$1=zu?JlyOocvY>OY&>ik1q6B3&0to%2E5vy<{rK-R=mnEGaD;j zoxhg`8s_#^79PC%c9tksK`E*KQW#$;rgN{P--RTa_qICZOaUVR4Ml(c{QH237Ebb% z?|;=j!T;yolb6%^zjuyLK=gm7d%}DmA-@0p9`b?yM<4$z{W(D+mO*_rR%n)g`-kxd ziT(r)mZ@naO=pxW!g31MZtkIB;Sr?+vvYX( zRL`ktnE%yVMD(xXV3g*%dip5ct^O+hUwZ#fYM1@1bMt@c{OP}R{;TrF|IqorRsOSr zMvR3TTM`TsOcJ!$Xqw_Lwm2k{{I4{qWs#o-H~R6Ue$U*WHkbE*KpJQA)IrpYWa=9& zM&s?gao-vuQf9^W766nDocUzK=zuSGt%m%D6jo#93xVjQP5XGH{55!ZRv3HG0(?#K zLS_ti#^;1tklBI7vz5Ra*lF~GiA#YO@4`@JE7fk)6kFF5yq$eJlA{fabv%u-&8;zm zzI1}yWBU0vDd4g1r@*B?BL;=?J_)G^$))jpC(2~0Nmj}4Y4;{l{;uBV+h5_y$3_8X z=nWu^E~-O|(^!>@fj#ZD_>rAu+k#~8Uq90CO(dz|4%;fZze&NZu!}*;nkns*&-Y6Y z8!6pC@5yg07@)cH|dFG7Tnc>yRdB%-LL)8ciq=ts$gtb@QxG3l8jJ? zz9ZacEq5)5>V;YNb!)KQ$m;L_*{bkQ(Ptp|i>NWL@9i8>mP5@Mu@Z~#q^;T}64Lb# zdu(o z&^6lm>u%cJIq>auLdVymP`(6_I`boBgV#bOi!x8ryC5^8QUPBuXT)|B z_h>zIt3SEc+V(j%?{r~c!RR=Mw|>0lQ@VQBsIW!})P%`B1*HYcV9($lG=4$gv_u+M z_s%Jf8`b*u&Pl5pVha%LX(q*(O*@k!xE#L3tTpU$?Z-YbkeZ$?Ly+EZ{}Y#mjUrDD6eyCCdlBM zy*w)jP>4PP3vt(Kij;e*xMJn1PnS3G`&cM2`Oq;YNQ|QqkQl*8 z*ZjizRmV$0H@-#sN5o{zN1)cB*rnU6yy%jkgzF`zDOFq5H(cN0ilLr(q%vJz;;?3i zGI0ydFRH?BaCwZH;4P(bLl}Nv8So}Ysj-whBqqLYTr7UZB8j*5q^ap72=HwCH@?QH zaI%GR*{y|VoG!;?kL~wY9JMF@WLzKx>d%QvltD_c&dC%=0XOZD(affhqTV--S8TN> zIV6I55!0i%m!x{Qj|)hpHkSGAVu;DwyF1&IR75LSU?C(z!;4~Jv^UW3*LdUkS~G!e zI^l*wj$P_@VaE8ZUUr!tcpU7-C`7lm_)P!eP%Yxvvth;SC~HS)QY5Q&`9jmd!d)%Z zDLqhb2k&Z{Bt5i-XwMFTwdn63CtWr8bI7}-iAWz>kHCnAhTuIWA#HDN2+I+XCp ztF2g0luuWEz>e7?4cl?8Ujpc zt7}Kl3aGGKH$MB(0i;S%fo>cK+T9BeIY)IU2Y4UR2(uk>>fd-#)`MBfu+lVjw_p7LM2l`fnY^sg;~^*UCd5~Fq3268cA z$hGxRPe^@XyXy)R76|evP;4-w>(-L;3B>nr%sgo9bZe!%Nip3wxVCD?J1^=#gQCo4 z=%C}HTY+Mq5nZYs*Vm^-8eXEkj%3n0hVX|k+?OqW$HTnaV+C};6~yrdna&=^jrlLf zz%yl?y{M^*E}Gq(msf$=J*R+%ndvJe+|HLLz$4Kfc^b{_JNg$30B6c3|9*T-zzPg4 zFz59tdBe=vB`fcb|H!<5`K0@Y)RAdjVm?R1zn?CYyYtO9@h=phKm#OhXL#%PTU?_R zc4Gs|Z zFe3ID^wC?RU{BX3SxnG(%)YZi38r>*r+3k7Q1di+ts>t*%%GlRMF`O~%A60^eGB$C%2HMc@cdo#`XtHf)9tpqk=^86Ie4Rz1u+)QQ@M(6 ziDhb1-=}OYyw`;Xj?7Ia5x2&o(aA4=*3wq%p)6*EuLTq<4|a*2+azQWr;r<%0DF~o zs&<@~k`F+TOc>XkhPB|Gj`hVILH&1CDHOS;I|QOu@?d|vkEltpG@~7#jKCiTvSh}osMLjXD9>RR@vsd;K80K%&EA&6 zM!!;KP-g461Q#u6G7ba(p`}=4DlGXKEHf$cC>y2AZgFHH&i0A5f}kRt+o^rX?;& zBWbqV84JL7^_80Hq&|B%wzw!4_7FLav}AY2S6^AA`AZ&x?YojC;@HFB?Y|CeCkE+` zN+uJQ>z$$ilH^HSJq&Em4G_snzEpTP`Rr&$ZoSr(1B`|JdO|~Kt_k`J2Ycw3qnqes!rAM=g53XRzGugkWPk+!dHLobCOphO z#HW{K&!^qigvx-)b$;!i(6xLi>6zMhU13e-Urezac;&0fKX~Q}4}rHd@r(MR z^+P~I*^SkaSsktm$?$u)2#4=jy^fC?m{H`lU&6TSh>$iVd13L4DHNKtQt#nHL0}N) zcC~u_-dQ15VJk&mxy{^|DitaU+*5u<_xX0FM#XUIo@0_*naj4!4%fSvv=|h34(yq8 zMm+W=MzCS{O>+Tlguj1kY-Hn!(nDt^D#f3zBDiw)cbBVgv2*3gi7+0#xXge_!_Rt` zBVwP~s`H6(zhjJDmvnk$SOQGYSISlWc9e~3o2STPLFSxk?QpcxHSQ34uZ}abtFY;z-Vau4|S6x3{EiRra zlKWXye!15JHkjMcador4#%{dq!=^j#s^UO17yGrh;xrCmLy1&jc%QIZkaO@VC?i24 zHfJ)`b_7rIEnw}WE1^A8GkIH*;&oZVQ0=tp{K9E}de*q#cT6Km6IQj?kwY&^+e?%C zF_ZRMPmmr0M2n-a^KS=3W;Tx~gB!fQys|5`+*sH=vOaDowXZ*Oc9D0|bY1Gd6WHJ!vHuVMVlh2}AJ6LNUkg8I z+fyH34&(J`*dO#`I!w)0c=*xah1@X7EWc_%0h+f8k4r;spof)l94sX4I#Vl3Di2)S zkh(T{d-Pzk*4osv-n=(l3-7P+(MKWBtJ};{#vcOq{*$}2mG^i7Miu`8pGy~eK#3Fz zseZsts3cMI!vsCARDHY}{dF6uyx}R8KWO-n+y3jGE(hkvfxmp)!;iE1;rDxsZgLPW zwUzY?(B%o};~%4dtioFqM%i6$@S#Rs=+#Wnp)&}GM+TI&xbh;Pq7V_dTt<$?vr zq*d#-L7PGXxa>Z^+*?(?Kv#kI+8*}V0De^MNYwUq_bvCmujj7p;IFUlJ9?(vxxx%h zLlTMIivGuYUlSv#5EZF(dtKXB88$rZQ9F`n;Z2hHccex|9`vE`sN+7qnHfx*nz4zt zz?}qVum0?ye>S(S?)*1lUwt?C?hyPHyZ2H-VA#dF&u*6mr_?_d(}(AO(46xxhQE0Y z$tR9(`F{Oz!`&X_KK#{d*fQYPaQ{4T3<>}J%|Ri+m4Wyldhm))K>TpcVPS?w88Uwl zUK-HxJfmQA&@F7_PS@ee9htu$ZyC@*b1D)w((Ny4J&D>h958M|)PiLX6e-xYT`9!5 zb#l3#YSr!9DJ`oFIa6y|08+E{+}uMoU$mhM&txG3L@fu$?l5WLg=HnSz;b{}i)*)- z&V6|(ll8F|bYI2Ju>E7@;hci^?1{4;raF(wuvd^-zgIOrWLeGL6{^R}8D>^4eh~Wp z+iVr-w#2w77)Lp2I|s&M1rc-SluFHFn@L50p&z`tHC@9@=Ina-SD-q@TRg0S>t9rx z@(S`>8*(;O-zU?sp4cZwl-l?sC}&0R=k*-fw1W2N z6hj}+#Ki_+>xOzyA<0Y8Zywy+L^t9&Tc?CmiO&7zN&2xFKj*ekukn&^15rA^YRL?w2TqT53R{Xl`} zpI1JJcy)~)!Q+Lr?dg`(A3u_UsdnCaY!rj3Yt`6qAt8F6o}+aHPiDWr%!JNry-_v_ zWTB}06uv}nCI2=q4;wL+)nc8cUf0^KJD{Cw*C%lyrx($#!4Yru*=2B2pvA8_xf}rLklUK%GX1qYb9SD;OITbtMAuFCU_H6Qn*xiNdY_)ig$mE z*y>bN8j3Y=IB%8!IfVt987-D!%7A# zs+^NrdDBVyET_;Qw9D!&>eNvY$={?+%vsu@uDy_0+j1}|QUyrV>8!RFAfqRHr3dtJ zsOPg>Q|{^43ms^f+5f86CZRUp^46s~3x9Z#<%G4Gtp*UvEqT{ai`_J1L}zQLYc~G{ zY}+x&ACh%QzvWQWS>p~!7)YhHv$IlX;%Ys1{l_@4C7G?3D#F6*OIe%z42W7y34e~= z$nohHk|tr6ibDj5I@*_0xE-msFT^4moow!luge91ziXlIX`N@U$6ZpLAzs=F3>AN{ z;4gKIuL@)Z(O)7f#IuJ3ZA;xG+E0%MUdp?Op#tyQk$ahZKRbcRKlSoaho?B}afhnH zU50@_)JqAzIo3g{uQ;9?=SZtL0OD;JDBHyyTUo1Tk}LS6vUQ$snQ=m)MV>@zJwZt2 zq))(kJExLlR2^^@5K>7Wj+6M+vFVFbi)6|3^3h3gvE&g{tv#M0D>8bkdRi_#L!HtZ zq5cE>Qw)XcjI<<`d5ChI=%Be(o_UqQ7P#2lk3a3%{k!L<2gp)3PUQpLq0ry$7nga~ zFFS%cQ>qh^)7=u$BT!l;>qXE(^zF2>m}Gc`p=l9D-L=J=#zftkL_;fMsh$=A&HZ$w zD~DNpBLnZ(Sj82a-@kN+~*Qmk3>CNMX!u2LyC+hs$yay76%v0{KMPESi44&P(|1xvTKs;`_lM&0uJ zn5{B%v&_8pbk$$@{a?JjRa;x@8nzuAf)v+4u>c9);x=(eunl+N)NuLc&bue6XSb1u@y>0|~ z{V>%@U1%J)$_5-#-!qi-C^d;Fh`%>{{6~`YM?lYe^K|$~Ub1M7fnDINoL~|GKqu;- z&NU^VVnGJDlixXj3g*1)1*fxH71ayZjSO**{hN;SG-B8I44Xgy_`qHF@X3gEnGk=U zTxm`>bLx(zG-3POl@87QSWxQY^GjCg?Dq>tI;Wr)U6$fQ2AQ{(-l;A17siQQ%8^h> zYKi8&ycrpn4G4Wt8HPw^7$o<}$c<>8KR?njP|hG7`5X+pjUP(dc^z1gm04usE{UyM zmG3;N^_V!5VHwrgOSq3HZtv&xM+7aXOKEA;>Q$E^cu6{3ZDW_z-^k=N%c=d9OqRqZ z?2)|4c-oHmncDIi7zu^d>4+D+N*Z8LcKYZ5Vp|Iu0S1?hs z{p(87v&KhcpHGat{y8<*dhp0!F5J6!sbo?#SltLBrP`(ZZv#m~iN z;UxBfP0uf_|9_TEQ2qHIAY7#2#OWWS`KX^)o5LR#{s%y+Ln8puAAi?h{rf+_P;sQw z)5eN#=(E?I4Ut1O(Qo#}Wo>ep6au$Gqc8t?I;1*TsWl$Cjp}-ye>;gC%s=sr{2yTX zYp>h?mjB-j?&F%?6EQV>KMS190Qt(lkP=JnimrL_Jb3}PBZ;(Ps{hP9lFBUJ&Hbv> zKc6J?tDO-?3U~GTC8=`PSA?wLpn9risk&I0M_20`FAVNt;CE_TKzcno<7lPo1fMlo z8LJVY!LUOiWm-WhK7PXnZ)(2@)-^{jw&mWT+HES!t^QIW>*M@6Rz}yz_ea9}VOAM~Zx^e(GoOyl5uO1D>hjy@ z?TVMy%plDd7j7N>b!P?*ay-S+cZ3UiJ56WOX|AB00>OFR$4^}g`~>LI$j3=n3cg|g zHJc=;WS7=m6b2IloOZM}+51&|w+yQBX`NwW>{dvJ`C9umi{i&+;~3hGZ32l5vGng# zm0iu_&OP_b&DdGV{{+PG?rktOQbP3R3gg@!QU|oY$q|#`0Ct*S38&rg*wE$OsE@&R zx)qp$qY5IGK81TZf1R|aDXB5VD&nQJXu&GQXo_-!LOmMRwD3tsv6@25^x5L4qHj`R z5mTMmrsy4OS&7E@wxs%mLJHe|Px*0I+649yT)H}?;hrxOTqTk0=)7s1&ch1)Mw*W2 zo->Y_+J1chN?MzC6zBCi1=AzRjlIVRHq3FksQitzKrVsqqKHpZhD*sY4Wk8q!e4vK z>kGcX%R^AD;r&4RxtfvB>Giym_kWCljoJfnfDBf40-J2udJMz6TyS@enRtAVfg#uG z%!EX&mivs`co}761%FR_p+0FSO>Xt4h%UiZr_WzL=oa_OB&$T~Z_`mG-49N7;?YP^ zjYd~$U3hs;s(F^cYon2DgK%?=1Amx|%8DijBtUF~PLgxhy`fYTTbbNa37*LM8aP!Yckglm@lll zCwbYC?TT5Oo4n61GrE2HlZ6)$$J6jS{8!}?dx%dsouH_1z2&TB>n2x#Qjvpyukn-{ z{2POtBQ7pLh+ae}ThsX5c#C(MxjjOz{J>v?=WyNYb_Vr(pGNS*hJjSDVObd4+!qa! zI^+B-O!(J!$nBKVb@)R3RH}!EWwgJ{w|5&c>eW5eA9+8otj70@F_h-SrcnA;Weyd*nI*#)Ws3v@dA5x0J)Gls}G@Rmq1lsA4<+U-}u@`b2mbL{uT(w>g(h zKhs`sRk~}uvM%OWo0C<7X$UM*LTGT9 zkom;%f%@m65tB~-iZWV%=+W@$Xy+(xra!)Ahd|S^m7`r;kjsUx`1Acqjybo%-f_EebR9ye8~{P;Pv`3kcMMJ1V5Y~mMltsv>-&hGSXDM{<7(h zhF8TT+-d6UrJcy(W#S@4^8d!6R+PAl!YKPXwt>ciJG+-P-do=v(oT|D@h_XcG2A=} zK>b4K!sC>#F9qfjDv0uJCzsn~_Z0^%TC?oy&`&)Rr&T^~kI^aQssb`_=I!-vKw*C9 z@lL?It$mez3!ssk8YraT5ec|?c&vF~Oa5pZd>%Ree@1>UW3e4Kqh~0>S!Vp#Z z<2tu9rQs%(j6?oEmfUWj910=9O@i06-=4P$g$E+G+w5rhspH_)_tLvm5M_$M=9#>_ zR*I~!7oNC=BqL$*drVDU!w!{bSB_YTCbKp=jx9C};M=u2p3+5G5v88rddwswKNWw} z40nwf(OtwYn2GXv>fHK2d+;tnsiect`GC6g+p$Jr(Jvzr{{;CHQy9k&lW-tmlnQR7 zaY^rpp^E%z8<~8!t+l^YG(E^kMtVlm{!siBR04>8!XT2*H)j1}CGU@NMaD@qt*WuD zYMJAR^)r?rgSWl%v4+cN)9kNQIB4~aKTnPYQXOuxPo~?=GG!mk1V-}_TNQ};9Hu2J z-fQH{$+C#1{kLK#d=69;`<9#ev+SmF0=mYBe9twFD@(8sdJ&9n=Sb_g>_UbpVq1~^ z<+(dFyW?%)?OYLG0x#Nk``@XrWtameUZ2S|)n-zyQv6O9(^d&rbB&1Com+`3`}$qG zA#W4s$tq+H-^;o?!M>wkd_@Q01mrO;2L_tB1{VD$$9R_|5pF=wRiCwYHL*Im43ZtG zOrYeWoEg|(;nzG2a&zRw)NB8S$5I7$y=2UbuL*`4hcV}WguO2yv|TxCAmAvEdRtq> zZ20*~XO9T-x3{IM3*Kpqq`8p#5CCW7EO5faq$s^xT+7@Huzy*Vc2Nw_YiVR9--d2L zAkm_@%~LH|k>H-r;u1B91{CRe(;IGU#rX^ppS9|TtZM^<^FiL!= z3zf^7vmp5iWt`=_8_D~qL8rs|h}gRAfmSWf8Z;1J#OnIV*1!Zkc5pfQ?@Ux!z4LF-t`c@DB0k;q^09cAq{@O)~pJ z`L$E7oAQ>;m8#oTiTb3Rdm3XlSRwl(=tifz#INI5q`?c220uY-DOSEDhEN`U5L5$i zJDBJf(CCL`c_xEZ-jv*&hP(h~J%sb-s_8XlOE-^+a`JoQIV2=R^UOVbgAPa$zqLli zGBBKtHqM%TyHWkZ;mxU0!(##tMh|1?n`eD?7j4FCTx5dl5Do@Rco)Tw@lf*%NIA(e#)I*elb{qBS zT+bh%^u+9eYu!Lapk0iwxLgZnl=y@UPj@ugzTRwWM*dB)%kYIkam!<`+Mqbj;^OUc zK&bODGsK18dB2=Im#aJWtBQPn+Fjd5rwtEms0WHWDN7I`O9Ubxmg?GxSKwrq{k z4E93$RLiTKCUF2!ybW zT3OUWLxQ3LsOt|;)b0&;9Yr|kHf!DpjO)FOhGow~_E%p@G#|WBD8S8c@cmnLp>6WT zy?glx{?9$vzFMW)c$*B0pf30F9(I0`8R?Sgb-U~ITuR_3Bk-eAun6KXO?NIzYx7t|WY<*5iAtQU;t5y!(&8 zMf9=XpB|&cFTNJIUX#u5cmGGj~4zTzIIt!wvfRKft-sJvrrp=EJbPfBycy zJpbvwhFdkWr}!=G>if*K^1#^X`R&_@?B6nhngbW#Csn>QY_|S}7w2NNR6g5aHL~Xa z2l(YweDRocZ5E(Q+!M#Sw3HSYxjj-Zw!&(PS6eWW zB(B~%R>h}H^qDRmYysE?z+kKCyzMCfv~a2VNnBg1KfPRc#Uo!**1#vjmI6_rFKuNE z(>4Z+C5A|93ro^Ry!`w;0#}o)0AqP z5n(K}JQ}W1;5oL9d%0XHmQB$lo|dCko>`DX@%7ba`_d;>8?bbf&K-rGE_1FlMzU(n zDz2W(SVhu3kf2_-Z=hQ}=VQ&^c(IIZWnGf%DJQm+`LZ z0LSoW`9wwhXM$f5sVlb#czJwqFhTj@-^^6cEsV8~g#u#?-*9UY;vdLp8QhFD4@cmI zAf{aQCmR1%#ajpOu>sYpRVr~SkCqp8bmpG~GlD%}(7$!G8G4}zCGJ5?CpI%3`Gaa_ zFd?pjI8MR#%WI|a9#&L=%lObK@Q*7i=IOiQ7d~E%?yo=v4h-lIoPU4zY zB}>=TcIE#$K_4d_2ze^Vh>D=4dim;B=jiKBj>JqgmmcbFa2Vh)PqilCq%fnV8g!@Yj`G2IaWpl48|6Dz^yq zuzjN4BS&40`Q4rh`6F^=(J-`&m+9DOfU=C4?5-&2oYia*?;Hf8L}@d%=bpPd5UoLa z3BewY8?30juelWENRTpA!?5sMcEdeti=y5cutQ4NH(33|oE?W8;xD_=Kju_-2Ndt= zMpIq%Gd?~|oK-J9sp_YwXh3Y5pJBR6Pytz3Byy3cW#=A8O~Wnf@^07FXD&@8HAZn) z+#)A#G|0<;px9xZIX*v0X(jDI{LwNt2`6jqpybzCd)dfC)gLy{(^yljZf5?1XDsaU zwZx1`NLo;ZPhFmdN>+5ptVS)p@ntM$Ns089^dR2Ny3aCPtd5rwOUgKoB8%T+5O&K_ z?y6veJ!M>ist8MQFYN^|K6)j;W(S18QNJ%$x|*9Ft=E)oWv@1%*elznw_q=W`rh|6 z_{3d;`qWV)3KyRM^Xe@a2hn_MW_3W8Qe-lNfvp<9m%X{KqAdG9nXgG?+_pBiE0x@9 zTi)T?(xhO+&-ZW&SLHVKj(V`nw>lrI=L+QHg?9-VY|aWaN;M)7I`f^^?-V80Bra(< zo<)!0#_J@XJ`S$*r{4d-V1eOPvaGoS!UI zy0*CqDa+EYNg_%^q&s@C1^EzTO7}oSya$2b#7muSJ7TBPgx2egxnG+MGM{Hk)01#3QQV$7t)3CXdyNVRF_x0DTI zJrE3ubhXqT4a*W|drKO9X|O%&ZI5jPibL5iJE^}o+-*X)ib7|V9J|C@xIS<-8IrEv zPLCeyY-QUKdp(PSd1nV`Qb)3UEG=t&jq^ra&VSd(dS@xDNf+g8q;=h@cq0VWK3lsJ z*XU1;L^D4^8Rs{nM*JNZ_@6%X%TjJG%H^B7 zrIErtSGapuu>%Qi!%b;;_GIzhWxbif#8}zm+E98#X{lAw=h~FIT&-Rw@n%h)(jb~w zk^)aDoE$7LVxkHW-m5h1oE2%cu=Dq7`Q*daBz_A`bVI_8kMpB8k@`#bSm%mK+h2Im z$Y%4B#q5R_IwLGO^QUf&z6iH~mE!0(BaR^hp`)F=>zM&^1HG%}i#qHVFITPuqfupE z!N!TnIFyH!s4_pDRr{iOL>U~Ll(g%B^{*BiBly3m`}R1aHc-{9NP+UsA{F^~Q%Sw` z(0VZ<$|9A>e~~G4*5Spt2uvsMqIf*XTe-!>>u+0M`!DUgs`FhJ`gcLb6mmyC%v(x^ zPjo@Q_(kZ=jo}^O1e>V%sGJQO{|Hcfb|$8hP6#EyrxNk~81BE?5@ryP)%13CXOt05 zo=05Bz^)lZ_g#aF`E&~oa|L25#@s0-wv_ods`J~D2dDgb+nXsfun|lX(ND*FX#CkJ zGY49=j7P~Ye+TBX`n0tr^Z$@BO6UgPEW=U9XTdN{W^$OMd6Fn!awt6hQ5j2ZBp+%t z-dfcrq4GauUHU0Gw#xRhQoI%YA|G{x+XsiOMX3xk{xsV8&>N!gMOlrru1(l-mJsTm zkJ$tE9rcGuB&k3rHFY$nIMXmGE_m2z%4hTCIZvu-w58j$OO04{AyL^hbr|7Qm?_ay zE-Gsu-$v&F#Z;Od(bc{{Djla0CtkWyklJ9jEssEnfi?-MRG3h2fA0)z`N~T@Ux;Xq z_iBHi;--rl#b9Jg29wr*}%rk2o6*TW9IR`R%xnGP_GjNiz# z@VMshs^>jpjFF5eG;~yiZULQtppu!5n<9)Y@qNkPQv2^PW~>94s?l??%B(Bsfwi)dG}2& zd-jozPZ_DTy!{^S^TUcO;?k*OD^l4Px%Zs@4%hu>uh+kv%|>dg-j|}6PYGYy=)t~S ztsXojWZnKa>|4SNNqTVq833jum?wLtlvLPGaXu^O3NC%h33-wV%EsKXC$GMLt3QV8 ze99Jvvx5RQzgo}A@%f2Oc|SUH+?Rf{FYyEHvuVjQDQtRDq-v_a+6S_yH5s>=q4V2& z`}|F`@oAS;2tj{3ppb?M^m%8Jo9mffdX7GCzw&TQ?Nf#Ko~SPPo8{Ub{;L_lN^|^c z>A;PycZCaDu=7=U4)fg!>kC8Y;c&3RovKJ4?Y_de74U~-7Iz#H13{?PXgzPRMOGj) zba-Uft7{ebxIT8ex~Mm7KdKm$a z#7>AB;CqdVxS7?9^9@0#9WHaPm58K#9h$!nb19i+CQMJ-%|y--=7{}`dt1dh2)?Fd zYP6I95+i}i$!@;AA4d-B2V|Mm*-TGy}XVNmGQJI4SejQ zvGUroI@yGEAF_SS%IoG_A7A4MS?|u~2s&h)?Ob~-xxkPZU)x8v8RZrA?U2Dxe5}yt zf|lOw0sUMn7|(sRRlHLcNB)`WhCQ$OjcC@orZB*4Mj!0%SR8bArlG` zWy6I$`!Nt1h^STi%zo5oRs*A>zUn$>8G!|7P@z8;er8|b)VSHsfIfkc>0R(EX#{Hc3c;{|;6(rhK^kyataCzC-n z%Dme@!<6C4*}1DU?&~FdGFBti89)4T2`1PXCP6|j1MSUGP6BaE`|sX%u}|U?@DmqO z6?ai7o;52S5$3pFm|*SdXRh1a$R#|}Z#rTn?b8z@XgjIJkal%(IZb_f$8<0BAIdRbv+_Aoac0jl7VUHJlgwW*UB*`4nC3XcfD3w0_;O$u(y6k; zsj<5xXiG=0YMUX#NA$^Xj!i^(+C+9;BOw|-2A1#Ls)xl8^Q9{oauz? z<5d}8Lv5b;fk%)$Z!oSN@&=(zL3x-hVYnB;`cIYg=%eSGJ1Y(*)~M zx-g-69++rCn~vFDYi@{9N}ZFu6ul3|a;M;e=QuHJ zsBh|sc{o+jsd8z%2gfdRYvtE%xG65`80e@X-(Y)sm}D*w7MI)m>3gcdKC1Q^cl>rW zF)*zvcYAsJH-wnV5|aVbhKNeAk}n~b2^K{NMZPi}c;-;Xov?;6H<52(f?FS>08R8g zoOWmL!Qo}L)|A??bb7@8cAk#xzH~dg5@6$(0RNiZiipG=>T*}Lr$#*C`kk$MrTM06 zo2cNNF2)^=g=-ZSp?fvnK(v|49y-5B$4s{V&fp-w4N*X?;^_o=fKm>5^N$^|Wv+}tu8X6zCd|ItE;WeO|7&wnEP!5UR&^>h#N!#on zvj4KvWWE&|fQrKlFk@pK6KF5qDdgGK1@=2pu}n^`4Syc}NB>QFsV{#*x;kcw4zSeA z4=<In+HpAm`@IQRmMz;GG+&09yXx?VPE)caI zpcQ|>uPWpp&w3Z|gNLmV#8|M22t%(?s9uWY|5o#_HA&WgJs+44q;h$)zk2I%@x&?o z>@JTOE_hx)Wk01KJPwf%vLo4{WFzA5jjVMo@$PLXM|ijwL7R>yL|zoxJ(`;%SzP*; z+}&%%1t#?%wKjl)8Tl0VVQQTG`|KKg@f}fcg|l#XG^;B~s0-q2<)v%D2iILi7RDJH zlgELC-4c8Mlj|d^{1?}|z3;x067cGgtesYf1eJu|>!efdPS>}}U^Q~A!cQ-I)<++O zgnpGBnW@MFDnfq*iTvd~E$Ha3Zq-#5A(@*JOr}6|CTQ=24jT6fL;PN36gHa5C3<3WqAtD8AU+ecw?@OHxSVM?Lu9M) z21^k?J+-crQvOf*5Cto|i*HiR| z3!jt;t~Z*_&W4tqq6Haza;{IE9`B=aiG=i7Pz6-+vq%n{y9#((<-_e=O{-Yfk0zPz zw1j8@4zVvQOY+P(FAMjGLi}60K zLG2R92_PRRUCkI{>4bOn>{z#IFflBPX;rc3m}ypi$Km_7d8VI24{DnS`R^j02IRE(m}yW8%cXaDuVzwwqBrZliYO;g#1WnfUNq+&iglNjg;(O~p7e7avVUq;kpwi7d4 z2PdoI@eIAxe^V+Wy0vafl?;mGJ}iFr%(898*q2K;ek)l$SUesWKd>#lYyZ-qqxns{ zAQ%#2wXTXR{AYZoe3Ksg49~CpBxdQk^ELA(P0IdF_EU$L=<8gSR6rKo>UER%#e}tt zrV;bdIJ$41JsBvxcoOA$m3A(;wE;|Y3FHH%x6PUiVLc?*+)wNP#>?U$FRnVAltf=yUp^0s! zrwpSkOOTAq-_SHJ3^l$4HzuEMWTln6*{!sBsBX0`dgYxev&C~R@zZ6kU2wA6Bas#B z0J8AB!cQf2Y@XDfv~-vSCJ_NC`D_z;oVf}sXRTz82;0UFy9r5QOLW$Vwl%;U%b=OUK55lb+Irh-cD-1S2ieptXCpdsbw5>y(Wn;VQ{hL&%q(~jX z3Y4zVG!HqMcfSrT&ce(^KfxvKJZd0^nwQ+`T>ce&{9F-yX1hmDsxCEsd`^(#cU`XEb{p}|>i zqCXBBMW#t;`GuA(Yt|FM**6Rboq?kt>K2axugGSre%e!?ZJ029oAguQH<+oa4~l*4 zu2dSLjG|~daP?Vf*Y7l}(Pjb(ZSK|o{7^QlFmdyZ!LyWCy$Dl*n~XLW25UkfT#wkT zBSG4T893Ia<*Cm|}n5Gj6dbBWwD;+oG#Yz+0~#(6m#0 zH=|3jh#0tNJ;Dqiec3C-d1ZlS=3!~KyLv4~Y0JA*&0j)fPG7ksG>`3|G_RutN}*o)9^VA?_+M zRQk%L4pyOg;*J_Rvo4u#I;Y$(*T9ps#uV~vp9dAQVNLugl@JbvZSS?MBDeen#Mm{; zF7_3Lw}nPeWh|7@0kXOSMdMl33>dFl?q zQ*qZ;F?8`sPv6%ke7$$rnqb`d0K0NGE2;nVoqsr!?wUyR%8ywxzXl{r%5bctfSdWm zzHUd_iB|Mk8=o-TXx%+_ElZQT_AyOJXkINUVL67@?24)4FJraezjaKvWZ2KId8s6TF2&-# z%(De{yQoE0xlyTD+Y?yXKB(`K(~^nI3mlCogb1=ScF~`Pww7J;UZr<^D#_SzP|7(8 zyM>6WRoR}<-ZFic6wqB*V=<`tOE}p!CRMfMNCR2Snb6lNq;u|w} z8q_td_fe!ViDmF)aVqzpu4k|NahlH9LlIQU@sy~ttN2ls6It%g|AcR;*uNDIy5e>q zuxbE^Nn^nV@(ANke0?pk$Xadm zAEZ>pKzN5Ze%lxQYZYRGTO`LSi=uvntPA7nF}gB+wUB%jlwVq!gK|0PPsj;HTG=RV zTAz=0tb83Qxd@^SKJ-n12|?SazoC2W*wS9*b%B3w*jv9(KqM@d%>njB*;iQk3 z1PElN{FH4C$f;dt=mGP26{(<@mYk-V-InRq>fZmu`VGgsX{m~y*DuZ)3WE9i1RlM&OpJ~oVCLG6D2Z}fHqu@S~QY8fBsmf z5%s<$-_OppS>bmQ?j(>wB}dim)r&IL;=ut3tqk9wB6m>Y_~e0*ZBISe4vq<1AtE9& z+>%4opHb+L-hD*%y4jf$0ucPQbHUWlMF-o=t?J%6>VwDb1lnuPh3#QsoVshp5@g=C z+>)yr!jJ9IP-#v=(?*J6WsdQ<*Sk3jW=F6-kX-wd-ml$^`^>}e*h{BaGIKEf3k|{n z>rC7k5wfC9#?%!Jh#5$xTy0(}RUk$e_B#+FZrrxDT3w)e%Yl$y-9FmGo6YA80cX^y zjUqWxn`Cm+!0iXcVkGH zaorQQC!}9r3NkR9|Bg{yPvu1mCaz}z|9hZp@8tjf#Ce;Qz7$&pqD_~U*erTfJCXsL zVRCZBG?)#*&yopSG`4l-taTd`k2?b}A@2#XPU*Jao+}yNy}}iDB}ebOjG>E2-C|uW zlDd)=^th||EJl_Sq{JrtwYmR#MQ~ZOm@a!E*o<=mC92du_R-UlU%Q$>e9Yjj)_|tS z2p5;0*63bfNzrP7@CnE?dcSSPyq%1xn_WA;^XBI7s(%>PvcZn>@kN@Mi6`cpyVTXK*eNzCgchGQxC76-DhdX zVRumPt%*|ZkEtI{zWYnRb*!xxSa1VHF}QcO*u&?XdhFJEP>^UK5-OS2XiR9Plvnxy zK9tw$P4pfZY&q1(Y1PY2SS}ugz`$%gGd=69J7rDMDUA^Ao)uQ5FIEcP|AyG4a0m~k zQdG_3O-ezVr5M1@(wY2J9Za!}1l(R!hh$)A)l$0<96LlJv^6&ZaT(L1|sOMKVN9()( zi%;CwYAd;-;LDJe(R9SQ+kME%DR!E8hCP{%9(mr84m}uaybA(&3Kfr*Pmgw16+GYp zJxr3XBXoxBFiQ6>7c%3UNrgos>YnRP)%5p0iKl*CoMeTv(tJo?%V~3wx6GXpp{p== zh%pG&fUrqT5H_JFq4MB{+d7&Ym_pk@4EAPJ4p_JwQ(+x#+{9Y=0oZ4dZY(0--`B@` z$<`zha>?JiTDE`wTw*c08cpu&1O$Fl&(ER!(Hq$bWpQ|wj6c9w)qvO6FBDW6Pne^k zhhft1k@?Fo1O*mlzOo)ZI73KIojz#&)SDZaqKv!LS88fa<(LWvX$)~s7_x6Z$w5~b zrgkvM^i@$q5(+4yZ6m|`Qj$K8!om+nzEX7+@VfG9DBdjUJ{Bd?_0z$Ww|yM_q^ygy zn8H+YKsqW%5l=_iu(EAtXV!y7!QrSd=pULiu&V3oXYmJ>kJi^NxVXSN{ieiw2 zFH3K<3vdX(+Wa0TyjYQQ3V}AYRIMWHX^+-E^!03`BkACrwR!M#r49Rwx|Ob^om@cq zz%Il>qQVQn{ehFdba3?g<1u{{wq?(^iXOpnZrEDjP4(J;+uR&uq4Md|Ky(1nB-jSY zT1IpyED4fX#Q_*Z{lg= zbZU7EJ5tq{e`+G$YLX$v=jHo1alOIGXx3k@;K*WqGkp~<`R&^UJ{Rn!LX zL$X?X$9P_0jhMTNbsIo(L*<)(WC@neQ2>5BMV5XzPic;#2~5KN!MoRH$& zJyNMIX{mE~XuILqJk!en8J+w;r-`qhS@U@Bqou>)l+kIyPAWBR^L({$N51~J+1GVF zY;*;u(`TG@?3Rp%S8oH?L(c)0wwQ#G(6FLHY*fkpr_Xnumy&J3M2AP`Rt)_R5wTmD z=H?B>GUOn6^+qO9$9P&&R$87E44+!l&p`R{V7=Fl4rWJfxt`g!hC%Cv|HG7F#Z=Vu z^1WN|_Eg8Ap459fOkc*5kG3xDTp`#w+1Gq~-LDbI(meRW%7K`Ea$ebIWcSH@wpd3` zC;WK8s*|mgvFJ6O@Z;@JG?dj+v;=^sv(rK5GM%c&85L0($)RiDiZ7o&aE0oJjUaGJ zyl@~QUr4|2usuRI-RxaT8Ygto5yD4rVLn4@+8Jt58y)D(p?UA%y|zEuWL|x9F(!nA z`*fe9+3^F9+0owedS-y$SGN8%(w&sm1t0Y(aRTn4;*NIFMxJ}58P2E_El~Rs@hQm8 z#CtHLdb0Z=B3WulxSoT-B%|H)yL;3__%qsxw|-hVkLp#&!OosMBWUs&st&wnge8R1 zLpr|`FBSHWZCJml1mxVsNuU>WG1%N)A=@l#XO>VUz@FW+yh7eI$ThCBGXd7QP>q-P zm;-u?aO+|3>J7U+>3ftcL62)OJo=Ewd6HjWV>XacyYU*~?1D+hH#&gJyX!GS(=4v|4+rl@Jti97J@7pA{Mb@l zT<$pP%-Qa1FVRgBBQaKY3y1irJ1iHZ3W;>7)r)-%Gz_%-nbbc9+0t+ze>5{~!+}R_ z=>TH4udeX9jZA%=iI5*YFGE+)bu>8_saZDnL>HDHaaGV&pyu6 zg6`;sMbU5jopJB&q1{xJU)Bl}n46q*K`jtIhjUS*fF;646lVBE!R#*~AmzsdDGt^{ zD9|aKEy%`i#uAFe7MX2)s4whApBJ~>ZcV4WH8+hL)^?oqe6p5ro51pk<1ao@_y|3G9IDlg(-4fhVev`HxY`$tlRO49=&2~pFyt$ zVqJO1kB0bCjc@M(qWpK^phdw7zPcJfg4j1%B6C1?PlC9NKLHgm(szj7{N+_rjX|{QhU>_45@ug^Y4b6}SuvT3F%+G3!baspFq4DW#t~^w)P9 zODyEP?ip1I8;6HSl!<)5ZdKc}m zMC%GO$*L%FA12E98k35s?iD8akvVm# z6m7>GZ@>Q0=#ugKVI9dK@109K>0i#WY&A>e*GC6u4cXDXzi$n#d_FuhP@EhB*&_4X zedpd$1hF5ck9{V4x%0|NNMZWtR}Eq$D#0ov0o5#zUk1jvgz{uDm=b@#9qo$o6s=w) zgo2*2pj;o}r(GI$4AiJSlrV=X3n^SEJWF9#{ZmEX|QtsOYPtQ5#dIsJ=9U?P6t2Z(hu>pUhj-1c8srr zs%>ozAFb7^ib-DuKC}@YfJ$CX$>^23vYYEhGp^MHS=lhK{1N!9-kFt?J& zC+pDj5;K$L2qV58jsN1^g)-yHO}z&s;SYcMrIZ(7YQ|ASOYCf*TF)2g;{=mpOG8|b z!b+1>Yh_tCpCwpY#j6Mv$MnPTK9}6sLJ6@IGK{-89FB0y<0LL_x0<&Y8j4nPuZhS* zf?#4(VJfUm9q?NqE)IzmAE|!S-pDnTTzWceWCmg4OQ@d*8VQB|QxWy`5A(%_ zr`2i6ZR3%kPV@#qOT3V1 z)TYW|SzVsQ#d8zIf8Q?=4vcIPq)}xUccLA7TV!akntpeSH-V{SGqDW52668DrjE@b zR-R&BiCt6orIIA^(<2XFRBljSMt1j0yOf`ISk{9KOWTmri7qOWcurnW?04u_ zJY@5uA0K-Tr?c5z-+GsqQa3fY!L(@$|+vec72KF8-B8LVY(~x_)>dthmJt8GnBeFje9wf`B;ksOW z)>wL7^>RsvGsX4@L=&8Tk zJWXX>eT@Ek=+F~!90P0cn?6rviRVzXgaLWhM3|LsPZ+eliZTp1+bv#IHGsxqdpYY( zyrLmMN@8c&mRp(GS3&+-PY1XTz)i2p(YClEzr57Nc-K|sjA6|Soo^ozts4%7cOZs> zXyf=lkk$BXFL;Z2uB|=dmO;Gge*5g%CU2;b+4aI=L09jl;B>0kYYN#Vm}Tn_De zh*Y+bsXDu57_Orvc6`?#?p{&hb+M^|{k`-Fz zz5DdGBbf}fL?fSurndEuf~1tU@Vw8!RAyWT&+ zy9d@zh zuY#i7_`#L6tyu4lJm$TWJD(j=6NggJ?(Scz+9=4+W=_>$%uxKWh6m#VOUg2vTI~92 zAH5_!-x|Xt%OT5Se_Jz)?(CbI{QEGI$4~8pVVOZ!fq9vSldCG>B+ws4F;(!CRoT*J zZv6(3pF=c(YS~z$AJpK%mNmEa1?qCr$1W%00uo8mw%#~-BHdS%*ySgz;B^eFjR%Q9 z(`IXqXgrC#is?He#x2yV*knMxc$*HD7ZAV~7b>>*#l-`xwt`iwYw@*@?0As!55=-4 zO3)YccVq`cL~xt3|N8XPDMyaVz!Y%aDXCC=s zyNAMZe?gD!a4Sg}`eiNVttM>Dvt5&QDpPtUL4)1oGMu|f$q-2$Aca;2`38_n-Pc5G zL}pc{d&|7L`QD?Ule{*8kwI-7SuEE!HPdJ{VF~iJl4|{1b*z|Q6%=O;$JX(NlC3o z|MI&s_d=>XYWuSI6v3N_M^pL*9ZK$_?mg_AvLwgTGqdr=!Cw{|h<9u(0_B^ViC zKo@4{^MV)`K90n!6-iKQe|#3=TWb3 zS5{1tVVHEUEN9_m5OLwPu5hsSzPac~`xEv-ow%kSipCgEIRPt}UDE=Y7Xg7yx(H>=b;0Zw` zoc7{yl#08rk{e%q5|GPrP$qrYCO z0&ClfxgIv}aU6eeTQYzgro<_>C*t3OxkWDd?BtuwX=P{eLW-Ra6`6z;ts`|1b64)kN^Qf za48PK-P<4TPzVVQMH1Wz4n4R-afjk9T1ugQ&iV7L^)-pA^VSWdt&%9-$K6>J{uw>CF=;ePZD1CZe zQ4VwxggI%%CiZZDj_R~3yu30O-9LsDlj8xJC#|g@FflOsnbUIL%6LLMXH$kqS767b z9x-BUKdVt#uLQw&>;Q=tqQ-d?jqiSzyFzv%+~9&nI7m8FxfE}T3S1*wIX&98fj>F0 zQrOp?JFtZsJ&B!st%WGUIvsnn#!Q8{1@oD~P?x4_V8t_Dj25ea7vT zuJ#Dknpli%fALopZ25*|K$px}N__G(&0@|;6qlCRhllnl zq(h8pcp@!0k+@xc_YFB!>#vMA)T(m!EFU&`mFa3w!f&QDO8cys!Aw>buY!TzIPk1CAaK`^jsS_`Xz z>7n5H{Mc)nnoX?$ zp^>HS{JmhM;1@>vEJj~_yWFS0uHsngacfcS+nDN?r%g-?HP);4_ z==GCFBEk%k`D<@FN2hpxiGn}Z21g9x35HIjz3mV|G0N0ZTx9ciW^P;%}urYL-ZotyE8@CEe}c4A-unj7KXka)b4$>n^eO zkal@hFCH%P@ZGWyvkWg_m^<3b z%znqv=b2M3y%(qUQ@)D?B;dG5`!9*Qub;e{^9DK~y$Rj1tf?-{%OmQ%(G~jx_)&V% zgBN1>aR0o87+7nq%~eX+;0zmXLv=ilQS3-qSF6aR?RP9YFq$$?z6eQo_)Muk+lS2K z1okd4_*}NJ2u*?fL%HwzNR{-wt;0krBTt7`(kb$WRn0nH+;BL8yIy&Pr&>z0MSl4Y zPcG`5>z618xnnWm+NGV3AY=?B*jvBS3q;HycX?EfXH80CF^LyJRRqL2C8Dwj!@m#< zMJZZXFOJ+o2qN~ZM#cI(fTpOZxb*d}xg^N61&)I>`RUdttiojy_(dx@$v-`HUaJQ+ zD|v}efKiC6luy@WW(EE{s+K443K=R0Y}>4Au4z)11Qie>#wqQ(l@4QWSw1l;I8cFHk^g2l}I#Yt1@pUeE(HOLNb1ck)?J=iKj^DTi& z?&BL`K7*_;DLLzGQ^l<2vx$4l$3hB_{3KN4Sh{6^ri@BzpT5fHZUZH4l^gO9{A{5F zq-;~8e0lj3gwQ#<%qo6)4nGXFF4j~j1FCpILu0nDu#)qvWx=1&5wl8LtX!DD&@o?M z*>)6IxQ!n3w8POi>)ZGkb;kSVA-YR9hW-~q;DslHSI*6FWYn(8E9T4gd)*$k9_tlqDKs3!fpethL3?@zad zx|RRzFbjIcv!iL#B0?q_x@OP@_f}VQdJ->qBA26y{fXY8x^qy(ZYF@-G@@8ysBAy^ zHr1o(XZ$;JSieIh0BR5tCG7=4O3A@fu!3a3*^?wO5ul3%kUhsIthCfN58*55NM$6! zS#~rwfo}$Q2F3P^Q?K*}P6tsDnf>fDa^2E^w7NGO>*1ZU(x~Cnf{ZLwrC=DbGR>l} zSpth(SEQc4J!oU}Ky6iOmBq-brLr>XBH7{?VV-&=59q2XX{l?nYoWkSjMnX+lZ2J& zr8hm-G=jAyiZIGsHIyiFW+s3-2SVICPj#3K%pjiLMskYgD8dE9%rT!T!{ITJaKCQUlm^rTnOjt=bK{*uJv?+KVkGb} zQZ_!`3kEXJku{x>9nq=-@rT(gugg{F1TnQ*CM4?dz{;n>i`YsgZz>_L0fLP8G!8qC z_3}515PhIp&b4l~*Qb!B*;4e`FCDX4?UE>0;SAen`NygvLHGl=dw9w{T4a;@wjSJu zg#~m37ckecHho;@Ttf5*+h6xL_~$62{?~nd?nE921GK86ETf{Zt=X|30-mED zmPZKuCVgl5Xuh?XyE?yR3X9kJ za6Ds~BJ5IZ06>8;pOe&UI+OkaTsYc98!^_-tUIOTA3X;iXSYjK-!>gtJuGEH*1iMR zlN%@&82Flgd!=sy=*??_qxU?iyEwF=h$Wnzy%mr`1Ny6v<0D74M?Kvt^M80M_2zzP zFx#DTSb!eSXFg?_LYapaVfqgKuKWuh9$?_GPtz7?!cEZP@?r2BV}2=owXu@lSJ;jz zOU}(k8`|e5Qk>iKNzk1(6o?A6^KjXfuQ<6A2d z>1K%Cb`!Z>Q9rDkc%h1F^0!_9UM(a1aCqH2U#yS+R-S!`%k4yQBaTiL>_MA>$0(C-{4PmvxHi2;ttuWSN7ODDO*&cuP zxRCoyg-9y@?UkhHHe>vXM@P3fAqtez1~tuC{G${4FJt5zO531qd>s{SnJ%Jc09)1r zIgeL!$4)1u8zO=s*^!e>#hjZnm)8qtYx7)|S16G);Od8kywK^beMr1IU)N#mtyJcd zF}%UXUAc1&2gxo^FUnsAzM{~uSyQqXjY1LQcB!ji4I;kr!qm$FT`)wd3Q&0#9d5RnO`oU72mQXR>;jQWwzZ0Tsa()pL(=3aBW zbL)6(mSMy?k_xC=XHN>r4;m@N7H&>ngY(a<%mpMIY;hMsoo?Zh_yB(lj;I&kgoW9` zwWMy#b4LXGK&o@yPQW8-4L52NvK_MVi`~9F+NqpnkUPuIfaply&sg)AI->~^=%FOl zerzU(M6`i|vQ1jx*Mu1r-IvD9%0;t5DyTYv68BFJsY+br-Q9e$l^ z%^#i%XnQ`^4Jd_*#aEP~4R6;hid>R8V@!lc6uN6;zfk%b-f_!>xeEGsUpXDlEo^n) zGpvw|Q|=srFD>=_^D`?7eU4j(lyZd;+c(Ar>+&--oGzYsyHwu))5Sg&*#8nKu;}+= zYD+&xM*Z-y2$>YwC3P--EnUSvA@(-Op?L~X^HCe>u!)?VO*bpWs#hZBZH0cq_4}SO z47LnaQ3d*{L$-Kn@X_{!1Kp&Az43I5=~agCKo-qX^q`6==FfF?$722ll1#u1MWwH&Qzfdww6FGDW^Dg%Ag!7l zd9z#t)LI>jtrR)((sR}v1T8{|@R|Lz)Ug~BNFdQ#8!tNt2GMo>&^WFv=#D*T zKew1)u?MpPIPp1U=eSai)C0qu-$!8QP7*m&-=u~jnrQ-Sv5{<}4XrfJ^M9$kN6zvZ zdGU{=A-Ymztbp1t4G5sN1bA?tuTluz_5x1eZa)*(TdFT~2aXWnkc+UnTzY!y?VWpU z)u7{w%#XjrSljDe7>__S&oivEJHFoVarA_2od>qj`gM@cmsmTN4OwSOmCJTt~vIRJztDoS$ge zQ#im#;lg2@b1#$g2uoKTkYluj+ts0l$Smyzorc93U@S0`eH!Kg1d`(nw2qg)hAhycO_tIa7t2U;&Ni#yAG&^@*5{Thjk#y zByi4U9|j=Vbx**3>LP7-MK2NA_Q=3{%KB+~t_zWH7GHZCLPri$^D?4GM#4dlGK=^_bERk5WIWGiJu^&>rA) zUgtBKYrpBmAs(DEsK+*{kP%r*Ly{z8!QVGUStGSK@bKgPaSSPZSoRmAYl}fv_n}nP znTeG;p*f>mo6&Wp^V869ysRtIsfYH`JfEL%%E5}SGXyOrY%awO$>!7>e&o%qR#_GN z-~`*)8^1Yol=X{G5=f`T^clVf$YO~l(@c62wLe0Uf5$ot;$x1wDz;=2e@d2>NaV^IJJZIf0ne%%-VNsmBSeE`%lclj6(MoNDWd7 z3Nz_wUg~DT7*pXK=Vf`+;&r<_mm7tFSdRd3Bi$B8k71$zL~$z3Q#1O@?t^EokM3+n zCh$R|c+DTGtX|7WIlm?BYzO8R>BPViJ{!<-sz5#?c6N8whQqK&5Q!M0L zx20-Xi-!+K*6lBj4nbTM*TmTAqgEop?e4YsO812&om(=Vtv#Q&tLk^%_B8QKea*qm z<0tEj&r4?vKI#Z|RU}26dB4?hP_;W2Jnd!nPq6QL-}(H%O-lb?)i$mEC(#N~Z&~o` z&rYtjnDRU5m| zK4r+>SBF43?dWtwI0$vGuXxjbCf_jT?0Sm{0;mbKOQuZ;(uRg)TWnpz6TeIAkL4aa zQ-7S>Ur~0$4bW#MaRWmsj)CGf!w>32FU27fS_W4OyMBg%9!WLQNi)udu&+TRYFxfaCP zd-sg0f-a;ICYv-;q+phhR&;tBL=HEkmg?TceXENec%zxYTbpYbzYSw1fYJ7+kLm|T z=EhV*vm3%T>4N1NgU)~D|FkA@_-iFAVT|l)x@X`uXmN8aKfbzj_l$yUGsb=AO<^9tMCm@d}M_^io1GVqRM`VDEl*V3XBR?%inY5Mr zN&p^K3@9qxw-D_8l}+an=6bEl3cs8!^Bped-I^Nn7rQ~b_1`Z%G<+swy?0^5Vo^uU zE4n)r!|v&&;hBQf^v9*fNpv)t$Zi*DK6P>F6(G6b@|fSLZIMY|uK-}dkepn=%Nnth zxj;hNoOTn&ALKeSTWhhxVvmV?Ys+vn!F3+Ft-u2s47t^wV)!i7oLsF}JKW@CE!&4M zfd7gT7}^NpLGfD71-fFqs+XD9YGI4Z-`qFgHT(V2GTcmAU}3KMBqpFRIa@K=l-P)M zJ;|r}I8Hj@&})Uc!fLi-DoJ4`C?ttDD(3P@H%Q{1z%70G4FAjh`e%-2g|F9|H-pr7&J793!=ALZ=z9S{ z!&%e93*VY)p0>n~{JA{eyUwfh-8@sIFGxlmY{l^;_4`4_#R_gCV>6|XXh#DcVn(qN z39g7Ke2}?VsF$;ox_9`TeP{0gH-}L?exNI%YrGy-AQoSMz*kjizM6Q7YC>7yj^;0_ zDyQ!`E8@booGH(PAHGX$p}F4>619~6LVC#(Bw@er`I06lCW`am8wk9xs~5Tyh=(hM zs~(qB`ZYMx4I1g-y0ZRKWF`vDjAEgeCD^&PTWIC zx0^p5n0b8;!8Gz$kZ>>)0tAqF>tF(|3|d~ni6IGcCgr9`sqr5^O@7;9?2yn_;M$FR zfWq~-dyG`t&GYuNjUk_dc2Uf2I)hoZK2ybD13Ubbd@@lzn%eI-voqUl-V5s6z)#c) zmV#%xuWuEitfgHAkous9GRNFk1s-QRtSugOI?k}LEmVPDYLN4QB-hr9E?mcyvwqJD zSv6)nGRi<+JOUE1EOuw51kpk5wpdf_C>rjwFog7AxX;&jU zKE9R#vgFFl>2F+bF5IQaMA5=6Wg7_&SzYVi?k6zKB^M>oBnV3IE^)XVnx7N4)`aCC zRy}4N8zxJf?GqDuXMO5O*LSU=zp}21(k$DG2%D?f1yGn$n+RcIX*z1Y$fI+biREP# z6@4TmZuGBF9FmW5 z1Ah8kP$A7jA?6JIGNkTWVsu-Ti==%6U+tE!+_&6K3(i?YW(M0~NNj>_)g2FAyN)a* zK8Z}iY|2WQkuSvXFADS%-$G{AxoZSXaTTfoiu48sa`9CVq>RKV(T82Q?KCkK;5%G# z!dkErsRp1`G(b$$d$8Ip?ot!Bh!Y6)3jEH}WLl36+LCOJA( zV3BNyU%6^Oa7|4&s1(DBXUDJQB(ys0<|lOtFM3nLVtHyR0K#;J67PLnyL^kpg00>S zYH;XA1n5%gzSi!jNNOr}dYSZ$nfjpo_vL6~D)uN7xQo7MsV~x12|CHCc1582PlDiL zc_Fb_cR9IUmMy-eWqS@s!Pu`O05)P!Y$=pjIap?t(3gXK$`gxI=og?!FNPm`QaIB) zQDI`^p#*~ihzXKC^6c;-rAFXvIY)&u4WrIbM4fM!2Zga-YQcK`r}y*W3%DJcgEpB! z`U}YO5GDW>yn1UOTPC$c6SCk-aJ&u+JK4fG$z%=gc@KW`X3CEt8G|sAIP-pF+#h8a z515^e`1$CDL1oy=;?7BDUU4o@K)OR){buVxfy4IqxDN~tfKNrrszz8#bbrgpFz^gf z8l-mY?@g;H#2}_#)lBb}j6S05C3n_3tR0K|=p^^AUo~KfLxtCiGMs4h)hMi-hQOsK zbw05!K7dP{jN2ny5uY=75VQy!-g+%-J#9qlB{t`*0{BCeh$~<-zlO^Q|84#?NbcQa zv2s;MerU`6HpKxE66>I_^o9md+Hu|O=D}?GRFi87QLA-UB;231aD{pQaIaiI#AmiY_I zdRTzjwDv*Q)5g?zu__{Bhrv9;<0Rb=6z|<0g}x^Dn7-(FSW0& zt@Gy=6*Vi0iHncPUJ#X%9N?V%=8?YRSB#!U3SUm?rjgFq_Ja|<+Vi!hKt%EAZXlJ? zE`>L*2oCEej*6{ieC&FcfPT#GxVEL;35Q>yc+%q=HW>^X(I2R~&IDcUiu$qaf$)HG znx`g8REt0VtB(2=-j=we5_d0iHb4D0v{+8p{3T7spOk_V0z^ph*Wqn~QpK{>o*_VS zRnzRB(UOOUPm5=vX@l4g4y=dJ#Tr&USGyK9u4&_*mh-RSZ}mq*|LCQ7E`uW6dL&MU zYS>bbZ9NNEojk=++ii^M%^ksBXy!~9d2t&L^E?845 z232QA_ez7`x4v)E4h(Kl(d(mMmCH<6Kmm1AQor+gyuA*$0obNj9;;3xPyX3)CYN@Z zOES#ZVckZr9WqWk-koz;{ilY(lgKp^iBCR%Y? z9@+&87fM)p6o*(luTOoKS`t9Csjmga6cS}Yn!7Q+b<=V_D2xxa8R6f^gD~Q2)7iw0 z%^5mxUy#cA5|!q{D;bPst{gx3w&77U16u(5>BQ7CmHolVx@jCt^EE3TKn0SfE1zzw z5>u^~d42Fas(Bm}l4JD7exwi7rzD;3_w!Ri9)O`ZOs9wOEjLslPF-m)5cbg>7iRR` zN+_@mJebHRNK%y&1l0~xsB9YfSKA7iGj~yWTeSV<$=}Z3#kE*KJZyu^N8(vQot*q! z>aHa{1=Bn{vGYr3Iuv1!&}I5-6?NP1P^;|QY0@sLykO8;{l0y;d>s>%P*X?OE^^5t zw_!?oaQvRXq3b!-En0lS7|lzIaSt8BvqJwn?o^bKn5jpTD$2tQqZ))DTZ) z2+3IH`Cv)AxPm@0TdlVl%WOH!5MF(AF>}+i`j>I^QK?#C!PA<)^8%Jr+aSr4^V$vi zLB!YALN?c{?PMde*k-jqK#8_GWTVB;$dl$*^&FvTmhEf{(1YQ~TDDZ#cqABMW*t1D z@N|e5(4vU?Imtt)K0$mmhE|BP;)4;}L7X=V8MlVS1Y!VAjTXi+(6``Sf}7cV_jo%o zVyaYC-yDh)FU^)Z7qW7Rigw-N-G^@h4TzwL)kzkrftC3s`x(B`3s8G|k3Obu;K6SP z{+n2g#Xs}MRPpVqKe0CJv=NJ`&da*HrqHa#&pipIqhfv34f)J9X6O9{@INo?+%_DH z;_WP{l0=of6l?pTJ&;G49&NW9S7KDZMXrVk8Gi!jpzuWcT1QDS6VRGJ(UOKLM!_ZL zWOxE89|yjp>3mtyWkdbN8T>}ni-w?dCbF~f}R&%|XIweQ29$81=Au_2LEPN!kIc6X&ax@AzO~=cTQdpNLx3h0wxW?woK#QQb_(W=f9RfmnjBw#CM<}iU`--7;V}yxfdbYt znHEPQatoJt^3)ruG_|IE>S+YEDO1?ZAN#>dp)X-_*ZJpXD07{xQZ6m7bO+Bo&2rB1 zfcQKu0w1%1?REjN=9HaLiBigE%A#8yHOV8Kip`Y>nhN;}Yamc5b0}CYw0mbcaOGm# zU>|kIe!V-z(b1hQW*2Cn3}D)3b;@+pTCcFz=Mdf*UTwyw(<&m+4qa9$VD)EGNwE*g zTQOIwvoc?+VJYL~2d!y&U~+U*2^GseuGJGMwwguw4R&~s?e9*ZAi=X1dH=J)IQ8Gp zv_1>>=Qi!O_dP=%+2qJ=(mAlNh3VB3{;`acc&8S*m6tb=$uP)lVVD#Go1fZ)YS(P{ zTcdN;cV*MMqtU(tFI29J{V^&h9wH$1C)yP+ulIsJhOr=jW06)x_~0p0T#XKz>(BpC z_|fSMcD$^;(J){z1Agx&oW{Y6Xj+nVzwss!gbIDO4)pYmOxODIQnRIkAhk!Pj>B4W zatbk{IBp~xNj$7nF(NRyR)$%JIVj$zy7s766qE`ZQ?cF-tyX2SSJxVLGHvGF35IQyw0xJNP+1R>^S0^+mgP9U_SZD|jRoJ^+)lT=bS_S< zKC9^~xnSLNgV-;Lsj^2g$`I{$A6npd44v>5n>>Y6c#7HhF|a1*Bu-R5l%Bwkq!_fh z!@g7!b+(c7C`X+@0bg>Ckw~2>u(tth1yIKpQ*{nIJFEI3#p3-oaIMJ_;Qw*>eSao% z${O*8P%|fqm^HbYSzbT!p|stUsAdO+4EYk4%5096Xq@#unF`gFrONz@GWFFCNUS$~ zq;GA43*=5avu*&YoI`#HOEdfZlp*1!HmIvIGnk(ySZKR1C)afo!K;d-$0QVicEiU% zo=vRb{y7E_uWs@@9eOA7X`j2Ra(3fv@foKw%{T|zw=c+(xkVLr;wN-g$aoS`dD5>X zRHl?4MjnJ-9L*D^h5M~o=!Z_#N^l%27ryJlViW6K%XCuTHK;6i|AVf6Hi#LJDYzQO zZ(*Yfx~rwqx89Le`T_ZXH~jo1uJayBv8Gs?u_yH#3H?3z&Mf{py3-L zjR34XML&A|i<@^StY-ElTkmE5GEZJA2^{z(b8wbxKK| zey{Q{Ezf4~1lv({O4L&mA|}+B4cuHy`zM%dl}}hfz(4^ZfK*f=)n`*VK+pPxbOUVfj;>Hy3K(Tco@lt0XrO6Y=vU&%h@ z6waRcsd9;e6KNTJv0)EW89g(lX9aG&$UsWGz77i_!5CJPntPEfIhT++DSr<+>QQZI8{P_`NjyE@$dG>ov`6S7oA2O}hdlmfcJIkgZm7C9XjX7(VABmV$Nxv(%kj768Xd*` zkC#*FU&g>14l`NC3Ko0QNDW|SV#Q?-V`r%qet-;HECaeA@S{OXidRqzUf^TL4_(=7 z1Ib{qt5VA2Es5P}KGV)14QoE`1wBKk;9S}z{6?kL)d)e{w6H8H z($lxk$X9i9wvP{`gMo|?S(=^-PEDB6H+r$-tYc)cI~swWPzU~ed;`9ZW_~~0R&#df zhV4vW*b<62L!0WZcuY4b)9YU}W|D_Dr*Fg_u&4g}jCU=i0Y4J1K982#>PREGnAgDD z70pW9@z!fviiy;?#lL(@qmb7wpr^yTC=UM-I60reZIu*Ax1ChYcuc2L)4VZBXV)k1 z7CQ}w!C^5{vqPgXTFr4E+xbP|=bzytOm78VhLtO7Jf)i<#(I`si?Of^Um4+k^3j1k zsTT!_ClJk_?3C+KWolVmGL}y)??meikGWStNSbbvVY_k*`F2#k74*|VMZAs@8v@GZ zPUvT{*!|ovF<})XO>k*M(bLmmgy_In=5zh?p`ANtA*y#b0zoU`BS}(v$q^#)kIuu7 z;4~NkEzTWAix&E>p>F}pa`N3q-j}#c$?MjF5;Id+o{2^{@~zvH0W^dg7NF++Qb)4$ z_jeog((3_9q7Y$gLGwzP7LqQZFS2z!0Vj5Xg~rropocfa!nt+QXYX^a(n7_Q3o)Fv ziWEj`7HIm=kMDiV%x-0FCg)=D6!>kz0w>G*w@vV9$W|kDKow047p&40W_7YVg;-Oq z)fJ%6_BP4UFyp;G4Ss`&#^*OLt0ldS`eb&U{7n3^3EgcKoK=5ox=k&W%#MWwa2e%h zHWh9iLzu*J&XnTt3q!trTG~OJY9W7*e-m7PHXv$2>J9do4I-ZPTASkbR+rWyos&vDM-_p zlM$I>`O3$KWXIyqSYweUeJRoiLKi1nIhRPb-oWLG@K#X>)y{R(^He#(pQcvW{7L)oPSiLdgbiny_6&O z3?$urOLpoh!A*+c^Im6R62q)3_M8E0KfXIQ8+95_qTx?x5xnvg6UU*4eAV(35LJ+L z9ZiNVt=K@_b*!giV?O|-evnN!F~J#k`*?T5osih}Hmb~7+hMCnP$ zl`dUD-TjvTXVq|+m&4{n&n$4#YSb5T%|R4Iw3~V3@r8!o-Nh?P`4)lz6U9T8d4X$; zCB$^E!b(J zy)o}nw6*Ui98l;?>1oyZ4sHCG8uEywIXynt=uVN9!*9DV$d!pMU3X;6>LNroq6{b^}e4rC20v3u=heK-KS>ua1&@oM)yxJhq)+Ehx~Hkt2OLC~QDTW}@a7ED7zL7jmc~^`!;QwM&qR}37DjV$Kt)5j45 zblsP$;!*`keogk4KEB7-x?9$s2SocOl_yL@grgw*OU>GBC)q=k*F4;ewZ?hU#>&8t zSA-9ui7YTFSE9}TS~pyH)Wd4CH06f)8FIor~bJ-fc&UXFd1x+mBTq@d7TsSLp62569KwIyWccxvUy)TGMr znlhScY2n30C!OF_`316)#@(CWy|Ca?I+MlFT}Y2qHg2XAW3G- z1nb_>V@{}Q$w7oe3N6!kKyVuf3|vAnIQxiKb<`aCY_*HR-_IrexH)=9=yc2d7!V%` z&I%5dzv@=g{SS}a`NR-dv$i+lg$0z;KZ4S+^k71mtpE~}rJC8B+3n;MIS4G*B%M{bpEumW-2~V-trcObSGVQ$RD-gYU4s9umja z_QV-U2`;md&tzTlaba-FHQ1 z4US3~5iTr>@e53=$UF-ZfIrW&XkTGY4sjgI-8-9ZSS6{abPb@j9iA$TGC0Rv}O^oqI4e7rxiu^TvJ$5cTDobzjYbSQ9m_E_IUT;C&9U^(-^* z_-;>B{0}W--r{(Ds<>Ri4tPb){hnKoo-Jh(uXVF6Il}@eZOZ6ZCg_2h+6Q;J^J_t9 zPcx#{Kd{#SIVZ&6Q&PQWhdm1QYTi>H0b!bthtVi(9*sQqpVKzVErf@4{UKE2vv8eF z7HBUOop`A%*z=6q6;mg0My#R!fP%;U8&s-eDw8rY&CVVgFdpGE$rfbh+2EdY4Amms z;itQVm6C`pb-oaIDQbkniTJ=Ea0wzffH0R!lL`!o-W=(my$3~nAYicx>1Lh)C&ubY z99y*MnUdxbJ-tP(hn|;0dZ>ohH6Hm1yS2CYu7szONY}D6IzF19&@vT_AW&XvJrk=l zi0q8WCo4?6(lLEpjPozSKNx~8W%fWfgghkHR*(qQWEbbOS;@TVJYW3QZDA`WfX-nd zm@eNmIIF2%$K_1mS9@A*spq;t!Z-r2$?*2hQ(p?u)%;6? zw*U1w($id?ZCyU_Wwi=RDG+R1f!d;KhwETz{o4wVEmL7q1C9n5 zb5wuc%;iUpXWO618vy~rS*p|Bev{0V(!JNT=^;Dzn)tG^ZU3AGE-0}9gM_@3RhA2fir(%H4ns+I5YarzYPtbjpe@y~-!$4ApRS*Q{juhPF6Made_0L;CLWVH`GB8fSGR*7%*x^i~1Kt5xk3 zlpMVo^h!b9PtXL)y&ssoASmWCbk}sEegX}62adC3u4RN*eUZeRWZ1Ls#onu9dG=yd(YBE69#9{Nom`w7bs%se54oDYEn<$4!lGJ{8;?#L{%{p3AR_ zdt9L|_C9L*6JaU=`Y-6=rQg-#LKWi45AuIrvM!ij2fgny!FKxDwKuVp`%l|+(`JA6Z)rE*YkgGN{R~;SH_$F`8{a0Yr0np{AHcvV zLZWGirAo72Pol(32+Gpo5DS*wyK~}XpJ2l+)|KrU)(@iUc)t^-WjQkvsP_l&QPw%^ zA$^0I^2`MH@Iq*KA-~$^bl1!#FDXY<-#zFdvfmm)2WwnwUW77MZYV&|raEv6yi$ar zchO>O8dp7ot0cX^tGyYtpi_6TCzGg`X&WAXcdyUg-*mIQJV<*CiKwS~Lq}+tljv14yGfyqk`Ya)>oThbJf288h=%;pFJpY!Pf3eIHESi#P>at!rg8A zyBNQ1K!jy4pO_Z{S{GYo)=|?&JvFf6F4ITgx_>Y`PQ&{IE(HbFHJ9WT61AF8uOuw~ zL4?`qRQL!b>5WORahh4!CwB2LVt0rBrs1xAv2iM7XLQP|9T1DaBetyX z{}Fck$KC$h!4zMV?R)O4@ehis=l0nLg3!pF{>f*B24wjxR6=q@C8>gYL{d4hX_H&J zS_$#8@E!>zo_b9s1B}ug46Vk&_T|fcz%xsH(!c(S;It#BYa|gdOS{-@t4Q}Dj4z&$ zB^&uzZWC|oV+|IstLM9b#K+U?-~=A`Sd)yOh?TED)e(+~skI%aBlCimqrPm|k)U>G z_Ok|*7NdMmv1G6Y^{OXPgd!fvDn&Dmbl1hd+OkBB?F34lu)^1$XaFB%rZ`mjz`rcu zAzUIAIn_I_?u#o}jDqw}9m_{(U zS`g~3qfrcnMl{W_w$tN$$nXgLeh!LPSSt?83lw;IH0zEuu3KAORng{(#!)`^GucCm zULFT$yI#C6i*>CH{Ni+6^-RebC-8DtPdPg*&_4>2peMMXUTW3m=$be znN*>;807Nt?-BXZlQ9nmxrcD=4_&p$F+{+PDK(llx2Qr@!-gUUBus%CI{!<`uqX)7 zYqTv@X1mz>B%kbJ0&K~VV7_+?xZx^!dHU2YzgGlb+&2NE`U?C3;s&|TbO5NL@s}!vb&YHTWB0>pP;9a6$l2w`8 z^k+EosxGc&a`IL@ER-;_)GMHw&ul<}YTTn-=k3my;AM;YHuYb+2K_ppW$~r4Y9@l$%S(ni11`q)N7xyK;rl{ zaEzJ5p->}n>n!!tt6U3X(XF!VzH-RmyFp9$f1az%W5?M%5D7lyxul6fO!T{q0bo40S`HF0yPz= zsBQ8~GJElc%+gvT#)Hy?+C2Qj*TV8NYI!FF`^~Bl8dN3CAYoEnjc(^kY~N#9$|jaU zTcPtTX@9U(vhw|6y+@K}Np$-?Ka=Xd$)&U#^ffG_qs%OMQKqTlUSAODlk2F;!=XQm za6O?GBxl8++WesB?weAguFp#2a2@mlWyfJyvs^W%l}_Ew{7yUx?G~QOh<}9dT#)tf zIlMcoXhpH$991PL!#L%p@XKoQ>#aiL$EQ}_sS{knoE66EZlv?AI6DRYwK1?I&tE|R z2o?2xuIb5fG5rC7Pz9C2kJC9=b2W6_iFfdrhF$tS?7@S0^);+_v_Q_dZeqQ|Eg(Yioo1LthH6*jM^A zLwf9lvELFyv$?jGPUhWyA>W4f#f0i~P)Ob7jfC0&yEvXQ0{fGet&ro5Ks3oPvCL3+ z*S>(OE{Dra%df7uekaJc@gTDK!(V1jlks-G)Po%dP}XT=Eek5bA#Gr9U^u*+rECRQ z3upqVx5Q}neeAoLj6W|Gmc5%B;*29U3+;Wy#8xr=w3s?;7OnKb0wIg8iLsOM<5s?k zz#21b;vo$o`*VAag6o!w`seSs5Hyn-eKGv9yPvJ?LFd=(vtjqP zO`Mr$4>`Y>-y6x}tZvtkcW&Y0nG!_laGmX=>F06^plglU*wWR&4;Ep+E83Uy~)X1;L^_yZ8m_c5HU@3hGra2bo2 zcgt;Ytmc$@>)ZZM3JDmDPI+{+=oaSy>b;AKX1Pup3#`YoEb1|t$;JoLoQuVouI0MIIlY#Oj0f|qiL-Nds_c=#Y|KR} zAi>f3!TBJypXygAIgIb2k_B@La-_B~PUJZ4npltKz(*@->~z~OpFN<{KN-KxqTXCsTaP!7Sd+ubT=1F|kT$Xq9B6Om|xa_Hp3uNd=nIRvGwX}#@5a(%TneH zgN-7_07R(~A>uAacbUCuHQ80-Ss)3vGMSI?iR(3M%$7{KMAmn#C&VGNaXqY7$2jox z;VdV#!iyj)YvPt>zR1?u{2OfGmf~DEcSlY`rGZ6a3#R$|4_#RiTS^|BCwE+!-cEe5 zkP(;uO5+dxqtw5QEgaj`KuCYO9@Rb(5)$=B-@6d>TwmlTc%;d9N^^=kM(<7R<1^;L zv-GPH40iV0NpDAO%#FPZ4U}sf72^ScvQPLqrpF6mNvJTr=#srbr~EYc6Ki}v-;a`D*LBby(9C1;WP)mX$bQ3^OCv^OV2b#Ym8D3 z=*VJ+eRyX;Coa{QEKirfv%8}EgOk%Uxv2X(tme3<22to&yv%t3uHnbU8512ZQ0BV7 z0r|O}A&eQhBd44WZ)~mk<_L&I*jOaG*(slsJd|prhl6dyhc8&gw4MZ=!lcsTydX## zm{cc39cCUldtovg_FfXO_Z4pbWlN1S5by_sZCd=KY`V@rG;--emE!Xc$11|e$*7_S z`D6{}>eZJa<$IbD_fG(jW7gGkq~z6>eS?IJ;qQrw%%(ykjOg_exy`64tW-GYM#Vc zPgDn*++-HuS9sBMQ@A!tm}>UOPoS*lpTZbY+F4wv+um`}qPM2?0{qm|i0U~4tOtb(7X^bci@A^ zGE1prX&`09)77d+{?>mh9^uudNrqFbmxe#1hmwcKWhKiiDvF4{&3zOubK4czqXxg5 zAD}}k3N7i!l+@3OB-@#qLt9C#iyY~QXjbiwLO%o$;>aHwd|3dd2Uf>*)6rYCHjGhISx+_w0DrQ zlG1gG*I}91IBDV55ji1Z++{Nkq2#s=)i{)HL8V9pkP5EjN{Z%aF&}D;MBRH#;%sXt zb=5ph<4Igfb7O+kRHT(DNY(OHWL#M!sbGPaB_$k6oV0vtt$I_nM+)&{PlcT}@g?g_ zmZiht8%|{QxO&{U?6ogFZ9b`cEvbbzXi7mZD*;Q&xReYEhz5WFt}|6v8gB;^Z#Jl; zDlP{@Za6q>#zs#I3IVjZr7b}yNmcD|kWJK7dRq}$)?;!l(JEOSW~Y~zz(Gx$WJ=kM z0(I5lC2A$ts+kD=HeMB03PkQO&gTxtit-;DL->6_vshdb`xoCi7$kM<&7)DmOdD9Pgr&m zQ~@F2j>$e9!Ns1>v&*C@Xjw-}n%C5YS?LcxR<)>=DN0efQi-`Fld0H{ zBy`YFlqDj7JxG~K5`=&Q^n;G?a6@t1i-{`UOZTKYguezkAxUW}0Z4gP(5#J8JqMq4 z+{IdRm+H_<+2T??Q?tV;gSIU~qFQXdOpSY7o*8EsX<7!i8(Wmb8^^Ih4X`kGYlr1m zD-U3H@f6k^Y9w@=s4K8iTF`=_m?XHNpc)SPf~Ma#gZB}y)q{yX7;z4%;ubgO-v~f* z=s2HOxf%>Iw^u}hc?C=;^-7gnA7UwDqbCK(f`tWDCLv|8;;eGRZFaqYws4L~=;le# z<$b`zU?*F^26XV_&I#CMsTpum918NI`flf|2ex#aorPxe!-<$g%C4z|-2ovr9z1Gl zcHF|10OB{ZcFRn*hMG=B$9J6@TW$);E%y}`j+wd`ZyEv3jIWIe1%0i7Gy@q-a@R|bFAN` z(kasR&Q6zz&1lspDw_e*4 z)vuP0#lX@E&a()^KRnf&BJA6o_e2aTXbCs~O${nY6`{_s;coK}!fL+CBn&>)A9rxf z$*XNntpcEw>V;%@l$MYHAf-XfiBP__j<;u(sJM&uS)dqY;nu7N+S5xcle@g(pvx{C zww|>}ivIv=%{;bL^S8^7s-UZCZyKu<<5gr*MJS|^j7xAkax1m!rYNZS54iJcA+LRO`n5Z^>3-oZnahS+Cru)_9{A>z*pd6SuJ%F(Fge zO!;}@9x327yXc^Kg`WOUHq^U{Q;!Mo<&L$?^&^p~0c%oFj?z+=pp=C5lgn+JzzUnu z&<<(j>Qae1NddIoG)FHoQQq4nPe>l zj|+M8#7>8jvX7c}IJFi``zbjRqmKwq9k`I2Q8OqTF+E{~asVBW?lOUap|aRYT7@C< zph?WP#C+n%>|_(quhMK?%-E{*(#i749c$F>#Kw#QOR6Vm9csrQ1-QC^V-sOQ`Uyi- zbj3zNt>h4tlXKLkwe+1==QE@vy<EpXrqOkAVv*d<4;92i zYg?`c-x)=~LobZv_2?IVT!GnO;%Mx$$-@!VDZ{k^O2JJlsn-#PJl%$5NUz08?7|*t zEuln|r#~4AAQQ}hFW<1+Q%*=IX;j9By-TD=%VQFQwAa+`#~{scB)US=;i*E?mze+& z&&3-AuNDRe0zruPMHgE5cnIV}aRUJpgPDo;d#r+5vv?AM8EnBZfw4iU)s zriH&2p#>qeXKRd*F0PYm2HAeb&|l>C`8J@J61;P#UyeSU>(1v>^L6;v;c8AiB9YNJ8b=`}-;NtmU1%q?n+R8fG0VzLmMpUNY^f&KE(DDY zz`3@h_eCdynMV7}pHtL=%^RG-Ir)?7dXckdxpCp1IAH*Kf~8_C4+^yhz{7~Qbn{Ac zBYZ;bJY2L&Q5nLb)rm?$^aT=nTFS7r$kZAVRZ^Xz8Za8mdP{I8*B5h>V$(l%7NtaGC_% z5J(**rFPS4XH-uQehO@vt#c)^Re3%fC*e{Zyvc3xY1wL$b#9kh%IWf(Fe)bkX}}Uv zA~u^?i_<)Qduyng?TqKmBFWr$1#LyQN(TU&;CZ)q=Vxt+Q0A(eF(y4-n0##9)%Hxo(1avfM61xn6BoKCqBcP>)uE<$wGJpwKWSJ}CDn0U-GT_0 zbq=D|4{B^&?o(wr3raV*ZNNtppuC_gYu@gX2q&?vCf0JIr6o4DRw$(aNUaSGJG>B|%!x9aE<_p3VJPyWDw-DlQB)&%o$_W?)A3cX$6v~&7Tl7blp;#+aRVeDT z0di1Dx{^NT8r&;F)3XEgP*Z@9GHG8^!x)dXtdz_P=nmfP_v22`vy$pckcUdTVOsjI z`QhA2NXC@3;hb3Z1*oEEL4zqSC1Kpd!pKq0;hOXm4@&kr_dqtaj^vul><8)Pg*yFC z)?15Cyps18hrSKaMy6502NQIVcuxV8gQdaJ{nAKK=0O0lP-Yo3h=$#B}-_xdnH{Ws!nOB z1fA$sVuNOhIJb9|NYLs@-Mm93R%U1;wC4m8l%>#xCd)aGG=ZqLRV^tP)YP==MMGUq z4Whig_`+M2o@|tBj|kd1IJ_|eu@vOAm7zl}9#ILZlY)pK5~2vrG#9oIDh)z!lkOVD zP_YwB4V~M^p3T(kZXj@kUcqTqlbC8Rps~}uOcdmTrO(IYaKt3!lGr~V5yKFZ60S9g zN~yv{JF#hdgY%N%KQZ4?{$hNy^8Q!Sua|v|eU}42DAP1A;4^y`z&Z+p}vr;F9Zya=KS`s#9=qk2myd zLG6b^9#o9UX+Rpb6q~?}$p=)iOly&-%R0i?=KS8F!+v!m3~shfR2MQoPs2dV;=Gk4 zD>GFh5(0F&O@c;S9TH{Vvf6Bb?8~4Xigtj~oFf?e#)vL$cS)GLh6Te)dI)1^hcOFR zOJ;<-R%M`2fG;SxRFou=X-;&^nvk3-YH$@G4_3u;afMjOtI_cM2c1fmR`W@Wz&aJE z6_u$#1HDCJeJ)Vho8~=WXbqZ` zJ1J|SOQ0dQ(uFuvnF;3{5-VI(LP4cTBC|R*a*sfasIXOmUJfj+Z%L=6*O#fv6roT^ zuo?gW9d@}S=U%2-{~*T-CaXdo40GZ-GB#v`pp+-&O6uCCL2E=|k?>C}XkmiIca#M&N7 z1zN{}01;3wiFVCRL9J;`hPXGFQxw9ZQf1?8OsovdI7ma#P~9-8#a!4p8}LNxr4)wA zKVxVzt6{rgmsR5_Q`9@-euI*?4_2I*e&cWg(DnPNj+iO@5H>lh|QZXx(;#fvpgHvVy8glY#TiLR=b|I} zSdEyPntgYc7hY4=-oSmcZd$gq$$n){saXoCMuTESL7>Og%*Mo`f$=4T{Aexw%-f}A ze9OLw`q;-;yvqF%^|7N@{L7tl>tJiV3gsFEB~qbI!%LY^LE@I_?b#94nJTi3q5_mf zhK9oDLzL~cD2Ixwps~uM+z};YN<8B4l&*uOIrEATxqCLo5{7f{E{l!fCxyYXG&j(>vU7w4j zQ!u-XL`g(Y-7T}>qUuVL5?sursQ{!7>mt)@?efu_nLZ9TC#75iNQESdNCEu8JNd~u8;*={&WN;W0*M8d!GV zf(jI^Qc6Yds2(QK7TvKnu%ms-90gQJr&vUE)cfzcNm{AKqfb&WIO^7FqE9RrA4Et| zo_Pq58O4qo77~=|b?UL|zR*pV99RaXFs_=SdXd&Nk~j@UjUR~_ImaDCAj+)TB!Qp2 zHrQ(VmQ_Q+pI>BPT|z*{IU4l1+fE_GITtb%6fA+v8;?WVV(OGALF@OUs4Czw$oi3p zWd|v(7vMOV(;8&90<)IZqLX38<}#07JNs?OS!f}}Q9|ko>gT~3?%zqMI10xhPVAH4 z#d`(7#1#5#czN|Qwi!YuHtL;IqFCq5*3ut_nX5{jK|A!^A);+lbg z8#rS+tmCZ-2ZZtn4R1%XV;thSIB`zVC{aWzYHh=6Nx5+Ad&>J0O|?rhdOG6L$WpJU zlX*boc2OcG^k+b%QkQDA@3=>;hu^T*>@V5e(xj&!nwwi%m7yRZDK)4hlX|=mF~b|| z#yC=aI-vreM|pJF%+Eq(GWvp?Wk^^`vdTt>AirOw+gZD96Ac-66N2iJL7}3BHiL{z z&uBD@?I;zm5JqX>`Aj&p=hz9+d22diZd!Tt>e^a>UafU0N|l;Wj55PMICLnzn0VG* zM;Y4+P*_A49rS<36w#%H&tfer(zUB@CzD`v*Zy*W%0hCKD zono2~R*9L{XFrNAm)d?~FcaIMJiq*@Uo%(6&Qt57pf0qJ<7laeT9utCPLWv*hG+!_qH z?M6~65uHPcTS~fD8@nkfcey8*cn*5#nO%&?4Lv^}Ohr^6u4Ux$CroM>tV!NG`fUp!* zVPvbKP4f<;x5=axHldDD$mB^WY%qy4=})%XsY1BTA!tg7wwFGXr9-Q2DW?{u(%>h6 z=i!`oMl})0(_*|eLzcr+-lNlD$D=ZKaEOZKdJNF^92Kx*N1AAf#7`hT{l^fR`ANbh1G!MaoLDldZZyYq2cc z+|rnrABk6$;i^(P)bq~27u*D#O*03Y|JG0_i(ppn%N=@_2a}K3St>p(66l+4Ns-mQvcH>II-%g`pXILp* z3^$##W10g5k<@#!w4~afO7Oqvk8&s8oSO>YFVPqycT2R08uQe~KHYL7nD+}&jU_b- zT4<4-rzok`;zVt}BTKMRAqymw5DugOoX2mH6AuN^L0Isf^lVu+i~8HED>dO!&#F8y zf=*}JZE2fFQ8Mex4hkl&s-Z(53ag$XfK;2Y48axXRCy!<)Wg_nBW@_ah+*q-lA$ zaCos>`IWa)Uf^@CeQbOs-Uao~ayp%TcdP54TLO$iGUYl%q&*!8jGWMA zC#T^+OUx3YlCfiCn}8FhZTTsOTus#lig29AT9GXz1p00`mEHp!a~Wf~>O%`hC8cz@ zYUbLRT*^{!DK2l*Pysb%W}pz9O->k`f$I+MSIMn~WW%UEf#G7>Q6-}M1!|s!o&&ei zLRZ`_*8tgBdy%%poT{YW4mYhSJKz^l*1At6PYAAY4LM<(GGr(Rb!U&Uz0YX)a2clh z6)~gJ;5f^PX;mmH1R8mgqJRp9+6<^@D+{JSs5w#N#-9@gN3YUJLQ!fal@Yf-e$*7%k65{;W5d z=2s^BNpYz=K}k>q5bz*_h#-kN5JpA_*e`suaQRI!`gRvpCFd`iMKw>D#aFtJl*?@8 zB;7*itbuYuwPzXUf)rd(`AV+Ww-L6cilOm+CClF`rF|?zX(us9otG+;v*$InuZ}AC zBAH<<*#{~TX|kBqI=E+iRBUYk;T&gBz)}?}D1{|Z0S+qGK+LL|tmwZ*UWLf(-HX~f zG`U4<*w+!X1?=RwYCBnuAgS#geof7DDRfgYUcZ#fwc1k7S(CDFsU@YMNF*pI5THdt z2XdNIA`Va)#xG03wIxH8tOYI`y(p6#rl%{&>*)9*N>rUQ4Q+9$1QUo$KBo19S_aya zQN(v6uaV+7M6H~L=Nqa+wc0Ob=^(pCC9G>)C8RYpr>Tlk@=Zt;Bmpd=ObMk)0=d$$ z5neNeA+TjQE61Ni=2?am2e`HDG-tH@TkZoQ9W6nF~T*)-N9`&mf_| zH&qE#inl_QBOI>`DiUqOTl%cOOHBs5hOjKiF;Ijs)qf8eO$0XDfl+lcBcK}+ETn)1 zlA8@Sh;m+8<!HAs%Twq(rDif;3uZ$YeXzKK_eerT zPUR^!wT;p_Uchb1jUI7nBs~6EYiJLpF%dnZGY$%+Pu7^#XCFxlYkxtld6HJllNC*Bix1wti^thDT$s5Wp;qlS*NRqQkdD`p)be-RCKy$ zrI_i+D0IGDv1_`6dkeesRc}&pG##v=+03?GY-qf?6ch-*g16lfdEh%xytM53i5ZnL z^Ga=El}f=16#$BY5^)Bj45Ro=fTLuC<=n z)SG_rSO7MW=Vgkr*GdwJnvcvHLe4wY1G*Zjxygow;Xyzd{G9oSDsW|d%(FZa6uLd@X0Do#+gzQ zQUK}z13t~1#JWRaH$cc%y`k#C9hIVW0`o*9bm_;^_2Gfc_n39JZzVHkMa4_hj2~&T zqA=W*q~H!_gkVw)YC`_)V~*pGJyJu@I-<3$Y`Uc>N;fJ|DI%!5gi5VFEjz8OlSWlL#Ivl1uo7Y zR|1kL$69B>0v5YYHMk9^tz9@d?aMe!+6SQ^cH4RwA3t-y@jLth!}4 z5=N1S;<%JUZK`CpjF(D4E-eN1D3YQ=FKY{E2|Ew9A{k8*k`CR_Jxb7F$(h=4jmsZK z45K&J(Y?2JoH(-U!+%2gj?UTg9QQpWyYwm~zRO_=rEv;MicK*jkxYmbHJIROl&m#Q zOV3y7$gNCG8fYUjkLvx=bbCj zr`E=oiL3Lo=#$)tUlUd5XVE9Q7!?iTQz`KtnnkhSK&Z1gfqE@QXt4J6ENvRtEC$)?%)huG= zcB1^p>oFdgIluxMr^pvNB?v-8r04(xnLd>5y3CHPAOxH^$8rf7vb7C>5NJAd_aWaa z%>Mwy*)X1TT2O#VCSjZgWRg)%GqM;wH$I<-=}bUszYR{S!(^|tWvD6jB_U)I>U8LU zG#UYYZg$X^k#Xk=i)Ya%xdYRUE%!>U9xc$ztqFU5=Peo4JF6i%Bo!v1H8ci;6OKH2 zVHpa2O>C>||X>BD%2hk_F9eL2S z(OQsw5X-7KaKP}0!n-$}B#VwTp?eTYlS`nGNUAZag#k*ix}=b64PF_A5~EtfSV5YE zbyMj;PO79rc`o=t%-e2&rd)43h!;_~&V>zg+h_|-#j!5q*G*0d-3_^sfd>x9Bn{3u zrrBG>8k`0rZrz~a*gQ}>Q$nIMz&IeHUCh zDMdMjwaj!KT4F&`Qb1fF{HSJg$VQ^&jI5Xl{vmB0Uq?^cxPi^F(*E&iCr7yZR2SPajZ?{=iw+dMp za)|9Sy1Jge$mDBhE>p6eQc&hZoT>1KR4kn|BErX>*;q?yK=r~gItrCqc4Lu%w9U#$ zZNf&Q%4c@Yg3&pTL?hsDi?Sn;i3&XDF%2Z98^~fKF1qWhZAnjtHc?@iCtTfHn;%F{ z+u_y`XSzzoR6qiwVXta41dUR-O)$H%Z|d1^J(UE$2><{OttN|Qj7l9E8Gsxr$6VdyKYwsBAb>GH#A1a>2C%qb3=$7cu| zM+_?Sq0Xmn$VaHedJD_M{6x1Qml|0?gg{UW0NUV~P6W)PR~^@GC-ih~9r;;{+w~7i zG0zY!M@kLS`T#V*kb+bJ%AhD$f}@5sZZHFDHsq3jHM9kvHcZoEzF9r760UC#Bw2ku zlSt8-{{WUA{uZb(VCGdb9XUo*t7a{F6u1)jVL8h#L{i8}QdMFUgph63-ncC#y>dV= zXf+;+0%w(S&JI%)kVh@<{CN95i>zLzAc8vayWK__#u4$o9Vx^0h8uknTXYC=Kw3Bs ztR;3p1ZGN2k5~to+oiWZE6%DaT5zY993nAk4D6z$m%B;Io1wxZ9irnZmmnw;hS9?p zA3%*)e*xhI$$>ellohnojxDFls%`dok1c2k&0BlVmKLnSQncMrBnqaL z27p$yg)GrPn{a|In($Jf;366%<`qFeElf#u)%2E24)Y)#NdS{_Z>NrSfY-DQF91GN zBU=dMeWoQq06SIj>bskDRKr!@4!DnmMVACGi^>Iy+A%mE{!ZE<@YcF|?Rg#~a&#gG*o zg^zf#cqwL}UP>fFaKw-UE-VDySxG5ffJ&|})>Jj+v4x7e+nQiSMkBcrR#NIpX`Uky z91#}AHC0HV;rx8WmKI|#!20k@ZxO>+g>jrqDrh7Vl(?mlm9t^bT-I9}xtAqKG&rLX z%RyT8DYrP!XR&qV%aC!!Idan)^(nS8u-)=gw`VU0TV~TpRx#HGfrynYnv)%&Sueqv#J!X`<%_pT zDdPi^WNHO@fPBkF`3C<0w|2%P73L439mwy_s`DqVJCT^lE6g86JCL_xcABBpo@J@c z3VX{g#9wN?l%Uv@3%a6m6O`QC=z7M|jU`J)BOX!Qf=K{o83yU7&vZMG@z9!EwsKaM zRHqX_upMj~`KlBO1yZACVy1=)*eiHws6sI2*5mf{6o6cIBg<3Gl5(p@fx2`Cx{Lj^53a2Jw7RY6fuDUKuzHh?H1 zc8psT06ZRsE$O~bxAw$rmDi!4M4sem83lQR=!bFwjDozu^hxeV9Lz&WsY7}M`pgM2 zB&Q>dE}JUEUgJ>sAc8Ik)E!2vE2^u%x8abi=tBC0dx4buKiO z1q?w7PjlhIE0pd2_r(!7Rl?_4Yvf7CF4zx)fBq_}Su?k7J<~16bhLd?B`Y<_) zj<<$c=LC((H$N_F*`dIT!#=b+EbSMS(<>2cVol0ooL+BoumJ}a(oHV|ffWXrVj+jD zVhlIDx)YeDgI|LW5s%&}gMpsND(>a!^(vj?vD9 z5ek+rdYe>Ff>CPGAE>uvxQ1a!WltlJB&o%Mr1f&sOPeHZKB;Aaf_osrWs;X!Hxz?+ zjY%{;Y`i#NznSdga&b1T=8i80Hrg8!D>9O%r{i|(# zVBv{#Dz7qnNPou(m$L)QPm$LJ-X7X%oWI;zoBVw3ysB;`WttY^#fVO$?UGV)B2P5b}Tw25p6K6V6e^gV#F9S}f+3=3ScdU=D z#8Xsn48`>I#vcj~Gz7|N0TQBFYnTG2lMOZ$2GoVLai(IYhb*88#*qcSf>eQxa6^05Yb&=g~rj(plSZ^e0vYKW(5>IVNj;U)IQkVc`i zk1{YKfglk@b~5Z5nwp1V*6Zb>OLGIJxHzq{4r4>q^3geI z$Ly(fCE``Gaw=zf|9+>%n%RH z?6`V*!UzWe_1Z~1Gys#;;{!4(-Qg-?Fijd)fg9C}GZV~gaU{v1Ei8p;X2A@pd^Gd0 z0IZF2>6aR%HKZZQLvSBF6+Cnb1G9%7H4?NR6ORkh_qx=2pE|R8rVVR#v8H;m>weKzkJxb0vPb?lICCtQZ=YDMFX>b7xCH|<=yr(>-;#$%{JAPLd=Y; zfN4o2I78*nm{#=$+u54XR8c|;#}ki6UHxNwrrLfcpJ}~6ej+)@`NyY)-#Gh^>Eqzy zZhu1}{;~bjZVNd3P3imb&T{t0r;ohl?T=3a3~!ECQIaWaQY#YidU$YD5g00)oEP*_UAl?|t#QoUYMr`GG`pc8s@FZ$Bc-)e zBsP|)PJ6A9rOi>~Ni>NxNa~iY(vG;Rafqh|ByiUX91Iq!7_L1!6q(X7!7RmXPACd$ zLX}~nQBVtQy^*xEfaY0kGQ#I;tk02hx`nq&aP zoq!V~T^Br?h5mm(5weiO;0^UEy9KEa zVj1%!ROIj>rBvvRg#e(~wo;p2%Y&Hp4ntD|Yv^)WQM%GV0;hJaUerQb78<2oAt(Za z9nm~|dm<`kS!_5^ti&_%F$^aZ(+QZRkeycI0&WnJR8(w`G#-#_Anls43A@>d)J{AI z#|}XlpixlY1td+Dma1|%Xmv*5K)( z8xvSu&rdrx=Bxvr`CK?2v~DqAy5d6A1$j>oByxr;bFwn68l_mIyu|ROJpD>n1xNwL z+I_}LWoZQ3`AEMjgWlP%qD(D@3P_~_M+m?eKhVi_A*IzmWN}~(VqU{&kfV0Fda$*X zbMV{#3$*p)1fe`pEE*nXvm4s@c12!VR;=ld!)+Xel3POUpx0HMlsaQEc61JucFb<* z%2JsSK+K-!sUC}a0Tx?G=3-Wq(5_|DtaCS8O?a?K7;r|7_~bD0?>3|PqqJ3-G7RHi zDo<=gqo;6rA>*g=l+lU*0Lgd1g{n4nv=LK~RFx+%K?I8eG9+Ag^&2`Yw?UTxY_E6K zfqOk(Fgm@s@$J@1LP@3~qY!qHjSdG4jSVPrA~tw2=VRi$G`3`}I?YZiWTN2Yanzw{ zxav|=K^6ZNPmm3 z-i}bgZi$VdRj4p)Evi9f#Te^TjiD+ox1s2zM?+(6pl7Tl%grge4jj%=uQKE9F5x(i zPNZ@NnBRD)rATrrY7-*2P>fW=sf5$0ZFVU(D^Sc*Kv5o)Z6{-B?!6a^0U+bLBej6~|6pmBO8f zl^QQMCo;<1yK&KY8jvVTl6DntRFwmTP1=fr2_E5mZ63VDt{xzAGNCw>Wp)rNQ));l zS;`7Vp+eb-(&pE;-)1C0Rt?wYQNL(eE=wq0Mtw9A>9;exM@E#;nP_<6BoMlagNV+# z6q=ATpsge47sgF`l3QmHrOJdgaieC25p&6C&QNR=I<5gwP0fbfmT66|q2PLG`DVGO zcBQ-yd#=o3&}(g*BGL(1ECWphru@=u2)H^OdF|7jD~M;)!0WOKZDl2_M@<#x*05$Q>Bl9W zm!i-}JFdvC!Z8PEp^Wt6EeFtgN2KsB{{Su9sk3qNKc|dlPuo74H96DU9-bq(p)oNf zHF2KDEh<|VTt^(GC}dw+N|2nvDgwu!QL!Lxm5Fy6RZ`79XWcQeAXO~wbvSJoqH9C# zWLWl!U3OHhyq19F+KL)u!U?GBR03dCgSU%az*UzO6BU-&TcMhSMZ*hi#GynVK~M@# zxl}(k2?jy78E}NUil)3L4lz#y)}+;;Vl_O+LB^E^^fq+EnW8kF$4k;yVMB!>O}Hij zs3P!5O31*2wuBsbK|10Z8+gswSfdMXCJa_95yR43ewL(N;%-)WExw%kzfs~mNK}^3cNlC+Xv$2N+SMrf(xV9#kI>e}g2`M0q z2qTsQSi5vJSg3lo-Z!Mp)UIa^B(};%o*R)6$RnO&KIT4zMt*u*iUBPtJf$AGCoH`u zmo#j!t}W2(Vy?6>d7tx5(fdAKQuFp{dl9Q4<)DGJB-VswcM6O}NT35@h1K=EQirP3 zeqn9i?8lfsm)As}ij8@~y%K$N7oKVQ6ZgSiy-M!E9|}KJX>q9Xx3Np6!2mSF?m&|8 zY~P}Vsc=CE>I9o7L85g}MWtv-QDCU?6oc?l7ikG~)x^rEoucp^rDxmafE_!Z(aTNr zzh~KsV9?)5diqti@U9_TIfH?qHN4&7mDgj@q~WYzy=r}Gh~r!)LTJvd#3N4%P+VkP zBbp8KAd3wxlzMhqg*~onOy90GSObqG9>NnOTR;Z){PwJC`%G%D-*L;obvdJ zNrLoD-4lCo(4=N04q#l8N!wC#LUF|nQtl0+iC1qJ-jY(A7gsHY&E0)mp`pyvNZ7KN z=Q~SA3yq2dEKi%r8C^T9PzEBKp^yYnC$c}hf7{-pZj&lPQblxt6_{Aps)pe8-(-fI zDN459ysO7^jV|PrjJ8uKX6VvFY}UX{Gs3m<$81)gVwz2I#Ng$sOB_7;PHeod*UxJY zqU{4>%Wgh8Z*NE;J#I)|w4XffUmRXH>0QyrnECZQcoZUe&lEmcN=LSrAWGYNsXxs1rHjkT7%`x`!H$D*O?uqZ#X8!m|d4b?x`YS z4V4fAuGE@=h^YfC0S6ErcBbR*I`i0tPdxI<*0skfQq-ezr4lYlCtbc@!+qF^#L0w! z13sD@t@Ahu01XzP{HTAe9MD`u$!y1W5s0j;_+#pbrGzAEPE@3ld&9rhIqli7w+#|% zc_XXs>f0w%UMtZXr1mYJqt<$+=JaeOAb>u*@g(E`3M8Gl13(GL7%9`LkZCbf4xhYG z!wFGQ0*pygk2NVp1e4;PRvd=gT<&(GvkVXrq=j>c__Hz)mvW{O`dQ zfO9sSw&sJP%`P&7yYcXfnp7kx^(#z3+6e|d;bv1^sD;#VnU73pl}LS5^(d`&xI%KE zl1U=^iwo)vt~mC#g-J!@%TCFTmXQ+e&@s9>Zu>dGpEMUFED1e8vJ%tFPUGvOuIQ~V zT?)%En&3#tfJ88D;%1m>46(e_w96<6ZM0B=Qk0}wDM$@~00P5k(`KlenQwk~;CRXs zYFPB}np~omqE#h6ZO;=u#`oubInG1QJv@98KI8g$i{gxSx_v#= zF}!uVGGa?@1kwr!8U?RDROPTb5v}d%ZS=?`6s)~IXIR^_tgUOE0|B1y3b~%>Gxp7) zd`VwzvI@qvDXnXDIM)J3IAvTxqz55QexWinCNYiOlHfu~rznKn>ZN5ujeykYpc`>a z&>tJ@#LKKDq!lTQ2T$LI-KS;CS+a|me#*Lp3X{)0fx5(#fE!K_%R;F|roxW`COfov zs12Za6ahBorC9)6ok_N)=WPQhwJN2Iepdqyw5JwSTEz6-_(4yV&CIRkF+!qE0?h{y zsV0LVQgDG*^09-`)e8;6#s+5@Np?s~AkfTBnP}LH>(U`Y-N6TKxd{*zdsRcTby$|L z?9h;>l+PyXu6#J*m&}_(buy1y^D+f(B`Ug0w?GLMabQxaz)%#QG$>A6F+Mdqg-gS5 z@uHU0r#Q0jPFg~nWkpKNl__ajR8^MN2g6i4NgHhQs+R3bIDzK5E6LuBI-=w1bxmcK z>xVB6E*KV4)i*seYA#lY6-raA-l=I=XaWE=NJ&sM#I`F!s>bRiMcRbOkXgp5<4t+E z=qsmLIh;^Pxd z#BNB7hvA`=D8)iaT9Ls(UqD{y3OWI(>f}OnnE1^LSg84~soTRy3%3?Z4&xOb9;^*G ztI8&s!N#*(G@LhEs`xD897}16!^w;klsf6KB`Qsgw7+tvV>j80iOg*Hr3RDNaZ0--&D4q#gP)+^gOuq##?kHBIsFl^@OMnM=HUw z>LB&(Nns?WT+~w&+7MTx4G}16oYZ?lCu}xPJCk>B42G+i%^CvwZEeS@>zePCFJ| z9Xb$y)XV73I>z%Ki0ez$e)66l)4DWIFWhE(tN8vsa0An`+1Sg+j(A?)e`@^^u%OAp zXSz~Oaa)S%S;qxlFANsiX3dOv%?bYjX|RnMm^bH8PaAB|C9`=k_Jt;w94N1E;Jn3o z(d!nznXiRgosq&zyBXX4Tf$6ly(mu%@6AFT$h_mU(DY{f`^FclJkzoXP&7_TQ9F@$7Pw!twSsgzy)(hM=kUG$ zdaWoHf_6(sdpwG>JvZ1dG<>y<$&4?Obs&Yh1@JQR0W^597H zQ->{E*S|ZpI~*ONtMVu~rEPz1;Zt9CI*HbO47$3}JkH51P&MCewJNFRuJOLZuS7nC zCwp1PW4qD7(({d1HXZ$TwQIIRfV!#V!NBzs^6Zuw&`%4RdcwvR1yjP@Xi!?&pw;ZF)J= zt~9<^NP?-S|{oCi#Y-+43)b8;R`c5;Nhm5A#y!-Cpf#>ITr`yJ^ zV+i_xz4i9nclsyiOzr;p$M0dsAH{2bH%%zXVWd3WZO-<#x7u`u!iDI*UC>GWi+&$YNa);qc}^VeU@(Mwr& z2Xj0j?4jlp*^xyHbLU?%Tzma~TJ2t%=^oChIbGlGK&lpXtx3AFX~ROlZ;}I!qXXdG z3s1Sn()?aN#Tl)`$X`0?@Z1RF;(D~&yaLCPUBj)-PI{8#l}b(8>49IQ`*S)-`*oGV z4RlN9-Q52AB6n}~Y4)uj9I`9V?u7W{=G?pl*D5yAKzR5@#3nSXGkqM+*=l$C=jWv9 z1`++Km|6t~^zFo&FXQ5v+nuilkpP#Z69HUj4UFN59c;ADVZ%^eEbthTo zJadhmom8$KK)kWPHPU9;57ql3Px$pY{>VM_<_z~{`1ZrZW4GqL+!A$V&U-+;_wdj@ zYv=cu7p#7>i2GP@Gc+t#wZ6wH`_nMr2=cGN^EL() z=@$yO!|NWTf2{A)HiilHe)z>^uf0RNybZuN*EF1DVP>$z z9aFS1SrCWGjj-*orxo<{{**-Bj(1Bsh48t%SCEWQP>`Rx)T>t*WO8ZwoTB~C!DqOZ z-YeeZ%&fSe$6q=xW1pPjL3FLg)|oY>>85V|RSUR0dCKjQ6Ruumg^PCMPw=?SP|at{J${<<9T|0H}sBE!AV58KOO)C-AnHb|iNaHtWlIDBiW(T3ia> z?HD09ua(?iYK;y~{APnv#-cw@2hN1L|_Pp#kV zeQ*N*)Anx;J=jHEv%~wT|J!N5)+RWbFF8(1_c5E!@)gG!%bB}WYeZh@ZBkiZv$ADS z+GJ6k7+smwkxv`AT%LLkch~%v6Okppr_@gbj%bUvx9>_<^`aKr`hAmB>P@ZlHi03cMHtF8k#)`i7|MJX_o^4!UmFo~CT2cGy;C5Q*_U zreh~^>{$WiB$W3p$f<;R&fVIYPQa|>gL|G`WM*dX+T>UCX!%(;-=$>8hJ%R!X;U>c z$WByxLc)MQcJXc56XU*b&b~;|;XeJa054g}av)!)c8Lquko)k8i~Ga=k_8p*n2S^E zQqz5F&s1-gUM_zfxI35huBUHvO?0nud8yS>GQq8ZQ|f~eK%>f_yIi$88k1>w2D;$I zmE0O>jQPCA>>r=n`1rYQbR{22Ut;K0fB3P?tSou{8Y<2{Jo_8<{T&bMo%R_2v|!G< zxwwbSCAt3Z29Df5b|WoXD@+rk-U3c`sdRu}X90I}Bhd7q>ygXD=J@i@`nG1yji~KD zHs)_DAbfXU?I$*|$@Xx=%{zb2^}OG5U3!Nwm0Dkh!pX zZPeiK;G6n$B+|Dt&g@&V$?JJp3#sxL`@4L=YuixD-38 zt!dshPe?6!c4nDpPI7Er-u1I-w+=;zZjPuM;HnL?AMai0NqhHBd(Wk?>@APIOq7M4 zZGp|hxz3PB&DGU8^KC+#^oxbdwy9E@M!AeSOXM0R!hqHfnlPa6X`u=%QCXEzH(`L zWpnQ%zK^Uw8_BS%)V2yJUH830?4m`ltq$IrGtcG4JK3sB8pq9ULr$-YUp7-<{pf5Z za%cRM4Q`~9vt6p69@Hsmk2)K%N71CVn}C~g;fUSk;aImrn-}%1@`V_bSu~SWa+#h9 zcb3>!)f_9BAK+{^n?XMc-DLS3aN!c+T9tk?DtdJnG?1ZrSF4(T{VBGp+d#DM{^OrQ zrk8cPyZ*v+gJU(YD3 z#9bBR3Uhs~5N|!qItcMz$~0s>axpOUXe*_yU0Caih{KnZ-cqOW+H7;Tt=SNpcB=Kd zTjCGv7`;CbS5kFs9dK#7)Y1#S?!&z2yywvYuGO^ zHWZ`!u6?}jQ_QVLtKu>rQ66mq8_MIJuHt*I4W_lNOkqsr)Y+BmxzM8WORqZ81gwW- zEwF+w+u?Bo73U>m&!GE~hwkVS9?nOmPK$<-JbHdIk~R@$i7N)Avm{>P;oCZ^X{EM!@lJ+Z|o)AKX`FhfRpt0 zu^#)poNrDq(}Z{!S5)%XhmlE zWxZVq7h=@5a&FRW0$%iFE{!^OX?CKGsODzO)gxBN4&3+N>~ZJ-;i$&iD%kwBX~gf0 z5{u3~*|?IG=d!fr_;phsx%ep8-lE3_D}IKb+|Emg>tTK;7Oo>qf7N7=j^2cFosJ&`n0#Y%Xhd((Ik*U~FC$ETkFDu)-dV9gg$RJ_YPRaMhTCZ<=_+5T0Z~nG;!{#TAmq9Q~_6Bn)3@!C{oL^8s zw9VeAw^-KHx8eAc9&jhNCDVW0d1R)2h+oFM+uHZ%eruU^c&@h)*PC`I9kU?Kb)I^g zjj{h9HmfYFfH22IN|Alp;2t;R<`pQ?FmhHDvkC(@5*#}JJ2XHNu9h%>4({kM! zNy}HOy6HFo-Q#&&Rpb$GYgn4^HQP6Z%J8YJ5auz0|*cz-?RBWslvp zqU6PvJuZV+kFoa`^{-8t5n-}r3v#!5+K!`ZsZTTz@>N}C-nEO%f?$PH=x6+vKB{6j znkl@PhLlV^FZ!&o-5eqtMWn?dia#yIo#%aajkE&6{~j9KHE1l0(0_@QRB?N169`E zB#-$QRcSX5!uD_C?Aeib{VBX~+tDM~J%X~wKND9WPd_=|qIJn-cy2?M9vBb~uUniN z^~C)f!|KEPV%?U$e6q-{O!sN-ECY{w!?jI|+1oDlozs1C{gv`Qo2aW0&F;OwF7LMK zzZc_Zn%H}2!K!_wKRg5*w$f_*r@ikSxY6ikbLdnq0kX)ZIgFzi-ry2^uT^9Ib`%it z;=q}R*LdZ7Zc|#WT{x5eT6^kz_go)4P+ziH>~}FoMH{PMP8CBKsa)-Q5d+m`Ilnj!mK09qTq#(=3uNt&u-g!y2>D%;8XHPoc>49mk zk&tW+(KZz98abD0Bz?AOh-yy2H|~#mW_>%(DbyKq=cr=*6$>h(=xP3sYmdCm5U)~m zYFyQnxcO?>k^ZpS+KVnIHVz7^(f$BZ0I7bPs#}gorS&ux>~r(<%5*tfzjNLGx*KX? zsCcg1B^Bv_3)zICxW`a%*Mg=owR(zQw;vtxYpF{gSuLyhC3(-*rbyq45+^PV9Mra` zCS$$9;DXY3zZ=g*Io&Tq#U^l(Pum6=4Apv1fUTM$yiaTTP~+E)LT-fzA07D zJTd6W3F!Ki@?S0=d%kG~djT_{{`O0EhpRI+m#;0i+`al%?o^e|WNC6CH|9t;K}-XM zcNG941EPV0F0}ecD=UTwcC|S^s^zd{Wt7(fH#Czb&1s17(;8f&Ej%elYPlylX`_?wi zL@ihBQJep(lk;ikDC4`y>vZzoL>>^}Q=ES^bN_j7_#MuZ7e8s!ZZa32o(s;X+|v)g zdB*e|bk|z@cE4Fq%{K(}S$MoF+?h8;i) zX*KExmhbxIs`k4ROS*s5l$wRVTl4(TL+8Tv=bzVZ&|CcLX3LJJGr#Rq{ysB5R<>{5 zMXU-sei{F?S5ZI_&#e-{*_5wXmzTL#08DW?I`38ese@A8%X3US(>l)0-+ZOJQYrwd z6rly1yItQN6=HsQkW7`p9)=h_7#G!l1zU+Y_qES)-=*Q`+c z;U3)G5?KNM+|aXD_1ft-7Pb7Ba#2*Ox}CGhaY9ICmb1Ct?$)dM^=(aB?l#^6?rtey zDDJR+WK9K^INU0A-suc%W=;FTn%&!Gdbfn%K_1aNcv6yeAiDYb&f6b~!$i86S=d-kjDGz!I01+|&2kO5rHZqfmb(U-f;Gb0tE-A$-eGr6WIc zRS-L>5!^(jBf_(Y#HzJ-skY35s~yJ9_DE&(1f3&q^-apm4D=0D)L2aN^3K&q9!)ng zTmz2@(AYC;_jJ7;(Jw~Ne!;q4yKZ<(cej#voRarZrEIliPpz(J)=7T6>3k>t>b4y* zhv%lv;w_DwKUF|od*->}+Ea%Vw6L#SFQ5HR!Bb_fU;nNpI$P8f)=rbmUU&3TbQbB7 zPqcG!OcEobRZe?qh1fL5*R@*(K2JGJKE2G4{HPaIceP~K$x6x#Z!zblMSsft?n;Dp ziQ*}6u9Br!qYu50Mb4B-gACV9Q;P15&E58f_oM+Euzl9+a~IZE|4?r@Qz2_tvO(ja zET5N8`kWoq&t&m`zJ3DrFvO$1eJchUNFPVa!fLuJ43R|s1c zny_Md7(Zs@yV&3;1uJtaGMzl~oxQyoJ90$=FKoF(Y)oA2van?<$hKwH zVP>4LRgocK4j%K}%$y>lSA;D$bBgA#2;+o>#D<2Mal<0RBUX?t%v_eO08cgZ3IiXE zTov}=2_j>{RxFPUF>?=F7QP~aY;J8fhaVGW=5OY`GI+(BxG*!97=Cz|na{|#{&Rz) z!a`P<&5H~L|I~8UtWO4GxT(i;DjE_u!m$7Vynp}U3k=vj8@F|$%d-Ce=dz~DjL*ag zetTIKx3G|jF3aYxUlzx~=P!I#47!EIq(3cdyYY|fec$`1fFcY0FAD=g!4C_7zP}1V z0?@Go27U*F!@vWMfR7xAu|p1pLdhY}81O)2KOR#)-9y0Bz*FQ92ss6Lv^*B803IWc zO;J?*@F!D7?i3Xjl@zh~i4N%BeFE6ueS-Jb0XTquUk?yb01R-119$*}hd}XA7#{Y% z8BzkiS1|O*J2rMe(BM0TK+2&o@{lhdltZBb$cKk9^0<*RAgEcOocZy90uVTYz+mxV z;K^tVUWurzqDoRzr%<(NI=XuL28QMqmR8m_wszCm4je}(XReE@rnuirfX`2oQp zpotg1P9 zsP^!YqjkrQH#9aix3spkcbx9(zSwiA_i|tVm7!a=@7%q2|G~rIXU~6p@$%JAuiw1I zj~EI^n1_F|7_@)nVkivHj}{X~P5!;btTB_vEas1z{9m$oa3Yi6UjY>1pq+Rq9)<^I z19Jx#88;6D_1IKqlOoksqFu$zOvO^`Va`q*5_E}DiDoqSpb&aD&2za4Ob!~MM=Z{q zwlQf9rQNfb?V5@pJyWy}BE7!Pf|E@B1*R?4?eH63SsO|)MX6*|!YeLwGc8%2j$--b zL5CM$4?N#|kE09>no%zFQ=kkQy-Pr+I>>j$k>aWimhtOY%*9@$9^V;O`+ft_3F z3Css4%Z?=vB1rval#*hoe+em~o|CEg6|v>k76m$reZpbGB{DE84#Q`}*Uj&v*CsUAcDs z=D^_4$T4v9#`UZHmoIjo?KoCeT?yC!jU`mQ}CM@}`KY-l}M zTv;UnS6Aug#6a-h+Sz_4*Jaj1U$@yz_eJxfmPU(X^LL!-ym0AK&xfPy!nypU*kv*E z{pa|3Fl|h&U9C)vEsZRu+c|lLu38boUmh>3IeenFrJ-hbMM_X`!pfCAj-xHze8$vi zWCe=i6e<#@O&GxfWe^w4^!4@C!5jEhT}>X`>58bMM8JdnIRF9*hy(cGvtUT; zkWrICFAIes@l+P#w?>aT*>Ri4T-HBq@|Ql#ZI}|ONpBF8utf8rxF!hKUNZyfkD{k? zsLT0zV)Q`ybn38>V=JjeQHzQ+jbu$w6unUw&3Zks3Lm7BY-meT!8`+H$#l}ZVoCOHh_qZ5ZgjmB9SavhC9Cw;yR_7ni#>9nA>VK z0?=sEDmjl=BE1vI0|?XgDY#C-YX{*qGC+cB2`_#l+k(3W6q-{s9oR5r3apL^css~u zI8>47xr&Io(Xb zWUzB!l}93;(?mg97Gk)Xi&WuFsd+6zhITpq89$(0m!#($9N)(>gFdG;;07WhEkg;< zJF!~!I9ngc>oC5^Zis<`88@A^cTa?S;bu?h*evM(Jl0v;O&aTL&Hu%^kx1c>BZLoF zCqIgHUX#E&C>rt^KL>r~7%+g}z(FJf(GCn}KJar0AZN!PeH;RSq@O_X{6Ox}nBQ^T zao`vSyMLDKj$j=GCPz#7%w#wWfy5K2tP!vqHJS2%7wcU4d|4+<1c?(!bMK3AVh=&r zMz+Ayr^9WHCK-J{OFsZvAE+)5&EewN3sT^)q=+F&2T+)xOU|jcq}UNVgBG~?%b4r{ zL`x(D?-P)=QFMda!nT{k)O~R*&q-lw9mJT!Zfv&$Vg5GQ%KQde0&+B z{A$vER23_A?G_0W{>rjW61WDti<++AExqW`2wiJw=JiaowN(^gne3V4=yNt&!1OY| zvZ&=YeqiQCH%YQ9hb;jHftqZCOeqSJZ;~{yz%ePer8H3cwAdpuUK1}v7l-QSoaV#g zGVtK|FneSRO?`7t-8`p~20S&;b)!f-%v@4WCJeNpbbxF~O-b^M)?ySJFJn{Vij*5d z-ILXqDbM{U855TvJe5g?(A59|wa{_0^@YiQ(c+23&y=>VTeFeUr;?x7XU6`%``aC<+c} zLiP?l%kWy_ic)A`C=2TA3k6~8(yRl))YPrHT{RN-~j@vyI6I5OK5uNV;lRVP& zQk|wa$!`-bGsCg`3B)T4%fEhEe@(oyv$mQv%dz@5o|`Nv%8i1e^21R4uIa`NZtmXFz%@p$e(2|-=Tom9)X6lZivsdd)miGwQx#A1qu$# z>J=z829e0s%#OsBF1MBG%7Ppl#7+?e=ci2ko(XYF4JstaI+*_S(7G834iV|uRfo4tyf&PG&{SJXX=Qt3=NZ7() zeZg_Y_4Bc)NRnpQ-0CIF#b~5rD>H!!af~4w~b$LE=ih5mIM%dQS&l9|Pnv^Drs6v1N;1V+szRJVOx`eY-1s+2ZGHz(c9W?evNfN)5cF@@ zI9Z1DNe4m$=tQjIkJOMDYgIZVH?Kfg$}qZv1Suf4w5*FGP*w@HAeK z@^yxUfH5M+Ngb#IK@sc^kUD1YIHLZc#s5e`@=JX3VEL?UDYhj8>J)e?Gy8ROlrD~w zOakSfhd9FU+J!9$7+LC@oomVlu0b#Z6^I{vQdz;EMhzu^>kUV5FPp_$q?JDAZ4h zu5mB_`?S%xlmCasm*0m*(2=y>*QwO_!v8v#`kPehKVa3D3*R-akI5DCm{Xrg$UMYg z6B-&b#WOA*&cgYMr!!9?P{d>YI8yUQEv%V}>Yj}g`}4^bXHBMF$DA=4ht9CEF`u;P zVfXLKo~%p9ehfL3fq;otHXN+$8b3x9i;>lf02eR#``;$9VIxUwFgb#TepuOHJ(wIa zd-U87E`6k6hd^QRLD_?0?m3zj9^>$%BEr~086)ujM8zh!vO&2Tf?Tiq$>vWi1kaKq z5S1y^kv#T?y4c^N(U`&iFc^KgvYk3kmO|UiTccXjA*r+nX=`?Gf^PHLc20iLqr)M) z$VJo!{k)6bl&$>@MpJpLlP(FpXKqCJTRs%%S?a#D-CaV~dBRuho5K>+A^#0TO96=g1W1E9&M83-1 zRbC~rg#v1#FFqLR&Ylr|e^6IiPBuj5tMICFl~zz~A%VfyK3~>6?1L!wTzc=0NvSqY*_&rfzTuDh#<>5XZ7q3<%kC~}u#aQO zB5z^)+2S~cjsB8edHB}6UE$${56ONG3-0euKh{&RscKbaZTqE0!BpYe=V6^H30ETK zi*v8zA_6-*v+Vt$9_Y?8+)Ncqz$S)zYHxB;0j~Z~rIqsW&OAf)ekb>-ielf*b4wci ztLvBn)RRS;fC`6rl$&EJ?Imch&?uKDqX06Kq+|OtgRNauxz;B zb2s{YH)-`8?~ZFMpPm{Y4RIPgb$~_HZ=Kp%pfl9((rP1CFxjVPpk|=OQJxD$F$ns3 z&zRG7;VxRs3Ta(?+-92R+p|RU+~BRbLMfnXV_JhOX>{+{^9^mQ9GkZG2F!`(((H4P zN~$I=Xz1{`Cx$5X2dU^tFy@U8syyfrMqP7YqjA5Z^$wh48wbBl;(tdJ`f%QIOS=Y7 ze;e=AflAM{4eGCpq*rG%3QFsWiYezY>3*{->tFlJ8}4w+T<<_W1gnD7r`E*l30PD%j?6w@d@iKpo ze~$f5+g5?IG*8Jx554qAbVdf58p)S0JJe8-rqk@XC{^jfEkTBQIcX_--DdAFEP8LD zSNuhOzrqi{O-giY_e8BX@FQaYo+9Zb(+LSDXx`j2DlBpzP z;nL(5F`NTWtKHhn#{w>ei;Tkb6R53mdu@XU+)sNFnQq&zLPO_y^}2wwzvrEv>cLuL zQEAyV5U9wsbSVoo^3|7{5|pGoYn#~Jh7j%r_G3ce%l#WUdOemf#T7;a-`cwbyGsls z_Nqc$i_gnz8hU9k%w;vNudm?~RNbp0&T>u<M93PrT+r$<64=m#> zRVhHnuYgN8MSsUAwe{NYzSG#Dy2l297<&>dLDc6;@~Y>LjyyftVuBhlOmk-_q>6r%o_9zM&-OK_j{@V%%}guFb2hrB$f1m0Ak z&kx80KOUF@c~Ol6Zv@Ej9ywrmk38^f9~OAN7e7%8oaH}Wcg8Tcn>^+*EdR~PPBuIt zjAlf#CJIl!=z;sK;`rOxWds~PDi5Q=17`O8Q3wIcSK$aefyQ7#KY+++Yyt{+|G5Qj z3_^0ch9?vqC)ory0qp&84;)xyi#Pu&P)|^)G8RycnLMGrf4*yPa;V3KK2U;ifMOt& zE2IbqgIZZ_FitZB>Vtqf5?La9vINVF0)VtI3bTt<0_8Ld3z!NVB`lXIx2dKQ&J&zY zT?MaqHzdNn;3&L1sfupBk=GD0AM4`8RBkOJWi}a>p_GH#XDOZra*7+=3FL$1SSL0c z%kzvnBl4V-|J)F6P;D{GWhxO6QKkP-mj$l%fHOO>HDO61WkrOj0 zNEyz&TB5}E!EAU6$xLu|4w|1U`Bj-VcQ3Lo%dPc} z8ygYq)T|8%{2=HCQjrG^zROcEHa~cMCq?*wB-YHxvl%U2GZf28ljjNDnH{&=MD%^)W z9}@Rs28JjU86=$!Ga^Br2hqqP9x@&)aL{ju(Ykj*>VidvG-7UnzacilpGRUa>$|eH zvT|w3G`%3r@;sfUAhB3&STBgFVL(huM;h}C=~m*nhWRhZf++R%p-i6FTYcd(S+EeM z;+lbF@%59@L{tURfemJf#5^+FKwd?Ei$4xWQx;=$^@Tc+iG9>RUU0}Tx14-xn_*$` zFMpjRf5nd?dD0}1T<%i=&Bt!$-wI71lE5FJ{1cM@F1L-RF-F9w-}Z)m0p#QK^$XP| zzPRf{3Ev+Q*gx!Mo&d}LLL?g$EF!10tXs%t*uub=4aS55w>OAg)1XyJ4qi);?$ zAer)wVlgRbg+I<&9y)VRpl(+Q8__Hdg(R1nTl))GDypEM=EdBVdci-g zNzZH{AORb7fo)tT9_dOCWEA6>ZXV}(#JfJl(8OSG46mXZnNwG-qDH~$7O6>vvbdmV zx&-RJ%v=&gy(1Rgmv7=V^8#Tm?&^T8+%pB_4l*~`U95;3uD`}Z-H8y0)9LcVW{Mj< z8^v**n_d&432kY3L1U;G3&%>**N_(Ao$tvRWTLph(n4^iyC#Il?*_Pd978 z!dcsCQx9}0M;k8{=HhIK7tlyNY6w$@@-U2=y0;|vh6)r*Y`=V|A zv()E;J4X^cv1mdN*9u9u4ixa@pBJeoQwP%3!R;@ItDiv?+?i4dN;5}P6m1iPDvW3s zvbLgBhWpC$azb1xqK#2M4RZ|hhc=p$>^6qL_%k3*)*VdmWTBTB&EVJd;N$Bv!Ct~( zAfHb{b|#DAc)dF#bv> zo8{lA=loq(e^OIHZ2m+w_`lgbkYi7-k?nslyN8%FcZ_6%eQXSH*2M3S`O7gA|7$q+ zA-e}djQ8Gs3>dzuEQ}}j{?| zSv(NXgrgPcZo;aea;guy1x-x5{_&D#2E+DGB<{`sEh(Jr+QyC2t~HaOUGNdwHL^e_ z%I}R7JA(@X{wZ@0fyj+dWPyxmaA21z>*MMkji1Lj%=k+AB3Z_7_W1(H_T=+#iOFm7^lZX$Z1OuI@ ziWd}s$)%-c9{0n^S}pnU7pwi?LHES&yc$l6zR16zwal}P&c`tD8HBaD&;m#Y!BSEz zSU(eR0sLLC>%BGOLv78?Av%#dc6V0NALnRk;WYnD+=jd`9soSN=CC+G+3*Mogkgt)Sr{;jA4_(3lq;{mLGKRxXu{SK*XqDhaL-^a% zLp32snur2!NewPE6pHocsaIBP_6<3+lNTgsAk1+rEax;si9^9hP0JDUN`_K~ zL^wga(=9okfwuE3lj<;VJPqpcEoC8r-j!sk!kLmTgrlwno#e*1sWjj?G^h{3I3ca6 zpo7HZ4*UDJz-a=TX{L&HCB^M{lIvT?Icoxcr18}W#-715=e;&bCJcaQkc^bp239>R@ zgth_kifs{>f0^l5nZ~3@sm{6XhJP`^`r-LoYU^FNPsY7&;?;6SI z7wzO`cy@{mP2p?I3L+><)1Xe4bhcZTpn(h_^Oyz=9g!x0{!AhyQ@5^Q&8?w>T&6P_ zPdm?OZ_ToYkh0FKi6#&`B2+N~$Ex(o_i+Fl~A z@A5K;AB;6AN!y&m-=7)OL9z^*0(e7E^$nQfjZC~scDiQ-8V6smZ`GCF+Fr2c$Dxx> z;H#-{8yJ!{MMw})Qat>EqHB*@x=Z<-kbLW2%X)YS3$ER9q3}nNcB@PeodhDHF`qi+P+&#b z7m4bzjLm4RC`67m|2ObLVX*!)B!0m-NBHJHLf<|hA`EU4^SQ|gFtz@BZSw08@c(Yg z#soqdW|9dKhyc#28B)!MY-9&Q_vg}w2VgLkicK%E5umoDxdN)HFr(Wco)kajS02Hh zWGJ(NRWG1x1$mPI6&18?rwUH?1n!`GDQR08-4$N1P8QJM{?tPdo^1pa_jXqLoCGIG zAiJ@SV+j-aL;Hu4bGv(vc4n#c5}BKGWy4*#h`0h< zTT2{LfZ7iPMpxnRg5%Y756+P+A*K-S{LoD)DHsS*b($T`!2|PbuHIDtc9}1WL>2*^ zhfA9s6yy`*JLKR4j8!)fQ-~N+992M4eokeSCuOM zOS}=hM@3JO`a)I5mZJ^8pf`!nDalEIxrwjAd?Ov8P;y_JHIP(G)m9G-%oxbYG&N~( z(pJY0_^BZDiuI+qVJ6%j&lD-w3;n6rHTg1Q>aiXasu5?T-ixW%;WxC#vs)D!6*29% zpnZ72DP%7mYmDG82oCZL5-9%( zt9k!(_zQ(QjN>m1fa1NrMBfQJUd93V_hmxyHGi0A86O+_hf`xG%s+on^WaFc@g^Ox ztq6i=usnzVvj#b4GYG)^-;TQd3nIlIHx`X&`M*^2j0dV&8cya?N1XpfvSJDuQumnb zrF$A$!AeRJ06~C=4iTh!BC8omT%4{VDWMS>ArhSA*4kP^!V>i{A|ITP$xla+A(2;* zjcz(YVYzd0B{)MJM~I)W~!r-$@_`w`1=wE;D~~N z>ZQVV5Vf!r6ySmCKLK-WXRD_osC${}2Pu-&Wd9r*3eim@nF^BO9^C3a_j+rXXJ;i< zCh!oL8o$*g$JcE&7hFKu5@|j-qzL>KO`_0z7Rpb7CbNLeSgh()xZ99+yamv#ndRuB z42LE=K?WQ6?4d@{fB*$JqifVNn>+H56+D02xZ9E(I1H6rnu)5%^Lkd8(lMq$ks#C( zPj(5$b`=QNVG!WbkUu_E5#FNCc5FC?{!Rmh-eUy&mO(%TDZ|P86~c84uoQM6H!Qc#_aAo0lYN<&yo@T)S9NwNxb{EhG)#Q@XlcC_?K)k*(nJM7Kh@nzQ;zMmd zHB?!+Bqbfp&X}U8^&-@1&yx^ijFE;bG6Jk-0Ge0U)NQ3E?-3=V$fCt6aJ)=-iNH^j zlCiQ<6l|wvoRkd>?I2A&E7$VB*^V(e@@xTiZA^ARJHztdEcu@%&)E}@X9yra$|Xnc zN6R=r%C%pRXHaDLki9@7K4r-v7~Ao|JRdqN@dV{hb)HJZuZ{d356*wfL_g-p|4z;1 zB(mgCwB=_V;3G|;cml)R3%sw<0gAf;BO}BZvJ>m`Go%FOYkNYm$3jn z9F2!Yp4=U=Iv1;fatX*umXN zTtp28*ocK7OGqsc39>i=-ZM{yGbj+CBJynEQlJUZfh~rUg4$Hln)!lFg{8qnI8|M& zEIX}E9gd*LlG7;zw53A%e6=Jt<-zweRH zC1!|nsBjLeEfZ$Dp9B>>!-=q}6~UPe`92}(1uI$SwNU!GjY zmfX}J1Hhn6=a|r5m0+njSWr*qQu2H>q-3RMYLetWa0eWqTS<`{3-#g|GbnxL1#nEG z8bX%>1>SLk@kiJwTDwOA_}p;kpwpacGM6Fs3dWHM{J7Z6TpUZ6%D@KT7GuOnz7L(O;@=F5TM9)bK3ngqupT|1 zxj!|7EfBl0c35DC>Vg85QDCt`Ei5oHeQ>bhHoG%1?%5qyzI>KCf(?Ne;q36-3Z@=e zISafBl9aLJDHg90C{%BHjCIyF#DD~6EB0{@20_Qn8C}wUdM>rrt4G*x4 zk^xiOK$3Y&FqG`?VNFkivrz)cA~7%ku;AiE?KV-a3aXCYo{VWiVQlZKC9yCftUxOT ziqd|tcDNFcQikK~q+&Q5{}r77Z`Sfp4(HAPOve3RlKu~nbl|tL@dy}xOjCcvd2sU! zi!sIvmbK!6uaE5+&&qvp!e?e~I(P#dNWt9mjIj3>L8y<5ZYvDa(miO<2J_SqGP@#=)?@!F9RqLjvIn zHLJ6HMv^7GE;)FptgNGDP)>&VE`*3!%XN{25#h$T(@RO4pq}Px8?)scg#=R*6;r@X zqI=uVMa%*VC&{{yqE`JNi5I1ymjSUPLo9MOW8J?ESmX~VrZ+6lGhE^T$)MUQ@nQ-% z#w8GsE(FlvuG^;O-*T4wTz3zG-nHB@Si@Sb`z@YBhf!P;F+;FT%i;j`%C0I=$b4kfq;rNs?yr4jDoRh3Nv zv>D3v@>T^0OymPv30AO?MxZ2C$N+-8$d_7Ju11uWWE6wHOrAA0OMC`xtc-%u(CmZf z61era9l6d9iiAe4t`(z6jX_u0B7ikM@5B)Ya0>AY4!OWGBZ=^nLExK)4x%YRw-&Wx z-9h+wF3IpBBrQ9O%n<wiNx-}W|A#&XLR_-hkx@41Dc1ugD zsW-HhP~$EDTx#fPP|XNm%d=$nMGd)ERETC|L-KCH9$g;9a%(UKs-eHY>TEb!KW|v9 z*B`gAQO&DTzF>+A#2kROTUcR(1_0xGai;ZIbz{>$6{Jf8n) z-u^`!^#^fy1klHL`)@?=k-;c<3iLNAwQ+2mY#OlZe-zKbD;jSo`{Vc5 z=@5NLbG1)B^e(PODgxpgpv5`qDbyf|l@Dzy`Ug@`)` zl!pzV?Vi|B3o5Ibz`eyk1xqI4%w)S%gZrQ^c@R8M9MA**pq^@F%H5Rs_;^NfISfg1iuIS>S`K1k4sS zthyKj8@S&oUtGUSveM--hFOjC=9UYg4bo%ucn#E$)+;TTfs!~vuBkrg#MJ4uQ zgUE&C+uYLlx&a=uTHDFQQ9@2}PUW}Q)D1)H9AIG?ur1UKg*Mn`gN;;#JgSaaOYNCM zXn^BbQ*wnASFotHhH?tFNlimZ6G0!k&B%9*VD93`UMJ!pQ#Ij)=>tMV391g6At40H z<6F2PIwHTfhEP9E9YRXhRMg;r0LKWzk-1D?j2bb5D@}*XQR-QM01m*aREjZG#T$e2 zd1|f695}5eXyPeXR{zbmGporA#rQLWK&}7HU`|$q`80+P0Wc>JVgAgt zZDIofOF9S?uy)`#dd8mz^S^=R|6z2@2L&Da`5@4d@;^KU_S-#d{;bJ0lUC6Gyy*WW zId>iyfYytE92k4vP=SC+ksxi!xa7Jh#6b$eNsft3AtwbWyWj-F!F*9irvGJmKBCy8dlSeWAmo95GKC@Q;Cif$a}P7mf+ z35Q|zmOqFwQ%;_9f09uI^M?7d!hkB@rSV)xW4MuRxAtIu! zeNzxxT^Y5I$bqwn%=rW?5*n%A7000qv8bOk1#O_RVVVo2AW_AH;$-<;3+*7&YhFh~roA8HXucm}sl6YX zrTTt=t?_=4NqRppi}e2HbmjLq!TTFCRNh~=Bfh_3HPMb?R-g4AeA+UULH}$IwjZyo z-}Sujo3iJZzbSimdBg5!y@K7tmxPtzt>TAE8>@ck0dE&KRz2-b+Vi9{dEetM@OD1s zz@rN(2OgeHt$6_6?w?LObiX6*(A~C-BjD}u?Ut;gw_7rg4mD*T8*GpszxjR6$s6D0 zo|<4LwAE(?)U0JIB3aRq`~>n6esn_ESN2PFh>cwyn($%wx{)317~l=OUuedOjp0Ww z`|x}4cMHuN6T!VxLl>-AzA}tF@&(-GZsoF&6_K&a$W~S(Wrbd5-VyxJ$YtRpTcwi0 zPU8{tKJ4TA;o;Hw+p#ObeO|$*wY0Ocv#^-pb(W3oruWH~5u3(e?ZdNMjJd!3PMAAJu#zV7edhjII?ExxkZ-{?E@ z!B+a%*0NTXW^W2`P7Rq`jVg*<*^miN~qP zUw%&9wr7Ub;a^v5*=Kh+@X4{9Q#+y`xgNgGt1^3g{*qBg;PjX7cVgd`I2^e!gSOK8 zjg!}Izl0x~&2Qf_y{^B2W4hq@`WMUgZh71?b-vMyZK+LDwBzZrXYcefpKR#ryJ3_0 z^jEseFL!dyZ+oq6o_92ETFx`v9MJ(9Ke=Rpg1);PZcj=!KsGqy-HDGOaSigiiOeKK zb-n%lZq0%XDrfH@U!D^r?tWq_ZK-5{$%e5l{CqARB2Dxk|5*XS1bhFEuF=mMCb_A^ zCIv+inFMtHtom$q`dxE|9&FITUUEKl{cVGiqo?GbopaTDs?E%j_#d?eeN6 z^vs2lBby1uK_o(Q_?9VU7?_F@(M3*v}PFny%VrW=mSSa{kI=Znj8SHwpvK|p)y%vtI ztWjZh!ZXYnmf$HPvHoYLeE9j(V*L91W&L>w&P~-kyT&`0PecsQ)jNIu4E11|K!3li zeMq!G|E}ewyh{b`FZhM!md+OEEUgY{+PE(gu4c{D`uUd4y|bq-BzRs%RV;O{u(78z zl~3|aAkT9&sv2Ov7kZ9WY}E`+s#=-5J(|Xh3632)*?~RW#W{JYBIWeYRmlr?l{r-? zOb?Dtysy9$`z?2y3%siZl<`mZR= zmv~7;J(&I>QFIhVBXrmQWA3ek>dLn5;our9Sa8=M2lwFa?(PuWHMqOGyE_DT2u^T! zcMbj{-M8;e_si?PRj=x+?~hZ(sb#Y8QUJ|n%gYHLlV+?nHv8=ujJm~VoEPlF)Rfk zn&KOr1K#N!QW{nnYf^HrV6!(U&1lRwZ|?B#ClOjj0@FeHmDu@>Fne}r`Gq2Zdzj&H z`Jc%j{K>F+bN!tW|iTE0yImUR+Bf=ZzD_ zddrbnD?x{5_qY$P`b1aYCM;=ylUnabY!a}9g>b{}dI24DJDXt{Wnqm1`yh9l=!ajh zyv?^-h|k4OwHw{cC5(uXhW1>b|Gs<;+CSlpB_w!WVhbwdK4yiC-HZ4zwucVqnz2!7 zmRdb`n%)z!Vv^i}W82_~!Cr+`zsYL;cBe8ux#{Dcr$;-0!L~hqaP`yM(UngmhNm-f zwz2J;fvt_p1z}rD#|LMd_bVN|?#$2CZRzP16$U%gr#=ce{^LVU~)=Y9!dZty$?Ye#_ z+V~S%cx3tget{OIKUB{zZ6CnI{A&9@XvxpE{}WC58{7Z6g74M#drhPkwBNj0dudLT zAcZt-%3A`PaOwf@!y(Ebya&y}6UyQyrwUlC*6#}v$i&N&N8bIS^pV5aSBu`ZYYd*g zD?$os{owB-R+OE+3uf44>b=7zQ-YTd!}6W zp_z6*@`_5(^kiEvAmD%dGQgIH8c9wrkl&NN-Gr~{X&T&+ZW>)D!gp^Vn_w;>yuaY9 zTq`9S`BYVPbsZIL!4;or-v)ksfxNXfXaG^!t&~uI2VFa|Ih5k2Qs0@NpTa@1iq0IH z4j^_66S>2wWGB%Nw^nJRryixep(Su zFt?AHf;=rJd$Ln@0i?e8yxMnRNO1}WRjElu{8$$d7eiHu#fQX&g|yI7nSBlNz~|P> z{K2fHJ9~k1*i0Q>;rm%u;WC69{9Lfn=k89P_i(VHm7bqXIek)RmPze}+<`lQ#L@Q9 zRyrU)w`T;niwofD2H)%D7sAjbo<#Cof2Qu(TDeO)V%MrDg})B=x1zCx1QKd(d6uXQ zIPh8a1}ssbhc~Ni$}sCeI*9tmz!`?xLFWsT8nNwfg=R_4fTBm7%E*C2t`>}}GZ_Zg z!*H))eahj68&J(Y4&AOz17y_73Hwqfwof?Qh6+*v*dX*H(bMXIg=5?JCHG+t_cgwv zHj6D}Qy~X6NQ zu0?vh+a7Zh^73;a0Oi|!_bb!>gJk~Fv|kT$WMulm^M1DMpLpLNA&>4SCVbc#RD9SP zRB+H8Tz1eERC>@BQgYB1T(sXET)y8CQoi3FQo7$9TC&#}TKW2^*lP_d-)jji+ief8 z-fau7-06&{-{}mm-RTIg*=dca*=~=l-)@Vn-D;0)*zAmK+H8OQv_?0rcSL?!Z;Sek zqOP_@|8F$)H_G-S2>p73uaS=NM_B)Pf$LL+wKexpC-8) z`M9DGs|P)b8_Y;;A4kZOxD-BaWKHho zZ&-HSQ3ckpe5Sue+MSh5T`%Cp95thn%mmww!z^e3>Q{{JmUm0 zW6Z922AGkCnbD?K%!Deb01~^e#JLFL^?{-1ig@oD(1g{aj^2@a+K-$-4kvd2&}z_y zYXmeO(sKC&X8Hj$eYA=~07Y-~31;*d4RjuO|5O9vR{wUOoCcg6Av*Y`QPr!tT3Ww0 zL|!cn{)nrrfQ+26@8bm-SyB#}5e+#JP7@#&SI;C@ZGu;ZXf7IzUrI1Ok^09g^DG8u ze;Uo|UCpMt$!UENaSCUe_F_5^fZ^heDJ5Yvmh~aAEar5`YU-UJ3zTv_Q&7rMP{@*H zFWf>krSuM#$mH^so=gdb%j&7vc`6j9p*Z3jvCHC>lHn^OJEyd!ydymbg4sswQCiW= zNez@;QO#_*3$I>MakfvaE?uT>Usr5tnBWn06%ozYjCD{XBPNK|mog#ewr1u5G~t)Z zJl1jp&eJz`KJ+RFZrr1T4Wh_eLl2@rFNz^=&@W+OSzQ_=q%22tL0AyEJ`s0buYk{H zC=F(~k!Ela&^%l`h+GT`Tx9GF7_>({BoimBkUB;ZG~n*8Ug0PewAOBt{vasLvsq7@yY=S(G=H4A{ZF&Ce z8r~mW)%?me{6TkrjU2%1spLOcYx7lk7 zFWv15t@@YOsruo0c3UE<{_1^RJy7-k(F6T9<^O^P|5Wh%N(H*-r54^`y;1?|h{ce3 z9CUAB8?zx9)-42tFl|U3ah_d{9mFuh;H5mgdTyD9fZjqp=m7<34v!L#K?u(~g74k$ zI-0bRM%>z_6 zA4t|4m^`{Wh_}BFk5T|XXR0+Fid0ji>DdnzQ|kh$8-|#X%1( z#fZDA`6(Jvy@#gmsT`eJhWy;U%C>$6cWDIJ{xG4}9Io}$Gq>0>JnNku4UJ=s2B$1w zd59v76WIF3%C1<9TwMb=X@8?Q$%2=2L^?16zrV#C-j!cf^!Z1Ws`56kbul4{u-_719i)SRxdXi|Ezx4${i(A_xxs*#G#M72sHVb&mXdGM*HRyIh5i2`ux zLTsv&GD{&8Une?HZS$_de8sn{eeQ63Z_9y|u1O(WnfWXJq9M8YD!JdM#XQ1A#r=*p zdu*E{bzHXkimsdGl1RN(6%kMaEx3L^bH)P`3LfDGT`7908&sc!K z7s!Y3{vcH_CrOtaPtlwzp6#|89VI}0TM+$O5tj>omF5vOcwI2t2Xg}X5eaf#HQVbD z3aU~TrV*6W5DTjW{&a~HU@w?=_DkFnH?Q$cvyU&N(c)1k^rGL$?{VoV)B z7Fb{3ooJA|x3<_+2^F_;@*W-=*r!vMsUFBC=TR3uPZHa~ESGv@@tHiP!IZW0?ZvaH zJn549e5e=E$doWmSlo3z)~saHX?9XmY`T z4ZVS?MP$Aep%E-&bst_rN|@E|4y{n4QWL#g;83DcV=ei>`VRNgaCKkER839EwVZ8X z_!zjEFQclMnxYxGSYfh&-t;%68GFsz8^6U#j!nJC0%-OOng|Q?qt8fSxRq&w~XKn z@C<{*5CihMS!C#7( z8-bq(G-n|AizvU$Ig-3K5G4i=9x!4qfi7>Qx5BgRvVxdx2K}Ho9leK)wZ{3g`NMjV z1K6)2POfp5 z#IPIDZZ<@hI2U{u7XvY2*G?`sPvTn)c{oliBc#?T{A!#~NZCHyUZP8Gk&SL4rk>-C z3ZspV<6sqS3cuau29YelEzm&F;zZ5oVixC|6ml;OaA^$rGOU=Od_3xGO3&Bz-gH84 ziUeM^c}nEi9JB6Sb7im5SbBFlPEQ+lSNN5#6nNEk_{}-VQQMoDCpBeCIpy2uE>*0~ zV2wVc4EsZt8D(Zgr;jsdT&1tXQRky#B~VGX5FiFXX z^TUK(>z>Faw=H;VL{l(hWruiE zqp!$cxnQo4iF2y1VaSFcuX0|ZDuOQZY&Nn|0a@8lHSPe&BJ0&3hu?i~*T_?p%Z6w#LV5&|AKFH#3&5I#h~Qb5CofQ&41UZJtd zGx87!A_`9~s5s;xN%Oo4nda)#+0>QY*wxJk$%6%J-K%H_QgF2SBDmxnh~(B3UgTVd z3%-)mTv~hS&xsY5d8o!rGi9M=BjX<=rrwMU&mH9mUhvWbEOl45NYGdZz{}$6RCi3% z0haJ`f!+viC54s*xcnM~psQ5oBR#2cjFgu% z;1|&_U0w93eW>uP_`{`1%RR~SKsvhVFWl&`@^3rm6-EnP?lZr{#C|@Q>?H@EexC;^ zFT}iW1_3qzA4gy8fIG!TBcB36v0M0^u8<*D<~(2eoai-wsD>ugYaixP1cCA#5?m8P zApHm;t$LruASVY7?MfDABFbaZ2=3R4Y#Du@S((wL8QhEpy(_0KGvIX?x#*AI0LOC! z&ud82#0oN>kWcg#`yE5LjTNjxI#t7=ptJ?HVAAdo706VCtT7UCIyso2j43A1;73q$ zj<-R#d21|Tyc-%pj6sgX9u??GIV#BA^kn||(y)@5=;(Y|m*CJ@Cdh0gGTJ9BHZePq zr)_?2v!AxuUl%96cOtHtMK|@({j>TNm(9}d7fZrf`v41kOwT~`Q;uq-Q^KKzk0&p^ zIBT@$kO5WBSc0ePc+ZdzRd+Q$J)1R8ZT$rgg9Qbia#B*a(J)tA`pk8i$9ZUVA8S)I zk=c`s4lEZ2KNKw{5gWK_tK12wfec;DtOY;Dc)*s&G6!TNw0+w-3z_V@R@h%0D6Zwv z>eobJ7SuwyzCN5A+PMFI*meJ1b$w_`b^UT`;rxCpWs@ex@**RDb%$%TWymAZ{RQ`@ z5LE&91@c#j`dgLt8?9pbi_H2>cKu_BdM!Tu`CSfdH_+>Q2;|rI5X>7O4aQU;wsZ(w z>pV7+TXF?~4XwDE7OQ^CYKC7t>z%Mwwc%BhvU-GgEnFmkV5u?(yQS%e883?jov!ul zCsRd+NrQ_@wZ%?iDv3p1_1D9vgtl)Q&e%oUiQhBHulrCu|4b)UqtttUHSa%!-!DDM zYppyZ%U`78Z{vTSHp`!;jof_*?M?go`lVn@tfuJ^+utv+Fpk)tt)109f1J88!oK&B_Bw9$u}ypQ>L*ZA~oY@MYIO zsu2i@^L^7yDiLGKuHXfk@cn0d7b7zl2%nXXfje>L#Uo08R-!gDI2G-X#`wIjA zZTydG#{6@)=2z`G>MAE|h7NXC5#Os|k&*%oY$FFG!;c^xRNGgJVVl}lB!2OYL1LE$ zyX+`c4x6(m&XCBQ`oX(e^{U@;=AqPa?9#%{PO;D%-n1RFcmisA4G&YkmAmCz${@dB zA=?ex=$920c!i;<8(A^tJvR9;f2WzNQFm#}E1oKd0SJLJ?kd2DrVTH^n&~a~J}wa& zls+;2H6P&1pd?duBvf!#Kcv8Fj!)N%v|Z~I_xeL{{HaL=&xE?q(HT#@5IL{TK-U}n zl7K{1pz3+>`5p$90m!D+H}i!)=6J2?3{wz;hy}D@gKr0Ma&&~f!J?-H6zO<2BnNf< z^_en{ucA`ajoEb>#8a^)k;dyIqOm`9@-WqYIxWyUFBpaK{ zqB@F*!T*gtEZ+!e#LJptnVdnx;{xeaotoj%nZfN_tY9~`7djcQJ}KNb9-KcuTo2is z3G8gVw>(?nUp|K1O9R_$!P=jq3&`AF`O3h=OJDZOT!zVjGFn11N+FC0b;Dsg!9$! z1Y8my*7)w>R*d2+Gc>xI_w!D8Tv}aen`Yc&)J{%DmX6!fHJTR2sI^*0sI-nz70X$) zJd#!0mxflGmy()S?^s$V?h>7+?jluAk5F+7UksUJJq>XvJ$KW`{U5p7$xnB2#ZH6O zuH;?R=3cV~8Fj0}7In8Ci{{6p9}7eeEAGm64pZWGGPaGv($p5i(rg4C^>ozSuGR9M zZLCu$>d+b*Jb(5`K#Z9}zk=7_iUq)H8i$ePFJj@h@jt?g5%A|!@vy5LlFlowKM#xVy1YwXO5KrOPOr*!L=}bi(;BiP)WVSZkUNp@yNkq*zh(=A6lcQaNLH5G; z)o$!U_5}!qzkzMe;Gi`mwuuJummoqLiNfw1_I=yOaNc$@$m3{4#$z4K<9Pr2VtJGg z*e)PNef$_$Fr7h!NOwzel0(oNp76v(7AjfUcSp^CXGA8F=z?dnZAX&l9mlvj@Dw*# zaXY921vg4U=KV#i-$9scBGD39iF~IUVymP?hyRrcYYU(I*4 zK{?dr9$UN3v2lahILtjk=*I0MrZzuGT?p)^K*`$Am`$N6en{mpG*(mC`$XYjiOUlN$x&F^4Ms14UNK#R_Uv~&R@c7wjEi97|xh4K?}s1Sw^_>-eT?6 zpBb5?Fiq&ArR(4 z4dRZ!b+=vdEn&M^EI`X(r5|J6y>(@wxlg_1jY=4BcHo$Z*3WMEz<*hR5U0Yx?6oHm zMd)Y(;5V%aj4ePU7bBKU<>%jtDi!0W>%CSccu&9yUQ-16O*K#@BS0m=Mp?2@1A> z*XuF5%5EVWaILk?iUU;#meHTuVOos`t@Io?MBeb`aNHc>8BxW|JeF=7&KcmNF^186V&I^mxvt~r5Wk!R^&Ec}erx2w@i7p^LEXY3mD&NT zrX}g}qVJAs@v^=8SVK?kzJA-oY@M{8W3}qq&Wp;qW;=QFdLyFc=0jD}Rr7a0iBpP{ z69G-Cmp;l_L%%QQ5r5|0-*S8NsJT=Ro?_Rn5 ze^3mjYjX1|6#p%me=P&RV`Tjcng5O4|8oeT|Fb;qHIl*rLVvTSwKOG|#XG;L+|Q6) zoEHdd5D1CvEfZ^w%nGkUlV~}?3 zuA+xc1r@F%^W;*CcMIRy>AjY?!+0{r+6x#fNyWW{-qn}1f-^#1Wh=QDHQZ|Wrjq2! zL3tit5IewB23aa6YsEx$NhRlPnT`rtATHt3DUAdnhq(A&R$uSyXM{9*VlO{(Xs?dp zwXSa>3OmV>vb#hy)#6rB&fFGTI2 zXm&C?xiGR2X$cD^>bjV5h+~imT5opANNeCj0v(mPmpT}S2@^nMtr_vS5x0;}cpPA? z-_ixvXvu2cTIW?nP_{g!c75xQqL`+nb)61K zttJK&T4k^p7CH-7ly9TISW#v{e33rnL3_ky_DxBop6scOGQ^Pd%H^6A|J;Z_DSVI< z=8L}&=;JDPr6r2%E`n~Mg~L7U^nk^@!r3qG=&6_g0ROX1PK}iH|H>x+R%iiU6#^sc zUzFBw%fIcqbj#K+nUi=D97{Y;xa?X zMI*gaoMQ5=-Peg@p0RO^yrNjdd$R?XiSB8F)sId`lPMWhXlhLO- zKZojI%A0aJc#2iX<%XB>kld-q?Co!9YbAfphRlh$!{rJpvB9jeFdOwA;e=cy13q* zrR;tK@n|*roKb_@aXmGR)#&j6u0HX7?O++WF&BRvsWCMP%m4!|cGozQUx+)X51jZr z%C10W$7fW~OzvIaXku_8y?w2CKXFkzyJ(}#cQ!I?gI441#B4XJ>9Z~I`^B>#)Xqh% zDieVDo_Oh|X;kX(?`$T{)OAa_Vus_agPH);bl00$X7=J%wVMn|^pY10IlvD?WMd1T zxgu;zuMs;Z-iDZOR(3qG5zXK0_?O@!rAl=Zd457iD}5W>V(G)-X%^{2?3~YYlVcsZ zjscFw(Tz7a3%}ug?ZIQbzw5WdMLu`%&P^|4?bD4MaG>QL3K4s2%iIE?K)j}+@reN* z@Ap=r51+27^Fi}9U7(QAo0|+=nJMQ_Nc{3Gc#V(xd{fdMt6TX9ZX^YDj}dguNU7)? zHwfOv#hu84Ze&s;VAk^GB{USp_J|S_qf+2A$u-VRjp8>ShuSryaXVxlJGjkHhKmfB z)lSWeiX4~aPR(>7icxweW6bGXH4QKyftlx_$6vH0kv5_aKVhuFh0ns~qV1mf_IHv>8ynkv_B;1{_NQ0h{qNUT?@n>3 ze}$31Ritzbulo*J|Ds5L8~-ClSpK3&N1f$jAQ1Y`m9*iH3?`y@S;0ZKqpeI3e3rcY ztpY&1qJV8;1A#X3$Tr$ zwT%v33=UM<4JqlNqz_b+4NOoc@Ze1PUUwU`+akuHrr#pLag8OIgR&_|A}H`hxR>l* z9yz+rVq{B{D-PiyHtZngzNL;E#pGz#qGb;ADz7D(Pz5DlyB<%&cFyW3U&W|E#aF=w z!z`uT%mhu|26g^~4Ev@MEfHQbGk)8t97cugX_X%P+GJiCyz;DhetRZW1(IY&kYhtO zRfA+<0ZJ*vgbC5;31}|vn2!ogIWubf08yy8NuKxWz|>)j6nI+;Lj5 zvnuORt?itqnA2K0I^oedg2Oe!$uZv2CehMFM`uSU`c7s=fX|8IO)J+8al`4! zHcdpzc%+s%5(XCW7B>FY3CYx~z`%58I!(vQ0H`Yn-_dpR{PjpRJI84GmV@Ba(RY%$ zbGRx_CQ`#WoTundt1OG%T=funr`OetIND}Ml=c3Cb66RMwnz9WIqx2wZ@rX}FLnKu z=v*1uM*FrnFl8-6C4xkrBj<;T`ZuDSI)(<{v`Y;mrFwk8K}=01C2L*t%~&Ndy0drT z8Lr`C?5B~tRk@_8y6FWjc^1%IQrqYq1|9>3cXqIhihB@y0WWBGewX@uGV zQ2#-_zwR>pO|Ac=-dX=U^$z$m?;m|o`eu&~advy#`~Zvv(nmz*=-Zvg|0NnsbNpT0 zvd6wwk>u^+zTH?bn?sklgltc?SC1|_pPoaO77f17i@x_L7Vna>h_lM!>vBDfJ;Q1CJ-j5o>heKyIl+Mfz#mga zNo%D0nlg**d0|0u=|-)&t00xqiD-K!fu>stYim`3*016}8-49<|3>l*?eiU5^}Q~a ze11ZfZWt^R^59yI;yGt5VVh}<)2$_n<>vCnvI5zPYKRkM7@f3bjMqcWmRq+WYeTd2 z{Vl4<>SnKvgOb-3(;U4I6Y*wUNz&!E|8SG3T%VlY=+*SL!BQBpiB@^^Nd;a0gDG>~ zvi*#ml)Hy%M{zDk-j~?^EU~m@Lvj1lDq_ywWPPbH)_s=`%=-&EB412xqm3MPNT0t7 zcC`wmSSes2mD{*yH}|FPl{1liaZqMja#9jS!{vAX-<_N}<>+ zuKZLct?{XB{K?TYgycXL;dl!FfPui}3wK!hs9bg#+()tqTvkkl#%rE!HvXus0?5Mm^^KlNSWW}5BNSXw3th@rDZ{QQv)8|b5J zv}&P9?=VdVY)uk~s`v}ExNZ7#QusH=4&)kgLpd$r*>J=fv(<5<4x&quXOjy^+D;Ge zr=H_yJjRLLD@58+x754u4Oiq=*FyJRPCEwy9VnwpPP^zeRfZdCdZ!=>^IFfzTyLnW z+OJTsGjI2>*9czRqbx(K!#$*y!rI$Dj1Ibym$EuuBy`cK4j6_Dic zE3E##Mt?n6lZp1nB|l^Jhi3oBpvuhr)0vmA#52lFE=CCXGX(IuqA+H;cWelcc`Y6| z7zlEt;1F@&8z5*z1W0sm&|_tz$MN>PTClHqK)lH<4elV1-Ua>eV@IR&w&^uS2`TwV z78q$u49K=}G*eKF0_tK%s=Bk+)fG>{K8L0%CD`iD8tTpzjixlDxO+q&mn1z3<67F2 z+!|6ITSYIZ^0qA5t4LicJ%6qAr5o#qTfL=Z;+BRr8IV4 zVLg(3%{%*M^l2jbz#4Tj${rU+Uz7{I)-zqO6J5?r?XX&%w+*^M-(0r(T%^71+p$V& zkcZ^FrAPc9nU>keS`QDtR8<_I5P z@$vxOAJN_qN78=gdO~(z3VD8{cIoipnhEDx@aLKfJgE@!l=V4zfNSmd^QeGbmJ6oV z)Oc1&xSj1SLWACzjyD`f^)|kYF}Bq+j^e4E2dYirsx7i$*v|nw$>cQS!?Yl2XyK=3 zld|CAw&;_hUXr4o60@idS?Y1G4#BU6iP7KHicG`AXJ3|Ln(OwAj!_AVcE-l9K_hFh;VB4LWN79Og|HLNFhC$TIGTM93hGwbQsGPQ` zYoM68^Ed*$TcR_n#G5Ka%Ay5p6)$Xqy0|5NF*cK(Tkj~+x=eziMp)M-Zc5eFUZo)E zxMKUIsdK-Njod{*IT`W$_#eT?MEmDWguM@P_||XUoW0zhNXqFj#YDTpm8DZ2Q$cn!XJh*A|_&yx)^5h)do|L+2N#grh zA*J>GkcR$oIuLR$n;QePr zPly@tSbYQTVYLV1LBV#G+Z?S#jni+@(_F00lVhR@uA##dl)}uewNooOJD*xpkJM-= z)sE?)jS}M7zr?!1%pFC`sxgx`SPRsp=*cf)mDyQOC3X#JP}H;7n0Iz=_is6bM_O9> z4)?9Y)Jw{2pCB`&!oYn6Oh7 zS~%Ie&Ue2to;%zWz#!clnK2DRBrlP~I}M6a+&A(DqclCIA08mKhi?j{IBDD%&E!W( zZiOVA*d51$P~&_0ZfC%K38^Up$Y^F@HJ8-}ts!+O4P>G>W^ry~|I?JqJ*g?@kNn!d zH5v}svc>(-^;x|7FnsE};2oJK<4BV8Q>tifEW<|6YjFF~838 z&qDO~@jt?rnf|BBA>km{u?MLU9jsS=d-;?umKIoRL5;{Lg!;*YHsxc-@(vx-uss2+ zZA3OdVUVy+bT+-L8rdlMvdFC5vHX`+N&6}C%-0peS_EUwZ*7?MjB!do=(BKF*-x{D+yt%`HdC2t}F z>{YkNQ|2clEz%icxA5UxuN2|(=R!JX!*ywOiVk*dX`Jy?!hn_;U|Z}^L1=b{p4f=* z-(mB=$dz>^=Xx{pfS9G0=!c~cmr9`y&dmAQtWrX`kLBmwCQ-TQr3qLLW9|2YIPMF@ z7MP2GemDn?@5hksycpn7&R+5*p5!|SQq0*+&)Ew~r2Mk!b;1IjLHQ+{*iK*+!Ek5i z0XmV;5c={H+Qc2`9&7{Ou7uJABAA`;d=6ocfSoT(ki*Ra?t})kT+VSm^ry}nV|UnE zK{=x3d}%OM5bSXzkXn9eNHEF?B>e!xQN~r^*i4LgR5@IFjrvK#<+n128_A37ND zHT)izAClvgRz3{$R7PE|+tPqLH z^yj$Z9A;lcQ<Kr%P|fM|0W~}%~l9t z)|-0Q_kGb~0SehVe-G~%xa}VC^!W?+_pW=i6ABLQRLUiu#m~SuFv?@QNsp~P^N&>A zD_nR9*XlDi4U>j=0oHJ*V>+oLmQ3v#%s?uShGigh?~N?pz=mF9234h>7hKnZe{Vz` z&`$6C{-Wx|glu%2Uwbk9pSvzF0e*|g z|6A9E-}&-CW1aEOiP=aKrDP>!K_v_nQY1o2>yE%+-l#%lL;)E@7y^NVz>QcYji>P! zEQG7H6LxOTj+6a>))S4}a-$3{PqdHYcWk_*Z2Y7bQKQwVVi&0K4=G@tG+!#ACp$W~-PEgj)3jZkS={TcvXXt;f9=shWi{SO47 z4`+rh=lSl91>{S*NX+g2DKMLcXx8-jOJ(FsTSOMRSdQ+nw}-SATOcRVxXe=#F%j!n z)N5G7n@1z-xki3?lBO7>ckf97{xujKL2uVTJXm-6u)u(@WHeg?Ys_uCAITy$Cw6eD zbdL&EMG($C;2)*EKN^8Ls(W*DKAFpLBMyI~&wS&%)$fa_^PRIeS|AM@vboR( zT0xlynwoV z*m_%7x=M2aLn(>T0I7|{d9dMbgq;~sLmMnxcS!n$h^DE4{TC=(?!9+zytnM3Uzz$; zpmQ37tI&GpusY`;wTZZNgl7Wbb@}fBxt@e)ID8KJf&B;(6NGo=j(ZIWd(+VO67Qex zk)J3cJdy-Ht_slfO~3%IHfdd$eAA(_3rHs#`o?2&_V97P4Cf3@y zEVCvz)|RA33N#Nxn$(71*VYg%SYmduEr`IDAqYG$hLYIVE^#cZe^509|5O{oY~4Ct z?%X_jLDDp9>3KnMGP_7u!7Px~VP+CGbIGhK1z&qYQCm!`I?JlsZaKmB;J3pUXIRF2 zS^go`SP_Q7GTd16=hcs5w!apz{ojh$en#R6V5YX(qL<3IR4qv6h?@ov4^X=h30ph z&GE!sK>XNi-!q@2D~3NbQy3Q>AIwjrr8NNGNgdC*<{r|ZdAh)&(}TtiFU}|JS)H__ zylHtiSZGK}PIt31%^J^w0TZs18Vjh4FC#rV^7@3W9d@=3edYM_z9a1vs-^Cd6= zjj!40A8Ebe3g)fXujy|a6>^<`zbm3|zqld(S|)p#IW@M>)RtizGjGh^jBw*GTa1e@ zAr!9I0qu44H7%mjv18@>^kY&Q9LqW{oJ~}K8*(OsfSs%!E$SvM&O2$|QUkJne(^4S z`HnDhr#Ec*vgSBWI@%a+g*|q|9pdtx@b7>?0Wi~vVXTQE&WRBiAGoPdbrDf>;KVAC zhomF6A@M`O`NsoE81%ptv%yL#G2nIIW-Es%mUg?CcLp_^&G{c!cI>)g zX?1T3Z@`Xjs0JEIwbK3ekvp{) z$S(6;bI&)Y*ziIK*B)Z5E{k)Dws4pYVl3o@Ub8tKFjqwmn)G+A8wN+cXh9EjZ9<&O z;qDs(RnjfI$rf%weM|?zdQO6&?>2kiZTPZKr6WlN$2cjqgnIyl)Dh5nozEq#6l((6>>7S$JxaW5- z@7~lVBDLpwwRumaLP42J-CC_m9sRaiN%PvNHQBM$(Ys+-ZGF1c!?I@f!r|WIF5;?S z)NbKq6z!~DnV5|%pMHaM!xAI#*r?~`VXV@`#jE`A`d)B(((zE}I>I0*m8d{i#2n^S z2h$T?Envjoj*T<++4^2+A2;7JcU4SF5?8b#KjoX(`ffl5CKqRm-W32t<-5%WG2tu(38VN^CDj(*AX{>yBvT#g6{$}kWaJ04hjjxf z=+~Eq)s+sBE#pik%-!qK`(>Z`D;F1%iC^I>tVK}z#_ho5T{x3v@&wsXcz2_P<$)^r zhrd?4eL?!<5!avjiEu7WWtS>>Y^H}ij0C!EF#CR)TqW2;?yV?iX=SYxq)vh>Z0|;J zX#@|-dwi3q)rQ~@uqQ=dUJ*)#ql*%Y_C>M52;y$Q^JfgBe9)nDLs31}PH|S{_(XEj zA=zSzAv*fF?&>A+?dnwH{0n7CI=QtTe7bp8mq8KKHS2-?3z$4&bk`jXUWS-_gt7Kq)yL& zXa4|YqHH>qU(Ekrz(5ubxzqT~6nD_VXXwPvAbTK`mNAMnH+Gfb?2W7?QlILeQ*`21 zf+Tag{QKn$r(M+I;~w7kr54 zVg~1&#afun`62;!THh$JQO*%ok2qZLVHX#SbNk@r5>(xS=*MDF>)BwpAxYWxE=<>b zQ!0DW5{8lZ#mBNHgr}JXqzDD1x^4uh>B?arcrt@}^K2)QzBthwZ|=F(J7VkySz)Gs z$BwW=wq?P+-Si*52OO6>vax>POZd4!@Wio%D?f!x6a4%`6v08NS zDrft0!dxJKg5X#%e`6l*tK#$;Q*wp@Y((tz#wzGn-P{Yte0-l&55iU{`*ZDL*;rX4 z8gvDrQ^na8Gk2{Nzx?8x)!BUlxse;vpv19w;K!D?DC~t4gLdb}e4)sZuAP~Nu(G>` zOVde@$^p*-qbB#K$$mat&8kM@%Pog%9OvdlVl3NH9};ZhaR^fknHDB`;$?IVk}$tP zv|$nR7)*i{y`bH1U%>@VBB9`6(M^9q(kYklEhfd>-^VEu^ci%|>jEVtc`}m~%8dG~ zJ+6NPrS?s{W2RI)g&0(^`mGOYy-sEDC-hRo6hBZLeN1q(Ie(tm*RerLFR1Fge<$1P z_vxR|&9zhVK$%{zmoV?f>tll5Fs}*hFns;a?-M#l4-;&CvgxRCQo}j_G{VBO)YlS@ z#-PK{)7zC3Xtxv7y6R4CqB1Jh0mw?C#m}F7X}4)fz*E9e95Hx178O zFrktZ_FRxXZLSwM%Jh0gc$IFpE&Xy>t0B{5Z8ULc4#fHhXhvXdI!zBL3RiwO6vv7` z{Zg<-eZi1JQ}jI>O-#u;TU+I(9kIq_Q@oy3W$!(ZQ-E1Ngt94~-~Ffr%vLZgTY zazKh(u|^M_?HK8UJVuX93oOndu(BKsQOedRVYCu*SVgm9r%91-s)`LYtts2gQxxJ} z_fzac3~t*Iy*ZH=i)N%GWhY%cy&PMDW#?KbRGR9_X|mDo8AmLV8ws|LjdXZev|M0M z!SQAH$Ta96XKj8J0*j>T zqp_=psbi=r=WiHfaz26;Xu@8FC=^JzUS#}g@kq+=Ak)3$9O3osDfr~br!hxkIS$JsU zY)Ia@gf)@#y(pBkUnSsFb2#q3Fd#vL=^_&kmXinPDMe$JR{ItuJZVnrj(m+zwK#LF z32k{uh4T+zB|`{mv44zw=FtebHTE#Mu1tj*-4JQVb}qsxh9B3+yH{*IoX}V!k>IMc zfhnDeQO}Ej>LRecG3)L3(1{f+B7ziiv zwjxU#>;IAW)=_mO&l+g(;KAM9;c##Z?(QDk-95O4K+qsTgM>hEcPGK!-Q8XC4w)e{ zbLV&Oee3=4){`}B4V~V*d++XDRb73)udBX}xoctL;o%YCF|7%FH+BeAzbs5C`tIsi zFS9b&Vl(fql>v>2+=WLFp0S-Fd?FTXyOS1p<6g6eR2Pg)50iw2-3>OBdr1{UCHVe0 zo~jbg=FQP5MjAC-913Lzal9z5u-Yg_g;o6b-4JWLL=L)eL1R=lZ4L?FnXPgBLg{Y9 z0QD-D*KiL`FcQsb4^n;0PU^3d{Aet8-5J2S8pW<#=RT558uW<#75 zBbti50n>OD!}4gZg>*69uphbo&0s}1vlSE?vwL#Xp%JnpnBR&Ws6brO`6A5L(LcP~ z8hQl*yZ2@KavGY#lZ-dpD~1JE!H;HFe*M;-aS+Y^3Y?Vq=S%!7@Gr~mi`$=S^BdoW z?Blo&*a!~u8KYIiYJa4XkYUu>t>z{}~IcTtJWvR!rBU>fu= zpyg)%CNNT$2Pvd0Q5TV6YjFF(6Q(`QeBBRXlZxnUEVY8SZ)|8wSh|KKz1zAV;#`KX zRFdQMNEi3CpPm4szAT)o`W9EW5!C$d{_xQfhRmI1M!($Uf|#|{$TVRkTAvBz=m?`# zz$-k8II>CiMe{)Sto;6Ig%3F`TCtfKV9~yaVxdP7HsbAf(LqT>;oG@u2uPL1=wDxpV`G}v6#rSG2Jt+IuBG+H? z=j$cxB6byd#0zpbSlXT-!0Wd(m!vjCHictY-E4ND+zC4y^4q}%de(a%!41@?WTh3>+I_NL~zw@i`W514j-NCTI<`dp=`@slVO|K19`c;CJ1z~ zCbS=7fmAt?>d_Dq7*)q#3HDGs%Sxc&?G8l~Wkv@CVenow9WO`;h*N&MpDaDHM#a5a3PVWzDxXlE3>2Fis z9!xQhN%Qq9O>RRaTdCrS982yRO%0YK{!oJ+Q)Vh*bj_134IV#dvrPp#?{AW$du$8M zXZif{+iV_~!|kwnmpEcN74~c!&C771{0VyUQYWL|ak*a5SI?~VWitV&65aSReS#V| zIX=y&`qz$Q@4pi4Y9Mcm41vF4!svlsZ6(2O6vPkDnQ2qPFZgg5y9Nb*9WFVd)JdC+ zNqRtGRhZJ5!sdStBj&_KymBtz4xha#56WSX{c+KUl^88CsgBPsfqd5px$PMDyR&MF z@~Eig8{@;f^gid#(ty#asgiWQACfQu=b{V#4i(%xh5N6(OD#;s+M&!S849lqtW#Oo zqp#nx8Wj^ni=cHdLZD(2z~(vI+3P_Gi$<|rb5XQU^ZCCNA|EwgyT!g*5>XNEyZ|tO z0>|A(V8w>LG?NIjm(m#PXB=3TD$#kdpPjiX8k`VU=&xv$w_SN`*GxKqcLUSHUiRjD z-irFNl+RF>m5?U37M`$cdQtCK zL~m;yQR41*96W@j$bkZI9TGVx(D7o)o5{@eEvriz@HyWL>+$7bXQKy|w_0XOE;DJP z>3m(U?ih)w+nXALMD$2c{M#`U0x?HGNfR)_!TDc_3ZkJ13YRWRASil^fI||MDU!%W z;Zj_n$W$5`0keewQIs~J8f)t;9^=#DYIL4Ec2~Yw!IN^22QnH+W>-&6nQ2?U5CD_V}D zi~~z%jaX8=G;Cjz#n--%H}TE5meLcf1+3N1*cP0c7r#xp05N-ZJ@3W#6dFr(rgI$LuBUo@0WLEQQTZV<>%rWeFs1Cr%48|Z&CUcBA?jc+ z3FBbr17-#Bu{4cn-Q*KYF$kD*zww^FCO0NCXQjvfr5PXQ$kXs@TK_0RwY;`b zIa0YopTvy&MrcQ)*cA7Uc^P zha7H3qwPDXXb%rI8RZcB5jNJcCQ>5^bHkrfy~$dXJimy)>T`ip^Eq1kF01!yTv|`P zTHB|4j=_w0kiHK-cBAVdKUo}~L=F>-dUa1*dv5mpk|#^9t;fW>s3Qaa&HRU}yYv1# zm*QenQ%5@n(n-z-@zcx`apUf!roH6JV=r$6y4__wjW2y< z?8ra|l1p;bmeyo-d<|t{ZdLWJQM%4}?N>70xujTtk7o~Q(*j{MMS7EeT=OS#U&e}G%oFXlIS~NyN zy?iA+da#=w+;F%)4-UO9xnLM1DsU{%W7Rb>7gc0A4hEp%`EU8cSXLt-vBP{1>j(_! zP$6NcVm5pOiC0iwxnJ8Tq>^}2PAqz6mwaF>+z~qT9#8csW%6!3T^);}NWg>vPy3=@ zG|}Lz)t#ee)`6|3uTk;d=fxx6le@sc3Tr!o4=s75F0KRhP+JZ?VT0Pd_%~B=loT9L zf*fG9533PrvTQ75tyVj)rR@;4c0CboEm*Q@P;K^790o`MKw!&26q8a5kU=DHd`7+yvmBxD?S%9hYlRy zCp5D|v@&kVrw5q^clw(-hS)|ZFr>|{6A4t;QC;m|KI}~lTF<#oiClbw@zsbEt5o1x z(<`#|zskiO5jm)5J;3av?zr)oC1F$qzeB`0)zE@Sp^zJeLy_|+ijs0?HL-_3Ksy8q zkB@@uNp^_fu!TjbK=NZ%;+_M|aj21j>BxD-ys@-5`ZVc3!$;f9!X7IX^+laJ`K4YB zR7#I4Cvys=DyFEP9kn9Ac`)l=IAM$&?WFA=QmR@^D(n&vlyz?zUG8Z;vtVJ$f8h|J zhdxIwmmzaP8erH3S$^E0f^Zwzt9p+(Ad-563`{G@S31EhMzvEartWmR4EXWo9aC<& zAxA=zAeu)2xz*t6qa?XsDCSBy;6M*J?kFw5-^eMH~5Bw_h ze$f4qU{YT?qxBZU2jyUNzCiC5202swbF@U7RBSVN<9il&l%KQ98XeFs_o0JwzAs&4 zUE}Nbzo#O6x?G+mDv*({x=U;KapRZn&+i(=BJB2{fua`pP#fcVldN-FaZVFVW+5G_ z-%;}z=r%f*S7Tm5gBCAllJ}-?k{{+Gn>(LI#l}$-{|0Y@zc#-Q^Nt!{rC{wRA zYr;T!I`buaZwTW38wliW3NX(y*PR{g!KGo3k>Q>aho9*4ey&NpeCID3Wc`~3;y&Ns zvO8@#jMM9xaNoN_8FtAow6m{j7GsN2HXa3jd?>G9@+dS^SDgBOO=I-YUmi!m1R<_W zsf!MW%B09KP1janE^91(KFi2AFnx@c`n`MzeVl(C6Aet6Q$D7wUHII2$g~LS${1^x zHTQvMg6lC?e6K)`jUj?@x?oQg%DRzZd_JPOuYL#9uwxnl)soemd9!Vn*_*G1y&9y6 zWRn+pA_|17Zm6kYX?>z}wAknK8 z!$ggIu{h40Zq)(h$PSJ74ob+wYlPgFDPl(Z%(@)9ZnPcKCEa&&M?6-8l9okowr;S_ z$&qCbNhf{RKe5YAjb-CQ(%I61Dv52tcW}#YdpdfF424DeBQxBzeIA$fXaWI^W#vO` z{TZyAl>PdEO}TA1y&k!|x;GbKpEx$(g_I6-rzsO%rn6wVFB_+;Aj)34zr@o>wGWQoiIq z@|(05ds@Yw*NBmbBLs^LyG)CAy?VWj;y(_;{J-APA7NHojB!cAQB#T%x_l8wVcGa1 z3*{}p^HHueVpy3wz)S=@ncvczIEi~0EI4nI$`u*|2(64@3ab`e^kSZ6=1pR$@Gj`g z1E<*1OO|f3S8t>^QS*>^vGU~0a|(CJWb*M7-f@I`lyVg+eERk!L^Zb~*L>vIb>xH) z-xBsA_q4?kD+d8DrNYELfy>C>Pabf0Ecs5QWhpSq%yRwV!0KEp@kg2--oO_Vz8bwr zmcA-YZB6m~a{omd*1h`y0s%d?iy!G_h&oLKkay zR0Ud4ZpgS5e>YLikWGO;pfXR-gVd6P2h{KrI^SBYyA?El+M_>}O z0Oey6Ha7re7vW-hYA#~pWaMaJ?`-Et{3}M05|fOfir8MW$p0 z{!tGE9rI%brQ`q&6f^<9{({Q?Zu3+FWa9))2OH?lr@ySktiOWqf$BlAvjD&1oHK*^ z&7L$Z zK-mCsvK`v`WCs?1^E^5lizbbGAy)N!wPu6$W>@cWGLVmh0oO%0#U&rh)xp z0K9A56SiZvRjXyI&MDITgfz?xwOt0weVssSwQ@}u*Y;jhid0c{x*7UYjqgU$Z)~MD zkDKGJ2u?Y_uPtwM_O}g zldb=EBNMXFCh{MQ4B$zIo@qnRMn*?O5AV~jM*g<;42C4@IKYprX z1DPQUh#87CVTC@Ie$ml#+9986-?24+sge;Onq zAvnbY0om(Zt!v{FyrSRHbfWVP@`33}j|zl5{q(wlEU3H3Q|iVrEiyHnCA7 zW&zdzp6I_;1tyI@hs449w`5&^eCWRk$#3iXU#+o-g{i5DqX}p=0<8{AW){ZG%q*a! z?Y|1lEPy`?tenpU=06K;&jsM~B_PZ5J?wuLfPWUA=KhZk*`7OOd42>d*K;f2p9R40 zo}XJWKeqz@zQp$2>iHhP@7H+l5cu4R_4#JN^COs_UlsWKHJ)!~=G6UTnxALvZ!#rmW{Pssv63nvix6!{83%n8yg)+Yx5qFWRIRF?q3W4-$m`WWITT@mVbZ0=Nga&`a^ntOW|+fV|o6x ze|^a38rEl7Vf)?u`SU-E5ew(D^!yfx-{Sa}JpFF|U&WdkWG?=EvFCn%%N+3eHGm+q z@k?!=r{(YR^fyM|Z+G$ktR?@KzxZ!?dg}h~z7*hZzSMtl7}-Jblm4SXu|Ek8=pYUd zv~;k6goKR?WTrt53d@sVfea%jh!hHZazjAQ4hN{7?a7M-h0FXUI3O?b$;Emy>p+k& z0YC!uR0e>S1~z7p(6NI44O$kS+Oj>lRZre2=>8{XhxOOtpa1MG{lBA@jpLVd`A-k} z*NXY4UHgETv7_|Wv`XqwbH`qsvT35<{3fVH<&hNmBALZ+EA--HG_}<%zEXDmK?tc4x?A~ zrzXj!+g4*pf{J0s3k-4#!o#}k&NpX$OV%v>}hj~$76?6%wbNl{H`fR%@$ zLj%{N=fpyVHkJpI4IVSKgZisRID(zdOqybdxOruYZ}6M~GsEUpBUbmn0bb<%EVd*2 zrmKB1p@FqjZ;wu)xWj3{Pn_S0SL693YVtz`8Q^Y>c8z|*Ew z>6i8U<#qj!2K0aSy#O4byxIT3_X7Di|C8$lT5SJr)&I6h{_j;Bw7UlWwX=P)#=?J( zCF!kdrJ*u~u^{Xo4ladFl-WN4V)P=tgdXptiZDkPEq?Wt_#G!Tf>9=)s_%}vr`6Hm#TBkA=6WD?tJYtAG~WHntTxP z`TGg&hS1E1c?{1EEbN)BIf< zyAd&4Q|gm1;ljyX!>-Z+ZSj^eQ+t3AgiqLfR-!3#u&SsokwFo?hYY^#lV&{I_=iod z(=2l|Q(UuM3nrhf^7h`#CEGIErVR4b>$sJiO>cQrSy|Q`>dojelq7kI7m$sQjZYp9 z@aYM{bueUbYfZMiv()@a`=ibxM>MCpd9JeS%T89sh3+0^e#zF?RO=&#RNdLj;T%Xv(jnf+BTm@7stPI3(|a2}_WiPpdvkJg*+i`FmYSg(y7+3oLF zDfBa^vVvPzcpixJX>EmFixGmuI4y~>vIndAgp`;L0`YAKq3T?=UG#fTVq_$=zK6E< zV3oWWYk-R})PPlKu<(CyBk)H{pJ*+ferPqS0#_8U2@d+EhvcwuN#caek|4~cv9kk- zPc!IZDw^>4x~qtmN@D4h156siX_E3NwDF{X?&}~?o0gl*(#w4l+V%I0P@6BMhg`i7 zaB^=juJbqH$g@daqAI0Bd(6f8T~-4OK5jvU>HB_zzRsE_SY2KJQAq-4FVGonGI9SS zJ#mZ3UnY7NQF4hLJ4o~;JPXU^nL$?xlaNn$UToYz9>MxBG$V~31@l?;%iI3SdbiO2LhJ$5{37R&{;v&in#^yDc&GW{ zi-WoJMCf*Mj?zYM$xYE!v`Z|q96xR$s%9*N(_fvjWqtl(-M^mmQ@8cH8-*Bbp2s^% z;()H@5N_hG8SU+ABYC4I6IGN}{66kvS%nNlDBcJ4FI_EBMcrSQ5)cdpG1^3KXC)I? zQ2+~%teloO#tO1zojzmIhZEl4r;>)==HS%}Qa)Os$0)bpovO_Mf9zYMfTI8U1+aPh zv166nAKQrOB}?Z8R_$VZSB(TB*_()?!G$jvSV`+Suw<4Ozny2ydYE@XN zw?D2(m>&Dl%w3ASgmgQLWLLx#aK&5P)yX|*^Ud}nA}HiH9b#yLFTUYfi!54{efRGG z*8Wr^W_-ttIO>DcNv|POxXJ5cqR{MIwqS(!^P%t?7v-@sAp9;! zD29xp<4Byq0<{L5aL##e@On9wUmPEi&UR{1L91da;JYmjIZ!m@R}2ce__hzl$in+7 z30Hk4|0u$LCcfvR90gxYwTxs>l1AEsJugv(etew@#_PU5BeEAx_Rh$O>P8TQ-;e=B zR2H&QR3jWp!jnhMgK2refmd$v>cjb1?=eJ-L7r%gZxjqk$G~|Cp&Z1v6lz0sg-va_ zKLO80FlQ!?`{c45LJqI5DN!kx)6hCvH5H6uoJ*J%JGRfXkcgAd)#Z+oNBzus96kri z>XEWA!R@z@&TnM)%8rtTL*gpe0&2RMA(Z2HSykmhsUx=+3bMOLyWpBjy|4mh5rG)< zjW4f-nvxi}^q{{P7lS=cNW?YA#`P?Aji^=JTvd7^Rx|;ILd~P^W?o0 zOFkGE9WCkV^s^<1CHY>* z4jTezT7u0-rGxh&Hj)!nG~^)WQ1kn1J^|s?;Z%{AMr2D7X& z$Cc4DRTc#H9pBqFhsI;~-YRz*iS>(N3JiScZ>k*epy6FGJ-2wRwu6Xtl+kw+N<#VU^NAQqmOPdy2s$X?*3ZC#_BzW-F=zu5h}4^MKJ)=0^U0h zF{_`+tjtGuye)HArxo^DZb~5v=QIfW59iKuJf9u&-3|ReMc#`Y%XTJs{CLy0zvL`! zlCc;wp{xDw@n_jl^?nf61Ope*Yj#tUH23|Nx-Xrhi%CvXF%NG_-q)4xRtEs91i}}b zjOufk@q@c2HIi~<=gmQGa*KrFelJnbZp{$nOB0`cNyq*uvu~?wcq`$n z2QM{P5Pb!XYG3gXP~TZmTC0Rufa5eRFD=J&se6buDC7pEWyd0$Euj49`DD~K)Q+$6 zaFuL6Ik6iYql>+1rJePjd&337n&E*7)@tO(cX5)YG}Ifv;CMqPHAxiORF@_N1}DGP zl@+aaHOWqx87K1hwaZY^B;y;UyA)GY7wCLquTQ66xVB6=rpL^WphOSSlt5*Z9$)@4%{f% z`Rw>3Pf@3;uI{wosazN@#~>_~Svr-m)28HHSW`&0S?J3I zikmOB^ztdr^-*j5aNki#S@D!T2EYXUs@52QzMLKegL7c4*V!Rsc5$*P-}}YU6h6j8 zeG};iXC5JR8D;&%B(&>YQSkw?r?1~n%^i7v6cJ0@tQB8;9zG^)n4XkgN*_8SzwQ2v zf#?mf_J=(UKOTCTWT`vO6o-bL;Pz2tOYyB< z`MzV{I5RX(1==T%?vW4YMUvP*gjbsRORqQr_=4|ny zK>^Wz95J3(wmm&o&*he>48N<=&QuA9ZI31=1Vz1M_;6t7osT$){NUimMZ$pjW{RG* zzbm8`up`J{do$|2cyPPp8e0)h)!v)7i}Y8DiJQo^E+M*UFB`;UQvz_PRa+v=vu1fr zY7`i+5fT;N_hW%VNipV`oaDk9?G$RaO zeA5x6F%v1QWLVh#-OFHtUmQkvc*mvQ0=aW!(kW3Sb!4c(iYVSq*#EDU0!m z?W)}2X@z&R+e}2!Q15+=|4*3%IumjqDi1ic=)6P?P4d8mo>ugBam3up~FA3(z(X=T2bztXfTRbpDT{^2nTFibt zy(z$#E(DIU&piYua*nPIruG)0R*b_Y`aGp@Wwd)9Ai`h8g2h+Hl4p7^xOCVtM`AN# zH56MV#J$C-#Ve`zFsgia>h!~Ey_D4dfU4D5=$0iwCwDP8bu4YgYCl^By3%?J{Tnc+ z$m~Ty=@*_bh9G=-OJJpqj_+rD$9D;CX$Kb89rd`m)k);iAr` zwXR-RQA=5bp-yl|WuRlphesd^xm4mQG&Q01VQ#|P97dRJq}Vq0NhCh6MZpI z$G?mD=`lTRHjglP`o@y*EUO^F43@v0BV+wGmH4Zd(j||k96FX;ca65P^mq8;XhCxt zA)Sc~hAi@JG<)3|2**PE*HCN&*F{{rNHks)QUMAC1+rL$xw-_MH(LmvKJ<-{y(#7P zo)DNX%esvS?G+>%W>4iKHu*3pfrlh9z0KOOTlmYK3YSvf%kFo^xG^-+;6qA{62=^D z{Cjb;aWJe>*EgX1Jf)V9P$Dlqna20$8f77EBuw+I3etO_J|vfBt+%3W^siIHh#kJ> zuF|(MtK3W&I}7(5pW)ac>Xkg=Hl5KR-=aZswc_gUo)|)pRO}NYyX{ISXT{AWACijy zx+QG!z&7zH#0wz%ibj9*R?`Ho&|biU+#!J|cx=*SFsc9Cn-!9vb4ee_7Yd|$45xi> zsL%{LKf^*$Y3&V1*H!z*x~mk0diI*~O|osOltpFAnve&}J$jy{`IOJ8(?`m_fD*aP z@0PlOV{XdF58Y0VXI4q;m2M$)(L?~h-Frpa`?gp}^}6&ol&65VyN~4RxQkHh1h-P; zoE)t?ZS}d@QRZ;avALgXNMb)*q4ETcPNxy`X+(XIDuA9~hf4xWZ#J$TpC61;3I#T$O`DsXT8F8BmLq-)rj@Qn^4eP9J1TKApi-m)=d#4Zo9ThUQvHg! z95%>3cUD_0x=r&VrF`wr{*1zj`EV1F6LzgbM&q1YLkCL^CyF0=j@NxsY>lcV2SbThBtHQEe$uw2&lSu!i0L{LRc@=HU=5 zyX0F&aM#caC}Rvnhw8f?a(v}^=yp03=&XnZf){lm%dXXwFiKZ}+EZr=WN%R5?PUxz z*k8rson^h!ZNjgoBHjK@1BaW&>wzYm^NA|n@9uh}-BKX-&JZF0qv3{Nj4d&F*_`k7)o(KB9g+QYyTo1v;h=t3Fq0I~v{515 z4b+e|r-_LAL1MEElIKY0kwM|&2~v!o3UiS`V#!Px7nw|`z#t3@K6Fi^fc&8^(|rUw zNLTm1ODzzE6XOVd7x`S=TkjcHIe8wUf>yg=Cs8!tyi%MlGa6$w33i^U#OJk5#a?~~ zC;f?*4z=tSCs2JUA2*)7B8W&EXwFK+_i~y5y{njowV^sxB6nlLxp%XJ3B)RV6M@cQ zzGbn`j&Fma4mK-spr5Op1|QsG@&k_p>`1$G{92y660yr;7dDqpL35~dSr8)aJMSCT z3OVEvi8xuY{#~6k@2gd^vRg+c!}$fYKzgyTGQXJ~(3w$9&2vS4%;nBz_7|EQ;kcUp zUL(gJd^a#Bl=~?Tg<$-+bTq^oC4SW5NN^n9cM=fQak=@147>97hV7>_{ZN#12or?( zYEps1UtdH}YJ2WR%66o!>G!VFVe!M;!m6(lvMaLed`$@NLd{M*gr~)nk3C)NJ=QhL zfEruC347sa9od$=UVrTrTrRSe<;8YHPC)^+gnvO_|2&1^al| z5<}K2&v4TX2btZJ&`kF=(yU%R;R0&h;`r05z)r#{Vu!joDX1ZxTKF*T1ISVgtZ)Ns z>hO!&I*+|xAV-PBrKAT{T;VV}X(wNAAkcZn)spM$q_^4C>m}j%rY7bMFg$%4 z{CXMA+j}Td399Vv1FbwxM!H|e?%{zAwlM6i1If=&Gw80 zvOa^2AOh1LAmKAm&I0=3_g4)I;5VZ9j8*;yEm@y0{f0V!!{YyjL;u1mpIiOL;(^ak zXZ`(Rzmds*Vc&m&mcN0`=jOoY=D*QY=I3WUW2Y>jFwCIDh<}b2M1^Ak;f;R`oel8c zgP)u;i-JGIddoFWzwg`CNOldn9=O;IAOjYU zAca02qPJt%6^Dz!)vK=Y!uw53ut)eDo8XG=(~g}hrVHO6a)ge^mQL?IM)Xnpy5Qx_fX7B=H2)&Iy^&!O{kuRY&mkcwjd3W~Sz z%i-XSP{<}M#^>28Xrc!bFL?fl=Iy_SdIIhht^5ZK{zaSkFKnOx6`5my7R~?f@(%uQ z0pCE>kpD-4Z@=E>f7M?g2Q%wGtiyi>-&p+(M6xr5AivvJ;d(=PNGb|a$#Sn~&3ujr?UJJYpGkm8gV2M7Sm0k1=C$!{Y zLf~rAX^?+wzv)tIudq{+fi_|HVmh1*O|0`WGUcLefBgI;T=Ppf>lgwVVAKo;P;me@ z0HHcyV4Kchz>wQ4XEMaj&0%*m-8h%icEvU&x7sKC`ICECjdKz|DtREel-PIdWb*J> zS|@UG{#cXK1Zy$GJ##FC z*xO-5+hKP(Mhh%R4n@e;b6C4!UR*@zgr|=9)76KyOtlA()i=yNpu7XHu8jnDpoYWM zyh8EIt(giGQW-2`neX~oOz}+d5)^kT0ObJIa?}dM+ZPnH46-<>DQU4bD&4s6LW++>hreVa$S_?G}xUDg?8vufIh zmZls;mz6$qIjQRP&M#t3NL2y{^k0jNr^iGvde8qg#L zW~z6!>T;p%@|I9wTEKrcTO!kX3uU?P5dO`DY8)oOPY?3Q{Z8JCc<>Xlpf^v+Tk5%a z;xVoAatOt@shW_Nk|uF)0Y*zkVY>ulW?YmF6;XRC+rT-9Z*4O4C;D& z-j&!%ozQ;dfL+0}6`Z~afT>aSPIG*d!T&ScVgUU^^~>^FS1y#~bMRQD&VA6XdI`BO zrh?^lzMYc$<>PnH%tj?-78;b-%fZpGa!k=V)zzF}2?;cr3n>0(;*jO17q}9#+Rv1D!HWF6MUmLdf+H&L(C|s^tyr_%DqoQ~OT8y;bkE~(n#$kMw}d0% zq31Y=4DRQsv5tf0EG@nIuZ2j3;#Hl7HVeG+1*7ymZ|hv5M?A^gE8ve!rsu3}z`Q&Tl4O>9 z;`v(3N<}i;)?s!oZm=b$S7iuP?21kFH#H+i>TgCVZRvsKuq)NjgqJsvv5lF~0Nz_f ziPy&}v6DF|crI43fmQi~Z9kSy`$b#%=)Cf}S(jJhDMwGy{Fo4ZUvH&P8VT9Ueqo6xxl3=Tp2@+b5ZCp29jkhim6ni4?Mf@e2|4uGtgluZ zM;l5A_&}M=iugBApzn&mf%7F9^0h89hX_$$6}9VAlW5~REGp0yEdJV8{Jy7k*k?R5 zg)&<&tu?d`eN=f53ZHWg4z|$^tbqCx^3I3H7)03_3}|NntioVpG~jVJm`R{ zZJ%Xx{ZXG;y&o(^J2c8oG%|Y==Il0s!J5rIbzwdfog`l#>gA+OpVJX9>{I!rzSx&e}OyjCD!Hxur5D%FVU|Jdq>~$Axdx{KVjlJ;<7lR0+7w z%yd(#!@v%{e)LoIYTvwCr6%Zdd+|kE2JNGVhX5T-?MhA=^mMcvwBx2#vWgAdz=#jk zh+Tni|2ccisl4oAYxqZBR|7U}>ijmz^DOS4p)pY_Zr4@s5UKeNyGKveQ*fLg)e|uZ z(1!9{PM|RB#~xF55sNfyLIsQKrJ(t~XTXPlj$C`c#TDkj#OA~jeCg(_EU*1wkOAl! zIZ$yuEPD)&!}e<{fr0P)bov%ORcPs&nJbZy)3-R>P$`^sN~d9X?(m&6m4k9dY32u(@^PqF!QgMXqIezSIMa zG^$3lD{#PC8tGNN|Djg%veD$(;NwaPl6lqsN5QOaa&FuZHh5tYmMf~v3l2XfRKJ{L zwK={dtrlzF48rYkywUGMue>zFGa~%RM^e1M%yD6=u^!C399kr(o13aa*5!IqSyfw< zd`EvRsb8rAHhC{15n3qiyt(?NKVMfC(%90Op4(1Z`vmjo5fS>xyr9;&@dDPq>RmlzS`%1o z&I9s@2{`(ONB4YqQsa zslg+0MGZ&H`M^rFj3o+}3Fe8@3ltHoj8sL8mJg0Z(-2sB`VX&~dd}`k%={sy*{#vRrLcF{v|E$GPVd{QGl8@(@2}0T;3%3mij9v5 zvd--;_C7ljN#`M87o5Ew;@w?B47jdRo+w}akXe7cA-T&&2cd3n-HZO?a?(M_L(vCG z&#ZR#RM`g+iZ@o7y0dBZ1AuE?Nd;1L-a=|;{lW=N_Yz&_)?pbi`7JfHuRCD)^NG)A zgLKOjCLjTnoY0x11!qz?jy4I+85&!4Ny1N;x5-M$)bAp7b1~k$SWO65{)sLIa7XXJ z6$0#wcAz5hzQN*YD%ezT!`pQHvL?qYr!TxR#qM8X}?Q6;^l_JATnuRiN)I< z*~%4sb=a}bsj*w8vpd0Nw|m;Ne^YRb&RcYu(dxIQ`nG-|iuq(ANZ-imi?+EiA>2g? zF3lARwMYz@%8uP#+YId+-g(kKCIUua9XK{kVxKnm&Ms};Bywy>7x>F2WK5un28q`NDy7`@$a z!&F{{?3B$KYlt_&@xtZ@1;RKtjzs~lY@qx#>CM!6=1Ma>L}*u~P*`Z9C_p|CU6hVx zY(!+$jqYVonn8=WyJ6Y^dFky8Y5G7`6sjHbnJbGy)wXp`=r;2d&9+1+C`{C74Yjbj z5GW*zID4%RHITgw0TUqAU~q7a5!(G{^GSs@*sVu|Mm!^FNOq=BYHoc>og~^r4zw1=1!nvbhSO@4@2km1hxeo@bbwg-NoARAFjzm(CcWbm4o(4DcY=G343q3C!c3sR$1JYDm&#iDI z)aC}df=C;^dLNkk&bUK5SjvWN&(LGFZ|H(HW1*<(lY2{+^dQ$6BH|F1M_m>S3!EEd zidy=07;+66OmksL!47kY?2N4RC zQ<)oNv9+FBwFzOi0X9={VI(c7uNXTUX;(khSYQw^a+JT1qlj#vI59awB({2+6@ZFV zB*d%>{;H~3^;PGcbg=?I+zn3}@|*YdQ)10t(@~(9EqtoU8#(5!pVejH?NYGOo8OD& zW}BhyU>b8n;B*|nl5~OcE6V?D=E|z5LVg?}m#daUH}ukEKz--hs!B7>$E-82E0&2SU-*y!TDaQ7RG@Cd1_P zmhy%l0uuyy?>Zm83Zr#nNdE%qfO zbe+Z47z|ik4aHAykM@Iz)Nb_5yvJwSmtCf=*6bxQ6Iqh8vfHwi)l?z1#tvj6q54h7 zokp6`m3r39CfFj?t#v|ObZJG20a8_D=MZ{{W|4KqdzZSdslJtvFZoHBKhBZh6S<`g zt;8?m(^oNyGb;88(RUeh*Ps>|30ugq=X&pd`gr4U%zvhE*83K1VroG)o$AIG*g*FM zatAHkt^w8V++Y8E8;u+Yfz%UW>k~;5f?bmamMO$MXKdQBn0txt-5g;avIHZlSuB&> zBS#VsLu5bm@%6D?QQjjIQsT0nY^a7 zlCRKET%{v9jUW*;LfH7~5lHsw7HO@dU%1Jxw-hB-X7N)hl4c&(F-s>>38Ke)NzqRk zp)0QU^0-Sp9S6qF(qSP&jJ0j#t0nvi0iC24cXrCn*GLi7-OTtV3@0@4H}|#gVw+gH zAcS#@oD9r;((z_D5@hRwRWNnOk{Pv~CWvBN851Q{AOgA=I@H2HF1(yRM>aRwgK{=K zdVKu_*G$?AR(73Lrbc$5zbOi4ahY)bHjpzr)hP%Q*+{_r3p*dye;c*^isOTx)ICWYiqv zH^&$=eeLX!B%&FEgFjq)>@AsMQsbF?5;CnrMkASz+o75Wi_G-A^s(^!X*q0L@4yuY}>67Ai$r%Wx z47{uNlZaoS_r?#Wrziy_MNo+L-0y^YEOvrmtG#9JA;gDb8xh|0WIovK*fwbyU)PaB z#>f2*A2(JK&PTY87jJas{ntYYm|sDoGP`CXj3RLv)t&n=8v!v8e*(wgX@C#GH$z#$ zbH^}(Z>K5q{M#OF{H>v2XHxXVrm`A}c@vO;bACIC_Al_^3`yuj>4_W%Ns$No`S>XO z(Von96mE#Um27YH3*fevv9GWct@z_LJA<=dmVW;aL1|#Y#Bb{*|I3z>ek&KbWkxtT0I**<|O{yo6<)o~GKD6UD+e5^eq~v#wG5kC8m5)=NY;8UAI^+ZM^M64C!{3p}?=ktl znu#l;l!iKYlD=3uhE~@mMO8<|q96hc+8rHYs_C35IX<~+R_M_q_q3f-#JyuE{*aJy zG#Ro{SkVDJJjucVGs%qYXknHWI!%GQ$`brRCC z^YK+I0jVMe@T52|XGE=p!MSoO!4(JkJ6={{vZKPVX!$-Enk*2!#Ly3^}r-3gGRqT?}o zIQCfOWrs~c(}Ucy^c-5hkIK+#(W=9$5;2nRRHT`@=(KeVhfK^nyB3-{j^(AuFr2&4 zC58P1){zMF++_C2t=x|o$j)(&bKB-TdiQn_mpP`->$sk=Bd4$(IXH>#Aq%fQv~LOx zHxGZVSX-HrOKxnI>+UM_+<@;k3)BO?8eIJc;V7fGf9k6+z6xP5Zi4vT^R<^CrsxR&<#bJ%UI8D@w&3MqH_6aaN(z2#!!E|MeeboD{bu9K= zU$f&NslN_^NM*cf^bT_4C>opujc%iSO1mUXqGbireK-l-v5@*q_U-5~X*Wh6>lTH) z_MnJ-$|D-HXl@!%a`9bn3PUuirYF&;RI#V7qr}^ZHwCo#XU=O0SU+MZ$|+^|<~YDvH)VJTMvU=12;|IZ zj?SNTbX&BJtZEyR=3BG1JCfU)Iemb5nf-g21nXC*`4F1a)*zx)6ijyaA_!r2JY5*; zltA6}r=!RSx%FbX(OG+(pyP(+-_GAx%m;0rw(OI(bVsloIDiqdULUioS)CnNz;>5=nJRB`fPv)i0)@jK$9M67-#Oe>OHi_ zH$3bNc*-uv)t8?F&g*jiO1w}wyAte(jT)k6HwAJtkW{?$)i&kn9r{{YCZ_<`_^2Ys zk0JACbq0;$g2&R(2Sst}JknpR(3g^FwFHElW4oeU@mWI~(2O*;9Ec$M~f5hVCn}_(p`u!>ruX z;%tC>-bAg44GwrQ_Y~@|9b($=UhM8sR|_2~X*U?XW};vO+S*ExW+AK2z+I@NK@K0Z zW=Z;RSFk;Qsouc7TH==ZQ%P?!yq&oJ zm3U8kI%I3nO^`(~N1a$^;Z>zvrLjqzYfievngA?2_#lZ_2lFF7y$9mB%*gZZDT(1p z<#8^eUl`UWXg49xhjFtFNT0W2eS5iLKKo(lJ`onASMV-@93f@7U9xhIG`S>MoO)~w ze!UVxj`${+Uq>oS^S}U%9$=4cy-@g!y=b&7Jjh|2WXk+4xMs2ok?E#}mt(Jvtdh`1n0KLbf_R_ zHSp4x6pt|DbTVO@Rok*omo-)&w@dKOE3bmt*jJ*O*?-krCEGrz{L*#*o0bymS4?|L z!gnR-_zUy}Quedn3ek0Jj%}vghl3 zx8pJ(Al0o~aUp|OkHaSuU-5Ag*0Gq7t4eYcsm{8-M>y7TJbtdke0|or{~a@-mnTD1 z+`FK$>*%vH{Pa}<@MmvGLWejU#W3Tj)w#p0Hp3`9!%fN^$UV@@Kcjfy+X>gcSn|c` zz?REC#-tr{#cXh2x?fYFJB#Yj(0rD(Y>XqOr2*Yq&oGCGjy*3G18b9g`VPzppM@pN z6(Ie1-DYi#i-f09AVI_6_kmR|~&*#Qoq(Is9?Oy!~dHxBVA40CmI7X64K zDrJ%=thZvc(9}j0ZD=Af!uq-}fub026buBK8l)J})q+EcD1GyYU>USvVDUkM5cBe3 ze$_=7*`fk?lfD>qg5K1}`;LRJ&fa`uGHt6~INv<8!B*t5osA6M&c^E5GHM}HFj8pX zj(_5i_c*f6RR(P2`4dZ#iAq3Tx#IGG|9kmaVv)i<`(F&n12ou+LLaqxMVv^w2@TlVKTD%6y;eH=$r z1SIPG5ZowD{l@9a*9vKm#oP6u`(zK&qLAY)>jQN@GT%8qUl&%%DqTv!{`x@ku+RDV zEFqfHo9t|f=L?iJ$E7LSfT%C14pQbuGI^!9?o)aHwHpYcI4_5NXbT0E=psyg1*UzyHHdfQ8}w8a#iR8cq@#!Z@;+13ycE^ON=Vo* zvw8=(?LlCdgP#blm8N->QefFPeMlhZt9cn>ksOQ4fDU>>E09hV3f?ov9{8~+8ywp@ zt}p1pvJ4dM$~sAem@s9X@ay_IFC4+C){1;zuWuz^ctc|ghDRjIg8D;;*4oHl2+F(& zv}2cj4KAYopb{Y`w$#5pFK6T#bAqEhUtg{}#hrH#A2@bp6?(sLVS4)Q4aJnd@$@*E z(nmxyKEr{~9T2ynrdkc@qD_gDqofea$zsOm$a!-Rclp!Z>Tw|b7f*?sI!Ief!~8*p znD>i^@KuzS7x3u=ea~~jGI-TWAtFq^Q9vFCX@vXsWlPbQZXj2WKq1pmFF91f;xg&I zxKsV9gho@m3|?Nd9EXwMrSSWLedKzYkl3E+#h2>7K=IJnxVO&=E&8T`s`U*YX=f!! zXzIqS|I9bM{9HPr&zot_)diwO-j8FHi3FHoD(4r^>G`Qb>YII`nT&{sZGZ6A@ROE? zLiT;a>N!O`Mvq+5Sey4jdQ%*P=`%iTunR>fD>{=^PKGgF_aY6Wjzg^Qwj~GH8rR^sxC~WW|Cu$zy2zi9UK9WwW-M+S!B0g5JtFLRi6oOaT zC)w^r{zrs83Hl%*&@!}{+0IBHQ0kR$n4u*- zcD#oGs2g{k$xG0A#sAE}0ooykQn<-KYo}=5b4#xWT(hvbob}aass_S=S}(AbHd9s5 z5LogosY{B=a9yvtmsdVucJ6)(*-I7DxZ3U7SNBf`gvWMiw9w?er6fm9UqMVzsTMi` z=wup^-s2Lf0aVtMav%eDl)e#~rVV)oLuNnGmVgu6BFroiF?}Ns2ET!Waon+tT>HRi z9VJLmD4BFKuP-&TeW@y)Kn)b&s>j51Z1D=;kw|+b;_h?K4-@)5TM2TVr!U?YJYX5^ zSu7qJ9iNZKQSZfZT3#O)l||&F%3^u2Xa#oGdGgp@ec)uNhuz*NZ^K_nyqHW1dEm7z zZPVN2Ge?4n3E7Q=V4hr0>9tI5SsksCzHG>vsIJEoY<+g4E6~EiqqM2Rbtg05@JmFa z1rIC2HCn}c?qf{O`(;o!8oawFp5d7Dah2TMfCk33t!5ym;BbGiv&>Vsb__G|(v0*bL zbTkStt(~>55t7BQoqB+xN@i8Jq8WhNo(kCy0A+ghIoMgq3+*|u9r#<3XI)<(61|;K zP@XMt+DK>8$d!hD2%iK8#ad2FwRkKyqW<(lbih$YC{zy85Vz_e$aD%eh^-d~HcO}i zD$z{IM$UU2H8rUez9=uh!lm`cUD|IwnUr7c3vQ`P&;_=0ok72zwuI3MCAB#XXy=Z0 zynE-EX}eMP@T|!AoB}SH)L~r17}cB^Wwt-X=|CaE$d-T=FxpI>w!$Wo5N_1-VA5*i zF*l%E1W#Fl*y-^Y`lN6uoA_OxH-+8`rW_r_VBA@B$~zw*7DsA7Mzt}0~mTF4o znd#|0lZ3Ll0}b&hKGb&hPPSB7Pyze@F4o1BF-kqxdBbuHGq z7D*n+Siwvl9?8onqn+WzXv9%f##ZP^F`Fc=bmtLEYcY(mvf#cX7_(^PhaF z%(RFcD&5|p^L`0;OVq}_QH*se!c#Po#&!z5zI+Ov7DJ2|esBFVRm5m4hDC{-D|gG( zn}iSL1~54RSS*2ZO6l6n17G9v*Cq>}U^yQd9_b4#wZ3Q2@(o_6`f52t`gP;Yx+77& zWZE_v%p!fdT73Lz#ZpR5=ZLRZ>46hoN7tUr8_bW~b0wl43n=tj5Lzhf9^(V=v(!LM zldY^QaXz^vrmCI9NG<9J)Hs<+4#Tw>rVJ_!bUJ5|il!q=nXThfPgU@Bi?9;~QnBil zVV9|>FE0~dNGw4>n4B5^`V>Rc24r|QHHMtEIZeM|(L5dAp}y1eCQy1SBg`y~ zZE7&TSu%u)N29eb z`>Rnc3+~IzxW5sxMMO!6hSNW^^l8n7oUc=}aihD^Y(qFRxP>aEyFN^ zoTgz}K)_-SvN>sJW0iuZTAW)JCS`^^RMl|+UK|OnZCZ3UGg5a z7hU2=87nW1Bn)sz%zYsgMV42Q>1e2dyO=O`GBR&%JkD~kV=Vi)wKaEqzjxQLEFA1` zcK}h_J?1HK9tKecn(}N4qjxM~-zw8HwH z=e#mN47Uk6qgwdPg9B-E$Xu8<;`soRI@VM6fp%TV*o!i6+OW56UsRC_b8L$s6q)eB zWkULDAuwC?2drB=n)gA2-yv1R69|K8_NSdesld0^#Z!aveSSKh+qJEnSD%sz8rMNa z)YnS{xi8^+M%Fu?1(Q9emqFi;7FKb``P=8Xm^CNj_$lBJ%YI_@q%hn&X3LN*yVh-H*%IH5}Wm{23_RQU18 zszW5(AzwBPGaI?xAS_xeZagw5;bA*y0CRF_g4x92OA!twCqG7sew^AbD+mNRFYzt6 zH}Q@_nNu}{^lIX9&V3PTYTZlI6gR;id4zWg?$rEbOg0cGmG7a95X6p6nk6PRTXgd0MG~Rl?ifOBE>**s?N>4}^M6V;bGBRzd0P6J**4-?L2Ar#n^keT!XkXZ zN~KeL_?ol}&H~7}rLt*oe4F>@ozw@9J)^#OQ<}Y&Mp{h9B2|u@`4(`s-6$t*0Md1fQ&$>a{obVRxB3iueM55-V8`L#oBn?9 zsd=S1WR(9>BLZwk`ac~8uqD;SSAK8% zbafbiDjB+{L;2C`^N$rPe;vs8URA#r8U0@rtFV7>^mpArF1r~2wk&WhJ+2|eWyjsfEm)9OaE2gl(?L5zTU2wYPf2N4DV0|NsG1BZlwfP{vEf`W#D zh5`PAg@uEIgN22Mg9pBVKM)WQ5D_naA|N1L{zO1P{_PVm0RjOs1E>RmhXLt=1_K2_ z1pzdH41j=wf`WiTfCE>fe|y0}L4txq!-7G;z@vbG0v`$o0uBXpQ8EX7fr4WzMPMp` zL7`$`;jk#$zlMZHhk&_5N+t*khlYzs&cu9|f|BYUH7jtt zn!1LjzJZ~Uv5BdfxdpJBxwFe7*T-(&KF@sp`~w1mf+M4%U&h47#V4e_Nzcg4dYhe7 zT=MRHX<2zi<%jx)#-`?$*0%PJ{(-?ypNED=M#pAm=jIm{mzGynzi#jB?(H8O9vz&rsuqK-}EhWpIDQ!`Z z^3|{@75MOfcq2$Wq3|kv^KGBlp|Tm-X$~vu*=IbM^VR1NUd|70Z@8tytvuYYULd($_oC zJ@G7UPKg-tu&S%q&1&1>@p$wI8+jJc6a}R9;taY7l(&;a^FQBBkCl@wppyt z*9fbb-rd2g;$nDld($lmZl&PAR1r9Bf}N+d4MEkiclhtm)k?ba1?cHBI2pAsiOow} zETip*Aj2|0YHVhhK9nUAF7g5lr0%x4zG~n;Kt>+{fQYYa*R5$iU#PD*XdD>NXk>Wj zJxb62z&SBPi%^C~hU(Fb7TSOhW-%Sro!f(3BHT*Cf2kJu^W&bVm5g)hL{Pb%tqcbt z?nh)X>rJ}7Sjp)7w8k^y5nz+G;8~t2rhFm>7);&ceH}Ova>OfVk^Cs;t4hnqr-z~g z$)S+?HH~G$`}`ViT~kW3b*H%R9wCfY`CCmivfIoga@chzR+w~uVKLdfy>LsCUqBf2 zi>vZB_7UhC%kG=(0YEGvaUT^`@5K*>K%yRUW*<$Z@fh=Y13q1f`?xz1WvORXOMju> z{eivA5srG~PiMxXuMY$+5RV&tfx|x^N1%t!tEq-+o`iFgTxl(L3{HLSMpmY@Obqz^ zD-CAoR~pRluQZsxUuiJ?ztUg^ex<>DpUHj^)xNbeKQnr_cIIc4xwSJtqs*`ZbHj)c!SGWys z#yv_Y<~H2Z=N{T560QC=G1NuBYA^TJ3ow+r8@ueKsggvl)Oqyo`H_d7a=YJ)-EzSb z+xtV>7_x6m*^UT#iABcp<)ZC9Ek221FXoHf9^4Y)RucYOwP5aKd@z5>POTIxE7(3N zQ!3e}Uc2J4hwoR02PcdlEgMu+7<*#t~cNd=dR#1-H=2uuBHf~M>lfjX` zY>sbDrcHV7W1SwpEuZ=*T64BacetfsTk96$ar#N?_TnuO{#QxD@<+la@a0OYmHlD_ zTR9%I9K#6f;K1y)uQ!Ot|M*qlfYEF6n}K^;|DMA7^X5CiEvp%1Nm%}sz9}ALpr^-d z=Vb3-jHaj8)=hH{&f$?_U|^`C9)E9LOI;TTR8V^}WEdzYABl^ur!F-()RD_`Z&Z5Ga80LfIkB$LP5pw!!SkZLis~-BOrWJLN&1P zM?e5OK|nZNyr44RdqO!lNL`EE*>$x3(dbAEm|bgR>}q_`&i^7AS5ZuegbBFk_eFNE z&czomvYOd}+kpShnj1*zW&FQO>16@#=~6`=cq-e=?O4GehCBkTn8c^_3#Xxd|AN+f@b zV#AJ41%+3q04$J*ei&2)8Qbz{8gxi$odS6C*ff>*?1mkNz_v>T9Eod{HstM%x8%7M zid$9qcb0+>`@)ELH`XqfR(+t(^Q+rWH81eXsL0uyPpNsL|4Bvuh!W8Mid|wbI^e?z z#0Elmz7c7bpHRztg*1PU^wBnzh{2V;>N_l_0tbcCz%B%xVlFLD#%ll-(t zwCAZ888#iM({aBw*6{D>aWd_SP+-}6oRknDXZ@u~p>UC@_`;u(y*3>3<%1cW<+tT;kGW{iFiefn^) zx0i3paw`u1Mh%cgJzy9=>wfTcAMg_D!Yzs&Rw`1AKUJ^kSHxj8ACQuKy*!g3Zc7ut zrUV$gRLUw50%1NgT?UJ#3d42COs6{)QEjIc|3VFJ=Ey~AJx5IE-q#JTdy<5CDcglb zFY)^)&mXegH}C>{`c($<`Bxdp(62I(;a_DSeZR^;`hS&ye4kT)0rkDLBY!q%w|3;u z6uGq{f2PQ-9r-gwekD8NS)7LUL=@Sqy^1gStq!uqSw9b@3GD}mJle+BvSB0Q`jmx~ zdLAuaJS{%A?^_z&%D|1wK!8+&!>E$Ts0F0Ax7`xtRzm(4>4L--Y5^tQVY=$ZAka+opGxeB(QT_`W(`i_ zJFBduVgQDFkGR*U37v=f3(B55zqibPqhpP?W;U$#;KLZ(?a5n${GWv(ncE^u!0YxMO~f5l$`XPj2R5||Mg{C zyYFAV(g^pmG3;;sXMg@|w*SA+Wn;MRnLnEEUYA13%)(5;G60Drw)UNt+l?n&E=j0em>Qh=M8zUnU{hu4dU^HWxYHg2$v${ zB#Ip^=BF+(^-{L#JSgh(-_Z9)9Dl}ZsftpQYS`_@FzCM^iw7|!TWU~~Y=zhq(^Vcx z`*b8}#iW{R@VPokSef1jBJ&<6x-Op;i$KV^&w7q6G~OnmvEb6LMgq4ZYwyh6eJI=# zqU#@uUA>1(?~22Cu}JxQcDW0>8Ra$E<(JK&|AR_(VQGO%#df(l=pV%BhoSy8#E6;m zZxy5VAmUI;PM_^WB5V?u*(aY@+Ta@)#t9zlmW?{rnmJ5+_FHuxS5KzwYUC3xz2nvj z%VKjOkfRnDi8-@}MTs3Nx=#x+3x;0?{dg#k#GSu2VP7{Bu``(!rY6~<*_~$;FOV+Y z_O1pgT}z0>`Hq!mpFlz@099Yi+6YCNkB*Sl?T+YV1*QSg~`cQ}ly z=Plb@`#WE3`^54!LL!4h{XvADzcf?2PK2(^rZ;bi*x4@UCZGsic2xg^2wiP$|Gj(p zKWT|rS#CsxSX)Jp(6PRG=2W!>n9~c9eDe&>?K{ox@zLY$_6BS~n3A~6dkxMtK{pgu z5k3|?QmF#(?L^`M?zB**P4ewRW*$GIyObGI=OF^QTq~{=<&hHp?Dr;K+7^umMRj2t z`ga1$^q8`Eyq>7ep0ay8nOvMfX`~nl2_?LjPCVTw!g0o<9yOmL|rGgiq@LV5n zV_h{YF2aXbS+h(dm3JL$u5Lu}kK0cs&KvRMlp8yd>IFa``_{k%QSJ~4zVDLG8VrQQ zDisi-C0DJ%REc)0-G3(S4@t>Y9~a)crCh7_fbc|P3alS(O^~QhDXMU}|=D+$9r7GTSib2zQwAdAkDPV4%N*dMo}Fzbxg6#AV#|n=ksK zjPG(Ql^=fDFTk4{Q5)XIaX3&x0-)N|K-?QE<$1^QOq;XGPf<~lzD&Df#=l&|CEpp2 zE3^7}ZL#~l3_6yHM3m+U?|ys+JJ!m>gDq35qs(V@^DwlT40K^HifwJkqBVRQ>LrUg zvxLIo2oxgpb)5EPf>b%#jj_jbjtV5!S0$%7$dP1-u$5;<9PBON69#(;MRzNlGCVgF zG8srfm z`sx=1l|@j}`x57U_#dvRVq58K_YypdIh}6QXTEb!j|xqS3NpG2O^8di3lQCv&*f!R zF|`9Q9gb9O*4=iQg5`9AY}Gwde6*@XI?Kzb77nrB*B6Q&6=-6y$*lA!S&3pZ26yu@ zNi&(qVQBEM(3h*aU~0(jeI3Dnsfd$_ll>+LuH1TIr*NS93XuhTVeDaroK3iuP(w)d z@1PmnDc;H3RK^t4p7s8g$&O`eZ-R=xYX-Ti9v}Cb^S*8~sbJ({s&Q~S%^0;#Gqs`l z+84PP!zk0SGCh4YBi}|ECelD(HLS78_cJU=4;e}AUhpG{O^?7tHx$#`S&iI@otq!y zWP|Ln9*C@PBGCRIS#=;(Uen-#;)X!T`yleuSAyZt!eJ5It!$EkqpJ$RiuVBVI{sWK zIsO~*k?-3Y{R|&rzY<^meS_k-jCX$u+OS^@mHu(l!OU_aR{g_;gI_O29D3>T@39*I zqez&h2cfZNp|}jtAS)o~Ei{5HdhTpEfx1gT#(cy1aS#EUVKt(yf2)sH;)%qFWCz^m#|1ap|gMlIUbz*-d{QUbQ?62ICx8{QSR<8XW%~GQPb0!;89kYH(gcv?T1DmsI%! zHU1IEnB(6=#+R4>bJSq}jT#((fs8ND{CMy`ZuXdN1~Rtl7={B=KmqU5dyImL3ZXG# zKHWRc<6;cxvfp$T{W^n!ruZE9GqD^C<&5A#bLf+MVRkgE+VHXu(C8cIdHd3Bd!EQy zW);kiNFZ4|YL1taldUI&T0d)m@@3PGC%nTldn{<@ti37_zWma=C}*6F zDlooNGWO{HGlxpakW;dDm_XDe2p~g@amcyt{WTZq0?+jrU2FqyU`R-+c*x3S$DixG z=&5Vld;Gp5XiXx6Y-v#PNf_lqSWS#I^nFQAFyoN|FSBe_KgmQ z;WS>Tm+D|91jC5;OmcQz_wiZ6^|6-XsHvYJCZ0Q9B@Jln4PG!1AS6h2RtMm+N3{frzMo^kSYdj_KyAQtrnKrHD5I(J{92XIKi zeLfYn{ME}VuN$BPTLyU4q6L`3v^=)eN@`A(*ywjfTMHtWVnjLhp8CR6?ZMPj5BL<-^KC_{ndxqez{)p#F;0?x^H)4kMBsPngmdJ zCSZ~S>`h*LXx5W{m2zG;F;sF3>$ zgl=iocCD4;9Q4&FUxMc+Iom2`g*7&#zwdV`bL-(#>R__V=2td2x+X%NEz(S2wB{%C^@{Z(en6P(TW7y zu?mEj?|4O`odiYVop@!EokZn3d#TE#dnqbpd#S2-_fpg;_S4iT4>D9K57O1C4l>m5 z9b{_K9_6aj9OY=z9p`G&ALVE>oD^s=o)&5|pA_h@d@IpmJ$tXie(?rWXtSS}>2d-- z=x_n5ba?_eUZy|vw;|(%|HUsVk`}4HI@am8_NS)O_c#% zrfPr=b4@_EnFgTWOdHT=p?e)muLKXjfZDR$klIcN?f}(RpAxhsmhkTR!(wdkIVq%B zK;cM`&$f!?YrvAV==sAUjBj3(LLi}XiM!9XVOh=rlrpY>RK|JGxkmpldhTs6)&O_z z_W(}!xBwe|)BHU9oL;uWb4MSA1I~uAtVxCpPAdgNHcq)^%C;<7H3W~wEf9woI$1UN z>3pWc;XkYMbq(tsGpfBjJ|n;+Q8n`95e_=;W);okP{N4Ul~dGn8_nw4D|wi*VjNB| z7-GZKvXopB+B;_aR6SwaJQrgw%EY{-6;UxXd^H`1cu1TX?5c`Ru((2B$Io91FlJ`G z5y03@ovi)nt!&b^{WAy@DJDMiNE7z~g!*1hW1Q4d@D&$aAms)GXgiP6wEVY43lZiz ziMTRj&vv94PBFaI<5%{{AsIbcL?c!%s9&z65;xT&Z{W!5 z7z534q!C9bK5kF zXsPz&NfO|21(fLppHbUBpy&<<&ZQhhQB(tZ&MfThpgSXuDM!!Cl0Q-oT^Q;|}0aF0+^R+m;>kVrrD!cka4r^*hcP z+-v2fIRbe-CmtW6Z~!B(>JJ>FC{Qem0h3ToJWh2-TQ-DYwN?9^=Uanw-@F8{1NXTA z#LV+2UZ0-ghsxpXJl(#BUIQ?d@g7M603O481F-2J0T17!o_jUR?g8#XZv%$co6e_- zqK>>K1ktWa8gZsW+jWw51=IddME93q8W7I<3%JL5B^LbqM4am~H2f);ehEhWLLz=6 zaU%DYL6=>9ci@aq04OjiOM8#iq#?UPnzys0z*t`2}_C{Xn({<++O+=xo$|Lr?_a4o=Ynu0NzaR77 zHGhdd{7%z!6I%vJV7=+Aq&ouI_n|ZAcFl_YEchHB<#~D3Q&*qd>8g7+4J6;}{d4=W z9v6_NE`134!#t^7Z=iXdcwdPu|2`?>yu`A8DrH<(VyM4wP+XUY^3Ml##p(YW2lema z<;yYu(8n7Gj5rv-!^<3ue*xRMuKHIu{$TbWsnA@1!L={X{P>IiaVX@bQlWv9(GN#m zjgb8O;XCv{IqKNfzQAehH%GlU0qCgTW2pgTNgthGI#_R@t~lz@Ku3LR5Pa@pp7gYZ zo+ad7uPrwREe3jSG6_J>&8*1dVPQR7!_-jDJ5QbLo|DHxQ1CEbnt2^N_OJ0ezfaEh zK#NH)XKY(jD#nlTP)$nn@wzhdMsA}F$W0~E3~t6a51l$0fj$6~fkcbxMr5d*Rt63+ zhXga9%?mwupw|F%b#^^4b``(I{BZq8v2zZ_%cWrwcCO3MtBXZkSEu!VT#T4lZzSDO zx&1Ps#CN715hESO2YW24seE{-)JEkKUxK4U(QvgGM zSR`NoU*3+PIzkVTtUmbB9_STdjI@XU0X6fdO>?#nbX|EJ;S(QPt~wBo%rMPGy_}V{aV=YWsYW zqHZrHD~Ga@9>%X`_%6TT&Sk;al3@PkcB6pU~Dv9jV?s3;V`=ft&-uWBOv zpv=g1?76bC{vYsjxqe%ExYWBpEMi|?`DG0HO=)6BJ6r<@FttlC_mzA)iEAHwkk?eR zhb0Yt>LRPECUST?xkLnsGZV9Tr*;q5QvMsNI7qKr2z(R6&NKezu!Cd>23MEDweTeZ@l{sa zZnMYzmDL=KSKO;#Kof7q_Gy1lrn|6xA{jv2w;B($eX824s?B3!ER@jjZrj^Y-mI3Q zyTV_zJ~O_4MS-r7hE)F%Yc^$<;X^BJcBTb{ib;2zbkl^G3Bea@DvD`t5_*sN$}E4X zD$uO3>A=AJ#?GM}!cIi+N72Qk>d=^VM|}zv4Uo0u*Ptk@Xv+ z?=mjhAAlYhi~)gdpgTJ?teO-+t;ydVr%LT)UjZutCx{oL{)`PizBhgfFZfI1sjc6L zYi$`_Q$cgl;W>{JMr(nuQh1NuCJjBf|C+o#zLa4)6@^Vl!fSDNIfO&pM#J+ruJjlT z5pY3~!2^MZlF2hy*I?|^*wd~f_b&zJGI8EWos)74aH>(j@t?8X6eKrl$%`)?!Xbx_ zB$w>)js}l*NIeMEX>(~?ILha8__|kJLZ=l29Qb@`U)+HDE zBaSM|y{x`yhB;Vg1~p~OpujJEXv(Gt^iz5{rw&WdAv7Axc_3N6$-2rSoj~om? zmL}!>^mg4?32ft7x+y|#bWlc5k$8eSInE+1_^zuS)*#b!yf_i3&_;5j>8m*toeWaW z*Kz1-`0&rWUz|6h5F(e(z(uNc^|L^;M;kpoJq5xJ-sB33^y%7mudB0m<6p2mCh&UK z(LBrngM$O%j3A76Y@>&9@SF^aqCYiG7D3w3UYboQeg$jMUP(hergvW5ZmqRN(Ju8H zn)==Ip?lDYtnDzyiO%j^iYOxscU?rGPb1}#jAfVMT8k~vgOs|PE9rv*q#9KUWblV$ z>hkZ}+e#fQk2LA`7Dz>|e|8+LVhC#GyK1pe5ycL#W6(bWuwI4(KdryzV7wYF{PR-7 zbtC8#Z}Y`6I1beGqfJ3L!T8aM_+(-kmBC>Q29qT0WY1Igs|SntnS z2ZO(iqsh#8Bc+Sdjhz+^7b)#qUPy>0EfOXacb=2@P$|N>^ivnWH49NW&1kipB4*r` zw9c&wHS`$+r|cOG?A?Xj+ePpQ(buzA(lc{J;Ho0pCVk*zxULNsYRq(h8-R$D>0P%c ztEcKv^16vvIWBf$FD-w9I`)R&7*dnVp-FTK?&KAj zClU^S8mXypIzO{;xx4Wp!NoSglT@NMLdL8-9U_@kUIW za`Qu}26>!|%C%=0-X-11?+%l!;Yd+YNks-^uobW|Av}7e2lGwlQ{(7HTUR!8ICOb= zKP#;(Kgk=pPeF^ue@KWGwBwz$(^J%UTvKZB#PDlY1x2QUHtx1FE=x!^l>y!we8VcQ z5nSh;8Ath3P8I`uN%f?!t>inNfz@KJTbd?cV_vk8KJUuGGf&sNgXo&UXbTbs9294>e|8n#4@x7xAP(ChKSN@=nx_w*{Oaa7i#xyXk@0E`v3-^vP)8Hx%q07r^0YTGizcpmBdtmI zEmMzlHF!90CMZX_7|1ir1JAAxGH>~oQdbUA?Zj7+_`KpAv>~#ry zsFylPJ4j)uhVo;JxfP;+ zpO+*i)|;tcZd-x#kw<}?2B$;8)E7iu>H0ER!z`(38**$$*otzpZ69MnD1XLu2t?LN*!YEHrUGy3s2W`Nz^JnjWI@fHP z+*$h?!07@bE8iIAC}+1KhKLuiCSZ?0P!*059`wE?n3hp#$i#(#b}4vCvD#g9{`D&u z%mvMDwCsqtZ{HGZPv+SFp}x{`@>&Rq`HHvo3&{BmCB$D@t^=Drm5?fJ?&D<{9#9crVH`d56~`mGbn}=`2#>Qb;q#>#`04^wVekjlA@nREv#~r zeUgziP%5g~MH^3RDj@&lG1~OH!AsLF7tAKPF<*m|U78^A3yqyc{5*g8M?%5auyiT4 zfl|ulp?52jhpo#@FZKvdtlh4z`0+oNw78B*SA6teK!4OU}wCCAW@)B^gtm!7-);#BDF+fi02XEz^`{E!?oHq4H{Ce% zDIN%Goa;I!U5#1(`N@UrMnVVa=1v<>g-awB!dz&Paf#WKf(_mrT`&QrxEMuM9D6q* zha=WLH<)z6`dhN0{`LY-tG8o~W3a~@fQ@8~^FTN)-`ff4zNqiJEsMFrxjBnrRS~`6 zo#)mpr*;i5n_l#l>PQ%Bk+qzQDK}+15&{7>Ak8{MQ(hre?-wyQ{jiVlGv19h?3MJeK1! zVEH*7%lw~>XIOs2LV(RO|5*6U!F(m2`TL@O=1Xt*r_n$2l>~>sZ%{1%9`w8%^M5W- zxSWT9ki@0C^ar@=G8p~w;D6k%Ftgss3J*ccxMYJJ$kT08Ms7_7Cq9LKzfaVb874IN zmX!%M*^oLA-W>hlQ1qSe5uz!^$Ol`GPTqwOPqn_ocvXa17jZ(hzBjjy^c9V$X_PpP z3VD}0T%H#}ksD?Q3pWFU@C^as(tUQpW3xy}_u!6gR^pD(tzDzA9A>F~r-w54-|3gZlYku_$u##h$9=+DXp~^$t4h7N+r`O$ z50W7nMVVLXjrEF9WSK{Mq45cKndorMB16=h#E%)VAKy4SGMszM(laDv#XiRHI005b z{a)loUlnJ1jWzoJ*n1Cns{8kU{MbbHrb1+79rMU2dsFt#I!3naQ1%ERSs5W|D66bQ z_KZ*>l^GFbl%4Z`pQE~uyVL#EeQW%GkI#8L-knDbsxJUHfT}ON!3dao_UNOLTzrT^0x3Q|C8s^7{R9gMzr_nzx}@+t zmx-u$-62SpS-h64YR0wfN*mL}%~JnK8jRCVgKv?Rr($*Sj!a=nfHx}$GgI{X`&da* z=*Mvbt3sd|=K2hJ6piuhr1|XvCT9Iw6;-!gW~Rq4MhGqKjg-C^p-*o}Z+3a)NhyiP zb>DXyMm{HE?1pq4F}R1q=9|Mg)WbM#-+=jY9EPT2~D-%+1Q~7Hl?uw3H$YN4z<1?y$DSRdgA=dYCPfRS-GNegr z?=~NcJ##YNP@TbTRw<1$ZGAx)l97oc8T$ z_DTeond&R&#$Ky>iG*Ido8Wx0yzX2(pQSA?q!N$yQK3RgGAoQPGC;rXp}?JsiYm>> zJOdV~GK#T*!u-fkaQ8{2t%=|a!UErfbN=4~ZV>3@`{0KE=YksnMBHW&=KqGQMf~K? z@ngHwEM(sfG{hYv#(dl~Yf4NMNvv?~%*6X>eC`vY8R{k14n^V+U6_8CJ!smqIo|`4 z>tga1-!q%w+7<0sk@L1LzM==(m*R6wO(nI1bxdJOY~hLx0taW#pzX`je0#RO|eQv8cO}=-PKQ6V@FA`bCrp^LOeqp50>XSNq^4|5P#MPLiv}ayzw&-^1cfQPi z?P7x;v(HJ*7(AJAh^ei*dN0;%hAXrzO(aic9zi*-Ww1}HbO_>?i>OE5zc4{U(N)3E zgUr)ezZOC6oxy;npIP#<{^y&JwHvOUC2FNXe=la)DKN*L~lnh0<_%}UY z-7nivSdbNbkD6L)SwLc)^ywu@cUwhYBb$z{gXVMoR_s;o6egmyJhNv@G+ndP7WA&D zFh>UGgkvqN;Cd?$i!e8hwgfYy@paCRWn#tlVGEMb{I(+WS+~OUVlx$izh4o@9yY(<>+aH>yOycj? z!HU+tp2j8+o*|H(U0XSBVO-iTW@q)jl!x*FMJ9=dcAYiXymnbfw7kHEj>?b&JYhPq1UnVcXZ4~I>#XAw=D+?wx zpvK}P_;d(cLK!@d%+@`xQI12kM94_`x04^cH9ZxP=zLzHD3?15t`P|``W=B-18nEL zRhLB>u}Pf9(nJoQFL0tS2J0L$v!Lycj||cm2=VSX(UK`^WTAJ6Em5ep?V27-v>>CN zrhGTQJ@bj{br^%3jY9H;?ckXO@^$q3>Z{y*^ldM$;ixvrQtE#~ZKLppiwVJ^!h zf;$dqL$Av#Nd3dG-Wi9=tCM*x<$k26F36hS@A7sG@9o>%+uKe+FdS4MLA5@=CE-A1 z6yHxc1dtPs|5uHsn^`u36lzu*IK$asSjj&|31&+zbLpg^1FVL!1bo4od{B@1ZvLog zN{87cSMmkx^ge1Kn#gF?!h7rbVFS~1h=h#l zO~i3D-#8R?+IYC<%2A`ZasjM6TsOvD?C>%7#hj66dc!x?ZQ->f81U?vL4n!0IBAo0 zN4|60ZD*$2+prABxB?d{qxmhQ^Oh9HcS&bN8u{l0gWX9MjXDhR5xoIf`C&4?Z0M3* zcQ((IFtyjc`y>!19_C1NpyT08-|;7R12IEvlj+Kj4fV|&kUAyQ0V{nmv(kS0sKKkd zFJ|N;>-$rs9S zo%Tv$7O}F>9>^W{w;Gz|eVCovwrL!AX>Bg_?WE1|J;8Di^4z8(9)+0&^!xeu9+8yN z#Hgl5xdS+rIX~fX6^%|{;nn0uYD#Xi{fr%T^u5HkGpwPCypb*pk#R$Up%PTvL`ddB zm5WhCvY#tJCX5&Z4;aNa1FMA*l4O65QS6R-lzj(4d6^Pm4%f~O2jWPwZ>Va_zkd6w z^05JxFMsphz`(Ezn1?QshbAOGmW!f5S3GF?Xf-pwV(;<=u9C8SXJ-crS}#PUN0oWE zJKLNW^>~tA8G2fs4llC0FEr5HluiC*6JA?HWxJM$lmaxjc)~2@+lSIvWD~G9zOh z3>6o8F`!3P@MBkbpQB0m~Ir0Lf%q`pLXMz~w~gF{W;++`DncT2?ErubM~h*w6n zq5rI|+})W3ZQll;W&sTQ9$vZLxX9fm=rKR{NfWtgHRJlCoOh2YXADF4J#k<> z892z$nCjOkZcxW|ZG&xvYud;;bCJpqc|%cLL^beR7y-$@c(L6_7+boHKurCnV(@3_ zdhOb5SuXKaU?*oJ;x;Amlfq7_Ucec{*LQ*OST&rRe|k3@Hraa+c2WuN(^+mo>L~R* zY)R+hAsD}+1WcX9CvbkAc^Sq^YP@*>Yjn(o5ZKd@&7;&#Fxc_@Sy)h!5Nx^805){M zV)d+NR3l8h+Y06>pRzebVY}gEn9yA_OA>mvOpbcv6?qoyjCAn3_t9oYYJ@{=HVvq5 zuAX)eU+dClJatqT=Z5de{rMYy-seWka?$n-QLeY2H6G_#c8@Fgkc1_nadN_2**{~F zebY83tbeism^C|59^sq(?$82UN$`Fvcc2q%C43;xUl~SbNc>wATNxpR`^C6^nz#OW zvt|%x{Bm9ETlKq&i$@DQx>)^+1ZRVwGS}cfJve$ICX36I1aje|X<5<3~kC-RBmT$w;vlkRx5q<6w4e<#264tzjii#I;>iSYOVe#=61IZ2{$P#qo1G- zn}@B^M_->@%HY2n%f`qN%wW!7@P^5tBU|>$0oS&{sFy7rT5i=U1=a?4SLVeABr){0 znl+zT#@mWLv&_B2Yp-w(9Dg&LrD@`TMsjRz!`q`9MYRH@$@^Um_jtE69PN>Gu|Iy7 zfL(=O#b!kC!GxYUh8`h%T`GR0xbumg|!t;jhV%7JB^p>ht zDo)oh!!)c2`epQCvy8c*rLn(Pc|_pWak7N9 zI$Ob-U2I@2E~kLY0oHul3AkJkSIgs>=g4shkpHihQR)Q4T4X$ZSH(-?khx<2yuRDI-~t?PWjRKxkA$-3y0 z$@=KK6Lm4A0F{L*<6ww`COs`#lmHIip6v}iiI=<%Eb(M;8LXekf})hF-wW&!xa_U zkJ+kpA9GacKW3}%U&>KGfVgsxGc4yFXI#3b!L*#Gd2scX2J`AotwXD~v{+Ye>9DQc z(Pm#S(qdmP)Zth!(&2>1s29|dM+WL)YXOy3)mLT!I_?Fxs78cxD*X3^k>$sJLg&<$N)3as z@HhQ}$P#1!YT$K8ET&=cxur_NQ z#P!Hh1BL*`aKQyYcmaOZTd5!}IEaRW=`SJ;aKQ$+a6=^^-~b2Ta4`os7ze~1;35wQ zfDVX0tQVLF!ofRS6ao(D;UW>M`FaS^h$R5 z2gePbL8BED0nzz$bBjJy8IyZsUUc0wuE>0P#991?^MsGaM91pY7jcU&H!zxWq~v4d zWtV1%7WbX&Pn?y^;2QiyZ`ij!AY|&x(;EutrtfW^Wj5rkzGMTRmksD`0jl?pAj%VP zSxWdo?K|?R{KojejBQG*S~tP|_<5x(SYs4t@tfNH6M^B}j{^EJ!=tHrd@zcV7{{=L z4~8x}ViQan@1@z6Y4z3_5O6O6_aJ}y1;iTh ze_gWEhQgoKwuBM-aN8_qDehM5-R$uY_=m~!6~gS;VH@Vg0>gKudqu>YF7mwaqp2Y zI+yZlPd9$XTr%m)ZaO1Y87fFUUJPG1+RJ*vnvlKu?iSe;oMvFA)Or7t) zs-nQ$vgQ5K(L5W`iMkwPb7k&&rvD|T~q^fx&_ae&}r ze7F<|*|NXx<6D7w`^CgQti)b9oiROsQEqm6xZ>1oYm(B;n@tU&_U<5^R_6OQvBtdD z{X8YrOp-bsWGX8PXDkJ$paKhyQsa5r3kBNK*Pa|>zI05lO)a_qqnmw5=+P|mgXaVd zi=ad+ug~^-QmvTdFSSbens(MK@-H=Av#)E~&ucEd^c)R4zh)90hD@6UY1w^5wVD4b zmiqz+zCwT>fdpHkq}vMg+aSR&q33@dB!GuSgl1Hj9PpP5lf#^3d#;IO30LID9&koi40tbxNDIMji|9smZRvNz?}d?d~CVoEV&ACOg&w#>z8zyI>#UdN86s| zNhspA!g};5+bv}CqqK`s(^K`7?{N1uhxWIaXxdxVu#`3l5k4208NSZ%;qu~I7%KHxHGckyXX?qz?n3D}Tc*ujj!R7n;EPo4nJ8ZR0n{yLziS=8n)!dR@*de7J6I zG-{DDx+n9N3)h{+d$r3}FCquQBdpEuxz8edh_~%hfhblCS(xwFCk>E)P8uM8R0B5O zF3FGG>y{m*BHet@sz?xAQ{ZuNrKm}fJh+C-lOkyBQcT^+r1EfIV=JBy(6}H5+_NU2 z+5^_2c>ZZ)Y;$JU#E;_ET%LZo?0A#w{a^&4uM_LQT-8*`r1wjU=EcfqiR;>BT+8hq zq70=YKHc{1tJzQE$GmeWnoE3?m-6l<+B0liZ3>)q31NAgLwcCkU(ddC;mX6nkCIs; z?Vr$zh0LmxEZTf|1`}2tuhA@~yYWvLvReUC=&H$%hiLgb(S|@Wb5$^fKp9C7_Mn zqZVht?kNh5dN%fvrl6SyTss$ydGOlh2ta!N@IdgC&K}&$;FpTR7T6>AQ>;3ci&azJ zLsR&N+QHE3lcwkm6P!eQvdV#FF)I>juV+&3lV{P%zi^mSKeI2nNa9A3=@|n%yr!;c zu7ONp0~ax;!Vxd{S{J_z#RoKSf(p5o-Az=#O0S-IMqb_ zv#XLTWAyR?UHJ5vl7PxQPHjQ^Oh`4i3(0Ef3vGhnv-vKhp8(sOc_v2%*Btw+Hn6hC z1{>9)BG(4KP%}RxVff}qAi{h6ofO)|PyVbiExaYWg3Jp2S(;{G!QFwu^#gm*(5TOK ztH&iU$0sl=n%H;r`fLj>j`u*^e}xAl12Z)@<0Z%!G**o*M)%Gf?Q$Y2G5aOTvF zmH5IXLzP?W7yy(J^yCtOk}!2bf+P)ff<{6-H;ZDV(b}r_QSKyps&wJWkMb`8m=VH5 zE|Fwun+WyRv4rXr>8A^l*H}696&ZIqN()(O3Y9#Izdcjt^0?CsM?QTudhE{3gf0>5 zgN@Bj+XL30L>{g(P)TplOt>=3SI~~Vhdd*Dq2emq_)=h*AMig$o5L;{c~}`#t7Q%C zu6M>c3hb(GPjz8+dEUK(%DupNv11+qeF)n>f0=L6Sd=i~gSL3(DDUlJqn;S6==ARh#K5NnlZwbF4N4;&bYQH_Z1Mi0BvqD7h zm#F8&t)N7zs2Imw08MGl;1X50YURFP^k{I!f>c*+-@*NwQD@1zGcU-D+pR2S5TpdX z&g8M0@oH1C9^5xo4Z5}QE3Y~C4O>cF8;K3@Tk=Z^a@a3~rAK9^ z9S_yhF+CCDz1PasAZc&1fZ2<92WofI{!8N2A4UMQ^|cQ}PE2zTik*P0FZZu@!hhm( zwq)nN>qoa~(ES7;xFwIsAiO1qu+1=kNn^oI5dnC2rnLn(Dxa4$0}d7@jZuac7RH8f zGTTxfjC&&R=zW@tCw=uTiD@@O_MJhSu~9yIcM8qUz&(J4%SMeqwWk10#pVT?oWPR+v`>#c=~lA4 zDCcU|Hwcidmp{{i6_xcO0k_{^y@=ZG_pKKRqI~t|yO&HrK96mKAY`VtJ9H!-^p`&t z2=6~rFn^d1+3pl&R9e;TYSBPp^VXIk3he>o3_$0EBB2tOh;wZGI799wk73g=k>l<7 zs}4e!9X1J16+7!#GB6eDmiqNF9YX3*Ij#KB2BDL+!lMcJQ5gmEN z;y53!>pS-@%pW9iXM~@P5l}ZSy}=Inn}daC5(sCI&s85jA@us&eYIs$Ul74>kIQ^~ zyK?m1zJ6970}a$X|2{R6d`gzQgeu2mrZM|!eCyRjD`-gyt%dmJ#W+i*xc!}}gPnc% zjPDOdn|x&Qhd#(BIv}2w^kFEkWHhrY4~I`}Pten`v{Ui}k|k9IJ|ef}Y?nR3H=0ID z^XsmquI|0(>M}4OIFO<}aHicyndjz3gX7k$9M*OwYE0RVV)^fU6yCK(y~wroE>iUF z#`8XHF&!fRG;?3#Q3@?5UxiJDWBbt_)a%ko7|xjmI0dew$Dqy1dp!u7*r!)^yaufV z{hr-*lK_|1Mf7UqrQDo|-bA&Oe-z^h7TA^CHmcqmzt)-l;fT6OJTqfNg2iPLvQ`rB z5~hmNm(6${l?^e!KAoC%%t^_UDK`Hr(uac>Nh>b8OLtsG+UB4hhG;y z$SKViZcM0fv~+6hR9)_{IV*YJ*X9%TqN#-P z?yp4_-bzRoJBjMC|53ywcz2Wl?17;}0f5bo6uoDTU;;QD#du~S+o5Mvf}dI?35RU0 z6f>Uc#t05vAfW3B;JR_)D(Or(&Qb#eGn+obnTZ}kHi~X^_QfXN;hV{%{_M~MO-b2H zTBW*L+N$n?!>_cI9lYFz2ej4w_6h_)Q?O7Kc&c)mYZ!U7RPVy!22>CG=MshxUIbCd z0NIkPLBfe!vF?kb+p_9BGym03#c)vL^VZ$(*}r3b0*-`t}S?11M1?bjWiW7LN9jgzUJ z)CgM?HllTQP{MaaraKpjgv3#87bIZ%>rDrtue6;7*=9OO*!Ac2|NipK>t!TBgkujo zb#QuEld$6uj+>rlP*h@;9i{w~Un5vQ^B{i%>Y#8-mCp9r^2-3vRD9>T56(IJCq%F6 z;}7)r-8}OA(v=+g!dAOhp7d<>$`EULlOz+hN&lrd92%aQT*lXNW<6YTQe=ZoK{C7HuG^FzcD9CAHl3~_GMkG#aRgzpD`6Z^!y=J{s@^)VQ^!( z4IzJWstnm>$q#74$ToB?$qt2#@s=z6b9T7U?$#@ulp>76uQDr=db3$Iaf|97coZ+b zUM&_=!^oX}q)SiBdvhOHqPo6j{_(Q-{tW^)&!iWDAEOT>tn%2WOYb0>_ zu4^A>nma%1OJ<6gBTdp$hs-hqjcH41`r$iSdw(L9ey}Xw1Td|aMY3JYZnwm@7$9Io zq}le#e-yOh+ntUvg8B!C4*}JhVR@x^N$ey7B}$+rgzpVD3pAFGnmR#Jsg)s@IrpkU zyj!>TkaM*t;{jR7$;r%xGt&c&j*5v^`ia)EI#${`n%7$o=qnd-zby%PAh&cGV$+#u z|5}|cY<8gb1Z(qAk*PLEwKK&@B@&(MtD+AZ8Iq($I-cS_%XtyyBHH;9bNQl3W4&7^ zoL)ETT&#*cU&T4^l=AG7(QAk3Wp@c7SN^hU(|@z)uYPAyj-khY8dj8ZpO~}dVLXE z-l2_qaa5m zMP4X2p6k_qC7=ER!@b00+Dfc=*}ld9IoIt3Wdp@@Y&_PzW1QEz-zb*IJ~6}Zbs>>3 z3JxfF>_SQ#gT4aAS*l-}x$GBxPQBE^a0!elWdBG9!?cys-Vu#o=)sxy7-T{^J`WEd zuhl1O`+8Js^*b47$d*p$_ZVjgLYVjSKK~8C{vV6t5QN6vALE2}>BKL=mnMq~4GfAj z+^ttEd0T)k3qCesYH9){T|}RS61&ogc;+c4{{_f-A;5kv-BR8tn$Y6o|EcoK9Jeh`4<-b zxv|UXJ5CyXn(zs~Z00EMns6WduGu@eMR9+gS88WU+H3EaB=1eGaVA)jm+^!Hi|*;@ z<)gm&lX8v=`ongjo-5c$*pirDsvVW7|JNe6EzfGC_x@!5QL3RuOf6F@WZZP$RY19meZHQb)0tEF{1b3mgf z?`9P!@Mxz8=?0|v#BjaJ8GmAb;im!bUuqe?DkIys@=C3E#JktJYq7F9X41WYYx$O= z;k%?+k7M@rAF~G%7iDj;G%s4=FHJ^M&UDds3>;grO&1xw$bsJ{4?S*ls%fFHKkfDR zJBbHvuc?%2MkhP6(1Bm72v}9dnLhLq?+l;vsgfAGr^gV}ZBa#=MbuCkrCaAt4N!M~ zrPJy{4yRGLJY>DA-;cz0DYfKmQa_9VqCYn>nWI1`+EQy)!G@DdpAb|}s3gKhRl$}^ z4`Gv4RMar1D@ie{@3TC_3=@>NaPrZ}lpoO%1<&}YQC^Ztk!idK$@rMwDM^gSstmz zPJI;Bav>3!f539_@5<~$`}&uMrO`l5BhNg*O8SpN&RKWl%wI9{kH;(7=7z!+bB-S9auv(m|ACfO-(=63s(scz zhgTgsHV#>Fhj^E(Ih>6)@Ca#gjF&qUaLHuc!a8H3kMq$Jf!opSGf%0PToXK8(*T)> zw2%{N6}+7txbG}+h4)|O2P?4houeWg-n%|UxH`Y)=jP{EPFniGLGh$}>n$Zm{Zn)r zZxxG`de$Fk)m-c_yy1HAQbF#s!>#2T#tHt&o3FFyf&!}5{3Xoq&pW*ZA83KH5*`U@5CYrHYKY@#{p-ka9QlIf0!qPJaP1@C%7ZoPjJbaU=$z>S4|zub>6 ze6p5ad1r1+x+TG;oiD;>>|$Z>Y@%Qb&=A-Mi$K`NlfJMeLoe8hwmWQ9!wI&kZVOve zw}7oF8Nt@%bzy6=DzG(adDyzRBy8h|2y6oahOP5)!qzzt!8TYAz&04DVH>n$uur6f zunjz1*d_)BYz>6IyaYm9dE0dqYeT z0gh9Y*}Q%4hC^T9^XD2<&<9hqgC8!tc@e6|GtrFLB#crwkC_GbFtggWX=+^)NzXc> z>=3gi7ESO7%i#Ro61T)R+`WcbHMD)@CX-e{gO3UuUkWXY>|YRjH+PqA55bbxDA;rOt*vGKOKe%sV-26=51 zvq~YzQggq5srYuwmp)KNhx=09gL}}kLa`YYY_3ZZM_zG`Fo8#gjX42Z-My3TKux$3Me&I@$)DmwNWUch7Su(QVq}5Z9wLTYK#GjjrV71^zrfTN@OH&dH_E*`EX=X9ZU@* z+NQkJolNH)<7FwK$J^?datV5Jud*ou0JU?(E$seKTx`PqN9(A5j?Ev#fcG}*n`~ub$sbfA8oX#aJ zvl@C6jv?#X`}?F~n%y&mY#bJ<8rwbkN8FRj9>mUN5QQ8c&uOqW6ro?##>>lU^Nh|c zU39K>5*HZlwc$5fpxOi$>}wltrk#2&s`Wz3+x}Hj`EMH1A$;F<>LE3xL$>ME{r)Px z;I52M;A|WKMoWW2y9)^7G|1V>Lu5{nwgU3(G9*Oq&K>++(@tePI_+jb7Wq)9y}kjy zM@O_cztJ@x^YW&C+ScRPJ!L*UuaAWtbQqISPEE5_czM$Wd{ZNiPghCj#GV%|$}yt) zt#b?xFBGS)GJBCGQS)Sz#_>8yk={l3om*^VHJP8o*hB_He8s$js0;!rsr_{Zu_d0i zja}Gg5Pw#}E3hj?-yNK`1dgeiVvbx^3U%OzqQf)?Id=Cy0rI|4r{Uc!1?a)hie&wawaiDk(4AEv}!6_4%EJ3{$QzFWil-Ad`U}^)tJqu-by7t8Lfn+In67Yi}ymFad>mn z>_5-+gkM^mb@~SW#fXq~JvoB1Ec|+R)9Y*83G_)BBT_SgzReBA4Aenm_M?1-oJ9S|B2^DNWy);9cr6m+!rI{<>v?U@k9R4Q(<30 z!FNxEZN+%N{J#;4-TKK-x5D3$j#tN54Sl{4^C*Ftlw&oq74U1kCbsN#O>F7w>e#yz z4=$8U*2EOQsf{X_dU*cMRL%MP>FUTEGc{qkvsK~Q^VOkgAF6|smLCSjuhs;_tX7>1 zU#mP9yjFhJf33pLbG_n>%X*pDsr9>_maBI>P1Xud>#p2#Ilgk!UVbUZUixFUjo60_ zOTqa>3*Pwz6ZUs8h6iUt_4iE$YEn&}IYBn=rb;;KEVt*CwKVqglMchSuvXnVlG5r=h<-Rz&H1GXzUl34v9pps1v=$O}Fl01q^fxZW` zQ6;dkxE`b$m#dgd?VOZWV;phdJag!zUwv%EiGJKvYWaMa;*&Z7%BagP>N*sh4KwM2 zE2iGypZ}2isI^-+zHq_bFWse3jV!6(@}gvjgPOS^gI`k8W_ClhjL}qBF-(t<+vVmF z$g^-|qiJ>{I__m>JC3u5BhIYrj&!>;<{Yj#oblkKdezz;FQSAM0*z7R_IZXB1sYVA ziUdi1KN|rS5aLmHwS>AdfO#~`9IgKvPxtxUEn>*!=gqM-*izHh2WluJ0NC4UH&>{c z!`?j#5h|^NaLrzf#|+a!RG3(~{f<_j)(z%EmF%9b**3kD^@T8BWFI+>ja6zo8l?1~ zho`MbQ%<%n^TAR<&{DWLgyUe?#djCiYEE}KPf_7Djve8B5vn3KO_CEKEiNRWnF5}- zp=<+Y?7B(bXL{Z-5=WC^*Gf~R;3nXf;pL}>umR>=?4er{Opvchxh4(-XhdBs1O7ev0ft zrh1{SqEp=|lB$f{O;)mO4bUK>a%=J$E^X&5y#s1g0 z_X*4lhkJ@#Y;RmnOQS>2JHpzWdYn2&J4Ra8{G>)(;7lax{S6}dZkSV%4p~zQW|Cs-*^`_pODNc%&|do6wvvWbnDTGG$|&1txsJ+33Hn(u~$? zd*zLQ)(7EugJY8}YWQy!?z~weY41LYyi^czB@+}&g{-ajwS#*1;K!D@3BfyaQE2t!oiI@8Bx5^_4P=Y-*M?Adcf zhWJUA=To5s``o8EZE{(JesdxC+##?|`zb-;hRG*uH7K5b z_Y;#DDi!6-TuA9ROmx2Ptj!^U9Ya`O)HE#2wow_O*(>$f3fF+LGdUsH+Qr&H* zF^Smy^~DSG^aE{noDYx-N#YoCC}di;mg-A3{oA=iKE7Q!?!5+Smwj`Pa>Ft5^4$83 z&On9@$KvzD_t`tqO~rtAGu2Eo*kynD>Sr%wsu(tIk_DbD6bre}4_bB~-9I zU4SleP_dM=Y;^Wqf9R@JAQob9I$bxV%Cm!90sU!H2AITQDFO3OkMlPj4md_{+T=CR zMIOboN((mm5NggN-GuKbM=+TdP1AXV7M$kJYXyLkzv_YL{m^I>sN~O5paVm8rP5+w zZ-`%O3hXb>qvu>B@um8w2FtR7adXF|M%tY2i8$_+RvRQL_Pc20H9b#BJNap}`@Lh^D1LhaZ5TSAB=rt%k zTZk%oKi_Jp7nV+luM)2^Uq^PhpX9>%{?}Ocr^W8K?$NWB@wl|a%0kVKCKpK5Ec3=? zzmI@k6Q4#cvd`@pRZK;-G=J1U1wQ^=34=%8nszw%b%&3nm7o#R@uzu$t;&b3FdGgL zP>Dy=@c7UL%(I-7W)L#3nz1HmxMu3h@-S*%i2?KE-jHECGb! zqYh9E7K?KfTc0(uYTmqB7c-_+;K)Aj zlb)gr)l;71XL=_aV2+U`58(=c@AHn}`=`BT!mQi2)56c0W}{k8B*gpsnI=BIT{(R7 z#bKJI-kJ-WQv0666n;PmcbL5-QGa>NJ+X|lU*AcnS z4(uP-FL~8f1bvX{Q12uBGV!D1KRC>y&q@=`$zbF2yw-ry1a_0I^dss5OmvrXG-J@C zn!MHHb`4(Lbde7TXn4G+dDA=vEg_Tk58-yXt>=aO2{a$oO8yphdrRQwyJ>h_ zjfwI5$#tOM;k=&&ZkIynNUU)FAgm-l8dLO71RJZ?xWNhEmf?8tYbH z{@Or#OiurkJl+?a9{1@!)wQ>dXK<$Cr2D{P)wJ8VU+>$8>(_?j5TF5$Al@Ik zkL#cOj(No;@jNju26AjpA~LN*WoLg>7X(;%SDG4Sn&1Q+JT{*_rZO6Mbzs1wQ=&Xp ziu|=yTL?bPU1E@ze|1x`v$M}g>|=Swp%;24BU;e;g1N9w0 z{O)i@T7&XvvgL@N<|mXH{B#8s2dk*K*q8JTdOTm_ZX*VB6Eele~;McJPC`77| zsSBY$icja;oiRX_!&VK>we{yl0+S@_WdVeH{*@e{5+vClJYSs2KK2?!##>ElNzia8 zN;gQArXVymVE!I2|1~?32~%J3CW0uZhSd7`M_vqSg{IY)OaVnAJOx$*@Q~U)^XiLM zXbn2RzPHzV2Yp@)1Q%>`!#*7EzGL?7OS}id@n;^cxI~DrU)&=~NbGL_ZJ&q7CjHy{ zCKr9qbWXa*81baim!B*hz$iM{bxTd&gxJ4#tYO(B@E~juuX6*g4P2Eu&A9>>3vSlG zQ+L3+GQu}??9c)<>oWEB&EGz2fkI;z@^fY5Ac$}QurESzRI=@q(^uIzF)^NBXx@mb z>35?WvNGMT`%?d`><9VJs&)UW%DttY_x&e@3^RA1so4_7VSsE6`9)@G{xD57{#_{- ztrb63ox!Kva7oNt$rEv8V%TswMBL>{fju^$2H^klJrCf!+#~xuh+5rw0%t^6ocq{J z!}87EII7^kpzip?PuT-8Z@tqGJ}WW6VJIE*HL&fPzgh>RB1!!vN4f8rodK}!67LWo zskR^2a0}}u*|z(zK8^VZ*HlXvz@Herq0>WWO%D{rZfNqnU z;FGBNQ-va9ml(*J+R={BSa*1}J`11EhO4O&VT8gNf^E6Vof9@F=F~$F!R8COv-?Jb z2v&geL72=o=d(>nZTCMIg77lH2P0bIwplMyQ2zt6v)!3qxF*mnyFx~};eYdfOPDRU z6vGBQ9>Iw%Q?W+@Fx7(d4=+owZay>a^aZlB`Uqs3wQt6%>pBI<{KYKVM(=CxrKO8u zrSPD?&_2_DAZf7hC`Tz2VYG#hu@wdj#n}qYA7omz`y3q%{peW9_4Xx!U81P15NFv% zdwoY%L;fMPQp@T~mbJczYa>_X@&Pn%a~O`sDIHtgxHAm2VG0ZP)W$noLh6^dbS^$+0sen)!Ageza12AQ+lrveeH1AoU8UAyTD) zmHpiOW%fuF#FJ0IS-0U4O1ii%5_v4YZo}*j$Kra$H0J@Tn?=3``Fk3sIWv=N3Vq?r z=x~pg7+BGhIe1O*MgH{SDqe#DeCbPIud*%Wo&cwLAecp5Lk;_y+q^w%) zQGrGJ*ke=36Z;uEl`H+aG#;0ZrzjbQnOU5$XS>)JYz95fd0t1MisL3J=bmfFc)OB# z+eudR$^4rd1XOty{oc&Qvv}c+g<%VGH@KCb*gF;;vu(0hB5*t$#m@V)#MHo$U4fSN z&49e>33#)Z7|52HDGQv|o|a;1rlhYB7g9V|*z`$gELC}bOD4bad8c_*GNC|A3duI6 zQmdXvv{q9``P@57Jfh6vdK10xP(XBKmrA&w7P0f!72W1#3J$uoB}bTp86H_aHG`5ji~J4XwJ6GI66L)05AiI*Ny!IeCV_NGz0aevaO|>6u-A z)UpievlZlh!}dXT1=Y$RXB&S2>$oeetzSUDZA@5yp7$L%=)ZQk1)j#6iVZ5xeInP* zTGmX*8d7zk1dWuDr2(>Jsu%EyMdu&9^BBegG?in-5KJIYMX0eU9rJl*)Ah0HRmP%s z5Z7ccttfz_h&Rd`GCsN7*gKeGZde)?B4kgrU?0$*`q4jz>+J&-!#>d)9{C7z;;KGS z(E#|0bo)-#Dyk5U|)F7v+(4;g+7wo-Y<)RA&0Bn51|R}h#$Vc+S+(h@xH3L;;p z;RnEzIRKs>detgtjs%9GZ9_`cUN)!>2O^TYFR=d)Sj}D8XO+Wd51ru;A)AQ!3>`1< zTrkZKG6WG>$2o|9}c>#&D5{-_R1f%d zjLDWX_IJsNKTCXWm(G5FHn0OxJU%phCLe&(<+vSg13*-MilX7c0ZoC(AOK5Q=Ox%r z9{vbmDfM_w@Jme5N8ZK(H08nPfm3pvu`&06!UT}dAI1yjN_Jv3lqwQjoYgu!F~|;- zF}Fy{!WUilEGsfC9<4DD0SEs23&lAxN6|$~;hhCQR`zhk_7YcfuhN;AJV6iou2ZuR zgo3-1^SFOEdcz|%z$K-7Nv^mj@ectxA22^hv^E9yNsBdLS<@&)LdBB|ZAAUFQE&~X zE5#>(^nlX@U(XWXSg;^QWnxG<^Di?oq5q=}hDh=MU-Mx{CiANAOY%{77RkrDtgm8FL=p3vIdb);}RB`R#95jVm6H=st9Lu z0WJ$+ZbepGgm^1Z2g{~doV5g;+CS96%mVff)=S~~YuV#BU1)dc&(!KiFM^W-qA}L@ zJkkK3pxi`YFkt?#l6jifNl)OE>eT7cv%PPb=KOD#46n1_kved#0@p8fjEP`-$vjxv z^bRTmLrS23nSntd@I3GPO`?dmzZlr=(+OLuX#l~>`*&h~n{3-wbe48?akb5J)nqx zz}5lk=4xxfqXKobcC%sN2lJ?zIY4>zcr@M3-MpQlJcKl)qy7?)ng&U8q zttIfQ0>~#&)=KO2KhQB&^_-v%-IiNxJf%8^Vx_k!!~Lpz6Z&`e=5zF^;_xRoQ3<#Y zjf07!Z9DJ69!1fI>IT0B%Kv5Y1a`D|d^^5D;2`v0$A{J``Xt9$$zgh9%u3s9ReG^h zs0!7{+HRk-=l^nZJF`sw9pBtG%S5c6IIeox7={J9?=~|0@HE9ds-;6hQa^fkGSYww zrG=9vl;`uV6WPhaf%$|4cYJpck-yds)(?9JB9ydrGKYdJ;rE6P8$`nfp?`g00RM%7 zi2=MYu`uB;tgkN|TwGinEWACy3y)yyMfCYkG~llRe+35%3uiAr9zFrVUf>0PkBE>E z@he2|KL`m4$p{HZP`%Lq>py_;U;hEvOAscA0QL|>jtjyA>0^ROKxiar=p^VEBp9#; zv~1v6VIVZ4;ZF_m!ofoW9u*cg?jC$J5E=#sAW8c5g@cZb3qr#K-rj>x4F4%6HjnMs zcM*S&gb~b#jf0D~hm?$*f|81whL-6dGs_`XHg*nv0YM>Qh{zF1DQOv5Ie7&|r4t&O zTG}o;x_bHsX66=_P%CR2+f%Nm-P}Dqy}W$_0)v7>Lc_u%BIDvOCR|EPN=`}5%Fel( zdoAz!jhjWqC3o+YmX%jj*4EWGG&VK2w6=Bk^gemo_pE>5`N-(l`0I(uH&fGd^9zd~ zJ}xb5{tU>saVCP}p}3sfQ~R68hAE{=6^e=j zu&HHb+Nd$IbaDggu�(dKmlKwomX_o`8O?^uGP{#5DE{^lvzh+f!ym^2-F?vZ}q2 zSK3kMtjJ4GN@HdglrE(}rZmY!%Z0huUX`Z z<)27TajQm`(? zamh}+bFq<3wP8~nd;96not9*&HODFz(PpN7d`usB?@A=oNXQfiKD`gxxdD5MG;$^_ z^BW2fT?$^`*D^L!@eIeIR>S=)huvw;^$UO!PhA(hT7fBeNl|mp=+&5uMe`5qIUv-) zuQ=VpvT~VaxnrJxBK5I4*0I{+I3;JHV^FZ-B<%}>JMO+lz>h85%M1NZmD?;HqcZV|h zqNKqc+9`u^LkNc!;YXd#hj+3WdwO|DbMg78MV^?ype+x&rB|gGXk6QtP0Qd*X1C?N}5f($g% zhPCNYKqCvOx{>U?coSPy3`+x<6&~0CDtG;D*VK-K(KqgTM{!mdvhzR-MvAom^VZ*s z7YJ{SzU8ekL3?-Lt;N7CCB`LC9xkS7A~h%T0n}R=iD3B8$ZLmNnRmy)>wjB$3j+Q#^!pcE z85_Qp;oA`aUVq!lz)!cfGWO@K48l@V|GF=LP0shtzChZ_JKM=f`=aO{k=MThUI2!{ zRMPx;U-=)u@xQ=|e+OPCurbjO+tr>E#cQlPmxqIP7!ACa1tTB*SS)FM0PgX#s5dfl z3&szo_us_i9i@lDK)3QvnF}!Ze;E`!m)rS9#sJ~}$CwPl!QD!)zQp9eZDc+dcyoV&<}NrZYABhj%x8jj@vjuE<@3fWOW7T7to-bV9OlHPpeg%!yYcC&t}_{L+IQ#F0yHXf&*0o@ok^ajuQwJx49#C1qe^?)LU)8P0E~luV{w8Knu7bel6JK zs1rMVduJjD0rxM|^$)t?e|u-ZeC3_q8B%Jb5P?KOM(*8Kyw>$0=|**P-yWCzFUz(g z>-+(FeA~@c(qHfLVpqVA;vuUA1akgbxcDxjR#f-4yX^69o8F#1EF1lsR`KA|wz1_yLE}c<~PH2}f7>2Y@fa`yXl~|2nelyf(SbL2cD0 z2@2fEo3_^`HDgIGp>k2bo=^nFjO;XM{x5m?aTel#$qPUzVoK}712p1=jz+=+{*t|X zE&ecmQ~mi{#p-Vq=wD8C*DF?kXCXc(FN_UQpnL)d7PSj{J*X9A8?Hc&Ck;A>l7tZ9 z{SRy+3LmvIfcW2g4B!(dGGw;(7_?FBqd?`Tc9Ufh+)1HY7!Wz$siPA7AIY*qk_Bz6 z@PP%w+6k1x-70+Sj4eeokpHshKl7;HrC4@Y_xOpMehW&0bd>-9^OgVZr(}-N#)8hN zUHOhj`VEB259H%W$&W&WkA`jI5@x6!C$T-#Dttk{k_{$tG*3}^qyIpo{DRC52@?J< zv)fr_x1%~N7T}H$yzP$`Z_qKo|CrhRus^EZVQTk7b=bdWcHn==MSu7k|8&@N5*Hhj z%mg&YN=c3df#B(39g8(P0n)@n#knFIsKPbQ@(jNr3+h zg^L3J2g>kYx+tNYlTZKa>jN^oAFE2?{YStA!u{Ozhx4VpjCn%!EBe5Y3P3~uhy9M! zDzdGy@4IQz4jt5w^z{MdW%T2JRm9OT{*f&E^E{ODxhq#5(p(wFFFa1B$F>)Z7(|SQ z+AsYFO8j5$UC7Q`j{nEX{3t84!;(*o_dL({`+dGo^#Kc2$hSJ@f8+HEJz;@t8nq)16`S412NvGL>M1ms@QEvNK*a<*pZicT3DAgiKGasI7*|;PpyFv+ zZ*)H9dc0afBTcqpGo%TLre+N$CED8h7>BSPUGXH>)XHv4MSL(5mTpmXff$SIpm=aN zEMh{S9vw`Wf~)#u?5|YF!bxCSJ?k>wabyP&Zgm`m5n`@FiDOI-=87l~bN@J^J_P2< z9EgEfiEX5p`FN$7Iv5Am=-b$CW3J4B7;JFSnqPmMM|PrR*x>NRRZalV>$~XM>>zl0 zdKLu{KZ`8bt5Mf0Ph?SauOH-bPd?kAQ3hM^>CezzarQNbiysB_O}t97yuokxp2(`5 zJW%`6XWR>{Mho=&&rP4t_P8Y0Y516oYS_s&%N{X-XV)PPv=2mSxA0mZ$E ze1{S$mK-vlhZnb$hfpjzWImXG#zRylbq34ijs2T}zAKrJ*baER$AwZ4>xeIFeNI*7 zx@n)idp77cYM`16eb{AA2l48NM*;c~r{c`OGEBvE5%c1Q3$Vok01Hwd)q4ItkmJLX@1aC<33Kdj0rsjDoqX>&t@JmNKpU_Xc?3-JcyuV2>Zp zUb(+c?oDtuXENUXJ>H0k#pj1X(&uxwAQp(p#=&klE+^q)I}j6`kB!)4*$Y7@w+uSk zRu0Zq%5ZV-ww8qME|@rvVDX`iTKw+$to{X`NN%a`EcE{S)0Ibis<9l3C-D-kDM&-luL4zlS3-Qs(@?tINnp6%!f!l;*++(%) z8p)vEL{daTLM>S+aU?9v5y`gEX-uGua*DE82|J}0dAWb-SyT>ov!C>rBG_^1P{5|MB zyduMn-qWhcAar+O65`dpLndjvw5r#KSItKnAVA{D2o)Jb;=H-n%u72L8Ro;QMjs)T z-Tr-jh!({+Hv{_KK(GlEsMI?>@?mBgi10(P;FZl{x4iYs~!dK6F#@t(l~ zYWXYplc+z=%7+N=>2h7nPpbG*mKg7(>Rq6P&{@^fVYt6OIy3RsX!gBBn7{d83j>#l zoBPeiySd&)SqOD|y_9AwM~@?a5#V@ahX>h#vRI`VLU-p#GZvHti`6@1qRDi%*V9a= zURH#YW;!GsCIttPG-J#%52u$kPctw?LfH2$>Dn#5J1+P!tbpU2tI*$$Yas=h0T)m8 zMYt!K(q@z#t6zaeGI!FhaWsicd}T+_BLEj|fZr_B%$ToZZ=K~+Wz2i+3FqVqiz8XS z+4Cmek!%OX*ux_$j5vVmfZuGbjO~ZttUW2=X|e6?{^O5j;fT&i)}{PoePks_l>tC6 zkb}1w8g=QxVpkoh7Lu?~Tzly7;JydY!-%79j2^D zZfpZg#}3h6$L1@3z&fDLBv^t}r6Ie|feZR`omh?ZB3&-6iv(;3c;3?znz*jXk$@kE z1pEY+(3bld5D~T+t1Fi@Q|xwMGV~$1oS?u;=td3?B-5^`WgOJo%@c6kk2z&`5yHL6 z4-rehwwRkbL?}e_uL-!bSA=3+Lz9v_9QYEkLD2T}i&sPA;b1r_6w4aAmcVj5+a^IR zLzu*~O26G!46W<<9^E8p0;=QU>T`*C02n`h)(aR)k39fPP z=1k!TAu0|D86lkA-7Z{0Y>_C0c<~`N6WzoVZY!0s)hL7H5w%zUcgy=lqY~l^s4x6G zmbQ3#{?+wQr^aog4H-6Mc+$LYd{cJDg2XkkJDHPiA8LfAjQ&~i>z9Y~3Zg$w_;=3x z8T0Rab(#N7*sp)bE!V#BCOAFvSJjoM(UbnT^X~i)o*&S>VE>=|vyCa~hke{@_7A_D zailzA$)Uva;luZChJOq>KNd4OF#ScpGIr=(yuWBWn5rJubhh{^IT|ve34zq+B8vbv zj+Uv@S}kms>HSk3XXlo6LuLW0$W#Oq0#18l+I9L63nUy^6oI=b>F_exqfQ7?^)XNZ zgK{uW;zW@_!RR24C;A=g2Km7-D(84MtMRdwN5IMwKO!9zhwc5Dy~Uk%EK}k;JTtI; z$UIehb!W1HCs-==Su9(u!o)~f9^AP>)hPFheFhT$vCCNBMN2}&ydL5Ar-7r^Zm#iC*VBO0B1;r zij?E;NrMq(mOzFd%zZCDuw_YgsAFP);KYClc468X%t+gkYBHsLA*Q*L0k%*}WC~_e zV(y^wZG|D5d&xhrvnLXg;?LU80|n;YhboR?WV>rgg@#beNYw&rEaA{!>L z?jxu;htFeh$=0DPtILBT)^OnhAvLc~md~VT(kq67`O@j*GZvJqAuiXm`4!yE9MYS5 zgm6Nmd^W7Ab|hw^(R|+(i4G_@iMiWRJ_w>44Po0~rj7HaodA|CGl|ts?spp-kE&#C zi)M?VTo&7O06h^xW*1Gqw$_Oa$wx4$ca-XF6(nj)gPUOp7z>5h;sDZDlQ|4y4^1e0J?WuZ#)1H;!z%40~vB5DSNU3$cU5 z?IFY$M%?wp(Mi}?dmy+r0=7_Zq*hP>E4|x60bp5s^xCOqJhU$MpvCTi7LwI2#xRvj zIEU8bBc}o-e5lAJ1=ezzQo%8Aa6)?#?V{))DpA0s2`d+-rAJJd9^bA>=wb9qh@Vm- zNB9yA-(Cag$!(Y((hQ(bQGo?VRJ4A3_vuNP3FjWFn}$oxO-Wo z89d)njQ1R$??EPhfX2U#Y%`Zd!iY!)S#xcsWNd1Bh#o(^%@0~N5Lqf|5>F~1gWWF2 zN%(z#-wR%B*dyW4uGt*5gx1=0qg}I(TE{#>-&!M^&m(B?gZ2>!TZpGxheZ_@v^K5b zML_R+hx9?zUMwgqDk=Z#ngsSGp2f;%1*f5bCB!c%` zfK;o#mC}ExQ{|$eLt|nnwOdGHn5i!p4CI89rEd%s2=Fy7p+q$<*z}E&KeuuECWHu0 zE*47&_s2nIbAvI38#n&osYRK(kUaEs{D0)b|I;#@bWV4`dD|bO2Ol_F^VY_@hZq0w z*XQGT3+4nXX{4k2u@_cwa#ExeO#sB8>tn%ZZj!CPK9d;oPw*fR%>1lhO0(13q1@*` zCQn;X_cm~;5ecORbiv!|f!juXvxM4A-?;JGB9~DIf!|Sylk)lKMV?PL%AcMp;kCT| z^}dfk6Sb_#+WAq-Sk?=3=X|ODZ?>KgH=5wFAeG%a|@0+q6EyZpaH*K2Z3Ez^n9fwN@?M)p6A<85yoVZh< z$k7WCt*T5%vAuIV*1b@ltckhUt5uabf&pO&Mt5b^ zg4AzOn&RX-QUq8FB4|kzI8$&gpbM{*&_^I^a4-xOK8wBMvS^Cw-j^Ca^kHoRv)Ubv z5+PL5yu89%Tx-~dVvA)(p(7^ zDkXd=p9TSZRZ?i*i*>@o2zNk^0-G>wX-dYuUtsq^{MJ4&fNjzkc7iRRv}7z?sTVZs z1zK>xMW@#KHQx9Gjp&B}GFcJq6vuHPQGyv>~2%(ezPRR6?O|E_jc)Ygz!A7tbQCS)7iV~dKK)Lqzi@FkB;;F>vlL+b$QO)~7E zB+2m8Zr_V{9Qs)caI2Sgh?oj$d(kbcylY;aLV%|-$!9y*Lz8~3`(SXm)ihnZe&d^) z-`@J}`|f7qQ7I4>Zgvu0A&~GmK~xVoS7X${(M2i zv1+qiY@FFSdi1ZB(_-4##Kiw~TB{crjUK>b*ZN-Q5Jp_+;BY=B-29usJ9`HVt(~>{ zgk2*{t`P$7%-OXkPalkO6pCVw)R|JDmTomj{nn~;>PH-lIo*hVM1>I*HQ>za;2cqe zIP#v474kx)oi;2IZ08<{`(M01RYrDl zn*nQBv;t|sF-8FrU7}1Y*Hq0Z%kp6&Jhks)D0cz{Y1{-F5&F=4d~s!1-wOdki7z5_ z2=#2H8=l0WrSj%g7Pw`%;}3YfM2D}Q^{64{>-mH&Q4vnvXGmB>9aRk+C7mwU zYIdppDH?-Yp%&k+BdqUPep~kcI`nr$^R5ZPvsZuj|A8&E^zB4gCV{-kZ3pkjd2B}f zQK%Y|`oUzDI|70*0|&5kzKi zJMwQIuYIu|Hhl8b@CpS-E#>f}$*cJIEPt3CEPqc?_aNd(mRZ@15rZrDy?iDNy|--N z%h%p@fA62KV{VYlNAEtq9{3#|-fjo?*+XT2IB`dCvBQ0o=)q*d>M#i@X2H+GEbTET zY*Nc{r~-QoNOTi)W&EbQ6GR12p7Bz(ul$%TSUgexPQPhx!V_jbu2{ zeo}M+!uLJvZ^KNj*wHfB9M~K?1KY}07?|(IV~Ne0e!K$QT4(#9mcLn-XZHYJC#Vj# zFb9VbLPjMIK8wnmpXt&H*$#BEvnyD9l`ND5^pT4ut9LVm4A011QmVoqp+%5=XEL_A z6!<~GLWwYuGKGn+0+86D0_bV7CXT*4EK9JECgwh5O4jyTmRKcgVBy*c^Ojln5jLm3 zjs?gUZT8J0;yz@q9Rc|ymF z^&!nKuTwI(1}a?Ym*>Pu=|2Z38YCQEK=5E(a9+~)k{26>^Bg6(?NQz9C3q*goX0mU z0O$}Cw=bTvHAEiLek~Gd+-y_N0b#vJdkt<1Yn#uZhsY;%j_L$dgUWtzf@Bmanc0vE zSdCXyMFOw62)OQ4t7+WHHq>kMa>Lq6SC()S{OFyeA)hY2F#1Ixrl*lmJHrWzST3eDvG|M0=g zURME_YxGE%M$c+hZwDJ;>lsT}kwkdhs`G&r-}u5*>Bw@SpG-PvRUP8o}g_2)1Y>NSJ$-6^4cr4@AkiKCu5Mkwq|q z$sFiT9W@fp6+ajp=o%X6-gwo@ufa;S6v(QRyTCIZ0c&bs*Ml(3 zyPnXw3@^L`$_}Qq56)e)1FF55BX(PM@I-xmTQfdEPgK2Od0TgD=!D zG%#nwLum17%{YZ+$#t;BLs;p?D8aieJFr5W+j^*oLffZhnfzDpq_XjD>k$AYLByF2 zi%;vzH?fCsTC``;F0bENjTRaUfy%iM@9ugNFA)ie7*L1VAm4PDG}+i~IpOX~>~>Fc zCjkc5m9&l!ktt5j%vO}toQj3ni5>DUVq1^9FKujQZ646N;E2DTv^~xAI#~o*sMD$; zR}THMTT6oz2m!#btq~V43AY0->FKc>M10$+1&}-ABzmlBjm)*E`hamYxCzW%l}z~> z?{Mnfc9Kw{3?dE%SscC3U!DKSKNTLj#fPPTq<=7Q+XTj7^E)g)KOhC~4$V8urOzyx zw_>JnL~wXWcu>&nk&#Oms}?T7enE(eMhIt*j9QYmbY6PEr#6+W&{`U%S1)&>-U#w_i%@l?g{Cq%T>Joq>u&LPt(oJ}-SaDjJ!jTC%|E zmfHUh?O$h)oV@V)^qHZ-*bS`6UY@R6?Bdk&`GPcy_ZRb3Eynl7MXHud8FO3T4U6Wq zT+Eo&`u=QwO3V3-=`Ek6PieW3KDqUMHa)4u_^zKfvE_7HLdzLdZ0q|(>iCwEs;HI| zs>qg8bEGYGN?A+o+;J^+v!81Dc=nii2ivmMfkt{DI@=SXZnc0-c1So>zye9f9{()^v}1Fhy1xW+5gYCl6?RB=47A$ zzNz5-zDt4rzGKqhU$-j;{knak_b;zc7;tyng#LG5i{swe8r$#gYvVocY>DPHzZ%W? zd1Dm&rwx&;A4?*ccn_0V7a&`by-=39P_+V`ugYAJJ~Coy=F;Vpvs7v6<}M5oOP4Nh zedMsmr0pp)e#QAV9B6!H>W35%_6i1oP)j5iH|l(Y!gz-S~(!Z;tV}Qx@yl`q&sB zpKUSN_i@}`UXSDc`bNB$@$oV~X1|qB9B6#xjE`RH8+!~}AIIHEeB+~Od_>zG)#M?6 zyfsx|e0+_M@n3IG8)kf@jgR-e_ot39KI+Ct-uUPnL!d1bW`(wfhA~8pZ^Nuntzlyf zpJQ{dFv7yg7+S3%hJ{*t*cn6ceCov3kTiyz7t7~)vyTR;BTXKLMm zJcJ`{VPvr)49l*8KPpBL3<{pUPbGqT1@G^<&dT5~JCKIh`6Wp^sx z7hU(8>w|`BQdgWj`|`~-)BYZgN*c6x7FGFi=QCncmGgwQ<`}?+viK|ck_>i ze|laLe{&{%D${%Eu@{H2VupMv{CeX4^urtGA6q{1Y|%G!cDtPYCv(75;f3n-mx>ph z{T=<{jUQDXk^Z-X|AO%4S@TcbtGTSX9(&m5+YNE(J6SiMpZepOe~#9c{O`FBoj+MU ze~9qqt2gWZd*rOwny-JYY5w^28^>E#YTs)7AYe%y`uDQ@w;JAj?j8R2Z;uqh=E*UT zm5ShgpysXD!^n=t2PO%{8j?=g5qp-*`l3ENwZdAhbh z)p}`wAURo)?CPZ5JzQ7B#$C6Ioi=tfIz5c*FdJ5Pnl(BOf{6&hL<08Cz+1<)xoXAs z5%@Fy(mV8<2UM!JWv&jXFG`E9>#MR@#$KJ2R`9S`@W9U{)}ub`7qDO4`(R8w{@g25;47%(lP$S zSVV}r9^`)vb);1`EwP;t$rusAluMDN4gJ=H-W|2e*)JkwnV~sY$!nW4X|`8HtXYNz*-Nk z&q{q-JvS;6Y%Em&x`c+V(tKL1mX0Us{oVPv=8jk(o6!h%2eOD5_7z5)3v|fBi3ak0 zS-1=48enY(VV_XJ9QtCb%$j6kLWPd7=(DXBBq*vQA+y*Wmu%}5KN90sx~vW?g8Kso zIwYp}m6ir-trjdgu109|1_7@AQX~}huJ(;k9QWKTK5+E+Ef=?ywVXPTcCXbeeoWZC zaV4q7>dB;C(3kj6z#}h2)@&5v%EO#pib-F%AR`;&^<$S{By9G`r1VTx_QI9vt&qaP z#p&707pAo{>o(k}nXQ&_a|h;v-*V?RcBjkJS_XfzmU=zyxx$uM4%PflcmFYhhkK{y zG>whe2hN=msn-lCm^WYw?%kO&L3Sq|LZ4!o z4akldquNc9h$}5W0aqEO???ypjL#_C@-K)2VAG3)eMdq_*b5;e#uwT2qS9zIDw*zt zz39f?3VXS=ePKY@AH)6#l}x6(IMbaO3>WOx`WswbTYrn2@r$dgYgfo9Z0~=dSC@s8 zfG1Ak=_G=)&4tL)*nq{uwte1bT}<_uNlI^fTUAStbg|7boD@CH_=vQ=u(Z=Y0o^f= zWV+%GmZmmOS7S0_r#zX5`sZU(@i0TN)^8PC?pj=AEM#glcEW!CZB5go)i)LKI3L$<~9 z!!aM~qxr&kePb?C1xX9kZ!%!GUIsO841OQbwWwN1a>iXQj8&3-&zag{P2xayu%h5W zl|gG9n;4f~Hyko| z!Ahd%ll~1dM3~EAhVTVULoP@v;zGyE8-?5-e&aiF>#+*bH=ZUG3`k|Rnhpta#^IAM zqP{0n!-*@}Md6N;+t$!_w=+ds`vY2lwpflP6x&2obdw!{g0~K|Z7792eoA}Ajgc=1 zyFId5)?m+L7~1-BZ6SFUta0fNmywWS4O!Zp#81;9h6Xu@Q!eBw`okICPQt{l()A-C zRBec9N4h4Ou1#gPy~aGP;e*7z`F>L;RY7e2%u6Sleu`MA15apYTn+ zPu_YhCMPAsNr>pmWztJ}capS`dc0QIMNMr7f7(-!KDdWt?9X3So%)BZ`ibrpN>=z2Kx;gvy*4jB1U9 zV`z$DI7$AV3~8CU#X_mx?KediD4)1@WdnqIiXh^d+N`563MBX=n_8-m9&b6d;(Ciw z3NlIUW?qfJ3kKmhScrt;o~Q?Gk$eOZp8_$n;<)n`6Ka0T88p8|2frO~gMO)Yh3>xV z41PPvhJJgG3H^%w8g6mb_vEP!q>IS0xrOLSY(jDDUG`{g7i59V!lWcZ1E?J*apL6U zDO0DVOrOyw$670jLn4Q(%#c}3yusqNy0e+We<(8o-ByNHK!7czEac}ae#GJq+*l(MtTAV&IW#r^% zQnNApnvt=KRSVKb8cjq-rc6p*l%AG7a@xXqm}!hd7eO?%?+a|50NxtNP6FF@t1l|e z$r*EGvRuX1IkYj?anZu|IDtsmx;2E#A{&j>O>xpuu{`=XX$@^MGUDm>OK!6@!x+^r zVjKUGRrimhzG(G21GIxrcxA=iffZ`FiEFqq_?ocRJ1e#rj>zjDL!TeRb9Kqj7~Imp zk*nyMI@!-Y6fY%3UMEKW@K)gt6ad=2*`6@$(-d2pEbJ zH}~7AWf#rUc*jtT&GagPcB)gP8|{o)iCsiG9(~kx2iT(q@Buc3og+O#3ZNk)_yr8H zRFThxuN7&v?0Ig;C0Hqhh6+l#zD(t3{diZCd4Y|K*coGKlM2<4yCm}hlgD9z+~QY7 zh7w*G!#!HFM&Ygi?y<{4kD=#u^E~rhqjXHC9h>@a)4mLb$zWq#W4 z=^B6ZBiC~Ww3-OxkA{~Y%^gpZ1_sDe>iv-m175AYifFG?-$}WGa<9BttiJA{yR7lj z!awQD+|hmGhIzog9vjD>NDFMN+?~wv6+^2}6*mp6*pXOC(I}*^gnv)pHQ0m1@cM?; zlzast7av}SIMWRJ89p&Td*!Ksi+}N}U+5-qZ*M@)2DqNle5k%C+4J%sozhnru)BI& za>h7lC)E(Vy>ORzDOZea%A;H$67}WO= z8%#=kVtZ~fCM}k@8{F)XL*cDeC`=tS*L2B7WD+Yv6QM4WQ`hO#Jel^P+CHwTsxd{Q zR1Q|<#BiSzlFQ{}0rH7gYRwuAkmtIR3n?opXnfWe^CzUOhIU>?fM%$Z0_o#XEv4AJ;oJ+e!RwAiO0 z?JtQ%hBc*@uA|lPT{jm_hC+wk*jgyuDa=yC9!w@gr3J?s+<`cdy{t*di}N~r{N(xL zt3x=mUZZof>hzFDh-M#~9=i&_m;2FIy~f-_IUA`N%Ez}nNt(R>o+78qiLA{RfDf1Ws++&eTk9^j~F#;I2&1(%P-!4 z+ShkpSuy}lCuDL61zX{Z*=0jcWbdBBed>6oVyHo;*ay`{e(vshIyLGr8o*Rj$?zJW zc-KH*BRLq)4lLibTsVkBgE_;R;TUphOi6+-vJBQlFow}+%@uR`!%L4B)dnaEhUCF- zvb7Tf7yzZv0198GZ8@>LDKO?eze^=dSD*-dIZ2%6Uz?#%@fP_z&F9i?$iiXM2D@6MS_7 z{zYy18|4*?DW25)z^`WMc1|2~v3iNZdw)!D4g*PHzHyqX4=58Vao5!m&Tvp>F2tjrzEP7gp1{1GC&5*)Y;%3}8EqDIj*)rrV8=K*c z|N9kehPS2qt1B(OMHUMZ-jj`3j#rTe^(OgD5Em5^Hy&^}dl9WjO}HqPK*q8}OS;EJ z0Yn>X+N9Ka{8N1rm$d?;=Gs-?HnfBw_FxBC@&M?;Sdl_x68~Atj71j7EDKT`EH}}_ zKKDVwYVJB?q1T!lPTY~8>yN2H+4#nTQ-_u43_z;!I*ABN8}=po`btN(G{h;JWqj6; z!*%`zBl|=C-(BDaAFJ!)NV9{Bwkk{sHP&IF#KmzAMAXI@C*hilbfP!9o$-DY?tQ)O z_GPY#!K!Y=G;cz%j()T;o*>|G$P5xCG_5^7w-Ga<#H7~rY+g~cU$m*C>`+ly^}x6-a7pjs6-`_xYoTkT{FRIMXka1Bz%3zb1QBAAF7V ze*c}!`Ni^Np!%Nv9@iz0?#qx>{Te(JKDv%2YE-CR&v!nWNvg=yHgafH7noIEh+)fh zv2PgLt3j4KV~pD|MXoTX0a81v@O_$r5zqTI9`*9 zUEWX{`AAqv{lFWvn%D>=MJDvWJa7E?s=7%Wr<3!fOI9W@odcI1+nJePHX#z6V=2^y zZ|F<=yIoh!J4P|A9GqW!Bo|#dU^P>48?DV)d*#acqZd7CWEXUcn5N9h6fAXdG69J~2&E7qm6?+O>*`T_7qy+rRQT#%**y{x`eA(w_Y<) zpb>;ja8FRAs4HolR~d$_7x(y7&0BL)n@gkI$*-@uD?ryBBdLqjSW_BV$4ThtdJNJ< zth!iP4h_tw$~;I&umQ%DA#tucLeoBZ1(WAb2YAmfbo6UZ7`^DMqA&V zzsGGPdsARTC|8Ar5f=wKEM>7oWfQf55HoqFwknaaRP$hg4JN=zjyE0qB+Pe&kan(f zrm{#=c*tij9s8}+21J@*#>SAaz2;AnrR>z&TB#Q)6$W}8JO!T0XYGAP9qGlUoj{dc z%pwH!xqK!}LVOlM0t1+HF2;IO zBwp4{91|l|AKoQ*t~V2eGMx^J${zz4i1bj=@m!iz41^2%0jW@$#T8`~cQJtwWQU-_ z3iTnDkwZm<6|W9tmuM*8M|Kh1-M6-&J{XB*WbeonEL*qjzU_;V=JMvkqK=eYv18}1 z-EUUz*;~E;z`^$pytB{i|JB9>kRLc9Jc1ml3)b7ZzO^T_jF)X-Pa5cvGnhp zfw8dF3#3(8*k({cL9kj)iY9{(gbYP& zYKP6|^s#}H$Gf+*&b|;VYp?vfkK;$x!FLYhY1(p)T0|*;WHe+iQaS8x7&S!qr*whO z1>2zm=~?+K3bJ86yC~R^iiuXxCh}!HPAcx6d?6!78BO~OF_IL<4w8Jof;Km_#Iz9@ z`Es$HdEvBCFCD!w;l!pXH#L_yqa@u{&;-aAge+drem_Rultl56CAG3e#wc#3i}0?w zBZwa@`O>7(lj0;pTmuzsNT%KxSR_CrnJP`W0S<|wERxFW(e-(xlxmsIm2r8zPEnxR zPQ6t@-vWG?G6PKG?UlkWMGASo%ujNiYQPP-K(BtoJ>V@@IlKRwl%X218j;?u=hdpU zv<9%-xp+VcX&jITa8uaw1tH7M6qWUhDIjMT)hik=U4>~rvKK&>{P?vsFe2Tbl!+=&8HwLO*b|WcuuorwHWre2`l1LNC_fPMy-13IO+q2sDIQ}()&u>aiqKIO3%^y9sqZ==otl-Tu%#0tj{dZE$zR);M8q>4K{wm4fGmZRLfzij`Ngi z1X^`HS}hssIhJ3vErMhj&znt)uO;U8lNheqcw@?91wTz?Fapg>5w)0mfA|HlBBK}n+BDDYzZ zJs4jt6Wp7UID#D*aVEoon-D$qdkr_S(r|;$GaBssaH6%G9~jgL8wP0uQ-maDg)ACgURpy0a;uBW$B-e4Ufp~pFG`(-a1OR zzP;qm{a1oiU7HU@ll#NE9On{{DAVWgLYW0RX{jMwQPrpch8@z2f}AXAL%F;QSS7g6 z6>(vwWo78V&ZkT+3aLY;fz!0`KomY1M8zrj;(j~^u>6>sNlXAMupp= z;dN9ZwpJp9kYM_KSp<$S%8Jl|%yuWh*oJp(D@y0IZarT~pg6zSLvMHjC=v-7(=qdH z9Dn8A-_hG~WcBEhdw9hU7z*lKiNsf-U=>@C9;4hSxU5zNi#p`5oSh4QdNXb9fsehPE~D2CzW4_kDjsZJm5dkhe!#6t zh{{aRkWeEYnlv&pJ#Fc{^qImDLR1_QGD0|eWY@))SV-h33$j7_DK^7BV+ym+O_^B- zK%VM@4?Z}t9;+@UZekS^;-$21K;{)*|g1WBX}{pPAvO!R@w10Zwr3D zQ8@L2+Xd94=(?n-?)c>~Q)fT5xZ>ZxEPk(l)UvlW$%=|%FPwQd^VU!Ow-(1e+Ze=% z82-5%V{O5N5gChatY3F-_0C4}zLUwGlpj}aud1&(ShqLy-j%vBLaMfE;@j`1yzzSZ ztM9*({NnS8D_;2I%3njl?bAz?xpO|z4f+VuG|{h~`0S-)8&%w(^{;xkN z7ms-Z3iE9}={4H=j&F_SAYystT?Qtb{_qRFAc#$r}ltSpLk@`0E?Ca--tj9ag zLi(Hn6a|Sx2y3Su+7IJ_M(jlER{PPJKd^9e0^JYZ0ut5CMHFVW`iP1W+s1CK%4D1) ztsRVSeu!S+oz&9^Wu#eUZ)`pMk@SnzRdq)biuC4UKvOcZhFJbIJa4inC738_zoi zfO1#u7cSXSeI1RPyF;s9~q7!bDi=rYp8*?nZToRe`T@|Rm=9{I^pUHPw8?bzX zuV%eo#+&@5al!t)&O=COdnQe;AtI4YC@ZYQ~i)D4Ipzu}tD2VF!f zoj2C~3hI@h6NzGbG;2vrDw?uX>Ah{<))IaMO|MUr z3$@;Za=~*X=ac4L zKYsj05zm9cX$C;3hyqoYSJRyYUW{6GhK$8O;ev3x*c}$q=TtFv*b_H=a@h9u;IQv? z+dlIp3Rv+95X@tt^C)P$VL^xH1DB#%R+~02eg1-sg^O&~e3(oY9)NeYmak;;u*Jq| zr}foZaAUTdooyDn18E5eTLp4Y^#Sh|=uyb6ZV=CpT<3mCNzU%1q2&{n2#QG4g2F zZ^Hr>sxWuI+zNRhH&}N`(KxB`TH3LSJj$#AV`eA)uvs{yr2c#0n_fd&czRcIDO0wC z;sOb`j+#|7oHTZG;>xq$QdBB;RmmvxvKWnDWtB}WRONq3IT(v(WhDt!TIgAtD@k7l z08@%8fEKudFSW8{-yMfE+s5$%T~Kt?2GG{SioCK(CA5 z$=^9P)15Op=B5U0^c+adGPu*pE};OdEe=jTO_iP)j52gergP5Af#S1+U@g$!V!D^1 z04y%yyj7~zkY5Y92-mJHaI9$Evkk2|N2KoAF z53yVlRl8t4A6Ch*vt9xQ(SVCmQFV-xp;4)iKes=lS%u8v2<2)pBuTAau?ktZI+Rh) z+o5yKNjmML)gesP)~*_xo@fZ}8!r&+VuA@*@@8mW%fCl?w0srDZuxfzv*q7nx0bKR zd9^e?)vx92a8AqDq3o7xk=`xWWL_=Tp7LyI8spJ&J(|~YJ!)Xfb$S1mYf>(5A7cln z+A|HiL`0l>6r11um6o4?t8CuV)O0YuVt<;dZ;3GqbiVe_^FeA_LP+7kz3}sdsq^|>ePN1R9veM%>a>7YOV1pBr{>6aM@GF;wc`cm^RN6f=Ij6d_~RGs z!pK0+G%h8orCcXn|6PG>sU~>6;KoW)OZvzX8gf|k`nZ$D7imik<+74E(PqEra=)7T zmQ3`z{5JI|nK1LIpp28$muaWm2b@q|NelUT(Z;0j-p}$Lth(~ysizNYd4FTl^e^7e z@{LUt{@wVScK7hlbP1o|^9zhmrQ&u2xM69d`0wCkMwrdpJCB=BEHwp^7} zSI#K7Hl``3fqG=tX6M(RKlH(yhj;lucglV3^#ZqpGncIU?R(yHla`KOoX5Nqi57hQ zQ%z0q-fzEIeeCVuHbu!JKc%tnQZKyz>R)R=dvDiA7xMRB+cz)rWA@-1HRAqZ2c3O( zlpeZt?eDLAS&;&c>sR6b{r$i1{jlMm(v$n|YLBk@WSlnV_f@2c-~Q+HceOX~UQU@j zJ65%F;?2?6nQFql-VPxR#?2RY(Aho4{D?m-oiM+B`|q_B7R?Zjoj&!SmW-$$KR!0a zMS1Ve-9=U0;(O25?05C0dgeCyc+g&~ILMAP&heQ30uFeEF2Vf^u!H>TS;7pn0rNBq z76+f-RmN`lH$Z?%`%kkoUs`E(fH{xRJ&i#$U3Qii)?Qro!1QD41PN$$AoJntHa_2o zQg$eHI?`oNFZsb2+`Y?#8THaRU&dFhY&A^?kONg!7p4gzMA>YN#a_8EEj?nw^!RrA zx~E}FyvR4Bt{q`ZENqFGSVP^=k0hgKf^neQYH_W`Su1u z2lCxUKbkFlHj0Y)_p4m9xV1){x-ZN-pEUMfad%-`oVA$*^mSmj3#daY^!WO@kiHiV z*s`t9;WyUWDtF%^wi>z^$Soq$^BiG7|y2S#D3okWyC?mO$J5g_>v>~yN!Nkd-SUbL_hWZ zy4|+L+Lk6Mt;w!c1%E$-o9_pNuw`3DIk^g(+oL<#IxlbBQr*-_o%T*8d+qv-Z*G2j z>$~sG3Rz0}5E5k9cT?{UkVAO=iiJd>nkN6w1cFIP2! zC>m2w;RC;^Z`Cc2S%XXmSyKL;?=~GbaG9@i&^oV)60SZQ|bb3YB*lO)NJvg$s}&-js1oxzJeq0)>;4^e3m^q4rdXg7eCQ8(=@ zr&oIx7Oq-PFE08sFrrcv10oNw&}3KU#)Rj;iTM=J_66@5G(7cPr&GzPYEA)pOU;|K ziRkq!Ls!4%S-UHdw@k6!byO~g3HZ|sN`_Kt@h(qkD-TyI?p78j59MVJ^*9(dk-R0E5GH`h;GhNMK!0P{ZYU3k9yL#r(wU zu#&&uIpb8ITyIcw(2!qd^C0V)H-cuQC$hPQElLhQgJ2lT$s^Vs2p4SqlXHrj&@=S5GO4v z3olW!YS~+J-rPA+awUp`DrkVN0AJ9L`$0kK=}q|!!RcV)&5^Sg*n6gZbZUgH9MGNqt=JHoVeBiA_{tgF`j; zR3Z^XTvKO;b{fZ`_E+2+M;rWZ=HIV46--JFX?as>;aO6z4)eg1L4?|&1F?d1#UdiZ zz@jj*4gP5&hZKV7;pNtb>v({bI7JBz$YfKJ27uaXZj14Zt+)i+piJZ6CaoaodPu(0|GxJX{nam`ObHIwX3X23zQM)fG3!Ik> zI=3NG?mh9PNfSp5_l-Wi_pLpkFo))Ob*vYSwmGIGP`z%KNTQo2-c+eLR1xvan<>9i z)zh7$M$D>C^r9%&C6{0NLasx!Kg_DV_WRYX$k3 z_a}VvP0__ypI9^Ij~npuiHMB?^j7VeQr|>4;fBwX_!4f z4^%lJ{;x^UgmQSpsR?S$Lh6Ca{vI3_9SY}c%~bG*MbVe-xm@aA5dZX`b-OeHiEfGB z0c0t(Y=-~oclHDf-~YS(%Qp|eH&gkjX5gaK-EjTUQqHi#b#L#x#fRpQclJYyzi;xU zC*PuZ?q~77JX$?}-N^ZyHtyj#$(PTcEQUW^=Jr{>O9OvSjT2XHnD8ZXMdRN<-}$<- zcH{J2q0HD9Ru=jVY5CKD=Rc4hjBL3$$0;Tj@}C~ZgHMJGb(-h)NJ#(C2=ubFkuH-LV@@6&=azY30TJ^dS}j$efqzjm2^JiQX0#rut0cX#L3wO7{c zoq<+t`4!#=2{y!BTkNHXd_N!^``Ky1e7bbo^D4=jgC#!fZ%gAux?!v5hHqPw7hJ81 z;{)GD_wNfY&Y8NQIw5I|8d{QeSRxgS-_}3l zuCF}Cd3zjJu5(Tf8VU+Shp;^2UtCO|>tB-m-s&z23_B!i!*nOQr&sMFGxvqINs6Hsruf)y#2DiP- zkm25-9a{5&f*6DdL_W;-Z(nf{Jv;=2J`UlE3D7?{V)mf&&^?_ixq;zM&V5w z9eb^GyI0piGL3l`Yc&er!SEBTs~$=l`-F>P4XOxrxm>-A1|pOZh4}_eZXR_DECO<- zo++i5fHFSX#rRuTpHuc>;WkV=3ms^)t>Ns1)7W(altFhS5yr&d2cz31cNQ~YFiC8! zJncZG9y!F*ib^3QNm^T5hyAk^m14Cnlz%ehI2`Wjlh*at8zF%qk z(-bNWA{#q!1+355t9q+N60{e*6@mJ z7gMQWcJN?0#}c8q4I*wOX3^4OnEAfH#?iJ{R{k>y8DM@U1>Qjq3V04LT8#UL8wA=DQq@;Z|p`oSC&s=_M=mnXV7pz z67tbe8dXEnQS!l>#IUL^Xuh!CWWb08wS@RG0>>I=+k@KPHO$uggUl<9#AR(%xGjUV zIHDZO0I4M~B48Q>Cghv}$4= zt76#wq}lVhsfJti^SD()URi1vQk+(|i>0ZHT*izUDPNeqLXo~aV(H?nrAyM6WTTRi z5lb_dE}xvGN=wI~?X8kDF)5COIBV~i5Vo;#paZ-K;Z72}c2tAf#%4drsNYhGBa)ee zn4NdInmUK>6JA?5KRhW8J=hHNFxC`ocOG`(t%uNk+|>ls*mTK#!DhEfaeU@Y_arfd z{x|e$XU4KGc(h6>Cd83rLY(77Q{8RFN<8xLXcN~tiPFt3*?74&uikis;<^f@GLK9F|KhkHS~zPa4HW;z zD=inR5H~EQBS3IeGK71+~lsdev`ny`ZREZ6Dq@R&wZ#_J#&iI%XYuC!x|KraYpNzv2HV;bAN`vg%F z3F-)df>%|{{Cwn`(D0(?>PRh(v0DAQJY%0vgWR3Lj@XwVtm}eol=QiFKqRz*Z47r5 z-b6#%rF}eDMIfZft>eMiQ*NAXfnbW!d#(LNMaV{ij$#@~gQzkS(qxp8VkNA~L^yU? z#o~o@Ux8x~OcR)m2jAb2#p9cgG`FirZ9jw_x{NfgTtKR4I4?M9fJ&TWQwMrz?nn^c zr~uGtAZdb-AsRjK1AH1XYS=d^%d>BlYk4f~81Tl)NFW)iPT+&QZ_Z3Tr34d;Bx_0w zBGljkILfOlex67b3vH4+DOS?HA~uv+=LSYHF_O<5V|THSuv5lkUKZ>k7YrnLQ;ak#kEFbaGFnp z{{g!@}EOFJ;Y%jafrmH`6aChZ&N`oZ7#C zFo2Z<)yc2v_`^NFn?0z%`j5$4W&`7g@*p=FP)?22uoUkXl{K!ZEiMwCx&`^h7>1Hd z{H|r|=HjdRBzCASa43+6D-Jtqh`JGEDGrOK^dsYu9}+tl=bn~q#F-t(=pxbM-BhvR zjV{_!u~~V)SXOMTL=&t+5Ol;rNloSt&Ap_#@8rBjB8{8fp013!syDa~OJtV-u-kL@ z2Za%d?@LAZG{b`nn>&rhS@3%V-P6S zx)X+3$FkX?Vr+bd#p7Es2tBHMntO32TIX2qyr`JWYwf-|Tomo-7axA9R&@n1)O@{u zW6fQZuN)SY57_K+YjfEwVbp4%0J=e3buNQ_?ijfaeX+mJZ(bL|FbPow2Da|gh^yM> z3oarw;TI$%?({4+%iJ-A%d397%W#dmus5^pa@exJ_B|KBIdJ-+%+L028a9ojsowPA z`_pm|#i9LAC!M-|^_QE&r+?%f=(6#0aP^Ac=!FRrPLKHMr=PY3ExY&kbMdbp+d2K< zZwWuXxMRn1C+EGxK6o?Xji49q?c1eXs1J01bDd_(j=32xPE4HeOxkA~16FvRn{zPx zJEyAol&PUFN30mqQl>jtv3d8&lW%yf_%?9PL0ZL@5>32x))#fd(LkT~cOF_OPy1w} z*9y;1R%OgzaPwwq@#o^@u8e}%kxxIpc**VU;Z%TZ>|6VzM_sH*` z-`w-hnObj#B@%ZDuRU_9vXxAw3TvO4kp=tcGETk}`4gp36D!N*FoS7;6F7Il8lmut zqKmavT-b@*UL5740*m&$-tFLSKZ~>Kwg}_3;n31H`OVGsBDQX?UlpWo@jP9ZC>-R z6HLJjZ;b`2*-8qFVAkLj+jfM8k;-niJDNLzDUg{)t`!*V9Lq#y>^Kd=1Nwt%+Z%+= z)pmTda$g=4K?OT$00xZ}hTEYuCZE%97M0>%L^>u{%VIdFR7MI40vQ=fsrn6OBNVv< z9W#tJt_xDf4!ugBlRAelOus$ElGK@Vk_+KM1>ttE_C39?AmaOU%qkJg<7(x;m(PTu z_m=H@`C6EFrV+L`K_Oob^@_s1KRd`c>q?7|8aP-SWP{Qu*v!VuQEYWvY`M4T5=5ZH z`h3QGH4)=jY5R+gP^eC=hcFG(CBQI*mUF_p6S{UAR>j16dLh3YU0oC_VoP2C_>4Knyy>EIIA0Bd|NJ~~i1>Pf8 zD6US@x_k5I&Gp|RpBLwSB;mvCsz0Q3iJ;uGT;%iB?{!JnPiFiRBxs7e7xUW(&v;Y( zv)AVSc4;h_awh5Wk~^!z+}V59F-eky!}&E;mQw327_(wAR z9LtrH9kg!Dl(6ZiSa5CX3~g>jNy_4Nk*+>l_yY#qO!rSWsqpI@-=q^q;%2QF5>x+axx&F8i>j6!B5T#QqJr&CIPdNtNpww)7$`V|CKl2*Eo58r0EGxG@Dmpu22 ze_lhjRG#8KzcS}#MWvK11wm)d|EI?LbS(3SnWI(0ttH3HcGhni!B3j<^BcQhhK4f( zgq-|&+g|=4pJ^8+3w`#j_q{YFA*p=ah#+b}+zj8`at?V*MED2OMjw7n^u>|6#{^Ae z{+_{ymh9jw-d_DL<(S`wy6-QF)g^9%j^2nV-@x87aP&KoS>v6*efs8SN7kG>@zR`M z`c(;N{gRGPD7@$|p1vDaeE(YgZqk-PtZn>v-bw2h8S5M6Bkg}$`tJenB;55W8Wd1} zwBTm6?mru*0F@{_z8L;nZe@)Y|We`zYSCr(Aq@`i!di~EdCRFSPErPltJN@|NbEw?diJF>;w-{Cr_ zySc?5;PK#6wycx=4cBDz6C2M`{JrAie<_yMp_%#u^2F7)#B|GRuOeeR}N ze_5;G%nxe^-f*;yb2zd3+?U+if(20q>4oJRT4LCWbFJjdN=$;dbL{Gc1~s|b-_3FB zT|na_N$s+TJJ}qYbjFSHjWtxNprF~XX_d$EP$z$Y0L^TsC_fHedrYgw>*w`9_@2JQ z4l(k*jM|B-EuzA)c&P$q*$YN~bJly6dUvEL>8|cg7pkkzi2G)qZ#4vS_^@g=L4L5! zw8>k9Y0hOGIOmJnG0SB7nsl|_$_rW}7yvLcCeAI2FvI?uX)7nC!)&)whF!z;KmDDG zH<$f9CxprC@y_Gt(I{6U+$G=H+qLCxm&rVx+a`P`TAtu! zoR%K>{0}R9IqF&QUmQK_b~f?i_o|zV$+xnR*&>~Dh=FVCM6Jv<16v79Nb6-=m*Wqh zk1xen_Nykl`EhcP22f4qt>4|K)3HKiuZyrOffA$qxYNm0UL$ltB9{c&E2XKjasK^9 zdS0_q9vB_I!^k~{4cTbRI#KvrKCkRb>DRcR~prTdg1cQ_L~~}d<1@Q2piLlxPNuwS?@Ed zwod*xUCI*V%D?Z~j6%ung5|kTT0Q+LpZVvh?!Nk5r(W2t%KA$5wB0K&$$b_&u+?ZVt{Tp+cUWaC#tdyQ<9TQu?M^c(|u3qeHj@i~9subhG|L*sKg0pd< zX$9TPoK|j5>`7}*!+oLwL!;oQZKc$+;5<%xkki_OSHksGe@G~fl_Ei7<}DYwbuzC*c*^r|JIpVHE9EpVKtkz3HE zzW0t(gWP=iRf*V>p_Luy9F*j`bmv7H@beEN&F52@4wk%_@08>WT`I9NHvVXjFXFmS zt6aacrt-EUH7ztPnO1@16N5Vkj`7YG1m4_a;2uPaj;!6dLsbzVk@gl`v)#0-Sf%P- z=a-m8D*o$lL!Vt*v|eb(-N_l~f8griXiVWVyOg_pvKpZ?^Q@CnyJBs#TLZL;y=GVS zDC3IRe@*{}Mq2Rm5|>g^4wD(qC1aQJNSfU{vt9ikuMqkDlo+YJ__oPRltwd77Ulhr zM$L=N`x%}W#TCX;W*0tE`f;`<|8(x}zP`SD*FCHC$ka5OVSl{g#d! z$PFz!duHmSthOLP`cOx?6VOWxSU<5F>|AFtU~R<2C|C?4VLoku$#iKt*O*V#h}n95y^^#yzd-K_;VcS8vw;tA939r7TD`62T45r0 zB*UYx6r}1HCGwbQ4+&70S@svquGADs2ljb-Q{j<&cIf+Bd2PV&{mwS!q^q-$`DNyu zybbb$=gr{QrM}@Vz(pZP6l&VYA^jX{C5N!ld6d8Tfz^PWyi$2q8q?#?u-40(Hsrc5 zP(2Mo0j~<5zv+;)qc-Hy(O{;Bg?hjoQO6D)!-BIXwxl9S%M6NY<(xEZlcw#zVvFmw zc3PBm64e9mt<)jy)xwIX-=TrlIK%^$7MD5RVRK@HE%c;EvqiV}ODTygzgqdHY%!Zl zh47f+vQW)?8QeA7Ju_5oODuxwW&G-H1m1K^Nj|jwS1&Xbg6`&bSlzf{TVZHdCU>wR zs-eYwL!kq@qB77+hAMKfwai=^Y;1Q|R2AQAofv}U)hjD(Sy0azK*60Vmet=~%3GS@ zX;qBjw6<>7ijU>8TbFn2R^lyns7**@2{V;d%v|f4Wz@Z)tdr|BB6rkU<4sf|92}#g z=B-F)Xw{}4iZjIhut_J~TeOqgAB)DRRJG=4*1nPjXU87;1%2DbRbzfIR!cE8Y)w~sV4-y2jWA3;^h`J_AzPc~q;+EDsq;^Y z@*?xwv=k#9jThhcPHUEHj5x0)7YlD(-e%=c5Tr3j@W_c$V5wr{e@*`&kNN2Gac&_z zGTA)cDcnvA=V$Fs;_lH3SYyn&yCG{P@c8Nj8tfwb5ytl>+k@NyW0Lp=kQ3<#$&8!& z-W=kb=_iv#6!Jj>pRi2|o;&^~DQT#e=CQvR?3f#wtf1HE0HktL@A@I5%}Hz5Xtp%w z)ECIhw%^==?Zv0=!0bTE=(B!UqEG_cNla_On!lJwEyyZOZ_htM(dH@Oe>_y_NshA9 zsCmR`mvg_RZXyj2+v?UCw}aGY#Lf@4QTP#)dP35&(na*Ohf#3bwLF0 ztej0SwGYmTr|!4O6;RB3Hnpeb!sR(|enywET!?K0ju@==(NZ zQ-urm|$g5 zy)5?dg5}ZA?Wh{JX!Er1DEN1sfmkc&yPcDx_OA+#A*Sg*4^3h&5(yOf3hsf&WQb`A z3O^$s5r346j?uB;+brow{{p%1yR_Mbx3B$Hti-g?H{P+!O7-ytQjEn00@Wn7uJcQC zKOIZ|jDW6th8A|la zkD;N+PoqI%zLIvq#``uY$SWZm!_KAPGC8%PY(AhF&JUoU{;|W?Z;qb6J4g99LW~=o z$4ohwjcwjOmvO?{BFxIWT&iW}DJYHOj^FNh(vs$5BfY9I9_Hkiw@2xCYju-@UTezW z1#`Pbh^J#hegmUIHYLlU*GtAtQ1_kHYM^WV9(sMT;Npowc@vF@XXpHH)YdLQ<`L82 z-J0wc3;bU9747;8KCYe7ieB8^2SXD%bN3yk1;(C;ajEKO{>LJfO4q!7 zO`TOv&Zse+=?4ov^emOQG=>v-C_Bimc!tRqgAB(f8H{Rj$sMIrf@PeKm_ED?h43FbCCV;_A-$w(?^$GCv4<$(?WHyi- zIvFP;d2|2=dAJ`78Q3oa4D3e%PY)|Vo|el)9+$~M9(^wZ{C;#A^l1ei^7IH6@&x?8 zSfuEEG?5?w(e4)_fd~80z;F97;0F$TL=^DwAO`#Z9}Rr$p~rh%h5??GVj)A1E%wnQ zm4uC-h=28H5)l$ck|TQK-nGHYb7TguFk}a>=*tgYF~$#G13z~efuD^P2CvOk9P9!= z|7tdE@Yi|M2Y>xiX|Tt9+F4Uv2rNLf~ir7c}k3I4EzEHhk+Md3O;m6jb747BvKkw^MDs>NPYlb@-IJOKxhaG z{t;;@DQQ_5lne$V3tq#&K~8S?x5y8Dl9Q902y6qb)2H?qz^3{a4DT6!CQr0+AYX5FCR0;5f$#g+$_{2cyuLhhP-z z8x^X5lvNxMID)ik!{C@=N8&OM0uJ8B&@(!`KLT|!-wz=*AJeBGI zGlgQwC{1OBUajf29KJGESX2gO+hw|u6lRbXMPl=<;ha7r@7OAX;D^)9ti7w!Za~T{ zSvlA^_a05nW?va~L?j8B4@9X%k~D$HjCz;~#~_5^gb(huu}?mi-tS>At&z!&?6u=M z-PjVLjN!S&hmsERYzy*8yVNPJDkje?os*-&-FmC2{UoR54Vs#W7L3~71at7;^fImc zJ7k$xthAgJ&IKmAujs%`H%0nZS1G5|+hrlcwX5t*oCqw-D>@=hBL6C@N|~v*Hx^ll zcdR0y?JTEa|x)@AOtqRJ9t(GFpaE(hZ3BDZoW$y(Tz&H=SHT$jMQ>Edmp;S z2en2q7h!kCTA*j;<%VU%2Y1JD%}Lx~N;rT*YSwEjQE>T==zAXi$s}CoB}`8sj1SA5 zj*^>e3WtZMF@jDQ0NA*o>k#c52mH22qye}Zp_yvzS5%%(pi(Frn*6W_e{!{z`(YE3 zBQik!w&1&mQ2$YqXq$uFf5aXdA5xAZQJG_GJP8M=anJXeA)4sW z8o!zz21ulr9dm92Pm9+l)xo?vL>_^h_lQsKcm^NF8ahqDQw4<{CzloyQL^RJ zFF+aEY-{g0a%6xn81K5}f8UX@xVoCD1oMOf;Hc;#=wb@4WCNe0gh$qq+$YfCn0`?#2kp8u`-91i4H8>;63+r-pc)KUY}csFt3Ld~xo& zeu+Ng7arqa;2Nq8_Hf>IoR>RbbX%~8c(3qC&$NvzLKmf+@=~_kqdBYHp0?i2L#}P6 zGW6N(2=-ztj%TY|L%I%6P!MmkN3~-y4hU7MzUMmNiM3SJ0yJCK{3)ZA%@5YhBguu| z<_1{B=d=5Ra(|Y=a_=omn7Mv=1h1#>V5s9PAUqqKf|X{3ECHY~ZyKn+m^4K}It4i+PFFhwSc=lcvkXQWc=^PNN&( z!s*(Ug2lL+<-1%hv+~mAX5UCDqc9juzT;juVs*Y}Y~IEQG>x;f%8Z;g+i$ zH!G;27v$-lW|Zh}U1O+RQr^x_OU~=yRUC9!8S8plVTqMpkWbMDCrTW^L+CgaAKCAI z&dv37^gYUAT(whJ3Bf@DZ4t6NmuR^7FJb76iujD~GlcM>pZTJl4J<_C$&3C5md~;G zcOM0RaIs{~BI!toC(^@iX6%f>LiDslmVJ!K6_H=XnOJ!nLNk^tlaU(K5K`Jem&|JR z-lU{?*%!Cf7#;FDRL1u9_JUa!QCh&A-}jvS6s%{Y%mN;FoLCs1g=7hGyq|A(?)ih98VsC&b?TLba;L@m20TBwROs~ovKi4{vRf*M5kUabh^J=kEIiVwd~ zRK;+!ZDT&y5BuVmR6TXYCp_;N@N4i`n*?TY)1b}@McnBXte zaQjdL@)6NbQq(Do^=xu1ZEt-2uMCT@u(Owxu*xf><<=W6ExRlERsoEu8e$o z4#*Z=_1|3%w{_e`Ja2F!Hjhp)3tx12`&_fRI#2GUMS^Y(t@{?pOh2`bcuDjA9Q&Cm zDoS@$gI6K@lfTiEDrmb=#8@8N5WnfdZcp#$1q0nhvqQ8Ahn+&zkLDPAxDXHNrx1Gs z?|Uz-KZ7tT*a_r1!U^y!NM{8gIEKM4{qb3T&C)9!1wFg_BDjYRE-6yr&jaRaWM{PB zq@dCZEHRrdtA?IeL3wPnO=M+Pb_l7&&V-ph8_wHBKa8zZSK@ThckZ;yk(1kQj^`oP zZ%SQdAY8Xg*{)$-mS#t*UG#TONQzt&4Irj+Wxro#Tz`SxhY%t+q|bM#pYPbJ8?^-! zSl@nR#u?0JVc|N29DIdF^uFaFJ*nbTSnqi_g2vyr3jsOexQm#>;is{9dgYo|$}~AC z@~GTp{iM>n}lP&AM3;Q>E)%99pR zTA9@xepfnCdtHGMTCf5_3u&+`5Gky4BjCLjcQm-;;D=WEYX*fUE#LA0dy^fyt6N{c zY(~@4-hwh*LEw53W178!I(kFMohFMc!7tYlsN4B+C((te1JT7_$BPz2+Kpd?FMfd$ zAxTdLM0}-4d$~||4Nq%i4F53Vy#Cf0L=AiYB9=N`#)?XQaSpNHJ6(?ZU5S3#w0l=;bI-ufKrg7WfA_TFkk zAIw_UtEb5w;hMe*Hn%P<2;Jrwpa`vBJIC9AyH3fqIZ`Bjwd1^9uB=Ou|#U z)nW009r_uDRdd4+&qcb~%(rv4gKo*RYOgryYhJM^8UfD=ZF4>Z5`QXnP57bw@Evd9%KdSyw8{A8VHtk|qy zHY6$+Mt;Q!wB#PsqDBlR=epazZa_pWd>n?V z%EVjf+gfph?9CU)zHm5f%sAmFpi*Pl3!L;U!mE-Nr*z}B@}f?5d6^?Ae?@L=4@nlO zC||RiW&UgcO-+4BxLMel%HNwkz1d?rHNFSiL{qj#u9njLfy$=lrOw0ICoqh%+cNyq z$Tx~Y=%=^z9=Dxd=n$>BtKt?Ict6F3}6m35TUe7DNjq4o)=|sUcq{| zUCc%wq2LkJo!%CIO1R&YTHbAExdl_R2Ij@0q>s{53?sj9>+SSDmJjvs<`)WkbZ6H}e1_GdH*=K^< zJX@->(bK5Ssi!sfDgd{1`8(wIVwb2C!`hv=oc1NA=k2G*_^hUA!Vg`QnZ;5!uv_VH zXMXyC9w>vlnWLc<)|BlUV-6kbRJig~)9 z`9&2+|9MU`>yU+%8vkDkZWU%Z_RsQSMwXoxSOyeW`D#fiy0PnZG~_J{%fzZhM4eR>fFh2!uq5uuTO?B6{f!NMk+fRbsz5}s>W z8*PE%qaV3f8JWrF<;F)UVXYA{;VP(Kid^y{AaE>M88fZ$c&B@a2K)(9L12eRDWh1? zM4EI;SzeHMe@_N|3UdYT7xc!Hupk&`Iq?}$l>||R15-7NdTS;M3b7lt?1hkr5Slj; zRWX3-7^pEZqFUCo>A!kfzjMN90?j=DfxzdEN$$Zr#!X?s@zZPWZM)e3z(mqlY1cXc z5C$O!g+n2q`KyyKx4u&VsL)7Z9t9^JTV>Ec=opP8XSlJ6^)VkiQ@9qmVORggLnydBO{IS|7m2HtywW{jbJW5n^zy*F_32g*SIJ^y@=5yu?n z0R+SnT?4Vgy2~d}9?~PN0UUHWuz4$;5k_|=_KLR?VbI@4#AOu_80r(E`<`dBvE)XM zpEv7C8q6PTv))_5Jf1onGJhMP4kh$)ocL`1D3Jk@Bp^*9#auR)f57a6BSVK7+R=M{ z&vN3U-13_O8JmGyLlst9>me*tyVip*XHZv7vuF@+AHtwZDpe#I8cyEgO;4gJS3Slg z6b$3Mx4E%_DR&jaN!ZA8opl)*i`})uGYfwk+%_9&v*+2FO&fh<1jp9=`o}dBIfbmB z&6jMouH92Qj~pGE*>t*CSUn_TUjFn^|3l|CUcAwYjI5_@Q*=^> zIrFntMdYpJM=uo%W}E&D&i{@|ef&4*{V4V=nSwr4jFd?-b*$u(GHw_goOl2B(H_{ru+2{g^O?%RLDfU6fY>3)-`*R^L>DfQILLT|Dy9R6Zx0Fr*a!5Hl)O(L8oyHgPFt$KKsT0eB zV`*j0<=MRZ@c$@lH(uYW3xm9cBuu6C_~-%&TYgSXl~PW(OsRu{D@_)H1+WmYNIHW) z1)bviCNF)-#qHyCirm;OUtZvK&qFRe)(7*#KOd^hMsw58^Hf=4bJK?ua7m=!n#{)U zajE$;X82Cb@Ks-e0Hh@03Eq*L-mSvKd%Q|qLo&?CqVAtU2{qi8yq24A__14_>>ZD3 z&BjIzK6-Al=+0#tdQ^dUjv0(KK~nnU^q%n~(1g#DOGzt=Q8WP|Nz|fV;q_uFinq`N z0AV{SUj(5+9DZ~s_GDw=lSS>D(BP;w=@=t9GHo-a_LhX4_#|k8okKF4#XP+oViB7d z35{e30KHiX82SWM9b*bq-TPJ*dXl$9uT>Q1pjvR(=!U)S?imxyjACj+-Y&^?^p}W9ijgPLYuJZ=Z(9J*CbT}|kCKM+s1{IRif8iM zYk$XS0f($O$s=(wdMLjyk=OHIWkK(z4%>7ikP^4J1=yL2VF?u7VKeRF$?9W9Vk)CbSG@ z3|^1m%x7a9{78jys+j&SCOEkzCBVdlyO`EOqO;q8F7eU*T5Dmp=KFI&%EF&bZt))m z&;~2A=fLwHzQ(D9T$hUx+i3g)oYEvblwW_!@#FELh9S$`QCv2=MB#6-&-V{-Mv^yD z<2cLDxU3|&EF3^iF=xMx@Qmk-AULr4dPTvE=4^3|l%(a?2dTaW#uDIA9|eIxS)+?T zLCHC53OG#0QH<^lqDWh8)xOd#E4`~#$sk>oje z9IZ0Mco$Fy2irt!`uvrcYEoHW9rj^r)N}VTuewTi1~yuFJ)&*_fnA$xFg|Z>O*d2) zo42OGCy6%y|(nDK90{!Z)$ac`U66!6IRlPH)>Ld&E_|Gb=5!ghbOM<7h`yn%rJUBgGp zh}d|1?+hky+-Uax*Pb_T=o7)G!M#!&kKXe8wl!1iYR2Tz;HOn`9asp zfB02IFH!n&!%e`yo>+J@+L7Q|Qb;j|3ovJLnS-rpzz~82;8=yM34{1UBJ>i~StgSx zwDiVxz@LNook2W$WD~^%@nlAP-#)Tm+b0i-0LUX9*N6z<-*o;B2l49*hhg9l1n%WR z`TvO{+or0D1-LLt30S0!`Eon&B6N3s1Za%MT%K&nA}Xt?kPKF1oh-Z{(_n%G1iB&P z360pmN_|3=?m3gw+R9pZ2TCCGV`ULoax~E$*BwZ&=S?t=p!Y#heTl{o4D{%dLqv?v zOSUBD=-#zt3&ge&asFy3Y5JCE}3%_VXPV zE?(-qd}RV)9|lUFk-B3Ozr!sEj=_?~Pa{*k`56;X3ZSa#*&L3NNS{^5+nZX^FQP5axlttu&y=mHT`|m;+(Q}KQW09<_v9YxE^9d`- z&Pg&n3gTYiUBPdL^(usWJZngUMv9T0AIhT4%tilEhw8MA27>yByV8z7y!bpPUkK}y zo_%Fk4db%vem7-TO=&4Z!QuF>eP)!R7{^nQ^!x6y?d5U0=!%qTYVVqkKTI)u(<}m9 zRPg^ffi~$;+rNRpUY#!zXj+7=-I<{2(C+Oe`pQM#v{9-h-I}oBOkCnN=J(k`13~GW zKZ?2Wb6cO~^u;baL$R>(b!ZN@VeY}t>X+?o`@<^}dvB)G0uycKfjE@D)=u;s)vWZ5 zq=L?w>xtf8aaZty5;&E|YxLbpd(avaOXb;~{=y*OQHZ6g%SK#;xlHwGqgsxy9!IO2 z4*-R@KC2ZiT&uas7m3t)@>iDP*o>>$ikXf#^*w$m(^D<>r?wae)ApXB$#{L`V;t|V z8tdASTfuO;M|>RJM`bkG&86LzA8b{nP&~Idk@ma#>^7n%_o*S{0?) zWv5YUlXq)o=!R6D*I^vYNz1Ln9X)ulwP#n9y|dz}@2ECh6_+lB5>6VSGt{X$JkhM) zJ$mW0IP6Mh?;)%DBPm*0b7`y6)7R%)WXxKb5}=zCyhMFNT5RCW(_Z02-z~B_xaCW( zGYe_7JfWYSGFzdis(Y_Oz6G#o!}op#0yfe>8 zCa_U#8)d5DIpQw_H#s`enS3Q%QA$H?_73h0;LdvG(A=B!4S2zh z?(mIkBh!xG#8XaY4&1a)@NdB-&6ZJ^u3nnP(Ow~=xS{G=h?7eH>2n1F&>61xBzOCa zu#BQQybl|8F#+=Tqm4Ygui2y8h3Mts4@uBWtL92qkqxol?3y(Z-QA8RggfHS+9rD9 zoL3YxQCdkbrNa-rD3Odc*ECrnDG1rjw9MsNalbCkpv29EkZm0MHaB0R3bt?f;T(Bg zgsa}FHk+L@Cf88Ar8STw~F$s>s~N zBwgVQxd-7-%V~LL557&aCU`aXB!s(cNZ6r@;K}6kb#i!2NPbJFL8yv_8hVA?(VMe% z4D{3VjxL%l2f#@!vAlQ%1&eFE4hA_up8cy%fXe%E?vdBnKIXAJ+&B zK9d}ikze$<&|nUFU#=A=B}{OffIFJ4a_%PQ_D!o8!c)gqYkmrMeO@L{8n#Ih7%NN&k45>!EXXA<^=u<+@QR%@#MF6v7R+^r>z zi9Rr^*wv2~k_5={0R?W?mao*^EbucGZun{hnZgrX55y5Irmb+uj_Igf&Z)7W_yKQMqKXf*vRBh%IlUoUEPWwZ^%z0#I?c6*G^oW|uluI z*3KAbJnu9)J;XSg`5R2W@t7~ichoLjKnmeTY*K;Q9Xy{I|@sXPPV3Yyd;|Os$H~(dR$kd)pY;aA%+@RrN8X( z)UJW=^n^MxZatf!a(}%}gVk5l&1yCB?Bdr_Di(PFVL>eT9xRlEvD!XAQM15LM}0y1 zEDNr$h0w*}%o$H0IsAG4gMIp})UU6_N5`1MrI>|*%lyphSERaRv2wF#eY3nNqu6>* zBfcoc?@X#|R71LPa-e4nQK)^jg3*qA-X3mR90;=U3n)i)C84leiw(h02K=Nc0#m2q`SJ1<(!1os`bF3@7^vX7-Mr!sPOeWA$f>G2V5%P_(V$VuNvH}snE9_h)?t1eShPMg|?=5(I%6#8WO(@$5e-%*ej1-fmn zz46c^tNU>-F_VY+7PP;tw$!CI#-e(QjfKI|PF*n}c}4yn=tJc-$a|vfl-rkOp@HRz7M9lJ ziw-6ito8I6IWe>L`sL?UJ%Rx)4OV9>yAcV~M0#>ur6}TBp1yL|p{QLD{LJlXHn)wO zH}eEF-cJ4cYpug=iQao|?kLZ-M25@lU-g%{6~W0m@6>MIiOl07!LIf59P*)o(hb`# z2DtPTK#5OX5*`(?!mFOnBbWambn%fODmKwI)WF>aH~n|%%f`G$q1Uab%U7OjXaWIquiiumm< zq^JV8eKJig=$Mx9;kiChJ#jySP$O=dR#* zqcB7yPf55QGk8G_p@9Tx~qK`!lLV5&%K_348a=x4R_wt8`+ zG%5n^HNWn~-gb@t$;c*JPZ$#yU{GA`o!sAm%sHi9QC6+NoMG0l+5|M{CeBGNxO@iL zTg2Cg{~mP41` z%78(@)1)WyW;Qg#s)M4G6f%)jVr}Ao`c$K8G2HlYlWNbUy;nOIKeYDb>^kF}d>vPg zI=LaSHpw*0G3cr^`O25#g;9F%BaE8NMkbT@V&Dh+xSE4~R^-7xj_P0^TY0c=Xw#C_ z7em{YUT$3iw=WHCVd@57_pp=)yXO-Je+4%+{c1`W-q6$qZfd#)ZfqLb;?$*&6-)2F zk6P;E@7enO$aLt?ny}xGf~&*8HDON=gDb;^*NEYU*N8nSB|sm4FAo{oyY=uO8W8(v zA5thK5g$L9JtCi}EJ?+!uSVfuVyUdjpx|!_rQRT}$&3*Yd`xyUhJ5|wqVHi8{4H@S z?v=Q86a^m>N{!-QV`$yG?EpTyP|B9{kX*$_rg&&M<}{)pF4P=ofqzwJE++yxfo4_j zee_ZvKR*q227NntF*xe)i@`B3+BPPFucQ9D7##PaBQ)_@`=-=CF9j$3c_}36kM>RJ zf1KZxAvQlvK@jzpvPPo(WU4PY)o%DXK}njRkb_kK0SUkW(<#z)00KFrSC^6=Ro0AK z8U!k9MoBs``RQLU`1+D-N6Z^lat`wiQaJpu^VbNmIF_IO1-JYrNN?TR-OU8WK(lj` zxpZs|l0;?vhk=Gsa5TU_?CT=zelKE1>NCKT480~F9Pbnzi zQt&S}zvM2#7oZvu0S?~c$>SF=jTUa=?)V=rgKTgI7Mp`>v#2Te=HmF!b!;p5of^VJ zDGCXwoM|R=H1M%xWOt$nw>U_o48Yxl^?Zt-t-y++7U>RXd4<@({5j^PsBi;HLk>Xk zI=jlcpKQ>Ic3*6~9VoRy#_U5~HCdfpmSk!bX|LqL{mWe%UIjQuhHsdTUySkq;$XtR zl9b_|H74CeqI-(;W@i-E(ttO!tN>WSTY?q38~mAo(MQgLeqApt4enI~Dr4K-=E*|b z6h+}^E~nmR8xx=)u!|tS5oa~nJnN}mPbk*OmMYjQa^PsrO)4YxImSKQhpe)IZ`;zu zML~f`r^wt2S8SdroU-+SS&fNXbk=F+Ow2**Mh=$W3M>#=g*(#J`BfW6{ ztpo}0Po5^i;soKk;?tqNq-ti8q4DHB03|BI^d@1YY%;D0=k8n^nGqGeZbi__ zuN*9`jEuP;Z@$EJE=@~&miheo^M)^-S=w5(xxB@T%uG$JjSLO+^*D5k{B|Z2?=hV>>9DI;TS>e1UWn~8sOG<_gk+J$(Y_&R~ClPmy ze7vcnm*q9w!foW>8!E5$Snsme8^J98soAbK%WFGkvPYF8D*?z=1DFLIQZ3L(q*IV2 z0ahKen6h$$F?Ib9sb`fel8q#9ls`{AN*c(cK;DO+czn%p0u+UfMzWX^b`%zqG%9+g zF!DHom<@Eu9=gg~(2(i4Hm4?iA0on{N<%lH*}JW7E;QXFMbpIu_{C<%mM!jRnNlre5( z_47EvJI4uL6;e`w{1gkRH(f#?0K)vMk*Wl2$3Xy%0eb^N812VL)9-|=M6j>lM;+fD zE~H?vG0@{BPWeBTe;*b(KmazEq-GT++)le;M8LX};_%q%o>WsIhE#2zK*>=w24*MZ zDG9?m9awNACE8;;KhC;=bk9gvcOte$|9vRa$*?W@k~&CF**J3l5q~sCk_&@YpC+YYv(P#w2RPsk=jH@NNvEC{7mBUGxsIz*6 zpOBt50Y41>5D3Fzww?Of)GtsvrR(>-f4E($GnK~BrLh_qMTF*Nb7H*d*H8Rwd3i@R z7p3*;+zNI&MkVLWB>zD2fa(NXc|mvMr%*Y)RQ_e8#-FRHx*}p5wb!1rN9y(q+t6vs zEp1=7Y)lsTU6W^@zpVL#*_!I3#iDP_qN6T&^d#!EC!RhgOwK zqA{08!y&f}(J~ZRJjqO(DlZMSL`hBH8*d;fF(Sqr?k%2J!bp~U3ms!zNBgh8m57qvu1z>TkaOP| z$zlR|oM*~#llQ+K$xJ4#Du+PQwSWSh93rFc>`GWJJI0;v;?NIh>93dobu;+%%$Kp` z;MC_>1`p*)Iy6r;mftS1$1`70mLueC<*PX6YZQL|ZzcA}-VY0fz;GkXml%kDtdbbL zV~NtwB(jgVI$~VC^x^9hiL4vsM376DZ)z`ENiCQcN_pPu$InS_hO z=T3RjVLa7NS?X1%JX&0jKi?n#jv*24H6iZ$dfPehfy|iRD6U`M3=5Vfc=D^3U_>A~ ziWHAUv4pq$f$sQSVeHO=V_EX9OdAXZ1~|ZhU@qSxmmfs}h_uMa2xaMLA~hBnX)uAB z-CzoQ*n3vlMv{YHg!g`CC9L0EvOCNhrOLhs3FnDRtDWjauDzHtcS#D>eZ|VLZVp@_|UA!klI4btOo=> z)cS)z9+~xkz~_#$Py^t&w}cx1rkEe9FaF18J$P*cu1pTxD%HC5hO*{EOlvH6sf-dC z*_r|2+OWt3Y(X;6?en3=3h zMm)hQCpnonV{1?r%vy%{IESR*@a^`>4qWwmT$|KN>g;YMX0RF~g0G{VSQSg!kRDN# zJjXK;dH~PNKy>m4Qi!vlo8TPww+kYc*WSuIh(`=ymftZ~2c#KDxz_Dk5Kl8Jsb)(X zRxLMuKsI-7l51OD1N{!t@~3&0&3A}cWKnJhunuT^TyX=CN`v2st)FFi@3sM8rHP_3 zfdV+6X_S1I0u%*P$mW)uAF?4xl{$UZC^(bD&p<5v0*{5ad8nDxdTxo!4W6kI4)C4Z zq)7HTGlP+hk1WzwVJ%n1&m{57hySdcCZqR$-*DsX@yV)}af3^H#unY8I_!azK7x=wjL9d2uhSY zIH`oeKOmKu#HPK^?CPWepsBK}Z{xVH37?@K*umhVY}$KGDgolSBk<1{yZWyNfJ#fN zB9>sG;b;Rosyhc02Nhxo?kaGB30)n7kRwe5{Jf7)Vlu)y0~3j7ZePna5z|%EYn$9{hQI&Z2a$UvKQO)8z3=D6{vMoG`ZkyQYs?o~MG{NZs4GB9)KIh5+3{K4bA(&&QxuAj5^+hGZe<9-qB6C}Z%a`S`+milj{S8#% zjfuKf<+JR>oh^o+o+C7poLm^EgZzv{N`^#Eb*2V3j6{M^{HSo}HHwfd4vHL2)c-s> zFpNaLxhEd}*5b#1Q*-kspka%35bzyAW7yN6F%D2q&RUG^7Kkr`4L>9`Xd>B2hU61* z<1_5%@O@|azS{7B1aMPS>-@LM5bX0`(QINs`F~6Jju+8_%;2c-?q7M!Z-(!JWDjyA z-%kny(B1h?y^hGTobYMkkZ1%3S88~rYL<0rT9B&-0x82B1k^0@1PFU66JOu}Lp_Pa z|3Rvt>5Lj=f?%HlX($G+lt`R6i6+=+Yy;cyuvx*A!Pws3LF*>clQNMfX~nZa@8H|t zCSPqkj5e7;{q`iGNxGf1^}tDV?Q82!pQzE7i7iy7K)t;0(;K`O1TggU6$Jx>jWvG_ zp4m<&)_%DXa~k;{@E-vyJH8}SHu+*e?2}FbmVQr?>GPN~Zu|vZxM4E-UA7m23Iz#S|S_xt1e-Ott7JFBr*k&6=RH2TKUJk-mXB``*ZXqPuu@gSu~ zemuNw2h9G`Txamtmlvp!P+&NY)?f^ zyKJl{8iX~Jlw|-xtsx|3a-f!Ei!t>kaXRabLrl1__|#;DltoT1$x9fea`6ir&uSHy ztO;DZ>h7I;w{Iw1pO)^J2IW;o7xv#sBV1U#B%;9V#4nX5n1Me!H{vm(Cc>?7#K;)t&AtTCsOoC)c6}uLU(97*7<)fEZ$O6Y#;@giVJA^^m%f<@J52=)#VtO4L2!7WD05HJ9 zOESEB?qz?pXYfdU3y3~&m%oN zlmoU+V4L{HXu#XM)yI$64lO)=X`(bPmPaYKcL(z)b7BTNUx$Tb(L6SRB<`O7d7k0T z(qoYz2a{_7%<(&P(Vs*^uIL--;CfnFVP+t?6n_45uk$&3OspVqCKG8cE&d&e|TuO@~}C% zBM23t&|*UV8f43c+T%Ann;dydZ2G6SjKwfJPd zMxrybI0&D-xT=YB%402ZuyS;-!>fVYEQ7uha7rKa;J;y~#E5{qaM9;|hQbUrt# zQ1j4Cc4o!dOQvUoRs8CZRT!Zb@|p`F*l@FkFuTO_R6sYNQJLsmQN>5(sc$w*#%ixz z5E_>U)wzB=&X#WiVBuMMX2?ux4*o_fuBv;b)E-(rf44<~_Uy|sy3oPaWqYsR0LWbS zi4}8B?t*USQJVr~rLG@cP+s6!9RX;W_J?y+Y6Tq4D+MLx>78?B&KUrxV(x8cLiMy3 zPp;ZYp6JkQTr^O5mZ?K*J*jN1=coxt9dO6C`KMo(MQ!QP35uhy1OiN5PPmf!OZh?A zYJVkL*pfpgIa2CU{kxw~lVhEiL)}Xb6q(kw*X*!W(Lz-kE}Yg}=X(;~W#z+}eyYU{rs~K1cusqHr;I9X4eNkhLtbPZts`g`0uS%p@(f4-QJv z;4D?g0V>xk6V-D(>;NkRS0JVIJDxqtJ#L{PV{vABkJcPiss*YhpJdwTzS+d-b}3eO zu+7cSwGUuMMn{I@@`4oL5AmiYv1wL{A-`C=vmqgBL;K(y*X%nNCkZ=xS>Cpl*nohdd= z(=dfZWmMD=d;8>FaJ64~^0VrkwD1|u$xNlVs`%g)vJQ5@sXF)4o7!;p0+e~01=3>` zF+Mn?X-ma!gPV*xA%n|DlZXo-=HdQ|#YN!@pJpv_=96wuD@AIvg96Hdv|8#4H;oM@ zL3~tQy3;v2Y4c3z9y)x9qDVa}!B+EN;U!qXvb27r6(GC08+WKUS6Qmiqt{Afw@XT! ztW@tZ{&f}i44R|hCerH824pM#l0nb%g*#03grt_Q#5em!Qy|0NB1t8~VU0~CKYu@S zEs_?|uecWU2j^NKfVAn@hzp3{DUcbgk*;`zx)?2^N6)g+!*{GB{$xco1d61sd+YR7 zU^RqY4Bpz~D?@_-SUA5_1|puMn-`o&!cUsh4Ri%w_J9 zf^8LfOyDVJ^dSXJ62`OST-)b({ujja>#_(1vfijH0yh%SqenGkWShyD8_XwfltBa! zNgtC%yfWy(;q}M&_G2kX&){WeKX%8TxVm@~@4}OFyx{!Ra>$VG1@Tq*RL=r5)*p;# zg&t^?3YEmSJB>s<*1S=jGePw|1)5et_yJv^6>HzL$--| zxDRa$Fm7xMv;|N(a4u}u>&q%mcTE$!titHiOCF3TF)Z*|@*rs*9%T_Fk~~a`cNp(F z1Y=1^Jcuc)K3U5IKp@Wcqjl9sawGk4in=%R@FGYqQ;E&bg%9x#7+&-XIMhEh1@3|4 zS51(4-$&#y@y3~to1E14*M()jo}9Y=Gwq?cq-*>k6%GhxnBLPo(Iu0`|idP7>*qCb7x>wZh4)uc$5v5vdwVB2NF6H{<`<`wFnAw(o5^ zq`Re4a_H{vQc|Qty1PL-6{TBJY3Xi|5|9!kq@)Bv5J5iBdll~G`i*+;@819O2+y23 zv**mrS!bWU_PgG-_F7@5KKZZ6(7qcn`BEkIcY1w+Q&Jqj=T%}l2YY|TVF43|1p$I^ ziOcs7!5JW+--VzqB;o*PQv6oz#uw80t6lhQOZFd0#Bn~(^;BbhCCR@Ty76y;zCR); znU-ds8>k>3k=5X^O;8UQCCG^l2B{;k(V&Py9^hW_9{h_aEcTypAYEeR0jI2h&rWe} zEK3AWUL)--#tO?$XQ9A5ucz`_VA3zuQ$InV|EO#~T5hohrKsE4?_y%RhtSBEmU8}7 ziu>=IV1UxVEWqc@y*R=AMmzX=jAHkrH1lue!FFJIuwb9rDqkpw6diQPOFQsi;8%XQ z1JQGPor5oSV9Wqg-=%T^yPW24q*lJ8)ZB#*biKaNwwKZEgXgdFWWtW0H2Ok5l`u&> z(Mu)#36kYUhu)83pf3`JY2sI>qRd`k#~{_wZ7vn?Uob$Kf%nc`=)ymMJl~;%3!^XW zBbvu$B69qlwkS{&13Me=#R1Q)@cM=FzKQa_Zvplc#)rUGe`T|D#L%ep|?SNu9USvhs>2l~vU>%`L5M?H!$6-92Ad23;Du{>lG% zzC^(Py<%3vVBV7-kOi=px`aIAQnnwwvM zH6x{0mM`tLp8(%~3abJV)&L(d`3u$n>;C%(Va)~d3IbsBH{cpuJ9`I5r?arC65roZ z&DRp0Un~3lD6BbGZs82p0KQeE^ZSw5x6Zia`%n3gd4ewj6LQS-DU;+?7KA+Q00)m%iy}8nZTKB zzLQqJ%;Nf|HPd z1XXeg6a)%Y{4jL?1O+cb+#Lvbv&%FR=TF#?Kd6z|f%o+NO1J>5M*0#e1ysU?pU_AE z!Eb4#FCnYIdd>b3M;|zd#Emmc;nUxLzNXwCv67I`T-sU?NCyNuWI0uuOq8#$7Q`(+ z=;q7gq&WXxt^_E>^uwNpo6B8$8KWt`c^W92E+j;S4o45XR7L#+Yx2*ls9&|{PE{0e zc|yPFD4=T5{jiP#gJ2Q_{Zt?7a-RB2Fv7p8qyCT6)Gbl7qix=L!a^V#t+!;ny`{ZF zV7!Bn{z6CnU*ZSx3wxd8FM_942)MmVHPheA4+5uqf7Dj}5(mbD$#yz1esRr@)?9ge zsc`=SNyq{`G`x_7+m(M*{mn58v?sFX@EXaRhXcWc{x4&x5YNlmPDzx1sht0Nw(xsa z3o!o5IrfiCFR-8eoS$n5g2R5siob24VLp37zf=Y}ZJ&m){fkUYr{dUrBel|(8S&dz`Bxs{yU+Ol3_FS!)Y}^MFV<;s{se3ICydArOqL>cHsE92eie=b79##e`9p(10u!$a^LY#d zmuc+$iXTwa-$wr_Li{~J(bq+c{{fcjb0ougV(mYF%6}ZgVxR)vEI#Q1AfTLo#i{)S z8~&r5+IP4iFGN@!KIswN#Y6Yf*`V492O&HUEUx2Xe`$~-fbn184uMy?zY@cJzhMs4I?L}uP8Z_GzyQCerMWEP{tI{b zZ4~kk`UXC0T}bisMdD9At=~XSKw`cB9deQyjCvzLgFF|7;Ufx?ff@?xeE>psdAbS! z<4;hBe*#TF8L!_H{`rgh2NpDa;njfR{=Wg5{v7^!9yEcSvTENL3SUtZu)NyeZAJVU zH2vpK`H!GUdNy4Eklv&%kVq`RND7+feL15BVEhSA{D+~_4+f{#;OBQciXJj!>-b)nm8aI^cJ?_FF(nIMdeahY69{|12qd?5Elxz3gqP)optF&wTi zYqfOl59?pJC!^w#$}W}hCpeTJz9)gt8F(QSzXmh2-5KH9bDy#cNhG!u;Uz8=?I+C3 z9~KSx<%JhS<4VhFvi80>+)8m_(Jqzi@5SE0txo!xE(<66W0$3iBkNo$+P{Ihfe%o= z&}F}w6{_hh{vPBic>NbvDlJQ0x}pcb^!K7};Q9{ud-9@6!OiY=zISnD*|P|Y=u129 zCs6nQdaTvN=e9e?UL0$?#qbfA%Jmb7+eeYql(KkY5z@X|}BY(-gBb zNYtzV^_#hz}Is08;|& z0v!N;N(cO%#`P~c;P8)hfDQ~41lmoIHH+=@8s!IBy+bdiYuo&M?$o4L!_qIZdT^P9 z{Fj*sfWMbP0m`If{!w%Mvn%X(n>7Gou7DZrJarjshct4jkpBXg!VJ72bkQ*XL=#0g z42~nipO-R|LuLWrS zd%jGm*(lvvZxt{hV#GkOV#XklEX+`FTqtjoTerx;RG|L?0sRDvcnLcS)KF#yz7qKb z*7rOD8hWpAVFuN5piaG175@awa*2Gvsp20+2UiQaoe3f;{)i6VkiaWnD%;;_c>>jQ z?BBCI>sK+C?=(GuRKmX)q%T_dzo&%%$RNSY3AA`iLV)}weZ>3|Cg`7#6j17kogH|n z$OQPc#`1gDSOQh_xC#(*pd8@Cz{NbF2#FngA0QA@_yQ zfES*Z+v&_dL9zTvM*#;kIDp4czjW01TYEt1sPBqgJa}u zpSJymeoKaZS=z`STnGM#G$V@Na;|+{!SOZN_FH9Inq7T>Q#gv7!0#E4Ucn~ zDa8EWW)lA(*IDq=MY-0a;Ylu)>+fX}fzrJ{Om3g0hv8I13xT~D1R0x(G<2zKe=0Y6>#9n{e9OO+4BJqpx}USR?@m;k?glrw5!iQl3?#b0Mlu#$7wd= zzn%#Hb8BQ}kc%yBh`d!miKtG~5evWw3j{zk0>FKmZv}B(S&3l$i#2!5KfxmY2_Uio zm1Bez_!x*^IYxjbqJCT11oaQ(7y;D~Ka2YR^!GW1&|jg$%dpnBLm+^~THhH10digX z_cK1NiFb+r;)@CUA2{Vd;zJPu+$a!lxwOl3i36DbUS1q1VDY0s@bJ?TQrNSyX3Y`*$bbx6>Vc8&d#j^?j!%Iv%;1kID&T?BFGclVP*hOTisua?roS<9>fcY8 ze@=M>CGxf0!6!u}2!y5rR=57$VDFE}NqTn0JKZ78TZI@JBnuuB3`7VQ0!GOhyO-=qyo`j(EKd_1|1H3eC7o@{E($n^kA5Ws-yXWFH*7r1@}@t^)E2uKc{~$8m@9? zSn8L`^%HFPCG!eU0GJhcC+h_d@}UCQ=e7!@PmeS&>LtP>@Twv)H&OeX``0e%w- z7b1uy^QaLnmG?YlsB32^W@Ty5AgypiUS95+prfIssV$v^p{}C~gQ%sxm4T_HF~bd0 zOF>IJ(=V^ZOiyzM3Y+NK60xu`oPAux&`#gh)Y{(4mWYYv>^4zikkS3^5Ds<*Wd}Wb z7i&WX6VKVkphTNsHrPMvRTOlS50+ozx(R`#<|%1Fe?!KBUiso3jTS$ie`%Xw<% z4_8LP*2>w`LRZepQI}51(AdFT*A|!y#0>cJ1v)$3^B0Ko>jgT!I7|#G=dR8fHn{BS zu%4aj|L>pmQ{B4Xk7E5)p7-}xU!U37&#p8p8z&Jf>sc#16MzW7e8%RS{c|vK60tL$ zUQ;$!B36#GTj%uH(^{RZ?59V5$|if(!UkZwcqM-)gEUVmWdlQJLxbOH$}5QrogRLA zsZX~`+Gn@t=S%Afap{Gu%ng3mVS)zfm?6U8?+c`s4Rr95ohH=2Zs`{Jb_LN zUX2n90;`|hFz!^Pq(eOj)mun?DTz2*Vml4d?S?HAj#i#r2HH7?3Eu))l&o9;Z*KhX z1AT++OXqtEHoTE&@9y1(Rz;6;ADrU|z)4Bjux<{Jn(=KPtiHzMLGT)qY_IPF;rftl zl#se_dmP{HvxBjR;u3ljrKR>WvTtL|J_7iRBcs}nrP>}e&#&P5rQ6(45tS_U;m6dIVs`YMCi7@^uE zt!e3n_N_#dgf|a-ssjYxbw-Q7oY?N4TeyDE46eGJ>3N#H<_pDIMw()OndUz2MMk3E zI!4e=-_X*Yh>3}rgF#r=TEfuO*u?&H?6RK@w9jwRv79*QNg4YHDr>I32K`?n$LjO>(*x zhQCi3Uyi1e*E2V@aWMRJgtEP@p}oEdgPfJEg|7LhrW>D6kcE+vLDF8=+*DuC(%9UP zh>i)splokwah-^RAPq9XU}JkPviQNvSR(T zJsr)zJ)b|~^Y^i_u@jv=&L+XL$EVk)Q{AU&@bvZBCs6k|Ma=j z=L?_v?K?P6f$XR6I{W@lQ|H(7Kl`3fkJIn{egD(%{MHUQ``y#W+3%h`pZ(_V$Nm0% zChw>B&(81cbEn6ioyXbp?~kv)_>y=Dsn z$fEm)AvY;PiTGbfdoyx80l)dwZ~G~9m(mnUTTIkqz=`MK>p=LhrcKhUO}G5CyH@X} zJf^~kPdM#Ii6iDl%J-0qrY&;yI6CZxjoympCYl}9C4MZBo-lTqbg$Csbe^cpp}!Uq zbs~jSv|x>dv{u92(Mfy4G-6{iY3F=U#>o?SWWDww(m8ko+eo+KiUUu!U&FoQ{T)I$kcHCoC%&Ei1Wuq64 zJgQrZQ5bM_Jc-%l+syBAj)Xixt-A2u#MMD=b#cGJ;|##;ZErJ`q%{ELo@l&weuIz62xcItF`=G*)}2{}w5 zVfPJd>Zk?wGZVQ~KT`^(a9O;@25gV9JLPbV>kQ`|bF1|*#h1<+=j^t>zOhaL41k&8 z^W1)_J{Z{{7N2Od&>dmHU7pd0~^+?5me>++y#b50b z`htv%c!n!|VOr(hwwdrKhGJIx-6wv}lm^mNVM&5tk))4CwSDOCsn1^}JT`i{RXKLk z?a^^nW7)n2w}-75Eku)+!mZuh8?_?dMOu0yV%!9Id>9`6x!8@#nm|8TmV*bx@qHqP>3L$ST4@z z%aO80&9KM0s5M9i;fXT|2HV(i`%!oit3bA8?d)XFHg@0pC!iWhHatT6KgYFt4RztRj?2pnN%7e9}?#5&oP?g;i?Lj5ioJe~`&3*5< z2XwK@R;oJFSp-{T!=X!0!dc=;}P z&Sp+>PMNE6y|6Z`_vPpa#(e2(+bx%?F~)wzv7L+C&W(Ag_ifN@8L?X#uP|??-t53y zkkay7vthREoPK%$$`f|K1aV98nwdOr9uh)EqY^E1ictJr(UT1Frw3OU7Pf|rdQ>y+ z*&EgXB5`yc);)4hGgsb;-}dW)&DN;CCIAsUL?V?HVqT(Dh{mZ`z(FDxnwW8&N73)W zHkc7lBF?^kN8)Qbdu_su#>d>dA|5gKw~r6!7-2Ng;`F_TdKklXJ63YSBH5R4-NG2c zio#<%Toy_d^U|@E1M!rLySI#9;zf|4$@}?>KN)hdvj?6 zi<}OPFK>9>IYNA17T(>U${2jI2qV_4j2MD#StD1O7x%z4KsYO7R1>}b%9Sl)oI*0H zGIe@|>ol4NyPi)scyC5}gtg8vAg8}`dB+OHV(zk?kdQ~OY**)jH)^5vHeVy^IT$WF zU6&>_-!Qn>C?Q0n;s~_)sQXoo;xYCE>N>aKhLMKRka9rZ#;E6@Em}EoafSoiw!(7dLK(-1QQxL_VnOgzD=@xaN zFQhe0$Q-3J(i0(s)OQ-=FoezQ*8cL==pw>wZA~^o0h!kDa;>l&usO3(ZOxoi-pua( z3v+CB2+MPt2Z*R?S1g-_B>Z6+QIet{x}(6U8H4S54J7>FCGJo&V$cwyJ#1xp09tm7 z!u<-~EySlwH=6OR(LB99By!UPFj()t!A?mdWNYa-;C@4t#t$_sBT@yu&jcZCgV`?z zE?YhrXi-8iS;G6c$*BaK4+&}3Z9RzL7A1TqJI7=C4*GG7W$Wu}fegA%>!60#7;btD z{kCt58Q!&i#CNzc2ZA5Out0<#CVY$X)xtFn^kqAhtASok{PWiMKBRNRop)?=y$2Yf z^qCMBni0mVgYk>R@)2K4H7+~XNQe9OO>%69k5llWx|ss9yWK-(!`{cN%T4D&@1b|L z*~C*;_E?OBzBSQ_Sc}b#3Rxl1&gfO4<&R4p#Gpx6qRA{!k;8Zu$NfsKro(9&N>vHN zI2A-)?A&i(}BUYRg)IYCK|KM%N!=X9lKjR>&47lp8)yztbiePcIj=HR60F zo6#o4e!D&)i_0)DNr=tC7gyXOFFA>LEH;^06*^vQKv~>X@Ud!UUhFtAeQxk;5gSEI ztoHd3s_3Y(b2RG--0Fc;;cXUO6oqdYWUjV8rL;=Rdr1PepX^zFa(s z@?zFWiOy29`n?<2`~%fnA5!2TP*H`D%ZdZYiGrjd1>=hEz<`Dj5pi69*Jmcso-Kh= zOrk7`4%!StBF%aQRPaf0=5;nm2!G_bw9?>Q)#w)~3^>?fz4l^U1l;cd@ki0_I-B*& z`+SYdU5q#+etkH0&qFKpJTzP4%CpJT6Qr3UZrUPO1T1sw;gR{pcv%|Ewh{X$PSV| zx+Weq^F&GU0C^SJ{dvZS*=JgTtuFXi=b$ZI;>nA~vFUrGjqbYm_u8O~Cq}bLabI`Y z_c7=)*A!gp(uyb<;_;=NeD)*^p>mN!`{q5Dodnvb_Y_lw!+aGTh4;kYv#pXlNm|J$ zOj$V)$ks^PC2JXvJ+H8%eq6uS5zaKzc8joo9t3fL*@8ek%1^(mb(zDEW){Cc@pdtx zjtTVBb{zZ`MfZ>e4xd;K3z~Up_r-UnI|SCLRrpThi#4REl-n^x_g)A(b!}L4XP2r( z=PUIg?UR;^d+K8*lA{tEPFHSn!^S?_baQGxo}~{#xn@ZAVzE}BM>;G@z@3_yHbq40 z?%h}uhJLNvdgR@0@y@ZgXyOBxt}9QdFiH0T%9_ntRApIXP4Yiv9|Il+=9!wslPOP) zFj*xo8pTe~%C)`F!B7Id0@Jo*&XS6?LD z*;YurRWK={*?ql|)f_|e-js!*>9q|q(Mf5%RU(3oiYFQ26*g=$&+l*Sl)UP?d3fKQ zNLI?Bk|S(DZ$8X2hRTb^B&x8icWGk$m>-F=r$U2p{rv$0b9FW zCUkZ+LkB8C>f zq2!P+$eM>qu4s`jJf^6fFFvO1QR8EomAGPb2tF-@kV`x*6`sp9Ehd{w&6>G%SB5T^ zydvZINZ_Orw^aJOyHb_P(61#-M}oPOv8G?vJR=whuNh7r@pDyTs0npdCag&m!n@s7 zv!8GCAx{%JR}wl;`cAIwojl1c<@ZKj%EWH=aHaTgH;(dvHAHv2Q+55@$T{ zFA!+yK0$#^H67!Bl>Bi-m58|Xf&WWWij~KhlkHa=AD-}_tzbz89fp&k@B61x&W#(Q z?mQ;a{b-09p+hkzf`Up<1KS)a*)&K(wyyMyeqwH`r*Hn6L|2ZJ0~J3B=z%1K%nc18 zGILc_I7tbr{$IV&LB1L-_F+_X& z1(40sHYlJX&c;fU%_7$aSw;D^cD1A6w=?03UzM9xc7Lag`i4_(9$juh1_hOE4!@zz z#oe$&pYYv+eqj^0TCl2GIICKyd10%od6SrVi;;Qr^}5jgH+&z1k%|$fO2D~G;0WhQ z*E_DRt7Zt1DcDf>13=*;4_h#dz(izuMXWY5H1_#kgf_rr+TRt!@h6SBDmIcWBjD18 zZUokY(FY-dWgvuamPUaJCy^Vmb_Fm;^?Cv7MNpyw(pV<3Wjh@)>L5t?W1@7X7-}@S z!7LMsG-{0uj7dxbA?|W9ybbbn8IB0_^0AbtK)D217ke-#^j&|;6+yyuO4m91T`|In z3F;A1elFjSLD?_N@dOJjWN|I7De-0o_`HJ@`QSG=@c6w;Gv@K};E|mmX|^6@K*QT= zn_+W=`c+&FIR;Km=&{6yX7~s#S6&CuhNn7@j5e{jHs`rAfjUARn>_yLQ6n~vj!?ts zF`&>+a*slhL<~}w>#0ikatRA}?nA$;IYDeA^2u3XTFA7p39Cf4m^=x4xGt*OnBwv5 zzWP2zq;g|UbR%!15deM?0hHCZ-stavlIu0H6Xm9L$zurq0-nc{&lC5A+ta{aJBJJQGAITi|Twl`EWqihjqdXYaX^qKm zs<+ku?1{?9Cr4t3e94v!M|OOZle z*MJ>VZ|M`lW%NEShP(FWs=S*2A~*d(z_oRfAgZ7hzN1NuVu1|PH4$8Hg=Zt(RZ4o$ zcy!O@^o=Lm5?+la7(|<`vJ4~TB;R5-38auSPmp}5T;PSx75-+u+6qf6Y~jtFSP!@T zWVacQ<)jbX%QO3!_mMoz`FxN%J>7%q1O4e=XCD|JA7EofCmyEa5gEn!it60yger|* zCnl)cxY@K2bF~-31(*IUgmtK~B{5(k=A9M>xW4xX=G|f17R{<0H*W{T22k<`;k$YzA;^0XYGD zb37evzW0!i=Wa2%fU_rh9Qe)>*LF)Q1V{RV!0I_v%tLvFx+fd7M!4~=YdneK^sCsj zD10thn9y3B?13}W=oDBVcy9-N@^yfY0Ob8Eo$pm%;9n^TX@T~HW?VJ4vEq>4x2IM2 z)_Mf1R0S4wAU$i%(5)V`(bc0xYb>GXs_~k{O{%mn;cnHSo*ZNQKximy2Mkn-J`R{% zk=7#CC~aepVfW~$OF09y0!on5fhvlsYFTG)h7KV`|JBuwXt%4_tB8^I17TzoHspm* z?LuyY)iOX5sp?LGTx)?Oz(;I9&Lnt>{Mc+A(8cbyB=rh;*T(4+oUfvrgmlPz(XL~;= zo>J!50V}>#(ep@L$Z~umN9k6rydii<&q3ZJf2~m(H*BLzq*C8i; zRfA?F9IDoG>IDejnc<1D^x`YI({Q50`gV-3!rqypaLem?Nu4iNEo6!0c!)x8zLP9% zljFSTEv}e8<3vA^TW@=1GV3i%1U+y*Yzgxglo&Pd@9n~2^(roq}wtn&zNNb zs6Z}dHPnJiJLYt7SaaM^>JtFWle=?_M^q3w6F%E2`S8!-6Z3ZBSwSl*ZMec5zAR()3F?S4J;cwIK;u=u=Io)tm*$tg zX>QBiw*_jI#V}Q;cx7Fgg~iArT|-NAD^^8OP!z^Cxq_JS`3Fx?iAGeCeZ+vKST297 ztLu-GohKxvAGP{@EQwtf5smOyYEUi|YE>=2-j;@4Xo?V`s>h9qc0Vt5TS!xZTEI7) z?-fMiP^Md^MFBwQ$WA zvLQEO2g?T%l#3CvnmC9W2J{YH2RaybyV!?^#7B6H?$B;jur+P-4hzu8Bv!5-#6*zq zh>2b$+mdI1tv_iJd^yVvki)KycAws~v0$C7yX zJIZUkrcMr+Hl{PZ#w<<7tO$oc?hT~mMAVl$kamBx_cj2lc9Ndzu8a6c%lz@yqz?QZ z7TUW`r4L5pn3^$Sg_2M{HSz~0#~*i8O^sfbxs{@!E|?eSym+T$L20w6Ly8)0Nk}S* z_F<}K%U#&*q>RvP%*K*nlFEgkLzgcIMdvNbBb&)ofn!*7HQngZ06Q8=>BVQLx_l@# z1#d0H0@wQ*6B3VFnyVckez5)lL!+=U&soco$=aGblUnmr)l)YqCeVxl0O$nz6B8ZL8^qjR+pl6W zUIMPAJl38(FxVH+*+`!Q&zx)<=)bBp^<+l1yyERsWF~OHTJs)b*9msEvlF`*jakg}2Rw|0x8L!nkS#Xiq#QkM-cQLN>5qg*dg3ks)h&JEvLT!H_6XZ6!X~C+ zvrz>W>UAGuvIIOK-h1A-*8O6eX9puq92GVic!qLm;gD6X53f!7W7N;0U}#HSO9+(N zXi!}!??7!??<4H3SQ@Jr$SOH1xwgH>*lT6NV5*H%4%wM&53Iip*| z*0%AAOa5%$a8Qc`M#qPBe@5=-5>m8)Yb5}zmstc9i|l;(42ifYM{vV3Xsu7&6(xl< zSW&qm8ocf_=o6!qrV~%Pp;jcLFHQ?$M11I{b!DQAH+i>mbwz+0F&i!_VvMM{4qll0 z;oe493^|)rxkLu5r1(8_J_h3TO4rwj53`*fA3k>Mkymv9Nz0} zy!2wLWAn1LdQlvI0--dgvU{{{&-E_%y?Sm-#xP_pbsc;Q>h!|cn=}w;g7F6gx96>? z?QXTkg+GGVWM%V&)@a@?v3JKeBE>8m#~+s}dDPyqB_OP+Fzy#VVIx??==K1^^1v3V zIIP+~gGP`(W~Hli_9JbuQR|6h(axLPeD1@|sX*FT3jhwK3!@B0tbm%(b0)}UY@aIh zkg9ZA9l_^FOhg5^7}O(XSqXQMAgFJJLxIV@hJu2YxE=ach)^k_}_mZK;xh(^3oQYi~Lly8=8VXSI`qCKi_CulY3PkRJE*+XGrD8S(N1YmN_?@6hc zCZ#9;vn&fT6Fk^SG2bWAX%<Gq@^%@@78xGN@(? zzkw<25K2V4Wxrmep+I57d^JajodV4RYKs8(3a*GzTNuC51AYUTl;RtK20`!8^dM*S zYmek?)(7TmW+W433Si?gqSQe@Z$|x}Ug;|IhBpQXO3D#{y2YTe1eX}Xg&%uXCwOX= z@H6W=3C$C{Wye5RAG7za)8>9V&CZv|>$X}74R<>LY4`A^&;XXU@IdYObtK-R0E+I1 zHw@s~2m-yS)0f59p2H#`C%z`BP|03fHMV1VY=-Ei_6Roat?|IKh=ex15wa38FNdop zyvz?-68oq*HRKs~be#Pbyjz_{C%NZ><4SN5BafW+*YyTa%t=WMTAQ9#Rb^?{#Z~)m z8?dH42pS)RjYKE`GmV8bWLbn+Jr-{WA$taO^0-(g$93OFb`E6~rS_e~M}hqDXVRrfjvA;(lC>Yh{T zfthBy8cLPUe)^5c$nNkruT1EJKWIntp$lE@^D%#zJ3(Z|raWSf%!(({2c=jhIAWfV z+s!0{6Ao*mCzSL6nUbO{7}h2MZNAN)V-Hpm*%{92fn`!{5r~)H<8J3yuXG0Ju^ngy z#s&!t<->4Gwq6<#tFP|VJIyKAln~_vjt2+8V=x?rvkfKFZM=wIcy&F-^KM%%lL%3( z2`}$6sS}~Nxy`4`L2=ddMe{7_+w>hlPBp`72szzC?x?&nS!$1MjhpXwb9(lD^Z-{{ z*(V$-#MsO57;m+o(^9H2E4rq>lWI0T^EfW_Wo>Tp?ECu&v?-&-#hIM9!waRKCfzn9 zSF0r#rMnN}sP4n#Nf+p`jNMh`9o8$-0coHm@OhI>Oggt;PXV||w9r0xx`71TM8jc- z+BWNQrZZJ+8wL%FV>bw8?_2H)eY;Ao7q?!2QvcpwQ$09%D1QRdLrlgc`liO- z!P0x_WPx?mX$@x&@VPr!p}mgqJ>0`WAuPF*ATzHq5F$HyKCUFF`|A{fj)igTq48oD zynQEoi(N1=n`LuGVI5v_Z9Nu+f%^{SJ&P>Ij%9QN8O-an8YU5~5jY9qY51VtC{avD z9x!~c1h9yql&r=OL(1ji2M_HldwE;g{V4jYQ;G_cYPfH>%r%#^qVWv*Mp>HP%lyDe z@rp<2&f`L?yYr>t?>$U78p-WS4-3WOCWR%Xywueu9U+ z5<`9}F-c9K*mHn8Gwxw_Y(^8OUhf3KCbfB%{w6%Y*Z9yGoLh^rqA} z%Fmq+ma-?*X9U6RC^vZ|uw) zsxl*6t%!7<654KFu*ZtfQt%Wd8bf$C7G7|8hby_4!<3WK-A!?R(rcxK`pZUI()61z zf^_kixFlj=V<4i)yvabxV2LCtBv1un>~YYa-XtY5@ukY5K=J(0U{JILzSkYy{Q>v( zj`2ozcKPnR-6Py?Lai#7{w0D~cG&D@*Fy`O<7of;(I&(?ZwUcd9tn327ke8mi|$6& zFmGs-3$o<2cC^GcVb!}4wh=; zfs0p~1JdGaKtl-Rbvt5jX5XYLU>$3I>FN$|bz4!KHBz~f4J&=AwvFb=Y>0!;oY;mI zm#afgTnYW#*Vjbz`wI<>M=gA*M{HqRq`T3U-&tB}dPI4Z&lplxZ+6j^ zzRy5A!MUN2>@CEM+f}%jcnAUfC>dz7VbE@S0RX{^dbP6RI6dC*3d91`+gR7ZKU{y% z)@Fir9|}jx_*!OMFF?+BTJJzSipq$qSe?`771LZm|2!qqu=Yw}6CcTryEUaeU^nhK z_O-sv-dpNn8l^+$WkW3aeOalXWTBa=Aq+gs#@Xm)OKJK1r$l4N-TeAuFEMP(*`HyI zxy`1HNJ^En91eFrFWi{k9|;r%w{qEotR)dwzZVv-zqzpBhEQiY*tT7n6Ukqdo@n7C%bd{Nlj^!^92}YGmv=hrs*ly#Rqa+OD_$v&$LHa8Qz+ApLKw4V_Lmzdx zvt5rA*EbEfuH8ant-fh^K8ay_iq@of?mO|d`$r#N zzW?}AhXsOI2sy)Oz;lVZCw0M~5L0LdYc<_A95X0H0RbVjlhEtq(W-8>l;+qqQ5^7? zeP)aqb*rMfWNOaECv+Al7IR)Q4+`BgU);D$3Yh|nXF71FGJ&rk(Po!^J1sw@vAAHu zm@YW(I&-%tgfu@|)r>CGi9K>pR#7bFbD|Dk?Ayrtf?<$Mm~Cpv`lDnk_Q>O>?#GpJ z!A?Xj$H5Z62m<@{G=1oEO?YPwH_)J5bXXc7l6Y$LSkn(t;FVUrhvx@uN){1Nl*io5 z)2K$3pBN5pCIxQyB*#fp-a%I)zaLroY@Af{CrGQ14f`vPnbvHe;Gt$X@-P@d`zyweng#jpjsXxCMmLawMO zf?lJ!6(Fm2`g+_SgH89`ZhLPc-B8ziru>Kcdz5;}352;zvmunqsjoroiLl&PqYL=^ zy43c10!f84m&ILGn%vKl;jDi%PH1;W!KL#0X$Vf$n>+pd9`^V1>>_hw33)0k z-m%cEHNVVL3V-`Lh2D{0`thAH+u^62(E`#ex}%wSxCOC!6uBX7W-;^@P|EX>Y>X8? zc?dEVx6Htm@g7VzjX*v8y$R~9K?NN8&KLfm+c(E z$8(ZuN0+MhYI=%z5J7gTspf=TwVW6`6jw;ublcpisqBU06;CaseQ^AGW&UmIGGy+m z4lQRH4;S%=!F+jMnZ8%|J2ocVHmhG``1Vc2ia;mS-pj~~#^_nfXIhJ>m)zV}6!D%9 zlJ*9)%e?dIOuw09-YhW=p^H2+v_jG^2LJ=(hApo?cyrKY9^zib|I80@3-$oKnne{K zy^da9$+w;($19WD`N{S=+df+nc8NKc>`B~1Da0|y0o|D*-YSVj>V)*Oh$_G z@r@(04XqZ>yi*+dc_s(zrR4GD)n1sbrdUV8<%SA1y@w1E@}`2ge8VV0EP(Dy6H+B^ z<+#unLwp4`BMM$o0yzNU8yhoY3X0dv4I_6L_VTj zW++=}9lgVk#}`IpcJuA)PK@_4MS7}Jz4D9RN_fZtCHf{xm5aIyq8nidtKwtZzw-!o9_}!Qq;>F(-=iv zn-&+?M+w^`O+yB|Li}lCqMV)D99+S(5Ikyyw~(&kr`rC$Y|Mj|LvhB|R@s+1+h}NX zeNoW9A1`)M*UhV%nJ0dxmX^_?bM%c%hH6si&5)#?w4304l*7gkIv*msS01iiy>i1p z0qc-NWHA6BY<}2Ufbu96`FOujm0~D##OX@h(N=xlkOAprmRJ2)lA;$xWh6=UQ~A8- zF-w_Vm`~vY?-X{q#gsza+w@POMo{dwe3#hob>hD#W1M&uDu2g#2tIF2V`Qz6E3)oD z7~rKz7~dE<)Qt_+wPL_CA>#*{89@$D-4-k?yPL)xBH*(50wxZ>rBGeI;u>6QnaQ@S zp$`|c1wEtVNDg;LGo%)0=7! zQCQq(mx_g3qPzK_oZWK1q&n4j&u*+@-Tt2JfkRgrUpXruh3-&Y#M4DV$H8~OGjsfV z5%Gti`#B?l;Jecyk`*6X6IbJUlD4@SP^WM2zXxZOUU|z`dAvU|eeDh(U1FI?F22M^ zM{Ioj*;z&oj;3Z%L_}+AZ$IJ2f#`>2AIgvJJd}#iX5f7ZIO$z)8=*^=wTZ}LB?VAM zbib|5@0K)1-=dio-rOy0;Z%GaEsWKO-5{~K7n8DPPFczrsk6qIs(@tW5rKkvKf!0u zu_=R~Sd8152VA~2A+iGhHu!VLLO-=)#B%WK7SM>$y4jWBh~&$&Yxt9(cO0A239L<^ z|Fny<;VsNPTke<^>ci2%ETCz?i^UyJFZtAL#)-I(+i9z0xDvdFdT}bz_|B5D@`>Yi z(QcEIk@<#Y;YmzL-i?+XU7Ach(s`K0+tyM_QsdI=Y9hWWz5IPi_KBN|WU&YnuT)(X zt~a+Icg;$mFCkd-G;M=)g5x7yvQq~d0nKqU{COcw=isr?uIW(AZAZf{8N$Y0%@qTa z`6mwsu#xPzyQx_#RhD{#OY-_|)8E-=trCw+ZY<5CW89n!B)AsxjQJ+wv(1X($R|%H zO7iVbQdc!A^r6vdbU@#xI2j>2L?XN#0VtAlIL$YRE`T>Md#%I`_i_f9XYpLU>()#e z6%JwXF%3b2#RfM97bF;p3^&R|AOrOL&ZM^pIO-!IDW(yrkgoKgBt;QK(N_w8y^%}i zhcMVeA0^a2M1y6~xIW}ixP;e(RuDmCmXZFjH#~<1j?C%E8%_0oY0PT&Dz#GmGsil! zgQ3@l*WQDgsdVDqwV&;RbFkvATx(gZTzTo-Y3>#!mcy$ow0$==BiBa5O80s(8NtWY zk4B_;Pxy{~4iZ~mS=G&1@f?M-ABA%uB3t3RUBK=X0p0E#pp&GX%RI0mGx4>8t9G-Wt^TOX_JnI!iDmOO@*XXt+xoeUoMM|2GLl7BUog5jPs2v{_`Q_r4oXmG-D|&uV#}D z#~-{H=}B;Ku@eo}llyqPW!AH?EZA=*xsrtI;UKf+cCfBtjHZk8+DxtFNLFccc6KA~ zh6A~q@^ELvlVcT&iK97A(SZo;*c9YM9xA)t=d#ITPG~bZZkt0o;&@#_YUzQdTA~RxU zk1sVkj_5Kn^6*Js(fAO@uvte$t=orV?fSdr)d9VKl$Y74uj^r%v#mM zk%!?!9{P72WLM+$!naN)#}8@}MsPjMRx%Nqw=?x>VGOnJR+p-nPBp!?C}l9CESDLq zT}bD0irBc5#WnN-nIOeI5_<+c!qHw%HI0B^awz@M&Gcvl;>OBO%P7M8=vdPHO>zoM z&hi16I~qELF=}JeiE7)moSB8CaiJf})Acc}s(5&)s|9=Em(YzGi*LU!x@YOc%@)~x z(3}{c+S6J0ZXmifseKaRa8r0}CYXb=^1h~qz)b&$9%r>mdu{u?l4kMi1A01Ug`)oI zDIeljH|xTA%24l_XzcWLtf3q5yqJ9-LZ;cYY#Fl=myx989M>TZlgur?SZ6 zZSMB0x9L7Yjkb)t@5pV0d*L6UhVIQy&+3R;n54weFUMmiWF+HgZNn4;IVL_*87sx?&$K74_-%u!V2b-0x7O>9Vjkl9> z)=47Av#H$C_}pU?AMp2=0%wxTEw!XH5F?yLuG!D^B0mCL(4C^b4 zZ0>st4dVAE?Xw0c-&ztunfnm?5p$Y>!o`rjboXz;L1?OZpY9=>`<(3)je|8~!aNZ; zdlT8bo2NEtT0hrH4<d zjxfLsQ|{os59@39Za<>;Z1@{bL z!fg47{r?Di3;4E~Z_m4FnxtWBn3>~-85&N*&@eMIGc?T1%*@Qp4l^@2%$zsRz5h$Q z`|kSZk2E7owlvb{9FJzsS0(b{zNc1(T9~U(%lD8*wzBszVGV)y3yN>cr8rvVWS{dz z?#AEi!{i~$C3=41=nCdp6S7FJ0_N2V{WoD?tHNGuO{BYd?`sB!BV@oK26VV9GYYc3 zJCf7~;!@vn8h{&qKT=v+;1@c6ta!DK=F zmy8w+;hc(Rx@Xjl5M!P^&nzL1j^e#w-mQ3+b+k7tr@>_$UDd-P;!A|dU%Ao0H99rK z5MFmw`N3v<;RrGB3E&|F_`yzWF+WVhGbkKk&#FZVq_dGXpxQACoc1|QAWlr%p?uXm zqIio@TxLx~Ow7=$uuq5Vut#448^&%NUyLGZIyJ{Q4_RspIhUa}65JWJJG+wZ?kPc$ zAK8YNUPhj+N}7Pe(wl+rM?XcS&}4M1-?7{y-rRm`LgDFe-fYZ)>K|=t>3NlcxBh&j&5V- zd4zfbop=)1UmA`z#AEDD#U=5)q*3r0>-V7ZF#K6-tTgc;gU5uLfbTfYvirtVdkvEgR9I^|5TlcB|;1w zwR;5PjeP?jY%=MZRqDOb^Jc$E-1SKU<8SpJ*~*1P7q_P*D^Kb+_91vgI1#Vj`f2lH zpLS`!TcO*6kl+Z<3lM!^asp|Scy!*?_Xb75?xd-bdSVOvLLHU!gs5D@<(H?9pf@J>5BA4lP=PQOMw_m@8D$BoJX|jf$WOM`@mZ0%P{VA ztcY^wboaMWN|bal@o9>>Oo39xiTGODgm5gMH&Pc(xR@03l1W!>n+5O z#{(|+thdi`f_Ih+jVK;^`nL#AanE{7;G39$M~_)b8yZ$w^*!Gqemci})igFMFl(^W z*=BlkP@%Q2_|~^kiJJ8qe*K{d9pq-(_XYRb(H|+9K;~J68q9%Z5`NSeL*ORWhxlLq&RzYZBG zQ_Dw96Y3B)zgneXn2pF*WE-+h7$)GoVj|R;^eP(I+C}dR!%mwP_Iq6C_DhT;>@v-o zZut!5%`)H+Hj_fO(VqgkB(3c3$1dl(_6oO9NB=M~j|7NYn8(mW(k~qDDb7oly2rAo z_iwIg{^Qk9+X_40l3m zw7&*zN#DTUOTx|wVThxF@}Nx5QXcDuvZK!J!mdU5+%kcSSG%n%F72tz>D6{T$(Um$ zuFQC4N5z?&;D)xD>$Df&xR&zJOVVl;YWy20je(-Ih(u|#>3wy)0+esm*cf}b`>-%# z24ZbETO1N~d|27pllB#MGv=&yR8QaYiDX}7op`DR=Y4%Q3A4XfrXPA)-NU?)K0aH= zVhJb`1-#VdiN0MQRn2`4XtQf?6t|4jf^8IudKApn)G9L3ZUkV{A7p=rcPUDjcw(+9 z(-7*S>8Ly!(x{AS*-)fHgv!Yg;$#^b?&~!2>>Fu%knn`SqrT`imS4E|Ua~7E&RFdjLi>LYl7Q6Sf(}e&`;m6e% z;|AXDZfq_g6}nI|rXA}M$bNUAXxzXtel zivk>`Wx7f2?uOa{G*fK^t1hVxO?UqH9z-p>sa2~Xx+5=h8xnU92V6(PtEX&&8eUU_ zf~QAb0v5P*4d?Q=`u^No7V!)lgm$TxVej;@hHFV2oV*MdcQzgAXq9Xk3T?NVcG+J} zciB0T{3${`p7gBvcu;wYmdM3DN-kM*sNQuqdE+_`x17(^%^Z<(8#FnBxqfmHda}k}-6UNPc-zk=P#Cr%H(2p8y`*hjq!`AGXiJGQFO|y7oN;%w7Hkb9sol zZ4n8_umQszssbyhg24@EUtAYwVWsa_pmIa4CU??p- z;?Ei3EAK8UmpqrL_ZKg`4GYF&rU}V_!Q%TZdZKq)1}txO+j#c}l0NYTeDyu9Lx#A_kR|W8w_+P0^-)=kev&N4f*gJ|I^$j}7^~#&z(8>k>s& zbC&4ZB*`ER=ZbS{=KEd!pLX^KEZzP33Lb4^>(<_uaiN4w26V4k*}7V# z%%llnr#uQR)8{`8ua$2lH-?75HlyY65c3c&z`=FELsqsrSL7UM+8K~N`?HGRq$Fl$k)FyFuX)}y#+6;H% zjT^c=gtz52T|B_^z0#g_fnFFg&fPcmJ$Q4x>T-Icn}*YdLU}P8580JUiQvI@4(7mn zld&-M0%CVDJ0&#S-sPF@1Y42)5)aqe%}D%TIHgu~t^smk~XMD!Zwb&z9Xsb zI|@i7jG-`JE7se=s~O?He%)W~0Kj1{fB%@wd9~~s)Cf}Ah%&15EhCdQyz6PR766XHV~CI5+` zar|f0@Z3wk-8{q{qtEkKYuVzgY9UrD|b%0%|4sRPFp3#l09&p8OsPBB%n~33K=lzFVme5?t*YOWO>SQ z7s?H|l=@P_ zZQO!yKbLIphgpD;=u_AD_A?*LfSb$GP^R#%i;hF9WihcOXbq(3=zz3g^u+HXNZ-VN z5;hBn(IYjh4*O+W&^K@U1@HLn_zjb%QBoEwmZ1;GkCo0SQ4*(x}c}L<^7TFNgi`UCz^S}=sXS+&df`Ce=I^Dqy6s*+P zqx3AMM-+{}u)`e!8?qgwe1oxPS#;XvGAD_o#yiNK*?ykZrAxHUe9r21F-GHUU_H^O zPwU8ty9&8xOpn7VU}yYYbBsUH!d_7{aNyy@Z)>0R%HeC8$vB>nQ8QlQne}4M=TJC@ zFN-4%9BC+vznJn2xpq@4anS;i@_O*XR}snlU|b{6iEjvFsAcM}f!eL8GJ7yt`;AAS z-@dExSFuqD#HjQDa(Kv!pvU#1Px3}&=j~f;eLx@3Yb{2v zD-Ww)rSAT6oC2&kc~E-nRXM{lZ$aZ?)om*y;=MZ9VgW(qtEm5+S&uB(@LB?m4r+lI zB(E)}TkPUG+3sU9O*z%uOI#k216|ir{fRs-wEh}q+SadGZ~Z+{cGpvU=WX!*E?Ti1 zdX@^iV02o)V3S)GaGlkw`v7WQGYgZd>|0@L9owWc(oQuv>*kzPT&A0MFP?dq4bYF# zUrztPI~kn9dR6i$o7KZX=8O=jiR3W8+%=`m;HV%w93oSqeKa^>vHibPTW7rer+C2C2g z*HluS1!G#z;)H?@aBrN9H{L1bJgonZ*N5_Vm&0x3N2GTSq^gfQpFmn3bTv<5l-E%xf4t>>5>=9PDjk{t$ zTg98(^HQdzq*5I6(y-S1jtugkFxPwM@T?rhsu3dv^3=uIoZ~UqSC-NZ9iSA9I;WR) z`S4&PfD9|Q)8>NP~fND|CqRR&zwXG9U| zXOdtf@?*6Klpi@r$8L;ju4Ku<*x!<#nd<7mk5zs7F}$-vLuIG3)V0*)6!6M#5h-a# zFN3n2$8Hg+sc5P)<&ke6TE+=VVl$2juz^&Ri1Ug`@kxJDVBY+5#CuL+b9>vTb7DhS zdK65(N%MmE>dZy5*_o1;`?Ao6Ve+ABXX_XzsqPhWe4qMmt|5yu-7>u**JG)@bGjJW z8}ollLxsJ~Cj<=i%=C^zzh5&LKYL1}8p8|e+Vt#l0r9ba=zOKV3OE5}+~?k8t%-4!BSJPR{q)CB%S>#suA@Z4Q^6QCS4T{<45PAMfv*%f zFY)1<8hBXtpkNkVIe(&z6^a}V!aEED;VyCl{W~p67*TBkDia2?YA&-h7whL1PYN43 z%L=T_O#f!$38Vm~lMdQ?llDPp<~D@^TYl|+9}BR~+Rl8=t!;T+HxAyt)@O^-&UBb_ z_-Mb5Z(e@{_w~%>kQq{mwW1+)z*NWui@@n22f4ujpZg-9SK$xT9yOd<{H z`6VKRY3c_dO#B;7iY{02sg4LYXZ9o@IjIedsfV@xN*{&OAB9>Ci#Xr%%iIbe(2H2# z_K*z^6dZ+lHA{M8`;5&`{=%;6Ig#QG-1#}rcord3mM)|dFNLD zT-g-J;KsH)_i*K=O%!jIKPHzGQ_O5%BtqgyLarZrur-k!YMLC0wIX8GQ_&3Hq>p~y zozX0jHo}t};ciQCUL?3W;-4HA^b--$d^S~vf{r_q;;1*y1qSwtIkTtE1tIKcP|vOU zn?w!VSj|^}9+{FZ%YqJ_Rxf9JxN<#_Wp|kiJWfrBR=Y1-4OUl=x=R|b$hKyCk);{z z#t_s}DB_j7#jMgD@_X>vl5fUR!1|JZ)D<-EfYvLt_n`JA*8O(Xqej^sEN*ww3b1o# z`~^FRCFwnoXksFF$~ww1XD?4NG`^1Nuw)bCp}{)U1cYI z*0wq*_gV~l7Y6q_M1U?mz)<^s*YI=_tUVo^BUsty=S}h?QF|-|?x=2iXdj24@(s4u z7|4akdP^))k4UsGcmU20ZpaQ-f;|%zQ;%v)1qdT;Kvt#_v8dW7-X0Uj5x{n3B)!ip zeFz8KqiauSx^e>U;I+p&Us-MREw?8GJkIdBjIu+4A;4c*M%s z5@j7Qc_dESB4-`yb#{|!j2dbH(L7>kT0+ZO0?nUL7OxCDd+*k|m7lOb`fPcA!s)V_ zeK~K5NzxoUP*aDe1JJE%nA5E`P8hB>*0ft7G&EXxUT}Quv^EBu>5494IR&ii$}HjB z2fS_bvtuFz^lghh(&54n^_GX=mRCT?V3?41I@SHnvtyn z)wi9RQO^VUdb75xE}fe(&V#&r{V%N_0o-s=y}OsB-0+jVH=d<)=NFF`Fn#r5qztp8jDjf+{#_hST^wpw9En{VqE;NiSsdn890h3-EMgK)F#U}$ zhssNY>DBMR#5d6-VBw$28gzf;6M6I(c;r`k6nK8*n|Tzlapd256!ebimC;i`w3ge0A)&)=#%Kh_^OC@QCWYZN1j#`RWh# zi1D#agul&@xkZ(^&7rkLrnSwou|>DB&BME;{}%@Qmpn5G6HFc>b{-R?{x#~Lp2eW9 z#-P3jxsCw2o*ucbJh{GI;Z~94h@#{Kv*ehA<9X?*hH^LdtPaDeJxVb$=>I(CU_Qi&R7Zyl^eLykma2qgnDB_lK? zLlz}t_yq&H1tYu#L!Jd=a8?5n)`KXE-mIl~zB(*#UHi{k+^A>XsH@(n@9v}{`X80n z`CdonUeEeoSNmSy8)1tdVMhmHTNYv0Ci1gZ?wCYwt3>X)NN)*A?-)pLD@up`oOS?i zNdk8)fZH0tT@U�s0+1`fYjoUAxMy-<3ONmD_5SyKYunB33&_R@+KeyH4l9vh(!k z2l(gvyyu5t_iNP+I z#?Gt3F1kw14oS@)NzE-uE!1YwWMWpRV^+6kR=#1@hOL(kt5=bzR~)O?psANHt5-9x zR|3^*;nd5e)vK!4|5>fqO_t55ow zZV1ic0L^}3&GF5)W{Ku}iI#eA8>}QpjwELYWd|~4Cp2Y87G-DnMF+Y?C%i>Ro<(PH zHU|>6`zWiOthG75wiIt$`z9NSCOh*cTlFS;cV`<>XFFqOTV-c^=LZ{^2RrKrTkQvX zZ^TP}#A_YID_O)Fo2W~%sB4p`E0w4l7nw^TnQH@?D@B=`s?2k&%wyHeGmcD!F5xJ_bZSm1h3;ujt>A1PMuzP)fhXt&bRu7?F>ke+4UGE6~5_c-X+{P)0+;f%zWH zEX?Uq$CPH!>3yGmb1>0yk;!%Oc3+`bHfPo#Qt<~g=hpDcQZa4Ls6p8B&+430gW#EB z+Z@~d+c8(eYNy<1usuch)0er)6O6ku&!LqvFJ$RTBsu5=Ify?oUm$#t6a|T6qr-n__?{H| zrWOaR6#KUp2R)nk(Ac73=OSb8nlb-UU>3Bm?`CO6r<;bUn1-~RMmRfblYn};pFz%; z!qT(>Z_UNA68gtkTl<@43u`3|xczk8vjNW>4;c=(qL7d}gp3T|Rfh+4;C>+l5@Wdj zr;%vJbJl?y)Wc=o>x1HR_(A9+@Qndq_4U|f`quO%k3w6g^53e>VhJ( zZOZL$e1)4i1nYtf*fwnUQ@+C18p3fwwcfUD_jkU+|8&M4kqEZ+J^W;@uy}_)jp(NZ zE$^o;AH*&n;4B}4wCE?d7(}-iV6_-RIPItZG_F^8PP^`}J_I#TeA~vae%eR`$keM1SU z$_ItW8B(a){pMBuSyaOsRD&E6)&zgmm8 zdc*0ob$2=}eL7Cx?yI>R!B)%VUQJ=WGtnN#DUSthHlU zLYhzzs+jOi?rTo4Vw{k8tbuq8O@8ZKbgI0BnFL-5&0T&cb2QC9wJBvpevJm5RDKC_ z+`)`MWsLdf@SoU)8IhIWT&93Uai|t8&fgTrw3>U6$JFb4BFFSR`9*7_Y-4nGWw)^# zvDBXVRkv}>EmAWDT?WHnuqaa)#cD~_A(hoMO(Wo9aIvUcVk!Czn!}@G7=Me5o!JG2 z$J8)NGml_oJqjm%g%->CX4w8iTr6||N#VDFp9)H1u#jP{WbBAMwSqzE8kO@1a|%6^ zLE(7pGNb6hD0d0~cF(Fs6n&Ifl~%%_gf?!!R^VKURq(wg5Nn!3s6qBFnR2>ZOcwUZ z9|D4k0WT6A!#pP2lwHAJLsAMxpNkKsFfu6j!_SCg-7_7ka9;r5j z%qfVCBz3X~Cq_t{LzpiM9roDS$Mj0ljawl#P28D~p@P^?OF9L8vZ^hZnJxF6U%u6t z1#Hr6hDHx!v?TwIe6X$r z{A|aA0gOj_3E^OW{C49YU2-Fees=aY)K&1Le?3#v*i^2eH&bup(8A#B+eBE@(#Wbjw!il2G!suz4cASV=21_^%|HbK!mnT#JgtH`{p=xbTWB#vPDmx9ex3;a*7xgnd`Mo zq4mtYfwJJivSItOV9xAoT6ff9lT$Xbix28hH?*6bjPOCehwaQi($|+U_*!Z`45Jmc zq2M8T)SN5@>EwuaDfd>9Vb#ieZo>T}{Tt_~j@q`J?7o(<@-fV;r!G2iW>$AKL`61f zq)En&!m)hC>h~c?jU4(`ODgLi{!^);qa}k$7?j=h;C-8p8rAh`ESTrK?P$|);~}kR zGr!N|+!xgg(Z!`7lu$22C9A%>4)9k|UWd|F{cI;5qM@xaFEAq2Id+p9{acJ5iI)}m z8!inZrdR%DmaYGuJU^&!H!e&sDm>a~si?#brnGPfuD-WbJHRs_j@dAktkqLeBsVeV zMb#vg0X8&)KW4k*10IAL$+Bea&alny*Bi0=(0N9yt3JHCZuPG z=dB%QxnJQ&)R`GbT4S-t+_6vt<@+t`i+1`v$l)L+vEFcns!naGZZ)Yx<0mOu|Eb1k zcNJgfZ|Nac34DNlIW*U#1s$VNBaQRA_#MINvt(eH=f^}#`&Nbdrx zUVc9z*uMlkBYntpPrrOQaD<|w-@?Y&;?0x3;lLzX>?9dshcDVv-3=hG?!RZ6EPQjG zWOMEF$yVU`?uI9L6$pCaXBTD{!OR^pr+GD(0PiD6?B(m@pbE^=d;FaE+W0p9Tbc>Z zJMx3!m5Jsx1?@cs?R^f$TkX5IEW*bqg0~t1-}-m&VCeu%AAI_s-;Opq^CT4d@9+te zSDt*kJoz!pFy=JC90 z_8}Ul8(1~;Eg0OJz$P$qfBG7zCE^bE7KdWE>JyZP4C|G&c<#m8UWi7I$bjM9Pi+F<7O9)_!tw|mU z%o^IhT7GKka#3VlI#>pUn$zR_kCG}>gAt-h`?DrzIbK zAwLaByEb={<=JzN3GOo3k>Mtsm&6%I88!X^jjY-5oO7sd)+#@jAws*`HycieKx+}c z${5#vBDqR|>Tg*-^19>0@mW{wR^&-9Db?_h`l)ljx^1e?EipV36qymTp$i!`j() zCLItkl7u$Z)C_N~Nkj(p23y}52CyNZNAU=c%P4ckT_uYsw%N5{-1x`HGVXForYLwz z12V+fCs4J-XR=51F)CBOqjrs(2QW!lGrtucJ4zMLOJBrM@F&m zl+3VeMkDV7WP}r5H5Bqb{>(~9b-9|4V&F&C@guB4B?4seQqY5$0Xr!Ss(h~7=?$c# z$w;tT>I)!_b9R>Qij0EB zB1Zd_@jk*Nq+}3;*WtvNk%7O?m;{cSV@ip%Cz*K`Zv|$nQq5+yyG)-oXCn)hQ?<-j z=I0h~MU;!j0MEK|)Tt4|e|d6vj3heUMVKf@+P76L)C+r2PD?aYQ1C)#Q`h?KSJL4Ya?X}qD1tK2!*Yf(yIZyy-j{e z>?LNIF%3!#tK_dI6NU-*zAq`^U1e?;WMml|3;6vV1cR@Gu_h$Y)d1aO3>}bG!Y4|8 zHSYcsU+&d+EtGdD2;vFyj^AM78?5o`433odfa}SA2R$R3wEB}p)RVP<$tVhNoSB`N zyD8`o${T5nO*KF_vw|(k@2Z7X$~n+ME;8;SG-!;CR%)6p(l?kVc`?DNWQK+X&z*FR zj{RzAQ*tOj0`^5^1U+ONc^+O30e4@dU$u^h3D9!IWMX7vI*BD?a)?_OfH&FdNxTuc@W$~aehv|s3g{6Vsg!?TslvE)xPzDp zt%^788h5f(a=P$fewe(jWwZ^(^1-pFZ3C-{rpYcOLG;*?EV2JM7>3lF{hLn1F3s=a z{D{uhJjy^-$qs$1B1gUGMc=XXBXxYLYDWSQSqX|0;XKSRk|2u{GZc) z0ns$xGuV74K*)IZFG5yv2g3*H^egyzXY@<>{%4;l@N&n7h7}cmr>5IclPC$lKwcw8 z8F(|M=ctvnIlUFHWokNT4T3Bxdf~O(27SgWDKmQ@e5KddYPT}-N@>TCX2FUt`VLSG zFkjYFIQtB-=g%eoeuZD-@^EPJ4RBw85$M;dQo-!|JTPU0!q9G>M@Ikgb^QaQFCfHh zEUdY&DV1q*G0yl?D4k5Ji2G|oWWV-{u5Byt*JQ#Ead)3kUsL=Kql&Te4oFM}i$gL8 zj+XV8>zdompBaHOfFz>(_%)#w{m(mp6B}J!N@s_E%7CI5Rjn+;XPi8BLJxuDEw?P4 z4rqgulK7JR_!5e6QNK&9vm%oZtkWW$57ky^&WieezOhl$H^B9a4yy2R;4l{9_*53y zW85z+8??FDmB$ycb$#|JnBvapg^N}-L#mQQUI}xo@v0@e?I?6CL^d9G zhl#$d;@yg}z{#VlU^CV?2L8ZR!`69>wm@EKG$6KAm$%U|#hgSOE*w7_ey+MluBncd z=&IM)v>=0&QOh3&+0H=mNbAXrOw@l~rLV*$NW-`UyW#gVrDIC*f7)ou2xn`%0iqd+ zdFR$)oa^Y0UAT^Fk*!^1Ck_e+w>FkU{9Y|Aa^J!3z!)&sho<2=KuJl!Q9myZ^m5#= z_ePa!%bKGk{hra9BkK@|RTS9HRG|jS8f@?a#SRHfewp7r&{1eAEF#jCgJMhZ@=WS+ z%eY<5IPv~`g3QSzxVh#Wy+m#)c}ab_Nv_jl|DNrAVb!LNN&Y*#0$3d+HTt zax{#ShNgqi)+Oi8$5#RQv-lR(6 zt0uA!8H7`n{wR}}nCi?48eL;Av3Iv8WfX^s_2|7en=lAouB>RszYguGVX=X5EPA+rT?B8AWeb){Wm zf*VzQUDsV%9+eE=*`L>T&)gp}Y0>kq`46o1Yj18oJd)JySBH^B$}G$qYAKg%4XLF6 zybFXj`$sh!sivv5=#|B;C;bo;AXOsFM%o&@u0s52&%blPy)<#2@-993J)-AS`?c2l zs%r1nDs9gFVMpQmnjr0U&t6`$M$0SYzUV>zWWPx2dZz5%lR9?MdDVqZJWlQUQhZ>o z??I6Cx5gYtPD!xvvEcFfwELW*s*A}!>4`t9?(f%)Ixi;Zxz=? zfAWkUOZ!`Yi3F1RAY%f)MS@vfwE zeNdJ7w~7^p-5h*1FKc=*pL~k3EsH7fh8Me?h?vNf3L}q4S4hyf^&pPK+R#HELG2ss z#{S`xQJR5wf7=PD3tt{>qDA9io;T@56TPbO>4eyAG|VoE&vIv!E3AvYEJKq{p24$p zb!qtzh%!-Xj<;vP-EyZMpddGd90pvRFD2N7aQrpG$hje~Ip9BaW|J7*iYJ|Lwe8V^ zn*z9SzH#ytA8RS+BkU(4B=2m)NlZf=!vn?|!WWG`+H}%7vui6|xvB^=e3v?34O?kS zud6y^a!U%q2;deRn2ehooAAzKvYjiu5_G+nxB(GMltJ;RT8}>8yc?(wO}=Ycn4iX( z1ef%v8c8OUby@B_+q!XQih#WKNQbj_P6d$CmV~G8H`eHK*XgzJUfV(18}n@8r5wsT zE{T)HgLS0=+;y|!jfqWMS5!n^mDg{?6LOdb|K@O;5$P{x7`=p6;m zzqkpavJ?US?a`#GNJ=R!Gp&!6ROMz^DpG3x&C`#G^#?!3nwR@MuW@)VB-V%~p{t3| zJ%hNRc#H!btB+dt+O}2iP^2Y23uCsIKTpg*LX;53M{}WkrcMlHKb!Y?qNlMzqrK5Q zXyZ)Ga3~qGJR#mB`A<=78XJ2IdJckL`xk0CcrKuI!(Ix$M!OO{>Bd#vNSZATCUHys zsisysuPRI%H!t5a!QRE5Y^Q%vP{3UlxfYi%g0wWGRzWM9wgS7sOp?(vbR0};wAhKD z=M>4)*O9tShFgE0&ZU!6*%wsl0K^D1Rh&740!6;=;pA)&6)N3|%*A z=2I#Xz3UwPjVzmROy=jkPTr>3$z^%F&gfmLWnBbY9;GSnj_|;nkQR;cnGcxxb8{Os0XEI_{J?rf9hBgivBP_ffO8;dGvJVvO;3 zSSVQ@0aT30g~dbk51bgs$NBJ#%CLQUR}}L<0lzK{4;LG&k%R?HfS)D%55B);l z^*rl7jrHha`d4k=s&3^inoG1t7;cEnuQI+x-3nVJM`iz|av4KUYHqYl7@2^gUIiR{ zkb-I!q_%%m&*GN(CCekW2Yl!Ml10!Cs_I+Z23MjcF#|92sHKy`v|`d)N9Z*g7XJ^n9QdJl|F*v){8Ugzyr z8_i~V4U9_I#Q;#w;r}j$Dwz)6=TEi%m%!Zqr8~$|Zy&G!(A1HFbFkIFNh|n2b<`0# zQzS)dg%S5yB325UZsQd$fyE)8aUsk=!}qESwBm0+4aWTXD;(;}&vOtHB*?=3j-Su4TW zq0$!V^AsYSop3!c!7*5(B-z3B*1hkm^ZJc2@I|XSiBe^erz^{aw)lOwp7rGVXtA$J z)cKF+6i?EKKA#l&$_-f+#wppTfV&spm25HPX|pW`R1=SXgG+Akp!FU-GC$GN#_zYLPSDBmh(FIX7OsF|LzC`!d>2lyuUwxq$5)T?-9wW9k#c%% zpS`-dip+B6^5UJjy3rk)Y{TOtIDUMp-n|II+k_5@ybx-|^X4TItxB}bjn`6dUzA*#1b+XL+JH)SibTf{`n^B_V$!VeVtlHt$?-}qok!w zv)R2PGw@nMUgfMXf2CbC?b!qWKAO?opW0sO))J9{LWJnq;0&C2zEsPUMdPWW>4j#AA=?+gipUER* z?+zYM&t8zPWI@-Xa;hNxfw#Qp9qB|l>aJo$naOK+67Oe@XJGfPGbFvAMF)qQ?P?p3 z;`&6(del&rS0uVzjjJRAm)+e`)La`D9X{J#8j1PE0pVlPeJ7%5(uei!j)VsK(4Pd$ z3&vqq*LN42-AeV2z0v^7+*{ow1CVmp0cfJ^@T6<3GzDYi`R7H;?#A%67uzOxRN&@# zmt|}%J2$>{Y^C?uqghO)^E|;hlFZ=lwXktmQtzB>p$bHq9?O%7D^Zk+PeNxYPP;N* zdDz{jL&9E#xK+H8Z5W>c+!wTYDrhA+zYb!4SGzbY^X4_iYW*}6sVcBzFYO$Vb01fl z!hE*4#vYKswXcI^VOtr8_3M+wIoaVDDmRZj;Nu75Uf7I_L#f*);!@%MynK!KuUW~jp z+3J|;HpzhrrSDxdA8U$<*!zB)feQu}We5@*lUQ^k9V&j8>aCt$IKLDM)DzO5 z;NxE%b?}S7vSfq7DSftPQ9a5KW&U_A+Tt_(jJoj?G5y<)zezxQPnvkaG$6vultc|q z36Cb}tKJ68MzY@%HTjfTm9-*bl#r0PQ2f75n5S9q>h8=2=&vtM=)CTep0KX8hjleu zT6_K&XA4BpGb?8V2v%g%aI2oxHOznA95fHOH-~Bf>7K!vp?$p9VgT_h7qHD6L5l12 z&M8?nv0XRp_U;w+?Q)kmJWh@im5(i<>U9|XgBF)x{0!%M;X_7fdO)l(V#&~ul3x}0 zAwCaA2Rj+e=yUh?vc6&SqnbbrZ)NrH`Flftz`e)Fq5ksVLM`*X&<(w;a_E@L-sjDF*wVB)~E346EmUvEWRqYxedW z-phKm;SW$tRgE@YN6fJ8={Zp;5=ZfrAB{_P070<^{Ld*N8W*Ip7m6~sC`2-(kMaJ;MR|2f6D@>9ur`IFihmA{E&)1)Ux1(zF0cw z#Sd8O6r@_P6qEzU3Nu)Qn3$NVOAFv|ojkb6F@C{6gz^cAA$HNim3yyTw@9bH=pBTj zWrw24)_gTX`TjxuT6S60+XeIA6Q!4By#W8rUy}knk64dbJ9@!kMD&5p%u6hvYM6>_ zX1O%mnn!91bU`(t=uYbPKnec5n6VEEbTwJV1z}%wJ+QCxk!94*p0edCRt?>2@HZMd z1p2xlI%{R`yLJGue#oZL$*IgkRjYS_>MiVb zEo$Y71$3(wkra=kPn8~f%h6G1j_<0-*rqirHvXY?__rk-O+s1NQJutQjUPdToPW}N zC_odmvKrvO0|< zL5mw*@Art3H*YD&Y*iU%)qi7kJ3N2?M!65R+$!f?8f95_{QBNl8PuKr5k9o}9EjG&hb#teDLcoah%W&iyXe`m=50 z>&=&s1{o+Zj3)}br8D9)H>kJt_fT4-l=oD)Svp2xkz)#XeM8sGwDVXNEvuUuYSIE{ z=ShnFqFXKlc7dm4*gcQGys;l+^rIiTTCnR0AKW{_?61e%*85tqADAzaUY|k1v#x7V zlg}eu-;>*FYG1Ehqr7TqynozKvb_@fh=e10l2%1pj=@SURav>yakbecu5OMvj;bB7 zs7Ac0zn=$F$Zd3Dwo!Kh->JR1$XnsMRpHSE`qEbkbT$YO-j*9jipO4Qk z4WFQ^u8+^9q6`~(p7T0N2G*#JO<2VTd%ONB;lDX;14$Y-;%dcn0`zg@ zZz+o+UT#*Nx!$=C5t-$N9vR7e#Jk!bx3entFQelT2OUcmOvlQdp%eI+ACui%C2Y;r zH&>4dpfq=oIU9zQ`*1n|qovkCn)5=^OIlNyzdxc?N^<>v!H2 z-+w2LG7-gE{U3>=|FCZV7f$t0Hje+sss2O@0|ZTU?Gy|hC;|31y84Cy8(lj?D+@y- zhksAm{ll{c*cjTGS{neQ0Ez%zfIh$gU=~Vfp+WM?D8un}7dq20>n4dj~s1T}yZv zu@FT?cv&e^Oy0vx_j71xnYCH*^X+sR^!-n!>l7tl82mb`9+iB2<*1bAgITq%I(pk6 zPz_q*cbcLGRg-tVn1Ry}eTkAjGPxvI;=|t9(nVvPlM~Rx_#pklbK}8vqLsfu#$k-yy`M|3B8=DN3?%YuBuFrEOKEZL>0~B5m8YZQHhO+qP}nW@l~ud!N%i zPWMH}h>KV;R;)F@xcKIbnDc$!bk5PZv;-YBY|8~egfi}Nwkk$?OqQyi7(=-vb2)zD z?e)Wg{)vo^tgb9owJC|yxN;pEHM_!Lr7AMEAOev`kO$GW7y|Nlen|vI zNF5e{n+VcRl(roBmzkI$fZHKf54`H!~JZGRYdjaDPt==%2_L}ECSD0NiO0l zc9ZnvHw;Trnu?YE#gZ8?!(ZY|0AJ~Hk*i42l-}1l%9qd04l|l_OSV&vtPIsl7W50z zZPnfduP8k0nC-#!$LBjU=N~qv)DSPw;u?{Gr%?HI%l$mtiyp*wymE3r=XcIN+Tf;t(hl?Dvb!(}>+=YW4Lfnj^Zr43z=_e|1>Fcp zQ0oSJ>;*fQmLCkrgh7s~eN@`p{ZZh#17_Bn-&SI~!>I40@9!K>XR7@E9+C30icT>G znWU`a!b*nUcI-gsi@Ws(&qLrGmtT6C& zeFMZHRp{1B_HY;Ug%WXliqQ6kRJTNE_F7f*E5`F*ehx(1zgzhT7jN|Y`}Oq)c8-#q zbnWgib&LDB)u&WPK}b~*3w3_3O4qugOkoKQ|KNggvYzM8NMd;_c4^L=F&ua+B8yc@ zY^X76pws;bxmO4_wd7Z;L}d#o9pLidFrci0Mvo*di<1HgsAq8IU4a_;eD1w?)Aav7 zR;GrxBXti`+QP#1V=g?wQf%0(voC^>*j|Y^?l%$&vcmT~Z0w$^TBsMOrq1B$MGY7A;^U_$-P%Ic4B5?BT za(r`sPvyM!$I>^(g=PG?)w06!h_kh95-OQ~<{on#N8(1Yp^>%rS1(WyOyBON5i;w- z6vV-*mOFH-TXtg*!z+k{5sMu{(^YX?V57@5m+vNj(yw?4{PDxMm9oZZ*;K6SX^5}m zlwKj+X$aUnL%f=nYYPbu!tXx}iY-)?TfQcRwP$sD%W`s@+_=xX%WrFjXnq;v=_tl( z>vDJ&vz;E%2iFoiPGe#kW2S=69;5+7E^v~dtX&z~*uoI5Oj-@Ul%PibaWLGxj%8ke z|1dwft+e!NvY8u5VyO_;pz#~bY$E0Z+mS+N>^P`hEQd8T2N1mW|6EQ{PJCYElfsk! zIT~FiCNTCeYpCC@__$h%r*#Tn0b*wV8d);Gm6HGQ9jkYd9q#%B6Tm8S8mR3|sQBqQZQb^y-LEp|;_n%2vQpe2L z`YZ1NEOagPj4cdl6^$+UENqSc=UCut@pgX;k01Xk4*uxd>e?7v*;(3rrFs^|zjvk; z)Bevn|C7_c(y83PlN;?nB2YBevoo?)Wng7f|L=s!LjV6I+J8s-_x@iC)wZzvdrjNF z^~T??Lgqh95Z2STurs!ErWX2N5-c69oTa>l@z*-_|3=RAj}QGL!oL^#UjkzIPeA_% z|93h%dglM}e`jW*V`2O64DP4ktc0S7R9WJ&4qxjPbPb$(frlH87+$)A8!pgkpDR#n zU1`MA%%}Ga424-kx;8{G3`=dYzYn!Ci)1={ApB5Z*PTcJ9Dt!EH`SNr^Jqr@8|GE8 z!~Ir%zEp8uow?Ja@atZdN(T#BVd3nXU2`<0f^3}Pi&0Ny(PJu zii(H2Te^@|Kl9FSZ}=LQfWi|(OV+vCR7XwD%=lpduIy2-U6p|L>CL=&Oofz#q2}aH zU#ya}aNrM+2P!CCmEV1IL{VAG6C`3ipG*#pbtFHnZJ8f0u+ig;%q*kZL)_vw9l-+e zpwe63&Io0=@6zJ0UbfPTCF*RwbeVD!{9JtR(lC3^AbR01%95#EKXIvywyuq?>_FP6 zZmXw2-v+Hf5iE-WO=_<>cn0(6!a>XA-$UIPu399)<)8JgbTiFzp7m;fWSSxN$N>8_ z7!-pX;qpBh+7=j_B}5&BBXlJkFMYQU>k(!{Hr#b(!%y6SQVajGEx+jFej>&j7FDJ^GCVTOx}U) zH6COHa=*?-@H!|!rwM})N2f-KL?N_(Cvzu?jfA3~`}!B4-dd|O>m*B%+VQlAbqeJE z@E&1(O7K|s?hiLWa*^?#{Dtq`X=$WtUK>7)B)|fOApp~p<-;V5VS}XrGZXtYjBr4B z*GJk&jrpJM?}G!fU+(Ypvg6kWI=0Qt%VVsL$*$DnCR$)h<7Hp&?_aYQs_Eq$3%^W* z?pv4#Qnbgbqs3Qz%zrk}sk*Lespe5v%pWh5pM|V%;^}#AY^>p#WE%2r6gZ~lT|Hgx zT?ON&+RxqUWq4}jwncH38r-^165f?7=nPJnAB zWjx5VA>bY%@}2-L%;~qQu4^qvpDV*o^fu&nGH$l+DA&;KDD)8Y1f!`9rnOrDo2A_( zw`6i*+`eu>s#_LKFUitSp~E>XsoeTV*trRB(`fCf8{Fj!Rh-l$WgO%YMy129BlGoN z1NfQ6D%>0AmS^jqW;w|?x=dZM&tHGQVuezg?~U9~r;2 zhqs3ZvU&&0I{P-OxTx_=d>I2j`nWjzQp24^HPv2v=K<-8N_)RhlnlV^kJyRsPY>mY zr=|$C!nHfMejlwLy-zkRG>y6y^tcc|G&@u?H0Tcd(xY7rjSL|j2>Lt>L!Wqbem>zo za4Lne6g=fdg?B4}_?UD- zcpH(zuaUoXHtN>c+~T-7D8QZRm`_U)wRNq>uUl1#S14aUeC~CbE;SKueKnQNcxM01 z40QZ~@Y&EkNC$DiaKPT?xar$p^=+ZYV9D$DCw3Ygb^;&jnm3>d_@G;x%qLR|*Ua0s zZMAfp@CmfTJGad@_a}J5FRC;zHa76VZJ0DaSt~4yUtDTlwN??2&cJH{@LL3K(3^Y& zay`^Z@WOOx1KuDpKf!E%q7K+vCVxAQg2bdlB;fqbd}k=4d(1JUeqNdlUER-l8n z=z*_7heSmw$_YTq=#stb1%JZ%0O$IC6bbYMN3a$M@g)lUnw-t`CQ&i!RanA0Ujk3u z4O~Lg^a{M&|9_!LxQJ^R;b!#P+jsgxUuCev4-%_4LJw z;s+_}jD8D0;70ZtQ$1gY;wO5%3}$?+szoB_5msh8wj5vl8Z(kL70EUmCWR`+hlrOO zW^MiL3fQvx!`~5phbV4++GW*;=-E9xOln=dvanua6baluOgGImG(&4dnuOTlAF>kB zl*P?#g#}X3)*5P3$ip(bb#bpMAzogqCee%*&i$;Y2Z>x~M?(f83 z?(aJpX?^NN0cg`Y(bQ-`GSUQU|Mq^bb^=b!`V$vyvyHacXK(Fm358mdc{aL!ngB%s z73l=!?^fB?lUNSiL{TdzKQEUZQ&RLX^HWwo1&3Bv@5XbP7WwGQLM-gFlk;)o69m}X zPn=&X0D+%>$u9vA^-cJPA2AUy;}0$BAKJ4NWCSa53e#RV{R-q{t>1n0zjzW!lQKnBmBdp|BD+ zp*HTJSd16HeS17q!|O6mn}FA)3)tct7U_&-x}(GEmTC*qc9N5s`I3SH)Vf9aJO{ws zLQ894Zs##TqL+DKVW26;-p2IbUcMGO=okyDaIH54lGvymxA!%F+-Xc+^u;(&~9MtLw<30PTOabek! zKPfdPWStYWPp}!iwf5c~iZ^os zCIQnezz(}O4?74Fq9<%VzH9-=PZ)-FfV4sM7r3)-!x$j=U0Iwi>9ii}v_4X{Qp#;x zH)F@poAdhDGd|ZLyaqwGgiB7ulFvGA-swKYqj-YI}y={Hx=5s&?ctD>d%@@ z8_>i$^fQ3#u!g~SfT(p|yH2Hzb46F5R$yqg4!WQe#jS>)-bdAXbW!9PSW;9aMPK~WP z8<}))iQk1`$oqddsnb~`R7rb{51(+(F)H?;j<#Rug-d$vps`I$mr7nDUmjm1S-KbM zf?0%l%Wv-(U&!C{K78@=1xq|mfQAPiOE*h+VisrQ3Qm4O8%LiM*~ojU@QbEPNEo`L zqH!uqu!QF@GpX3il*@^xl&+LcP^j(;wOkMwSEi2S+*1H%9I)fFRf-x)(lsPXjq2}D zs!hDG@)VEa7Yt8|z3XP?n1TyhJTxL}*X3KVa==qdNGAHQ8;iA(#F#B6al-;vZNM9M z#VmSpn`49Nu*D;q0|#bM-pkhW3W^}^Z3{}TZMeo+){S$Hvo#8A z+fo#*ft2OB%(S-KMSe;`d!oGGk-8Oz*7Y$^a$*IB3`Z1z0)z%=0MT+OBT^^;S!D{r z{bFGGJkBDdekpz7E%~C7JS%wlT(%O4YdK$}A`)U5r1>1Z5^?(?n)%!pJ5uJXfIG?; zX6BrMIlq({^|`Q=+4VUenSc1d$B7unNthQ=>q~KtB6>H;9IYG?3BOv3qu4Y!XdHZ5=gv6IT=q02Zkhqr`t6( z9eux^j^4?W3=Re7wu^geZR&jbFtUEk+Kr5Myy6O%-R&RO%)8$C@GR&QVsQdIK-13t zNy#G-;z<&d?JF+~{+!H8HX#_7sT5(zAZ*sEAPQ+Df**r#(T-aGQO>82cBvsSY7ADM z=jekY1Jq9W)*)zWj9Z=vQ!O3S_ZoxW)2wYu#%LCMh9CybX;gUhWHC&rozL?N0#FVg zC}g$n1G*R)Q+1BUg%W)=N}6ql2-)cEC;1^rl$KEDslf1_y!wk@4iU0bN<6Av#flbf zh4K9`m* zAFJ9c5~PYL5@+&FLZBya5-}tdA0jgpq+TL9>KVV)zeez!b7V7qpCKe`KY*~_Jwre- z_CC`3f`BlbRFQPkbJX*=`ZVbgW3MPQdiBJ*<^JIbFV+^J>;&>9p|{kbIoPItgT37z z1g7dEXbb2=hwdEm=21QrFg{*w}Sw;`#oX@BVrfyumAgJ z6sTL6q!qZ~wee4+g>A0C5=fcI0gJP48meBKvM!M}-!CtC;I>fauiqK}R^?ynGJZr* zKS4C?fVc&jKaukEIGlA!{G<>9Mm6S_LeARC>8R2c{}w6>A0yaGRq=}OB?u)jA`{6$ zAwUE~627#MWN}gWF$3vCn*xvcGyOz^EDC-?fMk~9%!3q^#&^sC!pfmJ$%ahHk&Xgo z8c=7Ao`NYi;!)YX=t=QH69QnZ1Tg&sIW{6}CMtp)oQ6w|L9UrnX4(c#|FbA1@r5V2 zLv-2FxcftUhsMh3%W)(qc=e4Ul!R#5R^k^D)(~#|-ltI8Of-QVWeB5bk%L!FEF*{< z)oANCj6>+HlUX2rq@k2O-#MOTe zbXzOmLHG%Wz9sJGSPUmybe0MvG}bO=CSvVM3g7oTaa}NZ@+B;4Mq%w z>sj=h+CB`YwF}!!adU}8EM_9@l4^Q*JW);TPL57S4ksQqIpAga@WW>Hz>+Uw0i$3| zqh_N0(oiU(q@6%UHVeA#bJok~kb6GI8%}25U`j3?R8&n^|3fgV_TiC8RkCvfWdb%- ztXk<&R~S|p9T)5}(4PUM=qsu^mICbvVdvmPF2XKvrV+UjJ>HRnL0ZRBNIEwRy#N6> zzx+HNFA7O);}jicvd>zvu8mwtgar8IawtFrTaWhn2<523fbCO@NNr?O-X>hAmU^7y z;nyN`JW*|@QISj#v!L;kA!Dhbz8?Z;%Mg^^f6+6>CbZ8mvAG9p=F#N!dCixIzA1{^ zmH`*We8k<=2Ue4}AGp3;bKC?+Gn|4VKm-AlfQcYcAybK(ca`V|VGuMJWy2=%ck^38 z${Az8&>=9$L(3D$JN%a7qd);lra-X9)-NTT0~Rm>gyLqUoIgCKJ6bw9Lyo3DPkyG^ zPQIjDa@IkseH*cZt%_qOd2L$bHn<4uFm0(((7fU*0!7_+Q$EIv4H0UfT5PXbFgw5~ zbT@O&rz&Vm`aC^q#i_{YNV_pRn0t;0xE0r~8(R}s<=CGNI~{%DPCorTVLMdLK;JmD zx+|ALnfz+;G3h0`rQ-zS&MI>Odq8J^XQ(dtN;PsDJ$YG=I|h8Lr9u{N6OF=f0ef=F z-m0x>XmkpCqZV!V66Od#_ zY$9?~$=HXXUs&yJsZ`Fo98-tJpzTe5lype%QzybG`XK)Os722|0P%?0wZWHf26oyF zkriRD=v95Rj&_3I`{{eS-244y)8Za&T^d)OTN+oIGpl3dq=Gwep54?}i{y5F0>=}y zlu*6^cPLbDSn;l1`dq+X@eymRoTH!xx$2}jL)yLs)nY;M5ef07R6U0feOK#UPN9gq z)B_v`i~5yccCU8IskopGo%0pJY>TRPz4(a1;d1OsZor)^bfuFKaG*Nzu%QU&&MFPR z{^NE&;O%)OM%g`Zg?0^p)y%8}qQdBbhBG$3fT^f7q}D6`0V?k&pW}r;MQiBP>IL)q#rVhhL@LX zxJ7FdN}4KqlQ=`6jIM=g4jZav%|zR~?wN%hRYNPQyIa!thh?j)o4vm_X%4__t1pJF zIvkT+(ET~(mR-|4)pM}h*01Kfc_&g(E3O@OX3f*xC2m&hc|z(9raB=$Nt*}T-ak5F zmpswI&P}%->gsnj73#(~p?6o$-ydcCMu@`S-@F?vqR%%d6x(9!9IvJ+*Ctm-FsLDP zwJt$k9(Q;yK+La{gl|R+q zeHxAgHT3V$EK4&8ZA4yOaxpfkZ>p$foAMZHUXd2YB@*cRg1MLNnZj zXrJIKZ8&4EcSuJxfN|$?w=J+G`@i|4vx-^ zu9t_cQY`a%Y|+FM59xuC?SDEw!eS!e5(^T_>bVm^<8yuEwPW;1P3v_RVPYkxH{M`z zBe`D2v3wPMdt=)f5m^>k`{g)pDZhEVxXNt;)qOowSb%`j=ukBSBe$T0JYmZqrV?r> zTU$w9+47BstzyPi>9NwL>Qpg>%4pL{z2#<2ciMt8x*%Q)fj#&(Z z(dZOL65N)LdqkH)T6 z30v=}O~Ad zg@Ogt?tH-&L#{q{h@G-K)t&)8bG3Cy zpTH8_qm09+r2WqdyT-F^d~UVPn2s(MnUkuW3o)rTu)Ms@becLmI=XoDRKgGAHc>6q;%s4_wFMYj1dgPiupb z=c+Qd$+y*+j-b!uv19G7qmtP-}w>%=Q=s<5#+)Zd|D?t z`?)LDJGJxrpA*^CNk8P#NmsGfuYY4pF{18s07eLjXfmAubz=QN_;sLR=< z){%&Thu$bupq<}HwP6?3AciOXa6X+MxW`-Pd-|ZSK~65S=Z&G|f3_**)Py>6^{PHT z8Wp+QM@+}ptfvx*z$0c2>MXg8QDJCYq2A-rc4`@76_p+Q8G9-(u}6g|{GqSV1n=?e zDsy(Y(f^@pBH{GC!!QI!kY)CFYu=xCn)6wvPx&8{J42G!`S`n;8UwWBd*K{12dStA z6iPvE_*N9S(>U;NU@*O&^3{*xS4vF_Wl<(qJ?IOp;Y?>ap%jCOkhn`)A3Xiq>l!d%6Y1DyT|ItRo=Fi%!JgHUaa1$gquQ|b|%d9)jb0(ZpUccTjm3c zZg}cO76s>)Yxj#!-`oQ&;4fKpui=%W0UGvqzjOu9PX~?NC);5=eJm_xxB-cLMqgBbhM{oqf`-ABL>n)%TFSR|Y*>BVAVo7+^cjvbLZ{k+i_ zN`=Co!-{ez847RjZDQR9T*1YjzLwnjuru;mxOokSZGsAJ!>CK5k7jlE*nNBza-Hzo4J%C`F($WRm=7d50&cE}ddHjAGh(VjP7_X@Bq z)c2yftBfF7P%IRxF*}uFt~4~0xftLPCjT2O4Q-VYV7Tbj%ZqkaAA)Uowqdu6OV@|9 z<;RbQM&$)*#3~bG)@eMQcJAvIzSmCIu2v;4z5ce|myMis!Pf%g%Z^v=m!j9fj%zbF z_1EdwZF8+pETs>ZgikE!y9URX(Z2#%7cZ42poc?t+xo0E zcGzgG(-N05j(*QvEItf9b4+~*5yhfh8is{mT4dto0&S>8pQ-m%bNzm0od`xxCER^@ zb6kL$lnbXo96kwl9joP`WuCTPIApl~NYGcThMRb8e>qMiigAZla*T4IJ|}v4KXMZ| zpy%-9=sb?JU|cO-&F-AvKefy~tZx5CIR{%2j-68})+exxS~%uBGnU3GXzO~+XKWG4 zMK=9B&m;JXeQp|dIqeb1Q`r0{Zd<(V!pNf~+lOzYX?4_n!!&N~lu`dV(?MyqsNw0w z#UU`~DD|?36)_9(<@h(llWM%{w2?03N+*%|?#7$S(%*_q>*Q#Qn=aU_?u(6x1-lC1 z^-$dw)oXLYlC?L(2wt^Yn;S+SRbs@IEuU5*|BR@2z;aOW>;vnVoTZQF`ILu!6qYQj z4b)DL*Sqkaek}+V#o+u5tiFXEm~fS+vcZ5>WJJs8S8`_5O@6Msche}b2oW@rq(A5= z-uYcvjwRit^lUpYHebiikw8j~DLFs%Tts)t+kg0=ETY`S=)riquKu_Cx^bM zBllWtv-@%()O<;jgT6rtz(W$)OCK*(c#*xmv7Y@%yF7RpT4x!h{s2s`%A3mMj&^Dt zJ}6s|QF~;(0DFnmfKOOPpS`<{@olw!-ks5WA%Q-79W(T-yvgLTAFug4szc6|iY_L6 znjp#Q4G#OL%Lc1hFWpPKc8$W59<|OM-x(n}rHFTtBs4 zWBfK_{dBob1Nz^PaCKe+PlU@cLLp7)H5yKw2Du5qO9+j+>*tc452GzixDH*pG8Edc ziqsHUoJA2py}@cn33UQi8LMG z{+MrnU<|uzdBRjLYSZr?<8L%)<{C=gwFPB>oG9OI@sx+{{5}%FXila290;KCe|})h z8r2#bZ(^(qFuRHiaG07P)tf#D= zM(?tCiNDpWzzJVw0D&KtCJ1lHScoRHmWb%lTLFCrFBqD4%*reUxSpug_~;Fru-zcd ze%eDM3ZwEwhv$@=_2E^lMwXW^>1Or?+HjAseUJ`Q+j#A6gg6zS3Q;QqL0^(52~NY$_T7(>ZPX=t z$LH!a>qD%BWI}~No|`;>xZ#m0eICa|K(>D!_j4QH0~Bm-rSm)uf7=723;gp!Rw64T zm;!#oWg!kDgtNls6r^$h|1ub(9_zVil<;P%aBGUgG43SobcY_XR@&mA`wDob%AnNw z>Y!23hYFfsHkvi zz69;OEwxH!{`!>%0|hx$t)R0&qYvm6MngLJ%>eb1GJo!O^?*erPAi`3QR+hxSDy9y zev!7(;CriBewCWK1EPpri<6SM;fqz9xg?)yGyL*`SjD98_aZkK1^S~bn`lE;o!}Fn z$E5=%oJh41@TULQ2h-1QnH2IDjk4}$AHM4cJbfXl$f9hY8 zmw|O^AWh@dbx|TxPeWi6s$_G+3D$w(O91M^X_^qGH9-Bsj-2YyBWpmjiAK*T2C&PE z%%d&q0PE5y*yg7Rp_-WGuG1QFm|uF`z-fAtPrlsUqS!v(a0~63-vW(!7dyvVc9iOs zg`LypMabO9;T}OP<%MHMPA3W(R_(lW$DQ;o)b^y4EV--4H{9DUtEmjV_YQOBw{H4& z!1aWx*z3ZFiSJ<-W_L!p_zTbbwE~Xw@A0Stjq)lg-lhCd;X z!s)-~AlN>uPRz%Ln&th#?H5b!#$m5}PV$8UZDcR@g?N<(_V7$$%*o56JJLg$q$wtY zPvFoEwRz=udC!tNynf5sxp5}uGwd@Wy&2w;I}}d8`D3jOaQ3j4PJY%BtFp4F;^JlH zY;Up(h)tGF;w>atiaT0M=I9f~U0UQNWKQDf`|^kWK>6H?`*qTOD_|QjnG%!Cp6w`G zfRg?N^xI2hUzRYYqwNfP|2|tOTTx!%AHYb z`L@&tdjZ!ROYHDsyN@hKcC@Kl)Ov#}@m8~NPlsf7;-@4{wCg^^jr+&N4*xUqe5U^R zW5P4ryjX)?g|Rr0C-nF#LjpEUJ8-VD4U6oBh56J=<9)LI7zfZ`i`KlXdV#K08RG)t zDcPz+FgvtWI6wmad*`%gzvq(YXy>};nrE`)W!qv? zE8fKFN9Wu2XPN?7oSY(BoBTWzj9>RUxMQ++w|-Rj`no!}B9TMq#H?z}_ zZqRv#{$$3vZOd!>|?|P!ydfAhe46MQAmSb=H|`kq!ZIC zNdIDCWM@v*TQ-a4$FrpyEEhfZGB;laR|ZnW(c79MiKK)ijig57i_1fK>xZgZXO_jW zgJumu-+Mu{rOGB-2T%uJ2TzB0hp=033xQp=wGaSS^Z=f&-5fi{AtN)6F$z%!H z@s6({LDw0Cr+#|NMt{q(4RuIF*9NfKL7#S`jzOL#ljzA&whP_%qfO{k-I=!nzwRy`2WT`=)@KqINraumQOvBE~O;;#S@98@wq)lpXmI5grd%(^IBp6a@n zXWlmgu}pz4Ymt8bHYv82ptczEukUMK3XT(KnIYOr`7fX!pELfvZa zsD|HW`ndMZX7fG+;$aG}+00c(@;sTl5&dCCW7%{ud1Fb{)$sD%*S${iA=NzqC}``B zj=&8OG8z#~8WDCH5riHQx*8F}8WH|F`Ws~QcMqX3BB2mHp$L?(fp(#ACZSL}p-7ma zAh9dKZw!Rcz|sHaGe==NN1;C>_`Q*N`H=Z(p$H(N0O(N!A>;m##|dD@0odaN!Q}oB z%L$;$0hr|kVdwr(&k5kp0l4P`|FYAW1dy2kj7);ib$=-RvY1!0s8_PNIhNq;{*c-U zpxXgh?F8ZfwmJmx?*P1agWq8Ke!vVo{vUA6Ndd=6-pNV+%Spb?NrBHwUjL2Jj92oX zSMse_3cO$P3SaUYU-Btm3iuyHdHYfzeic516+)mDhM*P7pcM|O6;h!UmZ25ep%osw z6=I?lrlJ++g}*ppw@xlh?qs*HD$$l>bIA z6Y^}cx)mT20pNS5Myp^1@dFG&JqCmB^oaxvPz3au1PoyY^r!|5a0c|b1`L5o^ax() z>0{~0W9ivt>4;_NnP=&!XX&{a=?EF8Gl9Nv%rJTi2D%OhS`r6376;lI2f7Hiwcns? z5PX%B07`NFN@>JOG5Ja<`br7=N*Sn1(eX;j@=EdZO6kl>vGq!+_DYHON|~@rQQ=ET z;!APkOKH?gG36LN3ue6yW`hrBT@hz}6K6dYX9E{!-5F>78)v;8XM-O&UEVl--ESGc z+2Z~OvZ>3Ku=@o=XN!(yOO`c5DO}N$s3lLcm}T!pvnrt8`43K$W{-g80EuRwf#wjZ zVvnNY0IOo3qv8^{PTRWio&N!0enP&y!Sg(D|LB2m8xnLIBXt`wbelkT8&-51*L)7Je2%z$ z_Qrn>?!2xQLm+lW5zz3LXL}}VBRJvncI*W{3u0?fL$-oS+59TFGp&xfNn3(YOe@?FGqW?fPXK~d%yS%cJ2qPgY6yy z>^vRp;`i`5vhW3r@OifIMNsiMBJl+j@p&fkMVRq9s__M!@p-QCMPTYV0_p`M>Ujq0 zMX2&Qit+`l@_CN(MR4;u67vN#bNkz42iD>XJJ}P9^J$H9+uBnP+$lcX8ExEYY1~=s z^eN%=8RP#OfcX+<5dJn%@L!S2{C<1ai1UfXvK@JgS>?$j;wD;g(! zx9>dQnLd-SZxHfZG>+>Knb}Beh?7+WXSnJk@J&7=Ld<-PnI1&E>!eu1boOS zgy1L);V6{hC>-*r|CK0z#mzt{I;6(?1G|P$P)MCU`t5<5Qpe?auV;Hxs|^ zzc9kTMC-bdbe!JTJ613wtwBu8>`~6R&2g^G?&AZ>8FkQc3dbD7=rC@rk!n%aQ zdW^!lmBMqgbZPt~JC)h+YSW_4MQNm;i_S+9#(mw;K1 zfmyeLS?}N0^jXhWLtEpl*8``E52r^Pr&}7Q*E+3BIIYL{&7YAi)bHA-i-2aE z;iLb55poS6bM-TF4MMl|QML_WxAk+j4MMo}k-80_yY;gMXe$Ni{)$2w zzY6OL3hNsR>nREwI11}d3hQ4A>%GKCyvE3cOo|FlN)k?r8%|0iPl_o{N-<7KI8MsI zOo~o^;$~!ouDyZyyK8Ml{^iIA^WLH#7~mb~^Bf#jQg!)I_4T}kch-Int-<)*%A}e= zq8gT=8fTyywV|4XDjO0h8>1*2F)5qCDjQZQ8|Nq+bt#+tZx0AGvtb3ZaTc>t2eV1I zf5L;$Ml8-I@Xm%c&c=DpMm@f49&m>EzBs{O?hZH;h&aR2IOFsZ!jhL@Z;I0j; zuZ?rBjk>Q*f^ZG}<{Bg98qwvNK;{~j<-&E@$IRGoo?@E3X1TnwFv@#;_JV&7ihTByd=8s@_Mv?asr;`!EA!c3^I2RQMPVD|dkzt08v$9) z|Gr@zarVn|^(z7s%MlPOAQ8(m5Gz9E%TeSjVCBnmNkx;a%umEuE{+5Qxe`vZ`tvdiX`S0k2_$(K{nms8l6(?FGzj+axG z|2rn9&MYTeFQ;lRr+6=?2|FhhKBpu;CpSK)Mm;A}KBr@fj(y&AzKb1d(GDjQZ9Ro zE?a>vd&BM%=b$~;pd&D;9RaBW5~)1{sUuXO9Yvu7R-rvdp(D7V9f{}V*u+lRNB45t zI{RC$Ek~l~&E!XabNZlj`sDL_DRfg7baR#G?Iq1l4$T4YTVZIcpJ+>*XlvMLOWJ6w z4`oXXWot-jOG;^LfN4vDX=}u3OU7xdH+D-jc585IOLA(fziLaoYHRpvOZsZ7FK0_E zXKQF{OKNLtpleH_Yis0dOXjPq7lca`glkZsOH!b#pP);epljHmOWL5T52;HGscT4~ zOG=?@fT2r*p=-pUOU9wAH@ZtSx@&NvOLC&CzoJXLqHFk~OZuX#FRM!|t7~YZOKPKQ zprcEoqif`&OXlON7yL^U{A*C;OH$;kpX5uNJqll#eO?ymC$9oXZ{{x{^GJtEA%k$%lKG?LE+iN**p1@ z?N#DdW%s7fSJU_V7rKD*$?*!m3CPk5tO>GF3sD5&+b>KCDSxcFY#?zZAAKe7RVxUE zZJIS-)}GX@@hdbZ$~M>yxJxg`p4P4PD?BIKHuw#Ad@uN(z^&dZ#3wR0n2X*)ZPDYWB`{?{Z*~YfO zz6<^I#hKU!*66{Z`JyqwK9PKZlwiMjM?H^QuU8;XKi|H4!0>u!_DpUaUO_(*zd?Dx zc6x92Ty8xw;|W%ha^=$6Ah8lN5)$YVMJ!n%)A!W=KY!Og7R62^YbAEnpQG_1?4Uz&iP?K8{q)|^KScd?i$n6=? z1nc@xK-H1IGcGYpFoZ*|zk@j_tUs1zuw%hNv6A>>2abfxlzoE>yq<8E$N4ma|nrHP}L>_9gX5BPArbF&4Win{cnV z6T2k8%a{z|22>w1wiixW<`E!?*IHbRGF-&l-Nit|HyVOlgA3MV*a9W&Xauc#{`iU4=W z><7y`%#dfvA5r~D-;m;fwcm%}#q)84R3o!VUy=<8fYnWqQ}Ak7dE5_={-8Txc;l08u5Ow8P{NL=C=cq0%I42)S-ML5=e(x z0IF2-2xv&0K&UZW$B)poNwS7vDs;$jANoTEFnLr~QN4mhxe;X_B(rJ;WOeuN$v&y+ zdUmlSPjOrP1&wP^hrqTYJtN2_!-}}gheHj7tqElr5$R8Jvsz%wXEi8}qh~Wf)q123 zdvnpkd#tX4$!M;y(8IdSTjDIT$s!!w4L91{)$y*Be>p03z9}uIPEl0+LR}@ ztj#k-7UMa6COO&J9V_4LM_Ald;v@=q_?OqWgD8e_88};t-6orfDKNCqG?!!LT4?BX zP2M9&kIz_9Mj)FpCFE+!2Z#8eg~+?{pn)7mm^s`4QMhVlTfw7#WVRvdc%tfc#gHYg zQWAn--9ir+Pa8Coi{8|2l`IuPyA)$+`)83HDs`(}4`Rt8mv1So9o0dV@S(4r#Pe9# z&xKJp1>n_zsq)duW)nCk54JgjLp zM#Vg{LZPYNMG1#)U$NbB2@Z|3QOu5{(MjQMm z^6dMO+DN%bc4!)=$b)Y|?Ps6ux^&;Ik|&>pJWj>+^+j(a^y+w!%}iR$s7`$A!|$jNDz5pO0AS81F0(7cN z(uU~@>6t6cXi1&uL5Y#Mv{%wJoU7C^YouwaV)J%64kFZTl1bdgu>E0uTfy-$-OQ@= zuY{9fFjrMPo7%OD#YMU2R7_357eP|;7?EV&Zsv;iQ^BF%seM<$@tJAJ!6$Oe%03!& zlwqValM7HWH4YeeOFVUU)0j}>t;rMGs?BzkP370ZEuF-X8D;b#@vyrgKsCceTx~%@ zRxLrzeL1~EZe}EW)onM7t$XJA_HPt5KLc067cYl8*h#LXI1F7if67Im%e*I+!}_Lz z<72Hc7>QYOGdwM6jcy_Pa)PgdbAmgH2d;FO@=#SUkFQWUFlv+UpgXzr1e*`DU2!=G z$M+ypovJt?#RfxU!Cl7*+SH)l$;3$Rx5r0f+hZzn1ASyd5u1}Zg=*{(b@1vd(Nr@K zD*Z+hG-G4R$!AK;MepPd%OW=oZESgx{2e8f&`!r^z}T(%qCk1$3a-kzaX1nc1|~ib zr%#OYMQvLFTWKwW(pf*ibj4@aAVu-Adt!H9{RNvj7%4+#@>NB-&1`f9|_~Zms`b*_;eCaZYxr zw=vs77xNwS9#qQvPIpcw%=jC{X4UBl(A-dEje|UhClJ_JdC)4Hp=XUvh zro`J~?6c`Ra;naIg1qV`gOT$xT%U&#qA^RG7a=5OM))(XKPS^66Sp;|Ig++Lw{!C7 zL^%z4)A%m~KL$cF1Hb;T=&>NZfubZtRK@`Y-;pqDdS5ig3q1iU#)}Y4YkFM*Mxd-3Mn^qODaI$X&?aO(dJ=>U6CPDMb}}d} zG;Jn{8!MX*XWUMG&(CoN{54-jnvxQM4V}i9Y&oEB;XJlOImg)1`I4Ebz*f9p#Eb(+ zE+8C%wO9YEYVYc*RlB=4ew)axK7KLcxA81` zc@tZ%kOcZU*4@m4_Q9E)C3sA2Ti(tfI_lc9F+5c#lzU=B`Ci;hdFI-W)CoGKpl(^@~_D6Y7)>HZH_k^Y9ZS#w=lf&Y>nGk~aqRgU4|2XuA&Tq^s5L2QOSf3J-LHl^lB4b7F6)xEr=)WCPyP=& z!|7xqUGHpI8XptcPfh8^R=NvaHxfNeK>+s!?wh8Uwl$s1fQ9Eu*J94qSK5>;LjmeaEDsfL}={Yqx~t)EMSqrBk6@ zlQPSk#uHhi?IXGzi1BT>iEX&pr>@TBrvfdfx-F+YF_l3Js^<9z-^7_Z)es@qVzj4;I>d~TZ-^+^2 z9n}=S%@lwo9n#xm_Km}bK{vopxE&8@sfLsr=RzVIN-LU%Fp`yy3M+9?D5s#5r595o zEA8jY8pb}HM7dLWZfBuK)gGX!-Q?wZ$pJ=*yi~NSS-naRKK6=wKW|{r`ZidjaK~8g z|C`Kz`Si;ZS+HqO(`#6f;jp&Nm8s2@I`mJ`=+8+D;I82rgQO6h6crh~DL&FEV2QV@ z)Gn(TD>6H3_{xcQ^-kW9`(deA!d@yom;gy5>I~ucWg3mFbzbU6YaFz(e589ab=)PtY0|kP_Bv}kye_LJ^-(;neg^~U#$9E4#~mDenSZQGYB z!!Z8(M?lT>JHKkkTzS8UvYtg|!f!~qb#rB{`&}O;G{c1oRfo?v`f>CzaTd1MWM;D3 zJEraV6&}i)RVEUPEJm5Qv+~ICtrBDD1zsf@d1@uba-F03s)ljDjtMk_kOa)#@U$K6 zV=_+Cq?#jCq3R~$KUNUDd99rXac6xj`|PJNR^PTRk%SCDfnzwl0b!4by8{4Vq=)U7 zzGv2De+G-WebSY8_}$z4thapgz@?0t`l%q|jldhY45#793j~IBn!b7SKrbUx1`%lZG-j>*I&Cd*HG!G%;;PRR3tyjAaR!Qcm4mLG z9k}PX88f{$Bd+g6IEvD=@P89@gKI~Y?a!LEEXcK&pUC1?MIP=e58Y5+lqsE2<+hTqRndyuun9oqIOAlS(Fp?WYnn!*U$g4}S-3HesAZf-$qJ2W#{?v9Ivpdp3!ziFR(Cf*?IaAA)rg zAim;Wb6>hF@gqQX@?O968MQ)*Ho92g>u-II3jYC6ir*JRR5;llpzuz3VG;K8JD}Z{ zWC0xzJ$Jm_7gEHGv%JdAVwfk8J%ngJ{&%2H=Vka|1_Q6_<&lTq6aNIPD#`_H8fFV& z8-c+x_%&ykt%ejX`?4i7$DAK$_{BV#br5QgGtg%fuG}T=VQ!lH9rG$7|AD$)xeZ$V68G5xJmkG**=fQF1ytO|%7DTw2W8edM2ET8MUj*c5(p#ycv}v{+E5S|wOeh{?SJGR_qm=2oZY!Tn;4UyvnAdNQG~-jfuhd7X zpY%hzlcpXkzfJHiI8Urs)<=uW)vYE5JSXLHA!rD@R#y9-kw2i*v*^?UW7R z-}LDO`F9~86NU%PmG*P=TBhxC4h5(FA$%faEqH7(P2>A_oi8%4*3L|b42jOoNT`TH z!CPH^2LXqIs@W2*<|Vv+omrP;Gs7fhKDUXg|Dd`K`&jv=1d*Ed5YXpTdXgTM%Ug`u zV+GnJcN}zxv+Y9jsBzh}W%cJM7?>B#`?uHsB2c{k@5$nE^|EQ(s&6x}3r+{Clhxhg zapkgM+q`e-KOzzPh-2C=`|r?1duknC`YRe+Y3;R+TBjXyP6d+$qW+NxbON7@r~fk* z@Lu0%p9(DbRYLF}xZ>V&AGu85WFK<82)MH$^dIlgw`+*J0+IQy(2lCIKje`zu=&qXh3@4SQEjc}ti?lF%G-uYe+Y2usG`iJ0j)?Twp6Z!p<5_%TPSmX+Ve8!6@{yMrK|d?9aEWsmx|Db zG*p0B!OolVz>5be;6br{v(&k(YUeHUuN*eY4M3H1m)e!*XW{j~q(4O}9@8ub*vRFs z;0o2Q*fJP9PvmR0+uT(Il--j~QTz!s<`|DLMqGc;*1{RQp&rSWR@}t(vF9SllnGb!_3iM0alyF z9bijs7!>@PI)mW z6j6J8#kpDM+U=~&TaZh9Rq6f}v)Q1ENmk^p+Mtf+faqKM>vTlFr~u37Ly-94*rO%J zuB!XdWd~C&x7vRA{MlvmJIcO#gYXK(;k)dNiCDizW+BzxvcmJB-n86gNyYLf0kLF5 zVFO?B(0PHRx^jqz)lq${6W2Ll8w{+f7S0*dq$=2ghJL@f1kHr^_k(~ykipN=RDgqE z2Uh2YuJ-|-25sf%@B?{-+v4Nr1$ji+;=82&GawMbc)2Pkqijs*xtoY@ffsQ#=?>#- zK*5KLSA+K4Rg>Nu+MZd9qJ%_n7^cHwLf%l z`~;(j{Krhx!wgi|UEBaFW8QSTZ9f4H4iAOxT!UKj?p?jdhD@3jfL`h!b$P!g&40<4 zb62)ErH%vq2-)H0+UP0nDVHhJLjzh4poUGE$G}2@miAALev8p30I_TV{q_BZ4J^tJ zBj!`k31aU9dn8VLN%nUd@(e|K)Fn!-~%Mrvr zJ0O5dqVg(%Y!K(dvA!GK)jDG9-u`Siq2q?Zs}=C2YPdPPrlOB>smArrwk>GEBAXIc zF~H{?T)9OTuR6#j<(0_O3vp4;vx{jzNo%9~!OgT5Yv*89>V6Nc{5qvy=$FPo;6ptw zGwaHN=VP{```RY%+I^E~UdIWd?fmaayhXO*9iC)To|ePSbL)n^laVvl%HYI4Pt5uD1ng^5wYYWxDPv^*%cH`F0x;5)4>Geo!&@^}$;BJ1668OiX0BefScC zHr>!FKg1F6)m|&vOgAig@)seH-c9eWFJ2(;;ID9xSeI;DR^6N4RbO;KIzhR=$o#;4 z27Lx~LE00EMibB`U6HC!GhrKZ+_Ml|@~;eOm)a{MRL&{daZ%i36XrvnGSt(S;to=~ z?|US;#vshfv3Wk^oake3pBS?`XX?515)c5lxkBqgoDcPC(Ch3&s7jJcELc`st{LP3 z4Cic%sG!owcuuh5#gVhqnei`yFO_k2-J)^yIHF|7bX!Tk>jedCI8a+j#D3_iQIEEeoYWQjyYx*eMMwBd9EFh97Vs zu1su}w`mwyKvGfBOlfuseolWHD%;^XJPO@8`8~~Ju%#oXB&=d&j zQp|PI^+Cb4+S7NJ{C2me31dUi4fk!f583xh_o{S?pwL`*=O+=Da>RX|(Wp_S0r#O@ zSG;`~wC5I!gO7;Jwhs^>ppTEgFn=IG zY6q^%{~h7)FSg!)kZb=i@9gn8SQ-BX3CzYw|4)c7Gdsh72k~Y2gw)~Fd}iV^Ff*|J zS;4KY4tA@PL1+ z|C1?5rz&RnhhvP-!o=`zNWMR~zW-0C?k9uqUlDwoaTB3_^e6!jydsHnB3ERjrUL$p zjaz!2=*GC+Ck;g5a=BWM_sDkn0Z1skac%&P?f$82h04{CC%nQc=v39Yla=Y;n^GcY zKbn-?bo);lQNI35N*!6+NVOWt9zn zco5M+oyFDe>1E9mX?K2t=jPM+W62m8*?fW>n_gG@uA_)ccm5qa99h>J2n zP{_ir_<$Y($!8-U0SQhypF`0w)LWZ`iiBcm1@$6t%jT^&2qKi1Bo@uyjT zHu$HBpKHWq zWq$o$TvNDRwf)%(_Oo_#Y0rYYlVK7Vg`L7AG75X<(bxD`KeVdC<22d>#d*3xSKlv5 z{GGDfA>u5-VxuB0_f&)ONXT<^brIzws@cJS4d~TJDlIK=F>B*HdgqtzvWhbiG4I=0 z<}g|5&`CkQR1UqYs2&Hj#!B2qHjCAEFxV@$7O3r|%jzdcHyLoQ)^xcI!Q*f_oTIo{ z>+h-XUGYAGHjErzRUm$?3`;?L3!6E2jh9`w@?Ri(&~-bvVtCuVlV;$MrLz&{YT$#e zVCriT7pt{3dx@3#?ZY7Tpgh4c;EpDoBX(A8;2~_FLvE$9-()`E1LF`j4;r22uV)DHRqjeaj`!E9!c!UU|H28$ z>KGS%MTcQP1L(h<5q|`G^j6lSN$!MjCmdcmdU|(FPF+2?gjvfvi$97r6U2vTa*}Gr z*h+fQS0Mmky6|X88at=K`g?wmDMT7NV{5ORe_py|HB0L$JS$b?h>KQ?4EqGCc1GEW z|E-&}7FKyYF_v0?OpVE0x2m>DeDZs>`($^|t_!2gu3CF!)uF}O6y5AFifzC^FXiV0 zI1YPBwn;;X3xi8`2y4{Ogwve;_g;3Ob`F+yxJx9}NqH!r3OwYC=J8?0lJYYOX%(W5 zQ;)L>j}J%=A`YbO=yXr>q=P+#C3V-y2Ng`b{VI$%1;Drl+o}227lIF=c1c-r%x%h+L!6gQ; zZU>tAX<+sOPGbnZ^-^XGFu#PaVaydtO{C;Lm*!`DzcC4B=6${k%<2<~Lg?Lwa!inDB(g{hs}u^Yy`8J4c7 z?L)J6#g3;nAcG#QIH;t5yiRo&U>bn)Z`Q&7> zNW`I{YZ`EZaL;>b@i7Cn6`2}~17pFyn_|=8J**EseIsYCbs9?1_I3TJdb@n(BX9*S zAsW>h55_%g(T+ngrshSay_;+Qa8m#^mqbPVi|l*vYrvqUS;JZQq}Pk`{6|`+zu4MS zlxd|JgCGzSCB=fjLL3&M2nw)(N9`2BwczF;ntQ)<)9KQ>>k1DuFZMA$sWdmhy9G)Nz;=d^qRIw z=$UNa0uQ4?wr5wF+P&$MFk$)J0qC??1D8ZjM!#{#E(Hb6qv$m~lh7;CVfrE&7|z;x z`V#z?P3hZ@HW)NnLbp%2nA+JBw=o6V*n2Ny+xjnOYv|j5Ny5@~@$}L5wy*tczTaSI z*F))Za58c>r0%=(cQo|h76p9mi;4))eMm-Ewwk)6>@CNHt-{s)omoPVsQW?Vzf-Bu zNg8PT93q({Ta!g=2|R9+Lo^ISSV=FI#E}~3%g+bbCk;KrvUTfFE5;bHMhG3{@IOf|tN8p4gI_w{2tg)#P`65hn2jdw`P2m&D2a}94KM!z}z!IG& zSDCoiCDBl=~iOZz*2G2s6BKL@qMOi}>dsHSM`66v}mXj4$r$ z&e(jyZrNNAgy^6KaJt>r9+vZmGtY|3Pjmb|-COwk9Jm*UK_XNaLZgt^#DboiIMGuq z(P?7nhR@;+G#1$U?G;;k+Uh;C9pkPwTRYv(DwZ_{(%9|~Bc+kdC63XatBmcX2&u|H zRE`So*G&pc0wnVUjmDw!(IZjvh-pYMf{^ai$kGi!$i?2@aX5+AkcW32&Tj3K0U#}l ze0BdFkX9eg`A#BU=2Wdvp2Fa0e;Cig#>!^#OtdZ)l+iiZj56)PMQ|;9X)bW~=DQHQ zHzEpNvb_Z#6eX&6i5@cE3x})V;{G~Dd6ZggA`ah19t7!8JpKMyZ8#^|(omfBdXM*O zEJM`ahS_N(J+>XKvNoy1ZL^_ZD((8YnGsXSj*~4p{s!0azzEqb3f%!%v=*l(Ag*?6 z_%&h%SqMbwlzL&qroyYIc3(tvay-EVNT!7 zH4Dx&N#x>=$4liwQm|qDeE<5P|%r1m;=v75+uAX7aI zWD|{gevnGF8?Cn_XsdO=;ToB&hIc&TL~V3hw@gjqa6eRQ^`5liI-j$WeGoC_Iw^{V z>ba}4r70IM6JH~E8moud&X_g%+cbdhTAQV z$MWozW?!vChHdUSa1;UFoyT1HF1AGov!Cy2=LP3c-QbdCyVE^njR2g(;3C>@bXDjl zi0cp1ezI1He0B1LV)6N7wJGqcB*iPzS?~ixtmP#;@3bcV$MLo*^9<`d$~LSx#eihV z*ZF1{$(~dw-bSr-OV`E#52`h>b4)*l?JTzlx5ckt8CQz?W|hFg?|y>|PM7n$?|0<@ST8(4ARC+u9wSgoL7rXcxV zb4p5>q|8py2`7hnJDTgF?0MUc%TE`3gjXGZ9x7k=S1_gPy|6gyc^BL35^Jzr3Oi2@Y0mz zT`S`%jNKM_RX8tqKcrR(q-nPB2hD}oF|S}r ziL7KbR4bhS;?we7dy>pAHbf60L0E4}%~?Y_!Qz-f=OAz@${pZ?xj84O^>?Y5V|HJ< zX6Qb4(0!|kVp90+l%)19K@(f?A$Wg_-Fm&B7cx>fIl3>CUq1Ycym$2ebtoT|LnsQ==%UpX`sogP5rWNjH5wo(wv&`#zM7uM<{5zohoY(j{>=<)| zqzitMHgO0SD_)D#$>9E%IXKJL;u!pJP%~m#BCz5Z{?C(~)_EqL#n&CaIwfCtl`c!b z9~FCwp#ONjGN?`4b5q+`u424Ng#|?|Ve*VuL33zmZGUb?4D#TaUv+dF%7c z250t~V`C%ma49OJr?U4mmP+KO(F+kwSDpF~(6y{zf1l)pF+r;?&^Wdg7DhKNgsZ19 zZ%vq~c$zsXZ_f)2EhlaAFvzkOpQh2yu9wMvpc=>(!{CjhyZZ|U(ZBYR3z*&{W@7BFyA)#k8T!_T zX$&Eb%y9s1V`8f~coA5{;|@wvkmB^rkX@6J$xp4z+BOrBkv9rnki$}czdI+n;zp0p z%)SLJAS34?i2IpPJy5OkGkJ6m=Qn{W%y{q2BNJ`s_LuEj))>Lq;B-X4FXB9+yMz}n zZ0OU$5SZ}U+dzLCMvQyVa?D2H#xKeceZZpXPbum>LEXBsk!*3WmMw6^n;*oRgly5@ zuMc+88Zt1=ah!XtI1gdCLtd+CZ1Z6546Fyd@~?I0E{_)e^jTw6OwIZv*ztTMK^L`tl+Qcr%mjbr|+ z6x&qJj!N`RGML4fCz{7$jR<2m(u$I9bE`rrPQ=E=pIa4Ak@saQ^v;T^-EzuaCvh^B zn>g^6P-i2Flh1%BAp9Wm$SupVA9TdR$Fe>L>yH(%#UgI{%j95r1Z7R|GeEz9GK_w+ zw6Dj5L|rKZ5(Gn}^p^eN4~?$~lmiTj%3u7q1oFqb%b=&V0dm;a5J|D#pA)iIM=^0w z^uJi=^6Kx=smDE6>F2hP7-MuJJ44KpOzAvXrcx7Eo~T>Yzjn5Y!0zibJP$voS`_W1 zJmR8T$|}id`~Y9F)pkmwfKw0LohW8f9V4feRE$ofbSf55AG8*gj81gCsQ&0m1D0V` zHu9nxHUZ<9hUU{uA?wTZR_askX6-)t`3jeVY9z2u7?L53;h^xU(hl``*)rTuCvtRB z@O|I5;O6Uq9u_htrX(6I8(OA21_DMRw{6_TS{j?z85f91wEdaRq%1A>cZ4iY+volZ zEIo@VBtgL;?>i>axwFVL`&g^RdHW`DF5*aj=oXZ6J8U!>S~2Ah27T-psCrzGD7=`O z!Iy9y1zwQx>3LYGiT~bU|0NG**ZfQhW(tl7I{+|vIpr=-%3yHQ|CJy9$K#(5>ys4Ko50I9mV zapfb}QJp(PG<2`7<@4OTmGt{gEp`XwCxH_pZaNTOzjf%PR`vBac_q{9#(0`m9c~?$ zw)=%M&pqZhydLi!bGv+6q?~;JK1xysP(oTiNQ$46pEUYx_z3!ewJkw*p>`Cs+K`$S ziWs3B;8_%CO2~lh;84&K5-G|vhpq=laJp?VjfKUc6c?tK1CNgnkDK?dITu9A{@%E= z_JrDHm^0qx!+S7j;DE0*aHeV@yfQz2nNCeYwC5;5NLSodPRu5>=o6b335#BoS*DOL zDFafFX85(6>9{7qqwTLzJUCqov^(Lg;=#u`FCO1~40xk|Ev(@LtK?Vug<(yj1c1L| z3g-x*{0~MgcN!mh;tZ!Er6YN{T3DAKC6ELfB$pole>OsAyd%j|Ru%J63C{ywK@# zT{AP>3~ws49$yyXwPQ@&*c3C}~^F4cK4|X-(Bxc$=!T`pEYWMva!)HIF zc{?k9Y=J;2hgQ7xlgj_P5XZbHo>+-vCKePT{L9pf1*qct*%(aSw@5YRtnhtJRai0Z zjn!CJU^2s0DeNy&nP~oP;R)H+rz2{B0&upGIE6GFTI+^Mqiyu;ZGhI6CxIrxcp8l~ zGGfg^P;yjla&C+2CA7EgJA|t*CaCh+Uu!GI=Ab$`*-y5MOlErFD?y#W*nULLxg;aF zZJa{X8*sU9qYOWSub@2;;5okvgLyFQ)mv~Lj9>^Qn@%6FS{cTA}{v){YlA&hsko%p{3aJ>0qTP z2jZ(Qr{DJCC2#7guY3csJC@D0zi6$DT$dAZ%HHV_dy2AIlma;3aPV_x>OeT8X72}w zb-SiqMRy5gdg%XRl(!T?rBU}0kZpf8ulie+NY9H6>5q(4gTS2i-d)x9vuVtS)XH>T zgs`Q;O9A3yP9}e;->RKfx&pd;6trKC47OS%tgO`O$;q4?#ja^_>prIYrC>zQ-{b5n zT&2Pd?j3er-5{E@NfNF0!NLLL9|fCwkNo3AccX6yq1S0BMuHCA7HXFO}+J0rdJ~A!R6peqhLtM#~4r=kkO6>r4!w6#kPV{9`@0WtXX~ z!qX>ACg{;#!kx4EbgR;@4gP|&zevda|1z%m&!LcnK%XF8T9buw@JZtqItm7yG~?X$ zL1!3I7=0d|dr8>VjDVE6vP2ZASvX3z_qV5u5eEj>_rVbuPR^I7%ruwk=C#W}fL2@G zj8IUL6CR7%ZFhNpeffBLkCi36rWS93*OY*eMCOFJP0{`#oMzqi>%NmqdsM@Ej3w3n zmK<&f8}ZE+StrkdxI6yw%sN=i_~lKl5)<1XsG>>8;Xq=aIb&QS&uq#ya75-)F>x}k zW|>i|TfYl(I|j&Gm}h*mr_wWJ0r%_SLIp_JT8(1q1>%iS!0nY;=f=-fI7i=oqK>xA zVmmu5Q@r3qkSn>D&{2r_;hkNrHIza}6v;|{F6jEa|K5Za;DD{j3CAqP^oJpOxBf!q zwLEM4qS62SrD;#Cii5`rCsRJ2fyh2@a;f9PcY)3A#57IK)7-|iD(NBq3=6@g#Lt*=*3YG@!VCSdlpU_5YLn;+0^?tk5Mgtb?0VL$lhg_p$!T2rNN+wU3f~YHB$-Yxjlvdoq!fB70GyI$+!r75>Fx9&JuxsFkN{wVa zTpx-aNfmS)JW-b$YN(`JkJ}C8cO=I*AOKLasPRDlT&Hsqnranu98EWE`cfTM{)V!o zZ}UdrW`>b}{Ll7pb_**f{dEn^U2%L=krTxJH<*ro_q|VD@r=)*9$+3&`W)vOubKTi)2Olc@_Pur0!Dyci~vcHbnP z*y&*|f##6n_M1N_J)K~e1k$}C9Nhi%skgqkio1#HlpsGf)Hj_gT+%VQxPe(+HcvsF zvMt@xiy3&#baO=s6Pa0Tie3s#tG0N<_j4R_rXET@6Fp&J2|D6yPmD@2f+XV#<*W9a zGF<|viEa46YpEXMlL$9%yTZ!SMkeH^EHp+W0toqX8Z{an48R7x=uxJbhk} zvoFwUDi!fVSm(C+Ne)cSV`;Cxw>yq}xgj>2A;* zxSixhY91ElSw~k1WXDT3UVq-sm>n4jM4ZhO4O0JoN3<10_a|f}*Y;cA<;54lrfK-4 z;%O-6UXSh$@_H)g=z->Y8w6mMN1g+G37?3@j(Pa;x+`|&Sg$(miyAd$C+v@m!{^R< z8t+g`*%bCzwOV{3Uy*r96i$X#dUdJecmni8a$B41Ytlg!Y7s;RjNTGcZzQ@4+`$2t~Q@WX?g%Tv*hhbJb!hs;&w1fr$9 zM(8bx*9!5pkU24~&b%G(tXvkFWsp7S%5GoH*6OTkY%l1 z)BFhbL!Hs@_t&66tDPLV+@CjhVf0`bEaO?@_p150OHh0K*oW4;a(_Ny z|K!y@SR2i60ixZX9ip~do@QrO5hu3WoMip9#PVypdVEn1EF$k8xt$v&g2 zxWB(dr4+HXFTbT)}LM&m6X@(41~Kcs5{7#y#bJ%xd2l0P<-U zs8-OhBk!y6BFbK_`8fYIpszGs+`RFBTk*UHVTOZ>;I~fY_O10^4RY0h(e4}pQZ5-cU-!iCo-L>&OD;>y&)fZScVCAshD_S^R zgOb&@=h;c=qWNYY{Fxx;ld(oHZWcC1-1u%?Q=zMh^k3x)d-3+s%N!1pZAMv_+RZtW z-A(V7gjE`X4?G<;`*9eGdvU1D@37BaSqjzuT`fX+bHWZnkPwAkDcB!M!>=?*SdKq7ESJGZulw%W`>vZ$`(FEfgE ztoKsk;9`yI;8MCAn_jd+^CpuLy+Ym;;FSc?3u4>VB|ONfGlo+VW%$cF_L>kQcCVMX zk!1w+5be~?w$zMtfkzx$ddJF=b~ZU}gQQDrVI=ty_H@E*>sL6hQ@KECUh2s1=I~It z7nO0gXCqGLjP1Mm-Wm^$8K+kq_vSBN3v9MYtI`QQn%LVc7#Z%MI@etv)tCB-!xGV3 znjDVut1~<1VYSHV$(itcNoD5>spWMb=(tWwTY3(`w6PrXsZk>@;jz;HeVR+KJL?C znbyoZ0XMZ@FA7swjd61m?n#;*DXqFj^%M%kR^XjX(iO)iIFnMbh|Kiu9;YIZKE#4^>(e7_h`TK;U=|ATDA;P5f&{s9s%^!d^;qUu0mY6 z`e>C81Yh2SX7VHXw>bu%2+3uh9WE}BIbDAfuALcA!TrlEv7HB9c zVeTRj)rMyE36d(%>|J4FT11~-R~+N(Htn3-;wj3)RvZ?UHw%5LQiV@x+KawHa>TEl zKQ<2ZC6EqjM@aN`kcO&h|E_$a1?~x(nSHKZEfzW5B+Q!|h45hG+~)K4lft8NsivCd z))2?FR@#CRG+hU$QdwtIO&jDPYOEdMq{)!wuthzIZB!w2%ew@!Nm%sJ%jqN;!wNvL z$&J=(%jN)ijVJ#e-vNF!AKmc^)0upuHtdzf^_Hu$ zWj?IS)D2+i@*9}XL&&Y#4!E?v?|_TYfa!wmLii5)Rsh1<0E4GxdPm+uq52KSxKAg5 z~w9jI&M@I0M3*0;30GC;*AIFTqio;A}jZX0f2V~WLM9chhk4EkAQ;EHu7Y*4F z*XmOp^;{E@9UPF;4jzh5$#Sbo~IS#2FsguqB_1qVXcVG~1PUkMUgd(eAcYbBT59l{eCvR@d{j z42BcpAr-!-N)l07<9yNH!}UAJWy0*w5Gdb{OLJ1OyI3WT`u_xelYt`0bjfPhxf z>+dTc+gpaBZYrydr8TskAruP!R-GU^>Sjopu2%-X&*S1Be>bo@8(gO6RxZ!|No zo8Yl83(3esX^dEI%om7uE6;o_5-_jJgWjjR&Yy=YFP|F3FW5VcBXls^MpK`kpXzHk zBiV`v4R$OlvaA}me|R9oPPIM??eTgzU4IyK$k@KjZL{>>!k}hVb8l( zWP2*}Lg(>iRa`f6K*l6%2qCYd%G^@lY*Z+&|OfpR6%;z*z+U}^Ub=# zU5^Nq+DNOR6+cf3^Yyb$@M>#6X?Wp#*~dj$@EEuP05;m(=n&v2m6&Orhy;F@t7Zp6 zOMxL#hoTaNsux^ai@-u&tKt#-;GAF{Bwpz6c|_OeN>%Pb@!5d}$IECmtCz|xnJVPO zJSB=_MMhSLYkk{TAIN4%Da@F>jcVh{a+?ICZ{ED)KD?q!BXAdn+G#g0B|S7-8(LMLtX<%k2;kmr;m z&~|gZ8V8_IrQexlhaHfJfLQiRI39^>KGLFJN=e1|9 z*Phf+*2%gt&h#1p>Mz;M@1(n3hI?OMX7}}xI`#35!yq}*t`t}|2&ZCeMrERDHxUJ& z2&OuS?^DD+K1t~C`uh&Q2a+3q@9<+?jxa6WxTC4iYosF+>_CqUwGryTBA;3-wfmpW z77;2b3zsVP))`_>#hL2G+ebf1hYH(#9a^9ggDU;}OYZvs%Rz{%o6ZF{MnhFSSSv_O zp#`Zh%aH7X7VCLUGasWC>MPvh%isz1jX`=`Kb+lXHW6)6>iE zYUj)S8w%-c)>&Irr_b9W$79O3AtvKm^zK*l{RpvyQzRNIl$dyc?0syOFxj~RImt1m zZ2=4q{p?ad{)tuWg27h{kUhP7cnxdGceqFm!D+Mg;LXvp>Tm#OMmb5J z7>P?bIs=dX<&-7*!)Q16EzH4kF~&nqw<{5Z0R-&`d35%swyLmG9(O_0{>v>kAZ1ypEq20YDT#4}h?JQ&iA zs>R>q9z%~hk2%?hFEs1)Sk)Z7sFO7+^ zUl2hu%Ib;G4UE?5BSfk_@7A+IGMjSVQ3Kbl4*7M%)M% z%UoL4Bpq(2C6}tVfRA0~IKVWP-T3RB_ev#J$qA)=a5Q?ME+r&zueN-P_i)x&rue2# zXu9eDP+q0m{xyOp@!@e@OxFwHsZ+vopM7PXb5Uc`rTE|>2NMsh(y;6urg>9@edHOz zB?QlwHca>yP_wWSl~EbW&DxV ztaD&3dCg@*^-u^SGYMCI)F3w0%aD@Hj~50cn_ndz2LE8@X*$W~Eak zwXee>Vuc#P)W)!y;<58{Tvgg7mWnksXq7O2-8VJpqUo3d3XuqC*@Zp;|i%paSRaR( zw5vtD6Gjxjgtuz7bXFrwofapv{G=$K$uJR55F^Cf<6H^(Dj1b%eEkxwh}e1`(AN(a z>Dv63fs0~}GCq$Q)WZd+GRz{ux-jjVNyOiCgP$TR=9n5c&)QQln#$aR-g^YEDWHx# z>28s!Rgq^_B+mIgXKz|=yk9jlv{!AoNRw|(l`u}Ovg_kQrL;1qq#y3lX_^H`M80jL zsU#1g9<=XU{f5Oj!QL`(IRqDflE_|taPoe0wTLA|PyTkKV9N(}|dn}Ue=5KLeAKSiZ3Fz#~eZ1PBEPrd zOoCNRVpbY!p5SN6YH01ZUgl|=u$@WX%!C!~IY-glF)s_V2XT%@4ptmHj3TH^JmmnC(`^-#C}EL{1vTUr66boKkFuhI?Y-z||q5;o-R%bW{F zeEo&{il=e+`bRX(3uxnCkPmr#W01X>^+(!2U>kHSN}!KsV6cH3EzsD;5JU&YY1rCY zf~;QPVXXg#n0mp?{71wT$J@U{7rwQ-dI!7Ra=|X8Z<3%$to&PhbrfKe{;9p(tbbkT ze?n9g>}_1ltPJFAoDGdHo#G-Cy4YYPJ`}0`L%-+FK*wnzDoP+&; zf>PMoUf^F!EHVcF$^zi|6QA+|OkrbDu~D@)1J?{9XJ`8zzw#%z416VHM^guF_O~wy z|8Iet?T_+rdANS7i~B9xzv_I;@%xzFQG7Ya0e%QLSzjPYoaCIpVW?ita`eFNp?}H6#?H<0uL690EdPKH z`t1=0qpARZpo7TYasgObIxpStrm64exbQVgcy_*# zv?C0pdI&X+Zw*RnDsjDU{>+rJ&LUjjS4Va_8~hFP19?R7vB-SIkzet#5d(|&s6XPx z29q8}f=3ISSV1QQhd*+OAzNT+lYhl!fnL7VRK#R$k0IK8;?}mLOll`rT`b&u7`8yS zB7|jiWGbwsg*nMDxFYx(yiYuyXlNQp-l&?4xRQ<$+#xsc?X{mZSI~8F^tCVGWajK$ zztzMs$JVG;X-rJ-QJC$kGFq*NYZI5%|f1-c>kCPd_doRRWF zB@37cD2Pj@Mw`T~eLg?U4X1>dz#ZXXv{G!|nh4;2JrVC-ms=XoQd1K?ZEBXhqL5H) z@XnxyNdQD{HRR1Yhf6^A7e_xxUXCQ@w(on6bCV(EQ*P5RhW3S+m9+ICN!RC*_a((` z|@A~|nC10d%SD5&MsEivS7Gp^QLcE8v;8BQ+N^LmUd)^py& zd^h`OdvjF~A9HuHw{>@T7|H$XSKsp4THSH^v-ADoWnk*uYM_fvnL5p-@#T7;UfHWr zYn!DuzNDv$1u zd}=5kw0Y*<@~J#N0g}1wmoz-yulXMS4bZFjCb-sv1g-OkaIdwl(ghE6&*0FB#cun) zE&CZmGF+F%4VsmP$@zTsGej;=4#2|<#`DJTzPin;ly&jP1onA{rR?( z!*zlCk8L_F%};lC<;T`#E|m!mp=a;3KCd#LWiqE^I92z=v^ihrCyrW|TU$Rr9_qQb zV+BNdXguGm_N<->20E`+=mIQ@h3`p79u9=vPK=l=y6-;qu8uJE?-|_sy}JCe5lPm0 z8rT;pA9`dbdVRk4xHvVh{_Oa8Rs8(tC#}@_6G*gX5_DYWhdy?VV<}}}lr(%BTl1@!ZgVZDUc5|yN#4mp)FWRf@^K`SN zl&wabUSJ>h+?Luo+}~{`@2@X+T_0O}wz^L)3#pe|mwDdq&K?GOu9|t_9$O0#r|GsG zxSTv3-gDbHx9PdYJK!~~6&nU;(FU+vLium)%R1#|GR`2hjp>+`W%B^zGNcqbs#i2m zepKXuV@6k8z9Cx)1kL0G5Rl>v6P}crb7sz4Pab&H$a4gN&6wF09`1d&>bm>`b|YJ!n&05r(sXRf|-1>Fp*BvO|a z{&Z&)PC$vb&)Q51{2iI&!PAn2B!pptluDBV60)L!8GQ+t|5RSZ9QJg<>#oEt@R4e9 zn5dW-gKw32kCGzcpfC7Nax+RQvka8YdNvT=h=-|$_C-s2IWCZ+B{5gZWjwLE8HSf} zO;24a)e#KS{K&sq#wJl(NrdIoXr}~H^`ohs0a#YBf|MWlD+jG9W{O21lPocP4|M>c zdC*$Ueyd$@C)ICXL7yMA`H{F)44^G3bqvwDE(4B?X!LbC7&O>t=bxA4!M?LLSu zv08Tl6oW=AdKpR+w>*+VJE=dYk6e`;?d4=OZKul2%AEPgU3G#8vD$_#!5o4!$duXp%c zKEDspEpYDP;i-^J#jbEpy+qxv`5Ha10GwC+aA@JjutTeXq-Sr~$<3RiQ7*JP>QRgu zJM0ZUgYX%GeQcpe;nKpXdm!2%70*wRfj$M0iqKiT&8%AyY``!?Lm6}!=x<~U@?)jYS4NVOkt_8C20MMc|0YtA0UWe zxsWWeXK1ra!m8K@k+`reO(WEVGmFWAKwn=NRK9cAqR%n()*CHbJz5XQ zlXrs;_DO~zba{#3s5N#Up8%0ye)<%d$k3pi(c*Pyyi?sAj`*t5y3+bYquxPChJLd( zQWJX^H0=9<+zq7&>0qItORS;zP8Qg8-}DtFTe@Cq-dgL1M&C+QSfXt3LTTB70UtBt z#@Om1L(e#|14D#+GS?LB3Kpu?G*3%hx%h?@5GcN&3zaOtpPn9#E8~oX?NJP{14?28 z6=UD3L1UI0ECfxx1k)ukhb-g$o1Qi&|2PUulaEaMZdr74=F%mqX~vTpzRB z>7wB0d|(9|UGLeAxN1*pjc_BxvWD|!RKCT4FVJTHdoM@rjgXT}J18&AZ;F;%V5 z>M(~b#wk$)6Q5zvaek=h$$$n`@?>CZa4c2yl_8D6sV_u_*ySm*C)i%5pw`>MeiV0F z)Jv^aI+&r-TfA2c5m^1^)-1|A@dl{0plDYyiN-ziLzcRkld|_AzQJBYEHwGj_ z>qC)B0K#wt>BD*a$cWTLyQq2+{4I~ij}UlV zld)Em*NH$>j($V6b_d8&SU$WHofjgir*VxI2DarSzES9$>l+qHiIDzY?+nBx)KBRM zwROBK=mV$<W=vil{EXHKxqcDY(3b@GJi%7!Y1@L#4IV= z3M7*_t!g|mw8ZMza%i-x6`gL-qR3*K0jJdF*jo5;m|~g!ilzo&(uwd9Pn2MogjxX! zsr2R|f335io^_C;QOH5A!k5E)1;rZ^E&EGXf#NQb=iZ4hHvlJy7i@Jk10V-tTSa9x`FjINXOI<*~&H(^{BFgp9}B|j!b22m3* z&M;idEI9{}v5DUg%cvw&_G+LBS0Z?JbS8tF=)#2K&3CrKa7il}bA(a2)md^rqAwr) zPAt*WP&>h;kC4znB7GDz%W!C!f-bOu?8FnQ@yJBzpayTiVq8E~20$tUJ9dgAW$!68 zgBFQGL%Swi4F+W8<6?DEhPvdWZVDS_ph?7N0lw*q5>zplIszmLS1;fOSI`37*LiYv zq78FD9jlW%)Ti2xWv>1oaCCFzqC`2Se&F#eMz#MAEaU2*g8OqUtfE>_tLlJPT>VRM zpBD5Z8K_Ih7&ar=N4N4{c<678^zYGHL5Y6eN^%Kj5Fuj?i*Z!Dz1v!Zvtb$Pme}T!e#bz-EuMO%Qg@GP% z;qQY*G>j-^E+~PDPzY%dTiCllXe#Qcgd+4>Py!|>V#^UaN}(|y8UCi~b>=gBtbx&Q z%!pc%e$ZV_W>Zhybm}D_%z=YeWua@C>j%aBpUCu=zEUk2N^c5c5$Qp`Qb{kQbcex2 zdd_=EuV@Vr?U$F}z0?YZbfu;05gTns+YQtke_?Gjz-I{2?^=C$&57680mdD9NU5eX zLqk9l36(fOD$+m44!+MllP`QwMuLws6v$1Kr$bT+fr`r#%%xTMox~K(g;Ah`RFQ)C z?h_8jML1(B7<$K-3;xqgN<_s=6+CMI4LGCg5om2i6s=s4Jc>O zfnti=%wk{o9wvPexLQV@=?f!u9b42|1{kQn5gC6s_+#>aFu=c9A((om%=}4X@%9X! z%94H{Q7SEOuYQBp_>IKq27By_s8Pi$Q)MT4L^ZHSZ5BsWoM3zzoueO(Efei4Y0oyl z1D7Vr{AQqs$|`BYtSUk;NVF3$z)fS;NtFt1AeCei8#Z6e8<~l4$!NNv6Pfe@D(Z%Is)1Nz^cWPwJ5$lV zezZ4k`!xnK3N*9@()RO+3{d0f>J{U6RqC2P+Q1mLzyr!JCr?&(-E+bi0=49 z^(riJT$USWcz0M<_$=uU6DIL?|L|u1{cU~D93yuj%5n0mv5u-jRjLIJa!J6!2QQJ2 z6XjU?#acy8hZCor3h!}C?8BKYl9#?@-LQxqM;hI5@q4h2T1K5{1Zw@BnsLWb@PuLx zPZ>a#rOZJH&e=Ieeo2($>33lpMSAsBxr7qd)%s{7$3xbBRA=SyAGUuR*MB8gA~u6b>|%euR~J~m40al(7fD9e%Abdu z&^5W9uH1(vuXlK$v+L&Sd{g(Ud}&$dz2}2nJ!UOSYnW~Bz>|jOUArxXJzCuY(NS_2 zRzh_P>7mivMx*D0gyK4vcfZm_Yt)=SIPis@=oTF3&Nwe05D$?((Q>i9aY|QjK>5-~9k5O-lKmYr0vm>-ZFYrfa{Bk=|`ds$24PC)|F&uu=T@ zEA&|Zi*4NmU6Dny&>7{=dUt1)$;>!7VHQBo2p>cPungGJk z0>@Wbd5OgWyHM;BDbP5&4FUiuSb+{}wsOQH!CgFd02;L99)oItC2rvGnyo%DT3A<% zohv(9LhtGX;4@L6&3c6+aePGAgq;R2T3z4j6`&@)btQA9VU55ygq!b=pnP$J-SUq5 zXz66(q=COu{{cox~PKo&1$Q{%T>YT^fLTl6QNwWXqN4BkB>Lwlm;KhM)?n^v2Z9H-r zJoLtOuGP4<5_DwBBGS*2W}OZq7UoyCNkXHdMt(m;?$%nx9Y_n2 zL-!Nv+6ZRieJuGswYiw~da>vjI-8-QHv2~T%c zxyvb}dQpp&c}EEmuEo-Nkw(xgcDEmXj)GUkSax;K%-Zi53LRF@7In2d*NA?y4~$=9U+rwFFWd*dD)^**L_q!GpLLAoWnhoI!Kt-8+v?OkR}^(TYb5*)&8o;ygOi@{=DZ>!jH0aMS=k^ffP~W`!6!2a-Za#5m)!B-(18; zvI`f!^vIf8ypE^Az0ePOqxVDa@71yxt=cXOrgEQG=JU1FJ=ym@z9;x)b9O4}v3zs$ zQSZ2|lr9C+b5=j)qXz+SFh;3YaH!>-|D?-PLgy3rU)Duvh}Pmm`G1^$`I~DzQCCN> zvDyLb#p^dyHQ0}tnWZDh{>3w(BS-}FGC=}91)gXj=i%o1mkTR!=C|zs!APw<0NKup zpw)x1R(j8(R+0Ym4G=xN*TF68RA}K=wr~w^sL2m^*qAk|8byr}%15A*6b^}X+*AL4;H+j|ZzRuKZ$z(51#6hNpkR zNdiI`x`niZVbmgktaa~%E%zW1l|WionN`Twp?Qmt5u8_4?O%W8!HB0`(k>Szv2={r zP$^_Map?IPrQD98BpbBC^rcxKM(FMhVR+fy;*MW7r3sSGk`EtNviOT>v+D6=fm+uP zU@ui)e-n=?W>A#0`9b?S9VN9Sv&g*2--3-w&42c z-*y=;*E6onH2h$|w>CTtouzhGVa@E0FpyhLwKtSU{?VbriaZx&t&AKJT>oS!uzCj~ z5K+gl6uRtY2HeR3VL;%$nA@vtC_aWjgPV6SfZBmtSN!7-a9Ur>(b%H*TpEK41Wp+z z3)0vp3P}MX6}x{qn9NDEvY2N@_kIp}Za0y1arZ+*(@VTFo_%Ujp0cO;z_Nb3~rEB zZ(HcR$8%v@ODh3k;Zo?8#iw!p#rJ53SDEvd$$G+GrnV2y&O2yb+mEB3?>VhMKP^3H z_PMN|yYu%=?A7oyh)vXOt7k8y^hkE3l#*={hS8w<;zr{ZspW?gh80g`Nct5{34Udp z`kDzyoCBDK_&L{Pm=Y-#$CONj;BFL(X(?PdT3tjjidPX2*y~#GM5jtPzn%@Aa#rH3 z;1U<~G$_>*tn{5ThYx|q?lqvaJNocp*dsckbYG0049e);+_SVW1``x2pH}?X2&~qr zsh&u(pfssf=nlS3M>d7LjdPcg3pWW`adqU!k3vDicN(y`Rt3_gM9~?1kymcK+hMe` zV*{_xg-l}C$D{H&Ml=}b6xuw5m1{DYGG!TIhq67=MtCTtxN55UoAGJ8vaK*ks>|GJ zn6r!!&*!RrUi0=Q|4IvI%ybIlF6XyM&gbaK)*TOM4T?bAN`==t-(iK>ORQ2pbR$KY zNI9@GgQ_-5`M&kN(BT{APQ>~INg(*6sYgpDce#>2?1+(t8kj~?UhLLM=4IJ@k)sq^ z?e6JLMB?c9-LWshqsMM6;FKjcTKU=LxwAv!6B<@<`Ux$Sj8fL z@ORMPjdN9u`HI#u$3RNb*%I57ixeOUBm5npr_8i7sSex*0KFw;3T>HsjY{F??|p>*+eEyrExOV_GS-**;(yJc{}+t)uh~B~ z0Q=kjov|`1YeRhzL}&~V$6t1T4rQ8o!hTB^lyj?-X4)Dhv1F%6Lp%P#7x$bTzw&rE zWV!E-N(E6RE2N#OjhlH^7G0?$;G5Drn47VO5!=cZUSih|@~mH?M>81q(BBazC$6$z zd6m>df1ZdG)==VT!v8j+RN`Y4(+u~>Qa%)7rsVUUEjz;z)_l6rU?q8m#8lHqJd~u1Jaoqg|!ZG%#l%#wBKC zVSonttrb@9Fa4bYtFurl?d%1uH{2o(vf{tTVYZ~8vKx-vL-p-V`5Gl#vZCZfJyld7<)moxT= z4iG4ZBOcP<@-`aHq$}LMF7pYf?&wz9Zmt%rBM8%T{-g~{ua*J4r6xkAWl>{%ju=8O zDK@2Vf2DX$wBfrxi6ULZ?1bQi!_Oqr8gM=h-B%^eZ_C(x2l?kCl#{p|lERJBqX$~j zzvzp%)PRznUw|2m-YDBJ)Dm+4T1$~L*6PtVduqdRXmUW{UQO)m7-1=yPJMr5{k-_J z^!eHRSJM%hvsRCD)u$G(n~G}4<%8wVybn)nJ&WTvtK|3U?+cTTYu|4!eqAr++kUv| z+g?T^BSTAnMJ7Nd@OZa1v`n`AES+7~$`hBlLTegnf$gY$Ry)Ht9)Y9|5IE%gp6*OI z>LD<1X49}=8m_t*Ud%_Iv$cf@ds{^Q>sa~HEPb|o@#FaCg?!Jh?P`y_X{$IpEl@3y zx|<4ZvXGlnKaIa4@vp;b&&6%_c5MPRj~ZTftT6}=2rO?XlofBN0*F{tknpU6b1Vr+ zd{*(V-KMWSupvW7fteOB7I_f%x5F$Q#WGs;ScXBI%@BLh2Jj(TEcB)zkHX(}B0P#C z;+rn{cX{ngq@JGis4SH9L(|x9e}_@3sCw zcYfoF(=3&))bdLBm{A@k!@(S_e4X+=RJZ-=+YGp$-h{~XnvPXFuzLko*NXE*3f_>P z>1|*}jDwPp1R>#U1tC@1`9M+&arH!Y;H6;VXf4o+xFBiUA<$^OdE@Y|ULT0|t~UC> zaJFmshIKhXBULnzg{aYLQCzXJXzl0cHO&h`5$Xf26o`JpeP=2NUJbhMMfV;l#4-0L zR4@WEDIotu`p#ScH(l;S=1++qQf^`$D zp>WEkH4bMvf)C#VccOKwg?CDej~lO!(6w9AC_@dD^o@q0MwGg42*@%p#V0(MAI}oT zDS%S7W$6~4$*Yh}`sg#;lc*c^?~&yX=7dLu&L3L6B_N~eMwz!S?V0nH(x>++gfUrQ zjPPzj_(X8n)2rgCxYT!00|}2U2n$0FiOTxm%KV^kBe(j_|2VYM!{|9{v{Xokbz_uWrZFBe|sxX8SsGya}~`kfx7w+wkcV!*SMSjt(S?5A3R$ z^eX;EjEb7C>kdYknntCKh*SeLB1CNd)$e$%#Cij8TVG9Z6-_WexZ`Z0I(haqpk{?$ zWZf{lZ#tnd7IyYbBaH|s>W>>m={lD&MFWNosHCs)$zo4|lX$0VOkW6qF?CU#>B_K0 zf;a_2wEhZ67?`iACgts$#?M6r-!LSV3}6AzM56dGsN`Y7X?%B88YXwbY4T2kY#(kv z#beY5@kwvgp-5^+)vg%561ZA1iack&(W`tuZ(A2~JwYOE_N9WCj5r6L5D|XI8jT3( zPZ@WeTa_*^)iL2~A^H{JMl+ns=`yh}Dh1+eDEshg$V}1F&o9S5>gULiVqJ2N{2XJ< zd2uaKf}72yhR;!c;MKYK`PGBw)xex})s=P$liajts?(D3qIK0#oko)m$fG1A`zokT zw&d9B_H27~eg4|Zqv6wS*HFT1`{%XKZng1%>Z|0EA=&9m!u`|lu%&#an?QzF{N*1S zo+y!5zhI-0u8t|7k>-W!HzHgnFQztUic}+hlO414HNo1(o3KbhSMfmE1DwaxjcI87 zn_KkPBe_`r_*H)S2k5{5DsyxHsqV0`a{cdLWvc&6-Qj$VA2tnEcP@ppZe%sr@rcOa zn0Pz%yC0O)OOlG^7ZOY8Kgg)XD7-1oCXT5bav7jYO3+biMA0gW?vTj-a(2zvc{sr7 zAOjjAfVh*3GAQ=K#g(nXAKZ!VthVTJac zB#drz;fkVt+!?|0Q#mOh0KNz6-jxtAqu-)X=~7gY_@U62ExRV9eVCBvbdwL1m3%4MPT17A+qXZdkRc`NV6k`cicAR6Gp4QO)OwlUW zzLlt7+$sV)Op)om$?I~VX8eY7eUU^Qg0LfvTj)iG++ib7=-UfinQ^cI62YOc;_1bx z5!Pv30I|Yy@CP0qHKK*h()M7OBK~HoEA3|LS|2m{8=Ls5sXMtlcPXLf(|l*=S&x+#UReKu*M&V$k-m!nz=}d`yp_JJCY%3 zvEwmSdh}@9NWX=~pAGH5h0X?MCuUa0mmrNw!?^{sjW~jpf}9fC_u6*Vy3V~hT5`_3 zUD+{XM`FBC?$@ARf%o8;Tb43WDqW*Ojp9Y@O8tX|LxJ=UaC&f-f2Na^=KQ_?7OyT3 zEt86%(ar(wA>IB{#PFBK?y!h!co`Kzv#fj<(&@kK=%^ z#);MeyC(QbT+f$LL2L8KBOCjhtMUIrx#0fu*FrWnZl3?0jWH_ELv{(iSZzk?j@mRjF0$1P`4l+kMmK}6 zknJ|Tq-dVO*bYyoJz3VQw=fJQXc_V)@q#@}2r|u*`OF3z<58xV7E*+W->K#ivQgFnY+PGiCr&4R~6gv%PeBL6tj5DW~<*W z^Gexoqml~X2}^x;8w+Y^8j}#<(j5TV$XSd~iA$wQpFXLO$P5Tu-t(douP4CYm1jci zZuLkV@b8I1Qx}f;w&eO$bZ|yuL$iWVB27f^IN7#KXwA}$I}9?72Ve%9Aj5Zr$NGr` zx|wVq5W}-%b&1bd)y4o_ghH(0F35z!`;8fFJpxFC#U&XTmFlYBZawBpf+&v+ zPw=F}2`1z)omXn6!qs&Xe#oFt{muzv($5}7Lsc?d>k@(95>zco*HqzE^Ox!G1cOrd zTQB?2FguOY?zZLcAFY3pm8Iv`o$q?wOx`|OJo7#9Js!o>#l=_02DOLm)_S zd3V!&DZfRaLXcqhhJiZejiMs&fLKGM+7na|Y=(qEpxPHy>-2-{#^{efQSNDQ-VIdU zjTArCM4BSt?S;ZfMi&akvuhDs;A2~35Z$S{%qoTF7t0J{GV414CjL+zl?y7W(1w&j zZ$+fofH7OmC>jtsP;l{AMZT|vGRU=m>kU4*fq;R^EOBIp!!|FE;#TOrphHL%E$nn@ z2i$&GUw1qwbHOrgn}-4OfqB6!N$lDz!!=n0N-4wG=8OVNV(&Zx1-%|CMNQ%YdYh5( z4H6aAq~=)9DUPUxAA(Q@f-(9$)chNjd-(m}WZ7dE#>RL_MOxMxlriYETGzCqSC^CY zel>W6a9NPAr`~)~5&gi$CnNeS0gc+NqMDnKdl7B$4w^7XM%6)OHDt&#Dx;`VKtkWA z{Y`gBDk!u!1yxnjFNK0s!aK_$!W~^4noeEUFB2iv57Iw?N&vI5YEJ9Z9o2U%X7E2ec{s7nySM z5&4Aoiy2au#|OUC#0t!tajqeb!9B1L(gOPftx)_(d7=tsnLc92-Zx-sW+SGb%F{8p zue?}4Qw59N2ln~i&6aSXo_OVp^sUG6b8}zyi3iE@FCQKp&>B;z30G9Op>%@^eG9*8 zT^*0j8QPm;(~|(H>>9XKm$$B;wpEsDl7XqCiw~n0;GbmwTV4o2h(9!<5_x+JERt$M^ksl%UTjByK?f zX&bqz?Q5|qx}p}jK{S1hk>eDqa~08VRW9PmCB9K9`Sq8H zeQh}(p2NJpdn<4|^!rAdy?J^g2a;7!xosYr!yJVbOyV!&b z+kpPbC)g-;0-xw*5`Tq&s|PrVPoB+X(n~9?c~^YDs%kz;n3#UP_~DRwLG&+rJvJG)yJ<;qMywRAj4)W+ zxc2A~5Crey6|r@;aNA7DbmBNxrVh#X;dr;fxeE{#;`O`4>!}*5DyaPh1%T zZSU9??c8tDkd-FQfX8oQk+!ypUQ_LdbM<2}FVv^iKmO z4beeCN;#=QIuvE->c-}sq0|(eSeVQdtC#{RG4_11mF6XB!+@!O@1p%RZ8g&HNtter-X9zaZf+$U3b(Oxt* z;3v2pZXR7iZ#hHCxUtm2w&yW9cuQ>X3j;dGS|>bjT|c~>Pz1}<6B*Bc=^4-vF)gPz z|H#Y!2EF=kcp1lEDk{%^G#vl(>0w3D5~T#}&3RQqFFjJ#BdDCXupG>~urMV*S2;XY z7Et0lSVEQD?(8tO!rr9yP<4FVHNIV7hwZc%@U3wVyBnnU%_ucN=)DX6Sn8*>tof=7 z$R(%vY}vhTy)QG?rDo>(TKQ~c4K>N_DJ5*dODcS5RB~jLn+jC|@E$MYio(j9opd+R zm=gyI=GHN!!g34aU?`tor)-(u^deuw)R6IO50YH@Hv>>%lCtDe$rdIfMvVk>=3h461riIp&JmTZB|sl9$^yfet#UYdk8`&q} z#@RJLCi|c786AGM`Slig!H0{kRlstZ+K`)8@Kj0hyB_`}-Q^?UqrBY+x$NCI5#8PBdd1JSub$rTo^5}=mVsqup~wgsMEF80 zV6!aO29lJ1efvCG_{3A{0#qRm3x)e@#y9h%*ABE+FNZ!qcr zuEpq;j7slr1|G9+4&3qTMe$^YlqRdZzKK&}s8Qq2CXLRz_55UO&N)n3{5FXEk$ zQwzDb?dP1Q2^-`p`Ix~3^Dcjqk4Pw;$@WSt!XY}GwimlSVJf$T+jpfK{UiB^UjEo>O+dMT1t zYhh4AF`68WpMAhQcvK%)wfb{pwk`%h?MsdU6HG1v10?A9{>_a`s&cxVR`7!;JPwJf zqtbXmX60C3_#0H&jI8jGT3JrL0?45OVeQxtqJdV8o-S}<^c_Eih9m@c8DmF;b{WG$ z1*AeGz1blY;2`Gk8l@%{B^%!jSjt@}rDNJhM=6grH0FU<+kSf$tvIeGOvC(j586I^ zP-zZ4s*0j9AzRLtpBRMB=y^HEL98N6E;;HsIJLTrrrB9m$iwObr*{q>NYU3!kDXY) z5@qrgJDBCBfM_>C_E!?jFjOrP6QNY=fjO6wTImXPkdn$9ls?Ic-!FgN=>45P>J@qG z{}X@w4eIyboAAI;IvJ4lM@LieVs703QPvxP>|#aG_Q&{v3jSju_(C;TBM@@_6SMq5 zOBCW$o+&CYI2WU)9Ss<0@1Byd0je3Lu5u$?0rmRN@%W@k z0?qfSaffgfGTuB{fsiKrH0(h7bWDJjPPJYIJ|<&C2p$!kB=#|)MmA`!X|=kb$zCwo z_fgdk3Zki8^k^ff-WdXgZAj}m*VrJn@SNXqe#UY`i0rfpzLxAB#zV&InC54c-8ekz zq_lCtBXw$OIw=?mn+k1h)h8H(GSPIES@1f+C+6}v(Lnn^#urZ%di{D}^Y4c#7IEEjmRz@OH%ZPPb&JlW;kbUUAK z@G2g)4{m8^(pKe7CGY^t`f@;#z}TN^VDkk>m5pe${N-{4u0{U23BsPNsUMA6$50h98RT{?2!G zc+^bpq7!qi7L-HPoeUvyoW?B}kZHD%HqM;cSlL$hz?h=H96e|7n5Hy)qsiFPQtwDv zQ)0&AGgel}nDkg6TG?DkNooJwo~Cw7l0=c}&fBUr%4IM7sj{*(V)1PN@5WA49NDdq zNUJ;grKJ+%$JzLAfFxecav^ve-l8!{|2L>}K7%evA~chd7OJK+Lh7=tZ~fReIets= zg;~5V-d}zEqBcC#VzJR;A?0;T?Z4x32XXo9zV6pDJE%tH_RdJ-Gx5a1x-Q!3ZY;E^ z<$Y$$aqC9=wyr(b_y|K1P3Ydt66_Oa>o{f58pKZVggZri04jC!_{a!OYU~6d#oHU?#0e2S!S(OT zbkbjFzdCi{IlU9+wB&qtjee@_PIPT~{h_@72S>y_<*B&9>7aO*xaaX(N#}AU8$yOm zUK7>60H}DPsIVQifY&=PSyoUXY1EA#tMGM4hQ4BmjqyJObrVnlT((N=EF&J}E=EUh z`vjdVU5Bz(sD4O(HI(v=#)z}an{AVQ`a2)=copRSk9_cN2=M<#PJH_}KFIyQ>%4q1 zvlw6-ps;o(jKlE?iBthXEqjv^5d z8s1ZJnp&PM&y3D}rJ~IAGtC~y_C3h(Naa=0C}bV3#}O%l!NAJ+g{|vFREH5M0pHdq zJW`83C{pddG7nYu?tDo&Y2B(Dy^&}VSS?q%0DHX{Hc$2icM@r192x3W3>5m+uTpT4 zDC`Sw?j>BYf7|L4zj^4C4GSC<7?5#CZc6E^mGL#C)!P|vDyRo!s@73U12c_b-x`Oj z+Ew`&HiE5sBo>THKPv;o2?_Yv2UZlp6&lI_ATXjjvQtq=v(?SIjF?4)9b56T!lh{I zoMbxdef*qSv}q6ajbMYQQVKIq5RTxkxUy_^E3Ut$Orv1u`%8m2-z-3>zj*b;%hqD! z8)t~kCJYzpVSF<4#zJ!Q>R9m9uf2#0tM3g^ckNZ_8!WFoDwb2QRpbw|NJ`?6`8?QN z{flbrki?MaEx9k7@mAJ37y0`a$5pP5dhqW9py7u~Z9}sNXZZ7BFYAeN$?1LT^TV6s z<@bC~0%di_b=t4z798sq#Xh^#4e~fO#VJHEXnE{8%L_9axh^lZUA(ukp58|W)U`LI zIc50MVOzIH7cT^EcSU-(?Z0}Q%=EhT^m?fFdSHV}d}ZEEFKl?Dl7)%H&E4KJgZ-2$*RefILFn$?!x~QE_e6467m6KMO}LbR39$> z8!cF6JH6=Yw4j(oJY zj#e>6eXwh~T#`p_Y?Dijwm+%@SH-)JeZT?ku-ORmDgA%qC* zMa8`~>}^S8`Jg^<_<{V3HrpzxY<;S-Mp5t?!sdAA8DL#3VO5idCC--ugs&7pvFV>` z@9SfNZyMmUmCHn<5~m-7C@e9M7aUmAd~xYT6iVulst)KHf%*hpvgsk)SdTG$jT} z%tXkj6EQnd6oGZ@`Ofp*d(5?_{$rZ>0tEjDhUw-MykTg^0cy@hx6CiSvd*Ec53t2l zoMI$YoF;C1mZ!QNx$i{7MVdZ#8=O+9+eb@}0||7nqk9}Fm5I5wQ=a3ahjh%HPzX!Q zkO;3U1cB>k!kiI{)W2pPl!!lUS8VsP^Wma~#|gh|2!Kdpp|A?61#(@UpFcFw3?${? zqM-Smow_j7gE4nP7>0P)2qmm_Ocy9&!rvVrjc*}4`=6Zg+XvC~4P<^E!GRCwU(2Xu zLL+Qinw+GVQ1pq#v94HPBcG_jE4z5n{G?x#Tk@z~^gtwFKmYD@(yMXya$dnhgpQ0GMsl?d!-4WyX|k%bb@sd0 zNw$7lYED>_U(sOX$5(7Kg)Nx?VntM{@b>|cy#e;;+)xCh$kvD!vY+u~hu_cbOqwF< z0+@La<*^qRHf0}RBlYULtONQXjvACAd!|meMXi}$GwwH}hbN*@kts?>I_c5?(agj%(by z!gUCB5?XrzREU`j_S0R9WAGRPMqkb3ue}AP^NsAtsmbXlgHMvGv(Ovg_uMKja?*V9 zfz|0wL0^%HP=LoJh?EykJ~a%;2Ty_jzyNQANRQ3^V{>;P&bo#Uh8xsVwC)73tTbiV z8F6m_Y`)x=W-)fHg-2x8l>&X^foj!!NN z_UykW65d{(JgIqF8}!kUP08B2++SWu`(%ouS9^qLQOl=>9{a<<+Xr}uGYM2YW4Sf| z%p2=`F(h%uf*eiC8_ViN-Z9ACFFWrJB~=&pOCYqyvt%rN@OjVUL1WzSuU~RVu=(eT zg@1&%zvYhke}T8Zj6GK7e?!xMgSS5e99uef2IWIHMFoA~XqLZqv(q}`hMp7;TF=m3 z1g5^qFn?93Hg@HRh;)i7y&p`wA8hU$%spESNU9f9PT+yn9(nGP#)|#0RJE9WO#ou) zFHFhb>WQr^eo_b*G*yAX;*qZ)3afGPz;MdAI^0q?JA4N3|FIc;C^sQaX3OlB+cC_4 zdLceFv_-=%>j8zetuT)7Qe#8J7@=wCU7)YCko4vsGQ0j&O+;0I7<;Y z)|g6bJ;9cpA1b)t&UWwztC53bn1+K8s}CPwGmC;@%EWBQ;0p!NN6zE|1=c#Kzm*$yHH6#v6Zyl#Ki|kD83Lhf)^FNR`i zq0o!?bYd?rAvwm(_2j1S=UH3X=`XQ6TMbgTqAasZz9pYy#XCNYS)4UzE~S^dUZc*= zE`C1ju8IC3jE&pz`?Kxcv%?GiF1Hn*U$#$7`)$1! z)gI#p0ZMcQLcTr^(>Zo$zTc0l*7XfArZ1RHsFwjqy6T2p$iC8!_^VHQoMMc)v|m)Z z0&^#5zg#C{W+ZUk`XvKEXA!7xlq76nvcfID9~-C5T%!%tgs#%+=LRUAW%D~Jnc-+g zit8t(2~=KcqkRy7r)j&#!{h|oo1>%!X$P5pZMJnc`{t@Jqd}F_&wgT7c5M;w`yuUF zJ1y5QhWG^D=kVz{7ev!X->h)v>Hh9HJ|5Wd{ji6jw=#M#H$BL_%z!Sx)f zHyh@c1slFxX4YhxTAO`IWm{ql++#@}GzT{A=?zKOtpV1bd$sHz183i5R&F?lph49| zghQ=ha1Aws?7-R!m|0!-nv1dYf*}pav|$KW?CPdW4+t-;G=>dBa4AG?tu8I-6onrO zC$4y(G>{CHu&ZbNi&~H{H~8!g0$)^Ys|3}1S3Zm>^q(alyeCV;>z;!vl(bI4;LsEa z!BUHI?w4NpxGkBuGyFkMDhQf@VdEpX8DtverynSWBiQye{$=3DLlCa`8|#0E$+B#> z%YTH)|4_~JH!F~p`+xU|K`FPuLzv;jG>n3=N334^<+mm~E{e%9uibiL9{48pFNJJe z^jyVqPhy7B+J>~xw^mK2W4E?U(VE&xjkM%0%13Bs9D7cwnuXdJg`nE9jRC%Was1hfi>6@3A+(JcgSNn0f2l$oe#ia|6(s=B z2ZvzLf$t0d#x&i)EDei$d1Ut`H(Om7?k8XOolu-5$D51uZ6$z%Pro7X)rlJGwe6(| ztUm`kNJ?Ly)g2o*Ke=u_SjvL+Grmv1{Z9&*SRUi^G|Zqum}vV&hrq0D?(IWo2SbN2 zyWAi46kW<>m~eY&vay#JN#D_B56b9O56bdB+-#`id7c-OSTQEfaPey&-~;ootD{sr zSHjgFLkDSndQCLSk;>>fl}A>ra0H7Y1O_Z?nz{#Cv3&_->0+DHSg68<(+G=r;R_nF zdSc3&0;EDtd-5gSHm3eT%^dpSghP7Sg0kMhrL_)9;M!#*`@x=jfklC;X*bQpwePKkYsR!Pf zjI&p!o-eMgzXgR}k~4kMI0!Mli$tXrNIn7(U>c;HvWJYreY54sj@Wqus}`A8;DC_s zK;t5z?2N!L6`$z$GztZPnM9tOY14}84B$FO7CyUJX^YQi9`D8 zh29p)0Fze{a~-3Qht5>Fl-*irWC&QS75Q7d=6ajv)Ay;h71cdIz%Ngw&}go zVXHH3`RJdhYc)n|S`FLeCg~1V^W<>Y2_~c3{*lZ6%`1Uc4qa#CV?e>}`&TOI z%Vh*QkVDDdMej3Q3bkt-PzIeMP)A#k26DtVKKhrmy8kuRvbU-81Y6fPe zKa@NX_ksQ~liq&5%bkmMtAccmmi2ohyQy2o#WborR;;STr8>ER#G(dgB-6V0z1R>p z((5pFQTO|Uv9DI}CEvc%wox~!t7+gzLRT)IOGfkdI_{`fUn^N-*Bla0LnK0fLd;}8 z*U9Q{nOY2KmT~G9IO=l-s$R@?%~(i23BPx+b`bAUXG09hGAt*X zxuxf+kay|&Me>tIC8p;)dXAh%E}i;BOw_7!Yi10~bha2j2qRBnmxo*BVsT+-Z(*Ac z<*9YC$3r%7)2ov6Sz4nk;*ql3I&-oO0bp$r}kp6(CW3E9}S+6^wh_-03>Cih%k zc;mfWE{j1J(onWjh4%4wf1D<)YArfFE%9pa^!@D=;b_lyzu0DxyQPA4%E>6_B1mzk zO7?p;*LwcE#T+UlGzxFHGCl%knSG|1#1)AF&vNFR-LhIwEJCu;B1)jhd|{)zm+9uY z4@kM7xOe84w(?3+Z0+d9!O4KmOUFVpvG~!>k`<-@bARvr4m0OZsWwS!;C}kCC>n0t zagbgg3ec!zR1Ey5{vERg16O^cgs2$>r74jPK7B=U9&si2A}{{nM5uWR^)ma;?r;LX z4D0vBJA?LL8|&LMsC^4shSyj)kWp|!MsR?T_!KRHp^@a@LQ{_hN<%-fL??if{%A(b zfPlP6quM~R?z|0UEmzZ0VabnCLpbGt4|^W9o(7(>GFXhbBEsS%UxD&3FRb1|Pe@b2 zgj@b;#AG6pfl*K{=yTfj0=2VAL);V$BCHYp9wDcn!2+C2He7gGYXdwkb#oWmz%~{k z7#X(BA)c`9wHOKL4NKuYF}NH3TcGI~3~j)RuY3Ql7I2vpT9h4 zxV5*uytKD@`+3NShrI-MHw<|o;vmu+(U6aQP{qMn2wqLGV0A4qN~Cy-qN1-3hE6eV zJ3KECCXEn357`Z-$kN5m>y~8Hn}ooPgRz5w8?DNHC?Hz>>NGi z?}fW%*q8#FXHD{O9sVDBOBea-e>VO8LuJQb9`akB)&Diy>R;&i<{=-)t!dCiOLS`r zq*8rgBEQV08NEYyL1*CoC^%5(;qd&H^Heenz@}aB;F$KZPDM@9=0!~w5u?IQnQ%B< zhc>nOPr+k$tQ;9iByIhhC)*NSpH{*-8NxAt*-DXRJL_%|{S7Hol_Ej%_5RL?&VYh= zNk3w!l*ShNq^aYIYr~ORFX?59Z&SWcyp8%{)66h5-RSCK?fnk#3PrF5Xv076UAUUu zyuW@vYX9l8coM~evP>7ErlGmvU8Tn!tXD5@T`)fbMF$y1x%h}!P9fpyBO$M66mYWY z+Oyb#?Jkt|`=Smim2tAwA%3(6pPn)VL?gVD*xHVrZQ5)mQtTbIaQ70(^dri7mDQi& zvy8xohSwCQH>9d|s&>Lg?Cvqztnsf6s*Ti*qmc1kViHN`U6g`R1Z2W%B0=iFr0{xs zg_W8d^Fz`>vYDzEmM?vnfAGJc$T^xcJUc`{JjT`3F(g1i%X&BM@wS;|(QC-H;-%`L zkC~4(e+i$DwFQj|s)17}3|SS}KSPm|5W|y{$QaKAz%pvDCgTlJ$Akt#~muvgAq zhrj=GKZ*Xs&(F4}LOCDYKFhg;Ku>_iMa339M*BFM+F})|t9p~$X-wY1Y065ZSN=|b zU;M(W>tQvz2!BOdK&oJX_Z2{Z!_8_xJn;C1NmWDBP^zo3U3yly?sEVec%((({uetr z&W|pF6=ihv)t$?VxNTDq+w*ZOJZzMz1L7kKiSNT>BZ6xZnO)I!|5*0)dt8W(&M5)) zQ2{A=nIVxCI|F0OM4`-p+yRq2`K9?wM&h)ic%qaJQ6Hi z)K)QoOdL=g%mlJE9@v(@@{w`eNGC(=s@?6fV!8Kw-Dt8aF z?CW1oBqZ3cn_}aCH1GcZH61+vMw<555Z{CbJBZjq{9-Qm88)INjp?K=t*Sht(`NQr zVDBC*$^*GOeVw=&+n4|)!lB7qUQ>{=0tmS}Sbt*@b7L|vVKP5qQW>3gZ#{wDY(p-x z2qY|6HFQW?MVmFhQL%n>__ah7*68!i1qrkN64EjzBj$j6>LXZ)GDNcSmxUr;_arrR z;EUSEbQ!OErWzrCnwosKNxBPktjjzW|7~?;f)T6xx6?c3%fLZB5~$Z?MV7H9Pl&JC zs@b2C3A(4Zqf_r%=&qRQI77b47MXBR<= zE-ew9wMvM|$y89UE``U2gH(~p1GIo)(t1Q&3Ztzcu|rS>W^AuIf&y}YcSeABAzlyR z_~YUf0kI8C_Sb|?nFQQ|9fY20 zb}SgZGw;_cgLAxt#0%MOer06z*Ee*hlC9JGZauQwv+d%!Ih}sjvu(bH7@IGT=6WI9 z?|W`&1*(kEciNT#%J;9QNub zt5aaPoEa)y!r$b-{1S^PVb);DRi^HB=e^SD+=(~qYk{)bw7u=QdWv_FWutc0u-X)c za^w>GG>0?g>HXnRtN$S<@BT`!?Fch~Ilz;Rd}@DxcJj3ONO5(x#Ot9(=#_BI(RmqX zq3z+<5E%<$T%l=F65D&Y9Ca%;Ff%ZgR zc<(4TC5MJFa#SCS#uZ8Hm-?)S&Xd9yJE|9;u5#{+|s~W z(hS{?`8x!{Kskx|6lup~m!w1}QmxWjHZ3^@rhxvh8P`9p-8BF?bDd`*`Tmf+)hwT$ zm_ON82-7K01yW)ruFY9qy*#(^0fDcX8q2ZE6{?nX*~KR*WFM*}^s zZwd3S2Ee3=O@m$WIt|%5=YkK2VyQRPh~Cf-XD&A!s$=F!v#3BZM!0__HNp%IWx$~S zoQ-%?kro&lnj_GWxU<@ztVu#UBHj@~h#uU2svWmLB@XI_riwg&Qi)2Xp?9`$mnz~K z!f_QdaT*63I|R-uA=DWqac&2OyX5T6B9nH=)ABLzn=J#qFw|SK$b4e>llz}B~Y;`Ku=9~b0d0D=FLwm(fBp&@Nn1jl;^N`FQU`wpb zRVeXp`Eb_6_?hWjb8{c-gu6B5)-7W6M=s!BlAZ1b2zI&C~m`YD2b0_s9Ys2@b4bjMLE~*cbfhFyXXzA095H)A|hu; zQzM(Vy*IWW3oG}3DDvR>%m4j%F%a^%5bvLFp5#|QlkXA143yzy}Jw?z11l0=Yo_bpvsj_yl5kgu8*rlW=`652mP zutR_?w_|(n>j(n&*S%*jpSBzf^J0|A26L!Mq^ZdY^G65na+xws%jq()eDnFdY3HLU z^CcH^z)Q~;WF#@&uoyzTjD^Vji@VBwVKJtdHcmCB&92Zrf}R;*3mAeUe4mW2hnpky zh8XfFv*T2_AY)!U6%TxLCO1@cYqShO$++0!ukUskqc*20_wP?RmE+r3gdEfAY7sbf zwF=Z$0yDvpc;3C%Re^0q(e}R{qZPgWe8>L#7!l9!7CKtUi+#uM7N_F%Cl{#9=*R0Z zKBycCRGxHcD!SU7Aph=z7}N1VGIIwFfRTQTuqXPaqul<2G>r&BoLT5ue1-=gIm1IQ zKK&q^|I0gf+F5YQoY%nIeq})$kaZ@2$UA6mazL>4@QYygYMKY(+v80;(%iyT%s1Q? zXwmS-vrU)PGEMP>>>YX5bN0V$b(6;sUV#gJ2M!S>^V zQ$b~-+T$Ump<$WyX-O8uvF?jNi-KHBTzFRbXbHGciD}~K#D#M3VwG(^fZb(qK z0Mi8QFS|T&eOC_h+_TGon*7y8<>nOLjygUv7wGF%3D>>8_ z3y%~z7;@X*PW$Ia?OjW41Tqzz&xggB-g28d2r42>8)7lW0R&E8)Gm&4C5rEGTJXaxvOX!l)ZdT!k2sLL~Z zZS444DOIN%>V>}h&BmRb`0I0pn+nU@w~MiYEqwyNx5-rMptT7z3-SE!zX@58VD?LM zg#QR(|Dm?yZxF`u?}qRae+GcUxFF76aQDg!7dHGQTN!^!L-eL^#)CT@Aq?2a9^F72JZFo^69xuJokBtJA0Bq+X9`F^%OUY4X`1g_8s~-a zHS#na8n2(gvAitGU~-s7b&ug7%l|ND`Z-L{jdihhh|xAypzIanX?*c3G_q;YyIFg5 zJPfg6Wt!f7ZsOBP{R|}0k<@yi6dzW)c?UcmuucXamEJ`2doyFwXA5rQT`Z5%hvLsGCU2(!>?46APo#$57Szi`Jy z39czv%?QuA!4#00x8{5~9lV*e7ZiBuu)QU^^D3CLT^73Lvwtx$3pzj{?Aze|;d6j8 znI*~bW$^bs@AH~1R|fQ=V^^5SO{@X9NKu_FyFWlIl)}XEhM@(id*ZubhpsQuey=@l zHdF7>=kQ2H~=a(b_aAZa zxL<9zk;^8tcg)IC(mr+=4MF;3yctrmL}V`(a{vAigGBPrE$Vd0OCHDA<@CMbHl3s_ zy(+)D;@5+8Q@u7Te0b<`)uf$f(%RW$2a_u}7yfuXw4bCoWRuQj9!|4Z$u>KQI~oHG zYRHJmNCptGpDMO zj0&D`>}qO3AJKJqZh>go5OpGg^er0fPXrG%BF*zxk6@iJ@n9wOWAb0Aiog5Vclij$@FCg-)WhAi&l11A5Ih9Q>>heUh5{zzy$}NybTrjs zvXv6r2#;v-3$SVFDxtPH4E5UHYl-H4ppgzhQ&W=+7_msh4lNxaD=&_6N&X*6R|Hw2 zw*CqAc;2Q@`hQn!{4K{M%fC~!kthBH_y030>)87{5_cpsBbAF zQuIQLuYLD6euya$t?4vR-A(Auch~RvV~qv?$N6O40aZx-i=KV*2fKXO$E&wO9&5b$1RB#nIv!QHwyYR~vi zKNBY1EYZ$Np9yek%hk}Me=mx)1vCDT9D_SN8f?!4@DI{3>u3p=dbf1aQyS@n$QN0+ zXOeL1mcW%my5D>MWi*UfuoD5s($EkG2ahxgO3d&hj;DThuD09ZYxkO69q}$U=I$S* z2)%|$bw;W^Q_g}!J(381C`s3}|ih#rQgfmSY-a?E$sWgZ)~$T?MtWMO>UK=(>w9yR6e7CmLz zf(=PmPus+NTExS$-0z1%{S>OjTYGIOIFna*#<535!BN zSX~d**6IwhXaBo{VCiilT^l@AP^^K?g(-Tox`fOJ$VOeu!xGi8Oz&&&dyb z#z@J=I9)m{^2CAkn`otwS=VZW+{Y!n=)i)1treiZ6};!?DunQ{G@SgKHK_s&?$&ja znd>6UdG_~7i%$%B=RKf#;;)qQBIrm%JM$uN1hwPQh?!QKl}eOX(s_;V%T)of+AQwQ z;obQScmyZrkMy3QS{(YvCWZ3ei4i*Oz2n`aMjXv(II;xeHq|v|E%-rY_CGiXV#)y3 zQQhy9qp|$1{XOm{=eIs@p7vpg6^G|^llj8LKI2v`Pj09P1xdXCfG=$B*OMD8&Ek_N z{Gmur;>2<}H>(0Kq zYZ?N?tVLq(Wo>_QefW_RqtwZi@zVAJ1an>HLzy5A!+s-180u*eqA<^U^QvEVL+~L+ zy%kz*RJv(Avhfgw_8-9z^-CM?SVEziI6s=Ag1swUKzU17RdO`>a@FGZ;@kYpBcMR5 ztCo2$&LR!K?yYj3KlrphDz2#IYD?}X6|;tk-xL_TJ;EIjIz>I5H{8L%MC>)zxYr{Ig>QJo?ed-VD#j*PNy??i^ zk){{8G4d#olKXd)Ztak%fIJvp^N|sOh)SVWk_EPD;~-3VXL4@%K@J*7Dc1A(GFlz!v{G2)H1B^`WT=EoqCm8YNocE$N-XUh(H?P zCyx}DqNL?bYp$D9>|RXEeYL8Lebnp(uE(qo6p5~~H;u)nI=FgpiQhZoL6}#+ECQdZ z#8$2N=Mi&{h32peSE*F~7~_pD*<(547^xYLwG{lGb+*Jfb|H-*il^d)>0wJz>kW%y` zS$HGf{0JX&fl-$vdv&Iw=B{5WqfmlC=S%4F2z!sK1Uhb^vPd*e?JcU<((k@(o{n6Y z!-xtGU@gCL?7_EujAMc#;zL#Dk57{$A@g4h+F%M6v;KhE8U@v|~9 zSMh-Fd0}I5vw{Xe{Jq=H(YrLax$i6&QzMnLKU#may0&~D?vSJbDA^Q)9`zOr$;Eml zbLl_-!3YyuXj+ZNrHLQe;*Cl$>BK_d%MjX`|GTDKT6dadeskh zC`Z6h3G%oXty!$CD{($Fs$pX{Ju(CFJ}6uX%N_DM;kvKT!Nj@^G2eSCgql_~8K2`Y zJocDK0)SL&nkUO;De$Z6q(6d)W8^!%NNk~SHG z!2%cn8FaZdg!{2->ZShramxLtNDer8Ai%2r!=O8+B$|a>?%Tv}==5z&oXoapTprID z&vv=;-73!5CO>v}oE;p$aQM1okm8onR`l>>+vF1(Tc@)DJsYSX%A;}I8++CC;G8*m zwe8{i=;`+0<5?^u1~4$bmjooBlUItU`k~T@^h6U!w%(`ri;rjrJT>heDUt5hg>3ux z%kkzIJVEaxIL2s_(>wmKM@DRAz$U@A6F+%5)|wKVBIAoa_8yPJEJgvWn$_o;)YywnH}_BI#jb$QN2C}@zO1<5T88$g;c zDMS!S?KCj*&PRRE=dHG zY(-as_vL%cm2ghrN8m?rN4{A9oL~LA6~DNPMv4g1v(Q)D^){_aS;D{j&8J%*EC&*| z88&8e=uD(Dn2r0G=}|_PWe5pc=vvd2+t+rrzz)z=Z!n74r;;>}#yO^{WGvjo;^pz8 zLTON`Rw_z<nYZ>_m$kP_{UgA65(y69I!d7u>Qr4Gr`u~5~r zdSs#X%)qx_?e2P5V~+R^7ZhfTq~KYR=^-RTPa$z+&>^pgk=7E3H=C4L(*GRQfu(gs z4&MY!;O5jIx7OZS`cy5wY=QmjXBBF?ATJ+Y@{aMbGQy9qp1N+UioCcJf?CD_0n_lM zqti@f^;gwMSnT>#bmrG+L6Sl&=24L%CK2>`EOMcrCkk=cUHcey8F*vfIbY7_g2>LFGyP;?C34~vQj)~PE%Mg9?AV-tb9>)L`TmuUZ{AxL(ul-5V^kDBeMJ_< z_ODUCMYc;E>}6F)j4xcCwb|cPI5Tc*R+pv(Ik0ux>@p!|g|7-$JJ~~@4S`F&I(JW- zMs*fVLX3W`vlkC%rgcxv%ivwNMqAxgUd0>4uo>dG08;yeAO?RJYjz{R&uW^_AcG_Z zkJ+*-uA3YJA8FCDOA);AGJqN)5hhdIa2wYCGtb(RpvH4+7y>e$eUkqjVZD+;)|Hr? z{?UpKr>>nhex@)jmrzHxpG%RC+o}G<>hfgo?)rhpVM(V3o`iRW(k=&tT*zXfF}Gn* zkP|_sleIf11b#fy#~^{WZ%^M6WX3SMA`W3IV2e^dMU+mrAi4TC*q}yiP5Ck$-=3ec`BPu(r@R6X$ROfaKv3N!dPU6h)M#Kkb9mPRs*P5F;VU&%q zjL2N-_*>By4IkGy!iS45td*4K`D;bA2B0%}^vMA)5~SL9(EixnY@Xps!j$qg5IZFZ z%vfJA1l@UcN5+K3ujf@~5wUj^8!Be{XBbs?pOcl!y^VJ<=yH0*%`lIS<(7W!$-8%+ z<^}eyI)k#SxXs3gGRkyq*UPyK3P03ewWwpiHX;Z0h406P4L_M-k|~NAnb8bL4fNg* zxofV4|NhJIfCL*v@EZF^tM5M)RQ%mgg~t1~N&Le!Ss^lJ+@hG4F?tMhjuhkB!91%D*7}ML-N#%Csw;3I77-`5HVM(=y5agTEZl)3!yA`4|IY=yIEW zeJ(kpxvi=Sw+G)_G4&NzU{oK=l9PwDWaQS15`*j}OV3bn-*Gq}`pN4)=Wt$J7Br|+ zxp9%wd!t1J8_PHmNtDsyDBiQj9qx-CC2F;vFJ*+YnvK|hTLF}{F7h^CNn91`I0tw5 zC4~h;V?uPHJ@FlUy0oHq^5lzZ;_*g9-`x#7aW$qy531Z_BSZxgBj)hZd#HKNeH^TZ zjW$hE+YC=l2i@u?a4eAR*^1%$oYbgOXI_n{cxvF{J45-^6E{%WwIoK-}XlOBFY83GjTc#cE^3 z`R`ah=Z*9XaRm}_;7999*b;QoRv9B18w8heVWbqhm$ee#Dve26O+Mfe`BL)>mwQ7U1;MF- zLSt}3eXA>9GKU{rGBxU=T>T4P<<|u(YQu!DY6hta`Or`DN!&Rc)iGdt>6#vbu$(m? z*RSthakV*D_O*0wimT5ff{eMIG0pNgEc~?=BJWMe@wLnZhNGnN?L~v zIF1Mwtgz)Em=}M7vz0E&16A+JzM}B0^L9Uh@!nWf+!!_0LVkM)beSkxB9gO|-U#%_ z9j6UXc5Hk0Ojte`F?XqzfUej$R!wZ!BQW7 zg?m2*IO9#qnZ^V#jCGQaJl# za#z((A@8*p?XxW=(%+6vzukT{DrM+-5q4JG9f-krC$>)n%CW%1$Pue=Uw*#)^BN0Q=&7XS-YyRsa&qP?*xDUbPlERM1xU46hqY6ua$!p>k`4) z@vgy8yUGhiY4E1D9RmYUpXVhY-SB+q_U9Fxn-u#WF_v?8to?rk>i;)dJwr!^9nE@7Q>$byAS(KQRK=oC2gwstF~x9kOLjh8%!iW=Q5Y2lHYtRUy{*A z6@YhEgI#}gw1dt5p_REmc7Wsf7QcUF3Z~_UFvBU>aF*wJM{(o~sbD{IAhqKYq_(3- zc5;MBeu{1q8an_EPvAN?k3~c;jqnOHXu!!47EdV~nf=zJ^FHbaDCb|% zFo3;sSVG5vicwH#+-It%C=c0uErO({8?74%UYP-J8u~1O>cC4aYk# zlwZZJMA)4_A6nFpkPV|ac%duiXKADd0^=iDE#Ld))eIuon;f#Q>-4V9(ZKeR!b)rv z{^(R+DWXK^t-yWy%U#LToPLAtXDq(}hR>uF;1U7Oz12qj*yUbyj~g!f8uW6ZUC{HL zIX3Bysq>9VVPN9kR2S~-WV>5m-QQcYV-m3uMcBY_7R#F&M4X6y(tWpz$>lflvb)<4 zWyxENf~FiEw&YGNDVAkc9P1xyUaWDUObEW3QW^kZ`BAM99QyXa{#oy|aks{sJH^j; zZEmvdFzHjGIlhf{OQiyUgWl>_Zl5w6$|`$KSy}J84s#kG3NG4C3^SRDV^E_O+0MYM z-bG6@V-AXvOU-KX-H$U%gLfKjy)RXxqo1fM;!LL^E7k-A`3bc|i+;wY%hZ;j4DOR; z9S!>2eE0Oe*D_n$v0Q1EdHmj5>Prx#UZ_{unw5d|G-cvl`$hv~$Fdu!u2?Gj{{5G%_U|u!|;Id1|yMdG z4XoQq1T_SxjJZjF>HihWEQ|Xn3d#}a;7Urgx6`H)CU?Hna%JueL`pRGf%XvQ#aFQg z#vzmD@_*Kq@4O^;^n@ST*A-^k7Z%Ed%pjxd3%9Wf=7-bOR4fZRgrhF{@$9a1{2o`m zFX#Kq4oo5X8FH=@*7fje_a)-aCi|CHTisEO%<|^~P4j zUw$i)n~;OSmqT%TX4E#Go}ql}fD%bjGh?I~wvbWGhjQLaPzAS{&=LMDPr;fzG-o!V zM*9A3Up--L@p~~!)1`k9R#ZNe*5H>BoE*|AV$DJBayjPa@MI{}I#wBS{O# zUxGhwt~as}Co_|phrKD2lCkA`XB$DmfAK02%-6`{m%;s&;Y2kYpw>0+4Ct$?sIPKy zDoALj(-Q{FhPiVX_CzlFcxfaF)WfkRLz%I1qyiL)5E>aJz@#bzbf9!(7)R$-MQQ~~ zq-vw90W~ucwPn`{$COOcuBms@1IpXvUL)+o`n9sPP1Xs=O0J-yLI)eVPqM1ib7Uj{ zKHliwyvI@!Y^lg#T4Xee6i-5Fil7}~dLD8U{<3Cd_c`crbKQCzRCRVp)?#u)M%;;C^d>a~xOnwPa$biLAPy z)h=YcL-br720MQRK*s`4m(Shz1HSnr?Su{lV765eOzp>6GCleKOzLDW~OXNC@K(21ei20 zvOd_L8Mr#%Y3D2)sY764&uLB(i)@k&)#Bn}?`SF$ix@%v^2T=7Wai!0#a7b<&Fd5d z<>5T=(^@hVng<(GIxhBvMeD5;ngMi{JpqCMBDlo!j$dkVdUfpxh9C`o#_i;w$#`%lX)mmzi ziB}=YIIdu*M~J6!{FthU8uxV6*3}CgMK0r4`XFR28|Qwq+5tUE!WrS5lxD*)nkMRU zf<2YK-6b9)jM?B;Hionw6Z9ST!?qxQ1_GRe&o0^uBVk@c=Aq>|Fs|(6>y*H!ZxW|z z1iAGu-}?7r8RjfcEBy@$H*3!wPOoj!pmOpFLy^N~fz=zEU9h`hI7d!pi-ibxVQYqK zpPW3_04r@IxSuI#PQt_X?CIb$`NEuG)Tp>2^$j~`#}6*At*$koHi^ccy{*?< z_a+fWaEzN<)u*)4k#CLZhO9%BGOc>RrUTtaZHx$$g1x}M({1@w_8DFX$v(sU_ag-f zHUw#s_K)xO-_#yrb}qKg#4Malauy$*bXZt<-iXespqW*9-spm$9X94S292uTpYO4< zk(sHJpx|4re-fkrIR9V#nm_B}__HcDPR=*85LCmT+dpa{W_`Q#TlH@d9Z;ppMvkU$ z*JtJVqx`*2J{XDgCI6At={LoHbF6vbwCV66T>zz z0VZ?N>TcQ%Q*5T$vSh#7T+Aco74lV+Tjc)#cE-Q}bF~O3wu(@C z;~vU=`12tV8vhO$`>pfbZFRDlkuUe$;6pZt`Ksb>Z&h)}uByD-WmO*5@f-J57mqIA z@83yRO{(YLzJI$9)cot4Ki_fW&3eCBE%u8C06qWX$D76S$Myc??fU!8^|RA|{P+Ky zo@`dnPXD8QQ@pu(vHoH6r(bsKZ-4ps@0P#(xExlef4unY{NvfjcQ@}C?d0RTtLxjd zkIzmQoaFk9{|@r}^yJWF|KqdM=kbe^zrOkU-tNCyKkV%2gtrGn_|5uu z`+m1v)BJbGmTiMTbf#>JQ)7c9iOYpZe^S_G_h*??8s^+`0JZp=yvYHj`Sy7zNrRBq+ z9mW_%{P-wU`*@T|TODV++Fbtpn?`wPDPtV=v)z5S-CkYXX~9?5$lm7rYmnw?d-D04 z#d34K-`@W4#iMQAcbJa#=FQnx*SGt{^>Y2y%ZvB#H>Y`W!g)y&=&<$5-xrkM@> z+iq68O>bAJPM6hXe;9V!*T((JZiD78u3m1J@8d)n9~M7dF-3j3?yIgzvubGjSyK#) z*|6%GSzR{muvoQi*ItfO92v%@k|~&BwOTB?)UIar+f>e)bxO0e=+o@&Wl{7))h$w5 zk25^#Z6kk!CE0{Rzqnf5-d^17w%f}y1a0gqzqkG`*SpP6>(%Ss_T2#zZWg=Sb!ghN z(^1tPi)%>iL08W<52q4b+pwp$XsV%Gb+fdt;9A3;hM{a`McH@dvh0h#N#}Fx{;;Np z(N}&ZKVWA%% z(Q19Ucz?AYmny$~7+^fXM<;Z!2zNjoI*)w+X>+^Z?tXssi{N2k`?u@APpRWCt~S5% zpzkL-AnMs-8A5ik++P2*-tE_`SUyNQ(jS(6*DEHwYk)v4u#D^7?ZssX+2ZErYO`F# zX!DP=&GqUI7xvr9Zw?Y{1N{0dx7*A82YjLD-=oO?JLcStJni)BgD-zrTz|h_UChT# zkAz?E^5KW|^}oXMy9FFt=^*FxIKHdR^z`ni(?cC4#D(B|wLH7r?%pl-7mxXU;OfJ# z9%er0H)mh(wyXEc_3oa1U*mNAdGmI+*!_G`_D?ZDlSb0{yB!n3qt}b8TYxK?j->mR zcRP6Gf*dw@N5#Rxxtf3SuK2?z{|xPUcDlp+I^v4g2Y+((IKzq}R$;q7e|Z*`v@EKo zEZgE>ME_6}fB0g4Z<{_pW|#iOtdV2)gDJOQr) zkD9G1Puqq`WZu5*YLSZWweQeP4LHp1-|A z$LkNV;B=0@O1j^^?;_@vc6d-m>m$~bcB#|z==-75y``!#UZtwHc~f2V))(Q>wWPX@ zuza$Xgw89U6W2F3UR$-g=G3;Ox9g1ei8P|}AazCKw6e50y2|Gm5E$LZkW4>@qD(r+ zP*f)4LxF28;|&GEVYF1(cwN&f|AwwFjfQKevNrTZoBalrOZa%YMrHpmo)B%|S~(Z>RD?yKWF(K||kcUaZfQ zf3!;gg06XJMYm{&YT4d~PINlj^{w*duo{`8#D42|See@U*0wj$zSr|8i_|JlOR!ye zTE=2@E#;9p%G%Di9vh9?oO@mO%9MDt_Dy)&t0j&|8E}^xNBYY&!K}&ibLDTi2 z_@!WC2@NA9~(>Y2E zh|(%@`bKMdYuAvBoV2R}utH=bXr*8nI$rcfYpYsx2ImxUnVu0e{Me~%)IH)NF+|W% zI9Xp82q?6k#O-vybwqCx3qiwY(6t~2qDK)i)q+jXD$sp8Zz>2)r{_@zO)v*qtM(j+ zt4+P^1KJ?5csORQ?w7El6T1pn^}X0PXgJWiK8&8kZ#CRQGi7fL2?XIO!KM1`oGl76 z#RzEi;WqCP-q&PX2U{PWx8Nl0V4tpqC`#ge+97MYzSQ+`_xO0;0pt{46bVm&owZY+ zHQEuJN;|fzd>KmoA(2yPYUAsn!X=dRfTlTxXs5UvG_@%Qn#~Jt6jPfL?bI&`n)>|E zNOvh;Dz1w~PH9(*4WMtOetXdPNBGCF#eMPQjHOG__I8i?3(AB3WqTVY^i}Dge;<(gJomFSgsx65H*4QGe?@IA73dTT3|0 z+7~dkwRCL6+L3TlTCaJ58pT&16B;V0a{zyKZiLukR~y{tLE`fU_gP~XYzLNRx;KK4 zq81$_8AdEVJ@ckyyCQ$k64{5zeh)N>VWADoqV0foT}#5{pPpM&CPZj@z6YAk5$OY6 z3z{IlUi59nZUv2?MAk zb;7Hv>~OJkybh;EX?;~XO=CaiNCec{7Z&Io+=ZdA|7L`rNBebtXR(8NcA))#7L zplKc?+L0L0we-E8N3S{k=$jN{p=oY}b|kuNzY#I$yrhto&!l|CH^V`)dxHbb&b*_n z#mB>9%Dizcr1FQxNKC>UxZ`@}&`e&q1r=W^`l??7jex<{$EBC@g%Cn~R{ADjO!h%M zqjnk;(mM=deN|REB{Do**^NZG~V|C`MPF;HRUPcrP(d+{Uj!4 zeLX>)j@Ku-m!w@HxYBlmV^}I`YsZbI+IUdBH{DO>7Ql9EvcK>V92d--HKH3e`bqhBuhtmfXT3pWRzQ!!s8BAkjw{Ci^9xR{bE6*4lYsRO~DP7`4B+ zaOR_v^wB#4@>%3cRbFZmt>O>WJV{qv!zHBDQ1*dkw6)YY2sR!nXnlJeZ5@xanewV0 z%)i3LOmZJjQWTRc7*-=`lK-P!XoJkl$=SIz_|G<8)0mvX7SkDGcGDTI!4%iJ)ec=D8 zZ;Nr`rd@ad`xHB=@-RDyQK;1iuDP``*&usr=L`B7pQ(5JA{8!dB~jz#zne^&#Zej@x6Uk$zSl;By&Ya79hVdvavfx1+>c=fDQ2O!hFw)=X)Dx9iP* zU@Fva!YSeQQ|BdyP%OdoHXDGOXf`kIVssx=?5O<(t}MS15T-sH**dgqx;|)Hn}<=w ztXeznH03NQCe)e)`ZAoX8Ao1os@ywariCvp*L3O=LZgsT){K9k{38W`Bc|;zTO#)a z_D9;GGNKDadFHnh8EAbIu`2a1+819y<5jNs;%U<3{5^e9C6P5Q{5!Q}By9^jHyn4x z5>g&y=VT5XB5&t@2}$6?o3uyw3k@`46&){<(njkwcSB#pE7B^MZ|&P!Zi#jvzO@65 zmByXAt&eMGJ&yoNry(&q9x!S1a)n_uuHIF~xrH>j=XTNeOF@mTnPjf5C2odveeMro zrY-+Mv}!SN(A54$iL3fF(6sg~E_?JI>_D@95KgO2j&zvGGtrP@Y*b~~d0<(6yxR4n z@wk>$n$|G0X0%J?4=FdjWH^%pXr^17q|^j5N5{ppoEudIntLFvXLkvt^(c?hzL+<~ zwPr9Ig=;diRPK_OzVd2bvfDj(#GFspj+ zLOYk;?#MpyW7Y2@vhOvP#B0(TSN7IetbvOT17&@9KI+%ejuH-SM`~SV4eci^YS`?0yg$!Ig~14XI*hM}4uzDbTd8o_UdRA8%0E03r-? zpy6feTEGJvkIcOCDj-LB6(w0VUajv_STiK$DR-`R9wpaNVtc5SEH!3=W_iM>i&P&N z8o;Le?MRv%&GZd8wfj|QjoMmh{G;OmCaMc1DH+?F=Od`@wA>~%t#yH?>4>ZicK1$4 zt?8vNu7$3T>twZ;m=A&+*&B6Bil=caWb#6UXtIWDrg<9DC7hDZf$diLBZFdk$=$Zv z{V;DD+e6d3Tq^0vWU6d%8)dQq(kT|xcTjA{aijuY_kr0{S>v|M=LIH>&vA*X<6$jq zydyHsWt-FhvEN>6{DX$0qjPXXHZK*U-VVpp`nsKo%Oc}5B?-2Vl+;(j1tB`sImq+d zTEY-oJ3J1dMM$h`L0rt1abcnNh-7mt=S!8AzI|w*nV*B(L^X-7g{`UFN6m!FJ*6(j zdvfN+dt4QhjeugC!*gz2#9+~NeFR~8Mxh?wj)=zkTF!$xxRBCzMBZw9$h>O)Ic}3R z#*W)ijaQ**jXLMSTPX3Lq2X}oTF9jt@1t7R+HsMiG-79yE9BJpG7w2wU-via;qa}X z$GMS?y9vFY!RfTRC1{qziwuS4rEt+L4n4T-dcKH(`7co^qi0Fx#&|{CZ8{jYC(37{ zK|3QVL`(-sj~kzf#m#5n6_xtq1hx8BfqFp2_f;qck0iyC>Zn$ybf(qMXKJA@TxRqseWk`&X1Qd0&i$?Tuul zVg%PXzBjI{Rfb5gnQbJQra2iBJXUK3&Fa3OakC-vg4mmXz^fC}Rgwy(A5l`IazKEt zwY5k%_klVumnXIs-fbI=H@7NREq55+PT$UcnW4>%&+Mc9ztyX`YLR`doJCc%9V)lVq^E zO=up^P_k%v8f9)OL);!|-UknzC|1{kuWak%yP-}yHU}@-bv&@x_zZOFd4&4vnu)|s z_t~w*B)z>mi7Yi6mbJutA*T^ESv#H^DUFIG>kGy@4Fha_t!|SHfYsPg*-fOZeQ`MS zj7R}EuXqQkc!g+~j8leU@nugvjjb6IV0)vi)XoS$(fhi;7Vj5ShWKoX;Y;#*hA6YN z*nn#$vu{+USZqLE)M5j!qwFkG<2c0Y6s<|1fZpypxSV z)u+L_S&cO?j_0X;fgGc8b1FE*Ll47ou41gN>QE|VeF^=H#;28(2jm^q? z(qZqs!b~6OJ7_+PK+V^}b0LipX~$v8KB!4Bx#Id#eU)$zG=CN4{3g5cDnxaV+=${I zeM#W!TBv+go}z7vyF^y{Z5tl#kmM1cftM}jg8;gP+9=BAEY||fu$W3UEQqdousjG3 zm(`^~v$r?U5H=YP(_?sw_0TwlO9;zJ6X;S7rsGA0gwi^zGm2LycII5A+J31<(s(N( z1I>AmghSY5UgAczWpV55G+vnLS(2u5NDeM-`4ylkjXF%)KH(53t_uMgY}lzgUQ@}%0Boeo92eGwDu+#n$`M2v-~)Z zaWI9`IU-`$d^M1f)I4-cu~2jG+Y(s3wPEU zgHfPv?*gIWq|11eLfH9IN2@Uy>dVLKv@h9kqlGoob_BM19& zL+!f((DWN>SSYkwF_Gxa{4lgb?{PRvG9kKOHYak*SDE;j)U+L+owj!(7)#3`M_OLb z7nSq3QSB z&*#fNN!SMgD?BQ*8L@jCT8i;Ra0qP*v$Vk+YRnAK5`$S~g#*eGng zxCYbp;caNH03&U8$3auS1e)1FXjIt`8yIGaxM3^c>t@a{GL0*&ZJ)`#$Fz7x38Z)@Vm^JzoH2(nU|6C{alxvKa^yka7k zx_m`Pm+U;Vovf~N5T zG%f_DK2nrn@-zLrTr%yB1DP*bHnJ{cT^Ko#@gUBHPJji&E@nGaY#)FIp84pHn$o@gbgNz3m z4>BH%9LRW(@gU>Ds14aa$as+PAmc&CgOLLn4>BHPJQ%eh`v(~hG9F|+$apYvAmc&C zgNz5GHe~-G<3YxQj0YJHMh;{=$as+PVAO`}A7nhpc#!cR1_75^1WIV`tknv#T zK*ocN2N@4WZOHyX#)FIp84ofZj2y^#knten!Ke+{Kgf8H@gUBHPJji%3av%M8KRD9Vy|MK~(msR_`d{w=8{_5hqt6sIwyT0mP yyl9)}seRtIeVyu;uex^Vi&w8M{_Eo6$?blz+kf1xFQ1fU_vH7#fAyEwPyPw1|EkLX literal 0 HcmV?d00001 diff --git a/transfemscience.org/about/index.html b/transfemscience.org/about/index.html index bbe916e1..baeaa28e 100644 --- a/transfemscience.org/about/index.html +++ b/transfemscience.org/about/index.html @@ -1 +1 @@ -About - Transfeminine Science Link

    @@ -370,7 +370,7 @@ Using the term desistence in this way does not imply anything about the identity

    g^2iP4p-5h#;pT1X|-x|`~Yd27}r*%pq3 z%_;R8p#@;|8W;kNmEosm5)MTL5x1NccS*{fpwH7CV=F+m>as0l3#8k-rS>~VEbft1 zICVWRl2Q_)eG~iRnvUo?a$GB%TW2{5Q5y>%#_%}?fw-9L`8zu4F3c0CJAcnmYCGYM zH79_`Wvq&H->I;_=N!}?8LKQpDH@G*8XmnNNz?wBaTN@ z3=85VE>%`i03J5~0Aw`gI$qW4;3;#Ghz+d~rTy^p$AXrCNfpH|Q;Eb>0sY9s&NN z@g70_60o2;jem40WI|phj&}ao03)V`6g?b(C1^SVb=+)xceHa*r;JcY7_DBk~&%)4+4DF${n8xz;%9*XXq|iu0LT_w?*IW3hyZ}gQyFz3V zKq17I(hlWI765vfix^n@l@%X}nUvxJ9HinI6*Ez$xZX+jh)au>aX~0`O3JLxBI&-j zAasj7a&REcDGC`*6k;g~q9~K|0&bZ43Vo$X`ofS>Y)*6Du+ZAaSms_T*T7ypJC;vg zZMrTUm|=hjOu20%Z3xSMh2n|lY1wSCl;w)JWZo;oOQ_1BX`I9JYZWSSBI#{Ja}<^7 za6ry16`{7ai=0`%6?063JbPILaR(C|Y|KisGP3J|V^gX}x(}fL0D>=8F^Co|O3s#RmnlA0F^>MWCSYo9?8-W!%Nw$t_?^Oeo)_Y&x*1B85Vfg;VRg5vl0Y6&CKA+j>`YF_e0pPs zcy_kSpefmPhh-9PeC~{d17mGKI$9j75ZwmF7?I8hP?uDhIqS88rwWyP&7oTWMbG08 zP}(Zz6jq+Cyr-X9mg31Il1aJshmJ^7E;gV@HwOENQaN;5e*(Ca)*P(L)LFB1tW9)2*tkTsMZb9|1ES582^%Zk zHj4f`2DNLNCt#g2$T*S1Sw1MzoutpE?Y@gV?77Mt>BX9in`d>`*@ua5MY^ zoqCHr2{P^}$wz+sYaUkv=e%q(44c&y9XTRL#;#{1(%hV~fBJ&ARLXNq?7E@{#AdaKsyf-O* z2a-G7Q{gLQ*qvd2Kd%=S^jTs);eF+DaM zZPv<|eKrb7-6{YAPvH`A{w5|$h<(F;*VS$jOc^z=+v(|92@fesAve&CO|chgOky58kFj{eLSh$pp zQlWBl6!~jttjQWBL`q;z2TIYarMV|dk`A=BOS}>iq&N-27CPIZvTm4zESnNkM0XnS zVZ~VTk1n*_C8QSypJ&(76B$w!r*hRX4keM{1sOAQ7E3K9Hv>&HxzHWFA~TJT@)$nV z60Kv}JfUG(+IT5QBd>Qj-X-wy++!=)ri@d@dZd)-WGP8$1SKm;P$JrR`9;!HSGHV# zV=gy2#rivx`ii-eazr4lM3UoVcT{hEdL4C&&MF!ml5ssl^v?unw8`^RW>vQ4Z*rue zDZTt`HHsYBB>I*(;DyIKA+%IkV3CyWbFIfwG;CRqGEQ0wAx5Oa_Tvb+UQ5)6nQhTP^Y@0cj~xL9w=k zXh1#(#waB=Tt+6p3pgP`!7`{-J+{`H3ptfHK4!pc75qk4_9bJ2L$Nt7G880O5z;AU zPKnT`6*S$+)g$tS;yTJ8?eC3V#nseEHVHYb1?nb z%iddODMD7BwpGYCAjP7WVjQ9_J38aJtaSYD8Ju-WYN)|eD^Vo3Fxa{jo9HiV9lc@L zPME}yqQ-RDjxN!hb-|LmLc4B(yUim*n4QQP?tLQP6zk?foNweq>BReMX?zQ2_lJS& z64@Mb_$9>z@cL=VDddN#Gvk#s(ymehw9W>i<9&=p&xgcA*s^FQuL*I4$7MRYDYH%) zoHJ2SRHV@)^0Vp^K)r^(1I964(%?K*Ynm^(eEN3iSVX=Nm!?h{l&Z5b_zJMLUmZPT z68KtW+RtcD@#nOpuMea>o?gnEbvaU-ojmjrbHQ+KZ^;nzW~5YxGsJGDUCEb8E<8z5 zx$7IuP)e6#j&i-oWm%psDMa-#Yh*TXY2VJ?OJj8?51E3*7LQg`o(h+xN={}HEg_`L zsUrC~!``q2Y3O!_^=vZ7I}YHsa8%5*l5QpTd8J5jTFY%iL*;#nPSGAxv~_I67Zh;& z{haG8;~E$uMqyx1%LA1OD&E01^%@%(qRksEaY~1aw2uMgyHZeE#1xeeYb^zW0Q$jh zq}bn~ioX}aWrA9cr}sQ5uSrv!lbmCg{HoN_t_AK6#P#xs98B%(NyNLBm294o2@)A! zov?8&HwQS$sYo$5Chf!7kTakW?;%z;Bhbc!fm(Zcids?v zm{I#G8fF&i0K8qTipDjVzk}7@8p<(MZtuuC0@|2C1LgvW1a$_)M;MZ9c2Mmk?+~0u z8mkbcx{@WIQ6*WxxJs{kgSSYJCOVD0XHvtsmVL@qURg5p0ct=}Yz@J-`AGBW3`kl# z+$`*1+|5M2OQ<}S6p~w5NDFD?o2OfiJap7)c!!c#u>4gMcZI#FU*WvT!`P{`w)-l` z9|YN8XceYlFTJl7(&4XkOO9UT`=a6*JXFwnO~B$vznn*SnjTU$0MS4$zh;`X;vC{V z79}R83kOJw*&!ID>%r9&oySN;ilekggKam9ZWk_wLdy+B0?;ZoUdY&y**DNvET#95qhLk!P_ZKRjXpVE>yb?;*2SD* zzR=VhM=Bph(y}g7t*`1+6O@w}Xs&+KoL2U#q9!TpDN+a^q>z7fGdT-Lad=nS=5_f{ z%)m;VNVUmT{&3fbD@mt_F`VZWr<#>b{;@zC6JRf{h8mVmqSQ-#;NA^q4%6C5NV-x5 z>^eqsh|c88TzKgZLx~O{O_8FKN6bWc<)Oz5D2I#^X9ME&sUs>@@dxAS8x9{Pq?tpS zG}yg#87cm1c5nmni$sdX$rX!o*6{S$b6@7f-^^Oa)+=&HnKlwQ{e$r#nQ6vWebuNR zRK{~YJ1%g}i6z=Qhz5@&=xFX7?X#9oC&94 zsYE=|0lGm1r8hSok(}c)x3O)42!H02?58Sp0yB9wWxNg9Db8(yh;l>d>O6A71(_Lg z1P5MO?4})yp$!c`XwDh6#Y{f)WL@@BR@ty8O~$cz!R6BaC3bvzkybnvtg1n`sZaaT z>bfuY6l_Pp=^Gpp=x1`GM^c#=C{Vf<3RDin9pYIW=yqwvZg9fAF^1+8ODiSmMG}3* zYNXpyVZTpE&hhwcx8ZUYaO*+#%7;-I?FGJ~vpAttnx{`VnP*nggNg*9M1E0ihZ<{i zM9DW}VQar#K6f!MPeMD9B53S;K2)7LL)1pIO}QJXUKb=ns7q%a zzlYIVVRG&ZX4NX{l?{mVj_I?OJRO@jw)FOTEkReCl@>`PlH+4Qt#95Pb=E2Pyd6SDMFfjP&P$6ZFv#jb+L^wF6q&}3O>YTGVkVS_TS|ckbc6Ybmy07q6M|(` z@sF~u7{^miv=Ss{f|L@rl8_WfiflFbh|_TS8%0)F(E>P&*yg>%@Ta9eo=d0gCn!)J zV>RN%ZbEF2QuW#FGUinkwzQpzA{BISkbFJuVOhaWCo9WRM@21Ue6Jm|rIB!_w?vL6 z2x_E+B}TxgX8r~e1j>+{q~o?jlFLehhfNRV908l+CuT}kG(itAf=E5!goS=v`NEXw z<5pMK5W5Y%NGe@D=PkHGf=Ky-A;mEcBt69ZG_2sIA8BD(2ii#le1R~u#L%CoVh5yD z7KIe3bp(PVwgiL0oun#we=1g>@<&GsiTU67!W5Ob0b$Q-XEq=(g5myfJCAjGK^r)W)`qseW?_kawGQi5+BM_JEP z#6pCHON%2z0mB03)`$S=(<&-TfhH2rq{n)XQ4S0Bh>}F8v0}vGwx$?pbTFDJFda9W zd~8k9U^-(oluusd-=U6j1DNe8$zn#Nbk;j(4jYw6QQ`7l zB~6lr4T^O9qC(0t;2N7>uHXfQH2Tzmuu_Q!d@!hDriZpME;&;o zOAAK$P+UBnjMWdUXiLn?tsJz1d5bF~5`kg}NYz);#@gN*XpZ75 zoZ>}Rr82p-h7&O9yN;!l0!^*9T%%3w2D-q3DmkrD(56bRdF6M%Os8?{ePLsoPPI0X zF;!Yv3PNsfR;?0|Zl}-lj;1Py4vE4^`ok!hWyYJ%wIMw0&8137)Fr}_f=@wv#~i5R zM4QAIUV(rl8JMf`+^NhZAhcW{G?XUSHY0mzZK;l@Vi_K|nZ;^4C77mR_Kou9o0=&D zI@Pmi7gds-vuH`akgF4PBjuizs7j@3TGKIbGT0Q6<9pm6gmhVzsWhMk1ztLI8IzPp z1&CVYhqR=P!Gtg;=VuNnuZuLZhbk){Ny#OnCorNe;|(~KmWUQ4q$fk(Hj3Qvt!|(Od|{S_rec_=CQa#?tidWv zreOm5*^~lBy#a!bioP7x#b%>bn{5RwyzH}#llI$F0?Hmli)npDpnD2Lz4nyM%QC)= z<@s9i)1*D)teo8jNfpU)%=Q$L>p&dErM%c$ljZ_?>8|1v6=IvA%dTQKXtNTflye07 zf}1z6Z3ss(N>+zpE$h}e&Y|PL?t5I_N%Z@Vtq!;7TS)!TwCqbqet*9(%Rl1Oej>pB za5IN$NQ6AQZ<5fYa7Vm{WTmDh+7@#nl;43-1b}`bIF7TSgKFx;(vtHJB(&qGN|b_q z)es2>Xj*n9svE97aLi(=WA;tlLuy-O0#0NCq>*mD0PA~1z8^P+$oaABMSfEzrtwcc zlQ}M?+?QnqE-v9nUxJfiq3C}IzEdh(1YRh?PSxd1llBiL_TR%#4zb%gM6B%XPi3;r zMNS7Mxk{CpH`O2;gsD9&KqF#r4CECQa@yj(ONi4Ls!mtxktXDVX~=aU8C>UO&ZBGP zT9bWq05*X}s4mE_K&c9*C#lMY%QI8-`P8`D^ew)n5aLzWx)MO~7B&}$=tY{9Oc?Z~ zI$osPfF)B>uFJTRNgTOk0yWcdZlV>Y&L=~Ajc2NORWp=BF1}M!?9>CJ-9t_if}OTf zm2huvkevgHM6cu3Im#tkk5@U}{hzav08hyXiMG1#K>&PD` zB4-EB9vs#WHKPkZtko)Xjl0FsVW zre@dmRB1V8+(Je3zcnh{vJ-xRImuD-+AT3lOW&hkkq&Cf1H_(0yzL;iY}%Hm8c9|1 zr;wtc4^e%Oq)THXLxs4k-7(7U5t?`~rtd#bm^naha$SDXfn#EG+aLs+lWeB;h|hPo z-HssqdcxDv*jdS%nv?CXNk2H~NXus*m}&c3!rCia3wcKze-EIx#>28V6NBibQ>x6W zVp3kN(~?dm!E)0iizpo~g(m4zNw-^G8Is!mLg6bX7YF!XQZx0M1w<(b&nr18H;|UY zlCy>8l-j$w(zGm#UqhPU!!niA97yW%*>aK?vSGF|q%N5AjwL^NQw^;|`IvG7WJd9Y zrs~pc$WA39Y}6V6r0m;_H!uoz%u8a#b@dRdu%p;wi~O~aue7I%>XQ_QC!0w~O2pKJ z=d==lHw6kMHX3(<0?^Jy%i=i^HNbv7OmSBd$;(xqviZT*$q7mva=|M)1oy~D2Ya0% z5`v-F%W_>-`#?QGrXp@llQBv)iTQex(_@vjt+v9m06-sDNV!e&?+~6X{zQ#J*9zmw z%mV)a&@~pz$d_ybVPs57k!Id(+g$)kheZ!~!!9Dzvy+LqaW92w(*=fAQo=P0t@#$g zFUh#0-hGk@Dgf%X^CSygctk9avG~Z3*w$Ki49U~v-Izq&nigE9)lqI!%@JWN@dC(s zBf2hCn`2`Xxo{}GxfT$~XmhD`fiX=EBxO>RQ)9T(Xr-KVx-4SsS5jt=BscbXKZr?$ zBdm)UcM8j@kuchUQ;)4KOSnG5+rD(2b+|fwG>06wIizQ*yg4b17S0e=G#c#L|Lq1E_Rp4|P@4q^4T}hJDI=C-&Jzx!ln*&0sQJX0oN;H1!^A_@8b%w4 zl-U}T(i}Ndq>C@8Bj>z35z6j*lUtCcBqqQldPDIUaTGH6+MLM@rBvV0M79? zPFP(^MTeM<>N%ipD%^RdR8O-s;tK9G3rQf2ZU8Wr#V7@>ao$3T&oRdmn-9DP=Nz-T z2J)HP7Lhul*>@tkW>N+HHGs}_PU42_+O`ta>Z#kCUMNv z!4`Eu`C1cabc~M?dqFP*o>_C5Ft2s6K|j{;`9Pas;)e1|wH-#J-!Y^mX}J~(8WFfX z)31~b(bW`gP`f~!LZ>CB{-NS7fTaKwI^{ZRIl%2YZDG>VjHtf-Z{MEmMFS?MgIUO?vXZRt#KJRm7KR#fY{sj zM=0o?IOw#Yayg09Hk~%ScS+k5cw>q}t5b2A!(^$o6ey69nLRo}r3yzB_c+x~EzAc9 zmvEs8xYEY<*uvH!E@CO}Do#uj>zYPi2btO22`?n4PvvFgaP-Bk~)ibWj z=9q17%DARV`^!pBg+r~p#CK=R=z*Tc^DHbS!d7k$Z8hr)(1!I1^wrHmac|nnUTgmV zS`}0#&rQ+PQ(#5M?~a@jFVdV@%hot>-;$ME3d&BsAOoznR#jzu-~bZRfFb}6%`HzG z^y>f$x^+1+hW5DdfDSbE7|qWlBw4ZvCeQ%BmEqV+iAW(qTM>9j4!o8FOo|d*umM03 zt@VbRI(I5G=42j9g9~+{-Hom+M_c+pfKXFgRWY=Nj!>lCAov|&4CvwDu5<6EWSxQO zzLt(1G|@*>GqVkyg3`1r^;NIT8{Rkq(oUwTa04h(Q_}XdaP1C7F18ZbS_c0BX7C(2 zn5j)v+b1bXx7V$pI)n{6U+FhXKx=3P4kQ3h8Co_ z2={^2HvTch3|V8DM9#}4D;GJ&Q}o|lQodv4G2Q@Y?BKb+OlC=B6-wTfz z0PE7^QHP~p2t2@+T_9h3AnDc@5i%-!g*Dl%1j{wKG;<0j<`%Zbrz%aAabutc=fW)> z)l~z%KFS>gBqc{=?iaTDMOPQYZD^mv z=IARi1{_`+Wo%RyrW$c2wM?g0NLH6#YjV%wezBQxaeMy&BJn#SUlk^Qye)EzUY$~2 zmZ&soRb?YY%rbOk^M2?lNf))RZ+OMW32j$m9&L)&;_qj9%mIsMn{HLf+H9MRx}efj zNtSfxK^y2(pf|O~@utU{WKrbDxh=ntxGl;D(=AGws!GaG`E5tqB-C{J=EAHjcR7W| zu_wmZjNoci@I_|=P}`fr)9Ih3XA75@VF7PTTT;`>0ePD7B}Aip5eaj!(heQtr9&1j zTNF)6^3hAnOskX|=4thJ93vWUl;zhFJ!)Sg{)>N~yd4ny_kiM{_b~_E{7H|yT z4(f9f6KE-Um75z77Lslho7&)wL4~7|9UcZ(zmzibICaJ3Gleh7ES(yiW4zy=d|e%N zBSRdTv3TTOmjL*jo+x42Y4vwz8%b(q2HBGHUDbjH+KcK2`$lIb4J@>dOGSBNoJAwr zDyu()>YyRw`-YP{(Wd~qnO&`Pt8uD`I|#7Gyg$^9H>iXhJK=oh3&u^+sz}PDxTGrJ zfTW!+FKrJMmmKT z35IIp7+{8yd+a|>BlcFjy>9tLg4fl*Y6NJ(1_dzrk zU$49@mXc7-#jdh97t>FSNRGs8j`k<-W4sjX+wWDLN&3P_Bp#>b6n@dorBOeG$ElCc zY%U8w#ymE(N^3bMcNC9;sK%4rt)ANmX^NLMCeZq0PhriY;JTBt^0Sf|gOdqaXaIZ5Z&HEcqBR4l(j2XZ zY?1sU?blMlsZ5P&rA|vArR3JpmyG0MRmokfITa6Sn@vw$5@37>G z{Nm?p>cMvGeekZPa@!`untme zHMUZ9Jx1{&7}9s#W>eT|ox<{XN`7{OR+r|rHis7@G>~jk=*)#A>3baxq(tbVD`F3` zM;RL6by8++?OQFD%0U3AjkoZI^5XFo4nlfKW5XZriMLg+CPt=<34Dd1g&{x`k*FZ-L}h0hWxQG0kdw@Op~yncHdhC3?$8Ls z?21IHwI{z~pO;wE`!|Ku?UlSvT_~yftX%dj83odwzwc<-;Kr9DJ)a|H#D*UX>UA+< zv5*|a%{o{%EogLUiZ&#I#-ciKPE``#8=RJ(03J($WjD6odfFMu5&UeJX~UR5wVb9_ z9THVki=#S*V6QBz8HN0>97;aClz?cX5F+(*6M}7OaZU{Q-)-qgMw?>DD zjUv0da`8R(mW(-qBygU{XW)FI z6w8~B#6#SMNj1T4E;Q_~@?y9-vQFs2)oV9>(yfkD<9nxZ6}(m*TcTbZm9r;?I9+Fh zv`IO7E#8%Ruz*U6`Da^LkfKGlxs0T^MJC-At20D?q;Q6zP%Ep~7Nc-fRG?GR_8S2f zI56n_h9^5BXBIJBywd%hqAcH-i)?YCJe`q7sZtI(U}48Gwuc9Uv<2cy+_PX^DNtIy z6RdU1VY=M54hYhj;jugr1~v9`uI4zJk)tbqAk z-XDE-3QAAaf^@kc*r%s^Scx7g$9w{9RB6&!=8?%!OVU$~02B?yh|t^}#{2n0GIlO1 zh=0KzAkB7atviG3B${;6iIbQ;)C~Izs0|OPv5KxI7Nuyh!#dct9vZOBvkRC)Kp+yU zbt&ud5lYpTNQ#_j?R>)%2#}>b8lOXe1gxgSkFalZ-rDxio9h$!eht0Y&P>S+mlgQ! zP2&wYucX;rtmLBkQ?kxjD=LM#iP)5bRg|Sx%W-W1+i~lxH7r_%sZl0-XX7eea&d{IC=@!v7Nc== zl?&L|?mGBF6dDz(#utU0cd2mjhbfbR)aULN{sRme@89AN@Vp_Vv z_Eq1_EB^pi7viPVM~2w#U{1@G;&aTl8c5ubuizpy__(3S;bo0*7l2Z<9J4Dq*L_q$ z7bBn-ijE_Wy@}Yc6WT?@${-;-2&&di(sfyTF@?rfaiXDnc44zcsk1%@cbbJ0O=vRvDkVtT4~LoQ|? z7^s{{@sQzhn--iv*|qYW?``7CfX7T@h@GM`;rT?*KbOwYq>nPLL!!EPYGo)+$pRi4 z5*$;O{#UXo?Wa4M@^VWLwm@~o7&k+2s7U%GX; zicTvH?u#5bD`IWbrMbQ2>I`Qx#I}Pttb)pfLS&RE*WO5mn6zMR%%&1_>#*hFXyBr! ztT+l4u>>ECOvK3f5lfw-@Y1+9icH!;67MehUfEag4SsR5;WFw;_A~rMDUTi*s-g5H z+uariFw|J}i{52ZRA%D64atdVYV|)^+G4`=)VSAF_37obM9mFKhw;lxEJK3)K$qeT zA&I7sb;j>&i;Xo&w@`G9-0HL3d4cFhK)KAqZ;+7ZP887xu*9Xkr3Zsmc4@x&s zXgtXZN$}Pls~Nf@-w{i^J*Y}z347g@fbbiX9S-_K8L?XUk7At`bAfRyIJQZtmQ)mn z5EKX?=tcTQM?NhKzQsLA?oKh5@d8nzQfDv%Ap?hMMOV@u#>Qk-*J>F#ibX+AG@=R} z&F~{w)^J;*pNQDj;l~vnc`0q}NB|q#Sh!HKwXw&=Tp+`oT4eilx^t*|=_DwBWQb-? zg(APWq5aP(*&Oo}8Mfa*xeP2RE4P3ks{a6lCs?#W3`v7)d^LEtKP>YKN!+18A3{Zp zbm+Ihy`d_&CB&{>+{*Dxk!p+3^kzj?H({{RtaaXS*x9SrQn9eGw1+J{98AI3XkMYbQ~9R3|pQ%;d% z<@_LS&Zk7Tz`eEd0M$*dZ%pAyN&K~l^Tm9JE6mj<3i zgfi+Q#cvNxP}Wf}f|8vMhxdqxKGDNV*)}j7Ix=&%G1>!{iSv8n6%jHL5;ZfL#vB_K zj3hk`F~oM!B$p6C)R=C?h$@;)z0!IZc?~f*x1mANDiAxmF1i73A3~< zDN_Zlp@|Q~SIN}DwrvbD(CT89x5LAKNNicM+RI>rtZ?bLiT*)OumGuMVX5)w>j^q) z&EdpOY9P7_60c#`CA$6)y+dksS0UUQ0UWNNNiE*sv0JN5!C488#?C=nwr0N^M{sEw*k0& z2G8NAInrw)-)CRI>klcZa~smo=wQw~)-Zy{KQo9MivUOAWB5mTayZrVCN2%_Q6W?b z=3NUr-AM#Pku+pCKBZ$W6d7!VLdM!O9g)7!2&0uTCPZ-I%reFUr~lKf*W3!$F2>QxdT1w8rjXkf zg=Jrcm6|m_MK)v;Y1ho94B;+Sk%Ja84kXQVehnHBwPD;(3In1dPf8u(4^jW#N=E)$TUypc_w_U06u=Pap}ApO-PMBMqL+BkPb91!|jHoSBPcZJy2mxJ7S z`kaWL?f}bbRge{!T&!5;7QMFCIMLDG;)iPayiH4DN{vmHm6nz{l#t!fg_GS?v>Crx z^@QmX$X8#)bsS8xu#~Y6H*mvyahhhN=0Q4%d9CjBmxHM zHnxTulrLc|(RO$z7&FHjG_7`A$>1Um+P+N3}NO=~s8zCoBfavR2qXi1|knI&JU{qcJYfka&G;y*^kf z=Hx9dtPy^?8%HL(iitk*@+B02cS%pi(4Iob^TukN#FihODTzkiDsS4}TDDeAM~0VGe@vWhD0=N(x7U!6{ILr$<_`=&CfCrqq+}sj@y|9S}qwF>u+stgq6N zpI1|18BSXO_!qJq+V`=_N$#syox|pFbomi-;=RaWN2@=G9a`N%FZ72_v-rA8vCKP;pZV3i?f%xq09dlqPYO70edi>b7Hh z-0O3AacppEFtt(Yjsv3?6a!5=G`H5HvQX)5KA-?}^oLRq*~G&9Qj_9*;;BqFw};Vl z5{j5Rtw;sti3%6Y7MmpBKyALTnQSc*myBs$ZwTS()tfD$B;vh7+rQ@(b-VeK6FA+! zSqBUt_2&cgAjG~CpU6gDMQ)+5VWmvD;Zc_#+muvYr?0e2>dFq{&O4di;lq|FqM#n0UE_AqswXwuAxJ!sk z;oN72=hO;$({IzK8z~{DT6l64;2tYC4kYFo)1PHp6E&;v<}N!N?kI3JXS4jxFPJUJ z#Is0|bY%tEH&WB7Dk&vh)mC5;a`K)Vg`oYS6Pv&h8Ql2Y-$q*Ep41kTUR<>|o4cHXJ~p@eVjEkM z6B76sr4)xAR;gxU!{VJ_kReNpu!x}vdW^Wvlr0YvrNT%T9yS}oY*52uZW%&5##%yj?Sot8Y?4lokRCR{5BfbV|87-r)FCqHI$L1 z)}tNp&TCzUdb!%xsDvtELNg=VUcBaG(1WYQyw*es;mF|r%yf~2A z%y+f4!rKc&i*4|+bds`?i)*#Dzu^kf&RP)|gS5S47AZ+f%Wb~^wGZD4(sINszY(Y9 zRn2Y31A|=I)qkDinogYwo-WoaHcZQ^aUZO;AKwK9g~S;61O%ZrBF6o1ZGRZzM{G#srQwX|=>@ z*;8P%rpD$KpiZG)-xnw92?5oTM_a4-!gL+fZOZW`d8K>biT*G+oz!+!#M#2&Q;uiX zsXxX!r0tvYoN}L+AuK%NPfx5>zEG8n9K_s&^u{5bO!Ui&TGX(m6&vb0YYCF0t8qaj zSBIw@TL+GbrASkUTS7qRqE!wrH^Klq>!uN6M(_c-B`DLkO4F$8;Ta4cB9P`_t!)h)|>!%D=GZpaa)OzSlyiuE}<(d=mjlQ z<`ASPT`EF>3P~Ffb|b7>G6^<&AkZ1Y^-BD#xFLq;idzS8lAD3kYuI^57?OVC>=PxA z>B^CxY&g=!hQl%xHd+Y>D#qZAL4q>U#@uX+m7G=m>Ln*wsI0p6J*0#!SG?0M0vcNP z?~)1^;zjH)8XQ0Dg-%bxFdPYCG%07;VYIb3HsN?BBEhiXzLw~l*lQQq;8jjTSBvmX zR*u}wVwC%Wr7E>JQWaq9X(yPK3yY4nxrr0S*lIJbW7)u-IJ3t}L-KV52AojktfZdn zo3`Q!9o3~nFg_!Ag_8=Bzf?=bl8NQP{8-->=sc>55aZ0P$vMO*W(r$JAyEeY__Dh1 zyk>Lonq^%J%vtSOQJu2tlQ>e3IfkAqeo|JT6(caRN}B~GMS^wFAdH(?I&_C|VbQuf zJer56f*eC`ysR-?g_Vp`aXEyN`;=~?-zob?V^ zGceOic7BSh8Crya-eI5uQkMX^vCg2Ow@8qrN75p2)m6^V6{clmW>mZ}h+0dsZo6`s zcO3Upqz%GWLKodl(r=`7u{C1jgw?u!B(2TU>J2w4x#mYOD2<0&ofDJWc^!*S0%cDFYf4(e^}(-j|NaMQ5e*-v%p!U?|TQxZ|uXyJMz_=;r`>?Enj6cUg;OfQhzMXB&#vaFpBaj7Y( z)gq}kF6anFyPe+YBwtL{>LEJmS;V>+c%z2g<1HF#sm8;2pAKEQl#3HHER6$%oyZ#K zrD@U>q$`6abZYls3)vZ-WQGFXmTQ*5MP zD|2WWW*bP@T!O7_xYWc9*zH*^6Wn9CAxW0R*urv?Fs@AewLnfws@>&;T@JN=g4S01 zjf^nW3ry_xkgc%y5@h|HBskVotbt-p`uM{c6-VSb7rAdVH@T85kaq$yGJBT^5$m*! z+~opVTBjh`dHDq?<+FPi7*Hs51Jc0XuG<)s!#(J0BG{-70O5BylZ`~;&{ENSuE*B> zV)s=dy{jijZK~?4RVsEHmpWM`LjM2(evsxSHIRmQ*M~D)HcM4`H;+!HWpALya`qB36ze-499AI z&h;6(to2r&*?Eq0fxt4|Dhf9TTl#4ngzQwd9{$Jp;Z~Z2-ry-F-;R*- zRx;fci;LtJD^r+4hN0Ddan>yl?*sS)QR2kXQW9I0O^c3cV4k~?5+H`BIwn14g4Q9O zmBO@9d3Fd6tvXzfc%6me%#zdc8H9Cw%WL7L24@3P+Ldezr6T$Pufj0gZda04X}D~9 z5V4w?GV0PREU-$-?Cqo3?vaXUvo*FDOH*tRR#23SgVgDL<3a5HCEk`n;&H07iD{I_ zXWvY-V5w?WPzL1Q(WFH&XBZ0xyHCOoXGui$3TZP9?SATkQcsad=wVJ&Ggc>fquCu; z&lSo!OhH72X{61Jxj<~H#l(%aCru(8-J$qwbtSk6zR!5A6uxquVM}F6Dga*Rdjdy@ zihQ!N!U~IB$29XtpmQ4cTL36qLXtJO>O4eO!EQ-qTg>pLfyQQ?nnFE^)G0}E<`N1L zpns%p*CWgwqT&dJCqe^;(^VeG)#W0r&pMGl+L(Pn-KUsyOyDOl3QxQOf$)dW%VXWe z?laOb?3}!dOKza4JDEA6l?OR17eW+B*1+4Pt+Ystt8u1^!>wWmW}k6MxC>D>7wZMt z-bIb}IqZy{DAQ)=>X%4)wI*FwP0+9|l_vUv2=a=aDnUV&@z*m02gKaHZM`7l}xWZ#0~yI&qomRWl&L zaB4(xx&*9>n6HS>&N`;mu+wu9o3ctuCnE}CNvbR9nvr>JJc02t?6NR%UIPdAb{@D#zmz7upclN9se)CGdiw!CKlVGm28A-+2X>O{}yP zc@hVlF+G;thak76eF<={4yO-c_T}0ZvjhQdxnm!Z>TJ+KY<%2yi7w1yX@%T{C3gp? zAjOO!s)q79WTc?><(rnJ%1X|#h0RHfsd(m6h#M;UkbHHAC&H;5j%pr^75&mj-C9vF z!dyt+C~sGUQ2*6j;^?;}rvmG6QQfaSoc+JLAVAWdybul)_W+=w+iH` zSex3ZZ)QuK{_dGihL-CVm~m-T$eAZ@$B%`aaFgT47*-#zyrw3kR)x#WChJ;7?Q#w7 zHWmaOVN=G?l{+WbX3otL_({=Oa%j%F@j|8?4KmYv5n%2_vg!^F z^Q5Zee4{_dWPFP*8YIu+Zx3X+olSb1P;4!yQa~gEQhF&j2E=rVc;sr08NnJhV5_2Hx0Mvo$rm<}qS|Lg_EI8f5R`|UjxnbO>%7WyhpbW&PT$eio z(^0G~s}h|KXJW1|9C=Q9k34c!B*L0?B$8EOlq+7Q+Uj+R`S8^36QP>xL$P8}7;UaBQ0h1yXG)bEt#V}8msq*5*FkNp4~CG15mr=&AEKN;SVWZA z$Xk6WB<=uL#t~F5?2uiv*feS0OC<7wTg$IPkYH#L7x+0xo5fXDC78@}EMCW?B6|x( z(n$6`qGJ|Ji<1kMt0e(oqbRsg)1{5N>kzdM(H!w67RG&+r-Bgkj>~R^g^(1H;*hfm za8u@msW_6GguT1ksf5Z_+Db|8mEA`F0D*{EI8MZvXYNe;4Pu{&k|t@7hY+nwHn*ki z6q#^17BI=ESO$xu&LY*1*~)pvOPj(u3g&gG^^i1FIT;CPR<|%67fFY#YK=MR25L#l z>Ou7Y!q!HFxLBY5M@coaNdCzF5IoH1hKw%JCD1bR(Qnxh#IiBP1ahV6$fumGfD?Pz zdBY9Z>Wv*X-;P<@I?TF8q8>~`L_+POfW|MOnS_g!cT{XNzQ^YpA7O|K2fHHX8ypgx(>L>r$d&RP^3GX>ID9qvL!)B_!@OK-IJKE| z?U_TbjiQ$}ZQ3lcV;{cRJ(*C6F^DOM$_O0vBqRW&0mR(yiT(Q>UH`zyx zMPKnO@~q-68YGfP>Ys;5T9Aq)&l>n-);(ntEvU6P&5Lg$!CGoAcl=-E-_%;?L2OzHU(}0mK`m>Im?R-dIs_30bs+ z=1fCqeBw?OOPj(O)2AUi9TC*dF-<8kl*E`i8C(-#m#`ZADn2t zpO&3>DtMS$E0eRIVWv2^N9)Ptwt8q6}iiY$w%Cb(6M3$w3MCXQfIKnCXN zI~{I3j4pePp-qADn)^Rb%+j1H_8FVKD65{~QL>R?ahK%~r-4Y39JD!X)EdPuhdt|( zZ|my}LKU#{m7Q#7Mikmp^G)cslbBmW^M|yFvZ^b6pywW|F)Zi>u=)b7Nz*q^0|>LC zGqnXaVpgK$@oUooYFy|mKX5PmQ*4HGZ1#~oFTB?OGwyQmoza!#XVYvMQag~5%@ zSuJty8bxkZY^(y61L4=!9+Yhj##A#rCF0Eg00G_hIe=yd!%##Tt!xX z9b{f*hAg^EHNtq_M<2?fYE8hjEL;(P-UMc|;CS6K-yTIHtmM8^749@kOxu(hNQWV? znGjR84HM}ZvIgZR@Qp_SDk=Dtu@9+~mnp<3bd3~M6%E+>VN6uHTO~*537jk=Djtan z@*lCij6swdBq>>o5#effIApUwEX>LX`)El}^duWYe1#A{iXDLIwQTbgX@$!=ZbK_d zN(t};Wwb3!2my{bAztBQr8BbX2pc$(3P|zplMW+{_7CC=<{em5F0D4`6i4J?#K!p( zONV{6DmY}N4=k+%qSUny&O4^g**W-m+Xjz}id&n?!-r)I#2@luIz?F{ou$ZP=6Q^% z3qpqA4Shs#2#dwe%GA7A6s}Nh-@JsRADyAZ#@SqaL+p`I!{tkpDtQUHDIfv|&tHTp zju7J!P^R$m$aM-y5UB1YoS7U)F(^fpbn`H$0J3!O4~f%ngv+f(O)TXgl5Bbr;Snc| zG5F1*+_()f^xJ&5b=-WSgNugtT5$5Q8QO~jvr9mjY-&fAzP^5OML5$fqbo#5!`vHx z7cgIwbmq%^g&_Pl5QnkUH8mtJ4ZK^K8B~*EKi=@DtwLL)p+7Rz^FX0NUXUd~*xb7; zSzckZI5aM(>*fe*L$MWTQ9^tnp<)iWGn3~JL~cTB*luBCW>(|~H?(jl?Muq#-V)ff zj=Ck&Z#ZqS!(vgg+Mz5`6tdF!wT7D=Na;#G6Q;yMWGM>exE#381sOn%i?CI@IpgBvP=Mp~{?FF1Upr%KZIE0B; zDsD=+GMHUhn-}yq4 z96Mr0e+jhz073E)t!(8D5a1(({EUhE#sYc)DL#ZY< z?Gjf8cE5U51W&b;jmRoc{ER&rxcQAr36G64wbeE9ke5I{9q-;EWOEUo5>;TnD6xrJ zOO2>0ByKMgBb=19DP8f|grI09=4GD1oUr zw!qpON{)GBtpb%i60bFs|2am6vWkz+kdY$4AVB~*K+!>dXp z6K`~joh<~For@S$ubM9m5&+6!BZ8j}VaM?@*4rhthMHT>E!Bh|A+d5Ue$m+@a!3#z zNYIpg6s1REFK9ymleM%LE=9B&2;tD?b*ZF_XsGGKnBp^=2;({_XcRQerEff<5|Rdk zsrf=ckobR&FW|aBqDo4zsZ}k-JX|@H=yKNtTT208L5>9sl~O`O+E(PE6x#|nOJv-p z{V#rpZzxMTkV$k)C17N^@Vq2l9a%}Hq+AXbQo9@FR;fO|P@4m}iZRs2DV6p$A-32h zBqa@{Hp+C=0Dm1|uxiHXs%RwmUJE&-bmVdRxM5A2XOhFsPBqJQV&!2DjJZf6*9W{d zAdTaLazctjj1&wFMzoxRK~EyZ$CMm(!Ucf=R|y}pq$q8oFj8jzkXd_9{mziP~JlAEd|<`T@QZ7Dj1t;CSoN!aSE_1Y=)57^N^B<(8>wv~65DXyd+yyJ-k0q1jX zI78+s3jPn(W!|iJxq%13!*drBVl(<-&N3HMS0hz9;Xal@lU!%QLklxmsYuuTSJCBGHUJdJfaWzGrTYiSFV zj#uVL9v0D2gQVJ}C3%-FIY}o%w4nRe`It@F);o0}%~Fy)1-?+GAm?F2d6z=BS_vMB z7J(gM*q&;3q^_wl%15o2sS(@!fJ$N}Oq|rJ2+^sVU-eWkf1RU;Q0^|FbOfF9{{XOj zVZj1Iqf1QcQkMpbaVrCDQK&GhqnyZR$6gv#cxuY3)P(11S!K}LQb|q8Qnv&Ys^$Qa zKyAPG*y*%eaQUxhK+BJ+8CgtmC&Wo_Z<9f7zyW$(kVx@Td{gii+AShLk~FCJ-e-q$ zb4it1_7_HeU4bpG{o;~uY{Nn}>I5yT5OHvZ8h42Fsp_Ph_pqgjfiw`~V4)K!1-#*R z`)E;0(`$9HA{K?KYX$8`-va4JrK<7!&5JjO#LmUhP z!s&bz!x8R9+gSz=j^}A?S?}vC^VUv+xZoG-iB{MjK zarC7w)u*J8|P^6R%WE+ z+ZTE4DKydszVhZ)fIN4HVy&?fJDei+byRU2q{2hFCTD|gC0Yj&E)b)BpykuRfMRYZ zcm8txki@@nSBd8q{LK;kgsF2G=2vSB$~=t98v>(i>@VhF?yKYa4U%Vpp4&Hv@hcSM zrBmsCeGKKIb+BbM8z&TkL)_H%Uj{txNtXTq<9{CLI1{is4t3tUXbZlt0geq?G$3eC?qe zwG{42N{~{mEH7gab1l>OqFi|jdW5YnvJpIMci^$0q+~I3aj@=}a2bm?a0SLx0G&y_ue?vht*?swj!BF>^-@Xf2S3iriif$UODe+zkl#uN$Kuq&e z+ljC$@0%vWUCy8I!;2D&r^rjmYhniRV~BM+-BnWTI<$n8poIW?`zY1gU4PpKy_JtailE zsuWWqmkTJdP_^wGv!X&$kx`j*l-g{c8xjEdLdK1m>Kl@82BuDMf(`l+3PKs!t&@mc z)LAJ=N=JYZ)v%EnJ%cT(VQNBJFg1triveQ>qlaOd5N$fg8#*1C9H0wpd%y-p@ZUI_ zjW2lRouhpiYap;1dPgkn3F?I(*{`P1w8WfMQdKv!D(K@@ac8jSBo$v#(iEg6#NG-_piK5tez2N4bRMhovXC|wj!;>K zVf8r4(?J~pESa^oEPzQc4 zDy9&E2b2PWIJBox*Q|8l2{#Y`D4#9pc8;74H8O-CsK5ddmd#PZPr4yoj&mFu9F2|B z(h$y$H6^Z8o4LK>v2RF8!7o^Gx@roFg{^q#9Ep5(X4z9nPk4(ZciYYtR3_~2;TIN^ zE1GVjxiA6MpTa;_NrCn$38x;Q1 zbsInfgG79pNp!q!=m0GE+ekw?JCtj+l_OqR3IoMA{KPWF9lkDOx^vG5rO>`%NC z;*nr?@X|V!oa8phs#N8kVG`;bxu0=L8Uy!EhQvo{0QJ>Fl3}zR9XS$zYpgOXa^#ui z1eNLtwd03IOA+BFX^%KqvOh4v(-jD#R z!_*e2g;O^A(lX}q-qF!42T)!IDYA~g7~l$dI?<73DkAF&NKo=R6CDF<69Z?hs#1*K zh2R04Zh+P)mrTObeqwaJ_CAro6g)qmnjFJuP$4<3*J2^)a}h2?9N`rvU94N|t5!z- zl9&NrWSqZ_kzlzH*){t)r2Q>l%q*nTLVigCIUyy1N+#&Afgucl{jjNwVp-VhqYl10tMtqRjZSe4*s8e}oGE=7ep-9Hpi3fCt4 z%1T+AX5~&wF80gJ7fMM=wYJc$BVwNj;(B&ELo^wt6lt?lt8z#Km@?bshvgQaK}(I3 zod)EP0niv**$7BYS35sXyE@H56-K?S3*}0kGG5T`OsU_AJX ziSu+>=`2S)$xTX4pJk~fKIHtFHs&{=0mi-MCd0d~Xl66Lj>;WPZqqnkRv?mdy#7bO1p?2PG?i~a;fTESK1fQ+v6N#Y@7T7;e|!ol)fpc%og5T z$>p>~iju7?Z)704xc&B`!7kxR)^Xh_8Qhclx{C<}m*rKWk5DWL zxvc)f#>xfaWH#+f+8Uk0Dd~3HYua5R%WNzsDi6F)=Kce3IGe+8 z&U=jI%Az{F6_djFikI}&8MGz0fm@yHsR|m9uJN%3CnVQ0Gh`6M44yP&nfjv5<>g6A z4&%CPEJl$sDu`2daC=Y8nYxuWjK_J^IvriVR@S&0$6SP@NPaMIHd>D57ZpmNGcw!K z!eJm0%mjg`y@G-A)+?VC(3-II8*Vu8-xpx&-H@h1lm zp3G+^E~I|oW-oIPVtKPQDrDxKDO0Uw$}^1=K(Mv<+AY+|=|s+oCKaIKdXg*Prz@Ps zZPXn~by9Zeyeie4Nzmv!#hJb&kDzc|lI7)3b;*SbrrQ!tm2aGNOf((rUbS{IZb8(k zFHFqYa|^KVl6LQ3yKN1vz4}5WB{avQ2Nqd32e_#r#)?~2DFc^WuC!DNn^#b5PpI1B zGF(O-EYM<=qCexV*3_&6iB&?MY~&-l=u$um8>EA8gfh4}J<#`zkf6lfqHuiWG4xD4 z9haC-Ddxh^RuZiVwqSJMrqMqS4JZuHB9RBUTiLE(g*fqr%mmI-Dkv_~=Fym-8-)au zwrsc3=KICmCffKFITa3n8S1jMxy(|;y?`tQkPhWY2|pWw5;`I)*^(E67~)Egfh8+0 z4`}*5i=2chNVov)wZ7H%8pL@osPsz3nd9rcX2vRc(UrE;o?h1gE5reKtjUg(CqhNo zRl;W}4@<7uRLe?Fm{M$Fxgtwv&wE@|o!|~6oqAa%*)_VPI@z{Wd`LDni+GUaPreoL zcMoxLR7t6Tj?lNFHo(96)yfb7! zCNIm%Nm?yp6QaArePW7Jx4B~!W$bjtMT$9kt(Z(WwXMLU{Lz<33yg3wZ$%Zl^I`Vm?|U? z0p*(#bcQuiDJx`bty7K|oN*1Cp(-FBD0%`~(ktmxe%Y1gRgvTnK^uZ1L{PutEQ9!>-HVyyAFJ24`l(i+)HN{#(2J}|>oyBu4XDgvj&8iMHa4%vLr z+KLGYUbf9*0fog_+@+-Mao2(_(dq5frQPP*-1HmfNjo08bm^=+mxZm@LAdAW$oYV! z9gtr%oT**Y;k-wTEOE|@YwTCrVBm?reIx??D>T<)prrjI4VS6O`gvQs0$y<69c_Y+^n1+ytmF-gg;`LH| z5AZPT*wRGL?F%|lfT)gru0atBTUjY|D*+XLUZlijF~J##C%vUwM^msn96!Pj;~Cba z83dK60&Go(j*zD4M4c9KJ4bGc%(WeYIZXtGtEKl*Fwn)>YupONRJL&XjGL*)9{bEkodE+!Vsd=FwiVJ_aXXs#-cR7gvF%z@yfG>7+BuA5gn{J-6d10$=B#4 zrggL@n6wZ{HU`QXjW*gJgeXL(X5I_!(d$$vW)71@?$U!9|nIZ0M_t zSQ~y&!@@nRb^Ba!;$E>)ki_(W7b#IwYRrp}7Hx1yxCHok-XP0=ktGj@AA2Lzc)u?r zJ0wysEYchnQ8|z;&_pMewjNQj%k0b94qJg}RZ6H*UjpGo6oK;~LsFih*v5#L+JB9c zb5+Aop(#O9WF)CJR-SeTPgrsgu@apOpAtK1S8>FfGV_gDOpO<&r^nnMEuqg0M~FE% z9#;(U!i()Kz9cIW;D?g60+(zqG|Vl1uWjIPqpEgtF!OkW1p_%uF1W*Lveep2k_hNc zhz1yx6uFM6v`wxLcGlH0m8Qu%2QHNU;T3tfE8P=u@jV$oF!m>=W7dO`k06pg(xI4o zfMTa62Dz3H$YQC`-IBRTyhCuJLY0Ym3{1I4c}q!29y)xXDT=EcNm{^oT*9nP9aO#? zfaMq;8KaC26X_tsOmNpl!GxoyR#nTxv0@l{#SOeiDDw*FCjkYQ4NtvvW(&)1+D$tgaC!uEl0OZ8U@*$zD?4dT;tWKd; zA=lC^9)4qL(+7FC1fSwbn&d>^g5kDKfW^=<#x-gE0OeFBOuLsm?dTs6x*!? zs2?$C&r2;b)j*=&)IFN&92BXVr93H8rFqb#B}XQ=vD|(!XNx+?@gZczq>%gsg>5H_Na9wBzlOS!{pM)*<)n{aqow7oCL(~JisBc zqO=eVl#+E9H;uOsms(93+}QNG6f*eWPO4h7ByBM+LW*uX==*5vuZEk&lX{3XMAyaC z);Q5XYHm!9a#9^+?m@SC2Hkoc>|qQ9rvR&FY^jGq4j_=AcLW;{VVOs$>}AlA{7;_} zbUCZ+v|Hm1v^ixn;C>u8#A?fzSW23h3bwaWLb_Y=i1L=5*z8r7(Th7aGsO%n^ntgv zOWoF#LA}a#PKNsYVh6nMmqqktX7fVk5Rj%r?$9j-PXK?x{&At;iq0U7NT&ydjAhMR|^Yc8KtpPuHxz1 z8uU@O`}sxFz@^O<>myu+MJtOu>j#DYA|lU%>^ige9xOSJWo9fhWxt6LUz3KCB||b} zs?}K&NxD=B@**I((JJgu&o7yHb|Z2%SVi`Mf)tVz@boh$L$OvW<#1`77fBzD;isC1 zRx32>cwTChE>cvV5DEFg9EwLCHjPSpRE@#(v?@m;cTn#rZNFGR;mUbr8}yExGD}V= z1AU{Ebu)A6Qbp8Ea)nuu6@;n{CoJDhObZZf3>retjI~E8*IUONLc={%JB`G3L@X-F?KuU(H{J>hI=i z;SI|gXHFa2Lxs7wBSn4TxcTT}d?rPdPS*`M%~jze;UQ(l zuc}3?eqh-8X&sWi(3R#`rw_Yj$X7C<`?SB-Qb76X30WLOJW28;rWWHwoo>Om60hqg z_e7|11X=Loza@&=nN9EcM76{arNf{9)vKhqrGs#97eY*CO-~Mj5_H4#FdLXn9Xw(?v1{zOT0Pa$p3@i~HM;P^R{b9GY+Lh1Qy&DQC0dRce?Gdg`7hlTBjz5 zIP|hrowTi7wT+hD`>GpmJZ%g$M2NFo5e<%;f~vL{TL}XzmdtwCbiafGk)q7eZ7N7e zAd3t1^n`)Ma#*@`1`?*v zRi-6z8}7LZK>wY9CFl650r_+y7rA*uXA!}5%W zS)xmtiAhLWii=r@wrqu0xZDkagbNx6PENPeP&T|E>NJv`Tn9|dkgec2YS$^J5U^zd z2`(uFsO$o7>j2!9jJ_?vlQ?m0CD%i(tpRNmsHg;zbRdD0=x!lNj6H`34bjBA2v}9` z1)WG$Gl(RmU1_P6DJW9@w4hx{M~J@Xz(;Hwq4&nPR-IXWQ}j0wDLkC(Q>x0Ql!S|d z0Ka(qpaZN5L1cfIsxweOQl%*uuq0bpT4yfBe5--93qpj3c39S&wZ_(trDq0n6yfDc zy_q*k(rFYLd@KkuPKa|}+e`TV{|8Vk7&w1a%NB;1X3Hq%I{;;~lim+CzU z58g16Q!KYBpb2TS)54hm3QH}WLH z#2hx1Y2n9{?`0`ZmiLY$yvAz~Ri46A(uGPqr(_&$C;V<;yZYPmgZ3BC)OITEnfZni zcOyCcEedkbJqwD_Bt0bgWjJvWZ?U@RS{w^x^OhY*#aZID8MAo*+M z4@J<_kxm?4;Y8mBD$ALt03_XTsf~0>)NZC60^e4zv(O%~d4npS#I4H>B5M;?B`Xx` z$^}|z0uV>&$`$p9Jpmm&MWSI9pfE-`rAT4t@WkIem*$;WZN}0HR#relN$GC48gzvr z3|aBl2~6qD)peXw_*I2^A!BQm0Ub8(%8(GDYpR zl+wLL`a~H@*(xYbW3@=tFhvS#w1t{;YW8{Zl!Ym>TU5ASU2YPzi=9XsfeXgzoqLdP zi<~A$3~+?^(bEW!zo`;vl01PqB&P`P2{}j8;sU2ocl3!({(qp=ef-70 z39*}8JDz57YO@nHDalF1_y-?RY0xwm3htAsvDzAZzaeXw(s5e8`^m&D&y2H;Ib6=0 ze@3}f21wNCPy`Eg@;d(jayRxonMz%uBgVNd55X%iss8}AoQFS|Wu2O(rCn~3Fs0__ zOVuQ9uC58LXDZ}u5)@Jnmc6xz8P)otTo}vaY$-Fs%FSsEsYpu_Ow39UuW>%rn1tHd zY@&1)(840G@5mdW*pjb1#d&Ee(+s3nnwMWTT-YL`B%24DI-Jg;;Z5cs1z3nwW252u z1=$Dq%UpMbQ&j5p3FV1DY<2l{5<<}aK$j5eG|J$xOP0}KUgjmL>+=#YxFdxX%za0i z$89UxQq4`(Pc@tCawMU}K9H|?1t^6J+-PlRcO2=b=5ma*3;_QC7x0Ap6t;`C8f8#S z7J#zVD>j^pI`5UlCgV#56RZvN^MAkO6=Tag*rI2L^a+eZEjONeSuIb<wqApma zvLA!7{=^ERR%?^)%qS*}RdKcy>te;1+-VNWObsrT1r?=Au~JF4*NWM#i4h(C8F8WR z9x3cOiya=(D&UuHYgKbwT5~eBD3frc>w67BxDi`Ccey4q5qwdbW|u*#)o{CsenMdY z%&?F`8FxBJnQ0bC8xY}5@4P{l6)m48Nm&}-sNZn%u+}q^Q+ZO<>J;45?T>ZDodeCC zZjwFZlbI)_qMM1~-Z$h=#hXyRkwbFrxY-)#xE(BdL;_K%iP&msrW|hBkm*W?krC8_ z$n}Y+If*RWGIdEB8(tkkTM~G07S3SS<`9cyA!^8PZeo*{Fc$+iiG|7m|Iur=~W2pHau;i7APKXRK6GW2JA=RtZgxa z=Th+RAr7T#Ma`9wR{(%@^6-w%8j;A#j%1z{{!vfNPNY~k>f9IT6iEUc)k=<4u};Mn z%P6;a8<^#t6{*9nxG&J_9Mp1!jXw&Z$ujv>+)|W~pA4hY6R0RmBAls&DK_sX@`c!g zc7rFG%(-^nI>ei}=Lt)&U3% z6oS@iNl-T$80DR#i%+8@q<}V#wh0N^)fiM197hz#Fh+UWJFK9TjYhG>+mcr4&E^z<|{Cc~rvBI;=f7EskbGD$jokbj(}>KZrTDj>jF3xl$OS^&@mR&`OrWIE~b^aW>fKwfz_o^){qhe3Ey%PDnP4(B1*Z3=G0 zB}Z0OVo^jLpgJZilttnzwxQg(KP{uF(3Y%K(`d@1v@El6=cIR-ay#-^k#x;%e;DqN zu}3G0CEp{b!${-C!%*eXxPvb!M>9|bi5tUy6BVe}uj8s)pcR5oUgQfC4M@4FV zyvb2*wS|ifQd87^{{R?Mz{L22=LZ#$$2OBU zCQ3r)S{X%-rvCtxcR*RaH;gFs)f7E8-H)mL(aHmzQpdP%n!$Z@h`M|MzvTvyu>&{9 z949!N8OIa*DYx!}N!vQ^_K(5kwR0yPS9dCaN4zbu(mO{iNiVi;3B!!?+YT!r?v7rX zY&5hfLG}{lMhtt~-eR`3B8x1PCuFZBi1WT^l?+{2%%|94ctypTX}YUS&lR^Y?BZ3; zNZD#oAl~Hfx$}z%VQhyilu9ZGXxF$=it6sV$$FUV*)s(K>uq)eI2nbrm1r;yoG;(25o!&6em!Nhj1a?*s*@wUfHN!`9H0j$Mi_7*=Y% znlUV+c!pmzxOod&Ne;H+4xHA=R#Ko1!QY|qj!9UgI~}U{%}b^zQ|QmF$0g?#G}Fnr z3D2%jbT+lVHycC=MfD{nNcwGdM~zrLx`e)8YGkEOB#UKmi!CR9;{N~;b=n}iiyx~) z3yUfa;9NHSE@et`lQ@?bN`Kx{4P5er$hMbe29_=>y{|*^h`I8t zYQ^J*rdf{|@N%&8l=-<%?7C)H4j>yOSlZwVd}9%tKBj0fW1->_O;;tIm6%9dF1DuJ zNf!kw7TDKolVn$WodI=_bD^Z%IDwe z>=x0v=un|;w9?u@)|5Eih|a~c(wKUwF;ScD%gZzr;()nGCfBgnPPT|yRi?X-VtPw< z<7a9bcL^k8~XXf4k8?^X?RH}t}}53`Q>-zR=(yWOi;u!7(ku*oEyiC@y*DK?FELMj#ut5*ir zvKEyIV*|$AAuon;w1r8eCA3e1=i170jV8M@pZ%GwZB5QGzKq-d?b^{IQm(M z%cY6N61%3_sXOiu#vOS!_#9BO#jAWNrEs4LPc=?$4LBv$m0$#@n{*%p4XmzAf5S-> zImJFNRQSl{K9@S?Z)R5^4iciG3ako=CggrmFPNCdi!bcwf$F`Q=c$g&Iu{{VCR$~% zyulL!>S<|Cg33s-I*@!K9$af7CJ#vj`*zIxZZCRfQC9)m5;U^31bpH~98NJqIWk)h zS)xesCl0OIE6dj@Xw5Rv?xJOn@Pga8n~c{Y;w+vEB6y_L><`D;YR(>+rd8FM`Z!yR zsbet>+o2@vZUwDqiQ!)^qMkvGkP}>2n6AyTZf4tYE#|(W{n6Ifv`g^%A}f)-z}ZY$ z+1-~Wr)B-Bg5q+|OBH7!m1wmkvY-ut*MCT5;dQv;$gg3VtZ>p_hq%4f$SgS}FxqA% z72?aIIxnEH1423x5VAsvFp+XqDvQt2q~A^Krd!YHmfwMjg&Jh*Dzk&w8lA=3wSJFM z0bIkG3b4%DiLzFbLA8y6>tbSBbTUP1b^)&Ns}i|Qrxkm1FBAsCv|WyySR2El3HJ9H z*y9@w$W0|uScX%$>k1iA^}3-~BR-eZi~7LM8$3O%OUq3LryX)mY%lq|>tv+g{2QcP z+WuCExmLrlEEbi<>Xrv>4dPjTe42m=onUhTAL9X4{z59{3ns=wkBD4*qG9SYlM)Xg zt>lo>LP|+d&1Jf}xYW6nEYHiiB;y?*fTt?vZAdNxSNUeNJT}ew7oklof^(m^n zsRqGpx^@ty#9cmumMST?98e}`6$j;K+bzD8o26d9I)XhS`xKOx z!!ljOTMjOY;97m&u_-Z!_(x`kU2;j*r=-?feWeAVNhAkf(WaD=+{H(4# zqIWBFoQSG2p6@lWp%6sX4~NuVO5r zqLM}QAl@P4j+-P(R*GO-rgdpR-9!(ZJlM(ff7sgsHG^=taVY_6WT=n@^&XK2B)26+ z6qVYJvOkr}d~DmGk?5$Kj$D}wDji-ZqIz&OQk5!pmpH;s_X#9fNh#@KE;sRu%6}rZ zOylAH3Y=wy6;P4@Ov_A=tw6d+8g0;z9Il?W zh>OKy(;FmV$!xdY!Cj=)#X4c8Pb{i-Qpvfw%#McSoq8Da?mGsTYmukn@@hqkO~^M@ zX-v8SO2GsXc&d!FyCz9lPdrb;Pxej3ZcZt#b{VP?iKcW?Q=f7X-4`2!V;epPidiGS zG*NLFv^(g?sm5Ly{{VZ(kv~sYv{0wJ^3H>M1$~tZ3lX)g7V3J44m3JFq9&M};q4r@ zZbM2RBdj$ick&%w3Wk|ln^6%FD;8|iX%5z0OKpOsDA)*IsshP4Q^O|sHB41bd?Zb} zp5V~s9|58G!bsDVlLNA!3(pfhuAx4QwCYrrb6D8efU6tpcw;2!e;h1>JWj^-?#)<+ zW=)q*ER`Wml_;S}@USCJu-p7Zs45{{PZhmVom|-@DN4+BJx%;$x<`x5{^##$@rotC zll3PGo^3x;rCjDmg~>XP$}96@r(=eVwA>ckJMj)0MX%$1tno4##gV@y9(1U2Q#}W*gU5MekSRT0bF1DszONFVL4Ph!4R1{ zIdpb#?`g`Mw70Ul^NLD+-tv#;ts!w|EWt6_8mQ<}1F9%cAf%~QAoL?ND$WcH%S)@x zXB({B=M1zsizDp8i;U|l!PUS*g3|PnaApZw4s5qK01>r^#wz%jR_o?X#VagNiM^%e zxDS?D^rW?wB_}B-QL)rTOUC87HA;%;?E~BW%xx^WT4rSC1Ql6Hu>RCNj~1R{B|GFp z&d-?nwBi&sR6NOP>$2`{_N&n<*7}37*3l^;hazfXPS0|wpIsVdv;z7H=}eEUq5)$Z3p0Toamg1}(vYHuo6JIzploex0zNQ_LWQZ=;P3;rME3|L)``LG zGEagYX~0&JZSQ3&wfy`cnPai&%yjEqbi#Pe#T84cS!yJOG=Pu^^4CvDjVLkYA>rZm zQmsuuoT0v{mQk&evK9w{P0~-o@e*-QnIOUS1aY z6S3#+OR9BJjl`CN@(!g+=m@bMTSZ<>T1n8!X3{B6Q^`uABaIKIX4)K6QNyP5bD6h- z&QXQqnmEp*R@Q`_Hzjw4MB^05Un#XH^hrO2SYhTynMfRAWxP*}U9i4VK6j0e47Nsl zKQ>9a%6@>Qt!F{WSkuQYk!vWG=!#vHDr=d<%LzLzB}2p*r_8Aq7`c|4+B%e)l{LGI zl7%Pmi2OYC$q!^!ikHESDvvO*c1q2@ak7J=iK`Qxsw>kHEik6Z?lgwDsZt!m zgdbw+E7eNhJf`U+Ch?o%<)s%G6|?AWlQMBRU=wK3@cH~j=8BBiv=282 zIM&`bVGcQ}j*7VZLw=?$AuU8EjNB(}tS^h^q!*xYmzeWPwIksWc$n994 zxkgj0qzf+~MZN`dU|kRM3cDE+GoXm`H4!cse8 z&y4&)Vs?OzQnh(QL%0KYM59BhRz*(CSUJkgOjH{-NPR-zczMM)6+J8BSmBMb=Qv|I zl4fPKZJ24~K#cpHIxKXR8U50J3jY8mXOmc!KuT1gtBVglfJM&J0jB0JvF^SFMnz0{tEmns`NV;NhsHFu(x#;66a5Ur4gUaCn;3>@30D~*DjYU35D{K?F zi|8_{Xd0+)mdSbD5H~RL8fRk-OH0 zQ5+O!M9uWvco+@`a+JkEBwa`+a5g@pV;xR}k=uyfn<;qBDl-!33OBQ?r72gbxQA5E zQ30`!V~VXQ#VVHKCL0$a3SL#)(1eeaIGBcr+giibEEM5xX|=Mk<8*_C7X$1DrL?CHfp#Hlnmee9t1>!IA37^GLXZ7e_ZeO=>gT~~!8jSOdJ zWdu~zgRwzBC`$xgHwMQgO`i}Vmx?Sf54RX(MM{q1R4y{A{{SeX$hIxwL|(}gp3N~c zE>F1O{t+FaNt&IrXOrv>C0mjY;}%>3{6sz{kxqDyfSQ5|kT#7pp=Cmq3>8L6a!WlT zD<#HO7Fw|MuF5|%4KyoAxQ6s?L_{2<@6vrbs0z*)-^A(ipY)n;T;oJ#v z%%nJ!!Oj{VNQlV@T~kmPAdpN)ks>3BK&vKAR#3h6{stmWHb{%1$uCRP5=U5#$bXoV zp2MjGlz>5p6vViRSLkI&${kZ1a1*n%$7Mk(0>@}^NihyIajp@e-WG7oB}3M+x2$r) zj%>>%m0Q9Vgqq55?jxrRjZ~J6jp0CN`bpJ50GgVSsp%a`#IsfWLPpv`v4lO~E2K z)tydJ?ltLyWkzsXYSE z@q{{JsiFJAy{zXbfVDUjR0iVz0FBl8LAp57XaCl#^-pJumd;RKagH4^DPC}crkjTP z7y#2!HI7&ZY2`L|j#<%7Ay-m#*vD)r)u=vZN^@?V2d9J~vBY6ya|fhyhY);_kw>yx zICL&s#{k=BxHOI(GC&7PR#9_DB1Oryp)Ba=V-k!_B*f;P-zozW3I6~J+H`Hv(&-(= z0j_|U;{mS&G$dL^QKry?rgSKvM-HPfUU3{cZBy7YuC~BXN}XCz6m}Vnu48~Yn8SvX zczUSiDTdWB^pgR}w;KedDORCG?396}?_(TC7{}rX6wM1>n08uDmYKB8GN%iH371NN zUAIz|t-v0gVbnQ6*H9Ti5TKxvwO&Gr2UruMfYu#FP-gp9-W2x=8|G^>m>zYCl!}XU z63Plfhg%&%y~T_%IONRz!TWq1b3wZ%(jXr~s7xkymUR;y936!LyD^8kN#BsxD@cZc& z8?omVPd>F;7nRiad}GI9`f+*v*s>m8D> zodRT<`cV^%vYi5~tEa#PkqNLIsX64UGKW-K;vv+;v;?fTJ%ynCqN11%46hq0393u6 zE|GUx0%g5*yE>^h{bb+ev4B)Z8wgJ)5I@cy=xqT%5D)K;ql{Bb{aTiyY*S((M+AGb zW@4nxHpnL+H#P?-1nhibCP!oOLMOC@gxzq;E|Ri6y==PMi8cx$7f9El z$`NbsNQnH0kn`|rRh&&ns7OsAE;a3s2OB#SzLdB}_KLRa49ZkGm61n?{03`>v^w0C zJT1z5uFA|l#-}46SceLAD(;dOr`?C+n^DaaM_$9!=O|P4DHk^h!p*IqIc{~e#BpwQA)f7xUy!NQs?A8am93gI*qO_I z>#1xa#PvBy+7|`4$%Kec*)8JS{RJcKR#2h+R@DlZ`(MmVIsD1di?NiR3E`U!vfxEo zJgStS9`(}s4yd2JQ{)kQ9=Y0&X>hX}_V%HF%{+lI>eUa;-y8ClJd0 zWlE9{ebofzQ>aR^+}rL0aqxmJw(0kR@pF2y-kN)~UKHn_;1{jMR(t)Bk? zuk#h=h)=`LFwZkJNfkGVkdh^Yw5tG_X@#j1C^`akT8X}*))url)c0&0nYV{ z4kaLN2qGL1#~!5AtdxT*XY}FQxRHHOQd6g;?+Hg3gPoK1cLS__qyV7~A*OV&{NgF4 z(zKGLgxL5LoBlD@aO2d9s!nFuYk!P69fUKvg`5(3fi~U=0uoq)w%onS)Bpp!>kEjP z4HNZ8CkmXhi$PW^vC0&71lrdsO2iPf>-P zC0brM&ZDbYQc5m2go_iBkMi~WAUJG$SeI&H3qT>{W!LPGZV35DDCplxr;&1cL&HKs zp!juJhW%k^Nrg$xm(0go0rkX;mC8!y7gHz$&~83Z!WPVQ>EyQFea}H0XzFJ|NiVoc zmF}2J6pai=Pcsc9f%c<_8HR_4rXRRKI};sXjd$zr(~_hu7gz)cZu81c z_qXRAXAvzaxLGr@=v!#k*7*2(#9`qNT*IzPuU5)Wq%8?zSz*awN`VRSj)@c#7(Q(h zD3~ZwD{v@_eSsYVjQupv=4>RKrvCs4awtnZOX0iNgp^CPwW&Shl_c0++MS`qAnPxJ zQ>Zp9tRD=g_{TuioZw9MT^e2dhQBMoaO~0hJv`z9=2jZ^~9rfB5>l4hTSm;kD<*mtUIqCCa#3s~FeA5--BG{e2ZY~1){a!) z5U5nO04G~}Qb7ES zIUX8MpqG^!QvIT^nyj8fzZIYLVb67v=qJTTZxHc&4o^w{05e`!57{K#d`Q+7xM_9} z^C1U8;?+E*ZOtVr*6CJjTzG8?d?dOFS(j6tR^lB#UA3-Ui;Y4Fzryy1W5Y|Rmz50q zyF$&&5)i{+c<6t0NcTi1#bU09#Od5jjLJ$ty|lORjy@ekPm0*`Nn<)j6hdB|nMXJa zNsijHyKlzF}>Lk62fQ+~%=;zzUQ2^@))(qP|+Yx9O(ZS`zTC zf|SO)v;}r&0apyPql#_5Q$(a4E>a0P-0EYi0+-0{vsDG^{IVtj)T^fFUA$tqBGTxS z7h-*iWAzeKokb!UdkRX<^H^=k5|yMAWddOqDu>ET2eF7-=SiaK2r64b4ZpxgJqQy8n zhMJ~RnX*Q5kfM6)3X~Aiorq30V_)R`HgcgdIca4jsbmvu&K=0{)7Bc(L#fz`>> z4yc(WS$+{qCRrqH$dQ~KH-|AxaWX|=alaHxaPqH+XC{DCWeh2_p06aRqTA{>@QpSU z+)-UUnMPIm)XeowbJGDq$6YHo7VCcqnD%5lB>w;vIDIW$mzS@$EhjqK6ENyQKFcD^#V}*`;FpNzmYj`qa>3Vq?mdXe7nQzo_vZA$HY~Wb$74u}cqjR#}D>OpoE!(#^ z+Q{TDyX_L{J@gCgw$FV(Xp4ama>n;0MUtP2(#^0y{TzNg;#oB`ME4Gi|w)ijRKaf%GoU>Sisc7SEQEY`FPq>BoW%qyJice_0iM%N|c)>8+bO*Dj1tmF~zU4^o z3w)y+n9yPa2UXErl9!xDfz&53JEcV;;QV8d6(mD`)R;vQ_1QVa3o}%en5Ik~neEJA zoqR=x-m$dyMqRYNg*O!rr6SHtDu+1iviqeAQb;~VG{qk#StkeCmg5r(qE4tQtvkOtHogVO^6o&6A@%`4vwx9 z!p>vb+Z1%sqXX3|nWVI}bjaw^{{R?uF%&ypwy{&vI8QrdrCIVDbxBRc zFAnT+@+eADXvjRw+1HlpR(=NNEQU{@dZ!F#IId_IhMhDFqbY4}vOp=YMZgzR&21jfP+$-i zgYJcpP0Ca{fnnnlbZ@D4rbN}yW)oIk1*jR>HRTQh+`+%* ztX+s3UTO@Zj|~cx+5t)RxVOR?kg{Xp-q8W1{T+#A7fqO2ZJE@N+m{wPKgg|^LzAU0G~kPlI=hUP0XswZMDhE>44IU;vTnn?7xiXyvhEdqN3 zMR0blB38GZ+lZGXLh2_mMz5f7K{Wr8!@mx)9(3Oh~ zmQlj)4;C`@W%BWMTjSyAZr{W0VVp%)Z38HIZ9F|xixVALb)%jhlO=v| zRccc*q=06riAX=Jl0f|8UMY!jD?&nYpT$?7!Z@8tmZ-}WCY?OJHZ}~d*+Cu(Q8tZk z4VA8?bhp`&6N#KLsc^b+auqgI*%!#NJF8DcB#VL%k&6__?Q|OIMO@Py<*4^bg(*;& zqD^pHitlj3s)^=%?5uL;8v8CZtrU}?>C|f+$sI$Hl@=|*$?8ip@8L5~4d+;YsQ~D49deDLIx(bkK|3 z5OyGqMWS{$scb~a%@Rq2#V7cG z?NaUcsq?^s4$ZmtReKYz$6?kaMbq*bXy{`+Jns=?moC8ma-Xbe9ab%`vX(B$w+od{Ess72ugvt)M!BjMTZL~2V`uqy^1NTVVaKws*@N_sFgiS zeM;n&Y%j4Exd(2stH+yCD5ni3hiF<$*nbC7rPK)tZQu>OS8?Og9hTN2C4Erv4E`)| zB3*|UbGS*j&KN_DmKVU@5>j|%kEANjAj~9PC_N9rkq+shiAv7m<>xy<){!kJg&8y~ z0-!s#zmAa?E>#WK<~&W7&pS_Rf_Pl1l-rcvzMynTuH?hE zDoTjIk4v(wZ(iG^A$^FTS_Qd=u$h1($NY#F>*zFa5sqz&+{mg zE~L&$sJ7WA#l$Dwx0v-L#s2^fimbJFQPS9mlvCq9Jh$vqwJIUZ4;b!{D`TQ zb%r<@T;c-rveS!6`*yh3;siFL&JM;Q>}6G;NSU?V5o@H|bJO0uFGw++kl@u#+x<$# zy4(G+)S1SSzlXR_KUGz+cP+C3p?z(wj+(?An~%ZJ<#zaTW?^hhEF6z8!pDZG*YSu7 zG>J`-vx3+*myW5kDVjy6C5TnQAgQzEa5RUZ1tFIMp zJyUy~QbZh-wgN)#}TR%G%3dnolzGu;bTWFx-}pJ)E#dT z^wA>hX860n+TR9d%)Lro#1F9LyQ&^U5+OD^gw6@#T}J{um!(}&3QhF?0D!|&#-u$L zMVs)Wj#z(=>0&PniNg-_(}M=mt)3;1l=Jn53~E?t`Bl!MMXa?%YEAqwy(}MSl-Lv zQ%PJ8xvR4v4AyF%flV{9`v%9EW*K~NEQ!epr;zdS7zLBKkh!?kIOdxtO9 z5|Dh1X`tzpQbfw)l`djL$>JFRRQ!^GSRZK}N6W~=nImE%=(BzeaROI}6sBgS)|Dkm z2Scbf)hBI1(8f25!{M_300vD+aOMzFVyZ}4omQ*X}IMGR(Yb3MCaY_~zSBzWX!7juMnNe6= zM&a{yy294NbyJ4^S2rhk(n0J|%b6r_#s!qA$SR#Qk(FowE2>sDP}ig`#>S?K(~^$A zNT`nUcWJIOp&JI~GFwHj-e%7S@k?;%FujsE~RYbzarHv0_WwIZIE zoJriT=NZpvOQCbaBEfLWf?lTZ9YRcJo7}NOW!sMg3}J>=pq#}CJ4Lq#I%G`ow0z|7 z?}(FpE}uNL5R|NiC&UBjV^0Zb-4yeVqTRS@k4F($Y4jY$Lth=e1WVMJ1;wG##q@;D zNID98!8ZrYYZ3ChL(t|+{t3^DjX9Nre9a*IZLDOtrEI^z$C_ngQ3Yzy2!o)NsIGo7 zPMWn)mdC^POsN^ZFiv3E z^#;n4P^}aXhr%2ZOWquI)XbE(P|E1gT%4*OB-p|w6vZhMPYUr`g^f@PPoOC53BT|o z;vzhvI+(V4jNHm|GN7=04dJH|b|)rjPB3%^5l3vo+LX!EM-Ck(XG{Qdt8{sK>TKd{ zzKa?Vd~}YdKsGP%&-q%vqvwJq8CW4XlVj=#AcN%&YYHkOv=;^y!dBP_%p{4%- zzeuOzkv|D1am#+uOn1N_pTa37wk=aD@3VZtlC4iPbnhR;!*q7ePi=XV>~`y?=N5bq z@euf)MO`sa32`9oQ~~&y(3M2#nd~bsk0sMFB>Ir0pen@$LgZh3!tq~|GP)#242FDA z?01Oxc%>*yE%ry-Y+p}6Nf95#L)(!;p-Xz2vWHNlC~gR`hb&rV{T{BlB?}!Rm0~2Q ze(=sYaezDD@A8Hx!zqf6cM_i>GE6ciI8yWZhkHG+)}w? zmiit1KiLep9a0x^HPlWED$t4-VuhMqywJE%*Q7Ss8^Z~;YmdScU~=jhU@bXqdwD^q z?F|)c1%;}`7XbJ}(U_M5|JSQ@H_KMBZ~>i6ae<_+>?G(GzNQj%*HS@_0j{HH1te^+ zyIKRMT5NM$%r_CiMhZju!M^4=DlFvSbtf!v3@SE`9RV)d6F_H6puh)SR-x?r zjSq}*ogR9p4{G>go{Fr~KuJ55DRnDKf#wT?@%Mahl|GE-^p)!j=H?WxySn<@}4PEb^B=m9at2Q1W@ zb*9$NZ2FZQhn2eD#tJ!RRo3bayzIl150%XzCDkd#65M&-NtwA(F(|2m zwC78xZ9bnT=hF|9HELi3XxS+{ON5irokve1%OD2!AB~^w1qg+ z&4|@7>Ksar;hD*)Frh(On@gs`tfkecN&>hxXAo+h7=p1VOE#ls18!1if2_1YR zj0EQl@p`yzR7!(PGlOCjXIxd%mG$Pcx9=Kah66sn^ z!7Bg-4=Y>FC~_^yQ54))mgc`NFpUZVQ>T^x0CY1YLx@&l3|tXLnt8omX)Pnum{JM( zUK^vP97BhNQjobscLR<%<0mD%dmJ17Gw{k=iPVQ= z)ZTTpyrDwD#4DoENZfVt7ZEECO%BE~LsB4|)(AKuu_HXbVLR)*i8{Gx0YbO!3B9iUmHPk(rs798wgt zf?Gw<+Rs#*cpF1a3rvx8$|S{G2+=Z|&9g4bP@;Bm2+rSo!!k18z{GbE#Unpw+)XU? zeyGHv^U74%MD)1VxZ`Im!$fSHiaG(Mwk9KGg)1aNRz9^!G(S;(S=5C#^onyNi-MkE z3Iuv8BJv(Ze(;|JjvQl2$~jGxiCLw#z4?qd6UjHzREwbaS|-9)hT0L_cdK(T%*?We zjbYh#SLT-#*gxl5G(0cp{{S)`P@Eg$EBMa=Jxr^#GD-p|^Cs7Ea!)o22_&4zN`|TEN)r3{8$9rNDeQoZ&2s6grpz=A^3yVJ71t zdAz3k8-ag}H64MEW*ntYd;X%9!gq}H+E*X2vsl9pwk0Pd zr;@6SpaHh|&xGA<4X#Q8h`seD1#e~YI?di0aXx>BRWwzpYRu_P=Ot86E@85J!AS%H zvGz$j#pJQ6?dA9LBdO^f4mt21Pm6TrV>}L=@^0Nz(mEk*JNC*EUwVDA;hrM9jw!T>+KE%MI7X=|pb1vSA~i#)*}vNx zi8B~W7EMuU@0O(zQu;-nStBE_vW&_}1XvTP1I7^*X<6AyheLtF3N0EJ6Sp*Pz*y#}3979LOtQ_?= zVn(M%SF=satjh8pHb8MlI%QtByvoL8vTjm4ppj^glODB9ax&5z4c3KyhoGEw0xsT7LH35 zaWwMNZ$lku<=NVmYbm&dF=!;~Dk&pz2^1&54QO;Q0h+wvYyuD2j-!liU7AwC2?XYc zXhEQiF*`DQjHy@fg$Nh8TZWVMcaV-zx_iWF)5beNW8YTc-9#srqzuGu<+L@VU4+B@ zD4T3q#`PMDk+*~nAfzY}!^zhWa+cDNe$s#<(48l2)`<%Rk-Xe5oJ8sKK zFd1q=wS<5GS}rUEt#`$pMVC?=ejEM5$^)C6n4L^RuXwnmd{ML2k=x2gk4xZBe26%yGCMX zT`M!L-~LK3{b*X@qIG0!<~ha+_9jqF#N)(&$wmJF6AD-(9zrLPikYgkx@E$hdBp&|S{+@@Sl?WeMaEVq0#pCbByj5+Sl$Zy^ei1t>* zsrQvGJzr1pgWaEz&m9_bJ(w{Q2_!CAL=A+(E`J#6;op#W=x(T-B%iOowiN3ut-FPD zT+68NHaCJeTk;2)Ax`&anYnXiPD&5?OMl5Q;=ufld%`$1ZV}E>RFwNny7O#O;UIeH zq&eWV*lp%Ux;R-o)@EFP%0v7iUIX&=6XPR!o)t~Z9Hw?yU&Y0Ls~mWK0J5Dqp3gO8 zO3cnnu3lxSR{5`Todl&9wrdbC2$nh>S!_j9D(+I`KC5!0-tdU+SgR7!(i3=<;M-wN zEk?j!tS@ABGQ#*B*;nXBO;WM}QX5l=Xb?wrIknTRykUp9t2Ve_h3ayw&(F!HB(Htj zlVA`DAOX~!w1q||8#kzP?c>T++l~Z>Lk^Ogeci1RR5qc#M<=oxT9J{dJm!H4Pw#|y zbcO07?`XQxu@!O06}UI^p7(O<$(`S@fP~G7CRw>nY zb!-^PjQ-ElxqJ#3hTI1wZUU-)T%j)e?{imJVe|)gXd<%T}aZ`fU-U?2{B(jW>l-oFHa~)UZla7=4AP zTfDs&dw@EF4C}jJ0o^p$%xmb_vF;6V5KYXIDOiUhb8Zs)Y>{v+YaK7G(x|P?4N8fa zr%bc?hT}gZTcZ@O)u?)i5Fqtd12s{@%vuF4RC zMqr22bSp!mRFwdvn-gOWEzpbH<5T-To+?u2@Vn^eGYtZguArSS z=?K88M`yY!`;S=N%ws(C!>P*R(ApL))d>Kd&ruh+rD(3n6NlNhl!~4rmO{nA%zjBG zB*%6}lcY^P3u7vuXXT7U&S{Dq%Y_r{f=ZcQVgrdq(ky&+Jr78U#Nb&YPt*pvwx*JLg3^H`b=u(DTSfl>vzD1J zGQWs+nL=EBkxY$s*V@s!ke88f2LM;^jd?*nW0An@Zn`rpOrb?CQ)k+E5qpN-`nCQx z(@0F+uZQY662>@<*(OttHKAFSS{QNW(6>?U=2umxx_1`6&F>YfEpr}lu^PS~HNp&T zWI(cJWg2o^k`30?gNe8UdlEdM_+-|GGDe4Ev=0TToO49nSW+1KqQjM&6=Sqwah zfR<3CrE6Afyv1}jzL(Q&B0gB`JB{v6-Us1EaWx`-fiP0Gon*4Sq!1JZt}n3!0xlws ze9L%pDOm9GV}`idx@^Gjvp5nB^dmNh;|-3JD~P;JnC$h$S0_L`hw>LuxLOKD&4Cv- zI$jf|z_6Y+J1xYF6*TmheVK`1`!*WgBR^e;wV@GI42hCcpUbWux}=-CF47%I>K4j@ z>*Ws#9X>KlH^vSey*AHz>2?`$(kC9WR+w#C(CGunQT22eF|XZ8om~33DlvKsXqh)Vv+MEB9SWG z0Icz@uTXxN*jlCDAz-KiE_C1bM5KnBEcdhi1FlX}B&F-Esj2!mJK5gO2yvC7*;T5E zAnmY@G;+vU$C`1K!vi?Gt~mPCcQ(!A>k?w9ZM!SO2-Vdn@NE1c=7!?S6iqUMU{Ib@Wq zahjWrn@pu`giXpUge_`7Qk%YkNm7X^*TOoZr;uHZ-ZkupQKcl$VP{0_nHh|`jsWUG z*Sn%pM~1Ncc&g?%EH}tOaF+u+H#0E&<3+P5JIGknE7M!~S`nX!+Lus<64N_9aH}gK zdG!1J;0=zQ2GN+~IIGyT!GgCX`|XBPlnVjUDJ-x^h8$U(O*;}PMBAAv-^7I&u*Jw? zXhlj-rFfp0qpBU3aVPq!i+ntYQ`mvLRN;GkLB!QTCV6hM@GPu%NL8$>H zRh8~{DK%zz&nB!Fihydk#nDfkP`-5mqi#5J9eN!ESgBUTer06wF9l9u8TX_oQIYl* zQlaR4VbtvEGhq6!IE1L`A;>e2V#7E}>Ebm3>P)(dYZR6HbvbvjQUzxcu~_jFoDfZYAAqFJ&h(4#ML@l=$l%%-t$E5_0xuTPw!1j<$rOoYM{|DHa)& zk(m7BAMG?~I3eQx=sysqaAhDhE~1?28iGdtghqZiQ|4Pav@oCC`t3nEF*E#~tSxKi zq`4}!W;Y#D2`AyCJK@(Mw>#!7J6+RJT*U1l4Ms%|QxkDZNed#>F1X#pxm-l=Dp#BAJ3hU|A97cNDyaQ^^L+)!Wd8uP;c2BOYahfIUJRO=9h4~fdBoJWIqtXtu~NS{)IvpDIQT+rF;bUW^vdFI z^M@z023-$mJX0pDF)L4=V40*AU66bv6seP9d)knsn}VG>5qPcYbdnhR9UMJ@WrJqR zeE~l)3CFuTE=4io`6uvYO{%o3%1K(T=Xin*_ZGIF8^(hQtf^DM4{dMt+c&kNwbT&K=sMm^Sq$q`_UXxOl$#9XKyXlbJ3ypL(h^^4#+}o(} zhOvyQD51{FshN!SEsq|T?+|>WigeDkXFC;Q1~BS_4d0!rYYjacsSUG(u9y5y>W1?e_`@>y=<$F7mbE7%spSzf5i%;4HH z3P=yjOg_@?1;I+T2f`pV`V!MSox7IQ)h3o!y;RyDICcNjrgaq%Lv08jGSLc2DBd+%l;JXCZ>Hheoym zdIeY!v4&zSvZ|FzQ;ZWXE=-wPZ_6flKOn>y6;Mk zIGMwlo*z%WBQ%1C8c|6ekc8-Y4b3un$~(z%wG^o*LJ1Msej#X{{3`8tR^i;YvzH3l zSoas1LtXUEXoTU|QjqbxUX|hvGwFxfOL?8hu3AEO)EjI0#91mIPQ|?=g?OTlfi*^1 zDG3WoOPN$b7a2$(d<~(!pD}!gQvmkboWd{t8;RIhQchC5q^x?~M*gDk#P~HnL$TsC z^DHL-@dA^?)WAAf-dp7^|NQ;mnyF)+(pzD`eaVg_8?Jm}E@nG@_mNhGIC* zvrZ-Clq*o6LG&>%8>TZNiF<4Co@a*@bxox=mUNXiuzC}Fbks)EgUqIk{{RsRc0>w( zEnM0;d5yd^i#=p5B!TS0;cpbnE5`o-gjaE2!pS&!m-UGxKAxg2p{k2l9-~;IQ=-Yl zs4CM+keqo0eWHGGx4}J8OrpseV=2Vi_-7vUYq3vKOwQ$nIxG)|wFdE>Bq=shRG-Xsiv;ZunxQX&u}t4*I)dB* zPEp@o+(6Y#sGUkva5A2@yjO8JJVZ>xmq}*WA09|?7FjRJIvfOFYafw}zFryQdzU!# zDGN~|Zw#y~cUh}mo^FdM>#NWNpPWCB9lAqukxP6`r2R8eaJDW~wG;6%t-*`%q*3O{ zxuHbE^KxoQLyJv_`$i{54G`rt$vsAsQ{+1Bvyd+iP{8g}nkY!iybJ~_jPs4sDl)U+ zfVCr*_#HsmUSvmN3~IRbfYHQ?QYRSz%}S>?PWxk9ZK)fLw2owrii4tDc0GDtVusq= zwa6(V+Y!<--q7Y=aNLP2O;0AMPu@WM3{XjKSRw4M;kI#wImtJ`C~+if<~;8Y;+~cw zYR{RD*qxW>cs*5eVYKFybwx=~BTJt_8oU`)kx!NySs;50IA-OtDBOZT{9;sI#5tnI zYSckA!kXw(Mg9;;*~s%d9h+;SlP#3HazLUDqXnhS8VT3q3#}=v& zODGWHR87GHub41vQRa6|jwT`O6;O~zGM?xse5zmk@*$_5ELVoe^;g1JlY`D?nQ2Kt zKJpYwe*Hh$8%5Vmjj-gPXM1k$kOy^4TZM!D_0D+F6Wj1i(&RuDMKJ+L; zFB^jD{%p}cHW5|D6LAvOzK(S@2_aA~r}B%K=^;C!!mLKMuswCM|aL^?Ja z#fJy9hBVv1uQa#+&Ax_B`5sYmye5RYFJ9i;*a+{Yj{|x+Hnsy zH3?G1?d4zuSmWYUxsm0Kq9s(YMMniVTApQ1C~2;v<}Vfyl4Ln1jEuT>1|*@gqRmms zez0gv>XjY2JYe*usaliqFx0qc%bFdIXC6bTh4|9^lF}SrWNC1#k@>||Z)HYF(LWy^ z*D_sUJa;WwNV2RHHa!pUjHX^5Shi*MJj#59H0px~#6)4?FF#NM;6l%}Ox+6W zpob`IRU-$rJdD;Ezu(Fl@md}5(-YMUB4rXn0KNAR>~h;1mO2nMNmpe?(Izg)?NP;I zY^d0sVQmOZJkysE)N)4#VI0Jmc?_`&H6?SbJebQy?3}P{f*@y79C~~G*o`6hv$rns zUa;F7LYkj9(NKmg-kWJIjbn#d!eo|LzR}Z&R7+)heRPJ{u&Sq|T!FkM!hl1Il+Z$X zo#ZKLn3&60D8p_dlNQpL%(Ow&j=mo#Mw6oQM!3yMH|y3KlA%b}nw4&0SG*)y|In-% zfz~bnDn@Y}U}?O;Oe9gOYi|hy67-G%r<(8!K|-uxI(3?U;?Mv_fMk**hfdoLDdgVT zM+K&8Jnt`lk;AqXc9`!ce+c2zT%l>`U;yI%bcC~}%0Mx|7Bp(y(it*kYgDp`CA-}> zNw_}j<(}}|0}G||F%_A29$q_*Y|t2hu%{ei`h0Vn!9+S~1O z6qtKT^Y4K{ZmL=2ODRiYs2|MQlq*S$Jo<@!snfhv+qDHeVAhGhfs{o)pdf&p)!=v$pszPmL zA883m_yc1LLRjeHlm*GTrS%E}_DF?^LoY(Cip0s6zx;wKXHNwx#UC`CBdhlmcw!{W z1u_U6#>fW$0BZjL?2Z7tm6%dx!@UyPZScL}M-Dd{J*C_$P<}-vQ;f^4#sC)~WwI^- z(2x$s7L}ZP3S19X6!sZwTTU8mB?fW@~ zW3QFrQs30#{SEn9!6!KD3(;x`RlIe${3EHHq7wGf!jpK4nJ_7h7aX@az@K<>h}d=1 z^oiUyN@PsXv@#qqm!M<%V{>zIZM!&>q)cy{HLMDNwXbV!znosh+A3wR>PXP3O{poC zl|y#Ep(GJ-Mu&J^2(gXBnC`Q~_9t-C5zl?Kb7^j@r8j7ka4rZ^o4K%2xe$#4wGrck zyiHdFu~UuC<`PXj=_|FeB4s56kz#F_f_%W*5j=Xf9E|9+$&6U0DFUukm)vHXGy{nu z&Z!ns6bRG2EN!n?t)4yTnHdem05imuQL#u)Nta|4!?xHGKyfE+lnEMXcvK;z?yD;! zju_E(tYwL3LUM*FEQAjh+L&M@?Xeo)z{ZOQ;a?^BkTN~Tns$bYb`@eoDFMlBO+9oZ zj_ZQPGF5GBJkPOuA@2Ee}guRx~UaMh*_)p9qlWH)$pY3t^h=)I! zY(1AasV{|a`q-+TN3bGYYH?e8Ji$Dt4TggE2dEmIA~e?_#9`x9%)N6JA@nUPmR%ZQ zL1{NhLY!<|5z-q+ME?K_YwR&fqq_2gL5hk{;8ukN4K2Mv*Qh>*@z$>XAF0&;05OcI z@pax2SEimv~w2E>@MJMP*7tiB6GD)4F{7llksN`sZdGB&53Q zwU(YuU1(~K`6n|u0awxfA;TOoPpL_|lUAlpCSJ44 zRq~mTR?C;nMUqBPP%Lk$(mSTB;mkP>M`!Lo&tqEsE{{=tISlJgt#$*P<0&Das{vzg zJ#>f}@g$o=@X2J`;QlzLP^eE*s#7Rs>B`MXGJ(ZgyxYZSw}8!{B!P2pD5#tXF_5|A zEfK6p*qlo#no65Xb5h|}=QOW*AwcM~p7InmxUf3IEelM8{7QO%hwjQ(Bo<~HWGR6< zQ(*ffkLGh|*Ocl9bSc0Tt;Vp#@Tsa}k;$Z2@ZzOP<21mQVIo#-#HgxG#dnZKw{1r+ zF$(=#l=X^S+#`eX?pQ-QXyansD>o*j$)zNvmqEXPNx28Wk2r&-iC1D9iX1u^wSen+ zlIloFuqNp`?eLDLM;_v4W1btz{+U1nPJlv31}_lROHL^%9d(CN5ZR$mtA-s41{_ea z8mM<qVLK%uv20c@70ekt7pTv<0O2oHEW@?!)gwS27KHCkaU{(~P z=n_eXBZgAsggK-p-{OWHnIW`KpmYUIs>9YD_gVHE@uS={<$9Y$M>YA`Qi3j(A<(i% z?55;;5DXseF3-^Kio1xP@0&uaK9+sC4K_i$ib{wFps*MC!q*8t!hB?V6im_BKwEV= zcQ38dPvyLIaPsWLyr|Hg#CTzrf}5)5aN6k%tK+Yi;|@L&OQ+Qw@sl|7IL{B#(pKE! z<`r*sEh#^VgWV*-W=PYdaq^cWqM3`@^rw{rt=k|N^^b_x2c5^Bmb)BCFg^ChIBxj@ z=ZbV^c#VSIuxfy{`nur%07g6D{m^)&b#Y2wUHbge<=PA|r*4L>NI*Yk=Tm5nI8&kc z&tgyDJ{`_aOQ8%;7TQn*B^zt;iIKwkGCP>4Uk)kqu5#w8)?MswPKUzbR=h3Zp}j!W zIB7cSFKNJ{Nt=Y1op2P{TZFifo_Ej>2d%}PEK%9&PvTC-{aI}7x@8ath_ zLr>wYHm9ViRLZ)gwG|)0m|upO%|>Iv3E7io>60XR-}jj3gpTTFbJ_Z&jZGcj`KkW^ zJx4qw8kxqdaG7{@9Lf4T!)%Xv&{UwGG820U>c*Eq)Wqb)4-VNOmXzw$ZIBg(U(!19 z#Nv|_l#UQlD~c#vD{1675c5h>vo=-ksDee(d`6I;1}s*#F8FDJTEO-ELraxWQw`Fd z-^Z7K6V@2gmoFj986M1ZYIS9qmMUR9l`nIpwcZ(uw8s-B?ia(DCju*)!|Vm`a(5F$Q?Y7%Pbz`WCeWK}T zr(&7b8x}$q0!H=#2;+#ju}#_a!nxBg(MeJG#aFa(tryiYR}U@8kz1wvD`5m!+V=H~ zq>C{o!UH5&`9ng5W*5S>4L4(GH0hsWJ; zY)-v@bSoZBj!Gng?ENbHSXyx^KUmz_!2N3rC`E=X{YY5|cf&@5ClfkFz-hthbwUGniYDv3&Cck5Ooy7qJdVg*d~AIEJ%Oo1jRk*BKKIHkQzkbj`Ngd|`=X zW6^>wAF+>SAMaBrYSkovKYUyT3lxtFW+U*5jQmeTSmVRhi_X({q+p++<{Skwf@xvL zY)V@T7S!0=e!dW3&8ovLIuN`k*t%Lof znA&ik?PVVo%s}v3mo19ulk&(=SzRp&P#cA|6hODiE>`Ikub7|VB|(gB!`g)v?Pe&` z!fPUKToSGvuPq>0oSyNu&YdDOR@L$pw>#sB6C62JHenAX>YW{Au;8{?`fSF%)2ejV zwDPj2D(K?MY&-XYIbAn zzP>R_Gd{!RwTDU_Pu;f49pP|CPcJx&G5C+Z4($b4;C!>vRaEDjBvKd>JKP;p?Li zVdW^Vn6UEz3oIo0++N;ShUdfTUB@GyizDH8Yf3K|Bp;(yie#rBX>BQ|Nk}SENZh3( zQwWC+p}OhNljG{3$ zurnj^5R-_$ZqK}CqF1oQoZQsgO-!)TTX7{|DJw?z2H%y9;=3jm-pG|4iils^7mify zTB%oQPUomdzn!O%t%2NL*-pd8AH$8qnIA0Fxd{%<9C1|!c7CByNpePE2~5%lM3Mne zu)WiAtvw=gj-*7@M-IJ@WN=M-dSaOJCZ*m{EiEM2=1qavkVW+e!W6bSRz))X$YL@KwF^j^ei8r$~XtV*EC`6R=Nz zi0O9Kz)Gaz%3XD|9!%4%1uSiyDgcZ4+gPTKsA{ZMxf2Ao6cnYXr1wD7n`yLYcx9?ZPF;yX#f$?thoqGz>w(mem!&3C zZd}8AcTLCyY(X~$EpkU(S|Ua1V|_|~eRzHOCfp^3_nc!-eIrGS>u@w6Z@ec%(eOu8 z++6Ux7yT*2TD=`=y5y%2^J(f3@<>1B4?W_dE3cC$MUaYSXPVx-+9QtG;_wM1RkHY` z!&&(YN72^|B~?eDN~@k$qvxp(&M-#tskEcq>>kldUNLD($Y_)u#FoZb1juI?j@_vhQey_)j*e8i~zE zp68eT2iIoxYIHYfb_kg&Oj3k_M)y~K-VSpBsFZKO#tbtc7(Vo0+kk7 zfO|toajsRFdGv-VGbpofCs6)fa*zT>V0v%ic&N_@k8*A|sIZ<9@qUo|D3DX_q4vN^ zfi^c9YLWtz@e!Hg7WP`>M1ydqX*rNWl6D~6L>)wpBoFNuDt?`0js2W|oFdbQc16gj zY9!`W^yL_zvWcZ1P5%INUSQ-_`jRz zrKy@vt+1xZ+^r(%+<|kpu{BDDC{FQqj(GP$H5ZyKVmd-YRVi`^ac!qWzn8n9*;WU{ zm{ez53tN@tPm*$y_FyyyCPfX&k~@Z&?c51dm8vj%%s2{%iVlhgL!lRk=N(FpMpRkn z1hJ!BF2=4)p+Pj9K-y-dRetX@i>V;%sn<<48%AH+7~Y?OWr6NmJAp21roDY*6((Gy zK@Qy5ZecinUZpE??1R@9`@4bry2ajHJ>ttpe>i)LYUdsclSUp;tqatl-LHc!7qCwAYlTA4sts z+i0!Gze8;Z-WZdiX$}`=E-{4Tlr7Q{+|qJyu?Fes@QlwN{>b(&xKF}Q5AKZ7l~tfM zGLdwK_YqF9mQF-5;JzBDGQ2fEF2dZFZ!j+)W(iW2-b$@Lyipk-Z4w_I<)wdb=Rq61s$?RTWHf+*QU`TUK1R1Z!<= zaT;Zlad<|ZhyeljATL99q)R@vvtzb;azo4E;Ig(TYk@Y8EV zH7%%+Il`=6S1)tAP%4#je0`l&ZT6=#@uS4@#hPseGW9uVo-P3 z&E8Nu<!3D-*rbZ*qu1)PRfgwjZ8|2~SRkPXy<@Sswy_pWl@wTaXzmHS$E+^K zByL?z)Y@nXgcOjYZxC|r>8OZrB@(n*Mm4H>>CUOA0ZP(HAo)Ylm7PV6c30u;7mV@^ z%1t(rHpwG3&D1xsu><1}GfzVo7}+=bK=7VZhL}f_CfIEVT2w%}^0~P&31rmA^wHjb z8qIL`4anBzi6AzFIt7R+$~Dv-y&-VjgXA+6&OBi5J2ULH#**9Ggg%uhDJRCs1LR`P zI9ldKaMr$5g`lS2_iyRqVJ;=EssGzPOc44mY?x40)F5`^mITn=M5%4B7 zP~u}H%&L|r5=HPsgwxb1>U`>&SP6IQ2}v3ezP&m`J|l=yO%Gzm*5%bu=X1&<$Pdah z{vm0gtp3q>eHd1*w+D3(4C(mpBVX*!BUEYhDfp~g*#J19I^4r*2~Z^T1}-NnL@26b z-Pm$@O_$rgfmisGXwCaW_)CrxnQ1J{oWlPA7|1gHAwV3shKB=7RLruqFu2NuxY-dq zaPW0pP^1c^k_zT!ll6&6xhNfX>FF9i4~R={^zSsgkf;wUv<8O?ib4Z?)p>T5!i{j1s|%MJVo z?` zoi0-uIYx`5$vaM6+Yp3xkyo|`0dE>%*U3g@wvtE6E_gZC#4ORWo_iMJL}A*i)c1~3 zmkojSi|ELzluLSXO_YV^7Pj!<(F^#uTbZCwmn2p~92(`Mz3I@jG&+>*Ep+e$8C8e}a-yfVHQ2~2<$(Gdkwu%W@{ESGCAuMb^x%*P&zUnXb zj4a|OCv4WeqLP*U=E(U+P!wx}<~@qC!oS7=^Dv<|%Fe9cH<&iQhp$k%I<5n|R>w*-_Xo4PP zD!-Ba#6-+oLx~!AtbqJX>B{u9p5Qi+o&Z3U~+$j{7>-up-sZm2pjvwiBo3 zV%8bdh?2(8$j;LjENrxtp8^Q{;y~HPT)LV!5VRy;;Y?iZ9D#iVLeImjgq&HN2~CGM zveer_x70M)^&f;}_>X5eKf+((;}p4yl-4Dxx-{Vb0Dma2mMKG;CPyNdCT_|~^3)Z3 zh-tCJI&u@?Da*7*XnixHRvsQ8#{~##?1ELTtagX7$YyA5rzuELI%+qGsgW8J6S9RH zZ4RNPjtju}L#SzqIn`x4!>DbYX*o;Vz`)oF)+y&;eLUfY$C5ipms>hROj)wi`3?H@ zjta9en^OHFhd@i@pFXj`I!sRlkIoX%s}%B81gk@|HqfNb+aVA4KnF|1Y*<;D5S_M; z9iu_Ua;HOR;2j!eT~dqkw%!rP8wABT#Rx#}4Siv~0`(vN(W}L(<5D8v3@ts9$DrO2 zbSv}R)3%Yrrka(SH~|zRg3>jXm=2oYKn6~3NCeri2Q?-ELXv}8YmypxSxGjy>L3F= z?4zWZ3nAptE0_;Q_7LgrAwzO)sERz;w7rQj zb~yYtnoRVpyNw&Ptm^pRP<;)>qPA+8ArDgG^$8{fIeV2mrp{1c}7u~U#xo;is;iL#q_3)>Ok{I!aoc#cODhl$w)RKL|fI(6=S&RH}x2sB!3R2 z*sS8o$0lA1r?ov!om+PYGFy@k^AHY-9l#gmZwRr9=kol9Tii(T60mEkq}CFZ5i>P4 zG`kDr4!o-qy@0xPCv&_!`h343vQzNK7fWGxoN8%6$W~{kWo9l#lBH!z6}SK!l#*|$ z5y{85khI1>AK}x(*=nT#zL}I#;1^B*?q1} za}Fo&xisPb0GoB2!}%llBEBLc%%8k7ZHz}rmQ2K>%ap_tvb4t>u(J-Zm8A+d(<-!5 zPNv}L5u~r`#ik?a6sPD;E>2}?=E~A$8E`0*lb1Gxn_pm4-WzCqBb7}YI#W-(UBjYq zBqX@MXi-W|RFJ}w6m5H4p*sEJyeWP9g^c$cumtTkR!W(eI^#HrmSsZjTn)}P+s)Y8 z{IXQ7v;=7pWXEWIv25ctJaIOrlopopESqGFMs!G));WHx~%XA>P)9f!PAc9g*;%=)0Z7<|v9NU8=$MF?=#V!!J!Ku|2f|W^`Q7tU$SXtet zO@L48c!<$(JX*=K=2z#%r;)wF9x%>!ey9n?0-mKz9J8`|l$4#;+Ab0n2UEOA;&^o} z(2QAVTy~k@grwqSamEx;nWDO`WAf~r!G$YTDJ`I7NBF^g4zULfsU-S+e91H2S{dF8 zRwZk-N!&kKm{O_uf?wH;!k3$uFbG_$*_3QDsAVeDfJhs|nd8-TIgQ`UQg(mCY|`JJ z!!xX9#8f)3(gEOr6t?A5gsll*zEDw_Rv;wY8;xSQ{w}|4ksXH%iPA_)1EEPJGc{!7 z9{LtaCs=tt0ZH!W9$d~TH;#-0$wRh_a5aR-DmJTQ7* ztww!HlS`r6eELbu!`vMI?wILocoDb_v5 zW%Vv40O_4K%1){lh%edklVpX&v~J6BEjU)SD*VXLOqoDodS4=xb28``wT<#G~x73_zUJWJ}$WoJ}co?C9giYiJ948wWz69n6{^VBHJGUN|O2zCB<3Cq+pu< z96wW1WjgGcgt}pjOU$f%6AosR6Gik0qZn@`v z3tTEZGLLUVk27Zmp+TOgfF>p$a1Xqt5%|N455P}|b6UX`-Aexee}p)&hQIqx=LO3hWx$kYVN; z)iS8~q{mhz*fp?Rrvwcpkehy_FGB1mP({4i0V-vYWA_E&O)kjhp;XMeGKB=T0UB8# ze&~5c32fh&lyYF%4xt`I+7(tN&4)01JUnSwn$YNF%{RSc0Q&hub7flCeEv!OF9j@^x`5!J&sc6^(GZty8g^sk@iO zZm;)r4ZzoOS>wiSc2+uf)7wm@cc%k9W;7+QcC%2@F0T{k{M>StfZ5K zhLVGBnqTDw0k==X6PT6mO*%A>^z6spXxB4v}YPFs%=n#A95dc=%-b0f`;6wJhmP}-f8 zaiqFHZN)YMReeR2cZn{B(b#tmN=mS~g|%cMB}CY4H?$5398wZ9S)>yv`sJ31X~o)I z;-2dAs09Fah6fPC)+8mWlNG0)NV{r`erH!IHu6KH56&F)0H4d6ivIvfR4Mg%{{R>O<5uyi z=GrYkRw_!gBc4bjz>Do1)VqZV8f2;@+-9LBrrlExg(Y6|Y9DC}x8NZ@Xa$ZH#meFq zCZC;J16h!g8%}_wyIV_}?Yt%~+d3^cX0=UX{6U{w^v9L(EfWmBeuJ?XzRkFM=~+2| zgq1B$6o3Z0ogt_#g_3?-vfR~7=b2VS9c%%=`LPad5@LhmPS1$Ja^BfZX){kX-f^cB zs*}_sDBsA#BZqAqT&Ck(G`UGdzfYWDA62eEmmB_!C=zUTDKP9K)I(zlN~6!>N^|q` z>RD1+Q2|%JgME5lm5rT#@k1hFw!+>XQwe zB?o1C$`M+bWRZ2S2p&0A4P+dNvD!+A-W{kd@<+4GpeY0&b;O(7!>RL*V|@ZfPS36h z%sDUy{?_?FE5*hi)UC=w?i{E2zA9HvTEEW`vBqaI62r3kvQVW|H6GHt`Vb;wXTt$EgBflQnIE|rgS?9VvzK$T8g7(Nlv;_-%y39k*7g>^brG$ zjngJ@@1Z@L?kGiSMC&QL`=IJC)Tbqryup@F$11HGE(Lx9mx|^voC2tx98-}#_$qDw zQ*HseLe{qR2E%b6{^|Q{1-u_xgtkQ)L~~rH@Ms?F>z*^B#)SJw2oQEKk)b z6xua3^UQ`|;MA-KJHb{7*zJ1_qNgm$@QEe6Ch$$}3sI8W{{Zq3;R{lHJ{ANY7=<@v zn5rP3ZX7n8IaRE%k(H^y#X+4cGZB%?dL8ZaiI{l|WGfdA;s@xHExOXwn=Lo7BTM-h znM8KWVc}AwF|4bfN~AY2AuyCCqS{9}km$_H-%+_!7w$MtqTwEK?umMOTRIj8dO1EDzsYdoCOW2N^#`;>SR8RCY}GE?@hlc*oQ2uvjrnBqPfm#$4NafF7+ zQBqWZ5=D=f&L43(7Dwzyz?#KT;*^l+J@l)*LV|_C8b?%ErzAH^;Wb|iP9Q$Y(_?VF zs<+OxJCFKILpLp+JdhHS) z4v@mnVrzjIMKxw?6yajyX<4^Yf|5m{tZSMVCq@nr;5ud-ku{p=D`~~L(@p92G+KyI z+;rDSL?cSY-t;i_#I=NR3WT}5tkYy5_@Tu2e7CeV{{Raeh@_)XCmg4ya!@FHGDF2; z<0%Wa;u(~6A@wRPTOCcSh*aHch zuw;tkyN%#1SenxXDwC^7h384S6trkf#eul7+{CO4QX}NpuLmj8xU(54l&dtf!--wT zP)(1O{{SNsQX}0KRoTZ7Il>G={tc+Sr(|YR?G&e+RmdBuyviVa5;q1ac)WXGVtxs9 zCa<%pQ?oLY4JFxUP?aY#Zj*fqP4p+j$|)X3nPQ`5c=n#)MHhz^3Vm`_qQsoa+?SkE zKmo33AqzH00U)07Cur9DD~{IcT+%8yz8<$k6U1{hN+TwdJicQRjx4adl?;lus8P_i zMU*Y3w~c-~OLB@xMKtrTQ=WQMlBQQ>r8|V5wPDktFqup6wz?gP+;#gXaP8hAwO*&7 zS;yqUn@-np2QV8Q_4vh7l`Z)*V56(#YAIxkHGq#0H?~-mfD_>n`tW!B`Q3%TfCKN zVPm(HCs5@a9?vxy!HTKQFsB#Fc_eC0g~pH|CodQHY7o3jNLmJTsk)55nv^f!ww*7n zhsG5dS_&$9txPRkcxYkds7oJC8Baa*6O$6eiMm9~b11RbmPiVifE|`weF0V=r~Xl)VPI+HaINB1_d zYgMXy^r!Nb%Q{E~#N}3?i}~Db4CIXpi?b(bno>?SYn7shDCzr9z?Mi{P@iaiR{rp| zo}w0pSqZo@`%-*HsJ{A=gg2=wAOJ3Un2(uSC1Ne_4r2)%R)S?7LdrB!LV+XT35?eh ziNWq$;+31#2{g{61psVxhz(gO9Hi1gJ4aF!%9QOF!78^8aU84k#5lThv!2k_K%>c0 z{{Tpx00~Jt+AlHA*8Ix(LYXc5PH>eRTEN-gNAtO6^Pxm{w$yA)KN&P~QL+_(b9WRu zN|~6ZxT_YNBETdc|yVQ?g5m^V8Z(f-Y22 z^u($!Hzc(;FxVa9l${m;7u%`n8tfUiMJ{Z6kr#v%35mM9U?hOu%I*lT9x*pj4WjSy z=M5z*JUUV)kTZmb5UUG?+st@Fel4?_X%M5c=WCOJCI0}En1!)7O$Q=*gE>NP`s%O) zrjVXuiCx8>0mrXX+wPZmA6s#P{vtaZmOTpsS%se|Q(no?=s=5^GZMu+~ zuO*fNDb~PSb7)JSpVU^5B3yALDE7)$J zmYP;}ln}iya2AlD4wk;Q(j-PS$nthr9sn)OVdo{5pjO+(OHIaLE)Ju8M_81I%!Hgs z!-Iu*#kWASXqrO7@j~pNdUP=kTQW>{MVIlHf#V)h+pkiRJ+Y?3yQ4=?MamVF5_HgO zLny}SXDn@45dCaRusmP*iK^j`e#yHp{U#DkY3Q{LzS)N-+Q`rzz z-ATD4eXkUpMrN63iyC9?#;T(@28Q#gLPK1&CoP6uMw)0MBr>*1a6VIbhLz$vtIjal zIowr(Qfaw3n@ZA9Gm9%^`v5OoE~PR}p8Ia4LiP$tKOjs&c-%=!R%5B)mTHzEmuTWMQK zwUxK~h>tn6JqXyXqpu?XctdtQL{RNj!zVb6P3B3PPD_GN0k(0}XbHcEoLX?1^g4W* zA1*COqYOcZD^%%)F)+i~fwrkv?~NRCr_`%(Cr@NtD>FqmaSBOuRa_Cb!YerZs!=BJ zkfvC(lYt8nmTbI8RLe{SqVU+WR&C2_AOoRBoJ-)eyA&)CLDUd>5fU)Yn9f*POI@>g z5WW=F1yY`piD%W!K}aJauc#IP3wrGu-Wx8p@H5%*=zdI-ot${WG3_x7%_wu*0VI>X zx|@=HV$u?_wrYpoZGhSGKPZrh>_AuOOugSiYY?Oiwk)OeQYxKBTs9Z@A7pmDYaQet!#S3b7PPz;+@B;tt90{!=QKtsDGsmDKW}B zvm9Tj;zSU&tlx4(zrPJGSX|k2xI(0t?rQ@;hC4PjQf#dqH!Mu5YuCc3E9{4Xkk&6 z142Hbg(T~MrPk0v=u!yz5MpjVA;*x!u_i`NEcP>|;^}p}D%fT42}+v)3;EeGdxMO< znO~Cyaw(4+V43b7&nbt23u$^0eQbRMTCxpMaGji{O=g_a%has{@P;xAM4xdP06qj5 zWKj!ydP;|wE4J)^2$KOUh`ofTOI0Tu{a}7@;F8VzT2oasKuXiCl7A5$Kv0Z<_Ij&C z^mu-7p#|h{O+m?UeE$G&ivA>*h?`R5JetS&vlL~bE4K*%j9)O0q!K=NFxa8P?I-oJ z3t9Uq{Ni^F%!`+iOL(n0ls!l17v*7posR~3B&h!Y7k|Ps+-kP|CAJPkwXd>UmvL#` zDI|O%p~A_@kYZ=G+@=?vRFwG2Qmb4MZ^c?fzjU=|vuG4X0dDPd@d zwH!S$MOkiPrL>{ZNh9TWm#Hy^sKmpImpT$54Opb;Qd4mY(rN`NI(e9nJTacl4?`=D zA?m~YMj!yQfA{r@4BpM(V&5Md+<2)t!J37DRgb9tF-@0+mOf~*hY=a_7u5Ou!$WZp zq=`wGs}AN(^%_TDCPN!lt(M#(@n;y2B_oL4PueuS;dMeaSZ9UB;bK^XtoIG!)H5Te zORk}`3+hC1qp6BHOibA~wV|gG#UVn~T@xD^X{sDd%3n&%BvF|Q1_P)%oe4IyaOsqS zZEfR#XKlqY0gh4AyCqjFs1tibZX%NvCcKxElF9Y!4QUr<5j>ZFD?vwW(wIEI5$OUr zC*PPa6J>3rJ3?&#(y!O)GLNUan=91C)f^I4<~^0Ll#Mze7%0p&*mwH8IK*g!8j#F0Ur7g%FeC0k!@+!e}hrlxbCG5iH0n zb=3qR19d4{06feGd7HI-Avb|0osgbka??%NIMV&(k}fY|M#LE5!y7JGSm^)?>?ZqZ zo@73LrNsm}`zq5|4x_J)uq@9G>I##XLehhEGPNY9J7;1q;jxZ|93(Z&NsgRmij|j6 zupFayRi!UTQWDOaF0Gv{q;yH!lBy`JD9O3rJ7*ddbND~$S$8HcsRY~o%yFv(Ab3l} z*`5a1(NSm>%Q!hxE%b4tqPiW1x@!<~W7V+aT^8lTSqVVdc13AbK6U4wm0DGCk-(J? zLKSd9vGR=mMDKrrEgg#5g0nP%-nw@32Jsz>IW*}!?b!RO)Sob6DIFdB7UCFv)r5@d zVL6r5hQYA>;lw46+jSI823LIoQcuPdBxL9fE%j6^KB@Jbr~GDhB>C(UTwl)v|#c;BssY)c<^Gf>4o6>Jf4f7?5goS}^22C_J@`Y7}itZj)XKHn+ zq`3G*jEzjr1{PA3mAthzqK&L>G#e6jyh(%vY9hZAsc+Kjn9+yaF1U#n(4~=Ug+9p| zc?~`g^>hCKH3R)eqk;4?@?_>!f3KBgqIc9&ozmVQSdSf|d=}q*(9d7K!^4Lu4dwPl z1TD7dGXW(&=>ct!pf?8kkabF~A;zh%h$s0Dj|%W54;j&BlT=zl+$qCX94kw8dOxyG1b0a-kW$LX z+QlZG1tU4c`$l6P0Sl6@FkR znyQT;tzeIRu%;DjXi}n#!rN^P&NRMn_Y|J~gG<6Wbu&|RD&JGk;j3&v;9yo95iA*W3^?p9qWMUe9Ouxgo;0M55tl1D3{hSw18>$nG zh^aZ|cRtpZ!zaCQsmpSlqgz_{yjDsy-a$)%DOl-wkfbqyg)f2f-tj1enKzz@|ab(afN*>}wRqe{PjHhFj2N7^bmki9h< zfz~7C$4_pkR9NuT9Yf8^)2fqZa}TXqk+5aIhVW?kJccYY9bz<+{bL|i8uH> znS#I*)P)SnYfQ5;E*z%Ey=NFFDf>!E7qy`&U*Aw8KM=TiBS3srsY?#hUTtj4&FV~& zoE9>(0G!FS`;Iwld!+3Ssdo_2++s;p)7We|suEgDsOpS`AuoBMN4l$MlVjF7CUp-N zZiZ#6NTEx<_?JVhFY6A%#Wud$7_Q-QZpm3@Lnb&xnqUM>=SJa4UBUFSjA=0N)Kz55 zW-5*!lB6c{6Ny0ZE4le*ygKnApAnk0ygf#%jL4m7f7h}36$t9ajybbD-5!-l8oGsl zTIcX47p8<=iN^6g9csvj5q^M@FZ0q9XjPoLo-vY>aV;>{v^=AuNF<-Y7-~|XNOWjV z)+gE?&4-;g`${KYn1=7jaM+!|c*?Ak%cT~<>0$gJO`V~m#S#^c9VrI8AhuXpuy_Mx zpF0B!Q?7i3G<7gzbu4)>>ll5pF~~|(;Ydk2R%{dktas4cZm{mF<;YD4dY=+kN^$v0 zg9Q`P?kTmWYpEv08w(_l#u4Io0oB5s6UJEev`n^y%dp}?o4IbqCs08u7ll)N-3k`} z0P<=$oxjshGT*C=kM!fZeEx?{WmB_FYMj|yRar&2KEZX7f12$bP<{S@L|k25ewgdB zGbl&2Hms^~3JOiZ*4DaDs5XvEVYeZ|;wB82!5>ArBRnQ$>MSM2TEw=k0=k_qeGRQ^ zLz0G`PncMm#x#bh3>PJ)%))@wWXt=^cO(>fJ2`CLuQD)9y)o%I?s})C`LDO#Je6MA zPNe+oVKQ23pEHS^$7+kJDYo8sDjanPTJ7$oM#WzZ;kN8>apo{pJ1s(6+K@z}PP;1l zRG+L{WE6z=taA>4pN*h+)ljC*I%RNFWSezLT3#vd1o)1>7F~!w{OUba?>efFo3_Zt; z>g_#-Sr=q2!P6=fKhcgP7Dm3({9~l?K8(3ZSq#sD3u{(v$vz-uAB;-I)JAe{h*Q8? z)4VaPB64+(bf`*_>q@Y=Bc<k>24#fP66R)U3CDCkAH z2v)SvX*Lr3bMlfjh0X`1Bwj8{qn1*nm2L{RBi0z$aUwb4+I>46Od?77#^f9iKb_Za zl-*>c-#|PfDw3Dfe@zlrM}#<5jM(+CYN6=){$gZ|ZqWF3C#vdG50TL= zxG(s_yM3{j5_VDn&tOxYuf(q-7g%} zzR}t>rnt3-q+Bg84k;@Zx=W7c7Z)03zN1m&2DB7AJPyV9JBw9B(pO1LtIJ7KYA!87 zWh7lB5G`?iZyeSsD;v7r6>keQiDhL*R^@7$P(JE24L(L0i|6qa(EkA94i;0eGZdPH zi)9lJJeJ&6VnWcib1Onf-1Ls>u+u_E4$F!*C&Vis(NNTX=M|y5x9B-U6~R1onBi=S z*pV4uacWYW(%^Ig;QZn~t*CM_HzoUG;%Q~(6AC{R{{X89aIw@$ehv1xt>fv&>CUAJ zaoeRUAvzwH0V4O>7;&L?OUw$Bh~*_El~Bce^Z5PHJnAuSQ(jTrr$2~L@k zVX|Ct2}wHH2~fWFAn)ZC7BFV)81J;n&7T>hAIb&DTu77Jjh<#KsoSIKhcwzbbR&3A zJi28{RcPG02f)NmDmRW_0!A13k!v*vRa12isA^J>uQ48RH)Z-Gl-CaCYgH+PHG8Gg zZ!mT{!W_~KHc3tw@M>=ZO`@jbpr|CIqb;;h-uF6>3u_T4nM+~#l4nELi@ z#A2OAmTLO*mvQ7`UO3t!&C?t{#<=oYnKOuFRDYc}GO2{OeOBGBmx`h&pAW z-(5Unp(4i0dH(1MJ({fZ_R*(gRDL&&cL4tY2h6GBmgF{bA0nMho2IM+6h5r=3Pa_@ z{KAY~xop?pGP$kAmkO$KIA%{vA@mEGjei3%To#DjOQuX--rc7o@1QC!g-YM=K z4^-{pXpNC~*me^Z*r$Sxik!YN;rzgwr#kWs!WcJHx|D8nrAjITebNL+Qm$jpBGZVx zEq4^KtXYHJ38|q4GxE(SE1GTJP}bV-lnr`o0-lz2#>j_F;_GFy)kUQ;?T9MY#O!po zkvbW#nHl4*MC;&2CZ=LKJiADoV7$%SAgm=;2IDPFXX%VTjgN*p|M4~XJ((+~;DJjT;b-1?n zG0A2~>crU;cvXvLa8@Ojsk++Qm7hzET|&uF+Sei=sc+=TT1U#MOLBJzNIt>~i#17v zhQRmI;ngG5d}Er2B8XkaiW|69`Bq&@khy!N$`&CZS(Er33^g&-N&G!H-XFn}t0Y=s zz?6Duuip!MD+{(h_)D}Lo-?6SsM87LPfE|q-MvU#K>m;$0d2bVjQ;==g{IkUhazf; zl_xJs;tnpTQ7TQL!pddlC5bwW$N@lF*9O4v6!{e^C&O}4y~DbD2}(mr8AecSbOcz9 z_VS3zYk>=vNlc-}PgDgEa@_7W zweO~p7bfb77~L{-aN~-ot`=qHl2YT6&CE8t9`Y6}b{}O|N%$VIlgS!o^c|o(M>{60 zH#nKF7cS#kUt(?0_}(ROZ}FiSmdDP86Nmw<|S9I%Z=rxZ(!^O1H ze2m2L3aZ{7s&Ha;GpI_8jL6K>wgtBvR>Jy?w;PClQ}A7_*CCj~_AD>3HArGQ{KWGu z98YleIgeVl}TT6ZWz-W@9v1;nMyVzOVa5HQ~5L7saIX%0-mHhHB44M9L=Q93%8=LcX?Kl1aD*<2K`A3R1J0Xpr1?UJ>Ip5>B=4a{k=I zO}G+Ql}gL5Lvk&BwHiV<7D`SK*XVp?!wGI(D0Wo0k=AouwxBFhb~hakmx|2taAe$R zNNI2nXIeiD>ne4Y?o?Fc3pcPGQEQz>_d3O7_{lwqk-(A1?Of2q^*Tl&K>lv#c?rYN zA%sjj^SDKSpwnr2Pn7)VQ7t!2;(UXGMnVc_I49#gP zIEBkSeE>_M!AH>8^!1L7#nUHmWL$AMg(?%6HfWrI(pm>jw*+aZ>%Umc`(Fp))$(P( z2a|dxP9SN@V=pGfFE@1{+k0*!8&qChoE!(*8ko%Mbh_eF!re$yZm8&>O|`JF`NWvQ z)r?A8lE%Nlsy7lPN==r_sWu>zH5w@-D^G+?!vu0d)ktB&_>tUyjHZn zrAHBjt_k<90?y+_dWh5_o>Y{R zqPIVWrj4GFeP{_g2)BB*z6U!ww)rYBeGlyb?rg?%M?u%f-JM9-F)HYx&hYgW5mIMF-)V% zP)ieEQ0>l_KIuAm`bQ^^Qac$_C$}G}D0d#p*+8X9Xq|srE2wd@T;pmQW*(PyI$J3g z^t^El*-G41qt8}xgw&-m(A3M}e4uUht3}9c6QEMMU#^{DbUdEIPqWt@>l`M;NW#3iRV!_xOx51T0SRiw^Jx>#Oji}i~j(SB4XiOM!aOl5k0Z6 z<}#I=r>Nyxf52w7PoZ7J;UgjsHMfiB}sg%Y9yRcj4&>!dX2Phm<0 zckyqsb9gSJ-A^`I<8&=O0X`Xx$DB&U^$pEXtKg)}?`BH#GHxunL#ZerDCm?rb_d=d z^wz+_bHd^neT6$k$zqCgG>O*|9?6vyG0D(di7$H=&&}Ce4~{m*6r4{m<{g+@YH`L&iVC&0?YH}4G-A^v4BaEL_7|Zm+8yO0#`=@~ zv_H7p993~o3UJ*Vp)|+|8)mlOIPZkz$p*C%fZ{i995E)#tf9m@6qP3`R88(JzF2-7 z6o#J>611v)r`|Ge(7B1o(?04CJHJjw#Hfl^g9A zh=ke5nx?$or3$yC2M6y8@mtw2%IMDy`)`LERr(QPHuQ*jRgOi`XT6v>{fDt_Ik_5> z?Y92_EiJf(n_nofR={dJBEE5GeKT8)y^LjXFjYehynA1@W0HcGF;Sfs8Np86Y*YeeE5IdM0PXF6fKHKLlZEU{hJNJO zRxG9B>0V@_%u40V^Jy+OZB4+|+K9g4GihZ{5sOlyk~n8jbB48bH1*Jo z`BV;;*Lc%G(Vvnn9*a{I#uDRXC=dZF6=0v_)Kd9DF%kc+UX6 zz?@LIG+ivXNo1dx8k2am#hY48g*5Ov9X|-4iX#(b1)JgXnC7NtRDy3|dv9*BX&jV7aI#Y1{t`7# zN=lQc>EZao-c~iBcoQVW4ISbVJmIclhLad^HeO8fTX7(r2BT9CM;MnOBSxaTh#ky9 zBXVK%gfoxDy41c8l3G%r4XwY<97hWB!4wyGpIlCavXy35o_Y?O$7d}n&ZTAFaL)jI zK!d*xrw_@Y09wh6rxlZ1EwM(ByqH8+$dwjxA8Rx+JcM;pRExsX5YUtk78M-2J3{{e z4^(rIl5~p<882csNR?ACET{)jm>70rD3{ZT zvQ43pL{sgdBkk0-m$_31^8Wy2Nya6W>)5sb0AsGGezHg74+$@vC-P;d>Km zqTexx2Z|5n6>&tP=5w~~J#@O-+(p1DF{0sPu@f`gix^jnwLB!Wsh1Q2PMd!N6J>!& zX*P-f0Kx9xvy?)H=NEK~T$_I6Tt$9f4#!q%=2}M#yIj#RvuQ3ogp+O6p!nDiouaEJ z2I5GLWXVTPt4h|87cBA?4!Rhxo+ln->UM5A)!~+hEZ|R48=DqT-W42kmzAN0_Gy_qUC-7f3_p!$)tJ^)GjAD zFH@%{G8$30OMkW__{ooWZ4I?bT4sijELv(-PGgWUBeP#~M1AqH1(F1@$nI zNu7yzbny_Ar%`K4ga8pL0AA6?blYU}KGmTt>A1?W8=i&|&Z8v6@?X$z2~nf1oE3se zw~RP&|I@9s)H21*g&Ci9H5SSV*4jY#0SU`fM1u{AF|D$w<3IpGjsPnbfq|^C90L&- zfC7YAzz1@Y+2*AE(hPM0-p6$E(wdz|y61Iv=&|GKBeFpjC35E%hQ*rBr1XGMfU6{N zoifY2a~vExXkEpi17)#z;{$$8WtHXxf;9wmJs~GW?-C^2#1eAYj#vO(SF=x{HW?pC z?m1zyT~AVVSTLq>jVjU2gwex6>1{WG31%kM%G0C_>C%y#T#K!~(uy2yK}b+GDNxvh z;yht2QahE5Ni~SxRLtY6ef8Trjwq>Wu&~UcNjeL9LJp5MC!}H8J{XmHRrR}Cn3%iB zB_%B~l$`~&1d=!3$^mR**_lvQhtdHA-g6qSv}PSmGHEILZj{+_S=)EsZ6j0?b17E> z))v;#9U|o|;_^y%AoqdX9|%wz3zR$C;{nEZF#RocM@va52O`!=jfIj4I{Y+_p(Yt- zgVzT_4WU9#jH4MQ5fOoFD%b>#;-ibjYR91>e|>8Ywp5ELZmBB-YA%Iq^R!csiHf!+VuIY0 zE~zP8%ZO|XfP3JPr>%qvHVunvJ$T9oN)4RupaZ?hu^%V^bg8w%?5k)5g(BdO8yz6C zloJhuF4MQzJf)9~kLMjg#C{;5i3L<S>Tz4arT> zicoX`PB7)w<$S9q7h3@^D2rsuwJfCpohVXu-yjF_j-U`#Tggp;e@635Nbt;+-rpmn za0S*byOgD*{{Vr=ej*gWLE%rUZM14Gl$-gONzi9;n=&=Ze7m|W=B9G(md&VI_dA`( z#yWC=;?qJ@HBbiSxyIF(#49Uge2v5|GOtk%HbcJI{1jaM5>|4O(B{gQR;-D#ic5uG zWNJa%;}$$NTG{>XLCp&i92Vl!JX)uvr@NIIR3tc)p-@hlg~=yveB(ooc2neq531c} zriDwq0+6(nEFP&M#vY-oE0-Q&S-uoZu0eU#DDHI0I4_m8EkRj9&?FmNTdm>Ph-Wrd zeN*!Ikfe~bH7L7-t#w5pK4B=y@RXb6~54fVd(vm69d*3^(*x$!Ud9CH} zK%XJk;p~jaoUF*p1r<`?N@Y?GT-TRwTqD37icuD~c-|#reEgs3VkN)d$aiS$w@aH+ zTjp}rNS<0!>TT?#yDNvui8zdce>NP3w)nUYjH=xGge!d21KAu7-Ij7Y7Y z!HOCV&F|Y1QM^Q)_x{p33ZE$b_BkGZeTjj9Ql2L|)Z&8EEil}b9(jv`lGMWr3_M1n z>3JZ6cDS&-H#WaF^%l1yCub@|&JvohQKkV(<&=~VZZ$;1VDICU9ihB?F|=9zer*!- zl?T+~nk~+}q^&mHxnwHK2i`)x)hDPhl(t_5`HsKW^dkQNXxWj&*05{yRzjM3Mq+Cy z)jwXRi0DODKj$Hc?Hy-pv*#BoJR_V;)S}d;Nwchya;-gd1Pk~;)$GpWl^;MD zGl|%9jFb=f!A&_&ohW70xKVbVP_l1wLREis?|TspsJw31K7`FmNUN^U+!>hQrAbl` zlJ!1f>XMo_A!z7@s=+zOmg88_@cF!G@6V}UlOBd2vo~l@??EuS6=-`-9iO@!ZGG^` zR)t9lAptt;q(#k&`Ey)}IHy|=Jxhi)UI|vI^7N^d%;5Tz@@82mQCn@Sr9>q~ARq&! zyht5HKu-DdB(+?M^x{4gk-#)8Ia#N=;wqEMo_1%wZt5Q?X-Tz+wTRrpB8KI$FnBq{ zT5o7{O379VTdPU9mA0}{kusFp=vh%EN;Vf7X0$z~&L%BhZ}~4dT99$&A*NP=Cc=s3 zrT3MX6enb;+S&nli;@G0lDe&lnGV(PgD$5Nr@zcv@gIH_2?PBESV)#dUQb zG;vN5Rt#FE86sI`4XJX%rZdlp#Wv)q-vEN}!URNG6E)KN7cT0$zRA%@8vr3Xj?m)&0CY-`Co4jd_JvwusV31b5=LU-Sh?}bU~WdcLO6bB zb8;(R07* zpjgAQc$!_DF=r%@!)9SfAf;<0sOp^w%0N479DKmwV!FL9O@*qTEVMn8fTgQ7iPGX0 z>2d*6U7Ex7EC(SaD8Mz)?q?Po8Pj5O=3l*KX_R?%ggT(B8_o-2sm>DCo2b1aiN@?u zw%%;4SoKZqWe$cTvB;`rivIw~=uM$EVv@=e&}6Xu6%96t2MTkx&1D|sjJkiSul3<4 zNZrS7(6vr4(~UY|iFS~srA25-3a~e@B}U$QLzl3YtY`RLTc~ixc{K`S;kR<-QdM%5 z1JOWQ;C|nka(VdP||Xo!`11{IWwxilaQYi%{pl7p2DtKSnZRA3S`Y_D1p=%Qv z=crSZ>6OZ@l{o4YQlummSdU0b$dGAclOu!i1C4^kIbl5sZC}D4S=W$a$BH?gakv3t0rbX1hE;!V=23o~WPM$qMlfcxY22hnO;80=H`Je^mw$C$#l@}+H6`Z7uYq1zJB7m#ii6KxD`_izDe3@mI&IV_{G*X{ z4mLkj-XBv~uc}D4l}n~#rh$8E8kPz`@X=a<;}W9p>-h~eM#T#aqPZmFGBO4AJ0&7H zh-e&-vaq)lO}*s~=_6CuNRpy3Wu&zv_8?+XdQ8cw+OyAw<{L|CEjY$hCg($C4ThSF zZwDYWXjpnxs$9uiO_C@xHYFnY(>78L-tgER`bSP03$0RR>$2;04W*>K!pr$bFCt|^ z3Uh6u^|sfASOHM>2I-S4LRuyqsm0B$Ex6hx zvZrwBLQ;@)8uTFF#yKtb6p+q#WTL898&io*l;bY1@rF4+lN5(z7OUE4F_Jn7!oQt_ zAsu9t;vd#haQN|f{u1|&Awv~6-NYE2j+7zzwjm3d(i3p+vz*5kq&==t#D_wPOJvxa zbx6u@=M6PV#l?Qki~4tAiDaSVtaouoW{D09)0I<1>Y1BtU4WGU zrL1jk=r-{p8r5RziGRZWFtfx83SF3Sw9h57hg-}7lu|w5l5TJL!;xEvWMt!^mSUXZ zo@1D)hAbS)4pNN(zl>R-gJ1ifCepKMJ9|n$I7;Mq85X-oj%F*W{{YOwzcUkYErd^* z$l%Q-GnI)XD`h+R3&cJ?I&sPQ5;$jaMUUc|>L}>uuHhP6iIwbhyEM!MVcF$2Z<=k)zG?pef-kTy%&N@D$-&BxXU1Ak#u!cYv_XDR49?3eZWP^((nZdr z!rrlVR+9ID98GJ9v{`wetGpU-m@lt+BVEs1gXSU(@zW;4c8DX}=9VXZmtWdQre*%I zSc`rNbxYz#;uWH)YZN)P%&559(%EqdDk&gbkOsSJ(l1)Fv5%i=N@DnJh$(Zqcb1nb zw#!aHl@6DNx5;Q1~ zWu)ZP9-ICUP~D8hR*K^wtpKPbl9RrW@Ytfkc&GVAE!`uS*(h;72cfrt zhT0TntYK*^LXzCvyKW@)C>QyW4NfVGjM^~pCRhGV{=VCiOH-7Zf`q)(vh@fn_ZF0k zCqt#rLujPpFjpem25S=4qgUWyaK%?jvT><$B*TR6cl%&) zj!sgMOQ*;%guaK$S;&wGzN*+?&Jl|{lWmI0i9}=gyMpUDMvWmzrGj6SmrU})Z<{(* zVx-tyo1a^CiSWs&izsO#&uJ`LjxN#Z_5M(5Z6n#IQWKZ!o6suSk#yU0d-R8r+vYae z&0?x*m_kZiA9`~lz9~rk(Bs}eF)NuOtC&_wlZ$AQ!zwP^t8N_y@3A|1YY=#)aV6k; zl2^3#I(vh7rHb^5$V}X_CDgr6M=SzKwX6?KZ+pgiQME<9T@t&4TyL4h54%CHr3_V= zLS1cXxNc>YY~y7|GKkq$8W@EvRk|dp*vkI^bOVF#W4bdnc_edRk^Lf4E>zX-NU$X3 z{G!8zm25@Mtccy5@!Xy&t5YQB3RaW?*h=hf4z?hj!4Y*9Rmlz~Z)pj++KW`F1NCc8 zcG|s?qLFZvfuSetj;0x$Z4W{2NzTkzf=`JQN_^rQ2$_~b{CuZ?AJFZAxp1F1wA8CLs^cbw&}21 zRbNPq>mN|MA5`~Ue6mVuK!&D~l{QS9@lWd1&CK83INlJh@N{IJ-fY8J5h}5da z{3<6W_cie0rqW(p&6GNos1l)LznF@CD>nN*iMU~~h5qTrA9hvwI;sIJts`E6ZJkB^ zEMe{!Hm!#9!nYYo&MV5}I<*`~xUNjlLys~}jl5e+YfXVYQ-2#;CNd#7xMwcPlg(rV z=30`g05wUru+tJlz9n$cd_{8`swyvd0mBypAFE_YIJe zl(>`C1y)y4sNdlot2@ZLF4Ie);`}zU^Qa8YguN=|(sH;!u?JfNau;ZB5!_taSrz`y zb1TCS%&_Xj)VF_^nAuIIMF0TT#B{Vw@a+t065WZrLaT#SbxKdELZ3E5T)EM;^ijHi z9&ua5VeuokG)lugFLLzXm1?@%Q?jc|tse3gf)%0j5tPXWpTN9}8h+3i9azH))MWt7 zw6-5-O+wq(O%LG`xJmePOm8%GBA0tZNQ&&8GZ8dDa4D+*m$l!0K-sTzra5 zn-L+d7Qfv_7tX>n?U1cZSd99P7+$v~ok2nhLWT7gBynOc`F`3PxBB;{HA1e3Sj`9t!trW}X68^X+DOcsqrYCq=$X3aB*%*QxPzWy-RcJEHzZShbyR6h01c0 zY)BW2-)8X|9d{yU$7rIiFyOO2)cI^0^t_%!KF|{^KHaVzY+pqL+yic!`Na6-vK*pBoD0RN zjtt@nTt)#*oc>m7EsKPu)b~`fE&w+dx`{fNb;iV}L&e*(v$U=~rlS|o!cQ~d^g${T^i5|yDrY3M?dZ~LNJ8f>t7UO0D+HKb29a`&<}tf{_^ zHZ=fTok-duWrYe-Ec*-B-L6WqhrRaFH{Wi)n?yE%ugM+_zs0Kb>+%kAsub#iTy0m- zqSqkU6S(PZ358JVWMJ({K>9No1?31^lL#j$wz^;Ogv}2`y)GYx%i&~|-u#dBVynZp zS*ag4TyUNCj7;colAdji{4W=H<5Y^-yKHpkxJxUFC7k*-z$Y4Lx*NFfr6ar(VRPdb zGvQR0+cFP}q=$2}vobCzDk@5nY@Vhqoyr<|??=NR@+`^lMC* zOQ=CfxG5hoq+{myE#ib<7Pw_E#VUJ}Zvax_6oNGCu@?tWbrAOto5OY^COt^`^T!m* z?*i(tP}JhYy4RA|R#hQKLt|mLm7`M}nw6rKP}0k&;AR0cctl7!bcfi=2;C%&2-89i zq7kcbaUgNx%>5F5cyhk7W+dEFT5)9EN$75)t;LSki%bM8r?|_AT3sDQX3Ij5<3{5} zpn?j2eWFa^u*_w-WBr=8DzA=&GFz99X4?ReJoNSG@ ziiU~BeRlrhz9imaj{ zcM`EIg%YmuVT212x==3`szq#~Z((e7yin(}Jfh%8%7qhqcngwrha)Qx<3i`Qyq0-c zG6(48SqJ3|A;M!W>&OgxwP|%2HgFbuOmFi>CeIp%ER&Q1m57&=2>~r*YE= zzaU&mn^dq`P)NFoP5YwcpM+Mt4lJIhX9Ke@7-`hpGNzWKw>2+zl-Vfy^rS& z%ZF`_M3LYv=VqL{u1w%q?MfTrsE5w-as;P}U{Y{FuYHUNq%QG(NY!R)B zg}p4J4#R;%a^m(8%E8qN(zDJ?JhFGpwOjFt@ZlUtGvbpLk{km?Rh;QsRi?WC0J0_f zvLe1Env&ciYKW^i1&90iM^*%Z@ePiZCj`i)BJHG)8v=hQXC}g-CMyxbxjKq_sA|Xc zMgIUOhb)vzLt~2g1lwS(w$f61plUrup_xj@Qy9t463x-v=1MJSP&!zUe*q0PIEPaV zagP{q*bI+2>q+T#tL82tmMst67q%@k8K6qyStiyMp;1C_>)%n<1kN+qkAReHZ7ymU zYHShj7Ru5}JwibsLS%I@r^B_JLBkoOvgmj>duL8!f<1H=h&dvpON5#vMPsz(ONT@$ z^(Dj`T`IXr7QMyPEfBrkNSL!YkIxHxNYMDMo?2W>6GwC@NdTWN@i88JK9W>3sSfni zj!TjL$b~4ARD?|91s8~|5|bP1jmwbR7AvW%%7Gj@C=xk|K2g(xb!y0c3^q7ASaxqJ zQg;V%d^{pmz@{F40)WZc3)K%Qm#^Q?J8FZfxvPpM&zL zm9ERI8zn))JU0d@IEAriiIblitLX@2S1;_D+qZc8j=!;nEi4Rm&m9kV%h3q~? zCu7G$5|GGZ3@=nxy{*V-=?#*4=&u@3#do ziLmXoaliOuTf$1>Q)gR<-o;h)nKiIZtvEm*6BA{+BBI3~8PI$!3<@KkYAGW(MPXb0 zTF1y3m5fU&^Rk#xYe!b_avTV`_%Ecky25Fb2Pm>F7;2kg81V$JyL%&2uM>Mjyy<_O?h4b6Yz;R ze~4y$if_h?2L8XkFACE0`xC4#i7r1-Mth9r%Pc&J>bCQtY5i0AMN}5##(d}Y{im5~ zf|f_yF{I(S5OVV?eo~n1`fl0^t-XOiluogx%u146qO7E;C(K$qb|%MH1Y#MgGJ=?O zNj?`gKBKHAtZL|++%D}$Qo+t6Gm8n*>AH$OS+t1Rcx5rzW@xki81}S~#HdPUic+#Y z;6_vEO1}uB%fVM7#u@CCw7g9vUr1XnB;U+`7^}&N#FZJ@*ent05t|Ekp&9g!$o{7onqG?8DvRd zAs#Z|y-N&c3v8?l`=I9df(PLiFv_GwaA=M76s}c83c6G`2Sf6SNNJi3)fSBjyeY*q znvI3dmqZ#vQH7bsFsr1;92B{NlS0mwiIwiC#b$m9b41)+L+UGAd`)Z8DrFrcN+khC>ooC929G$g`1s>2MvU_6TSZcd~oUi)T|OB;80uSIzR>&7jv)1 zIKUuAZDWZXFu2vApfprrCrxrAfMZDpI0jUwSO8GcTDb(m(Z)N>Qd_P{IWDpWaiQ=~ z)EIWGZs=u9xt1lhXrz(|^AR423vjAzM=0oCMf8B^;$s>G8jDM$qD4jOn~l2lN!zF; z3R>*cxJmBaw5KwbpLnjvXiW;Sv2i@J92945>p*neY3slPo5Em;>Ge})R1+aQ63o(x z03jtp&TG{NQT!vQOAwgSlP5r`&dJlCGcs&Gw%C5w<{>7*R`Y~{Vk%+VKyc^tR7@lV z6)vLGk{?U02NdHfLu8UUYb7K(=0F5k>E7~$v1rj{(2)r`Z6#dO90Ri>N^)T63HU&E zi7&xS9Z;65NY1p{k{g&tbD;XQTq^fJ?SSnH4$*u)MiZ%~u_`SkKBLUG$ao(2Tlcpb z0UbCsa)A>F-s8qP21zzc1$lQVBj*5Z2|lkv6wG1PIK%ktEl zX&tkaZ?N{@pGYhy(Gv=s%!PfBVJAj+5L4WzxF#DVD?+m&LvTbhBy_pX%=}OO{M3fn znzz!jh)TTPY-kmr0^?)WDl_5I{{SKA$Za^8geB@Tb9Lw4EwxOR31K7rI#pyS>*L+E zh}I%S^zJFHqr9s6R_hZPY`Ko{8`!iGSASgB5W|SH$JMt}F!OFCTEO4W!V+}do2oZO zr@c7m=+W<6r+UZpj-!IEl_F+WFyXSBm`ep6dz`BsI%^6zYGXV!)lOBi>OzYxJ(XQX ziQCrDG<6!7VzetVtSbHHl9BOBidFbPg$qnb(jAdY=XRY+ujQJ={ER8`IE8H36$xUM zd#bhl1Sx=+m1Qgf5}xRDz2Xy;Wj_l-PLclr6ib?pE~YS`GPcUr4^VETtMD2OQ5 zvI*#HE(x$cIz+r(eSVZ8OyXCutFp5)W@Nah+>@D-cQ6@}Zbc;d5s%Ue}6XKRv zkq7%WhaV^N{Dr^Ji+z+Okc?|bL!&YgBR1lPi1s%L5zN~pyqDI6L!YT<{g&(0L}7Q= zGL$mplgza@p86CV((1jv2)4&d!esaL4upE*Ym!LCl^Mw*l{Ymcr;CZbmzCD_*U-YE zgtj@HP^j|Ts6Lb3OzhUavaJCeg5~gEn>#1@zsO~~Na640T~XHG%%Jq*+ia7d64adS zfG?(15`6Ei;W6aC5A{1Pe?QP?xD@yEdViI6oo_(OkMD)o-^fCLnj-%IXjxM)i|eiQ z6Z01Mti(AX%M<)Iqz6(Kt-{WpA{~TmMbNUV%}vmnb*Xm>8(Na3plnKg)9N}x-oT4O z?8n4PcWWFl_6o!%^U}yBUDJEz9_ofrol<%esECq!9;Ndq<9gLHxcI}vs*eXMk5Ou< z@1s_n(<`l?bz;PgM@!rt;@TNCt0T%fT@s72pC9J1#PTql{{Yw1YAJOR`K(JWmef*4 zgpqOL0Nx>IUw@$|9EibR!Sj4vpkbMMasuWVot&hUTo0`)_J+wOz-CI7<=r~NQDG%! zOjFsizr!3oDU0TTWGZMd<2q+(Y8!BnqkPIq7PgvetVn8x>WQ)0@^o>l4C3eKKyswi zguYdSWnF}+Z8@cYInXY8+Q&l?^7CI2*ls81c#k~y5GgZNc~Y5`Q+|!8Gnf%D(~OHO z5G<0kIeeo~p}bb)j{c*`lVgNa>Xd18Cmi;cWq@5iVCY_x&6FiWaJEg_SW(Pu3EmiJ zP}gx!hpmSkX=p2^%{W|GPK%V9NF}+Z^|`&Wt-p0$b%>IcG5D((&fPK-Sdsc0WeS*5 zWXU!b%tEc3%I8}{oHXj}PFUF0st7ct3j#1eZc)YfT&!L><38fF zBOJym!Zc?~EmDfyPu^O`%S~ZEBRi!XsT^LJ-}wW>!ztL8FZqZbPcy0_u0m?7G5RV( z8b7U+#}w1*8cvkzae+;xq^0fu04Rs%A!(z68TN7eM1tFGgW<_AwIt3Q$0>O6XY`|A z`6MH{k-!_lxXO7$oivuo>2wqLL9HF3VLQS}$(c?}%>G%$D>4_Q>;|dI6{zcd2-um)q+B=Y{M=6JJ4$i6_UM}+q^e)0Ax}&R_A@XLsFHUsvd=6ISL}fVf3hbwih=)Bd?Hz&{^1~*CZ;Oq%`n8&=#g` ze(-Na+s!>e)(SahwO4aIL3~(!kT2GLB}SR;JbIq z4$e8sNxp4HZ4ZP$sBVPZ#|Wr0YIW7V?p7v~CiaRUGYd8d-_PC`Pn;`Inloaq0??@Q zNkY^~Y1UesLAfpS{{Te0-%w734X+AQXBrl5a4QB&xYW9vF1+l+lE?u|7kQ*-S_!>{ zhf}9W?zVGD-;u%CB84d{KHQ0Mxt3mevz>RdAEX3dajuUe48KX0j@056nC>Hf@=u9SSpdmOlXU5sxmx^@mTs>h%V}VPmT82792rKL z)B!2b4>&C49T~}`%du8<2P(x9n)o8az7&IhTfhflcz+Rbl*~@c%OJBkCW&V=DJcpl z0?rGR*;m%X=L?|bY*NtIWqK)gu7tf-nR6=*=KCVRD3s6Ij4eNMntB~n_PktNVW90gf%FOOn-4@9#A^{MpE2~sVC5t06g|deF&1=m|Q~RQ#>bqcykUmfVnAGTzTRy zIgF<=n*l)UZOzC8!8>6^NFC-^-)%(hbT-tRM-;DNEl}xjGMz6kis%J8K4m6@yYzFo zd^YfoOY~<^%f-XlXK|(a%(kDJ(+&Oo4w5s83gt-Q_CC>ZO1Gl`M-kRBa}EY7c(v7= zT8i3l=2DO&pMRJdeTAQHW>B?%tVvO~sfIFt2)umD5Sfz5Z_+B+G;4UF!bxr_w=UGu zibD!27QUff4TynCjx}Qu#tsfrxM4wD?5kuE(kP1A(EjK2r}J5|I!z?N;yH+i9DkhV;)<&J8J9oKF*h2dH#fMW z?Ee5RCM&et>|PNYj#rKR2l#jRkzu@V!U4u6C797b^IP&z?|A$p%yUOeG*Nbkhk)3* zjBSRJQQdxBSzbp}sX7tUZz!eDk4t3Ca*%p#7xMPzC3MV!(vDe{&F^%L(4Tk@IC>dtVW~r@ zEN8GRw-|8p>F6PC%rX}$=Yy$D+apnH>_PF?8Oc5DauGW{g>n0}iX_e-ozilS>2E3D zmZEGn=s_EpqT_M@0C=|H<zJqF)Z0ksmX( zMl2F<0{;-TCwg-r>bG}9z8?+t}&S+t?WwJP$6zr2zXM@_YhtWxMf$hNW!cBP+Q zBw}7%0;g%RtSGAYyK72F`CrZ@&zIDS_ZucC5`05$pY(YCc`%~WjojQUC(grCH0i8% zRMKb`&aj=^SJ;?Axi>=W+nwth>*KJzSmD~y2Pz`}02Qe;>{Ey8&$5ur;af8?`>`-OiWBkQl*Y{xh~mSbkrux18wd!H;Q+T%Ox=}#9U-Jktc_zg1-R)(|`6-LkBG?L~mx zLe?}VSl4l$mrui0DsDEQ0@Q@#{{UXjx0jhg9M;ZlPl(VD2$zgvLch0mKTUm_WkOMR zTBX`vanPNQu8`#8OXhMiI=zK>*lHMvrex(c7J^>zQ|*1b0ijZNwS~p{#cvynT2HDc zaM>x*U>&irNyQjOWP$aP=P*7gKNzgVk4q;`Rz?oSRguK}2R(<025L~ahQa7f)PvKl zz&DA~RLHAw^z7foCvnt^w2I?E&eNPS?v(+kPKi1IH68@TZx-m0iZ)8Bbrx2Hl?hgo z&{?{&^|VsTZIhy?Y`CSvnQk&trl_-rTefc>Bg%Zk|<-MRc02G_);iOt)TQ4#knXSW26-unsS1nUbrRTFUmE4Sus2*DM zJr!eZ1a?>!@43k2=sUfZ`$SIgR=lh;QgFE@r&P$jyQ&7jivoWb%==4(PnR@Z@R|BD zjxk5rrLdTkpX7bdu-Q)P`h zD?VkSfToqYNfBg-O%HEpY*f=TQ#1+lX&SS9g%h$J{)Npo(N^jOjCB#<5P+htT#@lDZLl%^5s7RtV&U#n=;mm* zO8Qsr&4?V`RB9*&E;Q-AgmG3b~nsQ0Q;?Oyo zC;Fz{cGSnGdowLai>ATn;B?2)%5nYpEtMbmNswE>HZ7Q72oNM~^AO z0=@v)^@v&3q1bF+rwQ>hRr(CP`8~qWQjel;V*{Uu{7k>cJ&5I8?a4*L^%coXSfwf; zp76K%Fy=l1wPTXZmc>5ywBmy5)%Rwpvjt49%1VaB9Y%z27kKdLRLB`8Y?a^K{^Rv} zxjHHCubnIIEh@Fe_BXZu5!vHNXHcof_!Wk$m3kD)Z7(#XIN$22UEoH&51cy%Xkt!{ z9?m>$bA%5&f$>;BM@#~Vcg~?9dwZagJx-AFkFP;0bXU)4+$z@(F$C1BL>9w@ppC3` z7SzMlLUj+1VTaQA@v z*2Wy6)KzzB9xEJYh}@h((YHIN%pXAmjgF^9%ywGs3da-hd+f|838_}B=a{v#YzN8` z@z){slFC-%4LzJyiDuYJwOW*0J}MVB_{EMKN^Y44EbDYR90H}z%;Fhv)$_4%vE{J` z*J!lIAE93+C-||$<{qrfAzxFO(lzKw&>ei?Ij||a7mq879j?sO`Hll(<|OCFR;JPd z6`=&3Qb8BrXw7>^hG{z7x8ZXp_beZ`r4Z$o8=6a%fG4^Re&VHQz=3QU3j z0NokFOush8L5&}|MaNJ!>lYj}Z58>MS+Y37ZgtkAr;3USfCz_4bVQ4$SuX)N zVOZfr_2k{>)8~*-@BFnD%7H> zQtGfmTVX2nQH#tfioB#Z;?58DNyUk4@~kqC3vM+rVMGZEp3l_Qd*>B8*BK`=} z!>|}++~dy=Rg9$PQh}S7B-4rVC_cSGG1{}MVydtOElgA$mnpf(yN?lVVVJ~n#gZ{B z<{MB$PALT%B#!~N${nM+j&!y%o1B{n3OU?2Q5F|ICrIT6p~B)e5nSyoOp)G3@Z_=D zu|6k3H^F5$EU>k7I>PYt8q3I))AL@^JG(^k0n4XOyCS=b#}US2t<{zV)Ngo9j-hkI z>9kc+T2ifXr(Jv^4-l(zULE!w`AJu)=T4DVEy<}-(3?|^3y}yGH#3MVEZkl=&Y5LY z%*ZXcfn&Ho#uCnn3`4=03`z+J0Y|RC#u}0xOlxGYHD`gdsHxMIRLT!|I#{QwP07%Y zC~88{Kd{40Vusk5Ed|R>q%9XGxKF%~9S+7IO_Cxty`y*nitLKjPd(zRpr9sS>w#5$XHbjlqi`QSVkpPERYXK zWue zaIL1(m~22I--(EMc(*-?IQV@d_KC3A0Cb2pNz!#?CW4`HVp<{>ZMtG-Xv{y=4gvVa zhuPA$*O67lt-fSGpwta9*;j$rD$uV*3r39;%zv;1!fNtvG*7tVlYb+qgk(Dtqb+J`EVN1u1-c7CvNXj# zZxMZej9w&GS#OkznkL#B?mq~Q<3owq-EsYZ?E$|GnZlyzfL=FYx68Cy zeg@!dSy6e=uU2B*swB_d_Vb_tt#x_{NWhWld>wz%IssU987=kFB_-u%F|~Q zn;$D5z}xbOnJ_62$16pJaIdw%nF(regW|FKz)$5A+4vsChCU#hGz@biiINLz0H|DV z6!XI3O^obRs$TkyL`P_L%_pUj=(5Gcacp;(g~WIgTDpRl5)==NNQP$-sbjJoaZ|D^ zhAl}cY$apeBKIHV55_Gp@q|g>D~pMpm1>wJMNE!jI&3ul(Tj{+LXie|nj@>U$7D%E z$S6?IgA)0Sax|Wo@Q$1`2`Dkp6_i@&}(Q;v04ON?KN^rhZC{3sKC_W zX!>s*ICT+JN=Jlpj@W;uP_w<`ly=SeTA&(UIY61zO+Z^n;Hy9X)vQ$`Shy5p%1i)i zma~K702>l*9gGM_S+)uU4FH~W+tv^$(Nl!S8N&&1ji3W=UBaEql3*o+2)T- z0L;!65^eQmHro1#n7Z<6VT;_o2SZ)b;vLI#|0XS;v}0l4M|G*6*Q7#fNK8$d_|9Swv*_9 zK3c~t4fZ&xGTF9kkIV6n*qR)CIm9$$1R6a|=9Zbdd)6Q*>_%chP&$KdkNP#e!>VDRONsy_4fWDEaOhVs)jtXcrE2`w z90<4#6rTAP7b^YGmUP9!+;3FEvuLkLODsv#o@h9v18|e6N~}O2q#WBrGg`Jfivr^w z2LAf#keQ{sdQ|knUUZ=MOK0l{HUwr$fk_9(DnHuW9p)*+&9hEa!$}2gEz65sgxCdv z*HDq`XoSZHo{cbD}OA){{WbP2SW%tQrd|m zq{~YwAnY=t$LG8&`5Zfwb#`VI?26Q_3RoYi4nz6JY~>9901POzG)Ly??<9t0R7-B_ zWue6tjZTD%*xCVN(-qAbs!ZQ5BV0~~(8z-fb zrG7RxK30y!36t1z=!4tl3&fwRb!h|8kq;rJHk?f1%%2lQMx8of*tovaC0a2Mw0WjQHqyX;`Ig z%sRuV$hOozAdSc67D?F!jlUG|+GZVYvnE4xERmdn?T>_iPG0GW3a9<+JH7&D3@L~z7!{#emThX6ZmTxT-z*Zc)2hfw152QgpiY9O; z0MV*cNr#m%iFrrflYPT?3ll*KQWUK2pWkA8@LLQ>aUxEuMpDCStWzoTELzDc-VHbqBoK|hpJ)$8+5moV>it;MMw7IRpjI=j5&r-!uYa6k6u(9J z4*ueA3re{}Ew?h-*)O&oV67z~#4BQgeeZ-j1|g0;Zj37O<-`G*BT){>;$wfos>H?% z#VkC^l-iP&lVV21Uu#8d-v0n5OvSS=kByuor}5U7nF^XhR;JLYNx%kXol-%vmO-*f z=r{F>oLpPP{{S>vOA?YQi-sI7sqnvu)M`CZqKDX;T9TrZk<=xp3RHqX%#*j_7n08$ zkhDWkada=R_9y=G(zDpJ3rh*gJo&W5vXjhmmp+1|^D?H%LI^7jtefRFG1xVKe}5CN zV?zmX`ggR=b;=!8#5E;ZkW`XUavDU#U@l$TDM|rZ)2e_cylgKL@3%{TxYgLnaQ7M2 z`zF@vl*)qyIWa2ijKfO`0clwJr%`g7i|UnX2qwZgN!OE1;&fSsRZ=`&mY<$WVY#|2 z%@t`XuyH4pggTurLRE5`Tmn)rv{z+@_3`}dkeSxU*a~;)3C3uT2}#FaOvJe=C~q+V z6D^#g{o#?&2I@gkh*FIXAvpFisbX@IJfCK$(h{>jEI|pFK+~FlP1J&msVX)Zgjdcq zNP`@HCD*0!w6!jhzZ4}ZB}#H}Oo1}FW0`qU z9YD-ey|&bN#H8qs(chcKluDijB}!`i!PezAB#whvP0`vA_@4mK@Z_Y# z{LIsjiFrdfq&DJI;@Af$S^>4eIse=E?bmnrNp!9P+9Lpe`EtKVNpW?K%&ad!S0lT(3fLn%<$ zkd*##)v)ZpAv8yy3~bzLS~gT^I@sQB}T~1 zE)=3tkh^bfB6M-7A~dB&?B^G2GGb|_W>%ynn%k|csFVEN#Fhv**d)adYPjT*W>q&hY0k;12qY!e8$fpUIs!r4-W$S}BbtS0 z57RBdi9v{Qbi&`PPYmqKX3XLct!xmx6yL47X#<9>kS9lWYqZWE;u29!u1GDKbmCQ# zV4*$Hn;>)&NEub3S3{&H!E1B6?29OF zG#W#y3G))=LU~+#tXFWsqPnu+ZL zf?017AxLMXPK$ycQHwEPNZ2~d&Ft1cf*isLkYxe6;$l!G}4=WbGUw>rh;C%bC+il z;(Nl$0^;dA9b>Knbx`qE>y1`raRj`oR`btQTb`B(PGGdNl}Z6Z{p()9Z)4#HhQm?D zJWQ72@6&Z@bS;pCQq=QnuqabA7FSbX2KU-Jp+_4q;XGYEh#z8ZnA!GSmt^XNpOh5@k=RiKg>7 z>Xb;cedJ$V3W+3n2wt1y37mXIhU;87TP#$PSX<3ZE?QxgEh;N%If7KJK3m#4l^kr5 z*b}sG&`u0Jj1ng$otI_iCKR0NDRl{PD0exrBKlZvAv$TD)JP%PI}Avr9?q9aR-lH$ z8%Ro)bO}w3ijKf<9nczvPmCO1!yHYMM3qujWvO+{DW>L%Pzx`&Y`_vuRVL#w-q58Q z65WY$z*;UALMrtNueM1vgdBn3wJix3Z5Fky&;y|959vY%(yxf;xVci5Qe0f5gR(UT zr5b3IB@N3Yh+~{000i|Bx?hX8JtaroJ z=oU!c%4(ulY15K5BugfBFFKd~qb=P?Q2^a~n{0eEh?x@~fa38wl_^D|p@|ZnLvM21 z$U#UMn;AhGTU`f)CJS+L-E@o=`<+_qc@&?zo+C;QRA&b)cdWr7mNVqL3^Ch_%Vq#X|6v6TF6MnM;z# zbF(zWFDu1QxhSAURVXYF60LQzY%Q(r1t+(l3N8j!Rl|&FO_v%8E+bjvF!k@FCR*Wh)C9?sl6U1E^j><7vp{wF+#LWeeTT}oI+KJRM-|I-&BLI!XU?o zZI8UE5KZ?dah+99D61pQl190Eq@O;TMa*KLsIQc@G1BaLBqn4lP4x;E^$H|KrWLsZ zDBEz7X-l8QN>=KWe4m_N{{SMaoqdMpuY;KfqplC~jp7#(I%D|bVyio_=hK4W4R?-PbvFoo??zwUtw^p zs??LM;ZlyM(b&sNCEahdOtuS~W?rI&Bsvy(iAQxQK>(>n`VDnE2!Qxr#Fd=uaZ`vg zc&e6(YICS~&8Y(DP*4cCB%2ct;NjYK#xmwjP=RUx0Are99RgLal2Vhe@rxFyhMCRm zUpSZP^%oPW4Mt$3^s!V&$VIrU1+V5|$wx{Mp5>=;=91lG1i4V6u$76&*qM1PCi(K) zGKy2V``;VHEnNw8MDETQLXS$t#$2?8%TLRuZcr^LITQ_@Yf;eNz-j;&hVn|5$6*rL zF-9Mku1HN&lF|ZRmU+CPBkdsDr;VZ#l{+OgeCKhO2qs=$MtKR!qLs_O0JWWAMF#$4 zSexq>t8_z>J=x-9Oik1%>N-!!I2-=}lI;C!M0wpd76j|0Ee%zdRfcAyc%g(PD)S67 z`-znacsh`)sj*{osTzwDeIlDaX9no8hBYKaJbT$?y2B~NSUGM<%%q-duvT2ICv@4g z>~~JOq=OLs?GF37nu)@C#xs|4w@O))#8OKE*3+2{%#5K$DoRFTyWDGR!_F1&NeS=; zMQ1#>vG=-sF zL@30Vt(U+^kLyBTvcsMcwLP|&-Ha3Onu{T7xtW{-R z!|YFsCE41nn}s6UIMRY#Kkswn29uhGSBK;3mAGHV3Et26naSxxcFTn?G;ft?zQh7G9XuiFLs7`OEUSY2f1~ji8%}#A z+is%6Y5`e6=AdOz(4F@ilN8)`7NcbB6Wp;X3(A;DLcYeID9*H43Q1XJm?cgWqoHyoSaE4J2D$m#k-%ZZbqIy16W>>NsRaRKq>Nn%2mA4N}GHo zS&~5p_BRB0gLvqnKgLeZEaAL6MyW~NO-wXW>HT}$9R;>F_(X;Hwix(`K44VU6uGgq)-`PQ}uxCHh;*W^4hfrIvR#8i8^R$QChY?D^BKfrm$krQ9>Ht}{R4=-d_LhD0#b#VrvnED;M{RhG99XVQ&miVPh%Mi6fv_W69~g-7 z=@qKYjDJftDuo(FBi@=y!177ChGc~yQ;Bf$X;ZTZNV-dlx5UFu3rz3uS)ZbDlbTpR zCffZlyEXZkZSB+&i7%npHb4>ZWOJ zoX#}jiE*^w`ZHiGJPb<0wXqX)aWPK{o8ug`{N)y9mr+n{1;!Mv@*F_!s04#$9gXjC z8m_ENs8)+2T zaZ|rCd?&F@SdR(SaXnsj3^MD^vQ)LDDN>XY4yMChB1}+*HWdcckW#Qhlc7l#Ao+tG zV2MT8bBV3+;}$TN$V|N145*!giSC_98^T;|2yTl}?K2>j@f4)WKjdMdw^9%LVa!~J z*?ElZ7JCozk+-OG;V7P$Qi4+EK)ZvxWZe1r#E7LWh8t*!ym;)%INEuvElw6vZJOm- z2D)LB3is#HKb7+hi| zOy=NHsNgsSKdHgibP$m7u5te=hMh@Q*p;_&p5N@cFeO zS1w&_18)xL>3)$&;Nn;(V|S03rebPivUQ}PEV_b~XUk!6YmD7u$A)ys*-=gSXAm#4 z&LUici|5i@UTJsRIer8Yr_zYl5C1Jt}E1W?L~!6xTUDLoyj_b z=1e-332d3Yyx$^TNndN(WzWXY>e&rF$D6aB0H$`4!_v!o$en397PQzYd3u|LT-(MS z@mzNqc+(;W8n7Jq1}Z{9#E_OI6zgjMfTSy}>^0L{M5xbFvMi%SoWi_wVwXEl_N4{M zPfDs@V)i9DvvI7;H1m9G6K$-N(!t`Kt;8VK4Hj`oul}9 zN|cv!c2Q{N7yGD5O^ZtzlAr*+wH7-=kC0glcy9AF>_;TGfKx@ll>@bj>v(49RTl5Y zF3+vGNnFi6H)U-Tmec|WR#Qmn4Ger6U5D$ml>%tm*un-`+0wHguLiH7BZNtihoJwET94Uqy4bV zvtJ?TVy@U7@NIXaP>Fk^0B@!+Hly$>UV}>IqA# z1e*(!ZGJF^0Y`89`PZ=1+_$^d`wk?KLEA!pQ5tAkLzP7BGbcM_)FpXp`^}8M=PDR( zj_DsvF~sUsbXs0uCjS6s!U6mVhMa{^=zS&}MU9k$@dSQQ%VUU<+ykZ}ZkDz{A6Dyy z1Hc_@JU$TzFERLxpBk~#_-W-OofU9;_y7aEw>Sy38g_^jOQ$0D%OOD<>~N=4AG z5=q;}EIcm58pYKA00ZQ4Qy$SM<2i<*Xt4vsF$p? WyEM3`ivKjMxZ%wghE`(?GK z+pQJIz+Wpt@lAF4`(MVe zE(;E&xB9fTBrD)9Zxy*XcOGSqJnCG9-_a_SRe*>t6iidILVi$_a|n_anX^eets}8H zBO{NLsOufGf!;p}Ce8R(JUL`615bwN5Z@@yvm{CjtEr5_Z z0c(7rzY+Bm@u6``s*|PQ);96bS+H|v5QcRc#c+{n8#0d+7*b~%8_qr9HRH@TG{Zvg zHaUnMY1Z9LT<|$`$gbjX+9`6S#I;i&VU^uEPE~`U1ZaB3u}GkCCbt0UB5X~j_qjsH zp^nXsq2c27EpO3z(!%btOPX#%Y)H~8vTjLFtV(AdN`;qAS=~n#8nJRTwQSYLj%5HX<3D9EjlX zUlg>2dlR-p=(w@dF!3HSNyNs{V~Nos)I!C?Q?hzA79qAcY)hL*P?mHQkl>Dqx;V2< zWQJsiQ#o#6vrfg$9lo^R;$x`k z^a7N7ejR;2EZ^{s9kb^@v;?owm6sFx$Mc608~t;;Aqh;53goUCr$#_7yH1pfdSZiU$7c7~F@DgOZ3Nr^bQjZcw9IF)_%e$k7v z0eIblo(|EN@*kX0alFe6Jc}u9F-(btDgOX;4o@qJJq_bQ!*U^IA}3-~?D&`{bp!K< za`GF8GwAM+;8O|ojJ{rFlu?3mMY*s-fIgxbQ*q=wr7@buycee8)G04Ag~|67a64gO*V@F0hfZ!c8Xr!~ zF0dD&7leuu)qFC|K_x0kP&VWQ7~({p z3oGM^9gk<}DpQg|<6iE$eilxjlw4!t)8;{z3L)+!!4(WNqKUb85pTDU<@wqtMruT7 z7KA#1L4^r6`Wq9)VZCE+(ksDCn*+I@n1dDLWg{iVcC`r+3 zby^F+bnVMd9~eNR|JJPK2)Pz&=CO_(Hd<^LQaH`DAT;6@eb99f2^Mc*_U49zP2tTV zEJjRWw!*D=Ye>5=j4sl3CJiBC?*Q;(XNe9ix^sNRp*fVC$p+q8h=jCu$D&uU7ARb@ z=Dm?CEt_%@>v_nv$sPNAH;!x;Gt%OVLUge1 z!|i27Gn(l8WyK5lX<{K(a)dt;_`KdbrmCFOvKeET9RWQQ1+RMoOd?LjBrx>GQW4&U z=yJ`c+d$Yy7_`k*ASY7p67p7}+k)vAIv%O`M?h}pClxYD%x&upF=*v1o~95uk2JL%j*-Kr<106W zv!_id&DIihI$GqLgS-a~wkFiwtVknbHw0`%DKm`^9d2pfEXlbvKs6~QlB<9MoM{5e z)LP^XdYvIdVk-z@>6%lCn3Z#u@>5{D1EKOF1A>lo6;4%Ma%y41w;Uiiqo!*OE(V(j z=o)TLA<=yx1I#}twReW_956QFr?|DUqLM)YLqa_a05^DwpEUkrTvM0U>Nh_#31bWECTvrMBv(^-8jpoZDg ze-5|KZeTA`P|KD*Q?1|u&cRi4Q<$G>z$RG%DYxAy%$*@f1SLki^qwY?Ybh+Qp5oMP zp;2)p3;5dRIs^9WNOE3f%h@5IN&Ii}5zrXiCs$own>vLZ61L`2d_~Rw04PYY_6cr! zPnG)Z1zVzk3jN|1AW+gPUrb9WE*#IxoUR`fgQC7Z9x$u3l|)X)xJ7apqE>Axy`OK$*7NX~C6lu-l`|s2khjKNwsXiJ{cP=@QC&pbskl01yxF zhY;M2dV?9K+;KfyMZN^bP7zg)y zXoB*1#f)UMGh&JRYA<4-k>0+-;xzd3DHL;tk;10Qm(Zr3*5bq+LGm#r3;~94+>H?` zRMEGvzRcv6uXfhbu2XTiP$XGb0{dto#_SfuU&3w_Pe@b}rse}p%)XkAiM_e*Exum& z()##=v`CDpF%&Fhn)b@AHKMYgWs(U!d4Z|LHDlyR3hQeD=My6D@5n`c{KqSUIO0%O zrf_`QY0EZdW*AY|Gn~~GB#T>Aj;7JcY%U~Z?UJXb)l;5A%B2@7{Hjnzxh~5%hScAU zh#_O9vB_-~yuUGbxgU4{M7I$e2WF_VUxhV)#u1zNzES-LA^ZMJmlAwOPYiI58O1V8 z0W`~R($J7!xR0XZy-ZRqrCMz{Q87+!&v{`nkgoq3EWXa(lRb+C5!*@5_&jX%+TLjM4EOIbWED~<5=J-V|W@pClV zdJ|Ac`pE~}LW*4O*=lV>0I__j(D=kZ8AsH2MUmpMM4#c*`Zg$g-X}{F3<5x zIf3;AUh$Wc+`2?@?8%EMovV>foT;`xo1s0MoIUj?DM18)o25YN4eWK^CE}BY-Neai zDq9WlHh;3#GON-ikR~Z=oOzkq7c8coXsnP*NLap72qRxO(O_y^{d~wX*mSttz@{*h zGWh2OElZ&~u;P${LgZb&>6ca3;rpNd`qRSJB^ z(bLZW0-ZwB&X#dx0dw72c0OlVB}*qq8$*sZ;D@*o?qnC5!t4ky6z_?YyY#m7fHolhw(CHB}>_bd5f@ZkKRGgqQcGzOCF*Nhw>Mz_00^r`)*u=$-$k#-u#8_Vf zaHR>5sH>Xt6J<0xiZ&XOs}e8N-&k@un-btPYf~5a|?#>-0Kf2qfV$hGLf8J#@=a7I-J^#&TEoyds|36Bbvp`t|*vw znuQ*Hwad-QVK*i0wGv&(_;e_A_XyJGLBB{#$6lhfSh3?SE^7zBCJSZ9Di~FnHj*wo z&Z^nAI{;0zzSj}R!&j&`LRNNP5aNa&QfVs!W=cX>sJNShBA}$W2kY9!CfR&UI_SwPEc-}X0?eLb+mWFt%Fg<#+{|ASlc+DA7Q1- z%}dKIXaG2%@gOV`kWwrSfR4w8U3UkNVWq1z%w;a|lw8!)>{J{|oaZPNGLxbW)BwG= z8tV?M3Gza9u{}iM9wnmHW|)+onUsE5Ogvax%D`=;1%w>LgK=?vd|>bs+KzaPoY+GX zNcO|S^E4XENn*0YVOpoXaxRC_V30Q#0O}3lD+)(-*u>CyFOO-AB0$Tbe3s^=`N}A| z+L*9i_39EVtL7ds`o=e?2QnOTfBES`9jn!dYrL+#L5Hd zV+>Fymzt$arOrPx6mt{~T9lL(Yp@zvkUSvM-|uQWWO%~3Z4FTBt|$UiOqEhkhcS7K zB}Z?O%N*Q5*V0%>A!^E8uP}nI0HzRb9@6r8sk5pFKG-(&v>Y&2d3NBrJx~MU-?Sx~rY-cuI|PJ7Ttbw8D5zS6qcgh{ICN21?Y? z9l+?iR0>gZm~DRxb&h@5Sn*UiD}*sqZ&vB^Udt&w&~jl76`>9!caC%gCi;ycEr4?d1=Q&Z0_rCE9c|VUmA_CsG(J97>2gA$SD$s( z97OO!J=>~XVYCC6e8k??)67Eo92;I8aMu!IHr%Vr%NHDw9P7Dy5nkeAfZS|Let(BCg72;lqGFvQLDthE>t^3Rivr1 zH1dg>a%MU505Qn!^m%)9mjg z7T(5-ZA0~Pn}O@r7o;#L}3)M;~*wK;T41*Es?xHQYGvIN|DjN#aOP1 zN1J@Gw75Q%bAxp8GDDf>X!jUnn9W?n4z;+Vzl zmL-^OUAHosfPevZ+oej#6hZSb*EG2tYQ}#GcBTGHF6>IDFSI!@l$Cp`alTrBId;pS z2W|I*#qtxNdAMgl#r>e$&S=wxoDMlDeaeOiWR#SfaTnBb>Q2&uP^x02GX>2Qjs} z!8F^TM3(J`jNZl7DQqa+^2-D|`ns12K?HbM9)=pL*j$+2;CX4+@r499wHI3pNl`kK zB#r$y^9%i*jVT7omqAsK3ew)XCg#uPg zdVd6|vI6e3msR4S{?iq?9-?Gb2<|dhoZ#G)y!A3!u2Nq@Urtaviqm@&5!xNGx8nvb zlHy$@O;6KQ#QGZxm3S*Xi5YkZPMXAwaG|L?670~KUK*O4d9as+s3h9PS3DUwHLu~6|jBM5v3q-;*?ps*i${TEd7&O_-9FD}QRqJS0#>)Ad#hxM# zLAc?wJesB|K+^RS^n-4ibSuNB;1GEN>ulj0s1UOA;dDA~(4g!81_ z>WPNC?UA#7<(91Yx>$25DZ* zkc23bl#AIugQvnC(?bqcM{d$wTb{tvO-srP8HUs|0xz$2!r<@Y9FiP?H~S}W^~@cG z8RiQ-{{Ysn#FcB~6**_U7MSC;j9+c~kffQ%7B!fpw9wxk0tJI|HSRTjOPGHn8UoWa`+h)UbiN~2nwJ|a)axA5> zFSy$&O!flJP=@7ZTPRAhm1Ix{Du5dINE>*=lY0%rnbGWF##wpnDK}53JQws+;1#Om zE?s9RHn!T>jZLDmUx=`d$Zfd5nQj>@jDY}tKruUd2me2 z237_-;oXl111NL2Me2mK%e?tOq?R2flfapt)lyP)orw)pQqi|t>SJqO+M(0J=egG&dp(# ztFpCPQbSVeB{L$*0HMHAq?FrGFMk-H1i6sp$de&hM+|Xf!e!NV6sKBA8Ulrbl=X(M zM1rjnZ;KQu%qu5J#1e$6PI)rzOaZc8Wnh4HxwzD51^nVZN4WG+BXQ>xY1lTgT9%w_ zl}{!{Wt9urE;f{?9R~gfNRJiBb@ep3S&U?-B`bAF(8}C(!s}r{DmPL{7Sl^as3D0Q zP7q>>C2tSRNmbO4WoFjuGZUB)a|IxeOAt4XD4aU2b>IPkFRK&V$MUt<579(N5?uW6yV=_ZEQ@}G+{9E)j z{{Z6o$CEM%*%d;iodlI)CDZa{hrc!2gu`xiY%LY_bkV`{hZ5FGd z{VYg`Pw^sp*s2aP&Ph94np}dy<%^`Yv2Y4W(|vw$;IulOmuRzz#PW|ND@a0tBzP0P zkr#^o~L_ha~ZF9a&%AeXsPZa_Ljt)TAN&@6-#1X z!C-)J!=pY(uidWqAhrTqN9RO~!&F zIM=A+c1AANd`ywY)kM2YxRy##8w3$x00A~2TH8YtW2m(39YjYH_-iFB;04eE8&TXZ zDYdrng-0gm9CjPPzUa;3lV#4ZE*}{jgm1sEF&Co z<(w&kY1L^wrR;$@2)?!%hN(XTXvXB>bv^kS7-pn&J3evFkJ^TlHA$O76Ex#1ZRUv4 zX(L4r>OdpP6AW4%p-y^=`r;-4cN9@-6e)pvwi|IpqJ8HiiPKx!$k2^cZ5j-6AW0SV zCZO_5ZVg6}AZczpdn;B zaC;KDN}XP2lybD^MYQ0%YZktQTdl^?10-yHGEYh{1{BD_Gjme!Y;Tin}wxTrl zw8d$nQ57J9IrCl6KUb_-aCltheGwlvO(?3RaawuqVZ!d0TJ;xz~38oXF_ z6?4m^mzYnDm_xNJpr+zUcAK3d$#|sZ2gE5UPv;Vp9xc$*l9?6wv)KNz!71jeG=&+; zdu|1#Xs{_w_9HPnc|@4z)$t;{R5jRNj8%>f;s+}fg{(HE-PU$Xi6-SLN`d@DDo(*{ zNo)(+8xBk3BU+VYGc8eICSj5ZbHyXpSR78`pyX`%~>AHPgip2n_nbpe)f|kxwyp{{<1^U|B>m07VM7Ls4cAcBV zH1jJufF|-}T93VbkJ;-I7Hx!hV}IF6#iti7N&f%{3_zDsL`$HSIp@QJ?h*6WAhodi z=1~`GDzW-yrgJL!? z+nohi(Be)VOmN>6E|lRYJko@#$ej-6Cg5L-;zr8$qp8FkFI2&kPDxb3%n}rp8(B$K zsZg;x5f%)H&tZz2Mo&8($4+LR0{!m-M%ws!Ly>z4PQ(@`sx5?+TPWHg@eZO$#k)BC zKH|+whckZBAp4CQ>JqC0JmQ9M)VD4pEj){P?BD&+gEs4OHPsa%RsqEuk@7@S<=~U# zPKJKvo#TulPUCG2ZL+YmIE=|s2?TW(Af)NMMu!ij*!z`~b56nv!kD>OUlFLyNj{|| zg*a|dPr6b;DhHv|U#wnZ*%gySoZ|lgV!28!2{lOtDM5v$WD-rAKKAO;B||m3A>_qK zWU%%PdVuo}qgK*I$BGVwZ{T8Yh?=4fnjT)s6;)ySwPOzFDNbcApCGM8hx=lmiC4Kl z3nS0>L->6;Ci4^S49HRd%r?4oJ$mmD@kp9iXACAoRVjSm;ZymRm8~dQxa!zKL-1?B7aseS$)QcS<&Ki4+ z<&MQSQB^aESjf%PWztqH&;xk7i?XroayX+dYVES~W4)Hk1INeX3X&1bN6F*biO9s` z&NzXUBRM9?8Ud~L8b>S>qQLl5*=k>k^wmyEua!8;kmG6^->=>sVh()X88Z|$7d6BD zHnq^(lAQrgC6JSSbpp{rEZgi^#v30x9j`EO!8P}smlkbHH@22L#l|d};zP*|EbeeW zvwZ&m7?77+e1^(Gh#P=^tUm};vS{WC7Fbpe{^#8?Q2@^lV!vAF{WBH$IQry29v=CR zB-dg33S?ewh8yN7r3CkN3buqC+D9Sn26kLBDuWR4RhQVGl~Z9eQmIiIYuq~Z@Qb+Q zvJ{{}XHex8;)QfECz#(MO)WSbvWDP;@`SNO;^RdUUa3N(R@*=dafG(&fYhnG4NqMn z4nf$Gw*Yo-q45%s%cZ8u)Y3^&PUMdpi$xY*A>(w((8Z|{*NOd%Di~p9`b(=yMxh|y z-yHD5<6_4j4$#L)V|-D<_c=8LIO_n|+=KDzVc!sML2CVuxQN~-Y-Lr#@28mfZZ?Rs z$-d)?8x4PHl9p;Dc(_HpqT_+;Le4OgxJ{~)MMQMoH1NQhDy5KY+s9RY5X=YV98qN_ z>lr5KQhdR`<)kMj1o^L-*ko&wJ$Qe_+&9IU6u3)mDOL_L;!2VgZAFLz-UMkC8F*I@ zHQcesl}JeAzRr})L<*_vLu%;Xyo2aUuAj;vJSmdaLK@ewrDKFMAzkz&8>FRHBhf&Z zZQ`w%wLYknTpsOTFxg8L5@uV_ca4^xj$4?8n}bhuOU1=>Wa*;fN^Ur3nNNx( z1A9e2Ts6$KhFjzVvP+aP1;&YLR%t#jtR;#xO3FIN0NF~)ga-qsSODrszF9Yb<5q9a z*8Pb|3fWtF$8}JJ8#A*v&#{hK+M}q>kfb4sT78rVR-(q^#9AldBIQ1RyH4S`c5y4o zl}JJqvaF+PldNnpyGYMuTau@ipceNdSSrYTC-E$$CcL_v`H z8mpH#BiYWwf-fgl!KI%do`>F9$G!3ksn?HbDX zgHUFglXWJw+m7Rq27m<^m&0Sn3(NSh@VJV$sF;lG8%I!Oi#GU5XBE!pzOWl zv~tWZNr|Rb(b-8O<|1AfOk*KLouhE+!}WAJ1+u^R-rtCgmML0A21QJloFts*%Ov=u zeBwzRj`lP@(}$*$;78{jOLM&nL=Al#iknc=>;C|J6}Y=Tf^d?=?Fqr+$NC~T(bRnQ z_M2z^Hd?ye-{%WLBu_5Kj^w8!^?*;ySdW*G>`OVqE)s-~0~Iq{lcC6rTvD9+FBeHY z_lZIDFv~;9i@rV0^C^o!*+|#mA?!Xo5 z7L%wt7<_0_(lM;<5avSFr-H0uxnoimrqL;QaoTcjo>RJB!qK9bm8xQJ}Pxg(V>Pi0YdM5eGX$NjCsP zs$*^k3T}gtbCt zu&wgEvH2J*2I6hS&Mi(jr7deEN>Yu{mASkJ4$Px=B0E54nP=J6rp5+z z#hWxGia-;1NU%dh#~7fBl`7siEb=9}W&k^~sLC$@9WT-gKqrt{dA?PdT8KeV>!9|3~VX665S>_ZJ2Sq3C zB-?ODNLbqy+)l&t^y!AH6v1kBN57C;>K{6-q6Uc<)gx159TFk)^O9B%bZ##l02>_O zL;z|`)0Rb!WFIg@0CX19*nB52%vOtx+S&txS?Px+4|w0>95{B7JVG+%7Pj_|0FbOT zn#&p#kU{XYaiA^NvxgL=c$rA{R~-tTmS|;BP|V|CSc7s&T7N4Tqs@y?=tzu(#wwgc zQY!!+bF8=k^tc8f4w>+EWiutIgqyZyLT)x7Y59obKr6USSWMkUt#5TmY>V{?Ku!K& z$4)dU=Za??mvK9=;7R?G6hDL{=%;FZGjdMJtyxObYwd74e&|wX2IGY^en_ZDyh&4f zC(Wg*T!PI&}+7gE&0O6M?PgR|Cf+rsi zH{uh^NFe+~DI8*Mw;(GO6gYw3_BXQl+zh%xI{c2DDg?8SQfaLaTXdnIrEH|~&TIJ_ zfIct-BtleWn|0-AR#ETEg4Y&15!UehpWn#@e*Hv$7aXcqDO1xmCY)v0DeC98;#4m%+L&!l z>$!0yH&*1rvVRZXacFLMOs{0(1meHJ(Pxj!o?)!t#qwX89fx1OhkJ|FiR@!XO!T^( z`Z1!3hS|C9E>R3J<-qQX1%;;C+UH2@xd~#+g*nxQ1E5{UDA@;@T;XhfaG1MEc?aLr zl6VgeO<^i2mw4uVnOeF*7rn&3MED!oIzcD@0Ji>Om+$!zE3`@-!t^mpq%>Dbm=Y7O zyas%;iIPg!Wv99{QBua>i=CklmHd4ZIWFIPhbp5}`ezeMzDXu_a$aPU)oYZKDn6v# z!?@KizQHGKj9sFJTxVM!^7{V(=Mi#q`7g*){aJ3kjssIzbRpy=#@A1$rD#wDDLkcu z2s$5(W;nU&e=^q;Z3zx4a86m)&Ks#+GA}5uiBLApD(bcNR~#d_f^=jJ$9H=|aOZ1u zc6iZPO;Km?E-8|v)f+9$u`uImBoG#rwxoq7_P9PVVJzB}jK&mSH3FjAaH1xjT3c`E zp7NAH0_@mapFJXyO4&U!vi|_Ny;M}LI9mu-R^F6*GH;@aZEZTl)PyI@-|cV18Gg}> zOyayg&^3xv?@Lu=kO6VV*;z_nN)if`Y&TK&eInC`$)WGaZzOecBCloM&=2rtc(&?H z%_3-W=Oq>jla%P95J*m8=NHl6^ztC5M83p)DWl+bCZ;6TAHevjj!Vua%KAEJ9PB!x z21b(GhSxVKNl=b8zn|aH{%1ySv*%%H%H?)t7?B|~i6lAol)VR3Q(f~niilL{y-EuZ zN`L^NgAiH>K?uDnB|zvUAWZ?K_Yy#w)X+hCx6!+FX`)mC0Tq=d@_fPPegEIR_gnX_ zby@3VmznwPnb{|E60-N6U93eGK2IOkJyDKA+F) zN^fvJ+wR14-g`XkjxD;05w#dw;*-s%H~IbO&kbR~3D@SlVqBoBCyuv#d*AN4aUVZU z6?dx@2qemX`Q@Bl)6?DcGR`1t$SPKbxk7@A-QLaYabBkD&PDWS`)e!G@O9)lb$i3a ziTj{{VXXyF2%Fnd^CP*XuK>Jh&ZBa z7jmPYhA^}0<&&5Y2Rl067yH`oIwb|F@k%K^%~)uiV;j zS6orIK>irfNV2!REJ@E=!2hs3Vu+0WuD`IrHYKLpXFpD>cF;ClrLW?=AMwf>pT-@8 zEo}Y(;kj9EZko}qZkx1xhiN1D5u_9pXNueR>xHG#^t_$$#1WK$cLO?)llSBuoi@GL z-9j}g%5@)o!!kP&=t}VeeUFF_{AEeJ#X^So+g8T6<8za=a6e5fi+{S+=}eTs2IR_U zEWw?3??+{B?#R$=+T1k>aNRtJp<>I=%*%RaUE9C>5p|L`4z8t$!tb3)68lV~MtUUX zU}4MaK=N7QXV=bDweNQRcB%Dbdxqp#$o9+nP%%!cm)#r=VdBV29ea7%9fMyg{v$as zw+bngUKN?01#Iqj(Jy92_2=&%e_2qtB15Sk z_P}Hz4G|6O#tu7mbR`JNPPxdj8vK;`sl5szvf*B!F;SWtq6o#*EYiQwnkrC z*&kY?$nvzDIqpsoWOSbTFVNolr7*}F$8*@6!8lS?bg(*yv!jZtwE>U`xe)l@K%Z*< z9&*tuo!g)VONn+z*Kptfnw{iGW{0EdbK{IpYO7Ghm3j=F8)+%CQEsUyw#1FrH;%oG z6+@s^ApWS>6SDMnv2XFDSXO9_wx6zU5`--0$2pSu>=f$jKB;pr41z+#HQ)}1uvS1K|lxXaLVYqIEWvxZ%;DgI^+%$=`FILr&hU&V;dzu|BwwSzSH79iuRoI()* z9$AjD$TVN^kfcKnbF1ISlp5Xx`6gL;spY!9qiK9{U%tBgwQXLGdAUUtljz)kGUqj} zU-F|NTE0|K&;GF~DuTalrbS4M004QJloX-gkC9|Tr%zjTh{TVTZsr~a$MHI&o4vLy z)IrFWaNSg-$C|8QKYKrlP2OIhYJfz}roSo_VUlS@Cj-e!2U}P-$p^J^JHZG~1$C^F zUPju`y=W0fy92FyGmiCM32@|R86o&OYD8CrV<&LQ?W>qL88rc;Bp@J5KIo(>6x^;K}bDF$c6q-seuFh;+2TD&`W znQZ=Hv--Kn8~Ph@S0S3@mQ#&|AZO)YJhsBWHC*f4BPXZF96WtYkY&>1pf%P+DR-NE zi;Kj$POd2qm_p)t)RlL1auo#?hmZW^9TV2)9+W+4n2y=F$*7{=BS3*cdW>Ao0}lHW zpf!PYntQYG9~0`9g>b%S!t|SH^5JwX z7i86^`ff%{LZpdfKue?`XMJ1Wj8TWsCe!?Lsg+!Bi>2|c7Zq{s=30SaA@4u=iau6^ zkHGcE4So8fG64#aa0IQF|Jwl58g!1p9)E^CL2T7*zR2r;W1VH#klntXGL-**;3UW_GVKZDz8tS+euulB{o zu~P~CdBo196g&q=JC<14K3%%W^z3Fbl7qRA?)l7(T%j)7@_rYc4v9{!g+EbR#u8_x z?Y~f`WLXz27_yFk2=sa2jOh%M6_jUREf1+>ev0lHW`|m68`+cco(dDPV5O4{*X*SR(cxdX%Ru7M&QeVR+LjfmLQkbVAE_yi*gVJM^Rt0iTSVtH?UTLwZCQ9{- zJUs*3f?PU!EPE}~@3<4HFMHp_FJrhv%jJ>AJk9rz<(p9dObWtiK65X0Qktw`I~}Ih zw(u%z3Mz@29H9lU^uVWc;AOuN1-f5f{y;zSqBfYwuQsCIU^-9#RE5B2&z)LZ4)!45 z@_zm&SHSYcy9H+!9rgR!XcYGi)bc13yDL?i$W7jD4ez(fAu0j`bpH^n^WW!NueGfk zUC<3XdOS{+s0=Rbl-@mG=Jv56lZ*SvPoaM+rOA`G(~m#(H@(5^(;C0ywu?wTfk$O4 zP!T10Kj6)~$jsANHp&snlJ&JRV<+R`k4qQzM>qTDl{mroxDmomroRD>R`5lXrOu-3 z-8f0U#=Z@I|70c;Hlui8WjLj~ut|EO2&xy(Lzl#ZC7_E8Cpb=A39tod+Td69C(VrKu|6~+3Y8))?ES?u zZuL)6mdvbOo`&2iOS4xJ$Ccj7WwVijk~qD- z;a1+NjxBhFT7>NF8>bujeXcM^RXb$cTeYt7)3xmB`cf|-ddSmdhYR$dvjyYR9yXVD zqrzxTgbG_Af>%cGt<6u7ghsn*cIR466!uwmf$~;z0hRs3%-cIAJs8Qk+U;qd4+)L6 zS)zT-KaFV*Yky!Z`EAhV008ePU-4{URF=i_~GS#Q#hD%lQW7e$A(l_p!ksaZG^iAEeg;#gs6K%C|luCu6vLTCinq*twE(@r` zi#hAJm=A#w>~CanWM;FHqMw5*kVSPj7E_5!SVyZ0pnWlcdB{OyvS0;J)q^r-`Z`CnsT?=17rODwvCq7$?O35Vnv$!Kr7Q5^q6Izm379q=%NE(9UL(6 zo+M~94(&=NVw$a@(s0)2^m@i+57c(0e9T;BOY0LZ=0#LTjfEk6&|u;U)a0*#HWm>y0+`{_(`|ZLPpqr0N&fT zpsS`1y?J_868f3};*1h46|O2=xFxvUSAIQs0U3qPS3bSLlMZfwTEiD`5M4{?#|;IF zV{wp;j+tbW8j~#3$9qEQ&zNogOqy;>ib;z1U~}RO42k$v{Z`x>)e~)z zW@1r?NS0;aG$ar_FB$YO(><9`nl+9f>gLQvKSx7Y;>U-(>iLvp{ju!FWk95y^P5d#0Sy%=-q)xC z0aSm8D=a}2|66!V*Ya}iiFeYdsK zZJeetp!QLW=^Oso^5@%SlvLc)JBmV^Il+^~g;vJehGXN1Vv$MNvAXv7vJGXY2ckM*^^*!lK0Ke6z4b}4e#mvy3aznlt+>^QU$+*=2 z&OG5lY$qQyEkLM4vH$Zoe0Bz8PZZ?0V?(PbO%dd)6Q9RSDDP{2uha|2xlL?Z|BOtF zgr8XI*hph1a2QnVCFVt25+kbS9p^bd<1#zel`W!}8PF-ufv69SXcTmkPHGqEzZYdhhH;4>l zAEC}sH0jH8r4^a;ZdWu5?yw^eD}|WzZM(;EQsW+N+xv)c@T>K52K5A2(MXK$^o*cjsibPe%*FmAAz z9i)c1B?pdrip$L352Y-z{Fs_>q^9!zlKSD(%!<@yFQM-saN`kH#Et#N7niW-oA*4T z@xe4ez#50h@^fJhx!-U3ZJz~I)EJ)@--zR~VB)p4v3ua=zUj~-rJOcg{PU2x_dqNf zkSQw;Qy8VtdA86F8ky z<7vn@h-~aj66)uVXWi?AUrS*bQOFjyUvchRl=>5)a#Bac(zZVkkrtSQd>IzN@SoI+ExvK{Wcv1Zve zqJzUbro2f+TY$1K=0+mg7L;$DqDs^jpfZEA_P2nZcih|p(4%s;T=ASh5Uam8%}t=- z)}oPE8xUDRq-geDPXD2Da2o|680eS-ep(?ZA=3OSI1LdYQN;DY6ozNlMVpoLK2lbmRB#7S31yKSS95_YJCMj!hY9kXrrRkvqTa0ptl z&h)IJ%EB;9deDEgq$4b8ulduq#>`DOMMC`M?Wx4-felo(&%LPhP>;Szovs@qS^=4M zA52=>Vm4jM-WO+8S*rLozPPcU&rx68S&n6c?~V3Uk81v$E7Lf8XE5G&=W2N#AZO)R z=-)=t$1Ty)&%?KPhbCSN07u>RBWUYRwaf3pA7QtmX!q?XEOr70hd(_ydcst;x)|Y8 zL=vb)wi_VG+j7^Uo}TZC?D>s=hRcv&sCOG-{qFlm8*$R2)Qr8?4 zR*IFy>C)S@GKzzS^vNW~%V8LT;~Pk0g_ZITc1B6Xm6PYm;-@NSZ{ppTcW3K;*XFoI zm#-`fu4pv}t^nUaa=r(S!rVoK;OC76V$-@GngUJa5p_yck<0*rffaB5RBD9B1N)CL z1tlPzg4ag@4q-)3PA>1v6-MI_r@(y~RWY9N{i!)tpIMe@*e@dH)Tp!~;hU!e3>#yl z&5BexCRA0*!BE3RD^ru#F1NuF*t{!ogLQ+;ft^ASrv)ocBpDl|nwLgw$$I9jsnQVu?yu#?^FU6M*^7`<-@UOA0wdt%kQIRS+Xo-;$6uL+#mVD zh|)=x2`Go|3(bbeCL;D81u-h=Q`HocNiZpR;)2Y&Q%cn{aDQ&dCY@5G&r8YXGInNg zAtT37cW;*A*JU-7Yh&m#QHuD@p`64lr`ky6>C z^{!7Vj^zg!J{*ux@m;Inz=S_i*@H=}_&ZVMv(o3B93#`u>!H-~-WR(mB$hlL1;|aO z%}tL)?P>M=C@s1T#W{Z*41+`OXVScwWF6_NqUw{1Q#kWjmV1S5Rd%MqP;h~lpQodjc{jgD#^5fy7QWs# zvOpktPd6tm8+XK)bYr>#Y*-w@VV{#nYRTs8WRNHP5p!iIOLm7x?Ghc>8NaZ60uuQq z*)%i~dizMoNqw{?ZRnVZ=2Fqg3QtIdAZL9Iu@JMx!jpUyk6(yfSg7g< zDc~LY)#&jhy!;U#|FXuip}#rRX`1>(1tb~?1W&l*D$HI{qs+=)vj7jKRf|LxDU2L9MZ?9ZUMoK~CpQ2aFW zd`P3o_(b!$01W%_@cyQox== za2s*C7PrVD?5<&nY(@$Nba!r^MC9SHxFJ%${=BdPnq%*H>o|!GHi78dhkW94k#SKe zU{b#CrfK)Gp9GjgW1FCclKELYca1=0*V&=#Mxx$ivX%!d)OqqmY+B3#Ci;28pY#V( zS@xteMdqD_hhcPv`sFC$bZO*gxW!{QZB$)WFNZ=DH-UCB+3Q}A_xJwW`SMozItL%j z-i#SiR(T|MnzWy2SZz+0o4wy z82ZzAGxkl6Ad@A3^qm@IiMzTl!sOn4?k`DjmuGiq*`yHr0KGp79Fxif?V?SW<=(Q3 z&y7Z>@@TV)J4?=D1FX}bRWD!ck*w{X!As;^ENz&s5z!pUhCCbqZUJ zy+UgAP0Fq0dH9c{!3~SiM*0LK!u5Z$`j3gJwNAH^{@5lzcYgt}fiaN<86 zZY*$n7Y};jI9yM3gf7kgOe*4lzU`$$vAS0Eum=VE68~jO_%<0(>7K#58(n6w`&g2q zM1>j|gn)aS@6GBRN?wq8dAlNKg3Kpb=7LQb%DB#~1&j^8A}<63w>K ziloC^`NgU++j?UMjAMwK12&J!DtTmI{-|sg)|t?kZuOo8|4v`OM8Ty7?$3 zZo(oxU?UlE0Jefr;tjV&gBNirmQn>~Cl4dhVMuOqd+*(C9&Lea7J?=zV#I`*iSW0q zBH1ikz6T=;(Fa=x814lymekj#4p#I|T{6Zw2=>|XA-ZFkb=2b>^KOuPL34xx z>&RZM0}VR}7Vns6kc9EHnXj>~0~C`3g>5a1BJy%Ca(zGSELfWbnx|w9Dtv%%C0A%j z94ea{udzMKd44%w2h{POBB09pY?b}aZeFe7Uj26gpG)!03-da&y^CquGnWgql>H}b zhvda)I?$j^oPViX5YgAClY9B*KiCS%eCvhK?Y9;Ik`uB&Kj)YA)PrNZxFx5y;;VQ+O)%3ma9gZ+ITEDEbayVZ&xE)(XHc zNG2z`U8Z3U*TtVwQNbnWDl#J_jt~>6wX2Fgez)>k3UtpOdxv1n_;lhtH~5 zm73t-v?6=Q;tCsj4Qw39oKkI+4oBu)sQuKF4B^>gX2ev|Xb&!H4Cgma9!4!)+>7yq zZ!GI*^z?k!T}vm})_q?cufHHWXKsGT+#|Z$cAz!JwyO64gm;gLMQOMAAx5}V=p@%K z5?Fr~1tTXPt#8MtYvgEX>sjaz95y^j3+{Yl(WqT+;&e;EKlQR1petgB3sW~PDNzp~ z;_OoQDZhHHhFnbkkRuuRkY#N6UDSlGiIk2$q}5tsb`#XTpNX>6k7QV-vCB{EmM2#A zICeg%Z;K(!lZnyTB zX)(AcWLAwVj7Smx;eE0Q2h<*4G3t!aKwN1tY@86f$mbbSJ=ohbYJa)b_|ZezA#L#L zO1+h`4rsiAfrMqHWbe`4&UuI;w}zJrSs3!%Jq;Mu$}OS z$ZpXSpL)~e?eM4jHwtX2l_8!1m8;wsOd85lE}!awP!Wzx_^iRL;YiK-IZoj zhZYlc|FR}JERWJb5kSH37smE|(?!Bc@6@Mg^q9}_3t@)nH6*faY9=ON)Z?`e2?ANz zMD;`=gWk#FN@Zampc{am2L}12*JPrmEzN&28pqVxxBWB=&s#95#Ej^QF6(Z#jGkudeYTvbRV` z$Ayq1PUm~Q&NM6(?022Kzq$zT-0^9rmDs?}zTIM^sZk)f@#s^?0)h1xJC71wxlf{8 zhlFgQ4alIL2tqIz(09C-bxyJxa+?@3i6=^%g8VDP580rHt*U-7P~OvS3hV! zj|>{nvJOd?Y<~J@>WGhz-gwKA%^@p?pn(xLXX+WiMhS^7WmAM`ykhy}99UswpS4n4 za`=0nD4h6$^pX1DiePWZov8++5!a&Mvmim<%uFU2NqPNaNDP*kn7Kup(>AS=96(E6 zVT4kwM3vCzK-F6r!gW(}Aju;w!h<2?KBzt2r{vY#b2z^x->q%8RvMsITFi=z6W3thS+#`rYOY+9rNfD9`ef5s+k(qB& zM!$petc@m8<17f<-kOdHyq|?uKq)6JUxhXHS6UmP5CvMiXjo@V^!u{&^O_qA; z2ePgS6;Y&|TUPHh&BiIbOfwKtMy5p2Hstg%08ye(Ykx3Fq2pW{HW`A^O)lD?~v z9~>ZuW%TS}+xiWQ^BWqptaQg~dBCdg(x#eabR_a4DR zuX$x9JuT~jRPnX}vgOb&Cz?-`ax?Ixv$PK#KN74#Q~eWbZ(d$d-c64B_=6V{MAqLX zLc*lauRq}uru$-&pLVA%xq{L;Ap?Ij=Ad2iSs!bsYJ>>gmi3s?k#Xgo|Ag`Er1ZUH zqv90E_?NlY@qE;DKJYn9%xqHT?S9Bz$h6ZSONu0tC({mX(fZO}Gtp2^jxqvO74Ky8 zlZ0qRKX0Ghn2!8j(dBxT-XX=>NIh|NE6j8t-SXjOy1gkd?K5oz)@{+}m#vNJjM0wx z`cVd(&g&6IDd_2+NmvwOX5WJnjHn4y)By4M>hp`sbr0pNQEUR8sGPS1*`c2BRf0_0 zr70bV3b*BVHkMWjY^6^}t94fGYu!Sqt8Ug8>}f>%qnt=aemd$!OZAxhguI*4Pvc+Y zSmc_W)A*4an-~v}*C=>Ntdv{HM2%V7Fe2VZ!e|gQH?AiJ(S4#bs<8a|R8y8U!&S4LlBz7XY~$8F zW9PEie+W{YY3S;sL=bPzG@0s_#nP9DMgGi?-v?=_X$?u>4|x;S%q9alT7PlK80a*H zeOt4+!S_Y4+cAYwm0GB?sV=Efx3Xnk?n4Z(MQBuk$qCF{ zPPl{IBdP*%ud;vLvRA2xfAuwCtca=d{n|CG4i@tQRCqMSGj{y?7RiHJKz1u5D+Gao z1z12;i&W+(`U?|&bJ4{WiSKQVTozoLqX6eHj1lG7w8-tcNC4{;Ls8lT-FjGizI-&| z2P4166#-IT6VrN4Y^aKIDBubp3+6X>e$9GOnHIEX!Wbux7M+$Qe4Y#B9G zH#E+v%)|O^Mm|Mg!>o;jVq2J{yg;6t9<;z?S5-9sTD{#PpWQ|C2-EhPv>LF)!~eQ- zR`4=EKhJtuZ<&n>@=5nMPNA^%y^9P+(bVjOa6?m@P~o82v+~#!sd*G-zW5}=TkRV! zzZOP%J{@tyr1L%g`Jdo;6?`^1cVWA-Cl;7rNN`%}^D44Y1?ZkX`^??tZS?teRZdhD zikzFyQ+%7$vwxocbMyFW9o3ze}@H+^1tv7vShmT?`ca6C?*7-9jxP+rrluIn6ZZ&6Ze9F67wYN@Z zd=S5>Ii!1H+B>%+PnzM?ljk%iVq3KK=>qyajkbwNV($||a|@;MOKc=_3}mw<_^iMq zr(Fjbec`Gas%k7#-T#pO8+MRGqh+;h^R=c4mnaC~DlF7h*U2yB9!z8B8=EP)cQ9e> zM+Z}eT*$9iAE_@ma$ z%V~$Y*6;0;LT52n*(^2*R6+qD++3rPOweN^ptn%ZkSKnAg_qm%;LgT0qtER}Z!|Vv zamXxDr6?=HOkUQC2-9MsM`pW2_O|IIR9TOt(so5=YWhjMZFrWjPR4!9bt{SeHAqhf zonjc{-U_$B6@$DbrfvoY)Y{6Rny2t_pE-Hqgfvy4dEnwIJjPltz511M+XlkZ-V**`yzV=Zfuf+J<#mseIG^@r?nnZGA2iFBI*Ge*Y)yLAXjwM9I8|xW~`V1d{d_ zJ7yKP?1Hp#M~V|-<`MIgbFkY zn*42`;*RF4Jr5Z5ypOJts#09Xs?--gxTP;ix2Nmh6ED5>n zlEZM{Wr2>nJJMA`Iuq6EPPQgbVphf(VE3%ctkDbKv-3)(Md)IZ86UIi$D3eE%G8>i zXn%Q9+a6WS^#xbjkY8H#cB!&2p1d;5e122P$c5FKh$3-G=k=tR1Vl53IxwQ2tm|jS zGiRDRUcm-;oC>Douw^0fOkELN{L3Jo_~B&KI=vmULLFPj$#K&A*&%3~mhbE`QTOScJJ@>w`nK_7y#gy=LStn#1<8-KtK6^a~ zUU{V5dnZ{Txy;W{5_QI`yHQRrW12_Te9*uF64(-ht$m`op_(tYx$uhD-;ms=?$O98 zs@(XVOiM8UTBVhJ)*qU+`xrE$x>%n(;Xto+F-4v_?R|eJu;e6#cQz8#R;rc0Nk!*9 z-tgRVnV%iK8>qf?X=@`51|>FTmfq@%I298%Lv$RddAXv&~eW4Bol4$ z4-!>2s|w+G2D3;T?+6{Fr!!Vwq<>0bq-K^V^_R_UTG6s+P@Bi6M$#Z*!-(XV$ZfKY z`v}r@t@Pts#D$GI=Dy-eKE`B9$B$p;-7$Uuw4~Ce!R|E3w!O}`7BC#uo7&KO-#iM~ zPJFL6+dEY@sU2Y4COnXAm;1U6#t1&P9?#@n9=tL%%F8M0ZBvO}u8!lFK$dT`pU^z5%Zv-KgqbH}%VG_rRXo-{Kvr5`RK{oZg{~;jx zuF*fBtm`oWGA#c+&>NLnpZv(H)x)!F!#FNxrpPPwqR+P%e-7(R2wgyRr4Pp=W@CyV z7&l<1NWc63UHj6w-l9W#$#;f4-8Soxoh|v*)8vUDo~)!WN2J|lDfcF zEmYxb5aX`ENEycIfQYjcac<^K9Duc!pX(_Wd5%~uex{G>svTgp)3SYR(=R5lKtzbF z38D>*>xbHnd&WpLdy4x}z89$49XE)HW8150Oe}1XbWM5FvRV^R`Q>dC|e= zr6kx-Q&~37lB$Z5OZ*v}d)Ho^mNTX?3ES$hlP_o{sFL?0eAL`s@NY<0w8ePBlZVN^zuU3`T+nRlp!NSpv+Xz z^JDnmPaDqvNx!Kh>+37yqww2s`c#PkUio{vHN%=@$ z96e|~{L%U_`nNDpqbufD20rz&oQCvqK2x`yzSo#pMF5wzFw{#d%_=27&@Yy#YS4Fy zh~DSLux2s~T7%<-5r_Wd)*Sxmn+NK#Bz?UC=*4LKL8%9g7s4f!wJd^L8vYveLcimh zN77#iLN6Sz>`6EW%J0iMcc!4rAdi0tUzVn88v!X=FMIjjKost<`9l?rt=4)H zX$~KRRYjnFR^*z!pMXV&KX-Xcc||2tOWX8j9II!v2Dex|cm{{-8jA^e%e`0=ocI=J&Z>)FDPrTZyE=#ALT z7Sk6lqd&0W*?Gdc3Dt0n8_#OVYjWx5vy|y`$wUTv7T^gMU(Q@HjZer<=7p(3)iJuf2->Q_ zCwT5A`SG(f4dnDk$q7Jh#RGtSi%G&hV#V2%zlULW!VQSUy?v-O1N1OP4_($K1)tUk z(*uK=eHEjG&-S%9nHn|wxSDYb>xGmoY}d>Dz2N4>vvT z;1p@gpTbR$rZ2|TJi<;c|XNeN!>F9^?McH{=*Szdq zDJA8kxFxu+Yf4JuP$O{-Q~=rm1w~lE#f`*`eeFE`yzP8Zo(@6c#zEdFacy5Oe{U6) z|1B;3zopfDG3s7{R$xhx1oz(;h?Eq*Dkq75wGmf$N1+_A>DPVN7ewZoQBDf~Y9kKy z^2DG#F@D^Vax!>Cq&U>q%ln#J0?%`OL1d)=a^qiZ{?!7{3i->5KsloA{$F_wuGPnI zOM>O)|8gTyeqR2*4k*8Cd%fJfe2u*A98iCa$Lj_87gI$=Tr&`(ZG^GIT$8kou1OHN zzW~}slGl9ys;O-R#zV`MEK6iK{I|28DA zrT?b|#ska#PfLnhO5!iDxUuo|__EhCg@-WyEA+R4AJV|r%fSeRu@X1X&=NOB1!8Q( z&F|T}q8zRj(el7gh1|bGYkA<+kdpjYQ@kM3>)JYQ32`HgufGH4UqAVA%iw1n?eYIH zk$>+413PDwxB(jFfP#5CdErNbd1|2i(9WLts)m}*UYCFS!2fAq)BZaKo&j<#hv$J@V_)N3%So$<>)H8X5MGXGCp60O zKPE_Dldo0%FVuB;E&d<1{`Ozn{cW77)MZi*`nP+PVM#_vE!z*Pgo`{@R-B;jh)XRt<0Y|9AuM!M`g0 z*F)FzYjv+@1#iM%zU%sR|9|BF_Wjr7>;CI8{=@&5@49_`{l|QKf^zZynrZ^mF!s{( zau;d`%T#H3{8@E-*KPaM2|K@!(WOGtn1i;zy1EkcqcDkkH2$+u*3MG z1NG2;*U>}5>i>x$CIkLgb$PrCZ2p6QpWOcnTu+&t{D1n*(2f|F|DpU2F5Hrm((-uJ|2(a@pJiJ!q=&p|L zzfFM{%<=-$k?cg??(HK2$wpQ$OFFp7@0ake4IVE9w7(AvgT~EuqpA^&?Qc9xTM?9n zIYCZxQkOHVJr;7icJF-*yk!Dk222Ic2CbaW*v0a!2M?EWEk_re3K7y0hEZMQdtT7} zWBMhL{GgBI?Gs;2_fh4xzxD(CCVp;~Ect+Eb00Ipyc938`|Am!8s%`$`ktR{w#~j1 zJE55Q!;4gXQRXFG^Lk}c`AnL{^R(vo_90h6{%t20@7Bv#=Uv(r70#QqPfnfHhNjuU z)Fd~~%PuL7-p=%!ZHxBxK9sjtIkBeldS6h#d+YT>0X1jvtrl^DUk~H}WED@@ac8cq z%0-?mzdniuKi%84PbBqEqOBt1myBSc*Rg++cwcu5%nkL8<7E9p#RbK5#~t-~uzZMi zX@!Ql_t~%<_9?c+Phoz@EQ_zh8!TgX9UiiU9<29tequdY2WpuaJmI;?zZrY+%t&Ly zSYj++Eu74+;maVn{$9hTD^D{QMMS5t2sTx)LA!$q{G~B9n(UP__a@Xqg#Mcha}a3&Q?Ar;;~Hg%-0ag%PXyPQU)s zq1V(T`Ov_kZQY5}dtuQR@q){~^`XCXRdU>|aO$~jVIpF6n#c1-qlF&KoJ-K;? z8G$K-X@q|O140KZ#8{vA7EE-*Puos$Q|WnL`Ufu&4Rz&40RG z=%dYazbk8ZjtRRX)Qz<>XCa>R5G@AfC^b1Xx3V-D%i{g2%HZ`;b(|6XwpOfzr~USt zp63AeWGjm&In`~4J;b*l{U1bY(UZrKRw4&8;g2GhS8v-z*yJ8l6PI)qlU)Ta3X`Wq zPoNngGS-ZTrBq(G^JjUz7j|(GlOPPffGsKn4lyi7zC$yrNS#>4P?sC%d)%|R^-?}C zU=g=cg4#W3fSZ~Aek0R+huTVWy|H0$?9Ft;c4aH6MsjW6oMoWVTG%4{qfX$&Q9Ru0 zk@u$X(Fq$Pqu@$gJb5=ejnX}9WdKV%RruUfl|p$$VhQbt zcQaR(0`p~7SVijtY2`Pz-%T~5`hPwsZDzd3c2ke0ZcuVK+kVrvr^NVE9(xxc(6gtB zWze@d{ew4(%FG|S(r2P3hoxg28GKw%I4wNNHDsG`bf3vfDHXL2d3i^!dRIZi(Bhi} zw3D@F-oOc7HIgFym`7Fk8|q%l)_oHdYSj)kLHxHE)X(rPyScFTUCQ#(1WDcp-}d&F z0wWci)q0HnJUY6)Cd%=%;md8pU$cxI~gf{Q4By*l4c4A+JuMneNhTVGY|2Mp4#?;XbRxjrh7)iM)X-W8V z(>^YcnKA!iTE#^akzv5w7+V*<3yzB;vCA;F_jo(MHQ`NEooUQmK>4D6r+H}(iF=qB zuGjt zP3G3)^|bpIRlM>hsZSSUVz85XclVd6+>_?^#?OOg9d-o7zYuL33I<1qo zZQHhO+qP}nw(UG=+qP|;bmv#~M|4CDs=K;7dQ_7=diV5s_I}rW-Aj)qZ;o4=t}V}v zZr<6$tqp1(L-g?O(%0?dACS!G-B$J{h6GhuCwy;mL1VzsWBsi}KBS~fws>esR@L~k z{f?0!$x>LZ@tV+f8hJWg9h&%Y2B&G0TR%sp9BR_Ow{vVQS^vlS=L3mi7y1Qk-Fz1o zdqRC$zAe1~zo$K~1lyVk8FK(DU_9t82q`jU$Xx~pc~jXo>4jdX0`iW}twdx=CDJ0p z`&y3e&A_!|@4D|*x8OUu&)J)>2X5%sIg~XP4=oYNH&l*|8eA0@^M-J}{UZcbl+V9W zBlLndQ}BBqZQkFq5VCEf(O!zmj=yO=nF+Z>w{LPs-QYuAzS^k1Hak&xQ(ouq>JvZL zf7AG~Ul&3EW8vS}#=PoEpND8yW(aW8WppBg{nw!;ybd-l--i2pW;dREPTJB1^&L}d zje93hR~zyKK-}tYy7|~3+mFCY<4+f5{S09PTxSiq(WHCloyIgAM(npUIgFLbj99|j zuhy^!^kE&iOQDl6q%;x?914l8&w;l2RV!Dg&uNtQ71PJl?;a_;Tt#-L(Z0Z1Bg$y8 zKn&$TUz*kU*<9rM$_T-?uuYjPM>w2_d>a|C@%6s4SK zAbZ!(kRg&pAwS``5J4{@h6#$Ji4PhUm}n-S?MQAdIGRq*73)L!_b**5_B%{_@*s%p zVHUDnoZ{=VE5>#x*OO_N=IzU5*U&YtTfonaJX$p0;I*4GuBhAQvR{6O5K$;8PT{#} zmrlRk2klgjStc(J3-j1%t!p;(-Kh`-qJy@k8kg*KWsWmN^=I$K*Ya}gs@taIGQphF zzTpSaacmc#!cDPM{pF|41kNeUD3my|dLmw>n>I6m7l^Iy5nZj@!zsATjS}=>uNm0% z2EjvLKIAEcrcstal2?hM3qEMZUOKydoWcoYV&>@H8l*dW`Ki4&Xp@rHlb|xiD01Ni zUl!m1hcn-ltkJP9NEy1g|I)F&9`T7OYbK}w9c{_>It%7BS&~$jHNx9VQkPG^#VL@d zm#mZS)PIEus~9j%NNw?gqlsqBLpOsClyu%q?@$`r@nhZGPr zNsN5n+z+2ms}e$jC5)LEM7iWAI77aoYX&g$i|#96{!kz6b~csm7gcGhDtEmOf=*+s z(^&j^+u8}^W%JwDN0sc_WOyZ$f=u1%K-XzaA~=v++q3NpuVfXn?%Iq^(ZsfQtZ+fwW^t%cCeFAM=xi=mm&RX_qvv zkwE#y0}Yb=!66Tb_Wb~RMRt92S9+(-f-sp52H545eW6b~tUaSUz=ZwkR*bb%qS}ru zJ8F6Yc7HbxoIf&xWVYd}T#-pk@kaCxd0BOopz(*6xkQ;YhN|QS+M?Ro%B9 z7u%z^LRFL3j(4eNDUca!_IKn;UBp0W=ub$apA^yF$lRGVI8Q$AZ{!ZrjFlZkg4P^hqSHtgpyS0K+;(TkL7q z+PrrWjn;W!K;78#v94)VEMry%Cb&Dig}+pxD`xWYJvfHtwtPb~gIOJCgZt1jW396@ zbOMZ?@QG4#_iTyE85w?iP%{ymG9viuh{9aqb?2V@1E2GiCS<*($%VqKV#Ta z$7eT)YzZELIb%W+BoibhUFlj^Ca$^4i=3;7tmc{nu&~l!*+0=>HgGeRae^?wkKVm7 zc#qq(d~-bUPq_Vw+OlJ$4q?ylf;^eSSD>km zOXeHtOOw%A@=Od~6XzLJcIKE|9$eO8LM*mOjwrK=bW=gY*i(ib_->aE23&sS5VDz0 zzC+$ll15;()Y8U^z8YyqoTPXY*Kvy63>(MN=7%i7o+Yl8Es6O=LGTSSErohb4> z2vU>d)G+j?V2cuiv~78KxI=mM*&yZ;G@Lkz*ll5oLzYJz_p(;ex3Nipj=Q`!?m#_d zkciGXv~#E|CHwYF%kqgzP4T{(%}F3Aj+JQaph_wmrhvItyZte|n}wNyTnqIw_qL-U zd##wU#F6~QOj%gR-YW>Ix0vW-chxmJY$KN~S*`W06Eh@Tf3jm1$enXC3 zoS}gFX;KDC5OrwJRoBsf z?ceIRj`>F$Pi(()HJG;fVodiecp@rHkEU-4>1nwnu`4?&=$e+-V+L(zWUp+zF3&KV_k#vHf^dW%$m{*rJj9AO%q$wIS12a$y*+l|Cz<< zTlKxgg-2d}W*%SNiqpM+y0&QY*@%aW zs#Mq?=b_DL_5$$%d}yBuBo%I?PQ~6Tmd@&mtF^5iJ6b%uadlL|hP^(lgtae)jPU@g z2my>Ap5~lM;a87mCsBNV@QI}j8-9kYhNXxoO*^vn_F~AEuC=w>Q(9xC2pD5Oa<-^O zmVlN&x)VDgqs7ei!$#(070wV8*T&x{5lO`K7oW+ZUqniui59+e?08e9=~cB-r0q@Q zyWmR@pdchS!c94S^s9O6Wc%8bmgq|1MQ&*blQzCW~oVKaY zKw#W6M-;Rhzvo~_(qJ*6eWApt^2;8(wtQb6;c#$(MnU(3SCu`xYVZt#Lq5?^8X8kl zTbyf)p%yv_&+FeeZ>w6#P`r$F`COsWAr3xH$IOjC7{&#{v77~jUlnS6Pm3~X3RdfS3 zf;NVX6w>?8~<*#cV^hmc2C2m;=1EfIQ{Ip zG`k0+>ak1AIs8>hEUEy<2=*Xlw`9D42d%Po;J^gTO(4VdnsJrfc0Sef&b!v_ioh?KICu;-nP?A*$F)eJo`O@Q9tcQ_ z9Cds(lcdVG|}!f8V7VvJ50a^(u!P0&f7EmDEL;iGClB;;(gQL znQkoh%LP!~DlpPIqAq1}ENyy*A$G)ZX?||E&7!g(WX)m=gndZ{o;wa+hAur1_1uE1 zvzR$z{q}}tX_ECD)S@Dds)J)U?A0gr(svRX#lp;7L<>nglEYGxS6g;&Vq2-}GC&e? zm?AcU*q6DxAI~cEZcR;+5`Z*!QN?(y7oK*hN|wGrB=95)A^f+{D9AGU$5_uSCz<2&8Y|o z$_M0LI=csu$z#XkM?0QJ#sMmXG<;O*`HAkFsX7tCQxSD!4`sYiPt!tc=X8xF5ow^=LINn&Xy6BRNa<{s_j$oCXLJpH- zyi)mTO5%^%xxfa|EZ9CL(4#4&$;n?Gh{Nik0F4DF14oN#*;8AWC5+rC=IHE>pYQwX z6`HLMiejZjr+pkGSMi2gF}MKzpAeJFj1N~QgtS#`K6Y^1p_!2s44-FJ5;+G+NMI)P zsJbD-0-qd&eCnZeA|j|T62X#_FPiD)G* zoJHs1)OBQ!>yAqZT~J#k-_fP@DfS!D{#Yy`TzFF|>B7_mk|ZpbGNFqqbf}pR?}xa| zT!erfm;SU-!&rf*%0%oY1q1hxT=Z(BW?#S?NOIn2rxrBfq?^7 z3qCiLQO3Xlp|Ip?qEOP4bh07Q4u%1W8Vf2~Q6gj$sT+#DPR_0bM^P|Pr^ln6hBYq= z=MB7rnh#%#9IovS28JWe*hT0nj88&LHk!?yio>tS?@<=Z{SjfWwin_{1mJu3eCJIq z-AzPf2PNZ8P4P$az^CB5D5U&=%~o;CFZD~r(AMkLuc3E8*8PW1?^NZPJyY!hg;{Re zxSRgB)%FZ_G13OE4YcBVOdn(lUaqMBcXKlUvELs}eZrt!|H8&b> zRWDK|caVf<7qF8`g3YQ6+fcI#XGoj(8mbY*>oa*b2f=(st60!QN)JW0BxUkFUa0sW z?!fo!pT6Kep~w^0QVyhVW2aaS=UBz3u1lQzYEZ_J0n~@I(st9j@x!EZbEoS>Y*wVW zb13574Et*fH@Ym{N1D(fsr)c@Le6QwIuQ6$vQ3*dJJMw;R+IKxO<(%T+9rIW&tniusX86M`;1yA?L8dcM9vZc}@nbkt$9#~7>D9lL83`X)TK zO}=r8pZGfoy|Q32sb^yHf9X~pZ}mRpJ=@)Z;D<9geW4X7r8Ks94|Sl7@?^K`{4LS` zZ@tsKHh!x^AZ1Toy4(E1d#raqRk)x2Aa5rWWb3XUpjD<0Y$B-~?i)ZlL(8i7`@OMa z;|^1SxKgCV2nkRf@DWVo(z!vAREE3*RseJgJ~4JBChiR>t#{H)-MQb1>^l@RQ8|@z`S#!Yv^l{L&GaXiTGgBsO;@0m+b*T4K*|B2jk2LVGYJ5;`ngiynTT(?&KB5 z4NTqBA!<9viu+-07z5H8UqwjH$pg$1gt3_+dQ!lw#4(s93FFZLW-i>%_>%9}k?dc~(7x(!Rl(1YxgM&g+{2_D} z8^Wuq_6zxXMMt6%auxe%AxjihKv$Tvl4}*Z#B54pqOjN8t|>o8WC9CCJVvLY9fv3fH(ono`QXJT5YL(3*|vSeem*s3q@wHsqA3A<3& zI;B&6yryd*7i!_fU$dQW+FARH3*ozG`KySV1-P6SQ8#RzEpB0wr)h(J<7(_!d4Y1V z9v5UG+7e1HP(@zVC=JeL&)v9e*Udhx(!`Yqnz(M+d^e7cE!{LT@%JEvxc_=0IY-tX zlxE?b?L|j4{NlSw7QH`QVxC$o&|o_KH4&`?4h_3HLd27*pw;4ML%~5RGI7*r%EO;W z4jj7S^%)iCK;pvuU`(SD+X?Y&zlR-L&djP}Evu9ZMJd5uiN=k^kx3+B*q(5JDieXHc7t6_c3%`!SlEYi;AWS8uj>Ocy03 zb#e!C)ZylkBW=(WPxFb}cdGuRjA9nS4_7->Ee*#DZ3_i7c3sNBpLNHO?Q%$bl- z-@7V$s^gp}`6!2n(jrdY6PBr!bd+;;1Ira)qBn1qcIMyQ(g@-VyGMg}l1WU;#D)5M z+rkK2Z9_`ZTMiBzo3F3*sb2^l8EswHyhxmBneDo*n8je9m~Mx~H9^js3adz(Zq_f(4yBvU6F|jzjpKXjgtXhjJBUo$fm6KRWBP@BhS{viHop_sW4SC2m$Y4Mp>%`Qz4VQpKQcpnm+o3 z#nW-Own3PiX!MogAU zDBdHzRnUy!qrt;&hc5G>NhJh1q_{sZhmPeA3!LsZP9e7j*TTw*A3dVm0$6*Oi9WTC zF9cSSZ3$XwNik&INL3>12gm@9Iw>S?Hb$WvQ=fWf4VPp;t$;Glj$VETte^Zcq*unk{syci_6HQ0L zQ%v^Qenvgp%g79c2p?FF>QDBO=H-SzM(L+lVfs5&mtp$3k4g-1q_rV$6MOxBcAeNW zRiulah11BMi>KAqgT5{MCb&Cs(p5cMHrzI}JxP8ijQicU4l^P#sfY;VS55)wDz%tv zw|QhGw@*fDBafhqHkN57v(M0KKDG|DaTiYZJQhJi!){-DJDmzST362@E$%Bucrlod z&|T#nz02Ldtt^C?6UlrDx~E&k6c;i;HB6RuX}BW_Wi_$^?Cme=q6vB5b^VQNC|TLk zD<7ZV6=;7D&HYci>iqAAKVc*8&y=H;E}AOp!%j5M;6j1LNw}(0tIZsZ#`_>!IAB*j z%Wy2L{I^`>CMso?a5EkrssL=`6pK^7m6_7p7e#0CZ+G_ilzRdc6PzX!N)_ z4C1dcNGyga`&&}O(?R0&Rzzu#%ZF+8@)GXvqKzL39HSR*7%DjvLQOcM5r>oH&ksVX zv1REoWWFi+C#u3Z)*1pfdmAy-c>Y*0-b0+W810}S zRup8*9L~8P)#-h!) z-*aYmm2@GFxtLQm%Zgz^zh`@MuV0W;$u{7>UMYlJsyD#G%R~{I~y06!%K^qP|I?j%cdOIM{Gn`a(O(|ibawj4mJTPd`sGgW+Xuvf; z6zI^fp7v5Nf-+z}ZgHlSOyr?WeH>l3l>Ock9)n%2>vB4K0~oQqGqXi`cE_St-*>hm zT8dZ>g=^*Er%TrH7y;D!_kW`g;jt951F{&s-Pjd4q`M#`%Dno${mSmEt!Av*VhVALZ*FrXly!PLz7(aT9S z<`*eD1Xdsx%xzq6@9 z0gnMV3W?G~c;a?FmDxb7JC(z}0afw$sq0Z+b2ea}zb<~06;+5@fLtl(lRQyXPPsr+ zkZSREqp&ceeO7weWiv83&PtfbdZ^AzwNx2QT}YT%Ahqso3u?$_t7pw>1shzliYyTl zLCJR$?5E61i1)Yz6}nfjNQ(dFk>OfXLunA=clbYRapMW_FY|*KKA3<8UwJ zVpqO{Z^i?YTTW#$ks+6&+p?7H!}{L>?B#{ZVNYR*344Jd1h1u=2YPYFy4rOsy8vkg zJYelFbKBSR9Jm;(Ex>5UgPmh+f9m}isXJBq3sj1e4Qc))SqE};urBVk(N zJ-Q(B?^y4wbeS>SnMZ6r%jGhDRG$6Ncg!D_>0n_xW$F``N!_nQ=a)aVHYklYDu~09 zlXFvH_$9j5UxitqYG+CmmI1;Zr3wX7wxlitJLtX92}m+`;#5rYm`tx+kPsn7B%~T$ zBb3{PqHPy0w7xihM#|W65|LAcNd(LdDK;ejrpMTG7`I~!zV&e(NWhqIab7vacSC&= z^YJ^fgqclm{W-up-Mlus57Mq#iNa0`KY|Y^kqk+v!E9KITGMqtirq8TDSYG%IP4c-=T*n`s@ncw+fEb)S4D1e@jI z#_PBvTh+TG%)JaRmqC&29>tg^nZOfEC~Cg2V%giwLuD}gN-3K*6fj*`p<2@w;7YUl zc6(&>?XxW>P%UxGlfg|mFD`jhTUs=MVCjoKB@FrEA&9ly-rj@1=od@Iw)kf&ms~{* zazQ;xys6y=BnqZ?fb72MoCrbNhu9F62U1PSW{Vs~k!2*2gm;mJB3qMy1sc zh-ZmHqTpPBjxm3vD;S7Lf;cF6Q~S))o+m^bLr%0-Cv}L)qmOf?!YNPXZa%$aDIseN#z?gMhh&w^ob8gtT%dtA(|bd~!E z+{tI}U(~R&4|=t-kwHm`)b%$y71d$5LN3g7=@4+@xlWD8zARebXnu0vcwd{nF<5F3 zDAb6X-#!IyfP8<$jo%ErK#tM*j6F1Z$PNKNWoHs37i7R%x`UT7-#XZIr=whYbZYos z;{rlk<0cFHDAm~LmtNSb4zZ})s3tW=jWg>W#T+%0ciHqFU)iHNkx($Bs!j7ga#>d7 zlEe||d$p~jg@345u*R%aEOHB=}KT|iv-4YjC1&`X;!yTvxZHx(%?WDOJ!TisX^)2HfzV$Ex%x> zkB_spll6YbU0RqC<1^Mm4tSKQ&Dz-*ndVIP(?f$_QdJ19lhqqg+yiRtAPH%qAJjG+ z@TIUjIAd6cQ=dK?{`Da~aD$zmsF&(xU>u{EuumCADl1oYZj4rpEqQwmunfUM)Ao;- zvRk@jnbdu8T3Cp$x=pmq>r5CUoNE-eGySHRnBd#8hgOrO=Sv);+F&Lvv;U?-F`il? zT<$~?qzCUUu#>Mh8Z?lvp*I521c?5TvTt^H&Vxj{un*H1&peyLzKR~_MY(h^UapN? ziEfHz%aS;hy$Gr&fLPIJ-I*+n7p!c!P_0W@MmL6+(3c2d9ohWY$5yNooZ#kdgMx57 zVkF!bZhfm5z{w*lpl!<{Dr=|pv#0xW*{}0S8f3=n0%wSkGL8n9->1*Dhe*zH3A$*D z@veV@fc)(wPOBP4yqhI_W}x+sgx8^TL3%Q2SnuNoOQvmGf&XOtGR_xG*kNFm4sKLb zcePrX@;fo^{HN;eBS#yyLfE)uPLt5f{ABURM%2%!c3^K|8rMnr>mHbs5D_JukP_3s#d>2J5IqP2%BI z7e&3`-Z(b7Y^?@e^{L!t6pVHoyU1e!W;1+q7fjU@dBe9~j(fj1|5zFs+#RgXbWr!uzu%ue02azt811}q!u4;s)xy4-1llVA0Km`BfBOIi zK-`OT`cF{$e*`=KQ7`|`!Onj~$$x$O|0A&TU(DtI4%qqc1m}N)o&PD=VPgGnNaq*t z{DK|k|7M*26Py1(!Os5%I{*Iy9fto6bp8WD{$B!}|573UOWx!^{N-1_{7N%7NkKC00847MwuF?hH7cX6Vgo?)3TyxN^MwD zm&7HV-d@}A0eZseN)1mpcC>Xw5%26@*N1!dqZa*`oaVPz92A__{kom!&o?|Sy&cdE z#oc)yD&klh9&u{`1ovh|@)py2hK3-vKf8S9&ryr*NwLgOe*tTz;|Xd&PFhX8c2Wc7d)1-l zXL5iUq6HssBs@~-zj6eVVu*gkzJ*S_Ys&Z8;gFypo#onG1;H>&2PN5&o- zgiSS!{L3UhFdO*daY|g09{pN#XsB0SjwbJ2UkqY%leh@tbOp%-_>(>tkX{d-jo-`} zC2mB?u?>RH4B1_`B%x=4*fYUQTg{nvBsh`8S}N_Yo&r{qVyR59hS&m@Oumw?rFB3* z&tU*JNsK?d)Py;`IeAc#h27i-lx1@B?6f1SmfRQ`HQmAq`iuoZqbY zM+pH11i6B~R00H?w3u2VhoypsBNP6rqN4(*KK(Uf*|OO9%5iBA#Y!MS;|3k71yqwY z+iKRFy0~t8BTaA)R2?ej8%vQV0reDKKzkVyW0aULtliR7e*blE>S82IT0E{DT1d2# zGcOW9*kCoNPIGAU^9~8QU_%5oW7H#4Tb4508KXSN2roTd84N4Q0AQ18eH0uE8nmjW z-{Xu346T?I<1e^1vpR~30yBCf)v=5H4Ic}(wUF(30pj0vDU)-U+)5xeugO2TsF_?NvRUJvtsPirX0S#~By{81Nbtg`xScrI~IG+yavZ=~$*sxtv2 zPvq0s-dd@<=G$tHt!{b2>`wK#Fk7GOAa|~I8=pvj2FwR7CdX!-1DqCh zw8E|ivn(}G+DAlv3Mfw^8uO!r37W&J7V>sxH6y6@EQeL5z*`6>*E}1JXSC>AgKN;V zY%QJ*rPeeXP+|&ItuZ$7Ta`($hHi|khE z$vVQSX;nY!#YWP2GGqp&AT^V2G#h^bA{al5wy1_er0RcGKGwjI#}I z{h8Fo?}jmoUit8BS4*iYym`%$)07wRtnC9=-)u`kFAy_w#+-kZ7m`|)#l6(!CH zM2U;rrvEzp&c%+9KvU*v$mcEs7$5WF;U0OHwuvIAio+KnFwwy3CF5Jvee^M8mpBrf@m0reYhx(kFnpxrn3awb*Td-M7RneJP=@?sDz@d(2V5yI{fc+F!bV7AGZH!$CQ zVFy*o{MFeSs@gXE_AkA6?0Ng^6CwJTl_e4_OV1h8d(*o5N;h|goLkit1fhzpd69w0 z5hwUXfV>5)LJmoKnNu}s&zVcM1V8Q+ed~qKG zGi?52{ON#1(T-sWBYM7zN?gi4EngOy(B9PvJefDxrO&!h8n^XQ z<(5#l<{;}<8D7eM77 z9r{?X1a%4WkCTIRdRYJIgB{`sjcM$KMv$OU8aAyM&g*Bov%fp{UnP^2MN}=r{}rV?BPLgv$`2`>7j&uBxzLzGf_81Pz@Eu(2%7_! za{;zwPy8LTN6~%B4Ue~Dz3K99PQC_*NyVxKxxDxndo1L42n^VD{qYQFY> zXd1LPpd7@zKjGqxQe(>+?k(sRq6%fjDVqO%s_)hekE{aP-=HD*bE$Ax*q=c1D^IB@ zKYvh?0pVM(@jH?vDhU9ocTL;ZaXc^r#*4PZ?=f@u>;}jvy%f$LNqizUne_Daag7ctAQn86!v=>CS#`ia-q1s;;4QjICZj z7!dN7L!!C;-sDZAXWLyHh{#-Mt1Nx(a>X7|WV^W7mDGqiJ9K~8phBsgub+OBecb9S zdZ7RO=nHbofEIQlFI(H(Y{{%z+#A)UK%tx(BTqL}0yu<=h|_O?rlsGDSby!%b}n|1 zfEcROQ+OBw0TiwW&TRh7n>%WNBK_5f_bAzDqC=1FAHevmiU2qCiy*h)8gWrJ265%& zpf2Qn?7mCk3BUmcJC!!8-|q;}E-Tl6@L9(k96rE;J1=f_{%Y{dl93CK+aXlNO$rtH zn9qUsCAe?tnLwjGE(B(&$=-fl=A=^A8BFM8Dfpu9bkP1~>0B2D^#+Mud{%DSKN^5e zz&yrumc{*r`wefWs)fUbB;q^et(in^SaVt`Zb&4h4?Y|HP{dfNVv8=a#;RPu9h9Bo zbk%Ow+>?1=uO%=Wj`j~vsb1MfHki;HR(4TFlOhfje>6x2X~8FAxY&Rl;E%}a7Tn~| zyKY@@IJ)`v`dFJ;s?Z^(QM&W(?Q*7cr1yQQHg(%DPI%7S!_C?SCR4MeA@|>Qo)>G{ zF96~=FL$XMuq9Iy2#oa^aXLM;(M~BJTt;24FPCAO5hCYZ!hn-Y5m{cUankV9q$|_b zY&$=iNDhc5Bd*D{C}6DpH+MDexJWMf)f!~UKH}B@m(^iMj@~!e2S%d9^P}A~J8?O= z1a*lg#lqZHOUgs*l@x#%81(`%-tX{wL3}_2Xx*2ajKqF>cgj zJqh1dwA!`9oy*4Q3>UG{-~=T+PQ>^np`B@na7Lsrl_uKbc?cQ(>F9@V!ImYvu+yy3 z0Az9|5zQR&8B7^y5!c)fBCjxq1Z&}uB_+FOByQE2K@%zVacR)BOyj5N3RYe44qksn{;|dUI15qnWwI|1!(s{AMqA|~ zgrH|EJ_k=CjU*E;DO!O7Qg^RYlSe32Y2Z>bru3z%Db<^o3KDgD>7^hh=4U!pA=dmU zT|C14iJH)nni#Jk5k+U73xdIj4B&b>6`#xx0G*2Ps&A zzEiwQL~3HIU1WJzxP)=Rwtk`67yJ=DJ=>7M1QZp4%Y$t~vR7!DiF|TIvdX4&HqGiEyf)*6Gm#8Q$Y{-Qw({%zdc2rcJxjw<=Lo z_)0pnBDpv3Zcb=nGCw)e0j2gZW zIOLog_509vTldt)ym25-LXVxpuA;pEjFWe%lQU^Iane7YKXN8LdsnkGSYo$!*)f~b zhm7F_75HzZdLCtDkfATA^P@Vowtfq>38Pb#rC-WLX@s(Q7jd&(M=2CNw-MDdhEzvM zhIB}$vIX-S+9M}N(ABm-i&1cLEWuTkTiU<#I17!#EOc5|I!s8Jx?J1uG1j-%5>0EP z>M;{b$}Pp7E7%Rmm5f2R)X;9FMR}zLG^=+;#pG`eZ{NNKJ)c9J ze*lIbi5-|~!b+UqX+0w$rK^T(`eUe~XzZh*yEBiS^WaMQ`YtrTE&`49L{|^52yKj?EhGiF=Zby3o1%F+5L;#M*a;Ljl6{^-zn&gIRQ==K7YRCY zqrtzZyU_Leb=Ht60E~iSX+=d@o)swtEq;}HMuGfsF1aG~+i`4C)7^xqIU0svvqD+T9ZL6`Yl9yki*Uqhp zyU4Uu!?JV&G8!yG1k_;y-vix_&{<}{mQtSSB(FbR&mq zZFls0{^ro#j=8GFkAK>>k_5e_es*i(tvheQ365KqZis>vSC>|M;+R(_daAdOEu+rO z0Y(8T;BeO{0EhVzL}`=hWnoCG7UpMy;i+b=3(1P|j^8{E7rFG|9HcOGg)=69g{>(5-_SXHO*0MEQ*6iNJm8Uk(zz zs>N;H_IsxZ798N@^b+ZyN3_Ki?=GDYc>N{ZGiXrXI*s&Ti_<^11g#*=@T0cNIG%h6 zbIYjvB@!4j=Dti+$vKm$S94<{P8mPUuDZStelJlFpxC$-og9RLq6Kn6>0Q)6%UE*A zZ=#Wj5*yQ{NzH6FfOwW%`;al3$;imboYGdBX~^qk;~(EgAi01mz52v3^DE7l7ScX5 z>E&I9o3}J?clGJO6pQjMTh6VWKVoSwnicSnJZsE@FsMv`pr~5}!no{;dhApJ@-<+L zj^PZBD-cbL5KS(7u7#`MW@QVHyv)78Lbbq;(}4Z@v*#R_`UliH-Ig)+vvYRD&d)!e z@%Rk)=(3FtSuCY0iKhU4MiY zA6&j|6#f!yU#-zxziH05t5Q+-?P25>x<^J6n#cy>nzQ4&_#a4JhkRMSPZ;K;4(PCV zPR#&ad1!VJ7B6a%=X;&-^aPQC!<`W_(O$@dpKLkD0myMO1~24t5J4UjI*o*tk4DtG2pCNaX+Nu(b zsl|vjdXxsvP<_qCk}^g8TS{N%a2BRGrup(7^;Y+()sT|_$NTn=s5gV61Jv)lY6dug z-c3M6K8v_ZyUmVy$<%T6Z&vD{%I;vnB`Sq|Cb$=p7yKWCp0+OxmET;}Dk~lNH!Ex6G6+ z7}p;CuJwcCrn?Fa<-pi@$0WhRJ_*{Nt$r>yhAbRQhudjP{cachUZTPvL7A^a&yF4GPPl! zp6sAC&tn@g2+JIKc%)L3kj2&+^XeESY&lqG-QuC_lw*>{@Y{gcz+63+C0xh8*bBkp7;3;aOTC%7!rC%TPY=O?(ZsmFr81p= zIdBq9lddJ)h$HYO@ktex{}iRYkRDPKEgIx$>q5V;KSN$oVtfC-P`b|8*_VJmPRzcQ zZ(^n)!nO!@8cA`aE0}w4-9VjAiDgn%v8ZI0k^bw_v$cgXxoIf#EwYn_)|*qm*k>jk ze-6Wd#y1YAMqU+@-|keo!>9D1sVDeRiKqRw*M8qA_dV*{^4w};y#M+g=}`<2b-d*s z0SwGoGSui2RgO=eh&EtKV~fm4HE#2D`#NPGian8Ns43mGW~0y_D?ZyX^+pShCD(4n zZBXz=OrM9WV67;xbDtS^M3Q>{EG2?$m}~M4>Sgv_N#IDGEC#K?zUe`9RX+vRVzQ8B;_%us{`TN^Gi8^*a0o}050uDC# zC0jBNU-_w7Rvx7EnL;<0zF5j7Nl>tQDS5Ec(P*l_$buR=6y7_|%G#$Ly z1`uq&9(axP0tj1n^e`@I|3EeB)*@{N@=81%Udgtm|99g4#V_e2HImGA!{o4Bs{0|{ ztt_rox7Gd>le<6l<@4P{LZBj{DriZw^Qv_TAP(^lAq=g8A5e8#!IP`ApH%iW|6v6vM1@!5fQfE!6K39^+red&n2sh zY>&jQ@e|H@!f!hN9;k#z4e=}5l=RJ<&CAg361t$yy0YD^Cv#N;B0@I0p{A>Dw<_TgE_u_z#eenu1typFNl5(Vi}z z%Mejxo(4ML^Oigh6^V={-PE$3$AKw61u)Im3%uaz?(ksCXE~6$Yrx7RmZwaBBZ1^ary&x z@Pv}wIE(GppS~6V_maY>J?(6D(=JuQ5BB^xZ_&7HlFP0fjWEo*yvW(r853$?M?8Xz zO3IA;6t-{A`0trHBM`M;gb}JfOlE)&*~Wn-{nfN>+7KrT?*wooUpOpH0JQ%-gasK@ z!QI#b<>R8PK9(}&{569MhzATsGc6Ld3ZVneudWOzIh?;zk5bXHR2hHaG z6>Iz54Pvb$hsAi28wRX3o_2kP{GiQ)nC*-HAMVoIG8-zbP$S!u>S3uhfTu-o%@bf`0TIyblGVvraGS31)bi~Pl)1E_Sm?w%j? zH-}s)btUIl#A}6ZxJ=-RkA+0BO2u%~LgqcVlX;>_FSV+ZQl>T21R^=L1Rl=&EXod=U``;sJmtEvf*=5e+8h0cVdUp`EaCXuo8B<*zs_R$1kE;o&3=A?g}QM<4pvgW?)z zhIDr`4N<|{3{woqjAror*G%qRyIa0D3p~iD0{YURt*qF5Frp!6Xc(qdS$Zqo%hV+@ zQn-JiS1U-e20VNtC=Zbt=Kb7G8HO#CE^AqI`u^Jz$)_X>xmR-D)^{SO^a^clV;&F^ zy6}uX8WXHPNBC~)NZ5=pRK)3q>F*p}Kb>I=Du70Lw0t+uPGFem9ugItvCma?{l0B; z`F>c-fo*IZ6)cc5RXo0ct6UpHP>4W5Yc$Q}+ur~|V;o)nnj+^9>mOIo5XX`j#fk;R zjb9s$O7pQ5RFuW{y1@-y%=T8XT&dQcKbDF$$I7Q92aShhFC%pmM9V_7haYk79`j4W zP3OT{lygb2I2Fu>S*dT}b=MWOQCQyEo2Omgp@tG{bdFCRchGG9!t`0fF0MQw6uu5Z z0Kw$@^4IWgKYnCqeEL|&@cu;{!ig=8{ObK_jd}d+i?}Z)`vr~(Y1|TcJJ;0vH6&uG zlRD{IL6wqdE|b+#ihX{Vf{y*n$C$r&>&Q~>#FYKQaty`q2{Ejr21TVXgRlf$YuM$! zi=j6crJXTKkY=IDPV-84)N*l)(1ZND9dt8R*Wl#29b-U)V2t}NDrW~zj&((hP&6k$ zh5kc#aXF>_R^W0zVL0PQSq!e;a4(~T`rQ0u+4*2y@CTcscy+2GAevKhN@N{1q28&uUWc&eht`Tih*!MAX2`<8jQ3NS< z5+n|#*0B-e#Thy<8E=#7eP1&7b+2r498~isi>!@O_uI3DQ)MJwEk_alHfeUt9NVdQ zIQ+1kRr1YlEBtw|5hPHpsob2)C*MNyHJ0sF%Bfo8zdM} zaKC6{bMvwqyZ)XuYQY-ZvFMJv9A+1E1hO{Apdc5a>y`_aJO|vM@6MEbS^e&Tcj7+x zU?z{|-GlKX3%oFGVBud0`g48;|Dm}7W9@7#AtWNLbNr*hJMCn$op+8I7eI_7>OM{@ zx%-AtM~mTr_2j!J^=IeEFhEv$7f0veyBzZSyBq?&e|`6la)=S$S9rmUD3EqN!_-hY zPDh7E(H}vHh3MLt?{diUzsezFZrFo=fkQhAEa^niL;KUsePWvvLfUm{PFDL)h!^@Q z@KR=VipSR)$z$ko_?9!WRRY`Zs{^IxtG{SJstPZQyBOE(vvoN^k=18m&+6+n?X7Kt z&Y_Z%>r;lCgJ2?-4Ld0cjQEtv?y(04bWOMNiYJ}MezdeyTBRR1<3@& zL!LxPDgr6P$ItVy9YygSv7o4{q#K`cQaK?vjN@J0SKB@_jv{R%d=O?9&zL?^Q`Qof z+Mv2nLreHjlnc2beR>N5l+Ia)s>sP$g^hdk_^Fbw1y#E}+K{%Wteq@Vqa#eebGxmq z5ezB>ku&)POn3d+7`53r=b{;)I^qOaEJqYYUD=EfpK4Rtm0@2aZm z7RmCIW3^#Yh)DoK~`4~u5xZtW@b*N5Br22z1cX9BWSP9F*Ktf1%OYL|FT9P@bfhWUP%2SKTYut`UeS_vP z`%;^^@=E(X+)$jf<=pgJegLgB~_H;56H+YOSGzLyuuNM53yN0 ziWEJAcs+{*rQdhDT*J6v`mmG7y6?hFvf0m|=SJZxh3iQM60$d|*6Sa>XQx~R&pMq8 zm|(L0A7g7I{kmPVwIsD^VH>H2*5wFi3%g4^RQqLHQIfP>#{O3m%ctA3)2GX>>?SvT zQ=A!mc(Lro%tL}mpuJ%zX^u!$6CC9ShF;uajoak&PmPW&UoFax36M;KpXaf6=D48Y zp`=1lNTINyADMOoApTr;Gyt3}S4psri+5(Z5S9g6*N)6EP<*kih+#VrgdA}tVll_` z)Xz&Y6K^&GIWya6QgrDNkp6s{KF^E_RBA=&nk!B9n4=N!Qjz!@mI_eZP}(ZyG3)=tpTI>7>K8TTgMnHMT%EX zbj%PVCykN|C0|YBzhcl|GT|){c@o2B-+|K+w`cqxf`@&Yd}j+m$bShsoe@Jk6>pF` z`l6s=)W4;b^f0<~3)gj14s87j8$SF1~1OJNT$N1X*PSe{5{p(KWqPTn~KPWz|tE6_~$nihKG zvq#UEv`g0)UzMNmfW{v!(@o(IPyaASrF5J!{HBo=xSpZaEtR*3JJe^_pSx2-FCa_X zaKFdijDti9P)&`DR@%H?^#DEX;NeFmneZqwf^sFDe7upW2weRsRRL?f#51NjT z(JYl9?woy!-CdKvPrpvfwhr(eiQ$Jroa9(SMt`p1PFL3;9Yqfw?oD4uy!_uy( z2T;+LMdpzu=v_VeOL?+#4`~HzkBAN$VFy$H9>)t%8&`VxrI24%ViQ?dylF#H1T$^Z zVi8aEVcaiWadA<4%qCPm6!U<-68da)e6#$Ai~WgOqL#U&VNK3ru}mo+3(?S8!raWD zuYlZIahJe`ZL?|>+lHdas#f6ocyZ`+= z9^b9BWnPFo`gp3b8Gl1SG^c&IUp33!+_n4m13Cd&0aJTxeRlm50CS3_@*AgG^0zR| zGH?d%-^*O^P@ob(BnUF7=tG~WYqYk9Q(F^ zzg^Aj!x~=BLF?LyYs>1N3oyIM-yYD<=8u&H@Znt7F{E&f_#7h%k8{^l z8FV>~496$0O0|ncX`dX%VMM)T2`UAyZjUr$G^7iQtQ5Y5B~?3}$@(W~1l>eJpo%j@ zqFr%!0%36l5+D#vQZ8PN2Ub5{Zp~I~>iRP#s7&qg5R!$1?o-;X^W;&H9~{{(nS)n# zDP;&r$^^$|Xt5COkN0Oe>Wf|-m3VyLK2vv17(0cVFxWWK5$&bp!$5{wc^m^IC_zR~ zEbs0@x4NM?6Qb7JU!*~Vk|uUAZpPMGK=#7AdmF#I6LF!c%lKg8a3NrbKcXR-HxWXJ!*v3Jhzh0_1~-v2qVcg}wcY5#ki3Qp$l zgDWxo-xPcQMl1dSTl_1D{-3N?d=nP`9Q+^WP#k_Fsg>e-Re{w-OfL%*?;w zhJQ*6|Gx=~e~K9Yi0}VDhWiI$!N^SbZ=KXq?-?OmNvobR4GWGX6c1#XskR|8=+En<`=be{~DwaXFDc zw|e>rAgO+?UAG_*!B3Em2Lty3FskWGq2m2b+=(!RT-tqo58XPpH}>67)VNOV8v6y@ zU&<>=^*-n_dsYult~^r;_gp?-`NYR-S354WhkghrSQnLx#jaoQdH^ATd^z2FdY@>& z{PvzI8-VDBN>Rzne4F6wo+d2`(gY6Jt^dQRym)*xAYFS^7;OC z7h$pm@l8Fm>*e*?B%DKWD{KvHPlj;o`%U3cI+z2LIZ1&-z4&VH4t>+hyLFS#j=-+v zWZeCJdie6`vVZ;&<@K-M()SWu@Au>5}Z zwqPKLw3|j{tlZawj%r;@xDs@jcBhqt6X3kXwX?kp`3F9e?$a+t17-G~U#XL2K$$m9 zf3Seu4P{CFOl8$;pHr2DEZKP7_`?Q}-Ad(3R!l}QFwK7BB&8foD&!x7^fh@)hQHjl zj(-I{T!Qv2`LGUD;di}y`fOUstxgI7WfeU%yaCCP4)i~J6U#-pzyCS<+MF6%$b+%+ z&33Kfx};4g5DGRcc2x~m2ifAWi5~640*)2H&`#ejSEPZ1t3tM2jTgNK%bM%&&e%wr z&2l>oOy#_++#A}PB!4%wBUj^|k-E@n8OY)ICi|~PUVH{Q3K=XNt=(8cl`F7O%8KI zFWPh?e@RmdTmzD5)v(E-Q`R2YiDvh8@u14<3Hd~1+V3xlMTITMbYHFqJ?FobOplRhf(KrCT)rCTvkrXi~Wq$TAqkjiFg)0ml{{B?`$YQLUY-kcq^czg6J-%rLd{KNnmps5@7GwTFZ^dV0IHQ zwRIh~cq^%ImHNS8g;GkkUP+G8JQkJ$Z@ST0zKBJky4NgY3tqSkgsc5VceuntciEX- z;1bo8kbp8noY6*ZFls6Bcm)7<`DWoN5A4s$_UJ4E?VcG-%(*V@Y`S0i_J#m}kEM+O zDuF!P&v@GlYK`2RTPgnCN7T4dq2_~pIvjQgP)B}5DEr#@Ll8@uiGmu4Oj#nIO8wH^ zw>rpYHgF-Y+>d-s<_O*dhcqDDB~%ISb1EB6&paK{AY zUEX0}udMx>CXdjSaH@gvh=m`k6p*66C`CHy`V4tkRnXFSGI-JiLj*|J=Xhe1&qjnllM(TNjpu30f}70yEaI%$YXC4ya^!27$d#WmrsW>G+Bf zf~&wVt02FFxJZmyP#9#5ScpcZx-D3@-q`bL6K z6jRK2wHM5AUCWbX9%#u=z&5VkdzC4!iBtvN8V$w~DbJ#1&2! zo|$D%Kt_~F#TKo^qSZLqH7M0MeqoikX#i!_kROi8pk#circm`X5TM2EHrd))yJ8gN zx=chkuj9O}#xfUEl;k>0iMJnfxI5zJJARyr<_2L*Teg&_@e1$eQv5+-rJH}6uFEdW z0=i@mg5+9-kPPxY-~4<=pdvTJ+OhXA%1qvuyvri_9V3E(Hd`NI=nmMoA|SsXqR=1^ zxi$L(H;~x=ahgOC+J=EAh%Q8wmgmsQ0sdQKT1L#8lq+Eg#3)fF8qXP ze2%8EXhNAyt<{gBXe4|~*$jG;$gLm7Bo{ak;9ij?w0n|$?$yv~PNdo`;}UlS;GFiH zyR~pJEp5VI-|)J#c%l@j&7&AiPlIqZQqX8}_^R7~^Eez{lgmA=GR=^rLce z%gfuVp(z>(4&`2H%@a7t;5NK9Av-+~Fc3!whW>ouQl4|`;{C3$!)ufV@a>F+9mJQyF z19NSqAfJV@W+m4YcCw4^8apJ+I4lVcZ$7roSfW2bSd=QCspxl?CsGF=woH)PQbQmQ z1uh>5pY*fDa~%)HV`9JWjqE!+K>{bOk2GUOQ-BpbX+H$>XuU~BD!Edjt0^($BC?9K z0$t1ww;~;0r1mzDFgWSuIMyGo-iRQvBMoN>0#Tb$skIncD;-p?`=-{Lg;ppTCo`$L zsQ4=8SUNwLXD9^*xc8~Kg^1$;(acm90R&XV-;=1Sd8jEs6U4vdq0p41?8#|=RZUcpB zK0LX2WQ6!wvuY&2y6LL+t|W)&Qm^%`)e%ttZ2J|dm#dFo`$I~aNKE^&|Hl9XUy;5v z_Zm#r5Cq#+jBn$^L#e!e%L!EB;p6c9Q|5H-j0bdXr2b6k>g##w<^IF`@-U*OucS$u zC?wIH!W&#yT{hHzpHY75SrLP^Q>&b%K6z~h`=&e~9q_Jq30xi1@HhyCQ?ELPj;?6+ ze`X?r52NA%9MqzuAbZh6;|kZh=>_YZnR>^C5p^PY=1%qmlw= z<0@3n%w3t$fYn+=E55GeN_-0vv38_;tM8^SO~~13pce8C+kE6`_J3*71iB39eD)-N z*f%lD=^5~%IxLe;dYd_XFR~ZfkYJd2ot`DvIjwP5_PlxyWE%^|nhQCb`K)49PdqP)agAgtvk~;oW zDO=CSxsF;X?Z6Z+%Myi%0@t9J2IZ3h65k_m?$=u@;oXRP0n;^=PmRU*Vn#KxGMNBG z#>r$rfKtuF$H^_2slSYIoS7(!%?e;1EZ|p7rW`n#;-fMj2H}_SiXFG1YFLCeP4HBzVJxL7h2Zo$lNvYLM+FgB0 z%F24z*PMpL4wD?8Wb*N}4g`!`MB0uw*&k&TF2deEed>(;yd56iM4E-D`^^N9AT%MS z^|yC8J8=fD56GmC4oe@vhv3#zY|%Rd%jbsaosJr&0dYHP+bBc^Yu6Te8G4UTL*926?czJm==D#3{nD zz%K8JJu}y|%8anmL%p)u>gF!1x3hNlX8QI1r23aZryk;18~0ayRKe7XZ`8 zsfChWb-Vy3t`+b@fyB*~Y~05YByD<&pW%T4{!B|c1`YF4$2jG!#ACHabx!iv4-*%W zt7CJG=Z-)HMFtaLT&Py%<1Ic|1Y}e%l?k(Hfk6SysM#W&>D29*y3qj*`q!8inTFp7 zd!DMOIDhH&eZTB$u6=`SVt)Q2WEsW1?dkE7wi_$`Rj+|c`Y=-Jbldb!z?LNvgfemZ z;F{sBrh0K=yZvvx~H*oxTf?st`7lEBMHdb%&b zB}?Bc-DR40-VL>vgDAAfiVx609zhA{zh28by%cqFboCUR8qTuD-_+5KHO(U*zJ3fb z-szZ0$tfD`zu!CCzb6t_^R;mC*M1~MxVpr!QJO%&q|687yj`?fs#kU$mYNXB` zE5>IKI5BxpSG09v9%aw$q>hDB0MZ2Ji|YAU!|02FQ~|R6TcGwPRIESuBv|3~<4Wsp zC$Y3SgbJm=XW3&2H<8$?YvI*=>pT;yGWYBkHkR$Zw(i394V#>^n-yGwbz0G#p3zj% zX6x&F-sk${@7ag4=<*!VGbbJs8(CE%UWU4Cc0KvherxU>z1Rr0>M0gS_QOwC_vSvm zNe^kW_X1DZO>%2Z;^7>L#8gY*L47)-dQ?-eY- zC4LgFvMpTlS`jaUT5hW?Vu_4e67rTP(!&)j`m#j>&&@ugrfi_}(=HvAXtx9|DzMM+ zOj2g#1SCd1th?3Dv;R?5doJ7bgFbT{;}#X8&V%{{wqjmVFuu3rtQ~0`Q=hb!(L)(PW`n^Sl?e`KvoPdhbRJFrsH51Z_&s4)%010)ppC~V|)@aSj(c?hQv=3 zuvs4-MA&D{G|IcirA~vZ^^OZU>KWCXVY7NGJ>@9z`|XOoqIQepGzW9ly|vk=rSy@f zQe+A8M%V4fp^j)&S%twm{1U5f60^WlTrOnv?>Lahc(<%Z>E z71ipywq;$)^JR@yO5G(HY$zudp~ZL+28l&w4N7}vP@}`rA(;8Cl|EA* zj~jNovJDMe0|HTur{D?rW&~k6#VP+E9%}8ZSp4rx$hR`aWNwo5)1+anajuqb?n(U1Pk7r=PUmEG>T zfB+;Bpe9ckWHkL6SQay!Fg(P%@N_j4px8?^K{6mBc6KuIc{&OjOwCWI^9WVbg>Bur z*2dDYfra*as_zCzFH(Ph{R}Crs0`O8rz_He(@E)CXX0S=^=dS|w+3wG#p)pk_L$e- zRm1^^dRqg~?EWZDpS5aLWVNl=I_+004n;=`KA$a5Qjkhba$y|QQx}5H8xstZ?b$BPXWS+EAnZ?@`$0yUX zlgLAY-I_I@xIJVTFU~QvSXL{6(vAzv*%*-oFR9o1cgf5=@ytACIKLuMEGf~bX=(MU z1%K+(qE8=Oyv=u(q}Y?Mi}n2+;u~H`m*g`J_exVG41ox9b#2T_&EY$re>}E^rRC ze~?}S+&WJQ3OgW8(T&035@Z^NLrJ}HDWwt#eanf76Yx3IZejJ(Ad%#}NOsb0gx8t} zDISta84t^=k~Jn#S*<|QM1kM&%C=9+Tc*T7Efx4nf<)-5Us*dAOCH?2)LoKV*~EIA zSb5H%KHl0qbfk+sXaU?s9y;Q?rR_HqaygHsBQRAb$L8{R zNlXMNv&e!i>XUXQt>4o9hOvpw=jdz{9#B}Ie=6b(DUN454tZ)TvSj|2GKiZbP{H7{ z=qRu3l16EoZz-=;Cw929&agEvvNjbp!^$7O(0|iw7j6Uvw^Sy`72-{Wrnc%UTXXGmPFi_5=(2=MP!mzGiUO;7x2yP`*RK;O`41o!2ra7f>-kdeZ4=ztbSTOXZxY1vD(=g>8frRVrD#}ze> zs;v)x7IxLmuK@jV$-+aCpF^Fy z2`O1o4~kVe^qMJxaF>(qgKd?eC!X-1Kmi{!)lqtTh# zy15Fv0^1^;1rAVDl)H`D(0vn8Bs9i<9=brB0Sg?Y{uvquEU1m?GA@$O zi{8e@+`~W6Aw0-IBA`!#(mK`z^b#F=X>@frF6dNZ( zee16LL|`0XV2o%6(LBDo%vk}PL0OY;TO^m=}VBQLnuyw>TyrJ#% z7sT$eia-9~>0#(2sL0L|;VHZ2Fh4WFLI0cpL&Fa9S+26#L(t^T5x+)C2Rv$hl8w`f zYEfB62TgOxKNiOnmRTcUN5k7q#a9YqYQpk|p5!acD#s#1fvJi?r-#AT0gY3& zP>ZSk4Gm--B{tyL+?hnot{k|8Fj%klWG`}-vKvzGzw%^nuyd2I7q(s-o1itw0JnUE zT2gCy7*!Hk&{{XR3}||rk2GW#4W4OY1!H;3f}_z*8E@;D=3L2y2TlyEO11;XAfVq- zAuQBvNk7cI;LGhHRX)a59JT^SCMfOoNaWED(471Y)>`9GSLG;n@B*fE`HTwE=Nauz z7+i2$^e9oDM;5c~l|$6irAwEGMcNgbV>3EwR_|H>gmxc>4(1Qi;KoIA_y+8~GY>U7 zwOHx-7{H?a$~ZX2u;d-@_>6(#GkX)Pe9gDNCv7PbxNZ7uK-J#^7tkY6ea_H%Yk*H$ zXz`LNR85Ukg2gABano?OV_7r&#m|rhG*6jg$gK$7KhMVLZvaf5yLl+>gch&AJkA-G zn%RM`#Cn41Pm?duHlbeW^_dOl6xP%$W@(PvPYhbP4j1I*G(tIr;U{KMu9fG@=Q7t3 zD^wpV#4I4(x;!dn4!8SJ`*75u?A2~Ci9uG2t^~Jup2pVtVIU+XBILNVVA3i)j5(JN z%pHraFK}AjeX#nT)OoraaDjRJn*`>Njx;xA}b|G7$9MZvKJ}9!wT5jC-=eNA5=Z{Wk$uAqaZ*9`?t(+e- z1o&Zt)mpR?Wxl6sH*hVGf+i5MrSMy$p9%D5-1L2(s?r*pa%1f>5ytzQ!Ga3Q$u{E< zl4o!J;yz8z6%chgZ`t*Dui@tkkeNt*iNlwK{tPkek8ibB?j z)_In$8B-?1#5!rf{DRD{Aae?N00PG$GyOEyTAgi~4C%vi@#6BWWxM zJutm3xjH8adnW9xKpA^l`9jy@E2tLs6WuhK6q_|tTkWy&rC((pZ$bDx^|@dcR!?7%bd2{e}}4N`2g zN|^a!#C3SSe4Toxb>Dg}`~EGp)v=z44YG+!v#6;lnlW3E|1{cu+P{)saolvZH;V>TSgmc=;$!ohB zPm&o?%HVW99)y_#B|#fdV@?~YNKc`CpvrVj+%*5)=&8IA))M zQzPFDgARihPZ;Z_(rMC<-qTZTJ~(x)7Fd;8W}a0B0Ht0e^}V9Bg<>Y!)W3RvT#_-v zh>Ixp3L&UJy_jWAUtyf9wvet`#lVq1p4^T=s4*39WW%9H2u~)jcK~+|ADS1B4LbF- zebChG-UI}z+-UYqNwum$EVp}ZUhlf14mxLy1$zFX_5E2n45!5cUW(~Bw`x*(dF%zA zQC5X#x3e&f77Ix~$;4eLPn%o|bcg1DU7@W4tTxSckG$EqBH6k8Nxy&Yrnj{EL2l~^ zN&nLC=SJ&Jer8DX2+po&t1*NMg*WPYw>#3tDzC7#m`+){30U?f!;u9A$xI$AlPNf?lp_Im5(nR5xOX}L!tg*@QsJ3z3&;|96p=LLI41!*`s`*@YO&%Y+FQYOXE$9<6Nx{QzF%4Q84a z4!Yzsiao}AL!^BxY-N$mz=lYGTFar7C>`WYMyk)5oS9R;G_i==dqvcW9N)^{#E&mz z(DNXg+cHxeO+}$`7YP)K!DUgs>!H zqnRW|qzm8&6t)a)czY#)i%6F~!zg9uGzKSUtOUcCM^E-<8&cr%BshIrtM^olF+U{t zo-1S;RP1}Fwo!}3lz<+_S`(1>W&TEgd*R4l!;0ie0GQi_mSeEFBDEDcon1bf?;n1o zjZ*8DYlrJyEQq4n!;xb}K#=$e*-b55@b?A6AK_!F^N(=?^gviYz5g(3f$j_^hvKJwRp(T|w zOzsuLegJ6Vll6kYjB#vH$b<_R<g{ZqI)8_S_i8zZ_(etXRIzZF6);ro!gr|i zi81u4BEhU=E;fNQkSuVUV-=`Lp;osW?_Jz++vgPH5H$xn%UU91M^`Lq1Z_MZ&nZLd z8DxE%#{x^5hKZ5(&ky5Gmqi0i6hnP{C{L}1C}LNKa$JvP6P1yf;jIu_A&6kmkHI9pHaM)_1J z2#xv@QgKLrxbJoExqVMaulZ10O?T&aKJrI!55UD{v`nFZ$ui16kD{oHftSp8p(&JJn0P_{7DV16EGW!dtf;$4eJH7o1)<-X-yTS~3hZL?7Vh1`6)(Mf&ai!Ly*R9u-kaYy)FSKcw$9knYHMZ@(OwMA8Th zm}sx)^3?x*o%cBdaUlBjQ1znX&ba#ysH(WOZoHwS>!wOH<>5Lmj@Xm3^?m`XmWSQ8 zZ)`k^ZP~K1YN%kl&Tz91ZEI3k$oI}w#-xGFe>|$kZI39t`jZ{m9u1Fbm5aeNxJvK3 z86L+>g%#SC&F$gVi^xDWICX)XydQ%R4 zbdpGp8vi6q?>O-Rd%afxe#{3mf!5LS>LgNe(nLkeX3K%8SWKCt#ntWOcIInZR?Ymg zT%9HT&8VMa{ue6+I89@KwIJb)K;U?#y1L1STU)!H{^V2XAi)Ghm>P({&vcAi=N$LhVuFIv;VE z_;NTQp{U<7WMg6$O>zniL4(Me9EPqMM z#x9a^TXoyB4&#PS#v?-Z`I$x)sIsC$G_^c}vld$)@T6+?b@^yc3?n8?Fn8u{fWzBB z<9Jb{X-ti`v&rV=h4J#z=C?NNSCn&_{`cvcV>jhgS}mdG^9tUQz*#(`u9b}TAW=or z48WjyVC0jd+mqA7)39V9c2s(vxqLS`DH265kS;D~3yGAhWUd2h?-OjD;6i*@VUVu0 zgG^ir=->&B^jr0d+|Wr_JU@@Td%)HSZNuNdt#S8xeAsEJ6S^oFoA zE_1GnKFRbkcypX&z!%o87^DmspM+EmxW2bhsO$XNEDw#-xbbw}Paa6e2!;!S8yd=h zz=&KeggW2wq(}c9nk#x|kaxkoR?WNH?!LdIHMSD`I*V@q+x*}{x8g>-7g{XiGW>i_~MH6Ya+q9w{+@XFSopxK9+>sCMK|iDr5<}zt+{Zdu*<# z|IWvk)Zv`mR6Y^#FEjRJ>($t!96sONMoV4wd*I)Yj3F(>IdOS$H(oBTk8Xp+ulaE| zdVS*xCF?bUV|GvJ!{)qZ7bLXDpynO!^go72Z({hR2i>9E`6QJln8PDs@f~kPCkFW_ z!hdZJr-#sNet2DB5Q(p3FnYOTJGGDOr`0tg$KaTbY_~$>%!?ObeSSG<`osvb-trT#dqI%{tytL&IIA2z9f z9j1#*ZwIcz@js7MQzs9Ybj`yv>kHn z1GqoZkAgNPq%bj~+l>|Hd#XXB8)F>hEfO}fRB#O{|0iIpg) zR@Kwrm}$13NJcTfswv>_{i%)5yhSa^QnPC}OJ-in(r{97#H-0}tGnsTLC)_Y9*1aL zVXy_RL#Lh^Ugu$Q_P`o4+VZvdZcIF$d<0hTU^tngURyKrdgx$1*>Uk>!JfSHU8E}(DeB{N+uBvMC zIOLUL;wGcE%utJNA4^%B4)~I<`kSO2$bF18-x(z*-_@A2k&c07qJjjGvTg4Cc@~wm zt)oY`Bq@Hv6OBaq+%1DC1tkALM`<`wQjVH;Y7*nM5FB$5ejTmhQSD%+0@iO22*`m) z%0);3d<9r&YBdRox9C9(I$=|1op3%R6!Of45?d}#hnGoV3*QsLMbZ!Sw{m5E2~64h zR(8A@JGp((!oz6EkjqubQ1$LPBfIAuN&131c;cIwt4jNTt-CI7U`tAL1!nO`mdn6a z>?I<*t693|jWA8HKlpx1doMnezzfg1`vemRQtR4K)EDwLTWV;+f`gbUQOF{RP;2?q z30AybyT2nrEn=sud9Enq?Z4^~=;u1qx2^Wk=fq31ONJkC-$yx>+|xdn<%mX`Kv5}s zpmz#u-4tcImE>vaL;1+;B$@!)Ix+_5KfU)bi{s1EhNsEQFYuU&I>nUo;kY4X@J9y% zm%;%rY#ptadDI4WBd!7UJ5tD{b`at}Hxzj(RX#o)3Bq4AluQ^RTw9qpw4}1F!r22b9c1{hdTeGqcyaZ}tH&;_o1#O_cy5Ug^s1dCXs zvhlUPrib!7W2l+A@mmfH`EZk|&gvuFTPF^=i?MWr~p|-gB zD8T9T63cKoL~%Pbwp5t@tNRwhZn+w>-{IOY;_u;g8zJ6!5fJ$ahlL7= zwtusMqcyqC9R5V|F)Jj5yN_{5?)xxjJ$in$Hn2DPYw~w?$U~%#2G!Z^{Dk!Ed*2NB zA|yhf%Rdm^%1D$=?g+ksFDpPaCc~@$7E7NrqJe`WFd+EiH)`{qQ3HebQ27n!4I^`m zW6l4FmARHva)m=SYn*@S{ccxDzEh?#>Hb9cRn)^fhh{N10m2KgzNpetn@muU72v*y zG%NnRs^CZiw(|h~%pk*5iCmbWm3AbyN_hONEE=xn{~tw{8vF#7|4Fs&pZ&1^c(sk? zKfT%p_-9}3-&Jj6{jX}9iVD+rRgU!^r$Om|yV~|&*b5sQBO?n7BO}}Qi-rAr%k;ek z{M%<103XADc9re>Fsy=n{~}%F%@hpHO(k7SZJi~*^R4Elg#U%T{Id!6eW1? zQ^@+qRqTIV$YKJpeAm4GWo*GngkPwy+u?8`doQcs%t9Eo|FSm%2W}uW@2syHIJ03) zqXp@YN12YgjNUh3^6gRWYwMOQ2D; zEdV7vDp0EORz(B@3tE)vofz0lgWGp=g=kc%`X>-+pC6j0&Z6(T_<)4un4&>E!b5UY zMzC4(1V2t8)O56gg4b^Rap-gA*ulxKhoDVwq7Ro%kL_75EAG!zE;U~7HlNNw+QE~p z&<-AT)N@!fW`7ofuoMlq???!V=pW_Z+2lk0Xi3WGQNj+A4w+a$P_`7p@CjRrBUIvi z8ipbe%j^mb>L40~j-pJtcU0AdjGi#{#Y^DG2rGZxkVN?X=xb|1N;#={KDXoB4UbG9Mmu;Er?mqg2nz?eWKcu~g7*FTa&H@Sq}*N<+eE_3DthcnV zAP1AAhKi@JZpIqLPNPsqukDwNmaiQ2f^zsEET8BytQc1ISmTBmYRjtKvh%$khB+aS zVIvV27G9CyxDe@AjEvGu69tbgQpg}BkG2&+P)I8QcGtvRG}O|J2&d61hg|+suTnnS zfJrHX%f~U$u+^B}E%;7d^+!cJ!v9{Ds5VvGmf_d52W^cC0etlG=Hnh`=qX4qmIEq6 zdc7@X*g-QK3qbmkfE`IVIRZg!xR^Cnk$=r$niwSD@JFD%xNEHnNsW-{$jAl2niH;% zSiYOCfU5jX2%tDUI8${Zn=eSw1#oSuyhEN>dK$^EDvm?eP9P6kgrHXg8f4c@s}HMo z7zjk8TL=xPE<~7W`3hMYwFJ*^_hCi5aJ~i6p z)S-iWr%IbkY62%mJ!01aqX5)%y8sVPB+A0t+yOwBrI*gSfJmo@Uo!QF`;V+jP0(vA zd83VC*qgiuK+$}`p=`c-u80?WuJkX9wf%`6S`<0~-x=CtVt)8;BEBv+ zSE|U10G%PQe?MY@yK*YY)s=mM~U!p<>7A_0Ly&&75sX#R)^!PcgJg}|xb2A5SA=1?d9%SU;q2E2O|feI z$5O3qv{!r!x$9X3YpZ8CB8k!lUHIpBy^*&a!sZJvLei-&0twK@#SHE;=72Ec#qR`H zwJ2d%7quwXcA{G(1Xx+`XpQT%C)#AzUZ!|dW}nnnd#=QMixxVN-|L>gF3S=WvX4u9 zwca9yuy*kj2Yuz_C7i`{!QL||HTs75?~ZkHCU@-ntUxu!x{$l^J#u^!xl?mNn~8!j z>v1gEwz1-yx>zKtecVc{gTnHJuTb^JQl)zoirURc%+-=~TJUd2-PmQbce$|3c3xn| zW~A5mTR`eMxpR4Ww}0$kdV*egBue!!2~i7`YT8dmCpo{iNbf634AZ=QXPy7HcQRC6o<$5o_juN zPc=vj#&!k58`l1{RI3;kbN-Ou_T-L3<0r7&wKf-Gj%$qD=wwBwK+7p zGN$$8aBh6ErThD-70Xxb$I_XAlSoaXBPS*IT1ccuRiPk)6iZSY8UiedDqn63sUGUb zYIV@4RI_D9nC$=*lo8!LI@;2-FhQk#%Vss(9`(98RWzVrDdKB{Cj21O?&CXuY*>g= z6Xn2GR9VwPCu>$iY%{c_Ho9G1**OMaP=am`E*?HA{6cJB>!JrTgog@_ToJpqI=BKZ zu5?_?0HqPSYjMIlw0jl``}zJqZzvo(I`GtSqP6w~UN803yC>#(V6 zczipy;}9hGGi_ycYk7L{N7%V*eeus=Q(Ipf1&d}=atx;?WQb^dlV8M8F#aU(bx7sFy!QS zvR_4)LoRuQ1NYp*XFM650^WKfbl2~p^h)Vhm?F(H)_K}M2J9$EV^~6fqRVu=;#VV4 zcG3f)1=nuodaDW4rOrxf9K_#tSR{w}>ru%a z83N=jpHNa6J+)0VoI?(kXTn2PjeV2_KUF-(HH;C%5Dz?RiD2OHdCBZ+5@x{ zT$lLQFjUPPy_cZRBywE8nA>Y;DUjMp`#V zcIgk#bB1|r!!rJn#ctbz?h4+X-$xVs{yir`A?_Nvm;5D!)HSzJNnU>&Z0q16V44;+ zQe{wMc;yPRB22F8kPX^xioNhsiQ?nf&YCsR@N4vt?VAV16Z2V5zCjN zukN-Zl@czBPWMlk^WIIyL}i{swpUDH=Ivr9y3k9jQ@dz7i_=j9-k}Y#VaMn5>|qXt zoZ*+$KCua`H8uOPh0w~LMysENpL{4(hwDaa9RdiG-?jV#Z6&?J$H!wNAZSRhzHD5f zcs05Gammzl$QVO>r+5gvSVN{`&_+n9fKSCD?XI#**j)A66E_~Hhax8?J@)bO3~lkJ z1%n?EB!q-!dud}ARz(r@5M81WKCOC}x=uA5)Cz}ToBmkTqA^PYllh0h( zy?)FTY$Te6CdjUCv#ocH_Z6K(P0n|5Yt^EC_H5HyPapxsJT;9fNSut~kMIHQPjlM{ z7Bd~r0e5HPI<5q+RRF2L%pbZnGfDC>XS(VXxbxQCuRzAgW;qtGRF9|fRP9~zAR;Ri z+;HoiJUS_u9(j&TI#e6R^XuGC*Hg%x6G=tI2-PpFKWBI3*sUQ&0 zIY9OP^#f(^m~l*BCUT|l&6AOQ2V01Y^i0e7Rq^;0vu93~?tAK`M-FtJpFKi&82$xZENb`iLtl4vqu<>NRmU_ zwzgJmFV7$SD>)4duvqB2UjdO%ny!vl25%AQb?{LK3kebXz}E8~#I%&m5J-9Ilf1rH z;CZ8y)>LF<1Bf1L?fcIWr%;l0&+Oy@us|E$maUgD^bk3y4jiM=yXGi2sR;dS;5qv+ z+8sz9v&Elq5AY|hG*UzN==ua+T9bpGTC@bk@l_+e@$4d!*gm004$B+i7p$cl;Zd)K zb)>erqxY^EHzr+@g zXCaR`n0u_i%~s%+2y)!6L|K1lVMWlI{1~Ho_=g72Y3)hpg`KUtwYB1*Ie>Hy$pf3j)XXrl`Cj|xM?JRSIa99x(C`;Ve&SjM7xo^r56&p<%|(J4$QX* zX3;`9TNF)Me)W*c%{%)psh1zN;X(@)P=F?yuu)HMe1< zo-hmC`@{LH?V86f`$^#wSGcO*WClbYa;Xu-QvuIT;cVlHEs7&9Y*W2mjtoX?8%kA- z6D&ECV*WzH)-IRU6}xIzTeIaLX8(svS(8&kt|LzwtK!}{YX)mLrm@1ch^x&qh5mOU z0G;ql;{g_Gam`qyHeEE;h-O|1RO(vtnev~Dsbi&9(HT5O=`n4}k1hq3drF|Ye5rbz zSKE2XBRfS^MEDResvMOImN)&PXO4NhFW?W?Sq|8*sIvP*CLH3Or)k|piMZyB#KVD7 z^wyc>P`}Mzd?1@NUv&zz=2bXJsBKZ=hvJX14*&(eVvlNau`}L?IuIsa-H-eb4&URXGBi0EkPRxbC8Vxa| zE~>LtcMpZMcdt&Wj%r?kwMh^6;lFtBqkJNg6zYVn0ShEyfLA`w^OxX*n%v0m7*;Gg zIy!p<&+^!w-Og0Ds6?_f+^lzFINzV8-bZs4`VC{_Zxo2?Zc1+-!QU3eRu8$HzwO-^ zWR|MBwA{}_<(b$Y>DfVQVN#&uZxCb1tUSLMA~rhg2Z^xPZsL8W(OFRG&-2r;XbYj& zLIfm9Ux9xUg8v<~62QA(vEK~9CZ$CUmE>|p{twpd+bGXLX!zD#3cq^E!aM4rKyIZL&pR}GZE1T-hK5^m8{}g6g z?3adPa@lUSM(?oobj=(VI2Q|Sjlq`zYtV1cW!E9=t`O29!v6$J(G9{Ct7vZq(b?ja>wUgHPk4IE^&2H9PKGU=N9CfDy0LItcK$T^ zZCad|df>J(y(g6?&h05jn&)a@@!<8M@>g5NRv8(2PX^&~QP9`=HN(b{L%$$BcPUnX zPBwfS_nzMBHjtAkU=>3o+1a5`HaD!j8XPgC7=1bR9{V%6!Rbc9;eP8gw-q=#5a3~X zg2*U9G`hAvELv~ZB^&qgm+~p1YnDm$;l|6DUedk6BKJl2pd19I-hph(uD;gaUAlEg zS}p4gGE&CY>^#9S?tL@S>^m~ONZs`qxodxW@?)(ns<{bEV z15MAFYPs|5j;(F0H6NnWnxK>KF=(?CwMyy$|LMa>6#s!7Zkt zAveetoTSh|w?uhX+vMb$4a0rfVcZ7Sjw}Ob=*VW7#cp<+ciQLCW%+FjH)!VM+;w+w=e2K|<7s=SDI{#*MtV37bX#vq6Q5(rz#&8ifiRQ&-zms$3 zQE@;J1Bj!M)E{!HDt^~k5g*a=(0Y#$A|gdS7y$ln@5BKJBuH68?s0h{-Do}`f*GP# zC?g}P$Ds*^s){%nZv%&z<3T?0)!aKt!6L^uM$_L0dyQWB2A#+Tb2mFNa+OF6@DaFD z>f*IkV)4T$3{mgof-qc%kwn3}FFVrNJ=bekA;i{I*aqYKJ{66$T57Ehiz$J}rQR`Q zt0Y+{swm0!NsdTZ{%FMGPe)!0pE*N_8_k{UD{4Wj8k)cDSq}cVfl6C7XF?OmgeE zw4IH|qdUWP&zTl6^_Mw3jPqACuR5>*-C@FW;)H62ax7T58mA3FGN{dnwm$AU$EVj6 zUcMDnr1xVe?qt?b-sa01=>(p=AXNkC4-|&T!%7s`wae~=ZGU6bL?k(S+(juObcf!D)p-r6m@bHO~IE5OK zl4FGfR6#DJREnB2Q8o~HV*8m9j8`-|C|5;Pa`O?45z2|a8fUGVb^ny(1zesHq*2r& zh1A#wKNyMwhCaAU95ywl+<;VWYy8EY1Eu(@6{dB{OLg+<#2_?gVg(lrNSf+OQq4>y z`#tBg@>E)5ynpkoHeH62fH-w;*%d>`0g9Ok(2>r%X;YFy*AAG%(iXo{`F`;{?LLZ& zG`+f~T$LgSU^JJ_al%b^Vvxa82)@N>@6rTVLE)PrN4cuMHiL7PzcOq&$7dgR!ux#r zqqXT(wRM97ecF38+tAapnw&{>bklvoE!DwlYMh0f z%MhzhpnXL<_43OoiEGrT9a73F@t55DvuTLN08M`TD;Aiz@pNflpPBzQZ2yxTmwEGP zqrhAK*THr5F0|L&>M*|nuD%q!ZmHE`S6+12P2t&|&&}|o&-qJo{P`PMErj8<(*aRH z#>n)3dDOwq?rw;inR=@}*!II-6DAqgQr2pEIwm-RzPH+Q^cu1JbdC@*>Ue_6jy7;{WO{aa%{#^4noR#4l4IvG) z_<%;+rHtfF8qO|%GOmj`@(-h)gtXW-t!IAV!t-rcANL-l%H*%V>Z`xmQ^KZcN}>~G z-U@%!JR9e-{BZsx=XL!!#&L?-a|(K~D%jl$=zX^8rJ0}nMU$iMS*E9?8@vO)o8ChP z#>P7x0{c#GkO}p<)JmNUF z>FW)41{~B=?sVsuO|AW1OZ@5pVCg9(cgu7N!(-AXRN>{yi^xuUTuA7I$K_UF?U`Q= z_Ih13%h8GVte&09~}3bTbapD*opjKpCBue_^VZei=e5WcmD>M~U02F&wt z{Db|NJ}BNGK(C&inc+<&^})|&I$@e>n^@-j1u1jnygH~rdB-e~gc2Qih8jR#@d~dt zyOIg9kfk;0{Ce-IhXGT=TXW_v6Wj{lGnE?eiOeSe(t7IKv?V!W+pLp;@E1m(s*EYQ zj}Ofb$G=9BQEXuaWI%xT)IQq};t$&KM&HX58lav(!Ts&5lHQ%fT<7d%2u73NnN}aa z?-X5eBYi{QzU^0(BV6`xgWpvQyS-PxHDy*GzfV@Kn@=lSIp&#Cn*d&OXckdAo#wM1 zEn#U7eHVBX{yfsQCbi2nQRjT~e#EVLkw{(p^%D)zivTWpo&(7wG$~x1?M5b!LutS7KhbUvUksY}Qb3_$Sca>?r7%n@FG^YbyFotzaJuyO9S znnY4*Pwp^|>0hVoy*T+aSqO320qn^1=rjo-bA{q_O5OJ%4cJZgAm8}Z@>>Vw0*btM z+4gp!E;0XlbwII$e!y$uFoOe$!1$LGr10-Z8#6oW0Mfy7-2?Elp_5(+_whnT7UTk2 zF@=+Q_KEfQ7Z4Caa1GXkMvpF40Ar!=-hzuH>E5(rtW*9v?#eBMt_Lxn52f?S<;Rwn=U{u8z|Ry`;GiCAOsg*^ zy)8hK3kyncj0qxI8aEIa?C{e+0+nhTA?i0+533y>hG>p>an}$- z;TU5?j73S{+J0{s z$)s{{1yTl$B679r(R5RA=MQLLnykSm2G77-l5xgo!`D}32~Io6pukhIZR^>kMaOI+ zie#fllMJlD^yQek10eu3V8Ah=nveVQ-5mZoB>P?Fa9U?rKNP^&J`<2MV|$v$^Q764 z%R6sdK&6Vk8Wxv{s+0gnDLo)3unVh1tB*7jy^zOj=Kd#HqG zgPDT_#K^ork;zl|SA)7=(rB9oIGX+lhuG3hxh)emeAN=K3nb9j*(D2S(1`&##CJ}= zn0ndLE_KqC$55*i-1W_-HBU4iv&ztMWd*1HDm}bKr$m!RmoJflAz?ZPnZODGp_TmZi!0V@@I1)k3{`y#_ z=WQree~HDOxy0ASY(@rR7^+ri0K~D1#UZ_aWfWP1JultOZEXsKTL0r{qUUpT^)+nKQFL*w})F**aRxuWi4S zi>Iz}Djen9BBRiqn(5dVk34T3&lwAd?&>`SB4%P}16GYlJPEwfjn7vVoaxo!OIwK; z;J7mUt5!$bCvTX>z(e3?4s6-dY1ULfFxhwP+elp+9RwN}Oabm`S3S*?znmYeCY>r< zVH6tDNH)fB9(@XPB3HD4DfjzAJ}r<_}*_7!r5$HVIsGE~!I- zl&&!bojY0ZNmSP`YqR%4HWwq6wo!-i*OR2R$9HC8Mdzx3)VYnY1zd_e2QQ?|CDoD< zvYq|HbwGD6bSaW@2>o)lmsCO;J&c2(kVeNcts{)Mie_pu2=bHT!#q4yA;ba#oqnOc$3yY07AU=#g2= zU!6`!$%LrRZSjnxLZ$6Njc30n!Q!WTY=vkPFGtQqFmvZN9z5TF%TYW(dqn3*klrP7 z62u|X_)58*pJmdj69j{y8`c+|TW;UJEpiE2Tdr6oxc?baE}v2mVe}DF?{92AUf3L2 zv9dVhX0nlJ<%Nd@PTKojuh+t3d8qmF{sHL+Y(a|EH!{&$2@J^DJOquC?pmeVIcd^p zqm1baWMlXJ$>VxC3`=hV>HOR)&P0elcJk8AJ?E5tOh2P7^t%Ca3OEfo*DerBu}OU4 zrs~&B7ymo9OC+&gpVYnAI9D+q4-FpJ#!0ik#8JskimhTtgBQBFcn=P6Iy>)Ywc=QJ zWy37~Yhu}yNo4879q*KyCHgyr%e7G)MvG3wfV>()OXWbVa#d$|s6>k`a5l$KTjj!e zG#CXzE!WWHH|mHo4(g8;riWx0&qf&NWsHD(rNK&rem5ZvTrzTb&nR9XP(Hl6#FBpT za)cVy=^=VS#+7^qqg5605o4=3Qp3Rjjid8UUJbTuoVxByz4WA<&nnD<>#Y~^*E*fwaJYI~)+$7?0EH0D%Z;9XhKN_KcRd2k{TLMytRBNKYus6!nT zCVk*#oL#Nf@y7svMIq7Pfw~uVOe>b3mt;Kqp=?8{IftQlb6tQ)aN=FrnNO;9q_x5L zx4Vim=AUlJStFjyM=KB$Lq)*KlIdhkOK=}5TQHY+*VqP1%s866qBp%F8Z@p_XqjMX zF5RS4xWwI%n^*PxSG49ijmhdkRY+QD6z$dtfI~_hG|tZJu&QmpaWuiJeioHbVDKaf z5wY&s>F*i=$aiyZd`1s(!c#f(e1I>nSUQvd=%U6jZ@5`fM>Xw zX%b}?X9IXZ?Ts0xwdes!Qmj=+Hm`{un#EBmFil2GZ@)g+R|TW&IgAo=X}FjGicQEm@MG4<7Ge=3)-glddCy z1vCROfurHZ0Bpj>Q_V0j-188q?^!0#9>LoJD8sR(>lL0|&6u-i0iH~Gh0JT?Fk^3} zSo$Yh?$tXZn!^dSQ>Dmmz1^K-H7dp~EmLmXyI}g(NNaSnYNE`&uV}zmYozY6G47%jr}Z4RERoKnb^!}D5|fuY zb?KBSpeNnwS$*6Me{ zwxJg`f+~!b%|J}HCAo8L95c$$FRNgPDM&@qOiYAs=u1xpUQiQsSGJMbMXptEVGwY$ z>H4IWRPnDEM}VzXV@n*zmrVy9jL^yy>N88Br8q%Dra04W?oIlNz1g)6<|}GyX8JQI zOTFH<$Q4b!O@b!?kiTINA*VApDmVRW6sSJ{R4L91+Q@s z2jg8zgbzB8F7I&@F%2?qauki=4CSF-srp-)2P-6U!C(G<&PUKm+g-3=R`Z&^cCAdD z;fN(l$x|TNl`(Qh)@nsk9 z#_w>9J*e}179c%9S108b_4QsQm^(=E3^53&faG9Yp>Mx0JNHt*1~{@X7g1{U8?q6; zBtn6@PGg75-7QBV@&t8`*c=)Rbrbczly!((kW1N z;W-Mf^HqVC*c`!6-eYcm!mML*)B9gb-s-Wt8=`tJ-(fvpYfQ4*#L7g&)lO$B9@N|H+F9@X(0rn~os8w*Mt$(u3u;udXOOgxyfUbjr1t5OOb ziwxUk@75|lfo3GHA>=YZjDVwth@BEV;X-b&eu6)FPXh`2SOe~<$d$_F&r-c&6#jUo zcC=#-*L0!{@;-KGbF^FqM3cfrW4BYEw|b$>TgV|1BJ6Rxb{+v>PSOtDU8|o;5uyRW zAFe4lyCFhsxIE*UxE;wuu3ebR|89$ms9M=aT)5}sTv=hB;mk+?pzY$ALwBHe8inRT zF964s@7wSy37fpgHe-VS9xUnws}UQPy}`hwVn>DLQtE1^3N3D%1VvnJ@yQW$4D>$K=w>T-^g}v`fvg}`$s0bDN zqhGnfiG-g3A)u4qgClEa2kLg~{o&}o_v+tFK=LP@em1~BP*xk=ugKn;_2a76Z6%~T zsF6QS$Q@OAak;ys(;Z;D1CM!L$1nk*Lm`3+(e#g|lGqLZjcRdIT3L%4YP8#dO7HCT z65)pN-{8iN{`xdjYUpd}{Zr=M>IL%_?b=@B*RCQ7W1E>l1`#O*5doAVVa`bf42=>` z7NT+&ra<&b#1c$ei*xnEK-V?V`khaogxWPS@JJA=OwbjPPoDeK+!tvIRVJh=ie3|p z>)Rb zc?wIEO&nsA<{J8PDidYmS3;ejlFLKSq^&fh1%yl#DBE50C-4HZMq)IGzizORMvPu7 zBL%=yL^@FI-J*Y9db-g(b&K)7#aHq0BZUobIWTqPy3&PlIlN`(T@Ao1>~B^`u)ntl z-tVEu;XtT`3FIXca(e_lWZo)$k6-XS5rL*p%zOFKj)u^HrLmJg&X2pRzcDq<4A9`*3jnF^jGjUsEQ5e$2dg)e-;@rv(U2Q(=ag6viz8e7&&O!SpP?n5d$j|EeHEQ<*c;q z>^gLeS`74TjQ@y?{;$1Aj6cmX{FuuA{oH?^{m=D(E=FSK_$m6Qi~lRcNK6d>wDJ#w z^B;qzVfvS2=|6-^ENuT-&lotEX*vFR5e)RSKLgbHH!Y*=XkhDPYUgNU;A~-MD`Vj7 zXyGnx;pEKCO-HZwKaP&^Un5}R_)$dtM++(v!v9eL|L5J&)BoS$aQ;~X{wFvb1_p-z zmcwaQv-l@s6@)18-4y11{p6SYLfuH25=w|SLXVns48iaU*8H^U1>RK zBbHdJxa!(%<@rybR{aOdfQ6xZfT9ma=da)eYpxfczc&3pQlv8S5{ln7pf?Mk!r&kJ z4=wBuGujvL(UZhMe8dUL`CVlJy`RkS5G2x2@xZoGz)VNIo4am6ZY7Ac1NjJL%n0_Q zA01fPsWO>fsuRQLSMk@n}!t#;osm0p;LuCW;dr2R21KfDib^M!b@{fBAB&bUZ zS~f3^9UlBcE5{Gp2gc4UJ?R7@j5osjzZz)aZ+nI%#Jjgdl;W}!TC6M*k00l&N10SrzpZ^0BZiiMS7x88$^ zG2!guB8BS*aWah?&tsNUJP(I^*mQgMFO$^p^MgT@Qm}|wP#)Kl-5)pyu|^R5fSkzo zU4YqsQI!B2%~UD2e?eO|IHbAf}hK+8>g zLg%`Dm*jg@&ax)YJ6B3FeV+FEIeDdN&fSFEa2R2I-*G0}}gvPa8q zWBgepnA(_0t+EdJ_8yW?M^=YiR<3#c+^NqYJ1Jn>INLP-c`dRJ2-%rck z>|wu(C8B9uW8W`{R*5A+gQz%u*nBKj*bggfT$!OK4y4x8WdmX1vjW|&NsV+}tmEK$ z`)(N91E@9M&litN)!fUx&R|LrkR}Dh>@m8(d8l8YmQdNg58p2=smbB5kV%d(zUEnH z$sdGJS%++v{DujpymFBpc24z(T+%x#!g6DCE(Dd5dDb}J`a4DPVHw}IT)bG;r_gFU*2Kt4J5nNEq7~Gt(pQLAtENRR}_zz>fCvjSAoUk{o0TzJ_ zU54#j?A9`ka~Y$iU(WPMgY+tdI`-_8L$VOgn0zahHe9m7GFw+C)=|G8+vLI<&t$-t zZL*NtTM_mtduZc!+<}M0TpMo_3G+OJW3y+RLw+yT;e6H?Iv8iH{-tUlF8a_UKPGZq*y>$$?C>j!Iv$v;7`l&r|ha$-F7t% zzFmgq`B;C{A6uSFPH~7deXe?H=0Y8&1%+XOvc??84c$h5a~<7gFYl-vUa&9k^u+?< zgfaZR>7cRd@!gGVsnjzRLa`{DNd0W8n~)dLB5gLGqCS79jZyLPTq`_?ccaN!ywZ_M zd3dB%Ua)Aip}DeXG&$h}7Z*PPW5VKG#SK5ymsF;YqnO|X^^HTSJ@d-8_t`xRE})@_ zd!JWz&rfOpv@mN?y{QzJps!FIK?sHr%ezMdo>^R(Fq9mgiryWuC+vm@bbC!4 z`rGSSw)}AYHxm41!wQRMz%vk$@w;aU2$-fW8W&vi)yFoNChFoWkWIzeCQU(PqqC^p z!cAna37AGT zL}t*N68nUrNWuX#LB+WI7xRlzJ9-{?KAlvl9)2VR z*Q?u?C;c4QJypH;I>$kdRSez-jgBOS4E@06_Z6beK$LoS_<)rppFxybCcR)t0{snY zAW1g846*$LF$-?*aQa^+K$M7SwU_C=q06wLmj1tTdhdOr*~`O^yUS5|BO-&|#PDHH znay4^#o_>K)9pEw7p&{1M$shR!0Tuj-ezX6c?hPj4cV+X_2Y8LQu!pKYfV$HU^uYN5S`)B#5}39ivh?{!BE*EobVR{ ztC%#&)S-fb7Ft7hpWX?2I@)xO<{wey%ow(7a_NBu#Er0@383S2@{lt6nSgLW&Glc# zI?0NM;iM%$C2itwHl7iO9EcgiA`lA1r=?G`if>WN&*fe-xaWogFILA$xsg z^@?ziVsv5ByQI?Qf_d$5fwH1kSkLHptLp6u8f)|>T2%G z`uY}V%ClCw2DDeL&b05L1+yR~Ix90rIt#lPtpzXh?aeR~b1_-`6cyJRI0?798Ji9- zW(e0o0hFhWz}i44p1`%mt0+mq78%%1b0S8)S>Z+g$L%RJgSN;07LC`B^tBlr73uys z2%Ml~#T>_Q*4((%m6C`YdUmX*E4CfGc5HO>D=&EozVqS5@ER7qn~%F*&aXb7E-f0g zZe)Y;Q0mzOW`#4NC_p!b5_V`)jJ<19eSWs{Hi4vFS8zD{2R_>VDy!BQIwC(&eOW{A z@X8rc(5bH|r8HvdztMNLG&6(77ub{MAw683ilw=EJP>3>MS6hHE`kW;wIRA z3QS1`R24Ch+sjDi;N3pe7~{EvXB{{STjK82SUubjeKb(GukrVkmz( zLou=oPt5v%Ywwyua#1;44y@2ILo3ZwU@xk}c(}KGb_a%TTz>`ZT&glRpWOHFyiY0jD zp5aUrSKv#WgR7-dtWiQKt^}W#>HTi!rJH&EtYOt$&WLAy*;qNkgk8&awMy)PQy^;WXj^SY(BY*)&jf$g z5_-9sR>RiY#Kq+alF}SLaf_Y>;f zG}aYOk`{d<{NsA(A{pW;aW?KfJASVnA9U{~Yg?@`A^SgjqS}*85NQD5@z#vF2^L(g zYG3LLHf&it^sHDGs;P>S66arUJOF@q@u_D;+c293&!CoZXeyc(VLbL@F($9_#U~C%9w5y`e2{?W8!X#4>*-Cv{4vxs4_pH#vs!2 ztDl(=TpJ9%)7dGf>dCKeY!_S7`|_~&oWoF=oRH;OVc2+4AaKb92H4GtR(u-1l5qOt z3`!l>BH>J0fa$WA{z!){UvF}HzHX0nZw8(_Sb0Q87PjK}?At~)g$@6f1re3e1MbBu zY`@~%LenyMqo5}turoUEJ&^0_+#6-rJmpA064+r*%fUzDP>9NzhD<$s@-i00d&N+B zvwjmFDVH+N`sFl{xg3jAbi`YVObRGha*Atc{9&#{tASge*K?JoqT>6Zt_n7J7gQqp z8?=b0MpC2`NuOL?irF{)!JG8=vuer-J&WZYw6IXNTGnBX~rDU@t0ZIQKX>H(VN-+*L)a#+;O?m(zbv% zKi)Z6N7i0$(nasBmOdM-h`n%&!3^2Lr|Q?PkK^F<(R8?A#oJ5+m*2b}-V>}%i6&96 zj=ol6nI1kNt=J0ppOchlnr%U}RHOwLq`P~ve|a_modwpHVv9Uao)SagQ+_`;5Mvba z@h9hZC$FTv+H{!q)lfdQYVV|=Fjy|wDkSw}03k6fVw1UT1qMySUJbv2hKx=UGEhgN zqQYoJrCeSntY_cycAf|k8D92{n8JoYG1VCs-ImE69SFT9>TF|YeV2ZxcbBqSN}Chb z-g0|(X(C&>DxkX6A3VP8zpyZX3oV|cK_(=`k>0xiLeWHag$1djkGfAZQhTMy)xxoZ zH@3znB+X^=_5r34+GSMpqDr~K=sRikn)0PinGBTX-Kf@ypU4OfIzk}6c>@uF20Ob- zd-)dm_4UO|XNHBtP=@F(E!SbHb$N{?;K z@Q-J~M4m|F1A3%VIN!3N>k@(uVof2Jv&eX|rhPN}K;@be*geeRMX3KcH^h*J>Vn3n zVYXp(s`(|NW-8wTGPe6`ZB0$zj6E6xEMGXY>?AqG$j-GmG^u`09Ey3ttg^IY7C_Kj z-!2!?=c4nRdvdpW#)K}8E_SyTy}u=u@GFsh_26Jyg(2HIGV)tr5nL)Xc|;2uumSP(YBO{wPyNPqbz&qP`R z>T}TGUQeC#OPri5Pk5Q8dWqgCb9t$6J#;RlQTx$&2wux->Ck5y9TD(GtKdtUV>!a) z{Lz;baSG^}tH|##HMS84nPEhJO){MllO2(}NYhd3oD)afQ%e=^<5MVfs|0xT5Myya;RDkHl!QM4VX{RwEMXETk(ztWBRvl!&Q0*_1n+h zlgmmW;<8q!7>SW`!0q8Z`uyF=nS6{ZVi4upSW$19DvP0B!->RZ+eUR}9h*~n#TQP! z#BB-v5>`c;Qiobia3j$@`&kUEEzwdlO|oo&0Wmh=My?FA<6cW@d#i-$3D;F5izlLt z!EglD)#^1#d=tUZ-R3>yu~%^Ak%jP*Bg(ImJ#F|9ZWU(&wTjd6!Q9z1txlpXa;;;} z!_&!-=W?4Sa5K)~Ysl}>#~xim?|32to@8dRm?TWgn`p9l)2hI3m@JJU# zi>PmdY!EIQAe$l=Co0L1B@+I-u`)6umv+K-1KW=Aq)#C^L{fmMO9gF6tFI|OKkw@J z>iY5Y=itv>s4KS21^dqw<*~?Vlj^y2;JO5TNE5s=bb5jrta-{H5&hAt!ZjLwJT(*f zuZdKPTD_s0$dngjTC_(tnB7~mcB-&5r{Ti#v4Qe>jSn78(rqdtdQ*`}LP9~GC!X8D zbGE!4n(&bFYTblZ!b!pqKy7nTk})ngEci46T`eu`M0C+*9Rrys&#U8m7G<;{x%U@} z3;|TzbkFN#E+_EXwzF_p-5y#1{X(?i{Qy8`gsY~X5eC8Jxm|VF(E7S>5%5=xpqvuM z8$g+*9g^h~&}C5(xL;B3Z!GQ^Y}3;m(w*mTJ?|;HFV6R(mbUc(F2PMPAs*y&Rnf7i zJ2?2WMnkjz!roiOM%HXwx@IghGcz+YGcz+YGcz+YGo+czShmZ|%xssL%Xa(U`}8?| zrTcKyYF*uj&WDsj5p%6rsmvLvi1E!KrZ%-ANVsCrV5K|}!8Jf%t{hhDeM$Q!qs7+< zaQ4!e`qFGjZ-`2tinuM*XB1il9$Ki-YRb*9?RryG$8qT~IX?@3E!3yA7czCVMc1a4 zeyZ_%zW~muoj@=j$rwgsGZKq)94?Q>QyanS)>ON=BkRsj!ia&6p<2UFkSzb3)#*Z$ z)wg5I|qQghEL ziHeA7u4dV0>z#ITd3+fvH?5#>cL7?d4z1HkN>3eGI_!0qsb40PRgz6X%flJ{Sdsxw zI)r@3B&bDiWfhf5AVs3yt|40s&O>c6lJQy%V#r4mGh!}Y8zsc$Ok-q@*RXQr?PoyG z;mU|^-A+rWe`Qvbg=fn1BE98r!IIL7Y6)PpKbz(s`&so`PcEtL4v{u>)${ETX}h*y z;&gbs3b0l$7~Nbj1W25HLLZEIP9>aCV5Z7=1movE=?wUy-)L2PccdUX8ujyp)@qrf z@(ax833oUR=I%#|!xFCrq33hM7=z6=Eg9bqY^$4fg7HiSa49AwHD?sk+yI+8h`Kp4 zQO-WDV`7P?ES;R!>jD6;#=sYP7Hc)Rmb=cH%@?hRbUg$|?KM;3aucr+ODnI(3Xrgc z8!#OjWEGGLHdQRXe7Rv3A(i!GW8eHnetuXLH)S)j6hy_QbOoGtw!5|*N^lxaggVcfXK z#^grTXC*D}@Q|`HBJX*$IkhT6{^3h-qEC}JOd2U_g6{1f9v#CHOLkOvLki+5eXLy{ zaJbg)`%Ht)Z{Gb#E#dc*6@LFZz#^CT;!DwJl77zgJ@LA^f{vGW93OvoO(;3JRb79TTy!4De3x!F zej2EKkk#;|AAA$!3k(4``Yd}}K4A6^ah`WbUSAxHYwqFvVZdenp0}dVfxTCNDyV+y zHuH=uSOlq5IG4&|H5_oHjA9q*4WPoNPd@BD>FDS>^R%JUL^j+DKa)%LWPRrZ5_#W- zRTp-}r{~;F{nh9e;kpKSC?1%2cFIrXDiUZP%g5lXx`=xbZ&ZWIc_%x-5z=_y#@LJr z5fy1pCqRDY%$#37X$q|IP+fk`Ul2H|NK_1Z;sbHIJ}6%XKM>jN?>a9W!!3OOL%{1J z@n!W*h;uR2auPCXDTFsaUg^z>xuEP|wT6A3tP0~Pe(;LS9$d(Oon#B`9OUA<HEuUy>3fe;=Bu`55l)^nvFZ=J2h;KvCPhddrXA z_y#`V-9-lo@8;`Xw}fyp!E-z-tI74UaNRJ+KA?Hd-^Ap$jd;qA^Bz4Ow0ay}{SlM= zkH-(`@L)P80gnqL*~hO#_;u|005oq^iO^QPYr6MBD@KuSTfkSg!vIW?*Hg;`hl0;c zk#a<%lqw>Xp#eu_1zqaNs<4j+J~xo`a!r6)flKANVfRldT~2MONoHpkmCoJz(Ab&ciZM-fj1+%%E4~94Ric zD~^Ma#o&&wYpbsBx}Z5?p7wpj7{95p2J4JW+8rpwt4-&MfWcm);CUm?fz_WEI}X>l zJ?)-HkM-qmn5{--!_i2Rg~PYEimA7zmLjiYMvP|%FC(iO{at38CGb#m zC|&DA_Zg9UkuW$|TWGkbwF7UKZ)SW(!KGdDnVoNrY%-PR_n*|j2v>I8jCOF(LM4!L zXj)-jy>d(U1K6|>TGZrkelMjwUmHA4Tjl^+ChOLk>V-c^jM2i=d{t?3*+P(BPSh1TbXUQ)7`iBjjcmd# z=SA}?Q(0puR;J|qQ||G;C__qZ6XU5tPoa@~|KQHwJN*IK5K#fI2hD19WrW`4s3+_~ zr;P(ldTMqRc*qRwLyIl(x9ai_<;R{+9%hE6P(F{gWRSNZZ0;qG&M1)|!lro@91me9 zjT3=N%io3$jne(#Gf!~-9ij`Qe5W~A+DgUCcjj4Qt8G1lz+K5BSc-2%?6l#xGW8Bl z-Y!1F@sh(=m$K;DdbZ)4K~hO&54OsuE2OKqp1;gWLi^;DEiT#GTz0W-EEx6t*6Lkc zLG6J+^Syz+3;2S$=vNXBf2w?xxL5^-%3&v#Gt2`gl~Gz{7GzpQ=KuE$lNGIda zG3~x~MgN{$A_Ww4>hSuebG-7y{rezA6#J@3eovQI6T8;cNpr@B?WDRa3y-tfr^<*D zhkGEeZ!djOnuXe(HGJB`K7MH4Z7mM<)=C-Y_JBTzdft%6r+?yzhkI-tUVG`eM*7@Y zqu9IL^P>hRSY@?L)? zfMM(NBhZ>C} z@s-xfsHxD1v0!Sm7>cy=HqNJVqYF&Z0&>RySKNO5ZW!NR*pjj!v+irLyIdgq13!bI zFzLh)DK^oX*Bo(oo?$DtL`qDvXm`19U9*T8z+)PDQBzX_X)rD0^PDcG>}T~rl#IrS z{#iw0QQzb`2#@%Sh%@?O_YuR9Xo-3itLInHp(648)5+GuS_K(mD-Z(2HQka2z?Z#> zzn87noY0B0Rl@jTHNCh|pY z!tliPvIP-v1V~x0&OO3zC^X?B5$17@>e&3YQ)ZK=KGVcS`oX5x1G!|beL7d|IQ{Yf zkw>E&_`oiwjuWt37S`eIs0r^vi8XWZOstQWF5!b)&6r|$TT%xi9*w}rdDYmU4U+(WqE05Oi(@TwBLX%x=yM1I#m1wsb<|0D#F9W^mY3DK7G$WY*qr-6&86tMO3A!Y zA00V$cL$JrH?#8cy!5*Ykw#CHyEFW6apvmfT8zwpoG(guXytOW5*F7H60s6+l$VR{ zvhqFE3tT>q5nR82FyTBD3WjtG1q?h{ot)cJ zA**Zi@2uaqV(8_Q_FfDPdukFNs*f~0o_T4UFYus$MVs6KQGd zB|PreU+>L3U$`^(0ap4Wd)}SSFsk2GK<4tj&-Q|gO77{3 zvsHF8siqzVZe%NCqIT>Yb`BXRvIGjyrPdt331x~ZEN*k^nT~Mf*znb9`eXcdXqnhe z)Oj{XE^?PbE+UGlSymq|hz52DeNIV8mN_3Q!1Pn}wUJUq&q~U3iV7NsP)~k*&kyh{ zDsR08FrIhCByM&zqy?sH7T)5^fAxZ``J6-$6t-I{Uub>{$shi8Xf7W_$!C20v%8gJ8fFi0Y=-Yb;Gb?dz0>-XcJohIEN#$7^*p*hMk?~WNHPIiTs^!EUdwWS0ZJGp5+X@H z6?awE`p@a=kTY1&4_U12QNuqtw!>;U~^M9JvAVqi31*H06OmNWyCiCQB*z@&; zjoRE0cl9sU4{@-vRuxfz2-Qug7#P5b5HmiS(Zn9_-A5ji2ro;?*5PU1@ zINRQTfz~TvIhuji?N_SzOv`m;DXdxM|7rWm?Kj?nzN(jfm(74fhV+8i{D49WRjSQG z#wKILgkL?($eFt`b(Dg|Z;hnDAKmp5U5ymB724;h+2MN-ux3in+b=of^*vDUgg z=gYkvxG?HuyYa&%e}*D4G26rb7Qv^)Thlh&PjX%LCba}d(^}(X^|puzmGUe z|M2T2LN~zI!!*eWqk>fil7*(;E+Pk?*27z*EY)3V8ktj4%QfxQEbXu3IJ585Z+eaH z&Eakpq*ckm5(8FKeY8xr2Wn%#*x@*HmWeTz2U17{hw8gqZC6-8dr!2-H+NjVP)hD0 z&c_s41s`yNdgp6OuLQ};nl2m4fx0pGos-iCAl#F6e}6tkZQ0WEXI_m2ka@O1TXD20jY@M)uTg6^27!A{d>xLgnNvfF1XqGQR8n0(zwx z4)vic=?MlRINE$H1-^KSq`e*Sm4?NqUBGZHd;r2;*e9XYu<~jbEa9U3DIK5}aWpO4icY7)=mw zczIc>o265Z_Ux~cB(DIgiQzB+<|ffKJF?x~M_)(us37U`*F%P2cyo)QLs;0H&;6!d zntV;nVXg+1(;iRM6(+Rsxg=_jkhwhSS*Ea1HgDObS5h;E!gd_e21)Yp)35s>=RN1{ zJp1;^GwZSXN^EB9u`ymKWyrkAu}9-Bzd%AAieYyE6;mR=J$@4Mjh`Z=>JF%Wr@19r zOtDYeIa%LzoPJ%eBy>&*JqT>n=lRU5d9O3aElCsioYK-y)lYJP-j!>uceEXwNHmS| zaBW~8S@2M?Q1@0XhA0Y$=kjRCL@(8y5BpU#)@w_hFf7Plfas04KeT#$^Um!(^?ozFrT^<+T)tnAznSZH7*Zhl2DCi1M{7R-hdK;zYJG*UuaLi z^dw8oMv&ND`ZuV%<|J)j(-%f~&9bxTfBPo3tRTw0VCpoZ5#JI|EMUwwnB0~TD((|vHofEYwe_k4jEsKDBSGGXAe+lpg z>4(}+{Vgzrhz(Rt7h49ChRLT{JoM}L2-vD9Q>?)JtP#zN5pl8up%J57Jb{1D3GCWb z5I;f2e!9~g(%kB`AVy7=O9u7~`?*ATtN-vxZXnR}vDgnBF*Y1VzAY}L9FQwTo)sjb zW3*=O{lud4x*3yqLh=uX z@xPCdaQ#>G{}F`bThab6F66&~kT5ec{cGrd4 zX10G}FW*7p4)*`3tVNg&zOTjn@A2P_?*OL%@K|9s_$Pq<-!oTb`ez)|zbE$H_?NH9 zf3}#vZ^QAQEfzu+#(&c_s;d7?l;eN;kNlSz$v+}(X9p7%Gglo3MNx4ERWnalJqAq$ zV{0>$f2JjF_fO!zZ!K>3Jt@}zc-ZeiWru&Bm5}lOA|wAFBP0LUf8<|~#s44uM>rV2 z2?d6KTw*k=OkFMilZf~il)?WWuYXeNKk4(|iR(WSskoJ`tC=%{xb63EO4Q86!PJaF z*390*)$*IBU}5@pHTf_9ksb{zmjy}e&p+SXLmoBpb5*)KmBuR!isU{Kx{T5g`VkDg zr{v`b(@Q1 z{GwQMOTcN57)>DJOTrw+*Sv;b-5-{0a<0FLq-7vmn;wf-@ABD-gQ$U|jyj~7Qa<*d z+pd>svYs$7Y`OEI13YghDUHo0M>EJ@D$$hj=+lNJbEIEk%By_ zxh&n_jt0Vu6p}Pd-2T1R=KKivn@@&uwo+HQj9wU(jS2C@PXFd@T z^eHi~5wk{kwFC%e5;Ac<#cq(uJTDTfV0HxlBrl^Hg7juxjHqy}H8t|j9_#GGss&pz z&M9blkaSYrl;;X_G5Zdmdw@Nrl3tuTc@v4>kS2wPqg)hC%6+v}a1Nc#oK z%`SUEX%rI^6JjI&U!-K1n00zSjlECi0qPAd`p}Re0_51bhd24f2)0g?$zG9N7ewm} z2*lim=oa{1r1y*{3^83-hz5-yH4sEn)}?zt&Sab0?ON0by?&TGKr$v6f!Grle2dhS zCxT_Wz`69L?=bDW?H6blhh2)s*=)Jx=t<)#VAq#a2Q$Y)vnNi%VWx|JaQWkjux0j6 ziF9kl79ks7nmdJqNa3rj>#+ktG}Wml$)(o*Mv-V-k~HEqEKo{4q}M9UJ3}Q zvV22D2iy)x!!rv~05l4?z&2@-fIPh8FdH}srD5-m&CoVLJmf@sgfH3DT{gq0L2Auk z{boI6KQvVX8H;=EI2r4+Ipl3nwWsjPR(>j@WD%kx#|}tkS5c8De^nb@;w*@&&83S}7v@QYEV zI!ZM>RjaCdR)h~C59i9o=4u$yqfXeBQ|I!8qUX^N;~zF-z#hymZ`oH%msARg*m9BZ z6t?`G%Pf|lY^cQ#B#>;9_nVHhehH)Cg@iMpeu8FmN|%h8C7vh&Ls7VQYt!GDjl z+>Qllj9G7tg9R^%z^rSYa)fC(Z3AxYD5y$(HXZ^%il-m~7Z4cU^_Lvm_|zQRkZqN& zyP)W&EvCeZ9^QX;d~5gyJbj;=OinD(&tJ^ZiSKYUBa3si0+poPH3Os8*s*>O+X?+Y zuH?yw{K#c)WinR1)G3M-lus4QHF-6&fzq-*?}d_94HZN*qMOgqj)2X7(it z2Lt3f{Xlrd_R3Ds;R!kNtW6yUri|xNIuQFQr;qoRAQP3&B#tKydpz6%W~9TQgsQH? z@MCO|YuM0_($XX@`IOk!k4n^=WZPRMts#QlBKrQQ2u$ypM5Z{>yC~#@wjc@hR|rqr zHJf0G^kN9l@8jq!ZO9DPCy1P@J9mG8*i6B5d8G%_SJP*k*vF?MukfubCc1X)+gI6w z57W@;f=Go%A_D3ITDxKN99-5Qrxat523ZC4xM+Oz`!vDU+O80w@g2>b%|$Y{N;HSNn4pn~ zO(s)HulpkpCW(w#rs$k<(~xQjU0^KprcZIHSYZ!y=;!aBd)kIC74=&U;VCe>ALj7e z0^2N(!dbFUnX+ElrkzckDWk@UlMt8{j!=qp&YTt>`!i2W+hq0$Xg{=-)9))-i{+G1 z+4GsD;^aNQ}7c3sggio*`h)m(sslT)emq8nR?qn;vhF-hjWIs z@TLueT}1SZY<|*J1y*!|S6(J}ysJ!NWIS34DD-}$x{vvlT?Ukhc(1{<+LggwTnP<5tS@`{RmIHKX4bicqDf*woX& zSTD(#lv5L0gmYW0cI<8LS5a~Mm&=(lN~-EnJG2}r@A#X#)}0aZlJd|+se>)m0kbfh zgp&uTLWu1E@=sl^>}Y}~?G+nVfAFJG)o5?pX*4!s2pjE&Ucwjn)x?oRO*Bj8(rM5< z7_;oyuhdwaI^WEUvBTAblnN#3F??+o$2d$f#4P#taUpei1-3Eaij>`11t%=bH+&Zq z4XB-U3l7hD^f+3(w4)g#cKIc7k4nQ=`4T@!uRvCdmHA5=<+FsRm!0khuXxB_Z3ljA zwEL%VS=BM?co7})Y3@?~&ct~6)5wEmTIu?S+7^6~eW73`V_E%76cwr7=e*%!>tH3f z#rbC?0xP51+tKM20M&Wb9aIyDDWv^WivXKhqdjX_U8Wmiu8W=WfDxb2yQq6>@^K7& zan$=B;lUgrIyADCadciXwYg@3QXS>Ds--3^BCpn=F=b=vfoX)JWu2XpgWDAq=RpxN z@&itOY}_dAchra?i_ycqZk-}GXCI{UhQb2#qIBtXR<%J_QTml`LE8D|n_3ojGlMdU z>q(Y+7XMFIN83RK&Q(kN%(GSJ{wy5zQvTZ5)<*cTx>k}z9s4W9JFrA%2v^nUN1TCQ zx-qr5s`B+48dY0Ac%$SSV3V_|XhYge>Q>HYtl3TmONQQ1QaX%AktUGIUDWqJsCZK2 ztlfUD%egE?{~ZmUT$=`1!@u9{xldxfPTvRMO<3CsZkmoH{PFD5rvEcL2{!fTn8QGI z>=k?~93b7kHdWrDyE$QNT?_8tIJmwN2wP~dZTofqF*{!LGdUyO{dN1qbR)mosrX@a z)2G?m5tjv>7BcMZE-)eI^?1QJ<{?dVYh=j%qfyUxxduGDfxr5F(})~lW9sjLvtI-~ zdH~%Y{B0GOoJeg(=0&}2hFSNxdW--%g7l4an%5kn;(ZB5Fyzhjv0D|K^L zUBI*7a%?a)uGVJb+uSkJ{I9z-!NYl9lRE%)izu2MnVo>Mx*Cz;H9|Z45@40PBqqol=G*4u|!SbFeN;wa(5}TYL zZG$(Te8+J{Y(Z5(zUdUdfDgXz^)z)5+#2+}>8+_$R2kv!_rEXx0tn}W4MwcYEAt4< zIw3oBIr5SUuA6(e<9}!emf8;9uT1A6o0`Gxn((6=!2379{jL+(U)vxx72UHpU?KNj zFm3r^O<)h&()_iSKv?2i$NYbru>PP1wlDbT7+Cr=r#}2Wow;Z}Cr;_u6`WqAk-Y;aDQuHgLs5q(?~`76GwUts2cT zV^H<$ygD6OAy)b->UGwiy^L<=-nt=Nh2BfkEV!k(G{$qyV02=@XNI;;D<<1*mqZY% zU@W~Bk>M0?;wiCeY=j?8GmRLqI4gq4hkO(^H%y29K6Iee|HZbbd8fQjRSFD}xbvvQ zP>Np~S~75QB*@v>*C{^!Vd|Zu`;0@^-N3y|##!ClpLI&f0@})JiiPwnI&731mw8}b zViZu@p_jD^b@}5QFOVN=S``$u?aLPr0cEkj(=zfP!cJyj!w;7TsrfE++|QZAHnaI- z;Rutu_^x-wrbR~*wITiDC?sDr{WWdbbd&a6woiKmj@>HjMy_FXnGM_;Q?KCW8N zoOdG{2_&OV3n#z>ojWRVZRIFrv)F(Gt1J1U^S5>aTHO>h{Wv$b@gc0uLB(xnKJ5-C z@Er4sHY4ULpOKK64;)WJQ*2gX;(*(%YkTNhXcg*P)7L9N*DtYQ_G&Ba&EhHHR%?i! zw~Z40&%jHgR+$cK(itv#jy(axbT;0{Ds`X9VBW2B&LDP;>*p$5q;ZG_W&D9YbG|zh zW!J1@VvDOVKG!niwy*4pB@FEy;mmA;bFci|<)rU|%|R-!>oE7)Paq&BU0vRx`Q`?IwKlArF0u$-i%`;zAq5V~plidlA!!}T_SC+poG-PM=ht=nh%<%4 z@1`HN+>zAMRRh(5V#mLA{GlVzMYmpm2bYJb)P2{l*IbQPGd}5j!RoqF(+Vxh%X@g<{n~kazHw-b_-ehj z8~$6mUV%CqbmWoenPg65*st~WB4w^8A4gK4eeB5vZAsXot&~CKL&r<(lu?FGnKze= zm9;M9rRrzf_L9bZTB5BId6jVj`?N<3t!AgFPHs_;X-%gRV%0zBa*Nw(Li zL5%CiErX>pa+eh`^^cHdPdCn2|G5(pZ92N;oxGri?VSkh#C=e!n92ItIEhUO#p_Ryr00(|TW z0~Iz6HtY4#$GwH<$nGe5)jx zU}4O#_eAjyT*zka7G)DpVlmQkXwDs0mTKi*qSPN>!YnPlI!R^}V&~pQ^P9u2iccsm z3m4tt&|i=D7Io;eg@5hluFH92e8bAvSDWd?3HB_b9cV``YbX^g9;_{470OueiX+uS zb{J~{grz(saVh^I#gdDmAdvBNzNLboGbd2f;*wUl;nD~5iBU-pm;XN77Y6>@%xdRt z%Y{U;74{dyPE)3V3hv!r-^W59SsJ*J=eA4juSFt5fSKyg-nS~*IgB0@fe&esB)g~| zqy&&gs#5aZ+(ThCEXx_4luY%qfl*y@=?2=uNPZIYTVU4U9+_pzjBS~=bDTp#pPE}S zd5i)sXU;*?wzurcW2-IiT1N2GI~=KSlNXxSx=Q2uXy7 zm3Hr&)yY>lRwz3QWF1m2%qRb#$^7bxd})2=s2Se z7T^<~ah;g~5Vz>uwo~lUuFpU?gDJason*FEH-x91IaDuS8v>C7OpVcgwD@gh7iKM4 zDx#-I3mt~efea(9Fw2Kjjiu71-YYsqb*27BAZyBcBj5ss-lT5E);Vpyp#kKKSk$ah zRF~pQ8i6GR2p&&zxSGCes;Uf3``mygR6;cie(Ztr*FZ_U;@Mr&PG4Kfgk#nB3`M=; z{OO4sn%boYPXxr^za`NVF0cy9c;g7+Z$ z{8F4c`6>Mg%uLI|Dh;sh1ozL3pI%oq!*?2UeIK>$pSVPdJM_+{`&zYMwqRg20H~fa zg37WNV4QhV&Dq`yne(`n#<bEwhI~odCfWbAp z#*^pR(ijw-6_=TD(j~ZJJAZQxG|jch<9=}pHK@Z_nV5q*8UEz zF&pO;i1024(uVDP1c1Nq#xSg}`@rE}h}D0R-*6ngdWsSK65Zj6khLl&VW(KUEWjMr zcqeGNIF^9l^W;38H*fV8)yPV^oTJa z6;oqFHU7R1b564a2^Q_`DG*m5Pp>|Ng(XS@nj1QnGDfmX%z}EW=Bf?r(qhZi>HR&{ z2yxVWH(m^b#EUu9BJ6kw4sR@G>_A&$r^!aix;t$VyL{wOw9%S^G=arLU>bX&nwmk| z<%_%~K_jyq;M7D(L>@^hG5+MVmeJKIn1xCS=LueE!Q9=fXV8b1=o0{aA?@&Cx*P8TW5xI59=5hD0n-hoHD1rAA8fwu7=Z8 zGa*6;F1Gu{0an7|^h+rx-t#^Oxl_ADXj2{6FNq67eUJyWIuLMUYvrlt*)C(oRv87QTI!@+MNP?b@+ip3iHV}Y zB&Wgh4Fr~^?AvJ{q#3dt)|sw+}+yE3UJ7BSPDQ4tHzevx$zI8IaAs|ntu zr7i9ctQR0DB!yF^FXTzvKY#LwpNyYy2EQi3F8Iw8W#HrPw-f>S-GgD45bmptnPa)FVGs=(ytwf6bHj~Dj3h1lQtgn(AeH@qS| zkVOz-3j^}=&gTzzuJ<{DfBg96m@#lYkc{Zo+>H*|2-I;*f-P=-Qp4Q92prKDjdeo+ z8hKObJ3a#>v&msqH(|XmSC28aP$UPt+X~KCp9e$F({(z@th(xAE_cbAat~mZ_{#@pH2_dTcs+J<^ zQC*n0E+=FW!%RPz@X$+0vARr_{k*;&`vO70A@306SHwNwq?FGFHhPWs;yB|#DD#2 zKVoTu);5&{WQ^8Pc_19%T7IwGX@oE2BrtV+OK1a;IHVp#0)z{1HT9r>TFS^7#(xyQ z5T(k4-=7oPjPOQ0e#qV@H#!bBNIwelbmq!P%>Y9yI0SZw!0F37uFTr&MMXjxB9)@7 z3lOsl?PDA?crXZhfhBX;8NUxNq$Gx6k7sqU7QBUZSy01iF2jE{_o1aQj z%t-|>o{T|>q|Z+iG`+3FiR*aNQ7w$dOOg`DXIo0`zlaWN^||nld=9o*Rm7lagF(p@ z+miuWqInFej=wapr9M?Z^!z%s5Lv>yAa8Ck0!ZgeN@flW5A1SuS6_j_?1FGL*Ze6> zn-q`QWjb&dL6;<17Jc`)zpG2-uhm6lpAKtxBw8) zQjbAJGLN(>?}j5VJGlU=B?XYw=f49UH0y|k3TGJK!sCv8h>!WL9Ra8Hz zNr`LMwIO5MD85z7Iw(7Q;KHw2c2ld`G6SH=z%(g8l_~_h0Z)nGT&y4p&eh%!>pp!s zWTl@F+5u#7_R{;z_MLHJ>N+@LAU8gxS`Z!RCG{e^v!cLs4019XnQEc)_?IZ$WM@Cr zU)lS&jtgK||NQ*>V$t-L-0#};?xZ6bn%9O{W61v5x~P`V!T3_|h`0Rr2FO7c0sP8W z;v#E_p~1YQFE}!Mc)hoj?Zxihl1t>CDz#H5eUY9p=Zy_NwN>rB&W)&P zrWRjf4i|E9uA$fZHmxbv+PhgFS6`o(OB?MfqVLa zM}v_%N#+KQzRE0K>A-ntZ3{CB5+j0Y*&5)^s!9`~3LLcZYvhBEQ=o zjrxkWp@Lpd4G%{|&h%w$>OEpp$}~QDJ|7xRv6+04OPgszH^bbXg2wJUMQUNURbWEy z&qpy^+MEbpiZA;Ua-Ug2*N7IitK?B7EE~rT_9iM-1YcE93TNi{5(&>Ui>aBmRHOw6 zZWdv}h;TVg)4RGi>jsE_Y1#JuTxImNny(f=T;8|-WfgSsd5%*`BbA7{1S#Bo{b0#3LMhwn{EL*}w zj>`-W>i_}PMjTu9n!g9;IRf9sSsogN09VH|M}BkpU{!KnyX0vp3+Yj?grCBWHJ!!F zTIV`M6zr3{5@iW_x#05Hk*MjkV-560c6Nr)70m+^QIKpumiJ!)P9B#pi`nQF8%Op4 z|E&2yrxzr*6+Rar4GyBdpI3|q3_)l^4h0#Otk}>D9ij~}OXp2%T3|Xt=L(JBI!N93 zI!*7&1LkKwWYrm#xeV<$Cfz#z`g9x(>!j6Vbar`H_oWdpfeKQ+F%QmL-&HA`6e3xO1P2!DdURK7A zVyMpxw)hCm=o7LXnB-2gZ~Qp;&cH751S+GV~h-6DEbK6##u1?5x| ze~=%{T~kU~jLM4-Q)F1P3t zZPj*aoDv7%Ltw9oT1-{3PC~ zkIpMpSIN90`+YDCbv8cDGLNPfJsqZU`67mW zsieGgAofWZUF^>mcf)E2mUQE#mhzD*>tQdkzP7cRa5@Q4SL-x^{uIogKJb9HxyWSbo1)Rs97&4uXrQ?&Mv zlkxP+9*_5BNQu%XwtDwyzULA=Fccch0Rua|ktZvjo{?ke7;3%Obi|U3z$Zu0wQns{KjWdZv&U+S(-!KwCk) z8ZGKa{1rL8f#Ym12*DvbQ=fPz_p4QY5M9dm>?Jcwyc~Ro9ClX+u{h;WB{yvlg|Q>C zgk$f+Dk}r3Ddg+e%~N*uQnDpF3wtP9Zv1%7dBP>DGxwrBb;t^}u;``)F*5F*;k>w| zZ+B5pU?vh= z#7li(LLP7ai34nFEZ*KhxVFFY+qHCvj19c!VL8l8qA06;?N*NT7KE!!>c)ZRI_(1Q zf^s(>{QZshKsh%tI&%*F1L zp(-T%Q2h9C%C{?XUmUo1b))BSpr4c)s-VCS+8 zim38khB2JyzL*e3p_h#g{Xce$Hf_Rvt*{K4vM9(Fht8KDBrs-QEwQ&(^PWjCl7o9f zzKXy^!jM&t_p@(dl;PkBlhMhARdjVMRn1SvyBZE~-K8zYu|HZTbcV{P5d(MRaoUbF z5Szll?a)9yF3b~7qttbN_I9EDv~G(0(mlE**E6G>nw^O8+Jx|u{>8T6bGF|uuQADUuTX<-hWq&-O7Do%qk37ak z=*}EGpF9FWd5Cf2V6X!4q7jO805S~V4O$GD>-gR?1(kxZAj7m86EO!&MWMnr|HCa1DCj;A$UxEqcfPz-N_K9`lNY+g(v!z~3!T&@ zb}tT_Zr#y+;!JrqAXVcnCe=UKwobECoUevWTA8L-A*5YVK+Ri`PKCUYFJv<6M3TtY zP}%zCapcMk6MWBdU0X%hDX^l&dNf=XEnJDMQhRcD*)s}u??w47u9SPuj!>rtYdDI~ zN6loVI+!Gn_2r>N=rwGfC>(MFJFy)s6^nc4nOdiSnK3klQ8u)Npo2sT=g`+alTewA zm^zJo!Zi9>ty#O-5@TT-Gc_yg_m)9J%AJe>d>$zHs-C`#3y0$ISXU6yR;~Lq=kBW32xXW7`n_1^2QS2YCSq2M4>8W1sGWdj6@6 zUn=?O-I_=S)6dg$y96*`G1Q^Y=Ed&f-X7!BV7AqF&BVG!xbo8nH8|UqaQLP6IEp7L^+Q zUV@neuISS-h4>b~k%CbUrS=%59jnMfYHs%baJL*VM@q$M*?k{+@o4@M&rHC3;0Z$C z5<8#|Bf9e7(k(tiBc?B+gb6R)kH{Dj%o*s;asD`c67d9OhfTt7=S+FtSs@074`=q; zhcFV;O3iH(Fo?bbw~$mWKRI>-l0*@`fn0TV4ga}R45=C8n1xdsPFil+M(f|pdtt=3 z^gq~p=OA02#!s_t-?nYr?!Il?wr$(GZQHhS+qP}n+Wx-pZ0v7iHg;!cCuVmeet%Tt zIdw9#PE+Gx70?0W;ddWvCt2wNPkU>rn@8DCKyPp06{SN^FABz^^|25tHZ$$dPm+oeyXZ(So z|4ZxtL3H=OspbDBy8GY6^#7me?*A8fZbtThpQeBD+)V#syZ-@G|2Ljn(aFKt&`D0; z;YU92h|m6?eE0ukzWYBT0r3AZ@BcsKyXhGIariU+DC++QMgp+>qwxPfj|5<1;-LMx z!v1S%{=fA9G)zn^v@G7|DTKmU}FBigU0_e>i;*O@${_!J2ZYm)!H#b4C!mC zCN)+;IqC?f)v-+?8Tog(5f|###?l*Qkz?(CGzm$4gJzqqFAsfhZ!X}}YP%$qWI(o0 zdydax1{z3zr#_&%lKqz@3!5Y~Xcq1qx&^N=I0`^<-m&!B7 zA0H6BzbQ(&>(M1Pw%n(R{Ye0~yUjNY&=1cS*HtCHpu8ynsS%22(Cmpm8y>%hCJQ1S z&_TjPyK}<| zU*q_Yn7tcsAqIGlgQ;V~V%t!sa!~s9x+M~|*pqz3f>67e@@J@BktsMnr6jJHT2~*U zejNdu?K1)8AlC4<--`ieaft=*dK$G?M^kDq=dV4EJaon_h87`|EjF)hxBUnUwX+y=i(rJqQb6C=&K+42{SOM|Knbf=ha4qO?@7lOk9!G{#K=!E5Px zMY*h{avDtk)Ii8Z-!oq?1J*WM2rx;)Km5QC%HAKBLkWm8^Su@agQb9&?-j7P!&io4 zyXQ}tohS+eS`JwJph#P;$K?A(>##*;e0EqjV?69lP?konF-CyCJ+|qD7gv}(TPUOYi#(V2 zxF3<_J<}mJEj$R=SU?~&nRQifQI8SALdc%`hv9u*2hN4Hr6!gqVy<*!oTsE>{*aw0xw7+ZK3T= zRu&iq(c~gjI2FuWj7~>#b#clWA~hsL%Bm1C3LCG6e?F zsS#KZR`s{e5Ny&rfDf!^f$Z)!^ki+bt#PcmOC*6~+wWoC&X`*{LtuAI+A7}0Of1W7 zk5*EZvKCZXFCreBQq{;b5IFzN^jk&hbAEdKm5ZKlk4|dWNPyjqGJy9RgPP@t;Q^q0 zSI!Y@HgpOr3SL8!{2W{Bx-Qc$*0{a$XawAdzbNm%1NyD$nSG19BJO=ClECRv=$sFl z#}mS8q6stqSpOSl@om(CwVWjhHzpr+7F#6nh*q9~{e0M=102V#Sx(b!s`-hRdth8& zt!$_nCvP}>Oj6pk-1_!QXnSc^6x)qtp!B^LKl5EpgBe>&7OQvFh_hmvqj{l&qq*vI zx~`}o+VBOdju)FrKYqvJfYmQ!zxvEEhUU>G#@h1D(dyJ}AAM`{%{~fPcR?)IzhHU| z!X|<1d|JKvp+miS@^resXrF#OM6(kZx=k^;b)7=f)3<~gCp0S|=_Qv+?{Ux%L3d`V zG>WARA}da*6Mar)H^|Dv{}ggHw;y)3*8DlRQJI|}W2rwo4wiBw4wg$nS4=bbSAE&= zQ;?P1Zitl`yElO~%4A&oZ(yP(n9yR}g!<&FC!-v@W-`r<)ojehXB*k(n58G;z?-73 ze1TxD71-!j+gfWBn~{*m7P`W!e+~ot^m7<&Df8K0@$qCN0S|o*_Y{YoA}78$Ok@^h zwE~{DH=RRcajuH-rOl33YLu#`MSwLXU@O?GzU>*IH#i^7V4`DoSWDnWlH-M!igH^? zPOSbm%x8d^a3f%Lrn0_l4N7&Q&RyYcM4Jk;J^rFHnze3MAxlG+DRQFf=kO~sm?({R z=6?2e;o;$eK@ZPZu+gUz4;E}1vU`dM!U!1|nUY@zSwp8BkKd91<+mf+;4U6W%nLlz z#80mv{kN1DvK@>{1jHcLbxYsbn-?c8ls{Mx9Axy&4hm<_i*Yk|mNvmHl)TjHP0p>R zEvjb&2>@<$_#rEcC>#upHKh7MC?U)jqo$k9xF;xggkk0^;tOLFfp8QkFXUnfU`?3$ zjKVL}hK5^^nLj%KSutpl6_Js~zm;Z(_#yE`{qaEg&~#KXhdAfw8u86Fq)vWM22z4i zGHU8Uizf8yO3Cv-oWU<)8%oLSruUQV8lXGI)b-xLcPD;0&JjBzeQ)*c^@{B?ipA%s zi_!~+zpxvP(c8>8wWVgo)`UpCQBVGfs$R5eO4rTgTA}n40&blGEkTD85k;8*#B{kM zcOVZDd?pDsfUmt8a-TS^7<5Co%gGnu{x%MwHC3$`UlsP&&5Lw&V&%#agoXK8h=m!Y z+mo$Jb9`)S#@L!^ig#pF96K;L)L7KwzW@L0iV(cRX-!lhG-dxVdlB^VKM1`$2`bhSZMHDSZ_p zEVu&hI{Iba0-ARHGsVp|P(6hRet8287B6uZhuKKynv?MP<_><;vzZt9+mFX1#j0hr z1aH8PGFvzAu(1NLvFZV9td3%LAj~hCk88J&|45G<3bK-b@q>;Lm)SA&2q76@>PwY^ zPABfpf6VFDH}h^zgp1g2T!ab6>Mo234o69Ws0+3)OxayQVdER`I8wK!UjUQ3Z@b?90HD*Uoj3yK^^?G zrSE_+M)@0Z2B6%@fhD8sJeB^h)!Y!_kp5*#?$%!nYSaDG!BE8&pDkxgp&(WZw9Gfa zc!9}CW$vI!EY^wJS0@HZEJ`K9bXVsh=VcaF9%?UIyM@_+DbgEJUjl3W0#ae6(+_&h z!5LmvhQan_F>J(BF850;_EXx!f;wkz|J72Dt&LUp z+vAhR3F1$4$oF716q&}=nxw6vEnYrd5se$gVW6n)>|yN}@gXJ`NKk07F!^r9rBkZw ztrfI2xxpzHgWX`mIS)x#gJF-;3$n-4nI?vVa$EG*XM_}^>U$8`4fsHcv%yx7E%i3b zEK>J?*U5ED{Vc9&_}Ek6+aKac&l<$x;w*|TbM1u$q|2z>xv^^T@e=IdLWU2PlQ!+y z;@u?ET!EESMN+3j5+RpHQXEE+7Z8OZA_1JCkR)s)b?h-$aHS;D2&RDo9(I9hzh z!%rqy`Uu((k}_&VMvU=D^>)tIJtjNwi16f%49SK+f(nww6vbE5(6gt9na)^_VdUO3 zgfUVrSK}A=jj_4Lx>-8<$+4!pYVh*6uZhAcrQ0=SHBUCR*S>S6PZ zcJ%bbW-%H}GRZ>Q4riX7k%M9Ux|YIkswXqgT36_vUQCt(_~*&dYRW$len>tOq}w*X z^@+7RuGd8Z8*m%JDj%Jmzm!4)`!h?b!azCU{;h1oYKd<+K$;vQE3U&H$bm?xpFD9O zgNa$Uv4-Qp>C^_DppVOc)=p<$X*eZ>Xwx=XchXe9=KQ|8u_uQue<&iy?Z9#CamP_>Nb5FC@7lR$@1M|KZoM1*q`oDDV{&a4k%h9#7UQ}N zUS4G9aFmoxoVpGr|CuDcKLNzmIk->>%Y(->F9?QEab-7#DaqjosGh$zZ3->RFJ*8w zmz-gfJzx4@JsYK*GRHg+05u<$JkQJEZbfyv7-dC8y=QWr6H1@P8}p6$1c5kX|)z9Ugi z4x_Y$wW|1N=ZM9MLoHTc7?qBlH|*x3w!!@9gUj7!sRX|ikoI`cua>mJ@p`*Gq=*F? zJ-dQ5D8h9dyGe^V%WY;)64L=ttH~EfuJEQ^WFgqwERDSz&euuKP+hg?sP6TN(jDwQ zFBmj@Y@^OjUjOwOy|i3_u@qnz4BBLdFAc{(-mY%`sIw3@;}Szd--deyjB>_5QsMpW ze$?>bfg$G46NR(NlHxK=`~0we`6rPMmsl>gPh_bt@DFZlo0x8YI=6iGidK{Wc;Mg4 z$i*YeHlSY;L;UARnMWxsFn@*G)@;P;-URQ)wBu@2*FCy6@Q?Y0fx`eEGiQ{B1T=_< z10!G1!CDUE#xw&fOP8q}cnBIS6ul}UP~u*YbyC`;=s#9g(H_JEk8?kO2_4Y0J?;~( zb8dN$TA2TGb=y76O*J}2R2QY8ir!C2w$IwWZkSTbGUMJw!O6ha;?}QR&>z~lL4zO# z{C?*)N0Q}YSgb&6;T#v>hlVV#IAj7EYAE7*%bTCc1$0BG9G-=ZHH;jR&&@j@QpW}d z6}~R1X+>a~Hlx2!I)A%c(teXWJqT!I)_XkVU1PE4zSdY}lkDe|zUQ!{z)%-;2LWNA z@GCUN%=UV)>7s0o9gOgrk&_xNEzM!Y46EHqgb9>gx2mO|tU-j(WkIAq6n0p8ba!!f z6gk2(b#1w?fLV29sf|L=?|)Pi8}hof=gRopKeD*B$F@v^-Vf$B<3yK~+6x*IRUC;Q|Is7cXDg>sVfI>t>V*Ip1Yi z%t-TN_J=}eE7XV|Z{Mg~A|s|tUgTSTET@bM90Qji>$58g-_w^Oj*z@nSSNTseZAW7 z^T-15R<&U@!WMuRO<8>M<%_V^=JA@}20-w_oLtIfkGyREV&)y}4@d(1f;}P(iWPc% zBfG5!n8@<2O%008&NWHBhf6AUeogG8Ih!7wUmpJD;Oi){#Y0npw4N(4Vog*(bscR} z4lehct_aa5YTox_NMq>tBS)53if{k81Xjn%$K*kyp6$93Ba^p4`W*pQcz=BI#M|K_ z6_+)Q_N?BGPVSSTkA!p9k)TI9&km^$r|xG2p+K^dl4QST*vw~Ba|dmw1gRF9K~X21 zV!9t>vE0Z0Zizf4)MQqV&JSnz=-X23OYBiRK8g(9}gX!^bp=)>LjP;G{d z`RIEjV#;XQHf?)fCW(_t4@Q7@XER%0!?YXj6-66&>m`2k4qu!aqY!cPm+W>YuhGMl zUF0KD!0M=Y(XUYfc94EcX7JBW$`L2QqxHAtmU>)hKR%w028zzBEdy{hT&7+^SZ!0^ z2(zm))Gc-N3!}zFGqOI8`L85~)m2hoOl@rMnhboo$xD#KO@Iuli_4+iI~k)klKhmX z?1vjfP4_gn=fW-g$K+;lG_FBNiHIU`W^sk$0N%V){@qOfG~h+o=4SH7mcCI82qcTM z>tu>6jYIz7#`C$3!&R($rh$Sffr~a@aEN_c8er~xEIP96O9${fzB)BebFxVjKU;MV zm<|fSdc||inwf%ohsT;dF0-?ad>=RJo}9RjVT$TDN=}PQW3vjgt;LlE#wMog2ow3W z4^~)L3q6v_X&VxpmRcKajjM#MwQ?KK_YZ-t?@g%Yk0W=AWzDW?ID086_)w;Mj@m+2n%gM6MvgsRT?Vi*^CQH)0p++bgDIwL8V(()OT|UlRMw>@z2wv@M#9 z@5)P9Om}*u_aBQNZ*Uy%;LMuPCD{qFhN5J(1B6OT4HX$wjNj}X9a*}@BPT*Y#Knl{ z>X_j@#5;e`J)ETG!;$QD33|E!n1ITEO^oc(r0H&Gn%;p!ymP3uQ*n5eI`xYniHhP` zjMxZjE(8Tm5+-=SlvIs;?0eZWWDo`7x6#H3)Lokihf?)zaec(|T(n1J7hq`>pXzZ) zc@SRitj04m(CrGuS^Z5%6c@kmddCi9$K$EIxpQKpykr(EtOA;0H1Kmpak^MnnT`+t zW#L}>nEwEJ3JX{+Nf$4moRu7TL&4w)!-TKiIIKo6Ulit41YzQ2p=keM{FyNlPq2ze zf29C)xePcx*$(!t@afvcNzf8m_T~89a?X&L7!+08n+TU*20QK!4x1y|@R(9h+kE~u z|B|HTRg>H^VpWycDq3m|SzXFhP)0+;$K1#6ulKMb$S^U25#){9U2Osx+64J?x+<+(setG3Ck|ulACI zsMmgU_pR@lr5q#egH{UR+U9Bnt|S*#!jV04$VKGD6lDZK^3p`aT9f#p3$wtmzkjsw zYBZeuGuYAN#FKsMm!u365eoWg*r^zNQC1gdSouzX-UDHjNUb={PjmfiCz_6AISqxA z>O)6i(WCP$A(S}99YvevBXSke4P`2`K}xS;@Y6Z0Z{DSSJAEwU&#NetssPy z5+i1~A3tKXyM1(T=9q?tW{+2=&z-jZQb4X2Xh^6?FZyS`tO|TgL=Uz%F`qGAj(!AKjKjcncN&JxC6P2 zTJ+Gww{=ozMco{VzW&;>Xj|B*=B#Vwib3*wn5A>?8`e^`E4@zfX=praS=>@a0NIT+$;?KJ7c ztoFPrZ>OvlUkDclHa_X$?As%l0{S;UhcwO4w`ug?ia9Y!Y}J*ILZ*_DfuAq(sjmEa z!pC`B?>Q(0bfqm(`4T;CUA<#o*=?&P__gab`$D_g&Zc3%_c%*aC&g5f=y8j+BXh+5 zNE9ivB_4?xfGX{Q*_8-#bf6Irs}HgY$s{#8t$F3#@Hf8=kV$^?_yT zlLb7J=1?IxBdOB(Gn{;gqNRhfzt*Cp!z2#TBvt_cl?aHqM<$QxQXuJvl|9A|ldesQ zYX|{3mU$sWS1%7Y5xF zB6qk;!7xod!66)xeg7C{ddDL#8V4af2WxNhTXHnEI|3lWprS5`G>rT={Pvzn!2ovp zb_IP;5-N;%kHH{zrbfHI`tRWBxEGG+H@onS*D@)fW0A68sq_q<9$v6McoahM8}LY? zU*TZ<0A?DwtFgzXhKQ-*ETL*3Ys-WP)rzR(z}XjS`z-*}L?|!F5)kU<3D@ZwDB=<*A<4ZBZ)AlGnM^z1Z z{c85s_K3iqZ&JJ+y5NkOYgNjI?;spfn_;V?uIu~81B?92;T4FMC&9Fe zSN#WgcxoF@pHSNC%y18*<0&_n6`y}{Cpv}&IL`O9^rL%Q$6?AXJIXwP(new`|?#THCYc%HDjjr@J=f^hIF{Lo`%z& z)!T)$%Y&9^;FlA9rOMEfnSB|1c(dfdJhzZ$N^#mzN@&R`H^+=zx?RX^{Q)J1(D(>m zGqnqVmX?etCDbo(xP81hdr)jj^};RKJv6^cqdwiQ-tX;X5T^$^iVo%YdM?=wzO{sb zoq0w7vK4Wz9l<4-hHl2jqW&WXkWvPS)zMUD0F9qsi>dC1353 zZ(k~-h@38qL75G54@DIbgT0j7ww5uHupforLkyWgpFuwrze;vnHDi4dm4>b5MCfyS z1F%8}T*_@jbk0Ii)1b5^%x7h2zii^^fPox*VnA$e&fz)jS$}2*d7_|C$#s0P1?8<( zo9Dyz^&uzcw_I+tNWtsj`bOVPH9jUBt$OR7lTUazTyZS@*WvyC)A_8YQ{6|MwzY%j z>|pw2yl`k33%cObdTQ7+?x#F;B#^hSSLf!Jn_Gq_@g%20uoh#jbWp`le!1rSamhwO zJCGc^glPJWeus~nht5_ybUM>^!RZ_CcQ5TX9vpH!{|^Sf{+I|1wZU+o8}j|-1so9w zLfu3NWvyy!Gjqgp3rmPPTB}svTa+Iz`o-ItzUV;6FB4MmYQS2FisJ@{GPaB?1*t6; zy+{|%cwJv4H~ z!pF1ocf;^;M`)3DS0`@xohtAjKXf1?I9TMe2C}i+?i8V%JeQRl1eO4jmV|PJ)y+q* zOmwNzIp?qXZUHd&GGHJd#7U(GUsIZunJnJwo)$9LF3z@PxWI@af`06QbVDPh+MY1# z#7q~vDI|8uS7!d;-W(&wHc29}?7Pt0mP#Bo4om(RZFXm#dhacaOe^5pal1y&I?u!C zT!~AiC>$hDXuR#I{A5qt)5=U+@B65&*zu3}8D1{wzI?H)Mmsx~Z-_M*(cOV3s>7G} zeUAyH-^haGw(Ydx{n?qr{A(vVk;pRbQ^xD_7%i`}g2t#7i*^YxRhB!*U z!(iZ8UbK3FPg*pJR&JQ!8&@|2=ZS$DnAknV=XmsF!Z)qPRT_hlAf)Ma8ww~5Oz|kN zq^`}qnag5!0@t&V)Yn5x)Ju@R39Jujw+*k(1ND0|p9wrqk_q*3K-fACk$tBQ4L+iz zqznkpmmbd7Sz5($(2Is0_$Xm1G%QuvpjB2*RaM^oP1(-WLO|W=WNpLm*`@|KtdT?! zzDCYUzm;)n&SYZSMrO6IrYG`{A^Qf6<}-Cf4)$-U3AG8PL`H@}dymY{g;LK|QPLps zoYmbX#+9B1e;!>^`tvX+Qnr2Sz0_`1&Um>$-@NPt{E2U!#zlyp|9Z#C)jzAttsQB) z?7zUBpS5eXyHSmo?u9J{=wKf3YfQzdz`X6qwtz7L!qX#?y>pJak8h@}w$0o#pqlV&qVSFLon zhI7x8@cG+0$j7~h^Xee!y2vkTL)K{{%)Hk`x(cXW92UjgUdG1Q?k8o&87xu=v)0(^ z?U-xO(n@U`@WEoDSE(Pe{~4)wdhthuT`8{N8vhNVlwLhL@gP6&^z7?+ejX_c^~A*6 zw}X>k$oN@;nS&qA8D-_;$FlPKhCV%{EAu}LsZ6q}IQxH#z#90+mKf6HgyMU?b&nD)-0Xv*jo@aSyg189Q}%t0IUSY1V&BTor8Ob*uRkKZnHB81@N|Ck z>=Ga&(#Q}Xi7N6`${T-M1PF4W%kn?oxf*l^($O0b-e$l-SfQDCnH;Cm&T{dWPqy5R zE}O3dVrV%Bj&`P4h@Cad@I3%X4)m4q8ElNUH4=iTkwys|%gd3uWq;QADB0JcB#T4c z&tPdO?Whl!{{-KQUTb<5j^QXA&WXap#>|A!KluDsX8Ga< z{(e3(x0F$FyUv&uU*l|j&~^Jjp{-ZLFj2U?JRPgcPK2NsirnAy=Jq*zqxhWUSCTEO z$P6!=h@o`+SKinVJliy24XK0D0*q@gl!ruhKV^6jOAwF}{g*9o&e!?Z0vz%bdlO3w zb!6pBHG}H~QqfSjgA4XPvg#Zy@Dt|>`{3NHoZOH%CQu>@H!>y1vVgivFB^Y<2<|&d>s+0rSlfL>Apw; zGJ#()wC~H|mVD%@D}Eahyi$g!-b)PMj8}l8T@9z`J18|cp}gSB%h^wLLRshb0|Y+}(QRf?5ST4OTK} zV0yfVgv@yDgpnI{C{wE|At{(~VVOLoXH6U%D$y-v?p@_whU&!GMm;6@94Nd-^;>$e z_aQvitymE>1+6F=UjJ0vt9HKYM*os2loMtUK{damO8cWs6(Wyt5r$DJ*hN`R)OQMr z;7ge#t4@4z*P0Aw7Fo_C`Ku$D^ufH>Fe?XwFwGHtrr63P(g;F{a#ICgG*C#QV2{Xz zUsBXOkWIQu?%El*cPC!v{vO?6TJf}DCW>ML&;I?)OEGXEwi@W9QQbRQB^ zJ3hWvX69qY0IN8sIMCA=3dj2OT3?-He;mPUO@L?BsTX8|M9AsA+ijy0kryRZqlg>= zi&css_HT+juF+W!LePoIgX<8*KLceMI@sV-l!_R?&3fR25<%Y?y{Wy8qoq#St)ils zO<%q+Cr+}3@eJX8Q;k<;9M;F~e@o;>ZALK5`qsik_JaGew39_&3{ZV+(9_v9MtMyU zyo(XsGhV`U7CO(GZ@X~C@F*10yai^oX4H|pu?(scEV0!N!}#^5?IX%)nN4cWwO?q( z+DQ|SYTM4p(%O2izMg-j$Xr)45mzE|!VyBdqD%r=L#y2m&nCo}i70&fG}-__N0A8$ zAfs`h=4i}_RDpE+@pVxuOhz0;q}L^)`4V)nTUh?D$TJq zeFOdnK-_c{+UEZV5dQ}s{_h9G|FK~Ij|Ig4rKG0&Zvw>st;7CLK>R<2-}FCrcX}o^ zdU{6TpYlh={IB=yKjqKH%KB6O>|p)b{;9*t@KZAX`}GgTO7}k*2>(yv_y2c=-%Kq3 zcc|unhN}Nds+og{nejjRz86$A9oNKAeU^WOET#1#y3VWiZBT}L>|pzTjH_jCRD3XwLWvwNpOfd>6ZGxA5A+hEU8+=3Q*2wB|6-Z} zW95X28l}6Q&0rCLe9^rrbl#FblbvUzOiv@hpQA~@dqTdFe@de2mE9?GN`A=EzaYIMqTM(hIzyb3`nnJN z#flNwV2g9kNt8e?n*?L0ptB+zBTZNrPLkGtLfAkN0Qm?ae6UYVOZ1YN-8AVEYdL+R z6&e5i;GDr*e6IZlNwaL$>8^2obVH(Et>CndLDr(Z?X*(`e)YznMR`CiO0e&P93mD3 z;uJq2=B_z&@iZ3cUCaA>b_GqTU?C7_7)lNwk9?w^2=rZn5+$UbeYt3R+}S*C4ke`= z3Z05Rjgn;8jkb28f*&FW@dnZ|tQ+U%f;B9>4Z7GCs}^Wrr=hVU$mr=X*SiB&9CWC$ z!>bzRAaz`Lqb1{4^5)cKv))@XAQioGhoqQ^F5FtndYqD;R0mZ$L>%6IS1;1kfppbx zp{GS;{A3~t5@`5$eGu;fc*3++LjLvls5g2>r0`I8($hvY_atQW5n)h2PZIuM(oh8R zL_uW-`p7geV-t!ALR(5+`S7e^IaNdu!d&;{lV#OKtC>Ga_*74oQH^qoN)pTh#?&|w z9MSyz0=_X$l(comS~P=T5C&L`W)toYA_w3M9`tzJCpTB06Y-w#>W>{`;h_>Ctt1E2 zV@{s6)MMA+Ag091zDHu84fOjBUTnoCu1Q9<+-(dnl>yq(Oe4m|A;)6L0}>YMELrG< ziL|cL&D6FM`apUH5A>U&Dxyk^X8l(y0p<_q+=Ule5GG!*39I~*=-ax zG2zNhdP>LiGk@f3%ZuBB}g6otB!L|u-Hz_8;%eO92R%f5(&7*xy2UAOXHV<2C z$Q_#ArB-_}RjWN@tJ@J|t49c`8w7&an9n8K>|S#}wVtL4brodzEI5u%mo*s0+d-FAe$m1+r2HABq@%on$B z#bw@C7wj8isObYd?7*e($vcV@yi|XI^l!&G>effUzEs8Jxm~ff7t=i4E3ERRFq=vf zcc$uJ3|_^+MDTGy>VNEzF->@ zfvXiy>c(r{)wS&qQ0Q+M=;jYnRIL*e)SXJgCpAAN$@3-rSZ-^xpEff;ZSwnqtMdrB zI@{nR?xIWwcBM`LI;7+Sa7<%8`dC|4YAqwHP%Z$Lpbm!mu90b5eZuT7=w>Hp%(<=W_~3_4sEmxquLZ2h9@}h}lZS^3FTV{y zUP(rdyX(m1j?|yUDkqOfckuyJMu2$=Zv=qohP;sMzX^uz4t_C6sBDE!U2HzO_fUbH zeaw{Ta-CH2VM>!F+H0z4VVVICu$#9pD}yW&UabgYpT9Ser7VTdg0)(8Ne}PdCPAA z^k=|K#2DOpo!t=9nD8kLf?&DUM$!F*&a}V>jWIr7#^LoHVH2jLA!C={C+8>ipdDQ& zM~KD=qY}Gx-uLm$fwQ}_n?LZ&X=O^0T!b$q@&d(D(1I}_m>x+DAs+zDUHt39lJh&k z<~z9fblLhXwc7Q5^R9=2bDj41{1Mxkz?bkwGz6SCrDKwlM=)@5z=Z3&QK06t3?5w4 zY27`Mww>6|%oX+Y$-V(>V&3EVv-v#{vC#fv7{~?`k!1wembYmA)do1ZXEk>e*o?bd zV)^`G{@F&1q~o`l*O%etG&LiUF9kh%uxHzYt1O_AL<(5PCSqabfC4{mNK- zfE0j1!jS6=yI_{ZEj^G#D)R~5nGjaZJj4B6AeUP7HFTHJk~B=pR@xM?I=jc_rHk0*7W!b#r1v)Tx3K zgj4A1{;q)_oseklyzmpPsma?X|4Ne}E=_pxVVBJHoI*M&P2m$Gk`l>*LSzy9$=obz zhj{KY9FdsX1ykm^F02;0XhQUXs`*8{t2Ll*4EbXyct#xqhOiCFqjEGMems06N&jT% zPMe^8=WD|q%Ss&dgp%v1^N#YK5KQ`rrhdgPR}ik3AE=|ZUC27UG2!I!O^LPyX!BQ&)7Lr4>q-vL%ai9RbAR1V6~6V|TQUn)9Uf6!^yHYh1Qq3; z8PiK=z38UF3i=Q+v%U+>*x!Vs63Xos>YKR0EM`T=nr&mK-S2`NHPzC{@i-I9&id~< zSNSqX=D+aW!ykxd8Vr!?x&WViw<@aIq=}(>rho2em5ePL3~rQWvyQ8<6`XnqoEz)FN( zOdwS#RZJ~_Hu^G1h(vs!JQ=TQ0VyThQa1C)5D!HqJRp7%aZnfZYNNvMB+lyf5e01EVbHqkER88HqVszd;R=%sRDD*77wuO4?s5K?5nahTVXjYE-W?g<)t zcW}zMlR$2tJNfFBa9-0^%lVzOrM60(@E&c_KGraNIpD2wgu`NR%u&=k7L_ow`TcatD<*10smnZvwcnRk5LMJUsM+J5ibb8R8jL`(%^N@vW=9Rf zwx*;Tx*`B>@H)>>ce-gN(7CN-%p@*~x{lsY?O|dc48F1OWDb^2kq}x?l9Lu3-%Nl$ zdDY^cL)YJ17&zAw5chT-b8UxL*P4x7(_2tnA6IOt!n)08!>Qs+h8w-naA$rdeB^y` zqB0R*u;OsPQtQW^jvyT={Zurf!arsBqBVBFU+}zo3{C{JdsQ0+crtPpZRE?>0@!tg zz7*%b8`JI^9B;xBy1<{t3^vo~J~_{dqkeWxQeX;j4=QmUEQ?N5edHb;Z+)8+!C~?6 z^At!*l8ou}@gP(h6W$DIT=ME9KolIfg~_x5^;zX(BSUM5(oz55pn9LWyLgnsK0T8@ zO<6@#5DPpS2my1yX=Y=%u-vVn*v~p+povFmdq3Tni=>8W4gsv1tZ;>=@!6zntQme4 zswR6#)nGwF79R{6t$h&u|aUTX{KVLc7I{RXZ?->M!mP z$>v^&f}uH@Z&n9fTjjs?7IuYz(~UgMZ(Fx=4T5RMy&5!fa)~{uzuIV3MO+rBi1c31zF11nDzrDwsjqSfhzJQ26`!cEpU`*DXU-j*l z?0cUhy>Wn#Srd}ZuSeE!;uyV44yuP+QJfz z;U9^x=}G$i$61C+WB@`HL^U4njz2il{A2+&F{g*b8l;in{i1uvscVjz7V6mA=eS~S z!nK!UpBNq*K`i!&$rfKg^(m!Ylo0Kn<3AN=SA4yYBuGRm_`5Ea5u!-H`J@M7j7_1 z&OMZS2=-KG5?U(7q@g*KZHMdd8dRMFoo9_$WG#8A>^>C*lZQ$Q3zZ0dx(lnn)mpgclH1~wn9qwLD_PaH|LF3FTgP; z=$suP`9@=r06g<1pUp|sv5l#Ik97wmbd8U_hkl$xwtJ$xmYW{$qE=fHh$pK2=@xTs z9!(6Fz(e_w?mq`HyAcxLU%9eANsiz-R#zdJPH=!fPIqbq81MY@=r68UT* zus4kciy5WQ5I=($<+?J{<;E+O0bd5>X!&I4n4C1N7?X~4$DL*0^)pb@C9?AX7qBca ze5oRTC;3pRsLOJ_B?E8dSUE4jd49gLMUdB;g#Adq8NV-aG@O@eO0cmJ0FwD(TIqL! zFfbxlL6bCJp(iNa!_6P{*9OFddymR-ho|=MFw=**G*}^Cd-bxBz+Ny%!v^wX!|B;Z^k>Fx|XI_CEi6ajPqNov0;-moz9k6({CaLw$^ zMDVJCLtV}|^?3m<0gfwqlH(SQi)2!Fu=vrru8G5gS!3nTP0wj8_!se=cT}cjr8x9cA=vSm; zSsg@YLTik4-=BlzfnGwIaCgb%@0@1~ON$Kg{OebgdvaAo?{o}pQD~7r@dT{_{)000 zWd|aC8kG@suEvVGbv-_wqK<#)gz*(YL7Qne=e^%D=j*hFQ@vufHec4jmau24pU6yJ z-_@ko%joORl6%#BQBp`tc4C7@B9VpK2!veaynJs!M#|D8lrX$#7EzcA~ux$CxV;fYiH=$bqSSkB!f9(~L zs>&1_Oj@T`Po^faTS`XZBrF%5Tu(i0{ddoYM5 zcAq)=g4zb{2998GO{)A}Qsp}b8MTA8e7`EF3&c7BS3>&P`T2y?WR}lVFC9AtWPS)a zgoFMOt^psJt}Waw0oSk(=FCjlITtLu|6pI~XJIIVDDDIY=IhCodDl?@-reDT7f4Po z?-`7z-v7ehdxk}|E$yNpf@CBpiX@SsNb1~xlC$KDh$KNWND@$xjO3h^j7UaFN)7@d zNRE;uNk$|G!8^KLuD!m!_C4S7obS2M{c(N(-OZeD*Q}~{RE-*A*2G~wG^0qTF(V@* zLCP7nloPmL?|piBp8w^--7ECEF88`?PxaoX^4LAH_OOs87VNnAqKH-Zwq?9iKi;=% z&}WhgRWlECGz=qI@oz6@Qv8#c4f^tVK4 z37v4}og*CDPnO!&(0n3u5YTI|zjJfrV`0KX#7z-O?QuVeavx&*ATp*IFO{qFuQReB zG(!%Qu&HYc9qnD3s*%rHUIj5ffAkRMj*?+_?8n!B@J>JXlZxqkJ?5jC`CMNk%PTpI zwii@d&P9HET>bc+rFqAssLPRYYFW&nO;BjAkE-IW8$7LXCf#>C@uieVAoVmlF6trR zMkUeDGOSMI^X@$PkG)!zg3a$TOg7ELybY5TmGah(LCo^VS=}OLpi8zm;*UlQn9Z;u zxe8x0JKo~H8)?y;ZBS^f!u*4LE|ZM+I@1}Qg6QZ#bE3%5tRagWDy<&PxeOx7Li-B3 z=%jm9O?;;9sfA>ZT2W{c>xa-Zv@91xv6lQsN~Pr6lPP1Bp%dy`KicPyb~itA7GB4_IG}~M9jU@pMSnTz zHW!5ME=BMD(c-S@jn&G$Hq%Hv;a2n6<28%#kPT6qo;lmHZ@V-+E!V_p-YY)bSpUAe zZo0viOj@6kd9stHS7uKafy|RpL-)r5YH}G?w z=_)gHFCF+P5({Tv-R0nBm@=}TYK22H`Gyb+H!?e)!gakJV)jSN@(WK$;u`d9#>(uv zJ39tMg`Sq5G!}^Vi(J&AXfe92epO$-H|KDw>yj)>wN;i%+>0B^^9$-~Z!a6`#rnMP z`1F3M=k(Ql&nx+Oqg?vqw2KZJH%>V8k3H5KV*)kitsc7%yvD0OMUc)vWA-@I!!46- z8>P>ipIU3|7%QyNk})y*(3d55)Tu^jRiC8Jlp#~!WBq8+@a;2ArEuv9Un5h&4T)Eu z&Ds_-W_Ip4QM0^ydZeZyR5WxD!}PRGKq}LIQX_3-W}~Af??dcqoM%hjc;6kW4=+-_ z8ld2K6^|-#zNy`Q3{gu2s8>*cWgA(;`amY%DbEqBI@uK0~4744>wCJl9>Fz$?lsnk%d!Z0^exXQJ`=M*fGIBu0;W;xo=FJkOhSrCy-(E@z}A znsfY698h#;N`4VZvZB|%o)O(CV%$9Z>6WeOF_VQ4BikC^8R28Kba7%UFIO6hIc_AO z@rsb8#U=5n!MWCSCA^~hnwC}1?*uU}YTNW_r$brz@n#T*ZP|iz}aDU9{S#C~21k zf03bkgyjRrm0iI^vI>s;o5i2%earDWDhN)$64yh9E|w%pUMH@8l}#aG@g!qHoCcRu zX>QHES)eQLLQ-4II6eJI1BrP8-@^FaAFuAvm_6%ej8_WKB8f7poFo1^;5ecg(DPbr zY~yV+ubEgF+dyLWhBh9do!pNGLAV)RDc!_aN?%v^13Nkq+SjwhBF6$UYusdbPu2Tx z)9!3}#d?_bltOq5ieAVpovV6XXwGF9$jQg3dFy-PoTEiuKUc4eMzzh0xxT1CwO6#y z-+TM6&s_`nqHIWKMyoI=le;=+Mu~rA)wIuXgLJiKKuqu^t8&9bk>f8^y0 zDYCpkt{_?D8GBvwIeA4dRs3K`OceU15+1Ej-1hQgZXaT8UkkMhH|fM;+50KD{oaV` zTHmfL6f}G(`}rQ~3%*IM=Rt+Q81!JM>Z%>>Tj_17mhZ0RU^BP$)Q5wzMKQW^6QyGT zA#&xXMEZ*j6*&W>Q)VtVC1$^7jwOF9nc`fPTDkC2h=}g1Z6%pi4eayRdj?q-UxjS1 z&F_8VThZU)8y2Dn?K;zJ<>G##CCF5Jk$cyezPT$|JO7JRS^NBf-jCf!)!L6P1im1x zlE{2_nT_+@*lqo$5jKDF1;sCCTXz?~eT0^UC}bHSWm+!F%PQX97rQp7qs8AhQbhfb zmxZF7rsm%J{V7qki0b#j66Ds`jv_B)EL^kLN?Y!yppQ)s@v@;oRP^2F14ceD`D}8=^ zWv=i(zS|BLL3Q+H^Fc;Dt(00rZqKiDFU(uK^%O94 z$=s_wvrCZ|uT>v6xVdEL{H~bqWN;0n0ps=qufvXl;+2C%&#-u#O;T3XR)6eKvMqad zUZd`=rtqUS?%8$1i(^#Z_@CT8N3vbWQBxM*{e<>h8};_2YwazCn*J?-qREE z>nBwLQU;dsTi%w3U+r;2(Qe5!A4D!!I4Prwiuk^?2}-4I?G(6u2{_Xt7g>3y>&HYd z|FsIg2fF)Jjn-b<(&PkEYiZ={a_z|sos7@J(?rllftIFkx@K-$9_UZEdud+nITLDe z)WM&uMy7wJz2zD__GN8s2kDa-LBphPx4v0wqSe+zvxs&wpGuM`!K*Hk@;1;sP{s9C z@J9{Lc9E*kydx85&5L;!WWb?1z|WM5@}u`qGd}&!eIwB_&OLn8<5R4;bViY75Z9S9 z4c37q4lT(PgR9Y#wW~GlMDK6tEl9*R!DbW6t{a}w^Svh&XS`XIvfgn@FQ(=3Z5~EX z2~!^w)eBOi(Nw0%!NpC+#rp18X58yjxuor$VFB%)LBV-<8hU+Cof18~+M(3~OMRyO zv^Ooep+f(g$YawE*E+G(j-{A3k(ZK)A4gs+K{FATr7q+JQT)iMvvBJt@Lqhb|4Q1e zq+_*h^^h=ZP-5naf!Vp8vyv)GWQCvTH}{Tqo1-qHTY_>2sCS`!r7+vcngbRO#|_7a zwD$>Cikwu>62Pi6WZqmc2$ffVGZ$MVcS%gOZQ${;8uB=XBV)zWfW7?Vxr*AecMUlP zxM=J;>^kVjVjjJ@^N=I=3aKRLuty^UUr^CUVuR!eeqh^GcC?_BZMq?|hSWSB3A{Iq_9$ zzVZ<<8q6_w-Mid*_$onRVe6ws`J(9Ml`Z3lE}XdA6bwzur2T1{%XdbHU)~g%qqO*V zr1D5E%hcjjFL$B1a$f9fJ@@3R!cW-?7{@FxbEpQ6T2#HIa?%)9Ryk%D9kUe)mXfMH zYx_N{BPX@{!b_tq>mM6OM_bkG7E<`EiO|g+$?(QL(TGCJeT5INVt$|>;VvBRn~Jk5 zy`t@Fo4;sqHFb~~A6+)c#PRCM0Mj$80l!w;drr(jopxC#@hU4|=``GZ@%g$5DarK$ z$}#E4mH=9uo3FTKY2;U)T|}34Z55Kb8Qh5<9vrl}yE7&+t;UvG{N2n9X7up$m+RXl z60MJmudN7vEITaVvCW$w;&soc(;Y8bPM%=-#H*E>-%{|2FfsA+iyqfpqxY!n2|sGT zrDQ=i-sBwp%Vbt%c5*26p*9PXNht3|dT(dj{-gb$5YP)09QyzB{h$Av zJ%J(maAp`1{j*)Nx;p3tibVZ-17U_h5!g4F-D>u>#{bI=pugE6nE(HF2>$~}>X{@CA&*$a!=|BBh~3eNp=e=Il$_Qx^U&oKYT?4iYA zf&H=A&wk3rFxEnYke_ z>>DUQ59&X(;e~*XyZmTyFcisyM(goH_&^(8e$W6IGztC%3P+-OplBpB6w1c~g)$>h zC>|6X%?tyONHp|seS#5uC~!6u^!)|fKmj7?VhrKOwh4w{E*OsaL837KWQIaOr(q-t zK%#jd%wWGV4=@@4gz_WcU`zx@Vt#(T|F^RMG!zSsX|)W&Gz`YVBl&pXUq5XVf&qeJe_;@T3qgKr z6|evbE9rM2lF5he}M$f%7@~|x)lZ${QSvOOpkBy+<`xc3w#6( z9OvKgum^*4{%pSu1ylu3E5MitDD0;$0T2SyRU66!Tnlu@NALkRf+LxM_W~jR11K;b z4>*z;$&Vp5a8oFtD?t58;XhCjfPruna8oD`_ye383Gg8x8Uxox1ET$1*1yAos|T6@V`g}mf&V$NU|7Dwv0nNs2!hN2=n;gIUxOB)2r%GpDHh9DI7XjXJz!p75{y3-`%_vd z1O=G(TS~z4737it7NZF)ECghPK)65c1qB4=!|L`Q8w|@=5Ox9LFTO%SXn=$9|6j0x zz)%!M3I7xplVpK-3{Wwk7eAOhZ^pjbQoNTvU!1I)aO?{@+$97|XP z#-n~J0;5_muYh2Z)L#QE6u1urn-2VAN5B#mfpM*$n!v#FBf%u(FBu#RGtt0?gMXUA z!Lft|883kSMOYY!{`?^C{Zk1b6~N50en+=h!UF05*k6Q&fw=+vr+@uq17->bNB#~Q zFw>WxSuu8C0qERtFegPY!?062ZV2!X@CJ+#|0#XNSOH`onCHfz!CVu8Wh`)dAmcB_ z!a$aR#3bs!IDmP)4f3}_76Qvy?2~h_YQ;dqz(5Ow{Us8@fU@CW()G{16@g_e;1ZDb z7h_=^bu)pXE2h)Ej zW@7!zTyV@J6wDBR0~SkHP-g+Kzvv1F^F$OF`ThlqNsxcbxqxOtwFCo*5f~#ckPHl0 zz|%mY{c{2f!{oMquQg%kl-wX*0&~Ljc#&AHg3=Oz!m1LyfP?%M4S4=90YS=vK>bc~ zg~W0diE$>Zsj$$1tN&$22nXXW>bIsBNGw;ebvCT2u(05wkz>VbtCQSUD0pLhb?*m^C$4pT{ zu?2}CDHKb4thF!}15^T$1#kewEs*+h!!Yv;BqmMzdyNScEdlSqxDJXp{QO8zzXcZ! z_=yn<<4zbn45dJ&6$k|QiA{qsgzOy3PVpQ@DYH7 zp*vPII7lxsb009j0MB&e1~V-bKN83YGG@T*|4?4SBuU_NFq=n!vOPe>uoK3IAwAaM z{{5VNq}fPMY%^8I-f0Ku>k zteRjzenn*Nzn=T&v46YDKmVi03s?eH5il3_OArLcDbXNp#+vpQ;D3J5AjnNY`5Lev zjL{&Rf=dHD0eBd!Uoru80v`aX2E`eW%pv$ekq;;flPIG9ZdnkKV3@)sHxhw;?x5Zu zEicsV4Q(7uZSAeGYcvXmj`rp*^5zbX*kzi3*Ah1ZTM7n@1fK8<0W9+TIsp{jfCK+d zGY!nT?|<7&0|CtZ*Jc`JTGqB>XsVNS{l;+Q+3Szb<&LpIb6Z>*qo{?a`APn9|KE@+(1BK3a5 zEOXHpP62L{=)3GEUjm=pIyzOzh^lO<7%3nw^ALMt9h_rSdc7`vhu|aA6C3AS`%%SA z#M|Y<-Sy;D!goh>qZ-c*q5MKm5wOk%Mp5;0QPNQ25$?$-Z!M-vUrK(Ycim$jQ)YDKCX__l}1sfi2mi5Q%@WO~j#y=1XXVm{Inab7MV&U^;JEy4gJ zpQ_tCp9Go%sM#=6hve>^lH!caFkv$4Djm+X=GE7@W`9u9nNq80^XPz>JF+9dZYz^_ zrFU0(aIGYOXS0Y_)~n=`P~usCrw+Cgv%!+nVvorXq>*nLiA~Jb<)Ny%%_*1FrHQBIKJZO3T{UbN||7O;CuCj)kgRCJvntoLQV%!r}LLs z3Vl>=n~<>mux;d{r#}_8HO}dgn8i-$_w+MSW9}DPB8W(?0%>&q4WzIqW)(-aQ!WVQ^1Pde%qabwX_{8f~k(=gNs2D zJZ%9ru*mnM1RhC{VqK}|wn4?F~P?@+L=>Y|hi)KVY&qZ^gmztdV&FSu=I z@sV0ApjxI@au5al7ocZ(U)ERi_AI846lrxRY!|tEYojgPseWcvoNfa`v-FowZU%A35uWzl9i0ys3usW3{apOR>FlWg zjWz#wb=zA5(s+IrBqnM_{e>TblFOnuD|tc{Z+2T}!e71_Afk^IkSkB1G#ojWsUb=A5nU0hdmu*F zcY`CK-|wwf8AZ$9*KV^z2Pb{2lrvGw>5jfdsVO&2n~}AkwF&#`+q{Nqd;L>AEt?C@7gxfi_oGiDjyJZ7jRep7 za~3v_?tNWpV@Lw6j@$GPDf`2X9In&BXl-J)3+q>(yRl@~tzRJB@w)G;TsBtbbVwp$ zf^Q?fT7G^*g5KE9;yn$?++h64paQqM)U2cjENSkHcixq#X|%cRb04OHr&fz^-^($n z2bsr-^uP3fmVD>q0uyidR=16CX~$mX9xQW{aB=y>cG0vVA=HNbzL`)*chQUBk!>cb z_&ZJ0qGJ6Az3XOj4Sz5(*{_qL&&w!NrLx z$wlmtmK#^o&0e{6qG__EW59!AWuLDZfDMo29^Qm0O^7t^81(Lb8mf`5ot`-u`pQ55 zVmQ~x&PRFxc3XSta*UvL3)%A+DKdtXCJ^&GSEv;ehrUu=Jc%rh{!t(LSXb}1|JTg6Ymm!|GgbU+=V#Zba1B53 zx%ZxAf4_*>AV~u5Cg4KKr=JWHwp2To3ajzNMh&6K+K$m^9MRNVJex8*tNpGa=m~pzh(+$JYdK7dJsh%ffC(5ZnuA^Z#A5Jid%E9 zV@C6qndvBNocvs}mfy*oT4(iABFKOUSKoVm<${m>b%r;BqApPx&)(9#+T5Ya@Di(J-I3bOx~oJu z#XvINF2xikj!Q$aOjv%3noaq-F|S$ zFR>Qyd1cROJ#Rz9^Pj@SnD9L(lw@%3&2Oa>c*)|gC&)3>Q0kwoa=&XZFt{g&4<3{n zEV$j)y<_^&w>4OU{^Hf|noxrq?+f`=uTrGiD7$c$H(6Lj=hwu&Q)nfmAS?Ld*grAe zmH7bAG}JjeXPWdSAtza?)`XJSVx{Ecd(Y1WHgK3se}4!cxKQ9les-EY|L(wU|M6z$ z+z8v(vZ7mqvzroGM1u#;1&h^W7Y3tX-OJ<4(I%4PIZhsATxLEawc^1Vc9Hy{F?K<$ z*XVV2DNkH2o)QmweYH(x>BUH`j)B0p0C~m~hyA+lrI+-0_h!{A;+?aaBN(It5-JAs zc5lM5mbAanxrJm+l7Bj$=x#B!zKE&D?|7 zW}Nq*opW(FHbZAmU$Bv#UZIqvAv&KC;rmi1Tqtb^)>QlPlk8`4hTa)mNe`#f^voCi zg~-#I*(&D7suOmmb{v;(3@~-lmU`4I621=PvwBOoTAut$*;7RlZDqX(IxEex%QYQe zr6Fx^P*vgefK?}i8Pn*?2h6tY8wm(Y&6x9N`A2UDa}IjetB>YfxTZIzKl+AwYnE%%G!SktvaGNkN zz;C3TU*NTUpm^JAFW8jAB3#QoKYoT`j)dzwveJagSvC8gKi}eY#hUM zhl-o(0L&PT3--c) zJ3AKTz5^9klGp9mF3{CHwL0y~k@?)=(O1&Sn|JRAn$qAT1&dD+e+9QN6z3m=6Qd3e9f zo@`a4bhpBCY0pG%T%mfu%VgUx81C%lL8>Zu#TSA7B0`;<&aL zR_Ws7#*rpSx%nkC(ddbP%~abrv#`Vd^irk{&A2`Prc?So5zLgmUuw3(w_40*Zg=#2 z+?gKn>Mn12UqW)z+`4PLZ?FX7$Zp|h(<)y%DOj&x{40>jOY5NhqDeiWA z@?4LEY$9!{Tk*3onX0u*pXy*$O2N`JQ;lvGlP=l!&u%22Sj1XymTyg_k4^SLlU!ma zb5>Nt(ZxNiIwlVTErTWol1PjgcDU(Z3(T&-d2OcMjIysxwlVT4ysSVw-{c`0-(7fT z6q`OfO?W~i3X+}!;YUe!=9_pX+KkhG{qc2eFeE2iuc1~s*K{_e*%kHvxe1F=4 zMLeH7oJI?T;;3$0qw;0BA3oB$V6IQsNk{6{)(&Z>ThuaN#1}0m*yq#Oj z(DVM9!KYkDg_!dZ15O3K!%YT^g6l#0Gm8r9=WSgwHFk^V$Q!KGng*&YU)dNseK0O9 z#HZ4_`@~%@>(a>Hl&9|{zO=WkHgER2x)iI+ODBifiE$F7;qtG?G~7Z6ww54C3Xv<2 z%2S8ot=^97wEGmQYzzczg-K?2BU5Kz zJJ$O(ujR23v2!(^HO5&K)6(-A?qLox`5XgB=8`=}X_|{)oF{lEVZ491w<+&En5HH! zR zVI#o=N=@Io+N$+mgvQN?D4|!nqZDwCu7h<5t2qe0umvrh7Mf$nppC zH#pa|-CbGb&oGYI^wVqh zVVVo4?y)%kGkvgB^(=_p2?f{JXlvh)-QiOegCR2q)qwI7LulVBY+p@Vb1b1`mjKsU4Dr48^f*6$V1MD^9A?)D{)an~u($R6Z{Lvw z7RvstBmd9bkp#9!{o^~5em1ZFAH5?9tf*tZUJbLg1KfE4-hi^Yq>H1pnxmnk38>CX ztATY5Bv>lO94GzrI80xD%p0&M00qlPKTndfwZT;L#i9D(1hCYNIRv}`z+m4p=FR`X zy-E{0n|?_A<;+bLLu0cgT~xEgZVcUiu$#b_FIc_m}NZ7;`sk!DUSa)mg2Aj-haCk2X++y*R{AB zEo-$g8O&N7glV3W>x;$}y{mcOr3@Mq4AxY0KMuxrP<|HVyJU=PsjpAz4S`?j2*Wpx zzFLtzB)```p(MPO>9p_a-8{pPuz8 zHwYdY4=tlnf+r02Y-#L!x6@97fA0=jBUhGVu!wf8-h6j!bfNx_%wx`lZteU7#pvU@v3X!9E&2hmaq$ay=WX9Wk0{%6xJ-z)D-dZJ%cUN62A(Hd^=-V(tJQ`<#t zvkqE@NFB7C7#&RWfqPU18(t`#Bkvj7=3-7_ob%5S3g!%VSPd`JqDLQeus?E3e?S!w z67fD@)f6o&eLp^$=EKZtXd0237N!tMem3ZgLNx2cS zQiN_wkgy~BY;?dj;5Qw9Xf2%mYTB-4=*t@-v`I!Z-@{-7vk*ck9o{Y3rssJ#t8a)$ z7iZ>wn=2T*if^e>dOE{Y)&$RYvXV30fPfVOzhuhKyF$!B#_JR+Cj5|B-CasKHAj3u zWlCO2rS!Jml(y967CU%gn)HXE#ogkzXd*eKfW?{Bd+4_ox1MS`$(0@ppx=>_zY3y#M4XrG=&~Vy7DK6m!v`7`8K7i2DN&}n#|2;1uEP8&$`t*;ntZv!Km=@ zPPO+1Psv(|r_kL+t%-B>8ay;ZHy|Uy$0kgiDYcd4A0IW12Y-<3b$(!M+rc@ySQ#5t z#ccEG6e$eJ1sUEqVmWc`x9izlE4(}7v*5PcqrCs(Vr^-}h z3NZo_E#XfTs3Yl6tM>i@op)H~x%NS(aH)Fzlx%%#=H`y>iEi=2cZARIeUuj6&=;MH zk8;f5@=9$!?Sg{-e2j9$M&nL%nL1vlvQ$WO1hw{Jtq*w}lepuG7dO{&LJ92jo+CGN zMrFMlBTHED2XWxD6&LFDny016ugML^&mVdStqwE{I6pW@Vf1(A`D`zA^^r;bRAyI* z-LB?Woxtp&YmZB|#AEO@FSIioJ^C^_yvls)_4Vix@m#~$)hIk^(jTtsgZxsDk{a`# z1XJ0uhZ}w-aa1Qh8~R|*KtHkF*Cu6{c(d}OWwcsS_1B@0b4p_LD7DMFRLx!_x#8o| z4~rGzI9kYr8)rxy88X_tmkMY262vQ&I==QaM<-V#QJqqf$r1G^7~=L%kEIh_=~VMuy3GVQ5Qj_9dvXI)ft?-L;SR(M^j z*r4Xs>rc?&hZ}Ol{ABrO?{!;dJyzgXIjgPC{lOIf4W+tNo^(R!r(ymf?e%~U1CZjSYL&YpV_#|cK1~@ngia~A*}P`0z8AK?v!n_ zYv)ExQ?Jov*_|X9G42z7j=EXVCskG5aa)r9?4?KM&iU%Ru&i(4b_8KJWEnEYIE3ghc4zJ1w3^Jzb^Vb4$32r{kS8N zy}TMVaIxvw{^sTJwS>y&1>1VvTChjgjUrw8G8a4@jXc*5ZWJ`mxP)KK`>}UtK!i#r{KOtYHU`a zU}CaPfBt|*HexAIX%qjVf1v)#3e{sJZiPhQA?`8tFWIO`KPLU&haWsjbS%wX zxNSI0Eb~r4T>MloCVmaT;^q%JXt#y z?m=eh$<;<_zr0d25Gd6>jabPe%P<s^G?ZC&f4=ePInQ}D z$3b?QNfFVfpXer-t*OP7`P|)Iytn8A*i{$G^ZNQAJTMn&p?SWnpui_ijJGtEm~?`3qnLq?@g|7mq|&4Sby$ateL&oCbrxeJ62+pM+bhU6F>+#LlJ@C+pJz)6jJHa9+vmyEAW0m9A&c5U#=V(bYG-c`kiX7x zOo?<9uPPng`$`VmSYYrC#2}2XEc9J$fta5~jE3n9p}U(3XDv zU5L?4fRJ0Z-Np6&k7bV$la1X_$`O|&-0mC3lvH=<1DwyWpP$;!4-4203lw3Zr-aMT z-8*y{l8K9e#Ru%i&K%#0v2c)>aO5<`rGw>thjW_r?zfZo>!Kz=Q}EN2o(JJFtM}yt z<$Ijz4{gYGWvlLXGkQdOUUCH%A^%N7MStmuV}^(5UM86C%@R3TUrtKii&_&^ z?0=28NZxU9=ZMUvMS_8diCgN5Vaher@$eJU=%@;=kdEG&*Kf#soyr#6rUZEpcJJ41 z{h(?twu=*=VoWR$i$5nJUuai*ggd!=*uA|pX5p$>6`g4wzlyUnaOK(S3R>?Rr`CyH zyBn<0;hD)R?IrzYW85!-4SY@Rnjf2bEHzo;F+?prd_CW4bd_{ro$Dxfr((+W$@#+u zuEHfvQNYWX77s2?l`wJ=nRm5e=1OFZMpdXx)z=kTOh{w z9qpZD9r}{358lUlRz*rP%+=uPaF})7Nq?9sWe(%xWN&w+P8ZFp0bJ;?G4a|>$+kh# zd_gVv2d5^bqO_8s9Bm@OxW?|x^CKVJ(Q1=~QdPqBTv`Sb$Xk6KUrOu4%s*_mj_;Th ziFwkEW?zROF z=pYQ0G?}UtO7ZgZtn2u^q!LE36}^LBYkDTvTnuNG196$floxqf*Yfaz;Q0_u-Ei7- zB7DkKPyNG6_Xn!p)-rB$L{INrsPNA4DR*6x60*eWZB(W+e7f`Kp{z8cf0Lm>b*4(? zhBq>T*QvA7L@13DD!=M^n~-U6vf=670$Ek<3W7Kf71`jDh(rC``q>qG`oNHsGuS_Ao%*Jq-*Xf2sjO-G6}IJ4H{D_B3YUL2EJJ226i zo26r)L$iqsHN30?Nw#VrDcNR*YywGnvDL{b-d*OdYw@GuJ$r>Vo=XrA;;1z4`)u&TW1jjmBV*)K$$PQ2 zha%@SZ>oRE*=FKW;=k(0-2ccvQvWdrUjxD02tNDEXxlSh2CN|le4Ab=gM4u{_&krM zY=>w{a*FrHKLz*%W{J*OZ4q^n`rMmPu<0_mV?9rBM%~l3lOy`x2$NEPkD(EK%_gQ^ zxbCD@czM^BsQN5f-qzkiHsOWgJy*w>(<-=gbEW-Xq?s6<-S^}ozWPQ}y0+j^1tJ&v zcqo}FXsJ}9wTf-$_$PfxVkQ@7Z0vX4Vn`qP9yU$cbJ;7PvZ1LlbRA-`43^UL&N!i8 zUI`gg3a?Z6_Y=KkjG#a*KW@1uy?i#hviVZw`=i+z!5LzWJ8BH)cZf-1rSS$$1d`(9 zQ`CBn1p_U*2{zM+zV6KFFP+j{8n>;>-ZI}!{WzZ{9C4dgUr&#++@Fkd1IO~gs;`rd zT^*-kaz~6JQ_Krb_R~>s3^hqaP~ME++bvy%J5yzAiLO==a7V^xcc0M%ADH{1^3w(7t41ZZ8E$qs+k)6+Mzvv^Wb?+ao2P@TKxFT zrP9xNcg?-snM;hyC`kL>p842#Hsu28)dEgFM+Y34(rl54#dib(iRwSTRLL+r|L(<; zbs}|+rDDo}`5@3;>)iE$G}t3Ygosh)Qv!P8dyj?RB*4XMzjIZm9Mn#Dav4P$tm>u( zrdXft9ivXYpE~_Qc_pn}uGLbQo@F@B#w!%BO_i{tCNbb^X58c*(SuH4P+57#WOeKl!1<8p^XuIOr*CmXZ6K4ox%e2wTcREw` z2qHqdarKl+1nt1JH(|VsLYePZ4?N>(nE4O)izI40<35krKxl7yL zneJewfP&Z@1Xtm>)ivIWJo6(74;X?vV21?f<&E?U;``Te&5C6UNir4>n299>ZG^H< ze+v}#ZL;9Jb?(Yb`J%-t^17>p$V8K#3rb$CU1E3TpbPSnXIR^DapSr~j-qjs1bQZy z-6=w=#~ny{t@4fHj%W=ssFVX7Sa-j?WV|5$wdWm`zjdqFv{CVwcT|0D)FjkG1QFjj zBrA6#b>W~42gx>-;$Kyw(mO4*BQ%W9Fw%66n&MOh?r2f&J*Mk388HfudU1rQ zws#YmDr>(`%efeB1vTdx1>&g@^2Es3Evr`@y|t|iFJs+yRy*V&Xq}R}J-tU?FPMY2VK}NE9%* zM)C78u0R7`w$pRHOPj%y2-Rje_55@+j(EHo3njzYThpj(?AbQtO|>|A5#-XZZ&bc) z`RdU=Y}cXrV#M!>DAnzK_E~pQaSIV>SXX`Xl-2Xh49rD)}MV5UgG!!VORL2hO60h2p`_M75V-qdmoM>#BY5wBcGat@IVNrrdF_bwxTC= zZWf=Ny05#YHCoQaB08`sFDg9g1*H;!ZrS9+VAbrMSjl2Oo34Alp1!lY5EA^P#5e1m z@5WNHK6t`$!qz_dKe+QlokG1=wDi4;;CTa9deXtwal+&l`|7@{uStYVlu}F2xyqoH z795{HkIu2GRb;wfVp`?GtRI(et8}mQPS@~Sk}eZecb+jleQH<7IQZQ25u@o6PB-7L zjRj>4FQf;Y&Q&1d29NMUYZZ&0>AqQA*kfIHo+;yG91xen%|FarBr#^9JYx{7erYSf ziu|m;;0tC!a`t7TyXuBQY0jef%MN|Ili__I*>#V@cR9x*SCAQBkI!``Z}-rzlNem+ zF?&Ei5=o^6gY6T}(N_nTWG7zN07-67zKE)JA=Y4x9L00O@uSnX64$_9 zgN{UodPwP|(mL-^bzJ)97kxj*ons+YwrQhUjL-YG_2!>-bN4Q-+$yWMeYnxWCg46x zHIalMQH`!>+?-F$GG0sEX6HZp%x$^8qu|bQMS@^Bez&~xD8zmo`7QY7Ijt_Tph#p? z`y(gY;rFJ-#z#%M)_Hs1D(Ma~gucOK;|7PL<e?4bjOqW7afV9hZ&vJPvWs)aV7MN3cH;>gQM&Kzu+yBGf zo5xexeSN@Wh!m2k%qf{U<|#7IGRvH)DDzAxv&@k(6eW=%Lqup2QiMVwsZfTHF^S%F zT}Sf!-S_i6`s027di#9jIOkm7v#zz*ckQ*--e)hO;SaRmrpIv^A1qEki8*~-i%D&k zm+$>g7RLMJ`7f1X>}}QBh|LZhHvKeus=n#Ua81nWj^OqA_7*bAH#IxCxa+bHC8^qd zwrrYwVv4^=?>LjCFR@F=u;04n)$OMpMmta6i2hC;`nro`@<#JZFMS!U$RCPlr5Icz zD_Vo|hEz-+n?A@QZJGD>3UExTb*gthH+B4I5@vJ;|GiXkQ{(c-l@_1lF`-eNXSw{` z=%l3^Xr8H-xrK?`y7JN9mdK=DW{+87Ue$q@kv#;|WZZi3i=-VrJNWp>&Q9D4$|7A< z=bWiHG;y$`!t)XLxa)d^>DM61C9Z_kxP-OZmY$sUJv3w%(&9(gmdR#ve$Fh@9C0(Q zuedkHvSUU!mGE7m#p5J(Z3iV*zCCYlmc-T$1$>SgJ@u~Xd1wMDuE%6ZmaV7TKz#G! zv8g*({A$}TJYgf0HJzZh9dx|)q&-3+cu$8&-#7p3b???Y3c_bf(hpkZrjOQ6e$e8I zec@|Nf7E*TWk$`x*(rV&&Aq+}U%V0yRSHYuGtz36M9p3DCYrhQ#GyK}vU`Bas%?rf zuQE0h>XphfGXuuDdlP9U^~r+JuZ<%O;QEZoDM!I z(e`p_-npzz)OAAA`EENS--KN8&b>`U@>EL?|FUFLAwyh?7{2a7jpGghb?@=+v$~yH zxD}-;L7t}`*~PIhdT+?_^yp#L6S%&u)a_RtyTZa{HSE=*+Q(PxONeq>Zz=74ppm6T zG&If?;w8c2TTn*SJ0AAM;7r(;hM^y!b*}|g#4Tan%Omf6e=BANq_Saq0 z_rJjVzTE%P#Tb|%)o(M|o6eKj$g+6xcvK0I!0ClG7o#&ysY8?dFA+afu0F`7P)a2I zjrh?KX_g;zLUOZDBgr}2ZbW#Cu{LmIxZH4)Po)SkYNL82k`p%k)JoA)njyQ}Yn2tp z@+EPXu#S_6INvw9iTZL@4i=FgQ;b<$C$E!*zG)-$PLw>Y(YkQ$ z!8*qS=J_A`7;zWXUq$X=`F=BmydlYZ{T9*sGubGMv&vD8&Q;#Nu7WRagyPimlZPBX zCpYVGJWBeja@0B}tE8{hiM@_*XSF0GoemInsXI)1$}Px=_g^P-I?ch-PwHUH{=Rvi z^~dh$FOySWD8tW$p6(^uoByh>F1jN=dibul;vEz9s8TKl-0#h{idDLjJ2XP%qD0uu zN4T!N`q-tpvXh6!H=2-~@3Y@4d)FGzoUh z79NWl%D;Y;jkknIdcPt5%tG|Au#BxkyZ$wzN22arAwCX@v%Do2a`Kg)jl3YO;Ocd{ z&JN5k7lrgA?!_7PIJLRLOYAKhlGvtGCe~^*Yca|@|lKl;!U*s=VqU(McpiWV-S&k z<6Gb5JCZ;fDK`9- z$07U~jNBbLWgL+b;)l{Fh_8jlI7LTJS0W)CP4 zHEJGF_?*z(d0*x|b!24Z^V?6JmiRDPNS$;4!Q8ky{c&!to#|sa9*-wZRg(}E7aj%X za?Y;OWZBP$g6`kr;|=nk`+OyVscHGW<xOgxR6fIL2n}hJ#DU?m}{N4i)NR zcCPb9T%od0J1K%9?=B|aYzUumA2&&KetTiuZnW%co7Xev{3n&#^;m7RpSa3FVv=BYOqNU;7v-JWV5@@@-a8K1rx-s}JQyNbMgj+a zUpr4k*u3ip#TDX_eASz?QYWAJ6=!00-1fZB%xY1({}-u&ukX^rLulGQnKd*x)u1sN zA}IRc=m{&uW0l!2@|+(;^~DuDzbP$wbk@@KIs@@*{7tMrHPX z^t@JHeR}nRZqWEtYCRv*DTW+!HG}S(@s{1bUXc@K^7d14y9nohcDHom55|z(x~Ikb z{q5EKj#O*C$lE1eQ;$4uke*RIF@4vb?hDCMZ`YYGe&3(*`yH_%BmlpQv1 zMVEYVr9a-9BHw%c#kyI4MZ4^1Z_(j2-VwgH*YcO2I(|tuPA%R?Zj0}0svBTHdCN;u zEG>;z_Jjokx7o?)BWf5fk{jwdLF+e8YwxX;vu_owzH#T3)kH?jK*D9Q2AagM$B*1o z<;|O%qHi_I+>H+%vU7@_W+ps*>h`B-{pLL3n4ZrwlrMF!xh*;0GE^#xxI$|1*2uYg zd8MR;ms0SGgo#l)-I~#Do3|KRLBp2pNA?GVdiks`r?x$~a-v)ExoyDe-F8GEDF4zppGM_;h-(+`dht<`Tx+eDyx<&X3KB z)O>Hu*rQB7tKT;1km01rgJYjTIid|@D;e@%6mW)*Q$CcF&eiFl+9Qo@i z-!eWwU8+C3x4AZ2lE$gw^;%(qi`lye9+Ri^KQ@=0Uy)huDYa2{R`3XXdV|ztc=a1e z$8K8J5f%PB!5<#}V)`zn;+`t{)bj(H7x8*V`^K8Yt3Fw|E??dgX%TEkXfxB(}C7C z23;k0;i#kv`ykUVV;*VV>OpdQ^3NSzYX7#5V|8L*uS)WdprKQ}Cgk0haYF`_?liw4 z;d}GJLC<|K(z@cp&7)&y1Sm!ZUr<0Biv^rWCzgg066sHYPCOjEKd6!_;`bfQ1 zVCW29=SRyI5j)&*sV~ySAF&A8aarQWi;oZUE*L{AwnfEc44oujFa98Az`<@ASGPi` z)a-KT*e%+9eW$phi+B}u6NETRNq@Dm5B&J(+}mNQve%pQ{2N7?d`)G+cPH4BS8vB_wwC|jcCZ#Qy(4dotH>iBf7HsP67Y2 z=p5B2wx1Vm!g24WKH43}qV%F-cCfrg>!f%*aa!1%LR2BU-}j=_(5rhs&=Z6Y$!Z+4 zDM@(9_67H}d~1Eyk`-Qj^;g2oST@yjL>4M7ei}-cnLA>#O_H{+&kx!&8$W*Ju%D~o znZjp98i{X1Uq5<3Q}=uA)saWjmlU;>=o^<3>iNrLT~dJUc&6mkWRsIdDM9pyx*;n+ z2LAB*pmDl4Oh5dmodSJUwJj&TTaAM5PX@esBxX>W%=O|r9pRC;UKOz`KH2!5)h59l?k`e3RkNPOs-K-(@d3d}c*qT}4%sUz%G>VSw}Mlf+Ae z!Y*Wv-mK*~x7iL4N<0qF#Je<``rN-cow^~Kx-~3DZP>e^^cdlY5gKi_+sqXA<9 zEDEfWcu@sHCooB25_33HMy)sYrQkSTKRUMXhW&!8eUVv@adC#^C2=Y$-P@H$6*nYh ztxBg(<5lrgTzx=$;As^V#WAfFqG2vE--ToCv7?t$aLfztYqJlZj0_$ib|Q!xB+j&> z5-)ycD0}Q?X5yu}c^aHA1vBF@#5C#SM~rPQuw@q3zv%sp6NBNl)6&NkG?f>~4j9Eb z(HA~XY!@cf|8{jKuSQk;&Q*(52E1LuVRNoop*hnN1{n>8N`rS_4-fCt`;H$2x!F;TnUSEpa?V=1peskD>@t+;{jbK|A=X7uD@Pd>|db-jw>0GIK&4MQy5!s9)S zI*PeZ%@xIqqS?e~OY=2y$|_AnNIyLEKjj-&WtQweYi~oRo%)F6wy@mi_Q~r9OD*U= zCcX|!gN5f5f#;lAZ06Mc7!ix=_1fa(viEJ~g9>)jA0FF2jqrAXdPJA=@ z3P~fA+5mpnqeFGCLwbl+7T&B(&V`BdV> zao^>+llL5;Ou zseE4IALwM(#p$N*&D#=;9P%F_7t~M*BRGB{Q8x5N`&EC1^V%fG#i(TVWVf{u(v5nZ zxgEy4@~)|u{k~zfm|S}-RWmcL0i_gy!KresmLZAYxQ6{SMJMJ$`vsI4?)lGFvSeMq z)+wp2tG>!Qo7fW~8rGj|kxqTZq3SE4aXk|mM^nQ5wd8c46T>?PpA!4&uJQ;aa(@`E zicNXtTi+4G>-n*PPML@!%?tIk`WYq8WEcBRh^s7@jXq$tnY&T@q)}_IdBo%zZRsRK zY9Fqi*i2eu@LF!!=b>Jo8nVT^&XED5HTOFr8DjNDC2Ai_)mgbFnICzce!frj*pacc zK74a+m*Q+wZT(y9IcsX#KSvo9ZFbx`8$+hHONEblKBd-F%~vXypsz4TT7IQ1uk&5p zyW{U2l;X^IdCXdgoKUaIvV2OV-+s7uFTjSdysCm-Lp##u6#FmtOhs+qX6@@2R!w415F86u^kD9B2}uUyV~UEcXQdC%x~U!$E5GHtEN1(qVL*gACkt_>@$ zW>pQ>9`MY^X?ovtb@e0{S64$`w+iPpzvp3=e8rruC&sVtw< zw6`m{EyDxvxevFp>1)qR(Qnu}QoAeYys8^rr@~3yxYM1DCh+w}Eo%kTPv0L<$WFg-yF&XuVful<#tk=84{ z^*FSwp_->n;KplX`dDwr*@pI;Ppqa1cHm!Dxa(Xc`ZiysJfD+E?o!oRM?#f}@%%ie zs;FoFDZF~0W8b~vdU}wWY}E7!@v*08DMzRdH)J;s>j%Cj23`i`g_tUGpQ}>qni(R#mAC*fd)ot^a#zw1U z(r4M{v=^(DKI>?6D98C17u+O@Xugn#ZxkkC7Gh#wS=^OJl$#jNRzy}~lzOF7#Gr!V zihhBtLAK;B9P&l62}^^93r2J2Ar2Ph8Iy#0r@nmZj zY!y0v1nyey)WlDC$Se+|6~0 zE{~SYkEs9A_qmMTJ|n3#N=#=h%Km}!!w+r)ruiT;b2WbCE?^8BgHo9b=pR&{MVU_Tt@kroL4y zVL@6~4qvdG%DFY)lUr_XWc{o8Q~S>nGbu&C&lf}Pf1+Tq5;LbDzqoqj=$%t^M|_^| zo|Ii{R`oY8`&KgFK6%7%v`(kv4UNBF*5zNGGK~`a%?93`M@}7ST5&B(FD#$8e{yf% zM`@2AYf0)Jji2jE?wfUwhD`?k^x%8r=JRYv(r#Zi1ym6jFa&-0{b zt!G~ywT(SL`1V+3SaN|~alA-xX=v$G(`p~lDe)B@3ol8ZE)qGl+XM1rXNwtctkxjj zc^>i3+4r)O2h^fpd7VppKA?JYuAa<1crEX_$FJhEHGE#iHS#cSyM1RX$q7rIJN_ql4p=u(2PdNP58pn z_|7!h$l%;3uV#1%qeb6~o#9A`d8hrusQb=6ZrjhHe&=b=9S#y&RvhFW_8th>ef1XG z0Gq`e1zoLDPw1b&7Bszb3&UQ`*(X3Ssk;B+f^o$#Fivn~_p67^n<7V!03#llq{RtO3oc4_(yg6?_Ew}f2*Q0F#DLp_UVoEn3aC=q)}h-+o3L+J9rGT z)1A!nLX)EEpWGVC`(FCSh~Pbu=~bQ7#9No`Ikg=QeVsn(L{%-Ms^cl?c9oh>Hz^|q z^CRi*+2>=NyQtgA&sA_w^b2`#E7SFfP|tTuJQ9^lb(z`v-qq-=eFd(L`VSH%75*=#bcPp_HrE_TKC*wg20 z$`6mWaNpnwzWVU-KJEEH=F!=PIGg@(*G~PLcRad@q;LlhFuA4UxAeFdWJoU%Xvw~? zzI^!P*~>?j1rAfZ-($ehVdtp6LV3=j;H|yr?vhrVeQh7islIA@bEKvjNQWJadlR*2 zKQXQx-gXiv*@nBD$C`50^-Lrq<3x>CQv9B)c~@ADWNY<#vrk_uiaFVOr@nQS-TA#7 z#Sqo2WMf0FL+|*xsZvIB>=sJz_cC8gxnjZ1cHFPdM3!3w@%z^0I#m%1!TWU0X1y`i z?Lqq9PcIklBR*t(%pYUCd_!u@(QUe5waPBe>MF&lCpQX9Br4@IOn=aeTD4Ogd3Q9c z+t9k5DlSRDpC5mZAzw~wtedNL8jxo7=gA1mYtVTm((JsjN`p{z~T&uxCXmR+8O>q@$`ei^suX{StE zNf8d|ked=d9c~jbp@iH58VRDdSLi1hZ;DcgPOGS^#dg%@=pOE5*HI z*q8a@Rg9Brlh=u=ohKLv5x1|$VSi~dq4ey73q}M^Cj5au^+j(?1_Q~yO^|9*x$1C) zN$=5I?32~|C1PK9@YT+f{*mfm{mdrj>4G`d`0(`na5UB=FL10erAw1($PlD`ls7x@ z@{{g4#F_b#8u=QViwnINNE(zfV0t6q+gecSv|k+;&rmxFM`QkY1!zU|WbChi*j zK17RZ|9ERVL$*nB%<+(YIb)|dF!Lq;EjO<%kxa<#;iKnqYkBxgXxLS-q@*NL&ZyyD+q*R-YA=u$TC#8L~vgL9M4Z_4lKI2Y)>QC#M}_td$d zYlUucyPJsq>?Ea zkuFV2*0UWhoDVNc$@a^op9oJo=k?mA)UHe+|7PSN?ZkmIrRBx}ccSS}kw0C@T$zor z%V1ja*3xmZ_beqB~ZW>nF%P``HbtLoHU^!IPQm?XFKm^nylHs*K< zZ;$eEU3Hh|d7OJ&Kh_4kI?FCSEN8$wd%&ue;Q;x*`N1D&l5Ql7&+QqRDAqB{i;z%PIX!FT$9`b$2GJNuKh2Tl~K!q^l)3-F2l@+S-*1iT>S?nO2 zy6H70)_G7bkC}N_)1XmYD?6P8r%95nVXgX&b_KB)O3H)J!g*INlteyu=XvUs#aK~m zn`*JcIM(YtS*^#+58j1aFTW_x{-}zSb>X1&XRn=ern&$c5w6TfGt21oL+*SG*IiVP8qf1#v%df93_TSd>xMYz0%=YbM z3hqvqtDVn$D;qwx|2(xKu=e#>K?r6zLQ!lf8!&W#Q`D-2B=X^rGE&ng>Pr2ZHldSUb4oL8Mem7^)8hK4eHq?5Fv zfzt1shQ`r|hYiL+sSFZH1-}Zl)H>%MgrEl}PdJlIA$BIXKjF69g;OrBYmc61sKP|pb8=0fSOwc7P z4w{z*sJ%@2yg2xC*U`S5K99AXUuwx^*z3M)b@wbM@vc#-rb(;R`KNe(D;<~n>1@z< z)xhhks)6WLeXr5rqAN1`Jv~PZ%-4&HV#sXYmA&#BEt>2m>+u>7E#*3oXTGfR=4oUb z@A>eG+cG+DgKs5Hm~|brBK*`pboDbsnn8BrE?)ODlGi4@46X|_d;a<;_oaEk=fVC{ z%omb-KD(7aB4~YFYv`Cl*1M+TnDV`AFzsjB&oeDatfC>($1yY~cKy0l+@1zOtOqZ0QM|E|w(5-DwKvIGyl`Y_J&*s^-9RnB zj)XATMvl+`n^j)z2Eq5q=XZ2yQl_e%x#@lSgXNVvudJM~eu{9Dq1OA?@6XvkP#E%6 zrt@#HnOh?9Tb6`VDCZa@{RSBPR>SMR$_;&ruV0-UIm$bd?K2nj@ZB@fxl)gzOUvQ+ z2VT0>nAZ-7Ojq~S-v2rns4IH(U7_TP@?c>8biK~9Z%W;&(z{P;@2d4`W?nlPO)%1V z^<~$srqrz!6b>+I`>ZC`@x3tj9-Ef*u)KJGrfH4S<#TpT3*L~kq)P&c%Rt9~*XOU0 z<_YnlVP77w;JPm+#q3|J?T?kYzfEWmMN;lF%d#FI zC$7tL#m9Wke_V7+rNy^T)X4p#BlDGeiX^U&)kl_tsgkY<(z!ixTPKV^8(_Bc+@Rq5 zOR*)AS4um4UsbU!?`6T^P_;=Xc|_{Ga7`(xkj}c}g*k0(WoBfs`<&3qqpWe}Cg`UP^z_L~RX7}h34gTrq@(M5X%1J~ z{){&xdS$FE<^@J4+(PC{ALeBQ!~8O3}IfV@>`Rqh$5k*3zZ!}h` z=lAPoyM4LiQop)VUHNgjd>;?phXOxi-$}{&if=cUm%bgI@Zc&~5#!*&J>2HR<+wji znCDlUVe0~pV!B}%KXb1OL()AyT@!zmYlKxlG=!fVzMy$fzPoPhtFce%(d5TWKbRJ9 zSi@wR^KCiT@7m#9rjSa@oTTOP%q~gk%qprLJ)tSFM`*+aU(<=E@N#}{ZQjQZi6^jNbvJ6U;)qR1V(lgg`1E_r+EUA)Q1ryQSM=8(^`>qgvxvsQ6|B0F66=C|*^eTh-) zVtdCG17@Zxn!Pn@@n2gH66lxQz&T1Mcc@s|xT244UcM@~CB^tI_wu=-Ix%^n``)Z< zJ5*d&_;KnlGRd?zmvDWfI@aCvHTr=lhTKy0nE8~p%_X8F{(I^N-vxXO+0Em6*Ix9C zLsL;fL3NdTciyKGrQxH`b7C(=*W0%YuSYdI1f6L6+|=zWRl?GEG)!9HVHib=p{!G@ z^B46d^E#2D*Mud(y&>~X%{`CAWDiw_jo43-<7J(@(d+fL$B|Gd%7gTw z<{9^=v`VqLyb*6TUY^m5*ENv#_*CCh{WI%mv$zyqfNjOzz~+Q5<}oftv5399V(F7B zH8~ERI5#cL%p5vK+#YUW|&k|6Zv_rxr zkurh&MS0~y>CkTG&QC~dYdP3Bl^P1*W+e$nfZ_f(8Z`een!nU(Hl+?2cDC+#R+!Gb!!ob*ui zDMoSn&Lg-HJ7oOu)Y88$cm+(~cH6%*_Xd9Cm;3pvdynqrSfoqXQCfHEvN&r}1_QCV z;T@Zrd5%jDo+aHoV>P=hm$7)K=8Hl?tMajon2YXCBn<(CrfP1%v3fx+G_pO*p@(KP z_APZ4^G?Ig1|p1>#$Dpa&pu7CULrc-d`oPwz198Q%ho3*bNSiFuZw-RGJI|;AmcEp z68I`+j;NlOdZ_T!OLD?~Y51zt<9DuM$Q zeHP_;&(ABJx=iMN@{x3)<@B9*$BjZ6U;D?hGQIeiDdF82Et9H#cb~i7>vFEMVedR7 zo@nzqw0B;&XZ+b38XE0-N7+T2G*93C=9#GH!%_Z8y$duaZ(qP^a~zn~>1xxLDw{Sh zaUC4yvZqt%5jBW&C@v3bQk{BKO(1a0`(1_}-lO|_g3NgOio&Ufw1%l{(?lusANB08 z{?aopb@Z7$!76hS4;=L2c+=UJ10Up3x$nn&=aT~x<4DrJl{t~y%z-agz&HN#Fk zBPK}DAjoQ9X7bSYR?)))p^?nPnkQ{}ng(+TVzNT>agXi2e@VUzS0S@EsmQpQ{fb6K zQB40uhl@&OkDrVCUZSP8Cux_s>#cJGhaolCYVSMleT+he`VS6rj(mz^J2*nODEu?{ zyKxYH5ie6lNbboI88#w6(@UBo{qeWD42|8L^AEuRTQw?_JWFQ|&E8>l><~QLaFdrU z=55EC(1Y_I$BfDL3G8Vi#XF7v&i9421diEWla99HzBfLEW>!Rd&lq;kA8d_1k(PRz zOlOA6yj+llL;jd0F1gvh9SX1R?Y}f{Cl`NO`c>JzBkiB!4%zo92JZQ=XUxp`nB}ph z@JRLsDYK5#PLW*P&J~RZl~$`%?zvxDyqS`JvNz?C{63dksaMI2m|7299(1}#*n8n| zW@B_cgQ;Qo0~w_u_k%7gf~+$SeZ&fCq-e*wn#+P;94nFhK`y(d-; zo_=L=(JLu|gP@BfV}|+IL8i=S;-574`HN_~$L8wU?>_d#jG+62551&a7t_@yEi3+x zGmJ`?emv${d0Nb&)xQ_#a7a(={z8){#~9M_^o9545=ncC+2}r!O{~^_{@BV}p`>2s zZVL0Q$Fes}9=#PC`?5Yyzan0Ikuk>d7+XjAPAb<4G$jz2+ z_vbAd`n^k)kLNmmB!ti%biQ9VO&m6|?!SwlTyQnPsu+hm>B24!vD+cRZ;$PkdKWKE zOFphjHRI?fS6ua3Y|k0|G2DG&g)8zDw|QgUyT$94{}7rbJzuWkG}SAZ`TFziOY(Db zJ~EurYDuI&KaHn+ESO(tn$h4%7kNfPfmpQZ_lAk5{rshX$jf z&d({5?6f=!Fn%g2K1A=}0a4SAUj;6+C#ZlT^{?eJlJyz)I%(#(<}xHD#9T z5k|RZejUqvzg`!)r+dz9nRAIYuiG}^z~QH9PN`n9E$4UT5pwR*CERDgk4MZ-yFWzy zm<|cQC5=c?pfVXyv$gLK)X;i+cE7%N9nfi0q6zSWz z_y2a*6w*cg|2*mh+7k2Wd0BhKe1~sR$Z;GEYM9hIeYz#1ROP#@>zns`<5%eT$X3qD zJ+)&f%lmojqLFDzfJb9#|H7wbW#TNVP7~rxr)(D{mcy5;E$&k=W=G+#?rb)g8D}ih zYZy-mdp$ku>TAm_)qPFm{yQGciTqp^FH51DN;_(DhEzxrX%%MeV>F^`#(Ugbicbxywg9)E7P zG#OX8xS8UB1M`XMu7ZvVuAQJE?EJy8d<{Yi0OqMC<%lzFsaY=qNauWA!l z&!78Js@UO6HPQC)i|-x6uOAf3sUo}&B5&#|5SSH&K_W`18I z{5|{;OJ_=>wtgpPlM{idN$f5Y5jsILiEz~qRBSPZ7J|NQlZRjLZ=;1RnAB&}+xpbq zrJgLlSbb4ubTZS9_Dc4%^s^P8O-`L!Kf%Ls_HCP$J)h~yQo!3Y;Y-DL>ASr@rO(l9 zF;gb%!$tpQrpWPJ8)ho&VFM>zA^kPP`Q)u!RqPy2+j}yLh=}sZ+grKo*?F?_dAM5H z*zw8oDe|fCY4BGBzK@G00~FNAY~#Q2mPtxkKu8DMIQp@}0bRZhPFBoXF5Xtma*kFuXF0GhJ2=`Q9mWwN>7vhQSvlG9 zscRb@Kd!~KaTRhA4|);$4mhgI&eO)8PYY=_;)p(FguM;uCeNqpY31l(BkO$H5qqqc zos%ImMhwpLLgLi-Ps7gnw5L7v_z~DjW3$BeGfm9oEi=+j>3zszRPC8bDA+l|>3_(+lD^QT$|c;8b$+s`gEcewtTh!C8$@|oUAQ-!+=)wDxQUJ66ql5=T?Xy9JX#t-muijoAQ=^RAt$i>0^nV$0c*~K5uBM+^&SBFq z)x7>RH}>i3$9EGK^uJYDZuOOP_x^+yDL+E~+u)8N>a@h9dNM{)lqz4qU7}874oKMct&dwHj9X&}4 zc@^ylDTcH(GUt;A13*uB6MzQJ=mB=_F0RPCku$K69}%?Mp%~J4&72RF0!A8pyxsp> z=kmeXcN=E}!g+iD`yqYkQGDnjeb6Qrl^;2yZ_DX@z$HQKL3+x1(5ecK4?}KJSr0u^ z@An@f$Q8ej&f7TE4|{f>$e&aA;G8_@@rPUuFCpguLhm^AFMT+mOa!_t!ym}0VD2t9 z;5AJ7v=x;2^zD2-`Ba^(PTR?2f2o@Doj7iN#?A&gI8ez6+DT#0-h;;&c#J)pP{|37 z@)Q1jJ|EJHYQq~i!5u(PEaX#Fk!wY;&#NNWZa#)TKn;W75J zRGma%Jh7jp>Ldz}H*VyAISUZ;|DOf;|MgjbLgIW{UQX6_?k=aa!J6PeM!w_j4yPTQ ztsE6xY`mO+!m0{VN{UKK(0*2opI<})e)B_HM@4un1V1nnAio7=;Ro8ViHN`tG`%+eB@gZkV=4;$wKv|l6$%4K z{)s@>H!K(iTD6Hl=e2({>4I}Tp|dG84})f1V!#?e1nGp)W@cz(JQPzHnyX<1pnDqh zYlD`J(8Ep`aK(Yp(32VZy8iRfLU;o-<%H&rNSj|#XgUYlGll+ahyWP0qa6y2L3-iA z>7#;T0=(k<&>0R|j`L!m^_U=BD2(}MYcd{aqzzZV{X^?IXeN#TgAT;eUSr6`8wy1q zV!#Umuo%)G4#E|X6nO%G|E>AnzW@s$z{nhfh`9+2!vd|@wnz->{|&rNi3Jg0L;)CR zfVv5cw46jvf!tID^dCiUVf(5OLV!_oK>OEWb&Pafg%+_}Q~_;(g~k6$6~YKGYLI9< z(+yx4V(8_*1y}&aMDVYGMG#=b;Gq-wA5}nKTrkQls(|jZ=q+qt6`}x)vI^QvZv{pg zdT&Y$eeguY;KYXnKMQ?+xA+T)Lqzx?&G{QuAiNerXH(SQVCxOwGcX+ zqMjKG470r$#8#VDhaNf&3Gd&S9YSnqXN;%<0mTACduXx$kQh4r^8cm82(h8ZIRd;% zYzS7xgds!Rlo*+Hz!&|M#0as`ARB{vW>jLp;omwtK^JjRA#~c__G~JE@LCwo8081V%aDg`Ow-%*$zW_~w_R++j>5v^2_2A;;PrRd4P%QM$^RI3BOTyH zAfN^pwh?y=B7_!335|MutiTY@gNOJdFJuAYzdh$ReP8gPV!p%wWbU~ox-e`joh2%n*KH3GajPs87k%xszVkWUu) zyJUDCD*Er<{r%oLG$bD{>vAuO^rv;Y?+B8=ub+Xe=s z5QZofa1lKtD&c{4-eLj}TmFf=VbaDxHvd1y-QaVDq4v2Y?iND$EP~uV2KDqeHkQepyh(>tO#^Xr* zfV7YY_VEZnGj}jZ_#~K4|CxRWBGm+RssWcMA_{Se5JG0OtpNu0#;ClIjY9YUC~zZ) z--NIT{zl}7uJ(}LAhY;J0E9l~5kT^9o0 z`pKhF04Vt1fH5%Cg6Ifr3M_0Y#*apA7}U9;z(Pnh1My|kS$^UgJ;DZB&lmIahM3v}Z3PS}0DJFoe z3L&K?9;gaHz6ov)${9kCWBxI+f*1y=y@B@>!2)i&du(YC13?>-ouTDC z47e3RaMb_6`(4e0x+f$S$RL8(6hU)GG#~prgLK!e)z~YCv3M56UjzZ#4encoF3aQOML=^%l#39*4>x7~xD)>tgbjtXX-~o02 zS6RW{VATLw6WTD!%_n&N^HLBR{3gr{hz)F7un@RAQ6MP@DGU=nNQ>wV*bIg&4nfR6 zq!xsVs4$QR3|2r;5XMaabb(!_`jdnS!R#j>AixaMwg}AA2rMWLyfc!yLcEL^AwMK- zn?nEoo9Dl-1bA?sQ1wNG-kh6YsRmpi*do+MKt>)&bdV&4SpY&wWJ%{ALStak6opX{ z0RJl_0Gty5*C~Qd(SP!={|goDQ~*8!R&F*mz3~Lke_jgkKxq-wGo#rU)|R0s4tOr` z3}9tQ(Ht0#gfM9JTo_W3e@G1x7z875J8*kgRRfd7(0K4qE{5ftAToX%;W%2H{1-69 z1HgxY7(fdFpsyGjsQpQjguzW>kn|984PmIqg8=~_kf{tju{fC6KR`twxfTS+DkKU< zDuloSiN(+`?N5q?m?5AcsK6gUMM7m5`@cX14vV22{*xaes3J(#46v}k02515j6Re*{stEK zD~5(=s6#`i9|%OCQUF2PrX@gO9*x_#FD+;n$O1~(R56b*KR6$xbo(0?W*Tq{f29N< zt{57e{mF|^yF~*sAQm_o9tcAb|ALK7kWC;U#c$Fgk9q#7TOcfyN)Txga$=PL{sCLb z--Lx(04<-uh(iXt4OoP**qCq2L;+ku%ybJX1Vvb3w}*;w7aS_ciT;P&5mF}qUEsj# z07(wfs?xTFMYxN`dt1^WKtW@%O=;0+5{as}4U3Q$8}1>Lz^WEdeh2Ft(u(pzZvGdr zNXmkmz@O9&s>0%EfDXO~3Z)Q9LX-d>4dexCLWT=Q0JE_m%>2KtVe<(d;s3hYoDa!f z#L!fEOR@zwA_M`SAUHmx6b~*EYGG)!5Bk`asR?{Jyov5_i8ZlvnyO6BI zE;8gltl0vJ5ITkZwl8=BTP4}9KNm*03-KPnqVpv@Kw~d{w0QAb2@v^US+`x12_xJ^ zBV&}n8`2`h>aBAn#D4;iKK#XyA>4)K36S>B3=Al+gbyg2N`Tckqy(|;Nlh5xE+nM@ zi(qd^3!H)^bqlQEhL6~`ZV~Q6HUqGKrZp%nKp|@@EaE8tN?L@wu*?Lof2LrhK!H{X zH-`)|M|4qjyF&)5g&GB*B0q?UAw@$$5eRO0U^QqXeg-gvn*U??42%^;$|0N4vk1an z2s1(0O`iaBHcY#SA^a8=l0js1-S*iaf^ZkzTYwT6J7R!>HH1xAB-PrOa<)Y>5rn%S z6-fJsyGT$DrJpU*g4v=~?`^9V;VxpH%qW33q=mslSC)R8EmSlh*}^JeTi#X#;Vu|C z!2aPbpg^t)D4VcIZRKxBCW3Gma&Le|MBb1V^4pDtG3?v`1x}&gLHYKiMYs#aLxBCm zT|oKImwrPZip*=<9xsHrkXZxfAL2sM2m?ij zEs6z_{MB$FyoIZ@_#Y0#XYfNo><=rT!Ym5ydAF}+QG~;2Sp{`w*pUMi zA#@ksraqu7{Tp^$1|f=Y7+wBA-OdIqICIp=Zo)!n1G|d0KSzin97gN9sN30qg&^cV z;yc*<_IL4}D8gX~l8`Ot@ZSb31R{nsW%-*qLKNXJtl|PJVEl%K*ck!&jS8C< zv3o1F%QaDi!f5Ro^*UH#0R>94TMPk8iWqdIX1jC~MJNnY30ab3COa?--L~#2#uk@4zPb{3_D?JKvaA`hVGj4kW)V31FOh-R~{4-+s%WblEA%^>ebevrpJzbocEu+{>FYAEfC z0efNBFuaI*v<)>t1@%9oXQ*>SjT>%Y+wuZ?#rcuXL|xhjESUes;w5&LfHz>D*fuP% zR~&=^*iC;XjC>4)9h;Ub1nS3bp4>JpuvZ+ZS23e2cc`=o3hdV13JW#|RsX+G0DzZ!mZ~sq{A&aM5 zw}JyI?6`op{n`ACt>lB9ia^4Gt>r^}Du%4>`~&az>KO*+SEwGF^NAyzMR#bU{tLZ( zcm#VFA>jBeCeRrJYj$9++ZGeyEGi=Ezff2}fiD#R%5PXCI)n7$Z(tG5qPw#Z&25+f zL}LONM7rO&kO)E{AF<$Vi;IvJyZ(VX8dP4SGAfGf$N7zm6cmu}`27Vg!di4sG6wZD zC@x|JB509rV*?Qq2cfw&M7~gY{l}pFW81zs!dmP)JL+k$ut+Q>h78ii1}zK{C&8ac zJpC`V?0=#ntVOqFV^Bx4fr@PN!V(Po?FG0U*r(;BL;3;9`&sdZ-pQaACed)8K7u7hx{Cdm8yd#fFg~-(rCEf~~l~ zWi)i!CNAtvuZwd^H?AkZ+dpoBm_yVHFf4fN!M24VrHt zz&CDwUx0ie48HS;0vkEldfIQkfL^Lvh-PNRK05IVSbw{=B#8Irm3TM4R6uh>3hQLJojT}Ijgm3B9nx6=85zP zR(xCA(~8ZbO&44H=oma(4I>Xs&W^nuTm9fZ@9#0!<40>z|1QjGx&2uh-;>$lo-w!g zX+4b#Yb{s!tMlY(lZn^&>?yLCbse!{(B-k=eKvDRq(Q3NxMy|lm?UW{(Q;+NuH%E zUwbU8jbsKa`sy0|$GtHT=a*b(zm1JNx3s7~KkxW`sxn#GQYzrWZBshwUq9DF`3Mu( z>Ce24cs)mZ=;csYF)9DJSh<&mg8BYhfDf=cvG|Y6IXWZXP+a~MIR4qv=#^(R zil2pNe$iSy`%+BoyWEaQt{nMR zeU3D9x5(7elWM*oxne>B3KfLmQL(wp@0&Y7W@*1a zMmC-x{39KX!GsTUDGi-^(0QJ?9nVP@1v#Zcz3K9wvOKaknV*l`#o00L8L!2%htN=n zmN34$YdEA@z~maWzJeyzwA^eJli?~csLbxP}Mv3VVV z=L(KQBJsgcO*#YkiZsqoBFYOS-+6JkI*Um(G~B@ zizjn)$sJ1;{0{AVaDcNQWk)oZ0p}pW*WpZk-7BRkOb_xH&8R-oUq4+~`2L|`j!@;p zqV9%W+!uE=K0JJ&(^Gz3h_>2b?z^t+Vt=R%a&`WzhjKva9(QCeN)Y;cBi5+Zvt;9UM4$0 zl3D4&1OH#n@x;%oF!Ch}l$tZodUijqCdt>{ac{hCCjInRYZIsEv^d{W?C~e;amewj z&+rRbS186%#Aic$=z)nqx)mkQnppR+&I_zWr?RGXK6Rbvq8fTc8b8%)D0iQUizrj~ zkhbWp`gC&<%KTv0|A(-52ogpMwl)8FIz4R7ltjnsNjT89FxxkeVa5!XBNwYAO--s%$D`{o zuJeNQLQN~sxFo=MT7SqF{KvKWa!x%AF;QzqP@Pn|o)LL=j*>K6VDB_Dw1a~20l)i% zR1S87SdH|cj=a)jS!%W^Xz4lx=nE6je{A-q!gKr~&8bUZlh>p6aTP@1{GkHUO#3~^ zs{30bj6UGN1lW__0>W-^N6B6K+5PZ91z!3RkRT=g^yERnT9slV1r}I8E2Oz#z?gQr zu>WY~6V?ciaCwj;J7z&h6&UnRHS`|=L;EF|c`v@Hvc(!2IyHWO=|_gm-Le{V7k=gnVEvI=;1LL55QbC$q-UXz7wS)l*JQIRwE~s#W6P4<&X(?5dc?SX? zkT(H+*#{IH429Js9xT&w!|;Tc@LSzhC`GhsCrkcNYbDRVaQWLH*ruSD^o2#ZMFO38*awV>^%20% zs81crF%27n(I&`Amw<1PVfCW>zo1~}|2>8?vqJf9{IopB>dGo!=0NgH%~23wEz%VRJinw?=4!AKj7#D=?N720 z)#s)bz0etHnRvU&3p53X!jEXmZ1|$W9v8Q7Siw7+G(>G>F4Y@@7_MXjF1dF48g%Lr zTO&B*CwfInZ&P(<8mJdxUDOO#W4l5>D4sSjeUxqw>4iRXF5zGi8uO|sSOn_4UuDnH z(-Z86vU@l*)brEU{yJ#}ow`;k8(jauFbz6CB;RO4#u4&1^zh&5x}FIf z76A{-?8fh4h4T@|;U)2c;lc#WV@gK^A5`alR>a|>D3(QDxk6lcg=0qruA|2_ToOwG zW?e~51_@@=T%~x`7!(0!eLn4~=a!e8EzaiJW@@}c?a7QVI{&QASfz(@8p zB=_tDvGC<#Gwwdf3-e{qCx#x@H^jpJxn;k$d8hfMW7TK%UrgXnZOdNE>z|sHnO+Zn z5Z|A8ke$C0NlYRhJT(M9N`*;1=#%|~7^gR;uMUf=IpwF`YZZxD>K6Fz8M03R8PmrZ zL^o>pJOK0tAU7)h$FDyVVWP?k&(Xy$MC;zE%!n0g)U=#%@!c_{+?%xv(wz3O^k$QDe$HHy6h7jACD7|8N ztZx-cpNcb>=fl5Tl+H?^)X2yHRUfKikv#|31b!&l@K%d*CRX8G_FHpcRm`~cNKQ+_ z*$kf0sZLkg#5rWA=wXwhC1o1bZF2eAdb^;nn|GvMK8F?aM(bY&*PK4HR&OqL)Z_@X zZ8Dv=BP?x@WyqQ5xHi6@54w-nH$NTDdHI@=taO_5E^Hd`t<6FZvi0mdQ@k>*2$75QU#{1&`@4DQxpFzl(NkN4wDj}Dftxfy;5U%h;^Tftmg>5{gp_7Mh?e3@W1Ddgq0I+ww z_lqih=Qh+Sjly<$RSlsNbqlbG4^#n zv+mEqex-*H-6a#^pHKzo-S@D^9H@i~xfv|`V1cL{zSzo+ zJjcp2Db>2Kl7%_D63sa!@L?C=w~vMicm6L%ER)&#sInJm;?2yuNR$0w+CB2r3p^~@ zab8Ye1u8yY1@vC6A$)oK_m{!42vYzfgFJ59;{yOvUW0v(JbJZD-=b{r00z{UJP!L= zyoV0#4tM_x3nCBdOao;DYg?eElsRC%VbBGmqXAJ5Sya;O%kMjym$tfICbLU3*!y0& z5!Ir?QIgh_e5d8h@-?mGtvJixW7v~v67 zo1{*IyZi0)HD%tR9aZ9^d)qK7oPfgcqBe5cKa31^d$L#c-}$gi!)| z1I-qe2BzB70byIpT0#EwS%ldwmbF-!BA{~PpOi4n>iRwm84en$KKJDb^hC!Lzlq3K zomQs&CWH(7qL2s)%CVfX^q_#p=OsfhII}qZ`3-W)sQblu%cwGDNkFq9%2+r;FbCZG zZ@Qbc${_)6IFWFAm6h$yn$w+-CPWu)rR{_)Do?wS<;x-x8Qfk$ zuf!@Ui<)H?b)*ce+I6V5+UkHJb}8f53C<2fgf+9$P>PY6nw;4(0|UtxfFf~$A#Y4b zYO>$H`#bh>m=k6Y(f(l-1LcXvmYZch!S3%r?ljmXyHqJz8w(OyM*5B&n(49!uMn|= zF*b-PoOfmsKiqy48FM*x$US?8IF7hYG>0-awA$)i0XHEAImjiXB2pgYNu{~Enp>NR zI)`yQ+N&th>n!%E6c&ZTuqhHnk;+O|FBY>{5l)oy3LnRnk`oEiy_$v)e=0b}DOwr_ zJI-;H{2FzXyebjDO`l(lT%U>}BPH)OO9n1Bg@epXa?c#4`D~hbJ`ybiU?lO1MFX0b zaH+u+8lfV6nV1k*q8o6pn*JJhnuZKJB58V4>-d+~n92(x;A}6@xEI&f>FEcKNb%wk zkr18*LkLgT^X9RW2|JjRD<{lrq6!&Tk5(6kG$R$DB&+IM&l%PDun(({lm}!rA}-Dw zc1k%g55AX>I#-b*$~)Fx5^%$?0D7SsT^+%d6xgSCPME(xm^WvKzn-+Y@y@C!CiVyUpCSiSgzEV+>IE9Mh z(h}M!lCc)ZCuKtQ`|3;_VdG8eWv&J7S5_(}`6>b&5g|z?n$d2vkv_0gCX%@LWoyMH zo9aF=0KNwPIP-&1L%QjUmq`$>8Eom|3wV5rGIWouv0XCBRbaO*8I~Mmo}IiH$eGZz zFwAY;_)w?P0%I!8uKT1oo2OpUjv*V52O~7?dtE`Tl*72J305*WuKR_*1D|C98oL`O zi0II$H!B8C94e^~V`Xbg9iJK5tELk!1fQQo3a6d``a$vTX5G%ZBymdRT19cGg71RBQS&PF z4l7r*63r|4QDrYS|8?Z51amyyFrc?wc47Jum^d7V6(f4b`O8C3p}d^km`;?(ZL0d= zNQ(8O7FhV+f%nP{jpzG<_s%J6eLFt62|M)6wnrUiXKP~Ot;v!9SL23KX15vmpu`^j z5V@$Rs&I6B?o6(Ym9k{EW&kTONx#CBe8ba-P%sM(5<*# zsBeN?gCzbnl2owNhA~#vL>a!SlAuaN`b3yfqiGUsJYH?1xDkz2U{O0osLHy7(~LPT z{Q8<2SRrP_`E*oH?b4!F=<9+e2ND%wxXT&37dh8zK`O(5a#GNRoQ;Qw1LLuo{!Vpt~ z*6Q87B=4gCddS&&%E2Qx7Fs>BSsB!T-rK;!^?5Vo>@?-{I``yxQ^IMmM+`pk`!<4v zq+bHA&B{4f+~h4^Rnh1PGb2d}vAluDY;+~ZKN|x}@`reIxKM^Th}kik%{idaD=W{q zDiFcMK=NkczEI?qmT>ENJSO=BQ)yEl;u0-|NKajJI7k0O%3J7GE3fq?%$*zxDQKw> z&T1QwM$??r`l;);3)y7y>*k*aDh)Dq5|q*UOXIvLb!UNHD0o-gDgghe$>@goND`C` zs{!nH>M_!4-v(V8c26u8GhM7{ytmDa4Dh+5$3j@=|d2GCk<{By_Nj z{6y^;f@QIOJ2}nJN=lA;29_w_z%V>C2I)KNptmc`V53|%e$W=_i1nR%gWQov(TuNA z-=64j15Z@e{p_ zNle0D0)dN|L`#d)ehe}z2ASqxRU3!hXnyn-{9!t_Ox{|Kb1%uR#Ba?$R3v*P9c2-p z_by>|z3hU&nK5Xo7NKQvtPJj}e;c~U+Yy5NvA*`H8kLvpnpeebbsz&Ke5W%Cd^qPm2U~T;yp~<7y*lg!%hMb(qC=ptTAU&yd_4U zUsZKfivk7xJM`YJ3dBUWA@C~v#;SK|5DY5%ADkLj-jEurrzjp+J8~{tUq&P;5WBS# zP_6HpwX+GOQRp*SL>6o;4X$wp)CEWjf$24m*0^QOB6;*>EFdH3A4M_f%rv%%i4eav z5|C`L4xo`fOJOc+5{O3baJW{;` zpP5)E;@OdLvLkD%wE|_!v);j|<`qmd9Gsit(y7XPLWcYiZ;|sEv7NHbX091Wiuro0 zpyojMQ{Oj?VM>X{I-K6=RWpRIc&uN? z&~*XDAglaB*tb+#c0lM$Lz}ua;X8!PKkdxLj-^K^|GYo?K#F^2UgcJ$1V; z*0Aq1*dS%ZvTo}nlA%X=t(3DU<80-#u5BtoaM`9j9M?%x)E&&R{U^KfVHm*NSF{yD zYdX3P?z?+I1V}uT5_F{jY9TYalCKAdfZMgOMf)R%liQ)UL&u?L33MnS*)2rdB|lTw z$T%nqInvxp|0#Y{ z0>7U`O$4XJwUn5y3_!YS^N{uaJY02NkErm}iQ%*;psh>#m9X|6w|%dwhL2u0UETY2 z|M*J9Hy*Zz+epNBN?wq|w+}j&+CLxb2#tuKBp|+2mTPN93y7+AOQmZnCu>inPRijd zOTO*3mbbb0Li=uoP7vl8OK1MTipNwPg=XNQ;9$LKUa^hzsP~zv(jF;F>dX7Rf?6^= zL^Cr&>1aaJIKwpj8#OSDoXz<+dQM@RvGjD`7V#B|D!M#!{z@~SUb@Ywwj#bS4Ham< zwta1Td>Y_1gsLe$*LE1{YBFw|2X5r3QOvZ-#H#lwXouOo%LVEiGPd{jRN&r{(s=Z& z4*bxN6Yf(MU*fG^yP2v8%5(Qk8dD*M;Db2&Kh%8Qpe;8plOSk~4?Jkm4Q=z~S}?gf zCrd{UB*30&3urW1!>9flj_^EfjUcUe6Rs*di&<41^X+rl{STUL{>Y52!zh;c&R1e% z>-pQH^JZ$(YZ0y`wW-W4to=;run(9l(m`NWr4=ox%$scBi}iIp%-{R7)(7ys{aIlhsX9W|e;Hm(sq^>(v+ zu1*L&_xcy;j2cz>DRZBDFHNpqh5N)4+R`e@&H-6pB`8djWAt{Lm)$RmmX^m74i=FNmW7l z`)#brDPUXS)Wtq#Prgf>4u)(iQO_CQN6RLUFNUsucS?_+RO!3=x{r;pFAi5xmGuuB z5R>&Ax1m05nkr!*9j(y|>(*CV`@T5wTZ`|AbX7RG;-|T<80%T$tkl$Qi=;eW&bP%d*ZD%+ee zvz{JoocUI4)WlNizwDKk4yachT||q%u2bB?gsqkF?9c&pDi{*yZ;_M?a(P?ZeVw@T z*Cm&SaEM9lCI)4uC4Xylge)F@pPKEt5)K$7qC1mldngeU3K5A^ia;2vSkeYE&R@xO zbY6yQ6-HweT(MF(Qf$*IlnjSY8LF}sbzWdxknB2Nn~>MWOrNKcMz9j!LeZJnS$Su9~x##qZ|$Z9HraoQ%`AJs~o-|o+_VuE4j zLzBU}Eomu&R=0QT-F5c{m(BNOM3w|0?N!FNON`-g3Ho=61c0ld(J^TN+Xx5DF{9O6~qY+ew-HY$sI5y8@6$E*Hx7rih2 z-|z~7oZsV60d3Zv;Sd4uH_G7Okpcgp2;%ud`sb*DH%F4t#d;_F4@Z#mO)-O!|Oy4=&r8YQ#k3;(Aue``Xd2-lieVv<*Sf&*yfB zsuklBL`@6a-U>o?N7Z6Eq(?S8lCm*`hHIETaerAC=H>^*gYb5GK|F_&wN5MBu{Rs> z!#}2HZbfZz+1acMMxMQ?Y|Yh5bKfH3QPV^+lX#4jQ0bllV%NAVj?~=0efaPqfqIj1 z%Ek!8<8HLixk9K$xJEB)U)-S|*Sz z_LVKcM%MDSNasydr&q#VifU3gm`G31&m45#={Aw?hHPYI{K>@dVUfHl@&*m>a9=Bl z#8WmvZ%&aN{wTl_@W%|zix9{K;BhVUKWLzg1GKJv4t=m%j^eM@rj%Xk-~Rljh4sPk z#pFF&2yCnMg!1n_N#qROMYwOm4l-U5?R`DY+BYo~o>pY(u-v0GO74UA|D5u8!(DIN zwe=OZkVLud^jty*Vzu07nX+wga`!7Vri2*|3 z8fM*iN&xX*Af^=0R24DlGo^JX$VRz`xjH7A5SCofxAHOvX9*))34Q>K(kt^eslgU$ z7P02Aqe?9LY?_QNeQPcx)+QA0pdcy2TuAI}w!S#T55U7R4F9F^{7<}(BHCrl64 z)^lfIhUl6-<<)Uq-HjZn3Gry$aZQnTT`TE(d3Fy(pNPa zVUDgzgm~7Yu8Tp&QZfRCER1oVWT}Z(ECeu?nRA@ZPy{;ve0z{M$tr~cj8|wnT6*o6 zROF`w6dE`;ktehz!Xhd5>}Xw!D>0Ek^arC>sBO|oA+>g#)sY5#R-N|WUc58{B zr@)@R0^r@J8U|;tLb0?e(eaSD`yw!?TVvO$|Ll2tBEQz3ar55v4}FJ8B~FO4!&b$D z!C|=a0?E4-dH1_;T?tkT@ICBjtZjfiazb!lw0L~x?GggAO3p@aZ;LT;V{z8 zAo`JCRpkD;i?y;qHu;sFr=sr7y#TOU$Hhmsc<)?YDEb`VkQ|9TK4T?y-aZt3mhcUt z70<=hDbcc#K|a-w{uAZDfI>5`b)64_yC4gJKX~n zi-gC=ioHvsd(IbOS8@wVo$x7`!1;U9{OMIava5J(SN*pzaMD*w`3EBW5g)WCkqkHS zi4^hp7fK3uw^oUrX^mT_p?6K>(_G!ct7PnOrPr@l4HuebOcc^!W2Hb(8kt>&wdTYm zReN#(KPzjay3Nl-YIxAUs=f|-%3N*DNM~8EYljTSj<1rkVpZABB8l&+Lbf-p?LWcp zFtM>CJ={$pB_SadgTh#*pOy}6vO)?$#kQ!rXPx?RuS^>*77#{})3y_Yf{nQ+^Nw`^ z4xXEY9BfV)4XCGRCG&W1HWLpD0CI4oGNcFtvB@=nTOK?=%v*1ZHqC3+iEG@J<6D`y z$z|I_i38SLlX!-e)N?x`uVLeW^z7N0JANY<%k}&PO6OAloudpdJ`w zIq76_X;mOXuoHd60mW!wl^(CDQy?_hw1UIK$cx@OZ9{~R1Tz~yZ=~xUeKTF5iB@U~ zO6%>;SMr;ac&;C5 z@|68p*FE+nU597>1QWP47wKnC2E@Az0H>Bs8}F$97k|cPMOLk77l9v>asKc#hSiSt zfH2iS=oprDiTkG`@t}{aQ&!xJ2VLe<;c-95!r3EdXf)aB(ivfoF61J3d3gEb-g#(N zlLs)-`6xqL3cGVelr-VP0=Mn{>m*+ zSzSkt2iCsXnWsSKqHDKV0|3*1$1>)k?08ZB2){jlO>OmW0|?DfLp*6xJXMnOoLYmA zX0+0{#;XQQU;qbMFs;wTlq6a z;Q&n7!fcV2p_7?8!J^!|tA9ELiB{XKGg;)VK}N(9|3tfgMtK2Ng+3FUOZL!_iiU~w zUm1;{QiG6D#bUP(XN06e#WO_!Bh%VLYs>)Mm~1~k&sZY15?``4S@McPjAz~kgJ}s{ zVN}r!#WJE&W?hPgS#tmtM`9y=hD(HNAS`J(2>@Ak%%w!#SY-ac5V7%T*)XvW<8LUr z4C+0{E1ikQ3{hvt5G&^1&5O;&XNW6f`1)Uuu|_D>*|bIkQW}hjMBk!$+7U{JmbMot zMo_IH?Ik}{Qm8h;w_%SpX)XaJXf}r?Dc69TRJLFYB**xGyhU-1DHjY;DzOfjWPZi( z`Hr|m+AwRA462vH{2Ov(N*=iXoRQKC+4Tb9QHE=2{NEd5{GD5}2}>uuwMA^>ZY5Q= zD^BsCj*^MaW)kP@4eW<5c@tCXPl^d|T`)P)#1ybC^~SY=k>%@1=O%Ymm|}q?ve>EC z%fXPH*p)LEKb)PQ>1|%_BiVTXrkN|N=7^Y$O=^MCvxnO1-W<y#-VRMOOyem2Nec1oPILcrU5qbHmWVoAaJ5w3WTd8AA%CHyJ~LvS z0V3x#4)k24TbaD{pdqmGuPju&D$zW*&3}^`1R)Sf^d{Yn-+(7M*mPV;>{#*gw)Gx~ zI86Z;;a_ysLM_Q)(OHgH%dSmHnJgP>snuB^J4b_1r-Dr>fas|gGUmo6=J*(%fr8s4 zr=7Kk0-_sSEp8jiM(#+4qloslk+_Lu56bZBLG1N^PW7xWvF>YHmI(f{IKqIXRd)xk zw1|Y>hnp9eO2)0T|IE3M&O(!+6CTfMde^n7!U=YjS!<|z<40txR?;Ol#dFe}eW~kH zAZ;Z5nN6HGNtgETGqow(6d@>4o)wyd151ez30I?Bcf)%X*s1Z$r;ND;E?2esWqc*#WINO`OD$36LaDrcg0nqz}#!EVnU_ma6t z^`kD@+SPc?J~wV+#2N8yLG_$Zr3>OQZ&d|C(|Ipg#2{2FoRB!@>Lr>@ejlc4nQI%+ zM5y@#yD0n7IGgk!;kQG3T_=G)v9coI-siZ8I}nH)5+@|y++%Ng`>|jIH>h55ay~X-I}3ON3Z>Z%O2sZoCLPU9!UPP^ul)qe3;8{0=Ji@-h`00i z_+g$}K-~85MPqdMk3bL3xEE85Qxxd_j(a5=vAZ1hRh$7zAnbMD5WIsmo6%lJd;h#* z`2D|=DY;0})M{l&3+4cf@ZtX;jGqY5;W40tUCy5I7Kns|p(>HP_sLSO7;w#{BcbrU z<(>HtpCxwK2|;?UzmLtcIcmp`T{4U+=BPTB_W-)ufP6#Cz~(PE9f6qQKBjLe0Tr zvFvitwO>t;ped^h+oKmsm=>_}RB7i6&p-nQPN16(SpJCN7i3Ide*&ZqPh#ATJ48Q^ zx6_x1hs;BaPkB;!ZEIvI6;z+JGAcQLh8{+$ID1mXFaol5jPJ&zXdDE{6aqom+{gzV zM&e10>d?k>dXlil#&adx2gN4VFTTcxmqd0{4&68`}<;0NXJE*%Uz2nSTy0uV;@pX_EyYRYHt06&2)QlcMDmzpt(a1JpTco>Pk@Qv<<-dkEs;F zA`0RFcW^c4a4H8!|P3J#oX-;Zt84_XC>-Ix)2bk zbOugV9%3S`npHpNYeoQtm)koV!fVI&^0gHO61*XEu5hcZv$xk-0!LKt>mZT#oaZq` z%J*Zg?&9^PPAd;@My08(Q4DVQvCgh+Eb}LP9r{k?D|$iHkhow+33Sx+4s5& zue!II>eeiG_)n>*jx#VE21$bf1#ppum&PM#YGiyR?FN3VtZ*3F#s1ZWNT+H|Bk+s< z3TL~X64;?zropmdG8Dy2h-Y;$Lb$0hK$3SPvtC6Kjsj0H^Jo*&mHR0u`hq4GAgKu$ z;v(g4T4d&y@u=o+5Nq@YioMpSe(@ckzYS|ygK>Q#`OJe~=b>2e$ERAV#@;(S`na@+*GU2sD*@}b(dz5kfAEl3)3%Z;{pJs451Z!^HE z?;pUci900SgU*s66+n3>a`3B`2YTxbVxIvPOq#Wr>~+_-dpkn0n@_;g8-nmD_wI5a>1pf_1+Uq83zuzZ zp~ix5gWR*fCDHQr|6q76U!?d?W!%>4Slb7ajR_ZTa)>#OdRgiI3}%?AJ$xARhA?p( z-N)D8G|E?nTCJTd^dFX8Ex`E4rJSO=UrmxAb{PhBk;c?};lT>;6~PmfBT}Z}*d6!G z?Du}UUyE z^cpCP`o`UN-S`o%zYuIrTtecDzdIX)KN^(838&Ka2FuhgT~wdf#CNPmfsod9YPWz* z*ZMY2G8NPv^67~3x=BBx;|;;B^ciK=6C7v5f?N3~zKhh=1cM7XR)M8vo>Y5L@2~mi z?Q=E8ThukaXwwvlNb$E!#cbT2i4N(6UZ?&#LNbWV}D0l=Btd{O3XAK4iPmh{PJ2dd5jX}gqxk0>CSil;*W z^&sdgJ+z}9=9~#S90%65x9T)_%FtT>0}^{lZb7S(PEXHhTt(G|p%ZtgSDubXk~zso zRMVBE$O~VN$M_*GWmCojB~T^p+C=uy?K@4b3ttc(fU2n=V`xlmMQrPsyj`4=? zEgUo@b%&-SaA{A7R!68=22-5&LB?td1=sE&l!%5mwVwV~wR*88z;^8kHjp^NqL6Jo zm~2%(>s-jKUSgx{tMGH;v6h-BDD;;#%A&GUG*j>}8!|>mjWS}AzAa{P@vJ%SJd~LW zxxbN)+QSusBTGw|ll~XeSNDC3=nP)Zux=Zv1tUFP?5cY>(=vUCQX6Cno5{4Eg+mqs zEQP#6GBYDnK}F2vG$xwJb2HxzatpZYgT$)H;~`*xy90z%fZoq7TYoz;VKD)N7DL zo;_HMz_Omsj@N>0q(sWioEU*9Q#(G0Ax`9ECpD}z8=h0I6^j5Dc$aPCXSBV>5M@U< zR)RXY`sdKCWc>(niW4N5YB7Rp!;^NOc&P~_K1c)C6WD(`*ECTU}`J4->$j` zttGguF?lXmi^mTV1>N|=C*)J?n`E5?VFo15$<)!kNPFi#GmqLCW$UQWpd`@%rF&+0 z(k$ar7rC>6L7<;`i|%B^FW(I>_UWJGpZ0t#>$4C_Qfeix<-aCU>3zy>lR`m@fN*}p zhu`i|;-@(12pkVjM`j;Ix?_!zr$Lj1CuuwmWm7Rs)F_v4@KZ`)p9{#iJ#7uVt?CF( zs+*dMzI=e6ml-Y<=*ulf+CQ++_8&u^^Oi5&WH%#M3VM7V19dFgM<2M zh-w1a{q=^ra)k0xT0fnHo_Hg#xSKx9V3YbAprq~3)1!2d-!z(pQxyxz)9aHQ*v?5= z6B)hQQtzVMBRHZvvHI9_BdZerTHEXW{(Z@_TWsu2X&`W8dfuhqHJ6OnnV&M;ltn)^ z1XP3xUyG+(jRqQanENMVm1TD3 z{CY-z^(wqWM2-#Z6fnPWptd~iFYQsQ0?iqL?4%Jjvbj3^mTwz{DQl&|fKqM)?13^D zi~Ddo8wo#qKf?wAi3j}bHo3=qd5P+YT&b)wFyxbe!{WlB&=Jkcz7V`0`!A}q*py|(XUOQsJMa6LOo z^HejrlcW0sRR&W-&tX`p1hKP~pzEU!WvfzFPz|mzf~c|l!&W(N%2pCHS)q|7;(xYs zmy*~Lp(zqGTe|3*W%2yw`1-8G21O^=mj^Zy$?lacDR!27V!Idp^h|?( zx+K^isC(pI|Lr9L@+V3){Yq8>MR~*ZN!`k8$JOg0&4u6<;v~mbKyRrW#}8zk3p~81$UFxbKueS=a%jno{tVos-*yn_F-t_bT7Cht9hY9KbY9BZQ z%1!->yOb?oN;+#j>TY5eg0G-VpU;Ah;`N70*^UX^V6WXaTvcD6Q_kV&?#sRY0()^Vi-ti8yyo=FoO>hsLe|gsp!Q+#&Gv%0aiT!`2qhHp4+ijj}MB`9k{U;wy}U^ z#b`>PO`8j1bB%|indqZTJi_0m@vv`$ZtT!A<(a+%%z>=34m&I=7K)oL5Z8ZgW*;be z;!Y^j#qH6(XpVGAmHGV?p?XRgoqD5OGwv{0>4T#6>5xOpF&N0e4U>%huamXJggk+1 zWD7%c#&>WR5|@?jJki<_{|*1B)U+bmxZ*B_S9D}WXoU4|#$}s%Zy=|(0vuyr;w$|= zFn4V&sSlUD7n;plf}?UwjFRV+!!C`IRw_<$rtY6yADeKdKS#fA$?W9EXo|C}XlT2*Bj_eZH-5nE6 z|Ka$-g+$Tmo7y!`ir1Q6=>JP5im-2;1%bM%km0WAU&PwjRV?Y}ui<(Fm)jpvXc33j z3lbE=b=cozbX)CO%6DNnbS*8OdTZsZ*72jXL4GzV*52+GYeFv1`6a*WmL`H%$M>Pi zCZ_kCk89PMRloWp+970)(>nB~+s!j7I-xwytDf#{4U5g#kqo8X?i1sPvyzCW3QQk1 zbM?ykjbikU?=(;;J@rFq)B4{B5rYX)XQE0{zl==zDcZ#%t5mq)9XE`(j5zspt}UZ( zGUVI#uQrxO7dcIrZi5T5Ws(~*)0+*hLSMU5ICfsPmgXvbl>jfZhaixwFO$WsKmCE# zwv|QCVpWx8?MJd=)s{4Al?oOW^SuuLLJ*XhCFRW$n-zWmjF6Gcgbwxq3?_+xNBlPa zv!aWK_vX@RrB#=vs%|$$XC%q)U>8c`gE?czkrtcRFHXR))KvK zAc#$nkLTvyvAX34LICkp1|6BzGXs%5L}AYKO9EIG6SKe{&8Tz#wl>_m-nnYjGZXTC zHh68ZRvd9Do47|Ot(~Ak7Og>*iZD?OvA3bnlx%#MC;~ErB_UX0Ql(tQC2%7lq7UmB zqfs}@)-ymdved!`E>ex=32bzuV!nw$m#WA)#7veNpF!$+f4faJn5QW7ong4 z8t)Fs@c$4llkK|!EhJp@0jjrh^XccbiUymFvRg1P$ZlIn0;RQe_8fd=2Ww2Kh6U1@b)-Pb`?eaO_t;u+Ifw1VWbQ6Ug{%lu#sJEIV7 z8P3+)KhTj^$m&ItV@qICXLxtdD|)(qupGXk2{k?|Lubr9iRnnZ&Vhf<*szX24rYD4 zc6uY}On?Yp`=arUV&!@i>#ka40$Z76Zl=V0zzFwsE+*G#Cn-+px+mXcvwOF~Dkwq-$f0D5&O=FKR57eLy@eBedFCdygXSBuE0Ne_)thP!C3tHVi9(mr z{TBJhLu)M*G(r*C6st4y60b<7%L6SR{7A+{hucBmS(zn@i6y;ipXeYea4?(KENk*h z-e#v=rG(_|Nv{k8#yoX(WPUvG&KuL4iH|~YamlY|{})@CdItlwX18%}ld~k;dnt27 zhMS^Ta@||mOpXMwYPEFJ_oadY?}5ILoO{Z|CrNZ)uUxT@m}9QTkEudftdje9(3 zJ*edqszL>~2@|lz-0QdxAxo<#N>r!$qVp~YWasqlwZyzT39r{KeLwBv0jM^nNyPm2 zX*!_?69BUxJS=(mwZ+IATF~K%fp6&X;rSXdSuxJS`w}d3;|gL1MMFK+!=6_75gZSl zja$1=iHc>d>&zhFMv_Brl-@{yJ3vbTIlbmRrC~;xR*naXIyONU3v1}bKRQ<-L1i)+ zV9~NN7K#GV#6}}0AlF7ue{v`I-lf%$no^h&03c=fkp8IQxJs(!xhV^rpcB^{el@W? z-5%MpFn%eoIu%+vsr;s5qZW7?Eww4+gH%0LM<;!QPwmgy8oLwJiV%x=vjA`{DwvPU z7y35pQgJq73ET7P&QGQfb=STcjtKw|#ap?@p;X5idl5&W)bGEHg^gb-ZaZ>qx4^Bf zTvK*jDjAy?i3kIBl;m(BT6lTlk&Y-?4E@l4NE2Bf%rVXo6EA{NdLJ1=!AcLnE-R1W zB`V4=Nblq9L#5&eCV&hd#!zUmd@rn0RFEmlho*KT>yym~4nEl~xlVf8C3W&MM_tS1 zA{ZoJEbP>AZXwy6%iv)IVIgZ5l{7~rK+|fIIKc6;m{)!GCz<7+?4vmWh;ZdG862B2NP)5-4La?~IMa`(nq?l~!6 zX+ipam#^-LwzMhS*eHLUL|cMZF^OY_Us#T=r|21V&e7U)Xj#b!`h->U3^gLSIE2C# zH*RN=XCe1#U5ld~<^DGDn3bJ_hV&tQ>1B-BobfB)9d2|Fq^%sn6YZG_BAs2o{vBQW+PnH4UB@}O?s0J4Waq%n%A#fO?6H4& z*}L}bU;BcYy}gy3wL83e<5^O=$(Fr-p#S`LGebdX)}m?B+E&9Caa9FAp}&p=Uva9t zrH;p)6u#M8Q>EOcx%HG*vj74~eyXXcjSI>Fy~jWe>znalbaM6FS|j-Xu=f^VaV*=~ z@ZjzeJh;QaFoToe?j9@*FgSy24EK=WPLSZi-4fg(xI=IW5+orWzJX-#lXLFA`<#2v zzW?{%=S#zM_q0^kta@wJs#UArcGxeVmWqv|`P!;1L87IYyEBbZ-j|WUX(!)6!9|2h zZbtfE9iKczXq5Ry>0Q{6e&?H~eTlEs9+k6%XSTmFmh%csYh@4uXdG34s)u)H{DloUw=1c;mS49%b=MQ zvQmfDbMqb_ygc{lG8){-b^V#Q}W?Or3x#X|lnhZHOrMf@<80$m1$Zs^|EzFSPq&#f1G^B0># z86p%$3CE|YLwqP?sJY6v^C(AgZiNQhVmg>`S3{C&IfoMSxm%;o2i2vJ1q>o?9+l}# zIvuxpV#$3iy*8p9d}B0WOD4&T8+#~hS-TChwxJL*KjxuE>CudsFy~s<8B0%V+GoYe z>@$GHuexV-H0jjFx04xzi!TpX4Op!POHL0$^Itj(dLiqx z${^yyp7FrVt4cMme4P7icq#EgDFHr3Nm5M?cCqE>n%CbB)*Ob>=svVdK6vXUbHpsd zMy7r)%WI5f=lF@&F%_CDr}u=rUm8d%%bWY z7*5j$n~h;-gnp1S5RwmB=rWlu>zz~@Q0Um!NqXstBaqvWQzB`cN04bhphsd_PbEzW zv7d4nFrv+>bvJ#M<0&t)cW>|c`MNg;s&Cdi^n0iNt!7@#bg>ELv0t_Jt>r2_g@S0P z$0sW+r-!GjvS*b5o3}f4KC1O+IQ5_ssw+401ELG~P|`#`?k9KNI}(8y;8PoRX$qZ6 zUI62s#2>S3b`*DLku|4CND6*aJ zfu*ZADnf+}30Vv~7J&XT1sMBzf>7?WHFKJEYc~w!s;?( zvN+E+DGG1!`LRB>nf_dd2miJ`9MgivW`(xJ>V(Z$PW~w5VvEej&4@EbpE0)?Ei0M) zG}H4z=7F$CW|h7a2bYqz9lkek4}!06_Tf6(=v-ddGhe0*t%CD{8_BHg%hL0A%_`iq z*-Nx8m^t3xH$Nyn_Mp`ZH<79W3dv#PVlu3X)nVS@k9a5=f)T1rM$Fbnla3-*dA>W` z`stePgKtqJCgj=j_-1yo9{u8`RB^nj(uu*Ek=~Ni?f$iDMznR-uh8_OEajZGLVEy>7o`Bc*+zp z@1>%}&tN4XtI;bed6>o`M_%XQj>potQKWZwQ#xByCNrQ^|M?{0##;{xCa_b22+o*+9x=!WSrw&Pp6YDBCL2{7)-`H5NeSG= z#w4HHZy@hT;v7ewt6Cem;E;47=agyg;#N69rvMNnyC6#)e@xZDi;1_M>@-SuF^Nfw z&BdzxO)(SJfL-AA>rXJ+`@+`tylU9U+gRJ;9(R!hCl~`4B zpE`;#GC9zOiR$T_ueC!HM6e4DkmqTZrqN$8w;9AxWKQC^WjDodQC;IaKf`uI7PTp# zU3-l(+l796N+x&0zsFEyt$kwCW(R$xhuS9YmELpfFV@{L5Q*|Ha6b>8s>6@>O8eDU zua#9TvS;~cqEO~=+BpsyPE?uMj9Xy8m0G9B&1=sm*pJB=v|E0tpJd=~*|c)(nZqqZ zG2SKX?+=D^-kt5NIBOzE;3|7zwOo1~K3#?93uw!W!BBpEf6EFZItIl|d#z;N{k`CG zrgnkb=>c5B)P1jq0pEHOIYwG(A3(G2Sg^&->hMcewuEP}-d)_6hN^T|iuT`h#dD`_Y7R_d{;zoE5>`(Z*hbC^PzV@a$(e z_D*`4H(cz#R1cG}{O8PVB^$ zxOCNS-s)`7vEO^uk|it#wTo{x1d0;+;FaF=rZ`V_52xoTokKyGihoPA@I?w<+~q0Xc+`5u1Y6VYmb*%7@nX)ursvzB`DXA>UfA9iw6&yqu@_`KbO9e zAe&1Upl#+W-Rjy)luhZz<*2e{t>do}tX!T{%f|hdx{tTm!ZZE2^kV|D^gam_Z`z8D zi=pvj6#Q^Iq+n3<7l4M4KU%8G^F?#`7-h3TM+`$*x0o0@O)83TYf15%?6QSSv{kLg zqxeN+!eITmNIpiegDIH+`(31S36!s{a!!ju<5oLVO=jFEodSBa9$aZIJ}FhR5qjewKM+X$1^Vni`uYpT9P}m{Y z>4{L00uU-aK&4WWF3U8~j!w_WElTQ@riE0W*n2>uZ(FJ7K@Izyu%N!DU*i2$s^sqG z-H>-QZsNEo#Djz#^v8k~?T*}1^LcDHXAClGX11+flUoExbGk3DDHMe@*8qAZXplUi z1b~V)aX|zhOH*KDsq`GJ&7;RCu3gudHdWnd%majV+9ynHs*F(jUsw(@DC%Y-30UGO z0Kk|e?D+Qh{07fdlWFQKF`v~nm$R^<>NN#ejLr0l>AT*Skf~D?B!p*rDH@;+etVjA zi@w3HtsF-P&Z4@TseO!})c@cqoft~p;Vx;in4*g*6P6{^+;nRX*KCi1Jo2eyed2~s zjrNl+Gl^RrWDNnDU3cRVVPS^}*zt~o^S05xxh`JMVz1j#CwlJM>z-zrJvJytpQQlP zA2(MgRMhxmlVEH3HElP#Wk?Lvq@B&bB)GY9-iduCa-ro*_u^w^_T4WBr_Y$5Yi`8( zy*k-DJJ2B;mX|40oWnMQh0Yz=l05zp12ES(MvT;#=?X$)0(_^|wgP9)pXoa8K~6Y` zD1w#Qp4!@glP40wqh}@2++}vs5=(=$Kg?}f#_-E7VIsXw!;@->dr2jD7~@3Di6LVy zUmHICunEggrw6e4EWo9^`msf}1eTdQm$D)iLuhOm;b%hKwxAwN^jE{RT#rxuuul54 zS;_^cMsU8N55Y%Uk1D&& zc$CAS`*G(J?ZEkoh|73Ak8I0%&4=8w()6?b!5RwvkOv{wVIl5Q5A?3>s^(%8#76jK z=bFKCl~3cV?t+`sh`RV?%`DkSKoF)TKjHhGA>y8XwM67pP4eTsFuBAGb5G#;6F^NL z%dM$+Q#=4<0e6G%1J6q*Aro)z8Z^soZK0>jmfp2in-i7i<;ptcx;af7gdJi##R%{Z-t<<{(7Z&dd ztQ_t{Sz}kJX@eQY3WD5Wa1xxK*`$$*Yc`K6QUoWCHYi(|H{KvAb-mFU?9ekz^V}a< zi5tW4W6UHuF^9WaBotT~=O#>2pUPOampOT+8zRPMMwyKZtq<0bZp z!HbLYm#<#L`3enuu516|xlv#d?S)IXtKd{g3T_~Uwke&{;M!ZR3YWC!E(d=&HfeFi zmU?#HK|a@}le3`NAl2pk;@+!Az;8>+C+7E;4Bs%csr%k}Bye>7c-^P*BC7@}@lC=k zMd=ycaAN!`pijG9+%wtX8~i&h1%XV(D$z{SPY3Iz}}$pO1$HFfuJgF&7C#&0U}H-1x9 z7~ICg7V(PPzcHC!TwKH_rT}XF0d_)&g#I7_5Q2aCiXiohiuIC?^~cBb_h%rOhJWW! zmC*sp!o2J(VKQpBRDeqK)=)=x7*OTMRtI=R_UZz4gTXC*fx5mfFrb2)v!~0A8-Gg; z^taTc?L6EyVQwZ(2R~BaJYy|@< z!t88pJrM7y6$UE7JrK77wPB73f>|%vRRVTSFa*u4CGa|vH3z$->s1fjGb_$Lw0T^s@MrL3GSU;rzG3=w6r2#^6FBO{|A zqoARpqG6z;qhnxVU?Tppu&}YQv9NHkaS#h)g^P=ehj+Qg#l^o`7nPEhk(HBIP*hUZ z(bdy8FuY|1wXn2;S=-p!*}J;Adw6LW-&bC5n;@@Z>Z)O>wtf}hy z7OlfM55wZJn7QcY?lrnn>QZy=3hIqHmS)czNL7~y!A#KyoADAoejWZLlm9tDk;JKRo17iJn><}w8)zCQCYjI?K7xA|Ea3$vF(G4@h4{kt4f<$J0U&>Wb5#9!gY0V zlGqXIm%)t-2B@1J#ZAJuAEI$JXjsR9rekO}KXxeF1}2Q7apYp_$dVR>bEpw&r_tww zrG6d$C6oU#Komae@EO*pZT7oQwV|fim4O&kZ+z7kur?@YgMT7MhcU4Iu&#>+g=7C( z82zW07ZXpu5ZH8P5D2nu|HUr9yw5{3V3{Cy`+J zl2?b@Z-r_nl|$G)ikc~M>1^6XoPSRy?8Dl|O*)iN2~L;W*L?uv|h7Rf0jCCJaf$Yq*ukn6ThqCw~dy z|4Ae~5?`ZdORUYcDXNc;a^W_>b$ks|n*oF{~W3%Lvs>re@g=_H;{yO|iCjUc# zu`-}kR!HNCpcJG5_TYO)yncBx^Bu-OvG#-8lqP#@ejm5y z-d0Qa^f!pF8JZ{foh;plkcH}IjC5jm@nY1B`2YI*UnYTo0?w|-2xyezreu0=j2ptV z#_#*x7lz%gNZH-VJInv{anejoWFm%a{gGJrJDZEyOGNCii#8jhRAyMam`TTZ2W8oG z`LHO0NM4Gs$7v_Hdx+iZZ6KQr)EUX>>7+4IHxa3sceX29nbc}4$h)H^f1dX65JJ6R zFH}4A>+mm`{0{*_N7bi3OM!b~$#8wbRb703_DH<(S%!AG-evJuUz-`KP*hp^Z7C2(Gk?vCEF5+X=_r5Oeo1stic1l32h?iS>FKJjLzN6W51* zoIX@KBbm7y?vGIOg*~bUGg$gcT-0f~eNUQAm^>Qg_go%MtWoE83aJFclQEZhiGCga zC6oUlKupp}#P{#WFRd5S+4Ts&t?Cr_JXuK0H|6%k$qMR2ry=6n9*uE**Fz)Bm^_kc zyb&K{t$dstN#uZyX&m>u$5oD4BX7HcwLeGX zCNHV|I{8Zo|1Tne;%rK%f5%%wh~R88?iv5yoeXHtksp;0E5+NU*%-0Lldd51@+8r= zJ`M89)w$AiVXi1~$Z*QKBOR3i8%ftq#6ZH?=$hwN_wrqhwNcAHlsMssJxf0Lh?>de z%JvA&g`02B^8Ru1^^(i#`0_z}({5xJzSq4;N)3`<|Gy;g{~HO2^HS{O6dSs?q#H!i z+${}+K2o7^?a30=>!|F@kKtHvAgfw!+!#s62=lSIA)J0EaATnRlg7p5le0tVCXC8e zasGt&cX@hfv=-GmI=`6q(AJ)R!HLmhYk0&j?oo=razo1~gRxFn&fX<*YK^S8lS?O9 zzYw!bo#@x$Uo!b01BB~4U`&YRVqeATl54SP?b}v?o(zLUwHIA95|N+n_C5g7hJEb& z;_hl(Og%XX6%X18{D?6hhTeyA*cDpU{&B6Vr2V5qqE@+{e3Ks4mhP|JUvl`XL7=nt z2%n2&zc19a`_sv4FU{}#{qSMH%)%>PkHtH4hYrqa$n#yk*S5SR}H zq8H?c@Cplq=>-K5TY89)056yiZ2DVtsXQWp6!s&&^eSqV9&{D@s{LCSsjx6m4T^{> z^|^|bi9qEHc6D>?BYo_!f8i?|qZ`EMbs^3HBfe~V02jKJ;W z$M)yLMH`bS>_=05FaaKKqmNl9qREI1e~+=%7B=YTUy;nHx9Tqkx({C$0H|f9rF4Ng z8=kEfA(?)l(XB^15;}Z~h|l~z%$Pff0Pl}P3jRr?GKjogMh$BN6%c!u!qx`r098Gm z?BLGsb{;?Ce$}Av4nK$eLjIP5l#&j;hnpu1D6IxmNBktHBTz=_QjS0k%^#7(8k%bK z{6HP4@7L*ECWd&{WiGV8hwT0?T%aZN>Q-l$@3;Q^Ou-+|{FB&bp}%G8FNkfvEMI2} zdptxLO8*`5zzF0C2=V_wo`4XDS6GDqPmy<-vHwNLD{lD{``?4Sl&L?{d3Xrq z)m-YlbZL7PQ=`*M>&c||EBYX2*~~bc>@2S^RCMD3VBz;{ugwfz+a&Au5$5T zLEdjV4}ta{vnGCS*M6H2!7q%^u0JM1Tu#&Am-)F}QPsJpsjEl&!1>w{ir0IN&v*H1 zTH4<8^=ac+WoRjlXFp~jO9^MDoqcSYq&L5OOW%-K?nZ{c>D-O%1CG=D+~B6PVy0Z& z`_WL=#C$aYB3Lge--7PWT7GfMTMc*Xql{M{m(Rqmd-JM=6tkxl;5pO?S;1hu${cgI z9KEetGJ(RhNj5r}V%!Y+y3w^DHdTH*-;B_kJ|-uPoHQ9V*}R`hIG)L96x%k79^Wpp z0>(b`(uker*;0X*j+m`iHJ6bOY>YM-Mx8A$ve<-wyw07V%{^MC&rz6R!owR2qCrz{ z7}^_s{}{}uSo_o@Od{A#oY|0ZON<*!wns!KzrAU4&2_Pi@t0 ztUImu>wv1o>4RD2GGoCNCq87Y)cBT|Dn9;UgemvKQsuWPuj@ktW8G2-e1(Gz$yE;X zb(COlJ;#bGG+0g^um!+5BcN=HDmiy(uvw*XxzY9SNrVb7dlMdezwoEva*uw$TBts z0;Ji}R$dex_R#d+Zt63DZ}P6rO(m~ut5;;uh>lM$vbyDysb%$YBC+efy7k~J z94XH=tEJNK&9Q-cxonx^H5qm`!5 zYfab?tMpZv90nCy^cb~go$syQ=rpm0?q02Lx~nV4V~Y-FsOR_Z6vv5^Unt%LP>ltJ zirplXX{{JB~FGSLm_s z45u2B#ImmM7wKa)C{zRH34PBN@?y(uDqrJrG(WE~If8gxcieB9NZG+_TRU{JoC~%| zji1bV<4bE;)4u#-O+?dLV6H7c>ETwP2KF=E&(zVXV?t7S_jPWKzUnp5{4zlMs^R>T zv1su1)K4W;xAUu9UUh6RqP|EsL=vAdzmW-jP;{U4W&v~Z9xztRIzFdWIhQeP4ydIa zvDgZGQ>B8eYChtD+LhUt##JvCRA}^B6m8V_=soxlyKdHHYWCt`z*mYFpYFKr>6)e9 z$Yypc2gI%gR{AtEiMzk&eKc>l_wKWU+$iM9TA=4?PUzR(igHNTggYa*rh14a4`=7u zp^p~KUKVBHeKFqpvr5Lmvd3h%LTyFp8wN4cVWFtVpp;E@3nHI%8jf0<_?O=v2~HGF zM=J#Aqoleg*nYc>=q~)OsLi-Q1b?Kcf3o4E+$}HXk@55KL4Yz)mmkx_1ceaaY@u!l zlbaprel@vF38)E#0J%PR)h&gB96W{>}@&gfy)5e`%00fkGhI@Rs z=lF$$=r7M*J^^9+BOZfjN)cz}p-y&=zU)$#msT)6!n~)KafVyL;O;Ohj_()PIl=_! zK?2{+m&;qOrlYB78fa*!bA7)LaogoxJkrjNh&L-EF3~|u_Vci`MNEqOk=E5wgYR?S zg!uS?N*+*0J4-3JjU$Yn52)h-bJC~h2l0J3kuOuY{5@`VE*{QqK*Jxxfba|dWFrgw zWU~I}?FC5Wr%8p15hk(A_Q8CFA#ct|-J9-I$(ojt239&YtjawoIz&ORMoK*muHh`1mEgYydfM-qfd+6&$pJ0dk2=B zO8c518=b*`Z&E$eEqGpRb-0Z-Uq(1Q7E~)gi+bN#U7lXJo-yvzpKT|(rijt@_Pp*1 zkxwnHk(}pY1B&lAue)&aobWSo2-CHY(nFT!71e%O`8=c()jX)})CR7IN-*Vq%q4zs?I)zNp+yk?5mJ9LX8(Pg5B!s1 z`xm74o5}in-$eile%kW#};a32e(1wQOA}K z(VxHSeg0`5nR64Qskk%YO@OZ5BUxV_8z7Rvr^zP((XHeYoDu*aTcYTMY?|;EVxoOr z#YG8O$3>gP43Xr$bW{AUcq(}Ds{f!k!9SVsh^{dBQiA`2SqT2gR{!sINUk3JUoZ>7 zKN+)s0aku8Y_Iep2mudafy=cZqPu}ug9Lc_{uCeIyYfHGQ9;PRg%3ggf9@&)jR^=s z^!dgFYEX&Ew+pc4_Dnt0J7oA4&ewj|9FftUvc7UDgpyC4B(#7JaT^#~46S zFJMj%`-gn!S#ErSH=$$mel!XAd%=ij;WGS@V18rk3s!I3c;Z<>0^9b)Q?Y$^W2GA%AIO1No1Q%@6s4`2~1E{FjchEBOi_ z7YosqqzSw`F;+>{v$skG9 z<{yVOuJZPKmHGd4SVKTiBw6K^z^r5k%M-50I6qr(jJNSW{!y*_sd2gV zE?<@Fm5&edU2Ff-aSepze=p{ro2UQExCZ1(BLDihhTvbSixHjK-+#e(XbB>QDz2af z;pG>(f)>JQjA+JqK)fKne*&$my!{TXe^Xl^!16CxcK@Nd6OgcUw?uQ-k&salK&T4= zM6-ux>h3N<@(0b`S5|DMKLCc{PwM#R`X>0Jz6oC`P(%&9tZxt@K8WC-*0;a2cK^-# z2D*YA0;D?pKMyJXgVlFcs(+EyCrO8D?T)mCCw1D3jWCuGhH?S9AHszG50Oe~Ix&5CRtb*BO5xB7bv#U;HEC4-$g#r{|LJ=f{GA z*rK4KAQn^v{|{n8`+Y&M0AXUFU9tdSWBmi+4-(=w#4Q+TXc%}nSO`)eJj8N&4FUdl zZXklo4L&|T2|g~-A1w&Jp?@!dE6O2K1mzGBCg2I+2?~O82#E*@nF#r!8!7jScnBFW zAotsXg^7)z8@i+w!oWcSpa77O&@PF5ek>T6NNDJYvslS{!x{C;a zjzP@8k4ZwxD5V7rh$Ul^)^-id!NMlLhF~Z9!A%7EjhyHosfm7PCixTzl4n2=~bTpkx=PB@G1SC z>EFnde&wY43)!tNMyZ<5lvDx#?wWD_`V_lD{v6Q3-a3)DV6_*d!>Msb- zeM`$3RuQt$Kh+@7WK0tknM0e;sa0HQb)jn^4iBDXx9blbm`@aeha218s&UUxui+Yq z2%n?37hp|$eO@--Wre$iE#QkQn?fH@0A3Auj8E9?agxLvTa2Cia9YFqArrU8{u)jF ziH;cSYngC5K{?;IJQskblbHOZ!e{mCXLh@;vCWpk!G*pJ?D4(i1jE9R*u^UFS?Qy` z4lxT%mN8Q`BEQp_C8wFOGj*0;Q!?o>>A0KM3~(TR;FLs6n8{p0+D5(F z5J1nqhp-NcqyK&N;$rM?<#G)rMsN}?x*uVeq^-X`BdwkARJT|e3_!|A_jpe4pd_-$ z5{ow~g!A@VPDKIr8jH*Lh)KU-;dtfYv+%h@4nia)jBtM2ji#DNHj_L!QV7MX8fHs4 zDn9y6@l*P_opQ^d#`-5&)DhI0@KC?x@nDCScQa*S+v%JVE^p}29zUMqlHF2r3Vxl( zkguk$dcJC?6e9RA_pC7%-$o?+HAj&7YGNh>b~MbiIY#e@(qn+29gTT<&?36|t5f4! z-vE4~=HPw%7I!yTY+cmjS`6)iK`ESRTd$R~KbTb|)>Kwr0P($T?>zBAosxf3ZFbkvTm_Csvsob-f{4q_Z zxCGV+)WlK+*q>`MXD zO&lC2<47$Ir{2Mgps@&7d=%DeLNzec7_Zl`E@Od~-pKNZgQIiKJ&5lso!qAgo8S+b zneph%IZN`J_UjztxOiZF>?>6co5`ll_8~=w=c$j0Lq4&L~fCdB*G&SZ9aOCo*#ck zQlPAdrr$|qD(@Mct#Mb~p|1+BVPDL_kY`J;-e&*&NuedC=7N&w_54AD7Y3a+cT98z z2KnO5vkS7dOR^JAu%9pn^f=ghYPw@b&ZC6+j6JEhNO7ULg=&LaXr%0D9*R1s$ajN% zM0RG=ELlL&FlhzLUDYwMwi+GATC6F0P;bURPD%VZ;;X={C?OTVEGJcsqM2h6)>AZO z7~xcOP}dFZv4c)dV{3}#t2K?J&At@oiyDH@#AdWoPRtv^R+sSh7eFcp^sHke*JLIP zCK5O-+0lGuibdB<^J~vOmh}!h*hUny_WIL-CQ7?pUgXLvxh=#bEDtNyzN_V_yJ=L} z6~LOX^cn-^bdI-bb*rzQSxvtM(r2^N4KU6kb;^;xPhZj9iOlb3!HTJJ6hgWID4O0p8wsT_9$nT-Z*?+`^ig5&q&RFtN|kf zmX;X-mg_gMYN+y^XLy!AvtFm)z|ha{@MBqAiwZz5n2n7kfuyMDafF9PqH%heS8syG zR{P~SALnzKMmmkM95C*CyR6w~ZwFA38d01VSoab{LO89xxJHk_(>hT(-UasBx*Nx~ zDj|#!eb!~1L7sArqeQnpFB)}*D#IquqlIukC%y_gBmxz4zy7e~$lQy0jW}C zSjmr)vlL5Hk-1D!TUv6|u`R3pR>Zsy|I;3Kb1GY!Py6KC@bNHoae3JmklH7QsX6Vg zcdwyt#cy-p$f&^ItvOj3Q-b>LE$Qoe8W=m-N|Qc)oRg@BaYM#wBrNLA4Qr-!Dh422 zlNTq~64!<~n|~~|sD&x=oVomD#Cq0Eff^hHHxLL9QK=9d*D6U);0}SQ$ziHj8iy{_ zTRo$eW)?Q6rP6czh$AnynM%x%mr?YEvaCp~47aW|^M=HZ#kJ^?((o!0(>R{I+Ksvz zmOK#$wwxPa?R6}(UR7gzs**Tw8Tg{5X`)X7I?U(Go)(c7;X|n|PKM49l&Dk@d3X3* zzTH$bk5eF{Zat1^n#r6<@GA@lxg!!H0`jqmSmd+>xeeF^4b@bdZe~{oto}VZ&t5BC znqxPcCT`iXjAWT-4GRxkW(lLFCRD3TpQZ14b<}6?wZiH|QcI^L6V4HnkZ|NuyE{ft zw;4mHvT&i?`Av-TDQvvYgp|gVO7C~1B3`coBz2G)r{WqqZ18#}JyT{VeKCosf{ytt zSlTn$!SrMt%3x(}G$l4eK;=3W))<*2>gI$NJ~3O338QNLWMYp1kvDA5MafV(9G`hp zS2?1@b-6&MQA>8Sq*P)DLQKn45Ep$3I?S67!A7e`A?d~P@;+%`NIbcn9}m=xUtuPLM~T1iFTP&ze% zU?yG~9Jzj6NiJSGl-*lU9a(n&wD&n}m~TB3Eq3mDs`R`{n7bW|I;nwav>ohi_nf1F zHMM-kx`SHec6FtSIi%cEQRg{z+?26_nRE(cO7U>VTxF6v2ackQy-RK|aqe~(zu?Y? z+KlKEI%uDs?X{hUXkEvzNd+-os6cTBRV)(*eD^$ACfw?JkWF<|3JHt53P@>!__df= zpRceq0Lf>cc-#qSqzycMwmWw45lSGM4BxNof2t`IQJiM|*e?@*vW!OVX>5W0ASFjK zLxbJoilVUgdh=SnnU%dk$WFBhjndogb;`ufp}4`4WbHwZRe6iY?(l*Y+~o@JvC+;H zO^)wGH6g>w%vC2Fk@oS`>97QqDqX ze7O>dRG$~9B&i%aJGs!wvPV#i;#x?1<=E1c*H{D;(Jf)e>RnCvlR&{APf%lZ_&g_DaDx53hTt+E5Z!$h3xK_$CysH$5%Ne%;0Ehp6od;<`A{ zmWOQM>uEz;Ql`s3t}dOVQ4RR^M0V7)xo-?<#`%T1c!{W*h2RI}rpT?{wX;jS&%^b@ z`|i`{hD%bdnLK4}a>`)sk>M5t%ip~_K9ODSZ^oQNC7BVk$}ncbYz>eaG+)sv#k8kn zP;s@=jn~pKwG&*|w@k;!ay1iQTvzP|*i_)BKTq8+;m1@?RpfA@PH=dyQ&!(>F~PrX zAmVheC&f94+q9qG_&(==Y$dcnNqgN&2mBh`dyOi%PE)2xakTz4wt|dm(VfN!+Nw%d zEA#L;)4j(ndL6yW!DSL{Z86RYCl^omXpz)kMz*WBOQu&^JUqp){_z=ay?tVRC21l` zIsL+uuWAUTPMpt0WoqwFq*9|a;Oi;Cul5^XG7Qp! z&Rw(NC`EPU^g5yxmw^>6K0nP#3VOWfz~YqV*gt;@34&GbWsBRimt*VSpJ3`m%=duh zx#mM5(v@5_N~tNI^9gXb2V<|Ql_P$C5d2GmjSP77Rt>9#3}jSCHBh7|QzJ=?bXd1j zj<|?D1YEK~eu}0!w)NG0@nu%*Lll8@CjsdkCzc%sRRccz)~bR|6X`LCi&qOuMMD@d z$!%9N8OBDFMw6zo$)R!XHZ5Cxr&M$(gCS$F^iYU{yN!`!S-&IYd*xfB!Aobgqekia zdNl$g;YV_$I0MeKD~tMCB$$}|sWf5bk~B&KI?qsb4J_fCSldH#BaKUL<>A%o5AprY z+ML;4lyj_I*jZA-6?BtF`1K2sdRUv(AdAL6UWawW&_mp5gIFs?5DuQ){=)nFOzL53 zr1o-H@gFUCp{zX43u zyOxAw%37X@mI>^E89_!>YWY0dJ$3Z$FcVM(9qkihjw$7%;r_RMH1SFlv8xI; z-b`Az;U&h-Nk^efy<bHVA9Vpk)v6X(NUXOGFyqjm&c(%lQMaPwoQpIuyQ`L z-{84lthSj@C89U8=vn-91s8>IQkFwa*MQ8*3VYXN!&t?h7N!Owv1kg0%yTwqS$0M% zISsYG;;BhVt|KG-#IPcTgk&O{?e33m?7g-6LfF8t)sSDYNaWh{w*pYgh$)(TT@iOn zIF*Aaxw%G*^h%v?(Q4LcRqA)X{Gz&@UcS@`VxvoC22zyQ^Lfrwo z?G-d^7CAlXhoDTSru!67?%*%A6q;)8JUQcLF|t&EArjnj8C08A6EHteBBXrG+b> z_)xzmPQFc|PkcteUd(B3QP$>?1JRYoJ+91vuj{)U1nC({770EY8Df%of#FO&*j)qDqLpw zGR0A?)z}PWqZQJ0EuMi?8s`vqwdT5O&NQ++ib2&x=e?lSMHGZb;x%PuVxqU@nU2b;0h6U1-XJ>OOLrZ zV%A;f;Ts573m=XF9K2DS4<`sB8(U(RDj3|lm@#$fxaoFezI`TNS-oUpjBJW6e@~Qe zPmh`~k^P`7yQ{^(ZJ(T5(wV-&xXdXWZ*Wj8G8`xpvazBtHv8}F>r_wORRr}i3(iE1~H&k-MWvzqURrBqEW@yRq!4X2Nyi%1Tv)E3&y-s}$=Sk-Qn>RhC zsk11@eD1vHIq{`hA6yIclrZ(p6LEu$V^@13EZ4}gjL9j8j0Bh)w7f}YwV*bS*J+~uWZ|otuSg^)DpKiM(Fr>wo3pI?d?_5Bdk)!5m1*$YSa3z! z06A+JIc{rbQYtN@skIP#UgI8)3OtS=4Q5~uzXuU%7d+WvQ(NUdsKv&aO=v7wThyL< zT0d#W9A^taUO2BC^`uUy;BJM~a!nmyD>$usa4Vf6#lvKZK{FIPxV5$FO)VF*L{rA8rnfyd09@_Wv^C zR;HH2gKxot<519Q#(M$iwWphFxS@yT_Ed>EKf==1ZrZ>oKZhNQ%{Uxs*V38JjSmQn zJeaI&NZeGKR|n$_@xd+Am`+j=@agWqi-rj}SF zu4^=s(Qz(V$Ia5xskA{i0`i(1;q@7T_dK|mRe38X*Vt&B%pylRbn<4{!nn937Bjd$ z622Q$TfISB);Yl>6M8Wa_a6g;Xa)6RoiI7=o3ML*k9~iRn-T_&(mdT;?{wXj)R15?PLIQRGn) zZ1p**QcsN#veQ~Yu$ci){XyZI2aR!MMP+b(aFQC9pH-Yni_bB<57rfUcxCr=&bdtaoiR6;d%|C_lG}rP>^%PpXtO^GQdt{1DjT z5r$C{k)is0N4dOaT#Cc0!!FXLRyeZ6QnA@N~OOsVT+D$}ptc_6-iX)zdtw zyYv82oSx$_em_&D=%|oL54j3*+GuGdY)`}H^1B1Y^;YwEeW1^QrxwCNMHL#78qN;8 z6BaBQ!^ZkBavb|*rEK&S@#QDXKmsIhbA=Sv1hdX0(O|xZDvm?zq!8;Y4s2>^`7)p(eEyOEBoT4Zj zZGPKuv{1mnJl$u~E5R^0z{PaHm)+c~kukjp$I*%slM)Sbe#Y&)ejaYa>vr(6eK=#R zzfH@>hBLV=B1&^FCP{>}AomFj>Zh#j>b5?mOO#Z|(%@o##Nh!_F;ywyFlE{33`=Er zPd>}u=IbFa_NJ@$3+KdvSP{1LV|z?7YS+DRXGiJl31lz)XE6QzTjV_1r;ANeL5tPW zdy#mY1__GHkJNGjxv}Uo2Bx!bIn`U=P#$jdMWtXUi1?JFhIrfByA~OK9$|$?ca;;9 zv(yJ(h{mkyDsz6xpG#`GU))XslxX!#-4j9neE~<-8~8x?`R-j zl1<&p&bG8D>d~BXbd^gqeC@w`vI=mIP>t5*GL0dp>SMcaY0U175XztN_G&nk9BWK0BN72_>e#?`8xAvMmIk?2ijDt ze#7ow1yB5dvtKIz>(Gd-E;-WI(m^3RW2I4o(1>VHS}$T1TOX^7|n)L+wVLq;VGe8}N}0ol(;MiMRHqE`%m3Wh}Y!{Cc)e z4-OV;%36?T0u%$vc=EXt9PE!H4GrbkGi58eY0qSL(<{E~Hxc$+Jp zw0Uuu8R`G9_ts%;X4~U0P@s5mhY3ys1lK|bhXg4J!KDo(K!5}YUOTu$A-Hw0;85J@ z6nBaSXYdv&15~Henf}twnK^ULSMI&fy?YS>L&$1CrJ>j85f2#}Dv>GM@aS@H@+5DdHw6>yy zji`}GWntj`mdrLM^F@0Q^uv1!KPGYX+kAEET^aL?LmA$zgQYy!>Dk<{!B6s-={o^& zYH9TUNR3myV)d4(IVT@}=9}K$5n1*5LJ>{(eyMV5q56oujUZjQ$6A}@p%OBg56;Y0E`qBgzh<;J(&! z-nWF|Qr#`2UfG~mM$96gK4^roY-*spo!H+{O-!Y3Ga7Q&o+{O} zuw^9__#|*&H9gtf+%^f2X!M#Y;xWGApglwxFQ0R3f&uvI-gWYEq%)Z^O&5C?kk zjsy7=4)7j~u=|U>HSXrPLHU zQ?VvK9?3rbTPu$SGZML-0_cgSgH=l1h(X)W{_!5hdn^hG;SkLAU@MZ)!nQcy)N_ib zs>4Gn68Gr4I4%8rnU`|3tMl^OF&Qwqlj&v_TCL6HD9CakgB3yPuwyG#foSfDnq?eK zRSI;-$c9~+3vEI8Z4Xqa+&sWitYagv)r@5ZfP_Gq?%IZty3e#RO?NG`+p9Q6*YC3L z8PKuL%k*I)zfBjxj-zNf>i~PPzSQ!~FbU`=2y= zX9D7+dr~_uZeEA>@(GuAWervKin7b?Kbvm5lM!mTO7!X(-hLo7HYMgpWJ^~MhcAnn z<5Byp3;{9>8Vxloa2s>ywpE|kNA@4T_r9K)4_@GM)&8xVrYCuu>e9piT|i@NVsIFw z*EAr#K~8=;KY$C6VsmT>wD0+ZUU5qAq{7-CFh76zOR(T!ZD9w>fsOa6yB3HZ zAA%|(8QV}NJk=swIcbcmf@VUud%3B@tKT%H(k!EQ!?%v29v(p}cnZ|?l!qHdkX@_# z{dmG&p+9qyO-m<7%Xg9+#YbvA6SaSYC!O>bD z>t!4lxJtK3W1iAUocAd!wjz0$uH3kTnrgI=8<{Cw;WXl0xQcFEJC$2ayV5@&5UK0i zI^#4wQifo!`k9C?iS(dI^r2fzRHJd15)G^JwRE3`muv51hUx9}u`?le<{E4ox&qwW zXSn3X`!h6u#Q)+>D-4e@YG}JuR+heIPw^t%N6D$Z>ou6-W&PCZWm(F`xi!->QM7ne z{;=r1#Nn%OmBc(?dmFKtc2hs;Qot$3y|J=NQhHkLrXV0EQsc)8uwM@l!3g<3(>xYMG3zd zcglSRhUlSL@aG&({jA;aeSOt1i#}i_d>g$O^ukYcHpTuoq~j^nLm-vvD!B-LP}(s* zN(r?*`Q92EOD9=YH=MRdA#(5c`|=?s>h^vh#kL~^`LeZyNdkf(ZQK;?8*gRhQW0Tj z+<1bM82V8`>&fThF1jnl@0|M`)An)Jj_Hb~nj>($Q$NdMDrGxu+q|o0odxT1*$Fq5 zLmXsgDc4w2F|tRYsY%37LSy0~DUh|pG zs$46@h-=}Wk{vwP6g@>RWEnh*4r=bcp&`&Q#tHmb4X_Tz6QEH8A88Ahua=SPT*v1+2n=g;Bkjn9V^YShaV_});wmV z#g$ph4MV~yY{h*u-x3lRcLaR!ldE+33pu+rUF1A`Hb zMTOU~S|`=?lkCdb{5}*PZC7t$2jVJsv%}mN&1!k<=%W(~mmd(>_v^M^1%V_!nATwE z#LS^_?Pk?b%ibW>i=Am&gAh+0H&T+sF5;(>+A-W`CULE-t_G9%c*{WDETU+H6O7%E zAyb$TtR*GrQV>P~CcS;52-XVtGMb3BRa8+ISJmdrR00oa<=eYrrBg zcGIzkaYfb}E48#5T#D1PS(0VT7DyETy&Jm_WS1$&Ht<&S#7o15$K!J9?tyO^Mu?4b zS}eT|#{BHN0O^H9u2S&>m1@o4y^T{D+C7svH*Hv(ecKQ84RYX8mvWX*9Ou8YUqs6O z7?6>iYoN4V_`~3!6xVTFjvgvr8IV!~uSQtw0->oR(W#~#f-w-Q&H3wA;!DimRkyQU zSUN7`qfGd{7QfdEeI@(d)`U26{i1nI$eUlK42}Z;azUWrgvZKgu{JvB=3-MJ#h_G)#9mKx26IwC%Gxz18o8qua_GV!uTW&GWvk2oHP%(|o`~c48^$HTdVdcsqq~ny$hP0WNhLWB7zs zygSP3xz(2M(Q^oo+3K0NRoBt8GV9%;M@(fxt~QWde&Qr zUiKmoF=xHf4&k{=gLG1zTmYteGQLlID`6`3k)P0l0~|?gHnIYdx~VP}MeJN~Th-T^ zX~(st2Bf*s74JO)PgL7)3knRHl2U(Q0cb914f2=)G8#jM(j+D1xYIzjGR>V_?UEu> z{4hKO;I0n3LOGk7_xSoGJym*syRe~M5zAwn^{K~fdV8(pr*}N{3O`6a&T|QNnTpho ziO$O_R#VftBFZ^BnwkLv+GKbVQoWcvSApvCa++PO^%7a*+%2mad3jL|;1l-lJkdPMF)rt4Hqw*yN26T8(mPz>^k@`UK~Y? z7S(E;N4U&*yI)uG_Ds85V5{tnolmMx$s3`R0`E2i=Pc;Ovh`$)_q-m{O{Oy--Y#;r zQ%KF55p*n9%w*ZfGN9wsr<-vJCmn7X^=bB>(=QEN(>l#f7L$$og?(lM#1|S* z|04W8YeDrGTk7b$REFK_9&WR8X0drWy0klY;5r!_Z3t5YR*J<7cm!_z$iRZ>E^C8% z2r+p;e}1joQNcZ^H%9HpeU&$I-GC%2fjK6+RWZSJ0!L_P)9qyimrE9^0y7lj}reah}qPvwN{a ztL4UJZ)&Mbn{R4_SEkg#XxAR(_iZ(}R`>7=RpfGCO;mCq3P*0{>>KB29yT>FO z2-e5!anxqJ%Q(UEd|!VCrS%n;ec)WKAna7JU2`e!5_fYl z>TcaKjy*Y?+*vxAPc&jkFIbeo&-uRIvouPX)Id4MHc#m~(^}AXV;YxJdlin#d;>qA zm-`1VG-nnb#tS7z&>V4=)$3(L8eNJzS~BxnuI0unE%2MV>$@kf0MNA81 z74S97KgA4kHbix2lYEC}*duK;5WA~z<5}l z&FAGW6uksK?G7!hT6FG!MS-^@+s9n^I`_sa=zN{@9Lj2{U{kIGv7~VxF?uvE?o!sb zmf)L*+qaEMo;^R@i7o^N)Eg;$?w4~feJ^O%AkRDJ)*!YAESPDOX-;3(wgrT(!-aKN@oUl=y;=*3d|hJYik@HX5m=nhC`y^qsFN)^(9%-}$RVv4#DmZzE6*&-=YF}SUwd_zHZ zVVV6o5V_2h4U{mVUUao?=Bt0!E<2igw0q#(;mT18ul1Ridf?efb#D4|>Snm8)@^m{ z!g{J>B3hS7608i86OV43Rf@!t)jTM%;Uo~g^=5E`n4=Sity2O@^xOoapP@nX2U!kSz2<>VtsuJ z^)g!;5?JtW5=`^FVu2k?+!a;)g-oQ2pCm8zWct~`==)zND0w7>L7_a4+>q=7S*8B$ zFB!b-*iSI5J0}|`(VlnGKC&0X+>C}O^>sFyF&H|e5nAtuWW66#$h`LfH(>J~?@3G$ zkNrX-Cx@U*)A&b1AH6DJY|QNI>)}^{{5ppk3DI$;eoGL==u<+x~=Cb+X$U$dXT=kye_ zmH7kJMPf%q!c2f-RGL6fR8wy0;l@N5@p1(-JV-z6$e&uPXGRBG{%LiuvNGqYo=L;E zsBS~>r0g|j&ZXCm=8me0&d487C@3m&=0D+ab0jHq>SGM0bxz?psuyb{$D*J=w z{LKRGex1EZr~_u?WD?5R;1CX3PT*Q`8XhdXM^ma{&OKiO3-x6L%N9NJ5UcgEfo$Cs zzya3}10c6Ue&6ukLAj`{viLKSa$|>I_#w=^=|hAV&DB6HL{mS}NC6I~Pg9ETxH5; zxFH!Tn2kJYHL&mQ`tHZjiQb>-y2U?fLBLU%mF?J=a0qgk`WRz2Qw&38r_@4Lo%&-* zh@$?S_ucIQD%9uejDrKebiL__P+ijR^0Q=UoOzvRG<(EiGGJMWWK4ddgF6Z71l~ATP zu!_tNWVy*cxDKdjI0WL7m>nw$jymEN+ltkNG6XG5nb%OR59+ft-ExTaiA4tyP7BYQ3ZP&Yie@s>F-wN6!xTR=K;C zr}-!L4shm3PxekX+Y?a{5-cs7GO28hnrNWNb+e&E1If?TtRmL3uPgs1d8CQ=SG7C- zTZG!oZoKBn(uZp@-{4DY!L#+4s%byvm_zbPBj`L zzdp(c`Q!JFDhv^o>CJZfY9MPRcVRCjr6!j2eNDm@XJD*PYm(L4jhGJcrL6Ov;c;f4 z;wH;N+NIpWY_?Lt?zP=e#wvE=EcsMxa_Ky;;Jl%3*J&uzMW?QUN+7@S9)eXeUk z-%+8KJWK5$rF&- zF<)Zl&wgS5T$g<5gZpYPhF{OxhX!?SrMxlH=B_5d*t!xlry8z2Z22Q+Zki%6G1W{xJ2Ph5WU?g3ykRP>rzwWh7yAY$-iT!brJIr4rcv;SdT@S!O9(qbXo zyc}NO?v`qk)54&Zbilu8BXpN}lXKuzh%?)h{jBqe+p%gJ4ZQF8OUBiMp?ag&+0!js zHnTJu)pqZl?<`$w>U2E5^JNbAq!C!zGsyGQ^ElL&h%pN(THcD$e~aA-e{Z{6I^id* zATu4M|5oQJHlmO9h+C&MZGIH_)=FdY7+O*Ms7)|#Gmx%cGyJ1NZe+dYE?)M#_I=Y4 znyTB5{U%b8iJ7i^J}_?v)Q?FU$9psgR?5wa6~#3UG??}7=b0a@jGXGt>x9=MHT9W= z8eB<ltLlW)`uw^ho7q~uikv1jY}+}nJIIXw555s4{pTUtM3ylPl`G_*Mlux zO&BofBSG%aE{gxu&VwTiq-8cL#v9)Uvv%s{rYbBNG}QNA+Qc@1xO5oG+dA**Yvv@g z$lz61+J2NIdfCa;UCGWXeL&KQ70p$}o&T}w77MWrM%oZBX$SJITV|$R(U)ZHc9TwWQD7rE}?TY*!bm8Tc ztz9@Hlxwy-7^Btk?j={!#@(W9O>ay+MIr9u-f%%Xu*;%XyC~TSx4!T`cwXpHFqd`o z^mkLZOv-~Qc;(}Au8-{%G;BYxT?2!B>PatEN$URYG&^f^qbKt(R(;sV=q}>KKSPCV z?oT?UD0(qdbV|p}fhhy38)aS`Lh&^Xfld>AJPB7k1#OnnjowaOy*^*&{l=?B2YKA` zbS2(qnzs?7K&>_>H^)Mfdyw>!W!u^w2zf~+^1o-UX4P-dBNDAnKAwQ(Ztey6&A^pP zDW$HQw&9uAQ;cH= zt55CnRQ<1r{@g~x*`O;vA2Z~tbVN^mQB4V7R9xSN;Vm@b_r{D(a zGgcPxDIaG&i9H%Dz<9r27$4p9TN<#Cm1~-TeddCp@_oY*DG)MbZDzCy~P-6D6F|}pu8&HSQ(ohNa zrR~0s;O}Fyrh*k$j9jg-8P2tiv3TYP>J7L=*{u?J%|m^rW9auG=h>ZFP5y{ytiA^Rv(A!RgVJtd#SDk0rWN%ADsiQ&bf&5$ zd=s;lZJAFseFvNC$Ke;z_7wb-{xY_Y#6ypYy!(^ob8C#mI2Uq$8i=iTG`;k54F+dt zBuNK4O}m3#Iqf6E+n88#Xf4pa&z<}5b`MQUxKHfweEIqUmancFYcI(H)m`Qi_LB;({}^fwv_{D z6MVtFU%foeS{6F-try!o$pf2Szlbl0dNN&!n$4ZY%hku6)B;E)p3B(A;#RZWBfDZ5 z1=9B_eOm5;Rk-1vJtrSK@k<3CY-0Fz13o)v`(G0sRl^oZw$?XMcwkG$?v+vIcn_HiSgOkf}JBgW^f0^ zaipd)xtcDYDe*4BoRW_2=ojYPELNulHCr_!+-s9}-{9xNI5c$ax>2EETKbN)*f?xX zM!qzqn3vqR?*?;&S9d_K%sPpMYRQMWR4#n#B@iu$+Rr1qI)6d{OVyDI=iJ>YLqHFffwyZz? zx6FIBzu|5EWc+H9p;&)1e(f#H|KN*Qpo5SoWDxRSyaVkptuU-VmRt@9!}{U^wZe2n zktjbmv=;gAuf_7BfNvr}K02a$Un>Ci7FJ}wB_0jX1S`t9D<~)e)HT6K4U~$ys?QdS52^GEa+13(*(^3Z}C8vnC3@|KRMS5T0@mb`puXec;T z8SIDmlvmW$)Rb3Hl2=laBTL8yhU0>eVRE=Yv9Binu<<9`661#he6@*m^9v5r5fvrZ z1O92;-^(w^FVM@+|F0%+f#7eQ1H1cS<^QUd{|cY~yCTFt$X$gzEMI&1moAy3>Hf{R zz#x?T-zC1Oe;d4iGh%`c3JQl{k)G&46NoY5FFRzrV9&30m~VC8T=B$s1pOB;$bxW; zr&mzmU#kD+ei+jKn+pD$%)d2_a{o)kKN#=(&1;mqJlYqHCG$}O$!d!KChzYX{BMl} z2co|gebe(rdB~GJ`ImQp4V#wrx5W;0L^0Mue(pZs%D;``za;d6gS`CkfmUBv1|UzA zjwqRBN?t<2EtrfX{SQ$CKmYJ=UHQsg)e-%=Lco8K2qr6s>xe>;{z%+^R2q^oM+SH_ z`5UDpN{&HAIR$k&MHPgCg4VZRnQ!0!p+r_dVaP%AZK?o&%$5BA+#6Fg66K4*kwZcs zgAeioV9A~F0(hfC(Y^qAfZNxyz#uYe4iJbA0)(L5$(;mX$sXY`NZU@#}ozr zGw?BF&3}&J*NFHJaR@GuJRt60$B;ZxWKyg@8Xpu6fRkqwNrubsa3 z3Xa5)bAs}JE1(xh9s`J>j;Nxtl7_mbin4~nH@UxJTFVaY_HB8LuMzpb4u!lg+LOFS z1etXE6{stR^u(jTh4J^nLD)N3@&pEBb;vmbiNm-{BC-BAzZUvfW*MVt>ie^0yZLbmyO4{Ga;t|2(w+JOBP{?3;i8>5ul;8pDuUV4&{~%`M|31b4nudRK@vF!mqw=?-6uIz^ zGV;;y7K66@UkBb>4F4T9=}*SoS0L~IYig3p|1D~gvXUy9Li*2B1c1`FvkLhCk5T$J z9Mj)1N(KKFqeKQJU8DIElSD!B2S(}oSB?@RB^fjHl^yl3S~6UTj*^<{+Fux@Yc$mK ze=>>4f@Cc=GDe9EBGQA2Dh4z&aEdAEBi$lfxc-h&`cH}y+!|qHYe$BNxRdjgrx(Wi zFN)G%M52tpkVK_re1R%%q~Z&J_J;kH}ah zHfkDn4iQBd?R7n5Kx8u=C%34$GCZSnV1AdLf$J;$NlZdgN*V|vgK5>&H8i#UXO7Z; zb^9-`|8lzJPp|)S`Y)gN_74t^UcNd$xwyP~^Y-2Q4hiR5tVEE81lo6CYn#&x|$2}Yx`uV zelFxP^hQG38}b!$t|StnyLdIepN+%)NtwuL-HfWLa+-MkW_?oJmU18nf4Q3A81F16dK=_=4{E~2V8!0DdNNMG(&Nmw9=!l&Fun~b z#%v2}&vTSTZVp&`Do-d|%}b@%7MGN+=TrCT=hZCm>djrYuZ!nr+3a8l?oxxtxfMe} zj@59MB-;=Mg3ySezY&7ZR_FlAFC6~58;#jM7{D@AlFXLPpX6uSte0pfHt!kg4IW2E zNH=+~w~!#vdSCFQ^OCWt)mv&p5!27F%&8%t>o#hFeC$AGU zunGaSjI>BP8(#u$QiOzos2wKRngq&>A5F6O2~KA>MZD{I^g^SzJ*i(UAcB4YERpMU z=~KqSXZ{<=-tsP#1cGdhkHLsi$m0q5dL?%DNu(WZ$DT_~ofxhynez5t*#(mx9*F=pEHnr?mbyi!AXl%bS7Y0hsJ*-kEVCvpb=#KaJwcS=HW#?KKQ`vq!t{%<>^bQ2tT){f z`_Be5=Q=XSlRDmtV*jD@J)Lb1-qz&$N978KaEF)CnEX2PUh6_S$+Mu2bu>Su7wnAW z9;Z=kq6HFSI^ij`?1qHyqKs9RJ)p*nMuTyv+4$w#&$o6%=`5!;eHuQ0p3a=na>>eu zi=#HoP=XC+5+yi(?;ph>*a{P+z~X)z1dDPfU{Yw9cT!t@;U#6(=BkeAvZ=iZW4 zyOb!Lej(+V1zkE+IY8t79R*0COr*JlZ3PNZ%TR-@sc?N~;pSwD9@dx*t2Z11+HmX5 zEcj{B7v2*p)InusP6rx^DI1u#dB{l+olf+jDea2&x~BZE`8Hkz85-zg!o02XT7wY^Krhb0 z9)?r<1wOhFGj$vDCc&3p3I>LQ9*jO6{K$^uSrWy)RE?~dT79BScxIk{9IPXk80s@e zq$3WNAI+Ig$c_IbmXwqz43fz@X+DdTU32`&gsO7JBXUL{@?^w#N;%fd#`C4`!A6TR zndS0Q3cZ?_Z*k5IV-=zGrVvQkdmKi)TEziXbcq%n5mQE%{OPETYXZI z@vQ2E!+X#(cQ@??RH+c_Dcxm~P0cl}!Yq29=e8pf+*H0Me&$}ox5&&sm?1^u-QicQ zE~joMv~;hOGbdX1Ni3g>saZ0|6KsU{Cwq?-cmr2t5q_uL9Ga9;V0rMiAm?x+-^)l% zrBd?y=)P4TGeh-(wG{4(W9h#mRXSn+vUUUTH?>$=(wP>4naXGndp1pRvcXQi~WL zd1y`DPYD$2ZNK3#B|RdXuU`6M-Ix?l+BPCT3Rjl=Zl5=zkh~aZ5et)r9zmo4#;eBWSH~1njj^BcpyW6|id3 z!@&b#Gez8RH@!Jtq-kuO<7QcH8heCM)03?I-`PJw9v)>F_1!axRMyte5op zK9Bz0Q7AkWqO}&Uf1%YJHU9KJ`)%&jb-1|ZMD6LQ*@2orjg7JCWQdP}IeCtB48DeP$v{c%h z!2xiC%%*E5WW6%e?qdy_c0PVeq-Z1{#oJ06d*)Kp3zG)rx;%MxcVQF%@!&Y4&~y`VWca&*6jlqrXi zi#1$zk}MO<4H&&VY0Y)UrRRu)&ZFvMQfFo6M`ZXEy?g;RIc+tfH(^>6c5dNmF={HP zkz@149=o_gMGdHILqk?&uboRF(Qgq|I`}fC zW;MD{!->N=rPjRV`Ue{Z@4md3o@H{F4rIN2aOUcC4cb zzs0w6)>dlpSuG8OJUKcu-}76g>sWMW$TksAP6WwhW`_v9D)z`TsLnpK%>cno;SdPF zo6;xlio)@ch?Mc88=4ZgCZBtta&jBZN?bF$rI|y9LrrrdOqA2->c&I(^wR>;>{@(* zld*i=LA7^F=T6!fNdZp%W1Nb9>JmWlbKS8=>@AWW9(U)qJ+y4&`g(qYokWp}%n_~N z2)szn$T&qV{kjP<9)dzy|dEu^P35 z?{!$KVWP;}!tXS_PL)7;Rnw4W=~TLwxb&#>b@E+2+RtULgMxUC{B0}DpeaZFA2QC| zd72#92_EiChlG43!q zy{vHR2S~46V%{GfmN8^sK)KhVu7vUH4j?d_FS@k3oiw!MWOF+NvLAd%xpc}>_S^9K zb9ktNs1`WBBYD@$Hw6*>@Stw;?%NhGUlJ4)!8G6W9ZsSt!)ahBtJ6juB_-t6ps~v| zX{I1AH?67Ao1Udb;7nDe0@JEdfr*BcMQmBp+1~X}2v5qjsEt&n(~!wrpO|=?CF26A z(_8So>I0uocr&x`OOC1CQ=mS=P(sH4N2wKPy5bXKY;;z^ zXDYf3L9pFWhNW95i!SB@qqsdcb)l!(;m6JXU2YB6?X#|+OM64tY{4e}f%m;gV)YYE zKbkz_r*~UcAdXX7;zv@41;M!zQtLOSrp>e!zr$iQb>SAP6Cwt-rvq={HPSK7(wg~8 zd|f9{|BLwcK!Sca4Eru}NRM`G!m7T%7EVj@Mg0cKi+8r?UpUSzwAIan^!&z@estg_ z6m5^PA5X0(WLnMTblL*t^PM!HhUs0@iIS|v_3yO$eo$%);V`$D&^~C*;@1es=9KG{ zzA_D<_E~5HIkUPs((|_9Zf80Ox5Bb#_C^=LNoyrJHL=E~TW%Wbo!&3KlJg9gl@emr z>Imx?c8WRyknYZRR%5{v=>&IKmmZAivX%I(9q6p~iqyXBZM#rX_Eta*%O$JSwd|eEQFtqoF2Nbq zrZcAYTnz))sULRYX=eW$ZzX%nQ{gsah2dF;%`xwK#-04K*!H_# zueCDoA>yE>S|zb2#Z`z>rGUYl;QblJdR6Onq3IyZN6CSAYLzwJJ{%^{WFLMI(W>3K zFUCjraC4V|m=!=5Jq}{+NhBC+ukh*H&Ki<}AG7^~vFm0Bug*R1el#dBZM7zzVQCR0 zfmoJ)JyIq2`lk$;t?XQ2=K?${U1M2%l$DT^;aA&IS7s+7#y!NR2IS&uaMPHbaXhsv znZ8wfunMx*=SiUiFqQqlz*bfqU(NI?>@!k6=SNG7aqf`{)6>%}pZyl2KbE0QrF-a)R~1Nn zQ&}_^z&4|}fFrS#XF#-vJ$}0N0$IDV&PM}w&6fh~;uGKzLP*sLc|V%14ZYyll9vQqxM3^&|`frR*NF!CJ8b2A2L>A&o>eqJ&e}UhRcq z+@KVoxvYKyb=+!bpaBH4CoKr?T4Rr6OXWIDeYv;<6Q{b*=LM)8S&cp12CMSiFLd;b z@&|%r$|XNz?rFC+x`MT22ZKT%xD4@vv#s{yOqkc_9X6AYE_5dC>h)t^mL3UXZnT_& z#etpa71C^BK&!4OmQhWyfIb?9rfAf6&1%1IIPfh2mDL=3VZ@s$DFzRUrs{u6BtDY3 zY`Jvg8!VaL$U2k&b!U$BN1^7R)k|;RfNaL<+#6F-3NTyY{H4*}3w?B*Y<X}}4%FfK%%jcras(qPTF!);Qw6`x zrBtzfk5(OVAM-u8BnOLH>)iCFjZcl%@G9wsFD;89UZ2zIwc%D)<6<3RH&xvt9PGw{ zw~fviUG4^oC-k-^`d%gyW+rYHd!4sOafBFWTPog?cuk|!I3qb{%3MEzkl4sW`q&zh z_awK};mk1g%ab-Fj{}W680`%BUEvR ze1#Gbg-9>%Gri_6$k!E5tMNfayUUeXvT~)d5+NbUiF4ZIW#tnZ5B4K8P-9bP7RU+6t zlFN>)jOpAGhi%?@I(n*@Do2~()H7@|a8F$bJd?Ases6YIS#5cio)Be7T7^pqj6P0|MGx_pJ`sW@&+q0?H zp{CO+vj)TrCu1ps?WaRFm+|2P{rR($YF=?OC?2V2x3_KaYfhGv4UM%uj8Nqg|6tCe z^iYDxPGFG)1zYwFPrGmtX^mfUEsgaTO5Fg!>8VeLp+JK9w)?tz1cZVLqE4ZDFqTfc zqQqSM=yCquh=ulKRNWgJXd-WKq_r7_`V2mE8GjtgV&?T*i|Hjqyz%i(HpUwcf`HSQ zG&3(~^8&cf#ec<6qNE!Qby~{L*@#_t{*b0&Y47+}fk93^;4_36s8IUD8 z-VK#@D8}jUZ8eZqW}b9pY!|Rk3*n0|Vm*N2$u z5fTlL5?szLPaKerY9uKh_$afCLmG~(Y=ehW?@?~Tj$@3@98`g=C)effRzO7|FN7mz zaOnKX%5`{1%ivJn@HT|sL^j-v6{C__cRfZ_`tBAXzkb`;k|`wQHI?PuE_;I?dTai$ zCIo4UJGeOa2!Eem!4W>0)zak7w)mQ#;AU%XO<2FxEgl*uqOU>5K^HE4FfTf}m@{S& zp8v8!ju<|V)d82xP7PJJ)pZr~rXyy=+npy_?ml4X_^g-3tVRa`-mVt0F6b&UO0NeH zXjJRLm3JW+6tk5=Sj+IGE&cC8s= zeSJ9Qa|_|D=#7bVKw?bf!%v}w1LL}iIeRD8HKkoIv#ylz2`A%bS&EY?)hR_{=!$`g zDHgf5J0gm*0k%`mWw?Lymyo>dzQb)Q>t%fV3BvS#zCPSTSX@dq|A)?rXK7!B)v%EhSdc`7xPkM9?0XKi8z)Oib#Am;;~r4N3GFa89n0_84&@ z;3(w%yk&-=N;K=xAX29vj5Il6CkF6LG&V)Hxqh>i(5#wwK zrCGi;h+k2hEn!vxrtWjj|Aw3201j)H7Gw8_#+&_H6qOv$nYNJfzc+^( zt#+t#eF$DmXP->C@zWz2-NNLULv{4(u;D`*1FBrk!5UC*nuxDB){R?y_F%xU@2lT|-xT%F{*Tq0)6?(ajV+J_8#i2&6rVal~%i(+eua@%71C@d%rBo){ zVwJv+F%w}|p37F1xj^+2w8my z-}oN&`jC0U#T_KssT&OR_NoDz|E4vd^;hwMl0chpJV4N=7-8KO0oIW>W;Ot_78i(Z(x#8>wL_4{~ZH z`hOM~Q)Lv9{FTN0);fBV+W%X$iCgQ} z^GZc-c-Nrw#|EarhKh`$fuVSd{9oeyc-KLegsTq*!WMw~WrU{x0mFljMf$2K7Of0C z0`Djjyv&7dgZD`lUEvD!0LpMp3bt3u{yX8Lj@}lrJ#P}R(vW}^ZXA?7<6feaGX+oH zNdwfYOcXRIOzWor-<{kr+qI@6EGoA$dW*rgrUVn14u=hTmhgo`+-*4~# zu=gEcQdHT(;r-wH-~YdwZ+b%AI(6^4=bm)Wxu^X;badT> zM}*#W+v``4+?_kBePz+I!QGpf%eTMjV#>lpxoO0@ysKA2GU~=uv-QMyqg2xM`TcFj zfHM`N$Lsv72Tl8GV#AfIOZrhqZW}_K4-S-8vu((CwhG&W z5!0TdM~~ikqu5ZbT7@(3|9VdAy?;L5yf579+M9#+K0~6Roma2F{I;CyHQ~Udw(ezcd+_}4rM{YB(ATmpUya@j&#c=ve)Ti{PriOQ;b@a&Lcb}t-trdb9YZtj{IuCh6S(J)vrIejz~Fn%3r+*J+<_3=s|8vS_N?mMDbvf@bF1!Ji%nh9YhSmqjpEG})~%0! z>bzHyEDT>FEvPE&WfXK6~u@9MJb-W$A?YWv*b%af&RZ&Ol{5y+G# zuEz_+fgUfs@bT~SBNzUu#``v9t8Ew@nqHKQ8Z7&~|Elby@c#Fftkb!!AeUx!IVt8h zxPN2$X#73%`~&sr0KHy%-1gQ4Hzb??;`|<|o!#<##wTVTZ(CQ|$!<@+U)^w7_wsV( zuX_5qiYP{MytLQ#lXrZy z48=}x{OaQ6M|{D%9Ic)h`QWMHE3mWsbuYR@tsYF(K6d)vZnrIN+&}Jy;)Zb{n;LZV zMsTw4o~5nNpLL>(UY!*;$hQ5~$PJ#~wcpr>CLbE<8unSI9Bn)L@PQ-+JG&n+LHE_Ppf^ouE79bVyl>O~3l(v7b} zUp#)!9I$RVfzIBurJ-rTU~I;h`=ZN-R&%D4#$zvjlHTrEKmD;c9xJ|}G#;UU!8JAY z*!=W+Pv>Cd#yh1hUAVVcqfs)U(~)A;&>3wn+%u=sh^gDC7rXYSx1GFmjAmf;^p}$J zD<0@~zIw@$$GTlOV!3%~v}MJU$wjT9fkOFn<7DNBGoGCmYAb0tY1ZB7H1paLewFi$ z6_*B{?!GXlVOP=e@}IiK-dz$s`o>#7TU5`s$Iau~ZId4E_Q`wCp53dQw@lo7=t@&# zX7H64G;;<#HM8mr;)$>S<UzbOb;r(L=brB> z>?PkIHZ_b1-Qnv~Q?JtZKK88pkYw<+O&?6{GyKG=s%P%~-Gcn7S+8F1o2cD={klAM zHTgOE@%&TU7BDkcJl!X$|DCrMsWZ*Hz0d9UKCo@ubC9^^lfj-pcKH?i^w@jy@0lkn zhgVNzO z&PO-&{J4={cz)m!-H!Pa;P-_jllgPk$1D#v#Cs;t;}cH2YnskG z7e8?Hg5iV@_j>$& zw?b`xd4A{V7onK>gONK@okyJ>Xw0jG2lIXB)YmUqqd9E3;#91kKcnWzkxgg!%VWgc zi9?4(o?u(4+PY6}A2>gOFY&Gr#RPic^{E&At$z9Ew=3a6ZQ6_99^HE_s2gk!f1T>K zHU8OS*sfiURF|i5ZL!<)Tw`^=4TYg&siilYMpPyCpIF+(*;{kFdEi~$w%tA0yhZcw z>@P=D-`7<;N;5Q^wxM5+-ure`3BhCOS_4CwHOsl%U|9ed!wg7wuyj=o7xYJZqGE8MnV;`$BYR{h2fZ(umJ;*BW%#mzCNK6tOg)p74_t3Pr$Iex?0{x=BC$cC9|79F}3zczc-FILX5 zZ#wlNbDy!{0z?pfD%$ewl3=bwyRqPk<^HvdY^ zt^+rj?IY-%=dCK&p&k>(eb=6NW$^lQ4HG9d_U4uyt~)n8qF=1GUOx6pb^a@CrRGrj z<_#rJHZ&yKKn*aM1b3z@1i?7_{Gg)Trv@X24=K!$tbKvO_mYK)i9(DY#>%>E+n#QfU-M?kw zr_-hkYCmlEA4iL3+c)Q$hVh}BN19pylpEV7)w@@IQ^Tjda^EUHKWn|?;_E|viw6vN>aEY7^o}{Tadqu6&-Nq7){Z}V zVRPrlM)!O7v5S+2KRka_f&Fy<=4~T8yl8yS+CBM=)C2uu*YIiRq5^h(uWjI|2fF0bZc0p#jay9y6%A*Z~uJ$vYZ6VtOF zt-dsF;_8nUKc@PCsJry*@h=5v3#vVhZ0r4CS8U<%O)+)d)GfMmb!%7JCVbAGGd8Z{ zx}Uwauo`a~-KWvx?6`ZsYxRe}*>rU8h%-yIlSckw>PwDzDL!+?T?cNfJ2(qkmWj*4 z^kkgkxpm^4Zq?L=j_NLZE+qB{FLIv`wugnT6M8;Pta%F^Sg%zj(0A^$Kchdk6OKccdt;(2Q2M38?p52^MKUx z%yMWs7kKaS)azDmxn<6nWx~=!qb2X<(V=7I9Xe@rixkT7_cXaiRF8fZ8MAP}jgz5L z$BA$K9PHWeEOryoi5vTr-7PM3;9{g%<}g1@der)yZ#XMZY^m>TPA;! zYWHE(x8=~Z-uq_X_WG`i=ib`!Wurnn^a1b9)cMRv<(i@WdL3C^RkdTJzGvY6;uzh` zcE8wl#AEGy;`rt{fe+_AJnG0(u4Rj(HwHhVpZBzeJJjG^%B}tSnCtL>?OUL~W~1U0q(kynf03sm0R@ zb;kGkq4!T%FhX&M@7N4sOHeD_dGI}z<>2*Zb9B!n4;~STZOk(pR@DQi@bs6vZWwp@ zy%k6AXdJEUF|%pFn)z+e^TQ_}vVEjHd}h*vi<@xn{5LB)YtEm%ymB$+-`~Ty>VDVC z-yV2lac#qz1s7y~*K^#qiMSy-@!`j-WLf)qnchxxK58J#+7dJwH2ls?F-_v#UoRnfdgejc(~l_Uy*hkB4Yzvq=FwLg4ju5<9MAAq4#TxqTc-x?DW6+5c;&Pkcb}f4KnY?i*BPef5tko<~lcyt;Vx z0FPzersbQJ`#J2xWCRpCdN!TAc&B&lnUf#xo3-M2ba03ID%VSg9zA#Nl{4VTwc)2G z-(1SiYhX1eKHPG!e(v1R803ie%CnvNwYpEYdCDN_0o#(3K<yWmmW3y&$`R)B%ZIApcdcAJP^kWXEbfn4=`^JO zH}_xKaB)`Msk&LCs}INzEmh*C>XGmF`Sr0Wi*~;w`q%5uLnE8cTb^7uasP?!#CuKW zMqjXRhD@W{eEDALfk)!c53!Fv*yU*NS&c{fzuWHEs=AZwMt5KTe4EF|&OC8pS*G{U z@r|3-){FoQ*fs94`$xaKai{WhtA(+F?8eo}g-`XU=8a#Z^M_ZB*|cf`6i^4hv( zo?Q)f!(1~vPw#Z_&{g}0%U|#BP_p*_&7^Hh-E$qrXGV}L9{vP-e3pC7 zkyA~5RCg{|R<|?;qsVJb)eppXY%({j9W-^=^)LLVq6<0A&cmSrhC3Tos+)b@Kla-4 zZ>)Pi+CFad#W*K!ov^*h(x+Ble3N&bzu6S3J+Zugp!P7RwD{1xIRo5tzq~kda8<{N zOP8Fy^Rn%do$TH2W5*!vos-^N+o4OCpV-Q{U~Rl=HPr^It(rV>Le(&Q<=vKU)|rZbpK`{MR%?Y0eAd3Qr{(nR~n_3yR!Khsq< z8OIk+iaqD{>aL9PekPwY>)5E598GuhZfrCUsivZ%;nzq`v>Rz|-N{Ab!DI8#;fL zY0v9Rfs^B4t6N_!Zo?l=g>Tl5FXF^Uq1+m?aod>oBQ(t$*s@Mf4w$#+iH@Zgw(gwy z@>h?Jy_R3qXY+<*XV#Bf36DC{bZDKd!=A|D#se=_Cp0?`5!2T6xrqeB>*}^{vR(T? zp;OL#af52gL+!q7WJ{ymT;C~etP8qM9dbe1alFEx#!y0~qCbs)Vg1#R3+;~VTYhA) zX@*sm+`jwrJv}<*Kl@0ByPm{%iJ#p3uqeLv#~z37X|rvl_~tvBO*?+I{{8W*uYE9Y zeN)dD1X;Jkg@@wtPkLf>DE>E7I>JKopro6+@u*7rTE} z-v|O$F6>vmyOE>UjxVX*G}Y9kuA+%2TD59( z5o^ye>pSnj52yRz`~9c$jHw~Wkc2nf4J0Mq$}^@Yl>Yxc(fA+Dw*^^{ z-zVt)WKM5OuH>zR>{wE*iGjq!@6x1y@__&xiUod@(+l3A*Z=Pyip75PL?&x)P6Ykm zy(VKVB?Z_lRPrl9^Qs^AG?P{4zsuzWS*<_W&mRL&=0Wo3k3fW?AT=7M+c z!Cz96Z{>UcAesC}Z%=|8W^^oG87)YV6ccHXmkSb?n=`QCa8d}|N=~i4mHyV8Pu!A7 zjMX4`4USk*ycUtvVq^_MfsEq6v`_d$V(D*NGcB!Y_xBAe$;p4)@TbAHv`(b0iA3~P z+P&s4r~$coW6>d_9HF>BQOH!^dWT+L+ngxuiTi}+)LTFSV?!Z7=m_B@d_KAc_j|CK z<~;ox4?~JIA|=5+h(J=fpZoy`MZ%YBPRhLn!vBwhFn~nvP}~#!A*fsqz#$bFLNge_ z;4+m$hN28gNNJKm6gWyEw4DAyH_SpDiiEG#?cJQnvr*&aDN( z8I|h4eyU}W+&c_r!Z0C~nk*4FXAVeZ(tuK?lPWV(sREXmq#2t!nD?uhvPaDnGzxuA zFO?FeNR*dCh_vOBNkRMOODP>$Rg~T%H8npBE|XLSLxfZjQANBM7nQ25E&rB^uve-9 zHv=Z6Olnig0ydQ_5K+raE>2zusAYkGP9aTb<%NW{1)xGE)hnch=5LciN*I+=+Mtl> ztty$xsw@_~>SD&n7HRSO?}Cz*6@0uxinzcVT6t@@Y~@3mP>*3oDmK!0^DmfJX7x z?J59GQaKncz>7~KHzjnSsT{mOAq|-1;C}!k08m^HCQEOYNu?@Kfxc+6E7eL&8S=T5 zHhoeZlocICQ^+W50cgvzL4DC3qUGjNAg_#?%4TaMr7gK|qnx*y;t|SF=7WBlo3$#C z95|0Tq37hmfIG+m)TJzlJ5vgNFmTNWG?Jh zsYCvVUuDDTl%ZTG1(GcQ5y)5$a+XL|Z?%y|bJXv0*pptT3Kg8FIqHu26COu0?Ny^W zFZLe|zXc$qh;j}`lnl9J$(%3lro>3f5J`GG@su`}N>Qb3ItArn4sJv%_+S* zS}g0`MT$*BK^*aONqr(r_+&;_2Wi+S6sNtJJd&o-ENhIG2-IkY8Ff6<0x%%csRLNl zAFzZ9s6k>Z8VeB!wu**;ge#X&F)3wSB!lM#yF@?`zl1bWsVJ#I zqrf{RX#uFtOJZ1npaWWoinJK4Jb@&PUNCD+j7TVaKC@_G%vd=d*CFv>7*{YJA7p~d zMKp%y6JA|er`6%sq(iQzHS!jKWs@CKC{t3_Bxdc94wtyCDX2t5oM9}A`y~+%o6Y&$ zas!xiqcdg1L@!guLr_GEsfs!^D$iImVMS3M34{$|WynSwo95z3lyH)sT)wPBbtSJz zOJk)nT`ob%WVl32)P55lB+u_t-g~I&Dd{0QBh8 zL6=yDlHiQ7R5ogGTFj*|tCc1!n2~_I5tm;y%5*w~R?rmiu;_%aB9m78Ep$=vrxm3# z>B%!D6p~~eXocI5InGTMX>%xRa@oy6wZW)!Wi?W{HW1e5)T~PDE2=d{xr_!XQppoH zD%fyT>t@w%Q7Xilq?v-;63SQ#lHq)|GRrjSjHPitt@6-DTQ;5z%iX#ZZ=o{fyfc!u zm(m3p5dq6d6Tkr}<8UmgP(-4v)*bN~Eh)xias&lI)Mwb3t_5I;QMm-SThz0Z*`xAX z5Xhp6Fv=VtK~>4eJ413Y>@46|sjN%-+(853Q~AOo0a>j{MvT%{wT4tgh!hcY>hdiB zS&69(RyoZ3C8U7jrMNaqavsXh`7GI#$Bb$s!LT4txXoxH&ByW*BSL_r6K&4!6+IGb z)@!#ENFcsaJe0;;06JCSTt^U<;`i6Tj!%{w9?BF2kp8=v=;Qm`tBIzsAv zHf9eYnqZi5v8rO2bh1o3=!s`d<+7MdvMm6E1Sjgv5fRmkbXM^4R#f9iIrH%nl<}K$ zTu`agJJRK}Jx(McMj28N`Div~jv=%QcWAkgA&U@L9JSE_sln3%5Xi@50cX-$W7$np zf=5Xg#YDVR^jS=BLO?wXYED?Rh*1f%&QwZcH$tVd5)2$O28c`mN+7I3Vn=f}w?R=6 zqhccLOTny_(Q-5?2#h7?GHP-O$}AW?7?iP!lv}0r$UsB}g`l=8WJ!SB{O1a*w|wg4>3y?|q6Atqmr zLtey=C)5#>;LO@`nk?AzF)|v1(xcDFSaT{_+@@A-HNl%1>l-}>hazJhows4UV zBTNgxa@l0G8;W*JoBNv&8iQjvnMGsPvN?r?6Ee5MQwnluD3ys8qzOXpE?LUDVzTIz z7_&~%&;l?h(IaXw4wW?L%ee)M#3Qkl%Ta>kU4$(IDMR*1MxFBLd|;xzVZ>v#c#Txj10@oXs4Ig6BN1F9 z)5p`ilMr%tA}azB+iZ97upg>uU)d59_2~(g1xv{VpoK{E74nt0G zCnPD4mU0lmSR^P%%r&^m(%AD>sX%EiCj@(F7s-_rPrziT`a1mfgsGfT)e1N>j_fMWMkzPfOdbh zP;#52A%PXevLAAZq|3p^V24g;(=euRhIB=gJSLSEqhW>J88(H&^0Yje26~mBO($Kh z7^g~OLCnqCtStbQIc+XTBTka0!+biE3z{i=%4dk+>X6=Z;!K{xgdAcF#aNlfWH3fs05VZg8&UY-C`uBj&YZO%K&121d_sq5c}>(K z)oMtMBxLZ$X-;M=6r*CY%1N(m9~b8s6Wgr5!Md6r}1}D7Q>2fmd&x3NVa5Vv7HvcWUIB9uyvyZ+q=5)+GPVE&tk7ysLFHhyM7tuIa6m7{I0YBZ_t`BpH&r4HK)*Na3wY)oKe0F|6SSqcM7C?WORiV{`OU`x6y zmXyyH5@IE1oR0D?D1k-8Ucsda#G<$_i@Gx|OSu?xB5=@HL@>R^XiYnHM$#H~b3w+G zfW1&Q2}dk`se)rP&|_} z_ywsapG8Z0zq3G=qsgez&aK44*Zk6tX5s(ad_1Mu}A+F_shh0`EfumUs zEk@Nu1gP_7E*Ue6%AiW4_A0VUXN=7$QifvL5w9pqtl-c)a&ZS(a56s4mu0#Xmb8=& z*^)iZ=%`%67BTo^Dq}nw^XoJ&w+y&`!VV1Q(U?)Lk10vFl;k2Y*zS~9gp`vnVF}6$ zC^YSGNbH;>B=ZUmFOjsfiFk;UrhMjnkqrjJY#54N=i-jFLnTApxyNJ=zxU?igkxWUC%F|ktXagkWfx}Tps%!~|!v-z`c%_61 z10&U1h)3h$m_li1csObEtB{HnV1-R|(HSc0(PB~==3PoXUWn;)c1~(6+6YBDlEDOf zK_#)08K5(`?9r$*RgBQaLRRH)M#H9bzU0@X?L}V>OSCM#CH zEQfnFR@7iIxJ**U=);JtDilwaqY=?*=5f>uOfzE)kfGOJlL*_@q@xjZ^nMz#!DL|{8_iz04D>rr#2KqO~$ zDw7$2i{70n01@ja;DS621q@}04$fzA#>?m}^CVnZobi?~U3P8VyzAwgpvocEj5SdLQxEnJCe z*(j2Z3fYh>6p(rqe#~pIWz7+Nun_mUxje6qmh)g`IU^YpYC-LujEh5+(VPsaOp4av zc7}_ZL!m9d&3F_H%6n#W;`ItZ7? z0!58Fze$>);WS+cm24VbW{CqcTvk!%h)jZUsxm^5H&Pos)<`LU%2L3X_J9+ealBOKq6T9{NENM`h!EukR>taLU~9=L z=Y>=$B_>6ikp?UYQW`keVnp*4AP+sAvwQ3?3OwRLAF#+oCGCaSV4le2%SyQ7c7}Cg zk#;I*W047^eL7vjk@vuC617LNJRb^&eWFJtrb^9hi_$v^=Cm#xEc)GXpiadF1s_!! z37-qbV}R@`LssiZE1gS|)+|`~uz=-Rhr!O6NIk=`8d6tq`VdZo;iWu{Mrd1s@UlK! zVRDHjqNH{zbS~N%hm4^BZ^`Dcr!0oXryx$Q}sd5%022S9Oz(kaWayY_zSQ*8^R-C~ltcgkaBVkUkvWy61 zyhO~4Mmpk)_`>Fr))p~Eo#vpa1&4vKD-d94N~y*p7P-O<4s4f3gODAV8OgXh;R&!= zMjrA6eO{xXV4%!#$R+~!v=pa2u+u}kf+jr9l(V_Ap;WP?;zpIut2SmCoWc>&4czQ5 zEMkwli#nO7pj8HgCY#;PnxyVB*yu24XgsSiDZ!4CNe&TuPr<@-PNa}lQGSoD;#n#g zRSt>XOk{Hm5rso#Ix3QB&`Uy=iNfG4VMuBOUVFIYEpsr>LNR+Y*eXF28|lp(t!Eym_;7|8fhGtaAXq7dE~q-o7JO+ zC{EctNsUZl(bE+jJA>FDHRj4$u{077sclw`C@W{2F2Pv{%3Wb?kXCXWQj~mh&+=?lBXBR-JVV zMnf_UN5XtEK|@~NN7!*u2cb${m&|0OGEt$1v!;?D8cQCF+M=?iOu)e#Gx@CfV#zSz%Y=l*1%3AcRbs3zG?nO)T4Cj-s>nU<90@&bdmgozVGRIICotggR$47d&y6 zN<(O=oX8kF2|JyQq;r+cg)$3s7Bc7d##~ec$&|C42A4`QWXg)t)?he-f@Pt_++`-7 z@qwkHCTXMq_EC&<0(eRaIXe$iIe-E+2Ky`CIk1L|A>j3pIBYS4D`die$Suh*gG{SW z;Q_6h;#d-gqaF~=k%9|~BwUdB1&vt=g=wS074}ABxsoSS3=?j$BK3eZNh>%aPTOtZ zg!*z0*5=BnmO|Am1?gfmoG-aNVHb+AIRect}ZFS=2&iz*Y&*k_a5} zRWw+{>8E*XD3*hqDbY>@RK9dEU6Ofm)~ZiinM7IXVKsh9kcwyGDy>tcbH#JO$$`gV zgUJboj-oQJ$;hTcW=E)HQdAndMII}&5sMh+E!GI(k#NcgUUs<+WxWzOAF^yDML8kh zHk0GtWCBg`_H@c#l!k(dl$e(mEk+_I6w+D`S@9nN`=Jyw*y(%>ErE%KjI35d2yRG~ zw};?{^)9s@E=b@onJa;AgYC((87GQP%HS-RERfx( zOW|w^PIzr)wHhG9s6eQS|4THU%lUmH|2AUC)H$@mPL=jm~ ztX9JFPz<)pv?<(e$`zeFkp@fARfb78>EtWS0S@3qRwBYuup`C>4KP)V1GNoC(&3gn zA|o1smjZa&;8H?tR_U}d*yjtwQr^i*9H^L;fUW5~kew7%0SNhsm=^-OqNopsEFM5B za+40c(U}2tByupTMn#Ge!v)0Z66sVJ$|$HLaANUBMk2%kOTp~!JgFx{dkL-xdMvMl zrE*|mk|KB&Oa~aa3}wK1IaFB;7g-h1$P6$mm%tG=4~b};g&kg6(BvUj41@hUAK*Zy zyb}#MQMf`jk{I61mRJjfI*D8i7-i8gp_1pEML}Nz-X=ZmM4iCBVlUhBU=zql!(dw& z2AUVfLQ*&!vgw-9ph`h3S|MyP3>U$+H01{B39KR%gb~3>(4Nf2Xho1=wXl)V24OU; zfB~6g%HZV+W3iBh6Toeka415k5LGzgaN4h}Fj!J8lDRAd6f=zQ5XFLM3&K#w27{gy zqb#HpLva@jdPv&<4Qh*4fC6v_Op3+~X`KuVKC)n@5D^GpOvK$ykCA|tnp$xsnC=V8_iWz3=tyd<21ad6B$@I4d8 zECQiff~*L7w&*hvVk+-Wmwl{E2Rv0_F-PUW?wH9a0_yQ$IHU#>>X*T3FJ$0xSi|Ol z&65KrM=(whz{tn~;)>;>aAoOnP&x~R@<^C*kYE$c23zt;nv&-koaQ|?VE2c^z>f^u zAp?mEVOm!x5>CW#Ecg*8EY$^!5LyOAUXE*>+KL8?;&31yi&G{jN2hqoh~ftvo`b-@qiK< z7bwOf)G#DM)({wh)-Vi?)cAZJQsNhI+~;E|L0}aa{+|j6^Z|8_pur)(G>9oAMFIhV zg(OuY0+xlKz=evSl|a2A6&Q(sDI)MYAnAWMB(Q?5?=ZoJKrNMY=?5Wmx5_m9b;w*x zz-q0hrLM}o!!jO#zgy97m0LfBK0+!ZB#1&TCuq4+f}&D}kSiDvyoix<8ljaxhENC! zpzIBXpb}6HsRm=3<47^276sLjzKmpk17!%Bp?v-tzt2n7cqAYW-%A1BDBvPO zdKoW9Vc5Sz?O-i8m(#PNNG(p(l7QMJw~`RP7XbgU@Q@F|u(8O0k^uR?h2sCGAOD3;jTgY}TrXe~t~ct!76E%fdKu$?)hg}G05NgA3hxaKcZv*H)8}I2~E+Yp8>`=N!LgK z{ngNzfYf-XW}YlE1cFtv;{JvaG*cqpVo{>C7y}fte~J-!)=DssF_z{%^L*k-ytrcFPs?LwWOk{xMmL zgGK+}g4X`-q~q_o%}=uR|=O9KPud z=igqb<76o_M>@0F0EGv-9c~JiGZM4k8h~ zb;mDv?lQ1SDdtvQ8eXZpN;DT;m8;aOhWoBYY^6kOzECWczb_EG@aaX1m)xohyX9{x z!=5^Q=IlG?exkrC7<-$xtvlS-wR5`;k(MsEYSXq|kMI3_%9buy>e^Py+Gat< z5a{z$6DLicGIiSY1wZQZ-_(UY`QtwSs3vUpb^y0M+Vp7Kqt$(_emPfpxIxbZbBQ8S(us zZ4UK_&WIg;4FoaXKJSI)4>xY)kI#m>x3hfn$(L7@AI?28w(U9ybM!wk-gLIt$4}i@ zt3G;9*>r8z^f&G)ow@MHoNX(nzx>ds-+%q*R?cB_udZIaEH?JYo+%I58+WW|c;=OU zJ+i*nCP~+xdv)_~=PrA#d{KH-dHbw>FaP}MSBG_)I$_w5sZ)ow{IY+^Gf&UsA3ge7 zbj=ZZ+ltbSVfPMwHFIoW=L>xvLRY&w*{hyXrSHFs{PJKt-(f=t-&&V$gRv;VfQfUP+-eD<4NUw!Q+ zIEnW4)AvmORJcn2TlXD8Fj9cFz>!qxF$4cNIrg|E$|lB3YF+Jviibzv4so;ta{<3q|B-8S}rZ6&&<`<;pj>xLfMUwk<-UX?tdo;rqqDEV*Wd;e+R zn}xfUIMB_%p8Bb9X`N>9GyNt_xeC7o&sksSbK&6C54wHzis91wZ;~f=&6@QGb!KGK z@O<&1zCWA4>y_x;^vpr+(t0rFl`Q{6b zOwFWwdYp)KuWstnu>S37d`jM{+wK)h&s`a+IQPN$;(_`Zoot_EROu5PXO3>ty4}K= zOdBLnczY-~;IQ`lzC2k}fu7i_#vk8tf|31k{&r!tCfa{ysZ9gd zv))pVzM#aOf2h-hVJA+eYKG0dE|#CG9({>5%D?EgV`Y7^+rkyGRpYI%)XnH^o0*y1 zjA|%*>iL>6A00g2A5@uT zeev%0`{z~3Ba;y?(qnh$b$|5FcTC^Damdwf!_)A|g`-zmpHb{t?&UpK|Bc+SdWrkk zq+@jpdPb{mj+q$re*1B9z!CP&;c(LRi#$8M3CHT39XzMUJd zJy12ZI#l1Mt$AV3iDz}GuYY?;a%{)r`S?o%zq&rB`}`TdeCsz4KDOZ{$%WqQ)>92T zCmsJ?6-<8f$)4Bw!`oheYT(TegHNA%diAcgk-gjZ?78&v&gwsq&wP6Cmm7UPu!0ZI zvDV!)4(@vU;fHqry@X%&^fJkr_V-QR`tEDoHA?dN;G;_#=Dl;N=zQG#U6W&Ce#&P8CKzK;J9n3q5sFz;YISvN$H(KEzG3V6D>Kv`qi%<9@Q*U zw)NV%ahkrA{vtPxx=XorX+G3YBe})h?2iT~d^~%o@@6 zj+Y;~^Z2rDPrl#vQ~Q~Pi*r}{uP-$Q&ul-i_0w79!_i@SSiDel4Din|jWTHM_wP#lUD zZ=vlv>9Y6R-#BNSA7}4>&j@!IBlk1sHRm-|LIShC-#)AWE8{g(x!fa7IpFUu@EfrYx`M#(n}QQTzL+z~x>^f5};vFrrY zq<>?qaJ?B^CXQ?x-=Qk5kY(16Hl5n?J9h}olcYekbkM~zYpnCAcE8uSqv6AUe9RKX zW=h!Z$Z*6w7oG(d{N`9nlQm6PmcgN^d`Y8Cpw;vweXnME-PCM1hKj=I2$+V#tZHJB zbGgY|xn#HrI{V86aVi>{!A(%21@~cEvDpfRZ2{xkp|ogh-E$h}5Fx2eS)TTKWVjhV zA*3EoIDW(5HN3-MV5~aabv_I;2BRHYa;Sc7(lCl7Of8rP@NzbS0^%F(R!v ze>vN>kT#${H5yMB;!ZxGNKMnNu$#@Uxj!+sw0}sg!5}a>p~e=(;gnjDhxpQBR4#%u ze*^(8rTtPr(pyVysQfY61i|}Ga_wIcm3~Gu5r@<{22C4DT!r_<$a?6U_NNkHyy&%O zI6(w(!iBWx;Jg38J2&lbj$$zVFDApozkRHnKVLXpS>ZD3{2Mm^?}{J)ucLtTx9j7O zEN>gWWBy&S^y==nGXwlruqgiWB&`1NjZ&2NPN{}`d9HI^;ow31=+7j9=$(^tdG*cd zFMr}s_y8ne^*4{JazcLl921UOwb~V9&bk=i{bkw}B;W1x5y>_1j`kGyV?z}_+RUF= z7BD60O|9cG265*v>l5E(uV1{v>o!;Z$n+Yc?6o@GvLM9mWPxcUt)K!>J$8rA)!GWaARzQl8& zdJZ#}MkbDH_S}tTRa*P@_D-Dw*}iVw{zSOiasRD$tX4y9AcUbLivhSfJ&v;{cPGHC zh-4z({a*X~B?DtO)CN;yx=OP!Yibq>8D+6m1a?Ct0l%?GVc|JBzp3SEk_Oh`lib-n*b9ysAMI{zXiehdr*szLLLAqYA;yzJeEDm#^xRn(Z~ zS!-pA(k-Mqz%;3QX^`Z%uaIN~1!1-d$VJE{G8&my0XWVTY$OOu@Fh9P~@Fj#@z1*#2P-lV6+EcMT`Trj8%1mDAAc@4=LLf)Yj)5{Z%uQ&e-uV=zyyuAwOR4 zkhP5XqP9#&$4*SPfEQdFPE73=OW_-PFs0@T-Aa<& zBq^ez73*+`$s`Bm80$4@JL1{hXhNmX3z02}n0w}KKmNr7aS}Yj6~>l?yfLfSRR`E; z$`eFuOBj;gEmYvRdo?-vHD3t>X**S2B{o=rosO01jjzcT&^qi&pW`Lr}u}fTEqdcdjXc#Iha|CeBgCM--lkCB*#7J!N9$lB3hk}ojM{7o?*=Yv zl}_7@ykwBJ`N(A3_c}@t$o(UVYPPZRDJ7Up@410bLtALpD;2_c5cpU2rdskhBjUp0 zMePy8S847vxeKQdI=TS0iC9Lwff!~FV3;i$%UVu;r;wu=Ac5^9u3-LqId9O5aCzaQJL8Yz(M>xd3cfCP>4nELm#~M5x8X_| zbb&0mU$&a+d?+=unDeaeWFz+RxoT@!+B6D9vtpcXuH#E!?2$TaH}f)nDoO)!oECgw z8yad|V|sh}RPP^X9g!j?MsH;}$!5ukG`GRd@T=8lIdBg`_J+R^(B!$LdKyG&wy+fB*nG9l^E3h5~LqU%I=tTPEn zH?nnAe{D{x^OtDOpg6|%(~ik{W?Bh67u;feht;nR#kUQ9r9p?m`g6DA>UXC2LNIkZ zUhiKOwcxpc&y!|{q$jPFHV5iM0vBCN#7G9ta(c!5NxBq*G_enud@hoNm@Os>%Li4J z*SQ~Ii?5AneX2#a?>Mw=g7be^_=cXWHatPkeIDL-rX9s>;~Lq&5tmNd$c>2Xsk->~ zPFY+2Wgy`UU!&Bs1{6ZYs6GJ$edz0!|{ndbV`y7uBAEJ~2Zto((OCHIG< zNI~rW7?x+~lXB}ZY{m{^SzK#bzM4}agVxB_Xv~Iuu<92E=7Yp&I~5zMuU>RWB#+DD z$JA8dbes!C@CIvhlpCqG;zCm#L$D>%Hxr-4xx>!r$%KXj-?el;(0k+6cF0W*^ty|+ zAh!&V!Nz&RpRKn#mh5J_^mB*iz6CD^lZ2b}_7IOo}eL}v@@w({pVdmY9t9>+=uZ_vBbRDNOf3d!`(&;oKHGhW=%;7;;_9`sNACajQzqZhr zy`Sp+p5e=W;Jy!JHM#ZdL^ALRc(yw7ZM|>YkL10(2On;HK+?E6jm{xN@lDrDMzwU+ ztsMVWN|H}9aQi#g!0AaKI@udCBIENSMD1%;(AjsUsbMShcPX%C$h^eevMU8RtpCBn zj^Xmfvka$~?BO0p*)l~=a1v*v2Jx@Ms<^0tC@q_`vp8KwK#51~wy>F;J) z7B0T!oc$#0kiDhxE4sz~|6x=UE$5m-(GKt(2PL z?2J{JEb#BkK83?ID>~fEz>|2HD{kE8_>Q!cN)c_ZB{9tf#8jvOqlqfcYu-^6xaO6P zSRH^{yaVqh=do&GCfW3;L#pDSi#Qo)JYBZMT%m}qK|8mNk%1(hAJGRY*5Yw{3+#ne zVcE%x^LTHFZLvxRW0MhUyr^XGt7uuv8@xLCDZ}IY=iSdkJ4Rdo07!R17rtm61-# z2H*|#p7T|{RhA}-{i_1D2XdAzEqKdORIMT#{wA#xlF#0`TwdO>X@;-)j9#FDbeUq% zaqYkf@(YUZmwbvOJ8)+s+b{JFQ0+=DPsC4O>T=uo3Iu|h-5!eytI@|u0QG6ia~;U9 z+BJ(k&@*+rb|u=(@*H7&iJgwzlp)RJIot2mU3K(cU)Oj-9!fsV5Kf~RaXf8k~O&J6L zP)Z}tc65|a%6J(>)CI&wPb*f6^9u~Tj+kBE1^@&RPp|D`VZH6i83vM~&gD|i6|Pl; zX4^&g+&httYrDW|6Cd%1<#3P9F`qn0Zfdf=dD0V_%445_fnXfDO=99|h8G3G#yj2Yg#Df>H|Lq7G8HK`O*Zk{D5pVEnV>s)6jYI z?CEnKuY*BbGVEEWHKsKVbY8hQ2?A;U@4;VR+a7r!eSBn4BzI z+DIK0Y7Z0d_G4Xf6%9CG=v1-ML~AvJdOb|)>K)o16BEFj!7$O7GW99rO=kAA}G-PDgsr*aK4!TR7Y!bxHIX4IQ9eQ2po1@#ev?|jHk^06t59+d~{N-XE5Sa16&85KgOm#g{OQ?mZ}i~5pH zk#GCfY~(ek-a#1!>(gVx!{wbeQI{v$ZjQL@NzB=|6u`l-ul%Ux&yLJiyWn-mCFG97 z5H9Y9dekYAt!~t zPybHlk#SRIDUIXU8p0ljWj^Rwao>eNJ4v&G%7oO3FsvDGc?+OhdMVBJUx??k(V_Rbmi#GG=l}BI3n7wDXE${rRh-D>6!IXbS9rDFA^McFqf4M$L6roNAq{jElpy~Xsw34|8f^sP4{e%php zyD7SlE9Fpz=;kX8b$wkD*suwk>23Ed-)&L9PUMaaYsvcc3(O^xK} z!zC+tj-%$$aa^NUs`0PvcAgPKPF7J%Hr0~2jNJ^tYx5hUJ>x*NQE@+ENmTabybMeq z@<<{bD){Mv2u5b27Pd zahpyGN*jS6YywkIn+q62A61s1y^Mx7gTUuz0eHXNXVwXlsyv}!B<%9b&f4=J8sUuGV>vzA$N%PSFS zdo!VNYxi&wu=vtcDT97Jv=feXKsB#1;g15z>G^36)@jO91RGPOg9MZe1ZjwTva)OP zZ$V5#VbITl=nO#r{({+jHKM7SQTObX*6SB&d|)3YT4YYg@|a_f(n$u2HgrDleaf@< zOk`T-D7fZT?uyGo7)hruXb(5ERr&E>jra<$S7b2SifYb(?IsjWBX3>Iw6BP|;6BoQ zVgah8#>C|g{vvivEH_e0XOxOIf5J+Q+f^d+Ve@n?2(GbSCWgsId>t!(yAbl2=eE%o z=ePLE$LN`|T-fol-?2O3#dS&JhE&N`?y5bMyC!|Kb2QG)s_&!y&6b~=B{kot)Z}EX zLJJIJs!)P$R(*xSLM>q{6BUCmKXfCh%BI04nI-Jl;T5nd)7R;BK1!ZC`Mvm9n?tE< z_QCj>$P%jJ=#~d4&aI(sN>5TUy)h2Q$O7f$=BN)LVJ?88r<&$L^uF_6YK*egk?E>> zqWU?B>Yx27KlNp7+X&aOH{VyW5dBM3YCawWsCL!e$p*A%S8D0TSw;JQm$S**7fN$) z+fa^bpKP4cpxYI9Sr*w*{LGb}bH9Ten!$5B8=*urRq0O-33x*|1)SY6A+wWwC8$k4 zdr+ULAUM^JgKIJtb|c>Z(?z?TP;5|!!j-q_W&DLV^fA5p=QFfE>1!RwGR?b-J&`=% zOv5MR)C=SpcO1d2wde3R<6ty%EBYMe*_bL%LcK3J?9^Jh|Mm@i%$q#L)KquHNv+ik z=TagVB|%uIBSdqD`VF7CLV{<6#jbo@RfhVap%6ifepHPyayOHJqlTT z<6`nJ(!6x6#@y4^2(<>+IQich$571IhPEpRIJyi++DRR|_R5iTF^jJCk6(zNTCRH1 ziL$YSsmHfH{fDI!&k2ZImzv2%aIaQzrBkV$zEthRDbmM&@$i1*nCoF=Pkzi`C~*SP zSOw99b_x`s&h+N*2T=P2HP56ZqGD`K?M7N^C(}ARP zgNzJmfQ=W~u86w~SwLYznD%gMxukI+ua;Vh|7ih`YM@FUq3({z-iLq+mn)82)O?eA z9!i+vtibhS;$+G`m3^q%o*6~v5`l~jY<+>_!XrUhj+jM1;zUB0&`W{A#D!RDpECz905?)y8UKrORcpEBR==}0+2?8alwE_khCq(pkpw&I4AIkH^x!fov z>BWa5m;!k=7oRHtF~{jUH#dANZZBO5_>kAo}TBn?SrG*0uotjJ)}rvuW@ z8tZXVm$l;I$jWV$Q|cZFclx-fo4qDzu}4!gkh z9IfFbx@-kLWHXA`#fk4c`S(nGCn_%{{pkDP_EW=PYV3aX!gMrUGrGtAB(2|Zl@!T* ztVU46{{%&B1elnrwcH_~QwmarZ(CO#V=|0FU23tRAqbM>~Q9+&2r{ca+pP+Tk0FRu#P5xC&qJNY(V6o-Hv7b2R^W=)# zaq%9Qt!Hu8J?W`OUT@X~ZP|?o{kMxFRb|6pk>T5g-$8$?w>?j1SX=OwFkWJ6SsoVv zu@?~f8d=xmOU)UbkKA>&Hw-E;mWc$wdv&5K8|BE4o#%I;q$Gf2H=d=K-^kcUW%RRyJ&&Wl>^=|$v11LF=_p}0^-+yhG->5z7% zB92HpOJ`RVza{OF6Km?uPRm+ttgnDE;}8aM2c0YB9GU!#yi1$zsmd!cN$3;T(fqbO+4U!4 zEYFdOcXtvFs+q`RK&pClc7zRXcnYK(F&dLFS%(qkN2D1A7ZC?zjzK?gA~h77An?Lk=mHui6%_Wi|8Jxq6$vYQ+Yv}R|&#STpEot1r7&UzBMiEZIUs_#EV^FwHB5wuIz^}XgV$;a9l(~kTF+tD6P)As}kZ8?7cKsQv46>X+}0PN$x zZOOCVhlu~A`ionRw7~smOv^^>+Gfo+eU(2krhfK&-Vstah;Vlb>GBC=>~-bwv)evWKMRT6FUyi&>57Bfw$hy{SsX`? zJms`hqh6&YPL2&(3Ch(}1{3)(|JBBDI-%(@U&3)+tF$C`X5|8DOAI2$I7dbD&RNnp z`-&u4>Rn$&(Q03!s@-m4_T84@(scWF!|+5i=>Af7k)pEVXAP}{jUtAgXEoy)DqT!Q zn=ltqBFY2D!+3q^H>2P&PlhwsIu02hx9i8phwJ;Q^{bEL4pCJt310emi?%SP&6I4OaM7dQy zmdbcsgaKw0UfdTy9Nb+9EOhVERJBqWflNj@i07=I-%yWR5OgW?mfFPTtPY+=T;>D8 zzRRDF;qyr6nq>sDKO%ICIF}muak(;AomdH*y>7R7ZzAaN?YnMJoU9TSrLt{I@doUB zgz^8DE9=v)fBMay->PhVzMW|&%q!Kr^!ZtIzWk=3;+Fd1=2=Jd39zTG9=h4Nr88ZG zYaCPL{as6{Pbr8d1YJ0a`w@q92M|Mq8XI$HAJ(~E?k3Qc*!7nd#uWk>BNw2$q-IxOcLj#(o-7{gv*C8oLeQOrrMB=uI07_#*;)= zY;lwS%xx>MIQOXZ`)6u#$W5UZnURLr^0a=b86N%Z8dt|+4gcUhjILkACvS}uwzT>U&$!;ZU25rlGBE8x`#5lCZp)i*^$Q-167pMK z`gDRLgHO=18~e!2f7$z+?ECzO?6U>@P4+uHsmf;H=+!08Fyl)8Id$a8liPU?sfF@0 z<%voCBU-@id%yS95fv^IzmW=<*)8qpMD#z-^yhyw{Zb8ZUDM>DIy25Jh%^0Usf1nV zSiq#a;Ml~CDxB>WU4#msLW>@)E5L88@0e@m6`pIvfylRrU)Jo$>hApuS-jjs=92UX zgGYOgzNoz2JVjdAO>N5?Y^~)$cS&X`0-aLkV*rAO;yQ%|o})4Zl|XMrY^R`OILMq~ z8(>?-I+j#N&r(LeM{MF!4oa3AmkG65h)-yURIp}pRQd%IwvcOZ!MLg{-WQ-7y?PW2XqFA7D8y$O!UrN= zSp>6&K?>X#9H9D+97onxIJeD6EC4rq+PZ>LWyb*1PF>PxBufGC%F9>3=!8FlP0kkM zs^7lHZ2K^VnWYuN_?d27DTlIFeyG4pKxi=B=-MZ8?rUr?SG`F>e0E8gj zEn+o+FN?1S2eHnD$u>{1kCND& z6r)+dt;M{$RVt*1uXGoS3lJJoA(9{p07a2oa&jaqwp1AN+}9Ov`=xrv5vXOSh55>i zd%p*EFLsa>ra@YoRTnbYBIqsurV(?s-qOXtk%`|AFPrP$qPZDQvcMC;>jqh$E0i=eCGbINy)k2Ny)&@G!FR|G_OlT zi!1J@z|rs7t}U5QUGa0iUemgJ1xKGEeDTE;U-=rYM|Qfh*vz4`_iIYgM5PAmml%}o zsVH-DB&IJ2pM=O2=vya>AZM;B=fxZ+yXBtwh7N@;8*%$4PX;?oa%ZB+y6^PAwN|-j zllpFFwbw(TDstwrX063KAA8wZ~BjK>;9=p1u{}h^n$cu zxZnJcQfmUwjfAnD_2sME%m2{&B#T)8fcZNM>D!(^YjgTj)1WnW>zBm?*C*W;lRACq zM(3rD4!?Yz4%d$n#swy`l=pna@eMo9{#DBy$vBW=hOD$ms7TR){q$UH zD#dU2#wtWt-5-c{Ly%PQ5_J??#%^{&UH%GgFG9`X8*8}iP*5Dsz$6oPFYQP2n)3+E zFQP8ucJ#sR^H&jRLR=O1r;J&suLUTjWw-edL&hxCgr~fzJ{5a+XUGJ{`_$>2YcBO$)2@ctA{$JR1V7D~cRDr0%O)m0 z$PQj!#=N|L=40eJdtgC;EF~+)z1$ue>BJVYkj?Yel(=140_-a_GW?CDJcy-!-T`9M zzLgFGT(#whGY(QEzWwTgoAlhrv>ew5FBW|pJgngn(p?vSWVw37k)BB=M}K4ji$@cr z?RBf~z_?eH#;4tdpYbH7w^C=*Cg=UI@848zccTnUoSiq+oEyoZv>bcJASe;bzX02F zM)#fU!!Jgd`O36B*))ZF@%F~zf}rG&+qfFG8xOsJ+~>1HAU@!hdU4=(+3_o$c5E*l@dR9yHC zMY%kSsE*yuyC2BEktuh^_iPW`a`pHnn_xF|nfDX+Qis_4@3?`E>Z!U;O;@y2nZ?=* zqYO&|9SZxBQk+6UHRMtd2>{>);FqnvXQ&?YENn=2P(7{`#i9@OAxV7^!DGRU0|3y0 z0jL0wuEZ0I>2MjPB6#Z9?3Y9PL|se4KJ3^kZ@S2Ij8UAsikw z3vcZ~4dRn?W@Q=kL3bOXn3Euqwl~r&FBY~CiOs*!QXhz=Ax9i9J=j1Ajw3?C(-(|> z37Asy@L|cdYlRJ%K$vpb^y0S5fz&r%VWG{|GLF9Y&87h?16nvYtq^9k_-?G%UickR ziS_4XMZr_uktRh29UEx?>~DHlJ_50(iavX&b?bdWeoKo{Q%)>>@a~eDZ$;uUC;@-x zt*O@We!&xQ@U(T$Pxn(NEH~&x7nrN! zVTM=jn02FJ4>qNL@;vYme8@WcV>wL=&9B{A;^2rV$dh`e~{SG6mgWC?Yc2{`Y& zVoX^xR@VkydD>5s-`m0s&H*QGVrY#karZ=jV=J8oNH?%Ra#k|$&0xTfz*wGFmbUoa z6JIxhSG|@)U+b?E75bJ1W45d(Wj&f%N`~80dYWwlb!3+B}?U0Fi)us zlfuvBBC);bimJ;GtK&M4E8W^eDhlVx#iDa1C+meWR=4^ zHl-D;?q9g0@i?q6-m1L9{N*(t?F`A)sJ|o(cPWhGdh_DMvtCWy=1_Cwm0NrF;^C^P zOb&W9$Fv?0qifU|hZNF_f@(5h$M*tisb(0$FaUe-l8-$i*ppPkOapGJbkVA84ImWV zwF3&YOC~3@oVvIk`zh=(jTXI-OX>FWdXX(^;89f<0#(#6S~7N1Ve=2!s3D4@0AfbV zNqcvIB}mGekW?hTkyxu~N2nP$aa=vonhMMQVV1MYZ#9Q{n!w{cga=#1YKJM@4zg@q z*HT`jDngjI95+Qq0Y;_jtgM<$CTK85w<7aZBdGZUKp=;`7r(?Ua(?XO0j#7SqXaGC z_D-pNkE4`fRSIsJnphD@Do*_hN|2cNP+es7jO-)5&6h&|?Sjv&gk3@>sJ-NG_D01# zia9_|q~pVEKK`jT6T0&@+U5nK!laQOtl!;{c11%UEp)i&{Y`8tu8=eg&i270!63{8W z8N1n)=E~m}@Fo3{ZC_)lV?$G+YJ7iL)%LBBoNZlO%;CvI89>4+0UZ(dzX)a6yVIgbPn6 zMAnUX{`xBFal7K{%2RvMe8)RTuG|gla3#~d-$&wKTBTpmg@><+BKhsixK)1(kN%=kT}i%wBo^;;qOLAIDG#1J-q*8;m>k|{Hwa>LqKhRg?g2p zHM+Cht{)+=jSQJ;g6qKokc+_=&1o|Sm*TtvBbp64EsKqO{}7g0SLt}vATDeXzb^@x z8?h9DYWruID%sxDho952xq(MJG=h$R%7Q)!@!9AnLOI~*S6ST$Rk^10>9?mnNKPTb zG!wo}@;%IHF2O|%0r?&10{+j=c5SDiX#F~rKAkUAHfRR=FwqD6a0ylFd~29dxA+j- z5tpoA#(3mJw%@(P4%4xfov%zO(=Be7Z$XDOy*oaME*og~OZq}!Qv(lHCe z6JfCQC6*Xu#{Nozo;$`L;xtFwkf@G*WPkp=*2PuSze88L*gBGU&e2tWqq1_Xd}ic} zH?6Ah2Nn%B!1~k_{p-PKUeDylf+!TI-H-~h^GbddMq<~goSxHkD=nw56%fHO!U6`s z8P}$pvRqBRqD5zfA`x>#I&Z3{Qe2p^#ZnpQK4@T+F9OLUOz#jUR!C@Da**D$RI|Re zb&RUoY(Jj&_Iz`1i-b;TxiZw=s{Bm(gI#BZ%<2pvDOG&LFm?LC6^pr#! zVZ7gss^8rONNMh3J#068?3Dri8V8U?s-s$v<8I|TLa}s6-FX|cCu(Ry7HAYKFgUND z{aBXio?hB3!0PRw8bnFbp;r>>m#}~F#sNNF7Mo@TM-t$i97vd?vYfYOc&)X`_pR2` zUN54f&a)YSFfx`Nl_~v0hD_Gap6{^igRC?2^jDoq8PKUcO6;L~Z7dcuj?my~%4XqN zW3V5_aq8KL`vbUgZ$kr%&mo`i9r2WX=qsLr-mQzYj~hcRGP;haSI_rYJ~F?7m}Kxh zI%OwU#)P12ySBQTv#7^t1+5`LzS9OU?97v5@e;fqh~YGXxs1y99*Jgog2Y$nJfx5_ zGt&jHsBzACgP;eWCQ(QM+pod(s@yp#x${@%{t@m19+tYzyTl>AT$y#mJ~AIKzX;karR({#pgx?CAPXbAO1-g%>&FSx_k~w^WS| zpd+Nx4>R+pR>h-67}D@Y`(A>OGrGhY(=^3YmUBrrEX@HSJ zo!Ckmf^iyhqH6)JnCv7i&S=w<;^yCW#in1}jot!f_X>F2V6xU~SBL%Gpm&{K0X0$lt zW@MvG9=r14viE~jXyQ)Sk8O*TdXE#QaK4fSkC>dCcsA|-0jN~_I`Y&Wcjx-D9w>Li z9&sXV>E!aYQM5F~p~=$(Tze=l!lC|{dWrqME28%3ZZB%f>YpPeOIC;N?#7cPKgff> zkRi&Bdy|-|OthbT(9+q3F*+z|sV*xnCKa*yIPf?A+FO;KZn9 zMqd4|@^izxVV|z9PX^4NXvIIbJ5FJpE61KM`NWy+zbR;#!g=>Y`N4Kk$h0o9h0f*8 z4wp&YeycVMQNEl}DDV8*M9O<}R(d5pR47X?RZ;;&j~i#kc&54NGd8<7QiOZ1b2v1^ z+dZ-Ni%Z0t)ws%tvk~rfzJVOFNlQnP6|XquGiNYRp!p)KwmMblOz~A9i$?gk(3SYLG`fz7xE#~K^iXW%X7%TZ@j@jA z4-cDS3DRz?WwF~u%@+|(`zEJ!g-BHYhYlDx;(Dwu`-E--H{!Tm82CbZvuF5x-mTg@ z&z466EI0%1ip1M8%^>`R0iGdMBqdO(1xK$;_w6|VonOA=*ytTXxHp!G2wZgUX6Cn(CT>Q|_s<8?&%e@mG2V-|z+0bx#zdWRRduOvd5kmD-c} zjDL}KYt+QW^R^t=rzF``3BC$8e-vG$WYA1xIXN2GdU^--wr+L)3q%l(o-4I#sG# zH8$n8+m_|R^-Ge=hO}Z_*Z%g1GCR#IK$%ya4aFdVpcK!GDzhxNb8IZrhDaW91(Uj^ zIFaRvQ(A;WO2meyA+lkSI_f5pgwC$}g-f!H2)1B5p6oLtw3@b#*Y{&XFF`lYE67Sa zrZ>YsQ;yf^`(9Src7ICJHh9p}JpR z`E`;Kkc82AtMe%8{RY&MvojMrhbIB01dkKK=^#PlY^enl!zrg*3t0$}UYBGHY1=6r zD%mY8WtEJG89Xfr8w+K748i&HFnyX-V+!-tE8UXaz_AFtk)e^Ql$npVeNi2)-#(&U3IJ?-vZ zIjpxh5V7ivV^;u=bkLyE6bpje7Z1!AqR`Y~QS+ zmSfKN^Wyu&z-o&O7hCAsHK&e#Zpe0w+RMTC1xFnAF|V=CujuZoxwo|d%5t?*GE?hH z5;+r@5DCF;bK+jfnf6a!+#PFAs*&Im_^_uNHz!llSfJh#wx~S06{d$+OYxF8GfSvDt6Ea6%vKx_BXHDTGrieONnX z&H%~04fna3c0(D!p!VVwOBY9g_Sb=e*+OX z@bZiQ*FZ$=2f{<-Vr#@tVzkB?+GqT9ZL_JJt)p(j>yn-5!l_>Jkd^hulGg$Zgi>ax zG;U_?2Qb}E5))W$qwqIgXAZkC6M(x5-aWQ6JuU0-7k0AbMClz0f)fig6pV@XI?{h_ zQPh#%&Epk38k7H+xVk~v&87}AH>$~9!DaPNnx07cRVp&@{9>ot|EJ%sV3zPdNB9ke z>VSGTAZ@hmbv@+r7*ncnUN)d{N0qx8@L>J$l;KP^Vh&m~J$T#*F_qv(2y$VY?{8o{ zs}SR4!!p#eQ}iKJ+F>}<^Z)WKMg2HQRTVIZ%0Be$N_kH+f~y#MpN_m_l4S)+93}NP z^G< z%-^-Gc@s=%Lu|Ox7l{h9y~ND$ zxQIE^s_vnFmpJpM81(U?tIA)fWpBMWo&}OphRJms>$xXqdJ#qeDV@Rc(XQU38&fSM z=2O@%&Olz#*KRw+lsX!<)pXXD!qk?bZabLKS2_U!AGjvooJQ+yKPm6STl!k;mM%9g z7sd5KnEN97zdxyu&e`~t^?>LJtrENV3^nbX(IKV|-TGzzz%3@7(X#YAA26P^C^_M- zqxNUMkYVCeD=y=WaDW9pZHL-c_~x6T*N+TON0}FB)eb!-m(BwhJr-#|^=gI1-W(VC zcTHTMGRc0*@n0N2`EdGN=ytE5T$UMkHz!H!9XZQfj3*b3Hyt?Wto)}|fk5r=S_KW< ze`*z`e>W$<+ES~uB~l#vmQy8EQmbx%9sSSq`Siz)5)!c?Db_FFE9edIc z8p~)00-0o9i-h+Q=S_+>#>4-n4q)V-_Q6J(=LNEV4#k_UvuzoOB3ZwqYP?JM8h@l2 zUtM++&nz#3iui>*p5(GG;?Dzw73T>x@54MCI$goL;c^}W5e!@|998om=gJPlK>0m; zqwz)FHK`dHuRIoR5N!Weu|rNaHhlOIN;J4DW?kF%&a$tWow;d#J3`<(C|Qln*}dOq zeCABCZE~WOLB*z}PempiboC;@Z~8~s%Z;p9+$gGwt#6;T4ziA^F6Vyk{HmjXnr1lS zo_Ppy`$a6TG7tT?$0q*EKP3HQ@%=Ntj16Olj}G%%PEJm;EhBs3vZM=CZzRbv547T| z$s#fKUE&5f(n0faC}L&TQ52sdJ{@Ej87m4yGUj)#RPpuc6SvQ9l|lW~GV zg5Bi$go{x+v0|;}xL<1~OeyhwwGeTzZHJK38}=$shZ0cB>tsSGkLr*F5P5*Hgsm=y zDaeDNa$SOXqGU0xy1Cu2*G;K(eX6miHc1@})8ZA}12EWgK$N8t2>3r*#?@pXv$0ri zJML6=BE()CS` z2tXyTB2<*vSAm+B1V)GNw&oa1je9ZDkSF{Y6M+;yLcP7QuguY?pHr_kxybZc`-T^b z1H3!Nkg~Q)5wuD{=a!yfg^KP(1kgY!*9-e$I9iuLmLasCtXMzLk_j@yCh51cL;;W? zE{}AUnElDb|Nq<^`a{v%lPSi50Qr_TS&8P=SQE73O}J+8aVY0Iwv|&eFgpD*rv0pN zK;inc&}0Vs{uM+~nHssXg3rn=k1Kvr_bGT$-p)pGbH5{f?BXoyt{HDfSWj7AOoW}& zZgwpjMHb6{^4uzXJkjZ(UZh&+vBufKHr4FCdvUVZQpn3*Xs2l8nPMGFMM{aEY$V_% zG-^X+A`=?4K+wxZ=_8f~RGCNwB9O_-q8I9qt-VnBU&Ot2P+Z%$F4_cwyL)hV*92?a zokoJYy9bxXoyLMY1ZiA?ySuwvLa>C$e!X}0-gVEZ`rZ59t9R=C*Hv@Y>NV#YHpl$F zF`A2phV0@H=~HKm(fW za(2Nxne2dqs~b1(M{>!xR7yN(E@mO~P^Qkn_m(@&>EJNB^LXq9ZDATaiQ7!PCT(w( z7CJlexD;uJO?6A^-60`&!CAb|$9lP$9V9i*T#;}+wlv?4yb{Q4UYo^#U8XOymrk>~ zmyV`&e;+Mkzov#hVR|7GNh%ZQ!L;Ux3($m7_;lyJa22+>Ux4stbHHb_BZtOQgMQ9E zv6j-!RuERSMhl5?P4_hA(tVa!dAXiL(l~2d4%hUf!>sq}EPnu8OaB1q%;WJ7J%$Uu zy#Oyw6ZQNUzA+1~u}|mt8zx~9?v|nSLK~==4y7>_Xsw5yqAzbea|jfFvomNoHM?hO zDUEw1|!tOf(!ThW0lD7d=Ja5df@kq`z!s} zW)1_Cgf50193VrF%ek7V9Z6WwM89sgMV_6|&vQ#+nKo`crGJkv{vIx$3bRVXJ-m{C z5U9O_HKuazhIg`t#j_23rxcOIBOFa9$46yD@)9dQ&>7m1MGX~Y<|aO!UdJB3u!Q~@ z(F#NrO~Z3+G;C8uzt9B)aybMd;u+zKDvBJmKc1KUsGw~VCQ85xFxdY5oLQ^&&yim5 zZ~B8quvE}T*VP=NjVz+g>TBYju?I=B9MbP!vu}9qd1{@mU*f-U`d|3Ax zyKqmUf?T*NvV2j{BW(vL3)Vu*oURJfOcjtMVRyrtXU~#PDO`hYgP$3V#NXKgH|UM9 zTlenu@o|d6m8E`IbTcmHNi11aj&pc#oeS=~Y48>=d7saY0 zQ%iHPC6^>)TavKgruh-HabhAXaSA)};wX_l6cBKvkozQ2bsWMYWwBvZaa<1^VK*YB zL4Xz?b06UpVD|Ai)mT?D9X!noyp$l-)Xl^Mah5$ze&cBqP>2so~iE9k-D%GANa zMFY_|61M5O+OF=O85pWH<;CnUiL91g@CSQvF+U4ecoMHUpf2DwO~qxVi_i7>t$?@7 zLL4DqQ+GT?YBwz!+J-}}!^(3Rd{rbIm7zu3#8@Ip2RDsYZptOGNiSv% z4z<=%_Zyj}Vi%BqnU%<*Q1NXBjjFD!iMbIk+oEGD8WA-{DZQZZrWCjS6B#4H@eN`< zU7oN)y%oK}S);v@lp~>VTdl3_r8}Rx)rS5L!|cqMgC}@R1tItRk|Z?Z;sYIb^wfhpPQ2ac9%ZDED<#0g5!7{1kL)sQ!G6Y~dDW@tR?Iwxa24e!EEmt@0yM_lW_kkQhBa*2KZdU1orX|)eodV3&or9urU`w) zd>L)7RzT9`r(-?n3l2clKDt;sRr0{Ce_6P-F5#e93tT8FOh_T=zRG1V%hq@)9Vy;3 zpCY{itRtOCT+c>KG()f`n!#XJcf(0%tG733Tr>NKOuH{yRc$%StbJ9knIg_0?SZk* zt2wmo*x{nX2-0a1h@p~bJ&whljr09M^~f^Wq9)O zHUd-FO4ECK+}kzDA$OeFJZ4I^8g^ai{~PMStEv{l%a7OGyJTa>L347uRi8K?lwqL# zjlnMRNba>L-3_K5)1_Y#C%^VOo@0~rDYCc8t8+Z2{$%}rkQYzhCa+?>9+~3sXWr&6 zp!?*w{yu{wab-zb@7<uEP0L@`y<1EL-J@*XF_QGB;BJKC!w-3gZ z$KoDJ4#^y57;3n4c3IgVfBG?35UZLszMuF@UE29-#n}xtmdLmnaL6WpptSO= zeO*2-qsmIEz%-f=ir9|9HJ4D05`DB9x_peC{ z1)b@BC%2=@lm1A9z$EoA2Kgh8nKsMdl~vx@>l)cIdJoE1cK@3HqTkkE;qUSC-@|HK zYJP@8!qTgp@;3xaNf!|G3da=Pl5J@8Ie!-zM5jW;tW>2Gtg` zEnR0(FDDNKXdoVEU3WMAyJdP3)^nqBTHD^Myy6d$IS!3vZgvGxpZ? zIe%)Rp=3ZEYx;hXZa`G~)8?HlEMEy)I2Cz(&JMw^98j3e*D(~ROoazZHU#YKRYdjhgxxeVhjAVl>Uankd8>HoR$SJ@ zlMi^Pen$3NT_TTHh3o!H*B}4h+F!Z`m3t>!gTb0%^Yo_I~LDTao!b!w_LV_%>8t47HZ5rwk2sl=M-N>Jb+m>wW8x zRpuIujUe?+ubZV!^e|CRP6TU#1e%s!cD?nqw^Ed z*NHJNyRWV$GN~v{z-B^!sFDEdj$eYmTxy~CPIRzjHf!XX9vHE#zt)yT^7iH5Rm6|L;%}{5t>tvN(o=7@M3*u?tPnX%erousZ!qs_VHXAd^{eFP_n+Fs97eNt&9HQ1{cJ4n z=7`TR_phxfLr;lo*{6}`EY@G4JAaoLAZxld+fI~Y;Kbh8d`bKlwBmoLz5wjN^2f5D zfpop{el4$2wZdj9J-xA4O^Af1Y?x%bz^ZNgI&NJy#FFvABSbU&k=dez(C*q z3Oxc|VvI0uLmUr6UQ>{eT_T`OrF#>@&F2!`T3e6B9s}NsY!Fg+fN1>oap-^hnacdT!ZoRYMB9h zTgoYc>J*|R?PT$TcEd)VgAtdB=u|pp+#BD``7iCM8er2~F0F~(tJ8F%qn1-myz1M=5uNY3vh*;<(am{5CG#7}=kqBM2Xp^u zHt&lrSj>5>d_i^GUd{ODt^xJG)C_&O(R7%sqiKh5m4j>&NX$>6pDIKX8I2!Hgc>;d z3_gpXL}pXiqej=SO0^lLMcK-t*MK&6qKv`q4#7LXO#LTiy1jdv$t${*=jo_<8jv~|2m-Z^gdCM_4cdH5u&5hM8hi9>shiFV zh!AjZ+*#80=T=xyNWMBt*-L6-O{^OkJ@1(i{%24B-cm1wcg1pHug7xQ$X=B{F`bIO zt50{O-7Q+C=pw3kVqU`e6-$ZyoyPw6MoQB`06q--Z7i2{<*pnC2 zbq1Yv&4jE)o%^=^*x{VEdk#TH67ho~Q}tw0Px@NcmLpg--#S)@V?Cv0NzAMsj6o|9z?2?qNPG59 zzkV3RP?uV{FU_?UN{@Y#@tBlEG5Bc?7{ezLz!nTx**zq8V2)wYLFP@R!BT;OPbM0$B$Ran3FL9 zMRQ$`ToNWS;Fb?T8ahtf*#%i#2%;N{7!PjPZtARFqi2ejq+V&(TtR0(hI5k+feTwc zr?0Iv?6>7}!^})Hp@Tt2vK?X2+t8{abL23Z(5CSe!lvp60lVrjO9pz)LkHL9QQt#* zY6XR}MaM;V{;wq@R@2*(&C)rBf#i~9cGBqwLO-oYwjZNaI+3JfR%4t^sd6VTPjawD z84mdO4G5xLAlN6FyYSMA3(+B!_HSbzY`x0FV^doP7IZ@yBsC?80Jqyjq?{zQ_p%72 zQbpyMA2|t3u{{x~`#Mc=G&JU7D(i7fVm{P&xhZ3Rell6;!u@hR!MBKBNZp#6PE9MJ zsL2M{dO=In-JV5Gmy^-(xd_IfAZ3D8=Z^s}z34MKIMj;&;2HP<__d_F%2daS4C|we z%w9T2`(&PH+bH1B9<|lk-Rsf()(liEB@}NMBmrbqHqSoOW%c$EaH?WdMB34r7F=!H zj;&`&)bVIyr%a2dN%=i1*Z#v@{>N2CA)HV1`G0FtROjEu$-w#l16BKg6mx!ee_s+x z35y)B*OLB>9Oa(r{xoVFdw&|W8bgEriyAY*&to~rT1_vMl1_|XkYSvjY&n^%?#3g6 z=FhaGtTReJRT+0KR6D(IP#(^)bW%iOsbOea_9!zrb|sgTrXsB<+@}u?QP0`1YS5}) zDBIQ%sx7B)1!$w*?mYCMcc$Aqi{9q)OtE!U!vMypU!e757Z!9UhViLxZ@SV*H#59e z7KI4d4#^#r2!DW5YfjyU?WdP*%R9;H3F9dvNCH;j4KEImY;AO&Fp2_dnVWemkd_mj z;5pqgb5_2sXC*XyhItc7qxW2f);+lC+1lvp!q8f^I{plhqf8U~$HN#+&Xzpn?w~=h zb0luG2|m$B!czoSFlV{QeRy^?@L$1_dB053g>(2lqrT^Fx5V~c_t4^g=h%QP<>=Ut ztGG+S=xaVJ#N8qhv3w3H7}V^wYt2^@6A#wL`WazsdKo>x_juFjt?=eg&p*|a=rv4Fd){>DKmDz!;E%u8M*fde7WwUy zMgF!EzhjtmkG~Dc+(qJc+~W82e|3)ES>TPzjdoG$kFXib`RAcYg8T0KtJGtVddAct z2QGe=cxCM+PK}&3o9^`r&zu9P*&P4=Xnmb54fjjPmUEPwqaZM5Y=0&exv`>X;XW1F z$J#;BTsPO`Y*U1EVFIzU0yfuCQWo_<9Ady?!m5~FtiT|js<5IqIv+?%%V&!H=V~0F zhye-8V}p-O-)Xw+x4U3b0!#4NiTvic3=HzGTJCM`w#2N4=)0UN<(O_L42soQZ6?lG zFh+syEC%?KVxq312&qy-OTUMUeSrK$Llnt7O@kNPi zj2KCV@F$5kW|tGNWpqYaI{>m;)lCo9EV0R6Y>38)MqQ)4+KM`X_iG_eYfx(+aj%h? z2s7cVgXfa^G8V3Qpv;q3QAnFL8P8Z433`u@K~RvCZ2-d&-<|<5&NE7pB+4+5RU;~W zHo5*4nj8D-k*i76oa%G2_h*`4pp+CmW_6#e29b zcXC#;Mo;1do2fxaG!HAr{*EP3LP*Zq4V>`cn%j9I7j@Edbub$`r^MNL;1HzjxgnhK<@%o8t3wzD7`M@1 z*}3Pr(it>-Je{hnbtuDC@5Hfs#Qkd`3*SG{S@F|v1I>#4udo<<{Ut3L|LU4_wWv3z z+KpBv?N3}WoJX1E_O+ja9diFj>z_^q_IXtclkVj|%dO-67FE@6B;$AxM*G^0i?D#S z%z;q!+u9jELb1*df!EU-U}N@qH06e=#u_BVmy=-WZ;v%w8HLs2CrGQ6Si2ysRzk{*?f#Rvi z?=ZDk5~egUw?8Ms|2Y{LWd3%(ZC`n@$Qh-|G?xAVyyDTkZZJlfnw=u-b(-$J!`Utq zUgX{-P49K%tFzM)-TIkT_9gjPq4&%YqqmGz8Cs>U{bN=c=n2yNnx^deS55I!^;QFS z#S@+5b4QwTIzNco?%cRU{p~(za(F-?Van%nE^%^ zRrK6sBH^y?SGam-tKf#ZA}S*#mk%Mt=P@?~sG35lZ_8%KRr8c1zwlo5*vHHd$5RU zn`W3H#`5ti18f*DQ33Luy4dN zd-rku7suip;oNfi9%l7^JC>|k2iQ4dd8iqU<07J#aG<-6^-m`x+`4i}XYj&@{-NSx zvaZ}ynC0jr8SZe6O&!|IM{?cTY29_OVNoZn9Q9uZfs0)|Y?|ySFSmAMbYs(Lk~CtO zTAm3+lS2;`hrnz5&#m?GYEsyPzmE(N)+EcR@$5=zqnpt)Pbk~#-N zBCWUVNN>1NzI@kY&Ww_e*yZ!R8?`{n%+SmLkLd}su_Nz^SW|rsBkMktzq7&kD1yNn zZ$o^v?)gI+E-HC*z1>Qr&rkc6ZjGv*4Flr^9&0uvTf;E1c3Y8g1zsIqf)p`k!s>Ya zWf(aZyhI_K9Nyx;>44Ha%OAqr=#p>u`W+dfxYW@l*gXSSfM@^x2KnFQ4^&KHsYE!= z`c(eR^2kVVL#sv#sVbkCeRs4c1ASG@6`;lgfnuj}voiw6G4a}sKuF*kye{I^rv1)S zENpsi+o+Y*|7mE(f5>M17x>2ipL5>+vHBOsrJ`vyLKS_4z>be$>h&r8UA{pxC0BYZW7dM?YnIq!K5yv3CG-Pygj^Zt5&c% z@u?S-R}t_p@QlvA67uN#&L0%U>lL7 z9J6PT7-=Rc>@{_yJ3-FW4Rt=Ga><&2o0qG&ja;|MJ7fs}tGWP~;{#5B43ded2k~u* zUyNRpNwHn&$t50~wlAf9-XjU=Lj=^AO8gc(N&CZXjSt%Y8y?Y!P)0*mNW0ndU{&+7 zO>>%?IkEMbTtV&O8Vz+#4^)J2EP`8_GJF4ZgP~brUGze$AH?;tq_YGm&k7{wC7Q00 zv8L)Ne?UCce<-9@Tl>Rw!csr=PqAi_qqO2FiL9yXx7KjHPXtZ1=U(La@~tDFJsWBrft+CavYwx4xsNqHT`S#!Mg1@Cluz{$!j1BD@iu$@jJLJQ8~oV3{DtWn=QL)$|C z0#FSei+XC7xegggUuTzdn%RY{2I48TU^Cs-WdrNA^i;k0@jfJ0Pf(;HVT`psFpPnA?&I0MrX-YP(BW}d3 zKs7NP1VL#b5;aZHm>^0uP6H-Kp(-!ij;jzW~2>P#v002+)KUedvjX%=|oZ&`zKBI|wPAX4En-+C(UatN4L@VvWSZT)}o($n`eA`WqZ2zc|Q}w@VFPQ zR#$dU@K5~t8;6%>U6>X#!WlEO^Afw7))a`|c;QDJr$8Z5Z70uDd)zps%0o227I@F< zaTd}poCES={^B`@Tk)T(&60DSF(Q&*OkE_!W7lJ|y1dMGpA~ zC+d6iuYbQn_nk}aefpnc7%Eb$qQg@k{VP;1sh?e#asK;yyi{{nr0;h$X>)^YO3TDf zMceJ|2|IQ;EdN=j0gr)g&D4}qQx&s1xfc`{J_}9}uvxO56q6;4QpZr=hcce)7NBIC zA&5(>Z-9lCBlf6?*g=r)HpG*`K8#RCmBB3A2UnYFfeFZiQ{nWr?R6_89`Ad>B#3KO z1`#CBDpiaP3zG~QHfWN|Kv^j2awFl(pCLj!E60eTDJp_ zvX5L+(bN%Zth30sXfaU~VR*bgx*XT#h~k!2HqR#sHL@q4hZ66aRJP*(XkMk) z7G`c`NNGYvv)^GB_~z(4+_A=SWiNOkX5XYH16i{*DF6R%$v^e^HnPjF3!K5l{Hiu7L6!8tBtw0|@pG-Sv*H~=CK17B@ttjIPMb0_C4 z2Cm`-8AYH+*Z{}&uRiG5KM11`S<$D)MkjB8rS3vBT85V$h6A@lQSk-Eh_qk0d$0wM z&12fzTay!UhluZ&#$C)6oD;;vD<~t!(6D@q{nDactW$ABlAdYkeq&9qgf>Idcit4T z9$&B6A5Dm7qEJO@=8bfVJ0ZZDabKtXH|Hh zB&kPNz2T8=p19fsVVOHgwYQ6cWL&^*#>J}$J|DCc@)yQ!tWxl##_gsD`iX|;r#Ndw z8DW(TvnEE`PBXt)FLfH7PO)mT6>3jWG%tSWVy#YqB^x4Eaz7uq)Fj6b*#JrZ6fU3vj z#hKYMPbiQzQ;G86kaU)0v{d!E_N6`g`CoLvG;w$y(c0Ob9H}uxybqVN=FpuLjW{PO z1zSeFUVI{Ag`^5KFusf9L?ArX*xuPbgUyALmO(_kW5m*L%OO9JZe(K}&6yh{(Al!V!EjQf1rJkK{Y^f# z9E7*r>6LYyHOjqy1X)=@cq)8%Ho}fAv0uvZ>54Bwlz5C}BjD)w zd%WzVP{w2})mH_cXOeRM+A2KCk|Us_L_R%; zm0MRdufV4oZ#LOk7Zp#`9Nmn5BOQY~=S1eF&ftWPJq+0{0is(Ex5cp?|2#78=Jzx8 zvHtnD24Ya{wRalr>o2&`uN>JGfOnD|q#O$Iy8eK0f+^zAiLx%#pvBaN!)}1dMl!eW zMO+~m=nW*bq9s)|T`47Enp7o;Y|n6;tAnG$aa<5MxU*QF&f&nMQ%BdHXvl5u)Nj=? z%T}@b$btCW0T4!>0rOWJ7km&DWEnU*mNND$ABUR^X+g;K3~2O?^JvIf*fS2nOQYJ- zw=9U|bu({_Og=k>QckjltU47pHAXX+{S|OZ>wjczx|iEZEpLESoz0*dBQ$xEh4yrbJK+{8_V8_XDA(`guu=(({@(Bon7 z2_z55Q~t~|f1G?_WPxy#cBx^S;wc3+u_s@-M#S2#j$@Hy%MLS;_&CC#)r7xew!=ib z!hK74S}59Bx%+|TDPx|}pXBlrB`@Jl0b$A**sUKTnKFW+Wha@HBhd)~g|=@>&gTi- zqsj8xuB&AXxI&LlH6y3DJ;~GwLw#=(O2dsC+!KzB7i-vy>`50=1NR9>z!~X7UY80} zs4OGy+Xe_f=Ku7?ZaMbOe|j$~Q6G2TXnX$eL@`Xa$8Sc7UN~(q>G61qCQ~_vVxw}U(xCUZYqj|x*;50tTj4pO) z$AZ>@q5;TdHF`^5AB->WRld_rg?`$%^y#lX>m-9g#Z!@Y;?=teRswg#_ts=YPdrdRMkN;S(>-8S2Y zJBC#FHq|Dp=ny|y2^1Bs%jAY(JQa^RtcPibEyxSsMdoigEsHEW45^cz;Dojm*-b{| zm89T92(5BqzO^vkDg!b>05X41%Ql$Mn3KUib)Y!b87)=F#_2qL$k<%VAR9sXMN+sb zE|97IoZ}Z;-eRGI1F{tyN1aQRR!qE3`30L1dxppkZT0x#P+qm>MJGQ(yP~0dXA*dW zRM292MMQaNo>$>*&WM6(ScBIUSOz?SPt9?noSJb0$lRNRc?xR$g`T z;7n_3VOMe_Hm8+Cl0ra1#3TPu7cvrqMtfBqJC1dsTp&YZy2IAI;l&&-|5#UT?qSuI zWyk$=!=$+ppVmki^z_u^+t4+zX|0)rh0I@}&TWyNP|Gb#i*%VAK^JO*xbWEF(wqjt zuOj5nFW$S2Qn&jmfw+ZeZY6bY)`Aw=psN;()DVE<*?d(owNH%bacQGpHgD{S#%9u0 z?>E#3^ieehV^><`bn%spjhP#W0%#Li18X;za8ji@*4VGAea^>9NP2J?&0oa~5({!B zp>?E~@@8x)E`(}Ns$!HiUU@hl$A;X(d1Ga@=96L zO-s05*yg=c>5fC{quMVp*$W%LSGDZgC}w}|qay^9E~3CwBNzVq$Cn(^|LtbD{*Suy zAN`N7uuE-7u zV6OU=g=4A0K0S&h|2VHb(V>|HJ>Y^>M83DLWy;ublj2U?jnCQNVoN_`(KwHl>z<4A z0B0=>#<;@}WC9cBO%l>%Yp}D&dS20Ey!5YO;1Tk91J{1xqaw^yqL6@Nb3h7h3FmSO zbfzb&He~&p68YkAs#~mj9e!EXE@^cQ_Y|Af^=>&(VjgqOtR`>Oi4g9>7Hr(#p_4x3 zLZj%G!p!pl+oRuZ5Q@@>WNX*ErSC+BG57L2#^A=X9yz%=Ci5cERq-HfQylJoXa0;anEX7< zj-0Do$gJ^aeu3z^1%a7GQz}G|nW687Om3V2?K}crE7}fq;(g^CE#Drl?qdUH`4{6- zxNPaA7;sd!09%|}R5UZN;3gxpsKbW6)9rTfoe=;%1TF-?1DDJh<2v{fX~3hF=|TJQ z`hSzBkr(Ff(;|`mFri68j}f42x9imq#yhqx*yJO>)@^V-Y0!j?t`%`$J98M9S6hDQ zZ1%WxX_Xt=leP^B0q1XpJD%uXg645um8FxgNoLfX1ggDWo20RF(lgE3#d^;z%Bz+Z z0qC%VWIxKrpVf1^Rnet-PwWUQ=qe35GMOh>NK23a@ZqGn&508^ym1v6J!{9l=%DTY z`NjlFlSFM~1vVB>wlg>Hre4bgSpjV0KJ`7d`k(a((>xw$evkMAaKZiH^4PKM!t!PA zX*Vt)>kCbrMksp(ED7M=K8Yt7ah{~cEPP`mFd=|{@WJ5*&FBWXzPU7hN@6N|d_$M4 zq;=C;iFio+uN4L`1C{M{m~*-(o70krOgy(0Ul+ogVuUv0(huJ2CXDH`z$nXF)hLpL8*v=Pg(3@XzH}pQEU0)( zzD$`cjsM^qyjV_%DU$ArnZui*5SPIHHbN!Yb==wRo_c`W;)=oc^p-*km8To-Q$2gx zwVM`(OO&Uv=sFri5g%03TDB>nMNgH#fbVolT=KQ*Owk+ZO!jd$r z@?_jv%ua)epGU$_W>vkMS~&>KXG6|z$p^@kUp%+VlSs^f`IdD?Mri~+0v@ALcXcE5Kygm= zDfUCqp{|Mi4C*#R13*Ury+p1jS;{`{*}ib8#+oDvuXFV`Ck*TTA&1HRJrA{lG0BzU zzKH@M?+*eG3_1f41uuM2Cvv}`e8H#me1K!VsK%w)dNG-dp0^y~+^Ke(j~7-B*vgDl z+N`7(Wsvgobo%}jm^n2yxcIwf(=?HZmqDeJSK3FSu@rbxqeBV8m+Wj`KVk2KVO56F zE6cvI#VngRvRL~?;mgIqsp72D49;}x(-_ln*{-Cug?PXeL7JqZwUKfpZ;9h}kG!%Y zUM)?rm)J^6)vY7e@@oYtW6^g%md0Ho@H(qCet!=E68EXDsQW>A?Fn&x$r^V@1>qT= z7y+<lBsKtH?}*QF1n4BYXAx+VqrW2z8)H5_F(3P zn_(YHl{;A=oT&mS;p-hTGFXwBjg@ywGKE*FI8&_*M;vj=#}~h*(=n$!MBfeB$Mwc( zPU5&hr1FB_M^}5`&N64IN8r~XPAG8D*^0-suXAmDy>^I{WQ5ydCF}f_)t4NHOTzB@ zB7ziWm5-*nYGf_!{9E_5!z-0|8&X4f{hgQaXyxxezSo0Ii;1RCxK|AEe!dQ zmrGn}9!Dp>|CO)QY36t@z4X4FGq^N+io>SC`|OB?XkKZ$$Or2|65l2)sGVuY-eEOv zx$Fe%MsdK|rfu(O;am2h2Py)ULXFtfHh&QU$s81*M%DUd_>;ft;O+K z$GDv-JF)y#PP6Q}W4&|sh3$jXul3lS(Q05;mReDc+?L=^Pr2c#N6u}^&Pv#yQay1V z+cW8As2PL2bro9ZS+m{P%M^QUSp+&-b7kcynW6^nl67QLajornO`#zsdvmJP#zUH` zT+bi1>EH4AaGNc&u{(4dT}WKKf5nc6}U2vwRlIf zz2BXpeb!=t@?>L`8S5jplzw`O4Y%yM!Cb-q)y=FUw7gV{QKVz7lX7Z8c`)&`Axa4M zT}kZ~1RZ%^E*Llr{SnkqF7p?0x;8cxyae;_6K?1}9qkOoA&Tp;uxg}i zN!WX4j0rg(fx})tf{Z7`u4x+(OrNA#=MHw`Rga06Zi}Yt7IDkr8wdElp;Wmb;`D({ z;$9@DNUuBI#wPK%J%bOaIz9@Bj~}Co&htWZcMZpmbZi|cQb?M@!dU+RuwD}eZ>iPN zumP1_pl6R!3wT7uW33%dg}XWQ*F>*VJt4-nWc6Z<1e&ua@18M#R&X ztR!K6?Ophb5u@wxtu^b>4(`z$Sm_#`siRP~e)#-T zFcnPh_Ohi838bK~BM=`!3a;G0?xC}$bEUcADo{IZ49A*MROZx?((#xLc! zx2kQ_X1F?p@)Ps})AfmHDVHpYr931YDqU)fbjC0}jo)&k&ZXhK9UX4(nO~oQl>iNcRvOyNu>r`OT?qJCZd!&mE1}S%4c}R);}QnRT!1peItY zl0gJ`5$!S)GOuGhgO3e9xBRr}obm+lKcUTi+xn`rRrm1cQ$MWJAaDcNVHs1X-1!r2 z{@1~qXRrlxN8GT{3jK~R(|H-iA8Q&WFSzrd7YafvWA}MUBnk3@wj8-+>9Kn z($;;)Xx>k*a37^G6Sy7Tw?NqTR$th&hQ+ZraJ=TPLLZJgfg+jAufme65+21De$mU% zMXcY_I=~da1@S|V(n+g)@Ouc()awt+C~v3or}&l7K%a<2yf|~#sh@)_wO+#w@)E0N zT3Q=BE#ID!&%kmII<+EHm_rt=wU^fBZ=pCL=qw5yqPX-B_BnIx!{9^Rm2A5LNQw@+ z@!_$>w9Bt@3*qEDLLb@`2_MPL#x7W?YhYvlS6ItPVZN>IK}U#ZkzC?SvQu0>>qpv& zIjA8EoGU}iPz{IoNinG2!>nE4^9u(f{(7e&<6W+c_u6GW5AR;E=afa)y{1op;DoG` z^xar$oG|ww$j(Lcpja!L9_mMSd882n7S&@{J}&P%N3anotE`EFUu%YGBma+1+0;w_sy@CmlJ9EMcM@U>7>q=p=%*g7}o2 zV=0@55Y=vD$0tTSz`mmG`n7PCQp>KHH)Kixv7cd*@@GYZdCpMo*&NWV4elXh=EgBG zHJ`pGUbWi^*MEO7I*70fpf^KNH}Sf}I$z9e{}U!QXSbtI$;NWV*=Hs9cv?>u*3_0x zS+^wdxP;3#iml!W5;TC4w_n;P?h{jAr4|EMR+Grs^Itw7JB+A+t6_4KLDWC zO~RPetUw>Xm9$PbxB+my^6R6;`qvk*dWo=h6W-b-?tx#^Ky!0|Aue{qID&a{lRM1= z1yReT;zkm@!ToZE8V<%{&rFgnDU}tU?mbMADV1F-X>1{^EL|~(02bi z#a*}`{wr{xUyWbgAAqGP%O(@cnd5FScUyovXVAN9rgHSi0Nv)ttB>_Z7Efxiu!6Gb z(M2{^WbUtS&Pp9iEbt<#&e`;*r!uH><095PmEJh-O03g4ny?cB-!F1rb`ipEHw`k@ zjY*oRyb5feqpoedA61|_FQ2w@+(rxBRE73gKugYLc(rLH-$A5IT!5AXHa!`)fN{E< zRM%9G;!h1D$`@ZD=_<4dlan8Y+Rp{mHx;!!oTrPIMI8sS1j|cL$S>I%IT-BcOu;;4 zb0RAumR#rY-v~0@$IVPm2^e~n;n$(AAg{%Tkq!2FxQ55dd0@YKc>+T#^UZ}P7iWD@ zir=nK<(GvRXhX-Rt)G1tE9BvKbXpobud*8qS6lw6U7fIl*G+usgj^`qvuy3|({C&0ZUk$TB*?f*-hu)06j>tGpu{w+nHG=9BMV>eqsvy2|x zhMJr}>4yXEkDf1%y3C)@ZWHFRETh2Q=h{z$DjCjz6Q`!SMDCigYU@_Dbz3Ots$`Fb z(nk;hD|_&`%U|cWNls{|jSduq$AL_yVi0lzwyJMcO+&r@$q}t^pb4+se85}T65pnc z%vmLo+v4(!!5FraV-7~;{d?aeb}M-Rz{oCszYhtOeS~%F;+!XOX3=`-s};S2-BL*R zQe0{VL*JTRBYZRd7eNUcAs(tSH=I}_r)$i3C@rb+aerazDjW#i5=XK}M)t&^aQ`Hu)=zgX7-WKy^H3OR#drJ;^qaN5q zMCS0?U*$ur;YsR(D#%=PFX6fP=3u3%6qZl;x5cQ2W3MI3xDP|407=%2mBGx6LMvaZ zSJg@?f9a*BY)Y-|9KBLn=iDBBxhlDe+hjIH_b7)>T_>Zh>51^-7mOMeWqDIG5~Uno zD_REba9GMDOO_k~`4p3({dnVbqxJ}0*@qh8e_=WQ@rS37A?ng?1`uq_V4yZ7;)Q`C z<*nOduP8e%p5Tom_vQ_zCP^Ir93~!=H^ZyZQ6WxMC@a&>Bfk&UAyk6ry|LEx^k9}* zEcP50<=mzU7Ci}D@^}zuiUIZc>Ya`tzXK5=KfNe5$`{%u)iiA5k1nt0;{sjzyxFIC zZ}Mu~Zx{~t)_8tm^mxjt_uP+opih$^ejCtMaNPJ*5c}smTEW&bp@v#mWvAbjS9Lhq zOtzf;@{_hpL_7WfaDBshNQW!t{0P6Zep!5f6t|gac!T!`pmKEi{qZZJEH zLk-@RMQHt#t^?xP)iPX0Ap!U!f;dt>IpZSb;a!Yad8kWRyid<@!Fs6Fk~u#(`@CoA z;L^5bHzsCVyu~dm6jnp4)`8;JM=0A65mtuNjc#&kErKrihU@kK4YA>Bry$1?J<*$@ zKjLc`Yd<5yw0Klm*(L^bK}tO$4uBxrNJEr*YDVvP-`z#UB^?ED00M|ZfUjncLE$Qp z>~z1;@OYu}Rci&3aRC8tuSm0z0O?3338A}MS?5odRtF+@lhvz)1q~_cwi@olS!8=t z`jg7DUlcGn#Zje!tYqfTo)jrWD53(+`l%CUBq~y)bu|@D>;i~#A1_rTF{rM=C&C*3 zcKXc#4M!_WZ9=h}AAlc+_Bn!Fz#kN_s`gg+yhqwp|1vaM$Jy%d@4s)t(q z!B_VX`YinbL1E#FB2*JP!N_GsuwMw&zg)Ijwdc)vSx7Y{q?f~Yk|5!H_JUVfp8}ECbPS)?eikwwJxY^x zQ^#uwA4(82c0&XyRh(L4*ktE$;Sz{MV-m>CI}qTFoo^Sk!0kj?8Fr0YG~8G^s?PQl zX((14@boQ?qUV(Ca{;Q@wW_^fF6LgQD^7H8yl#H8Zqv%Z@krz-_%69tHn@<6_x+vClU#-qMd*fW*P^&Q@Or3)R<2B&QPZ(p-%a7W z|29^Q?YFe>dGi*?*jw+V^NfsGVhaay*=sJ}c@6X8V(k)G`3y$Od~3Q5b`V`2BPpw7 z$`;>LhG4%9Hu})Ix>O<*nr4c)JVtkY7SD2KgLdFa9ot>)Hg_^?NfMmndU>E5%_~`k zcupWXR<1vqo*efDN;!u^xa%l765q1NOm zeksSAUE88V*n;f1^l1VX{g^@{@ZBw)m$lyOcZpFmL-W%lq2t|>JHVdtml~S<_e!Up zcuwps81YB(_wUsczLvG^A@%i6EMQ^2sL!F8CFUKVluw|#2@Mp+LS_CyV8tVcGV6{$ zRC4nnp=|2pj@Pl~>?|D?T&4=}o)`o#Ad;GW;7McOYz?=TJ;NbBC7ZL~+%T(m=cP&H z_SQN73QiGKwN^B1=}nKQ@`DslDni#~uAG27QUig=#ne=xIUO-m4Uvl;j9>WZ=FV1BQ@h$1vf+*pYgC_;L)alx$KaS zQSWpP*wtdHm(uX&b}=A@_19^&T0HYldwTh4DUBp@>Jf9BJW}eJ*$>LG|ErQF=8OPe zlSLD6hN_O|6ZJs)#u44l!0o%7F!MnVM0Kg8T1Y=DHzseSG$pyjh%NZt$+7B%6U|i}lAzch?58pw?iF4FHoLhuMZZT>t9icTeTBK;mqRVudMs&+*G2L& zgOGieR#!rJ6{w@E1|y(9YK5E+m8rF2Q<&%LH3Cv+A-M&BL=Z>O;NMKe_}`g|%l|u> ziU2INHpObKQxjD7$==O46e3-FmFcJi?qrn#Zt9M35(K83(OgI9l+bJ)@nicU1su@g zTgzO~qTrdr%^}v(k>mBg*o4&ugf@o}-%mc#$@7)x^fPWiyS=-B_vZr3e+D|^*^{c; zJD%23rN_0H(DW!IYnhulzr;8}%@Yk%zkzT2fC0k?v7jthJ7H6}pjSdo+ z1PSi$?hYYA26uOYhQZwegy1l^Yj9@>?(XjH?w&vhlJ`vVuC?~s>)PkL_MdZo=iglO zNOxCv)zj5g_g$1-bsC$17t9JldFMMTHLfbjda!WNP_-;r%V2rZeHD%3h}@TXfivD< zukhQLdUzAk@m-=tp61u7oCeKeR0(YliigA4yvoFpkM-bYFrD;Z0y=Ho#Rt-ly$Tl7 zd0}?!0{&&8GzIJ2xK+AQ7XXL-je!W+kp^rV^l{m@Op(hTY4UnV{<{=3m!*8dMb{sy z4#(VM&)zS3R?J-5A`SJMZNK6iNBfBlAmfy1)zA~kG$qrvah_n+GBw)`ZSdD6EPE5I z?|rRqGvew=gK7rc7~IinjjDf;a;l_Ltfa9lJ@)Bnl>la)z$6r}H=8j--8OKex*I z_CqDYKGIHhsL7|`(RTjV_UpM>d|~ni!q!t<$a-1ewyTJi^+Yi+|()%NlrJG6m74%js|b)Dp7yKUgM%@ z?D3oLoZ5*cU6bd}q{Xtxj=o=b-}0ilLStyFGn^SxlH3y58gV?gWjj0(q`<9dZ=J`IPnX<>9h+xO0uOg2?A)odJ`^*cD4z&lDgN zQ~j7xaX0~0EOBlNJrE*B>R9>MFcDDdmg8U{^Msu!Mz4+0^HmL*-BM0o?-6D%2J0o60Kti|#$4`z8~3{|IeH-k}JLxMYL9 zv9?z6Q@4SsSiZR&MDsW@qM6-T>>bs}3Vcx50zYx)6u&GSZrMl&$(3b9X~?X{p5GhA zka&o0_aS&AlB_55NcF1{{rksE7ge(w z#;wXI1=iENe!N>D!gy`Ib_r}VSS!NDxp-}8l1{hs9W@a=xY+9W-fFva1DGR7NN>%J zD#wv|XsoCIZe6v`g3}awg z;Ir2Eft#e?%WFhyMmHWU!G8#~Z{Txl=4B>BsTSk)3G|@xFMv8HwX9cyaPkc+_v*BPnaa8tScwW0paK!vap_Txn=l^VcG|-b@aB9Q|yMrNo_h!B`_9sVl&ti`IQ>Lxe`es515X3n+WM zGVmhpw;Ge_WkzMS(WhzND#VRrM~D>Y6Desi%%?4b@rcsU6<8==*cH$nD#hcOjl2oQ z!$uj#fp41Rs;IqqP_yTLUnTmL2iFR|%@k7Kr*W%U>h_Yyvv|qr<)df8>O91@z$g^+ zs~}L6H+~h%(o&BGGiuC{xZphqWMF3twQGt`%1JDx(FsOFB$exz6RF6gz%(SB2ZmZ71!5&Zlke;IMp5Oo3xPl;A!EX-ZH2pjB zm4GHr5UkX;4ye!)po*UgE6WJ^>rchfg5R(KjZn5VWt)lgzEs2bww>Y+H0sXfSxioG zwG9Oh#Up*W&W-Om&;J7qS6bxc*%QmvpgJDCcghn za?ZN}BRhRnu%|B;&TCVRqq}oWUh+ROEB>8b3@Pot=PQpcQ&c;~+Fwj5loKKb6Eo{I zV2Rwg0+hmX>g*WQRK|3Q{2dcgQBQ8)8$69eN#sZQDg`F!>MUsX$WL&Y;@!PT%7tho z#CGX96n@ZpF&FK1q+1jw8fSdsRack8V`H#>Nd|hkM7)=PVb|^;S!Zf2j38~gwzhBo zrhm-<1qoRqbn(qxr`N!4Dy*U<2`>|U18eA{=+7lUANNOVRS4GDeD1$eD>T}wKRPuZ zxW9Feyf}R7-IHEWK?>`5dj0W3C1f_9-CozBN%>bkxz=9*o2-SKudJ_q?;D#xQ8Bv_ zU@iSlcF-7=Y)Svhw|&hv%BTKgBoXxkzR*K=(FbzfcPljAtY6Rtve4=_XmAWJ6pJ&8 zcjU~XW3lR4%d-M@UP+fpYUyK)?yn(DZ}Dn z+^z6_r|Z9eQFPBJl6 zCq!csfjAcz0(&UK%7$MW*Q^!3+QLYDVpNUHG;U;O(C)h}*&(2o)dJ5PT}lUb7s0TZ zKk**bOut-1Uc)_RFlQja#6q)I(j`Mhj2Z{C>U_qVSzn7Per90Jkezc4*dr?<0#+h3y zk}V49?ykVZ4GqK>?W$kQ^(Jg8K4-0E=!Wr=?6(=@a-5wb+6lkcb_UtG^EofxnXJ6- z-G#$PTCH8O_l(75=VvL$Cn>1=_X9a$(|VC`y}01m z$dW?OYL=fkE=e(VX}?C_RC9V%wVJd(1)D7TUbfJkzR>|GN9SX~FPcVtGkHtMC~9GL z3x}Ec7a-$pi%7ZE8TxGSM%sxu3yXKpf#a_@$7PiWg)o*Wv)8r1|& z?yt?Aod}q1d3hJX2+u0d3JV`=lGIEz@*2y_P^5XePqlhkV6{5HQwud8SyVAOH)ZR- zOQ#-dpt(Ku*(E|hrd)_h;f|5gw#ghofn zMv6-cE)HL~k|`+{UyFl{k^)mYt@=kyS_CQg=dUD8Pi%TV&y=6w84s!FbRSrtve-A# z@}-0NjOcXz@96r%2G{~D;tXbb(BS%83JuX=`A0D3-ZK{3ajLwet_ageFPR}2%3v85 zC_hnN!|zm6u*BzH5_WaQML8-wm}(7u$cey7O!D?RfK}IHgOzs0_zaa33P~NN65+rX z1`y1BfJfLBk$7L8X@%tMOm!-lwWCxZe3;)7fySS*7(>q0c_KQ!WZ1LGh>NLM-+6@PsAIKT zBE4Y@Fk%pA9CbPg9~ao!#M{!a!OD!W)paru^^x%^r|{CPOwG;lcW#--kiP(xVfW2n z`XBQbHHjF#3dr`Kpde&9xi_MZYBNX7Zu5wgR9&UgDzhepEHa<{o0k9sc|W~820TN$ zwFUfPqc8z2x$yO^%eZW=T>tY^_;`w;O-rhKtJe>2ntK$uLA06>f z=Mp`mQ%$T`09bm~FyKU@dNU9e zGPM@oh!ks06UTbvu6K>f6QT@fHr^ZiO>moo9gvUlKg$fc%36ZeoUpb-hRm6su@-Z( z04Iu1_k|5z@6$7dKO3?UiPW_X$8cS(4rHvrko8;$VcNks8HozAp-#NGKi!$2 zOeT3LX{2~b#X~2{h|y!Z6=?!D*Afs#bOZ>dZu^qHmTxZIk!{4xUF<=mfXpz2frbjo znZ}@sJJ+S-Zz{)9FcP)?ZddtrRoIl$ef4J8&RpUVro6KmY$M!0@_QpZ6j}p+yFTma zd3~9;$F;nRO=jb8i`(Dxw`UF8JO2O3vt}!kN7S}f;N@mja2hZq9MWN^3E4;j=7xjC z%pe9^z~Rs|V~a{tcVR>s$4tF#70@|w8T{oHTfi^(GEnc5h$& zPF}7=w$eaIMod*%QoZ1W-kyo}ka7UJ4dvX`Iu-9viw6wC_=muHCPgBWd4qYL`%2#w zI&Bqv$9`tCra0s7TDtd%-cM>^8Vf)c7GPP`0qm8)2-Lox1eR`#bYN^MLwQyeMvZN*PLN$Um$pS?%}lkx1uNc<(-oTU8n6+ zT{+u@SNPfeQFXuLzK%9WGK+ire<(Y%i&%=YTAH%S-a*q^D}$a=PrN^Hy3PzP-P2VX zGpy+b8dzf@gww_+qEa7;Xi1ra5s_+oNzP1W^XZlwizYO+wwVN?ZyyMY1TQ}1L9+Ok zBlPnqE(rHUtgnc5QTQ&nBl6gMI+n~-7p39UR& z*vrsL%odh5mrSANqV9b?!Ev##*Xf{ZDQRj5I-t~aM`x|&!oGunziz73earmUw$Ri-qD zUaaMUGz&gb5!s?Tr)8a@46!8eaIO$vs~h`1x|=QH=s}I(BZdz(!w!O%%cw$UGBrAd5Q09135v>i&en8Rg?WJ&}`B+OIdu#p)WZTD33U-I6b( zdc(G!e{)5>!Wu`Ky5doF!z8F*Q@eY|sfYeSv!eu2&!;kDyEOjIDlG7=p+j25PdWr$ zq5OE^;R-V&8Zgp0s1InlI$;gOwd%kt?0<}WpVZ$YsPBV|K z6rT#4y6d6A0P(>V-GUZPP;SP+_A$9K910ND01>N`Pol4M| zgCa1*F8RwVy^&Q)szIe-Y#jICQn)Jv*j`5p6*e4 z-nhj=d`y+xIq+MF8ulu_H9J}5Y#Z-t=U{Gh`uAHNK%Ktz6i(KIskQZmSOF)ht`y&4 zZGGP)Sf#Ci*n(5JkbJUAE63cPR|UbiQ)^_s;%H(7-5}?hPZ63BM%J-5Kq?qi>_7Et z25thuOaS8}f7s1@+_6<-K4uR;H)~8Yv+Ig;9`z$%#-ci|l;M>%q!D60JdGh~{Eym} zzui@s55+$^iT!YLp$A0>nu=bU0d3CGUm=(U)c zA#KAs+?2zL&BM-3J3E6=IdK0T&Npkk_{#*>E`cKnj1MnX0v^#NaH5rOdS%R+iKZYC zD+wMaUJOwufH#0j6RBL!UMd)rWTa^QT18%wQwRu!*MQ93l3mJ@I!3Y2bOlJJBU@4&4ble6UseG6eUm;agu!Y z9n$W^%x)f*^u2?u1UWgz8Dlb`JbX@$0{_O$RlXbQAxH*VyuAXUojxZkupRRriLRju za5&)%9c?B~_-rx?#HdOLzNA1FTwO*Ii)DzPuO}DAdR~J4ejQ2_n>SIDWcP1F_&+7z z*9-ENji{DaC@OU%>&iR8*Bf<}@)3Q8*$#xfZr1muCEXp+ANX%yskv2~3Gn8A#TBTE zB#6@$1rykmoqLU3n4!;jMVVZ?l;&%>yN_*>b5W;D5uLOeIk%>QMFy(wn`i&=Kf@&> zWBkC}B%;;q%XC9d$u?r7CvbPM4ziTpBR-@(+L#eLw;wO|3M*7PexDWHqx^%k6OQ2nY~uf&%ozG)eyU26o^ z>wYcTS`SjWn9P@=1$z3HgLI#xx0u<(U2jouUtrEy9Rq>SK;Roy z1lV=(RNeW8Yk0!#7LnfhVR#Ke7INk}4y&JR3isX_i#;P^iKE|OSL`&aJ2J1;UM4S1 z+92PLGF+1{3lh|5(`QSS8s`wLtsMkScP&Xt-leorVpR_DCDl@ljk2Uye&!Td zYL6Bt^MEO@F1}u~@Ewuz;E`xGgdr}%5veso%kj}$F|UY4RM=};qvDfZav$#U@US9F zW*@CqgP*Cm3$)IipIW4*FbfH2R=q8pB#_*>ZdZ)%?RK5({>BO!*NV}|u0Ve+meRT} z5@%!Bb)pEXsPPR5e~Dlj)YZB}yC+TftAlF84k_-H$Mr+Xd_X%AjS z+uUPDZ@u)L=GQ&xVe)Y!h{bEg(av~zKP>x=nY;uTdHA&aJiV_k{oXy3?faw}rh^ff zy`f=&EvcYT!WPpE2kM3<-Xa-7HZvO*fW8fqy5@yD<5o?J^(3a0Y$&(V|Ikp7b5vearb zFYE6HhL)#slA)<|8G#5PY!+V4%q4sp;v^`!9VuOAh+f+Xt`;Eky_&$#;#G92vJp0( z!g;59^dZCi*Wu=aCb{5^9uc_@$t}mg@eWKqzDx&Ygc3-4U$cIJTDl(iBK$ZWCALOyat1kk3L7|}7-EM{N;PX5u^|E2*_@n{Us^!uT6IQ2^>avD-H%oqO_*nr| zcHB1JKE0=F6#QI^-5#R>VTa}D^TaecJRHS9($0)q-ngmerKF2p7>~@Uvf-v%%hk%K z`gW}R%~8owO3$I`RPe?$^~KOr9WO{#%fmL3DJ3$hc;-R`L1yd2z; zLN4Sc>S;jGyz?8Iz#a=b2n~6t8tf$hjK-L{fHUu#UCSNxjcO=y5Qp$EJtd`#Yqzq5 z7KpemC*(g(j>$4K_F@7IFf*F@p-N4-Lm~iWbIJj1)AP~jWfm>=zY69~FMq=$ND39Q zubw8|+w_}OHIw^p)ywUeb!Not&}yS!P>`iGLa(!a9d!BXK2AM1j|R8Ws?)&EPu1wb z>?YUOD0A>L=D^}U?qw0~OK%r4L?a-z7^1r*{x%MXYtOWe##(vSP%};-w&=puX`y?% zBjaZe=V@M2X9(46;TXq9YniE)1q@44wlmci(ykj$Ly*qV50MI9(9St+yz-21W@}$m zYSyuZW!rDtqCr|A)ytR}3=CAwYCl1}R^Yny)^|Y#q_399?fbk>sosC-x^G?>6mKOK z;6Wg43h`MDYj2z3Skzqkmb5lFkuYZS8j|I0Ju$JIv3meYQy#=&D(H2tNupc#>Ji6? zEsuv2rnZvK)aT;iOA#!9OMx#)vNHMdo1ZfKxVe!~REd+zaThy9is zE1wgsd#Il2t>wkhO`?`GWe1;z&y291+3OZ#9tW4xB<>^Qm1*I_i(H&_f|Z0g$Dguy z%jM5KHSt+W10{aIZ0NYtDfg;8p$s^ zUONiPvCXiK(tzMC7LSZ#eqh2XVKE(81f$c1QB`GGD)fRCzX|W)^QfqC}kmYy(c0KNJX(g6#J>49+1+sKp;4L!MwOqHf0D2ZU z4dCS@a0+UMRGZhhr`WL#KnI0FRkfs0o#ZZxR4-}1_$|XId2IJEP--H?5q># z(cSe-?lQghbdv+(3lGm2(D)i!`!%CjF$QeXfq-p6#xyCH<0S#2UCV0Azy*2fN zp3Qw!#fQ3Qsgpg6&Jmx6`4|eOj$K$LCmVVrQq_92WM~CT@#mWfpslocJnwX7Ko^QL zh2{Q@7UuhzL)Szzrq~kcw@s>YK2uklS_D6Kuc(H9>u_zm_VOdQfHG`HLq>ekOZMc4 z$Wvsdqy7)ghU64#nU_Z~{(PAzx}u??5$K2m;JY=A7irx}7g0GcZwoF&a%#LHA%QED zVmi3aD{N{V92rdCd{*d#P#&;cNK-A8=bSIC-~KAeOQ>O{W)*qX<>oqXL$F;E@Gmzg zyKCaKY!Rq5)AyF?aU!zR?FfO z=g!cX5sAm)EtGg4^L-j~ZLT&)r22j^#?Ce>$yz)+fLe?fIfx|ZJV-yRSQ|%$Pv7dr z0WC8c-G0IVS=9{+zwCxq)cpvXy>&E4v;noNnW|EFgRBc7-=^?FtK&AZ=hi03;B!OC zXre&a8Sq(BTOCdXog`0oq(XNe{&drcWJc<$Y6EuEmVR^%31N|NWKC|Cr!Syc2Hr^; z3%9rvIhbyMmO<_2RwWJp74xMV{yXNY|G$a(wl7=v+Ov!|Q|;wSyT~Hj zNcybpZQ%xZNLS)lhPyLIo$Vq4*p2I9fC3>$s?X*J>&0W-Ts zzt@Hw{tJtKXJWb)W?0Bm?s~XjZ}X9=tIPdgfY-AbY=W8=?)WdkCjDexpq*&kB+`S= z#Xc&Y^E>vZ<`jHCr}f;^9l|&4RJBmuBDEtw%-oAv8zv@lE%Woy?aM7Sug$UW4A@xe z?r0_sC~==Mh@RMoFI0TIV%M3L3XHMMsvZ7}NB1g6Fzgh|xm0mgZsv4g1#1OJ_nal+ zI=EiQLm|#KDu*^xdSN;2`m{<3=Z|qnGLBRniub@woOEedn%z|MTqQ;Q-o0zhgDQX%=UVN&OkvX$BD8}eC+VJ5qj!*SMV#U^Dg?6Jg!88eu1v&7%wgfQ;woMmdJ499n zURr&+DcY3iM#QAJIbpVl+L&m7NSTJrf2t|U zki;>YSJpj$|NXJrp280z^Ho^pi|<+(0}Mpciv%=z>b$?Z)KT zdvsKC08oS`QC&%y^C`xOKJi|e?R~it2?E|s z{Dt@_rDB&Y!z4U22<Qar=X-lzc1)4p&oA; zY!%~(ic~+C;cMPdSjr5K9qGY$7m^bT`bYN6B3ckvu-4WU0e8Hd2JQCp$36_P0Mc82_8)HEu zf5OGTokx&*&26laoQv+a0pBA+J?`S)QBZd@+CIB6y-RXOW>c3*M|N7zKB|5xr z%!o@fdmN?9Se=@xBLWV>-br*PHk-o%#r! z{MCLQR==O{HHo|`_bmkXCRjWvZYO4kGJy$R!>iqVl(S4xw4mz3|1w^)>At|M+srQv ze1mHSR?azRo%5{Cx?8w1kRk&>9%gyT{6JSp%HX z8t81)Cdis4VOjHFP)7>RuZS`@+jD016CM`nF?RP0nbMa(N@2=+CAQ4aT#al4YJiK; zXIlru#YL04OSDduvXyO_BB$PnLj@E#{R5Nlng$jW!g7YgJuFDnmFtR#6iRq5 z4JZsEzp9(FGf}m*QVKd<44C1<5ZhvC7ee%9=h62Dy~;Im<)viUJrNp_7SC=>bVd7y z^9@@efawOA9llBTPQz=_sLRA@g#hWe4^z+J%NEiVM9$AVcli*MSQmv>JVKMLv1D9L zpa`{2OYmMpBji3WUD&giZ7`GHQJpr7j8r6=KFus?9r-$yc({iDNtM&)^K#VmNKNTq z0M1X27vd3t1;l8?n2fk(Xnl|gySq0snhas%KeE+u<*1fq)ac8ikqY+KeWgv%5)LzT z90ntG&O(@Okd8IulYPJ`Mm=Vk?&-=gSj@5sBCif`OpepmHWX3;7zuuSOS2iik_iQ? zE(Rui<3)4^L=%0U6K+BVilai~W_eP@lD-_M{Lpd3HCmiPJWv)@wDZ^h*L3cmNQ06x zD25Ttqd`yR1wWHw<`AV^e%byyx`F0b2`k}ye<%gE5EN*;8W{0*$1n9LN3o5MH9Gg+ zHH$4H^%>HeJDftIGOSuO=Ly6HxF2nZT5K{xt;O2~$b|9L@fNm6dm>5}ucEZk1PUhQ z7#WZyhF&N#SLK#h*?Le5C1r<_Xoh~o+)|;1x_s06SV|a#=GfEQ@x~j+V7?o6{BBW3 zwRP6b1mO}JcDJ-xO`xX4YR$D$v_2*9d{^GwacjcH2e!}8+{ag2EcjA4<4 zN=yyyFA!l`mAGWTF9m596i#j3?-Qd48 z0SLH^@u{V8crzln&MdDAx%6t8z9+8wIHkNpQ5>aqEu6s>CFgw z-;Zlk9TAt@%$SBxz@-}^m5uO;t9czXs7%MZK{;04F0Kn>*8Y?jAtopO4nYME6HIH- zrJ_Rh?Zw02KBc|Eum6)z894faSh`u!``W9nt^0XcM{(@#JK4jAhPF4gMeXkpv1TH` z%dEoc!QrvYRH~-cFyl+J-n84s6Saq56=-8mcu*)ME#V;*VmR|N<756%O*_h?CH+UT zQamF=(GW1XFRxw4`SyDTc6%1UKQZpTM*sVJT{;lAkDN&**uiXZiDWKKB%Mg+7V6M@b;(!BRi>(Cp6R8GMSBwJ!I6lLVZ~OZ zR8w%gM5I6phSZAUE^|2Qo5EsDM22WRlPM}bX3qMqs444+{(Zf?c{3FCVjX_FAIo|k zY{5suIY*pfOO6VRDV$4P)B`yE9<@>FwUh&v^zA_o^-Gvqt)wMm8Z7@3U~6VN!YD7Z zbb?EL8Ef*SO{=4GaN?SFCxL$DEgQ&%N<^O`!halLaC7?m^rupSB*HLzbWo|&Bfp1q zVqOg)`gKkILEOqLf$z-E{EyiNr5WPC7Q#2*x&e!h2Iev$p(Dx-l&x)Kb)sH3_ z9o0JRD<3bS)?zd;)tO04Viy{zS_FmfRttQ)$eP1W7SBU3ph-=zjL55xpGQ>PJTj`xB%w{Y_Dfcb=Cr+O8ter*)Y~q(Oc}z{(W4{8Mpdb5pvr$PTQcl_ z8SW<3^#-*U%w!w2>Y32wt24QGE})J8wvJ5+ezAaekANoVB(Zj8B|% zPSC{S00-LBvBD6ORMSEoZkNXFn4M)|GLpn7gm$SFWACf*VEeWM>{Dy?`1%9@A?d9g z!wp(?E*^xOqF47(EWs+WjucIn2yngGSj^@Ps_ZO988UJh%W`VGh(SwmOOY4?&GUkC z*;%Muq^BT&9bgR5g{h*3HW8J8l|DD~ugU%W{bL5jy(OgcSvWiaMlv0XEO}5TmQG5r z&3gEHlv*=ALq1>ay@q!4)4dn^{)2B+h!T-*!{TMP?SyH{uZ#q7E%JL|_ z$rH6!n>18``V`czW_YYy6j;#`pOmW?_Vzg6no~yA5UqQhhf+SlIWjfGL=x8~7|2lC zz}-EoBko$W#hl_8-`i!S<{mv0GPD`~YNC#qYa|lUj2ssfNO>qz?0$RON(t6@HSl&x0m6=`(p_9$GO%mnW*k2ha) z3Kz7B7FhSlA)VYypBw`7i zin`UGhqzVqPQ6bzbBF7U>8sI))F_;tijmp~{jlr~b4aIZ#w3GA!}5<*ebinD^1{s8 zTUZt~pZr+bT4Nln5W;HQ$KUX6_C4m6`s_xFXAf%f79WM5_!R|jP=py)WB&qpfZiX_ zu4aG-jBEu~!x{B7*l-eZ0;qA!Mir&taaxJ6O?j%fFhD?oFov=N?qQ8*%0o-A9bp&qz*a)~gFp;dz(xGl?nql-GXB*t6bZl4I(2B3z$HkP zXhvTZR$exwD%Vt)qW_*~`<198D~|xWnSb8X8t~aT2{f%zRj7?6fJw+jI+ro;}8D^ zrzQA@cs`M5OAdXxDc9N4FjO(+MsAnbvl9M5l=a|=BJK=F^KDS!$d87($u(WSC90yX z^UqBeAiL?;n=Y+I-Z>EkI_FZJ^|zR2^@x%>=VF+CTIkkwwgk^8`%7^~E9z)tGv>=~ za8}Nm1*J3wILTcUeI}&+)v^S=F-$9IK*eyT0RasHJ46ymJb!Vf-pHB{s=b#&-!quf z;%Q2mY;jqu_qDRFSNKTV1KehnE-7J#m>JS0OY4z-dh;3nTHXvspnb5SF0h6-6ubAQ!@yV#5D|U@C z1h7DfY87%d;7{)5ck($t)y1uD1QN7=N&HyfDelk=sZ1I^5TVa9g%KRpMpFyMefn$u zzxhe9C9h@MY)+?7RL!ZM&qY+x5MM|MK%4-G$W^{WX(+Tk;h&Ona9-3n<_B^{nIuH+ zT5cRH!iVulPc4v^3@VO9NW&MrQlsS}p{^Wr-VtO>T6>;q(Fs#k)Nwxbg%-5XS$v82 zTJ{P_oP{#v4lKkc(aQdIm@rJu&0vsmMX?@WpZMI-l;O+%7(@XqAXN}%B!))jBJ!(9 ziXB1xJkiDU=YIH9- zZ}Wo(nZrju%`xD}3ctYuAJ9msc_K}%7>cNr_Z0lMj>9DFJvV}9UqF*p0~a&3gWsE5 zw~O!@|1fUlhnnwq>GPixokA!s=zy?2_x8DLUyM${*_=j>Enu{?&ARN5X_RkSe=bAr zLT1*#sbTx(T0PMueP2M@!2vzS^nZt-+h;S2a$6Rrd)f&ERroX!d=JGPJCh|2iTGlw zgySR=Wz$*|ID%=N(W4=i^d()PMA*lK9RAJNlUcy?8m<1S%Z(i`hRHSY7{q&)wJJ7b zDv`!o?j67ZSm+Yoqq#uBSEZT*m--6PXz0nfuS3had9Dt?JrQ}TGJRnmZ3AfYX8@)N-;4qS~6SEzM-A=}6>S2id)8^xEH z$YM>`WndRoQj%D2+T;6^<`6MK1-j5bJTmc)BYmK1*Cu@mD9EXnF91?5<2jB{7@cvk zOWv>mG0ENnSCMsusc3+l8JM}}yf19(_A+IyLU2@J#0N2KX$ruS+2@4sXeTGQFTg_h>0DNMj^{e+c1qL^SvS!AX+d;apIH^-fBdMO8g^f;> zJHnnj1s5m9>`l5bNun295-#)b4~1Ou4oKiIht5Biiat>KxfK7o?1jn~5459*ij70r z>6E04eCJ4of`%n)N0aS^(ZPJx10E89XJ-Th`Q-q@{(stSARzGH0-eS5-@$yGr&3DO z5kOQvdCs&SUZ8*8?ahC+KlrBsKZpzkO^%MOj^11Li03w(LQFre|5_K{{wKxwPrYd? zOrEhPmJxmr#K(Q0tTO@pO>zY~hUwQrwlC(bpUYR#KkM{4_oail8uEL+w=c^cY~J-j zevm_s@q=j?FhJc)954JZ(BUETe@lS+ZvQ!jBe?e+4h5XUFMlQ58SN-{uI0 zwKg4*c@yXPj0D*qM=10CsIYhw5pZ}Defmcvk3I=19EJ>KG5!>+9Aw;|4R zbdxifjSLEw=Kk<5=Ahzl8~MIE*lK1_uuP*&X~_itHh+3{+AwNjn<*JLkREluDpmB| zhPnP+0R>_K04e8%e}t)ZCDaQ3^BiPiA@=`N zwvYY|pUIi0Vc)*8%v^PA#4<~<(C}q_8Cd_@KK7=CP4xHKW0lacG%YdMJIay?+ENp7WnO23XCZOIAXZ_z`M04RAMBeevkgBN zQh~6^R}8065=?=dygd<1QLjx(sB$7H zf=d$AzNUBu9}kFd02#_kS{hy_;ZVu~l@MBsL69f9S@O~B|Q-r|6J=Ui=haFgf4_m9(BJr0%+ z-m0-p_aWG+%g_vqc$P|j62;qznGc?3D6<@Hf-njZO|F}Z zTkxqKJ&A0};`-w2Nyp6}B+%GgynhG?K?nUgm%kO_=x@iH*OuOHAhVy9Y2o;(pQg=9C;)~@~M zBs4Ag0}sHVve(VhV)t(6(oERZFqiJ!!zDt>od&Nid)gX8)|{%+OvM>cDe51H_D6vO|GHd`K~VFl%xxrQ=KrK*T^RS0LIjC1*fvPIkU z^VgpW=#830^S7iEp|wIly;wufL$R;!my~|2*`f<@$3l&WHl2ep8eo>moyHL(QqcJu zS2p3cAnAWy>@DL-{&20oPp|q>*$^fAk`i;W-rrjZ+D&wMbrMCJ_N4VwcFt&aQGB;` zNYdr}Jy}Azqg3mYP`<3?C)^G-H~hNWsiun?Op-?(y=FLUxcB+3=jppZU? zEV^| zp3pyr4=&MdJKH6v#r)S}l=DSn3;jF%ql)6=haU)jGBl-aFt_1Ta(u6iPZGIHRwj@EMcU$=#p&qI0?suoCIYOMt6Rv$n0Oz)YNt zkMO-vJ&=Dhf3_?r#41zkr}gSQkvxwQ!%fPfOs7pS$$b-fAyXz{$1{2v7Ga)~{(doR zQU3;_E5-ROz7o84d@H9Z!0r1$szJjoxzjkR1Y3l8PSS~4RL_+-E<0O(iDizKkKct# zWGut`9g?$D3u=FZ)rCNh1`LP&UC)dfTjM{D+*D#=(AQ1Y-^)9^pG?gaa@V9f3Hkh> zR@$9$IdzgtnNE+}q30$Q{|6y^jDPN!|F6F1&WlU%C^7rg!Sv=g6Nc;z`^vVoC>!#z zTrrYEr^G)-2L8vu5(0hYizl|;|>pp%hiEB5i zGQ)Vn&RVQ4kj9WE&>=l*Xho3p#kpWAOXQ+>{?g*B_W68&$FI84!RBKP+X4s@K?q?M zn;Pb--cQ^liMK+XU4(ZEnr^7|Zc{$gZNaz291Zu#Le#yS!^-OAPjK1hy(Jdqm4Vx& zdvuvSt6L;TF{p#IZ(wn zKV6(I-_dY>7oY}Cjo6C&PRV}Olp}<`@^0nVKO) z>_0ao$YTX#5B&za;{#Ie4F36wmxWGzZ9c<=lPlYIasSo^sWg=Jk2RiY$}kc& zpE*2te3ZGGyLme|2I``HPC?IKNN)MvSFnNNS8^_}%UzRifv2?>`H3af7S^xPP}NiU zKPH=}l5R03ji>q1Ky*fgS0v_^8`JUSCyU;a+rrA=LD-aOW7`alr5ij~l7q>JzDPf$ zg*72|)@;vt&-}6Lip=5ly9bJFev7Z`V$hVSVfiu!@W#uIM6dOvCx09Mzi%)OneZI% zDJW{{ys^K**ouYfg5`qu(%Tc+FYbda&pjQfTCmHt1jl&@m}bOA>)QK6arQ|>XOj0_ zf%W;lwpuM{WD8AN)aB9u>6th6kB5)LgE9+E#D>2ZzyCsqecfGW7@7xP*R?pdKi zVQvgWe`?Egjk5V%zqws}3wFmY`mVwD>6`yL;>c zZXz9oFR*==Q1aqy<>zhEGpqkzx%E4J>NNXt8SgT zb*k>nKRqq0*XsH8TI=bjd-d`bWzM2Vs-_2&$PHGzu{G!l0o5nf&Oebg;PtB8WW^75 z)|vG1)VSxv%>4Cxpd&Ca@WD2^TD7ssCAiYH*J&Tg`5v%!@L5)B)lMO_9EU$$=m9GJ za(arF-+^>MX54<>aefP&!xC-cU{G7fAD>6M-1;L(2?QwQrPgJfeVQ|`(jg~#g!toT zakX}+-AHm_OQ%>ax^^ULRSmi&g&x8F@v;tX!9iMJ56ETGZ1R7!JA}@=7|jGQ8Sj~6 zLOqa>`0w+j*eyKjx4}*tQtZ_Lv8e9eYFvCe6)Tp4;#u8jnT2&Y?iF>i=qLw*Q`UHF zY+UxeI~e0%T!p+XQ8kT{b?wwi20sVwS)zi#oGn6)$T}=dAJQFaAl(-gA>h_x9F?Ii zW@68tz~$#Hr@YRB#Y7j$)`Z+-_zcIp>|$!l2a0?I+?Zh#eY0Wl>3EBKeEX?aWVfJe z;M_prk_P`SiT=N=zzpxVPd6RiSEkEbF``9P)NCg{+REG!_K$eqCXARAN|XKOM@k7m zAyt1Bl8^l=`<3Q37-Z@1ikjI~Noi~y5;}9Z8_i0;I}+e8M}M*Uvq`LwB-nmDoDqHZl8or?8csf&1RRRmdme1hddBUDSfk zo)F$G&aPWGBC)_)Zl&uQ5LWA>OyWDF@Q@u zvs2UwVY*E^yDp&#*`H6GbEBePVw!{UWWyzKaN2QlPT(wmP$&LeSl1pQ*%=guFH&ou zC?>{!L;x}tySU=;ch>KfmPShJ`U045+?sdvl7J;(sdF*bQH zJZXQqsOL#Kxx204_!l@KDQ`IngZEnETGB zpGDmQvhu3mat@q1|8f&I8QLYrT_Cu(STR`Na`F`hN8VWfI2)L#$s0ud!G6Jz0&+?k zI!bv+P%vTvfem*;hSk;%g}8|{)ObQc&}^X4$dbTR9W9%uDjb8wrj(-~?|a`zywJbz zA^nd>OLU9`p5U)Qdd<;cL-AQ0sg$I8!9AQ*$Hl(M+I)NCu%cc1j87Sd{SLndyO_c& zM}rC$Piwe+Et#{J!XhTT@9|*L9heM3yJS16aFN#BqFWt5;_0)^?+hh`n}%}+8s!z% zLL)HC57RX*5G@GV8xtKu8IzC?nk0yR3w}RShVjl6G25s&CTtJY|8U;;i+)S)SJWj8 z?<3HYJ4SJczi_METi8pf1>Aw@6NR1W$6}`GLZCOpU7gEV8{03wui>U#AJ|5{drxBa zv5lCnbb~g$3~-Ii%&4QwAcgMgt|V@8=V^KEs$wIqn_a&LEOeBxZ8t1@{H5!R1uanL zT$QI2cy`T?@Ks`p%C;~uL6=Psh37)LD!U{$C&@3Lf<&^VC&Y9!abuwFVYq62K)@W% zF`zOV3@@LPQ>;r-iJ9r{6cA)8z9PcZ0D$_BvHkP>PK+Fk@<201NM-*Dre=eqC1d{N zU+i@C?skCtN=MDZUt|+cLGZu6(EtgIBCO0!@xnOd-g0_i$cUga8gWa~Wf95Fy&Sq# zHbyrz|7Tywf8B;Pzm9BiptH>Ukdnn+$F2L=Rw2jRz9h49?L*&1SM=+@X;G`EgI~mN zGk4erq}Y*KM#y*|cD+x13<@49uiyr6sEL-ZxIXwVoq&iu*Z!VZAZT%G{_y1Z>7f8a zXwTB_gnOk@Zn-%17#9CG@LPv0N%{uj2 zSd_JNbvb-3>!F_d=C{TzXp1(%CGzyU*pImnW&dvX_v#Nn{M&2BI5njQ{FKL_c5SkI z873=RPIM*iowAekp(b2gg2zwIJpkE{ZPZFk1JQqlT>Xc6o%p+W$M+uS2q%OF?1Hun zd^fY*I#gA>xu|aum|UX=YTFi%3tG=#3d(oQMAm*JOgu)WJ{t!$?G-8a5|F_DSAJSL zJxCgpIZWWY6@6skHo1j{vBHk|**)!@mB*L+jXO`xx0I@*@d(3iXot_}wCb^~hA75R z1COF=xGZM!u3uFP&iS87&D*dDN|m|x zfjBgtS{)}q_HPkn^`YS-dPP2v-+X{%gP$})9X@L~vEcW@_R&e9h#&wp0yR(7TAtuV z8b=}1-3X0a6!ZhcD2!XYrPdvTlo14vdI7*CP#smfGn&k=*@LnM^HKQ{BKUj)%}h@l~cR3|?FqJ-)Gfjv~AIvLE_MD-T>d@bMVGY~_hcy0>ikFB{eQBZNo0qvEg7 zmWYlhm6BjDL1UVpZ8!&B0-0u!lex^=2mHoTav~283m=F;eboJ=}{beHj>*lF? z_ogh>mK)+tAJLB|i_8Z|4!Peo^jdIJ>rRNFtlBvD8!oH5m)gtIhkcEN{rw<;%x>Q% ze(0R>yRG)1Em88ep?+U@tnY=iF}_)5tM0q@M?%o;tF9prb43qY%&Qx@XxzAW5j#@+ zF$){tRXyZMlTT<4wTt)d$6W*BB#*3qb0@RBNErEV=-z*gFls0-bt%uC;yuBUW3Fru zIx(2Kr^~?f58Ni<{C9^YfAtsp|50}#6W`1!G!uVL;W~!$EKV-Gqlt5-#{W?36B^V} zY6jsju`CSQaY{z9LkN+LU^|mwKQ*k!5VDDEf)%hxUml;*FHgZi(>kJ2%gb9Kawc=3 zlrQVfd?JEz8g{QNrDHnD zPX0kDChsa{P!vT`8rFy$X=@eNBvTjHZ=vfyw(^ocFJSjuagqKb6YJk1Df}%F#`hjo z+z-u)1$0=BIXQ*fQNq4ksO~ z+#vK@yT!{Yc|@WM)@nyd<3(OvqMy(LlJGY)lV-L3|pV zz)iFE`*#P3WU2F6Huxhcf0O4TwTnQBkUi(uaNq-HT;0ftbw!sZZHyJ)ab&+^zoZbh zwCO?}BA__5%w5)*elge!AL9_@6zX}ln7)JRcMXV|bLet;#NT2G3#hESj`59Zo&<38cu$7Zo}Y#`jMLiTi; z-1i;0^f#d4pYY@BNllHsG1;aC9GMz3_}9_eR~dFK zy_<^i+&ph;PP>)<*<_vO9B<%!O%3BzY?ph4RfM#<^X%7C&c4&347jizX}`OHN-IU$ zDZ>nU#5hd1&_!(SS}D&v)PK|K{uepvM30&?bWtWAr&$r#N$0UkM7gg=XKpO~R9spQ zQyp^u$Gh>seq&k$yFFSnvv3Z!L)E8O{2n@e>CqQ!>G+=dM{uS-znI#OCI$2wM_3D} zh#uQ_F-$bZ3}Hf)+GTpl!iO*@E>hg9`nw?IW2}vuA%D9cV1!3=npMxS0lPyLCtYC! zlQY%2gX8(BTJS9FA~p{@%{pJ?4JIQBlroBmuh zZ}|K-U%L4h8Y}?VaVjp|?}1L@U7) z*k?I)4)`%>{;P$QC+AHfstFCy#IQpL9dqUIoitg!BrL7pD&Bc3&%HAQ$yA;wV!;@J zQl=OoR@qM~;kHrx!-V|;n|WJwo?|z?p7vI%kIsasH%I_1O2DCSO^O1S0@yMqN4;&G8@MsTlK!dxNE49xbSSVSNUp6U>P2ClKkZ$eJ92rgfuNl5aCj zl*!y?*1~9VFyodmK%O2%0P3v+g!4HK!>PJIEQC`#;|xK@+EGhGm!W9NLCNQph`em{ zL{gg|{yY>V3ENqeR6#A{DR#3|5s^p_G?J*i@k=6sA`(dTf+hC(>GSmN+a=}@vTE&` zxMB0M>)Jb+?{+k|N~x)L6S4Q4fTN%tKpa7(SzFwwQ-cmv3ukQ6=;)L2;8R-Sjj-Ln z8v=Z^@djrMcV1WwUZf=+NjO8dVM^3bbD6bHFgpQA1_#x4o;XaN6rY}>@p>>W15gvmNPTcJ}jZiVItv1OAGy!Y4e9v%VI7N50+T651YI6q)M?@fq77~d9~Y{T?xZH{ zyNWb|{&6YJG7}`T6#bS!2x?fOX;d%&nKy&1xCUd_7!r~0Uv7nESM2zv^?7g`6QJL$ zt9a`Ai4(*Ay!y>~AlDyr)Y+W;$Mh?>;g9X$b0cW4GVDsd8KUp(b|i0BoZ8B_ak)ER z*KDZ|v|bG|K{C)M25kD`XA%7zB2O1Stx8n+O5m1^yW>tD;d1=g+M+v_@@8kxEO&%$YgKXF;8Xq^ zmLXCY`s9|oYZ|G|=GChXwxg4B>&eB@Eu|*KpcfspcxzzojiRh|Fe>Z0`h{Zr<{)4L z7JVoM@<4~a8az@1=2w{Mhj&<3o9OVkeo=}bBE4(d>Aa9Hvjzl&aL+gwT^-n+pQv=Z ze*IUj|A7)$+LLSi+3F-`g=JG*Jv zZ2cTw)Yh>ALAz@2hI-8?GC6y|@Jz+P94V-jEE@CFSCi1Scbk3h~N%cRa<4xEyi`@0el&_{)Ezu5HVfu@-F( zGVw!n1yPq`N&MS=`xgT&UC^x{&oM7W;^;4bwA89#Y8mz9H_l&-O-X&a`O6(uuAeqJ zfxWdsWbiHrxsCgOGc0UdtZ~3{3+37nko0-(E%x@5nEM}R^q9#mkosai%ja;qux?3s z3MipjT`2w~oh;4^O8vNSUOGMqa#75r18>qNn4__7s z@XsAR{~S;J{}X>!<^EX;`tK5$uM3DkO9MN5TcEDRTgpn$6p@LIgNT9XEycqFkOW#9 zf!07-*f{|T4tn;^)wmUdj< zc}a9ZM1fqO^jkK7gy>Hddox}Vfwux8RVi5_AuC%T5hpz(ojwBtBN00%y)K6V3p*<_ zEfEs~6ElE;8NkF$$H2kG%EraaPW1POgb$vG$JW4*OJ4ZP-@So;@sb$Z+go!108UO$ z^iIt5R<=d}Movyn00R?%iHQzWgU-&`(q8vFouwV=8;QSY2m|f(ZB4B0O{^@5-e~IT zSvlDAl8}JPiT)*uh4nwgE$!(4h()h&WdZoEYYkweX8`<1WhtrueRT_qzgmC>j7tbK z{`OY3idI(U{~8xDb8`pKu)bvz2`RAtA^uNQAm}{=ke7ssfsuiZk%^9xMUjz}ip5@=~p!~qbp zGPkl-u-4TF0)&B%Ci*~mQ9)2j-^u_et7~gv2SV8Ys+AoP^ILNV3rjm9HWmgxKEM|f zb9jfX)HS-E{A(Xu}1)L>bP@ZSeq+>^ACmwt_8P>~~ln5vO`M z2*~{rQiKYVT?n>hI!~fF2cLewM)42MZYv=^4!})R|S{x_D6T;%tqtdd;5*fn})Bq&q6{%EK;GX zdW(8c5*e`qJ-{$ACi+N;I}7Tk=bOb^UyF&lv9Y>{2ug#EJ;tpiGtrfW2z39*vh0bn zY#l;Ax7#tT1l|0^_9(bG;*3+zv-Qs!8t5Mx7guK-K(cp^7hti%d4&mcH!X5E6EXiJ z#m5g^S^}i;`>LVsmM6Vp4M!02I~SF0jafvqig-5t{IYI^JDXWo z*Xb?rk)6!=Q;!e&*O2ewWiW)u=Fh`065`78_XJu3tz6@!R0UHD2MB9d^>sC?2hE>e zzK0;c%#0c|*6Cf_Tyf3-7Tc}dRJ(j>sgXa^3};n(joxK|`wCAnwHHwH*_J81wq3m<$6-_2ttd25P}8?F z5K<^$xrtWGA&-FE#z?l7=ni9qQ)7lzOPsk$fQ+A79~jX2F4?3kGpz&Oc$5FzWz^^wn3aVC=o14T%Ljbk7qPYNByI^VU=Jp-W}rR z{ZiaWE-y1lVAiwt^MB&Vly-~4cK5bApA4WF$5s=7E61W(kA2;l1_?7KILf5&?Rg1f zk!Xd46n^%8I5OhA-V*urp{DxhR_Xm>5$#H9^X*ZlzY0b!bLK|ej8~UVFM28h`Pr>M zD(J$QX9t*a35mxhggtm=~3m zm_9!edN^Fqo?(s4tatlZYj?Qf4@ZUX_ZIY)PuwNlbs6^Eu6l^8@w%iUM?>7GehtbV z{1%#nQ@+KiJYa0avJmx6Itkk)tYkSQum0t0nsX+p%O}?b2Wbxfh|898o6to?8BS&F zQI1`&>;cw*Z=_%_@S@T8O#2h6b0 znF{keu@Of*=QTDNs$Xae7FpA6t6{4LevHFFK&>Ti0Q_En%XqovUDUfY*h{2SpLM%# z_JA%|3EQUN$YBg1G`i2+l@$8s(9}lKz0T#a)1+8jBU=w>@BO2r)?&^QuV#c~e(Yef z3f)Q%&~!SfQ>CS~f3W+6hZYQj2(D}WO}PIHhja7~RbNHj&p$L`a{}E0U8G0?zq3GpFS_T$Otj0woj^T zp8K?TpPjOsw=B9k+570oUu%4}Ht~O57=Z2X{rtX2MS7!LFJx3Iw!P8Z&2IhvB-EYL zFmmA|1o+}-Yu(NyQeS4G{Y>GC)>KA2xVk9V!gPU_`^ORKb~wTwupw$8sfgSYcB|8- z%Wg{FL27unB%;dr|zaWKQJkv;P70FEx> zSoP}I!96$JbRC7k8n7ZfhE_lCeO3i48JSht;?{h;IW>yuc`SO;nyVrmR{dlRXm^gGp!d{mS4yXYYC8qQMid&5dSW8x-*>{T9ldnecn5nb)nSPcN}D z@s0~^kSmgcKS&Ke1bor2%#GKzu;jIdPeOPS=@5jyAs*%WtfP?Bz73174Zd*@9(9m=W>K;jM?8akTQK6H?mg;g7MYlznDfY^=bJ#FJG|(PLF;hD$if6 zo}gwp!K`W((BJs8#i}T28u+(|P_bc3t)p6wsfnFg)>|$o3p66$5N*GYmB}V$Y5p+Y zVgnBwQ~lmf;3wouIX&R#WlV~$P1`8+7@k;_)!-!2sHT7+C6HjCZ z{`pTB@tIeskXG7nS)=-Ovo|Za;zwxOGh}O=3qyi&4m7VhY_mSQu$^rDro;^F3S*uz z=KYWG@H$v@Ww`GALuO(JP#v*t&D|eUF=ZfRL_hEnr))#GTD+?mU~OR~&Ss4=LSA#d zlidPn6HOA@EMw7zTXlDpTnwb7`{nD1mV<&AY7&}bZ~FWDO-!xSd!{Snsb8aNo<3}a zzB5&M$=dPm?61<6Q>I&1R@1G6139{Hv-veA+}gf&;?X`otYmz z^r*se%*08}W_bzSKl0Od-1LcSV5E2GEQd#-El2uB;)#qtxRpPtZP6wdy}tUk?>z;z zTp!TJW0ozGHro`LiH#)*Lj8VEA^l@)c1HDRUf0Ykjop*v<>0~{h*2CMntKHI^vOBk z5zXjhqI0aKb1?> zF{8*%TRCr6Z@Un_8N$jZIPco=5o*&9y5GKxweGr(iR*-QRXR(+L?7-24~GJW(|c># zEmv@wSUJ9%oekBRwH=VJpK^!)=q^1v;RMWV(IECF(t83fR9GfGr+)&x^q>5_MR4vayjpC zp((*{dx+Ep(u7QarD{}2XVOel*Z?7cH(um&0bZK`@16OGpIsB5?!RH$I(SGu2X2n3 z7G!{1negHkk7bz?;1P}J@K6xXnWq=4>_E5=oS-i*E1A`Y!+j_lT=zvCUhRB}i8>Q5 zNi?MHfy_;gX-BRvu@)U2i0ABF+D|GkIOe&P2Vp`MyV+rlmewW5WGhgLv zXOF`8{H!8ts%Z0ThnB!N!-UQqS{_%Agz3IUzi?U!cxIyBef4fvm*8yB+%#Wxgi2>= zTSv<%dz48wXm%~6br`a%w0e)gY&xJ_TD7A6e6efgSINNkq*U|>Y6m2mqyAVc1#(-Jr zucYC)zNgT{vPnONB$oF&<3A%=QZ*)XSkU2&LfJ_%l}Rt>?uSs)(Xt{nQ(q!)R?l!T z*VFyMI5lS&L$3H)k3OxLaNFER#uzv`^ZvSV_L3T;3=7t9&f2Arm+!PfdMb4drbd8p zdA!kLQ=|zvIi1(~Cq)IEHmQnX`f5zZT(|5os6&jzsU-qS)9}7uGd8^zwYZMqd zpu;l;CATJAz3+Ue)c0FW##rGB-Wx%5NX!flIc@=xLA_{XzN&R)oV6uKcZ)@UGhA2b zWeeMET(y)9BQQzY_K582M;Cm*Eh|4Vfy{*u%~hk)HFqBNxA|UJs0p=v)g1_U*n8tdk;AVGREMZ+j$ghK&YZKwH< zANyRvRKesy+2U78$Gx|N?}Bht6Dm@mGREAl9p1+i7TY;wa3SZPSiz!-CzTduP>GYP>o#7L3=_*b+DjNC8QX9onIjKo|&ka@)o9 z?G;LHcrve09?=|f$>qyv$1@|Ep|A-9JNfA`su*W{x$Jqx0pW?A#_Wmn{Ts_RWbKBE z-wI_Xxw8(Zr^6lTRZ+*9&xMp6Oj2g!k?Y;?<_Dz|`bPAfz#T>0Ht4MG>H81C?GiJ| zqs?4V-+3(i&g+|t0m`v~3pG*qW)%;zpDi#h?y}6CN_Aw%Dl>ma)Reu)#RIA|t$HdX zrzb1?HcGl-p3{jq>QUjuv?dAzy4^ zBzE?{MF&Ioa!KWJxYbrN);t%xeAf(cTCS8&5Vzid%@Gw#vwQ7~1<(A*5lM{NFanJz zy1td1%0w;tRYMR@Flyhx1pcGp_O93kgmb2xe?8@gWs@;P7W{Ah2U%2DzS(!Q110t) zDtjvir(0TGtio#i->%8!vApLs%X0AYUE7hRZ6{Iub@>TTxk%)iz3MjHNt8Pd1o#eN z3|)}6{JF#-t3G$?-wf9HUxyPy3uU4butdbeCbsUD4YN81vvsR9yPttSZmw@;F5M2m zK?Pd9f6v?IwprigL@ z8`7A6QrZs@FJ1*rMW+Z=!V#T-^Qkb;xwhEKgOcPOKnG?dkxB~B>~so+3_+|dCA_cT zLC1u?d^{T0&{}wVQx8*Yt-;=jG1N<$#XNO>$VUcGhwlooZL{#}0Ce0R9*&d{o+jk5 z?+C50VtMf;;%-!>nyMRamV0scxc69o7bOA9pRJvwp4sC0%nE6NQY-lYtc0_~_PR~W z`ae21^-GbZE&&!U4DxRtHKj}MFk3L7A#bMC)ICpRdK6|e{b0V@j#Nbx%;~*vfzg%{ zQ8)mA_*9&y8yPl)xLIyJwqFub4%LB1i_u3`4i2f6s+#caW~I%YJ!DVMU}`*IAwGFV zTpwKcSCVE~bsYTK@IOz%S>%75c2o3INmjoaj2j20I2J^oXKmNt0D-h{x7bOkN<|HqX<%zEKYrvnFV^ zy6_&{5pdk)ve3s@crm%YXDdHzW$w`_9J=4#aR)i-8_Ev5FWouy@Kg%>5If})2mbDv zJ}{;{)hhKPc6RI11~0#315VO^=*nELj?gcY&1^jjWZX1Ow|%|1!L6ERC%eIlC*`z| zI^6J>ynn!kennqXWAgp;cSU|g(jWN24(%~T@zFR|{Jk<^X7`grhCRWN{?m+FF{Q+( zoZ5tO85pR-&5lZL0ALxY(x|KTur0LhvY%X zkAp;<{5XaRN7p#MxUxv6lMB>mDT5je&ZF@IoCcB>&%%LXqUbm(8b&f+U;EF5iHyJP zgW(<>zSa*#bxF%RAC3PN)FN%6!`1udO zl=to|*2#7+OfROReCy?5Lo0Wkm<7P>MmLeoF_Nog&wZF&diLq;XQU^Q*V+fN#izOm zg^6>gQ%uoMRY$-CaVFd|6@8@EZT=&bdn??2jF)V9(raRIbig2&*kDBQa3!gD6{Xy? z34SGQvosD=onF6k*{qaY4OI*@-6XXCqfjW+Ao7=~k5ULMK??ca-Z>77>M$l6%PYyp zsmZ*CjhZQOlo~l}fyi4&M@J*6?98XB^$HKTrm64Q!#zC?*HUUrOLD>v0b5S(-%qoj zuiY=G6)RtSmXQ4(`t#^b^0+S!0J-q7-wL%iN5mCJ%`!{c*{C??4grS=K`%~8tw;*r&ZiK2c&0WA=Nago+Dv~(mA&X$*k-k>hF=rsF z(;*Xt_q@f~FP)nJvkJle>8JRVvu{xp?vXq{<0+_{t}tO^U>>-c+q1-~XfW4LbK`$Z z-#y}HGjo@=8`8tsa$<)`pIr9?S|92J_aT+1{EMw#OnRu&PrXuujB3 z3knU8RG;cj&j??x{PTv@iX6ri`z<$FpALRYnuf~DPisPD$*&i-$E~%zIv?r;NACvq z)2AhUw_$KFF@DOWUSEgGrbN!i3hV{n@8C+ButH$ybGMPza!WRxYmP+NS-$xG+}aa>wK^@S zDJ{+Q6X)ae*2rNPh0eQ(F{V62ED@<~TYJM#&KJNt|77Vgt)^$4EcieUuZPgjJQ2S* zwrR(qHpCxZ(CI zFb}@^FgB0VbzuKj*DPIrlVG|s=WUF8HuIOfB5Cw=+mtcVIyt>LM&&>sW3CBWY~Zch z?`7}z(@9nK4>>SHeyR>lf*jJoxD?D281K(VY~T0GgD{BNxDYC6jS5|!F`Uc3z)mO% zdHTavVWxZs?9YuIltM+a zmLy9h*;o~ZA`of*Q2Xv=<4CBc#?^ZEE8*5hRM?)f&*0CsO9S9J)a$c4@d&TnixELkdJ#oRSX;@NR<1P{f-?CjcXp_)`9&iglYE@4-RYr+OUL6a=< z6XnKLL$UcdS#Y5A# z8cah4|HJG8^jr8y8wp{?2O8SUFFt)4B1m8H6pEyu9m-OMJ|(^B3Rvhl&RUw4Yb9Sj zl8iZ(Dw%>M6>S~3hPD-wpwO~RKXM!;LBbVY^fD@lh<%#06Y07(PjR&@+hh51kD?QF zB9tIeglU~=o$(ZsH`o%PECn#nZhyJ980;+rp9u~3|V&M>Is-4l#n zdnwftYH_998$U)Sy4{(mP&DS+@Do%zwu6F@Q~UhP>iwWWE9;303#DfkrJtwZ9IBKC zFVuNP{U{)8co|-5gFFe*nD>-HD?l3d#a}d$mNpPfqHoYng|pr-%dip=9q6g_0~QM6 zJjm#Q+p~K$cEWN4)-wfuQ?iJ4K zPfMqj^gCuVdFFNm7{mODlgESUX`3PhR*3;T`kVx|N*>&gx)evEL@2O;pD$UU?@8J- zsJjh+p6F5RXd)6buIwRCCru)!6v;3a)XGfZQBL{l7+yI>&rD5fQkWW9N}E8Vaxc1} z6tQL*v3>Yt@e56-_ftPVm#hlsmhz?az})$Qp5-f~w*)S+*Q-Q__@BQmKI+ORCi4(u0)#T6ORE#2I}w$d2) z;bF2Qbigkbpxq?_dRPL1Bh&DR&-nlX*BnIP4R*}Pl^%2IHky8Sunoc^DQJSfJ-jB+%6xvTy|2jf+P7}gkuBp3tC{IvYrOY+o^NgAJ42FOwx_MN|xo?G6is<0!vRNmK7>+WGy$LtgZH=cdlHX!}cI`3+3OU24qrsQ(kTu@uC1 zSDWn9CjZOA*P*0v^9|TJ=!(n5Q~r64IW$vos1&r$9mVHPvh3_}C<>a#)If;R?q6W) zK8!!y9Cypv`ELCqcHYwsy$kbmo?(mZD7Qu$d4SWoP2TkYp#k%|6Z6vT^k9=L&tx1t zdp<sZ{~h>JjrAKBkgNfMaxkmh{2J5~RKnOTbnz zk^_lEs&p5MtiS7`eeJMG_>2uf&c~9nFt@^daVJ~hXAx8SGDBm+W9roIv2xvZ+u^P0 zVXKG7PgV`RDHXAvyoz8O@Ds7E54`2BWjZ=cop4c>gr(!FvZQyhftI@<58O@vUZzBt z8eVv*Md}wNhuu}=&{Bu{J~SV=z95^iM7>s9FzbukD=tv)jN&U*M{;sB@Tgc)!3v zV*A;*-P8jJeEkp?BkLN)A}1nK9`=mbJB=Qew#OHno_8XHF+pdy(+hUJM@;$X0lKne zUf_`&I<}KM&@WuPHl3+kE72cjJ#Q9x`PzBc zo}_4)jvlH3Wg3m~^ooN&XHb1ETR$vfM<0eukB+dCD?6aQvc8zs`-Fsqn9}D;4#lb) zy%RH1R6b0dUAjkM!OX#Y-1a!G*K1+#b0+Zt^g7E+SBBr#VJ;MNy;czJE`^nZWpeBZ z$XR#W-4F58-54g;z~3SCIcqrU#QjRBV3n9RC!f2M*n3}EP>-l*ybBqvI9HH`#H-+0 z&tz^V5{+EF1Hd|S>Objb;v&NTQoyRvKUu`z&^z?*XMvY)7{#DUiDQTy=paxiN}6AI z_f2V8!o$vJcG1JkT)jmEc_O!!N2Y}fiVtd#yA4>=y5-BwNsxJq_Wae)9anzlrouid zbT^$f_g8a9h2yKAO#^b#P{WVnL2?Zr?p*qbnJV7JmhOzU=Ih#WX1kWf8z_Q4c7>Wx z&l{al%~^wL1P=Rn#4EogVD=DFh(Ze;qE>dZC5fW1m87e5)B5Un5GBXqKJ`rtObz|s!|c%Yd2 zWvud5*NUGBa{|EF2gQyZ*%zr)>0h#Pd+T~{0%Cce`Hh&GZwVQeo^mr-?!B(zC(F_%lH7rEVaHKA%VJR*SG&l|*roXayfYO-$f8giIcihL zGYdR8W-=kAX<)B`i@f-y16sqRVO@c!7z`@WI&+xWQ@(lKLPzh`sf0gjHs)dE312QQp~o<_TJEfeVv5b`h29Y=;s=M+ zU9*RN{lWwb?hDT7fob8bQ&@O7?!D{7@;!+wA}Prcgj;6j6bTXe;FDkb=Z}Kgu%5C#wrH3~92MizcZfxcET!$qOOs5NO9HI+h5=j`Ik{ zJ5Ta$z)145^zY0g_5-z4Id$Mqs!Zd^Lcf!%s*+@>IcGRATmRnn= zWHdWIiES-{cg<$E+!9CO_ZM^8vrRQjJXah-Pa;Xf1xnu12!v$j4!;8;rhZuk#b9l? z8_(@gP(hF1Tc+Ukj3=A3wv?Zdl1o5d>FDChTwhTs$ljAYu}%y2QLR6I zd7YDu`boFROc&O!F7R6-#+POz#V2|#KYSQtivYn_Dl^Hy23cQqw4pujmP7dA9->?nl7+x^(lj@)E~}2xoKtLa&9A- zaXVV0zMb@m_iQZK?H=JgP)swU$?BAkqzyb^+JzhK3EHlI`aa~IcPO@ zSER0pAD=4{E+d%CQH_&-*MhFWldR7L?NjcC8T%>id(YRG!F-W0LN-|NepV&ovBP*@ zXdASthW+s8KmQE^>EsL51G5_+E`g`RJL(2IkoLP+(6-D5pp`k)QleZz3!Vjba`53OK~j9r>LV(|S~`&`A`!pa3tM0VVP; zpjl7n#WYV2b-y#RAQ2TrlxfpOwgE7W2y1*+(WhsG{(>bupO1!8EguFipLQ$4X+=Xc z-&Jo5yvC&0lFH`A<8Hx`MZNn+%GT8P0#T`ze+4<4+;%X_^-{C+i_4zq1L_h?eKuKk~)Mv>1 zPVz2PqQ@sKunUsDkz1LZydC$6k(t>J;qnK_Qd1{ddnk}IAw5-|u21M`Yzng*?VW0K zSsRV(Fn9sL2B<_jLXHIXuftW!c*)LErq@S$)+EX4B8TIz56uN7657!eM`PPNMlHA_ zVm|w>;9{W@wQNr;oW^-UW6iam>YugOmzU3LA9fwnmDhTR&88-G>8#>HZss_4=`f%z z{c1c0^dNrQzF|jh>teHQL(iNKO%sW3-DxGooD5;wb{vKAJY9aA`1GLW6n8h0`9Q36 z_uPY8-P}cE+Vo{hlMb*A0O^1ycw5{5LDDrw$JMRj*tTsuX>6x4+SqQ~I1@XK-PmSh z+qP|+lRMwKf9B_`HS3&tAMSS#zir|)!4n`Xuz2nl3e2>1xB6Rvd-@G6AsO%&;^7^~ zVC>z@Q6W$s2Pj=xBt9t%CG%4$YsYk~l!0U}D8FDG8?8p(}TiEwkHY2OP|1e+AoZpY$ zx6*xTJmg?PP(*~JYH>we`!#R+V}*Z_A(JkyU~xLW4F5l)-qWaeoB?o#V7@|bUa}n^`4&Nbp(w?1rLhH_1g*@P#T|>h5W<3wkI_k zD8Qj9r86_q@zCee4y(G5?YcA)I>9h={u5}`9l2jwv+x?JmUnMlA1K8;(Zq3(t7jw@2EZ}^W+mk|)Fu;aC>`OLHneat+2 z(q8goTGrvB@y2t{#mWoR4DeU-YF|3hz`yXnwiSuK;X(R*;nTHM#pMayn~4x42v`1H z?dD>Bzo91^Tp-HydX69Bh1A~g=#eppbo?Fv6~U}4gN4=M`fUre&oB}6yr?`WDGpdq zdj0_{D;Q-Rq+aTGK9FrK`V%}CT*s8jyYCF?`?XZ4qoXoUQLB`lp85Gpkc?6Z5TIk>3$3~RqFFO)Jgj&h~66)Qu2(wG1HuHTYS zT{%Or@$n-{NJ%@i+`@aDoTjnw2dKhf1}UOHJCjjV1^J>D7=?apFvy<$m)?iro~hs6 zFaCuwf-0dyi5$*?jJDxnv>UbfScA+l_iyyQZk~F9GCwn|!iuDYSQFJZ9AEC0MQPY& zQyhLVO@2n5>;mQrmyhbs_Do8K?}du~`~e-2&P=zwci%EbYF+%AigzV`{1VzWwnnDI zin!6%X%>}>D{A;v>Zmjcg~{(&_;_P&loQS;3RNn;;H>7wNTy?MSB#{DhF}2MUVy-$ zA_&%Ui9fb?4HK%$g*F&hLQ4EbquC1m0ij9o*QneISj;eC2)wlgZ;%bfP3z`!y|}kb z^t8=vxVM+bvcX-Tve9!3->rc+q=Ji|sw-Z&wTpb(ACugxp-Paw;|U4vLUO(fNaT>B z4*j{Gxl_Z3OwJ0~MyxaqI)Zx-ez zrr(eZu>&4`d?BNvvc1?>j}Fa5r){oDL|s?u0tzTyMUBA-ztOWjH6GN<$4Uf9H@Y1d z9l6;=vi~Q3eQ-tVq^C!P{M$7ishUVrKL&IwE2z7J0iceTOlT$}O2rGcIL2GDtRtRM zTL#t7F0bJL@Gh_5Ma|~Ni^ZzR71%SEznJJ9RyN<{EVaKHZrLxwbFR}MMx_2yZ^37l z#bGh-uui~!`gv#+RUed^x#lueH5b$xaXPA>?(IojAgO@8C|ICF^pR1$h&#}13u4rO8_Rd<8q9cnZAqlWOd7^ZBHr=Va(M6h3^SPjn_H30Q=tsahvaA* zp++CxjwZVAk^l@nQ-WH)k^lW>URtUK@N60yL%ijGbZ$IJoyaH&>*PhY$oUB_{@EIN z67dd+=L89J7aMO(_F0PhiFxJU)icD@u{F~();74SA2mrYS6uFtOFFkQzlbv}oYwo^ zz8QXqkJLxprsm<31ALKO>NXRz)KMOwR^pkIOfYsdFg}!2wR|6&?~%G8w_fgg^wY~Z zUXAjrjD2evdQ9AjfaQprJ%-_Ca)%CvQ*#Gty+80i99^i?ZKXFEo74|pO==qMF5Zy4 zb29#-OZxV{M4?aALIC}|4o)1faQX}n1e(NLKmFz5d?`T&LbH&I73$CbzpYQfV$7tD zmM>cpBa3{r1&SyaqC~wL*XN@1Bt`*LIi(2oyqKA}J4jzAxT?~+b z#|5iHRRDhuB=Hh%{zWf=mRxqOsD>PEy8DjhUkJ}$yy=8~$8sw9pJPV5qfI(t4vIhpaI- z=vc!|HD((BMtr8~z@AG)n<37XzwnXwulr|j1tlKEZ?#RGoo9HzwSH&2`J=aN#PmP*lKIK0DH;=oAI3H|k!kW%S7(bAW?(7(=#G&g9|P|Y$~z4;HP=&F z0>+H7v9X3Nj(H6Yi5;N>kO88$C?6Hw1qB5a6^Osk37N~|tK(}hF)@#)vVywdBJ;H> zb--~wR_o1QUta~>ub>F``0$>fDmy)HO_bfI(RgBr#xB>JL!LP?+8yc8bosPa5cfp$ z!7&8{_yyJlbi}HlJ bIV%p6**QVWb4!VyqU1#~jD7I-hYV#zu@Gqc5*;KIG z&^5saXiCOr;<6h~Pj2sp^-RfNZ?A4FEnZ3QHF4)HutQ&M5t$o9fYCX@H#N8nyAUCb z)qJ+rus@1C$n(Z!2`bM|_;vV=+2neIMWex~oFO6L+0)Qldi3MT9RDGjQt;}P=0>m> z8#!#qFQqIUzkmPs5SCK?WI}705gY5W_3R0ldhfW-GS=K@rkN@E81MNG2dN>b=c_pS z9NnEDX4=~TR{3JTUDo+zZMB^sYw3Z*6r}IAIA;v(Qwsc&zjL61y}Z0cMn(>BR99D@ zpPMVMs1WPbs`v+b9IVvT)Gs;)2EUruX=!LQ7&O0spX%)uL&A=4AlG=jg;lWo4zEwRL(<4sG(^ zH4+C+V~6_V5O3pOUDeen3C1DP1*cb6Bt%5PU$b!NQAQ&N2UJoXc^_qE^bg-fM~?5y z0DMF!PAFJKB_+7n*z{NkC*t@3_=(w2y(OHQWnDwVoXkwbw49%wf`rCqUnRQ!pzuFKR z&Es}YEcuO$Ht!YvAOyW$?0$4V2UskGl%<(C(k&c{k-qWb^p3j-%PY>lp^ye(e}d?) zpY_?kt>UHQHQ)wPN6kR#M9fjJJdTXOWl^5Q@CgeW=<8RNmXcwkcBkpECMmbOr;c+A z3NppZI;vDGR@cZoSX=A?_9Gc!a3Nv45^6FK4Q{>kdQFb7}p2-Na``jkqp-R z>f&O+P#Qwk2Ph*VSnmB!%qA};1}=Mla}$R^?#)&f-~-Q?=a45!8Vg8CO;uet$DmjA z4|C(++}qn58ykCgXk4`ml^&TG837YA4nzdU$@!S6ncx%_{_YGjwG#K*VGi+ksx0r ziy?;dC8XI8y!M{u2}8;*Y!h}DIwAGPxe@kiot#v9!0Xk=;YZ#Pqv=T;=_x9rW?-}P zLViEF^*}?E42XzVgn4afXfSTx*9)WMbVATdO-{DAx6c9>HqSX`{a9A=)y}Xll_mce z@1oV(-g4-AynTHCY7=B4V-?VYVv6Dqc9lKMeReU_dtgef=!z`mZQAu`KM5LPJ=>8g7T2pE4 z{UakID=U1=%vB)F%A!mh^+?PS^yF|kQiO$t<>YJ#41^F;;^N_XdwuNybd;dD!Di&sml06+g!26q(i?nFB0uV25a ztE(M*R##i|^2D0Ovu6*m8LOD9Is^roCnl70geTXD^IbtGZ#`e!%e6tm`)gyf-TlzH zRjc!C{Qd2XgV$UKbfFv}{^!xB`Nqq=ptZI2?d`3YBb&?R8F&8{^b!C?=PD5@!Ol1FPA7<*lL4i ze?VbjVOtyj746AG7Wew&pH7uWA`)u=S$=&dGyG_)FGg!d;K>N3X*RBq;k+`YD^|z}>9rhL`3CU@ zG#EgDn#1pAqph7f1D=OH(&_!&6YH-9nu!|dm40{r)*!-`OQNi-?7@N&vGV*TDMx`3 z)FFB$Y_LU4OiZA?2%0l)V#fZ4bvlAfUl?LS4Is7z)*cb>Wblhc4*l1UKGWcY1Pl=1 zvnngAn%=$N#^#j>&b!;EF2Bz<6b@=u5Lb=wgrhv`No6%mc-~M;X^#6? zUs{5>llr)gdebu9?7K%k4p+|<0SL3o=>R*Qp1ph3s837xGxJ3-jJkv&FVr7STftE> zRDXtEO*7eIdK^U0V&vl=jIixLZRWg(6cJ2x7gF}u(9sC+`5aD${>H~VCRd;MW7Ssr z(qgDXuq&J*`gm+;ZATJ%M(rY<|I)#BWP6k_K%}aOl61Z5ty4WRpEt9cny=9Hv83Gi zlb~4+BQr!3PcZ_U6N6NPQnaJm@z|2%GTyf{k-`nVs+6QutkuqZt&42b>)#t23!y}M zQK+h;qWpc(G1a67{L|2Ao7=f)RB4--V(Hnaf-z!`w{$zZ@0%+vZOPNqld%#Jvj9X( zL-W7>m*O{!RKxHa4>VNE>1^l~2wE|A0YJ9|D^8p`F6#$2GnG~Vp!cPbe`Xh4L)d9g zQU!?);{}FmsVX6agXyoJ6UG~jisL~7T=rKb`3Q*N*DAe$6}LZaYVIm#H#RlpSM^&= zDk}08*3dSmEjdFqLiBrkdk36-NBM*D`^jNCQ)FhjW}1b~{_1Zt(Iv4XPDDgRpOE;R zni^;_b#`?0Tth=cw=LQ%h>~;(`@%3qkQs^Yjz(g(1@*9ObomOTMfr|0qux0?=Or#^ zcXTCB4B+Rr2>^hC&xr)8YFvT=B3s!8;lDxkY-<;ZOJt)R6Z;{gZXEZRD!E`0nE+yOgH-~I{Yar z;KGzmzj_U(j1J6wc$yVSiI^EEwa)l`B^n$!2=)adW42-MSzKFAWrz(uulqX*T6QTA z(7*2j_Z8ZY9Q5LDY&C{E%%C}05UK%C0)|YF{Y))x%NB`}U7?5^!?>&A@@p{uAS6gm ze-XPH*QV=i;oi!mw!(4T4#1$Hp=o!&#&OP}8wLhg4)risSJ#)fw?H)Z0b`2S+-O|V?E4D| zFE9QNaQS|ma+J*}%-1d;4;|s3055q31@0-4n_-hsULm2Xs;d3HJy(J0`DueWTvmgf z3)vR9*o&{i@Ff!VtGk<kZPJaH3u<0?_$k3l4 zLfq(KVPRozZtle&WD&>Z>UjE8<#nZs5s!owAk>YJ%r6ny zP(wxlaT7QR@~9wV#PS`>-murV6Ki{W>)gh%TWt9_7)>n2=NcBP zYwyzTbaGt~i_~Ou0p?^!#L@Z8NNsv33JmsNb zj4KgN7It#&?d`nw7w*USPGDc_x{^q6a19AQxy_zov{b^wN1usshI*t{RDR7O&r8%C zQZ2=SAs%wn`0kxUu9=d)Y1mjJM*`JLR#sNL+$+;ppbvZBXkYvlFOND#vQy0^xyZV7 zG9ZGZaH{ow`z5Sc!L&IV=gZ_Jq{z=XSC7ZF+i$9Jo_Zh$+Amf zDP0b$(`-3SlKt~aLR)*8)p7#L7<4D*Lw~>VYibl5ywk0b+MF|qpofZSPM`kVM~wiP zmnfGCqEf&N^#{rWDpT4Q56>T*>AAVPy}>UILmE+4J!>Ld6;X|WT)4nx3Yt;#DLMw+5D9)reps7{s&j-A7eTitbYA;jdv9OAk13AAvJDLn!-^5!30Zc`&n~fO z1eve}vm)X!ktNf&G(5)Y22-wj(Qa1cGApgIh9K!k?wh6MSlT?Tz4`Y zA(ww~vV}I^vwe5xJnIS#8)-^C$Do|OH%UDWBDs}Q>)b^ZN@$>?$XQ{n;bC@L9qIWG zHp;#sC%_#MRGQBzY@`s#SQq@Lge6x2qgFgmuEvn5qoX75r;9u&zwt~62QE%d0nfX_ z@`CwEH;g-|7l4@u6!9Xm%KL1AOn(@vvb;P7cDSc<&hHTsJ?NLvp-QZxD*8wCUKUUA zZixO=S{D7FGv#3qeB<;0+zj-yt#~3F@?84sg&;7^Z_k8hi(=o zoHJ#;51Y*xu=GIxY}+=H(Q#)jf`Z9E;(N&_dAB;a+YJ!ZWn+t;3|_VqU3lXSLmfVc z8HPGP;gSw2siVft=$6_)yGYB@x;^w=bSpdzY(Apol*SD|cCA3$G5o$e+N22sT6s<- zXgC@9PKW2zD}TxMBbkNPG}b*u$A#!3*GoEz;(gg|dhsiBvA>+Jfqv!r`FX2}Cq_bI zVs9$@pYJ>4M;jdm^bt?J8=m1J!O)=nVS=9_<9Sq6nviHNhhx}J-n@nj8EpW4V!0B+ z5rHj7CnwLBnZod&+S+0Cbb&?{ht>#}gIZC4^=)k{+S>)h^Mitd{{7>2>|q!s1e_fw z!cEcr$*pQ`cK7yf&-0BSINs?Ef=UXX;}k4zm`9$px3a=JzX)XRk+gMLx+!FLaFuBc z(*oT~$MO4m%f3w^E*`{!4Gau^|NgB^!kaDNf-?-evbwS|a_BrCazjw3>*~r?NdDzH zZ-00HC5)Lx$Dj4i&dNI7*9RdJ6xi6-wl*W%XX`P(7ZPQ}vezRE7JZER0pND+<20*9 zuEq;K@T-$^Wz%*kQnR+TU0+xTZp9yS6}(cwR&xq+VKK-$m&Y-pY6vQ`J1WlmRg@|3DH9)~ddt zp|wv+&G(=4sL&%E~fqBt=Qvf{x+)RhGj3jrUVrF8p z8;K(y`BSWvxwN!YJj=c7%H-5hNi^R3SsT?%)BXDKdQVc7M=K)%{RWFf$dN=9N672* zOOieEHiurlSW;R#VbNHq1@;B;q2U$7oyAjGK|#XH<$6mg}JF$#5z&pw#d($DHHHTo_Fmks>UV^^9305}sF{Ya>gG(5+Imu4SQ&$_H z>!XkS_;AYk8uqRCPWhDHsndcq_B}y||1u(a93_ROr0|#BGFw3O{K7*9*I*Ma)?|F) zP7-^_Q7VhA$@J8Nux>(&n~dBuf*r1zy03u6lE`e%KNV7@5tJB>--*xEOw#<(q}Vx& zD=U(xEQnbp;kVD4Ui7-B!B7flVc=K;W>Pi;+e|{LqI~|^hr9S6erO0dY66vp-PzIX zB*CruDsrCQoeGX%GY3aUk;8JESQ^N`suSbB8?liw(xko}YEVPv!$1*jZfu|}Drs16 zb$HTQpnna=5_Mv7?inoSuGjJy8LP4waVt{J?iccXEOg$cb9+6G$(J;ZW&F z0$4~M`!&fIM0n25ZOVrdC=C-`8ykip$R$xZ+i}EBO{?LB#!jop=SN6ZQ6e_iFW{%1 zAijf{j<2uKD8JRH&E#cfvve$pkn_O^I;FH?7C&|erxaWfpyl9mB%ZRC_BL1q*Kb&l zAaP<4+xhuQA9Qm6gwt`SCn*VQmq9N;KZ_w})g^9f7RAmuJ~fq=$ij;J&S!Rm&xMFTypbhsmU{H2}X+UZNiYCH@Yg2 zLVM)6#@=gbtuw{IAlT*f?UU9s0Npw*P#j5`^7lC;>_1DaRO+ay2Y5Z#y%In<(hB}? ze5XwmNZWo-pP)DxY(Ra_!tN+M(24mK0z9r+(wbNxY$gqrVoo08e2ed9^Ao>IJs3LC z`Qm>aH!z@c0d9D1*akyGagp6!oN^|?*M%%c%N)(ksfok(pxl0dLLizkOURMW_vc~$ zcK;Gt46^dt+BgBx7d0)dP`WTBV;S19*n7XhhCRuUhIu?mPAU=<6qLoq#o``lND>i0 zL6A}vg-SS#SFP;6EvMD-*zF4erCs4SAoR8C6NR^1-`I$jhs`jumHiHk`=Zvy#0(N# zs&8rx3~@@@RZG9UHOdJKgWZXukAPRu@vD1XNgR%uRdxP|B8@kb`)xk=%yMzU5b z!zwMWsxmik0}b}o)ffV9n~#@UP~tK4Or11=Ad?K+-xqIX*yfbj$)@)nwU_zspsI?# z02xSr28zb|LL37xyq#tP0*-JTX+6k_b9=ZpQ4T(*s@Bs`LgdyQcfu%Ud+pX+U1;aB zZI`R-AiF*-P-!T@{b|BbNpZe+`@C|*AuD6f2S+dyFnB*|ch#F?@YBu0`N;w28uB>< z3zFR2f7#&9LYs8H6n9cG6uS@GfA)N?^N;`>Ho92jOA4OB0|kL^<0;IOE7keYQn5)B z5F*wHI|}!_!ioP{dr2B1uMS-Kgs6CExqc~y3o^=<%gRpuI$w}-7RsFOe1(3T-Q!NU zQ6^{R5{^=-bjXCRhwMwVt>HO|wo2;eM|^(s$NLti1H7mHiW|7WqfSW~Fwavk<(x4L z?H0}(%{c_->P9Z9D7ke?1D)5)EA4`PgQ3ZK&WV-(l?xMz@(F zzCwr0?nbzT18G^%0uNSmiGYM&@8>IMM6DWwNk2OW2atm1->vEF6dExxGu-%yn}cO6 z@4)A@SXo;$K?L^$3WmrY^>-oOvpj7N3`jCEG9IW-O-+qldA!{d*eI_B5EDD)-XBl% z+JFUcFEmP|06mi2j9#{Cxc}t~m>cHj=WlFoMhqv!${Nx9$+-z7&UzUf7^vM|jaYB8 zhpewCFCX{~PWnmuXikE?=r(*?tHC87ellCmPBTDetN0csjgMs!#@>TOq*NH`B$`A{ zRzXJNCSy-fCC<%V7}#6IQpWg*r@gTEEk^6Rs)mLrordZv!U)r6m%Am2!;w%JemPa= zG0D{aly~=gd$;%X^ZmOuNP-+qjl&@+#YtN{rFSER$gx8QhXCp?RJ{=|-@cFm(|=hr z8U9@BvRm~U1~38d-Mky8YsA>n>U?0?>|y4GZ&L$nICQHg5a9l-KY#wHdcAY?V(#BQ zTPvQamAYU^2&jp{vT&#~v9P(MoUiVL0%q8#jhTqe)`1x-%6i-(9$cI4emF$RD>bOP z_g?s9487-cgRDo=?->_IZv`=BB1CI<0*>Vo~F9kR81(Z@I@NvmrpE&EcXFbRY zwY0R9Wq%Nnq?uk%aNpf{U2k^S26?QY%o=2@(n*1^DmQq>CSKO{YU5jz?-f&IoJ#(L zgaNT2rG~K>rmkL_(|#z3x9UW^X{uoLG*$lb z)~MEN4V;#V#se2gWuElR_R^IjHZCbB=m#mRVT@Ju1c@uX3qX8!d;^#Bfvnx}RN&rzIZ5o%;3t;aDe-)tfLe6}=UgmK%U>_i(e@?{vTf16jI6ALL=kG~);@zgd1lqa5`gR5*I5i1%6#Dt zMPp{c@e!@*=B5X@>guH&ppB;SlF8`#6IcuwmeQ6YpUQ|~WJ4hojmc)q{&w|xFdzc9h4t7m4A6mqZ)gwLE0~XV+OARvH9zKa$3*NGE zQ4s6r%O~F)G7IWT3@2XD3$!96NanCIm$*zxf6V4gpk$Lk4N4aWa8VlX=8qBbRvm0jkDJC;0M89&21~-OIU;W7FOl&-@iP+HmnZK8yru)?xw0<0X=hQ zM0}7T-P&%;UOr?CJ1Fw90ito4nF0=5f||h?jLxrvU{u&ZAP{80+1cA)E_zm*&n?(+ z?>Szqutzyf1S${z`8^KzV+DsKLi^JPzTcRn8vx!SDCc zB1Old-zKTX{g>UW&<+umRCpkCZ{c>Wuz3D-+Mwf`emRe2h3^OTg3${iKUC!2a`m>Q z!-t{Y{&7vfA9&XnUfVn91ZeVduHV$QGO>!}A5t>1%7&$lQ`;g}bns{u_`v-2K0`?z z8v^p}$g;_?G=@lKI{tN~o?cakzU{2`X&5NL8ZVIJIAFlCoa)zPMhsD%PyELsCO79v zTejPjehUSkMo`GUD~M1}WIEdvoyzh_^qE|5*w57qec|8WUM`fW&#;G!uy8lx77^*< zziq56leSRhgTMFX8g*(}-V(g`?xi~%$Q;FXwHga%-YznE>;pwr%>&=rK=r5s zm^ZKY9+bbY9!E@1_NQ*-itWEI2@o(_z{P-yiQx{JIf9*jm!zVXzuJQzhv1VYo$GIaT^-!*A`sgDntxI z`uXD0&}l8NuY_=ZRIhfxNPu{@(b~eofc^-V7}-XTYC4~jiMBTG{rql!82S?^+BA56 zXx#JB)#H$QDdXb6*$UD}r<8waE7#6XF2TSLhHYquLZd|xrX zkZC5QDn7`Lh9i7{hy0~5JW-tzD~K-FCkcZDd;6s{SsW%=eumL}!GFq{y^Y^pJD2WH zm{uiIl#&^ubX0P&Dz)6zkc8SS_En96oI&c%6 z{|H>Vm{HAQxbUAF-ph*uNKfyuw&sO|grG?j9tMNqaPE)vwIG6qTX240l|gp%{>*9?A`z)ype{xqmoLJ2Brewo#}4tHpY6R+5vjyF z=XPFg(qv0f&EXdiNc=~{?--Y*;J9oe^y^^x?_Z*^osoEnFce}DzmNG6+b@o%_ zWZqv1ok2~M@&bral?%x)P;!BZiI^6yZf?{qB>*^29~z{Sym zWvFT56kkCCyg6Xs@Qb1D3L7g~|ApqD1JV^Ta&ls$qR*q%oHkZ?&q)_L<5uzI%F4<- z?_=uNzMsT(Q%_UeACH9$!X4ZSi2!<%baJ6)%EMw}VnBJk3n)GxA5S^LyC%*e1wKlS zlBEVnetB1Qdu)PQK0#x7vIF_R%^9osik0kAwjuEN07%%tP>E0^^ax2s=z(#kY_ZPW zDDxbFZ+sMdM!_}B%C;_1k8Wj)XW)=9x&C+0&({|hTu0*kzV6Ens5D)ulsA%0IL~c3 z1~n0O&4#~c-w*9 zE4`q$0*xNe8u=xNH9+mL)zkUq1+dmm$Sz(AIHn!g@u>nBUT_lE5>h#?8=D&6USBBO zBq2^;BKym+89h5qeo9F}o3wb|TWsN;ou3a!;|C#zAek*y{ur2Qu$=Db=zxHP#NTEr z&SjwPWMLuamCc6REsA8l(M~rJ7v--|r<8nF{5d)2=oJjZ3$z$f`J^|ku*uPh0xHjW zXe@*?REcRnnYzU>r6i^3NGZdZD3=Jwj-Vt^m6+EoW4wDY$I`mCYZ*`?s5TTRSy@>m z(nPTz=iT-Wkh(y-4CKPwXu<`Eh?n~`I^Sw}; zDAswDJ{QByeO7Imu*ST=NwqpX0NhLzOUspVgksl%2&TctOi4>$1CE3cW1m1t?Wb84 z1}hu28M&&f6c#s=jFhC{ejP^qe0ugrdv|*A>8UkL`9_PO8@JLl$b0X6?)2+^_U}_I zkTym%i^d#|3is({$a?RwNT8JYLv{#}Q8?c2(*8rQKR=%WBv#Ns70v3##-u8Ea^%j5 zhqC!N_{-4M&`>7!ZMFQ-0-0Eq{2o=StUhsU!I0IwSt~`*!phV+W_XkUj#|VuX&D(p z0m%d8AwW)Zmw*!n69lp7?)Je^1YuwkR%dcU11B00Dd}|lcSD-MAmW$Lzwy+AdSUh3P_BI(mrCojtL2WA}on?tNG zA~nmi_Ahubc|M7H_T%TSi$8p`!|eCcva;R;P}2pTLG-Ne`e#lU zvmq_~D3}jCAbo=y56E!?9mx3^IG4X%y52VFH2N%{c>j!D^jdzBV*q4-(<2UGk>iE~ za%`>K1SqR*b#+^L9U{i+PEH5)B@`ko?z|{$`O6@FiflDC%)}YGcD6RM0&EF0sRPR5 zM67@qN)V~#zCrV;H9$AZ)X>#D-tviS?g=4w>AgQ2L5S2MGCp@gMm&H#&Ry0k*S}#E z;18IV3|opo92^`9TypPy7eCvHm6RiaByvUs9=;>g1m0@H?mu?1b`c-@R@W-GZr_Ry zpCbY{pf-xoE`jcsNaRQWwc$$pBDK!GLg#^yUR#3p)ijFQ_LQr7rsO0b0T&yN#iM7Ox308BN8$8bVqfgkVApGI z4IMp;0$$ZbW=1t z>Zy=m1_P{Ln@dHrgnng2)TR*cfY{^Y#lidSlQm${sI2C9g!$LM>XF~YMm!*mOUbx1 z(Mio1U$}Ra*M?9INhL{|6#moc;2+9TB1p%`vhJYQQ#gY*ufP;xcW?0&3UJYb{>jpP z!#E>tphHfzcS=QMJoh`3y+N>I2(pfjj%lD?5h!-?Kzew10Ig?3eO(Jt5tl16eHb=@-(Vz_h_)GEme=gCRLX zqpOBsU<-srWMs6oVTia(s0X`0A2l1}$k06wzFl`_v(ybm7y?z>07=>_>ua+cb+sc? zQ&-D6y|YV8ATO9Jb$4pUOwJLmY*G>XyGM0JMUb~#13b{6RnPn=RbhNqt^3^`ycRL> z)@d^1^!Dyh!JvO!Hw4bz$q7`+N5>k$DH6%*2FqbK0}kB#$`^!?gP{EU#O3{t<3w}Nz2XiQbxM)rX>mT6GOJ?!JGqSANnkY{lYH0VI%D)<> zs<$I0nlU%K<38fx?n|MzWLu8UAWpo!3fKX|wM8o!iNz?hGQ#GM>~s4_s2{9KH~Wlu zIydHdsSXg{8AtcHQ$UFYx>69U0V) zn+NCIz*j))IRt!VnAp&|OuhAXzVB~2fkp^;m%V+caaFGM24Ff%AdDk4xNQgLfSRir zj{}QAtWJa!nE1YaU1`wyQ%N0mqz0zSRHlYh@4L4ACGgKH^eJN?Q>2d?NeH%-r{E|WU*M3+FzgxT z-uAN{A-W(9r73JN(uwZmF}uD^p?cI(C#omRZq*FS@SZ(mmtoQ_4eU=QefhkQygj@= zc0D7=kv*`5>{Bxqh}m&8CvA2qALzo}Mo_DZgL{sr9V|L% zt~OdHev>{tI;wxMva&*Jq#!2`m;m{rNIhZ(8EV=3-mi1KCu=HFWDXUJHv8~FgrESF zj5TZh^3vDWSLw2v(|Kw%krvb%Qnk+INEdKtd80u;9F347f*cD(cT;0lTha(%w17)ip5sPpFxZh;DF zJ^23NJX(5;>T@bLXyKG=AR84bEBE}o4dlNOGTJiLfmrMvDy)Y~i>>GO)LpnapWX}6 z)ad9aIVbeE#&0tVi+q2dr;GF!efR4|QPRCpIZPUpRL~HOo}HLj`g#UZtmx-MYXx;9Hg2J(>gmKh~U zSSz&KVD8^)4z9E54l>B>0u6aNK;#xw>+{3uJZK?buY{(VnVFA|;Cs#O2dMl>6F^3rn-%SPif_#&8rrM+=h1orv*3Nx)RL2_&I;DwBT=6=yWD0Zc)L@ z(t#2vz4=2z3im?T&Oe0p;JG~rs$s*Q?EWn*q>3r#mAdCS48{LTiiS4RZJl&gkX#{q zDE+ZIcPDaG0ZmtajueFj9w9wgTou_%!LJzxCtX}SZn~;ZqJHp?-IO~J?hMR?yh*h2 zXEM7ON%H1mno4OLhfM)QK21K|*$dg3VwFP=4rWenAS>3&@TL3pD#%y9+JsKXa6HOs zKh7397Wp~{ZhrwRP2cx%7hvUn%zeX$vR%0_lhjFARs8XtBomp#BqrXZp}#;RGW-WN zL6%gF%qRKLXEZD^@e<-$j^hm{GkAqT+&wqc8~H^xi1o>i0Z2jSihp`>Vk09a5#756lXS3yh#bgx7)kU)uZim^ z7CrI;?DSfh+W>|(t1GNa){^Xqg1N$!wWxb@=}|zc+zti#P)`J7%K43dD~2Xo!bp;? z9*JYXEOc5fDm@jLEAige30+|Qn4vt55=A}Ur|LIw)YBpOmwSku=4fR67V)6ORJT{f z4rau#t<>(=$;IyT^fq&eK@p86$fazNtq_Hdd+ zuMX!iYQ~|!O&=u~0iVHoVDC!g(5}=0+E9XO=iOS+(y}r&g;ERWD49AiW>-vXiE{1X z>Dem`iYP(t^Hdi7Gj-^Z{R_glyS8ZmmDoYIHk z)6M(|6T+YO$i&apzPuNBxPdY-!9DP=g%eN@@~OVB|ICZSIW5Ji?hVxI*Nro6k52ej zKzclwV&gj(k3#JbRzxYQ!o=KU-%LL{=TQ-_)fWWzy&e}l2e=5jN$%<1%QSZnt{M{5 zfcF^< z`d(XP2SGAWp}DLAA%ImH{0ZbJ)35Ph@=mGmbm3ODdPO7TJivG$I20&k=yY?SCZ5su zeSacP_7V0AgdoH~un(MoE>6PQ%k%Sp?5gYO-X5?G2@{op^rhvWY(y2vhRp_p7JEHy zw&3qIZ+5W7P~vO&XIK~*Cb6PI>c+-^kBJ#T`^+N$VcvS2{2PadtD+(bIV}rItVdHm zyLXNe);koUX%WIN#`;&hHq-iOH#GyW32!HVf6TKs5U-#DmAI*e2x%_RaL1jM5NY0X z=XO%Zn5xl4c#)chMq1VK&h2=N5z1*j={jR~xjT{i?31p*aqoOT0vxTVCDf zoFU@IDkMp;TYg9OvU@G2*V!W^|1Og`l`h&s9j>U!84PFhBCsMyxO=ae2BTv*#zd#Q*sr!+FFSNE` ztme_E_Pek~x!;7f9g77Tq~Ttap@qwRWlsgq!{J8?K1u|l5a&}-$Y}JlloGZ12YSK8$f zEXaFjI{Yf!m0g{m4^KsX zF;`W^@RnE5UO~*7nf-vHzFwZ_00m;mx&yf5Czcjjvhk#!EG)#}0;5}6{((0WLlkkP$vSJ>C8Lce?n* zO#cI;82o)090r1YO>v*+>+=J+yEhqhv2@!4j9HM?JE=eh7=#1FG61#_m-l=o6ZO4m zUY2Ui6BBd9eTp{f^z2*i7q(9@Rykd&pRrD-QV!Y(2IR4Z#HFRrbJ_0R0HQrT)TV6Y zN091NQeMlJ)6&&N7^ONzPVwL8Ttq^#0aJ)IW15b^g zO>vQnunFEbe6xEXJ2baAFz~D9ue^M%q*dv1NRBFn(sC-dnK_*{1!+rR(hFV}?T)}C4B9uPQbh}^gcs6U%cA0X7OqF5HIyifMsJ?k8QThVvl zkmu!IyhuY?`yA)n{bjE5z4S-SE&N^@_9D64wdprQ_8p%Db&h@cC@ttk{p{(Iq++2X3&$qx_a;kyof}gxG@$xa8!GO zwAJ3uPJUqs12Fc5J9ta&_FH7aF1@}?>w7U-t^&dpKgQgqGG;@V z(#1^pt?68XPDVzg4EWyP$x+3AXE?S2QJqmqVzkN9p?U%BF~<-PQ# zAU+EX!w5QU1ClTC-{W6j#P+~4ynGn9I63M^vL`Jp11)FiOBnZMxS2kDXi60E1PBRN zSqWzL;+a-V7b*;7wggoy3S9~qgitvQIlfR-7z%7^+*6o3)0s(FFwoQY!oqW+{j1Qb(xwpj+4A#k z#P36=$&nJ+7GSree_L11ncvEAD4SVdFn+;}21|9YKw$wDZ*1%P?>=4I3=Zq7MGS>B z)J!~Az#Lqmg77LS&;_7+m0V8tclzIAZ6f(%-s zZ4H>g)s7SWbyg|GYe~e#-u4o(*o)A!P@>n&fB`K5#!d z1rkZ`#sZdgx~O+O>M4hOzs$&@^1?rSoUii>j)7rquIJ-cTHS9P{SoA;T^}o=9;Ika z73Z2Z9sEq>yhE2&d3KtZad+4|-}MQ5;29@+e0*HI;o&Uu_-p0pT+57%_~EwJTj0{x zF$|hS$=98<7?RXzTo*VRw=ATjM=FqIM{bF%BbBVeFOqjcHsx4A3oo3DnU#9p+lcGS;u zC+Ioy_TKH0W|G~X`ZxW)zdWg^fFFNE)UUE%W}6-y^pL}5vyH8oR1@gpQDaM{o*o%D)jjI@VR4b4bSv()l@q{MVrKYsqc@lxzu+1 zi6;eKLK|vFi=2=$KB{5kU8~0%_-$O-y+(QY?dYPJrFWAGa|Q9Si>DSPHEr7^Z?nr4 zSHtC5YGfH&SR|`pvVq!^rWwQ|+32L8imH_XBPeR9-ouaRE zg&Su4;?okZfUJ%|%TLUAE-mtFtc#DXIuYKl#(s}qb0>ZYIgy3lC87x}7WuulEM{obGZGx-0f1)U3Ax=DOeGEmh7L7WeLU@E8<<*2b1+z%L5 zoMnpWDzmkYybQJ zfjn(0{>{(QrWe)7;)haUV$$BP&tAgnQI$88nTt&}3w3I&1Vdp6)uZm1ss zAT`XkUuMf@G&x_XYE|GnR1z9P_oo-{k8ydefUb^#j>bo5LVh3lIpD=avOlQZA(ngB z6@3E8Yr6?HoCBPnMrxl1aF4ARKm!a^AyuNPp2~^ezq1@lSOUsS7I{q4qL?s+??zon zEvirIXrwS>gp=D0GCSZ(PMni)nU;E2F|AUb(o5zdK3pzVnFvai4hluNRheP&VpGQX?m<5HoPZx}Ry{<)hQ$B*L`y9gz#1=kyK;g0)${7REpSE}iYoX>v z;Y-B3$b;c~ zYaX)!1l!QukIsS~r%CVyli0ohCG5JOozTDo9@W?#p=&IY8#xaS1^)uXRR&r%?#2y- z+wpo!F7`zO?$r((P1ZU*98NMhKgW%sP5`S$FwX1{3gowoPy=u$3%DIMf=M)g69Ak} zD56zN&%Z$Y*^V#b%QprPm00|TX(8OV>r8b_C>Uh!5>M;day2Q49n1Y*X$aWJ++xyp z;b%Q#V|24(c;|2Qm*0Yo)YU1MUqQSR_`_6xQo;x@!TgQH03XG`8q*Urth9tyn3oyf zkX>y3y(Z7yd5eldT10@FIKT#FD|N6)l7Ydc>rvv2XxfgK)eFOIn89)$;*)Y-Ka@4HvkDxhf&FlU*TCej*WK z=7fcII7;>jm`OEjjHs;wNEPc@tM?;(iOR5&nm_PoL=d@H%3zsj&As`DpXkLuhEVCz zwP#r)@d?rsQ_;|i6byv|#0kV$xRbuYz5=l(QTZuA+$!vP473AaK*7`kipo#&=E-aQ z)$i%0`glJb^FU(AVz;x)dH2ITj4*20cg{SHPe_zd;Z_Uc&PQ;YHSR-f0b!eK9iQ32 zH*<4i7w{IL3}?IAjuRAakMVgnFPD#8d>{Bf(1`iiMMZl6zvlONBi=>j0}f)P8z$}Q zz@HXW5FBF&s$0TrZ0FY)2m~1+SxX@Jr?!9}4Xjq;&KMqNEAnMfC^lrG$Xf4Vz?sc& zHJMK#8SZ+X8ZUYgv7|~$rDfZffo)Ex1Q8XKuDk#hi8o#Wn#{WY=`tI+)Dg16s@z|r z_dIoNDJn88qN&&~)`|1LL;k!d*_O@2V3|5!K<_7{LEP_Ek1=V-eMx%|K%Z}~-h!}? z)=+|?B@gb!vA}#Mb*KBTl^&|0%$9MWkW*O;Esc|JwNtN6Q0=Cr3cXYblY6Hpiimse?3$)LpLdxlkw^oOf;`+AwBQ;YJqX{Dk& zB&OchepmZp=9OD5W?O|N75V7+qd^Z9PI}hV&IbtzDLBs3(EjlC>0DH2cn9t$uW`lJ zociWt(=kV)p-UlLAvDFe-oY-iL$t5lc1tPG-(324L&xYO&4-g{TEoaPobFEkGEjXt zY@4o>q8GHlQp?|RqoZ;phPB2k)Q#MvS5wrZIVf>V+)?;x3wbflR9j`VkrcdQvdGa! zk!Sz6f#z)CdcHy<;>+#P95x?A&^PRCGHj zi#x0RvRFrf!eo}gm6GFIF!f~koxmg;hdClB@M43Hw>6?X)yVI5t{nN^l-jaope*;! zzJKMS4}mhy7A#%{M#iY`omV4FTPX=>?Fo2Lf4xCopsi1v{rTHUI=_qM2e~S+-ch^M zt9zC1&X-ljHzn9za8fU#jMpv9W5G50d)%<-y@jdPWOas0NiGJ}^T8{iWsIU$yBF)d zZ@*ZC$L5%Pyz;vZ=7-ssj7!g}N~i5#^~D?CuC92gjo;muDd!~F+3l_HyX*~J zS?)B{odPn)q5EM^u&o}1HPw2>hoqv?Lfp?*tc^C`CFKYP@!x0^s30cUY&iyJTai9H zK9ykTH_TGd^%?m;d>RWROMgF+1)Z>8DRnG|kXeg3L&EiJ?q*fR)IusM2=;U#Bl2#PM%0>PsN@v$ zD3`<9%B2PK6VM9qM)}MFD$R^Cy`(Es@q2tpEYcnB0O!p;7jKdsiGT9Yg$gijHzsQe zx}WIY?>wOEb-ApL|a4pPtZ7 znw>w5G(afFT_}J1>;xx*6R`xJ8nCnJWU^5SfjEB*U;@s82uL5UY@W;rdUS4o+!Odt zF7y<{2pNAy9e+)HTW}vo}$*L;eAoIC(Jwfn0EJ9v;X6N@m z!danyMUW%?LuN9;HtX`adwg2+`yFqogqbY@XlKb#vdh~hecWvsv0gnt_ns5Rs-J)SI(tWcG&{{%D*{y4o*`3wEPcE&^- ziLZrqD%yV4BZTRl;5OJilGc zLQLR_93|<*W=m`9r)ykt3Xmvw-el3)@Zq4^3Uswey1=R0Q7>0+ndpoS)9lojzVD8QwD4Ky0;T>E2S4)V@M#i zEnF~)49(Ap?0R{dfl8zIW5|0?{PWUYf96R9`_0}`Ah-xoi z=V3fk-=Zg0^M~+0!00wwsR^m88wRtOs-GwrC{qCPsIyElBbe)+=E8lFzA^hGa8mt{ z!}pj~Uj2uqlACinieEMrc-Wu|n>VicoOjWs>M8Cgsq2|Uv1zT4kT|TrEc74}w*%cl zB>DH76C6vGiq*UN#3XiasUvX@v0(SBShldlJBhB!QWTS&(gouHVFs2=^~8p^Z=Xg# z8W-(-MOUGYE(hJ96eVY?9s9=VjYjGw^$B!yCD@e0UM@#XqrGUwq1A4 zX^p%x@{!5X^+q_1au?WcOJ|j;>zi4X(PLZ3*nr_dglf{Tg=6*%exE}0O zcT6(aVuK}M*9T1 zA|6}aY0L`b{)EqSI^}HXG);^XQ2Z^G3CaH)k!UYNmFf7&L?#(NnNJxd;b#~onrl%s zf)6*_$Ghg)?^5e`P!OTM@L!8uw3#VrF;x@#BtOTv(9mCFw?x}ktN8`h%|8+o^GF4D z=#SG6{7n&xv0}XTowv`S>UjjvekJ#(oA1s0hVznWYZ><|H7lU{K{f19{6U(L_i&i} zc3ua2%NKd&fW5=PvxSO+t)Lh9;&gCXD8F^6^=I*y*q;h4)jm%PaF4ZE&%i+qmxhf6 z2>4eu+RT=V%lYElH1EJk4#z^6vKjd1qHdlBJi7d48o@}Py3+U+Ry^`HpR$=}H8&d$ zpl*J3aBy&GY?jrR^zsAdx2KN{7V-zWIOW48CsRcc$V4li8ZSggh;L749c;-68G-U% z+7EO4QcsUswxeN6L%s0bIIrDqJd^w8Qwz>$ z>L>y?QZ00#cnDmH(HM2oRD7wZsc3AjQR{(_(T6kUVc*AL21aN^<@uG8>W^U9ONYB% zg4Jw!;tNAsP;H8Z7ADm6bKInKQ zdoRHgF3{EiQNN#~0%BqrC85{c1z|1411jpE+x>Lu#Fw>4=K!gb+hKTxa|G1Z)NlaU5 zJWDCGrZ00*!pgKz-PAL?fBuYU{__2|>aoq}0=uRSwQG#bVmu!EaJ~Qe%2@-r#aV_K z@_cXVYhzJOo9g@`c2GCXfw7UW1VfgARIUqO#MMQBJ3;lKJczBq<>~Ge0TSh``|0d? zj{RPZr_6k=QVX3-fcVNG!u?b}`WWC>Y*e?z9fPBB8326_Xl~3rl2@n%w?F$o3|`?p zvO%^Uh2d>$O%uB!Mop4f{4rA>XRC;PUW)`EDpa07O#EjPg{~@+A}tw~YfLZ6OsUf7 z=RXTZKB(-r;EC+1?%4$2P@`FqB!u%q`ES_OjNtz5x9?xsf1bHcojk%sf8{faDaENN zrxUDyqg7I9*41F$a=fZ4j!~{*ht4ghTVqeLQ}Uc!x|+JE#W^aaXXqLIB|{r;&7IHEvSEU$dw1UXr^grNcQ~1AWJ~2_{ZO}h?y9Dd`FP}> znVFHn@PUDj?)M~uo+2zeSfP?wDc`>7$z&;tY}IU978CORa^PX7qEoEAxePLzlsMu$ z;>#0j`>Y&rlx)OAuRe3(`IsmT3+S1a0jUU7xT*XSnP4pJz*w)7QB)XznV zO7*uUdq{)#pR3MM!Y_Kj5hmzz1NQaa#1pD){x1gKb~@OWPEq$8^CJ5eo5k?udy@rw z&%nuICHXl)z6>RK($RN7iACz1H-6d8#KFMBZ)c2oa8k>fb#!Zg+}$J&&Qn`jt8nv~)|uEWwQhMg#7XYMcZD+Vbe#qoJkgIjCA{ z;!iIozakxXIr|Zi^dr6fcETW(!oiStM%;6`yg-ojKJ8cxud@4iAt;Du1bB=enRnCw zK|(@KPYo@$I#IDza8R~uB3i1}wK6Y3jBv=8E=hM|XkTSA@qOH%TB~1eg|$puz5iLI zGcMP*0{h^Dn1Gm+@~*5O@NqJiyGYbUn;R~C@V)HOF|)@efN#?e`}y+SW8Q0zWu%P3^Y2>fF=l`JmWeC4sTe~k(2prK!MVt0Ncl%MJl|LPj!M`=! z`gIr1=kYm7%oB_F>N1X&q5{VaH$?G`A^)h(P}Y|y-SOvQL~O+O0S`VRH~KEO9dtA_ z^`hQzx3|TUvyba`t(BEuX}v083cBHRCD=mAMMRA3t`4TCbi*uB?b^1#2SB3-%aoZm z!CONgVR+@GrR^I!9L27zoa>t(PM0(f?0W#`Ak^2!My{7C8imvZkw`l(Xv)yfH^sFC z_#2`B{GRT1+tw%6dP_E0`TZNuE3W9f6iO^Hi&^1`VOqvKRe8jqkjF{!0+ry9*vUfvrws>F>=dV{3`qX(ozHzjPgo}&C9bPDtwb!7#}I9*csR5D~T_~MX~o^A5lRo}ljW0Wii zKA|=i5ol`3j{*C_@$3k8kIaz5-mhyjyIISR*gnL`D82YlXDH(>~oP?cta>!jR!G19gX_#>2csIj|@|EyXV?Y8)U6=-f`(kNL#qX^nZzrGkw7RQG<;=C`Sn(xfy86wO$J)>OU9&7xS1gWSb1^NIB zdbpfqA6W}ZJ&ADHFI-er6BvC@fViV~gt%i^30VO81B zB>FR#%;P}!vQ=WO-zU<28dYMlWs8D>0un)73an&mtpx+GCcM#~F zGS3hcS59}!KP(`-C}d3@Kxo3&?fEaEHq^{aB0?Zg1x6h;xgb!I+R$Q(*J<9rPb@zq zNywCbFC!zPZV1AiYmpUuBk=Gm_h>>s4(n}`sCj#_}o&Z{RaM!6n{e@U$C(X_%?Ph^;y}zUYx?yV4Xv* z0-jXhA3vyNog-irOEAaxC?hEFddDAOpCXbrQm9C?P%hFswZ2Z4y0HtA^AE*(jzek2 zDfPpdqP1}KjN>K9l6gJTub+70qinBlyT03|Uc~(Qt*jdlbOshlxx9*&!9PZH48c))0(y+Hst01h z0wtbCKPz1cs78}zVCTNA02tpTjZ|3iQ2F+^0`>hyP{_bNvYl z#4K)`@ash4k!vv7Ku&;F*U-?m;|b`22=*3I$KPLF;=ds}-1K9~)8Hy*@t~UgcTvn; z_s%bIzTO&n208}#KSZ5uUp6ksW*6aNe4_pv^7Q7mr9{Rh-Y5YU+`67a{MczUX}S zwVxeFE0P(m;)Ov@a6AU;lDEq877?#KDAREK6tmFPcPfXv2uCwkkWFgLiSdv$1-iqH z-uL@ZD!2hLG=fF_s@IKtteH(ZYsIX<6=Z$+Aiq!F92yk-UTSfOU&Lq{Cft4hFsQ7O zUvoo{$59*fjjDljN6|lMab)B}+%I+!L{!vo;e%C|69aYXu2%!{`H{U}wQt5|@v{LO z)W^guv?LSpm2-`xRnw?X4T>%wvSOc%R&0`{78WL%01dUkyQAJkx4;*?n$X=$e)shp z6^Gp61KZp%)ixq435NxOr%6CVZ@AbCB==&423;*N<{HvN@zM8%#6>p9GbHbNMCa(x z!hcS+-$lFs3>4Hw=>QA%VWT5ByHk|B6gEHZiWT_dPzgpG!!kI<|Bp6z*@k2xY0` zmJ20o93gO!7QuL;SNo_}9i7*Fcj%tK)oRY)F1J45o}B`H0f)X7@eZ$+ttI^p=r<6F zW(|_IR@%BT99*wu@_o3$O%}sgqr{2W8!+#7cXo8=+XDWr-R-1&Qd0Q~2LsueENhD|4cS~ubJCBnfO zG`{G4f5R;3_t;1b@XI)R@;f%u`y;KXX@wCn>TRSCoNk{tAkKsK@{gR#1|rwAWj^+J zqapM3{D+{YAhm zniTn#rwNf_A&ZFrA_{lGC3$Za+GqmwwmXeW^D%=WCs_UZqb(Z4&^xMu$;|Iy^5{N^ z*Rq!3H zWrHoIa`7P#;CahIcrT9VHcP@z)pXrGr1iZ#d{&B-5&dAHOpxOq#tV$|VK9h<2UA|0 z*s?=*I&{4t4V|=dzennKhCa}j+}yZ+TUr4gNhRZOzReK%QfmBs_m#3-MeJ@pDDRBedhBxFFA9I*&H+ZyxoiKR6fzdKbdS&cJQatT_tegy>B-Ejh2On z5(+aVOVU@5`}LDvHd3TS2CrTfR5)s>V61=w7}jqy`0p{Xv8kH;K~`AV@6#KF zz3K7fq-u2XLrzM{z!zOS5|Ww#*!oBmqed%C`7W1zW&Ym#%k7e8ZB0#G^Dk(jsF1-} z#vcFj>ljgvDf~Y#xduudsN_B3y+Z1rz$)ag5gmU&Z134Sp)yj;y?*+;Mem1CxQKFy zydo^8;w(jql!r|s7Xo{zz0sbZpTBo;_d-B<%K)=NqK}D@A*Sw;7ZhSbn%=Xu;`MFe zslnx)!}0a5emgai#Z~H_oK9UJQd!@}@2=hi+9x+#3eJ~l5qx>IlarKkbYaXeo3BOB z)ZMB2)_wS2Qs*|>jqmRXo0M+8eR2lxNZOD&z#ITGV$7C+wx(jesN4@_)K=WjAS^ELWPh$z#eE3%hFj)FQX?YbrPbEZSG!&W&hpJe|)hfqL^7`Dft z^H#^Fo%|UYX}I?tj2O)b|0(P3g!Prr3{DEuRqQ9h2^Lz*OaP`g#6|*v+q^DQze+aW z=D|X)*RS>U^*V~3(U6FxmjnJvmB}43pY&J1J?0(qr9hTkA%Dsag}$wk*HI&{t9vz6 zGq@W#t;#NZe z76#^GV05&qx*8?7Zw}Cvc+6kFi-iqfYEk9S<+M3JAlYu7?u}>l;MC?vd%h=VZk+JF zzu5G1Q6-qW1f`rxZPq|7Q&UUaOoob>!tOqR2EMqhkm#uG0z;)V^>{W9dNc2d#8Uh{txD{i6eiaDTzhnjREHUy4E$EBSibl0Db+;lwtslR$+uzfFNcB z3kRpavO8<>3p`ilw8Z0R37)&L;0}V_R?)_t^F*?(7yb* z`K^$MeOD{;)|?M+8|V^*DC_ePTeV^*lbRAzAChA&kTUx%U6`1Q(XbQkFJz%>;1U`U z(V}{y8B<=_a5c-&7k9mw@SV0ls&EnbFILrE6_LCreov`}%h3S6-0G zMv|bR`|(P>Grt+pitVecLH2Q=J)_j+_xTYfd^7g3>5G<)OD{jJq=g^^`y2Z8{p7L@ z#9sgPT^+=ZqRC6w2hAxVK?G@N&_e6Y-5sni-7@O(XSo0Dy9ct@ z{zrP)Yp39nm1FUg^8bXh=7>2&m^~Nx3)>O&BQ^ttmcs5ZQgPbOw49t8Qd&B?Z6iFq zv<%MA&Sj5s4kdq@nZGdb{B)~eSU!&C@YOXCrQowd^8b|qhSRZls-JDIk&g1ezc@(z zwS&V6EEB=}7j#3KIorUj;C*`(hQIv)oOmoYg>iK`5PjE8dl)T%TWZbE4?I)JJNGpB zY^$P-X`h%xop;bRT@4gO!&PY+$jkJ5|Kc(}N~)NQ*Q)Oe}7Rku#eOY-&y4c)6e ztr_xo z6FFSgNd^2!iEL5!Kx~%byhx@{bJU#EuKDUYme~}}Gy1v-LU?+>?cv}2*Yv3Uc||BN zD6Lc_&z`Huvd89w`7rnZj%O>Geqp zB}1tN(9H3Z*zs8!eyVOlJ6UcM7fv10ssx<7(CD1~^I9t*TTS-bANK2vdpiy=EesmY z6UcRc?f`HbUHbaz&pJ|bdTk>5fcaM)A((!*iEy`LwIEccp8FyO2-sr-yQQ0$lgqqt z9f5!&vbSO@^^|(*BxpS}vkf#93^7JnH|$ll?DVuDHpZ2;`j9d|IVB}-^T2evjYH-G z*+!K%;FANw0ZtD{EHGa>0WkTM2J?KOhcG^_m{H=&p^B#GPO~xZWv2{=U8xUj7h~*l zW;HF-rF3Bqp~AC6&fkouEMnpo>WXgNrKRC=;GQwyp8g=%|B=vHXWFej>fs-X$=|s0Ab^ zCAsc{VvJC@5OdceU$B4Gwp`sT;}7<)59QPP*6~0#FsCqKRo$i;2_yQ0`Unn zE0N5@pY0%|DS9w5pIKM%KvW@5SV4rfGSSW5{;1)s4|kEbH7b@1g1a_%m!n!6 z&~oM~+uPetztJVzg+QP{0~w{S9Cn2n!P09VVI8={;R^L|GA}bxGWnb+ z#i4%JzAn&2&^)|6B)Hef;!cyM%Y{dd~8CB0O!XobabyEXsSBB)@p7T}5vQ#k4y%8sq{Vmm2;I-JWDHv=WWb4YuUKkD$N7e`5Hp<&RQsmh6q7 z5bq1cKssBjmz*6i>tr>B_&b@k86m~}YwXXTdD%~HYG)3nN@Q*)Fqf)B&ZD&3fD)9T z2#lUbWg)TY9}NJl$;gn7eSpKqX^r&CRaR1J>YR!x?~B`=wI&*BB{Pf!%AiWd2$ zQ3Jhj54;2ld?v(~vtP)R z2b3JkPov(Y1IIBgd6bo6qn0TEM{r&nSX|$HqXng|CO9~Tk;MclSV`kdKO8^U+XjCE zuab=>&>q*p&)-b>TET%KA(sB33k**L)hFDeAe+kTd)i7=;=tCWyDTY(W)$c#HfOma)c4A^*u7uA;J*cV?0m?8K-a30vj?Zge2x=PB z;}ZH9b_P~~oK2O=e7@;O*+pt;%BiS$s%IMyc&DE?2_Q;N>bMNTG_h|at!&sqkbjBZtccqe8hWr3Jz^_?**cvubO6zf#DM|s z``Xy|7sx?TDqm?jt-W~B0_pA*rzkv&ABWhWsjd}7%i}ljGGS@OiM9q}^?TVS`%qK# zd!;dPK&-@Ab65YK-q0M2cvirtDX!%*~Tv`i87)-058)1>>Lejy0T z$#{DO!mA~01>8^W*Z!?ZYjjD83``j`+d2)&IGG~K%B>A2gi8Az{g1f!j(4Kk8itR8 zC`GtPFVcHBOeV=B6RPRGXJ(R!z+^I$HYt-#CPfjIBGMEQ@SuP+DFO-z2#8Vz=|z+# zqKMK2kt+4uCr7>B``+hy@Av)lou3?YGJCJR+FpCDwb!0KgP+m2!=@?S9nHT}&b3dv ze(vCzwaqRbfbHDa5Z>Y7XQJv%7JH_HCcU*(>7f7=9YFeB9$I~x?{_|hlhRkaNvh8 z%}%Ziy+}1*^N4oaOZ{WLCO!T3p1pgIw0y&J{`~osQ~GR5SjF#RCfVRUPfd8j+I;(C ztbb~#fIHAw`?X; z$2X7dX^fg)8F0>!$z-e`EoIFNs?=QEeX7O#3l^++MElgNJ@-JqZe82rQ@?a{?979^ zdoB^J2b??ziYsO~i_hJ19yq_V?d_hQgYy8deQX#q)w^|HyEo_QUYc5?F6`d9YuANS8~bTz9y)(k^uxL(>Z0>VLHQ)8Vx{ag}d^6vfuP&%L$?th6CK z+PE`3uw$oAL2z~I`&}B`uC>Qd3%hx3H}`fkLV5l8hCDQ&=ZCYE*)M*Z^!pbNUmPIp zfw)Hw>Sku@zu(L0zS{f5xsfN^O@_facKI{!j_p*n`SW|@S4EDsowFOfDUTWS!Re{R zjsqG#dTZ6Iy?VU1XH)&QeEsuT{k=zPy>=I!*6{j>J<|syM?KSE^y^bJIY$W*6DXoclyWbVV%~t z_I8n}mQQGZ5W02g4ZLB!w?(Eo-z>d2<6dyvkUrDbE_|tPo7a*p&-8rOeOmDkkpdao zzR~^qLD#RtXMgH^?9=(e`sLR)f0e7;cjeZGTbA`5Pxf#9{L=l`&Tp&OvnIOh-ET(G zZFh_vJ$Lz%dTQsny8}DjxT>jt_4$PZxlv!ON${$NwC?5Li8Z&I+0zpn$9^tt{EhK9 zZ_sPmt{MH^+ii!tRQ<4i+1lC9UA|{e1jk)t2OrrfZtwyUubXQb-m&I$W4+yVKI+@7 z+xu_tdS=w>=!{NO<1-H%Pt?CT{5yZ4!Q8Lj8a}-C6L&^W{^=U_Y3tY9J5v{U86b97Ij-$oHK6t1~Z;*fX!@4euQuC8S;_Frq!V6yc^q)MeRk5tJc>a@gGL+>r zG?}RWlnTb4lqkd<#2u13FXbbuuaL;-nnLB5!#A)n0(d8tSOJ$;I zKAK8)sD?=fQ#pP>r%vE`hd+QvSvCjgB>7b4uR)U8K4tRyP^kp;w+0a0M-2VFGvLa9 z?o=St|EaOTlnDRt9l}sF5&oAkLeyV9(zy&>n5{ZB5k>zy)VBsI)_>VoZWi@is*;Fn=(K-R3+4=8W%kpme zpA!8qK!D~o0RAS6z8aw3KxjaHy{Q!Yr{0?=e1%H-hB zzGCrT?aO%6|7~kqDimdk|JEAuip6Evia;4`i0aFvG6@pMC7K|^G!#qI;qnt8^S*%I zP>!O3de=-%Czx1lG?*bX#SXBd&p%PK+4?#%(Qq_Lvf31tt5z?Qc0i|GE*k2KXeDA) zDUm6qYQ0ts!%A4DLJ_4{D}@m;szLuG55RB(lM}6;avGM*W(RZ%(F~bm|6(*~VM=Cs zGD*?Z&;jfFM8N~tN=SxMfbDo%Aq)O(kiR2X4I%_U zC}eU{3`^vdQgKLHDMQ4PN>Uk8R?1|QIEd1eREi>H+t8tZwZOfRTq2kxqinX?Ui@J( zR4iZfSB(K-qvc1{#v)xkdH>?G*{L&>(J32}nrCI+59kCbV~|Xxa(UtbvpcL(tHL^! zN2NBYR9Z;kQe`niLs(OvQ@N@; zgCCbl4T)qbZCoD@O3bXv;4OcxVxXYP1RjQ6I<*SZsl%9F9gZ8+F27lm4;$3suvM!{ zSv2{Sr3_H3R@t>w z0*(Iqap_fglL4^Bs8PiMdEi;tr2Y4HH2_^I4WJhAg)(VeDJy8I0Rw1NVV4Gc2RH%% zC2c@hHaFnE-sCnFT)57lljx$9Ux(S!hKRaA6kJiKx(pEGjS*WR5JffaVp!0zu9Dju z=PX6P)Tyy!u4G*9DA^++EMW9%#W|D7oU)lUk#Hbl2CU;eVw|_*7Img5gPgiDK-l3G z2YiH{B?-6?^07)HAc>^O1fLBOh~SsH;ZPEkwENNu#t4fTsY4g>lg6kiVTsC$_E<`! zi6b7IP1F8FpbU@;Ce0E$iCAK33z106qu_4RTsA|>g_K*RG6C{UTD1$Pi_5Rm0EGxv z^ERT>sx>-~4b$l{w>@GC2MXbUu2=?`3L5izo6#-v*fo0G9Hj(Z$*gs2!x7Sh6^W={ zVb!RmPLG{7>%xT)7SD&vB%5Oay&)QkhxC{fFbwF9Q^5Su;VfNHma0=cr^r&cr!KJWY~G&XV9b zd6Ca>A^{?Sq5(BgX>`>prbSgsOvWknK0o+Hq>Y5#5GvK^A+EL>B?dPOl9S1}E=-XA z7$Zetsm({lP0p-YqAIbxmkR^}1nr{~j6SMUdmLgbmL&W{Hlr&Dyum9fN+U`~jZlPu zBx7Rp9!CLjIJvCJBnuafc2usESaJpY|J|=L$^W67HN+%rbdq($tlz3MVh~sIDbt9< zsQ1x6vp5?}DiXFpDVBwcj-n&Ok+!s2tt>>MWq=;7AB#%Jf=A;qo7LiwD=&)UrL4&# zONEt+v{@7LD9ol%G?T^uufNIw|EG2wMw5`8j?#EYmw+=wIuRC&)N#V&#z#39;bD*mM$B6qS@fNqE5_)|H$F z)U6Au|RpPuME(}a&)d*o60Kn zKl}Qa4G>1i5GR+XmNKgR@84fpL5;>$d;RZ`uuN9GHfC55#y-|&`F<79(`UlP#!bNY}9a8S!(GOwE@Q9@!8g~|Y3 zX}Tct3MDg|l^T;dDVl;<7$F0Ul@)u#3I3eZ(W;0Gktp&p4H_1`IIPER?722FT$6IxULK&c2tw^ei2_%s$*)t3q z^VzLpsW;?<4X}syMyF9@)GlH*L5WtWvtf=uq$6U=02w3! ziM(c104e1y<4`Gv zh-kY45dx6424DhcS5ATkSUw25^!k#HRpmpt3iFtWoD^fMA(v7p;3B4a$e9;mX#<+0iG;^n(&6fyA{{n@ zH7Fya`cqS+9#$86+0W zrsSzY!E8ajX}wt)1y&dr;@&KUdxc^IK~Y$QS(U+(%kE-%1EQ{3Q~W9#)1{0gVS+SL zDURB3hDstq5gEc!G3a0oNq#4u%7!i$FB37uB1%62x zLo-GP0B;f+Kso`SsS{Rn*-neXNhH9CJQ5Vl9Bt4bh9H$C;ztRqnZhweRK_bveL53$ z`~8@dbQkqljg)OkwFS6=*;L*ZbLrWb9gLK~5t2_>3U+HK>p(piA(W`J$l#AFgDQ%b z`emXbCC-K1N`;0gsnH^72VOVttC=aRT*(I$8gb4S3#C&5Ocw^154$kLBv<0aj0jUp z9bmmNGbJHQhiFRaKqc}5;zM%`n?~GOuRX;%3yGXr0!m-XBp20^IG!dnrYz=BM?J-8 zT27Y&1}&~N^F?b!E@VZ7kxA;2l7+Dgac3z6EQGe0%(!#Ggxo^t;SgaFB}zHgP_ydk zLqaTS3$kp0^@p^AETBuPG({QaPq~0PN=P(xJc3!}q#~putyxN0Kn&rM4;7mr3xtGA@{pO+mjMbi;TIRoCYhcOq{5nP z8cW8FQ6`<&TLR87qJSf8({0mB$7pwS4lfnaWWe!nd}zyPd#KA zETN-9Ql&2u^t*j3r7a0a1GX57WTSqTk0c{ju4q+Bfl;ZM(5UMFn9wOfMER{XQ9vmH zSrQVO&^X*sCRB8IQyD|j7Ao2>TM#U-6tA?SnLO>Y8*}<-BmyflLPRYmxok`#q;mlp zx9GSGYN6H6T#ee`+Cm16_;Py4E-i|KRNTW5MlA-#ZMJY6lDU$4GZUgMMnnlEf)HX$ zmI5Go6LNvUQk++Bm8T%25QI?H9;}%uXn}>HysFyPqyg20jMtz!GM&Lvh&c^s>>)ja z2p(5XFF`#PKLx0*NU@F1aL2g%LOK`8gG&g9EvgTr0(#9zKXlX;;QV_&j_WAO&YU z8PXSZ5?QMR;bjt8){-ekSr8%_WSkAB{dTatB83c8V6;fwOYr)b&SkZyJyK;_>7j$c zn91)^stZz4jkRGkUI~i((v%a4Gc0U1#cj?+%wvpG5tB?TDE!%yPORb7=A1X0F_~rH zzeFS%BM5WBEt9GO9;Yg-FzUhdOnA!}B8=EzMRS7PmL(E^tSlY(DNORbJHq-2aYU`w zD0E=W*JKH=QVm%JR$3H6EaWvZUaLDnio;f$-&FK?4ZNoYV4>j8hNIC~H0H6G)keKR z#hFqn99N}ODo5C00e&HEq`|E(xH1z$QL!TKvUrs~UJhxZN?t$&9g?z1{3Sc9s4-t2 zIpHwawMp252Qb8%#RE8EN{UiMLXhXVNLuL-iwMG`!=*UEKnY)hk$?zDmrE$fgj-`$ z6j3ekz(QFNG|^>}IeCdn!oh4d>yHORTu~>O3QCEjDD{=>s*u7hu}9Uc#TOE>awrWY z{G`JxM^mCqR_oDAR3b~FKnMa{^2vC84TcUfs_{7$o@6W%v!!(!pSOg@xt!9IgbkR~ zCKfmr%Ek>`nAV6SA$?4YQlRd@!Z=Y0NqF$0L!ogNb2%sKWY8L+Xe2xzfC-6U_VI`x zmg}vYROyXLB!r7&Qh8l4S1167TP3)ic0I>tkSJ`?*sz#K7MH0)tW_6g+&-(i7z(gu zfO?Mw1RPqx`Ut}Yk)!~L!**THNRn{eo#1nB&M$FMoGPh|hmAp#N1GshmY~d|^c1y8 zXGsCsfEQ~^c#$lmC<6>SQjF4#B`jEqw^MMg6w&F^oW2yyhvQL;g>>sVIxXW|Hk`1D zI5|(JGIl4YS6JPqyayF$FuBFa+bEpz8lf^kl{OX;c@kNLLv4?Wr!r<1Z z#zII_WK1k|*;wF#CG}B}2UyJ*W058p%vr)=jXY~N3BjU-)WDijo)BlV0aFA7(s3*n z)SGCGtPu(lLCKz|zAX7x-PIriN zn{-s7ppfXjF0adDu#omtS}zjE!dzbDclg2Nw@Y;aRWuKR16{T(lr&@&5pY~klsv%{ zaIVEfDRoqq^Czfi zxC~I~v81CE4h2{@A5+9^3XG%>QiVw5$t*-@wI-?3Y?PV{Ao_-3@Wy)!nJdUcVMpE& z3Z;3c5rp}%qBa%sa^@OWB%Ppg0X(B6Qg*8@&P&bmP+V{I*g|q$NTZe|(_Vo!V=bKzLZwoG zjr(dateHWm>TfGmPGjqXf~2uc*x6$&7>b8Z=Ngt+r}S_5v2d{UO*Nv^iv8`pO`-0FuO+QUM`& zp2~W3aX+182%hBClto>NIct_t0ryI=uq+jDMl+}gDpkA0=C~;66iG^)5yC*SiB)0@ zD&rwwLwG^tFUo<}V2%|CMJC0FPM!@z0gED*cEwT|uY_ixq=`Y3vJ56wp?Nd7eu1!?tns2ja8X)= zMvKb*sj`$AhYvxZB*v6fAbQV>B^nP5!d+V7ab>Jt*o;ISCN|{uMG9El!h2ymqq1Ob z;3r!VOD+_GY!)qHHpN6SySgSJnG1l$KVnm;GHRo*fEbeyh?J}fYrzG)vJwN9NJ5$@ zL41siK(MA*?Jf!WIOL8MVW=2Ound|H2~d&r>7$7_l|kZ>&N6%lTn zVyL{s&FYK^Yan0r#ENDOQKT`a)fS@?Vu{KKnSn=?BNDjL>o19^Fj=#v*qpMcz%v$z zmBTDSYP~XybwxmUj&XUpP6wwbTga(0wIJ((#IgO6m4e`Fwo&3 z!ZD?g69ms8JAsO$P{sl0%qbJYp(UeCmNzG3T*O(ZNn!wd?f}_1`5V97;WMlB8!k#=(REwRWfnCC`fR0sK$KR9BGLo zLh}KiBrRo2WDz11cACQAydovlr&&Lahe;h?@F+!)$qSS(jB*eQ5)1}`5MU>!%LPEx zr}Q|8Xs%3h-jZZ>)%F9$oNfyDTSX)TvSdD?q!Gg=g*YLG30SRZAOTbiRLtRIkd$2Qkd*=YJU*C&^|T&N^TDtUBo;Lw87ESMwIvcwNGt`0g%FgD z>oA5DaAQ2^H}Nc`Q_xbao&ahV2c`@uu#nB^3zh*U>`GtQ5GF~F)@-NZb_cGAnDkDI zAQB1%LJEfv3(Cs1h+Pac&aMaPYDrXN@whpIhs46_bb!!XvanO8_5WeMyiz?DLzQHZ zmZyPo=H&r@LB!KiNy5j1ZFq|HC9U>gE@}maCdHLhxH%2nE)lk{IxswfRuLq($umxyG1 z{-RH9QsA00zybu9NF|FRjJm*ki&`MX5*=h5G$(hf)1s^>XLp8K9V-~Ea;ZAtuv*;= z7GRC}xYCwKMIJ0ixs5VR>WZpswmswY<;je}jzw`i zrlArR73G!~0+MLbk#`tUN+pvfsk~k%&4HZ4uTP8VXr#u<0CTU6+ zL=Jae?Giy=J)U(U5!wr^OIR#1Vs0xfwF*Y9CXSVG(h|so7ZbZf$%1y z5->-i2--%yGs%Wx)*27GE9Z*?XFNh zl*>shTne%Ui#{clvpSV#RgG_>Pn)$`%H&T+3h|s7q-K0^Oa>VgVNC?Q!X39Ui6CMi zLH3SJX_N&u$nlD!$&^@UGhvPao;qp*Xi&F2$6if*O2ZA>VHfHSvI0c;y83;TVq-!t? z^F`VniFs_iI8(qhAb|*0Hq_>F$m~=sU}gvbVI&dWX?8>b#zA>fhZw^Fy*3F&2};2Q zd~sGGbrxdch_l9>O9jCGN0>>HBFMpM2~{#K_44{$$fPuT0wEV2gdv=xU8#876AoEI zOcDg6F-VSATbmR}igP6q!HBdu1|;>%Jkf3h$4;_BYIfl@Oe@|=pI5J4U!&<$7aGpEQ=ehu*A>E(?EYfcDz^+5hB){ z)>%ctByBB%bOPciGIFN@s+lR0xQ7<>7S!f(gd@1RB#Tq5S&J(yDLZ3MB7_qO#3R8{ z%j9G*Mg{;3~G zf8H#GLPZm<^h0>TfTwdQC?U<4F|;ILMOq3r6Vx1@wj!|rBQ~e>1tb7FVY3U(+WC;v zXb_7d0Z$>WEksBtAeDz~I0<{b&Y}{I8Zp02umvT`QjJi8ByLsPjRmCOkpyjg0wr?^ z$gT)+ksPlT=eac4;{bvI-ff!a{i1*ttbU0EnNG>Qxnib7$TTHsHj^z{Qe@4V5-XxA zM-FfYQNaS(gRnsHtXsk)IH|y!_)OT%_yWnWD}|SbnY6VmUB5RJ5ZB95U_yd&j&J*P9zE(SDbOD(pZ>JCF4=8(`>GB zMNEcJD(T8{2_tO}<75s5?-85_p1LB9>g-6+NGPI&n9K`yyO`6b{NW%0#wJJSobW#2GjUC-J-`CzXWl zDDKfai$;yytu132jG{4E4XOkciI^FyNv5TYJmmFQ93H0_PMZh`Ly0631B@w3P|}zL z`5BD&z~&Hs0eHh zih`ITC!$sAKp>rBBPmnL7tw$P*b%XN;k<+k(H>_}0FeOg58>6*#3yJuDe#XCq^)MR zBA1Bg0@i5UipKI@rP3W&iA-TToVP?288pdT1w%wHrHh`to6K-@CSkIO0|BL%aM8(< z8}@6=X%aR{ILu*5*EsD!Svh-5r!NGp8L;^;7t=;}+AUWjls{+>x;)W%ibwsBOWLPkS4G)}mzhoz9W6b+dbQM_1S<1tgZDALDd3K<8s zA4Oh6OiCo_fC;fCAu5B!5+o7CAg`a-8c+`G!B}iXJ&p-Rpx>G1o)3& zZ(2#jVGb9>q}3-ckQq%1`xAW$o*ok6deB;vNH z8)P67ancs0U@|FEINWGW6rcfKl;E-bhfz`$>f2$1s&&9l;lC!2e6#*2`AyCQrC+BLu z&qwIwzgPH5m3^h~-zt3n0uucXHLk$9lSpJTaV1S6!Acp}fT*ml{Hm0}VpPf?A-O~$ z`PU&ys=APNK&LDz(4jx2_5U}`|6bMnzta3)*Y*Ad9Io2QW!$z5}Nz2G#>? z`|}{jzj18BI+ogb<)6!C(@}Tm_{8?NRwhgy*~msKF;H z6{4MFCXodvOa7-`*$&d`?zu!V+d%;<1`dSuQI@AO5GZ%$=^7Z2v22$*NaP?JndHHk zkeddNfjG+}N5M&xOqBZb^a`SoqSC((tAHt8eZa*H*~tVr%ktN$7E`$%zI-6T=Lp7V ziie15!&rmGp9frwuU-23eyZt?R-3L4LT}6*{@KP{t(b0ZCnS2fc2C>Trxs&oY(c$F zOIr6#ELk!!F!jXD)m(!$+*6Og^LC4okBon(YU8(6zw9|xmA`bf<$iL+p#CS9O+I$w z`4_8F*!QDX-59_6@|BSzdY+y5;Kqmxqdn$ry~bata%WT5KffCFuV=hP3Y4IC{|KH#F?CZT_AgUN}#jUAAr7 zx>l!tnxlWDqGHiHRGjPd$uM!oHsXH2sjIO=&biB09X&F-J^Z%s&e28P6N~u%vqvoa zbojxq6^rY4y*?du>dZJF-+pJr+27mWSWop4zu@}nxj8Er?VI3RFi;tK?&%xxrMfOt z-oHEg!BhvkxL4m=6)$y8z47Q5pWp4h=({`jkF46rtKYAzI`Z=Ohv&XH{N|5ahsHmc z58iP(>&w)M@9*1oe)xDr#iQAm$&0%dv5T*r9klb~?>B6ju35V9%rCVxslBHSJ;7Zx zH%2Qat{?K<@#N|T6&2|ErC;7%4nOrx%gOCRV~+L_x9c)Ger@vQ{KYL!t=axur)o@hCO6Jla$)HG zS1-xE7u+3hu6p&0U!`N4f1ABNdxAubg`0!k!+f{icJ{&d=XH za$}t@wpM*_xD!0TXufOt{f(`=Ok6$Za~VMHiAG`lgI^3w`n|8c9$~cmr?$PE^ejRHSQv(s?NK&?L0!HGaX^ zn;YOdEmrVTtml3o`t}c}PE)2QD=Hdp%v^hO&+%RpLl;UNj@KJ`f7ba)`+`$tyFQrx z?0537y*K&+oaZn7^2QI(_lm~a*IJR9(BiFDBl|6^MDETwc=6eyiUH$9nypMghUn$?bXXD);ch*^EKU{I};y~%rj#7ZH_TIW7C#$ABIGMUz=O2(<+-^d8 z;=#%O9cOLajno5W@5w-79jQA*9}W?AG+flD-M$IEr*)e4<)|5V7oSfB+P8kIn!m43 zCT{Hcpzlon=Lee^{Ur%?piQrtJ(As)iyKr`_jfNH-fhF)k;w^UR2$GfnA>j_v~j3k z6RKv%(Ye!yzF_HQJ1^Plc;WN{aPw|r!0`EB1^>$5kw_NK;9^HhU{ z$#>@a2j73;;yQNcf{Kcle*S6SZx43uSaRY3c_A2ozu)nx`o431{%%dTMjM+|RD9IP z+VjY01ubcZN-s?AD|!M&u{wAEdwBj zJ5Szz-Q0Rf!v;?;huc{X?V0X4v1`l_Fj)$HzQ%ti+V4ze-)J?b`?OB@+^*rF3SH{g zmtJmByP`tae`nhw>x+i{pY=KXbtI&puQdSpGk?1|_}r5~ZX2^zF4k%}*zVm+bJ}bT zk7@pNWpL`Jhd%#p@sk^Y5&9^6x$S;p|E~FSPJY?$Gx)Nj_hD}1?d3gl<<0{n3l7!4 zvXfW8HmT|6i(726PydlXhM!z?agG9vd~*wqEndF(JV77AJ0EP>NWbBdsr&ACOy{~* zkDIP?oos$tMs#v_TE72QkHWA;z1w}(jk1LCGmF;Ho?!BMkOKu!^{?Uqx4b1iRcYf>s zK$Z{R5liR(n&U=j=O0?L?k;u?O!SwYlfLua*M{PcZ8W1MjaxX;+HKs$hxImg2ekHE zvt-;mui3wNZrDy2JK^X=>lfEj4_cNmFkXHz^CPjZ*YsAGtu01U0}6ruuGS{$(84!( zx9e+wiFEf`IQ6mhkk4`XDygP!scn_y`OiT!kw>0^(uJ# z&yyXG{p2fN$(&16<0FpQ_Rf04Bq~@giO&~`;eG4-tdw8h2cX^x%Av*QeXsR+!Pq}O z>YY!f%f_`C`pFjY;`xi^Ct$U3J*SZJ`8tGEw zKNgeBf@ZI=pPL8<`sLWJ+217Z#Ah#=zgT;F+EM1?v9x4PixCN1<5CvT*!}D9n0eD3 zyF)MhD4lmkdS=Uh_E@7&!Li(rrjWF63UvQ#dW>LLH|W5b)4HpLVWFpcb~@j#_e}54 zj+Vo-zus0&2X=l9we0GLU!41W_U@1UkL#QE?==fvu|%rb*H-krs9E)-HLhASaH*~1 z*^{QJ_OBNH9%1zTfzl|So}O=^{;(mC`=-Fq*7~8u&yGbOH(TFz&Fu9fw1$P1t0s>= z)wZJI=xZNNSn}!GrOc#@llM31*;jIL=X}@FhgTl7c;b`(0MU8BU7ow={kI~oHhgWS zRP$QT;^nCiR*(3mk)5ij5MS6e@!DswwrSrkLd)5$jx{>Fu6@(*hBq&TD=JQ(zcjM` z#pUClJ#7BiD?eV<@xq~C)lipv#rFZ(Z46QK$9%qP(7dbB~sf&3kDQIKW%+@L|mC+-9nw;~du%^`STLALu4^sqW?x&xl`NG@_zk z9k;G_?IoSG*WL)sz@zo*-mZIe%%Jbxnb z{DzaqN6X(8p1+%4d#Ta-cH^3~ytIDjk<<;@FPBrj#t)TWeyZQ#`}$9vjpDl{M=Y-1u$kanb6WXW#MT$9GSUU%b$!RC<2uo@UK@c^5h7bkdKNoH^Ke zhv>uP;Avq|kHM}UbB8_lk3RM5)o#AL@R_q+V_%OouN!&u}-B!1-p%1tE**j+jGqsO8FGTw_{NV}a#Y)x?r;~i=1>m7sW zh5Fm*dedt!-|_MmwBxsjwm!Lq?N-@5CaYJciwV3EaRZxQcRPCJ;e#)aBs@a~O?Z9q zR=eYF-9cAISG6DLUU2yP=Evf1*1i#15Y!e!rNM60lat!K@r?(n+!B>PyA)ruVzKF<%r!@?Lko}0 zYuVt*-#;Dl;X4=e8`hDT!Lv_%``wjRZQEY|UH|;xBkg+4dUC9!R$|7%wd=UVyswVR zd+T6av~$AzacjF)eZMjPBJ*W~)QP%-2A!K8ssn%fXlEZIL!QGV79hKhBX1d8EyPE^ zz5C;Z8y9DfxVjy@KeSPM<;oA1Ub^v({PR!9tv}F~RgE*5mn!BwT-9vQh_go~zVqF^ z=Zf3=VMmTEw9kHU@w+}BpZet3&zI{@X}9DnCw#c$&I$crX=!4tU0c-&>4UoMCw^Es zdC#KRCJFV-v{r@>20H04Zaw+J(TC@zyLNm&z0G#%85y*?@vbf3T{-``u<`7kW74zD zntgzO_@)0-S!H(lkk`9*j!Z!U=gzcDN@iH~$3?HAsu0Dd3~n+)!k?L z+^YxbCSKR9zts57u+9gL4X_f53H^RFw6z~R)pbInTe`kosOYxu`6s_?cIxZHcenLJ zWrs!$KX|jw=JDup>B+V~KXdi1SEOxWVy&h2Z{Bfl59_w0iT`Hp9T!$?J@&I8`sF}q z^X{r{kFL2J-@Et9=MQ(}E`GDBx8)zBPiEX*ZcXfGY!6?-uq%sZe8gmd${m>qY;nJ zYDQG_Jn_8x^7U+v$&`q+=VPp^GVe&BfRpME|&E}vMpdmI%j;nqDjSM+T1MqB*q{ieE$H+-3u4VxOdtGh1DpdSA6Nt?IdUi3=s)vclD zhhCZTnL_?>VE6C}Z^_-p^`@JvOVjmNzSXN?v%vEHZ?_RQEWR^%-OFo_bs9K%?aAhA zI*fg6R*PwCCpY@Za#7Ram&BS&?{5F_;mwIIdy`&sgKkMJ?eo1y9XA`(Z{#EJOA^p{mh4kN!jNcDqMhKRI{q4^yxFa^lv{j)CXTUAlht z>dF?{?Xxys*;_TGLfYb$*V=AVZyEjgmNsoKj8$!Ure%2VjNI*C8!vcz#uK9|pMCV+ z5MudPmyfz6sRu8l+rKz?{9|7|_QXqEWX$4u?1%JV|5=cU35M)cG$U9jgdAp7SvfGH}v?qF)`)|>O6QQ zipT5iFPpz>0uV%1<9Fbu7PVSkERF^yex&8{oyu7s?6QpIR(!^9>htA<&V~=>xO>#M z&FJ}N+wsjiBvh4;#hXriZ`Xvyn?KuSUWSKPzkgr?f4zx)db*u9yk`?RrS8TC3y=ei zN`pH!xx=12vw7%SeZ^D0SGBf(GGV(~v!qM>WAT3Qo~Y06{r2IYJLk?!nq*(lxy93W zZ?zvavG<;{jels~^@>vh{91|M8MQ^wr?wSEf9;`}^l3et&(s{9e5nKF_q~?Vj9+ zhO@i-4|ut;7C+DiAG7AoE;F85bn(W;p`WI|w+uAWznYB=UBCPqX}9R`;Sg3LU^_c_-l3<0ZGXIA8F2H= zi>K;KKU4}0PCjz$u>0^~y?)6y{^e*@Rn@f?_nc_$?H^eeOFFlnzrg!uD{H;L%a7U5 zFX?lrSMMvAjML_wtk+VE%QWMwwsHMCs#Xo#yan7jICSx{r=y0`wRU{9aQv?OkKZWu zKRx+qT|s>4*rLmtFJi0jRCSmB_}*@5hHU<3AcQesl6OaIuW#yCKv1JA377-+ojwFVgkp@5yyAv%vb^C*3IJKEo?} zy;U%5eTI4FDEDr~#^WasWlp@f;l`Mk-Wj`05t!HH+t@m8)#`N%et&TP?hgweZ~x-f zBZ)Jucijn(+0*0dsR6q?@4Y`8^5wg4zZDU;9I@*B>JJ~>$ThvC?SEtB;vUj& zAMvjqjM=ItOSWEFyLRm_J$jCAZ=7cuvv+1=PyNK@J)uV>QHf-9UFXss{YU*SHno1z z^k%>BO1qP5#}Dbz6S?=`)T!U>9koManx?ln-QZ@9cZ>ta zW8!m>A6pBViS*zzeYRuUd?)uFx$>*rk5%gb^&{Y8(Xgn#kFGVR$IQA<%3fY*fAxf=d#%k!&)QeiMZajd`>3RAt(V6< zbN9e!*O#??;+KDnF)@dP;~iJPxBk)l%hPS%8uQHC)}E&~u)i$-_&E0Ysts?RUEOfb4}YIO8UOj+Z?B!-aBtt>t(O)vD}Jth=;IUY+d~F@6I(s)m!1#58Tt5|%l1CO zv~4q~)s!{GZ1&zt?~#Q5<&XN-HIRlm!Nej0V@=Gr>%eDH|W+5XmE z)Yt_XT6w-_qv5w&iQd2b$+hY2pXe?8xYHFGD}Q#2dh(v8dyI3BjcEmM9X;)lk6%8P zo~WPl`Dw$5zC}sfS+cG6$%BTr-gCOJ!nNz%C;1W2Z7z-N`T;^UA2Vg<>s?>n9-J8$ zH*MZ*_3FHKZL9C2ofmvMXV{oduXP*U3Z2xr<&r6*?1SPIynO`c3jTUy)5lXq@@Ii>3Q&z8}x4r&MH?pTvUW_`&{dH~(@w{(rV{o^Ok zeR#OvOl9|r7q-nD_x9wzhn!-~WbKqK4Vvz6Irqt?M*_=Uy!dtE!6OexUA}vSSo>Rx zKE3+fDQ?QYl=z^lOOtmr>3*PYpGg;o$X3Q4WUKi$U_-lBw+=qjvi6PzL)*Wwf0#IU z8hT9neqdD#>FKJ;-|q}Y7vS;c_kX+r?r_n&k2U+@{_npHt8?Y_tXZ?n(|5D>wLVG3 z%?_qB!Pnlt+M#OEoO$h;wN0v;kJl|c{LB9X13~=0+P%BGyC=dkRVsa}V1^=z#>5Ov zNH^3XV|h0$cp#QkD%JL1?HCvsj6{-gbF4w%y!B;%{sObnsL^KZ+_aj!dms#?;j2Lw z2L`01@820>1AeeuFv?fWn~U;RkzN<+tt35_l-EW1sz~2{(pOERUj?*)@iml}p9t&t z;$fqjhYGg@GorV12fX{jT}=}@6|gK@OgMi4T)A>}dwa()4~+YuG-)ZA zp-7_Sm_Z=Sz!B$*(VH-A2q=##wWhGBa4-;vB!=gqYuBz{&&$u{gD?}vaE;!&rD&B% z8bVtKDi{tJWOFqsVg?Yxe!vOJ<03s3WK$XG*$d;z<^$B-Lv+jgbn6kS{W#Trf@(cV zwH&5fj#76HqUl~3yodCZ2M~uK_CUPBV+JjOnc+tBG=j!A?+^F1z$VzF{*3KB%(AYk zYPCwmlSA^85gcjl(P0W^Oh7Wj43ugFDrF9ba;o{c9N2vL4noJHDqTy8yXs-yGLRZ73e9Hf*Fb=8Ur&3M@ELtU@#^NW|X8jh7mfQ ze$%Ecef@p$>r3Jp7$ZM_0Uv?(XiLS_TFbVg6@KplwzXEm7-X{>b$Qh5_X8x5-n~?F zHFfteeeVyU#~+8D)`vT9hxtkC^@rrppt0 zb|v`aLh!*K0YzY0;1jZ`obtNRf+F6Gf*kMwKqhx;!vp^w)1ShAS(dGIxzrjRjtzGg zHqyiPw6ru!dIq6j#>6Ev%;1v(?ZslTX1)5ui=Wr?yX2<1EyVd#=9nS!+Lf!dU!#VJyvws#{z)gENDVU*1qGXss*e&VS*Irw+cI`T|NdN<(5=x9f zsfwZgs8XpnZrf(h#k(j^IpwROS`O0>>wqg5e+L`v=fc5BZkP?Rp#bCmngQx~{1>|Y0}^iGt)RS> zq?B+(_CTM#RbarXHDo`lI?5(KK z>U7Bf0~6BUq1EcvtbMz`-(Ol`a|MWr!IZ z{}LN(W8>wltSqxRO_nh;(lEYCLoC_m*)$r>`$vDnaX!XV0#dg<1~=zpe{+H*=u@E{Ybs{lD44MQcvXU~vcSS4}y=+QFjlM zUIZJI&rLSFsXH~4uZC>eN8kHB$1;&oo zQE5Inc5J#`u3&~DiN?f?#Y>iSc6P%^il%q&+O5`VqdjyaW7v6YK<_%8p{Qs>S9cdo z{Gz@-E9+I1-S*6pSb`&o$ZfG$btdbV^`|1ir?K*YU;t@q09>*RC%kb(Ke5z{(9?Rl z4F;o(qh)kMr$4B!HkL7D-?PA_`(O%z(Letwy_f%hq$}&u2TG zJY%3}#}T673I9Qh1v=`yPe1)6GDHF*VhF{8n<~tRt5v?ST9z9;RbQv6)giw)Vz>H#q9mCLm)6*<)*1K@w zLewo&QA|gXf*Fb=8b4+T9ro(gYffh_!UhyVqc&5(41nkC?3|UWRzaPNUB}RS;#n${ zx?p`_zu%AU#d6V(4vn7``ukKT1}8ww(D&#b#TzpL=J|EH{X_D0dEjMy@ zRQOYNm?7w7-6^xljM=c6{##RS1S+{e8fvv>=R3Q4dV5pgZ3QzFNi-H_n0d_TK|`ZG z_4>j2ka)tS}wQqscfj*c`;rcvMd9gk3#Hy}q!}KQNH+A-SjxzxY4) z%Qd)(>x$zak{DU9)nl~}tz?5A5TF6i*k%Gun|3CCF(Fff3-JtuhuuyKA>)A4Vhqh| zOzDF{3wH7egJTFGJd7V$w!uI#CKw1U1loLPDaAP0*a7+d(yHg~u53w`grr@QRMnX? znw7P__uPBW`QP7}__rX89UILVWX6VOhpj`cHT_rfM;=~se&6}2q2V+Lt5&Nwp$+j` zS+EZV1298W#YurNY>p9fa&qCi^!Q(4%qQ)bRNVx&zBH@jP(g;IBNvKP?8@nDRYB3t*yhN0o%r*i^f z%m|yC1%MfXp)zi2YL1Ja0lzYgP&JUu9;?_(rop?8ml@Nu&pfj{`?a3lKCe-75Fk9V zHg9i19d-Bg_Vo4l_Vw}ZeLRjTkUe34c-|Q8y=xon;J(_}aWX+>sjGu7NvG3!t0~5@ zOq~vgWmi>K^Z#peT1gl)g0t@+W=I|kO*2qjP@xt}-K6hlXkZ4*j+J)D!-oqNF4Uk! zJ-dP*bMJ3JMBsoY-)i@>a;o?rqRHjfMCKmtyTx*1Ha%n0VF_CjMSNf zNyvL z*Wd3?sBkGi=;%0d^jJ|*(c)JZPoFU(Dk>W4NG6jj6)L!Hz||^Dg+b`DLw@cO%RzzLA8YIC8IuVy23o$+hloLPMnz4n zt*f)U@)BzgV}>Y`5Hny94AUqSDuqHBv_l@^xB(3)ge2L$Mp4F?*w|aQZ%^)ih6HAe zmFj0lkAoo4(9zJ6-#D%(OGExd!9;q!9s~z+(qxXFH}A#N)U=Vay1^g2Ie(`}}fC{PgEB3=2@| z5oXBc^3`kB3=9ssjR_*bvMxn&ueGhL{NoiXR?eRNJ={QOG&;Bu3dUaV@S?T`$`}UOv>iZ8IC@%gm zC--M_6B2MeuGiy;G^D%TAVP&w^@p9iCU-wW0yFGf@!q?4FCih3t569j)ZO`$?L1&KVGP+Q{(oZj=Bv zkdVUZkR%PC$oW|Ub&Anybtx&SBVo)4&_rSeSj&~GbLJ#q8ZDrMpXUxY{&UYhmz(?3 z{sF`oZg;x#w<}k!ZOYG|Icv5OL{O7QAaweNpW1h4_XA^OOmiNKSSlMj7zxU#Ye!aCt+Jg$DC zqUy7w$4;HHjD|5IKof}>eEIzA&Yje>R1K!{=g{H0*J`zSc^e0ZhR4U4P={yFp3lt8 z#0|Jwg^>hl6s}$ID#1$xy1^MVrimgcSiVxJOiWJNUsh)Au?kBQu!42C5My;sEsjH6 z1R6?cS3LyApq|1oEheVn^cik6yNzYN>5WIs-~@!BNFzy-7n?5zdB7oU;xS_^)zxZE zamhzPN5Z%b$PVxwGT9ze`F?24>LebiOm3 zqgk_&MtzM!p`1H6;pUgOq}K+YV|0hv=24U}PIOkVB|#>nuDfk#D8ZEQU2 zSRy}^&EqzD!3<%$AgWqRotRS&Rg)MqJ`5f+CK^y>LE%>DNl`l{#bsxLdemx+?R>Xg(}*iW(R5^e*D z4?5(ny}ct?%n-KP+HHL`^T&!vIf#p&=T1_z0Vnnp7u#&ywd**wwyz&-`}I3;M+1jY z9Gp*rO8Ck~_yj!AYIT`QvM#q=aV%5_ud=!tUcmKwBjaNn1~@~n!(-#(8_%8d^AtGD zPLxVlho-n_+m3TZ7gFr(H| zOCys2?It=!(r}x;p`HbEhzq@=ap zZAn3oJ9>Nj z`S7Z1YG@;4Fc6H<*QEx(>UH|~>C-PXHKASd4}3YyPO&T)6dNXXlo} zZU1Gz%%hsh?l^w>hoXV3FUxy*3DR)^wSwAK8SE@tVA`Wa6hQ>kcC^k+M{ucxMN}NE zBDTk}r~~6Nj-C;>In@r}8MRJ@00If3<5qP%CTszcK?D*AN&0*5B{6_tlz@T5_x!lr zB=_C-d++}4@AtVZHUe9?|0Tl_rx;)+5sC`wbo%>q=ia-2Un-S)czE!*{J!0TU*S!9 zd3jNcVZQ(~m<%Soa4?)SayH5n95CbJ2xh!U&WRaDDi;~4t|==!o6cb1WL)*rPd1D5 zyWh`mZPSudJ3iYD1I+j~FAwqvnFsn?p1MScNQ@vnnDf|IUr{$Q4tlle?Cd;#{P$ajg&stg|BbSdJJqpKh^Cd)mw=?0B9FB`n0VY5(Utd3{&ahty_P~0M zv^PKF4$CU$V*)%H>}a3qGrYVegNH=jH$USG9urb4n~hAEI7uoke$`c2zGB6wQKLB= zF3bSNA&pIn!{NBNjLFZ>H<^Y}262#_7c)pvD^^uqGi{nTk0-D{l6wnp2tse~>HmB1 z&>?>I)KJF^y#aLA~wL(lWSr{|i&M*dP-W ze(~aWw)e7QTMyJ@sx_JqSFIj3dNdpl4;(x=_-+i29E}-)BbYIuG8zq3eX_Jvj|f?v zPFF6IK^2o0l@t|~NQ;W4#YNKMVxl80E+{ON$>qBCc49D0Vl*?x^5rXOG*^HNOO3Xv z)cEuD1%%)WP$78`vkb$#cKR^u05UmaxNX=#>;YN;3%R;7$Ix*;=I%K`{L5+Me0|2v z@$-3a?wnaZ9<#jNr+T@I-Ng*Hh(<%0OqPHzfD1`y#25uCFfHD<8@623BY;@~lg(i@`k7)coujY=K72Pin$6V5HQIYK>a0Y1C+R zx_0x>UYFR|_2WRqk<-bUF~e3lr_V51Y!UtvrhSQ%LJ=wuLd;*fbY+129Kx7Ewh~Dk zKbVrp5`8DUl!n9-rsw>B(ZTNid+$LTDdjfZ>=qNB{mw#93f2mX47w*W(3=?I67U>FM1fmc{RGCy1n?!g0kc}*!Pv7Rw0#xQ3DXsDNO zpg7F}dX8Av9v$=TjgGp5lgs%rgQ`l`3JO_l&MU@$k6;5sMGQJKH!t7eeo`8`m;tJ( zRn401%Vu*NhZ$m+YV26ow6t{dJ)B}&IfWC0pb^Y)LfM{YjlDBBRrn~zFi@2bDqu%j zho-tyUEQf6tfNtB(6&$msF@68Y}czbOT)wAydWehv~8-yyLB*B$Yd}++qt8vsyZYj z6fO~o#FjK`f7nCP6@y+qRw@tu_k?G+N8 zJWeN%*H%Cqr>!8U!*Da+bSJ@dcT0O^lKQ&j>dBZCNs!;Krt>%gCIetYNO93?8ZKfo zSyQG?Ei04tSPqlD)t&$mqk&uuIHWW@)ig9|>VMLxni|2LwY9=T#5xea8!T&RZzK$F zIX`AlYbBKy1B;?4W(n!n3^@Wb7_7Yfi;nk`)R4xEGiT3^9YZ6JB#tqN3RgFJRMg52 zeW%H?>zrh3nU68US|gb8=47<|Gm!PE*H|-l>N=b1+N&ODAO6sGTh?;@Qqz^wn)BJ} zQ)%^IY_HEwR;9()?pa@#x?YvKv37S%?e^8R$$zG-CV6%3u21XsZmdm(0UPSm6YI0K zH6Kgau_o$gE;Rh5jDZPVUEQ`OZ-dGSo-{Nx1}_ewxzcf5)b+wXGpbN*o)Z_bIea=@ z@Q$y~zOA7TFKyD_N;2I|)K|s>S7>FDHn4JNu}O@A&5HO*uznbB@GAd-8DfvHfem+#mhr0kYk{;dmB& zAD44Pl5=G9>0_xEa`s+0o%P+fN3Z6eFTHlDvP|~lgWHP7k7}w^nntZo+gH$7x<;F? zhIFbL0+>NcDwVRBtbQg;jM!N?gTc(p8^Mh3f>ijYRjX+G|l# z$Ak71cFJhg(B8f;(FkS?yolp#*V;t|RhJq@^$n&@eY3hjxuJEA|_Z79ju61q}&jqT)zZNLAC1^ zD`SGeU>IEWBzj?WOz@p`ArbG+a%1!H?wDacpovkGWQ=XeMvLFj);BbUgoe2iNx;t7 zz^U*+QIyW)PW#2w&v!MZfxENWh^N(k0t55Leh4Irteyk{hh-Au!!mYNg(7V1Oy-L?rLXtw6(hJ%uaW@(^~Nb29f|FVi~n+p)@1` z#H|ldfh0Whuvm8&*R7*ycOBcVy4~t-eeq0DL{RH+13o}e0Ye}p*>mo_xey7DngGcT z-+XiU?&aj1@0|19@B5u}j3@v<$n2OQ#rT253>m2yW?(&`0Wre_Uc#P`H_UZ%KpN)y ztWyU!F8jk<6#qaZh=ozmxG;mw;RZ2T@{CN2#X9uN$O?W9y|baLNKgvFfKRZ&K3>Tl zKnp^39?)2gLZndu_DIku#ab0qor*NTd&1UYwoWPDuS(FV;B2J5XYT4WHdl9jSMl)6!h6c(wse8vlSo7IYII8kx_KpcF!F?gx$MyC=}|rGA;bf5gLst;=R-GO{%Ri%dAg_*g%p4 zi4!%Bj}SRzy^fChB7NUJZuh)&fs###tg6oa5-JP_|0d} zdWSC)x6Kwy;WsCuigExUh_p}vBqZpRI6sKUm%xTCP=$zqih=|TE$jwv<1J(i@LM>P z{XI4^;1C7b2M`Fr8(zuY$inRCl08CoZoF2R_Seq~P8~aX5mHBI_fu29$w{Pn+ZD-M zFhi*-q|pK}h;>1^p@7m6Hs{>=|4xvf-isL}YK_lKA8^fa-FbYgK|Fl6V;4TSXMPhN z>6ANV8Z#zPh>A5B+Q6_FyNx$0pPv4*UAMh0D;`aaLN_mO`6vQ|3O>#NC}ate69$># z1$4BZO9YQH;wzFO=Z1s@0@45>02u=m=MWl=zGTVLhQ`LBiy;~5>eU87AOIf5iV8SX z03$FoJY1bE>aWkTUCRJ~VXTok@`I~ttdaIs%dnB9{d&3WM%LxyDewMnG1WH^1U7f9 z&}FlO8H_+>LBS{|+4A7-hh?f*buK9Vc3>DqmE-6$9wnGWtW&Mi6%Z(*Q3}<0yy88P zg*k%K+{Cit&yJP;6F#}o4!@fOTjxoR~C>0n5(V?*r7PKE>pA>p&< zR#n$dke^1urtu9@0V)+5q(W$?2|@LTq#@zELKovziJ&t*?nKg>xnbb} zfvjK-7t7NAOO`HeYHEIdK^SH9n)-OW7z%{~@=tK^D5)S6#Dt$;z~V)(T{xC(Ys@m$ zN{!Wk3gnOtAZbY5g&C$Axv^Sq1iXQdSuL|QWInhcUnhKjrXQ1yZ~$qH4jVyCBs4U% zvZ~7YQDO@}{KLQ27G=X)uNx0(xL-wD1z-#?yLi7!tOcr!Q|HI3^8_XPRu^W+YVtPy zsdVo@j(l5JdHY_Q)nakF7LOGV#|$gRZ2J1EVPWA2g1EvMxRU`4=5H1*x^?@Gd;KKE z+c1Mb;`SZd#;@A zD9dj9V~U!ULGQf1u<^9Sc4HgliW->_ z@IVd343nDxgTM@|HDcofjKK}-)pXO3nLAP=0~t&NVFPzZi{9W+I*qYx*$3U--6I`k z$J58jf6;)lo}g0_bzh^LY}nAK963jcscM~08L!P3s`L59xlu(qiDd;lj~_l+ec`A3 zfHwvvKFr-9o{Sk*d-U(xz022^;ua?v^nmx?d%wG<$8iR?iML?}0rNjxxWodVE1TmY z$YCFK2*Tp9IqW)py$!o2xz$^u9hx79E50twusZEvbr{NObNI>V{jEdVVMBQshfHIJ zyJTpl7%+A{yLzdkT+y~o+_Gh5%hpxsC(&eCZ*{2h{7K{rLR*L0QXxhfqQ7s9M8p6_+7=H8@+p(4UivgU=RHrcb}X-d@pwkn!EwgW-g5 z@>yb>m_fejkjH+#KBDpRd1tF6!Zb1Q!%;?2112+I>nCoO#z4XE5^i!vHY(JE{@nG?CaXgd8fHx!# z7ONw~a9{v){(=QR-MKT;2Hfv_lysmtR-KQN#-wA$_-RBT))oLGUYpM=&WSGGyYY+C zKc7E)>#o6SA#Y5B$T5u>&k1>*v{(tkH1+i*B#3GL^bogHz~EUFU&@9}8{M&U&c#bH zLn2A@@$m(d+EdDldd}g3j~%dFdHEstdf0C^S5#CK6c!d16&C?5F7Zq)#uWH@@zQ0R zZHm9~Y0P*bvDyKVI6Tmr(5B9#C2d(Ebn6O3^4eC3y_!ofoocigS@}2!wS2t#u{O(Q z?z0VtU+nqZ`Tx)v3B(~)yh=w!F8sWL{bh}S9C?=N~cYIP8u!GRe*bR^6G z$&E^-re|b0J#TyyzWDdIQAIhhi0cZb8Yi5qSO;2#NUIcS6@WCvI;B{v5UO({i*iId zh2raqs#}c%17>1fu#Q^D6f}jI$ipzhM&N~gOXQiEz&&ybS3Kl!z-Kbc-_QTR!Go^v z+eqR?m_bI}Gox{BG#?xv*A>9PH#s;2VRL4MhTXh*)4kq4>+M~$ChDb^e&Gj%O2rf! zRH`3oW9@T_^`u}nWrY6@dr2kUQ=N4fG8YB@wGT`D3by|KGiJ=#xpS9$ci;tN8Z&;T zkO|ppv!|gxwCT~2B2Y}xk0Q`ioekh{ zuGKmN2s>7KdV1t0yiI%oBne8AJ-?d}B1tqMH-_}^oGklcHp-*cbe@B8@~^kT|w z!E+^t_1oL^Ijf&Z#ZqQH!fyy57K`(}m5=sbzU=?j-L7-ld=-qlxc!jC2zPcX_GsZJ zo!Fb35$d3)ctc-e(B?JPidr=XPri5Yn=3Q0G1Jn{Ma&2gH*bwqR8+x|&Ew+105x39 zfb|xR=gyy}D@p%|Bg}Bkw4m8+dHU%bRw@fNER-T?gA5Ey*|>4j#KZ)>sambJ60sD+ zlGFJa@D!*I5_N*7^S$Ty2=_bs3!nW8Pmk=jxaSf+KNDC(taDhQDQ%rf z3K*1bS_q3V>~NJyIn}9jbt^{Ct4@6M`pzTuzi81F8NgC?V6Ps}HG<~?X*7y8`yX5R zD4WH;e;YsY$dalmdB7Hczq`}Z2R?YOpjExFF+(pkYUlh1U_)%sOVNq0phY8Wt*blr zhrU5_rlmoS7=i|Un32w8GCPhQi#(;Fp^*>&^wFxEoP-318%k-x3=o!-@{^yg86F;v zJjq}YkC@Td_ciQdcnHEGVhk$nOhy7jRkM%wRIN69afyVPgoV?qAr2?pQ3w0I2ht!z zXkE2hO?wf-jYZ4|C7iQlL2YbZF2`N_#MzUBFN?{t&E^UO7^GZ4#vT~Llf?r9TWgS~h7(+7k4aOy3BuO@!YM>LmNG23TxBqoc`+K!C+WL2uYc+e@~%BRW$nB zmnJXBZI=*QSWQZ+iGl}{!Wt4_DBM>~cPjuh&VIbVvg1%*tG)U;0uSi$isL&>5Y|Vt@Y!PxO;!sulrk_miHBd5vo6LIn&z1;|rs1lZ6PG`}G+ zXx~12`qu3+_nUVH8t=mix-bLYY-(z1Zti+zb+w#O$O%GD$itEhE>S9X?%esrlRw0; zl%((sC8VWt$&zKecI}F8J>v&6s1+48UT0@lMn)!p;tXcY8#a*7!i#(J@LRNJYqi>o zip5Y{db=VTqA(+I5i=HYI6Xk&A#JDA<=yJp$txqRHDvi_b7ekwG%`>bFoq!J*f0;w za3^oxyJhmy7c&EQ&DquV_4Q?DXR$flz%v?_1w5V2=4NNC_(xgcb!D;Vo^rRm4}$YT z_eZi)0I)H5Ks@%Ba(l1JikJZygRqCd7&i1vAPvINEhoRIX*^ylY-|>YX<~ztZD7NT)w*MmcE23{Y}1-~j{%ixPFjl01QhCUg~x#R1Es z)lK+mRD)qy^6?WVqFc}S!3=M!ojm#B^5v=Cml#P8a5$W-tnBVfJ+lv?nmY1i7cpZV zv4|PL!r{}FPR~b|!|515`+-FzB6n{lWt5pxvdEB=TD-;`C$bPCQ2(A61~j{;$47&e z;!s^ZlL;1(5#YUh-hO&wGDrU0+8Z?`h`3}3DlAC;NF(&%2O;d=TL?eC{`RkJ|Eacj zSI;1X($=ZGKV#hKR5-hc&rZL(>q!09R-g!-#E49jQo~$71;#LH#YUafsQqO}bJ4+l znHgCeHYeCR2E$BZV(W6(kByDbse{*f>rb61Xx2!LI`rsR149IYTIrPJJvBhjsA{9uN6 zS{aN+SZ5H7MO0)Y7K`=x<4^h)8DRz;=p1jD!C1tMg&aOj>2&|yoxC~vu9htQIayI) zCPb8Jf@6v-=qLo=Bx8*Y^C1nn$h`Zx>%Z3ps{^?0x^?T5vE;Pi(<&7v^JTL_irc;0od4aw0Z5;Ev&?(`!q9;i^G2N%$a`%tI1zY=L(wDGi(!c zT9~KAp6b=ZKuX%{^O_FsJ8|sl$dJ3+A2Mjri5Wb;mmzt)NN$A(W6^ntM?nh=FflRl zl~;Zf^?Jq$X82max~?u^86yp+;gzMNEMK)MXLR%i?Fq*lW+bT98rq8xZY*L(ut4qa znFHuBb&VWpRP>i_j5!$4ffln~PhrNU+ZR6#R)^l+|3Z6k@6#bTzBGj;+q~w6s@NhE zJ?QBo|1`)w1p}{%$3LmE_b6@mVulsaqElh-RNB$G!r4XKyr8OkU!C6u&Im@Sqr9>q z6jue_5F2!oBTXfmSFu+?;m~bHSnh@mW8>qr zCme5>k+_H%3pt!V$2&vc4%e0Umu)c*i{8vG zL#J<@qDZB9gju7|9SqlAuUqZ{a{q@%ZV=sh(;e3Y&@I z4a69fOo%ZY-NfjZs@Hy}&Tr94j9Rf#N13B8bQ=XG5gYZ}-)dUDA$K_j3q?k-e#Wrm zXP?cToSY2U8xz*ss^cAk7LCLhdp4j`My;@|9tQR0*O$Fr;B-9<*7&Yt298!(z}IC7 z+jjiQ;c$4W>x@=q;|4Q)DzK}x6nY@?oMB$WeT1SStKCj}!tsL{{B)epNMN`zBYK?{ zN-Sc=17m8We^^samOUSyfi85Ru~=k6vh0PCMuo#RHh0)gv=TZTPO(_RU?k#r`n`bR z>0}(o8Of>J*FH0>DzOj(#4WP$sziFQM`*4PSoRf<{jJj8tFi)PxYen!qoZ=VOL618 z>h*UI<+n6Q+O-m+mo7rZ3;+xu6LGsv+R>D!tl$A2ad~M$_D%3rR#x^!lPOR~pb2aI z`>Cx>wbGb_0X=j<)yIH}11G|^I;l~2fg%mZEN@0PzSEe2<_-=(&f;WeuekixSDrTV zFkE!%884XO90bV@#p^o0096000030 z|Lm82R8#jE$NzMNn~;$A+yp&cX@_-MS9>;hy18x@tqLka-gpV3?cqfYn%o4nbsfr! zKtcl{Nqqs)DVxLXoK{O$*K;;YMI9D(R%bzbxQX&2pn!#FNV4C(0cCj8osb(tvOMR@ z@7%*VT%PB9pWpBK{7!zt=ks|yun2q+3=5;8=u4Nz_x1O?LMZG*{oT54ojI#4Dyc;& zL6s7VDpaHtTM-$Wv%K$EB|+s*Cs^7$Zq8q@kjZ56`7j>~c*=L@@!)7aT$j1JUn2wW zv;vpB&%}zYVhbWc6(Z|ZED*%dXtaig2BN0GoH^CnA~BSDo5Rc&ZVqNt1t{&E z{Z$=ztnO-^e%xW>QB+(^p-{mw;^RRyV+Bf^HEUK$Y1x0Zk^lTG*$WP2-_r&gfkKHg z)ENDl?0DqnZ36#`46Cu6H*MK6<_C*MMr^Xwbl~mG?^Re36A=+vR$k%4j`L@*i9N>2 zlVQvt2q*qkoX)ZS!+X)ZRnwcEGh8UPO3^I|_dg>XrdTvLpJlT-e7+Fi1i^Rb3FvI@ zg1Ff0N@*8DjzyhYQo73JBNq_cr2<tNNd zMM-pO)WlfF2HX-2PUCm4iLoT$1~ee}TKgCW;5Iio@g zGlcG50$qf47WfgwL_(AmD_0E;4f)&2aX*6uGn|vUD>p9>^Z-dYQ#Wr`I2`0B97LD_ z6bVsl>kg6cf|n7-48m|Yu?BtAYq_&46IHAYI1=~=Go%)!*pk2YLCYymJ~TBoF_|pz zaS1U4<_V&h>?J?_396RfLCDBTDM7c2Eo#ZorwZGZ?Y4{R(Tf`UCC%OQJCM4)B7;^A zAi>80YSN~g%d_gLmu-|s)39@xht)ErI&3shD3rBplRPFWZ(6QY=b8I@`*lNt85 zwqL`l#j)G3un~%w0lRq>Uj@%aMCv}!`_I6seg+R_JdT{)TpTle?E!&6NTE_Q*Kc_E z&`x^7!G#$Rg<4;Kgme?UjWA{q2FBQ9kNRqhI&)WHvri?qAku(?0lBh*b*l*7nq<3m z)sqjq_w0cnil+?)^94VkF_Z~!bZ<|yl9G>`e-z@b;>_BLiH-5N1t`w$6Gv0i2sm*31bY}3o z2b&HVWi@4i<^i$=EHb(uD#X=g`A7B*4BrR!Ivmb0W_TlTssahzj1d_TnU1gT=}86`W<)}i+PXueo8WDPF~d`gTs?;>R$I1- ztx7S94Z+aC3~Zny_;Y^B?E=Z8zHYo?f*~SHO#_Dv495_DbRHLu;0fwdR}5%msFIA_ z5KLC3#HtVv{2^!bN`d1Na{V7W*PAP3Ms2!Ti;qGru4zxw3ORVshaYUHDStlhMK+5C zrT~8NbQdKY7f--su;S*v{Pnf#gzaIoJ^bzQdWoSl@L=F40oX8V*XfHInm>1!JV6&VdS{fhU)7|4Q?+E=28q9bCucdp-p$KRa>QC2sSU{sQezy4M1NZKc zo^Ehq1}%zq^jHJwCU_fR%peTs*rQ(4E;KK}5<+w_MJOUc6-iwsIrhOmViR1h#KhH9 zD$Ub|VzIchV_*F1W=Wq~LJnqN!VOo5?-ZtwouM@8%sRQL(znrB`D8U~ zGY?d~`o7dW*>E|DH?qBSVBH^z{wA z{`xOzG~x{f!-6OVXK`HY6_u<@O*V`vC1}3*!AF~{=XY%Quv});k~~1o+VuzY%Vi=K zEgGxE!vPx!LC25($y1XY`uk^V^~ISX%NUsCX5AWn@kgyKe%or}5ki zUU(t)^5uWI@H-=!E_fMX%pi>WpB(MXS!qSU^c3TRPaJ3@@Pj~gxru#;N}P^|geJ6i z+?qfC6*@iIBW5tU3G-gMjYw}JWMhU(f+|G!Oj)N-7m8{CV*rsn&9iE&6LU5&Ky^I4 zI^I(S3Sww<`mu&%MBZRq_K#=JBvkInG>0r^$jy~NDODwfjYsWvJ6^WG&Zy#Dv~WKDH?DX@Tbtc#Qwu&PN$vFgmdRx=gj#bi^(Sb;(S3A zi<|PR#od50l%yk&1kD%SD@rr`es_vdD+iciBzcBr)#?+r=0?*QFg_ZH4p;%5POq=8 zf7%)MwEejCd~$V(JkT)UXH`lKWp5ue+#eoxg)!rQO9)D!KvXW5tJhbJjg4WZIRkKy z3>M6o9RI#?BSttILp2`pmh>uZ2!eJO?Qy^P{}M9<95#2sf>#0sx|1V}8H8aiNV6!# z*u0w4UMe4`CfZvr`Q!Y1a zuXc90!kFRlNQd2LU^IgXQ7G~8%UW7m+;s(nFn zW_&ej(`w4jfAh7=pF=Z9Fk@1m;Ap|;foCB|o55f~5arcHukG7^aAfr1c%KA_Fz*()Mamp*~fw!(d}yMTV&& z!-!)Bn1kkN@&<+(8U-_&0TZ`0ABJHFqV9Z`05ja6(RArTXk!M(7$)6+*e~~>rtU0` z|I?j9ATM%55^jQpPF>e+?bvD^DNupfoyw~g^16@&QM8H=URT}qxjI^u1mu-BD(&uS zb#`m*R$X0RYjp+O?R3UgcUvDMfV>q{Se3y3?oA>BHx*GKtyDu$zo}1zw1g6YRAWMi5Wnv zR*p!@F5`&m#$}Mjrmbr*IN^XjgnxmyAvBLDe+8Dp4 zOtGs7phcRoK&96z^?)%(j~TJ+*Kh(j?wXMh9|yK<-8wWfjvjLC+bU`4F3L&3+m@=+ zrs_18|8vz%nvf%MF#|vVDbFD?I0zO72J%4jWzgv%p&^UX(+?m1^SzEvha-0C4|PoA z6f-`_-{s>&BP9)BIGE;3Tf8KL+!glp*sp&7!^KONE?3o50jsXLTva^^s~YgJrn=@z z^_71oB_%T$SQWr9Sih$o+1J;%vT}bPc3$;jNl6|0PGSb3>NhX4=1MWlpd1FgX|*fj z+7A}@f}@d0m#eBmLPEhrK)mBYLKc@VjSOpCi`1iv5%E~vGdIn7$=9-!MHw4oQ+0C? zO9Wz$MvU`;rI^GirkE5nxQY>AW`G|tG86bIew7Z<6sgS`rM^IkwZf;QFta$2;fPs`7{vsDG1$a7Y+&G_FviHu30dXJGHsekqtXM@Du>xd4TWk$(IQL9 zf)qKI&2iU>ghCPB-~aPN2Zu(+F&Z4abUwaldzzt$aw_l=W`L{Oph+&?QTX*=dhB-0 z@jh=2MPy+H*fkD^V=$UCmMx>v{J=--Y$Jm-V0^UX1@c2eUp;^R!qZH!~n0xo`tH0Cq#*8=FOt$B<;eh7{i5PUotXc2a>gxLj za@Pw48RHf+@RjHLyzDCknIQ0dzp!-j_xInsZ{L`$e^kP9r?jk$=1cRu1OQ`zD)6Jx zw{6@0?DHwqBxVo_>`Ln&wAK}Iw!8_88CGCf$#=Fdd3?9oT^!_c1ROGMGhYDH1j0(> zgZA}^)%jT2b6;AI${JB=VaCR}3QM%YgagB~EMfW?%;@J003<0UV9`?Jg5`QZ8fqhs z8N=+M#=^zAg3xKd41~C#Dg{K|aUkxmrcb|i?K)v(dhAaMzWQ8Jny;oB2FN!I)j%+{ zDnp^H>=X1)md=L{y;f>Yk%bxH2@D2Hr!#_K$WKc1T zw`10kFOO2~oKusS;ZEJP*XmHIHCs}btEdAl5~UstNXCp@xiwo_k0w2Cxr2L5a9D2G zw8h`wEoQ($LSGiNE`DC~Z&Y_qqfOs@-yG5;F+Zi(C5GMhG5Y z2L5*!sFgyUMM)MA{R4sdV}M!Ev>B)5$`b>EHKrQ z(6atQMnh=cn@iG+phaqwdabi#4lwYgR&CILHkxiMnj19_V!Ou-VK9Tv z%+KFVkQ;V8xc=B+P1S2sbQ;RRzze2T>$Qq9O@_JTW>bA1-UYl>X)ck78BAtBW&r*D z^clWDz~>1_Ar08|5XXz6V#JM2P0qydc8o@%@rN1D#P7`6a{&Pye9JstKep)tkz=#M z!ouns>Rqp-a=RQ*_0;7rj~)fnoVzo27`$kmX=WH;2=$62B93S1gPWqXV%PE zTb{z2E4QH&4m0xPwV82ukAF%K0lWmRUBCYN>u-R;&0Pry_FbAm+V{BjEnhACn7!};qwzGe2US-wjDZ< zQBgvEKkQ(@y;~r)l^~`?arM$ zR1N$W5?n(z?b$iEyu=WGBp85WR+hoa=qH`d?22`Tb(o{&DwQf_!C%Qi!VIsiUcDx2 zNEG$`z+?P~&U{CS#=|`{D@$|l-hFmBo(KhtRLo%Y|DSvRMgM*TK~Zk7kR%NOUo>LG z^JmVUWuh_9?tX=UsokFL7~fp{_NAA8Din$oqz!yBQD_*PqZKPx1v`sJvO&z~+q&n? zdAH+Q?HXe748RPMF^p;l%NvpFObSag9mYBLhzp*c%hCIO>hu{zuApE$z(GKu^$JCl zP_`^R_445%;?|TEPT29cO#|-+LKpJ>b7M}6@N&{Z1uQvA-Rtx+~UTyiLnbXCw z0yvBcq_3lj!Z7du>_A^r@fC4VQ?*`?nK_sKP!g^C^CX@goV^a30fZ;8$0xwXZHU4V>+U%2LuEcGrTX3 z#>UsurbI=@4t(Z)haW1Io}PZ|_ARE8Av(SfutCgt2&1}1ZI6zFyBtLsME*>I)l)~2 zy20q9s)2O&iFLq?2BU^pG_AR2jW^fc`LAEU5t>V3M(^`ZEddmb6-rjlNN!z`4cr1n zfG1fQsy^T=^VW{j)TU~2ngqCK4AxV0_M|M^lw2&kqAbT|)stw^jTwfTa_zd`4jY;v zlg9OPMFO2lPD#Dq*49ToJUb5U&#Wu~X%06nJRV@sP89?&17HcWXsSvxD@yG9_T0UH zkIdQytJf9EH5EL}aQjGq)#j?0*ciot8N=@gklRlnocPM5%anC~b`hcfgZE0-|7c zk1T&)u}{jhc!BU!L}xcgjO_844a|u<4MA z+_`r*BU2sAgFxheMgq>jqbnB#1&@k~&drPYj%4L=qATn46R4W zmdWLEXqj5AK6m~c9WF>v?F;LjU7a{?M--?)AVif)Y723dok}DUk4+rgM%|Ct(BT)>7mm8O7UjcNXK7P4K-Du1z%-t|nTbrWAL%w5Fr%VTUJ7-O!;4n<^^X+HTN6-IO{%q(DECjvqUI zB7N3uK3@QrGA1KL$rWah63pXU%dCDs?@1tyLCkn~bJMs>waw-6-2LW@<}Irl3T6`d z>4Z^37-c=qe=3nbv!(W(e#UX%r~AcXiCo^#oS;DFe5u@;nbx)} z+d&o~tJySn&ypptYVpb1;L=5J*htF6Xa1%#2RDPH8mdd@)s*LK{KLpmqh%5qqUiGu z3uFBB(?2XKHu;@R@;<`8Z$JFmobq)B%&Lz-%+PNkfAc)ds;$~Er+jVk2lj(sf8laD zJ+E+|<&sWr%h%fv3NRBFq;6zFoArl9jtsujK4Lv zafSZ=)k_`*r96IP+STRMXmrqGR1x3L7)av~bojHo7G<<8(={5Q4w;3yYZJA#sXCkj zfSTYl1_Z(ZGm|cIxz* z|Fd7_QBB=h9RG7P3xOn$Y=9`@IBjRt4qeo0M>Y+jShj?O5a#IAqbv$Y)l->vj>?*V zY#|AYS{G;S`_lQwYAUntTw>L4QBN8^om4c4}vtT zY~Vl_SY^XxvM3ZvP|$0+`309QU+(Pc8aXhtmdtQ&Kh@9;4;?wW>UZz@`AwnI=x|IM zy~2l+J(Wt|QC8~c<#&utV8-(sR4F6EMI)&#Lw9HUsiSxE*Wzi*@U$o$wAT#@`fRa& zgBV9mT%VobevlZ(Ayjk~-&z~ldaRy&LA$Sg^5oZ$V%RC@2w+zRzC@X2d%ybfjK=li zC!0hk(^iK`HNTNmhxRjovoWJOL{g1NLlYv>#^jXCtCcHjN<-sfFb_{lVX=1<8~+qn7Rag;Nos{mRg|Q1H$@Ec66D2lwRr%H0e~SxcjRiN zxT5f#(%h8Ys)LPRKWuyK^o{a7<}%D6#jS5?dE?DDG0b~dJ-m1TK2$0#BQw)-pmYyw zj2p}VyZDbwPJinO`X%G-= z1`c%B*xmKy;+OX-Ht8~A@U@Y6Mw|{{!`&3|447da;OnAq=cO1r+E6Jr*}QU}!C*{I zUO5TQfW&^Wt<1ip3}82TFtMh$UJ7cMlOKY#whH^)z$_~hV$`i2ILR{P$jjl#&KK|!zk`}F6%^Et(~P#d3icQs#pxW81NBga#h z=~AO~nejvu&l2J8CW>J^0l8QQ5vE18pZNmb!Z6HhUu$ai_n!*KiV?*i0J`?VIB&lZ zBu-KWC+-fDRzu$pmAC>kLdj=IwZRf~utY0N-nm$^lIP9ldUJ@l2=ceP-v#IpN-x>5 z!(Ot@DgOSpUZzn>s}#`3WzfOZZbyrOT%kbNLwd1X4G|WJ$_rvkbCWeCilcu#-E{Ry zSLYA~j~#P8W`J$nw3$Mo@kjm8L4Asd0g#m)FfH)P)o-1>Zo}EQz>I$D=;#ziL{KSI zL>f+L)~E>Zc_a^z4bj)f$Ct+wU~G;j!;?y(0X6`5z-svUO$i8?J}qE+KtLduD*y@6 zsC4u#jp5-1rxgx|>m%?58NlBGGtBb~oPrr3c!*7uknq%C>>GRgnzRYbaG;q?{UF)< z@J{=wBljzF^w}bOO{6Y8T9+Azy1BW(k2UJRv&6U3SKL)(Jnd*5L8}U-61Lhi@HwA_ zv3~jM1wv_Ac+$=g0y8v(0|rPm#774MMvY}akW8pV8!WAfNUmELCP$3HQ2_?A^y;Fx-F{W5Rv;gTzU!0Ms-(ovx{_ad&2Z#3nGqab~h&hWW#Q zvSKnm?QXfze&+KByYp{<@LPRW?5#D6@sudt`Z!%y9CUeowuAr=k~-W(8U$>lMcpY% zH*~a`hG52k@uka`184jkV|$Z%A66Bptz&G~w5k5V%hQEG8i{ow1Y_7|2}B?-#u!#^ z(FRLv7t8kuMftDHdY$9#!Q~=h^X%?fvQoieL_np|3yX>eCek*w<$pdDTbc`u;Ucj}j*co)P1gdGIVN$q`-=W z&))q^CUd}Mx4Y{FsMz{&yuEo`cF?>CVPf&(q}?GB`?@<+On;m?)&KPC(bl|`$Ox04FdkyW6d;arX+usg8Xehr|vAHED317DYPm6+H zkEcY!RkuDyml;nufdL74rpSyLR@eYY04yQk!ORaMJKzfO<4p8N>pWSOsWRj7lqmgs zvE41reZw~=ko5aoa_DrrK;XkS8?oO7AO@a|Hu%0gt^mWlrUwQt6s{4<)L}_G!w5Fe zge00dAyh&RYLHv`L2H8()}O&u6DrXlV$p^s)(PcxVR0YMd2JyN^W<{4JR&fXb8Ha^ zl_s7KR4N*cKL4$^T3TBAP-^Vj!!-DhpQElx?oBt@t1NWggYkmB;b_dL#*1 zU-I6|d%#?sHEvZqdek#6b1c$2E^Jao5K+`xzzvtd zP93Li*ijg#tvI-_giQowUrm_beJ_EqibFy|n(z7fe7tva?|t|F?(g^crJp}@=X%!D zN0l`-Ev>B<@KYXYHDs~hqdfF8fCAT z0V*qd?&;;_Boc{TT!!Dv%(V7y^h*xRu#)uMGq}FBsimT< zN&B?^`}FFIiRFpApG9ve3Dp#BRu!%b$X^N6F}GkP5XhW-fRI&lw5#T6KM5#U6Uf*C zgd(3JASqz6#KZ~=4;Mg7EovN~U5#KSe>HS9Cx0blKs9UT6>U})hiXc9t*OnpqVI(= z*wEbC+Nx5ioQ82|nhnT(hh-EE2wXO(y; zhPNut8~qszExnnRUP`!+h3CE@NBloL>>KzO*Gb+A8ej%voS7ogh`oj&ikYxjBpx|( zR92SZsP>is9u(wlPd@smW3eB{MTErco*x++7`byn)aOA_pD&040NA-ODl9l^mvaAK z7e#*oS0Drc5_QaO72NEH`&}l6Ucp0UG_>Cp9QDOQrXSQ*WLOZ>b3k}#aP$|yKN$W= z;+I>#PS|(x^wDeIT>as0PI3OT7nOC54PCcmfSza@8hp%P)m{Vc3lHaVdGK?Rq>TP- z9@2n*I2`Vd&qBM5Xi?cQW`J_@@}^9gDi8?T9R_YF^K6!_8fElwIW3csGMqSl_MEl% zp}%rqh83kpiQEu#Ohb>psiw8Ouqi*M;fIXszkgNvRpj%y(9-ZtC1ERyw=XT+q%2qm zkTAPI<6p3RR{o0F1uH)QPAC9!SUpd>dLGb-mbqy+c$JTy&nZ~(0cs3Hq4C!Ox2y{& z+_xU&_%S-oeEQ{SyaVoOvo0IjK-!&KK>)8qRFmJ>EDJdy9L1LKHc-Z@>EKuI3 zKM}CVUW-LD9txoV($9pnd;jKn2VE~DqFvFX9Ys8Yn04n~A5BSXA zI)0*`LP1ESVuC=#&-|mwS5-Pr!JvC{= zi9;(AqW^d(99SYaI&5zEj(~`;`4KzkM}#6;hz?`$1K=TS0RoZ^3u2x_o4|;jEK$r0 z|12;v43Oh@2li^>Bi1Gz+?njdeYHkY2B|3(&AS zW@P<4Ys83=I8OHI#{cJ(xLn?JkM}EIyl8V^hMBZy?>-)nM-U{t!sgvFTeNn}plGfW z*MH{h=jCjw9RkPSff?45o{2apQ|OsLbcWmR?U3p8Z7=J}Tgvj9@*gxj%&hxQMqTEO znj06YE+4JFe5^7#sv>E3AdB@2QUSQpI_yVm+0yEMp+pP#*#m@m9zAEKZ!UB*9nx z<&1@)lf6R5zB5ryN~D+&2f}~^0V9w!GLwVZqd`(zvUF)fV`Jx)?qTt}tG=t{vKD5TDr$es8*dC_ zFvHBGLDLE+C#UrrHkf_gdXwE_2585QP`*GwATl)PX4$4ua&$CkO2OlCUEN&s^77i) z5Zz1Guqin(!>a0($ywOw(f|R5@$IWR(-}ML!Srly>U|#V#mWJcFL?mKz z1RI~bCJXe+kp1Pz*GM=ulnn3$;}bI3s9*eY!X&?m9%{e&8)vC@`Kcm3l?Q!PvA!XP zd_rPymCSIa%>+--}WHrn%arNfr7L{5JzCjy2 z*^ID3kp$^9%qi*k35zUWH`zC4wC`DT)P78Y$z=GzJ;#R4_-T}a%i+3BaL;-4xNS&< z00(CLd}O)glzJwWqG^#x4Dp$Kjo{3*B;^E-i$y{l6DnxZg;pr!BSwsRYrOk=ZWE`Y z>$}rOj~P$NN4d~0G!2c#5}{Bg#gNmIidTgfz!`;cEDA&r1c$@bEMMN(*l3n@8A6BM zmSr`}=&UDCpN<|qMl2Fj6m4G80OFNMu(#fRJ3IR!Gn8eEQ2WLV(?c77_%LvWNF=dK z(xBuDrdEPDMhWf5Xn_(PIP*8A5Nh$O3Lo8xBFvFpNh|Scj%Rk7@p6=nn;c!S4qC1_G zJ`FjaoTMpIVQfz^J_(T-;Q?b5+kiqh=>9c4({NP?_(EDSJRu>`ICZ8VVkyId@!p|+ z$rdn!b!50M)2!fdxM(u3<7uxpk^*n!a-Fws+ivdl>neN44A>^XG+mqVPqKQwp~PV~4ua3}RjZx(0*M%- zQ1Iy#3WlPA`w4|2oFKy^qKw7dkdy;695RzSPC@FKGrt}0%H{HKT+Wn)gM7>(H7H0_ zIiegP5{Usdpnj~XsFo=^ut^<_=GaNFD zx1c2+tR(1&nQV8^m4%wSz) zSJf>@c9BL3~9>Z z=adBup$H<3$lcxj=&_`x=H^cGb6|!|Ds*R`J)_lrE%A*ix02B!mUDp%qE!K_T6%>UK9!0*T!acLO1Z*$JE!0Sv^pIf&9gtrL@W#_;o?YgE%%j)o<)y@^`v^0TMiGR`g$vDF^77`+od;Pe;ilE&7S?@i>qpCYI}M-le}T1`_yiyQ>j!@ z78~mfj6X;%rRXaIN!U`AQ__%Va#S|G1Gi}omDuz;6_ZPp0aQVYd*nUfvl%moV< zb#&bHbDSYxG1=|h3xP(ODW-)nW|Zv&nF=8W@1?Y?LN?2yB6xD4k54#Rbh+Gbz5RB2 z`cvQ-TCENe2z$)oOFYFQACph`3TU%XQDhAEy~9e}a?Im}r8OEYrob~YGKxz|e(Iiq z1+>1Q0XA+XEMssvYgj)NN4I17a)cR3qv-1OACFcaUAt~=N=k}KsfJ7l3?IN;o7EB* zgcG5F!DBxcp>P-kms2S4xVXm_FJ8LKxu^BZFMJ~h8a~ZT^K-z%qFuY4N<0KJtij1g z)MFMUAG5fQL*lmKxU#gYeB74MyzlV-^K)E;;uUsnxoBvBao3pEVUQ9>ehBl2Z9hn;@~cNDHvh-Q8VYUb*C% zrFw&b1u!PzP|S%2-i3wFHUajK8!blWWUp=DOTab+L8z1}yBE<3{xd@9)gdcPw9# zYPVahHiZIHsZ@d3qylXuS|K(~CL#vI46(*Ja}v|jGq!BWtEi~F^v&hF{R86F{9J}% zJrKF!)E57GoJB>6iHUZ5T5762(9+mu4}3~H(P?1@Q9N2-tdWi2Xu_wIvfQ{j2q(y<_w?N$oNR0wx@N+_ngC!^nWiZ4ll`5@P z58k?M`;N2c&J7L@g|&Xdo>R1SvaSx!m8p#E_j1CpQN}lj?xdvT?3|Ze?w=-mPe@Zv zG#BuYy(RqFd;3n8%hlZ4a-izqrp=p8MuLq>izMD{##mEE##8(E|FOQ|RD1i?o*qxQ zIAqrG@yq#UPN2?od3rpZon2jBZfKodF786qT!AM1bW5&X+<&3<{;&6etf5C3mGjo_ zTRnn#5loWa3VR(G<8ldiJ8s+r`DLvu9?#D=JHcdlAX4+(5zG!dzy;Iv_V)Ux8bEcoBsoBvJgNwp-@Z-69 z?Z;0}p4_&5$Lg%C#~yziSE(?i3WqP1#-NWS2nIZC);OzmHl!e{RoZNUi`g&?2Aj=f zY%HPC=#)6jqlAfcI=ww@?klgpnqN?Gp}84qWq2c_{17HfQQg<{LtmtEiF?V{Z+MQM zyyEfn1v+Wg10oVdST(n_LXeVVm@@*zIK*srPS#kaqgjIBR~Omf^?E;U`1boB+#_}) zAt538{R0Do|M=&>8c(0zv-h3c+*g+V;+M(EDHh5KX(vVzgJTRc;4FcJG$nLmD!8YJ z!4wJwNm>#Tk}@+hSFg_6x^2e?HMOl5FaD>!eX{q5gfxxCmFutDuFd;(*~`DJ`AgGx z!$V%~mXE%_V&2lyN)Tq!93C?;Oqr9DH71h;gr)v(_s-6O-xn0V#kT_HGrzF#cRLG;OG*JJ zYHR;oSKsi(mtVDCZ66#Q3bV?D>;(yFrs}h={+sfA>5`W!GFO%5<)1j;`tM=yaPW|O z2U#Rkkpzr1;SJF-fixi4gm|MF2@xlXJQg!Zk_=@G z4l{5}m7N_KGw9%tz*3jmt{3h=dUh#c75gY+=I*30|k|DE&SB$9p-I8LPA2CiTXbP z0096000030|Lm7}a1+-Z$N#T8Z3| zX?4qhu}OcQ{CIi$_PyWxz2C0)_f;?m0AB|fhT%GYY9A=7HL3JAlCqL|n@VR>QFKYI zxv08ByLE39efq+co8xyUBi9Dm#Y|9eGIVB0B9X~tghG)OWdxC(k@3yi+8TaQ0;W8^ z&##ZrZwzhPw!gU6R8-SZM$x3+T85&ca8xU5%$t65(ChQgNIC!j0001ZXoQqP;Fmj2 zpqh>}h67t*ea_MZiCPcjEFtzoOqfyY+WRO6%#ust%-i$OalmqO+E9Sd zdvUMbF+RhY0RRBt3H=-c0ARZCe>_Z}VcVhQRVEUbbz7{FI-8oJOSG1!*R>aFEvq)| z`t6_p*4=xq{~yuqHeO;WT<$C*t<;V}4+DC=r`*LLp04RQPc00000%vrwt%JJOhJtgZc zsIr&EC=H}NNUlR!%W&zpawD2X)S*l3J4@D^i|b59wVf-U`+Z*SB8fy6tua`WO6LE# zsJyt=Qe0~;(OOD3bgrhbt|0ZIEqGyLE#n8RBqbWh^23If4}AF9Z08IB0001h6fkUi z_0wC=KHpPXPlsxKq_M(-!qs2RY5)~w!xkw>RE@hd+E;UP7D}a3g2+bmf<^)W0001BZo*aS56@mNUEf(o(Ws7#Dm$++ zNIcT1YGChTLw#fx6(ur!*-dJ9D=@6FGDF?iO|JU|k(Hy&%FR~h zDwR1(9sRw}tA$U|;+Ha7l}bE3>u$QR{5Rk&7f zROz~fFmOmDGRlgy$Fi#Srp{Bdoi_jg0000|z+jaTeCPDlAN{0*Y_zHLHnGNFtxMh5 zL$3XK=KOC-r81dJj=}#&|HYV8CRZrLG9$v|gj}u=Cd>JbocD-*vg4Wa=I1S5QrXxn zk{MWIsHiR#MXPnz<<;%Y^!u}&IRF3v002_J$&5qqUe2p%E8iHaF|cWn%&2@pmie88 z`e7PIq?{wkT#%QSzqZk!()UCML)p}NYf+7P`|EG}eE!)^9smFU007Bgf>>wt{{2ec znl?>i9F0M;GDB6lSt@xbG9$G~GBXp&43eVNI=ZCRwC$DSZjX1ilLvf#;Pf``2!9ka zvdaT6|pYr>X8KEDu_a#%NyWKQ*NL(cu!FZo3GS7r(-bWa5z0Eo)!$_Hv zIdTvHco2+TrweOLWIT;AV=^N*>GvOz|h~g8+ z%P^vJ#XD5`M+rM&;yI6aG!a`RJX_?sle{@h>iLVU;qVRS|gEhI#=vGy}5G^z0M6%0dmSQHB8F?TxfN7CdQBA5w;?;O2$Rw;P zsrL#b4T+nOwl|?FCkqGP2&CassAUmVQB)0?=(3vHVKDAllO%xQMO^$<;cA;6aRNx7 zeZnF$=3c0rC(;|~E6zZ?qouPjI{Dm7$S|>wH60xpt&jj<_AuH$NG3Bj_K@o~%Ovv% zMK(boQ=(SE_d})>##6`)-iboIFx1aNtyGe^WC@ZPMvxgm+VJ1fdlM6O2f~RPhYK0* zIoV66(=#=Ne;oz_t}%4WF*<4=AHORs#~!Apy!>Q`W76&6M)7=?i}mTWu5nJ6>rij+>rG9~&4&K| zQz&e45`+UfIahXPD0qh*pKCIrM72k819{ zdlT##onv>#LmtrJsNK#zQ;*jhv5AJctr5 zj%s3J(h+*ioZK^Y2qXA4!@>YRg)uwAG3p$11=tO|Q$GHo*zNqY=3h<}w{z0%W_Mx6 z$H&oqHZYgp@8{mbiOI=PVVT?QMmwNkl&;XL7)ocrBei zpC5z>@CYzkKPaqDC^IxjW>jvLEcmuurjW~#5o{Z4Xq-qTGYD>)$VrqpB6Gp~yv0i@ zL1qBc=cA8@nhi!{OKS_ZHr86urLm>O(n;SMxsB#bdA)D$-;X9WH#hh94+u-~w{~RY zc6)~j&o>%B`}|+r=NFaHUAy-fjL1ow$k3dYuI?TrY~n`3{gAwU`@d$3rNxMX!Js85 zl9txC-Xn)6A{XAg`6Z4SPsAIsZ7a9S-hKPrSRnDBg|yYC)|BTL6y)a@Y^bMBzWt8a z6;dqw4;(O}Oq{@c`r2!uYy=~F*T47zMQ%WcXbmR; zjT}4PH|d!QCg9?wi#vDzMN?i;z_Rq|rJJ{GK^n>J@r3-NN_XtoQG>x~Ft!{&-X~s; zN}&ZMu*J|}GLPCFiFV;U4GwC~MUwRY*e~~>sIEJXM}cMc?)!D`zF3SPl2I!`2Xr*f zG$62m(IBW{cTGD@1+6t!#dljDQJZN6nz9MR;+OZKOD88z(f<^^jASg=HBm$|5 z@)Ci5@4dUrMi<*mlmGTNXD-XRzjMy-{Lb&*@8=fTIy(o*u)4Y?Gb`J9Mmbqbo?SK@^y?N}Xdfv+5ff*ucPhnRFRv@7%S! z!@2H_o42+)N8Pz|hdr6nBS*K=q2xHiz|m}T#ItMHF19#9hDCOJCS4CXY=q1Y`nj-L zZI2&6?sMkEYhL^DEEAZKls5=w*nk;Rr=?SrR7J_vD!H0cXjC4WR;5&{D7D5x8ZS|Y zR-@LbR4O&4gtOYy3~VD6ve3{`)6AJs#$qpKc*wdU@YjpnheJN#Ef5GXu%hAw+u704IeN@b*iMN=hS|`t z1dm6I4GVkt@X;&csjIs^Y}o4pfxsD$gqcJtmCEAc441E7b$OmYf1X`}30T6eg68MP zF(f9mcRED*$+Up&z`;hbb6&?I(B8oEBlO{fAyNR{v0j>j*5zId-8RVsUI7Xm&YZqVA@Ip+Du$mxLVxI74gYyq7r{OEKpCg#sFOm zUAM5-(KFhk79npPX2 z(*;7L@Y?0`g<4&}ty^{Q>FR!FGR+kWA(66W85!=gT)%!JP#;K45;h56X=esZ3)YLR`WT;X}4G#)#Y;1g03H0}`Tfbf?6#M)0 z;u8iiqh#+ssZ`DsgPzMH)~#Fbx|NbL3z-2oy_ah0?taF0Ui{(`YDP(tXxLg%P!LE1 zUrYdq@?*zYpHE6kP-aM}3}vR%5xpBOwN+bQ72|>*zghR6BwD4l=9^1Q?|3>#7TYNaJ5>8e4aXehV3+& z&AvXqC`jZP)s8vUDh+1y_2tk^)kY&q(?7oq3wu+kB#{9G%n%gacm#pseDJ_CReH^9 zKa?@=ng0DpuDlVS8)LRdds21>dziLInTn^HwxdPU*B#N!4`;)_yJKc=84(;r4T>4^ z$jNcBb9Y9;+5EzAXEPT^o3}?Bi#^g#l+n&$Mu8VIy!L{zVtM(>6{s7uc;TWC6$*-? zGyyvOrcIj*3N2{OE#LMtm|--UMFPBPB}-kH!HmCt{kmSSCzX^+tvP%49D4_t5jkN3 zMN-g_`RVg*Ma8*!g}M2KS=(}KMfUdgj#oql%oq_ut0YOOHh#4E^yxDd6~~t?%fSD5 zBE%x`;nGsp^Fn1610l4CuUY#$tIeL5Uzk@=uyt$J!GnM8>7lC~*O-`C3H?nfkB?7i zXs9nME0@dV1dqq@=kDGAXLhR2uC6&o6EH(AS5AIwip6Tp&o9i)E6B?$%+AieRa@)Y zul-2>B9P%BLxwJ1vV`T?Yd3Ce-I{4FvM>7Z zH*y7tgbE58v1#*`LW?cG(DKz+U-#3P(KjpDWndQppgEQnO$3Vn~h=phK;CCAi<0oNiNJdUU4EoKTM_4U>7dTC_Pe^wQXB| zfn{n;3@SmXAj8LvD=5H0=j_|RpIsD~F*Ym=n1MX};)4&0?AuYjdHDs~a!_KH$8Bw| z&Z^hE_J3MmUoWl)%WFamIk9G2w9)1fGot8zTXd=wDj#ifD89QxH2yX3n3}RNIC%IV zn1N?p9yuv4)@)~I8)PA7EznM?eULDK8Tm^$eA?CJ#SE{xtd9j|mmND+p-|$@N`{8M z(cIkXev82jlSm*EizKU7t#-dv-_QWez%T|g9AZRcM&tyNRPngP$x|o4S6B|rP(V^t zN6X6C&SyQ(CrzG2k|YGEpwP;8R??WEmCH$d?bg*dyu3Xo^6tr#--4Jx(^s$kEqm+e zXXV8^b{5%-uUxsz_5d@CMx#_JgKC@2b3G*MrF<>R$PfsGARMhW03uspvA#SCm=P2l z0%_z61cweEW;@&4JI6;v%A^WDU+{;I|LAg_mzK^a2>Pj~REIt-b)N^i34yD*cFonp zV8#NGNXp|83x2iG-MP8BdF04Y1~Y>GJ7%mK3^QcxD@do+i-f}1xVZLqTDwzHX1Oq< z%ZV8qH*Vx|xe~F=V2EdXs%x(8*s*K-j-3@JPWAToy3twx$y29TaSwYl{L6oR?H{G$@==g z`|x(;F=Dn4m68V$z$BS(*2`N!3P z!|1^bFop7j!Du#j;<|OK=C^+S6sZ&m3H-F=Jgt~PlL|_$)@;q#UQk$sB@9O6vEzoC znmb(N9cJ^4@EL@NP*Su;dkIG;It zw!_?E={fkE)z;R%j!3R^?+gZJ{mzA{iG=We^t608*WCCD- z2jA@f)*+XQN)9uWBt=aP37x-iL9ABm>*uGCqg)JDDJ%aQ=UILE?;||DP%$1)uz!DU z7t0u(W;@7m_|StH5>DK0I|4%~P$i{OHF(T8kPG6%48w^83TDWMD zNJI!lqF9~Yh5^@a-0<-ki!Da=#Ds*$|A#f)T9qkRflb zNlxW_Ed8`&H)fC&L#t)3a)1n!6XGJ5$z5DrmMve=-qFE%S}}v+Far`GVxwYL89H=W zR`wp-giw$#w`D*v1p=W|0tsdit&7WBDJdzCa?Yo%txc=bO2kqKCGK)lLBxj)aR~~Z z$YDm8r90&MhI_ugzNCV5l}cA9B}Ya@Lx!Xh*O1WACr_Ss+2vJHRRzo-ak?1>b%T%8 znhWyc@%ixyt4*e7oM-jr%bs4IP(y&tehybG7LGD{Si{m~_pcW-)Eev>2+*3ln5{G+ z1|eXT!DB}5L1Y9H2nZPWLq(;}SRV!0QY@VjK6BQrNI(J>nHQ@w*MhGePhOjix=(v9WkTR z0W%u9F+=TUZD7oeeh|O$#%~rcUNUe=o#wPxVeEl9TXHifYUi&VGqhPD+RPAL=DU#@ zo3qY4F~eyC*h?`3S_bKvH0iw!8#kt;ewv*6>ALkBmoEL7VbmnFSxJ|cm2>{Uj35>> zln|8Y+0kp0QxXyqS0yBVvNHZq-r<3}ki!g8ffGSfBnib*TiGTkFnC)=Mq^Wx&C`k* zG}cwoj8-4FW=-;{?p0QvJBMy(xxmuX^EG$wY);=2{>O00ibA1;T0#0t%ew<^Ycpwe zI`9nA_wyf@xOz=O;_7%z6~8JieakZ|W>|VKWBbmXP;(_kj~+edU$wPo&Ys7dIIZ}( zo0oUkK9`D04l@8^8o5k?Xw{5bA(u}L3CYaL<`{#E@5gJ`#*7&&SCD+ZVB5BBU0uCY zW3jJS&u1HEU`HlSoU~yByCW&7>(;H`ux!N&_SHctJv}`KhZ(sC4qB^3`uL1(X=&ZH zdpDGyK?-tGt#-$DqZ71Ry#ofo^V{45^A|2qt2K~j5UI%uuWxX0xPAN9(>9asD~B0k zu>=)fwtTt0=YJkNzz(7;BRstZhZ&#+mbm03$mijsN1dIPSgn@F6Iknp-B1ffM66b4 z!+^(+AJ^5@HQc-Zq>at}%9SgCOj1GddAx;-{^YPChZ*vhV20$EV#fLn8-xNOUZmrG z_ij^jGdFnl+<6q7q1EW?^B2Ci_qWH4us$%O9++WmV1eO;@x{7Xx}2!twAW}{cU`(t z7pBjCKQ_}U=!3+7*Nqw0D=So=9T2|tNYT|UCuBISe=8^~g2wfO8P9aOIQ&`^OC+n4 zlI(B&c>TJ@&5a~U2vA9BIX4K*V1x}?93P+Xmdo23wHx#_EiK*NyP~oZ8Up2ke3zA%x3so2vDOTg!PQ~z zU?Vp@`!HgbxA!P-?~zGKNl=sehI;`4Etmw> z*x1o5xB#v9fXyKBG z86ybx%IbpBY`rkwd#}4~z#uvtlK>J#qTj}h4I6+NUaqdRnf)YanJV}>ViD>Ex+AZCCTNX+0LJAS;M+u~ijkqFL(&*ztxmZCmJ zqY=FdG6rcN?5kB(&uR@$Gn-cA=3y@ui~StT(CC2~*bT_D=gX4zc4M2Pf!ojz9fMbO zcx}LI^2YuTj6Cx@cMY?a?wOpq13IoEFk?t0FcO%tQ?+o{_|$DDD{sH-!VRot7`2Ws$(wzA{Ly}958o+L~HsdD~PXE&k3UUX0fbM@-Jm{EOOC=}vC#%10IGvX#d zUcnyW5?M@4Y*bWqR8&l4RJ2kVb@JqCYT0vBtgWpTg%B!<$IHvlw6;DNJ1&mH_U7~a z{QU#U%PSl!f4p)Pn}RfaeFajfl-MOYIyx#QLaCgQGSkq|*h?zcioBH|3VhN6p;RhW zTwEL&2AKv11^@KZ&$a|RyB6duVlr6pCKLvNLl7-SbaaeDuGqhSKeg;pTie8h1QwGe z5co5hY&RD-m(i}HN4t7@crh{Q=MPFr&&aTG6bV8hA)$O8-_yer6xZC+5*ZZ({pI-( zT3Jzf*0~N(+uPI9(rGlBzaRkKppCJyu`#i+NR7#4Ao#c58uiC_|75n9vDj>}jyvdq9S01Com%=WtL-d@7{e3CX37EOYN8e+rFci z?nUqwFvH7>0nF&KW5%A65>ny?*fe%*oGK~Fhf4s-s8KFEckb%9$p4D{h~(Kdd* zf*C2Z;^Pwlx&nU!ic;s!>$D#VWhS$Ed0wt3i5bb$rlX#HYp6x9atYQINF=h@*fC^l zp@*X*B9z~imJVLk;Wg`Xfc%v+>uZt42$_|*xQHKGeQRo7Nqok3V8+lH;Duub5!=+9 z;z{Y-zrS?%WfyOl?M>efuN^BZV=@>lCL74y&=86=FmHMK!v5k#EL z@jghdJXUs`&R}?Rd?3LPUbR|Ht-So>6+*ALK7br(HpymE3d~5)S^$B=n}|fdvOvf^F4Q30qA zo5lHH^#@zGZr!wb^QKLkw`|$6Y}qm_2E9Nc9UKMB2nrUn*=!dVmjmB^igoqS^mXgjySdT;FwU6q)z^E$9;iTQXs81-OeRx$W;#_O z8qGa3bAbah9zA|MEjiiEjmG!&W3zC|bO=4%PD`Ht;K4(OTPnwsr%uu74Ae>{SJaT{ zKU-k6&Yd^k)x{P5)6z4#?fxk{cm6zs!Q^nf(HKXLmQfz9cF*|Y`0L*`ArbHx8q&+t z3#|Z1Kq5k6;JNb``y~#{czgLWH#aw|oSK-}A2ZZixm>|wa!`950s4wXv=$2ipaH(# zyKnHSzOgsi5zKNUvIicp+L&l6fgJMR29W!a)m-7kxq8;UkMKXvEMuVcr?Ny4R(kx@TfzCulQbabZ7oE07}lgT6G3Z+~gAyeQ-1e7IQ zDlf07q?SFG66^2ZPna?#Od`dzCr_1Alj}Y%5{X0Q5z1gu@S4Ix>cOh2YY`EVa=B6_ zQ^2{L*ozpUlJJ?c<~Z~bR{8zesfkGh4nZ&2?BHPW#!vp@tYTeV-T4LYU<(->5&li%&S5t-H&2>089_th-+S+U3kd_)ZrqHU zFfm*v4-J)+9X~;>TwhcaEEXvvqlE#&!oosI;2ed(E}w1tJRxC{pPv9i5AO5f@x66V79=DL3|hQ+ ziDR<#;9=B1Od?B|G`YFCrPmIe)z#H;<0phmWkJEB{FMdWJw1*`YHDgx9NbzcFN*9Z z@L#-S$-TO|fjgc(`){-b+DxTNs_z>fP+>)GE+`ixFTam}*ySr%aKzXhM^j!=K}|Y0 z5Xj*lpKX)LWVlXII-ImX;GZ&c_PO&H28LlWTUM_rL?YsluMXBrgJH>>|hSV~oU{;>7GPrey7yxpeoh zwXfkpSDZOBeMU-nxKyFANsQtZ9!kh4{#8UM!=$n~b5eh}e7U#pMfyUmy}cbb8Bj-~ z(|33Gx#4mDLq^qFom!)AX>E1>69`0SXaFN&badL#2$#0OV9;oF)V%Y+WV_KW(AGY8 zJ7qmRJqAOgMx(<81Q=Nevj(`o=uC1-Dm;ADzW&nYY9zX6K za5N7dJV16BdcEFcHj!a>>GTE-=?b}6$w#_ueh8{W_$D&W-T|&|Ro^~Zc4FWD165Vm z>zwr3Y74lxrKMFvq_1mz_|W;;?yhb^k>LNgU={H2=+UG5sHsMW^L5NWdD>2#9Z_+8 zkI7`EFoWC}@CLW=-_+7#am-Q&XEOcr%YP7a>EXk-Zr`@ylT(eT)kdR{0BJ3XWazPj zgw+-gPN9`*68y0ArBHO24aIdjM`H|pJJ3AWuHP&@c&O~e3DmH&^Z6CPUM;P*^Fr=a zM?K4>$7FBde*Hk`=2QFbBVcIq4I4Lt;iXdft9idE0c(-bksp5aA;yT+?KLs0_1&Vf z@$*Xrs0@7ni&TWvD8IeU12WGJp){bu;^;T#TEE{~DRF zPO03%&^+D_q9#61o^Hw6(r$;l$>FqVZsl&R5qlVV)r{2Qd{&zd+ z>058@kPFZ75PkDbZc>nbK6jrNEo01Bz9>j?d{23Ma zaEpyoDBysLeM*UAKIjJCu>GVurzA5E9pwSifP(eeGZw!TKU5}F43;ZnWJ-lxIam&B zg#w9ECXP{SC;T{?QLdd*Hvb==bv^3p?c>c5Y^$juX@;wlhcI50aE$|k0aGP5b|{a> z-@JJn8SJyc4+lU8;k`fRo*ne6`izOGe;s9Bb$f=@YE4fcCy$9y#xi-tp|J)WLkSY> zj4}oeC*DO6^V*|dkN8DtRslNA1ET@Df{LuXvT;+3(sC$C&smk0vl4_@tV)|)G=BQ( zKsg4`n2M}?JatYuAVWYy^kHlVZ^li4?=4F-bIr$Vf-UNV!CZj(APxF} z3Q#0iWJDxLurtaSKm!vew)5Djo1-R@G$TN!q02AVU4y0=`HB!vRKJu*Xy&lTCyPg`)WQmq3D@ zPR0N|_&7SO&s}KD%q`EzEzisggkxmp8-Sbu&7fI?4sjLQ6ul;Nkh1?3gp?pF1tEg$O*hRStF4C@R*A69-ym0oYC-n99~jhi6B&Lv}jyIzQH zH#WcVhmC17)&kAYQN*CP1VD$x;6@${kI@5C%>Zj%ARLDHIq;vn^3sG*qdYJs(65q_uOFZL@x)n`SFScW z2i%(xPG1H(5V3uZFo1()ZfMN)y#LXkxp~f>{SbU${)&C7*GjVrfMe*1lU*NlYC(&R zkd*0b3g6jkwzLO3RecPSGU0fL?stQpNF7$2(P%Q6%_g(OjIM;3%*{rl)n=oVJz3{B zSFhF8A4O7k^!V`;P517*YB<$afap!lmeyw2(rh7PA%g-3jAm13r=3)@cG{YoAxfmv)z#&0r@f;c{4^O&Ev+qJ zjncPvpqu6v(jbu>>tp-lbROE;+sUk&T@D~0hzxXCJ4iMABRjH5C_!R~Z#~TV&JS_V zZhwSQYNG39AxemDxEHRi!`ci+!MMpx$3l3BTUsoj2}x-0=-#oV6;fw3xwQeAMlj+^ z9o}iT6V1(q-qAr@fSf!;IWf1iw31Ij*P}-!i(4|0LF!q6WWZkJ z58+7xe~jqSFnRV&cctLllPCXMSBF~kNL~H^&YyQUJT&Q;O%}_4jvWKdBS-2kT)gP) z3*fHT+R&JLZlSL}kutSRmshUK)9VU?Pc1yfpexX;Czt+Z>1V;tQ-1*uk&JHOxQl0O z*}6@oRwpB9wb~T8!b+pjCaP3>zt~S{Qv=L-@zSNYX3u^xK3*&VU}CXEDveG^NLaq2 z2u6ChGJ*RK9!#75Yp?@`3A0*_Mw6PFS}?P4&)$6wYJc3Dop^c)*9Q+DE?Ks0#Hf){ zsZ1=U_8mHGSV3Xo`HPn*Mb~h(SXzHK=l3dgQgSjGOSdE@s^AD9EkkHYNgBBM^H*M3 zv2vyRrX{6ipqZ#rzdd&zeLU^_WLHAM=wvECDM?AmI$ieLbLZ|qPz%SI6VV$ScWbfv z3l=0MCTf$lL^@MYa^asQS*=RizGDZebNZ{(<1;cyH&FUDT3BafX3YEZJ7>d|AN0-9N~-n3dfovs52sKRe&&q+*F zs}j{!>o?NISAX;`2$O6B4KfRhloV|m+&OjnD^jPSp&>0TT}#$fOJyT7Gh^<&d1o6M zsG4>&2;AYIN`3R@w+e;w{UuA?Vxj37`g7o5Eo4|j<^x$yR;!b;vR++LR0RBoOo)Tf ztghaaFnSDK4p)g&p>Tg+ycjkFoqPB0zmb~{!H*p~_TMF?^rq`JR6}v$er|4_trO+s z)~#EwPM84AsiBgnC89%x8#5-cX8TU62X=j`RwJb;Q>R&6-A==5wUv~vfeJ>;(XUQ;RN#O67EJkuHU$kk*SM}V#C}XJb18FD#avH!T|-?dEv$Q_3NwMe+%!V z85vnoQEY)g$mj97upttNh!Y+jR$F_JRI91k&f%~jWKfgKV-6oaOj}s^-l9Q+21T)= zCjIKQwzhWirlGPbEG$fjvLxWJxsW1aEySW_GYboE-M;Ol4ok}OU%vi2=!=A69!~%v zgAY8ylR;r&rEAubI(7BOq|tIv03RUjY?L21pC@3kxp8qrKHt6P2dZ}VY=clJVk1wu z0=_^fgg``GE+2f0ij1O9#^R6u85R}}v5y;<0p}o{Tf5z!mOd^bA~K4_DOy!bn_aZ% zZxP`UVvz*gfM1c>gERu_>+4CK<0nsGQVePe+d?yd&rnvV1)If&_V|3y?(RB*I1tSs zKYm!eIx;c}SXI-#CZ`t{A^z<8ekVSK~ZaIh42m_$or{0i~IfM7a~UOIQz%i8FS1ydVlAh-?`_W-~E2B!=got+S}W$ zkw4kJd(xyyD6bQPTs6&+;Yg-S!{F-Gt0~O5+uSsLhVN^yIlS`9s~;sLJ({~G`PElPzV70pz`lzJ5f+Q5=s;}6_8mLN zo{ijgv)l8SvAQ*Q`N7~7nR8Yi3R!U|RH4=H{kSsXaVY?j9a)?jEPl7FgY`mz2ol3J`@vBEcc7R;zKd^V4XhGC7OIhAcvP zBO)VudwWT5^J&@K+yYJE@%TbQd#4l;zE^ zFr+7y%5m>gDwTd34PNTy?aeaZ7}+fL(PN)lW|@!tuI}!+^A_NlSR$256)H8k9O~!p z?xELTp`7zhp5k!0BGO6j#AFB0p54*WNj=)Mc?+ZgPa`6i_TRT)#*v&{45CV6krZ(} zR4RxF5)g?bkh#$Cu-3NrhZ6v4apV#xuT&yO5-ODn{$vg+l|rdJlAA;MT-Fz%q=SR(GArzscTCJ{ag0R|HX=$mi?+gzQwbIQUi;#$AVzIZVe8dU;PZ7z~t; z!BC8MnHxre9CSK=tyZgW#X>}2kAT2{rlxxj9}$(` ztE&(b1T7v7kXL6I2$lByyHU2Vh6P;f<#H`e*I9-R$-}*3#PZhs4i< zmS)U;2aIv>=Y|U!ytzN)&W+(_CFW#ye+ zU6cR4NhI#WB;QmSKHG_E|Bf}b*!VH|}G&=oo zcFyp~$k6cc&0F89RbD(k4=?@m#*I%+iRwORP;yEtjfT@(#$>T0m%er5=1l|{869oB zdw17gc4@SlywCF}YMPFYp<(hXgpTpr0 zVlk9v&3P+W|f2?T_z zQdx5I20}rsj~@F>C={VR_1u9%tW^BCMLkNK0m=^GSUC2rcM{|_4)HdLqlj&d_IQ{XM1^hMMX#V_xDplObw0Z zkAjCf@7|q^k(%1tH{J-I>f__<>swNCG2N;giJv3 zb^d{^ZS6J=4+aKok|k$#_k_=z&t`K#J|BGW;j@D0<(=XImnsI;ROT*;T6;%uCxmmE`lTh(o`ySoyla4zj#R`s_MjGZQQu& z$+wT03#iv$k;`15m13#vcIkK2qxOytPcJV7MBNGtzkG5kpl{;;8yXrRQ1GYG=x5Fp z*mwgooEX?#LHOLcHjhHz3}-P}9A~Z#W9Ha2F*jF-WH8NdJmU#L_nFI+f}>)UswrMGXF z;vYEus2=#Dun^)S5E3$({Mz;F=CLvBU$DRLPIjcx2}0x|cfsw98fTRQLLDS(8CGO-Bq z$6`7E=C{Fp{r8a-3gXP+Mnt}4#fBdmpMrB= zSd(8Iu>@Em5D;3eKT?fLh>welk6E|wuOI)-s+D?ukxZt5UQ4C&GiT4$nHp;?Ed6@#e*Jo5 zk>G|bq5^_SSQHR(0*pI4WmU>(O-5tIEfYtRnMsVIAV!0tG~j?m91&6C#%6#hh$Ap+ z5=Yb;MOhUD!lpyd|Ml%|8pP=MVfbL5dezl^-hKC-d(P?m|6Luy7b9kfC3w4BF2`DK z-mE!w`pkG&SImi3%$v8M_sLT-VO;z!4#x_Lj}BR~Wa)<={sD_yu@X7{{k0#jlQF=I zNx%$&5SX!f2+R=s`T2Eqcas=MGV2=}y}W#+5}M*s=@}V1-GHMO!3-?i95X;r6DD{9 zv(7)hva+&zdItcH#Vq#9R(AQ0|AKu1 z3-<@J;+{0@bYZ%JV-9%E*|YC(85^YqFJ346CUHM@NR?6pF`{W&p-?Fpg-j-Mard}; zx0a0gde0snj}K>HP;kdk2d=#QLjB`%Z2LIA5ocXpy^jyhhEj;8N~H!}*x5Ue>R_Ads%qk_tg2=d3TtZ{isC~H5S2h6eCy4(AY^0!!3;2i zTBSz7xU0VeHr6(gkx{0}^_U?>!0sL%+qUlzi=`^15=xzr@b%WOwo!V_h>o6X!i*GP z2G@WYjZMuu!`W04=bw zDPb|go?#dyM~!dx4jMZ{smeo!c(J3|h`&#?ir;u`7Ya49pMh zMub=b#pNMw_>RN^Z-hc|T-+|xcwh!ns@B*U!e&hbO`I7L($?NV#*~$p12b>|(2!)* z6a|tXfo#||)22;tY;4l$4CDZ7>*$y^-5(V}hq$>TS4uo97K<~#{dQ2a**Uo=gi@ha zFe)%Dl7eoL(+r-#Dl#+s$H&FRb2!#2l}4#hkSIx^QRV!?0y2hRhDazvGPitYh8YRF zxfEY468ZW1b$1UC_lAZBFE4M2gyvFIdV0p7@P@>UpMJjKJZcp3FOf>mp35W7zW!6% z5QnvkW##yra48;Afqxv9W@~FZD?A){KU9S+X0iXxnjf~m_kODXyu`po`-dGZ41j^p zMF#>G9q^r>SXy4gMrpx}*U4DSprAw=hz7J(B$S9m5^UGw#<|?9HDHD|^$_-Oh`zVC zH-uI1>(iNa%CYPmDXRzy2M5QRTepc*j~P=WA}F|;rWuwQXgLnEtaixd@$vC}`c1g+ znT8|3FI>C`;DJ6u&Pqy4$gS$?e>ypj!kL$rVZUdU2$~4dJb3UR82}Lv3!4pbgzDi% zRyg!pS>yA~H{KY88BkbEg5zXUWAn0Q%P`Gg9@KA@%k3Yiw*b zg?Y2)=BUx5u_!*DuT4oa%^w*R1>J{^;}H&G;2;RA5hF%;d-=3JHpdJHyj0I!04k6d z1I7Rbj34j%!-b14Q@)qL48BsSW>|EjWo8DAQ>!#s<`9^nwiAoQY|Ka=hYdR*Ah5lo zos22FRKa2fa8#+1q2@G$vZBP`C^t8^lG0Kg(OF|z)Bcu$rUFa>MNXYQ6B!lF=Lz@% z;dK9iwzf8%nGzq*If>o_V}Nye6dx-B6rnCag)N_d*3;XM1aa}e3@a8hlq%E(L2_8L zdi!loeqj+Ab03)DMKHs5%a(r3*u7^jm&*ra`uPDfy3NyN#0;4pGtvhob0B8466e3~ z)uLF)En4ny=HH34uWu;4VEqPf#Xqjho4*i60bro+z)S=m8Wu(pVlj)os<92$-PQZ? zUvj2I?+uDc>R0(;x&rlpp${O*e|}=XvXtgWZ8{5Oyk zd&^g>B*#)%L1B?VAW*PkDmZe4?4<+t(N(M0*xFK%%CTd|*51EQoDb^tm?4%yMj`rO z2BktNmC%8KL02j(b^WtE({Xz5gSxsgW5!?uhk}2)X%o5A+WPqWl9Igqf(sYQwr!8a zDHeJsmC{+qvdI8oMrc?#5CSL?78ahCc1WvDN!F$uOis?r%m0rtYA7;<2I}nQ?*91k zV~F)T&dyS)3_1@TK`JlpbVJN)YNQ>Gty$Bke?{L*{25<} z85EB%lgXi;XV0B0D*C>lu&}VGD6gQv$Hx~02w5M582|v}Av}C`+M#ru2F2ERc1;->!iQ2p2%kO%6o(^}4EcX94J!Y^<7;`VJHUh@dF`2P-~!`qa=xb#=fDA8gtJ zf#{2^TW5#Q=J9!Qh8a7~1vvRCSW{*nKW;vzqpNe_qQwv| zL_W^N_3ph|;x}Oif?2n2{ScGuKaH5dxO+^fZ)k)E5+&gC)hd-z$x5gJGdc{I0sVrG zKu!FnPHSuL&>1E<=IH21(+ZJL91s}zsO6FAEs;^t6qm>2QJ-%5(@+a!KTAq405gyu z7Z=yBw#5QA5RX78oD&g2RIIPhB-hWi7h(pF$Ct|FA)&Jd-3p#D6G$T#N#f%ZOimUv z_(J&c<#}%`E58J41Xkg_aq+vskSKvjD4ZD*(%RNWR%gPwoD(_7Gow&JN!PFcHn#6CUv9b!7_hOiK{NaLP3w9^%N>>3T*<72>1dYpDDPjpTDo~*`6~xPMllBH}kEPUarX%08NP3|D66k!#m~B*Q=mKqez* zG{Do{^I!I>Jt(T{jDy0m%Pz3M!t&T%G%9KoYOD!bO%z3qjatyuSJF-=?Ksi;hhwao z&iJTJM2&(k_6ds0dqJyKjT#>aD#$}#3O1Tr<)K!2?0Xk>>F?gNds)|4GLsoP<9>6! ztmk~^obUX;@1Ec9m=`Tx3{r+GctKx9{i)Dhi}-lY5m3x3l}a72@A*W zph>Vnb)njM2T4iuxLh836O-m0IeM(<$We7s5fwwey81>f@u6jg1RO0AOKvqbZT|aL zJRUDn6v^SRSFT#+nt+$st7XRSJ(SEqa;MLjX>cNRv&AwkApt}W5K>ZiG3^^DnGp~a z6qJ~lbmGKGK&LLmgRl!KDyxalweoUWW(bE49rmy9?`+(>nZ;&_MG`L8Z{^BW&br88 zGW{lT9wrn;N{~c0o8#f(;pyQa5CAlo$UlIemzU4@Q!*n+0FW_xRduyXK{yMplvKzJ zwlFk2diaPmne_Pa6Gc>(kLDMsPoDbLY_`Csr^mWr;Q|haD+~)CGK~DFx4G@5Mk-pTGcH(> zGk(4_fhPKd{*xK@XNe+yk>Z0T${Tg}dmRMfwl~LQautsoK(WTKVGo*Hdg&UVjQs7j zl4Gy4t82lcMc}fC2ocWV06t$V7E{MHk0M|Ez4&qj z(XwIVM*If1!uiiDR@ftWQN=NJxNZA(Fg`B0VZv~*5>$#rA_)lO2l9hN5h7m>7ia$C zM~|6-9i3gXKAIiK4;G6C3Bw{lqtF}FJ17{7?%uPHxD^%^1qB9!GR8n=JbXwRn{MA8 zJ|a3)5DHqv&2;|!1x_;KAT$8TG(0RaATW>z^7i*fP!I{e9M0FtTV2A2%;5R@iA7PN zA;Lh=c2F?=7C;oO-}pD;Q(AgeA{itM4HJu_YHI7T7N{Sa1^;7_u{UH`Bg;!$znAiC6+; z9MDk@vbJ{Jm&B*6yc`i?#UVq6-fFz9)9WY4$NTv~ONg;nUVfi!`0l$4D2&JmacF2b z{-R(+FzPK15rjrYLbCE_&zWoKwh;e+96N#15(*=b?#jxlUZO&s%8_7FM71d2xx5)u_P2yUQrM1_LCbg7s@n7ki7 zdK?!wULXkdBwWK$F= z8aU7kvdw5PI6&US=5X*8V6$QgbY^HoczA$6f8wM`PutsnOw!%vwilX>{$$ASulJmb zOWa2bjP!(0()(Fve4?88Tlq)JvQ0*FU!-n(V{FIHR8P+V)ZI`RcJDv;={B3={%CXj zrvBUB(fQeDe+&rVgJN;EgDD^(aJut&ez=^bI5Y-RKh3ReqejQDSU$M9DU>R-baZr1 znG)~i#llgHvp0GBww|7zUZ+pP*%-=B*_DDr8%zi47YITGuwa3|pFfZ5H}k`pO-;8Q z1E^Pfd&i_nA9#6rbGd%b4}wG(-|R>szK}fw1`K4geZiHjZ4a46r7{`Yht1>pdkyrS zF>{tyt0V1*AH#V(@EGKVKll_A1`7o5e=s>Oui*LM=ggVw>EQ`avNRn77o#xAU)HQ8 zJ{K-t!j9NJ9AJ3mS{YidmX(17xxT*MUfw{s_;SgsGDq+C`#X0Azcqx-<{*iO4rjTz zY~A(^R`l`l`PIZp2BVQd)nqo0d-pvc;O))&YD+TXzh=!^4-Zeo>A;Og-tc5(Vd>SY zfB-9kA1kY>(NccB0`v;W$MR;O5{ip2qtRe6&ieIifPexRIdasMtJmrqZr-S=t*NbT zxOsESwyi85kgYG^IdlAyg+Y!^8?$FCvoAZmB)@cC076Vm zj9zaShgO?y-MYU*8)HWxeUxi(kN^?_zf*VZa>CI*eQRs$+i#EZrYkmM{{a^;r7}6d z!N%d!(caP9`^=>bBIK#NDl5r^_4N%116_x+vNT#P&0f@SolcjPl_Qr^ z{zXTR8jU96UsqR;;nX}zB{dGSt5m1Yp4IB~FG9(7>h!n7i+Y$a@W_=VrB{gCzwg~s z(!J>!8TTJFlg59ZJVoK7RP9aMckcX!*M5ypo<0SPm_(*f)HgJ^^p=%ZpbG&P79BO4 zElj(`V#&`}lf9JDgidl$dgY1?O-h1T--D2lcM?oXOG|os1{(Jt*x%aHO2(c(b4DhU z0hF{f>DhDV(DL~4;{%xok!WQ9{P~M6fjxcNo{_O1t3cOXykzeM7t_cqRp}XRZEd}d zq&NXMvdGaCxO@gMk7kjY&JWOI)41b?|%P>*w|m7bbdK*9ICgtq=dL92&qh(CY9yoqQ(q=N5 zNiUY58>r>lJ37o3v(2FpUTwGo=H%vMMX8ix!m{h-CI_21%M65vx$TeE=}m9ZXf)Dy zSDVRbB)i6gkciA6q+>9UF3KOXk&T;7CelK`?eTXra53G<3ikji#fs^R>8icXyKwYABFRE*xbrm`ImatG8PF`fN68;O}6R^EhTmn5Kl}c6V>8M_t zBL)}iAr(t+A7Ik#y#-Vp&6+okLl_`HfPo|g4Z#P8kN`n~LvVL@hu|c@-~ocWySooE z!Ge2mcXuazL*Dnwo^${E?f&=f-EYrHALy>0dZhZPr@Fi9`BnAJo;^!~B*xP$rj%O$ zuowK}qBN2G2(W3+btW%5N$D?0x`lWI_X0)L`ZL62$vjMn@~>?_^mlu8^_AhlIVj=CnJ zX5#DXoj6GUe&22q#BjpdGa|gVZ;I8JYUBRg_fJ#Q5&7vn%pvh!1fA|c{u zl#HlR__uBnkrB`qg>PAXwofE*;EbZVN!w+}8Nr*J!y~99LG?+Q%ON3OF>Gy~?=hLr zd{86)Y*X^;N0@ozoUoftG_!D$JqMO+?uI;y8P}`g8UwE%s$v!)6b^2ZPtN=dwlkg8 z`Ei47Jp`Btd{5~j=K!RXj|7t}{GRlob96Uicte`n7Mm62unC#Jkw9nB!u?5Ko*xB< zZ4LSyQF;t?fiPpW%F>Sm3>dOV9yFr#=fmB70yK>rlBz(xa!M=AZhR4WdIq4RSOMt1Sz z<*eE_!z#e+<-tW~L)0%(_VBoadMf8^JEP%>aVceX)*Z`uY}dH@;pmZW5$h)hk(D!N zMy12$-GrIN6FT>o+k1DtcCw-zl$=Kq&kwC>+Gc3g6RJF$kQ5nGj}2~nZ&T&M3vv=0 zUxgCQB$#Uni4G`r8ys7 ztrQlTZ>xpFhBn|B)}XiS!-Rn$Qhhx!?0yALMRKK^O1U(7NX}Sc*`IO_J?_Cjc;}*N z31J_PDvJLsOGngi;P-w1L+t2>CfKb6_YXRw#pS!ZDe!7|avzhW{3EtpX0ymAJs8_n z7x+}t1HyMm55=LW>%ka2NpV@rRI&aXCms1zkTqWGS&6i!UU{ek^WAFu@v+$*3-n>J z&0-^`eKWnhq`t{&T$5uaNhj+Mo_5z7V;2t#o%TarNVShYkqjsvNUR0EWc}1Vna5T} zS7jr;9mG#x^G5Tzr`hrP@m}6T-N3O0cZZa*w7V^BpFtjfam0+l*bbn?)+H@W%{RRIQL6c%pz3LLZ!ctCna}$EXydbSuAT?-H}uFf-S~8I!A{`~9hZe}^%jjQ z%@VD_howqQESIeKJ}xQa5C%%BR>M<_QC0Cn_~V6Dn_8IIJ*-ZGU^GM1&WpiPsrL0J zE%!?nFgTPVDXR|==68%Y0U%=>fgTT)?83lzt0BmlV|%nIS|FKS@Hwt;l%(5{n?DKuD$M35 ztg8OO)8e?X-(1+S5+)WK`Ndf6{Yq+IhaA{oVnWd|+o_OH)lN z`sCWPjF}zAW+C!6oI$4d^L8xX9&t(gHF^PaoOJRVV?V(>3TX-gR>_HYMn{aO^I>ckJS>t|XCAT?# z;Vqf+-7>|4``7T`AoIqyA5BkB4@Xw!i!7KP&{drQpQwuD;(sOZZ4mO<9+NUkc5bMu zHIfTbwCOm>;*^qs1yNqMotU*`7?a2Tu8bQZ|W*Mk^!@{H*F5 z^0BDh4wuRiKaeoIcx~^ZTYi4=sgTI*eq%OllNYA`XL1Wn#-BGAL^$Q-JatS%D+7B6 zJ40Q|hm^IR872!Stlvlakb3(TBw*@bFJovYXl-d@ZDnZXK*|LYw6?Ielef{;Hv|b8 zI+^MlirDG8z>@mb28J@ac9!=44x2qG^8>%5r4=m2#Ky(T3lcW9a4@t330vqo82%vy zBx-1CY~n!5{F)6UX5|3W3X(H~Wt%z~{?ct~Y3N{Qst=Mhv@&)uA?4uYcny-)wKN2& zfaD$Z99(P+L1LD=#)cq;hos5}Ju^dn2avL<0gU($rGH*9x@h2TtZMx#DK@wiiINol zk!S!Cr4RxxITYkB;D(-d-kUnOiC{vJUHinVmrhZAaVJK z1NSLRfF!i35e=?Y1YR2sPG%7R2Z!zs5BKgf2o8?=5E%{*xfym-YX!o=;awuYeM0!B z5gmKoc#k!dPnZ=iXg-2VZ6Cby9x3J-HTgOcm}8F`=3;{XmF>>i>gkP9t{(iQq-PJX zTb3``@jLa6ps$zQ-ncbqsDWF;N@qk%QaDx&n{p*C4`?)odM4F*lKfO}K zs#t`%*6f+SH}3r0D2)s$V#JO>Gykabb%4gZN{>G651Z&7E4BH&CXtR`8&@NILm*=B zKO{8w<3snqP~{N#dB`Tmx#90bH`{DEd=5+*Hh6r9rCqkG5yY?*QS;87tll=pajAr4 zlp^z|mE`p*Y6-Kt>=W)24prvku;{FvL=7^F1E*q4OP0`4k#t9XEvJK2ks6O22P>QC zrf|uM~&An4FTW%_yXjL|P9+yOLUcwe*93B_x-J|6*AU{F&h&kFH=H=eAaK59(l^=vPd>9&;OQoKI_h(bWzqDaXdY00eaVm`ucw^~OR7-|(T zVn%N4WC^&i9q@Qk)y+}!Q7O8!f=vNWM2J_-aj=F(>i|H0_PMrt*baoa0IZnaK|dbk z0@5vY$^N9$BEcouO8q{P+??j~h2O0==7saO_P``=buDBMGD-_w4!t?;>G7XhK-$e( zW}ecc)7p}TI&2^-+fl`{S3?D`h z&F1b3S%j7NNzwWD75Rlr?RqlaHIvXZC|&D&{CT13>a)2GQspisSc&ROYw{n(ct-jL zLsQS+To;X5G`cPexx=S3I2b1H#z-sgCw?nWfT6hf@fGnk>OK41u5b3dr`H7IG>|Xa zwx^G;{ZW*mg&u8qK5wqc*P6_KNm@$O!2{1h13B1<4m34YRauqC ze42-tI%Xu*NFwufCbgE1!wCx;369OQ>pr0P(>{)2C-U;aH?eMR<@wOZYP`IH^O+&4 zG#KM%D=6xHGd8_jugQy3@D5O9WT8~B@;!e{Y++B7isrmsrsKG#Im<4-yHp#nnJ#Q% zEt7$@iw_ISKYd&+(Ms*y=GKFS*Pe*>z|?myaEIhmQBh>-QpQtA_LUfdQGM1 z?b->AsvU>40~zD8q0KdQ`stwA0ppA^5BH@8x`t&Y4?ToM0H8ORu0!T|Xz-9oRT7A4 z3eT}jcH;3xFpfOab$$tFeRuw~Cu9D}xhzn5cNtLY7DR(ZA>1r{3H64px@w@y_Wd+f zNT?6;deUH`g+7hVH zy7v>nfgc;&EGPxbJ={{6o0|^to@mPH70Zq&DpD%~A-uK#mpl&{Nh{;Y+N6(>|1oUc%MQf()}l zEHOHxl1jf8;*pKe39=?g6mI(*7^+X~loE9tpEJdcBcWBw^+TpB$T5P1tbgFzohAMV z@%{G3`T#=KK9XDyLG*!yN z%f5-@qL%!nejY~s{Sk^(eU8{S^kaC#c$Wg78;htfz}dpjtQR_fO~DG4G-hz_OCd`i zPZMb5k9apF(f6X;QV+X_tEaTcT@o9JT@p_xrb-W70ORl3EU9ggb+5h0)|$)E9Gg6V z+I7Y}eP;41B$v>5=IU%^wymHGeq%Y4QjBxoF08u#Gu-$oqP6nMKIwFqPJv+&84H?j z3{0FrQr&g$v5sa^JK2jP2Z7#BvH&e{D8@!r-DMs=k<9TNPSx?I43Woyn zW9Adz=nUrfo;Vgl71!9CanxCpz?fSeipehEt@+5ePB?8Y93D{Dm)TCQu>DTAKaGL% z5t=zE1wmM^X(b54()RNcdJZ6H>tu82XmsD#(^grRT|@eC23}m@s7)jn5ii=m7Hn>v z1t8gnEw;Gd=Y#NAf<=HqFE*NWa4aPCMbns58z+ICNfsp9ha|WnR1li;g7)o_mKDG$ zox_3y<2(x$-8^ctSUQA-cMOR2EtBqj>Aj^wN64Va@Q4t{$9xby$&-E>r(@&>R;o%G zZkqCjor6m#_CiPhb)}tPHtk=S$AK?A!~!au({pHsY-m&EwCkkwQx%`5>;QI3Cua+# z9xVc1DK+kK=es|-c@73;*@hL5neCF(0@%3=(v7=?6^~vpzI<}>o~^_DO?fP+y{2<4 zpMho(;N@lM{`g~V4evZh?q8Kn0ADmQ4WY*yQj3Wl1TZEx4FUZO)VM<|l$s+%1%b&Y z`PK#Ut-y(}3A*jEiT0T~^H=UvawFKs?;O0n8dqLQd;YP+Spt%6Q>hoD>{<( zwtxb>$Cpq$0}aO?0$M8oTHffpCB_IvGUbayzPJpDXPznjE|qwudz3`zQv!G*x@_xtsYV&4uD2uKN5W> z@bJPP{^{52|JP5xqOJVaGaeEramok|m5+;3`wfhwB0MP%$9FwTZMtqmSzlHeue53~ zB_3$gK2s>-95fpyWN3qiYN*s9Nrd`^buj*zI~J&{XU)FG0)|Hyc?y4>X@B-Ce8nRx z9(TIZR)-M-###^#m@%$a>2^bY#yuLUQAe{&bJQZ-sjg>Ra?AhJYr z2+xkyzV2__lFzJ3vb2}If8OWyC48@X1++r1zh_K%(-C_(C~&)+vDQy#CY@Glqub|PWInQF$vq#-? zlIvTwiC!d@v=amy1}8k(e5Ub^K<83Og-cJ#Kx_8^fI{)IA*nsVIw)UYFu~^yIpcGC zzLDBF{GSXpJ+xc%91)VRHI-~dRVpjLs?o05e)7Hil|3S#7YA)O*tRMVCs{OrU zo~qzoB|*0x#L#Qv3wI1dy+tCmg+XBvE@PaA7hTd2a{`1l{2;l~9{wt}Un_vt?50k` z<_=e_HZuTl!Xl`9kQqDO0q;rMmQ$lR6fi?u=nLq3$#PZ;eFRi=#Awe|Gq4?d&5~+Z z@xK4jDKaDJMlG;?mX7vFww{SomwTLjx2XPnIq=(huJHYP9r+nrlXk0U#nYgttarsW ztmsk$gaPGnAhHqZc+3X=^OqEUK zQOvumXKL#m_mkzRDDdlcmt-6p)6=O;V8Uoj#L^{nDuqj&R&ujX5A(m}A*#GBwuxXB zyg=(Of82r2NFS_QnY*qqNp~ebX;_Q?&5Y85RE{J95T)xLgZ{0IuLB~x4VI@=^#>8I#bg~Em@dKGI%zS3nj9E0%9|bOB z+e>Yh&V>*U(}qGic4;4&?%kerRd*A8K;Yx11a6LV@d6VV6%hTAXAGAJiL;k2Wi`6p z#BK?IFU%q`IhYA5C2l>?fRWDm%m&XN5tr zx-56(z!$+!NH_%5`#`Nlx2}8r;G3LU&t!s-;v_C^DJe+hGlvdHiIU4qD)g zUe=@J)OY~;>w2PX(}Pc~u$UUl%WPy_g3!R&q}uoPOB2rDg}FyT_DfDXJ`;2!dQQiD zgWyFXwVe2KEHsSfI#PLo<2tIvA!z=xq#wh84cVj+ccOoI5JRvMZTusyx&?L8#Xb$R zQh7s`tdH+>4m*(3HKK~(GugCDgDe#-EJFd&7ZEl=J*!uv7OL;0%i=@oX8Hr`WhhWN zB`CK3D0v>4_=Jxv0%IKY*A;Vn4YY~J95L6U?sEze{j00Rs~8xmaeyNtI{Ei5s7NT< z8rTJa5mGu)p8y_Fc^l@H8fc7Z2{8ZjnPZNyprRYJNDfVj1I$-jgVlQ8kTP8^d&`KA zefO{Ko8E&($*6; z0D9N8sWp8ZQC>#OW|hWeQI9yL?;qC5Uw(XtgnXnyn87A2qt*&eV>yaAOeu>_v!kqR z$u-U4_K;Sgi=b&sY1bv1k(Vyxo2WqGMe17j>!W9 zm9r4;B9yY5rk@6&?T2$xS+wtyf8}|b_BlQ98rxwb$t{4#`L%XC``a9tV zPtw=+$Fuc~*ASfQ00yur>1{yZYS1TMcrtq6b$4V09)a!B2~P79&?DBx3{x$JqW#Kl=GLF}BIZvVdO(#NHIC3v5!4s;Wr_^fpB5gRGWYDpec@ zqnK0&E1mBN1UagU!l!Ujqg3;_1Mo#u&|C& z%k#a|N^iO`#-cbX(54o12fl+h4T{D;!TjO6zAikoyH$u&FLH@23B*phF0f}@+J>E~ zA+5p}$1T*-?E3VC#WW+?-Y#8az#<=SnHYN$R=^nH2BvS|&CJCt#SRU$?GHBHyWlE0 zRL~cl!M&XyRCMwm#`s?f`yfBPf{o7oC43TVUSGtG z;TP*Gp7+Q2-aCPp55s)F&QN#j;Vl!QqT*f7xo_MLK8TKF#g=Y0SY47p%Y?^HTYO^$ zar>UPe=HJB6V!S#mizJ=MQt7R1vBglGP69 z`IEm54qhH^MjQ-^Rt}34*pJ_W9CcSe?z(TAxQJNor31W))D>us&jr%RPkL7Q#>v zl_&o}PZ%tD)KWK2ZQ3N^&_-{JUmH8(Jl-!f>y)ELSg|J{Q^cb2^pYdYr z9X~6DKK+op%N7*^w0h=dW%ccuFVESLgSqcgw8!8bt4Ln<>&Ml5D}ncOB*P6SI?OAM z$}bm&k+)2qIf_45GVK-yGivByivS(TJUv3*e?t~|uPAt`X86G)iE2i{1_v4WQR89? z=M?kI5UVv|O^0`20H!#t!}u|=CUy!!=774hFXc3vCU)Os1|!a+Z+c-QM-B;hje!Io zel#33FV)CeI(u=%#fuwtHtp+*@nrx*EKEOls<*eV4%ijlnL6nm8&$gEyIR!eSl za5mCI{UxgeM{8;6dvLD(ARVv2j~Jp^mz?G0=F4Y+WH`BNCX7Kb*!D-{Sw}J4qATdzA1A-EPmSa3vj28uOJ7Tr{JJ#e zLNlu5rMn<7t6$q3QS<=&c-{9`$zt=Nqs?a>N1ysv5-~A>3FavY5P?|- z#WZn$T0$%`e-_XG%VT%q%IrO~zQ+(TaeGd!MBA{EnD)N)&kL_kfX^l1R*BTZ)??x^cw%17r4ZyPcW<-9JT zGfDQYN-^a*!Xv~|GP9F4#?}@+V_F5#ZfMBa6;k6I8L#^xpFo@5RY=jiLKOJck+VdT z;X~k$OuEa#nVR<_RZFHsmZ}cvA<3@~_9G&<w^k0ms?|46kt^C&yegq$ zt*By1sVdlwcGm)CiL@%<3XQDtvU&e9pLIr)t+jK)8clBchg+#vHyM zU+WQ4;p38?dZ$;}>q&)4E7k|VEa7~*N8~&!>qBS_q;ci%Az!44dK8!Z>`Mx*6;>PT zJdlRAV69i&{davWKuWg6T3R zV;RiQSrgknq;+*P+Qu;_OU|Hf^SAnhTGV<6E@Bu^$H9O$ zz!6~!u8BN23hcX6ZNmdnDco@8&+h<~Qr5V~5c)<8D~&1TE)-&EZX>U`(Ru?91!BiS zmD?AsnzA0#@sG|E7lv&Td^qx+$+xQlp7Nxy(650#w^l(b%kFDRO{6HMij>Sr2Vff) zz$3n4KKP<|w^@ zX8vrzj#&Y>Xp929HogRJcs%AzJ6!nrRSQjfMA^A5(Hkg`B*iFoqmDb#6KPIzXM|T3 zexO);#i->RvV8>Qj3A(LPFHEvPPysk%+3J2Uvxkg!`cD33BWPTDwIioj|zNfzZHp> z>YV1PWpgl)`+!)g-GIAEN7_E9`s$|$gmYLARjWH_>8|Op6~LT9P_hiZpJ^Jre9?FA zO^wpDn03Pi3Me#j{1JN11g)+CRM{^K0UkGDlbOSVk|gWKojy~ccqAS{U%B$nC^eM@ zIOiXEv(pB|N%{kuT+Wt>C?5}x6yISVN#Ec{5biI7X?6mDKXpuW9fp&c8HaHMLhf?a ze(dWX0jTfHv~ZN3g2vhaUYk~lANz}$sea`f*Ow&gcNE~tH>E{c)O`UO?NVr6O5F>% z#m**1ax03lQxmbdYR=e;yszv_yZw+#E!%EG0+Lh_Z8}Umik>K~<9y{<5K*AbVz%pK z`n{@v+<9sE2&%!n2wo8Ss0LYHPwGn-&$IeoR*olCNNbM@@^##S$Y_Z*9R|0*=p%~a zQg{^oRO3n4ehCMP>aYQUqF!O%i0Jp42LfN*feCqzsQO8{$%$724*O+Qs~iWM$q0NJ zY;C9bweskxw44o^h8h zoyj)912AUs(pR*BznCriixQ@^HiO%E&_PJ0Nb`4El@g#=!h?5&BEAbLF-zB4;ZDoX zK`OcU zR_y|ycDgg)a9@0k6LUjs=QNy-88l6byTO_3bpK z0gXWS?^KYK+*L8mPJn(V=lqoa_BK*6t5S`LFVz1D7Zh-1S)L=++8z1SJsgOI{mm6L zR+HYqExY3zH*gJX4t#FxN>)OsZBzK2Mrql>-0zE)^3#>r$W=*DTqL?!f$DgGiyVnG z9Eh;G5JHL-+MA^<5%>hMC{0V5pUY4Kg96|_UqoIyUT3TuU&W)dZD5z$ns12;}}?X?8UCi|=@0>qON?IpLOmFEr(c z2r2uL8<-xB4Kj!+(kSxXn#fX!x#5t*SudLf_=o^c1)j;^d^2{_UBa(bOVWEONyVgv zMz|O8%5McSB-{=V94kz$TT$|tFES8Y9hcAhCQp=OQvrl}aCHE}Ql5H`KxsS$Fq?G7 zXtm;wEvey;$^6`_sSUGb`3Or!7@7_z6$NFKxyYksbgF@4&q9GL+QN+O;XAHvxZeV` zCRxAL71+FE(d{S>NU3o-1rnw^x?20;z zP6XVY>iRw&3q-+#6qs{iWgs^suq^9bR#tVUz5D_xEa!*8dHGB`8lX55m+p&D~Tcc;R%Ta?;x&j!nrAm5GbtRehZAlL2-@YqW< z1h+x(2zr>KuFkB_q_wGFK((7*a=Z=nn`3NZ0`Jca=qBlOlxG+}{@D0nO@t*i^{`ww ze%0#+U=)d2q|*%VC}6HIxt$Bzqi;C)V&CbZs*sG__}_ADfbXWgf#-?nk%v%D7|naW zzo)^==x|EuQ5%Akor85(!DEz7hf)`2#=~J{$0}2me;5Z1xeajtH|W~#k7284%oswl zocs4)_OhfV&!!`c{6=!5_gzkd@Q{nB5^wIp)NMiACtp*&w&+BH!7oSWGd+cKXDn_^ zYMk;nyR1>Ko4;7lSJl`M(6Jh9JSmKVm6kHN(DLn=ep@&4(!{|4n3S;nDr9OpJEPE^ zjL}`rY;TEPNw^z}T8Rd6RnX+;iN>Y#-VeIdXKeJ{>R$l|V?bCh>EF_<$Etf7wF{&G zpr}5s;LhF^rNT+v8A}@cuYe`ADfkXr!%yyL!>6vjVM!`wc1sFOA;89Bg5K}QJ7D7Z zKz}{+C&uM0{7wSp;zXn*0@bg8NyL!E+NQIYz$^*M8hf?k`(D`wOtU$;;dl+1g&nQ( z>cC2sc+xlND%lv}kI52eZO+7=0)C=?OVNodmh4jh&|<|=u|qVG+S!k9)J zrzQidD?_YDmxhe?j!}JeaHR?n=^MQhgV+sk*LzexPF`SyhK#rFh*Q1rfnlfj$Hr&b z6%zL8s#?!fX1Ic*?p4#{8yV%+ad%^DW^Yz-& zuMYInA$Lt9j-#-6JjHROJ@(0H*+wos&%JAm;f2e>zge3rb=SDk6iD&VrGS%_9AP~%ge)(-yNdq%jtZe%$8dbl)lAe_P~!l$5rZsxz!Rdzpwb>#mFLRG8NH~&Z7 zVz$3^iv{KXM4AdpsY-z4K?-)dR`xc!c7|5^E`NYLMeM8{ZFqVA24Q9YlUtn`)=B=m zf6c#dH&Bpeclaz~zq z;bMXbllu!Im5U1`r3-_oI{(uC&`p2%e<;PDX-ycQ)!y3CPT%kWEc@QsK}6mG27iU6 zMdX=CSvfek9>l@Gu`+hn`tpVj>L3{*;XgpF0-Aq8w8E&xEMX%6oSc6U!^r>AR~NRn zv*hLd8_E>}%8dT$9R^Y>Z)rDbU-3NEYd3!Sj#nxw#N%uMVoTz?(A_`d>xIbU=9%{2Fu_xo^I{4m_JA)LW4m%X2X6NE!RKtM!5 zL`FhFMnyqEK}ADFgZ({vgpQ8>=n()N0NY?Y3=G&ucpml`7+Amd7#NTLJl@a2A;B%( zx55F?;D%6<;NfuK?%Ux;;Nam9;oyIP~dPPk`%f`;Z$@Q9>Ur^}1 zu!yLbxPqdRvWlvjuAaVup^>qPshO>vy@R9EM`ssTZy#TJF$LmTv4dq-zi_xGORkvpcS+844>XrI?0zZJddr(pCVT? zS#5E8ssZ+kCDYCBRx!0B_sqfwYifnV*9-IY8_QkvsuyfmDbsHZ zbGY3ye@tZ7%H6iy52v9+#?L%_ow_8)^Xvx=U-Yn@Pf2MliFx)WMk((V6ce|V_Yjxw zQ@nI-n(s=stuVD<nmqB#)Tj3&M9h*vAU}p^%g#&zdq-gG?93JeB9~2~cs~e{Pr6vHgAW+XnwD{NVAEn)%j@ z#jQP@UI*#6l|p>aVWpe;^ERbyT&K8#S_kL6LI%$$qg}zOh}ci}W53!%W(DUPS;HB> zldld8D|Vq)83s}%^1tcs^SfRCHyQT-m3C>C zEAUTwdMWnn^hWn@UUqy@V9O%bZ}`-xw!%J7KE)`7RAk_676316Ayui(`4}ZkJgFwe&U!n>=S#T32y>P-4N!) zrKbvpXWcZu%rNdAk7XuJA0HG*iM#f0N6MvCTxX5t7B%Oy)9iqL|M=S=zn$TCL-?oM z8EUOGrzvwn?af!-5Y8EiZI90OmjHH0r>1KylUwSNFeeA~6wZg$QpS&1l@^qoQty8Z z-h2(JO?WOdXJ=s3DjtSlO+zW{h)~C{&{2o`sV#M(KO0^q;#4~tyqh2TH^h1b{L(Rdw|efI$dZjNTFOudWbb=Ey!8t zbB-l$OPx{u{^5VEJz}Nj5$~t|5ybNWoB9Cp{CA+Wum27ODhNZU{(`fDL|~~0(5)N{ z!Yk=$X=-I{Z|d+TfcIg_>EGdZf8lBW#F746^sgAHk*Rv+VyxjPL7Trr?Eb|DUj378xcu z0YR_@qsN5~BKTB~k(Gji2S9;rug?Q`g3Kz9$RkgItZ5IxE~Sp9`vL=1{|%pedxTE* z4=N9K(f_x~{~e6`7s{FyhJxl|eZWFu^Iw70uoD&-X8XZQA3)ZBt`H2vQwu-fskt7o<8rVxGc5h!IWU@kr;>J+ zB|_vnSzb`uo2Fi|ofU7m&p7&u;>x}A>{eopfYp<#(n z?SAa#Nz=73k9B+7nX3Jm?s8*6 z+necO_1AhSwztRMdKa`ke`@QIMT+eBm`DsmJQxaQxZUV)A)Truyzl(&8Gd4zo}B28 z^kStN=NG;RjWn-X*$a;Pc`WzgV-nZ=#kOOTVLQcXpqn&_FcVpQitdVYvT>znldk@$ zFqc|aZS$?OX09r-iXl$jV+)I1MUQ8dFZND93DFq`VzF)D71V9)bqp#smJQlo);Gbv z^xO6N7G+-Rny7f;kc;8g$!5{|oHRx{u2w?#U3>OpcToUHQ@4LNmiR=Y%t0M(XlL%) zF@^;+2*=jw?u2-n%fS(u*}vF-R@a`xyp8C`!GxISl1)(kD4I8r%E8s`GroRyu_bX; zo$pY)2cRUkcelu6(+RlEtkb5VX@U$VXmG}sJ7il!1TF3u9@Hub7rfZJL<$*xe&R=L zck5Kf-Z`SEWJMehO&Z&WqYx{yp5=^&Vvr$e>q6BKJfqptz@Ybe5D zl3l)E$gv%qN9udih@MYrUehG#JdH9(XH_)k-5LtkY(tFfR8*knik;u`ljO3bDkQ)q zwDM#4&W7~9xu&fpY&}RBBPHJFI4*?U1A~}OLVW^7O-8lS{kx1`g@7+Y&m{%RbnM5f z$^nN7(mBPqHWYZ4JpjwqXe`6`FO;;=!e(66dM)4Cx_*&Bn9U^5QG*+dg$z>3M_hd$ zGj=Idq_hlYQ;3cxxMk@V8gR)w9+mhK-Dg0*?|}a<6EVY_$27CJ<_G;GAVq5Ru&Ei3 zR^6qw9fMk(o6$h|bBPbTvqFS{V@aYN{7dElmA14b!eO^aya>UgB+)~D@ic$3#5WRH znF;3D&6N16kxw9zZDmMLKU34n=+y0y9@o+hi{|W)Sh3jjem}!PC(WWePjE;uv}%8m ztC^uR&OOPw#hw2=+F?fu$Bf=Uij$+4#pwIBMb{#bj%Ma2V}i}H19=f~#iQA9x75PRl9mH#kl<8{_a5SBxIiPCG82}ea| z0!F#IJ{bYKJv)!UtijD5-STuU`?myQD*hVQ^0$Gws?<5hxbqY6=f@csD^yNq24cFe zG=}5eiDu4ln_fAz1Fbv3J=EYNwa&U}ee zKy#1tN$?eaBOlsev-2}B^SM%7fD*$EwW(5;ceCd^~I`{2i@& z+LTrh&Xp3qjuk`~jGhBp!6(?_zADw$L#6=N#{yKl-m(P;07!?plG~=L33=J933<+u zuPf~hMAn0SKxT*O+{;m)WsX`V)WXG%0!6_Mj3c~y?#R-3`VwgADzrad9MH6-Wa?X> zbC+YSjGSr6f`W|dK53Nk2;&24D?2UM47(tr@HL<{HwZgX9$~~Ued_SeJLc{r`N@#w z-O3p|o}zG8E9hCpIR{=JrkgY~9BoV_CDze~W!Gb-P6eZ#sE-`9w@npR&QEpif*q+S z<)e53Mmm_EWu0=nt@m%&4cJaLP_Xf(1UM&?LUg@cENKnHx!kC%cHhn`JU*7BEQ#C> z#V#X|V^%Y2%StUg_U_DBV89QFpW+Rw`BK7f5@?%QKC}DPTy%cTtL=iPx5BaVW%ylK zenl&$;4|fdPg=DKOQM8t6l284@dfK@22uM$;i)p36#c?SF)Ztr62Pl9_h+iDVIVhJ zsvj~k&1t$^rs0Rl`laK2dA{t^#GcP5_>{amUZ~f)tmx8nj^+v9oJV+CP2Ep9H+z4y ze_vC2IIp$etFT)V68%2<$B$`^j=h+-CZ91)XubF{idnkm{ns>8J=Tfrxt?ACQWm|$ zCiW&-MM96-iQ{B1X-(pAsk%P*CMh>NuBUsAk(fQHxb50OW}}ESz6hf@PNMQ`CJPWB zET+p7{mxu(@}l?*zRu25a3EK@nLo7HI4+SyXHNdmAhI@pgm2Rt?=w&TM+lWTZHEZ% zyU<>(3$>eq&d+!G1T7>iUQx=zEendX2Wpg)>y%BWx#35?jQWfUXQFB&1US^&i6q}e zv7{$Qy(>4}oy!Vt4lRdrg(~LXwq@Yw&ff%u1&@6W%L2%{$m{Gh*%WK9+&EqDJc@Zn z^;0FqatGc+y~g zZd08Sb@wbK8rtxsh;C24Zf4pl@RH!g$;!{L%My+6Mn_1X(h_$zUZ{0~w`@4i*)vMr z`Qcbgu`jr*nv*rAYw}rpqNDvh5}!q8;Wv~mCAk3LQ?h3IHSsXXgNTEeln-ijedlpv zeJ-m3QucH9Z;4;0V4CLTRqIr+OCvsKsxCH~+i3h`TCXX0-XhMUO|mH(mqNRJHPdk_ zYRc&ZcPg4DUM5%nwMSL+k<@N)8FS$PrFxdtYdi&>qjL=n#e6pM_<7yg$+vT)>LS-7 z{%?ueP)$R3w|Znu14Ua{*itACr?rlqlSCEH&t6b)Ov#G zuY^xdO+H0ryz7;>6sa-%9Mu{_oK8!Rk&nw0T^TPErq-LD^tzqft{A`0sq28#{bjqA zVoq+2gI# zh;654k0!umwQcQq6+=ZtjC-!Hy3ukE1cy#NpZ9$3GfCT|9B0W?89Crf&Pqh3hSJV# zqH?YKWjPmiHHPb1i1i#<+*MK!!*&1WIHj0+V`(mNN@&HtSbT`(&tY3$b=~>ZRk5js zh6d{oWMZ#)b!%Fv%X4XZ$}J73!l=YzB4kc9fB1wEP<8n4(f8IC7xYu@$oN?>-64LB zh0cv!R!de5xZgg$F^oujV~4a<*aYa#bKweyN8FD-XklV)rjC#U9Omd|&P2Frue|OFDMlwRi4_b<75`Dxu;zt23!lekgk%pLn*ZEv8+o)sY+~Z!2L2{vI zy$m*eSzw)^=S<|LMZB?01E*%S@NHyA!rB|O=tppHBM!w;sNPuO#-~=OKhUKnfb5MI z`CL$G_@i3G$N}di84&6XSE1W5Wv&CK2XPv|rDJ9Zts#@MLg;$qA{}kaH!~-m1EBOY zI!}+RaD4*7W-sbT;{96hgaUI2ij!5w+66w4}1=j4i1jV9YO`-2e6V!-GM0OGAxuonB z`x*fr<#0WeAW12Xz-$XiZB%$K&RLBy$PY!wd%#(Xp4sk#*m~&LNtD88MfE9@C=6T7 zyt+NC8WJLIV~@m_vFg!AD_e@T5wui8*ph0A`SUX+V+KX{>l`;d#y?X-WLM<2%zwV@ z%#+<`-WC!2nMy5&b_6?8eldzt>Ti44m2cKB5qBI+SR}E*cLgXR0^_iBExLeMXuAxBpf>WKB?r9GmoXm7KQ0DY0?9HCiV3Foq6B!W~DHU;OfiNFE& zA7Qz&u%bsMY^>q!V(90?O3#S5E*DEr>tr$;z?aqx#P;{5b^}mZFm%~{Hf!RcbklP z7P2`ozes{q_|EYNd0^;znl*}ez*t!o!YbB5SUN`Ju>n>!%sA%Vg`GYymAhl3+_swMWpNq z=@wYq^Pui~4dWgoRMb5{A`lDgW}L?l_w#q><2==(j8q7FNJi zl9OF=+Gj@%OOr;?3_HZl4C!g7*vvCd%;MQ5uYm8= zyylmt+0V|^po8-kQmDx_1|4Ucfi4PRVN_Vfn{L4phfAbb>VZmy)CD%71;Eb!>l^f< z5|~jFyM@YXEIkp-jwC)p1VJm4C^u*0eM$w?5WRLje2En3%KS3Cq;OlsWx2rdaU}qRNe! zskd?=ltXezE$*8QYn9HKH|#hUN5?EqTPD0K*DOvYqlX-e(1XYHEs6Uq1`QNl@~aI^K?TR!D6G66|s?K)p<~yj%1W89V20J57)Pa>x4P$+f7~^biQ803T z$NFII(-N|;VvZEauN+AE98nAx|)CRgYAN@Qd zV=U44qW=j+5*20_pUUZ?5l4t&t_ve!*C2Ne)Cin&A%;3vJ<^U!Uo`4gFp_MC|AR3~VDC&3N=JNYl5#a^J3Jyh@M6x8z6Cc; z@pQkbm2f(KyzBrgtlHys4b+1VBV8E4un|jd+oDUx<$90Amx9%4Dp?Kg3^r6-xIjx= zf49biFXJoIRc40C6o&|V>73-3wQ=>qs6Q@pkSI}}B#Tz5s?-@-+F2%hh>e&RQX`W5 zLskJa#HFJ3vSF?X?5HSL9DiKoV(CRfwGSwWI*B3{9-p!TBaFg9rSvo8&3#YVv1TiVh!Gfo*;(wM8?02QALCR8VL?^R76@D4P|=dIvnH z9I6B{vB-&k{!toTBiH?I5g^@F7u##Poqgm$)mwMN(5nS%EWM^d0=Yr^qzHZ3u9}5s zQcC96^=)7gnT0+gK|h;Es}6?nqy(1ES}bT2RrOJ}IJYdGV09sVfWi^e&6CaLR5G%Q`9xr&koH&&Gskn%w8qizT`TQFq3MIF zq}rseQL#S=>_)LL#bBJB(Q`K4Bh6lxfQz?mfdovC>SpgX{}`vnoSUo0x}0@FhNoPk zX!^OYoY@yNW^`782!$bNqMLP_gwvmAsy7O__1pV6IFfqa&G9q1Q#`VdUk}Gq$^eZR8hpMK0tWo}m z94p?fQ*?}cmt^8wcTOhrkVeTmjj{*kTIfAx0`jnOb)zKM(Z@o5l+=aC<*~_;C5}9MG5Jsf6M%CF(A9kB?K%HEG+Qt4np!FTzS+ z!h{h+&7Mygjm?NNW@KxSz9Geb{BFC5q2nT&R_SWFvq793(Bw`k*KR0zbr+dCt6SA+ zBFD@1+Iodv<#@6^<8N31uo=l_a&= z`oI#_+I!Bg>G=4(Q#NDk4mVX-W;cVM1)>%~JDgH9$+5jodp#gg%9_rfkxPOpqK#2_4oPr>1D0h5SLCb#f9cJw_2JT20J(*)aYTqrIcvm3EA7chIKk}pM>GHkYzm_=$UfEPg_bGn2JGoJgKjMO zYO5C;a%f7k3twa_pEM&eY9d#a?Gl4Y(Lnvp_o3W4G)zpfGJm7*(k2Qb&@##+9#o#* zKvUUcN}Qm(bdh*lq>-ytZm0ilp>&)XxD_459hPo1TOJ}OPs)WJGgE(XY0=>8K%rDh z_cK9$=DWqkyd;#u<3y1gj7vle_l6J2Ux54$t-a5i^FWWf$#?hE1AwdKF49P~%0#cn zmHccVGlN64!v@AYj6NrX3$5D$E3b!K63snf4iQXbScc6l^%7JFvmQ6Q!D(94A~2Jw z;ikYI=f4TM( ztVMbqUtkkOeZfBV^=zqn6mEP4JuXpOc&0JBwLiyi&s_56h%vu?MO-hz`E;ygf~-*_ zP@7*?myeXttxO{5$wrRrJ37Fb9PBKcQjuLOBtjH1XUASWra!q#Wf1BdM%uCok|d-^ zbeHQ0o#$SB>41(w%#vxbpuWGOq`cZl40wNm+?4!cG9R$f;8j5kPu3?4U)(fXSr&g_ zR6$@6nlaLgKGfh$Pt`Ng75t?XRSS%HwLw-{<_cnx7miofVt79tieQB6TX6D<*06`G z3{iU}E^DVQDqDaSdhEKlX%u6#L#$KwZcFP5;4q5G@z#ET;0AnB%absU@F}brUFbWo zJq3!#xmC{Uy>d`3AP8-lDFblg=`GwY`c(CL?u82Vom|JVuOCe(uW}q& zA-ZW&$TprwX3ncdzYi?GNv@Pw;Q65W8kbrPuY`fssxz5Z0TBs=yKG6P4QG=`-3scx^J1sxF{)FWW8@Tqo8L ztoaOdw?0DFxwN=p2sTujhegJEexYm^+=d|T4ADUzTn3$ z%btU*mSA!?rd6bz11Y>pz#VaGAEFC+&{F?7!+})R3-LoUF99cPoy`(UYrUDBhD6$X zDJE8cSSXd177N=5Vn~D4gYAd%l``tR)-YQLH?Ak@jURiv%xdxV8l(w>{t#jImA=-BJe`j#=xE13TiGUIr& z>fQQl=*tDg^FgCml+xzX;FIve)u6Ge^Tv_$q`5*@$nQrkT(9?z-d`D=q6u`;Zo0&W zZ_kDEBp*@Om)x3p@YyCvfX!B4URtC+5+rccN5K(YgAv}|D6n4Kc%-+6ohz@7zOuWD zHZ9(vy>!_iFi7ulG#JlvQ^NFC8y5Ra5rIA zYN#?MDH;(9Oym2Ct{fHwnn+3kDSs>j0K4$0rdmsM_QE?iKSAPnRg%MKMP46qWQ0wx zsb#2FMyzo{Vk{xU)K90Aa3WjU-&EvAM8L*t2N~hXvZ;hmzY>w(9yYRMbD?sLe=1lg z0GBL=O%6yAC!X=W3Gt-|Xd+GP*mPzIdXLJ`th;{)oG;;#KypT^M>Ea6jLySRKpVR_ zDEC~Ht{KxQ>hR@vz-RA?A@czl(*Yk)oBYNX^hcN*2QcmThwvIM&#&bsklLTpvyRdiB46~ zL=TOhYy=q^{4S+Mw+q^6b0uzoHTJx7zSv536NG&{pI3*qvrNFTDN4w?l^m|K5Q=gl zz;h%NK1oj)!r-gb!fw=e^!GJ1U~f0f#qp`RUP3wu0l-qJhD_JLM>{rhrib0+71%xe z61TBs*u~pcL6liYKsU+VeTbX$L6uC>Xzg(eQc!D5$Mppt~2(mk{G5bOi4w z0#k#PB6i2aw;yi36NHW=P?^n(Z`cx;QGup7%#y|0cW%|$BalQ!v@5p0pz|ETi8-C7 zd81%_?C$XV+}0sM2~*S~$kmL|>FlY6B1Xs&xt>nsS`imN{TSJkpt?;j{a$x% ze6~K&2eT%z=c@zZp1+|g#=M^nVTGwjPZr3AAPc~TnV0(m6~LFmPM4!;HiL^CX$BjN ztamjH3dlM=*7Y1~cHgbAXJT>DMjyMQLN9K*MUzc#EfkhRxHw2p3L zZ>tv^S4#UiceghO>7RohE&C&t{51At9Rd3zcwKIzYhMj`l?O@+ZtyGPf)|V%NfUv% z)&Q!6#U|K!h*0&bVY%8aw^bFd{bg1;aC3mKnjVDumk1F6!N=$&PAhz~s)y=BYOpX#n0=J@ts;yU!xg2Y1JahUWwx%l>NT;i zxD@D~h;C9fn1f7y%38#-MbqP;-ed(@e(zH3g<;fN&W@krvR}t76c!fWt?$;0cs%8; zCD@npy(>x8W?~tpD@Xn`v(~V>O)^`Ne_Pz}eWMg0RBJC8Z|F)nkL}={n6*piJhh>; zChntR!8^{Fiuyg_D3<+`a3?fMcCIvJ0%C7inG0V=)On-LhZw84O(y$lKNrcT-q$y~-z7oNpLl_o|TY7I+pzI$tTb6W!#W47aJM%xFO;iR&Js-Gv*jm~~ zC8p)bwuwtb0DL)zJs}vckoO+pTd8oU{#+tLy$-J6g81IB8q~*lw98A^cm~Hm%(nE3 zwbK(l22(@NC!N!GO;Q|^M**?sB;JDaBwczuHePs&&vQ-dCOw5!rkC_9te5GD#!hC=nG%Y#y885IJ6>;2*4 zipPdHLTka$Si%N6j794E&m<}-KdU>%j>RCBeXDPUU$x4AzQ$BV<59RxsYU{JxD5n9 zBHVbe(OI@4g>*KEG9!*3o{`xO&Z}{))$;4-Mm1ztE78Kmqpc70G$#RM6E-i%eXo6= zLJNJJ|HVuj?Q^|7)y7KLOZ+BV$#z#jQ0eS}vy{&~eUI(M=oRELv((TiWtCJTg(|Id zQrh_Uohw@hhRO9OSavD%MMZr!qSjXPl&j&Sdy5p>E@A00Mb`l84x((>aQ}XG3$)Ga zJE|kPXr_RC3!_XSlSgr~0tYb7p^zGWSFbzsuq{z|5 ziRsx)(a99JLA@-zNBd^S{_K&kz5BiGXZwSN*S8lS0se{5NB3Qm;$IQ^{t!BSW3T;E zF=Zg9Vx*+}gWO0@`|oiZe~|wEu3t(|`+r5bqoM!La2r*u*mxlR9ctr+EZD)n^2DF@ zT;E8iKdFvyyuY{7Pl42bgLL|5@zP&3QA%=p`ZxX8H=g1fOO%eBksh0jft-%|UosZ| zCI!p%AEjVv{x4nmeyzojb@Z%x=i(~ApI>`>FtP18_QzF|e`jb;j=#U=$a zJ15^h)WuZV?L6H<4QnV+tOwAIiEEV&Z=z1dEA_U{g^@as8?%_3K?W zZwKxNzNH<^b^al@OQEIlv#FW+ucm+EAOAdve;NOn>CgP*H)t~bWS;(jCesf-?!Uo@ z{#ox2UEQBz#Y}IMWlBn#U*M#t{Wr1sA5L>ds{dx#buAXJmfNg-ZAr$YlCU$<05h#eX|0|5;@I#K!*#GXFf_8(3S3>sa!b znV6fI>X=$%Gg9!F8Nalz(_wKDQEFaKk~r1&`hBS-Ykz-1bKj|` zunlnR!AG*GPfB^Twc-Y*=@ZLb*$rO5&A)x}mjU8f^_!&~Ue}4J^ofAaGjE>b$bk*d ztex>0>(?cyF}K(8(fe&J3$~ZJo8G!mz5Ip%m8AeI$qVk*dh}NSW2Sd1OQBLVDke-$ zLdUs^Csl_?HW{Rcyb3e^mBp}nint?Hd@1@t%;Ue!zkTvo0HU#&75Y%4e?gR`X4$mR zDWd&a47ZRa0{x&wOx6z1>$p|w7Ocm1JRY+l1^RVj^!~)QyDlH+fIR2qGq+WLa>DWs zhR1^$zD+}O74H%BxC2Y^2Um>fxN8degRQ;fM&?e-T+R#56m<{g_V+fPK!-qJGobKA zFa+}0qGi9$zkTu-0K$*&5NrnBP1+_fe?f3m&L**l?s}|<~Xrb z-PL9KSzrm}21u#ENpFb&<;1G$b#n9py;PD0k-#}(s<|i6wRh$epTGo>1#r)_`e9ad zA=8QIaTdoWH02H4xd+Ngi_HSKw%k&Sn9Ci+){K}gwI*IBi|UKEbM(tKAAhg>_Q8K; z9N0G2n#Nm0K^HdK=})Qlw>@3PI(G8o-bkIZ*E^1j&Sy3fU6v{@`KDCJ*@CPu)lRXs z70zKL*|-@u`bdY_P9`65ys5+j?J~8bn-cpSID0HYZAh~R9P&gphA7Qpsa%Kk2`%!P zsk=zcv?}ghndxv?Y`Io_%1en(vEfiKk={!kBC9!rsab5}UNn0LVbTQjd-b4nHpDzxa@H^ zN?iFt^7Epq)tdm<^xH{^&zcxtfK_%~y-2D&c_3Q;5QARKzH+>BVaS9!hox=vy>GAh z?bL+sQ}zxFn8V7jp}=N<(pn13267?9+vmdi3i==}FyYA_4SSXT+xXid{|pA6-bK;c zML#OIZC5TsIw!!hmxg*o*pegYD95L*DnpL4{IgxPXZ{emG~Da?MRdg8wWo?D^elp! zrCskgg}66>CdZ~EKrcAXiVjU4LY2)0?qJ#5p0H>J248O;ziGjxAQrPnY(ZsLTTFVNS@td5( zrfTEje6sWNpv!0Ml$w1^_}AH=n24L;xhbh`5Mi%8gvjbVWnXUP^ILS$xl%gpok%ge z#CcGYw8Gr`^_%ZswFC*PN$z5ZWhQn7n>FL>?M-RI)Jp@hJ!clXzT9MQVisk0+HQ#q z7hSvx1A86&@6pZi{~q0(`0vrp$^RbR{BbjmpZs6`6#994@?XE3zb;b$<-PfP-28vI z4*VYt@4v^*ztWrkoyJY)*yf+NqjtIm*M9OYRqaFUr^idS%djXe>!#!H^qPlcKo9)MrO( zqiF|zL$J1NYokb_{PvSs`+>J?(;Y>v-=ee}$Lwgx!>KE|#pNm44Y?%5qG`lB$FHY( z^u#*ipHK73h`CcLTGxtnN^@x@H>dSNpMsCX${WVEvkV!^*?qRyRSoG_;IG)T4}I#a zQkQ(H;gF^Tl_YRXcz+jv`{6$W0;$TH6!TgrOM-!Cb2ZT{_(zW@-Sz1K%e%)ENh4VQ))H(D3ubq&V?xHnomD@_fX0-25Q zTdK`WGA#OUU{7$|Iw;wc!wR*`JeR?BsorH3c#{c#K+l!r_&|UjHLcQ?=h`}ROLA+Q zKbOXNT{$aeC%7`?df4aUOkh0DLiJ!rV0$*6ml7Xs+gls%pF%TQFJ!-z)nqEE%0NVc z79AHdAl$S4dDAlT{P%|6F8Tik3~v#^$iNgD?}L>UY9{2$a}M_H&{m1P=J+SI686T& zX1=4|(G<&zQ@etbt|#HxhQ`Kjsmqd*<5COah}+8)zaNCV7@7VMzP)`ZPW_+uL)5(h><4rKcAC&l_81UQp+ado928dbeC3~z{lDKM2 zKa++vnG?N_)97U-C)#cWj?HRIBgi$&5=#Q;x0?0{du~5ScGJj!%~&2gW+pMvEROl& zmkfn5ED779;x?ksLern33g`%=4Mp>&QY7-3GbL^KvkpRjn}7S{uL6WrwFBQYtLeeD z>W;n2v|;nm8B5JUu8)&Jz@|*sF~}Qf?hXKw9}m{QOOpyE`2R-*Yyjwg`C^TqNt1u% zcxhPa@SB-hQ+$&bkm318BB*0*t7C1Tr9r`Gs%55aV5&zUXJE=@YGv^Eb$$a&D{CHo z4NL5|q@Evbd3CI`EDg-9&E71Oe@jZ#_*)e!TBg6hbwc_rpYCU3oV1yYslnT)>%8Tq z{YshqY5v&{IRkBLeJiD3uk!fuVgEe++VX2jNB1M$?jO@Xum9RYPtSn;V`iX!OICfG ze_4N&{;?NEnjZ;U3~w(G`BC#nji0TksQ%RAAN%=L`mwj4^V^sHqx|C&|6cyFhoAfV zvHY=zKeqhwm*$7xb>f{GXd>=qOeGoMQN=Y*T&%V{08t3Vve^YaL#l zABTYAZ|}dLrJ?>uE|p+_a@3&VCMOKv?L(mImmutV9hq)y$R5$QAO{#RcFx#^Q1vA^ z6NmNIw1x&857;^8jK^3}x@_mh)nhG=`X{?j3q0{l`C%&Hv+J=7YoY5)y~gV*v$d1E zlTWLviByAR&UI?J=JUOi;nUTFtH$Td*^N$f)}2(Wy7#41K2yDwPWG#qm@2MyA)Bk_ zU>24>N~J2uqOyAeG%v>F?b}vI2CMUq9Ls5>m(81_E|4RmqYwjCJjf+llfF}3R(%H@ zCDny$$BKG5wy(t$Y+AiikKNcV}Re;28 z!8PGiw2yA-odq_%KkZ{VBbnbi3_LA9TM48inJSX66vujnYk zCK(z?Myzn3&rBEiUfHIwM`|AX(E)I$9&AKpE+`#&9Tj{;d@e4XLPssIC3*y0FT1is zVZX>+mYF0u=6_nrd-y7a!A4Sh84qHDALh&0{0B=3Q zdJBTQzW!VQ0&H)LM*OP;#6P9R{;!WZJp&E>-w;6cmU&D~%kXCq7|S@wOUWT|+_vBY zy~hv77XIo?fy0Fa1_PrbpiqUIAuSS^0V~ccUQjn(ARqU&NU?ajVXC@Daq$yNH6S;M z$+96L53-RG@|5f4Fcyv5kTcDtNN)U4J%z^jP4lVgZmQGCX;H01e}y8bC(>HFv!xFc zV$&*yvCeeJO^#dFlH~hvdw>V2>kHkLMzRR?+_YKR*6~_;9I@^vUztm6T&ho;4d9$( zv(pPkrfLrv0BzO)3H;MI?Sp0q?c_NnYW>gkE)m7NdV4SBvK2#=*K3mD_Mw6E5%Cqljk)iC z1_TB1;8HG=+>-F|E}+xs?1%^p3Z7txFGd@IaO4RdM_|DvXUDP7j$~r`JRKR!PONnm zKU8#-ywvpMS-uG#6e!#yW^b#xpH_dD zcCzTUwx;9=%kzm--F4?NmfOSq$g#Xgyhm@R z`Jhdl;H5XSmN0l#W6wV<;IG#MnT&H3yxTe_T2J9%xJ#N0`8|b4t$4LuB=NbUIAD%h*NC)Z? z8>HR3NR4m{~hwaHP0BG`lB^xW^}U_po(f=a0MUABwzdH4vA)k*VG{t}B^y zK|6chD1NM6W4Xg*_lU!OFWMG%2Ds!)2Ls??4m$IlOleI=9vW?p*4TTv3{2I7Y|UME z4!l&;*vt!~3`5mRr3{|D?Xe6^)sI0Pnvk-vaZT^;!%4f#)FtfB70(?4yH}xqGa&Oi z3Hoh^4x|5_aC;z0HNgi@L43kK_HgkJg!%AF40(%`+h1xt-0H7MaTZNXx+?QOf@dza zW7W;e;4Ql2UpS9@auXzYK_vQn+rQIO##KAo3htIF21Yww!+oUjpDsiun9_%R;)` zlh+M+Bc6z>8y%P;AnoFoYCPlY0!NBhHa>Y&iwq+#15!JF4 zO_~9g?c0g$pO94ru9f{37?!Zja{s6nhqY&o|L#bnp0cs$tKGDC51_m%@nrxj;X8 z3iW_e`+_mZJOhhEv?r&1jvEw24%YV4v7IM$YizJqzYhRjhFp8bm1(FIp3AAzj{ls}sQe$J&aBApj06}*n5i5<(DQIprd9O-DcihIjp z^yMIS;vp4t;hC{okGbDgjW>ubh=Hs-X=^XQes0DCgYS}x>%0I;d}9E=B)Tr}P2IOH zP`ccuYn?faiNd2Ve2nUu(FQUWDjJaS8MS>iNGg=kLBbn7?9h2egWEnl6K0EFF?m*V zua+`|)WiI}BPj+OO449?JN8;^XrNPWiWK-@(CD0yqpc29DFzj_v>s%XfWlX)W#nUI z>-qkMiHRiZYr?@f>04!&oh*&2<0scIij_o--uLvdnHLBy0AQ3Q zfNHRTF;VXjrO&e3LFlBYJtxpyM*YVL_^!T~U46FTc`q8N0or2&R}dkLdS~wV?GwlM zmOSI(tE}LGon&=kRgF-lbYe<65*AJ6?LAPfm#XNzB`TqJTO4?~h{1h%rp58Ch19BW zpQ7Ys;u(lk6Qo-ROSLtGf;~s6@#cv3`nC4@Ii2}o)avR137%uHAww`mh}$t@*}d+w z)WHdT^=aj?)+rg{#(eqYw+)g(fZ$Zgk@L|r(giGhPQ7EgR^Fx$2G zkfb<$8U|HXs9<_Ii$V-{xR5Uk?J&0;3&;u6N+8^hq$AdPL0x%3TN(m^d;xjUcVSIl zzilRc&P_jNd>XekkXIDhMe1|B>j;+8qT?g%&r<@YA8um_4^BLgFltV4aH2GI(Qy;+ zX5{z3)Xk6%Rwxe4&bh?^%@NB|Rg46ZlJd+a(#RK@-G|WC)fpikJA}~H(H$lony&W{)$=}J4ata!fZzPLi-fei6emSs(S}d^g@SAB*76> zVaye}F(4a{l5aG}2ZLuCnc@MkoE3z`uY~ZS0c^~4LIhdG8eZT8L?lTEyrz&mS)`WB zE610C>)Y+ht*)=u*Y^$KclLq?E6>SRqsz2v!o9OlGtxH4YYP_rwmo}iv$uqJ$aSae zTL_t9kyRUvafo*T?7HxwIIe{SV333wLE`+Jy3a>mj*rE#Y4IZ{UxMDXeC-P5n=;?c z6q_9Eu9Kgza(kIwn6AmPhF*-~SlU><%swz|Nx8v7WPkz}ek3u_SGZdx%NtY@kHfJ$ zg{=j*yBYT@eiNFW61-Bu>)Js5bWS-etw%elUu}Sn2t;f>-xRwoCWx8oB)YSb40&}u@r9!&y`?nV8<7EhZVURcBrq=M5lWZq*eX#_EGWCNK)L*>9N7n>X*VoxmetYhZvcQS)r2WhipTeSKGKJ zz$Bd4CldCKL1pCRZojZPGI!i7TP2(wGRN53wo*GX@~gZRt=2Lt@DZXxt?Kg@6VbBw z;V|LG;ITZ|z3#UD0c~Kk@m-sI9flHX zS$Yn=<+y`DmF4&I2<1V(q-pIh8`~+WwIFDwh!@A+BZB6_OKF&vHe>O1-D8Y4`g71n zLt*9b)|D9LFlk7Et^EWx6x35>r|> z7LX(Z%unw^_-}Vq6A(zczV`*fe4`b5pULIcf6P<#_M7%uD%$F_GM zp*NfzjO)N>RCTUH>iFJx9=hTXje3!Duq<7KEle0Wo!fZ2wvYp*I z5?RfOo<%D`T*OU+98@5@6kU#ysPpw5PIYU~dn`sV2Fa9hPqxgPCDBy-$)N|o4-K&6 zmqC6@^b!@X|8&bvPMpJV=`QQAt`gF6$*pThuj)YN*CG39IC1SAB!{|iIMu{H&}=#Y z<^wdHmM6_DT-ls>o6GmSU0ozO=~Pdqr?yJ|YT2DNcV~|2#u)}Q5~V?*m8?(5eOm&O zLSk`pQ!uX@;)8*uE=IS@afP~0^}Ej{XB!ziZwl6OI`s=;l?nXHPaIs_uJ@n=Jzfx9 zM$FtpVHv7xOs3rq1A&jQXNv%x-@$he{ruhg9R1|AU?0c%#8#+EB8plw-|n zN%}~dp=hm$c;PKv;bsLTS*gNcQdUzh(!K$-BfSnQ84w7r}=#vOM(1gH@l z{2q^R7=SR30h)L-mpyhN*9jPU`ZXKIKXdN%qEN8}X*DsiB(0#225He|>AFgyC=DPP zLwdx2M8T$9OGXmsP4AnCsBp~GXIy~K8+I3#pqE)U;u^?#=e(dvZXQdPm^aV#!K+xy zRdyn8Yh?d)l-jS!>I%2_YMGLwwru4#ue-=-%Mh|A>pBzhb6c7wyur~Tk(|(QcXqMs zJghX$Alke`c1=T$fP_o!`Ydv~4$(<_QE59|e{9aZaYC=v*g=cb%ucjA8f)@FWI3z2 z3fvkz)-YB=F*d~TC7OOvrU>y_<26m6hYtYA5zSXo3MMN*nH`)Nn z9QQ{~W!pYosqZ`=eZ6cFO+)w8b(($IDm&lmyBDKJVRorNepgy7@Bs)2*q(>+dDsAx zj-neWg0V7^a|D{dgp(R6z(wO4%%tY*CrT4p?NeJrV%S zJ*IM)d63I}nQX%u$V?>cTi)fot-0AI)HO4@s}5%3l{+L)fpFNq9^B)R$>mrU$Wo_$ zx&|iNXkx}S)k7)#TzGmRSrt=H^GtAh0J7=AMKTw*7GN-+EMuooGht~c%?>zgTLG_e zF!EL%WOcn!*G%sbN-ja>bOL)FoysC6QH(BaL`Z``gfZE)61u^0YJABqjfNcl;uLLj zy!E93@3>z!Cw}(Zb0v0?Wp4DGLc&w*((wrr;EO#yE}{p0Ksno$XtN0?Epxy6M ztk4Rq0)`LuFv_mJ`?+)HZd56#OA4-sdgn?iHW(5sn~k%#IMWick=JITdDA9NVoI*_L{w>;*;2=w3eum zY4P9;_|NHd%(bj8dpN1o%6H2?L>z^en?(=x42647ecKZm-5{WuKi9?sJLabB&Bi5m)j#x=I>+jlJiHq)}o z{Usy%UGn)RU)s%CIwh=>imhC26>iQ7opZi0atq8p_{AYn_01r2gTef`k8bRTpRs*H z6EH%Y9eiz2RA^Fs_G#@kdcJ&X`O?Zj$~#?#kcWA92w;h_Zc5Xv9!g8e-;*|oqxCuE zy{{M>-6m-)6WMJQe|)w!__@*59Mf)7ZZm-wd3eqQdAHeFmYm!6yi}bU5`6{Ll37UO zEyqqFLrw8PVA^A<7K^PW%PV@L_gy`C0DR-UR1~wRg4AR*?V7dE#2Q`RRJB^5!6&_% zfM_9Xn+e(+mwC=I4h*$CTKpCOtoQYr5{X81;%M zUU$+Pv^+FhowQz#Fx@^hS*-|w%a-Ew!Y*fo5aSkTE~_FQ78zE)s!r>AgWx6=4lmbs zm#3P#30@s0Nirw*v=M?&Jbb_MA1v965CGPTT=$C#av4u=WI=}r#(z}orW$XdabiqO zfXq(o1I9XQ^jgF#SwBygDr)#5d4BRef9|9?HNA85^6}}rY1}Hx8E}rImxnzwbHvHb z;$jn93ukL>_GODWT3USWjStMip}*2@(Wj1?JRD?m9bTGxp|?$o6vr zVb)!ol-M}&FKZJSw0Q)r7X`MU=i0WqIn{QANB%(Ep`vPN;68C`sVZ(XlvAtY85js7 zP^I>8iXxlN9OFx8uN3rp`N<0UAw%3zHn5Zf>jF{=?qA5ZN3T?hmoE$sH#|zd7$sG@ zlViOO7Ng95R->lJJPF@Nk_#SEh`qV-7pq7$w`8m#KwG#TdzK2jHb``Orf_+LTkmo$ zFMFBTYk7CN=N}s}O&E|=Ho^6H=vZ)N$V0{gJ(mP*%&K150YXhTQACM0j;9h(($`uY zheVNfx7?p>40K8A@e%a;XLQiQV26r#1#zv<47^% zQW#KSLE%gcOwfWA1ji_QE?Fvdbw__1nZMlZXq!S%(P4()G96`0V$Q zElk)ZOxnG=ZY)K6N8x%dU(Iv-mDIHsE zn(~S+I8A`vBH>2!n6^yiDZTuL=xQ_a!N{%m0R#Yk4%isPlN1m|-0GWO@%0sgc5wb} zsD`uTYqF}wvWI|%61u(eLU^vjvJah{0n{Usx-du&&0N&@ByG?+tHQH_b1G-_XZ8V1?P&# zQbSnkn5SZwb&8FCL|a4WOnEMoYbj$qsR7)A=)PEMb~$CQN&}{0RY@i#i(L;&%qAWa zR11(zm#A|#5O|L%t`s_SARkXwF0I zY2mlS4U?F`dY?^&(j2o&T(wQ*d!5QwziW>&j5|2kMXSvTTr`7EjDk=2Sxw>X7^-SKud^ml+N!J-)X)IozTj+Y;@XRp?E4+!lDWAT|9e+^| z8n{tf%q0UkooK0PHGPfS{J86W8CNV;>w09__^k@7KCF&IKdAb-ym`uX-m34i#;)-; z{x)OukmN;dLF^SPDY#|U08y=#CfTqr%ECgFEcAlsM%B1$Z?*_@LV* z*6a17u1_(d@a9#-M#OlK8=-2a%CU4)Xq^G!3b1SI#_^gMCSh?=Oi*rG@u%^paH`bA zWdBPVqBJ7coStCo@74pfp(Qc}JM)25jmZ=-a$mQVr%8iR_#F-U!{Lbe=ZoUEWr8uO z<79^osnTcy5%Kh-2kSi@=;he8qLD(rS=39bC{cx61xF~62geTZ!#a_SrWGJSbSu~E z%koptCuo6Cm;1&$UBhw-S8*Fj=isK~=;eO}4vc60=n*Ov_{HG8S}Jpz@rKk#c0R4O z32FBtDQ!;<@BqX<>V48YuF5LNgwIVneC$@1C7gKin<>Kj{83Pd^E6x{V=~n@Fnf_l zGUe3JM8JflIwi#0NLwscYoqE#yg~N5WrnEEh>FF6&l9wGc4S)5c~kzM6;6xCF3U1J zUElQy70XA#_VsJ7Qr(gAl(Xnx0^Lo{HRIbY8(q6GmnzM++>k8TKr$N}mH(?Oz3{{!m<1dQ(>YA(8sWtn#Dsj}Y~* zfbt*GmsVOo#3z|(s3>?e%msA}^z^N<8K@ZF6exdfA)}_I`w`sKv-%@8{Y$Et>P=kt z$2M%LHx=3+?ca2D-vZbC8YTwD4upS?c@zDz8W`)m1#X#s1kfaZT0}KW-r}VH93cPk z2~yUUI@VhHe@MjsFv)%_D7%J=m5V0^fXM^^fZjv)U^M(Aoc&;ihTK!Z-m8OuR_#eEz z1ymi`)-4>|AvgqgcXxMp2=4Cg5Q4iq1b26b;O_20LvVNglkUE^)Ax3N-y3iI&&(0thF@g^yv)gjOonitmv%iZ0Kz1oGAV@RwjTQ|BbOSGIHS40Jh;X z08&8%WCLt}F;+!m0C#V0YxAeAG6B8?Goau9ZL9zK>~Ew0&!!4U@B6o=%EtOXnko|; zAp7c{^YoX5w}Ss+s{iiCzceI(9{+BEf7&P``+wT#@1p_875=A{vi_r$GSUA&UH?l+ z!py{m&jiSA&BPA4P7FV7;^(#cf3YyJ{BF-|zs(Tl-!eV_dR}IRpWB%LqYYRCdiHZ+ zX8Aeee=a{IBdjcd7Qh_)+4tXDf7&+VUo7_LxB0_j|C#1z;NSq!Q*c-hH$AsQ6g_<{Q@A4=i2wS6mdD z;5gJYgz1^Y&v=2~nw&UNHM|H?6w);7)z!lTYt*BvN1Bg6wLe3D#D5`LnK%+@hY8lHa-g%{X_9&d4;N4IR9)AEDtJzn>XF zd_jGJ)hzTBloME{7x280h_F)2#I$I z`&LD~_ec3_&b*T}V^CQ^4&eYooC8KXAU-+y`^mA*M=X5I#vUkj_?~KbGa|`+Gek_v zG)64?l`yrPmwW2U{?7Yq< zPh*mq8TT)Ddq-+)39eD|dl_RQeHOX&aV3xT?cK23K?j3v1lZpXTER%iF?{&kq|*y@ z9>A1WUA_=nOzMg>79%QlKjyB`${vMW^JeBYfu`L``X-yRet4Aew&9aGn$WM=?2=UG z_0|4hg=%Ta9&T6@^h4-pp+TyP&iY60)JxS#oYl{b9qXk`bE%e*qau5>F$)>jdc`WV3m-7~O$p7h5RiLhzl?joqH#WN- zg%#!r)g`cGIk)5UDinNFT$8hVz9`GK&AuZ$$zCV79@0@gu zL{dJFQFh%|w{Xj~YR6n;-eXSmRj{cg3`UdeS=zH5)Jf4C(xjvINU&|TI)nhazJ|Q1 z9d|3@hBclx7_u)~66l`h*raZ^*$5Ns6wr;}B5WZ~~Lx+2h@5Jf&u<$QW|b_NKl9PFWO-n*I+9 z4dNQt+8Vi20((nuJ;QIvj}cep-I}xwm`_+pO+kVw0xu9 zW`wd-J(7&K zvxu>CqTl#93Y+Xa$Rno9hV7ZWtGMPai$kZhVs!q&u>X&|#{mNkuh*LL`!#}>uS2l8 z-vZ9R(p(ky9G0WasU=PW>a7*F-{&fa5+_Dtmo;iKZ23a^YBh@en0C)GS>j$l(WhBE zR!(<6;xwngsrs5Twql5iK=6&Uy~t)Bqd|1HmC|;qf^GQbB$qWmb{ZA)HHr^*Q`MF5 zh+bVki`fOYDSRZI-3^X+1Rqc&g~ck|&x?ck~Nt(cQU3mmsrpzU<}4oj9@eFFla1%a{1QZ8>?+4V2H8?v~34_mQ`L3psdV zI^bq=M@N-oKKp49`gH|ryFw0S9(uX+iY4e*N1z#LT9yt7J`fAT+$nFmtBCQl%V)K0 zOY^L~A;VXQ>dGgCGMOpk(iIb`UvieCJi~bB>$G!gKbVNPS5lV|>?nHpauhX}M`&Ml zS#UZ_3vCBb$Ik#CoV59vgfG{r1wRcNLnv+{78Y zQfQK)OR;jqY#?Exwe)>#A6O-`V3@>Kjizw4skeHsL>~pGOE4-~-{9<4c@aU*=NQfH zHsPhy6XrqpSMMrv35xc=y{q3b)*sm5CnWn9`uZBQ+I=m0f1=;Y|+>3$ZlP^MF%Qw1Pv17|BM<6q%4BO}1g z`5WI40K)*jAHcO_UFWRhmGMt>{S%@6 zH@g0hT>*R2h`9X)YKyqp>Dw3?8~xV!hhO+lU>o3>{*P#zg^~H!EB=e7_dn70-}mbu z2men9{&#Zj-@U&-A^5Ly?*DKUnHYZeJO2xUGco-$x z%m2Rq7wrA@m5qhtH>EZ^!%ruI4dDE+GXLCzo#j_WHv>Hb$8SySY`=@D0c*gHzsb4* zA7=yji~kaX|LgVFll;GV4~P={1#kpx@TUKD7BXEU*<2Xr5h0nUx z0dI$O%uug?QvOQQbdD}$i9u%1BnKb-(UoY_aVt9^BO_D)hI){y64SQ{sbYqwymQn9 zuDu2GDjdWD0ty98{P-|uaiP5d1Q?-KhK8bQt({;z@0%qn$cFm{-v&1}5gv~iA4&*1pXp?HcKE^3HcdD#`MpVUrPpdbPV=Pl zT6uwe5NZ&|BNS!i9ZmZ5yOQU@*I)0MiuZ{Ye|OLPS40X>QRsj0r`R|c{|A4{N*PWb zn z1q$oH1q;g`at6Q>Y55(@L8NqRSYme13jRUzZGow+4;eeLUN-CBq`KY+0w0-XKbl*&f1qjiSh%v+s>O;&A zWtg2_4bjDNlVTH6EJFu22N+u+Wx3N6HUX@v`|atKl=Rnq;G@nRmU34hpQ&Kogljx(+QBgUeL`5gd zx==5XF#D#uIKt}-XPr(FAy?|VaA0olY4MV^Uzjx6lWy^0@2xj?nauqV>I1o#QaJUS zYfJUT_uRR8u*#Vsy^7tW9~eOeJ&>@-d8Xem_X%*~#~9(0B<7hg!A*F2?=c6Y_lz>e zSO>1c1+AZd5v7+F@)W+Y@2$=mm*ERfW9AG!u*bpxdw%94S7?jfq6W6A=MQquI^$ zUR_U2Pk;{?2oVj<&L4f@G@Gz1)nHRORCc}#>WWY`!T`;!hYMOm9tagICQ#=ZO%F{~ zT|&rfL4dlKdyEUxxXI>55OY^Rhc3xj0}PuN6JL9$x;-%vS_J|1!lIcnd~^LmniNg_ zqk}-TPCjg$gIFd{3lBU_`qEovji&bqIxVpo4m4Fj;iIBL?7B5LPEa1)tS3@@zqrhyt|_NP^+4yk;rQdg>Y~?ETqVN z7B)pcApp-Z4N}VenO>`3Ki^xvA867S+6Mmg;%mtlU|`eI(a4Q>I#}Ox%7)mzr^PG@ z8hb!mTnMtpFh;Iyq}WaS+F5$kyGfKtIM<~A0Fh$UBO5Vj<+Q`GbVHBQgDd_SRQ#-N z*}a~n(5e>$Cdn7hO3z>0H#<;Eoh9qx94cL26zWXvi>kg*X_jK9GBe&WnHhr$sDcvwr=%54~{DOL-K%kT!;&7`fv#PWDGjN|m(1)3W;h}rd zkHm{dAx#_JyC$=pe0FpykV-FPZ;n%h6l5F#9fBlQijhdXSDrn!GvKBUKQ=s?71d$3 zm^b>|YaFfzXOurm?swtHGMugQQuZFL2E$1mI)K?p9=cyXqP}0?gA;Ce#rF7x`X~En z1JcOmHhIAS)>P(0qfnLNA_G|Rsgml1K$&?t#SZW-GVbz6v$T)o1fH<7R%!k^5A~3l zb_47j&299)oAC(CXybR4z!l*IEpN2m=o6RO?b`#*d5uIrK1F(0NOgBNJ-6?CB@jPM zDfQfR_mW7qe=e#**ktf+{Xv&vG~cLr$bk4!f5`2rVdSerHq$Vv5j8IJ?dP--B!O{7 z8DD0ZY`*})B%!Eq-hI><4p7bFAWTy&9@R0v(NsZ9J}ZxhP6LdX|GDM zvzm)N6np;eEE(Sd7grMOw5U9lNWe;8Ni&e93o1W}nkk$17?Z4?d@MlhcjmI=pw+#D z4^dS#XM?^Gm?{wSLV5DK=ZIgthMxA9?ZdrPgU@qsMs$zHMpz^|i$5S*M7+S(DtLN} zCk}CYH^5Op1xgd%+oV#8^z3hBN3O_*2CP5mcQ{y#jE&6U=!lH$=*WQ#FD4t+OId#t zT=qDE5C$kpcy^vlCY?3SSFfAg#QTXgdmPvkcu;SWMZ-oe(*+*)7O)|7TW%iQ)Hxc>e`f8UKjd{xkk#WncwFWC0K80g529urcGa0N%3# zXeCwvTf+k2AAYv~eE-)Y0G_l0w6OkGERqGlbg;1g>;N0%zaqOVfM_r~6APdP(8~Jr z2)}_~#-Hn-pZ|F@4tl0v(IVjC#Qy`d$iNEV#Qr(Rxl^+&n42dZd+=ky$^(+dS(yaGd1WoP5aWWgMUnGG0E+_-cH5 zozX&7N~OD|emY!He$xk#soH93wk%`S@<|&d31bbzmZ2~c31hjw&W#E9Wm#b zCZ&yIsJ0r3Yrh^TO)h1t+^iO%^4Wd(rarz`LOXlOmZYXSr>r_Qi-hY*O`#*T+OClf zI&U^#z)~>ZP_S_?-%P@s!Nk$T&((MOUdoT{GuY;`&b{5GMT0>K;7~RI|wr@`ws+ z(`=t?`IWs-y2K(B`Xq4R=K|l;%PQns*UFgN!*8);^I!3hHDr9Y*O@Y_dpz=iI-I*e z{wBmk*X>anD=J=CE{~-lw3^F=zv)^RGPozeW`f8T94=VtHu5nKDhr0yp~(F_MpPD~ zgO5ZIa}CP)JQl859=yi^_f2Soqdv%oc-1UFwaY==fg(Dds1(v97bNU^8WcSFC&GL# zv{{iZ!&t%2>g@+zY20^9G8y zq+};6H@;;pJr*3;uX%fR2b#8;6@09kMcrHqKzY|pzq;1X6r1M;aqkRx;^NbG`8bcFbeRU(r^5y+2h(sL=xblk2 zqY_U@LwKLRSY~`VDZgNccdbIKbo)^*u1KGmg zK3o6BAc(3`*3*jbh`A)zN~!P93f++% zUR}J#;R&=CpmaqMz{M8Lt|L2ghIZ(ohbHw=fGZx*=cRHpN`$bDCPzVifFOzxS@z$HU zqe_0U+vTm`j1qd{Mt8gTY*W+U1Q5{{qjzpJ$tvs;*+UanD9|jy3?Zz&v zA2i}JLq9NnV8cZg2Y;Qw)=F^~D@g4G<<~{{zr`yezIcyi}aaUwv0*Q=5`!Fv9UXclR zzM>cI-$!R6)zM(QoQP_HYUa=XGLbIh4WzRa*FMjE9tKaPU75_($v*V``?^4r$uw@u zi86|+{r0p=i~jPEtCeO+u?!OzRUl{*?4E_EgGBMHz1hD~uY=9ihTD zBg1Z0s|UC+y+Tj;i~hQ|UrN1=UL?T)%%;yOFCz?=JiC*tiZ@yQtVh!Z+>6!B*=)i3 z(=zr`PWtnWL;6Qs_}4iE37wQm+XJ%xx7)P{i4X8+XN$|(uDus=)M%tHh-g(;PHc2# zrw->;5|7qL&vOW5SC?fQU1?6fSc818$HB`+CN0dFd_jV`X&07`x1^DS8!p=FX9rK3 z>{qsflTU{-h#aOVw=)kvmg;>hg5u@SG~AL*YTzarFNE$kTPX+O2X9@O`cI6PvW!I< zz2skk_T=Ft@(BYra2ehEQ9qOP#OX;?6RRUp zLnVPqeIf}bAqXG|i0O$F7}6WYH>x&zU)U&ZeUa-{GpB6v(SnkNh9xmADNRx)9KAoh zAYeuSut}kvTnB|N41F(>!dAK_UtN)!A_+w*jHEx#K%!>1I-l5qSP_W>i6Rs`G(k8@ zSdvhTkR+Dq*G1u`TGNQ*r4*V_K}CqTl=Z#Jk*Q0+^1WZS?$M4CJX_R5JK4%Ab08I= zj?{&X+Zy!C7N2e91!J1s(S_72pm6rTZ$e68gpPk_-G4(R{gnGj2m>Tn0I|$ZH%Rd> z%+lYg|CoQHT>h`ce@p=C;D4li{zCKoQ6K*24Eg_4{P)|8{W--nnSS#U75@}P{^scZ zG5h`?+!%gV&i+#s37|RtlX3eys?FBf;dj2x(cF#B(bxsR$o(c?q_Z&xaB>3wrr@N1 zq2K_*wqHeTEPt!GWCFOmG)yc2#U%rPe)-wCztC=fIQ{rPy?*?EdHsJO-F|a!|C@CC z+i1bhEC0{(Hh^#bxAHaydglL;absrxRf_qWMf|TfJa#64(CYV$IspA13t$v}{ju~? zm9fGaMD<~kibbM`m5QZ$l|V@z<%>n3aCjgJMY*99LEITpvT58PIxVl6h z*BTfAOc|$yI42@!?N4}~Ggc5Ymg};DLca2~W?INI1mTn-_yf>NA(%z_QTjS+Kf8p) z@kBct)7gRN+4w3|a%T-ZX)`=Ftd}uGD)`MEl^1;G^FC^}Boa~Qa}izE^2{MSuaxP8 zHdjY1-?iMkM{B=11h$1m*_RvFE=-6ab~_~-5X__3F{yiKD=Y1m(&;K-J3e05?cKC( zmM6=10XXDmuL~>l;YW{CLS7FORn`@o*uHOu`Pn&9kNr|VRy;1CI>9f-Xdlq)x1Qzh zA--8hnBUW7z2hk|3^?WF$4K)*uhMRXHQe$P{NB;=Zp@A^P)skFk$NZBnhp%74~*0S z*=Y_G?PLD|?vl&9Z&!fF;H#f;32fC|hBnf<=;!NTth>Ff8+;-3FCGdfWmSfuh|RDu z6%b9e*4UKxJ~4%lD)u*>tY&dFoTOh^muHq9eHsaY`LUXqUj;2SYI^ZRN%Vdf3hn)6BGS@Ollreu*+lV<_V*a%c629QN*Y3r!WpF zR(rvUT!)rE)iRTY;ts?JO9*pODv`I*@OIU6M<#_N`oK;=3+f2DaeTI~1gF*kbz->Q zd%RQNfXE zIWb#g8@skMc*Cc+?{9lXvoeC&9U_qJ{}IkHz22nVV_po`nUmy_n z?zQVv9+vZpF~paVv{;pLYsa@qKCMfW7=50$?n;Grp>tM`O;{3+sr!yJZi2*|apMqW zs?E@qc{ku0$D#WPefArkxr5V8>Tx#SF&v5xEZD3LllCn-0$E(g-tcEvGle7r8)Pw? zBR9FFosdVX8{LnQfyGP&P`i`;Exb%PSU<+cZjDKIDjOetuLbGxF!_?49mr&t6r~JP zFVvg%kUR3&%m&4K=5)gP4uw7|RRTqmHkIwUbpmm!SXp@nAI_%vJPp*;~)9R>Z(Yk-!f0!9bN0&uUHQ}?cSzR3aHeqQW zJW0tpRi2t_=90h;CNwdp&5}7XSA_?^+C03clq%8Zb|%8ikHX( z>b@m5FDYSacZBP@2^g>ztOfgf7m5LOces2=RcJ)Mmjvl@dMbOYy10OD0h+JL3F#kA zTv-7(q1d%2qcaAmSuwZ9w?>DgaBp*F1Yrgk_SDa0uRIcXJciw%ceqL*9Rb!Q=yqLn zEg*!vCwL5qDDj)Y>Q4GN&Lqpu{Mo0LHH*1huZ4)E~!0Lx$4UHE-eO3MynZCC89Rm4l=Qhhr8@g1JNfsVi!fh z&p10LzU+x&C`?;g3(ECwb+@t(m_2!Y!6Y=9z#mdg%}8bS*eO_=RQ;Zra?IesBM6k~kuib!G9kH}1hmeRi*U+{csvfUA>b7bevcz*n!8R%-7Bya@{`1 zl@v^Ysr_TGzXd(!G+7vjUUyB$HrAllcAA%^afB+WVba}~y%(S9^#R2`W6Oh>krVzX zjUCwhPa4CNhys11@$nT%ESafgZ)roLRM)mmBfEDup?OUu_ZH@y>~N7#9;hG%&@p zS~(^9>eP%iyJk-Z_tK+0L?80STws?-{jF9lGDY=+G$!lLhEc}0do2=fs{nF)?yU9ZY*852I* zv6iVi=f$;Qo8&S>fe|%aC9(^FbbzXS3}!7YJ{sQ4Ozr=AXfTp=iicgWj~g8$ElgdI zxP8j%%00EQYW)<>hGpOUG&9jxy`&Gf3o_Ac#MX+e$bMp-ojb5mQ;va|b(wEk9#wD= zWoN*@)wbfCGb1>cB`r$hk*@oSc$N&}orZ3rQP>0P3a zfOAS@X7x=!j!>p%Jspf?9yB$qC`>)iX3wjfRF4q*4&S2I5}C46!1BFxI01;;g;M?d z!_|8*({3!yjV6Ek#Qg7NqA-mH0VN8dr0pl4;8VqgaY2T>sj-$+m;S0Q&ylp?_JH5B4|p>m>ub*nj;(#SCate{S7JQb%#GS}FI_(p z(Kc-W#}fK?SlN7!qfPTGVxfMGf+j=n&hT|s@OYN@ST|&slPZh;rXN3&uUEGzun{!a zAZaOq%!5pLf3vgd_LJ_ap=Z1H>W+8&nrFw^ZNuQ`G1CM)rilb+s{RZyQw=~FQDD&@CmAdG zg+%g$O5hB-j(h;HUh^8KLoLGC_m*$bA}@u7n3we%-+RW zeEQ}A- zFr7KzoZlzw({4G%vW5^S;_Lgp_M$UVZa?!XCS(B<#aQWK+7@-Bgt9G-Xa^oK@%tsU zm7ePv7{_(7%h9-nV;qvrgv4V=VNu@?{ zgDDBciU66B0t^byTl@t^KehDxO%^0)7EC%P4@aIFU+!f3&O|kIRq<%8QjEIS6Ce;Z zw8J&4)XPyBxNnve>s~Qi6q#3lIsfrdMW$~PZG)t!)i&PN*&2tj=-CFb`bMf-HP8c@ z6tx*kAaevXLwjo+~P5Dtp*ur!mv9t}xGbH!1P z{v@iec?1dxq4dmOHo@d_AarBT#4K=oCgN;g2^29T`#FB}AQM$C&3$BGW>TfM#Sm4S zOjxYKm9bcVNMO-P9i8mLzLIv~!*AI)$*{*@`8s{oaNGaToQgve!LtfGq2uOkazC}5 z_?hIeArgjcSVi0o(dHm6B(BO<$h&(yjO+{Ma8Zf}Z(wYp#;nq8`7y-pRuTG?0spF6 z?YfQ0mxFH_T(-ePtJ8&jt!$h)4wxH!_$8T)8mF%)GoKHlg<{Wo6opW4Tc0Mc4`r8L zbczD3VBdz}W#7oEqk}DMd+`cvc_Q+a&@_q?GRK=^TWn1+YYCA#3IqgeHdNSycWnkj z*RwRUA||5yIZ1t!kU#jEKapB6n0`-{SZTjv^UZQrEgW^Dtwya!xSUp)fBUXw!FKL) z80gBm>vKoL{q2L59pvo;=q;@LnH2JoA9s#Tc*RMAR2P^gzfibAclXN&T=8rZWz&?8 z8AHYhG28hKx*fh61lDb+mtC{z7*mG)o9HoQxR83d2`PhUMrGweyDBxH_fy?4=L-Hg zWICw)RynbLNZKxs@ryn(n_VpekT2UM2!|=PO{=y3 z;=}q1MK6|utP<2#4IfA}hdw`N(D7$xr{E8YWW$7OkPuD1sPx%cGeZmQ$$HQr6i`f@ z^Qo)5614|pBCMsm4d2w6QD$;eW^{K7 zQy3^rAM}H`Kglkgb&Sh9hFh?9)Ov*Ciq%eHenV0=2ZMXSR}O8{rhoT(B$p>PlBH+e zvgTbSq|1PC&|=16q!B7d-B)`>MDPVc9Fbp`$oHK8hplx$K~Yc7)}#oK0MLCBS{K+> zy7mb-SHK%>3p-oiu{SO4r(v;2St89q+%N2~b~6`Yr7I|yYvH+J25+KUU#4FJa%+{Z z^530`vp9xuHbA?+rO`lK3zscwyJ!x*({Cq8=lS52Z=zbap6&d)JwyWhs!Vb&rg+hJ zdD`<;ynjOdQ;u!lm4JyJeM~VKR`w|SyIM8y_I{^Y40;3K#CJ{TKut7GuQJ7c8e@%6 zH~d$-h+U|=5@jTtO}oG?+O+b85jw^*7~*$r{5;s6iZ1?~BBH&-`3evuxP>Jf7=e3- zn7z)quKlD@GP1T2a990dJ6y{O8%btk_bo0&9^5f(b%Jdfd>x86#sl|H(nFRzBXDwN zf_mncM#aP^JGdE<&^z`;Nmxz@WI@PaU9l3w1T0+wc}f(! z&GwGW%aLVq%f9W}^IwVy--R9-H93B8U98BWe}?*P5)dVRulrrj*M$>|&3dAoLt>0x|;GnLGBEpS0| zDR4a-Z4Pl#WI?~ZzEN0+zx&>jvtOJ^M?3T4{330{&UspaV5H!NzC2h3;p0I0Xo3V! z5Clk8r(+FxgSi*e+?E93rp#uJ>9CFdU&zwN z2f)KeZ|G%Af*i-~I1aXvq$NY>IUS}4f`e5vb;6_AuZJC$C+6d92GDC)KG~G%Fo_7A z?KcDez@B5DWeRkC;aJcZyZ;JLRKauvw?rya+yuz^S5P}gcPj5L58pIGWfN6RWW=2Rv?;d(q2 z%s?RuWqNfyy-%!i8kc3`+|mxafxk0d5$TgImkOh4wp_cxv{7GwAKXRUVi6s;Q4$b$ zmM_nCI3R^A*5_ zFHWw`f-`1xzL%6rO=^A+c9(sz)V^i!Y9~_3F|=<<%gu^%!^-hlD*&&;VDvoZ!m!z% zFR{o6WM%r`tw8oGlq|?y5yh9{F@b^}d|F*! zmo%ZJNDTuI+{+uoPOqClpC1H9vd>RVrw1OEl1Fu_=Sxf|>h8&-wg`$Aa4el}EW@Q+ zCaasFV7)^=u9MoLX=aJ=oMe@gEj%ceU=2L`P=fX}r7c9%OVb7lt_$gEdc)V{hE|^t zIBa4MT}$pvOBzwi3Swm3)L>xJocMY_Q22pawZ?6u5hJ~r4m;V~uk7=;k0Zs8vR+7B z!5(Smo?vm2X=Yk(&F=!53Fw{}hr>V4+k|Mah_h1P3i@*Rxf_HT^(r6kN^J*%U0&L~ zm~uSMmJ}9?{|j>GeNgs2P6S`Qubrn27SQn;+ut( zkdy{L+yn{qvc;;51Sj~)%o4#2N1(g4Qjz6238~lPS3rk9DfXt{zGAS`JaW##bgOgH zF}cxRhaSDNeq+;aS+)414~q+HwE-ssW|y@u*V=*%7(HPZEEXb0GO$=VG?>t)mNF(6 zx&%S%(NB;NkwV1}LS7Y7fcrCa*2)Y%q4*r(5zCwJMC$T|O~%6XFvrv6Nte&tU7PD5 z0vH(dB#s5Ek7I z-)7=uZE4tMC<_M3E9NI@n@kRAzJB8Ybw&xspN!?xA-a+mbHt}*v^?12x~gWBIi?1z z7WkTyc+j#!;I)0@dF9|T!;DK8)$l^Ig|trtstlFJEZ{9X^T}LP!8)8Zbpxd^J|(7G z-MoWab}NOek~aadAY`N}(Q_&?^-fD49f(4+>~^<0GmdejWybQgk2YRr=karGL0+HU zRZ|P-oERBmXJ+=UDKi^yy8f z&-I~aUluPMxP@gW(TYNc&y!j;1M@k4mUrN`9fYuPW2%)WOdORRV(W@QS5g4|=rDT=6Mjn3`kSOAg zQDqZ)@M#ZKV?6qC&)-=dpEw-9s+Zw~ds~DCUP3K0K)Qyi^#-~|p*|200iZbUi8}2< zKX$|VJMf(iuaz$mkt{|Ih?gloK=6F5@Ww9PrDFG?Yo?2Y&nqH3@+QH$LJi{Y;Dpp+ zO-%8u3CY^w>qs#SBuDXS((jc;14q#g3glyIAuq{?G(oLhnvgH|$gVl>{ZesqNGZj| z!`yw-K3at1^&S(CL>ne)ms!AR<4{24egC43kbg&7c-hLzTR_tGV~K;8@|R|DA_i4-RG*vJ6?F}Ux7Yc%x1m~}TPt0#+;0Tr9{ zLHD-9!N0mwQh~R)hGM9>%bsL>use@YG#vcENx4Ng$8?CcHzM$ zs;w`Pp9f=Z;qC0=(op%~$wIeKhjO0DdqCDYu_15oa=Ia`W)R&3Ixsb`d1<+w3H%Cv zMU}Yep*_!!y)U;wow^T`%o)!Tw?c^;=OY8xwKIMuL2h*`zd2AoSRHN9)D}TF1T;Ch z6Wb*#>43uf1KtmePcCaSO*`f655d9esB@gp#2~>Eie+RBWSxf6tONOuipkF~Du%Eh zN{>T1^O4_B;$@_zIV-9ZG!6Pv0zQSJ;T4DzVS8}D0s0AchkFeXb`Diq?LdD3*?=?L7u2%AnkrDma*JYJQod)E5 znkgB#eaE=EOX#wJTHDvvY@BU$STw8-^P=QdKdvY{&1P1yFvM>NRNWijq)M(i=hmb$ z;_p&2u(|St>@JI!3EDnC`kGJZ(QSwmK)p8QO z#B4*8SqACk#owsvXk2?VXU@L9lZ2VuzMF~vGSA(2=RFMf`ldkkqqmYgRa?Qp5xg8J zDTdslNkX3Q1 zs%YTH(XlB~+^)?F4TI9KGW^W^0#!k(zOA|PNBvox9E5I3E)KIpiedqD8FLuWI(_Cq z!nf`BIl~{Tk>+^gbXx4LmN$8PqdK98CuQ#IN!Nq&lD*mja2j-v`2BaxPZ2llcw$crT+Un%KR9G&4taw}NjO4VAu6~Y;b!-z=J;-&^jMVN#qRaLop83?TJtJl4K+agNp(4uVYe2rZ=(DtCXW)mMh+ELk& z&G$NUD|P;g;&zXFcuf4{a#NkiOawdx3uKkcS$)YQ8AO?C5%ijKLpcAj>3h{jw(qM_ zqZP^MNeoy}?&PT7dEI8@s#8id#?G0!sZpC=KeJH>c%{6is^)vfD3|thgG+-4A>1}B zGXxMF@30m>0c8t>pdz0M)7ERaVSwq=9(DopSJJ%jZtRm|5p2VH0=qOoJ(|BeZYUK~ zH7Bv;n3Ys<2n-n3n!D*|TM_%N=SzwiE9JtXtDw77{i=5zyOE=jf;rV1j=fhL>HuOg ziF2>K5V~frnanRBsBUV&@^KeL>JutIZ5tyI-j|Pk4p9NOl0(eG*abK1a5?#sXEBSZ zI6GVwW`uR82y;}uF1v{E86rV=QR-A{1MuFK?$JA>JH;Ax0-USuOB;i#DO<#LI zAKcSdRziAKg&a>0Ey8Z9NO8Lo=8G@^HsxL-6I~n?(~IN8f|i`*w37FOvwlVNW5G2> zLBr$n-U2M-7ZI!Ss=CsA`Tp5?u1WVF(Vp;9Gyqe+tRhzw15?dSTYuq^pR9 ze3l&!76)2jdrcV{g)R&v`r0+uQDH7ZI7z>*-xrHThsu>sHDW4TEkAD`!aegDz%o}Wa?*p>; zZR4f6*E32FyU+2;&czRxn$)1+P~jZp9>=x%&98d3_gFL?E?wTYQfU#1bH5y>^8tJ5 z26Ex;b<%6Tj~P*TyUF@HLLx8?jh?WWAZ&iVAGkTsvL8^r7XCBn&g6`?p3thbOEM|T zbRMY%EE&9LmBUOp6aYKJkc_R7&W8gDah&A|QbdF2gB?+60N^lkl zcZ-2$^MFl?bLXWbtMm@M>R686#Wi13To4bePQ=OZdoTY_ci=pRTiDoF#~;asg`%}3x~#@ULt%XwCNJQRmFWH)X@S^HO&*`%l* zBSr>B3JdmSSha?ZL>1VKq*Rb13LH5|2~)=8W#-AZPh--kN|KTiQ%x9CHG;~E-Ivw% z9;rvoz}6|zRg!Rx90b14z!ml^YGp96h{VImupp^gRTNTZW9*ej$5yi2zP@)ZUs&fQRR*Y{U+UGi_J1B{~Tf^>VL2Wka-SjyzMzY zwfjjRMtAv(f3wWUfqcl3Kuz=BztYE&I3CfiFyBJ|RoM9*)?)5&G&{eEa{gCo1oK~{ zU}@dmTlTNxpC9i$F^}HPe7oO)DPRN6^`}56N)&S9?@soA^w0wf8~d-q3$284n{V_e zqId4lbgLqXeVvOoB%eWnh|#X{a<1ORV35wd&wY>9{zA+VA{j6zS=95==?KS0(^zJ$ zbVvHKtUaQAJYHi{N~=THR2i}VUd}mw7m%TSna}J|JL}Fm4nElR&Ju5Ob>B_Ggem^@ z1Fp`~sf`ZW{N8)r_-iq>{z@C!{XN$jPnPee3yr=z9IPF~V_r6;ZrHEWP2Nx5zEPx^ zQ61K0+wSX|n?X#vXZP(*(@UX_BMHfrI;-B8ZQhPy!_-(hj!dhtRqjaXM_mWonTElJ z52l+kwywRabz>%1p`ar<2tz_rhd7j95X``6zQ8FGnc9~{z8sLI(BPFjdsNXinFlak9RDkz$ool!b8 z|4wmTe~set(F2-?h9@xV&&}K(4hUa)*iQwTAqIIM@3!cXBCzkitOfMST{zxT_`vh^ zPi`08b3CK)1!sRdI9Gbc_6f@dY($>n`7YQ>rY(M#5A!|CiC{gRHs5n5&`GW}=2QZG z=7lKJ-D96(Y?evRI4jGY^6Gj_DYeKnYlIu*N;v{pG)$peoBj!w>rO5JNMmPA0nk|5*;)O6oV^89T-&xS3L&_=LvVL@x8M?7g1ftGaCdii z*C2u5F2UX1U4N0BbI-p2?tTAzpVk;Ps;@bh%o?i-TJ_Ppq2;@L-CtF+eiOU?b?f{y zne(0f=4ua+kCU)6vIdag{{eSl`*mYHf95)TJN${ z9KVgr0PsmBKwR$k3Nf&=0dl~K0M>|sgI)u$do2bI*5Bvy*N!cK;@lsKHGtCh zTLA4pl)m53|Gz4MM)18k?*Cm5f4GYOSLFZ@mV4(n{-2e@`(r{2l?|D*||l?^bpIt{k9m?R~WY;$}<$b+h-M1v@}Z;{DJp@0a&`2k&S9@0|e7K#POn6QI6+*Amn3 zSNKmw{HZqv_CI$J17HXPpauaG|62k4h2HwlJrK+cfBo=EMSOb8dVPE2yZ3&3>*=!b z0ser23HRSVD;sa1GXL&9>MtrG|E0^q_#ZOupZA3SkVXN$hyPJ01SoU-OHSp#k!k4x zuQAQLY6k-o8{i&dW&Cfv&i~RL`45-#yV`Cs_vs?|+Abh%g=R3cS{;8=oTy|_`a}PyOSv*Z$$b5U!P<|> zN(J)?qd&i~`%7bRvI=@Jys#T(fw+jFoZg5sYKta%ux4evDt)lpNnA?q%CuR;-m-7{ z67c_5FrVq8gdt0y);ANuhuW@cr z5gpD;{RKbff14Hk40D1{&~Bi>$^y@$qg+K>7B)$+O&mMxYO79N)MH2ZDAB{6kgG?z zC_>cJDW5FwUGGaP9&2rG)^`*Dv2yV>k6RGac%Bh)x+DB%H(IbZ*yB8!Y)+c@ff_Hl z7et6SVkAqGhp$md(Cp#o2Xpb}Y|B2a;3p3+@pSK!F75L+WR5tcLNF<1{ufRH3^enq@?Sv5q6FLg2`5pvs zl{chkcjq5J3O0_NdZ%ZsE(&sFXxoOT)2n+?^o zng!Hf_|KNM`(+Q(@GCgS3{wdDodqKtjcG$LqtqW=yaL#wawH~3G60Q zgXpv@sfqYyd=Inh8+$q>v4&@-Loc4P%tJ}HN;M+gDXF&wR8DjmREeWB=?%4C6TJuZ zhezu+Scu835h6{_kdW1w8}J4_p5j`NYUD}D^Bq?aQUYfK!~($NAwdj`1kD3SikZeK zFqouX72q@FjmPK>HTDZqOUd9Zs&JbX8=L0Qu5X911%0pT<6BKgrK39VUk#o|SRSe_ ze|C9p>x$yZdhkV|WQu*}j)E~sJo+Src!#j*SG!{-JSb#+mt=(1KE};?W3S>cQSHMwsDttnRMy-!1K`O+JSGypb~8QCO9Qw zVun}39W`^-nKDfZBEcQ~6U0ofMBD;`*(~bPDzr9Cz5XCnu2{r+lIvzn!MLP%j{$mb zxe4wXhkfSiO5-$bubx9JNlVB5Vsr6mI8xc`0(9Im=$XGGH5BfLJCd|+ zz5t9h+aWID1-DX+=tC;29FONv83zC)}6G0E!G_5 zpbZK6lf88{_JkliJWj*6P8OJGC|d;r8M7ihEHpGvRB0?wPWQJ)twa zfdz@`^?RPu2Q3mU^aDRVdSX_SWiU`pD-ycwxDyf0NR4jL5M_)ldOj&vtu~DdxF3*u z-0HMb;`i^7)#o|KANKWaPs%@-f6)QAh1hSX63BXpD)kZNFo{PFqQn|265aLZyNntq zI^0QqehhnMdDT=LGT!X0+Esc!q~3`_AauLrWlz<3zG|eM!4N2D;Lc%{B6|)t7gj-3ATgqZQEeI@6^x1DDu$bP~9x?o*&Pq91?&atv3^ z)%7=toRVc9*XG8zDYf|6c*PxIki#p*=I;YfVo`K@=})F`wRKdydO? zvmoGQxwW?)EBBKz64n+Pgk>w3+C61Y78;M&eWx6A_~Qzzaw~YQdv@^NGMd~z6sYl; zv?3(%wNE;o9)MP8EWx8noIy-OyJ4vZZ<2WJk5ur4_!Y!Fmi$6-Wf5seE%n(FWh;04 zJVfuL6EN@q``SUe6$oZ|Sk1|LPR3&2WW+lZj?mfXss4(>YF>!C6&5YCyM^aPvAXL&W191nao0^)Uq%}613i5vmNblPu zekH_g6FVgM5A6|CW&vXMB}cIb+6_xQK1$ zh3DO^RSeykmDZ`UY$8{)f4Rs<#GmB%6~!s+$|1}Oz4C-!UD<)fGo_Qo%m+czsqrQm ztYBi;=}OWe%4s3V^GG3jMHTqE4pMQZ&v~;|AScT3qM#IZj>g?w-BI zuiTUQd!UF9_)UYD5}Kt+n;p4>JJJVUh~(=t$(6^Y2|}- zK^xIfZxcS2x{Q)^_-H*DClu@1^tvF!*SaiUbC2%WAU*5ROpG~3S2R|x zAH%}p8cKRksyyuS_+IoTCPI_4q$F`JKL0w#S02;3@IOo7gqwK6Ejl36!6Ws*rR7+Z zYrn9NY-O-jS?GwBzwT?s9q+uIPQY$VdBHy_Vn)(Dv3`Jt)+G~~H`RD?S-pkS%r6FO z4{f3ko@&FwiEH&U+;G zHbBCqe|4{lm&F5K>k7)mKrN++hQ#QKe5HDJ?%IV$Z;sXV270~$WQN5r4N`0h!~&aL z2t32=lL{s`{Reb<$Ggf)`o!QhP#lysSc_OjOkwTSg(N5G|CRQn&;Iw+UB*0l`o06o z$wq#{Mso}mS98*`a{oR6u5y1p^gTc^63r4~Axa0o1m^`ieLUJ7Y=&Ep%1ZC)s`h4* z%F_GfuWL*n{evG21QW*KZxVKFwP{`4c6z^?VtOZu&%Fx7`9bm8NUia!O@}@`N9IXi zk~BMAF5Dz;YIm-8PnLwt(P_&oG^(?$9;<7OcgMX8%P$uq&Z@W)*j&fsS5zvGGi!~n z_Z5#;i&nO;YabsC8_JYpU|qv9Y0Ju~-LaY@4qn^hPb@@yVK$Dpa6&@C4Gf_fpp9IG z77V_@C=Y!7=U`DM2u5X~-SN@Gd|(;g!HSoI&f#1T{C^2)=$tM&X|JQF(FmON@pwZR zF?2ApieL8(Vv+@$zzW#E!h04+^FJ?7;iDhermUqrJOjH05oeH1W0T6xi<6C)YF`+5 z?UafX^o8W<8=q2|kKwW(uc=hUe0s5e}>}oh=mW0 z|2D;&&fPz28X?F^RB^(8%y6kt^Z=gZc+$_AOjaBs5Vhaa5#7TIrWYOOVZY8{T8F_u z_Bu~EtZzR=U1YJVR4rPI!ua;N`}3zOY{=#f-z5aD(FNo=(^dPe!!d@nE8OW`p1>AG zVD-iy(U^)LVRg)yVP8Z~&qt3Pt_{pa*G+}?YG2Hz%0NXF2pfsyP59x(k- z%D#I!lC;OVly~gdGa6_bJjBaGmecB~8|=PH*M)%^Ps2~i*o7i`keVJ+$Dthz_%Q&Qj43a*HDtx!CyX9~oA15yGbF~;v8)f9 zL{X+ZhihPJ$nV>g7)nGYhbbmcIzn;7-X_(TK-mgMM~nIvOj75+_{x5TK}KXI=cGXzYjj{A6MhgxEGvXrgoQH~{53;XG3z8X)+~-fPmF0^cc~}# zQ`t|U2nE4*!Yq0;xrmbi^HE=Ki*aL=bZc2bqw`(9NWlaR%8IH6(LKh_Puw4mfyzdd zzd7E-cTUiWuPdlU)=5j@cC;62s7lj0PIya9&vH}q>U8dv9=xRb`a|F#1*my8A8Dgd zA83$DuM6s7$Ict39f>15&%_NE}hzR2lv+%EBYh-tqYAKJ|*!&edN{1T`ht?!AH^mf7`4WS- zkCt0SgpIiCpySYS^!ynjrrWwg$V9C%m6eA|?gg z(pGcXc=^6>9R=#d7v#G|0bC;^A0iq!jY?By~ zqxU63qNyX=$jlpN=KjF;smD$~_#_4?7k{dbSOrJ&@@JNqdAj8!liuo!-q;b%{bVQ; zSAe`H`$ETk?@8jsR%d!O>&TD=f$KF4c0!?5U0WMY(nb4Fo>i}%ZTs4id5!Acrh%Qm zlvVT~EMtoRDcis{SjzIJIPAZIP15hU(F)%12YPuLO$=oV*WfdQR^Y%wg6pr@VAI0m z!P#byS{F^k-kPxOpR2rtrwSlhsHVQyNyXw%Y_WKMS`dc%w(9CC$|^I?%}-Tj|Lg5U zVoh^zzOwf?co@aU;D%zh%i#25@Q5U2+NMQ8ndxNN2xX|qHrZrT?^~=kOSL?Xv4hds z?U?y@WB0kEwpt_IlW!Up)ipKatm{94{cH)OLq5kTe2@+y8j@XtP=X?ffXILTC|(LC zV3r>&`U9b*V3&$YehTE4Ud0#9)<#w*$h2q*p!P84Ybzsn zt52&>tS3gK^eaWwr%P-TW!gU;lwz^arhi!PdD;P~gcx_UB`H(!w9oyDTqV8bcw1g! z&yE^r8PMqAoI>b^Z*e9)-1Hs8->*f`welhVDId#JJuH0&RG~(&!NNpMpM0-j-T`ic2X0Kq*IOF5B; zA_Jb5=yE{%r&RbWCuB05Gt)vE?$25Y!=>=Axibxm*J6T=7|>{p#?;8vWVne}=VV zzqQjYRL?Ahbs4)&b87hzQ4nz*aIoX&}ou>$^Z~;LRNG0Gy5eU!hF}?lQN%Z?xP>%l@?7``v#ZzVoBw zIc$W`7a9dHko%3-Uzji|2$*k`EY`DLUTx}yLt#rc)`VGmU0Cf`IG^fL3mwQ+kd*L!J+O1fx zZ5e!==fd7Q`d(AmaK&EFlo}tKbSlSn0B-yGi58MYJNSS+WMl0j_fk`NtGRrLlGwwr zX~0a-ZJUyFe9b7D@PZXY7P>XR3{{t}RuaxKU3L(7ke&HduIv+%<372%59IKsTBBd0 zBJwv$IEWJej4xx2jnXMfO%^NqS9Nxz)jEBI97^(uQrhY)s0#nUUu!u@Hc2xR{;OmOXwn+4e|jOVc&-z{3GY53E&MQsP|_Gyk-TC{MjIc>ZX}EOwFRm z6DEWcCW6lwHHXzk`aA&*C`Uo68r8R7al5*oa^zPFHn3RFzSuQa|1ie(X#B?j!n?Fy zM-v3iuxN+jBO=Wrpf4GPfe4KeQTXjbu*~P{WwC9|7r3hQmYf>fqg6@xlU#k1XGY60 zy}erH5$z76z48z~eakDh8X2b$ErY5_+nNjeR^%O7<|m1w{ML<{&gU3W-p)&hm3eE= zm)GrqSTOItsV%aFB4)Reg2S{AWauqb$loJl4|;Yxe#{W?r1-^9TGMMWW2hSnqD>2t znd^})w3~q+on#<-g_Sbu`yqSG)(i~y>^|YVe%fR8U5h4W;70=aU&4o2j87p1X(Vhl zE~4vuV63^4fkmoD>)=uzX;uun>TBP>S$@TCWSw@aIvr&@RsJ1zVx{s}By9bftN_K;b6gN-q00eYK@lCbVJ(q36*hkEx#-2 z{)gHD|DIVl@qzJhj7f)I3S zi_ZFo6mjler#Gw?F$r9Z1=GL58$C}Kf2UV59$=9yHR-9DM(l2FDUv?%rqe{%h7d~= zTz$ZwR=e%;rFrdY9X(DMXX>CQ5qadbZo^xwM6cI^kC+i!x|wj|0i>35|2?$%}(6Xz@kVBOlD!mneZM{o;%ef!6MYCbFBa zLD4h|F&UEr#tsvhxDKM=|CB;<=J}5e_^-)3*bCwiAV##6;ZV6+hSg~D3OZdl0pX0n zM<(^^@$&zSXP6QWXZFW1B@|7C;3L(`5BZ%2$NY~p6rf&V*0k6tS$4}be(8I@ zWge;2#APu$iBstC+_m7^&suoDM2}EOzwm6BnE*3TAcLmO&38l~S)|J*IH(9Xvt+kH zwU+&T2(^|MaQ?EK7^T=6AO{}6`Dq3?2M)rKzZgUi7va$7KhO=(J772U%O=>tXfj%j z*#HeTMMUVIQooU0f;tnzIyp?aT*4finr1|+@XykC4|GSru&{d_Mfb)|-NNV0$6fHu z=i2b9+P^YI8eizwFx2R?h5+k+_z~D#_>FTtKn_O0_oJY6hL4LPmPjaawjhbj$NDdz zrIbh?>*dS*kcfjy1x;59v z5Jnh3Sa{-l6r;0zf+jKWM}HalL?7wZ_tE*lQW5vUl19~bBlNDkbG z6KDqbFA(iJpaz?*0l{hCpqT=<7QPE%64}fw=411bS&ZNQe};2*#0ebT%ETz}(DP76 zd6oi5UiXP1#GsO!DapLdg#ziQH41JyicgBbDNqAS{DmJFQKL(Iq(BWQ{|nlT1ptN~ zoP8zVAX&G%?uLdx_T?igLy#pG_}5ZjU=RxG(|Bwky? zJ@1yy{>Y?_eNGRMI3j}XJ+3+Zak|sV>0qk%;yPr$c^lk0*onlzM5=jlnJT0+&tbQ^e*>sF{OqtQS@pSRwD<~Aag8z|IS$jaxPwB`w64Dy$SC!oHE0`r zI4qYn;#HRWD|gcu*iciVGGiw(6(I?i(0a><(hlya#kxm~K@lt}(p&u_cQ7;@oX^r# zG?@Z;i_H(<<|%XsKz82iTHL*X62>qQRwkJdFnuYQL}>!4un2ZRu3;m2{_b!_RFCkX za2dP)E~EYCyk7#X;>yWOriXP~cLq5Z*)Hlg$GRiF?2U2Y<8g7e?Zj=mf3Wu6z9NzA zw0AuQT?-tx?3Cg;%v&x>kM{sL@b(vVbN&;T)Dpfgm+;i6TMQhL7)xfB7^?K^ilWVq< zxolgncdI1N(sIXMym#Jvz%RG7$cyo@7r)cnY5$ixL#y?915rObt!iiN-O0*871f8m zA9L32lvLSJ6z3)bOXR0WUx0B<*@ciWVl@Ma>4|*_AYmlFihp;C0}*$vAF%nB6QEt5YAoxlyd*nB`s%? zx=ve5YU3?vJl=)-loV*nOoSu^GC8ugmu@4P<-|+)%>ebl)+xGdDLu~jN`G!p*O+9w z$LpEXS85m8jO=Fk0-_Hunv58AZb3GW9JWAH2c&s2@6{?to&AJ|F3XE&&EFu|Du4$Y zX(gIl)^rMXx=wczHjK*w0e{pOxhd6EOmoQ#Ijcmkio`~d4Ri-aF|0^u#7Hksr(Cbk zhxgkXS+oyC6?bUnSfSAjnY$s4Q$zT{Q~tYcWGiq^_JYgwMI<)iM!98JPW)aBp>Y|e`pHQ|Ic)T5-=vXAi!q? z3C&W0^13irqQpdjGBrMwwBS$bqcWMV#7u!I{aGYVVdXcW4$a_u!X%bK zJs4(%fT(%&-=t0&{^7Hqri=0}#`&L_mhX)}yFC>(d+<%}#$#;O2OwKZ`+~?}N(x>b@OewAGd8RxVhMxm#&l<-)7qirGkQYv< z{^ufoQz95A*lKgyW2~=pKy6_2EM1kr?|_dM$RCJwV)BAfnVg9NeG9AC0gRb`GcoCl zR2c>xo=!U(#A8H;%wxu05=m*sk#NnC%4su(=V1$xG)em%t!v?$^G^0v$(8foVfwxQ zfuygjH>dOC^EG~B=gp>&1}$}YUk3CYXBY!nC4WH@fLS#PfeAgHnQd9!U*uu3E(C&) z1&}of0^?;q&+&za{R^~v2>>E41Z?vAzK%YK+Uwxqk;XmgL5|TolBK@rmH(Pd^zG!S zOS2&>vK?o8I5x`Vl|m^F`M@HdO$s$5?3+q1hYV_#%P;*euu$V2H>ksw?_wF)QUT%S3_{aUeg~ewRoC!J8)5D zpks4(8;M`3eVsQaYlXttu7mUKtgJg#!c(UZ`*Ow8KDYLY*^li2&YpJe{EYRXS`YbR zd)&A`9X>d{RE;|tS1F8U?U?LrDdu%5t93%fm5*R7ST_GIt@Q={P02gTChFY%>_vGp zOvUw7v7{L~~0nWGZyl7jLzkVf7SZOK%MFsHNFCQRVfTab#YIdJkq9n7~C&WKZ$jng9r_>b%>EU##CrMcx z=_l0{LzT%)H|z5p(#`Z?APeF+Qz=H7MX(!29Y*qPMe(ekGTNMVe~`s&q}APhf3kl) z<=C4&eHb`Mi#;}9obF&rKWx7}KBIfMI5;z>dcZpO#IDpXdWP6Jm)%w=CDDpduX@Cj zbee2&#gy$SS){mHuFR=sT?!m05t zlM)`1VvF@Dv}S}{DAB`tz|3pd-vNiI&ovb_4zsYQ8V6tfJO}iD36=0P_Y<)t5EW!< zGD8r790Xei^AsV|U`yazUv;Pkq`{;Z1@9ls>eSAWB%Q2SbfDU2lGz(QmZrv&0(;|Y zQqr8zBgMvF&)PfG^h4{Sy!HYb%ba_L&SPl`%o}=nyrXX+bDiBWZW&BhqpKh?Fdr=| z%LCzK@9d?>QF%Pb$v?MM1*=UK<>F%*#?X2~$smhI83fwQ(m&?hQ73E#iNiOQAsdA& zuN_>&s#%V9RQWs(jY5-D`;=Vj>=(hkk-9M~5*Rg{BInF$h$vr&Z1wX4a z<)_4FpkWpSr<4<{aSX|PJ+A{Z22GC(7n$@VTgt5p8=W+&xx7!)lW?di4t~{6D~t%s zMC@(PD&az{=;AOOD5*JB>IAhiHB@rBO&SAY`Y>XXE5!~Pl~%z(kdqQeCOt|mj;C?o zz(J@OP(LLr%>LLNH(oD2I+()vg8d^NQ}o(BS2(}NHDmHl8|{%qIt<^Ehht>^qlBQa z8~8SiT#SkgDryZ+uV=;Tj^<-CZKJF&1ZqI6u=rUp^<;ND+x2KWdi`cp1HRTn`JEx* zQepLq;W8|rj9_GMOueF1*dQG`=9HI4_|>9O90ziNCJr1YW7s-5Ns1ox!|v#)ev<_U z$*wS0#Fd`t^>x+=kb;eM95-ELGE0-@KjY!A`XAGQKuT7D3R~}MFm)8`_S-~=J%w+QR-M1IH)oJ+|v@F4E3cmF+ zWDL^#+bVQVv5F1?9f}EYcF|cQ+r-;PFvO%XGMj?eQ|6=aBX8!_^fb0+X0EMHn*qvU zL29)f8_Rxq!)Ta`s03(UOc$DB#j4c(_Zp!K&Dl z)#Bls&)8?ODFV1Oh$gvqw6eq0xh_7tv8!!y<0>T{U$!YPP*VPdQV^un#VKCoqJM4)`L( z(+s1|O9w1@py%Pady0A!?3%y;iyuX_0m3)>pn9Z7+I^{XYx4H1g4Kx@S+W5-!_Ww* z#Bu0@IKnm%cDVGr0alD9Fd+8>=Sj+m2Wl>xs$1X_MziDT`}QBsDSj|NwYaYR)@qzt zR-!IU2Glm(!xUU#l*HBbb(m65oL-<)H{FLjbYH`t*NshGRi8+tr(cDLMqq~gUyStM z4!Srac`)IB&9?}nizB@SeSIDy;v#6Q$#Z$Xu}Z&_iqXnE-}{n7hF!FJ&ZIFaTuTf-vPIp| zIZ-!Cgg^R@IZ6&g6_|T~b<4fy)kve+-9EgggLa4A7?-0^Zvxm}jZSH?7ga`0rbvWG(9G)^c!ga*%xyxfG0@KPk2`b+wtaOL+T%K{PH(|Oub}HS4ivBB z#5>fx0~v}vk}=pyYpu?<>%^;Qp%B70A9Ubrz8G76Rv@o4n~8_6C1D=)j5YU|E21Zq zsv!NrEs#cyypaMH1>-sGa{CHazfGInBFcU)j`0`*^Z{TrAZPtEJQc8?=TBW6&UEKS z>s-()U!YCGYVfZa3;3(hmTORSSQ32J^3My;U{DE)h8eas2_6#cPM~_!l7d{wfu(zS zpO>KKs|UR?t~3lYt!?-8-$-@Z;%gvksp(&Zr5|PXlSI|lQNL!%S6@i6k@}FXSy1+= z8+%}yq|n%nLtZvvrG|MrtsmpEvkhy)uX-(xU8MwZBv8X=^|xL@}9*ahh{{7K$ow1qjbO`*uzqN%T}W?H$Yno-uap8YQ(s0jAzkpS5ra1 z3O8Vnv*!MTVNwGw>-*tPNgW(R_;6efGNBwf-z|%h%Q|fPh0KNp%2}6Fls%XQSsN+7 zaYrPEoAO-8XUm^Gkr#|-tox9+BAI2IRG=OBaH-_xHDOrg93idF3cCej2HGA8r~a>< zA1N=~TWnK5KM%*`u}-mG(Yk$nxQe!gzhs?DOd?OPPZrO6z`)lh=7xIWjcm0GUQ}9{ zr*;2u>irth3X+_JGvMyyD%CQ3pBO50%(AVcqr>tsP;<`Ad+@UE_0j`xE;?!_j-yrM z7M$aCrC8vL5*WS|7R13?#(gEw3-G!9I?1{#P`l2@QsGJvHlX^r7|#B29*?4|n{1h! z=#xGtTgzZ9E--Nhv^c}^JvUid;BiyeTjVacnX4cJ>8if7U;6}BQ>D!{^`Tdh<&$Z} ztK3pIucT^u-Ps#mZ76u8+iX{Y*#zh8bgXUd1b1FIT$s#s6U;PET8vh=m`LHAfq*y}{*Q^OPSB%4m;}lFWN=JW+tNKjf06*#W zjzPOsRi2?as|EMwmg8mS)T!Uu1Dw)O2DWwP#JwZ*az*7x6RS@4asoH{>@7dZ-A1Js zwSWA~IZGn=yGRcgaqqd;01>~ipbt=roIGK?PdrpXCqs521jNh*u+!&gC^T|<%v6QX znAGupC#vd`%GDX{Xuy`DHPS?i#Utc2s6UyTvg$gYo)EilsmnKD(lenth;uK0={j?2fg9ozOyh;G0!r1 zLKzf7zlK}$%R z%jle@?Oao=d;YTKF{P`Q9YUHVNqe=gk(@A5JW=12tl*AVn^P!)VRkeFm9|&kozTe& zlUAFMs=vxOD2=K%%yynut6<}>Fsjaa>Y#Tct|hWl()%oUWSX*EoUx%j#1JCF)cXzU z2=WA5NgaAC(UHozZgQzbKuFJ<6JDIg*q&o1)dg#=dKYK;n3}$Gt*gqau@ifz$VexZ zJ!ZmA9&>aR-b8YasnV-nY}y)bQBySuOU)$VW709p{$ue7&Z1R4xN49EsaGV@x9GA8HpK4R>D4SmZw{?bYRni5ZROmm~S7knbJkkmFP zv?2Pq=oxn>D$ce)a37k;)NP0U(lo%_LRA0q=~ubha|UGJZYqP-gXbM|3)c+%QaB#T ztLqskdI(GVcl3#7$4i(FT2ioU_=ZEmCkLB_74poxOoJZ)0g=z0mjT}zTV)qiG;-_r<5J?~0G$QZRVuSln<83*H)zJi%y3i{;4aPu#3q z^nUHsp;^0o`=s$4ahdC_>V?o(irt;e=|oKeALs)P(m-3R#N5{l=>=WYQ!|05a%>So zF$P&2_}NAB$nUd%U*}PmdVhR;`?;bj7~gLD?(VSnr8mPX&29xeB}?Qg%o)zhCqpU= zAJ=M`qx(*KBd?1F*>b~s+}8(Qa)~jHa@p{ubo>{5#{L2%Ntz(k3B1JflRQQp-SQhY zf8Is5L{Se}qQ)Y`yJjXgR(|(gekjic*0IdC);ZiW11FaY`f9bHwY#XVN}FEYS+;zY()Y4YX>XGpOgb4s z&VoknVLOO?I(U;0W_->h>btofK*JSMrsj?U(7ZU2Pu>$I(r~PlY&*^b;6m=j@)Az`-3p}SJM*3B^x$u`douQM`LMFnVE%luCD4a$$z9~@ z9~Y*Z9g_MLm}8~562DQD%W`E{$Rx0+;hk7{Du=oLJv7q*uC%0iuk3`U+@AF)y?=F> z(N&jljk)z_6(p~tEGYWqnEm9K|77>lWH&>-9jdw!=q*9!(|i&!vU`$Zpt2eAOm0F` zUcw$JjdRN66-#ZuIzgE9%M;^VMcm1l((FFuYfj)rx7RAa=@Cwkmtt*(WNbz~lVLFv z8V|15nn@2ut>WZc6JK1)>)keqGhevquaQc zS^KG_(Rga(+!o|Q`d4!m2Fc3-vdeNa35I7pSX8}E0SnVl;~2ecPzEJ>u8gCpf~V85 zj+s=TGX5}#E%!NXYNR<|$VA5^Y_~r=E4Yc=N`?*C9>8MGk{_5weDmnT!6m~Iw`GPt zi6=2#_I0Hg7q=byngTO9AZ!=+<^DzMVjlY7mVx;yZojy?lSi!&!)~Ggb#o~}!AIu! z2ZtL@8CK25iHIZ({ku@+Y?LE1{<3D?sw_*Dyu32Q=60Yq{=lb|g1mNQ9_>#lV_)?y z&`wi|420vDEKc!GL$}_lr(F8EU-&wsaf~&+eZmeIr(x; z#IMvGsKagbF>jqMO!eRz-a0zh8G{eLY%BTW;16stM{OL#J0*RtL(v3^Z8 z+crZqk}^H%vH=4ex!z}`?w>HeK`$YjX4w5L^q)1jCgd5pMtfk ztDg?BS0r!=_;AP-yE<@B^P=KZ`aG(t5+z@F@-y|KQhH1%eUfS0IuVC1>}49fQ#xr( znXLuZa~;R#^UL8N*onpC!;awoF1ppn>n(*yk@>a_Hqon zA8fbl`OSU9>QaqHhhyt&(%?z?9q|*wo<#*pGmGtT3YE>Soz8O)H~JD)LD$(hCr+M+ z)NUJ3HMZ*+P>VS0&I%*G4*F7+WMms~8&P@HW`_DPRsC9sC$^b%OP3e8XG^%FS7LIG zrECu0Y?pd{#^@7n@e_;dsl)^5RR=g2qc(%F2k#oK!5jLL@dh#Hel5yI6`?ipEwv>} z_>bpyt>teg`QffR4`KzuwU@~nvMXu#lZk{)>8-`o#vO6#c(JmpN&Twdel8G_p>q1r zL~+pRwF!!;`K^T>w56Y+%=eSbxz2`jWxi3#r4xi}{Cu1_k5E!8w6A;Xy*E?{@Wy9- zYmMT#gmc!;JQ{kYKY6x7rqzt=~f~x*=K!IBX0g!U-^dL<~X;=j1mO=Y>GT59Ry+DG1BBeU17d&5;lffR7qEd zN)&8Wy)w*o^)D2q-+s z7aHCdQY8I~cuDFM=mNeAWskn$#S>CH=*JZ?$L%%tr(XLaS6s|U=a93A;q?9y(O`Y; z6mTOBuf#dmgtI%2+xD?Wwt4T&C7k|Yd#i^g{+!Pm{4sYW_Xlj7>1cs(j92&nA#CG-5i`imi^_17VvW##d#az(C)33P}O)XeZrbrYRDOFC|SbjM- zi)gfF`&Hp)s1Dk1JU!%anE6($Tc#=TO{>K`v^1po@L)6xeRt7*{535(Jx8M-)V z(W%PnnHlOk0LF@1z8~h@6%ydXWeGS8z@8eA^8$YUOF2Z;+RpN?QUU?W(or}fFzt6$ z#rk&hsdg>A1>}STzyW@O@f!i`!bE5YY9eiF0qb*DnOZz`5b-#LOV&e{ZJAn5D^?UZ zvcOS%5BC_v8#in_Z8rChmQbA@`9ozrDr^+r@2lGvi1XPmdbplD1jLH-a_(@|6HHf)via0**K3Gl4y2;(YaHQ^pp`}n-u7GlErz4S?ezlo7;_!Ka5MLzH5>+>0t>v$XA5KnNXn;h7 zK@|f?=vOW5U>g%Ux;kXV&c;o|b&3fGYm9yZpOWla%s}mwgvkUDju2q<)sokKHbb2O zQG(_s(DV3$kPkKwtPh0i9+y+ zNqVU{>ha7B$slIbs@2M&{>s2+xNUTltSNBVvk0t)7DxcG@9SeX2j#Ak`NdDIZht!J!N1!$nErp*`|7Z&wykfvyGx`SHn{=mZloKeyBn1bDV0uX1O%j! zMp8ONQjw4bX+;5*ZvpDTb3Etj(dT>bA9wL=H}199Vy-#I_>CTO1=Ni4Vn64t@_|+= zOs|Fy59wjo?vZL!#+1bEy%*FP?t397_b-XpI5tlC+9=N7^95zxOCg%6?)89Unuto}R%!l6>&#tJ>8t&$n>qdh{ z)3RVL1oKH2gQbY>yZ7D$T|)KujabT8&{ZN5^~yq5TrN!U(Ma&0i)sr3=Q&)@qg_ef zG0o!DzP3^zX&8#1T_MuJIhk&f_PU-DRdZodK?5IVY+Pv$CXkV1(?ztlDd_pUaJeF* z;T}?H>%6pkR;Z712h_G+pN&{-CY3fs_-b&(WqHzr$<9G_u_Agn+eOGnm!RI5hFji+ z8GyX|99LH`Y{CB)#~{q>M^pVpmIjl7&v#m0B|W+=GDP^AjOf7oiWtp~MaHuZiEUo`;N(GNzIj|r=% ztS0X4h+LpGS+aC(U`Lq7h+j|Wh?RB&mycwzrzH85Pl26XlMCuN$r zhvv(4$XeuYIZ-r9vObV=ly>T%&>mii%h_oGm&@8b(n#{ECJwu-!t;hRoc^*2N4Y_xW8Fq~>g7 z@8W3WY-Vrbb>87i%Gtrq@j@@0Gi3kVI_7+*Ob!-yPEMdZ77qs}3n$RJ2F$_3!V9#{ z;s$fDaIvy|SDu~S6%Y;Qy@bxUJ|qM4{F-b71KpGUlcZr+VucVD3$|tPerE_B{Kl9? z-$Z~CTNM`B1X}=`QVf;@o09CB$i%ep(1>&vT|DD$k22w-6T^W&H+Hzt9NljMTyGoGiR&Qw(Nd z2PmD5otuq?3+OZkW@F*t{AWr(SG7LRG0(43`nl%zXH`tb&d9<{^rA8*11Mwc+-Ggu z{!sx#X%j&5V?}`*7Rc{L90A$+JlDsN+C@N9l;}7P+?x?I6KI)`Ga@Gyerx(+B-aDt zc1{Y4$ExF?k`0`_V;KVGl>=_}&Vg&ckQ2{S7O0s?C1B+rMNycJ6bH z_=g$qj8VTZo)|E@XX-6T3P7{7c?PM1>XTyeX`H_`IN&iurBAHtpGO8Z#Wms z1^!V01zIScqQ)22W&J;3T`}yR;#`blr0d_Ii?av$ZFIqTVN?2ZAq8gR0>soG=m>!2 z56UR6b5rL3a*Fji#8iJmN>TeGO@42RFGwj-F)|LWbBO~GF6WOD?gg3iFWHR)==S+j za*p!?r2iX}nFsuf@(k!Kc{<>~TFd}7ouBwE7V{a&ezus;0OFr5=6mXLHaH>}%|oTD z3xh^C8tRV_MdTxCq^SfY`9tBgBg5f(#Ke7@uBm%$OQMicy_WZW;IOX$QZtsLZ+vc7 zjFdZs#Ne@bGdML?bMR&(X7AK;&wY-r**tt~LJLM8&r}dL57j+4=ds1tcAQ~pVX$p) zZ><^EA0@&k;Uj;#gKurX|I+567Jhx3l}ANnu{k29igprTtSA)-fnrJ|#5Yeb+`Bh_ZtIyWMk=|=k$oUD1>y_u4k zeze`<^dZclc3$<30qf+68NA9XX%pfFFM9`PUf61^>|e>eQ|gy#xt2zNUV4; zArdM-v-yClnSE4Mi`D^~mYu{l^l9qm{XCBcVbZrq@V&BiJeO-@!zOL>LmHR#8faQx z8dB@_Y-w){m4iSUVr7}v4T2&&fZkt(DB?~SNp%mG2kV~g>IUh3W%M=h=AvkwFE$$~ z_RL{bD#S|hB<6}5%)n$qbc zw(Nt+M9D5Qrf5b}LF9alq&I{WL4osBrU<+{=uQFVw2m{*mUakwYUIZf1Q+F1#g;HH z7aC?Ah4*51s55d$w7uC}A)e2w zRFi9|Wd^W|Nm4>!bwjzLnQ{f=xoTJ|rHj*24x15{j#`Cd6cP**=GuGqGkoZJSy16j zEIMu<={hPxn9=bP&r(-xx{oOYy9O(SiOCh7;^1=8iiEjZzSiuE)}#(wxiRIoAk$pB zv;!W^iu*0S*(pbN#GYwh7HG@jQ4G#>d4Z8*v;gd>NxrG|kZPfuupsk2bhSA*;qknr za=C-mH8tLMYUC@0LFCSD{&i`B^Xs0wLWy0UbdHaWwWMrw@5y;=hukW?CXm6=r{GBE zFpbf-b{YP};iA?eNaefxJ?K0I$S*Qq)B$k5v45iog1LBExY$ljp8u!_a(=4_{-QhY zvkUL{DS`}(BOd5rC27zyI|th{4lWK>R(38;z-Ds67C=UZhK4qQ6{8f8Q&lBvpYB&0 zn(Sy99q!O0=S`HG<(Lp|rOsfC`o>~{^+3Dxy$SuTY9QwYHSkQbeO1W-<@^+*|D#HF zCJRp&_{^<(>Q4Rq`lHn{*9EQZ*EQF(fnB61W-uE!3+tJNa&BC(|1e3NjqIxu_+MyS z@By|325gJZ)pC5ted7a*%NTOI2zVMIfNjCPucVE>^ERd^0%(BE>XQ|Nn7O;i1yd;3 z#?vUPsx>y}qBI3pJ6rV({z7wgVMTO5v*$BL zCu8RN8-M+0{|3;){FMAY>yBW~Uscb~RFQu)qEAzJK713o6>bRtta93Ok$G-?!Em;OL9Jz{>*ktUh0DAV33z zNB+}d11;(=F7~e?JJ5L^xZTe!Hee{o35X&8$a2GDA*p_Ex&H*E;IB{${y```n}*-E zGT;lS`)|~Lz?NqJDXtT9uyt@&bu=>2OEeAqdGY=n z7XvmlIHi%ZxY!xM{PO}&Ys%cAuEBhHqPhsnp4yshgS_{IxV2tHBmu&seRV4sB5ek9 z8#cN4Xz3BmLtC7v&i5q7*V(*%f)=_G#e^O|U)dlRIr(V50qVN-_>%yMkZ(1m@A1yZ ze8-#bO1scycegXpU*f+IvLTSVVvQuVrpep<;m!N5h5Z_Xaf?m&X#@Ob(xtWg?qkN= zUCy1GD~|E*tNAZ1NUr(#+!Ta~=}}gxcSd^Ky&yaCWOonI+4p)!(Mn;_-Mh|X8h2du zn9ZUT>jA*(MUji^F2{<=dYm9`3f6c=t@Kn(*7qs;M9q@Ly*YEASEE^xj1eY_kdvM(yoa_{hksEhC*jmmzPB8;q$_t$Id!3LrWh*khZ4kA1Ve)*laD-<=vc( zd>TD!#<0o9b`&C}VS7E(l<=ynp;EBQ!BWxtw(9)LI3Cn9wlh&DkPQxHImvnNFz@C* zE%f)W!7Ra`i*iyG%e&(?R^}p#G1;m)rYU3e7%k3@StLhLk4=J~lWNlx(Ou2ig~3j3 zn0Dgnv(-1@EN=4Pe6tep0}HnoxDn<^>bmpvsr3h$;*G?d5etV%g`%(HMmrB0VLsgB z7^L7Xgn`p-3dm7+LAyiKYQ8zyKYH2UlnAUOuv?5v{&9lRz@hf3%fe%sxy1sTtD7^X z`l^A|jRFjswr=HWv7@>q$U6!eZ{w!JwFbK7Wa)D@2PL39XbZh`?Z-5;Rpi)tTy=|0_GKx4pX{=u!2zmoUK z^rOZEQ$$Dyhrxt;aaw6TdJ0SEsMd%l2=-aRsq{~;JWB!5j!2xW)nF&OFNF7^c^J2D zB(o6G+@QIG?e6RWSqZzLjzrpXsY0w-WdMhP%3r#Y+q0VbM(LdwK96WnTvBwcU7m#` zj$R&_xUpW?Bc13bk2so9J~N`-m`7iCUGUL^SS;zblG2!_tGWn#LApJN@al$CF6|}v zHtsZeY@thLr%ubGRo)F|59a5lR|s@@fDx9)6EEoS5IXi&suQdBv^zhySjz3~fpw>z zh~t2nd*Y7Jf&ZJM}5|F*^~)YgRYIAUa<^`r8ew^RodWeh_Y z3Nm&LhH8XcVHz>y^sjcda?C|1&9I5Ub#h7 zvVu+5>0$oOw+40Nq`Y+S650+(=@0p=B=QmoAXMzTo5)v=XXoN@cO-BXwUu=ao(QWR ziHmghQY557B57N^zoI8)yyH5@Mlns5j1W2A-5P|gDlEu`&kBv(l6u>JsvnJJD_+I$ zdR`!&L)$VL2^H^TF>c-x`*K8Y1qw;zbi`yJ$#p7PeC6U7l_nSl4ZQ87|WO!X8YUN0|oTHqj?Hj*3^P;honUV)Lrc7SJs<9lWoGLB~$_7L^e zebHVjgv7}Q=J{9Bsu5+RCJiTDb7zsN#kRHxlb*U$@PX~3xZ4IcO(S-bJgo2R^CF`k zU7f@*4bnFx@9nn2hzcX_HoAFl=tplET{Ey(hMD-x+x@a{ZIg~*VcdTGMOU9Ynvu`-5HCoMp-^dfa8Tr>f9h#Te*|Lg1#}v(Q2Z=u?qte z)0B;AmD8TyzNv|GpYHbKkYVKsQhlycr^2SoOWl0hI;{4f*b;XbvpFkTK@owGe~rD5vp1a^`I=b|)}3~AAns3)14e^x))rv#Dlh9xZtn4R z$`u+~QgS({^Wxj9>yI-f<8_F`xQs0NijJ~5sF?N*5#^B`sa;`t`2MXzH}sET*ZIt} zmNkuMh6%dl!ft4t}`xDXP(;eQ$O}=#u_AcD$*qfTkS#0Lh-Xda{bk zTPnBm1Nqo^@I-4$_{(&8%QkcQ;o#7#zLsv0hD{15_B096BOR?l zjfRx)XxSP2P+HL=q7<#Q2u2#E@+sOCcq(YFD&VJkOl#dxT1`t-vFuv5ff>x$HPh5P zs+3igKnr4W%;sckug!r@)oPCcCmNk7G$%asbQF}aSJ)bJJtOc;t?$J)=$IyF-o)zm zl^quMtkJ;TxG%$&fgf3)HB6jr6~qx^!E&7sC+{lGJ&dFq=86cORIr+`Ydq9<^)bve z!aM2`75uYM5ARrN!(gf$J<{$Lsymud&>H3N6-l4ZVd)5SAq#}5ux6oVPa+#`OzEpC z%-~A6%~y$Zqb;88DGE(|GDxwvfn~})=d#%h@lCUY*J#WpJF6ZEksPhsyHaBLG~zaf zHJvxe=X3o7rSyBKP@*O8Zi~A=ytl>alIb3qBHVEhw$;M>u>2Ns|JLoNt18v3x@ztY z@gRv(`LWn$KBu<@q#@#v+?_ULV$Q|^3RXr&*%ESQ&nVOk8#o;}L)tGdiAUb9a&{rPdJRvx1d za9)6ykvMNek0mQeyS`hAbYZz-Uirr1pom(kgam%e8|fMuarUPxSKIyY4c>ml7n6*- z-rH-PNyPC)Eo+t~c_fz3hazB2cmpedZ9({2Ec-5QQ;4DIEnV#$V=~BU^d0ykxekL} zSy~4FgoBR?wA^XauFlVT9CBlwp7p@5E!vcaxj*nxyV=(M;6~E%#w~l^wLEK+$$oXt z*o`DO?B<0PdPrjhz4n>Sn=Al<1oDqIQtFmKNw7CqbW zR}hvr8YxSPz5kqFXXQ&Q8!rdzAJCrciHPz6$ zb{$$#U{Pk^>wJIV|oM%?*}Ef@WSWD2FvcsWLEDV)xVm6 z#=|GVl!H4G5M*b`IObPS*E5}NYJ(oI*h=(}tfS_i=wHEfP|3Ny(PTYHSdP&}hL6hH zSU`t-vsKXRwF86OD>p-Pw|($Fbgf={PuKkYrn&NrC~ZDo(vP(UX$YjGPbA7}U%lsn zvSMq-Yj{Tu>~izGTOsXOa(TZT+q%bxWNMJV1S`gQwFejX4UepJW3Se=wxXOjaC}D( z?Hy!$a5Ed^k?cuer>Nq2KbU#HFbaces|?0lR}&{KwF9|b%S`hnzjw6Ay_`V;XJiQot}bRLDG2TYq`qGJBj&idyf<^!-TM8yP&kiCA25NnCkSTJ8^dQerUN z5v#YK_J?%ED|PqI9ZSA(qP14M%58IxdB{3VIjLxy3ljE;1=icmTh`FnPeY(pA5TBs z-F&0o;=YT~nu&k6ioD`7xl+T!OJvo{cP>RPrXtLIz>mi{?yNPuY_7>`5$00Dr)+1$ zr=_H`)hJ;5SkAG{hg01j9!t-+a~FY<;khQ$`(y0B{%8WZ7lS&{n=lpLRJup*X%ZD- zNoEbmbYAVQjI!c%Y~~?XIjT^7Vm6DXl%6f_q8#-LbQdLSGpJVdzw5n{xBeitei$_1 zHWak|`k8$e!t>WC$4MQ^e5Iv~J_1S(Swm%}Niz$SIqP*p&(u04BnKGzhi@+Xcv(d1 zw7Cr2B;BRqdR{wIw0sW}*(uaX0ir!3ym%Y=pvS~ll^(hjnnO9XCi$}8OCm)2&wF-PyWXyg@9eO$1OQceU6|4lyVa9TphF|d7)kr}X>Rt6yJ<>t2MgWq%TDo8 zabheb1({vSqOa7S9AOz;y3alN)WP4?@=}pC-QiuXJpMjsxKS<#3T&D@vfXec^ft8U zWi*Wav~=V&+%SAzrW^GI#?mreb$MZV)YaxR>G>8=7P`7ib#K6Kf=vHv0$Py=oS=Gm!Qiv(ZlEM@(;{?t1hXE>Bw{NYHJmblHIDog%fMOQ!N@8 zA7^C?6`V}}A;`eCiEhpTKWoQ;cnx2ua;zhyI~im`%Y7{Wp_1QGR-2qzzG%6?r?p%V z54C~s&=ID+E5n}nVWYk=<&~17s-b=!QA0SnH6236V@$kuquK5~QG?sbhN~PX0ipMM z(@A*QTlD4YATI0Y1$I-(qWTGRClkseV<4I&Vkl%7zK9_!%Gx)k!p#qrbcfXEJ=n4;UO*x4^P|0Wk`Ge3eM8l? zR<4JW{S?rR>wZE2aKpNMF|PUbKNCy%un?%odB@z^`wut zYN_@eA?P7%3?6R?uaCW?6z)ic!7G|rzCPdkagVWI*$Lr7Kg^g7%|P6f-5x1Px1Xor zt2b{QuNiKxTH|8cuD4csa*XLv{jQy4?Gi`&hyjYd{Bfd`>trs6AkNdQ8+kOl3415< zy>}^LPMYE_*Tg-(|ABewaYfu^+?1ZU#*oDT<@<^2jd6a<_dT#sL)WT?MM|FW>%B0r z5xz^f%ipc-&~H;CQ~k-fOTPtTY8lz-cHU;O{zvjxNZ=H!W-W)Fo|GF8nyW75^h9u7 z-_`%{c73WUclm0o`bT6Z^^*)|^^--tu@hfCE|wA^Zq244^@YX4o6hRZwG2W|W3_eb zmmSAEUls1MXexM1p3K=|Wg5r|7T4G79_89TCT_SwTwP^4XjN9Vz$ukh(yeXeXZKs*>p8dsb)G_{Hv$38)Zk7$FnBGtEQjiG6nfM=$!e(8V z%c^z}nHzBx91^HoxAccwaJft59}{~^Byy202Xvv%GW+TeJ=sT`^@z+1^PXY`hj>hK zMY2<4X4y(uH~VyHmtjEpMCr~-Ep-ai=3vY^a%XikR-k2VTtY$3th5LfdPa)y`jG;z z*TeVquX*FkUu_FrGat(7rTLI>SAB|YFF|wPYSo*4COlFTRMDH;FutvG(o}8WYH^&Z zQ{z}^yi`z#_VKEm_oZpm0L#Nt7#~iomLNlyTe?Eb5wJIl_j;V`dtH(7nHyDR+^SEa zpEtP3jz)bv`ry(_BAfl3_`WqCp%W>2es~oUG@?!xVz8J9eyT|H-JmX_H+i*BMCWB4 z-(`~J`T54SGbY0v>uQUeEWvgig>g#5iG>P zqfSKH!x=nd{~{F6ECxpz-S%6e14@TXmp!fbNu0L3v+RxPOXfH`(!!1kxZG8;6Rcgx zv2X;0CFbKsry3gV)H?X#vYZJcSTXPaIY!mL07gz zPX(e0RIrQ4y+@$NRG+ocL@Vi7U0~4EP~%{kXIg!#+$W{at5NB2e^QU1dO0^t(|q|_ z%C#Or?AN$LoC?iBV<|kZ_8Qd6o`nbMnmMCkKI%4nay93uXgVFm<<-U{R~Rl|PCa&O z=Ok9Rrz1`F%FT6Y#=_LwU9lB+p)+*#(>8Iu^a3YfXquA*houvj4ew#D8zcpmI|_&Or+liQW!0pok~3or^aKv z@h;sO>!=xd9agqJT{&pdwPW&eWNLE4)sk(0Yb!jjtS0mD(q7m+FO;DMpXJq1-bmt1 zTH|%N8_sV`p8D%d?j>uYfaDmV^+dG@I)?efXv-pHNs_c0dmjkTwo!Q75NCaQ9_OyJ z4D+yKaxw6L`bdRgT$Z1oFH!9lL4_0_sex$A`$2c}e4bk7{A4;hNov*E;uFVfTx)JY ztgjgapa}Yhyeii6-p!837@D*1&rGny76eky@Hx;>2>01^Ib1V2)?Yh+b)c z?H7f@f=`cmVQhl2sGV#!0eW-zJ}giQ6WM$a`B6LJ&6it0?RR;_W8!eVXSl^m({=?*U1zR zNos2GKJO$o0*dG6jBrpxp`U5or6)3mx8CMLz2lklo$Qt+sDeh&2Q08 z+i*scXUs<0>x}9(T6n%}U7Vmn*~%@l2q1d@oJC{l7&(2Q>;P?VE2Lsqy)zJ9jW?bG z855G;V1pm#rgqpiYouA*d9rDc`IUTDIEj3 z#t76nqcD5*D4)1gyEF}Dcj8zEmY0qxgWsZV(`oo_HYgMBA-$%VAa>VW=Wpv~l!rkG znUjj&)~RbCp;IrZ`b5SMJWktteQx3!ee07+W#rpl@E&mu$+e>GUL|NydVKbIDS3Un z8U4`hnxst)f+C``#SxZ>IPja^>f2Kgxu@Pg9d9}X1r1>1-L2D!dVP~YHZp{ zml^%)r2-Ev!X7aha3U6c7*R*2E&*Xrd*66ICUSB$U^bie2}AC&g36X&J_ni91O9Nt_6cMg54t7=`MMM?I5J5H(P{o*-)M^zS>L0~I zkjHTyAP>k}M(U~4J4&yELt;79^Vj<(iyQhmTIBbp@Iv#<5>*!bV>g{1b!Cp`@HJ^HUtjrMSU6@{NY68v*BN)G-fdSS)lri*f@TW*3JWx zU-Hs9ekxY_mw4#Ur6c_YS`(S*?*_7vVCc+@3o~udFuA!jr3aTr-t}`SIrgj|Eka%7 zSo%%0!|##Xh2Z~hAh$08^uH&Tv#9Ye63ZD?{{*pcUyP$0xtN`9n+=lJl2R9wXB06x z%~uDCI+<0??5vDWH;b3B2g**Z>@7f=R`w$HE>>UvFKOlM;woloOXGsrSKymHqZ#)2ipMJ^(EHoF- zDRprGe-9{y0y3?E4eo)00WMZxH+$e-r=Nl^?(}{(DW6H>@5_KWxOp#D&+5et*axzr z_-%WIlT3)g-tV-c23j9#yehl=@CCGz@s(W6Y+>}qkG6VlBT;16aQHq2VB;=jxo#HZ zyc?ddAaQ$kh1hY`AxqM`)n;Rq;pwA?UB|Yc#`Txf#d}t)2+A4tpA|7ZdkW8tW|H*g zS>-0ER_Up38G(++*wt&DURgQ&1IL$N58u8r?p4AJu6ioBbgc-@jWeHFPHtn9hnao_ z^vY$gAl9oHE4jXg=Y8Q5r8>q!raan-sjzgttjd$|iFZ|Us=k^cW{B`zY^WVl^OU>h zTpXw!VUBH$m@}-GgV6hFjTlnyS6KAk$cssJwy(!C;2<^VDd-$?eU<&)$G)MMgZw$~;dU1fJMFSiRy-b6Vj zz<@L7&6(#Qa?0^fbv`+sCasq^dU||>2UYFeZ0+*6?%BikF1t5P6LFoTN3a)i(8fHf zx4#1>+!th*=-=|0=)dMMwsRrzmBn~?|CYnp&((PG~h>MAty(<|TD<>~V%*avN%*w*jl?fCo0_qk`%s`H2&Q=bl zAQ6x#NF1a9x(ZSPo#uaPf{Z}MAQO-&$P8o&vI5zFY(aJ)dyoUj5#$VV0l9+QK<*$9 zkQY5rAbI|`nAw5UA)pA~!sQFrou`JevvQD~o&(Ci0A1pAM1V2}z^SB>ot3Q@-8q_) z0dPw81y1SD&s*7=0i^=KoSdZq0aqv**#V{fe+$B=H&u0YHgh$x{8CDI`jO`6XJ=&v z$+#NXTA7I0TiBYBv4T`x&FnOQQE{H@5U1b$1D!!ypXZE=jq^e+(pmM=7bW8F=oLU_ zGvp9eOoTXr$(&;%z@SLe&fM7Vy^8|`w zz&vc<(Bp+X$G-<>b}rsOJ)hV`u$EUxR#Vl)^B$t&7MaKN6zqVRK}N7H%7kJFL%4sVK9ndKB&Dd1@Tjs}`7=BO>#hgk*VgkjcA-OcV3~OCjO{`vl#emw6!<+yT4(SK zfS*Vq)~g&ZE;eo2-+FnxRXN1V%|v;*t&FKCOffVxgHV8l$=mD^y@g206zzDDoh(Nw z>!gO1c6ITXg1uV}J}az8eb4a>iDt`nsrMSFw-pua#WHv}*b`nF()-?;NZxamRQ<$m zQlePe$7POpJ9Ia2BF-Z%yGRTO8aNM9PsC>R(&s>nWoyGjk zo|$a|g=Tq(k?Sb^kq=~L+L}dv`HiU=a!4_ER4+!3KGHsmzP?2eE@t=;&MlnHaKRXP zw5Zv*{rJva#rOjD2WXQ{?rZKvZVCJ2D=XSZ8*T>X(Yg`G_$WBolR=3vDE^Nb=jcT) zfe{Un;U3Y!caOAMAczoQ+vFJD5Y_FN*DZOQ3WWdh@b?*BY^mr z5|<}<&ccBbm-U{WzhkG7VbHdSE^Nii33W5mcL64X_`_E_^(z_!A~i8S_10YqX$NB{ zp-~>rxZ_(=&Fvn0JKhB6lUvnv=n^vwesI*>r&@=E3-t_XaV*9u2-xinlGvLFT_$A z7Jv@VAvXx#b)ak|eS}4zfs!NSfXy8%OR|e#lj>N4w3v%qak*ud!6;~*QH4Y&pkx(j zGnv0y{WfCawb!uLOJT-Jq>pS+DN*fVNkMYL{yv5QdP*&vq0p390`X~NGB#iwA4jsg zN=-=c;0QeBLR!p(UhA5eqjBP@lEiI_8skg)pg~|HHv`Mi65&V8D&)^y+vq!#U`9PK zqY8mq=S9xQY1^~6hE4Z5uSX!Tr$bC6_@(p-(P$C%q5{RATPF_O?&Va7Q4*^a zAiiF#dt;K3HOBpgv^Fjk5|8bKm{8J#;3@sPE%VyX?c|GNmAotun~_s|M@gFx-#CuM zlu8hYq~iyBEHE)ErelSgemF!Yqfm!hxo0x9&s9z+`Pi?M*5^}1cPln>ZBAiJJ-#TA zTl21YcMf|l8u{^Ss>n~=wzKH&RkZKcbjlmyXbXhp$Y#dd_~+4AGC#WVS7QmN-8aSU z4$LBl=2zp1TxH{gdACBDg)HHbAo`lWKs`&EEWll$rmT$dJ&XJ&+}HK@idql_VeUAT zEsK>x9B`y4snTR$oyv}Stf=0~s#0ktWfpOuSSP5j1J(~)xVfN=J53;d<8ghx^WBb8 zM%|{hg@KIckMI(Gy_yUF&ob03#!(N`HqZXCv2|GFdrFK@RZu~ zTlP_zF(`I6jG5T(ms51^qZ0RVZx#*bUMl|dUXwYpj)Mo@q)qsaJtTcHAtQBxcr_Lr z96RjYQSE26i__QP#O~;C*%pPp!K||iez{Y8>mi(hxtreu(Y^ZDxVz7jkNU{A1>81Q zd@r$6JH-1@YBqns2rCOqr3pyeX+5^;eBwqi89Q=aPQU5N^O8m4olQUO z)#Fd=O^FQ@Gw51;V;oF}QikFz^=0slTLG&0HkCpdcOJfF)MB)qwwh|zg`O6@{w!!d zj;t!@mZgpp4@_%N#LJ0;@Ky1IQc!n#4k{bxY&7^KuD#s@+s21Y-c;`H$sJ42ipbvM z;toD1QG}DyMvnhDE+5$5+Xc@eRQpN)dQzxnE9R#hn9|I=FjbXjx4kIT=y{P|K0;EP zGi>kG(G#|NDY=cWbi(2XUHDX_N22kCDyK9kkSCRTUF1M%PnF}+5h~ISRV|JVIT04l zszlof&T49UX7=L8<&!MEqXBSSOkk;zQ?e0@eMx?Mdm{>l{|tDDsilgiTlj;q&&WUX#7K+Bq_>@63*PoW@z(gOSTy0`P__dI&>)$^tAC&s;p&jr2IMt2>1lb|`f z{n+>>tUMftPg2Cp$EM%`PrJp4rHvbTOz}55X0)$8dr5ccnvh58hj$X!4CuWz;b{2G zLoAlvWqT#L8*b-uS_mNX+4)NHbr%z;? zWlQI#VemaiiK|vu4IG$Rl`Gxs)&w7EhF`5b=Bp&9vkjs-vBY3WLg8F)=*zGwo~52_ zKK_vO1WA6kjX1!UPx8ZfQ8j!*+S~kBk2hd_-!04?Z$0~%)|vVG){cjhA-TYbMTBF= z%_w`fD0_PFd}PyX;Dir;sxy|B*42H3eO=G4ZHznHF}AaBvz`p@ycekHEfK`AwC?lY zBQ}^_ar&@qy8m7vORWKuYSNQ`yFvKe&YwcD+6{iO332SDf3aqPYBh6DqIA z;UvJyO^m&H!`Y3DUr>SUu&Py6Ws~>DV{kzCvCUTe$<~nxY&S#A?AX*}-u0G{t=k_< zmOct31a6~Syz^ju;@!gVy5a7mN6~D|@GQzgL2D*1zFD>FB?ppZ~?C z{FDCrhdBYbgFgFce%*vTRmcBqKAwJdZaSWNPEOVBzcCxXQOhs*@BZH8{$h)Lb#0LW z^_pjf*jJAh*Pk6)Y@f@wzWB2^{^HI$^=zHmSzjjxC?w=&XD8zVoI@NufCa&J?qcEw zdP4y2f8Yf;fmi_-5n#`px~EQEP^S*B)9-NucIBxP>db})oL1aGNjMka#^O5t?x}-{ z4RAi4y0w58;G+6w3cflWKezW$)CGy!8kyMWUugFOScaz$OvZNRrTe3>@yxXPLS9y` zE=p$3Vh(nW4)&)8HxKBKf|v{U`qHCLTukkAhq}+!B_~M6-W9kI=t2jyud{MDJGGjvMe=oY}rwUk$;t)+OhJ_PLeZ`IM5evHf8^olKr=L7<74IvATln4U%w zpiW*u!a+cNJ)nW#pkaV2RcIJkn9~FH>j95|fB+ARhy)ynDCY&!MBCoqYxU^bHLS4I2#w^Lq!>uigOqS8s6g5&{O8jTQ(T1mG8B7zj)V zNK8m5Oeknf=#vh}Y+$aS5l?6A>j8-f%oHpfJOUCj(75nVC*ctw&(0zuA!D3f0i&$& z$Cc3jP-j;nB4J`-JUJ3+xAw?f0hqhn&@;u8{+l2fv>b8_$J zz-@H9| z_x|t*^K_`t&_eou3>kPD^3#XCIOLxjar8Gs_74dBJmg;(@y;JZK6ws-1_J@C85AZo zCWH`#+*}zSWGh4gOc)tdlsN_hTfdeOawZHy7!#T)d>a;~A7xN6QuIAm-;=5DI3am1 zI{SZ;qc3)y{LIrFKf=?T96!v`fd9z_aBCUap(06#9r=PO_f9$^=~x95FTJ~rf1;w( zak8(?cDi;aCujdaLqI~3KK z_$SXrAM&p+-w#1DAliNuk-vQ`&LN5SeWJ9$h9EG+7oSb65O4E)OLoDhEBceq_V0uZ z4>#8jKN|SLv;9xl{GGTv6E+B6gpJUz3LCg{VFUkF*g&hv0hDxpK(j;sqpQ z|B9@+fZS)o1`<|E{mY0UP9-NBKp#C5kA5tE;0Ux>#0di!>r7yztyAT3g%|oGVI*QRIeT2qdy39#2Ha zRdnNfS8$Zjzc0d0mGgfI?SH|E9}-~PKv?2OA&`yd4`}}%PW&TIK%e6TGz8Xf#|bD+ znXgQDuCIQp;QhgKKd+PicBcC)P5|mTHru%lj);Wy7d`sF4<{rs3_+}ZbU{#h`0!yw zaKeznkYIr>rG@rk3=F?vby2jet-0?r^M%0K&kFtT=xINs(ENm+_N_j8rl-LY0F?Dr z{Y1NWneBVJ%*C!yzpBgp7)Ajta(@`3SpSDnrzZSAo9-74XJ`ndU&JUt=tG<#(RXzj zC^pD1?EXE&`Tw5b&oK%{R`nvRvi*at|9?N^KkG7zbHaXvMz30s5MYHVao}2l&|wU} zk4YE3hQG?ZKZHo!-2Y?VZ@g!}+3WS&nHLgTLHP?OK%S}ff2-90w@8n^K>a91Q-zH1^ zCVm#j;1>NIJ&pG?tn?$cBtRqQF`=KK5jG$V?*~F2+&}Ig<+-4_NrzqEKYAKyvvM_! zx5A@+#H{khb=n#nyt?G|wwM5-Ae{F)^A6qT&y=-_M7Tzy`i%gaMY?% zQ558v{aSjF#C4JghzKl;7&?MAYin^HErZ7oh72A#O$-X$x_YhF>$o+7``Tll$F;kzOV|7{R%g4?HoZHk4BC`SJid{|@Qn-MPae^o++RhsT7L zGard9?p}Ub@BXQZ@RI(c16xJXdjW0P#uc)%MAwUpCCLm?D73V--*U#8QcDEG^72lT zR6Z+ecwsKDTkdx9bOGOi-{@pj4vcQ%z7Vwe7BwG zG32+L#^+@DBHRl(4|<@l!eeP37vhSNtcJGs-C$fJ(qXUby%iNIWbeG{`M{?4)gLKj z)EK{L#a^+W_WkgBOe*SFu-W?)itWs&>ixWdq%qC3nz4#tv{qcByZ2wlv z8;`xo1GkODDi6gZPS_-fx?oXC>?NGhQCAccf0^OY{{GR?j^W{9VJQVJK^BIVYoUD& znO40W=~Fh~?dRo}EN2Gzu3mfWb+Y;H@~Hs(YI}Lixg33ur++lW0r2#B9`w)f^bhHC z9PB@?&+)Kd#QhX5ljm_VvGsf}h}Xkq_eLrgVq@C%9`f_Q?vIP-s;=$`>hu#P5f2Ry zM?yq$c5y0a>?Q7%CR(jKK0XYR?7-7dn;5NfeWQ?G>Dg1U#HcZl!e#e7H>@e`p#o}r z=L14*#Au^I5qr{f8uMk@b!(!=o1(&j;^N{GetsfRB7V1GRV57WXpacbK5rYEc)`d| zQ`1;nT%J>8G57&iE)k?#XMIq-rb-haZ(CYgEZ^5HFCB^GT3%Jo#jc^GzOaOgg@p%I zuLy$z14~HYr?_Zn7Hw`kIyUCyT84f{rUx=*a(ax*Xsa<;uGRjYfQz-SuY-lIs-2UQ zkF}ntv8!Li?T5G0!XCs_q!10?7M2oKFvVD0SutKQjZKV?i5aeRcXq9Mha^K!2YP6| z1(Cwz`!w53nEM-~M|xh!$75dZuO7yl5H^YHvcjPL@K|Bs9Rk&C~^2nBzU zi~s6ZgH^nGk&C}@#2b8~)~hD96n@qi1ehMTIOwxDBq1qu{M-t$+Pp(ohz$Wpa!k0gNI#LEf(~W^8cVO9_>qBf%Oky1{~s< zxBYVx8!Qa;S4;qMsZR5~PQ7+teDP4Q!n$A1Lt;Wele39@NiF#59{Y+KUpepxbJ%{n zZ|n>+U|`uTz6==x5*qV#yzHkz&aVT$5aayYREV9w$-DbKWB&UjHrc0!JE2enF`VM8 zPoTAgA#t$CQE=KEWgy5zAPk?P^sos(^RJ*FKuXlQFblz5yRH7XImSd3aIn}1SJ5E&WL{8bDAxO)ha6{@Qti{%7{je8gv5{9`k z?IBqZTrnBq?3lO|1UOy@h|Z2VSXp2nf>Gi~I?w`6{}#CuJDoTrLJ%1P60a1s6rw1EG!KcVYN^)DM%PvwsU@gm{pCgKD3j~6iK`?}1GD&C@4q;fwd?l0+ zDOji|a!4jAtO}9_j7xBMsH2dgQWAKuZCDt{?Np0&Mis(swWKq({4 zYX}rN`cVjzSM5wl!a>lllw?C4+l?U*;ZUSu+g}Bu;1FZriwDJHbd%kNa%E*Ah%&^9 z4hUpIrOb4ebxcGd;)I4+KtzPYq9PzCYlVX3k(ZJni+~{5ARsZ8mwN(*rB{X$n1n$N z;g0}=a8(IrmxzviJ_OawFOMul91nq_B?FEQI17a+PGHzl#vP75x~=T zUTFT?J$;<)KjGwIymKJSms@i)YMS>&m;A+z3u$~4{ zYSKLtob|=mueOY=t*woXX~@aR;h;nVZt7jXlG5u8Ilerj99@?z0UQ4?c7^3$ll99- z&|UU3H$J>MOvMMy_#W*Y_Puiu^3khvS~yygOJva(xUu}^!NRR~n=k5}rYhDrj;=Hi zr^>dOy!wa@Ek-h?_wo(u?MT?pUTvv}`mb&wLy29vig#Ou$7Y!RJ zI^mQzv9JO*)z#fl-@qISKZ)=|fP{oJASKnn!=sV#A|{k!jHrEG{N_V=ij2!L$e_`E z|5FY=DgVvA*PRVDmj%5KkKVqJielC*x%Sw1gJd{?BVX|nZhRv zEo6@^!RrT$V+|e|Esr2Re&bD)lOB@zo;UG#=J))dfaUxN0n7HkY~`~eogc{XLH}Y^ zIQ@Wtg+I3{;Lb~9VBmrJn6C%SXIBJJNpxNs0|_VoHR28l0r=+Flz+gg_@gxD`;{>} zpG#wYw~BshRX{?)vV9e>z>tCAVv?VEBEDJ`|J4FkSQtW`ZJtME9!mux)bJ?+6ur_e zP&-2o#TSB+trkk%y84=N5h}pc)bB{#WVp7V!w?eE9Fa8+*SHv+zjLcBaA04lBp zwJlm}LkJiaH6SV~+JIPb2e-Pl4U39f3u>)e+XCX&+E%UYukGvdA3#EYkxm4){ttQQ zwZ7^*XQtuX?!Djr&IdOS{e0Bh~83u84{`1%YQfpA1FfGA5t^pd?!`_nNaqf>=#D4P+bQ zBL!&u31_qOs}99M_{H?OtDb}cFXHkDVLwHJB{O28MMFwk(94w8ij%b9DD5c?K!Q8A z8Cv-UNlI^r2E(#n-(<9|3m7D_zrv8Cv3*XM%!zITSBd2`{4Ct3N!aL-yUh%;V(}>| zSOvqSi4eqrWC1LMtsP(Ibt*+yMSh@-ltm^cY2_tarC6Qr2-G#RXH=5-L0)1C*Xgic z0cnPe0~Rf!Bx$Lo@^{$u>snr*@`Td;71e#cn8z%>6zK{CvMfUB4}jCq7P;;6#+o4A zU<#dHtgVKt5HM{emt)}xs>I5Z>2T%Jpye8heFLDCPqLYc?Q|_#u6+P%zXa}!g*v%8 z6et0j#LFeW>gh2P)LE1 z&@^QwFm(te-IoliNo;JScnt6AVe{yV5sfu5R?{^0gyz(3^WZNGl+s< zz5^gkZkwb)2;sNfVsHJljwLK>j?hc;cx~UR&1b+cnY6PV?NDV3uF1eNZ96~+f+?#z zJu;cX6q+F{D-M@Rdkj{#`yxD5zUjR!LJw_+eX0Jm3<8wFk9H{Xc{M@GQv1cDRRY$H zpt`I3tWug%_?Mch4ruCqtj}aflVR9AXLS$^_cg23?P~c#i zBNZ73%^hRCy%PF_q8F>eua$AR!(!G`eHpMm_p^UYYAcP72 z=?VphmxwD$cXPu5ZDaV30Ppyrz&;H_mP^rOoZB#Nr=)aub`bUWdlOcnHYX;r%q?NF z_{q+`YTy8@u{q#=JT*8ajw|5`K2>>+2>39MOK#SMfeW(8V*`>Wiz|@RP3U@etM>vn zTL-^Iiv>2H0n;BaDXK$L)vi^{tN>XY9CKC&X%Oj%w_tMCF<- z8ZmNZhr0>@4w&cVC(Kd;6~ zWAhtmca~rFoHp7eh^*kr(vq{IT{0NMpvGFRPY}f7I_dqKtSW+Bu8H$&UE+(Pcgi&D zY#q5?t}5}vFESQgVVs|2Ejch}vbi;H^yfJnBT8&C7BRF(CfUSYb1ng7puYA*t)0kO zs$A}_h}9w*rA=5vV*J;-NG?>bg};b$&$rpl54Y0S)|7_jxhH~?e0Lzg8!^h2@RWpY zLE-DkpOtNufs7<~anJ_l+yN!bVUu`&jsGRumuo>zovW!O*K8Z(!E=%Z+f0>FR%m=| zA89#MJ8X;2<$IT=Ios8BO6t6NbTV)3_+M-@isb`^yi6!0NV*}(O#OL`+t!<9sOz#^h$Eh-(b>gdQ%N~St2{d&>ZU*_>$Csx+~hvF5>koq770>@T*?vu}E@OaKIt&(!e&5Q!XO zC5hBzbN2tA25t3Q9fMqhbg&))K_ zTZ=bnS7@@{OHP?RXVT;;Q>VTDMs$qZD0lav!#uGM>gnm>F=VLYU^o7&BV}X#Bf~={ zhKx^|Id4ho+d0`Q3)ZdO^5L$1$E(hK_QlnE_kQ~6;lqbF?>0Bz`0A@KFMNLP)F+>Q zbaZ=J=?A*P^|@FMT{{2GSrg(y!y=-_1iUiR)zyK?!sf!(kChdR#b68=WbeXr!mJ{E zf}}#p^u)OdZ>iFh@8_*9+IjHsvD3Aeu6*~yj}IO^_~n<|H=AxYfAj6N%V$rVIP%G% z-TSv~+FY<|O}hG>#qZ7-7aJHn8uPy4vYlP*>_O0yL^f;vP+-iN2(X}=)2PTmTN`gL zj$pX>wRnYm(ZU7G@;8?3sQ9@0Ww{A6k^F>|#sbj}K{^XOrJ9d^7Z`g>b5Z_(; z-m>>6E7Rtv=B2Bry`gv$`v#Y%EXO{X$;k@&nAfAG&YwGH_LQ(maT8}H&0L)N_Nw)T zE4G(?xM$x-N2^Ypxpe-*SGVsp-n{vB)8}W89zA?y|AB2EaDz1sR2>FVOlb9%*Jg!xosXDvKE+=BuoGh(9OS`fc>Q&H)z@tq9bjo=VLjMkkQIw*&#+_j#jnZ6W@l;E6l^)Duc`j@^yPEcZWw>}&2yI( z<9+u;6_S`!z3Ce*#Bzd=I49TK8G)(T@)A-?^n| zQ^A^5Yqgn6mbd-@%$xsaa>}&VUmf+DI8Y*O`MA6Bv2SSFn5e0dQ?T!ULhQJiG1C)M z)#zlW-KH8_RG(|{&2VPn{O{(Id}e(BZrReE-P8RamC7a zG8VV`PmOPJql)my(gD^|V!6QF#>U3l8cPOD1_vGDDDw63779Fvg@uj|j>m#DD}Vjw z9lLfNKXyW2bNbr#+dn@1Ut6?B5YMuw8$ws#IhZ*$kR-}toJ(-T=(B!ZU^BA)%QD^rApUHxDQQKZx0$T*;vG2I>M?BvKON$WAFJ7iJ> zBgEit*hf1dZ7~hWj5PZ&^f;jLvQWnZn*z>0Q?MkWP7$aqhLl?oAW$BNRGmvdm&R7} zVTLL-f>lMv)usCgh-#OJ1TvwvOk~2S=GCuCCmP6b8)ZQP?0Xr=ziinB1KhfpTiP&_-Jwrg>YWa#ecWtEjcv{En{;U^7V zu2D9Ca{$FTky{eVrNa#k`U|xvNnTm_#X;S~mE0fg^9;7@3h0l6e@a({T{;z z$5Xk_d)(F%4#9zwu$i>&gYm1J?&eSif~LnO#DyuBN&q|=!&C_&V0@w%K-pafa~=_J*|;RkVb<7$(31#y_T-ZMUeUWlo1Z0!g| z`P16k1?+M?kz5FOvLBWVpl9GA3VkWFAoNmx{>1TRFC%l5{?tV*by@d$>N3_@yd1W6 z5EN!4YJ;&x>xp>6Q}$U;Y_o_u*cWcoopk&#tbqN;o zKdJ5%TUYeg2cZ|ICJI|Btl@3{Su4uIdt2fJP^)szG-41t-AlmM%11!_^}RZ=0CUey zpI9Xa#EN6BAM<0!Y|Misf@D_qQDLy3-yv$k@qaE_tSV{x>yM%c@7$|%y*|dy-fzqI ze(=r1poxnWOOs@}z3W_~yw4r88}aJ5ua%8;W<9v@n|R`+w_{VatM+b;5-)qtYvi0u zuY7f^>En#Quc?|3mjiDOxIAMadgjKOKh&pwuUPrnu2N0t`|ljH`oI$|+O+Y_IeSls zXInhj|B7}ZE7&4)==u$(^6G!R@aLsM`LVyo+2#9e(MnR>zIuJ&L7$J-&Tt7?_(tez z-r{#$KaH-vJR^Ag7tV{_sQNS&3!dd8ty|G_KPlu=Y|-k?pnlsvk0>j3eX6;{Z23j+ z71e9}X8}ux246%L?ELcVO|zXB11*A&VE-f{8cw_O=#QUotl9oaW;PcnInYd1LL&+F10n%&XC*JAb*uh{6o$d$OBQ?dv6o~FYp&w>^tE;mq0mje~pmI?V z+Xvrs$EWou)KdmIPGdkQ%tsL4bu&ULTTaFtD82vBgQlu~PK9ST`XEC*18;u7r#y@Z zZ~W6~I>R@Vu4!4>GUT;;G{GRe`q`KJ^Mqd5&jg#H{^dRlnZg9xf^ak&0N384768Spbp-@dIy_$0HR3H={JafT7#$R(0ln-=YDA5>hV$ z$JN#Xj2!$x?@MNd5P%^vfmspu3!aFU?LHGcbqjQW5)s`NGc92QVLSQVSXD!y8-j+Q z(x84xN7N8iN8ntm>=Ni$HhP(j`y=IAaXQ7Cdw|>!DL9$tO-GeWkr-4!p)^`?PO}fwW`{a z&M0SR@lUtxS8p1BdD_Xs$wjbKt~SLB(4ZVW)Sw4V$&;IN*73efsD~ z$%!j20yMzeY472;{wTFMyDl)%_ou{l`4jyXJovweF=vL(Uw_@_{i=u4&mK~hzWw8M zj??aK-{1TGhSi$5kw+F^P%l2acHVX1@_~h?=1-qCc+ODQpK6Zp*pYS7<=m!YDbCQi7FB0jd|&K!?46-@aZ47vG*5W@?Z{05Gw)vb1zA7s zUHY(*PU$ypxChMmeDlYPPUoNB=vSHe>pkH+j~;2x-o5kF2d^%)m0fhvSclH|+|g{n zD$S#klb@{jUbpLwkLI6RIaokNliwK-K78(-jYkse<8_Xx@+@$(Dq+wcf6VZhd~Cjz zZ2l|x=Qh9ESdnq_+c(r?O2 ze?2gE(%~6{;w%Hda%|~c3;?ujvCH>(RfH&k+h^)vKM`@dR@g7JF|o_-{r$*)(Fn3Q z5s9LGMRYH-&mvkRB(ARMSN#(13k@K2 zZ&knDsd8g%s^yjo7jr=A?7rCU7-DjG-0!0)u(L%GrttTf**=Sd0JgZpmO}cZcNE6uJo@!6V;jk95qh3ER7UY`=uFb=&d8MB5F5Ph3g#k-H*P5dviu z_@%OhTus-|igh%RhN=!_a@U`B8w#NE2pUDqpfFrd!Y4zAfpoY_sx|8DG9uHCVGAkXAaG?`(S&fORKGqK0K`yX zMLj&1587Sh#}h|;)%hxliD1B!TbEi*L zReo};V)xeK_1cVOi{>Q6MMp?q^AkFAcphG&z{r?MiF4n2KWFU+AMQDPyr%lh=U;qz z^{cP1f7{s9)O6#r>lwc>G_B8N#j~xJnFVxott4z*B{PLy zok!}9XKwcmePa2|n=$hV2U7cn3hvsqj;jx?@lpc-lr1GYhyj2x*YQ&ixfB3h2QMNGFcdRBfpp1=BrW2}uP6XvP-wGlU*n#RWN?dmRtJU)QZo)ZA7)Ntbj8w;^UfQel>dBPn+96=R+PN;usdwn8$D&w30 zW7-icC$wDzz!_x;Kk`#Q@xRcoU2{UTP5l@KS_z-bOh3u^5cp!n^4g?Wt=2}VPn{b} zjSaHV24#otCGqkx^y*YDCz9+SdaYVLQJin<7?@(w0DM5=1lyD+=7$Ot`G_F8Kpzuw zv)D3k8d&LcNq~k40MC3fG9l9geMb

  • Wojniusz, S., Callens, N., Sütterlin, S., Andersson, S., De Schepper, J., Gies, I., Vanbesien, J., De Waele, K., Van Aken, S., Craen, M., Vögele, C., Cools, M., & Haraldsen, I. R. (2016). Cognitive, Emotional, and Psychosocial Functioning of Girls Treated with Pharmacological Puberty Blockage for Idiopathic Central Precocious Puberty. Frontiers in Psychology, 7, 1053. [DOI:10.3389/fpsyg.2016.01053]
  • Zaiem, F., Alahdab, F., Al Nofal, A., Murad, M. H., & Javed, A. (2017). Oral Versus Transdermal Estrogen In Turner Syndrome: A Systematic Review And Meta-Analysis. Endocrine Practice, 23(4), 408–421. [DOI:10.4158/ep161622.or]
  • Zuger, B. (1978). Effeminate behavior present in boys from childhood: ten additional years of follow-up. Comprehensive Psychiatry, 19(4), 363–369. [DOI:10.1016/0010-440x(78)90019-6]
    • -]]>{"first_name"=>"Mitzi", "author-link"=>"/about/#mitzi", "articles-link"=>"/articles-by-author/mitzi/", "email"=>"mitzi@transfemscience.org"}mitzi@transfemscience.orgAn Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters2021-07-16T12:00:00-07:002023-04-12T00:00:00-07:00https://transfemscience.org/articles/injectable-e2-simulator-releaseAn Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters

    (3GAvI6IRZy>vwqF?hJCAFl6@5a6*1ZeSMcbn8>kway{*-gj=j2Jd!3u*Xi<#AWHS+NQRY>b z@IOS-XdJsY%Fe6EGuq19g{!GdgD@4*L{t!^qySi+Z}$3Px5Ueu@iTUam3!ci52XWR z_V*%3h&emzjWejSrOcqBHT17ewKWZBBi=UdbM5u9wg$si6rCq%O)<1hb{36b{j~~+ zW&Z#Qv$|3r?!)2j=^_yjbEz%@amez=KK*fPele!}Llta{z#hO5 z0VnH@or=o`E@B8Eb?!y}Lg-+~kp|%Flb3m0PvG?}9$TSwre8srC44!4TT4ilaf_tF z71_B+;>O*vOQ8JXcO}G&*q0L*14%{IrdZ++G0Wt)l40?~NS_gOPO8%5GJ`G|tqhdr zx~MmkPB>#Dg#_4Jw@ed;#(F#R9f&^90=TJ2)M)~ABHg357D45o1vGIiCNGFx4{Bvt zeF;%0TMjRDz439W#i+LDd;aUc_A-!qB~SnX))D>pOljRv&x|Kpzk@0%PWrEiO%|ka zVM|a!zj8KlfrlBQPx&wMOYcRk$^Hyy>!h#nKa{i#wSGS7AC;M--6cH@OFfl?5Tqr8 zdtV%mHAYTfSOWm`v8CtlTOtP!#5ieEBy7R)hdP7JZT3l1O;eQQ{{SgeYN_L(rlpFY zDFS7uj6vqufJOG=sM?~lLxGuT6STDDx6Mt3Gfa?m&Rl@369B(JK)py6!4KBV}=7vBY9 zH*5SF&(~gRz7cdZsVmL#1xe~4A1_ANllc+N`R$2m@j4{x-+-d<}+s3FddeoO3-8TSTl z+gpow`{F_+a2*L!$nEH8%AgpLq>Cur2CMlel_iWQAC-EcU z^TNLnHFkBV^*4^WZkx<&Ts=ly^ldbeFi@5)xPM0%JRcFMkPNam>eW6)W&B@;H>V^U zpTnZxtU`oG@PXiT*T2OEOgr1;i2eoo`{9V<6$i!qiodFno)*^|lRcGi{{XJK#qgWp zT`Lm56PaPZ54SHQf%LQEhhyp+<@}1jpdu;o*3+0S{x=W$N-+2}p}Y|ADziDQ%Y1yx zbD47rUzOP`5>xF`+sWXY@(0`V!mNKui~>O!XG(PrvCJMy$-x@j6oK)h*2K^{PSQD} zs(7d2%A&mfBIL);C-Bs6KXN;E!U2Rk=Kd-F0H7;@$21!j{{R@l=4Bvn6Ff1FPgjZg zP#l0+$rkEBusr)?!GU)te-!oGxR7YLZT|qOv-E_~KZ~9gM9=24H0HL`dahcDbnbHwXGV!{HYF+Q7U7YA zV1E5@HD($PgFYe=)Z8mJLxk@HA99tfhN0X^={qi#@9&6#E;nAA3naA0C>GwNklckm z&LM5LUDO2kZoRcl>SJ#x`fN!~qTG|;+TAMdcb zwI)?mD;Uj7lw@+&#}&X4k2)VTvuzhEv3C7$#m0{mhBc%BZxY$VnQ#kf12SGc&wj`BIECIad3aXV{U8b@aJ;^ z;9kEwe)d+N_)?iw9+t^yG8d^iW>-lS4H&DWdP)44Yyo(r^(iLjk>3?YRnA>5G92J! zMbB89NWN`}RufMs76UK_$2Of_&PXNkap5kE@qbTg=rvYzo#lfptdeS4oRcb(Gn71_ zD+h)zRlOq3ZaKq_ACBl;1;{OQ*cRF~mp7fY-7CgmeIi|LwSHeCDvi_pDR?ag^CyWO zB0CXc$)l@KfzzA7N$+lO?bz)y<%s?5q<@11xNzwCKgUPrFYomwcrRX-Ul4ppXvYV3 zkgPZN0`LrSc!pn-{98x(d0qS-e+T&K{KRtjZtyR{-wHLxU8uC~eXR2=-V~OelxG@t zqK1(YWiiMaNfAfkC--4T65?hXa0YQXX@X9pYNiG6VvfS#Pgp}twEpXHq0=ax7L`-Q zEENbg5BR_3!~XzLCxhW5!H5^< zpv*j2b0*~onIwK`+%0422Hn3rNO<)>R&N^QW?e`1LZ@#BBK=Pq@8usOwP=sSmY&mk zJ3`XweI*8W23MC4PxwkgOiNAC- z$ueU903|Lw5Q}~9_~#!X2_%0A{swxT{66tOXYq_kKjZ29u*u^ z=fl5;-wHGytJC_2C-C>hcrywL$Y-Rfu1Y4R62^Bamv13B=K$mQ%_q`u4>OdI*0-!+ zgKsr98-_lc=c&r|2=%SLt5fHY&3dOmT2Le+!=o+iMZmqkmMboHYuZjz07jyG{j!|3 zunT!eJgsjfpI$ipJ@|jFb*^`xX1*MFjhg0JipKSInsTa!9J-*aYQOC7zTrRw9zC&S zz;RYnWK=LgKNP#%3?$gD9^!hXfMpxO-&=$rhv8SkQ?gI)N8=ECYyj5fp@1E@eh0U| zI5*+y8chEHV{rV$FyWO4#%TT-@_On1rB4f0uD%X<#%+FoNM+slJs$SwpSCAFYJuNC zZPB>?WtYPPQK#2#qvN~vmDBiV(RydYtb;kobe5OY*$p(ce>GPIr!hRz)DdGOZ3!qr zP%m$#@m0lR#v-9DE;82M*>}9@ zSpn#W_I}vynDSaWz?d3;kt+juZem~!Oh}*b=KF&1JSXtBp`>Q;3&c4Pl047SaTQ&@ z*6V-ak3BfY_vQZI)R#wxxu+~Qx2yjE#uWF$?K`D(4to_=neca3WR(>t^#1^)Gb-5U zr;Qrhi=NiNIE+K8fiBGx0{&E!j1Cu~C9oSYBnZ-ft2>_}tOPO5OHu`{P?g*dQOVuy zZr`2~fM?F$TMp65Sc`!ihLQID3a8e1RpC6Gn8PW-*Y98A&G!U|_($O5yGIYhPPJ)66eINFg;U#} z_?Yo>KXm+~W(j`B`R;rbNAgxY*7B)Z8xWLsoqv}M| z-(1eOZ}-XaQ`6x2XDe6)ZAf|6D$VH=m%c|wPnYTXoPw5?F$6h$^&WhXFJ<4}*sHzb zp*Nnfypuh*4Oc33jS$fz)fzN6+@qc;={$>8Ww~rxgF)2l^`(@&6m+?Wp_nnSC(I;Y zpyR!;#|4RX2LKFC_wofV;y6Kxrrilu=Md4{J$A^pY3H;{t6K=(b>^6`D5=+FX5JgNS-ME7ISMb-to<9c- zWa4~>BOQ?4C=G)}NL`_(@(euZEosFD(dl8?g{UQbJKSMT2dHO9wZ zW$bz0$?0f=9K6QbD#e+2Wu~XD%wDVEs-rkrCT4o{)X5W7F*h=KMb~d%&kZPIjzQLl z8cjhL>;+e`m^QiY(&u_q`F0Sz9}9G1BQW?=swOnt1L{c0?cdGBzLxXx7S&fwE7b)qenE~3em=9LLEk^g5FWJuB{=t_s0gWN%8!1RP#pBq0#C=A2Cz*jG(q&hfhXei%w8Gp`4R1)Ko9x{K95Z4m!alDg0)o7vBZnNQ+-EU%M*E(iB zT^3!tMMJC26tX;2GS`YU49ZoQxgz`@;fXMnUL63D&L_zWjilE$@!|pZf`(1ugljy> zOYpgrHkfVG}-Nrr0VXkudOjr>X!R;1O*LN*y+NY^~{TdFyTuOehBA8(lUc06l`s zK0Z0)FP>;ZkGpj>WzYD^>;7C_xJUQfyNA6{KIja+z31Ge{{RH>nKYM+(MX`iDsqeHkGYyPZrc@l!F|`)VHu}Up@Zx;_MsN1_(jv%)GJStYfQ%|i5Gk{ znV?##bqA%&uwm1%II7nBmKw0hT756Na^LUBi$-~2_O{3?Q}CDKc9T<6L-JaNoyjVh zbxr1F7B}+cQTYySik>%vRAkG1RjUcd=~Re1_J^ImFmT=y=lrJ&C!>#``Bc03hy zvP4M(sB{G_$2YfZQYzs(DKRBmX<}PfMIjoBhbqgn%6RIMx+;i3SAoOX$oxDpx9%7b zw4CAz5Ttc%mO))5QI7CN}7<0|k&RH90LfcatlJa@l6E#DP7xH89_&}VZu?6P9qT#F%hh#Ib=S7!CK z`hK6wj(FB8T&y~Jik-&gxZK_Qae`=2Wf24c8n{h?)LjEsp>hQ0`TW{4o}~tzY_?hC zG1R2dlw^^H;zr&NUZV~v(G`g6W*c{Gfh9y>%4W}KW1lc4HIZD$B9pZL07Q^_^ua~l z8HV;Rfkl4-a}485txYv#9PzDNNIe#x?N&+o;amKCs;K1pBy(4+dX>vA0a zo}(+0X+C*Sw8`pKC*Is~e%R0O!L?Zq8X}8`Jk_}H@R55ih)B09y^H6F{F-4m}1x}uHX(DIX`(+navvNUOk#0D| zV+!X-X*cHs`O#f6YSG$4OoFpi=Fny|j4A8X)yB?MqLf6c5MQq0&mQ>Y&U2d65tI?_ zKg_ug`cMuC|pqk!$qOi5K`q7H8R9jo?n`k zxGGj6K>Wz(1J(YwTM11ne-`-@`bhGdBvKuPKt zDUUB&+WL8xa<4-l;%i;E4&UX(uOWta*>DDAOv&`tL7Bc+o0Dl0%dieEqlE2MRS>jR4pJ9R6-;}1y2x*^a{KB%T38`|bs3c;}<`ud|ymk9w zl`7$?2MA7H9pu$?xz#*gX-Y_E6MnOh^52V(d-56mi(Z#-%PNbaB;sXe{^!xcJC%s?hDsv*`3KB)E0et%f9e5*scpcDaDak1nduW!p2 zA4L?zO!ZCuiFBiGP2xQ?wE4o#K`ko6#Th08aR-gU-(!T8FeK%JGBoa97s7_jXA)OZ z$Cw%DGbnbTW9vq8J9q1Y@`nIRZrl48!OF;ZQ1umbb#xHsLK75G$4?nN$P(*vJ90mc z5o2IFbeoi044{vR^p*74g(P{#TqBe_m7M`Qtatf?mXJhmP!et9` z?-eyHz9LX-ocl4CInAoSylZ5Y*6RYf@|m^;Q?~qBMX!VFvoj*%2zVz_NHRUjN(Kth ze+Feba-UOXR62qv8mBUzvOx0se_Dtyx4$6q-xPOMaUu>v$hSDn`c;wyO0IgJGR!Ba z&GSn62hKrLB#hu(Jvwr%f1}jcV2UI^C>lEF@ubRIQB_SU`G##(o!7q8M_lB`C9l!1 zVeR$Bwy>T2R6U#@q?(;crg2}AuAcZPI;BkrhQQp)5jcVWPB)%K-#U2 z9MBv~bzL+iz8=d_ka)Y{q!lp6^it=vZ%s0v!m|+=U-)j*R^s@LqV)d&h{>Dj{YgzMxonjV(yTQtO3Gq(vw6x_X!qn|mfD$Lo-Wro?X-NL zLb)-dvfmki5r56PZqgbfPWWw?#gXaCS)$7zyT&D|YR4u{OL?r#aC>ra1|qI^7ad)F zzcc`irU(EXfB;_6_}5aX>)>IwK;RR>w@e4pjlwK6?3{A?%5+(GZjg?E4%j}8MuBrG zDvc>rj|c&jxf@Bg%UcpT<6T#cX-UkhBB&9*@3uM43hEaLW*2L#s{z5bB5_hQCNG$c zQAmx8Zm|S?dfmY$HktG$+g4iNposRXObD_+7d!8fD3|vjog9u{P5|x z$6>*9Nb5A_p9qg>M_@2wthK|`dtBc8ro6tkDs&38?u`nF)-tB*ig*_!^cYb>w)Z9m zs^a!$HapLb>(*y3U0qDjW>mtWnrTFG$0^$zEBXqtxa)s>H>EXn7Z6a@ni$hOl0WVv z;iXJN$?)?eC|EEn=5Dw9Zfuv9}R890PlkZ?|9Lftu;l-5<3U zSv&5cEkUF6$*Sed=rRc_yv>dC^%Np@Bl<}(4aOK#!?^AAk?tV@TNO=)3-7&w_kz3B z>5U4D8YZ97>dkO>RAtIbeF1yl{jcZS1oRGe-<0pyLJU<9Ztm`@e^q&0lR(gHN6Yk# z17(K!veX-gUSxhxzB%-FjlP#3GP-s$kofleQRD*WlCDQfQ#DROMUn;DRgO&5t_`~H zG~})S0MCS#+UC^j4LkhPEIXM|okMQuPkHT4I_1@J)x{dqs)mu9ZpB`gZr10U0Eu$tz4{KP61NXjY`OSei+(ZjN>fz$b4LuXQBk9;2?1VO2T~7m7oN7q z)o9fKz`yO~e`1B)PL)e$i>p`R1$`&>qnAEWOplkjm8pD}Mu@4E_jzP-w{`7`z7_At zbGG^2_Pzb7Rxq}!^8=^~Z(o=ic&Dn&mY$xD6x}qnE{h5$?QbpV+iTwVV8HjfGLIA~ z%F(XLhM!aTX&Nl>=Xxz8nN_bG)IP9pVhQWU8XO~{3tQ|5-jWPZ8`So~@g}eEz7{53 zL8BC&{&fjIow3t!j`=L{VDeu2d~Z|drs}^CJS@xMGS8_rY*7YKKVL}4a~my{dA;}_ zd_!J|V`R0FzFKZ3H?wc-_bFSBFSOM5$|8!YqZ)a1Q4}G3wi0bnt!r%^En|K?@U&HQ zNNal_mWbNg4%qR!WEj$YZ=zH~P;0#}rE4fDHI8eN>>pQi*L$t+F_I2Vg$ zXM=yZK^`F9bv}3Vh2gw+@VY(gCy3fwGN!=%RIEe$~!Hn6M8QkgL0;?Z?+1 zg6)^UwRD;qsS7Hqf>aW3>HM+X*OJh`nmXAeVv$8)2Rn~JYxD=bvG-YfnW0y$Pvb9x z8aq0u%Jr^KmPwscGc40pWir$-SpaRPVsp3=&ue1Wh2gbc*&F^DZ@7t6ZX?9#QmR9Z z`+@g@qmp>z@Wk&Qm6B=bxi?{u)i++pcozJyXTjC})gFI2C}$bNi^x6fXX+%2Xtj#H!`QJtgYB80kgPq&dM@Y7C6 zNKhthy#s8u$D|Y3;Tv(4K+{{!dY7K}_A5xh(-zGUZ&khj04KG7K1Zh|Xk$JaWCX2< zf6?i0+WBl3c+G>yBR>&=JsPj9c~j)`#6JXbK&&%q=~a~Y&j z1hnuEIBvS{@6X@ukCvc)d2y8lw}!^AbW8SIOuRnqjg+&5pO21hx;IY2*>J+#Td!G%KnSZ2VR!_O|S2M z*z9m>!sC(n*?z~daCnP1Xw+z|c1x(6SmiWX=2cluTbJf>dGysFI{DF_k|}<6p2EYB zaZ-D#XnB!#<#oCFc&kGTHq=MbhW;pc-KTyWDe{cZSZ6JlQs%NvPfs*d@=Q#TpmTWQ z1*|SEezvTKLK`cok#--c>f1x$}n+6tMeYGQ{e znpH_*a*Uyu)6^cAveMyIoZnejs$(gWpz)s|Q#*fTqrj-i4XiV%tSs-jn?idxEZ42;owSZpNz9tJA)So&{pG6?4z z-{O)tPjK&Jn%z3XHK%e${mbu)J}YGY2x-OD+N!#GY_2+}DIQu%aWtXkCug9Mf5LiT zydD;%eF?uW+7wudtfylGypTSCRdj#sj`$iQjoVn~j7S$%$;lwta!GrB>^t}pqqQ!# zWd3?oactPq@N@qFQFf2}A^rvJR{rQ2!6e+N$&LQT&xnr(s4bb%y`%HjLm1EMe?9*I zsGoGl$4`X1{{T6l(>ixm=CxUlYdTWW#U@r_jir-?48)$N0%CY|S`01)41)GU*UhMN5|a#AL{U*3ZAPk&8wXg;aZWAa-x`gp#&8ocvE5)ARzM z(tl*Tz~$s>JwnW_&}BB`{x^eu1F7=e_VFk~k6``p^8WxpTx9;qUxHR8Gwn+tVhP)o zfNoDfOn`L1TzON2REs^`w*uShLY27oa;NNh@+!diGvl^P@e`3%>TNAim^B3*SI9T% zD3K)+>{sAM>^V|ByJEkI!qlMh*AvwOB!gqzPbAk3QI!CI+s~>9)4UF97x9#?z5)1- z=3AH|ppe^x=&Xp4KI09zJ9C{zyY~@qYJ(eCQ|o>Uyp;kU9~u%spE3Qilj+=oI7%o2 z$7nNjztCW&a0j$TcY9-UeAD0Pnu~3ec+-#Cy-V@+;p~jc7gR_G;RnkLZ=$T<&mA5F z@0RbLqaSq?en{}AD39S!#V(rhzdwsiWVBh#HAWd~1huapk`fgx*Hm^Rw_F2^;g6uu zONqYbb}7dW<23PZaA=IJF7-0*8{_LErcV^LwGc$CwvmslpG~d0{{YVw$`a_l(e#yT zsT9X#c@NO2%lvTUc~y36M_H5R@|bGpgLXC zkjqY63DIzy{4`% zj!^@L+qe+KA8a(haPLe26Qu76XB6T?hqo}B+Re@8Ap)1eDOev+p?7kpJ|&l$B&S*5aFA(&vPgt_X6(eWnH3QoV@w^z}o18js2D7SX z!+8Gyr97~LI;7s18h3ZAGfX8i!%H6G^2x9>8-T@+(Ek9N2^tCN&V+?;aRf=zEa@7b z=2XKt_~6r8cQDOznvD~gR8&yaO9M*h z9GQCNCPrF$8`mDf6n;ms`W#cMVLB%{vJ5!rv`juPrfXde64C2wq8>JQzMceSd3Jd= zpKR6&%Ab`H{Kt|OO@+bTwDN3!b{lZs7%>iw60R}DJqekhnQ#{ERkQtGSrj5y9v)VF z%ef)iyZ}e^NGZt0fN%6K`F8i#gZIRFk8UycMY5qU5(J*;@Gn!U62Kj@6KiZ9) zeR1jFH1(0<IE8H$kJP$_Xti)HPw9RR<(86&ztd6XBwR z0R(!(Ln_(9c;}|Lwas+pof-wZm9_|pBgiBd4`nyFDi2Zg#bk*j_LXBMK+|Jx)t;Xm zL?(Tqzy`@jSoilPP(QC1P824SyNA6|KIjD0Z;!c2ehTt!W2*Fris9M*5e_**!I2h(|g=RxrUu<}+)4+8!x zVqhZDx>6=2Hva&fQa*y<5yw3}@ppIKyg(zySeG||{{R%VGsx|b zX!KVn^;6fhktP2Cq7^u{IUje90@V5MKc1z3_n+b4CC?X&We_8jGun`khChk;o=GE* zMuuw^En6c1J(O(pkLUSgr~Tj5kMF;?&q7lE^L!&tuJ+I7B@%o!d`qm#Wu(!|Ozwhq zf_9o{OzsVn_tokS}a<{{XxCvppZ%=dP*$0C~m}dA~pLi`V*>z9OlsDjzF4 zPOg?Gc06-N*6zotJuMnAmQ3r*9R-@+0+I;pmA zg`bKEqk$9qOoT;nPtM59+~1S4w{L7j@4Nb-+LzJ~z3OKF0C~m`Sdw+nN9Hbr;YZ?* zJAZxXz`T%+S0P?{l0372>c=PU{;|JB^?zM*-|suY+t#%GKfp@pz7>8a;egZrme89+ z8461*k}*GjC$>C4ca>acCY_*ro~38^pW$hYqc!^h_px+eh5rDG1d2uZ-2%kjfG*_y zmhp>YgZFz_{7L>7_@G{YKp0VIJ}htYWg(N{kK&mjVk&erTfn-Bh%7JljPdrz&ilQq zyFV-ZReV0+Fr#ze#{U2$o}~C@_@}2|DxWgYQz1ciMP=GZ{5NRFBiv#W_i&FEW=t;ZaCz42YB#?%tg z0C#WPiF-?V+nS~o(ZQC`$kp2;nr8HsHuW$T0~0WkWM~v5+UfrQ!MR^cRmmXE*DjEU zEM@_cKzmsC{{Su`$2X-Osdr%at{C`J$?Njkn(6fd8kBk@l3-cF#AHx*vZ(hs5HNrl z0M6shd}=0~v&CtAO3Lb|)wzhMl9AD&6P`9H93Q7lNN`??=w_r{Lh6#DS+09oo=rV{ z5fu4(1{jeR)b~r5BkFj;Or|M_I_|q`l%q#@pH-3Mv@^p_nTN=iiDP~MUB$Tl=K$g` zVymFqQOv0bv7@|4)jlIv2g~y4Okl5>1Yie6?m<4-Pm00P!j7|%Om=1c;to%$wCQ@o zlGIS6PIpxy4z7#`79RNP309p^8MApWo(g2qdA32BReXl5%O;wRp?tW?u~{RLje{zV zLFeu7g7Hj!F`Ai(`+GU4$7*iWf7&*g%GXuapGI4Hx_@4|bRcLV( z=dgq;*d>4e(V}{HSGUWyUqMeR{G#kHD8B;sKTJ_-VWi0_SxWVsd8Sj5<$17pCSRO} zW>u2xzFP+5cIOe$%I6lwp-Nq3N$|Teuhbg<08(d}#-O6gWvrx!WmQCkM>DUYIOHqp z3cX1Kfq^k}+tD?nXPe&Lw(~?%an0b5dW+$I#nj6)Y`Z(wS_dnGQCCuD5!BC}R7A3f zP)4Slc|68NfhV}Zn0z%dT4lkZrZW}*>C}$x)cq~2q1xX;>JJX-K6f$BG~RM2rjipT zpRH=o!U^OuF4OFJzdqPqR|p#D9bqKQgYHq6$W7h~cs;5ni+cPZg-cJDE~=;2zH2mf zCZ8mHzM_>-*`$?RlFPfJUdNnsS&a|sTe3;M`hbCO3a08a9ZqK*6*-w1+k9S97PF3u zZP88`(j+qeDgYr`4~5t!sMir>S)BC|)>YC?GuM2R)l<;=6}9&h_(8G4 ztZo<5gF{YHoL|7ADLW}$d}{F~zd6j(s;?tz8aS8=N#vrIk*Z@B9)FcE4xx$kh8;Vc zdrJ)lCv865)Fz~+?-4v@&oiAhN2jvQGmz6lV~r=RYITb;k#_|V2~Woehg zrA|$)bU4oPwbOJI(^X2%MVJY%7TW-*k%=w==aa?pR>k0*(l`>$N3Y$tpMrKV5EMJc zT|JrTnz;3)7IT!;p({;SmQxv5&4QqWe=pBPQp&e0)PZ~vLWlz^qVWW5N9{mWeBD%v zm!i#5q-6B3me5nq<~WgAy(&$`yMj6Pxj1bFq-N_AzjlZ@l@pIVpsk*VET>1y^7-Ym z&sYkDW7L3p2ILE3b4|irWV?{%vic^dClEanQEp>~L&m1!)WSUqN*T+KtlM75q`#K|0h0!(5?0`?>Gz5waVdixU* z_U5G&NJun^%V_m?hmz(MGAgE^%VUBtyGpp3Lb3NyZGXN#tC`KImwIM>iPizR9eL&WT!vE+_AjIT4C$xg&c9F)PQLbmERrz5y02(X8usWvw@J}S&lP(g_i zJ@)fe!}}j~(^mK&md!O`sAbLT;oBwH#*v8jDwF#@qHXVdeaESWS9xp+%OHLzUvTP% zr8Wb2WKVP6Je9#l+Nz)e#gA)ZuG3{;0u!EG?y=A4+CcsH!PH4JJ&GEDC5&YZOORE0 z#FrZA7a*>62_aQroFCaAUikUIp5@a>Na`b$AwhMzo42>q5IhwiB2;V1YwZ$T+;Q*E zPtO7)CI!_E{>V;SB)UUESH@+IqMtcrfudri%k2#v$9@IBJY9GbvX~;pl_$UhK_Vh@Fo z=i&mMI*$l-^s$x0--r?2ahU;LE8z zg>O*|$O|3cUNMVeNiHY9-d6d9cT{%;PX02o`g-X!jB+6oNGG(4#`|`UY-oRTjxAw5 z%8U0KP-fl@ur&iynV|E)1?#Pg0m}=fk~!RCr|;UdYW<#TS?N)A2X9GWr)}G}dwby@5X3q3oIeSlSzLHE z7P6psCcAmmEsBj>=Mda7r04`z3Tr`AINo~w)fe<6-B6-y1i)+>xPCe#w^^7e(N9|Kt(E>)6i*`P%= z30*@3OnL=nEI|AJ09Gj+ZlQ5&j-i4)PxCEH?sk}CGK~#GJ_GsHs_`-pJ3(v6q)=V* zind|cZ9w0`*jvM_>+AgK?+`M}X&hoxC3tk^T)!mUive6FK}pzDI%*)r_6>aTo7(aR5ty`pUVTg66Uyf zk9bAX!LinjkGQYWufuc@r-U9Gq;QB(VaY2;uOhr0BBm z5c1lHpjk@gwY4g)pn&MBYhS;p+Xy(;A=N0x+1d}~A0>bLnZq%)2^J-ezld6aB||(k zY~#@+D(b97$G=Ye;)|L<6(@0B~AY+;uq*je16Ya?%)QZzeIkMyLk|sj$TvgpqHxg4PQ%lg>)y z}&tivIvvmR^1E?}U)n82KmO z61;nU_&*qXip;#XPi1oo>1wH>MvhM{1%<~QIKwdMK?(Q!)0SnXGL_4umKqiPQiix* zOI!{y!`}#oD-rNJlTzjX01!SOy)-^YnU-gJ?0I6ea&Uis1ghfp89F(>=ORNQPvD=d z#k*Nc5t&kP&zQFQb8@IDz-KelME**!a1T(l3ZUFS0_8k!rf-OMp$9 zM`LUK@qKCPx4X=$i%rjekWonV{!=YKG!a}z7~McW!yTq{%8%3J*;O@XlGKP+M84g< zFNmr*f$c{$NboCez5!!1cm<{qk4$;CdJqGC1xdwYiw?Q(A62NF8-OwR2kX5x{{UoD zYj_8ltFHU!xiAWQUPu081#lB{-ctT5V2ca*gJ_$8 zy-kv3j;CcJ`Jmht;BkohO_agA!Y+I~K~BCdct<33sS7r!%Mi$-*BkmDz67jGnBmwy zvs9UbE=1Y?0N`(5q&&gh>!($Var4U3(fG*x)%bD zYpKVFP(=BJLVd3vn-<{W>$7;j9q_Xl;~oV$z_Tg)b6cVPjv}Ah2Z+!?5J+RzE@L2B zHnk*u2X2_F@i#~l@+te?nc;*~J@q}zMvsjObw3Z@DV5}kT0?%^RKW{@fOY`ZL$4ewRe8LEw%A)Ob`gO&q8=uB0JNEogoGY@Z>ExbRsp9uy7lChVMDu0y zHCA`v;+8o4PNi7ULQRq8Okbs}i^u1G;e>eMnW9dP{MReT1$JE4)rae|^sN}vksQie zdOCGj)rcGSej6?S0IL-I8J9$J`m0LCyQ2lf{iG~al1O3|$YMhv%&Wn0zmC;X3*$wY zkHv4eEG6bkza8ILr+SxS7xfC!TaZV7*e!}DG{R`3f-35YgDgrwjDxswwD3pn#C4r2 zYC&ojf-}7S8Tfqee9!g1akP$jtDRJRf`M#MIG~E2)v|Dd_pVxbp;yKm?$i1R7>Aa* z)B0FkT*Pntux)iiD9GXDU4BXQevU;6P=!j7=~abdrXUOEr}c z246_o%CP5*2~qz5Zvv0u?K$uExLT*+1jqZ6=uxwG%q2(--0YpLf44ZIaTjH%;mzmj zwQL+L=3`GLkF4}0_||o&)7mguUMh^*W@T}3u9WNt^TWOnJ#WN5^oNf+K>Ts_T(kO& ztwl>YNcN}zmKHa*EG5u>+?5T(?cfvrafm_8Y6;o_QGWgL8;q#h6@vIsi{-pSfgvc; zwpUhMFtYhPZ$ELxzdRx0QfZFIk2Q7RFbk*T{%~3#msTTSC|Oh=aMl<5;-?V@w0p|X zP3O4#)_weO$0*bqMVi|himl>4`zMY>W>qU z-(zKTFSUB^^9MNdi2<2}{EEL`nx<806ZrK0sasJ_3rGj30)G+fa!+5~fE(5^-}DlK z2kqig9G^L%&c0=+>ei+>WN2h)+Ul||Rs6B_I)bFZm|Z!gy6(HOxZJ_)6psAc>5k$Q zWXf;MGdc=d+G(-TMO{rQ%TG|NBr+lN zx*h=-lpNO@6$627j-f7wHr%4!IUd~Oriot!#g*roZgE#%LqSxMO_%XHFI2ty{rUaa zjg>=*18DkZ^e)`OE_Y5*!i*o0xDq%Q^(3OM}u#HUrlO*HY+y+ur{78s%|#kv4GoOx-JqV^`quO-fC z^&KNuWzwZZGdn1C7Z)8yBBt=|G+n)=rs-_a?1D>JSy=S?bjMH8a@|x@PwJeawxnec z)Tyt6KQ-V#jZ~A*=YgqKYm5am>5+6ns6eY_TkSucxIEy;H4GPuRR&XGYk_O@>yH41 z@hcgBvYA-f7P|1lsy8a%p|dq6*A_C41}u1XXJH-QYO{zpD=sp;&T5LJ%f4AF>Z;~c zfnAsJ$o55D?5Yj;xjpbtM>iHgXPY7(r_s9C!|IVqt2B*vPb_XBKRHDtafv!?S&I2j zatRh@z593Yuxw>S;|e92=e5-35e3q9B3NwPUysQBI%Ag88uCyVsGdzjlF3me1w~^* zB_I{Gti=BSje;CpM1|f`>!Rf~Mt78g5~t$Q?rpKZ}H*%7A>0k-HzP#!ZAXA&`DU~*WB&mj(@anfv zWx}&fM=X)nS4gnWPTO7M0__>w_*f33wij2$ibg6$hT?9BV_(@MfvsE=!EE7pjwd1Ie{;+N*fW5gGhlz(4 zfF=&H;Girfx|<9pNk{ulv8TuRENgT7b$ffa3Rw) zQBgrlB-Hnb6-@sCux_i@oBgkex;(;471b0QBF@rGfzvamN_prizF{gtlOQB)3JCYN zI2x-my4$WMP~MYMDXp%WdeX7V3q>ItS8d2VzaM-Z(OSWBu6KkUCT5g6J6CB;wz9IB zX36VnBdyE)$iv8~xmV0zP5Sihd@e5No!&>iGH8IRY<5#30iyMcf?j>ukwt$D#+haSJdg)Bg>YbDi5+) zqaj3-GkRJ;I3)JM_m{E(oi_V+sl!68e-R!EYO|c>FQv5gbIY8qO=D1&K~S>!j2y7( zcKk&28;8CK!?-Z@$rGfd)tkvzEaqK7p|shXG^DM|V`{-mEH$Xe#$W}(Ez2PH9-nUb zBvWlyz`4{QW>*}RhFv=pIjj;xQ$;M^Z1ObUfS#cTwm5sbLzhEvywGMISdmg)xZ^HKPLRjTNvugkK? zUN@zYjME3Gi3AdF0BsxFr#*0X5uTFZUA(B=GOCl8=Crvi(9}sJGBYGh`y2IvTFgM* z&jkIwvGqzvHc_BHMMIb(mw>)0Y8p*@pZ@@BHPs0XeR4o#ibPgwHC3|7>0_}ZB#;L^ zJL9oKE?(pBT$ipt6q=rF*HUIiqN2Mu&NBF;rm4&&jwGY0Sf9*_I&iIaWny_{TXYw( zu`H#bCenj_XtERdhnF0)NojpwoC=C+%<3>z+>M`%t8h93MTgWJMMZ=X#@tCh{4%_v<6bd~d%;PRSu?Xi>fn`TEUbvSo%D!7sRy?_1 z&q?|^nyj?7DNzZxmmG=);w~;vUNB8MMdlbf!&}Xe&Os^jT|t=CQ%osj%j0s)iE*{m zn|iPNSYRo!fR9_4?NOuGg_<^pUS<^(+0JVWQ{{-0evg?!E}^$vk*@Kg{-xxNRf!|FKtmgc7EfZazt z6Y+P$toK@ISnD#nimcHy2$qsa)Vx&hA=(+i{CED3?AW(#1CHVK=`qGYWH&H8vken0 z6?Qq`4Q{qmRZ_gUF1U#lw2hMIX&%B@vH59vuCtRGeILA@;u{8UE_qFTlRBF5js zD(8TkBe1t4uUlfe{?2E~I{`Z6?E7j>fdtzA-EeLl#t(;@j<()DOQ5;Bgg%=aoOo`z ziCH*#n(es8S@H%tf4-lm;;etw0V?C7niwZG z6z#vrak#1|BwQbB8+&5;MbP6UYVAlHo@*ShhIwvmj@xP35?42+5Jr-G$Si<>X(sD# zZ|J}V`?p_|)L5YT9am}c6LwiF(n&tdvaWF^(120QRnG38gY*2c8;fmrYrBUd$sdBE z{KKmKc4F0Bf=X7P$sQMJnJHpMCg6v+s1+bu-7%I`qzjC0PV>6kaP-bl4!~^+ul!q5 zSJWnrtftGRsg9V``OO4PDI3%UxKMqLF1!k}Sklr!Hi;m6)hq6jgWnDSmdTg|=+np* zRC4+p&N``2=xorTKxGW<7Wx&0@I`WmXIPv)>wP}R#V zT#{vVF~=Gh$Xk|-b!&6l*jbM)Z8s7@lE{J&#_UfxTOMiv0RkN|2-x!hYP}MVne$;n zStTs|llx_lEC=p5s8MjuAZSn5T3efFKO{lhL8{6>AGF4#%sfW%4z`C&=F-QQSH(0E zLzYy|j~IvpwW3BCzfi6m#=##OQyZ+u9ffmhxR8BXa6lv;uVNGCS|?OhWmPdQkkkt7 zfCM=$XkYl(mBtQZ;Of}ltdzNyHg(6yK58$dyfxN&RBVr-^VX2H)C``nuWoq#RyxE1 zQPwSv`Pm7Crdrq`+wB{LqTdJ^R&S8xy2770$m_D1>#L~hDVDmHN_J$8b~iF2+SVN} zd*YME2+SG?Cm_?jtuuksBAl56JGJf##p{}Sy6q#YDCsGrnx?BRsfH+{Qd&u6U8<@F zCj9p23vef*a3`J9++9AAq&Iy%g=6(6g?=QhEj=&yI@D%Lbp!QzEn(p};D~H~_c+m9 z;Nu{OJk~lWI0%c4eWg1?;SY&&#S#w<^)cAQda_!}^Y@D!7lxaW;EHY)-(m;6h3<#J zZxs~OhCVW#{x@c#fP&0}g>>I|Nenyv{HtH&}einYMxarVY_QY4UM8kI<~7Bw73z3HVQ zWXRdO&W!`fC-{cQvn@;EM~Jy5Q$a3cndUh})bw<)A$ca1oh*u@sURDDu;+%<6y6Eu zIr$+mVnwZI{YNY%qxgUEmYyuN4}ima|T3@WXR{S&g-I&nV zP{rWxrdFx))g+RH*+^i=b^CBR?T%STqanoEvVXqbb|a9DSH-42DE`Y!nEWOBD9Gt$ zp~>{!H9%#Wmnh3A=ZyZuu+t(spQvRx&gu~Cq-Yw!za!7RSn%>EPhI+cG2}|muk3|* zL$172%zP@Y(OO!&KWwTz(mL4a5m}-$G$l9gBEhz|{AA+g!)vwF@@_zj6QMkT=BwDM zCq8RZoVC!mTgXOS3P8 zUmkN6D+hzw+Jd`(TRj@`KJxU(t)O=&!LR*Q_F?v`OZAaI!Ec8D02ur})sW}9m&0t= zE6VBe>Zm8EXQq{7+^XBijzj4iIl^u;Nc1+74{NRn^+Sf>e5G~!oW-46B$@Md^+uOES+YHsND_xYBrTC8CgR?a5=DV~4t)AiFaM zeDB=HAlrXqQ{oDxna+%XZb`AuGU3<$EMc(5v|1c}o@%~$RGH~1kK;V4CA2@-&iH^1 zf8VP}hQtDMoWJ^~IEt=0v7^5y^@8r73dw$!pZ4G6m7@4z_(1Vz!0NqEHmt}ZrK8NK z7Mdr9wwkGo!cfXK!tG#t-rr96t8wBnEg3=T&au35Cz8AU%ZA{b;ODf=MqK{@h4Pr* zdrGzgO6Q=ZJ7w(7BLrNnjfX+>7sWtQa0^E`s%G=L@-%j$o*>Oehf6Q zp5t)u?~Xk_k+?SedOmekag@olx8_&!Vs5DZ$A^uT%RQvhZw*{*h0{M)QE++_)c*hs zb?}WQL%9%rd_Kf~RZ_Z+g#0F0jNnxNcl^2UFSHo8c)MQ@oL}8Z-^S5+BSLE{E&W? zMRNZDfFB%b;;D_N(q$!YF`e_oA(-_XeSPqG#?u=g7t!;ofarnV@IED8-@sj^_!;rI z(=<`ZrKNMhMAQ)NP&#)Qh~wGF_&*Q)svuGkt^WWLuj(Ub!ym$Dh@KSqo2GT9tIV|e z(q&OsMA1=Z(N8au_q|kR*Vx;bHOHrQ>^odqoUNCawPPQPe*~T*>K%2h z^X!vWX-KmC>ou&ejyn9>DtXty>p}3PSD5SzQ$7>?G^+4_!tA3+ z<~i0`npaX*SJce;Ra({4#A>7xd46K|9Nze^G56RO;3$p7Uo(~hdH6jrk60w>e8z+ltW0LF6_ie=kVVAW2_D| zVT_xDZ&){8^$s@Ij$AZb-Ns;>vL$+BdWN z@r5rLw-)}g@#ZBcZ-XsOHs~Yqr^5ne7q{u?!!KR{+InNA)^6?mw)rnecQ5Tv{be)o zm*EpI@b_G3?M0mU%i;XAxh88(m^3t*>ODlQ3tUGUI)Kdm1-a(|;;{`Zc0qCgH<%fO zp9oXarsokL>o%m}v2Nu2rL=W5D?IH}8h|8!HF~hK9m3@E-rn3|p7&=Zz}S*Ubj0|_ z(3~-y8*<6BV9AcnJQhZLU3@8jb$=A|jZl14(RyfR2}<83pXSDzurv`YTfCr+={tDE z$A)9UYlLXyylg*0LyE!{5fh-%zs?nAe}LHBJk9Y3;fg6@Hw^K|KVc3WjAMCyGvrWb z4O5f8XZLB#EchOiCx0?8h#w5W7Hj^Rk*Tkvc#r$4(fZi!nh5?^1rchXg7WueWl6nDq{#ZMMKO?uX zZk{N9Axou(^UcqfV#rAT7BU(~S{L!>NK?xQM09B-d6Gp?9c-Y2LtJs~g2xgs8S)(l zy(gV9^h#hjSq31U?3~Zx1>SFl9VnZltoVh}>Up~CpPTd~06(uBjCpXgKfyeyl`p|3 zlfSk3)Cj5ISBDxa!mUub#J)4+I)bO=W}>5@%VDV!yp=me*vg8wUB2h81jgbsGu6rk z$%>~>;5Ic*cxDaEc@S>W+q#o=Anf-OrqK%FWzfk%EzwlB47dCYM@#kq*pJT@dQZyf z8{TGT=>&Z$@m1ON+C90<4s>ox@>Sl+<>t&fH?F&$0E z@1AU2JA>C?Jy&Rdd;NI!_$!IwzEzauT3;c^vTXe`x?Hjrh78Im9tD^?w505lkS^xe z#ZwhqrhBL59)4gg6Nk|>X|_R_6EXRug%k0sKxKXc8%EvaAPamucy^v*$MGGPg_Huv z`%r1e-HdU@bgpUnZ{Y--9~qrQ$s8e(j6~d zmn?}Yg&<2LWLu|OVRkm8hxz@@EvYKYwsStU|} z_T_ECzZ_z|+dIVTt?zYkbukcT?TdDw=2Rb1{5$w_K6jr~=H4#U@hT56`W zMI_C;Xqb8%>@jJ>@gnw#477_*-O87a;IDN@7G{EHZNTT;k|)F0gry`i`1M{mB!$uy zO3FCut;iq1;FFG%qkky?e&_4EW8zpBs&4>19?P3>@#8XinF)Zwr0N@Y)01$1*yY&3 zL9=ZKe==a``36&@vV50H=F{d`R$7wB6b_Jh{&2yWA8r$K4C3HTF-I4OOWs@@j0lSto{i zYBs8GHIr%mTJ^sc!8jaQpy(0S8}@q;oJRxcO_4Iwn#Mah9%{0ufW8cQiRXBmszVhU z8FbW&jMn$V{{T)RY~Nr$`l_<;x%cLa_`L6Zn3kUed>pHQmhl%@2x332E2mg4?wweR z;uFLO*`|L5zsji{_d4@8)B2$v`ehLODbQXUczvlU>+(%)sPjC7Hc%~o{VtxGHwBvETLN)ay;%wIFlX@dU5;RU#!JXtVUOVT&MLGz0~-TqVlqSdsyXE zzDs#?B-K%Zop>Po5rx6bX}gDLJ)j`6JLJv3N`2E>b1bKdqPtGR3&EJMsAq;j<;ceO zkxA>j>5r)4GD%<%c`qMYY~v7~7cHN8ykPyATc7h_fkoVuCZOh!SLsNrYbdh{+6~jw z7HH+LJ4V|R$K{S6hRi`N(?ugIWfm#UOukYJji=Jq0fy$_askI?iCpx9nqZ>IqNt!s z8p>pvId^V_*m{E>+ELpPHi04zibrAqHaAOXa%IclT4)g>f<4Nkb(IGkDC`D16iY-6 z6mG5^sk&WGtrf^AWfu<4Hva$|b}5z5N;#$sza-0Y+S;1>NFa`?t#(T5BH6|GzuTYR zjvI%{Ndr~Wu|dEBbWWxqOCL5M%zxoUwZGgkCqhby)^9Z$&vLArI7)S|o|bQwkV_uw zg&QPWSlbZQ!t{_1%h8Dq(CVM64KvzVD`|=_Qr4LOA6uV%OlcCMIEIbVLi80AnA zF|rjX)lt}?`dnfjgv$HUo2;ai8GcKUK-BcrlvLEknXGDJRV;e?i{s{DdNBb={99eA z1HC9U`FU1Y^I8IIcA%_Q0L&MlPSq9tta$QfZnx=`%Sq9HyH!5eR3I ztD#vIE0bpR@$~%gGcclN)4Z5nzlgFUF!56QobxD=RL7p>jKqd(S3*Ej`&Zxe!Dg8} zybPgzK9Km$_QLTNpws?pBkGK%_W%Ky)7Q4&VnzkB^`EF@(42vejc~fb+lh(%;94ld_{Jhe9O-8<8gQklvbILj^MO7L+f*p#% z30XMkz>bFegY?AINd^w+357A$o-%7acS{u(X{>V`%9J!tkmglppvNR=5m|501zUdX zb&zke8l%b7C%t||=aq0!(^pVrvBjP&Vb*=j(#sj@HsN!r0!v(ans*dSDkI0ke~S8#PGtG^ zj2daFqRlfSnXPk%jj1XGNpuIWeVqI5!p<{Eu4p;5$Pa|ay)vNUbwpg}#oXsxX0T=S zxm0Uc9BgV~MF3rG>Ne}%_rei@Z6=qKVr-0cQgl#E$2XzU^i>&!CS6r7VKch42^5mb zotjOthC2Zxn;vXC;e#nUv$Dv_Al$-)m_a7f^>SLN^D0$(zt^~)@J+diAFPe`m2Ns) zrH_0#HS$;oTGoA%=ZP!-(;-m!bKz}$92Ci@d`!)$>!Mj27&Qb^()p~mDy6{ON5AgH zL62bU}I?Se##!Zok*}z9k)dq@)=}&jI{J$n-9J zD>H~;siw@SB%@}Pj>v?>tMntN9r5Nl@d3UoKYUX7SJD~-J=2+vRpWI&U8Aa`g=)TLCQ6zJE$T3C2YT*P zu}4CFxM1pyHVw|>p&+<-kTul=0dA(lZ9biqlGfRVi}2sUY|6jDU4I2_PFXVi#FX&u zYS|=kC1(HvTq)cTb~o*a8A1$`H|t0(F$ZIy<>I4tc-jZI>D@c$TAxVgnw!FW{*zlx z6*JT4hPmXqT3Ufe0NU-w<$hKpBa zo?#&bjV8%Y;$Jh}P5#*X(%DGd!9xtBTv}Bv@gL#4!`Sj{>9ln%MLlg)q2Z$Wvmz{N zZ?fmHzfYzl_*I~SUnBIP>(jqiMO^Y6!075af6_EYj;qc{7M($rqb(-IZG(~lvG%>M ziR!neHZmf4eLHA{4vjTev&6i&#GNyzKeRgS9sRs%-9to*YV__}=~k8^O_E5eQZTH% z6Y3)1cgHwM76b^mo9WxSEPzCvP#a9?tlw19!!yN!Xxx4DYOG5=oN|1JVW?Dn?9k``fEAOw9LOPS4~?@rm`C9 zW~enm9n8+rxLG4$Oj}2!_3ANbG(*4yfe<@v2A*kUceXU&v(6P>)KK^nH1f@+d{5R@ zNGg2#T)Q^NQdfG1vV>~Mq>Sw(i~4Rc?QA1pycU~$T@s45$I0c($k79}>Ju@S`%L@b5`QLtQ?st!=W`P*cU*syjag38yuyAgn@<3N6p;xFv|3QmZt zH<4-l&%vEJJv}B-;q6rq%ShEVm9;eoJgZ`*ni$#;RP^-y@g*0v!d;;cKdts$8DhQbScZ73k5_FYdYd$74CZ5Y-6y6Wy zRL&6=x+wJVnd4~@Tg*uu5pGXC_`*;PLjVo#YV!UPd?++-dw`Yq!=Df`Eb~$2Fy)>X z=NqD_im&IVrizM|mN^ZCzy$=M@hg>I!w#zbrZE@{vaONpkQaO#3`iE1^`eVX7RHIcJftt^9x85(ikVXFh z$$mTF8dl$QVH$Y*5M$ySR(OS{DYV?07guHZRV7t=$}G3vdyw)3hE~2Kc%hgaLWf) zBKm5FtxGdawN5Kj;*9ZGJb8oAMU-h88?F6`;^y6Z+ZLZrXc3p~>?)S-6ee=(*+1cj z$$FNv#XaEv0IC7v^qs(IS`Y!^*4xMK#6yWRd{N?K^Hm~hdZ;tu)U<9A9ppjB4X#qDVR1?Lz4#NXt zaq`@<-)%$g^HX6sWi~oRAV~PYQy%uu(xx%yP$vDg3Ic_=O9Rinzpo0I@uZIg<0I&ND%&L5taJAl&t><;{&sJ<;ew^xlD z$Bkr>o09(kHj+8%ZVHQiua5^3c{d}&H|sBc0-y(|-tMLU03j{PpFESa2L$gWCWX25-yls7>k9&R~hLk#990rpq-O#R{Jsb<~Y4d@5F|h`WEi zTi=X2ZalyM{S^t57Jvo*xcOvSO5>y;7Zu&5_Ti^ zH@FVd_rd3?_u#riMzh3&?1n2*;VK$EC6!au=QUZor8JVN3A+3}CBxi{cdW3yZ#YI41u9O{a_!DaeDH!i*2B?<5CG37Dom z%cQ>#^!04JwYIufQU3r}dAS3v_!#(MV0>@ll;)`AO(m%KZKSP^LoT@2hCTp8oK6%U zzp?Hy8KIO&n{%T*o*J(PD=E^Snk{7#P-Qff`FO6DcBM}%eL-fGt=-$X`ruYMw1!e{ z+i4xBms4}h#;Lng=uEf7q@_xlyxJwEV*9eniD~x^0aq#1eLM4l`Vm?U?Z^Y~P;`cd zxkuw6okzmN;jim9%JYpW1tzGm*%lKxoPiDKaqMNqH;=>cNpga9B z`&X`_M*bYo-!|~0O6yAMjL7FYtX0a&1bI$iV1)=#a$_LaV#Pv3eM#l_uzl%XDvd(m zbCv`wmBelL>WAF8 zC&QMDUp=MF^@9*e{{Wq+OCNB=3~~d$K=7o+)3cx54d+_5RC2$-tq(z04Krriy#uLz zqd4;&+m3xIc=!CU4QyegV6+bUOj6OqIl|RkdmC1-(v_bBJU;&b2R(MGkXq!N*}9(B z+5U_|IFxKWDKQdoRU+s6ZC}zCxcn2)H0uz9`)6B{F4?IoZaUp@)UuQq1)8c=f*W9PVCJ2mpu)_a0Vmv^4pK_HU%rGJlb{ssZjgLQ!N>$GCd<5 zO+HCBWh8B5A+MawK;x5v-H8>QJ(sW^V@T)rme*DfbPFlwK zN$xXsSZ*nxe|{ey@vG|mDEM6nP@Wd$Nn>^mBk}nPi;u`-qtgrIG1|HGux--)zGza+ zi%(=44vX|oN0bb{fJoaZsg;VXkJN(1oF=PQ36XM}F{Qv6nB8#Hnh#HSg-ZriskHS5 zb4MJWYC)JWSp3g*w2A5;pKh2p2A2zESP8R^wv zHr*v4gYV5o7`vu$g4X+CE^Z;M(e919pWH5z{5JSyC?02qdUae8{>|!dulyLtIVu6_ z3G8~9V@L0;dUvmG9Js@c}HRK z1?B}pd%zy%ghpDKUR6bjulPle?H_jh`dSpiv(Pb^W>ow`Uk_@=DKS9_f6@l zirH-Py?s;yd!Fo#H>djl04y0t2QnF5*!1F z^&9+azg+wz7*%kDF&IK)4Fz^RMOcE1uYcq<^z+@6!fw`BH`h7Qhn`gC#v3! z$EYUL4=>Zam`vK^SOQ*8<1-;nIn8|p`E5eynO!6qcLt(N)~P9}7RUD9LKmN|Jf}(6 zj;LVUQwVzQ6ne$~07R$^nP-Es5m8S;;p-k4&MWe!Tc2aUo}F;a;YhYtc+`*DmyRGE za`*VPIJ}+}MYYXFh1z--t;)Ikdi!J1gm=lO?T^~N^!9wW_%(Qp_-kEJ9X3|lDx$Hy zP{T=Amdj9Cf1r_)++Vf?#Ni78CA7fMoco;-R548bUF z_V>eFE()blA%OR#Sd48pIx`;$@=Z`{9|)&DTsh~5(jE2+mAOH&M0)eW5{6oRNuWPg44a~=%NJ^n4=u-Dxb3()gGRTzn(?^i9bHfl;VCwi z&UEH)6qWi)rzEbX{1en(38s=_wU; zc9ca47)F@WElQOGhb1>(-uOn&6Nz(gZ_%>SJ{iKW^_&T|yI3bm-xIt$3G(u4ohIBb zDAeZcJ=sB6T!_o`O6k0B3o>dpJK;(6_PNnIroN9U$@4slx~fHMMMAK&`;|*w zN&s!gYzbQlQkjP~+~N^fTxBdonokBVVhr@CakHy2RTev&({iAD^*sAvX3~QL z!7z4`bvKkE9x`}qll<6yU8mumCv|A$g<4WUAchtoe-Gi>B3<*+=kepiC~k*b zX}9xi8bb&nuhelEw@&zs@ans_zo?=3a}ITLzIu`5+M6%Vk!o^T=_{yaB*jrkHo(j{ zA$T1>uNC@}NyV`q5Umul)nIc;gQS^U^>(?)bQLTWx|=eCE2ow~k;_#ZOA(NALaHMh z+Wy#KhQqqKfG5II+-5SK5xJgi-wGusk6sxVg2UoALA8J=txEh{+-}_s?_=K$8^Y?e zY56HA`=P^gJ`Z0d_<-=GzqjH{jRW$v7JWe=e zZ6oLd-n#yX@UER^4zK=lh#F&AN3Q50&ouneR^@dwFpgOf;8$Vzjer($anyIkYY@tm zoJ2%-c`I!SwCgdhX_;t?%1h!0h`Dcud2BhpqObWnMwiKoaZc0il!8F?gU=oDCKC?) zOR~38fyU$MV4Iqx#_`W&6n~804uFwk)KZw7bH0JY7WDICoMHLlHKR+UNA9By_*35t zl|RNGhmt@en^j7Rm)MV&y8w4}7Ebv1aH`rzyUlWb>af|TtugYHvrT+T=xuMA(qy?N zqMEBPs+1~5a`uHB+VN)S*3^8I$KN0@P5~%gxmofY{eNv1E!haDc zwGOY*+7mma^HYFW_5Hk0=wR%Y z^n;tebCP4DH2m<%3(zwbYqR{s;eq!Dem?XNc3yOYo4$LO_x7i!qF7@zvdrk-nHr*F z`CorHkKpF=UW(awch5d+qG^3M7V}eh4ZEF^e@`j`_RWF=4R_3S$R1IK{TUnBq|ku3p1bMUmbcF z|Qw2+$Q=h8>Of(9X?e82U`-vvpxHEn}qxjz)w+1;b4Q7p(SIaV8s0{>5DI{=b1}^6AWyOB=+E>MD$kEHBSPj@ySLOCvD6O}Kf0cGJZIwJ*X4hI!GH zWL3GQoby-AjYNXBm^tiG!nKF{YvZp+anz%S9c#4*#Z~Q9@EfnFW|FTVuFLfmJ-08( z%pj;?-9!?ALHD?~u{iX|5fGoV8ppIkuetY!Igf{RPfx3|{KF<|aFukeu%5$m`c3f( zld|wU)G*t^i{;f6we5CyN_A3ee>E~n`m5xTY72jSgh&FJUMGn$5mmNl#0O*ozxQ}|INjFG|o zL+y&bKa2EiEe*MW?M*0Bo2y$znq`ya^;wV0%OnwQSsf!NRpa#Ye)h#ar6&i5$dk{t z9zY7VX7!P2yyq~UA2O5lge1~dZ}kB7HY57G;?YWp zoz%GnWV$O<4o;`Xzx$#iWli^(IagD;Lq^Fb{=L{>ZOq7qWg=qCQ$d*XwL#M8sbbATe^ z2s6)51z@DoZWEuwwyD-bDc6f0kFU&XDD(QM7M_ln%JH;-%Pdj^V%7td;9T+F1=M(K zM(qUnuPRh8*JV*WMb2W6G|Vbz%FP)0+T^WX=o|-h0319#* zZLaD#y^jYTu)s1U4qmG+byV5raXb@dMz)XI$xR zHJM~IdW2^66K0ZA2qjgPQzTGBXyYl^0-#&%h#OG08ZUW{Xts&6o%l*LP&>!00(^q8AaEHW|P6n3hFvq3Ou7w z=lN1Bl*XS>c{H^bb|iUh`~V3(dG^9yl)2K}z)xc@ZGvl1hP2AAUOnX}!c4w{PUV_$ zGGOvaRW@HuIgt`aV;Z}-{7%RP`wMZ0m~iKwxii{k%BhHaIUx9G%&04KnT1|U7Gpsg zyG>78uk!2}MelC5ErtAF?+p$YGhwGK{?ehNP{q-sIm~lfnykXFEXy(syDg_f9UU%N z14OJ;*huW%SpNV~!bdipLIbnO5<#?heWgq3B`nb%Bv9!}<42iQtXYjxM(gE5Dgd(v zu?Ml_Vnc>;>oQ0j3myo ztS?~AVd3P3H6+MdMewDsVbpqiPPU=VwXFtcHC!nSSzE|xBnsgXcK*__7HfVH_riLC zl-vwS=Wde#Y_}Z)dXpvy3+?E@d(6`us7&I z!>W}ULqXRd^H5VHHaEJapAr$%CcezH%_R@$v6GLLt%{tLD^?EYWO4YG#cY1~nW6-x z^=d?gRkIqVk5XjR5XmI)!8}q&c4r=Djj@^xneP>TSu~WnvGHoCs z04jc$IF5w?K`yZ+d}@_5rPs3OI&&-2^=gp{I+>c9*8nWQTpM*El;CQVOH7M}J1R(D z+GD}(L#eYomZvQ7COE2cy5m_yvt`mqDd&xPmQZiB8v)+<@tC$YTa(sl2Jvl5DTe6z z7PZK8$SZX2Ypmj`&cYNxUeK3+`)hKM&`G)hG}HvdDH)1kJ7!Mm-Rr z_MfYp+(_C2(dSGQ{0pMaIn|QXl|zM@YlIKqle5TK)hS{Zqb=l4At77 zEzPq!I#^nwqP~gJ1c6aY6>EC{aKjCbsYvxsqzJa8+g}u6qQVhlNo09`qR29u`U)8* zqpF~W3V7-)M3kXHP4???Yn%k?gcBpI9N=`;Oz4@gDSZZtl7^;^q8fDy<|vsw&E8x} z*VqrRw-{B76BgCYpJ+^|G)$CQ)--i%rnP+84QplDjV4o=)=<<75VJuGOuRQAv)=|# zpdRQp0FrMK1Ehu3dWDUU0g?suxr7z?N%1p0@vp-Q9aXAlTAa*g6?9E3NFxlC;Wn`g z#^bw^Fh>}`Hw#p>W*|WsjKCl|2eoy>F$SwzNEZa#Pg%|U)nttIDYSqreaZS` z!%clW(rKebh?18(cvIAS;xZJiB}bk#8^Xp9s{6Z-wg-W9UF@lU$1ZuA==~d`vwVo9 z(>QdiNh1;~$0SBExldqQ_uCeZ5rn6RA&>aYba#g^s9lMvhb8U!wJ8UFBeMhKo-*vZ zmXT&Ou#hZm;n^oWxr;1iIX}H_fbWc2`X7Bp1{8(7f2FpD}5xXjb zb8swifA~I&ek#XZ#_=r@OJ)bM1Su^)#g~mLyVLYZ1P)s&ho`sUIE>+FX$!{j+(Exr z>GB~VtN6b0k>fsO`C=k4VyTwEn?O9=*l>8n2L*?HqhgF_7{r4kCF5DrM>1B6<)vzL z-bqnbAo=RbI$5e26etfeZzKWR+Zir4n^;J1GYe|Nmp@+5Y+V3;A-qM^eicyU52NZK zr=Kx-Rrk}Y?^w`1#^7;h`<=s6sU_k_1L>7h`=Q0uqS&VrW@dbqdZhTS@z%aueww33 z{iZp6Hv|iRLl=>Tqp(@g;?>5ve=GEb>ofSL@$!XLpHkC{lGl!soDc`lC)XXEEhDmv z;cBOL{$J@TZ{a7zCyToKS?Ju8KhGkcEX^y#b10>TGbCuc0qX2+y^Amp-76f`p9FuOg#XJCA5%Gt-tsuDNCQgPY z@m6v8NFX?<&`PEo+Tw;tYDTFxJ`e&1B2urH-F^ zA$!Z~AnXFxu(k0};C>i+;n={;dpLsThhDYAO% zxF<1(F-sb$RtiDAi9CI8+X7&i3$7#*m~lFeq};<%A4n@MPmO*z2&kHG66)h=q714Q zA^>m*0EFkL=j(3R&?&Ws!L|!4IJ(hy?fcjpo_em0;|Grlv2O7$ye{h@^bh2iC!uG_ zLAx1Hd~e8NZ%-IJZOq`z)BC1oEU+YvATAVoL1V}RpH2X-+F}EnsZ-I!)_=#3;14Cb zzYO&g*7#MS>Z@dGikh6FlA>wf)Y81j9J3zho^hN83Ql`kAPSW}mz88S9aAfbl32~> zMmN}`K0oRT{U6~Mi243WIi<|<%$}mAlA%Yg8C9cD>Ifp>G5cZv01KomKP$9KF}0me z2bYRjd{q2Jm?=QK8lr68d`56?mUU#xey%o48XS6{`&`*+f7&Kr%OvMR+-XL)JU_-S(4>* z&p2BdWRe7CkpBR-Z&CZ=g;AgY&>$9rtnTm7th5~^#!Z~z_V%pu{>dkZI_p4Hcu;gU zsIJJT%&GICIHH)sk{DV73AbJe`(Nvej}4;7GcgmQuVN~{Ibbn)&>wotS-gDl&aY^1 z6|IF2%I*W}psz9wz8 zTn@O9KEY%+#dT$7TjKVmq@m2Gh8bn12xFO*Z1AA{k}<0A#*Tz6JC9>(I}&BY4#Ntv z)#^;@8DxOx6?Tc)NB7K@x|>{ju;eguRYzj#O`hodW8}Kf>MZK6UoEqG#s=hpRVPqC z+hd1-28+5_ijOg!-#GcJv+xk}W}53dsI07>V?~ly%%VwHt;-~LJBjJPj8=H~hBn%} z^Gd$`$klV|K1n@Ri<$V~`7J7fBTTR>8;zj{xnXg9XH5`3+=AFkvtO78%gK9pkbW;v z-NOAwBqZ*>0BpKO@k|Qr2&D62e^Bd=GX)tCxD_Sljxtrk{va*KIF2Sj)l1rRP;9y> za@yyORFiT@J@5WKm>{BSb)&W8E-=BVcux?^f;|rwfeA4IzzzQ$dq380% zv40ORy#@z}_pHA7tE6fCY1PreQzZ@7hjE5RP0VT6leCNDSD^f~#+sdbg2Xu6b5}P$ zqckzi3!%}<@T1*W7VC0x>8?i2Rij9Acg|5ty)jt~b&PXruQCYUTN$0M zstt!9?&BRZ7-U##H17y!QjlPs4yJZrr7wntX*?D1o!OdJmmsE*n z@jw{!0xtRXt9K1~cqHEK`k_?c?4i;ctpnkNB3FSbH62`1G;Be$Q++bZ+a{{A?n}Kc!=XwsRxI{{S*`gKk4@ z+V6W;=mRWm`GpxNV$&chdVW4f-s2SdVrmb^^D5b1%s1P~er0@p(zMn7D)_ZgRPwQh zROWD~4nYB@cCoj$_{M_Tg{^2GBzdYJU^6__BA3Ffnx>r9G?I{v6_unt{{H}Mchfm} z(S({04RT2{0YnkZY=rOLc<6gzYPgrMNJP@0*O()hy>1uwJTlmFzXTLg?%n;cX5vO> zH~mbeG`0T##kMK@P2G19sWj*257Mo8F&SD-gK9_dk50eY3#N{z;qO$Lw_ZHYB>?WX ztIy*8;>7Xa2k=)ANgUGND$wH5*nE}D*EiL<=P` z_;-@c8c3voqtr`qPChlA%|X!`ac)YlVnD_C0=_vxZSyRKS}Fp2M#MfCurv=ZZ!o_1)th(5$p4ApB6j zKOY`ic7rqV{{X}TRTB>`izswk++5MZE`7faG%PJb7(36nDm_|YxbJmTKeTLwB_Ej? zytgE)b+PC$V60B+E{JkmB+!{!SAbQNs#5E~0`1I5#aArAAdh?ROvEaaH230Fyv$zv*GbT(Q4Ho}FOZk@-QebBG+Q z)oFe%V%gvii;vfCOcW^WK4LC$=LBq2(_!YL<43AHO#4^n_axFeMO7?P)WQQ8l!NX~ z?0-C3dQ*P%u+s)Duupl0gUMiy7mA#3BanI%Y<6B_Rq&!GL~i&x%BX03Sjycgg3L1f z$)QovXAyvn{7w?_8l}|W{I>gwxc$%20;7nx-km+!smj#MhJdbpl)ucl+dat*aj*hg z?Qn5Nq}X`xKH{}ZQ~vb-0L8a-* zg2C}L#&=ueJL?t3zr*~to+zdASyb_R-sg-+D!ZCk>L6^q<(gA1cAg)W-dEaqAyBWt8msEE=$J`dv z!E&;bZ)~lPr47C`3WU;W zT#9+;jpiP2aOg&dBG zgT);t@l&qanoP)>i`mj6WB&ji!X7D5ntJI`pPa5-2dh%U;yd0JrDRMVcm$2O{LEvI z_UaBQR2|kIjrvxnT3QM0KIMwuDr9t$Yflgvq1^H3wXxjxUBHj$jS7p1V|%>H#j)TT z&+i{pCb}IVks5bJq}?%$5Kl|szL1^L?1Pg2$@IMs={R9}Sb_v4xVg9l;eH|H4O1K= zMsa1R9}N2!!i^ZQ3vV^f%0~c+oFD4NFNr#9Kk@$nF^g5;{{Y`C>|pxuP|u8dSZcIR zRFw_7nR93hi;x4fP8Qbp=L|SdA=dk9ll{;Mr+v!K+>0rsGcrv^2_nE1UYrl=#htGw zQnQDMPCBD1%Alv1Q{~7cOIe5(9{n*mD~1Uu#qhsDPbRy|7D&|yrKpiv2kokE0DbL* z99U*#c7>pQ&2=76;FY5BN<%b~3n45?BarvMKfe@)b)@#6p=n0I4#26;#WfCJU6|>5 zjL&jXQBziW)vjfkopuk)pWlm*3w$yLw)d(Z9i=V=?LOr9{g1rDg)4kms*#$Si70Zp zWR=h1K~Sg^{mK3qZHVe+F4Q&i-Iz+CRm1eehU!axsYEQd!$^E_@p5{7L#y+At1hL; zYNUdrE2uQ@H1N))Ar3#qy8wEX7!sX!zC<*V`(_d{f%_M}g#0*eT)+YGOdFf22gBx{ z%`{_pwL_U#zG{@&wIU{AQ7Dq4T1Ac4BJ4kE--`bLwR{G;sWv@H#j2RP$SYJx61gOXon)VIcisU!jlSQ%1!YRQKtPkM z{R_)xO3WC^wO-&{-0{~E1}I%#Z#wxe5$1HxN=H$D+4Xe3KFFdNfNTzn?L}lTz`{uo z7xXc{;cut5J?Q5}BkKl>mHks)3=yKqGQ_H@>np)rebADGcDJjL(wg`eL4{MUqAykbel^ zoOBpM7(>0}`o-ovluj`}%Lj6jQ&tXI>OWQFapZeZPqxyL;M>{n?PD}z>3Qf!dE^5Xk~ zmID1cW4?t&R}dO4bfU95j%S5hol;dBn4%D@zWn>+?uA19Sg1gRh~`nVNMdWh_%Il7 z2V8g2fQLA&#zDI0HfK(xM>LyWWw;0l4Q>eI9X6ckqjn$*9bKn~?OYP7IOUBuyOH=o zh=8ZqlZi4edQ7BlLRMtFiqXH7AZvtHDocBUI%ABGjulMn3EG!d)l#gKg4IzoUTCVJ zTA17DR#aeq_ZIs0h1hWGqUmuLQ!vxt%f$)xSA$*=_=8s@`TmMZT7&A6qa}9B-rcYsr<6Pi)f%cS*%eKlJ;yisQ{uFo%<`k-dH zBa54TusNquyGnmgjj`fq=Kwv)pDXZp#oq?y)6r06Gioh23;ETfAa$N!+WlCJuwcLt zdK-)31~Y~>uqEIJ9SKkH*u2+~eo6_hd}z#a?8bs@!h*jcj-90Q^2*9dVl_8mu-()z zOOw};gqVI1150f3ba>eqaS~Hq4ryDhGwE|@$|A1Hrihh8C}B!~TzXfF^*E9A#RdlE zhu_EcFNI9TN_v-C#jCR#+8SDrloCZ8E61o6up{Y+h7{6hI=fXVcyjksptKH3!kTFj zWCL^VYZA;&&N&#G^=<--AYcF0xYKDYw>XxH3H1he%#nzrRICw4xFH5ciDOXGFc)Sd zT#SBsr%{y-Sp>L}CB51nO6uTPt0Y;UhL4fbLnQ!wX?|x#ce~#Y@XDrNexoCAYH0xjINfK4hJoOdwAoCEA5z71ZIkU94&<%vlN{1bH}FrdwQO`bvgQ;Nxh+I0&b5ys)U~g0s~TP(U4Nu|(CubYf2EWv={0rPKMu8Ge?^;>+lAnPj7=r%RNmmNqFP$#6Q5e|{OU zgpRSgLQT-pzJhGNlBTg@Rf?s_QiIaFjmTf1zCLLL$0Z~sAA_QN`;_BD!&LbF*Wre*_zi!LPgylAw z$TJF&R*-p<^^moS20Rcg+uIR05mK0fe`1&^wx8B{)|i4CT(2~02(rnAm@)4qmMCoxCF)%4(N9sn1q=vCOqVRz9q;*L;ZAq7T@yT) zEl-?QOz`28)c z#}#Q!!M7#j9yV4VPE_amePvh35$%;l(>F_wf>A|;J>%&rL}F(%;u07r}?su=eG zY&oWFGJ$mZ3qRKRwqH$~WwK?}b+sT%DZiA=Y*ok|Ik(^P!S2PfgGp)4mf#~PUdu?l z71ueRhdD)lL$7{Ve1zXGmsHcpU1d&paC`BJJ|NSo@4e?aq>y%T*W2W+R4Wz;J0}km zHI`4}&X&z|t1 zs?fO<8D@D2nWzDzrDZl(g-I$%?O;H+Ui)`DCBGZ01Pq0 z7^+9$pL17O(VCq86MgEP{{UmX9-qM6wnep@In7A`_5T0_xBeJE?utcse+TL{dBP*2 zXX2mmN{Z;mE2vgu={*Inil}ra`4f&@M4oA}vFI&=Xxz$*poF+F;2`GThXzWDR~|q& zO{DeuV~+LIN<&i7t-(Kt9-Vl^Mii_Gj7KR$$4m9=Yz!D@#3H0Bd;O3&)}O*GszzHZ zxztG^J!}TDt}!&Q>d1MED-u{MNZ1cs8bj}#}#7DJHI*0 zL1B$~s85VQp9=g!h%r`+DR~J7!GVz!gZuGp;HD}7Qa&(ZlcRRO>N#U{7YRyR)Ws6a z4Z?t+0gL16EJ^GqL|CF`-5hKF5=BtL{jeLI3+7?ntR_0@c!fTB1Y~d8R4C+06y-}gK^uk3H<1xfp%i36EGRH~0dAa<`G@SUy{*bpsqi=#f? z(z42w@8CVjEaT@wy4>%EO|5&_1Je>Y>wpR;cnei5dh5c_TWd#~IJ15mGIM|3#u4Lv zN}bI5%Fn|`-x=P1sao9fBGnKL+2n8Cd*Ytg_54r0Y3&l<;Q1`5_@u0b{9N%zbiusZ zniJ3XwCXXY(|1w7Zc8D@u=J)rOFpPU>Rj47Xd2V)umB78?~ijz2cbKpl^K|ssa4x} z1duw|5yAYi3(WnyLN1#&`)F0u_(04eRo3+A>}L zmlUW87B}Sket5pqeoa z!|~W$#(&%}zY{e8kCfl66!aO<$?RM2@U<#`asL1f+=F9~(SQ$AuxV&i6moY2ge~SAM?|g!(c^m}a9`1hFalz`tz~}lx6Bx)K^3C-ezd5;H zdzQl$)R|LH42zo5?FPhr z%69435aoZ#cgOAU#T$?@+=5(@2G-|6FR3kHfu}=y**k2t{rsGkv)2`wd zZ>rpm5+^Cs!G51KO+bAiqKsn5*$z+vAPXp_isy`H^-i72(T8ki=a{V3{>nySPeoba ztg=jqVvA62XK}GZ8haCedvW%~kafOga8v9E~Baq$*zg)F?l@ z1%U68<>RWbjYavS^}2&9o=KEeQ>k!G#EN+xIsEb2X*)Rx(gy8T6XA0+q^R*1B#xG< zGG8mqV{(!Q0_umGbiJ`(;;e9`dG*_`@Ro=7Hs*A?gEZf#dsdXZ%p(BU$++0|3OM8M ziZ*CkXcO!UkN_!Ga2VZ`{c+-xMfc2+0FTR3jbd1}&hMr=1dA_#1j~pBSSQ^T7dsSS z6LFv?+^bzh6w=D0JKoRX*rQENL#%e3kzI z?m~;2_jOI04Fq~3}uBS@>)k?_YAGr*l~lRN)A94U6wIVP$iItQD!FmeJ_a` zGPoYlxh6z?v@0?`DXFKb@w-*a6%9p6T6!5|6twR?)AGsqf&*pu#+62(=tPh%bs%!) zv2HNZF$MuWM(7FM+>q{!OHT-SGQ7+Z^~zlMg?BT3Hna0K;$MA_Tbi)&`bLl~a5I&jD(E3e*XaP7>d6Vpz#8&Kc3YsJ{w)X5#Kdl4}vNz;vXEe4Q*aQ znNZPDCS;RIQ$;F9hI&^-yAS}})?d#E@mQ)&rh4ooxse1N`x8nSN|Sbx40fV7YTlf( zphH;!klYHCAd`Fg?{nV7af;O^b;qsii|y+bVyxb&16;1R@K@(M;xi-ElpZYjsT4Y6 zHJ&Q{MO#-3)6h*KNRl~aV8Knny~p1dcH?Qep!AF$w8;Sa$C{=LEk;`@HW31L2zgDF z>li6aGUy#dUPc^@vSW4s0E}brOQP*6)A{4ca&WaiL%wQJL8P^{MNpUfo@#D|RL7Oe zdmpJx4_6UM!a7=eTQu&B!%?Um>N?PLjX!GIe}Qa|JJNm)Q01BSQ&pDME^(UFe7$T< z4Mxf2E{w>)TKwX<#H%&$aTgs}BSX|`b%4W`K{F&12l1Sjd~swM-nj5LQRO)nQ&E^^ z4_%YgEj2u5Nm@83-0Z5VNwBsj;TWdTGV=qUEmRys4C;gy?K^?Xn#8Ja3j9cCkxzyC zrT3^+woy301N=-`g=QTd!a0PiqImeQck46sg!3naJ}1+{kPiv9O0gCjvdM@)y)hq6 zO#F7QMK}DP%4h2$uY_I~c$rPDygoIa7-||iT)RHYa|*fYa_Lei;HQ@E#kPxB90y*b zDKYQP3^CCisH{CFJ;AXOe|)Ai2bnYAx9d7%Eljc{%DkKR3tq>Q!RNUa`r@5mtV!6P zHDRFGXdA?P)+PLGcu(RUd*g1j&vFe5oo9JwYfYAXwN_t2ElfpYrHLGGRUk6H;74m> z{{V%1UdRz4&enN1mvW}R4ECKSd%2!uD$1S&__J1N79R+8VQ2~54plOOK9@`sPF+aw z4?aaiXuFrv(fR4n_yOY`LzxGI+N3Vquln01z#nxOhM~`Fz<0IWk6=pBr&x;%`#QD$_^)vqt+Pa!V|4@#UClee z(>b$9^_`&yX7VK)zARKr;8%-@AFbrcl~e2&%U#PfH#?xC0-EX<*76Nqc@Hn-)JP3Gi0F2}|#Ums9l% zV>od#LD-n}Ro}@fK36rMmQ@yxRV-VDDovQ5pyv3gvDsV++vLYR=gDYzhUa5|w6{&R z3o~uBvalp0>j-6HqbGK|NETo=I09p)}@0VZ%`~^cYoY zo8XV)A{vP&Zw)~&_^+E$0D9Y`*2SPXyxphBS?k7QtA2O)E9}1lpAa=JN$~!f4c!Z8 zbYJ|t9h$9g%K4~4gv@6%eWd%Civ9}xDEPtQp0CNZ9;?z2(Pf!r6@po!&1mH$PafV? zX5G|w7)`{O9Z1Cb%{LM1&*@fP2GGjAXAKNSZ#IQ-^7j>a-;9Zv%4ePB(9)|GB? zvpwqEctxVKj|+4@Nu_lnQi|FMD;ig&tcIo$6s}wYBo4}L`&|!ARXB}rzPS9N9jH3B zqhfh22Zd5Bq|vw+>N&p|$KwGysOOI!8|L0E>1Z;nf}<}L5!b<(ADyg@mMMI+WKY#d#C*jzkMbdOS+z)vi)Er|9Yg4wPOE~>dRaS%G+rD1U#`Ay2YW>Izly8+h>zg+!@hsvrl`qt+}~MgN~&5yN0mdI!%hjllSd#A40VC1j9Vc!_Z`B`U{i5 z{rIXH-C}u?eWaf?e*!@45$r-=5WFJDykBZ4^O}k2qM_VDgPVr2A&0jE?S>dmBI+*c z_}Wt3cMWDFb;R<#Ce0<_hDD%Y%-2ij8I3eK#0g26Q^>)iof1`*diC1M7<+T?iL3E9 z*B3uTAZYMvR9zvuUs>$)Qc5olmo2G+vX52fW#bz*k`V~(Kp*bs5c)>Lu@UGk<)ys* z(ycS0CeadR50UD8#+CC|GS&XGZRKXUWi~whdtd8@RQQRcd=hL|1*KdN;HH@+C3Lw~ zV=YZv<^?kbr-DfomyVeL0a<_>k9+sU=Y-;odzJaC?%#zs1pffN4t~onyXlKWkqfHa zTVdc1y>Vx2R!ZX5SPOaXlDxFgs)wfxjmF#9fqujJ;&9kNRC`9tC5DGsh0c^3ull z7P!ZtO7YJPy`w`Zw4`a}n8alWxUjaud*hO{{TFA0_D!XX6ww48ijlm#`tZBp#UcdhrHQ$rY6>fj|q%L1WH7T+|X0Gb_epj23X9 zv1aR!klD!7wIzU8-7Tui=H zl?h@&>TUc#EPA*vAdwQf!Xpg`=FA%FZk<1#JSeJAH%@dCO_!sJdEPd1MbNSzrz_3| zs3kPR)HKIeQl0ZHN^^Q4L7P)UnMAfpA*+oiRu(*Zy;nZ?R_qI2WgGCb+ighI3-b>K z{4Ug#a#78vDs;+Br*%$6QdNT!)zSSV4&&>9D{#ULf;>}fKNQXDSq$6Yb1kK$o|i^= zinUTnAbCb*P32TPN1H1z0FHUW%vB1lGFaC}f@Aip6+BZaZwLdQd?9$hlGjfLU!>|Y zDpotlwsgQeUPl!y2J}^vHLUEnTD*S`JBqoqUIAzOgbzpB%8!&f1)qP-x@DN zl*of^m20Ib-!btvvn#En)DY?lgsaPWq!P*$H0iI{RmSmwJAS8rZ? zL27L4L}_Y_yFZc~!U}IHwZ)06Hva$$Rd~At)P5h&3Mo+xd~zyEl}p4Gmbt9*RAw(L zQ%dFJa_(fd=@{Sh`{LLItd&F}1r3re})8%hF8#=lDb@yzG@h1 z<%UZ25v*qAOLo1wW78D`odmAfV%*V=KMylVvcXj)d4j4(jFgC9<9%}AQ3GSpU9K?1_DswjZS)-yKSu|Gl3;#SxU#`Avdm#MoWjy$>< zCa4PaS8)s~_x}Klj^h$kIm`_gjxeVgZev9pRF%~%T5W||BHx9(aoY>t!zH11+g(Dl z0Z(0-NgOi@YN>regA0%^$3J{9rVCqr0*&pHDkYj_F;hzfbqCC8RmmZMb_>ZO*e;Xv zdaIHlLvtLTF-p2)M**IWXgtEN!vGH$DU|_j^+V*{Hk{OEd94Oq*IKCNUngneGCE%p z7WGL|GEoT0pAAcv{=P?{GYI9GM$mw%zu(ntE{1eu?u=l%B}J=so}A2TTP>!hubp;9 z2hEe^s*(qoLh^a-g-*lLdu8$fxrm#0`6e{q1z8Olq`YU;*@|Qt?}jqRnpH#d6xE(| zU!&!Px${FescbuTz7szIPDeubI%MU_=DPi+8hl7jnN;thIccAR4MUh_(ZQW-9KR!5 zGqoOBJabmN5G+(T9dFYIQNkA-t^j^LK;l1w-_}!_z-X(6uF^gc=&eI8o7F!O`Q2fl zsylLuES1e%bE&_U^#MwsU)@UjQ2ad2 zpJb_*cx$Wm9%&_1O$K39@=~G@f5V#raHIlM;d_TgNy9OSyG=@M*YH@^yV~UM57If) zr}i>_ljN_~uGAHp7cH;Mpwe?{hmHoPY?=vxnt19^tB}XIMzJ2m;&<`=H6lW=RHxI^AQA|N0s~FK7VD4%-`I!V4$W0)P*kW+V(lfx#o|B$1B)0;L|j;da;L$EHG?n%QZj~t5_QN( zo@lEZ`F1g>Cic5@!ti+`;&o2he5~&vCe{}g7av?1M3SJWA$#*n5^vBFc(yxsrF;VE zPaKtR8pby?httnbuh+IcZR5oFfJ))yG)d7ybbhkQyh6yM)L9*1tIOn)Xd`gDKUoVD zk#_$8io^5AwP}_}aLPmsysRDc=3O$Vaj{<1O9t|8FJdj!bAVb%)iHs#w?IFNokx+; z>FkRu)cO*uRpph_sz)6yf5|;PMaIWw{h(Z^x6u3I%Ymq7Nz0Xwb6wW7Kt8BC$khnk zIdJNU%=R_ID_yLRde3A;9VfXCa(ZJOEj&eJg;g%FJMU5?b-I+r%dxLi!sS_47KPa%%G}`BA$(8Sj|LX!x;Cs;VszxFy9YQ)4NUVfvV1v z)`)|slm(B#eHgLrkKxBr&VUAQ_x3}xrS~r1!a3-1W*Fz4T_?xNlB0YU8EIe=Vp=@v zrETDTjgM@Sd^PG&zzbVdMn==zA8&kiaaBH7*8WLIIB@w?=kXc*s`XLe$A{6VX+9eB zU|3x?>e%`DI-_l$pUczurPH`Db-|`ggX%N+R7N?J6jX53{)L)?lIaW- zMo&HIk$70i@3eI|q11=Gk*3<~zNO*=CWD|7CzS2n4>Y%l@ZpPP;@rSG{xJh&&rRV5gRfUu{v1*%wz9NG zQn`zcwmnJv;>t1A3A3H~U#hCZfYWH}Ik11JgY`)XEPf2=FozkdCt>X{0>VpHKL6r?mBTCTWs*36|w`l+GoJx;*lw-k<&) z2`8kUx5QYCW2!KNJ8J5lMNNm`bg=KunZLoL#Bf;vK{JKkTg>$vls5#}^fo`w3fW9= z?vL7^5tzl}vM1OOpFZ%*Pim~|H_RsRizn38m1-V*!!pilX&IOc01`eH-TnB(dKkBf z0Mvoo9$_WMaC%j`<-xz$T2G9RVvi?+c}g3v!={dtXX5_=e>H0b9j-gzv5O;mpF8`s zsPJlL*~g6#J=DGH-9Lp{N=jq@08_q%43=xQb(pBydS3i-jzn03~4I z_*P*V0n>5u1AWY7{VS$b8PDkJUogr_yhdn#QldhuI74f03T&-@w-^GLyx!5GZC9)# znB)(<6$Ad~*;dhShP^W@ejv@A$V{8PiofDM*5ej2iguFk?Ve_h2GC0r$2Y_-#u6f22KyN7JubfWAHdYck2>zbhCZ2!(%SArwi}wq$qp#cZS%jvoP8YPKw#`uZNBCGv{{XmEd{Rh9g z!q|<~u_S8K*#LW-x@{~t)zwGaexf?&Iksh`@;tV0&`DoY6tuLnQf0)fbn&?=WP~28 zA6s`AT=%+@0dNG&7PfNVNPQO_h~0FWX{0y{3|u)&#`Gb@TMY!c@^x6z({NN*p7+L@d* z8f(K!7E(hL)2lmJ_XU$5QL9*P$?XjvR62gpy)>wudSl}WWd0rMxZ-fRSBH~Igb_5F zX(JqT;4VFNTJtBPj^KUlUABfEKX#M&X^%0RS?LY^-i zhzI9;A7Aq0p-?)*UHi9Onq*x5 z-o+4yJIrC$)p-Q4{{XFjq9d)RsQ`e}vsvLJe%C@UZ${QI9M`?3EokrE57Ifr%WNVZ zbUN6LI=*S~b(e}61jd_3=`9xO3)NPMs2 z=?~6IDe$MBV_O_XBl#uPUlKkc<&$z~-whsOw=QYc;18()kIx1GRZwOXJHn_sDb-9)TF%?A(i-cxu!9 zFPTI1mFc4Mxbdrq{YCHlVEBUFAx$@-RDdo6T}NJR_p$u3-fCZk^CJ$u;_vjnwNM5qaJP=V@W?tZ@bPT*`z3kwf=Ye?9Ed!6NR zX%;{Y>@Cf~-G8OA+{*L_T^J!)!3Ho%xgm-A6ZFS~f$UzBAGSV}>)>p9mR)J$)fP#s zX2|I2Un!bBxqUrjhN*$snlmUTX|TP%m&3PNtt@t1zcr?M#yr-4#d5j*b_blSiI&Gy zO~?n7qgcXE}W}n&gqTCILVg4r)2XijY4QD|=}HdH|lsey^JM z{i*BOMbpN7)o*)|kY(-1xCe`m>%n2icN5qIN(!b}{`#l$%>66Yr=iwxXuU$2K6CnK zQq$5%`E>PE@jxf5U%(v`&@bNu1`Gv%ao|@I)TR=;(YRbcPI@e{_@Wky>XLG_=f_SKf7jV z%6|&BMVFpFpc9UtP{*w0>nYPF4Jv;*%e5Y!*3r*PK4appWnWGk_4I9&QPamd5;!d% zsedng4DjOKtBjX7Uz2%LwKvYsv-u>@&HpJ{TTch3cU;69p)TZ<)`)Bi4NIW#w zA3~iiql=`y#J1BcgUk|5*L5)z;ACw!LB3Nq_5{ zXBZQGQfBanJ7qDqin{v9*Cf{YZdd4ba4>tHRGBY)^2=`zz8!oJ8R>rYLi+3!5cxzYMOz+4}~s+vm)JWbcL5J54` znY^hl_^h5-QV)A#I@KRhrKRrc2=zalsc9C2BApv=ZzN4Sksv~{DUCL$c$;&P^sx1N z{qX^?6E76vr2WQBBvxZxPAqchs{6HuozR7@yJ$j;`BiL%F$a6ucO_ ze{i~XQm^74h?X4K>WRs3pe8Z?Y?!=kG|@T=4Ixlk4C6n{ywSCvJj~xP zkwE6iTnlvO-%o4~a=NBzI&NXQgMQmtO;V}Jl;oaZN7x`|iXISZ3U3bnAn57yC(RdC z#U_5c{z`5;PwE9uH%e#HkTU`2|GxL z9fwigt45yijcan+8rXG)uqib(GJzJQk|a{fFJO`9chQ-f4O4412 zYmCmM-uJxi-j`MQA(dB1=1obf7%;NSHm8xA-N7E%lyMWFECaV9lv07IJ=xN{tHHdV zB&w#Ci#pCEk}G;@GuEg_KE@`*FT@Ih?q`8uMbdev&%_h&M3IuR7^5{*yUmT>sxAfY zLvjc>iLs_;{PwQ}c@qc0r^yYoF9h-o!mh5mTAab8sFb{-9Y^KUjsDBOi`)2P(Td6< zTW;EC-n?!jzs0ZpA#rbqogz`Z%Br~wiz)uuE~4EB=4s0hNp{rR5E0at-@qRD>|Kb*FON z+Bz1jh0QdTS)#tjf5S9$Gy28BvG0KoUBsNH)jEJIX7SvK6$}G->r6KH5$2p~G=5Q@ zY3#Qo&httP%jIK4sFobw2%bkyuKQ#JU%ovZLI{9vZ1EQ)?hiExt(cgb#;h}72HnY= zd^_kSr81>0G{E1>bDudtPf>N6*0u`tr|X~cnfi(zsW)fjJtm*P9}D4)Wu6SQfK>{9 zoF>=lYfd>l^~c_r@$t`tnfi;DWp%QCL;nCsN+|ps@Viad(^k^d<#}aIGpv!bXT!`V z*zcLYA;t0Y>bkv)jBg|#a};cIXqgN%*vI~oitU-@+udI_%SlET0=k^BUdF(a&%MS4 z&ev-Z+xr40<3Q>BL*|4T?}vU8X4TcTd86bKRL=gRE^esz`j0$X_w9ozRj9$$CObs= z7*N%FW*k0qW7%-H)_6zBGe|`Fm-= z@VS(UJT~w&#~Y?urnVRIm5yX~`G=zK6LNUs`0d!LhSKTZUnZg3hGPWf?yw&8s*W!V z@+_}2$g<5zk>!+?k=0Yn3|XoH8L5q;W>8&@;6B&30xYQW(hy8R634h$kHNAqRBIcP zNC$Q_-ZU~Ukmbk2q{;IAADrqOr#yo!g&`h&K@B)dvcCj$QaQ(N4-PdlxOIt^(|7_v z{0_z5a9flakToI4#DZ?QE=Ax>NMu?~D9EHK^J*IEPh;!)V2+xo{qXkWspJ9}(rDLi z?={5bUIhiTRQgoxJLNum6ev3nUN|*s+SNW~RUi$I@;@}B!Qj;lkWH38l*{TBmTGxm zmQOGd(%XsWt*wZvzO6wKQ|47(G3;UfdSl$AU)%nNs%CSqGN^%WOUU-zJ?sxS1Yn=Z z{xoV2eyHC|18M#n7icx#hRSMcrSU%@hy^Io`HrUj%H4l|<%6kU9Cml{ZwNZvVXTV* z-%)^lV7-5DJ{QRZK|EE+5ZdE)OA~*u0}>7x_^@}(dK~fQ18~!(l^92b%4~zgpA8JH zANNeij?;H@Qo%|3aBq$q!|L*I{sY%v4N@XTQ~WkA{{Y=D!zf9U`=?~JFWNYnD4=zc5W2*A`Y5dvhC=xhW2c2e*b2aQuu0KC)U0Y>` zVkx=%3vPE!vgTPNPqL>lq>PmYHxtIlLF9U_ZHc7@{2|^v7bx>wrD3R%v$_OmfO73u zAE`zE01v2cBlv!J>pUn%8(l5UAUc~*qNLO3^h~lw&ZTEVZl8z(Y;ni>X7C8t%-*JKkta#tkoJrCS zXn#i*9joEi8b%hXNwrp73T;~oxc2#E0xik>@y|#(sg4NAoh|0L)$45;EV9xrvdZJw zfz{1yYZud>_g@h@pi`b4YFKIGvr+p7gV&(o$n^oH|q&Qa9Bx+4Azf9fu9 z_=BLCB84^1NUnp;UD<*S!rz3udUt&>=T6df9tKoD1GqLi*8Bs%cpQ=%ZxQ@Gk~MeN z`8t^x+7noZYlCp7Z@)oqrxJ9-n&5C+kv(pHrzGJQi24V6Q%|dMstMJMQo~VM9C9I! z!p9RnHx1A4$A+NhyYvUot5QD^=`_AN_+b-Fk!t+9_WuB?#Mpk;@9mE|LCr+$ zBZS2|pE2u+@z29#dTqMbEm0sM{{S=_ZNH~(=J@#33L%21G-XTw08?>J5&S`TUqq0H z*12rAXGrCcP)M4#wwju_sC*~QX((ojV%Dypn_yKZaq?wr zDEzPaV=u#S=FxB=;P!w-`%_xg3xdtW(|Mg-EmsR6rdbZ*yV928-AK5%HpR0r(Iqm8 zo)>r(KaMralw}luJ5WT7c1f@egOR(~^T&H)3b?0HHr`ikW@LQv6G+XV^0@MeDUeoB zLX?uMXYk7i+Ti<BMfEq_I&TkA!vr*dA?#RItqr zB%8_juW0biuYxo=5OTz&)HIn*6cakWU|C}*eST%d@9b}i>*bCoVIFF6dnb*5;O%yq z%jS4|Wd^5+O>2eqzj{Ox=YIGR}n)oa#zE*jjDWYgM) zC0x82O*xzOvYVetAD8jPlM9GB`s^}yDI3L*kHdO()H%&IUzyXiDH@mG<^WZfn{)4m z*q54YE^fX^QejFpcA}D6p^-r!==#4uY}IPP515-3n&Zi&% z6Q)C^^6H%8jy+ACPnTs5ALc6QXeO_gJ<4nnC;@SE)bzFuWhc8v_^$zJQ!J}M#Z?VO zHc?cy@xWQB>cTWZiam9c}xRlqQ=lNk(W*r0;?>y61I0JN6@Y_@BtxukOu6yD>XGN96Pa;II zdc;wi4T8iqi1z3}$5k>w7aH8usCj4!1Ky9O=_-Av@=pRZwR6|hYFzGo)}B|}S7{!p z*QpH5PSbwJwY{;}%O4naGyptc52jI}&}^I})gB(|4E~am39BkHhW`9|$EJZR*&SMlUP;28p;&$&z87MRFdzdH zy0c+vIPVHoN#eJPRCC2qTk!oX(DLgxTd5J`*~OTLBFE{7o+(U%>HI2n2eTkE;*Si} zXC5Mv_mID{FCH~DG~Q-q;0CKK=Ii9<6mx0P-Fbz+E8vI?hg^g%gZhr6ldtxkn+<*=*$8wpeN4>Irji{s-;jW1F8xn<7i`LxV!jCG2 zN;3}?^Ft$uycN~bbOpY5DvW+Z<}tw(j-}K1m4A|5id6^4r}q9D=NF3k>a=Yig8G#m zPo-No$`srJdEGf2{`_+^W+mS;uD``ET}APCQ;zBU^#{?_=fjM)OqWi052#X!>Z&VR zoplCUSWi1{civ{;8w;;NZZXwL%&y`dT`)c+T?U`IF9sRxY=^LSFnPT`L*fR1=rec| zsN~(q5o!#j5Oudnxjy&D45f!ANq4fS{{RaLSDL$2XNwv7=rQBphQ+B2ed^@kWJhwnbO0lx+ei%wHLYos~~!Un24Qa`}rsY z8t*)=k-ksCY~l%`Qmpgm6oZ?dcHCkY;iwN)&7N6m+wxVH4T`S+09+Q0q|zUrmoBf? zD-=w8AE}pX3lp8wpkja8zaO7mNXiT%OPfE5SM&r^-saDT#-;j7bf?ySAv8`$gmU=- zuF{<5kwE_d7yKaUiN!Xbj654vLS83-15Epui1nX{Lwcu#GR*Q^C^~`ws)wF7P2Sz{ zBU-_~I5xe!LjoQAD>^#9vT$Eo_~Q=a_mE# zBRimW(jT>ShfwN?)>oIng@}-D{{Y(>24)1>%3o;yybA0c7Y@^}QmXJ(cs{$MYf>Mz ze+^BmN%=@T6sC?r9`>3|KsO-bZ~gb=3U!B5>)5v} z9unnZLI4ce^M(p~@*ln?V;lBi^Qe56l>l}6M}9}@FX5|vN~dsQ@S7*OxVz_a9pH8? zznl@(ZpXpD-KdqCwez16rAXdC4z#2`UBGYCHE2)V zAL04pLi%KA?_)>jq1w_3`{ekO?xeiY=AJ5~PR*ipU@T8H8P#cPo}Yvt%N;b+Xn;AXq93D1Nu)e4hidK09+hGMJc;o{jbUExTw+n`EBmw z{uN}hqE8lGrfGDBkch^1EQ_7gnCv=(!D0F1$F`oq-;w(3%2f<{-&^@GxJR1!rA~?D z>CGn-Ddc{T%p^wt0D2LTi1RU~*}as{z3NPkI=ks`{L$vV!=HGn;zs`0bc&?Amfty8 z?SHM~7ROy9e+%Z*@^a`>=I_dP@?*_>imSz%xLJQi=(t1kaXnK=w&-oM>4?ji;lGHc zE#l+kx{Rjgdoxt>VmJ6_TjT9sQ!{+Nf~SGM0Kh;$zra-qYaN)2gLDbkrZ}ZluM=-Hy_>Z(T|wWb4ACR3{{HF{UWzcxbSBn{)$Bf zG$+-lJ2SZ`FnH%8A0oFy#@D)UhOR-k>MS`O@#90rx_43w;%M&LpE=8nRQ^6whgmE1 zEQIn3QPe2E*@4H-E*`F**nGiU%>(gj58=6XRPp0?qcYJuZFV0eFQtdv4!HHNskit~ zlNYf->MDHquTV$hlY;Z-+DbBbDIQ$iJ?_L}CseJp4)aWVsg>SLIkZ&y&;21KpDXd6 zcic6ul|ne$bntS2-iz~Wd@5AjH|IC`5~dBq3kKBr?)`QBEgy@}so$-%<2{ez(~*mQ zO#I`ASE@cMesJ=l7fq!=?NjH!_0u%8o-zdeUx@hz)y(K}T6?)`Mbud)vr>a@ORQAy%PMDH5zmIJ0B5W05+mo0Cu(th2{r(MJn@EqO1 zeg6Q!!uEw0bd3zm$9z{fxPWc=YO~POc%eNF6qD;cHy+_(4K|$<#sKemRZrz>W6w#a z7HDwhU4QU0uHz2v97u51CJFJV7cbHNB}(eQ+tx;i)^;hSAXCl#`t-*G7f<)L{O|EF zz8GhGw|gi2H7zvWCK2UH;wD)ry@LM$Yc#`R_B}>CIMyGEJRhgzE}4YOB$r9j(LdV? z?DU=@7z9VethoRr0CdC*0piB$Nf+m)IrO#-N97+XWp(JkjXV9bBx5V_4b_-HOrQ^bd#|S!MAGgcaLqpwslh&H9@& z*mlRhklC32+I*>n7^Tda?P&8QdOCkzsh4Mp@YtX5pW6H+kM`gb`EB~&wj>yq6Q_UQ zYI!kp(2^!J{1&dCp!`ChQyKAb3P=GYCX^fd=U7*RskJ9MMA|`_ubr%YDg!0~GrgQK;C@obmI zJn80E8xPCEMTb*wW82#u`dD?yY5pBw(icsoltc^iV?RM(%c6CYz1zk-=?NebDc}d8 z{662;`D4+G9Gmm%{<{03v`6H#^%qa=J5Zy*B=L7rHSW8SqllllPxa$h8J}th_?gwVoztVX~@Rrl}=@Q5AEoQZe;P6O@YEcK65C zTbwqdVU9V0g7Y~~E|6(IN~-Y}wWp)X9S&`Y11!%b?;k?5DdApaDFOUp)+F)kj;1sx zfI0;FU~uQmm*4u+{{WRh7O)TRrs{q-_baqM5!M-Qo-S)f+z7MQqg(4@20CzazCZT2 z5Af9tHKY6OzdQSs+P)8F(bX6i#%*5U?kvCF%VEbG$E){aqhkQyoH&1m-FVTtrr7*% z?h}l@2l>(o{{Xt)vRKN1VHHuEx40*qdTB_zul;EG)m{q3X-%>C-`pLV8 zFKb`VjJaR;b;JV(H7@?sKjErFiz2~|`QO|nFW`kUm1#Ul)u~~%K&oD!?>O*aq?c{K&^g1U^vlpgiiYjxF0Uzs5)Au1oOq zl**4z-XQA2qU4cS0b+lpX8K|#@a9gf{vn^r71Ocrk5RwIIQyCxiVuf;j*E}&(^Zqt zEtuRd`_0Yoj$MLlts}yNKUsAAYsvLn^PZHafEh3(uDjJh@;~732K}wu9Jhwk-2VWW z?fy`CuZB7Q03p9U>!bJqk&u?v`l2UNF3XsZTkmXoI8{E+96NtV^IW?a_iW#s_2E7r zvPO9}>itl{#2wj_e>{44T|Q&NjWO>fdNHqUvbWmel1=dMrz9xvsdZmXn?`oQe|9?< z3T@lRqNKYR`oDwp`LC4!01bLFBgSW_ScbSSoKJn^&%pgL@>3({ znxFv*Ab)H#?i+t-5S?+`=u&8s&|{r8pCF@cdag0m`KQU~9ZBH+LgfI~I_*mXwGOSR z?cUy5u=c{n@p@0Nr$%l+zL~Nu+$gu>yV~>l_DYw*tu%qdYVB_`fNrN(RSW*;#w7Ss zi*3=;p2|&8H-}Ug4|mh%_1i1(Z%Id-ExR{sHq`@h^0>c3YBBV z9N@Tp983LD2#AcaB#mLCk{c7nD$xQ+Et|l~U;=f`*sC6%@SDSY^Cil2s*H-JM9gUE zYb2GkYOYMku1A;nR2%VbpSuYk#Hv$qYps>eZ&xmWoorT%g~JCh7J=3Q!ep2r5petJ zq>*?p;ms_LVAJzVoUlgBYDht0YcGGkIy^wTcY9brH5w?E+o}(7KKHNczXm)wmPllW zOiGDj&a0SIg3Nfhe}8O!>CUtldsu%pd?^w-*?wpDYvTAP;rf`8O(+7yi~$vsv$1Y{ zY)H8u*N(k0)2qKH^;g1=;{4C&E2KUN_;(CNW6~&ALJO-^)LP>F@cpmf9~^6s#&@-& z^H;5>_`fkNlfm5rVcObWIOE&`UTF%U{*d+e>5n}n+U9?Qhm#kjzl(3dN`JX0hqDER zv~?V@t1k5~B9!EAvkCpTV`H`=vNbqqLTFp?ojODl$qs zxw5Hq+G?sPZqh(LWW6|lP-aku>wj~J>SF|E2rZx6iIAKF%4 zTyl2_Eady{f8~iC#2=<-TkzCF4kCG_YvEsqk`e}m%Mq>GHsjcjUu=8ui~du-dGaA~ z=)iu!ed#NBYoZh@e`y&zHOLPoF(li+FOM6JsUEYwd;b7kPw2p(=3w$G(|Bv4Wf!W_ z8ClwIWT)5%wT}FDF>fCk-#z~Tq_1BUnTIwBhWGHZ z2j(xd`XfhgN0Uh8#33pJQLU_go&Nx<5e##Vr}Cfr%coJac{KiFR5V_Wcd2F3nI(`Z z-uZetHoxs0csP@<2E(<-^OSy%5wCz?{Ke%ozL9l}qtjVDMNZ-5(jqtS7>MIb_xfBv zIZ7yz&&E7}N~6fM%gN4}%3X=#SEEATnLTmyai>qtf9o!d6RrFbwbQzKxYJR#LzO(B zf~vGghrdEG<16MlMyK$dxA4~mrJ`@*nyd01K567Dr?UI+5jvVAxFGu<_Z$xVNr~id zcc0Hwwv-$4OD4*w7Cnb1%da6_sA!|GUIsmNZO5#1*G=^$cp49cpr4M}2Ao=)nPG$8RXWrGPN@D^ zw$t_Rg9TR+>pL=oqaP)?d!=*ISq4n>dWnBQ<>5^-xZO;fjonttPfpjs^(wfFxzamG z_b-~kvs)d|h#m>iiA9%YB7$kCcri*M39-)x`+9fkF#Ch!Ud9+Cb*wUo zJ;bc@?xzQys3Eq>BB3F2wp66wz2;J&SM>(F!QI|=qu*%(fB^e^9kAy>}>o!d0wqCo0}2I z&gw7x02uIbH@i}NBh89`K?CIc-|m-5Ke4y)@3?=zPdDSY>AIVKc=zE~4c+Zv{Kfa7 z4o&%|$?NS$_Bj3>!$ygsb0!4xMs-p;d*VNZ95;8)XX+_N3>};EU;4|b{>MMVs9>i= z<{aPtlXXAG9(*S5Zu!jpMdzXpP5GzI$#j3%@A!3#(lixY_w{ELJ+aBhIorR%?EOXW zqjopue|EjM_C3BGVM1HO`hZ9#=QgQ4e*AcG#9X=lFCI)@dOU33nf&D~%>E1f57iYE z*=}p$@RmHTnJH;yOu~5OFh_l=?1XOH+Wjtl@D(g$nB&%WKU{C#)Jw3UBnI~NKb$0V zpV;{LcZN;h+~TQ${+@4E!}1&OWB8Mu^2c+>lN3V@$T#MHcAe?I0)8Hln|NRw+kJgm z{{WNXBad<2{xAMuz4UIz{Lkkp)cgm0JHs4|d@hKa4z-nM_j>W!$GSCjzYTCO@_sMO zNz>p@;q_^ZiQ!!}*PmT=Q78AlBltn&YVV%C^l%OG{Ken>L|y=@#s`Fy02>m`Q&aps zc>B}e&EGwH=;QEyVo-hxd;?37;T~M0k#?4%-@kqT06w1h^V6Ppch6k&vLK}EJ zlJoBrtbdG$1^RVQ!uFHyLV6oX*XRS@mc{UI;8EJY+F@_z(l;OR?0N8w zLEGaC-$QQ4=xJV);Sa#Z1dj+b*&V;U&-K1N_(kMt`De*=Fo19QE&T<1i{TT&6JhYW z{uku4^;hutT<~BuhlDy_z<<@Xa53T!8+|VyoTm(T%KVmos^)$gd>vNU-Vy1A2KJhDA8l4i{+J)IE~wCe~Y=8 z{mH_L_<@+_7yNgAvObOoy|bJ0Tl%a2&o{k25!Ul?2Wr77=pfpz` zspJ9=9OEo#Z6`#Tn@stql^L8`JQYnDZ25j!G`}rUu}@PkrQ2&bKjI%!+Ta`F!P5sA zJ8G7`gleZg9_VdBq^78>uFg{_6{HB`jmR#n0V>3FHnsu9V;Nq}Z1e0~HkMUB&MW7h zN{poum`5p)@u{)a5WbEeoMlbsWdX>)HKaS3{tvGpE9i1@5@`;-x50)nZy&Q zFue@j4RcJ%MrE01RSu>vm|A70h7!$Tz&v&*rWrAk&?9YE5Sw!fjZIOXH8!8q)%8{i zNP>msQ2bbtV{g7b29RvM?Gy5ymqcwGJF5DlO;v!?xkrtakjV9Ve_Upi%lPv8iE3t~ zGFr+~nZQde_}kL__QJ~8id8^kUc&~^3y-t|DU&#B^%3Gg_pj|gpgdF2i#*z&!rbbb zfc~~ABUsu+a!DJNeL$P^`eUq9DZF)Ec)n)7J;5)k!op@e2tMRO)Y-PT)LDB`y)|Vu zDk8}d%y%l<--5@GaJG#)bcik?#La;uci%*&u_aXe&Vr(kG#++CT||;`Ji-=rCA)_H ziMB0t-WS2`UQqKdx(u$NuRaRsE2>q?j2sn(a>jfDSnQ|JB z?I%4AUkR_S3>Gq%bmy++KVkO7wHwm5)(ha%vMXnKzEFj#ncchX=L7{w`3iM zwgIJ0!qZ`*`Nw3ZCC}k7%Lt@+B{tiwy_6qr_?WPn6P1h%An}UDZxB;)5yMw&;Tp~lDr>sFnCj%aFWmC-dPi+MGj^t=Zei7 zw2o2t4}1RrAAEdQnGYn_o_uQN8SD~eIo6cQGwNZ&)H=yaQsdpEkCr@QIFwgIoI$Wd zR);0jGcIjWlgW}(J0{9itCnb(lh*QbKHadJ5b_K)K}C&ifs|a#Gy3T!l9wdQ)}or8 zAjY7RwJfLKt+0qw0`D+NXa^){@ViZGOz%6>+17bTnLb%s=}i=qua^YRU_syYP}p6H za~j-?xskj8J5jW3R;1;=40t78Ycs6Ef`)i@f{WaBLjVcgwcP zjvA~KOU^Q#Eub?^Ia=EP04U6p=OA=(8>32oh(8JScf!i_c{mv4B0JTy2~fShtSfD( z^Q_BHWm*1vlI5}HRTMdWMSL_fPSGtwLmNuNa`G;q+W@hJ?*haU0hzGpViCj!wjC`O zxB&H{8ZX*}o&b3A-x0b)`*9f$=szy5S{J8|t>;H*_M5A?1ogK)G0zyo`Yl&B-B8$Y zn}S#YMTjy7b4n_FY0u_03IXB#_(yPrf-X%i_Hh^CZzxcu*gZ6(Lc?af~Skv{Dwf9FUwc5hLVA-v%&#o|UCh38VEk(a}qx?RA2Ij1BZrr*C7KYe2hl!i?$?Tq4jYN@)G8h0*TrVD@KeNG{{Tznc_vwz zQNbM~(X~}O85L%TOZe4?UB~xg=ZE1;dviGIs60=OzKerHbZFi;C|57X_lS~80_c2} z$B?2K2t7LbjqyLg^uAI{{S(w57xL0-zmM+_Dga6JR!DFT#{%T_nxv&WrTKEKO=?*%^$kLW?mydBt~#;2VZ5Ep*Or2#?aP zoDYe+7T0HNMp(Se&*)aWGiHM-)R~1jPd6{iYAb?m1zDm{NH_Mlzuy2-q$-%_3EnEP zqR>X}1L!BoWlH>X_>nrVm67G2to0yRT?tTZETj0I__()&Qf{;0v%~jESj~mx+{Wa2 zC%^S^c%!wLX-t*2u(>qv*l~NX$6o|d?eRmOx;os4gOf=3@$pCXvBi+&@XY(p?~^US zQf#+kIN;m8vE#T!5xLZ9?DJj@JzA&576jeXqe|J2g$(a7*8ULbEc-Rt^Ld0))XY(K zqdQ1JV55P1bR986b``W8Qk!NQQQG()G}YLrS1o&@O*R{M6io3)RX2v(2V3g8N^vbt zN0iiN5TO98JX>rS9;2K7ST_NM72T6dc5@uic$&q87?FRWr1>m(q5jH0jja>_X`g};6xcqc_WAZnX+iIN>3sVZ%;przcTcVfVEf*j)7Po10QyTTFa z6u`W{$y8b>yvj(K5kWkQ{dqVJk<8iqXtXMaE1@`0<<&WqvC~q==Tzn~3n!~CJ)K431t+_PK6xBUR` zxL)ftWDkDl5ey}Nk?!&(dU(wTd}Y!6E!HNP8XT;bEH{=T(g)xAvG1c-4YN18=<#|J z>kk#iuRv<5K=Q$-=a5(jDi5gpAU#iBnDx}EkBGfIPK&j3Q$22#)e)d+avGT#fU+!C zc>d$Dz)x*M>oE8Neae4Mqo{LzpnKOia*at&=w{NHn$y@TkxWYy+>2s%=4ka@>?7Wz zIO<<1zdU&_epHZ#`JF$WMBA-(%bAH$(-U-n{8xP*YmZGEIlnm~Su&y-WqjrWZ*_d0 zL$m5igO7{b8n}2g`1xN%O@@megb2bRBP=q?DHW?>`5940U&KlkZcVbXAFtUN-{dr zVgCRa=J+Tvr25}i$do^(o=L(y>rJAG-!RM&Nni=dYfC8W%53kBA+knp+2sr8;~y3P z&7hdoHh6bFkkA_c08?xB&uZ$27lan)~ zZ<+^^M~uRB#JmCviva}8WzG7?+`kao6d3mA(V;8pE=WrobAF%X!2LXE*IL?7Z<-k4 z$tSJ4ex~vJMM!+1pXKDJ1hA@0oAeeR*NK~nCsvW()8wK!GETote$^vS5wyfYI*99N zi%DV#%%dD0uc(2UQ`~#?e0E;m zZ18&UVIJ!c@!rRzl^!x=kf!lbM)x2K*2D#mu_XTh40dr%9J~y!#|d|Dh$G&cKfC6a zhEFP5x?yYjyyayc_HOpa&BZkAd;vb?A>h>j)g^z3oeVhL2XEfpG2co7 z(bxP3{(_?%Da31{LqEjUgQu(h_|CG*SiHU9immM+JqR6-wmcOJof#h;l-_)TjodZO zZ>$aXF$s=ei!Tf#AzM^ZyA#qfNw?PB@zG<5vnoXX_D8*Xa3`C7a#(&UJUh;5Yvao` z97$4PbdEt2v5G_ZT!0P0$JK!iBP-fWK`lOB{g({kk8u|S4M29GbJO1v8eSSGDYI=y z9%opbNmETnDcpM-1mNNtReCo4^D*s$J>*Y*=$hO&q%%xqZLOPq(z(7UbUhQil~r{V z>olM z{pK@lavM;IIXfb)DEj)S>R=sAzz)-terZol@pYp;A!5yoDF)+DW)>uI&EopvE|tUN z{{S0H^_L@uIP7oEe43l;{wXwlT}*XwHguvm{IeSA%JQN8{{X=L>~ivRX3X0SI$B%* z00~P^3PW;{zu|tWT~F~vrgG@TH_GY?uRGMz9XDPY=dk@&I%Qmz%*S?`w7*$$>=}8O zh||{nRGNQ@{UI!G8OwDKs4{xA&SFnL?PA9+bnj32+Fz`_^mj7%J=y;NRYK|fZ_%D` zG12N7NV<}`S2MB$)F0I0IN^bvU}^9Btu6lmhM2muoFX0hdw&6Qi^fee`q^V#?mewy zUrJ_V?d|@fwhyaSLwp*GcA!#JFq6lG{p6Cyi9^Q9%w0-W*S2&rJ|yOgJ0Cd zki`Nk==tMCNQT8g0(1a%_r4U?z%k^w)DldP9Y|c<{Cn!HbU2gP*dmySfiF7&@-3p3 z9b2TKF|f#W(!b!edSY;*!}hl*_v7=&zKKj5JD2X1hv%t&6sT-EKg<14zE7!ip=hFf zi^KrL4YEb2NCcnu{XZ;5>@7WWk=<6Gkt^fHDz|D!zdGwCtkTgY=(JaevbbRzM%h9r zZ+7S31U`i?lyA?o9~zIb<#(mk z84JPYN8$dw^Fo{Xw3Ly!_P*!qh|4Im<9O!R@)yGyS?AWH?0EAD4LyESOifq!GS^~B zN3KOm15nHUC|ABXZ5j+PUHNCph=*fqn`Wcqnml^RXwT?27f%N@+|jLoXP+)c@5?cL z+rIrUS*M1NTTa@C+{6>Hn1En9jr$2667-QZRRSwp!7X7Cy)uj(%k5yb16m*mmqRe3UIlDYYR z0<|dWN=cvPOuY01^@774wuT(~q?6jpzo@+UQn(j$erWTkS9EOdoSA>P4t}zMYaKTo9sU> zxai@qy6Si8R`Ozt;X2xMjroi}PJ6F1*XkKfqWE&nTb_-oXjBjJc8A1W78%=qMkDnX z9|=|;x{n4^^Lpa-TDM`_@Zno#ARB5*AjmJ$`}xOX4~LCECbydxXNlDP_ws4^Id)^L zM6O}@dZ_aM01cm0QSIb?AFeqRXp6_>)%^i?@RN5Xk>ZVBIKMlpUu_({0 zqecwhR3!H8j>Q~1L=Z=Csuw>BR3=4f{skq;a$RP^Kb81=qEwE|1iG*>2cG``i1+J` z1{#i_IQUdP@)U!KyL!jLl>C89S1i^cW!v!kmB}oY^HFs(?;!sGM4WWWR0;J7?`!`6 zT}M+I=7|-Z^C|hYGUpl_Hq_C^D!v&qd0ql7^LmC>U_R&#`gg&2daR}Dwd3&xVeOiO z!aGpHyQ=#2$Q`Yv`iV71hI!3ZD9hL3r%kmk?=Y;H^+`>@a0Qa%^8E4ZYcw3uQ-4>b z`hNPmFB)|H-AZ4oo9H|@)HIP1OYqgD_DDRpQ=iqAP;bSo7Tk9H@zBK6eamW|Q_}wc zDuym|Y%0Y54KLJ6sWc{~%VcTkei!tjuwET?9N|bF>OS4^D62{KaCsbvs(-@@gQt5e z+QxeYA^C~Q4JoT9%_*~{_;k|rS*;vN6)k7!+QBBoCu*Z0JP)oStzMaDMi}zhoS;+@ z+j@djV7>1zbz8(sg(KnWSr;Axx_RV(^ltjeT=VZGAL(;p5X(`E{U z058!u`BbgkJOL%ZNj3(2Y|#t)e-J(+W|7bKjilj1f5EnCR_4d(iEMmvqm@(LO@sU} zu7(VA9zU?I?XEr|$=aGXNu)#tL;6y?@qNNu_v4>T06}eQ{sTW*craieS-(${6MUM( z;*79LeG#P;9v(){WM#M15Ey<~DAfmd_Xbn*s22s4<_vgd{YCCwU-3Ymi8OYLBE@56 z%_;{!UdR3G^6!pKVYsRDDSs-y=oz=?{;J^GkK(pK1X^E4KzQ|<*`(+F=ZttOZ};B@ zQS++2=&AO2nuFZL(VJ$U7&Qj;8GeRBY#Q@QIsX8OI5?J-X1h^a*@qwDg+%&IW`&2m z);{1DIII3J;*6S#JqtfUW}TB^_ZHy(Sozq7@~h%7=kwH=7~}CgI)5-z&Rd=QRJ?># z>5UkKDgA5}&AG_w$FamNtMW}xnTP#lAg4@NxOjA)Y)*8!pTv3DCS^sYw_JlAElYYw zxA|}-TD2zKFMy&w&qgwx5H|78`T~*E&EqXt2_#fBE=Q=-&AqdO1RlvVI0)NpXvF zfLATSvF9rck$B30{{ZU1nvEZKhMKxK_+~WKbWF*9+ipu>s%Dw})tB5mf0(Wrf_ZoM*mq&1 z@6uA5UyT}gDIkS3Ux_nVZ4%D~F)wbUzf<+L2X-6*{ro&?k2Wbi0-<;J(?@4U@d?Vi z;`*wpjL(*7U0F3mMMC_=0fHtZ+hLdRf<4b1;tsn--q;)TnZAZLOs3R$TU=nYUtrVu z)=;dg;^R~%yUFVHK2x6QY?6yF%p<9)hbw&O3YomI7?CNGL@I1ZVz*K)ak~xh3~P>l znXDjaTh+>S1V1jYB2vyLgcy2x8$tC8wug&?APk-6W0Gyte-zs1CrX$TMrS$w9X(}Z zQ)YXG5UZqlSi;Q%ozck1K?ndM{W-uD16X>s8xmvt@Wl4FF!n?z&f$%$M^Vist&jr< zkT2_yd*_mUsQ9JVbnv1};O?RjIJ&XSLbwN!_&s00oO98%TcmHcsMq)^0f1|ds_x#c zDEjF&AH?pq%U!cbyfM_S$~KthuJdWa{hyy~M9N`?MMijE_LUcETD!REYv=}-8ozn~?D?slB%Q~1h5%&#l)pW@Mx@8Hz( zFGaMdug6;wPvwpVAkX*ZKjNyd9rr&^K-!P+x{{Z?ff=E0^(?x3L{UJw9 z9#K;?!DU^=9LX3(B~L9S?0Rv6h8ByM*MR3a&GiY6$gBugFh*kkad`62d@b}y)c>CKE();lybdMD~UJi=U{5@)IXRC6mts&vHOgS!mHr8g@^ob0W5K^%w zC=7G@e8NBDxCF8EY6xy=o~(wFmc&YOM3;tLr5)(l-6i6j$`AH$4HtO~_sx!C)_W zzqImHyi-d|6d@&$YwC|jvBnn%utRr+cMT3yU1EcrVDWidEAet(n51R5i`WTCH ze|{Gi8L_gAH|R|;=6|Bg<}u|`Nl{9_s-73Hzaa7UIPAAQx%nv=0WyPn-%P;K$C=W_ zD;l6#(5Wo0c{jJz;msEa=7^&A1K5WVY0Svey-}f`%2Q(gSs)M31s4Rw)c~SLhWbj6 zHKWb5TBaNF=Y*t3@jsYI9-j8MKYV-)t{!D1%ru>Dr_bp!?2d@fS5Tg3lM;b*y@jlP z*!Y-U4yd{;W*!%Kk21wYSCYCzNwl`+R44~fea9FD)a1$zn*}>cJ>-TQhb9YOK{WMB zpx%;bRa6dzgZ@9T`r^G`0QZ@Ps2s8;)rRz(c4ORkDF<)mP!pXm(2upuLVZaZ9fkey%MjC047PJx0P|f_<=Pgb z_-CxB^cF);lI3(6R&4U-PA1JJr&_l8SsV326WFL@`QoQr5zsL8Mz2GXBM9a(*>N{TInPMFcX@ULwPfo`TRS5paAu@O` zHsfzAKCWN86^!HGx-s|nAHk>YE6xn>y)(Bz*DCR*^#jXo&2C5MiohpjV2Mt&E&dYR z*{;|!i9=KnmP-(3Hy{QVx4tGKRAI@v;A<-YEDj)hcT)#1H5(iT3&!gc?T?+R_z6uj zuaxXms7s3x-uM`pHs%o`{=%tW_Cl$*ct@vdcUZ2Xi(>so+*|kwjMaP?5v1cY$gi+a}YeJ&k!x4L9MkY$YW89?`62%~imE+zP%(ou= z^~Z~XQzmN&HL=~3$`Rh`!kAVnj@Kry$ z9ee_zSqX|Yog`?tD==H_5o|A8wav1yXIHJ5u z&*LqYm#90umP`C&%3$%gUM!NR-%FN(xZ3{!-tqLtn}#2I3mW5R@1MaQ@~hTcnyMse z=SBDkw(IveBn4N6@_On;fsj=pkhcn3i{B8Cr>3tL!4%L-sC+?hH3@nQx;WKO7P!7D zd}7%@hxw~i`dfNk&}!{1ixQOE~90h!4d&arl@SNiL{ z%~r}Is>uEApH&dPBcmVOOU3UjS--W~|(p%_f}GH1S7A zEVHS#Dj~VCQZK;!V(Q^@-{ci($9}=?OKLS02}Aw$8=Ksl^ZDb*C}L77{Pu!eyFD?? zuJcf|cE5eVi+=2K0nFa;ryi;9EA-#syO;2@!qwA$3kKv5-67IK)zOh#- zC#>%A^%|!i;TR44k#Du|5xP4?^X0>kr9mot_s3AZF0$_%u#kjNv;pY?`1%(HAxFGH z%c`W&`kfUSe9BA42>q?=kE*crZ~R{{r@&Qjq*MHFB~WRoW6NpblQ61Uc*p^n#{^h= zbNjF^7M5Wh-sPZI#RlK)sZkogA9R<8Ih8!pQB~%xOy!EwF6-LCcB$l^Ph38u!sn`ewT~ABA5;x>CkZtS+B={lc_J!}lain;qpX&ASE}A>kXL+p$m_JsPc}+}i%k*0u zKzL)tkwb}1`m3y8AHNUoi3{rLxNdFw?6Rp(?+Mc$o*4LCd?9)2sX}~h_yHs!$>L=! ze#r4nxP8XVayU!RKLzi?0)8*H7Xk6h@c#f4>|YaUh5L$Gh~wPs$3uoZe6M7#{WKqw z^V6XC(eM^TSwFhP4cmYM${YBmICl7$c=a(bosx$sJ|!k@*gw&KLu-;4dz z9QqT+?j8`iIJWK^^OKbq#Qy+6R;?7GYxjt=BOIzHyAHyDcEkU{Q61nv1e20UV zZ}mrbP5@EjzCfY*=C(8>kEiF3MiQpqRd?`%Iejv^NAU;YWQqXsM^Cl?01x-vXZYiT zhHxL;DMl@)LG;2VWV6YsDVH(HGYE4UIX?uH&XPpK?l3n(__w+d2NO(dW8P1>DwihC zBMep+H@BzBQU}`{bWa;81}2%`-{!bUl4g^TuS!jaEMZb(zKMEWjv-$bb!h^9A5 zPMw}c*!fb}1GKd=5nD(TYmolG_gD= z(bQ6`{{W)oaNUfapgMn(9Xk}`tDIL%pwaPK7t`Txl@eY$NuX&MhW%k3dX7E#$DWXM zmnk|RHfnI2!>vAuf;Fm7EjEIc47Oimh#daY;sN)r1u@8YCyhU$a!EA?mX0VYT2IoM ze4w=3#h`uThWEggaRgd@Zmxi8LEE`6$I^;#G4V>%dg?^^nb=XP`q^*g3-#_tz8TfS zw7B(0h@F7)S(Pe~(bn6XE-RKQs8K|Q{F_CHeHp(czcF>w{ukvg-=kt!-PVOJEqg_8 z-;VtmzaV%uanqlb`AewEBC^RPDCihoI}gtiw+=o?@oMDa4w=6xeUgIgKfI$GxwwkL z*zD3DCBHR%D@VrsrO_#Fge@4`+^Sn1bVKBi2CjNZ_}@&gsYb-c7M&CZ7WDIT$3Mp& zbYphxc7^Xr+cr@O%*!@9x{oEK5yMO=TCP#$*v%O`Kn>c&AHDDuO0V>W(r5vpxvnQf zLj^vB)HgE&u}!KesvBtXJtEu$u?O4hgI>wlUiN1+4LX2sy30i}GWl>=n{&49j`DVW z5WW=w)UUrSQlOC&n;r{uZ?-xujhETm&3`o|Tb8^;+zxGzGLy3Nq;8VB{Ed5?`Azt3 zz{gn~$$8SVn&4)u<}M zS!v(xw-R(tPa$NKT;r2RlX3!g}Ck~~s{%JUIoDVQ5|^6?;LL9y{s^sMGQ z3?%bpwboZy2s?*9U9l7ByzHfBC7MsuDOt&LA22wld)xXPkEq9e6T#6%=``Xce}09` zS&K9d$KPi-?9-@rUwTb2B3Ja8MqpSn#UNq_QEofqo{9T~=)|*{{!D_cn{Yzr#{6E# zA9M~Y(~4-`7om|??f}!95$$Yo=!90 zJa;^wwmK9lE(R)@)p%@%y^iICx4F3fH^+Sg`7Zq}oY%$3vl7ZYyZdsyW0z2=$$0Et zK5LN3D}Z8RP;Ps!J{V_>mtL7pbzNh~>sWt-OM%yN@rfCSefl&kJUyo%w9jW+Sa=W`|v|8vB<(y*e=dC znB8@4KU={t0Dq)iapSPH4$IF@XEo|9mZ&giC_63PdHy3GGYaBv7Y@a46r9tVG*Z0dRZdofSQ`ogcT~FQdz{5FsagEx15?5LzQd=~j02>qY zkb{5t-a9x#Ie3^}jAMIzM6Xw)*}Ue|UQzUxHIR|?zpEblIp#bJuMR1^iSBCP-yqvS z&L|0AYUp;`>+8g44cesip~>Ghctb!{pY+~ZMf!^9Kp*k^edx|#dRs=$`K!mBmT>Ey z4Pt@0z^H zS(6BZokf+PKezfqp2z+_j~#<2mx}OWqh}xBq;lrD917lMsmbFO?e@a(;$z~w=A_eW%@YeN%dav7-Twe( zYJPv?`0vqAG2mrK>7Rn{WF{&6VDQc<-kyIG^vX<&xW?JFJ=A?{`0LQzZ$AG3AXlRr z2gPy{_|xMThE;k#T39?w$fuS{`d5rnW>HTeaP|PAlEHc9x(@i~7lU!6Kb; zc&7Xx7#mzTf(BO$_$upA89!W-ESCfI(MVn<76cIM!Rz<;#Zk;G^|j_S`wiB+N#V^A zq$F|Xl~KCxo?U|AT0&Q!zBy~jQ*>?Bc$R9qWhLq!&G>y@o^k0UZn|s~)~jtte}poP-Y5;<3+5t;*Br~H5&uugFeqRHB44x zV{}l_UNveBEta;OO<|eBuEondrg_Ve!Yr@&BOKTd!~3uUn(;X-(sUYqxu^|$-&G%7 zNmnd2O<5ohQ18BW8<~mjS-O+lj<_7r8K+X9&nQt2Lb(NWnYx%~b~YPS00-QA-wjPu zQMoix8(k4Ikxj2?XedTO9V4uPw?zBeQ}1rZ{EPy}bO)+$jpL5Xy&Vnb=ustI;sof_JPTBuM{$%<%v3pcG{|DI}X~=_Y>;3)i5kd5oR=6Yr~zv^BSdzpLIE_n9U$#?SIb) zQL9rCpdJDicg1jmo1{q>)XEg=ddhu69$_tXl2peuJ94>Ww%F$#JkWUn^cMQzt{fU< zMX%Q92{SPLCdz-IejWTo@sso}NtIOLpw>OxwYrOP~&9!1^wH7J%g61G(Op%Ch`}SNPA7Y0UPmNXxRIkh(cM zDzKe|l3w44UfkQR0(;4EbC}lYIo@;M@j9dJDno;$1+$*kftTsI@u{Wt8zO?KQ!y$ zgZWN#r!&cCYI>Afh!3usSk|7Z7Z(K{CjpfI06ZSXK%Y4t2Tx*H{0%X+`=LF_lTkj# zk_T&o7#6v=U+cjvU??|G4f9C9wd|%je6^?98*)K62HyVwzXbF`R6Q77qsX$jlVW9& zsN6_mI2Y=0b6WvM(RAgqj+K1sdMa?LHb}cS2VZhNxbzuBC}wZr_D7qU<)o&IFP@=2 zWkK4__8mInP`er`_ndq_YP~;M9ezcg(>t>TR%(GyBJS39elss2d^iCHqo z7Il@;*G7Y5GES*3(0Ovn!~Of>CkRoP8X^PE@V4n`Ry*F|1=NcUNcwx?IF-N&PG6bQ z<}4B#$mG}>$cL38*SPJDGRl+~P5F?ktf`IR%%_E|v_`!jupi{dhL~OElq$|N#MyK+ zWi>!gQ8eOmm9aDhfj8PWelNKGya4J18EuL>m0gju!|iVdn$+4WEv3t3proqIDQRS; zi`NgD%q-tPdA=(6{0pB=?s1Yj-oyOr-@>Z_QKRjlTWMIQ%+)BL;RZ{afPIh3OKW{S zu#XO9=e4gtlAmJF-bdrJ>naERju$Q9#Zp`cT>7vUKIKyX0Lv47(2u{={90b;FL+P) z)jsF{0D?JQ6eqoaQQN(aD$E?!fG2#k0+lU$dagZJz3^o{4}yZOqs4!Dd)sMqw$~Q- z$FVDsW$>vb0boAAOnACYwQ+fplmNd#K)(Q$HtF2`aSQn=nqegQRYY>$wg=ky`K*P} za;M+f8G-)*xc-}x_wuv&S$O`C{{S{Fd=SH#+A94-srTu7=zoHQswv>AdSe`?cgxbU zDE|PsOa6RQDG*J$4>hQOa^FclNu$JCWq%KRMrH$d=t{cv#(wW?Z!Ehxfe{;x^kX6 zhl_KV%r4@`xEIISi26O@6G4IQ0O@~mTXEq8i64hLC1RPGUoMH!*!BdCzm_uGSnE6S zo$o93CKLkDMwuD)Rekv1gl1ZAL((}Q4AOn}J*0?#%W-Ak$1L{`HB9@WWZh@(Q>3VC zK=Jd;*Mc4nI>%og{xo69E^{2h>a#}`At(p?XRev((<%n+B(~0|d1&LK`dpydV4KhOqWV@SKWR` zYvaQ7I87O@O+=9A;uzF2W$hpqwTL3;9tT~&j6KB>@lSDIre6UMo#7{h%!cv4najdA z`@qEu5)NZKzNgnJ-$FA#y}wbYmXxw@TMg^TKXHLF-$ZV48m9>;Bg^Te%(E$@prwQs zl6r|&DAfm3xxKJmJS*RzORHmBPSYx$>+g+8Fvr<=gFv=-`=8MIBxvQmu(mNvD=$ zCz!T-^&gfPv_f3x%12NZ^)gE%0s`2EC;4JXTxNy*C27316-N6BTi><4@zgF{^sQZx z#;OA_0hvf2k>?*pmx1!WO(jV$X+v+@=qk4F^f>S@rF8orWXIyKAL1)MYt!Ok0;Pr5js; z;C`}X;o4`74<{JM@G%(avQO?dt;YSZz14|W*~&;L*l=RiCdG$ zFN(T~rk-k*f@o#T8*3|fBl^4HUN)Fx3=6`ua6&6q0EKYOUSIeroyfNKke%$us~h|K z_r_i0xs|^Qi}o*sF%lJTQZFak{r>=lIfc-Gyhe>C)3bXJI`sSFhc$diOMocXk-1xL zu;SR2vZ8g;+C_$|cu+U~$+tm?S|;iz64Z;ylsgf$?Y+LZ`K=(S!-OPtH1f?PXU!)NN>>^v^S2V9k{bQ}vD_{Rx=mkIQ{v_p;j6fw*A%T>e zn=RY9_wS7so)A1wTgCVBv0tC-J*_$}HU9t+9zE2BAKhXKebx=~`2{MpXY=fP;&$MG z=i>9^0tD9ue}8wM9pxp@ivfgdVdUi$gL&-5d;M|gz>&|v?opgTTZ zFO6O{#_Lf2HCD(AklSS#feA#MFGJ+b$ovy;Ag^In?p zlTYGzi?u|t@xwNYi@%qa(d`4=Sd4ryOyuvLe3v~s;=UkwvpGgSIA_H+k#R>#yMgH3 z6OWDtpC^3h{*a;R(|hZ`6yY0>j(UaBNe+CN2Oh%M@Zf3kJ|*Y#*Dk~^RQmq_#Z})l zel_Yj_grja5{*|^6i0>fkW`bw3!iC-eu-Xg;kerJo?oDf(NwZsw6 z9X+w|!89(-dD(wgYOfI_2(RMyt0m3%MVdIcKW}V$FkoGE)Al5(sddCjEHikyteFo- z8Qh_P_Tv(IGY-mD;s6>i;hbwkNeA~+)$(q=)wB6Zk;f~3jgF2Hr%*gZu7z>!O|>tm zNrjult!XD62BWDAq}%<+9eOK1OMYtL)?FIAP>`_6;%>2azvBMcDs69If1Wz@R(zKG zAr5QC>!jmQD-$1x`o=^H)B9E9h3JAO-7!nx*~o(#dymo~oD#meqox|XR` zuh5V?|XrZlTRb6+h_#UwOj;ydhL+y_}9ls^M$X)tU@Ra$A62IH# ztqj}}H6>FkFJaG2bZ9r^wQ_MIWR)pr21t`vYPBbZQ>dzdKT~XZ=jhuOJ#M7Q8cx=xm}?`4Bn&u zHa&m89}FW~qke_x#Fh444U)3R?@^ga`k@$ka5Y`*l86HOO~dSMg= zqpf6N>PO6Ha7g{Tm-^$ghX(MyIJipX&{}F3QB0MVE;#w=_AR@cK0X*=c3hlXuA{@; zl0fdURFvGLDXpBVTlR(D9*i*Lz8J36<@7#A#%U*6*#Pthtek}-`XkI2KTLMqFdHsi zj44)U;N?D_rl8GpI(k;h^XUBAK?Y)7-^;SH%^J(OI*uFbZigPX3@1ecv1zDyeWbuq z`WinjL%67E2~*P7^A8x5(T$gb61*>ldN|1KE}x`fanI`s?`wMc`{Ur#qW7l@qIhwl zzgr}_a*j)MXIU;S{`Zfv5TzA@{yrY)xsU6#-4dm@2=+7lj-a+AZ&Cn_|pkW;t~zjN;_>}}64!tv9# zJrtv5$>Il^PyNmGML?O~BZYQ0>jLX${GXBSj=D7;!UvlAz8+|;@d)xLWRm-p+D9pK z)D8p;@b5>HOs67+f-^fKJ8T5-PviaA^P-KH#~x!<(wju-Gzk)9 zuv(qjqk9v{>MTjWZ?-t-dl#Pwor?Z_52fiALk2@jbS%X@y~gLM-TC9gN3le4?mMro zrgXKV5oAy@tUF^n0kAyuKU{gyb}v0O=XJ_0J*R2Bm0XUAn)V>TyR3cj;iMNnl1bGh z&9uft^77IqRZJmfEDAyeo7&?a3S5+)ka?xLKg2r!019MWt2bAw)AL%!_i9jk+t_jY zv0TS+u=|Cj{m*gyjtr@$$B|aS8irarT+WV9K8mqKkjog}7#`%}jav!P8?A1YUYmJ4 zp3RpgMxG@EHOBbRS|I@CyPNvIa zkL4q%ia4i`FU&a#Kp>J@-3Q+po9Ue)N70Z}GJ`Xt4Vz6I&^$>Y*&vhg1w68z;{`sM zBn_c>SXxOdthvrvm{!s}(#mVuhQk=VBAVPWKYV&AIgK%*fQ09t>PVmEa^p~jAtlWF z_y@VSe%OMJA6G6&n<7?qm1#_;Dax}t+Q)x6g5DW8ZdU$}bACTO4#z##3(SBd-Wqs` zm(%KjlO&NmP}j#Olgm4!r96Pv@5Uvqhsx1V_k9SeCuKVLYt2S&uC@DzX&|1ywn$_u zRZ5d(wffq}3AnpJ=)V(sH4m?C)XL|GAyk{5BK3| zl!e>6;xyZ1-;ZOC>EP;O%)QTWjgX`kg;T zcx{zZ=zNV;qmAQ4nz7fj`K$t=xAaB+r;ItFfu~8aX!$G|M~U^64r8hrH$2>A{N0vr zYHas2)%k@+ah>LMd9GzM7M8B2XO>nz`aWc2m+U z5&^c~Q-SH?TnrnH!28?2W9{D>ud32x_Q}~2-)gG*x;*~?!wSU8{6f<8nr@-?k20wQ zvdWA)nuBgib(1r+v(j)FaX4R1_X{l?T(sdcvO!s&-@hC5~Uf6n3+XWnLGkhG@OFjq#U}_dOY7O zRL*i)fdiRQH`{RNt^pj8)Z#Eggp8#`YrIv`TAE`gi~bFauBzJ(rqCzlCk|Jao`suZ zTd5XOIqQ5#S;Wv*}W>Kr({);1#rp-2YX)J4!Df46iZ%` z=-M9y_3ozAr%UEqlR|1Le8QHd4KbR-^RzWJ5x5>*Em*UFZg%b*^K01QFBJ!&b*4mn zO0aN;MP|;I_br>K%X2BKv&bW(kk39>nnr*j8>D(y0aoCSSlD+brYJaOxwT0xux&x? zXY;G3A?!4Pn+MbS@#eGl`ybgRZIF0VoMgGKPgzG>9)CLs>ZxUjk3t43yaIU^KWuyV zLh)9!i#oy7=|SxoQRs`{Tart6-3Lv=%+0NS?y^h|#_~Pr?gxgT^g=E>Z zuQmgnn2ePztW#=|%tCMHk-@q4>5m(9K{0Zw*Y-j5-fN$DQIyhUxqU@tLgvuSV}>>@ z8m+F@9G(g3i+2orXg-;FffWSymWcNyl<7MXDz=!+bIU|p2<3*`h4abXs z_pBnH4XQxuyHAtaRH?;fM2j@ERfKf((#UQ1;NlNSY2Cj(c`5z}sy-{P_y@^1)zDYT zB00+|m0C87cgjh~V1LB=W1(HA<1@v`iX1MbCrNAkDUyDj7R2~PKl||XgmKbJ778?t zgsAGm#NX0Dwlhpi^Sp?jv$v48+&chh2GZ8+>soa|{{V~3uQ9I4bTZK8HFZKf&RHc| zXdYHr%wa*W2j34kWl-F~#5bs7OmbB(x(aTq8Dz-HLOe(izb)=b3Fvq`5szB2-zyC(LjF0CI1EaW&c);hDE% z!H5qJ~cwR|;Z29C2uwC8PBT>M=4eXMiO74! z(W&S~x%S2D3yWZ28HKr+S#KA>x~)J!v2C)6+@Ka+;jXug#DhX=Cw7d3{ythpUIAv$x8Mj$^zJPe`-4J;R* z5DxvMLb<;Oz8~v79bK(+4EIRpc}!V^6mY<6=%uHS$qkRC90PCi;SUvle4)31>G6en z;4Bo{=^#y3>ha0j0#(s`pEa8-&tMr;->%E+A&7Zxc_nzr3cpftj}FqqE*6yc8urv= z0w($y=CQXd_;B%i$fGg%W2mGQ?JBm+s&*Wki#F47i|?i|@9**jWM>3EGk`s$4bL(Z zu0H@gU51Tf9v12{#jZA|H$TBT;HU4SYh$GQ6@$vnKWd8sLrX0uSCu#9be6`{{W5j`r)=8hX&m!ua0x~l|^-CrPSUeSFUZY zH6>=EtPD{Ri$O^dzXCc${aS%vZ_S8RFAOZ1Z7Z4 zM=d%6-nM731xe!{WnRkYl5JSRf)!1RbsTobg{$21x|!sZhE`pqk+hC+^6-?6p=A#v zCi8L%+W!D-bQcZ_`+LsGZKXnxKp5?C9V?=4GNBv+zyMnxF4|XhLA_W(YH@q1z4^z)FJ&N^9C}2A?l)oVPCSJ> zO6rja+BFSiUU}|u0aJy_2_us^$>k)gt!xE_uV5T=Zun2cj8iJhzz^TTzV-Q?2h3N_ zDm=6sNt#e2kLt~Smd0A<5J~3?^g~@?JeN3gtcF#nVXJay+@RRz5G~EUy5N(9b5Q3H zEo(|hE2$(%id06@E-&uA*08sTXw~y zEH>PIu?0tof_W*J!^t;lS?T4|`k9h+XOAy=5G!!*I8aYv&KTgbx}*-on~P>`7hB@H z$x~V?`h=jPhN33(SyOU#3w}+HaqW#ljW7cI;a;KLEL_pjBCK|{?W5{DV1rC0-6HEx zT;Uujxf~Pij>S1#=Urp0CAlud0C;NyZpZJAIu-9olr?m5NV9skk#T;D^vAsl`=(z; zVb0HRBq-q*f46jz-hX3uIWDIzs+NU0o5w+wDAae*-mfTm?hL#)R)ny*kmtyQ$u z$FPO`ETr@}Ug32(bfWDxVyV8G0H~C{hhx!r=rC;-uN>%IMQh5@Ndtfvp&!Qvnqfv> zx|*q6GB>SU@&{EXzCIMfvN)N2>iX??4ns5LYudp<%IDxw%v7Q|>>n9CQFKx<%fac^7hv6Zgo z0bg{>q>_Ur;;AOfcTw4fKIj6FRV&NXG{kw5*pYAuz47Rv7hNe|4MF@8F^nMuHSc4O zdJq>vp)1=MG%mqIpR& zR7#B@QaS}4y5qd7g6U6D=F~JH9)~e_ik+yBc3TeI_Q$zbQn@y~rOEu|tE!5t%^!*o z`=ckZ2ev$g^ul%1y0Vj2K~Qqo%uHA%lE;bbyF=7VKpZKU!D>-+K8q@wAiB?_`B+79k` z_Z{&gX()P0T})(;B^zif`zGWb`0FHWzRbJ^X-J5%41&tb)9a7AIa0OD;E!q>5yu4H z)+eFI#eqwic$F#v5&569!-LlSvF1R&E-=3Ngoa@l-k>R4@<%r#A9P@^n)0|Rrq9-b zq>xbeA527P1usZf!aSF{Ty8fzx)bk+DzXA1o0mGuXzGNh_r-{{WUdIlDX;Ey>AzRh^NT$d7Z)?soqCa6w;41tbEYV&Ce6wRl)#0Z4(?YFEFe&lktbd zjO$I)gb zu$~$#f->p`G}Mc4@e=p@u{dxkwU+?6^KqY}LEIP2!x+>wa$t{Zjn9g$^G`=Y8ahB3 z?r!}_J$XI);&9hL*3)GPEv8^cY+u@UO!c|LkQ9?^AF;&r=m3VTi_2lUu-YG5=`5Q@ z<+P8H8Fd3zR5ew55wKHV(6&8KUVDCc6A;sw_$#*q#x{*0NRmqXu5;ZbU!`TrD|Ecs zeyEnBI=Xz)Mky4OO~79$``d=^k7;IY^&6l#{bp9`##8!LaIVOqqW=J+_?q2;C#Ai< z_+Z+_+bS8L8>vrvLtW}m4J%;H^uD95%IhO1Z1hzUK)?~my6{2vJRE%LO|NGG=j|6B z3)|8X34_ULr-R?wUe-B83z7JzkkV^hq^`$yjyP*dY$KiwGIi&2-|9KS%G@xK)i&he zm`3p7*8L0CRueiO!SfrV-kQih6TTxqU!e7T{u*jpy^1pVr4dt_hXhztR1;4zB=X3> z{{RdwsK?T582}%RE(C4YZ&(gnql5DqfbL)zJ@9OiYu|<68ayP3)-F>|t@5EAjb=hb zbtsF*=cIPsAtSV9hX(ezziq|kyMzH3vzzmqapQh#$5CZZR>zSLd(OstIVzJ~7LnGq zs~v45lzFui2Dhs(%wTZCx1rUpI$YY=Yey0)K?cWp1Rm(O+UOdXN3|0xwdajB*>ygi z{^>_H(~9cmmpO_Ws^nBCAWor(ftm6e24oFi-mEyT*bDCD9uA^6pzY@BJQahe* zZT2|kP}LYhiBM@BL8IZRm%~k6nQ3RK43%(D)=ZSsDe4*%!1{i8m>EOnBURFg^IWEm z8fxmsuBIjpjs=BBbnl2F_W7iKrd1xqrY^7*q7s&ttVc~w$ow9!*$2o%Xl zESFWCLv<^Do$rKPRK*t=fCcZDeq-rYUJ3!K+4oMxX{B$29xPDQzsr15=i*g+yfS6+ zO=tEO;=}qlrXDJEcxGX)T9t;wajAuCr-IM%ZMRa7GtTSdX%8It?jI60PFCs_^xY=Y z_h0v40-SX>>K*=FR`Vmx7&uEg9|p7ZA0)JC?;e^J^1dMGrEzd$n@Cbz+v|@;J%B)I zJ@}f3-%PJQ3~c;p=agI7P$>pOl6c`Kn%S3)IeQgbY=cWuhCh6B>1L*l%l(zk{{RaR ziFOW+IO@IKzNr5I1S#q~o5h18qj=Zl5&biTUeJFM>Fm1y0FcMR zyl?qWUiu>q`Z3~VHO-TFkuMT><(PqR0gFv#+iq|9-}rmu!-)r3J=H1?a-En)jVZU= z9z_ehY_9Q(M&R-EzLzG)oyN0{gtMK^=JOhE(y*p#~h_bo=c~dsLWC z5Zq*pt)@rdinBA%EJSw9_92}%RpOp+QqpQ47b2>hs+iskh5%G?btQmbw%@J$Vmi3C zRWcf9wxiGHx6N8GSR;gPQwBLwYkxS(dYez{NXtl`C(jp@eJT1Pk?zLV`;H81!OVcKoNVJ`Z3Xpz)71y{7Rsm>=%fR<;Lp@?>!7Gzs1b{`z*{76=80}Z@+v*yJ884|m{y zcDwXSLrP5W{{R?}H;1)R#4qATtCXKyhD^YM#B~=PanU5-^FN%a*#g}gL}~VbmnK7* z(MtdTk{+R%yJ<7^ME{8raMin8teI z9(#*-`{TbzEwud-fMx=bGtslge3xa=^VKHC@kd{UZ&53#j@^aHBajU`7l z&YQ@5JjvfZ&vl-*N=2Dr*+-vL2^6`o7CjB|+aBu%2_{FX%{4yd_9el<&QYYB`6nGY zk>uLBW_+i_U3F4vV^U(1Q`CT)h3w%7Hv=3q7-~yMjr~?@q4y!#gkXmN*A92{PXofb zdCexT@UDft4-2Hv9-j4^Q z;iJBMer3{kW2RNg|H&2~t8a?9PMtwa+Y=D2ljlRo&VeWBc z!r>{=um{KX1gjBT)DnHrfg+BI3ZYXp^;wN-1A6?zcdMx-y8f}rCeWKODW2wq~3=QgaI?c@tvp4jPj0`DL!g}~inK_1L8 z^5`_KQ8Mgh358RG=<%JF~2c0oW~%3Y-Z^WnkNz%R5I~ z8yo#G1Cb4C;X<-Qm}J!?7KLkR+E%}-%H9KiJSfMBrd6MTF!aI}jLDNxX0m=I~> zP3^d<3vN7f`P&|b1smRP+*U&TYSP0^;^uxMj7EgH2XB$fCzb_Y!X$4X%x$?0k|9=~0&z^{ce!T=f%O@z znqHc!wqrCVM@oI>QpWdT*}r}Ypty06pJ5IoVvz;EAxBI& zLbbCNCdDnsBepvV7a3d#V!}IyU7nV;y+gJ- zP&mTy7^jw5N)T*s?r|sxV&tK>KpM$#TIAaJkOk;^^hcQ9sK^9fz*}vfdG~7$>8K8X3Y zmFf1!FuY#8re}~Ugj5y_YxMee$Izm4<#R>c$tYGP#Bu4r<&Q$LL7IAhe?t?}>+ zock5YC0W^b#mW*b-}3#~`AQxak13AEW+T>Ygk0MkM5(j$OJ*#jlNs{QVk|F?A$6H@ z3n1E?0*<@KQS`^qyp_$+)ofjbnH!ONU+OXRLim)PyDg&3Ji}K*6#ID${I$n8`9%;_ z9r4<_Z8@#0sdDE?qmC#B$hlBicOU1D3L=#-=E@tzt@QzI&{a8918@s)E$@z0tzZl6 z+W!DOMe`E1l)q)^^~ci-kibf7I`2G`6*bOp(%$&{G9Xh5-26DV>Ab%_lQ*UnaxTLW znL4L^zwY+OQipg}B05y1R}fOF!oz}tZqv^g?Fitye7Ie}gXV0u%k>8zC>&vZT5_IN z&H{@Ip8du>3NlwoA@gp$#NdPX$E%$e6+n^7T-keH+~c6Qm|USo^CK|+HXS|2JzRk+ zpr?@$#?m6)>ORLGDTSAz2=!j%Saa`>l#R0S2t|d6v+^vbx7Qy+@R(fXjrYd4Q*&}h z+xoHL5Tqs&IaDNYwTp7Yo`aE(7r?JGm3cOe+xGfgej9fO5WGqyr6J7cmXeX?iB*+W z&O6(=7)@M7(@I4!<#p*(Qz)-t>rd4qo*8|J?mh6lkW(sdgyEEGY|Fx#rIvy}J0z9F zm6SKIiEqr2j@I05g&3R|tvvQuZUe?m2LMfpg?eFBsiB~+qp5QRZ9H>Ru{XLfxWCum z6qiyX+wNNvDu$9d7{cHaxHn6>1v4#Y-=f{jpt#& zVB7s98+XQGf#Dq!rW|}oi*{i`v&{tcma)lvK+Ge|weN`Ut7eUvljn0E?`65Q zmYF>YKHYyTTxduT&_{S9={lwEV2Pi1l9AJD%{LOHIWA#9(Z-=y$*~J=+lSwa;IQz| zTFbW3FBV7_GHm+2DDs+l^Q_H=<)h2ds%B;SMx3AJ?~beE*v9MQw~y$8pl=Oxj-Bey z=r4j_7Q9M| z!_#GnbC1brll;n0na%K_@Vh9l&U1M@N7gia7-^2#PX5}sRV2?ehIOiHDm5mn&1y4x*)J@z z)lAavC%xOJ*l~}BHLdDX0Co+0PN&5)^e{*+mmb}`1&4wTS7*PY<|*YxEMuaMgZ&s{ z${EG=OYt?uB9HzFX#W5U{AaJJ%JsIrT@4`e#T@cdnW3oMY|2}Oj@A||z;oW%9;Zo% zxB&K$;s_Y#jk5Fgm)sPMZ=uD8*8=8IP3jZsYiFe>j)m~k2s z@w>-u5u%s~zY3rvUv z{=?jwbdHyfEk~#5tE6#7RbNdT%Np+eOUMj=x5w^-O*`Tx4pWxuh13yIWi(X&dm=$4Ia1+i+Bp3qYS`bY-OfJY_<&g@ z+2;AV$om8b5#hCKWI1x?4mnAatWRJuZsMt~QQ_u)oYu#eW%*?Fm6H%6r>2a{E3xUd z6c#^_;|zT^z40KaR}df;fPOPU1L?V4Q)N0bUI;d^AfKZ} zRr#X|)(Czz!a0dNVmu6f(`>3mI2h@-hC4aVr8U0iygH)2)j@Mpx|75pL| zW`x&s!2}T{^2+x$nQH)d6omdJZ4Zx{E!aMi;M?$p zt=p*Z)mydr%J9#{NYdItZ&1RI@=w#o@>)0PU0Bz z-VKTY^xsFEcJ-Oybsi~vUkI5lzRRCD_;~Slhdics5`Kuyss!Fh+7FlKAoG>~00^_M zrrmMVYrTdI&f@gl>~u5f5~D8;5=LI%S-;GyKDx>Ee}nZxhs2#Fm}JBNr!ayeRh7H9 zOH{^6f=^LY4t zSD+@E{Hm&!Hc5gm<9puV{jtd_uon!bnxyItC-UUEk2axm6}qT?ZHn(1aOhnlWA#e1 z@M2q8qPD+&^dO+W3rsN|;MRO7S@vdmipjEI!>y|lG42K!7Uqh38cd!^;##9EOmr_?W0i&WY`+7OiJw?+*n|}uPnPYJXUOa83+0L&$3`O{2Xfb}F4OSb-dj>Ynoa){{|Xl(~*s zQd*io8DFUT9CGJHjf-FqiltCINHPj>N_LV(c%ov)z}R*BW8RPwq$Vt&dZ)zPlSt|e zlTB1N%v9!%A^~Kvg})FCKbPACf=gWRBrplQYGcI&{8K5A34?h06w^D*@_dY`t<8eR z9fONpt;s!o`NTCU34zWuje+siaxsnZx{v3&u6(mqXeugU9ac}Nm4U27bcmB>X7)TB zPR5fYoif{=V;^qxC&DZM?qK;Y-Yo0NO#zp?<r`SNA?r5t8CRs;IIrpJ%n&I+l8ENKSe(d{3#Q+^#J z=0*)u<7Hl>(lxmz*eWXhM9n-Q(NtK50RGUivF(AW;m9C7e#PUs;Wy@-{vAAE)9^|t zYl_oXW-%B|L0~t$V3j3DW9{18W7F4_(GCK!G=(_}8tel+KLOFq;TS(Recij2-! zX`(1tC}zIp1E97$uYu|{)a`4Ye7w_YTy9Jojg_2V8Yl$|rEDKBRV_+IPNw#f>Cc;6O^Ob!xtk4{ui^?qQ(OdvG3m$kszY<}eosIcX?np6z--p2{ zN}73;yTvuokW`CwJ+aej2Z=hb9MUxGK#z)it5oNH7iX!W^HG*nqpX$FObw1-{>m;n z01i*v2T`cnZVqrIqH_V;r_%_0t}Y-D*Adlov=OhgOf196bWUlK~mri&$lMsE;?x>STqh2ZG3450AxCYi$-Vn@$A+L9u0!5*c_IOi?E_#*&iVdZa<%vNC+@L<9 zeXod)DXXzWuX1>YlUcltJD90&!1ER9^()CZ_*Vx-!KDdqU8yp>#H3%^?qy3SSEyqV zr)Bo%)%)={shLDu3D$I@B*z20M&68>MNc>*rQl zQ%LGpZuYE(HXw3rr<`<3j1ej^nwa$UJe8F)BykaPM1b-*BoWrwjn0HiSV>uQ#2ZywDdAEV zM)d@5-k)IUhLCB?jii$1Gf@LGuYcIAkB0QHQ)*o?O_!jaj!M{Kf?;!da%`?ux#SLg zu};Its5@MC1IFCe&%|9gdW4&beCJ_r1(-f1Hg^`Q)}PwU@y?XF&T5m>)Q?-Rmz{^W zx9-KQf|vkQwS*rZ*r?Agdx>lvW_y+X(#bVmo6>DEc~Ts@79m!_NxtR!+Z5W21;hs@C)#NS(y(`$^kInfWA#g}Fpl7gm(E)^b>s;D3^fm^dTKs(`|40P1?B;0Jp5ki(`csUC*AC@oD>1dFkq;w4M%{{R}-zkF*fG8gAOQ*xN^j_!UcV6^c> z2!#ch@~64MElJ$GY}#FXy~K~ezqM}19WDq;RH}q3mwR%)-%raPE`s=`Fu<&3N%l7V z`0`h_OIv&aOKrC0Bb)Q}$I=%MFq$SDL0_ zR$zvmP}$l?VPK>#>;C{OCC-=^r+p1wQ&mk5>s6LXBxxg%UttE;{;`6nzU$MZqDrdm zCOx1latXisKA3uh0syi=O}|$Zk;}-cfeUa;HPrpF^uqcfMe{7c($qyuAXS(Uz&BF3 z2Bl)sq-{C6k(K$Y7>46wN{+nSrVXV0!3R`9Uc!{}(5~P)AoaMxjX}7|@I}_{I3(R~ z&(heGF9C(x1mluL_)&Y1e!qNlx=GzoN?DK#a7WkQA1@_);sB$}-|Fq!{r>`jL+pW$Uxfu@-56RQ9kI>+g@3S<+b$x)tE1ufXS=e7kU!;wVwP zu(F-Y%91(zW5T3hmCV$~5=y3_H(uQ&rTF6FZBW*lGM{`m7% z%a{ey$CenLCHa+%Dw56}Y(cgp0YYxP$x}?O7v>d8jn~`_)cvvURl#&Fe>qQcd7~W| zDPT7baeRA~a$O;FsIH-B7pjgWZ`(2f&#<;W)kQ0(>53>vlNCxA{*C!z?lJKSKw&pc zo0pTwrkNDKA(@5lzkj|tE3Hx{%_}KTxz3|iX0sMWAqemMamwytbca5wSlTn3Qx)p1 zAYJTz!1lgAUlr1yKFt*zy=@~&`$x!7rMr56pT0a_1?Xx#(o%_2E?wqZ(qX3&56ld3 zN}0TqLhCB%B9g4FD?<~wWKni31-SO>j!Tz?yDE+27FnM7k*J?MqRO3w@xv0w8v4Ih zHuUd&KwOKYa@jHIO*5QRQD%93xqHD?w5_FGq+b288>(ep7J^jEN_;%k&Jv?LsS&J~ zv`K4_diDIV1FI>+IWARy4pYTD3VQ9)@3;;DJ1!4wbJHnu6lc>qlP~bH8RO0B5uvEs ziV?2BfO-#nO3LzKK>993NJhjO+rGFS?^56{-r?V{#fvdUK+bD6?&T~G09U+9a(`| z;aZ)Gk<)NP&Aso_91#ob>9So%LrSPx3btN=M@;X-atH(4z9WfKhe}VI>Y8}+%BO;w zq1}|PmoyC%SogDg{V<;xGK(hIYp8^Ird0A}R5_C^Jwb_DKQUcNx#$Vw379kKvSw_F zl{9KS6Z(TF01FVqwaDy#xRayIq^D4@$W!eftDj9z1QSamP^jDGhPX@iA52%Vm>@dA zY1|j?gofmJw#v=H<<>(TMI^hRnQkBUhtT4%cUm<%!Qw%&(Q+t`0;FIM!?^w(Ky~>120$RWlTOAX7FB)xh zk8xR5fZAC1=q-+OL0#$+I)l1LD%ThNo|uWwQ?OZo|JJWGKNnsf&MH{><*ZIec zl#ofF{txtIl@ZA4HEm3A$3e3Gk13r|i3jm=Y_No<<|kmim;C;Hvp;L-)jPI{P7FlR;aYcZiu$hZ9j_M{m+i-$M{v@uBY*a zqOy}nWgc3?7noZzN2H5qP0GvwYkfbj2(cB}has*Z#LNZ|_gXeOYK)}J;F3!~jc4cr z$f%MhiZw%Ue`%}< zwNf&Bv87itGoL%oUt=?mKnBbvT7O^EBN&;+QeuO0eJo!bVI>L=kR} z5L*&E2p%>~(df?^v$`rxZCj?H%o@8lhK6>XndO#+L$#aY2zM!pT@afU#2N@4I8N{){YF4h*CJK*kzGC%PYwn0u9@eK)_Wow5erd zi5Z$;j*nKmv+-4imKv+6mpHY+ww`R&Yr1LlZ0elkwV;RGTS(bMD1I3}B7PzA3aYxD zSRl&YvQ?8QugzzQIOYs@UKZnqzfPjqCWjQm(~(V%cxm;fnClP;)x(;s@mxFJ@zYfl z%bGf@ruPh@!tB&q$(k?hUU;(vZEVL*!pukpTJRaZ*Z0BS4mJM(72VnCezHn1G})y= zJjEKNa)bLB9xGB*(oa>GWD}xK33x_ewq#cf%l5G3cj<^Lan^>A7~o4?1Ui{B1|l4H zUXC2cI62j%0wi=bTWJ%mw4GJn@q^)q!hI1({j+7d_;`0EXO|1mPfoLCb(M&K>_Gg) z9I5<2bK41U_>W0!9=n4x2Dz>-uo=4a`%d~UE0<9-m8}Kwou!THl5)#kU}IRh@Ku9f zcr&j&H>0A>UrN+xS#?AUD%RwH)*uag7L7ehpd0QyV~jhSTmlYR(=qD&;iM^x#p3Wt z(m!vzlB;pjPatzKQ>?)|*N-BhA;G3rhpWojO+fn1H;@6H-(l_*v1hv$f z=^}g`m)~y!t!9M&$Ulo7AF9x5IO)7X)8$qfBFrFIEA|B{e^|FizkT47Z@vl?+gN4w zc>~vPhsGXOO6t?eaULBhG&qBYXdH(~-ye)TmoC7xiyWlr95SEL>{WaFXUdYTsB;OW%kwzo zG0B(a5Ir?QuVg4sE<))u*ob(YcdHy=idl%4(S_HvXxJ&op9rpqkH_8`0D9} zDAh8~%3_X!w7Fq$u{11&jkz}6&~kA_U?N~nmO5$t)>qmN114w#GjF(uPnFeS_)40Z zr@@UY6$WQbm{ZVIS5bNJMI6Q1P&EgJ3r;Zn%zO@T4X}Pf<}x^9F#_Kq}lB5*_!DuhDzs=Q+8u&BR;1 zdI=rL42fnT#rBRzLO$ahPcVrFZV-Fo26SC9kiNuFxrkmx@3?=P1XgZpW4!q${1Vll z+QcE)DgIo>ilkf81-gt501&M5OwPy2C?Yt_WT9ts)AmQ-1qcg(>0e#p49n%Oq~6Lp zW0w&t?5En5L^m*%BL|Dvi*b)Zo330U%lpbnSb!9d#HQc1k845DB^c*pcomZ&zO|et0$1 z11YpLOq=(@$nhLl)OmE;Y=;@fZw_$jTbqf0R#aD zwn|R^BH5BrFHiWDp7?aDNl6FyzF@=U6JQAfSXi+?d*FXW6-jVCVe1}cPe+cs4l<1j z`{GB8dWSKsp^qi3Y8sfLSCQc$qewfj9{k($$9P;5eP`$wRleyeI6&1`-A0vFS*0F* znpA(T3|3ZzisupJ1CZV8Ay1tePWTlz?Qd6mB zUDmK*JAa=HslASnbx^tG9WuPuqM{mj%EJ@+K_v5J^2?~|JzWnx;XPVI^e%(R(L}1L za$Os!XzFvw%vofIa?MXB{{SiN$1Cnm2x)b89GDSf| zJQ4ZfbviUK&2g#H0@r2C(I93ZUTp_Urb53;LtO+Iu`%pgSD`iCCx{w(*w`L=;A&ON+A|ZJNOMSy2@Q3v4rl~IVbGdRA`Dw8CTE|qNh3(} zF;_=DFsY}jr<$5dcj0Cdsa=QYZ^`X!PRALJVgT(o9_7v1+6{r(`j!=^VvNE$!x= zs(aiYY){ezvY;}RQh0%;rznwS)seAbxyqYc+T+_Cn&2pl2~C-XqR}(gPnhOLq%APH zNUrWzrwZJAb;LpWj)qQ==DiIf+b8W4RhxLNUb$a|Iy*Sd>;Qi@Gftdkt z!}>}#usjiLLDRU9HzL-}x$OhmdnKZ$~o5q*^M4E`Hxkbn4)4yy(eX zQ!JKe6!1w4$Oh$%%As57^*H2Whc)j-2}D|Ux<`tX2*;eqYP5<7anycT=vK{T_eQ^@ z(>aX{O(jYyh?oW1BdQVg}o{J;ErAb93r8AP%@9g-2Am01p%N z@9sm@fFMtey@O?1Y4g7cVKYnpv+Btuuvo*vPqS#ZKZw{Hn_rQCt_pi)2P(z*J>tK@ zw}#MFY7I@2>K$dC)5?Z|lDeJ&OB{dESj%~LQ_kmBKhd{0S6>ZMxh-^t+tqeo=kN)g zEJ&pVu{_9_?&QAs#r>485VbnZl=yi=Nuu&I8^V!N)5RrT#^UB;fFZZ^0PFV0bU0Hf z*ufuy+@tjSRCO^$=QZbHTC`*_pZi(5TbZ%qzk1x8`!%F@j=Xu*%E$tRv| z(~M7v!#UL4+IE(}{RrF^Bnpi+4u@VwARlV|3T4@)KD5>uUVW51$4#0|O;T>*Z%y^CZmsA!Db+JU`mki5h|mOx)4OCU2NL zwN@+@%!hT=d24$NT(Dy^Ac=r2;#E5oVZeuF1Z&~^>q@ljj5MB?B2zP(7#K~osFYjr z?QT~7#}q1}HjcaP{3WE}hn2sA)gqVzsd57~h_J`R*-F!YYW3zx=b>2(5DymZY^zf*-RM@ROvqH4AWgU z+QP!$d@##%;Hpg|Xs++}JKRmGwR*^f+~l)2?qQ0T-6L$y_x(b&kGSW0{{Yzjy3+pu zB%x#^Zt}ye&8$f8iV4;?f#$XR-p|;DekXWwnE07N6&_B~Q|B6f8l3)~swXQXW{m`o z5@ZKy;XK z0xui)N^gt6Z;6GoN8q6>tVwAr>49$dx0pTfNyUy%`L0Qi4kK4H!NbWo!Qe;4&&HROiNayJ#HB?FIj(FbT!06W< zu?eV$G{iwwn^)Cl5ul`vNii_nDEvi9xA3+U)T<`?DCx2jW}nV$a^|U`R1C#8F>_`i zy4w&qfu@MPQ@)GS?N^w`w=ig6Sxkl^eJscPmdDJkl!Yc)2>8(?Qb^MBAJPi)2pF-o z@+AOTxvY1QmOB{2@qP%lJuY5llrOBRT{PDwesqPNxiTRdWQt5l$1z%vjrRs^D|f{V?sRd1Cb^lNXqYCE0ml{U4?~3OIzB zUvDHIEP!r5rQ05oyd`y57H(qX*xvn)Je9<+5ZTHL1=vlG^oZ?_Nm0otFRnA7`QBDC ztihSf+DPPoL_`oedvb4u*qlkGU@qxU&MmP;oU=HKJ4X@TLr&gHvkn6AJI4=w?R3piex!)D$kcvsb5E!k=erbQ2yT7 z^c4YWSuRVK$Qq!~Mtrak0yi-GpJU(cj)I7V%3QB6ltlwk(^}!S81A5s@_%y zvW=aCQo*>}^}bb^SK9rCJYG7>gtU~a=oHa2gXt)ny+1?z@#6Yyyrx-66mqK3MCm6_ zP1GK}G4Wi7B=vPUZ5+|jO-ln!GKUHy7qH`idSW7_4-<6f9$f@5uv&FwaeDwRzq=nJ z17&e~D5DW7Q>zyTaIoEOJ@FYU+^~?<)5W$+(Wn;MtUxBf^fticsRL3;8cJD2@S-b6 z&;es`1&BSd9H~QjrX7$yT=mjWnx|whC9S*fxcg!Xu7IYd(JQSC8HT5mFQ&>+*Vk0a zA)(8Wk!PAl=z-4zfz|dVU~DZk+r~u zYLhb0DtIO7 zvXR>dxlHOgwZCJbj`_o?d{Ug-;Ty(H2Tr-)huOwc;%=NOWl1O|gjSfE%)hHGwVP@E zl2086b188fb+-8u{{U!!@!M$cN$X(SJBiuC54S_v2r~w|g{oUF&vJ^KlQfO3B`tj` zK``=j?6yYhUs-|AsQ*-i0h&g!pc=e!vVV1?R*_e7T4&NKMYx_ z`{b4)TOi;T;@gL}=Y|Lqs`#!+Z!S30o@_Ce6Ut>SXhgJ+Z?Woth^O#NBBN&bKQI(hTe#x@69N%H zl2mzVB$Xfqq6cE!?z0j&=y@M+d!G0PZjH*3)KdJUGZM)z(hm*E-S76cA*|>{QE`;% z;fIRHN>}F@eswtgA2LVe0CtE?&f;P#;*O>v+DP+O+)GPU zO$Ajud9hCzmKGh*-o$?FBhY=dTBSOjBoUzt%`B2ipvFse2K|3LdcsbMM*tUihmu$w zp>1=T zco*<}mw0dC{+jUzOX#HWA3x6W`V7gb^Q^`yG^UcG5i#;iiqVx)=Yz?x=My2qB(W>g5KM1_B2{wH;mA|(b`wxQ>TISTrZJSM>HNSj4?j};#;#$L6TRUBB^PXuCIFqWrgaEo`@lEsXS$_ri8Lbz6x4+BWWdVh@i^HmSzAiRwo5vFx9I+tlDrzfax6W-9Uh= zSe`E0B6B!4K`{6DNgHmIiOop7&3$6$a z(kDV^=u+0=uR4v!;QK&MnoIj98uvV@8Dt(8WEEA^ux@E(sd!#N80D@=^*37#Sl`0g zhhRCI769~8?-L?>QpV#&NgsW=I#q_-vJ5E&2lhg|Th1%u%ji5O)2s7Aq=GqQVu`cy zF+2M6*ATl6PM9RrYzVNWYySWX+NN$K7_<3LO$W!QqxqM|=B-U#mSkFo!Yv~lxs^pV z4D+Qwog|d=NT|R&5)JRg`dbowA5RfXy``|xKi^mS#UF;Q=T&7K)c||iKfmk=(_pnT z#tg2L!F?H?=Gu2C%c^C`%E^||RX_zSbuN7bD)PMXb@t~K;ellmLA*Fw%?H-JfOiUP zHa?~_^^1XX9VM?a;N1Zr8!WWRf3hp$Hft4TVIPMYGM-vlWD>lPOe8Z#Z0&V73Ngx^MS@tKIO5AInHGeDCanoVdun8Q0*+B6wZ`LP=8casbd-*jxOLuGT z7rrNc0-WmK;+VJQx5JX7+ESx0ZEdb!N$2$yI%bYaxH3p;<&tRrQf^S~klZqh00;zkzB|U$ z$i~Zh$6GuhHr2a?fluhD5&dL|me;bK7X zFI9u#LX=0~){ZF}51D%EiNt*W0DSzzq`S}b{VRXV9`OvuqvZbRW4k3dOfbMU(F8OD z-7bY-V@oQt+U?PAe|#;27e~3$o^oh|dC2{NHo-Ik4zSTjyjAfBCGd|+*6N(aqi0LU zPYVnAlNCEfyYp-@r$o4QJz`)^m)3hAZGAgZ(_ZjN0BZ;v@Uih%lzc_cRi?8{uk>!C zrKWnBR4?kLg&%I>FQ)x`2meAcD~FAe&qk>~FP?fkFCHTXxTD4&AD{d|_*P zojc=3kQ8+XC!ZsvZS}01gC$aNBd6^rP<@FW`0bcpk(GgNxd0kLV{B(*eNi;At!`N| zFMjy4yShVOY3*M_Njv7qwMHdrVg|T&RO-YXXDX1iMI;L%ZChWSeM$|#eTENfHal8ApES!f3u>cv+S5$rm36eW zS=BT()Sg(VqzBy{SvaFrzXr*?_b}!8`55cH&oc-bkz$UfCPBeF zueAL~7=#EJm^pnDhOK+_d@+%eN;k4YSHY>LB; z<#}JRBOLl8+S4L$bsMVyfcl5T48pTF`7bZZrj9~c!rh!+*ZlC_jv1{Tu!QL|C$XH( zUslvPBG=RAQ7+}48MjBY0)N5w>xlX|68OtIuQNhupw=}sWvTTI6IU57rKFC{y8M%g z4FK!YAaaG_baoB^;(Yl_QNa!-(lF#y`%qC>Z zp`X_bLw40>B!GUSx6>bHmKeF`%@osgRo2zHKk1C$FUh2eJf2mJqm|<;F$G5D2caPQ z;aw&W0p9z>cJ`+XsE^r3XG!69S>gOTAuIJRb(j-THcvrQB+=DTulQJ|rT+j1IB&$= zIk$Wutw+*}jZCZ%24^Akm4=+q4o4ejjRX(xkK^XIt@ePd`EO%(FacA$bZ zM`Ax4NK?{H{l2&cok3a8BPk6bq0DQ*Ff;|^k_OueFrHO!N0b-2=Kiy@K(t3G@V?k!M;%GOIQ7A=+hz zWsHcQ-ovNohkQN#87(62BqW%gxt+3z`c`W%h#JQ#be4-y)S)NLj9F|6ABb)TkUC=0 z(%weUEMr8C<`Zsd6dJaZY*ppMf-c=xmm3;;ms1#MU(;~nPoZS*3FQ$LPD|t%Mv8+= zWg0Z;kkfy6iu96hf!aSzzM!V7t<9<$X_`&aG|qg}BXwrKB%gE6Jj7P$%r{S?!4TaO z-hJU-c+^!BWL{BqyGs~tvUy~1N4@bCENe4E*N>R8skxLDboDaDS-4Jwh7HNx?TcFo zB3q(XOrwW|-Y3y%e71b1eJ;7Q(nww@eDaKd{Rg%14krzq$uJkfrd2r4yjscf{{SU( z9Sn^lui$!?Qy3QD8y|cPM-Q7rV5I2|p+wijofTB-t);5UG4)0&5y?G(B|#$uy9jx& z4N{DH4=vH!#Kd8unvS6y?O8>dG5r-kmp_&(Sl3jeH;_?u+zOdz6Xbb)N<~Le^ARko z6wt{X*;}Q8k9?n<}hXr7}l#5C#M&x8h~|J%2yT9bx)L zjKgBQkQ9Cze+%*&)T6A`wfSQU`a}{-5Z&(G@cM~;K{9+4a>?&qGdXlH=O*!d#b&W- zY2`-xSPrY#?fKz_HXY~14^XwbC(S2IpffD?mo3hGdY386XI3*;Qq#>Of>CQJLTnV= z@@@yVBzs&1fG4z1>`}0SZ>QURk;gXpjreHzZIT7>uR?!s`kt8u^%iojl*VrIDoUl8 z-=9h<@x$OTf;E4?97ydl+3rXBL|LJr50mSB_`C6c;vwgQQ0l6fGPy|$mF4Vd zXq9^d8uIqHRww9rI3Uw)D72C69m8cEFkC10_?^{Zt)ZdI;C9fO_#C2XA zfa79i`CLdXdn+KmG74mxjqg5d^d=wV+h# z1<~Jil}(QpKb8b=MGaRvdlnB19m+V}-;viI0i~gzug79XwOi{sZXqtTdHWaArR?xpc;OR&+GgNWq53;Qk)Hv0~tu zF#5TUxlF2O-ECsrIU8ndeJdJr{{R>DrkoW~Xe8>8M( zJ+HwdraW|$eGii9g2IoAc5mlsyufiQiOC?c0RBx8Q2%eTCfH)jnoOe?Z8Xtd{3)bP(4x=xss;HQLi;_9O z*wo9+n}_U?@ASetl{1@_I1r`uS$?(1;EEcZ17E&S1OUT!mj3{SSL$$m3`awy{k}k< z>e0{pC-x~p(LOZHP*eB~sGs$U){;2US$mDv;2zh*x_IWDNj<^m^AJaeyJFG!&riq0 zzZl?=rK|7}qB=wl4xR(JR?lypV0%?a%v$J#}u=;K#1M z4RGDRJb5T)w#xin&@s`SSK)k_D%TZ;i_NHomRU$F3hBT+$YlRuEEL7T-G z1!*dR^>VlM9`?h0J~N}S({zUuhnu0Kt5=rKCR>?Py$)+ZA%?P!L1v7OpdR6es2;n6WxB7jB{40vjA?Md5pjG;2oe&QjBIWRx$DK1uhSnAxrCwNNcRC?6dTxI zueLme^sZEKgadWk+!10%JzN#{&5aleb=akahj4l1e_lB&?#1aG$W$N;Fa)yR%FEpT zc;_^(GQzC7zgZ$`=yN==Ro2QZp!_-UBgR=7G**kMN+PPyo#zT@vbf{t)~_cruLtmR z-`fB`7317J=D>KEJ+PTl!UO9OJ+Qts3J-M~^Y6p6+RX!%n)syCVB?LJD zh9)#iODlQwbDPl_n z7@x#iPI<%n&IO%YF6d0%Ni)3CYC5?go{B>OQRRT0@VcE4M9ue2bDb1&t2&mQqG%|j za5{%WV}9IVmQn{&z3EFXKGKZd4tRs9v=(NWmXpl$9Wh*37J5QOETf-Hus@-f{kPWL zP65Qz8oR9;UI^}RxYM}qhb}o{6}8pgJ!(%Ba>*&R%|2P4RL1cZucx4jl4)ZH`f2Ls z*1v0EF{cien4ONkF=O_W6SPx}J>Wiy@nSkSyg%_WO(UI7mt3zfA2CBLqU5if-k?eL z_s3MYfui_xM`V{b=@$0cN9gUSH}JXkZlhYi!k--c9h1q`+6GMSfQ$Z@$dAoai0@#| zqm{7a-}1%2hZP4~a?Ars?t5+L%_^_MfHDX_LGc?XzDut({&QR?W3GiO1(d+;wopf6 z8~Jv_Iyk`bq47(fhlMDb1~LH6ZLDp!#Pidp7>l5sBFoW*mvft}fc_)FBOMZ~gxvn(LcWRLnyyJ0b(iZO1E&sU={VhBrHkp*K(m?HqDctqYX~Uo;R- z^QjX$+_k?DJq9^bg1J34Qzx1tF~=JLz&Bg>7W-gYsM=;zY&FtqDBpC_)wB*&F}oE# ztPgQxg>FYQ!id#)bKy2yK~b7(eBW4Q%+q?M$wX4ds{Pp|;B@BP;0~CV27nH_fPLg5 z+9W1TbGe(o|j- z>I!V$e-bk+_L7dCJJCK$7FlLDASw#1qmuolA~wB6}fkJT=79VB09? z`PWj{s1c&5A|rm^*N#i9n1-2Mg-VMEzgWbb0gns$ zE`uXg=A}_KPa*QwC2OB^#yEXI%as`+vpOU>O?@_d0jb=h*2&NKxaX$Kq+zv7rzSstmN%W?{Oe5h8PIaTs3Y2s7@Ime`fYlGZg*sX9ZV68!!+%pz} z=yaUM=6iYerg+*e&f+wicSV)8@K49AkH=~m^F2M4XEgLEBQaIxnN0K$)vJSNrZd>c zo}O57dwb#IYXa<|>3L}hp*Dv0n`)xQ!#N-IMgHfT((GfwssAKf)^_{{XWkJxu;0Xi5d8A}I2AWSg_I z&myw@Huc4o$0i(hJ@em{sh$y&SRTRkoS1$bC~}H_hAN!XT52kshb$Vdrz)bJlP^lC zWSXKCC>XclkIdW|hd?n(#o)zvxy>__HNb(}^eE`KX0jv0JUT9>cq(d{vnU}dM%%F6eYPFJzZhIWtN|KGMRcGl#hhokg?EU$ zY}Y%o(`Gq&8-~&coV?o>iZq)}gX847d?6LW>K9_D{{UWRy?&m)D(jZ7!_8?8EC9$P zq5!bm4=76k?`zu?I`x|Vkiz8PwsU+>+`3UXY>_WMtLN*i!hqDz6Stp zSG3Fr9`@^p6)2XyqvGUgNLb+E;#4A@oMl;iL72w$?xWJ=TmZ*{E!*FpY!)4z(%bz! zw%tx2mdEYc;;+uG_azK1?a4AVO`bUE%`zFd=4G&A=M~51H^8Bu@ zpwU*xEo8ZkR0P{?Nivd35Ns{%aJ98gJ@Hej0V5|THX~uI{R#@TLqr8vYqKWPw6T7R zs}+@X_mSmZ01t23>_9x>g*tsVtlY8jdq?R@^O#I9=&CwQ*D9-d{Mm!Fl85{!aO7a4 zT$Y#?izqWel+BgsOrE(k`*6;aa>Xmv!oQ1)ymcbC|w&_Z6iCQKR3yB!=4{QYC(;Mi$>4;2u z{T5}bsOjopmN;`*WHU!D;2D#kwf_K)JEmJekbPJ_-IrY^W%t57t!ZV|a4JU5>;&?# z8$_(8_9NfEIpPnH!g*V|%0@aA=Rx>+rgWZpljfCs1x*EXHRORFwO~Iz^c)%VRZ&#OBVIP0U?Mr$Uw~Vo9myE$ z5r@k_JLKljNDXm<$o3P-H=~XNtEjY&(V<1}h94DS(~{-dW(?`8GAz($b^c9CZLM74 z>OD{_X~9!s!|7}y#tM>4q(KtajLa=G$jvx;cSv|7xqmsB~4219hPOykVe8TBPjTTM#HOF*)K@XYq;jMf+yy+ez3Kq0JlV(+8P zaO#~Ho@vA4A2!W=Sk9<3y-!Y&=h=2$PenXX7G!1Gtgg%bB1O;A*z*ZiCJeRj*Sg7j z->2JDlBdOeSnZb6$5N>xQLJpys;8E*fE0juxE-5=fj$kSWS^I1@1!1ZgZ?PzxsG?A zP-nTNOqI1WQ%6km%tq%(`L`Sa^c)V@b%tkDv}hc>ZA;xwyee93$1tR%t<5FNX|k!7 zs+}SmqYo!rdv3lJ@dliyFYcXRH2VRKZ88ZYLD^l_@w-Ijb!$aiJF}yr?mx9|1{U6gUsp9fK!L%4EyKEWBz zA=)h(3myRMxG$y^NFv+Cqdn zP_JHSua~FG>nVszh|ylQn|0Y$h~O`5ABMzcBpzlw*DeW0vs}ttqK_s=Sn|Ed(kyGX zRlTlQ`*Y4bpj()~<6V8KB4%DpnQc7|oTZO3ijD+FaxTg(>aq5~G|3Lk^Aj+;CuJwh z>1eXZa=4?OHjODkXz%zOj&44e#1!Sk`~9oO8wFjwKuTP;Dm=a_FYl=(`HDKI#@*`2 zmHOL^I>O7ZGB-m$!7S7HeMV=TWwiN)5tbsGo?&$e_T#5qbydNwBp8JY8cLQ+6go#Y zf_$!^!%)n^RRorC*o*#n8J~V{SXq2!H0BzHhb*b{Gf-Ws3-HI(r1U5E;%3v#CAI-Z zhc&vEC7NMEhM6HHk;%U2J;(0BLY=OpluyVt#z$M1WwbIZ=}}OBT{$A*uhieSwiec) z_PCvdLOF)Wua!`ok(fFCB&xxcS%5na99!>&Rh(WvPii`oprYS{62YUjD9$p#@Mcug z2^OjsZOXjv|JI}{OZexsL`&Q_ij8@((zm42Q|s{*M{0w znc*7`wRmQp~qbV9$I6p(;>P!boo5Ie9%wq1 zWldKpqdF#SA6km#iI!(*?@xT&EdON=E*KnV*_|*jhG)&u&@d{8{m&h%Gh-1CKsl$l{@h-QEHT<%JRzGvXX+K zN6JUG0T2M(t4LGS!;U?<_rzFMF~qt_4Fugr{7KPKy!*p!^FOVvmoX@!f^Q;8VM2HA zwTdfpMc8%ei+wy>DS?;cG!U1EkbBeodJeb3T+$kB-kquF^IC9e>f|1y()K-#@fW2G zQ)Rl3x03nb&Cs_x)Ad@nI?J-mm*z7nnx=GyHy3whJcT{Qzm^Z9P*P!Yts1VW6LsQ~ z!#zWmYAOt!kW$r5>WM4xio}s(eus>FakSjR?LgTS*5)ebS7`{c%KVEZ0K7m$ztk0S zQ`XavQnm#t6S%jbfb8E~Q`=m;Im`f$l6FTzm{jTdb5|_&wX~4aLF;(@#aT%g1&8>* z<-m-ra@aVYdoK&1-B;aHUlkQaoDDpn#h*;?R`Ik$XsSoLK|Ky{V4_;~OSKk@fIk4$N5idZWIX0ha} z4durM?S-3XJxJrf<%<1!{TUM6*@zIEF_HW zDdX9;!q))w$3V*P8C*wEk5@^?hBjdG08f{-kJ|W+=WcWEQ_-`5(thgA(BoWS}I^Qx{rx#@>)17qfep;|7bYIGim-dHHgD3wEg zE27x`SLylUn~ptWKP}%`U+|pwA+z&BmCEXf(W?^7sz)8LIVhk~l%`X^f_8$(k716$ zw}JOAb4mMi3o^bmT9T8-YBNxmSu&ir%|rboANAu#!2)SJu(#@khkewKzPIsD)+)64 zhYGC}Y_uy$YMUUBx{xh=7lbn9NOM)3{>Q(V+TT&eY1w6yPu6)P_c4&i`C&&NW?;zK z&iaLDpK?_)x%2%`>xHF~%8VmIHW-rD2FGy!06p%I)5y;>j51H@U}0c$I`J!lk_i@5u|NoZa$d! z8D2D<(lSZ!j+B9XAHyFniuCrs10OGfUzKK6Sv_4nZ4FeEwJ=DMLp)AV<8?O-th|Cg znDB{Sg9|`1zY_dd*0E4iYCjTlT;iH|{N<#st(l{7U@hwWT|4yr@lwT9WSeM>Yf7I% z^VC^oVvNOUlr7qub%A5h+v)vyN*oJ?mlZ6AQdPy3K_oBcM=b5Qns7@oJnjH>!ywG( zQEiGEQ13PI7g}f-0n@%9XL)N@%6!^dYUycggMi1&VBOEt4Y15rCQL^nye=t|DArn+PBk)Sdebv8#H}zgRy$1-?cl^g7CzW1>}&m2 zfu@V>ZWLk-y?-<(yel)rGY0f+R1bc^nzYvjU+{{VNN65o^J9-=n? z0J7C@{{St)T@y~j#Spqu_|4)id$LKd^#KHT&T9|zml3{`TeDXVFt}Ctx3AC$pIm3o zhT_ee)!6+%!kl#0wZlfQgQn_z25X!xH3eO6cUfEti5S#X$u`fR+)ci|{9!xbk{}M{ z3(Tg<%>E>)s#s?;!z^Y;CidOj8{?r)d^Ax?MUiIJnZ|1bFiez`@-jv$8}LE9jpPnU z2HXsHQGtT`uBqIsqf@N3*Mhk-?uEnP&id1MXjY%Sjs zHfm_4aRXGck5uLA1eCEl1Z9yPCL!aIKMNrp7!$$ArkQEFT~LB-u7*+K=CAR?BaV+E z@aCsiYOI^_@<~+)ueHt3*3rcpmhmXzz$wQ6q=I zJm4^0jL#j37e3>kuh$JdGC#&W2k3Ll#q3VB<{>!+SyW@u#0PJMH|h|du0 zckxeOd>i;p`RPR78T>}%G_^T~XW-|{QBuV$wKM$vGnk@9Eb;^r7CTfPn2p%-;TP&_WMEIG*SEJlvBd|ti*4B`qRBzMb*gm^p3atvx|wqP*DiOb ztfi2ntTO^P00AQ7j(g$Q-meJ>#cZHPN$5%%R)V^t+I5d=O zzlj7xsTaEYTkD8v15m+rkAJvp;=6IkEUE8{e;Xbsc+%3QrPOmrm9Qw8HeBB&K#9ea z#+Y!y=Z#YqY-rV@x4UdZX zmA6a0F!-hMqr+-!%T8sw-mmm)(@z}G*OseD(nKoF6piagw?WW$!#B~V63|d-5mTs@q57R<3Z`|5#uI=uadHZa7|Z~AdaB}Ib<&Db}Wl!C4s%Z_g-l| zrOu`W+)ap`0F17H=8jSiBw)k?V;&>STzG1U^L#ErQv?~$gWnK3Z#Btk#^j~cxrB7} zQ1tY)sp}mJ^r@ehy>U?mMwg*t}hj`?u#i~CpK^)+~?2oreI;jKF; zxCb~6ZTDbL@5IN6xNZ4t{RMDvG`4r-pEdQq9DGCw1y95`hcwH$HJ36*1&2%BMk4rG z-)fB?n7$YaV?ulx{NZz-;k#M8d9wUX_;#fAU(yHw{n#P6>W6Rbfcu!b^cs7Ye9!LF z7IEMPbwZT!)_hH9Dy68EVjCxEe6~D>{Z~czCxOO3b~(fRfA)OI}Ipu+5JFkKO+Z21NA3oh~tSsjCq`ps=O%Va5x>X zV=8ow1Z^wK%ic$xEeFZLS4NDHIx7ZS`b!RfE8~aKoe9wBr=^I&?ekY$->V^cKC z6E!^EQ6|UD*mm>xx8EI-2m?|`_D%kT4lfcZw7X%ie#)il-EW*XhnXcbHR1Dk#Y1MZ zpGgIzZGlJ9Ffjgx3ZF_y9Z>GCbPqM3V>sce!U?~Y$XBC$W}7I>g)xz;O1l#wJxK!u z;&@1?;$d}z`=o6a2IkR!|Iu*qgT(s(01|u{sD`UK%QEbs)=)v2W#*Y)yI_$5RVb7Z z8lwQt%VxN+BN=7_qv*hF7#F{kNCjv|v?9T17MzNE)72VbE~GQCls z>PqkJe>~UuWo=4ccU+1jFqWqwo;H!4-ZDu54abkRDV$Fn_Y+LLw(9`h^6m7iMjxQ0 z-jba=i*?;3X10S-^z%WS<1W=XpTrFfew@^F*(G$k4{dR;QBaXa`INE50<))>;DYK2 zw+8)iXAU(h49y^OC*t-g-(H0pE@f8dXsHcr20~o`mrlY79kJMr`BtCt>ms7AuFt$s z(^YU&r0$HF2~F{;mJK2E(L-^_QDODP!wg&<)*y)6zh4zl#MGftu*MddFmq-RX#Rd{ z^7*K;%;vW@{@DmAHglgfWjvFvz-6AWyi&*kx`rnF3)mjG`xlGp>p1NP+!5GzHiag( zXRO=y=4^OtD|zd@DEPRj@gFeMR30E`_-al?OGgaLM8+B6S>Asunwcy3P&@^95<7p@2mtT7dlnYDXoGsQ{zK3GwF-jb^T00evC9XfeNSvjXc zxJG7xs=lw+FPbK1De@{KTb9+))THGPn^6=q2ixY3-kyHr7JNP!Qgcah%0aWP0m^k7 zuc+cp7YB`7e_$nB%|ZQ=tyl2}mgbs54-YcDvP#5_=FAehLhzW1koz4KSP%;Bx%^l& z8G~geb+Uq7-&USbZKtg7CG{Lxr>2=peX6u)c|9hrTKiBYU0q8wk}4tyl5ph6%q_zb zPvZQ$VO=*GaR)O?M)Mlmu|nq&-~dtmL98HZESpYGmnv4)9g8WmvMN~Fm%aG6*x;&I zVhO1>0&k{-e#H+=N+J05mdGQ>kP(%C+R#c4rS1#X;9kn#YRk} zLrdl~`DSZSj$*9!O$3O45$q4;j~!SN0nqBc3MZE~sISUo%qyzdo}T3(MYA^+z6yRu zx&YO1S8Y3=NkJ_n8HKY%%u~&h2EC%Ww{GjV995;7;K3hC?WPfmt3*=Qyfu>5%@k24 z*a9(9rR;gXY$^1T%SG)faGkVN6nc7>Im_$Whs^F#P>;c5dtCM+_~Q~yM>LJ6>5tI8 z1{a!ar!$%2k+Ue~YE=e}*>_5Xf2aK=7)SVTRPeYjU?i=DseJO89uy(dlm!^!}&Jr4m7s$@2_|Hx?mTY@qRTey64c z#)2u3H6$XbRLX9S^_dk{h%24yY>PjeA+YU^T-f@gv$X{2yf9V7I-oo;@(QXbkw zhc&LSoZ8LcgjGt}^i@+>&6j5N^wqR<0*1aR9xAB}q%+i`1LiqB2`3Hk?Q;Y<*@4r$ zk{dTA^1iimjPjN`x<{(1SkzBxZX}QqwZngl{dnz+$kJ!Iah*$bU2MhbrlGA_tBb`P ziMMkiAT}24Ma_-}!?R}#U+G@Dq}dPQsm`hEj@p?YF(9xKHu6vcK)0~LWvz`ZDitr& zT4tYIWcAtYeOl7bPZdo}q5UiU?u^7+>ud{Jw?N>)BshWXUVx)?G}U_QqL5WIaZ)ft z8F6CBE%;Bl?SkJFL5|Vv{j1>UMry4oBuQ5;T}krK0xy_%-Ci^z*B<`(O3L}5ILI^L zr_aeUW;K-Y(KS$^Xmbexlt`!;22y$F>51CInkHJl&Js;D^6FZ=(>kfCK`k=G6g8AM zBW=hX4mzp@5EwU~B>{A&?N3KdM%i{^k;zdkv9mN#dYgg=sC#3YB)VIqMg6J_@SC*G zdoiq^6xmLpnR6+ps!H^U&5Rpw8T9%{XS)3{BWk(emo!D7pBYjT zp&G+5nu3=xj;4BLa^zF2G6t2`b%ymFJ-O>_6^8-Q6XWEgc~ZBSW|~fp^s6NBQ#5MR z#y7^-Hwed|`(SV~R5#Rx$+%EI4rR@9iVB*Vij8HvjC09{83 z=P%DP%=#CpmX@f^Vr%J41HG~3N^WckL%BqAI;^`{(mYb5LsJnZC#m$chhjd% z1ORCnl^%Q~{`jQo~HaR!_o{Z9M_|jB{9;ekyumQMqy*KbzLY=E|^F#zx4U zb|Xf%?d|?tD1Aq?PTQjzB{}99JbSB`D2TOp8{=dC#0NV*n2EIk0Ke7qM1u&^qO#1p zEXr!%E~;t_+Dxu?l^M%C%&Je97=PO$_O=sOsN&#X>W2@|2iuZn%E6#-_l@fYHqKZ>$x z{KGHGsB&#dJSIH;U_p5{5#{Z1_^;5D>@YCqvpoV!g7;BVW&3;^rj0M{m)h%o>SJ8Zqp?cFhC z8BBG#CTo{u)yFNZuBoi4c#scVn|7G&dS7k-0N$}SBdJgq2@DNr?1?k8u>8bBM%dEcH>4SO2 zUNTtRC_TOH?TBbOwH=xMykE(DT?>Yi$PFwrRkD|PkdspsrQJvE4muDo&un#GyxQBu z_OAl|&8Vt1JoJ^iYddLasfNZi&#;M-)>FHvKho`CkEuJM8EQ01i;t4Ld?mVq8L9GW z3c6`UD@j-qx}^3ER7qf{buGDZHKk^7RMEf z>mII$RohH2Ra#cJQ7kf6LFPd-M^OZ^osUMKUt>3NdY`sEZFbYJHyVy}`xMM1DXnIr zrI_T@b*mj@VazK~>%CQg^xeJq!uC)tlHRE|j>JxVkW*D;86^g*%&IflrIl+uw2Bpd zh`e%1`&!s>LaX0M25e7~gqSKNsN>RaTTUveYNn&7a+IuY*dad=0G-07|@UY4eFf7!RoxjG15&HHEnGql!B*VEQsVA3;jSp zmI13&lYOO59c3BRYh9}|T*|jHooCE5C0Q#g*%!>3WdsL5Vbk-+&8$e1cse0o?7k>n zRY8_`cTCdfjw*g+l=Ip(FZ2iL&KNYi5@EKsh!Q~6M)OTKr?v2>rdnvJf<(n?AXP%% z*Z1jyY1XMi=J)q61UWj{^!;;{$|6 zwnr@u;!4xxbg)SZycCg$kx1Igsw^$<(+DfkeL92)Am04CC_`bsnam+1aTnxFrbNIPj3b%dE;zc@;bTRaP)qdus zSn7%xq;_~xMH@|-7y=E?U#=@+vjP4H_fMMGn)zshX;shT0yoS&9nGmArDHUil>v;A z-5lI6_}uaIzAYRQxDTC#syE$G`_UZXWYu?r*{v*QI%N5|tT%Z>g&+%$%lY3IHgN#s z8%>rp`a~ZDA*!LChIwhFMoA(&T}btPu*^6SDmhb$JTA`$T~C-LDRrNfMf_GhFM&NV zlM=j=pxK63QGv%c=8uvdWm~ zCy}9st)OvFB#JIkBtDWya1R*ZJQEV8br&>A5U*#4v@qs+H%~2EZ>d7%CJYY5w+b!X zTbuncM8!WXS4NwoBdQb4MwF(cO6J1pOm~iN}wg9kyX^}EQA7nm%tdB z!ZltIDrKE$e95R@ZkFjA3)l-lxqpMx|zzx2)N1axJ2+ zq;6J3_HYOeItKgUbvF>~%|5JyzIxlfE}G{G7;PmY9m5UZ}Y%3{+gMVI8^*U#EZ z$@s$_xB7E~aMe0fncE~UF<^>*7E;t{x~fWiqfl36HMK}mt1!#zq@`e|n|YBC_V>3Q z_!g~mnm`uPQ8fC(6t`05z9~|*Pw4L#H5EZi>}Stv)lItt=8N&u9k(7Fdd(fMx^^G7 z`yj@T@n>Gp)>qT!8pl`33`R*Ok1WnABXa)$w9d^VSRUu8!-o+7wg5cPSx)+e9IyC< z@fKRiS1<7cQ$bAc=#EVCvPl5;W-<%^04z=^044{57{2KZPmaDNqx0e}qGB#T=W|zo z%k{YRtZCVKoTM$|uZWV8B-i?gkFIf6Pv`pFdTBK5JXeM1nwIFl6}4_>Su8cWvpuM% zF}C>MHmNbS`2ApaV9WG2z5&Hj4Q+rO$|F#O@@X1I5{oE^-9&qZh`HPV;@sc{+TDwj zPz4IiHEycQGXU8hbD2=BM2NShs+t6O6!3ixw<71Q?SHNq&}%ZwfH69+TT*pIijUGc ze4DfLG?mv@GR|4#mDqJG-A_yNg>oJ0#C9oz(LSD^Gn-21A2m+Dtf!Tgh~y2Y3!306 z06D4LET{sWY*c;mcPLb5@b;E^v0b)hfjqNvO@sRkC&jo3UuLmSK1&E16Hv_~I8x;D z2eu>M!46$y!&^i1`j0K7m5j>*BQsm7uOs(jcDo}9=DcZuiCKc*~Mjj8~GJ7vQw!XFk)Z9Qxz8h`<^9)u>$IBrMr>$!RDjdAx0{s8Mc$4o@s>} zBxs0icYY=vMmuG9Mb}MvPnsi4 zS&TC>v; zP%x9s5cxtQ4UvTn&wB4TiWh>`In~s@PB@nm#Hl-zU?l z23=glib^<5!1V58818M(Dm6gF630B|X!Vb8>{g5gQ%Hh0MIRdT3ff&clj^D{+*A3H zQ%wq%4;nd9aqPo!!afT?bcU0zNwMZYC1@t2vWEmi&Zwi)nHEH`)=rU25>yGz%K+pH z8}~i%rIS*jF`8$q%*hAY0XG<&jgI8O<7Q_Y=vhis67keR5?A4erHMbE7sD{UZy=K0J1FXLqS9kq-m*H?B%#RGnNCmr=LID} z5qem(3=Z!6VV|Qt*9a3|Etmh&rkQ4%%5_F%E`LPx!&(fn`ID$I%B%=GRQ_X*n9k}} zbrFz;$Kd&*T4i+8z6j`wXft|xytV48L@hi*S)2xB_3c8ut@6#Vu;+0(x=oTK* z6rrf?@cEn1qaGbwPU)4&QA16YrdELLMtKJ2C^!W{3RrV&CgNevIU9Eelbf)CKIDB0 z-5uA@i;Vss8Q)LP=NS|~r*ep7gjLZ>(S}1Ie<(=ay`-K!$u`428;f-zA{r(jiS9o2 z1$RmNZmEWV%IP!us+_wqi#ViAwmGU^GniDoZ7f7uEsenq+Sswx#6FOj1Ury~zBf{B zO_tGkpt-F!UqdY|Tcm~<iX9h+`tDj>!#bwa zl@yu2QAn`8M49Y@V@Qd$Y2lDMmO!IwpuM_b%Q%=0)aC5wvW?V1O`0z-mR&=jH6E7`%Jy=4<4{Ks)`Rb54+9vORc_p5$5{9J)$J zA+s}GUl}okSk_vp8W;kP!?Gd=J%21#DAG8BPJ?mD4^_}mQ08=c-7@;wYLbqzS;WaA zT{eU1ApJ$KU}2*pQL=|Tiz#N5)AW@2+!?JVVkHWUwN&lOuAe|IM^l_-vD3p1MK|}m)T42@`s{w#KCU1T9kG~P0*g>rtsOV$ z>i+;PS;P$L%D$)a$2|7qziccm%yR<+a=vj-aQrW8Jf5o}@n*jxj+Y>%**jC#)OC>EthEp!@m)&F+76SdT>qkanASpA#b^RAlLr-1vY(p|53S>LIXtpN! z;!B8)F1{~Zsx$eMD~?)Yz%3+be3xL!QS``Y>2pfR#Z=~c%S@{WNTVd1epr+|kUJ%Hx<2WEx=Mmf$1Toe zF-hullw5*1EIz#9B~#P8E1IQ4on4hnU7S=LIB)ShnCSN$h`~4Wm=34IZui zi{$5%W!Wueau$OvmKw@L`DsLrv^u9d$ohX?IH>nEvgcUe+Px{-zfonm9%ztFKuMRG zm~ie$u{Zu$jg;K+Aonk35*ac&9I1wXm(-d{K_qdz)ZN-Ym~kEW>B+}g%leMFx%s#9 zT*{l~ei>D1%#Sk6qOLWx6;$;QOXMn&cf?B&KgPIU&jPa-(-0#m4j1}-*U+RD`6PN< zK+{xZRZzU~tt3&)R8%sgn?;E1Mh6v5YUeQA+wIMA)!R?iu3wg!OwCm_OmRm#mJEy) zhY4<&j=OU@HX1I$Ty-8*MHOVUlr&Wya>h)lC4Hs1Jc}3_LW$Uf1`>b!q4uVawQ~&J#XM zPnPGf{MJpIRK9Rj%_I!>SlLP3Q`}n})GlF%4z0XO?qM&NM``TRkXL7#g0Ysom?fSx z-?D2E0UgEh$D~wYhBQdn?hou<%&8WR(R7(rc3&Q-tQGK4)6X7U>H4WXLu#9Qfow%y zxyns2K{|uYdLaz_P}kHnv*r07oAa4z%I^{zv30jky^asS;hf-IQ*b=jFLxwLYOMEA z06(+=6d^z6zs3vu#&} z(4*REX=&t+xie8o9Z#W=j_u5P+*}L9WRn?S8*a$ppW5$*HLFXdy6&cI!iV^cr!x&xSx+WWNM?ys%e-ysVz%V{?Se41 zMG@9FU6DE|mYdMo@XfUTU69vH^VMpCPcin0i6Y>iU;(}YuZd$==QvnsIqHp~%P%K?Xa6sb&)Mx}{aMr-DB|tQU)xW1G_Eo%;g5n=By+KC= zepkWxfHG(%+AonaAvAPZxSKASH$fzeI?w3|xF1rVz7|#vdoq!(o(rU+EooChpXRi+ zvZGK}N{>t$&E+US2b*%>sfn5jPa>j=YY5^4Wkg(o zWF1MiJHyazEljli1b)@ge4uu7tZM#pk|-gm${~*aa%~Fa8*U*Fw{N~2Q=l^Sh$m^# za!`{gW}(h9tvQg2%%WU-wZJ(W>qW|tRfJL1T2my}b(1!CJwiZ1vjTPmL*< zQ`6JMLsu10G?DsUlk4@vArv2-vvInbnamgVt)r16qeh3%jno^u-)}ayIHLKU^hmO3 z%knoBq}1g=0;6kzWee_cBi^NHPL-0tj@a3ozGdW4$X?3C$$MJEr|11x>7}e~&~;4cp&l?UU6f?h37xyt`Rw6} z3p8xDuphtpVD29;B(t;40z@GOfK0Y3>TwQe(!(XuDc!cPW6$S?xV*#}5LXn9(bA5c zGU@6hjuvK=`eSp(?nV+$U=t>rCG_y-6+oKP{d3{F(eJNRL{r!=AT*k znI%t^D$Pd%(a5LJtf)a*0R8y6@aL0A@^hqnmPhwVS3Pd!45QBB%jKf0%2Yi}GnZEV zpvp+xKBJpphf*d%?DJJIRu>$vR@Q0!xYf?3qO7Qvc47F-Z#@0(P4UfKBWgN14}a`a z)5N*DD;c5wB4;^;KJ}VNyrCFrdIA3HV!Mdp89L3>D~AmGp?w=V;@)aS@ipQ^8m~h` zm1VCZN|n?VQ$|2k^C4ouhCPMN{{SoLh6)nC~~SfVvqeG^RcQh*`zR@<$92e{)OJ+lrwuY=e2t?=fbR%J71Go)1ciHv@& z-(U#8iHYiLE^IkC;)XQPaA4AB=qQY>Bg9|DYj49>z=wi*KP}SQhNul=ndfwnR#Ek8O93_#j(-zz zXfF`*=kRAzSH(d_(5*{PPegqpwc(_w{q{fnLu@5Cj#@ zauN^IwHkt2>R6#KmZGS5*?EwXF2f%5L6Ckm@5&)`9!f<|r81nKF`qS@BhVUWUm{*z zTd~JRyPh(QXH_r?8<^_szdNLlAfljpDBPX35e}!d{)Yv!iKcTn$pb~{Y@iQ{`hB$I zv{b8JD_Ec`Ku&g6jKnyc zyD90BuBybQYn5h?mw7p2%_NS>T%cA)0_2c>++hKr=FeKz^HcP}e44ONnmfT~q@z%? zz_E+9#mTVik8(qMPK(Z%C?AQm5oWPdX0&0cg2<|hRH} zb=pSmLE_uKy>ML$fxfn@kkP6hW?3w`9b|O1jJ7*V6*sbyFv^`=;zw#Fr!v)_>}%xI z8DEXDH3$z+Q>F7M5T4C=!No&}RW56DYAPS7^=aYYhCVq{zh_Fx_N)EMJ`=di)j)$s-cPEC)t$q{?`I<$7gVzH1?N%g)b9$Y_*~Tj-8|StT)c` z+VrH$r<$cFuBn7do7Td`ZU`R3r`HW>y`+#V1Bmu2=reUP@Utt=vx?fv=yGZ0%c$vG z*GUvxk}d-Ir1k*+06Y(jds^LZHb&vKQmtS{w9@r($?W)Y}44 zaG_9Vu#b8)i3$N(l$|-H^DRr1$2>B?7Lux=lFR3~v5kknTpdiBwF4b-ayyhR8ARxZ zn$N&Y-#}y;E~n0_>Em43#`N@nvd-xzs4xxGeX#zXBvlsL-o%~s@)R1(Y1L|EU^owR zZ>L-lOxZ%@hS0|=yT`gV9CK?EiA~oCrQy9b9NBK5XDqd1HThQufZMsh`_1sT7)WsC zztFgF)l1;Y>g(!h4p@Ja0~Z0Vh)9%0%X~D?=uSyVG!e-et4fBHuI+&s zHs7Jb=VI9K;tU+5DOk*=O0l}9A*9ZxOvf;!5!2F2pvL2pI+6$63|FYsEEz$PMbT!U zDc?)#+>cN-WfXBVk_3?oG)HdL9WFke_=6FIsY)N)Wz%sIsBels7}YjsU76){2?kyb z!lMFiFSvj@et5lLv4Au*nJ|TQNKu^&P4h1=lPd+-Rgt~%J||0|%ZO5XoW7-?iZ~}! zf0(o1sZQWx7Lh&+hZ#|Pp(|(4>&-C>ENaM%{{V+*!7qTp-n}sb6vkRfGV>BwyBQ@> z>xk}*6Mnwf6h3rc1v1Ite44t3dT9i#V=4vj>NpL@Ffxd1lh$ul^UxYP#z@6gkyVX? z%X4FhX@J{}mjuaCe5#61m=rMsQ&UKN3^|W__P=Y46H(AJ9S*D5N6kA`RjW|aW-Cn( z$|*#N)m88Bb^KqSPtOTzv{BPV&?&Dx@Y1@b7@?Y~I%J89dWPWZ!SwqP$M3|n@uGB@ z3#^DouIc_!chC-kh zJ_-^gH)dG`^i-vqZ!)1lBq_L1LH<~gwR0Zz^FWm6r|GKd^xk7QA{b(8hVI7Rqx=Rr zs{){eQAu)lb)to#CS zSaWJg(uO$zp0)&cF)jEk6P>>Ous$|GmYeeCjKTuvBW`^|S(IfkW+_c1xqVE}PfuD1 z*&qh%w2#Z`JK-HOo!a%c9Il>ab3i?+=lmS}Kjbz#kz~_>Kc53xN+y+i)I)-lW$z>+*B*Z?+!HXi`BV~m(uZ9!;|FZ zIBF@Y>Yk#aIb}g03h&hll`C$T`j#Qi1@85nOjrvDeydwOO=W5=2p*-!G_N8sL^dQ8r`mprAfs+RRhNk5cW+ts)Z zv9Z0Gdf4B#0DUY~YXeNQX_!oRDOr`bUo_r*oOq|L#V(E1HQ7F1fQoYUO*E*Wi!I-h z7~1~W9}`NR5{%VgdE^9NnsI>!tAJ^|k7nxQ_{Eb?9*mbL%JT@O&K0TNW|qb|O1JAS zt;XZabNw7sxPDew4tOM9!)X=^LB&@T+mvk+-kZEb)wNW*cO*4RDsuBiu+~@rW0?mM z0K5P}1X~i}Fug0x5*{Zk@+8Rm0tx&;FniFi#Ju{GU1d~MiB$2?Q&XvTQR;R@9Gp7g zv<@BR(FC15)l-dQdUoX+e#Kg{{Tq~Oe5-9fXHl2E-Ik&*0Vqb$e&?<&POj=syJxe# zQ>IZeih4TAT47X+Q6w>}CQ%>b*}*64d*OXhLDw&0j?4eksPrh>N`y`Gu{09YG^)E> z&5w6g^?z0~r~d#<7>kA2bSU&Xvc8I@rW$(1tTiusKt-Gb)p0SywZcxLRoiMQ92t&h zrs`>PyvC4AK@)9~6;jU}r}nHd2y0$4w^cS}C#KXHE~=@EH=(RYh(GHiLP6Xw!Bg&g zceVq4CsXQ?1n#;nmCsRU8Q!jp!BI3>Ees5ih~h+Psu&(5G7gs(^q!cVnQ5PtW7+od zTui3C*1tB>_0nckR8i(%DF^}ugm0Mf!M9(}u05lb;`Wkc>^s+C(1zYGX$J8&ri(JE zh-DL)ti2~v^+re=2nMidekQ!}rY|}~81e!QiY5^h4 z3>e)(J$?S4o(HE`K0}WBD4yui5A`gN)j-vm;-!3zDA^m>GO*_2-8z1FGKeiO+XNiS za>_JpI_@f*;uJ{fGSL^A03KN^Os(^bP64OBl2qnnS&3*ss?UCvwQ zvia{(olBqP`5R?*(#XwAQwp^?MzXsx<-Z~=f~Zn+!5fWxwo%G$)OzbJ)6~yexp{V| zVCAD1F2q{ockB6LN;p?kbWFnUq)ZtkwIXN(NXtEZQpp5tHx*Jlx8^ZBz=_x!t|nCL zCDXa?X&p5NX`3Wcj%BDaU&>xB>H6?68|ttb1G#hrp{}U#8$R(GsLPerg_da9BZ5f+ z@0A#!z4~q(kIxJ+{7JMR5x8F(IhC03^HAj84)}MU=sB_(q}P?QW%ZOb(ow}-lYHF- ztYeCHvngGVF5x1Sy}BD?&Xtu5+~ZDyicmn^%$0-Dom;xnOHqcP(&br z1#6EcJM2c_5Cysm3tJ2D<%P#sJb(wrHC(vDjcT0ZRCu8s3u+qKB%3dc#|=!3Snrv~=`&u3rpiGV+^rX(2%1TyRd-2akLwZ6oXKO_#^3Wm@xG zn=kPeYJovjGCdFqvbeA;FME58I&DKkT?!W@q8@ELc`lWTB#C66hM(2xv6jSN3+XpK zNgJ=6Aw}}~tg4GCq_3r{ymgMIedlY&$EuI^rv*Kw&MiAHTr3xf=<`@6nq0D{=9B_= z7P|s%z{h!k^{f{Xl*Jugc3mVj6#oD(Sh5F=-0{EP90D3-Xu60_Id+1or>TZ{D?G}k zDIvJrO5A_AVgrg0RIPG*{?co+4ON=|d10`^jZ3h`NyrhAu2%Q@B;+zZlV1*zP z{C=3?g>wybUKa$X78=zYGJjo4!6vB%>+{vWkRntTxJ zPv( z8+Ewpe{2Ip=gi}I1x(i|-c_wBHMV|~A_-%tH7g59NVJnNRZ=b4n~rc5TqCG9L9_@` z=939lcce1xzD(ivK@^fe`=lPJJi>Xn{{R-&$274nA-(E4gH>EL6q)q}btH7Ktwk*H zZj*BD0aS9u{=J9O7CKp84>_`0;D61B}8OqCPHtxHu!m6)V^l8I?q8+uBmgIshM z?}_N)n$ekcBnv4HjPV0FuacIP{Q9B}$>LI3f{r(H*kTI!cCmCFWh3!|N(x+-f`Y29 zYIDiVEJt83`|%YV zL)`LTXqD5L0-Dz8jN2?NMzpMIngS$LLeaQoxU-Jd zwK*;3rHM-(m+sxLvpqm$vPt(3+PeWQ%Cp}iHia^Lrcah)_pfz6OoG-RTdDfvnzXaG ztZ(vpE`y;tSEVMgtYoC9`9GAJB$*@K9ZA|jxINUKxP_q6Zh*)!B0ygBidC(vE3%5} zS&+^0fT~LJ%3a5~0Q4Jg&IQ6WR0m1DfPlSw$w+B4YCPq$S#x^7o6BHiG;HgzD~n$L z0MfH`IFQqGElfj<&vleZizv_F%W^Ei>Gnq?)pGfEQN5g>PhQ6aRi&Na9WsgUT!fmQ zeB!c`=A@vbsWmJF;Ydlvj|7qZ6OP@LrU5OD2<5n4DVAfKYI)l$p{Qh$nwZkg@h?aL zEULrlyYuG(F_geA0K|v~p5=Wqfmybk%<}xsoib;hd9KJ%3oHZ?>-_JBY^v7|wSa}n zCusb?V&)VX#$O?=Sj*ILd%5VV^*wOE5mPidhTAVvoB)PEdB5*S;2bW`DLB0iZi&$x}YQ3AuO7*oY8j^a<%5wwI zRK{Rf5CLajNGL}_arPLRU^Xuyc<47?D=KIz@`^n%mjuhU#Da82+|n(@_aA(4#t`RJ zb;OwLE0R;W&osq7RX&%F6^5L~6~sf93O!amiMYgl6-NV5oB1xK4m@M0lT6ZObu`o} zw1t`&Qck593vNBn7&nK%r6x_pPtv$^viPBvobcwl8rU=3;-BT=c1ecQ=|$qi{V>J& zkU?ON74t$pXPUHCfj7?6NGT*nZ!4Daj~jsQc;^XeVY2LH)30akQU${()H2iRNNZ}= zNHU6*@(iwlxk5gJ zz|}yr%|%*jYN)?ULk&II8fiEv2XXc1^Tf=iAQV@Unw3*HtvoOrBJ=QZJVB`eGrQx$G_1^2Zp$D2o;AB$awR zWcX0Y^!-kl%QUTA*}VFWR;P{+(n_qkj8yGV>ZQL7R#Vfdu)^9kp6l{V#u=rv$y4ob zC4Ym{Q)F3<6uEs-k~E!WKdf7~0R8X#tb5?vG`%2`$RxFj8Tk8jbRW}0F_{LggKU~)mm#u znx>_ysGcKRAt9uW8;$J}w*{4M-1Znw`fY1V;?|E8OI}f1#0@j2a!E6swzD&OvqK?{ z8i0JT&R3G^zMCzF=1vvUbHlp2YKqJVPFgR*O3fy8rdLy#$5Sq+WHbgw4R1E(0}=RD zxwZP(`(x}yV_rxR5i6#;6K=7{bG;jyXE|ck48J+cs-&fqO5ds`HnUm3qI+Ye2FT1L zMf>(bInYT${Zp7`QRb1wO{(IV07s}nKbuOdN2<%%j54IqMcexjW%osVhfL}{ca2}4z z?R8c+u?P2$&jJSZbGyMx9e7UqvbL&4t;q9ek~&mHOS^xwuW!G9&k)dHFy`xjVvv%8 znnOcQXUv~6joLV64i%rUBFF8A74aYemrpb}5M@rQr;j(S^Hq08m!VRD`73*W3=Y=x zV=pxm%%xc!L^bl%RaNh!fz6Ub#~+0M04#F(Xn>=bNi*8EuZC5UCTzNth*F_$e9MD% zHu`q&j;S{(2Xed2uJ6Nt#O;5FnGH5cEgQWtr)qq@hb()X zE^R5TEO}sqvMFkB6YIQNq)Hsf{*cNkVwSSDtweC`RO57oeMZ8|#v-QTPG7arqO^%n zUlqJ>r>xRZX;ekZr-?Sx)1-|gQvrSr`6YqB)0{VL8(wzNC&c3B!B+f|qfmUDv1X=- zq=-C-RSWrPZ`xzu5MmnExJ35K5}m?=XBwtVyvG7i3FAf!EU+)&x%TgZsnDCuFC|GU zsVQ^Zx}juYDkj%gVQCiQjyrU~t#PJAcCSf<%R{Jgyru(B6r@w^^*A1)U`hbFFqt=WRIN;hu@ z`CFVxPLr!iaM2N)C_%krp0$2)=ho6hwDCM{%@!gS4svZ8OfN-~`e*uoQL^P(l?_5tK+1l0A5^iBHxjGe zx#QUV@Gz$OeQh> zuBJ+O^4X>k!zI`cQEojWn;y8RV(T`ufU`iECSvjOZ?Zm<@?90+tjINXm+@ERv~)Uq zJE_P-w6M}f7C0&+akRo$fMhMp4{?B7EU4Vh4ry?Rm=Hwz*U=hkhl?tWN#UTX(&?6J z4NUY=)W)(^Bx)bdn6E1%9)vL?b{+bBRWEC1GkeJQ5TS7dLV0U`&n)~=IytbZOOOa7D?$E2~a#FEvO)_XyH_lRBju1;^f;NbZ{i-yt;X!$|?~vKc9Aq z;~@hez4vs#+Y!0(1TO;;*dt7il2m$@s&EVQ&ldg|;l#YI;eTW`Gi{)*pLW?MDyjv5 zzf65pYCD%;DSolaCeP^(#Z|3|(W4#O$AN+9zai}1bV4%akY>6wBU$67f;j2|eB{dz zklFEyO{i;Qsi)NmG-(WFp(@^8h!+62?!+z(Y!>gT=m^z9C~9gmnrm!nBv)~3U+uX6 z04x?pLZf$Lf@HaMbzW-p6|ngU7-=gCTUjnup0 zn^@O)f0<2FN@J<1tW@&pWKhOtBqq(LsPAki<17_NV|{MxlkQG9Y_Y(NNdwwd+4$+u zbzUBLd*HsEquCT@Z1*v*r%6}LTCC01Qg;6UMFBP+v-#i-6<0HU`Rf*D9mT*8p`jhb z91T|%dZExf0H36k>F~SpL!mqe%QM;>-j2R{yw~NtlNC3bL8nrpJ?qg}oBntXt`eh* zj7ZDQJ~2Z(7BYc4D2IyLzPH5I>%V$`j0u!=Af#QSTh*ok_v=v(JQN#b^2efD@?fo43wG}iOba7HeJv&D{Yq@V? z65TO29mUs+gu4+?I>-^IYkxu3Q&MD3ijEaT8+x$h{{UVr6xp0hwM$g%FRrGmg=I%d zeZ<~7bYa2%I2r6RzF+^;qB)LJnAYiRx)~{*s!qp+;{-m&>AW{0-SI_jK-z@Ow_id@ zMA`!(cA)VT=QQ&gS86KEsTG+<;EjAoP+gL9`5yQ%b( z{@9PA4eb^nqG@P1A`d6UJmeJ-q zXDg!5p_TIynxq8f)o{qENW?GrI+Z@6p}98hIqi>{3$M*`Oel7z&$9fVFihR)9-mL?xLAdzY(&Etc26&Ff&aeNEIVQ+#9{Zjy zZ_5^{dimwcwLK+uBr(Y%&Poa5Tc1h4aB<_n$^)4M?xmF&(jFjJ>Wu1anxLt8!-kbm znIvdHTWYRp8)YBxl7gX!|yk<+#nK1Ws29jJ)1 zdC0OUvmHGyZBM7OVON*4jN(~oWl9*B8=;PN<8_MM52ik<(=i~3v@f*-8dQ90b$ufNxq$&nWmu3>lB9*8?Ei{|UgTl7rNVTp#@y%yd#0>7yd+Me2noA_r z8lO7Ux`$HBRhVXq%{)esn8PY0YD=D;l~6v|?Bd)Q01*lzIidD>kWy*7Nolf>v+phC z>^oer>Ce*mCY57Q%d}9Cn`tMg%Bg9gsmSD=DkIq{KS0L!B=^M5Z%AzDjTeY@tF-k2 zf{K=cm2VWGnjlJzta;>nTL#do>ylJtO7%fOLy>2cl=R+o6mt+{yAvMkT#KH#`Num? zHN!$7=bB2syFR0qKxNCNjJv9_0LN}Rb?MW-0i{`?gj+Xilp^d|){e;Oqn4ak%~B#! zI>@Az1X)#Y(M7s;!pE|$NCqRZNDL^wcA%ro@-H(iNm{?>BU+e(?I}##w>UkmVSm0S zWdg_b^ow_|WE9n_a#~!|FOCPPA`(X3$8#?S(#P8!(5PB;z5Sam+MKcW0lTM9VUEjcHU(6+w_~yY=C)bqYBfnc9^bohkb! z&q$@Aj;2`Rm5GUy%(|9U;Dg@~Riy;@E;B;mS*mI1YHFxvcv&jPugo@ZKo&Tfo*y(G zOM>)|B%QKlsHCT8WSl3aXm_b8X9FZ+7K(tK> z1~VWxvfH);ZY8ZHsz@O?Yf8+!Hp^-zt}-=zVlS6y%M5HvszR^&wL!<3_rp9zF!uCd>m@}dRQ~`t)TcR?q-B)mqG{s~ zQtrUE(l`r$&jC}R(Z*w@i|4v@Lp;|>L0?Bb9%G-$N4*Q!*od57%5D26z8NwrvUe7on1Fi;!nIuAHLEax8-`u1but)}p>h8_e?* zax6Ow_584*)Z18>JdU-SKTo_V!OLKzdY@e6o+M;5RcE?dVNjARQ9AynsM_~(d#E@4 z_~MQk_*X+-BamFUf`OVUzIux3=#wj!wixCjBIrs-702TPuTFm0bzPtU>4QGi0RSsC zuIuu=lPjX4iK+bgAX5x`R;FDkz|#WaJ5^0 zx}InBpDX}Mx%L=6u44gsCN#46h(^`Zv{@V1=5f6|buh%fc&GINw0f+5xKGm>kkK$^ zC43O(Jx`|fEnG=mLG#ovC89DZK1jDF!?PX_+YCAil!Ug#DH;(@t02g!a|&8)wIY)& zj*2-1&=OT@OI)KV>9h+UwiWcx%4OG;-HQIF&*`-Eb=4VGXIBh!t8A!@nLMXswSc#7 z-<~=&%}C7IxL;?^F5n`D54N*!PB>v$^+by3J&RP0?n9Cd~8f;e|DQTy)hm6UAa(3t5Ga zxc*q~v)Wu3%d|)%w#qPwxt4Q2s->2OS)4RG43%D;&lndcZ`5)5U^Y?|9hePdM=4(B zlqA+!;n5V-tk4RqzP3%&%PRsIK(`=txj1KsrYqQ3i!Ke9Z7Y~pYg$Fj{z@pRVX8=@ zf}imtTbKN-G4)o8CMNK2-TGIdxvq$L{T^RUSsq(gsL~0@wK5aE{m<{ZxfsK@VZngfHlr@6Ri|HKKp+of+b5WjU z3pEl=`YtC|s?0Z9Xt_{GZ)Lybf~l}mcU#trH<(@&NtZgJ($!RRokdZbk1j|HdQaj; zF|jMxX}4T1=v`P5kTlHSv-zcZ6INA~>P)(gAX?h0+}gTPQCJFt2F4d0o`fy2E1gcE zm>B?pA8u>JvcEuObaD*KDX6HDs#V`qJk<>xt8#XaxW|<7PIaB2)46dFpt`U7V$Jfj z%OlDwDyIOtR3Hq6i3ZF^M&y4S8Aqe0OQZ{4SJ5exMM*=J>6(}|EhS`C^cAkqv72m0 zP6_moAMUp6XItLOcU~&J*&x`7x##C^XHm!o8~Jj z>Rvg5(=NlcW4*T$KHtM0;bNUa0FBRVt_9S;F48r%88k4ieq@p9LisY1V<6koZ_?e5 zV}Q;eG1qU#)l8+?Zi~{ndCBLkXyBfXljLO%eKWI`D)J8Pxw`ud2~!hL=E=LQ-MZ)| zJx85ChWQ?0n%6velZv#1E~k+Bk+%eSgXk^KwT1|%Ok!Rb+gq%ASHviGo75GW-fCJ5 zvZ%*XUcs6YmW4|mZS1^$cq+9f&;`UuZtK>%Z79JGoP$l%rcqWFrlM-#YHFiP$g$Y& zj34NmafN+3s&k6~E#jqbRY&}I(OG_LEhc%UGLsZ2s}%9KBH=*XN7obJaaSyJyFw#9 zlHDhwYN3KUCCaj@+RBKQ>0cRWBj2~wRCfcWIID>S=8_|p>%m$yQw;MWrOK(Y{J$j6 zGUu_M2m6L5m(t3f8#NEFu;hqug!x@>el?6wa zB;Fz4^!@@(HS(e!l@X1O!1u8}g2 zPp8vs_vw#b#@8b$T+URp^afw8KSO7<6TVZK($sEBz({hIw#K*LkIx=9v#91_>jKkd z9%QdEqp8VivkLQ71eFt1M;c32ADEK4vXvqDB=$YA;|pp4*dRuM4r>sdb+%)h=1^tS z`E_uIH=}B2f=h)|@_--$yZ{NfwmHKvG?MAd+t|4^NnhE8HfLV%Hf=3EbzNkhb!?a1 zWt4y!@Ab96EPa{37QfIS7Rzs2qsWQlCRj7t;RijhMAJQWHdtV=7aLpq)CQmOk*AK)WOG60#RpZ@e zZnab+B@a&UZ56=V(P3~G`dCiv5O9)2_9NfLD!*4M%bn{=y!=Z+MW*JiNF12z2^$cO zcQT%xIkp>7pxPZ`=qWu)h1#wjALTRVRCN?ulDYE+4gi}*VEN>)h$VVJqIKR^p z;+`5?1VMP2-9!R_=se*n^sOv(bCju~GDlqmwo>thFL=T2&5zVz%u^zvBnUbXyJ%0D z25BZzASspw%<}{iMZAM#URK0(C$4D;i6ygaW&8t9I+o<1zNN+ zTH$kGSJAR1Wco`k%U-ZRj+C`YxI#wg)y4f=ez)fURKz*aq>fy-UPK}Nd7`7BnoQq2 zmO9ANM5m>VcESeZX18KTAD#>a#Dd1#n)It5@Y5AdPlWy?<_RcjDk!GQ3}o(>V^;{3 zNF9Q;u6tV^VjGgKZgJ+AHN>@6oXU=?#B8f6s*0pm<`hsZDbR%1R?q<;NgojDgnc!TXN5U5Ld~KCbJkY&Sz)VOyQP zX|Tdzf-lvhKrQCE7C)aDK8R>+>noxc_GJW-Q`XT@$2C;aEKO1v+t}?m?WPQ!m(k4% zbA0}@Ad;UgXcDG5Sj#Os8?s#3j4*8>QeB}NuR!FS^vtz&zosEdSyGZ{n`D2FVX@?n z-S9nV5N6|3%^gXy4}uR#q4Nk{DI$=IG4l7tAh^F#!M+*#V`H;*Cqz`&Ez7H6niR}N z{q6WXmmBTdl)x{j9qO+IGrF7Rn#@c-QP{=WS=ZhJf^$|@JGimzhR(T+m7tMKL+PjDX=EmQiE1Yt(dNxUkf0D9r zd^?=yfF>F|I_+CI@gC3p#(Y=w0!~R#0QbGFN$x-g_u{FBGDqVx{179t_siq;O2MB8 za|2(IQd3dWqShGUX0h7kLfY%^ac}n=J;$&$$0kfim# z7S_SDE^(yW@PBWTkX9&7to%&V6%?8^TZDmzF-1`sf!%RK`qYh@fL9aRe zi;9)bi>9NKCaTT+G^(q~mbXjg^%Y4vwZfRvBK9u4*b+$p02mAthI^^Dpgy)+cgi}0 z!6UMKlr!Up;mVuBJzte)8ajpFN@~o$49_as&o7YW7tV#rIDG3{rEib&Ki+qJS!pa?ckoe@u~Bw4HJ`ok$4drq>6=sqCyD_3-Ebc zVLuSWwu^+!!H5~GB5aALK-2{C^HUs$!)-^C>ukeIYOK0UvoXt~3sDg_U|15DBZ3%p zBMY$@w)A1`k__rH+-q%=BMfPnM>;IiKJeCpwwALcN{T02BGX#Sa(zbq$m@izrB4_^ z59@MJ))0pi)@EAjs!Dv4Du`f#eAwyg!BSameV6JFYhjRRpe5Vc07{-$=XsV(m9<=I z(&k{pPO;5mu`oQ2dmcY_1Z@`7c3rhz0-)NP^yL;|9em1=R96M{B*SQOY(P=dt_q`( z&4HjrfQnUGGfm}GP{*3Z6uFg4B$3Y{ziZp;VtK-$iK$V?DIuehD&CLzowCDYAt<^|%9L}YA&I%!1G)Ck0zq#m=vma+D* z{rK$So-Ra0u5twc@ef7inME|PQ^4Y=kr`NkJJ7Z7$J+(rF)n}7xN{+PSQKUJQ#Au5 z5XPZ=_S~y>0ClnKFvg`O(r#yJxfdvz zm}DBlhELJ+*Lifz#Hm@gmjH6EzgzM7;dMH+-ZKlHUTQ;Yb6<5JfILPAGN{{o0k~h@{d;5P;T}M9`Omd-5UVsg^f$1N0$I}~`- zx?4#@qN(e$%iFT9>4coZf3jY8y zG3`;6#Hkp`R!he%d6Q=vvT>)XBCn*&blyczEm;>cR8!GI9Lj#q3jSE})Z_!t`IMo% zDz!}|f9Z_6qF5df^)$vJi?@R^ovMD^{#YorrH%sqR|xNEMd6y@_JTEYezR7z{{Upq zOa6t_T6)U_FCx=FNoQ>xpLN4srr~V>6Z;gbaQMnC;#?4Ge3A*YZjsbAbabln zRc3Qh`Lxm9irdYPg+YF&k%ky1nr0s6hX|0TFTspp1Pwlnk0iVX;Wn~Kpe9D z?A`m}E-j8A2ay9v?Nc<)iRVxzcb-zE3+6%zNmlu|4*`1YAA6ibNHUp_HnQlhIo6a) z>TI(ri!qQ)tGY=?EdKyT{xTRyVWqY!7qok9{QXa5VA#i;~2_sp!Qk zW*J^-2&aTod67ywFy`0)02_==MCJj)_fZzY8f03BE1HDm)pJW+0BwXJE{kr!b+!+y zO~lBujFj`0=={GhqgkTMPf4sCvcAr z&|NQkkVhqKPaVy%9civ0!$&e>Wit+4HCA)s-@#u6yj@Ls7l?YFGSE7cE6yHxt6wlo zxXqW#7x)E=ure1%MlH2VS(4lwGs2#eBMcUnXd%JJpF4Xmbs>9N$uTpjpD!>|CybdV zfO%G()fsPxo;_;p&p69rgvUWwEY%raaNc5x6$(WfwUm-bJ4VrK^M)_Mic>jBKO{6n zbBk_=+G76CFcf!7Wjb$8(9=g2YPC$v#MKt{xN=Bi&HM3nAD?PXchsojV#~KW z7aeVwN08D`)X~iHNMt7Vw&YuLf35M}6`9Ee4(CScew>#t%&O`2D^R?ZF1}l?{&tS` z{P7KT5YtE-Os+%aJLeT^MHNK5LsLn)xi)mSVei!Aifzn5i-p;84d*oRXSrxGS4&6w z%fl`9kbwK)y*{bZd9G63U#m09{JSrvrKwelh$u4=wWYYV_xHWA%^EEPlX=l}mSnkg z4IW*%SbfvGPKBQ(hPcU~|o<K3li zyOrCtl1Bdku(liGFy^afbh?Nom47RkROVHgJuH<|(>Ipz#&;x(-G{dT-yaEJhnpME zCF+6A;u6qR)EAOkN(qQm|s@LO=X$2Sf87s2XBuBmCG)ATb@%95FFJvGS= z?guxwetE=LXBWK4ww zrS-aX^XC!f*_1+90tnLkU5P!<<$%RZo~W^2#DsUqwB%1vMO?7S2g~_#s`~eUKL|el z_)S{5i&)AbfF$(PIaL!Ga_Wc6;UB7)Nh>lb9X$=x^2fa+i0gH`7kO8WO$4+Q6*W}B zYpBvY)l7* zw1pqO7RdwNhLUWo+*)rf(^6AZQ|9kj)Kub~LW>64MTtG}Up1XnK@bY=16ORBvS$wb{ew=gE z;F_2^mAdmYvK@d5qNxFrM!#24{KXaj&_Wu-o+DvI;r+st?DW&vdoWDX{s!qRI5sAStw%>$Cwbt z!Pxa;1%dnET9g49sk%g8u&x{>2fRwsVqv#@|l{(*6r5^VJmc$ z%UolZf`cp+a<9uMva?y7%Q2barfrH7b4JX!BkT3{wiL3dsnm-~?1VegS>jKV*4Jf} z?>$>c1#ER}5tx69r}lQ+4Dl3*cx&Vcu^SZ-vUjY_C}?up%^W0pxMueMR@ zSGD*D9J+vaS*5pJrrgGWYAU>@I*O{=G^s}hm4~85Bepwh@&Z5vh|_IXph}kN>imN( z%Enz$N@SphHHEhwyI5O~z3qW8?0emq7;)RPb@Pf9=emZPkQ|sLMDx%@q8dPVaKm`N z{hc-hiAIH!n8u|n~#_FMFD_p!%#DqSQUHJ;KnUAX2<{v2u=ikezH zza`11kSDIJkk*is>TTVzE-H`&x#w$lh3jo)XxB|pRM1t^<&=gADv~EMR5@V_At!LZ zet5-bR(K%2(-UrD%3=n|k2udNayTQ)RgFTtMWwGrylgoPr|NJ;DnhBxrR*03CK`O- zBh&ds3^C=qp{jPg5}PEK#a=|C!Q^E4j zYj*d?)bV5{e;-bq$TSxKDQ`+oMv zg0#SCgQW80y^d-(I%K-LCwQShqiK?*T4)#re=nPm2VS3^CI$4LC#*=ZUqXt>QIL3f znbszo%pOTfnAu3y2M>T`{8Q0*F2tcx{;I`J}B`qLQE>WPl4;?&*JSZg9IFjAc=j^IpVimQm)C zHGOK;Gx@O3B=b3IpuYiE=rQ$5BPaty3*`HeYlHGHJYPdqu z4wo0?yO~jKU7J;95vFd)DQByWz8#SK zcUWrUh?;4UKy;XNA&*Pj9hSO{KnJQ#*TBj};rY+&bnodm4^dLn3V5mB?9w+wDJQl% z#pGp7yF||=D=wvZ^<`$6p)$c3tEr?R>nX`3fc#x;*ml6QSSp+7bUfim;|b2aGn$<{ zl|cj|I)$I+f=CH+vH)$*upDAGW$6s*`WG&GLik6aBEStG9M_?>_{cunrgtVKL%%RSyeDHG)I%l?x-Obw5Nq@LT&A{=!ATu#H5Lsb*s>wy+#aM~3)@J% zMrc0tOA6tiYiKDF3G&KzdT}DhvyH?9&jY3UW0qm2TJA^aMhD88WEoXuO%`ueO(Xe^ z)irU_gtJB^JIr_rwLl9;aQX`CEXuzB0NCj9KPkyPBF><$nlV(Ghdr7~d3O22GY6a( z)z;;0_P!j~hSV(5Lq4jKLt85-sTcct&$BH-sp%tZxofMEDQU{WtK`T;Yqff!^dDQ} zyhrrER++uNlr1A7SKPiVuT$zN)?CQM3nIeJ_>RjEs(X$)cf=3PNu5#qQ6U;M$A)uf zRoTrJM_nnbt#g^vNQ<~6l;Z9H?Ql6Au(9~UKrR|cBb=$aCHM3$qRL)ztAJ#bm3@nL zRU*p7`;q&x%jz(|V1vngX&^qFpv?39+c6n*)ikM=$`S;10Vh>rcKWy%Xy&zY7&Aajbl4pdIEuPLhyd$t`_vHZ9I*=?6}C9r_`1Cfz4!& zc^(>PA}OG-jhuf<{cmhe%1vwzV(K#08O}5|X{*|bY~sBr(xfMn+kj?XyxZRs)5Nxq zswOp2xrou0<_V$n{YFKV%OuR?GgG78XK`>h1L^K;PfOubnrpu?Fg?mvmH}`*_lu?djtr(7U8WtLJ~HLO8S-s&9!pP{WQ$7i=6S6=vC!5` zjj$3uHu?_#0G1O~!kVN!nQL4L9mtAy9qPX79UT+VQ`PDnaRnA>K#ep|Q`5f5`nPr*AQ)sgUg#QT$2mg6iQqA)4oq8r^UN zsRbUE6;sWfBD(3?`i zILVQ2W)Uu@Civ&7%IGMi)3j?(75ubppDXhsQN@kn;1kb$5bD$hqOO*fZP{SB=+8F$ zWjSTid}2LhIbLl+kk?9!9Pde2mC-bjM#P|EB8U*ao}&utV{qidMOow;Jke~zxZYds zgfsCU!H*L)j%w#T@OpoqSp79LLNuatyONgx*!CEPmMByBwqI(T`)=_V0@AM{k;MbCK6P^d4y8g*r=D zy)E#oU7AtSL7PRL(bvP~GC=u~8aYWPXb2<#ot9SXb_C;!xZ2sFjRwO|8|)*^b?8lQ zrK#gE_-^qNE6b|rH13Q(QIBgXQ_~Nck8oy+QzA03W5^`jb8e>{;qi4?;9S>^a0|8V z8mP_=nfT1{FoU&U3%)eTQBP9d38aP;c+@>@2|!<)gz~`_?d|#DyKCk6)jx@N{i+dy zZ_1{BhCI}_PIv?34x1w}$vhXKOxT7-`HHGof)TXuQd6(72b>7ZV0)p?e0I?%-=Z{O zg&`r-{&4aIT8{{_{{V=L?>u$!TPK2xCWe~yX-iy_BFqZga-$GV(0#3ev8-)U+?_3_ zQI)rk(3^1j&7>SoKuiG!PW^#duN5+i{Yl~ezQ{6KNhi#642HUzk~TugEYBH5Kzdz+ zSYM0V5;EHxIflYTp3;7RP&kH6Np7wNb-PZ!#fDk8g<6Nfh%)S_#BDq>%K2&F+a)x~ zD>N#B306-=@oO@l!dL5u6(7<(h7%gW5GBALbSjNzz#2e-Zo&NN!mBN(sm!wKnr!wA z(ab23#Z&-b$#RV;kK57>y|4>vI52|3FR0Lj6OGrXYqd0W%Tt)t<&soUi9D$3+?5K$ zux@RCe0=6oEry3>F+J;`Re#sD`TcfdKy^M<3OWf441&nfo_IgI4=}A`8bva8nek9M zX6vmccbH~5Elngdns^oL$inNiiyfz>{=G+Rbmj)U5+!`o1ufG0inl6`iz%kfYV$Qo zO2bbflBmYpP0SI=`yolSxa*EFEX~&SV|j#T8RY7sRelv|EaNe#jq?hK>t&S5EKLZf z@|n3RsC!!yGl*5D(E`ImGbo`&u2xUs^ES%i+-}ms3|zQP9xL zx#X27l1sOI5-1>U+uz>=;jo@_ayp&8 zy9`(A@j*$4qvk?y=w-U19=Op%GN7q}p+wmt{Jg9#(SiQqd;x^TWOVy{R4-~Ay=?@v zbpebyoRm>4a|IxhIq80#Im29p8+CJiKWR`QR&SiqR+=iTu9VU?^hO1NvVu6{4Cyeo zK{I8^M9SQzpFhp1>l-o=Q$gi=Tb=GLarxnEYV>W0nI(G?rP_)rJx@Y1gBtwIp@bCD z9i@mS%um?yfhgvr?B`9_L`XqxCE&hcr>e6ksH^@~z0@=d5Z| zN_`L*6o}N03b$i|Mh0%qs0UTd!bOwmERv=_(wW|3^l(nZ$4u(V;Ptwm_>!e}gO!3~ zQ?c(-0XmgtJUIAw@Vmwgva(dy+IJ~}gq4uy6+T6A9eqm72m4HPq0{37K40NXVlgUodmHeE=x-!&F`&@GjTH-=c$0)Kh6vFkXis7sE! zi;)`{0GU0yDJf8Ej34JyCH}>ZS5*ZqRUeDgQ`63yZkFO|3a*)*PqdP&?oHzLZEkU^H4RlfO_|H&P{$oYtdPM?N}(f; zG&~isz1!4D=Mz+>Ta+CONheKvKGKz!+`<;?C~Gsi$n!;lII4hUkztH1W;f)Ji@>+j z1mT_-BVv`+GJ_Jqmr+5S?2-hnmDN(En$kz~w`sHi#pp({)@kafE5>-z)6AZzYF}|n`zv-hY9Zn>fO&-s-Epbcxjb?*HiG$* zI5Q)vi9g1-*Bvto@GVk17t+=L)}Xao@{$_--iJHOWKxYR6Qzvhu;tAJzj1whSoL8i5co+7-0;k_<)P33> zTt_y57{TpCPGA64<55x4Xgt=VN6R4IXy`0_Q%vSRvjVu=TDOs zKIIwe*-c>1YrI9sGU}-*hM#(vS{c4s1Ty(Z$A-7`g^%WNEk}$!LJwXy=1=H_*leT~ zG!#ukOfss)nx2Y9ien?&^@F)@elg=-;OKaQbRCPw2wduOYB^OtLKwu;S|aHC{X?k- z>wI*^AC02q8zupiWm%lh41y|&RDmETaak7jxc2M&uun+ljZAhg08y%1dW5TSRZVP;P8NUI3&0@NC&o5Bwa}|oT95zRK&1OS~T+_kSw3IesA?1@GV-xkdnG< zNnK&fvfUJClD!_K<9(!{GLnY;5IcM0=TvoZYbgMYQ{4_jmMvpulr+XRt3VN5&dYPq z9)p|=`mT(JWzh&_t@Q?Zm*)$VCdG}E7k@3875%_pZ>}0)sj=4s)b47%SNn$t$d6#;5@Fn9sjI zyAwMU9MamN0gn=*EEJ=(JT{bCYxg&37C$0l+CsI00i*^O- zeq5&`t*gtkmD(yHbf{gAW|L_IU3UWGf$8LRz6R+kG!`#JFJ2*3)OeelS7(~KI5Tyf z1a$8`EJ0~eMU_)xfqt8sWb17XZe{rIyQ< zc{SzgT);~{@DQ(fygJ4djdyAvW_pV*rLA1IH@#gXu^%i%pnfigk8Utvq~ayI z?xs&!UR5q>mj4bYjS8-zLxFtH1Us70e$;oFaa(Ov5OxS@{ea(Y0u)xsuGMe zv&4R8Hva$#6C)E~d+~|syCEZ3I`}VTD$!c_<=LOh&reZNmtE1rx2iIu`EmR)9wQ6V zHb%QC8s$97^9-+7RLJ6i4FxK{>lcY`%nh&`*y1gG4 zMp)bR$CG>i0E_RBSm)JtQ*#O;pqhnpeBU(6a-7h4R8y3!rj_S* zSsheL4aj?b$-xyX3Ztu{`K&01TconO>O8`H)>*!7f|QyH2iMFw%00DVA$zh@Gfxhb<+mJ`!mJh-GR0b&R2t@<2T8;Eln z1WQDroDs7?)@OM%Ii(!wO*hL?t3y#DdC4@U`{Vi$2jcqSUMMl}LDZim>ueAgDAu{Y zq|f8Zt80@fMvWymO>=Lhfn3xWfiSQl9@zG4HZQgD?7@gY29wNApY}#-BrzS zmjF+#I%QKdD7Jyo86Kp}qHNnJmMG}##z`5GcLTyWp#zAUKssQl=Pq0e%DL=KRg$M!?u%4jfn@uY@m53M20-;I>_?My-!h? zJy7#jI%wrIeXm@)x1Ze2$veV9c&lv0MKrw`?r*-5ase&1_i zT9$DQ5gzXsS{kg#TGk{m7AW>?y#T&km3 z(9frH`SPQioSLajExVg7)Hxl=AIk*4qw6#rg}{T@O7>SRR*-6Et~E7tQ&i@236hFV z6&f|UDechx_{X$Crxwf_BQlA}w?Let7u0#qY?4h?Nl6+-A@s9L5~?bZ?QC_3B!JLt zN%CCsP(0hjN{aOPgv*i#hW?=)z!x^>-v&1emeZ>HntZ3Gtk+b@LsyqZVyJ*THR?f8 zC$odl;wKS8;M{wc(I}0jt6;63+pq|9hi=xi0@K2 zt7NB1XY)g)Q^Xw7zst(&Yi6NXjrVSf*BeJ(qS*TpKo|5tb$|!KNK7Hjy6Z5_C2A@U zGMb92Q#y$wD$KXHe%xTehYb>L;1?OC94^mGGv*ZZ)ewYFDiD_^XgwRTHy6U0%tTvR zUg)E8=E;-LO(gOPG%L9s8sT{# z-m)VkjT}mzXQJ0CJ;=j)g!BST7$3}{0_x7?^(&b~W1*&xErr9gy+mGIskZ+Bg}-M1 z0LSve3WF`rTSy8?lo;_NQDkt<9I;m{)0U1lEO#x@dXeqP!)zrd#1U>>moC!CS4FHf zR!f*y)Me2}T}vU~REmJZXHWqE^z_>JVrbKQKsGaF!(VH!8h6Axe6p$OuVBRe1{b@Bv7k8I zhUlbiLgYY>d345QRg}vtQk=#Wl3KvK;zRh2y~*kHz;V+6?ILWYm`{3FLsMm0_F1T? zt7EGZK_nB>mHbUHx0$=P+uH)y#hQ#PaLaH(?GnE8QJ)yJC4NJY)tdQ|K}|cuYzxTss&lzp4z85IK!!zE>^^CXJ>tO*uxs2jAc22sbz*aVva9YmalF|`e06#l|69*N)*nUAgaz`cp_<^ zI4+)i=^oT6ZO5Dj>Y|CCi?a6RJl07)JxvokI#q_*AFJ_j2P5*tO^7k-?xG^ zqK>ADin%1sn(ojj^@D!Hz4103`A8%~c3zN&8E#dXHba)9QAs1wRm&?b?Y^SI`wjl5^-W8B?%!R{*!WsA{s%OkKMI9!h%VNwj=@MAn1OUQqb(h=H zPkb}R(hOv@!IA7-v=!xXXGYaa+W1_Ez%`Gfa6crI6J4uar@5?6k0<+~`4DbJGQJ7EPK!oywk>x-4o;rk5?rvn=+9A)ZS7 z#p8}FxINmFXte3~|U(AH+@XZuaLKx{WH8GRXmS((qvud^xPq5M^~{qbizuia8~!6(A^z7(pN*Ez|`! z=ndyDQOi+=m_9j+X?uFDU?{* znF0wK*#7`JXNRU17>>#5}ViuxyWDA+e}p!MV1rY5BGSPYSs)@!~r z?>|I%sB+{fc27^0mdmrGtxu4snf%&#r2ha0W#J1R#Ynjrj-^K#WObS#JGpz&&WRRu zDuq2pU6@4C)J5jc1lP24t;d%h-^>h2N(lwLhGza1=tPtFoMzC&~1rDVk=9 zJkwLw4=NdAit8vx{+0O{>YxF}quxs!9bvIEZtE^fAR)G^)l_*r)H+g3sgkOc>>=2> zM7QEr9c^qg!qF}rC~zR?M&S(brMX5|lhw?*gn62Ibo*M+$!of=Ndtcz4^i)E%a>i( z078=1YHG~h0UQy-ECm>(#@ANq+pxgYuj`kQtFYidKO`UAr3| z_Qb`s?ir=0yeU8=T}-q-h&i=o6%9^L0H~{zYy9TML%WUP&*40h2=9R_VhfK|+lYe) z?aducferOH!G$K6*L6BCF!2W=q^PK9XGW2lIMSYX{7|x~-{st)=r;q4A>vMGg4+m} zOthV*FYH5#0Hbe;J`Cl44Cw6B!|gxfAk>g&3QcoFs~Sg8gawU?F}nH%&mFIY6)U@@ z6%I*l?VC*pt$oq-nj#gA@Gw(&iIeH=IX{j1n@(o5Ib?ADiObeMAtI-XZscN(bo8DY z*EY9&K*qEao?|nO=aF@x!;&X9T?DA_!$!Kz{6f__?;*}SOwQ!X=;-|HqQ1Uhk|c>$ zG%hMcd=ODl!trb4%J_DW2$s0b#X>|wNSP+rQ#tpYVidbc(c~F6sLpfkPvRbbCT&qH zd2|CNkjRozM_`XAKZfjB+psuDKyyP}eNuYNAiU2hBGyL?PF)%d#;BK{WnL0zvP+U@ zy4zdSiC9T*oRTF_FKbB{y05st3#Cqz2$xhb&6L~+w={hSdYH!%0ibtJkqWQoSx>`; znA9;r`X^fEbP}wv)Xw>(T*NuH#y}>%)9U2g>E8_l!_B=>*-3}$U&(UJQ-HLC*`M{1 zb3yn$@Zm%9*|t%oHCm;1_5E&TQzR%mhf^y7*7hLcYS^Y%5a9F5MKRwH#U(nG8*p1E zS)Vdg$2ahwz<6t@rT)|Nn%by{5XlZ>A_&xPNcR+>5gj`C>=YrxBI+=T%77R43MFg(US4#RXO1gD>#AF`bwq zqRE}p20q+ap55`>Q*DC}jY&`(8=Z3T;Z6`^#!rp?Yo}|pj2dG>s-xHK&0wCgDv;3F zhKRIjc#ZlwkV_O{D0CE*>-J4uMU%|Mf3I#FvQV+gJ}=rwT0LW4%(iMM7TSv0EnGNvF4RxTbkps zRY`Q+bTw2|84WtkQC0=&9eoT*v9mv>!q&sFS)dm`Ku^*K=s|R7mzin`eJ>+q@?`5C zV@n47#ZFPls){iZ2-50~LhuPV?%e@tq8>uFbP19zRWYx(_OPEqE zHEg7S(#8$;oxZNUFcV29UC%!?6-JHKA@OHL#iwCR>mbyeRS*dV;YyvQdFQSA;?skx znB{PoO5PMhCC&8~LF8sKK#xf|NNQ$05fLCU2i$^w`0k?_QbyxJ+P-DGmB#RQO~tAw z)K8_f`pr+5fYVo0$7d`-J7Zq#K;sp>W_atmOgNV88Y5q7Z-%4N8w&+C(pu+F>KQW} zwk+Fabqlm|(Nv=(k+A9bz3h5nO>85nv^aG=5XdBt*xt zuGb@r;w&(d3D6~v5~!wa<>=hq#b22sS4X~7L+e(*C+&;fKk0_UcF_Xi3B2dfX?ZIG zJvL)SS{6uy^3h0d{C~-gjU!Y7Wu$W5a-~^bwWN4fqH0K^H0^l2m-Igty}zU}1xg1t zru^4nN?W8WGg_S5EXEX^`iN$cH(D}oe#7hA5n>w5xm-t&HSh#o7ptnPvr30r47zw} z%)4qPs0J1>o>}25>LZWDKA2R-wwUXYJ3yZ4T@xvnFQ}oQuA3~&8m^)WrapX?d4tpl z*}Xf4{zu#CiC!G$=6Gz6k|N!!u+>d9&O+Hnw;52VU9{3dVv+dsHvoSZu(QFdH=AH8x2elXv zGWB=Ng`Zr#4rtIlN5- za>h?>bTu$eDwoDU-;7WhE+s|#_3tPcXfJ$2SJ((}Bn^2k>f_q+0i<^-gW^ZP zwsYZjWur3evtLVC+J?EPDSmZYWc?sw^A<_(>Je~m6Q>vLgB}QpYffX9S($<@J^HCI z?-jE|jEyA9ag*Rf$NZ*gWNkyFvuNL$1g}=1N{$ZJBHY{e41He-NOfA*K(|%w`cQPS zk}mB>?{WK3&phz6#0?EwE>o>)GHQzVrfQls%VcM|C*uW}o)-TA#|o?DVd{sDazXCV z0P{EUgaD|EJI^PYdTL+M@=}n@#!JT~jgKE|TMb*1oCyYbY?Rb`3g(r1&m_#AvWBLj zbS2a{^)3BGjlF=wma?1M1uUpZUZ94GuPdK2&a$eh>+679(+^jfW4CbZG4U?Vm5u-o zdxhfZHFD&1lr%^rq|DwiBdtq%N*;knzqUTh(h}hWc5~f&h#5^jV1|s%D!-U_tk&Th zuqXN8DvoFd-W=D^l4|`|ooOt_mJLBm4MNH{B-HJ2%iDLiTzx`=DhXweCDAEvO{|kJ z29qmPrG}w)Pqp^QHy*3}apUm$I?lNo1tw+BRp<=SE9f2vdFiAvLk&wd_E{R_TzhbF z?jIJ?FJdOkpb1Jdtt6GXq%g`U>guWCW|EcL%Xd`+);+D;9MZ%?XGu0I%)F3Vs<%>Q zlg$MM8#Ei(rvCt0TlT-O!(bTUF6$m@6D$AMrM?;HEdIMPs&5nNWunWEnzc0YAxE8x z+&pqGBKNqrwlnN*HH>H!33IuF9^Pw^%b8uMGOatM>T2~qlc3CKPDNc!Ee(3k%@*Zx zcx8}&un7R<4hX&a408IFD@8hvVb0fPX%OoTM>wCQNG+mMn(Cal#NBhA>+MjnQ_Yx! zshS#9+f5XZ#uZXA_}Ofr-112{nxh>_fsBI=BonF3OTRgAP41tw-xa8(%_*ds34cN6 zbSP-%k~WR43E4F2i|S=Nf0h?g;p8y1MrOE!9k&W#XH@&EJUqxUJwElBW@{~F4rAoi zn9?RsDOCBYWLM-j^u56tiw}-{TDe>R%hi+EzI!r+F3EMZGQepQD2|;5^Bk11+yQ%a z?0OUT!)lmgGbHz@fs{PeI%2Xqxibu!q3PCkQ#|5JIFR+Y`(WBtghQg-*Cj2}S(c8- z>Z72psg|m~MjL8pO^A~o;P=NBnN*2vWgL`p0wra%boq52Vrc7T-&0e%IVp%fr|-{h zIkp3+^5+TI8TuDNEzIPLA)cnL8o8vJ8f03DBT~xD+*yI|*QO$4dQbrtlMCB~zK1cM zT$a@J2$_L~RDon0N#1xnewX~Q9Y%ori*Mk(B%z*^)jG>8%qG*LHlh{kj5pLvXx!T2 z3-&zlFv6`GZf{8jG_vuJQTgUA309MJ=Id$Mi>hO-~fcVhJ&5mC+KV zdLuzPfZ5- zCXPYoO&~m}1G)aZK}!_ceY5l~OB7>9YJ8?l=s};+O-{5(A%!ra$0)x9XrM5EULCk@%(Vgj5WE4zUzXLNunmF zk7i+2=1iolY{KN+0dxEaHAPqZ#&E6KbxgD%tc)YWwkl;xUfCI@PUCxLu%QyH1! zHC|*x$ui2!rP_|3xgHwLqBAr8tf=ei{KgN=4amCVu`j90RNfPab0Bqi3n;ZM`Fb#L~ZOgiut-3L4T>c7|%BbSWAbAoe`H+zhI!7dI z+)rCszkU?aqY~ooQS_*7X`>g zoN4#em5|ldhI%<8AR-GG)qfI9Fc0AZO^myaj05+&|q>Xj#UPLA= zrV4#&Oo?9x;`-67W-b|2Wis4S~id6ZY`v6oThsW;6+H>EgR{;hg9+TdaP zDmIjoI;Y-&Dq*K})R9llG@@w!i( z_;sr?Jv6zFjj57+iJhmF5rfny2H=$*y9MiyY2sU$*P9DktK`Q<-Oy>8$35 zA^Cb(sVU+z#-{T~Jx z)RO8qC67*VU3Mk4rLK{bn~%3*nXQ1Gv+YHj>H2K8pEt^Bs1juZeqS%37Ha@cVte8m z6kAl1*AhoR73pzOrOTzQ+P#_ z(2T=L(&jIoEkMiagn=ZDfeK53*4Gxl*A6hW4k5&XMoBK{w4{{zj&uyX0Se3tf95lnw&LoKJ^YKxJl9S2ewr^VWnQeR&@lvt~r(YvscyRIswbqRW>uLHJ!`as)4ln}7%KVY zpvl|mQnk5tO+F@gqmgHk)5DNb)YDBAXstAoZ4L((+x503!eE};yy{fBHw%u0)f#S! zohFvDt1iv`MAV4VRJR_Gug4UTcDbSaN%B-%oE(zdY-`f*YmYbcIQ7Ug$;r4H* zata#!x~tD=6V0fCC%(wdxOMJuFvK;+2<}{qpj~oLOKvf=UI&=qp2*kk^=<VNps%@vdq2{n^Wd1OP4zc zOgG#Vk~klk;{)ONlbzKqCBPC0T{uFP{)eW>L^b+uDq&YoLTIN9cE?m5fil1N)*OC# z2c$3R)SJn^z6xfZNxD_cq0QxY@P~sD$2YAl6gVWQ()PMH_<)D*@Oyd`er;b+6#Qg(sgP zqWv1VMI13vEs!--YqnL}b7LpBTnft0&77AzklV#_LTi}SYFaAV9KtAN%hn+sEle^5 zl##(Lf3_uSMI)KA37H2@$X?B%OY%6Vv>rzuT|t(k%Pz}KqzS?jH+sijxDKS^A1*c? z^({Ltxs@GJmn_UE>lNw5o?S#pZ7#;W{XdZx`r;-$L2ImF$8RKVSyN33q%#@obtmXb zu|8KqRhpgT-te@5zS4hw1;tek4G(NMje7(_BAXD8#C*<7&Iux>s4-Xhik~W=o$K$$ z7~oluiEmfsD5^C9wN*4VG-aw@N^HtGgkDQuo|fSC9{77j(rxPVLuKTXY3#|W<*dmw z7}__QC5;{>+J%7x1{nIQGK|g8NnNtqqUN5~`jaiysw?wAsL?2;r{iPf!%MByxJ;YjC8op`)udQy1=a zUG&4zrd3s#rdvlzS0ty*T7u0RyM7-mFX8odzg|7D&L%^{NhPp!T{qr{l^H!zr3>jKtPsXsfZp*x~y=IjeE7E0@6%~~fU*A$pwNh=S zsHfgHv6K2Y>Gk}v^(Iuz=d=e)V<@;jJFiI##dTIoSriK$O*Lw}iD_%yQJP?b)I*-& z3mbLERD+wbZG^OKs)_BD4b>D`4#{1z3TP#0nce>Y5S6XHSf95{Gs8XZj{~mD8_cB&XVM739;xmp9GnyqTHESjpTNw*g4@z@CH& z>RfZ}M78jg>bNUBSEXF`l9GJCJfx09p`90GfjBA!_$zVL^!)MbD)a{{j%Jc1cYf8> zX1W-7U!y9hD4q!^rmfEFXPKob!%P>K2^iqD@5t+ev6XYW)@T+Sr}i(YIs!a+cOinc z^R|X;gEY&jo`iho>WrYUv~PYd&r{O>09+=oG{#Wi;jrF*(HVSZlQ1T~xU(bPo+XNN4jW5${lV34XUX79RLzLo4B~7m*8zglo_mwxSI!r}HSP zYAI+$GEbSrgVh0zuE}QXM>~f=4kLRU#}F^pHbhf!gly7!x_r*Mi&xjlPPrXujcBD= z09jxSwOv$x$tJ}2IGAP*>j>=Rk7gp!irP?SnU21CDvCyWWvFtO+OU$nHF!5E}ViEp;~#PY@%UxDEk2`f5cAkNbSxTQg5Tg4t~Or zV(RpUP!B-(si_xDMW*v8p?Y?Wsb{E$Ar!_Nm3_o;SdIbf$-W@2#x5TFt(L6Y}G_kGii^x6xNTyTH*qBm3 zi2YgN{DDZLoEl~px|i1}tmnoR`;TLV*6QZ*5#5Gr+01e?2?^M3t1U|JY+Q>=QoneYi) z-*hDKoMagcwX}NHhFNm>AbFN}rco@?vw$G_jfKA0XNd*ySvroWwwsf(;6~_=Q%R(? z7OKl7sGg>qM!blX^m0kEZy*A$V=3w_du_LC;106^f!C7`Xf8JG)7p*0)d1f_b*k{Q z;MXY3riU+wQPyTu>XK7ZwOv=0BawAf-N*026|wGhDQT-5%V;z}*86XA4`O3U*@%zN z{O=^eolD^LU(PH-;g+o;U{GIlq2-0oM&E(Pbf=zFV8DdlW#;meYJN4AaByIi;&} zjLM#;^n+5=#Ybmpe~`r_EL| zbmF0L-Vf0UWi@P>m3+%j1>;f`<=hDb0mnYV*k0;kje>QXAOqyD?AOD{tFu}R?=gug zO5GJCP!Z7D;M?-Y6fvYUv7-Fc?xi_$n%9||M}+wyDzlK3->1G9H4Q`L)YX~A3&SiQH61stD$ue93Q6OO^NHWZ8Z5^3 zjr=5o?p?PIVr5x9HKMa@wvH+~up*5vx43Um0^E=5#cr|AWDnZC$`fsVfYlR8QmI&i zmULuL#Eq_cHOIClZB~f4Tgh_fpiV}TX}Y-d_N>SzlC7#dx@xFNRV0!_l7AKW`&;XV zwSM|D({Rfd2iz1{M(Mv-_-pfdMAdRgl~u6GEP|%~y`i{6{@42P?HqSl2raPcpC5YV z)K_l-@;yV~{&OC;%P8qH=_Q4ulPakJR!HUHy=}lY>F#bLwc#oS?XF9%0 zdW_7#kADcj2~cn^tLz%9@h4l8Dk%R7n_P zW4rZsJ#B)UfRYX1%*TS~r#dYj@CV}u#7#w@a{B7XsH!IqQ5?0EVVUP>oT+avGB&8< z*X#KlLiZdyivc7E*R?$8+UO-Uc;Dl$uhtcQ8r9Q195op}cTHX9M;)9Htdb3`NZM4` zUz|qlNp_|P^?w_0a-NkovOxI4{vWj%bDxSWUzbf;RJnyT^y=G%7^RET5WfWeFJgZD zW9MR=LJZPlM5-CCd{wK@s@ApLjEBt>l0?6PIa_naqq3I3B9}`gFR4*iU1^#5zCur! zR8pjp4Zsk5Idf~Y=GQr={(Q1_7wH%Qfb0o&UjJ;No(SZSBda!MX}sgYzg zd8IubPgPSbSPTQs<*#d!0X>DVZV~UxE{N=0keamacbY{7WgSeCq?Q{49jm~wBj2VZ zdm7>hUjYgoS67?rDJfO~QC%c*G;WHUtUK);`eJs5vS!QJlwYFJ3z$PSO!CV`6iR?Z zS8JC8kVk9)>_iwBmDmbn4ymZgGHGFlHu;)VU(~D~xf0hMK9|6zfP18isWZZa_;szQ zXRfQO&X!84qK-&uWmgM2Z@%5c^|2i=P9qL-fH&8{a@vXqnrcl!m(@)Z)DOg17DZA) zJQIT1MUEF-x}jhH(5qBgW|Gb`s*2p(InC;0kdqx7<`VfE`jCn{anq(VC%UyJWn)+` zs1vU>(2dkDQ+S1zrq#U8$oLOESwEpkw;J$7udI^kdjVp~Qxa*I{Px zB6YYo3!>A>Tb!FA%4qyG%c}J4bt2}PQle?+lDT7>`^$d$p|b)2>x#8PYE^b{Vdh8< z%1n!Q!XO(@C0I3IiZ%MrJ^uh)Ya*e_W{k&E1r%Ya&p-$&0`&I7>^}}}9gxwP;^4bg z1D;)~gJmhD>2n&bKTn)AG;&C<4MVVxX}?7$-@oO9UTV3a<)by^15ExWOmY?NgCxK#fJ=-cz5+nrS1kuwf>ri!0CT;+|-k zt0^fezf}-kR@@FREJFDI@>0%lO;)|3X(IWa|?&2xj&2iU^-x0wWz#i=eHuK0EP0G zQEJTVG_QQJ2|T4>k_qGT_bQSu2XJ||I&~^^+9$)sb0siCrFAB&)zq3%ki}h_%puF8 zjmr76$fTl%=)F3gg7}=)WjbZx5*jZ9F@i?k3&7G$9ntGo{5E)#qO|`2=uFvCmZe~M zDyhZfXz#hMvvg$ZVmsdp9mFa0hFWe!NXlXc%hypLD(~SX6>dqIPYqN>t>u<+%CfPs zKVFz`j(B?{9gv}=8Z%syi&5u|mqVDC09H>cXQh;KP8Bk#q{;R!!&HA&++Owr+~BHbJ4hqBeF(QpQI^dI&(u>* z1x&GlG8>S_{2QDAb52~+yM*nTtQn3~Q&pB^i%~E`ADGQ~9^N=!7@QbX9Ji zf{!$)cxj5ccZ7}47(H$K`N6Kl2bcm^nPC?+O420smFoUvaI}okC#72UA;-BK;btT_ zf;p)g5uZ+L45Gg?l;xpbp@F(iJwZM1`|ygs8O>nLq@rh%fLCZq^Qw%_y|W{iOw*f0 zeQ}lSZS}(uiVT1Rh+L4mWVuV_GCf??%~ATZ8?ZKv+ueI(szp+o{xmS!0xbv;8l z5-mNiCZ?`qUfSC0jrKr=i2|7@{bu~qWB<|du-rq}NYBYsI69j4$ zaH6`_vFWmA%rXqhHJzhTB`M|C`c}bscFVH3SS}m@(Lww?@h+C8lD{v`>Ll0{-IU$0 z&rfS$j7|)+hcph!Q_^$|d!9Gez+U&8D`y`Y5h9RoqNc4ft0wb%u^Ir#MvV`mH zF%-45wKTbbqRgJus~WJ4ZO||yp!fH|SW3hK2$88OC#iOx@Xsi4xlXF4r>m@Jt-c92 zIW2oO?*9N>2Ui^8GgC0oZ{f1!G&@w(`F3mIC3IO-Gt<`5RTkYo>&URMxrh$r3{G6$ zATxTTMZVq3*vh1uehj-dsi@6!I-<}S3uTnCwSn}7Adh}|#1)H~)L{H$?(xvU>8j*Lrbd zU$=kD9$_g|k;|WQ;lflSQo*aVZjhp-$mTIq<|bArYK17*YXaWHj-L2qOC@TDHR3PL zMEL;-^!|*@^S_W8^-Pswj#n_LV(S{aZgK$WazBO`Rm28KWv9#buBqHz9akXJiI>#T zD3X`XkxPjf#}uR6NS5h)_UgHXFYuLfjEg3UmZL3^o~F9e zMpIQ2?^3koMLGlP{rwvVAeLhc1Pd-Cl=Ag>p#!@qXN&(nnSJkl0dcsG!MJTIP;%-4lMFyXxs!t{n z2{y*aJxfk#VqI=79=ZpJ|N8#F~h69MYPf zDP#)_RMhFUQFyoIZl9h8r&+jp4U;6?^IV7WPVs46o{Koj^8Ln*=*XAnjFuBB@>BiZ z_=~1?QhjL#%dis7GvXFY4r!=-zc!G{%z!E1yKT+a*zx>v9c&|uTOw_*d@i(4^*QZc zrGRFsQ@T8!2bKWqW}ZP}BX6ni_QXPvrgHqa1$L8Un#U~F8F7O+T8etcZ#|V$Z85jt z^?mzy$4|pLo4T<8Mf(?lF*Zl4buMESCSf%rQcF^dmhzaw7o%?K4Xwr`=_#?L!e$K5 zZzaUdl$R*gv=io8wKZOBvCm1qnw+{_i?18+`@YzMtrL_GBoHNaFo#*~4yM<210}4@ z(o1^d4tM#s=tF%!h45`M%s*H*`>(Z7%@v?wtk2sk&y#FGNF-%#n@Ihjeehj;No!@g zuP-)D-X+sPr7LMNnpohH3UVZhc-Qrgr2hc2H*>~2!IM;GI;k?sHq`2@?^fykHA#`m zvC@fEYia3|%jWBS-+N(8D7K58n~{YYT=K=4=5^U6Jo6-q6jaF*S)yLy8{Zxdt3#t} za`9gPiB&mO7Ii}|Q8;<2RvoD%zu_BT{7l`>0O=h}=9~Q<3!JDcK1-IHW+~kUC7$b_BI;9{g?vrpf7xumhX$-rUP@41I zU7u;3(tN&0F`9Rbl~MS|2G;tE;(Bx&RkAfJ(M=($$g4GOZuy)vQb$8HtG-7|Dvkla z^T({HDKi-NTK;~vp}O|ivA;St^}cn3~V@FSI==$Ej69gQRRlcGbA%qI;3>5HQM9xZvFgz zc!skBoe`i>hp9nI?M<0OC2C7UOHP}`L}}^)2O+)ga6Gn)dbcF#rV39-RSi`gE6GsL zPG<(@OQXiDE_Qq1V$ul_e5Tx&NV64Gd5tM4JVrk}sCc*{FhEr+?m4~^k&w(@7gH)R zs;Mierm4*6Wrd!XY%#_qw2YSK>w_pmhDQxxO zbGr=bQDz=o)7Byf+r@B9qF%I$k2e{6mwF0n1O^w}MeMy8j=xMV!k1H>$v0j&$_2r# zA+P-?b1&9MPTLd<`h~bW{#bM{*MhvJ95CI%#E+sR;@Vt;r*wwg{t$ z0FZWGWlwr?Ox}Yzq@kNFXryTnf>!Nqwl;44Im9(XUdh#VM54xVNd-k?M@KzES4bHI zfEI}e>$nfT0HpHK%yQ%}CJi!{q>=(8G`0L&=OlP|rYc#lvA?KSUzZ_f}1G2penshjdEuwaBsqsjz%qi5`< zmGgIq)#b&4M+`B6c^3Zwv~ADjg;gJ!xd+A2^X&Q&tmch1y84n@T+)Ll%0^JJr~c{noC%?J;DAMjks?|Zg6$DUQTN!e2+_0Wx1tpS3^iy zCSGA;cHCSN*6r_qd`$Yq%?~F0`624FWTPOd)A?R!KAo+t{T?NKkqTyAw4sP3DDF7^ zIPR-n@E$MEv?!P&$;N4#k3vOVoBXu%L6}xk)vKaBlGASUDdhnE61@$&*n4B(!0Me_ z0t606bq;e1Q>A=CmJE?=Bd&IZ+hlCw>Z-~(QP|wz8rWXE#+t6f?5q4blRU|_N9kFo zk>H_uBZf%91qDG+_5-Que`{gWsI|<>H9lXpbx5Nfe!bS&Jd)aMt2W7|kX_mk*5j3S zem9Tbh0LQ(_J@ZF*FuhIGMD7q(@*$^6xm*3ljd~PkP_!LrI1A&EC}?W{6K#UMlk-3 z){!P`1fOBC?$qq24h0(WOou#Zo@}QrdqX`e>Icju zfF+ck#1aSJ5#lMa$EZOwHrhXG?T)fFYFb+TBaviULMo-KrK^zDWm2dJtCp7rI8+bX zMixJo1*&ry-&5j_r0lBI9}+WMmGeD9nW9tX<0)BMO{!2dDv_!X+!nC=;t^XYk*bu| z%p%c7WK+wW8dgZ=kOgI(4%@LZ`h~~u{IS(Gnv*9b&HR)#E2-y*T8~L)8GJhCN2UQiJs2zzQDm|O)Y|k@Ea?JNrilq!%IVu<| zsu!oIar?OT!+}V8&1`e;N#9hcHhJP7=-O&(46iVBB2+TU8*;kbUz`%mD0G(#N7AA6 zf~T4GZ%v)&6nTtGHC-hvaj>SAKuppAE(C|A$RBJ6PKj$sJyK4+n=iU)Rtrw}!TK&b zWy>_w^wCQZGtqEn5{{)n{6p$`;Y+ZEq>|zI#S+{}Zi)lqFNhx@Lk^&ts;*fjs941m z%BZkd^|Jl>zqSa&VRN{$-mar`J!+-G>NA=j?V5-5g+%ee2|M3w?PmaAYM*n0>48Ay z0`L&T6#&jvsvw}ur=)a>se;8BKY<)m-eqhJmi|vfXwuxFe0K5wv2k3aG(I7_xfV9iNZKs zv`21(x5vpcp;GDIk5>NxY!wxAfFLH zK$%5UP!^gXf_SDDQl$0d54HZd7ZrkY2yLBlV4mRkfTrF`8R9;_%4&1E+K5p~)iTPg zNDO$fwYy&UmX;OIzK~6loLzBH&o$3Q)YDbfqGfRzp3gJWr!K$^&2Qa^adh359qr_U zV>d`OZ;Nz}lr#}Q$u%pJ^7}0Qv(Dr6?fK)pE&;;(MUOOLdV|)|`MHfnYgNlSNQ$P6 zx1~+P3*m)2omhy1Zi8@zIH~apo@%c*%mQdpQu}vpP%UBY(-H;~`gy1%1p$-AoX!cP zb0HBI+L4vL!R|eg>{{c9mrtWUv8^huDk>Qjltp6v?PHY}sMWG?3RMdtW$@pfXVEP865DF~ex^zADN zgLCD82rN%tdfy)wQxO5z0{u&VQjiHLUR&^0t#y2rv*tc6>0LIkv2#yDShbTtN9;@% zKn1P z(0%bc>9N9E%6~SizL)?Z-1z6>sz#&KT4}2)C@V90vt_2M+XU=PFFZTO#&sMmz!x33 z#B8GW-K_(hsND4d@n)kgN~p68ijy&=j!68eUany2<`4Kz-4pMF@Xaxm#2d|!&vJl6 zqv)%$m>{aIriQYrVIoNHv|RMuez+{wA<{GfL#JZW&j;zU?I)yYs4HqhRTbKjtL}`k z9Bn^bR4UaEbB{FSVnDYg1l75OxqfX%($s>{5g|9Ydv^TA@eLYef~Gi-pRyknG}cdF zoaTAd(+V1hOb5$N{#v?##1HGf3!_ET5O2v2{6K^&mcK*R*4s(JnN2ig&jw{z=S2fW z-4-WyjN1KdFUAUUA51|aJ2gO;hg>8Tnx<^ksxt_qf;nAGUR3c03>VT!4gQR9$|1JD zf`P_WUC%UaMGm2YyD)*4hN@t%^27#GYCDcjITaLHm`M#j-O>OK*Je}AzPL+8rR^XKgh?@V4e>8PE>$Lr%*>J1mw4oFU925c z{vr3pj*Gfx!WfA|-1AV>XEl;lOEZ>h0rnVT%3*>LY^7!Y(W_dML24}-JqBq{rliei z%*IN3%(7LTVr{&viob*o_v_ELGb$MBc#!6o1{i`K2q(H%SqoGqi^Q!@nC5xq1tcvb za>6|55N{Hvc-q~%j)vGd_&Q8$Tw=n+nAXZ5^D0}aYW04(%5psOD$gpjJm^Mg^}`2aX|}sC8#8<)##`G$A*RQ{{Sp~MVcJLROhhe=0%`=i$s;7H-4xp+y!G`8JO61?zX2AtoGyv zC-=6Nk#h}kB*}}N5pSd;NQIxZS>;_)*JabRw3YQmyy{5U-WQLJrHA3TBL4RJVT&lW zu;2k`(Z_z?`PDAYZUXP0>wLc>qRZ(`EXeSxZwd(;hf-Yi$CU7nsN!Tnhy%rWGvJyj zJV1{!C1lOjn{j2Pkx4Fx_CX!^#LmJN{9oa6QRajO)SAv}T+XhdSCuKp_&A-7*4>u< zu;z^bS^(FYh`ArU0(fa8&2zlX56k8hlhQ_=Sb4**@EA+P-5@Y((NOjZhkQt73 zru@0Qd4?*O4NO$oR&W}=t)Xqi!y~e^mLQTnRu|_HW1kNP(VXGchcV%?+8TPWFRy~- zqcHWn6doT5^^RSpvi#P+FM@`quQi7(%i4BTr=QN<w~ElIRJD#T zYiYU8AZB+|b%bt2h3TYYw`DHWlhRRYx~!j2D6?CMp8Kl?3EMFQ++~khg#|VQ<_u!y*g#t23wZY)znoq>nqJ) z1ZQFx#{xMV+QZuY@iQ=vqSAJtgG>axW9B^@dARnbuLPPXQ*SAOIjv zgdz^7rycO+_yLD@P)R!zxwQM#Q<~|fEYB{~N{yFSuag2hO2ur^kS}H(i1zJ*iyceW z8mNj5=Ja*GA?e@V~XPT~s@iL@2UyGT=UQZ0QQ7uYF#XPh{xd*NHeY;`@;DcPfE=Z|0 z)@1o^U~)Jo-F?o%cPazaA8TXRVZ@BuFS~Z4 z)3-P*0qZo(3yr)Nz*%vxOvvlHwVqo~Q*hIc@N1~O;eG*Ek0t=ihh4sQakrw zdt73#UbbP^%^LeZYAK|s=BdY$f9|v!>-}}$gDf_&*h2TN|Kjv#X`L02Wc8Y&3FjGes?b!od9{s)W zb1T%uR3e|o7M(3WrpxUTZ2MWoTT=xNpNt%^5mQMt05p*RZpg=}HY2Y*VoDfXpt=6E z5NBVvCGn}r30GM@was-FODzpLq|v#GS=0%Gjufdq32ZYse@A0p3AZjq3|?HA^ww3H z>pB<6^&WLFIXuKcOCyiwI*X1mHFvgw&c=f=By(N@yXCc2+1xdG4o{j*Nm)eX69ZVt zr1F>g+oybaRic^9;0QeSQUe7}^u~RkXPSbCBGh#M0Hi4>Z5u3*Y%zi?q@UU&-vHt% zQ)3+V5Hk(CKWd(2sm7tBtgOnjDq0#;r)Q{Wk~T}nBw+0q9>&-Xn}%kW8R~`0+W`0| zEhmGJjIyUJS?8v#n3jPeYk@VoU-}q1{6{l`zAB8=F7<&rkwhpGI10}b$s-Fq0^$${ zbNPOD#8?-)i6k41xytmt4I}w_6Z#UOcb<-#FDfacUnQO)a6djUb?OZ9a&8nw$|aX+ zOsh?N#b!%g8&}D>qob=Ki+2`d->wUFS5@k|!q?=uaaH3q&$BW!EV@;V7HXfFbWkpm zatKx*d^=+sXAOi;HO;k8*)EmT`l>ociJNUM(+`-|^$CB})E>qrPNu+a$*B4Nt0bYy!ON*=rKp#i zu-LaFcYAfg88VE=Sqq&|^F(Rd${6O(b1ci{GRfoJ1GJv0ZNMY#dtmDI1CBr>fhVzg zVYX7Np0`g^S4%@f7n@O3hs~AF<07|EF$3E7Hc8V!yv(L~cZHSpx}PJ?GTg=*e7=Fw zM)M7xAfu4qLx3NSYZzKZ$RQNLH(hn*W`?ghmUC5^?yQDKjKfWJ5_KDaAIBeIMOJ{& zEdhNXsD_&GtNW+#P#}p@LgPQqdM2;*u7#Q(q%u|T`|ik zbIL=OQLB8x2Ge=UPk&?10)0-H=E`N(5!#^(#2UtfD|jW!Dd{}i#H%$^$GKPzw{Lr6 zlZJIqUpH3E*@ZXOI+8lftp-)(He`fKu|#gq86B6~gMjdqay}h7J9)25loLw924Rty zvgj06Rmmuuvc%`D$M3<_iEHKB4Lg?&Y?T(P%W4xpqM^xYh^nSBe8X(COrQ0yt(q6%v01-Mu zmy&$unu(!UCA1OP?RVYCAoL#CV#gYzEb0g-V{0n|mcu;-L3!)ZmbxXLIKvA^y?+V6 zVSFK|;Nj}}ragGYI4j*OeXcT>#egy2J6jmqqApl50Hk z!|4{EGs}fVG^|~b4dnnHtNZYETq|)Ss^~i}gQYxc6Q^_R>Vq-L=BZS#RC%CdXHo^a zGwtL8t@QqQf%PfAz!GFkFB{fOG`=X( z$wNa`nn6rpT8RgiqE9k)M<9j`=^WbIez)z3--EfzNb2f#QMuD@NL!U^S}Kg|Q6NIp z^{C}xD{&DwAP=>$!le=#+sOc5n)YB>7JM+1`((>z%JltnNmoN>mORAr7k1(k>DJg= zjA^Fq&kzV*u&JhHQ&4JQMW+(W52?UBC?>>%*kC$s4jS0$;JclZJv+mr>L!-1cH5ax z=PQNW7mc>v+W45xAXsVk@={DBI>wJJAuQ#8>>0aBh)?j^zWx73c_*Es7A=P>29 z`Ka=zyxAxX1tmsuja0OuBuQBQux+snPjk}#*ovNP#5M%X!uC_9yQ_k8MV!=E#vR~F zh@!fodh!7* z4N^3uT3b=(d9{5*)lW<$T6f(3TB;4IY~G$b53W3|L9A#!x-W~9o>QqQGd!Y_MXZA} z%mWme1p2YB9X938lS{Hul#WJ)f!1?H@DK45>q~3 zoW5NJUS%H9Ni{=6v9Y`PP5W2wFhkj#LsI^ zd83sff`tajTA4>Ox4F2!J#fx4OcQeM-b>MBQrEe(+IKgVBAip2nnagk65h!9% z_G-%ft0WX!mX<}O3QAQankiy$!*(CFz{3oI?v|VKL1tZL)`^j6Nc8qsGgQDT{(Vfb z+11%r>3;SDjCv@Szca13diXgdk5$rYY^Iugw=zg8T3;q=X;$uxo~x1UdHvY&^bI#b z9bJ)hRgThmzFwIYQ%@FK6#0EkXsen)o2llW0kNZD)CMXq*!Ss#l}VGEQOj8SYMD2& zIBQJHIPnWH&GV@=hs$Nz#3qqjDveg2npo5#mQ~;Y2R+UHnCXoM95n{fr2VyBK^`b; zq%wU;r93^(Xu?fPK2e>;Hdqstsic$?mL?v+g5OLr#67hgm}o>F#@%?c11-fs7f2O1p1R1MnnG z-7V~K*umx*f`HaU4Ap*bF3lGy$jlxPQ+O>kK`_qRW6Lris{+E0;Qik#3F zSZe8VO1cWFni`m)Gpp3oMxgJ7JuM%#?t9^m8xAT69IfpulUZ4c>Ww+7H0EoWQ0e$< zAf=9)LqkzjI1+(!8Py#?W#-lg^1}LUG~EWo9eF6-Sx}DG za~R}PVyIu$ZoN(|G#>hWQ+`DN_;u7Cmp~?YQB6xnQqa8iJ7!xIP5^8EcqQ1Lj1oqQ zC{tmY=Q<*;Op*+?Dwd`ChiBX91hf9z;cD?XR2E$#{a+#$0%&mrB6-7O(M&Tlm!rXG!@6IQX{fWSHQA$C34@eEcEBr5o*p|ArqQ+NwvZGZ`iTdXt%&D_ICz!TXOPD~A z&6&XxyC?(#9atYo0O2ce6duyronka@V%>W|9F*d_+oFVOj~cvEqoAzID)oH%j!h9} zRofSk>Ps9%j-x5@XGJaW6ZePNnhNP-h+;)X$bzl#(3DDCLwb zn8i^WHqfWj+x(a|hYMvYz!7YP!?1(==%I)(ne@MkUM$w=)X|k0RC$I)GN_Et0*O!t z+#Aduqi)yf+o{2o=um6(2W2^lJ*EV&n^d_!Yi%K`b!^!kRRuIOrh<(jm@C}w2bXWJ zI0p-er9?OrIh;uGUp`DnYA0w7IjwZgW0vO`ey*aSuc6!!O$?K)%HS(0F}i{_lhhk_ zw>Se4h^FvbX_5}$#D0`k9zdB=9bx)*zc_xq`kTh-rn3!@%-Sxw2bZI~YfIAZRzDZ0lw!Wc? zuC`q_Pd!a(4)>e_oxcd{f{3E-u4@GZ#nfv%qwy;^NaUx}^1DX%4F!+41QIyJ)ZIab z3x|s0NknZiOR1=6W2nw4Ybhn(M6gsSUI6MWPafC?yQz~5Ao7JMBnzmp&$3**FU}y3 zDVBDtc1fgZIa{6^@;xy*qVnKoBW`QZ<;D#!mn^wGdh5!3reQQPd38-IJdC7SM{Yl_ zA3mY$4v#d5_U@z(1xs>$DNR-J8<|kUsVVg4Ox1#1#=2kB(#H!#uJOA60K<+-f_S;X z)QC8ChY9OIH`w+r1x%*JTR)183-H3)KR7yHR8m*#m}x$1E~uh;rZr6)a;{VLTaP#P z7Qq;C(Ss(%z;C%6(DfgmWG(Sy;WtX@--q21;{8@Suupp~Ivq^N|EqwXW3BsAdbh^@=QReTf`?Sc|3%nAHQWsP&h4 zbD?t@XeP+RUO2~{1x@#F9Z0|Dg;jA?7+|jU?p<@uP}wy-1r+gl)X~Xkql^+z3wvXV zG;@;Ss^PCpIku`f;?mXABfT^-ZFsDAlk6}2aWyJE41=oiOX{MUWmsrvqm$-hQt(K@ z6;$;bkALTZfepDjDM2~~EX#8?)6}puu|pLWT&0~D0l^k4xO@Kq90c#a8+>ai;uUPp zD(0fqFjdJa1g^QKjz`-NN9Ari0e-l!Qg2cZ#eh^V3Rjoq`HfClSNd9LvgZ!MDINUC z+zaj6-p95ed)g0H{MV5P7eSRA&oZCqs>4Esw}{&A!EefpICJue8lg`$Fwiold8p}R zq4OFlcx8;4#lT(w+&f@QP{~dmtjg(zQ2=QeH1bcDW?F@)sk0ef*`i=0Ao3K0+V~9C z>AKBqz+LW(Iv+F{O@#w6PY&3-j<2E)3xtyqqYG9Ld#*iDBLAM|7_QT90?1OQG+=3|uBwLnf+^}QQ4%%FIQ-`>( z|Iz@ziFr)9-eH?PGij`eV=X>kOD^_k}H^RQOx#4 zqi6=zIY7Fyx~If{336&&zeQ#>sTQN5*yg4RRTHGiWhpC;NjCKs{5=PJR&bb1ReEN- zTP$;&M3@;}qhoji-Q^f+vS8|@`KD*0C~|R@>sh>vrfHhA<>HlAlBz)4x4SRmxgMf= z-wUu*Yd*Gi$#ZO647?2p4K8RFkvAf3y85k9&;ij`OxNOz!@mk@D)OBQ{#6cZQuXpu z(LfR!DT>&tgT;-9)b_>YoC^_*>r^GVNN97N)*xI-H!uhSQYYd=3^Z7vJRUjt%dczm z{OD^siX5u73M>?nffPb9=ujJ!b{~lSv1arsRgiAgiO>Z3Br-dbvK)YUE* zmGvZ|`^frp#yh7>HP_S+p?V#<@kbt?($uuouvVI>LIE;^a~qI*eF?|1`i2MqZ7Z@S z>DhAZw_CxLOH(B?B|ZG;qZ?l#$n>Bi@*v$^seeo{AC4dS5_XiBA(`W)3xGzS3 zhD@s<@lP+*xsIcbrY6Z54J`EaTMWnn+=X|p<^+2iU$yzK{n6K{f-Ge?CZQq=b6&)E z59UQ-+n>P^{5tT@OKK={O!$_AG0UERkV?J+LJ8%s!9R0_oJ)z-pytyMTKFy_T-qNW z=3fQ^Cz7ri#&21g(d!(B29lfSL_SpT`au-z?$#rVHT!#F*xF5LWlItPvGuPXp$c4w zc@~b=)!BBQ)Ui>dnRO+6bk!A6x+|lR7RmHGn25U2F-x>AYer=p&<`|wcx{+7RCg=i! zZn!dz9lSRV7{jD>yLUs?cSvP2>HL>1(Ak}QvgNMuR8z@LX_S7f2fdG%+TX_pSE%eu zTL$tk%|OuwJmmVHFVjMsFQul5Y2+TG8QAC#P2Xet?TBk(&1odu6)RjJNOjIdNZJlf zU6e%>@JUo@SW^wJF#zwBkGZxX!o9+#R~}HhaI&eoKP+6t<~3~;(ZNW;f_?zpd*aQA ze@9?Y;_0hiRgBFlC#$BCI&=#hMSXW*JDf>}XGTC8sK7fR=9Ed@8kt>+%xnPW*1!31 zZDYCBcKemdCX*(rtEQ%}nIdbe>^23(`i}O#K0S8HUXvD5tq&GxYT;T5e8}WBlYblz zynEnWK>%OD5WuXypUGgUu7@-W zm~)s^tt0haqQD>B(-7fl0&=vBk$L96ag`#ko{EL?%Krd1qNgy-5)&kD_W+dzoDbQ* z@%*qoIWpJ*t+u zx=EhCqMeqirMAgS3~gel_cm?4ez(H_{IMbhH>7 zSau&=5l*0Rk+KcJDWIpP(k&{_POC*!OonLyWfd0ST>Jk3Rw8@4Z&ciSw_Pzt^tPfxosG{>KSIm~0b~42)i|w?(i*Ua; z_Zac`=2o^sK+u5%crHjwDRjnfq$ncPb$Y%W&S@$_y#*~(OG{51Ft?+#{{WNekDXPu zk471m-m{yP$MpFw93t|Vd{Oa6Dth@T^4h4XRVmDZqB2#3o~Xe0`(kVc3#%qY^gdnc z7r$_;mS5sFd6tixSzZD!w&A}RH@GeRSbqE~AJyzo<~phMKZx1BsLiOP%`2(rT8K%L zqoLpc7$4fdTm$Hhrq~*Shy`)dzuN|!eAhdw%&D^4FwTt>h#4eaf5E8eZT#`|V9Kz- z*>|}}+o{YNA4%$}0biG923oq9&gsEEf_|ge{_F`;6#7o<3kBXu(N%3xrt^IjoXbY_ z&GSgR+H1A8azQ_Fiwzphtl5hw&5@75dOV*jhcMLjS&Ob`OHt)V5GK>bhzyvb$VMQ>ZEO71OzNb6$DGv(!yd zE!2-eC-GSFzn^SBqUOnKh{4hMZDKJ2v1p0PlC_ z@n4SEQqXBI9M{}!uFKIDILhjCe4%qcm33n+C!03NS^K1^8Wyp%uq0rN0>2{fWGBHj~h|+&s#;wAw_iFrISZwj=8jRiQ%X*M{{PkJb~;m zQ|R>0mgx(Zb)5rnhIP84eAhdQzcH2MrI3=0SJn{lE%vqxZ4lPL)plw1V0yr(x_u#C zs8$*BdY_qrrM|~;xC{RPMD@o8sAZkWeA5;p>VK>kbsZ%&F_cs)h-)K>Sz}(;BkgmOSlchGRUw3A^SGa-@hcc>84k7Nc8wQ7q^{bMn=aD% zv=U`m`^yGnMjA#_brQ<9XxrFy$CQbx-m`8Fyu$dlP+vWK)`elpb0?YNrMZa_fw%%GMT9yeE3MzzM}JA$9RvCVT0Am~TzUcK2>jMN?> zNm;9_=;%w*QdB`26qBiyqZ`Qj7QL{Jo)#&GI7yT2ToYt2%QUm*nXX%xRMN{D)n*Y> z2`#Z5q-z1Y*!RN@nXPcjAg5z{O)hV9o zX)?Op%9zqh6;c_27cqg}-TA>3gKC1&eGGe7U=okt51Q7hz2}0fEm579OHL_<{L|iMGljOIHOqrNOqLm~w z#07$pepG?i4X|~KU6fwSlIc%62RS*eQBhq>QBJYYLaHgyT2C-=THjnniKZIhBi1L$ zdLC274q;QQGKe!c*`a9}1=mSwK}IDFjuM@ zrKHta0I19C&{?{YyW>wYmcM%0*_71O%9 z_Agm3Q$wq1^IX=lqCAlmiqlFK=0_JHN&4~o@y$n?aL^`o>`;J&+IupdEk`>`Qqe~3 zwxUXRC>bwn+;qX!S~6|ohyo#6NtzsjqB?x2R7o{>RB4MBAxP>;_6G=Zmt4iPj^Eg( z1weH-h_o~UOtNJ)K1-NN$SrsG{P1NgCT_4%X5^)sXEuEIBzc*m^B`@p(uWFLo&YDm z7#6ECIxl_3%jumGYMM;rHj<*FJc6Sx%VAJnoyOzO7Yx0z^Ip~tsRZ*LXn+@7$1lir z93P?TD_)&eH2Haj%Qdb-oBQMDms9HjJk+4gl8pLVJfU)2j8scSRuOF+sd#1r--PyK zk0~|JCEea@=fLnxl^GAuPgzrwR+ySSqNY9Dy(94rzh3_UmL_dd0L(eUj@quZ`m0ZA zEWVkRHA$IBR7Km#C)I3lC_baLUG$K-L0p=q3JQ$7Hu74W`Ld8~=loDR@Cg~KBr7z z=%xY_rG8NQTP3|k9@^@sNzAmW0tF+J$3xCI4$kdtG(|8%lCE0=$rVXjuZ7IZ zPI#HCMnsNsY?CQ(ovAY$qg1N6u^qv^$oB&a@fcFl3E#{1rZk=vh}PZ~czvYu^vq~{ zMa{G6p{bSWa%{Go#RStzP5y01>Bh2b+mI{g=?^XaIl#Q-FjCzjv9qs^IRnRh|6%<*PiLCj`87N^g zp@cD)%!W`$H$))u(BsBBMfF@8u37eDSp`Gom06q=#&wQ$i*d6fulpY2O}I9`JYX@J z3GPExb)i+y5ZVlzF@Q&2)zKBZt8*lLk4X9->cxi**BStO65?S?^ya9omcAJB?8nNc zc$63OHo70^+rNAbQjh{ptL*5bp6iIST1s6$%M#9yyXIL&_qDo{fN4-HIoFw{$%9#H zD!nC3O8IqENX!SF9^ib%_9{B}$9QT&u`}SkA`sHMDa-Q>ne`;m(#=?Iv}gd0q}pz5 z+-cNYYE#X@cS>*In(CT&T`6_AY%nQ?l(5z zK^IT~JAJ+J4O~;IGav!i)GwkGbv!)ItKpJ-lDT1;RxBW>lEIaUAcOY72Nu@)+=BHj zq0^bABi2*p`M;M_PXKAweq%BunBFBi^7?-?KNgw^U0j$$vjAmYFJOT zxAoiya4{`c2S!sIhi2=@OuirGSx%>{udX$Yv(T9)dT<8QOufN9ZQj_E6H(NF09fzu zQM6uE+b_#&^Z@|L105p;;=`ta@7!bfn*SvA>ZEpj3x4 z(4H2p0@LPN%Q&TZG} zp~)%XG75@vzGBYzyQ`GiY3Pqn>$wVk)(gF&W(*n{jWZBXhtId9Ikkl0I3O zFyA7e0?xj&9Q`@O!OhV|;RQAd%-%@>lmQa8*-KpQ{{TKaENIhJ&Uj6Aucsnf`e3kY@PJWP*KAa5aqGeLt!9k;{}z0$tS@` zDnfP4Q!dUbs;A5{$R(boL7#kT`@rBU6T<*HU#0%Ije*P%*E-W4E0?^kURGb1!12&f zQqa@K%A|0r#t9uj9DVJNWzO}9C$)MWP-|Ft;@L@jq2y|~QBRbnQuN5}Yo93ng~;h_ zIith+Kn~lXOWi78r94N>wYE!2wGt7)3DrR;U?_8nv6@$C z`uM6^8Fx!SPy^SS6YYN3JiUS&R6rufwR#cf!@V6Zh;vOX4y8k16*!A9$h@MJFu5P$ z5zk)zJ+PA(i1ctJgv+eqxcd}kHs(X0AF@G{($msq@=rZY8i=Z!%_8Jjoys~eAHN0g znx>&8(Q;xu*VTHea6C23S4(NU=QoNuX>%HN6yj87mcy^B_CO?k{{SpP>hEDWd6g-p zDg)v?OPuAjSp_Ct6+Eyy`6Nwbc+?(!UGQ!aTI|PtR4?R)84rYYntG~}H>pV)8AB^s zl$AH?KA2$ac&H0TyC9x2qBL1fXO~GeE|C=S$vynai3*Dr=)Zg5K9R2LRGV^KfRK$v zK22<^TjX>ZtovDEkso)I!@F(h*TA?- zDl!ThN8x^Z8%nhqQ%N9pyD;YmHyF*0ml;a`)1=-V=&YZ_D#|GHjZYR+0FQ5-GlWC5 zU)IN`<%%vV66`qYwoi}d-3vrYuz63zo|)4*hC!`q^}Qre4+8AO>RYD2FBeo3Qg21BJT_@(fwgIeo7Gpuy=AbK3}1UZFW zC@hOIpG>k8^o1%pH|uOe_bbGmLWAg4v#7xhanNPZ9}5IdCXQkpH~wS_)|z8bcxRMU z#hd39l^H5I5L24Ps(_ZcvlezLKqT73gY@Fpgso2&;9Az_a0HOdj{bAZ_aLe^HPH>c z1n_58`2CpYbsAqMYRVc5nP)B*2pyEVAt$?lK)1FXWAQD*039TdOm6}w-h^ujzQGhc zG1K+cnqN_7zo%u%Aj|7!%BoSKF9S}5f;S&-g4j=vtOZ6lCVb5f4jKS-U53n{MyS=E zbuC6wK}fYvN4w3dg?6;7esA>S4(QO)#Ki5~gC|%{-V@P(Y)L50+DP)K?&9BtSoZ!L z;v8f0dcLvINX0#+)0%rV&1DYQ)xx~I9okF8Oy4myogkv2@)=Rln|B{OA8 zAxb1&v#Z(39SaOeg~fEfw(2(sL)i5ub*Zx|XsKY0tKv^CLcJO_>fcj?dLd1+bSG87 zaW)Fjcs=1hQR2+$lqGzxTM+Xq^4I-bZ5`}=W7NBk8;49)_^%Xx2xiJlU1qpRIkgZs z(qq^{GKDUX!qcCJ{{V*n01Na@6=rEcqv~>c$;gJgEX-=nWN|!h!_A1v&^KH6A8b(Z zJVLJ&AXTbg(VOLpEi-waUInaepF&e=VXVK}%9wc5rm|^#b)<25k%O1vYlOPC3jb&UBk>%u>LRs0^s-Q-DVcM zs=2Ij$o7(Q?BlTuyq-!= zNK0Hv5o5P^f0E}>3av}5b9%FwXkn<&I+WNf+&g!M zq8WqCp{hB|F%zrd_3n3DqjOxcEU+yc)5Osa zEqa@DzvqY8Rtn8Ign{%Rp4d?-GknJ|hO_%;g`y}`R-i~#?`sPY()YoQV_6wALb-)N zH6E;@gDt4Y!b>-j`;nz`#2a65CkIlXT!}pnDN~ACdv7ObCb|^H8{>TX=s3Ts8I8u*;NF z)I_OhQ8vvaOS&?|_G=50LdlJXO>%(V9m2OtgfP^&hK+0l6f8&|d!l=f~A5GY-OM zQKvN^X-M@hS3Xsi>Ws2{w{2Y}U}mJQhA%A|n~`z*vGq4+a~uteZWN#d89AMHWtYWG zElbLxO{#^rdb?PD{4#R`T_AX<9B!^hg|w-s@*KKasx6?%013l78{9DMipDhbuOK^6 ziwAYr#f>+UYHYJK&t8$^sfGfutTKAdxK&~7F&+Y|sSv}YuN-qAhK!}8I%Yh>HOrco z9IcD9{uZcj=?{NwI>Ztm4KteE%Yr#5{YJ2;sG7blF*KApe1OX$vlZMxx#{=B{Q!ZV zQDwxDWc}gm&`?lPYRyHPnJJ^GEAj-Fl3NfszeCN&BE*ijM%L^Xvv^WnU#}^(q$Zyw zpfgQEUP$U(o0y#N8HZ9WZ>9&Mh3F4h>b=b+ajx-3zM~+@G^UuQX>&LWO;=GK<~KGa zK>Bl!h7qB~^$5$`%}XiYE=<06sm^OP4D;2~!M)<1LZi$8UNEPx)OW-uGkT$-48a_i zovH6Qt<&1?Ei`p9!7WUX`J2GAL4KaD*0&?JIHuRoc5YiJiQNu#?v1L-a%!rI32Eyq zM8-HINjHHJ{6&v$*gmEvT?9qFsuvkfxxSLlGnI;(wrFUm<3y6tl_p65H$I-9o+4#t zvrDL@3-#ts`6tP(Hg!=`B;aws(zfmVaLR-8>MXma@!tuTPi9%ihgGoW&@xRjt07zY zga+=*?TKo&wT4}k;-INvVxroMJ^-qP8f~QwQ!%Y!gQ}8f zJt0Y|0=0Eik;4ev=uO7wu=c?Cn&y|PqNz}|#3QDk@RExxt$Mc4C#Q}N*2a*n<+$Wr zeQ>6(IJvQw=T#PD{{X19l?GXqR@YHWGUgs;!{#6X)bMT(Ohr!)a{%o<(zzy3dn@r? z3V3#BxkPpB2{Dj^fPZGg3|)gR^$v~Y($-6f8QhEgKw_JX!eNZFQuS)IiNd`adcEf`-lf#E> z`oU5-wN+lLtkaaQRk59eFpQYYP6@MaUPZmfOhRZ1VZ>g_64P^c-VqDDE;BIb7KIg6^^s!BYYXvK65FrzEr-9MKEKz30qb;w2#PdNisUA?VxC_*M z@CGA@AB%Ad$2^@^-EEsu|Hk)iaGREOhhHy`^P+&MnU=?s>P{ z6^gY(YMlB?Fld?do_|?glzg^xn7`>s-aw*7vs&JgN46xbL^aaUEgox!2}6lBrmM;` zN}R5ytttgL4RSwb-9L5@7%^x@Y=l7CP5%qjFQR?-MZKV*YO+$Q#LKLn|1Dq+bGqkN&-_*Jv>`vkzkfP zZBkFF-Lb_?Hf`j<`V?i*qE)F=qo>VvE9MZ@(p1I@AZtvHY;A7%C9zZrd2T%a0Ak?t zL=6w(1%7Ky1zO1zlvATKrT0o09_!lyV(?9ABS%?w9=&FMCFL}dUb-kL=#u-SM&vht zMm}x@(QQ`^bd)C79xrKX%$j=azM&0n@k*2r6@-zCpD>Sa^5LEn15t-7g7{M|(F)|$ zStU+Wmo{ybv~N()VH#`!MTjbUi`xu^CpE?mqu#z6$0Whx7NZ^`W;uK1l3YasLn7_i z0E`6&-$98ml)W4o9m}!R)k<@SGEBcs&~KoYNGTXBjZG*4xVe?^$-_yr{af|R+~OPiS#dmh7^et4FRBG=zl+H>#^L{sXjti^K(rBpGY zibHV|8~0()1bvTuMa1zYhy}Xe*<~b3wG|q70$D2`2Xk}IXM+5O6rvno74i*N)A7z&$gecRQnrm#f zwx>7E)*R-KGK!}zsi_Cb5Tf#g4xrdt{{UPvsNR5#faNWM2Iu*gCHn-sQ))pBW=d_X zSzgC+reL9*i(bR{Ul3BI-veW`{>27j6PB6q>VFmvS*IhlCS&BwBr?m#n<4^A9C~W> z2QyLkTqHY0U>=c?N-h0~0B&Ed>)s48m~mNW!R z%hj6P5r~~Y5J(bKfTCut)tL<}l1Z56(h8ZWm1$Pj^H>i^Be=rq6lyqGx*PW?ln*bi z`8=u$+~In(FCMv9qDJxrvKma2CK;6^D_H^p^#`bl4OekQo$Z7zt(Hz9p0U$3&r^tM};)a5zEnd-^|EK`(Pno_`U zc5p(I$9zRh2bdxT=ed0rKnm$I+A1k1>ayynGYQ|#r<5h*kxAs=_hFNAxX3cmsukij zL@hC<^&V@MO*VH`9XiuQUMPAzsnC!2d*C|NSPVCqUo@hRfYIh!QiiKO%O;0yY|I`R zK=pxfx1Vc&90`r9E`zW|HlS0we-JfvnZj4))lpM?%REv>s=Igbbr=o+8_l8=!R1UQ z8TOv0sLeHANlQ-^VQqwvQd{&kAGPoI80@oq&uZhODl4ONDlwF5$SGlZgsrC$)zKl_ z9AG(U z9JW}}3Y?ObIb>q7Pa^JQ5_Dj_jt7jkg&UtJ5k8%RS6AjQnX^MKLoAUcRE_A7I)x3| z{jkloO%MRSZ!g+|d6ihTT@4w`eA+*mGKoUSjdnt}?QWwM3NATrmb+DD^zVn+K1SJg zs?919so4rGDmVq3ZyS_!0O2iMOW)LPv-Bw%QVkQGeweOm>MWLKTJHWwBt zvg0V*^sY$Edy@{hq_3gMV1a4kh6-JUEY_5f?f1FCICnM9o@2s$S0q78mm;Rl>vZl% z3#3_fWMgS}3ASqjS=qP>3F>-cF;KCj{9t?|v2zzi+`mm{dP_5|%QKpac@mVb%S#M_ z)%Y7qGVsX4)=1zDkWtO<44?sHc{a?5Y?7M4)wH#qdLM4S6FhPQOZzMHZy4 zp=yekm1<^z!D_kom1b}FY#+|pAB4Bl2CXP*?nH63{_{ zZwmmAKybgpp!79)Wc9T&Q>?U!RE8uGj(P0=08C0|BUmfes~h3IbNVU@Dy+jWWXtmT zyt;}g&?Q8)#BKdtom7+1j3mXfNdR2OTa|(Y4+VQqxvNS&(X+hNe*{Re+X|}FbN(=KA0j@PYkVSiQ-(Dsmof0qCCP?sRjU$t$&fuQGz}w` zU+A0;Fx6jSJ~BR&r-Jqx+oZXDc5A9~noUiiJUpq+XlC4(inU;onN5w-L~l{=Yhov1 zy2Y<{Sc&T98}6M_qDTZ!fr#?N7QM?zi~;AKN9TcB1xHDr z48No)&I|!$)hENxjMMFO%5wHuODROnVU?l+*0T;C_vXWkeQ?FBVAMSKN0XBG;gnXp zzz-QHV5*v@M^;o#7ZJfgVyN>Je%8?IZ{vT<6R@?!G&R@xRLJ*cpP@i-j@I5L6gr#3 z&ljl{X3RV>)KtP!6&_r)6Sv#9&=fhjqa4V`Zp@s-iTxtgXr>bfdQRIZ&|qrV&Cc*gKQ z#{%b`*pi=I

    +]]>{"first_name"=>"Mitzi", "author-link"=>"/about/#mitzi", "articles-link"=>"/articles-by-author/mitzi/"}An Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters2021-07-16T12:00:00-07:002023-04-12T00:00:00-07:00https://transfemscience.org/articles/injectable-e2-simulator-releaseAn Interactive Web Simulator for Estradiol Levels with Injectable Estradiol Esters

    Ku)v3RcnUtRI?Lamnbax2i`gBgl_X+v^6T?Q3% z)s^;y2rL%DVLj%v;~=#F665Z=znM)n8cwi+@fGkdJF9jIO#pkutU?}`z{${8s3IjA zI+;aeJhmO;`qE*%cg$?A*%7-uh1;rEa$GB3p0ZbIC*^$hWJ}*Mw8T?sJLYR$M4l_( z6PMnN`BkP`CA4#UjE`eJ7oZk?j0n?xEH5`q zkOd3_bz{*ythBUxP8LFxgbKEFSSdV)cHHs6PQW|v@#0MKJDYYW6)G%qlR+IK*)q$9 zS@YgbLL+Vb>66k^YVbV&orCewg3ARJ26)5WVsb%fw`Mky4mrv|Qq=d}&B>ym|vwl`5IB{rU2Uzi_(wN+4 zbx}2gWn{a)~m&Ewqfhv-hAJAd7%3fPY_r{u*M$pph zsFlc@_Sy62u7i7f{WI*@daWD@qVVGb-6tSX#>OTFIwG^v^#n0q@n!&uEHuR5p@6jv z@lS)(XkpVr#=^rGqusn+455PS8oKcKs+iN|1ioXjmd%ORBu$!XD7`gTeyYq#aYT!&3r<3L(0 zge3lKH~|Y?lg8n)EO3&gl3sB7@z36oy>NmozeG+F>=_VO5l;%ib~y6%W|oS7ry%Yk z6i^2iHv!W>D0@s?f*G*N#V$3tO3?~#&HBZlOiwULMS;e-!OA@&b$0crmQ8M)N&MTWQra>0{Evv-f268s{{QHz z|4)hBe+uFLtHw8u{|dbQw*>XHAAsxw?M|<#y4KfN^c{A$I2Pw40>ATtc$JZ@@X;p6D_syrRPKY23&&DMlp)v z!?-iq%pIdL!h1T*r0bWns)^)uwytNRim92rchqj%mou}ub@&ONg>b}?ZDrYa@6L;) z57U{fjhbPPIRq0O+*8k#X=iVob+XF}KT9u%V|+rcO%=MVSd-O6Eq$wBf$#wCZy$RC zLS5DCu*QZfFNAOCuSmkO#`Sd0yy;XedJ4uSaF7IRUADU-3Bx|sh+1Rfq>=y6?RB}6OrX~NkvlkG3WV)G4}Jl9yD(@ zUEG)MmhX(<0SRiXX(K@B?c@2DZ;NF*}77HwYX_`!#ywvf_xy1}? zrSo-r$VZ3pz)XI@LeLWj)QP~u5^JMQQp8Q2iD)_cUmFIcjU<&rhpp7uW1Mcv^j&M2 zFKJ!+Lk84p}b8T2qA&j2B&`ToGg(Hici$YDMSG4d7k_>gMaOv>rivhm2lSv= zK9pnvL5#xO4AO+=)9z8xi5hE6lSD$2l)Dh$Lnx58n~9UFwK-!-5GO6gM+5YY33#id zwvkwcaZmDHQBJss6z^~QmqFbTbULQ%rQ!_HHXAiLBU4NHm?1Sy)!*l}9h=kED|N{C z-?6+Mr8~VU4-2+jB+TM`k^|#B z-`e8lyOI%J4zuRni@6GNr&)a;Hz((k8A8*fXWe-|%JQ97Fu~fX6Uk))?4j|wbA|X-%Q&bl*VM&xdf^v{7 z?N6Xzxpiz^VR82MV^zB1KtvP!BHAGHyUc*X0gpi;aB59M;qW@8aHkf6KkBWsfp}e` zxDsSM{1_32Vcg1p;@`g{EA2Ine~sh4=RzKP3Wu(MwKfK>xwZgqcJZ=FNVbiKFVHZ? z0|(Y9Nj`EN2tY%%5FtYJ2XM1-?4|IZUa&HqwvwRGk?OtbWJ5hl2|+StZ-RX0zqjN1 zc$IMR<&+S*FXGMTcI$64DY52r+qLV1Yx1-0`t$hWy{P6l6|fIyX0$5cESv5{*(|_O zkdf~~nads_v@)`CdUGRKU3qu{YesRoFnq%v!$mLr#o~%pNYP35Qex!@7D@Zzl`2`i zMK%#4CMG}^*Bt~#8gnoLWj0lZb9-N2B|G}oKNL70?(?nTuLh+tAtz!1L{&qSJU%&p z&OiCU=w`{VKOTM=_Q{@6O7)9t6+^B%amZD8T!#TWJXMg0CWM)g2$INyo?JSC4*FUR zrEE#=6wZVqftcfALE#DNFd6m00Kk(YR5O`sA8I|E*qTSGB5i_IU#wTa4z|8si|7Qv@Yqz| z?_0vvA}%<-LKgItZrY|56MFo@H!x3j<)Zj^&q=`);bs|_S~FeWBMKnFz%9+faZT#1 z2NPyUMF)+cjZM-{QI_5NUkWCi@LKW3zt5O*PT`AF%OG}Q`3B^@ZGi~p+_pv?X#mu@ zpK=%-Q7kCsmAh5QIZ{<)~GJQ zjP+?k+*voS5sG|ZzK_bznd;JGg3^+arNs(UX2FMc!ohPP@=fz+?T9tWks7TAudjQ#K8xlm+GB)mS_HxpeCOgb6F z(w%!&eUkg6ou18 zl(R@kRkKJY#UCc(ubg#@h=J}Ja{+JaSJx?)(f;lUwC&e~rGAa20paPqw$omWKVsGcrBUcMyVu2bcki4*7YW20_@L#DqtGC$7HB}z1gH>D7> z1a=JUuT9Gd7PTFOPIw?|?HPu~&#F0jc)Hu$deGW`y+5v%c(!Uw`FiSgw+`uHp|X0t z)0tN^gt|syjoTKr?_R8LPEG3nB$qarwJ?>`O_<&2^S7lDZcg@h7bE)B5nK$OxW3l^ z?(kGLd*D9F&Q-9OtOEQRGRuF``X>#$Y%vTSS*Z9Z*|4F-G2M}Q4c+TN2AU@#3TG-k z)vSAA=qXB!&86>lJp}f>1{;PgBq}X`9l;zg1R7b!U*X>@4ikGYVm}jOHP9h&bwplDSd~X4UPLkCAD93Ef1=~4TMGk z8LK8^yi^dGKp|nTgGWyGpD{&?Yaqdbo&rem2-<^wLxko+BNPV*f93Q?{V`Edhil`l zTb8h2)?-3uGT*g35i<}G>rcpH$jQGGqgwpIOelp71G8>u_1he#A1AT?cc)ipbS~2& zG*JxvXn*))`Y$MM!FikiNtG@Fx!WnLD1a|!;i1@0^1C;?BW?bPhZ8UU0_MQ<2-75m zX_E2@8CSv-{pQLL7Rxv)DWqlttxTIbw;!6ViRbj=IJ9Srd6r)1_G3dFfrO{`wv_25 zgxl!!x~B!5n`g=LG`a<4J7G7dz4G3xxb~^0qJWOc#t@+DGT4iJD`B7i)|>wO%P+Owb_;y> zOZbDt^gi}CWTf-kB(FI0LQl-zv2{IHmMoE;v^TZmYSZFbiYA5ruSa5!H;ZzznO3oI zA|-?snCz8&*WsuUBE>Kq$V%Bu5Lv2^zC{I0(0DI>x~|Nd*;94@=izVQ8dhJ&ELWpF z^^qjIRbSc11_IVm5v_?EM(G~9h6AJ7<}*QFzbXz=_}RyO3rOMcZPhb^IB~Vit|%fR zGd!6tjb?XR*B?X7lufa5WNi%0^=9h?GCG0Ox(>FtOvW?TNs<~v5od5_G9S>c7KswZ zrfb}?v7brLX8Kk;vbh(ZVP0(=6gi--{*-?iQXU=o;RxCUTEsh8GQr|y5+I2{_ilsU z|0!3uKlDX1iFIu$$i_^x6}0~OA?e%Q7Xd&P@YEl zd*)`ghhpwXU}UC^p5|FS#(5oqM1YU4Hz+D%N0FI(WQf|+q3OQO()~sG` ze4~&vCK>>y58#x_#&P098a_8gE2&zejUCsv%t!I?CHqc^>V1`nh7n8gPL7(_Z_%X% z|5&52ICH-RvEi@VFO?F)qt!`RT1ZsUtUM96ZPk%_EKXIQDg{rfRR7m%e0 zxK27udEIjamcp4>s#--W;~kD%y9F9I&@`*Hd(BDHTm~k;5qX`P+e}I&mITCGEPt=2 zX%NFPzRntp020OxNkJZkkrl}|CGVyd6l?N58eGae|=o$MSviP$-XnX2n zFd+4sAv#!#?ExKw%Iw^!Vm3WNGC?=}_TGNhy1~ltjf+DDVnPu$<;)wLt6Y-5P^~kp z&Ke%hF9!za&AJe;JuK6rl_cK+Vm5)J;GmfybioT8(*m*Ed7tPAF%Ss9ySBxpsz z!q-JEvJybRQ=zZ7=WGg68i&Ro-e6fsx$HqBlmOqOOcdYkWC)w0@GwW4^nqM{a2Zk{ zn5PWoa+k!%!5TDEUurHyFiSv-Y(Ve|GN>C~lip0)8?Rdzk-S3z(acq^ zT{r0^72a=)ljAVIW>$^E;lfG;A}&_vnovk#2~LqAzu#G1MIBFNr~f*LGKcKF>6+wp z-N`uUOM@_r6Hk`|CVz*E;Q{4eksTZ$Tnc9-4LztBtE%m*_COfMwo-;x><(VCi;lu8 z21P`?oO`bG!K`a*VIn4~Z$rI;veN)i=tsb|xyuQO=e><9MH8ws7oS$@zDiUIOQN_P ztVF|6f8FnqmH>=-mELqnOZ6|QOlqX;V@=D*sfc3MA-*}u5pb6E`A>5&l@#k;@_${- zuh5F!ad4k=!zBslp3~yo5rn=MGo?LnGwd zN;GGzH!%FbHT^sohHILVQc2k8Z81VvQ3w!=*5wC?J0wQYJ)(B4a&a_EoR5d)tg2_a z-iFAzof^2QSeCJWrw@)h_9EaM78o<@E%t{oq#jzHoy$URkckPK%cYUvjb87w#98){ zQRO8Ld*T578Uz7({zhy^Zw$`Wr)&=ja&^wv-#RCr&tq|;)I8;slU8HXyNu`Epj{nF z+c7yx<=-NMiVN_cl_8qV;Lh0N7AC1mw+iWqpNs#T^k22Lp|EVx`yi{9o_E)55SItw z%LQa6>Zy-KY1J!N{Ty$-9A}-}{B7Og_ka1?STQ&0`M6%PdAYuCfTF(%)b7m>p);;f zL%x-xKa*sc)7zOZcTnsGYqxnwtQ!%jlBe4&#{BMbzwlhumbVY?dG&Tq(L|R1h4Kf1 z_d;qB8{vJ{mn4~75*sd3Xrmk<1PvFxxNCtrCG}9#Y|smipVOZ+IxGj}j!X2~>>6yU z2UwqOu8_hcksdS?y6(fo);X)MvckNQyfq%vGj$@qq(V3~ktI;>a(zh2fUe4j8bjJ= zRL>guI*~Rm14KYuI)OBh71BZQHzY9#K}cIk7XtcTa_IA4fxG9rzTVX^Z66u%87OGf zdV6AT%L<&4k?o;2Msy$iU*l(_0p95i2&@k_tW6&GXO<8G{6(E1$b>Vm`~mzc+r)@H zgaNWa9?{RMKt<@>`#vTh8iC;8P1thU(W#RvY+3>d6obOday>4P2p`{`>YSk+Vx&$I z8eM5zQnBzyjoCAs30{;PEZ9(E?5A*iAb!U+CumC< zf^uF;bh9zcoh*t9x@*i|ThqHaBRka;R7e`aH9^Q|+d9)APi?M`5m)fI5U5)7()_RR z6I3{^i4b%X41vKz9vSJ&CJ(_lah;2>SuJACiZzKEYD>xu$VIin_kVMgh0+E>7*B;V z_|gKHnW>F?S0||=1+CGRMrvwrWG4pNPFh%3Gnk1*fn$n40&w=y+~q*p%e1IX^IrT= zWv6l+NKsbrYee#-*?uc$V;z97iOrLZ1n>W?Y)M2hu#AW3BXLg4c!I(n(B&7isp%nu z&?qL1%HIpj&DUcwT&Y<*vA;(X!+03wY#^g8f4$S_8T=CU8L4{3#J>isRcrLp@`JBV z!P`v1W|bYB6RKSk8pgu|Lc^KKUE!P}2F~C^$@FM78%m@eW;>C9HQ|QJg^@D@8~eR2 z2(J`8kd1=93VNK8kd$um;m=_*i`8~}ty(SaekHmw7+Uuyh&VgNtooCP1oHLS=VB(Q zt(|(p0e(i3pWamXrPLacZ+>A4%CaYyqilLQ-_jioKGOzK_ ztoMS>bidXXEJ4w`pu^E%_@V~Bm7LJ?%c(v|)|81$)?lU0F1bxCemb&V#qx8}y_UUs zR);AIT&G|d4n<{^3)p0+-YD@@cGED-6Zhi@5|X#FQXS3n-+c-X>kXhWjBFqFx$QjN z!u>^3k#HG9w2pltE2*RsCce8h!GlwkXVM;OfOGE&b(Q#`mdljVd%nLnc`Q z;N`CaKJHLrJDoq6ku2@ZZRSzKLvs+^IPc>9jXo8y{@A*0@y5L|XeF$ps_?M3drM`^ zQP=7$$Qp;F)xuNk2(81Icfho2t9@cFU~I~9O5?z6uA5?LJY3h*|CXqU_yaa-i*>Q$siL~!QL}Sy z_+9x?rD%qH$ngyr1_jT%TVf~I%-c;{z-HG@F2kruJUeZg2(?F;2`JKgT%IX_8cJW3 z6UZMK7Wt#)3cVuBK^@FZbDmkbz&N%N4sYY{*`%tly{;W_DjAG7)5#*l6{Oe_cfy;>;}`1DNM z>6qo69kEqYjJ==tjy*5uN$+nb8k7>F4ysjtZ%4O(6V|=i^G0cu92w_3e^ ztPbZ7rrfkec;-K_5RW2no)uw+pifXPuLNfQ{y^o$BqHz$-8P@DnkgZ7IvXHP_U0^qbN~VM2%R zJ$`9891L5898c1)5Q?@`_^yez)ok`%)z7W%q<={k*yh!HSY5E_^Rx*Ljs2D;ez~Pb zfd_*ZV zX}8dC1`dnX03NcciDs8p%m$>ATdqCN>#aErZZp@8VlmZ{3_tzL{;QLpEpP8am8nv_ z{bIc!tFk2e6`iTmGo`* z5?1T^Vrk}1fl)?rE9OCe{k;*Jd?5+RlyWS(HtxS%)s22x$f=f(bA@WPLn&}sscyg$ zaMmwp1%k2WHxX)vYsdmp=Qa5YAv|$=R&9!L zLp3H)Qbl;#ZcL=KC(IurHUAuyI-?hU(a{^TFvcKYH=gGM?L=(Oz&qNvkln+rn3eJ? zWvYE}OcDp!e@Mg884MkOeODwxC>Db_tIYbY@>@2TFQZQRqaqfs$ru-+dp+vb6 zcS<~y&H8!#!C3W;1(h=nv;CuKR~w9^6E{8|qUqaQV)soZ=xjWu3&fpMtD* z>)sp^Xb2+9)V6xFQUzCO9vH$krE#$skNf38Nn-(Cpn9DL($0(V?U9WXd%;JYE#V*q zHc(kp^4Cbj>tG9bKMo-z4!HiAs_=~-r4aCtbPb%cd^M?UGPwD%s_3jagE34wwf^;gVEUWLcwFdi(a z#W^3}TtS(GVS|=fXYSSGCPHtqT=Eb*&+#rk_QQ1R(WPiBIySCWn>da{HciLvaK>hm zEssdpXQ0E#TIp$mXlkmA09HHuVA6$6w-NUjdy z4=~;@hkwb0mp(=})wCrSs%bp5(ay}Ff%NE)fMGQuzWx5i**T3XMv?kbfdOeP1dB0wBL<3uF%Nz zv(wNW^U%Rm7lr~KJyv{8JpSEW^B;YOnR>38(YN$f%d`=&;Cmv_clBcrg`uwXdXft6 zna{bHFHQ1yH*|%-zQOi|R-b{xczF`AP0gwX$!e^Mt+*c++$XSQuVY;)mI$C8Glziw z@xaTIxYpKC4HLz6osl4$3DBKa5)G<6)WT*j_fE+v&vQA43{&-@#?poGJcVT7Y^3QM z6w_a5n1nu2rS$DU#p^wm^LL2QH9**99V# z?Y#J5F_zS!xahQ)_8q^~VGT}6qbOFn7}?DS!MOfrL!%@8>?>|c_1CHfCYx)`ORa0l z6BwEyw?g;`a;kzbS>-*|^cGZU5!AKpdR2ui2q!ad2~|WiVbrAHZ(6-2IbfZ7Hngu1 z1chJ<3RAr+I53HP@!rBuKWehsFYIE!gr<43M=nhQPcwluwE&0}wX@R8l50Ygb=A82uj~4w2sm;`l zeROS#*3&ud{KJBHtFW+D}Gq%E^NhD&9QWw+?KF< z>FaIi1gvAR5LnHb@lq^){mA60&?4~z6~&%fP%w#L0I)Ysu(MbsG&1OHr0n#MezCCX z!${M@=K5Vbm!c!*Q;5j*v^-T}2k#;>rMvX-?Z_+v%M(B;Zx*9L)2C_@d~KUA(ckR` zobCay=aAsKgy4bX!x^dF zpo`sDw)8n?jW@shVT}HUi;%a@kPcz!XYL^y@|a1}!WE<*@CEu`)M$Sd2O2tjt{IN5 zOBW|Re*@WpSL59wN# zr_&*}tFh=tW5Xd{TcIK4pTgskLmsZ;nE&;tEaAm0OjfI!V@9b;!vcQ0e?a`#)`cg7 zZ!eZ}q9L+-?jHD4!NYKT=1r!U`M*CUMk)A;)^L45bMXID`h*_^z zl*ZMDxIMS5!EQcRD#DN!Gcv5|`&C$Mc++Cdg_k`MV$l+-CCjYe`s*RO6PT!@4! z=iO3tthsW)BWcIC&Ba;1>88#6oQaumN5phng1&IoWeTU0OjcN`9Z2^kb>LPV#-!#| zA#KqtlJYn$-KJ^kkm%ewJEE;3Pg6W3e~n9i|G9Tt?i?MaoJJ7Et|0=bg}XHiPxJ+q zc=oRLptH=Vuu?++c(%4ojRE*R;F3Z7ebLxvkHy#d85-UUqciu>iag=BkwzzGSJpxs4V7_m&@W3wWy6*u~fB_YkFJNK}BE zjF+x$f~t-8)RnxwZBklKI5|p${Aq;nZ&r=Sf_~IiT;N1S(%{)p!Fxv$j(RfcxwG#P ziqzmd85|C8nUPsbWD5~oKhXPv6i=iT zJuOEo4~>~Y6o2sVifRsZG#fJ{i~n3Zn&)Q=ny8N>s!2zA4Z>_D@vmHs;+X$>Lo`cVxBelP!3*qGI;84GUjw)}s6_a@H&kAWzOQod?!~58hbk)!DMQ3F{mGkE$y%Tzf**su9&-)qKmHFZxSgh3C6dKt{YwL>)~RmY)0f1uwBqvF^_2 z<9Y>`B{rygutTV>v8v1wMP2E8LV43L)~PI`B-jm%9YLh zGEz!fyq^cGc&*C`G7S6>>xYR9=)t(z53Twc)qN*^Z|D#1m2NJhw7)^NCL8wl{^~?< z(AQE|Y{nOF@NcIJzlj)W8fb|#9Gksry+b6V!x%PeCX!?m>H9q} zd2xWuA~BoP3rgSDSI!ARyFO5WJx&@pms2iiP1=$OA!J_v*i%>4K)0Ngd44RsRpYST z&SB8yVc`2T{I}CzzrFe6{lcMkpmAek{*8NkCN&k~{!E5XjXQqide`ZpeiD zNe^+wo`#PT=3WtF*~5D^}by6pfxXI`^?v!M3x&qtbrBVRZfQr+{vuD5x~ zLC%bz#$^bob1oCem4I#X#@WcAJFTr=%S0qs?u5zn#MTPyund#NMf}SG<|sjS0V%y9 zQ>+7|w|&NQtW;!Q+5>9yamI-8?(m2{WL4wOw?)Pd;OtdS!JQJsRzLDGnUmV30PXUeG zy_46BdSm0u`QVyME`dy!=}}=x91Gh>{IF%{{ZciPZE8G}9)I+Q)b%5T76$$8=weyj-SO*N1T4Im2=K*+UV5c{>m+ zl6-x^;QUsx%D`>eSIV~KjJfpdHl@MvXCe1!nL~OqId^4454mKL#cCF+bCRAjkMwi4 zLjF3iUC#ZwTdD>jThrIMlhX1m5&qX=r@ePNs3FDXCg{_T1bd+{401v*-IO$WFhd;l zdstV{DY`F06W{`C`7?uo;AqzvhXF|#$L{gdyQvS-bC8vH)5sKUPB>1tK*+!GuXE-v zXvs<%xU$X`>wV4l>;q_$21-Z`rI+osJ~H+G=Jic5WsL?0>EvS5n)90ZSTbZdSFG2> zYF#rxalr`YfFapiL^!|;KT1aGt~N3r9mARTHFY_M&v0}}G!HMr2vL(_4~8Vs442I* zl+LC@qH9BKtwgx~&><8!xM-7aw#%f=Y=0c(DKCI7wQuy-VOZ0i;!3pxjo=e6Ha zPD)r!x_!|00;VB;+fDJPMR5R~lU?Lr>o4W~^`6wWiuAU9VPdChX_J~facRl8p#3q= zvZO@ik%yr9UJ*1kcn=wdWoPhg_wD#%@bGO9^E)%84*^Rj*;7kodOGa?LEJmXh!Tc- znr+**ZQHhO+qP}nwr%%m+qV0(G3V|~GCRqgxtq-<`$v71`YI_Tl~kpk_x(LFo$E20 zDJ#fRN^=QeB#s^XZegUKY^%UE5t2j1UZ9V!0FZ|_aS@>8@KCG!Uuh3sM2rpyxU#>H zlWC1*_*p^XtFsBZQ?8kU9qsi2)DG}U=eCVCj2(sLk%zNTdZM;QgHgmK=K*C&<%lwi z6FbJ0Nj}F+#ccKD%vF%NQ$luE1rNOt@;nCokI2f|OCsZc&f-j6#i}Vb-(UNopLkte zm|FFCs5&->E6$T$8bl_hpXJiB;O=FF>;<5P*q14P(wt&i7-anLteRrPog-UQD$|~Tw&pM2AkU| z807kbmCA0p&y{J0{bvEyMx7MD`#+8KX>-;e2#Y(MJ$-d+(4DcRa5w`4vo!maJl*&2 zeglt&Je{#+AuKU{T^lz@5((85<49cC4ax+!yn`9Wk_&fo8zj6MwRB}-qQTkGgU)p^ zz5Utq_T$UMWYPD`r~;e$*pl){%tt{7&2}@!YKGaU;F%J+x_R?;*({*#;<`y65xi1z z%rHl~c+t!%$x;RIm>f&M9KvU_T;SINK;IPo!KA32@S|yqRaQAMf|9jXGUFEX4$XUh z7J_nNP!|)f!jqu|H!uYQjO$E+Js#z%u@oE}xEWu%j8sj;e@_%wC6MYMLUH1D#1?xC zR;Cm9M`R_p3+_N;B6&Rlem>;}n#cdf`KG&JA{!)!cRAv`Jtl$Yt%M)JOGH=YuF5n@MPMi%i4WLAA z48;1X0woC#SM4nkEa1icfvY%mbM}*BP{(#O#uCA}MJ0~lJz5nFhih6{hiY!ZLM;AX zIW>ez@lFM!{g&aV*{tn~tUXT*$ibU$m^dQt8}a;XrDgF;FfnKs(WxeCCC1nV)Bh77 zx8TuEdGnWBOJwLTv8C`vpfQGdIk*WOMr{DIRae(2N~R9?6;RW z#B72smjd-PuKP$pKTObHDvO+c9A0KNrYk2| zb^J%xd1Mbf9X6>CetqO*T+^x6ydO;M`1& z!&>~K$`dj$$=+5&91(Rgg+V;p&O?d8dG}Rgu0ACL(ujJO*796LlZuZx$)AJxmki_M zZq0O(L*yi|f|#sT-Zk`8Wk zTjdoRU1)wlLkk>=oHJ97_Og|x4cbI^cNn`Wa8Gj|1QgcfB=dq(r-Z_CLjZje)Ep#- z9G%!#n$P2_Vak`eItiAY#H3DWGg~qbaw8hvQ!1P68vEUL_SF`wTd=r@V$ru?wDEY1D0Ix}(!byQROeJ^O41!4N%?rD)A#H#m;I_a8vgQRI{Iq* zRh>$;Uaz;aOT`@h%C(BAwU1XinT2-6s~GM1S+zDv6_)>?#n;Md#l%u+xcz&heB-1? zf{7LT^j>P#>rJ_G!%UA#MTA>Su_{rvdkR1rXAiguGXh% zAHYqO>Wgrlnf9!F@3z(50|Q=AxbSp%95#Z19;WC0Cm>%&zWlQmZ2PlVB&_~y#1Lkg^24bFmddOt8lVi6;5HC1bu3ZTa1TE980Yiq+Q< z^3)*=y!~19SWa&iy_0bfR|~vPR*IyF_xq3o3Cyy$*E;^~jVmv#5?c0^6H=3Ico$9Ds2FM(lPGqQFeS+bwKw(tsuF922n|zYvd- z)KQMGu1ChD+-1-$jt10lul*4_$TBjP)a&8Mh)cqwj=;7|AXcksXrSO%u-EowpE0DC z!Ku`u_h)SjULh^k9VrUBDf3|H2_o^XbZRp^FI9YXU~hudn;F^0NFv3hFSUNR^Uur_ zch#wOlNys&H-d2|^otezh8(quL)jHKhTN1y12(>`>ldpQmgw@k#vU@#L6IGGi~$3@69QoFpRS*`Qd0 z2GdU3{77u4)Z^)uNxzt#v+VD6X~|XKsOC~v#h!SUe3dm4OUlxzM~@y!qD30Ij?XuZ zZkXrs0Fs$t{Cc2ItXRM`|I(v(pYW?f(;Xyz_6JvVnSa@qbh_Pf)aFgB8N*3R+UB5o zp2s3Lytf1m@QcY6`L-oQw#5@pm_)zw#R)L;H5tP}2<($hX)b`$#8u%+Z&4&mCGRjmXa7U^~7cBZmBpwO?by^q~(^4-?XYVLddxh4vxq zS>|axA#QO!baEay31SdF1+Emzn_Fq+-GCUD%vbKYw>iy1qp5BweG^CD(S)*2XkS=y zGi+RRK?!Gn2;%m2H zmN&&UD^ahMX6i%Dv>I3b7-{?*DV-~^5>+JWEE(>KRG|d$eDp|GhnMclqZA`arpMhA z%Cu1sLc{+e$ENqJ?k5l&R+jc9gcpKtEJCfveT)<8O5N(#?{r-^z{ROs=Jjj5$(1(w z;wFKLlvcN=!j=T^h7^k^f=Q2A=O0C_9|0R|gzv6S`d-U=O8goRRAU|ETP=H|CBG2QO z6wxR|3I!Jq3F!HG`cTT%^--YL*VEDO>sQM3`g=K>>e;SWesAsTEmq@Jj5cJCPBKxT zo362F9n1@IxI>>zgDInfNSf!%@K1462c6%BeNlQ|Db~W9tquti{nLXG!2c(G>>IWZ z|Fn{FANZ?MmP7ifXL~t6)R51k z%34LY@DjDEPJz`&nO|9~a6~+~P;@5*hGDu|$b$UfGZmZL({1|F)nH{9j^Fx2@^X@e z%f+s%Pm&Bt(6Q0oI$0@}l=ym_XnF?tdv}hx1ifMa$IUJZkL3er4```|<0lmp2E!i* z+B0!k6-|MM=?Y^2^^#N(-u9dvG#p2%U3fpyYq~X%vDjD_p^3k^hjl}h)t_8=@@q?* zDXIkYx407OZb*G z34+!CYn9tNS5r9J# zloA@_X0AYyz$BBUerB^HC@&QKMp}F2cfFSU@v(bofN8Jc#Bfot9kn9?MeiEvwpDOpeP1kunKLL-z>pQb-w$5}n zK$M$}{H1u(mSZ$tzS*d+p^$^!zwkqfn##>MQ+DY7UoreZWS2AM3m~rpj^C%xadc4> zQ~6up1p4TsKT{@W$F=%!AL++aq76FVemyc8xpZTiPbWrdq~GpF6N8blKJmB|#+~$D z{bZbigLs4r3qik(EO#PR&N)irR9O&AWmH(5Z`QYniqm~22a+S9@j;!%n3pj3z|gkJ zn%zO{xy`okGQG@(cN95evqOB0Q7mgQ-Nv#7bx*t5c`ZhawcdbSy{pV~uxRsHyq4Qi zKCmsB_o1!QIoXn9q7z>DC2np4JQ8?vwb}2ekjr#FNX?Qz{Uz`WMS{dhf zz%ZW`#g98+-Wpi~szU%-Jk~|?Xg)ieFjYWr;bS>t2&u>@b+ldm`erc!o(N(Z8B7$e zxl-TTFM`UthwqRw5|`S_3&Uceqc^j1S42#f01H%6s{FC85-|C68I?U2WJQ^2+Xo*> z6^g*DFU1ri$~y>(susB_1gM*0Gdd0^z(wbuv8d6sHokzk6;I@b&-fAGTbT~3OvVcE$U)ta-45Vc(x>q$w+-i~vGqsfofV%q>RyF@&4*az&+u&p zZ6@MK$Inc;n+b;78K?C$sB4rJu+Y8xy2rL)l=k2Req*Hs0*Zj5Kl5|1gKEzRbp%|9unp>f5QSUm(1>h=u42AdIaM5EnGL8tN5VpByjg!U! z+IZv7YSY{nAo~^UL@!fVxOUthIke=N4Qi$Rd2<^mHRMIn2EQf1L`lS}_so~~*CFKy z@re89Hm-%IC5N3QUit7Fuc{b%q?1z_{`~@2bS5Q|`Zcx39igx)6Ds04(g)M6@J`Y+IL31u!n);fUq_?t`&4c&O3q3?sJ44sc^Gs?o`l%^!30KLRBt=% zfYh4~S&HH$ltpRZYseKxC$XH@_pA}wR!xH+eb12Q3t}5}aJ#J*_6hY8eU9tdQGkr!)I3cOZa<;)2x?E$0U6YY!|AA>*(@i9Fdf6{)HQm~Kws=_8L zy3g##BYDCX_7$RyugHWtvP_vL`{uTU%oWim*tASvFN!U_+oE{m9W6%1ihJfq1+#PD zX&I;BBSyOu1cY_Dcx3D<*l~cNZhWIZSy{zqO$*sOQ_mS^Au6+dr6mqwLBLBO!(tKX zhCd#~<=&}j*x8KJ%+T+D;Z)UE#oZ$05!`<1RPp_*`%Ds4Ys2vtqpDaRF`EUvAcD6r z0)mpWKJ%c`AvAK_nVcvoQP^~wNEn|XNQZL1Ae*s;MQgpxC~YnQdwGVdX;9pTRtMzT zFthGM#w`<5r=v(|5qQr-sssjr#r}@J z5i0f90Z8QEH;gtlzXC*S=+9oCf~~k@mIbA#7xK1on|mQFY}=VAfoiEnY#zO*o0cUo zEy^w0Mx+F*q?m^wQ1pqSUIt&~`-$@OQ%E&RtZk`FnP*Ds_8M(&^B#Kq&3%$jzl@vb2lWf?wkF1d`0rq=j$&+&p^CVS8wxsr4+QPM z#<76$Ka76m@nH5TG+H5)Ft6)2T!*!x71(~*IFc+H zJRLt;fJ#Kg1N@4RUk4*5KN(G6MR-hU__i5$ZD47#*9flZ0%-qHB`Z+bDtviymzDLt zpf~6j>(Q7Y(@lx_&@DycNyrBy4QZG)7~Di{*qS6wwMmxhi1)&$)?R0f#0|Sy;ft_B zFaM`M-!GTN-rpZ9v)%A(c1OECp5DAX-MzY9eiL|Qr?*LHms@G|bwd6Ba@+X5dg_vQ z)zn}0K~89r4m@6O;gt~lO7Bjs-p<|qcm1wdY-q{%-eQ*r$u|hLf?(|~aKTCdvK6zUPuy}b(>-Gn$2XT{}iAe+|>HZ#H%8(1iHK+ogi6WHI$f~_Z(M!62glkCU z?!xR!l?mqngCW=e&7}44!;V%0ErQnZKb#4sK8M^Tos7x6$v<1&TdlWaXuf#7kTKcj z3x^r8*MSRn;m!}hePjWgzn=3?rddH^V>yS6p`LT(@9Pz^%no{jL?PEN`wqMvac5mY>JM8gYt zwsp%GaExqxIBQ1cyAYqb<2X|+hf68m2PxSU^TbZiz@~kc_4RP zQCO*DIrtc0qrozcSp*Pb;KE?jwN>J%8p(J;bQfsJ+YvvwANS^U-0m>5_&qCLE!U(U zBJMf}UosXSnA$$oXx#0E*2+THZPKgv?zo|W_${d3tgIMIny2$;4~ImMO1*IN=OXh$ z1>_WLcrY3rCYdHok^lp69z^1U*|xp1U_>7XmQu#6c%xW&M^}Nm!rWpQoNJ9dXdAZH zt9{=R%+p1vsK#`gVH0d2oLV6I;4c2)4z9?JnCAjU``7^5$EE>hZi~&-J^sft;)MZQ z!Fr^u@ZMdLb@}++;+|`NFBB}e1LBitrxA=3@w%I48gu=VLe@;I^^?kcBdX2AvL7DN zs$@)K3?Mmuk~~fGUN-A9v~m4k8f#;ai-g$O_@m8UlxMM$g&hFu!sq}abZJkk+_s4G!yo~xIrXieZg(Xzq*aNLBn|0BK=9YV> z7WoEOK1tHRKyNO6i*Az_()z^}PfjsR$^5qZK~RStSTU9UV+%yXd(^X=D9-1wfQF0x zP|yb`roEA2{~$^Nb-bv;V7%u?AUAAY=o%VyTRZLvuX`-v_J$>3}AGH zl5Ytc6Wc#BnZ5TKVCS?)Z2J7Dl5YIbB$?!pS`y|+857Rpn1|K-vunqZG>PQuS2Fq5 z>sGv9K9ax8iid~w;J-;Gi6)(yvP71AQbd$%9Md{WY>Js?la2hRW~0^yhg>G`Svl-DNap|(@2ESNw*zsiF1Df%w)KgAVXbi<|mb`d8H9AERhBydW@_^GgHK%OFpSH6u57lkl~`w)t*Bcz@zE8 zVh>QCnEJI?GtY?D?+Ygg6Zewt92DuMIA?$o2>iTpovICwf$g0_v~|t#mHDs*HY(!` z`EjsFsJ?}|~_)IMPYH78WGvRA$yrnv?u=xvw(^q^?LV=v7 z`yxo}B6rv&FbzC55rJ*g#QXgBv!gVP1GDqP5ddEgJsP^6J~2J#0wgHx!{WFZ)7Tfa zr&D5>8aRD`k4i%7&+_16&h^YN4a)P2c+ z;f4PgE3M`XZ=w6}NKcq3LN`DYtBgTDqdBJyF~3C#2i{YDT8~)rN$Jkbc<;VwWVsP^9<<-N#L7`Av&`LIN-(QqY?}L#wKqi%t^8U5Ju2U8YK}DFM zj6$WF+q?}9IG`#x{em_s#bGjIBYIwmm?uXXJ=jpAmT$YFJ}uyFOr_ueXc0$mu&n;P zjJgFNpxWant8rj?=@4$5h$tI;3PZNU>+CLg@1AbTvATCN3=(*V$0M1i>7=%d=nXq? zH)8*xh;#hjrQXDTCe}5MnQz=x3VM6869fklS71Sw;t#?ZjI4c=9}b8@hIn~y8JS>r zj9QkX&$g*O1dEkF!L5}xVGF9KdiKtg`D2_Dy=ch z7uPp;+V{)DpulkjIaZ_~EF9q?6UvYomL^O>Q%sp>X1kzKwId-DPD)TT>;bnTf%09Yv_ze0{ZgmsrOG^e1dSY%yTm z+Y$`B#g1MMFUXh6(RuSu<;@{Y%d%~yk2L2BEqU~+7gjB;vt}fWLbRBn9&?TgsE(Sn z<;6tkqs-Qft10tG(Z;L;s!`s2-0~1N#_3J2}6-k%R#hn`0N5Ht+>)Mo*zyL zo-MOWTjlWRw7E=8daY{OHCsVueiShaeGIqnETpAIP?tnnHG|!H(<8;|n5dZ3(7qag zkaF}DT~@1RD@UX4#m>Sq~+D5_uv>8%IfZHI8CHUMRm=AnB8Ku!K>UBR!M zno%aD3T$56xYizg0I?7~83x2vWlp&p^Gu(4VC^fT?}YZP$J_KM+s4J+(4Ib68CI3! z-d}hxdJn#CXT+b+hV?f6nkz}u_^F&C&pCQ#) zsusoYiH{ECu;hW=7#m+;^po}PB!u5gk(w;p2Zq>qi{SmA$gkPuEu9oW*$)ocCY`ew$iH}04ay{whc_*8m+wECp1+!t(<>gxT6O@;8Ae=8tQhY9hS8u3T?`6~t=(jIH|{J_3OX*_fF!531C1L_{tr!!6*a6fRDiv zm5SGiU>!%ljjwk$;1i%48cjUMne8(ln637);32L0Td@X&-v9Zwx0b!qG>_-pPv*iq z!k?O3&r^LGIP9(m+kK@C~O{YdgzMq%tk5*2PMm;(a@>O^8JCQC;iN+q( zQ{lh*N7XK^sCS|KHvLo-)i#OrPz`(eI&=3)9%*Jq>>rua=@ta$#$nX%glNqrezGU6 znLZNd%(`dEUV3FpGwqf9%e!r#Xma1NZ7aN)aK1M6_zse5?4;d!BGAZ=)}*`S?VMoq z7L|p0zda~l5xN;Shp5yIDsMIDo6%K2E9|WLmxK;QBlt5^NgGjM>L3_3_f-g5tp_Fl z=q_p=pK~(mgujI4tR{za@2~&-IH9p2kwSXq(M4=~H*G=2o zS|v?I%&~4^m)hQ`qd^r6my3PrbyAS*_2$Iy79Hc~&m{~M`G@p?TF5S^p)%>3gfnKE zfi>}wt`8LyZUhN9A&Nn=FeQ+3&BPTjTlX_@+jD(a%W#NCp8W2&bKmEIDS@z9=aapy zCthOYv(;cqEqj_XO=GaZkAQGVrbhr;*Y?2@SGK|Z2sO06;08A@&t?rV{9av4j!1=7 z*Sul+%|`+Yq;kq!N0bnSw@7tuU4$yLtwktT&cPUun+P10uAVMZSqgj$ zf5Pw&64*&#iL*r$VLJfx4^8m!83eA)-GI0)_7>91;9qU7qYCALe=p*hamQK~>tjj= z7`R3TSksEvC-lBi3j`519u&Da<(MRH5oyK6A=5>{bf6N~ncyIpWTHHb_P8+hSY-cX zSyV-o*hQ28^Vso>BzU*Uct{zPIZ6%N@AA7SwUbBIvYGaA%?utrOX(@)D1B~Cj8e={ z9xud-zj~{g|LY@PX80_i=CK4g3WUz;rYqtxLFZCy8M+mcodk$y^3ft0VCD@&Etyzy za#f&jDp>XYd$?Jlf@vA*nk9v1Y5TWk=1zGavKq&kwqH*Ta83CEWmwn7-Y*U{BN0B0 zofkYkXs2-t&N(2KOh1!&@?vj zqm#+AlzN}!m|}2tA%{Np+s9DLel5;ik2_D0`wu3UJ1;5}Q&tAq z_VLE%d8zErU*%_t7I&>$)Ydrlc`mwi&vogKJBb1yJNkO_OuNk%S)`v{nbS_vjn~QT zq+#0!T2TLD9Gkau9Uv-S%A1NuQn^78OJD==z|GSy6mq*Op0oNoyO20wm zmPf&!LHehnm-iFS9tkL!uE7kohQ!j1c~J*K=%z=Q#E0mzuB6}I6_5@lCRz%*XJ}M< zy`e*Fsp`2g=GF@+nzCI2(vb4Kql@YiwyyrAIhw*mgf8w?pq4LInjbiEJt*QrGe`<} z_=9@pb#HJj?`Iv2bqQQ1N?f{cBwmXJ?;IAG*DgbbIKDb_awY zpJ_GAM9h9w(2rOP07^N>Kr9f(Q1;^=b|sl)<=XFZ|MhyBxg}BBDb-Z9kCU57xwebL zo<&G_^c(dw`lZrNjrq}~V8#X-%+HmZ(dRQ z{#mq4RW2=mV`$MOlByF(BQJt&u?*ANTmOPoeDS)&`)RC;R2zy1{b^ci%i^ z(&1aGh;T}WY`z6fgQ;cJBE)QM-oH_Q3U57qpM>NtqT}D^#6C_%IV5-JQSWc3Q?$Ky_UuTpxu|zbk?auxi^!NUfZ9SeeXsBzm&W1Vhifb zrcJfZG?%Y6EEs+b<~jFv27FAQQz_s%gS zINrEHDrZoE!`Fb(i{Uxdy_dw&{QlZ|v2SSB3Lw$K(Ii#EEOA4qJ0`5rp?OJ7G@FaJ z2T6EB#dHl;o7izrIH3k4$_N~(&NY`?jl#CD(i_LG-!6G37;cU3lv^Hnu-^*(y=0=! zYp%?}6W;*=bq0mX%C;i`zH%VAFhtt;&Quwj00fIfQ+vI?LK~~x;nl%3Xbzu6XL#-j zYG89%-mZ{MHve@^Bb7Rm`c3pD0MGZa)ZNeWwddnm1;9LdMmildA2C8l6rL-!i9rIy zCIRA9RX-qH`LPpGX=_`p9c@wUm}Amz{-nQiU)6(B%b~C(U9g(CgY{2e&LbTqT76CWTN-hg|F^@ z0wV3b;`L%$RoOpYa$Fj#{X7Rw={W{$F+`zw09{c{+`=;gp>v(3>;n&in~iJ61(=_~ zUI|krY!*gJwH-t>ci#q+ERW5P<5Gv9^KA>$13z&1uF=1PV;rr-SzYL~yF@G$g%ndx z5s;1<-fbmBVg1A9vkjQgf`r#C@vObglw9^%vD)Estvx0Q^DdeGzH48x&n2hQJpO@|I)_GfI)>Ki`)5C`wYg@6w6j~#oa%h{o z&jAZ2rkktxmQH|B(w4znimOXp4k2ONY=_<7sO$_sU z(iY10EnD5lexl6Ja7?!Jux_E==AGvcFPF}s2V)4|kq)-7+ah&5QvEs%EyYQK zi0#C0y0Z;fWk=!NsD)vMhD7k)%B({}j6lT_Pu#X!T0D|7Sr^Ul*n+FWbKeu3 z#Su|(4Wt}_?~$+@Cpm$BTo8=$oJ2o(9E9<)@PFYni;vh5L#i?D6?XJkc8QbRjI13> zvwtw-Lj!0}GP>9rS~~+wv#)OcWEJ7pT;{Z3i)4qiM0Rk!Tn~iG;S5$VkFZi@1Z>B$ zo_}EnDdd%#O3>;>AH6!}oe|;e70moP>e=<$5=)}^D!w}@q&{A}6o1~_puhfnZ*9fr+i!3BzTJPycDT8>JM=l>l}BAf zp*>pQF1yFf;x|vUG*_!OLXrNYvOPfLmfP}mSO+=z9b@3k_dnZh*Z)5A_-VQI;qki& zM(!=}CAjKdf?{&ZrDCB$HC)ME+|(;9v6Xxu@|~3;w39+L z;TV-E=+kz&e7^(%yag4afKNzd44(89gnU`#A;!eThj+{q`p{m>YdR8 z3V+GH_EXr5*@CLH<~8oC{7LN}rs^=`tu#mqamrgqUDfGG#u8^T#s&&N>=>O2n)J79 zFV1OhNhp%GGB5 z$`#bf79LSj#CzEodhdvmNnv0GlKDe<>3#rdq!PEHP;?paN;zx6E&iQ8p<}TKO14oe zUb9%}+$DeYnO)eDhCv-xn@d=*NY{eQ51^>3RkiFziZ@ZWRH?AGiN6s&@3tZR*))Kz zUNab8Zb_|@!OZF0n zlrp<5K9q$R1X^Wci!c}i74W3~2-n#D$&jI9s-3hkhbVHL*ql?@Hvx;eG~1Rrm2BAo zplPgln;vS@e=hQP*qFfyz3(KBwcKpZN0BDEBxg=@2sz^QAMOiNc_Xz4xSv!u=dfCLOh~+cT4X#*MhY9LYNwiUMHb$Tf zIg(_xLqu-45DW&|c3fQl#yFo!Glqz_8D6rnw1l~5Oj@vVYq7`~^9QrAD@_X|pDPdX zl5V<%v9QojLJ7YoLTo~mRgFl=<4K0H%X>)7S-6M1bEh{geyzweX1rHLjG7bU9C&Zh zaI(7bM3wLl-p-bkWeY8RV8gFuGeIpSg~9wI^p!=9YUj*@Oa`ClYI8w2y!}8iDFusReNQ^YA#isa(de$Bo4%TNV zgS{rK_b9*XI&7%)^OYKT%IZe9z(d7WuQfHk$K7fzxK&z4N^&1mN`hV|YiyC_Upuy> zHul}6F}RId_4#3zrE}kw3R{cQRbE$ysWyj~_(`}H<&?DdTy*HZSe}>O|5Fe|Vi1$R z5*p|7tsDuW4Q7xFMDpJqp^X2{X)ew|HH}*QG-ji!g^Ham(QEOMboetpD>N;efI>>4 zDL-EDovKcxFJXvyw*m>{UZI^%Q&Ixm_mIpO@-kBHW1iZP)m^+0dz(W0nZjQ81IloeuXwYFSiWq%#_At!S(FZ`^sb9D7s5PJA{8IQhCV zf?_f2N26C%Q(iLcf!+3iMOnMMW6T^m7*C806%mcUGyg#T8gAo`+*|D_eLtDJ3_Ogk zTeMN1o1iARBC^t2@p5TU;tBZ@Yj2o;m2j-F;A=kJn@z>1bD-MTiAR95!o#r?MQeph zb9t-J*RB^}Owl)OT$xO}K5Ern+(&IwQg6P2qb-?5HU_i;cz^_aW8CDxS=JDh=hNz} ztnF#Mr|>nGPDaCWrcUuZQ2!TaTjrVfdfbas!Tc+yB(Zm^*Nuew+i_Jo0N7u`(nKCE zZis!cPkif0qH{WqzZDksHTawqfEHWwedljZ%7vh|AkW$!oqz~Od>BN4;5ZZcNs5>y zCy)e4Ek_GYAPJ)R+#e=mM`TJE+ih%~_z-|!eBv4sMouY0g#pLtZd`_22WhDfZb>;W zBK(U6;f)|#>A<}n|!)J2fBqNY3?H5D-o|v z4RO7?rL}3BfFrnuJKD*{r;hPr)5`sgnDw|`8>2Nua^4~(X5nNf&z#Ub_0k--?Y9lF z&LNWBNl&9gz`iCxAEZzgwumM|6%Y_y*5)H_C+F3?hLsUwIaOUEv{bcdj3K^N2c}}r zsN1+~RV!R!38`av;yMC`zBv@Fdc$msg{&>tZ!=Cj#N%;yf5~YrN~y2|d$2(D$#I!h zX;SjdM~6uc#+IBfwcptrESZvf3kt)t+IKsW=+kgAap5qS{ai#sQ28528{;6KWJ(0K zGzW8k?g9dVZ{A=5f zWshKjZu=%EjB0MMyU;P>0pvLZYgBRK-VXz4jKyDDM&f8_h9(eyvj{{sl(Uq~?IS&& z=bUt)(=G}4%OC(YZ%;cvp&5N(yIjc`$Sj5ckjgm5%WgX^3oWd^ z{rQU(b&#*Q z%`IUqnQzT$S0ZVTpv!g5q(=vv-Sx(%X~l*Nk45ESu(-5z5%&oT(>0axl8~5(oOa54 zcDr771+aH%&gO1@-VD)DyQb=iRXHo`!ABvaTxA7y#je`CPre<0$KJlb0lws7_&2FPhRY&Z4? z3o|c4>uk;wHBEa?_=*!_q-Hx*zKi;LTtqY$10h}3{1Ef}JJy&?{4#)w-&=}`r!5z8 z`Y|3s$wXE)$7WgHu!Sd7IT%X@V1vI+K?czdKMlTH*tsFRYgXcVQ3HpDHj&Nx(}3pH z_igO`2bZ^)do$i6Gzl#WecQ?*lEj&0(hzHgB7<;f*s=r@-~Gt_G?Q#`0{&=>BvN|T z$1a5o^@XY1;uz+(z5j$1A*T1#@|i><7x}hEIB}YDXf-Ys?~XWzIJwLcQ#69yvT1+i zJ6mP-mF8p6mcgBPW2*@i7QS$|IoEv9GZ~0Lyo^qJPO*XhvF_X)P3q}i442p!6Qu_P#H5j2x+a-b!6a%5Dm^Vt+xz(EIooD?M^H^I?Nnk=5TA6;^GO|#bmXnCh zbtc))7%UC6F$O!=mJxaP{%`qz8WXmv51s#n#4!Cw!_WVq7ypyQ{C9lv{}YM%A8};= zfrym&_~;d!?2VO8U9{;HM8xP-Og&t5|4k~{yBNBd5-`v!yEwTTyZm?X|pr&OYq7creNB@p9$h*@WA}iGcJwJty?=@$@B2Db)L^;pnNn9&D_knG?-ozGj_}=H+dJWM2PF`-A`nt&LXb%b1W7r zG5QLSUpz1416z-HvY>-g=tuFrl9%NT&mu`yUdM_1-rnT3Zv!eO8wWhJXHF;usZnYU^V}q=zo(bn}NtNK_J-3{5J-gSH zkiS`e+mJAQrJb35!6Va_s@m>FZiC=oq~Oa{zhV5YPjWt};IAadWtYZuLA09~pmI4k z{ySE})+j`WT|28g$U;<_b}?igf28iK12p`^JFb>WEz(On-}nSJ8Gao7m52?OFxssU zrk^#RIj=QhG$I_2%@wlmb?yRWm;CQ=a*ZBdKyjr6g$JTQq&VV?-}2KE-}#2A;B8aG zE0?M>D#mMicNyH=4-t>au#|@N%9B+mp zvZ1$OxE_bZ9@BTomVxn^RZuy0Pi?AZDdh?PX_SGUXy8(oez1DK^0->K!CyH z0$g7E`FD2I*yT?F`a#Uvl1=^0ngD?EGf3#afSLgE{O#TB{2QIXft%ov9r;*NrY8)q z9R}6`@Fnd>a&kdKo!lPLwt?J-o&jw^nHdO=D=~%t&=0A6WqTxRwACy?funY@o8ltG zA{8PPP>l>5i3(?#P-pC7G$H6j8o7|(CkOq6qBNtUGix>vx}hzBBz6fpT@hWu7)7(_9^e zZMs%n`nFbgcw2BUt9)b?ZKRFQ#3MY8#OAL*M zC&Cxzhei(5Hk@rsGtf#gOd=2?tm}XX*(umJCK}~)_6HCnz~mc*dQFJ$I=M_xE0_FL z`QQZ67m2I50r=I;n_h}SpcMK^hQD(JX89!Mm5YBj_m8P~1JGA$I*sWM2x1_$LNd?4Uq+DM)1Vqo zDe*(Fgo6jG3+qiZYTG+2G`S)j{ zSkdGc1Tb;Y5oGc;{PXY=^lm{WXX_OjauT1Ttr4a%wZP7G>wGry8f`ZgD{1Y7s z8WL1sIFQW~(m*pDhKFfoSXqa{%jDXR3onTR#YwY+rfT5w1h{=&euBj*3&7e|};N=5?VLu3EBF$J1v2Ere*0`OGF7QwB1o$E77^s=f z-f9>PuGn+(5W#?xw-~5t6I^Fu>34#6gojJLigRBeu7``|0`{N$XHP)@A@HqQI}wg- zlsfE%>g@=Fy3j8ujt%6WyK8^4-PWN6>8M%iOrxM{657n)>aV z+u~n~#Q@`#5Q}%F4#|rMf$u;bGfw&0P}30$P#Y|cNf(`c>#dG;0n8tGlOju4Z&EM zdf0;s(RF<5}A&Agxvz6Fpq?u5e9VlQX{;K1H%O-gh%EGmJ_7z}1SW+1X^EoOGo zfh9^X_9o=)v4YyRdEj9e;_)tTykm&$u2DByL}es~5pqz|{w>S92pAu@|DFsEM)WrV zRXcSC3#e`ZBT}5tQDZ(|XlFWy5M;ZRf6g%*hNc&V>;_{vxE)p`kgY zP9_ZX2NbI=}{Vg{2&2*m8p6WSTW+UQa{wZb%jIv1Qz2K4t=KzL$+as0tsI zR5=(wCM%U!Ojrd8e*QO(-1WZA8h57xTf;h%o8PHI%tM%Ce&!6$O==3jI=bSuLJ%$f zmb8+QeK_uEwHyF#g29wb)b7pip?A$FdH+QDLoZ@cm-^#rQ*u7X*UkfmJ|u3oI3V2W zBBU7zihhq0L*)+BEp@#A27^F+zbtHe=c0}C{LF?`M$sXr+aCTr`YlG}nU@BomN}!<>*if|PzX+x<2>mRP zMnq`3;8-k2xmXwbl?sjB3Jr&$NAA@jp&q4JuvZD<4lNru?UPLNszGBdbLs#uN=4O7 zQL7TtXioOzRHA*Gh4mHvLf~VVv9m$s(^o}4jzRq}@?spDKi5E;A+?KFU3brAXS!Q& z#8anDy&9D$(6_eHtvcrSy|G)iBCU(kEjVMkq2d!)ih50XtriE}J|=L%iK22)9A7(> zvfZZO8Vmzc6H5suOx4h9b7uupnr|zs7jhcH1rKwYXMUdb!`sW%l;o7tJZ8E6Dy2|d zEI3@YP96vJ*|p5H7+-Uu&0YgoY1C^?AI~u}Ii#JfWMbdqXQ8v1JP0k1tFVQup3Sxn zc7_je?REx-$Qc~^=`HSuu*e<4M(v?`lnH!3M%PS7IsIg0XqDg&$(Qf6e9s~Bg*o@o zvl{n2sCx|M=Swfl?Ho87eAf=)g$&_qPyl0Enx=@}JS{DH&uvm9zTDV^&9DpC=GwC2 z+i~e~Yn?j(c(*cqz8Vr#mas*{>}5#(q4InUl7%#Gm$OMunYX6kR3D z{+wRrTM7U;6R-XQhn8!n0ZJt_|D~UPKEL8%pvShg`H#ph8@mzQH{W(yB>z}VrvmO>N#rYvR|;C zGk_N|>Tq?N>qY~%Y{jQeTjs3{jCz%kgR5&vVPk&SsdY5{&Nrom`na9lBFE;Y2YB7L zJpgFLigYIXAL-S$8@G`}-~AQ+vVgVlP{Z3?62pLP8G(Ta$!7JICyq$XILMIn%9CB? z>$fjer>dJAU6Ln_$YytS)v0q%HQ_cqo>+9H@ClN`h9eGQ2W3W<05hRAccBvqODt#N z9lD8QY+&7!#!WD}N9*>j8cxA5j1yrLUF?|w&$D6fNshGiC&zvE%@4$ZY_$Ui+T#G( zA9=}#@TF(Zn%FZJ_B7+fK64^)8=ZOk1=kt(XgGxyd z4@PX@j6o8p>?X@hSO-=Sybnz0vIh;EC;nI=Pho+e5L^Q-F=R1wvY6}h7SoJ4kp@PV zUo;0`2*hxH8WF7ERouF&HaAyF{Lz|i_Z4E+#K^e6VBJs~btA%3J4t02Y7MX>-ME+I0B9fWv{xR!7u1ZR{M4=02#vqjUV>WxNA z&k>^<$OatbDIwzc$m*W$T(Z2n?#}eNy5GfT%FGn;usv)~KtpM%W?k4^C_PfoKpg(3 zprWy$joos-%(lgbP4VJl@z~5@$J87KT1yFHwI1)8ZoJI4E9|vPJp&v#b@2$M6%WB_ zP$F~-AuDtOBhHYH36${!M_?D~DB6m?bhh55c=0)hc`F5v01&FOZ1}3{iJ7mtz6|H z-_)5SX;pXoMfibPHKg>`yq7NZORUgW?xXK~!1m~6I9futSFW}?avMwT-Y&uq2c%+6 zv*+tP^GopcGTT%o1H)Y8kK(befgu*&K@C45KrwlvU#Wa0kqqo+JdqYbxIEg#){RYq z#Do;)$be~OqHmgKWIAY{(M^R%OOb6#MvEQ8(v0HWxprJi&3@(k(AB}bopD2yR}~w0 zm`X4*-9~)@If2`I_B0ZTT^8B0T!AoMRAV>O`&{crYAuS~UBr~C+L25{+>eFtM?QnD zA}SS4Xa_mk@Flf0=_K?s^Ng@oECA&Ue~Hu~of8S`!AJt6ULtrlE!)j%wBL@2Y)Z(u z$h0WQSu0;jMF%tZU6h-w*lbn3Ul&teU=;sNUhpXP%}pFX0M1=fDUbSeTA+fVFBC=C zprB<Co8pK$hT0w5flAnwQyT zqfiq&n5mi*Xo|Fx3x)pV=yT9nds(BS4?^6tGf4;g9JUvcEV5Oxj`^mEi~y&%nVQ87 zQ@Za+1*R#hmoH&;YtG7b`S)18Tnnp5@&x`7fOmW~xgxbcC@8flbynu(qb?c%VoAM%JbTtn)!GtRGIJzg3JwE7CnDC z{{(vzUJyJECZtj30?XkII|TN(Hfmr1_; zGkl}8bSotSD*r`*RX5(oID6)nY3h7>bDMW&7_ z@84}iQe;Fz!n?0Pb~7OWM4PhNeZ(M4NL?(ETrh5#H{8c&kjCPpcCpY$E#M_geuEDN z^Y07)@lVwJKhWRL?qsLTFpi)ovl}GGbF;4Q*0>*pWG9{J&Ki+;93X1;h9lB-zoUmB zSJ(!N#8e@K1!oF9PPX9WM`{f2J>v(|wG3}C6C5cX2xuJi&1YO)gF5i8sW&gHtSYNV z&3W;ZIrnqOf_Bp8T!iyPYQdJA&GsXvy3Dq9@e*6XU<6+koVlVlY0IFUh2lF@C)JoZ zW!o%YZe9{tQU2p%QDrOFfGJE2u*BvI&wwH(;w4VqX%1{4yqGwD^-!$AR z2SIuvoy+L#1;0CTTVf<1NV1Y)#Rghzqsd5(LutBaD+l15H#2_ab1xrYvd^=aDsGN9Ju8o-)_ug9 zse>hn`aZROC4L|=Y&4p*V<_B;!WA>qLjJ|j7vkqDHAyZ#(P_N&19%wvis@3m2c|&+ zRfM!cA?+|*nxIccd{)6jE zXrKgXG_>7q+zGK4NUS<6ALgc}jjdN4^$|t^k2>bV-)!og|7-V1u=t8$(vG{d49vCm z$t(pbV8#QOJCq%_bTy{|C!-Z&->RAtX&z2#ej*at>iM;UnA*wa4I}||gfC{WsO+e$ zz=yWt2%w*jVE8yQ2~5&s9p2^C8*{3Tc~ z0f@uFhMc)%E@d!Gyh9_d%Jd@P&t;pk$d=`b*=8rx6W=tL4KpIZVPsFx3GQYTkFpD4 z=y*vgGOh)DV^b_{RaJ+8y8qGG#o;hIa8VjZWoo3m>F-`C$H*rxf(u07E&0^@;aeW%X+H7rfsU#s=I^^D*6UOiPwB zYOsZYSb&qMt4$q^120}421_$}<)SfPVk?9-Q85hrPMV4eOP)m}3s0j5Tlm!cN)a;m z6j89`!^09P*9o+y_=<6jz8p@VJO&sr1NVw5a|uP0>7=zInp;DmA;@|7pBU}{AR_K10elN#`o(krS=4b>~nI1IeS zNN*Xwoz?(EKf;*N?#yF!i6%ukxnDDZEpJH_r-^M+e@8{k<;gfwXPc_j^T?;`kLK0o z&*tsh%j=JyuS{N=cke!2xraA5xv?0%^I)xb&~m>l@@XfFjdGO-=zru!U1lp6%F>zi z+lxB$*!5j@3J>qY!!P0C5FXM8-}#X3;Y&JP1m)ZSwaS+3g6V~)xC7K6_2XPukRu?u zkFz}EQ-jqNg-P9{u+-jkf3Qc!cM}N#dmkVWJT4UTu8arM%EK#Sf8Q0Urv&CTE|pJC z?FRY*BMtA=r^6F2dzYY5q992K71BHjWK$**{6nsi0YIr?c}@)@Gy1^S*BwFLoiDKIW&fHE`R*X1&+>djvhQBp;O4dVczJ^XmTs3;;>&4>S!5Wo~41baG{3 zZ4G5^WN%_>4KgzzFd%PYY7IO*FGgu>bY*fcMr>hpWkh9TZ)9aJOl59obZ8(kIX5#i zFHB`_XLM*WAT>8NG%`Lub98cLVQmcxNQs=5d010d7QoMW@7}!dl3-jAv4-~&Nn8*_ zbey^rP}FJ_MV;1NKp^ZSC?ep3t-EEYov&ZD{hTSb4*5o{+qjLj{$B0LCz8&rZoKus%u4X3qu}1JI$V z$q7l1F>4_}*l9N3;8f=5;%j)9*)7ZtO3lj6k9A0Y0~jC!Oqrf(OH6?DsuKV!@|it5 zDk!FXGqp z#rzij3jdVo$RrX+R@46UJsL;X(Dn2qdWJU8W>pWBA`}Vd)ce%msudrbPovLc(Iz&E zk2E$-qvnOyrft;Od?S5l_}=W$M?X$~N`FRwN#CMZ{BQf$cMAx()#Iok-B4&aX*h3C z0*eB_2z(^@Nd{@O6eCTOW=ON7Inq*TpHwbYO1Gs(saf*KCfOo~$%Evfa)dlej+1lb z5_z+HRQ}aSjh&7DMw8KE3^fikPBg|DZN_!RPfVOiW$Iw+Wb!k0H%X>GreM<`(_qtB zQ-Uek)D)zcx0rXB_nHrzkC@BN7tL49H_dgH1WTgDYO(by>Q@wE4(SyV5~76qhYs7S zl=UfFQ1*qx=vd>}={V?6w#RKxcBx$cuEDP1t_ar%*C^LIgM5|cGXj?UPjJ8!E6U`usIpuKI82VUj@^!D+rzfUyTH}iWpKU8 zXh*rCU1MC8EpuC%+{0UGzx2qAw%wD*XtyYe@=FzV1_)t7f3Kfzg7&8N1JJPhuPRXSVn_BK{C&EREhJd26DW;?T-8P0TP znlr^|btX9z0jgJfSFK*fBp+V4hVbek)%^hOW!x*MPHU>F-w5z%FhKq0yBq6+@3P!= z*Wn#kFW$|mhhK{C#xu`=htUsKc)hi&Yl~`^)v~N}JGVCZHY4D?DM9q#G zN6nL4(auMyuJrWu{a$bSv$l0pL%e-QHn%=gpP^6Jr?vUJ?qmrh$8QfyKHa;_@f*S{ zZEJ4vcBzas+XWfPIQFH5bS2XzbRT0VG8x1q_SL?GO~PizSf$ph$BHZ}vP>-&!~faD zZLNKIn`r*WXiaY>=^FOtHA|Q*(=69~pgEwq+!ocUelya;?C!5DZJ1ZI;s1$i`?hO~ zw)bmaP`fs@>p<^w|J}5+wR>6Lq>Io^U`b)7j#Ua>_N%CFlW&P{9f0pIUd#8_Hm_HA zc*(we1zTYytl}bJBm4-f;Ug%9Kf^ZoE3AhP5n%;Wv(6269Wa0Yh5JV=C(Aqg%(GMt6;a0M>HCAbU^!3y6&1zd$)kOGbHC#Zr-xCW`v z0RMt@kPc~(0a>heWJ4*~AP4L)9~Qtu$b~#sRO?SR9A%fCm&5P>ntaI36cp3{J#J7>gomP>VX8j8otlJjbc{ z2YeUb!)Z7jXW&eng|l%E&c!&4#{`@QFW@>3!J(LlNtldQOhI4lfT@^2UfMji8YNZ%bR2z$j;9l744p_P(O4l;h!RGqb_n-{8o?>l3U$Jd!b726Xb^r9kBY~{ zJa~#Ixc#@w|9JyvY7nOrz6TwVO$2(b;qkoy%PoMhelYJk=sqKFhv^ zs>P}$s(&+FAC5U+YXHZ8&-wlGobx<~_my*AJCQ^XE4I4st=D!}YiU zH{vGTjNjlE+=|<9J0{}}*;vNOCNf?o$fmNHY%W{Kma>&>9c*x-Y%ANz_M(Z1_dfD^ zdwsmVUO%tDH$XJ@26}_M!QK#Ws5i_T?v3z9dZWD2-WYGJH_jXHP4GVUKJh;FCVG>+ z$=(!isy9u<$%e9n>?k|QB-vSZkzHjs`ICGsf0n<tH=>fCaD-Ho<1t0$X7l zY=>m1?reu0uoHGcETq8hpaA#6KG+WjAQcY6Avg?aPy>#@Q8)(2;RKw7Q;-fBa2jgD z8OVfMP#dz~ES!V$Z~-pDCAbV%AX_wmt8fkKKwZdzdTyL>A4!Y#NBci=AE6RB`t9E1n(5FWv|V!zlYVnk(8MN}2l#34~#92T*n zhNvlOi36gxsH4LWPy_{f+*^WdLm66L5WHn6~~Z}#c^>$oD`=}V-YNhK9Mdm z(2vD16b)JoU~w#gC9#w^EzXEcktNQGb66V7U|9?k=fwqaQCz}sEQb*oiBVV{qp<>3 z3_9!(R>Bx{SfycQtfG#nqkI*sVl}Leu~-9ZVlAwVb+9hh!}|CZHo$*iL;NTH3*W{@ z_zwOX-^KStwz!J#;|JInMEPYm=)93XCeNkW1m-Q8$ zt*`29I!9mEH}p-NtMhceF3^SgmcFg;=ytlj?w~vBPC7|<)?IX0-A&)s-E|M$Q}@yz z>W_49-ADHg%C*0~r_%x}^$a~z&(gE?9B#~U+=S!JUpCDb<_q^l_#%B#JV?FZrkudd zxH-4rmfVV4b30$OuY#|luaYl@LTmyLCiGPyNs5S=G!>zu7qfjzrDL}=k1eK&x zRGP|ASqh_YDn}6%=}Yjn2)enwFNvb4JVjFlsz{Y6hALAPs!G+UI>k~As!6q|Hr1iJ z)PN?_6mG+b+?I#%P#zZio)J8f#;ZJ)uL@M5x}|QbJL;~wr|#1ra(&}yFug+)X*5lx z=`_nfAQB7@z+Y+{irM}rpH)t(N~7@DA^R_e4mqcT;NQ!KQ#I_B(i_KW(VO`*PX&^hFsffddH zC)LSR$DQd;hBHS;>k7J}uB2mhWnD#+lLc=>BXt7a3XO-As*Ps#m0GD*snzOhwMMN~ z>w=HFL2Xo<)MjX)zENA$R<%uSSIKIJ+NpM_6t!FJQG3-swO=Kww*P0p$fBY;viGrd z)vKm_uP!c#OJi%IqN1XR8(Y&TAczE$Moj`v$ABlvnM^+BoS8FcG>B0IK}1w=i_S4- zCc)P(<1$N}NydGN>%=vPMo>W!_l=%vaA6#CPJSj|-1qAC-RjnTxBA>$MP4K6WFlU~ zAMg^^U@cz8D|pp(#B|hj4DKjprsJj)N`&d(rteHAO{d^*rqiY~rn9DVrtit?h5y z+E|pHNOH+6l1FBfPskiHm*kUqXjg00TJ^GeMZK!lsrBkL^}5=i-cTFWo6Lp@n24QO z9J8}{^_F^Dy`$d6Anbx&u^VkM!LxV{zsEWpiuHI6 zuVVw=z(%}@w=f)sVFV7x5jYY@;b@G+D2&D!j71y9srS_T>I3y58^gx31eVB>)JN)L zHjX8;6gHlvirknK0d&Q_z0(nVzEG!h=rn5ED~j6F+Rp7bO!(y;(Y&I zumk?#zuSLLfD+)vs@Qo}zzW%XR>X?g0#?EnvQoB)m9fQa30um_Sp{3hma`RXC0oTl zWvkg5R>{^ggSprSwvlaOo8_%>i>&A~>3p6?i}-9B&F9e=UO>xu5narSX#vlrg?tt* z<%M(+pHCk<^9b6352qcOnRa6SG?0%V z$M{IvnU5mJ`Dhx%BgqLKMZ555a-PS~t~{38cpUAX2$Gs$(HMPKDpNdx}{?M-fSC!a?9@ONon za+ijX+vFCXP8I4y+!W{#I+Q#h57|~04&bh7!R``?YXO@2 zxNkSxL(}%>){;lBvF>{BG(c%r4?hXWli}lGHp~0$;b!rMC+Z3)gVk^xe*2>i8kF}G z`%hb|H7MzdP2M=H&2)_HAR*7_;fe)Hp4oL&xZ(#*&$_M1VMuVd;2MXYKkOv=1x)Cn5_R;L8Lo@E&%=}vR#4q4C zF!PCW9XOv*#j-Q}UD|P_uiOjWt0(B*;Jywz)WLRG2Gvqu0zW@E<&*SdN>fhLAZ4V? z=riy+0J`5Q&p+s~TZxo8FO}cqBY$VW1)0fK&@`k-kOP}u@NyiS zN-TT;AHjr{lb?ibu*EkedSae)@}!LPwDBp)Ve6Vc|oE zgbf}vFmyowej$DP^nUe~UOlZnf-T*Z?Hivz>5opUa%+@%oW--hu4auPfh@fDrZV3y`=>NpZ@C`8llZ=2=hYO-3G7P_v z7fn(O?_OGCu$-J6WU(7Qz2s|6%yJsN(;UH8?L^QseTJN4bhbHygM$pOUh++lD)}a6 zS)7KJD&@gJEs_KSQXQVL)m~H|MwD}X;l#~$${ND-D-E{ z$c#EOpXaopC8NQXd`o_sLl2W=bI?h~?gDgWkcIDPv z+jl^mB7dS=e}prb#x_yIKMqM~Bu6#DtO+DdXakXGT1BLPL}hKF)F4$@3N)g^B1&mf zPzkBhii+ZE%2L^X!DNRULX-1u|DYH+W z5zPobQ>KtGi_om-nLmoGk%|pTbZQv;B=dE2cZpV}cO*d!T{lt+o`##Hh8t;0l8b4x z*|=%IPL4LwFPWp;h8^zpA1Lr&Hh44m4;izA`N5U;!aS4%*T=7yAd$d&gx|-1VQ< zgqR@cPm`&2+7IZobATsm{mpt_lsD+6%cv&Xtn0FqcQiFU75liaDw08W^i-H730^*n zx|xR_Y-!J=nngQ$lWEF)eJ&=>;d@K#qL{?c#z@YI4n{2`G-NyYdOjPfv(u`hafo*+KF( zOfuzLy1m6LZtJ1xNlSzMPP1rGlBSr*&rVH_^8sb|g_s)Allr zT|qSYT3V*)NmmBzV7tv(`-b(=ft!o8QdqqrHPn#@2-%n?4DEYuc`0rp%e00jrZw1x z6LYjJeecv6hbi!Re)ZHUuRi)g^8G?RGn0 z&U9jo|Ex8=wfS@xH)U9n$-gloOW*tnY+vP@nY$^m<+-O}08T2wBQM@kvlJiC^LmHz+?4F2cX z(1uqqJkhZiA_|T0g5A>cow_1TYe|$Hi-&bHMEkKBx@q6gU$H48VfVpmZL?pblr%__ zZA#f@yA9~#Qt|Y{$Ju7u_RwW&BIaq0cL&;gx%U4vd=we}+yQ+M*==fTFaoItkF~3% zGm}TDR?JrsJ!=yUZyh;xqJn!jQ&Eg^agNYGk~lJA+@i##20iG~St+ zVhGceZPX`MqCRs<0?=$JL#0$mClZ}N3&9jbI>aLAPpGQxEzgEuy&!$>&QlJnSD(HjbHO~npg8_L8gciCkYizq2x3H@DVr} zBt=A=#8vIKc$$n(`ZUq87)1-s@o>EB?$KS{nUg`lW%eBpYNQv!J&J(0VlCkrJ?09U zMErSWO7Zie!P9na>IvG?{zUuW5Yl9_f{eE=jj7ixX=(2fO`<=9vf}`*G44rV!2@wE z;32FFSdR0#AUPYUOU~k>VYaGL6=b187UbjXM|a*~-pM`8J$c)B#kCnRJVf4RrkIy- zhf*y-7ywQpm4qS5K3tE>t15|HBQsOEtBgY4zKUn27OuOxxGC^~0IIg!vmbb#X96tG z7YFxi4Cg4uH=5e_)~#F5YSy{_FTzur*EfSTS_00OF80SxvL5H9l@A9 z7*jdy)*9o1KqR(56k4%gbGuhUBm%$#<7Xir@CPuuKtPVlEXId_3bKUt5h9m`BgD@} zBGD*+M2~tfZp0==18z{0kM<>m2-L-r_Ji1BH7TI0@i{d)C)6eDsw&qD%hYQ8H?T@k zYE-Fatx}GDtJTY*JQrPt{{mcc`N)eiPw#v4`+N70*oQBU|M2|pZ&{zbYFbyU+($`L zJT%ys9sKO{i9W(S^2=k^^$lF{&-b3c0hqDX$dUo>D1;yiwVD`qdkHt82_d(S@E-n0 zx=RRoJnoR&y@;Sn{a4XdRgKS8qkw{`Mim59uK5PLo={-f>9^jpKF%HLm^yx_+B!kD zDDB<7+|fHv-L$TdRiF1=y)pOrou|mHZ|;5WX~g&-VqA<~#GqGOTU1oC-|dcvZ}_ov zz|Z?7KkH-tg7=6n2&IA2JiLfHA*E%3&}(|Y?XXFu@D%_pfEnj0ztGdWK+5HwV)T}^ zK`a5K{NT&SpMAml^%F0xV?NK_F8NmN)!Wu@7cN$iQ1|X{|3+XX%d-C9{`1+()*NEi zyKtRcbOj**rSPB@3r5VIV6hv_9(UBohJC&=DO?$5!giSms-QyBraIzOzN%)ebEunL z@=hX~2Y0r%JvP*te=_fGO>gY&+pwuOw=(Oz^#S6v7r=eZRR$|yhgJvo@%J$SH}MJ4 zNO-yHu)ds+mjq+M!+MM-V;Y3Kg0HcJ9|HmTC&ayDn(r%;Z|wd`rv{vwtHudGAD?q* zsm5#^8&nmYMYSvo$ToLWxcii&>N<40be$>*?rYY$H#Tpx&i=Tq-#Sa`T~(7qms>|Z zA)A?v*Pb89y~}LAJo=s7doFmr{joD=tO3fnz19P+pJ5CkK>PBpqLFH@AU z(H)ykJ;H9?8m_+uq8I3O;#U0$`uyD!=@nn>ymK&Y`M0C34+mX=!~2t*1rVP9V(0A( zVat{-xk`S(t)V>`FA75qj$`mD`x%^Z{Q@dnM`4fqZ_w?&04+=gPB8Ou3`c~01Jc}2 z;jc^rR-L75T*&4h^&r^h=>SADYCeUWJ6@6 zR4hMM5h!J#Lkgv>74Gr#ocq3)a$6{WeDl5ceb0N&d7krqew>%UTrdMn*YWzTzaz`h zd6eCiGBNg!toExU+s~6~FDWH{6FeE@OSQj8N&=ocYoyxUD0%*9o)41h*bb=-YXLKrkmUDNy%Z|Z#i3}7A|A`L)LDfcB{?SrheGM{_UQ+f!$--yTn7y3-WJo(;b)_+?H{3m2gP{z4zk?rnOe6(GPgU?B6 zP=zgx=xC*kiS%dZD3sZ%73NXjJmGDZF^bqUSsD3C{S!-o3hY6`8WU)DE?Df8%3QEm z=koUP9>43^JIBo!=3U^t&w2oDW|b@OHlT6USt@SihWn(v&e<#lm9ZL`8QTg@N+mHP8Z)X#jhXb^=*#LRWWO(Gq1wlG zYbUx&Gx6tt${5{)+OHamnAp=;uzZy>hTT^sp}JMgrCH;W*wC2NxCnVldOyUdjT6{= zoU>59qsNFNU!-|(D#n9V@)duueA&Ci{(mc9@;+ft74rGON!jC7lgBp7g6w6C&tWfr zmqq?^bBH{q`E6@(Qpz}-gNMng5P`L#gYA)zUtzGkRv~5vgRwz8L)WQWC(g` zASVC7dE~-L{m?YkKB`{F8H%K6HGAsgDd8^Q-wdGnxOth2T>hRKly9rGf@rj7Rq?5ja+_f zoUE6ptghIb=Kf#{ek14L_rKU@=*McOk+`pt&0d>4=5^ph;@hpkhdft(*>@Xx{*w5< z2QM_AxF=+i&G|QErF&VPwcjo>m&kF;f}iVr=0p2T$H4l`=Jj6e2Mv37@F{1dc_dye zgW_{|S3$kfv;UV23O<|4JN__OZCBkFQcsy9)@)k6Z*%rDc{VfjL%j^Le#i^sBl3aP z6ZL`4`8)En`r!wRKQ3$IXe<6b#`l%n*wc)?ZTD3kujGBM^tLf@PNsX?$YoQp`<4t) zy$2sk+&v{Td>^g&p-$_hUr+>J3TvTqSV!G$tdBN=V&a|}=#S;yNBD^`F@F0`%a96>ZOx0i9=5yRk%ZQPURBuehGe_t z@&$6^D)QuW@HEZK=@?leg~2oA?QCqCLf$TyrOqO9_f9$B442`ckaHgjO1waZx^=R~ zsgnZG+o_cT_PR#LclTV!cgd$|HikXVyZ`%# zdX456_kADvum{e}J(16Q;&koHLO!)e>eT&amIfjYsqEH;8Z>zNKBMTQDncfTSkN^RJa{dW`Qm`!#OH_ zEE?zqfE$-7igX=`&NnZt@fn=1*_Zg=(utcg{)gPNK0>CycKgwzb*)>OycvEi`cLjU zhkxILcfzZqx|PXc4GY=a3E71FuI4T6qcgcn&Fi5CW^&XkrF*7(dyp=i&I>(pr=F!d z?y2UcnR|)e4I<90srJ62`7-2A`no~OJRG1E}a}PwlX$I}FN6ZD# z3>rWSIIYkc*&Y08rVX?Qn@tmF24|FQ-FyJ3^KIb2@mEYEXa;A%&5%!Py#<@7p??MM z@mt^yuovue-#6``!)q~3evY~B_c0&)BTb86X3qLwHD~PEcLVy0Hqag)Z%)U@O8_^3 zo3>6r0Kr6jQ)O;}>)^E3@(1E7zPM^y<72UBtho{|Fy}!_WMAa>$d8dxc6`#5vvw&+(t(IqLcSCpyQ6IG1*NF6+!ia1)#YH^5nN<{|994%)D}!P-66d<<@a zlc4^Adk^n)?Ek0qGQDjsY|Lr`+d|G`kN@j#-~L2%kp8ijy&nX%Hb2?%S&!>CXy#M= zI#7Gb5SIXbxVb^C80OZQgP@l2`Cy=3CsPOXc^1)sjYWVq_R*`>_)X>l-~A?qtlxL* zpTp*7=(5i=iN3HOIz0B`a8mmmoLGbZ^f{x7== z;pUfYPQetWkUR!Y0B?e#yGULG4I#pH%xho_CM~CY@m9o)(_jV_|!LtIs>mza-pWXSf*J`c> zv&=E=lWmS4X6kvi-xnzdCGP3e{WX?j#}qRr6%GI>ZW6W@B&oj$+k9&cj#^&_h&P1HhXQC$J~wPJa?xBpwj(5y+ndO_=w#{tv4SGlL^jN zc`Lg@s(bCCf8QfhW83NBi`Sf>x9?}`supR~ux>^Y-5VV65^ z=&vsKQfzbE%@ys#vgh30bM#%DTJN{Yxu~Xx>x}HwWAFB?=8Mdg2j7BEbXjkl zEO1Ae&FR{nvgPY(n^2qEBH8JlW)kaf<^21iiRe7SwR`L@(tT*wU{FZ?zYhKZ+W7uO z+kz`qV-&!J7flrqf~S(qp~>cB6+1_H#rQs}8Idnk3)Z zF3a6#q|{x&9cQ?y*Z#_{p?4~ir6IVJnXRf<`k#cSaiDsg1+PG-qorRbBoy3VmVgY=9pW_UhAaP|C_w*>3#Ax_LbW{EunLJ%l=P#`M`EnU2**U-rpZT=mZ87DA18o zYGD-^BZvsj&ahGmLWh8aAP6!tbf$KwSQ#Lx#K0zDNnwnU1_~n`lnqF9fLWZ$7<0;$ z5oUl99oAL{+mOK~(6`UI@4fcto2?jM^3A#LzWeSy_nvdl`JUjCJ;$6^8TDGmE(%Uj zqn4!~28?w#vgVso>}```e+qoHoINjP{Ad{tDxGV*Z^0&)h|3khODc7*emeNOYtcR( z*=;v>?IIGNBR(uck7B1%^4;ykj^~34z3Y00Zk3d9Zu8*%;_M3EAx2Daddq0{pNwyi zUhWiXL-n~^_})9XqH8!!vP?O;`n&pxeU`nPl?pgrA%32Q>y2`nB~Ll7muqbHC8tIl zznS+R;*U$=eZ_E-jojg4_VyI#_!s!#Rw?mjNMV}~hWXNoWmoo;dDQfm>z=z%bNP9k zTePlo6kYZhu3uqqe?UL_rm4WDx?~RgmZiy`Se}w<6Va-Tt zz2^TbxZ?eu^Wi=^b+X#r&n9$;Yp)LCP+RR6*JP25=Zkg6zGdo!#hmvdVc0#(x(dP~JFcN#!7#|+5_uL;L_UzUGN7Kk*AlgJX@4BHTfZCS{HakMZ?PK4 zT_K*cnq`V2wVL~vBNbqv)epQai|xabOZ@0&&6dsfCD~?G$b3)<=J9WnK>?f_ID6n& zA-<)s8d53iQ5kEk0ovYA&8zQs}monV$Ba*5{zdK~4Ez(QZ zq5iB*g7FJN1Q+ZI##};2?v=(rXO`3^@XaKcL*ugPfh9}<}rL0 z-1xcjYIgxKdOtasJZbV-5BMR#-{wa+5aD4k)_z(Bg95vU6j(cCGkt45iQo)4OS_Qy zAB?!~zKHYA57D|l>{sp@B8s)+iCGy4Z^qjpx09EOY|a0Ni7$s~uS7>U0y+LsI}IOI zo;rt|FqZh}n*3hI__@T(IS~f>i}-)PiNzsCn4F%kuy-JLOC@=$##?UkS52J5mH*gV zWP)8U6WpnA6V21;W;lfMsdE##l#aT4ts?xhLU_b_J_d)Ocu>o~FEI5De9xg+tVDQsIC4Mtl}AfMno znx#0kR_@WU@QDiEE3A`zyN7Qo75qzemEqe|OY>hDk{n|9<{Z+DuMOU@;1o7F(E1H= zN$1NkbA{vLF&~gKqcQd)(#4FUPkq`igeyFR?$fvfK)ILuf(-Jpt$R6m%NYxYxQ%lg z4wt=C^1D0_@B0%zH-OxbFKhgI@<+Wn*FGk{wMrlRRB*t_l>sJ))^KmIi}Q+5ABo2O z;rPIF#vpN2Zpw2l3=z||0u}%d0?V8{Xe7~!G zlK(GLZ(Nt9nhX73quXuh0Keo6df}fr@CO&Z=NUd5&RJskt=34B4DYN_{;uDZcdO3I z9o4U#rII%KE1$pI#(&G~gT!df&E#w5cuYC6`3IhEYKA8HHnuFbrpv9?%c0FvEs{x{ zk*?P7c*jQA!AkAL#y^!Fpj&EfP-Wi9FR9BiMg79qyg6t#{&6kz5xar^he>H_d+=)L zA3>}2XZp@F_C#oVYqIn=xB$k;E&3m4J~6^pY;e{ZE_02)ZjAixRq3fdO8r&}GGGWO zCoYug_-r_%{*@9acXWcjs>j{P$H_^f@1h42zan0{yzj;x&_^@jQeFeT2OA!buoSp=*3VbjE z_gz2E^^d3QDXQe-^`3d>HhrQ!eAQktFL53WbtKwkta@PqohYvhMNxNCjq_tUx`|E+W=p@;Ygp@&pU1*J zhHisqQT|TfCej*R8OG+7T2Hy-m(|F-PV>C(h?H5Hb1wgcEXe4>RLf}M4uQIm?)}a? zVUg6JX6c6MebrNDvdAT2SDltEOMl0HD6wEHPqR#mugJB%m+#gz&GZPul^#5j>PuAr ze)5}ZX7TAh!ppl?&3fcdDdRlH<}I7r{p!1>nSArkwm{G>_a?uLoN&e&?Z$AQtgF5f zU3SzR50Y#aGz<7D+qDww|CNEFR<`(%5rLpFa3zgKc5*t z+BKkECa){<`Ylu~{AGuobmJAiZ5kfH59=RA2#_>bY-97&|EEP)O+3j&BAM}iB%J}j zn86B`_nxcT^U*v8Xp6Oz_en~xlU?RAOPhjTwjs^2_RT= zlT0%ETkUK7&DfP3URzvT&ZhCqTY&i8l%y9!L+8jUQYmEbbLDt1wMPw{Q|u^_2Y#29 z41H0DTL@ee1^D9D^3ME?x(D!}*BX+m_%^w;7f{)Fp=vx?xUsAaB3Yfx_YCxOs4CbD zzcJ&gz9)O6!dvDiZ=HhfBxS+z<(C~Q`Jos*-{o}VsETRL5Bc4UP=B?#ry2k+6zhFB z_ z+-d)KhJ?aqFT*<7uKTZZ$=|aG)fn%A6NPitk7Wbv4)TlaLJ-9_fQ`}}gd3=q zxqS+gIs!M#vMmFTAmjeefV)xxPuO4fAN3N87rqyk5|YhTD*=-Tio zOL2Ddz-?B{b1!Wj+$v9O1^)=%Q900yeHQdh+|LU(C(r}Tpz&e1N*>WeD&9*{W&$!w zpPJkz>~dm5bOmX?I?Qm4>vM^6p24jIdYO#ROwr}?`NiWq(w8z0@L{~`h$3SrE0@A~ z<-W%AE&p~+=AB2g7WQv*;;SB54BGW=`tT9+{Eo_+TnAZHNiYTl( zNnDVTh_%V1KAj@NV5?^193 zjiDn8XBFo9vBFN8m2jMEW`OLiORii~W%7AZ8c} zhu9r0;3=aI#KkfkT`~5Ae+VE6z5382??3nvAcT7ZQN2LaIx>s-BVC^@S1?Qn!w%J~^$iQ1F-YL6YTHUq^i|r|@)A#zYqLah9I%??i2+ zg)wyp_-&83_(+D3V!y8hql|09!|q+W-fB%9y1}mI3=I$yhz@br!nVDWH{-dQw(EQ{Tgt@c@{ZUxtaUsq za2oTD1%g@{mRCgqtq;uixw0>`*NKZy8c4>&Mv4Ht*eK{2=Nz08`trfw*V2}(5*5~n zZ&KZHKq5LyMQswxl_i&;%*=R^z1or08I&4mpA_Cqj`0v9i=!(~Tn_r+s~^+FO$Ys} z@vx1giXIGZ*EX?+w3xJunA8iD*%;oqPeGt74Jv+v0ZEgOnhe0o){#ccSG1|r*PiCq zmx(XFh3i(QcZY9lyo?}3HVOueFE}t*t#9ztigyj{^ZoL7mnL;&O~UWL$`ah`i-Zv( ztrM$*JWt5j1+|FN@u5w)$Aq6{^Et)h4&5}vX+uiuQPW3$=SOxY;v1{=Rpt9z8aV zVWYx~lFM)h(@74yWS(srir6^%^v{{K70lvS&8CGT#_ho6GSQ!3V< z1XNd1m~?jx!)|1|x4n_dMmO{TN3&N6YiTt$Ptp(0=zYaE=jONmvg`gl>zpzsLe1SD z@nzRslZshDc1qaylVJsSj+&tRsyM=l71UGEn?DM~(THCPp|-y-n6Nh&D7=ZG+0JjR zel-Cg(IT8fR`e;(WW9@!2r4pX-n zkS%7t@pd9Q!1Ise>hjDF&#Q&?F5g(NSJ%%DI%=?R#><+cw{`vee5Q~(GUwPy0SnqI z-;#D~ytS${VnjbFm9p;2dUZd1euQJ+zCM`ZAK`5pp5G+E^ll4(=TWy+8!8T*t?)u= zfcg^bZHH^Tdzvz~Bf?50%7$5*`=U6BafCDaz9sx7{4>^##{!;1_fFGu6l91wa9EXc zl^x9G@zue+rx&D1D-cWI5evJgZv^RKl&f2xA{ggA`g!fzQcXBwt>c=;eM@UW05Ao; zRtS-UWDNQ=Dz~OO0rA7`*sqQLuno4Boa)NP3n-HN>yKyoK4#*RyJ5+B=SYyyULx#R zhd5?>z#cMcPSfA2VqI=-uLTw}O8|eJ%EEskM1Sv7%Bpb`kEx!~9fE1K4Yi5T4Y%r2 zs+vYVVgUKg?ztTIyf{MC4!V}(j}I8toj6bLv6Dg)7+k?I`-0Jj$+q|s(6)7F70~#- zE`f~GuU(C+{u5ZKGOYB{e5z3IfI(eO|fz&eMRZIXfao| zE|AlvcDQ3HeCNc6etF2mmV{I^K8Galn0P+U*ru7r`K0MJX%)pK(jU<+q{$X8Z7|$V z64=y-?C6vhNt8AA7m%&=w(^VMKR0C?Vq<*8Y{USW&t$&|4|48D$#DzGF2wvj#e;ek zMMZt_v*WmOO9KrSX z!aiSCZ(^*nfnT&6-=PF9Bn8+0SB8c5@kQUYhS$C7Y99ag&wQQ%*N6BdNYr2ydM=^@t$_*>zi98$gLlexJyFpWs;td`w+sZvxwWrmlhgnfDog;|sb-4d%!i2Gx2})`N!iDT)3`8s#Vk_}T|F@^ zzgC{eDAFPrQlRsod)=sw%4WW^r|b8%>xTt82BC4<*}3<-{B+z!{{Ru4jj)XlZ*3Xp zrnXcH_L`F3A0E&j>4U_JC60L*S3UImh}pJAoi-wnFya>wrd~$bFc^A2$bMIffU|>f z@w2P~kSGZ0`UZ(|VGZCiOAzjr>;T`^i=BZ@2gsazIz}c=AH;Q+^1p*P9?t830}N@sg9sV1^m{ksS{Z}c{XHm#TY~$KyK`x zN+&eI-HuS}Buf<7aK=&l?+$?QmX2j>f(iUxSHpNgUl)bFNV%EwNIZA$a(HE$E-%X# z!t63569uMJ(xayV_+tYuSojrnCa{udKA z$s~yxpNVnb^{eglBL-#c0lK{YA)g+3$&35whjw0-_VEEoj!x{5zah7MMFVRKXNhTZ zO3D$r^-(|=$#up(!t%STW9Lc-=Xw=N$TnpMW5_dk#X8(M)^Pen;ptpPhi#lkzC+M+ z&@1hosiL$i?8&wD7w`FL7u`g?3ifN%MnK%H4n^TC#X#i>rEU25Mm|eV)`YX+5^;LP zu3hR?^ONnCd1Gqy^|D%eXMf&HEzR(A)vez}Wv7E(w``U+=X2`1dCHn82NwhT zcn6JZspcSoh%b08R#etK{Lt(_z8qb_JHDlU@kji-MWO4<&|N44t@a96etUXf_u9+= zNQJE+a6SJtEK$g-lAyKD?osCT?KtZgBV&5poM3W1JcQ`SG@3QQ=b-#=#xciiE6`Ij z=?lX4rcYNFvL@OX)$b;7mimr6hAZ@{(^+GD5>ASrSrkevuTuE-?XNppf42g?^eWXw zObf}9C{UwG=RzN~a=HK9GD+EdYSEA5EJm>HFaM5VHL#F!pdu;F<&WwN8)QE}$ep<+ zPX#y(oQ-b-M#w$Z0AYE&;+)9OvWQRWpBuGv;*XMzN4M{}W4hyHv(&pDZud(i+x7u? zy2C3uvjLeXA*QwD%7sMi^H z`Z8K0J`u+8Fjy;{9etvf1m;_Vb(x-NSw_-Q-cH`y@p(z7xHE?{gIb@|`ry+j`iyTx zr#z7@cAEN@z51-ath>%qw$Sf$wAQNv74!A_Eij4$V@!%xQX)*jSxDfhPlgE#LyxLO1z3trjm z_g`k>aMVP@)8S@5hIi`$LI}DgTjD@(M4I72*TS)IVSzV{Z*AeL(Lb#Qq%QV21_cwP zxU92mC9bLJbT)+b(R>*S0-q~)u6LK)J57$uf9QFY^t4GW0`@kSm&T-L3@POYNo(E7cM&kqMjDf z+rrBP6-$bH9~XqOmQ%WBfjQ#Y9>y0WsgK@Xub`NGI|U&PUo3_Fp3HJ|zjve9x+EM? zlc86uwpfc;Z=uBy>*AQst2We%op45w!q-mwtXL#4>#wV_x}UVFIUBrBug4fqH)ej& zA^os!;v$+}FGI1`$9{-RT~vLn9Zqv-$bc@i}JL-s}YQ05jVUdbi|%8oPmb3BrLgRYDg(~hN`t>cVLD3JkW>}Q0)ulzs0T4+{4`wKR(rZ} zp1`kn2(A}(Wj~&6(R87lvp}`Pz@u$~@w6%08=$+_Z&GL0`P%jV{sp}M?79XX1^;;6 z3F`mRH@LAJc&5zM@4P?)10~*e#0B{_OQPMb#04BgyA{L0MGgp27LjjRVgOE?{B(G; z#eg*`46vw$au7AZP#rk0Tlw?yPXg8U8}x?#uJSjH7UVSP8iMl4FMlZ^ltNgDnPzNd z!3Sr2F-0_G#)?5H{DIr}Tx>t&lOe4HU1Q%cW*@{er0Is8dlDV|6Zn3E2e#c9I~%GQvi3@( z$sdK^>bw}`aAL_p88iq#x`G@}`j>};{=VXXsN#{g%`#`|__yXuw@YYqAPk7F`wnmg z6w{m1MLR^Fl8JF(nkN{z5ByH7eC4dqej~L1+6QH72A#fe^gr$ub==b|44?Y@G>hAn zMG^TtcerOh9`FUe*!4LW-}c9I+CYupuVfEet#->qvcjXK+s&v(N{7G;R9zEI zy`_Bw`HH}=zJW~pW9cZt^0yKnz``4x@3-%Vm3~pZmW{zU8>_YU*`xgIx#e9%$Gj`% zNu~6#jH7*4=vMDb*aOE|Sw+_%wL#{@`14XWseglA0YVoEKp^sFxT43u+tkRzf;uy! zor(M0#q0KxHj|$2$)KI4u3QuBs9lB1YdJtt#~)3LRpygBAy5M?h)n8Z0?6u~{qU2R zpX|37c6j0nc6_PjEScGgWv@+gD|vKKhCiG&i0AjL&x$- zUirL&bxqF|GgDHErza-kFa#BjD3={01YRzZJAO{Uifjiy=`Va? zFU-T6KS9wkSgX9G+!M9Rb&hcb#|6QU36&BonzBWJgjyLCew2!2Ai!b{i~uc&4F#PH zD$bs3Q(*4oK5oLX>4E-yLf)26{%$UF&gO0Xp|gRQaXysH#W(N>za}#Zo>qMJRvcA z)ezojlISU2P`rZzg`i?ldz_?G@L`_vQ^)LF*?)Rr+r$rSX=tMmJHk=uMq9c0zMRJ0XJd+;1Xor|vD# z!Nhx;-XM#FdTE5eOBXuyQwPp-qw^Gg0znqtW%Sk(&<(bQ3~XJJrl2?$so#ts5I-g^ zVqpHOs5Q3#8ygD?C)@uTt)>@0>CjIEH+;<(8he>bLTK+1P9h#naae;$zYdDz#8Lo` zL>$)fDObW{Ewz(V`<(*+vDBC~3-Z$5TsQn9pJQy_M3WI20@z^e1tK%<^!%hc)yJ%` z=db&7Dhr#woMwj*O)q$RXNHP*C;pbRdd8NuclUgWFzC75RgfzmI!;(Wq%R((6Y819 z0<3FXAuF#1VLhBJ06QmBl*(ODaZ;+>$yp>1(?UeUyuqd<+joIkL8a0mivzUmfR(=g}AFIV_EB-dXWqjx7`Ctw;=V` z@Q2G|w#0UhPY$<2IlO@XfHq`7MCK<9(+}YOum4i$!~Wm)Rl?fE)s2YbKT&q9j0!~m ztT|pz=8TFaHmYv+|LM2YmRRg8Ot27=cz`)UWZdfF1Q>E%99`T<1(COwT}|jB`g+*g zyA8ZI|FO$4LXKjPFxu{(va)Sp`z~H;o^E2rHN?*$C-D%MB7$MH@Hdd`$WjOSgp=dJ zThM8q9b>Gu;PS>&s{-$6m@;h{BD#F8#%`(MHzmaCk@ zfA#D*{?nfS_>MULU8*qtf8;y*f9g15`R^P@|Fe?+3&#=r|29??n!2v*L+Jj?)hns) zf1;pv5oQuc;pn+5O?79b8rGvWA=3h-$Vqyo@)i%4pMm_TgTZL@&3?o^gIBArpHm(N zQ!xq*6VKZ@9lU;i79{umh>X(;le43C80jk$Rk1_LSmNR7lki5zBZP)(w!~XzQaFQO;n~)$^!Bs0Cg4_8U>pP4{wMVG!zw>MX01wfDLgAcbnoB zk~s_rk~lH z=i7TIcJHk@#-ly$67>!1=bwTX)%E>F(kLnFWq~2-#7#5AOO~{6));)(9QWF)ntYS( zzoX4D*A9hfx$CTt4J4#U>>v%0Jr#UC4G?84*$^zcuV~Q%KP!?%tRbYy$Kq%}^ELW8 z^02FoCj3vA0d2)q2n%X9s6B zky6Z}ksmO$iM`!rEY27yp{=&DRo$f8jQl95lzk>7^+FV=sENYGW+jVSATUiNu|beE zX(X{qRp!i?LD7VN$38`s){sK18E+O>9G|}BfB0*IJKIc3#-_~^F&q&7P{vE2WeZGh z)h7;r9vaiz%US9e3`=&yAMjlKgwQ0qx$!{>bjVi?UG&7-R6#~PLvU!Zy#!^V>OZ%u z-ApG`=CcoMQJ~94b=RJtWybvYn{3SUYG?{^8YeYDQV@Yv=ZAd%v&bSQhXN?B7mAKL zMOeEWT$@@ANikrIY@3J$X}aPXWPts?bzv@=R-{8m{ZiEz7ptnaS^F3_< z$^3KBjbb^3@e(G0i#;HOw$|we%#JG+-jZ%_4yaJuvJa6z>K^FJRX^URmF-KtDCrf!6~&oX3LoTi=0-P6wAeQ>?Y;=Bk#(b@Jbzh@~C{!ebiVR4yMyN%n;DSgfrp zx@S`Nr+mh;@Mk&R@p|?bbXia;?XQ9N2gt$1i`F;H&=W*#-KS$B72b3BxNgVw9?M@b z+yr%Gqq(@0ezJ3x;w024VE3OXQZmBFxH>K|8+fm1l**Q_P@pp~HEV9P)G{2MDIexi zF21sJWJ4G?lPLwz3u~GtbFziaicUp1Jp6lbEZ@C&RILEoiI>0F>gW{P2H2-$L!jGw z*wvk{HD7eevk0<-zrpk#wFPv67 zxxQCunLp^3MLIxE`?mJ@m+_{|6rHW~r_ONy+6O)=G~3pfHTt#;kM-4JfQ&r8#4cIp z3K?={!ZERC48Uikzz=YT8uoVyi)q3}->7Vm%B?|vkXdykcLa1E$q3fJ(dg6>Q<~ z$_xh+na(hd`*Vnv3~6Sj&XZ%mM2s+LXPs6e$|-Q z;4?nW_A?5IzWoz0x|G4nWoGEwP3C{)HP6^yh zZvU1YaJg*@k3y0f!i$wktQuF1Q66W^lu^21r+55|!2KY+>YYQ97rhGSVfRNiZcTI? zvoKtm-sd1m)a{W7FhLpmV29RJhqhoNATEp2b{dH19oD~^WK(xCLUU2qCoRGlN)h#a z9N5w^biJ zIf_$6o~+wHOyT+s3}$P$z<1qh*u7e%iLL`*8}w42L9$WW;)8yTzv2~p1u7zSR$-D+ zOSg4f@!ze<-txKH5oZ&97n(2Vuu22>Nf1EYR|q|Ab`CMzrI)dP^x&B^K{ zEPtER%6Gwx4_G$ttyC6eOmOrih%f_(ApxDizuG3tLEtE;74C{A#yD^*@vBqN+ET`D zl9`t_K;R&haOWzSg&S%@TLj9QEEF>-?`fkPuALlZ@l>F76KGoZ>fF>|$+mtrqjw0`@5{W^i8DDUeR7~ZpMDa!$m6yA zB|AfZ85}GPMZRbyVvMm{>rbRQSSgG3CvVpI$jd8Y?A#rhhDXB2Ou$uHs9IdO?-b2B zpTvn2ZfIP*#HWH5UE9J|y92GhCr^-s9c_J#2Su=?%+>?nd{tCOZS-0Pp%DeuG@Yn7E6UlJhrJuoxBOk&*84D((WWHlV zku3P({98MH%)8tFT?J6q7M65?sS8ZMs;c4vOqIGI&dNc~&z^ASrFX?x!PwqYYO^WP zZEW_Lf6w2$e`l}vjS2sGR`xC?Cecc;Wr-x141eSt+sZI#94(Fwd!>T?`w1e#L!oF* zv9C#c@i$H0>$5X0Z{}bAj}Cdm92m)ZL;C=F(rjq@is2Szt-)H8$pdd$OfrPCsb7>LzJ}y$@@>5wqWdzO1*r5wj*ZR+O8ayfv zTSsr3E0;3KS^glIN`?r0Y;!yo({d~%sVsb3xAw~~WLAkR*1@1lx=;`bp9)W%FZpQA zi|n+Y?aRC33npU)uumk|0J0K2VkwL~8A!0UpUzF~5Pa!Aq{=7@DWGBOy}M3K^pVGQ zYZv61DPdkU54hHu?xTNvH{vTzT!)@6v3=CxEb>1jHx{ukH{DQHe=?wl8x@!2!v)Bk zM|vOXFzlDc0$crC7ajj#V6vO)s)%U++-G zpD=ghJWbaSS1)^UKnla&v zNK1%fg8~7#t}~=T<|$qe!geY4dfc*fjGFD4{%e|5M37omWC$)SX@~QK&T;6P&sCHQ z<-}dm#9b<_IsTYt`8&L zwfvSPGNsvn^u)Y5M7B|ugt&~A>!YwWl_cI|;(Uzo{v_%chM@i+Z9sTG-oLqDix1*| zM%|>ssc(pLc0OWj0CBOWigsUYZD`VWM#uB^!To?h4C7hut)%?4_{>|B930& z0jertaAn3@%@Qq5VkJM| z!K|)^Te2|hH!4u(8_Z5qPxCtW*RhLEBWJ=WbALQU#%aiUueGFBK;?C)@1d)~QcftT zD&(ZuUUK}ZCo0HBLiu+6gLr>x#AP86#XG(F6M^Kh;cEe38|;fJ{ag%BiSOXs*pb#V z;aE}&p$rUF++wh}1eNQ9=y>P{1tNgrQZ z#O|V~u*K;vj09z7tDhSZ9hDGM5vMJ#VZ}MAapU^F8sXpgp>Ej{QBrsiPqW8BlDb3s zj3hCa1@2`V2PyeP-wKMz&daPpboqI?@dz2v2_LO@aR?u771tokjg_K$Np=*8dVjPT z%FW~5%*D;it`WY~{q1x{U|?uD)HIhR*y5)9a9SN8CunDus1sEm*o~_2IukEr`igk7(UHEnwvH6gTDHIv>Jcq_Etf4z_hyJTRdijxAG(N6O@$ z40tR_t^!dqT_Mj0zi$0W)pkjzA-jS$`Kvmm0o~O)>xSMd)4do>!x!cVl&T_18l)vY z5&9rAj=;kpORhY5!qxNlMS(IWbi(`Qtc7|rt(@Z`#`e3)_ag@YzS)^=sjrQ}aCUvz z=#`!NTtQ6F1vedpXn!NKcGX(CLFaZBsg%qdED|sX!JC)ShpXxE;8wE(bE!o1^^1d< zrHvc|KGi!q#gXRn{-P|?8_^C9s*#wHVt&5zj*YFGUdcSjTPsgS7<-7VMH9SJ@#?uzSyMmm_gsIqze zM7>IY{G(>l;fJ)9-C&*yD6`NqN6M9+?S?Jgi18JV5jU79uK;rf_r0aX6iHBMJ~$*S zm2EZ^E%Bh^PgVvw7$G-29h{GP0Q@3gaCRm7g2f*=;M4z)n>Ba znx1&s*04;QG(;Dq=TkfTcT_J&L1)shne4lIXsI?_yEB(tCdT=)x=67fNs6}@3BTuZW`%t(S=6(A4?R*4*9_C2Nm7QI2i z-jx-$MR8$E5$D2`gD2^8gq?+25{bV}=V;Vs9rj>Wmjo)~yc(svMHqy3ov zG`O*-Bj8t1t1%Z<1oSj~2|_xhERu>zX+))j@6-x!Dj`?N-h^a+<=q}`kIUjLmX!4R zUnfR6J_9d)WjrhZtl-(#z-*eCLo!8Rn~An1#ttV7D&9lr*gzw-Yj}QmOSx%Qf^nY# z!?fir8?tTe3NE!Z+6qzWl@(L=WJw#rKjTWc*Zox=9)71T5SWDn+xdJg2y6>mUdE2D z$h~SVLIiv0mxwWx^!jswIo#AFkZL)azG?(aj!N;bHf&Q_3wZNJ%bUEf5$Y{(P;bV3 zP3Jw$h(XnDikj4Y?(=(HB{)>s2gNOg{1Sy_+KRxqIgh-#f5}+#;J|6Wd)audrQb{4-}dy`x=Prde3W<^>;uW1s{hWq2RW)Z?iTdWUCD?&alb;L z>{z`$1or*LabtLiCz#p0SA7FT1`m9dOPw$$HJnzGif(w#@lT%o9IRbm20wwG`f>&w zjTtMxZ3dWzWZ?P&F6A2Fk0)4xu*Z7cwVd57t_IJ?;O;F2)qQPxmAvtsUuynev*Zhp zlYQnr1`n`556BHqzPC@TGV3?)KNqVXEF28YSut;bq=E_<>E+dU?FS;_yAm$0*QbNvU4NrfkAj=HQ%p>&?p zo=M52A=M%m^zTB+KFPK4F6>*m<{@5j3xSE1(bI9jH?tcGHXdkz|7lVr>lLvuKN?SE ztaistyuvvaadZoEgmJ)6mEO}Au@HLs(rloMmb_$=jvf|W++A+7zB&K9 zmH9_DHF&_2)^@dJ30l{_r}6RQXecRoJkiL@BBD+XkajMY?uJ>|z88>Z zj^o%U>-4#}RP>5RzwBI9ZxJA3ZkPLTobOli#{0S6Rp7vc1{c_82Mi^M)Z+&w9m}3k zbhv^?m_TnU>gx$3=;r5&G+NR2ff!mDazujo%-@%Bxj*nTyS}B7Do_}-Nz55Hd&`o` zSZ=JZTWOQ)nvZb_Ay4Io>NxE(O3BdKY+K+T)}3+-j%rd(17}i*>z&#OoM?6PVfZWO z=CH@J43?yNf55@URB)euh_tr;PmB@C*7is*c>Xn$ditoi&i-_I;(wXn_v3ZE)2GlQ z!2N1k_ETxt=Ws`@HU9|y^CthD>jVn*KH}Q!;UaMSm;-!56c{yFK%47Ch|zAPjnzLa zu?bPakH@qrKO*n6w6TWK5-3vqWNwEAYHOE}-Q#7ZC74#czueluII>2fMpvh?^t^N^bhmT`|?~Ee!JL*;^Bv)V*Che2h>Lh!c~pb%{M`C7zP;b;|kTXQ4Xm5qcW z0QdDmx+C{3h9;(DHp^(d<2|g3LEr-NTBmlnW$lL0!o-<>G=&6#w{Ia34L+^zi?O4Y zHM&|s3ZK+&gjxWk80#&>wZLj(3DDE$6qY@l(1(D%Ngorz8^aU5!VyPx05vBo-g~Tv z=aUU59DMjPJ_Z%nK}aqa`kC>1&DDHLu%*Q0|iR43z?qbU_vjSHv&+ zix&*`hi1>Q9+SXW5G%71X6X^G9>B=vt^hJD*ckEOJT$@8L5RrcN^nTlF&jJbC*K*J*g(E6KiBeTo}bF z#2AQ@-g%=~_R19L3I%pT?PP>Eae{0ra<#ZMX$Lb~orvs6Fwy0<4D1L1A>Gh5wzPad zSfsyr!P;!XPCu?aCt;4QTKaapwh;jjaO+_^cY6rU+=6Elne6CgkY$M2sOOZl=|pT6 zkB&nK7z8d~U> zGTy!E$H~15q36)D5-}d`5;C8&LjY3dcCccGDjD552~`gZS#Y2%aCpUhYw)ZZpC0@ zwU`>lCw7ViXWPuSVHc^qW*F_lnb`h1Zs7u|wLg}frnn-p9C?)xs1ZDZ52p(%uIi9r zD}!*fj}SJ4%6C-6t;o05Ra1@&xYP^tw2v7X-^ROzO*QxRtWHdE%L}s;y&g(pN z*c8ILu9_(C5d~tlV=R`J?b^If*@7!+C%E__77iKT+cXA>#;V2 zlS9Mk_(Bp9?{`f6f>U#_{v}T_;t%5&7ZcWst#@tV2l> zu0c}7rhk{x3}Pv`RI9tf+(Fog!U6ox-&s-`oQ&FNrKlRb$2KJCE4Q{E+w|4HfTVw% zdIo;kOXiw#Meu|cdC&YX$xvvnc$>pj;eyw4Rf5`E2hl%lmfk?&$5(Hu;~rx!NGpvRyyVZF_UlLCZ+W!z0B}KeNLl z^Wca4^2K$!%5n^Fr_JXP#uFsg>gV{R?DVBy<9V{{B&VUSnHip9lnM=h%6aT{;?FO`lBYff^sBmmPQ3$=8v)QonKnpM!W1W6Jjl%?r2ibfLYLQ5;6tGB2NY zcGP%Zu~xBPlI?J<%+_eItB_~aBW>=9Z=*FjizBpew}!7ZRPuO87mS@ zyn()4Nm~;@Wa$1oisECgiG$&@CVw*WCo{h?GWI(AtRr=-4Eic!Ot;^;xT8u5uYccgWph15*dW?k zxvmYFb7J+3o3huycL6|yQ5g@E&+NY0Y}^-D8cm6aqCl|~a-FF!p!)??0nJayC^kSb zlYDyegXa?NQm6>LMUa`8BoH>z)*3EeG1a*pB}Z<(nDXQ)?4~c>LCFdm!Y#vI0P>hS zH9Tw{o@!h~wzwWDJjo5Z8fKJXl3FM7dhifng#;K_c4Bmoza+Ew7)tUZUM8EF8Ghjc z{CXj9qJ*m$Fw#_nRMGQCyQ!>>Tv3slv=|Ba=7fA1X z?ufOEjBDdQkTdB$D-Kpa5+h~7q0Oqqq#d&3c zvoK8Ac_LdyKA4hzP_10kD0-_ERb849m8F0qM+ci!7wf&#&PfUVa{kVY<_HT0*Y2D0 z+qr=~Fe!HpO2>t(dLl+BI$&lHS8+R5WBwV=eg)2**M`Qj;FPrBxd{~BH}77Ur-k%1 z#4RoFWn(SU-FVHKG#ka&jy?Br}LNX%K<`ske@0e{-wO zva;&Be>>D0SeMX3-E_>-mgU$iVqzmrxtq3YVIqG1Vu9UP>0*`F#@N^q6R~>lA8>Pm zle^jP_FU@>{XOm8$k<>lxbyTG<{iP1uUej-$%G&-!a)y7aADjR!Pj5Z8wW(*@ZD|n zr1gxK8Fwn7LznR6NWJws3PZWlUn8 zWz$vtlrHNAXO*mIfyKhJ9!jM>Sg|jU$W_>_;u&WYhdyCp% zSf1Q3ynvY+BZh`G>R#M~vBe#8y~sxuL-_XKS+peo*_x{e6$gwO3o)1Bu$!=_BQ}|Q zM4ab}^-W|Rdoi;q+%Qm#GM#vMk7tY)ov5v?6$WOmXOfCP)wxvA1e3n`8uMe;q*Uva znL@J+?Z-nf=!LW2XqAHUkGGqk4elQu-sT_d%P20iv2(h=xIXx~e<|tlQ3gAiW=@xr zGXAmn@a*+c0n|;EoNX+kRDqRiO#jpT2k!N{GLy}1r9XIAYayU>Qkmwk96uRV3FA;v z=v?U$=&ImUr6B*Yionn`(Hn_%Oi;uVO13_-ORb|ul62f z8l*WL3O0ATjt+fqyPW_$RR47G%5f1gA~G0v(lnz^7rhBH&=DDy5UMQAk0mUAeAb`0 z5RA1HzjnM|`m>d@_I0ZPn_mWhI{mM_K3{r)fVo`X2%y9y^O>HT&8IAxy;nZFgR0P>Yg5$UQLz%nyy>hyus02@G*1G&xedoFw6||712G~UAKA<3rtFLXb#h+7 z9d%_df1Grc-k19)`IVkg%`1D6Irf;lltrO7UYh9*q(xB2cZdA}1G#1s3&WD{D7B)u zE8Q7UikDk2{hjt~ymR~(KQ`=y@KZrR-#w_FbebrpKIy zv{3~G5NrGRGE|!Nb_Y5b)WP^<(Ne+{Br=o(GNf>s<>K8ey+>@(ePIA1y-;#XmT#d{ zpj5n^d*`*mD*F~P(Cyq9qjxVXi)qAsSH`%xN`&@hSxjU*trNj8y_bqDed|NS0a zG_T{eOmSTV^YG2I3MpcQ(2wpAH*Koi5!RudHwNIZGxHSbkbFGEG+91;S9~+lJB>wMi&;qt@*-n_>9=3q_lN zc$bZ`qe$r}PMQ06a7=eFXp$8(cN(PiNO17?DH9V4h_&XAr~qt-8xZ_?@P0K*JY!Fq+!?uXYVEkRiT$PoiLOvzR>nAD zPHM#C!jEw*W)S39ApNlwfZ(_yz&SRfL{<{+d>bz9DyzfXKkIo=>in`lgV-Gmy$45r zGh%zPA;~z#;&X)#q_R=qTX#%H1iD6}lfB)We-x%Z28@X@H5rtomZb;yzp$Ey1kXM6 zsBe}{JIG+7S&H{V4pMD85;P<)uM3U~kDpUG`JnoZrzt${#D)~Y?R3;n&<$zeiSvpf zUa1C}-Hw#E0B(QKSoPR1q+L%jZ{S(cRT3YUi{#qwx=9AjgCu(^JSoJ2@(~%jlU79H zBj6Cx7P^s`ZwTB~cxn{X_|kH9>V?6o-y)kC}S@-k38ZRi!D47_Tb!CNgHW5wci%!2v!^8-ewf&aNVW4R&5UZ|!n`*AdB{ z!A}=Ad3Do0HJGMiiavx~G21odbP#anXfBPFu{VTApG)NI=z>cu z*;oo*<2^m$^w8(U_1Plc1ljCF;AqIqQZh;MKRO=)s0fvOY-aWEJ=BogR>dF^^q}Ec zdW1(JseheOG}bt64LBN;pf0dxBl@OJiS~qp=y=?NnbE?hw7ZPP(I*qQ>1akGAQvBq zsnLeak3VF{dMHMLj9M&3yGY^fJt8X?DqD<3D&r6=yn`t~Si)dS7B7fd!^nM)DTz@J zqZ1}S>Mi0okd8?#F;Q{h^dEbU1(;{zs_gbke{j!%VJp?|wE^mlLt&lv8)87}>O_y) z)adS0++^1ahVi(WRi3Hzog&c z9FK6UfHdQT-;Qa`=9`Hd2%NGH5rl=LuqP?1MpIWC$0p&eo>ER^C)Rd7L`>@RO{tD} zywl!Yth<(^Zn}#v~P}d{udcI6aD`PiU02moQdK8-wga;Ye3P~ zN#DsBpPo+1$-&vsNnYQ<*v82bpMm+m3B3Q$*ZyAy-mDC49RKgYTibE71Ht>Xwy$tG z9Nj0ZAjyQ$(a_XpA!bv$!iCdu8*CzoWH+PeCOLiUX%!9FW%f_r5wTo>xL*AlkLSzP z=JfDn?8WnCDw`T!jY`E%m%FETF|CdbYx%^|$&Wz}sd+}_bT%g5R3)87c2%lHPR8;} z`GiVx@wh`i>-8{QYOd*Haz~YK?sV$7pf>MR1ToWZYomJ#S$l_<6J3*oE#%|%j7@%W z?1@~%NC((QX4>+huQN;L>0zX|QJsn7wVGv(d)l|@V`?O|)PjMz*EaJA2en84$raRN z-DT&_hZS$bExX`q;0dLCi?s zbm>{bM2M^GJW5+e3-YPaItSD~>D*bMwoxo2?+_3ik}8t?i_H?2Mfa zDeG1_%}_n~Bc(E-Jwro_1Ky`UaJx^vXBq+1AncNvYH(H|%jslry%b$lH!|2G zYm0BfRXoA+{14`K3m>=s$>#|pm=FrEY`Phf=U{NXYUHvY3+sf3Bb z+>ga8aJioAuiGl{*n5EMB_n1;fj?bUElVCF2qDtU!t_^gA3fc=Yx-;^{*T9PsXH{m z!w6kpJ+hXY7Louklw+l6puzC)oSLB^_i889qY*Ki0E)`@^#**u*zZ&>cQZP&^wLEL z*P(h#JbEs@*|s~3^wz3nDN7{2J!XI59 zk`IttgMW6Y0Cjza>Hu$l5?^pI!|?deRghmOB_4;_vKsgymJaD`%IcEyVf9YRCcy#n zHRpgh)_P$$hd@|aB++$`zUNr@Gor*D0MJR!;uS)l+&?^*RHvC|xKX00dYW@aD)wrI zaJ&?eNtR4bT}Q&D32Q{D{APk*0+sry8A6`aXeBI$VtvG(!$6yVo~vk`EbKS~-2(H8 z;USl@J54RZj(m1~iaAIn5BRip)3!L0YOA=2UlUTiXI18J=Ts3mn{2hRzyxT*HhJBI zQ8&-t_th(=o!X1P^9@9zrc6ZEocC0@}OMm#q#^RHd=vSg(yADim_ zWDg0U*e2OQFgf{O_^yEDNReB$raBF}Bs>AGJ+LB0aVgWJzK_dS15XZFd84_$C6l#z zL1qW+UA4V8y8n&+^mQoy$U$}Rd`o=KA)UPMf7#x|cn|yg%MXVGS!0s{PG=A9iI3Gp z#8QMp3J&_E)J6#>lqABSz^>COI77B{IAB|~M*PYTROTI(UG9Z!J8k|&2LtNRY7S$- zFc$mfFM;q#o&W87b4gr49&?0&4v+VXKaWfnCaMmi%WestnNT^kT6!#pszqLvc#ATv zk$zOkVp#(Z;mkffk3R`yF0NUaz&A_4A8gjpvU4v=lZMr$(4Z!c7rHcDAPQRY7BhVn23g+x+@CRtpZ6nqXcVP@TovQO3*z_J z&lZQj19TADZp%W91&R*3NKmgUxH8WTTOMz16Rl<2b5Wp>cQg?bhybNl~O%pRi~n{d4tK`mX4MQQP=9Y$GPfysX;awRij1yiOTF0jv|mV znGxx9IOcZG$)+W9N*c;L>ZSmA>%BftJak5!%8^7mEszn;*G9-%D`3y`BX`*0AgWXOmQvy4GxEa?5fzyq1Wkd$+z)(V zK%=&_&v$=q9Q2KS8M(%>6l+E)$1QmRxaKe+#lr&LpWSV(^2k)Y<;zt%+ZtZ2O0919 z#}^N;)^#JBIv9bZO^$fzbU&2H=E)s0$Xs4nVhG$~icL-2ZE*|g(wT-+^#Z<6A0^VFXQ9=+YFudt z20n0_3Fc_ff5-O2#RVK)J-c1z03!5MLA~gTchf6EgZ2-@&Kz%-RV~*Y09yDO9Zts* zAj2$yWx|%yCt=lqW?>nLgA|9AuQuch`=S=hlrB7o7@zfln2;gZ9AxSQfcIRO;%R58-H&rgdg^dL8vR3FjbGsO{J zQYAzWPk3JGbMCt&1fLxLiIInM8SoDf?UG@@L>DMQ9E zrCE1VtaYjOhwlps7<)MzvyV&zfAQ&qZ$6DZgCgCq!MtoQH_s)AV3MceuF|lkWQE5kwLd;e^4I9(5=`Jm%w$c?M4VJ^e*gR+h-!FqK@CjWGyPN4FXMMn7XkbYnsDR zz;mZ45UmNw;|piTes!lXWvm~4Y^+#C?qqsNBNOq*djyH3#Y>smMc#Z4SV#3=0$PjO zK#Yu{qF5b~r@15y*VPJZvSsJ6C3OIh*P9-iaI#Z;scO;>_TeS7=7_7GsO$~Ii@atn zvFb)>7mFLI;*C}qAe?Ge&F;pMTMVZVjnvM?_B&;hut3y!@c61|u5VQfHEunJqF|Tt zB`P1&!=wY19%b4gy2w!fF~D<4fGpxE+w(Xg*MoqO{CvEaR+?M}O=5*Dxhh?EV+cb~ zDKbd4jTk1`pI-a>u(vL6bq!NH4*a$6+9&-6zwZckAM>v>QPRL21GafADxK2 z$(UrM)&tOEVe*GPXS0-`^7>TZ#p`=7N}X$8RNI}a+0s%bg|JrJSd)`&0|F3rH^WX< z$5ji6-+y~>}kt-ZFxj* z%L0R4#o#e;GY~6z&}iYS_0%CCsIvvElOL$(JI~sBFN;Fkb+yks*h7s!uJ-;o)NGM< zeD;^cgYW+^=sUe?Or1Zk7OaTt>{cOL#@C%4g`G=-0*n1H$m4;Zhu>k0wIBy@6K_sf z4AX#QVZ}R)W0F~m`IVL^>+{(Nf@`6K{5*?iz!%13E0xPDU`Joc)z~ne&2`7hkVRay z$*Ts)X(_7zt@pwtsqCluNf}qrpv-i$x zDo?#NaHCg#eQRj*HEFo6M6^l}3E8u!B=3YKFome;Iz`RCIlY)AexoeeZ*T%f`! zz4+Twu1WU+Jey%j=g$o$Y(d`<$y*1smcC61if{}1+am)QF&hWdouSM(AMNn)%;#40 z#W_Is2XsgNmY#Y;lJcSs!AQr5e8tSmad-M&-d2|O+3X&0Gs*OeoMavUb-rSkLHsCf z34~+!%7TnuUP$#MqGgq`uqvd#Ad=j6wTU;CrFx<3;?}=pp##$i=v)k0nm^nfp^`gz zfnMmIoK|}Ckp1+jI4wgBK7yf|z|p53PIMB0f3OPJvS*vGl%dxx{M+wI3Z6-}6o=H` zwyMcokzbqPG=OV__r~q+ObI8?5GStgRGzm!Kj$>{E(KKbNAe6MCe7@v*pkF1jiosW z3ErBs*G=cBtM&uX1?~wT{bxPCKS6-NM0=c?Mm(#4japRel3FJ;?`y5pX=0S76NT^b zqc?3TzDB~6-F6##U}{PN)%3{;FOqkbJxUvUGzCgevLapUpv$e8gg4)yI|i@^hh22x z1?*!XpYV#|$cyIHk(La52oAP|t6z`6cK{}HMJYvjrWSG>ibw5z0aku$(f~9o%hS`u zKfXUQmU_~AB530M*~nM#Xvj0qO`8&DKSc7vnmDRbaE)S(MKVfhcCCb)I1HoY!Acqh zziy?wZwG3L=6h6!#IA1#vV7wY3>&R0D$d=UiW!b!_p905CGnQ|IpJgCGRRJr>RGw1vPUwB@RpAvj_il1ggq%O%@n) z9#)IuGIGX3rU-WSrGzpvgji)-;bTH{z6DR|%qYKi-`I@GO=dKn<*iJC^0jKPfly;@knj}HD)4a)aaRsj>GGX@5Y6e%qOwS@d-p7Nq${GSvUy-*IPe+0 zh2Vlhmwp7%AE~JojEaE4nYB$|85R2W`wXhC42*3HTd@TOR-j?}?Dza(DJ|6*8;2ut z+IKTnvJ0unlN(AC64DMZTzZ_EC!9|VKL90?K7dks6&&NOU;k?6S>pbICU-bnpx^bS z6*v&f5V{V2_`?Gk>6R(^Sf9^r{vAj7d1Nu~KNxWaL#+#Ti6fu9iq@1F^javohHKJ- z+KJKuj_kKQJADKT$L!G=Ra6_Lig6zm%Foife}0w}AE5i$RZ;^?Q9z@#j$yGP;afD$ zBpn}cbI=L@IV#y=czAd^z{HW*ed~G!h^R{AAvOd@b_aj*k<%vfoTaCQYGxf>B2+sE zCNb`nNnA&s2{V}^N-N2C&GC(c~CEOBV(QWoR0OJHZGZWka>O^?9Ass|lA z(I(72{41vk>Wut7dH35`L%A#+ix3Rtrl_CFDYjB9jqyS3#tz^P#TtFu;A#2M-651yy z9lp9Cl+5X;^2i%LW%B5N4_yM5AhBz=M<5B!k^iC{5H2H5`nj9cUX!{+) zHgwV53$$-w2ad>}C*2QnJtVN~8KZ59D_g+*7gtcr%4RIv8?xQ4Tb)j?l} zqazKWD;`|j`MyC+^yA^*IJq0-l>o`phR|S5|C5WS11OFpJ`t9T=||E!&nt2KlZ;}G z4d+BYcz~ATEOj8q@Cy?R=u0Sh*|NTsR`?q|4Rhq%Fl@p%8YiezX!f?LxRmic0pb0c zvfE?TPMIH|Y}PJlmI6KPka*k|65^!OgzX(O5VI)8{#5T`P&w>%zJ~Tw!7VRAUh@U; zS>Py=pV)-lSzJt>2iuZ_$fO#VOEIl3wSdcG?ty9S#_HBG>YPHwdw-Z~((6(`Uxsxp z;fsF8a;ppNAF^2?f&Qmk6Py`fY-QrfoM$6#g$z@iLVx=qRB8OyKI}q6wYJCh-iUD= zpWnRrW={fWL%8>7JO{LZHX`f-U{flv+6R)*$xPeaU_1ijSu51GMPEe21nI35kY<^0 zJnVk!YBhtElTSKyq#ASi=rg{0Y$eam`itUPx_%^7^Kr-MC^f#amSxY`Jmby;%7NTE ze(9l#Y)amfaRgB<6dI*lGh(zKv8?Lx>q90+UH z1dhj$X(nw~%MhHL&b-}Ig2vIc7i0?m+x;l$I1Ra-5*}5>>|QjbHtaZ2N-vf=PYw}Q zi4LTkRv<~}vrQX_{Or4kQWgSK3yQ-{9ziSZ*K#CU^@(jB+LD+vyMdm@VhM3~uG(#Z zgwlxkXVRH0y%}?{onbSxO4}3NvALzgden$2%&busE7|xrng}R4d3mDTLTiNIHc}?J z$D}Mc*R*cI0PR%xIwi57jvT|t7>Z=Sf;&eA~d(0)rlMjqc_RCqhGFYh-!Lq3xzEqL+w( zUZe>b`@#XzL#nu*81cL_1!abqnv&NLMT$rgIMs5qSi_Q{8G9yCJ@!l=EzI35zcawr zNmh??Ym@5%IDAtGQ`aMieC?Ce6*rb5XzyD76PXlCzP3Y;n+LmarQTT|EMu~XkUf5L zLf~@Zp@t6PJE}oW!k0oy0A6_xF);%0qLQI?i@~TouUo1WE!J5x*Mlnv^~-}=cJ_+O zIH%U?!O9f1hsnB0MzQjwIKP3kV|~ugvu%4S!T9j&2U`gowEmi#u4<@RDFIB`1y5^P zG4Ol;h!Yet#ccF6QLewkn}i$?QxtXUv{iGN~ke zdMa2M_sIXfSbi~2FE{3tLH*d=KZ>1yc1x*RF2j{eY{%sJMyE?m$7K1q6^xdAZE^f< zIdpGWvb@<&8S$>#9##5wC>BLKYYL+xTfX5V_dFHY8Mjc<{U~5Vo|ryR>_*~zTw5nZY(~WXccA9DXc@>Wm>c047rDS4-2y!hyu9Wf!imcBMDbC6GhbNNa88 z#fZ(?q*rsUNBPiS#h)4ml)4P*eWY`@Rt&#l0Jme2&;RIGysEx6nhE3Iaz}Z&H=Ym~ zG-@3=PvT>hNkGlp0PQ~_)g@kc7$26uBb>GMdB(zXn#}FUGjK=+K87}2du{8iQ1 zs8oO%Hp(C-Ym`J+?AKSZ?{JnY^@(C_PqNf=H?I%NXa*tK`}32Jd?lvLVYa4#_FgME zc`)C~rEKXh54&fD>B-WVKnykk#JOH$7``(hAfmCk(+<%+w3{HL!j#=3ftJAjMuM|d zHR7z-Uv8%#hAcMU;7}thqtN$#a^C`*J7X)p^|acrlRkWsOkWhCy=Kgb_xw5Mh8OUX zumDw}6Jy}FtKSM5c(kk%3pW_e;^zC9?-DaAXN48G3Mv|fWcJJc6r^pC=6>@?^ z#p^ZoHeFXZR{Et0C=f;`_jY~=Oaw3!mzoLclpXfF#CP7;AM$(h1l5M5T)2 zpG8A)%?3rqE4!#g3s!d8-!pq$;uH;F!dAfDzO@ZUp@TcXfNH9zG^||EOdCqGpfDB# zv@}o%2iyilo@gc;^8D?w;j9r>BF8Q_fEe9k3a{?7b4PK9pS`#W4E5Im*X=Je)WN_* zuLN3XhQ!dGYV$$`6<;Cq0@ANmb|zWC(DnY{()SFdcD%&0A_<~vH(g^5*sA*=Gu$|< z@}uHA4y*LhMPLd6hI1m0$D;z7Q342-jO3r^1Fs`19Fq!XXI7`T=_s>GJy_k8&}Dy5 z=aS*s(k_pmn>xF=csROy7b`mZ_}CloShFg9+d8^3rjst3o6OF^m2;R1f|E2XCxddj70k$j!#*A=v^Uk5jpI<-H(}*n%|P&lVD87 zWR?FXWU|7eAnf*B35mv=yXI4Al&cr{M~Yd7b{VuuKDdYpe=og%qX!b49S{Yzh=d#p z)D~YhaASactn@*1V`C)DG6W(5e4YjPveYR*EkQlXpE2-&cjyi1D*{s!^T3@mf)r@= z-8seNo%-yn=rh6%^UrKvl#4e`?n@~tjfvn{EGZ9jQTuzHY)K_XVSlV+KS~)z@4llZ zbH)il2Dl5twjhTch@&Q$d8dY<%~=T?it%s_?D7Oco+r*!6p&$@7^E5LNnA4x-oUNn z7`=?AUH`$Kag%Waj?*+{XE|=+MOsR*DmWvEG_ICXQ6ValQ1ujy}(r@iZZAeT7xhFZZ3Y5p-Xv zmblS-W*qOHd)-MpqYW@8z>{8$O3rzq5T3&cCyW+_wXvZ!8e2L`1}|S5CK%KEkLW<* zq=L{v^4-Sv%5PK^MVJ6ZHYk1w67n{FSR0fJguEZ;Vd$|-<(8OhIox%%EZ%Nx4JQzY zzgFujWqC6T=Yfk4JO@l%^Ybbtc?;xyv=RNsp61L$U?BhXKiquld_lmZaQZ-~vy}3CF+MNxBJEUn zc}hq=kOM>k1DB1$)`%9DUIb5paTo^`>)PS>sJjL$Gf<)@1K+ER>t#T#tPbvjmy_e3 zk(y!U=7giK5NS+kXFVgfmoRQo8xVUp@ z!NLADA5eyjTtAVq7aV|S@q;9x!$W~Abd^v{=62}8mtHKI)?f!TNe77V)zXM4Uv6UL z!!Q2$GdRgiFZ63ide8Rcg*7O{Mz@BLwJ_75yKmy``R5H- z%16H0NuASh{PkMV*7N5(TekOul9eIm8=J~YW=~%dtstt9^ASbd}Z|7khmZ>@|DKC76J^J>N>rj zWKh>C4W!E}taLkIF%r|JIDL|laIR3RU9@M~l|yKUW~9FfsLWwF_L>ts=)))Ms5I2r z$lPI-+{GoVmk_4_Zk?R8srbqwIHCA`b@Doq3?qd#)Mv3!>uwk;aezpiezHy)Nxp3@rqb-~ZI0L9bM7Su&mhot9iySmGhBDN1mb z)X-4`!`8ttLu<*D>IZM2r)h)?v*uTGR7D{*@VtOj-EtLJ9G_-?R~uq^yDr%*P73V5 z@L&ra0ufeAkp|P*=lzu;Vgo2qCR;J#%KK(jhCyUi<*^|uVz1U^DAVQr+iTV2qm_*S z?}4+3DtsVQvL#Fihb;mAC?SM6S^Dh~;tLQHZTqo)_5 zRC5(=f(9f3LEZH4p8|z>>m?lH?Cg)9{T%!?O5I|df%eUf0qs_ESXn7X8hfcubLFoHGRk88;ve59qF> z*=%Z@IMZuqs{~}fv)~c<@fL<}ln#VW;1q$C!Omyz4^`loZ~KhX&z;gsS_@IaS{pi8 zz#|tp?@L&>F*mG!&RsO0Qdp;u8HymXdy#LP3TnX({m>TA4Ah_U3QIl_m?_sV{jpAL zP_~dl+3uPLarr6Xr(Jl_-e|#d<-o(fL^9wZxTfV~Jx`b<%dwNjmJRl#On&D_*J1FK9d$zOXRUs(H|_7q_LH7k88mwl^L0~ z;?X>%;<4>%wqz5hUW_?4Ib zHylXkNU_mNwpi>o6^3fzkBxS1?uw|{nFjVzjc(2J=7BCMcsxPvdzT6J6z1~e5dtrR z3l5Gcet`)jDFqQ;^W-i(hOLK>(m=(@n2zGG+}w?A_~F83XJ_wmaTmgjDo)#cpj46R z)I_BN-$rVDB(^pMzaN;ej60ww0%J`aeTi0CTyZ?N7{2i^+LynVH5AM|u1qw%^n|g{ z3dhJt%iLCj0|G|52Jm+b#DR-ZfT0$S87Sp~0J0x(vb)Bhrb%%mMEhYth+9-|!~YJ~ zF8|;5nC8Oldib>0L~aA_!IOs0-=e4TKJ@T^URSM(OomxFp?v6i2pz~p%cBhB+(?XM z=pCu^dP^&%htg$3?uVv3 zXFiTytskRWo%YJ!`kIXqdqY0RVi;Sp^ufVm_fh{2bGsYVe_KxI?nfwg*1B3~JDehG z*;>D#<#_KX9Yw&buUve-pHB=JwL8UZ&+s%R_-crAyRv|lYfut4{c4s;-jqwR+CU#a|}@_^@DVDHKKQzvH?AdjLvaxsq}kWKaU7@ z5%c50ZX8h>24dO9Z8?q+L6W{_-?)j+`?nW?Goy#RPlB;0)K0fsJ=hQU0xn<;qM&AN14t{=_OOJes=fkq@W5@jpvs3EN<1Q@5)`Y%vnHs^>Zowkp>3YE@BGts?1`>@jVG zz@mvlo4|SOftz205Ga1~4fPK9Ynp3nbTsmPwN_D^sF*h-8_y=UZ~M9?5qN75mtL-S z6a@chs?wUaYqx2Q4;=c#)1ek0eVSro4)UK^UeHBql%`VMt3!JJT){k8acG|Y+wV7N z6L-2kRq|WR)^>yd|M#8zq;efgEEScxGv{e;<@P;ol}bv+m+yRd%lPU&tWuJ&XAjtc zlYyF*@f6-6EAv`D&HFogEppj|H5Oi}i~g{LUbx&qO6BD_`~X&9}c@O`|w z>XD;PHkRk(^nEgE*+NzMgRvNjBD_oMq~+N8sL;AMsYMP}gY#bzNFzCk)0b9rG8kpC z>hD8CXQ6Hwru^_2pMi8Eqcn7Y(Y0lq#9|1;a+k|Old{xi++Ov2`Zq3gcdp~a(y2>z zG8`UkAoQaG*@(Kk?)zhb1eqV$np93~#-S5}ZWXGUrtM&}#e0Mb8FU8BE~4+3WVVM; zr*(jZ`xR zbSgy^*YxU+VltFPex-kvIBM?$cadzhX1O2^8bKkU*~Mp~;2-iWTS$$|jUp41!Du7H0cblKl?R90LTyFd zTH$D@@riAcs3+TyLnd@3pD~}Jsak-kgD(6-yLX9d> z0z2EzD8`Se8=0K5fEY}Ytfl^|d_R-M6B4i{Us*E2l-JXaNMCL(TS>`zemv`mk!S|a_AVyG{8*jO-d+zTO93*K_%2tgw_Co)X6FW@(zbuZ z@ot31dL1jlgGR+g73NnKSZoNZy&#b0X{m=Nt&SE$ckpXaZu`GM_eS*?gaQ3QID#4r zS|7Y@Jx`GJi2U_azE1MjtNM<8dr@EoLU{b~vH3uLq|~tygy%BfxyjjEK5!1&v4J73 zTAy6}tG5wP%$-1 zq(kj;b8sk}b*OL00nHwV$1%PHcTpsYE5=*AE#YT^mNn`!*VT?goGN9rbB?su{G~+= z($NfXz=ohO)0w0nOLZ&wteAw%ON8(%Oe}Zd;OeC3E_Ty&u#tNz-OpRx!bDLBMB##Q zjt>7ap`t44Cq5lmq7?7YvT^rkA7_cg*mMMq7F)8C29mHVJS0F+Ck%AlF3k@-C+loI z>)!E+nT{De5*Ju>osH(|3&2Nv(%Zk|{NwY}@C)$dBWdp9ML<_Izj%H5!MW0psCIeN z>F;}${%IVD)9TikvMHUQtxfM|F8~lg1_L7Of5lY(AJUZn(M0(V8+Wl&uj2um4b0DBmk`f~y0(?zd@? zM79(sowXH69Sh6=iBsRAKLQLbN$C4{yVNuBbV6a9^B@e-xR{!Hba?jccDp@Ce!Og| zsoCymS7>>^Zoj75E=8(!YS%zEcY4=PHFB?7xE5{&dOwR;H(pE9ICgq?{k3eSeXvp~ z-@YFnjr-8Is5 zMxblPdxYE8+1}WlkOuoC*NG|Y2(`cLK4*_w(R-%vS;US{*_IjQdcS4*x7DRheMQ3> z?XFZ8RqDD&{w3dzZ?5|m?RVq*S%jB#ibP6ny0bH63aOSFBTNjPV;s0a=2|&(;_MRGLO=%{1qD{n}_(fwTuE#9vYxDZ}^7@7>^8{9)tnj*nyNA&sZ$bVO+Llu2Y zcbDeGQ(+uIKk=@tS3B?yy!2#Iy>kyV5mX-LR2~ze^Y_Gc-@1Hd_^FRo0-aqFGnfe9 z-H!O?Jo4tmRT*rNm?frO6O`S+k0m#qt)1m1;v+%gctJ2vVKphv4@($J7DpY1O*XtX zp2eSfUr;BF@N+%FVlchh9U=FY(2k5L*UNr>h z|6uJLdqfKYG~Kps+qP}nwr$()zHQsQZQHhOTYIzLb~70y^BYd8D(BV1{t5gPnU9_y zP7AVehb1b)FDZ``_)KRI&E&+*%;+qp8+R*OI|81DnGe^IHC7E^7t|=>wa&r;Auz2$ zni+z9#HV>-p|;+-Qcw+wb)x^}aLiNuHbHckI;^SRzH}+09{Qb?S~akGF=%Ac5qP~i zopXlhNL2DJ)?GTYPm0!)`gxXh4`gI{Ox5bP{L&?m%)V&t(S$o3D1rp~f?K?Ya!I_m z*w^%C78PwBX9;Kr#7W=%2HDw8zbD`*w0eMvMHurbzMbDfn+23sd`=WVwm>mwA4cc(uaDNAtVt>)WVtR;%ePgp@d4ry5G^}<;U{pDe0gq?K9s;(&mc)UE{w_O z7eMha(YkB-0z6nB#TqQ8K+=XE8!EK@I=%XC}ENHL5+9?C939aZl zuV)k%r+_`9KMLM&Sa!|t0NrlER~(HZs+y{5>?=8~i;!vG`{zLachDW1Hd6%BX}LL= z_Yrr!ERXY*Pqk9 z=mHVHliwIirnCz3nUPsO$`i5|an8T13^Nm?Y_V08ulg=-kh=0>^~q&_)&+2hnFe$- zA>0MAB$0>s=8l;1Jd*8oDque~1!o*ww%{mHx?P_BSm_F*J1AbDU)IEO%n?~CWN2tF zdfBLw>mE#*9~Q~l^lW&N*km3-QX!&1l|f(@rmGe3qp;%1F=^X~H)_=PO%b2Mi;%gf zXccUqttfWkJqBWECMnhn-3i6xo8RG0R$@_W>}Xw&A8QU6C{+`;)1(bFw8Pi@yQH}#^x)==QJB<|5cuf&RhSeyecZVV#XTimiXy(&c5-&5bgIN+X z9OyQ}tWS4(5CGd|}yLup`zvYn3W5By-g zr-}ghXDCQFZiX!xrJhS>$h#x!o#(CwIEBIpM#rcihoS|9AZ5M>rSD z+3GfCfC|w6^#OAYB;L|DF!GaXm%l2BvUd7*;1JnktB$$xwCg-tu)OxpMNSPrq~3AC zf@+ecs!4D^t=wGmBa`lOhJT}c4&!eRFMzugwV{V9e}e4|JOukQ5Uq{OTgj1>B=}(ZVdb2t z6i1iPvW>B|?<=(!d6DNC94ba)Mf!agNeqrc4t>e@!%*%5#U_59B5P&@@3TEw3edpX zT}MBQl>@r$?CafyL~w1ew6Na}rEx@ZYCedamUG_TBg6zP0I|9c6v2d3am>02>4q$D zGbNv@cbTwB672B<9r%4%3^2p2biH}b0OkndFa4OpAr7e}g{qXIhR{wim7=31F`UR= z*W#V|7hs9jz`JFP(YA7_ptsnNFc_e@gf^HuARJhdw!>4k*xyvl8s!F9_yBh z{rWL9EzX(qb73+q@T3pdXs;8jDb^DEo9u-_dCBZE)$Ho}ZMx4hi#o8hQY#pOy7TTMya6cnV2u5S=as$aK6Vq;kC^OW}FEN)ldF zM{I31HaE9W2Cwkz!@adj7iyA|C2e&Fn>Ubk5tb9?w9Iq>$E4fmSgN6?yPUp8H5bae zNr^Er|FK)s8737SbJtn}xY;%zEHMYfNN9T#;o(Z+;JYTNHm>M~mrd>TWK>HyZP z_wAT+pHbFHTe(itxK^Y%IRC84G?mi=PE|F0>5wV4IyCGbBWFO>76di2&g{&HS7DQ#A zSfblfb6$0HIlF!^!lvA1pLcHw&9#!S5Djo^zMsT+fuw#2Eb`w7K+BRa!wKpc7O1_= z=!h8i-!l}c(?hR6HUOZsv}{2BF&(Hwj|H1phke)+{oHmE1bUBpr1ttfAnR5v+Iao5 zn?!Zo3}FQDV9Lb=T)3BHeUhnRf9qyeHo1W0^J)CFtbt3>n#e~zAiG+hH~%3UmQNY* z*5Mv&`)^Ho7B#_HRtZ$+2nLENd;mWkR(M0Y1UZdMaG2eXjMw=d+XE4Cdea#1h<&*qMqA zTS8tYR83P?rsg?aXjP%LMtj^(+U05p6+ah6r18h)Ae zZ98R21fO#1GQ_)xf;&&mh(k~!&6;-5<-Uwd z%IjY^T`W~B9Cr2FsE*UjJvBc8$ojvaOTPP19Loj|6pyPmT@#MDsrO_|-XJ)C^jI`@ zmGXN56yY78U-9LlF$*sdScFZi5aR?ar2^^C4-$Jd-l+9yKg806P^|9-I-e|$iKs|K z*YK2XtpQKH%uArRe6+A&7AmnZWHQBjl;SalK6phaP+ot(h`2&?hTLK z&`du*Acm<&KylUYo#yYD$>G4wJBGwRhUW{GZV^e5pyd3;NDrgC^!_v9hI-+*a*(0p zaErLh{dMG`j(oT%QYCX*h!Y~eh1+w9Kh&JQqCmgVBy(3gDg~_Hf%$p6P=#gOtqd8z z01*qXwLjx~IMqLscDF^=MUJwA#W?N>;3WLnqlcDhb!bKr-JA`2r%SU-BA=T_La)!K z-^0lx@o=TaeI-Leg}*D)JNu04{gi(3rJ1HCRPM<*EoJC@7uLCSi@mf4Z_JIV7*k> z8iTyLJb$Ls2<*8FBv=j*udnuRX`b%MBwD4AP?$mB2C=(6iwNGMyCAlj&zgl9bWdLf zi?=930}*0`ml_E}0ZcYub!njVxwP3s2ZkyjW7upoJwiL+y~n@{<)8K_4vGTtxlJ|0 zjE-kp#d(yAWUaee#%*0&P%MnD$S4wPWKklKIL>Q@u)EGFUj?d144YA?{erA4aV*-3obHF8x>pNSh1G+3#XLAF;3zVJJ zhE_nIFq7$V?$m>S=JSlh=9I@s+~_DE5?G-hU}w)-;l)oBLV$v@5|F1Ok1zrDA$3J2 z(TCB9-W)GIS**5Asts?N1F9*cU4Xl~pG}y5_n?7I0m_bi_g%=xNCyL2=v%?nEk;&4 zX?^)wIaj>#LG*5lgihR&8cFusy`NVAzMyVm27R0KUwN%MVf zs9?K$+jB6ocv~EDVEA_LyZUncjd<{}Vz;Dv@pJ?}~YG=5wO z?Y@39C?M21HxMfV6*M>KvMO#gF}Pxenzjf0V4YybBCEEcqxW9%nh}?$sVaV>vz)je)wNX5q57NAD^eO|o+hDL(s9Ht zuYwvk>*g#9^^*TCZDK{BcCH z@pD{Je8j)l3+17CL2E8ZJ9dX(5_e=q04P2rpknMll#IM2DP1)#eLp^=C^-+?j}UfNP^ zYQYJOgw<`rl;mBcv=w87W0?XH&%Hv8qw`B!T-|BnY^l+f=vr#9279d0KqrvsS}2)` zAC#=tDNU`3=1fgm3`>QW@ETKqF_Vqk(Za!Wuvzt7g^$6Ss162Q=22z2Xh!R$zB*E< zSlL%$uAg3BU)jnETQbb27f?gqMod64%dnf~DouOgGhC%HWziZLl@Wv5Z54-3op7=o zFCZSa2wGbAfcFym>Oa{o~B&xwW!mCOEs~h%z8G1Li|*TRJ;Vn zi&Yf)5qw$#H>fx))){*YozYgo)`3WDy%cPS(HihFpLYYxx=IoJ^sq<(?%i~-LRD7{ zin|C`4rZZqTxGTIIX)6`yva-{a=${$^dkMd1de}lODdu=^_cDeB3x}~Oe!)}>; z>A?N7iK!!h4)Ga(9rSfBnLcJvPH(t2zE}aYHhZExF}V5DuH;mJGZwtRAE3Mn6t*C8 z>}mv`Gz%BMrtXV7@RK!fgr?)1TknuLlD9cdBk_DGk7wGA%AYGN?!J4txS-*L2~C(@4Be*5yu`Zt=gReG%-??efNOPek` zr8Vx__6->_E=}|LQW@$su+_~>Q~vssYahg!U^%*gQ`<28kOh%1ZBV z;XOqx1(UL}nX5iG!Xlw=oGTb_4CQx?By-t}K>lu$lLb9p4j7fKbTOJ^fl5*=p#Az8 z|LXkqwEv7k=f2yy0+oKnP$QbA$7S)8=<|$HlVX2H=qD0pb8j33(FB8^S>XU zZOPw*N4mKxzv{nwm$!a(0_mEHmK!NlKB-{ke9M&wL)_Q#fVH4i+1=dz`>6`Jm(Jvq zsUH)Ph~a2J61=Cjz-~7iAVvhJYK=;rc2$OZsfohy9*kpli7@tc|d7x~Tqg#!LRZ56QpXA1a#57x}U!TkR! z;G0gHWB<08)TgBX@mV1effERDM^&w@54TlP{u-%0>`enx2o<}@2AD=aT--9J-!Sts z=O6hJMNB?jKb$cyTmr7 zpQ^F9Qmsa_;$pV%tP-m#%|?yZs)48H)75EvO+GIyUlx5eRYG%ib!7jOrdqHp`nj%y zTGH`WITh;G_A%~ar@yhG|Crd}7Jqf>Gn0!4J6@%)FZ)A`);)H9QvwKBYr@rV7z z>+?WJcBMCNn338=_|~W6&5%hKHMZkydAqog@8#;C+f}R6A%;KI(}<@jEV#WxV+B<+ zE4M{$nYy*rvRAHD+WAE7J$exx>ZO0z--Z7otHGAYZXNxz(N(Txb1w_7S?~Ui@6;8b!9Hu*S$XWJXb1M`F%W&=Za5$tG!L~N-J80AJHdNr77|{!}aup z_EY-z{$K@UX0>eghcHNahuPTKE>`~hA}dp^s&L8bLU7+l!`q^#H+!mv`nE2qd@6AA zA$~7h5%~4Sr^AQ$-0}_=^_wQz{IaHo|Fhpc!gHX_hIg`rx?IT8m-YQN(gx^X`@G7I zvL84Y1J}dmT}=tZxi$CR|MkFEDGl&BxXmV97Yhz50tx`N45+RQB~UnzOtPU2SFq8P znGfC@G!O8O?|RvaF>3VzN00sn{8Nd;K#ivAfoI1x%-yOT=IUBjA|mb1l}_d|Nl<(C zTW}LC@4+xvLMI*}WP^_dT1mb-Nv)56dw-45rP$ux*C8Xy4=1jW^4t2MQ?*=N(0w`8 zy!9ra>uQY*y@mG%7{%6t4{9%!*NWW-WFMqLV4`hC&vy66@xTtT$}^W2ClT=HNWk1d zpWCE=fYQqO6K6*mv!6}9)FBvtPXq;Ot&&#Xlb^wvtG4p>AgOEf{<3jidS2uT)|B8U za~7poF;YkoJ{HIDxA$n^eG`}>LiYwa@4g?b33eYao%-x4f6)@cvw=>>M zSy-g~R1U@Fr$2~JrO|NJGx%HVVpB6#X5;x7$aBg%pKN;|_3@mw&<{q?LZes74^0Q@ zxaX$8E3)Fx*CNl~8HeR@r5WI+zl$&$Z z(1D$Q%Ye#82SmncLq3$Ih;OA=GS+$O*ZPX1$Wk~@dXZ@*znh-i-?o1R1OZ6cVsz~X zV#@B;$F*srhYJtT#<3bs|D};4EyT$B?rV=+s#PxUi(#1Mqv0^%1cb3o#sFbgN&z1c zc(^4jW5NiNXL+bBTPqtXgfr^5UrSXljT*EZwRW?L)LzQ*zjVgPRQbx{floPG|5BJu zeqgeq+G>xu5rZgjbwRI0fcY<~&SxZLncZz^E=TMoGG3md*`pBKIuIvXwm+pjK%P_; zX-YSOU||bPCoajMtGOz&Bf9#08Sv55n)`m8)nZ|bWRn~&1|=8UB>8pumFemDDb(rf z>-B!VOQrtbYxd=zD#ZM|(q^oExs+$@S1Ed4^P2_y<5jrf3#T+9cyvj98pHYb2^_qw zGJm~WyQpOm)~bv%l6v^r>3GR7a{oau(b&+bgnAu#B;p+yi>F0|Mn#b@VTQQu-%dis zlHtc)Pvp1s!~yRt%@se(cg3$?d;VrP-JHC^vTj*I9B6VWSQ9g%%N}g$u0ELyaB{(K zm9Gg6CLw&)BT~)WmnBn8bm&_OfK?hwchnq3hVB`sa3A1d8{!o$V+oV^6dc8jEK`{h zX*+zb^Wje{f+We~N;>Tjfx0jRY&w*4UG=$uv+iTG^o(<=c`+!aPio)6Tu#)(kZ!VC zYE50eL4HscIq~yAtWf8PGh*dzz-ukqzyJq01;vpE#3$cEoXb{7FVQuF@*8(w-E^`7&v#DaFs@d-cepB*z8l^!>T&**)r5 z3b58a?CPcSyev>e_N%ofzsvbqG2FJ1CWJR!Hp*ooYMz_! zkzz}~2MV+ryOJ>UuWo>xT&`Ucz+}8%QzDOj8^4-RZ)8iG83bXd?Z|9vSP&@ojNYF` zCaiy$Rrv$8tFXvu9x+uc?LL=d23{;|@fEwk!@i-Z^=&r2?xf&yuj+oYGZ{^>u0xi^ zGK9ks>IqudgA|=km16*A0Nl1s#(Jd)uyd($lG}E$SeU0vEZ1l)+DiO9m%+u<1t%b# z&g-h?^^6$*Qt;mbRVG5F!!*C~WD!A;n#M5yaZ6?Gn{>Cuk_KlcUu*QZ50pU&~Rd`ez&J+XFY;&UoyrPL{%eE6hZHS*vEQE6z?&$n7+ z-Vu72!ICOhAVZp{v+15#?P$}F{p^$67X|)_bMF!pM2!?96=;B}<+k5EJtW<2_ebma z2?>my{dyC%o{i8K2s^y4s#9vv?LL{Z&h1gHijQ(FIuMj0=$@pw+S<6X^54=2i;XV3 z1A$H0_UAE4M#D>1ixsG_ux2I3Sy5cYu$)edPSuw{aQ%E=(`!>#cn1}*0N0z~)&3-O zZWmTYsU_`XeRhGexYydH`HPtXtR8}KcU}zW;i&@=A9rX^%!0nWCB7H z_0Z?G!j;AM|CSs>YzUB$)B#db58FfzhiDhx%PU|PPfn4J;Gjgz>fuj^Nqbq3@-4n= z`~eEkc)yQ`hrj#PC~T0tvfJ6_y;r&t&iMWFr5h4;p*b;$0C`wlka$X{aH1UcjL*zd z`rOZm9Z&#Y-*ZG|%$+D*l;?Z3K({H8o4I4qK6Y!4gc>g=AaM@?p0%UQRpEuuSOyn) zI4~gT(F~PbN7et-RBdKam8b@Zyww(U>B;75U@0Sd?dJ};5N)JpWhN$N#KQnXi(4SC zK^mBEB#b6YgR+`@zLln1&}_Ln_p3%>@mq=r^hTj=;u+(7JgGz)L|0AftI!M?ISTA6 zc^RP*PPwzPU&0y2jFyQ z$(U!)ZcEa6Jc7bFS~L{VLE0z2z(glf!Fo137!7y;Y1xO7msm?(wB+<^Ohehx$(kj= z6kgSszjDcOPiRCetFS`TKCg+Ny0UWoI$oW9s*ZS;MP@~F+|qLBM!;eZ7(TcUsUF}% zEr1WdSLGBS||$d!cAnP;Lls5MBf(txNMUKT7_#yf@vVcqAf zwa_$Qq0kg8c4%>N7moni;Vg`>rvwdsaoraRng?rcO@TR8fmt$UIRZfy|994NnRPgp zq~HBF%J0brBe3}0g##xLaJPYv1MY4+_?t*!kmD+m3~i)ytFHH^w({y?1?Hc@5wmnr zTRSl^Wdx&x_?NyNtgP|=q<_+ag9k6|u;8D+PJcAFZ+Ott21C@IT6CfRdoVHmesQGg zoJA4*-mlqIJwVEBrOF4EE{KM^ci4Ce31MXiOa6OG`2u(f)cp+ z?DAB2>0v%p#xL?cshh?XVa`@<+TAP2(Ka?CI%ar8l~I!+8gtf&++6%*`6tx#)$aG| z>}gHqtbM3Z%^!MBD#R4C^!%Iua9lv1~7uVy?V%H@I#ZDqE!7c1c7^Xg$YS0LIb^*+h-haBvF``-GZO}<>Iuri zh8Ekp=@EHm?6IP2>qtlHRCrE;u{>@gIb!pAzLkAlO#a;DK^=L1 z0=P#^B^=H?ivwexwx%i+-VT;8p*q82Aop))5tTS(sT7>SianDF1m4h~>O|B4u^|G^ z%%9Di3Z~Y-wk~5z_rgfef$oXayEb51%?X23vN7RyLgS*uZlxPm=3&AUjqDzqLs2!v zp_4`Cr^v0$7@K=Pz9xQOnS=8sX~VzjF-(#PBF|3GLyF0lpgN!Zw1+5^sbeb4lf{RA zZbwe5roq6|T6j>_cSfgvSj5=Rj);FyZBpTBw#u@Rx69j?%m)Xj#ah>x(5SF`LPZ)9 z;sWmX_KBhhyzF0>io|eq<7$xMpr|ACH_pnzhALXiRZp;tAQssmiuNhk?q*-vM2`?Y zVD;K-Y0zg|NT(|Lg5Il?5M)nRwlP(O3*GNVYiHV*f6;D6xgp&PJ-)VXNT6pek;=mo zG7$m^OypVv%pG+jlQ;66zucBq-20eWq}Rx z@h@CtqVDFwZ|K}SGjTQ17M0?*9>wucT&JNvKZ5XN%3M2y@-*Icm&En;(u)kF-e))G z^>C$}jxN;G_;AyIpOn)l2j0&qcsPXk=(lJN8ePWdX8?_P{-$N&KmOukd;O z_01R1M-J83@))4p7YGG?XbikR7v!H_0O>)|Q!h&xF-pJ0g8 zo-|=q4N1?|jhpR}^w}uNfS}uh4epsRq4D5II=^6_MLZdsYue9X@y2_?!LL)oN$J$V zl-Y4cAO1mQZVQ3`Mt8pgBbooBZ)rws`8fk~Pk=1wHEGG1lj48kX1>l*kpcgk$;|aA zV-nYkh(A_5=R)7^qWQ^Am!(SD5OHgOcxvl?_ky^%dLqaTGCmr|)XC|cY+q4?*`bc%9tbjmOzKclqiaP&{CPPoIG^l_r%>v?eA?8@you~ z1|t?&9Qyk+BJryF2PAm=rlT?1mvLA3>s-Zdq6a>$EB0j?;AIl*0-+Rv6s8Sk;1&~o zD(c;osp~G;=BB2MSrKSH#g#`4p8;}i`@|ci1-h29eJV_#V}$Xw)ZY84 zMMJGZE4`&d^K-8co!B>L*#&eINP;0?0rVO-YrFEM-AYK3xh>M|ocpmq2+SZGocozICAw-J8ui7Q ze5}53Q5^C5 zcq}(1s94I!n=POdGEIo$6k|2nl*p%$q;W`Db}H7v+KVoIJZnbqWYP@M&E71=6OH;} zcQMB);S8PnMu)0?TuKez3vU~{7QNLkZ3Kq6b_#B_#>=LfnRJK_aX<*je4GHWp!h8{ zhcv5|C6=G*vuW2TL~j;IA)AScL{Uf&<^x1Lb75soj`bzeq#{2eFF$MGeu1P;467l|ZdX+yY+!fkbDq z@Vm^bio-_X&7ni)vsa0g)dSfnFhE{A42g;hetcroGF)SwYTCdEC8S+VYvn#0(0ga8 z6#?#HS-Q1v9a1=pA`1O^yIta@dh`%7wY!#=Y%}@yHMnl@9!s4Cq9rR{aHbrHJjIEwLrFK1&D` zY_Xgrv=ycZU4b$)kk;RMqG*RA3v?3Fgr_VkppbQ8Hj|`t9W&|aM9WQSg~=a*Lb`DS z;Iu9?Fsa0-*tb?y z#mZgiMi@F_E5cZYz2J5c2?E_w{z%>x6-Q;BoB*E68Y7-#sA?z|^23^4(tDkYgduxafa9D76!*ciKIqcW)8v74GXcCcdcs?y}0 zN&T8q(zYndFn*+d96RenAw<`4*SKCa=CR7C!D+eyJFSbb!=sP6G!$4@pr3FsHGqBca@}!c0*_7Qu#M&c4$6=bQ)e8Lc zVTij9{14DRq^{@9WZ7KzMuUy+;M7NkJCzwxOo}MS<`6O!oB%de?)wz>$rT8EPF#Q# z`0+^Ofv=Oxg{5FjMaEh$v+kaO4CkL$XK{VRK^{unu!m}}N_<`nroc zWDfUwjxF-_a<0a56ScKxhN;aDzr!)RgSE@ zIXu}vJ$p2&G~Z=^MItkEX3;I16`Nk%JnH;1>C+Tz&HSg(L*HwxUB#qtrqI4W9drNW zO#37jE1Lb5S-DA*i+yyzt7>yu$z$JK!w#}__h8q~eO_{V_la};_QA`JtNAo(OK)i| z;JFRvUh6OU8A!iPe8|&CUo$9Y`mb`OR)2WV+&ar~?3EV@{)+s#x+WD{a zpJZG~yR~+~+SNR#o7iTPH2sJ}Tj7u;Hs&tJ%Bt09v7y#((0jw_Y=Vd>XM%qknX=KU zTY1;oUQ6Ku9P;JNv#BN+4h79vWf7D#*DAV|ICiD^wBhEhGN(vI`jP=oO(Bxze5>|q z!4WiQ-&{%glO9c=v*S=lZdj zCGGHjSn*}Nu}QczMK5`ZIB4QV2qzK3=Uh(A$&Jf(j_1A+8}+5WXx6ozD`t2a@#i5T zW|1a{wnapfg4L)B1&}l1`t^yajTn??0uz@DcwUuq@W%ZKp^ljC6jbP%I<}3=PYL@c za+jKR^#$6~T6<-kAm|)8!wr+}^$kphh6MALBA|mdc%ZRY`o@=1eAaM6rP9P5)fm(U z@U$BnAdq^?RW=``C&2u<5Gn?`jD0w01U|JBDCw}=S`3ii6|YQG*$ojJC3k(G_r#S6 zHNw$$#27-Lo@;1(YI{gw)}h<|cvTK4TLkc~{>YRwS%v&3-*Dc@) zK7!cE#wY`3`i0=n=j7V2qwLxjd?~fgMGMrLjAmr*lx1CCmoA5I&0RQ^r?G+hmU&$D zd-I&d$e%)o6I|t%OqH8{Bd*lBZ1LZ~8A~n*W_TMfz_}C1IsW3kTDJD_<$@#% z)YNY0?g7*sWT$tQw(JT?DEs9|m=OOxw8AOFs1j%g7o@1|2&4rc1qe?HF@+x~AyiHi zb1Ax4T4}~{mJ&oy2_qBQu^T6+Qj5@E*c)Yigql~sC96ls>VD&|H1R-+k~vkKgeNScP%(+O*@7ShE0ShP$uNX&yJMo_ zX*>U0qklC}Rg?^(hTshE=@O|;Qz?C6GpB+_T}-SNG3S4+bf zt{$79S~^;*VvMiCqYpu6F?%&q4#`ZH_wn1R=^3jFm+Fd~3OE9&YDUvSxE2}|)*!lI zEob2UDjsvbOq4gWt8ZThw|T~VD`{lUlv3lxxSsYVUP0q1U84@j zs<7tHdRvYj&Uyhcn~GEnS?rtF7AsHI0I+Y$C|#R+aE>Njiiu^|*aB{nO2-I_h%y+- zco`8QXwPtR_;Kg>9c6Lh2dv_~6f$r{Q6R0Gwmtre{)Vktb)Qlc+S*Yu^#Qq80yd`O z!r3D+W_h9vz|K<(%%H?lP<$EiCgiUMSfm*Ak@=^riu#nV6Ld*nynwyvM{T*X+FCdCw6NZ zD^c})s@|)J#6$|{%^Awwo8Yq2R!}5`xgwr^y71l5SEP+nAgGDHnd0MIoJ_Pai*&)0 zU}QzE^Zse3t`yJfB6??^qBN|6Ckq<@rEC-;H~E;BZtNo+{6+6dd~-zz@ujBqf3Ekp zCP(V~_eGGHlq&?>lpr&@$v8Zyu2+U@(-_$f)5K^^0eZw74D)#cyiDt}FUv?w8FnvN z=%#9mE|T4m(l9E4rpBTYpFc4E^jLwY9yfOQ6zA=!lJy@AqE(xhm7Q{l@+ zeuT`o2*ALrBD+A^T}F9OsbY0HTX%R^BFqj2{~?S2ZEezut_4pKXpy85%}@YlhCva( z8zEO}PYYQa>)ZKUUr%~}J{0+`Z=^Txzg2rRx1lR`0pUiGK$R6#fi%Wp5(o}suv`ok?aEz3(6mW>~OI6@9qc(Z#4nfMy8L0uOsUA*~5?o>+6 z-_XsIWD(0SZ;hpfzD%3)Q@O{-=t@dGkVdXV@>kzjVbbUE$QJ*w7>06UWv~|73iU4n za8-6al2UhsZ!iY|b&m-I;ovcX&YbOoRmfoy18Kx%8zcd{3&X6ioqV;y4-n|#CAjII zUzEXlo_n_oBWgm;n!TiHY#$*Ryg0{EEU1$DcXMyL#_J)K$Xu% z&J4BrL39zjCk6XXogNisqo z6)+h-84Ag_@g{{?YxRYSdX*Re8Dk$5n|vvvqfh_AaLVF^UWaS(t3}qQ3NjgI=K!7| z@2C>Qb-XmkDe`eAN^`UL&8hq?&UW~_ux4IL7)eo%TV0;5;cFJRyGk`iB~d{P31q;* z48OV|jWwW`i2ScbyU8$Q=VuJ?IXdsE9|PPPpt~Xl%irT00BxX>juY&cV(>!nM@0pp zf9cdC3B#$ff!cNcu|?9{C6J8(d$B>>bj4yv(E8?fJIb~X3=7HWsjvQ8;%ZK>6a`T*I9f}io?XD4 z-nI6#ms3rZ)x+nl-dZR!XIL@K1YYvWN6UyjVJ&z|drlBcQq-{ zBsH^p&Y$^RT3>%Qyd|A}`p9IjnH7&F9I9b-j!(4rs^CX9Ofz~X&-NTxKYwQ~k$*n& z;^}IEcL`&16hVFzgUMshgvv|9f{`K0@Z97Vt-6?LwYXJ^Z}YNMdZ4q?-?FX^w=K4$Gw+^4eYE-j zOsy^{rXT>xt6{K6x7cSIG{G++*v%r%c!>dHGRGdj&UMwY4R}+<2;s_hu$vx9FhtK~XDD zuoox5fK8J-v45K@%`o+9Xm@>nnm5*>;ZJ&F1M9uH+JCpP(wKDLd~W$Lx8l1$?@K%_ zDj$M7jW6|D^fSWoxB1XN`Kw`o9wLA2^o`&je@;HcvT{Vu*g#PF_Owy zQ}2S4cG9+p64(;baX&o9NNdD2SHo8RuvGN$-FEp4;y2)$m%fp2N57wZN5uzi#u^4B zYyl>jXhpBI^}$(*#X)GmRNfN|D;E`x0ZLk z=5Q6VduVnLV{jZG_O8T*D6ED?4a}=`>{sf2)HwtLP-cf1XD^(I186-ei}6c9l-NhR z&eYX5ShhX{$Ci|bm$Q1_`a^PHK-!}F&gSoiMSq6G=C7su)l)w ze%~j-k_HKZS^nwVS*5kz#dggHJFxb^2}M2|rwOIJ>C{iBa<)+#_hNjFn{gMpAB`ge*O)R)Ll zyi#fBDz9{GVuWWNG}LfwJ%(waq@MKdF_e9vYkaA&@GppkkpZy`w{;_M?X0w204Tca zwTn^FhJ*P1vT(KxK5(FTix$574JLnkJVhVs2r48_@J9&QHr<++zL!~DvswIh&|9Yq zAt3~jErFj6VNrAQjc^dUtntlcD!bd)WyGM+n76%UzU_Jy#dQ*jF4#6_$S8H!&6Bi? z!`wK8^>JI>9aXBEXiRKxNi4O?tw7u$0IHVxtmxSyp`r74h&ctYyiTub|xrqw9ah@AS}4Uff6&w7mI-71hvK}+F$ zPQTIhvLd2L)1Ye|Tw;GgJ3j@l)O4ZyV0xlt%ct32NTl;;GP^oL&V9a9^K;P~GuRZe zUjMDPa|hpBrfxoLIb+tiy1T!C#51hUzg6(ED?W0Ge^^H7`SQSjZ=vpEuKAmPZ;!l} z^!cqZa z69HOM zB%P*3cpQSxfOu|kZxq&J^`V3`6g|IEKh~8%QavM!pI8m>;f@BF4*xU<;y{6q3)Z&; zGt2_N^VUZpEeIpW2i|(jxpkq33W3=4{G<=Z*;U&mOc7LHv&>{x@%i*mtQL@S*2}l# z5oaMA^?cH8)TG=Uw~!-_cNH+@U@1wj!cg|q+`pXxtWxHE^#uSUEYl+Y+l8<$GJ5O@ zO`sEs%7C2)rLr2w0N~;n7R@3`4~qE`R13s{n*8@T#hYmNhVU`MYQvXJGnKhq)Rl(&SSGRcAk?x&cTHH2BVD&PuV5_9mKEvS+9ywTj; zHz$?!Z?c^0h!`BNc{4R%rd9ub4pk}&{ag{0I1c&&dQ6I1;q_w}^2XHhu@VhQ;B;-z zS>{8Tjxu9s>BQY{DU8ixFD7_A@;VNibe?DB>}C$r=JK%fR@~J{nt>NYc;YzIRGM^? z(Pkl_YH`Oo+!%bSI|JRvC2OIjl>QseHL{w=tR1006t735BPIQV_h=fR69UvFZ*!8>kmkX;XlXZPdWh_RMJY2a2nC zYysya`P`@e=`gZ;{1B{}$b-fN9B_x}7#eS>l7?a{O&^V0BItj)AsrZiY{^~8X*gje zP07ru$iYR7$;m%`7dG0d4edsJ;6n(a@&AXlcM9?(47)tL)MeYYZQHil<*I+#c9(72 zwr$(C?b@DiHWsnp%%vysq-DHumIl?bApQpbwMg2=YxR~kdr&$D za9I6p9dwcXwW7e`CT@5QOb6?EYQ655uW&Q4t7($1nCp|#6V7~2xK^{0Tk>Lg8Imjt zws2y29$ydemN0qKExjSvsadX&i%Q-+u>BP89PBesHTEgT!>>g?5jN2%+EVUj27tJB z9luu-G94s$p*b{Gbj+WyWKeJ)9n#SVTu|XXhF~20^%iqBf1M5dlH!or1QZ09(e4>H zY=d<1Hs2I$p3>J=p%}o%I8%k|j0HA`at;DYTa4avD^DD7%Nj;k+uQNaKZbPl64cCp zqVWHR!v22}1pcq)9+v-&4C((Bg`Zx*!OmFO)JdCOK}3vR#njD7_rC*3;Qa51{{QhL z|3g3mD<=!b|1-)^sQzE03@hr7+F`Va{kuZHq9;_7P5v~Y{!xYOQVq`nm%xc1PyeM( zv{K>aeLTPA2t=Ztgbs}Ji`kpg`~C6l{_qk@uZQo$9^ed#+3D`+;|@grXTtP1aPmch zd$O4(+=TWlyX6^mqeX{8joEYYbRL>!JB48z_Z!OxkM!~1M!z-w1ReduI{D-NOXtmer35o7K)3{S@I3K;%q*W zP&Of;4Y}9PSx<^v+k4D#y+Bbu48#4i12L9G0c%WY>g&|6>64B&jh*8Bq)yK^AKV)J zfIn8E*KEnu&4Dic>T9L6r&*&sPgfz87k5j}COy3M7iS2$%IXgCf=Sa7A4ReO_p!uF z)EiElNdp#58h+cAs&C_3`cD#62sh=SyfJspGI4FhJSLsJ$C!KTEhPDJdp8@ zVpt&jV)gA_4^r1P3`T*jgqvNuyACvi7{Tf{hBed_PLVC+&pFsqPpyzeA^BV1#Mwgt zkLpVCvsg5*Q86!ut$nV5d$k{^+u86pPXkRCd`aiwE0p93{nFX}u6C zV@k|1uC3NT9k0nh0$)1IhQs;_yYoSiaI>;<1qGoD%~DwV{N>hwPJ-8%Ve&7PO$M1k zK^AOMk;dfjP)}-Ow7gndN|RZ}gPMJb^+gV-qR<$;v744jLy<>-V1#HodzF4-0`1?O zH!O1Gsr7g)vkWat*~^;VHO` z6I?tRqDm}Wi5QkCUW>ZmWkgTP4m399HVPuZ*>E~wY@qn!1ByqxiLUYS?K z+Q9bLDA??GN<17Gw-VevtwQvbD`Q=@1&2-6?K!wyNd3hW!I1K~&?8vR8z&zW`YKzI z_QSvfOhKO@7^^=9NqZ!y=Qnz*Ats{NAAUcD;)4d3-(~& zeG8c5wrY`0__730F)k+WR9~m}NhxCvK2#mTU4;BPf6t6BDH*VkqOiZcS0(C;36Ivy zfDRwwSQZHufhRwvBgpy&qq_9!mA*K z3yX|9NR6>BCWPLu$k1w8HP-3S2G6fMj37`4jfL*WO31SwB1`8diW=zMONX;keAfYz zx7ypZFeC>RdoxqV$eskUzCCxlh!|)h$I)&r6EAuDJd`z#97ert=?3mS%>9VlTHVF` zoz74wD&GQPYm&IDnh8)-hu8C*M|3z3SZFXEiP6ckeKhLwjy&OzRgwb?Y*R{{Oed2_%0Ma>NCe&f2?8RK3OL}s zkPtp4l15J=5K94qvTc1FmFfK%t1WTL8^mB34bA>mYrItqHiXejQz0}W~j=B>)TL7VN=Qlmlk7@hpeM*=S zvejIxfv+}&Y>1B(SzMo?A%iv*Kr%l)c(cZ(qGW_B=e8{Thcs>F{cOj+1^OMUOhUBC z!mWNz?0m%j3fE)M#U^d*dCdy-ckl{G~!>z^7q!~-H;C&%+XI2 zt;-^#&HR!=$Oa&PV}i-Nu%D%rcBIq*$po(i@_U++-6Oq(sNyA>s&RDGV{w)Rv^&uC zzq+VTIn`3o}a(% zTdr;4?W@)68>i56eH}l$b}|>ssn8VIRJAJpzL%J5F}A!r(#tRNuXar@>8;$pKdpuS zt&m0l-tOe=S>*0NKD2H_$yKUtK2lNOR4qPs>N0&-IysMJo08VJRza&t+WCF2=C%aI zKCh!9kQh_53w-d@aF1oyle$tf`DJ?eBLp_W#lJFr(IEY0Kg}>cpP!qKW<$i3nnilP zdm(}z|F%P(G+h54*D?4@umY@g9=)MfUZjZiny{>Ch}aVG=_dndiI5WLTyrTMRA#8> z--ra5-*vi@`GSjKzpbs)ZiSZM;P3A)v4n`*of;$j`Ctl4DaVB13z4r$8<3Z>d4~=K zMbmPWA?konXQMw_K^FsrT%`)pDL%u;nM|E^m(dCs#1U)-yqT8XKq7A>vv zme!R`ss(0Ej_|M$%-(&Y9s^pq zaw$(K-@W~aZ6c@-wxqo4-Pu6p_U>L`*!n`VZRk2*0L7?b_s7^}*(p*HC(g6Hvn5Yh zvVzQvo*s3Ep|f-xxri8(0|q>JTnqi9y?d7CY zrihui^>GN!<(QOqw+#z%NEKAYc{xI7TOEo{8-UOtU&00J(1QoEmh;46X3iCH@#m)C zVna4Nrc+cf-c9`vQmv^SL!SFT`-LHh2Q6Ksq%dpZy&|zx<#?xCW(SuiJD|m_Gn_ae|)pJ3IxMR&4WadBy2&u)D3eR?` zigIubp*`fbR38;}Q&ThVeZmCXV@Y{_FQg};B^MGF`{KaVDF?R5A9v(-qFr!rFkq-s z$>djak_}m#(|G7{;UnQIAMGdtCnynMbRkC6lx&%O;+O!oYo6 zS!wvU?bBoN3YNl-lg|}lG!!(Oc`Btw{y*Ly$r2>=r0Dl58epDdYnj68KFmb|iQ@5h zM#JYA3wlTSUI?8hm~54&y#%=m(^+Op2%4Yu;CgU4usp*2_q@h4J?>lpxQ6f4!dr_j_O@HOxl0KXeE&qJxW+PWVdrVsi- z?;--e!c5sVdlgv_C%C2X1jp?oyI(rBtwxPGADnLd+S+cQ;23Qn@6wy*qbrjg{O28Pxon&yOTuns^*m`gtU>dRKk zdmwx>=nB}@3uXj2e$}6p&o1vc{JpGRjIPjgJKFYbu20Vva~hNmOwY(QsGS!lKkpdiE zQL9OpE@nVHJ&Lt23UF%BSiW*(b7OAlOS$ygpi2fcO0&7C9$}cTbIl`Q<83bt;P?56 zw8LMchOBjx^f!5LH&m1L$j-jt`BB+D?#$yAGA{_Ai+cT#^5yLtFGbhL;}v0C-IXv3C$NI;Wm z!56XtR&be}LOP`?qWZ;@j75;+i^2$GYBMX5&9%d06Y;O|z}frDrzy)*yyO=tkbQ zWR#L}W&}D%&nNw5F8Lzf2;xpNob5Rwksm|lzd?=g|B$(jic#r$@z>2bOE0ngHQUlk zdji307DwULE<4*BpNID0)11aOi;AG1F2~>GI<(g}Ar@#2kI7V+PF$#7WiTpb&77JH z@jl}0JAFgn%;iyS>mwG6zyC6<<>7a{%Mk5aw)0rdep(un7zIL$`M0R#!nS9e;sd1ec|o@r2SIL3Enb=Y zH+w6%_LpA@YBhh?($eS7@o(Glw>R zJUaf)qXYAQ9I3R#^D=mp@^W`n-JcI-p0}@{SgLbos9{Rem=LeSgBrMrrhpuIX9d1g z#3DojxcEPYR@IqDHK*)DA|w7OL9=QdsP-LNvWa*Zu?}`aL6uGf^dE`<8tMf4N>ENc zh%*l~mX)Fk5N^G`&2_RotjTSoQG=D0AXrJ$qjxR6X4RAnwJ6be6mDZ-Ybw~TUV|5k zIxmB~6d*&?;~PL^5Y|l?ilrPkuMxK6aVg5>k4pp-0kaRq)Kvnq+!fL2&Km}sGqXoEje;F6T>;!ij1wcaCxcsI{tH4R>MO)ms#&5HMGvOoA z3$*Df*OMEFLwS&bz2C&h1bp)V>aSxYw*2)Nz&h39C(}S_M1n|c1jK+)Oesc?A5z9; z(=?a^yeuB6!>8-Lw;~{R$QGBD0Xwq=ydHjBA%U;(Uw?1flbn7a_kwPn!0rwUFg+Zz z5egjr$p?FTDlXP@fTs|F2b-3NLbh~nm%gA$ zrayI4>Lzuh?$RMC?TQw~)Kecrd#6&V`tiSCEqyuPt}x$vM(@^z#XrmkZaia3nK5bF zVIAOckgJzeeS0wlIgikVEaIoa0E0j&(_#qGSz z>1q@7Q^ie!0+R#f;}8ZBFeS`)81jWYR(#CLY?h<#7KJ9L2wx&cv*dC}8IuxcL!P|FWyH5rhn8lUV~BA3 zO%Y_WHR`Nga_}fEE7T4N9udGZC#8dwXb+40g4P`Xy+tKLT8L>}{$L6@H&C`6!ZhOa z4jR8--q+bY+4F&h7LBT+Gl~LlZX#Kz#9;>+rcV@j$%@p>VFWUmtN&n+D<-vsu%k@+ z`j&R~^6NK5DF5KD?JJO3zO-(PoCdf1vgeTX5B=C!%{i4uY=4Wl?zea2+pLS#&0g~c z&9!`@vyApb)!XVKfo6&?erMqv)7*u(I4Tatx|Oam0IyYNP;v*l+Iyr6?s?|R@W~z{ zPZb1Gsfb%6mKEq?HzP#58VJ$P<`xG)0>Qx}!Qmx*=WH+=@Inl^GIKjX1PeO!@0pH| z7}3<@sn1ya`4-Vj!WUfHMMJeM;!J`*b!8ec{rlHJTS?-)uNWMS@tNqa@5uC=dt4-8^DKCZSFsF82&TfGRuFp1%w^!?1k*y zv>E9BaghI=Y>Z6*R(8&Rt1i8)sfmT*fAgw>p@XTd(?5hV!+&89DAE5ndCUKk83HDT z|DK)jUvB$X_aA;j#@pOolgHEftAh)mT_4=)^GF zT%*@nGzUL~*d}@9);Iaka`slrSiT<$_Y)ibmT%jv+stzI&ZFXzUZZ`4ehNvQCA)7+ zYTM>D7Z_T6p)i15jh5a;|Ej_S_&cwi+YzH$(KlcAbb{7qNP6Au_2w-`yeuj;eA$2{ z^Jf`-xKhH&?3sqplC|6Lo0ZFZi4r3eSnhJmzr=_=lr$`7ZrZq+&!ehl@^^j|uWYh@c6(lYE_zIXha)(>8#6DoPTghk7T)o@~fwws> zg2V>_#WlJ>2gcMwTN>uH_)F+D(KJnfUwTi@!RuF~20I2!XF@Zyir6*+5pxB`G=MC`z5#Xd;X5ifdj4`&Y|hnt z@g@}RgO}56gfbHsHy45y3=ciCQfPxB7DVr}dJ`#VPtCjALNF=ayIg$i*x2Jp!y2I(b!mM?Mdv>-3jOP}Thz2F zsV_f(8_$(MLMuA(#e|d8%q%HWddc}5wLp|umjoKWFQ2M=cfW4Ojz^)pC+SHT@-5%0 zn2XQ|G^H^~9QWZ#AiN}oAOfMmvgy!$Nu*y`o++fc=(AC~UWy!2a>^mUjw(bZ>1-R| zIbhmfh2E$$61Lg;O)5&p6IH&GSWw~KZc0@L#F2N(GWL^X<%C%pS0*R(uCa^pP`QSDbZpA*9y(W?UkOk za67h-|NR}7z8CPEB_1Kc!siWRs1(An`lJKrpLX7Srd4?pVJuo> z5#ofAY(pI-BhVR(R8~-YVg-$zshCV^!3c{%+9&{1ix454PJZx+=*Neo_y=MG!vZIQ zHpQI9--%DeYaUQLIC|(0lCR|DgGf2IaPm}m|KU~RSsXIjBFt^NSv|eC%=vVJMT+eM7ucb3!$`HYhqPq#%P~8M7m? z3mksea1Cn{H>o@zSXj6Y@!yYwoY@FovmiCS&`SSBFR68ud9jDx0m;$Kz1dqPaPXcIk-y}4 zyR5z>>`$yzD9@4Y7_mszPT=l1j$%*VheNCww5GKy|0dg)463@YF`qAvRxhPWE6|Cf z;S~Vuh1yEx!jG+RN<%Rfkogdr>(b!o*nZPrT*4Cd zIjG=@jrp;j3)1>NxnC#04#__W?AL8~{)~Nc_SY$I_|9LyP?wrBDX!Yt#6Oh84e6&y z*pCDCWwI6aMFwt|;Vk&YKShNwb4q!XETisP=kHD8;Lg~2YB=6IaRxupO?hFe*-YAj z5G4G7QuHj_%n%i;{CwqY(Zbr13@)yIg?ddi{U7uaD&-pe9!^%Phc-2ZFIO467R$q8 z!COPE!*LNXjJfo?z;Hy9(=AaM#xW7}ZegFCuHoP@5_s2F`Rk5Ke{upBu@7c_Q764dII_hFA)j5%O=cp z5Z!d|$vn=%&x}S)FKas!^$lug{MzCJ*@IZP-R?1S6S;9Eb`cg%JhP@n(d>h;+Me%z zKdab@2(YV%Svgd8cTm%)j_uL-iuy&d(E zY3j!3EUq>#Rl75)4lc%z%@<|HBVs)vAomgVx`W4%chsJSJ$xOJ0!4b+i1Rs*sV)!M zIz3OU*D$((%)|pI$9v>*C=1xh+C^0Qx}r{2jj2paOErNGB`h?1d#L)XfTZUXIzJOA zFp}T#+EeUkp0%Dv&nb9+o^>?m+WP)}?a7@$T;8=B82n(AmpWI_ zy|F_}x-=zSD~a<-6cYWZuax)(*RS71n0IYwio4r`x$11e$~ipS;RvH$y$^AI(&`dy zT6{weYCN{vIWw#t5jc`>J^g~UJM_e*w&w!}9tFPfjMHXtAPyXdiSG9d<}HVpm_MCz zfccG<5Ffn-vu!}pVef~Us4*2z%Nx&C2}qW^`&x*-Re9{=%qr|?iCf)m5h*t05;YFi z+-Q+uyMLQN=0WsfXcP?TWY;ZVaTH2*C}=K{BmmZ(H_DZ760HQ~6Ffku>q`VX7-oRv2?MKyr7+K9d9rVardMMd5uh)-l9J~xP*wB zA&4yJIN=5wz!>ZWx;tG4$QU&`xQ+raP9ZC!A|3a+dkbIyGs{pHBlClx#dX#?1=2Q! z(xjQ}{Q{x2u+~D7FNpL=lPmJu1XuoamlfQm1>R2pC_+_-=MmdqbvtDHiGuuAJ}?di7=r2Ha)&$*Kb#n=9HgZZnR@PLEev1KW@nr;50t%=LVM)whO8Q^(3 zmh#Vek!>@8dG_Rp`=uhE4p;*0Rf=k|N~O!l@|q9|+G&9i6CALN6xDq9Mu4tMB;R1n zq)y`^XP#@3QfRURUpH%xJ?KDtt7BW=ZGHMWUeuNF3c;7w9zR_PTH6Jv`iR^r#ew{)ZiFKZufdX~n8SjA;3-V-$ zBJ|h~HlI#~6*5Y5C)DV>xGt5Q7gNN*UjF5cAMIAj;zA$MM;5$ZLG*=nUb*evNcgGf z?}B%NG^FVUd#NnO!4ON7lb(A1qNBw&0(MIj`Emf_bIpkmr&NId3p8)`~;3F~HGS z1tVH1tqeAG{nf3{GayQ@WIF{!aKY%juH3JyOcor?QDIuK@5okFD>LOk-xZuGfcz16 zRLEY?7w3@*tZ#8P=JBfQM_i6QpCKt(&kMzSIzZkpQC6ZqN8a(miN*5R@_f-w){2yD zE8ma*ZFhp@wQL;}-1s{|9vh8?vYU?FpOoR9J!MB^T()f7vw@OTBS%xpJTW@(Tn1@;BLR4=ANkigWK za6pLN>C7C@pRk;>pdLjOx2YAms{Y4)7uP;2gyM0e)b!5&ToWxCL2IyHmHRLYv9@Gr zvMqpI#k}1$sJxF+lUW_ws2&TI)UQbcLROsvvtblvTGtL~nL1A#<-`mc{VN`2>wAS^ zb~zfhM7qwD?_OSqQ`r5|a*0{1(dkrnFUE{_?YRS$u7DC?6;IigUSqluBtou;QG&4|%Ya}udNL-r%-~4a)BmrZ9 zT144W7~Na6d+pVmkwPOOQ0-DUO0dyM^VISMReo$M3Gyl7j358jyInDAFJ*qlDqp5G z%|L`N&b8L3JJNOI@9AGpvhZ`FI4O5%I2MD8d}1M$oNw(Y9o9{vZ8os{eh-r$8p)OXSPo>P1KzS;$!uB zXztu9^X|V2d*wag>JQ0-hbt^XdtT@J)%zU3{$L~~68N%{Z%%RjV6oP>TfnWgc#V~o zRZX(MWpLeNA$SdvELoc4^ypv^MMCaIGG)HA`RLTaJpl_Z3BH}#5qN&aDe zM14JRHjL`+3Jp^dZvzyP#0H}JLv+*>caT(0n;CyF)`1{U|EOrZj2RANma zDBc=@X>1|{qZh8aVt^oS8ZbX1Kzl-H{iSu4j6BdVRgtw?uv$eVzG6st2wvpeRpKP> zAVr1dYpz%nGL^Fa%waQj)(5Y$ zc?551QLh|>j`Za9OLXF2Z3MVL>saB7ZqhhuDSs9ME|!jAvWH6v9`hujkvS+RhcMv| z_6)23%tOIqV?+2Pkg`vgB$0P1EPS3%Nk1Hh>QBb-f8QP-U05}+^M5_YSiNjb$=ViM zb;V764FN^v7`RID3nTqu5fkIx) z3u-?01qC<9faF)i15ImD^t?}t>G7zak@$bmJP(=>xde?gi_07&-#1h_r9Di~sLwQC zKiKtEb{3P@Ea+%^%zUG^vF$wcO%k9LBgzp=@!qP0XITv%-YrO=S7F{}@gLv=w3XX>}*46h-ZcpzKC?C}cQf`S%AgBcVW!Kb>bYG?kB=K>70jU|0TD zG)RItf%L%TY~fQ}4BDpJY5iqxrijj`y?#GRZXp<2%8-l}!_u?C+3S5MI>Jd*WHv% zdNEzj2sT^hej)zyD8o8IU1k}+&OfCshk^)jt*J?yk-^Nxkh7q4jG}v(1+*6%Iv7v( zJtWAs<6g{(983~Z23amU(4k?Cw zp}b5t`Q*e5-+KM?tBh=Oj#pk;#T6sj`Mm0hjMnGTs?PLtRIstRR{j&yKIaBMELx-kiQkrb@ymgb&QPDef*9 zABb$Gahhq2Gobj3*e0&hY|(g=KvURxDx{R=;{PwPhPMUo zyoDi3Do5rk*hC2ANq$mz`O}e1da=f&!VM&8A7Fm5qGqZ&AUe)7>ffc9a8;|V4O5M8^9Rv?+>&5!Iq;2qirbM8 zb_4cXFgc8(!noadR8@}h{>B?2#v3(dqL7EGTvgOaMR+ZLy}^{$YSSM7aE2Dja1y%HRQ?1GGP6S;LXfhlGRpF~;5yd>8+Kf~|8;5p}l7qh6nwP2Ve zHYzHA{?w~x2EkcXVhUBG}=;BpIg9R4Vj>=#Rg zGPU?Oae_3FUNrjXi6dSoz@D=ujstwwZ?Nm`ma$*isRTRU0e zMWx_Noe)@i4=r4hE{QA4oW(vMdoMAl5gay60)7HBFx6H5Ei^LdZd4acVgWfweF#8> z7DvnoIaFbu;u^+u*g@^V3Jk!9$;>jv(f72A(%a&B%lT)NkU7v){%1zXe+E%z`QHdp z{$DXl{->fCOpO0M@8tg=hSR5WQql?!Kt(rRLj zLH?evcMw8_2)L1Sb@}@}D~<1%ppat?9TN2T^x&eVhfg0LwG%=N2ixVNm`eW2P@qe-bTb*JJ6@qbi)|kN zQ|T*+?Pz@PG>H>iLOO|Od(|?TZacXwMyGaM$D2Nt@Pw~iZEB%O2bg-g^tUy9z;3P* zKQY)?m4B}v?)*0-g7R)SnJYYKGGxcr7`*inJ8L+5f2`;)Vjerna+REeik<7h7u|9? z0>n2a8Ra%NB8aX{=^P&jcW7~#*>oPAy}uP8WaR9G<@*9S!$2OpV2fWg4^a@kH-10xM8u9CtN<&Wp3kTw9hcs%zq<0e`FW9v3qQW1!g>hUp2=p<4x zAW)8Aj#4tx;nq0Op2Zsn!-Ii?0Q3$|3rodX#y&c2UD1fj4M8tSC9Dsjcm)gTAK}?SF$~BQAQdY7%&n5u3ak_H;GnlrSB}p8%Jw>yav2Ab{ZbZ z+>mX2vj-`IMK*j}qs$TWg2*svLiX{V>wsJzR~o%cT({)0^ux7MO*zdlPB@NJ6w5r1 zXp)+$Y(9A8sk?X4(Uw)!`!pZ_<~B3>Pu6V`7|`q3SRVar=G$d0l^m#FxDEXuD1knB?e7 zcopc?$Cq$@qfEXoH){-8JLaU1oaL96dY0_LJg7j;?~XaT<_^2d$4hw*{@v>0}E{ z0|H+rmCCWB9Xn(6d9E6bwIY#=aKfyg$U`^KfEuNbdq2L|vy*W-7yjd)}GuX)zw{ZHMc@8|{W*P?@ z`e#=$iLkF}7&!988*A&d?k@f$q;ncl3YN%G5nsG_pG$-e+AdhT?>m&4aiv}VqBeiK z!=LN^G`5DLQ-1!b(v-khXMlmDNgB%+{MUB_ruE%2_`D8YUpC~3XPhjRQZXbb>aMEb zv!cT_;`sPAA$8qC_>+Kv{6X+U73cdKlls6G*{Nzgx&U-d=bWy^bxN6y`cPzK?jGuvyMfVo{y$(Tu+dBPN2(cxE%UHH}(W z)QcM;d0>+QJ#pdu7k`WHKCy@Ac(F&V12Lk-rC7Zc9Yu)(DeyrDlCI}&&UvwhcbdPi z<_Sgoj!_)49WTav={^(LI>Gk?rky|c(}*!ix}yVZ3eweQ_)jFmcv`_Gsj)qruDd0! zizrS9AJEaoS~^#_T8Jy!L}FP?OCc{dIGtjdY|u=M9<5Z?UL|wHZU^(uWOBTy!(RQe z!qzFLib%W4y+07_U-7R`i$uv^>=KKzzx~iB;JfZ-4r@n@QT%4MM%D(KC zu}4Z0Mi1j6?Edr)i5k1SBJNuWc6t#q9%k_SJ>nSRVYsjoJRbb37jo9jGX(E0c7)xG zyp*=QJ2MDdZZ{kUa03J=JF-nGOp9wT_DS+hDqAZ0RDG{_7vqFS4qN}P+a&OCZhl3w z(=4esDyhyXrzQa}6JTy)%G!tBNLw2UKiQgK8kgz0n^?9)^V!gR3JE8G z+Dt7v&g*I0(jZ6~Hq4Ol7!S8#(dJX*Ne|25y&Pn#=Mr@aAQlTH*Dai#)D~%{u@aJk zKFH7z62#Gql`rmAk*R6|6GVzSw$$Qd*428HLhacLV(>NRGDrDff~hJ6y0`~By1{Wh zIGjG%HPkDUUUKH&p&h#WamHdQP6sI{n_2Q3CI?MZMDSA+qVkPHqLh>e&lk#zG+Qa+ zYITqs)xtd@LH_1z^ay9PxBG!Z?w#c3*>bmL{XVA*m;vEY2B7-3sCuqabfF>}x0IF0CI8xj>pP!I7#DhFYwvHV+S zB8+$bp zyu!1aF|iVe(cMRU)~Po^1F{8dJpc9(lHEMH+>`XxUC%hRwJ`4A3%1a#`UG4&ErH?u z-~URs@CL$J{@5A{p z!=RX_`KIaD_T5PJIIS!g#N}6m)MrmT6XPj8=@uaVa#9-m1WU*7%mBYsRPJ3?N$Sz_ zM!IBQ<(NB>H5rO~NZIqDWoOX!jwHRW%I*jW)_IR;?KPn`MPS@oX%RA`fdmio!i5r| z!=MCW7rqi?xHVCx0M{%-3oZf9%CXK3k!y%O5mNt%gEg&KGI`qD*aLWJVKQBDyUS7y zByeHbFs)da>&@6b2#5ZZUVTr{1CJZ2V*#;=k`U1$H7xU!*pbk82$&C#FoDo&3za$8 z**dRr=>e~mhMSB;I8|zN=aVNkaEfPPKh$Pq+I2O}Cmn9iw{909@H7{tlTlRlVlGQ8 z6$j)>?djCBe~=}q+^G6SM4Phay$HnuywMC=Z>;>H7kSq#oUx0X#w_hLp+Z{FSy$!d z=wu(`w{or3x8+a-{B?AZc)6fEc1s`;y+FTyoc%8!m=ckA3}BZF_*EbCYbKY!fCSTiR1zVT{=p8RR$;4 z-8d)dnh6&M5fC-?rnNa|<N-C`B}G5DUiGvC?qQ{8;o)ogOW3G`9HbwfPXpF=h?N#Hr>WCo3fxx=*UktVN1O`e@uJYcb_D z-6NLQUmgc|{6X9FQa?y{RNf)h8s4_Hb0=>s@a{4?9j@b%Q$4(c7egEf-@%Upt*n11 zwWn%&iW(A^J{ds@cFj#bEQI=+*Kb@z9A3c2NP{(1ZJ^@|yt8E*EL?{3h*JZ=LVk64 zEd)m)W!P3sSx#Wfj+Pt%5%8r3z5YvP^IOQzOWM}&-3Hwum>ch_>}jc5G@t_HHq<(r zr#Zw)9?>{x&lu%KnCnf#|5||v5*l6+!_=uZbT@$j^=yQ~w(RDt&Ys*(>|amPw%m=F z(;1jR(8fAIj#zcePq-FW^>)8?hUeg%()ccZMLvrqqEt1_2aSKlPU?|pmF;5*Xs(=C^q~05>}oSVy+Q^IRbesR%mpOv1!5mHH^HL;A%RRX zPE3a6_e*p?@qPPJy0H#+S3&8?Vs`$5_vyo;BqFXmWi~C9iehdf$Jzs!_%%v~n!~a8 zHyzouV##dNgT?PXnaOSq#c4oLNEI116i9s~RkLVlBW(f^KYVmd_J(2Kb9n}TP`;EFe-V(IR28U8y^E*2m}=F@0%38#0x*9 z@x>ufS)Sx5B+7NC=zN4g?sqlt4c(wk!X|~IOL_Z#K1J;-Xah8ms`VwXG^h$huJ_97 z^H*4Fx|~T_byIbz(r@uwk9Hk5>%gzc8xr*q{Daflmszm2Hf)wIpI3w~zN==}C-aif z=JTHDBd1oFIXR-sam;FhrkdC7(tk*;>RV7b0HV`HZtbKsg3CXk6dEG5t}IEOLi(Xf ztZf%{#+~x$`=MK!PTZhf;e0(_aMYRCv5)ca0@ zR0-R9x`Os@*n_?E9H{pG)W*tOwX?}Cc;T0HYTn!ESHZW1q=tO8ZIc))=roVzd@B73 zr=gCEG`}VfEvTt}X*`~0QQ}33$NR8@640AJ=5MTAM4B_(*Gd-Nbey~<7>uP2tLzsv zw;yGq>>MAuRdBh9=t>LIrsYKV0GB_(=8Qtnibvl>jJS`kS(z^BanmZmD1V3~v-7^%9Bo9O9=8fWm$DXKoF*3V$oG4;OOt3%2wjkS(It zhETj!(Ux);gN-ufk{@#0gSI`S+0LZ+Z+;USjeQ+uINU2J>@`G$M3Y`$i#yZ*GxhfO zcQ71-{HxK1X5gcSy+cPtv&s9p-MPS0Naf%XMcd_NTjFR=cv4@vy6n+?)Q*%ZO>?Jv z-Z87pGH~TK#^0RVd@*c)wV>}rr;Tq=`O_X8$O~ZqND@aopEx@-MnJ>moEVSvy);0o z=^088^G#2TNGH&NUZCmQO;Vi_7yle^Wn?9s>cKz z0$=b$(vHmNzMU96xq<}(#5_Om`uV-SfG&Ul&mB6*OhwbX<$RPG6|3B54#7Tc(Uac! zCppW)cK^@FLOY$Xi9gR9q?n>D#;GWblTP|8Pt^ufAvA7)rGCi-BRPk3Pz)R(nRJP1 z37sgawN&V5EKW}ovG-Ly3h7=H{ixd?7kO%h74v<;_a5m8R03E9O8AuLzdl8SMD=Pm z^Vg&7yvKo#vdUrbhzDlVH;NiawkIO#5p_h&j>J1bQchwphvL`#&-9pV0cHom8He!} zj>KPUCRt&WK%$|BpQy8#GuOm8sPp1 z*F*SmB1z(6bBzjc(DW!J7;I*(nd9B%b%5!vN@ZvW4VNV;R+1gz zt4igtn39hAu8Oeq&SM%|98i*?v`2+YbH%1xRj*~caO^<+xra)507H_G_EA#^J55dq z>cP-*QaBV?sjBTGtORL3=JlzkS=gT=l39sB89fGLX}Aevc6 z04|~pcItf!G&;`{2JRm4^|RffLRR-Nw%aExk|o$eq~!%pUS74>1{L}=oT5xf6h`Eq z@~5o-i+<{CyfTu()PA^Gx-ff zWgKVU#H2JUI;*cq#UbUVHg(?pQ%NjPnP6KTX7raV7%B7pxSSU}VD2Y5Ei-P`Lb2w$ zw5S#!QfZYw_RuuQ7YsBBj=4pGfRD01IpUJO1q~oz(-#L!TZEm87~62v4ugT}9)jSw z(u*JUu&emsrrHi?d%ZvRdw=;s%4eDv|0%ToPu^qZ|3>fe|01;hKlC0mGX7Ty_5YUl zn1zk`e`@!u+ip&v_`KAnrT#I{XE?M=42Xm>YM0VrXEDH{fq(Hw98K^fQi!hlozvY+ zWf`L?I0W#96PnIs9dYfx9Y0+SM_S%3%F)&Aba_%S-aX9L?)D&{(b?EC#Yb+2Mp92R ze$}Bmdc9MooHeZYK3RM$iO(OZYoz{GLhkIJEg4hIDNOKoNPfD$CPhr1O-wX%R@}{T zJ0sV*+rLs-wUJ?Z+CtErwO^?&(-$=I2D@eOOx?eJ?e)jZcbw@b#vRCwvl2EsWh%XK z<;abLNY(C!T8mN}yy>duBqo*`g?6cRbPf!i5=I)QAh}OaS1CIAW{ZVB#wlw*9 z4Q~uDw$6T_Tkwg!^LGTD8IIfqy|hrPt`l$=5WZx2O6Ngsbkfyq000&%P>TrP&t#y1!THMmC!DLl?FL?`4V@UbCGn5KZ{c=lj-*N zecfT#_XQGIjSQvHsRl#J?tog#$|UwEttiX+s=8LpoL3=Cd$EYVp%pMd{?&o#)@Zpf z66bM`v1kdvD$@=ow_cRQ#Y-d+0c-?OkOyFt5_d0H)iJqm z+6q0wri=L^s>e|E+nL|U9HCyNtPRa&>8irXTLjrUy+~PWC4Kk+b3WIo(bnKSJ*v}S zG_?iN=P|z)t=+nWgC9yX!&tOK0~S54((++W-r(lNAKZ2#N}Wk{AJQjCLi@ zH&21POKqe-^?S!0zZR4_#GMn1)mkc_u~?t>HqsKIx;G6$S6j$vAy~Qfz+UT=5zMSq zcr6MtE}D4CiKWm|FenwvrASApzVtAzy6d}`bFXjDKpnp!6=WEWlr!|T;rUEE{&HQM zNciaHNWW}+I+R?KZ{Z4rA`8rM<9j2E@3$L@Uw8fUPk716NM1V(FL_Z3Dx-sVa?nas zkrq^^)1eNO*8{2{-$QH@VvSxkORjHYL0S|pEbjwtZ>6(ZJVh(H8@h2Z!s@>pSD67g zUXWhKCe`b~=VGigY^8eFyHYCB?1S7ibiA3yw3f@P?p_7X=3=%t)TRGRsLEDRE2o?JiQdZrtyYijH@>e`b@b?6efXgPAsYsTOwZ_WGG&7F8Wl}on|HS zp$F*CGoXR*`m}Wyj#Xd0!MJ_hw$+Uoo!VZMR;UfDIUqRbq|*YMPC?S(D>Vg5gR_A&g6yoyhqt6=fN)<5axV=JnIhPMQ&T zesHCnq+{D@q7%RmZ!o9lx=bvZ>VUGQt#C6g1UM`-h2(b(Ea8vrp6750rYPLj0Mbnp zV;=z38m(@-$3lo2ODJxBtyXq54((qL-amGBkq7BG)>E&b^7l`-W5Fj5j=POGd5~WC zUn&qS-A7i1PFN4KvfLKv*39cMNjxTSu;Ob`fPZ#X+>|O=p5#TjnzY5bf(MKK?^wL_ z$VzyrdPL+-AeN!oUq+lO+RGg&`62W6p^xz4_yDk%z|IugpXAO4yAD5vEUWd%m>SzH z^L7MZA}}8+svf68YBg<_u-pNTbtNedSAjs_t*#S%i^)^XIp+$;0NCHF^pF(k=&La< zP4Yj6|JEq#OF^zUPgUf0-XR{wl5)mYx|0@0(+U-_pP1w3jsGMIJ>t=~ht|$N0oPy! z$GED)&pTrcYj1UgAaT=Z;6lZx9PgE)eD)cNR-qR#Bn#XWit&biMC)t6Xd2o#Fgct< zzxg_WItR^yC8X`}+9cni!*z5HTVu_(?AK-lVR(y46DvZ(5Oe>gPO*US;FX%Z<3Fs}MEz8_Gi^PHPx-zz4P` zU87C#zigi8vwwz^{hTJy5R48{!_>4OMNyQ*TTNGMBYWnT-xT0|EFL$O#eS@kl{;fq z5`L=WWTZ25^ofZ?Sm0ajiJ}=@bFF;s?4{$C^`yBS;dunQiMs%JSM$2fzbY$S_R+NP z=A2Y`V4C&x$a8hT>Plr=?@_X@359iLB8n@8cGslfia3c&&9w&_7=RiwekFtGygYqR z#MX51$LM~?qqTb0m_2_@ZQllk&fJ2zIbqj1cQSaxYoN`7%za6xrtkU_lR1* z$^QI>k3AZP1*E7ECoLzNnnO*6o?jR=@0iIS=zfKCLj&Zgcp)M5T=3G)vr&eBs!2DoJA7(XgmH#eV0BO?O8yDyG?#H1|fIeMtXTh z_2TK);`MArwhldO5)JLva@7;p^t)L(8Y6Oi*J*^c)tGnSt7R~by3UVSU?yZck-tt(CG1y#Z~2Y&FU-$M$B>LqRhAa^C!JD z+R#nxR#LB9ZNSCK3@vXe@xIi{h9cFjA+So-Z~H|n4l7+hrfLGZ)&yDGk-0 zZ;)I2uC2HTZeIp*$LRp8k27cqhvvqdz(Ewe|Kyrd6#;b*Ss@r}w9bn@{{U7Z{1Xe0 zu2J!1)5H7mk(>g8E86NBc1KcdyjZ$Xi;!ejN*zmOW}$*oj9D8&MwKXoRbbG5d~2n7 za90e+C#E330VgbpiJ`fP%EiK+`VljPMRz|gqU8mm#RZdC9xv=An#dZ${byIqrao;S zA=B&SoaoYHV^av<5?;=`al*n?{zUj?TTOkK1!g!H#UZDSRVGmQK+URfC_)o38%eqp zdLeODOhq-{iI*VDaQ*UjW)me56Uy{hL5#60E18+eW|zS;Hw$szF09n$!kL%Xs_T*y z@Jx!WBWqwgc!0<8f<0H!x2IJepLRu2VTZ&}X~)k*c(lbO>Ja9{f9JBbpBD8qW_ZjL zZiOFvuBGD(Xn2OvLjyjlmY;iUjP0IaWk`7=X_`Y~i<>OGy3?`lfNCF34bPd~;7A-S zae$}LDAGxN91o$vS4c@(J7g$fLH-|eb^%>yBo@fZ6&SG(S?Cf4Ji=Hg?uouIlgLx4 zkxmA8Tk$2$1;V@V$;&pyW5bwA;jiBW@LHP>!%`sEZ%nN|nt~V7h_ZS}K(R!DHZcDW zD0fc7Mj76NVxMG+y-U?&646n3B!Ty!^j}P{=jf3}5~#EI;T~hXJz)hR{YaJgYFRDy zEGsC}BA+(d%MZ5WDUcs$Wu`=9uG@R-i(euS#RP6NCR-UdY{+}d*a8-v~#G5(*zE{&GWvFKA?UH@V?(Zk0`I#UrT*(z*J`A2co=Ms_@iCl(GcWOnX zlMA4{3R=ihQnAK@rD#w{<<{%&W^08+ytKE|AruG^6eyA3IyW?TBPPH~7quTdjvauU z+h2#i4fNY??yzA3ar>8S(jbLmbd2k!`@=~AW{PT#5YlRF>n+1MxU1m-8ith|Im!CyTY5wQ7G3a2%>ixQ;i z0xviQ+yifSs?wucD`Baa7) z3srEZy$4D*D`1C^3V_Aj#vBJRyJ@f=Y1($z_N{iY=(qa(lK3*#P=VQ}L(h{l0q9a^ z0ve$d+PePYJmu=K48hC#e1g&f;b7}L6y*j2f$e9p3rzUHwN)me)Fon%N_-gJeTVf* zc18^tgwmpsxVd1sVpd{g;a~Og;3yXBa3zN^L9mIQ#e{I61IyK8c4MRp)&K6x35ZBP z1HgArjG(61K+LW=PeL7#h*C!_@ zpsgK=Uj_7Kj1rjtJvA_0`JF~(=W9|iYj~@tG2nC^f-uaSK|& zKdaKDXy?@syh~8%EAkJ0VXn1n9Gv>*>M=qdcvHaD>YpRGo$~hX$4$ZUW1=AXSFU7% z%tTqssCAqk7}vRPO$R!fkeLroh9nV!R)+fae9?0^T5z57i1z%5l;d+}(M zT1OACW$V4HB{87pOhs5ymiAw`b2YU-u1<@5AS?jL1vceWG0^0{rq%f<*0&AB32#C} zcX8O^AFdHVtHZdH_2r)6sZamGkdsqSC@Z#v)#h>}_i6hTCn_$B)CcwF55)Q9NYVmav|W#J%K;ye)xwOA&#C%=2Hu2t$< zF=;usZMG@lW9!bl1!g$4&9YA4+D(bb+272U&pVf~lDfQTRlH1HYrfrg<;RIW9f+)l=oI8-et3lg$AqgsVmo9?1$mA+NP~~HjJuMpE14-|HLFVK zGQ7m>@!QE|M@m(O!O4vV@qM|d1B!XcU$=yOg-eKMIs#>6b8#XX)_4E zUocs(?0(3Kt#*Qv@EB~g{Q00$c|ew0+RN zN9{f|w`!?gS13iug`%2*9a(!Fd5c{~jh*44Gf$LFk1Kb`hA7Rid?$D)Cqf@XSU}8= zGqbagt)Gw+2wZ4t#wCwoM~Z3HNnzK1H+m^=3F~yp3xR0nW`lrK2f>46dITbl2OP|f zyfR2)Qe-ZhC`t{S2$p|H-&q4iCyQ$29Hv+);NUb9RoE0PPpo1Y3&N3q?#XGvfSgIZ z!;h%V0@cOXu=<^LA~BUJblMSwN}Oh#YrSw%U3Rq#^R26;aEf6e_NK6X^(dYV($d2t z?TWl`ZJ7>)m@@lMC~+@S)FL-^x1-qs5?AXV~f z^;d8EZh|p(No0}>imKvamdz|*M2>$g#2g`LDUH4{hks9TzG*>c>e~a3=yP7U5nax3 zIQ?3i_PcN?ePzhCEThAa>0dq$H8WG!K+}Zm7VrA-% zQ8tBdkqH9R4*F|g5it@34*R)4N86;IH74O>vGtedT^4pGPo_R?62$kYx!AuE z_L?B6K0^URouO5!aV%YIg0?R3DO0Z* zkrO~V4ZGC@>;kU{$hrS~PRzYvQG{i@5#-|WHB8btu^}r`JlSLur-%_-7cAmm&GiQR zp`bjyo7DR)A5kyB)Ti=kNc(&qS<6%i;Oo45aS5z=f!EC$vmH!gw+z4XG+{&SDjjrX zhm5cpT39t%0E6ihImBUStkkcHQwF&W1TO=V9-^vQPFeV$Eco}FDmHzWFWn~N=;}!V z6~Bq=K(e@{^XZp1j`Bdc>{uA8P|5qj(Fit$yS|Sk zBiywa3Lsns)opi95h{Bo@>`dw|L*qB(f@$>*O6=J|ECcCKWTcI{~I;E|IHyh(|;Ah z|8Ht~S^s}E@g&trhfQ(Bt_!O7288`6h=0SYL4yb>hqoSs5qDAUSXY3A1Or@z0Gc7) z8@0PWO2*D?;_18yLxr6klvGR?4&E+z0^MHj_Kr{28pY?!m6I1#&Mx&jzhnQ4k4E#1 zBJ-LREMwZo>KlvXs$+|c^VX|nLe)rWnd4%Oo7r#9ANKJ?h3uEaGwSs62agAH#_0s< z>|MDM$A_U$x~b@B51#bn@ri9l*XKlYbKZCB`q<;Y37M8ff94x6U!)^R6u!HOOQt7DWe!|Mma zcJ-o@$!{o}x=PmPVo~p-LYMO|P48~T8|{v;mG_?k?C02VC;c6FF|2NvSzi{wv^7@b z@jkNG0O5_iyU+fwT4XV1@ymCV>=Ur};>OR}Y~u^wIHr~gL6g^cFtlY$Rc#bp4Zc$s zuVCAk2I)>^9Nk?g+)LYOJW5SxZyq|83GPf9Ef_rOtU(*q&dOIc?Tc$FAHQy;(N@gP zHd!SOL$jqU@%MMGIkSh;h*CPtol@l|)b{Ntz=8QObGY1wE3Ub2?&I;T|`iV#*!|*6C5Zn(CS$jg8Z@2Ba z*b1)8w;4+~gorr4zo$clV0a!a&a~hw0W`hw@p}>6dy%s{kUtevsP^PoNvFUy@SkUq zon)@0yohh8tcahy_@xh-$?^f&Ee%*6KPfYJ&^V|uv;zfO-<;WStZD<2tOBX}sJlnj(#Q_60;8BYY%y zB@>O~=Nk=|(n&=C*&Kw&;~g6QNS~EW0N%WxvUDN^-R%i)UVVVKu;h_jfDgIcmJnDY z$LzGDvT|e)o-{_ug|>W_Q*TlqeUpP9UuvZ9<{+WYfiJ3^uH46K77huIOhT*4`a0<^ ziU2UQP+U*u@ru%0oY_#fh8FU(KWeu+u3=-qm@FGiRfq#WLxY#H6(rDf%M*n_7sGmb zkWDD&$V}x29Qs7UPXI+lasN^9F(reIs5lPN6Yhg7<*Xqs#D0pu3!_1JB}?ER_U*hgfatG!68jp^WI-`;$BRe2X0=VK|P^( z5^vHA0&o-1=r*T2A{1`?;DJPGXHWQENn@D@UoL+EEHLKaRqo$V-gN=6ihQA9%)5_M ziH=qGnyD)2QG8S75U-x;{xLCjh|R2F%qGcJepuKkd~)!WJOO=ul^bu!BP}N}k-ssd zjEn@gNRBO8)2?`}S9Sj5D8lfA4EyRKC=}f*3JMIxCz_I1A5{p0dZ?(1=~rai!iw&C ztONSAI*yru^UK{n*Q{}DkW+HiJ(7n6wIhC>5A@%;dIwgVhWga&ayWF2C~=6GRQR zR?051PT0MUE8Y{`ch}CDCxLblpLe0y`(^#IW8h-?_)`f{E~Bj)fO%SIWg&xH?Vd2I z@${h;szwate{17z@+tB@JqN{pC4dv*!^2h0%WNIv#%phnnBc*N)$u(;BZ?!~Mu_2} zTiY&Suww}tfOwkDnI|APqf8(HgOH3$7phXEr(EX@f1nTcG#)LvVy1z*-aZbg(n%Z% zGR3ql`7eA2{lm1l!PVJYFg<=jaW@#{JVDTSt z(1sP^rf&n;jFxXItsjil^+$>%oQ#_0yMOr@*rca;rpNcfJ z+_aNAS4ClRD_05@WRo>ojr*@6Ko`83E-hNC{mH7_0fjR_lsA)!NdK{wPmhi9@XeJ* zJHF9;_huvTz3D<4Ti3v_jPDn&c=*c5cIANPodwK(p$=S2%O2ZS`BYs({DUut6_|6} zD~C+QjqFqfh1C@0R(8;^gU&EE%fuM(~Z{tcbOVg|AtwbAbTcQ1MUycTjFWeQVB33t_S}l zd(|f+&_cMQwt@NuLFE+jB19Hy&Ar@Ny}-!NPh^)6Q|+C~&=9C~+TB-!_;_QPL=kSS zD*>i_oM&rOv$Q@8_H=(VJiXj$nf%K#qOG0oe&ST--1`t}PdgWB;-NfNH%mDm?SE}a zSI&$I0a*R)U8jGnNY`AR^l8XA@{#Tji4j>O*2RCjArgnDCsj8w@cWlAbX%zY9y{K| z{LdZo0UiFNE_sRv)L}V*Rd56u18O4cjG3B$Rg(nP4+EMmJkhBjb7+>wVY?bs@t)QSgDSfqY>C+2;&BX2h{lEb*ihLQ@C><^mXwX3z$1HM2z6hzz>*VRMY4FL%Cyh__Gj^@Fl1H*2nF z1|umUXV1+5)M}Oz*s%IF`)5wiza~UXBFjUJZUj0*R(iQEI5!a9${f1_Qh*C7SOW{Z zXiymLQGf+&*l0eUeJ*ES%^$)Nh(!b{46pz&?%buJBz@~EEf9woEg86HoN^_an9xWl zz(BGgbAh3WT7g3qSstI7OxA1x4{*+&zufni2=oR<$@lYP1@KZ}!!ZOgMgRI!?j_ri zLK)EHjBy6H0WvUL6**WlA0H0Sy3}t0hb)@O=n@*Th_DJN46rV&)kz=JQPJ%%Ob1IS zh(>cgX|_Pz*)B0*bP&qcdg%eocqGyAg=z`VXyCLs;Isf6m1w454QkWAhVAQ!%!+fw zO#ZT6=l^Ad@Nv4tdwthh(`5ms%ZHt9MAaGzA{MLnfL;LTIs2XB^I=Vwu}gM}B;|$z z)VbGXWLbA*xB;yOS8=SWIPTNBVYZ^&-2pN_RUJdn*a%c3G*FHKnTM>>jfxFI@UH-=QClQV?DfQ?ik#IxWaQ5xeHxlPtiEi+_Bc(9>(d#g?&kGK>c`vp)m z^&x9`b`y8og4UwpV{`W5)>Lc&V~#pw6-Z8A9^}KUp0mzEnM4pM$=uUZSw?z89c(n# zcz)TB2NtOoA?T86fjAR&@i(zIRDwGeP00*r1M#}u)^EC3?Kh<CrYpeFD_h0A3mr|gYa#ZnagU~9x%2+P2s^)t%i|!QMFCARh{H_`$(Hom)Z(_y zl$vFQ;twwSp7mH}X^+P0fB8UhYeLLK@gpW?%keF%EXkdSO`%m`!?!5W!`pEO)>xHgXr`Oxi;$aZ3cIVY} zbyeyh!47Rm{=n6(-K4nwJQR@5%h3vV3_8>YA z*r9PM!hVpty)sE*mc}w>f*CJNIaw9rFbpM+@VHVUaDmV;L6s3xqoQwwy9|)miv%=c zc5COjaHQD*fAJrg>Km9_fJ6swf7`zsJrmU!q|II4LQUV#5()q#&G- zV-4Zcw!>ls(t+Q1gG{0k;q=3XB;_NYWi|NFuKn4Bn1aC^BuIjBfnL?m)my2HQWyf4c zzP!~3T*-?t7>}9@&m_nzb&#}bl-Nt`3|Q=1T-1V-fVf62pB8TEC@+@C)IbDS%S9Z+ zT!01?uPKo%-?I3bk}5XQp-hgGB=D!p2&p^8 zUuR7k;q!F9fc@Fr{G2PG$y7rZrMzAD^q6aL?jTe#tqgafmawuuT@7vzDu=r2)0leq zrFwVGregkuPAa(QbhCZKWmc0sEzKK9$-OOtg^ty=mGY=Pe1WoT#=XPsI(cN-JZ7b^ z2L=1$;j*`c#=A(zCT|Ywo}G2AI6dBc^7K%zM8&c*jPR{Ea*L$+z`;iD-UG_NYixlr z-RHO-ANZEyymDgGlYu%Ie&c=|;(lof7MTph4!bCmJi2KmeRr6TX_59M8+~F~oAdI1 z)PWnE&q8Yo_dnS5arYiVKYC_f4KMv@8PT_xsD^AGcIt93cf2GlO;V@J zQt0(en>v1}vA#LN6^AswGv-i;&NU&3l;Z_6@I1nH0zcgmsx%JXBKD-47xe3 z{FwpRW$4wGw{D5mwqfEMbjq_ErH(Y&e8o^{CBgY-O^1P#P8Aa5l{RS=h7w%gdYWRO z+ZIZVPz@sZWtaHr8m4IbC%(lotcS*Sfn&^l`zq}xIqxM`n58BYKaqh($-v`zW~d1O zPrD~*z!4LwV>|!l(xtZ&3Z&bz{>(CDI=Yhg%?;yQhZh`iZ@FDpVI5b6jn_K)k{jd+ zP2|jxzTMBc=UvpjzX5+bjV1`!3#SM#i2*k%7<%u%tAWf1?V{w6rzmNG^ME-PMtQ?8 zjTnBPM)h8<0ij}(_k9UG(H5XVwzRvfL`f0ElnOXNc0vV5dlNd-oHQ~es@tPL zcmpS~V^>V%*2U7jJ>hAY!v$)s5YEy4wZULmnepjO;H{hep3j+-V79E4p@ zg}q^o#&fM%Xf|bv;as|Kewm8ES|67B4tk`k-wa8v?D*{KUH2_!O=#90r_Gy<&wIv; zi8*7zM*PVQw@_EQaIPtXLvQC?LB|p+;{1y_f$!xnc#n($BCU&LPaD z7u}j-14nZtK1fT8$ej7x9(h*Ikl=wMr- zv(Y&&i+Y*j8h@k8=qZr>nZUfDIf;;Z6!Wd;tS>KLD?1(nO-Kok=@7@4pJ#{$)YO%@ zlP2+`o&*KhI5BLT)W(6#D3;;My_grauAM;B|PECdY#(@X9qbL(R!Fuo+jyrQQ?6}=l%1vCRSoGCUz~1ydtJV z&cKS)5?f_%V(8UEziphX2D~{6El8Fg#VIK1wR3JR-leC~~ce)tDr=IPtoD_r}hJv3)C1JX;VM0jk+x30D`;Hvv2VJPK{4^L56qBNXNtcO<9&a4-X5O(VwFcUxO|9ghjsj*cGp z$w~EB`emF`g~!wVcQ%)g$Jg1V;`n?xGI3G$e17rCqeh{*$A>wS?7_WcMKuDir%bt_ zV#%sTb+c5Y1oe!&9I|;X?zXLE=WGmx?MMmEf>Eb?Ik+HgNznO1l~70Z0qnMjR%XUhdOUJ!kwgs)l;8Wt z&$n)gh(R-&g8bsuC4UfU&$~)d9^fkS&76S@L`kYm1*RYtj{s(V)CMwh_MwR9a#vUM zZUA5a-yN9EDF#eS@sURcQi7buzc2=b-@dsV0kt+s96&aJ$^#g8=;+RF53mXnHy$q5 z)2?%%0LYCN1YoO?1(tn!o_1=Xk0n#Ys(L)-^7&fR8U^s+1K`?Q9@c&k zwxJ-AbA-atyev?s8|W;j75SE&n#V55s~VQWv;V!;~4O!e8-;B=x-NbJCkLpZm?uOPxqQVdwM{@49*H&3Edfvb17 z0FdSEW`#9VN;4ZZvF}<(g%3#e!CD6|=a?4ru%^up9fDtTI7k@ZLQ7LZSxXSO|M7ao zimMq~ZR;4SvkGtumc=~-rUS@0;S1af2;HSWLQme65!HM07^&x9 z8l<%RdsTI%cdm&S^+f;rZ7=g8N?aY)^hvNYl}*DF{EO}xDiXFGD_vlA7W22+Iz|g3(l~DDJaoARRirP?7tBi8G89<_=rL3jFSt`S3@k}$ zH*g~d)@^BWI0HLmoj^YW^4?0r$EQr@e|`c8gWHy5x7p;XZ*i?mhY*fN0#A`hMg;_a zO^QEs_X65`<1CXmfSa0(!ZpVag*!MvI;aWH5ce1wBwFHc9un5}sl?!xSm_iBIk$6aAnfo@wjd&9+BOg< z^0w-b9_2s8PK{EELnPk%OLF7US&Nc(mN4Kj*v>b^3SA)HVs|iaq!>~c)L?Dce%uig zTIzZmc06Epg~_ZTqgG}s2*^%K1304g^T^GLW8ESDcD4tCv#0E$kKBP(r-EwL)*WE4 z?RKys07A3fp?`H4#va;D_YV~G&|muM!p-5%6oWTWQk(D?Huqzn35#edHTSsr$9{zY+W1+z=eJ_&h!XLf9boz!i=IFaTreYFKom(a`qSeb|%%?8Fuo z8L&{#bKGl4&5-gZlu%Q0<3P?oz@^0{iF_mfe8q^zwo5>Sw?Q>CTdd-dj}$~TEH4Kq zLS2xQV;YamC@ny*Ma>1tYL;{spK9lE;Q;40y z6aHhgVr>mkZsYWe>Z$xAo;vm{cfUW!>AXZ$La1PIY%%hSH=XI6^V=Z2Fs$tPR!@Dq ziTc5Pfgr_ajH>bCw@n+oF3|8JeWy3Zf@Wln7=&(7-uK;jchnkOl79-$Mg3aDix*_E zoy;ORp9_r;4iD@(qf9~(aV{2- z@J3A7daq3Sa9}4`XwQa4{LcGV6OZF2 zA}!yoc>Mh}e>&9VDQ!cKm5A75R^*Fy)P^D$^fy19X?FCo--hl(s-vDRS_5jd$>|&; ze}ef*5~Lv(Y@#OGx?~2Vj-U4-_2GZK;h>&A-xeQKO-m`2>2$KPGF&g7w0@dey z#s@B$4x*hV(XBQ*yAh4qjb5Tv3q#VPRG z4mx?SG1&`eoMGx&J6 zGkbR+5<`*{ICo36`vXKP?7nY+R#Cb4aI@p%zeodAj5Jg~ew$QoQ73IOh2O1zHX90H zc#kUm*xLlqFGxtDwZLgcjpaT2aG{0;XEI>sgl^WYFb3ETqTU#$uLZqN+j6WP)N9X= z13STWPSS_I1(M1Vi`fPE5>mxPE5omEQS$!@J47)&EJL;*MPi6HgGLV^*H800?iOgF z_LA6;3*T^kKwHIii*rn6v?b>vxsfi~Cm=rJYaR@!Srff)4Feu!Texro2u+MTG!uEJ z{O(LK=56Wr{D-Cs7ow84-ll(L;s0%Uuo=o3RvdU^GCw_&F2BCb-a4soDZewef;cTU zv-0!?_o^XPcFnEW1BbLbsvueO=QuXo(zu3%FyyL8#_FQDe#1{%t$neMM zAh9+NlFf%iEN$R^WO>-al1DifmPk$#h?VRhVUx(DfwT9MJmdQ!^FunS>;$L^sXC@w z|J+G3vUy8Tp0^b26%5)-P(>qY?@NsHgJB{k(~-|nxrk0Jtk>RG3a>(~xzuyi2sP~( ziHcqLc?L{DkDh-l<%UA-j*Q|%B}3x1U+rgg-|r7on;^|(!n|0*4rNXLIloJ(yVW7! z2Qu0csfyXlfT+DUav}Tdy=c@f!;{^36DyB&nnv~^cwMa2UB0G_uy;|s(r_5QJXe;X zfL@fZA*o=NGr}$87(k)2Xrlc)kqpv~mZUC%Um+#f?+`81K|6I5t2p=M`0jY-n3QFB zVaDH7$tIZNNYXaAM*3=8q+x9G-?%+dvN8!-Z;_FfPC$Cz_e{8lFWXn~f%)cq2sqr> z>GzQV1z6VY36H$phu+HLmnz)oHOU2YOQ}M9kD>vSNazTQ3nN*SU|>CW0{egh{IF+u zKm&08M#NuFE^)Q=snlTxakM{Y@fFke-0J41uP(Q$uYeLDv+b){Avz<*h3Uf^v#5%A z4-hN=l2XU$8qD!b5p?}1X7+Wzi}9>_ALue#mPxj@!cVJx)}m?IZlR)$pip6p%yN`Q=g2{3xCg&+Pz{a~k6J&B1r!+PIumIH=o zfLL>nNcB7|lQd14TMjFU8VF~5Um=h&M5j;VlUjKYz(w8GVRUgwI zWY}G7F-a*%VOwtJ!p>8@QLmo!86r40ygjGMb{nf%^>>yyB7kqlp4pp7RFu2+MY~#{ z=b3#Nzwjn7;#Z3PWUO!oDs315qui~9*tD-!B} zzy{Vz>&aUn^)-BpkU}0eN}=r(+G=V!V+=zpP$kSRPdhlY*)phT4R*VREhb-?h&122 zJDr)DnQAa6C-_}QBwa0=s&QQ-tMJ0=0i>Pj*-y>P?B;*~FKzN@6dcTk4v4%A(6LID zS_(AwCzwr)#}(GkUWg;bGE)%7t%fq55y>#fa8);0DT7%v{U^V!J>-wfS&9{BW(>Mp zES|Yb1Mwy0RCi~2kizHFff0sY*E1DKaduq{wiiXywiK(5OT`=7f!?I9rE#d`iZTqo z1uflKt+=;UAdFKa^T(iFLz|V{QHnyi?qV@(&46?(k2JW{2b6eigk}sK9ko$4G9|6t zIgcMT9IW=bhu*%~UQ>=@ILTiV!gR9D>Pz0v*Z#3vf(`t&-?#Yp0Gzo12-CPswtY(} zSiYi@WiiX?g6sPIUK<#~_KHwMp;s#Cy|Pv&Nw`qC9NH?p@>ij9Jdq~g0i%D?++hj- z`W9$?%=MJ47r|QJSz%gF^mQgIgio)+ycNy4_CB#a4I$xm@I#kv?;Y%De7Z`q2J!>! zTl|8nSB*JK7emD|DC@lz2v6mM^$vW}=6L`67277&_yZ8|dZ^mGnf4qbw=fEo*|~&&xnkIgH-%Wo5nHHkMsq`1zq{3N2m-`458;w}q!p(jqFd`p45B zcl|KWlm%BBdn?<&OpF`fR#a?jFZxqA87R&sL$IZO(_w}(T!;2U3m8#; z2FVP(Y&ImIeTb}6!>mhX#A`NZp7?&G7|fuc7Bkmo{Su}o>>#2GoO9uB{apxGEw1CL zhWUNb;77<)a5ywK>oc?FxLKk&h1`j3%54Fh+&ZLokJvCx!E+-kcqZr9vZJF`j|EG? zw-*fTxs3^t>Qv~Mj17?uX{?T|jx!sIKqwNy6;z2;iku)~dx@8BZ>D1LaX#qug~a_3 z8D1KU&q9VM%yF%J9pF~HK+T|(N+rs1D|+{2rAwpF#apF7O1qIw_E9R$k5Q> zGvO|C+2H;N*D`0F+PtrdD45{TRZ@Vv+y=-PON+#YfPBys5X;g~F1@v>Q}c^tJz znWz#dv6*SXC9eYAajAJ{Zam~pEB>_2PHGr5%^D!dyq7nWmvYRuFLdmw;)>`7%|Ccd9T`XG>y4jeAmpie}R- z=x3vGg$=umtu>zkNBjF2kzU3-cv8?}KE`8a!iPJN8Ek6*J;B;8`&{bv+*L;7zQG|a zAyev00;g4O3Dg2qJuj;n7nlaOuSz$=*0N)y`>gV;Vi7&P2IKxqOAlZo-#`ZG6|FJJ z11J4O=EYgaKUK4>3Ap+>{F_b-9x;vINGkS8uXX0*n~}D)-otpNVxSe?aZ=iWJ#ace zvN%#T!YZ_Na3sVmW4CThuZvyfc4n&vrcL_F&={6eO%#L1Dx`Voor4s|o3hf;6~}hn z3J--$`?sC5QEbt9Uo};d>aorwkA)7ngxTTGEDvUDD!3cF){J6Jy<7t-jv-!K5rUy`0B3 znjbBT)@I19E_{s4e=U)qa|ej9Ug+Eb%php3U;n0I{KtNy$&!i>I|s$DSChYvKFUbt z96FSRz$cJx$W|Wps`8kwOyWYIemx5)cbJb~-gOQq#kqV8NDaEw**r>a#*bRqOQ9%^ zBcy0cIX?HR!jG;kz@#dK>>dJM;KL=n+fnKz1P*+G=qAh_#{Zzh$Ik_-X7nMPmkrz( zRiHLXVR2tmHh*tL6CI<`a@m6KdbMhwh9{<7QtOB5^IC8rvmE%vV1xVb&`8Cx&r95+ z8FsPQ-J{B@KH%&fES#`8dS2+! zv@gXwwiAODCw_o1zc(;UTJ4hcE0ruvsLShVk2g%B`o$Lvm)7DEo^c0)M_-cd{q+*W zbdMsVvQJgc7dm^7gv+G;PrOwj*dN#bJF?zdBHVIFAVn7j>!HN}#-w){8HMjP^|{?V zJ^rYG)Meyjj)$S08OlC|P>?93jm4{&@!J2*$KPx`7SW8W=D~z@!d1`Aiezqgk$e0* zB=Fy&Gjnr?Bf6HA*>A#oc(=tG)eaaH*^&mM+7r?56b}Y<$W)BiRR(m?_{xGRdIq3` zB(Bs_rp6J7t>3is9vFi)H=r9)#zHs81M0;eP|;v|caifJPlteWjC{{bi@?f-LBY?s zfY7G@$%Ob%QzRYMLhT8ty7cOjg*lX_@Aj8Ufz>VCJDv#MgvHdi*DcjA3scaIHl07mReG-+Kcci z-<125i*l;j{i7+EXGM(lkF1t<)?#9ijjvz%tMuWOF7qAjibt#Jg!Qa3;u=HORje7t zWlG}4V-t~2o2|(xwi{P-Tt)2_o#NoSRqXv1W?`DXOl;EB4#$^l{Md7+rXTuZvb=ON zKx;a#-57S;6a&5+<#-Q&_9EBG)Y%zs&ivCWkN_=Olj5>~RjzcyXeZx`!hD5j^0;9d z*(f9W{Yp~olQzV%r=P^K8Zd8(1So_GJGx99eCITh_tqEvui*YP;*Vw)axn2n) zxm`qvmD^$XH`C^?XQK$p%R5bv5$2(2IB?1p?yz!Vw#bGJOX{ZSis!vt?4O4mRF51~ zByvocbTOe&{JiB*>+|N==^8%SiD}y!&Pl*#nKIMAN=K`@8m32c(Qhs9Vd&hN#|U`Z zzPb25A!L}Pm8K(gI8zaub7YJ7PCbcyoH<*mVhOJT%8s~ytB5xInEhBOm&_@VWjKQ^ zx4&CyaR#G&WMV=8u0f0H1bON8&~(mUV*_qG1%u4n+!P!4ET{5PW}n&y`MtgxIo{%- zV%sCs6$hk@I!-(7I}Dqs&IjRHgH^|0?i%2W=CP087O{Z1#7~rSCgI*|i9e?}l0vRO z_WZ&=@PHq_Lik!)^I;p#x4FxWEck0E41qx9G}pNmqUeb`ZD>l)#+9EqsGKv<0q)Jx z%S=GvqO-5!2Ct5KHAf{Thg%%rcsrD4e{@c)@=EnrQC^cY8jcbApF4caaNbb3UNF6I1&1|Pi9@I$^guus zwrzf2LCq(I>ned0WXhC#?YR40oUuv+NrRmS@$SQWwYr8YakceBGb?V4gcKy#F5Z&f z^(u0M-p43nad*^MXjFGi9XJ~r{DLULgXii{qt3>?G2nIl1bRVDU`>}42$}dFb zI8+;?U0AG7d({OeT~2ym$cW{mX7|81YvC~FDIcAn-cQDwIX)%Ac_VTULv5ER~8zAaZHFtJJL`UCs^Sg#-W#XB&|gYuG6cU*~ki-tN` zv6$Pp-&Kz@7?cntbN4UOiNKgPyQm@+F+t8ro7*qgA=nVYaF{Djc3c5m&h#*(RGzvKF! z4PO*dI|@k<27Q4I!{#A1iF}M7>Iq>rwIm^|e5O3LT0=@c==vkp!tlh$$%F?t>-9V~ zJYOB71pyF)lxb#fV?Bauf-o(_g(r<7HR=|Y(Mp^t-0|zdN8zk7HGEXCmnQCM8Wf;4 zX&XHzd_bQTg~blHxbvd0lpIh%)P-T>G}b$?YN0S8lO(b#J5$eR0-}-tCa$?nq;dF! zs}bRux|=co@EbW@;ZVq=c0OQ0JWI1V%6#bHRXnGTdhFOIam$-Pcx0AC9pb(;r4)dO z8vet2&92WoPuU*o-yaw*EiqXjGhTQsBz*ABo#(C}rib}bh+@;Ff4A|Wt~QW{ilKpf zU~V{p;tYX*AQNuB3gS0wrQ^@wz1w_k5xAvFVI(+3F{pbMd895|OfdDhGcJ{=wUVlg z2(~>0f=}_KN2az22QU3L?SA66%JF~zQdZuSy8-gV3#noA&(O`=MXwr*@;3Fpn(AG# zm&w41dtASeud(ykM=RK|)z=4cYP#1`R<7@?8W$uaciWYm7Sb#$8EUlLQ;4FUUbkMX zKnNG3k5jzso^9sPi*pW8!YGI3Tv3*IPw&I)D2j^tB8nqbH_3~?uJXtfL7kUF>ku~Uhf|q3hLs_3^Ol#}J>PB1F@#>Y;`IQ zS8YV;$5v`hPCH(VUWSQ`-buc4&t18N^?Ht*7}h`tJR1&z9Tfb~e6yj8K4%99kj!fn=OiemUAUA4)6)J56JQwvpi0pJIv{TwhD| z;+BI$@&7UAY4cqCxp325yvX&lV`<2G{}IY_X`ax>UpRhK@i zS$7oYYa?=Cxd~#tKmk)NihYz}U=)rx+h(y_`$gN9u3iGBs7W_q0GF}aNrl0BLbJ!Z z0Wx1Rf1fW*75z@dX0ddN#Gq04To)ZC4a(AU{HQ^@!ZDLJYZQ;%S zWGu(w!WWlNmSVs5doEXY%pg=49D*hg(chYCGi;S zsUpnlgn`y65FmV#Nq*M|d}{arEwPvdXU7{ct>ctjJ-Lo|LgpTogtpad|EX9S>02I> zL56xcS}^~s)~U@TX~)zX!`g#V_e;8L$CMKC%FIH-2uwLb*Y`ENDWhdkzNPYaeWkTu z+=0ufq9!WzMRiwGz9r&Fr7EQgDHK=0rr98a*YyQ&OBJoK=eSyx^XU|U(T(~>EWHng zp_1+bxaaNr8%ezI4mBGZ`+^?4F1YclJKg7%U5~cR7e0hrQm|{y{`@koD}ixQcIC2? z@PWCUfbw>MO)#vab5}Egd{Q-KNaP#+0U*6F9cRrM8z{0;RDvdwZ0m`N_G+Zu9_)a` z^%eL&#q*$2Ron;{GBO71QwXpc6X7TWeuY+BAIRju8aSIm^Cm?L{KSrbi~jw#$Ds3d z8&M5i3c@k?p>^Unks|-KoUbeY=`FUxt8`{K{rm@5@2}G}$_5a%_3qCf?eiH$>Hhpt zO~+hNVt1e);+Z|h12Nm;ZRz;s%*fwN`5%E0pjXUD+TP?kR<|x!Q z;G1LD_;wa?X*wI(B{aNp3>G=u9FKPEkRY_do}F_~cbX4h*MSZg5)AiE&c|uQfqDkx zXnt8H;}KesT_ap$QHToK>2{EmeBdn=Qe?Z)zBt&lC3Um(h@rSDIre-JTpllMwY!S! ze|<)EWlK)afk{LfT{)>TwbJOxEUOe&AHb0cI;(JzjdqWG1Sg@X7rRiaNcU(Z9rHSDi_s0shU zHB6v<8cTQ>p-p2sg+7CatQ6)ID<#f%c?va}oQwZgu7o9KlZYyqt2+v{)>xgO2(q0k zN|IKo%PxfCd1ijX0Q>TmBt0#^%!m3Sej+yT?5v5VARz`gICY4(xzN&eupL=cfpf#k z<$h)H-p%c*ay=wrwZAPceu8R2-%KNmB3SI<)+Cn5P3gg2&JpgItJ9azIr97{;OG&` zXp`Kir9dY^@s4%XsvNxHE6i2Ep+_ObBHVJzoZIR*K~)(Y>F;@eX6b z5s4(|ZO4K*B*5Qw9Kv`}4ix$R!D0_Yx5^wX?>}fp84hp6#S^LKOcWl;3~{sBm{O-J z^>`lycOH)UOK#QLA9{l2DzfXPV^rLZY4 zb&u^eASfc?{&6ETl+89RQveN2m(xQWayem_`lJW8ODvS>1g_qO(IqlKe^X}|kKd}J z5m_{E>kdf;fV2vkTnUz7DX|~#_0E?Qo{1}~&kh{-0u)R!`}36sEgH9|4aS!arcc8& zEz$(ls0S1!LfMfN{&HL$XFYoQRJ0=dd~_JIilLtIV#E?0%4!yVo4XNw7zB{Pzm2_vcY8ipTO0s}UTw*r9_UGQfXq~&I5{!0-RBcI#m*{QX9 z)(u)874)|Up5wEl!;9fBOz1}prb;`7D&<@xpI^|WB(3embqz^j7=VwWz4GDkq`2AA zwz(T&2J1rfVlYr6TmrYSAvs6*m+Fv+?7{-)40bHuFE~ zz={FEk0nanJ?AlZ>>3>Yi2eF!MHlecz`4anvL%M8b^GcG5x7u}2Elnu3Xn?7Odo8| z$SqJphB78Aj?hs<7N~y|s+Obk5)y>nvwM+q(vDlw>eqM|9u3)-vKnCv8MB(gc9|TD z@XlZnXT<2RkGa0T7qz|iWpK681S%H-=D)M|u;A~R*>8F-wUbM9ob!+0t(oT?=>f8Q zfAUaR4s$ZXD#X*WCl1QoUEZSR46r}X_g9^zr-cc2y+0naZuxy-?R(#Gd*4o~8}RccE6vy&bu}@iA4%LG!|kJ&N&@9*j7a^=KPBV;zTT`zltzXYFtee{wB>mXiTTM zB&m&Lee;Op>~_o9uQ=MbdgJ{q%ungUgTY=T1|x}vp*9SM0zubiY}pyJ6o&y)ahj}K zs-#GE2XWbd_5(BE-@@4^V$`;f2UrF_4X%Y(+h*#rL1ecqDw)eOv z(hxx^ynbSd;dt!57x{(*|HDm-`la~#XbTZP#TQVVE47^#4orDu+@SL{3q8Vr|B>PG z@pTH{3RECRzM@%d(;|rHJD{_sDYT_49PN=Z zpsr5M)RoQ)v&A=`T&!{9h?Arj(X_qkj)0~I>UN(cub*$<)H3e@g-Q>)NP50J8s+BcH}aW7JE z0sM^uiYPjkBbh#u^7W*l)v;!qTOinx9salJP>6*hHPaPcWR>qM(8Q{$cHVhZrU?NR z@XLjYxISQ4@0@;dZP~o(a64qo?mnRk1@pHt#{7uUe0%jtxv-gB175~Ng_}-&5PYMo zG9gcl7wVBW!@x;n<~sX|1a0(IizN_d(Xk7jHT~oNuIhVQ!bL5 zCA@JmWne;L*z|kl+ZEH*EkafEW?F@2UeqCG1IWPYZT)g1l;ln39=1olJ)of)Pgj+v zRHYMm{x|M)@>t!N+ixs$kf@g)_kVi%)seKRC>vABTHl6>0z&Z|*;J63aUc}gE)_h5 zg@kNo+k7hR$!Un0;X30~^ci-2X@6!hOoK< z5KDMckLB0&Fx!-h6$_hLat;*MN1|gYUIT%8?#aqlTVgx=^pv+)$nK^ZPa~_gC3&y;VXAuWRqDksIz{t8TSvX3_KFCT-s2U&L?M*sG@PlCWO>w%LDE^aJUCJ2(F)ApgI1=l{X z|385I|6jR0+kXY*|9kmU4z~Ye*Ixa<0eMAhq2U~tj&3r*j)vozhb>n{R1SnjfTXQV zK!eEJ!*fQ)4IeY6QgrqPMNq%ayVE}$PcfOan07H=v^erMq9eO>_(%Ta^y0{+BfDIL zjz3%GV4PHaQkwOoY}N{WR_aT=u2o*OveE=O?S1p)==zLj;y@(kU7}B^NbU#K$^{GU zUL}T4%#%mC2(PERG)?`fu`I27-|*?oGI5r z`6*LOyCHfsl+)a|WLk1s_ppLdTJ(^V6+zawh+taTR^RkpdvpA7gYV4O)xE;KQqkMi ze~B!w=>s)Jx@qD2#7mIkv?3>afwjh`^x9k9ErzEdr{19C9lntAER-d`f`V3@=&tWuu>l#?O&U089DPMP@@sKNP9+{nrOK| zZOy>XHjzWU(FpWVJwSbPyRpK~k%_hH!)|ectRI$}n*F(5XGXgNh)aP=V^XoJ#N@-` z&ZxMRO{y2h)<6(f=q5;?&^qrqxJJGAf#hSxQw0d9FW=dFxj!0i4>T=ondrouGo`G> zxfHK-gtiM8*Ev66Bh&63nk`=mF?otrs@(|8Qs>oMVvFN4UJHJFAF;eQ81Hf?q+yLA zhzJ6=^4B})3MXoj0k=Kue4M}vyru_*gEVj(Y)ZTr(J76|$f%uD!kL1mRJtWiG%5s3 zF^pU42kn!KA$Eeb-1z=Uaz3YKA@(BYAxkbA)$*5rVFT;MvZ#Y8a@s$j&!#SSK#M}| zBgrtqgj0KGFB6H~aDGi0qqMk){O*Yv!>nB{&A5LR8Y^K0ebRE{$7RAVa=0~oTmfZR zBF1p?@FbPflU`-Kds@mxLEhbWHssVa#*sdC02XtX(iPXrTjIUU{MOGfSw;rMIS!d!}u)QSS%lXHUu)5<)(M(Zt^=#;*@qxIJ|Fk_VlKY<~=5OQ&tF7+C zAUos$jOPf=lCyJ<9|7j)E#Z9=M_%cl`cy9s<6le`QIcj2Vy70$RYqc^^cSVB$MQ>* zBXgDdB=WlL&?yt5(=CQ^DmWqBg`WNI*HSuXa6&Ybky$UBj!lay;+3BeW@Qy}#-3YO1uYefFIlG8 zBHkFJM>LE^WjitHa{k5aPy4#0wl8TC=2}BBT@YLZp$9MRiy7p_=ee`wQ+o+V@w1v{ zUK95+k!&;*Nj$BOu&$VpZ=BpMm%R-#95#c8_P!m9d(52fAGd9ZPMeWG*Ga0)dJ@sEQwJvA#cj3)UYCX;t^jPle-pY#uj#`B+BBv`-w$*_L=clb~JV+w`8V~LVy{>CH1x#?j<={kJ%eGpqlUgddgELwL2+2^nU4iUYfse z1oSVyGofN4Ud7PRV!X$Y4pcn2TV}!^eKF7IbC(w_5dqsOjLWPVVvDH9cNA8If)hS( zIIQsqfMn>m!eD{>L}wI)!@;;aiO>s2OZk9@Ec>$qI1sO!B!z5*EWM{=?rCuqSeRw1 zj4K(_+#G<|4!a|&y0Ifh(uU(OPsYMqg(cf!yyOSGF^!A^)z+E|=D>)o2P%9SKmAz2 zf~D2VSzKWsx_M4a9X;SD8PSec^!X%;m?qbE0b}6pi>@_>4v$oo(VJoLQpACSE`A@k zN-*v@!C5pL3yXhZ`Etd?lq`*!`IeiPuI3ni^7B%T69>Uo`%Kt5!s~o2g!htrVMfpB z$4i3M<$fD~`CbG2P6w2JZ(=TboYplv%!>1MQCX?SS6g7 zqGeN+6=GwyI&B@)JX!hipimE)kJ4P8PRUt>MwUl|Edb{vr?xKK4bgQ`e6w}^4x6%H zvgEk&v#wC&yJ$KZkTvL4a+f>{HF3isst{ZragPTdod2eh@6s~bHF_q*2?H7$gsrd_ zwau$eW~&bt{rKmWp)K(F9Qx_P)CAbL= zITW=hoOpOEmJL5XKlQRc)0f zUy#{-7||t^JM#D9L)GA2Wa_OvY%fq~HDU+UF+j<5N4sT}Z^{C)5w~Cc9k*Z3rd9AF zp-%R4IQCugEHdRev83OB+PY^?e-u0kx;~_M93hiJ)h!UED+U_qNM#3{jTJ)ZRz^M1 z3~TP)U?4a3wjLzySCPKq($-s;Gcu-g1lNp&P&_ z73R#bDx%O(sxlZDeIjH(c`Bryv*fCr|4k-Sh^fAoED@_Qgn0!aJT4^5Y)nME!i}nz zK2w|c2LHUC6{b`qFfcN!k9H{RnMvB0C^#iH3G9G%57luq&wnCKmO*$(8%SRSfZ{*i z>3v8UjF|{CttDOJL3XBnV2fku&4R)IBG%~Jj|xpkuXHlKAv2{Q21<)SspWQ6aA^S? z3s7W;y5JjxmM~fADLqlGbtYK6mO(o8t+&R4ztTqe;F{D#Bx#OHv~9ecAL!&{_o~F< z=g`kEoK&jB5%6bZxlbO8oQL>vBp*8Fj+nA3cfvL?5z*)+QLbeg(ZB}Oa1Y z<^kaxvEg1c<{

    cm#Ux7T(SZPANW?RX2OzJisHjy{=jII{h{ zW)^SfO`eTx>Hl8OV{&x=$2%2p`T5eInJS6nJy2~vK&9#auy}oC>02wwB-&U$btS^qOW9H?TdKg+U??~0t}&^#E>pDK67Tu; zo&aLU??BqR*h7Mr3Iccw@Q(n~qp~XNXV*(*y(%GSJ@&9&ZY|$SX29u0KrRU>V$_XW-4=Vdv~B z{;=O`Pu{`7LRE)JmxNB^bmsoh29>9gZ6(KhpcQS882py{?TWnTh0dX~<7ih(4gBPY ztMzhY{20_)_j51D^HP!d5yZv4MV(`1wk!5<>d->HLcFomx9I7`>XLY7fwcBa^1;7W z{EF7N*Xr+F`!UC9T5Qcx1UBb*e^#ZyCR&M0Zg=GOL7l4FXD00UNTVfOD(&{r=uuL< zXDW?%i3UsbJCfi@+Fl=!Zqyd(h>bb5SSRPGbpv9!Ce0hmare;AaeIgtrSJ3ZoEIMj z&KmE6ij_2P=i1e1BT7JUb=LatpDw^6Ta0CWhy@xgb)~Y^wD>NRjp^6&3G|Aza_t{=KeMNvJK`28^sA}sg z#l$jxvWSk%k|>NTKdL&ifyNoR_jsLVlhnllHf1_=l8Q7AO>}J`UuJ-EfLaWoxYdKU zZ&)8M*BIVBEVR=SLX_Ij+Z;U!XevNoy6YYO==qR6x;xZv!DS!7(mCnS2ThrUFP%>i z6~h&zaeqts$&W~$Av6RK9s-!W%2Rx-48#sILxo^Q)BKD*2I-TFk%cG~AOII)8m?v; zF2X-Wg6bbkqX9lCAsgR=>!!GgSnKuW%WW>8pG^j4okl-=JGnBlnZ^ z1Rj6Iusl9@cNFZeGCbFEb)(b9(vUh5$p0`n#z|w}N}!9yffS=%bJbQa6_QAPg+I?g znph@L36(7dhAuf@80Btrz{063G3B|A7v1K=JG5;!+hD+OYQP>*QylVw%oL+RC7Iyd zb8@DFY4YNyKSx2!op)%B1uN!SqEzEYf%%2?a2AAa<%-KiqQ#lpkv$-i3wA)wlH(G~ zT*e2_4V*7*gaeJ>Zum2aj0}2h=~bwj}88@iQwpM(H_JO!PKR)IyOZ{z#i7XrOA~ zuwQ79Hi-C9z1~+#@dX)(vTlR|`34M2ra0AX2HWJk@9o}3+j|O!XLki`XKu;gXzmZy zmlyN4a=gQSUVn6qw5(r2ngEpvjG)fN?BUaVH&ZFj%w3W6mVjb++Pn&5P@7n+n$T}n z;7dw)MaMFIw^9*(`ZN2Of&k3oybZN{7k4nq>C^p=>Jh2}ob=k~L5k>7L zyfc5Y@K5GFEdnx39|OLOANn6hka=1egbzRVMH-bCZVP1Y;cvfy$+MVZYfMCP{Ry|+ zyVs|aaZYr^Iew0fx=N1hw{c;(L`zbr1Z599|C<>mVlUT7To5QXVhpy`T(c;NBw8n3 z&GIRLszJU|2q}%tLNTPOypZQtA1v~1MZ2^;ZE2N+-Pq<_l`Gz~T(ccBzK-3=qB2gDBN z!bB6n0;k7wzru1>J#j6z9MMnYx3Xs+bn7gcv{%@Y3El?>J^@Q7R?-1d6Phtz!!ne~ z<%A!9zy%ysG`wp`vSopH@lOW`bj0n-1XuDP$s`0K>|KiF0LKiB^lIsWT@Wo1SJrvD}e z{%`wuS^uZ{-~YeLVg|R}VMe@$AJsq7VDxg$c?PEajY-k4ni>gBVh}#B_ z8H>MECqah2V%N>>QO>TgQG9;Y*R_IOud2ED#eH1c=5#a8=JI)dotJVYW}?&U>~u4+ z%|3r@(M)~so8*|f>!f}4x8Xm}i#1NVSb8$U^RWi6)7)EiGk-ix*S7v-psp`$JvY8l zX{B$T+`6#p8bSZ!@G@(+v0q%z@NlMF8{Olt28dsdxHEr^x4Sdntv~B;br8Hq-yW_{ zoYbjYFO5CzERA2ClrQ&HYgPm4y0$MzqvJXXM!}tvx<2XCttTswzHw^XTpxXJ3pk&d zVh-cCuBhH_&+w9-b*!;ClBU<)`3s{5S50CM<67shf&SJxJ>gNC_};_0Y+fD5_@Ah} z6`IfGWItEs*MXg`gfFYGp(eZ_d=!2N_}7e9y@__Ru-uiIx6ThamoDC8ek@x}hcwMB zFdsyk=qtk`ZHARH6p#+rI1Rf_?>8b4Z7}(-Ki~Io%KP=dWQ%>H7r(7K;uDH=TQAtgH2F~2 zLM0~e&zRI!u)dZ9i`Cu}J`hL$H9X9@S&}(1{duy>-`j%T%6yKZx4y3I_?!NfU471{ z;{Yp%X9!F)shunpQ@o}iw0h8@+31zM zVZWlZb0~a6uj!*_k?^%MGzE860hKD+2(fwCSVp;h&Hf@6y9~hpp%Oto#jh_SF@Yqs zGQizLY;K7Rg}+Y%E63E2lQ_sB{6dS3Sqp`o5K`*{CAX%?8j>?YyG7HA_|okA5&tQ= zueuk|*=9W74J?u&kT(c?BtC{Py6ci57;8h$_A5)inm3@n3sQG|KxP(#3wlKMCMS-hHxdtgzyoiaS20z z`dGqVWUzQ6K;Le!i-8iz>46kblby?7d>V&M@aL2#BBRS@OXFRpmR_`&@EwOZ6}v&7 zZYPtj{^Z7o%IG2ZPve#eRw};aFV73f3@)MOFI(%~9#OCF$3x1l>wyc-PiM$noz%M3 zbklfRDF%4+5Ygk@NbO8wBm5!bpCwT()6L}w+jfL3yg6%;JxEx>eNq{TP+oF&+cWCr zA9O;{?QTG4E&m1c=|egy2fqAL#_9%z<>k%N5S!|h$OOY(0l_bZOxvttF2R>liWfhz zO)Kl0uqE0&sU!P=NJ$!KBtyh-u-*}rhYvmI$7fpy4dNiwBx1nzto~Za8b%$c)>d}O zz;B6q&n`agLm|5u8t8u?WI%uIYx`E7uv60J6i02_F5Ai(0csQNqWU+8v8YJ>gunL= zH^fs4RYeHNi*gnFYVKtL9mj))Ub&<%{7|URKO9~*a+>K`HPQnKO3wVlWUulP^m|WH zpgxG#bUe!H5sHw4_Y++rDt9BZF#Ck5uDEgt(d(OfyN7+eV~yez`ZC*ol;>^2i??bB z-SYEi+Iqmu73E^ZKynfv7o}Y+g*bsf{GBC+@hu;Uk!H&VH1h>8<8;lK+m&In{h0zFKI zox*W5?|& z7f|vkeQw+*zm=HyjW$eGO&zT|2oanZZ^p(xah_nv5mRm~DW4jl=AQ4ztKdz4?w^92 zZID{8V^$+FgTi-r5fPFeNf6NQI?Ca7V2u^uytsvHtfo?EVsw6rGUXUHd)kjFfl%6s z@x7FHw+b8}B2oA>1umVLm;qBn!02VcOaSR6@o3ehGIOi{Xo#Bpq7E4+8X+`Cloji6 zBqukk%TbJy`RAP?ZW;vXB(zqa<*I|74wUB0|Rma&$)Ar^EZ24*fiy4(0eV+)W{l{igt?iHIR9)-rz@aSeWOojVikgIh^So zNE*+h&~>jvx=u$|Yhwy%zNCn)(q{^NYz?H;$~uymF!0paFmNr(D`Kf&<0eWG0u%Th z*O`flZZ1;Y(4NesHDYg|su$j5&6!LzK3Y@vxdr8?;gtve0O@5>I_xFkd$eQHpmR|- zM07Pr^fry$onH4V8r;)BYI6@EoVheS7Z1Xl4a?I{Z{!dGtuzlItb%q zA0QNoAkiSvMm`Q+u2}Qugpm9!{PDVCsls|?+DL;)ch9LS82&y5NZk<9>3kuMeQ4k$ z#YLW2n95h{S1;;Qe;>^3@{r^%87ky`ivviPF|I2db_2qeVAbY&AVJqm5Dz{Jd+(~6D zva{ey(KGGHnU}H5n-sAi&GBLY|90#Gb|m5?F27^aDFuLL?7eEzdd->-hyCRC53zkN zdJIrK3C_P`POa(`0>XbWk}9#=aicJ5@wX@Ligb2rtQdKt>~#Ia3LMIbHzvxeJ63}~ zCAEq+WLlwRn%!g0cCU!WVAL-#W-N6Dkx7F<6C?|u#9Jq)h+f0})Qr%>ece^^k<^>9 zS)XwPk$%U1S%Vs!E0FQZuNu_CcUvt)Hd+)m#JG0X#b&VnxTqZgwc4IX6!?qpcW{c_ z`rwG!{~Q@J0?b|vDiNn_moJ5Y$*O{bi$<3raqT%nha9s?ivgDihUW5Djc-MZVnxG@ z2~iG}VI*Vq)tSjO(Go7|jJ#bb z@+f=R7&CSF1SjOFV2wh$=_3i`^IHU*Yp4oq)h5pRNhF|>MN@{L0|GQ>M7c&|bc#$W zGLk)q;#n%}#*-y6F`fc8b~1~)tpXspoz7Oce2;Qm@+j7`M^4{hlop)>gncy0=Bo65 zl2v=8EYwy{#hk6Ozkhu{Q9C|dM!SE1u3xC}ZKp4Ex!v8*@NC{V8lJuGkKElaq^B*` z#+t~6(D0{Ri0F-|DNkwSRO3b;!%4w6sg&_ciMK3KHr0C z!|ew4B0K13A7=&}4`i-;{Ufl z+-SZm=8kUSxy0{G@3Nc7XG^@apoP>~V!}19vbeNTmq=u8d zU38HM5)@hfj~Mqd0??LF6CUbZ-W7#l)t|ErKR;|jjJ7|^g;km(&^B*u7t1YME%Cy; zPpA(qCR71o&;otQ6KJ%Q_0;v32}f-$3FzW};#U~}wCR~ozh%mDx+g$kEv~J9jpK)= z^g2EsIZDaF{t~>3Xng0A{Uu7ZX4sdOGjlz+A*;8^r`ycdB}Su2psHTJ+)th{O;?6S zzZTTI*PI7jXl;;T&?*3h#U`n!)&#ytB_%6nDW={2jscINUZH7JLcVk#f^0cx5>YO= zIk|aJ&1u0d<>+dO++50_iw7!3+u z8`Uh3-p5kPG`y)_*H5rlq$fT?4u8EYrhT}pLbhEhOox@{^%ykd=9-Ym7@L`_Q3~TP zj1$k47v?Cnv3chL*25=LwCk7ss_X^`+wMXkl5bzoLFizP0r?G|Cjhi$SGmxI-nRIL3Zs}Oxt`_?*)T_3 zP0xuUQu=A9Cq=CUa`wXWYMEc+we^@a9Ff4z*^Q1tl~Dfko7$ONxBn6*3ur3s@ws4; zs7@K@rWTw$A8FBvMU>^aYf8og*+}9C?Z|VRR7*&m0<#i}av?wyOI&hyu-kG{6AcL5o>fR;qjGwRq z-`I@`tz24)GTQ$MLBJ+P55$p1zvW^O=l)~*SO4t0Xn*QgQ`@>mIE6CgM5jnWgv7M}mE8+Y(LN;+u+Qj`hr%aZUzUHRI-zxFDr`E@e$CJ#?aD!@ilz zuO0Zle9=xHH~FMIHb{JIuc6#t(dfG|@xAr1Xd^Fr=uePjmGc>t5_I`l*?-obX z(GK|d+gl~vlnqiS7#Tie#Uz12v_aj}Hjrgh_4hIQ3_B66F`&Y+IgFsMAjf>vj-{r> z+O(!)Y{FLW>rOVIZW8}E@|uw3bdOyVLkh3TDt|P_!?%n70WF^;Draos&BZ%CDsJE2 znMHs7I>zauZRo#1#xHieb@VXaF`88Y;QhH|!+U~RnZ6IBdH;e*UEjUFiOhW)>OFu* zBrrSe3P6ZcpBR`-?s}tR@ESME&S3clpoBi65Kv3#J{;2@g(gVKOvV=swl;%hywW9Dl zamKTj@%Z66I9nP3u3-EWS^7`_(rlLjD&NHwg!t{Z^;M0gV7&FdgNrmMmrJNLaU2fPe{4PO#WRXu&_@eo;UXyH>k` zht8X#N#}oH40u(@8t(c%pwL^x4Xz-n>c!UOqpEU!SYFSRs@&b9=((vhdZuF6wh!Cq z{jJwmU1kM<3f(7Px)y@~WUMgb>UXkMiHYUVE>J7v&;;neC_2>L7Mvtd6?08NkIe!# z6^L$DFo}Z!NmA#3?csNsC*-FN%u%82o05jZU^V0yoMDldW`A z`@y)P_=4iqEfMdp{hs7-@cpCMeQ z_oGgByr&ETP?Xn^Lp$4zIyL8)I8- zSY-hn%w1q9jLz!b)gG3LEtS4rpGUqRDb6|a`^~9eP%_$uH?3KZnrP%$<}LJg<8j?w zldQC@u#qdx*i$>HjTKTRCRxM8mRV{}0A9wAsdk+{%atyVhiI(Q2Xs!@rmkCpx>t$S zZ^bSl4>&h44fO}^Nl~zPcb4D%+fOR8Ah5ld;*b9fxC8SEI@427fTyiCmk55h{;8_o z)YWG{C;Qj~^I3Pq>0+6uho2=^nE-il6~smtKLb;{$uqPN>lP2PkPgd>wJN`uw5-x* z1Bi1^geNCS?zG;#tFfD_XOyJwY89@fCb!!rZ^rA-HNQE82(n!rljA&&viMBSa<-eW z=B!72M*9IqWoqgzjxu~IKfb&doi9A#WAW+pzH9{b{GJ4kb?}ch+-w6fALJckoZd|t zGi=B_3Z+c67SLor(lbXSO?fOxw(*bT-Bj>vxIWUSzsGt4!?RPr0o=ef`W`knq@4T1 zW7F2xmoTUCD~c{S(Lu19c0|gmoRte`%kh12P^Dv64fT6u?{O7hEHhCRQmebn8IssU zS6#opuwyMZvuCntKOeFWw+7OiDa;3T<7tn&V-04Q(O$v8b$IC07jfTY`*+XfIUE3a zIfc$&t;*$_*Cb9{r$p!e`~){DMn#x&s$9)U1lo(O@9vv*a~CJw+I>12wWO_E4V8uA z3Gcgui6B*ux>1#*XyJal%8IqUB5n)6uaP$TKOm}AcAe>AQs|0@#p@0nHA;cq_h4iN z@jeh#pAZV58=R}zEO5E7T~a{FM)Eag6-$L^(A;Hffiv%5ES0l4>|4#{mt?Hsj{M2lxH?up?aov4IJv`(|LaMRwZHMe>9N)rbh{Ye7Ff}=jF8quP~77DfO z5`S8jJr&IK27azE!}R2tnX1u5@LKso=_9)ikN3d_(6=Ah&02c1!qVf0O`-DDXNoxb z(6l>l1)9XVIABAoz z>_U=iwB-F684187)O%>X=`P~lXXALuUsQ&&Hl&_@D4JMAO3u+E_>%Ag2Kw~(xciTc z;y<=~nf?#9d;kA4ivPzu@;{6y|GXprh=r1^lYx^7AtQsblY_I7)Bo)>aU^77o5O2!jGoIq}yoHY$(wkze7ms*X~$qkP{(2VEN&~>!)x?kQW z3*H{|c`NSYk+Q&nH#t37j_=FQ2M^UA-=7aB7t_rdmH+UBj$V1>xlX-GrD{Nz#)_q9o0~wp1%64RiDISHi%CUfaE4dLjFW1T z<$@P`FHAN0%fu(;cA*dVpEZ%{uU)UAzgsjPT$}5Ql|)<~KZAhX&E9p5=2+*OfhHo$ zL(}?(-p$DHjK99!b@L3@p04@He5?!;XxZ)p>vGaoo&q{(RyYkMg11*>DJ$)s_P)1X z5vAi(S_I=tI@W-M>RoxWlf#>tPqS%$1$=&49o>)}Q&S!5si!X~emhHo?cE5uokZYV zfyY9{&oQjl7Oj^W=Gz_xka6)vj?armju**YkJ9qkeG;+!p`*acV#lkUjK`TscMjYo zP<4;p{DIq&o{ac#MrbeR$8gze862x8@o6t;o%foO#s&O!--1SVpGS+yp3aXdLe8YW|IY?+05D-WAQ5G@MU@9 zj@iPf7GsBgb->9wv)LRJW!qNqc+J@ngRkU@Fd@e}#ee!nQ)^p}&y6wi2Yrt;utB z3PR@vA5VH`H7i8bIqvg+zBoO%9?rc_&!cUXtSm4!u4`w=nE%W_H#mn18X*f&Mo5zwZd6OYAyY?o z6fmBK{8bp{+J?p$x{pIIu@R$9@IDHe-gr!(GC6|NOnZz*wR9F~-|wE4zCZ?fu0}4mzB}NzvEhSMy65c~{mqz$m~o z7^v65nKB)(RTJ*MTu_pNr~gxhbC_2%1XDqPmoE z3=IVvd@{p)&1tMIuGWzyUC1Sop1w&asS-f~u{eB{Di|0o!cZd{P_GCnC4I!bjeW*X z^n({PkOx$^aMjtATttN!9JjQJIjQt}sVL@(n@|~T*YxB!%3nl@U+%BiB`g7{LPg1d z+jaW^b5IeLNiPB@5-O=oB@clPhU{=BQ7pG#zcxynFwr<{H8G@hKIpTv4tub&VVv)! z1(L37Rfd%tI>Jz2vy5#qj@g&}i;fi9bcV9rWkp4CA;#iw9Gec}Sveo9VxauM-O(x_ z$5!}=8De@=V28nyF)8$KZvyfC!o)ifT| z^K{ZCz>FMUtzCRnsffBX1B8l##*2Uq@j@;tnZ%C&2yBK%;ivpAybPvfsYa&JUz2_~ z3rg$tfe7#pXl7F5@3=~eH0&|%3Pn+)&5PeI?Gkcx zS9g?E10T4?fusP!=n?@#a8@MvUav%LWUd#he^#(YJAo*ox2yf{zHYsEdz{Ry|b$&EiLeHE-V z_1z_u>NGbSxfZ2@iW5za7a6%r7jEcCM%g&<3~la+OyTa6T3e|ho{y+R;ntO`%zB2b zlWMo?IZ8+G*)3FV)``oCnGDc-#Gu0c)jX3(jn zanNFLi16lzp#_mt2IbCoP)^G77J^Lm0~lF(h>y?_M}D_5H(H2h%;dW1j_~Sr&~Fy?9S$LB54BtASH#FkF}s&Qw6y*lyvadW}-29B>7`i1_0C zjzPr3q2D%IXh0TIHE}=vx6Ruagkd4u4nQ{kJ&r!cbPP?GDmtl)B?fznH6XAye-FvT zcfYhm^eyR*MB?hV6=3f*VeH{WBUH=5S=PraE~@4I-B1BAdLVdV zIHDOIj83cqCuR6x5+sDl~neSgZG86?SCG7~SE`P)J57RT%pLLwz*(i@ah^i0!6(Uti5@(qu-^ zFQsH!8zB^wkxG{byMiCaN9Om{(_a$7V`slwg)&e~fJvf;cqCXJN3O**hYrw8(V6rS zD62JnZEDKxvpM@#R%%b>(j^Fz@y+D=}AUP#Htf+! zDYTR}l6N=BTdcb5Cc!d|$uhJCIeoUDpKGwo-I3lc#?)^FStOvf# z1M`#Tz|_ES^F6)WE`Jj23IfF-pFPfK>XZO9_%>L^GM|X0oxM0U?zZ;M^%p-sGvnWG zV`E+)LT~So>N8NBggbe|G6;UH3ZB2(gLmK}X5$n2v`M#A9iZZ(UM(-Dm1WZ5EbH#M zay<)RA01l}+VUe|k_hX@#FDiQAPb<~NN}Y?f~`F^_X5vE?l&pu2<}o!3z@WMOYc9N z=jhmEYp$eZ8k!_X@7bNN2pQA4LKBbDQtAFi`#|z==)hnnaVj*?c7sB+POAOOHh`?v z;#xoV;nvRT)D^&{I4YX9#YV9r28`YsH3%;~8s@L!Z;z~mFW_fjs0P~{tntE7_)9;_ z4l!|W>U8VrDwvMkden!7WF=5`5S8R$7vq9sK{Dl2a?di+OMp;WFA7CYp1MvwVYXND z+$`9<6@#N4_CJqAAIgW;M1dOFxUtz)o>0|k8UpG)4cTUtm&E;9& z`ILSOtwKl@qx_A0=NVIsC6b^p>I-!N9`-i&_M<;l?!Qx}R-u)^7Njw0mmCpdfYniD z{WTFYc$rD#Z2zXl=j-F{_;jL`d@&rUzWTiG!ox8+{9Jf>v5}EB&#<^_JZ4;0!NHHF z&R_JCpbOp^O(FrvsogWdC=@guA{YA&@mv=;ZQuvT9L6^ekq&EPPc}%Sg!O0S{dRF% z^{Jy%(sE>M9DV(&rpDuGr_!K)!fN%BhNESRVMR{QSMSyTTm~WcY#)>l_l(Hb?wX_} z6vKX(Ll}9$fUwIRSIUa~(j3I-k|0>-fKuERUT+(<70wtlS46S1 z5Yk#+>@=YieabsszoJsbA;mMplp1y}J=AYPm=CPRvPmQ%aW{`|47|ZZx;91}f0sS6 z3U1uwR%DZTMHVl3eFNfYN)hypJ16GahT)Xjf2ij1477;{*~bR;^D$J??8vgQ%x=3B z$KC)VC{BI}x_<8CN1^Jl&xl)fw5H>|=h`_YtL@@Lv@a(g!VlWoi9meJEh&RI8beXu z)O*;Amj#=Vj04O)91<3@>s-h`4gqw+)DP`1vm{XT#JP7z&+{HzAt~5N*#5(({9sQ7MwUYJ zPu(V?WNd#zX|`mUGr(H;o!J?9V>Z!MBfT$j9~w#&*m{9n0FMEOm*`N(p1py%c5l<% za|Ah2PtX=X1m%;*`d0Eci(qX9E!fwHXBYOfntO4`CF?wES}gzSwezJ|4;4=4Z-%%p z!PK~i@u}^ν-3O=D)Tt>P-Fn6biIWYe?yVV$6A!t&K0Ib$0+0PG(x9oC!K$Ass) zD2dNI9NUYX%`E~9A7^Pu{@88#YbZaT?-Rd)zk>{Bu1$p|c<-aRS>AhYu1(Zm;&L87 z#iPikJR9!Q95pIF8KeUJGx@6DVipN?uTQrXH^tj^>s`feuH)XE5OT{opfNcex!Sff za5rPE?gg7yWYH*Cd!c%GZdMjkV{a)|!X8K5ZF}0d5U>>cZ&GGN3{%A+l?5R*1tBQ2 zf09r`Hb)@lRif8y4I_tuIA;&2M!_2NbuSy_hcvDyk4WF3+{Hm6hFp68#K3cbw@$C3 z!M)8IQ^!;(5u7`Pqc1dhX7h|f*!<*2P2*cA_tYGX;czpX51a#iUp4xU&G-M^IAumN zpJR8ophrH^x?p2U*VYual}YzIW+7mpo>`YKjs<5@bDNa_jfw_;U*1rDClI}td8PKc zXtdE)87Dhn4OGynzT$!xN>e(t7-o?qvN6^^#yhIK7sfKb^Y`s`>fZ>TcNwk)Y%_mc zF&IAD8RaI)@gunzY??dQOI(a+IhtX9)RueMR=Kl&iTe4$I7|oHTvhegsW&3HE488T zVzr|E!Ekt}mULfGHzrasvzO*?V3VU!sro{7+;5qV0xPv~7{*z*o9xK*^gY9io^r=+$b@!qIz$rZFc$nSO39Ls*E2X<=z zvv_^IV*&~?_v8~Ui}J~YA_##oT<7=apq#$&6w-@wB&ru(ZpAve*@ zpOYY`U-xZ15F-KVs&Mdcd`|CZQ9k5&SW^$#TAO&oe{G86OdgOk^ zNn-q+#mWXUABNE+-qYYCw@ut zM)K^;-HK$@690Yz9^RsJ_L-`Pi{@zfo(w3QFnQWts2kr(C$Hr|RBS(Umzds-p5=z? zlf$_5#ma|ulMLnkaWCE2C?p+0=nE^bKplm;$D2vDo2^p6!}gioA=V4Ip;aI%VKBdl1nb|?Ctgv_hvOeO>y?=lrC@8OjZGm7%uVzL z9m_ZsYUH+y$MbKaNc@)nvAEQm(whev4EqBB4qDC&N~~h!l_Ed~ z-U{Zn=$qkn!honS|26@TBqWGr(8)7<#@(T@`Nc4@bo9!R8Na_8p9x>3w+WfdMHL~A zII89ei6xWrE*C0?23(CnBq1e!WR2Tg#gH`eFyrw=XWCw2t(EEY-f_7We?5P2aLD5; zo}7x-upj{;p3#x~o?n?X&e<}1F+CURbD$G*U8xbMa04g2JYhQVu~iBl9+IHtgRy{- zQ4&M(W*sNpuQ_1UAQC{pmvd)J;Dx6K$vCRpS0!vx9H3zbF(nt+W3qJQe;nX8sY}r( zaId5&9Hi)pm{xg_G&K}MzCnwb$NsWT>9kT*t+62a;&%?KG~`txxJ<}@4b`P zJrbjI>=l~UYHnNeGLu=+&f4(TR9tO2ujC)){Vl$N^We)aZ^Z%Q@`8}R&1*_f)PB>L zo8E6S9$&is_E!IE+dCWshx9n*(66}Zpzu_TbquPZ94^PT7Q1zhR^jGGi`}1$ek>$q zeuQV3D;vrlTNqAE`tA(o8tt@|E4rjE@Qj=V(<)_4wC*u&kDb|?0+UM3<)$^2HN6v7 z7-I4LU$?@ zUZc`@czH#e0x6c}?D&b1G?yg$0+|AXM=i8)b42mY+B{-kyVl7YUFCXAkx>((S1--g z(RX|{tS}I0KR6=}sjh6!y6uF_dwP{D=rusxB8rL-_vjIEMM(A z!1_2pqz_wJvHat^GGf{epY}KHV>l%A=SCxu5p`uQ$?XR}TMve0j?3~WPb6p+v~U?goDC9363H}Wz4Nw}SizchmHDhg5aKNyoyIkXCDqLU*1+W~d)m?aFQqp;j zgC7x_B#Oq+C*D2Kf(|YoNv5%94n3s<&k0bj z+ytP^4F@DSZ`D~12*3wR|T4# znG8$wqk`jQ)mVNrHZS_3s8?lY0yX-wt@M0$=j~_=PRz$ohZe7yq%U%JhG*s`~%RFGQI282_zvaQ#nC@sC;jJNzf( z%733`aQ>GxuOem)bN5D~A#kbd-XKYrFo za5^TZR`l`c0@Cjno>a$lETxu4G5iCCBkh@Ep53>Zr{{xXhJ%ZXGbf)K%Z)3diqWICjITONqaZo-e8@4f(-*(f@B|8?P{yXzgy>!+)cx` zFE_2P4O%qi@|Oh&FO|MFzCDsv1S6rW$*S{dr(eUz9?f5~35DTP4jPXi$2O-|xE@%W zZOKV$`7+yXf9zV6`6 z#Tf?h(xMiB4MY&gJxli>YBrUB+=lmf!zjzdz~M&N@9uAYpot3VS%6BJ6|^5@`y@)^ zfFv?}aFqwQ7nf<{`{=AYUN65lDdS!!?!iXk2W2VQN!WLZEOOf;s5R%>42ebtwWD@@&h1Sgl8k28Ttk0#pQ%Z3TZf%=BnlccU z6a-N62^eHG>u8T`t9M4YM5{=d^K`r0EyE$QAO#V7-YtOHxd@mpN%B%4q8$p-+HHsd z1QmI*3JgWT^bgi7<_p_NZc3&XTi4{4N0OoIEyKy;fXW>5zG*a74BnK_T?~bRTol*g zXMW`3j@KeZXZLnp+j6fqKviGqrh3j8(eZMkhY6t`q^pDpUbes&H}FwU!X{RCB@A9scXda=S1NfFbj1#j>2G+<5ewecs*i0jhAb+uH z`_Ph3SGi}sM|Y{-3*cE$%3-??1fMQn$d6yh5B}t5-o-q4PC+(@I}x^uxKkjjgquY@nIhQ5)*Mlydn(fEAYHy{zHCZR)rHQUtCHEi zzGdu|$SxH|A0ff0kdLc8L|DN__qSFj&lG-hp>t@hkYfM3Xqrc9fVX2o>PJ*Z{!59J zWRRCywkpO!7q{oGGshAvx;KgF1uQVMkYdHDAljmOb`YFL&7i|2KJzS|JXtVC)V0dq z6H9$B%FYGxPB7vdcmZ}R>LH2tu4GRDZFBE&jJlICiF>Od>6RfhP-*!$bjXg(yODs^ z%{kOP`AYG_cz|p8tXmNyOPO@b;M@*mvY{-N^wVE{{3}!SLF>H}(F)wQ2|9$13GJ`P zDe3Cq6N)+^cVW(!1U$V9iSpf81@HJz;(A^qfBO;2$$%S+^(>2frDWgg3(qbWwWrtp zIYV^MjNve^^6L#!Ui}rf5Y?6dA*6xg`y=3XQiuVC{(Z&{;8&$|i}9nzm;6l$-FjoP zwXn_5xoU}|SSwaoC8xY?U0Fh#nUdk9+YvP>@r&op z;cJ%Cbe5OR%gC&v>RCxSt*vw6FH05ysCcSITaIDNx9jUbMO3K5{h3t;s7s3&vIn?=tys0xY{k({X!byu0x zfop6?R+QB|IvYDYmUqEr+A|F`&r@sORY<$-A+D}QUSr+|*p*6UUMpVSSc&)yseGj0 z0XKU<0Bg%%s>FA@QF&IHrPCZpO&s1ptIq)i7#7nXald&R3a1suI4*XFFrIxNMFRy9 z!qm0ql5xC)ea39rN7NqyzkB7baXic1m#wdo_qjJRGU0K|qPQ9lmTm2v?LjLOqk7P5 z+1YDO6wiH!N8a($R0n?@w!g)tHG8S+wzItxv#xaN&;PZ;=k091G4}KfNo_b@;j@i( zRYLg#EnyGTr-tTv6MVLDrKhVZLe7Z&ZE*q`Jl-2$XinR@G62C~-3*)UtJz?G1ifw- z|J0%&*d;s820`cT*gbxgsPqQWA%*OUVv~lR5dLkD+t3g%OBGQOXF=5x8Yykk2|wrx zZ*q81%51hq_YC)uq?%4Ug#|OiSf{p;KJk`d{0jbvA;8Tx(p&IUl z=?$vep@FmO0A&%}`53aYrZA+gHg7O%Q`f9wa=%(6u%O;R__gZ?ARvhu9O3i{=d4aL z$;d5bWh-Pg-DyKR39hPOH4j#vWS+vdRIy{Ss=#B*4UP}yf#rB#H*N?Fj#pvjqj7k( zUQ({^jzHZm`YSmovE}0qb#8hxd6*?#BIeEqr1M6VvjklQ6JV_G*Jp9TYW0^3#v9S%uH2nf6&Auc4}!I zQpS2^QHm_^-;$wYX)P z0$}arRYX;T&CzLF`C@yvrfE*UNH3r1qk1x01CZ3+ zmL}`HjFAh3%ngta+HNpnRa54(;|+;B`*zjk?kW3xE)d-!K~42fPvXxs|C=OEbD%1W-MSIL*+X=~*Rj5Wd$r zZjKJJDlIz=PMwowEhz@7-7V8bYWZkE0zr#lYCB;Z>KCAIc{}4vB+`h1HNvr)NRO{L z+7zDNaX{=_T2OTfF3g|qydPU18I8h8_=t~+l@OJYM~LV7YS+6xP*ep+fjeo#wU-QE zZAJ)T^l!w0=Ihfc9Gn z`MO7hJ2I^%-5XsMo@@sD5^n59ccRmV&7>Xa>>Y}|EN-59uBe#sXJJV9a?lU;sVwi> zG09jDQ_$h>#j_}Fw$`vzuplA^z-R`4VI!?-6T5lsn~#Xij4p5nts*HZiXqbI7j5ig zLikC}ql_?k={8I)qS!&P5hW&0QTQQGA^BI}WcK6q1v#n|DyiUn=l)#T|olf5e z@n|N1ZFP4bzkp_zy|5*jZ5u@#BZUCuRyv#LDu95m!ogSzoINKQNjlTT zkL+abq`7kgZ*w2$0ay>v+fEw2*X!l*UgE0aRoV#=1U|+VK05-pm(UGvM-}EOe(H6d zyKP9M?)Z8Q@e4(&!gdpoz!Z#ctLrQK!m{~j6EL)liwN`0hZJ2Ld%sT#J3UM#C!Y^= zi9?U308Z-a>Z*&p`(DjX#&9w&pj{9weQC=!32&gvOxUOA`XC>TtCUO|fT62<)XKGby<9A_ zHMJUu%*zDTyf4Cad@UK5A5{IL^!|%cr)?AMtUktko4CtEGVz z+L<1gpXgdwsuyqPN2HDJyo+2?aELP$!R~i|ulY3|KxEC^r8aI)euBSzl`=rSGIc-8 zF*1JZ%3Sf=)}9YKzGMk_nnmniOXog5+t%aX>DHK!V-2^g%(3;JNbB?^YuPJwJqy>? znd{N{mO7$B3TAd4!{)YcQ%$+%g-QPglL&#Oy?%S&r0J+v=IRiNP&lGh*YGmA(;7#X zo2flL5i8H_@|EttRQDi7g96CtvCE)h&A_{b&6k9pt zneOBdEZL8ossIuoVFMHRcP4Fm9r4RmCwjl zYjsDS*Uk?zMoBNuYnzGujD9B{HCk}1uX{1Ed2jQ1=J>%U5+(%Sc(u;``?Buz7d@rx zE*K`$ot+M5rq5EaK4ayILsiX=$#RVb|BY$6m;#H^?Jj0)Ha=bnN|9ypH3OR zT#UQx_)OJq8=<7Ma6VKjmTRE#clA2#zpakpf`{5T{u`Ke8H%@gbxP@;0oz|Df9o1r z{AJp*+NATCIpQo_M{VPi-k9;Xmxy+Ojo-x8JDtc;90BN`St`;Xs+h(?uh6xRe-dtdgt|URMiN_&9(9u#0@Y zQvL>V++K6?raT#QXP(ANdooQvE!{ol5Z!{Gc4LlvGG$u*f_nJg6lI{v4r+dUd(584 zW`9Cw*p(EZgyt+tMq#0DAVow;{pF<4ll}TD3DufpPV6Q#%=iZFJ{jr@0nWJzez{`D z*Q`>~#PM6IF{?5dqXbB7;84OcS|C%OMEj=F2)1yCdLnzf6+<4~kgOSbQ8-v;8^fvN z)VJsNWT~!TLMzKC8UL2J$5x`!Fe??tC_s9Ai>E}Zsh1glRh>@7K8LmA`8+V1moe?CgJ*z0Znwp_YIt<=E1mYTqyb6ORY z=+X;s(C4j|wPq|y0lKwl{b!lJv11UFIo!i5?ye7n6CcND8;YXtACIY^j9qAlbi z=Q6IF+HW@n-qZ{DX6H&krqhY@EBcVgA7AWZS_zZ>F3Zngs$BO!j+Wh;=eK4!te9H7 zG|TWIcq(-9y({bEyvFZ3ICZ%U!BoZyAacU^TNp!VP-FT+ZGNqrb|ddK(IfPF$vFf! z&``&l0qz>FzuEtwt31hznn)99p$)4G=KNWP&A?-PFDrq+t1r#;%m~&a@}|STCLFx1 zEs(e-7$oiV^Hp+lHUIMmAm@FMj9h)m*ar4Tclu`4tfLE8Hxgw@6eT&IQ*;N+a10zZ zzcvyaD=AqWxAEL3BHd;0x7R6It*sU2&N4o=-Ur!!m33#L5~5{JrG znoVIG8XsgZTqnM3g+;wryU0fU{`G7auFP=lPqFkT%{-`iL$o%^0%zJ2d0($lc^yHN zkv#h^yZL2Ml?Er6vav&+lnrOV&V7v(LXx5P;B=TNR)h!vaf|$1Uww`_(_F|f8XaXL zy@~+ORb_`rP?lS##zuw@XMr^nyNJmj;Wh5L*NGJ=@l4v@egCl<@iq;oHQ#y(5Rbm7 zl{+G`OK>cf2IeT<%#z38pa1ReZds$->*HveqoYUhTlu+^34JyG$f5#JuGwQpghN%% z;3`dAv;A)3zZF>O)vohPTj^{%KT2eI7-7C=VTR~PITrGz2hG1C za06&RB%6NkwpE~8JIXb#TV?6)V@+`xzQi8G!Jf3`OrL+{S(uBiQEU#D#N*v~Kfb$C zg-&~V|13rHFK^>`tu0YxYoNh|xO7{<>D;eG?fQO0_TB}1S(@1GVQwit1^#llUr77S z)l5r>&}2MwF0L{%E`dbT5h^LXtC)V#n2?#D2!t=PaF({65{c~`c3SCaY@sY^taHHk zMe$Vb7&AkJ7(!G2_V&)btGW*VDzbeq{fc;&&}%?(&OT#p?~#`H%70by3b%$2Db)u} z)wCw)P*$<55~U@`cge%sH_gOT)0JjuBwcT)fTQ2oCw2ZQ(~_6_xCt3) z`&$U{x9PHz4^lm$`cpusIE;n2`Amr1CE`GDDO4Lz87x3jGyA93rp^ToTM3rBZBXVj z!Cx_Ni?35m$DSZ(y(-Nm1VtO>2DR1rziHAGQ6~x}!Q?XfRlgLhoUf4al$lW>h zuA7H=6>Vv^9iK25%xwz>CoPgm<;$nx!+B&O020&cE~=Z+YZd;2ma6boo(JI5gs<>@ zGpwkTKSHE83SjK(LBqBE~=%_RBnLbY7F8$A10Ka1O_V=_!-B!;;mT)>jdhz;v0G?I#-cTip}bmES? zA3A%l7G;H1$?!v-j~O-6KVK6x0D%?L$;5OWFcU}}W_!rLsk!cZP@|8{)C@aX;u>Z) z9{Bl`kuQ#O=qW3?)@0G7hXMucFg)87tR_ey^+9D6Vh(Mag2KFaS{!dVEYq7BX53r`h@DFnR zlZX9(LazUMO^55h1Y7^D7BD*#3)lY!wj4KCkbG8aIT^BvxXGhvggltj^GPXOP^fA| zn`N{41;IqA(SV1M6U%ygJZE%g!1HKJ7bybz+OLi`ZF~82@w&hBdfqRd*2h1Tlgny* z`T6-2C2G|xMT;$+9a&`$NXM5fs{x>0@3M3U!!oic8a6oW?q%6Nf6YE3fdWWtrv~7p+}QyXEikJ5;aJfI++)>q6h^ZwJ=c#eyJD zb$D%+L#752lVrAU8M>FvS**n@jA=71r|uN+MY+|;Wsm2 zQ)z@8aZ+C=(1TM}R9CG>K8r4AAapFiIfg;a;U>WbJ*fa|PMD_{W=?cM{@%w$5k+*z zmuJwL+s+J7VSKxSvAzruSCp%w<9CQPZAaYKfEGnB#W~gf@OiQ`NqD zV{?y)>CN@P`tT#9@-Wm~tG!)~UA?-fapFyi4f${z2#C+En1tJFV-de(2bAj>{^k*NSNGGL0JaC-{^R(mpA&?Jm$8Sg)O}Ln*Jg;~kLS3f z`0Ec;3W&sbsX5_v0Y!rW|AxC>_!S5C&Y+cckjhXqU9_H~N1nhogjG~-#LOUBl)pU7P z)at$@gQX}YT#j&=?#54ZmbFgQU^xT?i7c7oO(;6FcM%vLkaLAj|BRufg<2x&h)mO}O}4LWX#<{9+fyoLdx-|zhqNx1rO7}i!60PV=w!uToL z;x^KgrMo~-aU|oCG&*@{*S*Fx;%Zvx#tOME^4y~#gDxDjg9Klm8`+SdEwXM31QBag(Vi*iuMDIQFqs5RXJ zaR41g)L{D^kE?PoE7)c?a~Lh3SnIH;Mo(aP zZa|<8*5yRMIpvO29r}h=I0M}~!awv?B&yr2+qf4#ZZ|_KS20zXrI2$lf^#J{Ch8{ZbE}RKujAp zL;RLh3>%`*RnYjY?AyD6pNj;~5E_0HaxcE59%HA3A-~T+xy5sQjBR(T2RSgb!L79y zHUYVXvzD|w{HafcCO<**Dl+(ZQHhO+qP}nwr$(CZCCX^-6!eO$w}Y- zaR0zsb0#Y*Gw(B>F$U}YVUqz!iz$}r#%O%&1u+-DTIZV{+k7olwiG zwJAf|tKr|b{fYI7!cTj|o{8$&Hk*d3jRHV;G0lrfQQ>~9jDwZhjHY8kr3Uk}pvL?< z3J(6#kaa&w7WLeC6Hm?8eVHOhmy|bQB?TNwEtBzEvP95S)&~Ar|1b>;x}LX>*esl^ z>Tc@)nCXp-+!`*MJaHAdVqm^-%$6{?kJG%5>pa*eegsZY%_?fA$y&~ZMrW~5{iQJy z?jkEMz*e&`=9(;8(l~!8sI!Pz?ye?~b?6ujlS8mse|)V*Floz&gJrXjL(GcWd0Ar_ zyX+=jErE~pUN=+waV#_^C6HN{ypV&k0+ph?R$%#VaGkrDapb}P=hGRO34w5`kSG~l zh$2g4O2xJT%qPH=AjHjMQ*ct)xi*)V?sbLjBFQSzD@jM5g;spGOUsyGG7cr@68%&( zF*`p-*ji2$okQJ9;X5m;r?LW1Jlvv6==Mvj;OOGTY)VRwq2n_~G1jQEDJeen z8cDzvn5;HG{U^iRGFl5J(j5QE>LEs?NkXikYFilzr~Qp@xvz0_E;)r_a|r*Ol}$x` zxDFD0h|vXk2Rkrus6F)UKhZwupxk-oUhhAdcYTKb?%k`)!p~Sz_)c#0{|n&+G@JD% zvnVwBXlsVFPNGi&07eF4$h#n52t;L+iFF}XOq(SprlmUVjHKU5DTq+^z)+PQSq!_y zpTS<9WfdLo=s!d69&a+0Qz$iZ4{RP5U-{~M&5%woBD+f7u3%w!km1fFJ+vw+1$t|-hN z>rbG{$;KP4_dGQ=Cj?5%NJ`}=XrJpY@d$E5X})`u4B_m=o@u|+BbX^nRPMT@^Wt)~ z{s$k5TD$0j!t#6w&dzMLAgXbo*^=plSd_P|2q+ce%r|{K11AkCfRnNfvIV&bx&zYP z5_HYBtaAcOJYXHu@LsvL?OB4iwLuhv1I#`CPt3`Co;bKeOD{|lt#**A*po2)G8w$^ z_5|2KgJ@?`q$GQ%Qk-N?>*ZLcocc|ir^6FCdi_x0@i+3}dqS4_U%0RRCl^_qpe^9(Wf_7%DI_QUEz~M)I2+K32%gry_ z3ztALvXIM|J*<$>4f!@m2~44UV5nh`Oe0j_@$;dt#0vu9D{UB~g}w{z=z)$v?983~ z&J82OBTJ5nJI{}mJ;}W&6uO+o?7i&7uJdD>k&s;y|K5`CmwWl{AaAp|`cnMtN+Hj; z7(W85^)BHWi7V!`#TA%E=u3Am9vvbnyV|26|5Bm)^#h9+Z`=(l=EOHm0XjHM_f1sF z4U+2~cEsGNH&ra6OV9a`0jb6S&B6NPePfXm??mDv!BEHGj-*>tT){bvOB^cA*YuET z*2ccp^cEB&4nL%R5L=@w5mBgJ)fd5XIqcILxt_*P)@X`+5XC&9ro3mPisHiuj0PoS z7$aqd>HKY^(*s`Fmz;E-R&>;bX0Be)fRq=chxT0J@MII=q3Wqf*L_av2THcXmfL@- zXm{=%bdACWWaIUPr2O|TKE4#XXZx_1Im`v@;qcm*yf)>yrJAT?R#lHa(vBn~98{RV zzI=kvv!cOndTFRJqCz1LAf6%@G9qep`<$tIbc@XG~U z!`TWk%F)byp}1yMr`FSNTT5k3qdUsT>8 zL}U-Xug1q{ka7R|&p#b@pTbm(D36dOGo}p^+qFhJ0rs@tEr_xP)NIosJH>{Tgw1%l zDq89M`^9h6eE4Irg_JIiMi(ttux@7Cq88N#slLHAm1tzEeWaMmM;W_$iTQ~CMvT2I z;##}CZBUZI0Q|BJz8v#yy612qsqR(8|UZ@*SFHj z=56@}k;^ZMjeg8~dW>sl0yUU5cxC#nU)q_B92^O{ao)#W^7Xt?&_LiE;!NiE?F^p` zWg0&~kaP@LohM8QSs#+{5Yk@wd9Od}O`#K>a&-2eL@>eqXg+_`h?R4g0W0s-S_2u-D>>N?Tgy*pAKKQ}Qr=F|{cd^7E( z&*DL2bM+*Ozi$bxTz!Ny%MCMk*M~POX?uzap`tu+q5X6P;0#Ab*WY|ckN$G3mIzU< zoOoPlEn|~U7ZqV=1>tDPXIDt2aRSle1rcd<*UPSL@_86VL3ZN(tG9nJNhIth@}=dp zqx7a<`wZ!Euz+#D`8-C6zNo66#Y_d7Kjm*8wjLN*!>kbQW8+KMd_wZ+6Yi$*YT6#S z!FJxa%&Ha(_!i2Tjot5@^Y%&h2Ud2^2JmXgQH(Tg8J!uoHAU^lVCiK_29uSkDCrpT z5?4|{3!-eAn?VZR@cO}CBPgErj4&_@01ElI=OKnQ;5-&#AafqTgT?2>lKy@HHD858 z0$u>0uW{8=WCkmQxop$f#j+IIJ&2!{0TQGzPT1tgr!=5a4~Y*ur-kU}*)8pG%gNsy z@8uJ^j#~;~@-o!hyR)lEeI_UKyb)|YQt$mRx)uzo;i}R@!tL=yPaFv2+%@vfkWjY_ zTSXXfX41(57@|?*kVU0IV~AqG4aT;F65RI)iv6`)V&rZtqQzu&4X=Nt=nA z2{XaosmO5`g7$prqCBHNa1ni~2rFrG7J0#0-%FSPlicz({fLg!$_l$vO z5!P^}gAnNtyEg09wz!kp&5ba~$-Leju^;A9OuMWT!&Kyq^Xub}@*^_4p>;VPqAwl) zR!-4R0L!LlUIT=U&AQiEZ0WK}__tI2>hg?YPwZ$b=nJ8y+rR!yx2&iO{U_R1{JA@Ke53 z6|q%8#kW96jLJi#m5#cXX`b!y6K|`5Y#)sOg1Pqo1NLvz)E7BOtZ~30`(oi5ppi8? z+2TRgaQDBz>er{wut_6IJm@1}(zSJB;N0>z*8PtAG3^@#5JqK_W7OJayQr6JN&P+=8FPv%};GbmRBdr&TX~tL(~>}Z&)AqTL&K-MuU(t`zylf zyd~7C28E2>k2wwPQLL}d*YCBv(TEj2rv;s%yPbaTmcAe!beMES{%fQYZ4gPQe#ktM zow4G!tFN45CtwVd{Gr6D)Ip`l_e;_h1i5oZ!(e8e-cz)bJdl{W+= z+cP+?$%bFCN1jz;+p!N3anWNU3&35*9tRnjr?>csA-u$S@kA1T&|pCJXbe9tF_*22 zMC-vYbcu?wxw=%xL~U(-sJ~(`7TyN&i>|Fkm6K#fH0JEHSpkiLi1D&Qj-x;R$t7&f zPXV;(4Po=ci9CgJJ0~cNvQBcit5j+DKs?h0sSvIiS8~1W53W=G%aaEmka{BYVs0K4 zNzq+F0UPNcNMnQ?u*^P|Q(RW(dMWCsW-g!|T;ylPvG6TvlOqw|G>KcFwlTsKaN8{+ z7W3YX_7M=8p`ht9>{l2QW^8S@e^1}BmSkmcdBDQG4^(35$`n5-18{}DUV67rY9sd# zg}^9vt9(2TZ4Nhsg(wL~IK?)6N3pG-8N`Q{FO@+zB113B{K)i&&VD%712_xHhRCYO z1jk+JVsi@ViI>tC$W7x<&LYCQM)^FRPH=7)UPhNSl+Wn*Ql#IrN@rN_z4xOuPxq^jkqY&DxY^jkid5oO|Q5Vm>P@4`bEQ!^F@X4$kj! z08b2(0{ewe34|_KrLczeLuunh%|SnLMgc+IooLd=+c10mj_@Hj*z6x&ck`kdVZfJQ z*eUTQf)q0!Jp@!l>7YKHIjMP3kpy~~#r#sDchn+h6Ag~Y)Xz4axVi8^bCWydw7C-0 zqcY-3H^&idXEju&q<`(1PRs9q=qa&D?JSq3?MTCog{(L7{x16bY{qBnKk)fi?gL!= zS8a^AP@Vk@U8VNrs`Q?I^!;US!aWIMqB&6VP$+Wjxo;-m!|?L>*QE;X77gH==3^T{ zk>ygTD7i_`=Fl)PJ!IY2ct$8)0x4dHKZgGl9QC$<@X6-sr(JNU2&FW5ZGKYBBbSGO=;GW+&gEW(8M}veZCP7L}N%S%8qt zD{ti@{+~J$`4T6kA#nhXUn9mPV-@6}#JUc%Fa|hDlc3nbgi_8w6DP(_e>CzfyohpO z_DH){NhP;Rz9B@MMj}XKVh+fSn{kBT?^X^P-;6i#vs!VJ%=*}9AAM@kDa=$+;x@jse=?ZIC)Spd0 zyd1A#xV{@`Y6ka9e_Pi*y4STnKSOh)gbhiu(wH~t7eiX2T7}b{TPgW8{LSF|uBCXN ztZ3pb)J*y}0$6UiP4c?B?#SIG8^^_K9C1jKQu4St;1a%D0c+m`adG%a` z2ygB|2gv_2@uy0)4IIgCDo!+n^w%knE+k_f9{@9*)an1jN26@D8c?mT`a~_+i=gRz z?4FfLh*_-PfwDu&#avD=zg!A}(x~Z6nr(pPet@*EoXzx&0rADLq=vT&kOOKF`lD@{ z?gh6eMsA&ZYTH9DLq%gJO^|C_C(X4d> z?uDX;2r-(U_^b4Y=3AtPYdCmJkYvC>!&4GOH|`Xjom2e2~5_ zZwBWx-5+eZ42on+Wl&@XtJ2C|FV2W&Xdf0kf6XS>)N+IpucTt_y+jE7c7f#s2$6!- zFD}ngT@H0j$UDYBHRdND$mjZj3g3A87_kf4a|)3+I7S{JV_1gkkzh~ynE2rL;+i^7 z^|+M%wH&h8?T%RywO(R+*Rm;}9*YnA5_Ou?ugyvfixml+mPW;~WE!OUh{^|w3>vG< z<8%Aj!1dEJ8kfNw9E`Io+H!){TLx^wKN9a=njUN`QUcdQ)7@KmKkdFTO=@ja96}WC1n4PeJ?q4#13vabP(#&ZY_J%MciQ!&n2BtU z>(%jO1u`X_Ck1%n=n^@^ySs~7;q>GTJrcz}IAu)X<0`6WWiW7y8~Nazs^@dIV3ra@ zB`i&`ZhNx1A1Z~kXH{fKCzP)vFC-aqEH;wm%;IC;^f~1}6ed_8UYRV^M@J-$KFcx^ z&$}efG&R{x6n~OyW?g8d3ok@M{;Qpe$ltU9J`+!0cyRQl8lIACNXN!c0# zZV9QK!TL%8H`HcJGr~;y(xavE_u4-jnfr+1cC}9v;XcB~yYCP*;}f!3Ggg#*-{d)L4>PJz>!^V_-V? zibT+q^>*Ilh?J6BsQc_bI>$1X+Vj0Yh>d#FUkS%)ki- z>Tj7LAfJUWAE1?~8Mlk+sH_2K z^O@#0K}(M8H>;NR``6)gNC%v6zM43WZ5q|CL6F($r%MoAg((`l#mE{}R@I36MSmo@ zvR=Ehtz-QWXkvaXH_#6FrVW97c_Gn;O{$)>KePWV)gU=zPyx7PCXBqx9B%)n(cq?W zjH}-&vXO$?q}er*Axcd)N%iWW1G+{cLa`A-w_FU#vO_ioYal#uLmZDNh1xglh8<0gr`ijrb)(9)uY-QBc41Lpi1mx zK<=TeAnd|W_h8|Nu<5YJZvM^+v{9hIBhHSCl#u-?lg(lKlx9Lxp(wNQjLLPSq zs*10ObTQ}-+Ko*y^YOSW->BAN={BK5+dg5jz+l)NyP>Miz;~{BqFR+3??$x3y}657 zXYM$3!3THFB3mWF0QsD019Ki8#U!g;c?jba=T*c4}gXs35TCOXv(GT zhLNUbiXDWmbCdtN1{5o$KBX@EeQUZhiKYUl=|1y}z%)V^ywPqMX$iHwegnY&V`~H=GB2WT`%vF*PK>>}#ga9tTjQhVQlg z-SDtjz+Ybg6PoTzM|?y`$hb zsod-?H@iRin0^~K?XbHbhDzHu-EgY|0m0OPFQTHgD$l=jr!aZV6}#)Sp(|TG$uj5; zhX>8IyQNUlJTHeU9F?xVflMz1v|DK&@Yf_8%W0m0;yG59G^^MCH>(pI^`c6y;6Gul zz&o$MdEy(KL8u(PAQ812vfcnN(>m1%=PY9U0n}P$Wu0|<77M^@eKFV<-clN>giD&W zQ4&f6EIK&1L|5pt>K*_wHt>IIy_duZ)S@{Nlxs)Q)huW6^Y*!+=7_}p+W7hLdxo1n z<(*e6te)sBpZ4N{VK{s-{MoxhlK{W7Pa*{>unUJmSZ2i2PQM?0K zwCSYe9&6a-vy!$Tyy(=MP_qUI)B*_Syh8pRu@53x3-#+2I5C(;E2oB*G8X2mKKJ_k zm9K{NX)SHGy)V!PY6VAkgnPvfM z%o=Yf3eO&`?*{=A57Sy1`qz`QrJGtwac<8u0z(0#nGSS=Z7lR?CPWcY4oPf^vkV@VB6p1i4Jy;oHM(b4r2^4_`Ngp=64t%bkF1=gu@Ef)5rU{a9# zZlBObynCUqgjPDs>4SRG`fxsLO#@skZ0y~LkZSU}MHRSKB+}Vl{YL(^q#_FUQ?98d z=+xsdw>Ysp0(?w1*?yx}w#1w*{i;)DkHy~D7Z*n8D zX@dX^ZdBxeMMP1E4>uz*5dtSqtQ}3oy&ssyip@~eB*>iu;4hk%|$`AyjY622=8h2E6K60?>bi%Vwh z9lqvpK@~rIwbX0v6d0<$J!M=sGSt@ab7O00EDby-K`RG z_@E>Q!T#U83x$Y`qGI-|6IwU^AgV^(S>4c1kY|K#_ki0VI|8GD6>UW68a*qcfH9{o z%!3j!i)+Or5Qzt;0g>)3L)t-@aG$Y-8qv(X=2mJM_L*h6Z)`Uf$t`^1pG8UKue6Bmoi{*YpR@)qBg+HJ?y^0?-D+W2dC5U5Qd7`luo@-ClaPy6K zeg6Gp&HZrAxSW{r87nk&3gZ(k)m$Qof?`Y3oGXfq+HZP^@@vszZ$J;&U~g(Tx3U}! zGK9-I!it!S%?SEo#`>%);lpBdN9?#2<*d)u3)+lo_vg3BDJA zhp(NN%5&#!Ku?T6S_3yV(~M@1fKKc;ho~crR`#wt$wGC%?rqDkEv<*8Q5%_5GtCZx zILK9_=w$kbp(HT<_3`h*XT9K?;Ocwq4Z7~|jqu1I57ZwO#n$8OCPr^vV#m%V`0ab; z8RXq?FCKc7?a1C3&ZI1sY0@BVlI+b|G?~Q_kt-*$O@E!;XF+)YpkzW$xZ>vEreZFL zDEjHgKGGiZFuzqn#XOxOMBS{_m-|^>l-ze}DMTXAjj5bpr=$1lid20aAwBe$w=M=5 ziqX5KrF!1I;>OD>s9@C^?Ce=ZI5z|UY4Z4s{f0U=GAcUiQ42$I5g4z^cY%b(%KPA_PEDav325dJRi6GHvW-!Z zR^$&}vJVRak~o$&W#}i5&1E~7$_o#)ckQD!4;?*Np<#9IQPnt3E+wqD9)W*ZT#!)69*KXROQ5C{eO_l`oh+P4uCLog%3uM-5 z>BE)kh8v1o@Yq6&p|g-6Ey4sPbQVKMp{+)RoVBQz=BQ2hrBT9)jB4QZq3XA+MF>Mk z%WE0*5eZ~N1O(*zC$XT|mR~iCl5XFj1W&V1Z>z6CRW8S1ip?jXK&u5CJuH1&Wf5oG z88|q7eAsw4nwe-ip4>ov{EH>GcCmhUsADNOqeMt3FMP5y7k)5erBz-;i`y+@QE2t5 z8^!VHB@@zs8@b3B9clBgWL|Q=YbUN|K7aoJjxj2txa@Nx=YPNJW5Az{= z3QSM5ZIASY_+VQW3}1Q|c=PEt48IA32ya0W$H+&#?C^Y>laZnvUI=vz=a27NQd zI!D3~*zHznVm%krE}3%dUhWQL6+3ISKfZz`^-|PTfx*Abg2Pff6VYJM`obXrh(S~S z42#O=nSbwh-O-8z4b4rw#yiUGaw=avyMcfEr6t(R^lD?ZD=WeSKSdG&=C0A}l3X0n8r6>an(`G{E+XNEzx9 zPU**9@#i1NyqPQ37;vwYuUi1CO8yfz+Y)=066Q)1XnW#6?~!*Xcyjl}=~n6=sutl1 zbrG=z@iiiA*9{CJu=*TkEOf21W-<~-C`d+GY7>__L`PW=6d?arV3~p3L4St>|_xy z7#umcA__Y$PIY}Yfc!25GH0S8uo*Cq}gK9erj~jT*zm zyo?2k?B_qM+f-<20{`7GnBl)zw?)jYoQxf4MXdhmBZQ0%ZHE z|Lv>)pLEy^Of2;5|GAF;5OXurvoieG#YCx2I%0{U-{yGp8dZNKXdNnfEbcT%#ux4l z(e69^74K{zs#A?!W0Zhm+|XW!QK|Yf>Vo$-9_|VwZ!DJ&88qhHzD&TyUd#`xoB&m( z`~awktuMOIpW^8i(9^~D`*~IOm0<>rvfeqxU^Yt^jg#T`KGp|zqE;^O zWg3&~V3-yLFc-jQZ{i|)v-Z2{opp~g>i4bDa&=SxV(tom#PbU{b{a&JNW7~KCCb7?!F$F{2v$~UomGzBWvbtw7EjeWR@=H5K-+iqYCR$>l zwvpkJfygbTn9bWyG1O<^Y*L}|h?OLLa_A&?oisDI4mipp!=Bncuv@ed`1AOr7eKRP zhtD|n;slqKRlVvM9Cv6-{mbQyrLrF4s=_Z}&=!=k4*%&>4iw;)k2A^#wh2;2lc z+x~N9dezqJu~~JsrnkZ48k1JH+rhnf)0{T6f3?@;ycjjr>-HcR6$SM~<8;>hnX-{_ z(R7vxmRp@1MZ{f;LS|yz=KhW>GLqP@c(72*m{eH?aoJsz%yp)6X2vs`yi?=ZT3xwD zViiMaP-f|d-U|wl`ph6~9fX~;^(b5f$&7?7GFCstw_sKh&sdtqqv9N3Gaz@~4VSw! zntR(&GGC1{f`eXina}k)%@U9CT@aV@zF5P>NZCVsY{bsnnLh20(ha{>R)3g5;XsP~ zChGBD**s#|aJ^w(NOP0rBpOJ}tFkWZJ-+Z3I10_gNov{(3LG)c{!?zZs8AQBWaa%& z%uL)HQgiiTHI&RS;$BwN&aa(;gx9=)wyxH*?bbGCbg8#{z`HKc0D4tL>H>s#IDW9q z7=X=%%VkxjMWl4DP%nGMX8eB~)2XYTmOHw)V$=+SHOQvONIjgFFY zSRcRJZG(~NPLNhBXtg_*_?y57IMV9A^-p7-zH2m%$BeH2)x!Ww%y4J1wvho(TCR+b zVB*_vhQJIP`uRWJp`w`e&NK0`2lg|8o0#;xr++v|6q`f%m?&KP3CH_Hgk-RBio@V? zt~M58U2kJnFwpo%^jmP);=!RHK-JMj>545Dt=FN%fcm2upcOs?z?K~L0FaVRmWsL| z#WSv>tCgrv&M|nWWel&^8z?4jf+)trc~0G5y7rC26B7|5Zkcl|$3oEBF`ADV4u-7V zQ?HSEht?*N^Cc$1Ib|Bbg`UAi2{7n6PxY7^!;&6lE`_m(HQK`p$l*KBJ=S2rb1McA z4$+V7SF{X8nVrbPh%1B%lQypC@HgVGIpC#2`_Ig|Y#d()A&XfTkE3VEylTD9 zM_D=H@iSkQAq7-YaP)-3t}K*(_CnlK3jldmfW}hjUg&f6`{fB;JRF`S^K2Ah^jXSg zs>z>o3}>h+({5g5+&&2lH1|*u$j2WhU{rgBSmZGPtZd>J$59RAfHC5M*`m)!0%r0r zMY5F@Uw)@AQO+0&65QVlOIa_Qv0HQ#1L^(&EMuck)+~eas7Fw+lXtL6e{PD)pAVh~ za!QXCw@wz!(E;ylh{%G-xW&9pj5b#rMd2F0B1?!rpsQaAq6?|5wDQj2NMaTZ(Y7L( zCLO3*u^!O6#>SYo8LNPWuPpHfAH~O{R$PpMi@rdR(JWy>x{eweAM+fe!KW^{yoLl! zXe|pXnbX83NEioS40=Z!14FSO0`u0suviYKJ+_D?>(FwIveSu$m^|TLz6d{Z0=%mz ztlCG^TR3>0vVS#?_2&2es3T{B@Hu7xxVJhF~hGw+LJ6jS@Rc$u49bdB~ znZ8h1DV9@w$6(PY)(_M_HDiwr0HBLv;UKrJQ3ueIB1VYO5sSk+*HEn;*U|`RAg+0o zQ)p&o;WgV|fg)1gEj@qqAXu0a6gAOvP)$k8J&iCTQIt?Bc}8eSi0n9OnjT`5oZz~7 z8}fu@;nf>)Ts|sH%U9l!mN9m?>1gRV;KVLWmS$+<6A?bKnLTIik7R>x$PmOCe6X(w z(y+5LJ!{@(*2$({_b*6bCAK68K>(Pg9X?W*fgYSsFii$&f*t=vIdpdq=m_9~*W?Pd zk{vH&kP|70-QXY9D!pUi)Xyydl~S>F;=jF?mXMCr8Ik$qFuJ%%NffF#x8?Buq2@?z z&mnyriu{<0!nsKakM>yDaeBzDL_YrQ9e)_NsR%fcXQ?>-eN`fFMrs;p=Bg zuqexSBDx8F0rLXv$$j^p_2qKmM?%`kHFq1Hh822HL?ONK8GKU$1k$&-w#$i2%r44H z+QKH1ct&PZ920lz*qvmzeSZG()lv}aRL~jSakdSZ%=HYvO%zc$yHu%U?U0=lZSd8R z$fa^SchgfG>NyF2K(V8qh*e9im85!Jfk2d9dr5@4-|xr_<&3l7%OY}@l2M9Evvb}+ z@J8-3@nsx8-V3+|c%I=p!E=82+*|*?`rRY0j6&nSG%OZ20jCzf7TybdfqlIbM9K`^ z>eiAYHV?7WzfZ(o6t!@oyT-dV`lkB!2h)(Y{&btP3olueZn1kRvK>3>F3^ zCN_4wz*NjsLw$WV>1YmiLB(cK|Ls^j;jGvFTh8`iyP;?-kE}f;$ z{^97cVte2$(0D$+TiV&5Oqbi8eQw#~i|0TF%cZ8T`a%W6NiWb-&z${0FT1ggX4>9X zIVxn`Su8X%Rjy{tX>bfY~I|YvRRilHZdZ` z3Nje+L(CJwO@qJ$%83m6%fkf#gP9Kz#Kob(;K3ni0Yt~O*%Jl;pJKJqLm~)-rDL8{ zzO1^$(n2ACT77>gdpG<1e)M>3hrBW*Q39GyjNN%8os{q{Y}8Yhq8nQ5q)e190dzbS zL$IQ=?zSBgX{>KI8Zdqj4Fqhc?MQp8w9mCHE0knNO0i-!o4ZM!h7@FkoCcTZnv*x| zSBE^;P-9L)O1%Pu`jqz7k_WGW`r_Zl^CE}{H2fnmgD{|_u2hZ`>Bg-%7_v{2FoBU^ z;IERbo(yv-$b*qPZDHNvmyr!22*7CAXIS~+G3p1=uvd)sw%-1!_ zmiHFBb2z(HHj-11Chj-XI$QG(Ua=MIdbmtVJqwpGUM%+^T zd~l0w=W;7!&R>d;(^);A5^uBY30()aj(;A>772bFQLN*r7LP|PX19qWgd|qPqsK6w zlSM|<#F8319g<0!kTZUR+LnY8YH|F)<@5B-sxRDe$uFxon$OXO2*>jg>rR|HTuEo3 zGn016wG38oh4((Q^JrpUi+Ayk{BAj+8y<&+cA}4wzr99O_b0@xLm(>kw zlNx-`EJk_|CC`MGXdFV;43t%+msextSY({2eub?r*uD`b${v1MKd`p3RvbZ{`{TF{ zPuo}EBV$&p)OYmgIH{^Y)GCnQ*lY(x8YxKeP>qEjZl{qGWZ4MFjmp=9A4|8vEvZOK z$HHR5qAdst4b(?1hWRPt5-oCqK2eq!^!%*}F?CXnJRpAUB9UY;?zp%WjV0t3vez=vghnj#a#&|*W|@tWTcp}8S(@yMYj5(Ae_Wc|PnNWU zRd;AyH)rBm1*hJr4_NjyZUx?6Fc!I{>?r@+@DEMWhL127*c<3TZk|BgAk`v9KZD{y z+`V`ye$ADtKpX&<5K^5&tnRo@SGzTi7J)Ze8Y6qVL=;X4h7p#8nqtm+ST(${f+(kUSxHC4%qFX;$8F@t)ga3;>9@;R@fy* z4?ti)do6ZOhiXqVAOK>?V2MHtq1;90My25(8bK(P$nRS*T(`Hl1c)4A$gks4`x%pI zY^tVWC@xV6Q7p4Thqd`gC0xT^bMs!K2rJ009T%9gv=kBv$CyA(zYXowXx}WZ96lbQ zSy`qfcJi}A*9}HxN@7Y$g~|ODf4~!krQPC`%b-3{jR)bB?TS%Bb$%Zlxsb}0!q)4R z)Xc2D%*LvuoM;^Wk^8hI#BAkjw3%RVCWF_c#pRazg?tbU53|nVXRB~JnyhgUbEPj^ ze;qX8pm6(~Km`SUPL!=alqFVwo(Zx`$w!Y1r)ZB)b=Qw=jv=$y8r>H9R_{ak?Xz1V zgR3)CqdzxvhZ&Mdn!(GYt$ol^sMIJF-x3fu9Iw5=6er`-!-;cya}$Hx+Pt>9a#MRT z-KU@t;<=)-Q8I~3s}WI3F7cSGLA1=81M8KJDT5R+`*(}+7f*KIx&vTWwxD%l{$L_P zQtM9Pt(hJg9fzNZD%{L3TX61Z^fUXz5se^p{r+0&mgZff11#06mYO=30oS;KUq98Q zbJE*7x!OV0h5503x|aJ6Z*TEi|JY*I@c2Mxx7FB2!^dl}={?$*b?y~yw7kt0_4N$TzzZbIE*h$Neoi#T z$BZqNwG}6OQM!u#k4PIR@J#+6FDN&7GXU&8#lDLyn;k4bf|bTRUCieU{hTw-#o-J~ z*pmy=^c==1PsCTJzi5Dld_&U!la+lacDQSO4w#dvbu?b=kWlqBC+9$ueF!tI=xu(E zI{-KNIJ1DQ{<8q9ewBTXeK8DFSLf+FU>6V-?18EJ+*~-B4^jzHniF!4o@$wm$XEEe-TH1 z(?H8Q*%mF&CaIq!?J${t$-+GKU9x*2x*p&!YG;y9H%~vmS+7ai*MEPbSqKgkhMYjk zXZP_g-AD|!s8WX1wg31;wbUN6e*v6+^YG}7{t%G*2*5u6K(dJ(6}KS@(L`h+vHRj& z5~K+KM6Br!eP<2dd#a&4MtUK*Q{5D=XA_;ky{aOvB3rt%u?#n7tf@|Ij+%y88*tnI z*63?*p)+Sy@~Fnt=Nzcb+X9Z7ih*1k8)1&N%BMb_Ri+(cebh(xgteU3ec4V_T8q{c zMtDU2am}@SJ>Qg)eU+Mx${t#a!L|~`7sCf9fk%lzA{r8eBU8W$LqdYX6Uu4ly6+>s z1O9^L4NR}rk!+s1;V^uZt8lEa*j?Rewv1-$f=+Lx$Ke|RtviLc`h=hH!9Cp>Xzz@h z>^z2l^2UDY3bf_jJowBZu41zW%~q4d%(C2T4XvAB#X{8G=;6^(tB{_#g_dmN46eBy zJo$`c4Azm1x*fwa!RZT~xdlJCc5#cnGaOpIEijFH20r@*T%pDP1$VQCD|OZX)V}Kt z?k;{isvr6l9OD%1!ZGy0{khFM%#3q|_>2i&Wp`V2HBIXc*v&dAwxIG9x(hoTP|(Sq zU>nUDy;rUK7CalwdMEYz{qtlhFzR`3`sVYOx3R`ID$U!Ve8vhs&~fS}kuz+5GmZU5 z|CaIX65l{t>VAteZFkTM)DRNqHUF2_D%Ul2ZryULHy`&Ca8~qI*ayaQ3s<*K6z6u9 zdb!b5?eVcUj$fK7j_$FbQJjP#)FN<$NUrLm38hIi^UsUhjHkH<*FCj z*VE<)+-tpd3v{=(c7!#px8doq9w;i{e^qH&1T6grTQ%I^yG(*qU-({Q@i7gp0Z((P;J1?};DwdGbDJ2xhC)-LAu&*+^j{p0TAK>Zu}*E7=7ZsQUo zPXJF9tq$;Rpl+`}?E307-l1*^-K`gQE|=*Sc6)N`wR9J1?Mg0hs;jj>>nU^>es8qv z+4APyyKn6Y@=kaySZ?N9&K@^A)5u<_A+m^nW1;_jHJ#4z2U-&cSz~ZD_Z7w_Zz@5*T+kdrX8ensLGP*7G){V#c$wpqGv*WHxZ1Af z5s}{^A3dw@Pojn6tLWx`U1rmjgD~bsEVj%>Z!>SK9z!jMXDZd!g5Hpa4yXnP4#ZK7 zPLTo13#5PPnmp%{Yaw9A+3lqrob|$|RoO@nSfwC`+^H5;fe*Xpg?}SG?2<|MtAn%4 zm}!NnOlw#)mdq%yL&#V1KO@=8h$j~+Wp=37Gr_L#7W6x%f#Dd-bnsed9cZrlgx|d!S!d}W>!;~U3F6hg48?WbuW~oR&o}qo-=F90-Q39Q-n?IpYJW|shYvR5AQJ)`?>AKIes5<|EQL)P_rm0JGj|H zk+!88Z}X|yZ>pv~sClH;#JgOmyD0P~Ljsg7cGdCu4&}7gcrE|FiZI(4tQ};=u2}P5 zp_eV!m~6z&!&fZ&b^aUp7a6KJ`ov$Bhkvnw3PAp3;L! zw_Nj{RffgXMLf;hEVWhx+8ZyGeW=6w!43MA)f5X*LuJF*p zf6xPwk7$pjLK#I}(o7>fN3xuAOwTWA)@t7OeibiAk16*Lo!{%{KD=*VuPxtPx4&Y( zFPGgQIwU38oWEs-Z&nnfqg;`1zkwXW2@e={e4EF@Z+jO$oN4}1wMOWB33kJaJF}dn zoU_MyKFN=j$9{;Qb~QmaA@(J?nQoqxjlVhgIt^r}eL~jcGM8;uat-S>-OX|DQ-*?C z+OSRYb_Hl0iv+%6gn}YjRk@~EB_JV}u zwu5?H^ySpFEQPMbwf+x=uKbbd|BrvW_>@p8a#xDVmHVbrRKiEfeUxj?hGCe^r-bB6 zLe43na>d+ia?ZIqGUnLa!`Lv}Fx$TVgXa&=_w)69KHiU``ZL-r0nCfc9@selgX`ed z)**TTdqex&(qW&`?gEP4S7Ow;+)((9 zGGC6q1{jau#itcBPebkyvdZ6}Gkvd;eFILrPZePl$MvV4MyuAF_5SN@TVpcY^2ZVS z$bO{cK29$9$bTZgV{%KfUF#hezBto0njhhH+I`6!ikHT`J-hJ1@XLTysNHFP_Akc2 z(aFcQ@48Bu`R@jF>}?NCoH1ZoLzPve!==NnC8}&(0eP(vY>~CXwAX+cyDB@aJ$ zKqFoIdgd;C50HFi1wVE>`k*9@)>XFREu+82y9s>G&FJ-%m{c3wyo0Ufxq#r)DXKHX zDHE&=t14Vw!?RQh%*-Yy4!#BbZT=A1LBkSV|_OcCNVF%!^P!1!O}%A=+3y-#v}d4z!(BO%eH3WGB$ z{o3Bi!!9>*7dK)DX+K%*3h)h5`&6MhOzd#dQz=rg1K@CVsPUA4eB%@hIbG4whi z=cuP$JGrND`dqNx^xFcW$kx2#*3{gF#a`ZjSOKDAlG;3k2cKm(-H!+LT8aM6;x09v zpECE#`%{qqyZ+%>%>~niBsLEh>Pmc4J`sftdj1ONb}K6)Oaim!Sox7kX1qVPGfKD9 z6T<@vk{^l`FHZeE(EXugmAWT&gKD$-+-3W%Rfp_okb2F8CuRhF6tQK4OHJjZgD-j5 z)>HyQ;1Crr-_p^ClIr07xQdR5jJ_s*zjeLjx~U({H>)IYpJjJaRg^Y|Eu6)93p`C^ zAtG)c!RJAbh!I`Cd!Ev&>rk8zf^_ajSijoB)s?qy={uL0?s~fwQ|0@@p@~8NIzCA| zUp>JS*=>(u{z~nst$r0fBByUu^A2ed^_8ZY z1s!9dn{5eJT==VVGME_l2RC>3HRrDyh4mqTQQ>~^4h>eLjdzp*3X+9G^M&RlQhoK3 z4Co8U?~~;nkuv0_=AYpnhvP~W?g4XUbr$4vDqra?)c>4boA`%>*|BPsx>`OQcykMb zLHpgIxK0!AOW0~c_mm`-e?B|tc}@bIb^|ArQN--IX^dw3cu|{MKhUeriFUoiy~K%C zw4Zm}xaAh`Vf#HQh5gDiLfTLIJoFsdNy$Z}pb2%~&thgV@~_%XVpHL6tfX7s_89W^ zVY*z9IHcHnAe8wO09AP4+EpMEACYV(pxlJ0l}A1N5NHU9-+75baH_q2DK>F#iqP^> zjGKxkrJMPJRlXXUAJyQLq@$XpF@*T4+pU5?ahgCM+z+&OCO|UeiM%}X&&82~_|M`+ zZ#0Upa@>##oeoN-by(%!J#d7=uyjLZz<7PSs$Zq!%YbO;Zk z2}n@>D%N@Q)tC2KeQG%5mKNK$-&UgV)i3Z~ymuBb1NaYeVl}_tVL}*|;#pC)JTwK@ z=&tdAW>2i>@6bJ?V#qZCvED;HhLO0eowmuGfNhBV9YL@6S9f_u zCThBlW z)93eWA8>C!KSFk3*uDB(?|<8zZ3}Kp=(pP%_ z*JJqi4R%mO0Wt(?yJ{zMv>EMael=+n^uebPVhxxc$kpIV5p$*v62o6jD)1TBC;G$m znp{Jxy6`x?6g%;^BI=Qwg7>CXX-2+;$SemDQeF(sQT2vvxO6D+wjX|f%BBbtljaiD z3N)$)`wun=!jP#P(CeboZ{RChMrOhxxw}-UFAnM-*ti)g2TCCNA>)W9mC?iN8V%5>f`k9T{-9V|hi43Y3#w10w96Xs zghsn!Re44pXfCQRV*T95kGYiA%#9(lh|+UusIGeTSu1sP;XUddo+@VpVn#8uJ+7BR zSWrMs?kgBBS(56lAYD?r+Tf-vqs+R^yf(q+PIfvb9BRlK{Aq0S?d9boS}R^*?; zmTc<uA+eAGIvEzF zU{pCI#yN|XXNv;x3-OcP_1t0w z_QG{TLCGqmS0-p;?(P!PRB0sUs1j`|}En1!2XUy6M z>R!6yzJQ7M3woOuIYaxDdr`o7cmEE^0BD_8wIGCZPJN5?UG1;vKw4c^%a#c&P^D|X zd=az1Yeu05XffxP4EBU9_mzqa8x7x_U?N4=YvOg|rdulss%L18?bsy(9wR$kmpr1-Moz9bqve*#(padFQ(U z|AGlzXVgkcL`%VLP?!ru$Y_1|2Lv}keavi~6wpC%?i2zf#N<*v*@P=fLSQ_|jSKW_ zzg%BbZwyY-QyiR{U}Qi-Ngr)oTSfRoekr-r9j{$h9evG}e89k;B ztlAfdq;vr$v>Q@c#>0V1TNALsL*pn9j=5L?3Gcjx(FQ|z3p}afeihoj_)bo+;@2KV zI}!G}yDGqQFxfMCL|FKO`=kt;9Nlw~>7YF@vX&d=i0Z5REVFjGMHJAYox45#Nd}s; zqYJky=nCB-)Ij?+tB#(Mwq5rD!CPhQ=zk0qp$#bX9966}gH*rU5Rek|dO&c6*q<1m z%+54-Xi|hMWEwR5POqQsU4VIdJk=P%&xWfbvqg`MvRMU0eUlwDdOkUWn}%HK%1AYRdEZtoB=&U9=BE)PRv zC^pEzS@FdU8^gysHKoAiGt-d;mdl1x4)sSCGKnpfr+UX~I&Bn|2sSe-4hKY)>6%N; zEEf@$s0bx{#uZCT#9(QDF~mctb!JWvBuOilsFNLYP}B3c=fn0)R;cA6!}IXqgR>gi zlN~1LGpnO!lb<}I4~_gOa=L=h4xCMDX&vi7R^hbT(0!P%vTf(dvCLQ_59|R9KxM4`k|-HnOZrTFB*SJ+ za-I8pQ*WH^CrO(sy-l)ab6q_D<7wnNP!G3NIabWe)b%DUdUOfs6M<&1rMk9Jk>baG zTa8%CUgv--_(R!t^iEi6&H01mP^fLh)0&ZDSiCL(`qz13O<29UyY8wy&1|;C2J$q+ zR$2OKXzG3iCx-MmCQ4&fB1F2(sjY8iBRMoM1+quI9=RGQj0NCR)Ryqpby^{no{Hj; zZquJ3XCwY7up(A|G_7q6Oj&ekYRoyWMx2qN9h%z*r!h;K!3hQjF)`lZe+DLxTguIf zck}AMxrE!kgxaTh9@14&88RJj*v3Qt>+ub~moz3L#zPm} z?RV-x|LBae3(4hv67^Ssfxw$g4PsO4IPjxiz7e{SxPA=TkVvl7CEF7IBDS*hcLRp>{JwnZ$rK|kr}c&ehB3)dhO`stxV!FI&K zOZG*1(<^nLCTvqrTJ?AqWZH{6R%7Kh)vROdwTY0x-0~?czv^Po^YtU>5iB#^f}uQJc~o_+7c(R`Ybi}Tvly4 zKwbn8jkrNIp5)xqZ7XTnCVWdAtbb7!w%0bM1)cmRi2K+i?}u+G^zko|hJybwOtLR= z{T?4WSX~zEX;c#{?Y{W6^|koKtwml!Pe4B+vChyNyzJ5g^_jjsAvEzAY!;un`N?bQ zdcf3<`wrzTV0~uCoWRaTDLR7`*Fs*j#rGhEEgY+N!5)o1vq+=Grb^eYECL8cvzsy? z&^=rES(`Dor7cC_%@%^5n~TmfblpA41^)$Q=z1$Uzgi*mXBNi2DY}eON9=E>biVd< z22Wy9aS|Vq<{W@>J_|3cni3=nt$ktklv)?5%DTcbk2)F6I^Fgr=3c#)5!3l6aB3;> zFt~!NHjAKmNsq3_I@E`zHhL<<+YY;2DvKuzV-t5TEV2gn4pj{kY#D#>)=iv%wKT>f z_WSOyGh~D5)mw*eEkFg?->KK((&VG3F{p7uA}_qL&67Ve^O9J6FqhM@f&xmotQ)mH zO^*)LIoVcSy9}o~k&#DBx<+5oCDW3{=z-0=u%xPOT-J@(Y=Qo~FI0)}yCMqo=1$$P z?CbI{ZJ+4jLp$6KykA#ql4madaE1A>stFq4FBvKu)UC60&9WGCmV6(jCXKrQ${Yxu z=ILGiqI)tL9pgzma<-L1)ne)q#PTls%_+{x9n6O7z>>y#+r$PsPw({?N0Et?BsN#o zMfUM0anp+$uD|bG?|C5bV*J~rdClYg#^GZjT*$3gAAsR|YrVK@XYc+g-P(@d!$(Ji zjUV$HVE5^6bA~u`^#JG~TP^45%2m=Sk{;9~x|b{C9Zt|>>{qyKqCW9&K%6(Q4!M^4 z@LMqkvslY%gL?adu~N#kEQ2$!q{4jI$r)(*8msT_qKdmRE(e+HPpY9dQ(bBU4FB^YR+<4@gpIlx zIjSkLNh6|sT(*Fg8Eh}O!$*6hK>?p+A}F8}giEGaJkA>rcU+a=%V)jU{*U&b0ggQB z=Rf`ek8kyoBIK>`bI=&$h+fyHI&S!x8Dx;8U&#f0 zhEGmJy*|f;NZuyw9wV=pPLg`WF+aikkAh(x+23s$X3;M)iH{$2=B%_8QHxl%e!2*j zpgXxWTfc8al=x>l8>5*k1tuMb~7r2ujk~wm_!G`bAAe-uZH&?+E9(SnruE5_hb+-)ZshSMN z-)<_!eg3=H4vsAz(x2L)ej*B_NCI$lQ^u@y=;Nqv#AoCw*5E1XseS-1;KX#)>mbX0 zr(7o}$ncJcwyE#%ImCNr3RO(KwT-`I(HG_9w{tf8L-!Mwi`xRb6Cwk0s^6K}(At#* zWJSjKW;KPzKc#kmj((%q<=l5BFH`sF2!ekzXq}i&PBMmPX@l<4O6~J3ohRZ2t16 zejeV2AqtqxYnJtDsOGG4D)9{ac|pVE%7TO=7j?B@5ZWE|goEg*ks6;ug}<(*vI_ii zUKw&FNs-B32O&I+2UC5mV@Xbbl%>YA7c=Yk@ZHU z(5wx*X;9(o)K}@ND;&kNcEf*TaIAAoQAetbeICN0f8`r_DBOav+pVqC*Q6Squo70t z%9u5Buvb_E)Bj2RiQf64IV<84O%Z2Qov%%i{0USQ-3T(>?u&|A(t{s!p&IMMxi1u6 zR}bBub=OYJojkZr)mzWz4`J+?Mm=~sc2^*X4^oLv;ZQbmnKuaZziPcy@OgvSu~zhN zfM;WwmQHJYuPpAz>LF$I%Qyt)-fSQkG4aZO*CJZJrv`NAC|O3Jwqy*{PJ3JX$&A=c z^~r*(47}>O3otS!c-NFp!fy<`@fScCrbZ?(JySL4{IW6O1+=i^RJWa0fmPGdt;0dR zDmkMTY;C!zC$u~+3dcyZL~!)QkXSIz*ha>Myqi4n6|2SUwj%5sVI#P5hL~|#MySST zZ3MPlU1arn3LxTVs}QWE3+Cl=Z(zS2Wr(IF<$l<>#fWJ7!Z{C-@}qmqo~ANVLnBfu zQfK;^#NX7#YR(HB(Gwb7-X=wE_~w3_F~i4o@?gIpOwd|Irs!PdqzG0ox@9p ztvxtb)-{qJK5G!3I7DX3MKw;*0cjPj+3oUNUyIO>h|e0Ar1s6DvaXQ?#H+dsiZ>F$ zZ)QOFEX5NZV9!(#U5KUUfYZ|+KtvF3=-W%?3uT)kaej`WBQbKFmkEhc^}kbEVO>VD zJE}<~%rlS_dju!)9rIVs_0qQ+XH;*eFJG=XW&kxKj)9LFG$`Bre)`CPb5XrPPm*Sy z5G)Hmzm$}z>w=x z$*4eXI~15lRO-WHInP$dtwW+47vPbDSvAUfe_h)yHc^*ZGWDDi(ZT{*!?uavCgNM+ z)ZX7Ws$&1noE!9Bp16FRsa*oApvrD_~(w=UUKX57C@PLSk zW?{qmxA4Rb?Bq)K@hL}tMB}M^ZzK2Is+?--GP`K2Rip)2J@f@zBj+r$7b4sDFK4Zd z(}ybVMZU4vyMI{AJTAJE>UAionvvQt$@*8-=xOHGsZEKwF|+wKw*hy>@uB1S4moR| z%4qE4&?(3Mg7t^o@0O}d@X!jnEjljrdBemcMOdEZ=bskaM)z3hSVNj2e+pTfLVMwxpVUC-T$h(SnEs`um zDt)gC@lVz{xnD-UnQb{({2^U02P=;G;h*9O5iJRlSZ03pk4q_GUE(M9e#U}su)j@` z56jUwPPL_{L8AIj*?|x>;&n^lM^YB^5_Y6$N~C1{x7f6wz>=y+xD-0Iz_s+9?SM+* zfP22gn%)6P)1&FD&T??hgG{t0`D#_BH?|Lj6~`Hpvf;Va+j$p=4d?@oU0bF$Hzhg` z(ScE9ghsEs!)2sM{wW>?otsQhP)fC+7495MBADwlr0lk+p_ly>yR2Y?*VjET%xPPX zrz8?Wn%PFbPBU&0c-e!=eay?Aky8%@eV{HL`t|}Xa8;=)-hyP(INN7v?Gl7@g4*$e zyq~aadseTDgQ^~dC9v7+4y*4Hu^(?Vnpn`+sqU z{BnJ@3fiDbx~Hjh+ps?UGz{k*I*DgaVsE~JVA8hd9GmoCMkfUbC<$AqRta=Y<#^CU&R>q-CBQF=8q79$g#w*`lJNcM6x=PzLWHLbyZ zM9>02u@Cu00&{|S8v4X2d3)o;N(!Mg9P`tETcVY>S!y(CxD1Ko(EHj5yC1nBe~d&0 zeOQx`#sK}IP5$>Pi-j6!ge!jfRy?t`d*5+Ud;yOeR8BHpF`nm3|V!kWiSIJ8&ZWw*@b&KcUAPFMTL6S|JB19*~Rc_ila%NK&-4 z@9Y}M5kEojOeKFA(lYSyU{!6nA30wWV*!oa%=1j#+jbS zO-JYUgBAXuA09d>KzC`=1p&0>dPZ}ncl2AOc_XxW3S1K0+a@L7rX23FUHNZD#+s)k z30i8R?>kK6$Ph=fb~lrdY9ZAn5or4>@r=;nwY|ikFop5|;_FsG(|~x!?8NTRs1Ar9 zf8^8dCvbhnm1~pZ@ zLk0}MXCiqaktd39;ZVPT3={4@LOk;-O*sYrt`Srn3Tj+$+fvez`YP!;pVR=Ibv%DJ zl_`u)a{)3Zw=nOz@kKg?8AAdX2sD)e{}Nck-3UUiy^@v?a(24lvFGgbr^WjL*3b+I z1L}3t4sQgAHz`Z-9Z0Eo1hgiVhC>Tl43@w%SBOGbL0+>XwV@)Q|0MLAt&}P_Ym#|$ z;he#8j2dGPuA`0TMjPTL&D#`$tHA#Hu3+&dK`x_aosNO;_KKq_78t|c?gQRd@Bs5m4VD_ zM;as?BTYtLhAf}vk|&u>UnlFnC@}o+&qZ9<+T42fzY~5LLT>L|0=Z2Y)=SCT*On=T z&CUZ}$-y0WZ~4Wr;p`aB2#QkN^+DHFP?y=_u0OQ^sn}#^(SkPv9CbSG@H|xfwD9oL z4RqMTbvYgH5y4XL5e}D#J2xv5wHKUOgN=XFHH&X@eGC9Hzv}0OUMfO01g9+H|0mXU z^>-F4Kgu%lGud|!?w&6X`LnN8=30)x8<49PtTfULgQn$eU<*kIc-t%I!xKQx{{-g) zOX%Ti-=uhxcu`GaDaO{}@=|S!ZL4gS$l+MHHqt+}&o_BGt?lz;#BEX;s)Gp0CY{|( zANmssI#ub0ju6t$@<4qXjM?^kGd-El`l1@h90)s;dKzAZx6HHfy3jVTD@V2TA|qX^ zVntI80uPY}GAwKkS^b^Xyb>Zv*mB~Xr7X~E(O|lT+G^a>LeQyLi7Bj^034Y<{C17q}*+;_&}0M8zg~lxCk94w|VS2mXj#NpsFTINXbFV zdi}IxczQml=U>;$oB6xXkmt_w_n{gFz!>4n z26mek@QX9tRFg#doIk@zq-nQoM#4RyVekkusMXuw#BUre+>E#|(GAE+g7+QK6mJlf zu62@>|Av(lq`@^jo`vw2t#S)jFX+fm!i^Jt@#M+t+rjP7H<>E+y1ORv+G<05Q4z-t zR_6XatZc}6l?~7O*0zww34^FvG7fE7VfpFw?mLi^t|l(TR7d_YFs;n_`m2imXH~|;96FKe#seU zhC}LhjwOOxjv5ik9y(puoICGw8(bHW5QZUyBfm-N=z&nWw&6cr2T|kDNqO3+wE0SEu!yaXDva+Ec1C?^Toaeo{5@Ql*oP zlRB*CwxH>8f8wQ&go71HznAXe0dL2Szq4$uUo~cV3u|{rfGYq61^rE7Nw?}% zKN&64wJ!?x4^IKTS_pd)sG#~G4;`^1mn!Y=BVUNECOeLWb~zgXB7R&9fVbD2V+vW^ z0aw%8pL++%ZrN|xMO5Y773H1trT~&|iddASA8ynyrThX;SkWz2NZWUv*47TR&8v`7 z2@d&zlIS7Lq7R3${eh~x812%$8 zvMuAN8iOF8p6Cx1u%sIeMbl$sq}v3D{#I`r=q6s3 zb6hHm`o?!Ge9}U52AZmeEtz#EI$Qk zs>U1CCANH^lzaB6Y~?)pFT6(utTbgTe`8H!4eG`9#<Yl8bhgZDOmdn#LsKYcjpuWH~(jmPDgv*fVtmo3;XlR z!iyCTlfGAW%BXa93g1piISrhTNDgE{@`G{?E>VlN%jkF3@1qK)nLAedS_>?HFw-qU zS=qPRVIV(s=j(SAj@sxOq8AXeCO}rCie8-}9C8yaK6(AKIU{C=r}Qml%Jm z%+~9wx4C85YWS&?<*sg+C%>!MRAX>8@#;YmP)BXwY3YhV6t2(fcB;rh8r9y>j(V6> zy9_+YiX3W_n;X1C>bs;5ETkIT)5vc|yiSw@4@ptisD9<{)^+b9u1u@)WXss2A|(I_ zqs3WJ|EtP-@aXml*RA5!AjQD{C~5@J$bvJN=NQ52-ESl}nIU+9jyo|z#i+Hz);wb1 za%1->uo%l<&ys6#d$@N4={s~yIWuh9LZ>SvZ z<}9yt%6nQiGe4m=MC+nsO$q4rSM%>>8yuO;%SYc9Cc`$VTS`5(8ly+o$3^2ebutU8 zW-^p(Q*U8kSMLg^I_3-hDHd$Cs3v?U*jPoh%^i=zRh?K>D~Uxz;Ajt4567BPu8G62 zos$86+6&l&v=N%a8YqC@66UFB?f;uO3O|ZSWHGB558>L zfXnkWINu}Q`M<(d+|Shsb(H*h7OIob)#$#-jJO9hE$WPDhn$O^1utbUkNyuD1zoQRPX`dL+ETs#Ed3$ zmGXv$Z(;p|%}H)KiQeB%LI{CBD@E8Q#^*?tyK6WC*sE9T4}yC1x*|CXl78rOX8ymG zp9xSd|FSpCRTDH2nYQy4B|?x3E;xMlP64y_2FMXunJ^R!<}qjdZ>q?~ajh+V*7CQ# zjhSOhsfCo*DD7nwUK;UbM=DA^$G}@#3d>vw{hxC~!oa$oqj-e$wp8BGe}nVo@CK7o zVVTcbWs7xFwq@djk}EB=*)k*N*f1Ncwh;vNEI$5$NUC3z$fxCF>Vl`uNsv2phnvIy zp{OTaxB`1e!5uHDobzUeSiKqS9@nKW;x0{x^rBlFfDs0?x+@(Wy=ORsR0*^E%k4l6 zEo;YRXNZ-t5{fIt?A@BM({c%9@YhQvO8hc5S74LRH(N0$?9luGO^R%J^62(i{gnd$ zPTls)@H3BGrW~}5n?SS6@+_ z;6c~@PDTJW6e2{RiH{wkJtzd$sUg5x8~vqF)zx|M2C3xff*lepYL# zA;AdY(#nJi`m*yGles#KjV$_{*xx{Ht+UeM%=1#Be;Gr}oj}K*n%hPJ@J-1sWGN&J zzWLY?8+~!I#ZS9=Y_OeEfDcW@Nh$fQcxXE>w?6hxD~T*-jxhgb4w96pM{8vOb6w7J zx=gV40^kFN0|9=Mbe4-A(0VP-rM6gVB0TC}rVNHR^wNqG^%*{9*am;W!n{gxPv9p| zLp=3NL23LuZu_cd1j%qqI|QE{Q#a*AmVY}nxPlO-`l)_$5!SQcm{@Jhe_@N5`D$)Z z`3TK!$!ejCx7=$d-ARhtBTEp(ri;$lB zf$`mjamwe=9%9=nLLBD+HUmw(V@nBWuIJx6~Za+lqX#C*}7^bS7{ zMU)@Cd$AE0uR6<~*>94{-uRw1zMqrwTAcLQi4s_W43ehzLCr0D3YoD4?}?3n%K*_l zH{s0xrkp;`1Ga@wj`nQESOf~4Zu6%mi*ounsl7$j94<{ zkTUAIA4_fZUWaU>N>YND*6`DGL|`@9In*ndZu-X$rp~wV3BrM4j5D>LY%NQ+YoG# zXSvL>j;K-_nP76Yt3KJ7eY!1Cy|r>thq#9P75SoS>in5^oLiM$uf8_^`>)Tb^TqeT z$=r??RkIq6TekZrlC&dGgUZ-MNSWi?MyPjKt;?sswLpl`90psZ%V1`yN zw~#6LPI}iOQb3}y6JJCmFTbH!o{TPGHgQeg>Rd3~3fBM>9*b;j`QiU@&Fy7inCh-_ z7iqailzct^6x)*ZnduMwgb@Q}1$*S%gCrkT`iBk$))T&3?1o6ahZP?llipiBt;LKp zHGnTjJdP`>9Fy>tzF29McVgZ^9%GN46Es-cwDP$}xkt=mvom@U z0{K1K?lx9l=L-Q_6;vJwI*B;DULqE)3!s8VSq?d@K0?V*cWD!ilcu{^YwKG#W()5t4Tt%Q}<6I32jM=8(-Dr<=mG0R@(-K zms&eid^Y{DTSh`>$$9RSPdX=zaJKUk5^{B4+cok-KhfeLteM)dx`++oykx=Ls!j39 zO&3^A>k0*Lq5~6UDmGEfD?8C=1)Ib^jZL7#d*@qE@qXD6n9<7TroyHMMOihQ_l!(P z@f^>i1DX_dkSPV+XCY}2R7fhSm=CXmwrgYS*8k>Ygt+Wg2v*bPn5b8@u$=TJ1k_B4 zNJKuh(4Bg9zv6#_65`%c;9wNkF;gXl&tWBInPzDBH&1Jc2;#96Fy7MM}HFl^#@8NJ9UAK5JzHN;rRL^}boNU<>m z{z3Fk5k2d#^n6R*Sf9>$;(KkN8bWTC9)ct5?Y`WLlU#!pYAGVud^+Tg&)SB>QBQ8A z0@H1%JZ<#gLEGMqZ65t&q&^@~mFjH>VECYtX?hQsRuTF_sf8z`($XiZ%9Wi|!;mjZ zgPX3~M$2()xIiBusJYv3@g407ae4+wD;;WZvK0t%Ei=%To1O};LM;X7&4LW(X?*$9 zQG-pIS)lXL3cUUSps;yb14tBrW0BJ|8*I)7Ns4!T(Td_h&pZ_9_i`hH{(ocm^ZG|Tkb7%TRG6m%ko1142 z(0XRmxQB`2+ICuXMB1zEKDg>!GW;NA@r$8Q@(1q* z7)$s+STIz5?_Sk^GoxPK3oO!l1L16IyJnv2ocKqOdVK+V1;lXtUL0!LIG0!+pXOaC z;<;~UWH1{P^*`Z8-f_i9%;WvdLq@>y+@V??*VR~^RQO|IKfk^H^1xNs{oHfV@Zvk| z!vOYIORwlnHX$o!szxR7x1T4Woj0ML3U64~{~E+k0^zKcs)8w-{I8dA7^-Kj4xIf5*FY^(@+v+8ELs8?ti17~zP?wa z(WnEIflmWpFeIP00NI3+Cf)v~A>2tvWB)^1f!_-fb6?e#)Z`MlX`0%L>a2g;mh#|4 z)AwQxkF~=BIffNZg;bn}nbiDoIwno!92B?a*S32>+gL%B8y>w4agBevaiYmC;H;se z)|*9M*w2i|=-ympC2#)Lt0n8dG1-_V&fT^{DR8+~Z?ab2K!9ZL{vGrk*7b?YWYCNZ zNp{Z4*qEnha!mLHH?hDY% zOn_6Cw&1+9;TxB8QQw{NBNqUl^tS0fc|;t`o@=yM!H|`bX5&EjqO0fYBtQCOf#DzI;NWll?4hXox35o2Ji zd;7XSol+^(9Y#e8GYAE;R4wpiZp3LTQ>>Zo`7?4#jfMrSALJ}6lek!lJhPZp$^uJp zgIybo^je5L?5rSW1}il$dY-cmQzVIq*-EZ;-%2Tczq!uYXx6?Ke|}+uL*^{NM8Itc zK<+$@3R{LzU`w!h&I(Kn%bDY>!WLjFhKV#Zh1SR&WRJ3M5qKw>r;^W)%@H1)$;g!< zuI&m?!x-pv03kEH&IrJBHzbc z8mkuV&r>bZa&;=P+YRaVw^o=z?=Bk`yS=t$DM@{7eDaKbzc@+C_2-Z<@rhH?x}#@T zv@p?pcQo=tE$Kb`Iyrq~^lA0z8T4bVd)iOVi6m59M_)M*kL6svni5Pv6HUG;+s~OF z3fAP}rqz2Ir52$F($`gqkJa`6nfalwa87Ri+P2PvskLqeX23hChXB(z1($5US@%(| z1B(9Lj4g{@TxP#;sSA>wRVlsGmu}ORSYu|Yfp^bZ?(_IoC z=uA;zy;IdMirbRCk_zhsY#=se;LK(R*nD-7*{ z#WTG}Q61@j93`)sR)>FbPl&hpZl@aY@#fj}wEPs8{j=mBvFRqoRX0*ZPV*)IaG1*p zeUW(a9>~7#{`kV;=8@`$b^nTP8eb6}Ie&h&!D?WRr)++O?68mn&K(jS(rhLw*!%SS zR8ItgGyY~j*|e&(hmG~#)XvJA{E5kORu-)pKX~@z`n|)SF9zPdFwKv2IB?c)&dkfa zJ^jMtS6Go|%gpK^Dl|9l8Rqi!2@9c!svCS3)$(85NO$_ehq;emLXsO@4t4r;&%^~e zm$q00YJCcoz7bvW!!ld1J#0JVT-B2T@$ahqLW(gS>-WMP18cvL?wOoZcJ&?#Cd&KE ze2noRSTrg;wPPY4bfv?WttI3)gN*vvnmqYMe^PQn&Dt-2&)WBrDHmNJr&bJT|0JCnaVqAF_-Hoy z+T3>`Ul&W$@f`}ir!e&>(>cWc(ciznX!mMe_&6qzGOr=KS3^9j*L;ybHN-xp{;k&9 zJSn~*jPtKg{@s84@Kths3`IOa>A_qk*CfLJvBIvOzeS|@*~16qBMIXH{0dNOotBbb zD9pERlzfO=n4SGKe(ySU0=nQs{+-$AYkPb8f4l>^#o{Mi6J5rr396(_Jpn%pa#zfo zmeKXMgLb|Kj!Sl{xH!S*O(ya$Dqh?u&*(Uix$QH|Dt^mDZ*Wi}L+HZfp zb^~?eZI^wKve)=7ce1Kp@^SFBb$qtcbhZVl;#V`oE9=rfivMgMi{i12I++?J-m$up;A_2)Uy`yVg8zOV&An+ zbWXz!qg{!1esj_iA(7%_=YCx6e97$t_eg!70h?s@z_UcHrmy-viVvvz~+!= z@4Ma#*?H<_SQQuCLD)Zd_jGK{=9+rzHOSCK_nH+%&xdO!P9sHGOaC~2L%l)vZ5z}ljH~*ErRhaU z8}B-gCo5IIrh@o8^s)j|+(ZGYMq1a>Hw+do4qCscE3)$Z>=QL2TzxI~>$vg(ff2Fx z`fbGUCAms%_*%2wqjY=<`|^Ni%D}#(6*;d~!`RDh;M)G>cVj7yx#vee>sbzGyMQ+= zl0@s``{ ze?Z}-m6;lXjXcIwd-8*m&P!|^r%sy~NqSz%Pr2vj{wB1B`sFWQ((iGW6*KsdAW%Ds zn@-6!@JSrer`c#hC9 z79!W^oDTo+uk6>5Z=m0^>aw`-spAz#!6c3s{UaNsb*Dl$v$v84eM?;Q?4RCH?)FzK zGdN>gQ*-w=I5KyY2^&-qG8^nV^eBmaa>KBugGX}*#fLX9tC*^JYhE8-H-f*t`R^21 zOrwzc1W{Z6C<(xqmnQ6nh_ze$LHPa_o1$Ld(Ifl2R#MK72%bVek!pSGSM!ebBhp%6 zutjRE?ceJ!vEw+`K1<=6KYH{5yQ&{`h<9k~^1RMMV!1i#k?xPmOzWZh2HhXj7QT2o z3oR~(vCe9a!0^I1T)(snVniiPeHL$?4oV+5-mP>kZ?t0+6;=xfuyQ`_-d zkWY8Veu#)6(}fKeSFmYQjZmsPM5=p(B1%RmTyOa(F8OFcC|~Z4Ep<5FFhx93m3mF% zM6J4y*G1zqot-yRw5|8*BEQc(ZXf|x?jDQhxNi*de8?&sBSqNiQ|trPVOy~Q*rhR%i1-FOQNMl@`kAiTL%Pe zYbWRv9vq-u{BD>palKk%9poc0*{xQmz_*vw@UB4ub;FK&n@=P4t*IGN8xPn3JL9j- zPf!iRlGVtIdn5H~UJ3!*qzxYdos6Aq+w%_)aqXy+yuj$UpFrkKI=9l|C zOu9gXp&L)rD!1sHn-*HwPdO^gx3h}7E$twXSux_`5%38rzVQ6Rvr9GEBfy6Q{%0XXs(b8NRE8D8Jal0nIFsW#1Z^iWgJ&y>OkdhvMB>y z@S9ok(BQ2-`|tj{;GAV6E8mw4JnI_)LNEVpaC5+caZPWPne7Z-b zZBxNkOz#@%De(2Y(*->vJY>p7xLF*34D_GD`}jJ8eD+kELmVY*(d^+s$hsEK;t({u z_Te|LGf=N*kI5#JcduG}>08m}VOseZ%@#kbP?>Z#@-5k<*0q#bS^m3)a+4%X#|_Gj zWaH29+>xJVy{j* zSbuEAU4Fe`r$`)muMzN~&zASlD+BSDS$y{wki9OGsv1FCOT>g0Ia##|nR$Q9H}9Qt zQ3vmTJGBskS5r3#%{3;cD#=*}OPxGOqI<=zhcIOg(A_z~gKC6!9G znqtX2G*0k6DT9=7MZ{=P4}>|uz4;$(A=uxY$T{BIswDXe7AO|{hYYh+L%mG4ox;+r zDr=`Q`v1?|I|fM_tZTb%PTMx7ZClm0ZQHi(p0=lL8`HLJPTSVkYvWt{MC`rx`E}yF z5tVOMWmZPkoB1Q-e(roODF&(Se1anx<{Ow%O7$KoeYS7jj;+3_l>TGWZq?#OX;)X% z(|TP$Tvmld&!H8!#fkKL_=^d6;rkDC3*6FDx7Q`dN2x2T8!c7BLFcPEkLd7sqVB>) zTntj|3F9De+95I0u;^2b;;?&yQN0+{)f!6;i6)01iSycj*;eL<3VWVgu^kx*_-8Bo ziN$niLx1q|_5TUKit6hu8mxY|*Bs9$t%=lZ9S(jm$@zA#o^2oUx?b5i@oDG`<=pj0 zZ+5rHVJ)81Tl`=?y4S6&=b32~R|gOzMY|P+rMB=+u{uskzl|W=8K2)z>=`~iG(A)< z-kTQiEVcI!Y?5*_ytxu>0FKy=@SX^ib|A8;*TUplZ=1=gq;Q)~tE3mQA*sCGC?aU7V2^ zJJ@Q47f&>Pxo3=T1*eZ`h{DqJk3Z!(BD-#G|9VEe!!o_xpCpc{_NVndp%#){M$Q@PmJehz(2m@ z`1h*+<@Tq9pYuN(#(tsad>;MZAAS3F?UbW>`}rvi!1_^()6ywFWu1)H z#A`0Xd1Vprr7i_eVoa|JH_?`2ZOlM|%dW+7;7FPpU^CU?*kR4F&FV-qH_^lD*qJWO zJH2sIxDQwy+uB5F$zbUJHbGHh$Qq0Ppf(`-byj_Y*x;wZ0v7nu^Y z_vcR(M#bXAdI#kC;@jnHHmqdHX4&Rg*Vt|j4~p9FL-E+d1m$94FGn@m^QQU(69sf* zRgmEAx9%_;PJPkOGZHiI^8HvGGJ8Xw(01tf3l-D~TtTSjA-ss}kP=DCl4s>|$J zC=#1l*G)VIEF)N(m^CM_tu}%H zo`0w1wN{?iv-Gk{>Q5)X=4@4u&gzOM+nqECezJ-AwQ0xYEEOwnZMa`@$ORJM^M5CV z^!~7L*cVl|{*etVm=e%$3y$H?i*H*Y!lmUVYs z^Xz!&@$m)40CaPyr~BU`2$=tg!u_A=2TYut|CKnPov;}h#DExbb%*M-s*B3{*%%15 z*t|3NS$oOnPj19sJA`-nAV^imGqP=X{sWeBqxvq;s4y%74IGSsbSg^6z$sZNP7A$LBSQ6r+PeGH6;{xT z`3MrQ02?fyO6ZUmrptA=76TO!cY!U@uDOI~@`;;UA-I!M=*4W9$dM_VcX5xVfuxus zuU#q`s`)v8=T%NH;AWzJr2Ysf=%VE_EQQOVm?Sq*xYkDF9P!r9TeG&bVuayINNX$g9oEIhM`rDwa1U?ZlI zg|BB&8iMi={tZnZsDLFj_P>4NEdTO}i&;22ITJGdC-8xgnURrRmXL*B*~8w1Ue3@` z$=T+gQ(?ZPt)OEC!ie}z?V%iLO_zoO&MA*@#%tae-i$_2U^^{v8KfP&)nk`v_4B#W z*p-dB0mn&8oMI{aSE9!voEtPUqOXNG(MyF@B%qcmbJ_`eKR> z&FR&=IWjhBLGo+QRDM%p@!Y0BsUlCg0m9Fi35i<5-GnL{q}a3RxXImOGYEC{phwRz z8ym?oQ0Mbadr6`e#fq~|Di&mzenSt!QOrl3pn%g&?8TL}-Zwj_oB^V1q2|9oaP5#?yVg2W{{1+zlf3TSy?d*l@+_f0!zQNAlFE&P|?~Hm!JsAGMAyK4PR{myuFmnEbP_4-KebFo0Ie*hg2pQ;=oE=?^ zod3N)Cql;Wb)jrv=tQsd?@L48z|4e?56;Ba_#ZfDCZ>N3{C@{Kb2700b2W)aRI07p zuCJi^JgH@+6(}Ojc1r!21B$?N*6#g9ILkxklQ&^BiWh}SuE2D;{G|P;dn_a=8_5?z zJZ+-4r0aFjauzlIw6|C>zFv`Ol@PgHv#qNa5jFn6g_f?qtw%FQD&thwjq)nk^-7mf zR5nPgQZYHtgfUJdbE;VRgpq4%ckH1Uxq5BVtsb$u{6Z|n^w6S);Gr0v-kL#wTZGh* z?U59<`loY73V#veqx;RMyYvC6{_D(Jf%FvBEA=_Vb#4`sFA;vHLzC}$w%bqe3cQEk z%J9;rmDO%xj@`)#iSPY4zNF0<;B9yEUGL0Kw}@PtOT;6?_(YQ54dZm{p@)8J^R%{I z-VFCN0*KzcqupAA^)*_q;c3ZqU}%lb%cko_(be$IShqX4XQ-5P62_-|t)&s&C!?#O zq%5AD&3o+Z>+kc~wG9XST(B7L`GD5hac^$-%-(htmR!Quc#&;})8#S#98(m_g>RXh z`b-i`FpQ%rI~AdXf+C^q5&888j|^2xC;yRDlGHPnqm+~f9Ur(~+-WY8wlN?g~+ zw_UZG1wHz%N~hedvQh2GtfF)BKJ_}$$R1wjWlp4bF(xVmu2&>Oh1BXHQt>vRcQV~Z zrX1EL>9YrgJJd_+a7JQk$oH=>4YRZ+0scEu$nq^tK;lWaf+3ln+z}Mhen5G$Wkrz6 zpPBrD$)NAN9b6aw`=zR6H5V6c2TjjBB;(ua!Bq7l%FfU=(e2YtTr!Q6P*IQI;3{t_ zv^K^i!p!$tw|%NHd9}BAL9EdqqLs$Ob;#R4P4K^dg=Gss!<|zE(!+O9Xa{#a*8ggw zr00^xTd|rJtzmvP-;Ijnj-Z_=xjfn(8GqiyHdq#go6a=XYG%o}+kDAA>@Low9 zeim=Er}hF?DX(P`nLsKjL%DAO{xXjoZmqeH6OgFd)TkT+=~-P3!RQ`cRy{}?>>PSr z+!v>t*P8|P00}q_0}^n^9L4o7d@sf=R?Hy&$yi@Qo_j*xb6?oPX51@Z>J>lT!^fnP zVIbSihA0ONR%I&09WO*~c?9!Qt9TO`xMUSN%Az~)LbYNPao6*rgw(3e4EQ@J=W{Lh zDK)VC<>LMiZbxyh@>5*V=2!^!KS(tRq-Oa*XCeVsy9gRUTxizkpEFzF!NL9>*Kn{V z(HgXfEWGZGwJ9_7*)Rr0fQ+Is^*9>Y`$CqVFqFYEQJuT$0ksM|HbPzHv^swiaOI(T zu(Ss)A)oQVvf#HtI;()CL8KGNWmI#O><88RWF$1W#Hm}k8X{iJ6?|s+exj$iA)r2c353VnQ*7l8u91}& zjNds{uqneq8Piosi|&#@#R>4pf+yz%)F6`$@}K*4=TVy`5#kC;3h-9$`k&- zGs+23M_t+PexQP|7et3_FTn}v8traeXb1^W2;uMsf1F34%?#8kiL`-Qujz_oaN)@h zF11%N^{gHt{YX&oS|#x3<@>3~9*Zp(>nu0~P%8I^0E1;(TLvM`ee#m#`H1ijVNG5| zT&J<_%)x&eR;eG$aJr~_uX{9~zUkPnf_IY+M(f2}=t2+@V3fHoQy`|=? zFO(B*ydOUy&sbIeq}NHFQxW5mEZ*-re9}t^h-v=l5*64$5q#@)W)W8pKL8fNG)_Ih zdfXlDPb*M>6%N|FBmxcxePhg9ScltZ&F~<>Z+L2{7B_Em4t(r<^==kbS0}en#pEdK zOcBLO22m2v+q{!7P_Je9(Z8>h2p@N zt2JpCKl46lr`^Vi)J%;UTd>Q89}G6Eb5_5lBQf6!T< znjD=fND$?y~VV|3fh-WrF4J4G+xKz z>gKP$t7~U)i0Wx3AAMo16iQ1c)1WZv5@f>+SV57T75;O3Dl9b=(6W#71AYopb6qrR z)YLUB9m!0LB{yI8`Y8pZw~YTUrkql-uq)L}=Fn!PyxLh(8>jel;ET4niLSd8L`s)k z0}e}?hG`GoGv9((4c3=wb9qM#yD0ASxylMX(Jvfx(5gTxz>^0d?Bnv#5y6L9bdYum*daZoj&!Vy}1VcC~--W|SQxK+3 z#U%dxl{#EUr9syKWM?$NJ%R+zjlbumV`Gz07E$zakJ@7Y4uJiJS%ne6JE@Xk6}%f& ztJ5Vx(PV&%%oJhglKaXbi~>b?l|BN7|0pFs84CkD>jb5sqpfd(RT31|S#T3OeYsYn z^tFuJENt}zZ|qX_mOvyWL^3OWo5qR;!dBd5l-uW0(2C0%)oZbp`NqjBLYXI(C&ch# z{gbfmyFLE+qj&-$h!(*Y1m8x+iT-d;_<;J`WwhI#u%UFJ79NQ$H!<$)LtUODL4GIP zSr@ylngOmJ0E1VdH3kt3=)N;u%Og9|mEy_2jg&t;Y?tg$MjJO?Rra0Q+SL8tY5m{L zmqNrpHeY9MXD;N*@K=S683C3GETiS+!H!L(%$YhRBXOi@1lc1En>)pffb6WbB;G$+ zq|bFz1BsmW0h)Z$B z^NhIL4I=o>o-0F+Ib>Z%q>m}%>WQNb`}sWByyj05T2vd6c3y$3>+qv>Kr=lheI8JA z{`9KpJ`oC&L~)a+6a=DS!4(LmncWVb3UWOed%As{0+2YwEXbT1JhQ$O%u);-pNJWX2Pb*lluO=GBz1+hEy2 zHx^kUjU-DBSJ=g@=QYo3n|i*#g(GKd`1hDdkN;+a5@cqVOw0N%zn zjL$ZS3eDPXFjpQc-hBF?gVK@~M6$Tamugeg07#Jv4#}*;FgtbCI4#Gq!+`K!VGteP zQ?T}}k1Q<9w+}LWQ=)oMAHoE343E&g@175OU7==4;4$I1L>o&{Rvaf*%HpRa;(j$0 z1Nyn&#RPxn+|8}BO-6kioh>EuHM18MN}F|rVksjSOn??>OE8pWWg$&jwl!QK54ht` zH)Dyeg+VlZ+%U@HN!-xIC?N3DKC$ww@OU|rs!Yq@mV70N{M?7`?{X@CC|gx2Irc?8 z`d>F1_{N+ry?~LEkuVz;BG?DrrSB(zzWtu$z-Z6hJ#_K35smxJ?!D^~swE6^Hx@W? z>Q4zgwQig`{Vg7}SwPkn32oY$GsNsn`3DDynF|73&YT8eZvz23H^;A z)s1#Vug`Z35>RaB6cMFRa|$Pqwy!3f-5w_56T3Lif5MAS-2+@yTwvd}`JhvT9E2E{oS1hmex zAG+an6)7k>;rUUT-ci_gA@uYgFd)-s;y|{8OCDxgNKt2JCrA&C1)T%<^WuaO0&EW( zN`tNoAx?fm1%D7bd63tk&aOBTcOCOg>yOL&D#gyXNMS2LcX+fVQ!>}k-K|tcX8M7( z+1uf4W_OyCTIW8N9=%nU_!|JW$lg35Tko~HZkBsNxs2W7h`m_vq^SioK8qwzH@Hs%+B~Sv&}BYDI_y+V^XgG^x~rFeMI|v}mNn=0@I8gNy3H5@%3c z^n~z(JIb0yzfVoZ5M*)^8IX%UXv=&Hh@Ue*uf$+XP=eGv&A)n;V}59n2yj}EpeD$l zbkJ3G0*;u(OdGd%Q-PC)b5d}DusY=reH3pa!hL+d?RY&jQhIq^kw!d8Ce>j%W%R-T zPdo`!Poo|6*PyAD8R>q!Oq*7Jd+I5RKdp!=aqO}7w_J{*@eXybx1s8vW&+2pOMsV` zho9#}y+}Q;s4~2S6Lh5#Z`4Kv3h1k-f+**aM-{H3+m#}Js5HX%t%P8N&={@~w z&626HGRxAy`T^w^9qk@T#o@EWtXVinf3~tM?&-+sbE~;;- z;7le13UGGBa%Q<~%##C=>ePqQS6L>meQ|~l4eAb}uH%*oHf_t{26=>bWf5dX6aw1O z3<;IuRI3fVE)bn?x$vF1K``41Uh3;e9IH(o>W)f`{_9^%S6d>0jOrA(bcs+87xP?C zQ#JcF!dp~0JXR@dKL7snJ8#MI>5rK9>ulsSP0R!6Rj!ycV8}~F7#RNRQ4yJV*X_^a z!A#|nOW9bMYT_LYUl7Kuof0Of3WR)-z_%=g82p%X*;D>o`((p$MTmmVSvO?;OK|e+ z)dE(Vb_IhUO~}xk>3KuiyNFK0h*Xe_Du%9s#Xn$%#nyrtn~?y;9L*{YX&J#t`+7!& zqyc5877;HDR-VcG3itKv*YoG87sbKB-1sTb+-J-IP?=a@7ie;A&HYiT)Pp zsuiB^v^|QdDdk_7wYH`h8P4t%JVYOitj=MV#sSqGQ3DH?DO|%P{FQN%8xjOsCddQQ z=XBuPryDa@8tDBB|4ZBt6(z1T2odxj@8Ba3ukrmQD=?>g#^0d@|TaSxDRIfuW`DnmQaiiNf$O7)M2E; z5tQ6ON`0WTy2aF0hRr2Ng##A&?Dej&>2<5lOCEq8tXZrrM1 zWK^2s9^148K{Vt?d|9Y>8pwP&BJfGAHZ}h3BnA!R-zn}oxateUUEiesB+ntxU}S2 zd8FUG?t^rG>g5bx4t+mFvQVdFpw~@$5SJXeY6p&(ZI8sHCRgV0Y(qi%j1pzZWieA@ zePEAAG3*AwlRP*bMKQ@`k#zV(rJ%u#{qm~uJ$ep&;DsTW`>d;A3A;Fo%q6LFExWdo z_;5%bNs{yzq0}M)ME8m}2Jia4MVpqW%bF^5uz(dda8v@uEQEfJP`&UBvF9cVBfM3Y zld-s~PkXz9C~vw?tItCV5GauJn?J^X8z*4@r?CEC;shN3Cf*DG|1nO$^e^KC{}}lH z9w%UD_mx`$%W4zjsu5*m!F?fVw4y3jqY@q!$&`#wqf?;b0!6MeKvt3U zDK*pD?bF&olCFsq3cdQjOWy7|OSUVg=q?8i4+k$EI&cyqD=OI8m-o&MnoW8V~X#CK=NZ^^0k~tQrDx58^=&?({L5(Ls*~52oxB zg6X6ap{%I5@AT$ESvBPIieDdR#$0kt4xcTfEK;d^?~|nSas0C8*()k?NAqI8co*kf z=C2>CIDUN}+JyDlUNfNz1w06UT@1j_UaPtb-Pqm;+~YbFVw|O+5xkGm+1hu&*(`6) zYZ%(;mbJz;ssjvsXC!$2Dz?p9Q#~85xO~;3))3@rx#el_0BY>Gi)LfVlOp{Ioh=dP z*3peJhq={iyS5iKWn%?)GTnZC$CIPQofS)tevgIS(8VImNqK2=b#5HKr)T*I92Wak6tYD3=cvnz&&hz zcy24awe|?o2?7H>>%TUX=%j?~4Bw;zDlsCj+eM@ZC=?Lzu7HK9FOQ4P1AsjCQCK|K z(51^p5|Gae4IhTTK>MqGT~GEE!Uc$tN0~rG&Zum%Rh>0P24eKA;UZf>BdYjB%TH58 zof(re$-rJ@B;5>aS{ zHMj5PpglCCz2a*X>ZPCK-S_?~5M9EDG&QZ@U(0+ zy%UIN1-wG>;M_1TjMA+tVZ0mnyNHb<@X)9F?i7-yO$s{p7J}ss@P8j6J1Y-iP&~yV zP7ugN)V*Y?4NLHnE0vE3CtaQ1^^a7q37kJk7aan6rzVSk^9qb?= z88#;oeCyLP?F<|L3ujeIBB4igk`Y-YhrCLYZgS^8;%_)+i?&>9B|${ovPzP97FzZM zOYzNExmZW}gGi?x*HXM}zX>~`;LcF?0(*oQ$9=w(QX!({2isZH;)B*UO4QnKJFPUI zL*MB2XmcTp^K#)^F>aWCekWpi&TF5pya7g9!w8kfI!UpY>acaq$L+Z&Duqy@A*i|H z4N1F^Fc|>8x1sRIw*M1+P*uSViix6E0Q72kK*#>x+fMc~0~mbp^0D7uV5e&BLSW)q za02MM&lbx4`W29Cd@tssEaGS+=mxU(XmVKHMkG=14iBNUT##vRUSE}i@qI=-NVlh9 zR=8vLo+GR-<4;oqCuF~;xYg6asw4AbRc>~6y^%cVDc2`{HAG9Z0zRa(!*wPj@w3}K zy+Vqx#s~u-Zv8y78t+HamvN#`0cb=IC)x;b`f4>uxn(jTm@hsE0os1on?k1+G58c- zij9Y%vfzjvqkp=uLg~jrbRVThLr6%J8QVEmPQ<-o=HYJ`DIzXO4Y-?I=Y z^61Pbl{I{D2<)OUimz(w6r>r(Fy!L!)WawEl7p2RqWr-*~i z_otsSkzp&%e^a^W9@uKdNMuP(cNGeakot2mx6KI{3;D!M3QgCE)U5S{50a1>o%?^< z9Oz&6JuST@2G#{a+!Z%nSz%gZ1Ai#YaEvpOm?4$Wj7S%6hhc~zFm3DLMSy5l5l=1( z2G5EW;)&|GH*b*VIfaJoVYA14N+V08RG^eGo=t9-VYggiwxAY9E=G=0Q|^BGHNSye ziP&gamhoYXPPMs zCFuRgV4C5q44HtfL}Ca;Hr0jZRQ0!$?SvBr}U72v#S|g9n5a+>}>7wbt7?faCtZq zv2=A#^SI5_u;HjxG?`e~ww%^*1zjaTE#)K?m#)KN#UR6haX+qlCF zds`Sq_BQ*J%{N8WDgE%VyCIB0on#WQOE%UxEKHvP&8wA+&kCf;yKo$V-$z(56^CE_ z!^rvlbVM(z8}tny^e2P7jwAoyiyxiR=ORE(zD>^tOtj8hqHfbs@I)mSZ!6IG`>rX= z2feo2oY7`mKsfeV!o#(=gg+&nFNsp*t+mQDh%tgZEVY$|a4^q+`2C8w0iLyU`pUzX zxI~vY$FH>)cnR~RHgMJ&92gv{*x{+i8a+%wSpt|OW3~{$wv{>>Gs+d{rqD_0s00n^ z3ks(~QeT|hQ$C_#dSJ~nhPlHq@Gcvu&!+wW^o}00n+ElXM_LX8xsFg!e8-^1sNQ__TrO_e9Y`e3S)3WN zmelAOLOv!-`SAGdWJy?<)2t%d>H6`x6HiH!eYkyXDboos5s-Oz+J47XxvoL{k9zrDse5 zKu1h04}2S6zVV6uib0%w*ghSqGY7dxrXPjXM-5-mg?~@Aiz`7QcmGdm^0@?w(4Qh5 zCF#uyL-La`Z%irll6zspqZ8qM#?_)ppI*PjohFE0{gf=s3>~S8yIOp1XyD6J%XB+b zxM^9I)A=bbvgQs-(4KuIyV*54`}Go-O(33>osQ-UanD$X-zFF|PM)DlmWcVl z&+5FPOIy(q)XDjpFxO3vG@(3~tr?K|N=;JD;R--*e`p7cE_gW#l1$XJ88L*xVdG~F zh7O|7rB1qeNh^lw2U=03iTR^1wYvO4^qXnJfBK<|aY-daUesbhr%eY6ia(->N5DOl z|6&3EFvC=kiEk)(Vyd*7d7dQ;4ifKWPY-n&0$kvj3zI;G;hFFv9p38caAK4ijpZGS zDnF(U?<}E0^BoH*$Sl8BWW47-n+X`AqkGJ2XW(~ShS#)7jsMQ>j9<1?ok_QE+keQ? zcg@s8P3D$#f5#_z7Qmah71AGtnv3#sQEyt%4r0T{f661a?V3yeCtl<( z;(O#5>vC1ypt(Z~5?|F~4gsd;HWJlBvL%j4R2q7<^scf+d0Fk+_vUbQecj5z)q#SJ zp5C@*dox@}Tc@jSc3PGCXY$%64jx_JpO7sxNt`n717-^=he^JlGNzhBGBtMOCbtAr z71hHwB+%W*Y7_fZ*JH>(6)Hp#dmkZQfY>kwaB$%tVaZ~OyLc0XIwuCdJ~@~-7dM3^ zo3Bjx#iyj@++18#NV`^ibv&OLdA+3(*6-udH-^IB{+Ky)7|PwmO7B~8X`w}H=HT%G z&zRj(?l=EnQz!~}<7Z?`@{LRzH^zo5Li&wJjZ{8hgog<7d*jy|amZ?5O9pJADXN#J zWj(@e2Yp^Dz0fuW)!;&N8BgW<{Q??)2-xzllIyPx#mEQ1*wMNKQV7}IRa_Fo-sWPB zbH{QpIH%e2tvu<`uJ%i)(U*Bij&!*6z(Npl)VPY!52clQhN@kwAgim6uYpRmE+E?D zAE%5&CL@b5o-;9Qm4)x@hT71;o4!|7zWK}j%6Y60(QO%f%i2{%GO6^g>gSal%Iz1> zwM_x=VCa5gYDG1Ms)5;{AMqNSo%MpQ}dg zY+`*8RP3)+&sjfIf9*Yv+`;TaP&!+kFuQ)Z%glTB(CLfHf-ojj$Bdd|y1^(tROnA#&bw;fQnQS&b_FYc^l6 zJl!X-(F(o%0K>6wr1;1F?CIIPJyzs2P=+%W$w^_gvm4Up8TBx1f+5`T0?B|JHfs z*{E_SHK|)>npl-CEXj~yGPIZBEA{^D8O6do0T#z`;OO=Xh}{3wIwUo8 z+169&3&htBBLns}De4Yq`Q7k@@`~t9{yzT96%gQLbmpcrBy`#HLO99t*>~8YPrY`l zXeQqxACxHH2C1K!O%P0tVIF+Nwt)v%KS0MWbVLr{ZhvlQfk?8bRw}xAU2n85VIeTy zbU=mxWY-YpGp1vZ4{Tu9WFbR1R&#?-%T;`oJeTHGm!Dy=V^(;G*UYHnju<&GeS*O4 z6zG;0D)z(;KmNn)*=TG9g*Wxm)iYTv&d(jqv{b8Y0p=ZvjMDVOR##Gmuo{td2X+Pp zXGfIF_ty^T`h0$d?kk&Ch}@KOdLgDjTb3k*1{Z#pGP4b`sUV10DaTY70mYf`%eTqW z-7Ab67VS3hS;0WF8Ne0!CYG+uyE7cZ zFuiUW<|U)%yuTy2lZZ&&|VspyyKtR;L`WdFyXV zv4ZO5k7bBakJ$Qy+J4(Tj`+(*qU?QAHwI&O;o^N%z$ZYvJ2)HTmgJ=!sZT0j^zlYg z9}sg7Y&JeSCL#1?HMHy%!e9|{-wQL7k%HQ5TNDC}N7}j6lmt4UfK|5ff)Sg_0Zd|G zYq3)#S=T1!#YSE$t|NoGT;RjQ^V>R2?m|=}+|jAL)4`lq%BGQrmD12A)PyQgArH#f zY7os+igICwcTC+`cYYKJjuWD`e8Y{g6P@`;{`t@m9E^@4VCI-Ln1irEdn}gPJ_n07 zpos=#>GcI=zJ#(<#6G}9X-FsjT2VbTbF3I7b_2ih=8PUi0-4yV7?~hxr@E#uoC@BB zEud00Xx+C*YFC-k++jYGg@ZNofFiViMSELLD(5MlwT!I}#V{AfduMmGp}c1;j+ZCR zA1WorQAEFzkcl#@cm|UfuiM4oqmquHs$Sfp`pGu@K3AJSXFnh*NPFM?jCngcw7cxM z(%tHLd6}9tyL`LS+YSjsK)5^L2V^{FxSl#`(JevOu*|&@(*{L7tPexeh)>*-sCk{~ z3gZ2idv&JoFIdO4_q(UTqs>>lAw+vA1*KB87eGKACX(9c$gVvB@BAXaUIHx~U{Q>6 zjY?s8z=~ZKE9}v~M|nP$3h@CK=j{`Q1kTMPAhxQFhqAd(h?^^8S&J}$EHSY-7b57p zG2n5=nL!*jqmg5+icHCGhI@cMJeP>6NTd#Kvo{}X9Q*s&k76ntvSBvLUEYl!nHKQG z?NfieEYu=v+L#dAJRa$&i7wTD+Q!I{nMzix>Gb&0!e(Y-9XB8*%qyr3jI_&I(^2t+ z@&n2xrm#tt%%knw+G%wNRi(kS|DBXsvtKATvz!VJ^Do2~|M)`?8p9>{BzOen9Zg#J zVX4SLpT-Y}67hlEm4PCx@?vEA!85e?RpOE}LtdSla$udW>+8ucFiao~tx>lBR$Tvw z?fpO0=zogq%-^Q_Z)g1f2jcpF`0oGRg#RCo{BH}syrZ3wl8Lhxy}XDRy|RhBv(CTr z}S6_aS+UmF7j`pp$-%Ba>Cqo;MiKh*#XyV2x&JJKX;VZi0 z3jhqI6s z3=$)isc&RUCvr$I)wQCXio*M#-MRCnD52abniNPTxod_G9v#e|$aKY#&$l9$To@$} z6?1%lu)sIlYxIq`bD)xS6Y4hhER7;B&R8fd(I&OMr)bK0(wHyd`_=A+_hEM9W@2e6 zEz_7X)~}4OqYzHCC0Eh|NTSIZmnj^TPS2v|?)XmI!`as8EH|{w z@EI$HpOWt=*@NWeqsG~6%SbE5v_*>1Gsnq_aMOG$&e?WlzZ1j=^5z}gs0SZ+kVe0@ z@F>AAGJVF?r&aAy>e9Kki~p`7X7XDaxhLMH>P`YD1kONe+708&oqqes@|<|i3LQ1a zPc&(4rKW%-f#~P0khHXMwk{5^nkMmYgz_54Y$Cqz5{feEG$WjPejxw{`-9H9e1+gkaW^?Wq#1IDsp+ z5#6@vLX1;;JIt23*7yC^GdneoUr>ez%zzTvv56CL4bd0wl3~{k5b?mO4W-2z2$%&# zfuP2^!lpIhh*g-3TUgU3r_*<3p?mu6=eruo^nyV82K0o_PZCk;L?aI#&Jug4|kyPHUFN3n;SCWbYj6 zg-gTHH;h*M!9bX!#+2i77dF-Vhi*bQ9x#6nG6!Pb{6MSGDVAcb&%*PQVUnt>%F1>}N02qO^JxdHtNBHkp-LuhVbp*Uj!)Y}5wicD_#0czV+Dz6k zRQ17m0xxHd{}Or|TkO6>>JL>YM@s#4ClC+TB2VhRGjG0TSmpukb~wmRf}nJv7N(17 z&?>k9WhOt|x4R{qZK`iyHkoy+dEfYJ2Re3ER+?j^Jo!hI>cOoqS(352ca}uQ`v*w6 zm1fQi9UbXg3aoEYN8jf$S!CKK=lBl{BadwgKP{0hsK!46P$YznaUqb?2OD=kwIYqQ zg#w=2MVA8PA%j6`wf`(C%js%#v?xt;Kv|Ik?lvwIwl+(r#$An0p4u6+!BN)4m$dn0 zWPtpPJ~#17E%uhI%A;`;HJQxN3JVK4Ob}sTh&2Df2b&mhrcQ_uXu0$^KwjNaLU5MtckquF=(`|n z6U<8WTw;Y4FbQo;IQD$b0VfVkcT;z-S=~nei0TnZBF^!gh4O;@^(u{kWG{cY0opZx zT^>Nm$FZCgt!6rf6RLnLnQ9Fu7A zrvht;9;0?Z7K=hr)aQ4r#@N$ii6h1$^yZbRT%LxI_fR5Z>i zIfRaKr6k()l@vX(G^MkTtqh(l@t9!9R|Z<5CFTChVTXiuLe>ITL*D%Gum4uh`SzA^w8w)I2Q^h zIaV*coydMl;g>w1=E`X>ek4)G7Lxg@hEl4^awN_xVi+8OouK#_5_g(rek{I@FnI(J zF0o6FyXOcXQk)w!8>x2RCW@l{#c|2W0yRns?kUbCk%Xk7{vA|GlpAxdDUIy%e;L%`s@{VuHY8<(e;oci*go2)zD$?Ta6OS{Bc! z8y33N3@1^ALOI|PMa@V zzlcG0Rt?CLsVpTMby*|av58X~+gm~*E}RS>jqD6J3z?=yG`D1jYIm0)$kIkhc7L<=DBk#CZI5A zF7yro$vLOls&|RYn!t_x(2DykOVY9##_p(&Z`13kU5TJ_qEHvB!eN(}!Q3135)xb> zB?ysD-gFg6*kG2xvDDq0#YnOeZ1DJn)we1|DfQ;cEj5L9= zo{=5U%Kx(ZZj@yeg}tFFLwnby&Noh-e3v$7gJx!N$XLCl&*v9meI!SA|Ep3c3hU*( z^b@4K<72{McW@jS=G@_6-4w?cTh61Z*LuTdI0*zPnUQ9lLH`9=nCsIthyl32w)W;v%;>3rwrgv z%tf~6;mfpct;AEeea{PRX6suy@T^0_q(I>quWr6N$x)}dlG40LQ$^c?X%;JHfG3xCpg z8h>xabe08LenJ?VlUk3Qc!$P!ufT#kak;mU`Rx2q<}4Wu;RiF(P0V9v-HttWmj{B( zc55Bd>5u=z+dBn`7Ij^gY1_7K+qP}n)=k^CZQJHe+qRwA_j~B*zq_j|swyh_>Aaqo zz0ZlU#+q{wf1#8Bpi&Evyp`1&{1io3mTWZF#wd|%RsvKsVU4IoD9kHGO~bXIFKgXD zQ40t|qaVv!0P;5goUKXc>yL>m)W#Tp+S!Hq9Xz;TpKS$xWA~_Ev2S0yqzN#O_owVqCS0!c18lIxMZSYKRKlGMtl3W_A6 z`UBzbj2Y3gKi+0iSKhQ9Iy8Fr-{b{KL~8H?vS3gU#gtGkQ;kBrzr#csBN-yKF)}z4 z`yFulrOFK|=S5ZD4QK#D zE`K4z0lOLEPL;3SzKL-2)S03t?(yd;qBMft9lFT)ld<-aIOaNsgH zp6vCr;=KJ&aSw;}A(80I(Tf~2OYu4pS?1}LDQaDiP-Uu84#+mNvw@#?YuaOrBl*qMot1^O)Kkn3OksnBUjtZ^FeS&J zeb)P7I*An+=2G>@_-E53$KL@m~j7fzxm`Z2!ND-R&|M2m*lM=r}S&w2-q5Jp?#4sc1u zu=?&OH+p&9F!JcVOIE}4Tb-lUdyHkZG#3`7@h{%)xi5YnBx!c`4I?xAXif{Oy&kQ_ zk}1I51zP<)MQT38bYR^&7?l|@Zcy#qcOH&d2TQp-9C|y8)pGaV@mhz;A^>XPZ+nEK zO5xbgqWc|D#Iv06^QG$_W&3gxw9Wu?@!LK?=(S*Ie^S$p@uck^&?wJ{j!Kr6SrGg0 z7>QNBpGKY4iv(awCx!R9|4JqHZ3?A4kxjl2-@eO4JICIunA{(Cum3s=E)FR{R*H(i zUV`u_Spi>a1Y+4gi1-iX^eWnwM~BQeVow;l2D{rUVM)UDnd}E4_!o)2EnpRnm|TPm zFk5PuH(Pdg6|X)9?R?RL;AY*!G{4DZFUyD@DS4gI(_gPvoYgI1ywUTQZL$(INxnK# z5#kGX4ST!Cm&9DB0dy~#_v}4T_ZYDLTVmm$|68&{Iqgdjih<&dvsfn!bQ{)y`2=5w z^ru^{jU<~K>oc9NpWq|DXrt_VY9|rK6xa1$qMcmcU9OdUb%bq%f7|Tddr3>>^rxJ`(Q7bAjn^f%A-$gxXMJc5ew*8_Ve2M68ipS}AaGenQvQ|T z9nwS#pqi{9G+tN~r%{qsHG5A932ey1`F2-uiol$s)W$FN8iWGoPA z#zNM5dKee-N4In^_0ZAqYi|jIFD0X zgpwkq3W&PkoPgPzmland!S6X2jZi~51Oe!sSA{z#fa}^|!ujkfSS%FJvrmkvh<^(D zn<`Xs<>MT&SFOtTTy@rGD*Q_jx3DM%tvv!5+5N^5Lcv$oFxvcIzxN#TO*snAOxc{~ zV-hIZVGnZE9(G~-=ABbfK(tx+Dav|qd1FYw?$%6%tEB+u>2Y+1E|(%`-uz4C)9_XO zh+_c-$hPQxF6hAu6Kv^PdC}c1!c=yN#~Q?qpR~f>{k2x}H--?60lw~9WC4M)I%WOv z>1u-7t8sfX`H@tNQR6Je-X^>9({`8%vMZ%Cnslw91cTnn&3KJbT$ES#JvBIaT>TaP zNo!L+0SXSCO!}a28^yoN%927BCA1b+)T}U*!q5Yiq0Vo&QPTDYgL~NvwTlx@s&^aQ zbj%V<#r}E0;bj9Pa{m<00@hOIkAKtea)Nrs5S5uVp@GV;R1_rRlZD*=j7>o(W^QeI>y;xY~8(@#RqYqZj&O0A{)nkcEs(LIu! zB~vB&M%N5zz69-BK%%RFWQ&X%f}8$t1-TQ^n)u$upk__%MM00;31rFYt2{eqjeD|A zziI^d08r{s!2Ny|y$GA@0_gz(T=KhsxK0rG&GU8{5ZQ5HzPG0lu?rL(m+XY1#hm6yAS91sgW zgRpMHM2|kF=*9TWC0CZ?B-aOr%R+ufJ*ctk+$;QG1lkL6^~~~V`v!AxjOFnlaDRKY zV36v^DgP}>HO%h7>b-D;kW}kiX2uf$aTQk@{P!)~IXRb8SeBdROXZ5chVMuik6w;} zOfHc9JCRY~!dm%v#H1lJCkJ;{j*a_+Z%bn=ruPIwQu{Td4-XqK`>6tf9Jo}RiNn)O zbH_Sg@%#+qy#fTlo>sw$xTJvw8G46bOGFv9WMrQDV+(0GdjkHDTtU z;I7adkTn;m;2lO@^Iw&$s+x)_CvlZynfe?Cvi3Hb*M@S(6(E6kxSDbm=hyeF=y*Pb8o{kTWp475)a&~ld=R}BR=jhGV4~|?KBt)ptrjjTk zl1PxF#0&6_%I1u)U^2!L0eX!E&bj41YGaJ5Hr=00_N_uQpOz8ThJvs)K3h~6MGeQD{B;k zGB#P|^Bz^B<-Z5gX;C$lBEQJLh_|=0C0k{)60F5r)uoLFcG_KLm{h6e%6<|cZ|+w8 zGPSr`#6P0Ho#Eac?+^x~V7;jOz)hHUj5R@7_U2?Om`-G2-d9lXACE<%!q?{E#hiix z`XPW%yLg-SFo0LQT(MDTvV2=eCu@bR6HAAb1elv-EmiBEM*8O;+r(hhWv13u9KZ8b zHZslrZ2+7n;0mZGnSEsZQ>~R~Db3$9zC<>?BxSS5WFQ&^<38KOvw&T776l-uvVN1X#b)u2Hjsebh4DDz06BVSJZ zDpKiR+c0l`F7V-g`{UGk6Rwb z_NGm7_I5|mG>dN8N5&X{T(^GNLdSPSn}1dfWW_6KS!qkoUmcmD2L-++Fr)uH_Ml0c z*89uE2AKE~qWJBG5u@wgwY`$zV+F`xsYSCs1GjLb7`DinbZ)~v{5GL;3j+%nb*(^( z;x`{qt|NJTMs3?Foz)yf>5JK~J^6>_6E7or+8&Wkpg;9T+}C+mz1fxkwxL>Ln@95?n$KylJUWidf-J4>+s6#RMC}w1R!%o&*j3 zc)04C_V$XeLybE%JxNUsr9cx5W@8{BX6S@ay4C>MJCICRnj4GUJMcYpU92NRj#l6A zZB`IGW%`91z0qU0GK{X3$3sAg@#B|P7LmN{ zbj3?p+&rn39m2z4Sl#A_126+*s^o0Gg}bD0m^;EaNYBgX{3`xkrG znJT(L6{yg+o0`{kb;F*CMva%kZB?P!VgO(|fI^@JF_ukcGhNKzBf5HgJ5PK&uIzFw z{qruG;mKi;?8Ck$t)~`S_fX+Tj;T_-kR^u*IbeDYTu9i7*7ObflYS9H4g}K9GA~Yf zIn>LDDCcT%O(%6L1?pGYw7}qsz(AVHFar?AzPcPZ;D#$}_lHMDleSU9yLtkyO7J+8 zA2hd2a2SJB#tH+VANNj{&HMH`dFKyYREwozatyVx(4;T!uGfT&;c29-9|oYn*u0i5BPdTU?@Mu}O8`Wt_ar4t@^*D=D!Ks_5_0&Td#G8p=-Y_q5Cn_LL zn-)AegNI_s685y}%uhmaWQG<6n?vp@Y%oZ<3H{);E$=(!gBd9p+oks=23qk zSg^*yTxNd=H&n|VY@|Gt{VjxBAnUim;sxEGHc8E5Btq?VK5&6->l;#JWR6({MPsnb zJA{qRM@mRO3?7~wb{2XXzq9`LC4YZW|AYrxt2JAgR$bn$q`b*(1El z_S33?uE_PcQ0sqA*l)I^Nkmbb%*MiXs3-JH1lEuX-Oj+r0wD+%E|3bG?A&nR5ISux z6i*;6{67w@%>Q|4QIYngd8<$^!ozdrSLHCaIoDKJHt!@!{3z^`)!p-#d;M%7d?LzthKrWoPx5WjyYs5(oWGVf;xTUS?Y zvJia}h6NjIk>-N@U&86eNjHHCB4eLZh2SDQe^7;DA`w|&nwAn2S4a|3e{v&M%y*_$ z!d3NBS*zcQkeaT6rH~q~C8&5kBg9eO_#fGY*ax?&8Q)qT3R z(K|zu^g}wFLJ*xjjoqywvo8_)tN5YHi+JD=L1{N_Q%GKjy(O|LI`22}oWkQlpXp~Qe^>v6x( zV|)v#Zr|(j3)ol8Jj++`q6bR*0d<~%yjs&u=l$6ivtmpF>oLSb3vFhhk5x0?S1~?N zF`fs0V49uOIhK_r-nh++C}>^!rE-uby*X=(>?$_Ju;5sXCK`4}I;DIqROhu-Ooe#k z4_(LOG>-5MGK$_&unA!&8rMB5L&WR$Hq~)ymRO&E4OLy+XiIKmkT1~FAgp^gvZFeM1U6k%3 z<&VPVMjJdd@B^XjJq)NwaJGtFL5_?C1AqUs4C^FeAVI z;3t6X>OfZN#j3Sd3!PNnkx{Xe)%HnfE9_oYYVEp46-{ZgWr$pe6I-FmAvg||Cl?!N z=mG=N{4GCQWinw)9I^9_+RjnvEd-lH(2hHnN-hRILV@EnE!Z0n!$eTkFpfg64KHV5x=PB?{1Da4+%6Dfh;6He>bO? znz^}n|4g~0)3N!}>LLPt?(#$xj4Q>N_tU)#PJcF}gz1Mn*jGBulK4>O$%lpi!|>yg zo{j4G$3I1BCG4(mvgy^0s$$0^e1)=)(=MiEt0unf$N%;c7LUbol(Z&&MYKnIO|WHu zdmB;(?gnZo{s};N6rFuuD;FpL}PYF~@r8$T11n@FNRqvtkizm)gur?WY^N0F5VR+%aO-AcE(= z`ArfX#10ehF9?!PXM}CJNmpVmhx(at*)z+d2!k>lMO{+s*4@sGjX+!lKCG0?oW!J# z^NQI7ORe5Z+4eQ4dOtariot(Q5w7a@y-PRK&Ghn@46_EZ@rA7E!(&F^MGl5ZZybg| zNoaCL>7gD#p`bpYfb%V+0f(xughW*UaKiL+7Q}PCXS(DF;Ga_QIE+li!V$7}Jq9q0 zW+Al!u<C%eIfb5&_HT74XJQ^iA|XP|uL0 zsn3kfj*g3>PQEAC*|%alKe zF48lQj1_Ifvl@oYa5OaSl|AG;I|dctIAT+{c=+NJtZ8qNuW7Ke?J5Fw9DbQ~-!19B zt~bCbc1Bd`KFCB|?%$>SaDA!KWgd&guh28>%HFrFJZJ9X&g7ea9;!+)E~_DxyZ!u^ zg~#O6rEgu#;*z8!9uqx7;e5$N*~;^%at;wK$3hQy#ci-hVIpbkM9>kQDpXc89?`Tv zcMli~z$(=ZZgL@I&!#|4g#BlK>@z=VK5Wv9D>w*{+-D>ui@Zg%$uY8Uu-Vl-m5Kl% zy*i3QlR{extyZ`yj%7lEqqB7`;+B2!NN=AKD_1e*@@LC999$P$G?3k=s3APn#L!!cS=3LGWe z-s$dMlG}Mc?7Zi!C!7$|RbdLBbhIo3G+@ zl4V4T2<_<*+84BgBrzb)9g=&xp7@&7mEhE^G(pbRR2|Fv}{@ARG3JDM?~8&`VLJf zBw^p`Au%4xD&NH(E8sci*keu=_h*d98-0V9|HBBrV%Kh62C+iC2^&yP6eeSaVvz(4 zMy{F3EXraoqH=bT_q@9*^lk~(WX~X-B8NAijF~?zd#$=Z zI*#wOXMT!{%U6i*kS9U2gTdGEz=6}zX1U1I9MUdPESgO4axKP-HNHoCp;;}BrLHlR zXjx!cq1rNTJJWl0w+LO?UJH09q(v}3L)&aN>07#vRMrz-U2Yu%rsD(U^fm_!7ANhQ zyCb^KRc!5*oe2W&Aj3GGuxF-e!`jL$S7FC(@2KUdp||@IRM)N**UF*(7%uz{BqlU& zhUTXqSv!M68cioq7n$EX@u<*y)Vw)N-ZkmW*D#k3Vm5CeTqnF@@X^s(pVdCy z81%^UWb8TB6l4Q*$`p{1AUiRk6T9CSh@C}Z(5H=Ayvd;$iMPz-HDPA_cp*sCMchP9 z5z+dQX0-qcfjHA{7P?s4V_VjGajIj&eL|jZt z_+e=?av0GH*%_}}&SXiY>@A>2(@G`sKyFx@-N!EJRi#4mEi65B3F#OlEH=C6Day75 zhPz{;*K3bukUOv!VQ2(Z1)Rf0)b)EK5G>BLtwNzagWp>jYk(Hce}S!|LZJ0*X=aVu zk@DnVTuoqg>Wq5}ZWcHqKyh5ASRG;CMp@%xFWsX}57n;jz&Tz@X$g@xBHzHM(VH!5O+cYq>lC;)Z@`>^&jLX z=%T*F7l`mkoFj!#GdrpjmDQRt3e|i4*6FtGoaub5FI5e?A(?XeU#)GD-$l7e9)gxF3gP7dv zc~}9IVtsr1LvEPaJ5-`jn6q>^d04$71M9@-H~zF~p&kRJV`anqXoUMn>TeJ_z{PeO zzF7g0rfQ7CnUBkynH@LNsu;Fl%VdNohzYQK)pL)fH!UVJtlj}b#&PwUAi5ftD{$_Y zC=ff63wg9dl9gu{so0hVfxrv}L}Ao$0lwjfz3+Uf;>f=RLH|fz@zO=*CHmECTK20I zGGdMkFj$~ideDKFJ^D&^6&A#n6S_K-v$2v{T>GyQ#*4P3j$U)R+j$?{ImbBQ$@yXcdNRi*aWU-xdVP7(; zd(waZ2S2*39?RD=GfL69$r{i3jZW|D?2mbBdLEqxmYdICJCs)E3Gan+FMVW(np^{y zvtRlTuq98l5o2k(tAoIf;`*dj8~h3HsDn*IV`!n(N%tyM+YjUup(@@?_lx0jYd}TP zzKr%|Mo*Ll(B}e`B$z3QneoG{@hc+y<9m_&r+lf*Bl-WuM44_CDEu_>1*1I zlhZdl5UFg)b4P_|cxxb^f@)W@ylFv@_ER@(LHh0C>R$=`_xfJZAnD#*DtSZD6hx9{ zPd1{&+(!YtA@?|cY|H#E2vDI_pDwjPA?m#3tgokwD@{0a)(Yv)kfAi{OSG2;<(|UD zVy?na^*XSD^rkYmS_*13&XagsJn^XUo1-U|xRhF0mAc!cdK0#j3u1TNVK0l7?v|6~ zVB5~&Q1LTE_>Q7Qta z6J``IIPinEKI*7AwiIe@bA50w5jgt@d_OPqeVyPP6p$>!v0CO?hk(>&T*g_MukH;L*GRf`t2Po8pMza6~x$ z2V5NQy$ljeM)zwGW3p(VxF0D6PZRT%c|8Vp_tydo+u-m5X6C(!%WmQeT7}QYnj%gP z2xNIsr2Q#w0=Idx-Y~naMa=@-zotgfkq<%@LF%cwwVgcz*V-lj*)%qy{a1$2LdHX> zW}X$BS4C3Bi{gxYdI5j2DI{~jAuDyFj`V8SP7Vg+D2pE)=JoK>xr+(u0mN;(N5UE2 z(RMml@_6~so^<0{_npiq_Y@Oqz(bE(3I*@P1{pJ9H)v)R#=8I0O}%Y)Q|ps@2n79PIa3a1i_% z9^b`DN6~>clOcdY%-UcJs1w()*Ciw(9r|A<2%u3^aHTVO&+2`mY)1KcJs{lDY z5#9XhDnPnzUpwFRX#Ij3x4YSYtA&Sf@}Ezx}QWS(*Sq^3d6ulJjHeVW5^c#Fa5V@9Mr#U>3u z6*p>SGSIhN`NPyl zA!}+`5u``C)m4fEBtjPz4EHp`^jwF0H*?Y_?=?uc@e>WW)KMgK)E`-B`WD_Kpr$M{ z=TftWV4--@btQ&D0(f)F1=%LxUkah>tYIKcP|KJbu2JmaYSc=n%?G47UHY}T`JF_s zE!`T~VfYB4_k0{RJFTonSpS%43rlbt*oTcv-7NU5+|h^Zr&4hFsGx?DN;_yi;ke2; zG(Ky{W=OpT!S+7j^nE(FD5h^HQ0AuY*2Tn^#gRkFJ%}n`t|<`Z!)t)>y=2p0f`HlK z_{LSQ}2Q; zf3#kYhtv`(ia-%dI9UKK%PXd;GNEHC78hB>mzY9gwLp$G7I@-lj0J{=aC%q(UmV)U zqdZ&#C@B6t!Z88lq&Z3sDG2v7?C=E{`T%%zB1Kk99V)P65KsXR0n{mNI)0E3T(Iwj zodXm>sImqT`T&oDAXRxIRSAq(0hT%^+J{dTyF%FcaIxLbuL%=aPNzT><;pv~@}Quz z>u?KDD$Rr%!po60(2p$y%zItH((+QtOa|8GRoNrTluy%Ox3b^n06P69AmTQlJivoJ z0Y;<+Q{GA`xg^IS6btXL`BMlM=e}j?XkjjhuCQ`+M=?w2%`?s=o--$lHu_g$1GVZ_>Mk_ameANgyB9sOeA0p@qIr= zjg<354UZ*b9=^Xm4A`uexf-ZhYB}CA^h7(0um7hqQ|_6=mY$WK8N|o+NX|#b<<^fj zEo%ul!)gR)ukJ#ef8{N*Z*^WJMjfBdm$0?cP48-jLgnztwN&-_9WAtUVSwFxb@4!C|KT~ajfBGQ0PA5eR>Y`g9G30>q^;Xn9$>aE$^X+$daZ< z6Y!A@)2w9WPO_W8c9Bq9N0e3;m+X~LJWBdoIy=hr$p)WNdSxLQysbWWAk*Q@9w#Q% z0_lm~_kQ*6!N?B@S0BGhN9j68<~m2=JIplaMFy%QukeiVZIy+yArIA%N-p0UGoqnL zQU21FxK^?F0!uD>OcOnr^jR0S!|ZQfM#um^7<$JM6fEOuTE4Xr8YcfJq7sth;|d8` z4kbaKC2U;$5~Ec4ASv}{##N{Rsw}yJhM86EDLrAa3)qXAH)$hYFZ;f^>tq>rA9HxIZ(AHjS_`<7H%J zy%`?juNRcwFxZjR0K~i4vX9x!AQW}#dX_sm;dj?N(%PkPQ5!yP9vIPTr3$8bdF z`rNRS>5Wm_^24bW9+q{dB_WA4gz)KMtU#OZq#^GTs;)O=QT+ETQD~bxBhlEvHJ+iR z&q;~S`U7F?5RO_$X|G_9yztkR;fGadbx>019~Iz+a#&(z>lc<3aM3o)f>(!V>3sHM zByAYnOsKE^(57?PBhf~)8<=c0bn?#5)@xvckH1U275bODRP5seMAM#h zGFPOO^BdRql7VMi;j?y%#%Okqp8#51QQ?KH4C47A%_jc&RUXNEXBgh3_z-R+2u_$x z*0sm2Q~`EDoDT-( zA$O*}7Dr$BwU;o$xi)Q!i&SFbE|l!N#-OnV!19t>7rZtg-kTiS#BOxqZ0h!4YB{;p zO;+6Q!bqfM*PURAbbS8G(cmT!*5*Fi<)jxGTQ}aAzh;QhUYfeCR+moN97XK?RNq5N zTQzNffaw=Mz)4P4?j5g{I(iuBG!TVQF^vdpE--pu^~T%Qf1L(MwmB!drW2Hre_h=L z&N?d8Ipv+zT#!~JFf12gI8uG0*K-ziUU%m6^gZX4*F1FLWLkpk1J59H2hUCHO z2c`lYg(UX#IJ69NSLtQrNhvIfsGbbYBi zZl;bp6>gGN0&f+Bq9LA zfkejRYEws=;=&@aa+7<^X7`jdA6oX3h&~xv#%BEVqu33#$yYqf4XC6aW3=^D#gxCiRA8M%f*t+ID(PV6;aB} z2~EJTLXwf&iti8tVk&MYBuamhLClx@0!*On3zuvF%9EQ8_y?MjJ||T$Xl5SkqJ|T$ zmA>z@I+__HOsQ?9$=HERmc6oW-3-B<913XvQfi>OR6;n*6Ndrel%>#6&Jx~x4g3s* z)GSTc0L+6s;`5=*FTIRX;>JX&^S_2bS9akdLi#*A_&%tKG4Ju0$VumL;Nhz zD4ruz&^#~|_si;;?bvtZTF=xDJ-u@bCGQpg%rW=#OMunjio0wrkF|XR?j6^pFT2!oce-eF%zvzJU*2e?U>XzIX9MVj(J&ZI zPO^R%hF=>KzH;f5qIFc2LmdZ*V>VtzQn)mbU?!7WnK8LMk@LMrecYs&Qfb3%Om%4` zq`isVx(S6p*V`J-KJZWaN9N0LD7Gb=Q9L!4oynUr>F z+g%6M{RN(-&0oYtq`u87qx9nThqfj$as%g%K*!i{QE{}!Frt}NjD)34u9sx3JH6Cl74yJQW<$WsiSJa5$DNx)++bIsI1rLo#LR%1IU)A@WV9VUP2jUH3Q9Vg^gRt35s z**s8ueP{#|ER@aAex`vy?$LcxURWSn;M>Bc!H5m+qnyjY?ajg~m!k9Oi;dyuFB3(x zgV3J-E6Q}aeg=%ctMAalm)LS5NuclBkJ|6>oO(^eC$$$yxuZ~hd&z)?f^0H`*h~$A z*#fQ2>G-}OKQi_|b*IVokmn~w=&eB8{Tk&!;GPfJ6pAB=DhsIUWLp3#5Lo+un7l%8 z*2Vqe3qkDo4SQnK9*ui`oL%)fIU70dQUF!PW1F7?DJ;iQUH}ckXt7;o=ygy z2aNfjM&wKB2VH9M68E%m4{1HC-A?LnGIg#3oX+z#7HuXWAXJDZUlZq%6X+gxAhST3 zof7txA?aq$e+2ntJ>HiZxU_pI$qdQ}ogEZWbOgh;`KFt$4-(RHy|KqUN~#VCD)-tb z9(m>(G_bkVkHiblUt3_SoCdxhIa%;<#!&ptvPSKXre+-yZ~O)l@z}?{V>i=01P4Gw z%oS}YmJ&Ad1swi~^5X4MRnB=y&kUwPGy1+>uSf0c;J0fHDJ=6Rpyo5MhbtDZ+JtlYA-fVasS9QaHENCV zCM^o%1Xn<}#c1Pl>nT5z9&0VJ`j$V~MiQ4=K+>kO(G;{a0%hI(=Q!7!}Wl->{@3|J6I^v~yWuq@Qvb3BPgg zLcpy3VbufMaBH%MLDnQ3sJD8`)?48(A2;3VfI)o{(@JN*2?QaW%jAj_qRar-W095J zO`^Tstze57jcClRM%Mco)ro%cZI}653Vt?k~jvdTMPZSG5GckH<24 zk~24jpc&MUZ1;Zh)`7@#o3PGN+5we?p#r}*d<4+sBIQEm0rKKSl=OT)xag?ySRKw& zVeaM7Z?Z-D+Op5P!pZn4Dz2APM z_d_=TxKsY|{%^wa|7IO6^Z&*=+W!?;{y&+7!}j0h=l^33wQMZ^H(|c}Kbx(RaDK0K z<>JoTx~3A@)!GoWXU+V-6IDqrgV))QSbCWG=#d73EJrh!`irYS{nR55ayrf2zw{WM;3dG!Bo?xqo zB-{1YKu5qgdJpA~i`!_rZ=&BJ0kpqN@|t*JKL zFB0rvtswPfwW=0`eDM~VMrTJgH4{=CcGlHQ-U?JVxf|L@T2p*^;?Q=BewgE%(3mZw z^xv}MGmR2X>B>&Vg1^`b4_9dflECqffB4h%_V;b7*0-7i*;y6U3Ph2;WS^eC}^LHQg z$xoq&TZX)D40+o$#Dmo-jAZn8`*GFgF?OoVD6SVR?4GfZ1bEK?eyyS%bAk|GB}42s z)nTXt zFYN<_fVrF(N$x^%d7r!)nV3l1Gan>{TI^ou1#c}S0Y~I(Eny2bw7w}B-Fs5fqjH_R zNfEG%JBP;)klScPl$M0)>01hUw3+XGP0^cwf+{XtG$Sa{{Mk$Zu(7G+$f8%Jx{d&7 zh1!Eypsp;wWbT@pX|Un^F0oHI#huKNJ)o_L_6L{S>Yeu11?BX|W>c+ov{3U9iYy2L zQdDkoP#V4YPgSY!6$l4!%J=3SE5hMPc7Al8gMa=_rMKcUZRrJj+PIAXqKXZYgkIl% zL}1>G4sWRCnINvvE^W+iNdw#%8}_%E>D|5jD zHmv|Zg(=(>fP%8-dkI3dIQ#kD6jL^9H^eJNN7|(xZ9ZsvA0Ie+rRU7Qop&vt zeBV*fvoTakv)5C*RymmD)mJ%Y1Icsze7n1B?eUf|Yfa8+fU!XQp+7!dUH=ML=9Nn- zmd=Q%-dS^rUha>n`#OC_rMRLw)app6m#WRN5i6_8#EjqJFQrN@6oV$zivG=agy=6W zrFTsU@Z4pGd^5~S4+Rce+B6B8;SV$ioB<`%`LkVkg1uqmJ7O*GE*X2%*kNqn_mr$oWW?F~63RdUH(oyL9xN~vcvq@?u7xN_O=X*jR!`!_O zZ^nF${_8o7`d4Qy#=~AW7%He#`l?3L^5?LKA_ma?2L3ruj!}q%6gq#|Q*}VCzrs1! zq_h0_>%`hLz}goK*v&2HkvmpWTRq=g83$5yM%gJFLC3k|Wzh)=Yw$~5mh#d(PO11G z0Por8!K^lu{y%;S^@la3(@rexfAI;+gUMKHei}baGs>2kF%BG#l6oAb9Z7&{HVAM+ zBI53S=NLN*`)#Kso4*qhUpzP_H7yMWPtt|(&-twDvpBZl$=qfla3{y?Knj2X!rs+z z9MzPIq+CVY_+oYtH_tsuT%N`>=J?%Z)=k2dh1#|xLI?zEU+v9gy41!!{^iq`?I-}@ zAC=oz+>Dow@3pNm#eNx512BJ*GYJJZs3x!u=U^7uxg4g5%5-_p6oM7R)@X&t>heh6 ziDpU`1I9;{3&0AqTwK9wMR{~yv_y+GOdjG7HC6pvBVWWXu^93ZA8oz{zseKUaX#qG{*5yC)bLM{ zSW&^1PYa^Df48oN1*l@fA_;O-^?&TPq#h9hgN;bFYy0A4h|Y`nJCe)uGKl)#A3CNw zT*wCUN*<(?+Pc`$pUjV%-uQp8_D;>BL{Ylsw#~C`+qP}nwr$(CZQHi@*|u%=sr%Bm zqbn+^BI+MxKIB@F-s*AVC5(R>#Emg1trrF3jqPo~z7O zRT7>z!31Ah#|;oTU2LX~r9>}yzYX(vgofO;fC%&bvlzsNh56_=~#~&)>&}}=4b}c@fo)R z$dmAeHCPUV)Bk1uHi5)GPvzIYu=prJwtmkM1srjf{_x?KG>myjm$N#Cj&3GvUY~Jj zcIUsa5Ek=vz13K07bm|`Mon3A+0R8j2X+F`y;-wRrZ&n>tJ>zb!2WMLD*|IRSFtuo z%2H795E!sXJ5Ga|(d?y9O=eBwdKfp?r}s_RkB=9LCDJ)b>< z;~aEh6?82e)GisNnvN;Yj_Z>aLyxQmz#9wSvWGXOfp9EeGLw+}*oB{mjF1+ZapdP2 zN`cp8Aa6u#Tz$12W05hDP&vmKS9nWbrN@SQxm2*D=5i)pHZ3*?axdPfYL**xXMhPbR6aPS7 zWRELJsp#1Zsp>gaiHT@eskbR3X+}7R#Wl7VW(djjfy0dbZgmw#rV~|?7l;ihrMEda zzEZX7d?n)DM>X1UGItTj)4KtRBvuk@a?GJ z+%G5zTC8nw2Fh{xj9j$uBz)`+DICbZHlSUt6E@(3K&Uw$QfXzf!fE@W6F$I-`TM`w z1W08pg9i{gOwoTgG)^r`C}YZPR<`OyU9a6ogYV2J2xL`=Qmj#P)~F`{le{Ak4)Vv2 z&fOTVU<0wMR3iZ@S>VdHM)K2?Hp@pW&ok#6J;8&#b3IZ-zm_ZxJDZ8M+LO1R_>8>+%^6|FZKi%ub^mhOnD|gNx}G?2C$y7)OX(RJxrEfI%*PU*T0%-j@omkWrq#E`^`tj-XP-q( z_UVej{yfj75`%0YptAM#H;OZz-nUF%V8|@1E?8|ziPG@<2*AbPq0pB1D1)Ftf}@kQ zGk^0N(nXYU$d=!*?%Z-`xP)8TE7(e&79$^73Vwf0=;g~=v)sxgkOHPcUwset(-zso zIu!PZO->bh#> zD>L`L;jBwO?lB$k;sSGM9|_<;fd0XEouLy&&=+$3vmd@&YkSL@q3}&5=f-j1@CHK} zkEJfd&Bi6PFk5mJu`spDE=&R?HI!7X?9TED@9i;{hE;U-4&`1F!E~C*^!NIu^_Y7} z!u1542jhhpdq|rR`%G~xmNS^_h4<3HrpnI#G#h-x#qeSwG0zNi!cA%&%) z0*#b#jlREvdi@skDpKc#10_t6jAdFs-+8C@46UVY?H1M{wV!_zl*n7qNKiXS7i`^og^)oVCJGvbJM$}Iqg&La{@<4$6n zxPqUe!QQy`KP7zn`7dW-uZj-V0ztyh*diseq{ zh|$4t3LN@9w=QP#wa;S!2&6<4AlvVdP9MH})udSoC_xEy z8~w~Tczo?&A0jSD{bP7;+(p|a&x~z3OJ&JgeSzZk{vPg>rv_{{m=*<@WMlkpzO0as z{;7%J)%Y=TU)r$3%^!wwJ)-Uk${K!0OEV7q0Hf_$>E^S&*X`Z9xf+7?%|POYt;*FW zOc~4bTi>4z){@41xh^>g9d^{?1tY!DW^@Mxz(Zc$6^-}vW;ks@CozRA>pq7X{d~md zAC9gItM&f(J)v8018FEF;~W?~x!U=c!TTVsDM4*WC2vn%^IjsGQOxeJqU0FKGf7=s zXHqctU!o{9l+b`Rl-q_(WorS~Nti%tJh|c!n{KxbSVM&8Fo{8P+{ZGSjY36;=XM+# z%XGs_;#ox7o)A>A><79Sz`?3Cn|G8kUomM5Xn^I#&KrxaMzLSxyWer~L2ZeF z3oPLF=gklM;J!KH+&u=@h#6n1*?`%2V1&t>t`6aHCFHvcqCnR?XX`8^6s11ckI;2G zodUTO%vY%J&qc&}&MMt&4$MKUXZg$QFM?ejUk^w)|E)T^uvTm}>vZ;zl6IdpWKHoJ zT<*-dt~|n*2*-Y!SHE;es$~+XD-N zOm-^Z!m@>F4Ym4P46bO6fYftdmV%q)~bT z=Y)Xjh(sWBOu$oBj553L#D1B~8)%I0YK9UIe6vW}!I(=grQc(#{viaqwNza>u&JVe_-mLvLTq7>;swuYZ@sDmU30gqj>TZvQq zs_cVk?c0Y@--3jjS!lf^(>iri=ZHpEV&BvfowJV=>X6)PxRYJ=c|&1_8yo}C39vxz zK*>yyC%P)c&xCVoh)9_|77vG;&p`LQ-d1kQ{JO1@nn7)!npW0-!m{LvlctKm8U3pi zo?Fo5v|$suVs@0TX>*g0qfefg`|qxzu--IGR`}wgQu9PDH8qv%0JaGR_R2TZAG(UB zF5ar3^qBO+`_r1?&RopPN`UhrwU+zgsgc@KE?lqrzAxjYdkS$l?K}12dS6@I7%MQ5He)G0gLgc8>=fj29AAM*1l z{G=Xc7%JRgoY}QJ3|?AoLsFVCRT%zZim<8Cn|}{8e^sx7ljGJDGOn|_I&$z)EPfd) zcdU~7y<*MU)r$G%*PH_*oP*qy`s|ox)28)WgqvB1N0VhHtP?U%sf8P~uKipC6Zct? zm8u(!b7NXM0M;Fh7s@LTot^6C3=Zm)^jXonsH-u)yMKRB>F9Gc{8}&%XpfUDOoph*XuAV)L`e-O@+A zvL_(@=~s4Vsh{0eIl_|%7-xlm86)uhP}qoQ9__|mErhMf@zInd5f}r0Fv4(>X()D7 zo`qZD#15FyP^KtSlB|Ns?>nIv#-T&c)TO?^eq9GiYP}MfHV1 zOU+dkqp=6S;@ePkKujTJHWGd3pLL(#He5X6dW$7?&Z zoTj$2c{4fj>{#q1qFu&cX=cc$7TzPp{bVAn?~w;t3<`wUQuT{~SoVwJM*tKC+1f|o zTuEIfH#!JwSc=vy%!IPh*qSxpk)X{ZZkAbXOludlTu~51u;>!BQN}!kIx3%_s_;_aw#puv$&p_ufCP`IVUE@_30U|iqm0YRXiwUUr8t=WWCGc#wY_M? zzgxTQdz0}81nAGsiTh6z^Z!)L%Jjb|X8o@d^Z%9I@ofKPV*cN9wX!lXvj5)`=f!G& z6^X=0CX~dMde}}+#_)EtWqEP4=D(hn7Vd|ydNO2%kTcG&ci3SD=~PFw@=* zvA}=LB4fS91Px#9a>tHx@PrFY|edwoEEU?ubwxS(!>lpW9yoo?*(V#xTF zH5ogm!jKJQ7v^)QeV(pb8oXRCutOR){nBHqol&vJAK1FFxwg?TL+Q3^QW7!U8vN0_Jzvqj+>r61QGGKqnooDBV`9o!i$BKt`~^Hr zNpwkf-A)%FLpHc%=f@i^ku~z@NtFO@Gv#~_U}`A6Hg-Sce=sOG#h>ducBDDA0C(#9 zhxP{T`{`+5eJ7wIEBj2o!+dPeay&P}-LQ{4Q?|`aN#a`mv>%$x&~spddYaMw?XVbr z)Y9(n)889)iazB_@G`vQCuE5>-d<$oQ9qKp{R2h^XVaJ})zEIs(bL`&6R!TpebJ&n z22apM0PM-%2^Ovf!dmfTQL-^VoUpBVCx_7LNgBz95pq>Bl5|wl$A}dqUV1Td(VKI! z9t7)6Ko7kLL82fi4;x9s?xf)`Oo;OkcIITljVNj)bnaCcZ=;Z-K;ngJH0#Cd59+Y0 zbpU&W-f1(JqKdFGDw5JY?<)Q0-FVk!ZJ@;G2e%Ff%CV9Z2nq^hi#H0|wTAwHhw0lQ zJSuVkXuAH2k3sUk0?Lt;$cdzRP*Ux>3N|aFkr<|vRm$Dpvvo~thMy4p+;uq`(*Qyg zd>jmm62#2<1_up8jjkQhlA$1$H}KHuD~-ltT49#?X=xh7_M2@eV(r09KfDEJtQcuF ztWiU?QnaRRO`v(Q(whuY2dHe(joJ=W-87YMTxu658V{L1i|`8PU>wy0Jz=;YF0s#v2qR#@a%lrt`eN3PD%md%4*N_b6KDh zpDU41rsK;FXu(L@hIvbd2h7sTujN5gGs?9n_S;ERiKa9C=al4$GLSz&U!16x z|L&vBO6+YQHwyZ5j`>M*h65`c>e39}$q!vjX!Yb_Y(t|x6@k=I+&kqj)~hnl0u(~k z^aLfb9vUx36r3u8^EHPY@)Qb+OJhxG%8joM+g@uFRqA}XW@tQ!ONS5wYw4mnrxxDZ z2+638X>Jn2&g5ID+)P*I^AjH7{$dM@Flln0*gBZC+5M}Ak5siN^q`=ryGNa+QnwEw zzZ|T16~=P%+bzyw`xCzeMNR1$p(eLa;0?~q&dENM zW4z3cqMtGCTk2ovOROspzdNO2(kjEdW$CmRIQ{}j>zcR@XTc^v4$QJ_cPj3*a$@>v zI|ooX&agOuF01m(>Coj$(8Q0_srg)W&A)|_Gz7-1As>0JH=Br}>MXR)^WFYZCaUZWko|<-a?g^WH^t|HS5Cdj}RHtx-;6`S}n2$}c(jwuA& z=JkX*c+D_}naPTNBlL3&D2Akx(&M#~ht-n$jmT|$nYoU3Lh@>7AJEd@!O<4^pBO#j zY&lsdbqUT6f%BAEpg&}!`M8G}Ck=t6G5e<}di8v!>>PJ-7|IO?IDN^lGqxi89==Y1 zZ)DI+UIxQr=iVu_j?fPP@UI7!KiviblYeGzX?Nel(c;)q#EejaY=4=VtR zq9MXUFHlzbBU`C9CbjtXQ0wMDl)w|LD}Uk2YLAX0X@T*VS6BiRaq0ks1StN+x0rMH zR*QE*jAE2IN=U=C-hpqNv1|@-58p*<P(ZU?}?Vid8otdo>^jC_uK;M20dX_r}>y! zLRja!WU2haKGtQlOus>Da!vb;JjeV+5-t%2D85s-jO!SGq6Wot!>STy&Pues^3{`K zM857EBC=8AyYSQ^u~6B8d(QQNTSij5m+C|Aq6Mgn)$dSKy^g*1+ZFh>a#3t(g;#tE z0qYj(pJHmbi2A#BrLXaN`JU^m-1~Q(1g@ zqumq*I8oAAF?w3XFRa_Uw`>>=D6WT)TniTW= z_MW!Vus@r%X+ZP(0h@;gcca?EOMs^0bdMw=q(lpDtb0;QvN;1K=d?1eoNqFf_{T0K z$gpR##&L4ESR{ZAds?wU>o~ciCY$isMa{=3<-;D5&H>V{NtJs4z1-$UD0>8>+6!ka zdk%Y5;-Hy=LRwkt%}|QRa=TgI%Y(-2ucV~#2AaZx81{#pMg-d5$~dQmF)cwp+59lA z4;uV3G`mw^jFIWV^bw)iX%^7e>v|En;t9CpKxcDMUwk|`43nu|k2zM&KDuvD>&udr z$i87u*g*!w=hHyrA@Z)~@-PV-m&kFlP}QE~3Mo(-Jhai1Qd^JrkL5BXr-ZMx$4U#^ zE%rjUUnuO6NaA;NO3 zJ7WVs|B14Xl(?8U)L6Sh|8ytH!oT^Vrt+q9(uM-ztt~%t-0L(*Md?gj&4VfW7#kPH zAVb5OYD_fQr^LQ7k~?s{_)8#IJ5JOKH{SXoA zfTQ~*MQCB=ZN2_W=RUmvatzW+0=vUH$)@OAg_K(ysl?u=n{kR6z&$h?)mjEpGjk953A+NHRtWtu zuWMnq!J2Q@{@`>{y&5tG66PdF){+wUcRHRycoQz6J7PN^SE34k4>p)!o#Kwuq^~31 z%P6)K@7}U#D4(O2|z5aK1f?6F`fD zRFKW;L9kVSc@YVQv$&T{Fi_1ecR4)Y2-HscVxgp~1f0_Jlm)G_DW!BPlK!~yUdL&2 zj9P4T_HzCPwJSOlomOu+YQq*X`GUs_<9$X84?vEo;~N8X$YpRIRojv)y7_v`kkj)+ zx#pXtAN`yYoF3<$8RC?}*@x2|VY=mE^b>DiU6u73GafQeI5mRbT77n$gkKc(2>*sL zH9A}h+z>n|Ux;uX4Df|Qa62_%XXcs~>44+O3tM5vtQPt$rJt?cUl_p`monURr$;@h4?sYCZ-kzgyLKig#`=eS*O^pDub zkExHIP1Ea?)h(Ao-NJlY!=aKDm$lC63 z4EbgQSc{@J_ShQwk;R39{ed9zfYHT@NP2GM9gm=#%feiug)c$6dFAp9JOx^i{0f1w zJ|cM<78cUxK~T$KSSnfMR4;vXOqjsI?{lWykY(L+)RQ882pm)EG71Pbh-s^5qcRTO z5yv*gWAbq!Qt%9i@d^#UiF??@9LMZ}S%2O#eM=}H^cev%rVE8`SR2iV8|9{6EqPe3 zCr@JF5SRu)4LtgwP8uOF21S>W!MAd{GVVv&K>DzXNy5)&vFoOm zm)ynLF09<9*`fbFy`TqAq@iGkGM9|w8v4}iB`kuL0=bRe&l7c6h=V#1Y0&JQgqyht zLko;s^8+)QCSwrIBRfWmCFL=x;1$ISn;3od?3ciJnH{>*cmFAnK*T_nyNVmPS<{L> zmsq!C9%@d$o{8LF8YaBa!`L5;(L3ViV0Eu$;>8wAOt7|(NQZ1=FkB;N|C7)>ji7#q z$znb`GNn^RTCAcqI@|InY+goQYZ2<`4M&}QR72?sx4g)4E}m1ubE(OZ6;hyR^&(Xe zVghIl<64Iy2m~#n3QN_tY`Px=Q8R6hu1#B@ST1XWXIQ{VaxVW-xx(2>S)mrXg?i!_ z(96nnBGc-m2p_nTsEQ#iwbmc=wvX*qc5K?f;HCa>cCtd=sgVZGd7mr72|O1u)_+3B z9Gi)Raj<9P+a%fMemZU5Jv=SWBb3b)@tU~=MU>-3oho(>2rzcx2h^NucO&BzRq6v) zj_k*pxQI=S!tufWY&C3k;(F?o^K@lt-07o!i$|CQUwl;hU=4;bvsdkyZFq|6tS}z6 z5)Bk1Nm>lHYT#f0~yq~ z2CPI-7HI#Q=BffUP?y7AS~8>+B+epqz$|{aYi|#|Y^bs`tIc`(kN``bbn5U+#_ z<33jlhEMGmg=qSg#0M5YebeO3EZC>_)!w?F4Ti{N01E=^x});)AVgFzM~G>|EGL)M zf4Uv^zDt>jP_=AlQRPpx9?}$%4*=&rdaSy%3bjJr=^t5*79KL?WUonyzBr%7~A#dM+_vJ*E-0Cxwn)B@4^u zp7VUf?gaSzXAX2jI}YA;%w7=986K{dQL)svJ@x1blkv9nA^;@j-B(nt=OWrBWd|R6 zX?ziXPrY&2V-=#xaGJBZ)8Ab=TfN7mQiF#YUJ@&O#Nl8|sF^}A& zGR2@0+*|V)vUO!4fG>pWo`x@U4*}v%sOvWy*ZD8?P0UF&cAl&L6)$XKHJRO3 z5iHN?GFIc7zLDuco^s4O=ICs*SG(m!t5hz!QJxO-S>x5~W53MlR2)ei`O;x<9Pv!3 z8tMDXE0lN~ymbzlKz8Lu=`IPUnzCP$<@SapvuN=c721SmQpalEL$+~-}Fv;4T< z=&=R^&^4~nV60&)=3x-7CGDbInuq)l`bRb~F^vdujy$1+|Hcc(XT?0bwVv4Pd<0~0 zqh~+3lC#F+sA!+ixK}<`9=3OT9@sU$X}`LZCu?4i*P~4>l^%$gfHQ`1Zfk$Wvr)g5r0 zR=)o#<}njtvg9{G9z*5WEVSq%7%bS%2V^Dbt?_%$Z7bIUd~XDQg1lO0xNYdkyG+*I zS2Y{3Tt^U%J;-=8R{`q zrix;14*-$yW*VSqVM*0q-le593>X5*ov`FeVF0Jg^Bbp+r_1+=s_wO3X zWxBp@-%rt;?#wyll9jIyA`>=B0+xSM8kIv#t*-<|=)C0lePD;n}ZJhf>)(*M;g}@STHRCD&>0 zi^sFwN4}sQ%xjtI3jI8+cO;G@VK7CeYc`4 zW*IkaR-PT7We@B{xSGF8l%R80UcAk%>rRmti+ITEF62!ro4 zXHxTs4=!u_9v!^nD5x-+^-*B8WW&Ya87>3*;D|WQfjJRMy`aYFPXs(7S#kw6x{{$k zj+kIA@dgqv9V^p&wB3x}7C5824I)8!MOXz}VbVG5!h=N86mv#S}>0B0gKO(sZob(mjKkozUh5R7X5?9ZRdk zrOHeB6_OcKh_)nMmu$}P;Xw%W_XNzX4+`CVRk4=AD;DWMRTMwRp}iM)y6C43{xu!N zEPK$)Xo}0rRpVPtxWZELk&!BA51DOZ5iLIm1(=Fr{N<%)fGkLOvhxSl_^JBVM#>fHxaPK(-XCoQ%2aR5B9W=4rqEcVFf1gw^vz(%e(5eh3 zAdv<4%P5*GX{;!C1wX?+3OgeUXn&Fa?F1<`w)1i*Up`cjbjU^2?<|=<Vv+1Hj z3lNAQKpim0pDwn@Ha>=6GDjxiLzd0Qny@AH^6Y^gmm#lq1B2$?ln3_2>H>L0RpHF# zQB-y&%%Vzg8m<{;7-l2QiIHNv7EtGQd10?DlXa*_F`DHoZiaJFO&w|Bm4x1yaz?W` zS{f`FkR;)>Y7<>y&QI4o$l8Q`vL9%uZ(1Y5SzQRZafo+SCOm3)m!ae^#*~{xr9N&Z zJ3hni0^X=ES~^zdK7rHABP}31&a^$ycHS4GJ|?gy=^_?#9~C$hcm`6qC>k_Os-&xf z1A$y-C1ELfh8N-yoY;Bzv3$2KJ53qo=b-O&sQNAkTrNVh=DGV;kJQK;==BJQbvpAj z)+|VczS_PKBnl?TO$rKdLAHTI9=5@E#p?4jBQk$ zhSPUBBUkiZ^bvbVhFM4AlR$^?D19V~Xtnn^$`qgE)NDi%5HVby)ND1N*lNQlhUZ2o z=Bf?MA-p(fyk9*EOrt&cGt_y_KB_w|(p0KzGt7&h6F*?fn1`&YOR%j=!+E@D-xwX( zmI_`|>za8Cy18l*+M%TJ5*)*|OBV4|v2HMsx0)xE{y2yL)Dm$c@#R`S*+P;N%rl&o zC`_{Z1I`no>n@)s_lhDB!9udhzhYB8lVi$4TN`Og%x*uhS(Rc1_(fiZZ8k{lSYBTV zK_{mXEZ&v{y#m&z=d6SGQ1V3im%q-P(DwdKIPVB81HM*F+J8@23T0oHs(#7i5S7|teNAN752vf&j)!)W}JFCx{tq;axEt1NRlF}ClK zb@!9oA)gL4sWd)Fzbgw(tus97A-#1n&%A>hdwq;*Ym(GF{+HK)1qa(Wu@{gGgjdh|Nl3-e0<1WXqbLG<59@Mvj$I9+tJr8VvV zsRFE5Ni*ku81<7NW}1fQUZ~q+k{Wtj7v0+Rifm6Pory*2sS8FH9Ce)~QKR&|+=`8x z<2Q1x2hVFyS&7k#B`B?QnRfX^XsIyzCfVU&x5PoT_IkF_ZYH{DuGSF%$UYMc5?Z>X=1bUB<|GqecMH<(fJ`k=Yv^)>s%YxdJ5h~ANn>{pqQ+^>`!SI zBRIc%!%9jq{E_{ln5}Jhno%K8mGc78wKrtAtoBoMtk)UjxkX#g(vIF4cGdX(k3K=@ zuLap(ypOqjNq)Gwhh4C5WeQPfyNsnPqfXs zCK?R0RaM$`VX6X;5k7&$f40~=z;4#XQmxz8`xfW?@$7JjP{*lcC@L3RTUd(YbGimo zEWv>U|9VD{RlKq<8g_Yw@O7byUDLwms*jsqsGa9ramn-oo;0F2&t=LpRVBcouH^8BUpd zBWr{$Y-WXTmSiW(MKIElod!}*yYFNof!=Tz3R)jc zCLufGYK-HAN1FW=sX6YHw#8qYUjqt(Wz#jf$eiVUdV6!N7Y*)-$P4}L@Jf3pmuVsX(i4gLOfJFgLd5g z6f}09h(&x-~)koz04l-Bo^Tw*Mk;@zAa$1<-ilGB{@pbk!2=fw=snN^fG`cOQxRX;f2|ysQwkf zct!Lt3tYNjBEk~{Y2hEwKD z(W8J+Pf?2!&bSckbK(7V<9!ss2Kt2W9$*@5NAO|o;U^9QUd7WkJe>LH#x&c#wAC+!l{MJa8uE$@6lCF(R?Pp_=AhNz8Z z3S*BqHnlsWxJyiSVT7Tx;66B_wYPOqzAl#65(o_D-h8z0Orjlo(o2C05A398?=d(6 z*-7eeB4W6%#XXX!EVtc}REdTUcUUg=U?NM#Ve@H$QFqorAqen$Lj2zr!&kBB(D=*6 zGe+m1+#u={V*W*RLS(UNGeBkHQwgkQZ_Bxdfd+WSVA(Xf3LyFf$=jagzP_qM3 zW?qV|X%iXI0DCG-Ny29SNeZBLqS@ePy-LuBaS!oa@{f7Fe}_1I+HpdY_sH>E01Eo2 z>q5idHN{tqG$eq{0F51q`iafGh(aVaC5L#7v}?;-rE0p!+^tx2XQj?zoiM)I+4U;I z7@qSA1)O%{PrO5w#w~V7;oC=4c2+X#ScrH{?`#sokNN!w`#8EAX!2xn8EEq04Rf!r zXE6D9T~jpv7P-QD6_t~}j!@v|6dl`y{RE^(_xgQ*d2eoZK*nc{zy2oQS1@t5ZI7ps zX0-n$DVILn)jg?~I10iN3B>a5MPa<;mNP3~#4s)5JBKMAnrr&MNiTl0Lti-N*xf9?2l6O0Z4t;qnvl^I-*ytOo6MgP8waN^kDCzXv#D2>3$H*T(WE^R;qKngiHgeaaG-%MnHe0~@BAzjSvAPXfw0`bLXego||z*jX-*Z*z^5I5k=*(mXqXTjf- zU0+J5A70DmOQ{Gxu1SzIc8sjEC8n?A6Y9TkzQ_l~(_LYtxLFddF_haye=ByCqq>5x zI2C&UZ2?&SX0IOs`z3ukhgupBL@W4IJCfAp!Gb#+(@Q;7o!t}R6eoA5?^)eniMo*5 zOck|)k~|XQa;Uku;07uq$&PH%OSmQr98 z2tmNU+BeNOd|)uxKYTTM<>}z|F<2|=><|!BDHLA|>lO1Mnw>tDK>iLP{Af1qELO3# zo=NUHWD+s^lPiFN`fX#B->4S=B~p4QxJd1DYHZ5KmYC0>7}7);>MWw=C0&x~3%86U z=%K)T2;JCDq?MX{fh&{FJ5@=q;*^a7o)Zi!Ln+?Ir zY4?`N8hkAAW4Z?(qreCk_witi=stn8&aAgB1<=)zC~DiL;sRfE>3u$iXEU>6kH0}Z zH{HDm1_h=?rfU`utYsGIHBFX71}{{AjK-*wS;@WjW<$easv1T|P@B!7Ovcr|&AYYJ zbvDlqD_sSv8+H^y-ccjZZtz}EbdIJ^>sozASiG{o`UhV0K(ve!95ixyWFaD#E#s`J zO_8i)agEf+BV*Ilz7Dswt!ohu8}7D?awg}T z;;$A464z643lei3VC$7jh~I;ItC3HSyl1vB*8HRReU(V8gmIwdAIO)bIt&RD;MPr3 zv48zWU968Hk-^3h z0kYd2!INf%Z@vLQ2+%f)DuEEGp@$)Z55wQogeGD8TA3=P>`$f;=Ugtlm)(G*2-2V*&qo^_-IWAkNqy~@zkO1K|;^Z*L7@)ft zgh)_DmxL}4Ln^Ls6!uCO(PMsPmyT;_ee$DKFgFm?xYii48lrf?^PA{Y7EAf|LsAW4 zS~0S}GQ?+jL}y;(kT6ThaLG6ZK@m@xo*&bg2T%)1_gI#>85277b2u*oy>!gXv@{&&kRgFtO@Wu|uv_vR*hR-9-3WHX8yn(jpw1yzjc-Ngf`bm?`WB!(1`c6tlj|+56H{a_$h59)u5(CELYk1IG;NV<+|@~ z)>NQ3RdN0JpA)CVGMGR~IJF)%>S^81n6vIgvm{*h0qiUWQr7Y6C^IT9r*~whe{?wcIL&km2koMPtziR|(H|w}i%a>2jUWUV(SHL%F z3A^V~t zl+-=3@PC>^PY<|_aKLi#mb;L&1n%%0+j*tLk6%I#yJ$_ZOaheTEOqm%ay_S4#A`;I zjIMM~)0Q0FEKn~n0Q+MljnqOTc9tLj&VWU;9~-aphxnJVStLNr`F~^j(z;7}{u7H|ClnXmiL`w)#HZfQwmpCbjJz-1M9V zd{;|g_*aqKcE@OK`vmTk1)P;di1+ejXNAge`%uGa`XP-<>-<5f-S9S0!PsmMO+NTk z+HQ@BPExmj3G3=|CSz2RBpTkOrlitoII{zco9Bi6==3#V%iNC7`{RR&Q`(cU?B(^_ zsqfYjYZh+h_2D)ynzr@Zev5WqZp-3tQn)HeCIFvex~7dFo0JC(h8w4=t?|0KSJx+7 z;fklDjxh<6R2heaOdTVTrcSi+zagA)e5j?lf&BrmEZ9}gPf4O zMOZS7!sNji%Hlkc4rl!jE-V+eq0_A^491u^uosjSkevLbU=(7-k4*0FEJppu7X8B0 zlkkY5HK^fD`-dNVv+A5G(qsI*U4CV~zxWv9>xEU19{8>vN-Y@G($u5;N`L{B(8+>) zhm}UgTEh+-z(FqX~cx zQe0KAIhbNllzTDcl*h6Q^H9fvEcR7C85Wn|{W_QcG8YY4IrW?8o>3f5)o>wbD+HX4 zCfR3~vl+YfG7n@%ei`e1c|lyIapNG7OGqZj2=Gco-L`#Q8{S_=G9|BvZEgt8wt`Cn zf>uUlpe;#RPppf%pTgw6a$4unvnq)q@?m{tMGA#a82tJSE7KRck)3?yolP7lMp&G&*$mY6f~VUNu=xM9MT0`yFuC3fy~ z;gd*3#m|;cVpEWzp84XrKHcdpL5{?E8VkEoWqry8=+R;*#P`w)3-XO$H zrsmyy^vyjuD(H6{a8W+Xn*}Ia(JYq2;?J|0^ND+<+qt91hcEl~;?6yi=YMTfwu2Ts zcyr2w(%DV*?B4kCq!Y)HNe}FFF{DAs16>(mD`+`wa7=A08>Hh>rXp@*OlIVI)z{-R z;`rNnVGZ6Wa8R-fF3KmQ3TE}2#mxj!J@potngml!-mLVt$#E5rO$3! zKfiJEp*!{>P}v9jc3EiwYGl+Y>5#4^7wKBR3y&rjW@WMptCRtXV*srW95VEn@I5pJ z;qt|O=so_s~Kbh9K)1oP|F1G8Q$%9i$E&SVZJ!P!& zBXX3E^)VHe7kTUZ{bFc77tRD&^M39va`$Gr?zR#Z?@G-zM8;sO=3+wyIspF!Fohec<=&HIOeKgT1P34T3CqNh4 zyC1xijpw&Ns1}qc#!Ll?_z~jqe6ic^xXU{aYaYFKTZ8mkbHrK5EUYs~ygs>Rtg}~b)cG@En;Fvr05%)l>8WBBOpCZz5}N%zesE}PP$UkV0b{aFE|t8 z67ZOKH|43}IIS}$S3@Ls5%|3f(M_DgsB}@R&l1e$U_r0B+ji$sGMZvTDYhrvDs!Ne z^ZM~tCTT4QR1XiFtjMgXZU3e3FOQg*&`JpHNB~JcHBmNhasl**a8w#eZE@HW2fH`; zSe}>3N)>d~_Uu@oyFFv4%IPo!5~Dj}kIi;lG*9jkai49U7ckX4<>`xX(1uMnWL18g^`;o3VYID)+1+C*ske*MBy@#tjrV+9}&g|pu^-fN}^Kj&X zhUPOZ*A<6Kk-G%BI!Ms9u~5<8aOsT}V6B~k04twNOZYYD0hvm%%1QL@((qtu;H~-a=u8n>wjf#_(?y5C=dbBu#*76=+5CV$YS

    +]]>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}An Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations2021-07-16T12:00:00-07:002024-04-03T00:00:00-07:00https://transfemscience.org/articles/injectable-e2-meta-analysisAn Informal Meta-Analysis of Estradiol Curves with Injectable Estradiol Preparations

    By Aly | First published July 16, 2021 - | Last modified March 18, 2024

    + | Last modified April 3, 2024

    Abstract / TL;DR

    @@ -1279,7 +1279,7 @@ Using the term desistence in this way does not imply anything about the identity

    Estradiol Undecylate

    -

    Estradiol undecylate was formerly used in the treatment of prostate cancer and in menopausal hormone therapy as well as for other estrogen therapeutic indications. However, it was discontinued many years ago and is no longer used today. Nonetheless, estradiol undecylate is of significant historical interest as an injectable estradiol preparation. A total of 3 publications and estradiol concentration–time data for 7 individual injections were identified for estradiol undecylate (Table 7).

    +

    Estradiol undecylate was formerly used in the treatment of prostate cancer and in menopausal hormone therapy as well as for other estrogen therapeutic indications. However, it was discontinued many years ago and is no longer used today. Nonetheless, estradiol undecylate is of significant historical interest as an injectable estradiol preparation. A total of 4 publications and estradiol concentration–time data for 7 individual injections were identified for estradiol undecylate (Table 7).

    Table 7: Studies of injectable estradiol undecylate (Spreadsheet; Plotly):

    @@ -1479,7 +1479,7 @@ Using the term desistence in this way does not imply anything about the identity
  • Estradiol (unesterified) in an “aqueous” preparation (type of aqueous preparation unspecified but probably a microcrystalline aqueous suspension) (Jones et al., 1978 [Graph])
  • Estradiol (unesterified) in different microsphere formulations (e.g., Juvenum-E) (Garza-Flores, 1994 [Graph]; Espino y Sosa et al., 2019 [Graph])
  • Estradiol/progesterone in a macrocrystalline aqueous suspension (Garza-Flores et al., 1991)
    • -
  • Estradiol/megestrol acetate in a microcrystalline aqueous suspension (Mego-E) (a lesser-known combined injectable contraceptive used in China) (Yan et al., 1987 [Graphs])
    • +
  • Estradiol/megestrol acetate in a microcrystalline aqueous suspension (Mego-E) (a lesser-known combined injectable contraceptive used in China) (Yan et al., 1987 [Graphs])
  • Estradiol dipropionate in oil (Agofollin) (Presl et al., 1976 [Graph])
  • Estradiol benzoate/estradiol phenylpropionate in oil (Dimenformon Prolongatum) (Rauramo et al., 1980; Rauramo, Punnonen, & Grönroos, 1981)
  • Estradiol benzoate/estradiol phenylpropionate/testosterone propionate/testosterone phenylpropionate/testosterone isocaproate in oil (Estandron Prolongatum) (Vermeulen, 1975)
    • @@ -1866,7 +1866,7 @@ Using the term desistence in this way does not imply anything about the identity

    With the preceding concerns about the doses and intervals of injectable estradiol preparations recommended by transgender care guidelines considered, the question of how these recommendations were determined arises. Unfortunately, current guidelines do not generally describe how they arrived at their recommendations nor do they usually cite sources to support them. It is notable that the UCSF guidelines recommend doses and intervals for injectable estradiol preparations that are nearly identical to those advised by Christian Hamburger and Harry Benjamin in the late 1960s in the first medical textbook on transgender people (Hamburger & Benjamin, 1969). These authors recommended a dose of 10–40 mg/2 weeks for estradiol valerate and of 2–5 mg/2 weeks for estradiol cypionate (although Benjamin additionally stated that after 4–8 months, the same doses could be used at a longer injection interval of once every 4 weeks). These recommendations were notably made before estradiol blood tests became practicably available and were prior to the advent of modern pharmacokinetic studies. Hence, the recommendations for at least these guidelines appear to be based mainly on past expert opinion and long-standing historical precedent rather than on pharmacokinetic or clinical data. The same is likely to also be true for most other guidelines. High doses with certain injectable estradiol preparations (namely estradiol valerate) were probably originally employed for the purpose of achieving longer durations and more convenient injection intervals. This was notably prior to the risks of excessive estrogenic exposure like blood clots becoming known, and these doses may simply have never been revised.

    -

    The reasons that dose recommendations for injectable estradiol in transfeminine people have remained as they have for so long may be related to several factors. These include (1) a long-standing lack of research and funding in transgender health; (2) injectable estradiol not being widely available or as commonly used as other forms of estradiol; and (3) many clinicians only testing estradiol levels at trough (right before the next injection) with injectable estradiol preparations (e.g., Mueller et al., 2011; Chantrapanichkul et al., 2021; Cirrincione et al., 2021). The latter point is noteworthy as trough levels only describe the lowest point of the estradiol concentration–time curve with injectable estradiol preparations, and can give a very misleading impression of average or total estradiol exposure. In any case, the very high estradiol levels with currently recommended doses of injectable estradiol forms for transfeminine people have not gone unnoticed in the literature (e.g., Gooren, 2005; Spack, 2013; Deutsch, 2014; Glintborg et al., 2021; Tassinari & Maranghi, 2021; Le, Huang, & Cirrincione, 2022). Additionally, clinical studies in transfeminine people have reported high to very high estradiol levels with typical clinical doses of injectable estradiol (e.g., Kronawitter et al., 2009 [Table]; Mueller et al., 2011 [Table]; Sharula et al., 2012 [Data]; Nelson et al., 2016 [Table]; LaBudde, Craig, & Spratt, 2020; Chantrapanichkul et al., 2021 [Table]; Cirrincione et al., 2021 [Table]).

    +

    The reasons that dose recommendations for injectable estradiol in transfeminine people have remained as they have for so long may be related to several factors. These include (1) a long-standing lack of research and funding in transgender health; (2) injectable estradiol not being widely available or as commonly used as other forms of estradiol; and (3) many clinicians only testing estradiol levels at trough (right before the next injection) with injectable estradiol preparations (e.g., Mueller et al., 2011; Chantrapanichkul et al., 2021; Cirrincione et al., 2021). The latter point is noteworthy as trough levels only describe the lowest point of the estradiol concentration–time curve with injectable estradiol preparations, and can give a very misleading impression of average or total estradiol exposure. In any case, the very high estradiol levels with currently recommended doses of injectable estradiol forms for transfeminine people have not gone unnoticed in the literature (e.g., Gooren, 2005; Spack, 2013; Deutsch, 2014; Glintborg et al., 2021; Tassinari & Maranghi, 2021; Le, Huang, & Cirrincione, 2022). Additionally, clinical studies in transfeminine people have reported high to very high estradiol levels with typical clinical doses of injectable estradiol (e.g., Kronawitter et al., 2009 [Table]; Mueller et al., 2011 [Table]; Sharula et al., 2012 [Data]; Nelson et al., 2016 [Table]; LaBudde, Craig, & Spratt, 2020; Chantrapanichkul et al., 2021 [Table]; Cirrincione et al., 2021 [Table]).

    Among the surveyed guidelines for transgender hormone therapy, only the UCSF guidelines (Deutsch, 2016b) and the Sherbourne Health/Rainbow Health Ontario guidelines (Bourns, 2019) referenced pharmacokinetic literature in their discussion of injectable estradiol. The specific publications cited by these guidelines were Düsterberg & Nishino (1982), Sierra-Ramírez et al. (2011), and Thurman et al. (2013). Although it is favorable to see guidelines considering published pharmacokinetic data for informing use of these preparations, there are a few concerns about the studies that were cited. Düsterberg & Nishino (1982) in its study of injectable estradiol valerate had a very small sample size (n=2), and this study was excluded as an outlier in the present meta-analysis due to unusually high estradiol levels. The findings of Düsterberg & Nishino (1982) also do not seem to have actually been used to guide dosing recommendations in the case of the UCSF guidelines, since if this were the case, the recommended doses should have been much lower. On the other hand, Bourns (2019) cited the same study and recommended injectable estradiol valerate at doses of 3–4 mg/week or 6–8 mg/2 weeks. These doses are well below those recommended by other transgender care guidelines and appear to be more appropriate for use in transfeminine people in light of the present meta-analysis. Sierra-Ramírez et al. (2011) and Thurman et al. (2013), although better-quality studies than Düsterberg & Nishino (1982), described injectable estradiol cypionate suspension rather than estradiol cypionate in oil. The oil-based version of estradiol cypionate is the form normally used in transfeminine hormone therapy, and there are important differences between these estradiol cypionate preparations such that pharmacokinetic studies for the suspension can’t necessarily be generalized to the oil solution. These preparations do in any case produce similar total estradiol levels however and hence doses should be comparable for them.

    @@ -1898,7 +1898,7 @@ Using the term desistence in this way does not imply anything about the identity

    Update 1: WPATH SOC8 Guidelines

    -

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published and made recommendations on transgender hormone therapy for the first time (Coleman et al., 2022). These guidelines are among the most highly regarded and consulted transgender care guidelines that exist. In terms of the recommended doses of hormonal medications for transgender people, the WPATH SOC8 appear to have largely copied the Endocrine Society’s 2017 guidelines on transgender hormone therapy (Hembree et al., 2017). More specifically, in the case of injectable estradiol preparations for transfeminine people, doses of 5–30 mg/2 weeks or 2–10 mg/week estradiol valerate or estradiol cypionate were recommended. There was no discussion of injectable estradiol in the guidelines besides the preceding doses and intervals being included in a table, and no literature citations were included to support these doses. As described in the present work, these recommendations include doses and intervals that appear to be highly excessive, too widely spaced, and likely unsafe. As such, major transgender care guidelines unfortunately continue to make uncited recommendations for injectable estradiol in transfeminine people that are out of step with insights available from abundant published pharmacokinetic data and are likely inadvisable, with the possibility of substantial safety risks.

    +

    In September 2022, the World Professional Association for Transgender Health (WPATH) Standards of Care for the Health of Transgender and Gender Diverse People Version 8 (SOC8) were published and made recommendations on transgender hormone therapy for the first time (Coleman et al., 2022). These guidelines are among the most highly regarded and consulted transgender care guidelines. In terms of the recommended doses of hormonal medications for transgender people, the WPATH SOC8 appear to have largely copied the Endocrine Society’s 2017 guidelines on transgender hormone therapy (Hembree et al., 2017). More specifically, in the case of injectable estradiol preparations for transfeminine people, doses of 5–30 mg/2 weeks or 2–10 mg/week estradiol valerate or estradiol cypionate were recommended. There was no discussion of injectable estradiol in the guidelines besides the preceding doses and intervals being included in a table, and no literature citations were included to support these doses. As described in the present work, these recommendations include doses and intervals that appear to be highly excessive, too widely spaced, and are likely unsafe. As such, major transgender care guidelines unfortunately continue to make uncited recommendations for injectable estradiol in transfeminine people that are out of step with insights available from abundant published pharmacokinetic data. These recommendations are likely inadvisable, with the possibility of substantial safety risks.

    Update 2: Literature Mentions

    @@ -2111,7 +2111,7 @@ Using the term desistence in this way does not imply anything about the identity
  • Messinis, I. E., & Templeton, A. (1987). Effect of high dose exogenous oestrogen on midcycle luteinizing hormone surge in human spontaneous cycles. Clinical Endocrinology, 27(4), 453–459. [DOI:10.1111/j.1365-2265.1987.tb01173.x]
  • Messinis, I. E., & Templeton, A. A. (1987). Disparate effects of endogenous and exogenous oestradiol on luteal phase function in women. Reproduction, 79(2), 549–554. [DOI:10.1530/jrf.0.0790549]
  • Minto, C. F., Howe, C., Wishart, S., Conway, A. J., & Handelsman, D. J. (1997). Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. Journal of Pharmacology and Experimental Therapeutics, 281(1), 93–102. [URL]
    • -
  • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
    • +
  • Mueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2011). Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist. Experimental and Clinical Endocrinology & Diabetes, 119(2), 95–100. [DOI:10.1055/s-0030-1255074] [Table]
  • Newton, J. R., d’Arcangues, C., & Hall, P. E. (1994). A review of ‘once-a-month’ combined injectable contraceptives. Journal of Obstetrics and Gynaecology, 14(Suppl 1), S1–S34. [DOI:10.3109/01443619409027641]
  • Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective? Transgender Health, 1(1), 165–171. [DOI:10.1089/trgh.2016.0016] [Table]
  • Nieschlag, E., & Behre, H. M. (2010). Testosterone therapy. In Nieschlag, E., Behre, H. M., & Nieschlag, S. (Eds.). Andrology (pp. 437–455). Berlin/Heidelberg: Springer. [DOI:10.1007/978-3-540-78355-8_21] [PDF]
    • @@ -2172,7 +2172,7 @@ Using the term desistence in this way does not imply anything about the identity
  • Valle Alvarez, D. C. (2011). Efecto de una Dosis de 50 mg de Enantato de Noretisterona y 5 mg de Valerato de Estradiol en los Niveles de Testosterona Total en Hombres Mexicanos Sanos. [Effect of a Dose of 50 mg of Norethisterone Enanthate and 5 mg of Estradiol Valerate on Total Testosterone Levels in Healthy Mexican Men.] (Masters thesis, National Polytechnic Institute of Mexico.) [Google Scholar] [URL] [PDF] [Translation]
  • Varangot, J., & Cedard, L. (1957). Modifications des Œstrogènes Sanguins Après Administration Intramusculaire de Benzoate d’Œstradiol. [Changes in Serum Estrogens After Intramuscular Administration of Estradiol Benzoate.] Comptes Rendus des Séances de la Société de Biologie et de ses Filiales, 151(10), 1707–1712. [Google Scholar 1] [Google Scholar 2] [PubMed] [PDF] [Translation]
  • Vermeulen, A. (1975). Longacting steroid preparations. Acta Clinica Belgica, 30(1), 48–55. [DOI:10.1080/17843286.1975.11716973]
    • -
  • Vermeulen, A. (1977). Transport and Distribution of Androgens at Different Ages. In Martini, L., & Motta, M. (Eds.). Androgens and Antiandrogens (pp. 53–65). New York: Raven Press. [Google Scholar] [Google Books] [WorldCat]
    • +
  • Vermeulen, A. (1977). Transport and Distribution of Androgens at Different Ages. In Martini, L., & Motta, M. (Eds.). Androgens and Antiandrogens (pp. 53–65). New York: Raven Press. [Google Scholar] [Google Books] [OpenLibrary] [WorldCat] [Archive.org] [Excerpt]
  • Vhora, I., Bardoliwala, D., Ranamalla, S. R., & Javia, A. (2019). Parenteral controlled and prolonged drug delivery systems: therapeutic needs and formulation strategies. In Misra A., & Shahiwala, A. (Eds.). Novel Drug Delivery Technologies (pp. 183–260). Singapore: Springer. [DOI:10.1007/978-981-13-3642-3_7]
  • Vizziello, G., D’Amato, G., Trentadue, R., & Fanizza, G. (1993). Studio dinamico del blocco ipofisario indotto dalla triptorelina, mediante test all’estradiolo benzoato. [Estradiol benzoate test in the study of pituitary block induced by triptorelin.] Minerva Ginecologica, 45(4), 185–189. [Google Scholar] [PubMed] [PDF] [Translation]
  • Wagner, J. G. (1993). Pharmacokinetics for the Pharmaceutical Scientist. Lancaster/Basel: Technomic. [DOI:10.1201/9780203743652] [Google Books]
    • @@ -2180,17 +2180,17 @@ Using the term desistence in this way does not imply anything about the identity
  • White, M. C., Rosenstock, J., Anapliotou, M., Mashiter, K., & Joplin, G. F. (1981). Heterogeneity of prolactin responses to oestradiol benzoate in women with prolactinomas. The Lancet, 317(8235), 1394–1396. [DOI:10.1016/S0140-6736(81)92571-X]
  • Wiemeyer, J. C., Fernandez, M., Moguilevsky, J. A., & Sagasta, C. L. (1986). Pharmacokinetic Studies of Estradiol Enantate in Menopausic Women. Arzneimittel-Forschung, 36(11), 1674–1677. [Google Scholar] [PubMed] [PDF]
  • Wiemeyer, J. C., Fernandez, M., Sagasta, C. L., & Moguilevsky, J. A. (1987). Estudos farmacocinéticos do enantato de estradiol em mulheres na menopausa. [Pharmacokinetic studies of estradiol enantate in menopausic women.] Jornal Brasileiro de Ginecologia, 97(9), 497–501. [Google Scholar] [LILACS] [PDF]
    • -
  • Yan, J., Pan, J., Chang, Y., & Kang, J. (1987). The effect of monthly injectable contraceptive megestrol acetate compound on pituitary-ovarian function. 上海第二医科大学学报(英文版) / Journal of Shanghai Second Medical University / Medical Bulletin of Shanghai Jiaotong University, 1(2), 7–12. [Google Scholar] [CNKI] [PDF]
    • +
  • Yan, J., Pan, J., Chang, Y., & Kang, J. (1987). The effect of monthly injectable contraceptive megestrol acetate compound on pituitary-ovarian function. 上海第二医科大学学报(英文版) / Journal of Shanghai Second Medical University / Medical Bulletin of Shanghai Jiaotong University, 1(2), 7–12. [Google Scholar] [CNKI] [PDF]
  • Yáñez, J. A., Remsberg, C. M., Sayre, C. L., Forrest, M. L., & Davies, N. M. (2011). Flip-flop pharmacokinetics–delivering a reversal of disposition: challenges and opportunities during drug development. Therapeutic Delivery, 2(5), 643–672. [DOI:10.4155/tde.11.19]
  • Zhang, Y., Huo, M., Zhou, J., & Xie, S. (2010). PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer Methods and Programs in Biomedicine, 99(3), 306–314. [DOI:10.1016/j.cmpb.2010.01.007]
  • Zhou, X. F., Shao, Q. X., Han, X. J., Weng, L. J., & Sang, G. W. (1998). Pharmacokinetics of medroxyprogesterone acetate after single and multiple injection of Cyclofem® in Chinese women. Contraception, 57(6), 405–411. [DOI:10.1016/S0010-7824(98)00048-1]
    • -]]>    {"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}    An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People2021-06-11T20:26:25-07:002021-09-06T00:00:00-07:00https://transfemscience.org/articles/sublingual-e2-transfemAn Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People +]]>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}An Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People2021-06-11T20:26:25-07:002024-03-30T00:00:00-07:00https://transfemscience.org/articles/sublingual-e2-transfemAn Exploration of Sublingual Estradiol as an Alternative to Oral Estradiol in Transfeminine People

    By Sam | First published June 11, 2021 - | Last modified September 6, 2021

    + | Last modified March 30, 2024

    Abstract / TL;DR

    @@ -2343,6 +2343,30 @@ Using the term desistence in this way does not imply anything about the identity

    Taken together, although much more research is clearly needed to properly characterise the route, sublingual estradiol may have a number of advantageous properties and may be a useful alternative to oral estradiol in transfeminine hormone therapy.

    +

    Updates

    + +

    Update 1: New Sublingual Estradiol Studies (Added By Aly)

    + +

    Since this article was first published, the following new relevant studies and papers on sublingual estradiol in transfeminine people have been published:

    + +
      +
    • Doll, E., Gunsolus, I., Thorgerson, A., Tangpricha, V., Lamberton, N., & Sarvaideo, J. L. (2022). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Endocrine Practice, 28(3), 237–242. [DOI:10.1016/j.eprac.2021.11.081] +
        +
      • Safer, J. D. (2022). Are the Pharmacokinetics of Sublingual Estradiol Superior or Inferior to Those of Oral Estradiol? Endocrine Practice, 28(3), 351–352. [DOI:10.1016/j.eprac.2021.12.018]
        • +
      • Sarvaideo, J., Doll, E., & Tangpricha, V. (2022). More Studies Are Needed to Establish the Safety and Efficacy of Sublingual Estradiol in Transgender Women. Endocrine Practice, 28(3), 353–354. [DOI:10.1016/j.eprac.2022.01.004]
        • +
      +
      • +
    • Cortez, S., Moog, D., Lewis, C., Williams, K., Herrick, C., Fields, M., Gray, T., Guo, Z., Nicol, G., & Baranski, T. (2023). Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 12, e53092. [DOI:10.2196/53092]
      • +
    • Jalal, E., & Baldwin, C. (2023). Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1095–A1096 (abstract no. SAT391/bvad114.2062). [DOI:10.1210/jendso/bvad114.2062] [PDF]
      • +
    • Yaish, I., Gindis, G., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (2023). Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study. Transgender Health, 8(6), 485–493. [DOI:10.1089/trgh.2023.0022] +
        +
      • Gindis, G., Yaish, I., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (May 2023). Sublingual estradiol only, offers no apparent advantage over combined oral estradiol and cyproterone acetate, for Gender Affirming Hormone Therapy (GAHT) of treatment-naive transwomen: Results of a prospective pilot study. Endocrine Abstracts, 90 [25th European Congress of Endocrinology 2023, 13–16 May 2023, Istanbul, Turkey], 274–274 (abstract no. P182). [DOI:10.1530/endoabs.90.p182] [PDF]
        • +
      • Yaish, I., Gindis, G., Greenman, Y., Shefer, G., Buch, A., Arbiv, M., Moshe, Y., Sofer, Y., & Tordjman, K. M. (October 2023). Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1104–A1105 (abstract no. SAT409/bvad114.2080). [DOI:10.1210/jendso/bvad114.2080] [PDF]
        • +
      +
      • +
    • Kariyawasam, N. M., Ahmad, T., Sarma, S., & Fung, R. (2024). Comparison of Estrone/Estradiol Ratio and Levels in Transfeminine Individuals on Different Routes of Estradiol. Transgender Health, online ahead of print. [DOI:10.1089/trgh.2023.0138]
      • +
    +

    References

      @@ -2356,19 +2380,24 @@ Using the term desistence in this way does not imply anything about the identity
    • Cheung, A. S., Wynne, K., Erasmus, J., Murray, S., & Zajac, J. D. (2019). Position statement on the hormonal management of adult transgender and gender diverse individuals. Medical Journal of Australia, 211(3), 127–133. [DOI:10.5694/mja2.50259]
    • Cirrincione, L. R., Winston McPherson, G., Rongitsch, J., Sadilkova, K., Drees, J. C., Krasowski, M. D., Dickerson, J. A., & Greene, D. N. (2021). Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults. LGBT Health, 8(2), 125–132. [DOI:10.1089/lgbt.2020.0249]
    • Collaborative Group on Hormonal Factors in Breast Cancer. (2019). Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet, 394(10204), 1159–1168. [DOI:10.1016/S0140-6736(19)31709-X]
      • +
    • Cortez, S., Moog, D., Lewis, C., Williams, K., Herrick, C., Fields, M., Gray, T., Guo, Z., Nicol, G., & Baranski, T. (2023). Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols, 12, e53092. [DOI:10.2196/53092]
    • de Blok, C., Dijkman, B., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., Dreijerink, K., & den Heijer, M. (2021). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782–e790. [DOI:10.1210/clinem/dgaa841]
    • Deutsch, M. B., Bhakri, V., & Kubicek, K. (2015). Effects of cross-sex hormone treatment on transgender women and men. Obstetrics and Gynecology, 125(3), 605–610. [DOI:10.1097/AOG.0000000000000692]
    • Deutsch, M. B. (Ed.). (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People, 2nd Edition. San Francisco: University of California, San Francisco/UCSF Transgender Care. [URL] [PDF]
    • Devissaguet, J. P., Brion, N., Lhote, O., & Deloffre, P. (1999). Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. European Journal of Drug Metabolism and Pharmacokinetics, 24(3), 265–271. [DOI:10.1007/BF03190030]
    • Doll, E. E., Gunsolus, I., Lamberton, N., Tangpricha, V., & Sarvaideo, J. L. (2020). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Journal of the Endocrine Society, 4(Suppl 1), A1128–A1128 (SUN-LB9). [DOI:10.1210/jendso/bvaa046.2237]
      • +
    • Doll, E., Gunsolus, I., Thorgerson, A., Tangpricha, V., Lamberton, N., & Sarvaideo, J. L. (2022). Pharmacokinetics of Sublingual Versus Oral Estradiol in Transgender Women. Endocrine Practice, 28(3), 237–242. [DOI:10.1016/j.eprac.2021.11.081]
    • Fiet, J., Hermano, M., Witte, J., Villette, J. M., Haimart, M., Gourmel, B., Tabuteau, F., Rouffy, J., & Dreux, C. (1982). Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17β. Acta Endocrinologica, 101(1), 93–97. [DOI:10.1530/acta.0.1010093]
    • Gass, M. S., Rebar, R. W., Cuffie-Jackson, C., Cedars, M. I., Lobo, R. A., Shoupe, D., Judd, H. L., Buyalos, R. P., & Clisham, P. R. (2004). A short study in the treatment of hot flashes with buccal administration of 17-β estradiol. Maturitas, 49(2), 140–147. [DOI:10.1016/j.maturitas.2003.12.004]
    • Getahun, D., Nash, R., Flanders, W. D., Baird, T. C., Becerra-Culqui, T. A., Cromwell, L., Hunkeler, E., Lash, T. L., Millman, A., Quinn, V. P., Robinson, B., Roblin, D., Silverberg, M. J., Safer, J., Slovis, J., Tangpricha, V., & Goodman, M. (2018). Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Annals of Internal Medicine, 169(4), 205–213. [DOI:10.7326/M17-2785]
      • +
    • Gindis, G., Yaish, I., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (May 2023). Sublingual estradiol only, offers no apparent advantage over combined oral estradiol and cyproterone acetate, for Gender Affirming Hormone Therapy (GAHT) of treatment-naive transwomen: Results of a prospective pilot study. Endocrine Abstracts, 90 [25th European Congress of Endocrinology 2023, 13–16 May 2023, Istanbul, Turkey], 274–274 (abstract no. P182). [DOI:10.1530/endoabs.90.p182] [PDF]
    • Haupt, C., Henke, M., Kutschmar, A., Hauser, B., Baldinger, S., Saenz, S. R., & Schreiber, G. (2020). Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women. Cochrane Database of Systematic Reviews, 11(11), CD013138. [DOI:10.1002/14651858.CD013138.pub2]
    • Hoon, T. J., Dawood, M. Y., Khan‐Dawood, F. S., Ramos, J., & Batenhorst, R. L. (1993). Bioequivalence of a 17β‐Estradiol Hydroxypropyl‐β‐Cyclodextrin Complex in Postmenopausal Women. The Journal of Clinical Pharmacology, 33(11), 1116–1121. [DOI:10.1002/j.1552-4604.1993.tb01949.x]
    • Huggins, C., & Hodges, C. V. (1941). Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Research, 1(4), 293–297. [DOI:10.3322/canjclin.22.4.232]
    • Jain, J., Kwan, D., & Forcier, M. (2019). Medroxyprogesterone acetate in Gender-Affirming therapy for Transwomen: results from a retrospective study. The Journal of Clinical Endocrinology & Metabolism, 104(11), 5148–5156. [DOI:10.1210/jc.2018-02253]
      • +
    • Jalal, E., & Baldwin, C. (2023). Supratherapeutic Estrogen Levels in Transgender Women Likely From Sublingual Estradiol. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1095–A1096 (abstract no. SAT391/bvad114.2062). [DOI:10.1210/jendso/bvad114.2062] [PDF]
    • Jin, J., Sklar, G. E., Oh, V. M. S., & Li, S. C. (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and Clinical Risk Management, 4(1), 269–286. [DOI:10.2147/TCRM.S1458]
      • +
    • Kariyawasam, N. M., Ahmad, T., Sarma, S., & Fung, R. (2024). Comparison of Estrone/Estradiol Ratio and Levels in Transfeminine Individuals on Different Routes of Estradiol. Transgender Health, online ahead of print. [DOI:10.1089/trgh.2023.0138]
    • Klaver, M., de Blok, C. J. M., Wiepjes, C. M., Nota, N. M., Dekker, M. J., de Mutsert, R., Schreiner, T., Fisher, A. D., T’Sjoen, G., & den Heijer, M. (2018). Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. European Journal of Endocrinology, 178(2), 163–171. [DOI:10.1530/EJE-17-0496]
    • Kohli, M. (2006). Phase II study of transdermal estradiol in androgen‐independent prostate carcinoma. Cancer, 106(1), 234–235. [DOI:10.1002/cncr.21528]
    • Kuhl, H. (2005). Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric, 8(Suppl 1), 3–63. [DOI:10.1080/13697130500148875] [PDF]
      • @@ -2390,6 +2419,8 @@ Using the term desistence in this way does not imply anything about the identity
    • Price, T. M., Blauer, K. L., Hansen, M., Stanczyk, F., Lobo, R., & Bates, G. W. (1997). Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17β-estradiol. Obstetrics & Gynecology, 89(3), 340–345. [DOI:10.1016/S0029-7844(96)00513-3]
    • Rosenfield, R. L., Devine, N., Hunold, J. J., Mauras, N., Moshang Jr, T., & Root, A. W. (2005). Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome. The Journal of Clinical Endocrinology & Metabolism, 90(12), 6424–6430. [DOI:10.1210/jc.2005-1081]
    • Rovinski, D., Ramos, R. B., Fighera, T. M., Casanova, G. K., & Spritzer, P. M. (2018). Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis. Thrombosis Research, 168, 83–95. [DOI:10.1016/j.thromres.2018.06.014]
      • +
    • Safer, J. D. (2022). Are the Pharmacokinetics of Sublingual Estradiol Superior or Inferior to Those of Oral Estradiol? Endocrine Practice, 28(3), 351–352. [DOI:10.1016/j.eprac.2021.12.018]
      • +
    • Sarvaideo, J., Doll, E., & Tangpricha, V. (2022). More Studies Are Needed to Establish the Safety and Efficacy of Sublingual Estradiol in Transgender Women. Endocrine Practice, 28(3), 353–354. [DOI:10.1016/j.eprac.2022.01.004]
    • Sciarra, A., Gentile, V., Cattarino, S., Gentilucci, A., Alfarone, A., D’Eramo, G., & Salciccia, S. (2015). Oral ethinylestradiol in castration‐resistant prostate cancer: a 10‐year experience. International Journal of Urology, 22(1), 98–103. [DOI:10.1111/iju.12613]
    • Serhal, P., & Craft, I. (1989). Oocyte donation in 61 patients. The Lancet, 333(8648), 1185–1187. [DOI:10.1016/S0140-6736(89)92762-1]
    • Serhal, P. (1990). Oocyte donation and surrogacy. British Medical Bulletin, 46(3), 796–812. [DOI:10.1093/oxfordjournals.bmb.a072432]
      • @@ -2404,7 +2435,9 @@ Using the term desistence in this way does not imply anything about the identity
    • Wiegratz, I., Fink, T., Rohr, U. D., Lang, E., Leukel, P., & Kuhl, H. (2001). Überkreuz-Vergleich der Pharmakokinetik von Estradiol unter der Hormonsubstitution mit Estradiolvalerat oder mikronisiertem Estradiol. [Cross-over comparison of the pharmacokinetics of estradiol during hormone replacement therapy with estradiol valerate or micronized estradiol.] Zentralblatt für Gynäkologie, 123(9), 505–512. [PubMed] [DOI:10.1055/s-2001-18223]
    • Wisner, K. L., Sit, D. K., Moses-Kolko, E. L., Driscoll, K. E., Prairie, B. A., Stika, C. S., Eng, H. F., Dills, J. L., Luther, J. F., & Wisniewski, S. R. (2015). Transdermal estradiol treatment for postpartum depression: a pilot randomized trial. Journal of Clinical Psychopharmacology, 35(4), 389–395. [DOI:10.1097/JCP.0000000000000351]
    • Wren, B. G., Day, R. O., McLachlan, A. J., & Williams, K. M. (2003). Pharmacokinetics of estradiol, progesterone, testosterone and dehydroepiandrosterone after transbuccal administration to postmenopausal women. Climacteric, 6(2), 104–111. [DOI:10.1080/cmt.6.2.104.111]
      • -
    ]]>    {"first_name"=>"Sam", "last_name"=>"S.", "author-link"=>"/about/#sam", "articles-link"=>"/articles-by-author/sam/"}    Clinical Guidelines with Information on Transfeminine Hormone Therapy2020-11-20T10:00:00-08:002024-03-21T00:00:00-07:00https://transfemscience.org/articles/transfem-hormone-guidelinesClinical Guidelines with Information on Transfeminine Hormone Therapy +
  • Yaish, I., Gindis, G., Greenman, Y., Moshe, Y., Arbiv, M., Buch, A., Sofer, Y., Shefer, G., & Tordjman, K. (2023). Sublingual Estradiol Offers No Apparent Advantage Over Combined Oral Estradiol and Cyproterone Acetate for Gender-Affirming Hormone Therapy of Treatment-Naive Trans Women: Results of a Prospective Pilot Study. Transgender Health, 8(6), 485–493. [DOI:10.1089/trgh.2023.0022]
    • +
  • Yaish, I., Gindis, G., Greenman, Y., Shefer, G., Buch, A., Arbiv, M., Moshe, Y., Sofer, Y., & Tordjman, K. M. (2023). Sublingual Estradiol Only, Compared To Combined Oral Estradiol And Cyproterone Acetate,Offers No Apparent Advantage For Gender Affirming Hormone Therapy (GHAT), In Treatment Naïve Transwomen: Results Of A Prospective Pilot Study. Journal of the Endocrine Society, 7(Suppl 1) [ENDO 2023 Abstracts Annual Meeting of the Endocrine Society], A1104–A1105 (abstract no. SAT409/bvad114.2080). [DOI:10.1210/jendso/bvad114.2080] [PDF]
    • +]]>    {"first_name"=>"Sam", "last_name"=>"S.", "author-link"=>"/about/#sam", "articles-link"=>"/articles-by-author/sam/"}    Clinical Guidelines with Information on Transfeminine Hormone Therapy2020-11-20T10:00:00-08:002024-03-21T00:00:00-07:00https://transfemscience.org/articles/transfem-hormone-guidelinesClinical Guidelines with Information on Transfeminine Hormone Therapy @@ -2587,7 +2620,7 @@ Using the term desistence in this way does not imply anything about the identity Published article - Various [PDF] [PDF] [PDF] [PDF] [PDF] [PDF] + Various [PDF] [PDF] [PDF] [PDF] [PDF] [PDF] Various / National Health Service (NHS) Trusts Various Online documents @@ -2716,7 +2749,7 @@ Using the term desistence in this way does not imply anything about the identity - Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities in Asia and the Pacific [PDF] + Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities in Asia and the Pacific [PDF] Health Policy Project / Asia Pacific Transgender Network / United Nations Development Programme [Asia and the Pacific] 2015 Online document @@ -2728,7 +2761,7 @@ Using the term desistence in this way does not imply anything about the identity Online document - A Good Practice Guide to Gender-Affirmative Care + A Good Practice Guide to Gender-Affirmative Care Sappho for Equality [India] 2019 Online document @@ -2769,7 +2802,7 @@ Using the term desistence in this way does not imply anything about the identity
  • Fisher, A. D., Senofonte, G., Cocchetti, C., Guercio, G., Lingiardi, V., Meriggiola, M. C., Mosconi, M., Motta, G., Ristori, J., Speranza, A. M., Pierdominici, M., Maggi, M., Corona, G., & Lombardo, F. (2021). SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. Journal of Endocrinological Investigation, 45(3), 657–673. [DOI:10.1007/s40618-021-01694-2]
  • Godano, A., Maggi, M., Jannini, E., Meriggiola, M. C., Ghigo, E., Todarello, O., Lenzi, A., & Manieri, C. (2009). SIAMS-ONIG Consensus on Hormonal Treatment in Gender Identity Disorders. Journal of Endocrinological Investigation, 32(10), 857–864. [DOI:10.1007/BF03345758]
  • Gorton, N., Jaffe, J. M., Thompson, J., Menkin, D., Nesteby, A., Dunn, D., Baker, K. K., Harbatkin, D., Do, T., Radix, A., Meacher, P., Goldstein, Z., Carpenter, W., Caine, M., Henn, S., Murayama, R., Feldmann, J., & Zayas, S. (2019). TransLine Gender Affirming Hormone Therapy Prescriber Guidelines. San Francisco: Lyon-Martin Health Services/TransLine. [URL] [PDF]
    • -
  • Health Policy Project, Asia Pacific Transgender Network, United Nations Development Programme. (2015). Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities. Washington, DC: Futures Group, Health Policy Project. [PDF]
    • +
  • Health Policy Project, Asia Pacific Transgender Network, United Nations Development Programme. (2015). Blueprint for the Provision of Comprehensive Care for Trans People and Trans Communities. Washington, DC: Futures Group, Health Policy Project. [URL] [PDF]
  • Hembree, W. C., Cohen-Kettenis, P., Delemarre-Van De Waal, H. A., Gooren, L. J., Meyer III, W. J., Spack, N. P., Tangpricha, V., & Montori, V. M. (2009). Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 94(9), 3132–3154. [DOI:10.1210/jc.2009-0345]
  • Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism, 102(11), 3869–3903. [DOI:10.1210/jc.2017-01658] [PDF]
  • International Planned Parenthood Federation (IPPF). (2015). IMAP Statement on Hormone Therapy for Transgender People. International Medical Advisory Panel/International Planned Parenthood Federation. [URL] [PDF]
    • @@ -2779,13 +2812,13 @@ Using the term desistence in this way does not imply anything about the identity
  • Pan American Health Organization, John Snow, Inc., World Professional Association for Transgender Health, et al. (2014). Blueprint for the Provision of Comprehensive Care for Trans Persons and Their Communities in the Caribbean and Other Anglophone Countries. Arlington: John Snow, Inc. [Alt] [PDF]
  • Radix, A. (2019). Hormone Therapy for Transgender Adults. The Urologic Clinics of North America, 46(4), 467–473. [DOI:10.1016/j.ucl.2019.07.001]
  • Radix, A. (2019). Primary Care of Transgender Adults. In Poretsky, L., & Hembree, W. C. (Eds.). Transgender Medicine: A Multidisciplinary Approach (Contemporary Endocrinology) (pp. 51–67). Cham: Humana Press. [DOI:10.1007/978-3-030-05683-4_4]
    • -
  • Sappho for Equality. (2019). A Good Practice Guide to Gender-Affirmative Care. Kolkata: Sappho for Equality. [PDF]
    • -
  • Seal, L. J. (2016). Information About Hormonal Treatment for Trans Women. London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
    • +
  • Sappho for Equality. (2019). A Good Practice Guide to Gender-Affirmative Care. Kolkata: Sappho for Equality. [PDF]
    • +
  • Seal, L. J. (2016). Information About Hormonal Treatment for Trans Women. London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
  • Seal, L., & Barrett, J. (2017). Shared Care Prescribing Guidance for Treatment of Gender Dysphoria in Transwomen (Male to Female Transsexuals). London: West London Mental Health NHS Trust/West London NHS Trust. [PDF]
  • Sullivan, C., & Dean, J. (2015). Prescribing Guideline. Pharmacological Treatment of Gender Dysphoria. Devon: Devon Partnership NHS Trust. [PDF]
  • Tangpricha, V., & Safer, J. D. (2020). Transgender Women: Evaluation and Management. UpToDate. [URL] [PDF]
  • Telfer, M. M., Tollit, M. A., Pace, C. C., & Pang, K. C. (2020). Australian Standards of Care and Treatment Guidelines for Trans and Gender Diverse Children and Adolescents Version 1.2. Melbourne: The Royal Children’s Hospital. [PDF]
    • -
  • Thomas, C. (2015). Guidelines for the Use of Feminising Hormone Therapy. Information for Primary Care. Sunderland: City Hospitals Sunderland NHS Trust. [PDF]
    • +
  • Thomas, C. (2015). Guidelines for the Use of Feminising Hormone Therapy. Information for Primary Care. Sunderland: City Hospitals Sunderland NHS Trust. [PDF]
  • Thompson, J., Hopwood, R. A., deNormand, S., & Cavanaugh, T. (2021). Medical Care of Trans and Gender Diverse Adults. Boston: Fenway Health. [URL] [PDF]
  • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]
  • Trans Care BC. (2021). Gender-affirming Care for Trans, Two-Spirit, and Gender Diverse Patients in BC: A Primary Care Toolkit. Vancouver: Provincial Health Services Authority/Trans Care BC. [URL] [PDF]
    • @@ -3730,7 +3763,7 @@ Using the term desistence in this way does not imply anything about the identity
  • Patel, K. T., Adeel, S., Rodrigues Miragaya, J., & Tangpricha, V. (2022). Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocrine Practice, 28(12), 1244–1252. [DOI:10.1016/j.eprac.2022.08.012]
  • Peck-Radosavljevic, M. (2007). Review article: coagulation disorders in chronic liver disease. Alimentary Pharmacology & Therapeutics, 26, 21–28. [DOI:10.1111/j.1365-2036.2007.03509.x]
  • Pfeifer, S., Butts, S., Dumesic, D., Fossum, G., Gracia, C., La Barbera, A., Mersereau, J., Odem, R., Penzias, A., Pisarska, M., Rebar, R., Reindollar, R., Rosen, M., Sandlow, J., Sokol, R., Vernon, M., & Widra, E. (2017). Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertility and Sterility, 107(1), 43–51. [DOI:10.1016/j.fertnstert.2016.09.027]
    • -
  • Phillips, I., Shah, S. I., Duong, T., Abel, P., & Langley, R. E. (2014). Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer. Oncology & Hematology Review, 10(1), 42–47. [PubMed Central] [DOI:10.17925/ohr.2014.10.1.42] [URL]
    • +
  • Phillips, I., Shah, S. I., Duong, T., Abel, P., & Langley, R. E. (2014). Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer. Oncology & Hematology Review, 10(1), 42–47. [PubMed Central] [DOI:10.17925/ohr.2014.10.1.42]
  • Plu-Bureau, G., Maitrot-Mantelet, L., Hugon-Rodin, J., & Canonico, M. (2013). Hormonal contraceptives and venous thromboembolism: An epidemiological update. Best Practice & Research Clinical Endocrinology & Metabolism, 27(1), 25–34. [DOI:10.1016/j.beem.2012.11.002]
  • Pomp, E. R., Rosendaal, F. R., & Doggen, C. J. (2008). Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. American Journal of Hematology, 83(2), 97–102. [DOI:10.1002/ajh.21059]
  • Pond, S. M., & Tozer, T. N. (1984). First-Pass Elimination. Clinical Pharmacokinetics, 9(1), 1–25. [DOI:10.2165/00003088-198409010-00001]
    • @@ -4488,13 +4521,13 @@ Using the term desistence in this way does not imply anything about the identity
  • Quaynor, S. D., Stradtman, E. W., Kim, H., Shen, Y., Chorich, L. P., Schreihofer, D. A., & Layman, L. C. (2013). Delayed Puberty and Estrogen Resistance in a Woman with Estrogen Receptor α Variant. New England Journal of Medicine, 369(2), 164–171. [DOI:10.1056/nejmoa1303611]
  • Rinaldi, S., Geay, A., Déchaud, H., Biessy, C., Zeleniuch-Jacquotte, A., Akhmedkhanov, A., Shore, R. E., Riboli, E., Toniolo, P., & Kaaks, R. (2002). Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiology and Prevention Biomarkers, 11(10), 1065–1071. [Google Scholar] [PubMed] [URL]
  • Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999). A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of Clinical Endocrinology & Metabolism, 84(10), 3666–3672. [DOI:10.1210/jcem.84.10.6079]
    • -]]>    {"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}    Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy2020-07-01T18:39:00-07:002024-03-23T00:00:00-07:00https://transfemscience.org/articles/bica-adoptionBicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy +]]>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"}Bicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy2020-07-01T18:39:00-07:002024-04-02T00:00:00-07:00https://transfemscience.org/articles/bica-adoptionBicalutamide and its Adoption by the Medical Community for Use in Transfeminine Hormone Therapy

    By Aly | First published July 1, 2020 - | Last modified March 23, 2024

    + | Last modified April 2, 2024

    Abstract / TL;DR

    @@ -4506,7 +4539,7 @@ Using the term desistence in this way does not imply anything about the identity

    Before 2015, there were only a few mentions in the literature of bicalutamide for transfeminine people and a handful of anecdotal reports online of transfeminine people using it. The earliest clear mention of bicalutamide in the literature in the context of transfeminine hormone therapy was by Louis Gooren in 2011 (Gooren, 2011). Gooren is a major longtime researcher in the field of transgender medicine and is one of the coauthors of the Endocrine Society’s transgender hormone therapy guidelines (Hembree et al., 2009; Hembree et al., 2017). He and his colleagues at the Center of Expertise on Gender Dysphoria of the Vrije Universiteit Medical Center (VUMC) in Amsterdam, Netherlands had conducted studies on nilutamide (Anandron, Nilandron) as an antiandrogen for transfeminine people in the late 1980s and early 1990s (de Voogt et al., 1987a; de Voogt et al., 1987b; Gooren et al., 1987; Johannes et al., 1987; Rao et al., 1988; Asscheman, Gooren, & Peereboom-Wynia, 1989; van Kemenade et al., 1989; Wiki). However, they seem to have abandoned it—probably due to its high incidence of lung toxicity and other off-target side effects. Nonetheless, Gooren began including nonsteroidal antiandrogens like flutamide and nilutamide in his publications as potential treatment options for transfeminine hormone therapy starting in the 1990s (Asscheman & Gooren, 1992; Gooren, 1999). Subsequently, flutamide was included in transgender health guidelines and other publications, though not necessarily favorably (e.g., Israel & Tarver, 1997; Levy, Crown, & Reid, 2003; Dahl et al., 2006a; Dahl et al., 2006b; Hembree et al., 2009; Moreno-Pérez et al., 2012). As a researcher interested in nonsteroidal antiandrogens for transfeminine people, bicalutamide—with its far better safety profile than flutamide and nilutamide—may have been appealing to Gooren. However, Gooren and his colleagues didn’t conduct clinical studies on bicalutamide for transfeminine people and never went beyond brief mention of it for such uses in their publications. Nor did any other academics.

    -

    Besides transfeminine people and men with prostate cancer, bicalutamide has been studied for use in the treatment of androgen-dependent conditions in other populations. For example, it has been used in the treatment of hirsutism (excessive facial/body hair growth) in cisgender women with and without polycystic ovary syndrome (PCOS) (Müderris, Bayram, & Güven, 1999; Müderris et al., 2002; Bahceci et al., 2004; Müderris & Öner, 2009; Moretti et al., 2016; Moretti et al., 2018; Wiki). Bicalutamide has also been studied in combination with anastrozole (Arimidex), an aromatase inhibitor, for the treatment of gonadotropin-independent precocious puberty in cisgender boys (Kreher et al., 2006; Lewis et al., 2009; Mitre & Lteif, 2009; Stenger et al., 2009; Lenz et al., 2010; Reiter et al., 2010; Tessaris et al., 2012; Özcabı et al., 2015; Kor, 2018; Arya & Davies, 2019; Nabhan & Eugster, 2019; Finkle et al., 2020; Gurnurkar, DiLillo, & Carakushansky, 2021; Wiki). This is a rare form of precocious puberty in which gonadotropin-releasing hormone modulators are not effective. A phase 2 clinical trial was completed and a New Drug Application (NDA) was submitted in the United States for treatment of the condition with bicalutamide and anastrozole, but the application was not approved due to inadequate evidence of effectiveness on the primary efficacy endpoint of limiting height (AstraZeneca, 2008). However, bicalutamide is still used off-label for this indication, and information on bicalutamide for this use is provided in the the Casodex Food and Drug Administration (FDA) label (FDA, 2017).

    +

    Besides transfeminine people and men with prostate cancer, bicalutamide has been studied for use in the treatment of androgen-dependent conditions in other populations. For example, it has been used in the treatment of hirsutism (excessive facial/body hair growth) in cisgender women with and without polycystic ovary syndrome (PCOS) (Müderris, Bayram, & Güven, 1999; Müderris et al., 2002; Bahceci et al., 2004; Müderris & Öner, 2009; Moretti et al., 2016; Moretti et al., 2018; Wiki). Bicalutamide has also been studied in combination with anastrozole (Arimidex), an aromatase inhibitor, for the treatment of gonadotropin-independent precocious puberty in cisgender boys (Kreher et al., 2006; Lewis et al., 2009; Mitre & Lteif, 2009; Stenger et al., 2009; Lenz et al., 2010; Reiter et al., 2010; Tessaris et al., 2012; Özcabı et al., 2015; Kor, 2018; Arya & Davies, 2019; Nabhan & Eugster, 2019; Finkle et al., 2020; Gurnurkar, DiLillo, & Carakushansky, 2021; Wiki). This is a rare form of precocious puberty in which gonadotropin-releasing hormone modulators are not effective. A phase 2 clinical trial was completed and a New Drug Application (NDA) was submitted in the United States for treatment of the condition with bicalutamide and anastrozole, but the application was not approved due to inadequate evidence of effectiveness on the primary efficacy endpoint of limiting height (AstraZeneca, 2008). However, bicalutamide is still used off-label for this indication, and information on bicalutamide for this use is provided in the the Casodex Food and Drug Administration (FDA) label (FDA, 2017).

    Although there was little discussion or use of bicalutamide in transfeminine people prior to 2015, this started to change in mid-2015. At that time, the Wikipedia content for bicalutamide was greatly expanded, which made information about bicalutamide more accessible. In addition, certain transfeminine people, noting its advantages over existing options and its excellent potential for use in transfeminine hormone therapy, began advocating for use of bicalutamide in transfeminine people in online circles. A number of open-minded clinicians started adopting bicalutamide in transfeminine people around this time and thereafter as well. The first clinical study of bicalutamide in transfeminine people, which began in 2013, was published as an abstract in 2017 and as a full paper in 2019 (Neyman, Fuqua, & Eugster, 2017; Neyman, Fuqua, & Eugster, 2019). It was a small retrospective chart review of bicalutamide alone as a second-line puberty blocker in adolescent transgender girls for whom gonadotropin-releasing hormone analogues were denied by insurance. As of present, it remains the only published clinical data on bicalutamide in transfeminine people. It’s not exactly great data by any means, but it’s a study at least. The researchers who conducted the study had previously published on bicalutamide as a puberty blocker in boys with gonadotropin-independent precocious puberty (e.g., Lenz et al., 2010; Haddad & Eugster, 2012). While limited in its findings, Neyman, Fuqua, and Eugster (2019) helped to generate significant interest among clinicians and researchers in bicalutamide for use in transfeminine hormone therapy.

    @@ -4516,7 +4549,7 @@ Using the term desistence in this way does not imply anything about the identity

    The transgender medical community has been reluctant to endorse the use of bicalutamide in transfeminine people to date. This is because of the lack of clinical studies and characterization of bicalutamide in transfeminine people, most importantly in terms of safety. There have been concerns about rare instances of liver failure that have occurred with bicalutamide in men with prostate cancer (Wiki). The reported cases of liver toxicity with bicalutamide have generally been sudden-onset and severe. Rare liver toxicity is an acceptable risk in men with prostate cancer because the risk–benefit ratio of bicalutamide therapy is very favorable, with the benefit of treating prostate cancer vastly outweighing the harm of the very rare instances of liver problems. But transfeminine people are typically young and healthy, and bicalutamide isn’t treating a terminal illness when it’s used in us. If a transfeminine person develops liver failure and dies because of bicalutamide, that’s unnecessary harm and a life needlessly lost. Accordingly, the University of California San Francisco (UCSF) transgender care guidelines warn against use of bicalutamide in transfeminine people currently due to potential liver risks (Deutsch, 2016). Aside from risks, there is also a lack of data to guide appropriate dosing of bicalutamide in transfeminine people at this time. A typical bicalutamide dosage of 50 mg/day is being used and recommended, but this has been arbitrarily chosen with little basis to support it.

    -

    To date, there are 10 published case reports of serious liver toxicity in association with bicalutamide (Table). All of these cases were in men with prostate cancer and all occurred within 6 months of initiation of bicalutamide therapy, with two of the cases resulting in death. While this is not a lot of cases and may seem reassuring, it must be noted that quantity of published case reports tends to vastly underestimate the true incidence of rare adverse reactions. As an example, there are around 50 published case reports of meningioma with cyproterone acetate (Table), but a recent large study by the French government found that there were more than 500 operated instances of meningioma in association with high-dose cyproterone acetate over an 8-year period in France alone (Aly, 2020). Accordingly, as of writing there are 40 reports of liver failure, including 25 consequent deaths, in association with bicalutamide in the U.S. FDA’s international MedWatch/FAERS database. (As well as 240 cases of interstitial lung disease associated with bicalutamide notably—relative to only 14 published case reports; Table.) Even with this database however, fewer than 10% of serious adverse reactions are estimated to be reported (Graham, Ahmad, & Piazza-Hepp, 2002). Hence, the true numbers may be much greater. These instances are merely co-occurrences, and causality in terms of bicalutamide and liver toxicity has not been established. But they are concerning nonetheless. There is additionally an unpublished case anecdote of death in a young transfeminine person associated with bicalutamide that’s been making its rounds through the transgender medical community. Per certain very credible people in the field of transgender medicine (e.g., Asa Radix and Zil Goldstein), she is said to have been a 20-year-old transgender girl in Texas taking bicalutamide with rapid-onset liver failure and no warning signs. This case has given clinicians and researchers who are aware of it reservations about the use of bicalutamide in hormone therapy for transfeminine people. Another case of liver failure and death in a transgender person over 60 years of age who was treated with bicalutamide has also been informally reported (QueerDoc).

    +

    To date, there are 10 published case reports of serious liver toxicity in association with bicalutamide (Table). All of these cases were in men with prostate cancer and all occurred within 6 months of initiation of bicalutamide therapy, with two of the cases resulting in death. While this is not a lot of cases and may seem reassuring, it must be noted that quantity of published case reports tends to vastly underestimate the true incidence of rare adverse reactions. As an example, there are around 50 published case reports of meningioma with cyproterone acetate (Table), but a recent large study by the French government found that there were more than 500 operated instances of meningioma in association with high-dose cyproterone acetate over an 8-year period in France alone (Aly, 2020). Accordingly, as of writing there are 40 reports of liver failure, including 25 consequent deaths, in association with bicalutamide in the U.S. FDA’s international MedWatch/FAERS database. (As well as 240 cases of interstitial lung disease associated with bicalutamide notably—relative to only 14 published case reports; Table.) Even with this database however, fewer than 10% of serious adverse reactions are estimated to be reported (Graham, Ahmad, & Piazza-Hepp, 2002). Hence, the true numbers may be much greater. These instances are merely co-occurrences, and causality in terms of bicalutamide and liver toxicity has not been established. But they are concerning nonetheless. There is additionally an unpublished case anecdote of death in a young transfeminine person associated with bicalutamide that’s been making its rounds through the transgender medical community. Per certain very credible people in the field of transgender medicine (e.g., Asa Radix and Zil Goldstein), she is said to have been a 20-year-old transgender girl in Texas taking bicalutamide with rapid-onset liver failure and no warning signs. This case has given clinicians and researchers who are aware of it reservations about the use of bicalutamide in hormone therapy for transfeminine people. Another case of liver failure and death in a transgender person over 60 years of age who was treated with bicalutamide has also been informally reported (QueerDoc).

    In any case, the reported cases of serious liver toxicity with bicalutamide in transgender people have not been published nor properly confirmed. In addition, the absolute incidence of liver toxicity with bicalutamide is likely to be very low. For instance, the incidence of abnormal liver function tests (i.e., elevated liver enzymes on blood work) was only 3.4% with high-dose (150 mg/day) bicalutamide monotherapy relative to 1.9% for placebo (a 1.5% difference attributable to bicalutamide) at 3.0 years of follow-up in the Early Prostate Cancer (EPC) clinical programme, a series of three phase 3 randomized controlled trials consisting of over 8,000 patients in which bicalutamide was evaluated for treatment of early prostate cancer (Anderson, 2003; Iversen et al., 2004; Wiki; Wiki). Moreover, there were no cases of serious liver toxicity or liver failure with bicalutamide in the initial clinical development programme of bicalutamide for advanced prostate cancer, in which almost 4,000 men were treated with bicalutamide (Blackledge, 1996; Kolvenbag & Blackledge, 1996; McLeod, 1997; Anderson, 2003; Iversen et al., 2004; Wiki). However, it should be noted that this was with careful monitoring of liver function in patients and with prompt discontinuation of bicalutamide upon detection of clinically concerning hepatic abnormalities. About 0.5 to 1.5% of men taking 50 to 150 mg/day bicalutamide in the major clinical programmes of bicalutamide for prostate cancer developed liver changes sufficiently marked that they required discontinuation (Blackledge, 1996; See et al., 2002; Wiki). Hence, regular liver monitoring is essential with bicalutamide to ensure that the possibility of severe liver toxicity is avoided.

    @@ -4574,7 +4607,7 @@ Using the term desistence in this way does not imply anything about the identity

    Update 4: Jamie Reed 2023 Bicalutamide Liver Toxicity Case

    -

    In February 2023, Jamie Reed, a former case manager at the The Washington University Transgender Center at St. Louis Children’s Hospital in St. Louis, Missouri, published the op-ed “I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle.” in a conservative online news outlet called The Free Press. In this article, Reed expressed that she had become disillusioned with the medical care of transgender youth and layed out her grievances. In addition however, she briefly described an additional case of liver toxicity with bicalutamide in a transfeminine person that had allegedly occurred at her center. This individual was said to be 15 years of age and was given bicalutamide as a puberty blocker by Dr. Christopher Lewis, one of the co-founders of the center. She was said to have subsequently developed liver toxicity and was taken off of bicalutamide. In an electronic message to the center, her mother said that they were “lucky her family was not the type to sue”. This instance, and Reed’s op-ed in general, were subsequently widely reported on in conservative news media, for instance on Fox News and in the Daily Mail (Google). In addition to her op-ed, Reed provided a sworn affidavit to the office of Republican Missouri attorney general Andrew Bailey, who proceeded to launch an investigation of the clinic (Missouri Government, 2023a). The following further information was released in the affidavit:

    +

    In February 2023, Jamie Reed, a former case manager at the The Washington University Transgender Center at St. Louis Children’s Hospital in St. Louis, Missouri, published the op-ed “I Thought I Was Saving Trans Kids. Now I’m Blowing the Whistle.” in a conservative online news outlet called The Free Press. In this article, Reed expressed that she had become disillusioned with the medical care of transgender youth and layed out her grievances. In addition however, she briefly described an additional case of liver toxicity with bicalutamide in a transfeminine person that had allegedly occurred at her center. This individual was said to be 15 years of age and was given bicalutamide as a puberty blocker by Dr. Christopher Lewis, one of the co-founders of the center. She was said to have subsequently developed liver toxicity and was taken off of bicalutamide. In an electronic message to the center, her mother said that they were “lucky her family was not the type to sue”. This instance, and Reed’s op-ed in general, were subsequently widely reported on in conservative news media, for instance on Fox News and in the Daily Mail (Google). In addition to her op-ed, Reed provided a sworn affidavit to the office of Republican Missouri attorney general Andrew Bailey, who proceeded to launch an investigation of the clinic (Missouri Government, 2023a). The following further information was released in the affidavit:

    One doctor at the Center, Dr. Chris Lewis, is giving patients a drug called Bicalutamide. The drug has a legitimate use for treating pancreatic cancer [sic], but it has a side effect of causing breasts to grow, and it can poison the liver. There are no clinical studies for using this drug for gender transitions, and there are no established standards of care for using this drug.

    @@ -4592,13 +4625,13 @@ Using the term desistence in this way does not imply anything about the identity

    Subsequent Burgener et al. (2023, 2024) Findings

    -

    Following the preceding case, Dr. Lewis and colleagues went on to publish a conference abstract and preprint of a study of bicalutamide in transfeminine youth and young adults in which they stated that it does not increase liver enzymes in this population (Burgener et al., 2023; Burgener et al., 2024). However, a closer look at their data show that bicalutamide did statistically significantly elevate certain liver parameters relative to other antiandrogens, namely rates of elevated aspartate aminotransferase (AST) (upper limit of normal 10.7% vs. 1.5%, P = 0.02) (Burgener et al., 2024). Likewise, rates of elevated alanine aminotransferase (ALT) appeared to trend in the direction of being increased, though this was not statistically significant (upper limit of normal 16.7% vs. 11.6%, P = 0.37) (Burgener et al., 2024). In any case, rates of clinically significant elevations in liver enzymes with bicalutamide, defined as greater than three times the upper limit of normal, were not significantly increased in the study.

    +

    Following the preceding case, Lewis and colleagues went on to publish a conference abstract and preprint of a study of bicalutamide in transfeminine youth and young adults in which they stated that it does not increase liver enzymes in this population (Burgener et al., 2023; Burgener et al., 2024). However, a closer look at their data show that bicalutamide did statistically significantly elevate certain liver parameters relative to other antiandrogens, namely rates of elevated aspartate aminotransferase (AST) (upper limit of normal 10.7% vs. 1.5%, P = 0.02) (Burgener et al., 2024). Likewise, rates of elevated alanine aminotransferase (ALT) appeared to trend in the direction of being increased, though this was not statistically significant (upper limit of normal 16.7% vs. 11.6%, P = 0.37) (Burgener et al., 2024). In any case, rates of clinically significant elevations in liver enzymes with bicalutamide, defined as greater than three times the upper limit of normal, were not significantly increased in the study.

    -

    On the basis of the relevant research in men with prostate cancer (Wiki), Dr. Lewis and colleagues’ study, with a bicalutamide-group sample size of only 84 transfeminine individuals, was clearly greatly underpowered for evaluating liver function changes. Per the Early Prostate Cancer trial of high-dose bicalutamide monotherapy in men with prostate cancer, elevated liver enzymes appear to occur with bicalutamide at a rate of only about 1.5% more than placebo, or roughly an additional 1 in every 66 people (Wiki). Based on power analysis, this would require a far larger sample size to have adequate statistical power and actually have a chance of achieving statistical significance.

    +

    On the basis of the relevant research in men with prostate cancer (Wiki), Lewis and colleagues’ study, with a bicalutamide-group sample size of only 84 transfeminine individuals, was clearly greatly underpowered for evaluating liver function changes. Per the Early Prostate Cancer trial of high-dose bicalutamide monotherapy in men with prostate cancer, elevated liver enzymes appear to occur with bicalutamide at a rate of only about 1.5% more than placebo, or roughly an additional 1 in every 66 people (Wiki). Based on power analysis, this would require a far larger sample size to have adequate statistical power and actually have a chance of achieving statistical significance.

    As such, it seems to the present author premature to conclude that bicalutamide does not elevate liver enzymes in transfeminine people.

    -

    Dr. Lewis and colleagues didn’t mention in their study paper the transfeminine adolescent liver toxicity case reported by Jamie Reed that was said to have occurred at their clinic nor have they published a case report about this instance. Instead, only the following is stated:

    +

    Lewis and colleagues didn’t mention in their study paper the transfeminine adolescent liver toxicity case reported by Jamie Reed that was said to have occurred at their clinic nor have they published a case report about this instance. Instead, only the following is stated:

    One case report published in 2024 described a transgender female adolescent prescribed bicalutamide 50 mg daily who presented to a hospital with liver toxicity that resolved after stopping bicalutamide (Wilde et al., 2024). This appears to be the first documented case of bicalutamide-induced hepatoxicity in a transgender female.

    @@ -4606,13 +4639,13 @@ Using the term desistence in this way does not imply anything about the identity

    While this case was, coincidentally, also a 17-year-old transfeminine adolescent (Wilde et al., 2024), this instance, per the medical histories and reporting authors/institutions, appears to be distinct from Dr. Lewis’s that was reported by Jamie Reed.

    -

    However, Dr. Lewis and colleagues did note the following in their paper, which plausibly might have been the Jamie Reed case:

    +

    However, Lewis and colleagues did note the following in their paper, which plausibly might have been the Jamie Reed case:

    There was one individual in whom bicalutamide was stopped after the follow-up period designated for the study. This individual developed ALT and AST >2x ULN after an episode of COVID and had a thorough hepatology evaluation. As ALT and AST were never > 3x ULN, it was not recommended that bicalutamide be stopped; however, ultimately a clinical decision was made to stop the medication and ALT and AST normalized.

    -

    Another concern with Dr. Lewis and colleagues’ paper pertains to the following statements:

    +

    Another concern with Lewis and colleagues’ paper pertains to the following statements:

    Whereas bicalutamide doses for prostate cancer reach 150 mg daily, doses used in the care of AMAB transfeminine individuals are much lower (25-50 mg daily).

    @@ -4622,33 +4655,21 @@ Using the term desistence in this way does not imply anything about the identity

    Bicalutamide doses used in prostate cancer are up to 150 mg daily. Due to these concerns of liver toxicity, bicalutamide has not been routinely used as an anti-androgen in AMAB transfeminine individuals, despite the much lower doses needed in this population (∼25-50 mg daily).

    -

    In actuality, bicalutamide is most widely used in prostate cancer, in the form of combined androgen blockade with surgical or medical castration, at a dosage of 50 mg/day, whereas the 150 mg/day dosage is used less commonly, in the form of monotherapy (Wiki). Among the published case reports of hepatotoxicity with bicalutamide in men with prostate cancer, half have been at a dose of 50 mg/day and the other half have been at a dose of 80 to 150 mg/day (Wiki). The two instances of death due to hepatotoxicity with bicalutamide were both at 50 mg/day. There is currently no evidence that the hepatotoxicity of bicalutamide is dose-dependent across its clinically used dosage range (Wiki), although employment of the lowest effective dose in transfeminine people nonetheless seems prudent just in case. Hence, in contrast to Dr. Lewis and colleague’s claims, a bicalutamide dosage of 50 mg/day is not less than that used in prostate cancer, and clearly retains substantial hepatotoxic potential.

    +

    In actuality, bicalutamide is most widely used in prostate cancer, in the form of combined androgen blockade with surgical or medical castration, at a dosage of 50 mg/day, whereas the 150 mg/day dosage is used less commonly, in the form of monotherapy (Wiki). Moreover, only the 50 mg/day dosage is used in the United States, where monotherapy is not approved. Among the published case reports of hepatotoxicity with bicalutamide in men with prostate cancer, half have been at a dose of 50 mg/day and the other half have been at a dose of 80 to 150 mg/day (Wiki). The two instances of death due to hepatotoxicity with bicalutamide were both at 50 mg/day. There is currently no evidence that the hepatotoxicity of bicalutamide is dose-dependent across its clinically used dosage range (Wiki), although employment of the lowest effective dose in transfeminine people nonetheless seems prudent just in case. Hence, in contrast to Lewis and colleague’s claims, a bicalutamide dosage of 50 mg/day is not less than that generally used in prostate cancer, and clearly retains substantial hepatotoxic potential.

    -

    Update 5: New 2022, 2023, and 2024 Bicalutamide Publications

    - -

    2022

    +

    Update 5: New Bicalutamide Publications in 2022 Through 2024

    • Angus, L., Nolan, B., Zajac, J., & Cheung, A. (November 2022). Use of bicalutamide as an androgen receptor antagonist in transgender women. ESA/SRB/APEG/NZSE ASM 2022, November 13-16, Christchurch, Abstracts and Programme, 127–127 (abstract no. 280). [URL] [PDF] [Full Abstract Book]
      • -
    - -

    2023

    - -
    • Angus, L. M., Nolan, B. J., Zajac, J. D., & Cheung, A. S. (November 2023). Bicalutamide as an anti-androgen in trans people: a cross-sectional study. AusPATH 2023 Symposium. [URL] [PDF] [Slides] [Trans Health Research Blog Post]
    • Bambilla, A., Beal, C., & Vigil, P. (2023). Improving Access to Bicalutamide in Gender Affirming Medical Care. [Unpubished/pending publication] [QueerCME Blog Post]
    • Burgener, K., DeBosch, B., Lewis, C., Wallendorf, M., & Herrick, C. (May 2023). Assessment of Liver Function and Toxicity in Transgender Female Adolescents Prescribed Bicalutamide. Hormone Research in Paediatrics, 96(Suppl 3 [Abstracts of the 2023 Pediatric Endocrine Society (PES) Annual Meeting’ to Hormone Research in Paediatrics]), 377–378 (abstract no. 6232). [DOI:10.1159/000531602] [PDF]
    • Gómez-Aguilar, F., Martínez-Sánchez, L., Arias-Constantí, V., Muñoz-Santanach, D., & Sarquella-Brugada, G. (2023). QT prolongation and Torsade de Pointes in a 13-year-old transgender adolescent in treatment with bicalutamide and tacrolimus. Clinical Toxicology, 61(Suppl 1 [43rd International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), 23–26 May 2023, Palma de Mallorca, Spain]), 81–82 (abstract no. 170). [DOI:10.1080/15563650.2023.2192024] [PDF] [Reactions Weekly]
    • Karakılıç Özturan, E., Öztürk, A. P., Baş, F., Erdoğdu, A. B., Kaptan, S., Kardelen Al, A. D., Poyrazoğlu, Ş., Yıldız, M., Direk, N., Yüksel, Ş., & Darendeliler, F. (2023). Endocrinological Approach to Adolescents with Gender Dysphoria: Experience of a Pediatric Endocrinology Department in a Tertiary Center in Turkey. Journal of Clinical Research in Pediatric Endocrinology, 15(3), 276–284. [DOI:10.4274/jcrpe.galenos.2023.2023-1-13]
    • Vierregger, K., Tetzlaff, M., Zimmerman, B., Dunn, N., Finney, N., Lewis, K., Slomoff, R., & Strutner, S. (May 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. National Transgender Health Summit (NTHS) 2023 Symposium. [Event Agenda PDF] [Symposium Session] [Symposium Abstracts/Program Book]
      • -
    • Vierregger, K. S. (November 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH 2023 Symposium. [Symposium Schedule]
      • -
    • Warus, J. (November 2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH 2023 Symposium. [Symposium Schedule]
      • +
    • Vierregger, K. S. (November 2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 96–96 (abstract no. SAT-B2-T4). [Symposium Schedule] [PDF] [Full Abstract Book]
      • +
    • Warus, J. (November 2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 124–124 (abstract no. SUN-B1-T5). [Symposium Schedule] [PDF] [Full Abstract Book]
    • Wilde, B., Diamond, J. B., Laborda, T. J., Frank, L., O’Gorman, M. A., & Kocolas, I. (2023). Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent. Journal of Adolescent Health, 74(1), 202–204. [DOI:10.1016/j.jadohealth.2023.08.024]
      • -
    - -

    2024

    - -
    • Burgener, K., DeBosch, B., Wang, J., Lewis, C., & Herrick, C. J. (2024). Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study. medRxiv, preprint. [DOI:10.1101/2024.02.21.24302999v1] [PDF]
    • Fuqua, J. S., Shi, E., & Eugster, E. A. (2024). A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience. International Journal of Transgender Health, advance online publication. [DOI:10.1080/26895269.2023.2294321]
    • Shumer, D., & Roberts, S. A. (2024). Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents. Journal of Adolescent Health, 74(1), 5–6. [DOI:10.1016/j.jadohealth.2023.10.010]
      • @@ -4675,7 +4696,7 @@ Using the term desistence in this way does not imply anything about the identity
    • Asscheman, H., & Gooren, L. J. (1992). Hormone Treatment in Transsexuals. In Bocking, W. O., Coleman, E. (Eds). Gender Dysphoria: Interdisciplinary Approaches in Clinical Management (pp. 39–54). Binghamton: Haworth Press. / Journal of Psychology & Human Sexuality, 5(4), 39–54. [Google Scholar] [Google Books] [DOI:10.1300/J056v05n04_03]
    • AstraZeneca. (2008). Clinical Review. NDA. 22-310/S-001. Casodex (bicalutamide) for Testotoxicosis. Food and Drug Administration/AstraZeneca Pharmaceuticals. [URL] [PDF]
    • Bahceci, M., Tuzcu, A., Canoruc, N., Tuzun, Y., Kidir, V., & Aslan, C. (2004). Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance. Hormone Research in Paediatrics, 62(6), 283–287. [DOI:10.1159/000081973]
      • -
    • Bailey, A. (2023 February 9). Missouri Attorney General Andrew Bailey Confirms Launch of Multi-Agency Investigation into St. Louis Transgender Center for Harming Hundreds of Children. Attorney General Andrew Bailey, Missouri Government. [URL] [Affadavit of Jamie Reed]
      • +
    • Bailey, A. (2023 February 9). Missouri Attorney General Andrew Bailey Confirms Launch of Multi-Agency Investigation into St. Louis Transgender Center for Harming Hundreds of Children. Attorney General Andrew Bailey, Missouri Government. [URL] [Affadavit of Jamie Reed]
    • Bailey, A. (2023 April 13). Missouri Attorney General Andrew Bailey Promulgates Emergency Regulation Targeting Gender Transition Procedures for Minors. Attorney General Andrew Bailey, Missouri Government. [URL] [Emergency Regulation PDF]
    • Ballentine, S., & Hollingsworth, H. (2023 April 13). Missouri to limit gender-affirming care for minors, adults. Associated Press. [URL]
    • Bambilla, A., Beal, C., & Vigil, P. (2023). Improving Access to Bicalutamide in Gender Affirming Medical Care. [Unpubished/pending publication] [QueerCME Blog Post]
      • @@ -4724,7 +4745,7 @@ Using the term desistence in this way does not imply anything about the identity
    • Mitchell, F. (2020). Guy T’Sjoen: collaborating to improve transgender wellbeing. The Lancet Diabetes & Endocrinology, 8(7), 568–568. [DOI:10.1016/S2213-8587(20)30192-3]
    • Mitre, N., & Lteif, A. (2009). Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. Journal of Pediatric Endocrinology and Metabolism, 22(12), 1163–1168. [DOI:10.1515/JPEM.2009.22.12.1163]
    • Moreno-Pérez, Ó., De Antonio, I. E., & Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN. (2012). Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN). Endocrinología y Nutrición (English Edition), 59(6), 367–382. [DOI:10.1016/j.endoen.2012.07.004]
      • -
    • Moretti, C. G., Guccione, L., Di Giacinto, P., Cannuccia, A., Meleca, C., Lanzolla, G., Andreadi, A., & Lauro, D. (2016). Efficacy and Safety of Myo-Inositol Supplementation in the Treatment of Obese Hirsute PCOS Women: Comparative Evaluation with OCP+Bicalutamide Therapy. Endocrine Reviews, 37(2 Suppl 1) (SUN-153). [URL] [DOI:10.1093/edrv/37.supp.1]
      • +
    • Moretti, C. G., Guccione, L., Di Giacinto, P., Cannuccia, A., Meleca, C., Lanzolla, G., Andreadi, A., & Lauro, D. (2016). Efficacy and Safety of Myo-Inositol Supplementation in the Treatment of Obese Hirsute PCOS Women: Comparative Evaluation with OCP+Bicalutamide Therapy. Endocrine Reviews, 37(2 Suppl 1), ?–? (abstract no. SUN-153). [URL] [DOI:10.1093/edrv/37.supp.1]
    • Moretti, C., Guccione, L., Di Giacinto, P., Simonelli, I., Exacoustos, C., Toscano, V., Motta, C., De Leo, V., Petraglia, F., & Lenzi, A. (2018). Combined oral contraception and bicalutamide in polycystic ovary syndrome and severe hirsutism: a double-blind randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism, 103(3), 824–838. [DOI:10.1210/jc.2017-01186]
    • Moussa, A., Kazmi, A., Bokhari, L., & Sinclair, R. D. (2022). Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients. Journal of the American Academy of Dermatology, 87(2), 488–490. [DOI:10.1016/j.jaad.2021.10.048]
    • Muderris, I. I., Bayram, F., & Guven, M. (1999). Bicalutamide 25 mg/day in the treatment of hirsutism. Human Reproduction, 14(Suppl 3), 366–366 (R-196). [DOI:10.1093/humrep/14.Suppl_3.366-a]
      • @@ -4749,7 +4770,7 @@ Using the term desistence in this way does not imply anything about the identity
    • Tomson, A., McLachlan, C., Wattrus, C., Adams, K., Addinall, R., Bothma, R., Jankelowitz, L., Kotze, E., Luvuno, Z., Madlala, N., Matyila, S., Padavatan, A., Pillay, M., Rakumakoe, M. D., Tomson-Myburgh, M., Venter, W., & de Vries, E. (2021). Southern African HIV Clinicians’ Society gender-affirming healthcare guideline for South Africa. Southern African Journal of HIV Medicine, 22(1), a1299. [DOI:10.4102/sajhivmed.v22i1.1299] [PDF]
    • van Kemenade, J. F., Cohen-Kettenis, P. T., Cohen, L., & Gooren, L. J. (1989). Effects of the pure antiandrogen RU 23.903 (anandron) on sexuality, aggression, and mood in male-to-female transsexuals. Archives of Sexual Behavior, 18(3), 217–228. [DOI:10.1007/BF01543196]
    • Vierregger, K., Tetzlaff, M., Zimmerman, B., Dunn, N., Finney, N., Lewis, K., Slomoff, R., & Strutner, S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. National Transgender Health Summit (NTHS) 2023 Symposium. [Event Agenda PDF] [Symposium Session] [Symposium Abstracts/Program Book]
      • -
    • Vierregger, K. S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH 2023 Symposium. [Symposium Schedule]
      • -
    • Warus, J. (2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH 2023 Symposium. [Symposium Schedule]
      • +
    • Vierregger, K. S. (2023). Bicalutamide Use as Antiandrogen in Trans Feminine Adults - A Safety Profile. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 96–96 (abstract no. SAT-B2-T4). [Symposium Schedule] [PDF] [Full Abstract Book]
      • +
    • Warus, J. (2023). Safety of Bicalutamide as Anti-Androgenic Therapy in Gender Affirming Care for Adolescents and Young Adults: A Retrospective Chart Review. USPATH Scientific Symposium, November 1-5, 2023, The Westin Westminster, Westminster, Colorado, Abstract Submissions, 124–124 (abstract no. SUN-B1-T5). [Symposium Schedule] [PDF] [Full Abstract Book]
    • Wilde, B., Diamond, J. B., Laborda, T. J., Frank, L., O’Gorman, M. A., & Kocolas, I. (2023). Bicalutamide-Induced Hepatotoxicity in a Transgender Male-to-Female Adolescent. Journal of Adolescent Health, 74(1), 202–204. [DOI:10.1016/j.jadohealth.2023.08.024]
      • -
    ]]>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"} \ No newline at end of file +]]>{"first_name"=>"Aly", "last_name"=>"W.", "author-link"=>"/about/#aly", "articles-link"=>"/articles-by-author/aly/"} \ No newline at end of file diff --git a/transfemscience.org/index.html b/transfemscience.org/index.html index 783b9dcf..be31623e 100644 --- a/transfemscience.org/index.html +++ b/transfemscience.org/index.html @@ -1 +1 @@ -Home - Transfeminine Science Link

    Home

    Transfeminine Science is a resource for original informational content on the subject of transfeminine hormone therapy. This form of hormone therapy is also known variously as feminizing hormone therapy (FHT), gender-affirming hormone therapy (GAHT) for transfeminine people, and—more in the past—male-to-female (MtF) hormone replacement therapy (HRT). It involves the use of female sex hormones including estrogens and progestogens—as well as androgen-opposing medications known as antiandrogens—to produce feminization, demasculinization, and alleviation of gender dysphoria in transgender women and non-binary transfeminine individuals.

    Transfeminine Science contains articles by different writers on the subject of transfeminine hormone therapy. Our authors and their information are listed in the Authors section of the About page. Transfeminine Science is written by transgender people, for transgender people—and for their medical providers. A categorized listing of articles on the site can be found on the Articles page. In addition, a listing of articles by date with the most recent articles first can be found on the Latest page. The Misc page contains miscellaneous content like useful tools, notable publications, and links. The articles on this site are wiki-esque living documents and hence may be updated, expanded, and improved over time.

    \ No newline at end of file +Home - Transfeminine Science Link

    Home

    Transfeminine Science is a resource for original informational content on the subject of transfeminine hormone therapy. This form of hormone therapy is also known variously as feminizing hormone therapy (FHT), gender-affirming hormone therapy (GAHT) for transfeminine people, and, more in the past, male-to-female (MtF) hormone replacement therapy (HRT). It involves the use of female sex hormones including estrogens and progestogens, as well as androgen-opposing medications known as antiandrogens, to produce feminization, demasculinization, alleviation of gender dysphoria, and other changes in transgender women and non-binary transfeminine individuals.

    Transfeminine Science was created by Aly and contains articles by different writers on transfeminine hormone therapy. Our authors and other information are listed on our About page. The content on this site is written by transgender people, for transgender people, as well as for medical providers and academics in transgender health. A categorized listing of articles on Transfeminine Science can be found on the Articles page, while a listing of articles by date can be found on the Latest page. The Misc page contains other content like useful tools, notable publications, and links. The articles on this site are wiki-esque living documents, and hence may be updated, expanded, and improved over time.

    \ No newline at end of file diff --git a/transfemscience.org/misc/hormone-conc-unit-conv/index.html b/transfemscience.org/misc/hormone-conc-unit-conv/index.html index 64b897d0..71246fe2 100644 --- a/transfemscience.org/misc/hormone-conc-unit-conv/index.html +++ b/transfemscience.org/misc/hormone-conc-unit-conv/index.html @@ -1 +1 @@ -Hormone Concentration Unit Conversion - Transfeminine Science Link

    Hormone Concentration Unit Conversion

    Mode:   
    Hormone: 
    Concentration: 
     = 
    Converted: 
    \ No newline at end of file +Hormone Concentration Unit Conversion - Transfeminine Science Link

    Hormone Concentration Unit Conversion

    Mode:   
    Hormone: 
    Concentration: 
     = 
    Converted: 
    \ No newline at end of file diff --git a/transfemscience.org/misc/index.html b/transfemscience.org/misc/index.html index bd5eba68..518f1982 100644 --- a/transfemscience.org/misc/index.html +++ b/transfemscience.org/misc/index.html @@ -1 +1 @@ -Miscellaneous - Transfeminine Science Link

    Miscellaneous

    Tools

    Hormone Medication Simulation

    Injectable Dose, Volume, and Concentration Conversion

    Hormone Concentration Unit Conversion

    Free Hormone Calculation

    Dose Conversion by Route

    Publications

    Clinical Guidelines

    Selected Literature Reviews

    Academic Journals

    Large Cohort Studies

    Symposia Materials

    Literature

    Literature Access

    Wikipedia

    Communities

    Reddit

    Facebook

    Discord

    Other Sites

    DIY Hormone Therapy

    Transfeminine Science Translations

    \ No newline at end of file +Miscellaneous - Transfeminine Science Link

    Miscellaneous

    Tools

    Hormone Medication Simulation

    Injectable Dose, Volume, and Concentration Conversion

    Hormone Concentration Unit Conversion

    Free Hormone Calculation

    Dose Conversion by Route

    Publications

    Clinical Guidelines

    Selected Literature Reviews

    Academic Journals

    Large Cohort Studies

    Symposia Materials

    Literature

    Literature Access

    Wikipedia

    Communities

    Reddit

    Facebook

    Discord

    Other Sites

    DIY Hormone Therapy

    Transfeminine Science Translations

    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-dose-vol-conc-conv/index.html b/transfemscience.org/misc/injectable-dose-vol-conc-conv/index.html index 323beda9..2be027c7 100644 --- a/transfemscience.org/misc/injectable-dose-vol-conc-conv/index.html +++ b/transfemscience.org/misc/injectable-dose-vol-conc-conv/index.html @@ -1 +1 @@ -Dose, Volume, and Concentration Conversion for Injectables - Transfeminine Science Link

    Dose, Volume, and Concentration Conversion for Injectables

    Dose and Concentration to Volume

    Dose:  mg
    Concentration:  mg/mL
    Based on the dose and concentration provided, the volume is:
    Volume = Dose ÷ Concentration = ?

    Volume and Concentration to Dose

    Volume:  mL
    Concentration:  mg/mL
    Based on the volume and concentration provided, the dose is:
    Dose = Volume × Concentration = ?

    Notes

    The following should be remembered when discussing and using injectables:

    1. Volume is meaningless without concentration (in terms of understanding dose).
    2. What is being used should generally be stated in terms of dose rather than volume. This is because concentration is also required for volume to be meaningful (#1 above) and because dose is much more readily interpretable to other people.
    \ No newline at end of file +Dose, Volume, and Concentration Conversion for Injectables - Transfeminine Science Link

    Dose, Volume, and Concentration Conversion for Injectables

    Dose and Concentration to Volume

    Dose:  mg
    Concentration:  mg/mL
    Based on the dose and concentration provided, the volume is:
    Volume = Dose ÷ Concentration = ?

    Volume and Concentration to Dose

    Volume:  mL
    Concentration:  mg/mL
    Based on the volume and concentration provided, the dose is:
    Dose = Volume × Concentration = ?

    Notes

    The following should be remembered when discussing and using injectables:

    1. Volume is meaningless without concentration (in terms of understanding dose).
    2. What is being used should generally be stated in terms of dose rather than volume. This is because concentration is also required for volume to be meaningful (#1 above) and because dose is much more readily interpretable to other people.
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=000&d1=0.67&d2=1.33&d3=2.00&ra=333&i1=1&dl1=&i2=2&dl2=&i3=3&dl3=&s=0&h=0&xm=30.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=000&d1=0.67&d2=1.33&d3=2.00&ra=333&i1=1&dl1=&i2=2&dl2=&i3=3&dl3=&s=0&h=0&xm=30.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=000&d1=0.67&d2=1.33&d3=2.00&ra=333&i1=1&dl1=&i2=2&dl2=&i3=3&dl3=&s=0&h=0&xm=30.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=000&d1=0.67&d2=1.33&d3=2.00&ra=333&i1=1&dl1=&i2=2&dl2=&i3=3&dl3=&s=0&h=0&xm=30.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=111&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=111&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=111&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=111&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=222&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=222&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=222&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=222&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=333&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=333&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=333&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=333&d1=2&d2=3.5&d3=5&ra=333&i1=3&dl1=&i2=5&dl2=&i3=7&dl3=&s=0&h=0&xm=60.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=444&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=444&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=444&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=444&d1=5&d2=7&d3=10&ra=333&i1=7&dl1=&i2=10&dl2=&i3=14&dl3=&s=0&h=0&xm=70.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=555&d1=10&d2=20&d3=30&ra=333&i1=14&dl1=&i2=28&dl2=&i3=42&dl3=&s=0&h=0&xm=360.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=555&d1=10&d2=20&d3=30&ra=333&i1=14&dl1=&i2=28&dl2=&i3=42&dl3=&s=0&h=0&xm=360.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=555&d1=10&d2=20&d3=30&ra=333&i1=14&dl1=&i2=28&dl2=&i3=42&dl3=&s=0&h=0&xm=360.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=555&d1=10&d2=20&d3=30&ra=333&i1=14&dl1=&i2=28&dl2=&i3=42&dl3=&s=0&h=0&xm=360.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=666&d1=160&d2=240&d3=320&ra=333&i1=30&dl1=&i2=45&dl2=&i3=60&dl3=&s=0&h=0&xm=360.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=666&d1=160&d2=240&d3=320&ra=333&i1=30&dl1=&i2=45&dl2=&i3=60&dl3=&s=0&h=0&xm=360.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=666&d1=160&d2=240&d3=320&ra=333&i1=30&dl1=&i2=45&dl2=&i3=60&dl3=&s=0&h=0&xm=360.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=3&e=666&d1=160&d2=240&d3=320&ra=333&i1=30&dl1=&i2=45&dl2=&i3=60&dl3=&s=0&h=0&xm=360.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=5&e=22226&d1=5&d2=5&d3=7&d4=7&d5=200&ra=33330&i1=7&dl1=&i2=7&dl2=4&i3=5&dl3=&i4=5&dl4=&s=e&h=0&xm=56&cc=1.html b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=5&e=22226&d1=5&d2=5&d3=7&d4=7&d5=200&ra=33330&i1=7&dl1=&i2=7&dl2=4&i3=5&dl3=&i4=5&dl4=&s=e&h=0&xm=56&cc=1.html index 6d86dac9..1bc0584b 100644 --- a/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=5&e=22226&d1=5&d2=5&d3=7&d4=7&d5=200&ra=33330&i1=7&dl1=&i2=7&dl2=4&i3=5&dl3=&i4=5&dl4=&s=e&h=0&xm=56&cc=1.html +++ b/transfemscience.org/misc/injectable-e2-simulator-advanced/index.html?r=5&e=22226&d1=5&d2=5&d3=7&d4=7&d5=200&ra=33330&i1=7&dl1=&i2=7&dl2=4&i3=5&dl3=&i4=5&dl4=&s=e&h=0&xm=56&cc=1.html @@ -1 +1 @@ -Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator Advanced - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator/index.html b/transfemscience.org/misc/injectable-e2-simulator/index.html index 60215d08..8aa7aea0 100644 --- a/transfemscience.org/misc/injectable-e2-simulator/index.html +++ b/transfemscience.org/misc/injectable-e2-simulator/index.html @@ -1 +1 @@ -Injectable Estradiol Simulator - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/injectable-e2-simulator/index.html?e=all_e2&d=7&r=y&di=10&xm=60&lh=bp.html b/transfemscience.org/misc/injectable-e2-simulator/index.html?e=all_e2&d=7&r=y&di=10&xm=60&lh=bp.html index 60215d08..8aa7aea0 100644 --- a/transfemscience.org/misc/injectable-e2-simulator/index.html?e=all_e2&d=7&r=y&di=10&xm=60&lh=bp.html +++ b/transfemscience.org/misc/injectable-e2-simulator/index.html?e=all_e2&d=7&r=y&di=10&xm=60&lh=bp.html @@ -1 +1 @@ -Injectable Estradiol Simulator - Transfeminine Science Link
    \ No newline at end of file +Injectable Estradiol Simulator - Transfeminine Science Link
    \ No newline at end of file diff --git a/transfemscience.org/misc/wpath-symposia-materials/index.html b/transfemscience.org/misc/wpath-symposia-materials/index.html index eb6d956a..84b21ed5 100644 --- a/transfemscience.org/misc/wpath-symposia-materials/index.html +++ b/transfemscience.org/misc/wpath-symposia-materials/index.html @@ -1 +1 @@ -WPATH Symposia Materials - Transfeminine Science Link

    WPATH Symposia Materials

    This page is an index of World Professional Association for Transgender Health (WPATH) and related conferences (EPATH, USPATH, CPATH) as well as digital materials (e.g., programs and abstracts).

    WPATH Symposia

    No.YearLocationFiles
    1st (I)1969London, United Kingdom• Program
    • Opening Remarks (Dewhurst)
    • Audio Recording (Part 2, Part 3)
    2nd (II)1971Elsinnore, Denmark• Program
    3rd (III)1973Dubrovnik, Yugoslavia• Program
    4th (IV)1975Stanford, CA, United States• Brochure
    5th (V)1977Norfolk, VA, United States• Program
    6th (VI)1979San Diego, CA, United States 
    7th (VII)1981Lake Tahoe, NV, United States 
    8th (VIII)1983Bordeaux, France• Program
    • Abstracts
    9th (IX)1985Minneapolis, MN, United States• Program
    10th (X)1987Amsterdam, The Netherlands• Abstracts
    11th (XI)1989Cleveland, OH, United States• Brochure
    12th (XII)1991No meeting–
    13th (XIII)1993New York, NY, United States 
    14th (XIV)1995Kloster Irsee, Germany• Program & Abstracts
    15th (XV)1997Vancouver, BC, Canada 
    16th (XVI)1999London, United Kingdom• Program
    17th (XVII)2001Galveston, TX, United States• Program
    18th (XVIII)2003Ghent, Belgium• Program & Abstracts
    19th (XIX)2005Bologna, Italy• Program
    20th (XX)2007Chicago, IL, United States• Program
    • Abstracts
    • Selected Abstracts
    21st (XXI)2009Oslo, Norway• Program (Alt)
    • Abstracts
    22nd (XXII)2011Atlanta, GA, United States• Program
    • Abstracts
    23th (XXIII)2014Bangkok, Thailand• Program
    • Abstracts
    24th (XXIV)2016Amsterdam, The Netherlands• Program
    25th (XXV)2018Buenos Aires, Argentina• Schedule
    26th (XXVI)2020Virtual symposium• Web Page
    • Schedule
    • Schedule at a Glance
    • Surgeon’s Program
    • Abstracts
    27th (XXVII)2022Montreal, Canada• Web Page
    • Schedule
    • Schedule at a Glance
    28th (XXVIII)2024Lisbon, Portugal• Web Page

    Note: WPATH was renamed from the Harry Benjamin International Gender Dysphoria Association (HBIGDA) to the World Professional Association for Transgender Health (WPATH) in 2007.

    EPATH Symposia

    No.YearLocationFiles
    1st2015Ghent, Belgium• Web Page
    • Program Book
    • Program Book Alt
    • Abstracts
    2nd2017Belgrade, Serbia• Web Page
    • Program Book
    • Abstracts
    3rd2019Rome, Italy• Web Page
    • Program
    • Program Book
    • Abstracts
    4th2021Göthenburg, Sweden• Web Page
    • Program
    • Program Book
    5th2023Killarney, Ireland• Web Page
    • Program Page
    • Simple Program Overview
    • Detailed Program
    • Surgeon Program
    • Program Book
    • Abstract Book (DOCX)
    • Abstract book PDF
    • Conference Website

    USPATH Symposia

    No.YearLocationFiles
    1st2017Los Angeles, CA, United States• Web Page
    2nd2019Washington, DC, United States• Web Page
    • Schedule
    • Schedule at a Glance
    3rd2021Virtual symposium• Schedule
    • Schedule at a Glance
    4th2023Westminster, CO, United States• Schedule
    • Schedule at a Glance
    • Surgeon’s Program
    • WPATH GEI Pre-Course Schedule

    CPATH Symposia

    No.YearLocationFiles
    1st2008Toronto, ON, Canada• Web Page
    • Program
    • Abstracts
    2nd2010Montréal, QB, Canada• Web Page
    • Program
    • Speaker Bios
    3rd2012Winnipeg, MB, Canada• Web Page
    • Program & Abstracts
    • Speaker Bios
    4th2015Halifax, NS, Canada• Web Page
    • Program
    • Speaker Bios
    5th2017Vancouver, BC, Canada• Web Page
    • Program & Abstracts
    • Speaker Bios
    6th2019Montréal, QB, Canada• Web Page
    • Conference at a Glance

    Other Symposia

    WPATH Symposia

    Non-WPATH Symposia

    Sources

    \ No newline at end of file +WPATH Symposia Materials - Transfeminine Science Link

    WPATH Symposia Materials

    This page is an index of World Professional Association for Transgender Health (WPATH) and related conferences (EPATH, USPATH, CPATH) as well as digital materials (e.g., programs and abstracts).

    WPATH Symposia

    No.YearLocationFiles
    1st (I)1969London, United Kingdom• Program
    • Opening Remarks (Dewhurst)
    • Audio Recording (Part 2, Part 3)
    2nd (II)1971Elsinnore, Denmark• Program
    3rd (III)1973Dubrovnik, Yugoslavia• Program
    4th (IV)1975Stanford, CA, United States• Brochure
    5th (V)1977Norfolk, VA, United States• Program
    6th (VI)1979San Diego, CA, United States 
    7th (VII)1981Lake Tahoe, NV, United States 
    8th (VIII)1983Bordeaux, France• Program
    • Abstracts
    9th (IX)1985Minneapolis, MN, United States• Program
    10th (X)1987Amsterdam, The Netherlands• Abstracts
    11th (XI)1989Cleveland, OH, United States• Brochure
    12th (XII)1991No meeting–
    13th (XIII)1993New York, NY, United States 
    14th (XIV)1995Kloster Irsee, Germany• Program & Abstracts
    15th (XV)1997Vancouver, BC, Canada 
    16th (XVI)1999London, United Kingdom• Program
    17th (XVII)2001Galveston, TX, United States• Program
    18th (XVIII)2003Ghent, Belgium• Program & Abstracts
    19th (XIX)2005Bologna, Italy• Program
    20th (XX)2007Chicago, IL, United States• Program
    • Abstracts
    • Selected Abstracts
    21st (XXI)2009Oslo, Norway• Program (Alt)
    • Abstracts
    22nd (XXII)2011Atlanta, GA, United States• Program
    • Abstracts
    23th (XXIII)2014Bangkok, Thailand• Program
    • Abstracts
    24th (XXIV)2016Amsterdam, The Netherlands• Program
    25th (XXV)2018Buenos Aires, Argentina• Schedule
    26th (XXVI)2020Virtual symposium• Web Page
    • Schedule
    • Schedule at a Glance
    • Surgeon’s Program
    • Abstracts
    27th (XXVII)2022Montreal, Canada• Web Page
    • Schedule
    • Schedule at a Glance
    28th (XXVIII)2024Lisbon, Portugal• Web Page

    Note: WPATH was renamed from the Harry Benjamin International Gender Dysphoria Association (HBIGDA) to the World Professional Association for Transgender Health (WPATH) in 2007.

    EPATH Symposia

    No.YearLocationFiles
    1st2015Ghent, Belgium• Web Page
    • Program Book
    • Program Book Alt
    • Abstracts
    2nd2017Belgrade, Serbia• Web Page
    • Program Book
    • Abstracts
    3rd2019Rome, Italy• Web Page
    • Program
    • Program Book
    • Abstracts
    4th2021Göthenburg, Sweden• Web Page
    • Program
    • Program Book
    5th2023Killarney, Ireland• Web Page
    • Program Page
    • Simple Program Overview
    • Detailed Program
    • Surgeon Program
    • Program Book
    • Abstract Book (DOCX)
    • Abstract Book PDF
    • Conference Website

    USPATH Symposia

    No.YearLocationFiles
    1st2017Los Angeles, CA, United States• Web Page
    2nd2019Washington, DC, United States• Web Page
    • Schedule
    • Schedule at a Glance
    3rd2021Virtual symposium• Schedule
    • Schedule at a Glance
    4th2023Westminster, CO, United States• Schedule
    • Schedule at a Glance
    • Surgeon’s Program
    • WPATH GEI Pre-Course Schedule
    • Program Book
    • Abstract Book
    • Poster Abstract Book

    CPATH Symposia

    No.YearLocationFiles
    1st2008Toronto, ON, Canada• Web Page
    • Program
    • Abstracts
    2nd2010Montréal, QB, Canada• Web Page
    • Program
    • Speaker Bios
    3rd2012Winnipeg, MB, Canada• Web Page
    • Program & Abstracts
    • Speaker Bios
    4th2015Halifax, NS, Canada• Web Page
    • Program
    • Speaker Bios
    5th2017Vancouver, BC, Canada• Web Page
    • Program & Abstracts
    • Speaker Bios
    6th2019Montréal, QB, Canada• Web Page
    • Conference at a Glance

    Other Symposia

    WPATH Symposia

    Non-WPATH Symposia

    Sources

    \ No newline at end of file